<SEC-DOCUMENT>0001370368-20-000003.txt : 20200129
<SEC-HEADER>0001370368-20-000003.hdr.sgml : 20200129
<ACCEPTANCE-DATETIME>20200129085101
ACCESSION NUMBER:		0001370368-20-000003
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		291
CONFORMED PERIOD OF REPORT:	20191231
FILED AS OF DATE:		20200129
DATE AS OF CHANGE:		20200129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVARTIS AG
		CENTRAL INDEX KEY:			0001114448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15024
		FILM NUMBER:		20556518

	BUSINESS ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		CITY:			BASEL
		STATE:			V8
		ZIP:			CH 4056
		BUSINESS PHONE:		01141613241111

	MAIL ADDRESS:	
		STREET 1:		LICHTSTRASSE 35
		CITY:			BASEL
		STATE:			V8
		ZIP:			CH 4056
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>a20012920f.htm
<DESCRIPTION>20-F
<TEXT>

<html>
<head>
<title>20-F</title>
</head>
<body bgcolor="#ffffff">




<br>
<img src="x_coverfront.jpg">
<br>
<br>



<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



   <div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>As filed with the Securities and Exchange Commission on January 29, 2020</b></font>
  </div>
</div>
<div style="width:100%;padding-bottom:20px;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <div style="border:none;border-bottom:solid .25em;padding:0in 0in 1.0pt 0in"></div>
    <div style="border:none;border-bottom:solid .05em;padding:0in 0in 1.0pt 0in"></div>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-bottom:20px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:16pt; font-weight: bold; color:#000000;">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>Washington D.C. 20549</b></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%;padding-top:20px;padding-bottom:20px;">
    <HR noshade align="center" Width="120">
    <font style="font-family:arial,helvetica,sans-serif; font-size:16pt; font-weight: bold; color:#000000;">Form 20-F</font>
    <HR noshade align="center" Width="120">
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">OR</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font> ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2019</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">OR</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">OR</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font> SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> <b>Commission file number 1-15024</b></font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-bottom:5px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:16pt; font-weight: bold; color:#000000;">Novartis AG</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%; padding-bottom:15px;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(Exact name of Registrant as specified in its charter)</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-bottom:5px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:16pt; font-weight: bold; color:#000000;">NOVARTIS Inc.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%; padding-bottom:15px;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(Translation of Registrant&#x2019;s name into English)</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-bottom:5px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:16pt; font-weight: bold; color:#000000;">Switzerland</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%; padding-bottom:5px;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(Jurisdiction of incorporation or organization)</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>Lichtstrasse 35<br>4056 Basel, Switzerland</b></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(Address of principal executive offices)</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Shannon Thyme Klinger<br>Group General Counsel<br>Novartis AG<br>CH 4056 Basel<br>Switzerland<br>Tel.: +41-61-324-1111<br>Fax: +41-61-324-7826</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Securities registered pursuant to Section 12(b) of the Act:</font>
  </div>
</div>

<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <table width="100%" border="0">
      <tr>
        <td width="33%"><div align="center"><u><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Title of each class</font></u></div></td>
       <td width="33%"><div align="center"><u><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Trading Symbol(s)</font></u></div></td>
        <td width="33%"><div align="center"><u><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Name of each exchange on which registered</font></u></div></td>
      </tr>
      <tr>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">American Depositary Shares<br>
        each representing 1 share        </font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">NVS<br></font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">New York Stock Exchange</font></div></td>
      </tr>
      <tr>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Ordinary shares, nominal value CHF 0.50 per share*</font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">NOVN</font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">New York Stock Exchange*</font></div></td>
      </tr>
    </table>

  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%"></div>
</div>

<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Securities registered or to be registered pursuant to Section 12(g) of the Act:</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>None</b></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>None</b></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Indicate the number of outstanding shares of each of the issuer&#x2019;s classes of capital or common stock as of the close of the period covered by the annual report:</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>2,265,008,488 shares</b></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-top:10px;padding-bottom:10px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>&nbsp;&nbsp;&nbsp;</b><b>Yes</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font>&nbsp;&nbsp;&nbsp;<b>No</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-top:10px;padding-bottom:10px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>&nbsp;&nbsp;&nbsp;</b><b>Yes</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&nbsp;&nbsp;&nbsp;<b>No</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Note&mdash;Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-top:10px;padding-bottom:10px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>&nbsp;&nbsp;&nbsp;</b><b>Yes</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font>&nbsp;&nbsp;&nbsp;<b>No</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#xA7;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-top:10px;padding-bottom:10px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>&nbsp;&nbsp;&nbsp;</b><b>Yes</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font>&nbsp;&nbsp;&nbsp;<b>No</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See&nbsp;definition of &#x201C;large accelerated filer,&#x201D; &#x201C;accelerated filer,&#x201D; and &#x201C;emerging growth company&#x201D; in Rule 12b-2 of the Exchange Act.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">

    <table width="100%" border="0">
      <tr>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Large accelerated filer <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Accelerated filer </font><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Non-accelerated filer </font><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Emerging growth company </font><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div></td>
      </tr>
    </table>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#x2020; provided pursuant to Section 13(a) of the Exchange Act. <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">&#x2020; The term &#x201C;new or revised financial accounting standard&#x201D; refers to any update issued by the Financial&nbsp;Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">

    <table width="100%" border="0">
      <tr>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">U.S. GAAP <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">International Financial Reporting Standards as issued by the International Accounting Standards Board <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font></font></div></td>
        <td><div align="center"><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Other <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font></div></td>
      </tr>
    </table>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">If &#x201C;Other&#x201D; has been checked in response to the previous question indicate by check mark which financial&nbsp;statement item the registrant has elected to follow.</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-top:10px;padding-bottom:10px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>&nbsp;&nbsp;&nbsp;</b><b>Item 17</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&nbsp;&nbsp;&nbsp;<b>Item 18</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</font>
  </div>
</div>
<div style="width:100%;">
  <div style="padding-top:10px;padding-bottom:10px;TEXT-ALIGN: center; WIDTH: 99%;">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><b>&nbsp;&nbsp;&nbsp;</b><b>Yes</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">o</font>&nbsp;&nbsp;&nbsp;<b>No</b>&nbsp;&nbsp;&nbsp; <font style="DISPLAY: inline; FONT-FAMILY: wingdings">x</font></font>
  </div>
</div>
<div style="width:100%;">
  <div style="TEXT-ALIGN: left; WIDTH: 99%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">* Not for trading but only in connection with the registration of American Depositary Shares representing such ordinary shares.</font>
  </div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="width:100%;padding-top:30px;padding-bottom:20px;">
  <div style="TEXT-ALIGN: center; WIDTH: 99%">
    <div style="border:none;border-bottom:solid .05em;padding:0in 0in 1.0pt 0in"></div>
    <div style="border:none;border-bottom:solid .25em;padding:0in 0in 1.0pt 0in"></div>
  </div>
</div>





    <a name="anchorId00131894"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Table of contents</p>


    <br>
 <div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00231895">Introduction and use of certain terms</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00231914">Forward-looking statements</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;text-transform:uppercase;font-weight:bold;"><a style="text-decoration: none;" href="#anchorId00331926">Part I</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00331928">Item 1.  Identity of Directors, Senior&#xA0;Management and Advisers</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00331934">Item 2.  Offer Statistics and Expected Timetable</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00331940">Item 3.  Key Information</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00331942">3.A  Selected financial data</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00333706">3.B  Capitalization and indebtedness</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00333710">3.C  Reasons for the offer and use of proceeds</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00333716">3.D  Risk factors</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00334205">Item&nbsp;4.  Information on the Company</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00334208">4.A History and development of Novartis</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00334499">4.B Business overview</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 54px;"><a style="text-decoration: none;" href="#anchorId00334566">Innovative Medicines</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 54px;"><a style="text-decoration: none;" href="#anchorId00340635">Sandoz</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00341486">4.C  Organizational structure</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00341505">4.D  Property, plants and equipment</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00341902">Item&nbsp;4A.  Unresolved Staff Comments</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId0010031971">Item 5. Operating and Financial Review and&nbsp;Prospects</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId0010031974">5.A Operating results</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId0010057121">5.B Liquidity and capital resources</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId0010064145">5.C Research and development, patents and licenses</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId0010064164">5.D Trend information</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId0010064174">5.E Off-balance sheet arrangements</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId0010064181">5.F Tabular disclosure of contractual obligations</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00431895">Item 6.  Directors, Senior Management and Employees</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00431897">6.A Directors and senior management</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00932141">6.B Compensation</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001031915">6.C Board practices </a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00531909">6.D  Employees</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00532966">6.E  Share ownership</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00532987">Item&nbsp;7.  Major Shareholders and Related Party Transactions</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00532990">7.A Major shareholders</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533450">7.B Related party transactions</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533457">7.C Interests of experts and counsel</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00533463">Item&nbsp;8.  Financial Information</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533466">8.A Consolidated statements and other financial information</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533530">8.B Significant changes</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00533536">Item&nbsp;9.  The Offer and Listing</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533539">9.A Offer and listing details</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533551">9.B Plan of distribution</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533555">9.C Markets</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533561">9.D Selling shareholders</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533565">9.E Dilution</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533569">9.F Expenses of the issue</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00533575">Item&nbsp;10.  Additional Information</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533578">10.A Share capital</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533582">10.B Memorandum and articles of association</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533810">10.C Material contracts</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533828">10.D Exchange controls</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00533834">10.E Taxation</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534213">10.F Dividends and paying agents</a></div>
    <br />
    <br />


<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">2</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>

<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534217">10.G Statement by experts</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534221">10.H Documents on display</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534235">10.I Subsidiary information</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00534241">Item&nbsp;11.  Quantitative and Qualitative Disclosures About Market Risk</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00534260">Item&nbsp;12.  Description of Securities Other Than Equity Securities</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534263">12.A Debt securities</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534267">12.B Warrants and rights</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534271">12.C Other securities</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId00534275">12.D American Depositary Shares</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;text-transform:uppercase;font-weight:bold;"><a style="text-decoration: none;" href="#anchorId00534468">PART II</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00534470">Item&nbsp;13.  Defaults, Dividend Arrearages and Delinquencies</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00534477">Item&nbsp;14.  Material Modifications to the Rights of Security Holders and Use of Proceeds</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00631895">Item&nbsp;15.  Controls and Procedures</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00731897">Item&nbsp;16A.  Audit Committee Financial Expert</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00731912">Item&nbsp;16B.  Code of Ethics</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00731925">Item&nbsp;16C.  Principal Accountant Fees and Services</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00731935">Item&nbsp;16D.  Exemptions from the Listing Standards for Audit Committees</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00731942">Item&nbsp;16E.  Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00732607">Item&nbsp;16F.  Change in Registrant&#x2019;s Certifying Accountant</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00732614">Item&nbsp;16G.  Corporate Governance</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00732648">Item&nbsp;16H.  Mine Safety Disclosure</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;text-transform:uppercase;font-weight:bold;"><a style="text-decoration: none;" href="#anchorId00732655">PART III</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00732657">Item&nbsp;17.  Financial Statements</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId00732666">Item&nbsp;18.  Financial Statements</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001831896">Item&#xA0;19.  Exhibits</a></div>











<br>
<br>



<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">3</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



    <a name="anchorId00231895"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Introduction and use of certain terms</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG and its consolidated affiliates publish consolidated financial statements expressed in US dollars. Our consolidated financial statements responsive to Item 18 of this Annual Report on Form&nbsp;20-F (Annual Report) are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). &#x201C;Item 5. Operating and Financial Review and Prospects,&#x201D; together with the sections on products in development and key development projects of our businesses (see &#x201C;Item 4. Information on the Company&mdash;Item 4.B. Business overview&#x201D;), constitute the Operating and Financial Review (&#x201C;Lagebericht&#x201D;), as defined by the Swiss Code of Obligations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Unless the context requires otherwise, the words &#x201C;we,&#x201D; &#x201C;our,&#x201D; &#x201C;us,&#x201D; &#x201C;Novartis,&#x201D; &#x201C;Group,&#x201D; &#x201C;Company,&#x201D; and similar words or phrases in this Annual Report refer to Novartis AG and its consolidated affiliates. However, each Group company is legally separate from all other Group companies and manages its business independently through its respective board of directors or similar supervisory body or other top local management body, if applicable. Each executive identified in this Annual Report reports directly to other executives of the Group company that employs the executive, or to that Group company&#x2019;s board of directors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In this Annual Report, references to &#x201C;US dollars,&#x201D; &#x201C;USD&#x201D; or &#x201C;$&#x201D; are to the lawful currency of the United States of America, and references to &#x201C;CHF&#x201D; are to Swiss francs; references to the &#x201C;United States&#x201D; or to &#x201C;US&#x201D; are to the United States of America, references to the &#x201C;European Union&#x201D; or to &#x201C;EU&#x201D; are to the European Union and its 28 member states, references to &#x201C;Latin America&#x201D; are to Central and South America, including the Caribbean, and references to &#x201C;Australasia&#x201D; are to Australia, New Zealand, Melanesia, Micronesia and Polynesia, unless the context otherwise requires; references to the &#x201C;EC&#x201D; are to the European Commission; references to &#x201C;associates&#x201D; are to employees of our affiliates; references to the &#x201C;SEC&#x201D; are to the US Securities and Exchange Commission; references to the &#x201C;FDA&#x201D; are to the US Food and Drug Administration; references to the &#x201C;EMA&#x201D; are to the European Medicines Agency, an agency of the EU, and references to the &#x201C;CHMP&#x201D; are to the Committee for Medicinal Products for Human Use of the EMA; references to &#x201C;ADR&#x201D; or &#x201C;ADRs&#x201D; are to Novartis American Depositary Receipts, and references to &#x201C;ADS&#x201D; or &#x201C;ADSs&#x201D; are to Novartis American Depositary Shares; references to the &#x201C;NYSE&#x201D; are to the New York Stock Exchange, and references to &#x201C;SIX&#x201D; are to the SIX Swiss Exchange; references to &#x201C;ECN&#x201D; are to the Executive Committee of Novartis; references to &#x201C;GSK&#x201D; are to GlaxoSmithKline plc, references to &#x201C;AAA&#x201D; are to Advanced Accelerator Applications S.A., references to &#x201C;AveXis&#x201D; are to AveXis, Inc., references to &#x201C;Endocyte&#x201D; are to Endocyte, Inc., and references to &#x201C;Takeda&#x201D; are to Takeda Pharmaceutical Company Limited.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All product names appearing in italics are trademarks owned by or licensed to Group companies. Product names identified by a &#x201C;<sup>&#xAE;</sup>&#x201D; or a &#x201C;&#x2122;&#x201D; are trademarks that are not owned by or licensed to Group companies and are the property of their respective owners.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">4</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00231914"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Forward-looking statements</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">This Annual Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;), and the United States Private Securities Litigation Reform Act of 1995, as amended. Other written materials filed with or furnished to the SEC by Novartis, as well as other written and oral statements made to the public, may also contain forward-looking statements. Forward-looking statements can be identified by words such as &#x201C;potential,&#x201D; &#x201C;expected,&#x201D; &#x201C;will,&#x201D; &#x201C;planned,&#x201D; &#x201C;pipeline,&#x201D; &#x201C;outlook,&#x201D; &#x201C;may,&#x201D; &#x201C;could,&#x201D; &#x201C;would,&#x201D; &#x201C;anticipate,&#x201D; &#x201C;seek,&#x201D; or similar terms, or by express or implied discussions regarding potential new products, potential new indications for existing products, or regarding potential future revenues from any such products; or regarding the potential outcome, or financial or other impact on Novartis, of the acquisition of The Medicines Company, the proposed divestiture of certain portions of our Sandoz Division business in the US, and other transactions described; or regarding the potential impact of share buybacks; or regarding potential future sales or earnings of the Group or any of its divisions or potential shareholder returns; or regarding potential future credit ratings of the Group; or by discussions of strategy, plans, expectations or intentions. Such forward-looking statements are based on the current beliefs and expectations of management regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. You should not place undue reliance on these statements.</div>
<div style="padding-top:15px;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In particular, our expectations could be affected by, among other things:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global trends toward healthcare cost containment, including ongoing government, payer and general public pricing and reimbursement pressures and requirements for increased pricing transparency;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties regarding potential significant breaches of information security or disruptions of our information technology systems;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties regarding the success of key products and commercial priorities; </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Our ability to obtain or maintain proprietary intellectual property protection, including the ultimate extent of the impact on Novartis of the loss of patent protection and exclusivity on key products that commenced in prior years and is expected to continue this year;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties in the research and development of new healthcare products, including clinical trial results and additional analysis of existing clinical data;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Regulatory actions or delays or government regulation generally, including potential regulatory actions or delays with respect to the proposed transactions or the development of the products described in this Annual Report;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties regarding actual or potential legal proceedings, including, among others, litigation and other legal disputes with respect to the proposed transactions, product liability litigation, litigation and investigations regarding sales and marketing practices, intellectual property disputes and government investigations generally;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Our reliance on outsourcing key business functions to third parties;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Our ability to comply with data privacy laws and regulations, and uncertainties regarding potential significant breaches of data privacy;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Safety, quality, data integrity or manufacturing issues;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties in the development or adoption of potentially transformational technologies and business models;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The potential that the strategic benefits, synergies or opportunities expected from our recent and proposed future transactions may not be realized or may take longer to realize than expected;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties involved in predicting shareholder returns;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Our performance on environmental, social and governance measures;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">5</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Political, economic and trade conditions, including uncertainties regarding the effects of ongoing instability in various parts of the world;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties regarding the effects of recent and anticipated future changes in tax laws and their application to us;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties regarding future global exchange rates; and</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Uncertainties regarding future demand for our products.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Some of these factors are discussed in more detail in this Annual Report, including under &#x201C;Item 3. Key Information&mdash;Item 3.D. Risk factors,&#x201D; &#x201C;Item 4. Information on the Company,&#x201D; and &#x201C;Item 5. Operating and Financial Review and Prospects.&#x201D; Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this Annual Report as anticipated, believed, estimated or expected. We provide the information in this Annual Report as of the date of its filing. We do not intend, and do not assume any obligation, to update any information or forward-looking statements set out in this Annual Report as a result of new information, future events or otherwise.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">6</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


    <a name="anchorId00331926"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000;">Part I</p><a name="anchorId00331928"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item 1.  Identity of Directors, Senior&#xA0;Management and Advisers</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">7</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00331934"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item 2.  Offer Statistics and Expected Timetable</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">8</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00331940"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item 3.  Key Information</p><a name="anchorId00331942"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">3.A  Selected financial data</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The selected financial information set out below has been extracted from our consolidated financial statements prepared in accordance with IFRS as issued by the IASB. Our consolidated financial statements for the years ended December 31, 2019, 2018 and 2017, are included in &#x201C;Item 18. Financial Statements&#x201D; in this Form&#xA0;20-F.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All financial data should be read in conjunction with &#x201C;Item 5. Operating and Financial Review and Prospects.&#x201D; All financial data presented in this Form&#xA0;20-F are qualified in their entirety by reference to the consolidated financial statements and their notes.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Year ended December 31,</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">(USD millions, except per share information)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2016</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2015</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">INCOME STATEMENT DATA<sup>1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 41&nbsp;975</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;641</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;522</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 266</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;637</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;385</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;433</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;891</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;718</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;066</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;796</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;652</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net (loss) / income from discontinued operations before gain  on distribution of Alcon Inc. to Novartis shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   376</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income related to portfolio transformation transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;766</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;98</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;142</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;794</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;712</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;783</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.77</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.04</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.63</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Diluted earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.84</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.72</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.04</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.57</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.06</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash dividends<sup>2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;966</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;475</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;643</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash dividends per share in CHF<sup>3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.85</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Personnel cost from continuing operations<sup>4, 5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;843</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;515</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;009</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;950</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;336</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Full-time equivalent associates of continuing operations at year-end<sup>5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 103&nbsp;914</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104&nbsp;780</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102&nbsp;467</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99&nbsp;747</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99&nbsp;624</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Continuing operations include the businesses of the Innovative Medicines and Sandoz Divisions and Corporate activities. Discontinued operations include the Alcon business, which was divested in 2019; the Animal Health and Vaccines businesses divested in 2015; and the Consumer Health business, which was contributed also in 2015 into a new entity, GlaxoSmithKline Consumer Healthcare Holdings Ltd. (GSK Consumer Healthcare), where Novartis had a 36.5% interest. This newly created entity was sold during 2018 to GSK. To reflect these transactions, Novartis reported the Group&#x2019;s financial results for 2019 to 2015 as &#x201C;continuing operations&#x201D; and &#x201C;discontinued operations,&#x201D; as required by IFRS.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Cash dividends represent cash payments in the applicable year that generally relates to earnings of the previous year.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Cash dividends per share represent dividends proposed that relate to earnings of the current year. Dividends for 2015 through 2018 were approved at the respective AGMs, and dividends for 2019 will be proposed to the Annual General Meeting on February 28, 2020, for approval.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Personnel cost include wages, salaries, allowances, commissions and bonuses to staff, overtime, awards, holiday pay, severance payments and social welfare expenses.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Own employees.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">9</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Year ended December 31,</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2016</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2015</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">BALANCE SHEET DATA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash, cash equivalents, and marketable securities  and derivative financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   11&nbsp;446</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   15&nbsp;964</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   9&nbsp;485</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7&nbsp;777</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;447</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;982</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;956</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;867</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;226</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;235</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;856</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;899</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;172</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 88&nbsp;866</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 105&nbsp;193</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108&nbsp;711</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Assets of disposal group held for sale<sup>1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 807</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 133&nbsp;079</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 130&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 131&nbsp;556</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade accounts payable</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;873</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;668</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;809</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;040</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34&nbsp;555</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37&nbsp;264</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35&nbsp;449</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33&nbsp;024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 30&nbsp;726</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities of disposal group held for sale<sup>1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 51</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 62&nbsp;819</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 66&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 58&nbsp;852</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 55&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 54&nbsp;434</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Issued share capital and reserves attributable to shareholders  of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   55&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   78&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   74&nbsp;168</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   74&nbsp;832</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   77&nbsp;046</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;692</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;227</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;891</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 77&nbsp;122</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities and equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 133&nbsp;079</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 130&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 131&nbsp;556</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 78&nbsp;692</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74&nbsp;227</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74&nbsp;891</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77&nbsp;122</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Outstanding share capital</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 856</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 875</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 869</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 896</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total outstanding shares (millions)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;265</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;311</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;317</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;374</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;374</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The disposal group held for sale relate to the assets and liabilities of the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Pharma USA Inc., as announced on September 6, 2018 (see &#x201C;Item 18. Financial Statements&#x2014;Note 2. Significant pending transactions").</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup> </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>     </div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Cash dividends per share</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash dividends are translated into US dollars at the Bloomberg Market System Rate on the payment date. Because we pay dividends in Swiss francs, exchange rate fluctuations will affect the US dollar amounts received by holders of ADRs.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Year earned</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Month and <br> year paid</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total dividend <br> per share<br> (CHF)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total dividend <br> per share<br> (USD)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2015</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> March 2016</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.70</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.70</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2016</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> March 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.72</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> March 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.94</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> March 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.85</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.84</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2019<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> March 2020</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.04<sup style="white-space: nowrap"> 2</sup></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Dividend to be proposed at the Annual General Meeting on February 28, 2020, and to be distributed March 5, 2020.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Translated into US dollars at the December 31, 2019, rate of USD 1.032 to the Swiss franc. This translation is an example only, and should not be construed as a representation that the Swiss franc amount represents, or has been or could be converted into US dollars at that or any other rate.</div>
      </td>
    </tr>
  </table>
</div><a name="anchorId00333706"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">3.B  Capitalization and indebtedness</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00333710"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">3.C  Reasons for the offer and use of proceeds</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">10</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00333716"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">3.D  Risk factors</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our businesses face significant risks and uncertainties. You should carefully consider all of the information set forth in this Annual Report and in other documents we file with or furnish to the SEC, including the following risk factors, before deciding to invest in or to maintain an investment in any Novartis securities. Our business, as well as our financial condition or results of operations, could be materially adversely affected by any of these risks, as well as other risks and uncertainties not currently known to us or not currently considered material.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Pressures on pricing and reimbursement for our products affect our business and may impact our future financial results.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our businesses are operating in an ever more challenging environment, with significant pressures on the pricing of our products and on our ability to obtain and maintain satisfactory rates of reimbursement for our products by governments, insurers and other payers. The growth of overall healthcare costs as a percentage of gross domestic product in many countries means that governments and payers are under intense pressure to control healthcare spending even more tightly than in the past. These pressures are particularly strong given the increasing demand for healthcare resulting from the aging of the global population and associated increases in noncommunicable diseases, and the resulting impact on healthcare budgets. These pressures are further compounded by significant controversies and intense political debate and publicity about prices for pharmaceuticals that some consider excessive, including government regulatory efforts, funding restrictions, legislative proposals, policy interpretations, investigations and legal proceedings regarding pharmaceutical pricing practices. Global pressures on pricing may negatively impact, in parallel, both our product pricing and our market access.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition to ongoing public and political pressures to limit the prices we charge for our products, we face numerous cost-containment measures imposed by governments and other payers, including government-imposed industrywide price reductions, mandatory pricing systems, reference pricing systems, payers limiting access to treatments based on cost-benefit analyses, imports of drugs from lower-cost countries to higher-cost countries, shifting of the payment burden to patients through higher co-payments and co-pay accumulator programs, limiting physicians&#x2019; ability to choose among competing medicines, mandatory substitution of generic drugs for the patented equivalent, pressure on physicians to reduce the prescribing of patented prescription medicines, increasing pressure on intellectual property protections, and growing requirements for increased transparency on pricing. For more information on such price controls, see &#x201C;Item&nbsp;4. Information on the Company&mdash;Item&nbsp;4.B Business overview&mdash;Innovative Medicines&mdash;Price controls.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We expect these challenges to continue and to increase in 2020 and beyond, as political pressures mount and healthcare payers around the globe, including government-controlled health authorities, insurance companies and managed care organizations, step up initiatives to reduce the overall cost of healthcare, restrict access to higher-priced new medicines, increase the use of generics and impose overall price cuts. These factors may materially affect our ability to achieve an acceptable return on our investments in the research and development of our products, may impact our ability to invest in the research and development of new products, and could have a material adverse impact on our business, financial condition, or results of operations, as well as on our reputation.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Significant breaches of information security or disruptions of our information technology systems could adversely affect our business.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We are heavily dependent on critical, complex and interdependent information technology systems, including internet-based systems, some of which are managed by third-party service providers, to support our business processes. We routinely experience cybersecurity attacks and incidents on such networks and systems, and while to date none of these incidents have been material to us, like many companies, we expect to continue to experience similar cybersecurity threats and attacks in the future. Cybersecurity threats and attacks take many forms and the size, age and complexity of our information technology systems make them potentially vulnerable to external and internal security threats; outages; malicious intrusions and attacks; cybercrimes, including state-sponsored cybercrimes; malware; misplaced or lost data; programming or human errors; or other similar events. While we have devoted and continue to devote significant resources and management attention to cybersecurity, information management and business continuity efforts, we may not be able to prevent future outages, security incidents or other breaches in our systems from having a material adverse effect on our business, financial condition, results of operations, or reputation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A significant information security or other event, such as a disruption or loss of availability of one or more of our information technology systems, could negatively impact important business processes, such as the conduct of scientific research and clinical trials, the submission of data and information to health authorities, our manufacturing and supply chain processes, our shipments to customers, our compliance with legal obligations, and communication between employees and with third parties. Information technology issues could also lead to the compromise of trade secrets or other intellectual property that could be sold and used by competitors to accelerate the development or manufacturing of competing products; to the compromise of personal financial and health information; and to the compromise of information technology security data such as usernames, passwords and encryption keys, as well as security strategies and information about network infrastructure, which could allow unauthorized parties to gain access to additional systems or data. In addition, mal-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">11</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">functions in software or other medical devices that make significant use of information technology could lead to a risk of direct harm to patients.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For business reasons we have outsourced significant parts of our IT&nbsp;infrastructure to&nbsp;third-party&nbsp;providers, and we currently use these providers to perform business-critical IT services for us. We are therefore vulnerable to service interruptions by these providers and we may experience interruptions, delays or outages in IT service availability in the future due to a variety of factors outside of our control. Outages and capacity constraints could arise from a number of causes such as technical failures, natural disasters, fraud or security attacks. Interruptions in the service provided by these third parties could affect our ability to perform critical tasks.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, we face potential difficulties in integrating the IT systems of the businesses that we acquire, including replacing, integrating or working with separate IT systems used by such companies, and transferring relevant data from such separate systems and their third-party providers. See also &#x201C;&mdash;We may not successfully achieve our goals in transactions or reorganizations,&#x201D; below.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our dependence upon information technology, breaches of data security, technology disruptions, or other impacts from the use of interconnected technologies, could disrupt our business operations and result in enforcement actions or liability, including potential government fines and penalties, claims for damages, and shareholders&#x2019; litigation. Any significant events of this type could require us to expend significant resources beyond those we already invest to remediate any damage, to further modify or enhance our protective measures, and to enable the continuity of our business, and could have a material adverse effect on our business, financial condition, results of operations, and reputation.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Our financial performance depends on the commercial success of key products and commercial priorities.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our financial performance, including our ability to replace revenue and income lost to generic, biosimilar and other competition and to grow our business, depends heavily on the commercial success of our key products. If any of our major products were to become subject to problems such as changes in prescription growth rates, unexpected side effects, loss of intellectual property protection, data integrity issues, supply chain issues or other product shortages, regulatory proceedings, changes in labeling, publicity affecting doctor or patient confidence in the product, material product liability litigation, or pressure from new or existing competitive products, the adverse impact on our revenue and profit could be significant. In addition, our revenue and profit could be significantly impacted by the timing and rate of commercial acceptance of key new products. The commercial success of our key products and launches in the face of increasing competition and pressures on pricing requires significant attention and focus from members of our key management. See also &#x201C;&mdash;Pressures on pricing and reimbursement for our products affect our business and may impact our future financial results,&#x201D; above, with regard to the impact of pricing and reimbursement issues on the commercial success of our products.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All of our businesses face intense competition from new products and technological advances from competitors, and physicians, patients and third-party payers may choose our competitors&#x2019; products instead of ours if they perceive them to be safer, more effective, easier to administer, less expensive, more convenient or more cost-effective. We cannot predict with accuracy the timing of the introduction of products that compete with ours or the related effect on our sales. However, products significantly competitive to our major products &ndash; including <i>Cosentyx, Lucentis, Gilenya, Tasigna, Kisqali, Kymriah, Entresto </i>and<i> Beovu </i>&ndash; are on the market, and others are in development. In addition, numerous companies from around the world are seeking to enter the healthcare field to take advantage of their expertise in digital and other new technologies. See &#x201C;&mdash;We may fail to develop or take advantage of transformational technologies and business models,&#x201D; below. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Such competitive products could significantly affect the revenue from our products and our results of operations. This impact could also be compounded to the extent such competition results in us making significant additional investments in research and development, or in marketing and sales. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Our products face losses of intellectual property protection. </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Major products of our Innovative Medicines Division, as well as certain products of our Sandoz Division, are protected by patent and other intellectual property rights, which provide us with exclusive rights to market those products for a limited time and give us an opportunity to recoup our investments in research and development. However, the strength and duration of those intellectual property rights can vary significantly from product to product and country to country, and they may be successfully challenged by third parties or governmental authorities. The resulting loss of market exclusivity for one or more important products has had, and can be expected to continue to have, a material adverse effect on our results of operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The introduction of generic or biosimilar competition for a patented branded medicine typically results in a significant and rapid reduction in net sales and operating income for the branded product because generic or biosimilar manufacturers typically offer their versions at sharply lower prices. Such competition can occur after successful challenges to intellectual property rights or the regular expiration of the patent term or other intellectual property rights. Such competition can also result from the entry of generic or biosimilar versions of another medicine in the same therapeutic class as one of our drugs or in a competing therapeutic class, from a Declaration of Public Interest or the compulsory licensing of our drugs by governments, or from a general weakening of intellectual property and governing laws in certain countries around the world. In addition, generic or biosimilar manufacturers may sometimes conduct so-called &#x201C;launches at risk&#x201D; of products that are still under legal challenge for infringement, or whose patents are still under legal challenge for validity, before final resolution of legal proceedings.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">12</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We also rely in all aspects of our businesses on unpatented proprietary technology, know-how, trade secrets and other confidential information, which we seek to protect through various measures, including confidentiality agreements with licensees, employees, third-party collaborators, and consultants who may have access to such information. If these agreements are breached or our other protective measures should fail, then our contractual or other remedies may not be adequate to cover our losses.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Some of our best-selling products have begun or are about to face significant competition due to the end of market exclusivity resulting from the expiry of patent or other intellectual property protection, or from successful or otherwise resolved challenges to patent protection.&nbsp;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Our former top-selling product <i>Gleevec/Glivec</i> continues to face generic competition in major markets.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patent protection for <i>Exjade</i> in the US has expired. Generic versions of <i>Exjade</i> are available in the US.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the US, for <i>Afinitor</i>, we have resolved patent litigation. Generic versions of the three lower dosage strengths of <i>Afinitor</i> are available in the US; additional generic competition may start in mid-2020. We have resolved patent litigation relating to <i>Afinitor Disperz</i>. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patent protection for the marketed forms of our <i>Sandostatin</i> products has expired. Generic versions of <i>Sandostatin </i>SC are available in the US, the EU and Japan. While there is currently no generic competition in the US or Japan for <i>Sandostatin</i> <i>LAR</i>, the long-acting version of <i>Sandostatin</i> that represents the majority of our <i>Sandostatin</i> sales, such generic competition may arise in the future. Generic versions of <i>Sandostatin</i> <i>LAR</i> are available in some EU markets.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Intellectual property protection for a number of additional major products is either being challenged or will expire at various times in the coming years, raising the possibility of generic or biosimilar competition. Among these products that may begin to face generic or biosimilar competition in one or more major markets during the next three years are our remaining everolimus products or their remaining dosage strengths (<i>Afinitor/Votubia</i> and <i>Zortress/Certican</i>), <i>Jadenu</i>, <i>Lucentis </i>and potentially<i> Gilenya.</i> For more information on the patent and generic competition status of our Innovative Medicines Division&#x2019;s products, see &#x201C;Item&nbsp;4. Information on the Company&mdash;Item&nbsp;4.B Business overview&mdash;Innovative Medicines&mdash;Intellectual property.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2020, we expect a potentially significant impact on our net sales from products that have already lost intellectual property protection, as well as products that may lose protection during the year. Because we typically have substantially reduced marketing and research and development expenses related to products that are in their final years of exclusivity, the initial loss of intellectual property protection for a product during the year could also have an impact on our operating income for that year in an amount corresponding to a significant portion of the product&#x2019;s lost sales. The magnitude of the impact of generic or biosimilar competition on our income could depend on a number of factors, including the time of year at which the generic or biosimilar competitor is launched; the ease or difficulty of manufacturing a competitor product and obtaining regulatory approval to market it; the number of generic or biosimilar competitor products approved, including whether, in the US, a single competitor is granted an exclusive marketing period; whether an authorized generic is launched; the geographies in which generic or biosimilar competitor products are approved, including the strength of the market for generic or biosimilar pharmaceutical products in such geographies, and the comparative profitability of branded pharmaceutical products in such geographies; and our ability to successfully develop and launch profitable new products to replace the income lost to generic or biosimilar competition. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">With respect to major products for which the patents are expiring or are successfully challenged, the loss of exclusivity of these products could have a material adverse effect on our business, financial condition, or results of operations. In addition, should we unexpectedly lose exclusivity on additional products as a result of patent litigation or other reasons, this could also have a material adverse effect on our business, financial condition, or results of operations, both due to the loss of revenue and earnings, and the difficulties in planning for such losses.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Our research and development efforts may not succeed.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We engage in extensive and costly research and development activities, both through our own dedicated resources and through collaborations with third parties, in an effort to identify and develop new products that address unmet and changing medical needs, are accepted by patients and physicians, are reimbursed by payers, and are commercially successful. Our ability to grow our business; to replace sales lost due to branded competition, entry of generics, or other reasons; and to bring to market products and medical advances that take advantage of new and potentially disruptive technologies, depends in significant part upon the success of these efforts. However, developing new healthcare products and bringing them to market is a costly, lengthy and uncertain process. In spite of our significant investments, there can be no guarantee that our research and development activities will produce commercially successful new products that will enable us to replace revenue and income lost to generic and other competition and to grow our business.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Research and development of new products of our Innovative Medicines Division can take approximately 10 to 15&nbsp;years, from discovery to commercial product launch. Failure can occur at any point in the process, including in later stages after substantial investment. With limited available intellectual property protections, the longer it takes to develop a product, the less time there may be for us to recoup our research and development costs. New products must undergo intensive preclinical and clinical testing, and must be approved by means of highly complex, lengthy and expensive approval processes that can vary from country to country.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">13</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Further, to achieve approvals of new products and new indications, regulatory authorities continue to establish new and increasingly rigorous requirements in the already lengthy and expensive process of obtaining regulatory approvals and reimbursement for pharmaceutical products.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Similarly, the post-approval regulatory burden has also increased. Approved drugs are subject to various requirements such as risk evaluation and mitigation strategies (REMS), risk management plans, comparative effectiveness studies, health technology assessments, and requirements to conduct post-approval Phase&nbsp;IV clinical trials to gather additional safety and other data on products. These requirements have the effect of making the maintenance of regulatory approvals for our products increasingly expensive, and further heightening the risk of recalls, product withdrawals, loss of market share, and loss of revenue and profitability.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is also the risk that we may fail to identify significant new product candidates for development or potentially disruptive new technologies, and so may fail to take advantage of potential new innovations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Sandoz Division has made, and expects to continue to make, significant investments in the development of biotechnology-based, &#x201C;biologic&#x201D; medicines intended for sale as bioequivalent or &#x201C;biosimilar&#x201D; versions of currently marketed biotechnology products. While the development of such products typically is significantly less costly and complex than the development of the equivalent originator medicines, it is nonetheless significantly more costly and complex than that for typical small-molecule generic products. In addition, many countries do not yet have fully developed legislative or regulatory pathways to facilitate the development of biosimilars and permit their sale in a manner in which they are readily substitutable for the originator product. Further delays or difficulties that may arise in the development or marketing of biosimilars could put at risk the significant investments that Sandoz has made, and will continue to make, in its Biopharmaceuticals business. Sandoz also achieves significant revenue opportunities when it secures and maintains exclusivity periods granted for generic products in certain markets &ndash; particularly the 180-day exclusivity period granted in the US by the Hatch Waxman Act for first-to-file generics. Failure to obtain and maintain such exclusivity periods or to successfully develop and market biosimilars could have a material adverse effect on the success of the Sandoz Division and the Group as a whole. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Further, our research and development activities must be conducted in an ethical and compliant manner. Among other things, we must be concerned with patient safety, data privacy, Current Good Clinical Practices (cGCP) requirements, data integrity, the fair treatment of patients, and animal welfare requirements. Should we fail to properly manage such issues, we risk injury to third parties, damage to our reputation, negative financial consequences as a result of potential claims for damages, sanctions and fines, and the potential that our investments in research and development activities could have no benefit to the Group.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If we are unable to maintain a flow of successful, cost-effective new products and new indications for existing products that will sustain and grow our business, cover our substantial research and development costs and the decline in sales of older products that become subject to generic or other competition, and take advantage of technological and medical advances, then this could have a material adverse effect on our business, financial condition, or results of operations. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For a further description of the approval processes that must be followed to market our products, see the sections headed &#x201C;Regulation&#x201D; included in the descriptions of our Innovative Medicines and Sandoz Divisions under &#x201C;Item&nbsp;4. Information on the Company&mdash;Item&nbsp;4.B Business overview.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">We could be impacted by new laws and regulations; failures to comply with laws; legal proceedings; and government investigations.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We are obligated to comply with the laws of all of the countries in which we operate and sell products with respect to an extremely wide and growing range of activities. Such legal requirements are extensive and complex. New requirements may be imposed on us as a result of changing government and public expectations regarding the healthcare industry, and acceptable corporate behavior generally.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For example, we are faced with new laws and regulations requiring more transparency in how we do business, including with respect to our interactions with healthcare professionals and organizations. These laws and regulations include requirements that we disclose payments or other transfers of value made to healthcare professionals and organizations, as well as information relating to the costs and prices for our products. Such measures, including any additional such measures that may be put in place, could have a material adverse impact on our business, financial condition, or results of operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, companies and executives in our industry continue to face significant government investigations, legal proceedings and law enforcement activities worldwide, and various US, federal and state, and international laws and regulations, including those pertaining to government benefit programs, reimbursement, rebates, price reporting and regulation, and healthcare fraud and abuse. Such activities can involve criminal proceedings, and can retroactively challenge practices previously considered to be legal. There is also a risk that governance for our medical and patient support activities, and our interactions with patient organizations, may be inadequate or fail, or that we may undertake activities based on improper or inadequate scientific justification. Our failure to comply with applicable requirements for such activities could result in adverse regulatory or legal action, damage our reputation, and have a significant negative impact on our financial results. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The laws and regulations relevant to the healthcare industry are broad in scope and are subject to change and evolving interpretations, which could require us to incur substantial costs associated with compliance or to alter one or more of our sales or marketing practices. In addition, violations of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect on our business and results of operations. A number of our subsidiaries across each of our divisions are, or may in the future be, subject to var-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">14</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">ious investigations and legal proceedings, including proceedings regarding sales and marketing practices, pricing, corruption, trade regulation and embargo legislation, product liability, commercial disputes, employment and wrongful discharge, antitrust matters, securities, insider trading, occupational health and safety, environmental matters, tax, cybersecurity, data privacy and intellectual property. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, our use of the internet, social media and mobile tools also carries risks related to potential violations of rules regulating the promotion of prescription medicines and the potential loss of confidential information, trade secrets or other intellectual property. There continue to be significant uncertainties as to the rules that apply to such communications and as to the interpretations that health authorities will apply in this context, and as a result, despite our efforts to comply with applicable rules, there is a risk that our use of the internet, social media and mobile technologies may cause us to be found in violation of applicable regulations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Sandoz Division may from time to time seek approval to market a generic version of a product before the expiration of patents claimed by the marketer of the patented product. We do this in cases where we believe that the relevant patents are invalid or unenforceable, or would not be infringed by our generic product. As a result, affiliates of our Sandoz Division frequently face patent litigation, and in certain circumstances, we may make the business decision to market a generic product even though patent infringement actions are still pending. Should we elect to do so and conduct a so-called &#x201C;launch at risk,&#x201D; we could face substantial damages if the final court decision is adverse to us.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For information on significant legal matters pending against us, see &#x201C;Item 18. Financial Statements&mdash;Note 20. Provisions and other non-current liabilities&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;28.&nbsp;Commitments and contingencies.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To help us in our efforts to comply with the many requirements that impact us, we have a significant global ethics and compliance program in place, and we devote substantial time and resources to efforts to ensure that our business is conducted in a lawful and publicly acceptable manner. Despite our efforts, any actual or alleged failure to comply with law or with heightened public expectations could lead to substantial liabilities that may not be covered by insurance, or to other significant losses, and could affect our business, financial position and reputation. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Legal proceedings and investigations are inherently unpredictable, and large judgments sometimes occur. As a consequence, we may in the future incur judgments that could involve large payments, including the potential repayment of amounts allegedly obtained improperly, and other penalties, including treble damages. In addition, such legal proceedings and investigations, even if meritless, may affect our reputation, may create a risk of potential exclusion from government reimbursement programs in the US and other countries, and may lead to civil litigation. As a result, having taken into account all relevant factors, we have in the past and may again in the future enter into major settlements of such claims without bringing them to final legal adjudication by courts or other such bodies, despite having potentially significant defenses against them, in order to limit the risks they pose to our business and reputation. Such settlements may require us to pay significant sums of money and to enter into corporate integrity or similar agreements, which are intended to regulate company behavior for extended periods.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Any such judgments or settlements, and any accruals that we may take with respect to potential judgments or settlements, could have a material adverse impact on our business, financial condition, or results of operations, as well as on our reputation.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Our reliance on outsourcing key business functions to third parties heightens the risks faced by our businesses. </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For business reasons, we outsource the performance of certain key business functions to third parties, and invest a significant amount of effort and resources into doing so, including to manage and oversee such third parties. Such outsourced functions can include research and development collaborations, manufacturing operations, warehousing and distribution activities, certain finance functions, marketing activities, data management and others. We may particularly rely on third parties in developing countries, including for the sales, marketing and distribution of our products, and to obtain the intermediate and raw materials used in the manufacture of our products. Some of these third parties do not have internal compliance resources comparable to those within our organization.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our reliance on outsourcing and third parties for the research and development or the manufacturing of our products poses certain risks, including misappropriation of our intellectual property, failure of the third party to comply with regulatory and quality assurance requirements, unexpected supply disruptions, breach of the research and development or manufacturing agreement by the third party, and the unexpected termination or nonrenewal of the agreement by the third party.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, governments and the public expect major corporations, including Novartis, to take responsibility for and report on compliance with various human rights, responsible sourcing and environmental practices, as well as other actions of their third-party contractors around the world. Examples of this include the conflict minerals disclosure requirements in the US, and the UK Modern Slavery Act.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Ultimately, if third parties fail to meet their obligations to us, we may lose our investment in the collaborations or fail to receive the expected benefits of our agreements with such third parties. In addition, should any of these third parties fail to comply with the law or our standards, or should they otherwise act inappropriately in the course of their performance of services for us, there is a risk that we could be held responsible for their acts, that our reputation may suffer, and that penalties may be imposed upon us. Any such failures by third parties could have a material adverse effect on our business, financial condition, results of operations, or reputation.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compliance with data privacy laws and regulations is complex and could expose us to a variety of risks.   </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We operate in an environment that relies on the collection, processing, analysis and interpretation of large sets </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">15</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">of patients&#x2019; and other individuals&#x2019; personal information, including via social media and mobile technologies, and that also, in many situations, requires that data to freely flow across borders of numerous countries in which there are different, and potentially conflicting, data privacy laws in effect. For example, the EU General Data Protection Regulation (GDPR), which took effect in May 2018, and the California Consumer Privacy Act, which took effect in January 2020, impose stringent requirements on how we and third parties with whom we contract collect, share, export or otherwise process personal information, and provide for significant penalties for noncompliance. Breaches of our systems or those of our third-party contractors, or other failures to protect the data we collect from misuse or breach by third parties, could expose such personal information to unauthorized persons.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Any event involving the substantial loss of personal information or other privacy violations could give rise to significant liability, reputational harm, damaged relationships with business partners, and potentially substantial monetary penalties under laws enacted or being enacted around the world. Such events could also lead to restrictions on our ability to use personal information and/or transfer personal information across country borders.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">The manufacture of our products is complex and highly regulated.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The manufacture of our products relies on technically complex processes and, in some cases, highly specialized raw materials, and is highly regulated. Deviations, difficulties or delays in production, or failure to obtain specialized raw materials, have in the past resulted in some of the following, and may in the future result in: shut-downs, work stoppages, approval delays, voluntary market withdrawals, product recalls, penalties, supply disruptions or shortages, increased costs, product liability or reputational harm. In addition, whether our products and the related raw materials are manufactured at our own dedicated manufacturing facilities or by third parties, we must ensure that all manufacturing processes comply with current Good Manufacturing Practices (cGMP) and other applicable regulations. Failure to comply with cGMP requirements have in the past resulted in some of the following legal or regulatory actions, and may in the future result in possible legal or regulatory actions, such as warning letters, suspension of manufacturing, seizure of products, injunctions, voluntary recall of products, failure to secure product approvals, or debarment. Any of these events could have a material adverse effect on our business, financial condition and results of operations.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The technically complex manufacturing processes required to manufacture many of our products increase the risk of production failures and product recalls, and can increase the cost of producing our goods. Many of our products require a supply of highly specialized raw materials, such as cell lines, tissue samples, bacteria, viral strains and radioisotopes. For some of our products and raw materials, we rely on a single source of supply for ingredients or relevant components. In addition, we manufacture and sell a number of sterile products, biologic products and products involving advanced therapy platforms, such as CAR-T therapies, gene therapies and radioligand therapies, all of which are particularly complex and involve highly specialized manufacturing technologies. As a result, even slight deviations at any point in their production processes or in material used may lead to production failures or recalls. See also &#x201C;&mdash;We may not successfully achieve our goals in transactions or reorganizations,&#x201D; below, with regard to our efforts to reorganize our product manufacturing organization, and &#x201C;&mdash;Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business,&#x201D; below.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">We may fail to develop or take advantage of </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">transformational technologies and business models. </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Rapid progress in medical and digital technologies and in the development of sometimes radical new business models is substantially transforming numerous industries around the world, creating new businesses and new opportunities for revenue and profit, while sometimes quickly rendering established businesses uncompetitive or obsolete. Such transformations, both positive and negative, may impact the healthcare industry, and numerous companies from the digital technology and other industries are seeking to enter the healthcare field.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To take advantage of these opportunities, Novartis has embarked upon a digital transformation strategy, with the goal of making Novartis an industry leader in leveraging advanced analytics and other new technologies. We expect to invest substantial resources into efforts to improve the way we use data in drug discovery and development; to improve the ways we engage with patients, doctors and other stakeholders; and to automate business processes. Our success in these efforts will depend on many factors, including a cultural change among our employees, attracting and retaining employees with appropriate skills and mindsets, and successfully innovating across a variety of technology fields. However, there is no guarantee that these efforts will succeed, that we will successfully transform our business model, or that we will be able to do so at any particular cost or in the necessary time frame. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At the same time, other companies with specialized expertise or business models and substantial resources are entering the healthcare field, from research and development to pharmaceutical distribution, potentially disrupting our relationships with patients, healthcare professionals, customers, distributors and suppliers, with unknown potential consequences for us. In addition, we face new competitors from different regions of the world, including China, which is aggressively expanding its role in the sciences and in many industries. Such new competitors may successfully impact our share of the healthcare value chain, or even develop products or technologies that could make our products uncompetitive or obsolete.  </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If our digital transformation efforts, or our efforts to bring advanced therapy platforms to market, should fail, then there is a risk that we may fail to create the innovative new products, tools or techniques that the new medical and digital technologies may make possible, or that we may fail to create them as quickly and efficiently as such technologies may enable. We may also lose opportunities to engage with our stakeholders and to profit from improved business processes, and we may lose the </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">16</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">resources devoted to these efforts to transform our business. At the same time, should third parties successfully enter the healthcare field with disruptive new technologies or business models, then we potentially may see our business supplanted in whole or in part by these new entrants. Any such events could have a material adverse effect on our business, financial condition, or results of operations.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">We may not successfully achieve our goals in transactions or reorganizations.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As part of our strategy, from time to time we acquire and divest products or entire businesses, and enter into strategic alliances and collaborations. For example, we previously announced plans to divest the Sandoz US dermatology business and US oral solids portfolio, and we recently completed the spin-off of our Alcon Division, the acquisition of the assets associated with <i>Xiidra</i>, and the acquisition of The Medicines Company.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our alliances and acquisitions are a significant source of our growth, yet our efforts may be impacted by our ability to identify products or businesses that are suitable for acquisition; by governmental regulation, including market concentration limitations; and by overtures from competitors that may increase the prices of potential targets. Once an acquisition is agreed upon with a third party, we may not be able to complete the acquisition in a timely manner or at all, nor can there be assurance that pre-acquisition due diligence will have identified all possible issues that might arise with regard to an acquisition. Our efforts on acquisitions and divestments can also divert management&#x2019;s attention from our existing businesses.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Further, after an acquisition, efforts to develop and market acquired products, to integrate the acquired business or to achieve expected synergies may not meet expectations, or may otherwise not be successful, as a result of difficulties in retaining key personnel, customers and suppliers, or differences in corporate culture, standards, controls, processes and policies. Acquisitions can also result in liabilities being incurred that were not known at the time of acquisition, or the creation of tax or accounting issues. Acquired businesses are not always in full compliance with legal, regulatory or Company standards, including, for example, cGMP or cGCP standards, requiring remediation efforts that could be costly and time-consuming. Also, our strategic alliances and collaborations with third parties may not achieve their intended goals and objectives in any particular time frame, or at all.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Similarly, we cannot ensure that we will be able to successfully divest or spin off businesses or other assets that we have identified for this purpose, or that any completed divestment or spin-off will achieve the expected strategic benefits, operational efficiencies or opportunities, or that the divestment or spin-off will ultimately maximize shareholder value.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, as part of our strategy, from time to time we reassess the optimal organization of our business, such as our ongoing efforts to centralize and optimize our manufacturing and business services organizations. The expected benefits of such reorganizations may never be fully realized or may take longer to realize than expected. There can be no certainty that the businesses and functions involved will be successfully integrated into the new organizations, that key personnel will be retained, or that we will be able to attract talent during ongoing transformations and reorganizations. Disruption from reorganizations may make it more difficult to maintain relationships with customers, employees or suppliers; could result in shortfalls in program oversight; could negatively impact our reputation; and may result in the Group not achieving the expected productivity and financial benefits. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If we fail to successfully address these risks, or to devote adequate resources to them, we may fail to achieve our strategic objectives, including our growth strategy, or otherwise may not realize the intended benefits of the acquisition, divestiture, strategic alliance, spin-off or reorganization.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Environmental, social and governance matters may impact our business and reputation.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Increasingly, in addition to the importance of their financial performance, companies are being judged by their performance on a variety of environmental, social and governance (ESG) matters, which are considered to contribute to the long-term sustainability of companies&#x2019; performance.  </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A variety of organizations measure the performance of companies on such ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG measures to their investment decisions. Topics taken into account in such assessments include, among others, the company&#x2019;s efforts and impacts on climate change and human rights, ethics and compliance with law, and the role of the company&#x2019;s board of directors in supervising various sustainability issues. In addition to the topics typically considered in such assessments, in our healthcare industry, issues of the public&#x2019;s ability to access our medicines are of particular importance.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We actively manage a broad range of such ESG matters, taking into consideration their expected impact on the sustainability of our business over time, and the potential impact of our business on society and the environment. However, in light of investors&#x2019; increased focus on ESG matters, there can be no certainty that we will manage such issues successfully, or that we will successfully meet society&#x2019;s expectations as to our proper role. Any failure or perceived failure by us in this regard could have a material adverse effect on our reputation and on our business, share price, financial condition, or results of operations, including the sustainability of our business over time.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">See also &#x201C;&mdash;Our reliance on outsourcing key business functions to third parties heightens the risks faced by our businesses,&#x201D; above, and &#x201C;&mdash;Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business,&#x201D; below.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Falsified products could harm our patients and reputation.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our industry continues to be challenged by the vulnerability of distribution channels to falsified medicines </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">17</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(which includes counterfeit and stolen medicines under the definition of the World Health Organization). The presence of falsified medicines is growing in terms of the markets affected and on the internet. Falsified medicines pose patient safety risks and can be seriously harmful or life-threatening. They are often visually indistinguishable from genuine medicines and usually require a forensic authentication process of the packaging and/or the actual medicine to ascertain their falsified nature and determine their likely impact on patient safety. Reports of adverse events related to falsified medicines and increased levels of falsified medicines in the healthcare system affect patient confidence in our genuine medicines and in healthcare systems in general. These events could also cause us substantial reputational and financial harm, and potentially lead to litigation if the adverse event from the falsified medicine is mistakenly attributed to the genuine one. Thefts of our genuine products from warehouses or plants, or while in-transit, which are then not properly stored and are later sold through unauthorized channels, could adversely impact patient safety, our reputation and our business. Further, there is a direct financial loss when, for example, falsified medicines replace sales of genuine medicines, or genuine medicines are recalled following discovery of falsified products.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Political and economic instability may impact our results.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Unpredictable political conditions currently exist in various parts of the world, including a backlash in certain areas against free trade, anti-immigrant sentiment, anti-corporatist sentiment, social unrest, fears of terrorism, and the risk of direct conflicts between nations. In the US, for example, the presidential administration&#x2019;s imposition of tariffs and opposition to free-trade agreements, including the recent tariffs imposed by the US and China, and the possibility of additional tariffs or other trade restrictions relating to trade between the US and other countries, could have a negative impact on international trade in general and our business in particular. Given that the status of trade negotiations remains subject to change, we cannot be certain of the nature or extent of the potential impact on our business. For example, if tariffs on pharmaceutical products or active pharmaceutical ingredients (APIs) were increased, this could impact the profitability of our products. Furthermore, significant conflicts continue in certain parts of the world. Collectively, such unstable conditions could, among other things, disturb the international flow of goods and increase the costs and difficulties of international transactions, which could significantly impact time to market and our ability to supply our products to patients in an un-disrupted fashion, and further erode reimbursement levels for innovative therapies. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a result of the UK&#x2019;s Brexit vote, the British government has been in the process of negotiating the terms of the UK&#x2019;s future relationship with the EU, requiring us to make certain contingency plans for scenarios in which the UK and the EU do not reach a mutually satisfactory understanding as to that relationship. We cannot predict whether there will be any such understanding, or if such an understanding is reached, whether its terms will vary in ways that result in greater restrictions on imports and exports between the UK and EU countries, and increased regulatory complexities that could materially adversely impact our business operations in the UK.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, local economic conditions may adversely affect the ability of payers, as well as our distributors, customers, suppliers and service providers, to pay for our products, or otherwise to buy necessary inventory or raw materials, and to perform their obligations under agreements with us. Although we make efforts to monitor these third parties&#x2019; financial condition and their liquidity, our ability to do so is limited, and some of them may become unable to pay their bills in a timely manner, or may even become insolvent, which could negatively impact our business or results of operations. These risks may be elevated with respect to our interactions with fiscally challenged government payers, or with third parties with substantial exposure to such payers. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Financial market issues may also result in a lower return on our financial investments, and a lower value on some of our assets. Alternatively, inflation could accelerate, which could lead to higher interest rates, increasing our costs of raising capital. Uncertainties around future central bank and other economic policies in the US and EU, as well as high debt levels in certain other countries, could also impact world trade. Sudden increases in economic, currency or financial market volatility in different countries have also impacted, and may continue to unpredictably impact, our business or results of operations, including the conversion of our operating results into our reporting currency, the US dollar, as well as the value of our investments in our pension plans. For further information on such risks, see &#x201C;&mdash;Foreign exchange fluctuations may adversely affect our earnings and the value of some of our assets,&#x201D; and &#x201C;&mdash;Any inaccuracy in the assumptions and estimates used to calculate our pension plan and other post-employment obligations could substantially increase our pension-related expenses,&#x201D; below. See also &#x201C;Item&nbsp;5. Operating and Financial Review and Prospects&mdash;Item&nbsp;5.B Liquidity and capital resources&mdash;Effects of currency fluctuations,&#x201D; &#x201C;Item&nbsp;5.&nbsp;Operating and Financial Review and Prospects&mdash;Item&nbsp;5.B Liquidity and capital resources&mdash;Condensed consolidated balance sheets,&#x201D; &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;15. Trade receivables&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;29. Financial instruments&mdash;additional disclosures.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Similarly, increased scrutiny of corporate taxes and executive pay may lead to significant business disruptions or other adverse business conditions, and may interfere with our ability to attract and retain qualified personnel. See &#x201C;&mdash;Changes in tax laws or their application could adversely affect our financial results&#x201D; and &#x201C;&mdash;An inability to attract and retain qualified personnel could adversely affect our business,&#x201D; below.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our business may be impacted by economic and financial conditions directly affecting consumers. Given the requirements in certain countries that patients directly pay an increasingly large portion of their own healthcare costs, there is a risk that consumers may cut back on prescription drugs to help cope with rising costs. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At the same time, significant changes and potential future volatility in the financial markets, in the consumer and business environment, in the competitive landscape, and in the global political and security landscape make </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">18</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">it increasingly difficult for us to predict our revenues and earnings into the future. As a result, any revenue or earnings guidance or outlook that we have given or might give may be overtaken by events, or may otherwise turn out to be inaccurate. Though we endeavor to give reasonable estimates of future revenues and earnings at the time we give such guidance, based on then-current knowledge and conditions, there is a significant risk that such guidance or outlook will turn out to be incorrect.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Separately and collectively, such factors may have a material adverse effect on our revenues, results of operations, financial condition and, if circumstances worsen, our ability to raise capital at reasonable rates.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Our indebtedness could adversely affect our operations.</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As of December&nbsp;31, 2019, we had USD 20.4 billion of non-current financial debt and USD 7.0&nbsp;billion of current financial debt. Our current and long-term debt requires us to dedicate a portion of our cash flow to service interest and principal payments and, if interest rates rise, this amount may increase. As a result, our existing debt may limit our ability to use our cash flow to fund capital expenditures, to engage in transactions, or to meet other capital needs, or otherwise may place us at a competitive disadvantage relative to competitors that have less debt. Our debt could also limit our flexibility to plan for and react to changes in our business or industry, and increase our vulnerability to general adverse economic and industry conditions, including changes in interest rates or a downturn in our business or the economy. We may also have difficulty refinancing our existing debt or incurring new debt on terms that we would consider to be commercially reasonable, if at all.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets and goodwill on our books may lead to significant impairment charges.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We carry a significant amount of goodwill and other intangible assets on our consolidated balance sheet, primarily due to acquisitions, including, in particular, substantial goodwill and other intangible assets obtained as a result of our acquisitions including <i>Xiidra</i>, Endocyte, AveXis, AAA, and certain oncology assets from GSK. As a result, we may incur significant impairment charges in the future if the fair value of the intangible assets and the groupings of cash-generating units containing goodwill would be less than their carrying value on the Group&#x2019;s consolidated balance sheet at any point in time.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We regularly review for impairment our long-lived intangible and tangible assets, including identifiable intangible assets, investments in associated companies, and goodwill. Goodwill, intangible assets with an indefinite useful life, acquired research projects not ready for use, and acquired development projects not yet ready for use are subject to impairment review at least annually. Other long-lived assets are reviewed for impairment when there is an indication that an impairment may have occurred. Impairment testing under IFRS may lead to impairment charges in the future. Any significant impairment charges could have a material adverse effect on our results of operations and financial condition. In 2019, for example, we recorded intangible asset impairment charges of USD 1.1 billion. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For a detailed discussion of how we determine whether an impairment has occurred, what factors could result in an impairment, and the impact of impairment charges on our results of operations, see &#x201C;Item&nbsp;5. Operating and Financial Review and Prospects&mdash;Item&nbsp;5.A Operating results&mdash;Critical accounting policies and estimates&mdash;Impairment of goodwill, intangible assets and property, plant and equipment,&#x201D; &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;11. Goodwill and intangible assets.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Competition, failure to adapt to changing business conditions, and complexities in the development of biosimilars may impact the success of our Sandoz Division.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz faces intense competition from companies that market patented pharmaceutical products as well as strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. Such competitive actions may increase the costs and risks associated with our efforts to introduce and market such products, may delay the introduction or marketing of such products, and may further limit the prices at which we are able to sell these products and impact our results of operations. In particular, in the US in past years, industrywide price competition among generic pharmaceutical companies and consolidation of buyers caused significant declines in sales and profits of Sandoz. In light of this, we agreed to sell the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Pharma USA Inc. This transaction is expected to be completed in the first quarter of 2020 pending regulatory approval. There is no certainty that the remaining Sandoz US business will be commercially successful. Sandoz has also announced a refined strategy, with the objective of being an industry leader as a focused generics company, which bears risk in a competitive environment in which other generics companies strive to also launch first and in which originators rigorously defend the exclusivity of their products. The refined strategy touches many fundamental areas of the Sandoz organization, including portfolio strategy, resource allocation, production, development, sales and governance. These changes may fail to achieve their intended goals, and may negatively affect the motivation of employees in certain parts of Sandoz.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, Sandoz has invested heavily in the development of biosimilar drugs, with the expectation that such products offer the potential for higher profitability. If Sandoz should fail in its efforts to develop and market biosimilars, due to the fact that their development is more difficult and expensive than the development of standard generic drugs, or if the developing biosimilars regulations do not ultimately favor the development and sale of such products, or if we are unable to sell our biosimilar products for a sufficient price, then this could have an adverse effect on the success of our Sandoz Division, and we may fail to achieve expected returns on the investments by Sandoz in the development of biosimilars. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">See also &#x201C;&mdash;Our research and development efforts may not succeed&#x201D; above, with regard to the risks involved in our efforts to develop biosimilars and differentiated </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">19</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">generic products and to obtain exclusivity periods, and &#x201C;&mdash;Ongoing consolidation among our distributors and retailers is increasing both the purchasing leverage of key customers and the concentration of credit risk,&#x201D; below, with respect to the impact of such consolidation on our pricing.  </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Changes in tax laws or their application could adversely affect our financial results.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our multinational operations are taxed under the laws of the countries and other jurisdictions in which we operate. However, the integrated nature of our worldwide operations can produce conflicting claims from revenue authorities in different countries as to the profits to be taxed in the individual countries, including potential disputes relating to the prices our subsidiaries charge one another for intercompany transactions, known as transfer pricing. The majority of the jurisdictions in which we operate have double tax treaties with other foreign jurisdictions, which provide a framework for mitigating the impact of double taxation on our revenues and capital gains. However, mechanisms developed to resolve such conflicting claims are largely untried, and can be expected to be very lengthy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In recent years, tax authorities around the world have increased their scrutiny of company tax filings, and have become more rigid in exercising any discretion they may have. As part of this, the Organization for Economic Co-operation and Development (OECD) has proposed a number of tax law changes under its Base Erosion and Profit Shifting (BEPS 2015 Agenda) Action Plans to address issues of transparency, coherence and substance. In addition, in 2019 the OECD launched a new initiative on behalf of the G20 to minimize profit shifting by working toward a global tax framework that ensures that corporate income taxes are paid where consumption takes place and also introduces a global standard on minimum taxation combined with new tax dispute resolution processes. The respective principles are currently being evaluated. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Most of the rules of&nbsp;the EU Anti-Tax Avoidance Directive, which seeks to prevent tax avoidance by companies and to ensure that companies pay appropriate taxes in the markets where profits are effectively made and business is effectively performed, apply as of January 1, 2019. The EU also adopted a new Directive on Administrative Cooperation (DAC6) in 2018, which seeks additional reporting. In addition, the European Commission continues to extend the application of its policies seeking to limit fiscal aid by member states to particular companies, and the related investigation of the member states&#x2019; practices regarding the issuance of rulings on tax matters relating to individual companies.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">These OECD and EU tax reform initiatives also need local country implementation, including in our home country of Switzerland, which may result in significant changes to established tax principles. Although we have taken steps to be in compliance with the evolving OECD and EU tax initiatives, and will continue to do so, significant uncertainties remain as to the outcome of these efforts.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In Switzerland, the Basel-Stadt Cantonal Tax Reform was approved by voters in February 2019, with parts retroactive from January 1, 2019. In May 2019, Swiss voters approved the Swiss Federal Tax Reform. With the enactment of this tax reform, new elements were introduced into law as of January 1, 2020. These include the abolishment of special taxed regimes, notional interest deduction, and an implementation of a Patent-Box, which provides tax advantages on income generated from intellectual property rights. Some of the new elements as well as the transition rules for the Swiss tax reform might be regarded as not completely aligned with OECD and EU regulations, and might require subsequent amendments, the need for and impact of which are difficult to predict.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US, the Tax Cuts and Jobs Act, enacted at the end of 2017, included significant changes to US corporate income tax law. Though we continue to monitor regulations and other guidance issued by the US Department of the Treasury, it is uncertain whether the application of new guidance, particularly with respect to the tax limitation of interest deductions and qualification of base erosion payments, will have a material effect on our financial position and results of operations.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In general, such tax reform efforts will require us to continually assess our organizational structure against tax policy trends, could lead to an increased risk of international tax disputes and an increase in our effective tax rate, and could adversely affect our financial results.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Foreign exchange fluctuations may adversely affect our earnings and the value of some of our assets.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Changes in exchange rates between the US dollar, our reporting currency, and other currencies can result in significant increases or decreases in our reported sales, costs and earnings as expressed in US dollars, and in the reported value of our assets, liabilities and cash flows.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition to ordinary market risk, there is a risk that countries could take affirmative steps that could significantly impact the value of their currencies. Such steps could include &#x201C;quantitative easing&#x201D; measures and potential withdrawals by countries from common currencies. In addition, countries facing local financial difficulties, including countries experiencing high inflation rates and highly indebted countries facing large capital outflows, may impose controls on the exchange of foreign currency. In Argentina, for example, where we have subsidiary operations, the government authorized currency exchange controls in 2019. Currency exchange controls could limit our ability to distribute retained earnings from our local affiliates, or to pay intercompany payables due from those countries. See &#x201C;&mdash;Political and economic instability may impact our results,&#x201D; above.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Despite measures undertaken to reduce or hedge against foreign currency exchange risks, because a significant portion of our earnings and expenditures are in currencies other than the US dollar, including expenditures in Swiss francs that are significantly higher than our revenue in Swiss francs, any such exchange rate volatility may negatively and materially impact our results of operations and financial condition, and may impact the reported value of our net sales, earnings, assets and liabilities. In addition, the timing and extent of such volatility can be difficult to predict. Further, depending on the movements of particular foreign exchange rates, we may be materially adversely affected at a time when the same </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">20</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">currency movements are benefiting some of our competitors.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For more information on the effects of currency fluctuations on our consolidated financial statements and on how we manage currency risk, see &#x201C;Item&nbsp;5. Operating and Financial Review and Prospects&mdash;Item&nbsp;5.B Liquidity and capital resources&mdash;Effects of currency fluctuations&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;29. Financial instruments&mdash;additional disclosures.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Ongoing consolidation among our distributors and retailers is increasing both the purchasing leverage of key customers and the concentration of credit risk.</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Increasingly, a significant portion of our global sales is made to a relatively small number of drug wholesalers, retail chains and other purchasing organizations. For example, our three most important customers globally are all in the US, and accounted for approximately 23%, 17% and 10%, respectively, of net sales in 2019. The largest trade receivables outstanding were for these three customers, amounting to 14%, 12% and 7%, respectively, of the Group&#x2019;s trade receivables at December&nbsp;31, 2019. The trend has been toward further consolidation among distributors and retailers, particularly in the US. As a result, we may be affected by fluctuations in the buying patterns of such customers, and these customers are gaining additional purchasing leverage, increasing the pricing pressures facing our businesses. These pressures can particularly impact our Sandoz Division, the generic products of which can often be obtained from numerous competitors. Moreover, we are exposed to a concentration of credit risk as a result of this concentration among our customers. If one or more of our major customers experienced financial difficulties, the effect on us would be substantially greater than in the past, and could include a substantial loss of sales and an inability to collect amounts owed to us. Such events could have a material adverse effect on our business, financial condition, or results of operations.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">An inability to attract and retain qualified personnel could adversely affect our business.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We highly depend upon skilled personnel in key parts of our organization, and we invest heavily in recruiting, training and retaining qualified individuals, including significant efforts to enhance the diversity of our workforce. The loss of the service of key personnel &ndash; including senior members of our scientific and management teams, high-quality researchers and development specialists, and skilled personnel in developing countries &ndash; could delay or prevent the achievement of major business objectives.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our future growth will demand talented associates and leaders, yet the market for talent has become increasingly competitive. Emerging Growth Markets, in particular China and India, are expected to continue to be an important source of growth, but in many of these countries there is a limited pool of executives with the training and international experience needed to work successfully in a global organization like Novartis. In addition, we are undertaking a cultural transformation to an &#x201C;inspired, curious and unbossed&#x201D; organization, which is a core organizational imperative. Inability to successfully implement this cultural change may result in cynicism and disengagement of our associates, as well as impede our ability to retain key talent in strategically important areas. This risk is augmented by ongoing organizational changes, as well as changes to our culture and leadership expectations that may conflict with some leaders&#x2019; preferred leadership styles. Consequently, we may fail to retain key talent, who may possess capabilities that are rare and highly sought in the marketplace, unless they are appropriately engaged, motivated and incentivized. The departure of key talent could have a material adverse effect on our business performance, results of operations and reputation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, shifting demographic trends are expected to result in fewer students, fewer graduates and fewer people entering the workforce in the Western world in the near future. Moreover, many members of younger generations around the world have changing expectations toward careers, engagement and the integration of work in their overall lifestyles.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The supply of talent for certain key functional and leadership positions is decreasing, and a talent gap is visible for some professions and geographies. Recruitment is increasingly regional or global in specialized fields such as clinical development, biosciences, chemistry and information technology. In addition, the geographic mobility of talent is expected to decrease in the future, with talented individuals in developed and developing countries anticipating ample career opportunities closer to home than in the past. This decrease in mobility may be worsened by anti-immigrant sentiments in many countries, and laws discouraging immigration. See &#x201C;&mdash;Political and economic instability may impact our results,&#x201D; above.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, our ability to hire qualified personnel also depends on the flexibility to reward superior performance and to pay competitive compensation. Laws and regulations on executive compensation, including legislation in our home country, Switzerland, may restrict our ability to attract, motivate and retain the required level of qualified personnel.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We face intense competition for an increasingly limited pool of qualified individuals from numerous pharmaceutical and biotechnology companies, universities, governmental entities, other research institutions, other companies seeking to enter the healthcare space, and companies in other industries. As a result, despite significant efforts on our part, we may be unable to attract and retain qualified individuals in sufficient numbers, which could have an adverse effect on our business, financial condition, or results of operations.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Environmental liabilities may adversely impact our financial results.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The environmental laws of various jurisdictions impose actual and potential obligations on us to remediate contaminated sites, including in connection with activities in the past by businesses that are no longer part of Novartis. In some cases, these remediation efforts may take many years. While we have set aside substantial provisions for worldwide environmental liabilities, there is no guarantee that additional costs will not be incurred beyond the amounts for which we have provided in the Group consolidated financial statements. If environmental contam-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">21</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">ination related to our facilities or products adversely impacts third parties, if we fail to properly manage the safety of our facilities and the environmental risks, or if we are required to further increase our provisions for environmental liabilities in the future, this could have a material adverse effect on our business, financial condition, results of operations, and reputation. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">See also &#x201C;Item&nbsp;4.&nbsp;Information on the Company&mdash;Item&nbsp;4.D Property, plants and equipment&mdash;Environmental matters&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;20. Provisions and other non-current liabilities.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In recent years, extreme weather events and changing weather patterns such as storms, flooding, droughts and temperature changes have become more common. As a result, we are potentially exposed to varying natural disaster or extreme weather risks such as hurricanes, tornadoes, droughts or floods, or other events that may result from the impact of climate change on the environment, such as sea level rise. For example, some of our production facilities that depend on the availability of significant water supplies are located in areas where water is increasingly scarce. Other facilities are located in places that, because of increasingly violent weather events, sea level rise, or both, are increasingly at risk of substantial flooding. As a result, we could experience increased production or other costs, business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, our corporate headquarters, the headquarters of our Innovative Medicines Division, and certain of our major Innovative Medicines Division production and research facilities are located near earthquake fault lines in Basel, Switzerland. Other major facilities are located near major earthquake fault lines in various locations around the world. In the event of a major earthquake, we could experience business interruptions, destruction of facilities, and loss of life, all of which could have a material adverse effect on our business, financial condition, or results of operations. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The potential impacts of climate change may also include increased operating costs associated with additional regulatory requirements and investments in reducing energy, water use and greenhouse gas emissions. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Any inaccuracy in the assumptions and estimates used to calculate our pension plan and other post-employment obligations could substantially increase our pension-related expenses.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We sponsor pension and other post-employment benefit plans in various forms. These plans cover a significant portion of our current and former associates. While most of our plans are now defined contribution plans, certain of our associates remain participants in defined benefits plans. For these defined benefits plans, we are required to make significant assumptions and estimates about future events in calculating the present value of expected future plan expenses and liabilities. These include assumptions used to determine the discount rates we apply to estimated future liabilities and rates of future compensation increases. Assumptions and estimates used by Novartis may differ materially from the actual results we experience in the future, due to changing market and economic conditions, higher or lower withdrawal rates, or longer or shorter life spans of participants, among other variables. For example, in 2019, a decrease in the interest rate we apply in determining the present value of expected future defined benefit obligations of one-quarter of 1% would have increased our year-end defined benefit pension obligation for plans in Switzerland, the US, the UK, Germany and Japan, which represent 95% of the Group total defined benefit pension obligation, by USD 0.8&nbsp;billion. Any differences between our assumptions and estimates and our actual experience could require us to make additional contributions to our pension funds. Further, additional employer contributions might be required if plan funding falls below the levels required by local rules. Either such event could have a material effect on our results of operations and financial condition. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For more information on obligations under retirement and other post-employment benefit plans and underlying actuarial assumptions, see &#x201C;Item&nbsp;5. Operating and Financial Review and Prospects&mdash;Item&nbsp;5.A Operating results&mdash;Critical accounting policies and estimates&mdash;Retirement and other post-employment benefit plans&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;25. Post-employment benefits for associates.&#x201D; </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Holders of ADRs may not be able to exercise pre-emptive rights attached to shares underlying ADRs.</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">If a capital increase is approved, then our shareholders would generally have certain pre-emptive rights to obtain newly issued shares in an amount proportional to the nominal value of the shares they already hold. These pre-emptive rights could be excluded in certain limited circumstances with the approval of a resolution adopted at a general meeting of shareholders by a supermajority of two thirds of the votes. Pre-emptive rights, if not excluded, are transferable during the subscription period relating to a particular offering of shares and may be quoted on the SIX. US holders of ADRs may not be able to exercise the pre-emptive rights attached to the shares underlying their ADRs unless a registration statement under the US Securities Act of 1933 is effective with respect to such rights and the related shares, or an exemption from this registration requirement is available. In deciding whether to file such a registration statement, we would evaluate the related costs and potential liabilities, as well as the benefits of enabling the exercise by ADR holders of the pre-emptive rights associated with the shares underlying their ADRs. We cannot guarantee that a registration statement would be filed or that, if filed, it would be declared effective. If pre-emptive rights could not be exercised by an ADR holder, JPMorgan Chase Bank, N.A., as depositary, would, if possible, sell the holder&#x2019;s pre-emptive rights and distribute the net proceeds of the sale to the holder. If the depositary determines, in its discretion, that the rights could not be sold, the depositary might allow such rights to lapse. In either case, the interest of ADR holders in Novartis would be diluted and, if the depositary allowed rights to lapse, holders of ADRs would not realize any value from the pre-emptive rights.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">22</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00334205"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;4.  Information on the Company</p><a name="anchorId00334208"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">4.A History and development of Novartis</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis AG</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG was incorporated on February&nbsp;29, 1996, under the laws of Switzerland as a stock corporation (&#x201C;Aktiengesellschaft&#x201D;) with an indefinite duration. On December&nbsp;20, 1996, our predecessor companies, Ciba-Geigy AG and Sandoz AG, merged into this new entity, creating Novartis. We are domiciled in and governed by the laws of Switzerland. Our registered office is located at the following address:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Novartis AG</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Lichtstrasse 35</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">CH-4056 Basel, Switzerland</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Telephone: +41-61-324-1111</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Web: www.novartis.com</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Novartis is a multinational group of companies specializing in the research, development, manufacturing and marketing of healthcare products led by innovative pharmaceuticals and also including high-quality generic pharmaceuticals. Novartis AG, our Swiss holding company, owns, directly or indirectly, all of our significant operating companies. For a list of our significant operating subsidiaries, see &#x201C;Item 18. Financial Statements&mdash;Note 32. Principal Group subsidiaries and associated companies.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The SEC maintains an internet site at http://www.sec.gov that contains reports, information statements, and other information regarding issuers that file electronically with the SEC.</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Important</font><font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;"> corporate</font><font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;"> developments 2017-January 2020</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following timeline includes all important corporate developments in 2019 and January 2020, and only significant acquisitions, divestments, alliances and related corporate activities in 2018 and 2017.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2020</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">January</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that its Board of Directors is nominating Bridgette Heller for election to the Board at our Annual General Meeting on February 28, 2020. Bridgette Heller brings more than 35 years of experience at Fortune 100 companies and held several executive positions in the consumer goods and healthcare industry among others at Danone, Merck &amp; Co as well as Johnson &amp; Johnson.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On January 6 Novartis completed its previously announced acquisition of The Medicines Company for USD 85 per share, or a total consideration of approximately USD 9.7 billion in cash on a fully diluted basis. The acquisition broadened the Novartis cardiovascular portfolio by adding inclisiran, an investigational cholesterol-lowering therapy.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2019</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">November</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that its Sandoz Division has entered into an agreement for the acquisition of the Japanese business of Aspen Global Incorporated (AGI). Under the agreement, Sandoz will acquire the shares in Aspen Japan K.K. and associated assets held by AGI. Pursuant to the agreed terms of the transaction, on closing we will pay an initial cash consideration of EUR 300 million (approximately USD 336 million). In addition, deferred consideration is due to AGI, upon fulfillment of certain conditions after closing, currently estimated at approximately EUR 100 million (approximately USD 112 million). We have received all relevant approvals and this transaction is expected to be completed in the first quarter of 2020.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">October</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that its Board of Directors is nominating Dr. Simon Moroney for election to the Board at our Annual General Meeting on February 28, 2020. Dr. Moroney is one of the co-founders of the Germany-based biotechnology company MorphoSys AG and served as its CEO until September 1, 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that the previously announced share buyback of up to USD 5 billion was completed in the third quarter of 2019, with a total of 55.8 million shares for USD 5.0 billion repurchased since the announcement in June 2018. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">23</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">September</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that its Sandoz Division has entered into a worldwide commercialization agreement with Polpharma Biologics to commercialize and distribute a proposed natalizumab biosimilar that is in Phase III clinical development for the treatment of relapsing-remitting multiple sclerosis (RRMS). </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">July</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it has completed the previously announced acquisition of the assets associated with <i>Xiidra</i> worldwide from Takeda Pharmaceutical Company Limited as of July 1, 2019. The purchase price consists of a USD 3.4 billion upfront payment, customary purchase price adjustments of USD 0.1 billion, and the potential milestone payments of up to USD 1.9 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">June</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces the appointment of Marie-France Tschudin as President, Novartis Pharmaceuticals, and a member of the ECN, reporting to the CEO of Novartis, effective June 7, 2019. Marie-France Tschudin succeeds Paul Hudson, who left Novartis to take the CEO position of a multinational pharmaceuticals company.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">May</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces the completion of the previously announced acquisition of IFM Tre, Inc., a privately held, US-based biopharmaceutical company focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome. The acquisition gives Novartis full rights to IFM Tre&#x2019;s portfolio of NLRP3 antagonists.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">April</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that Sandoz has entered into an agreement with EirGenix, Inc., to commercialize in all markets, excluding China and Taiwan, a proposed trastuzumab biosimilar, currently in Phase III clinical development for treatment of human epidermal growth factor receptor 2-positive (HER2+) breast and specific gastric cancer tumors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces the appointment of Richard Saynor as CEO of Sandoz and a member of the ECN, reporting to the CEO of Novartis. Richard Saynor became CEO of Sandoz effective July 15, 2019, following the March 2019 announcement that Richard Francis would step down as CEO of Sandoz, effective on March 31, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces the completion of the spin-off of its Alcon eye care devices business through a dividend in kind distribution to holders of Novartis shares and ADRs, with each holder receiving one Alcon share for every five Novartis shares or ADRs held on April 8, 2019, at the close of business.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that AveXis has signed an agreement to purchase an advanced biologics therapy manufacturing campus in Longmont, Colorado, for USD 30 million.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">March</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that on March 22, 2019, certain important conditions precedent for the 100% spin-off of the Alcon eye care business have been met, including receipt of certain necessary authorizations and rulings, and that the completion of the transaction, by way of a distribution of a dividend in kind to Novartis shareholders and ADR holders, is expected to occur on April 9, 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it is joining the Global Chagas Disease Coalition. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">February</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that on February 28, 2019, Novartis shareholders approved the proposed 100% spin-off of the Alcon eye care division, as previously endorsed by the Novartis Board of Directors, subject to certain conditions precedent, such as no material adverse events and receipt of necessary authorizations.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that shareholders authorized share buybacks within the framework of an eighth share repurchase program to repurchase shares for cancellation up to a maximum of CHF 10 billion until the Annual General Meeting of Novartis in 2022. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">January</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that its Board of Directors is nominating Patrice Bula for election to the Board at our Annual General Meeting on February 28, 2019. As executive vice president and head of strategic business units, marketing, sales and Nespresso, Mr. Bula is a member of the executive board of Nestl&#xE9; SA, a position he took up in 2011.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2018</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">December</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that on December 21, 2018, it completed the previously announced acquisition of Endocyte, a US-based biopharmaceutical company focused on developing radioligand and CAR-T therapies for cancer treatment, in a transaction valued at approximately USD 2.1 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces an offer to acquire Cell<i>for</i>Cure from LFB. Cell<i>for</i>Cure, a French company, is one of the first and largest contract development and manufacturing organizations producing cell and gene therapies in Europe. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">24</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The acquisition was completed in March 2019 and Cell<i>for</i>Cure became a wholly owned Novartis manufacturing site managed by NTO. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">November</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that Alcon had filed an initial Form 20-F registration statement with the SEC in relation to the previously announced intention of Novartis to spin off the Alcon Division as an independent, publicly traded company. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">October</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it has entered into a clinical development agreement with Pfizer Inc. (Pfizer) that will include a study combining tropifexor and one or more Pfizer compounds for the treatment of nonalcoholic steatohepatitis (NASH).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates that are part of the Novartis Infectious Diseases portfolio, which have the potential to address the need for new agents to treat antibiotic-resistant Gram-negative infections. Under the terms of the agreement, Boston Pharmaceuticals acquired worldwide rights to two complementary candidates targeting carbapenem-resistant enterobacteriaceae (CRE), and one candidate targeting Pseudomonas infections. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">September</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc., for USD 0.8 billion in cash and potential earn-outs. This transaction is expected to be completed in the first quarter of 2020 pending regulatory approval.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it plans to continue the transformation of its manufacturing network and services businesses, including a planned workforce reduction in Switzerland over a four-year period. Novartis also plans to continue the ongoing transfer of transactional activities to the five global service centers within Novartis Business Services, and to begin to transfer managerial service capabilities to these service centers. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">July</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it has signed a renewed Memorandum of Understanding with the World Health Organization to extend its agreement for the donation of <i>Egaten</i> (triclabendazole) for the treatment of liver fluke (fascioliasis) until 2022.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it has entered into an exclusive in-license agreement with Galapagos NV and MorphoSys AG for an investigational biologic compound, MOR106, a novel antibody directed against IL-17C. This transaction became effective on September 10, 2018. In October 2019, we announced the end of the clinical development program for MOR106 in atopic dermatitis.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">June</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces its intention to seek shareholder approval for a 100% spin-off of its Alcon Division into a standalone public company. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it will initiate a share buyback of up to USD 5 billion to be executed by the end of 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces the completion on June 1, 2018, of its previously announced divestment to GlaxoSmithKline PLC of its 36.5% stake in GSK Consumer Healthcare Holdings Ltd. for a payment of USD 13.0 billion in cash. The divestment brings to an end Novartis participation in its consumer healthcare joint venture with GSK, which was formed in 2015 as part of the Novartis portfolio transformation.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">May</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces the completion of its previously announced cash tender offer to purchase all the outstanding shares of common stock of AveXis, a US-based clinical stage gene therapy company. This acquisition was completed on May 15, 2018.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">April</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that its Sandoz Division has entered into a collaboration with Pear Therapeutics to commercialize and continue development of novel prescription digital therapeutics, including reSET<sup>&#xAE;</sup> for patients with substance use disorder and reSET-O<sup>&#xAE;</sup> for patients with opioid use disorder who are currently receiving buprenorphine. Novartis announced the commercial launch of reSET<sup>&#xAE;</sup> for patients with substance use disorder in November 2018 and announced FDA clearance of reSET-O<sup>&#xAE;</sup> for patients with opioid use disorder in December 2018 and launch in January 2019. In October 2019, we announced that Pear will assume sole responsibility for commercializing both reSET<sup>&#xAE;</sup> and reSET-O<sup>&#xAE;</sup>.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces a five-year commitment to the fight against malaria in conjunction with the 7<sup>th</sup> Multilateral Initiative on Malaria Conference and the Malaria Summit of the Commonwealth Heads of Government meeting. As part of its commitment, Novartis will invest more than USD 100 million over the next five years to advance research and development of next-generation treatments to combat emerging resistance to artemisinin and other currently </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">25</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">used antimalarials. The Company will also implement an equitable pricing strategy to maximize patient access in malaria-endemic countries when these new treatments become available. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">March</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it has entered into a collaboration and licensing agreement with the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute, both in the US, to develop biomaterial systems for its portfolio of immuno-oncology therapies. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces an additional strategic alliance with Science 37 to design and initiate up to 10 new clinical trials over the next three years, which are intended to blend virtual and traditional clinical trial models, with increasing degrees of decentralization toward a mostly &#x201C;site-less&#x201D; model.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces a collaboration with Pear Therapeutics to develop novel prescription digital therapeutics (software applications designed to effectively treat disease and improve clinical outcomes for patients) for schizophrenia and multiple sclerosis.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">February</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces an alliance with the Bill &amp; Melinda Gates Foundation to advance development of Novartis drug candidate KDU731 for the treatment of cryptosporidiosis. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis completes euro (EUR) denominated bond offerings totaling EUR 2.25 billion. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">January</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces successful completion of its previously announced tender offer and subsequent offering period for all of the then-outstanding ordinary shares, including ordinary shares represented by American Depositary Shares (ADSs), of AAA, a radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicines &ndash; including <i>Lutathera</i> (lutetium Lu 177 dotatate/lutetium (<sup>177</sup>Lu) oxodotreotide), a first-in-class radioligand therapy product for neuroendocrine tumors &ndash; and diagnostic products. Following completion of the tender offer and subsequent offering period, Novartis ownership in AAA was 98.7% of all outstanding ordinary shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces a licensing agreement and a manufacturing and supply agreement with Spark Therapeutics to develop, register and commercialize in markets outside the US voretigene neparvovec, a gene therapy approved as <i>Luxturna</i> in the EU in November 2018 for the treatment of patients with vision loss due to a genetic biallelic mutation of the RPE65 (retinal pigment epithelial 65kDa protein) gene and who have enough viable retinal cells.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces a global collaboration between Sandoz and Biocon Ltd. to develop, manufacture and commercialize multiple biosimilars in immunology and oncology.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2017</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">November</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces an expanded collaboration with Amgen and the US-based Banner Alzheimer&#x2019;s Institute to collaborate on a new Generation Study 2 to assess whether investigational BACE1 inhibitor CNP520 can prevent or delay the symptoms of Alzheimer&#x2019;s disease in a high-risk population. In July 2019, we announced the decision to discontinue the investigation of CNP520 in two Phase II/III studies.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">October</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it has made significant progress in its ongoing strategic review of the Alcon Division and has examined all options, ranging from retaining the business to a capital markets solution (e.g., an IPO or a spin-off). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that its over-the-counter ophthalmic products and certain surgical diagnostic products will transfer from the Innovative Medicines Division to the Alcon Division effective January&nbsp;1, 2018.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">September</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces a collaboration with the University of California, Berkeley to establish the Novartis-Berkeley Center for Proteomics and Chemistry Technologies.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">June</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it has entered into a clinical research collaboration in which Bristol-Myers Squibb is to investigate the safety, tolerability and efficacy of <i>Mekinist</i> (trametinib) in combination with Opdivo<sup>&#xAE;</sup> (nivolumab) and Opdivo<sup>&#xAE;</sup>&nbsp;+&nbsp;Yervoy<sup>&#xAE;</sup> (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces a collaboration with IBM Watson Health to explore development of a cognitive solution that uses real-world data and advanced analytical techniques, with the aim to provide better insights on the expected outcomes of breast cancer treatment options.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">26</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">May</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces the launch of Better Hearts Better Cities, an innovative initiative to address the high rates of high blood pressure in low-income urban communities.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">April</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces an expanded collaboration agreement with Amgen to co-commercialize erenumab (AMG 334) in the US, currently being investigated for the prevention of migraine. This agreement builds on the previously announced 2015 global collaboration between Novartis and Amgen.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it has entered into a clinical trial agreement with Allergan&nbsp;plc to conduct a Phase&nbsp;IIb study involving the combination of a Novartis FXR agonist and Allergan&#x2019;s cenicriviroc for the treatment of nonalcoholic steatohepatitis (NASH).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it has exercised an option to in-license ECF843, a recombinant form of human lubricin from Lubris,&nbsp;LLC, for ophthalmic indications worldwide (outside Europe). This transaction closed and Novartis received its exclusive license on April&nbsp;21, 2017.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">March</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis completes euro-denominated bond offerings totaling EUR 1.85&nbsp;billion.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">February</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis completes a USD 3&nbsp;billion bond offering under its SEC Registration Statement on Form&nbsp;F-3.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">January</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis announces that it is considering options for the Alcon Division. The review will explore all options, ranging from retaining all or part of the business to separation via a capital markets transaction (e.g.,&nbsp;IPO or spin-off), in order to determine how best to maximize value for our shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it is initiating a share buyback of up to USD 5.0&nbsp;billion in 2017 under existing shareholder authority.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis announces that it has entered into a collaboration and option agreement with Ionis Pharmaceuticals,&nbsp;Inc. (Ionis), and its affiliate Akcea Therapeutics,&nbsp;Inc. (Akcea), to license two investigational treatments with the potential to significantly reduce cardiovascular risk in patients suffering from high levels of lipoproteins known as Lp(a) and ApoCIII. In addition, Novartis entered into a stock purchase agreement with Ionis and Akcea. This transaction was completed on February&nbsp;14, 2017.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">27</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00334499"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">4.B Business overview</p><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Overview</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our purpose is to reimagine medicine to improve and extend people&#x2019;s lives. We use innovative science and technology to address some of society&#x2019;s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company. Our vision is to be a trusted leader in changing the practice of medicine. Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science. As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society: unleash the power of our people; deliver transformative innovation; embrace operational excellence; go big on data and digital; and build trust with society.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, Novartis achieved net sales from continuing operations of USD 47.4&nbsp;billion, while net income from continuing operations amounted to USD 7.1&nbsp;billion and total net income to USD 11.7 billion. Headquartered in Basel, Switzerland, our Group companies employed 104 000 full-time equivalent associates as of December&nbsp;31, 2019. Our products are sold in approximately 155 countries around the world.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group comprises two global operating divisions:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"> </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Innovative Medicines: innovative patent-protected prescription medicines</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sandoz: generic pharmaceuticals and biosimilars</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In April 2019, we completed the previously announced spin-off of Alcon into a separately traded standalone company. To comply with IFRS, Novartis has separated the Group&#x2019;s reported financial data for the current and prior years into &#x201C;continuing&#x201D; and &#x201C;discontinued&#x201D; operations. Discontinued operations include the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon to Novartis AG shareholders and certain other expenses related to the spin-off. Except where noted, this Annual Report focuses on continuing operations that includes the businesses of our Innovative Medicines and Sandoz Divisions, as well as continuing Corporate activities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our divisions are supported by the following organizational units: the Novartis Institutes for BioMedical Research, Global Drug Development, Novartis Technical Operations and Novartis Business Services. The financial results of these organizational units are included in the results of the divisions for which their work is performed. The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis, which conducts drug discovery research and early clinical development trials for our Innovative Medicines Division. Approximately 5 600 full time equivalent scientists, physicians and business professionals at NIBR are working to discover new medicines for various diseases at sites located in the US, Switzerland and China. For more information about NIBR, see &#x201C;&mdash;Innovative Medicines&mdash;Research and development&mdash;Research program&#x201D; below.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Global Drug Development (GDD) organization oversees drug development activities for our Innovative Medicines Division and collaborates with our Sandoz Division on development of its biosimilars portfolio. GDD works collaboratively with NIBR and with the Innovative Medicines and Sandoz Divisions to execute our overall pipeline strategy. The GDD organization includes centralized global functions such as Regulatory Affairs and Global Development Operations, as well as Global Development units aligned with our business franchises. GDD includes approximately 11 000 full-time equivalent associates worldwide.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis Technical Operations (NTO) manages manufacturing operations, supply chain, and quality across our Innovative Medicines and Sandoz Divisions. As the Novartis portfolio evolves, we continue to transform our operations to help ensure we can deliver the innovation and expertise needed to enable the production of new medical technologies, while increasing efficiency. NTO is expected to enhance capacity planning and adherence to quality standards, and to lower costs through simplification, standardization and external spend optimization. NTO includes approximately 25 100 full-time equivalent associates and 60 manufacturing sites across our Innovative Medicines and Sandoz Divisions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis Business Services (NBS), our shared services organization, delivers integrated solutions to all Novartis divisions and units worldwide. NBS seeks to drive efficiency and effectiveness across Novartis by simplifying and standardizing services across six service domains: human resources, real estate and facility services, procurement, information technology, commercial and medical support activities, and financial reporting and accounting operations. NBS has approximately 10 000 full-time equivalent associates in more than 30 countries. NBS works to leverage the full scale of Novartis to create value across the Company and to free up resources to invest in innovation and our product pipeline. NBS continues to transfer the delivery of selected services to its five Global Service Centers in Dublin, Ireland; Hyderabad, India; Kuala Lumpur, Malaysia; Mexico City, Mexico; and Prague, Czech Republic.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of January 1, 2019, Novartis Internal Audit, our SpeakUp Office (formerly Business Practices Office) and Global Security were combined into one function called Novartis Business Assurance &amp; Advisory (NBAA).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019 we created a new Global Health and Corporate Responsibility (GH&amp;CR) function to support the integration of our activities in the areas of ethics, pricing and access, global health and corporate responsibility into our core business strategy, and to help align our initiatives, funding and communications in these areas.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">28</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Innovative Medicines Division</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Innovative Medicines Division researches, develops, manufactures, distributes and sells patented prescription medicines to enhance health outcomes for patients and healthcare providers. Innovative Medicines is organized into two global business units: Novartis Oncology and Novartis Pharmaceuticals. Novartis Pharmaceuticals consists of the following global business franchises: Ophthalmology; Neuroscience; Immunology, Hepatology and Dermatology; Respiratory; Cardiovascular, Renal and Metabolism; and Established Medicines.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Sandoz Division</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Sandoz Division develops, manufactures, distributes and sells prescription medicines as well as pharmaceutical active substances that are not protected by valid and enforceable third-party patents. Sandoz is organized globally into three franchises: Retail Generics; Anti-Infectives and Biopharmaceuticals. In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form anti-infectives sold to third parties. In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates &ndash; mainly antibiotics &ndash; for internal use by Retail Generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Alcon Division (discontinued operations)</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Prior to the April 9, 2019 completion of the spin-off, our Alcon Division researched, developed, manufactured, distributed and sold a broad range of eye care products. Alcon was organized into two global business franchises; Surgical and Vision Care. Alcon also provided services, training, education and technical support for both the Surgical and Vision Care businesses.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Corporate activities</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We separately report the results of Corporate activities. The financial results of our Corporate activities include the costs of the Group headquarters and those of corporate coordination functions in major countries. In addition, Corporate includes other items of income and expense that are not attributable to specific segments, such as certain revenues from intellectual property rights and certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations and sponsorships.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"></div><a name="anchorId00334566"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Innovative Medicines</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Overview</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Innovative Medicines Division is a world leader in offering patent-protected medicines to patients and physicians. The Innovative Medicines Division researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two global business units: Novartis Oncology and Novartis Pharmaceuticals.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Novartis Oncology business unit is responsible for the commercialization of products in the areas of cancer and hematologic disorders. The Novartis Pharmaceuticals business unit is organized into the following global business franchises responsible for the commercialization of various products in their respective therapeutic areas: Ophthalmology; Neuroscience; Immunology, Hepatology and Dermatology; Respiratory; Cardiovascular, Renal and Metabolism; and Established Medicines. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Innovative Medicines Division is the larger of our two divisions in terms of consolidated net sales. It reported consolidated net sales of USD 37.7&nbsp;billion in 2019, which represented 79% of the Group&#x2019;s net sales.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The product portfolio of the Innovative Medicines Division includes a significant number of key marketed products, many of which are among the leaders in their respective therapeutic areas.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Innovative Medicines Division products</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following summaries describe certain key marketed products in our Innovative Medicines Division, listed according to year-end net sales within each franchise. While we typically seek to sell our marketed products throughout the world, not all products and indications are available in every country. Therefore, the indications described in these summaries may vary by country. In addition, a product may be available under different brand names depending on country and indication. Some of the products described below have lost patent protection or are otherwise subject to generic competition. Others are subject to patent challenges by potential generic competitors. Please see &#x201C;&mdash;Intellectual property&#x201D; for general information on intellectual property and regulatory data protection, and for further information on the status of patents and exclusivity for Innovative Medicines Division products.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">29</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key marketed products</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Novartis Oncology business unit</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Oncology</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Tasigna </i>(nilotinib) is an oral signal transduction inhibitor of the BCR-ABL tyrosine kinase. <i>Tasigna</i> is approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic and/or accelerated phase who are resistant or intolerant to existing treatment </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Newly diagnosed adults and children with Ph+ CML in the chronic phase </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Sandostatin</i> SC (octreotide acetate for injection) and <i>Sandostatin LAR</i> (octreotide acetate for injectable suspension) are somatostatin analogs approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with acromegaly, a chronic disease caused by the oversecretion of growth hormone, whose condition is not adequately controlled by surgery or radiotherapy</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients with certain symptoms associated with carcinoid tumors and other types of functional gastrointestinal and pancreatic neuroendocrine tumors</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Sandostatin LAR</i> is also approved in: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The EU and other countries for the treatment of patients with advanced neuroendocrine tumors of the midgut or of unknown primary tumor origin</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Japan for the treatment of patients with neuroendocrine tumors of the gastrointestinal tract   </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Afinitor/Votubia</i> (everolimus) is an oral inhibitor of the mTOR pathway. <i>Afinitor</i> is approved in the US, the EU, Japan and other countries for oncology indications that vary by country. It is approved for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Postmenopausal women with advanced hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer, in combination with the medicine exemestane, when certain other medicines have not worked</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with renal cell carcinoma (advanced kidney cancer) when certain other medicines have not worked</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with a type of cancer known as neuroendocrine tumor (NET) of the pancreas, and non-symptomatic NET of the stomach, intestine (gastrointestinal) or lung that has progressed and cannot be treated with surgery (<i>Afinitor</i> is not indicated for use in people with carcinoid tumors that actively produce hormones)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Everolimus is approved for additional indications as <i>Afinitor/Afinitor Disperz</i> in the US, Japan and other countries, and as <i>Votubia</i> (tablets and dispersible tablets) in the EU. The following indications vary by country:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with a kidney tumor called angiomyolipoma, which occurs with a genetic condition called tuberous sclerosis complex (TSC), when the tumor does not require immediate surgery (tablet formulation only) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children who have TSC and a brain tumor called subependymal giant cell astrocytoma (SEGA) when the tumor cannot be removed completely by surgery</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 2 years and older who have TSC and certain types of seizures (epilepsy), as an added treatment to other antiepileptic medicines (dispersible tablet formulation only)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Everolimus is available under the trade names <i>Zortress/Certican</i> for use in transplantation. It is exclusively licensed to Abbott Laboratories and sublicensed to Boston Scientific for use in drug-eluting stents.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Promacta/Revolade</i> (eltrombopag) is a once-daily oral thrombopoietin receptor agonist that works by stimulating bone marrow cells to produce platelets. It is approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; A bleeding disorder called chronic immune (idiopathic) thrombocytopenia in patients who have had an inadequate response or are intolerant to other treatments</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Thrombocytopenia in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Promacta/Revolade</i> is also approved in:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The US and other countries as first-line therapy for adults and children aged 2 years and older with severe aplastic anemia (SAA) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Japan as first-line therapy for adults with SAA</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The EU and other countries for adults with SAA who are resistant to other treatments</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Promacta/Revolade</i> is marketed under a research, development and license agreement between Novartis and RPI Finance Trust (dba Royalty Pharma), as assignee of Ligand Pharmaceuticals.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Tafinlar&nbsp;</i>+<i>&nbsp;Mekinist</i> (dabrafenib + trametinib) is an oral combination therapy. <i>Tafinlar</i> and <i>Mekinist</i> are kinase inhibitors of the BRAF and MEK1/2 proteins, respectively, approved in combination in the US, the EU, Japan and other countries for the treatment of: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with unresectable (not removable through surgery) or metastatic melanoma with a BRAF V600 mutation</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with stage III melanoma with a BRAF V600 mutation as an adjuvant treatment</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with advanced non-small cell lung cancer with a BRAF V600 mutation</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Additionally, the combination is approved in the US and other countries for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with locally advanced or metastatic anaplastic thyroid cancer with a BRAF V600 mutation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Tafinlar</i> and <i>Mekinist</i> are also indicated as single agents to treat patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Novartis has worldwide exclusive rights to develop, manufacture and commercialize trametinib granted by Japan Tobacco Inc.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">30</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Gleevec/Glivec</i> (imatinib mesylate/imatinib) is an oral kinase inhibitor. <i>Gleevec</i> is approved in the US for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Newly diagnosed adults and children with Ph+ CML in the chronic phase</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults in the chronic, accelerated or blast crisis phase of Ph+ CML after failure of interferon-alpha therapy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Newly diagnosed children with Ph+ ALL, in combination with chemotherapy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with KIT (CD117)-positive gastrointestinal stromal tumors (GISTs) that cannot be surgically removed and/or have spread to other parts of the body</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults who have had their KIT (CD117)-positive GIST completely surgically removed</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with advanced hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have a rearrangement of two genes called FIP1L1 and PDGFR-alpha</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Glivec</i> is approved in the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Newly diagnosed adults and children with Ph+ CML for whom bone marrow transplantation is not considered as the first line of treatment</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children in the chronic phase of Ph+ CML after failure of interferon-alpha therapy, or in the accelerated or blast crisis phase of Ph+ CML</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with relapsed or refractory Ph+ ALL, as monotherapy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Newly diagnosed adults and children with Ph+ ALL, in combination with chemotherapy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with KIT (CD117)-positive GISTs that cannot be surgically removed and/or have spread to other parts of the body</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with advanced HES and/or chronic CEL with the FIP1L1-PDGFR-alpha rearrangement</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults who have had their KIT (CD117)-positive GIST completely surgically removed and who are at significant risk of relapse</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Gleevec/Glivec</i> is also approved in other rare cancers, including: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the US and the EU for the treatment of adults with myelodysplastic/myeloproliferative diseases, a group of diseases of the blood and bone marrow</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the US for the treatment of adults with aggressive systemic mastocytosis (a form of mast cell disease), and adults with dermatofibrosarcoma protuberans (a rare skin cancer) when surgery is not possible or the disease has spread</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Jakavi</i> (ruxolitinib) is an oral inhibitor of the JAK1 and JAK2 tyrosine kinases that is the first therapy approved in the EU, Japan and other countries to treat two kinds of myeloproliferative neoplasms, a group of related and rare blood cancers characterized by the overproduction of blood cells in the bone marrow. It is approved for the treatment of: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with polycythemia vera who are resistant or intolerant to a medication called hydroxyurea</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Novartis licensed ruxolitinib from Incyte Corporation for development and commercialization in the indications of oncology, hematology and graft-versus-host disease outside the US. Incyte Corporation markets ruxolitinib as Jakafi<sup>&#xAE;</sup> in the US. </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Exjade</i> and <i>Jadenu</i> (deferasirox) are oral iron chelators approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 2 years and older who have chronic iron overload due to blood transfusions </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 10 years and older who have chronic iron overload with non-transfusion-dependent thalassemia (a group of blood disorders that do not require regular blood transfusions)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Votrient</i> (pazopanib) is an oral tyrosine kinase inhibitor that targets a number of growth factors to limit new blood vessel and tumor growth. <i>Votrient</i> is approved in the US and Japan for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with advanced renal cell carcinoma (RCC)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with advanced soft tissue sarcoma (STS) who have received chemotherapy (it is not known if <i>Votrient</i> is effective in treating adipocytic STS or certain gastrointestinal tumors)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Votrient</i> is also approved in the EU for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with advanced RCC as first-line therapy, and adults with advanced RCC who have received cytokine therapy for advanced disease</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with certain subtypes of advanced STS who have received chemotherapy for metastatic disease or whose cancer has progressed within 12 months after neoadjuvant therapy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Kisqali</i> (ribociclib) is an oral cyclin-dependent kinase inhibitor. It is approved in the US, the EU and other countries for the treatment of: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Pre-, peri- and postmenopausal women with HR+/HER2- advanced or metastatic breast cancer, in combination with an aromatase inhibitor as initial endocrine-based therapy </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Postmenopausal women with HR+/HER2- locally advanced or metastatic breast cancer, in combination with fulvestrant as initial endocrine based-therapy or following disease progression on endocrine therapy</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Kisqali</i> was developed by the Novartis Institutes for BioMedical Research under a research collaboration with Astex Pharmaceuticals.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Lutathera</i> (lutetium Lu 177 dotatate/lutetium (<sup>177</sup>Lu) oxodotreotide) is an intravenous radioligand therapy approved in the US for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">31</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">NETs), including foregut, midgut and hindgut neuroendocrine tumors </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Lutathera</i> is also approved in the EU and other countries for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with unresectable or metastatic, progressive, well-differentiated (G1 and G2), somatostatin receptor-positive GEP-NETs   </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Kymriah </i>(tisagenlecleucel) suspension for intravenous infusion is a CD19-directed genetically modified autologous chimeric antigen receptor T-cell (CAR-T) therapy. <i>Kymriah</i> is approved in the US, the EU, Japan and other countries for the treatment of: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients up to 25&nbsp;years old with B-cell acute lymphoblastic leukemia that is refractory or in second or later relapse</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Piqray</i> (alpelisib) is an oral kinase inhibitor. It is approved in the US and other countries for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Postmenopausal women, and men, with HR+/HER2- advanced or metastatic breast cancer with a PIK3CA mutation, in combination with fulvestrant following disease progression on or after an endocrine-based regimen</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Piqray</i> received US approval in May 2019.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Adakveo</i> (crizanlizumab) is a humanized monoclonal antibody that binds to P-selectin, a cell adhesion protein that plays a central role in the multicellular interactions that can lead to vaso-occlusion in sickle cell disease. Delivered as an intravenous infusion, <i>Adakveo</i> is approved in the US to:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Reduce the frequency of vaso-occlusive crises (VOCs), or pain crises, in patients aged 16 years and older with sickle cell disease</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Adakveo</i> received US approval in November 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Novartis Pharmaceuticals business unit</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Ophthalmology</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Lucentis</i> (ranibizumab) is a recombinant, humanized, high-affinity antibody fragment that binds to vascular endothelial growth factor A (VEGF-A), a protein that causes the growth of blood vessels in the eye, which can lead to vision loss. <i>Lucentis</i> is an injectable anti-VEGF therapy specifically designed for the eye, minimizing systemic exposure. It is approved in the EU, Japan and other countries. Approvals and indications vary by country: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with neovascular (wet) age-related macular degeneration (AMD)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with visual impairment due to choroidal neovascularization (CNV)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with CNV secondary to pathologic myopia</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with visual impairment due to diabetic macular edema</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with visual impairment due to macular edema secondary to retinal vein occlusion (branch and central retinal vein occlusion)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with moderately severe to severe non-proliferative diabetic retinopathy and proliferative diabetic retinopathy</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Preterm infants with retinopathy of prematurity (ROP) in zone I (stage 1+, 2+, 3 or 3+) or zone II (stage 3+), or aggressive posterior ROP </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Lucentis</i> is licensed from Genentech, and Novartis holds the rights to commercialize the product outside the US. Genentech holds the rights to commercialize <i>Lucentis</i> in the US. For further information, see &#x201C;Item 18. Financial Statements&mdash;Note 27. Transactions with related parties&mdash;Genentech/Roche.&#x201D;</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Xiidra</i> (lifitegrast) is a prescription eye drop designed to block the interaction between LFA-1 and ICAM-1, inhibiting the formation of the immunological synapse and reducing inflammation. <i>Xiidra</i> is approved in the US and other countries for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The signs and symptoms of dry eye disease in patients over 17 years old</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Novartis acquired <i>Xiidra</i> from Takeda Pharmaceutical Company Limited and began recording sales as of July 1, 2019. <i>Xiidra</i> is marketed in the US. It is not currently marketed in the EU or Japan. </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Beovu</i> (brolucizumab) is an injectable, humanized single-chain antibody fragment that acts as an anti-VEGF agent. It is approved in the US for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients with neovascular (wet) age-related macular degeneration</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Beovu</i> received US approval in October 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Immunology, Hepatology and Dermatology<sup>1</sup></div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Cosentyx</i> (secukinumab) is an injectable fully human monoclonal antibody that specifically inhibits interleukin-17A (IL-17A), a cytokine involved in the pathogenesis of psoriasis, ankylosing spondylitis and psoriatic arthritis. It is approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with moderate-to-severe plaque psoriasis</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with active ankylosing spondylitis</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with active psoriatic arthritis</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Cosentyx</i> is also approved in Japan for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with pustular psoriasis</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:8pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><sup>1</sup> <i>Xolair</i> sales for all indications are reported in the Respiratory franchise.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">32</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Ilaris </i>(canakinumab) is an injectable, selective, high-affinity, fully human monoclonal antibody that inhibits interleukin-1 beta (IL-1 beta), a key cytokine (a type of protein) in the inflammatory pathway. <i>Ilaris</i> is approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with cryopyrin-associated periodic syndromes</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with tumor necrosis factor receptor-associated periodic syndrome</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with hyperimmunoglobulin D syndrome/mevalonate kinase deficiency</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with familial Mediterranean fever</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with systemic juvenile idiopathic arthritis</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Ilaris</i> is also approved in the EU for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with Still&#x2019;s disease</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with refractory acute gouty arthritis</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Neuroscience</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Gilenya </i>(fingolimod) is an oral sphingosine-1-phosphate (S1P) receptor modulator that has a reversible lymphocyte redistribution effect and readily crosses the blood-brain barrier to bind to the S1P receptors based in the central nervous system. It is approved in the US for the treatment of:  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 10 years and older with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive multiple sclerosis (SPMS) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Gilenya</i> is also approved in the EU for the treatment of: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 10 years and older who have highly active RRMS despite treatment with at least one disease-modifying agent, or who have rapidly evolving severe RRMS </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Gilenya</i> is licensed from Mitsubishi Tanabe Pharma Corporation.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Zolgensma</i> (onasemnogene abeparvovec-xioi) is a gene therapy delivered as a single-dose intravenous infusion. It is designed to provide a functional copy of the human survival motor neuron (SMN) gene to halt disease progression through sustained SMN protein expression. <i>Zolgensma</i> is approved in the US for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Children less than 2 years old who have spinal muscular atrophy with biallelic mutations in the SMN1 gene</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Zolgensma</i> received US approval in May 2019 and is marketed by AveXis, a Novartis company.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i> <i>Aimovig</i> (erenumab-aooe/erenumab) is a once-monthly injection that can be self-administered or administered by another trained person. It is specifically designed to block the calcitonin gene-related peptide receptor (CGRP-R), which plays a critical role in migraine. It is approved: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the US for the prevention of migraine in adults</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the EU for the prevention of migraine in adults who have at least four migraine days per month</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Aimovig</i> is launched in 38 countries. Novartis and Amgen co-commercialize <i>Aimovig</i> in the US, where Amgen records sales. Novartis has exclusive commercialization rights for all ex-US territories, excluding Japan. The collaboration continues during the previously announced litigation between the companies and will remain in force until and unless a final court decision terminates the agreements.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Mayzent</i> (siponimod) is an oral, selective S1P receptor modulator. It binds selectively to the S1P receptor subtypes 1 and 5, and penetrates the central nervous system, where it may impact central nervous system inflammation and repair mechanisms. <i>Mayzent</i> is approved:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the US for the treatment of adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting multiple sclerosis (RRMS) and active secondary progressive multiple sclerosis (SPMS)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In the EU for the treatment of adults with SPMS with active disease </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Mayzent</i> received US approval in March 2019 and EU approval in January 2020. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Respiratory</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i> <i>Xolair</i> (omalizumab) is an injectable prescription medicine and the only approved antibody designed to target and block immunoglobulin E (IgE). It is approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 6 years and older with moderate-to-severe, or severe, persistent allergic asthma </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children aged 12 years and older with chronic spontaneous urticaria/chronic idiopathic urticaria (hives) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Xolair</i> is also approved in Japan for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients with severe seasonal allergic rhinitis (hay fever)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Xolair</i> is provided as lyophilized powder for reconstitution, and as liquid formulation in a pre-filled syringe. Novartis co-promotes <i>Xolair</i> with Genentech in the US and shares a portion of operating income, but Novartis does not record any US sales. Novartis records all sales of <i>Xolair</i> outside the US. For further information, see &#x201C;Item 18. Financial Statements&mdash;Note 27. Transactions with related parties&mdash;Genentech/Roche.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Cardiovascular, Renal and Metabolism </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Entresto</i> (sacubitril/valsartan) is an oral, first-in-class angiotensin receptor/neprilysin inhibitor. It enhances the protective neurohormonal systems of the heart (the neprilysin system) while simultaneously suppressing the harmful system (the renin-angiotensin-aldosterone system). <i>Entresto</i> is approved in the US, the EU and other countries for the treatment of:</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">33</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults who have symptomatic chronic heart failure with reduced ejection fraction (HFrEF)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Entresto</i> is also approved in the US for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Children aged 1 year and older who have symptomatic heart failure with systemic left ventricular systolic dysfunction </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Entresto</i> is approved in 112 countries. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Established Medicines</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Galvus/Equa</i> (vildagliptin) is an oral inhibitor of the DPP-4 enzyme. It is approved in the EU, Japan and other countries for the treatment of: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with type 2 diabetes when used as monotherapy; in dual combination with metformin, a sulfonylurea or a thiazolidinedione; in triple combination with a sulfonylurea and metformin; and as an add-on to insulin (with or without metformin) </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">An oral single-pill combination of vildagliptin and metformin, marketed as <i>Eucreas/EquMet/GalvusMet</i>, is also approved in the EU, Japan and other countries for the treatment of type&nbsp;2 diabetes. Sumitomo Dainippon Pharma Co. Ltd. promotes <i>Equa</i> and <i>EquMet</i> in Japan. </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Diovan</i> (valsartan) is an oral angiotensin II receptor blocker (ARB). It is approved in the US, the EU, Japan and other countries for the treatment of:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults and children with hypertension (high blood pressure)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients with heart failure </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients with left ventricular failure and/or left ventricular systolic dysfunction following a myocardial infarction (heart attack) </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Hypertensive patients who have impaired glucose tolerance and are at risk of heart disease </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">An oral single-pill combination of valsartan and hydrochlorothiazide, marketed as <i>Diovan HCT/Co-Diovan</i>, is also approved in the US, the EU, Japan and other countries for the treatment of hypertension.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Exforge</i> (valsartan and amlodipine besylate) is an oral single-pill combination of the ARB valsartan and the calcium channel blocker amlodipine besylate. It is approved in the US, the EU, Japan and other countries for the treatment of: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adults with hypertension</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">An oral single-pill combination of valsartan, amlodipine besylate and hydrochlorothiazide, marketed as <i>Exforge HCT</i>, is also approved in the US, the EU, Japan and other countries for the treatment of hypertension.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Zortress/Certican</i> (everolimus) is an oral inhibitor of the mTOR pathway. It is approved in the US, the EU, Japan and other countries for the prophylaxis of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Organ rejection in adults at low to moderate immunological risk receiving an allogeneic kidney or liver transplant</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">It is also approved in the EU and Japan for the prophylaxis of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Organ rejection in adults receiving a heart transplant</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Everolimus is available under the trade names <i>Afinitor/Votubia</i> for use in oncology. It is exclusively licensed to Abbott Laboratories and sublicensed to Boston Scientific for use in drug-eluting stents.</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Egaten</i> (triclabendazole) is an oral narrow-spectrum anthelmintic agent that inhibits a parasitic flatworm&#x2019;s motility and interferes with the worm&#x2019;s microtubular structure and function. <i>Egaten</i> is approved in the US, France and Egypt for the treatment of:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:18px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Patients aged 6 years and older with fascioliasis, a parasitic infection commonly known as liver fluke infestation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;"><i>Egaten</i> received US approval in February 2019. It is the only medicine for fascioliasis recommended by the World Health Organization (WHO) and is on the WHO Model List of Essential Medicines. Novartis has been donating <i>Egaten</i> to the WHO for the treatment of fascioliasis since 2005.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compounds in development</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table and paragraph summaries provide an overview of the key Innovative Medicines Division projects currently in the Confirmatory Development stage and may also describe certain projects in the Exploratory Development stage. Projects are listed in alphabetical order by project code, or by product name where applicable. Projects include those seeking to develop potential uses of new molecular entities as well as potential additional indications or new formulations for already marketed products. The table below, entitled &#x201C;Projects added to and subtracted from the development table since 2018,&#x201D; highlights changes to the table entitled &#x201C;Selected development projects&#x201D; from the previous year.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Compounds and new indications in development are subject to required regulatory approvals and, in certain instances, contractual limitations. These compounds and indications are in various stages of development throughout the world. It may not be possible to obtain regulatory approval for any or all of the new compounds and new indications referred to in this Form&nbsp;20-F in any country or in every country. See &#x201C;&mdash;Regulation&#x201D; for further information on the approval process.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The year that each project entered the current phase of development disclosed below refers to the year in which the decision to enter the phase was made. This may be different from the year in which the first patient received the first treatment in the related clinical trial. A reference to a project being in registration means that an application has been submitted to a health authority for marketing approval.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">34</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Selected development projects</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br><br><br>Project/<br>product</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Common <br> name</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Mechanism <br> of action</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> <br> Potential indication</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Business<br> franchise</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Formulation/<br> route of<br> administration</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Year project<br> entered<br> current<br> development<br> phase</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Planned filing<br> dates/current<br> phase</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ABL001</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> asciminib</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BCR-ABL inhibitor</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia, 3<sup>rd</sup> line</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ACZ885</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> canakinumab  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-interleukin-1 beta   monoclonal antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2<sup>nd</sup> line non-small cell lung cancer  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1<sup>st</sup> line non-small cell lung cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Adjuvant non-small cell lung cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">AVXS-101<sup>1</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> onasemno-  gene abepar-  vovec</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Survival motor neuron   (SMN) gene   replacement therapy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Spinal muscular atrophy   (IV formulation)  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US approved  EU registration  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Spinal muscular atrophy   (IT formulation)<sup>2</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intrathecal injection  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020/I  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">AVXS-201</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Methyl-CpG binding   protein 2 (MECP2) gene   replacement therapy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Rett syndrome    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intrathecal injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/I    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">BYL719<sup>3</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> alpelisib        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PI3K-alpha inhibitor        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PIK3CA mutant hormone receptor-positive   (HR+)/human epidermal growth factor   receptor 2-negative (HER2-)   postmenopausal advanced breast cancer,   2<sup>nd</sup> line (+&#xA0;fulvestrant)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US approved  EU registration      </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PIK3CA-related overgrowth spectrum</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Triple negative breast cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hormone receptor-negative (HR-)/human  epidermal growth factor receptor 2-positive  (HER2+) advanced breast cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ovarian cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Head and neck squamous cell carcinoma</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CEE321</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Pan-JAK inhibitor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Atopic dermatitis    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Topical    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CFZ533</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> iscalimab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Blocking, non-depleting,   anti-CD40 monoclonal   antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Solid organ transplantation    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Sj&#xF6;gren's syndrome    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Cosentyx</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> secukinumab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-interleukin-17   monoclonal antibody  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Non-radiographic axial spondyloarthritis    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US/EU  registration  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriatic arthritis head-to-head study   versus Humira<sup>&#xAE;</sup> (adalimumab)  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ankylosing spondylitis head-to-head study   versus Sandoz biosimilar <I>Hyrimoz</I>   (adalimumab)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hidradenitis suppurativa    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Giant cell arteritis    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Lichen planus    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CSJ117</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-thymic stromal  lymphopoietin   monoclonal   antibody fragment</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe asthma      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Respiratory      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Inhalation      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II      </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ECF843</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Boundary lubricant</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Dry eye</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Eye drops</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022/II</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><I>Entresto</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> valsartan and   sacubitril   (as sodium   salt complex)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Angiotensin receptor/   neprilysin inhibitor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic heart failure with preserved   ejection fraction    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020/III      </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Post-acute myocardial infarction    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Approved in the US as <I>Zolgensma</I> for spinal muscular atrophy (IV formulation)</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> The FDA has placed a partial clinical hold on AVXS-101 intrathecal trials for spinal muscular atrophy patients based on findings in a small preclinical animal study.</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Approved in the US as <I>Piqray</I> for PIK3CA mutant HR+/HER2- postmenopausal advanced breast cancer, 2<sup>nd</sup> line (+&#xA0;fulvestrant)</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">35</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br><br><br>Project/<br>product</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Common <br> name</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Mechanism <br> of action</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> <br> Potential indication</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Business<br> franchise</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Formulation/<br> route of<br> administration</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Year project<br> entered<br> current<br> development<br> phase</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Planned filing<br> dates/current<br> phase</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">INC280</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> capmatinib</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> c-MET inhibitor</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Non-small cell lung cancer</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US registration</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Solid tumors</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Jakavi</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ruxolitinib</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JAK1/2 inhibitor</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acute graft-versus-host disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic graft-versus-host disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">KAE609</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> cipargamin  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PfATP4 inhibitor  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Malaria  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established  Medicines</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe malaria  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established  Medicines</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">KAF156</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ganaplacide  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Imidazolopiperazines   derivative</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Malaria  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established  Medicines</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Kisqali</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ribociclib</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CDK4/6 inhibitor</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HR+/HER2- breast cancer (adjuvant)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">KJX839</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> inclisiran    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Small-interfering RNA  (PCSK9)  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hyperlipidemia    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US/EU   registration  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Secondary prevention of cardiovascular   events in patients with elevated levels   of LDL-C</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Kymriah</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> tisagen-  lecleucel  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CD19-targeted chimeric   antigen receptor T-cell   immunotherapy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsed/refractory follicular lymphoma    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsed/refractory diffuse large B-cell   lymphoma in 1<sup>st</sup> relapse</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsed/refractory diffuse large B-cell   lymphoma (+ pembrolizumab)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LAM320</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> clofazimine  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Mycobacterial   DNA binding</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Multidrug-resistant tuberculosis  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established  Medicines</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LJC242</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> tropifexor,   cenicriviroc   (in fixed-dose  combination)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> FXR agonist and   CCR2/5 inhibitor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Nonalcoholic steatohepatitis      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II      </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LJN452</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> tropifexor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> FXR agonist    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Nonalcoholic steatohepatitis    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LMI070</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> branaplam  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SMN2 RNA splicing   modulator</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Spinal muscular atrophy  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LNP023</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Factor B inhibitor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> IgA nephropathy    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> C3 glomerulopathy    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Paroxysmal nocturnal hemoglobinuria    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Membranous nephropathy    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal   and Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LOU064</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BTK inhibitor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic spontaneous urticaria    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><sup>177</sup>Lu- PSMA-617</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Targeted DNA   destruction via   beta-particle   radiation</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Metastatic castration-resistant   prostate cancer    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020/III      </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LXE408</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Kinetoplastid  proteasome inhibitor</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Visceral leishmaniasis  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established  Medicines</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">MBG453</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TIM-3 antagonist</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelodysplastic syndrome</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/II</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acute myeloid leukemia</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">OMB157</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ofatumumab  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-CD20 monoclonal   antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US/EU  registration</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">PDR001</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> spartalizumab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-PD-1 monoclonal   antibody  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Metastatic BRAF V600+  melanoma  (w/&#xA0;<I>Tafinlar</I>&#xA0;+ <I>Mekinist</I>)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Metastatic melanoma (combo)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/II</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">QBW251</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CFTR potentiator</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic obstructive pulmonary disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Respiratory</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">QGE031</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ligelizumab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> High-affinity anti-IgE   monoclonal antibody  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic spontaneous urticaria/   chronic idiopathic urticaria  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">QMF149</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> indacaterol,   mometasone   furoate   (in fixed-dose   combination)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Long-acting beta<sub>2</sub>-  adrenergic agonist and   inhaled corticosteroid    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Asthma        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Respiratory        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Inhalation        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019        </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EU registration        </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">36</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br><br><br>Project/<br>product</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Common <br> name</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Mechanism <br> of action</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> <br> Potential indication</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Business<br> franchise</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Formulation/<br> route of<br> administration</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Year project<br> entered<br> current<br> development<br> phase</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Planned filing<br> dates/current<br> phase</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">QVM149</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> indacaterol,   mometasone   furoate,   glyco-  pyrronium   bromide   (in fixed-dose   combination)</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Long-acting beta<sub>2</sub>-  adrenergic agonist,   long-acting muscarinic   antagonist and inhaled   corticosteroid      </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Asthma              </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Respiratory              </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Inhalation              </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019              </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EU registration              </div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">RTH258<sup>4</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> brolucizumab  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-VEGF single-chain   antibody fragment</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neovascular (wet) age-related macular   degeneration</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravitreal injection  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US approved  EU registration</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetic macular edema</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravitreal injection</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Retinal vein occlusion</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravitreal injection</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Proliferative diabetic retinopathy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravitreal injection</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">SAF312</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRPV1 antagonist</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic ocular surface pain</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Topical</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">SEG101<sup>5</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> crizanlizumab  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> P-selectin inhibitor  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Sickle cell disease  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US approved  EU registration</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">TQJ230</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-apo(a) antisense   oligonucleotide  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Secondary prevention of cardiovascular   events in patients with elevated levels   of lipoprotein(a)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,   Renal and   Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">UNR844</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of   disulfide bonds  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Presbyopia    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular,  Renal and   Metabolism</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Eye drops    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">VAY736</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ianalumab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-BAFF (B-cell-   activating factor)   monoclonal antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Autoimmune hepatitis    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Primary Sj&#xF6;gren&#x2019;s syndrome    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">VPM087</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TBD    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Interleukin-1 beta   neutralization   monoclonal antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Colorectal cancer, 1<sup>st</sup> line;  renal cell carcinoma, 1<sup>st</sup> line  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous infusion    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/I    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Xolair</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> omalizumab  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-IgE monoclonal   antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Nasal polyps  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Respiratory  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> US/EU   registration</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Food allergy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Respiratory</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous injection</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021/III</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ZPL389</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> adriforant    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Histamine H4 receptor   antagonist  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Atopic dermatitis    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and   Dermatology</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oral    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2265;2024/II    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Approved in the US as <I>Beovu</I> for neovascular (wet) age-related macular degeneration</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Approved in the US as <I>Adakveo</I> for sickle cell disease</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Key development projects</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; ABL001 (asciminib) is an investigational oral BCR-ABL inhibitor that binds to the allosteric site of its target (BCR-ABL1). A broad clinical development program is investigating ABL001 as a monotherapy and as a combination therapy for the treatment of chronic myeloid leukemia (CML). This program includes the Phase III ASCEMBL third-line study, and the Phase II ASC4MORE first-line study of ABL001 plus imatinib in patients with CML in chronic phase without achieving deep molecular response. Novartis is studying ABL001 in patients with and without genetic mutations that make them resistant to many targeted CML therapies.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; ACZ885 (canakinumab) is an injectable human monoclonal antibody designed to bind to human interleukin-1 beta (IL-1 beta). ACZ885 was first approved as <i>Ilaris</i> in 2009 for cryopyrin-associated periodic syndromes, a group of rare auto-inflammatory disorders. At the 2017 European Society of Cardiology Congress, Novartis presented data from CANTOS, a Phase III study evaluating quarterly injections of ACZ885 in people with a prior heart attack and inflammatory atherosclerosis. A blinded, pre-planned analysis of these data revealed a 77% reduction in lung cancer mortality and a 67% reduction in lung cancer cases in patients treated with 300 mg of ACZ885. These findings suggest the potential benefit of inhibiting tumor-promoting inflammation in cancer treatment. Based on these CANTOS findings, Novartis initiated three Phase III studies of ACZ885 in lung cancer: the CANOPY trials. Study outcomes may begin to be reported in 2021. During 2019, Novartis presented Trials in Progress (TiP) updates at the American Society of Clinical Oncology (ASCO) annual meeting, and an overview of the Phase III CANOPY trials at the European Society for Medical Oncology (ESMO) Congress. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; AVXS-101 (onasemnogene abeparvovec, approved in the US as <i>Zolgensma</i>) is a gene therapy designed to address the genetic root cause of spinal muscular atrophy (SMA) by providing a functional copy of the human survival motor neuron (SMN) gene to halt disease progression through sustained SMN protein expression. The US Food and Drug Administration (FDA) approved the intravenous formulation of AVXS-101 as <i>Zolgensma</i> in May 2019 for the treatment of pediatric patients less than 2 years old who have SMA with biallelic mutations in the SMN1 gene. Regulatory reviews are underway in </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">37</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Europe, with a CHMP opinion anticipated in the first quarter of 2020, and in Japan, with a decision anticipated in the first half of 2020. AVXS-101 is in ongoing clinical studies, including the global Phase III STR1VE clinical program (consisting of STR1VE-US, STR1VE-EU and STR1VE-AP) to evaluate the intravenous formulation of AVXS-101 in patients who have SMA type 1, and the multinational Phase III SPR1NT trial in presymptomatic patients who have SMA with two or three copies of the SMN2 gene. Additionally, AVXS-101 intrathecal administration is being studied in a Phase I/II STRONG trial in patients who have SMA type 2 and three copies of the SMN2 gene. The STRONG trial is currently on partial clinical hold based on findings in a small preclinical animal study, and the Company is working with the FDA to determine next steps to resume dosing. New data from trials were presented at 2019 congresses, including the American Academy of Neurology Annual Meeting.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; BYL719 (alpelisib, approved in the US as <i>Piqray</i>) is an orally bioavailable, alpha-specific PI3K inhibitor approved in combination with fulvestrant for the treatment of postmenopausal women, and men, with HR+/HER2-, PIK3CA-mutated, advanced or metastatic breast cancer. <i>Piqray</i> received FDA approval based on results of the Phase III SOLAR-1 trial, which showed that <i>Piqray</i> plus fulvestrant nearly doubled median progression-free survival compared to fulvestrant alone. Novartis is conducting a Phase II open-label trial, called BYLieve, to evaluate BYL719 plus fulvestrant or letrozole in patients with HR+/HER2-, PIK3CA-mutated advanced breast cancer who have progressed on prior therapy. Novartis is also planning to evaluate BYL719 in triple negative breast cancer; head and neck squamous cell carcinoma; ovarian cancer; and PIK3CA-related overgrowth spectrum, for which BYL719 received FDA breakthrough therapy designation.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CFZ533 (iscalimab), delivered subcutaneously as an injection, is a fully human, Fc-silenced IgG1 monoclonal antibody that blocks the CD40 receptor. CFZ533 is in clinical development to prevent graft rejection after organ transplantation and to treat several autoimmune diseases, including Sj&#xF6;gren&#x2019;s syndrome. In the proof-of-concept study, CFZ533 demonstrated the ability to preserve graft function and pristine histology, confirming preclinical in vivo data. Recruitment is underway for two Phase II studies in kidney and liver transplant recipients (CIRRUS I and CONTRAIL I, respectively), and for a Phase II study in patients with Sj&#xF6;gren&#x2019;s syndrome (TWINSS).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Cosentyx</i> (secukinumab) is an injectable fully human monoclonal antibody that specifically inhibits interleukin-17A (IL-17A). In August and December 2019, Novartis submitted positive data to the EMA and the FDA, respectively, from the Phase III PREVENT trial, which evaluated the efficacy and safety of <i>Cosentyx</i> in patients with non-radiographic axial spondyloarthritis. In November 2019, Novartis disclosed first results from the EXCEED head-to-head trial comparing <i>Cosentyx</i> to Humira<sup>&#xAE;</sup> (adalimumab) in patients with active psoriatic arthritis (PsA). While narrowly missing statistical significance for superiority in ACR20, the primary endpoint of the EXCEED trial, <i>Cosentyx</i> showed numerically higher results versus Humira<sup>&#xAE;</sup>. <i>Cosentyx</i> is in a Phase III head-to-head trial versus the Sandoz biosimilar <i>Hyrimoz</i> (adalimumab) in ankylosing spondylitis; Phase III trials in pediatric psoriasis, juvenile idiopathic arthritis and hidradenitis suppurativa; and a Phase II trial in giant cell arteritis. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Entresto</i> (sacubitril/valsartan) is an oral, first-in-class angiotensin receptor/neprilysin inhibitor. Novartis is conducting multiple studies of sacubitril/valsartan as part of the FortiHFy clinical program, designed to generate additional data on sacubitril/valsartan and increase understanding of heart failure. The PIONEER-HF and TRANSITION studies both read out in 2018 and confirmed safety and superiority of <i>Entresto</i> versus enalapril in patients with chronic heart failure with reduced ejection fraction (HFrEF) who were stabilized following admission to the hospital for an acute decompensated heart failure event. The PROVE and EVALUATE trials read out in 2019. The PROVE-HF trial showed significant improvements in measures of cardiac structure and function at six months and one year in HFrEF patients; EVALUATE-HF results complemented PROVE-HF findings. The FortiHFy program also includes studies to investigate sacubitril/valsartan use in novel indications and expanded patient populations. These include PARAGON-HF and PARALLAX-HF, Phase III trials of sacubitril/valsartan in patients with chronic heart failure with preserved ejection fraction (HFpEF). Results of PARAGON-HF were published in September 2019, and while the trial narrowly missed its primary endpoint with a 13% treatment effect against an active valsartan comparator, the totality of evidence suggests that treatment with sacubitril/valsartan may result in clinically important benefits in HFpEF. US regulatory submission for HFpEF is on track for early 2020. PARALLAX-HF enrollment is complete and results are expected to be presented in 2020. Other trials include PARADISE-MI, a Phase III trial in patients at high risk of developing heart failure after a heart attack (post-acute myocardial infarction). Enrollment is ongoing and results are expected in 2020. Additionally, PARALLEL-HF is a Phase III trial for HFrEF patients in Japan (Novartis reported results in March 2019, and a marketing authorization submission in Japan is under review), and PANORAMA-HF is a Phase III trial in pediatric patients with heart failure (enrollment is ongoing and results are expected in 2021).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; INC280 (capmatinib) is an investigational oral, potent and selective MET inhibitor. The GEOMETRY trial &ndash; a Phase II study in adult patients with advanced non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations &ndash; is ongoing, as are additional early-stage studies in combination with other compounds. During 2019, Novartis presented primary efficacy results from the GEOMETRY trial at ASCO, and the FDA granted breakthrough therapy designation to INC280 as a first-line treatment for patients with metastatic MET exon 14 skipping-mutated (METex14) NSCLC. Breakthrough therapy designation covers both treatment-naive patients and patients previously </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">38</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">treated with platinum-based chemotherapy. INC280 is licensed by Novartis from Incyte Corporation. Under the Collaboration and License Agreement, Novartis has exclusive worldwide development and commercialization rights to INC280, and Incyte Corporation maintains certain rights to exercise options for both co-development and co-detailing in the US.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; KAF156 (ganaplacide) belongs to a novel class of antimalarial compounds called imidazolopiperazines. It has the potential to clear malaria infection, including resistant strains, and to block the transmission of the malaria parasite. As demonstrated in a Phase IIa proof-of-concept trial, the compound is fast-acting and potent across multiple stages of the parasite&#x2019;s lifecycle, rapidly clearing both Plasmodium falciparum and Plasmodium vivax parasites. A Phase IIb study tested multiple dosing combinations and dosing schedules of KAF156 and lumefantrine in adults and adolescents, and confirmed good safety and efficacy of all doses. The safety and efficacy of the combination will now be evaluated in younger children.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Kisqali</i> (ribociclib) is an oral, cyclin-dependent kinase inhibitor. Novartis continues to investigate <i>Kisqali</i> in patients with HR+/HER2- breast cancer, and it is the only CDK4/6 inhibitor to achieve statistically significant overall survival in two Phase III trials with two distinct patient populations. Novartis presented overall survival results from MONALEESA-7 at ASCO 2019 and from MONALEESA-3 at ESMO 2019, and continues to assess <i>Kisqali</i> in MONALEESA-2, COMPLEEMENT-1 and the NataLEE adjuvant trial. These trials are evaluating <i>Kisqali</i> in multiple endocrine therapy combinations across a broad range of patients, including men and premenopausal women. <i>Kisqali</i> was developed by the Novartis Institutes for BioMedical Research under a research collaboration with Astex Pharmaceuticals.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; KJX839 (inclisiran) is a long-acting, small-interfering RNA (siRNA) administered twice a year as a subcutaneous injection. It is in development in atherosclerotic cardiovascular disease and primary hyperlipidemia (including familial hypercholesterolemia) for patients who have already had an event like a heart attack or stroke, or who are risk-equivalent. Pivotal Phase III trial results were presented at the European Society of Cardiology Congress and the American Heart Association Scientific Sessions in 2019 by The Medicines Company, prior to its acquisition by Novartis. A cardiovascular outcomes study, ORION-4, is ongoing.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Kymriah</i> (tisagenlecleucel) is a CD19-directed genetically modified autologous chimeric antigen receptor T-cell (CAR-T) therapy delivered as an intravenous infusion. Since 2018, Novartis has initiated six trials for new or expanded indications for <i>Kymriah </i>&ndash; diffuse large B-cell lymphoma (DLBCL) in second line, high-risk pediatric acute lymphoblastic leukemia (ALL), relapsed/refractory follicular lymphoma, pediatric non-Hodgkin lymphoma, relapsed/refractory DLBCL in combination with ibrutinib, and relapsed/refractory DLBCL in combination with pembrolizumab &ndash; as well as a study of <i>Kymriah</i> in adult ALL planned for a 2020 start. Novartis and the University of Pennsylvania&#x2019;s Perelman School of Medicine developed <i>Kymriah</i> under a global collaboration. Please see &#x201C;&mdash;Alliances and acquisitions&#x201D; below for additional information related to our collaboration with the University of Pennsylvania. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; LJN452 (tropifexor) is an oral, highly potent and selective nonsteroidal multimodal farnesoid X receptor (FXR) agonist in development as both a monotherapy and a combination therapy for the treatment of nonalcoholic steatohepatitis (NASH). LJN452 is designed to target the three major facets of NASH (steatosis, inflammation and fibrosis), and has demonstrated the ability to reduce all three in animal models. Recruitment is complete for two Phase II studies: FLIGHT FXR (the monotherapy study) and TANDEM (the combination study with cenicriviroc). Additional collaborative studies are underway to explore the role of LJN452 as a backbone in combination therapies.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; LNP023 is an oral, selective factor B inhibitor of the alternative complement pathway. It is in development for the treatment of rare complement-driven renal diseases, including IgA nephropathy, membranous nephropathy and C3 glomerulopathy. LNP023 is also in development for the treatment of paroxysmal nocturnal hemoglobinuria. Phase II studies in all indications are initiated.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <sup>177</sup>Lu-PSMA-617, delivered as an intravenous infusion, is an investigational radioligand therapy in development for metastatic castration-resistant prostate cancer (mCRPC). Designed to target the prostate-specific membrane antigen present in most patients with mCRPC, <sup>177</sup>Lu-PSMA-617 potentially offers a differentiated targeted treatment option. A Phase III study of <sup>177</sup>Lu-PSMA-617 in patients with mCRPC, called VISION, is ongoing. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Lutathera</i> (lutetium Lu 177 dotatate/lutetium (<sup>177</sup>Lu) oxodotreotide) is an intravenous radioligand therapy. A randomized Phase III trial called NETTER-1 continues to assess overall survival in patients who received <i>Lutathera</i> and long-acting octreotide to treat inoperable, progressive, well-differentiated (Grade 1 and Grade 2), somatostatin receptor-positive midgut neuroendocrine tumors.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; OMB157 (ofatumumab), administered as a subcutaneous injection, is a fully human monoclonal antibody that works by binding to the CD20 molecule on the B-cell surface and inducing B-cell depletion. OMB157 is in development to treat multiple sclerosis (MS). Novartis announced in August 2019 that the Phase III ASCLEPIOS I and II studies met their primary endpoints in patients with relapsing forms of MS. Compared to Aubagio<sup>&#xAE;</sup> (teriflunomide), OMB157 showed a statistically significant reduction in the number of confirmed relapses, evaluated as the annualized relapse rate; highly significant suppression of both Gd+ T1 lesions and new or enlarging T2 lesions; and a relative risk reduction in three- and six-month confirmed disability worsening in pre-specified pooled analyses. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">39</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Novartis is conducting a registration study for OMB157 in Japan, which started in March 2018. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; PDR001 (spartalizumab), delivered as an intravenous infusion, is an investigational PD-1 antagonist that may restore the ability of immune cells to induce cell death and fight cancer. Novartis is evaluating PDR001 in combination with <i>Tafinlar</i> + <i>Mekinist</i> in a Phase III trial (COMBI-i) for unresectable or metastatic BRAF V600 mutation-positive melanoma, and presented results from the safety run-in part and biomarker cohort at ASCO in 2019. Novartis is also evaluating PDR001 as a combination therapy with other Novartis drugs in clinical trials for different tumor types, including metastatic melanoma.    </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; QAW039 (fevipiprant) is an investigational, novel, once-daily pill that blocks the DP2 pathway, a regulator of the inflammatory cascade. In December 2019, Novartis announced that development of QAW039 in asthma would be discontinued after the Phase III LUSTER-1 and LUSTER-2 core registration trials did not meet the clinically relevant threshold for reduction in asthma attacks (exacerbations) in moderate to severe patients with unresolved asthma despite treatment with inhaled therapies. In addition, as announced in October 2019, results of the Phase III ZEAL-1 and ZEAL-2 studies did not meet the primary efficacy endpoint of lung function (FEV1) improvement in patients with moderate asthma.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; QGE031 (ligelizumab), administered subcutaneously as a once-monthly single injection, is a next-generation, high-affinity anti-IgE monoclonal antibody that is highly potent in blocking the IgE/FceR1 pathway. QGE031 is in clinical development for the treatment of chronic spontaneous urticaria/chronic idiopathic urticaria (CSU/CIU). In a CSU/CIU&nbsp;Phase IIb study, a clear dose response was demonstrated and a higher percentage of CSU/CIU patients had complete symptom control with QGE031 72 mg or 240 mg than with omalizumab 300 mg or placebo. QGE031 is being investigated in two ongoing Phase III twin trials, PEARL 1 and PEARL 2, which are recruiting more than 2 000 patients across 48 countries.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; RTH258 (brolucizumab, approved in the US as <i>Beovu</i>) is an injectable, humanized, single-chain antibody fragment that acts as an anti-vascular endothelial growth factor (anti-VEGF) agent. The FDA approved RTH258 as <i>Beovu</i> in October 2019 for the treatment of neovascular (wet) age-related macular degeneration, and regulatory filings are under review in the EU, Japan and certain other countries. RTH258 is in clinical development for diabetic macular edema and retinal vein occlusion.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; SEG101 (crizanlizumab, approved in the US as <i>Adakveo</i>) is a humanized monoclonal antibody that binds to P-selectin, a cell adhesion protein that plays a central role in the multicellular interactions that can lead to vaso-occlusion in sickle cell disease. It is delivered as an intravenous infusion. The FDA approved SEG101 as <i>Adakveo</i> in November 2019 to reduce the frequency of vaso-occlusive crises (VOCs), or pain crises, in patients aged 16 years and older with sickle cell disease. Novartis continues to study SEG101 in sickle cell disease through the SENTRY clinical trial program, which includes SOLACE-adults, SOLACE-kids, STAND, SPARTAN and STEADFAST. These studies are evaluating SEG101 for the treatment of VOCs in children and adults, as well as priapism and other complications, such as sickle cell nephropathy. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; TQJ230 is an injectable antisense oligonucleotide designed to target elevated lipoprotein(a) (Lp(a)), which increases the risk of heart disease. The results of a Phase II trial announced in 2018 showed that TQJ230 reduced Lp(a) in patients by as much as 80%. The Lp(a)HORIZON trial, a Phase III trial in patients with established cardiovascular disease and elevated Lp(a), was initiated in December 2019. Results are expected in 2024. Novartis licensed TQJ230 from Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., in February 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; UNR844 is a potential first-in-class topical treatment in development for presbyopia, a common age-related loss of near-distance vision characterized by a progressive inability to focus on objects nearby, making everyday activities (such as reading) a challenge. UNR844 is believed to work through the reduction of disulfide bonds, softening the crystalline lens. In a Phase I/II masked, placebo-controlled proof-of-concept study, 50 patients were treated daily for 90 days with topical UNR844, and 25 patients were treated with placebo. UNR844 showed a statistically significant difference to placebo in binocular distance-corrected near vision at all time points measured (from Day Eight). At Day 90, 82% of participants treated with UNR844 had 20/40 binocular near vision (or 0.30 LogMAR) versus 48% in the placebo group. Near vision of 20/40 allows for the majority of near-vision tasks in most people. UNR844 was acquired by Novartis through the acquisition of Encore Vision, Inc. in January 2017.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; ZPL389 (adriforant) is a once-daily oral H4 receptor antagonist. It is in Phase II clinical development for the treatment of atopic dermatitis (AD) to evaluate its benefit on key outcomes, such as reduction of the severity of AD lesions and reduction of itch. The Phase II ZEST study is investigating the effect of several doses of ZPL389 versus placebo. ZPL389 has already demonstrated significant clinical and statistical improvements in eczema lesions, leading to a 50% reduction in Eczema Area and Severity Index (EASI) score compared to placebo after eight weeks of treatment, with a favorable safety profile in the proof-of-concept study. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">40</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Projects added to and subtracted from the development table since 2018</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Project/product</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Potential indication</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Change</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Reason</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ABL001</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia, 1<sup>st</sup> line</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">AVXS-101</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Spinal muscular atrophy type 1 (IV formulation)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Now disclosed as spinal muscular atrophy (IV formulation)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Spinal muscular atrophy type 2/3 (IT formulation)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Now disclosed as spinal muscular atrophy (IT formulation)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">BAF312</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Secondary progressive multiple sclerosis</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Commercialized as <I>Mayzent</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">BYL719</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hormone receptor-positive (HR+)/human epidermal   growth factor receptor 2-negative (HER2-)   advanced breast cancer (postmenopausal women),   2<sup>nd</sup> line (+&#xA0;fulvestrant)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Now disclosed as PIK3CA mutant hormone   receptor-positive (HR+)/human epidermal growth   factor receptor 2-negative (HER2-) postmenopausal   advanced breast cancer, 2<sup>nd</sup> line (+&#xA0;fulvestrant)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PIK3CA-related overgrowth spectrum</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Triple negative breast cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hormone receptor-negative (HR-)/human epidermal   growth factor receptor 2-positive (HER2+) advanced   breast cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ovarian cancer</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Head and neck squamous cell carcinoma</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CAD106</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Alzheimer&#x2019;s disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CEE321</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Atopic dermatitis</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CNP520</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Alzheimer&#x2019;s disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Cosentyx</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Giant cell arteritis</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Lichen planus</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">EMA401</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Peripheral neuropathic pain</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">HDM201</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acute myeloid lymphoma</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">INC280</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Non-small cell lung cancer (EGFR mutation)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Solid tumors</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">KAE609</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe malaria</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">KJX839</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hyperlipidemia  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acquired with acquisition of   The Medicines Company</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Secondary prevention of cardiovascular events   in patients with elevated levels of LDL-C</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acquired with acquisition of   The Medicines Company</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Kymriah</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic lymphocytic leukemia</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LCI699</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cushing's disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Divested to Recordati S.p.A.</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LNP023</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> C3 glomerulopathy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Paroxysmal nocturnal hemoglobinuria</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Lucentis</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Retinopathy of prematurity</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Commercialized</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetic retinopathy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Commercialized</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LXE408</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Visceral leishmaniasis</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">MBG453</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelodysplastic syndrome</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acute myeloid leukemia</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">MOR106</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Atopic dermatitis</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">PDR001</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Malignant melanoma (combo)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Now disclosed as metastatic melanoma (combo)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Promacta</I>/ <I>Revolade</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe aplastic anemia, 1<sup>st</sup> line  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">QAW039</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Asthma</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">RTH258</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neovascular age-related macular degeneration  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Now disclosed as neovascular (wet) age-related   macular degeneration</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Proliferative diabetic retinopathy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Rydapt</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acute myeloid leukemia (FLT3 wild type)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">SAF312</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic ocular surface pain</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">TQJ230</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Secondary prevention of cardiovascular events   in patients with elevated levels of lipoprotein(a)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">VAY785</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Nonalcoholic steatohepatitis</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Removed</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Development discontinued</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Xolair</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Food allergy</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Added</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Entered Confirmatory Development</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Principal markets</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Innovative Medicines Division sells products in approximately 155 countries worldwide. Net sales are generally concentrated in the US, Europe, Japan and China. The following table sets forth the aggregate 2019 net sales of the Innovative Medicines Division by region:</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">41</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 net sales  to third parties</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> USD millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United States</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;789</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;818</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia, Africa, Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;458</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;649</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Of which in Established Markets<sup style="white-space: nowrap">&nbsp;*</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;573</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Of which in Emerging Growth Markets<sup style="white-space: nowrap">&nbsp;*</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;141</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;*&nbsp;</sup> Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Many of our Innovative Medicines Division products are used for chronic conditions that require patients to consume the product over long periods of time, ranging from months to years. However, certain of our marketed products and development projects, such as gene therapies, are administered only once. Net sales of the vast majority of our products are not subject to material changes in seasonal demand.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Production</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our primary goal is to ensure the uninterrupted, timely and cost-effective supply of products that meet all product specifications and quality standards. The manufacturing of our products is highly regulated by governmental health authorities around the world, including the FDA and EMA. In addition to regulatory requirements, many of our products involve technically complex manufacturing processes or require highly specialized raw materials.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We manufacture our products at facilities worldwide, producing active pharmaceutical ingredients in our own facilities or purchasing them from third-party suppliers (see also &#x201C;&mdash;Item&nbsp;4.D Property, plants and equipment&#x201D;). Across our network, we maintain state-of-the-art processes, with quality as a priority, and require our suppliers to adhere to the same high standards we expect from our own people and processes. Those processes include fermentation, chemical syntheses and precipitation, as well as sterile processing. We are constantly working to improve our existing manufacturing processes and to develop new ones, and to review and adapt our manufacturing network to meet our needs and those of our patients and customers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We produce raw materials for manufacturing in-house or we purchase them from a number of third-party suppliers. Where possible, we maintain multiple supply sources so that the business is not dependent on a single or limited number of suppliers. However, our ability to do so may at times be limited by regulatory or other requirements. We monitor market developments that could have an adverse effect on the supply of essential materials. Our suppliers of raw materials are required to comply with applicable regulations and Novartis quality standards.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because the manufacturing of our products is complex and highly regulated by governmental health authorities, supply is never guaranteed. If we or our third-party suppliers fail to comply with applicable regulations, then there could be a product recall or other disruption to our production activities. We have experienced supply interruptions for our products in the past, and there can be no assurance that supply will not be interrupted again in the future. However, we have implemented a global manufacturing strategy to maximize business continuity in case of such events. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Marketing and sales</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Innovative Medicines Division serves customers with 24 779 field force representatives, as of December&nbsp;31, 2019, including supervisors and administrative personnel. These trained representatives present the therapeutic risks and benefits of our products to physicians, pharmacists, hospitals, insurance groups, managed care organizations and other healthcare professionals. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The marketplace for healthcare is evolving: Customer groups beyond prescribers have increasing influence on treatment decisions and guidelines, while patients continue to become more informed stakeholders in their healthcare decisions and look for solutions to meet their changing needs. Novartis is responding by adapting our business practices to engage appropriately with patients, customer groups and other stakeholders, including by delivering innovative solutions to drive education, access and improved patient care. Additionally, in the US, certain products can be advertised via digital and traditional media channels, including the internet, television, newspapers and magazines.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Although specific distribution patterns vary by country, Novartis generally sells its prescription drugs primarily to wholesale and retail drug distributors, hospitals, clinics, government agencies and managed healthcare providers. The growing number of so-called &#x201C;specialty&#x201D; drugs in our portfolio has resulted in increased engagement with specialty pharmacies. In the US, specialty pharmacies continue to grow as a distribution channel for specialty products, with an increasing number of health plans mandating use of specialty pharmacies to monitor specialty drug utilization and costs. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis pursues co-promotion/co-marketing opportunities as well as licensing and distribution agreements with other companies in various markets, when economically attractive. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">42</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US, the US Centers for Medicare&nbsp;&amp; Medicaid Services (CMS) is the largest single payer for healthcare services as a result of continuing changes in healthcare economics and an aging population. In addition, both commercial and government-sponsored managed care organizations continue to be among the largest groups of payers for healthcare services in the US. In other countries, national health services are often the only significant payer for healthcare services. In an effort to control prescription drug costs, almost all managed care organizations and national health services use formularies that list specific drugs that may be reimbursed and/or the level of reimbursement for each drug. Managed care organizations and national health services also increasingly use cost-benefit analyses to determine whether or not newly approved drugs will be added to a formulary and/or the level of reimbursement for that drug, and to determine whether or not to continue to reimburse existing drugs. We have dedicated teams that actively seek to optimize patient access, including formulary positions, for our products.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The trend toward consolidation among distributors and retailers of Innovative Medicines Division products continues in the US and internationally, both within country and across countries. This has increased our customers&#x2019; purchasing leverage and resulted in increased pricing pressure on our products. Moreover, we are exposed to increased concentration of credit risk as a result of the consolidation among our customers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, drug pricing is an increasingly prominent issue in many countries as healthcare spending continues to rise. Pricing is a particularly complex issue for cell and gene therapies because of their high costs and the expectation that one treatment will have a long-term, if not lifelong, benefit.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, AveXis, a Novartis company, formed an agreement with Accredo Health Group, Inc. in the US to offer a pay-over-time option of up to five years for <i>Zolgensma</i> to help ease possible short-term budget constraints for customers. Additionally, AveXis offers payers outcome-based agreements for <i>Zolgensma</i> based on measures included in the clinical trial program, and has these agreements in place with both commercial and Medicaid contracts. In these agreements, if a patient has a significant negative outcome during a five-year period, AveXis reimburses a percentage of the cost of the therapy relative to the time passed.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Also in the US, Novartis has established an outcome-based framework for one of the approved indications of <i>Kymriah</i>, whereby the product invoice is linked to a successful outcome for each patient at an agreed milestone. Novartis also offers outcome-based agreements for approved indications of <i>Kymriah</i> in certain countries other than the US. These typically involve a full upfront payment of the product with a partial refund in case of failed outcomes, or installment payments based on successful patient outcomes at agreed milestones for one or both of the approved indications of <i>Kymriah</i>. In addition, Novartis is in discussions with payers about potentially offering similar agreements for <i>Luxturna</i>.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Competition</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The global pharmaceutical market is highly competitive. We compete against other major international corporations that have substantial financial and other resources, as well as against smaller companies that operate regionally or nationally. Competition within the industry is intense and extends across a wide range of activities, including pricing, product characteristics, customer service, sales and marketing, and research and development.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Like other companies selling patented pharmaceuticals, Novartis faces challenges from companies selling competing patented products. Generic forms of our products may follow the expiry of intellectual property protection, and generic companies may also gain entry to the market through successfully challenging our intellectual property rights. We use legally permissible measures to defend those rights. See also &#x201C;&mdash;Intellectual property&#x201D; below. We also may face competition from over-the-counter (OTC) products that do not require a prescription from a physician. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is ongoing consolidation in the pharmaceutical industry. At the same time, new entrants are looking to use their expertise to establish or expand their presence in healthcare, including technology companies seeking to benefit from the increasing importance of data and data management in our industry.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The discovery and development of a new drug usually requires approximately 10 to 15&nbsp;years from the initial research to bringing a drug to market. This includes approximately six to eight years from Phase&nbsp;I clinical trials to market entry. At each of these steps, there is a substantial risk that a compound will not meet the requirements to progress further. In such an event, we may be required to abandon the development of a compound in which we have made a substantial investment.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We manage our research and development expenditures across our entire portfolio in accordance with our strategic priorities. We make decisions about whether or not to proceed with development projects on a project-by-project basis. These decisions are based on the project&#x2019;s potential to meet a significant unmet medical need or to improve patient outcomes, the strength of the science underlying the project, and the potential of the project (subject to the risks inherent in pharmaceutical development) to generate significant positive financial results for the Company. Once a management decision has been made to proceed with the development of a particular molecule, the level of research and development investment required will be driven by many factors. These include the medical indications for which it is being developed, the number of indications being pursued, whether the molecule is of a chemical or biological nature, the stage of development, and the level of evidence necessary to demonstrate clinical efficacy and safety.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">43</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Research program</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our research program is conducted by the Novartis Institutes for BioMedical Research (NIBR), which was established in 2002 and is the research and early development innovation engine of Novartis. NIBR is responsible for the discovery of new medicines for diseases with unmet medical need. We focus our work in areas where we believe we can have the most impact for patients. This requires the hiring and retention of highly talented employees, a focus on fundamental disease mechanisms that are relevant across different disease areas, continuous improvement in technologies for drug discovery and potential therapies, close alliances with clinical colleagues, and the establishment of strategic external alliances.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Approximately 5 600 full-time-equivalent scientists, physicians and business professionals work at NIBR sites in Basel, Switzerland; Cambridge, Massachusetts; East Hanover, New Jersey; San Diego, California; Emeryville, California; and Shanghai, China. They contribute to research into disease areas such as cardiovascular and metabolic diseases, neuroscience, oncology, muscle disorders, ophthalmology, autoimmune diseases and respiratory diseases. Research at the Friedrich Miescher Institute and the Genomics Institute of the Novartis Research Foundation focuses on basic genetic and genomic research, and the Novartis Institute for Tropical Diseases (NITD), in Emeryville, California, focuses on discovering new medicines to fight tropical diseases, including malaria and cryptosporidiosis.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All drug candidates go through proof-of-concept trials to enable an early assessment of the safety and efficacy of the drug while collecting basic information on pharmacokinetics and tolerability, and adhering to the guidance for early clinical testing set forth by health authorities. Following proof of concept, our Global Drug Development unit conducts confirmatory trials on the drug candidates.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In July 2018, we announced the decision to exit antibacterial and antiviral research. While the science for these programs is compelling, we decided to prioritize our resources in other areas where we believe we are better positioned to develop innovative medicines that will have a positive impact for patients. Since then, we have executed two out-licensing deals with Gilead and Boston Pharmaceuticals for assets from our infectious diseases portfolio. The San Francisco Bay Area remains home to NITD and global drug discovery teams focused on &#x201C;undruggable&#x201D; targets in collaboration with the Novartis-Berkeley Center for Proteomics and Chemistry Technologies.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In November 2019, we announced that we will discontinue early discovery research at NIBR&#x2019;s Shanghai site and focus our research and development activities there on expanding the scale and scope of our early clinical development and later-stage clinical trial operations to help accelerate the development of new medicines. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Development program</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Global Drug Development (GDD) organization oversees drug development activities for our Innovative Medicines Division. GDD works collaboratively with NIBR to execute our overall pipeline strategy. The GDD organization includes centralized global functions such as Regulatory Affairs and Global Development Operations, and global Development Units aligned with our business franchises. GDD was created to improve resource allocation, technology implementation and process standardization to further increase innovation. GDD includes approximately 11 000 full-time equivalent associates worldwide.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The traditional model of development consists of three phases:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><b>Phase&nbsp;I:</b>  The first clinical trials of a new compound &ndash; generally performed in a small number of healthy human volunteers &ndash; to assess the drug&#x2019;s safety profile, including the safe dosage range. These trials also determine how a drug is absorbed, distributed, metabolized and excreted, and the duration of its action.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><b>Phase&nbsp;II:</b>  Clinical studies performed with patients who have the target disease, with the aim of continuing the Phase&nbsp;I safety assessment in a larger group, assessing the efficacy of the drug in the patient population, and determining the appropriate doses for further evaluation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><b>Phase&nbsp;III:</b>  Large-scale clinical studies with several hundred to several thousand patients, which are conducted to establish the safety and efficacy of the drug in specific indications for regulatory approval. Phase&nbsp;III trials may also be used to compare a new drug against a current standard of care to evaluate the overall benefit-risk relationship of the new medicine.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">In each of these phases, physicians monitor volunteer patients closely to assess the potential new drug&#x2019;s safety and efficacy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Though we use this traditional model, we have tailored the development process to be simpler, more flexible and efficient. We divide the development process into two stages: Exploratory Development to establish proof of concept, followed by Confirmatory Development to confirm the concept in large numbers of patients. Exploratory Development consists of clinical proof-of-concept (PoC) studies, which are small clinical trials (typically involving in the range of between five and 15 patients) that combine elements of traditional Phase&nbsp;I/II testing. NIBR conducts these customized trials, which are designed to give early insights into issues such as safety, efficacy and toxicity for a drug in a given indication. Once a positive proof of concept has been established, the drug moves to the Confirmatory Development stage and becomes the responsibility of GDD. Confirmatory Development has elements of traditional Phase&nbsp;II/III testing and includes trials aimed at confirming the safety and efficacy of the drug in the given indication, leading up to submission of a dossier to health authorities for approval. This stage can also include trials that compare the drug to the current standard of care for the disease in order to evaluate the drug&#x2019;s overall benefit-risk profile. Further, with new treatment approaches such as gene therapy for rare diseases, elements of Exploratory and Confirmatory Development may be combined and suffice for registration under certain conditions such as high unmet medical need and clinical data showing highly favorable benefit-risk. In these cases, additional post-approval studies may be required by the regulatory authorities to continue to gather important data to further support approval.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">44</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The vast amount of data that must be collected and evaluated makes clinical testing the most time-consuming and expensive part of new drug development. The next stage in the drug development process is to seek registration for the new drug. For more information, see &#x201C;&mdash;Regulation.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Innovation Management Board (IMB) manages our activities at each phase of clinical development. The IMB is responsible for all major aspects of our development portfolio and oversees our drug development budget as well as major project phase transitions and milestones following a positive proof-of-concept outcome, including transitions to Confirmatory Development and the decision to submit a regulatory application to the health authorities. The IMB is also responsible for the endorsement of overall development strategy, the endorsement of development project priorities, and decisions on project discontinuations. Our Chief Executive Officer chairs the IMB, and other representatives from Novartis senior management, with expertise spanning multiple fields, are among its core and extended membership.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Alliances and acquisitions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Innovative Medicines Division enters into business development agreements with other pharmaceutical and biotechnology companies and with academic and other institutions to develop new products and access new markets. We license products that complement our current product line and are appropriate to our business strategy. We focus on strategic alliances and acquisition activities for key disease areas and indications that we expect to be growth drivers in the future. We review products and compounds we are considering licensing, using the same criteria that we use for our own internally discovered drugs.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In January 2020, we completed the acquisition of US-based biopharmaceutical company The Medicines Company. The acquisition broadened the Novartis cardiovascular portfolio by adding KJX839 (inclisiran), an investigational cholesterol-lowering therapy. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In October 2019, we announced the discontinuation of the clinical development program for MOR106 in atopic dermatitis. We announced an exclusive licensing agreement in July 2018 with biotech companies Galapagos NV and MorphoSys AG regarding this compound. Under the agreement, Novartis acquired the exclusive global development and marketing rights to MOR106 for atopic dermatitis and all other potential indications. This transaction became effective on September 10, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In October 2019, certain affiliates of Recordati S.p.A. acquired the worldwide rights from Novartis to Signifor<sup>&#xAE;</sup>, Signifor<sup>&#xAE;</sup> <i>LAR</i> and LCI699 (osilodrostat). This transaction supports our oncology strategy to focus on medicines that have the potential to transform the standard of care for patients in four distinct cancer treatment platforms: targeted therapies, radioligand therapies, cell and gene therapies, and immunotherapies. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In October 2019, we announced a multiyear research and development collaboration with Microsoft. This alliance is expected to bolster our artificial intelligence capabilities to help accelerate the discovery, development and commercialization of medicines for patients worldwide. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In September 2019, Novartis and the University of Pennsylvania (Penn) entered into a new focused agreement on chimeric antigen receptor T-cell (CAR-T) clinical trials and concluded our seven-year research and development alliance, per the contractual terms. The new agreement allows each organization to pursue its own research in cell and gene therapies. Novartis and Penn will continue to collaborate on certain CAR-T research trials. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In September 2019, we signed a collaboration and exclusive option agreement with IFM Due, Inc., a subsidiary of IFM Therapeutics LLC, to develop a group of immunotherapies that inhibit the cGAS/STING pathway for the potential treatment of serious inflammatory and autoimmune diseases.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In July 2019, we announced the decision to discontinue the investigation of the BACE1 inhibitor CNP520 (umibecestat) in two Phase II/III studies in the Alzheimer&#x2019;s Prevention Initiative Generation Program. This study was launched through an expanded collaboration with Amgen Inc. and Banner Alzheimer&#x2019;s Institute, announced in November 2017, to assess whether CNP520 can prevent or delay the symptoms of Alzheimer&#x2019;s disease in a high-risk population.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In July 2019, we announced that we completed the acquisition of <i>Xiidra</i> (lifitegrast) from Takeda Pharmaceutical Company Limited, and we began recording sales as of July 1, 2019. <i>Xiidra</i> is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. For additional information, see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&mdash;Significant transactions in 2019&mdash;Innovative Medicines &ndash; acquisition of <i>Xiidra</i>.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In May 2019, we completed the acquisition of IFM Tre, Inc., a subsidiary of IFM Therapeutics LLC focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome (a key component of the innate immune system). This acquisition includes full rights to IFM Tre&#x2019;s portfolio of NLRP3 inhibitors. For additional information, see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&mdash;Significant transactions in 2019&mdash;Innovative Medicines &ndash; acquisition of IFM Tre, Inc.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In April 2019, Novartis completed a USD 75 million investment in Poseida Therapeutics, a privately held biotechnology company focused on gene therapies. Poseida Therapeutics has a pipeline of next-generation CAR-T product candidates, including a BCMA CAR-T in Phase II clinical development for the treatment of relapsed/refractory multiple myeloma. Our investment entitles us to appoint a director to the company&#x2019;s board of directors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In February 2019, Novartis announced that it is exercising its option to license the rights to develop and commercialize TQJ230 from Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc., for targeted cardiovascular therapy. If approved, TQJ230 could be the first treatment that specifically targets elevated levels of lipoprotein(a). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In February 2019, we completed the acquisition of Cell<i>fo</i>rCure, a French company specializing in the development and manufacture of cell and gene therapies. This acquisition strengthened our CAR-T therapy manufacturing capacity and builds on a previous agreement with </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">45</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cell<i>for</i>Cure to produce CAR-T therapies, including <i>Kymriah</i> (tisagenlecleucel).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional information, see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&mdash;Significant transactions in 2018.&#x201D; </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Regulation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The international pharmaceutical industry is highly regulated. Regulatory authorities around the world administer numerous laws and regulations regarding the testing, approval, manufacturing, importing, labeling and marketing of drugs, and review the safety and efficacy of pharmaceutical products. Extensive controls exist on the non-clinical and clinical development of pharmaceutical products. These regulatory requirements, and the implementation of them by local health authorities around the globe, are a major factor in determining whether a substance can be developed into a marketable product, and the amount of time and expense associated with that development.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Health authorities, including those in the US, the EU and Japan, have high standards of technical evaluation. The introduction of new pharmaceutical products generally entails a lengthy approval process. Products must be authorized or registered prior to marketing, and such authorization or registration must subsequently be maintained. In recent years, the registration process has required increased testing and documentation for the approval of new drugs, with a corresponding increase in the expense of product introduction.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To register a pharmaceutical product, a registration dossier containing evidence establishing the safety, efficacy and quality of the product must be submitted to regulatory authorities. Generally, a therapeutic product must be registered in each country in which it will be sold. In every country, the submission of an application to a regulatory authority does not guarantee that approval to market the product will be granted. Although the criteria for the registration of therapeutic drugs are similar in most countries, the formal structure of the necessary registration documents and the specific requirements, including risk tolerance, of the local health authorities can vary significantly from country to country. Even if a drug is registered and marketed in one country, the registration authority in another country may request additional information from the pharmaceutical company prior to registration or even reject the product. A drug may be approved for different indications in different countries.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The registration process generally takes between six months and several years, depending on the country, the quality of the data submitted, the efficiency of the registration authority&#x2019;s procedures, and the nature of the product. Many countries provide for accelerated processing of registration applications for innovative products of particular therapeutic interest. In recent years, the US, the EU and Japan have made efforts to harmonize registration requirements in order to achieve shorter development and registration times for medical products. However, the requirement in many countries to negotiate selling prices or reimbursement levels with government regulators and other payers can substantially extend the time until a product may finally be available to patients.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following provides a summary of the regulatory processes in the principal markets served by Innovative Medicines Division affiliates:</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">United States</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In the US, applications for drug registration are submitted to and reviewed by the FDA. The FDA regulates the testing, manufacturing, labeling and approval for marketing of pharmaceutical products intended for commercialization in the US. The FDA continues to monitor the safety of pharmaceutical products after they have been approved for sale in the US market. The pharmaceutical development and registration process is typically intensive, lengthy and rigorous. When a pharmaceutical company has gathered data that it believes sufficiently demonstrates a drug&#x2019;s safety, efficacy and quality, then the company may file&nbsp;a New Drug Application (NDA) or Biologics License Application (BLA), as applicable, for the drug. The NDA or BLA must contain all the scientific information that has been gathered about the drug. This typically includes information regarding the clinical experiences of patients tested in the drug&#x2019;s clinical trials. A Supplemental New Drug Application (sNDA) or BLA amendment must be filed for new indications for a previously approved drug.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Once an application is submitted, the FDA assigns reviewers from its staff, including experts in biopharmaceutics, chemistry, clinical microbiology, pharmacology/toxicology, and statistics. After a complete review, these content experts provide written evaluations of the NDA or BLA. These recommendations are consolidated and are used by senior FDA staff in its final evaluation of the NDA or BLA. Based on that final evaluation, the FDA then provides to the NDA or BLA&#x2019;s sponsor an approval, or a &#x201C;complete response&#x201D; letter if the NDA or BLA application is not approved. If not approved, the letter will state the specific deficiencies in the NDA or BLA that need to be addressed. The sponsor must then submit an adequate response to the deficiencies in order to restart the review procedure.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Once the FDA has approved an NDA, BLA, sNDA or BLA amendment, the company can make the new drug available for physicians and other healthcare providers to prescribe. The drug owner must submit periodic reports to the FDA, including any cases of adverse reactions. For some medications, the FDA requires additional post-approval studies (Phase&nbsp;IV) to evaluate long-term effects or to gather information on the use of the product under specified conditions.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Throughout the life cycle of a product, the FDA requires compliance with standards relating to good laboratory, clinical and manufacturing practices. The FDA also requires compliance with rules pertaining to the manner in which we may promote our products.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">European Union</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In the EU, there are three main procedures for application for authorization to market pharmaceutical products in more than one EU member state at the same time: the centralized procedure, the mutual recognition procedure and the decentralized procedure. It is also possible to obtain a national authorization for products intended for </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">46</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">commercialization in a single EU member state only, or for additional indications for licensed products. The procedure used for first authorization must continue to be followed for subsequent changes, e.g., to add an indication for a licensed product.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Under the centralized procedure, applications are made to the EMA for an authorization that is valid for the European Union (all member states). The centralized procedure is mandatory for all biotechnology products; new chemical entities in cancer, neurodegenerative disorders, diabetes, AIDS, autoimmune diseases and other immune dysfunctions; advanced therapy medicines, such as gene therapy, somatic cell therapy and tissue-engineered medicines; and orphan medicines (medicines for rare diseases). It is optional for other new chemical entities, innovative medicinal products, and medicines for which authorization would be in the interest of public health. When a pharmaceutical company has gathered data that it believes sufficiently demonstrates a drug&#x2019;s safety, efficacy and quality, the company may submit an application to the EMA. The EMA then receives and validates the application, and the specialized committee for human medicines, the CHMP, appoints a rapporteur and co-rapporteur to review it. The entire review cycle must be completed within 210&nbsp;days, although there is a &#x201C;clock stop&#x201D; at Day 120 to allow the company to respond to questions set forth in the rapporteur and co-rapporteur&#x2019;s assessment report. When the company&#x2019;s complete response is received by the EMA, the clock restarts on Day 121. If there are further aspects of the dossier requiring clarification, the CHMP will issue further questions at Day 180, and may also request an oral explanation, in which case the sponsor must not only respond to the further questions but also appear before the committee to justify its responses. On Day 210, the CHMP will take a vote to recommend the approval or non-approval of the application, and their opinion is transferred to the EC. The final EC decision under this centralized procedure is a decision that is applicable to all member states. This decision occurs 60&nbsp;days, on average, after a positive CHMP recommendation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Under both the mutual recognition procedure (MRP) and the decentralized procedure (DCP), the assessment is led by one member state, called the reference member state (RMS) which then liaises with other member states, known as the concerned member states. In the MRP, the company first obtains a marketing authorization in the RMS, which is then recognized by the concerned member states in 90 days. In the DCP, the application is done simultaneously in the RMS and all concerned member states. During the DCP, the RMS drafts an assessment report within 120&nbsp;days. Within an additional 90&nbsp;days, the concerned member states review the application and can issue objections or requests for additional information. On Day 90, each concerned member state must be assured that the product is safe and effective, and that it will cause no risks to the public health. Once an agreement has been reached, each member state grants national marketing authorizations for the product.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">After receiving the marketing authorizations, the company must submit periodic safety reports to the relevant health authority (EMA for the centralized procedure, national health authorities for DCP or MRP). In addition, pharmacovigilance measures must be implemented and monitored, including the collection, evaluation and expedited reporting of adverse events, and updates to risk management plans. For some medications, post-approval studies (Phase&nbsp;IV) may be imposed to complement available data with additional data to evaluate long-term effects (called a Post-Approval Safety Study, or PASS) or to gather additional efficacy data (called a Post-Approval Efficacy Study, or PAES).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">European marketing authorizations have an initial duration of five years. The holder of the marketing authorization must actively apply for its renewal after this first five-year period. As part of the renewal procedure, the competent authority will perform a full benefit-risk review of the product. Should the authority conclude that the benefit-risk balance is no longer positive, the marketing authorization can be suspended or revoked. Once renewed, the marketing authorization is valid for an unlimited period. If the holder does not apply for renewal, the marketing authorization automatically lapses. Any marketing authorization that is not followed within three years of its granting by the actual placing on the market of the corresponding medicinal product ceases to be valid.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Japan</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Japan, applications for new products are made through the Pharmaceutical and Medical Devices Agency (PMDA). Once an NDA is submitted, a review team is formed, which consists of specialized officials of the PMDA, including those with expertise in chemistry, manufacturing, clinical and non-clinical development, and biostatistics. While a team evaluation is carried out, a data reliability survey and inspections for good clinical practice (GCP), good laboratory practice (GLP) and good manufacturing practice (GMP) are carried out by the Office of Non-clinical and Clinical Compliance of the PMDA. Preliminary team evaluation results are passed to the PMDA&#x2019;s external experts, who then provide their opinion about approvability to the PMDA. After a further team evaluation, a report is provided to the Ministry of Health, Labor and Welfare (MHLW); the MHLW makes a final determination for approval and refers this to the Council on Drugs and Foods Sanitation, which then advises the MHLW on final approvability. Marketing and distribution approvals require a review to determine whether the company is capable of managing manufacturing and distribution appropriately per the business license for the type of drug concerned, and to confirm the accreditation of manufacturing sites and testing facilities for the applied new product.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Once the MHLW has approved the application, the company can make the new drug available for physicians to prescribe. After that, the MHLW lists its National Health Insurance price within 60&nbsp;days (or 90&nbsp;days) from the approval, and physicians can obtain reimbursement. For some medications, the MHLW requires intensive surveillance (called early post-marketing phase vigilance) for six months after launch, and/or additional post-approval studies (Phase&nbsp;IV) to further evaluate safety and/or to gather information on the use of the product under specified conditions. The MHLW also requires the drug&#x2019;s sponsor to submit periodic safety update reports. Within three months from the specified re-examination period, </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">47</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">which is designated at the time of the approval of the application for the new product, the company must submit a re-examination application to enable the drug&#x2019;s safety and efficacy to be reassessed against approved labeling by the PMDA and MHLW.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Price controls</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In most of the markets where we operate, the prices of pharmaceutical products are subject to both direct and indirect price controls and to drug reimbursement programs with varying price control mechanisms. Due to increasing political pressure and governmental budget constraints, we expect these mechanisms to remain robust &ndash; and potentially even to be strengthened &ndash; and to have a continued negative influence on the prices we are able to charge for our products.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Direct governmental efforts to control prices</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><i>United States:</i>  In the US, President Donald Trump and Congressional leaders declared the reduction of drug prices as a key priority in 2019. Among the various proposals introduced by the Administration, House of Representatives or Senate were options that would impose price controls, introduce reference pricing to countries outside the US, permit medicine imports from Canada, and make changes to drug reimbursement in Medicare Parts B/D and Medicaid. It is anticipated that focus on drug pricing will continue at the federal level in 2020. Additionally, by the end of 2019, 17 US states had passed legislation intended to impact pricing or requiring price transparency reporting. These states are California, Connecticut, Colorado, Delaware, Indiana, Louisiana, Maine, Maryland, Massachusetts, Nevada, New Hampshire, New York, Ohio, Oregon, Texas, Vermont and Washington. The disclosure requirements vary by state. Many states require multiple types of reporting, including for new drug applications, new drug launches, prior notice of price increases, and quarterly or annual reporting. It is expected in 2020 that state legislatures will continue to focus on drug pricing and that similar bills will be passed in more states.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Europe:  </i>In Europe, our operations are subject to significant price and marketing regulations. Many governments are introducing healthcare reforms in a further attempt to curb increasing healthcare costs. In some member states, these include reforms to permit the reimbursed use of off-label medicines, despite the presence of licensed alternatives on the market. In the EU, governments influence the price of pharmaceutical products through their control of national healthcare systems that fund a large part of the cost of such products to patients. The downward pressure on healthcare costs in general in the EU, particularly with regard to prescription drugs, is intense. Increasingly strict analyses are applied when evaluating the entry of new products, and as a result, access to innovative medicines is limited based on strict cost-benefit assessments. In addition, prices for marketed products are referenced within member states and across international borders, further impacting individual EU member state pricing. Member states also collaborate to enhance pricing transparency and have started conducting joint health technology assessments, joint pricing negotiations and/or joint purchasing. As an additional control for healthcare budgets, some EU countries have passed legislation to impose further mandatory rebates for pharmaceutical products and/or financial claw-backs on the pharmaceutical industry. The calculation of these rebates and claw-backs may lack transparency in some cases and can be difficult to predict.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Japan:  </i>In 2019, the MHLW introduced a cost-effectiveness assessment and implemented an ad-hoc price revision to coincide with a consumption tax increase on October 1. That followed new drug tariffs that became effective from April 2018 after the Japanese government reviewed the National Health Insurance (NHI) price calculation methods for new products and the price revision rule for existing products. Also in 2018, the MHLW implemented a price maintenance scheme with a narrower scope and fewer products, and increased the frequency of price cuts from every other year to annually beginning in 2021. The Japanese government is continuing deliberations on healthcare reform with the goal of sustaining universal coverage under the NHI program, and is addressing the efficient use of drugs, including promoting the use of generic drugs.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Rest of world:  </i>Many other countries are taking steps to control prescription drug prices. China &ndash; one of our most important Emerging Growth Markets &ndash; conducted national price negotiations in 2017 for 36 drugs without any generic equivalent, and in 2018 for 17 oncology drugs directly linked to national drug reimbursement, which applied to over 1.3 billion residents covered by the employee and resident medical insurance scheme. It also conducted a national procurement pilot on certain generic drugs at the end of 2018 and in 2019. These efforts resulted in price reductions of more than 50% on average for the drugs subject to these programs. In November 2019, the National Healthcare Security Administration announced that 70 additional drugs have obtained reimbursement access through negotiations, with an average price reduction of 60.7%. Drug prices in China may further decline due to ongoing national health reform. However, reimbursement access is accelerating and broadening coverage as the government aims to resolve the public issue of accessibility and the high cost of healthcare services. In August 2019, Canada published amendments to its patented medicines regulations to introduce three new economics-based price regulatory factors and the concept of affordability in price assessments; to update the schedule of comparator countries to include 11 countries with similar consumer protection priorities, economic wealth and marketed medicines as Canada and to exclude Switzerland and the US from the list; and to require reporting of all confidential discounts and rebates. These changes have a planned effective date of July 1, 2020. Innovative Medicines Canada (IMC), the local industry association, and 16 member companies (including Novartis) are contesting the changes via an Application for Judicial Review with the Federal Court. The Patented Medicine Prices </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">48</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Review Board (PMPRB) issued its draft guidelines to the new amendments of the patented medicines regulations; a written consultation period is now open, providing stakeholders with 60 days (until January 31, 2020) to provide their perspectives on the draft. In Colombia, the government took steps in 2016 to unilaterally reduce the price of <i>Glivec</i> by up to 43% through a local procedural mechanism called a Declaration of Public Interest. We continue to contest the appropriateness of the government&#x2019;s unprecedented use of this mechanism to control the price of a prescription drug and to manage its healthcare budget. Its use could become more widespread if upheld in this case, potentially leading to a more systemic impact on drug pricing. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Regulations favoring generics and biosimilars</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In response to rising healthcare costs, most governments and private medical care providers have established reimbursement schemes that favor the substitution of generic pharmaceuticals for more expensive brand-name pharmaceuticals. All US states have generic substitution statutes. These statutes permit or require the dispensing pharmacist to substitute a less expensive generic drug instead of an original patented drug. Other countries, including many European countries, have similar laws. We expect that the pressure for generic substitution will continue to increase. In addition, the US, the EU and other jurisdictions are increasingly crafting laws and regulations encouraging the development of biosimilar versions of biologic drugs, which can also be expected to have an impact on pricing.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Cross-border sales</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Price controls in one country can have an impact in other countries as a result of cross-border sales. In the EU, products that we have sold to customers in countries with stringent price controls can be legally resold to customers in other EU countries at a lower price than the price at which the product is otherwise available in the importing country (known as parallel trade). In North America, products that we have sold to customers in Canada &ndash; which has relatively stringent price controls &ndash; are sometimes resold into the US, again at a lower price than the price at which the product is otherwise sold in the US. Such imports from Canada and other countries into the US are currently illegal. However, given the increased focus on pharmaceutical prices in the US, the Trump Administration, certain members of the US Congress, and several US states continue to explore regulatory and legislative ways to allow the safe importation of pharmaceutical products into the US from select countries, including Canada. Four US states (Colorado, Florida, Maine and Vermont) have enacted drug importation laws, but the US Secretary of the Department of Health and Human Services must certify that each state&#x2019;s importation plan is safe and cost-effective before it can be implemented.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We expect that pressures on pricing will continue worldwide and will likely increase. Because of these pressures, there can be no certainty that in every instance we will be able to charge prices for a product that, in a particular country or in the aggregate, would enable us to earn an adequate return on our investment in that product.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Intellectual property</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We attach great importance to intellectual property &ndash; including patents, trademarks, copyrights, know-how and research data &ndash; in order to protect our investment in research and development, manufacturing and marketing. For example, we seek intellectual property protection under applicable laws for significant product developments in major markets. Among other things, patents may cover the products themselves, including the product&#x2019;s active ingredient or ingredients and its formulation. Patents may cover processes for manufacturing a product, including processes for manufacturing intermediate substances used in the manufacture of the product. Patents may also cover particular uses of a product, such as its use to treat a particular disease, or its dosage regimen. In addition, patents may cover assays or tests for certain diseases or biomarkers &ndash; which can improve patient outcomes when administered with certain drugs &ndash; as well as assays, research tools and other techniques used to identify new drugs. The protection afforded, which may vary from country to country, depends upon the type of patent, its duration and its scope of coverage.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US and other countries, the law recognizes that product development and review by the FDA and other health authorities can take an extended period, and permits an extension of patent term for a period related to the time taken for the conduct of clinical trials and for the health authority&#x2019;s review. However, the length of this extension and the patents to which it applies cannot be known in advance and can only be determined after the product is approved. In practice, it is not uncommon for patent term extensions (PTEs) to not fully compensate the owner of a patent for the time it took to develop the product and receive marketing authorization. As a result, it is rarely the case that a product will have a full patent term at the time it is approved by the FDA and other health authorities.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition to patent protection, various countries offer data or marketing exclusivities for a prescribed period of time. Data exclusivity generally precludes a potential competitor from filing a regulatory application that relies on the sponsor&#x2019;s clinical trial data, or the regulatory authority from approving the application for a set period of time. The data exclusivity period can vary depending upon the type of data included in the sponsor&#x2019;s application. When it is available, market exclusivity, unlike data exclusivity, may preclude a competitor from obtaining marketing approval for a product even if a competitor&#x2019;s application relies on its own data. Data exclusivity and market exclusivity periods generally run from the date a product is approved, and so their expiration dates cannot be known with certainty until the product approval date is known.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">United States</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Patents</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In the US, a patent issued for an application filed today will receive a term of 20&nbsp;years from the earliest application filing date, subject to potential patent term adjustments for delays in patent issuance based upon certain delays in prosecution by the United States Patent and Trademark Office (USPTO). A US pharmaceutical patent </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">49</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">that claims a product, method of treatment using a product, or method of manufacturing a product may also be eligible for a PTE. This type of extension may only extend the patent term for a maximum of five&nbsp;years, and may not extend the patent term beyond 14&nbsp;years from regulatory approval. Only one patent may be extended for any product based on FDA delay.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Data and market exclusivity</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition to patent exclusivities, the FDA may provide data or market exclusivity, which runs in parallel to any patent protection. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; A new small-molecule active pharmaceutical ingredient receives five&nbsp;years of regulatory data exclusivity, during which time a competitor generally may not submit or obtain approval of an application to the FDA based on a sponsor&#x2019;s clinical data.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; For a small-molecule active pharmaceutical ingredient, the FDA may also request that a sponsor conduct pediatric studies and, in exchange, it will grant an additional six-month period of pediatric market exclusivity if the FDA accepts the data, the sponsor makes a timely application for approval for pediatric treatment, and the sponsor has either a patent-based or regulatory-based exclusivity period for the product that can be extended.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Orphan drug exclusivity provides seven&nbsp;years of market exclusivity for drugs designated by the FDA as orphan drugs, meaning drugs that treat rare diseases. During this period, a potential competitor generally may not market the same or similar drug for the same indication even if the competitor&#x2019;s application does not rely on data from the sponsor.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; A new biologic active pharmaceutical ingredient receives 12&nbsp;years of market exclusivity, during which time a competitor generally may not market the same or similar drug. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">European community</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Patents</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Patent applications in Europe may be filed in the European Patent Office (EPO) or in a particular country in Europe. The EPO system permits a single application to be granted for the EU plus other non-EU countries such as Switzerland and Turkey. When the EPO grants a patent, it is then validated in the countries that the patent owner designates. The term of a patent granted by the EPO or a European country office is generally 20&nbsp;years from the earliest application filing date. Pharmaceutical patents can be granted a further period of exclusivity under the Supplementary Protection Certificate (SPC) system. SPCs are designed to compensate the owner of the patent for the time it took to receive marketing authorization of a product by the European health authorities. An SPC may be granted to provide, in combination with the patent, up to 15&nbsp;years of exclusivity from the date of the first European marketing authorization. However, an SPC cannot last longer than five&nbsp;years. The SPC duration may be extended by a further six&nbsp;months if the product is the subject of an agreed pediatric investigation plan. The post-grant phase of patents, including the SPC system, is currently administered on a country-by-country basis under national laws that, while differing, are intended to (but do not always) have the same effect.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Data and market exclusivity</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition to patent exclusivity, the EU provides a system of regulatory data exclusivity for authorized human medicines that runs in parallel to any patent protection. The system for drugs being approved today is usually referred to as &#x201C;8+2+1&#x201D; because it provides: an initial period of eight&nbsp;years of data exclusivity, during which a competitor cannot rely on the relevant data; a further period of two&nbsp;years of market exclusivity, during which the data can be used to support applications for marketing authorization but a competitive product cannot be launched; and a possible one-year extension of the market exclusivity period if, during the initial eight-year data exclusivity period, the sponsor registered a new therapeutic indication with &#x201C;significant clinical benefit.&#x201D; This system applies both to national and centralized authorizations. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The EU also has an orphan drug exclusivity system for medicines similar to the US system. If a medicine is designated as an orphan drug, then it benefits from 10&nbsp;years of market exclusivity after it is authorized, during which time an application for the same or similar medicine for the same indication will not generally be accepted or granted. Under certain circumstances, this exclusivity can be extended with a two-year pediatric extension.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Japan</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Patents</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Japan, the patent term granted is 20&nbsp;years from the earliest application filing date, subject to potential PTEs. A PTE can be granted for up to five&nbsp;years to compensate for the time needed to obtain the Japanese marketing authorization. A Japanese PTE may apply to only a subset of the approved indications for a particular product.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Data and market exclusivity</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Japan has a regulatory data protection system called a &#x201C;re-examination period&#x201D; of eight&nbsp;years for new chemical entities and of four to six&nbsp;years for new indications and formulations, and a 10-year orphan drug exclusivity system.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Third-party patents and challenges to intellectual property</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Third parties can challenge our patents, patent term extensions and marketing exclusivities, including pediatric extensions and orphan drug exclusivity, through various proceedings. For example, patents in the US can be challenged in the USPTO through various proceedings, including Inter Partes Review (IPR) proceedings. They may also be challenged through patent infringement litigation under the Abbreviated New Drug Application (ANDA) provisions of the Hatch-Waxman Act or the Biologics Price Competition and Innovation Act (BPCIA). In the EU, patents may be challenged through oppositions in the EPO, or national patents may be challenged in national courts or national patent offices. In Japan, patents may be challenged in the Japan Patent Office and </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">50</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">in national courts. The outcomes of such challenges can be difficult to predict.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition to directly challenging our intellectual property rights, in some circumstances a competitor may be able to market a generic version of one of our products by, for example, designing around our intellectual property or marketing the generic product for non-protected indications. Despite data exclusivity protections, a competitor could opt to incur the costs of conducting its own clinical trials and preparing its own regulatory application, and avoid our data exclusivity protection altogether. There is a risk that some countries may seek to impose limitations on the availability of intellectual property protections for pharmaceutical products, or on the extent to which such protections may be enforced. For example, a review of several intellectual property rights is currently ongoing in the EU (orphan drug exclusivity, pediatric extensions and SPCs), which could lead to legislative changes in the scope and/or term of protection under those rights. Also, even though we may own, co-own or in-license patents protecting our products, and conduct pre-launch freedom-to-operate analyses, a third party may nevertheless claim that one of our products infringes a third-party patent for which we do not have a license.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a result, there can be no assurance that our intellectual property will protect our products or that we will be able to avoid adverse effects from the loss of intellectual property protection or from third-party patents in the future.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intellectual property protection for certain key </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">marketed products and compounds in development</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We present below additional details regarding intellectual property protection for certain Innovative Medicines Division products and compounds in development. For each, we identify issued, unexpired patents by general subject matter and, in parentheses, years of expiry in, if relevant, the US, the EU and Japan. The identified patents are owned, co-owned or exclusively in-licensed by Novartis and relate to the product or to the method of treatment or its use as it is currently approved and marketed or, in the case of a compound in development, as it is currently submitted to the FDA and/or the EMA for approval. Identification of an EU patent refers to national patents in EU countries and/or to the national patents that have been derived from a patent granted by the EPO. Novartis may own or control additional patents, for example, relating to compound forms, methods of treatment or use, formulations, processes, synthesis, purification and detection.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We identify unexpired regulatory data protection periods and, in parentheses, years of expiry if the relevant marketing authorizations have been authorized or granted. The term &#x201C;RDP&#x201D; refers to regulatory data protection, regulatory data exclusivity, and data re-examination protection systems. We identify certain unexpired patent term extensions and marketing exclusivities and, in parentheses, years of expiry if they are granted; their subject matter scope may be limited and is not specified. Marketing exclusivities and patent term extensions include orphan drug exclusivity (ODE), pediatric exclusivity (PE), patent term extension (PTE) and supplementary protection certificate (SPC). We designate them as &#x201C;pending&#x201D; if they have been applied for but not granted and years of expiry are estimable. Such pending applications may or may not ultimately be granted. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the case of the EU, identification of a patent, patent term extension, marketing exclusivity or data protection means grant, authorization and maintenance in at least one country and possibly pending or found invalid in others. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For each product below, we indicate whether there is current generic or biosimilar competition for one or more product versions in one or more approved indications in each of the major markets for which intellectual property is disclosed. We identify ongoing challenges to the disclosed intellectual property that have not been finally resolved, including IPRs if instituted by the USPTO. Challenges identified as being in administrative entities, such as national patent offices, include judicial appeals from decisions of those entities. Resolution of challenges to the disclosed intellectual property, which in the EU may involve intellectual property in one or more EU countries, may include settlement agreements under which Novartis permits or does not permit future launch of generic versions of our products before expiration of that intellectual property. We identify certain material terms of such settlement agreements where they could have a material adverse effect on our business. In other cases, such settlement agreements may contain confidentiality obligations restricting what may be disclosed.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional information regarding commercial arrangements with respect to these products, see &#x201C;&mdash;Key marketed products.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Novartis Oncology business unit</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Oncology</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Tasigna.</i> US: Patent on compound (2023), PE (2024); three patents on salt forms (2026, 2027, 2028), three PEs (2027, 2028, 2029); patent on polymorph compound form (2026), PE&nbsp;(2027); two patents on capsule form (2026, 2027), two PEs (2027, 2028); patent on method of treatment (2032), PE (2032). EU: Patent on compound (2023); patent on salt form (2026); patent on polymorph compound form (2026); patent on capsule form (2027); patent on method of treatment (2030). Japan: Patent on compound (2023), two PTEs (2024, 2028); patent on salt form (2026), PTE (2031); patent on polymorph compound form (2026), two PTEs (2030, 2031); patent on capsule form (2027), two PTEs (2030, 2031); patent on method of use (2030).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;">There is no generic competition in the US, the EU or Japan. In the US, generic manufacturers have filed ANDAs challenging certain patents other than the compound patent. The EU method-of-treatment patent and the capsule form patent are being opposed in the EPO. The EU polymorph compound form patent was upheld as valid by the Opposition Division at the EPO.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Sandostatin </i>SC and<i> Sandostatin LAR.</i></div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">51</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Sandostatin</i> SC. There is no patent protection in the US, the EU or Japan. There is generic competition in the US, the EU and Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Sandostatin LAR</i>. There is no patent protection in the US, the EU or Japan. There is generic competition in some EU markets but no generic competition in the US or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Afinitor/Votubia</i> and <i>Afinitor Disperz/Votubia</i> dispersible tablets. US: Patent on compound (2014), PTE (2019), PE (2020); patent on dispersible tablet formulation (2022), PE (2023); patent on antioxidant (2019), PE (2020); patent on tuberous sclerosis complex (TSC)/subependymal giant cell astrocytoma (SEGA) use (2022), PE (2022); patent on breast cancer use (2022), PE (2022); patent on renal cell carcinoma use (2025), PE (2026); patent on pancreatic neuroendocrine tumor use (2028). EU: Patent on dispersible tablet formulation (2022); two patents on breast cancer use (2022, 2022); patent on renal cell carcinoma use (2022); patent on neuroendocrine tumors of pancreatic origin (2022); patent on TSC/SEGA use (2022); patent on neuroendocrine tumors of lung origin use (2022); patent on TSC/SEGA and TSC/acute myeloid leukemia (AML) use (2027); ODE (<i>Votubia</i>, tuberous sclerosis) (2021). Japan: Patent on dispersible tablet formulation (2022); patent on breast cancer use (2022); patent on pancreatic neuroendocrine tumor use (2026); patent on renal cell carcinoma use (2022); patent on gastrointestinal and lung neuroendocrine tumor use (2026), PTE (2027); patent on TSC/SEGA and TSC/AML use (2027); ODE (tuberous sclerosis tablet) (2022); ODE (tuberous sclerosis dispersible tablet) (2022). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;">There is no generic competition in Japan. There is generic competition in the EU and the US. In the US, the compound patent and renal cell carcinoma use patent were challenged in ANDA proceedings against generic manufacturers, and the patents were upheld. The US pancreatic neuroendocrine tumor use patent is being challenged in IPR proceedings in the USPTO. In the US, Novartis has resolved patent litigation with certain generic manufacturers. There is generic competition in the US for the three lower-dosage strengths for <i>Afinitor</i>. Additional generic competition in the US may start in mid-2020. Novartis has resolved patent litigation relating to <i>Afinitor Disperz</i>. The EU breast cancer use patent, the EU TSC/SEGA use patent, the EU renal cell carcinoma use patent, and the EU patents on neuroendocrine tumors of pancreatic origin and of lung origin are being opposed in the EPO. National enforcement and validity actions are also ongoing on some of these patents in certain countries. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Promacta/Revolade.</i> US: Patent on compound (2021), PTE (2022), PE (2023); two patents on compound (2021, 2021), two PEs (2021, 2021); patent on thrombocytopenia use (2021), PE (2021); patent on method of enhancing platelet production (2021), PE (2021); patent on method of enhancing platelet production (2023), PE (2023); patent on salt form (2025); PE (2026); four patents on tablet formulations of different dose strengths (2027) (4), PE&nbsp;(2028) (4); ODE on severe aplastic anemia patients with an insufficient response to immunosuppressive therapy (2021), PE (2022); ODE on severe aplastic anemia patients in combination with standard immunosuppressive therapy (2025). EU: Patent on compound (2021), SPC (2025); patent on salt form (2023); patent on formulation (2027); RDP (2020). Japan: Patent on compound (2021), PTE (2025); patent on salt form (2023), PTE (2023); patent on formulation (2027); RDP (2020). There is no generic competition in the US, the EU or Japan. In the US, generic manufacturers have filed ANDAs challenging certain patents other than the compound patent. The EU formulation patent is being opposed in the EPO.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Tafinlar </i>and<i> Mekinist.</i></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Tafinlar</i>. US: Two patents on compound (2030, 2030); patent on method of treatment (2029); ODE (2020). EU: Patent on compound (2029); RDP (2023). Japan: Patent on compound (2031). There is no generic competition in the US, the EU or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Mekinist</i>. US: Patent on compound (2025), PTE (2027); patent on method of treatment (2025); three patents on formulation (2032) (3); ODE (2020). EU: Patent on compound (2025), SPC (2029); RDP (2025). Japan: Patent on compound (2025); patent on method of use (2025); patent on formulation (2031). There is no generic competition in the US, the EU or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;">Use of <i>Mekinist</i> with <i>Tafinlar</i> or <i>Tafinlar</i> with <i>Mekinist</i>. US: Patent on combination (2030); patent on method of use of combination (2030); RDP (2020); ODE on melanoma with certain mutations (2021); ODE on non-small cell lung cancer (2024). EU: RDP (2025). Japan: Patent on method of use of combination (2030). There is no generic competition in the US, the EU or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Gleevec/Glivec.</i> US: Patent on gastrointestinal stromal tumor (GIST) use (2021), PE (2022). EU: Patent on GIST use (2021); patent on tablet formulation (2023). Japan: Patent on GIST use (2021); patent on tablet formulation (2023).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;">There is generic competition in the US, the EU and Japan. Novartis is taking steps in some EU countries to enforce the GIST use patent. The EU GIST use patent is being challenged in one EU country. The EU tablet formulation patent is being challenged in the EPO.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Jakavi.</i> EU: Patent on compound (2026), SPC (2027); patent on salt form (2028); patent on compound for polycythemia vera (PV) use (2026); patent on salt form for PV use (2028); RDP (2023). Japan: Patent on compound (2026), three PTEs (2028, 2030, 2031); patent on salt form (2028), three PTEs (2028, 2030, 2031); patent on method of use (2026), two PTEs (2027, 2028); RDP (2022). There is no generic competition in the EU or Japan. The EU salt patent is being opposed in the EPO. The EU patent on salt form for PV use is also being opposed in the EPO. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">52</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Exjade </i>and<i> Jadenu. </i></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Exjade</i>. US: There is no patent protection for <i>Exjade</i> in the US. EU: Patent on compound (2017), SPC (2021), PE (2022); patent on dispersible tablet formulation (2023). Japan: Patent on compound (2017), PTE (2021); patent on dispersible tablet formulation (2023). There is generic competition in the US. There is no generic competition in the EU or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Jadenu</i> (marketed as <i>Exjade</i> FCT in the EU and Japan). The compound patents for <i>Exjade</i> also protect <i>Exjade</i> FCT (EU/Japan). US: Patent on film-coated tablet formulation (2034). EU: Two patents on film-coated tablet formulation (2034, 2034). There is generic competition in the US. There is no generic competition in the EU or Japan. In the US, Novartis has resolved patent litigation relating to the US formulation patent with a generic manufacturer. In the EU, the formulation patents are being opposed in the EPO. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Votrient.</i> US: Patent on compound (2021), PTE (2023); two patents on compound (2021, 2021). EU: Patent on compound (2021), SPC (2025); RDP (2021). Japan: Patent on compound (2021), two PTEs (2025, 2026). There is no generic competition in the US, the EU or Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Kisqali</i>. US: Three patents on compound (2028, 2030, 2031), pending PTE (2031); three patents on methods of treatment (2029, 2029, 2031); patent on salt form (2031); RDP (2022). EU: Patent on compound (2027); patent on compound (2029), SPC (2032); patent on methods of use (2029); RDP (2027). Japan: Two patents on compound (2027, 2029). <i>Kisqali</i> is not marketed in Japan. There is no generic competition in the US or the EU.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Lutathera</i>. US: RDP (2023); ODE (2025). EU: RDP (2027); ODE (2027). <i>Lutathera</i> is not marketed in Japan. There is no generic competition in the US or the EU.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Kymriah</i>. US: Seven patents on cells and/or pharmaceutical compositions comprising the cells (2031) (7); four patents on methods of use of cells and/or pharmaceutical compositions comprising the cells (2031) (4); RDP (2029), PE (2030); ODE for relapsed or refractory (r/r) pediatric acute lymphoblastic leukemia (2024), PE (2025); ODE for r/r diffuse large B-cell lymphoma (2025), PE (2025). EU: One patent on methods of use (2031), SPC (2033); RDP (2028); ODE (2028), PE (2030). Japan: Two patents on pharmaceutical compositions (2031, 2031), PTE (2034); two patents on cells, pharmaceutical compositions and use (2031, 2031), PTE (2033); two patents on CAR-T-associated cytokine release syndrome use (2033, 2033); ODE (2029). There is no generic competition in the US, the EU or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  <i>Piqray</i>. US: Patent on compound (2029); patent on compound and use (2030); RDP (2024). EU: Patent on compound and use (2029). Japan: Patent on compound and use (2029). <i>Piqray</i> is not marketed in the EU or Japan. There is no generic competition in the US.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  <i>Adakveo</i>. US: Patent on composition of matter (2028), PTE pending (2032); patent on method of use (2027); RDP (2031). EU: Patent on composition of matter (2027). Japan: There is no patent protection for <i>Adakveo</i> in Japan. <i>Adakveo</i> is not marketed in the EU or Japan. There is no generic competition in the US.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Novartis Pharmaceuticals business unit</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Ophthalmology</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Lucentis.</i> EU: Patent on composition of matter (2018), SPC (2022). Japan: Patent on composition of matter (2018), PTE for pathologic myopia (2021), PTE for retinal vein occlusion (2023), PTE for diabetic macular edema (2023). There is no generic competition in the EU or Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Xiidra</i>. US: Patent on compound (2024); three patents on compound and use (2024) (2), (2025); patent on formulation (2024); five patents on method of treatment (2024, 2024, 2026, 2029, 2029); two patents on polymorph compound form (2029, 2029); RDP (2021). PTE pending. EU: Three patents on compound and use of compound (2024, 2026, 2026). Japan: Patent on compound (2024); patent on the use of the compound and formulation (2026); patent on formulation (2033). There is no generic competition in the US. <i>Xiidra</i> is not marketed in the EU or Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Beovu</i>.&nbsp;US:&nbsp;Patent on composition of matter (2029), PTE pending (2033); patent on method of treatment (2029); patent on nucleic acid molecule (2029); patent on antibodies (2023); patent on dosing regimen (2035); RDP (2031).&nbsp;EU:&nbsp;Patent on composition of matter (2029); patent on antibodies (2023). Japan: Patent on composition of matter (2029); patent on antibodies (2023). There is no generic competition in the US. <i>Beovu</i> is not marketed in the EU or Japan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Immunology, Hepatology and Dermatology</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Cosentyx.</i> US: Patent on composition of matter (2026), PTE (2029); patent on psoriasis use (2032); patent on ankylosing spondylitis use (2033); RDP (2027). EU: Patent on composition of matter (2025), SPC (2030), PE (2030); patent on psoriasis use (2031); RDP (2026). Japan: Patent on composition of matter (2025), three PTEs (2026, 2028, 2029); patent on psoriasis use (2031), three PTEs (2032, 2032, 2033); patent on psoriatic arthritis use (2031); RDP (2022). There is no generic competition in the US, the EU or Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Ilaris.</i> US: Patent on composition of matter (2024); patent on cryopyrin-associated periodic syndromes (CAPS) use (2026); patent on familial Mediterranean fever (FMF) use (2026); patent on systemic onset juvenile idiopathic arthritis (SJIA) use (2027); patent on hyperimmunoglobulin D syndrome (HIDS) and tumor necrosis factor receptor-associated periodic syndrome (TRAPS) use (2028); patent on formulation (2029); RDP (2021). EU: Patent on composition of matter (2021), SPC (2024), PE (2025); patent on SJIA use (2026); patent on FMF use (2026); patent on formulation (2029); RDP (2020). Japan: Patent on composition </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">53</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">of matter (2021), two PTEs (2024, 2026); patent on familial cold urticaria, neonatal onset multisystem inflammatory disease, SJIA and FMF use (2026); patent on Muckle-Wells syndrome use (2026); patent on formulation (2029); ODE for CAPS (2021); ODE for FMF, HIDS and TRAPS (2026); ODE for SJIA (2028). There is no generic competition in the US, the EU or Japan. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Neuroscience</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Gilenya.</i> US: Patent on dosage regimen (2027), PE (2027); patent on 0.25 mg formulation (2032), PE (2032); patent on method of treatment (2027); RDP for pediatric use and 0.25 mg (2021), PE (2021). EU: RDP (2022); patent on formulation (2024), SPC (2026); patent on 0.25 mg formulation (2032). Japan: ODE (2021); two patents on formulation (2024, 2024). There is no generic competition in the US, the EU or Japan. In the US, the ANDA proceedings challenging the compound patent and extensions expiring in 2019 have been resolved and the patent upheld. The dosage regimen patent is being challenged in ANDA proceedings against generic manufacturers. In parallel, an appeal against a USPTO decision upholding the patent in IPR proceedings is ongoing. Novartis is taking steps to enforce the US dosage regimen patent and the method of treatment patent against generic manufacturers.  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Zolgensma</i>. US: Two patents on vector (2024, 2026); ODE for spinal muscular atrophy (SMA) in patients less than 2 years old with biallelic mutations in the SMN1 gene (2026); RDP (2031). EU: Two patents on vector (2024, 2028); two patents on method of use (2028, 2028). Japan: Patent on vector (2024); patent method of use (2028). <i>Zolgensma</i> is not marketed in the EU or Japan. There is no generic competition in the US.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Aimovig</i>. US (co-commercialized with Amgen): Patent on composition of matter (2031); patent on dose/regimen for migraine prevention (2036); RDP (2030). EU: Patent on composition of matter (2029), SPC (2033); RDP (2028). There is no generic competition in the US or the EU. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Mayzent</i>. US: Patent on compound (2024); RDP (2024); patent on treatment initiation use (2030). PTE pending. EU: Patent on compound (2024); patent on solid form (2029); patent on treatment initiation use (2029); patent on formulation (2032); RDP (2030). Japan: Patent on compound (2024); patent on solid form (2029); two patents on formulation (2032, 2032); patent on patient subgroup use (2033). <i>Mayzent</i> is not marketed in Japan. There is no generic competition in the US or the EU. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Respiratory</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Xolair.</i> US: Two patents on syringe formulation (2021, 2024). EU: Two patents on syringe formulation (2021, 2024). Japan: Two patents on syringe formulation (2021, 2024). There is no generic competition in the US, the EU or Japan. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Cardiovascular, Renal and Metabolism</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Entresto.</i> US: Four patents on combination (2023) (4), PE (2023 (3), 2024); two patents on complex (2026, 2027), PE (2027, 2027); RDP (2020), PE (2021); RDP for new pediatric patient population (2022), PE (2023). PTE pending. EU: Patent on combination (2023), SPC (2028); patent on complex (2026), SPC (2030); RDP (2025). Japan: Patent on combination (2023); patent on complex (2026); patent on formulation (2028). There is no generic competition in the US or the EU. <i>Entresto</i> is not marketed in Japan. The EU complex patent is being opposed in the EPO. In the US, the combination and complex patents are being challenged in ANDA proceedings against generic manufacturers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;">Established Medicines</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><i>&#x2022;</i><i> Galvus</i> and <i>Eucreas</i>. EU: Patent on compound (2019), SPC (2022); patent on combination (2021), SPC (2022); patent on <i>Galvus</i> formulation (2025); patent on <i>Eucreas</i> formulation (2026). Japan: Patent on compound (2019), three PTEs (2022, 2024, 2024); patent on combination (2021); patent on <i>Galvus</i> formulation (2025), PTE (2025); patent on <i>Eucreas</i> formulation (2026), PTE (2028). <i>Galvus/Eucreas</i> is not marketed in the US. There is generic competition for <i>Galvus</i> and <i>Eucreas</i> in some EU countries. There is no generic competition in Japan. The EU <i>Galvus</i> and <i>Eucreas</i> formulation patents are being opposed in the EPO.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Diovan</i> and <i>Co-Diovan/Diovan HCT. Diovan</i>: There is generic competition in the US, the EU and Japan. <i>Co-Diovan/Diovan HCT</i>: There is generic competition in the US, the EU and Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Exforge </i>and<i> Exforge HCT.</i></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Exforge</i>. US: There is no patent protection for <i>Exforge</i> combination in the US. EU: There is no patent protection for <i>Exforge</i> combination in the EU. Japan: There is no patent protection for <i>Exforge</i> combination in Japan. There is generic competition in the US, the EU and Japan. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:11px;margin-right:0mm;margin-top:0mm;"><i>Exforge HCT</i>. US: Patent on <i>Exforge HCT</i> combination (2023); patent on formulation (2023). EU: There is no patent protection for <i>Exforge HCT</i> combination in the EU. Japan: Patent on <i>Exforge HCT</i> combination (2023). There is generic competition in the US and the EU. There is no generic competition in Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Zortress/Certican</i>. US: Patent on compound (2014), PTE (2019), PE (2020); patent on dispersible tablet formulation (2022), PE (2023); patent on antioxidant (2019), PE (2020). EU: Patent on dispersible tablet formulation (2022). Japan: Patent on dispersible tablet formulation (2022). There is no generic competition in the US, the EU or Japan. In the US, the compound patent has been upheld as valid after a challenge in ANDA proceedings against generic manufacturers.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; <i>Egaten</i>. US: RDP (2024); ODE (2026). EU: There is no patent protection for <i>Egaten</i> in the EU. Japan: There is no patent protection for <i>Egaten</i> in Japan. <i>Egaten</i> is not </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">54</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">marketed in Japan. There is no generic competition in the US or the EU.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compounds in development</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We provide the following patent information for non-marketed compounds in development that have been submitted to the FDA and/or the EMA for registration but have not yet been approved by either agency. Unless noted, the information below does not include anticipated or potential patent term extensions (PTEs or SPCs), or RDP, both of which generally are not applied for or granted until a product is approved or marketed. For these products, Novartis will seek all appropriate RDP, will continue to seek additional intellectual property protection for significant product developments, and will apply for patent term extensions in keeping with the great importance we attach to intellectual property to protect our investments in research and development, manufacturing and marketing.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; INC280 (capmatinib). US: Patent on compound (2027); patent on salt form (2031); patent on method of use (2029); patent on formulation (2035). EU: Patent on compound (2027); patent on salt form (2029). Japan: Patent on compound (2027); patent on salt form (2029).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; KJX839 (inclisiran). US: Patent on composition of matter (2034), anticipated PTE (2035). EU: Patent on composition of matter (2033), anticipated SPC (2036). Japan: Patent on composition of matter (2033).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; OMB157 (ofatumumab, for multiple sclerosis). US: Patent on compound (2031). EU: Three patents on compound (2023 (3)); two patents on formulation (2028, 2028). Japan: Two patents on compound (2023, 2023); two patents on formulation (2028, 2028).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; QMF149 (indacaterol acetate/mometasone furoate). US: Patent on compound (2020); three patents on combination (2020, 2021, 2023); three patents on formulation (2020, 2020, 2021); patent on device (2028); patent on salt form (2029). EU: Patent on compound (2020); patent on formulation (2020); patent on combination (2021); patent on device (2025); patent on salt form (2027). Japan: Patent on compound (2020); patent on device (2025); patent on salt form (2027).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; QVM149 (indacaterol acetate/glycopyrronium bromide/mometasone furoate). US: Patent on compound (2020); five patents on combination (2020 (3), 2021, 2023); eight patents on formulation (2020 (3), 2021 (5)); two patents on method of use (2021, 2021); patent on device (2028); patent on salt form (2029). EU: Patent on compound (2020); patent on formulation (2020); patent on combination (2021); patent on device (2025); patent on salt form (2027). Japan: Patent on compound (2020); two patents on formulation (2025, 2025); patent on combination (2025); patent on device (2025); patent on salt form (2027). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"></div><a name="anchorId00340635"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Sandoz</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Sandoz Division is a global leader in generic pharmaceuticals and biosimilars, and sells products in well over 100 countries. In 2019, the Sandoz Division achieved consolidated net sales of USD 9.7&nbsp;billion, representing 21% of the Group&#x2019;s total net sales. Sandoz develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Sandoz is organized globally into three franchises: Retail Generics, Anti-Infectives and Biopharmaceuticals. In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form anti-infectives sold to third parties. In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates &ndash; mainly antibiotics &ndash; for internal use by Retail Generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Sandoz strategic ambition is to be the world&#x2019;s leading and most valued generics company (including biosimilars). Under Sandoz CEO Richard Saynor, the divisional strategy has been refined to focus on three areas: developing a broad and consistent pipeline of off-patent launches across key geographies and major therapeutic areas; positioning Sandoz to be &#x201C;first in&#x201D; by having a strong pipeline with a concentration on being first to market, and to be &#x201C;last out&#x201D; by way of competitive costs and stable supply; and instilling a true &#x201C;generic mindset,&#x201D; with a focus on priorities, simple and rapid decision-making, and focused resource allocation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, Novartis announced an agreement to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc., for USD 0.8 billion in cash and potential earn-outs. These businesses had net sales of approximately USD 1.1 billion in 2019. The sale includes the Sandoz US generic and branded dermatology businesses as well as its dermatology development center. As part of the transaction, Aurobindo will acquire the manufacturing facilities in Wilson, North Carolina, and in Hicksville and Melville, New York. Following the transaction, the Sandoz US portfolio </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">55</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">will include primarily biosimilars and complex generics such as injectable, respiratory and ophthalmic products. The transaction is expected to be completed in the first quarter of 2020 pending regulatory approval.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Sandoz is a market leader in biosimilars, with a total of eight approved and marketed products and a pipeline of over 10 molecules, including publicly announced commercialization agreements with BioCon, Gan &amp; Lee, EirGenix and Polpharma Biologics. Availability of our biosimilars varies by country. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In November 2019, we announced the planned acquisition of the Japanese business of Aspen Global Incorporated. Aspen&#x2019;s portfolio in Japan consists of off-patent medicines with a focus on anesthetics and specialty brands. We have received all relevant approvals and this transaction is expected to be completed in the first quarter of 2020.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We received a CRL from the FDA in 2018 for our submission for a generic form of fluticasone propionate and salmeterol inhalation powder, for oral inhalation (GSK&#x2019;s Advair<sup>&#xAE;</sup>). In January 2020 we decided to discontinue the generic Advair<sup>&#xAE;</sup> development program in the US, following a recent review of data read-outs.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Key marketed products</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Sandoz global portfolio covers a wide range of therapeutic areas. The following are some of the Sandoz key marketed products in each of its franchises (availability varies by market):</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Retail Generics</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Product</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Originator drug</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Description</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amoxicillin/clavulanic acid</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Augmentin<sup>&#xAE;</sup></div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Antibiotic</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Zoledronic acid</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Aclasta</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Osteoporosis treatment</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acetylsteine</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Various</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Mucolytic agent</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fentanyl</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Various</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Pain treatment</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Anti</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">-Infectives</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Active ingredients</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Description</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oral and sterile penicillins</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-infectives</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oral and sterile cephalosporins</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-infectives</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Clavulanic acid and mixtures with clavulanic acid</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#xDF;-lactam inhibitors</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Classical and semisynthetic erythromycins</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-infectives</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Intermediates</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Description</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Various cephalosporin intermediates</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-infectives</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Erythromycin base</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-infectives</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Various crude compounds produced by fermentation</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cyclosporine, ascomysin, rapamycin, mycophenolic acid, etc.</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Biopharmaceuticals</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Product</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Originator drug</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Description</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Omnitrope</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Genotropin<sup>&#xAE;</sup></div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Recombinant human growth hormone</div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Binocrit</I> and Epoetin alfa <I>Hexal</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Eprex<sup>&#xAE;</sup>/Erypo<sup>&#xAE;</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Recombinant protein used for anemia</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Zarzio, Zarxio</I> and <I>Filgrastim Hexal</I></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neupogen<sup>&#xAE;</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Recombinant protein used in oncology</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Glatopa</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Copaxone<sup>&#xAE;</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Treatment for multiple sclerosis (MS)</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Erelzi<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Enbrel<sup>&#xAE;</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Treatment for multiple inflammatory diseases</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Rixathon</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MabThera<sup>&#xAE;</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Treatment for blood cancers and immunological diseases</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Hyrimoz</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Humira<sup>&#xAE;</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Treatment for multiple inflammatory diseases</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zessly</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Remicade<sup>&#xAE;</sup>  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Treatment for gastroenterological, rheumatological and   dermatological diseases</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ziextenzo</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neulasta<sup>&#xAE;</sup>      </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Treatment to reduce duration of chemotherapy-induced   neutropenia and incidence of chemotherapy-induced   febrile neutropenia with the exception of chronic myeloid   leukemia and myelodysplastic syndromes</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Approved in the US in 2016. Launch in the US pending final resolution of litigation with Amgen, which markets Enbrel<sup>&#xAE;</sup>. The US District Court of New Jersey ruled against Sandoz on August 9, 2019; Sandoz respectfully disagrees with the ruling and submitted an appeal. The appeals court hearing is scheduled for March 4, 2020.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">56</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Biosimilars</font><font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"> in Phase&nbsp;III development and registration</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table describes Sandoz biosimilar projects that are in Phase&nbsp;III clinical trials (including filing preparation) and registration:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Project/<br>product<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Common <br> name</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Mechanism of action</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Potential indication/indications</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Therapeutic areas</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Route of<br> administration</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Current phase</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">GP2017</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> adalimumab    </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TNF-&#x3B1; inhibitor    </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Arthritides (rheumatoid arthritis, ankylosing   spondylitis, psoriatic arthritis), plaque psoriasis   and others (same as originator)</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology    </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous    </div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EU:&#xA0;Approved  US:&#xA0;Approved<sup>2</sup>  </div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">GP2411<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> denosumab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RANKL inhibitor    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Osteoporosis, bone loss, prevention of bone   complications in cancer that has spread to   the bone (indications vary in US and EU)</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Endocrinology,   Neurology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Subcutaneous    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Phase III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">EGI014A1<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> trastuzumab  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti HER2 monoclonal   antibody</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast and gastric tumors  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Phase III  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">DST356A1<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> natalizumab    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Anti-Alpha 4 (&#x3B1;4) integrin   monoclonal antibody  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Monotherapy for remitting relapsing forms of   multiple sclerosis (RRMS); in US second line   treatment for active Crohn&#x2019;s disease</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neurology,   Immunology (US only)  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Intravenous    </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Phase III    </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> LA-EP2006 (pegfilgrastim) was approved and launched in the EU as <I>Ziextenzo</I> in November 2018 and was approved and launched in the US in November 2019.</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Launched as <I>Hyrimoz</I> in the EU in October 2018. Also in October 2018, we announced a global resolution of all intellectual property-related litigation with AbbVie concerning adalimumab. Under the terms of the agreement, AbbVie grants us a non-exclusive license to AbbVie&#x2019;s intellectual property relating to Humira<sup>&#xAE;</sup>, beginning on certain dates in certain countries in which AbbVie has intellectual property. We are not entitled to launch <I>Hyrimoz</I> in the US until the second half of 2023.</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Development in collaboration with Hexal AG.</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Development in collaboration with EirGenix, Inc.</div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Development in collaboration with Polpharma Biologics.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Principal markets</font>
</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The two largest generics markets in the world &ndash; the US and Europe&ndash; are the principal markets for Sandoz. The following table sets forth the aggregate 2019 net sales of Sandoz by region:</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 net sales  to third parties</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> USD millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;115</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;491</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia, Africa, Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 784</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Of which in Established Markets<sup style="white-space: nowrap">&nbsp;*</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;111</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 73</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Of which in Emerging Growth Markets<sup style="white-space: nowrap">&nbsp;*</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;620</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;*&nbsp;</sup> Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Many Sandoz products are used for chronic conditions that require patients to consume the product over long periods of time, from months to years. Sales of our anti-infective products and over-the-counter cough and cold products are subject to seasonal variation. Sales of the vast majority of our other products are not subject to material changes in seasonal demand.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Production</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For information on the production of our products, see &#x201C;&mdash;Item 4.B Business overview&mdash;Innovative Medicines&mdash;Production.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Due to impurities found in the active ingredients batches sourced from third-party manufacturers, we recalled Sandoz valsartan, losartan and ibersartan products in the second half of 2018 and first quarter of 2019, and ranitidine film-coated tablets in the second half of 2019, from several markets, in line with our quality standards for all of our marketed products.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Marketing and sales</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz sells a broad portfolio of products, including the products of our Retail Generics franchise and biosimilars, to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz adapts its marketing and sales approach to local decision-making processes, depending on the structure of the market in each country.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In response to rising healthcare costs, many governments and private medical care providers, such as health maintenance organizations, have instituted reimburse-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">57</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">ment schemes that favor the substitution of bioequivalent generic versions of originator pharmaceutical products, such as those sold by our Retail Generics franchise. In the US, statutes have been enacted by all states that permit or require pharmacists to substitute a less expensive generic product for the brand-name version of a drug that has been prescribed to a patient. Generic use is growing in Europe, but penetration rates in many EU countries (as a percentage of volume) remain well below those in the US.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Recent trends have been toward continued consolidation among distributors and retailers of Sandoz products, both in the US and internationally, which has increased our customers&#x2019; purchasing leverage.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Legislative or regulatory changes can have a significant impact on our business in a country. In Germany, for example, healthcare reforms have increasingly shifted decision-making from physicians to insurance funds.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Anti-Infectives franchise supplies active pharmaceutical ingredients and intermediates &ndash; mainly antibiotics &ndash; for internal use by Retail Generics and for sale to the pharmaceutical industry worldwide.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Biopharmaceuticals franchise operates in an emerging business environment, particularly in the US. Regulatory pathways for approving biosimilar products are either relatively new or still in development, and policies have not yet been fully defined or implemented for the automatic substitution and reimbursement of biosimilars in many markets, including the US. As a result, in many of these markets, our biosimilar products are marketed as branded competitors to the originator products.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Competition</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The market for generic products is characterized by increasing demand for high-quality pharmaceuticals that can be marketed at lower costs due to comparatively minimal initial research and development investments. Increasing pressure on healthcare expenditures and numerous patent and data exclusivity period expirations have encouraged more generic product launches, resulting in increased competition among the companies selling generic pharmaceutical products, leading to ongoing price pressure. In particular, Sandoz faces increased industrywide pressure on prices for generic products, particularly in the US, driven by factors including customer consolidation and growing competition from other manufacturers of generic medicines. These factors contributed to a decline in US sales that began in 2017 and continued through 2019. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, research-based pharmaceutical companies are participating directly in the generic conversion process by licensing their patented products to generic companies (so-called &#x201C;authorized generics&#x201D;). Consequently, generic companies that were not otherwise in a position to launch a specific product may participate in the market using the innovator&#x2019;s product authorization. Authorized generics serve as a business opportunity for Sandoz when the product of a research-based pharmaceutical company loses patent protection and Sandoz secures a license from the research-based pharmaceutical company to launch the authorized generic of that product.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Development and registration</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Development of Sandoz Biopharmaceuticals is jointly overseen by Sandoz and by GDD and is mostly executed by GDD. Development and registration activities for Retail Generics products, and certain registration activities for Biopharmaceuticals products, continue to be overseen directly by Sandoz.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Before a generic pharmaceutical may be marketed, intensive technical and clinical development work must be performed to demonstrate, in bioavailability studies, the bioequivalence of the generic product to the reference product. Nevertheless, research and development costs associated with generic pharmaceuticals are much lower than those of the originator pharmaceuticals, as no preclinical studies or clinical trials on dose finding, safety and efficacy must be performed by the generic company. As a result, generic pharmaceutical products can be offered for sale at prices often much lower than those of products protected by patents and data exclusivity, which must recoup substantial research and development costs through higher prices over the life of the product&#x2019;s patent and data exclusivity period.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">While generic pharmaceuticals are follow-on versions of chemically synthesized molecules, biosimilar products contain a version of the active substance of an already approved biological reference medicine. Due to the inherent variability and complexity of biologic products, including batch-to-batch differences and variations following manufacturing changes, the development and the regulatory pathway of biosimilars differ significantly from that of generics.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The development of a biosimilar product is much more technically challenging than the development of a typical generic small molecule pharmaceutical. While generic pharmaceuticals normally do not require clinical studies in patients, regulators worldwide do require such targeted studies for biosimilar products. Biosimilars are engineered to match the reference medicine in quality, safety and efficacy. This is achieved by systematically defining the target range of the reference medicine and then comparing the biosimilar to the reference medicine at various development stages to confirm biosimilarity and to establish that there are no clinically meaningful differences between the proposed biosimilar and the reference biologic. Because the purpose of a biosimilar clinical development program is to confirm biosimilarity and not to establish efficacy and safety de novo, the clinical studies required are less than those required for a reference biologic. Therefore, the cost of development for a biosimilar is usually less than that of a reference biologic.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Development and Registration staff employed by affiliates of the Sandoz Division are based worldwide, including at facilities in Holzkirchen, Germany; Rudolstadt, Germany; Kundl, Austria; Ljubljana, Slovenia; Melville, New York; and Hicksville, New York. In 2018, the divestment of the Boucherville, Canada, development (and associated manufacturing) facility to Avara Pharmaceutical Services was announced. In 2019, the Superior Court of Quebec granted Sandoz the right to reacquire the site, which had subsequently gone into receivership, in order to maintain stable operations pending a decision about the site&#x2019;s long-term future. Sepa-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">58</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">rately, in 2019, Sandoz confirmed the opening of a new development center in Hyderabad, India, initially focused on oral solid medicines. In May 2019, we announced the planned closure of the Holzkirchen development and registration site.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Regulation</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Generics</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Hatch-Waxman Act in the US (and similar legislation in the EU and in other countries) eliminated the requirement that manufacturers of generic pharmaceuticals repeat the extensive clinical trials required for reference products, so long as the generic version could be shown to be therapeutically equivalent to the reference product.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US, the decision on whether a generic pharmaceutical is therapeutically equivalent to the original product is made by the FDA based on an Abbreviated New Drug Application (ANDA) filed by the generic product&#x2019;s manufacturer. The process typically takes nearly two years from the filing of the ANDA until FDA approval. However, delays can occur if issues arise, for example, regarding the interpretation of bioequivalence study data, labeling requirements for the generic product, or qualifying the supply of active ingredients. In addition, the Hatch-Waxman Act requires a generic manufacturer to certify in certain situations that the generic product does not infringe on any current applicable patents on the product held by the holder of the marketing authorization for the reference product, or to certify that such patents are invalid. This certification often results in a patent infringement lawsuit being brought against the generic company. In the event of such a lawsuit, the Hatch-Waxman Act imposes an automatic 30-month delay in the approval of the ANDA to allow the parties to resolve the intellectual property issues. For generic applicants who are the first to file their ANDA containing a certification claiming non-infringement or patent invalidity, the Hatch Waxman Act generally provides those applicants with 180&nbsp;days of marketing exclusivity to recoup the expense of challenging the patents on the reference product. However, generic applicants must launch their products within certain timeframes or risk losing the marketing exclusivity that they had gained by being a first-to-file applicant.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the EU, decisions on the granting of a marketing authorization are made either by the European Commission based on a positive recommendation by the EMA under the centralized procedure, or by a single member state under the national or decentralized procedure. See &#x201C;&mdash;Innovative Medicines&mdash;Regulation&mdash;European Union.&#x201D; Companies may submit Abridged Applications for approval of a generic medicinal product based upon its &#x201C;essential similarity&#x201D; to a medicinal product authorized and marketed in the EU following the expiration of the product&#x2019;s data exclusivity period. In such cases, the generic company is able to submit its Abridged Application based on the data submitted by the innovator company for the reference product, without the need to conduct extensive Phase&nbsp;III clinical trials of its own. For all products that received a marketing authorization in the EU after late 2005, the Abridged Application can be submitted throughout the EU. However, the data submitted by the innovator company in support of its application for a marketing authorization for the reference product will be protected for 10 years after the first grant of marketing authorization in all member states, and can be extended for an additional year if a further innovative indication has been authorized for that product, based on preclinical and clinical trials filed by the innovator company that show a significant clinical benefit in comparison to the existing therapies.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Biosimilars</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The regulatory pathways for approval of biosimilar medicines are still being developed and established in many countries of the world. A regulatory framework for the approval of biosimilars has been established in the EU, Japan, Canada and the US, while the World Health Organization (WHO) has issued guidance. Sandoz has successfully registered and launched the first biosimilar (or biosimilar-type) medicine in Europe, the US, Canada, Japan, Taiwan, Australia, and many countries in Latin America and Asia. Sandoz was the first company to secure approval for and launch a biosimilar under the US biosimilar pathway that was established as part of the Biologics Price Competition and Innovation Act (BPCIA).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The approval of biosimilars in Europe follows a process similar to that followed for small molecules. However, biosimilars usually have to be approved through the centralized procedure because they are manufactured using recombinant DNA technology. As part of the approval process in the EU, biosimilars have to demonstrate comparability to the reference medicine in terms of safety, efficacy and quality through an extensive comparability exercise, based on strict guidelines set by the authorities. Regulators will only approve a biosimilar based on data that allows the regulators to conclude that there are no clinically meaningful differences between the reference medicine and the biosimilar.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US, under the BPCIA, a biosimilar must be highly similar with no clinically meaningful differences compared to the reference medicine. Approval of a biosimilar in the US requires the submission of an ABLA to the FDA, including an assessment of immunogenicity, and pharmacokinetics or pharmacodynamics. The ABLA for a biosimilar can be submitted as soon as four years after the initial approval of the reference biologic, but can only be approved 12&nbsp;years after the initial approval of the reference biologic. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Intellectual property</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We take all reasonable steps to ensure that our products do not infringe valid intellectual property rights held by others. Nevertheless, competing companies commonly assert patent and other intellectual property rights. As a result, we can become involved in significant litigation regarding our products. If we are unsuccessful in defending these suits, we could be subject to injunctions preventing us from selling our products and to potentially substantial damages.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Wherever possible, our products are protected by our own patents. Among other things, patents may cover the products themselves, including the product&#x2019;s formu-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">59</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">lation, or the processes for manufacturing a product. However, there can be no assurance that our intellectual property will protect our products or that we will be able to avoid adverse effects from the loss of intellectual property protection in the future.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></div><a name="anchorId00341486"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">4.C  Organizational structure</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Organizational structure</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See &#x201C;Item&nbsp;4. Information on the Company&mdash;Item&nbsp;4.A History and development of Novartis,&#x201D; and &#x201C;Item&nbsp;4. Information on the Company&mdash;Item&nbsp;4.B Business overview&mdash;Overview.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant subsidiaries</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See &#x201C;Item 18. Financial Statements&mdash;Note 32. Principal Group subsidiaries and associated companies.&#x201D;</div><a name="anchorId00341505"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">4.D  Property, plants and equipment</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our principal executive offices are located in Basel, Switzerland. Our divisions operate through a number of affiliates that have offices, research and development facilities, and production sites throughout the world.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We generally own our facilities or have entered into long-term lease arrangements for them. Some of our principal facilities are subject to mortgages and other security interests granted to secure indebtedness to certain financial institutions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">NTO manages the production and supply chains of our Innovative Medicines and Sandoz Division products through a network of 60 manufacturing sites, as well as through external suppliers, and warehouse and distribution centers. AAA manages four sites for radioligand therapies production, and certain other small sites for diagnostics and enriched water production. AveXis manages six sites for research and development, production, warehousing, its headquarters and administrative offices. Endocyte manages two sites for research and its headquarters and administrative offices.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table sets forth our major headquarters and most significant production, research and development, and administrative facilities. See also &#x201C;&mdash;Item 4.B Business overview&mdash;Innovative Medicines&mdash;Production&#x201D; and &#x201C;&mdash;Item 4.B Business overview&mdash;Sandoz&mdash;Production&#x201D; for a discussion of our manufacturing processes.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">60</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Major facilities</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Location</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Size of site (in <br> square meters)</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Major activity</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel, Switzerland &#x2013; St.&#xA0;Johann</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 589&nbsp;000    </div>
      </td>
      <td align="right" width="1%"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Global Group headquarters; global Innovative Medicines Division headquarters; Global Sandoz   Division; research and development; production of drug substances and   drug intermediates</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kundl and Schaftenau, Austria</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 480&nbsp;000  </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of biotechnological products, drug products and finished products, anti-infectives,   active drug substances, product development</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, New Jersey</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 391&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Innovative Medicines Division US headquarters, research and development</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barleben, Germany</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 340&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of broad range of generics finished dosage forms</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cambridge, Massachusetts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 205&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Research and development</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai, China</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 106&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Research and development</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana, Slovenia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of broad range of finished solid and sterile dosage forms</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hyderabad, India</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> General administrative and development global service center</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Longmont, Colorado</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 65&nbsp;032</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production, warehouse, and administrative offices for AveXis</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stein, Switzerland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64&nbsp;700  </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of sterile vials, pre-filled syringes and ampoules; inhalation capsules,   tablets and transdermals; active pharmaceutical ingredients, and cell and gene therapies</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen, Germany</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64&nbsp;200  </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Global Sandoz Division headquarters, production of oral films, transdermal delivery systems,   matrix patches, product development</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Menges, Slovenia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of drug substances and drug intermediates</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stryk&#xF3;w, Poland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of broad range of bulk oral solid forms and packaging</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Huningue, France</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of drug substances for clinical and commercial supply</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Singapore</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production for Innovative Medicines solids and biologics</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barbera, Spain</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of tablets, capsules and inhalation products</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel, Switzerland &#x2013; Schweizerhalle</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31&nbsp;700</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of drug substances and drug intermediates</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison, France</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Administrative offices for Innovative Medicines</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Puurs, Belgium</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production for Innovative Medicines ophthalmic products</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo, Japan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Administrative offices for Innovative Medicines and Sandoz</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Morris Plains, New Jersey</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;600</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production for Innovative Medicines Division cell&#xA0;and gene therapies</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, New Jersey</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14&nbsp;300</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Sandoz Division US headquarters</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Libertyville, Illinois</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production, warehouse, and administrative offices for AveXis</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Targu Mures, Romania</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;070</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production of solids for Innovative Medicines and Sandoz</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Les Ulis, France</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;920</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Production for Innovative Medicines Division cell&#xA0;and gene therapies</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Millburn, New Jersey</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AAA primary production site for radioligand therapy</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Colleretto Giacosa/Ivrea, Italy</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;200</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AAA primary production site for radioligand therapy</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As our product portfolio evolves, NTO is adapting our manufacturing capacity and capabilities to meet our changing needs, shifting from high-volume products toward lower-volume, customized and personalized medicines. As of December 31, 2019 we have closed, exited or sold, or announced the closure, exit or sale of 19 facilities since 2016. We have also continued to expand our capacity in personalized medicines and complex biologic drugs, such as in Stein, Switzerland, as well as investing in new facilities to provide cell and gene therapies, such as in Les Ulis, France. We are leveraging innovation to increase the reliability and productivity of our manufacturing network, including using data and digital technologies. We continue to seek opportunities to manage our production facilities as efficiently as possible, optimize external spend, and simplify and standardize across our manufacturing network to help us lower costs and help optimize the value of our products. At the same time, we are working to improve our environmental sustainability, for example by reducing energy and water consumption at our sites.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2012, we announced the construction of a new state-of-the-art production facility to produce solid dosage form medicines for the Innovative Medicines Division in Stein, Switzerland. In addition, we invested in new technologies and packaging facilities for pharmaceuticals at Stein. Both projects became fully operational in 2019. As of December&nbsp;31, 2019, the total amount paid and committed to be paid on the Stein projects is equivalent to approximately USD 0.6 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2012, we announced the planned construction of a new state-of-the-art biotechnology production site in Singapore. The facility became operational in 2019 and is focused on drug substance manufacturing based on cell culture technology. The facility is co-located with the pharmaceutical production site based in Tuas, Singapore. As of December&nbsp;31, 2019, the total amount paid and committed to be paid on this project is equivalent to USD 0.8 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, AveXis initiated construction of a new 15800-square-meter state-of-the-art gene therapy manufacturing facility in Durham, North Carolina. The new facility is expected to complement the existing AveXis site in Libertyville, Illinois, and allow for production of multiple gene therapy products simultaneously. The site is expected to be operational in 2020. We expect our investment in this facility to exceed USD 0.2 billion. As of December 31, 2019, the total amount paid and com-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">61</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">mitted to be paid on this project is approximately USD 0.2 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, we announced our plan to establish a European cell and gene therapy hub in Stein, Switzerland, and the facility was officially opened in November 2019. We expect our investment in this project to exceed USD 0.1 billion. As of December&nbsp;31, 2019, the total amount paid and committed to be paid on this project is equivalent to USD 0.1 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, we announced the construction of a new state-of-the-art advanced integrated biologics manufacturing facility in Schaftenau, Austria. We expect our investment in this facility to exceed USD 0.2 billion. We expect phase one of this project to be operational in 2020. As of December&nbsp;31, 2019, the total amount paid and committed to be paid on this project is equivalent to approximately USD 0.1 billion. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In April 2019, AveXis purchased a former AstraZeneca site in Longmont, Colorado. The new facility is expected to complement the AveXis sites in Libertyville, Illinois, and Durham, North Carolina, and to allow for production of gene therapy products. The site became operational in 2020. We expect our investment in this facility to exceed USD 0.1 billion. As of December 31, 2019, the total amount paid and committed to be paid on this project (excluding the acquisition costs) is approximately USD 0.1 billion. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In November 2019, we began to expand our existing biologics drug substance manufacturing based on cell culture technology in Schaftenau, Austria. We expect our total investment in this project to amount to USD 0.2 billion. We expect this project to be operational in 2022. As of December 31, 2019, the total amount paid and committed to be paid on this project is equivalent to approximately USD 0.1 billion.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Environmental matters</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We integrate core values of environmental protection into our business strategy to protect the environment, add value to the business, manage risk and enhance our reputation. For example, our Executive Committee has endorsed targets for environmental sustainability related to our carbon footprint, waste production and water sustainability, and we are party to a virtual power purchase agreement for renewable energy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We are subject to laws and regulations concerning the environment, safety matters, regulation of chemicals, and product safety in the countries where we manufacture and sell our products or otherwise operate our business. These requirements include regulation of the handling, manufacture, transportation, use and disposal of materials, including the discharge of pollutants into the environment. In the normal course of our business, we are exposed to risks relating to possible releases of hazardous substances into the environment that could cause environmental or property damage or personal injuries, and that could require remediation of contaminated soil and groundwater &ndash; in some cases over many years &ndash; regardless of whether the contamination was caused by us or by previous occupants of the property.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">See &#x201C;Item&nbsp;3. Key Information&mdash;Item&nbsp;3.D Risk factors&mdash;Environmental, social and governance matters may impact our business and reputation,&#x201D; &#x201C;Item 3. Key Information&mdash;Item 3.D Risk factors&mdash;Environmental liabilities may adversely impact our financial results,&#x201D; and &#x201C;Item 3. Key Information&mdash;Item 3.D Risk factors&mdash;Climate change, extreme weather events, earthquakes and other natural disasters could adversely affect our business.&#x201D; See also &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;20. Provisions and other non-current liabilities.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">62</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00341902"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;4A.  Unresolved Staff Comments</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">63</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



    <a name="anchorId0010031971"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item 5. Operating and Financial Review and&nbsp;Prospects</p><a name="anchorId0010031974"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">5.A Operating results</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">This operating and financial review should be read with the Group&#x2019;s consolidated financial statements in this Annual Report, which have been prepared in accordance with International Financial Reporting Standards (IFRS) as published by the International Accounting Standards Board (see &#x201C;Item 18. Financial Statements&#x201D;). &#x201C;Item 5. Operating and Financial Review and Prospects&#x201D; with the sections on compounds in development and key development projects of our divisions (see &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview&#x201D;) constitute the Operating and Financial Review (<i>Lagebericht</i>), as defined by the Swiss Code of Obligations.  </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Overview</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our purpose is to reimagine medicine to improve and extend people&#x2019;s lives. We use innovative science and technology to address some of society&#x2019;s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company. Our vision is to be a trusted leader in changing the practice of medicine. Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science. As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society: unleash the power of our people; deliver transformative innovation; embrace operational excellence; go big on data and digital; and build trust with society.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The businesses of Novartis are divided operationally on a worldwide basis into two identified reporting segments:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Innovative Medicines: innovative patent-protected prescription medicines</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sandoz: generic pharmaceuticals and biosimilars</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition, we separately report the results of Corporate activities. The financial results of our Corporate activities include the costs of the Group headquarters and those of corporate coordination functions in major countries. Corporate also includes other items of income and expense that are not attributable to specific segments, such as certain revenues from intellectual property rights and certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations and sponsorships.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our divisions are supported by the following organizational units: the Novartis Institutes for BioMedical Research, Global Drug Development, Novartis Technical Operations and Novartis Business Services. The financial results of these organizational units are included in the results of the divisions for which their work is performed. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As part of our long-term strategy we announced and/or completed several acquisitions and divestments during 2019: </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In April 2019, we completed the spin-off of the Alcon business into a separately-traded standalone company. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In May 2019, we acquired IFM Tre, Inc., a privately held, US-based biopharmaceutical company focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In May 2019, we entered into an agreement with Takeda to acquire the assets associated with <i>Xiidra</i> worldwide. This transaction closed on July 1, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In November 2019, we entered into a binding agreement for the acquisition of the Japanese business of Aspen Global Incorporated (AGI). We have received all relevant approvals and this transaction is expected to be completed in the first quarter of 2020.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In November 2019, we entered into an agreement and plan of merger with The Medicines Company, a US-based pharmaceutical company headquartered in Parsippany, New Jersey. The transaction closed in January 2020.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For a description of these and other significant transactions, refer to &#x201C;Item 4. Information on the Company&mdash;Item4.A History and development of Novartis&mdash; Important corporate developments 2017&ndash; January 2020&#x201D;, &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&#x201D;, &#x201C;Item 18.Financial Statements&mdash;Note 3 Segmentation of key figures 2019, 2018 and 2017,&#x201D; and &#x201C;Item 18.Financial Statements&mdash;Note 30. Discontinued operations.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a result of the spin-off of the Alcon business, Novartis has separated the Group&#x2019;s reported financial data for the current and prior years into &#x201C;continuing&#x201D; and &#x201C;discontinued&#x201D; operations, to comply with International Financial Reporting Standards (IFRS). Continuing operations include the businesses of the Innovative Medicines and Sandoz Divisions, and the continuing Corporate activities. Discontinued operations include the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders and certain other expenses related to the spin-off.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, Novartis achieved net sales from continuing operations of USD&nbsp;47.4 billion, of which 25%, came from Emerging Growth Markets, and 75%, came from Established Markets. Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Innovative Medicines accounted for USD&nbsp;37.7 billion, or 79%, of Group net sales, and for USD&nbsp;9.3 billion, or 94%, of Group operating income (excluding Corporate income and expense, net).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Sandoz accounted for USD&nbsp;9.7 billion, or 21%, of Group net sales, and for USD&nbsp;551 million, or 6%, of Group operating income (excluding Corporate income and expense, net).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">64</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Opportunity and risk summary </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our financial results are affected to varying degrees by external factors. The healthcare industry is in a phase of significant progress and change. We believe biomedical innovation has the potential to continue to accelerate over the next two decades, &ndash; potentially leading to new treatments and treatment modalities for previously untreatable conditions. We see this as an opportunity given our strong internal research capabilities, and we expect to sustain long-term growth in part through our 15 ongoing and upcoming major launches.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The rapid expansion in data science and digital technologies has the potential to transform a wide range of activities in healthcare, from drug research and development, to the ways in which doctors diagnose and treat diseases, and patients&#x2019; involvement in their own care. These trends could help society address the changing healthcare needs of aging populations and produce better health outcomes for patients.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, drug pricing is an increasingly prominent issue in many countries as healthcare spending continues to rise. This impacts our ability to establish satisfactory rates of reimbursement for our products by governments, insurers and other payers, which could affect our ability to generate returns and invest for the future. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We expect loss of market exclusivity and the introduction of branded and generic competitors to continue to significantly erode sales of our products. Our ability to grow depends on the success of our research and development efforts to replenish our pipeline, as well as on the commercial acceptance of our products. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We may also fail to take advantage of rapid progress in new technologies and in the development of new business models. Third parties may enter the healthcare field, which could increase the competition we face or supplant portions of our business. Our manufacturing processes are technically complex and subject to strict regulatory requirements, which introduce a greater chance for supply disruptions and liabilities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We have a significant global compliance program in place, but any failure to comply with local laws could lead to substantial liabilities and harm our business and our reputation. We carry a significant amount of goodwill and other intangible assets on our consolidated balance sheet, and may incur significant impairment charges in the future.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Tax authorities around the world have increased their scrutiny of company tax filings. In addition, tax reform initiatives by the Organization for Economic Co-operation and Development (OECD), the EU, Switzerland and the US will require us to continually assess our organizational structure against tax policy trends. This could lead to an increased risk of international tax disputes and an increase in our effective tax rate.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For more details on these trends and how they could impact our results, see &#x201C;&mdash;Factors affecting results of operations&#x201D; below.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">65</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Results of operations</font>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2019 compared to 2018</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key figures</font><font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;31</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;498</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;425</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;252</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;369</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;426</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Return on net sales (%)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;69</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;41</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net loss from discontinued operations  before gain on distribution of Alcon Inc.  to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc.  to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from discontinued operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows from operating activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;547</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;049</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Free cash flow from continuing operations<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;937</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Continuing operations include the businesses of the Innovative Medicines and Sandoz divisions and the continuing Corporate activities and discontinued operations include the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders in 2019 and certain other expenses related to the distribution. See &#x201C;Item 18. Financial Statements&#x2014;Note 1. Significant accounting principles&#x201D;, &#x201C;Item 18.Financial Statements&#x2014;Note 2. Significant transactions&#x2014;Significant transactions in 2019,&#x201D; and &#x201C;Item 18.Finanacial Statements&#x2014;Note 30. Discontinued operations.&#x201D;</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> For an explanation of non-IFRS measures and reconciliation tables, see "Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Group overview</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, Novartis delivered strong sales performance, margin expansion and breakthrough innovation launching five new molecular entities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net sales to third parties for Novartis continuing operations were USD&nbsp;47.4 billion, up 6% in reported terms and up 9% measured in constant currencies (cc) to remove the impact of exchange rate movements. Sales growth was driven by volume growth of 12 percentage points, mainly driven by <i>Cosentyx, Entresto,</i> and <i>Zolgensma</i> for the Novartis Pharmaceuticals business unit and <i>Promacta</i>/<i>Revolade</i>, <i>Kisqali</i> and <i>Lutathera</i> for the Novartis Oncology business unit. The strong volume growth was partly offset by the negative impacts of pricing (2 percentage points) and generic competition (1 percentage point).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">By division, Innovative Medicines delivered net sales of USD&nbsp;37.7 billion (+8%, +11% cc). Sandoz net sales were USD&nbsp;9.7 billion (-1%, +2% cc), driven by growth in biopharmaceuticals, partly offset by continued industrywide pricing pressures on retail generics, mainly in the US.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">66</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In emerging growth markets, which comprise all markets excluding the US, Canada, Western Europe, Japan, Australia and New Zealand, sales from continuing operations were USD&nbsp;11.8 billion (+4%, +10% cc) driven by China (USD&nbsp;2.2 billion) growing 13%, (+19% cc).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Operating income from continuing operations was USD&nbsp;9.1 billion (+8%, +14% cc), mainly driven by higher sales, higher divestments and productivity programs, which were partly offset by growth investments, legal provisions and higher impairments. Operating income margin from continuing operations was 19.2% of net sales, increasing by 0.4 percentage points (+0.9 percentage points cc). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net income from continuing operations was USD&nbsp;7.1 billion, compared to USD&nbsp;12.8 billion in 2018 as the prior year benefited from a USD&nbsp;5.7 billion net gain recognized from the sale of our stake in the GlaxoSmithKline (GSK) consumer healthcare joint venture. Earnings per share from continuing operations were USD&nbsp;3.12, compared to USD&nbsp;5.52 in the prior year, declining less than net income, driven by the lower weighted average number of shares outstanding.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Cash flows from operating activities from continuing operations amounted to USD&nbsp;13.5 billion (+4%), compared to USD&nbsp;13.0 billion in the prior year. This increase was driven by higher net income adjusted for non-cash items and other adjustments, including divestment gains. It was partly offset by lower dividends received from associated companies due to the divestment of the GSK consumer healthcare joint venture in the second quarter of 2018, higher taxes paid, provision payments and working capital, which included the receipt of a GSK sales milestone from the divested Vaccines business of USD&nbsp;0.4 billion in the prior year.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Free cash flow from continuing operations amounted to USD&nbsp;12.9 billion (+15%), compared to USD&nbsp;11.3 billion in the prior year. The increase was mainly driven by higher operating income adjusted for non-cash items.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We also present our core results, which exclude the impact of amortization, impairments, disposals, acquisitions, restructurings and other significant items, to help investors understand our underlying performance.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core operating income from continuing operations was USD&nbsp;14.1 billion (+12%, +17% cc), mainly driven by higher sales and productivity programs, which were partly offset by growth investments. Core operating income margin was 29.7% of net sales, increasing by 1.6 percentage points (+1.9 percentage points cc). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core net income from continuing operations was USD&nbsp;12.1 billion (+11%, +15% cc), driven by growth in core operating income, which was partly offset by the discontinuation of core income from the GSK consumer healthcare joint venture. Core earnings per share from continuing operations were USD&nbsp;5.28 (+12%, +17% cc), growing faster than core net income driven by the lower weighted average number of shares outstanding.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discontinued operations net sales were USD&nbsp;1.8 billion, and operating income amounted to USD&nbsp;71 million. Net income from discontinued operations was USD&nbsp;4.6 billion, and included a non-taxable non-cash net gain on distribution of Alcon Inc. to Novartis AG shareholders of USD&nbsp;4.7 billion.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For the total Group, net income amounted to USD&nbsp;11.7 billion, and basic earnings per share were USD&nbsp;5.12. Cash flow from operating activities for the total Group was USD&nbsp;13.6 billion, and free cash flow was USD&nbsp;12.9 billion.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net sales by segment</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of net sales to third parties by segment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;731</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">67</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Innovative Medicines</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Innovative Medicines Division delivered net sales of USD&nbsp;37.7 billion in 2019, up 8% in reported terms and 11% in constant currencies (cc). The Novartis Pharmaceuticals Business Unit delivered net sales of USD&nbsp;23.3 billion in 2019 growing 9% (+12% cc), driven by <i>Cosentyx</i> reaching USD&nbsp;3.6 billion, <i>Entresto</i> USD&nbsp;1.7 billion and <i>Zolgensma</i> USD&nbsp;0.4 billion. The Novartis Oncology Business Unit delivered net sales of USD&nbsp;14.4 billion growing 7% (+10% cc), driven by <i>Lutathera</i> reaching USD&nbsp;0.4 billion<i> Promacta</i>/<i>Revolade</i> reaching USD&nbsp;1.4 billion and <i>Kisqali</i> USD&nbsp;0.5 billion. Volume contributed 13 percentage points to sales growth. Generic competition had a negative impact of 1 percentage point. Net pricing had a negative impact of 1 percentage point.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Regionally, the US (USD&nbsp;13.8 billion, +16%) delivered a strong performance driven by <i>Cosentyx</i>, <i>Entresto</i>, <i>Lutathera</i> and <i>Zolgensma</i>. Europe sales (USD&nbsp;12.8 billion, +4%, +10% cc) benefited from the continued strong performance of <i>Entresto</i>, <i>Tafinlar</i> + <i>Mekinist</i>, <i>Kisqali</i>, <i>Kymriah</i> and <i>Jakavi</i>. Japan sales were USD&nbsp;2.4 billion (+2%, 0% cc). Emerging Growth Markets sales grew (+6%, +12% cc), led by double-digit growth in China, including the launches of <i>Cosentyx</i> and <i>Entresto</i>.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table provides an overview of net sales to third parties by business franchise in the Innovative Medicines Division:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Oncology business unit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;370</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;428</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Pharmaceuticals business unit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;344</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;464</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;776</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Immunology, Hepatology and Dermatology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;222</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;392</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Neuroscience</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;773</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;429</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Respiratory</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;825</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cardiovascular, Renal and Metabolism</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;050</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Established Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;998</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;268</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Innovative Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">68</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides the top 20 Innovative Medicines Division product net sales in 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> US</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of world</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Brands</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Business franchise</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Indication</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> USD/cc<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> cc<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> cc<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td width="12%" height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Cosentyx</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and  Dermatology</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing   spondylitis and   psoriatic arthritis</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     2&nbsp;220</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     33</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1&nbsp;331</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     14</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     20</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     3&nbsp;551</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     25</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     28</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;736</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;223</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Lucentis</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related   macular degeneration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   2&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 804</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;076</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;880</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Entresto</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal   and Metabolism</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Chronic heart failure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   925</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   801</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;726</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Sandostatin</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors  and acromegaly</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   881</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   704</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;585</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;003</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;539</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Promacta/Revolade</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia   (ITP), severe aplastic   anemia (SAA)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     725</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     1&nbsp;416</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     23</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <I>Tafinlar</I> + <I>Mekinist</I></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic   and adjuvant melanoma;   advanced non-small cell   lung cancer (NSCLC)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       481</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       857</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">       1&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">       16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">       20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><I>Galvus</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;297</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Gleevec/Glivec</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid   leukemia and GIST</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   929</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Xolair<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       Respiratory</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma   (SAA) and Chronic   Spontaneous Urticaria   (CSU)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       1&nbsp;173</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">       1&nbsp;173</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">       13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">       19</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Jakavi</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF),   polycytomia vera (PV)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Diovan</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 978</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;064</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Exforge</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;012</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;025</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 450</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 975</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 423</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 755</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Ilaris</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,   Hepatology and  Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS,   TRAPS, HIDS/MKD, FMF, SJIA,   AOSD and gout)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     367</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     671</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 316</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 485</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Kisqali</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HR+/HER2- metastatic  breast cancer</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   480</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   111</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;679</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;967</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;646</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;958</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;068</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;789</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;925</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales reflect <I>Xolair</I> sales for all indications.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Constant currencies (cc) is a non-IFRS measure. For an explanation of non-IFRS measures, see " &#x2014;Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For information about the approved indications for the products described, see &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview&mdash;Innovative Medicines&mdash;Key marketed products.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Novartis Oncology business unit</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><i>Tasigna</i> (USD&nbsp;1.9 billion, 0%, +3% cc) grew across most regions, mainly driven by Emerging Growth Markets including China.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Sandostatin</i> (USD&nbsp;1.6 billion, 0%, +2% cc) grew mainly driven by the US and Emerging Growth Markets, including China, partly offset by competitive pressure in other regions, including first generic competitors entering the market in Europe and Japan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Afinitor/Votubia</i> (USD&nbsp;1.5 billion, -1%, +1% cc) sales were broadly in line with prior year, driven by growth in the US in the TSC indication, offset by generic competition in other regions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Promacta/Revolade</i> (USD&nbsp;1.4 billion, +21%, +23% cc) grew at a double-digit rate across all regions driven by increased use in chronic immune thrombocytopenia (ITP) and uptake as first-line treatment for severe aplastic anemia (SAA) in the US and Japan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Tafinlar</i> +<i> Mekinist</i> (USD&nbsp;1.3 billion, +16%, +20% cc) saw double-digit growth in metastatic and adjuvant melanoma as well as non-small cell lung cancer (NSCLC), </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">69</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">with ongoing uptake of the adjuvant melanoma indication in the US and Europe.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Gleevec/Glivec</i> (USD&nbsp;1.3 billion, -19%, -17% cc) declined due to generic competition in most major markets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Jakavi</i> (USD&nbsp;1.1 billion, +14%, +20% cc) saw double-digit growth across all regions driven by demand in the myelofibrosis and polycythemia vera indications.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Exjade/Jadenu</i> (USD&nbsp;975 million, -11%, -9% cc) declined mainly due to pressure from new generic competition in the US and in other regions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Votrient</i> (USD&nbsp;755 million, -9%, -6% cc) sales declined mainly due to competitive pressure in the US.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Kisqali</i> (USD&nbsp;480 million, +104%, +111% cc) showed solid growth in the US driven by use in metastatic breast cancer patients, independent of menopausal status or combination partner, with strong uptake and patient share gain in Europe and other regions, benefitting from the impact of overall survival data from the MONALESSA-7 and MONALEESA-3 trials.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Lutathera</i> (USD&nbsp;441 million, +164%, +160% cc) continued to grow led by the US, with over 170 centers actively treating patients, and ongoing launches in Europe. Sales from all AAA brands (including <i>Lutathera</i> and radiopharmaceutical diagnostic products) were USD&nbsp;679 million. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Kymriah</i> (USD&nbsp;278 million) strong demand continued and sales increased primarily driven by ongoing uptake in Europe and the US. There are over 200 qualified treatment centers and more than 20 countries worldwide have coverage for at least one indication, including Japan, making Kymriah the only CAR-T approved in Asia. We have significantly increased our global manufacturing capacity. Three additional facilities in Les Ulis, Stein, and Japan have started manufacturing clinical batches. We have also signed a licensing agreement with Cellular Biomedicine Group (CBMG) in China with plans to expand further.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Piqray</i> (USD&nbsp;116 million) US launch progressed well. <i>Piqray</i> was approved by the FDA as the first and only treatment for patients with a PIK3CA mutation in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Novartis Pharmaceuticals business unit</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Ophthalmology</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Ophthalmology franchise were USD&nbsp;4.8 billion (+5%, +8 cc), mainly driven by the acquisition of <i>Xiidra</i> and growth of <i>Lucentis</i>, while benefitting from the launch of <i>Beovu.</i></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Lucentis</i> (USD&nbsp;2.1 billion, +2%, +7% cc) grew driven by strong execution of a focused commercial strategy supported by new head-to-head evidence enabling an improved efficacy and durability perception in an overall strongly growing Retina market. <i>Lucentis</i> received approval for the treatment of retinopathy of prematurity (ROP) in premature infants in the EU and Japan in the second half of 2019, making <i>Lucentis</i> the first licensed pharmacological therapy to treat the condition. <i>Lucentis</i> also received approval for the treatment of proliferative diabetic retinopathy (PDR) in the EU in October, becoming the first licensed pharmacological therapy to treat adults with PDR ex-US.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Xiidra</i> (USD&nbsp;192 million) is the only prescription eye drop solution marketed in the US and Canada to treat the signs and symptoms of dry eye disease. It is dosed twice per day, approximately 12 hours apart, in each eye. <i>Xiidra</i> is approved in multiple markets including the US, Canada and Australia. It is under regulatory review in a number of additional markets. Novartis acquired <i>Xiidra</i> from Takeda and began recording sales as of July 1st, 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Beovu</i> (USD&nbsp;35 million, brolucizumab, formerly RTH258) was launched in the US following FDA approval in October, offering patients with wet age-related macular degeneration (AMD) in the US a new treatment option with demonstrated robust vision gains. <i>Beovu</i> is the only anti-VEGF in wet AMD approved in the US to maintain eligible patients on up to three month dosing intervals immediately after the loading phase. <i>Beovu</i> received a positive CHMP opinion in the EU in December 2019 and a permanent J-code from CMS on January 1, 2020.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Immunology, Hepatology and Dermatology</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Immunology, Hepatology and Dermatology franchise reached USD&nbsp;4.2 billion (+24%, +27% cc), of which <i>Cosentyx</i> delivered USD&nbsp;3.6 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Cosentyx</i> (USD&nbsp;3.6 billion, +25%, +28% cc) continued momentum in the US (+33%) and in the rest of the world (+14%, +20% cc), driven by strong demand across indications and regions and broad first line access in all three indications. In March, <i>Cosentyx</i> was the first IL-17A inhibitor to be approved in China for the treatment of psoriasis. In September, Novartis announced positive new data from the Phase III PREVENT trial evaluating the efficacy and safety of <i>Cosentyx</i> in patients with non-radiographic axial spondyloarthritis (nr-axSpA). Novartis has submitted the data to EMA and to the FDA. Nr-axSpA would be the fourth indication for <i>Cosentyx</i>.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Ilaris</i> (USD&nbsp;671 million, +21%, +25% cc) sales were driven by strong double-digit volume growth, mostly in Europe.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Xolair</i> sales for all indications are reported in the Respiratory franchise. Dermatology teams help support commercial efforts of Xolair in chronic spontaneous urticaria/chronic idiopathic urticaria.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Neuroscience</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Neuroscience franchise were USD&nbsp;3.8 billion (+10%, +13% cc), mainly driven by the launch of <i>Zolgensma</i> and sales growth of <i>Aimovig</i>, partly offset by sales decline of<i> Gilenya</i>. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Gilenya</i> (USD&nbsp;3.2 billion, -4%, -1% cc) declined mainly due to competitive pressures.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Zolgensma</i> (USD&nbsp;361 million, formerly AVXS-101) is an adeno-associated virus vector-based gene therapy designed to address the genetic root cause of spinal muscular atrophy (SMA) by providing a functional copy of the human survival motor neuron (SMN) gene to halt disease progression through sustained SMN protein expression. The FDA approved the intravenous formulation of AVXS-101 as <i>Zolgensma</i> in May 2019 for the treatment of pediatric patients less than 2 years old who have SMA with biallelic mutations in the SMN1 gene. Regulatory reviews are underway in Europe, with a CHMP opinion anticipated in Q1 2020, and Japan, with a deci-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">70</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">sion anticipated in 1H 2020. AVXS-101 is in ongoing clinical studies, including the global Phase III STR1VE clinical program (consisting of STR1VE-US, STR1VE-EU and STR1VE-AP) to evaluate the intravenous (IV) formulation of AVXS-101 in patients who have SMA Type 1, and the multinational Phase III SPR1NT trial in presymptomatic patients who have a genetic diagnosis of SMA with two or three copies of the SMN2 gene. Additionally, AVXS-101 intrathecal administration is being studied in a Phase I/II STRONG trial in patients who have SMA Type 2 and three copies of the SMN2 gene. New data from trials were presented at 2019 congresses, including the American Academy of Neurology Annual Meeting.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Aimovig</i> (USD&nbsp;103 million, ex-US, ex-Japan) is the most prescribed anti-CGRP worldwide, with more than 350,000 patients prescribed worldwide in the post-trial setting. It has now been launched in 38 countries for the preventive treatment of migraine and additional launches are underway. <i>Aimovig</i> is co-commercialized with Amgen in the US, where Amgen records sales and Novartis has exclusive rights in all ex-US territories excluding Japan. Amgen issued a termination notice in April 2019, based on an alleged material breach of the collaboration agreements, and this notice, as well as other ancillary matters, are the subject of legal proceedings between Novartis and Amgen. Novartis disputes Amgen&#x2019;s allegations vig-orously. The collaboration continues during the litigation between the companies, and will remain in force until and unless a &#xFB01;nal court decision terminates the agreements.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Mayzent</i> (USD&nbsp;26 million) launch is progressing and efforts are ongoing to accelerate patient on-boarding and drive urgency to treat. <i>Mayzent</i> was approved by the FDA on March 26, 2019 and is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive MS, in adults. <i>Mayzent</i> is the only FDA approved oral therapy for active SPMS based on evidence from a pivotal prospective Phase III clinical trial (EXPAND) in a broad SPMS population. <i>Mayzent</i> received EU approval in January 2020 for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Respiratory</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Respiratory franchise were USD&nbsp;1.8 billion (+3%, +9% cc), of which <i>Xolair</i> delivered USD&nbsp;1.2 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Xolair</i> (USD&nbsp;1.2 billion, +13%, +19% cc) continued to grow in both indications Severe Allergic Asthma (SAA) and Chronic Spontaneous Urticaria (CSU). Growth for both indications benefited from the recent approval of <i>Xolair</i> for home-use in Europe and strong performance in Emerging Growth Markets. We co-promote <i>Xolair</i> with Genentech in the US and share a portion of operating income, but we do not record any US sales. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Ultibro</i><i> Breezhaler</i> (USD&nbsp;427 million, -6%, -1% cc), an inhaled LABA/LAMA, sales declined mainly due to competition.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Seebri</i><i> Breezhaler</i> (USD&nbsp;121 million, -18%, -14% cc) an inhaled LAMA, and <i>Onbrez</i><i> Breezhaler</i> (USD&nbsp;82 million, -19%, -14% cc) an inhaled LABA, declined mainly due to competition.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Cardiovascular, Renal and Metabolism</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Cardiovascular, Renal and Metabolism franchise were USD&nbsp;1.8 billion (+67%, +70% cc). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Entresto</i> (USD&nbsp;1.7 billion, +68%, +71% cc) continued strong momentum across geographies, fueled by increased demand in both hospital and ambulatory settings. New data presented at American Heart Association (AHA) Scientific Sessions 2019 on reverse cardiac remodeling, in-hospital use and quality of life, further reinforce <i>Entresto</i> as an essential, first-choice treatment for heart failure with reduced ejection fraction. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Established Medicines</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Established Medicines franchise had sales of USD&nbsp;7.0 billion (-4%, 0% cc).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Galvus</i> Group (USD&nbsp;1.3 billion, +1%, +5% cc) grew, led by solid performance in Emerging Growth Markets, including China.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Diovan </i>Group (USD&nbsp;1.1 billion, +4%, +9% cc) grew in Europe and Emerging Growth Markets, partially offset by a decline in Japan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Exforge</i> Group (USD&nbsp;1.0 billion, +2%, +7% cc) grew in Emerging Growth Markets, offset by a decline in Europe, Japan and the US due to generic competition.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Zortress/Certican</i> (USD&nbsp;485 million, +5%, +8% cc) continued to grow in most regions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Neoral/Sandimmun(e)</i> (USD&nbsp;419 million, -10%, -7% cc) declined due to generic competition and mandatory price reductions. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Voltaren/Cataflam</i> (USD&nbsp;417 million, -6%, -4% cc) sales declined mainly due to generic competition.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">71</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Sandoz</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz net sales in 2019 were USD&nbsp;9.7 billion (-1%, +2% cc) driven by strong volume growth of 8 percentage points which was partially offset by 6 percentage points of price erosion. Excluding the US, net sales grew strongly (+2%, +7% cc).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Sales in Europe were USD&nbsp;5.1 billion (+3%, +9% cc), mainly driven by biosimilars. Sales in the US were USD&nbsp;2.5 billion declining 10%, mainly due to continued industrywide pricing pressure. Sales in Asia, Africa and Australasia were USD&nbsp;1.3 billion (-2%, +1% cc). Sales in Canada and Latin America were USD&nbsp;784 million (+1%, +6% cc). </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Retail Generics<sup>1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;590</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;880</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Biopharmaceuticals</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;607</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;436</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Anti-Infectives  (partner label/API)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   534</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   543</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Of which USD 784 million (2018: USD 826 million) represents anti-infectives sold under the Sandoz name</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Retail Generics </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form of anti-infectives sold to third parties. Retail Generics sales in 2019 were USD&nbsp;7.6 billion (-4%, 0% cc), in line with prior year as first-to-market launches offset the impact of US pricing pressure.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Biopharmaceuticals</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies. The Biopharmaceuticals business also includes <i>Glatopa</i>, a generic version of Copaxone<sup>&#xAE;</sup>, which treats relapsing forms of multiple sclerosis and is marketed in the US. Global sales of Biopharmaceuticals grew to USD&nbsp;1.6 billion (+12%, +16% cc), driven by continued strong double-digit growth in Europe from <i>Hyrimoz</i> (adalimumab), <i>Rixathon</i> (rituximab) and <i>Erelzi</i> (etanercept). Launch roll-outs in Asia, Africa and Australasia also contributed to growth.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Anti-Infectives</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by Retail Generics and for sale to third-party customers. Sales of anti-infectives sold to third parties under their own name were USD&nbsp;534 million, down 2% (+2% cc). Total Anti-Infectives franchise sales were USD&nbsp;1.3 billion (-4%, 0% cc), including USD&nbsp;784 million finished dosage forms sold under the Sandoz name.  </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Operating income from continuing operations</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of operating income from continuing operations by segment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;287</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;53</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Operating income from continuing operations was USD&nbsp;9.1 billion (+8%, +14% cc), mainly driven by higher sales, higher divestments and productivity programs, which were partly offset by growth investments, legal provisions and higher impairments. Operating income margin from continuing operations was 19.2% of net sales, increasing by 0.4 percentage points (+0.9 percentage points cc).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">72</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Core operating income from continuing operations key figures</font><font style="font-family:arial,helvetica,sans-serif; font-size:8pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core gross profit from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;392</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;886</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;690</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;386</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;154</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;070</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;043</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">As % of net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For an explanation of non-IFRS measures and reconciliation tables, see "Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The adjustments made to operating income from continuing operations to arrive at core operating income from continuing operations amounted to USD&nbsp;5.0 billion (compared to USD&nbsp;4.2 billion in the prior year). For details please see &#x201C;Item 5. &ndash; 2019, 2018 and 2017 reconciliation from IFRS results to core results.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core operating income from continuing operations was USD&nbsp;14.1 billion (+12%, +17% cc), mainly driven by higher sales and productivity programs, partly offset by growth investments. Core operating income margin was 29.7% of net sales, increasing by 1.6 percentage points (+1.9 percentage points cc).</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of core operating income by segment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;650</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 33.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;151</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;094</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;596</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 28.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Operating income was USD&nbsp;9.3 billion (+18%, +24% cc), mainly driven by continued strong sales growth and productivity, partly offset by growth investments. Operating income margin was 24.6% of net sales, increasing 2.0 percentage points (+2.5 percentage points cc).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core adjustments were USD&nbsp;3.4 billion, mainly due to USD&nbsp;2.4 billion of amortization. Prior year core adjustments were USD&nbsp;3.3 billion. Core adjustment were broadly in line with the prior year as higher legal provisions were offset by higher divestment income and lower restructuring. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core operating income was USD&nbsp;12.7 billion (+13%, +18% cc), mainly driven by higher sales, partly offset by higher growth investments. Core operating income margin was 33.5% of net sales, increasing 1.5 percentage points (+1.8 percentage points cc). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core gross margin was broadly in line with prior year as productivity improvements were offset the ramp up of capacity for cell / gene therapies and lower other revenue (-0.8 percentage points cc). Core R&amp;D expenses decreased by 1.2 percentage points (cc), mainly driven by the higher net sales, productivity and portfolio prioritization. Core selling, general and administration (SG&amp;A) expenses declined by 0.7 percentage points (cc), mainly driven by sales leverage and productivity. Core other income and expense did not have a material impact on margin.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Operating income was USD&nbsp;551 million (-59%, -53% cc), impacted by higher impairments of intangible assets and property, plant and equipment related to the discontinuation of the generic Advair<sup>&#xAE;</sup> development program in the US and higher restructuring charges mainly from the ongoing business transformation. Operating income margin was 5.7% of net sales, declining 7.8 percentage points (-7.3 percentage points cc).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core adjustments were USD&nbsp;1.5 billion, including USD&nbsp;314 million of amortization. Prior year core adjustments were USD&nbsp;670 million. The change in core adjustments compared to prior year was driven mainly by higher impairments of intangible assets and property, plant and equipment, higher restructuring charges mainly from the ongoing transformation, net changes in legal settlements and lower divestment income. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core operating income was USD&nbsp;2.1 billion (+5%, +10% cc), as sales growth and continued gross margin improvements were partly offset by price erosion and lower divestment income. Core operating income margin was 21.5% of net sales, increasing 1.2 percentage points (1.5 percentage points cc). </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">73</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core gross margin increased by 1.6 percentage points (cc), as favorable product and geographic mix and ongoing productivity improvements, were partly offset by the impact of price erosion. Core R&amp;D expenses were in line with prior year, while core SG&amp;A expenses decreased by 0.6 percentage points (cc). Core other income and expense decreased the margin by 0.7 percentage points (cc), mainly due to lower divestment income.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Corporate income and expense, net</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Corporate income and expense, which includes the cost of Group headquarters and coordination functions, amounted to an expense of USD&nbsp;752 million in 2019 compared to USD&nbsp;800 million in the prior year, mainly driven by lower impairment charges from the Novartis Venture Fund financial asset, partly offset by higher restructuring costs.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Innovative Medicines Division research and development</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of the reported and core research and development expense of the Innovative Medicines Division:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and exploratory development</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;855</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;770</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Confirmatory development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;297</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;905</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Innovative Medicines Division research and development expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;8&nbsp;152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">As % of Innovative Medicines net sales to third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core research and exploratory development<sup>1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;706</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core confirmatory development<sup>1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;879</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total core Innovative Medicines Division research and development expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;585</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">As % of Innovative Medicines net sales to third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Core excludes impairments, amortization and certain other items. For an explanation of non-IFRS measures and reconciliation tables, see " &#x2014;Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Innovative Medicines Division research and exploratory development expense increased by 3% (&ndash;4% cc) to USD&nbsp;2.9 billion, and confirmatory development expense amounted to USD&nbsp;5.3 billion, increasing by 8% (-10% cc) versus prior year. This was mainly due to higher pipeline investments, including <i>Zolgensma</i>, and higher impairments of intangible assets.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total core research and development expense in the Innovative Medicines Division as a percentage of sales decreased by 0.9 percentage points (1.2 percentage points cc) to 20.1% of net sales, mainly driven by the higher net sales, productivity and portfolio prioritization.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">74</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Non-operating income and expense</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The term &#x201C;non-operating income and expense&#x201D; includes all income and expense items outside operating income. The following table provides an overview of non-operating income and expense from continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;69</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;41</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net loss from discontinued operations  before gain on distribution of Alcon Inc.  to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc.  to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from discontinued operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">        </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful        </div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Income from associated companies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Income from associated companies amounted to USD&nbsp;659 million in 2019 compared to USD&nbsp;6.4 billion in prior year. This decrease is mainly due to the pre-tax gain of USD&nbsp;5.8 billion recognized on the divestment of the 36.5% stake in the GSK consumer healthcare joint venture in 2018.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The share of income from Roche was USD&nbsp;662 million compared to USD&nbsp;526 million in the prior year. The estimated income for Roche Holding AG was USD&nbsp;748 million compared to USD&nbsp;651 million in the prior year and was partly offset by the negative prior year true up of USD&nbsp;129 million in the first quarter of 2019, compared to a negative prior year true up of USD&nbsp;125 million recognized in the first quarter of 2018. In addition, a USD&nbsp;43 million income from revaluation of deferred tax liability, recognized upon initial accounting of the Roche investment, was recorded in the first quarter of 2019, following a change in the enacted tax rate in February 2019 of the Swiss Canton Basel-Stadt, effective January 1, 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Interest expense and other financial income and expense</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Interest expense decreased to USD&nbsp;850 million from USD&nbsp;932 million in the prior year, driven by lower outstanding debts partly offset by the additional interest expense on lease liabilities of USD&nbsp;66 million, following the implementation of IFRS 16 Leases as of January 1, 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Other financial income and expense, net amounted to an income of USD&nbsp;45 million compared to USD&nbsp;186 million in the prior year. The decrease is mainly due to lower interest income and higher currency losses.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Taxes</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The tax rate from continuing operations in 2019 was 20.1% compared to 9.2% in the prior year. The 2019 tax rate was negatively impacted by a one-time, non-cash deferred tax expense resulting from legal entity reorganizations, a prior year item and an increase to an uncertain tax position, partially offset by the deferred tax credit from Swiss tax reform. The prior year tax rate was positively impacted by the divestment of the 36.5% stake in the GSK consumer healthcare joint venture. Excluding these impacts, the tax rate from continuing operations would have been 15.4% compared to 14.9% in the prior year. The increase compared to prior year is mainly the result of a change in profit mix.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Net income from continuing operations</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Net income from continuing operations amounted to USD&nbsp;7.1 billion, compared to USD&nbsp;12.8 billion in the prior year, as the prior year benefited from a USD&nbsp;5.7 billion net gain recognized from the sale of our stake in the GSK consumer healthcare joint venture.  </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Earnings per share</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Basic earnings per share from continuing operations were USD&nbsp;3.12, compared to USD&nbsp;5.52 in the prior year, declining less than net income due to the lower weighted average number of shares outstanding.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">75</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Core non-operating income and expense from continuing operations</font><font style="font-family:arial,helvetica,sans-serif; font-size:8pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of core non-operating income and expense from continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;112</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;557</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;63</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;404</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;300</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;004</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;920</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For an explanation of non-IFRS measures and reconciliation tables, see "Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core income from associated companies</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core income from associated companies from continuing operations amounted to USD&nbsp;1.1 billion, in line with the prior year despite the discontinuation of core income from the GSK consumer healthcare joint venture. The core income contribution from Roche Holding AG increased to USD&nbsp;1.1 billion from USD&nbsp;970 million in the prior year. The increase is due to a higher estimated core income contribution from Roche for the current period and the recognition of a favorable prior-year core income true-up of USD&nbsp;32 million, compared to a favorable true-up of USD&nbsp;8 million in the first quarter of 2018. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core interest expense and other financial income and expense</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core interest expense from continuing operations was USD&nbsp;850 million, compared to USD&nbsp;932 million in the prior year. Core other financial income and expense from continuing operations amounted to a net income of USD&nbsp;56 million, compared to USD&nbsp;186 million in the prior year.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core taxes</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The core tax rate from continuing operations (core taxes as a percentage of core income before tax from continuing operations) was 16.0% compared to 15.5% in the prior year mainly as a result of a change in profit mix.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core net income </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core net income from continuing operations was USD&nbsp;12.1 billion (+11%, +15 cc), driven by growth in core operating income, partly offset by the discontinuation of core income from the GSK consumer healthcare joint venture.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core earnings per share</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core earnings per share from continuing operations were USD&nbsp;5.28 (+12%, +17% cc), growing faster than core net income due to the lower weighted average number of shares outstanding. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">76</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Discontinued operations</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Discontinued operations in 2019 include the business of Alcon, and certain corporate costs directly attributable to Alcon&#x2019;s business up to the spin-off date. As the Alcon spin-off was completed on April 9, 2019, there were no operating results in the remainder of the year 2019. The prior year includes the results for the full year. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discontinued operations net sales in 2019 were USD&nbsp;1.8 billion, compared to USD&nbsp;7.1 billion in 2018 and operating income amounted to USD&nbsp;71 million, compared to an operating loss of USD&nbsp;234 million in 2018. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net income from discontinued operations in 2019 amounted to USD&nbsp;4.6 billion, compared to a net loss of USD&nbsp;186 million in 2018, driven by the non-taxable, non-cash net gain on distribution of Alcon Inc. to Novartis AG shareholders, which amounted to USD&nbsp;4.7 billion. For further details, see &#x201C;Item 18.Financial Statements&mdash;Note 2. Significant transactions&mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders&#x201D; and &#x201C;Item 18.Financial Statements&mdash;Note 30. Discontinued operations.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Total Group</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For the total Group, net income amounted to USD&nbsp;11.7 billion in 2019, compared to USD&nbsp;12.6 billion in 2018, and basic earnings per share was USD&nbsp;5.12 compared to USD&nbsp;5.44 in prior year. Cash flow from operating activities for the total Group amounted to USD&nbsp;13.6 billion, and free cash flow amounted to USD&nbsp;12.9 billion. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">77</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2018 compared to 2017</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key figures</font><font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 44&nbsp;751</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 91</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 44&nbsp;833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;381</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;510</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;633</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 31&nbsp;589</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;771</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;465</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;389</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;629</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;922</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;137</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;21</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Return on net sales (%)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net (loss)/income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 73</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from discontinued operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 66</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows from operating activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;049</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;419</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Free cash flow from continuing operations<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;791</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Continuing operations include the businesses of the Innovative Medicines and Sandoz divisions and the continuing Corporate activities and discontinued operations include the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off and certain other expenses related to the distribution. See &#x201C;Item 18. Financial Statements&#x2014;Note 1. Significant accounting principles&#x201D;, &#x201C;Item 18.Financial Statements&#x2014;Note 2. Significant transactions&#x2014;Significant transactions in 2019,&#x201D; and &#x201C;Item 18.Finanacial Statements&#x2014;Note 30. Discontinued operations.&#x201D;</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> For an explanation of non-IFRS measures and reconciliation tables, see "Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Group overview</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis continuing operations delivered strong performance in 2018 driven by continued sales momentum from our key growth products and the successful acquisition of Advanced Accelerator Applications (AAA). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net sales to third parties from Novartis continuing operations were USD&nbsp;44.8 billion, up 6% in reported terms and up 5% measured in constant currencies (cc) to remove the impact of exchange rate movements. This strong sales growth was driven by volume growth of 10 percentage points, mainly driven by <i>Cosentyx</i>, AAA and four drugs that reached blockbuster status (<i>Promacta</i>/<i>Revolade, Tafinlar</i> + <i>Mekinist, Entresto</i> and<i> Xolair)</i>. The strong volume growth was partly offset by the negative impacts of pricing (-3 percentage points) and generic competition (-2 percentage points).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Cosentyx</i>, our treatment for psoriasis and other autoimmune diseases, grew strongly across all indications, with sales rising 37% (+36% cc) to USD&nbsp;2.8 billion. <i>Entresto</i>, our product for heart failure has now more than doubled sales, reaching USD&nbsp;1.0 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our treatments for certain cancer and related rare diseases continued to grow, driven by strong demand. <i>Promacta</i>/<i>Revolade</i>, a treatment for blood disorders, grew 35% (+35% cc) to USD&nbsp;1.2 billion. <i>Tafinlar</i> + <i>Mekinist</i>, a combination treatment for skin and lung cancers, had sales of USD&nbsp;1.2 billion, up 32% (+31% cc). <i>Jakavi</i>, a treatment for rare blood cancers, grew 26% (+24% cc) to USD&nbsp;977 million. Sales of the products from AAA, including <i>Lutathera</i>, a radioligand therapy for a rare type of cancer in the pancreas or gut, amounted to USD&nbsp;355 million. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">78</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">By division, Innovative Medicines sales grew 8% (+8% cc). Sandoz sales declined 2% (&ndash;3% cc), mainly due to lower sales of retail generics, which was impacted by continued US industrywide pricing pressures, which were partly offset by growth in Biopharmaceuticals, including the continued uptake of <i>Rixathon</i> and <i>Erelzi</i> in Europe.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Operating income from continuing operations was USD&nbsp;8.4 billion (&ndash;3%, &ndash;3% cc), mainly due to the impacts of M&amp;A transactions, higher restructuring and net impairment charges, and growth investments, which were partly offset by higher sales. Operating income margin from continuing operations decreased by 1.8 percentage points to 18.8% of net sales, driven by a decrease in constant currencies of 1.6 percentage points and a negative currency impact of 0.2 percentage points.  </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net income from continuing operations was USD&nbsp;12.8 billion, compared to USD&nbsp;7.5 billion in the prior year, mainly benefiting from a USD&nbsp;5.7 billion net gain from the divestment of our stake in the GSK consumer healthcare joint venture. Earnings per share from continuing operations were USD&nbsp;5.52, compared to USD&nbsp;3.20 in the prior year, driven by higher net income and the lower weighted average number of shares outstanding. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Cash flow from operating activities from continuing operations was USD&nbsp;13.0 billion (+14%), compared to USD&nbsp;11.4 billion in the prior year. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Free cash flow from continuing operations amounted to USD&nbsp;11.3 billion (+15%), compared to USD&nbsp;9.8 billion in the prior year, as higher cash flows from operating activities, including the receipt of a GSK sales milestone from the divested Vaccines business, was partly offset by higher net investments in intangible assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We also present our core results, which exclude the impact of amortization, impairments, disposals, acquisitions, restructurings and other significant items, to help investors understand our underlying performance.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core operating income from continuing operations was USD&nbsp;12.6 billion (+7%, +7% cc) driven by higher sales and gross margin, which were partly offset by growth investments, including AveXis. Core operating income margin in constant currencies increased by 0.6 percentage points; currency had a negative impact of 0.2 percentage points, resulting in a net increase of 0.4 percentage points to 28.1% of net sales from continuing operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core net income from continuing operations was USD&nbsp;10.9 billion (+4%, +4% cc), driven by growth in core operating income, which was partly offset by the discontinuation of core income from the GSK consumer healthcare joint venture from April 1, 2018. Core earnings per share were USD&nbsp;4.71 (+6%, +5% cc), driven by growth in core net income and the lower weighted average number of shares outstanding.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discontinued operations include the business of Alcon and certain corporate costs directly attributable to Alcon&#x2019;s business. Net sales of discontinued operations were USD&nbsp;7.1 billion, compared to USD&nbsp;6.8 billion in the prior year and operating loss from discontinued operations was USD&nbsp;234 million, compared to an operating loss of USD&nbsp;73 million in the prior year. Net loss from discontinued operations amounted to USD&nbsp;186 million, compared to a net income from discontinued operations of USD&nbsp;204 million in the prior year. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total Group net income amounted to USD&nbsp;12.6 billion, compared to USD&nbsp;7.7 billion in the prior year, and basic earnings per share increased to USD&nbsp;5.44 from USD&nbsp;3.28 in the prior year. Cash flow from operating activities amounted to USD&nbsp;14.3 billion, and free cash flow amounted to USD&nbsp;11.7 billion.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net sales by segment</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of net sales to third parties by segment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34&nbsp;892</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32&nbsp;278</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;060</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 44&nbsp;751</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">79</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Innovative Medicines</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Following the internal reorganization announced on October 24, 2017, and January 24, 2018, which became effective on January 1, 2018, we transferred our over-the-counter ophthalmic products and certain surgical diagnostic products with sales of USD&nbsp;747 million in 2017 from the Innovative Medicines Division to the Alcon Division. Our prescription ophthalmic medicines business remains with the Innovative Medicines Division. In compliance with IFRS, we updated our segment reporting to reflect this transfer, both for the current and prior years, to aid comparability of year-on-year results. For details on Innovative Medicines net sales by business franchise, see also &#x201C;Item 18. Financial Statements&mdash;Note 3. Segmentation of key figures 2019, 2018 and 2017.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, the former Immunology and Dermatology franchise was reorganized into Immunology, Hepatology and Dermatology, and certain products were transferred to Established Medicines. The Cardio-Metabolic franchise was renamed to Cardiovascular, Renal and Metabolism.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Innovative Medicines Division delivered net sales of USD&nbsp;34.9 billion in 2018, up 8% in reported terms and in constant currencies. The Novartis Pharmaceuticals business unit grew 7% (+7% cc), driven by <i>Cosentyx</i> reaching USD&nbsp;2.8 billion and <i>Entresto</i> reaching USD&nbsp;1.0 billion. The Novartis Oncology business unit grew 9% (+9% cc), driven by AAA, including <i>Lutathera,</i> <i>Promacta/Revolade</i> and<i> Tafinlar</i> +<i> Mekinist</i> which both reached USD&nbsp;1.2 billion, and <i>Jakavi</i> which reached USD&nbsp;977 million. Volume contributed 11 percentage points to sales growth. Generic competition had a negative impact of 2 percentage points. Pricing had a negative impact of 1 percentage point.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Regionally, in the US (USD&nbsp;11.9 billion, +9%), the strong performance was driven by <i>Cosentyx</i>, <i>Entresto</i>, <i>Promacta/Revolade</i> and <i>Lutathera</i>. Europe sales (USD&nbsp;12.3 billion, +11%, +8% cc) were driven by <i>Cosentyx, Entresto</i> and <i>Jakavi</i>. Japan sales (USD&nbsp;2.4 billion, &ndash;2%, &ndash;3% cc) declined, mainly due to the biennial price cut and generic competition. Emerging Growth Markets sales increased 7% (+10% cc) to USD&nbsp;8.6 billion, mainly driven by strong growth in China.</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of net sales to third parties by business franchise in the Innovative Medicines Division:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Oncology business unit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;428</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;274</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Pharmaceuticals business unit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21&nbsp;464</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20&nbsp;004</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;621</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Neuroscience</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;429</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;287</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Immunology, Hepatology and Dermatology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;392</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Respiratory</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;617</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cardiovascular, Renal and Metabolism</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;050</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Established Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;268</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;481</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Innovative Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">80</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides the top 20 Innovative Medicines Division product net sales in 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> US</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of world</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Brands</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Business franchise</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Indication</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> USD/cc<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> cc<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % <br> change<br> cc<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td width="12%" height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1 765</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1 576</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3 341</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Cosentyx</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,  Hepatology and  Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing   spondylitis and   psoriatic arthritis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1 674</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1 163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     2 837</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     36</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Lucentis</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related   macular degeneration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2 046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   2 046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 806</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1 068</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1 874</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Sandostatin</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors  and acromegaly</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   817</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   770</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1 587</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Gleevec/Glivec</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid  leukemia and GIST</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   440</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1 121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1 561</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 929</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1 556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Galvus</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1 284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1 284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Promacta/Revolade</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia   (ITP), severe aplastic   anemia (SAA)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     581</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     593</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     41</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     1 174</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     35</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <I>Tafinlar</I> + <I>Mekinist</I></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic   and adjuvant melanoma;   advanced non-small cell   lung cancer (NSCLC)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       457</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">       1 155</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">       32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">       31</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 521</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 578</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1 099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Xolair<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       Respiratory</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma   (SAA) and Chronic   Spontaneous Urticaria   (CSU)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       1 039</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">       1 039</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">       13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">       12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Entresto</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal   and Metabolism</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Chronic heart failure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   87</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   472</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   125</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1 028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><I>Diovan</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 939</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1 023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><I>Exforge</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1 002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Jakavi</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF),   polycytomia vera (PV)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   24</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 404</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 828</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Ilaris</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology,  Hepatology and  Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS,  TRAPS, HIDS/MKD, FMF,  SJIA, AOSD and gout)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     262</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     292</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     554</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     39</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Travoprost Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated   intraocular pressure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   323</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   517</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 464</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9 654</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17 292</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26 946</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2 210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5 736</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7 946</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11 864</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23 028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34 892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales reflect <I>Xolair</I> sales for all indications.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Constant currencies (cc) is a non-IFRS measure. For an explanation of non-IFRS measures, see " &#x2014;Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For information about the approved indications for the products described below, see &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview&mdash;Innovative Medicines&mdash;Key marketed products.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Oncology business unit</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Oncology sales were USD&nbsp;13.4 billion (+9%, +9% cc), driven by AAA, including <i>Lutathera</i>, <i>Promacta</i>/<i>Revolade</i>, <i>Tafinlar</i> + <i>Mekinist</i> and <i>Jakavi</i>.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Tasigna</i> (USD&nbsp;1.9 billion, +2%, +1% cc) was broadly in line with the prior year across most regions<i>.</i></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Sandostatin</i> (USD&nbsp;1.6 billion, -2%, -2% cc) declined slightly, due to competitive pressure across most regions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Gleevec/Glivec</i> (USD&nbsp;1.6 billion, -20%, -20% cc) continued to decline due to generic competition in most major markets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Afinitor/Votubia</i> (USD&nbsp;1.6 billion, +2%, +2% cc) grew slightly, mainly driven by the tuberous sclerosis complex (TSC) and neuroendocrine tumor (NET) indications in the US.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Promacta/Revolade</i> (USD&nbsp;1.2 billion, +35%, +35% cc) grew at a strong double-digit rate across all regions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Tafinlar</i> +<i> Mekinist</i> (USD&nbsp;1.2 billion, +32%, +31% cc) continued strong double-digit growth due to increased demand in metastatic melanoma and NSCLC across all regions, with strong uptake in the adjuvant melanoma indication also contributing in the US and Europe.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">81</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Exjade/Jadenu</i> (USD&nbsp;1.1 billion, +4% +3% cc) grew, driven by continued uptake in Europe and Japan as well as the film-coated tablets formulation launch in Europe.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Jakavi</i> (USD&nbsp;977 million, +26%, +24% cc) continued strong double-digit growth across all regions, driven by both the myelofibrosis and polycythemia vera indications.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Votrient</i> (USD&nbsp;828 million, +2%, +2% cc) sales grew slightly driven by growth in Japan and Emerging Growth Markets partially offset by competitive pressures in the US and Europe.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Kisqali</i> (USD&nbsp;235 million, +209%, +210% cc) continued to build momentum with growth in the US and launches in several European and Emerging Growth Markets. In July 2018, the FDA approved two new indications for <i>Kisqali</i> based on the MONALEESA 3/7 trials, also approved in Europe in December 2018<i>.</i></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Lutathera</i> (USD&nbsp;167 million) launch in the US is progressing well, with over 100 centers actively treating. Sales from all AAA brands (including <i>Lutathera</i> and radiopharmaceutical diagnostic products) were USD&nbsp;355 million. The  FDA approved <i>Lutathera</i> in late January 2018, shortly following the acquisition of AAA. In Europe, full reimbursement for <i>Lutathera</i> has been achieved in several countries in 2018. European authorities approved <i>Lutathera</i> in late September 2017.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Kymriah</i> sales were USD&nbsp;76 million. In May 2018, the FDA approved <i>Kymriah</i> for a second indication: relapsed/refractory (r/r) DLBCL. Approval of <i>Kymriah</i> was also granted by the European Commission, Health Canada and Swissmedic for the r/r pediatric and young adult ALL and r/r DLBCL indications.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Pharmaceuticals business unit</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Ophthalmology</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Ophthalmology franchise were USD&nbsp;4.6 billion (&ndash;1%, &ndash;2% cc), with increased sales of <i>Lucentis</i> partly offsetting the impact of generic competition for glaucoma and anti-infective portfolios (mainly in the US and Europe), as well as price erosion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Lucentis</i> (USD&nbsp;2.0 billion, +8%, +7% cc) delivered strong growth, benefitting from the implementation of a focused global campaign as well as strong retina market growth.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Travoprost Group (USD&nbsp;517 million, &ndash;12%, &ndash;12% cc) declined, mainly due to generic competition in Europe and increased competition in the US.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Neuroscience</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Neuroscience franchise were USD&nbsp;3.4 billion (+4%, +4% cc), mainly driven by <i>Gilenya</i>. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Gilenya</i> (USD&nbsp;3.3 billion, +5%, +4% cc) with approximately 267,000 treated patients worldwide, continued solid growth, driven by increased demand in Europe and the US.<i> Gilenya</i> was approved by the FDA in May 2018 and by the European Commission in November 2018 as the first disease-modifying therapy for pediatric relapsing multiple sclerosis addressing the strong unmet clinical need of younger patients.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Aimovig</i> received FDA approval in May 2018 and European Commission approval in July 2018 and is now available in 25 countries as the first novel treatment designed specifically for migraine prevention. <i>Aimovig</i> was successfully launched in the US, and ex-US launches are underway, including local reimbursement procedures. Additional regulatory filings are pending with other health authorities worldwide. <i>Aimovig</i> is co-commercialized with Amgen in the US, where Amgen records sales, and Novartis has exclusive commercialization rights for all territories, excluding the US and Japan. More than 165,000 patients have been treated with <i>Aimovig</i> worldwide since launch.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Immunology, Hepatology and Dermatology</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Immunology, Hepatology and Dermatology franchise reached USD&nbsp;3.4 billion (+37%, +37% cc), of which <i>Cosentyx</i> delivered USD&nbsp;2.8 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Cosentyx</i> (USD&nbsp;2.8 billion, +37%, +36% cc) delivered strong volume growth across all indications in the US and EU. In October 2018, Novartis presented five-year data in psoriatic arthritis and ankylosing spondylitis confirming the efficacy and safety benefits of <i>Cosentyx</i>. This added to the results of a Phase III psoriasis study reported in 2017, demonstrating that <i>Cosentyx</i> delivers high and long-lasting skin clearance in patients with moderate-to-severe plaque psoriasis, with high response rates essentially maintained from Year One to Year Five. These scientific data are reinforcing <i>Cosentyx</i>&#x2019;s unique position as a long-lasting comprehensive treatment across PsO, PsA and AS.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Ilaris</i> (USD&nbsp;554 million, +38%, +39% cc) sales were driven by strong double-digit growth across most regions driven by volume.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Xolair</i> sales for all indications are reported in the Respiratory franchise.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Respiratory</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Respiratory franchise were USD&nbsp;1.8 billion (+9%, +8% cc). <i>Xolair</i> sales amounted to USD&nbsp;1.0 billion, and our chronic obstructive pulmonary disease (COPD) portfolio, including <i>Onbrez</i><i> Breezhaler, Seebri</i><i> Breezhaler</i> and <i>Ultibro</i><i> Breezhaler</i>, achieved sales of USD&nbsp;703 million (+4%, +2% cc).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Xolair</i> (USD&nbsp;1.0 billion, +13%, +12% cc) continued to grow in both indications, severe allergic asthma (SAA) and in chronic spontaneous urticaria (CSU, also known as CIU), a severe skin disease, driven by increasing disease awareness.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Ultibro</i><i> Breezhaler</i> (USD&nbsp;454 million, +10%, +8% cc) continued to grow, driven by positive FLAME and CLAIM study results as well as the GOLD Strategy 2018 Report, and further supported by the published SUNSET study results.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Cardiovascular, Renal and Metabolism</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sales in the Cardiovascular, Renal and Metabolism franchise were USD&nbsp;1.1 billion (+100%, +100% cc). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Entresto</i> (USD&nbsp;1.0 billion, +103%, +102% cc) sales doubled year on year, driven by growing adoption by physicians and strong volume in all markets (US +87%, rest of world +125%, +124% cc). New data from the landmark PIONEER-HF trial presented at the A,erican Heart Association&#x2019;s (AHA) Scientific Session 2018 and published in the New England Journal of Medicine (NEJM) reconfirmed the superiority of <i>Entresto</i> versus enalapril, as demonstrated in PARADIGM-HF.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Established Medicines</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Established Medicines franchise had sales of USD&nbsp;7.3 billion (&ndash;3%, &ndash;3% cc).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">82</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Galvus</i> Group (USD&nbsp;1.3 billion, +4%, +6% cc) continued to grow driven by solid performance in Emerging Growth Markets, including China.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Diovan </i>Group (USD&nbsp;1.0 billion, +7%, +7% cc) saw increased demand, mainly due to the recall of generic products in many markets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Exforge</i> Group (USD&nbsp;1.0 billion, +4%, +4% cc) saw increased sales, mainly in Emerging Growth Markets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Zortress/Certican</i> (USD&nbsp;464 million, +12%, +12% cc) sales were driven by strong double-digit growth across all regions. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Neoral/Sandimmun(e)</i> (USD&nbsp;463 million, &ndash;5%, &ndash;6% cc) declined due to generic competition and mandatory price reductions. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"><i>Voltaren/Cataflam</i> (USD&nbsp;445 million, &ndash;4%, &ndash;3% cc) declined due to generic competition.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Sandoz</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz net sales in 2018 were USD&nbsp;9.9 billion, down 2% in reported terms. In constant currencies, sales declined 3%, as 8 percentage points of price erosion, mainly in the US, were partly offset by volume growth of 5 percentage points. In the US, sales were USD&nbsp;2.8 billion (&ndash;16%), down mainly due to continued industrywide pricing pressure. Sales in Europe were USD&nbsp;5.0 billion (+7%, +5% cc), with growth in biosimilars mainly in Germany, France, the UK and Italy. Sales in Asia, Africa and Australasia were USD&nbsp;1.4 billion, down 2% (&ndash;2%cc). Sales in Canada and Latin America were USD&nbsp;779 million (+3%, +8% cc). Excluding the US, net sales grew 5%, (+4% cc).</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Retail Generics<sup>1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;880</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;409</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Biopharmaceuticals</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;436</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Anti-Infectives  (partner label/API)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   543</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   516</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Of which USD 826 million (2017: USD 880 million) represents anti-infectives sold under the Sandoz name</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Retail Generics </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form of anti-infectives sold to third parties. Retail Generics sales in 2018 were USD&nbsp;7.9 billion (&ndash;6%, &ndash;7% cc), due to the decline in the US (&ndash;22%).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Biopharmaceuticals</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies. The Biopharmaceuticals business also includes Glatopa, a generic version of Copaxone<sup>&#xAE;</sup>, which treats relapsing forms of multiple sclerosis and is marketed in the US. Global sales of Biopharmaceuticals grew 27% (+24% cc) to USD&nbsp;1.4 billion driven by both Europe and the US. By region, Europe continued double&ndash;digit growth, driven by <i>Rixathon</i> (rituximab) and <i>Erelzi</i> (etanercept). In the US, growth was mainly driven by <i>Zarxio</i> (now the leading filgrastim in the US market).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Anti-Infectives</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by Retail Generics and for sale to third-party customers. Sales of anti-infectives sold to third parties under their own name were USD&nbsp;543 million, up 5% (+3% cc). Total Anti-Infectives franchise sales were USD&nbsp;1.4 billion (-2%,&ndash;3% cc), and included USD&nbsp;826 million in sales of finished dosage forms sold under the Sandoz name.</div><a name=""></a><div style=" padding-bottom: 10px;"></div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Operating income from continuing operations</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of operating income from continuing operations by segment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;871</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;595</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;368</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;261</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Operating income from continuing operations was USD&nbsp;8.4 billion (&ndash;3%, &ndash;3% cc), mainly due to the impacts of M&amp;A transactions, higher restructuring and net impairment charges, and growth investments, which were </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">83</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">partly offset by higher sales. Operating income margin from continuing operations decreased by 1.8 percentage points to 18.8% of net sales, driven by a decrease in constant currencies of 1.6 percentage points and a negative currency impact of 0.2 percentage points.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Core operating income from continuing operations key figures</font><font style="font-family:arial,helvetica,sans-serif; font-size:8pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core gross profit from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;886</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;374</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13&nbsp;690</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;468</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;154</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;808</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 748</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;043</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;132</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">As % of net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For an explanation of non-IFRS measures and reconciliation tables, see "Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The adjustments made to operating income from continuing operations to arrive at core operating income from continuing operations amounted to USD&nbsp;4.2 billion (compared to USD&nbsp;3.0 billion in 2017), increasing mainly due to higher restructuring and net impairment charges.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core operating income from continuing operations was USD&nbsp;12.6 billion (+7%, +7% cc) driven by higher sales and gross margin, which were partly offset by growth investments, including AveXis. Core operating income margin in constant currencies increased by 0.6 percentage points; currency had a negative impact of 0.2 percentage points, resulting in a net increase of 0.4 percentage points to 28.1% of net sales.</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of core operating income from continuing operations by segment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> % of<br> net sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;151</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 32.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;080</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;596</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;385</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 27.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Operating income was USD&nbsp;7.9 billion (+4%, +4% cc) mainly driven by higher sales, which were partly offset by increased growth and launch investments, and higher restructuring and net impairment charges. Operating income margin in constant currencies decreased 0.8 percentage points; currency had a negative impact of 0.1 percentage points, resulting in a net decrease of 0.9 percentage points to 22.6% of net sales.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core adjustments amounted to USD&nbsp;3.3 billion, including USD&nbsp;2.2 billion of amortization of intangible assets. Prior-year core adjustments were USD&nbsp;2.4 billion. Core adjustments increased compared to prior year mainly due to higher restructuring and net impairment charges. Core operating income was USD&nbsp;11.2 billion (+11%, +11% cc) mainly driven by strong sales growth and gross margin expansion, which were partly offset by higher growth investments. Core operating income margin in constant currencies increased by 1.0 percentage points; currency had a negligible impact, resulting in a net increase of 1.0 percentage points to 32.0% of net sales.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core gross margin as a percentage of net sales increased by 0.9 percentage points (cc). Core R&amp;D expenses decreased by 0.8 percentage points (cc). Core SG&amp;A expenses increased by 0.7 percentage points (cc) due to launch investments and the acquisitions of AveXis and AAA. Core other income and expense, net, was in line with the prior year.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Operating income was USD&nbsp;1.3 billion (&ndash;3%, &ndash;2% cc), mainly driven by impairment charges related to the Sandoz US dermatology business and the generic US oral solids portfolio and lower sales, which were partly offset by continued gross margin expansion and lower amortization. Operating income margin was broadly in line with the prior year.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core adjustments amounted to USD&nbsp;670 million, including USD&nbsp;363 million of amortization. Prior-year </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">84</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">core adjustments were USD&nbsp;712 million. Core adjustments declined compared to the prior year, driven by net changes in legal provisions and lower amortization, which were partly offset by impairment charges related to the Sandoz US dermatology business and the generic US oral solids portfolio. Core operating income was USD&nbsp;2.0 billion (&ndash;4%, &ndash;3% cc), mainly due to the sales decline, ex-US marketing and sales (M&amp;S) investments, which were partly offset by continued core gross margin expansion. Core operating income margin in constant currencies decreased by 0.1 percentage points, and currency had a negative impact of 0.3 percentage points, resulting in a net decrease of 0.4 percentage points to 20.3% of net sales.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Core gross margin as a percentage of net sales increased by 2.4 percentage points (cc), mainly driven by productivity gains and favorable product and geographic mix. Core R&amp;D expenses increased by 0.4 percentage points (cc). Core SG&amp;A expenses increased by 2.2 percentage points (cc), mainly due to higher M&amp;S investments in key ex-US markets. Core other income and expense increased the margin by 0.1 percentage points (cc).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Corporate income and expense, net</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Corporate income and expense, which includes the cost of Group management and central services, amounted to an expense of USD&nbsp;800 million, compared to USD&nbsp;261 million in the prior year. The increase in net expense compared to the prior year was mainly due to lower contributions from the Novartis Venture Fund, lower income from retained Vaccines intellectual property, higher Novartis Business Services (NBS) restructuring costs, and an income from a sales milestone in the prior year related to the Vaccines divestment.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Innovative Medicines Division research and development</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of the reported and core research and development expense of the Innovative Medicines Division:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br>  currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and exploratory development</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;770</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;729</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Confirmatory development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;905</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;886</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Innovative Medicines Division research and development expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;615</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">As % of Innovative Medicines net sales to third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core research and exploratory development<sup>1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;603</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core confirmatory development<sup>1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total core Innovative Medicines Division research and development expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;034</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">As % of Innovative Medicines net sales to third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Core excludes impairments, amortization and certain other items. For an explanation of non-IFRS measures and reconciliation tables, see " &#x2014;Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Innovative Medicines Division research and exploratory development expense increased by 2% (&ndash;1% cc) to USD&nbsp;2.8 billion, and confirmatory development expense amounted to USD&nbsp;4.9 billion, broadly in line with the prior year. This was mainly due to higher pipeline investments, including AveXis, which were offset by lower net impairment charges (mainly prior-year RLX030) and productivity. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total core research and development expense in the Innovative Medicines Division as a percentage of sales decreased by 0.8 percentage points in constant currencies mainly driven by continued resource allocation and productivity efforts, and higher net sales. The impact from currency exchange rates was negligible, yielding a net decrease of 0.8 percentage points to 21.0% of net sales.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">85</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Non-operating income and expense from continuing operations</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The term &#x201C;Non-operating income and expense&#x201D; includes all income and expense items outside operating income. The following table provides an overview of non-operating income and expense from continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;403</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net (loss)/income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 73</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from discontinued operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 66</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">        </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful        </div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Income from associated companies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Income from associated companies from continuing operations increased to USD&nbsp;6.4 billion from USD&nbsp;1.1 billion in the prior year, an increase of USD&nbsp;5.3 billion. This increase was mainly due to the pre-tax gain of USD&nbsp;5.8 billion recognized on the divestment of the 36.5% stake in the GSK consumer healthcare joint venture. Excluding this divestment gain, income from associated companies amounted to USD&nbsp;648 million, compared to USD&nbsp;1.1 billion in the prior year.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The share of income from Roche was USD&nbsp;526 million, compared to USD&nbsp;456 million in the prior year. The higher estimated income for Roche of USD&nbsp;130 million in 2018, was partly offset by the net impacts from a negative prior-year adjustment of USD&nbsp;125 million recognized in 2018, compared to a negative prior-year adjustment of USD&nbsp;67 million recognized in 2017. The share of income from the GSK consumer healthcare joint venture decreased by USD&nbsp;509 million compared to the prior year, due to the discontinuation of the recognition of income from April 1, 2018 (see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&#x201D;).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Interest expense and other financial income and expense </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Interest expense from continuing operations was USD&nbsp;932 million, compared to USD&nbsp;750 million in the prior year, an increase of USD&nbsp;182 million due to higher interest expense of USD&nbsp;136 million relating to the level of outstanding debts, and higher interest expense of USD&nbsp;46 million on discounting of long-term liabilities.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Other financial income and expense from continuing operations amounted to an income of USD&nbsp;186 million, compared to an income of USD&nbsp;42 million in the prior year, mainly due to higher interest income of USD&nbsp;292 million, compared to USD&nbsp;110 million in the prior year, which was partly offset by higher currency losses of USD&nbsp;68 million, compared to currency losses of USD&nbsp;58 million in the prior year and higher other financial expenses, net of USD&nbsp;38 million, compared to USD&nbsp;10 million in the prior year. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Taxes </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The tax rate from continuing operations was 9.2%, compared to 17.6% in the prior year, due to the impact in 2018 on taxes of the divestment of the 36.5% stake in the GSK consumer healthcare joint venture and the impact in 2017 on taxes from the US enacted tax reform legislation. Excluding the impact of the divestment, the tax rate would have been 14.9% in 2018 and excluding the impact of US tax reform, 14.2% in 2017. The tax rate increased as the benefit from favorable profit mix was offset by the impact from the discontinuation of the recognition of the income from associated companies related to the GSK consumer healthcare joint venture from April 1, 2018 (see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&#x201D;).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Net income from continuing operations</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Net income from continuing operations was USD&nbsp;12.8 billion, compared to USD&nbsp;7.5 billion in the prior year, mainly benefiting from a USD&nbsp;5.7 billion net gain from the divestment of our stake in the GSK consumer healthcare joint venture in the second quarter of 2018. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Earnings per share</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Basic earnings per share from continuing operations were USD&nbsp;5.52, compared to USD&nbsp;3.20 in the prior year, driven by higher net income and lower weighted average number of shares outstanding.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">86</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Core non-operating income and expense from continuing operations</font><font style="font-family:arial,helvetica,sans-serif; font-size:8pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides an overview of core non-operating income and expense from continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Year ended<br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Year ended<br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change<br> in USD<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br> constant<br> currencies<br> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;557</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;714</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;335</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;004</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;867</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;920</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core basic EPS from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4.71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For an explanation of non-IFRS measures and reconciliation tables, see "Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful </div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core income from associated companies</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core income from associated companies from continuing operations amounted to USD&nbsp;1.1 billion, compared to USD&nbsp;1.3 billion in the prior year. The core income contribution from Roche amounted to USD&nbsp;970 million, compared to USD&nbsp;832 million in the prior year, an increase of USD&nbsp;138 million, mainly due to the higher estimated contribution from core income. The share of core income from GSK consumer healthcare joint venture decreased by USD&nbsp;338 million, compared to the prior year, due to the discontinuation of core income from April 1, 2018 (see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&#x201D;).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core interest expense and other financial income and expense</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core interest expense from continuing operations was USD&nbsp;932 million, compared to USD&nbsp;750 million in the prior year. Core other financial income and expense from continuing operations amounted to a net income of USD&nbsp;186 million, compared to USD&nbsp;42 million in the prior year.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core taxes</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The core tax rate from continuing operations (core taxes as a percentage of core income before tax from continuing operations) increased to 15.5% from 15.1% in the prior year.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core net income</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core net income from continuing operations was USD&nbsp;10.9 billion (+4%, +4% cc) driven by growth in core operating income and partly offset by the discontinuation of core income from the GSK consumer healthcare joint venture from April 1, 2018.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Core earnings per share</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Core earnings per share from continuing operations were USD&nbsp;4.71 (+6%, +5% cc), driven by growth in core net income and the lower number of shares outstanding.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Discontinued operations</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Discontinued operations net sales were USD&nbsp;7.1 billion, compared to USD&nbsp;6.8 billion in the prior year. Operating loss amounted to USD&nbsp;234 million, compared to an operating loss of USD&nbsp;73 million in the prior year. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net loss from discontinued operations amounted to USD&nbsp;186 million, compared to a net income from discontinued operations of USD&nbsp;204 million in the prior year.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Total Group</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For the total Group, net income amounted to USD&nbsp;12.6 billion in 2018, compared to USD&nbsp;7.7 billion in the prior</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">year, and basic earnings per share increased to USD&nbsp;5.44 from USD&nbsp;3.28. Cash flow from operating activities for the total Group amounted to USD&nbsp;14.3 billion, and free cash flow amounted to USD&nbsp;11.7 billion.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">87</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Factors affecting comparability of year-on-year results of operations</font>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2019, 2018 and 2017, and significant pending transactions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The comparability of the year-on-year results of our operations for the total Group can be significantly affected by acquisitions and divestments. As part of our long-term strategy to focus Novartis as a leading medicines company, we announced and/or completed several acquisitions and divestments during 2019, 2018 and 2017.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A detailed description of significant transactions in 2019, 2018 and 2017, and significant pending transactions, can be found in &#x201C;Item 4.Information on the Company&mdash;Item 4.A History and development of Novartis&mdash;Important corporate developments 2017&mdash;2019,&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Critical accounting policies and estimates</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our significant accounting policies are set out in &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies,&#x201D; which are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Given the uncertainties inherent in our business activities, we must make certain estimates and assumptions that require difficult, subjective and complex judgments. Because of uncertainties inherent in such judgments, actual outcomes and results may differ from our assumptions and estimates, which could materially affect the Group&#x2019;s consolidated financial statements. Application of the following accounting policies requires certain assumptions and estimates that have the potential for the most significant impact on our consolidated financial statements.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">New accounting pronouncement</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented the new standard IFRS 16 Leases effective as of January 1, 2019. IFRS 16 Leases substantially changed the consolidated financial statements, as the majority of leases for which the company is the lessee became on-balance sheet liabilities with corresponding right-of-use assets also recognized on the balance sheet. The lease liability reflects the net present value of the remaining lease payments, and the right-of-use asset corresponds to the lease liability, adjusted for payments made before the commencement date, lease incentives and other items related to the lease agreement. The standard replaces IAS 17 Leases and related interpretations. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Upon adoption of the new standard, a portion of the annual operating lease costs is recorded as an interest expense. This was previously fully recognized within operating income as a functional expense. In addition, the portion of the lease payments that represents the reduction of the lease liability is recognized in the cash flow statement as an outflow from financing activities. Previously, this was fully recognized as an outflow from operating activities. Given the leases involved, these effects are not significant to the presentation of our consolidated income statement or our consolidated cash flows from operating activities and from financing activities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group implemented the new standard on January 1, 2019, and applied the modified retrospective method, with right-of-use assets measured at an amount equal to the lease liability, adjusted by the amount of the prepaid or accrued lease payments relating to those leases recognized in the balance sheet immediately before the date of initial application and will not restate prior years.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2019, with the adoption of IFRS 16 Leases, the Group adopted new accounting policies for leases and right-of-use assets, which are set forth in &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies &ndash; Leases and right-of-use assets.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For further information on the impact of adoption and additional disclosures of IFRS 16 Leases, see &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 10. Right-of-use assets and lease liabilities.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Non-current assets held for sale or held for distribution to owners</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Non-current assets are classified as assets held for sale or related to discontinued operations when their carrying amount is to be recovered principally through a sale transaction or distribution to owners, and a sale or distribution to owners is considered highly probable. They are stated at the lower of carrying amount and fair value less costs to sell with any resulting impairment recognized. Assets related to discontinued operations and assets of disposal group held for sale are not depreciated or amortized. The prior-year consolidated balance sheet is not restated. For more details on the assets and liabilities of disposal group classified as held for sale in the 2019 and 2018 balance sheets, see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&mdash;Significant pending transactions.&#x201D; </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">88</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Distribution of Alcon Inc. to Novartis AG shareholders </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During the first quarter of 2019, at the Annual General Meeting (AGM) of Novartis AG shareholders, held on February 28, 2019, the Novartis AG shareholders approved a special distribution by way of a dividend in kind to effect the spin-off of Alcon Inc. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The February 28, 2019, shareholder approval for the spin-off required the Alcon Division and selected portions of corporate activities attributable to Alcon&#x2019;s business (the &#x201C;Alcon business&#x201D;) to be reported as discontinued operations. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The shareholder approval to spin off the Alcon business also required the recognition of a distribution liability at the fair value of the Alcon business. The Group elected to measure the distribution liability at the fair value of the Alcon business net assets taken as a whole. The distribution liability was recognized through a reduction in retained earnings. It was required to be adjusted at each balance sheet date for changes in its estimated fair value, up to the date of the distribution to shareholders through retained earnings. Any resulting impairment of the business assets to be distributed would have been recognized in the consolidated income statements in &#x201C;Other expense&#x201D; of discontinued operations, at the date of initial recognition of the distribution liability or at subsequent dates resulting from changes of the distribution liability valuation. At the April 8, 2019 distribution settlement date, the resulting gain, which was measured as the excess amount of the distribution liability over the then-carrying value of the net assets of the business distributed, was recognized on the line &#x201C;Gain on distribution of Alcon Inc. to Novartis AG shareholders&#x201D; in the income statement of discontinued operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. These fair value measurements were classified as &#x201C;Level 3&#x201D; in the fair value hierarchy. . &#x201C;Item 18. Financial Statements&mdash;Note 1. Impairment of goodwill and intangible assets&#x201D; provides additional information on key assumptions that are highly sensitive in the estimation of fair values using valuation techniques. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Transaction costs that were directly attributable to the distribution (spin-off) of Alcon to the Novartis shareholders, and that would otherwise have been avoided, were recorded as a deduction from equity.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional disclosures, refer to &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions in 2019&mdash;Completion of the Spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 30. Discontinued operations.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Deductions from revenues</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As is typical in the pharmaceutical industry, our gross sales are subject to various deductions, which are primarily composed of rebates and discounts to retail customers, government agencies, wholesalers, health insurance companies and managed healthcare organizations. These deductions represent estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions on gross sales for a reporting period. These adjustments are deducted from gross sales to arrive at net sales.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following summarizes the nature of some of these deductions and how the deduction is estimated. After recording these, net sales represent our best estimate of the cash that we expect to ultimately collect. The US market has the most complex arrangements related to revenue deductions.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">United States-specific healthcare plans and program rebates</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The United States Medicaid Drug Rebate Program is administered by state governments, using state and federal funds to provide assistance to certain vulnerable and needy individuals and families. Calculating the rebates to be paid related to this program involves interpreting relevant regulations, which are subject to challenge or change in interpretative guidance by government authorities. Provisions for estimating Medicaid rebates are calculated using a combination of historical experience, product and population growth, product pricing, and the mix of contracts and specific terms in the individual state agreements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The United States Federal Medicare Program, which funds healthcare benefits to individuals aged 65 and older, and to people with certain disabilities, provides prescription drug benefits under the Part D section of the program. This benefit is provided and administered through private prescription drug plans. Provisions for estimating Medicare Part D rebates are calculated based on the terms of individual plan agreements, product sales and population growth, product pricing, and the mix of contracts.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We offer rebates to key managed healthcare and private plans in an effort to sustain and increase the market share of our products, and to ensure patient access to our products. These programs provide a rebate after the plans have demonstrated they have met all terms and conditions set forth in their contract with us. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">These rebates are estimated based on the terms of individual agreements, historical experience, product pricing and projected product growth rates, and are recorded as a deduction from revenue at the time the related revenues are recorded. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">These provisions are adjusted based on established processes and experiences from filing data with individual states and plans. There is often a time lag of several months between the recording of the revenue deductions and the final accounting for them.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">89</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Non-United States-specific healthcare plans and program rebates</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In certain countries other than the US, we provide rebates to governments and other entities. These rebates are often mandated by laws or government regulations. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In several countries, we enter into innovative pay-for-performance arrangements (i.e. outcome based arrangements) with certain healthcare providers. Under these agreements, we may be required to make refunds to the healthcare providers or to provide additional medicines free of charge if anticipated treatment outcomes do not meet predefined targets. The impact of potential refunds or the delivery of additional medicines at no cost is estimated and recorded as a deduction from revenue at the time the related revenues are recorded. Estimates are based on historical experience and clinical data. In cases where historical experience and clinical data are not sufficient for a reliable estimation of the outcome, revenue recognition is deferred until such history is available.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, we offer global patient assistance programs.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is often a time lag of several months between the recording of the revenue deductions and the final accounting for them.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Non-healthcare plans and program rebates, returns and other deductions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We offer rebates to purchasing organizations and other direct and indirect customers to sustain and increase market share and to ensure patient access to our products. Since rebates are contractually agreed upon, the related provisions are estimated based on the terms of the individual agreements, historical experience and projected product sales growth rates. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Chargebacks occur where our subsidiaries have arrangements with indirect customers to sell products at prices that are lower than the price charged to wholesalers. A chargeback represents the difference between the invoice price to the wholesaler and the indirect customer&#x2019;s contract price. We account for vendor chargebacks by reducing revenue by the estimate of chargebacks attributable to a sales transaction. Provisions for estimated chargebacks are calculated using a combination of factors, such as historical experience, product growth rates, product pricing, level of inventory in the distribution channel, and the terms of individual agreements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When we sell a product providing a customer the right to return it, we record a provision for estimated sales returns based on our sales return policy and historical return rates. Other factors considered include actual product recalls, expected marketplace changes, the remaining shelf life of the product, and the expected entry of generic products. In 2019, sales returns amounted to approximately 1% of gross product sales. If sufficient experience is not available, sales are only recorded based on evidence of product consumption or when the right of return has expired.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We enter into distribution service agreements with major wholesalers, which provide a financial disincentive for the wholesalers to purchase product quantities in excess of current customer demand. Where possible, we adjust shipping patterns for our products to maintain wholesalers&#x2019; inventory levels consistent with underlying patient demand.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We offer cash discounts to customers to encourage prompt payment. Cash discounts are estimated and accrued at the time of invoicing and are deducted from revenue.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Following a decrease in the price of a product, we generally grant customers a &#x201C;shelf stock adjustment&#x201D; for their existing inventory for the relevant product. Provisions for shelf stock adjustments, which are primarily relevant within the Sandoz Division, are determined at the time of the price decline or at the point of sale, if the impact of a price decline on the products sold can be reasonably estimated based on the customer&#x2019;s inventory levels of the relevant product.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Other sales discounts, such as consumer coupons and copay discount cards, are offered in some markets. The estimated amounts of these discounts are recorded at the time of sale or when the coupons are issued, and are estimated utilizing historical experience and the specific terms for each program. If a discount for a probable future transaction is offered as part of a sales transaction, then an appropriate portion of revenue is deferred to cover this estimated obligation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We adjust provisions for revenue deductions periodically to reflect actual experience. To evaluate the adequacy of provision balances, we use internal and external estimates of the inventory in transit, the level of inventory in the distribution and retail channels, actual claims data received, and the time lag for processing rebate claims. External data sources include reports from wholesalers and third-party market data purchased by Novartis.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For the table showing the worldwide extent of our revenue deductions provisions and related payment experiences for the Group see &#x201C;Item 18. Financial Statements&mdash;Note 22. Provisions and other current liabilities.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">90</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Gross-to-net sales reconciliation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table below shows the gross-to-net sales reconciliation for our Innovative Medicines Division:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In % of<br> gross sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> In % of<br> gross sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> In % of<br> gross sales</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines gross sales subject to deductions</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 52&nbsp;956</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 47&nbsp;785</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 43&nbsp;127</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100.0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans and program rebates</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;824</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;921</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;303</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7.7</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans and program rebates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;140</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;652</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates,  returns and other deductions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;6&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;13.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;5&nbsp;832</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;12.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;4&nbsp;894</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;11.4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Innovative Medicines gross-to-net sales adjustments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;242</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;28.8</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;12&nbsp;893</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;27.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10&nbsp;849</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;25.2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 73.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74.8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of goodwill, intangible assets and property, plant and equipment</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We review long-lived intangible assets and property, plant and equipment for impairment whenever events or changes in circumstance indicate that the asset&#x2019;s balance sheet carrying amount may not be recoverable. Goodwill and other currently not amortized intangible assets are reviewed for impairment at least annually.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">An asset is considered impaired when its balance sheet carrying amount exceeds its estimated recoverable amount, which is defined as the higher of its fair value less costs of disposal and its value in use. Usually, Novartis applies the fair value less costs of disposal method for its impairment assessment. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. In the limited cases where the value in use method would be applied, net present value techniques would be applied using pre-tax cash flows and discount rates.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Fair value less costs of disposal reflects estimates of assumptions that market participants would be expected to use when pricing the asset or CGUs, and for this purpose, management considers the range of economic conditions that are expected to exist over the remaining useful life of the asset.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimates used in calculating the net present values are highly sensitive and depend on assumptions specific to the nature of the Group&#x2019;s activities with regard to:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected future cash &#xFB02;ows</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term sales forecasts</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Actions of competitors (launch of competing products, marketing initiatives, etc.)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Outcome of research and development activities (com-pound efficacy, results of clinical trials, etc.)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected costs to develop IPR&amp;D into commercially viable products</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Pro&#xFB01;t margins</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Probability of obtaining regulatory approval</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Future tax rate</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate terminal growth rate</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate discount rate</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Due to the above factors, actual cash flows and values could vary significantly from forecasted future cash flows and related values derived using discounting techniques.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The recoverable amount of the grouping of cash-generating units to which goodwill and indefinite life intangible assets are allocated is based on fair value less costs of disposal. The valuations are derived from applying discounted future cash flows based on key assumptions, including the terminal growth rate and discount rate. For additional information, see &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies&mdash;Impairment of goodwill and intangible assets and Note 11. Goodwill and intangible assets.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, intangible asset impairment charges in continuing operations of USD&nbsp;1.2 billion were recognized, of which USD&nbsp;669 million was recorded in the Innovative Medicines Division and USD&nbsp;506 million was recorded in the Sandoz Division.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, intangible asset impairment charges in continuing operations of USD&nbsp;841 million were recognized, of which USD&nbsp;592 million was recorded in the Innovative Medicines Division and USD&nbsp;249 million was recorded in the Sandoz Division.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2017, intangible asset impairment charges in continuing operations of USD&nbsp;652 million were recognized, of which USD&nbsp;591 million was recorded in the Innovative Medicines Division and USD&nbsp;61 million was recorded in the Sandoz Division.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, the reversal of prior year impairment charges amounted to USD&nbsp;37 million. In 2018 and 2017, there were no reversals of prior-year impairment charges.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Goodwill and other intangible assets represent a significant part of our consolidated balance sheet, primarily due to acquisitions. Although no significant additional impairments are currently anticipated, impairment evaluation could lead to material impairment charges in the future. For more information, see &#x201C;Item 18. Financial Statements&mdash;Note 11. Goodwill and intangible assets.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Additionally, net impairment charges for property, plant and equipment from continuing operations during 2019 amounted to USD&nbsp;202 million (2018: USD&nbsp;301 million; 2017: USD&nbsp;157 million).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">91</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of associated companies accounted for at equity</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis considers investments in associated companies for impairment evaluation whenever objective evidence indicates the net investment may be impaired, including when a quoted share price indicates a fair value less than the per-share balance sheet carrying value for the investment.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the recoverable amount of the investment is estimated to be lower than the balance sheet carrying amount, an impairment charge is recognized for the difference in the consolidated income statement under &#x201C;Income from associated companies.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Trade receivables</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trade receivables are initially recognized at their invoiced amounts, including any related sales taxes less adjustments for estimated revenue deductions such as rebates, chargebacks and cash discounts. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, provisions for doubtful trade receivables are established using an expected credit loss model (ECL). The provisions are based on a forward-looking ECL, which includes possible default events on the trade receivables over the entire holding period of the trade receivable. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Charges for doubtful trade receivables are recorded as marketing and selling costs recognized in the consolidated income statement within &#x201C;Selling, General &amp; Administration&#x201D; expenses.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Trade receivable balances include sales to drug wholesalers, retailers, private health systems, government agencies, managed care providers, pharmacy benefit managers and government-supported healthcare systems. Novartis continues to monitor sovereign debt issues and economic conditions in Argentina, Brazil, Greece, Italy, Portugal, Russia, Saudi Arabia, Spain, Turkey and other countries, and evaluates trade receivables in these countries for potential collection risks. Substantially all of the trade receivables overdue from Argentina, Brazil, Greece, Portugal, Saudi Arabia and Spain are due directly from local governments or from government-funded entities. Deteriorating credit and economic conditions as well as other factors in these countries have resulted in &ndash; and may continue to result in &ndash; an increase in the average length of time that it takes to collect these trade receivables, and may require the Group to re-evaluate the estimated collectable amount of these trade receivables in future periods.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Contingent consideration</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In a business combination or divestment of a business, it is necessary to recognize contingent future amounts due to previous owners representing contractually defined potential amounts as a liability or asset. Usually for Novartis, these are linked to milestone or royalty payments related to certain assets and are recognized as a financial liability or financial asset at their fair value, which is then remeasured at each subsequent reporting date. These estimations typically depend on factors such as technical milestones or market performance, and are adjusted for the probability of their likelihood of payment and, if material, are appropriately discounted to reflect the impact of time.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Changes in the fair value of contingent consideration liabilities in subsequent periods are recognized in the consolidated income statement in &#x201C;Cost of goods sold&#x201D; for currently marketed products and in &#x201C;Research and development&#x201D; for in-process research and development (IPR&amp;D). Changes in contingent consideration assets are recognized in &#x201C;Other income&#x201D; or &#x201C;Other expense,&#x201D; depending on its nature.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The effect of unwinding the discount over time is recognized for contingent liabilities in &#x201C;Interest expense&#x201D; and for contingent assets as interest income recognized in the consolidated income statement within &#x201C;Other financial income and expense.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Retirement and other post-employment benefit plans</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We sponsor pension and other post-employment benefit plans in various forms that cover a significant portion of our current and former associates. For post-employment plans with defined benefit obligations, we are required to make significant assumptions and estimates about future events in calculating the expense and the present value of the liability related to these plans. These include assumptions about the interest rates we apply to estimate future defined benefit obligations and net periodic pension expense, as well as rates of future pension increases. In addition, our actuarial consultants provide our management with historical statistical information, such as withdrawal and mortality rates in connection with these estimates.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Assumptions and estimates used by the Group may differ materially from the actual results we experience due to changing market and economic conditions, higher or lower withdrawal rates, and longer or shorter life spans of participants, among other factors. For example, in 2019, a decrease in the interest rate we apply in determining the present value of the defined benefit obligations of one-quarter of 1% would have increased our year-end defined benefit pension obligation for plans in Switzerland, the United States, the United Kingdom, Germany and Japan, which represent 95% of the Group total defined benefit pension obligation, by approximately USD&nbsp;0.8 billion. Similarly, if the 2019 interest rate had been one-quarter of 1 percentage point lower than actually assumed, the net periodic pension cost for pension plans in these countries, which represent about 89% of the Group&#x2019;s total net periodic pension cost for pension plans, would have increased by approximately USD&nbsp;22 million. Depending on events, such differences could have a material effect on our total equity. For more information on obligations under retirement and other post-employment benefit plans and underlying actuarial assumptions, see &#x201C;Item 18. Financial Statements&mdash;Note 25. Post-employment benefits for associates.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">92</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Provisions and contingencies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">A number of Group companies are involved in various government investigations and legal proceedings (intellectual property, sales and marketing practices, product liability, commercial, employment and wrongful discharge, environmental claims, etc.) arising out of the normal conduct of their businesses. For more information, see &#x201C;Item 18. Financial Statements&mdash;Note 20. Provisions and other non-current liabilities,&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 28. Commitments and contingencies.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We record provisions for legal proceedings when it is probable that a liability has been incurred and the amount can be reliably estimated. These provisions are adjusted periodically as assessments change or additional information becomes available. For significant product liability cases, the provision is actuarially determined based on factors such as past experience, amount and number of claims reported, and estimates of claims incurred but not yet reported.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions are recorded for environmental remediation costs when expenditure on remedial work is probable and the cost can be reliably estimated. Remediation costs are provided for under &#x201C;Non-current liabilities&#x201D; in the Group&#x2019;s consolidated balance sheet.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions relating to estimated future expenditure for liabilities do not usually reflect any insurance or other claims or recoveries, since these are only recognized as assets when the amount is reasonably estimable and collection is virtually certain.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Internal research and development (R&amp;D) costs are fully charged to the consolidated income statement in the period in which they are incurred. We consider that regulatory and other uncertainties inherent in the development of new products preclude the capitalization of internal development expenses as an intangible asset usually until marketing approval from the regulatory authority is obtained in a relevant major market, such as for the United States, the European Union, Switzerland or Japan.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Costs for post-approval studies performed to support the continued registration of a marketed product are recognized as marketing expenses. Costs for activities that are required by regulatory authorities as a condition for obtaining marketing approval are capitalized and recognized as currently marketed products.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Healthcare contributions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In many countries, our subsidiaries are required to make contributions to the country&#x2019;s healthcare costs as part of programs other than the ones mentioned above under deductions from revenues. The amounts to be paid depend on various criteria such as the subsidiary&#x2019;s market share or sales volume compared to certain targets. Considerable judgment is required in estimating these contributions, as not all data is available when the estimates need to be made.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The largest of these healthcare contributions relates to the US Healthcare Reform fee, which was introduced in 2011. This fee is an annual levy to be paid by US pharmaceutical companies, including various Novartis subsidiaries, based on each company&#x2019;s prior-year qualifying sales as a percentage of the prior year&#x2019;s government- funded program sales. This pharmaceutical fee levy is recognized in &#x201C;Other expense.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Taxes</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We prepare and file our tax returns based on an interpretation of tax laws and regulations, and we record estimates based on these judgments and interpretations. Our tax returns are subject to examination by the competent taxing authorities, which may result in an assessment being made, requiring payments of additional tax, interest or penalties. Since Novartis uses its intellectual property globally to deliver goods and services, the transfer prices within the Group as well as arrangements between subsidiaries to finance research and development and other activities may be challenged by the national tax authorities in any of the jurisdictions in which Novartis operates. Therefore, inherent uncertainties exist in our estimates of our tax positions, but we believe that our estimated amounts for current and deferred tax assets or liabilities, including any amounts related to any uncertain tax positions, are appropriate based on currently known facts and circumstances.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Internal control over financial reporting</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s management has assessed the effectiveness of internal control over financial reporting. The Group&#x2019;s independent statutory auditor also issued an opinion on the effectiveness of internal control over financial reporting. Both the Group&#x2019;s management and its external auditors concluded that the Group maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019. For more details, see &#x201C;Item 15. Controls and Procedures.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">93</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Factors affecting results of operations </font>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Transformational changes fueling demand</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Accelerating biomedical innovation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We believe that biomedical innovation has the potential to accelerate over the next two decades, with a potentially transformative set of therapeutic platforms emerging that could make many intractable, &#x201C;undruggable&#x201D; targets accessible to new therapeutics and treatment modalities. Our molecular understanding of biology is steadily deepening to guide drug discovery. Artificial intelligence (AI) and <i>in silico</i> drug discovery tools are also maturing, with technology-native life sciences companies starting to develop their own drug pipelines. These developments have the potential to provide us with new tools to help reduce some of the uncertainty in drug discovery, while at the same time helping to enable a new set of potential competitors. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We see this as an opportunity because our strong internal research capabilities should allow us to harness the potential of an increasingly fragmented external innovation environment. For example, we expect to sustain long-term growth in part through our 15 ongoing or upcoming major launches. In order to use this potential to our advantage, first we will need to maintain a leading position in new drug research capabilities that continue to emerge. New methods to generate, analyze and use big data to make predictions have the potential to make biomedical problems more tractable, and new technology platforms have the potential to make previously &#x201C;undruggable&#x201D; targets accessible to new treatments. Second, there may be an increasing number of contributors to drug research, with a broader range of possible therapeutic advances. It will therefore be important for us to effectively identify, operationalize, and scale new technologies from a wide range of sources. Third, we will need to continue to attract and retain talent who can harness these new opportunities and continue to build innovation leadership.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Aging populations</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">While accelerating medical innovation could help control some of the devastating diseases that still plague humanity, other trends in society pose significant challenges. Rapidly aging populations continue to put pressure on governments and payers around the world.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">People are living longer and the worldwide elderly population continues to grow at a rapid pace. The number of people in the world aged 65 or over is projected to reach nearly 1.5 billion by 2050, according to projections by the United Nations, up from 700 million today. Aging populations, in addition to rapid urbanization and changing lifestyles in the developing world, are contributing to an increased prevalence of chronic ailments such as heart disease and cancer.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At the same time, many countries are working to expand access to healthcare. For example, China is taking steps to expand reimbursement of new medicines to help ensure broad access to medical innovation for its population. In the coming years, we expect to double the average number of our NDA approvals per year in China compared with 2015-2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">These factors are driving higher healthcare spending, which is projected by the consultancy firm Deloitte to grow at an annual rate of 5.4% between 2018 and 2022, reaching a total of more than USD&nbsp;10 trillion worldwide (Deloitte, &#x201C;2019 Global Healthcare Outlook, Shaping the Future&#x201D;). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To keep costs in check, governments and health insurers are already employing a variety of measures, including increasing the use of generics and biosimilars, imposing price cuts, and limiting access to some innovative therapies. The pharmaceutical industry is also expected to play a role in controlling healthcare spending, including by exploring new pricing models and delivering innovative new treatments that help maximize benefits for patients.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Moving towards value-based care</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In the long term, we believe that healthcare systems are more likely to remain sustainable if they are able to reward on the basis of value, instead of volume, and rationally allocate resources to the treatments that lead to the best outcomes for patients. In the US in particular, changes to incentives currently built into the healthcare system&mdash;which can encourage delivery of more expensive treatments from manufacturers paying higher rebates over more cost-effective products&mdash;may be needed before value-based approaches become more widely implemented. &#x201C;American Patients First,&#x201D; published by the Trump administration in May 2018, included proposals to remove barriers for value-based arrangements and value-based purchasing, in addition to promoting indication-based pricing projects in federal programs.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the meantime, cost containment measures are becoming increasingly prevalent. Before eventually shifting to value-based pricing methods, which can sometimes be more difficult and complicated to implement, countries are increasingly pursuing available sources of savings including policies on prescription drug prices. These direct moves are expected to drive our industry to become much more innovative in demonstrating and delivering value to healthcare systems.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We believe that technology and innovation hold great potential to improve patient outcomes and quality of life, while also supporting healthcare systems to improve value for money and access. Novartis expects to continue to play a significant role in bringing new technologies into R&amp;D and into patient support, and to help healthcare systems improve access. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Technology has the potential to help change the way in which healthcare is delivered</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The expansion in data science and digital technologies has the potential to impact a number of areas across the healthcare value chain. First, digital technologies may increasingly improve the efficiency and effectiveness of researching and developing potential new therapies. The combination of data and artificial intelligence could enable complex biological simulations that complement </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">94</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">human scientific ingenuity. This technology is anticipated to augment our R&amp;D capabilities. Second, increased volumes of real-world data and the ability to analyze that data with artificial intelligence, may in the future allow more accurate, faster diagnosis of patients and recommendation of appropriate treatments. Real-world evidence will be important to demonstrate the value of our innovation to payers and healthcare providers. Third, we expect that in the future patients may have the opportunity to be much more engaged in managing their own care via clinical-grade digital tools, such as those supporting adherence to instructions from healthcare professionals. Patients are also likely to have greater decision-making power regarding with whom to share their health data, as data ownership is expected to shift from central data aggregators to the patient. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Increasingly challenging business environment</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Pricing and reimbursement</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Around the world, governments and payers continue to struggle with rising healthcare costs as aging populations contribute to increased prevalence of chronic diseases. There have also been examples of significant controversies about prices for pharmaceuticals that some politicians and members of the public have considered excessive. These factors have intensified the pressures we face regarding the prices we charge for our products, and our ability to establish satisfactory rates of reimbursement for our products by governments, insurers and other payers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We expect this scrutiny to continue in 2020, and the following years, as governments and insurers around the world strive to reduce healthcare costs through steps such as restricting access to higher-priced new medicines, increasing coinsurance or copays owed by patients for medicines, increasing the use of generics, and imposing price cuts. In this environment, we believe it is more important than ever to demonstrate the value that true innovation brings to the healthcare system.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To manage these pressures, we are investing in real world data and analytics to provide additional evidence of the health benefits of our products, exploring new technologies and patient management services, and working with payers to develop and scale outcomes-based commercial models. For example, we are working with customers on flexible pricing approaches where we are fully compensated only if a drug succeeds in meeting certain performance targets, or where the price for a product administered only once is paid over a period of time. For more information about these pricing approaches, see &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview&mdash;Innovative Medicines&mdash;Marketing and sales.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We take a disciplined and value-based approach to pricing. We strive to price our products commensurate to the value they provide to society, which is primarily in line with external benchmarks. Importantly, our sales growth has been mainly driven by new innovations driving volume growth and not by price increases on existing drugs. The net pricing impact on our sales growth has been negative or negligible for the last few years, and has been more than offset by volume growth from new products. We expect this to continue.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Loss of exclusivity for patented products</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Pharmaceutical companies routinely face generic competition when their products lose patent or other intellectual property protection, and Novartis is no exception. Major products of our Innovative Medicines Division, as well as certain products of our Sandoz Division, are protected by patent or other intellectual property rights, allowing us to exclusively market those products. The loss of exclusivity has had, and will continue to have, an adverse effect on our results. In 2019, the total impact of generic competition on our net sales amounted to approximately USD&nbsp;0.5 billion. The impact of generic competition on sales growth in 2019 was lower than the historical average.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Some of our best selling products face, or are expected to face, considerable competition due to the expiration of patent or other intellectual property protection. For example, our former top-selling product <i>Gleevec</i>/<i>Glivec</i> continues to face increasing generic competition in major markets. Patent protection for our <i>Sandostatin</i> products has expired and we are facing generic competition for <i>Sandostatin</i> <i>LAR</i> in Europe. Patent protection for <i>Exjade</i> in the US has expired and generic versions of <i>Exjade</i> are available in the US. Looking forward, intellectual property protecting a number of our major products will expire at various times in the coming years, raising the likelihood of further generic competition. Among our products expected to begin losing intellectual property protection in key countries during the coming years are our everolimus products or their remaining dosage strengths (<i>Afinitor</i>/<i>Votubia</i> and <i>Zortress/Certican</i>), <i>Sandostatin</i> <i>LAR</i> in Europe, <i>Jadenu,</i> <i>Lucentis</i>, and potentially <i>Gilenya.</i></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To counter the impact of intellectual property expirations, we continuously invest in research and development to rejuvenate our portfolio. For example, in 2019, we invested 19.8% of total net sales in R&amp;D. One measure of the output of our efforts is the performance of our growth drivers, including <i>Cosentyx, Entresto, </i>and <i>Kisqali</i>, and our Sandoz Division biosimilars. We also have a number of late-stage product candidates in our pipeline with the potential to come to market in the next few years. We launched five products with blockbuster potential in 2019: <i>Zolgensma, Piqray, Mayzent, Beovu, </i>and<i> Adakveo.</i> We expect to launch several potentially major new molecular entities in 2020, including ofatumumab (OMB157) for relapsing multiple sclerosis.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Commercial success of key products</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our ability to maintain and grow our business and to replace revenue and income lost to generic and other competitors depends in part on our commercial success, particularly with respect to our key growth driver products, which we consider to be an indicator of our ability to renew our portfolio. The commercial success of these products could be impacted at any time by a number of factors, including new competitors, changes in doctors&#x2019; prescribing habits, pricing pressure, manufacturing issues, and loss of intellectual property protection. In </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">95</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">addition, our revenue could be significantly impacted by the timing and rate of commercial acceptance of new products.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All of our businesses face intense competition from new products and scientific advances from competitors. Physicians, patients and payers may choose competitor products instead of ours if they perceive them to be better in terms of efficacy, safety, cost or convenience. The commercial success of our key products and launches in the face of increasing competition and pressures on pricing requires significant attention and focus from members of our key management.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Ability to deliver new products</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our ability to grow depends not only on the commercial success of our marketed products, but also on the success of our R&amp;D activities in identifying and developing new treatments that address unmet medical needs, are accepted by patients and physicians, and are reimbursed by payers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Developing new healthcare products and bringing them to market is a costly, lengthy and uncertain process. R&amp;D for a new product in our Innovative Medicines Division can take 15 years or more, from discovery to commercial launch. With time limits on intellectual property protections, the longer it takes to develop a product, the less time we may have to recoup our costs. During each stage of development, there is a significant risk that we will encounter obstacles or fail. This may cause a delay or add substantial expense, limit the potential for commercial success, or force us to abandon a development project in which we have invested substantial amounts of time and money.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, as healthcare costs continue to rise, governments and payers around the world are increasingly focused on health outcomes, rewarding new products that represent truly breakthrough innovation versus those that offer an incremental benefit over other products in the same therapeutic class. This has led to requests for more clinical trial data than has been required in the past, the inclusion of significantly higher numbers of patients in clinical trials, and more detailed analyses of the trials. As a result, despite significant efforts by health authorities such as the FDA to accelerate the development of new drugs, the already lengthy and expensive process of obtaining regulatory approvals and reimbursement for pharmaceutical products has become even more challenging.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our Sandoz Division faces similar challenges, particularly in the development of biosimilars. While Sandoz was a pioneer in introducing biosimilars to the European market in 2006, and was the first company to win approval for a biosimilar under the new regulatory pathway in the United States in 2015, many countries still lack fully developed regulatory frameworks for the development, approval and marketing of biosimilars. Further delays in establishing regulatory frameworks, or any other difficulties that may arise in the development or marketing of biosimilars, could put at risk the significant investments that Sandoz has made, and will continue to make, in this area.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In spite of our significant investments, there can be no guarantee that our R&amp;D activities will produce commercially viable new products that will enable us to grow our business and replace revenue and income lost to competition.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Business practices</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There is a continued focus on government investigations and litigation against companies operating in our industry, including in the United States and other countries. We are obligated to comply with the laws of all countries in which we operate, as well as any new requirements that may be imposed upon us. In addition, governments and regulatory authorities worldwide are increasingly challenging practices previously considered to be legal and compliant. Beyond legal requirements, we strive to meet evolving public expectations for ethical behavior. We have a significant global compliance program in place, and we devote substantial time and resources to efforts to ensure that our business is conducted in a legal and publicly acceptable manner. Despite these efforts, any failure to comply with the law could lead to substantial liabilities that may not be covered by insurance and could affect our business and reputation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Responding to these challenges and new regulations is costly. Investigations and litigation may affect our reputation, create a risk of potential exclusion from government reimbursement programs in the United States and other countries, and potentially lead to large damage payments and agreements intended to regulate company behavior. To help address this, we strive to continually strengthen our Ethics, Risk &amp; Compliance function, which is headed by our Chief Ethics, Risk and Compliance Officer, who reports directly to the CEO of Novartis. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Investors and Novartis are increasingly focused on Environmental, Social and Governance (ESG) issues. We have made progress in transforming our culture and building trust with society in 2019, which are two of the key strategic priorities of our CEO. For all our new medicines, we are systematically integrating access strategies into how we research, develop and launch products globally. We are developing innovative treatments for diseases where there is unmet need, including crizanlizumab (SEG101) in sickle cell disease, which is now approved as <i>Adakveo</i> in the US.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Supply continuity</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The manufacture of our products relies on technically complex processes and, in some cases, highly specialized raw materials, and is highly regulated. Deviations, difficulties or delays in production, or failure to obtain specialized raw materials, have in the past resulted in some of the following, and may in the future result in, shut-downs, work stoppages, approval delays, voluntary market withdrawals, product recalls, penalties, supply disruptions or shortages, increased costs, product liability or reputational harm. Whether our products and the related raw materials are manufactured at our own dedicated manufacturing facilities or by third parties, we must ensure that all manufacturing processes comply with current Good Manufacturing Practices (cGMP) and other applicable regulations. Any significant failure by us or our third party suppliers to comply with these requirements or health authorities&#x2019; expectations may cause us to shut down production facilities or production lines, either voluntarily or by order of a government health authority.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">96</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Beyond regulatory requirements, many of our products involve technically sophisticated manufacturing processes or require specialized raw materials. For example, we manufacture and sell a number of sterile products, biologic products and products involving advanced therapy platforms, such as CAR-T therapies, gene therapies and radioligand therapies, all of which are particularly complex and involve highly specialized manufacturing technologies. As a result, even slight deviations at any point in their production processes may lead to production failures or recalls. Sales of <i>Kymriah, </i>the first approved CAR-T therapy, are currently constrained by production capacity. We continue to optimize our manufacturing process and have expanded our manufacturing capacity significantly in 2019. Our facilities in Stein, Switzerland and Les Ullis, France, have started manufacturing for clinical study patients. Our ultimate goal is to make <i>Kymriah</i> available for every patient in need.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Given the complexity of our manufacturing processes, we have worked for several years to adopt a single high quality standard across the company. We believe these efforts are having an impact. Of 177 inspections of our facilities by health authorities around the world in 2019, all but seven were found to be good or acceptable (96%). </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets and goodwill</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We carry a significant amount of goodwill and other intangible assets on our consolidated balance sheet, primarily due to acquisitions, including the acquisition of <i>Xiidra</i>, Endocyte, AveXis, AAA, and certain oncology assets acquired from GSK. As a result, we may incur significant impairment charges if the fair value of intangible assets and groupings of cash-generating units containing goodwill are less than their carrying value on the Group&#x2019;s consolidated balance sheet at any point in time.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We regularly review our long-lived intangible and tangible assets for impairment. Impairment testing under IFRS may lead to impairment charges in the future. Any significant impairment charges could have a material adverse effect on our results of operations and financial condition. In 2019, for example, we recorded intangible asset impairment charges of USD&nbsp;1.1 billion.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Tax</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our multinational operations are taxed under the laws of the countries and other jurisdictions in which we operate. However, the integrated nature of our worldwide operations can produce conflicting claims from revenue authorities in different countries as to the profits to be taxed in the individual countries, including potential disputes relating to the prices our subsidiaries charge one another for intercompany transactions, known as transfer pricing. The majority of the jurisdictions in which we operate have double tax treaties with other foreign jurisdictions, which provide a framework for mitigating the impact of double taxation on our revenues and capital gains. However, mechanisms developed to resolve such conflicting claims are largely untried, and can be expected to be very lengthy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In recent years, tax authorities around the world, including in the EU, Switzerland and the US, have increased their scrutiny of company tax filings, and have become more rigid in exercising any discretion they may have, and numerous changes in tax laws and rules have been enacted or proposed. The outcome of these efforts remains subject to change and could end up in a materially different form from what is currently proposed, or could be administered or implemented in a manner different from our expectations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In Switzerland, the Basel-Stadt Cantonal Tax Reform was approved by voters in February 2019, with parts retroactive from January 1, 2019. In May 2019, Swiss voters approved the Swiss Federal Tax Reform. With the enactment of this tax reform, new elements will be introduced into law, for example the abolishment of special taxed regimes, notional interest deduction, and an implementation of a Patent-Box, which provides tax advantages on income generated from intellectual property rights. Some of the new elements as well as the transition rules for the Swiss tax reform might be regarded as not completely aligned with OECD and EU regulations, and might require subsequent amendments, the need for and impact of which are difficult to predict.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a result, such tax reform efforts, including with respect to tax base or rate, transfer pricing, intercompany dividends, cross border transactions, controlled corporations, and limitations on tax relief allowed on the interest on intercompany debt, will require us to continually assess our organizational structure against tax policy trends, could lead to an increased risk of international tax disputes and an increase in our effective tax rate, and could adversely affect our financial results.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Approach to risk management</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See &#x201C;Item 6. Directors, Senior Management and Employees&mdash;Item 6.C Board practices&mdash;Corporate governance&mdash;Board of Directors&mdash;Information and control systems of the Board vis-&#xE0;-vis management&mdash;Risk management&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 29. Financial instruments&mdash;additional disclosures.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">97</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Non-IFRS measures as defined by Novartis</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis uses certain non-IFRS metrics when measuring performance, especially when measuring current-year results against prior periods, including core results, constant currencies, free cash flow and net debt.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Despite the use of these measures by management in setting goals and measuring the Group&#x2019;s performance, these are non-IFRS measures that have no standardized meaning prescribed by IFRS. As a result, such measures have limits in their usefulness to investors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because of their non-standardized definitions, the non-IFRS measures (unlike IFRS measures) may not be comparable to the calculation of similar measures of other companies. These non-IFRS measures are presented solely to permit investors to more fully understand how the Group&#x2019;s management assesses underlying performance. These non-IFRS measures are not, and should not be viewed as, a substitute for IFRS measures.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As an internal measure of Group performance, these non-IFRS measures have limitations, and the Group&#x2019;s performance management process is not solely restricted to these metrics.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Core results</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s core results &ndash; including core operating income, core net income and core earnings per share &ndash; exclude fully the amortization and impairment charges of intangible assets, excluding software, net gains and losses on fund investments and equity securities valued at fair value through profit and loss, and certain acquisition- and divestment-related items. The following items that exceed a threshold of USD&nbsp;25 million are also excluded: integration- and divestment-related income and expenses; divestment gains and losses; restructuring charges/releases and related items; legal-related items; impairments of property, plant and equipment, and financial assets, and income and expense items that management deems exceptional and that are or are expected to accumulate within the year to be over a USD&nbsp;25 million threshold. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis believes that investor understanding of the Group&#x2019;s performance is enhanced by disclosing core measures of performance because, core measures exclude items that can vary significantly from year to year, they enable better comparison of business performance across years. For this same reason, Novartis uses these core measures in addition to IFRS and other measures as important factors in assessing the Group&#x2019;s performance.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The following are examples of how these core measures are utilized:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In addition to monthly reports containing financial information prepared under International Financial Reporting Standards (IFRS), senior management receives a monthly analysis incorporating these core measures.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Annual budgets are prepared for both IFRS and core measures. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Despite the use of these measures by management in setting goals and measuring the Group&#x2019;s performance, these are non-IFRS measures that have no standardized meaning prescribed by IFRS. As a result, such measures have limits in their usefulness to investors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because of their non-standardized definitions, the core measures (unlike IFRS measures) may not be comparable to the calculation of similar measures of other companies. These core measures are presented solely to permit investors to more fully understand how the Group&#x2019;s management assesses underlying performance. These core measures are not, and should not be viewed as, a substitute for IFRS measures.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As an internal measure of Group performance, these core measures have limitations, and the Group&#x2019;s performance management process is not solely restricted to these metrics. A limitation of the core measures is that they provide a view of the Group&#x2019;s operations without including all events during a period, such as the effects of an acquisition, divestment, or amortization/impairments of purchased intangible assets and restructurings.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Constant currencies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Changes in the relative values of non-US currencies to the US dollar can affect the Group&#x2019;s financial results and financial position. To provide additional information that may be useful to investors, including changes in sales volume, we present information about our net sales and various values relating to operating and net income that are adjusted for such foreign currency effects.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Constant currency calculations have the goal of eliminating two exchange rate effects so that an estimate can be made of underlying changes in the consolidated income statement excluding the impact of fluctuations in exchanges rates:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The impact of translating the income statements of consolidated entities from their non-USD functional currencies to USD</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The impact of exchange rate movements on the major transactions of consolidated entities performed in currencies other than their functional currency</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We calculate constant currency measures by translating the current year&#x2019;s foreign currency values for sales and other income statement items into USD, using the average exchange rates from the prior year and comparing them to the prior-year values in USD.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We use these constant currency measures in evaluating the Group&#x2019;s performance, since they may assist us in evaluating our ongoing performance from year to year. However, in performing our evaluation, we also consider equivalent measures of performance that are not affected by changes in the relative value of currencies.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Growth rate calculation</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For ease of understanding, Novartis uses a sign convention for its growth rates such that a reduction in operating expenses or losses compared to the prior year is shown as a positive growth.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">98</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Free cash flow</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Free cash flow is not intended to be a substitute measure for net cash flows from operating activities as determined under IFRS. Free cash flow is presented as additional information because management believes it is a useful supplemental indicator of the Group&#x2019;s ability to operate without reliance on additional borrowing or use of existing cash. Free cash flow is a measure of the net cash generated that is available for investment in strategic opportunities, returning to shareholders and for debt repayment. Free cash flow is a non-IFRS measure, which means it should not be interpreted as a measure determined under IFRS. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis defines free cash flow as net cash flows from operating activities and cash flows associated with the purchase or sale of property, plant and equipment, as well as intangible, other non-current and financial assets, excluding marketable securities. Cash flows in connection with the acquisition or divestment of subsidiaries, associated companies and non-controlling interests in subsidiaries are not taken into account to determine free cash flow.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net debt</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Net debt is a non-IFRS measure, which means it should not be interpreted as a measure determined under IFRS. Net debt is presented as additional information because management believes it is a useful supplemental indicator of the Group&#x2019;s ability to pay dividends, to meet financial commitments, and to invest in new strategic opportunities, including strengthening its balance sheet. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis calculates net debt as current financial debts and derivative financial instruments plus non-current financial debt less cash and cash equivalents and marketable securities, commodities, time deposits and derivative financial instruments.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis Cash Value Added</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis Cash Value Added (NCVA) is a metric that is based on what the Company assesses to be its cash flow return less a capital charge on gross operating assets. NCVA is used as the primary internal financial measure for determining payouts under the old Long-Term Performance Plan (LTPP) introduced in 2014. The LTTP performance measures were changed effective January 1, 2019, and from the 2019 cycle onward no longer include NCVA as a performance measure. More information on NCVA is presented as part of the Compensation Report; see &#x201C;Item 6. Directors, Senior Management and Employees&mdash;Item 6.B Compensation.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Additional information</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">EBITDA</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis defines earnings before interest, tax, depreciation and amortization (EBITDA) as operating income, excluding depreciation of property, plant and equipment (including any related impairment charges), depreciation of right-of-use assets and amortization of intangible assets (including any related impairment charges). With the adoption of IFRS 16 Leases on January 1, 2019, lease expenses are classified as depreciation on right-of-use assets. For comparative information on prior periods see footnote 1 to the table.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from  continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   9&nbsp;086</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   8&nbsp;403</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   8&nbsp;702</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property,  plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;345</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;303</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of the   right-of-use-assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible  assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;587</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;624</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairments of property,  plant and equipment, and  intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1&nbsp;340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     809</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">EBITDA from continuing  operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   14&nbsp;912</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   13&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   13&nbsp;438</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from  discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;73</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property,  plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   235</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   217</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of the   right-of-use-assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible  assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   174</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;052</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;066</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairments of property,  plant and equipment, and  intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     394</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     57</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">EBITDA from discontinued  operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   296</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;447</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;267</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">EBITDA Total Group<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15&nbsp;208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;061</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;705</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> In 2019, EBITDA is positively impacted through the adoption of IFRS 16 Leases on January 1, 2019, as lease expenses are classified as depreciation on right-of-use assets (USD 314 million, thereof USD 305 million continuing operations) and interest expense (USD 66 million). In the prior years, the lease expense was recognized as a functional expense within operating income (lease expense for total group was in 2018 USD 383 million, thereof USD 331 million from continuing operations and in 2017 USD 337 million thereof USD 292 million from continuing operations).</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Enterprise value</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Enterprise value represents the total amount that shareholders and debt holders have invested in Novartis, less the Group&#x2019;s liquidity.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions <br>unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Dec 31, 2019<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Dec 31, 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Market capitalization</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 214&nbsp;815</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 196&nbsp;950</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 195&nbsp;541</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current financial debts and  derivatives financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   7&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   9&nbsp;678</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;308</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities,  commodities, time deposits  and derivative financial  instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       &ndash;&nbsp;334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       &ndash;&nbsp;2&nbsp;693</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       &ndash;&nbsp;625</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;271</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;860</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Enterprise value</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 230&nbsp;830</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 213&nbsp;212</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 214&nbsp;647</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Decrmber 31, 2019 excludes the business of Alcon, which was spun off in April 2019 into a separately traded standalone company. For details see "Item 18. Financial Statements&#x2014;Note 2. Significant transactions".</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">99</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 and 2018 reconciliation from IFRS results to core results</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Innovative Medicines</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Sandoz</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Corporate</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Group</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">IFRS operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;287</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 551</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;752</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;800</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Amortization of intangible assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;447</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;158</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 314</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 363</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;761</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;521</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 503</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 841</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment related to the Group-wide  rationalization of manufacturing sites</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   83</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   233</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total impairment charges</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 725</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 827</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 605</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 312</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;330</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;139</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquisition or divestment of businesses and related items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 155</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total acquisition or divestment of  businesses and related items, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   134</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Divestment gains</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;091</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;089</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;616</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets - fair value adjustments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Restructuring and related items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;58</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;39</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 509</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 390</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 106</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;012</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 950</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Legal-related items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 999</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;155</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additional income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;316</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;171</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;415</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;263</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additional expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 156</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 50</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 327</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 260</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 624</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 849</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total adjustments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;363</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;280</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;543</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 670</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;026</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;154</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;650</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;094</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;596</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">as % of net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 33.5%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 32.0%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 21.5%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 20.3%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 29.7%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 28.1%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 656</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core adjustments to income from associated companies, net of tax</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 427</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 427</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5&nbsp;325</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;932</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core adjustments to other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes, adjusted for above items (core taxes)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;300</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;004</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;920</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core net income from discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;018</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;382</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;938</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income attributable to shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;377</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;935</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core basic EPS from continuing operations (USD)<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core basic EPS from discontinued operations (USD)<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.44</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core basic EPS (USD)<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For details on discontinued operations reconciliation from IFRS to core net income, please refer to page 109.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">100</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2018 and 2017 reconciliation from IFRS results to core results</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Innovative Medicines</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Sandoz</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Corporate</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Group</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">IFRS operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;595</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;368</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;800</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;261</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Amortization of intangible assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;158</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;119</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 363</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 454</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;521</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;573</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 591</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 652</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment  related to the Group-wide  rationalization of manufacturing sites</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     67</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 197</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total impairment charges</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 827</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 312</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;006</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquisition or divestment of  businesses and related items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;117</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 155</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total acquisition or divestment of  businesses and related items, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   45</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Divestment gains</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;368</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;616</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;368</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets - fair value adjustments<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Restructuring and related items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;61</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 268</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 106</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 950</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 393</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Legal-related items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additional income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;534</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;171</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;372</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;909</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additional expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 156</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 50</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 260</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 319</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;612</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total adjustments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;280</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 670</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 712</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;154</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;012</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;080</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;596</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;385</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;714</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">as % of net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 32.0%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 31.0%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 20.3%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 20.7%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 28.1%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 27.7%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core adjustments to income from  associated companies, net of tax</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &#x2013;&#x2005;5&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   226</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &#x2013;&#x2005;5&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   227</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;750</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes, adjusted for above items (core taxes)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;004</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;867</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;920</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;474</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core net income from discontinued operations<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 917</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;938</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;391</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core net income attributable to shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;935</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;391</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core basic EPS from continuing operations (USD)<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core basic EPS from discontinued operations (USD)<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Core basic EPS (USD)<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.86</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For financial instruments accounted for as fair value through profit and loss, as of January 1, 2018, unrealized gains/losses on financial assets are shown under "Financial assets - fair value adjustments," due to the change in IFRS 9.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> For details on discontinued operations reconciliation from IFRS to core net income, please refer to page 110.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">101</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019, 2018 and 2017 reconciliation from IFRS results to core results &ndash; Group</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2019 (USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;252</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;711</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 85</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 48</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 296</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;392</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;761</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;330</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 849</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;112</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;330</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 860</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;404</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes from continuing operations<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;300</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;104</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income from discontinued operations<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;382</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS from continuing operations (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic EPS from discontined operations (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">            </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;113</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;14&nbsp;425</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;711</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 362</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;11&nbsp;219</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">            </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;14&nbsp;369</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;14&nbsp;319</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;9&nbsp;402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;078</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;8&nbsp;386</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;418</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 495</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;3&nbsp;426</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;053</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;070</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">            </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core income before taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 427</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;086</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 56</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the amortization of acquired rights for technologies; income from associated companies includes USD 427 million for the Novartis share of the estimated Roche core items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold, and research and development include impairment charges related to intangible assets; research and development also includes the reversal of an impairment charge; cost of goods sold, other income and other expense include net impairment charges related to property, plant and equipment</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: cost of goods sold, selling, general and administration, research and development, other income and other expense include net charges related to acquisitions; other income and other expense also include transitional service fee income and expenses related to the portfolio transformation and the Alcon spin-off</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Other items: other revenues includes income from an outlicensing agreement, and income related to an amendment of a collaboration agreement; cost of goods sold, other income and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites; cost of goods sold, research and development, selling, general and administration, other income and other expense include other restructuring income and charges and related items; cost of goods sold, and research and development also include fair value adjustments of contingent consideration liabilties; cost of goods sold also includes inventory write-offs and other provisions; selling, general and administration includes receivable expected credit loss provisions and other provisions; other income and other expense include fair value adjustments and divestment gains and losses on financial assets and legal-related items as well as environmental provisions; other income also includes net gains from the divestment of products and property, plant and equipment, and provision releases; other expense includes a provision for onerous contracts and other provisions; other financial income and expense includes a revaluation impact of a financial liability incurred through the Alcon distribution</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Taxes on the adjustments between IFRS and core results take into account, for each individual item included in the adjustment, the tax rate that will finally be applicable to the item based on the jurisdiction where the adjustment will finally have a tax impact. Generally, this results in amortization and impairment of intangible assets and acquisition-related restructuring and integration items having a full tax impact. There is usually a tax impact on other items, although this is not always the case for items arising from legal settlements in certain jurisdictions. Adjustments related to income from associated companies are recorded net of any related tax effect. Due to these factors and the differing effective tax rates in the various jurisdictions, the tax on the total adjustments for continuing operations of USD 5.5 billion to arrive at the core results before tax amounts to USD 507 million. The average tax rate on the adjustments is 9.3%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> For details on discontinued operations reconciliation from IFRS to core net income please refer to page 109.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;7&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income, attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">102</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2018 (USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;342</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 488</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 462</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;886</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;521</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;557</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;965</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;5&nbsp;656</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 381</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;924</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes from continuing operations<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;004</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;920</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income from discontinued operations<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;018</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;938</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS from continuing operations (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic EPS from discontined operations (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.44</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;14&nbsp;510</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;342</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 462</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;11&nbsp;213</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;13&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;13&nbsp;690</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;8&nbsp;489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;8&nbsp;154</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;050</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 558</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 484</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;043</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core income before taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 444</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5&nbsp;790</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;113</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products, and other production-related intangible assets; research and development includes the amortization of acquired rights, including technology platforms; income from associated companies includes USD 444 million for the Novartis share of the estimated Roche core items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold, and research and development include impairment charges related to intangible assets; research and development also includes impairment reversals of property, plant and equipment; other expense includes impairment charges related to property, plant and equipment; cost of goods sold and other expense include impairment charges related to a disposal group held for sale for goodwill and currently marketed products</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: cost of goods sold, selling, general and administration, research and development and other expense include charges related to acquisitions; other income and other expense include transitional service fee income and expenses, and other items related to the portfolio transformation; income from associated companies includes the pre-tax gain of USD 5.8 billion on the sale of the 36.5% investment in GSK Consumer Healthcare Holdings Ltd.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Other items: cost of goods sold, other income and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites; cost of goods sold, selling, general and administration, research and development, other income and other expense include other restructuring income and charges and related items; cost of goods sold and other expense include charges related to changes in a contractual agreement; cost of goods sold also includes inventory write-off and other product recall-related costs; selling, general and administration includes a reversal of a provision; research and development includes fair value adjustments of contingent consideration liabilities and a charge for onerous contracts; other income and other expense include fair value adjustments and divestment gains and losses on financial assets; other income also includes product divestment gains, divestment gains on property, plant and equipment, releases of accruals and a legal settlement gain; other expense includes legal-related items and restructuring charges; income from associated companies includes an adjustment of USD 21 million for the Novartis share of the estimated GSK Consumer Healthcare Holdings Ltd. core items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Taxes on the adjustments between IFRS and core results take into account, for each individual item included in the adjustment, the tax rate that will finally be applicable to the item based on the jurisdiction where the adjustment will finally have a tax impact. Generally, this results in amortization and impairment of intangible assets and acquisition-related restructuring and integration items having a full tax impact. There is usually a tax impact on other items, although this is not always the case for items arising from legal settlements in certain jurisdictions. Adjustments related to income from associated companies are recorded net of any related tax effect. Due to these factors and the differing effective tax rates in the various jurisdictions, the tax on the total adjustments of USD 1.2 billion to arrive at the core results before tax amounts to USD 709 million. Excluding the gain on the sale of the 36.5% investment in GSK Cosumer Healthcare Holdings Ltd., the tax on the total adjustments of USD 4.6 billion to arrive at the core results before tax amounts to USD 770 billion. The average tax rate on the adjustments excluding this transaction is 16.7%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> For details on discontinued operations reconciliation from IFRS to core net income please refer to page 110.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;7&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income, attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">103</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2017 (USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization <br> of intangible <br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and <br> related items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;771</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;386</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 92</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 125</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;374</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;573</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;006</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;714</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;007</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;762</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;341</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;603</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;867</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;474</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income from discontinued operations<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 917</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;391</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS from continuing operations (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic EPS from discontined operations (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS (USD)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4.86</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;13&nbsp;633</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;386</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 125</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;11&nbsp;030</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;12&nbsp;465</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;12&nbsp;468</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;8&nbsp;389</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 187</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 594</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;200</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7&nbsp;808</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;922</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;117</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;048</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 748</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;137</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 514</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;132</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core income before taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 376</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;335</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the recurring amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the recurring amortization of acquired rights for technology platforms; income from associated companies includes USD 376 million for the Novartis share of the estimated Roche core items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold, and research and development include impairment charges related to intangible assets; research and development, other income and other expense include reversals and charges related to the impairment of property, plant and equipment; other expense also includes impairment charges related to financial assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: other income and other expense include transitional service fee income and expenses, and other items related to the portfolio transformation</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Other items: cost of goods sold, other income and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites; cost of goods sold, research and development, selling, general and administration, other income and other expense include other restructuring income and charges and related items; selling, general and administration includes an income from the release of a provision; research and development includes fair value adjustments to contingent consideration liabilities; other income and other expense include legal-related items; other income also includes a gain from a Swiss pension plan amendment, product and financial asset divestment gains, income from a settlement of a contract dispute and a fair value adjustment to contingent consideration sales milestone receivables; other expense also includes a provision for contract termination costs, a charge for onerous contracts, and an amendment to the Swiss pension plan; income from associated companies includes an adjustment of USD 150 million for the Novartis share of the estimated GSK Consumer Healthcare Holdings Ltd. core items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Taxes on the adjustments between IFRS and core results take into account, for each individual item included in the adjustment, the tax rate that will finally be applicable to the item based on the jurisdiction where the adjustment will finally have a tax impact. Generally, this results in amortization and impairment of intangible assets and acquisition-related restructuring and integration items having a full tax impact. There is usually a tax impact on other items, although this is not always the case for items arising from legal settlements in certain jurisdictions. Adjustments related to income from associated companies are recorded net of any related tax effect. Due to these factors and the differing effective tax rates in the various jurisdictions, the tax on the total adjustments of USD 3.2 billion to arrive at the core results before tax amounts to USD 264 million. The average tax rate on the adjustments is 8.2%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> For details on discontinued operations reconciliation from IFRS to core net income please refer to page 110.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;7&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income, attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">104</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019, 201</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">8 and 2017 reconciliation from IFRS results to core results &ndash; Innovative Medicines</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2019<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29&nbsp;539</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;397</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 48</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 116</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 32&nbsp;100</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;287</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;447</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 725</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;650</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;092</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;026</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;10&nbsp;050</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;397</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 182</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;7&nbsp;423</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;11&nbsp;617</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;11&nbsp;582</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;8&nbsp;152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;125</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;7&nbsp;585</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;586</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 347</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;069</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;326</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;630</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the amortization of acquired rights for technologies</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: research and development includes impairment charges and a reversal of impairment charges related to intangible assets; other income and other expense include net impairment charges related to property, plant and equipment</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: cost of goods sold, selling, general and administration, research and development, other income and other expense include net charges related to acquisitions; other income and other expense also include transitional service-fee income and expenses related to the portfolio transformation and the Alcon spin-off</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Other items: other revenues includes a net income from an outlicensing agreement and an income related to an amendment of a collaboration agreement; cost of goods sold, other income and other expense include restructuring and other charges related to the Group-wide rationalization of manufacturing sites; cost of goods sold, research and development, other income and other expense include other restructuring income and charges and related items; cost of goods sold, and research and development also include fair value adjustments of contingent consideration liabilities; selling, general and administration includes other provisions; other income and other expense include fair value adjustments and divestment gains and losses on financial assets; other income also includes net gains from the divestment of products and property, plant and equipment, and provision releases; other expense includes legal-related items</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2018 <br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;979</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 423</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 329</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;687</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;158</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 827</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;151</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;9&nbsp;870</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;979</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 423</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7&nbsp;134</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;10&nbsp;907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;10&nbsp;890</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7&nbsp;340</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;671</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 306</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;475</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 237</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;612</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the amortization of acquired rights, including technology platforms</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold, and research and development include impairment charges related to intangible assets; research and development also includes impairment reversals of property, plant and equipment; other expense includes impairment charges related to property, plant and equipment</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: cost of goods sold, selling, general and administration, research and development and other expense include charges related to acquisitions; other expense also includes items related to the portfolio transformation</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Other items: cost of goods sold and other expense include restructuring and other charges related to the Group-wide rationalization of manufacturing sites, and charges related to changes in a contractual agreement; cost of goods sold, research and development, other income and other expense include other restructuring income and charges and related items; cost of goods sold, and research and development also include fair value adjustments of contingent consideration liabilities; cost of goods sold also includes an inventory write-off; selling, general and administration includes a reversal of a provision; research and development includes a charge for onerous contracts; other income and other expense include fair value adjustments on financial assets and legal-related items; other income also includes product divestment gains and releases of accruals</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">105</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2017<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> IFRS<br> results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and <br> related items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;194</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;932</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 56</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 27&nbsp;213</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;595</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;119</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;019</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;8&nbsp;650</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;6&nbsp;631</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">            </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;9&nbsp;887</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;9&nbsp;890</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7&nbsp;615</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 187</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 594</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;200</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;7&nbsp;034</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;027</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 351</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 412</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;621</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the recurring amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the recurring amortization of acquired rights for technology platforms</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold, and research and development include impairment charges related to intangible assets; research and development, other income and other expense include reversals and charges related to the impairment of property, plant and equipment</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: other income includes transitional service fee income; other expense includes items related to the portfolio transformation and costs related to an acquisition</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Other items: cost of goods sold, other income and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites; costs of goods sold, research and development, selling, general and administration, other income and other expense include other restructuring income and charges and related items; selling, general and administration includes an income from the release of a provision; research and development includes fair value adjustments to contingent consideration liabilities; other income and other expense include legal-related items; other income also includes a gain from a Swiss pension plan amendment, income from a settlement of a contract dispute, as well as product and financial asset divestment gains; other expense also includes a provision for contract termination costs, an amendment to the Swiss pension plan, a charge for onerous contracts, and other charges</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019, 2018 and 2017 reconciliation from IFRS to core results &ndash; Sandoz</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2019<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization <br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;601</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 314</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 85</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 180</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;180</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 314</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 605</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 624</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;094</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;5&nbsp;334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 314</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 180</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;4&nbsp;755</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;203</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;801</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 127</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;749</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 465</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;209</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold, and research and development include impairment charges related to intangible assets; cost of goods sold, other income and other expense include net impairment charges related to property, plant and equipment</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: cost of goods sold and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites; cost of goods sold, selling, general and administration, other income and other expense include restructuring income and charges and related items; cost of goods sold also includes inventory write-offs and other provisions; selling, general and administration includes receivable expected credit loss provisions and other provisions; other income and other expense also include legal-related items; other expense also includes an environmental provision, a provision for onerous contracts and other provisions</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">106</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2018 <br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization <br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 363</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 65</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 133</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;129</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 363</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 312</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5&nbsp;530</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 363</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 133</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;4&nbsp;969</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;295</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 210</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;622</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 247</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;228</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold includes impairment charges related to intangible assets, and impairment charges for currently marketed products related to a disposal group held for sale; other expense includes impairment charges related to property, plant and equipment, and goodwill impairment charges related to a disposal group held for sale</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: cost of goods sold, other income and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites; cost of goods sold also includes inventory write-off and other product recall-related costs; cost of goods sold, selling, general and administration, other income and other expense include other restructuring income and charges and related items; other income also includes product divestment gains, a legal settlement gain, and  fair value adjustments of contingent consideration liabilities; other expense includes legal-related items and restructuring charges</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2017<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and <br> related items</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;415</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 454</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 61</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 69</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;999</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;368</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 454</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;080</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 454</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5&nbsp;216</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">            </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;351</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;213</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the recurring amortization of acquired rights to in-market products and other production-related intangible assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold includes impairment charges related to intangible assets; other expense includes impairment charges related to property, plant and equipment</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: cost of goods sold, other income and other expense include net restructuring and other charges related to the Group-wide rationalization of manufacturing sites, and other restructuring income and charges and related items; other income also includes a gain from a Swiss pension plan amendment</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019, 2018 and 2017 r</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">econciliation from IFRS results to core results &ndash; Corporate</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2019<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization <br> of intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;632</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;149</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;608</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 262</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;231</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: other income and other expense include transitional service fee income and expenses related to the portfolio transformation and the Alcon spin-off</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Other items: other income and other expense include fair value adjustments and divestment gains and losses on financial assets, restructuring income and charges and related items, as well as environmental provisions</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">107</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2018 <br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization <br> of intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;596</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;84</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;512</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 280</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;203</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: other income and other expense include transitional service fee income and expenses, and other items related to the portfolio transformation</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Other items: other income and other expense include fair value adjustments and divestment gains and losses on financial assets, as well as restructuring income and charges and related items; other income also includes divestment gains on property, plant and equipment</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2017<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and <br> related items<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;261</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;385</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 203</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;662</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;298</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Impairments: other expense includes impairment charges related to financial assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Acquisition or divestment of businesses and related items, including restructuring and integration charges: other income and other expense include transitional service fee income and expenses, and other items related to the portfolio transformation</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: other income includes a fair value adjustment to contingent consideration sales milestone receivables, a Swiss pension plan amendment and other items; other income and other expense include restructuring income and charges and related items; other expense also includes an amendment to the Swiss pension plan</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">108</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019, 2018 and 2017 reconciliation of IFRS results to core results &ndash; discontinued operations</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2019<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 949</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 165</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;123</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 350</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 58</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 337</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;59</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net loss/income from discontinued operations before gain on distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     &#x2013;&#x2005;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     278</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &#x2013;&#x2005;4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 278</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS (USD)<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0.12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;860</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;686</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;638</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;624</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;136</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the amortization of acquired rights for technologies</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Acquisition or divestment of businesses and related items represents the non-taxable, non-cash gain adjustment related to the distribution of Alcon Inc. (spin-off) to Novartis AG shareholders</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: cost of goods sold, selling, general and administration, research and development and other expense include other restructuring charges and related items; research and development also includes amortization of option rights and the fair value adjustment of a contingent consideration liability; other income includes fair value adjustments on a financial asset; other expense also includes legal-related items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Taxes on the adjustments between IFRS and core results take into account, for each individual item included in the adjustment, the tax rate that will finally be applicable to the item based on the jurisdiction where the adjustment will finally have a tax impact. Generally, this results in amortization and impairment of intangible assets and acquisition-related restructuring and integration items having a full tax impact. There is usually a tax impact on other items, although this is not always the case for items arising from legal settlements in certain jurisdictions. Due to these factors and the differing effective tax rates in the various jurisdictions, the tax on the total adjustments, excluding the non-taxable, non-cash gain on the distribution (spin-off) of Alcon Inc. to Novartis AG shareholders of USD 279 million to arrive at the core results before tax amounts to USD 100 million. The 2019 core tax rate, excluding the effect of the gain on the distribution of Alcon Inc. to Novartis AG shareholders, is 17.5%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">109</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2018 <br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> IFRS results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and<br> related items</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;170</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 996</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 389</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;23</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;532</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating loss/income of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;007</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 391</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Loss/income before taxes of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;260</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;240</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Taxes<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;222</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net loss/income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;018</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS (USD)<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0.44</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3&nbsp;983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 996</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 389</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;621</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;754</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;739</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;585</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;527</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;38</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the amortization of acquired rights for technology platforms</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: cost of goods sold and selling, general and administration include impairment charges related to intangible assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: cost of goods sold, selling, general and administration and research and development include charges and reversal of charges related to a product's voluntary market withdrawal; cost of goods sold, selling, general and administration, research and development, other income and other expense also include other restructuring income and charges and related items; research and development also includes amortization of option rights and the fair value adjustment of a contingent consideration liability; other income includes fair value adjustments on a financial asset; other expense includes legal-related items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Taxes on the adjustments between IFRS and core results take into account, for each individual item included in the adjustment, the tax rate that will finally be applicable to the item based on the jurisdiction where the adjustment will finally have a tax impact. Generally, this results in amortization and impairment of intangible assets and acquisition-related restructuring and integration items having a full tax impact. There is usually a tax impact on other items, although this is not always the case for items arising from legal settlements in certain jurisdictions. Due to these factors and the differing effective tax rates in the various jurisdictions, the tax on the total adjustments of USD 1.5 billion to arrive at the core results before tax amounts to USD 296 million. The 2018 core tax rate is 17.9%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>2017<br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> IFRS<br> results</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Amortization<br> of intangible<br> assets<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Impairments<sup style="white-space: nowrap">    2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Acquisition or <br> divestment of <br> businesses and <br> related items</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Other <br> items<sup style="white-space: nowrap">    3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Core results</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;189</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;015</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;204</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating loss/income of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;025</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;136</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Loss/income before taxes of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;106</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Taxes<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 307</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;189</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 917</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic EPS (USD)<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0.40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">      </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core gross profit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3&nbsp;588</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;015</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;573</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">            </div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">The following are adjustments to arrive at core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;583</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;505</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 30</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 133</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;61</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Amortization of intangible assets: cost of goods sold includes the recurring amortization of acquired rights to in-market products and other production-related intangible assets; research and development includes the recurring amortization of acquired rights for technology platforms</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Impairments: research and development includes impairment charges related to intangible and financial assets</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Other items: research and development includes fair value adjustments to contingent consideration liabilities; other income and other expense include restructuring income and charges and related items; other income also includes a gain from a Swiss pension plan amendment and the partial reversal of a prior-period charge; other expense also includes legal-related items</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Taxes on the adjustments between IFRS and core results take into account, for each individual item included in the adjustment, the tax rate that will finally be applicable to the item based on the jurisdiction where the adjustment will finally have a tax impact. Generally, this results in amortization and impairment of intangible assets and acquisition-related restructuring and integration items having a full tax impact. There is usually a tax impact on other items, although this is not always the case for items arising from legal settlements in certain jurisdictions. Due to these factors and the differing effective tax rates in the various jurisdictions, the tax on the total adjustments of USD 1.2 billion to arrive at the core results before tax amounts to USD 496 million. The 2017 core tax rate is 17.1%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Earnings per share (EPS) is calculated on the amount of net income attributable to shareholders of Novartis AG.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">110</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId0010057121"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">5.B Liquidity and capital resources</p>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables summarize the Group&#x2019;s cash flows and net debt.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows from operating activities of continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;547</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;049</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;419</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows from operating activities of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;223</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;202</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows used in investing activities of continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;067</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;344</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows used in investing activities from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;775</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows used in financing activities  of continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16&nbsp;884</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;077</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;318</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows from/used in financing activities  of discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;257</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;415</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of exchange rate changes on cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net change in cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;411</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;853</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in marketable securities, commodities, time deposits and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;068</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;145</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current and non-current financial debts and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;764</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;616</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;730</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Change in net debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;863</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;022</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net debt at January 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16&nbsp;184</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;19&nbsp;047</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16&nbsp;025</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;938</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16&nbsp;184</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;19&nbsp;047</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Cash flow</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Financial year 2019 compared to 2018</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Net cash flows from operating activities from continuing operations amounted to USD&nbsp;13.5 billion, compared to USD&nbsp;13.0 billion in 2018. This increase was driven by higher net income adjusted for non-cash items and other adjustments, including divestment gains. It was partly offset by lower dividends received from associated companies due to the divestment of the GSK consumer healthcare joint venture in the second quarter of 2018, higher taxes paid, provision payments and working capital, which included the receipt of a GSK sales milestone from the divested Vaccines business of USD&nbsp;0.4 billion in the prior year.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows from operating activities from discontinued operations were USD&nbsp;78 million, compared to USD&nbsp;1.2 billion in 2018. This reduction was due to the completion of the Alcon spin-off on April 9, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in investing activities from continuing operations amounted to USD&nbsp;1.1 billion, compared to USD&nbsp;4.6 billion in 2018. The current year mainly includes cash outflows of USD&nbsp;1.4 billion for the purchase of property, plant and equipment; USD&nbsp;0.9 billion for the purchase of intangible assets; USD&nbsp;0.4 billion for the purchase of financial assets and other non-current assets; and USD&nbsp;3.8 billion for the acquisitions and divestments of businesses, net, including the acquisition of IFM Tre, Inc. (USD&nbsp;0.3 billion) and the acquisition of <i>Xiidra</i> from Takeda Pharmaceutical Company Limited (USD&nbsp;3.5 billion). These were partly offset by net proceeds of USD&nbsp;2.3 billion from the sale of marketable securities and commodities; cash inflows of USD&nbsp;0.9 billion from the sale of property, plant and equipment (including the proceeds from the sale and leaseback of real estate); cash inflows of USD&nbsp;1.2 billion from the sale of financial assets (including USD&nbsp;976 million in proceeds from the sale of Alcon Inc. shares); and cash inflows of USD&nbsp;1.0 billion from the sale of intangible assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, net cash flows used in investing activities from continuing operations were mainly related to the cash inflows of USD&nbsp;13.0 billion from the divestment of our 36.5% stake in the GSK consumer healthcare joint venture, and of USD&nbsp;1.1 billion in proceeds from the sale of property, plant and equipment; intangible assets; and financial assets. This was offset by cash outflows of USD&nbsp;13.7 billion for the acquisitions of businesses, mainly Advanced Accelerator Applications S.A. (USD&nbsp;3.5 billion, net), AveXis, Inc. (USD&nbsp;8.3 billion, net) and Endocyte, Inc. (USD&nbsp;1.8 billion, net); USD&nbsp;1.3 billion for the purchase of property, plant and equipment; and USD&nbsp;1.4 billion for the purchase of intangible assets. Net purchases of marketable securities and commodities amounted to USD&nbsp;2.0 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in investing activities from discontinued operations amounted to USD&nbsp;1.2 billion, compared to USD&nbsp;1.0 billion in 2018. The current year mainly includes the cash outflow of USD&nbsp;0.3 billion for the acquisition of PowerVision, Inc., and USD&nbsp;0.6 billion due to the derecognized cash and cash equivalents following the completion of the Alcon spin-off on April 9, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in financing activities from continuing operations amounted to USD&nbsp;16.9 billion, compared to USD&nbsp;4.1 billion in 2018. The current year mainly includes the cash outflows of USD&nbsp;6.6 billion for the dividend payment and of USD&nbsp;5.3 billion for net treasury share transactions (mainly related to the up-to USD&nbsp;5 billion share buyback), and net cash outflows of USD&nbsp;3.1 billion for non-current financial debts (mainly driven by the repayment at maturity of a US dollar bond of USD&nbsp;3.0 billion). The net repayments of current financial debts amounted to USD&nbsp;1.6 billion. Payments for lease liabilities, net, and other financing cash flows resulted in a net cash outflow of USD&nbsp;0.2 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, net cash flows used in financing activities from continuing operations mainly included the cash out-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">111</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">flows of USD&nbsp;7.0 billion for the dividend payment and of USD&nbsp;1.3 billion for net treasury share transactions, partly offset by a net increase of USD&nbsp;4.2 billion in current and non-current financial debts. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash inflows from financing activities from discontinued operations amounted to USD&nbsp;3.3 billion, compared to a cash outflow of USD&nbsp;0.2 billion in 2018. The current-year mainly includes the cash inflows of USD&nbsp;3.5 billion from Alcon borrowings, partly offset by USD&nbsp;0.2 billion in payments for transaction costs.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Financial year 2018 compared to 2017</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Net cash flows from operating activities from continuing operations amounted to USD&nbsp;13.0 billion, compared to USD&nbsp;11.4 billion in 2017. The increase was mainly driven by higher net income adjusted for non-cash items and other adjustments, including divestment gains, as well as favorable hedging results and working capital, which included the receipt of a GSK sales milestone from the divested Vaccines business.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows from operating activities from discontinued operations amounted to USD&nbsp;1.2 billion, which was in line with 2017.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in investing activities from continuing operations amounted to USD&nbsp;4.6 billion, compared to USD&nbsp;2.3 billion in 2017. The 2018 amount includes cash inflows of USD&nbsp;13.0 billion from the divestment of our 36.5% stake in the GSK consumer healthcare joint venture, and of USD&nbsp;1.1 billion in proceeds from the sale of property, plant and equipment; intangible assets; and financial assets. This was offset by cash outflows of USD&nbsp;13.7 billion for the acquisitions of businesses, mainly Advanced Accelerator Applications S.A. (USD&nbsp;3.5 billion, net; USD&nbsp;3.9 billion, net of cash acquired USD&nbsp;0.4 billion), AveXis, Inc. (USD&nbsp;8.3 billion, net; USD&nbsp;8.7 billion, net of cash acquired USD&nbsp;0.4 billion) and Endocyte, Inc. (USD&nbsp;1.8 billion, net; USD&nbsp;2.1 billion, net of cash acquired USD&nbsp;0.3 billion); USD&nbsp;1.3 billion for the purchase of property, plant and equipment; and USD&nbsp;1.4 billion for the purchase of intangible assets. Net purchases of marketable securities and commodities amounted to USD&nbsp;2.0 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2017, net cash flows used in investing activities from continuing operations mainly related to cash outflows of USD&nbsp;1.3 billion for the purchase of property, plant and equipment; USD&nbsp;1.0 billion for the purchase of intangible assets; USD&nbsp;0.4 billion for the purchase of financial assets and other non-current assets; and USD&nbsp;0.7 billion for the acquisitions and divestments of businesses, net, including the acquisitions of Ziarco Group Limited and Encore Vision, Inc. This was partly offset by cash inflows of USD&nbsp;1.1 billion from the sale of property, plant and equipment; intangible assets; and financial assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in investing activities from discontinued operations amounted to USD&nbsp;1.0 billion, compared to USD&nbsp;0.8 billion in 2017. The 2018 amount includes cash outflows of USD&nbsp;0.2 billion for the acquisitions of businesses, net.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in financing activities from continuing operations amounted to USD&nbsp;4.1 billion, compared to USD&nbsp;7.3 billion in 2017. The 2018 amount mainly includes the cash outflows of USD&nbsp;7.0 billion for the dividend payment and of USD&nbsp;1.3 billion for net treasury share transactions, partly offset by a net increase of USD&nbsp;4.2 billion in current and non-current financial debts. This increase was mainly from the issuance of euro bonds totaling USD&nbsp;2.8 billion (notional amount EUR&nbsp;2.25 billion), and the net increase of USD&nbsp;1.7 billion in current financial debts. It was partly offset by repayments of non-current financial debts of USD&nbsp;0.4 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2017, net cash flows used in financing activities from continuing operations included cash outflows of USD&nbsp;6.5 billion for the dividend payment and of USD&nbsp;5.2 billion for net treasury share transactions. The net cash inflows from current and non-current financial debts of USD&nbsp;4.1 billion were mainly from the issuance of bonds denominated in US dollar and euro for a notional amount of USD&nbsp;3.0 billion and EUR&nbsp;1.85 billion (USD&nbsp;2.0 billion), respectively, partly offset by the repayment of current and non-current financial debts of USD&nbsp;0.8 billion. Other financing cash inflows amounted to USD&nbsp;0.3 billion.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net cash flows used in financing activities from discontinued operations amounted to USD&nbsp;0.2 billion, compared to USD&nbsp;0.4 billion in 2017. The 2018 amount includes USD&nbsp;0.1 billion in payments for transaction costs. The 2017 amount included a cash outflow of USD&nbsp;0.1 billion due to a net decrease in current financial debts.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Group liquidity, financial debts and net debt</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis calculates net debt as current financial debts and derivative financial instruments plus non-current financial debt less cash and cash equivalents and marketable securities, commodities, time deposits and derivative financial instruments. Net debt constitutes a non-IFRS financial measure, which means that it should not be interpreted as a measure determined under International Financial Reporting Standards (IFRS). Net debt is presented as additional information, as it is a useful indicator of the Group&#x2019;s ability to meet financial commitments and to invest in new strategic opportunities, including strengthening its balance sheet.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">112</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Group liquidity, financial debts and net debt consists of:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-current financial debts</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;23&nbsp;224</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current financial debts  and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;7&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;9&nbsp;678</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;5&nbsp;308</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;27&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;32&nbsp;148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;28&nbsp;532</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less liquidity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;860</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities,  commodities, time deposits  and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       2&nbsp;693</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       625</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liquidity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;964</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;485</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;938</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16&nbsp;184</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;19&nbsp;047</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Financial year 2019</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Group net debt at December 31, 2019, decreased to USD&nbsp;15.9 billion, compared to USD&nbsp;16.2 billion at December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total financial debt decreased by USD&nbsp;4.8 billion to USD&nbsp;27.4 billion at December 31, 2019, from USD&nbsp;32.1 billion at December 31, 2018. Non-current financial debts decreased by USD&nbsp;2.1 billion to USD&nbsp;20.4 billion at December 31, 2019, from USD&nbsp;22.5 billion at December 2018, mainly driven by foreign exchange translation adjustments and the reclassification of two US dollar bonds totaling USD&nbsp;2.0 billion, which are due in 2020, to current financial debts. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Current financial debts and derivative financial instruments decreased by USD&nbsp;2.6 billion to USD&nbsp;7.0 billion at December 31, 2019, from USD&nbsp;9.7 billion at December 31, 2018, mainly due to the repayment at maturity of a US dollar bond of USD&nbsp;3.0 billion, partially offset by the reclassification of two US dollar bonds totaling USD&nbsp;2.0 billion from non-current financial debts, which are due in 2020. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has two US commercial paper programs under which it can issue up to USD&nbsp;9.0 billion in the aggregate of unsecured commercial paper notes. Novartis also has a Japanese commercial paper program under which it can issue up to JPY 150 billion (approximately USD&nbsp;1.4 billion) of unsecured commercial paper notes. Commercial paper notes totaling USD&nbsp;2.3 billion under these three programs were outstanding as per December 31, 2019 (2018: USD&nbsp;4.0 billion).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis further has a committed credit facility of USD&nbsp;6.0 billion, which was renewed in September 2019. This credit facility is provided by a syndicate of banks and is intended to be used as a backstop for the US commercial paper programs. The renewed facility matures in September 2024 and was undrawn as per December 31, 2019, and December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In December 2019, Novartis entered into a short-term credit facility of USD&nbsp;7.0 billion, with a maturity date of June 30, 2020 with a syndicate of banks. On January 7, 2020, Novartis borrowed USD&nbsp;7.0 billion under the facility with interest based on the USD LIBOR.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of year-end 2019, Moody&#x2019;s Investors Service rated the Company A1 for long-term maturities and P-1 for short-term maturities and S&amp;P Global Ratings rated the company AA- for long-term maturities and A-1+ for short-term maturities.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Financial year 2018</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Group net debt at December 31, 2018, decreased to USD&nbsp;16.2 billion, compared to USD&nbsp;19.0 billion at December 31, 2017.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total financial debt increased by USD&nbsp;3.6 billion to USD&nbsp;32.1 billion at December 31, 2018, from USD&nbsp;28.5 billion at December 31, 2017. Non-current financial debt decreased by USD&nbsp;0.8 billion to USD&nbsp;22.5 billion at December 31, 2018, from USD&nbsp;23.2 billion at December 2017, mainly driven by foreign exchange translation adjustments, as the issuance of euro bonds totaling USD&nbsp;2.8 billion (notional amount EUR&nbsp;2.25 billion) was offset by the reclassification of a US dollar bond of USD&nbsp;3.0 billion, which became due in 2019, to current financial debt. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Current financial debts and derivative financial instruments increased by USD&nbsp;4.4 billion to USD&nbsp;9.7 billion at December 31, 2018, from USD&nbsp;5.3 billion at December 31, 2017, mainly due to higher net short-term borrowings and the reclassification of a US dollar bond of USD&nbsp;3.0 billion from non-current liabilities, which became due in 2019. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has two US commercial paper programs under which it can issue up to USD&nbsp;9.0 billion in the aggregate of unsecured commercial paper notes. Novartis also has a Japanese commercial paper program under which it can issue up to JPY 150 billion (approximately USD&nbsp;1.4 billion) of unsecured commercial paper notes. Commercial paper notes totaling USD&nbsp;4.0 billion under these three programs were outstanding as per December 31, 2018 (2017: USD&nbsp;2.3 billion).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of year-end 2018, Moody&#x2019;s Investors Service rated the Company A1 for long-term maturities and P-1 for short-term maturities and S&amp;P Global Ratings rated the company AA- for long-term maturities and A-1+ for short-term maturities.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">113</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The maturity schedule of our current financial assets, current and non-current financial debts and net debt is as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="11" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="11" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Due within <br> one month</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one year <br> but less than <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Due after <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term investments with original maturity more than 90 days</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   20</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   26</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   16</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   57</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   122</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;712</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;746</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;446</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;9&nbsp;150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;11&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;20&nbsp;505</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;031</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;237</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;073</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;938</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="11" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="11" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Due within <br> one month</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one year <br> but less than <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Due after <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term investments with original maturity more than 90 days</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   39</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   56</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;091</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   198</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   63</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;447</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 142</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;571</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;700</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;650</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;831</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 198</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;964</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;025</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;13&nbsp;623</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;22&nbsp;648</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;327</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9&nbsp;678</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;583</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;713</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;791</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;782</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;323</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16&nbsp;184</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">114</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For a description of risks and restrictions on the ability of subsidiaries to transfer funds to the company via cash dividends, loan or advances please see &#x201C;Item 5.B &ndash; Effects of currency fluctuations&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 29. Financial instruments&mdash;Nature and extent of risks arising from financial instruments.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Information regarding the company&#x2019;s material commitments for capital expenditures as of the end of 2019 and 2018 and an indication of the general purpose of such commitments and the anticipated sources of funds needed to fulfill such commitments are provided in &#x201C;Item 5.F Tabular disclosure of contractual obligations.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides a breakdown of liquidity and financial debt by currency as of December 31:</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Liquidity and financial debt by currency</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Liquidity<br> in % 2019<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Liquidity<br> in % 2018<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Liquidity<br> in % 2017<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Financial<br> debt in %<br> 2019<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Financial<br> debt in %<br> 2018<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Financial<br> debt in %<br> 2017<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">USD</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 72</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 63</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">JPY</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Liquidity includes cash and cash equivalents, marketable securities, commodities and time deposits.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Financial debt includes non-current and current financial debt.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Effects of currency fluctuations</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We transact our business in many currencies other than the US dollar, our reporting currency.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The following provides an overview of net sales and operating expenses for our continuing operations based on IFRS values for 2019, 2018 and 2017, for currencies most important to the Group:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Net sales<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Operating<br> expenses<br> %<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Net sales<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Operating<br> expenses<br> %<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Net sales<br> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Operating<br> expenses<br> %<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chinese yuan (CNY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canadian dollar (CAD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">British pound (GBP)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Brazilian real (BRL)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Russian ruble (RUB)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Australian dollar (AUD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other currencies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Operating expenses include cost of goods sold; selling, general and administration; research and development; other income and other expense.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">115</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We prepare our consolidated financial statements in US dollars. As a result, fluctuations in the exchange rates between the US dollar and other currencies can have a significant effect on both the Group&#x2019;s results of operations as well as the reported value of our assets, liabilities and cash flows. This in turn may significantly affect reported earnings (both positively and negatively) and the comparability of period-to-period results of operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For purposes of our consolidated balance sheets, we translate assets and liabilities denominated in other currencies into US dollars at the prevailing market exchange rates as of the relevant balance sheet date. For purposes of the Group&#x2019;s consolidated income and cash flow statements, revenue, expense and cash flow items in local currencies are translated into US dollars at average exchange rates prevailing during the relevant period. As a result, even if the amounts or values of these items remain unchanged in the respective local currency, changes in exchange rates have an impact on the amounts or values of these items in our consolidated financial statements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because our expenditures in Swiss francs are significantly higher than our revenues in Swiss francs, volatility in the value of the Swiss franc can have a significant impact on the reported value of our earnings, assets and liabilities, and the timing and extent of such volatility can be difficult to predict. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is also a risk that certain countries could devalue their currency. If this occurs, it could impact the effective prices we would be able to charge for our products and also have an adverse impact on both our consolidated income statement and balance sheet. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain countries have legal or economic restrictions on the ability of subsidiaries to transfer funds to the Group in the form of cash dividends, loans or advances, but these restrictions do not have an impact on the ability of the Group to meet its cash obligations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The most significant countries in this respect are Argentina and Venezuela, where the governments have implemented capital controls. The net outstanding intercompany payable balance of Argentina and Venezuela subsidiaries were not material for the Group at December 31, 2019, and at December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Subsidiaries whose functional currencies have experienced a cumulative inflation rate of more than 100% over the past three years apply the rules of IAS 29 &#x201C;Financial Reporting in Hyperinflationary Economies.&#x201D; Gains and losses incurred upon adjusting the carrying amounts of non-monetary assets and liabilities for inflation are recognized in the income statement. The hyperinflationary economies in which Novartis operates are Argentina and Venezuela. Venezuela was hyperinflationary for all years presented, and Argentina became hyperinflationary effective July 1, 2018, requiring retroactive implementation of hyperinflation accounting as of January 1, 2018. The impacts from applying IAS 29 are not significant.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group manages its global currency exposure by engaging in hedging transactions where management deems appropriate, after taking into account the natural hedging afforded by our global business activity. For 2019, we entered into various contracts that change in value with movements in foreign exchange rates to preserve the value of assets, commitments and expected transactions. We use forward contracts and foreign currency options to hedge. For more information on how these transactions affect our consolidated financial statements and on how foreign exchange rate exposure is managed, see &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies,&#x201D; &#x201C;Item 18. Financial Statements&mdash;Note 5. Interest expense and other financial income and expense,&#x201D; &#x201C;Item 18. Financial Statements&mdash;Note 15. Trade receivables,&#x201D; &#x201C;Item 18. Financial Statements&mdash;Note 28. Commitments and contingencies&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 29. Financial instruments &ndash; additional disclosures.&#x201D;</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table sets forth the foreign exchange rates of the US dollar against key currencies used for foreign currency translation when preparing the Group&#x2019;s consolidated financial statements:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Average for year</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Year-end</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">USD per unit</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Australian dollar (AUD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.695</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.748</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.701</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.707</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Brazilian real (BRL)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.275</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.258</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canadian dollar (CAD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.754</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.772</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.735</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.006</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.032</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.014</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chinese yuan (CNY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.144</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.181</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.144</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">British pound (GBP)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.277</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.313</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.274</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY (100))</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.918</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.906</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.920</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Russian ruble (RUB (100))</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.546</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.600</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.613</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.437</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">116</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Average for year</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Year-end</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">USD per unit</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Australian dollar (AUD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.748</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.766</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.707</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.779</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Brazilian real (BRL)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.275</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.313</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.258</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.302</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canadian dollar (CAD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.772</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.771</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.735</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.797</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.016</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.014</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chinese yuan (CNY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.154</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.181</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.144</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.195</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">British pound (GBP)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.288</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.274</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.347</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY (100))</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.906</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.888</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Russian ruble (RUB (100))</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.600</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.715</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.437</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.734</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides a summary of the currency impact on key Group figures due to their conversion into US dollars, the Group&#x2019;s reporting currency, of the financial data from entities reporting in non-US dollars. Constant currency (cc) calculations apply the exchange rates of the prior year to the current-year financial data for entities reporting in non-US dollars.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Currency impact on key figures</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change in<br> USD %<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in<br>  constant<br>  currencies %<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Percentage<br> point currency<br>  impact<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Change in<br> USD %<br> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change in<br>  constant<br>  currencies %<br> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Percentage<br> point currency<br>  impact<br> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Group</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;41</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net sales to third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net sales to third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core operating income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Core operating loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For additional information on the effects of currency fluctuations, see &#x201C;Item 18. Financial Statements&mdash;Note 29. Financial instruments &ndash; additional disclosures.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">117</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Free cash flow</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis defines free cash flow as net cash flows from operating activities and cash flows associated with the purchase or sale of property, plant and equipment, as well as intangible, other non-current and financial assets, excluding marketable securities. Cash flows in connection with the acquisition or divestment of subsidiaries, associated companies and non-controlling interests in subsidiaries are not taken into account to determine free cash flow. For further information about the free cash flow measure, which is a non-IFRS measure, see &#x201C;Item 5. Operating and Financial Review and Prospects&mdash;Item 5.A Operating results&mdash;Non-IFRS measures as defined by Novartis&mdash;Free cash flow&#x201D; above. The following is a summary of the free cash flow:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Adjustments for non-cash items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation, amortization and impairments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;788</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;963</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in provisions and other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 895</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 86</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;476</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;229</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;465</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income adjusted for non-cash items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;269</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;286</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;286</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends received from associated companies and others</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 463</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 719</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 987</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest and other financial receipts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 242</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 459</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 97</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest and other financial payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;826</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;847</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;967</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes paid</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;876</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;506</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;487</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments out of provisions and other net cash movements in non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;638</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;829</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in inventory and trade receivables less trade payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;809</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;679</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;776</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other net current assets and other operating cash flow items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;008</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows from operating activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;547</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;049</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;419</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;379</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;325</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 857</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 91</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;878</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;394</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;969</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 973</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 823</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 640</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;302</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;205</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;354</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of financial assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 176</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 165</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 328</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Free cash flow from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;937</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;791</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Free cash flow from discontinued operations<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 461</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 637</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total free cash flow</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;875</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;428</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For the free cash flow, proceeds from the sales of financial assets exclude the cash inflows from the sale of a portion of the Alcon Inc. shares received by certain consolidated foundations through the Alcon spin-off, which amounted to USD 976 million. See "Item 18. Financial Statements - Note 2 Significant transactions in 2019."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> In 2019, the free cash flow from discontinued operations was a cash outflow of USD 62 million (2018: USD 461 million cash inflow, 2017: USD 637 million cash inflow) consisting of USD 78 million net cash inflows from operating activities from discontinued operations (2018 and 2017: USD 1.2 billion), USD 1.2 billion net cash flows used in investing activities from discontinued operations (2018: USD 1.0 billion, 2017: USD 775 million) adjusted by USD 362 million of net cash outflows for acquisition and divestments of businesses (2018: USD 239 million, 2017: USD 210 million) and by USD 657 million for cash outflows attributable to the spin-off of the Alcon business (2018 and 2017: nil).</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Financial year 2019 compared to 2018</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Free cash flow from continuing operations amounted to USD&nbsp;12.9 billion (+15%) compared to USD&nbsp;11.3 billion in 2018. The increase was mainly driven by higher operating income adjusted for non-cash items, higher real estate divestment proceeds and lower investments in intangible assets, partly offset by higher taxes paid, provision payments and working capital, which in the prior year included the receipt of a GSK sales milestone from the divested Vaccines business of USD&nbsp;0.4 billion, as well as lower dividends received from associated companies, as prior year included the GSK consumer healthcare joint venture that was divested in the second quarter of 2018.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Financial year 2018 compared to 2017</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Free cash flow from continuing operations in 2018 amounted to USD&nbsp;11.3 billion (+15%), compared to USD&nbsp;9.8 billion in 2017, as higher cash flows from operating activities, which includes the receipt of a GSK sales milestone from the divested Vaccines business, were partly offset by higher net investments in intangible assets. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">118</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Condensed consolidated balance sheets</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;069</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;696</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;627</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;677</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;677</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35&nbsp;294</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;770</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;787</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38&nbsp;719</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;932</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19&nbsp;809</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;291</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;482</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 88&nbsp;866</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 110&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;21&nbsp;134</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;982</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;956</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;974</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;727</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;426</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current assets and income tax receivable</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;934</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;109</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;175</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash, marketable securities, commodities, time deposits and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   11&nbsp;446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   15&nbsp;964</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;4&nbsp;518</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Assets of disposal group held for sale</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 807</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29&nbsp;504</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;563</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6&nbsp;059</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;27&nbsp;193</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;692</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;23&nbsp;141</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;117</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;703</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;867</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;475</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;608</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;687</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;555</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37&nbsp;264</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;709</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;132</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;678</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;647</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other current liabilities and  current income tax liabities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   15&nbsp;532</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   14&nbsp;322</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;210</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities of disposal group held for sale</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 51</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;264</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;607</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;343</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 62&nbsp;819</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 66&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;052</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;27&nbsp;193</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There has been a significant change in the consolidated balance sheet resulting from the spin-off of the Alcon business through the dividend in kind distribution to Novartis AG shareholders completed on April 9, 2019. For further details see &#x201C;Item 18. Financial Statements&mdash;Note 1. Significant accounting policies&mdash;Distribution of Alcon Inc. to Novartis AG shareholders&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions&mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon business. The December 31, 2019, consolidated balance sheet excludes the assets and liabilities of the Alcon business, due to the derecognition of the Alcon business at the date of the spin-off. The consolidated balance sheet discussion and analysis that follows excludes the impacts of the derecognition of the Alcon business at the date of the spin-off. For details on the net assets derecognized at April 9, 2019, the completion date of the spin-off, see &#x201C;Item 18. Financial Statements&mdash;Note 30. Discontinued operations&mdash;Net assets derecognized.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total non-current assets of USD&nbsp;88.9 billion at December 31, 2019, increased by USD&nbsp;2.5 billion compared to December 31, 2018, excluding the impact of the derecognition of the Alcon business non-current assets as a result of the spin-off. This increase was mainly driven by the recognition of right-of-use assets resulting from the implementation of IFRS 16 Leases on January 1, 2019, amounting to USD&nbsp;1.7 billion; an increase in intangible assets other than goodwill of USD&nbsp;0.7 billion, mainly due to the impact of acquiring <i>Xiidra</i> from Takeda Pharmaceutical Company Limited, net of amortizations; an increase in financial assets of USD&nbsp;0.6 billion, primarily from the financial investments in Alcon Inc. shares recognized by certain consolidated foundations through the Alcon spin-off, and an increase in investments in associated companies of USD&nbsp;0.3 billion. This was partly offset by a decrease in property, plant and equipment of USD&nbsp;0.7 billion, mainly due to depreciation in excess of net additions and a decrease in deferred tax assets of USD&nbsp;0.1 billion.  Goodwill and other non-current assets were broadly in line compared to December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total current assets of USD&nbsp;29.5 billion at December 31, 2019, decreased by USD&nbsp;2.7 billion compared to December 31, 2018, excluding the impact of the derecog-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">119</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">nition of the Alcon business current assets as a result of the spin-off. This decrease was mainly driven by the reduction in marketable securities, commodities, time deposits and derivative financial instruments of USD&nbsp;2.4 billion and in cash and cash equivalents of USD&nbsp;1.9 billion mainly due to the repayment of financial debts and the dividend payment. This was partly offset by an increase in trade receivables by USD&nbsp;0.8 billion, in inventories by USD&nbsp;0.5 billion, and in other current assets by USD&nbsp;0.2 billion. Income tax receivable and assets of disposal group held for sale remained broadly in line compared to December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net assets of disposal group held for sale of USD&nbsp;0.8 billion include net assets and liabilities related to the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo Pharma USA Inc., as announced on September 6, 2018 (see &#x201C;Item 18. Financial Statements &ndash; Note 2. Significant pending transactions&#x201D;).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We consider our provisions for doubtful trade receivables to be adequate. We continue to monitor the level of trade receivables, particularly in Argentina, Brazil, Greece, Italy, Portugal, Russia, Saudi Arabia, Spain and Turkey. Should there be a substantial deterioration in our economic exposure with respect to those countries, we may change the terms of trade on which we operate. The gross trade receivables from these countries at December 31, 2019, amounted to USD&nbsp;1.6 billion (2018: USD&nbsp;1.7 billion), of which USD&nbsp;61 million is past due for more than one year (2018: USD&nbsp;97 million), and for which provisions of USD&nbsp;24 million have been recorded (2018: USD&nbsp;44 million). At December 31, 2019, amounts past due for more than one year are not significant in any of these countries on a standalone basis. The majority of the outstanding trade receivables from Portugal, Saudi Arabia and Spain (in 2018, in addition Greece) are due directly from local governments or government-funded entities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table provides an overview of the aging analysis of total trade receivables and the total amount of the provision for doubtful trade receivables as of December 31, 2019 and 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not overdue</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;763</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;916</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for not more than one month</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 296</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one month  but less than three months</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   123</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than three months  but less than six months</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   136</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than six months  but less than one year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   96</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   98</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 213</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There is also a risk that certain countries could devalue their currency. Currency exposures are described in more detail in &#x201C;&mdash;Effects of currency fluctuations&#x201D; above.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total non-current liabilities of USD&nbsp;34.6 billion decreased by USD&nbsp;0.2 billion compared to December 31, 2018, excluding the impact of the derecognition of the Alcon business non-current liabilities as a result of the spin-off. This decrease was mainly driven the USD&nbsp;2.0 billion decrease in long-term financial debts, mainly driven by the reclassification from non-current to current financial debt of USD&nbsp;2.0 billion US dollar bonds due in 2020. This was partly offset by the recognition of lease liabilities resulting from the implementation of IFRS 16 Leases on January 1, 2019, amounting to USD&nbsp;1.7 billion, and the USD&nbsp;0.2 billion increase in provisions and other non-current liabilities, mainly due to higher pension plan liabilities due to the decrease in discount rates used to calculate the actuarial defined benefit obligations. Deferred tax liabilities were broadly in line compared to December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis believes that its total provisions are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities in this area, Novartis may incur additional costs beyond the amounts provided. Management believes that such additional amounts, if any, would not be material to the Group&#x2019;s financial condition but could be material to the results of operations or cash flows in a given period.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total current liabilities of USD&nbsp;28.3 billion increased by USD&nbsp;0.5 billion compared to December 31, 2018, excluding the impacts of the derecognition of the Alcon business current liabilities as a result of the spin-off. This was mainly driven by an increase in provisions and other current liabilities of USD&nbsp;2.0 billion, primarily from higher legal and revenue deduction provisions, increases of USD&nbsp;0.5 billion in trade payables, USD&nbsp;0.3 billion in current income tax liabilities and USD&nbsp;0.2 billion in lease liabilities, resulting from the implementation of IFRS 16 Leases on January 1, 2019. This was partially offset by a USD&nbsp;2.6 billion decrease in financial debts and derivative financial instruments, mainly due to the repayment of USD&nbsp;3.0 billion of bonds issued in February 2009.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In our key countries, Switzerland and the United States, assessments have been agreed by the tax authorities up to 2015 in Switzerland and 2014 in the United States, respectively, with the exception of one open United States position related to the 2007 tax filing. In addition, a subsidiary in France, acquired with the AAA acquisition, has an open position related to the tax years 2014 and 2015.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s equity decreased by USD&nbsp;23.1 billion to USD&nbsp;55.6 billion at December 31, 2019, compared to USD&nbsp;78.7 billion at December 31, 2018. This decrease was mainly due to the dividend in kind to effect the spin-off of Alcon Inc. of USD&nbsp;23.4 billion (for further details, see &#x201C;Item 5.A Operating results &ndash; Critical accounting policies and estimates&#x201D;, &#x201C;Item 18. Financial Statements &ndash; Note 2. Significant transactions&#x201D; and &#x201C;Item 18. Financial Statements &ndash; Note 30. &ndash; Discontinued operations&#x201D;), the cash-dividend payment of USD&nbsp;6.6 billion, the purchase of treasury shares of USD&nbsp;5.5 billion, net actuarial losses of USD&nbsp;0.5 billion, transaction costs attributable to the Alcon spin-off of USD&nbsp;0.3 billion, and taxes on treasury shares of USD&nbsp;0.2 billion. This was partially offset by net income of USD&nbsp;11.7 billion, the net effect of exercise of options and employee transactions of USD&nbsp;1.0 billion, favorable currency translation differences of USD&nbsp;0.4 billion and a decrease in the treasury share repurchase obligation under a share buyback trading plan of USD&nbsp;0.3 billion. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s liquidity amounted to USD&nbsp;11.4 billion at December 31, 2019, compared to USD&nbsp;16.0 billion at </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">120</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">December 31, 2018. Total non-current and current financial debts, including derivatives, amounted to USD&nbsp;27.4 billion at December 31, 2019, compared to USD&nbsp;32.1 billion at December 31, 2018. The debt/equity ratio increased to 0.49:1 at December 31, 2019, compared to 0.41:1 at December 31, 2018.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The net debt decreased to USD&nbsp;15.9 billion at December 31, 2019, compared to USD&nbsp;16.2 billion at December 31, 2018.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Summary of equity movements attributable to Novartis AG shareholders</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Number of outstanding shares (in millions)  </div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Issued share capital and reserves  attributable to Novartis AG shareholders</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<br> USD millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018<br> USD millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change<br> USD millions</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at beginning of year</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 78&nbsp;614</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;168</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;446</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in accounting policy<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;57</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated equity at January 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 78&nbsp;617</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;228</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;389</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be canceled</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;37.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;351</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;492</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;263</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 756</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 77</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon employees as  a result of the Alcon spin-off</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes on treasury share transactions<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;189</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;189</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Decrease/(increase) of treasury share repurchase  obligation under a share buyback trading plan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   568</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transaction costs, net of taxes<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;174</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;966</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 321</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend in kind to effect the spin-off of Alcon Inc.<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;23&nbsp;434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;23&nbsp;434</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income of the year attributable to shareholders  of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;879</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in ownership of consolidated entities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other comprehensive income attributable to shareholders  of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;207</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;401</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at end of year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;265.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;311.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;23&nbsp;140</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> In 2019, the impact of change in accounting policy includes USD 3 million related to the implementation of IFRS 16 Leases (see &#x201C;Item 18. Financial Statements&#x2014;Note 1. Significant accounting policies"). In 2018, the impact of change in accounting policy includes USD 60 million related to the implementation of IFRS 15, and USD 177 million related to the implementation of IFRS 9.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Included in 2019 is a USD 69 million impact related to the revaluation of deferred tax liability on treasury shares. This revaluation resulted from the Swiss federal tax reform enacted in May 2019 (see &#x201C;Item 18. Financial Statements&#x2014;Note 12. Deferred tax assets and liabilities").</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Transaction costs, net of tax of USD 36 million (2018: USD 20 milion), directly attributable to the potential distribution (spin-off) of Alcon to Novartis shareholders (see &#x201C;Item 18. Financial Statements&#x2014;Note 1. Significant accounting policies").</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Fair value of the dividend in kind of Alcon Inc. shares to Novartis AG shareholders and ADR (American Depositary Receipt) holders approved at the 2019 Annual General Meeting held on February 28, 2019. Distribution was effected on April 8, 2019, whereby each Novartis AG shareholder and ADR holder received one Alcon Inc. share for every five Novartis AG shares/ADRs they held on April 8, 2019, close of business (see &#x201C;Item 18. Financial Statements&#x2014;Note 1. Significant accounting policies").</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Impact of hyperinflationary economies (see &#x201C;Item 18. Financial Statements&#x2014;Note 1. Significant accounting policies").</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the up to USD&nbsp;5 billion share buyback announced in June 2018 was completed with a total of 55.8 million shares for USD&nbsp;5.0 billion repurchased since the announcement.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During 2019, Novartis repurchased a total of 60.3 million shares for USD&nbsp;5.4 billion on the SIX Swiss Exchange second trading line, including 46.5 million shares (USD&nbsp;4.2 billion) bought back under the up-to USD&nbsp;5 billion share buyback announced in June 2018, and 13.8 million shares (USD&nbsp;1.1 billion) to mitigate dilution related to participation plans of associates. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, 1.7 million shares (USD&nbsp;0.2 billion) were repurchased from associates. In the same period, 15.8 million shares (for an equity value of USD&nbsp;1.1 billion) were delivered as a result of options exercised and share deliveries related to participation plans of associates. Consequently, the total number of shares outstanding decreased by 46.2 million versus December 31, 2018. These treasury share transactions resulted in a decrease in equity of USD&nbsp;4.5 billion and a net cash outflow of USD&nbsp;5.3 billion. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, Novartis repurchased a total of 23.3 million shares for USD&nbsp;1.9 billion on the SIX Swiss Exchange second trading line under the CHF&nbsp;10 billion share buyback authority approved at the 2016 Annual General Meeting. This included 9.3 million shares (USD&nbsp;0.8 billion) under the new up-to USD&nbsp;5 billion share buyback announced in June 2018, and 14.0 million shares (USD&nbsp;1.1 billion) to offset the dilutive impact from equity-based participation plans of associates.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, 1.2 million shares for USD&nbsp;0.1 billion were acquired from employees, which were previously granted </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">121</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">to them under the respective programs. In 2018, 15.2 million treasury shares for USD&nbsp;1.2 billion were delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans. Other share sales for USD&nbsp;0.3 billion resulted in an increase of 3.0 million shares outstanding. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">With these transactions, the total number of shares outstanding decreased by 6.3 million shares in 2018 versus December 31, 2017. These treasury share transactions resulted in an equity decrease of USD&nbsp;0.5 billion and a net cash outflow of USD&nbsp;1.3 billion in 2018.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Treasury shares</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At December 31, 2019, our holding of treasury shares amounted to 262.4 million shares, or approximately 10% of the total number of issued shares. Approximately 118 million treasury shares were held in entities that limit their availability for use.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At December 31, 2018, our holding of treasury shares amounted to 239.5 million shares, or approximately 10% of the total number of issued shares. Approximately 122 million treasury shares were held in entities that limit their availability for use.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At December 31, 2017, our holding of treasury shares amounted to 299.4 million shares, or approximately 10% of the total number of issued shares. Approximately 131 million treasury shares were held in entities that limit their availability for use.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Bonds</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In February 2019, a 10-year USD bond of USD&nbsp;3.0 billion with a coupon of 5.125% was repaid at maturity.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In February 2018, three euro bonds totaling EUR&nbsp;2.25 billion were issued: a 5.5-year bond of EUR&nbsp;750 million with a coupon of 0.5%, a 12.5-year bond of EUR&nbsp;750 million with a coupon of 1.375%, and a 20.5-year bond of EUR&nbsp;750 million with a coupon of 1.7%.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In February 2017, three US dollar bonds totaling USD&nbsp;3.0 billion were issued: a three-year bond of USD&nbsp;1.0 billion with a coupon of 1.80%, a five-year bond of USD&nbsp;1.0 billion with a coupon of 2.40%, and a 10-year bond of USD&nbsp;1.0 billion with a coupon of 3.10%.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In March 2017, two EUR bonds totaling EUR&nbsp;1.85 billion were issued: a four-year bond of EUR&nbsp;1.25 billion with a coupon of 0%, and a 10-year bond of EUR&nbsp;0.6 billion with a coupon of 1.125%.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Liquidity/short-term funding</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We continuously track our liquidity position and asset/liability profile. This involves modeling cash flow maturity profiles based on both historical experiences and contractual expectations to project our liquidity requirements. We seek to preserve prudent liquidity and funding capabilities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We are not aware of any significant demands to change the level of liquidity needed to support our normal business activities. We make use of various borrowing facilities provided by several financial institutions. We also successfully issued various bonds in previous years (including 2017 and 2018), and raised funds through our commercial paper programs.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The maturity schedule of our net debt can be found in &#x201C;Item 18. Financial Statements&mdash;Note 29. Financial instruments &ndash; additional disclosures.&#x201D;</div><a name="anchorId0010064145"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">5.C Research and development, patents and licenses</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our R&amp;D spending from continuing operations totaled USD&nbsp;9.4 billion, USD&nbsp;8.5 billion and USD&nbsp;8.4 billion (Core R&amp;D USD&nbsp;8.4 billion, USD&nbsp;8.2 billion and USD&nbsp;7.8 billion) for the years 2019, 2018 and 2017, respectively. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Each of our divisions has its own R&amp;D and patent policies. Our divisions have numerous products in various stages of development. For further information on these policies and these products in development, see &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As described in the risk factors section and elsewhere in this Annual Report, our drug development efforts are subject to the risks and uncertainties inherent in any new drug development program. Due to the risks and uncertainties involved in progressing through preclinical development and clinical trials, and the time and cost involved in obtaining regulatory approvals, among other factors, we cannot reasonably estimate the timing, completion dates and costs, or range of costs, of our drug development program, or of the development of any particular development compound (see &#x201C;Item 3. Key Information&mdash;Item 3.D Risk factors&#x201D;). In addition, for a description of the research and development process for the development of new drugs and our other products, and the regulatory process for their approval, see &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview.&#x201D;</div><a name="anchorId0010064164"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">5.D Trend information</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Please see &#x201C;&mdash;Item 5.A Operating results&mdash;Factors affecting results of operations&#x201D; and &#x201C;Item 4. Information on the Company&mdash;Item 4.B Business overview&#x201D; for trend information.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">122</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId0010064174"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">5.E Off-balance sheet arrangements</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We have no unconsolidated special purpose financing or partnership entities or other off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources, that is material to investors. See also &#x201C;Item 18. Financial Statements&mdash;Note 28. Commitments and contingencies,&#x201D; and matters described in &#x201C;&mdash; Item 5.F Tabular disclosure of contractual obligations.&#x201D;</div><a name="anchorId0010064181"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">5.F Tabular disclosure of contractual obligations</p>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the Group&#x2019;s contractual obligations and other commercial commitments, as well as the effect these obligations and commitments are expected to have on the Group&#x2019;s liquidity and cash flow in future periods:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Payments due by period</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Less than<br> 1 year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> 2&#x2013;3 years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> 4&#x2013;5 years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> After<br> 5 years</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-current financial debt, including current portion</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;650</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;460</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;243</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest on non-current financial debt, including current portion</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 464</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 845</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 686</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;439</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities, non-current and current portion</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 365</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 257</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;081</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest on lease liabilities, non-current and current portion</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;536</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;338</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unfunded pensions and other post-employment benefit plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;748</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 201</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;238</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development potential milestone commitments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;404</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 809</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 761</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 891</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;943</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 352</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 383</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment purchase commitments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 220</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 177</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquisition of business commitments<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;164</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total contractual cash obligations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 48&nbsp;846</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;049</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;798</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;665</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> For acquisition of business commitments, please refer to "Item 18. Financial Statements - Note 2 Significant transactions - significant pending transactions".</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group intends to fund the research and development; property, plant and equipment; intangible asset purchase commitments with internally generated resources, and the acquisition of business commitment through available cash and short- and long-term borrowings. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The acquisition of business commitments relate to the acquisition of The Medicines Company (see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions &mdash;Significant Transactions entered into in 2019 and closed in January 2020&#x201D;) and to the pending acquisition of the Japanese business of Aspen Global Incorporated (see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions &mdash; Significant pending transactions&#x201D;).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In December 2019, Novartis entered into a short-term credit facility of USD&nbsp;7.0 billion, with a maturity date of June 30, 2020 with a syndicate of banks. On January 7, 2020, Novartis borrowed USD&nbsp;7.0 billion under the facility with interest based on the USD LIBOR.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For other contingencies, see &#x201C;Item 4. Information on the Company&mdash;Item 4.D Property, plants and equipment&mdash;Environmental matters,&#x201D; &#x201C;Item 8. Financial Information&mdash;Item 8.A Consolidated statements and other financial information,&#x201D; &#x201C;Item 18. Financial Statements &mdash; Note 10. Right-of-use assets and lease liabilities,&#x201D; &#x201C;Item 18. Financial Statements&mdash;Note 20. Provisions and other non-current liabilities,&#x201D; and &#x201C;Item 18. Financial Statements&mdash;Note 28. Commitments and contingencies.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">123</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


    <a name="anchorId00431895"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item 6.  Directors, Senior Management and Employees</p><a name="anchorId00431897"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">6.A Directors and senior management</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The information set forth under &#x201C;Item 6.C Board practices&mdash;Corporate governance&mdash;Board of Directors&#x201D; and &#x201C;Item 6.C Board practices&mdash;Corporate governance&mdash;Executive Committee&#x201D; is incorporated by reference.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">124</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>




<a name="anchorId00932141"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">6.B Compensation</p><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Dear shareholder,</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As Chairman of the Compensation Committee of the Board of Directors, I am pleased to share with you the 2019 Compensation Report of Novartis AG. It follows a similar structure to the previous year&#x2019;s report, which was supported by over 94% of shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At the 2019 Annual General Meeting (AGM), we welcomed new Board member Patrice Bula to the Compensation Committee. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During 2019, the committee continued to engage with shareholders and proxy advisors to gather feedback on the compensation system for the Executive Committee and our disclosures. In response to this feedback, and to better align with the interests of shareholders, we have introduced a mandatory holding period of two years beyond the vesting date for all Long-Term Incentive (LTI) awards (after applicable taxes) to the CEO and CFO granted from 2020 onward.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Reflecting our commitment to shareholders regarding transparency in executive compensation, we would like to also draw attention to the following changes and enhanced disclosures: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Increased disclosure on the balanced scorecard for the CEO&#x2019;s Annual Incentive, in particular, on targets related to environmental, social and governance (ESG) metrics</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Increased transparency on innovation metrics for the 2019-2021 Long-Term Performance Plan (LTPP) by taking them from the published Novartis selected development projects in Innovative Medicines</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Added an interim update of how performance is tracking against targets for all metrics relating to the ongoing LTPP performance cycles to provide an upfront indication of ongoing performance  </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Provided explanations of pension benefits for members of the Executive Committee, which are fully aligned with the pensions of all other associates at Novartis</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 Company performance</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Financial performance significantly exceeded targets set at the beginning of the year, which enabled the company to raise its guidance to shareholders every quarter. Net sales to third parties for Novartis continuing operations grew 6% in reported terms and 9% measured in constant currencies (cc) to remove the impact of exchange rate movements, core operating income grew by 12% (+17% cc) and free cash flow amounted to USD 12.9 billion (+15%) mainly driven by higher operating income. Growth brands contributed to strong sales growth, as <i>Cosentyx</i> sales reached USD 3.6 billion, <i>Entresto</i> sales reached USD 1.7 billion and <i>Promacta/Revolade</i> sales reached USD 1.4 billion. Recently launched products, including <i>Zolgensma</i>, <i>Piqray</i> and <i>Beovu</i>, also contributed to our growth.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition to delivering a strong financial year, there were significant achievements across all our strategic pillars: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Delivered transformative innovation in 2019, with 18 new approvals (of which 5 were new molecular entities), and 17 major submissions</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Continued to improve our operational excellence by transforming our manufacturing operations and business services which, together with increased research and development productivity, led to an overall core operating income margin improvement of 1.6% (+1.9% cc)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Advanced our digital ecosystem, investing in data architecture and analytics, and forming external strategic partnerships </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Made good progress on our cultural journey, with significant investment in leadership development, external recognition of our approach to learning, and an improvement in our key diversity metrics</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;  Took significant actions to address areas of &#x201C;building trust with society&#x201D; as put in our ESG initiatives, including access to healthcare as we launched our sub-Saharan Africa strategy to drive access for patients across all income levels</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On April 9, 2019, Novartis successfully spun off the Alcon eye care devices business, generating significant shareholder value. This was, at the time, the largest-ever spin-off in Europe. Our recent transactions in M&amp;A are strengthening our innovation programs and further supporting our strategy to become a leading, focused medicines company.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">More details on the performance of our strategic priorities can be found in &#x201C;&mdash;2019 CEO balanced scorecard.&#x201D; </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Overall, shareholders benefited from a total shareholder return (TSR) in 2019 of 22.3%. Between 2017 and 2019, they benefited from a three-year TSR of 63.4%.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 realized compensation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Board of Directors assessed the performance of the CEO in his second year and determined that he will be awarded a 2019 Annual Incentive of CHF 4 017 639, which is 160% of target, within the payout range of 0% to 200%.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The 2017-2019 Long-Term Performance Plan (LTPP) delivered strong results with Cash Value Added (CVA) and innovation at above target, reflecting the underlying performance of our business over the three-year cycle. Overall, the Board of Directors awarded the CEO a payout of CHF 3 510 963, corresponding to a 164% payout against a maximum of 200%. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">125</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The 2017-2019 Long-Term Relative Performance Plan (LTRPP) award was based on three-year relative TSR in USD compared to the global healthcare peer group. Novartis ranked No. 6 out of a total of 16 companies (including Novartis), reflecting continued positive momentum in our business. The Board of Directors evaluated the overall context and assigned the CEO a payout of CHF 1 107 806, which is 138% of target and within the payout of 0-200%. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">These incentive performance outcomes, combined with base salary and other benefits, pension, share price movement and dividend equivalents, resulted in 2019 total realized compensation for the CEO of <b>CHF 10 615 740</b>.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The strong performance of the 2017-2019 LTI awards, coupled with the 30% increase of the share price between grant and vesting of these awards, contributed to a significantly higher total realized compensation for the CEO compared to 2018 (CHF 6 680 288).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The 2019 total realized compensation for the Executive Committee members (comprising the CEO, the other 12 active Executive Committee members, and the two former Executive Committee members who stepped down during the financial year) was CHF 66 491 488, which is broadly in line with the prior year. Strong Company performance drove higher payouts of the Annual Incentive and both LTI grants contributing to a slightly higher total realized payout compared to 2018; partly offset by the fact that there were several Executive Committee members in their first year and fewer Executive Committee members to be reported overall in 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2020 AGM</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In line with our Articles of Incorporation, at the 2020 AGM, shareholders will be asked to approve, in a binding vote, the maximum aggregate amount of compensation for the Board of Directors from the 2020 AGM to the 2021 AGM, and the maximum aggregate amount of compensation for the Executive Committee for financial year 2021. For the Board of Directors, the amount considers the nomination of two new Board members for election to the Board at the next AGM, and a reallocation of Board Committee memberships. For the Executive Committee, the requested maximum aggregate amount of compensation remains broadly unchanged compared to the prior year. Shareholders will also be asked to endorse this Compensation Report in an advisory vote.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On behalf of Novartis and the Compensation Committee, I would like to thank you for your continued support and feedback, which we consider extremely valuable in driving improvements in our compensation systems and practices. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">I invite you to send your comments to the following email address: investor.relations@novartis.com. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Respectfully,</div>
<div style="padding-top:15px"><img src="comp_0001.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><b>Enrico Vanni, Ph.D.</b></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Chairman of the Compensation Committee</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">126</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00932259"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Compensation&nbsp;at&nbsp;a&nbsp;glance</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Committee compensation system </font>
</div>
<div style="padding-top:15px"><img src="comp_0003.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">2019 fixed pay and benefitsAnnual base salaryPension and other benefitsPerformance-related variable pay2019 Annual IncentiveLong-Term Incentive awards cycle 2017-2019LTPP1LTRPP2PurposeReflects responsibilities, experience and skill setsProvides retirement and risk insurances (tailored to local market practices/regulations)Rewards for perfor&#xAD;mance against short-term financial and strategic objectives, and Values and BehaviorsRewards long-term shareholder value creation and innovation in line with our strategyForm of paymentCashCountry/individual-&#xAD;specific and aligned with other employees50% cash50% equity3 deferredfor three yearsEquity, vesting following a three-year performance periodPerformance measures&#x2013;&#x2013;Balanced scorecard comprising:&#x2022;Financial measures (60%)&#x2022;Strategic objectives4 (40%)&#x2022;Novartis Cash Value Added (75%)&#x2022;Innovation milestones (25%)&#x2022;Relative TSR versus global sector peers (100%)51LTPP = Long-Term Performance Plan 2LTRPP = Long-Term Relative Performance Plan3Executive Committee members may elect to receive more of their Annual Incentive in equity instead of cash.4  Strategic objectives are aligned with the five strategic pillars: innovation, operational excellence, data and digital, people and culture, and building trust with society.5  For the 2017-2019 performance cycle, the peer group comprises 16 global healthcare companies, including Novartis, as listed in &#x201C;&#x2014;Approach to benchmarking.&#x201D;  </div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Target incentive opportunity levels for the CEO are 150% and 325% of base salary for the Annual Incentive and LTI, respectively. Based on Novartis compensation guidelines, the other members of the Executive Committee have Annual Incentive and LTI target opportunity levels that range from 80% to 120%, and 160% to 270% of base salary, respectively. The payout range remains at 0% to 200% of target opportunity based on achievement against performance.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "> </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As disclosed in the 2018 Compensation Report, from cycle 2019-2021, the LTRPP plan is discontinued, and the LTPP metrics are transformed into four equally weighted measures: net sales compound annual growth rate, core operating income compound annual growth rate, innovation and relative TSR.  </div><a name=""></a><div style="border-top: 1px solid black; margin: 10px 0; line-height: 20px; padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Compensation governance at&nbsp;a&nbsp;glance</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">A summary of the compensation decision authorization levels within the parameters set by the AGM is shown below, along with an overview of the risk management principles.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;">Decision on</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;"> Decision-making authority</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Compensation of Chairman and other Board members</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Board of Directors</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Compensation of CEO</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Board of Directors</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Compensation of other Executive Committee members</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Compensation Committee</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:8pt; font-weight:bold; color:#0070f7; text-transform:uppercase;">Executive Committee compensation risk management principles<div style="border:none;border-bottom:solid 1px; padding: 0 0 0 0"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Rigorous performance management process</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Balanced mix of short-term and long-term variable compensation elements</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Performance evaluation under the Annual Incentive includes an individual balanced scorecard</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Performance-based LTI, with three-year cycles </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; All variable compensation is capped at 200% of target</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Contractual notice period of 12 months</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Post-contractual non-compete period limited to a maximum of 12 months from the end of employment. Resulting compensation is limited to the annual base salary plus the prior-year Annual Incentive as per contract, if applicable</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Good and bad leaver provisions apply to the variable compensation of leavers</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; No severance payments or change-of-control clauses</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Clawback and malus principles apply to all elements of variable compensation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Share ownership requirements; no hedging or pledging of Novartis share ownership position</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">127</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2019 CEO pay for performance &ndash; outcomes </font>
</div>
<div style="padding-top:15px"><img src="comp_0024.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">MeasureTarget1Achievement versus target2019 Annual Incentive (see &#x201C;2019 annual incentive&#x201D;)Financial measures  60% of total Annual Incentive, comprising:Group net sales (cc) (30%)USD 45 384 millionSignificantly aboveGroup operating income (cc) (30%)USD 8 129 millionSignificantly above Group free cash flow as a % of sales (cc) (20%)24.8%Significantly above Share of peers for Novartis Group (USD) (20%)7.9%AboveOverall assessment of Group financial targets in constant currenciesSignificantly above1For performance evaluation purposes, Target as well as Actual financial KPIs excluded the results of the Sandoz US dermatology business and generic US oral solids portfolio, which was expected to be divested to Aurobindo. The transaction is now expected to close in the first quarter of 2020 pending regulatory approval.Strategic objectives  40% of total Annual Incentive, comprising:Innovation (20%)Significantly aboveOperational excellence (20%)Significantly aboveData and digital (20%)AbovePeople and culture (including Values and Behaviors) (20%)Above Building trust with society (including access to healthcare and reputation and other ESG topics) (20%)MetOverall assessment of strategic objectivesAboveOverall assessment of CEO balanced scorecardOutstandingTOTAL Annual Incentive:160% of target (payout range 0%  200%) 2017-2019 Long-Term Incentives (see &#x201C; Long-Term Incentive plans, 2017-2019 cycle&#x201D;)Long-Term Performance Plan (LTPP)Novartis Cash Value Added (cc) (75%)USD 6.1 billionSignificantly aboveKey innovation milestones (25%)AboveTOTAL LTPP: 164% of target (payout range 0%  200%)Long-Term Relative Performance Plan (LTRPP)Relative TSR against a global healthcare peer group (USD)Above thresholdTOTAL LTRPP: 138% of target (payout range 0%  200%)</div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2019 total realized compensation for the CEO</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The 2019 total realized compensation for the CEO was <b>CHF 10 615 740</b>. It includes payouts of the Annual Incentive, LTPP and LTRPP based on actual performance assessed for cycles concluding in 2019. More information on the overall assessment of the CEO by the Board of Directors can be found in &#x201C;&mdash;2019 CEO balanced scorecard.&#x201D;</div>
<div style="padding-top:15px"><img src="comp_0025.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">CHFAnnual basesalaryPension and otherbenefits2019 Annual IncentiveLTPP2017-2019 cycle<sup>1</sup>LTRPP2017-2019 cycle<sup>1</sup>Total realized compensationVasant Narasimhan(CEO)1653333325999401763935109631107806106157401The shown amounts represent the underlying share value of the total number of shares vested (including dividend equivalents) to the CEO for the LTPP and LTRPP performance cycle 2017-2019, which were granted before Vasant Narasimhan was appointed CEO.</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">128</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2019 Board compensation system </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The compensation system applicable to the Board of Directors is shown below, and remains unchanged since prior year. All fees to the Board members are delivered at least 50% in equity and the remainder in cash. </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; font-style:italic; color:#000000;"><br>CHF 000s</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> AGM 2019-2020<br> annual fee</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chairman of the Board</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;800</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Board membership</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 280</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vice Chairman</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chair of the Audit and Compliance Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 130</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chair of the Compensation Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 90</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chair of the following committees:<br> &#x2022; Governance, Nomination and Corporate Responsibilities Committee<br> &#x2022; Research &amp; Development Committee<br> &#x2022; Risk Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br>  <br>  <br>  70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Membership of the Audit and Compliance Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Membership of the following committees:<br> &#x2022; Compensation Committee<br> &#x2022; Governance, Nomination and Corporate Responsibilities Committee<br> &#x2022; Research &amp; Development Committee<br> &#x2022; Risk Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br>  <br>  <br>  <br>  40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2019 Board compensation </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Total actual compensation earned by Board members in the 2019 financial year is shown in the table below.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>CHF 000s</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019<br> total compensation<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chairman of the Board</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 804</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other 12 members of the Board</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4 387</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8 191</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Includes an amount of CHF 21'002 for mandatory employer contributions for all Board members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 413'985 , and provides a right to the maximum future insured government pension benefit for the Board member.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">129</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><a name="anchorId00932668"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Executive Committee compensation&nbsp;philosophy and principles</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis compensation philosophy</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our compensation philosophy aims to ensure that Executive Committee members are rewarded according to their success in implementing the Company strategy, and their contribution to Company performance and long-term value creation.  </div>
<div style="padding-top:15px"><img src="comp_0006.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Pay for performance&#x2022;Variable compensation is tied directly to the achievement of strategic Company targetsShareholderalignment&#x2022;Our incentives are significantly weighted toward long-term equity-based plans&#x2022;Measures under the Long-Term Incentive plans are calibrated to promote the creation of shareholder value&#x2022;Executive Committee members are expected to build and maintain substantial shareholdingsBalanced rewards&#x2022;Balanced set of measures to create sustainable value&#x2022;Mix of targets based on financial metrics, strategic objectives, and performance versus our competitorsBusiness ethics&#x2022;The Novartis Values and Behaviors are an integral part of our compensation system&#x2022;They underpin the assessment of overall performance for the Annual IncentiveCompetitive compensation&#x2022;Total compensation must be sufficient to attract and retain key global talent&#x2022;Overarching emphasis on pay for performance</div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Alignment with Company strategy</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our strategy is to become a leading, focused medicines company powered by advanced therapy platforms and data science. We foster a company culture that is inspired, curious and unbossed. We believe these elements drive continued innovation and will support the creation of value over the long term for our Company, society and shareholders.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To align the compensation system with this strategy and to ensure that Novartis is a high-performing organization, the Company operates both a short-term Annual Incentive and an LTI plan with a balanced set of measures and targets. The Board of Directors determines specific, measurable and time-bound performance measures for the Annual Incentive and LTI plan. The Compensation Committee has reviewed the existing compensation system and determined that it continues to support our new strategy.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Approach to market benchmarking</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There remains significant competition for top executive talent with deep expertise, competencies and proven performance within the pharmaceutical and biotechnology industries. As such, external peer compensation data is one of a number of key reference points considered by the Board of Directors and the Compensation Committee when making decisions on executive pay, helping to ensure that the compensation system and compensation levels at Novartis remain competitive. Novartis makes the commitment to shareholders to confirm benchmarking practices, including the peer group, each year. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Compensation Committee believes in a rigorous approach to peer group construction and maintenance. The Compensation Committee also believes that using a consistent set of peers that are similar in size and scope enables shareholders to evaluate the compensation year on year and make pay-for-performance comparisons. As such, following a review of the benchmarking peer group, the Compensation Committee decided to maintain the same primary peer group of 15 global healthcare companies until the end of 2019, which will be updated from 2020 to consider the acquisition of Celgene, as presented below.</div>
<div style="padding-top:15px"><img src="comp_0005.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Global healthcare peer groupAbbVieBiogenEli Lilly &amp; Co.Johnson &amp; JohnsonPfizerAmgenBristol-Myers SquibbGilead SciencesMerck &amp; Co.RocheAstraZenecaCelgene1GlaxoSmithKlineNovo NordiskSanofi1Celgene will be removed from the 2020 peer group as a result of the acquisition by &#xAD;Bristol-Myers Squibb</div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The companies in this peer group reflect our industry and are similar to Novartis in terms of both size and scope of operations. Target compensation is generally positioned around the market median benchmark for comparable roles within this group.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Although Novartis is headquartered in Switzerland, more than a third of sales come from the US market, and the US remains a significant talent pool for the recruitment of executives by the Company. All current Executive Committee members have either worked in or have extensive experience with the US market. It is therefore critical that Novartis is able to attract and retain key talent globally, especially from the US. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For consideration of European and local practices, the Compensation Committee also references a cross-industry peer group of Europe-headquartered multinational companies, selected on the basis of comparability in size, scale, global scope of operations, and economic influence to Novartis. Five of these companies focus exclusively on healthcare: AstraZeneca, GlaxoSmithKline, Novo Nordisk, Roche and Sanofi. Ten companies are selected from the STOXX<sup>&#xAE;</sup> All Europe 100 Index representing multiple sectors: Anheuser-Busch InBev, Bayer, BMW, Daimler, Danone, Heineken, L&#x2019;Or&#xE9;al, Merck KgaA, Nestl&#xE9; and Unilever.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">130</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Committee appointments compensation policy</font>
</div>
<div style="padding-top:15px"><img src="comp_0007.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Element of compensationPolicyLevelThe overall package should be market-competitive to enable the recruitment of global executive talent with deep expertise and competencies.Annual base salaryThe Compensation Committee may appoint individuals who are new to a role on an annual base salary that is below the market level, with a view to increasing this toward a market level over a period of three to four years as an individual develops in the role.This prudent approach ensures pay levels are merit-based, with increases dependent on strong performance and proven ability in the role over a sustained period.IncentivesThe ongoing compensation package will normally include the key compensation elements and incentive opportunities in line with those offered to current Executive Committee members.In exceptional circumstances, higher Long-Term Incentive opportunities than those offered to current Executive Committee members may be provided, at the Compensation Committee&#x2019;s discretion.Performance measures may include business-specific measures tailored to the specific role.Pension and other benefitsNewly appointed Executive Committee members are eligible for a local market pension and other benefits in line with the wider employee group.BuyoutsThe Compensation Committee seeks to balance the need to offer competitive compensation opportunities to acquire the talent required by the business with the principle of maintaining a strong focus on pay for performance.As such, when an individual forfeits variable compensation as a result of an appointment at Novartis, the Compensation Committee may offer replacement awards in such form as the Compensation Committee considers appropriate, taking into account relevant factors.Relevant factors include the replacement vehicle (i.e., cash, restricted share units, restricted shares or performance share units), whether the award is contingent on meeting performance conditions or not, the expected value of the forfeited award, the timing of forfeiture (i.e., Novartis mirrors the blocking or vesting period of the forfeited award) and the leaver conditions, in case the recruited individual leaves Novartis prior to the end of the blocking or vesting period.The Compensation Committee will seek to pay no more than is required to match the commercial value or fair value of payments and awards forfeited by the individual.International mobility If individuals are required to relocate or be assigned away from their home location to take up their position, relocation support may be provided in line with our global mobility policies (i.e., relocation support, tax equalization).</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">131</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Treatment of variable compensation for Executive Committee leavers</font>
</div>
<div style="padding-top:15px"><img src="comp_0008.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Element of compensationPolicyAnnual Incentive &#x2013; cash elementRetirement, termination by the Company (for reasons other than performance or conduct), change of control, disability, deathPro-rata Annual Incentive is paid to reflect the portion of the year the individual was employed.Any other reasonNo Annual Incentive.Annual Incentive &#x2013; mandatory deferral into restricted shares/ RSUsIf a participant leaves employment due to voluntary resignation or misconduct, unvested restricted shares and restricted share units (RSUs) are forfeited. If a participant leaves involuntarily, restricted shares and RSUs are released on the original blocking end date. All awards are subject to non-compete terms until the end of the three-year blocking date, starting from the date of grant.Annual Incentive &#x2013; voluntary restricted shares/RSUs/ADRs (US associates only)Awards are not subject to forfeiture during the deferral period.  Long-Term Incentives (LTPP/LTRPP)Voluntary resignation or termination by the Company for misconductAll of the award will be forfeited.Termination by the Company for reasons other than performance or conduct, and change in control due to divestment (including retirement)Awards vest on the regular vesting date, subject to performance, on a pro-rata basis for time spent with the Company during the performance cycle. There is no accelerated vesting.Death or long-term disability Accelerated vesting at target will be applied.Non-compete agreementAll awards are subject to non-compete terms against the healthcare peer group until the vesting date.   </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Malus and clawback</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Any incentive compensation paid to Executive Committee members is subject to malus and clawback rules. This means that the Board of Directors for the CEO, and the Compensation Committee for the other Executive Committee members, may decide &ndash; subject to applicable law &ndash; to retain any unpaid or unvested incentive compensation (malus), or to recover incentive compensation that has been paid or has vested in the past (clawback). This applies in cases where the payout violates laws or conflicts with internal management standards, including Company and accounting policies. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">This principle applies to both the short-term Annual Incentive and LTI plans.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">132</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Committee performance&nbsp;management process</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">To foster a high-performance culture, the Company applies a uniform performance management process worldwide, based on quantitative and qualitative criteria, including our Values and Behaviors. All Novartis associates, including the CEO and other Executive Committee members, are subject to a formal three-step process: objective setting, performance evaluation and compensation determination. This process is explained below.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Performance targets are generally set before the start of the relevant performance cycle. There is a rigorous framework in place for establishing targets to ensure they are suitably robust and challenging, and align with the strategic priorities of the Group. The key factors taken into account when setting targets include:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Novartis strategic priorities</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Internal and external market expectations</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Regulatory factors (e.g., new launches, patent expiries)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Investment in capital expenditure</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Values and Behaviors</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The targets are challenged at multiple stages before they are ultimately approved by the Board of Directors. In line with good governance practices, the Compensation Committee works to set targets that are ambitious and challenging but that do not encourage undue risk-taking. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Following the end of the performance cycle, the Board of Directors and the Compensation Committee consider performance against the targets originally set. The CEO and Executive Committee members are not present while the Board of Directors and the Compensation Committee discuss their individual performance evaluations. Prior to determining the final outcome, related factors such as performance relative to peers, wider market conditions, general industry trends and good practice are used to inform the overall performance assessment. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="padding-top:15px"><img src="comp_0009.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Objective setting&#x2022;The CEO proposes his targets with the Chairman of the Board; they are then reviewed and approved by the Board of Directors, based on input from the Compensation Committee.&#x2022;For other Executive Committee members, targets for their division or unit are initially discussed with the CEO and subsequently approved by the Board of Directors and Compensation Committee.Performance evaluation&#x2022;The CEO&#x2019;s performance against the individual balanced scorecard is assessed by the Board of Directors.&#x2022;For Executive Committee members, the CEO discusses with the Chairman each member&#x2019;s performance (assessed against his or her individual balanced scorecard) before making recommendations to the Board of Directors.&#x2022;Periodic assessments, including at the mid-year stage, ensure progress is suitably tracked.Compensation determination &#x2022;A recommendation for the CEO&#x2019;s variable pay is made by the Compensation Committee to the Board of Directors for final determination.&#x2022;For the Long-Term Incentive financial measures payout schedules, a formulaic approach applies and the Compensation Committee can also exercise judgment to ensure there is appropriate alignment between payout levels and overall performance achieved. The same principle of discretion applies to the relative TSR and innovation performance measures.&#x2022;The CEO&#x2019;s recommendations for other Executive Committee members are considered and approved by the Compensation Committee, after which the Board of Directors is notified of the outcomes.</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">133</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00932770"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">2019 Executive Committee compensation </p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Performance outcomes </font>
</div>
<div style="padding-top:15px"><img src="comp_0010.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Annual base salaryOverview&#x2022;The annual base salary is reviewed each year, taking into account the individual&#x2019;s role, performance and experience, business performance and the external environment, increases across the Group and market movements.2019 annual base salariesThe 2019 annual base salaries were as follows:&#x2022;CEO (effective March 1, 2019): CHF 1&#x2005;674&#x2005;000 (CEO base salary may increase as he develops in the role)    &#x2022;OTHER EXECUTIVE COMMITTEE MEMBERS (effective March 1, 2019): All other members of the Executive Committee were awarded increases in line with the average of all Novartis employees, with the exception of three individuals as disclosed in Item 6.B of the 2018 Annual Report. These members were appointed to their roles with base salaries below external market median level and have demonstrated excellent performance during their tenure.Pension and other benefitsOverview&#x2022;Pension and other benefits do not constitute a significant proportion of total compensation and are provided to the Executive Committee on the same terms as all other associates based on local country practices and regulations. &#x2022;The CEO and all other Swiss-based members of the Executive Committee are members of the Novartis Swiss pension funds, which provide Company contributions on the base salary and Annual Incentive up to the legal cap on the insured salary of CHF 853 200. No supplementary pension plans or savings plans are provided. The CEO&#x2019;s employer pension contributions represent 10.01% of his base salary.&#x2022;Globally the Company operates both defined benefit and defined contribution pension plans (see also Note 25 to the Group&#x2019;s consolidated financial statements). &#x2022;Novartis may provide other benefits according to local market practice. These include Company car provision, tax and financial planning, and insurance benefits.&#x2022;Executive Committee members who are required to relocate internationally may also receive additional benefits (including tax equalization), in line with the Company&#x2019;s global mobility policies. </div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">134</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 Annual Incentive</font>
</div>
<div style="padding-top:15px"><img src="comp_0012.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">PLAN OVERVIEWTarget Annual Incentive On-target opportunities&#x2022;CEO: 150% of annual base salary&#x2022;Other Executive Committee members: 80% to 120% of annual base salaryPerformance measures&#x2022;A simplified Annual Incentive balanced scorecard containing:&#x2022;Financial performance measures related to Group, division or business unit, where relevant (60% weighting)&#x2022;Five key strategic objectives in the areas of innovation, operational excellence, data and digital, people and culture, and building trust with society (40% weighting)&#x2022;The 2019 balanced scorecard targets and achievements of the CEO are detailed on the next page.&#x2022;The 2019 balanced scorecards for other Executive Committee members include Group financial targets as well as financial or other quantitative targets that relate to their division or business unit, if applicable.&#x2022;Values and Behaviors are a key component of the Annual Incentive and are embedded in our culture. As such, members of the Executive Committee are expected to demonstrate these to the highest standards.Target setting&#x2022;Financial targets are set at the beginning of each financial year and align with the strategic plan proposed by management to the Board of Directors for approval.&#x2022;The strategic objectives are aligned with the most important priorities in any performance year.Payout ranges&#x2022;The payout schedule for the Annual Incentive incorporates performance against financial and strategic objectives. The payout range is 0% to 200% of on-target opportunity based on performance, as shown below:PERFORMANCEPAYOUT (% of on-target)Outstanding170% &#x2013; 200%Exceeds expectations130% &#x2013; 160%Meets expectations80% &#x2013; 120%Partially meets expectations40% &#x2013; 70%Below expectations10% &#x2013; 30%1 From the 2020 performance cycle, a performance deemed &#x201C;below expectations&#x201D; will provide for a payout of 0% only.  Payout formulaPayout vehicle&#x2022;At the end of the performance period, 50% is paid in cash, and the remaining 50% is delivered in Novartis restricted shares or RSUs, deferred for three years (see &#x201C;&#x2014;Treatment of variable compensation for Executive Committee leavers&#x201D;).&#x2022;Executives may choose to receive all or part of the cash portion of their Annual Incentive in Novartis shares or American Depositary Receipts (ADRs; US only) that will not be subject to forfeiture conditions. In the US, awards may also be delivered in cash under the US-deferred compensation plan.&#x2022;Clawback and malus provisions apply to all Annual Incentive awards.Dividend rights, voting rights and settlement&#x2022;Novartis restricted shares carry voting rights and dividends during the vesting period. RSUs are of equivalent value but do not carry voting rights and dividends during the vesting period.&#x2022;Following the vesting period, settlement of RSUs is made in unrestricted Novartis shares or ADRs. Annual base salaryxTarget incentive (% of base salary)=Target Annual IncentiveAnnual base salaryxTarget incentive (% of base salary)xPayout factor (% of target: 0%&#x2013;200%)=Realized Annual Incentive</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">135</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="comp_0014.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">2019 CEO BALANCED SCORECARD This section presents the balanced scorecard for the CEO. Balanced scorecard performance is measured in constant currencies to reflect operational performance that can be influenced. The Board of Directors uses a stringent process to set ambitious financial targets to incentivize superior performance.Achievement versusCEO achievements  2019Target1targetFinancial measures  60% of total Annual Incentive, comprising: Group net sales (cc) (30%) 45384 millionSignificantly aboveGroup operating income (cc) (30%)| 8129 million|Significantly aboveGroup free cash flow as a % of sales (cc) (20%)| 24.8%|Significantly aboveShare of peers for Novartis Group (USD) (20%) 7.9%AboveOverall assessment of Group financial targets in constant currenciesSignificantly above1For performance evaluation purposes, Target as well as Actual financial KPIs excluded the results of the Sandoz US dermatology business and generic US oral solids portfolio, which was expected to be divested to Aurobindo. The transaction is now expected to close in the first quarter of 2020 pending regulatory approval.Strategic objectives  40% of total Annual Incentive, comprising:Innovation (20%)|Significantly aboveNovartis achieved 18 key approvals. Five of these key approvals were for new molecular entitiesAdakveo, Beovu, Mayzent, Piqray and Zolgensma which were all approved and launched in the US. Additional highlights include approvals for new indications for Lucentis in Europe, and for Kymriah, Afinitor and Xolair in Japan. The Company also achieved 22 submissions. Seventeen of these submissions were major submissions, including EntrestoHF-rEF, submitted for approval in Japan; Cosentyx non-radiographic axial SA in Europe; SEG101 (crizanlizumab) for sickle cell disease in the US and Europe; and LCI699 (osilodrostat) for Cushing&#x2019;s syndrome in the US. Novartis also achieved 7 Phase IIb transitions, which was on target, and 15 proof of concepts/proof of mechanisms, slightly above the target of 14. Additionally, the CEO achieved his targets in the buildup of advanced therapy platforms. In the CAR-T platform, the clinical portfolio was expanded, with four new CAR-T programs having achieved &#x201C;first patient first visit&#x201D; (FPFV). In gene therapy, the platform was strengthened, with progress on new programs and manufacturing capacity expanded for Zolgensma. Finally, the protein degradation platform also advanced, with DKY709 achieving FPFV.   Operational excellence (20%)|Significantly aboveIn key operational financial metrics, continuing operations Core Operating Income was USD 14 112 million, which is a 12% increase compared to prior year (+17% cc). Continuing operations Core Operating Margin was 29.7%, growing by 1.6 percentage points from prior year (+1.9% percentage points cc).The Alcon eye care business was successfully spun off on April 9, 2019, with immediate and significant value creation to shareholders. The timeline was in line with the target set at the beginning of the year, and value creation was ahead of expectations. Progress was made on the Sandoz transformation, including strategy definition and execution in major markets. On-target merger and acquisition efforts were realized, including the Aspen Japan deal. However, the Sandoz-Aurobindo deal was delayed until 2020, pending Federal Trade Commission approval.The transformation of Novartis Business Services (NBS) is ahead of plan, aiming to deliver USD 300 million of recurrent savings by the end of 2019, significantly ahead of the USD 250 million savings target. Novartis Technical Operations (NTO) is well ahead of its productivity target and on track to deliver over USD 1 billion in savings by 2020, through manufacturing site consolidations.Data and digital (20%)|AboveAll 12 priority lighthouses, aimed at embedding data science and digital technology across the enterprise, are currently either achieved or underway. Highlights include ACTalya, the virtual assistant for our sales reps that is now live with over 5 000 sales reps on priority brands in 11 markets, and the use of artificial intelligence (AI)-based marketing to optimize spend on Oncology brands in eight markets. We also launched the GenS platform for sickle cell patients in the US, which reached more than 25% of the total patient population and attracted more than 15000 registrations.In the Novartis Institutes for BioMedical Research (NIBR) and Global Drug Development (GDD), the SENSE platform is now using AI to monitor all trials globally at Novartis. The Data42 project to ingest over 95% of clinical trial data from over 20 years of study was above the target (80%). In NTO, three key digital implementations progressed on target (Buying Engine, &#x201C;spot on&#x201D; cockpit, and Asset Management). In NBS, several projects were achieved, including rollout of an AI-based financial planning system and the single client engagement layer OneNovartis Services.Novartis made strong progress on expanding our capabilities in data science and AI by building up dedicated teams. More than 2 000 Novartis leaders participated in our Digital Immersion for Leaders program. The digital collaboration platform One Digital was launched, hosting over 260 projects in over 40 countries, and the Digital Awareness Hub has attracted more than 30% of the Novartis population. Partnerships were established with Microsoft and Amazon Web Services to collaborate on AI exploration and empowerment across the value chain. In China, Novartis signed a partnership with Tencent in heart failure to develop a novel patient solution that was tested by 90 patients and that gained buy-in from key opinion leaders.</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">136</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="comp_0026.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">2019 CEO BALANCED SCORECARD &#x2212; CONTINUEDPeople and culture (20%)|AboveThe culture continues to develop positively toward an inspired, curious and unbossed organization supporting stronger innovation, performance and ethics. Investment has been made in leadership upskilling so that leaders can role model the culture attributes. We are reimagining our performance management based on three elements: (i) ensuring that goals are meaningful and link to the Company&#x2019;s purpose; (ii) ensuring that associates receive frequent and quality feedback that helps them develop; and (iii) ensuring that associates are recognized in a timely manner and rewarded for their contributions.Our new global recognition program was implemented and is currently reaching 66% of employees. Equal global parental leave was also launched in the first wave of countries. The learning strategy was implemented and encouraged all associates to spend 5% of their time on digital learning through courses available on Coursera, Learnlight and LinkedIn Learning. Further learning, including certificates at universities via Coursera, is also now freely available to all associates. Altogether, learning hours per associate increased 30% compared to the prior year.Associate engagement of our sales force is 78%, and 74% when considering all associates, which is notably above the 72% benchmark. Novartis progressed in line with its aspiration toward its UN commitments under the EPIC pledge to achieve gender balance in management by 2023. In 2019, female representation increased at all senior levels &#x2013; the Executive Committee (25%), top executive positions (31%) and the management level (44%) &#x2013; and it remains above external benchmarks. Our median gender pay gap of 2.4% is also well below the Bloomberg benchmark of 9% (10 000 companies).Building trust with society (including access to healthcare and reputation and other ESG topics) (20%) | MetNovartis conducted an environmental, social and governance (ESG) materiality assessment, and then set a mix of qualitative and quantitative targets in each of the following four identified areas. Additional information can be found in our Novartis in Society, ESG 2019 report.ETHICAL STANDARDS Novartis strengthened representation on ethical matters by establishing a Risk &amp; Resilience function, which was operational as of April 1, 2019. A newly integrated enterprise risk management strategy and process (the Novartis Risk Compass) was designed to support this and was fully executed in 2019. A new Code of Ethics is also on track for implementation, and a digital engagement app called iEthics has launched in 33 countries.PRICING AND ACCESS We reduced our launch time lag between approval of new medicines in developed markets and availability in lower-middle-income countries (LMICs) and lower-income countries (LICs). The five-month time lag for Kisqali was best in class. Our goal is a maximum of one year, which is extremely ambitious versus the industry benchmark. Overall, Novartis was able to achieve the targeted price reductions through manufacturing efficiencies and local brands for all LMICs/LICs to ensure affordability. Access plans were established for six of our biggest innovative brands for 2019 (including Entresto, Cosentyx, Kisqali and Adakveo), and more will follow in 2020.GLOBAL HEALTH Novartis put in place a new structure for the Global Health &amp; Corporate Responsibility function. All flagship programs delivered against target. Novartis is the only big pharmaceutical company to be innovating in malaria, developing new programs KAF156 and KAE609. We pledged to reach an additional 1.3 million patients by 2020 in leprosy. Novartis was admitted to the Global Chagas Disease Coalition, and our Phase IIIb study is ongoing for advancing Chagas chronic cardiomyopathy. In sickle cell disease, a partnership was signed with the government of Ghana and the Sickle Cell Foundation of Ghana.RESPONSIBLE CITIZENSHIP Novartis successfully reduced the number of product recalls to below historical levels. The target was -10%, and actual achievement was -36%. Novartis achieved -3% in energy consumption, versus a target of -5%; -8% in water consumption, against a target of -5%; and -7% in waste sent for disposal, which was on target. The Company made progress in dealing with legacy litigation and integrity issues. Disappointingly, only 96% of health authority inspections were deemed acceptable, below the target of &gt;99% set at the beginning of the year.While important progress was made in this area, given the reputational impact of the Zolgensma data integrity issue, the CEO has requested that he not receive an incentive payout for his &#x2018;building trust with society&#x2019; objective. The Board of Directors agreed with this request.Overall assessment of strategic objectives Above Overall assessment of CEO balanced scorecard OutstandingANNUAL INCENTIVE PAYOUTPayoutBased on the overall assessment, the Board of Directors decided on an adjusted Annual Incentive resulting in a payout for the CEO amounting to CHF 4 017 639, which is 160% of target, within the range&#xA0;of 0&#x2013;200%.</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">137</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Long-Term Incentive plans, 2017-2019 cycle</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Long-Term Performance Plan (LTPP) is the first of two LTI plans operated over the 2017-2019 cycle and rewards creation of long-term value and innovation.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Long-Term Relative Performance Plan (LTRPP) is the second of two LTI plans operated over the 2017-2019 cycle and rewards competitive shareholder return relative to the global healthcare peer group.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The structure of the two plans is summarized below.</div>
<div style="padding-top:15px"><img src="comp_0016.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">OVERVIEW OF LONG-TERM INCENTIVE PLANSGrant formula At the start of the performance cycle, performance share units (PSUs) are granted under each of the Long-Term Incentive plans, as follows:On-target opportunity and payout rangeLTPP:&#x2022;CEO: 200% of annual base salary&#x2022;Other Executive Committee members: between 130% and 190% of annual base salaryLTRPP:&#x2022;CEO: 125% of annual base salary&#x2022;Other Executive Committee members: between 30% and 80% of annual base salaryPayout range&#x2022;From 0% to 200% of the on-target amount based on performanceAward vehiclePSUs granted at the beginning of the cycle vest at the end of the three-year performance cycle and are converted into Novartis shares.PSUs carry dividend equivalents that are paid in shares at the end of the cycle to the extent that performance conditions have been met.Payout formula:Policy information in &#x201C;&#x2014;Treatment of variable compensation for Executive Committee leavers&#x201D; provides details on the treatment of Long-Term Incentive awards for leavers.Step 1Annual base salaryxTarget incentive %=Grant valueStep 2Grant value/Share price=Target number of PSUsTarget number of PSUsxPerformance factor+Dividend equivalents=Realized PSUs</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">138</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">LTPP performance outcomes</font>
</div>
<div style="padding-top:15px"><img src="comp_0015.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">NOVARTIS CASH VALUE ADDED (NCVA) (75% OF LTPP)DescriptionNCVA incentivizes sales growth and margin improvement as well as asset efficiency. It is calculated as follows:1 WACC = weighted average cost of capital2 NCVA = (cash flow return on investment %  WACC) x gross operational assets in constant currenciesThe NCVA performance factor is based on a 1:3 payout curve, whereby a 1% deviation in realization versus target leads to a 3% change in payout (for example, a realization of 105% leads to a payout factor of 115%).Accordingly, if performance over the three-year vesting period falls below 67% of target, no payout is made for this portion of the LTPP. Conversely, if performance over the three-year vesting period is above 133% of target, payout for this portion of the LTPP is capped at 200% of target.Group performance outcome for the 2017-2019 cycleDuring the 2017-2019 cycle, Novartis delivered an NCVA of USD 7.8 billion, 28% ahead of a target of USD 6.1 billion in constant currencies.When setting the target for the 2017-2019 cycle, the Compensation Committee took into account the following: &#x2022;An expected increase in operational performance&#x2022;Key business transformation investments and restructuring costs, particularly in the manufacturing and business services organizations&#x2022;Higher capital cost driven by a growing capital base due to key M&amp;A investments in line with our strategy to become a streamlined medicines companyThe 2017-2019 NCVA performance was mainly driven by the following:&#x2022;Out-performance of sales targets over the three-year cycle by Pharmaceuticals (+USD 2.3 billion, mainly driven by Cosentyx, Entresto, Ophtha and valsartan) as well as by Oncology (+USD 1.0 billion, mainly driven by Promacta/Revolade, Tafinlar + Mekinist, and Afinitor). The return of Alcon to growth also played a key role.&#x2022;Overachievement of productivity targets, mainly in manufacturing (COGS), as well as further increased R&amp;D and NBS productivity (-1% point of service cost over sales) allowed for targeted launch investments while increasing core operating income margin in constant currencies.Following the application of the agreed payout curve, the 128% achievement versus target generates a performance factor of 184% of target for this part of the LTPP.For LTPP cycles starting from 2019, Novartis replaced NCVA as the financial metric with a combination of a three-year net sales compound annual growth rate (CAGR) and core operating income CAGR.INNOVATION (25% OF LTPP)DescriptionInnovation is a key value driver for shareholders and is critical to our future. At the beginning of the cycle, the Research &amp; Development Committee determines the most important target milestones, considering the following:&#x2022;The expected future potential revenue&#x2022;The potential qualitative impact of research and development on science and medicine&#x2022;The potential impact of research and development on the treatment or care of patientsFor the cycle 2017-2019, innovation is specific to the respective head of the division or unit, and is a weighted average of the divisions or units for the CEO and Group function heads.At the end of the cycle, the Compensation Committee determines the payout factor based on the performance assessment made by the Research &amp; Development Committee. In the healthcare industry, achievement of 60% to 80% of pipeline targets set at the beginning of a three-year cycle is considered good performance. The payout range 0% to 150% of target is based on the achievement of the target milestones, and payout above 150% of target is only delivered for truly exceptional performance. Group performance outcome for the 2017-2019 cycleIn the 2017-2019 period, Novartis achieved outstanding innovation performance against target. In this three-year period, Novartis received approval for eleven new molecular entities, of which five were approved in 2019 alone. Key achievements for the Innovative Medicines Division include the approvals of Adakveo for sickle cell disease and Zolgensma for spinal muscular atrophy, and the submission of OMB157 (ofatumumab) for multiple sclerosis as well as BYL719 (alpelisib) for HR+ mBC. However, some targets were missed, including the approval of RLX030 (serelaxin) for acute heart failure (due to the failure of the Phase III study for this program), and the approval of ACZ885 (canakinumab) for cardiovascular risk reduction (due to the withdrawal of the file). On the other hand, our overachievements included the rapid approval of Kisqali for HR+/HER2- advanced or metastatic breast cancer, and the approval of Kymriah for diffuse large B-cell lymphoma, which was ahead of schedule.Sandoz delivered important goals, such as the submissions of pirfenidone, apixaban, amantadine hydrochloride and tazarotene cream, but also missed some goals, including the filing of two biosimilar programs, and one low molecular weight generic goal. NIBR made significant progress in applying novel technologies to therapeutic problems, including expanding the use of digital tools for measuring clinical endpoints, and the use of protein degradation to drug difficult targets, and a substantial expansion of the translational capabilities in oncology. NIBR also made substantial progress in the early-stage pipeline, progressing several agents in areas such as immuno-oncology, bispecifics and neuroscience.Following input from the Research &amp; Development Committee, the Board of Directors approved an innovation performance factor for the CEO and Group function heads of 105% of target.LTPP PAYOUTPayoutOverall, the Board of Directors approved an LTPP payout for the CEO amounting to CHF 3 510 963, which is 164% of target, within the range of 0-200%. This amount includes CHF 262 600 of dividend equivalents accrued, and CHF 814 147 in share price evolution over the performance cycle. Operating income+Amortization, impairments, and adjusting for gains/losses from non-operating assetsTaxesCapital charge (based on WACC1) on gross operational assets=NCVA2</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">139</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">LTRPP performance outcomes </font>
</div>
<div style="padding-top:15px"><img src="comp_0021.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">RELATIVE TOTAL SHAREHOLDER RETURN (TSR) (100% OF LTRPP)DescriptionPerformance is based on our TSR relative to a global healthcare peer group. Outperformance of this peer group is a key indicator that Novartis is delivering long-term value to its shareholders.The peer group and payout matrix for the 2017-2019 performance cycle are as follows:There will be no vesting for below-median performance for the 2018-2020 performance cycle onward as communicated in Item 6B. of the 2018 Annual Report.1 Celgene will be removed from the 2020 peer group as a result of the acquisition by Bristol-Myers Squibb.The payout matrix includes a significant reduction (including scope to reduce to nil) when Novartis does not outperform the majority of the companies in the group. At the end of the performance cycle, all companies are ranked in order of highest to lowest TSR in USD.The Compensation Committee uses its discretion to determine the payout factor within the ranges shown above, and takes into consideration factors such as absolute TSR, overall economic conditions, currency fluctuations and other unforeseeable economic situations. Group performance outcomefor the 2017-2019 cycleNovartis TSR over the three-year period (2017-2019) was 63.4%. When compared to the global healthcare peer group, Novartis TSR ranked No. 6 out of 16 companies. LTRPP PAYOUT FOR THE 2017-2019 CYCLEPayout Based on the ranking, the Board of Directors approved an LTRPP payout of 138% of target for the CEO, resulting in CHF 1 107 806. This amount includes CHF 82 858 of dividend equivalents accrued, and CHF 256 886 in share price evolution over the performance cycle.2017-2019 peer group (15 companies, excluding Novartis)AbbVieBiogenEli Lilly &amp; Co.Johnson &amp; JohnsonPfizerAmgenBristol-Myers SquibbGilead SciencesMerck &amp; Co.RocheAstraZenecaCelgene1GlaxoSmithKlineNovo NordiskSanofiNovartis position Payout rangein the peer group(% of target)Position 1  4Position 5  8Position 9  12Position 13  16160%  200% 100%  150%20%  80%0%</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">140</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Committee membership changes in 2019</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 Executive Committee member external appointments and buyout awards</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table below provides an overview of the Executive Committee external hires made during 2019. When an individual forfeits variable compensation as a result of an appointment at Novartis, the Compensation Committee may offer replacement awards, for example performance share units (PSUs), restricted share units (RSUs) or cash, on a like-for-like basis to mirror the forfeited compensation, based on evidence. Further details on our policy approach can be found in &#x201C;&mdash;Executive Committee appointments compensation policy.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During 2019, one external newly appointed Executive Committee member was granted buyout awards in place of forfeited compensation at his former company in agreement with our aforementioned policy. These are described in the table below. Buyout awards are of equivalent economic value and are subject to the same vesting or performance period, payable no earlier than the compensation forfeited upon joining Novartis. Further details on the vesting of the awards below will be provided in relevant future compensation reports.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">Name</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Date of appointment</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Cash payments (CHF)</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity awards</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total value at grant</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="7" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Saynor</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> July 15, 2019</div>
      </td>
      <td align="right" width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 157&nbsp;087</div>
      </td>
      <td align="right" width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;034&nbsp;803</div>
      </td>
      <td align="right" width="12%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;191&nbsp;890</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CEO, Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> equal to 4'172 PSUs and 7'280 RSUs,  vesting over the period 2020-2022</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="7">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="7">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 Executive Committee member departures </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In determining the compensation arrangements for departing Executive Committee members, the Compensation Committee ensures that contractual entitlements are respected and that all payments are in line with our plan rules and the Swiss Ordinance against Excessive Compensation in Listed Companies.  </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All Executive Committee members have a 12-month notice period during which they are entitled to their contractual base salary, pension, Annual Incentive and other benefits. During the notice period, no new grants of LTPP/LTRPP awards are made. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The plan rules require that any equity vesting will occur on the normal vesting date (i.e., there is no accelerated vesting), and malus and clawback as well as non-compete restrictions will continue to apply. No severance or non-compete payments are made to departing Executive Committee members. Further details on the policy treatment of variable compensation for departing Executive Committee members can be found in &#x201C;&mdash;Treatment of variable compensation for Executive Committee leavers.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The CEO of Novartis Pharmaceuticals, Paul Hudson, resigned from his position on June 7, 2019. The Board of Directors agreed to shorten his 12-month notice period and decided on a cool-off period until August 31, 2019, during which he had no access to any confidential information concerning the Company. Strictly in line with the Novartis incentive plan rules, his Annual Incentive for the 2019 performance year; unvested LTI for cycles 2017-2019, 2018-2020 and 2019-2021; unvested Deferred Share Bonus Plan (DSBP) awarded in 2017, 2018 and 2019; and unvested equity buyouts (5 993 PSUs) made at the point of his recruitment on July 1, 2016, to replace lost equity at his former employer were all forfeited in full.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The CEO of Sandoz, Richard Francis, stepped down from the Executive Committee on March 31, 2019, and will fulfill the required 12-month notice period until the end of March 2020. Outstanding LTI grants will vest at the end of the relevant performance cycles on a pro-rata basis per his contractual agreement and in line with the plan rules.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">141</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Realized compensation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">To aid shareholders&#x2019; understanding of the link between pay and performance, the Compensation Committee discloses the realized compensation for the CEO individually, and for the other members of the Executive Committee on an aggregated basis. Disclosing realized compensation means that the Annual Incentive and the LTI are disclosed at the end of their respective performance cycles, reflecting actual payouts based on performance.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The total actual payout may vary year on year depending on multiple factors, including the composition of the Executive Committee and the tenure of its members (as new members may not have vested LTI), compensation increases, payout of variable compensation based on actual performance, share price fluctuations of the LTI, and dividend equivalents.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 realized compensation for the CEO and other Executive Committee members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table below reports fixed and other compensation for the year, including the Annual Incentive for the 2019 performance year, the realized LTI for the 2017-2019 performance cycle, and any buyouts vesting in 2019. The portion of the Annual Incentive paid in shares for the year 2019 is disclosed using the underlying value of Novartis shares at the date of grant, while the realized values of any other equity awards (including dividend equivalents) are calculated using the share price on the date of vesting.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 annual base  salary</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 pension  benefits<sup>1</sup></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 Annual Incentive  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-Term Incentives  </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other 2019  compensation</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTPP  2017-2019 cycle</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTRPP  2017-2019 cycle</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Cash (amount)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Amount</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Cash</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Equity<sup>2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Equity (value <br> at vesting date)<sup>3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Equity (value<br> at vesting date)<sup>3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Amount<sup>2,4,5</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total realized <br> compensation <br> (incl. share<br> price movement)<sup>6</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan (CEO)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;653&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165&nbsp;547</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;008&nbsp;800</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;008&nbsp;839</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;510&nbsp;963</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;107&nbsp;806</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 160&nbsp;452</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;615&nbsp;740</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Aggregate realized  compensation of the other 14 Executive Committee  members, including the two members  who stepped down  during financial year 2019<sup style="white-space: nowrap">&nbsp;7, 8</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           9&nbsp;370&nbsp;547</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           2&nbsp;131&nbsp;905</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           5&nbsp;809&nbsp;455</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           7&nbsp;013&nbsp;842</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           17&nbsp;932&nbsp;704</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           6&nbsp;383&nbsp;700</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           7&nbsp;233&nbsp;594</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           55&nbsp;875&nbsp;748</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;023&nbsp;880</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;297&nbsp;452</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;818&nbsp;255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;022&nbsp;682</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21&nbsp;443&nbsp;667</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;491&nbsp;506</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;394&nbsp;046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 66&nbsp;491&nbsp;488</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">See &#x201C;&#x2014;2018 realized compensation for the CEO and other Executive Committee members&#x201D; for 2018 comparative figures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 1&nbsp;</sup> Includes mandatory employer contributions of CHF 4'373 for the CEO and CHF 63'461 for the other Executive Committee members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 3'923'070 paid in 2019 for all Executive Committee members, and provides a right to the maximum future insured government pension benefit for the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 2&nbsp;</sup> The portion of the Annual Incentive delivered in equity is rounded up to the nearest share, based on the closing share price on the grant date (January 21, 2020) of CHF 92.89 per Novartis share and USD 95.19 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 3&nbsp;</sup> The amounts represent the underlying share value of the 232'425 LTPP PSUs and 77'904 LTRPP PSUs vesting on January 17, 2020, to the CEO and other Executive Committee members for the performance cycle 2017-2019, inclusive of earned dividend equivalents for the three-year cycle (details in &#x201C;&#x2014;2017-2019 performance cycle LTPP and 2017-2019 performance cycle LTRPP").The taxable value is determined using the closing share price on the day the Novartis Board of Directors approved the final LTPP and LTRPP performance factors (i.e., January 21, 2020) of 92.89 per Novartis share and USD 95.19 per ADR. Shannon Thyme Klinger, Stefan Lang, Susanne Schaffert and Marie-France Tschudin were promoted to the Executive Committee during the course of the performance period 2017-2019, and as such, the information disclosed reflects their pro-rata LTPP &amp; LTRPP 2017-2019 payouts attributable to the period they were a member of the Executive Committee. Bertrand Bodson, Klaus Moosmayer, John Tsai, Robert Weltevreden and Richard Saynor joined Novartis post the 2017 LTI awards being made and hence did not receive LTPP &amp; LTRPP awards for the 2017-2019 performance period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 4&nbsp;</sup> Includes any other perquisites, benefits in kind, international assignment benefits as per the global mobility policy (e.g., housing, international health insurance, children's school fees, tax equalization) as well as vested shares under LTPP &amp; LTRPP after the step down date.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 5&nbsp;</sup> Includes 5 430 vested RSUs (CHF 502 003) on July 28, 2019, to John Tsai, in lieu of the LTI that he forfeited when leaving his previous employer and 1 323 vested RSUs (CHF 123 092) and 14 470 vested PSUs (CHF 1 346 289) on March 24, 2019, to Paul Hudson in lieu of the LTI that he forfeited when leaving his previous employer. The PSUs had the same performance measures as the LTPP for the 2016-2018 performance cycle (NCVA and long-term innovation).</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 6&nbsp;</sup> All amounts are before deduction of the social security contribution and income tax due by the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 7&nbsp;</sup> Comprises the compensation of Richard Francis, the former CEO of Sandoz including the vesting of his Long-Term Incentives for performance cycle 2017-2019, as per the plan rules. Unvested shares for Paul Hudson were forfeited upon his departure from the Company. See &#x201C;&#x2014;Executive Committee member departures" for details.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 8&nbsp;</sup> Amounts for Executive Committee members paid in USD were converted at a rate of USD 1.00 = CHF 0.9938, which is the same average exchange rate used in the Group's 2019 consolidated financial statements.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">142</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table and information below provide additional details on awards granted as part of the 2017-2019 LTPP and LTRPP performance cycle, including the number of shares awarded and delivered, following the application of the payout factor and the addition of dividend equivalent shares.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2017-2019 LTPP performance cycle </font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> PSUs at grant</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Shares delivered at vesting</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> PSUs<br> (target number)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> PSUs<br> (target value<br> at grant date)<br> (CHF)<sup style="white-space: nowrap">     2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Payout factor <br> for LTPP <br> (% of target)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Performance shares <br> delivered at vesting<br> (number)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Performance shares <br> delivered at vesting<br> (value at vesting date)<br> (CHF)<sup style="white-space: nowrap">     3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Dividend <br> equivalent shares <br> delivered at vesting<br> (number)<sup style="white-space: nowrap">     4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Dividend <br> equivalent shares <br> delivered at vesting<br> (value at vesting date)<br> (CHF)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total shares<br> delivered at vesting<br> (value at <br> vesting date)<br> (CHF)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;323</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;980&nbsp;693</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34&nbsp;970</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;248&nbsp;363</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;827</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 262&nbsp;600</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;510&nbsp;963</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other 14 Executive Committee  members, including the  two members who stepped down  during financial year 2019<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       109&nbsp;616</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       10&nbsp;247&nbsp;244</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       164%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       178&nbsp;984</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       16&nbsp;735&nbsp;046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       13&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       1&nbsp;227&nbsp;397</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       17&nbsp;932&nbsp;704</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 130&nbsp;939</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;227&nbsp;938</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 213&nbsp;954</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;983&nbsp;409</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15&nbsp;978</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;489&nbsp;997</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21&nbsp;443&nbsp;667</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Shannon Thyme Klinger, Stefan Lang, Susanne Schaffert and Marie-France Tschudin joined the Executive Committee during the course of the performance period 2017-2019. As such, the information disclosed reflects their pro-rata LTPP 2017-2019 payout attributable to the period they were a member of the Executive Committee. Bertrand Bodson, Klaus Moosmayer, John Tsai, Robert Weltevreden and Richard Saynor joined Novartis post the 2017 LTPP awards being made and hence did not receive an LTPP award for the 2017-2019 performance period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> The shown amounts represent the underlying share value of the target number of PSUs granted to each Executive Committee member for the performance period 2017-2019, based on the closing share price on the grant date (January 17, 2017) of CHF 71.35 per Novartis share and USD 71.99 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> The shown amounts represent the underlying share value of the target number of PSUs vested for the performance period 2017-2019, based on the last closing share price on the day the Novartis Board of Directors approved the final LTPP and LTRPP performance payout factors (i.e., January 21, 2020) of CHF 92.89 per Novartis share and USD 95.19 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Dividend equivalent shares are calculated on the dividend each member of the Executive Committee would have received, based on the actual number of shares delivered at the end of the performance period 2017-2019. At vesting, the dividend equivalents are credited in shares or ADRs.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Includes the LTPP vesting for Richard Francis, the former CEO, Sandoz for performance cycle 2017-2019, as per the plan rules. The LTPP vesting for the former CEO, Novartis Pharmaceuticals, Paul Hudson were forfeited on August 31, 2019, at his departure from the Company. See &#x201C;&#x2014;LTPP perfomance outcomes" for further details.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2017-2019 LTRPP performance cycle </font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> PSUs at grant</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Shares delivered at vesting</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> PSUs<br> (target number)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> PSUs<br> (target value<br> at grant date)<br> (CHF)<sup style="white-space: nowrap">     2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Payout factor <br> for LTRPP <br> (% of target)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Performance shares <br> delivered at vesting<br> (number)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Performance shares <br> delivered at vesting<br> (value at vesting date)<br> (CHF)<sup style="white-space: nowrap">     3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Dividend <br> equivalent shares <br> delivered at vesting<br> (number)<sup style="white-space: nowrap">     4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Dividend <br> equivalent shares <br> delivered at vesting<br> (value at vesting date)<br> (CHF)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total shares<br> delivered at vesting<br> (value at <br> vesting date)<br> (CHF)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;996</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 742&nbsp;748</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 138%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;034</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;024&nbsp;948</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 892</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82&nbsp;858</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;107&nbsp;806</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other 14 Executive Committee  members, including the  two members who stepped down  during financial year 2019<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       45&nbsp;858</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       4&nbsp;290&nbsp;344</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       138%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       63&nbsp;283</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       5&nbsp;920&nbsp;579</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       5&nbsp;077</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       474&nbsp;933</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       6&nbsp;383&nbsp;700</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 53&nbsp;854</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;033&nbsp;093</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 74&nbsp;317</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;945&nbsp;527</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;969</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 557&nbsp;791</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;491&nbsp;506</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Shannon Thyme Klinger, Stefan Lang, Susanne Schaffert and Marie-France Tschudin joined the Executive Committee during the course of the performance period 2017-2019. As such, the information disclosed reflects their pro-rata LTRPP 2017-2019 payout attributable to the period they were a member of the Executive Committee. Bertrand Bodson, Klaus Moosmayer, John Tsai, Robert Weltevreden and Richard Saynor joined Novartis post the 2017 LTRPP awards being made and hence did not receive an LTRPP award for the 2017-2019 performance period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> The shown amounts represent the underlying share value of the target number of PSUs granted to each Executive Committee member for the performance period 2017-2019, based on the closing share price on the grant date (January 17, 2017) of CHF 71.35 per Novartis share and USD 71.99 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> The shown amounts represent the underlying share value of the target number of PSUs vested for the performance period 2017-2019, based on the last closing share price on the day the Novartis Board of Directors approved the final LTPP and LTRPP performance payout factors (i.e., January 21, 2020) of CHF 92.89 per Novartis share and USD 95.19 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Dividend equivalent shares are calculated on the dividend each member of the Executive Committee would have received, based on the actual number of shares delivered at the end of the performance period 2017-2019. At vesting, the dividend equivalents are credited in shares or ADRs.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Includes the LTRPP vesting for the CEO of Sandoz for performance cycle 2017-2019, as per the plan rules. The LTRPP vesting for Paul Hudson were forfeited on August 31, 2019, at his departure from the Company. See &#x201C;&#x2014;LTRPP perfomance outcomes" for further details.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">143</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table and information below provide details on the 2018 realized compensation for the CEO and other Executive Committee members, for comparative purposes.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2018 realized compensation for the CEO and other Executive Committee members</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 annual base  salary</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 pension  benefits<sup>1</sup></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 Annual Incentive  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-Term Incentives  </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other 2018  compensation</div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTPP  2016-2018 cycle</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTRPP  2016-2018 cycle</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Cash (amount)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Amount</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Cash</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Equity<sup>2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Equity (value <br> at vesting date)<sup>3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Equity (value<br> at vesting date)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Amount<sup>2,4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total realized <br> compensation <br> (incl. share<br> price movement)<sup>5</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan (CEO from February 1, 2018)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;491&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   168&nbsp;233</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;594&nbsp;801</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;594&nbsp;805</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;796&nbsp;381</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   34&nbsp;401</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   6&nbsp;680&nbsp;288</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Aggregate realized  compensation of the other 16 Executive Committee  members, including the four members who stepped down  during financial year 2018<sup style="white-space: nowrap">&nbsp;6, 7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">           CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           9&nbsp;297&nbsp;021</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           1&nbsp;874&nbsp;671</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           5&nbsp;727&nbsp;765</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           5&nbsp;532&nbsp;316</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           24&nbsp;079&nbsp;974</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           13&nbsp;131&nbsp;653</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">           59&nbsp;643&nbsp;400</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;788&nbsp;688</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;042&nbsp;904<sup style="white-space: nowrap"> 1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;322&nbsp;566</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;127&nbsp;121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;876&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;166&nbsp;054</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 66&nbsp;323&nbsp;688</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 1&nbsp;</sup> Includes mandatory employer contributions of CHF 4 336 for the CEO and CHF 78 403 for the other Executive Committee members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 2 847 422 paid in 2018 for all Executive Committee members, and provides a right to the maximum future insured government pension benefit for the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 2&nbsp;</sup> The portion of the Annual Incentive delivered in equity is rounded up to the nearest share, based on the closing share price on the grant date (January 22, 2019) of CHF 88.14 per Novartis share and USD 88.32 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 3&nbsp;</sup> The amounts represent the underlying share value of the 294 971 PSUs vesting on January 22, 2019, to the CEO and other Executive Committee members for the performance cycle 2016-2018, inclusive of earned dividend equivalents for the three-year cycle. The taxable value is determined using the closing share price on the day the Novartis Board approved the final LTPP and LTRPP performance factors (i.e., January 22, 2019) of CHF 88.14 per Novartis share and USD 88.32 per ADR. Vasant Narasimhan, Shannon Thyme Klinger, Stefan Lang and Andr&#xE9; Wyss joined the Executive Committee during the course of the performance period 2016-2018, and as such, the information disclosed reflects their pro-rata LTPP 2016-2018 payout attributable to the period they were a member of the Executive Committee. Elizabeth Barrett, Bertrand Bodson, Paul Hudson, Klaus Moosmayer, John Tsai and Robert Weltevreden joined post the 2016 LTPP awards being made and hence did not receive an LTPP award for the 2016-2018 performance period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 4&nbsp;</sup> Includes any other perquisites, benefits in kind, international assignment benefits as per the global mobility policy (e.g., housing, international health insurance, children's school fees, tax equalization) as well as vested shares under LTPP after the step down date.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 5&nbsp;</sup> All amounts are before deduction of the social security contribution and income tax due by the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 6&nbsp;</sup> Comprises the compensation of the outgoing CEO, General Counsel, CEO of Alcon, and President of Novartis Operations and Country President Switzerland, including the vesting of their Long-Term Incentives for performance cycle 2016-2018, as per the plan rules.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 7&nbsp;</sup> Amounts for Executive Committee members paid in USD were converted at a rate of UDS 1.00 = CHF 0.978, which is the same average exchange rate used in the Group's 2018 consolidated financial statements.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Realized compensation for the Executive Committee for 2019 compared to 2018</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In his second, and first full year in the role, and following a strong performance year for the Company, the 2019 total realized compensation for the CEO was <b>CHF 10 615 740</b>, and includes the payouts of the Annual Incentive, LTPP and LTRPP based on actual performance assessed for the three-year cycle concluding in 2019. This increase, compared to 2018, can be further explained by the following: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The CEO&#x2019;s annual base salary was increased by 8% from March 31, 2019 in line with our &#x201C;&mdash;Executive Committee appointments compensation policy&#x201D; as communicated in Item 6.B of the 2018 Annual Report.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The 2017-2019 LTPP and LTRPP (his first LTI  granted as a member of the Executive Committee prior to his CEO role) vested at 164% and 138%, respectively (compared to the 2018 payouts of 136% and 0%).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Novartis share price increased by 30.2% between the grant and vest date of the LTPP and LTRPP.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Overall, the 2019 total realized compensation for the Executive Committee, including the CEO, was CHF 66.5 million, which is broadly in line with the 2018 total realized compensation of CHF 66.3 million. The lower turnover of Executive Committee members (four members stepped down in 2018 versus two members in 2019) was partly offset by the higher performance payouts of the variable pay elements (both the Annual Incentive and the LTI) due to the strong Company performance. In addition, 2019 was also the first full year for a number of other members of the Executive Committee. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">144</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Compensation at grant value</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In accordance with the Swiss Ordinance against Excessive Compensation in Listed Companies, Novartis continues to disclose total compensation at grant value for the CEO and other Executive Committee members. The following tables disclose for the CEO and other Executive Committee members:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Fixed 2019 compensation (base salary and benefits)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The actual cash portion and the deferred portion granted in equity of the 2019 Annual Incentive</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; 2019-2021 LTPP performance cycle awards, which are reported at target value at grant date under the assumption that the awards will vest at 100% achievement, excluding any share price movement and dividend equivalents that may be accrued over the performance cycle. The future payout will be determined only after the performance cycle concludes in three years (i.e., the end of 2021), with a payout range of 0% to 200% of the target value.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other compensation for 2019, which includes other benefits and the full amount of compensation for lost entitlements from former employers (buyouts), and compensation during the notice period (between the date of stepping down from the Executive Committee and either December 31 or the end of the contractual notice), either paid in cash or granted in equity in the year</div>
<div style="border:solid #eeeeee 3px; background-color:#eeeeee;padding-bottom:0px;">
  <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">To assess CEO actual pay for performance in 2019, including the Annual Incentive payout for the 2019 performance year and the LTI payouts for the 2017-2019 performance cycle, shareholders should refer to the 2019 realized compensation table in &#x201C;&mdash;2019 realized compensation for the CEO and other Executive Committee members.&#x201D;</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">145</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019 compensation at grant value for the CEO and other Executive Committee members</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fixed compensation and  pension benefits</div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Variable compensation  </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     </div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Actual compensation paid or granted for 2019    </div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-Term Incentive  2019-2021 cycle  grants at target</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 annual base  salary    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 pension  benefits    </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 Annual Incentive   (performance achieved)    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTPP   2019-2021 cycle    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other 2019  compensation    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total   compensation   paid, promised  or granted 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Cash<br> (amount)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Amount<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Cash<br> (amount)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Equity<br> (value at<br> grant date)<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> PSUs<br> (target value<br> at grant date)<sup style="white-space: nowrap">   3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Amount<sup style="white-space: nowrap">   4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Amount<sup style="white-space: nowrap">   5</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members active on December 31, 2019</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;653&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165&nbsp;547</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;008&nbsp;800</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;008&nbsp;839</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;440&nbsp;530</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 160&nbsp;452</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;437&nbsp;501</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steven Baert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 789&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161&nbsp;454</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 633&nbsp;360</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 633&nbsp;417</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;662&nbsp;585</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 124&nbsp;979</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;005&nbsp;545</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bertrand Bodson</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 607&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 170&nbsp;178</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 341&nbsp;040</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 341&nbsp;092</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 974&nbsp;476</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 137&nbsp;826</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;572&nbsp;111</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">James Bradner<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;126&nbsp;781</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 359&nbsp;961</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 951&nbsp;720</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 951&nbsp;805</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;832&nbsp;511</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85&nbsp;498</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;308&nbsp;275</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Harry Kirsch</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;053&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164&nbsp;467</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;045&nbsp;044</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;045&nbsp;105</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;744&nbsp;591</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27&nbsp;658</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;079&nbsp;865</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shannon Thyme Klinger</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 783&nbsp;333</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188&nbsp;990</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 468&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 468&nbsp;073</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;600&nbsp;005</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 111&nbsp;375</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;619&nbsp;776</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steffen Lang</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 745&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167&nbsp;815</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 408&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 612&nbsp;145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;200&nbsp;026</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;810</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;142&nbsp;796</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Klaus Moosmayer</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 125&nbsp;483</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 260&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 260&nbsp;092</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 800&nbsp;047</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 171&nbsp;749</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;117&nbsp;371</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Saynor (from July 15, 2019)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 356&nbsp;021</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 179&nbsp;315</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 179&nbsp;371</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;950&nbsp;908</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;752&nbsp;732</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Susanne Schaffert<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 850&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167&nbsp;096</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 459&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;071&nbsp;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;870&nbsp;066</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 160&nbsp;252</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;577&nbsp;528</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">John Tsai</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 858&nbsp;333</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 181&nbsp;048</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 602&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 602&nbsp;020</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;064&nbsp;063</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 377&nbsp;544</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;685&nbsp;007</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marie-France Tschudin (from June 7, 2019)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 481&nbsp;667</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 92&nbsp;090</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 290&nbsp;630</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 290&nbsp;653</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 968&nbsp;249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;123&nbsp;289</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Robert Weltevreden</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 607&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 157&nbsp;423</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 158&nbsp;340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 475&nbsp;132</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 974&nbsp;476</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;860</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;377&nbsp;731</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;405&nbsp;223</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;186&nbsp;434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;799&nbsp;341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;932&nbsp;950</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;114&nbsp;040</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;322&nbsp;378</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;760&nbsp;366</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members who stepped down during 2019</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Francis (until March 19, 2019)<sup style="white-space: nowrap">&nbsp;8, 9</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 179&nbsp;315</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36&nbsp;025</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;914</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37&nbsp;435</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 720&nbsp;460</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;808&nbsp;445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;800&nbsp;594</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Paul Hudson (until June 7, 2019)<sup style="white-space: nowrap">&nbsp;9, 10</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 439&nbsp;342</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74&nbsp;994</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270&nbsp;451</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;885&nbsp;164</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;669&nbsp;950</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 618&nbsp;657</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 111&nbsp;018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18&nbsp;914</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;435</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 990&nbsp;910</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;693&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;470&nbsp;543</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;023&nbsp;880</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;297&nbsp;452</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;818&nbsp;255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;970&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24&nbsp;104&nbsp;951</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;015&nbsp;988</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 64&nbsp;230&nbsp;910</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td bgcolor="#eeeeee" colspan="3" align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">&nbsp;Based on assumption of&nbsp;100% payout at target.&nbsp;Actual payout (0-200% of&nbsp;target) will be known at &nbsp;the end of the three-year&nbsp;cycle in January 2022.</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">See next page for 2018 comparative figures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 1&nbsp;</sup> Includes mandatory employer contributions of CHF 4'373 for the CEO and CHF 63'461 for the other Executive Committee members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 3'923'070 paid in 2019 for all Executive Committee members, and provides a right to the maximum future insured government pension benefit for the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 2&nbsp;</sup> The portion of the Annual Incentive delivered in equity is rounded up to the nearest share, based on the closing share price on the grant date (January 21, 2020) of CHF 92.89 per Novartis share and USD 95.19 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 3&nbsp;</sup> The amounts represent the underlying share value of the target number of PSUs granted to Executive Committee members for the performance cycle 2019-2021, based on the closing share price on the grant date (January 22, 2019) of CHF 88.14 per Novartis share and USD 88.32 per ADR for all members except for Mr. Richard Saynor, who was not part of the Company at the annual grant date and hence did not receive an LTPP award.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 4&nbsp;</sup> Includes any other perquisites, benefits in kind, and international assignment benefits as per the global mobility policy (e.g., housing, international health insurance, children's school fees, tax equalization)</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 5&nbsp;</sup> All amounts are before deduction of the social security contribution and income tax due by the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 6&nbsp;</sup> Amounts in USD for James Bradner were converted at a rate of CHF 1.00 = USD 1.006 , which is the average rate used in the Group&#x2019;s 2019 consolidated financial statements.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 7&nbsp;</sup> For those members who joined the Executive Committee in 2019, the information under the columns &#x201C;Actual compensation paid or granted for 2019&#x201D; and &#x201C;Long-Term Incentive 2019-2021 cycle grants at target&#x201D; includes their pro-rata compensation from the date they joined the Executive Committee to December 31, 2019 or to the end of the performance cycle in the case of the &#x201C;Long-Term Incentive 2019-2021 cycle grants at target&#x201D;.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 8&nbsp;</sup> Richard Francis stepped down as CEO, Sandoz on March 19, 2019 and will leave the company on 31 March, 2020 in line with his contractual notice period. Until the end of the notice period, he will receive further contractual compensation that includes the base salary, Annual Incentive and pension benefits. In accordance with the plan rules, the LTPP 2019-2021 cycle grant (21 217 PSUs), included in full in the above table, will vest on the normal vesting date pro-rata based on the number of months of Novartis employment during the performance cycle. The vesting of this grant is subject to performance conditions assessed at the end of the period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 9&nbsp;</sup> For those members leaving the Executive Committee, the columns under &#x201C;Actual compensation paid or granted for 2019&#x201D; and &#x201C;Long-Term Incentive 2019-2021 cycle grants at target&#x201D; reflect the pro-rata compensation for their period as Executive Committee member. The column &#x201C;Other 2019 compensation&#x201D; includes inter alia their pro-rata compensation from the date they left the Executive Committee to December 31, 2019 or to the end of the performance cycle in the case of the &#x201C;Long-Term Incentive 2019-2021 cycle grants at target&#x201D;. See &#x201C;&#x2014;2019 Executive Committee member departures" for details.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup> 10&nbsp;</sup> Paul Hudson stepped down as CEO, Novartis Pharmaceuticals on June 7, 2019 and left the company on August 31, 2019 in line with his reduced contractual notice period (see for more details &#x201C;&#x2014;2019 Executive Committee member departures&#x201D;). The Annual Incentive and LTPP 2019-2021 cycle grant (31 553 PSUs) included in the table above, were forfeited in full upon his departure.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">146</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2018 compensation at grant value for the CEO and other Executive Committee members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For comparative purposes, the table below provides the compensation at grant value for 2018. </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fixed compensation and  pension benefits</div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Variable compensation  </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Actual compensation paid or granted for 2018  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-Term Incentive 2018-2020 cycle  grants at target</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 annual base  salary    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 pension  benefits    </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 Annual Incentive   (performance achieved)    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTPP   2018-2020 cycle    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTRPP   2018-2020 cycle    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other 2018  compensation    </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total   compensation   paid, promised  or granted 2018</div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Cash<br> (amount)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Amount<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Cash<br> (amount)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Equity<br> (value at<br> grant date)<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> PSUs<br> (target value<br> at grant date)<sup style="white-space: nowrap">   3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> PSUs<br> (target value<br> at grant date)<sup style="white-space: nowrap">   3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Amount<sup style="white-space: nowrap">   4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Amount<sup style="white-space: nowrap">   5</sup></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members active on December 31, 2018</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan (CEO from February 1, 2018)<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;491&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   168&nbsp;233</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;594&nbsp;801</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;594&nbsp;805</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   3&nbsp;100&nbsp;046</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;937&nbsp;539</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   34&nbsp;401</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   9&nbsp;921&nbsp;491</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steven Baert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 152&nbsp;914</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 585&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 585&nbsp;073</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;170&nbsp;051</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 468&nbsp;053</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77&nbsp;550</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;818&nbsp;642</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Elizabeth Barrett (from February 1, 2018,  to December 31, 2018)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     779&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     174&nbsp;274</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;360&nbsp;040</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     510&nbsp;057</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     2&nbsp;747&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     5&nbsp;571&nbsp;397</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bertrand Bodson (from April 1, 2018)<sup style="white-space: nowrap">&nbsp;8</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   450&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   97&nbsp;666</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   216&nbsp;986</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   217&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   440&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   110&nbsp;174</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   146&nbsp;478</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;678&nbsp;918</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">James Bradner<sup style="white-space: nowrap">&nbsp;9</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;094&nbsp;462</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 257&nbsp;018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 924&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 924&nbsp;004</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;870&nbsp;085</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 880&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 63&nbsp;313</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;012&nbsp;967</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Francis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 850&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 176&nbsp;368</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 382&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 382&nbsp;528</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;360&nbsp;057</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 510&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;790&nbsp;428</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;451&nbsp;882</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Paul Hudson</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 985&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180&nbsp;771</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;007&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;007&nbsp;352</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;683&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 792&nbsp;027</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 94&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;749&nbsp;866</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Harry Kirsch</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;040&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173&nbsp;499</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 858&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 858&nbsp;043</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;768&nbsp;008</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 832&nbsp;067</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58&nbsp;814</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;588&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shannon Thyme Klinger (from April 1, 2018)<sup style="white-space: nowrap">&nbsp;8</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   520&nbsp;833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   103&nbsp;448</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   275&nbsp;770</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   275&nbsp;790</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   619&nbsp;595</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   185&nbsp;862</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   37&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;018&nbsp;416</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steffen Lang (from April 1, 2018)<sup style="white-space: nowrap">&nbsp;8</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   540&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   99&nbsp;535</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   260&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   260&nbsp;454</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   596&nbsp;631</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   179&nbsp;064</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   8&nbsp;595</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;944&nbsp;663</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Klaus Moosmayer (from December 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   41&nbsp;667</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   9&nbsp;704</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   16&nbsp;986</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   17&nbsp;011</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   808&nbsp;821</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   894&nbsp;189</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">John Tsai (from May 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   566&nbsp;667</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   126&nbsp;845</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   313&nbsp;801</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   313&nbsp;867</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4&nbsp;590&nbsp;950</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;912&nbsp;129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Robert Weltevreden (from June 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   350&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   70&nbsp;950</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   77&nbsp;392</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   232&nbsp;337</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   671&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   155&nbsp;003</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   3&nbsp;715</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;561&nbsp;099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;464&nbsp;855</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;785&nbsp;446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;492&nbsp;171</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;647&nbsp;490</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;597&nbsp;819</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;540&nbsp;145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;460&nbsp;974</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 55&nbsp;988&nbsp;900</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members who stepped down during 2018<sup>&nbsp;10</sup></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Joseph Jimenez  (CEO until January 31, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   178&nbsp;601</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   19&nbsp;146</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   133&nbsp;767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;357&nbsp;371</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;688&nbsp;885</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">F. Michael Ball (until June 30, 2018)<sup style="white-space: nowrap">&nbsp;9</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   555&nbsp;397</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   126&nbsp;594</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   333&nbsp;238</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   333&nbsp;231</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   888&nbsp;640</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   388&nbsp;845</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;970&nbsp;642</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;596&nbsp;587</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Felix R. Ehrat (until May 31, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   384&nbsp;740</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   68&nbsp;918</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   153&nbsp;896</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   153&nbsp;892</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   654&nbsp;081</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   230&nbsp;877</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;346&nbsp;072</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   3&nbsp;992&nbsp;477</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Andr&#xE9; Wyss  (until March 31, 2018)<sup style="white-space: nowrap">&nbsp;11</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   217&nbsp;582</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   45&nbsp;646</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   216&nbsp;986</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   116&nbsp;060</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   43&nbsp;523</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;375&nbsp;802</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;015&nbsp;599</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;323&nbsp;833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 257&nbsp;458</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 830&nbsp;395</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 479&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;638&nbsp;802</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 654&nbsp;503</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;983&nbsp;098</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;167&nbsp;721</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;788&nbsp;688</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;042&nbsp;904</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;322&nbsp;566</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;127&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;236&nbsp;621</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;194&nbsp;648</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 19&nbsp;444&nbsp;072</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70&nbsp;156&nbsp;621</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr>
      <td colspan="21" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td bgcolor="#eeeeee" colspan="3" align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">&nbsp;Based on assumption of&nbsp;100% payout at target.&nbsp;Actual payout (0-200% of&nbsp;target) will be known at &nbsp;the end of the three-year&nbsp;cycle in January 2021.</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 1&nbsp;</sup> Includes mandatory employer contributions of CHF 4 336 for the CEO and CHF 78 403 for the other Executive Committee members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 2 847 422 paid in 2018 for all Executive Committee members, and provides a right to the maximum future insured government pension benefit for the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 2&nbsp;</sup> The portion of the Annual Incentive delivered in equity is rounded up to the nearest share, based on the closing share price on the grant date (January 22, 2019) of CHF 88.14 per Novartis share and USD 88.32 per ADR.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 3&nbsp;</sup> The amounts represent the underlying share value of the target number of PSUs granted to Executive Committee members for the performance cycle 2018-2020, based on the closing share price on the grant date (January 18, 2018) of CHF 82.90 per Novartis share and USD 86.41 per ADR for all members except Elizabeth Barrett and Robert Weltevreden. For Ms. Barrett and Mr. Weltevreden, the closing share price on the grant date was respectively CHF 83.52 on February 1, 2018, and CHF 74.70 on June 1, 2018, per Novartis share.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 4&nbsp;</sup> Includes any other perquisites, benefits in kind, and international assignment benefits as per the global mobility policy (e.g., housing, international health insurance, children's school fees, tax equalization)</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 5&nbsp;</sup> All amounts are before deduction of the social security contribution and income tax due by the Executive Committee member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 6&nbsp;</sup> The figures include Vasant Narasimhan's compensation of January 2018 as Head of Global Drug Development.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 7&nbsp;</sup> Elizabeth Barrett stepped down from the role of CEO, Novartis Oncology and from the Executive Committee as at the end of the 2018 business year. The LTPP and LTRPP grants (16 284 and 6 107 PSUs, respectively) for the 2018-2020 performance cycle, and the 2018 buyout award of 21 267 performance shares, reflected in other compensation, both included in the table above, were forfeited in full upon her departure on December 31, 2018.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 8&nbsp;</sup> For those members who joined the Executive Committee in 2018, the information under the columns &#x201C;2018 annual base salary,&#x201D; &#x201C;2018 pension benefits,&#x201D; &#x201C;2018 Annual Incentive,&#x201D; &#x201C;LTPP&#x201D; and &#x201C;LTRPP&#x201D; includes their pro-rata compensation from the date they joined the Executive Committee to December 31, 2018.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 9&nbsp;</sup> Amounts in USD for F. Michael Ball and James Bradner were converted at a rate of CHF 1.00 = USD 0.978, which is the same average exchange rate used in the Group's 2018 consolidated financial statements.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup> 10&nbsp;</sup> For those members who left the Executive Committee in 2018, the information under the columns &#x201C;2018 annual base salary,&#x201D; &#x201C;2018 pension benefits,&#x201D; &#x201C;2018 Annual Incentive,&#x201D; &#x201C;LTPP&#x201D; and &#x201C;LTRPP&#x201D; reflects the pro-rata compensation for the period they were an Executive Committee member in 2018. The information under the column &#x201C;Other 2018 compensation&#x201D; also includes, inter alia, their pro-rata compensation from the date they stepped down from the Executive Committee to December 31, 2018.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="21">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup> 11&nbsp;</sup> The full number of PSUs under LTPP and LTRPP 2018-2020 granted to Andr&#xE9; Wyss were 16 985 and 6 370, respectively. The amounts included under LTPP and LTRPP in the table above are disclosed on a pro-rata basis to the end of his notice period (i.e., September 30, 2018), per his contractual agreement and subject to the plan rules.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">147</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compensation at grant value for the Executive Committee for 2019 compared to 2018</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Grant compensation delivered to the CEO increased by CHF 1.5 million from 2018 to 2019, largely due to the payout of the 2019 Annual Incentive, and an 8% increase in annual base salary from March 31, 2019 as reported in Item 6.B of the 2018 Annual Report.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Overall, there is a notable decrease when comparing the 2019 Executive Committee total compensation at grant value of CHF 64.2 million to the 2018 grant value of CHF 70.2 million. The difference is primarily due to:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The reduced overlap of members (in total, 17 Executive Committee members were granted compensation in 2018 compared to 15 members in 2019).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The CEO of Alcon, who stepped down in 2018 and was not replaced following the decision to spin off Alcon.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Buyout awards (in cash and/or in equity) granted to one onboarding external member in 2019 versus three joining in 2018 (see Item 6.B in the 2018 Annual Report).</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Additional disclosures for the CEO and other Executive Committee members</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">This section provides additional disclosures, including information about the shareholdings of the CEO and the other Executive Committee members.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Malus and clawback</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Per our &#x201C;&mdash;Executive Committee compensation philosophy and principles,&#x201D; in 2019, there was no legal or factual basis on which to exercise malus or clawback for current or former Executive Committee members. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">148</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Number of equity instruments granted to the CEO and other Executive Committee members for financial year 2019</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Variable compensation<sup>1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2019 Annual Incentive  (performance achieved)</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTPP  2019-2021 cycle</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity<br> (number)<sup style="white-space: nowrap">  2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> PSUs<br> (target number)<sup style="white-space: nowrap">  3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity/PSUs<br> (number)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members active on December 31, 2019</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;626</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61&nbsp;726</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steven Baert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;819</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;863</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bertrand Bodson</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;672</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;056</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">James Bradner</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;999</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32&nbsp;071</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Harry Kirsch</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;251</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shannon Thyme Klinger</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;039</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;153</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steffen Lang</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;615</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Klaus Moosmayer</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;077</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Saynor (from July 15, 2019)<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;931</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;452</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Susanne Schaffert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;531</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">John Tsai</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;481</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;418</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marie-France Tschudin (from June 7, 2019)<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;085</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Robert Weltevreden</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;056</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 95&nbsp;983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 262&nbsp;476</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;452</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members who stepped down during 2019</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Francis (until March 19, 2019)<sup style="white-space: nowrap">&nbsp;5, 6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Paul Hudson (until June 7, 2019)<sup style="white-space: nowrap">&nbsp;5, 7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;366</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 96&nbsp;386</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 275&nbsp;842</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;452</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">See next page for 2018 comparative figures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The values of the awards are reported in the table "2019 compensation at grant value for the CEO and other Executive Committee members" in &#x201C;&#x2014;2019 compensation at grant value for the CEO and other Executive Committee members."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Vested shares, restricted shares and/or RSUs granted under the Annual Incentive for performance period 2019</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Target number of PSUs granted under the LTPP as applicable for the performance cycle 2019-2021</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> For those members who joined the Executive Committee in 2019, the information under the column &#x201C;Variable compensation&#x201D; includes their pro-rata number of equity instruments from the date they joined the Executive Committee to December 31, 2019 or to the end of the performance cycle in case of the "LTPP 2019-2021 cycle".</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> For those members leaving the Executive Committee, the column under &#x201C;Variable compensation&#x201D; reflects the pro-rata number of equity instruments for their period as Executive Committee member. The column &#x201C;Other&#x201D; includes their pro-rata compensation from the date they left the Executive Committee to December 31, 2019 or to the end of the performance cycle in the case of the &#x201C;LTPP 2019-2021 cycle&#x201D;. See &#x201C;&#x2014;2019 Executive Committee member departures&#x201D; for details.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> Richard Francis stepped down as CEO, Sandoz on March 19, 2019 and will leave the company on 31 March, 2020 in line with his contractual notice period. In accordance with the plan rules, the LTPP 2019-2021 cycle grant (21 217 PSUs), included in full in the above table, will vest on the normal vesting date pro-rata based on the number of months of Novartis employment during the performance cycle. The vesting of this grant is subject to performance conditions assessed at the end of the period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;7&nbsp;</sup> Paul Hudson stepped down as CEO, Novartis Pharmaceuticals on June 7, 2019 and left the company on August 31, 2019 in line with his reduced contractual notice period (see for more details &#x201C;&#x2014;2019 Executive Committee member departures&#x201D;). The 2019 Annual Incentive and LTPP 2019-2021 cycle grant (31 553 PSUs) included in the table above, were forfeited in full upon his departure.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">149</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Number of equity instruments granted to the CEO and other Executive Committee members for financial year 2018 (comparative information)</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Variable compensation<sup>1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> 2018 Annual Incentive  (performance achieved)</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTPP  2018-2020 cycle</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> LTRPP  2018-2020 cycle</div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity<br> (number)<sup style="white-space: nowrap">  2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> PSUs<br> (target number)<sup style="white-space: nowrap">  3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> PSUs<br> (target number)<sup style="white-space: nowrap">  3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity/PSUs<br> (number)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members active on December 31, 2018</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan (CEO from February 1, 2018)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;094</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37&nbsp;395</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23&nbsp;372</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steven Baert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;638</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;646</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Elizabeth Barrett (from February 1, 2018, to December 31, 2018)<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21&nbsp;267</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bertrand Bodson (from April 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;462</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;315</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">James Bradner</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;462</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21&nbsp;642</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Francis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16&nbsp;406</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Paul Hudson</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;429</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;302</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;554</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Harry Kirsch</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;735</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21&nbsp;327</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;037</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shannon Thyme Klinger (from April 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;242</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steffen Lang (from April 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;955</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Klaus Moosmayer (from December 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 193</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;857</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">John Tsai (from May 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;561</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27&nbsp;381</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Robert Weltevreden (from June 1, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;636</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;992</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;075</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 75&nbsp;634</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 176&nbsp;448</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 57&nbsp;505</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Executive Committee members who stepped down during 2018</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Joseph Jimenez (CEO until January 31, 2018)<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">F. Michael Ball (until June 30, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;865</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Felix R. Ehrat (until May 31, 2018)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;221</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;890</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;785</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;603</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Andr&#xE9; Wyss (until March 31, 2018)<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;915</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;830</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 19&nbsp;574</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;810</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 40&nbsp;383</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 87&nbsp;464</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196&nbsp;022</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 86&nbsp;669</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 97&nbsp;888</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The values of the awards are reported in the table "2018 compensation at grant value for the CEO and other Executive Committee members" in &#x201C;&#x2014;2018 compensation at grant value for the CEO and Executive Committee members."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Vested shares, restricted shares and/or RSUs granted under the Annual Incentive for performance period 2018</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Target number of PSUs granted under the LTPP and LTRPP as applicable for the performance cycle 2018-2020</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Elizabeth Barrett stepped down from the role of CEO, Novartis Oncology and from the Executive Committee as at the end of the 2018 business year. The LTPP and LTRPP grants (16 284 and 6 107 PSUs, respectively) for the 2018-2020 performance cycle, and the 2018 buyout award of 21 267 performance shares, reflected in other compensation, both included in the table above, were forfeited in full upon her departure on December 31, 2018.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Joseph Jimenez received his 2018 Annual Incentive 100% in cash and was not granted LTPP and LTRPP awards for the performance cycle 2018-2020.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> Andr&#xE9; Wyss stepped down from the Executive Committee on March 31, 2018, and ended his notice period on September, 30 2018. He received his 2018 Annual Incentive 100% in cash on a pro-rata basis, and the LTPP and LTRPP grants for the 2018-2020 performance cycle, included in the table above, will vest at the end of the performance cycle on a pro-rata basis per his contractual agreement and subject to the plan rules.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">150</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Share ownership requirements for the CEO and other Executive Committee members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Executive Committee members are required to own at least a minimum multiple of their annual base salary in Novartis shares or RSUs within five years of hire or promotion, as set out in the table below. In the event of a substantial rise or drop in the share price, the Board of Directors may, at its discretion, amend that time period accordingly.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;">Function</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;"> Ownership level</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CEO</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 x base compensation</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other Executive Committee members</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 x base compensation</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The determination of equity amounts against the share ownership requirements is defined to include vested and unvested Novartis shares or American Depositary Receipts (ADRs), and RSUs acquired under the Company&#x2019;s compensation plans. However, unvested matching shares granted under former matching programs, such as the Leveraged Share Savings Plan (LSSP), and any unvested PSUs are excluded. The determination also includes other shares and vested options of Novartis shares or ADRs that are owned directly or indirectly by &#x201C;persons closely linked&#x201D; to an Executive Committee member. The Compensation Committee reviews compliance with the share ownership guideline on an annual basis.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Shares, ADRs and other equity rights owned by Executive Committee members at December 31, 2019</font><font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows, in alphabetical order after the CEO, the total number of shares, ADRs and other equity rights owned by the CEO and the other Executive Committee members and &#x201C;persons closely linked&#x201D; to them as of December 31, 2019. As of December 31, 2019, no members of the Executive Committee, either individually or together with &#x201C;persons closely linked&#x201D; to them, owned 1% or more of the outstanding shares or ADRs of Novartis. As of December 31, 2019, all members who have served at least five years on the Executive Committee have met or exceeded their personal Novartis share ownership requirements.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Vested shares <br> and ADRs<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Unvested shares <br> and other equity rights<sup style="white-space: nowrap">   2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity ownership level <br> as a multiple of <br> annual base salary<sup style="white-space: nowrap">   3</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Unvested target PSUs <br> (e.g., LTPP/LTRPP)<sup style="white-space: nowrap">   4</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Matching shares <br> under the LSSP<sup style="white-space: nowrap">   5</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Total at<br> December 31, 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 59&nbsp;983</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 89&nbsp;381</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8x</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 115&nbsp;896</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;657</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269&nbsp;917</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steven Baert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39&nbsp;785</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31&nbsp;890</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64&nbsp;538</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 136&nbsp;213</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bertrand Bodson</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;600</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;492</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;037</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31&nbsp;129</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">James Bradner</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;794</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;531</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104&nbsp;379</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 172&nbsp;704</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Harry Kirsch</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108&nbsp;193</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40&nbsp;968</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102&nbsp;484</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 251&nbsp;645</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shannon Thyme Klinger</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;193</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35&nbsp;117</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;488</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 70&nbsp;826</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steffen Lang</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 56&nbsp;063</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;782</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;535</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 107&nbsp;628</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Klaus Moosmayer</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;016</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;034</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;050</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Saynor  (from July 15, 2019)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   9&nbsp;211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;790</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   11&nbsp;001</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Susanne Schaffert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43&nbsp;770</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;123</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36&nbsp;224</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;735</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 107&nbsp;852</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">John Tsai</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29&nbsp;570</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;487</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53&nbsp;916</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marie-France Tschudin  (from June 7, 2019)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   24&nbsp;715</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   45&nbsp;078</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   75&nbsp;293</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Robert Weltevreden</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;751</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1x</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;386</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19&nbsp;287</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 363&nbsp;890</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 362&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 583&nbsp;232</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;415</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;322&nbsp;461</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Includes holdings of "persons closely linked" to Executive Committee members (see definition &#x201C;&#x2014;Persons closely linked.")</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Includes unvested shares and ADRs as well as other equity rights applicable for the determination of equity amounts for the share ownership requirements, as per the definition above. Also includes unvested keep-whole shares received in connection to the Alcon spin-off.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> The multiple is calculated based on the full-year annual base salary and the closing share price as at the end of the 2019 financial year. The share price on the final trading day of 2019 was CHF 91.90 / USD 94.69 as at December 31, 2019.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> The target number of PSUs is disclosed pro-rata to December 31, 2019, unless the award qualified for full vesting under the relevant plan rules.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Matching shares under the Leveraged Share Savings Plan (LSSP) are disclosed pro-rata to December 31, 2019, unless the award qualified for full vesting under the plan rules. LSSP participation for Executive Committee members ceased in 2014 although some current members received later grants under this plan prior to becoming members of the Executive Committee. Outstanding awards will vest five years from the grant date, subject to the LSSP plan rules.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> Paul Hudson and Richard Francis stepped down from the Executive Committee in 2019. At the time they stepped down from the Executive Committee, Mr. Hudson owned zero vested shares, and 140'121 unvested shares and other equity rights and Mr. Francis owned 50'615 vested shares and 86'740 unvested shares and other equity rights.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">151</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Fixed and variable compensation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The CEO and other Executive Committee members&#x2019; annual base salary and variable compensation mix at grant value for financial year 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Annual <br> base salary<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Variable<br> compensation<sup style="white-space: nowrap">  2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vasant Narasimhan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14.7%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85.3%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steven Baert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.5%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 79.5%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bertrand Bodson</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.3%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74.7%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">James Bradner</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.9%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 81.1%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Harry Kirsch</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17.8%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82.2%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shannon Thyme Klinger</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22.8%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 77.2%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Steffen Lang</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.0%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75.0%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Klaus Moosmayer</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.1%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74.9%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Richard Saynor</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13.4%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86.6%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Susanne Schaffert</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19.3%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.7%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">John Tsai</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19.1%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.9%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marie-France Tschudin</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.7%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76.3%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Robert Weltevreden</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27.4%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 72.6%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19.4%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 80.6%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Excludes pension and other benefits</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> See table &#x201C;2019 compensation at grant value for the CEO and other Executive Committee members" with regard to the disclosure principles of variable <br>compensation.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Excludes Richard Francis, who stepped down from the Executive Committee during 2019 and Paul Hudson, who resigned.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Other payments to Executive Committee members </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, no other payments or waivers of claims other than those set out in the tables (including their footnotes) contained in this Compensation Report were made to Executive Committee members or to &#x201C;persons closely linked&#x201D; to them.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Payments to former Executive Committee members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Under the former Executive Committee members&#x2019; contracts and in line with the Company&#x2019;s LTI plan rules, payments were made to eight former members. Of this, CHF 34 312 111 relates to the vesting of the LTPP and LTRPP for the 2017-2019 performance cycle, based on actual performance outcomes plus dividend equivalents, and CHF 4 130 033 (USD 4 451 756) relates to the vesting of the one-off award to the Alcon CEO (see &#x201C;&mdash;Former Alcon CEO one-off performance award&#x201D;). In addition, contractual amounts totaling 2 050 096 were made (comprising of base salary, Annual Incentive and other benefits), and two individuals received CHF 516 957 in tax equalization on incentive compensation granted during an international assignment.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">No other payments (or waivers of claims) were made to former Executive Committee members or to &#x201C;persons closely linked&#x201D; to them during 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Loans to Executive Committee members</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our policy does not allow loans to be granted to current or former members of the Executive Committee or to &#x201C;persons closely linked&#x201D; to them. Therefore, no loans were granted in 2019, and none were outstanding as of December 31, 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Persons closely linked</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">&#x201C;Persons closely linked&#x201D; are (i) their spouse, (ii) their children below age 18, (iii) any legal entities that they own or otherwise control, and (iv) any legal or natural person who is acting as their fiduciary.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Note 27 to the Group&#x2019;s audited consolidated financial statements</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The total expense for the year for compensation awarded to Executive Committee and Board members, using International Financial Reporting Standards (IFRS) measurement rules, is presented in Note 27 to the Group&#x2019;s audited consolidated financial statements.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Award and delivery of equity to Novartis associates </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, 17.7 million unvested restricted shares (or ADRs), RSUs and target PSUs were granted, and 13.4 million Novartis vested shares (or ADRs) were delivered to Novartis associates under various equity-based participation plans. Current unvested equity instruments (restricted shares, RSUs and target PSUs) and outstanding equity options held by associates represent 1.53% of issued shares. Novartis delivers treasury shares to associates to fulfill these obligations, and aims to offset the dilutive impact from its equity-based participation plans.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">152</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Additional disclosures &ndash; Alcon spin-off and CEO one-off performance award</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Former Alcon CEO one-off performance award </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As disclosed in the 2016 Compensation Report, the Alcon CEO, F. Michael Ball, received a one-off award of 50 000 Performance Share Units (the payout range was 0-200% of target) on February 1, 2016, when he joined Novartis, subject to the achievement of targets linked to the turnaround of Alcon during the 2016-2018 performance cycle. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Mr. Ball gave notice to retire from the Executive Committee on July 1, 2018, following the announcement of the spin-off of Alcon but continued to work in a full-time capacity for Alcon. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To provide transparency to shareholders, the Board of Directors of Novartis decided to communicate the outcome of the Alcon CEO&#x2019;s one-off performance award.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The performance metrics of the award were based on financial and non-financial targets, including sales growth ahead of peers, core operating income growth ahead of sales growth, core operating income margin at least in line with the average of peers, and successful developments and launches of new products. Performance was monitored regularly across the three-year performance cycle and assessed against the targets supported by the Compensation Committee at the end of each financial year.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">After a significant gap in performance versus the targets in the first year, Alcon partially closed the gap in the next two years. Overall, the turnaround of the business resulted in a very successful spin-off, creating significant value for shareholders. Core operating income grew ahead of sales, and target launches of new products like <i>PanOptix</i>, and <i>Dailies Total1</i> were well executed. However, the final payout was below target, as overall sales grew slower than peers, core operating income margin was below the average of peers and other launches were below target. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">This one-off award vested on March 18, 2019, at 85% of target based on performance outcomes versus the targets. The total value of the award at vesting, including dividend equivalents, was USD 4 451 756 (comprising 42 651 shares out of the target of 50 000 after the performance adjustment, plus 5 130 dividend equivalent shares). This figure is included in payments made to former members of the Executive Committee in &#x201C;&mdash;2019 realized compensation for the CEO and other Executive Committee members.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Alcon spin-off equity restoration plan </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As disclosed in the 2018 Compensation Report and in line with communications delivered ahead of the spin-off, Novartis shareholders received a dividend in kind in Alcon shares at the spin-off date. PSUs and RSUs held by Novartis employees, including members and former members of the Executive Committee, are not entitled to dividends and therefore did not receive the dividend in kind distribution. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To ensure equal treatment of PSU and RSU holders relative to Novartis shareholders, Novartis granted equity awards (called Keep Whole Awards) to its employees, including the Executive Committee members, following the spin-off. The Keep Whole Awards restored the PSUs and RSUs to their pre-spin values. This was done in accordance with the Alcon spin-off equity restoration plan as follows:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Keep Whole Awards had a value similar to the estimated value of the dividend in kind resulting from the spin-off that each award would have received had it been a Novartis share. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Keep Whole Awards were granted in the same equity instrument (i.e., PSUs or RSUs) with the same vesting terms and performance conditions (if applicable) as the underlying award.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Keep Whole Awards aimed to ensure that Novartis employees who had been granted PSUs or RSUs, including members of the Executive Committee, were not disadvantaged by the spin-off relative to Novartis shareholders.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The total value of Keep Whole Awards granted to the current members of the Executive Committee was USD 8.5 million. The sums are equivalent to the estimated reduction in value of the dividend in kind as a result of the spin-off, and as such are not considered by the Compensation Committee to be additional compensation.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">153</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Interim update regarding ongoing LTI performance cycles</font><font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"> </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Following feedback from our shareholders and in line with our commitment made in the 2018 Compensation Report, below we report how performance is tracking against target for our ongoing LTI performance cycles. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2018-2020 LTPP and LTRPP</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">After the second year of these LTI performance cycles, both are currently tracking ahead of target. Financial performance continues to advance as we continue to make improvements to our operational efficiencies. All Innovative Medicines targets to be completed by 2019 were achieved, and our NIBR objectives were equally successful. Forecasts at the end of December place the Novartis TSR sixth out of 15 among our global healthcare peer group.  </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;">Performance measures</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;"> Tracking</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LTPP NCVA (75%)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ahead of target</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LTPP innovation (25%)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ahead of target</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">LTRPP relative TSR (100%)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ahead of peer group median</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">2019-2021 LTPP </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As disclosed in the 2018 Compensation Report, the two LTI plans, LTPP and LTRPP, were combined into a single LTPP plan for performance cycles beginning in 2019. The new LTPP plan has four equally weighted metrics. After the first year of the three-year performance cycle, net sales growth is tracking ahead of target. This is largely due to strong sales execution, particularly for Cosentyx and Entresto. Core operating income is tracking ahead of target, mainly driven by higher sales. Innovation is tracking at target, with a number of read-outs, submissions and approvals achieved in our Innovative Medicines programs, and all NIBR milestones on track for completion by the end of the cycle. Relative TSR is tracking ahead of the peer group median.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">154</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><a name="anchorId00942588"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">2020 Executive Committee compensation system</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Compensation Committee has evaluated the Executive Committee compensation system based on feedback received from shareholders; the Compensation Committee believes that the compensation system is largely operating as intended, supports the Company&#x2019;s strategy, and is aligned with market and best practices. The following enhancements to the Annual Incentive and LTI systems should however be acknowledged.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Annual Incentive payout matrix</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The payout matrix of the Annual Incentive will be updated such that a performance that is determined to be &#x201C;below expectations&#x201D; will receive a 0% payout (previously this provided for a 0-30% payout). </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">LTPP innovation metric</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At the beginning of 2019, the Research &amp; Development Committee and the Compensation Committee jointly approved to change the LTPP innovation metric for cycle 2019-2021 onward. The committees decided that GDD and NIBR targets would be weighted 70% and 30% of the innovation metric, respectively. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The GDD targets are transparent to shareholders given that they are taken directly from the first three years of the published filing chart in the Novartis Annual Report (for 2019, see &#x201C;&mdash;Item 4.B Business overview&mdash;Innovative Medicines&mdash;Selected development projects&#x201D;) for the start of the performance cycle. Performance is assessed using a scoring mechanism based on the number of successful targeted filings and the time of their completion against target. NIBR milestones are set at the beginning of the cycle, and these will be assessed according to the number of milestones achieved against target. Overall performance will then be calculated based on the actual outcome for GDD and NIBR versus the overall target outcome. The payout schedule is identical to that used for the Annual Incentive (see &#x201C;&mdash;2019 Annual Incentive&#x201D;). </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">LTPP holding period</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As of grants made from 2020, the CEO and CFO will be required to hold any equity vesting under the LTPP plan (after the applicable tax and/or social security) for a minimum of two years after the vesting date. Taking into consideration the three-year vesting period, this means that they will not be permitted to sell or trade the resulting shares before the fifth anniversary of the grant date. This holding period will be additional to the existing share ownership requirements.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">LTPP TSR peer group</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There will also be a change to the structure of the TSR peer group as a result of the recent acquisition of Celgene by Bristol-Myers Squibb, both of which are companies in our TSR peer group. The Compensation Committee decided that Celgene will therefore be removed from the peer group for the 2018-2020 LTI cycle, thereby reducing the total number of peers, from 15 to 14. Given the anticipated timing of the acquisition, the Compensation Committee decided to keep Celgene in the peer group for the 2017-2019 performance cycle. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">LTPP TSR share price evaluation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Compensation Committee reported last year the decision to combine the two LTI plans, LTPP and LTRPP, into a single LTPP plan for performance cycles beginning in 2019 onward. Both prior and current LTI systems consider the TSR performance measure for the LTI payout and, under former rules, a one-day closing price method was used to determine the share price at the start and end of performance cycles. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Compensation Committee decided that going forward, a three-month averaging method will be implemented. This means that for the ongoing 2018-2020 and 2019-2021 LTI cycles, a one-day pricing approach will be kept for the start of the performance cycles, and the three-month averaging method will then be used to determine the corresponding share price at the end of the cycles. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The three-month averaging method will be used at the beginning and end of the cycles from 2020-2022. This approach was chosen to be more consistent with market practice and to provide a more stable view of longer-term performance. The Compensation Committee does not believe that this change makes the performance targets any easier or more difficult to achieve. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">155</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"></div><a name="anchorId00942626"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">2020 Executive Committee compensation</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As outlined in our &#x201C;&mdash;Executive Committee appointments compensation policy,&#x201D; some members, including the CEO, were appointed with total target compensation below external market median level. Each year, we collaborate with our advisors to benchmark the compensation levels of the members of the Executive Committee. Taking this into consideration and to ensure our competitiveness in the market, the total target compensation for these members has been assessed, and increases have been made for 2020 in line with their demonstrated performance and ability in their respective roles in 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Vasant Narasimhan, CEO </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(in role since February 1, 2018)</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In his second year as CEO, Vasant Narasimhan delivered a strong financial and outstanding innovation year for Novartis in 2019, and made good progress toward our digital and culture transformation, and building trust with society. Further detail on his achievements is provided in &#x201C;&mdash;2019 CEO balanced scorecard.&#x201D; Owing to this performance, Dr. Narasimhan will receive a 5% annual base salary increase effective March 1, 2020 (from CHF 1 674 000 to CHF 1 757 700), bringing him closer to the external market median level, while leaving room to progress further, in line with proven performance in the coming years. There will be no change to his target Annual Incentive and his target Long-Term Incentive (325% of base salary in total).</div>
<div style="padding-bottom:15px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All other Executive Committee members were awarded annual base salary increases in line with the annual compensation review applicable to all associates in Switzerland and the US, with the exception of the members listed below, who joined the Executive Committee in the last two years.  </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Bertrand Bodson, Chief Digital Officer</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> (in role since April 1, 2018)</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Bertrand Bodson led the substantial scaling of our digital initiatives in 2019, increased the momentum in data science across the Company, and put in place key partnerships with Microsoft, AWS and Tencent. Mr. Bodson will receive an annual base salary increase of 5% as from March 1, 2020, and his target Long-Term Incentive will be increased by 20% of annual base salary as from 2020. There will be no change to his Annual Incentive target. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Shannon Thyme Klinger, Group General Counsel </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(in role since April 1, 2018)</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Shannon Thyme Klinger helped transform our legal function in 2019, becoming one function globally, and leveraging technology to improve efficiency. Ms. Klinger supported the spin-off of our eye-care division, Alcon, creating large value to shareholders. To continue to be competitive in the market, Ms. Klinger will receive an annual salary increase of 9% as from March 1, 2020, and in addition an increase in her current target Annual Incentive and target Long-Term Incentive of 10% and 20%, respectively as a percentage of annual base salary.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Klaus Moosmayer, Chief Ethics, Risk and Compliance Officer </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(in role since December 1, 2018)</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Klaus Moosmayer revamped the Novartis Risk approach in 2019, finalized the strategic integration of Risk and Compliance in the business, and upgraded talent in his department, thereby strengthening our compliance across the global organization. Mr. Moosmayer will receive an annual base salary increase of 5% as from March 1, 2020. There will be no change to his Annual Incentive and his Long-Term Incentive targets.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Robert Weltevreden, Head of Novartis Business Services </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">(in role since June 1, 2018)</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Robert Weltevreden made great progress in our NBS transformation; set to over-deliver with recurring savings of over USD 300m in 2019, by increasing the footprint of our Global Service Center, securing international real estate and facility service contracts, and consolidating our IT services. In 2020, Mr. Weltevreden will receive an annual base salary increase of 5% and a target Long-Term Incentive, as a percentage of annual base salary, increase of 20%.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">To bring their compensation further toward the external market median for their roles, and within policy guidelines, Steffen Lang, Susanne Schaffert, John Tsai, and Marie-France Tschudin will also receive a 10-20% increase of their target 2020-2022 Long-Term Incentive (LTI). The LTI is subject to three-year performance conditions and provides for an overall payout between 0% and 200%.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">156</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00942664"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">2019 Board compensation</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Philosophy and benchmarking</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Aligned with market practice in Switzerland, the Board of Directors sets compensation for its members at a level that allows for the attraction of high-caliber individuals, including both Swiss and international members, who have global experience.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Board members do not receive variable compensation, in line with their focus on corporate strategy, supervision and governance. Each year at the AGM, shareholders are requested to approve, in a binding vote, the total compensation of the Board of Directors until the following AGM.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Board of Directors sets the level of compensation for its Chairman and the other members to be in line with relevant benchmark companies, which include other large Switzerland-based multinational companies: ABB, Credit Suisse, Lafarge Holcim, Nestl&#xE9;, Roche and UBS. This peer group was chosen for Board compensation due to the comparability of Swiss legal requirements, including broad personal and individual liabilities under Swiss law (and new criminal liability under Swiss rules regarding board and executive committee compensation related to the Ordinance against Excessive Compensation in Listed Companies), and under US law (due to the Company&#x2019;s secondary listing on the New York Stock Exchange). The Board of Directors reviews the compensation of its members, including the Chairman, each year based on a proposal by the Compensation Committee and on advice from its independent advisor, including relevant benchmarking information. The peer group used for the Board of Directors is different than that used for the Executive Committee to ensure independence of decision-making.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The contract of the Chairman and the Board of Directors compensation policy do not provide for any termination-related payments.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Chairman of&nbsp;the&nbsp;Board</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As Chairman, Joerg Reinhardt receives total annual compensation valued at CHF 3.8 million. The total compensation is comprised equally of cash and shares, as follows:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Cash compensation: CHF 1.9 million per year</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Share compensation: annual value equal to CHF 1.9 million of unrestricted Novartis shares</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For 2019, the Chairman voluntarily waived the increase in compensation to which he is contractually entitled, which is an amount not lower than the average annual compensation increase awarded to associates based in Switzerland (1.2% for 2019). </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Other Board&nbsp;members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The annual fee rates for Board membership and additional functions are included in the table below. These were approved by the Board of Directors with effect from the 2019 AGM. Aggregate Board compensation is aligned with other large Swiss companies.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br>CHF 000s</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> AGM 2019-2020<br> annual fee</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chairman of the Board</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;800</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Board membership</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 280</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vice Chairman</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chair of the Audit and Compliance Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 130</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chair of the Compensation Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 90</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chair of the following committees:<br> &#x2022; Governance, Nomination and <br>  Corporate Responsibilities Committee<br> &#x2022; Research &amp; Development Committee<br> &#x2022; Risk Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br>  <br>  <br>  <br>  70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Membership of the Audit <br> and Compliance Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br>  70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Membership of the following committees:<br> &#x2022; Compensation Committee<br> &#x2022; Governance, Nomination and <br>  Corporate Responsibilities Committee<br> &#x2022; Research &amp; Development Committee<br> &#x2022; Risk Committee</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br>  <br>  <br>  <br>  <br>  40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition, the following policies apply regarding Board compensation:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; 50% of compensation is delivered in cash, paid on a quarterly basis in arrears. Board members may choose to receive more of their compensation in shares instead of cash.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; At least 50% of compensation is delivered in shares in two installments: one six months after the AGM, and one 12 months after the AGM.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Board members bear the full cost of their employee social security contributions, if any, and do not receive share options or pension benefits. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">2020 Board compensation</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Board of Directors compensation system and fee levels will remain unchanged in 2020.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">157</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Board member total compensation earned for the financial year 2019</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Board   membership</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Audit and  Compliance  Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Compensation   Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Governance,   Nomination   and Corporate   Responsibilities   Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Research &amp;  Development  Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Risk  Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Shares   (number)<sup style="white-space: nowrap">         1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Cash   (CHF)  (A)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Shares   (CHF)  (B)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Other  (CHF)  (C)<sup style="white-space: nowrap">         2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Total  (CHF)  (A)+(B)+(C)<sup style="white-space: nowrap">         3</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Board members active on December 31, 2019</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Joerg Reinhardt<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;498</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;900&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;900&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;804&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Enrico Vanni</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Vice Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;494</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 220&nbsp;833</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 309&nbsp;166</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;512</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 533&nbsp;511</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nancy Andrews</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;035</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 360&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ton Buechner</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;967</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 145&nbsp;833</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 204&nbsp;166</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354&nbsp;372</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Patrice Bula<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;813</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 266&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 271&nbsp;040</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Srikant Datar</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;602</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 460&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Elizabeth Doherty</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;544</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 225&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 225&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 450&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ann Fudge</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;262</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 400&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frans van Houten</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;716</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 293&nbsp;334</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 320&nbsp;001</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Andreas von Planta</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;602</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 464&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charles L. Sawyers</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;035</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 360&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">William T. Winters</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;620</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 353&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 353&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 51&nbsp;188</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;538&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;571&nbsp;666</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21&nbsp;002</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;131&nbsp;001</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="24" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Board members who stepped down at the 2019 AGM</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dimitri Azar<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;016</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;016</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 30&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 30&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 52&nbsp;204</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;568&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;601&nbsp;666</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21&nbsp;002</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;191&nbsp;001</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #ffffff 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">See next page for 2018 comparative figures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 1&nbsp;</sup> The shown amounts represent the gross number of shares delivered to each Board member in 2019 for the respective Board member&#x2019;s service period. The number of shares reported in this column represent: (i) the second and final equity installment delivered in February 2019 for the services from the 2018 AGM to the 2019 AGM, and (ii) the first of two equity installments delivered in August 2019 for the services from the 2019 AGM to the 2020 AGM. The second and final equity installment for the services from the 2019 AGM to the 2020 AGM will take place in February 2020.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 2&nbsp;</sup> Includes an amount of CHF 21'002 for mandatory employer contributions for all Board members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 413'985 , and provides a right to the maximum future insured government pension benefit for the Board member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 3&nbsp;</sup> All amounts are before deduction of the social security contribution and income tax due by the Board member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 4&nbsp;</sup> No additional committee fees for chairing the Research &amp; Development Committee were delivered to Joerg Reinhardt.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 5&nbsp;</sup> From February 28, 2019</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 6&nbsp;</sup> Until February 28, 2019</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>           </div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">158</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Board member total compensation earned for the financial year 2018</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Board   membership</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Audit and  Compliance  Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Compensation   Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Governance,   Nomination   and Corporate   Responsibilities   Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Research &amp;  Development  Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Risk  Committee</div>
      </td>
      <td></td>
      <td align="middle">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">       Shares   (number)<sup style="white-space: nowrap">         1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Cash   (CHF)  (A)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Shares   (CHF)  (B)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Other  (CHF)  (C)<sup style="white-space: nowrap">         2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">     Total  (CHF)  (A)+(B)+(C)<sup style="white-space: nowrap">         3</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Board members active on December 31, 2018</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Joerg Reinhardt<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23&nbsp;889</div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;900&nbsp;000</div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;900&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;336</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;804&nbsp;336</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Enrico Vanni</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Vice Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;854</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 483&nbsp;334</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;475</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 528&nbsp;476</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nancy Andrews</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;262</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 360&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dimitri Azar</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;359</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 182&nbsp;500</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 182&nbsp;500</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 365&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ton Buechner</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;270</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 346&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;336</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 351&nbsp;003</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Srikant Datar</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;859</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 229&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 229&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 458&nbsp;334</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Elizabeth Doherty</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;828</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 225&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 225&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 450&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ann Fudge</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;481</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 199&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 199&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 398&nbsp;334</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frans van Houten</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;334</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 168&nbsp;333</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 316&nbsp;666</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Andreas von Planta</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> Chair</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;859</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 229&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 229&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;336</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 462&nbsp;670</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charles L. Sawyers</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;262</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 360&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">William T. Winters</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;087</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 321&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 321&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 57&nbsp;344</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;515&nbsp;001</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;645&nbsp;002</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;483</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;176&nbsp;486</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="24" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Board members who stepped down at the 2018 AGM</div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pierre Landolt (until March 2, 2018)<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &#x2022;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &#x2022;<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;131</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   55&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   3&nbsp;475</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   58&nbsp;475</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Subtotal</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;131</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 55&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;475</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 58&nbsp;475</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #ffffff 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
      <td style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="middle" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59&nbsp;475</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;515&nbsp;001</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;700&nbsp;002</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 19&nbsp;958</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;234&nbsp;961</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #ffffff 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
      <td style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 1&nbsp;</sup> The shown amounts represent the gross number of shares delivered to each Board member in 2018 for the respective Board member&#x2019;s service period. The number of shares reported in this column represent: (i) the second and final equity installment delivered in February 2018 for the services from the 2017 AGM to the 2018 AGM, and (ii) the first of two equity installments delivered in August 2018 for the services from the 2018 AGM to the 2019 AGM. The second and final equity installment for the services from the 2018 AGM to the 2019 AGM will take place in February 2019.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 2&nbsp;</sup> Includes an amount of CHF 19 958 for mandatory employer contributions for all Board members paid by Novartis to governmental social security systems. This amount is out of total employer contributions of CHF 383 864, and provides a right to the maximum future insured government pension benefit for the Board member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 3&nbsp;</sup> All amounts are before deduction of the social security contribution and income tax due by the Board member.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 4&nbsp;</sup> No additional committee fees for chairing the Research &amp; Development Committee were delivered to Joerg Reinhardt.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 5&nbsp;</sup> From March 2, 2018</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 6&nbsp;</sup> Until March 2, 2018</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="24">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp; 7&nbsp;</sup> According to Pierre Landolt, the Sandoz Family Foundation is the economic beneficiary of the compensation.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">159</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Additional disclosures</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Share ownership requirements for Board members </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Chairman is required to own a minimum of 30000 Novartis shares, and other members of the Board of Directors are required to own at least 5000 Novartis shares within five years after joining the Board of Directors, to ensure their interests are aligned with those of shareholders. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Board members are prohibited from hedging or pledging their ownership positions in Novartis shares that are part of their guideline share ownership requirement, and are required to hold these shares for 12 months after retiring from the Board of Directors. As of December 31, 2019, all current and former members of the Board of Directors who were required to meet the minimum share ownership requirements did so. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Shares, ADRs and share options owned by Board members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The total number of vested Novartis shares and ADRs owned by members of the Board of Directors and &#x201C;persons closely linked&#x201D; to them as of December 31, 2019, is shown in the table below. As of December 31, 2019, no members of the Board, either individually or together with &#x201C;persons closely linked&#x201D; to them, owned 1% or more of the outstanding shares (or ADRs) of Novartis. As of the same date, no members of the Board of Directors held any share options to purchase Novartis shares.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Number of shares <br> at December 31, 2019<sup style="white-space: nowrap">  1,2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Joerg Reinhardt</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 563&nbsp;697</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Enrico Vanni</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;645</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nancy Andrews</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;265</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ton Buechner</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;950</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Patrice Bula</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;946</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Srikant Datar</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 41&nbsp;334</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Elizabeth Doherty</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;765</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ann Fudge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14&nbsp;114</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frans van Houten</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;764</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Andreas von Planta</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161&nbsp;035</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charles L. Sawyers</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;986</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">William T. Winters</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;170</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 867&nbsp;671</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Includes holdings of "persons closely linked" to Board members (see definition &#x201C;&#x2014;Persons closely linked")</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Each share provides entitlement to one vote.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Dimitri Azar stepped down from the Board of Directors on February 28, 2019. On February 28, 2019, Mr. Azar owned 18 750 shares. His shares are not included in the total.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Loans to Board members</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our policy does not allow loans to be granted to current or former members of the Board of Directors or to &#x201C;persons closely linked&#x201D; to them. Therefore, no loans were granted in 2019, and none were outstanding as of December 31, 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Other payments to Board members</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, no payments (or waivers of claims) other than those set out in the Board member compensation table (including its footnotes) in &#x201C;&mdash;Board member total compensation earned for the financial year 2019&#x201D; were made to current members of the Board or to &#x201C;persons closely linked&#x201D; to them.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Payments to former Board members</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, no payments (or waivers of claims) were made to former Board members or to &#x201C;persons closely linked&#x201D; to them, except for the payments reported in Note 27 to the Group&#x2019;s audited consolidated financial statements.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">160</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00945714"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Compensation governance </p><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Legal framework</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Swiss Code of Obligations and the Corporate Governance Guidelines of the SIX Swiss Exchange require listed companies to disclose certain information about the compensation of Board of Directors and Executive Committee members, their equity participation in the Group, and loans made to them. This Annual Report fulfills that requirement. In addition, the Annual Report is in line with the principles of the Swiss Code of Best Practice for Corporate Governance of the Swiss Business Federation (economiesuisse).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Risk management principles</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Compensation Committee, with support from its independent advisor, reviews market trends in compensation, and changes in corporate governance rules and best practices. Together with the Risk Committee, it also reviews the Novartis compensation systems to ensure that they do not encourage inappropriate or excessive risk-taking, and instead encourage behaviors that support sustainable value creation. A summary of the risk management principles is outlined below.</div>
<div style="padding-top:15px"><img src="comp_0023.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">RISK MANAGEMENT PRINCIPLES&#x2022;Rigorous performance management process, with approval of targets and &#xAD;evaluation of performance for the CEO by the Board of Directors&#x2022;Balanced mix of short-term and long-term variable compensation elements&#x2022;Values and Behaviors are a key component of the Annual Incentive and are embedded in our culture&#x2022;Clawback and malus principles apply to all elements of the variable compensation&#x2022;Performance-vesting Long-Term Incentives only, with three-year cycles &#x2022;All variable compensation is capped at 200% of target&#x2022;Contractual notice period of 12&#xA0;months&#x2022;Post-contractual non-compete period limited to a maximum of 12 months from the end of employment. Resulting compensation is limited to the annual base salary plus the prior-year Annual Incentive as per contract, if applicable&#x2022;Good and bad leaver provisions apply to variable &#xAD;compensation of leavers&#x2022;No severance payments or change-of-control clauses&#x2022;Share ownership requirements; no hedging or pledging of Novartis share ownership</div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Executive Committee employment contracts provide for a notice period of up to 12 months and contain no change-of-control clauses or severance provisions (for example, agreements concerning special notice periods, longer-term contracts, &#x201C;golden parachutes,&#x201D; waiver of lock-up periods for equities and bonds, shorter vesting periods, and additional contributions to occupational pension schemes). For share ownership requirements, please refer to &#x201C;&mdash;Share ownership requirements for the CEO and other Executive Committee members.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compensation decision-making authorities</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Authority for decisions related to compensation is governed by the Articles of Incorporation, Board Regulations and the Compensation Committee Charter, which are all published on the Company website: www.novartis.com/investors/company-overview/corporate-governance. The Compensation Committee serves as the supervisory and governing body for compensation policies and plans within Novartis, and has overall responsibility for determining, reviewing and proposing compensation policies and plans for approval by the Board of Directors in line with the Compensation Committee Charter. A summary of discussions and conclusions of each committee meeting is delivered to the full Board of Directors. A summary of the compensation decision-making authorities is set out below.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compensation authorization levels within the parameters set by the shareholders&#x2019; meeting</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;">Decision on</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#0070f7; font-weight:bold; text-transform:uppercase;"> Decision-making authority</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Compensation of Chairman and  other Board members</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Board of Directors  </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Compensation of CEO</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Board of Directors</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Compensation of other Executive  Committee members</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Compensation Committee  </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #ffffff 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
      <td style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Committee member independence</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">
  <font style="font-weight: normal;">&nbsp;The Compensation Committee is composed exclusively of members of the Board of Directors who meet the independence criteria set forth in the Board Regulations. From the 2019 AGM, the Compensation Committee had the following five members: Patrice Bula, Ann Fudge, Srikant Datar, Enrico Vanni and William Winters. Mr. Vanni has served as a member since 2011 and as Chair since 2012.</font>
</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Role of the Compensation Committee&#x2019;s independent advisor</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Compensation Committee retained Mercer Limited during the financial year 2019 as its independent external compensation advisor to support the Committee in determining the design and implementation of compensation and benefits. The advisor was hired directly by the Compensation Committee in 2017, and the Compensation Committee has been fully satisfied with the performance and independence of the advisor since its engagement. In determining whether to renew the engagement with the advisor, the Compensation Committee evaluates, at least annually, the quality of the consulting service, the independence of the advisor, and the benefits of rotating advisors. Mercer Limited also provides services related to management development at the mid- and frontline leader level and in respect of corporate pensions. The individual Mercer Limited consultants that advise and support the Committee are not responsible or rewarded for work beyond support to the Compensation Committee and P&amp;O on senior compensation. </div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Compensation Committee meetings held&nbsp;in 2019</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the Compensation Committee held six formal meetings, one additional joint meeting with the Governance, Nomination and Corporate Responsibilities Committee, and two additional joint meetings with the Research &amp; Development Committee to review and endorse for approval by the Board of Directors the innovation targets and achievements of the LTPP and Annual Incentive. The Compensation Committee conducted a self-evaluation in 2019.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">161</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



    <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(This page has been left blank intentionally.)</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">162</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>











    <a name="anchorId001031915"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">6.C Board practices </p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Corporate governance </font>
</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Framework</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis is committed to effective corporate governance, and our corporate governance framework is intended to support sustainable financial performance and long-term value creation for our shareholders, patients, employees and other stakeholders based on our Values and Behaviors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Novartis corporate governance principles are further elaborated in key governance documents, in particular in our Articles of Incorporation and the Regulations of the Board, the Board Committees and the Executive Committee (Board Regulations) (www.novartis.com/investors/company-overview/corporate-governance). The Governance, Nomination and Corporate Responsibilities Committee (GNCRC) regularly reviews both the corporate governance principles and the key governance documents against evolving best practice standards and new developments in line with our commitment to maintaining the highest standards. </div>
<div style="padding-top:15px"><img src="cogo_0002.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Our leadership structureGovernance bodies General Meeting of ShareholdersApproves operating and financial review, Novartis Group consolidated financial statements and financial statements of Novartis AG; decides appropriation of available earnings and dividend; approves compensation of Board and Executive Committee; elects Board members, Chairman, Compensation Committee members, Independent Proxy and external auditor; adopts and modifies Articles of IncorporationExternal auditorProvides opinion on compliance of Novartis Group consolidated financial statements and the financial statements of Novartis&#xA0;AG with applicable standards and Swiss law, on compliance of the Compensation Report with applicable law, on effectiveness of internal controls over financial reporting, and on the corporate responsibility reporting of NovartisBoard of DirectorsAudit and Compliance CommitteeCompensation CommitteeGovernance, Nomi&#xAD;nation and Corporate Responsibilities CommitteeResearch &amp; Development CommitteeRisk CommitteeSets strategic direction of Novartis, appoints and oversees key executives, approves major transactions and investmentsExecutive CommitteeResponsible for operational management of Novartis</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">163</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Group structure and shareholders</font>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Group structure</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Novartis AG and Group companies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG, the Group&#x2019;s holding company, is a corporation organized under Swiss law with issued registered shares and registered office at Lichtstrasse 35, CH-4056 Basel, Switzerland. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The principal subsidiaries and associated companies of the Novartis Group are shown in &#x201C;Item 18. Financial Statements&#x2014;Note 32. Principal Group subsidiaries and associated companies.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Divisions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has two focused, customer-facing divisions: Innovative Medicines, which includes the Novartis Pharmaceuticals and Novartis Oncology business units; and Sandoz, the generics and biosimilars division. The divisions are supported by the Novartis Institutes for BioMedical Research (NIBR), Global Drug Development (GDD), Novartis Technical Operations (NTO), Novartis Business Services (NBS), and corporate functions. A detailed review of the 2019 business results can be found in &#x201C;Item 18. Financial Statements&#x2014;Note 3. Segmentation of key figures 2019, 2018 and 2017.&#x201D; In April 2019, Novartis completed the spin-off of its former eye care division, Alcon, into a separately traded standalone company.</div>
<div style="padding-top:15px"><img src="cogo_0026.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Shareholdings</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Majority holdings in publicly traded Group companies</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Novartis Group owns 70.7% of Novartis India Ltd., with registered office in Mumbai, India, and listing on the Bombay Stock Exchange (ISIN INE234A01025, symbol: HCBA). The total market value of the 29.3% free float of Novartis India Ltd. was USD&#xA0;67.8 million on December 31, 2019, using the quoted market share price at year-end. Applying this share price to all the shares of the company, the market capitalization of the whole company was USD&#xA0;231.2 million, and that of the shares owned by Novartis was USD&#xA0;163.4 million.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Significant minority shareholding owned by the Group</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Novartis Group owns 33.3% of the bearer shares of Roche Holding AG, with registered office in Basel, Switzerland, and listing on the SIX Swiss Exchange (ISIN CH0012032113, symbol: RO). The market value of the Group&#x2019;s interest in Roche Holding AG, as of December&#xA0;31, 2019, was USD&#xA0;16.9 billion. The total market value of Roche Holding AG was USD&#xA0;278.4 billion. Novartis does not exercise control over Roche Holding AG, which is independently governed, managed and operated.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Shareholders</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Significant shareholders</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to the Share Register, as of December&#xA0;31, 2019, the &#xAD;following registered shareholders (including nominees and the ADS depositary) held more than 2% of the total share capital, with the right to vote all their shares based on an exemption granted by the Board (see &#x201C;&#x2014;Item 6.C Board practices&#x2014;Shareholder participation&#x2014;Voting rights, restrictions and representation&#x2014;Registration restrictions&#x201D;):<sup>1</sup></div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> % holding of<br> share capital<br> Dec 31, 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholders registered for their own account:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Emasan AG, Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.5</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Foundation for Employee Participation, Basel</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">UBS Fund Management (Switzerland) AG, Basel</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> % holding of<br> share capital<br> Dec 31, 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholders registered as nominees:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chase Nominees Ltd., London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">The Bank of New York Mellon, New York</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.8</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Through The Bank of New York Mellon, Everett</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 2.0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Through The Bank of New York Mellon, New York</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 1.2</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Through The Bank of New York Mellon, SA/NV, Brussels</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 0.6</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nortrust Nominees Ltd., London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.9</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholder acting as American Depositary Share (ADS) depositary:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">JPMorgan Chase Bank, N.A., New York</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:8pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"><sup>1</sup> Excluding 5.7% of the share capital held as treasury shares by Novartis AG or its fully owned subsidiaries</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">164</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">According to a disclosure notification filed with Novartis&#xA0;AG, Norges Bank (Central Bank of Norway), Oslo, held 2.1% of the share capital but was not registered in the Share Register as of December&#xA0;31, 2019. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">According to disclosure notifications filed with Novartis&#xA0;AG and the SIX Swiss Exchange, each of the following shareholders held between 3% and 5%, but was not registered, or registered with less than 2% of the share capital as of December&#xA0;31,&#xA0;2019:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; BlackRock Inc., New York</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Capital Group Companies Inc., Los Angeles</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Disclosure notifications pertaining to shareholdings filed with Novartis AG and the SIX Swiss Exchange are published on the latter&#x2019;s electronic publication platform: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">www.six-exchange-regulation.com/en/home/publications/significant-shareholders.html.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Duty to make an offer</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to the Swiss Federal Act on Financial Infrastructures, anyone who &#x2013; directly, indirectly or acting in concert with third parties &#x2013; acquires equity securities exceeding 33 1/3% of the voting rights of a company (whether or not such rights are exercisable) is required to make an offer to acquire all listed equity securities of that company. A company may raise this threshold up to 49% of the voting rights (&#x201C;opting up&#x201D;) or may, under certain circumstances, waive the threshold (&#x201C;opting out&#x201D;). Novartis AG has not adopted any such measures.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Cross shareholdings</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG has no cross shareholdings in excess of 5% of &#xAD;capital, or voting rights with any other company.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Overview on shareholder structure</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables relate only to registered shareholders and cannot be assumed to represent the entire &#xAD;investor base because nominees and &#xAD;JPMorgan Chase Bank, N.A., as ADS depositary, are registered as shareholders for a large number of beneficial owners.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2019, Novartis AG had approximately 161&#x2005;000 registered shareholders. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Number of shares held</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>As of December 31, 2019<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Number of<br> registered <br> shareholders</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> % of registered <br> share capital</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1&#x2013;100</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;442</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.06</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">101&#x2013;1&#xA0;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 97&nbsp;161</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.59</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1&#xA0;001&#x2013;10&#xA0;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34&nbsp;884</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.84</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">10&#xA0;001&#x2013;100&#xA0;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;080</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">100&#xA0;001&#x2013;1&#xA0;000&#xA0;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 451</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.45</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1&#xA0;000&#xA0;001&#x2013;5&#xA0;000&#xA0;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.96</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">5&#xA0;000&#xA0;001 or more<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50.66</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total registered shareholders/shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161&nbsp;111</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 69.72</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unregistered shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100.00</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> At the record date of the Annual General Meeting (AGM) 2019, unregistered shares amounted to 15%</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Including significant registered shareholders as listed above</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Registered shareholders by type</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">As of December 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Shareholders in %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Shares in %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Individual shareholders</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 96.43</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.99</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Legal entities<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.77</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nominees, fiduciaries  and ADS depositary</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0.05</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   54.24</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100.00</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Excluding 5.7% of the share capital held as treasury shares by Novartis AG or its fully owned subsidiaries</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Registered shareholders by country</font><font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">As of December 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Shareholders in %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Shares in %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Belgium</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.13</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.13</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">France</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.06</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Germany</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.05</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.42</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87.68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 42.38</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United Kingdom</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26.15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.41</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other countries</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.88</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100.00</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Registered shares held by nominees are shown in the country where the company/affiliate entered in the Share Register as shareholder has its registered seat.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Excluding 5.7% of the share capital held as treasury shares by Novartis AG or its fully owned subsidiaries</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">165</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Capital structure</font>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Share capital</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As of December 31, 2019, the share capital amounted to CHF&#xA0;1&#x2005;263&#x2005;687&#x2005;410 fully paid-in and divided into 2&#x2005;527&#x2005;374&#x2005;820 registered shares with a nominal value of CHF&#xA0;0.50 each. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Shares are listed on the SIX Swiss Exchange (ISIN CH0012005267, symbol: NOVN) and on the New York Stock Exchange (NYSE) in the form of &#xAD;American Depositary Receipts (ADRs) representing American Depositary Shares (ADSs) (ISIN US66987V1098, symbol: NVS).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">No authorized and conditional capital exists as of December 31, 2019.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Shares, participation certificates, non-voting equity securities, profit-sharing certificates</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Shares are issued as uncertificated securities (in the sense of the Swiss Code of Obligations) and as book entry securities (in terms of the Swiss Act on Intermediated Securities). All shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities (Genuss&#xAD;scheine) or profit-sharing &#xAD;certificates have been issued.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Convertible securities and options</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG has not issued convertible or exchangeable bonds, &#xAD;warrants, options or other securities granting rights to shares, other than options (or similar instruments such as stock appreciation rights) granted under or in connection with equity-based participation plans of associates. Novartis AG does not grant any new stock options under these plans. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Limitation on transferability </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">No transferability restrictions are imposed on shares (for registration restrictions, see &#x201C;&#x2014;Item 6.C Board practices&#x2014;Shareholder participation&#x2014;Voting rights, restrictions and representation&#x2014;Registration restrictions&#x201D;). The registration of shareholders in the Share Register or in the ADR register kept by JPMorgan Chase Bank, N.A., does not affect the tradability of shares or ADRs. </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Changes to share capital</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>AGM</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Shareholder decision</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Shares cancelled</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Average repurchase <br> share price (CHF)<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2017</div>
      </td>
      <td align="right" width="1%"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022; Capital reduction by CHF 5.1 million (from CHF&#xA0;1&#x2005;313&#x2005;557&#x2005;410 to CHF&#xA0;1&#x2005;308&#x2005;422&#x2005;410)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;270&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74.67</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2018</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022; Capital reduction by CHF 33.11 million (from CHF&#xA0;1&#x2005;308&#x2005;422&#x2005;410 to CHF&#xA0;1&#x2005;275&#x2005;312&#x2005;410)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66&nbsp;220&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78.34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2019</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022; Capital reduction by CHF 11.63 million (from CHF 1&#x2005;275&#x2005;312&#x2005;410 to CHF 1&#x2005;263&#x2005;687&#x2005;410) <br> &#x2022; Authorization of the Board to repurchase shares up to a maximum of CHF 10 billion     until the AGM 2022 under an eighth share repurchase program</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;250&nbsp;000    </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 79.08    </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>AGM</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Proposal to the shareholders</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Shares to be cancelled</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Average repurchase <br> share price (CHF)<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2022; Capital reduction by CHF 30.16 million (from CHF&#xA0;1&#x2005;263&#x2005;687&#x2005;410 to CHF&#xA0;1&#x2005;233&#x2005;530&#x2005;460)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60&nbsp;313&nbsp;900</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 88.18</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="top">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> All shares were repurchased on the SIX Swiss Exchange second trading line.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key Novartis share data</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Issued shares</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;527&nbsp;374&nbsp;820</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;550&nbsp;624&nbsp;820</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616&nbsp;844&nbsp;820</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Treasury shares<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 262&nbsp;366&nbsp;332</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 239&nbsp;453&nbsp;391</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 299&nbsp;388&nbsp;321</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding shares at December 31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;265&nbsp;008&nbsp;488</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;311&nbsp;171&nbsp;429</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317&nbsp;456&nbsp;499</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Weighted average number of shares outstanding</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;290&nbsp;792&nbsp;782</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;319&nbsp;322&nbsp;369</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345&nbsp;783&nbsp;843</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Approximately 118 million treasury shares (2018: 122 million; 2017: 131 million) are held in Novartis entities that restrict their availability for use.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">166</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Per-share information</font><font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.12</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.52</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.20</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share from discontinued operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Diluted earnings per share from continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Diluted earnings per share from discontinued operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total diluted earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.06</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flow from operating activities of continuing operations (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.91</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.87</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Year-end equity for Novartis AG shareholders (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.49</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34.01</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32.00</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend (CHF)<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.85</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Calculated on the weighted average number of shares outstanding, except year-end equity</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> 2019: proposal to shareholders for approval at the AGM on February 28, 2020</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Key ratios &#x2013; December 31</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Price/earnings ratio<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25.7</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Price/earnings ratio from  continuing operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   30.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   15.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   25.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend yield (%)<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Based on the Novartis share price at December 31 of each year</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Key data on ADRs issued in the US</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<sup style="white-space: nowrap"> 1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Year-end ADR price (USD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 94.69</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 85.81</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83.96</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">High<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 96.14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93.91</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 86.65</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Low<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75.40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 72.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 70.03</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number of  ADRs outstanding<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   315&nbsp;073&nbsp;094</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   338&nbsp;641&nbsp;387</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   320&nbsp;833&nbsp;039</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> 2019 excludes the business of Alcon, which was spun off in April 2019 into a separately traded standalone company. </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Based on the daily closing prices </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> The depositary, JPMorgan Chase Bank, N.A., holds one Novartis AG share for every ADR issued. </div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Share price (CHF)</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<sup style="white-space: nowrap"> 1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Year-end share price</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 91.90</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84.04</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82.40</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">High<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 96.04</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 91.84</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 85.15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Low<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 77.03</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 72.42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69.55</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Year-end market capitalization  (USD billions)<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   214.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   197.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   195.5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Year-end market capitalization  (CHF billions)<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   208.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   194.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   191.0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> 2019 excludes the business of Alcon, which was spun off in April 2019 into a separately traded standalone company.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Based on the daily closing prices</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Market capitalization is calculated based on the number of shares outstanding (excluding treasury shares). Market capitalization in USD is based on the market capitalization in CHF converted at the year-end CHF/USD exchange rate.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">167</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001033466"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Shareholder participation </p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Shareholder engagement</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Shareholder engagement is fundamental to our commitment to governance and transparency, and the feedback we receive during these engagements helps us create long-term and sustainable value.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We concentrate our outreach efforts on our largest 100 shareholders &#x2013; portfolio managers, buy-side professionals, stewardship teams and environmental, social and governance (ESG) analysts &#x2013; who represent 60% of our ownership. While the Chairman, CEO and CFO together with Investor Relations are accountable for ensuring effective shareholder engagement, other senior managers from within and outside the Executive Committee also participate in the meetings. We conduct regular outreach to investors throughout the year. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:8pt; font-weight:bold; color:#0070f7; text-transform:uppercase;">Types of engagements (select examples):<div style="border:none;border-bottom:solid 2px;"></div>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Quarterly results conference calls for analysts and investors </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bank conferences</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Management roadshows</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Reverse roadshows at Novartis sites</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Capital markets event (meet Novartis management)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; R&amp;D Day</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; AGM</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Governance and compensation roadshow </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Governance teleconferences</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman&#x2019;s dinner in Zurich, London, US East and West Coast</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; ESG roadshow</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; ESG investor day</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:8pt; font-weight:bold; color:#0070f7; text-transform:uppercase;">Topics discussed with shareholders during 2019:<div style="border:none;border-bottom:solid 2px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">INNOVATION:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Progress </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Milestones </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Data of pipeline projects (e.g., <i>Zolgensma</i> intrathecal, ofatumumab, fevipiprant, <i>Entresto</i> in heart failure with preserved ejection fraction)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Launches (e.g., <i>Zolgensma, Piqray, Mayzent, Beovu</i>) </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">OPERATIONAL EXECUTION:</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Progress on financial, strategic and operational performance</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term sustainability of financial performance</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Capital allocation strategy</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Policy and pricing environment</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Lifecycle management</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">DATA AND DIGITAL:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; New initiatives and progress</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">BUILDING TRUST WITH SOCIETY AND CULTURE (ESG):</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Clear duties regarding disclosures and ESG integration</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Progress on culture and metrics </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Updates on alleged controversies in relation to Greece, the Southern District of New York, and <i>Zolgensma</i></div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board accountability to ESG topics </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Granularity on how ESG is embedded in the compensation system</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Pricing and access programs </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Environmental targets</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Compensation AND Governance: </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Diversity of the Board, the Executive Committee and the Company overall</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board refreshment and succession planning </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board evaluation process</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Link of compensation system to key strategic priorities</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Risk oversight</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Independence of the Audit Committee</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Overboarding</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We appreciate the growing importance shareholders attach to ESG matters and recognize that good outcomes on ESG performance can be an indicator of overall good long-term performance of the Company. We are committed to continuing our efforts to integrate ESG into our overall strategy. In the last two years, we have more than doubled the number of investor engagements on ESG matters, and in 2019, we held our first in-person ESG Day in London, led by our CEO, and our first ESG roadshow in the Netherlands.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Voting rights, restrictions and representation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Registration</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Shareholders have the right to vote and to execute all other rights as granted under Swiss law and the Articles of Incorporation (see, in particular, articles 17 and 18 of the Articles of Incorporation: www.novartis.com/investors/company-overview/corporate-governance).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Each share registered with the right to vote by the third business day before the General Meeting entitles the holder to one vote at General Meetings. To be registered with voting rights, a shareholder must declare that he or she acquired the shares in his or her own name and for his or her own account. According to article 5, paragraph 3 of the Articles of Incorporation (www.novartis.com/investors/company-overview/corporate-governance), the Board may register nominees with the right to vote. The Share Register is an internal, non-public register subject to statutory confidentiality and data-privacy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Registration restrictions</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Article 5, paragraph 2 of the Articles of Incorporation (www.novartis.com/investors/company-overview/corporate-governance) provides that no shareholder shall be registered with the right to vote for more than 2% of the registered share capital. Given that shareholder representation at General Meetings traditionally has been rather low in Switzerland, Novartis AG considers registration restrictions &#xAD;ne&#xAD;cessary to prevent a minority shareholder from dominating a &#xAD;General Meeting. The Board may, upon request, grant an exemption from this restriction. Considerations include whether the shareholder supports the Novartis goal of creating sustainable value and has a long-term investment horizon. Exemptions are in force for the registered significant shareholders listed in &#x201C;&#x2014;Item 6.C Board practices&#x2014;Group structure and shareholders&#x2014;Shareholders&#x2014;Significant shareholders,&#x201D; and for Norges Bank (Central Bank of Norway), Oslo, which as of December 31, 2019, was not registered in the Share Register but according to a disclosure notification filed with Novartis AG, held 2.1% of the share capital. No further exemptions were requested in 2019. The same restrictions indirectly apply to ADR holders. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">168</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Article 5, paragraph 3 of the Articles of Incorporation provides that no nominee shall be registered with the right to vote for up to 0.5% of the registered share capital. The Board may, upon request, grant an exemption from this restriction if the nominee discloses the names, addresses and number of shares of the individuals for whose account it holds 0.5% or more of the registered share capital. Exemptions are in force for the nominees listed in &#x201C;&#x2014;Item 6.C Board practices&#x2014;Group structure and shareholders&#x2014;Shareholders&#x2014;Significant shareholders,&#x201D; and for the nominee Citibank, London, which in 2015 requested an exemption, but as of December 31, 2019, was not registered in the Share Register. The same restrictions indirectly apply to ADR holders.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Shareholders, ADR holders, or nominees who are linked to each other or who act in concert to circumvent registration restrictions are treated as one person or nominee for the purposes of the restrictions on registration.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Representation and Sherpany Platform</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Shareholders can vote their shares by themselves or appoint another shareholder or the Independent Proxy to vote on their behalf. In 2019, we reconsidered the Independent Proxy set-up and it was concluded that the processing of voting instructions to the Independent Proxy should be without any involvement of Novartis. All shareholders (who are not yet registered on the online platform) receive a General Meeting invitation letter with a form for the appointment of the Independent Proxy. On this form, shareholders can instruct the Independent Proxy to vote on alternative or additional motions related to the agenda items either (i) following the recommendations of the Board for such alternative or additional motions, or (ii) against such alternative or additional motions. They can also abstain from voting.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Shareholders can use an online platform (the Sherpany Platform) to receive invitations to future General Meetings exclusively by email. They can then use Sherpany to order their admission ticket, appoint a proxy, and give voting instructions. Not-yet-registered shareholders can sign up with the account opening document that will be sent to them with the invitation to the AGM 2020 or by ordering the document from the Share Register. Shareholders can &#xAD;deactivate their online account at any time and again receive invitations in paper form.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">ADR holders</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">ADR holders have the rights enumerated in the deposit agreement (such as the right to give voting instructions and to receive dividends). The ADS depositary of Novartis AG &#x2013; JPMorgan Chase Bank, N.A., New York &#x2013; holds the shares underlying the ADRs and is registered as a shareholder in the Share Register. An ADR is not a share, and an ADR holder is not a Novartis AG shareholder. Each ADR represents one share. ADR holders exercise their voting rights by instructing the depositary to exercise their voting rights. JPMorgan Chase Bank, N.A., &#xAD;exercises the voting rights for registered shares underlying ADRs for which no voting instructions have been given by providing a discretionary proxy to an uninstructed independent designee. Such designee has to be a Novartis shareholder.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">General Meeting</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Convening </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The AGM must be held within six months after the close of the financial year (December 31), and normally takes place in late February/early March. Extraordinary General Meetings may be requested by the Board, the external auditor, or shareholders representing at least 10% of the share capital.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Agenda</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Shareholders representing shares with an aggregate nominal value of at least CHF&#xA0;1 million may request that an item be included in a General Meeting agenda. Such requests must be made in writing at least 45 days before the meeting, specifying the requested item and proposal.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Powers</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following powers are vested exclusively in the &#xAD;General Meeting:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Adoption and amendment of the Articles of Incorporation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Election and removal of the Board Chairman, the Board and Compensation Committee members, the Independent Proxy and the external auditor</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Approval of the management report (if required) and of the consolidated financial statements</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Approval of the financial statements of Novartis AG, and decision on the appropriation of available earnings shown on the balance sheet, including dividends</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Approval of the maximum aggregate Board compensation (from an AGM until the next AGM) and of the Executive Committee (for the financial year following the AGM). If the maximum aggregate amount of compensation already approved by the AGM is not sufficient to cover the compensation of newly appointed or promoted Executive Committee members, Novartis may use up to 40% of the amount last approved for the newly appointed or promoted Executive Committee members.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Discharge of Board and Executive Committee members</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Decision on other matters that are reserved by law or by the Articles of Incorporation (e.g., advisory vote on the Compensation Report) to the General Meeting </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;text-transform:uppercase;">Statutory quorums</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The General Meeting passes resolutions and elections with the absolute majority of the votes represented at the meeting. However, under article 18 of the Articles of Incorporation (www.novartis.com/investors/company&#xAD;-overview/corporate&#xAD;-governance), the approval of two-thirds of the votes represented at the meeting is required for: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Alteration of the purpose of Novartis AG</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Creation of shares with increased voting powers</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Implementation of restrictions on the transfer of registe&#xAD;red shares, and the removal of such restrictions</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Authorized or conditional increase of the share capital</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Increase of the share capital out of equity, by contribution in kind, for the purpose of an acquisition of property or the grant of special rights</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Restriction or suspension of rights or options to subscribe</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Change of location of the registered office of Novartis&#xA0;AG</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Dissolution of Novartis AG</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition, the law provides for a qualified majority for other resolutions, such as a merger or demerger.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">169</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-top:10px;  padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">Board of Directors</font>
</div>
<div style="padding-top:15px"><img src="cogo_0005.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Composition (as per December 31, 2019)1Chairman: J. ReinhardtVice Chairman: E. VanniN. AndrewsT. BuechnerP. BulaS. DatarE. DohertyA. FudgeF. van HoutenA. von PlantaC. SawyersW. WintersAudit and Compliance CommitteeE. Doherty (Chair)T. BuechnerS. DatarA. von PlantaE. VanniCompensation CommitteeE.Vanni (Chair)P. BulaS. DatarA. FudgeW. WintersGovernance, Nomination and Corporate Respon-sibilities CommitteeA. von Planta (Chair)A. FudgeC. SawyersE. VanniW. WintersResearch &amp; Development CommitteeJ. Reinhardt (Chair)N. AndrewsF. van HoutenC. SawyersRisk CommitteeS. Datar (Chair)N. AndrewsE. DohertyA. FudgeA. von Planta1Dimitri Azar&#x2019;s term as a Board member ended at the 2019 AGM following his decision not to stand for re-election. His CV is included in the 2018 Annual Report (page 188, available at www.novartis.com/annualreport2018).</div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Election and term of office</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Board members (including the Chairman) and Compensation Committee members are individually elected by the AGM for one year until the end of the next AGM.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is no mandatory term limit for Board members. However, Board members must retire after reaching age 70. Under special &#xAD;circumstances, shareholders may grant an exemption and re-elect a Board member for additional terms of office.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Board succession planning</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Chairman, supported by the GNCRC, ensures effective succession plans for the Board, the CEO and the Executive Committee. These plans are discussed by the Board in private meetings without management. A search for a new Board member is launched &#x2013; normally with the support of a professional executive search company &#x2013; with individual selection criteria defined based on the evolving governance needs of the Company and a continuing focus on diversity. Candidates are interviewed by the Chairman, members of the GNCRC, other Board members, and members of the Executive Committee. The GNCRC then makes a recommendation to the full Board, and the Board ultimately decides who should be proposed to shareholders for election at the upcoming AGM. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Independence of Board members</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All Board members &#x2013; including the Chairman &#x2013; are non-executive and independent, pursuant to applicable corporate governance rules and Novartis independence criteria, which reflect international best practice and are outlined in Appendix II to the Board Regulations (www.novartis.com/investors/company-overview/corporate-governance). In particular, no Board member is or was a member of the management of Novartis AG or of any other Novartis Group company in the last three financial years up to December 31, 2019, or has a significant business relationship with Novartis AG or with any other Novartis Group company. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The independence is assessed on an annual basis. We consider tenure &#x2013; along with many other factors &#x2013; when determining a Board member&#x2019;s independence in the assessment to ensure that the average tenure is not excessively high while balancing continuity of knowledge and experience with refreshment. We do not believe that an individual automatically becomes &#x201C;non-independent&#x201D; after a given period. This has enabled Novartis to benefit from the insight and knowledge of long-standing Board members, which has been particularly important during the last years of Board refreshment. In the past four years, Novartis has added four new Board members, and two additions will be proposed to the shareholders for the AGM 2020.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">170</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Board profile</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Diversity is a key factor to success and Board effectiveness, and an important criterion for the GNCRC when identifying new Board member candidates. A diverse Board ensures that the appropriate balance of skills, expertise and experience is represented to discharge responsibilities to shareholders, and helps create long-term value. The Board composition aligns with our status as a listed company as well as our business portfolio, geographic reach and culture. To ensure appropriate strategic oversight, the Board members have a diverse set of skills and experience, as highlighted in the Board members&#x2019; biographies (see &#x201C;&#x2014;Item 6.C Board practices&#x2014;Board of Directors&#x2014;Members of the Board of Directors&#x201D;). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We are continuously looking for opportunities to improve our Board diversity, and in particular aspire to find female candidates for two of the next three nominations.</div>
<div style="padding-top:15px"><img src="cogo_0027.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">DiversityNationality1pSwiss33%pAmerican33%pBritish13%pDutch13%pGerman8%GenderpMale75%pFemale25%Agep&lt;558%p556025%p616542%p&gt;6525%Tenurep&lt;3y17%p36y50%p79y8%p&gt;9y25%1Please note that three Board members have two nationalities.Each of these nationalities were taken into account by a factor of 0.5 in the above chart.Background/experienceMedicine/healthcare/R&amp;D42%5/12Leadership management 75%9/12Finance/accounting67%8/12Law8%1/12Engineering/technology 50%6/12Marketing 25%3/12Environmental, social 33%4/12and governance (ESG)</div>
</div>

    <br>
<br>



<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">171</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



<a name="anchorId001131907"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Members of the Board of Directors</p>
<div style="padding-top:15px"><img src="cogo_0030.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Joerg Reinhardt, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chairman of the Board of Directors since 2013 | Nationality: German | Year of birth: 1956</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman of the board of management and the executive committee, Bayer HealthCare AG, Germany (2010&#x2013;2013)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief Operating Officer, Novartis AG, Switzerland (2008&#x2013;2010)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of the Vaccines and Diagnostics Division, Novartis AG, Switzerland (2006&#x2013;2008)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at Sandoz Pharma Ltd. and Novartis AG, Switzerland (1982&#x2013;2006)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman of the board of trustees, Institute of Molecular and Clinical Ophthalmology Basel (IOB), Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman of the board of trustees, Novartis Foundation, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Swiss Re AG, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the European Advisory Panel, Temasek Holdings Private Ltd., Singapore</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Lonza Group AG, Switzerland (2012&#x2013;2013)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman, Genomics Institute of the Novartis Research Foundation, US (2000&#x2013;2010) </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in pharmaceutical sciences, Saarland University, Germany</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-x.jpg" border="0"></font>&#xA0;Medicine/healthcare/R&amp;D&#x2002;<font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management </div>
<div style="padding-top:15px"><img src="cogo_0029.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Enrico Vanni, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Vice Chairman of the Board of Directors since 2011 | Nationality: Swiss | Year of birth: 1951</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Independent consultant, supporting leaders of pharmaceutical and biotechnology companies (2008&#x2013;2015)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Director, consulting in pharmaceutical, consumer and financial sectors, McKinsey &amp; Co., Switzerland (1994&#x2013;2007)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of the Geneva Office, McKinsey &amp; Co., Switzerland (1988&#x2013;2004)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Advanced Oncotherapy PLC, UK</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Lombard Odier &amp; Cie SA, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Banque Priv&#xE9;e BCP (Suisse) SA, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Eclosion2 SA, Switzerland (2009&#x2013;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Alcon Inc., Switzerland (2010&#x2013;2011)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Actavis PLC, Ireland (2010)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, INSEAD, France</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in physical chemistry, University of Lausanne, Switzerland</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Engineering degree in chemistry, Federal Polytechnic School of Lausanne, Switzerland</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-x.jpg" border="0"></font>&#xA0;Medicine/healthcare/R&amp;D&#x2002;<font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-o.jpg" border="0"></font>&#xA0;Engineering/technology</div>
<div style="padding-top:15px"><img src="cogo_0028.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Nancy C. Andrews, M.D., Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2015 | Nationality: American/Swiss | Year of birth: 1958</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Dean emerita, Duke University School of Medicine, and vice chancellor emerita for academic affairs, Duke University, US (2017&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Dean, Duke University School of Medicine, and vice chancellor for academic affairs, Duke University, US (2007&#x2013;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Professor of pediatrics, pharmacology &amp; cancer biology, Duke University, US (2007&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Dean of basic sciences and graduate studies, Harvard Medical School, US (2003&#x2013;2007)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Director, Harvard/MIT M.D.-Ph.D. Program, US (1999&#x2013;2003)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Biomedical research investigator, Howard Hughes Medical Institute, US (1993&#x2013;2006)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the executive committee of the corporation, Massachusetts Institute of Technology, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chair, American Academy of Arts and Sciences, US </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the Scientific Advisory Board, Dyne Therapeutics, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member and former chair, Burroughs Wellcome Fund, US (2011&#x2013;2019)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the Scientific Management Review Board, National Institutes of Health, US (2014&#x2013;2019)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctor of medicine, Harvard Medical School, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in biology, Massachusetts Institute of Technology, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master and Bachelor of Science in molecular biophysics and biochemistry, Yale University, US</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-x.jpg" border="0"></font>&#xA0;Medicine/healthcare/R&amp;D&#x2002;<font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management  </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">172</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0032.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Ton Buechner</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2016 | Nationality: Dutch/Swiss | Year of birth: 1965</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman and CEO of the executive board, AkzoNobel NV, Netherlands (2012&#x2013;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CEO, Sulzer AG, Switzerland (2007&#x2013;2011)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at Sulzer AG, Switzerland (1994&#x2013;2007)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the presidential and shareholder committees, Voith GmbH &amp; Co. KGaA, Germany</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the supervisory board, Voith GmbH &amp; Co. KGaA, Germany (2014&#x2013;2018)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, IMD business school, Switzerland</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Science in civil engineering, Delft University of Technology, Netherlands</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-z.jpg" border="0"></font>&#xA0;Environmental, social and governance (ESG)  <font><img src="skill-o.jpg" border="0"></font>&#xA0;Engineering/technology</div>
<div style="padding-top:15px"><img src="cogo_0025.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Patrice Bula</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since February 28, 2019 | Nationality: Swiss | Year of birth: 1956</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Executive vice president and head of strategic business units, marketing, sales and Nespresso, Nestl&#xE9;&#xA0;SA, Switzerland (2011&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Market head of the Greater China region, Nestl&#xE9; SA, Switzerland (2007&#x2013;2011)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Market head of Germany, Nestl&#xE9; SA, Switzerland (2003&#x2013;2007)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of the confectionery and biscuits strategic business unit, Nestl&#xE9; SA, Switzerland (2000&#x2013;2003)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at Nestl&#xE9; SA, Switzerland (1980&#x2013;2000)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Schindler AG, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Cereal Partners Worldwide SA, Switzerland <i>(Nestl&#xE9; representative)</i></div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Froneri Ltd., UK <i>(Nestl&#xE9; representative)</i></div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Bobst Group SA, Switzerland (2017&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman, Blue Bottle Coffee Inc., US <i>(Nestl&#xE9; representative) </i>(2017&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman, Nestl&#xE9; Nespresso SA, Switzerland <i>(Nestl&#xE9; representative) </i>(2011&#x2013;2019)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Hsu Fu Chi Food Companies, China (<i>Nestl&#xE9; representative</i>) (2011&#x2013;2019)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Program for Executive Development, IMD business school, Switzerland</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master&#x2019;s degree in economic sciences, HEC Lausanne, Switzerland</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-w.jpg" border="0"></font>&#xA0;Marketing&#x2002;<font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-o.jpg" border="0"></font>&#xA0;Engineering/technology</div>
<div style="padding-top:15px"><img src="cogo_0031.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Srikant Datar, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2003 | Nationality: American | Year of birth: 1953 | <br>Audit Committee Financial Expert</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Faculty chair, Harvard Innovation Lab, and senior associate dean for university affairs, Harvard Business School, US (2015&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Professor of&#xA0;business administration, Harvard Business School, US (1996&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Professor of accounting and management, Stanford Graduate School of Business, US (1989&#x2013;1996)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Professor of industrial administration, Carnegie Mellon University (1986&#x2013;1988)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, ICF International Inc., US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Stryker Corp., US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, T-Mobile US Inc., US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, HCL Technologies Ltd., India (2012&#x2013;2014) </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, KPIT Cummins Infosystems Ltd., India (2007&#x2013;2012)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in business (accounting), Stanford University, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Arts in economics, Stanford University, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Science in statistics, Stanford University, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Postgraduate diploma in business management, Indian Institute of Management, India</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Science in mathematics and economics, Bombay University, India</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">173</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0035.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Elizabeth (Liz) Doherty</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2016 | Nationality: British | Year of birth: 1957 | <br>Audit Committee Financial Expert</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CFO (interim), Cognita Schools Ltd., UK (2014&#x2013;2015) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CFO and Board member, Reckitt Benckiser Group PLC, UK (2011&#x2013;2013)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CFO (interim), City Inn, UK (2010)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CFO, Brambles Ltd., Australia (2007&#x2013;2009)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group international finance director, Tesco PLC, UK (2001&#x2013;2007)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at Unilever PLC, UK (1981&#x2013;2001)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Corbion NV, Netherlands</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Royal Philips NV, Netherlands</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Advisor, Affinity Petcare SA and GB Foods, Spain</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Dunelm Group PLC, UK (2013&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, HM Courts &amp; Tribunals Service, UK (2015&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Ministry of Justice, UK (2015&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Delhaize Group, Belgium (2013&#x2013;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Nokia Corp., Finland (2013&#x2013;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Brambles Ltd., Australia (2007&#x2013;2009)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, SABMiller PLC, UK (2004&#x2013;2010) </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Fellow, Chartered Institute of Management Accountants, UK</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor&#x2019;s degree in liberal studies in science (physics), University of Manchester, UK</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-w.jpg" border="0"></font>&#xA0;Marketing&#x2002;<font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-o.jpg" border="0"></font>&#xA0;Engineering/technology</div>
<div style="padding-top:15px"><img src="cogo_0034.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Ann Fudge</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2008 | Nationality: American | Year of birth: 1951</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman and CEO, Young &amp; Rubicam Brands, US (2003&#x2013;2007)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; President of the Beverages, Desserts and Post Division brands, Kraft Foods Inc., US (2000&#x2013;2001)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at Kraft Foods Inc., US (1986&#x2013;2000)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Northrop Grumman Corporation, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chair, WGBH Public Media, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chair of the United States Program Advisory Panel, Bill &amp; Melinda Gates Foundation, US (2007&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the visiting committee, Harvard Business School, US (2014&#x2013;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member and former vice chair, Unilever PLC and NV, UK and Netherlands (2009&#x2013;2018)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, General Electric Co., US (1999&#x2013;2015)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, Harvard Business School, US </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor&#x2019;s degree in management, Simmons College, US</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-w.jpg" border="0"></font>&#xA0;Marketing&#x2002;<font><img src="skill-z.jpg" border="0"></font>&#xA0;Environmental, social and governance (ESG)</div>
<div style="padding-top:15px"><img src="cogo_0033.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Frans van Houten</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2017 | Nationality: Dutch | Year of birth: 1960</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CEO and chairman of the executive committee and the board of management, Royal Philips NV, Netherlands (2011&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Interim management, ING Group NV, Netherlands (2009&#x2013;2010)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CEO and chairman of the management board, NXP Semiconductors NV (formerly Philips Semiconductors NV), Netherlands (2004&#x2013;2009)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at Royal Philips Electronics NV, Netherlands (1986&#x2013;2004)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Vice chairman and member of the supervisory board, Philips Lighting, Netherlands (2016&#x2013;2017)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Science in economics and business management, Erasmus University Rotterdam, Netherlands</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Science in economics, Erasmus University Rotterdam, Netherlands</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-x.jpg" border="0"></font>&#xA0;Medicine/healthcare/R&amp;D&#x2002;<font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-o.jpg" border="0"></font>&#xA0;Engineering/technology </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">174</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0038.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Andreas von Planta, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2006 | Nationality: Swiss | Year of birth: 1955</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Senior counsel, Lenz &amp; Staehelin, Switzerland (2017&#x2013;present)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Partner, Lenz &amp; Staehelin, Switzerland (1988&#x2013;2017)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Helvetia Holding AG, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, A.P. Moller Finance SA, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Helvetia Schweizerische Lebensversicherungsgesellschaft AG, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Helvetia Schweizerische Versicherungsgesellschaft AG, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman, HSBC Private Bank (Suisse) SA, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman, HSBC Private Banking Holdings (Suisse) SA, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Socotab Frana SA, Switzerland </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman of the regulatory board, SIX Swiss Exchange AG, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Burberry (Suisse) SA, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman of the audit committee, International Road Transport Union, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Raymond Weil SA, Switzerland (2007&#x2013;2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member and former chairman, Clinique G&#xE9;n&#xE9;rale-Beaulieu SA, Switzerland (2008&#x2013;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member and former chairman, Schweizerische National Versicherungs AG, Switzerland (1997&#x2013;2015)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Holcim AG, Switzerland (2003&#x2013;2014)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Laws, Columbia Law School, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bar examination, Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in law, University of Basel, Switzerland</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Licentiatus iuris, University of Basel, Switzerland</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-l.jpg" border="0"></font>&#xA0;Law&#x2002;<font><img src="skill-z.jpg" border="0"></font>&#xA0;Environmental, social and governance (ESG)</div>
<div style="padding-top:15px"><img src="cogo_0037.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Charles L. Sawyers, M.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2013 | Nationality: American | Year of birth: 1959</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chair of the Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, US (2006&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Professor of medicine (2008&#x2013;present), and professor of cell and developmental biology (2011&#x2013;present), Weill Cornell Graduate School of Medical Sciences, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Investigator, Howard Hughes Medical Institute, US (2002&#x2013;2006 and 2008&#x2013;present)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Associate chief, Division of Hematology-Oncology, University of California, Los Angeles, US (1996&#x2013;2006)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member, National Cancer Advisory Board, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Investigator, Howard Hughes Medical Institute, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Science advisor for the following US companies: Agios Pharmaceuticals Inc.; BeiGene Ltd.; Blueprint Medicines Corp.; Foghorn Therapeutics Inc.; Housey Pharmaceutical Research Laboratories; KSQ Therapeutics Inc.; Nextech Invest Ltd.; ORIC Pharmaceuticals Inc.; PMV Pharmaceuticals Inc.;                   The Column Group </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; President, American Association for Cancer Research, US (2013&#x2013;2014)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctor of medicine, Johns Hopkins University School of Medicine, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Arts, Princeton University, US</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-x.jpg" border="0"></font>&#xA0;Medicine/healthcare/R&amp;D&#x2002;<font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-z.jpg" border="0"></font>&#xA0;Environmental, social and governance (ESG)</div>
<div style="padding-top:15px"><img src="cogo_0036.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">William T. Winters</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Member of the Board of Directors since 2013 | Nationality: British/American | Year of birth: 1961</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; CEO, Standard Chartered PLC, UK (2015&#x2013;present)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman and CEO, Renshaw Bay LLP, UK (2011&#x2013;2015)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-CEO of the Investment Bank, JPMorgan Chase &amp; Co., UK (2004&#x2013;2010)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Various managerial positions at JPMorgan Chase &amp; Co., UK and US (1983&#x2013;2004)</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Standard Chartered Bank PLC, UK</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, International Rescue Committee, UK</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, The Coronet Theatre, UK</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Commissioner, Independent Commission on Banking, UK (2010&#x2013;2011) </div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, Wharton School of the University of Pennsylvania, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor&#x2019;s degree in international relations, Colgate University, US</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Key skills</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">
  <font><img src="skill-g.jpg" border="0"></font>&#xA0;Leadership management&#x2002;<font><img src="skill-m.jpg" border="0"></font>&#xA0;Finance/accounting&#x2002;<font><img src="skill-o.jpg" border="0"></font>&#xA0;Engineering/technology</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Corporate Secretary</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;font-weight:bold;padding-top:5px;padding-bottom:5px;">Charlotte Pamer-Wieser, Ph.D.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">175</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



      <a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Board self-assessment</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Board and its committees conduct a self-assessment once a year, covering topics including Board composition, purpose, scope and responsibilities; Board processes and governance; Board meetings and pre-reading material; team effectiveness; and Chairman evaluation and peer evaluation. Periodically, this process is conducted by an independent consultant (this last happened in 2017 and is planned again for 2020). </div>
<div style="padding-top:15px"><img src="cogo_0022.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Anonymous survey&#x2022;Each Board member fills out an anonymous survey.&#x2022;A report identifying key strengths and challenges is produced for the Board and its committees. Qualitative review&#x2022;Based on the results, the Chairman and the committee chairs each lead a qualitative review with their colleagues and then with the entire Board. &#x2022;In addition, the Board, without its Chairman, discusses the Chairman&#x2019;s performance, and then provides him with feedback. Outcome&#x2022;The last self-assessment of January 2019 determined that the Board and its committees were functioning effectively and efficiently. &#x2022;The feedback confirmed that the Board has an open, transparent and critical boardroom culture. &#x2022;The results also served as a source for potential improvements, touching upon the scope of information and the Board&#x2019;s desire to receive additional/or more detailed information on particular topics, including more insights into external views on the Company and its competitors, and the Company&#x2019;s cost-saving efforts.  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Role of the Board and its committees</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Board is responsible for the overall direction and oversight of management, and holds the ultimate &#xAD;decision-making authority, with the exception of decisions reserved for shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Board has delegated certain of its duties and responsibilities to its five committees led by a Board-elected Chairman, as set out in the Board Regulations (www.novartis.com/investors/company-overview/corporate-governance). In some cases, these responsibilities are of an advisory or preparatory nature (A/P). In other cases, the committee has decision-making power that is subject to final Board approval (FBA), or the responsibilities have been fully delegated to the committee (FD). All committees have the authority to retain external consultants.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Any Board member may request a Board or committee meeting and the inclusion of an agenda item. Before meetings, Board members receive materials to help them prepare the discussions and decision-making. </div>


    <br>
<br>



<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">176</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>




<br>
<img src="x_cg001.gif">

<div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
              Board of DirectorsPrimary responsibilities&#x2022;Group strategy: deciding on the ultimate direction of the Group&#x2019;s business (including portfolio, markets, acquisitions and divestments) &#x2022;Group structure and organization: determining and reviewing major changes in the Group&#x2019;s organization and&#xA0;governance &#x2022;Group culture: overseeing the strategy and implementation of the corporate culture &#x2022;Group risk management system: overseeing the most significant risks and how these are managed&#x2022;Group finance: determining the Group&#x2019;s accounting system, financial controls and financial planning; &#xAD;reviewing&#xA0;and approving the Annual Report (including the Compensation Report)&#x2022;People &amp; organization: nominating or appointing, removing, and determining duties and responsibilities of key executives, and succession planningKey activities in 2019Strategic priorities3&#x2022;Oversaw the corporate strategy, including reviewing and approving the required steps for the Alcon spin-off, our investments in breakthrough technologies (e.g., the acquisition i eof Xiidra and The Medicines Company), and the divestments in oncology (e.g., Signifor&#xAE;)&#x2022;Focused on accelerating our push into the data and digital healthcare space, aligning with the general trend of investing in artificial intelligencep i e d&#x2022;Oversaw the shaping of a corporate culture of empowerment and responsibility to help drive innovation, performance and reputationp i s&#x2022;Reviewed ESG developments and oversaw our activities and prioritiess&#x2022;Reviewed the Zolgensma data integrity issue, lessons learned and additionalmanagement actions to further strengthen the governance of newly acquired companiess&#x2022;Reviewed cost productivity programse&#x2022;Engaged external experts to provide strategic guidance on the Company&#x2019;s cybersecurity effortsd&#x2022;Discussed longer-term Board succession planning, assessing which profiles are required in the upcoming yearss&#x2022;Topics addressed during private sessions included the Board self-evaluation and the performance assessment of the Executive Committee members, pas well as their succession planningMeetingsNumber of meetings held8Number of members12Approximate average duration (hours)7:48Meeting attendance98%Subject to additional special meetings, the Board and Board committee meetings take place in January, April, June, August, October and December. Typically, these meetings last two days, with the first day allocated to Board committee meetings, and the second day &#xAD;allocated to the meeting of the full Board.Joerg Reinhardt18Enrico Vanni8Nancy C. Andrews8Ton Buechner8Patrice Bula26Srikant Datar 8Elizabeth Doherty7Ann Fudge8Frans van Houten8Andreas von Planta8Charles L. Sawyers7William T. Winters8Documents&#x2022;Articles of Incorporation of Novartis AG &#x2022;Board Regulations www.novartis.com/investors/company-overview/corporate-governance1 Chair2 Mr. Bula was elected at the AGM 2019 and has attended all Board meetings since his election.3 Strategic priorities: pUnleash the power of our peopleiDeliver transformative innovationeEmbrace operational excellencedGo big on data and digitalsBuild trust with society
</div>

<br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">177</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


<br>
<img src="x_cg002.gif">
<div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
              Audit and Compliance CommitteePrimary responsibilities&#x2022;Supervising the external auditor (FD),** and selecting and nominating the external auditor for election by the shareholders (FBA)***&#x2022;Overseeing Internal Audit (FD)**&#x2022;Overseeing accounting policies, financial controls, and compliance with accounting and internal control standards (FD)**&#x2022;Approving quarterly financial statements and financial results releases (FBA)***&#x2022;Overseeing internal control and compliance processes and procedures (FD)**&#x2022;Overseeing compliance with laws, and external and internal regulations (FD)**Key activities in 2019Strategic priorities3&#x2022;Focused on acquisitions as well as divestmentsi&#x2022;Reviewed the accounting and financial reportinge&#x2022;Reviewed the potential impact and implications of the Zolgensma data integrity issuetogether with external advisorss&#x2022;Received reports and updates from Internal Audit; Quality; Ethics, Risk &amp; Compliance;the SpeakUp Office; Health, Safety and Environment (HSE); Tax; and Legalp s&#x2022;Evaluated the performance and discussed the rotation of the external auditoreMeetingsNumber of meetings held9Number of members5Approximate average duration (hours)2:15Meeting attendance96%Elizabeth Doherty1,28Ton Buechner8Srikant Datar29Andreas von Planta9Enrico Vanni9Documents&#x2022;Board Committees Charter, Appendix I to the Board Regulationswww.novartis.com/investors/company-overview/corporate-governance1Chair2Audit Committee Financial Expert*A/P = advisory or preparatory task**FD = fully delegated task***FBA = task subject to final Board approval3 Strategic priorities: pUnleash the power of our peopleiDeliver transformative innovationeEmbrace operational excellencedGo big on data and digitalsBuild trust with society
</div>


<br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">178</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>

<br>
<img src="x_cg003.gif">
<div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
              Compensation CommitteePrimary responsibilities&#x2022;Designing, reviewing and recommending to the Board the compensation policies and programs (FBA)***&#x2022;Advising the Board on the compensation of Board members and of the CEO (A/P)*&#x2022;Deciding on the compensation of Executive Committee members (FD)**&#x2022;Preparing the Compensation Report and submitting it to the Board for approval (FBA)***Key activities in 2019 Strategic priorities3&#x2022;Made decisions relating to Executive Committee compensation during the yearp&#x2022;Reviewed the Long-Term Incentive, including the relative total shareholder return financial and innovation metrics, for Executive Committee members and other Novartis executivesp s&#x2022;Discussed compensation governance matters and made compensation decisionsfor executives transferred with the Alcon spin-off, which took place in April 2019p&#x2022;Reviewed shareholder feedback related to Novartis compensation practices and disclosuresp s&#x2022;Considered additional disclosures in the 2019 Compensation ReportsMeetingsNumber of meetings held7Number of members5Approximate average duration (hours)1:55Meeting attendance100%Enrico Vanni17Patrice Bula26Srikant Datar7Ann Fudge7William T. Winters7Documents&#x2022;Board Committees Charter, Appendix I to the Board Regulationswww.novartis.com/investors/company-overview/corporate-governance1Chair2Mr. Bula was elected at the AGM 2019 and has attended all Compensation Committee meetings since his election.*A/P = advisory or preparatory task**FD = fully delegated task***FBA = task subject to final Board approval3 Strategic priorities: pUnleash the power of our peopleiDeliver transformative innovationeEmbrace operational excellencedGo big on data and digitalsBuild trust with society
</div>
<br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">179</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


<br>
<img src="x_cg004.gif">
    <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
              Governance, Nomination and Corporate Responsibilities CommitteePrimary responsibilities&#x2022;Designing, reviewing and recommending to the Board corporate governance principles (FBA)***&#x2022;Identifying candidates for election as Board members (FBA)***&#x2022;Assessing existing Board members and recommending to the Board whether they should stand for re-election (FBA)***&#x2022;Preparing and reviewing the succession plan for the CEO (FBA)***&#x2022;Developing and reviewing an onboarding program for new Board members, and an ongoing education plan for existing Board members (FD)**&#x2022;Reviewing regularly the Articles of Incorporation, with a view to reinforcing shareholder rights (FD)**&#x2022;Reviewing regularly the composition and size of the Board and its committees (FBA)***&#x2022;Reviewing annually the independence status of each Board member (FBA)***&#x2022;Reviewing directorships and agreements of Board members for conflicts of interest, and dealing with conflicts of interest (FD)**&#x2022;Overseeing the Company&#x2019;s strategy and governance on corporate responsibility (FBA)***Key activities in 2019Strategic priorities3&#x2022;Discussed the succession of Board and committee members, considering anticipated vacancies due to the mandatory retirement age, and the need to increase diversityp&#x2022;Revised Board Regulationse&#x2022;Evaluated AGM and proxy advisor trendss&#x2022;Discussed important corporate governance developments (e.g., diversity, climate change, cybersecurity risks) relevant for Novartis, including changes to Swiss and international laws and regulationss&#x2022;Decided on a renewed approach to providing patient access in sub-Saharan Africain order to move beyond profitability ratios and profit optimization e&#x2022;Reviewed emerging trends and best practices in responsible and sustainable businesss&#x2022;Discussed ESG targetss&#x2022;Decided to pledge to the United Nations&#x2019; Equal Pay International Coalition (EPIC) to achieve gender balance and pay equity by 2023sMeetings Number of meetings held4Number of members5Approximate average duration (hours)2:07Meeting attendance100%Andreas von Planta14Ann Fudge4Charles L. Sawyers4Enrico Vanni4William T. Winters4Documents&#x2022; Board Committees Charter, Appendix I to the Board Regulationswww.novartis.com/investors/company-overview/corporate-governance1Chair*A/P = advisory or preparatory task**FD = fully delegated task***FBA = task subject to final Board approval3 Strategic priorities: pUnleash the power of our peopleiDeliver transformative innovationeEmbrace operational excellencedGo big on data and digitalsBuild trust with society
</div>
<br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">180</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>

<br>
<img src="x_cg005.gif">
<div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
              Research &amp; Development CommitteePrimary responsibilities&#x2022;Monitoring research and development, and bringing recommendations to the Board (FBA)***&#x2022;Assisting the Board with oversight and evaluation related to research and development (FD)**&#x2022;Informing the Board on a periodic basis about the research and development strategy, the effectiveness and competitiveness of the research and development function, emerging scientific trends and activities critical to the success of research and development, and the pipeline (A/P)*&#x2022;Advising the Board on scientific, technological, and research and development matters (A/P)*&#x2022;Providing counsel and know-how to management in the area of research and development (A/P)*&#x2022;Reviewing such other matters in relation to the Company&#x2019;s research and development as the committee may, in its own discretion, deem desirable in connection with its responsibilities (A/P)*Key activities in 2019 Strategic priorities3&#x2022;Discussed science and innovation in Chinai&#x2022;Discussed the gene therapy portfolioi&#x2022;Reviewed an external assessment of the portfolio and productivity of Novartis research and development i e&#x2022;Discussed the radioligand therapeutics portfolioi e&#x2022;Discussed a potential new direction for the Research &amp; Development Committee to broaden its remit to cover science and technology matters, including digital innovation i eand data scienceMeetingsNumber of meetings held3Number of members4Approximate average duration (hours)8:10Meeting attendance92%Joerg Reinhardt13Nancy C. Andrews3Frans van Houten3Charles L. Sawyers2Documents&#x2022;Board Committees Charter, Appendix I to the Board Regulationswww.novartis.com/investors/company-overview/corporate-governance1Chair*A/P = advisory or preparatory task**FD = fully delegated task***FBA = task subject to final Board approval3 Strategic priorities: pUnleash the power of our peopleiDeliver transformative innovationeEmbrace operational excellencedGo big on data and digitalsBuild trust with society
</div>
<br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">181</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>

<br>
<img src="x_cg006.gif">
    <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
              Risk CommitteePrimary responsibilities&#x2022;Overseeing the risk management system and processes (FBA)***&#x2022;Reviewing, together with management, the prioritization and management of risks, the risk portfolio, and the actions implemented by management (FBA)***&#x2022;Performing deep dives into key risk areas and fostering a culture of smart risk-taking (FBA)***&#x2022;Approving guidelines and reviewing policies and processes (FBA)***Key activities in 2019 Strategic priorities3&#x2022;Approved a new approach to achieve integrated assurancee&#x2022;Analyzed pricing in various marketsi s&#x2022;Reviewed the anti-counterfeiting activities status and outlooke&#x2022;With input from the Novartis team and an independent panel of experts, reviewed the status of cybersecurity, including evolving vulnerabilities, threats and measures dto address security and recovery&#x2022;Evaluated risks and opportunities associated with the digital status and strategy, and the Novartis Business Services transformationi d&#x2022;Reviewed the Company&#x2019;s third-party risk managemente s&#x2022;Reviewed the Enterprise Risk Management ReporteMeetingsNumber of meetings held4Number of members5Approximate average duration (hours)2:10Meeting attendance95%Srikant Datar14Nancy C. Andrews4Elizabeth Doherty3Ann Fudge4Andreas von Planta4Documents&#x2022;Board Committees Charter, Appendix I to the Board Regulationswww.novartis.com/investors/company-overview/corporate-governance1Chair*A/P = advisory or preparatory task**FD = fully delegated task***FBA = task subject to final Board approval3 Strategic priorities: pUnleash the power of our peopleiDeliver transformative innovationeEmbrace operational excellencedGo big on data and digitalsBuild trust with society
</div>
<br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">182</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


    <a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Chairman</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Chairman leads the Board to represent the interests of all stake&#xAD;holders, and ensures an appropriate balance of power between the Board and the Executive Committee. In this role, he:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Provides leadership to the Board</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Supports and mentors the CEO</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensures that the Board and its committees work &#xAD;effectively</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sets the agenda, style and tone of Board discussions, promoting constructive dialogue and effective &#xAD;decision-making</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensures onboarding programs for new Board &#xAD;members, and continuing education and specialization for all Board members </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensures that the Board&#x2019;s performance is annually &#xAD;evaluated </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Promotes effective relationships and communication between Board and Executive Committee members</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensures effective communication with the Company&#x2019;s shareholders</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Vice Chairman</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Vice Chairman:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Leads the Board in case and as long as the Chairman is incapacitated</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairs the sessions of independent Board members, and leads independent Board members if and as long as the Chairman is not independent</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Leads the yearly session of the Board members to &#xAD;evaluate the performance of the Chairman, during which the Chairman is not present</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">No separate meetings of the independent Board &#xAD;members were held in 2019.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Honorary Chairmen</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Dr. Alex Krauer and Dr. Daniel Vasella have been appointed Honorary Chairmen in recognition of their significant achievements on behalf of Novartis. They are not provided with Board documents and do not attend Board meetings.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Mandates outside the Novartis Group</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to article 34, paragraph 1 of the Articles of Incorporation (www.novartis.com/investors/company&#xAD;overview/corporate-governance), the following limitations on mandates apply: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Maximum number <br> of mandates</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other listed companies<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Chairmanship of the board of directors in other listed companies counts as two mandates.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to article 34, paragraph 3 of the Articles of Incorporation (www.novartis.com/investors/company&#xAD;overview/corporate-governance), the following mandates are not subject to the above-mentioned limitations: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Maximum number <br> of mandates</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates in companies that are controlled by Novartis AG</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> No limit</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates held at the request of Novartis AG  or companies controlled by it</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates in associations, charitable organizations,  foundations, trusts and employee welfare foundations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "> &#x201C;Mandates&#x201D; means those in the supreme governing body of a legal entity that is required to be registered in the commercial register or a comparable foreign register. Mandates in different legal entities that are under joint control are deemed one mandate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, some investors asked questions regarding the election of Patrice Bula for reasons of deemed overboarding. The nomination was based on a thorough assessment of Mr. Bula&#x2019;s capability to not only attend meetings but also to invest an appropriate amount of time in providing strategic oversight as a Novartis Board member, in particular also in case of any urgent matter. We are satisfied that any concerns related to overboarding are outweighed by the significant long-standing Swiss and global business experience Mr. Bula will bring to the Board, including his experience in challenging markets like China. Mr. Bula has attended all Novartis Board and Compensation Committee meetings since his election.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As of 1 January 2020, Mr. Bula will no longer be responsible at Nestl&#xE9; for the unit elaborating Portfolio Strategy and Business Intelligence and, he will step down from his roles as chairman of Blue Bottle Coffee Inc. and Nestl&#xE9; Nespresso SA, and as board member of Hsu Fu Chi Food Companies.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">183</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Information and control systems of the Board vis-&#xE0;-vis management</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Information from senior management</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Board ensures that it receives sufficient information from the Executive Committee through:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Monthly CEO reporting (including detailed written updates from each division and business unit head), regular CEO information on current developments, and a yearly presentation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Executive Committee meeting minutes</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Regular meetings/teleconferences by the Board and/or Board committees with the CEO and/or other members of the Executive Committee (e.g., the CFO, Group General Counsel, Chief Ethics, Risk &amp; Compliance Officer) and occasional meetings/teleconferences with senior management (e.g., the Global Head of Novartis Business Assurance &amp; Advisory/Internal Audit)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Information from Executive Committee members or other Novartis associates, and visits to Novartis sites </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">To get an outside view, the Board and/or Board committees occasionally invite external advisors (e.g., the independent advisor of the Compensation Committee, the external auditor) to attend a meeting and/or represent a specific topic.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Regular reports to the Board</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis produces comprehensive, consolidated (unaudited) financial statements on a monthly basis for the Group and its operating divisions. These are typically available within 10 days after the end of the month, and include the following:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Consolidated income statement of the month and year to date, in accordance with International Financial Reporting Standards (IFRS), as well as adjustments to arrive at core results, as defined by Novartis (see &#x201C;Item 5. Operating and Financial Review and Prospects&#x2014;Item 5.A Operating results&#x2014;Non-IFRS measures as defined by Novartis&#x201D;). The IFRS and core figures are compared to the &#xAD;prior-year period and targets in both USD and on a constant currency basis.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Supplementary data on a monthly and year-to-date basis, such as free cash flow and earnings per share on a USD basis </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Management information related to the consolidated income statements and free cash flow is made available to Board members through the monthly CEO Report, including an analysis of key deviations from the prior year or target.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Prior to the release of each quarter&#x2019;s results, the Board receives the actual consolidated financial statement information and an outlook of the full-year results in accordance with IFRS and core results (as defined by Novartis), together with related commentary. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Annually, in the middle of the year, the Board approves the Company&#x2019;s strategic plan for the next three years. In the fourth quarter of the year, the Board approves the operating targets for the following year as well as the financial targets for the following three-year period, including a projected consolidated income statement in USD prepared in accordance with IFRS and non-IFRS measures as defined by Novartis (core results).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Board does not have direct access to the Novartis financial and management reporting systems but can, at any time, request more detailed information.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">184</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0023.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Risk managementUltimate oversight of the Board of DirectorsThe Board is supported by: RISK COMMITTEE&#x2022;Oversees the risk management system and processes&#x2022;Reviews, together with management, the priorization and management of risks, the risk portfolio and actions implemented by management&#x2022;Performs deep dives into key risk areas and fosters a culture of smart risk-taking&#x2022;Approves guidelines and reviews policies and processes&#x2022;Receives regular presentations from the Chief Ethics, Risk &amp; Compliance Officer and the Head of Risk &amp; Resilience as well as designated risk ownersCompensation Committee&#x2022;Works closely with the Risk Committee to ensure that the compensation system does not lead to excessive risk-taking by management (for details, see &#x201C;Item 6.B CompensationCompensation governanceRisk management principles&#x201D;) Audit and Compliance Committee&#x2022;Ensures that Internal Audit plans are aligned with key risks and that the function provides independent assurance and insights around those&#x2022;Receives bi-annually a presentation from the Chief Ethics, Risk &amp; Compliance Officer, who is free to also request a closed session with the ACC and/or its Chair as needed&#x2022;Pays particular attention to financial riskExecutive Committee&#x2022;Regularly assesses risks and fosters a culture of risk awareness, in line with the Novartis Values and Behaviors Ethics, Risk &amp; Compliance (ERC)&#x2022;Provides an integrated Enterprise Risk Management (ERM) framework to gather a holistic view and drive a culture of smart risk-taking&#x2022;Our integrated framework was further strengthened by launching the Novartis Risk &amp; Resilience organization as an ERC subfunction, bringing together the Group Risk Office, Risk Assessment &amp; Monitoring (RAM), Business Continuity Management (BCM), and Novartis Emergency Management (NEM) Senior leaders of diviSIons, organizational units and Group functions, at all levels&#x2022;Provide appropriate risk management within their area of responsibility&#x2022;Establish adequate risk prevention and mitigation strategies when risk exposure is identified, involving periodic meetings to track progress and review of the resources for mitigation&#x2022;Assess emerging risks, trends and overall exposureCoverage of the ERM framework in general  The ERM process covers, but is not limited to covering, the risks associated with: &#x2022;Research, development, manufacturing, marketing and sales of products&#x2022;Finance; taxes; intellectual property; compliance with law and regulations; security; product safety; humanresources; and health, safety and environmental protection &#x2022;Business objectives and strategies, including mergers and acquisitions &#x2022;External factors such as the social, political and economic environment2019 ERM activities Under the ERC, the ERM process has evolved to further adapt to the Company&#x2019;s changing needs. As part of the ERC, the ERM performed risk workshops, and in close collaboration with all risk assurance functions gathered an integrated view of the risks across the Company. Each Novartis unit had at its leadership team level a focused risk workshop, usually in the context of the strategic planning process. In parallel, the ERC piloted integrated risk workshops in a selected group of countries. This informed the creation of a risk portfolio (the Novartis Risk Compass) with a mitigation action plan per local unit, followed by a &#x201C;one risk discussion&#x201D; with the country leadership team, which helped identify and prioritize key risks at the country level.</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">185</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0024.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Internal Audit Independent assurance, advice and insightsThe function supports Novartis in achieving its objectives; identifying and managing major risks; and complying with policies, laws and regulations in the following ways: &#x2022;Internal Audit executes the risk-based annual audit plan approved by the ACC at Group and entity level, and reports the results to the audited units, the Executive Committee (including a root cause analysis), and the ACC (in the form of formal quarterly presentations and audit report executive summaries).&#x2022;(Potential) material irregularities are escalated to the SpeakUp Office for triage and potential investigation, and to the ACC. Action plans are developed together with the audited units. &#x2022;Internal Audit conducts desktop follow-up for high-risk findings prior to the due date of the remediation actions. In case of &#x201C;needs major improvement&#x201D; audit opinion, a follow-up audit will take place in the following year.&#x2022;Audit findings and action plans are stored and monitored in a single application to enable efficient follow-up.&#x2022;Internal Audit also proactively shares insights, best practices and recurring findings with the business to foster continuous learning. The Global Head of Novartis Business Assurance &amp; Advisory/Internal Audit reports administratively to the CEO, and functionally to the Chair of the ACC, and meets with the latter and the Chairman of the Board at least quarterly. 2019 Internal Audit activities and observationsCompared to previous years, Internal Audit broadened the coverage by applying an end-to-end approach and conducting advisory engagements to assess and strengthen governance, risk management and controls (for example, in ongoing strategic projects, newly set-up processes or acquired companies). In 2019, Internal Audit performed: 44 Audits20 Advisories14 Site visitsCoverage extended to engagements in commercial entities, as well as multiple corporate functions and projects, such as various digital initiatives and the transformations of NTO and NBS. Recurring observations identified across functions and business units relate to:&#x2022;Improving project governance&#x2022;End-to-end processes&#x2022;The sustainability and impact of business transformations&#x2022;Principles-based decision-making&#x2022;Data governance&#x2022;System interface management and system security&#x2022;Third-party managementInternal Audit and the ERC functions have initiated a multiyear integrated assurance project to further optimize coverage and minimize blind spots and duplications. In 2019, a self-assessment framework was implemented to determine and potentially improve the maturity of monitoring functions. Internal Audit also advised on the execution of joint monitoring visits piloted by ERC, Financial Control and Compliance (FC&amp;C), and BCM.</div>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">186</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId002332119"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Executive Committee</p>
<div style="padding-top:15px"><img src="cogo_0021.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">Composition (as per December 31, 2019)Vasant NarasimhanChief Executive OfficerSteven BaertChief People &amp; Organization OfficerBertrand BodsonChief Digital OfficerJames BradnerPresident of the Novartis Institutesfor BioMedical Research (NIBR)Harry KirschChief Financial OfficerShannon Thyme KlingerGroup General CounselSteffen LangGlobal Head of NovartisTechnical Operations (NTO)Klaus MoosmayerChief Ethics, Risk &amp; Compliance OfficerRichard SaynorChief Executive Officer of SandozSusanne SchaffertPresident of Novartis OncologyJohn TsaiHead of Global Drug Developmentand Chief Medical OfficerMarie-France TschudinPresident of Novartis PharmaceuticalsRobert WeltevredenHead of Novartis Business Services (NBS)</div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Changes to the Executive Committee</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Susanne Schaffert became President of Novartis Oncology and a member of the Executive Committee effective January 1, 2019. Marie-France Tschudin became President of Novartis Pharmaceuticals and a member of the Executive Committee effective June 7, 2019. She replaced Paul Hudson, who stepped down as of the same date. His CV can be found in the 2018 Annual Report (page 194). Richard &#xAD;Saynor became CEO of Sandoz and a member of the Executive Committee effective July 15, 2019. Richard Francis served as CEO of Sandoz until March 31, 2019. His CV can be found in the 2018 Annual Report (page 194). The 2018 Annual Report is available at www.novartis.com/annualreport2018.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Role of the Executive Committee</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Board has appointed the Executive Committee members and delegated to them the overall responsibility for and oversight of the operational management of Novartis, including:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Recruiting, appointing and promoting senior &#xAD;management</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensuring the efficient operation of the Group and the achievement of optimal results</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Promoting an active internal and external &#xAD;communications policy </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Developing policies and strategic plans for Board approval, and implementing those approved</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Submitting the following to the Board for approval: investments, divestments, transactions, contracts and litigations with a value exceeding USD 500 million, important capital market and other financing transactions, as well as all other matters of fundamental significance to the Novartis Group</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Preparing and submitting quarterly and annual reports to the Board and its committees</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Informing the Board of all matters of fundamental significance to the businesses</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Dealing with any other matters delegated by the Board</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There are no contracts between Novartis and third parties whereby Novartis would delegate any business management tasks to such third parties.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">CEO</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">With the support of the Executive Committee, the CEO is responsible for the operational management of Novartis. This includes effectively implementing the Company strategy, delivering financial results, and shaping a corporate culture of empowerment and responsibility to help drive innovation, performance and reputation. &#xA0;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition to other Board-assigned duties, the CEO leads the Executive Committee, building and maintaining an effective executive team. With the support of the Executive Committee, the CEO is responsible for:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensuring Novartis has the capabilities to achieve its long-term strategic objectives</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Developing robust management succession and development plans for presentation to the Board</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Promoting effective communication with shareholders and other stakeholders</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensuring Novartis conducts its business in a legal and ethical manner</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Developing an effective risk control framework for all business activities </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Ensuring the flow of information to the Board is accurate, timely and clear</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">187</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Committee profile</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The composition as of December 31, 2019, in terms of length of tenure, gender and nationality, is shown in the &#xAD;following charts: </div>
<div style="padding-top:15px"><img src="cogo_0039.gif" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">DiversityNationality1pAmerican31%pGerman23%pSwiss15%pBelgian15%pDutch8%pBritish8%GenderpMale77%pFemale23%Agep&lt;4515%p455039%p&gt;5046%Tenurep&lt;2y70%p24y15%p&gt;4y15%1Please note that two Executive Committee members have two nationalities.Each of these nationalities were taken into account by a factor of 0.5 in the above chart.</div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Mandates outside the Novartis Group</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to article 34, paragraph 2 of the Articles of Incorporation (www.novartis.com/investors/company&#xAD;overview/corporate-governance), the following limitations on mandates apply:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Maximum number <br> of mandates</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other listed companies<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Chairmanship of the board of directors in other listed companies is not allowed.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to article 34, paragraph 3 of the Articles of Incorporation (www.novartis.com/investors/company&#xAD;overview/corporate-governance), the following mandates are not subject to above-mentioned limitations: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Maximum number <br> of mandates</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates in companies that are controlled by Novartis AG</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> No limit</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates held at the request of Novartis AG  or companies controlled by it</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mandates in associations, charitable organizations,  foundations, trusts and employee welfare foundations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">&#x201C;Mandates&#x201D; means those in the supreme governing body of a legal entity that is required to be registered in the commercial register or a comparable foreign register. Mandates in different legal entities that are under joint control are deemed one mandate.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">188</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>




    <a name="anchorId002431924"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Members of the Executive Committee </p>
<div style="padding-top:15px"><img src="cogo_0043.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Vasant (Vas) Narasimhan, M.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chief Executive Officer of Novartis since 2018 | Nationality: American | Year of birth: 1976</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Drug Development and Chief Medical Officer, Novartis AG, Switzerland (2016&ndash;2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Development, Novartis Pharmaceuticals, Switzerland (2014&ndash;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Biopharmaceuticals and Oncology Injectables, Sandoz International, Germany (2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Development, Novartis Vaccines, US (2012&ndash;2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; North America Region Head, Novartis Vaccines, and US Country President, Novartis Vaccines and Diagnostics, US (2008&ndash;2012)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Joined Novartis in 2005 </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Committee member, Biopharmaceutical CEOs Roundtable (BCR), International Federation of Pharmaceutical Manufacturers &amp; Associations (IFPMA), Switzerland</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the board of fellows, Harvard Medical School, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Pharmaceutical Research and Manufacturers of America (PhRMA), US</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctor of medicine, Harvard Medical School, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master&#x2019;s degree in public policy, John F. Kennedy School of Government, Harvard University, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor&#x2019;s degree in biological sciences, University of Chicago, US</div>
<div style="padding-top:15px"><img src="cogo_0042.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Steven Baert</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chief People &amp; Organization Officer of Novartis since 2014 | Nationality: Belgian | Year of birth: 1974</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Human Resources, Novartis Oncology, Switzerland (2012&ndash;2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of Human Resources for the US and Canada, Novartis Pharmaceuticals, US (2009&ndash;2012)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of Human Resources for Emerging Growth Markets, Novartis Pharmaceuticals, Switzerland (2008&ndash;2009)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of Human Resources Global Functions, Novartis Pharmaceuticals, Switzerland (2006&ndash;2008)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, WeSeeHope charity, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Represented Novartis on the board of GlaxoSmithKline Consumer Healthcare Holdings Ltd. (2015&ndash;2018)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, Vlerick Business School, Belgium</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Laws, Katholieke Universiteit Leuven, Belgium</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Laws, Katholieke Universiteit Brussels, Belgium </div>
<div style="padding-top:15px"><img src="cogo_0041.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Bertrand Bodson</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chief Digital Officer of Novartis since 2018 | Nationality: Belgian | Year of birth: 1975</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief digital and marketing officer, Sainsbury&#x2019;s Argos, UK (2013&ndash;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Executive vice president of the global digital business, EMI Music, UK (2010&ndash;2013)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-founder and CEO, Bragster.com, UK (2006&ndash;2010)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Senior group product manager, Amazon Inc., US and UK (2003&ndash;2006)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Electrocomponents PLC, UK</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member of the supervisory board, Wolters Kluwer NV, Netherlands</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, Harvard Business School, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master&#x2019;s degree in commercial engineering, Solvay Business School, Belgium/McGill University, Canada</div>
<div style="padding-top:15px"><img src="cogo_0040.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">James (Jay) Bradner, M.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">President of the Novartis Institutes for BioMedical Research (NIBR) since 2016 | Nationality: American | <br>Year of birth: 1972</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Associate professor, Department of Medicine, Harvard Medical School, US (2014&ndash;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Assistant professor, Department of Medicine, Harvard Medical School, US (2010&ndash;2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Attending physician, Department of Medical Oncology, Dana-Farber Cancer Institute, US (2005&ndash;2015)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-founder of five biotechnology companies</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-author of more than 200 scientific publications and 30&nbsp;US patent applications</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member, Alpha Omega Alpha Honor Medical Society, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member, American Society for Clinical Investigation, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairman, Genomics Institute of the Novartis Research Foundation, US</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctor of medicine, University of Chicago Pritzker School of Medicine, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor&#x2019;s degree in biochemistry, Harvard University, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Postdoctoral training in chemistry and chemical biology, Harvard University, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Fellowship in medical oncology and hematology, Dana-Farber Cancer Institute, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Residency in medicine, Brigham and Women&#x2019;s Hospital, US</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">189</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0047.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Harry Kirsch</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chief Financial Officer of Novartis since 2013 | Nationality: German/Swiss | Year of birth: 1965</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief Financial Officer of the Pharmaceuticals Division (now known as the Innovative Medicines Division), Novartis Pharmaceuticals, Switzerland (2010-2013)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief Financial Officer of Pharma Europe, Novartis Pharmaceuticals, Switzerland (2008&ndash;2010)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of Business Planning &amp; Analysis for the Pharmaceuticals Division, Novartis Pharmaceuticals, Switzerland (2005&ndash;2008) </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Joined Novartis in 2003 as Head Finance Global Primary Care, and over the years held positions of increasing responsibility within Finance </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Represented Novartis on the board of GlaxoSmithKline Consumer Healthcare Holdings Ltd. (2015&ndash;2018)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Diploma degree in industrial engineering and economics, University of Karlsruhe, Germany</div>
<div style="padding-top:15px"><img src="cogo_0046.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Shannon Thyme Klinger</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Group General Counsel of Novartis since 2018 | Nationality: American | Year of birth: 1971</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief Ethics, Risk and Compliance Officer, Novartis AG, Switzerland (April&ndash;May 2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief Ethics and Compliance Officer and Global Head of Litigation, Novartis AG, Switzerland (2016&ndash;2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General Counsel and Global Head of Legal, Sandoz International, Germany (2012&ndash;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General Counsel for North America, Sandoz Inc., US (2011&ndash;2012)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Partner, Mayer Brown LLP, US (2010&ndash;2011)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General counsel and senior vice president, Solvay Pharmaceuticals Inc., US (2008&ndash;2010) </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, SIX Group, Switzerland</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bar memberships: State of Georgia, District of Columbia, US</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Juris doctor with honors, University of North Carolina at Chapel Hill, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor&#x2019;s degree in psychology, University of Notre Dame, US</div>
<div style="padding-top:15px"><img src="cogo_0045.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Steffen Lang, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Global Head of Novartis Technical Operations (NTO) since 2017 | Nationality: German/Swiss | Year of birth: 1967</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Biologics Technical Development and Manufacturing, Novartis Technical Operations, Switzerland (2015&ndash;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Technical Research and Development, Novartis Pharmaceuticals, Switzerland (2009&ndash;2015)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Joined Novartis in 1994 as Head of Laboratory in Research, and over the years held positions of increasing responsibility within Pharmaceuticals Development</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in pharmaceutical technology, Swiss Federal Institute of Technology, Switzerland </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master&#x2019;s degree in pharmaceutical sciences, University of Heidelberg, Germany</div>
<div style="padding-top:15px"><img src="cogo_0044.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Klaus Moosmayer, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chief Ethics, Risk &amp; Compliance Officer of Novartis since 2018 | Nationality: German | Year of birth: 1968</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief compliance officer, Siemens AG, Germany (2014&ndash;2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief counsel compliance, Siemens AG, Germany (2009&ndash;2013)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Compliance operating officer, Siemens AG, Germany (2007&ndash;2009)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chair of the Anti-Corruption Committee of the Business and Industry Advisory Committee, Organization for Economic Co-operation and Development (OECD), Paris</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-founder and chair, European Chief Compliance and Integrity Officers&#x2019; Forum</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-chair, B20 Integrity &amp; Compliance Task Force under the G20 presidency of Saudi Arabia</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Co-chair, B20 Integrity &amp; Compliance Task Force under the G20 presidency of Argentina (2018)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chair, B20 Integrity &amp; Compliance Task Force under the G20 presidency of Germany (2017)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; First and second state examination in law, Germany</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctor of jurisprudence, University of Freiburg, Germany</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">190</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px"><img src="cogo_0052.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Richard Saynor</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Chief Executive Officer of Sandoz since July 15, 2019 | Nationality: British | Year of birth: 1967</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Senior vice president of classic and established products, and commercial and digital platforms, GlaxoSmithKline (GSK) Pte. Ltd., UK (March&ndash;June 2019) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Senior vice president and global head of classic and established products, GSK, UK (2014&ndash;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Senior vice president and global head of established products, GSK, UK (2013&ndash;2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Senior vice president of classic brands and generics for Europe, Japan, and the emerging markets and Asia-Pacific (EMAP) region, GSK, Singapore (2010&ndash;2013)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Region Head of Asian Markets, Sandoz International, Singapore (2008&ndash;2010)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Region Head of Asia-Pacific, Latin America, Canada and Turkey, Sandoz International, Germany (2005&ndash;2008)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Member, Royal Pharmaceutical Society, UK </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, GSK India, India (2018&ndash;2019)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Pharmacy, University of Bradford, UK</div>
<div style="padding-top:15px"><img src="cogo_0051.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Susanne Schaffert, Ph.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">President of Novartis Oncology since January 1, 2019 | Nationality: German | Year of birth: 1967</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chairperson and President, Advanced Accelerator Applications, Switzerland (2018&ndash;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General Manager of Europe, Novartis Oncology, Italy (2012&ndash;2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Head of Investor Relations, Novartis AG, Switzerland (2010&ndash;2012)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global Franchise Head for Immunology and Infectious Diseases, Novartis AG, Switzerland (2009&ndash;2010)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General Manager of Northern and Central Europe, Novartis Oncology, Italy (2007&ndash;2009)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General Manager of Germany, Novartis Oncology, Germany (2004&ndash;2007)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Mandates </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, Novartis AG, Germany</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Board member, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Represented Novartis on the board of GlaxoSmithKline Consumer Healthcare Holdings Ltd. (2015&ndash;2018)</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctorate in organic chemistry, University of Erlangen, Germany</div>
<div style="padding-top:15px"><img src="cogo_0050.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">John Tsai, M.D.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Head of Global Drug Development and Chief Medical Officer for Novartis since 2018 | Nationality: American | <br>Year of birth: 1967</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief medical officer and senior vice president of Global Medical, Amgen Inc., US (2017&ndash;2018)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Global head of clinical development for marketed products, Bristol-Meyers Squibb Co. (BMS), US (2016&ndash;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Full development team leader in oncology, BMS, US (2015&ndash;2016) </div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of Worldwide Medical, BMS, US (2014&ndash;2015)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief medical officer for Europe, BMS, France (2012&ndash;2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Vice president of US Medical, BMS, US (2010&ndash;2012) </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Vice president of Cardiovascular Medical, BMS, US (2006&ndash;2010) </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Doctor of medicine, University of Louisville School of Medicine, US</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Science in electrical engineering, Washington University in St. Louis, US </div>
<div style="padding-top:15px"><img src="cogo_0049.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Marie-France Tschudin</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">President of Novartis Pharmaceuticals since June 7, 2019 | Nationality: Swiss | Year of birth: 1971</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; President, Advanced Accelerator Applications, France (March&ndash;June 2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Europe Region Head, Novartis Pharmaceuticals, Switzerland (2017&ndash;2019)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Corporate vice president of hematology and oncology for Europe, the Middle East and Africa, Celgene International, Switzerland (2014&ndash;2016)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Regional vice president of northern Europe, Celgene International, Switzerland (2012&ndash;2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; General manager of Austria, Switzerland, the Czech Republic, Poland, Slovenia and Slovakia, Celgene International, Switzerland (2009&ndash;2011)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Country manager of Switzerland, Celgene International, Switzerland (2008&ndash;2009) </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration, IMD business school, Switzerland</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Bachelor of Science, Georgetown University, US </div>
<div style="padding-top:15px"><img src="cogo_0048.jpg" border="0"></div>
<div style="padding-bottom:16px;">
  <div style="font-family:arial,helvetica,sans-serif;font-size:1pt;line-height:1pt;color:#ffffff;">
  </div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Robert Weltevreden</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:9pt;color:#000000;padding-bottom:10px;">Head of Novartis Business Services (NBS) since 2018 | Nationality: Dutch | Year of birth: 1969</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Professional experience </font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of business services, Syngenta AG, Switzerland (2015&ndash;2017)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of business process management, Syngenta AG, Switzerland (2014)</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Head of finance services, Syngenta AG, Switzerland, (2009&ndash;2014)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Chief financial officer of the Asia-Pacific region, Syngenta Crop Protection AG, Singapore (2007&ndash;2009) </div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Education</font>
</div>
<div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master&#x2019;s degree in international finance, economics and business administration, Erasmus University Rotterdam, Netherlands</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Master of Business Administration in financial management, Vlerick Business School, Belgium</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">191</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


 <a name="anchorId002531914"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Auditors</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Duration of the mandate and terms of office of the external auditor</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Based on a recommendation by the ACC, the Board nominates an independent auditor for election at the AGM. Pricewaterhouse&#xAD;Coopers AG (PwC) assumed its existing auditing mandate for Novartis in 1996. Luc Schulthess, auditor in charge, began serving in his role in 2018, and Kris Muller, global relationship partner, began serving in her role in 2019. The ACC together with PwC ensure that these partners are rotated at least every five years. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Auditing fees and additional fees</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The ACC monitors and preapproves the fees paid to the external auditor for all audit and non-audit services. It has developed and approved a policy with clear guidelines on the engagement of the independent auditor firm. This policy is designed to help ensure that the independence of the external auditor is maintained. It limits the scope of services that the external auditor may provide to the Group, stipulating certain permissible types of audit-related and non-audit services, including tax services and other services that have been preapproved by the ACC. The ACC preapproves all other services on a case-by-case basis. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The external auditor is required to report periodically to the ACC about the scope of the services it has provided to the Group and the fees for the services it has performed to date. PwC fees for professional services &#xAD;related to the 12-month periods ended December 31, 2019, and December 31, 2018, are as follows: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<br> USD million</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018<br> USD million</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Audit services</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25.6</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Audit-related services</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13.4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tax services</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other services</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Audit services include work performed to issue opinions on consolidated financial statements and parent company financial statements of Novartis AG, to issue opinions related to the effectiveness of the Group&#x2019;s internal control over financial reporting, and to issue reports on local statutory financial statements. Also included are audit services that generally can only be provided by the statutory auditor, such as the audit of the Compensation Report, audits of the adoption of new accounting policies, audits of information systems and the related control environment, as well as reviews of quarterly financial results.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Audit-related services include other assurance services provided by the independent auditor but not restricted to those that can only be provided by the statutory auditor. They include services such as audits of pension and other employee benefit plans; audits in connection with non-recurring transactions, including audit services related to the Alcon strategic review; contract audits of third-party arrangements; corporate responsibility assurance; and other audit-related services.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Tax services represent tax compliance, assistance with historical tax matters, and other tax-related services.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Other services include procedures related to corporate integrity agreements, training in the finance area, benchmarking studies, and license fees for use of accounting and other reporting guidance databases.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Information to the Board and the ACC</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The ACC, acting on behalf of the Board, is responsible for overseeing the activities of PwC. In 2019, this committee held nine meetings. PwC was invited to six of these meetings to attend the discussions on auditing matters and any other matters relevant to its audit.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The ACC recommended to the Board to approve the audited consolidated financial statements and the separate parent company financial statements of Novartis AG for the year ended December 31, 2019. The Board proposed the acceptance of these financial statements for approval by the shareholders at the next AGM.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The ACC regularly evaluates the performance of PwC and, based on this, once a year determines whether PwC should be proposed to the shareholders for election. To assess the performance of PwC, the ACC holds private meetings with the CFO and the Global Head of Novartis Business Assurance &amp; Advisory/Internal Audit and, if necessary, obtains an independent external assessment. Criteria applied for the performance assessment of PwC include an evaluation of its technical and operational competence; its independence and objectivity; the sufficiency of the resources it has employed; its focus on areas of significant risk to Novartis; its willingness to probe and challenge; its ability to provide effective, practical recommendations; and the openness and effectiveness of its communications and coordination with the ACC, the Internal Audit function and management. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Once a year, the auditor in charge and the global relationship partner report to the Board on PwC&#x2019;s activities during the current year and on the audit plan for the coming year. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On an annual basis, PwC provides the ACC with written disclosures required by the US Public Company Accounting Oversight Board, and the committee and PwC discuss PwC&#x2019;s independence from Novartis. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">192</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId002532039"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Information policy</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis is committed to open and transparent communication with shareholders, investors, financial analysts, customers, suppliers and other stakeholders. Novartis disseminates information about material developments in its businesses in a broad and timely manner that complies with the rules of the SIX Swiss Exchange and&#xA0;the NYSE. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Communications</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis publishes this Annual Report to provide information on the Group&#x2019;s results and operations. Novartis discloses financial results in accordance with IFRS on a quarterly basis, and issues press releases from time to time regarding business developments.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis furnishes press releases related to financial results and material events to the SEC via Form 6-K. An archive containing annual reports, US Securities and Exchange Commission Form 20-F, quarterly results releases, and all related materials &#x2013; including presentations and conference call webcasts &#x2013; is available at  www.novartis.com/investors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis also publishes a Novartis in Society ESG Report, available at www.novartis.com/nisreport2019, which details progress and demonstrates the Company&#x2019;s commitment in global health and corporate responsibility. This report has been prepared in accordance with the Global Reporting Initiative, GRI Standards: Core option, and fulfills the Company&#x2019;s reporting requirement as a signatory of the UN Global Compact. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The information on Board and Executive Committee compensation is outlined in the Compensation Report (see &#x201C;Item 6.B Compensation&#x201D; in general, and for certain compensation information with respect to our Board that is responsive to Item 6.C.2 of Form 20-F, see &#x201C;Item 6.B Compensation&#x2014;2019 Board compensation&#x2014;Philosophy and benchmarking&#x201D;). Please also refer to articles 29-35 of the Articles of Incorporation (www.novartis.com/investors/company-&#xAD;overview/corporate-governance). There are no change-of-control and &#x201C;golden parachute&#x201D; clauses benefiting Board members, Executive Committee &#xAD;members, or other members of senior management. Employment contracts with Executive Committee members are either for a fixed term not exceeding one year or for an &#xAD;indefinite period with a notice period not exceeding 12&#xA0;months, and do not contain commissions for the acquisition or &#xAD;transfer of enterprises or severance payments. No loans or &#xAD;credits are granted to Board and Executive Committee members.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Information contained in reports and releases issued by Novartis is only correct and accurate at the time of release. Novartis does not update past releases to reflect subsequent events, and advises against relying on them for current information. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Investor Relations </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Investor Relations manages the Group&#x2019;s interactions with the international financial community. Several events are held each year to provide institutional investors and analysts with various opportunities to learn more about Novartis.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Investor Relations is based at the Group&#x2019;s head&#xAD;quarters in Basel. Part of the team is located in the US to coor&#xAD;dinate interaction with US investors. More information is available at www.novartis.com/investors.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Website information</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">Topic</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Information</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Share capital</div>
      </td>
      <td width="1%"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Articles of Incorporation of Novartis AG <br>  www.novartis.com/investors/company-overview/corporate-governance<br>  Novartis key share data<br>  www.novartis.com/key-share-data</div>
      </td>
      <td width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholder rights</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Articles of Incorporation of Novartis AG <br>  www.novartis.com/investors/company-overview/corporate-governance</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Annual General Meeting of Shareholders</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Annual General Meeting of Shareholders<br>  www.novartis.com/investors/shareholder-information/annual-general-meeting</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Board Regulations</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Board Regulations<br>  www.novartis.com/investors/company-overview/corporate-governance</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Novartis code for senior financial officers</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Code of Ethical Conduct for CEO and Senior Financial Officers<br>  www.novartis.com/investors/company-overview/corporate-governance</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Novartis in Society ESG Report</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis in Society ESG Report<br>  www.novartis.com/nisreport2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Novartis financial data</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis financial data<br>  www.novartis.com/investors/financial-data</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Press releases</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Press releases<br>  www.novartis.com/news/news-archive?type=press_release<br>  Free email service<br>  www.novartis.com/news/stay-up-to-date</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Additional information <br> (including Novartis investors event calendar, registered office, <br> contact and email addresses, phone numbers, etc.)</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Investor Relations <br>  www.novartis.com/investors<br>  </div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">193</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>



    <a name="anchorId00531909"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">6.D  Employees</p>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table below sets forth the breakdown of the total year-end number of our full-time equivalent employees by main category of activity and geographic area for the past three years.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">For the year ended<br>December 31, 2019<br>(full-time equivalents)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Marketing and<br> sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Production and<br> supply</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Research and<br>  development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> NBS<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> General and <br> administration</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">USA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;360</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;830</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;412</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 614</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 763</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14&nbsp;979</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;396</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 838</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 480</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 864</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 397</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;975</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;395</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19&nbsp;386</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;988</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;352</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;666</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 52&nbsp;787</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;455</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;296</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;026</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30&nbsp;173</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 42&nbsp;606</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;176</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;063</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;852</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 103&nbsp;914</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">For the year ended<br>December 31, 2018<br>(full-time equivalents)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Marketing and<br> sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Production and<br> supply</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Research and<br>  development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> NBS<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> General and <br> administration</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">USA</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;825</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;700</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;467</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 911</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23&nbsp;427</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;584</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 960</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 508</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 899</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 490</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;441</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;608</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 21&nbsp;397</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;049</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;845</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;780</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58&nbsp;679</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;636</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;613</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;289</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35&nbsp;614</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 51&nbsp;116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 36&nbsp;517</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;824</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 125&nbsp;161</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof continuing operations<sup>2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 43&nbsp;954</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 25&nbsp;862</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 19&nbsp;803</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 10&nbsp;824</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 4&nbsp;337</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 104&nbsp;780</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof discontinued operations<sup>2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;162</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 10&nbsp;655</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1&nbsp;133</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 20&nbsp;381</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">For the year ended<br>December 31, 2017<br>(full-time equivalents)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Marketing and<br> sales</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Production and<br> supply</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Research and<br>  development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> NBS<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> General and <br> administration</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">USA</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;563</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;803</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;680</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 726</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22&nbsp;867</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;477</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 900</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 471</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;710</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;412</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;173</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;903</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;469</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 56&nbsp;622</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;005</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;970</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;883</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;386</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;154</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34&nbsp;398</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 48&nbsp;710</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;782</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;416</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;869</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;820</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 121&nbsp;597</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td bgcolor="#ffffff" height="16px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof continuing operations<sup>2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 42&nbsp;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 25&nbsp;564</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 20&nbsp;060</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 10&nbsp;869</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 102&nbsp;467</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof discontinued operations<sup>2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 6&nbsp;595</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 10&nbsp;218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1&nbsp;356</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 961</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 19&nbsp;130</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> NBS relates to full-time equivalent employees from our Novartis Business Services organizational unit.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Continuing operations include the businesses of the Innovative Medicines and Sandoz Divisions and the continuing Corporate activities, and discontinued operations include the Alcon eye care devices business and certain corporate activities attributable to Alcon prior to the spin-off. See &#x201C;Item 18.Financial Statements&#x2014;Note 2. Significant transactions&#x2014;Significant transactions in 2019.&#x201D;</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As of December 31, 2019, the number of our full-time equivalent employees decreased by 21 247 compared to December 31, 2018, mainly due to the April 2019 completion of the Alcon spin-off. For more information on this transaction, please see &#x201C;Item 18. Financial Statements&mdash;Note 2. Significant transactions in 2019.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A significant number of our associates are represented by unions or works councils. We have not experienced any material work stoppages in recent years, and we consider our employee relations to be good.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">194</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00532966"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">6.E  Share ownership</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The information set forth under &#x201C;Item 6. Directors, Senior Management and Employees&mdash;Item 6.B Compensation&mdash;2019 Executive Committee compensation&mdash;Additional disclosures for the CEO and other Executive Committee members&mdash;Shares, ADRs and other equity rights owned by Executive Committee members at December&nbsp;31, 2019&#x201D; and under &#x201C;Item 6. Directors, Senior Management and Employees&mdash;Item 6.B Compensation&mdash;2019 Board compensation&mdash;Additional disclosures&mdash;Shares, ADRs and share options owned by Board members,&#x201D; is incorporated by reference. For more information on our equity-based participation plans, see the information set forth under &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;26. Equity-based participation plans for associates,&#x201D; which is incorporated by reference.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">195</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00532987"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;7.  Major Shareholders and Related Party Transactions</p><a name="anchorId00532990"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">7.A Major shareholders</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis shares are widely held. As of December&nbsp;31, 2019, Novartis had approximately 161 000 shareholders listed in the Novartis AG Share Register, representing approximately 69.7% of issued shares. Based on the Novartis AG Share Register and excluding treasury shares, approximately 42.4% of the shares registered by name were held in Switzerland, and approximately 25.4% were held in the US. Approximately 13% of the shares registered in our share register were held by individual investors, while approximately 32.8% were held by legal entities (excluding 5.7% of our share capital held as treasury shares by Novartis AG or its fully owned subsidiaries), and 54.2% by nominees, fiduciaries and the ADS depositary.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Based on our share register, we believe that we are not directly or indirectly owned or controlled by another corporation or government, or by any other natural or legal persons. There are no arrangements that may result in a change of control.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The tables below set forth information with respect to our major shareholders according to our share register as of December 31, 2019, excluding 5.7% of our share capital held as treasury shares by Novartis AG or its fully owned subsidiaries. The following registered shareholders (including nominees and the ADS depositary) held more than 2% of the total share capital of Novartis with the right to vote all their Novartis shares based on an exemption granted by the Board of Directors:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % of respective share capital beneficially owned   as of:</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Ordinary shares<br> beneficially owned as of <br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#666666;"> <br> <br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#666666;"> <br> <br> Dec 31, 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholders registered for their own account:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Emasan AG, Basel, Switzerland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 89&nbsp;193&nbsp;765</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Foundation for Employee Participation, Basel, Switzerland<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53&nbsp;983&nbsp;628</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">UBS Fund Management (Switzerland) AG, Basel, Switzerland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 52&nbsp;845&nbsp;411</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The Novartis Foundation for Employee Participation (the "Employee Foundation") is a special purpose entity that was founded by, but is independent from, Novartis.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> % of respective share capital held as of:</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Ordinary shares<br> held as of <br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Dec 31, 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#666666;"> <br> <br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#666666;"> <br> <br> Dec 31, 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholders registered as nominees:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chase Nominees Ltd., London, England</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 264&nbsp;073&nbsp;363</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9.8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.8</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">The Bank of New York Mellon, New York, NY</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 95&nbsp;456&nbsp;296</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.3</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Through The Bank of New York Mellon, Everett, MA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 50&nbsp;207&nbsp;591</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 2.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 2.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 2.0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Through The Bank of New York Mellon, New York, NY</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 29&nbsp;356&nbsp;938</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 1.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &#x2013;</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Through The Bank of New York Mellon, SA/NV, Brussels, Belgium</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 15&nbsp;891&nbsp;767</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 0.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 2.3</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nortrust Nominees Ltd., London, England</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98&nbsp;354&nbsp;215</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.8</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Shareholder acting as American Depositary Share (ADS) depositary:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">JPMorgan Chase Bank, N.A., New York, NY</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 314&nbsp;717&nbsp;099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12.3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to a disclosure notification filed with Novartis AG, Norges Bank (Central Bank of Norway), Oslo, Norway, held 2.1% of the share capital of Novartis AG, or 54 217 976 shares, as of December&nbsp;31, 2019, with the right to vote all its Novartis shares, but was not registered in our share register as of December&nbsp;31, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">According to a disclosure notification filed with Novartis AG and the SIX Swiss Exchange, each of BlackRock,&nbsp;Inc., New York, NY, and The Capital Group Companies, Inc., Los Angeles, CA, held between 3% and 5%, but was not registered, or was registered with less than 2%, of the share capital of Novartis AG in our share register as of December&nbsp;31, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December&nbsp;31, 2019, no other shareholder was registered as owner of more than 2% of the registered share capital.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Articles of Incorporation provide that no shareholder shall be registered with the right to vote shares comprising more than 2% of the registered share capital. The Board of Directors may, upon request, grant an </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">196</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">exemption from this restriction. Considerations include whether the shareholder supports the Novartis goal of creating sustainable value and has a long-term investment horizon. Exemptions are in force for the registered major shareholders as described above. Novartis has not entered into any agreement with any shareholder regarding the voting or holding of Novartis shares.</div><a name="anchorId00533450"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">7.B Related party transactions</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The information set forth under &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;27. Transactions with related parties&#x201D; is incorporated by reference.</div><a name="anchorId00533457"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">7.C Interests of experts and counsel</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">197</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00533463"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;8.  Financial Information</p><a name="anchorId00533466"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">8.A Consolidated statements and other financial information</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See &#x201C;Item&nbsp;18. Financial Statements.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Dividend policy</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Subject to the dividend policy described below, our Board of Directors expects to recommend the payment of a dividend in respect of each financial year. If approved by our shareholders at the relevant annual shareholders&#x2019; meeting, the dividends will be payable shortly following such approval. Any shareholder who purchases our shares before the ex-dividend date and holds the shares until that date shall be deemed to be entitled to receive the dividends approved at that meeting. Dividends are reflected in our financial statements in the year in which they are approved by our shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our dividend policy is to pay a growing annual dividend in Swiss francs. This policy is subject to our financial conditions and outlook at the time, the results of our operations, and other factors.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Board will propose a dividend of CHF 2.95 per share to the shareholders for approval at the Annual General Meeting to be held on February 28, 2020. Because we pay dividends in Swiss francs, exchange rate fluctuations will affect the US dollar amounts received by holders of ADRs. For a summary of dividends we paid in the past five years, see &#x201C;Item&nbsp;3. Key Information&mdash;Item&nbsp;3.A Selected financial data&mdash;Cash dividends per share.&#x201D;</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Disclosure pursuant to Section&nbsp;219 of the Iran Threat R</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">eduction&nbsp;&amp; Syria Human Rights Act (ITRA)</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "> </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At Novartis, our purpose is to reimagine medicine to improve and extend people&#x2019;s lives, regardless of where they live. This includes the compliant sale of medicines and other healthcare products worldwide. To help us fulfill this mission, we have for many years maintained two representative offices located in Iran.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of October&nbsp;18, 2010, a non-US affiliate within our Innovative Medicines Division entered into a non-binding Memorandum of Understanding (MoU) with the Ministry of Health and Medical Education of the Islamic Republic of Iran. Pursuant to the MoU, the Iranian Ministry of Health acknowledges certain benefits that may apply to sales of certain Innovative Medicines Division medicines by third-party distributors in Iran. These include fast-track registration, market exclusivity, end-user subsidies, and exemptions from customs tariffs. Novartis receives no payments from the Iranian Ministry of Health under the MoU, and the MoU creates no obligations on the part of either Novartis or the Iranian Ministry of Health.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From time to time, including in 2019, non-US affiliates in our Innovative Medicines and Sandoz Divisions made payments to government entities in Iran related to patents, trademarks, exit fees and other transactions ordinarily incident to travel by doctors and other medical professionals resident in Iran to attend conferences or other events outside Iran. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From time to time, including in 2019, non-US affiliates in our Innovative Medicines and Sandoz Divisions enter into agreements with hospitals, research institutes, medical associations and universities in Iran to provide grants and sponsor congresses, seminars and symposia, and with doctors and other healthcare professionals for consulting services, including participation in advisory boards and investigator services for observational (non-interventional) studies. Some hospitals and research institutes are owned or controlled by the government of Iran, and some doctors and healthcare professionals are employed by hospitals that may be public or government-owned.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because our Innovative Medicines and Sandoz Divisions have operations in Iran, including employees, they obtain services and have other dealings incidental to their activities in that country, including paying taxes and salaries either directly or indirectly through a service provider, and obtaining office rentals, insurance, electricity, water and telecommunications services, office and similar supplies, and customs-related services from Iranian companies that may be owned or controlled by the government of Iran. In addition, from time to time, representatives of our non-US affiliates participate in meetings with Iranian officials to discuss issues relevant to our business and the pharmaceutical industry.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Non-US affiliates in our Innovative Medicines and Sandoz Divisions maintain local accounts at banks that are, as of November 5, 2018, on the Specially Designated Nationals and Blocked Persons List (SDN List). These non-US affiliates make local transactions for employee payroll and local vendor payment purposes only with SDN-listed Iranian banks that are not subject to secondary sanctions. Payments to employees and vendors are only made to accounts in Iranian banks that are not subject to secondary sanctions. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">198</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00533530"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">8.B Significant changes</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">None.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">199</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00533536"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;9.  The Offer and Listing</p><a name="anchorId00533539"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">9.A Offer and listing details</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our shares are listed in Switzerland on the SIX Swiss Exchange (SIX).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">ADSs, each representing one share, have been available in the US through an ADR program since December 1996. This program was established pursuant to a deposit agreement that we entered into with JPMorgan Chase Bank, N.A., as depositary (Deposit Agreement). Our ADRs have been listed on the NYSE since May 2000 and are traded under the symbol NVS.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The depositary has informed us that as of January&nbsp;23, 2020, there were 318 million ADRs outstanding, each representing one Novartis share (approximately 12.6% of total Novartis shares issued). On January&nbsp;23, 2020, the closing price per share on the SIX was CHF 91.82 and USD 94.92 per ADR on the NYSE.</div><a name="anchorId00533551"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">9.B Plan of distribution</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00533555"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">9.C Markets</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See &#x201C;&mdash;Item&nbsp;9.A Offer and listing details.&#x201D;</div><a name="anchorId00533561"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">9.D Selling shareholders</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00533565"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">9.E Dilution</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00533569"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">9.F Expenses of the issue</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">200</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00533575"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;10.  Additional Information</p><a name="anchorId00533578"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.A Share capital</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00533582"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.B Memorandum and articles of association</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary (and therefore not purported to be complete) of certain provisions of our Articles of Incorporation (&#x201C;Articles&#x201D;), our Regulations of the Board of Directors (&#x201C;Board Regulations&#x201D;) and of Swiss law, particularly the Swiss Code of Obligations (&#x201C;Swiss CO&#x201D;), and is qualified in its entirety by reference to the Articles and the Board Regulations, which are an exhibit to this Form&nbsp;20-F, and to Swiss law.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.1 Company purpose</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG is registered in the commercial register of the canton of Basel-Stadt, Switzerland, under number CHE-103.867.266. Our business purpose, as stated in Article&nbsp;2 of the Articles, is to hold interests in enterprises in the area of healthcare or nutrition. We may also hold interests in enterprises in the areas of biology, chemistry, physics, information technology or related areas. We may acquire, mortgage, liquidate or sell real estate and intellectual property rights in Switzerland or abroad. In pursuing our business purpose, we strive to create sustainable value.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.2 Directors</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to our Articles, the Board of Directors (&#x201C;Board&#x201D;) consists of a minimum of eight and a maximum of 16 members. The members of the Board and the Chairman of the Board are elected individually by the General Meeting of Shareholders for a term of office lasting until completion of the next Annual General Meeting of Shareholders. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(a) A Board resolution requires the affirmative majority of the votes cast. According to our Board Regulations, a member of our Board (&#x201C;Director&#x201D;) may not participate in deliberations or resolutions on matters that affect, or reasonably might affect, the Director&#x2019;s interests or the interests of a person close to the Director. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(b) Compensation of the Directors is subject to the approval of the aggregate amounts of such compensation by a shareholders&#x2019; resolution under the Ordinance against Excessive Compensation in Public Companies of the Swiss Federal Council (the &#x201C;Compensation Ordinance&#x201D;).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(c) The Articles prohibit the granting of loans or credits to Directors.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(d) Directors who have turned 70 years of age at the date of the General Meeting of Shareholders may no longer be elected as members of the Board. The General Meeting of Shareholders may, under special circumstances, grant an exemption from this rule.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(e) Our Directors are not required to be shareholders.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.3 Shareholder rights</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Because Novartis AG has only one class of registered shares, the following information applies to all shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(a) Under the Swiss CO, we may only pay dividends out of balance sheet profits or out of distributable reserves. In any event, under the Swiss CO, while the Board may propose that a dividend be paid, we may only pay dividends upon shareholders&#x2019; approval at a General Meeting of Shareholders. Furthermore, the Swiss CO requires us to accrue general legal reserves under certain circumstances so long as these reserves amount to less than 20% of our registered share capital, and Swiss law and the Articles permit us to accrue additional reserves beyond the statutory reserves. Our auditors must confirm that the dividend proposal of our Board conforms with the Swiss CO and the Articles. Our Board intends to propose a dividend once each year. See &#x201C;Item&nbsp;3.&nbsp;Key Information&mdash;Item&nbsp;3.A. Selected financial data&mdash;Cash dividends per share&#x201D; and &#x201C;Item&nbsp;8.&nbsp;Financial Information&mdash;Item&nbsp;8.A. Consolidated statements and other financial information&mdash;Dividend policy.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Dividends are usually due and payable shortly after the shareholders have passed a resolution approving the payment. Dividends that have not been claimed within five years after the due date revert to us and are allocated to our general reserves. For information about deduction of the withholding tax or other duties from dividend payments, see &#x201C;&mdash;Item&nbsp;10.E Taxation.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(b) Each share is entitled to one vote at a General Meeting of Shareholders. Voting rights may only be exercised for shares registered with the right to vote on the record date for the applicable General Meeting of Shareholders. In order to do so, the shareholder must file&nbsp;a share registration form with us, setting forth the shareholder&#x2019;s name, address and citizenship (or, in the case of a legal entity, its registered office). If the shareholder has not timely registered its shares, then the shareholder may not vote at, or participate in, General Meetings of Shareholders.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">201</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">To vote its shares, the shareholder must also explicitly declare that it has acquired the shares in its own name and for its own account. If the shareholder refuses to make such a declaration, the shares may not be voted unless the Board recognizes such shareholder as a nominee.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">The Articles provide that no shareholder shall be registered with the right to vote shares comprising more than 2% of the registered share capital. The Board may, upon request, grant an exemption from this restriction. Considerations include whether the shareholder supports our goal of creating sustainable value and has a long-term investment horizon. Furthermore, the Articles provide that no nominee shall be registered with the right to vote shares comprising more than 0.5% of the registered share capital. The Board may, upon request, grant an exemption from this restriction if the nominee discloses the names, addresses and number of shares of the persons for whose account it holds more than 0.5% of the registered share capital. The same restrictions indirectly apply to holders of ADRs. We have in the past granted exemptions from the 2% rule for shareholders and the 0.5% rule for nominees. Under the Articles, the Board may delegate the power to grant such exemptions. The Board has delegated this power to the Chairman of the Board.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">For purposes of the 2% rule for shareholders and the 0.5% rule for nominees, groups of companies and groups of shareholders acting in concert are considered to be one shareholder. These rules also apply to shares acquired or subscribed by the exercise of subscription, option or conversion rights.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">After hearing the registered shareholder or nominee, the Board may cancel, with retroactive effect as of the date of registration, the registration of the shareholders if the registration was effected based on false information.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Registration restrictions in the Articles may only be removed upon a resolution carrying a two-thirds majority of the votes represented at a General Meeting of Shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Except as noted in the paragraph immediately below, shareholders&#x2019; resolutions require the approval of a majority of the votes present at a General Meeting of Shareholders. As a result, abstentions have the effect of votes against such resolutions. Some examples of shareholders&#x2019; resolutions requiring a vote by such &#x201C;absolute majority of the votes&#x201D; are (1)&nbsp;amendments to the Articles; (2)&nbsp;elections of Directors, the Chairman, the Compensation Committee members, the Independent Proxy and the statutory auditor; (3)&nbsp;approval of the management report and the financial statements; (4)&nbsp;setting the annual dividend, if any; (5)&nbsp;approval of the aggregate amounts of compensation of the Directors and the members of the Executive Committee; (6)&nbsp;decisions to discharge Directors and management from liability for matters disclosed to the General Meeting of Shareholders; and (7)&nbsp;the ordering of an independent investigation into specific matters proposed to the General Meeting of Shareholders. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">According to the Articles and Swiss law, the following matters require the approval of a &#x201C;supermajority&#x201D; of at least two-thirds of the votes present at a General Meeting of Shareholders: (1)&nbsp;an alteration of our corporate purpose; (2)&nbsp;the creation of shares with increased voting powers; (3)&nbsp;an implementation of restrictions on the transfer of registered shares and the removal of such restrictions; (4)&nbsp;an authorized or conditional increase of the share capital; (5)&nbsp;an increase of the share capital by conversion of equity, by contribution in kind, or for the purpose of an acquisition of property or the grant of special rights; (6)&nbsp;a restriction or an exclusion of shareholders&#x2019; pre-emptive rights; (7)&nbsp;a change of our registered office; (8)&nbsp;our dissolution; or (9)&nbsp;any amendment to the Articles that would create or eliminate a supermajority requirement. As a matter of Swiss law, certain other matters require a supermajority as well, including certain mergers, scissions and transformations under the Swiss Merger Act.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Our shareholders are required to annually elect all of the members of the Board, as well as the Chairman of the Board, the members of the Compensation Committee, the statutory auditor and the Independent Proxy. The Articles do not provide for cumulative voting of shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">At General Meetings of Shareholders, shareholders can be represented by proxy. However, a proxy must either be: the shareholder&#x2019;s legal representative, another shareholder with the right to vote, or the Independent Proxy. Votes are taken either by a show of hands or by electronic voting, unless the General Meeting of Shareholders resolves to have a ballot or where a ballot is ordered by the chairman of the meeting.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">American Depositary Shares (ADSs), each representing one Novartis AG share and evidenced by American Depositary Receipts (ADRs), are issued by our depositary JPMorgan Chase Bank, N.A., New York, and not by us. The ADR is vested with rights defined and enumerated in the Deposit Agreement (such as the rights to vote, to receive a dividend and to receive a share of Novartis AG in exchange for a certain number of ADRs). The enumeration of rights, including any limitations on those rights in the Deposit Agreement, is final. There are no other rights given to the ADR holders. Only the ADS depositary, holding our shares underlying the ADRs, is registered as shareholder in our share register. An ADR is not a Novartis AG share and an ADR holder is not a Novartis AG shareholder.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">The Deposit Agreement between our depositary, the ADR holder and us has granted certain indirect rights to vote to the ADR holders. ADR holders may not attend Novartis AG general meetings in person. ADR holders exercise their voting rights by instructing JPMorgan Chase Bank, N.A., our depositary, to exercise the voting rights attached to the registered shares underlying the ADRs. Each ADR represents one Novartis AG share. JPMorgan Chase Bank exercises the voting rights for registered shares underlying ADRs for which no voting instructions have been given by providing a discretionary proxy to an uninstructed independent designee pursuant to paragraph&nbsp;13 of the form of ADR. Such designee has to </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">202</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">be a shareholder of Novartis AG. The same voting restrictions apply to ADR holders as to those holding Novartis AG shares (i.e., the right to vote up to 2% of the Novartis AG registered share capital &ndash; unless otherwise granted an exemption by the Board &ndash; and the disclosure requirement for nominees).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(c) Shareholders have the right to allocate the profit shown on our balance sheet and to distribute dividends by vote taken at the General Meeting of Shareholders, subject to the legal requirements described in &#x201C;Item&nbsp;10.B.3(a) Shareholder rights.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(d) Under the Swiss CO, any surplus arising out of a liquidation of Novartis AG (i.e., after the settlement of all claims of all creditors) would be distributed to the shareholders in proportion to the paid-in nominal value of their shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(e) The Swiss CO limits a corporation&#x2019;s ability to hold or repurchase its own shares. We and our subsidiaries may only repurchase shares if we have sufficient freely disposable equity in the amount of the purchase price of the acquired shares. The aggregate nominal value of all Novartis AG shares held by us and our subsidiaries may not exceed 10% of our registered share capital. However, it is accepted that a Swiss corporation may repurchase its own shares beyond the statutory limit of 10% if the repurchased shares are clearly earmarked for cancellation. In addition, we are required to recognize a negative position or if our subsidiaries acquire our shares, to create a special reserve on our balance sheet in the amount of the purchase price of the acquired shares. Repurchased shares held by us or our subsidiaries do not carry any rights to vote at a General Meeting of Shareholders, but are entitled to the economic benefits generally connected with the shares. The definition of subsidiaries, and therefore, treasury shares, for purposes of the above described reserves requirement and voting restrictions differs from the definition of subsidiaries for purposes of consolidation in our consolidated financial statements. The definition in the consolidated financial statements requires consolidation for financial reporting purposes of special purpose entities in instances where we have the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities. Therefore, our consolidated financial statements include special purpose entities, mainly foundations, which do not qualify as subsidiaries subject to the reserve requirements and voting restrictions of the Swiss CO because we do not hold a majority participation in these special purpose entities. Accordingly, no reserve requirements apply to shares held by such special purpose entities, and such entities are not restricted from independently voting their shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Under the Swiss CO, we may not cancel treasury shares without the approval of a capital reduction by our shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(f) Not applicable.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(g) Since all of our issued and outstanding shares have been fully paid in, our shareholders are not obliged to make further contributions with respect to their shares. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(h) See &#x201C;&mdash;Item&nbsp;10.B.3(b) Shareholder rights&#x201D; and &#x201C;&mdash;Item&nbsp;10.B.7 Change in control.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.4 Changes to shareholder rights</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Under the Swiss CO, we may not issue new shares without the prior approval of a capital increase by our shareholders. If a capital increase is approved, then our shareholders would generally have certain pre-emptive rights to obtain newly issued shares in an amount proportional to the nominal value of the shares they already hold. These pre-emptive rights could be excluded in certain limited circumstances with the approval of a resolution adopted at a General Meeting of Shareholders by a supermajority of two-thirds of the votes. In addition, we may not create shares with increased voting powers or place restrictions on the transfer of registered shares without the approval of a resolution adopted at a General Meeting of Shareholders by a supermajority of votes. In addition, see &#x201C;&mdash;Item&nbsp;10.B.3(b) Shareholder rights&#x201D; with regard to the Board&#x2019;s ability to cancel the registration of shares under limited circumstances.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.5 Shareholder meetings</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Under the Swiss CO and the Articles, we must hold an annual ordinary General Meeting of Shareholders within six months after the end of our financial year. General Meetings of Shareholders may be convened by the Board or, if necessary, by the statutory auditors. The Board is further required to convene an extraordinary General Meeting of Shareholders if so resolved by a General Meeting of Shareholders, or if so requested by shareholders holding an aggregate of at least 10% of the share capital, specifying the items for the agenda and their proposals. Shareholders holding shares with an aggregate nominal value of at least CHF&nbsp;1000000 (i.e., 2000000&nbsp;Novartis AG shares) or at least 10% of the share capital have the right to request that a specific proposal be put on the agenda and voted upon at the next General Meeting of Shareholders. A General Meeting of Shareholders is convened by publishing a notice in the Swiss Official Gazette of Commerce (<i>Schweizerisches</i><i> Handelsamtsblatt</i>) at least 20&nbsp;days prior to such meeting. Shareholders may also be informed by mail. There is no provision in the Swiss CO or the Articles requiring a quorum for the holding of a General Meeting of Shareholders. In addition, see &#x201C;&mdash;Item&nbsp;10.B.3(b) Shareholder rights&#x201D; regarding conditions for exercising a shareholder&#x2019;s right to vote at a General Meeting of Shareholders.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.6 Limitations</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There are no limitations under the Swiss CO or our Articles on the right of non-Swiss residents or nationals to own or vote shares other than the restrictions applicable to all shareholders. But see &#x201C;&mdash;Item&nbsp;10.B.3(b) Shareholder rights&#x201D; regarding conditions for exercising an ADR holder&#x2019;s right to vote at a shareholder meeting.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.7 Change in control</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Articles and the Board Regulations contain no provision that would have an effect of delaying, deferring or </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">203</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">preventing a change in control of Novartis AG and that would operate only with respect to a merger, acquisition or corporate restructuring involving us or any of our subsidiaries.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">According to the Swiss Merger Act, shareholders may pass a resolution to merge with another corporation at any time. Such a resolution would require the consent of at least two-thirds of all votes present at the necessary General Meeting of Shareholders.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Under the Swiss Financial Market Infrastructure Act, shareholders and groups of shareholders acting in concert who acquire more than 33 1/3% of our shares would be under an obligation to make an offer to acquire all remaining Novartis AG shares. Novartis AG has neither opted out from the mandatory takeover offer obligation nor opted to increase the threshold for mandatory takeover offers in its Articles.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.8 Disclosure of shareholdings</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Under the Swiss Financial Market Infrastructure Act, persons who directly, indirectly or in concert with other parties acquire or dispose of our shares or purchase or sale rights relating to our shares are required to notify us and SIX of the level of their holdings whenever such holdings reach, exceed or fall below certain thresholds &ndash; 3%, 5%, 10%, 15%, 20%, 25%, 33 1/3%, 50% and 66 2/3% &ndash; of the voting rights represented by our share capital (whether exercisable or not). This also applies to anyone who has discretionary power to exercise voting rights associated with our shares. Following receipt of such notification, we are required to inform the public by publishing the information via the electronic publication platform operated by SIX.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">An additional disclosure obligation exists under the Swiss CO that requires us to disclose, once a year in the notes to the financial statements published in our Annual Report, the identity of all of our shareholders (or related groups of shareholders) who have been granted exemption entitling them to vote more than 2% of our registered share capital, as described in &#x201C;&mdash;Item&nbsp;10.B.3(b) Shareholder rights.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.9 Differences in the law</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See the references to Swiss law throughout this &#x201C;&mdash;Item&nbsp;10.B Memorandum and articles of association.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">10.B.10 Changes in capital</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The requirements of the Articles regarding changes in capital are not more stringent than the requirements of Swiss law.</div><a name="anchorId00533810"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.C Material contracts</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Alcon spin-off</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In connection with the spin-off of our Alcon business, we entered into a Separation and Distribution Agreement, a Tax Matters Agreement and several other agreements with Alcon to effect the separation of the Alcon business and provide a framework for our relationship with Alcon after the spin-off. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Separation and Distribution Agreement sets forth the parties&#x2019; agreements regarding the principal actions to be taken in connection with the separation of the Alcon business and the spin-off, including the conditions of the spin-off and the rights and obligations of the parties with respect to the distribution. The Separation and Distribution Agreement identifies the assets to be transferred, liabilities to be assumed and contracts to be assigned to each of Novartis and Alcon as part of the internal transactions effected prior to the distribution and provides for when and how such transfers, assumptions and assignments should occur. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Tax Matters Agreement imposes certain restrictions and indemnity obligations on Alcon designed to preserve the tax-neutral nature of the spin-off for Swiss tax and US federal income tax purposes. The Tax Matters Agreement also provides that Alcon will generally indemnify Novartis for any taxes of Novartis and its subsidiaries to the extent such taxes are attributable to the Alcon business, and Novartis will generally indemnify Alcon for any of Alcon&#x2019;s or its subsidiaries&#x2019; taxes to the extent such taxes are attributable to the Novartis retained businesses. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In connection with the spin-off, we also entered into an employee matters agreement, a transition services agreement, forward and reverse manufacturing supply agreements, and certain intellectual property agreements, each of which is not material to Novartis.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Acquisition of The Medicines Company</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 23, 2019, we entered into an Agreement and Plan of Merger (the Merger Agreement) with US-based pharmaceutical company The Medicines Company. Pursuant to the Merger Agreement, on December 5, 2019, Novartis, through a subsidiary, commenced a tender offer to acquire all outstanding shares of The Medicines Company for USD 85 per share, or a total consideration of approximately USD 9.7 billion in cash on a fully diluted basis. The tender offer expired on January 3, 2020, and on January 6, 2020, the acquiring subsidiary merged with and into The Medicines Company, resulting in The Medicines Company becoming an indirect wholly owned subsidiary of Novartis. This merger broadens our cardiovascular portfolio by adding inclisiran, an investigational cholesterol-lowering therapy.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">204</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00533828"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.D Exchange controls</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There are no Swiss governmental laws, decrees or regulations that affect &ndash; in a manner material to Novartis AG &ndash; the export or import of capital, including the availability of cash and cash equivalents for use by Novartis or any foreign exchange controls that affect the remittance of dividends, interest or other payments to non-residents or non-citizens of Switzerland who hold Novartis AG securities.</div><a name="anchorId00533834"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.E Taxation</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The taxation discussion set forth below is intended only as a descriptive summary and does not purport to be a complete analysis or listing of all potential tax effects relevant to the ownership or disposition of our shares or ADRs. The statements of US and Swiss tax laws set forth below are based on the laws and regulations in force as of the date of this 20-F &ndash; including the current Convention Between the US and the Swiss Confederation for the Avoidance of Double Taxation with Respect to Taxes on Income, entered into force on December&nbsp;19, 1997 (the Treaty); the US Internal Revenue Code of 1986, as amended (the Code); Treasury regulations; rulings; judicial decisions; and administrative pronouncements &ndash; and may be subject to any changes in US and Swiss law, and in any double taxation convention or treaty between the US and Switzerland occurring after that date, which changes may have retroactive effect.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Swiss taxation</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Swiss residents</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "><i>Withholding Tax on dividends and distributions.</i>  Dividends that we pay and similar cash or in-kind distributions that we may make to a holder of shares or ADRs (including distributions of liquidation proceeds in excess of the nominal value, stock dividends and, under certain circumstances, proceeds from repurchases of shares by us in excess of the nominal value) are generally subject to a Swiss federal withholding tax (the Withholding Tax) at a current rate of 35%. Under certain circumstances, distributions out of capital contribution reserves made by shareholders after December&nbsp;31, 1996, are exempt from the Withholding Tax. We are required to withhold Withholding Tax due from the gross distribution and to pay the Withholding Tax to the Swiss Federal Tax Administration. The Withholding Tax is refundable in full to Swiss tax residents who are the beneficial owners of the taxable distribution at the time it is resolved and duly report the gross distribution received on their personal tax return or in their financial statements for tax purposes, as the case may be.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Income tax on dividends.</i>  A Swiss tax resident who receives dividends and similar distributions (including stock dividends and liquidation surplus) on shares or ADRs is required to include such amounts in the shareholder&#x2019;s personal income tax return. However, distributions out of qualified capital contribution reserves are not subject to income tax. A corporate shareholder may claim substantial relief from taxation of dividends and similar distributions received if the shares held represent a fair market value of at least CHF&nbsp;1&nbsp;million.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Capital gains tax upon disposal of shares.</i>  Under current Swiss tax law, the gain realized on shares held by a Swiss resident who holds shares or ADRs as part of his private property is generally not subject to any federal, cantonal or municipal income taxation on gains realized on the sale or other disposal of shares or ADRs. However, gains realized upon a repurchase of shares by us may be characterized as taxable dividend income if certain conditions are met. Book gains realized on shares or ADRs held by a Swiss corporate entity or by a Swiss resident individual as part of the shareholder&#x2019;s business property are, in general, included in the taxable income of such person. However, the Federal Law on the Direct Federal Tax of December&nbsp;14, 1990, and several cantonal laws on direct cantonal taxes provide for exceptions for Swiss corporate entities holding more than 10% of our voting stock for more than one year.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Residents of other countries</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Recipients of dividends and similar distributions on our shares who are neither residents of Switzerland for tax purposes nor holding shares as part of a business conducted through a permanent establishment situated in Switzerland (Non-Resident Holders) are not subject to Swiss income taxes in respect of such distributions. Moreover, gains realized by such recipients upon the disposal of shares are not subject to Swiss income taxes.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Non-Resident Holders of shares are, however, subject to the Withholding Tax on dividends and similar distributions mentioned above and, under certain circumstances, to the Stamp Duty described below. Such Non-Resident Holders may be entitled to a partial refund of the Withholding Tax if the country in which they reside has entered into a bilateral treaty for the avoidance of double taxation with Switzerland. Non-Resident Holders should be aware that the procedures for claiming treaty refunds (and the timeframe required for obtaining a refund) may differ from country to country. Non-Resident Holders should consult their own tax advisors regarding receipt, ownership, purchase, sale or other dispositions of shares or ADRs, and the procedures for claiming a refund of the Withholding Tax.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">205</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of January&nbsp;1, 2020, Switzerland has entered into bilateral treaties for the avoidance of double taxation with respect to income taxes with the following countries, whereby a part of the above-mentioned Withholding  Tax may be refunded (subject to the limitations set forth in such treaties):</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Albania</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Algeria</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Argentina</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Armenia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Australia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Austria</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Azerbaijan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Bahrain</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Bangladesh</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Belarus</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Belgium</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Bulgaria</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Canada</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Chile</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">China</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Colombia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Croatia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cyprus</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Czech Republic</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Denmark</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Ecuador</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Egypt</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Estonia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Finland</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">France</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Georgia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Germany</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Ghana</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Greece</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Hong Kong</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Hungary</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Iceland</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">India</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Indonesia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Iran</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Republic of Ireland</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Israel</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Italy</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Ivory Coast</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Jamaica</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Japan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Kazakhstan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Republic of Korea</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(South Korea)</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Kosovo</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Kuwait</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Kyrgyzstan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Latvia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Liechtenstein</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Lithuania</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Luxembourg</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Macedonia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Malaysia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Malta</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Mexico</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Moldova</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Mongolia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Montenegro</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Morocco</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Netherlands</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">New Zealand</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Norway</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Oman</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Pakistan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Peru</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Philippines</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Poland</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Portugal</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Qatar</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Romania</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Russia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Serbia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Singapore</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Slovak Republic</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Slovenia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">South Africa</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Spain</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sri Lanka</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sweden</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Taiwan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Tajikistan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Thailand</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trinidad and Tobago</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Tunisia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Turkey</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Turkmenistan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Ukraine</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">United Arab Emirates</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">United Kingdom</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">United States of America</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Uruguay</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Uzbekistan</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Venezuela</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Vietnam </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Zambia</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The tax treaty with Bahrain is not applicable to the healthcare industry. Tax treaty negotiations are underway, or have been conducted, with Bosnia and Herzegovina, Brazil, Costa Rica, Ethiopia, Libya, North Korea, Saudi Arabia, Senegal, Syria and Zimbabwe. Tax treaty negotiations between Switzerland and some of the countries listed in the immediately preceding sentence have been ongoing for an extended period of time, and we are not certain when or if such negotiations will be completed, and when or if the corresponding treaties will come into effect.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">A Non-Resident Holder of shares or ADRs will not be liable for any Swiss taxes other than the Withholding Tax described above and, if the transfer occurs through or with a Swiss bank or other Swiss securities dealer, the Stamp Duty described below. If, however, the shares or ADRs of Non-Resident Holders can be attributed to a permanent establishment or a fixed place of business maintained by such person within Switzerland during the relevant tax year, the shares or ADRs may be subject to Swiss income taxes in respect of income and gains realized on the shares or ADRs, and such person may qualify for a full refund of the Withholding Tax based on Swiss tax law.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Residents of the US.</i>  A Non-Resident Holder who is a resident of the US for purposes of the Treaty is eligible for a reduced rate of tax on dividends equal to 15% of the dividend, provided that such holder (i)&nbsp;qualifies for benefits under the Treaty, (ii)&nbsp;holds, directly and indirectly, less than 10% of our voting stock, and (iii)&nbsp;does not conduct business through a permanent establishment or fixed base in Switzerland to which the shares or ADRs are attributable. Such an eligible holder must apply for a refund of the amount of the Withholding Tax in excess of the 15% Treaty rate. A Non-Resident Holder who is a resident of the US for purposes of the Treaty is eligible for a reduced rate of tax on dividends equal to 5% of the dividend, provided that such holder (i)&nbsp;is a company, (ii)&nbsp;qualifies for benefits under the Treaty, (iii)&nbsp;holds directly at least 10% of our voting stock, and (iv)&nbsp;does not conduct business through a permanent establishment or fixed place of business in Switzerland to which the shares or ADRs are attributable. Such an eligible holder must apply for a refund of the amount of the Withholding Tax in excess of the 5% Treaty rate. Claims for refunds must be filed on Swiss Tax Form&nbsp;82 (82C for corporations; 82I for individuals; 82E for other entities), which may be obtained from any Swiss Consulate General in the US or from the Federal Tax Administration of Switzerland at the address below, together with an instruction form. Four copies of the form must be duly completed, signed before a notary public of the US, and sent to the Federal Tax Administration of Switzerland, Eigerstrasse 65, CH-3003 Bern, Switzerland. The form must be accompanied by suitable evidence of deduction of Swiss tax withheld at source, such as certificates of deduction, signed bank vouchers or credit slips. The form may be filed on or after July&nbsp;1 or January&nbsp;1 following the date the dividend was payable, but no later than December&nbsp;31 of the third year following the calendar year in which the dividend became payable. For US resident holders of ADRs, JPMorgan Chase Bank, N.A., as depositary, will comply with these Swiss procedures on behalf of the holders, and will remit the net amount to the holders.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">206</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Stamp Duty upon transfer of securities.</i>  The sale of shares, whether by Swiss residents or Non-Resident Holders, may be subject to federal securities transfer Stamp Duty of 0.15%, calculated on the sale proceeds, if the sale occurs through or with a Swiss bank or other Swiss securities dealer, as defined in the Swiss Federal Stamp Duty Act. The Stamp Duty has to be paid by the securities dealer and may be charged to the parties in a taxable transaction who are not securities dealers. Stamp Duty may also be due if a sale of shares occurs with or through a non-Swiss bank or securities dealer, provided (i)&nbsp;such bank or dealer is a member of the SIX, and (ii)&nbsp;the sale takes place on the SIX. In addition to this Stamp Duty, the sale of shares by or through a member of the SIX may be subject to a minor stock exchange levy.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">US federal income taxation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a general discussion of the material US federal income tax consequences of the ownership and disposition of our shares or ADRs that may be relevant to you if you are a US Holder (as defined below). Because this discussion does not consider any specific circumstances of any particular holder of our shares or ADRs, persons who are subject to US taxation are strongly urged to consult their own tax advisors as to the overall US federal, state and local tax consequences, as well as to the overall Swiss and other foreign tax consequences, of the ownership and disposition of our shares or ADRs. In particular, additional or different rules may apply to US expatriates; banks and other financial institutions; regulated investment companies; traders in securities who elect to apply a mark-to-market method of accounting; dealers in securities or currencies; tax-exempt entities; insurance companies; broker-dealers; investors liable for alternative minimum tax; investors that hold shares or ADRs as part of a straddle, hedging or conversion transaction; holders whose functional currency is not the US dollar; partnerships or other pass-through entities; persons who acquired our shares pursuant to the exercise of employee stock options or otherwise as compensation; and persons who hold, directly, indirectly or by attribution, 10% or more of our outstanding shares. This discussion generally applies only to US Holders who hold the shares or ADRs as a capital asset (generally, for investment purposes), and whose functional currency is the US dollar. Investors are urged to consult their own tax advisors concerning whether they are eligible for benefits under the Treaty.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For purposes of this discussion, a US Holder is a beneficial owner of our shares or ADRs who is (i)&nbsp;an individual who is a citizen or resident of the US for US federal income tax purposes; (ii)&nbsp;a corporation (or other entity taxable as a corporation for US federal income tax purposes) created or organized in or under the laws of the US or a state thereof or the District of Columbia; (iii)&nbsp;an estate the income of which is subject to US federal income taxation regardless of its source; or (iv)&nbsp;a trust (i)&nbsp;subject to the primary supervision of a US court and the control of one or more US persons, or (ii)&nbsp;that has a valid election in place to be treated as a US person. If a partnership (or other entity treated as a partnership for US federal income tax purposes) holds shares or ADRs, the tax treatment of a partner generally will depend upon the status of the partner and the activities of the partnership. Partners in a partnership that holds shares or ADRs are urged to consult their own tax advisor regarding the specific tax consequences of the owning and disposing of such shares or ADRs by the partnership.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For US federal income tax purposes, a US Holder of ADRs generally will be treated as the beneficial owner of our shares represented by the ADRs. However, see the discussion below under &#x201C;&mdash;Dividends&#x201D; regarding certain statements made by the US Treasury concerning depositary arrangements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">This discussion assumes that each obligation in the Deposit Agreement and any related agreement will be performed in accordance with its terms.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Dividends.</i>  US Holders will be required to include in gross income, as an item of ordinary income, the full amount (including the amount of any Withholding Tax) of a dividend paid with respect to our shares or ADRs at the time that such dividend is received by the US Holder, in the case of shares, or by the depositary, in the case of ADRs. For this purpose, a &#x201C;dividend&#x201D; will include any distribution paid by us with respect to our shares or ADRs (other than certain pro rata distributions of our capital stock) paid out of our current or accumulated earnings and profits, as determined under US federal income tax principles. To the extent the amount of a distribution by us exceeds our current and accumulated earnings and profits, such excess will first be treated as a tax-free return of capital to the extent of a US Holder&#x2019;s tax basis in the shares or ADRs (with a corresponding reduction in such tax basis), and thereafter will be treated as capital gain, which will be long-term capital gain if the US Holder held our shares or ADRs for more than one year. Under the Code, dividend payments by us on the shares or ADRs are not eligible for the dividends received deduction generally allowed to corporate shareholders.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Dividend income in respect of our shares or ADRs will constitute income from sources outside the US for US foreign tax credit purposes. Subject to the limitations and conditions provided in the Code, US Holders generally may claim as a credit against their US federal income tax liability, any Withholding Tax withheld from a dividend. The rules governing the foreign tax credit are complex. Each US Holder is urged to consult its own tax advisor concerning whether, and to what extent, a foreign tax credit will be available with respect to dividends received from us. Alternatively, a US Holder may claim the Withholding Tax as a deduction for the taxable year within which the Withholding Tax is paid or accrued, provided a deduction is claimed for all of the foreign income taxes the US Holder pays or accrues in the particular year. A deduction does not reduce US tax on a dollar-for-dollar basis like a tax credit. The deduction, however, is not subject to the limitations applicable to foreign tax credits, but may be subject to other limitations, and each US Holder is urged to consult its own tax advisor.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The US Treasury has expressed concern that parties to whom ADRs are released may be taking actions inconsistent with the claiming of foreign tax credits for US Holders of ADRs. Accordingly, the summary above of the </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">207</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">creditability of the Withholding Tax could be affected by future actions that may be taken by the US Treasury.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In general, a US Holder will be required to determine the amount of any dividend paid in Swiss francs, including the amount of any Withholding Tax imposed thereon, by translating the Swiss francs into US dollars at the spot rate on the date the dividend is actually or constructively received by a US Holder, in the case of shares, or by the depositary, in the case of ADRs, regardless of whether the Swiss francs are in fact converted into US dollars. If a US Holder converts the Swiss francs so received into US dollars on the date of receipt, the US Holder generally should not recognize foreign currency gain or loss on such conversion. If a US Holder does not convert the Swiss francs so received into US dollars on the date of receipt, the US Holder will have a tax basis in the Swiss francs equal to the US dollar value on such date. Any foreign currency gain or loss that a US Holder recognizes on a subsequent conversion or other disposition of the Swiss francs generally will be treated as US source ordinary income or loss.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For a non-corporate US Holder, the US dollar amount of any dividends paid that constitute qualified dividend income generally will be taxable at a maximum rate of 15% (or 20% in the case of taxpayers with annual income that exceeds certain thresholds), provided that the US Holder meets certain holding period and other requirements. In addition, the dividends could be subject to a 3.8% net investment income tax. This tax is applied against the lesser of the US Holder&#x2019;s net investment income or the amount by which modified adjusted gross income exceeds a statutory threshold amount based on filing status. We currently believe that dividends paid with respect to our shares and ADRs will constitute qualified dividend income for US federal income tax purposes. US Holders of shares or ADRs are urged to consult their own tax advisors regarding the availability to them of the reduced dividend rate in light of their own particular situation and the computations of their foreign tax credit limitation with respect to any qualified dividends paid to them, as applicable.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>Sale or other taxable disposition.</i>  Upon a sale or other taxable disposition of shares or ADRs, US Holders generally will recognize capital gain or loss in an amount equal to the difference between the US dollar value of the amount realized on the disposition and the US Holder&#x2019;s tax basis (determined in US dollars) in the shares or ADRs. This capital gain or loss generally will be US source gain or loss and will be treated as long-term capital gain or loss if the holding period in the shares or ADRs exceeds one year. In the case of a non-corporate US Holder, any long-term capital gain generally will be subject to US federal income tax at preferential rates, with a maximum rate of 15% (or 20% in the case of taxpayers with annual income that exceeds certain thresholds). In addition, the gains could be subject to a 3.8% investment income tax. This tax is applied against the lesser of the US Holder&#x2019;s net investment income or the amount by which modified adjusted gross income exceeds a statutory threshold amount based on filing status. The deductibility of capital losses is subject to significant limitations under the Code. Deposits or withdrawals of our shares by US Holders in exchanges for ADRs will not result in the realization of gain or loss for US federal income tax purposes.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"><i>US information reporting and backup withholding.</i>  Dividend payments with respect to shares or ADRs and proceeds from the sale, exchange or other disposition of shares or ADRs received in the United States or through US-related financial intermediaries may be subject to information reporting to the US Internal Revenue Service (IRS) and possible US backup withholding. Certain exempt recipients (such as corporations) are not subject to these information reporting and backup withholding requirements. Backup withholding will not apply to a US Holder who furnishes a correct taxpayer identification number and makes any other required certification or who is otherwise exempt from backup withholding. Any US Holders required to establish their exempt status generally must provide a properly executed IRS Form&nbsp;W-9 (Request for Taxpayer Identification Number and Certification). Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against a US Holder&#x2019;s US federal income tax liability, and a US Holder may obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for refund with the IRS and furnishing any required information.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Tax consequences of the Alcon spin-off </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">To implement the Alcon spin-off, we distributed all of the Alcon shares held by Novartis to Novartis shareholders, pro rata to their respective holdings. Each Novartis shareholder received one Alcon share for every five Novartis shares or five Novartis ADRs they held or had acquired prior to the close of business on April 8, 2019.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following statements are based on the requirement of the continuing effectiveness and validity of the written confirmations (the Swiss Tax Rulings) from the Swiss Federal Tax Administration and from the tax administration of the Canton of Basel-Stadt, a private letter ruling from the IRS (the IRS Ruling) and a written opinion of Cravath, Swaine &amp; Moore LLP, counsel to Novartis (the Tax Opinion), each to the effect that the spin-off qualifies as a tax-neutral transaction.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Material tax consequences to Novartis</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary of the material tax consequences to Novartis in connection with the spin-off that may be relevant to holders of Novartis shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The spin-off was preceded by several internal restructuring steps to separate the Alcon business from Novartis. Novartis has received the Swiss Tax Rulings, the IRS Ruling and the Tax Opinion, providing that the spin-off and certain internal restructuring steps taken prior to the spin-off should qualify for nonrecognition of gain or loss for US federal income tax purposes or preserve the tax-neutral nature for Swiss tax purposes, as applicable. In addition, the Swiss Tax Rulings provide that no Swiss withholding tax or stamp duty should apply to the distribution of Alcon shares in the spin-off. The Tax Opinion and IRS Ruling are subject to the qualifications and limitations set forth below under &#x201C;&mdash;Consequences to US </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">208</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Holders of Novartis shares.&#x201D; Additionally, Novartis has entered into the Tax Matters Agreement with Alcon, which restricts Alcon from taking certain actions that could affect the qualification of the spin-off and certain internal restructuring steps taken prior to the spin-off for nonrecognition of gain or loss or as tax neutral, as applicable.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consequences to Swiss Holders of Novartis shares</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">General</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Subject to the qualifications and limitations set forth herein (including the discussion below relating to the receipt of cash in lieu of fractional shares), for Swiss tax purposes no gain or loss should be recognized by, or be includible in the income of, a Swiss Holder as a result of the tax neutral spin-off, provided that Swiss Holders who hold Novartis shares as business assets accurately maintain the tax and book values of their Novartis and Alcon shares. This means that for Swiss Holders who hold Novartis shares as business assets, the aggregate tax basis of the Novartis shares and Alcon shares immediately after the distribution should be the same as the aggregate tax basis of the Novartis shares held immediately before the distribution, allocated between the Novartis shares and Alcon shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If a Swiss Holder that holds Novartis shares as business assets is classified as a &#x201C;professional securities dealer&#x201D; or is a legal entity and receives cash in lieu of a fractional share, such Swiss Holder will generally recognize a capital gain or loss measured by the difference between the cash received for such fractional share and the Swiss Holder&#x2019;s tax basis in that fractional share. The same Swiss income tax treatment applies to Swiss Holders of Novartis physical share certificates (Heimverwahrer) held as business assets who receive cash due to non-response by March 18, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If a Swiss Holder who holds Novartis shares as private assets receives cash in lieu of fractional shares, the receipt of such cash will be tax-free to the holder. The same Swiss income tax treatment applies to Swiss Holders of Novartis physical share certificates (Heimverwahrer) held as private assets who receive cash due to non-response by March 18, 2019. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has received the Swiss Tax Rulings that cover the relevant Swiss tax aspects of the separation and spin-off. The Swiss Tax Rulings rely upon certain facts, assumptions, representations and undertakings from Novartis and Alcon regarding the past and future conduct of Novartis and Alcon businesses and other matters. If any of the facts, assumptions, representations or undertakings described therein are incorrect or not otherwise satisfied, Novartis may not be able to rely upon the Swiss Tax Rulings.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Accordingly, notwithstanding the Swiss Tax Rulings, there can be no assurance that the relevant Swiss tax authorities will not assert, or that a court would not sustain, a position contrary to one or more of the conclusions set forth above.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consequences to US Holders of Novartis shares</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary of the material US federal income tax consequences to holders of Novartis shares or ADRs in connection with the Alcon distribution. For purposes of the following discussion, any reference to Novartis shares includes Novartis ADRs. This summary does not address any US state or local or foreign tax consequences or any estate, gift or other non-income tax consequences.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">General  </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The IRS Ruling and the Tax Opinion, described below, rely upon certain facts, assumptions, representations and undertakings from Novartis and Alcon regarding the past and future conduct of Novartis and Alcon businesses and other matters. If any of the facts, assumptions, representations or undertakings described therein are incorrect or not otherwise satisfied, Novartis may not be able to rely upon the IRS Ruling or the Tax Opinion. Accordingly, notwithstanding the Tax Opinion and the IRS Ruling, there can be no assurance that the IRS will not assert, or that a court would not sustain, a position contrary to one or more of the conclusions set forth below. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has received an IRS Ruling and a Tax Opinion providing, in each case, that the distribution should qualify for nonrecognition of gain or loss under Section 355 of the Internal Revenue Code. As a result:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; No gain or loss should be recognized by, or be includible in the income of, a US Holder as a result of the distribution. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The aggregate tax basis of the Novartis shares and Alcon shares held by each US Holder immediately after the distribution should be the same as the aggregate tax basis of the Novartis shares held by the US Holder immediately before the distribution, allocated between the Novartis shares and Alcon shares in proportion to their relative fair market values on the date of the distribution. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The holding period of Alcon shares received by each US Holder should include the holding period of its Novartis shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Generally, if a Novartis shareholder holds different blocks of Novartis shares (generally Novartis shares purchased or acquired on different dates or at different prices), a US Holder must perform the tax basis allocation described above with respect to each block and will have a holding period in Alcon shares determined with respect to the holding period of such block. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A US Holder that received cash in lieu of a fractional share as part of the distribution will be treated as though it first received a distribution of the fractional share in the distribution and then sold it for the amount of cash actually received. The US Holder will generally recognize a capital gain or loss measured by the difference between the cash received for such fractional share and the US Holder&#x2019;s tax basis in that fractional share, as determined above. Such capital gain or loss will be a long-term capital gain or loss if the US Holder&#x2019;s holding period for the Novartis shares is more than one year on the date of the distribution. Certain US Holders are eligible for reduced rates of taxation on their long-term capital gains. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A US Holder of Novartis physical share certificates (Heimverwahrer) who received cash due to non-response by March 18, 2019, will be treated as if the US </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">209</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Holder received Alcon shares with respect to its physical share certificates in the distribution and then sold such shares for the cash actually received. The deemed receipt and sale of Alcon shares for cash will be subject to the same treatment as the receipt of cash in lieu of a fractional share for US federal income tax purposes as described above. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Backup Withholding </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Payments of cash in lieu of a fractional share and cash payments to a US Holder of Novartis physical share certificates (Heimverwahrer) who receives cash due to non-response by March 18, 2019, may, under certain circumstances, be subject to &#x201C;backup withholding,&#x201D; unless the US Holder provides proof of an applicable exemption or a correct taxpayer identification number, and otherwise complies with the requirements of the backup withholding rules. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Information Reporting </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Treasury regulations require each Novartis shareholder, that immediately before the distribution, owned 5% or more (by vote or value) of the total outstanding stock of Novartis to attach to such shareholder&#x2019;s US federal income tax return for the year in which the distribution occurs a statement setting forth certain information related to the distribution. </div><a name="anchorId00534213"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.F Dividends and paying agents</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00534217"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.G Statement by experts</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00534221"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.H Documents on display</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Any statement in this Form&nbsp;20-F about any of our contracts or other documents is not necessarily complete. If the contract or document is filed as an exhibit to the Form&nbsp;20-F, the contract or document is deemed to modify the description contained in this Form&nbsp;20-F. You must review the exhibits themselves for a complete description of the contract or document.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The SEC maintains an internet site at http://www.sec.gov that contains reports and other information regarding issuers that file electronically with the SEC. These SEC filings are also available to the public from commercial document retrieval services.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We are required to file or furnish reports and other information with the SEC under the Exchange Act and regulations under that act. As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the form and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short swing profit recovery provisions contained in Section&nbsp;16 of the Exchange Act.</div><a name="anchorId00534235"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">10.I Subsidiary information</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">210</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00534241"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;11.  Quantitative and Qualitative Disclosures About Market Risk</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The major financial risks facing the Group are managed centrally by Group Treasury. We have a written Treasury Directive and have implemented a strict segregation of front-office and back-office controls. The Group does regular reconciliations of its positions with its counterparties. In addition, the Treasury function is included in management&#x2019;s internal control assessment.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For information about the effects of currency fluctuations and how we manage currency risk, see &#x201C;Item&nbsp;5. Operating and Financial Review and Prospects&mdash;Item&nbsp;5.B Liquidity and capital resources.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The information set forth under &#x201C;Item 18. Financial Statements&mdash;Note&nbsp;29. Financial instruments&mdash;additional disclosures&#x201D; is incorporated by reference.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">211</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00534260"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;12.  Description of Securities Other Than Equity Securities</p><a name="anchorId00534263"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">12.A Debt securities</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00534267"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">12.B Warrants and rights</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00534271"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">12.C Other securities</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div><a name="anchorId00534275"></a><p style="font-family:arial,helvetica,sans-serif; font-size:18pt; color:#000000; font-weight:bold;">12.D American Depositary Shares</p><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Fees payable by ADR holders</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">According to our Deposit Agreement with the ADS depositary, JPMorgan Chase Bank, N.A. (JPMorgan), holders of our ADRs may have to pay to JPMorgan, either directly or indirectly, fees or charges up to the amounts set forth below:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="top">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;">Category</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Depositary actions</div>
      </td>
      <td></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Associated fee</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depositing or substituting <br> underlying shares</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acceptance of shares surrendered, and issuance of ADRs in exchange, <br>  including surrenders and issuances in respect of:<br>  &#x2014; Share distributions<br>  &#x2014; Stock split<br>  &#x2014; Rights<br>  &#x2014; Merger<br>  &#x2014; Exchange of shares or any other transaction or event or other distribution <br>  affecting the ADSs or the deposited shares</div>
      </td>
      <td align="left" width="1%"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD 5.00 for each 100 ADSs <br>  (or portion thereof) <br>  evidenced by the new <br>  ADRs delivered<br>  <br>  <br>  <br>  </div>
      </td>
      <td align="left" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Withdrawing <br> underlying shares</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Acceptance of ADRs surrendered for withdrawal of deposited shares<br>  <br>  <br>  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD 5.00 for each 100 ADSs <br>  (or portion thereof) <br>  evidenced by the ADRs <br>  surrendered</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling or <br> exercising rights</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Distribution or sale of shares, the fee being in an amount equal to the fee <br>  for the execution and delivery of ADRs that would have been charged <br>  as a result of the deposit of such shares</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD 5.00 for each 100 ADSs <br>  (or portion thereof)<br>  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transferring, <br> splitting or <br> grouping receipts</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transfers, combining or grouping of depositary receipts<br>  <br>  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD 1.50 per ADR<br>  <br>  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expenses of the <br> depositary</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Expenses incurred on behalf of holders in connection with:<br>  &#x2014; Compliance with foreign exchange control regulations or any law or <br>  regulation relating to foreign investment<br>  &#x2014; The depositary&#x2019;s or its custodian&#x2019;s compliance with applicable law, <br>  rule or regulation<br>  &#x2014; Stock transfer or other taxes and other governmental charges<br>  &#x2014; Cable, telex and facsimile transmission and delivery<br>  &#x2014; Expenses of the depositary in connection with the conversion of foreign <br>  currency into US dollars (which are paid out of such foreign currency)<br>  &#x2014; Any other charge payable by any of the depositary or its agents</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Expenses payable at the sole <br>  discretion of the depositary <br>  by billing holders or by <br>  deducting charges from one <br>  or more cash dividends or <br>  other cash distributions<br>  <br>  <br>  <br>  </div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="top" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advance tax relief</div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Tax relief/reclamation process for qualified holders<br>  </div>
      </td>
      <td align="left"></td>
      <td align="left">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> A depositary service charge <br>  of USD 0.008 per ADS</div>
      </td>
      <td align="left"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">212</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Fees payable by the depositary to the issuer</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Pursuant to an agreement effective as of May&nbsp;11, 2017 (the Agreement), JPMorgan, as our ADS depositary, has agreed to make an annual contribution payment to Novartis at the end of each 12-month period beginning on the effective date of the Agreement and on each subsequent anniversary of the effective date of the Agreement (each such 12-month period is a &#x201C;Contract Year&#x201D;). This annual contribution payment will equal: (a)(1) USD 1.7&nbsp;million less (a)(2) the custody costs, fees and expenses (including, without limitation, any central securities depository fees, charges and expenses) incurred during the applicable Contract Year (the items in (a)(2) collectively are the &#x201C;Custody Costs&#x201D;) plus (b)&nbsp;70% of the gross issuance and cancellation fees collected by JPMorgan under the Deposit Agreement during such Contract Year minus (c)&nbsp;that portion (if any) of JPMorgan&#x2019;s legal fees, charges and out-of-pocket expenses in excess of USD 50000 for such Contract Year. To the extent that the Custody Costs for a Contract Year exceed USD 1.7&nbsp;million, these costs would be capped at USD 1.7&nbsp;million.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">JPMorgan has further agreed to waive the USD 0.05 per ADS issuance fees that would normally be owed by Novartis in connection with our deposits of shares as part of our employee stock ownership and employee participation plans. Novartis is responsible for reimbursing JPMorgan for all taxes and governmental charges required to have been withheld and/or paid, and not so withheld and/or paid, arising from such waived fees.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">213</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00534468"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000;">PART II</p><a name="anchorId00534470"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;13.  Defaults, Dividend Arrearages and Delinquencies</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">None.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">214</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00534477"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;14.  Material Modifications to the Rights of Security Holders and Use of Proceeds</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">None.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">215</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>


    <a name="anchorId00631895"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;15.  Controls and Procedures</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(a) Novartis AG&#x2019;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rule&nbsp;13a-15(e)) as of the end of the period covered by this Annual Report, have concluded that, as of such date, our disclosure controls and procedures were effective.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(b) Report of Novartis Management on Internal Control Over Financial Reporting: The Board of Directors and management of the Group are responsible for establishing and maintaining adequate internal control over financial reporting. The Group&#x2019;s internal control over financial reporting was designed to provide reasonable assurance to the Group&#x2019;s management and Board of Directors regarding the reliability of financial reporting and the preparation and fair presentation of its published consolidated financial statements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Internal controls over financial reporting, no matter how well designed, have inherent limitations. Therefore, even those internal controls over financial reporting determined to be effective may not prevent or detect misstatements and can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">Group management assessed the effectiveness of the Group&#x2019;s internal control over financial reporting as of December&nbsp;31, 2019. In making this assessment, it used the criteria established in <i>Internal Control&mdash;Integrated Framework (2013)</i> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on our assessment, management concluded that, as of December&nbsp;31, 2019, the Group&#x2019;s internal control over financial reporting is effective based on those criteria.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:15px;">PricewaterhouseCoopers AG, Switzerland, an independent registered public accounting firm, has issued an unqualified opinion on the effectiveness of the Group&#x2019;s internal control over financial reporting, which is included in this Annual Report under &#x201C;Item&nbsp;18. Financial Statements&mdash;Report of independent registered public accounting firm.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(c) See the report of PwC, an independent registered public accounting firm, included under &#x201C;Item&nbsp;18. Financial Statements&mdash;Report of independent registered public accounting firm.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:20px;margin-right:0mm;margin-top:0mm;text-indent:-20px;">(d) There were no changes to our internal control over financial reporting that occurred during the period covered by this Annual Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">216</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>

    <a name="anchorId00731897"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16A.  Audit Committee Financial Expert</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Our Audit and Compliance Committee has determined that Srikant Datar and Elizabeth Doherty each possess specific accounting and financial management expertise and that each is an Audit Committee Financial Expert as defined by the SEC. The Board of Directors has also determined that Srikant Datar and Elizabeth Doherty are each &#x201C;independent&#x201D; in accordance with the applicable requirements of Rule&nbsp;10A-3 of the Exchange Act, and that other members of the Audit and Compliance Committee have sufficient experience and ability in finance and compliance matters to enable them to adequately discharge their responsibilities.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">217</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00731912"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16B.  Code of Ethics</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition to our Code of Conduct and Professional Practices Policy, which are applicable to all of our associates, we have adopted Ethical Conduct Requirements that impose additional obligations on our principal executive officer, principal financial officer, principal accounting officer, and persons performing similar functions. This document is accessible on our internet website at:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">https://www.novartis.com/investors/company-overview/corporate-governance</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">218</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00731925"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16C.  Principal Accountant Fees and Services</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The information set forth under &#x201C;Item 6. Directors, Senior Management and Employees&mdash;Item 6.C Board practices&mdash;Corporate governance&mdash;Auditors&#x201D; is incorporated by reference.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">219</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00731935"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16D.  Exemptions from the Listing Standards for Audit Committees</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">220</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00731942"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16E.  Purchases of Equity Securities by the Issuer and Affiliated Purchasers</p>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> <br> <br> <br> <br> <br> Total Number of <br> Shares Purchased<br> (a)<sup style="white-space: nowrap">           1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> <br> <br> <br> <br> Average price <br> paid per share <br> in USD<br> (b)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Total number <br> of shares<br> purchased <br> as part of <br> publicly <br> announced <br> plans or <br> programs<br> (c)<sup style="white-space: nowrap">           2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Maximum <br> approximate <br> value of <br> shares that <br> may yet be <br> purchased <br> under the <br> plans or <br> programs <br> (CHF millions)<br> (d)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Maximum <br> approximate <br> value of <br> shares that <br> may yet be <br> purchased <br> under the <br> plans or <br> programs <br> (USD millions)<br> (e)<sup style="white-space: nowrap">           3</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Jan. 1-31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;913&nbsp;205</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87.38</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 830&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;137</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;152</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Feb. 1-28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 203&nbsp;399</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 88.31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;027</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mar. 1-31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 81&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 92.09</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;042</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Apr. 1-30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;687&nbsp;215</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;452&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;716</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;539</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">May 1-31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;719&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83.55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;695&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;392</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;338</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Jun. 1-30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;852&nbsp;939</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 90.27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;840&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;247</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;433</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Jul. 1-31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;550&nbsp;117</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 92.10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;538&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;106</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;156</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Aug. 1-31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;966&nbsp;974</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 91.76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;958&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;809</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sep. 1-30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36&nbsp;197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 89.69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;790</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oct. 1-31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 84.92</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;811</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nov. 1-30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;065</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;758</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dec. 1-31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;567</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 90.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;903</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 62&nbsp;047&nbsp;579</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 88.70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60&nbsp;313&nbsp;900</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Column (a) shows shares repurchased on the SIX Swiss Exchange second trading line plus shares we purchased from employees who had obtained the shares through a Novartis Employee Ownership Plan. See "Item 18. Financial Statements - Note 26 Equity-based participation plans for associates."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Column (c) shows shares repurchased on the SIX Swiss Exchange second trading line under the seventh CHF 10 billion share buyback authority approved at the 2016 Annual General Meeting (AGM) for transactions before February 28, 2019 and under the eighth CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date. See "Item 6. Directors, Senior Management and Employees - Item 6C. Board Practices - Our capital structure - Changes in capital."</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Column (e) shows the Swiss franc amount from column (d) converted into US dollars as of the month-end, using the Swiss franc/US dollar  exchange rate at the applicable month-end</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">221</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00732607"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16F.  Change in Registrant&#x2019;s Certifying Accountant</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">222</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00732614"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16G.  Corporate Governance</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis AG is subject to and compliant with the laws and regulations of Switzerland (in particular, Swiss company and securities laws, SIX Swiss Exchange rules and the Swiss Code of Best Practice for Corporate Governance) and the securities laws of the United States, including New York Stock Exchange (NYSE) rules, as applicable to foreign private issuers of securities. The following summarizes some significant ways in which our corporate governance practices differ from those followed by domestic listed US companies under the listing standards of the NYSE:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Novartis AG shareholders do not receive written reports directly from Board committees.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; External auditors are appointed by shareholders at the Annual General Meeting of Shareholders (AGM), as opposed to being appointed by the Audit and Compliance Committee.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; While shareholders cannot vote on all equity compensation plans, they are entitled to hold separate, yearly binding votes on Board and Executive Committee compensation.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Board has set up a separate Risk Committee that oversees the risk management system and processes, as opposed to delegating this responsibility to the Audit and Compliance Committee.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The full Board is responsible for overseeing the performance evaluation of the Board and Executive Committee.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The full Board is responsible for setting objectives relevant to the CEO&#x2019;s compensation and for evaluating his performance.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">223</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00732648"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;16H.  Mine Safety Disclosure</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Not applicable.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">224</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00732655"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000;">PART III</p><a name="anchorId00732657"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;17.  Financial Statements</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">See response to &#x201C;Item&nbsp;18. Financial Statements.&#x201D;</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">225</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId00732666"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&nbsp;18.  Financial Statements</p>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following financial statements are filed as part of this Annual Report.</div>



  <div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001532099">Consolidated income statements</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001532952">Consolidated statements of comprehensive income</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001533485">Consolidated balance sheets</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001534402">Consolidated statements of changes in equity</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001537206">Consolidated statements of cash flows</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001538542">Notes to the Novartis Group&nbsp;consolidated&nbsp;financial statements</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001538546">1. Significant accounting policies</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001539294">2. Significant transactions</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001540083">3. Segmentation of key figures 2019, 2018 and 2017</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001552740">4. Associated companies</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001553915">5. Interest expense and&nbsp;other&nbsp;financial&nbsp;income&nbsp;and&nbsp;expense</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001554220">6. Taxes</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001554969">7. Earnings per share</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001555340">8. Changes in consolidated statements of&nbsp;comprehensive income</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001558042">9. Property, plant and equipment</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001559924">10. Right-of-use assets and lease liabilities</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001560876">11. Goodwill and intangible assets</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001564398">12. Deferred tax assets and liabilities </a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001567459">13. Financial and other non-current assets</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001567727">14. Inventories</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001567906">15. Trade receivables</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001568635">16. Marketable securities, commodities, time&nbsp;deposits, derivative financial instruments, and&nbsp;cash and cash equivalents</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001568877">17. Other current assets</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001569003">18. Equity</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001571015">19. Non-current financial debt</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001572683">20. Provisions and other non-current liabilities</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001573684">21. Current financial debt and&nbsp;derivative&nbsp;financial&nbsp;instruments</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001573842">22. Provisions and other current liabilities</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001575860">23. Details to the consolidated statements of cash flows</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001577644">24. Acquisitions of businesses</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001578024">25. Post-employment benefits for associates</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001581284">26. Equity-based participation plans for associates</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001582736">27. Transactions with related parties</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001583196">28. Commitments and contingencies</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001583339">29. Financial instruments &ndash; additional disclosures</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001590623">30. Discontinued operations</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001592172">31. Events subsequent to the December 31, 2019, consolidated balance sheet date</a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 30px;"><a style="text-decoration: none;" href="#anchorId001592243">32. Principal Group subsidiaries and&nbsp;associated&nbsp;companies </a></div>
<div style="font-family: arial, helvetica, sans-serif; font-size: 10pt; padding-left: 0px;"><a style="text-decoration: none;" href="#anchorId001731895">Report of Independent Registered Public Accounting Firm</a></div>
    <br>
<br>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">231</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
     <a name="anchorId001831896"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Item&#xA0;19.  Exhibits</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "> </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The SEC maintains an internet site at http://www.sec.gov that contains reports and other information regarding issuers that file electronically with the SEC. These SEC filings are also available to the public from commercial document retrieval services.</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> </font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 1.1 <a style="-sec-extract:exhibit" href="a20012920f-ex1_1.htm">Articles of Incorporation of Novartis AG, as amended February 28, 2019 (English translation).</a></font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 1.2 <a style="-sec-extract:exhibit" href="a20012920f-ex1_2.htm">Regulations of the Board of Directors, the Board Committees and the Executive Committee of Novartis AG, effective May 1, 2019.</a></font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.1 Amended and Restated Deposit Agreement, dated as of May&#xA0;11, 2000, among Novartis AG, JPMorgan Chase Bank (fka Morgan Guaranty Trust Company of New York), as depositary, and all holders from time to time of ADRs issued thereunder (incorporated by reference to Exhibit&#xA0;(a)(1) to Post-Effective Amendment No.&#xA0;1 to Novartis AG&#x2019;s registration statement on Form&#xA0;F-6 (File No.&#xA0;333-11758) as filed with the SEC on September&#xA0;8, 2000).</font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.2 Amendment No.&#xA0;1 to the Amended and Restated Deposit Agreement (incorporated by reference to Exhibit&#xA0;(a)(2) to Post-Effective Amendment No.&#xA0;1 to Novartis AG&#x2019;s registration statement on Form&#xA0;F-6 (File No.&#xA0;333-11758) as filed with the SEC on September&#xA0;8, 2000).</font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.3 Amendment No.&#xA0;2 to the Amended and Restated Deposit Agreement (incorporated by reference to Exhibit&#xA0;(a)(3) to Novartis AG&#x2019;s registration statement on Form&#xA0;F-6 (File No.&#xA0;333-13446) as filed with the SEC on May&#xA0;3, 2001).</font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.4 <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1114448/000094787102000101/f3_013102.txt">Restricted Issuance Agreement, dated as of January&#xA0;11, 2002, among Novartis AG, JPMorgan Chase Bank, as depositary, and all holders from time to time of ADRs representing ADSs issued thereunder (incorporated by reference to Exhibit&#xA0;4 to the Registration Statement on Form&#xA0;F-3 (File No.&#xA0;333-81862) as filed with the SEC on January&#xA0;31, 2002).</a></font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.5 <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1114448/000104746908000606/a2182117zex-2_4.htm">Letter Agreement, dated December&#xA0;14, 2007, between Novartis AG and JPMorgan Chase Bank, as depositary (incorporated by reference to Exhibit&#xA0;2.4 to the Form&#xA0;20-F for the year ended December&#xA0;31, 2007, as filed with the SEC on January&#xA0;28, 2008). </a></font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.6 <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1114448/000119380514001802/e612683_ex99-a7.htm">Form of American Depositary Receipt (incorporated by reference to Exhibit&#xA0;(a)(7) to the Registration Statement on Form&#xA0;F-6 (File No.&#xA0;333-198623) as filed with the SEC on September&#xA0;8, 2014).</a></font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.7 The total amount of long-term debt securities authorized under any instrument does not exceed 10% of the total assets of the Company and its subsidiaries on a consolidated basis. We hereby agree to furnish to the SEC, upon its request, a copy of any instrument defining the rights of holders of long-term debt of the Company or of its subsidiaries for which consolidated or unconsolidated financial statements are required to be filed.</font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 2.8 <a style="-sec-extract:exhibit" href="a20012920f-ex2_8.htm">Description of Securities registered under Section 12 of the Exchange Act.</a> </font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 4.1 <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1167379/000110465919020461/a19-7490_1ex99d1.htm">Separation and Distribution Agreement by and between Novartis AG and Alcon Inc., dated as of April 8, 2019 (incorporated by reference to Exhibit 99.1 to the Current Report on Form 6-K of Alcon Inc. (File No. 001-31269) as filed with the SEC on April 9, 2019).</a> </font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 4.2 <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1167379/000110465919020461/a19-7490_1ex99d2.htm">Tax Matters Agreement by and between Novartis AG and Alcon Inc., dated as of April 8, 2019 (incorporated by reference to Exhibit 99.2 to the Current Report on Form 6-K of Alcon Inc. (File No. 001-31269) as filed with the SEC on April 9, 2019). </a> </font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 4.3 <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1113481/000095014219002353/eh1901248_ex0201.htm">Agreement and Plan of Merger, dated as of November 23, 2019, by and among The Medicines Company, Novartis AG and Medusa Merger Corporation (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K of The Medicines Company (File No. 000-31191) as filed with the SEC on November 25, 2019). </a> </font>
</div>
<div style="margin-bottom:20px;margin-left:22px;text-indent:-22px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 8.1 <a style="-sec-extract:exhibit" href="#anchorNote31">For a list of all of our principal Group subsidiaries and associated companies, see &#x201C;Item 18. Financial Statements&#x2014;Note&#xA0;32. Principal Group subsidiaries and associated companies.&#x201D;</a></font>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">227</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="margin-bottom:20px;margin-left:31px;text-indent:-31px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 12.1 <a style="-sec-extract:exhibit" href="a20012920f-ex12_1.htm">Certification of Vasant Narasimhan, Chief Executive Officer of Novartis AG, pursuant to Section&#xA0;302 of the Sarbanes-Oxley Act of 2002.</a></font>
</div>
<div style="margin-bottom:20px;margin-left:31px;text-indent:-31px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 12.2 <a style="-sec-extract:exhibit" href="a20012920f-ex12_2.htm">Certification of Harry Kirsch, Chief Financial Officer of Novartis AG, pursuant to Section&#xA0;302 of the Sarbanes-Oxley Act of 2002.</a></font>
</div>
<div style="margin-bottom:20px;margin-left:31px;text-indent:-31px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 13.1 <a style="-sec-extract:exhibit" href="a20012920f-ex13_1.htm">Certification of Vasant Narasimhan, Chief Executive Officer of Novartis AG, pursuant to Section&#xA0;18 U.S.C. Section&#xA0;1350, as adopted pursuant to Section&#xA0;906 of the Sarbanes-Oxley Act of 2002.</a></font>
</div>
<div style="margin-bottom:20px;margin-left:31px;text-indent:-31px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 13.2 <a style="-sec-extract:exhibit" href="a20012920f-ex13_2.htm">Certification of Harry Kirsch, Chief Financial Officer of Novartis AG, pursuant to Section&#xA0;18 U.S.C. Section&#xA0;1350, as adopted pursuant to Section&#xA0;906 of the Sarbanes-Oxley Act of 2002.</a></font>
</div>
<div style="margin-bottom:20px;margin-left:31px;text-indent:-31px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 15.1 <a style="-sec-extract:exhibit" href="a20012920f-ex15_1.htm">Consent of PricewaterhouseCoopers AG.</a></font>
</div>
<div style="margin-bottom:20px;margin-left:50px;text-indent:-50px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 101.INS XBRL Instance Document </font>
</div>
<div style="margin-bottom:20px;margin-left:50px;text-indent:-50px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 101.SCH XBRL Taxonomy Extension Schema Document </font>
</div>
<div style="margin-bottom:20px;margin-left:50px;text-indent:-50px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document </font>
</div>
<div style="margin-bottom:20px;margin-left:50px;text-indent:-50px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 101.DEF XBRL Taxonomy Extension Definition Linkbase Document</font>
</div>
<div style="margin-bottom:20px;margin-left:50px;text-indent:-50px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 101.LAB XBRL Taxonomy Extension Label Linkbase Document </font>
</div>
<div style="margin-bottom:20px;margin-left:50px;text-indent:-50px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;"> 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document</font>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">228</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>






    <a name="anchorId00831895"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">SIGNATURES</p>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The registrant hereby certifies that it meets all of the requirements for filing on Form&nbsp;20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="margin-left:380px;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Novartis AG</div>
<div style="margin-left:400px;padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>
<div style="margin-left:400px;text-indent:-20px;padding-top:20px;text-decoration:underline;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">By: /s/ Harry Kirsch</div>
<div style="margin-left:400px;padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Name: Harry Kirsch</div>
<div style="margin-left:400px;padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Title: <i>Chief Financial Officer, Novartis Group</i></div>
<div style="margin-left:400px;padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>
<div style="margin-left:400px;text-indent:-20px;padding-top:20px;text-decoration:underline;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">By: /s/ Shannon Thyme Klinger</div>
<div style="margin-left:400px;padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Name: Shannon Thyme Klinger</div>
<div style="margin-left:400px;padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Title: <i>General Counsel, Novartis Group</i></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Date: January&nbsp;29, 2020</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">229</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "> </div>






<a name="anchorId001532095"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Novartis Group consolidated&nbsp;financial&nbsp;statements</p><a name="anchorId001532099"></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consolidated income statements</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(For the years ended December 31, 2019, 2018 and 2017) </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions unless indicated otherwise)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to discontinued segment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;498</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;381</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;425</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;633</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;252</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;771</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;369</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;465</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;389</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;922</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;426</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;137</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net (loss)/income from discontinued operations before gain on  distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share (USD) from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basic earnings per share (USD) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Diluted earnings per share (USD) from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Diluted earnings per share (USD) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total diluted earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.06</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">The accompanying Notes form an integral part of the consolidated financial statements.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-1</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001532952"></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consolidated statements of comprehensive income</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(For the years ended December 31, 2019, 2018 and 2017) </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Other comprehensive income to be eventually recycled into the consolidated income statement:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 20px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on marketable securities, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 20px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on debt securities, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 20px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on deferred cash flow hedges, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total fair value adjustments on financial instruments, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 50</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of other comprehensive income  recognized by associated companies, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 352</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 315</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;210</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of items to eventually recycle</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;986</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Other comprehensive income never to be recycled into the consolidated income statement:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Actuarial (losses)/gains from defined benefit plans, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;467</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on equity securities, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of items never to be recycled</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;514</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;346</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;527</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;540</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 10&nbsp;538</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 20px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 6&nbsp;948</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;417</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 10&nbsp;211</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 20px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 4&nbsp;577</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;207</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 327</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">The accompanying Notes form an integral part of the consolidated financial statements.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-2</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001533485"></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consolidated balance sheets</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(At December 31, 2019 and 2018) </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;069</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;696</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;677</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35&nbsp;294</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;787</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38&nbsp;719</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investments in associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;644</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;352</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;909</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;699</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;518</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;345</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 738</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 895</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 88&nbsp;866</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 110&nbsp;000</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;982</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;956</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;727</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income tax receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 248</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, commodities, time deposits and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;693</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;680</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;861</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current assets without disposal group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;663</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;756</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Assets of disposal group held for sale</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 807</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29&nbsp;504</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;563</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Share capital</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 936</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 944</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reserves</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54&nbsp;618</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77&nbsp;739</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Issued share capital and reserves attributable to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;614</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 78</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;692</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;867</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;475</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;319</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;555</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37&nbsp;264</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;556</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;678</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current income tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;038</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;284</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current liabilities without disposal group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;556</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities of disposal group held for sale</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 51</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;264</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;607</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 62&nbsp;819</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 66&nbsp;871</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">The accompanying Notes form an integral part of the consolidated financial statements.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-3</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001534402"></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consolidated statements of changes in equity</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(For the years ended December 31, 2019, 2018 and 2017) </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> <br> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Share<br> capital</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Treasury<br> shares</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Retained<br> earnings</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Total value<br> adjustments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Issued share <br> capital and <br> reserves <br> attributable <br> to Novartis <br> shareholders</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Non-<br> controlling<br> interests</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Total<br> equity</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity at January 1, 2017</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 972</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 81&nbsp;148</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;212</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;832</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;891</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;872</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;835</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;837</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;666</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;872</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;538</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;540</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;495</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;538</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;574</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;574</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reduction of share capital</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 255</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 607</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total of other equity movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;175</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;202</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity at December 31, 2017, as  previously reported</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   969</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   77&nbsp;639</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;4&nbsp;340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   74&nbsp;168</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   74&nbsp;227</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in accounting policies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 237</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;177</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated equity at January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 969</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 77&nbsp;876</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;517</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;228</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 74&nbsp;287</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 81</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;401</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;406</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 81</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;208</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;966</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;966</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;966</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;960</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;973</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;973</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reduction of share capital</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 430</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 434</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 261</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 263</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 756</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 756</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase of treasury share repurchase  obligation under a share buyback trading plan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;284</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transaction costs, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;79</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in ownership of consolidated entities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total of other equity movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;814</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;824</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;803</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity at December 31, 2018, as  previously reported</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   944</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;69</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   82&nbsp;191</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;4&nbsp;452</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   78&nbsp;614</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   78</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   78&nbsp;692</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in accounting policies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated equity at January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 944</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;69</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 82&nbsp;194</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;452</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 78&nbsp;617</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 78</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 78&nbsp;695</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;207</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;210</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;638</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;527</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;645</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend in kind to effect the spin-off of Alcon Inc.</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;23&nbsp;434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;23&nbsp;434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;23&nbsp;434</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;480</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;511</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;511</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reduction of share capital</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 207</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 828</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 833</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon employees as a result of the Alcon spin-off</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes on treasury share transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;189</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;189</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;189</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Decrease of treasury share repurchase  obligation under a share buyback trading plan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   284</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transaction costs, net of taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;253</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in ownership of consolidated entities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total of other equity movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;34&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;92</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;34&nbsp;668</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;34&nbsp;671</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 936</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 59&nbsp;275</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;657</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">The accompanying Notes form an integral part of the consolidated financial statements.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-4</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001537206"></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Consolidated statements of cash flows</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">(For the years ended December 31, 2019, 2018 and 2017) </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Adjustments to reconcile net income from continuing operations to  net cash flows from operating activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of non-cash items and other adjustments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;486</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;787</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends received from associated companies and others</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 463</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 719</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 987</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest received</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 214</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 241</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 97</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest paid</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;816</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial receipts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;270</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes paid</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;876</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;506</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;487</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows from operating activities from continuing operations before working capital and provision changes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   14&nbsp;272</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   13&nbsp;111</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   11&nbsp;916</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments out of provisions and other net cash movements in non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;638</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;829</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in net current assets and other operating cash flow items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 199</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 576</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 332</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows from operating activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;547</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;049</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;419</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows from operating activities from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;223</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;202</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total net cash flows from operating activities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;625</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;272</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;621</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;379</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;325</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 857</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 91</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;878</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;394</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;969</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 973</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 823</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 640</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;302</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;205</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;354</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 165</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 328</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquisitions and divestments of interests in associated companies, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;854</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquisitions and divestments of businesses, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;760</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;683</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;714</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of marketable securities and commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;228</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;440</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;580</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from sales of marketable securities and commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;561</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 472</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 549</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows used in investing activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;067</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2&nbsp;344</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows used in investing activities from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;775</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total net cash flows used in investing activities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;226</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;591</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;119</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividends paid to shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;966</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;495</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquisition of treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;533</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;490</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Proceeds from exercise of options and other treasury share transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 201</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 700</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 252</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;856</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;933</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;195</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;188</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;582</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;687</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;644</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments of lease liabilities, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of change in ownership of consolidated entities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financing cash flows, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 67</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 314</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows used in financing activities from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;16&nbsp;884</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;077</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;318</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net cash flows from/used in financing activities from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;257</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;415</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total net cash flows used in financing activities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;13&nbsp;627</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;244</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;733</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net change in cash and cash equivalents before effect of exchange  rate changes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;2&nbsp;228</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   4&nbsp;437</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;769</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of exchange rate changes on cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total net change in cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;411</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;853</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents at January 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;860</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;007</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash and cash equivalents at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;860</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">The accompanying Notes form an integral part of the consolidated financial statements.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-5</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001538542"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Notes to the Novartis Group&nbsp;consolidated&nbsp;financial statements</p><a name="anchorId001538546"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">1. Significant accounting policies</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Novartis Group (Novartis or Group) is a multinational group of companies specializing in the research, development, manufacturing and marketing of a broad range of healthcare products led by innovative pharmaceuticals and cost-saving generic pharmaceuticals. The Group is headquartered in Basel, Switzerland.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consolidated financial statements of the Group are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). They are prepared in accordance with the historical cost convention, except for items that are required to be accounted for at fair value.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s financial year-end is December 31, which is also the annual closing date of the individual entities&#x2019; financial statements incorporated into the Group&#x2019;s consolidated financial statements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The preparation of financial statements requires management to make certain estimates and assumptions, either at the balance sheet date or during the year, which affect the reported amounts of assets and liabilities, including any contingent amounts, the distribution liability recognized in connection with the distribution of Alcon Inc. to Novartis AG shareholders, as well as of revenues and expenses. Actual outcomes and results could differ from those estimates and assumptions.   </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Listed below are accounting policies of significance to Novartis or, in cases where IFRS provides alternatives, the option adopted by Novartis.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Scope of consolidation </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated financial statements include all entities, including structured entities, over which Novartis AG, Basel, Switzerland, directly or indirectly has control (generally as a result of owning more than 50% of the entity&#x2019;s voting interest). Consolidated entities are also referred to as &#x201C;subsidiaries.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In cases where Novartis does not fully own a subsidiary, it has elected to value any remaining outstanding non-controlling interest at the time of acquiring control of the subsidiary at its proportionate share of the fair value of the net identified assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The contribution of a business to an associate or joint venture is accounted for by applying the option under IFRS that permits the accounting for the retained interest of the business contributed at its net book value at the time of the contribution.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Investments in associated companies (generally defined as investments in entities in which Novartis holds between 20% and 50% of voting shares or over which it otherwise has significant influence) and joint ventures are accounted for using the equity method, except for selected venture fund investments for which the Group has elected to apply the method of fair value through the consolidated income statement.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Foreign currencies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated financial statements of Novartis are presented in US dollars (USD). The functional currency of subsidiaries is generally the local currency of the respective entity. The functional currency used for the reporting of certain Swiss and foreign finance entities is USD instead of their respective local currencies. This reflects the fact that the cash flows and transactions of these entities are primarily denominated in these currencies.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For subsidiaries not operating in hyperinflationary economies, the subsidiary&#x2019;s results, financial position and cash flows that do not have USD as their functional currency are translated into USD using the following exchange rates:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Income, expense and cash flows using for each month the average exchange rate, with the US dollar values for each month being aggregated during the year</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Balance sheets using year-end exchange rates</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Resulting exchange rate differences are recognized in other comprehensive income</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For subsidiaries operating in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period is recorded in retained earnings in equity. The subsequent gains or losses resulting from the restatement of non-monetary assets are recorded in &#x201C;Other financial income and expense&#x201D; in the consolidated income statement. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Non-current assets held for sale or held for distribution to owners</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Non-current assets are classified as assets held for sale or related to discontinued operations when their carrying amount is to be recovered principally through a sale transaction or distribution to owners, and a sale or distribution to owners is considered highly probable. They are stated at the lower of carrying amount and fair value less costs to sell with any resulting impairment recognized. Assets related to discontinued operations and assets of disposal group held for sale are not depreci-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-6</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">ated or amortized. The prior-year consolidated balance sheet is not restated.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Distribution of Alcon Inc. to Novartis AG shareholders </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During the first quarter of 2019, at the Annual General Meeting (AGM) of Novartis AG shareholders, held on February 28, 2019, the Novartis AG shareholders approved a special distribution by way of a dividend in kind to effect the spin-off of Alcon Inc. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The February 28, 2019, shareholder approval for the spin-off required the Alcon Division and selected portions of corporate activities attributable to Alcon&#x2019;s business (the &#x201C;Alcon business&#x201D;) to be reported as discontinued operations. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The shareholder approval to spin off the Alcon business also required the recognition of a distribution liability at the fair value of the Alcon business. The Group elected to measure the distribution liability at the fair value of the Alcon business net assets taken as a whole. The distribution liability was recognized through a reduction in retained earnings. It was required to be adjusted at each balance sheet date for changes in its estimated fair value, up to the date of the distribution to shareholders through retained earnings. Any resulting impairment of the business assets to be distributed would have been recognized in the consolidated income statements in &#x201C;Other expense&#x201D; of discontinued operations, at the date of initial recognition of the distribution liability or at subsequent dates resulting from changes of the distribution liability valuation. At the April 8, 2019 distribution settlement date, the resulting gain, which was measured as the excess amount of the distribution liability over the then-carrying value of the net assets of the business distributed, was recognized on the line &#x201C;Gain on distribution of Alcon Inc. to Novartis AG shareholders&#x201D; in the income statement of discontinued operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. These fair value measurements were classified as &#x201C;Level 3&#x201D; in the fair value hierarchy. The section &#x201C;&mdash;Impairment of goodwill and intangible assets&#x201D; in this Note 1 provides additional information on key assumptions that are highly sensitive in the estimation of fair values using valuation techniques. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Transaction costs that were directly attributable to the distribution (spin-off) of Alcon to the Novartis shareholders, and that would otherwise have been avoided, were recorded as a deduction from equity.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional disclosures, refer to &#x201C;Note 2. Significant transactions&mdash;Significant transactions in 2019&mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders,&#x201D; and &#x201C;Note 30. Discontinued operations.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Acquisition of assets </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Acquired assets are initially recognized on the balance sheet at cost if they meet the criteria for capitalization. If acquired as part of a business combination, the fair value of identified assets represents the cost for these assets. If separately acquired, the cost of the asset includes the purchase price and any directly attributable costs for bringing the asset into the condition to operate as intended. Expected costs for obligations to dismantle and remove property, plant and equipment when they are no longer used are included in their cost.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Property, plant and equipment</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Property, plant and equipment are depreciated on a straight-line basis in the consolidated income statement over their estimated useful lives. Leasehold land is depreciated over the period of its lease, whereas freehold land is not depreciated. The related depreciation expense is included in the costs of the functions using the asset.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Property, plant and equipment are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the respective useful lives for property, plant and equipment:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Useful life</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20 to 40 years</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and other equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7 to 20 years</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Furniture and vehicles</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 10 years</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Computer hardware</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Government grants obtained for construction activities, including any related equipment, are deducted from the gross acquisition cost to arrive at the balance sheet carrying value of the related assets.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Leases and right-of-use assets</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">From January 1, 2019, with the adoption of IFRS 16 Leases, the Group adopted the following accounting policies for leases and right-of-use assets:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative standalone price. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases. For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The lease liability is initially measured at the present value of the future lease payments as from the com-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-7</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">mencement date of the lease to end of the lease term. The lease term includes the period of any lease extension that in management&#x2019;s assessment is highly probable to be exercised by the Group. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the Novartis incremental borrowing rate for the asset subject to the lease in the respective markets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The portion of the lease payments attributable to the repayment of lease liabilities is recognized in cash flows used in financing activities, and the portion attributable to the payment of interest is included in cash flows from operating activities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease incentive received and any initial direct costs incurred by Novartis, and expected costs for obligations to dismantle and remove right-of-use assets when they are no longer used.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life of the right-of-use asset or the end of the lease term. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In arrangements where the Group is the lessor, it determines at lease inception whether the lease is a finance lease or an operating lease. Leases that transfer substantially all of the risk and rewards incidental to ownership of the underlying asset to the counterparty (the lessee) are accounted for as finance leases. Leases that do not transfer substantially all of the risks and rewards of ownership are accounted for as operating leases. Lease payments received under operating leases are recognized on a straight-line basis over the lease term in the consolidated income statement in either &#x201C;net sales&#x201D; or &#x201C;other income,&#x201D; depending on the nature of and underlying asset to the lease arrangement. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to January 1, 2019, the Group applied the following accounting policies for leases: </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Leases that transferred substantially all of the risks and rewards of ownership were recognized as finance leases, with the leased asset measured initially at an amount equal to the lower of their fair value and the present value of the minimum lease payments. Minimum lease payments were the payments over the lease term that the Group, as leasee, was required to make, excluding contingent rent. The underlying asset was accounted for in accordance with the accounting policy applicable to that asset. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Leases that did not transfer substantially all of the risks and rewards of ownership were accounted for as operating leases and were not recognized in the consolidated balance sheet. Payments made under operating leases were recognized in the consolidated income statement on a straight-line basis over the term of the lease. Lease incentives received were deferred and recognized as a component of lease expense over the term of the lease. The future undiscounted lease payments under operating leases were disclosed as commitments in the notes to the consolidated financial statements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Lessor accounting policies were not substantially different from those applied upon the adoption of IFRS 16 Leases, as described above. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201C;&mdash;Impact of adopting significant new IFRS standards in 2019&#x201D; in this Note 1 provides additional disclosures on the impact of adoption of IFRS 16 Leases.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Goodwill and intangible assets</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Goodwill</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Goodwill arises in a business combination and is the excess of the consideration transferred to acquire a business over the underlying fair value of the net identified assets acquired. It is allocated to groups of cash-generating units (CGUs), which are usually represented by the reported segments. Goodwill is tested for impairment annually at the level of these groups of CGUs, and any impairment charges are recorded under &#x201C;Other expense&#x201D; in the consolidated income statement.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets available for use</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has the following classes of available-for-use intangible assets: currently marketed products; technologies; other intangible assets (including computer software); and up to the spin-off date of Alcon business, marketing know-how and the Alcon brand name.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Currently marketed products represent the composite value of acquired intellectual property (IP), patents, and distribution rights and product trade names.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketing know-how represents the value attributable to the expertise acquired for marketing and distributing Alcon surgical products.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Technologies represent identified and separable acquired know-how used in the research, development and production processes.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Significant investments in internally developed and acquired computer software are capitalized and included in the &#x201C;Other&#x201D; category, and amortized once available for use.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Alcon brand name was shown separately, as it was the only Novartis intangible asset that was available for use with an indefinite useful life. Novartis considers that it was appropriate that the Alcon brand name had an indefinite life since Alcon-branded products had a history of strong revenue and cash flow performance, and Novartis had the intent and ability to support the brand with spending to maintain its value for the foreseeable future.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Except for the Alcon brand name, intangible assets available for use are amortized over their estimated useful lives on a straight-line basis and are evaluated for potential impairment whenever facts and circumstances </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-8</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">indicate that their carrying value may not be recoverable. The Alcon brand name was not amortized, but evaluated for potential impairment annually.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the respective useful lives for available-for-use intangible assets and the location in the consolidated income statement in which the respective amortization and any potential impairment charge is recognized:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Useful life</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement location<br> for amortization and<br> impairment charges</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 20 years</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketing know-how</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25 years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Technologies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10 to 20 years    </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"   or "Research   and development"</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other (including computer software)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years  </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> In the respective   functional expense</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon brand name</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Not amortized,  indefinite useful life</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Other expense"  </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets not yet available for use</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Acquired research and development intangible assets that are still under development and have accordingly not yet obtained marketing approval are recognized as in-process research and development (IPR&amp;D).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">IPR&amp;D is not amortized, but is evaluated for potential impairment on an annual basis or when facts and circumstances warrant. Any impairment charge is recorded in the consolidated income statement under &#x201C;Research and development.&#x201D; Once a project included in IPR&amp;D has been successfully developed, it is transferred to the &#x201C;Currently marketed products&#x201D; category.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of goodwill and intangible assets</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">An asset is considered impaired when its balance sheet carrying amount exceeds its estimated recoverable amount, which is defined as the higher of its fair value less costs of disposal and its value in use. Usually, Novartis applies the fair value less costs of disposal method for its impairment assessment. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. In the limited cases where the value in use method would be applied, net present value techniques would be applied using pre-tax cash flows and discount rates.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Fair value less costs of disposal reflects estimates of assumptions that market participants would be expected to use when pricing the asset or CGUs, and for this purpose, management considers the range of economic conditions that are expected to exist over the remaining useful life of the asset.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimates used in calculating the net present values are highly sensitive and depend on assumptions specific to the nature of the Group&#x2019;s activities with regard to:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected future cash flows</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term sales forecasts </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Actions of competitors (launch of competing products, marketing initiatives, etc.)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Outcome of research and development activities (compound efficacy, results of clinical trials, etc.)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected costs to develop IPR&amp;D into commercially viable products</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Profit margins</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Probability of obtaining regulatory approval</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Future tax rate</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate royalty rate for the Alcon brand name</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate terminal growth rate</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate discount rate</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Generally, for intangible assets with a definite useful life, Novartis uses cash flow projections for the whole useful life of these assets. For goodwill and the Alcon brand name, Novartis generally utilizes cash flow projections for a five-year period based on management forecasts, with a terminal value based on cash flow projections usually in line with inflation rates for later periods. Probability-weighted scenarios are typically used.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discount rates used consider the Group&#x2019;s estimated weighted average cost of capital, adjusted for specific country and currency risks associated with cash flow projections to approximate the discount rate that market participants would use to value the asset.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Due to the above factors, actual cash flows and values could vary significantly from forecasted future cash flows and related values derived using discounting techniques.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of associated companies accounted for at equity</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis considers investments in associated companies for impairment evaluation whenever objective evidence indicates the net investment may be impaired, including when a quoted share price indicates a fair value less than the per-share balance sheet carrying value for the investment.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the recoverable amount of the investment is estimated to be lower than the balance sheet carrying amount, an impairment charge is recognized for the difference in the consolidated income statement under &#x201C;Income from associated companies.&#x201D; </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash and cash equivalents</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash and cash equivalents include highly liquid investments with original maturities of three months or less, which are readily convertible to known amounts of cash. Bank overdrafts are usually presented within current financial debts on the consolidated balance sheet, except in cases where a right of offset has been agreed with a bank, which then allows for presentation on a net basis.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-9</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Marketable securities, commodities and non-current financial assets </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Commodities, which include gold bullion or coins, are valued at the lower of cost or fair value using current market prices. The changes in fair value below cost are immediately recorded in &#x201C;Other financial income and expense.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketable securities are financial assets consisting principally of equity and debt securities as well as fund investments. Marketable securities held for short-term purposes are principally traded in liquid markets and are classified as marketable securities within current assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &#x201C;Other financial income and expense&#x201D; in the consolidated income statement. Marketable securities held for long-term strategic purposes are classified as non-current financial assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &#x201C;Other income&#x201D; and &#x201C;Other expense&#x201D; in the consolidated income statement.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketable securities are initially recorded at fair value on their trade date, which is different from the settlement date when the transaction is ultimately effected. Quoted securities are remeasured at each reporting date to fair value based on current market prices. If the market for a financial asset is not active or no market is available, fair values are established using valuation techniques. The majority of non-quoted investments are valued initially at fair value through the established purchase price between a willing buyer and seller. Non-quoted investments are subsequently adjusted based on values derived from discounted cash flow analysis or other pricing models. These investment values are classified as &#x201C;Level 3&#x201D; in the fair value hierarchy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the Group classifies and accounts for its marketable securities and non-current financial assets in the following categories:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Debt securities are valued at fair value through other comprehensive income with subsequent recycling into the consolidated income statement, as they meet both the &#x201C;solely payment of principal and interest&#x201D; and the business model criteria. Unrealized gains and losses, except exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are recognized in the consolidated income statement when the debt instrument is sold, at which time the gain is transferred to &#x201C;Other financial income and expense.&#x201D; Exchange gains and losses related to debt instruments are immediately recognized in the consolidated income statement to &#x201C;Other financial income and expense.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Fund investments, equity securities of the Novartis venture fund and derivative assets are valued at fair value through profit and loss (FVPL). Unrealized gains and losses, including exchange gains and losses, are recognized in the consolidated income statement, for all fund investments and for equity securities of the Novartis venture fund, to &#x201C;Other income&#x201D; for gains and &#x201C;Other expense&#x201D; for losses, and for derivative assets to &#x201C;Other financial income and expense.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Equity securities held as strategic investments, typically held outside of the Novartis venture fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Unrealized gains and losses, including exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are reclassified to retained earnings when the equity security is sold. If these equity securities are not designated at date of acquisition as financial assets valued at fair value through other comprehensive income, they are valued at FVPL, as described above.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other non-current financial assets, such as loans and long-term receivables from customers, advances and other deposits, are valued at amortized cost, which reflects the time value of money less any allowances for expected credit losses.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group assesses on a forward-looking basis the expected credit losses associated with its debt securities valued at fair value through other comprehensive income. Impairments on debt securities are recorded in &#x201C;Other financial income and expense.&#x201D;</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For other financial assets valued at amortized costs, impairments, which are based on their expected credit losses, and exchange rate losses are included in &#x201C;Other expense&#x201D; in the consolidated income statement. Exchange rate gains and interest income, using the effective interest rate method, are included in &#x201C;Other income&#x201D; or &#x201C;Other financial income&#x201D; in the consolidated income statement, depending on the nature of the item.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 9, the Group classified and accounted for its marketable securities and non-current financial assets in the following categories:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022;   The Group classified all its equity and quoted debt securities as well as fund investments as available for sale, as they were not acquired to generate profit from short-term fluctuations in price. Unrealized gains, except exchange gains related to quoted debt instruments, were recorded as a fair value adjustment in the consolidated statement of comprehensive income. They were recognized in the consolidated income statement when the financial asset was sold, at which time the gain was transferred either to &#x201C;Other financial income and expense,&#x201D; for the marketable securities held for short-term non-strategic purposes, or to &#x201C;Other income,&#x201D; for all other equity securities and fund investments. Exchange gains related to quoted debt instruments were immediately recognized in the consolidated income statement under &#x201C;Other financial income and expense.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; A security was assessed for impairment when its market value at the balance sheet date was less than initial cost reduced by any previously recognized impairment. Impairments on equity securities, quoted debt securities and fund investments, and exchange rate losses on quoted debt securities in a foreign currency that were held for short-term non-strategic purposes were recorded in &#x201C;Other financial income and expense.&#x201D; </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-10</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">Impairments were recorded for all other equity securities and other fund investments in &#x201C;Other expense&#x201D; in the consolidated income statement.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other non-current financial assets, including loans held for long-term strategic purposes, were carried at amortized cost, which reflects the time value of money less any allowances for uncollectable amounts. For these financial assets, impairments and exchange rate losses were included in &#x201C;Other expense&#x201D; in the consolidated income statement, and exchange rate gains and interest income using the effective interest rate method were included in &#x201C;Other income&#x201D; in the consolidated income statement.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201C;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201D; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Derivative financial instruments</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Derivative financial instruments are initially recognized in the balance sheet at fair value and are remeasured to their current fair value at the end of each subsequent reporting period. The valuation of a forward exchange rate contract is based on the discounted cash flow model, using interest curves and spot rates at the reporting date as observable inputs.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Options are valued based on a modified Black-Scholes model using volatility and exercise prices as major observable inputs.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group utilizes derivative financial instruments for the purpose of hedging to reduce the volatility in the Group&#x2019;s performance due to the exposure to various business related risks. To mitigate these risks, the Group enters into certain derivative financial instruments. The risk reduction is obtained because the derivative&#x2019;s value or cash flows are expected, wholly or partly, to offset changes in the value or cash flows of the recognized assets or liabilities. The overall strategy is aiming to mitigate the currency and interest rate risk of positions that are contractually agreed, and to partially mitigate the exposure risk of selected anticipated transactions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain derivative financial instruments meet the criteria for hedge accounting treatment. A prerequisite for obtaining this accounting-hedge relationship is extensive documentation on inception and proving on a regular basis that the economic hedge is effective for accounting purposes. Other derivative financial instruments do not meet the criteria to qualify for hedge accounting. Changes in the fair value of those derivative instruments are recognized immediately in &#x201C;Other financial income and expense&#x201D; in the consolidated income statement.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, the Group has designated certain long-term debt components as hedges of the translation risk arising on certain net investments in foreign operations. On consolidation, foreign currency differences arising on long-term debt designated as net investment hedges of a foreign operation are recognized in other comprehensive income and accumulated in currency translation effects, to the extent that the hedge is effective. The foreign currency differences arising from hedge ineffectiveness are recognized in the income statement in &#x201C;Other financial income and expense.&#x201D;</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When a hedged net investment is disposed of, the proportionate portion of the cumulative amount recognized in equity in relation to the hedged net investment is transferred to the consolidated income statement as an adjustment to the gain or loss on disposal.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Inventories</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Inventory is valued at the lower of acquisition or production cost determined on a first-in, first-out basis and net realizable value. This value is used for the &#x201C;Cost of goods sold&#x201D; in the consolidated income statement. Unsalable inventory is fully written off in the consolidated income statement under &#x201C;Cost of goods sold.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Trade receivables</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trade receivables are initially recognized at their invoiced amounts, including any related sales taxes less adjustments for estimated revenue deductions such as rebates, chargebacks and cash discounts.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the provisions for doubtful trade receivable are established using an expected credit loss model (ECL). The provisions are based on a forward-looking ECL, which includes possible default events on the trade receivables over the entire holding period of the trade receivable. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Charges for doubtful trade receivables are recorded as marketing and selling costs recognized in the consolidated income statement within &#x201C;Selling, general and administration&#x201D; expenses.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 9, the Group&#x2019;s accounting policy for provisions for doubtful trade receivables was as follows:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for doubtful trade receivables were established once there was an indication that it was likely that a loss would be incurred. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Significant financial difficulties of a customer, such as probability of bankruptcy, financial reorganization, default or delinquency in payments, were considered indicators that recovery of the trade receivable was doubtful. Charges for doubtful trade receivables, recorded as marketing and selling costs, were recognized in the consolidated income statement within &#x201C;Selling, general and administration&#x201D; expenses. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201C;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201D; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Legal and environmental liabilities</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis and its subsidiaries are subject to contingencies arising in the ordinary course of business, such as patent litigation, environmental remediation liabilities and </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-11</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">other product-related litigation, commercial litigation, and governmental investigations and proceedings. Provisions are recorded where a reliable estimate can be made of the probable outcome of legal or other disputes against the subsidiary.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Contingent consideration</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In a business combination or divestment of a business, it is necessary to recognize contingent future amounts due to previous owners, representing contractually defined potential amounts as a liability or asset. Usually for Novartis, these are linked to milestone or royalty payments related to certain assets and are recognized as a financial liability or financial asset at their fair value, which is then remeasured at each subsequent reporting date. These estimations typically depend on factors such as technical milestones or market performance, and are adjusted for the probability of their likelihood of payment and are appropriately discounted to reflect the impact of time.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Changes in the fair value of contingent consideration liabilities in subsequent periods are recognized in the consolidated income statement in &#x201C;Cost of goods sold&#x201D; for currently marketed products and in &#x201C;Research and development&#x201D; for IPR&amp;D. Changes in contingent consideration assets are recognized in &#x201C;Other income&#x201D; or &#x201C;Other expense,&#x201D; depending on its nature. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The effect of unwinding the discount over time is recognized for contingent liabilities in &#x201C;Interest expense&#x201D; and for contingent assets as interest income recognized in the consolidated income statement within &#x201C;Other financial income and expense.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defi</font><font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">ned benefit pension plans and&nbsp;other&nbsp;post-employment benefits</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The liability in respect of defined benefit pension plans and other post-employment benefits is the defined benefit obligation calculated annually by independent actuaries using the projected unit credit method. The current service cost for such post-employment benefit plans is included in the personnel expenses of the various functions in which associates are employed, while the net interest on the net defined benefit liability or asset is recognized as &#x201C;Other expense&#x201D; or &#x201C;Other income.&#x201D;</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Treasury shares</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Treasury shares are initially recorded at fair value on their trade date, which is different from the settlement date, when the transaction is ultimately effected. Treasury shares are deducted from consolidated equity at their nominal value of CHF&nbsp;0.50 per share. Differences between the nominal amount and the transaction price on purchases or sales of treasury shares with third parties, or the value of services received for the shares allocated to associates as part of share-based compensation arrangements, are recorded in &#x201C;Retained earnings&#x201D; in the consolidated statement of changes in equity.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Revenue recognition</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">From January 1, 2018, with the implementation of the new standard IFRS 15 Revenue from Contracts with Customers, the Group accounting policy for revenue recognition is as follows:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Revenue on the sale of Novartis Group products and services, which is recorded as &#x201C;Net sales&#x201D; in the consolidated income statement, is recognized when a contractual promise to a customer (performance obligation) has been fulfilled by transferring control over the promised goods and services to the customer, substantially all of which is at the point in time of shipment to or receipt of the products by the customer or when the services are performed. If contracts contain customer acceptance provisions, revenue is recognized upon the satisfaction of the acceptance criteria. If products are stockpiled at the request of the customer, revenue is only recognized once the products have been inspected and accepted by the customer, and there is no right of return or replenishment on product expiry. The amount of revenue recognized is based on the consideration Novartis expects to receive in exchange for its goods and services, when it is highly probable that a significant reversal will not occur. If a contract contains more than one performance obligation, the consideration is allocated based on the standalone selling price of each performance obligation. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. Revenues were recognized upon satisfaction of each of the performance obligations in the contract and the consideration was allocated based on the standalone selling price of each performance obligation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which substantially all the risks and rewards incidental to ownership transfers to the customer were treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair value of the equipment, which approximated the present value of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements were approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements longer than 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &#x201C;Other income.&#x201D; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consideration Novartis receives in exchange for its goods or services may be fixed or variable. Variable consideration is only recognized when it is highly probable that a significant reversal will not occur. The most common elements of variable consideration are listed below.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers are provisioned and recorded as a deduction from revenue at the time the related revenues are recorded or when </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-12</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">the incentives are offered. They are calculated on the basis of historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Refunds granted to healthcare providers under innovative pay-for-performance agreements (i.e. outcome based arrangements) are provisioned and recorded as a revenue deduction at the time the related sales are recorded. They are calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data are not sufficient for a reliable estimation of the outcome, revenue recognition is deferred until the uncertainty is resolved or until such history is available.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Cash discounts offered to customers are to encourage prompt payment and are provisioned and recorded as revenue deductions at the time the related sales are recorded.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Shelf stock adjustments are generally granted to customers, primarily of the Sandoz Division, to cover the inventory held by them at the time a price decline becomes effective. Revenue deduction provisions for shelf stock adjustments are recorded when the price decline is anticipated, based on the impact of the price decline on the customer&#x2019;s estimated inventory levels. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales returns provisions are recognized and recorded as revenue deductions when there is historical experience of Novartis agreeing to customer returns and Novartis can reasonably estimate expected future returns. In doing so, the estimated rate of return is applied, determined on the basis of historical experience of customer returns and considering any other relevant factors. This is applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that can be placed back in inventory for resale. Where shipments are made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue is only recorded when there is evidence of consumption or when the right of return has expired. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Provisions for revenue deductions are adjusted to actual amounts as rebates, refunds, discounts and returns are processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">&#x201C;Other revenue&#x201D; includes income from profit-sharing arrangements with our collaboration partners, and royalty and milestone income from the out-licensing of intellectual property when Novartis retains an interest in the IP through a license. Royalty income earned through a license is recognized when the underlying sales have occurred. Milestone income is recognized at the point in time when it is highly probable that the relevant milestone event criteria is met, and the risk of reversal of revenue recognition is remote. Other revenue also includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales, and is recognized when control transfers to the third party and our performance obligations are satisfied.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 15 on January 1, 2018, the Group accounting policy for revenue recognition was as follows:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Revenue was recognized on the sale of Novartis Group products and services, and was recorded as &#x201C;Net sales&#x201D; in the consolidated income statement when there was persuasive evidence that a sales arrangement exists; title, risks and rewards for the products are transferred to the customer; the price was determinable; and collectability was reasonably assured. If contracts contain customer acceptance provisions, revenue would be recognized upon the satisfaction of acceptance criteria. If products are stockpiled at the request of the customer, revenue was only recognized once the products have been inspected and accepted by the customer, and there was no right of return or replenishment on product expiry.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. The total consideration was allocated to the separate elements based on their relative fair values. Revenue was recognized once the recognition criteria have been met for each element of the contract.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which Novartis transfers substantially all the risks and rewards incidental to ownership to the customer are treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair values of the equipment, which approximate the present values of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements are approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements in excess of 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &#x201C;Other income.&#x201D; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers were recorded as a deduction from revenue at the time the related revenues were recorded or when the incentives were offered. They were calculated on the basis of historical experience and the specific terms in the individual agreements. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for refunds granted to healthcare providers under innovative pay-for-performance agreements were recorded as a revenue deduction at the time the related sales were recorded. They were calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data were not sufficient for a reliable estimation of the outcome, revenue recognition was deferred until such history was available. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Cash discounts were offered to customers to encourage prompt payment and were recorded as revenue deductions. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-13</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Following a decrease in the price of a product, we generally grant customers a &#x201C;shelf stock adjustment&#x201D; for their existing inventory for the involved product. Provisions for shelf stock adjustments, which are primarily relevant within the Sandoz Division, were determined at the time of the price decline or at the point of sale, if the impact of a price decline on the products sold could be reasonably estimated based on the customer&#x2019;s inventory levels of the relevant product. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When there was historical experience of Novartis agreeing to customer returns, and Novartis could reasonably estimate expected future returns, a provision was recorded for estimated sales returns. In doing so, the estimated rate of return was applied, determined based on historical experience of customer returns and considering any other relevant factors. This was applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that could be placed back in inventory for resale. Where shipments were made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue was only recorded when there was evidence of consumption or when the right of return had expired. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for revenue deductions were adjusted to actual amounts as rebates, discounts and returns were processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">&#x201C;Other revenue&#x201D; includes royalty and profit-sharing income, and revenue from activities such as manufacturing services or other services rendered, to the extent such revenue was not recorded under net sales.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201C;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201D; provides additional disclosure on the impact of adoption.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Internal research and development (R&amp;D) costs are fully charged to &#x201C;Research and development&#x201D; in the consolidated income statement in the period in which they are incurred. The Group considers that regulatory and other uncertainties inherent in the development of new products preclude the capitalization of internal development expenses as an intangible asset until marketing approval from a regulatory authority is obtained in a major market such as the United States, the European Union, Switzerland or Japan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Payments made to third parties, such as contract research and development organizations in compensation for subcontracted R&amp;D, that are deemed not to transfer intellectual property to Novartis are expensed as internal R&amp;D expenses in the period in which they are incurred. Such payments are only capitalized if they meet the criteria for recognition of an internally generated intangible asset, usually when marketing approval has been achieved from a regulatory authority in a major market.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Payments made to third parties to in-license or acquire intellectual property rights, compounds and products, including initial upfront and subsequent milestone payments, are capitalized, as are payments for other assets, such as technologies to be used in R&amp;D activities. If additional payments are made to the originator company to continue to perform R&amp;D activities, an evaluation is made as to the nature of the payments. Such additional payments will be expensed if they are deemed to be compensation for subcontracted R&amp;D services not resulting in an additional transfer of intellectual property rights to Novartis. Such additional payments will be capitalized if they are deemed to be compensation for the transfer to Novartis of additional intellectual property developed at the risk of the originator company. Subsequent internal R&amp;D costs in relation to IPR&amp;D and other assets are expensed, since the technical feasibility of the internal R&amp;D activity can only be demonstrated by the receipt of marketing approval for a related product from a regulatory authority in a major market.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Costs for post-approval studies performed to support the continued registration of a marketed product are recognized as marketing expenses. Costs for activities that are required by regulatory authorities as a condition for obtaining marketing approval are capitalized and recognized as currently marketed products.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Inventory produced ahead of regulatory approval is fully provisioned, and the charge is included in &#x201C;Other expense&#x201D; in the consolidated income statement, as its ultimate use cannot be assured. If this inventory can be subsequently sold, the provision is released to &#x201C;Other income&#x201D; in the consolidated income statement, either on approval by the appropriate regulatory authority or, exceptionally in Europe, on recommendation by the Committee for Medicinal Products for Human Use (CHMP), if approval is virtually certain.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Share-based compensation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Vested Novartis shares and American Depositary Receipts (ADRs) that are granted as compensation are valued at their market value on the grant date and are immediately expensed in the consolidated income statement.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair values of unvested restricted shares (RSs), restricted share units (RSUs) and performance share units (PSUs) in Novartis shares and ADRs granted to associates as compensation are recognized as an expense over the related vesting period. The expense recorded in the consolidated income statement is included in the personnel expenses of the various functions in which the associates are employed.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Unvested restricted shares, restricted ADRs and RSUs are only conditional on the provision of services by the plan participant during the vesting period. They are valued at fair value on the grant date. As RSUs do not entitle the holder to dividends, the fair value is based on the Novartis share price at the grant date adjusted for the net present value of the dividends expected to be paid during the holding period. The fair value of these grants, after making adjustments for assumptions related to forfeiture during the vesting period, is expensed on a straight-line basis over the respective vesting period.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">PSUs are subject to the achievement of certain performance criteria during the vesting period and require </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-14</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">plan participants to provide services during this period. The following paragraphs provide an overview of the accounting policies for the share-based compensation plans that grant PSUs. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to performance criteria based on Novartis internal performance metrics and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on assumptions concerning the expected performance against the internal performance metrics throughout the vesting period. The assumptions are based on the Group&#x2019;s targets for those performance metrics, and the expected forfeitures due to plan participants not meeting their service conditions. The assumptions are periodically adjusted over the vesting period. Any change in estimates for past services is recorded immediately as an expense or income in the consolidated income statement, and amounts for the remaining vesting period are expensed on a straight-line basis. As a result, at the end of the vesting period, the charge during the entire vesting period represents the amount that will finally vest. The number of equity instruments that finally vest is determined at the vesting date.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to performance criteria based on variables that can be observed in the market, which for Novartis plans is the Novartis total shareholder return (TSR) relative to a specific peer group of companies over the vesting period, and that are conditional on the provision of services by the plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on the total fair value of the grant over the vesting period. IFRS requires that these variables that can be observed in the market are taken into account in determining the fair value of the PSUs at the grant date. Novartis determined the fair value of these PSUs at the date of grant using a Monte Carlo simulation model. Adjustments to the number of equity instruments granted are only made if a plan participant does not fulfill the service conditions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to both performance criteria based on Novartis internal performance metrics and Novartis TSR relative to a specific peer group of companies over the vesting period and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on a bifurcation into the components based on the performance criteria related to Novartis internal performance metrics and TSR, as described in the paragraphs above. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Measuring the fair values of PSUs granted that include TSR performance criteria requires use of estimates. The Monte Carlo simulation used to determine the fair value of the PSUs TSR performance criteria requires the probability of factors related to uncertain future events; the term of the award; the grant price of underlying shares or ADRs; expected volatilities; the expected correlation matrix of the underlying equity instruments with those of the peer group of companies; and the risk-free interest rate as input parameters.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If a plan participant leaves Novartis for reasons other than retirement, disability or death, then unvested restricted shares, restricted ADRs, RSUs and PSUs are forfeited, unless determined otherwise by the provision of the plan rules or by the Compensation Committee of the Novartis Board of Directors, for example, in connection with a reorganization or divestment.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Government grants</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Grants from governments or similar organizations are recognized at their fair value when there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Government grants related to income are deferred and recognized in the consolidated income statement over the period necessary to match them with the related costs that they are intended to compensate.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The accounting policy for property, plant and equipment describes the treatment of any related grants.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Restructuring charges</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Restructuring provisions are recognized for the direct expenditures arising from the restructuring, where the plans are sufficiently detailed and where appropriate communication to those affected has been made.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Charges to increase restructuring provisions are included in &#x201C;Other expense&#x201D; in the consolidated income statements. Corresponding releases are recorded in &#x201C;Other income&#x201D; in the consolidated income statement.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Taxes</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Taxes on income are provided in the same periods as the revenues and expenses to which they relate and include interest and penalties incurred during the period. Deferred taxes are determined using the comprehensive liability method and are calculated on the temporary differences that arise between the tax base of an asset or liability and its carrying value in the balance sheet prepared for consolidation purposes, except for those temporary differences related to investments in subsidiaries and associated companies, where the timing of their reversal can be controlled and it is probable that the difference will not reverse in the foreseeable future. Since the retained earnings are reinvested, withholding or other taxes on eventual distribution of a subsidiary&#x2019;s retained earnings are only taken into account when a dividend has been planned.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimated amounts for current and deferred tax assets or liabilities, including any amounts related to any uncertain tax positions, are based on currently known facts and circumstances. Tax returns are based on an interpretation of tax laws and regulations, and reflect estimates based on these judgments and interpretations. The tax returns are subject to examination by the competent taxing authorities, which may result in an assessment being made requiring payments of additional tax, interest or penalties. Inherent uncertainties exist in the estimates of the tax positions.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-15</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impact of adopting significant new IFRS standard in 2019</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following new IFRS standard has been adopted by Novartis from January 1, 2019: </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 16 Leases</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">IFRS 16 Leases substantially changed the financial statements, as the majority of leases for which the Group is the lessee became on-balance sheet liabilities with corresponding right-of-use assets also recognized on the balance sheet. The lease liability reflects the net present value of the remaining lease payments, and the right-of-use asset corresponds to the lease liability, adjusted for payments made before the commencement date, lease incentives and other items related to the lease agreement. The standard replaces IAS 17 Leases and related interpretations. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Upon adoption of the new standard, a portion of the annual operating lease costs, which was previously fully recognized as functional expenses, as a component of operating income, is recorded as interest expense. In addition, the portion of the lease payments that represents the reduction of the lease liability is recognized in the cash flow statement as an outflow from financing activities, which was previously fully recognized as an outflow from operating activities. Given the leases involved, these effects are not significant to the consolidated income statement and consolidated statement of cash flow.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group implemented the new standard on January 1, 2019, and applied the modified retrospective method, with right-of-use assets measured at an amount equal to the lease liability, adjusted by the amount of the prepaid or accrued lease payments relating to those leases recognized in the balance sheet immediately before the date of initial application and did not restate prior years.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Results of our impact assessment:  </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The undiscounted operating lease commitments as of December 31, 2018, amounted to USD 3.6 billion. This includes approximately USD 0.1 billion of leases with a commencement date in 2019, as well as short-term leases and low-value leases that are recognized from January 1, 2019, upon adoption of IFRS 16, on a straight-line basis as expense in profit and loss. This also includes USD 0.2 billion lease commitments related to the Alcon Division, which is attributable to discontinued operation in 2019. For the remaining undiscounted lease commitments attributable to continuing operations of USD 3.3 billion, the Group recognized on January 1, 2019, lease liabilities of USD 1.74 billion and right-of-use assets of USD 1.55 billion (after the reclassification of USD 0.1 billion from property, plant &amp; equipment, and net adjustments for the USD 0.3 billion recognition of sublease receivables, prepayments, and accrued lease payments recognized as at December 31, 2018). For the lease commitments attributable to discontinued operations, the Group recognized on January 1, 2019, lease liabilities and right-of-use assets of USD 0.2 billion. This does not include the discontinued operations right-of-use assets and lease liability on finance lease agreements of USD 75 million and USD 89 million, respectively. There was an insignificant increase to retained earnings upon adoption of IFRS 16 of USD 3 million that arose from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a lessor, the Group had no significant impact upon adoption. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For further information on the impact of adoption and additional disclosures of IFRS 16 Leases, see Note 10. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impact of adopting significant new IFRS standards in 2018</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following IFRS standards have been adopted by Novartis from January 1, 2018: </div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 9 Financial Instruments</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented IFRS 9 Financial Instruments as of January 1, 2018, which substantially changed the classi&#xFB01;cation and measurement of &#xFB01;nancial instruments. The standard requires impairments to be based on a forward-looking model, changed the approach to hedging &#xFB01;nancial exposures and related documentation, changed the recognition of certain fair value changes, and amends disclosure requirements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impairment of financial assets, including trade and lease receivables, is now assessed using an expected credit loss model; previously, the incurred loss model was used. Given the nature of Novartis financial assets, the Group had no significant impact to its provisions for doubtful accounts or impairments from this change.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The new hedge accounting model introduced by the standard requires hedge accounting relationships to be based upon the Group&#x2019;s own risk management strategy and objectives, and to be discontinued only when the relationships no longer qualify for hedge accounting. There was no impact upon adoption of the new standard, as the Group&#x2019;s existing hedge relationships continue to be designated as such under the new hedge accounting requirements.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The most significant impact to the Group upon adoption of IFRS 9 relates to the treatment of the unrealized gains and losses from changes in fair value on certain of the Group&#x2019;s financial instruments, which were previously classified as available-for-sale marketable securities and financial investments. The unrealized gains and losses (to the extent of previous recognized unrealized gains), which the Group recognized previously in the consolidated statement of other comprehensive income, are from January 1, 2018, recognized in the consolidated income statement. This approach is applied to equity securities where the fair value through other comprehensive income irrevocable option is not applied. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group applied the modified retrospective method upon adoption of IFRS 9 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 9 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 177 million. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-16</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 15 Revenue from Contracts with Customers</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented the new standard IFRS 15 Revenue from Contracts with Customers as of January 1, 2018. The standard amended revenue recognition requirements and established principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash &#xFB02;ows arising from contracts with customers. The standard replaced IAS 18 Revenue and IAS 11 Construction contracts and related interpretations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impacts of adoption of the new standard are summarized below: </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group&#x2019;s &#x201C;net sales&#x201D; are derived from the sale of drug substances, vision care products, surgical equipment, and other products and services, where control transfers to our customers and our performance obligations are satisfied at the time of shipment to or receipt of the products by the customer, or when the services are performed. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group&#x2019;s &#x201C;other revenue&#x201D; consists of royalty income from the out-licensing of intellectual property, which is recognized as earned, and from manufacturing and other services, where revenue is recognized when control transfers to the third party and our performance obligations are satisfied. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized from these manufacturing and other services arrangements, nor did it change accounting for these royalty arrangements, as the standard&#x2019;s royalty exception is applied for IP licenses. &#x201C;Other revenue&#x201D; also includes revenue from profit-sharing arrangements with our collaboration partners. Furthermore, the Group receives milestone payments related to the out-licensing of IP. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group applied the modified retrospective method upon adoption of IFRS 15 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 15 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 60 million. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">New IFRS standard effective as of January 1, 2020 </font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 3 Business Combination amendments</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The IASB issued an amendment to IFRS 3 Business Combinations that revised the definition of a business, which assist entities with the evaluation of when an asset or group of assets acquired or disposed of should be considered a business. This amended standard is effective for the Group as of January 1, 2020 and is applicable to transactions entered into on or after January 1, 2020. The amended standard allows an entity to apply an optional concentration test, on a transaction-by-transaction basis, to evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this optional concentration test is met, the entity may choose to consider the transaction an acquisition of an asset or set of assets. The Group does not expect the adoption of this amended standard on January 1, 2020 to have a significant impact on our consolidated financial statements in future periods. However, this will depend on the facts and circumstances of future transactions and if the Group decides to apply the optional concentration test in the assessment of whether an acquired set of activities and assets is or is not a business.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There are no other IFRS standards or interpretations not yet effective that would be expected to have a material impact on the Group.</div><a name="anchorId001539294"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">2. Significant transactions</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2019</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On June 29, 2018, Novartis announced its intention to seek shareholder approval for the spin-off of the Alcon business into a separately traded standalone company, following the complete structural separation of the Alcon business into a standalone company (the Alcon business or Alcon Inc.). </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Novartis AG shareholders approved the spin-off of the Alcon business at the 2019 Annual General Meeting held on February 28, 2019, subject to completion of certain conditions precedent to the distribution. Upon shareholder approval, the Alcon business was reported as discontinued operations, and the fair value of the Alcon business exceeded the carrying value of its net assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The conditions precedent to the spin-off were met and on April 8, 2019 the spin-off of the Alcon business was effected by way of a distribution of a dividend in kind of Alcon Inc. shares to Novartis AG shareholders and ADR (American Depositary Receipt) holders (the Distribution), which amounted to USD 23.4 billion and is recognized as a reduction to retained earnings. Through the </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-17</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Distribution, each Novartis AG shareholder received one Alcon Inc. share for every five Novartis AG shares/ADRs they held on April 8, 2019, close of business. As of April 9, 2019, the shares of Alcon Inc. are listed on the SIX Swiss Exchange (SIX) and on the New York Stock Exchange (NYSE) under the symbol &#x201C;ALC.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The dividend in kind distribution liability to effect the spin-off of the Alcon business (the distribution liability) amounted to USD 26.4 billion at March 31, 2019, unchanged from its initial recognition on February 28, 2019, and was in excess of the carrying value of the Alcon business net assets as of February 28, 2019, and as of March 31, 2019. The net assets of the Alcon business amounted to USD 23.1 billion as at March 31, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On March 6, 2019, Alcon entered into financing arrangements with a syndicate of banks under which it borrowed on April 2, 2019, a total amount of USD 3.2 billion. These borrowings consisted of approximately USD 2.8 billion and the equivalent of USD 0.4 billion in EUR in bridge and other term loans under such Alcon facilities agreement. In addition, approximately USD 0.3 billion of borrowings under a number of local bilateral facilities in different countries, with the largest share of borrowings in Japan, were raised. This resulted in a total gross debt of USD 3.5 billion. These outstanding borrowings of the Alcon legal entities were recorded in the balance sheet and financing cash flow from discontinued operations. Prior to the spin-off, through a series of intercompany transactions, Alcon legal entities paid approximately USD 3.1 billion in cash to Novartis and its affiliates.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At the April 8, 2019 Distribution, the fair value of the distribution liability of the Alcon business amounted to USD 23.4 billion, a decrease of USD 3.0 billion from March 31, 2019. As mentioned above, prior to the spin-off, through a series of intercompany transactions, Alcon legal entities incurred additional net financial debt and paid approximately USD 3.1 billion in cash to Novartis and its affiliates. This additional net debt and transactions resulted in a decrease in Alcon&#x2019;s net assets to USD 20.0 billion at the date of the Distribution of the dividend in kind to Novartis AG shareholders on April 8, 2019. The distribution liability at April 8, 2019, remained in excess of the then-carrying value of the Alcon business net assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain consolidated foundations own Novartis AG dividend-bearing shares restricting their availability for use by the Group. These Novartis AG shares are accounted for as treasury shares. Through the Distribution, these foundations received Alcon Inc. shares representing an approximate 4.7% equity interest in Alcon Inc. Upon the loss of control of Alcon Inc. through the Distribution, the financial investment in Alcon Inc. was recognized at its fair value based on the opening traded share price of Alcon Inc. on April 9, 2019 (a Level 1 hierarchy valuation). At initial recognition, its fair value of USD 1.3 billion was reported on the Group&#x2019;s consolidated balance sheet as a financial asset. Management has designated this investment at fair value through other comprehensive income.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The total non-taxable, non-cash gain recognized at the distribution date of the spin-off of the Alcon business amounted to USD 4.7 billion consisting of:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> April 8,<br> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net assets derecognized<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;025</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derecognition of distribution liability</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;434</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Difference between net assets and distribution liability</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;409</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition of Alcon Inc. shares obtained  through consolidated foundations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;273</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation gains recycled into  the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   123</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transaction costs recognized in the  consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;114</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gain on distribution of Alcon Inc. to  Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   4&nbsp;691</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> See Note 30 for additional information.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For additional disclosures on discontinued operations, refer to Note 30.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of IFM Tre, Inc. </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On May 7, 2019, Novartis acquired IFM Tre, Inc., a privately held, US-based biopharmaceutical company focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome. The acquisition gives Novartis full rights to IFM Tre, Inc.&#x2019;s portfolio of NLRP3 antagonists. The NLRP3 antagonists portfolio consists of one clinical program and two preclinical programs: IFM-2427, a first-in-class, clinical-stage systemic antagonist for an array of chronic inflammatory disorders, including atherosclerosis and nonalcoholic steatohepatitis (NASH); a preclinical-stage gutdirected molecule for the treatment of inflammatory bowel disease; and a preclinical-stage central nervous system (CNS)-penetrant molecule.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The previously held interest of 9% was adjusted to its fair value of USD 33 million through the consolidated income statement at acquisition date. This remeasurement resulted in a gain of USD 14 million. The fair value of the total purchase consideration for acquiring the 91% stake Novartis did not already own amounted to USD 361 million. The amount consisted of an initial cash payment of USD 285 million, and the fair value of the contingent consideration of USD 76 million due to the IFM Tre, Inc. shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 355 million, mainly intangibles, and goodwill of USD 39 million. Results of operations since the date of acquisition were not material.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Xiidra</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On May 8, 2019, Novartis entered into an agreement with Takeda Pharmaceutical Company Limited (Takeda) to acquire the assets associated with <i>Xiidra</i> (lifitegrast ophthalmic solution) 5% worldwide. <i>Xiidra</i> is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. The transaction bolsters the Novartis front-of-the-eye portfolio and ophthalmic leadership. The transaction closed on July 1, 2019. The purchase price consists of a USD 3.4 billion upfront payment, customary purchase price adjustments of USD 0.1 billion, and the potential milestone payments of up to USD 1.9 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-18</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration is USD 3.7 billion. The amount consists of an initial cash payment of USD 3.5 billion, and the net present value of the contingent consideration of USD 0.2 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The purchase price allocation resulted in net identifiable assets of approximately USD 3.6 billion, consisting mainly of intangible assets of USD 3.6 billion, and goodwill amounted to approximately USD 0.1 billion. In 2019, from the date of acquisition, the business generated net sales of USD 0.2 billion. Management estimates that net sales for the entire year of 2019 would have amounted to USD 0.3 billion, had the business been acquired at the beginning of the 2019 reporting period. Results of operations since the date of acquisition were not material.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions entered into in 2019 and closed in January 2020</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of The Medicines Company</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 23, 2019, Novartis entered into an agreement and plan of merger (the Merger Agreement) with The Medicines Company, a US-based pharmaceutical company headquartered in Parsippany, New Jersey USA. Pursuant to the Merger Agreement, on December 5, 2019, Novartis, through a subsidiary, commenced a tender offer to acquire all outstanding shares of The Medicines Company for USD 85 per share, or a total consideration of approximately USD 9.7 billion in cash on a fully diluted basis. The tender offer expired on January 3, 2020, and on January 6, 2020, the acquiring subsidiary merged with and into The Medicines Company, resulting in The Medicines Company becoming an indirect wholly owned subsidiary of Novartis. Novartis will finance the transaction through available cash and short- and long-term borrowings. As the transaction closed on January 6, 2020 the purchase price allocation is incomplete.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Medicines Company is focused on the development of inclisiran, a potentially first-in-class, twice-yearly therapy that allows administration during patients&#x2019; routine visits to their healthcare professionals and will potentially contribute to improved patient adherence and sustained lower LDL-C levels.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant pending transactions</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz &ndash; divestment of US dermatology business and generic US oral solids portfolio</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On September 6, 2018, Novartis announced that it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc. (Aurobindo) for USD 0.8 billion in cash and potential earnouts.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Sandoz US portfolios to be sold to Aurobindo include approximately 300 products as well as additional development projects. The sale includes the Sandoz US generic and branded dermatology businesses as well as its dermatology development center. As part of the transaction, Aurobindo will acquire the manufacturing facilities in Wilson, North Carolina, and in Hicksville and Melville, New York.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The transaction is expected to be completed in the first quarter of 2020, pending regulatory approval. As the fair value of the consideration (USD 0.8 billion) less costs to sell is below the carrying value of the divested business (USD 1.0 billion, which includes an allocation of Sandoz goodwill of USD 0.2 billion), an impairment of the net assets to be divested in the amount of USD 0.2 billion was recognized as a reduction to goodwill in 2018. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Group&#x2019;s consolidated balance sheet at December 31, 2019 and 2018, the business assets and liabilities of the Sandoz US dermatology business and generic US oral solids portfolio are separately shown as assets and liabilities of disposal group held for sale.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The disposal group, assets and liabilities classified as held for sale consist of the following:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> December 31,<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31,<br> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets of disposal group classified as held for sale</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 475</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 478</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 181</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 165</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 807</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> December 31,<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31,<br> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities of disposal group classified as held for sale</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other non-current  liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 51</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There are no cumulative income or expenses included in other comprehensive income relating to the disposal group.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz &ndash; acquisition of the Japanese business of Aspen Global Incorporated</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 11, 2019, Sandoz entered into an agreement for the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited. Under the agreement, Sandoz will acquire the shares in Aspen Japan K.K. and associated assets held by AGI. Pursuant to the agreed terms of the transaction, on closing the Group will pay an initial cash consideration of EUR 300 million (approximately USD 336 million). In addition, deferred consideration is due to AGI, upon fulfillment of certain conditions after closing, currently estimated at approximately EUR 100 million (approximately USD 112 million). </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-19</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We have received all relevant approvals and this transaction is expected to be completed in the first quarter of 2020.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Aspen&#x2019;s portfolio in Japan consists of off-patent medicines with a focus on anesthetics and specialty brands. The acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2018</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Advanced Accelerator Applications S.A.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On October 30, 2017, Novartis entered into a binding memorandum of understanding with Advanced Accelerator Applications S.A. (AAA), a company headquartered in Saint-Genis-Pouilly, France, under which Novartis agreed to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Novartis commenced the tender offer on December 7, 2017, to purchase all of the outstanding ordinary shares for a price of USD&nbsp;41 per share and USD&nbsp;82 per American Depositary Share (ADS), each representing two ordinary shares of AAA, which expired on January 19, 2018. The offer valued AAA&#x2019;s equity at USD&nbsp;3.9 billion, on a fully diluted basis. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of January 19, 2018, the expiration date of the tender offer, approximately 97% of the then-outstanding fully diluted ordinary shares, including ordinary shares represented by ADSs (hereinafter collectively referred to as &#x201C;the outstanding shares&#x201D;), were validly tendered. On January 22, 2018, Novartis accepted and paid USD 3.9 billion for the outstanding shares tendered in the offer. On January 22, 2018, Novartis commenced a subsequent offering period that expired on January 31, 2018. As of the expiration of the subsequent offering period, an additional 1.8% of the outstanding shares were validly tendered. Novartis accepted and paid approximately USD 60 million, resulting in an increase in Novartis ownership in AAA to 98.7%. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration was USD 3.9 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 1.9 billion, consisting of USD 2.5 billion intangible assets, USD 0.6 billion net deferred tax liabilities, and goodwill of approximately USD 2.0 billion. In 2018, from the date of the acquisition, the business generated net sales of USD 0.4 billion. Management estimated that net sales for the entire year of 2018 would have amounted to USD 0.4 billion had AAA been acquired at the beginning of 2018. The 2018 results from operations since the acquisition were not material.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2019, Novartis held 99.2% of the then-outstanding fully diluted ordinary shares, including ordinary shares represented by ADSs.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">AAA is a radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicines &ndash; including <i>Lutathera</i> (USAN: lutetium Lu 177 dotatate/INN: lutetium (<sup>177</sup>Lu) oxodotreotide), a first-in-class radioligand therapy product for neuroendocrine tumors &ndash; and a portfolio of diagnostic products. Radiopharmaceuticals, such as <i>Lutathera</i>, are unique medicinal formulations containing radioisotopes, which are used clinically for both diagnosis and therapy.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of AveXis, Inc.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On April 6, 2018, Novartis entered into an agreement and plan of merger with AveXis, Inc., a US-based clinical stage gene therapy company, under which Novartis commenced on April 17, 2018, a tender offer to purchase all outstanding common stock of AveXis, Inc. for USD 218 per share in cash. On May 15, 2018, Novartis completed the acquisition of the common stock of AveXis, Inc. and paid a total of USD 8.7 billion. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration was USD 8.7 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 7.2 billion, consisting of USD 8.5 billion intangible assets, USD 1.6 billion net deferred tax liabilities and other net assets of USD 0.3 billion, and goodwill of approximately USD 1.5 billion. The 2018 results of operations since the date of acquisition were not material. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">AveXis, Inc. is focused on developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. AveXis, Inc.&#x2019;s initial product candidate, AVXS-101, is a proprietary gene therapy currently in development for the treatment of spinal muscular atrophy (SMA) type 1 &ndash; the leading genetic cause of infant mortality &ndash; and SMA types 2 and 3. In addition, AveXis, Inc. has a pipeline of other novel treatments for rare neurological diseases, including Rett syndrome (RTT) and a genetic form of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Endocyte, Inc.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On October 18, 2018, Novartis entered into an agreement and plan of merger with Endocyte, Inc. (Endocyte), a US-based biopharmaceutical company focused on developing targeted therapeutics for cancer treatment. The transaction was completed on December 21, 2018. Under the terms of the agreement, Novartis acquired all outstanding shares of Endocyte common stock for USD 24 per share. The total consideration amounted to USD 2.1 billion.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration was USD 2.1 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 1.5 billion, consisting of USD 1.5 billion intangible assets, USD 0.3 billion net deferred tax liabilities and other net assets of USD 0.3 billion, and goodwill of approximately USD 0.6 billion. The purchase price allocation was preliminary at December 31, 2018, as the transaction closed on December 21, 2018, which was close to the Group&#x2019;s year-end and therefore did not provide sufficient time to complete the valuation of the intangible assets, deferred taxes, assumed liabilities and goodwill. During 2019, there were no significant revisions to the purchase price allocation.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Endocyte uses drug conjugation technology to develop targeted therapies with companion imaging agents, including <sup>177</sup>Lu-PSMA-617, a potential first-in-class investigational radioligand therapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-20</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Corporate &ndash; divestment of </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">36.5%</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> stake in </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">GlaxoSmithKline Consumer Healthcare Holdings Ltd. </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On March 27, 2018, Novartis entered into an agreement with GlaxoSmithKline plc (GSK) to divest its 36.5% stake in GlaxoSmithKline Consumer Healthcare Holdings Ltd. to GSK for USD 13.0 billion in cash. As a result, Novartis discontinued the use of equity method accounting starting from April 1, 2018. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On June 1, 2018, the transaction closed and Novartis realized a pre-tax gain of USD 5.8 billion, recorded in income from associated companies.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2017</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Ziarco Group Limited</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 20, 2017, Novartis acquired Ziarco Group Limited (Ziarco), a privately-held company in the United Kingdom that focuses on the development of novel treatments in dermatology. This acquisition added a once-daily oral H4 receptor antagonist in development for atopic dermatitis, commonly known as eczema, to complement the Novartis dermatology portfolio and pipeline. The fair value of the total purchase consideration was USD 420 million. The amount consisted of an initial cash payment of USD&nbsp;325 million and the net present value of the contingent consideration of USD 95 million, due to Ziarco shareholders, which they are eligible to receive upon the achievement of specified development milestones. The purchase price allocation resulted in net identifiable assets of USD&nbsp;395 million and goodwill of USD 25 million. The 2017 results of operations since the date of acquisition were not material.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Encore Vision, Inc.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 20, 2017, Novartis acquired Encore Vision, Inc. (Encore), a privately-held company in Fort Worth, Texas, in the United States, that focuses on the development of a novel treatment in presbyopia. The fair value of the total purchase consideration was USD 456 million. The amount consisted of an initial cash payment of USD 366 million and the net present value of the contingent consideration of USD 90 million, due to Encore shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 389 million and goodwill of USD 67 million. The 2017 results of operations since the date of acquisition were not material.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">For significant transactions in 2019 for discontinued operations, see Note 30. There were no significant transactions in 2018 and 2017 for discontinued operations.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-21</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001540083"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">3. Segmentation of key figures 2019, 2018 and 2017</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The businesses of Novartis are divided operationally on a worldwide basis into two identified reporting segments: Innovative Medicines and Sandoz. In addition, we separately report Corporate activities.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Reporting segments are presented in a manner consistent with the internal reporting to the chief operating decision-maker, which is the Executive Committee of Novartis. The reporting segments are managed separately because they each research, develop, manufacture, distribute and sell distinct products that require differing marketing strategies. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Executive Committee of Novartis is responsible for allocating resources and assessing the performance of the reporting segments.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The reporting segments are as follows:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines. The Innovative Medicines Division is organized into two global business units: Novartis Oncology and Novartis Pharmaceuticals. Novartis Oncology consists of the global business franchise Oncology, and Novartis Pharmaceuticals consists of the global business franchises Ophthalmology; Neuroscience; Immunology, Hepatology and Dermatology; Respiratory; Cardiovascular, Renal and Metabolism; and Established Medicines.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Sandoz develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. Sandoz is organized globally into three franchises: Retail Generics, Anti-Infectives and Biopharmaceuticals. In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form of anti-infectives sold to third parties. In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by Retail Generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Income and expenses relating to Corporate include the costs of the Group headquarters and those of corporate coordination functions in major countries. In addition, Corporate includes other items of income and expense that are not attributable to specific segments, such as certain revenues from intellectual property rights, certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations and sponsorships. Usually, no allocation of Corporate items is made to the segments. As a result, Corporate assets and liabilities principally consist of net liquidity (cash and cash equivalents, marketable securities less financial debts), investments in associated companies, and current and deferred taxes and non-segment-specific environmental remediation and post-employment benefit liabilities. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Our divisions are supported by the Novartis Institutes for BioMedical Research, Global Drug Development, Novartis Technical Operations and Novartis Business Services organizations.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Novartis Institutes for BioMedical Research (NIBR) conducts research activities for the Innovative Medicines Division and also collaborates with Sandoz. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Global Drug Development organization oversees all drug development activities for our Innovative Medicines Division and collaborates with our Sandoz Division on development of its biosimilars portfolio.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Novartis Technical Operations organization manages our manufacturing operations across our Innovative Medicines and Sandoz Divisions.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Novartis Business Services (NBS) is our shared services organization that delivers business support services across the Group, such as information technology, real estate and facility services, procurement, product lifecycle services, human resources, and financial reporting and accounting operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Following the February 28, 2019, shareholders&#x2019; approval of the spin-off of the Alcon business (refer to Notes 1, 2 and 30 for further details), the Group reported its consolidated financial statements for the current and prior years as &#x201C;continuing operations&#x201D; and &#x201C;discontinued operations.&#x201D; </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Continuing operations comprise the activities of the Innovative Medicines and Sandoz Divisions, and the continuing Corporate activities. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discontinued operations include the operational results from the Alcon eye care devices business and certain corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders, and certain other expenses related to the Distribution (refer to Notes 1, 2 and 30 for further details). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The accounting policies mentioned in Note 1 are used in the reporting of segment results. Inter-segmental sales are made at amounts that are considered to approximate arm&#x2019;s length transactions. The Executive Committee of Novartis evaluates segmental performance and allocates resources among the segments based on a number of measures, including net sales, operating income and net operating assets. Segment net operating assets consist primarily of property, plant and equipment; right-of-use assets; intangible assets; goodwill; inventories; and trade and other operating receivables less operating liabilities.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-22</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; consolidated income statements</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate  (including eliminations)</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing and discontinued segments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 783</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 741</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 141</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 177</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 38&nbsp;497</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;633</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;872</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;498</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;092</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10&nbsp;050</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;870</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;530</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 959</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;425</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29&nbsp;539</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;601</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;252</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;617</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10&nbsp;907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;534</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;369</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;814</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;586</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;069</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;475</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;749</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;608</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;512</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;426</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;287</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;752</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 656</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net loss from discontinued operations before gain on  distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in net income from continuing operations are:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 245</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;952</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;075</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;283</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;285</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;345</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;482</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of right-of-use assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;247</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;41</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;509</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;214</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;315</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;587</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;239</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;202</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;301</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;506</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;138</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;841</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges and fair value  changes on financial assets, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;229</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;395</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;165</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;492</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;521</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;761</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;67</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;239</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;220</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;067</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;918</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-23</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate  (including eliminations)</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing and discontinued segments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 741</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 668</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 177</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;743</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;633</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;946</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;178</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;743</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;381</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 898</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;870</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;650</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;530</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 817</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;633</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;415</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;771</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10&nbsp;907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;887</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;452</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;465</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;615</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;814</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;774</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;389</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;027</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;922</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;475</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;351</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;512</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;662</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;137</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;595</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;368</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;261</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net (loss)/income from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in net income from continuing operations are:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;075</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;916</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;285</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;270</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;117</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;303</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;214</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;447</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;587</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;624</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;239</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;84</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;73</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;157</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;591</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;652</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges and fair value  changes on financial assets, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;227</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;395</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;521</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;593</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;220</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;918</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;853</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-24</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; consolidated balance sheets</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Alcon<sup>1</sup>  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate   (including eliminations)</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71&nbsp;225</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 67&nbsp;055</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;468</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;328</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;971</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 30&nbsp;677</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;209</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;332</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;056</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;804</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;377</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;964</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43&nbsp;683</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;48&nbsp;474</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;62&nbsp;819</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;66&nbsp;871</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;692</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;938</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16&nbsp;184</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net operating assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;893</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 53&nbsp;999</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;664</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;951</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 24&nbsp;007</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71&nbsp;489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 94&nbsp;876</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in assets and liabilities are:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;098</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;888</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;878</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 549</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 561</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;069</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;696</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to property, plant  and equipment<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   822</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   294</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   519</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   143</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;774</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total right-of-use assets<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 136</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;677</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to right-of-use assets<sup style="white-space: nowrap">&nbsp;2, 3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 454</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total goodwill and intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44&nbsp;593</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;712</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;578</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55&nbsp;311</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74&nbsp;013</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to goodwill and  intangible assets<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   647</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;265</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   196</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;592</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total investment in associated  companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   128</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   81</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   8&nbsp;509</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   8&nbsp;264</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   8&nbsp;644</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   8&nbsp;352</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to investment in associated  companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents, marketable securities, commodities, time deposits and derivative  financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     11&nbsp;446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     15&nbsp;964</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     11&nbsp;446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     15&nbsp;964</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative  financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   27&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   32&nbsp;148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   27&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   32&nbsp;148</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current income tax and deferred tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;061</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;513</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;061</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;513</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Excluding the impact of business combinations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Total right-of-use assets and additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019.  See Notes 1 and 10 for additional disclosures.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows countries that accounted for more than 5% of at least one of the respective Group totals, as well as regional information for net sales for the years ended December 31, 2019, 2018 and 2017, and for selected non-current assets for the years ended December 31, 2019 and 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="11" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Net sales<sup>1</sup></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total of selected non-current assets<sup>2</sup></div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="11" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Country</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 795</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33&nbsp;032</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41&nbsp;972</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;280</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;618</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;893</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39&nbsp;082</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">France</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;442</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;289</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;933</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;976</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Germany</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;972</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;484</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;554</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;656</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;575</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;617</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 309</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 144</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;286</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;033</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;763</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77&nbsp;701</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98&nbsp;061</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Region</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;933</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;259</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;760</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 59</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 55&nbsp;913</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Americas</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19&nbsp;713</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 41</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;032</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;485</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29&nbsp;389</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39&nbsp;082</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;799</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;460</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;093</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;209</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;066</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77&nbsp;701</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98&nbsp;061</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales from operations by location of third-party customer</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies, and in 2019 right-of-use assets recognized with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-25</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s largest, second-largest and third-largest customers account for approximately 23%, 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). All segments had sales to these customers in 2019, 2018 and 2017. No other customer accounted for 6% or more of net sales in any year.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; net sales by region</font><font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> 2019<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2018<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change<br> (2018<br> to 2019)<br> USD %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2017<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change<br> (2017<br> to 2018)<br> USD %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;818</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;296</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;127</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;789</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;864</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;857</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;458</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;097</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;649</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;635</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;573</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;258</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24&nbsp;174</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;141</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;634</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;963</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;633</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;491</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;754</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;363</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;391</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 784</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 779</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 758</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;111</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;383</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;620</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;626</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;677</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;933</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;259</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;760</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;280</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;618</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;799</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;460</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;093</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;433</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;414</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;350</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35&nbsp;684</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33&nbsp;491</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;761</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;260</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;781</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales from operations by location of third-party customer. Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-26</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines Division net sales by business franchise</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> 2019<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2018<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change<br> (2018 to<br> 2019)<br> USD %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2017<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change<br> (2017 to<br> 2018)<br> USD %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Oncology</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;880</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;874</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;841</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;585</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;587</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;539</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Promacta/Revolade</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;416</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;174</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 867</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Tafinlar</I> + <I>Mekinist</I></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;155</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 873</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;561</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;943</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Jakavi</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 777</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 975</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;059</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 755</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 828</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 808</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kisqali</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 480</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 235</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lutathera</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 441</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kymriah</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Piqray</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;190</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 887</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis  Oncology business unit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     14&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     13&nbsp;428</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     12&nbsp;274</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;888</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Travoprost Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 433</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 517</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 589</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Xiidra</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 192</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Beovu</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;030</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;995</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;144</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;776</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;621</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Immunology, Hepatology and Dermatology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cosentyx</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;837</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;071</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ilaris</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 671</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 554</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Immunology,  Hepatology and  Dermatology</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     4&nbsp;222</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     3&nbsp;392</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     2&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     37</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Neuroscience</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;223</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zolgensma</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 361</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Aimovig</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Mayzent</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Neuroscience</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;773</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;429</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;287</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> 2019<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2018<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change<br> (2018 to<br> 2019)<br> USD %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2017<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change<br> (2017 to<br> 2018)<br> USD %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Respiratory</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Xolair<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;173</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;039</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 920</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ultibro Breezhaler</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 427</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 454</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 411</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Seebri Breezhaler</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Onbrez Breezhaler</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Respiratory</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;825</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;617</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cardiovascular, Renal and Metabolism</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Entresto</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;726</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 507</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 103</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Cardiovascular,  Renal and Metabolism</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;050</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   67</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Established Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Galvus</I> Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Diovan</I> Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;064</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 957</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Exforge</I> Group</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;025</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 960</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 485</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 464</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 414</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Neoral/Sandimmun(e)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 419</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 463</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Voltaren/Cataflam</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 417</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 465</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;291</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;587</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;964</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Established  Medicines</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   6&nbsp;998</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   7&nbsp;268</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   7&nbsp;481</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis  Pharmaceuticals business unit</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     23&nbsp;344</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     21&nbsp;464</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     20&nbsp;004</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division  net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   37&nbsp;714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   34&nbsp;892</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   32&nbsp;278</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales reflect <I>Xolair</I> sales for all indications.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-27</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division product net sales &ndash; 2019</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Brands</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Business franchise</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Indication</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> US<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br> world<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Total<br> USD m</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td width="21%" height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Cosentyx</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="21%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology  and Dermatology</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="21%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing   spondylitis and psoriatic arthritis</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2&nbsp;220</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;331</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   3&nbsp;551</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;736</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;223</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;086</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;086</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 804</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;076</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;880</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Entresto</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal   and Metabolism</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Chronic heart failure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   925</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   801</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;726</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 881</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 704</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;585</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;003</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;539</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Promacta/Revolade</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP),   severe aplastic anemia (SAA)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   725</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;416</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <I>Tafinlar</I> + <I>Mekinist</I></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and   adjuvant melanoma; advanced   non-small cell lung cancer (NSCLC)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     481</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     857</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     1&nbsp;338</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Galvus</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;297</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 929</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;263</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Xolair<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Respiratory</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA)   and Chronic Spontaneous Urticaria   (CSU)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1&nbsp;173</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     1&nbsp;173</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Jakavi</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF),   polycytomia vera (PV)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;114</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Diovan</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 978</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;064</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Exforge</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;012</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;025</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 450</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 525</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 975</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 423</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 755</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Ilaris</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Immunology, Hepatology  and Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS,   TRAPS, HIDS/MKD, FMF, SJIA,   AOSD and gout)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     367</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     671</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 316</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 485</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kisqali</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HR+/HER2- metastatic breast cancer</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 480</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;679</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;967</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;646</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;958</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;068</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;789</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;925</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales reflect <I>Xolair</I> sales for all indications.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-28</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division produ</font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">ct net sales &ndash; 2018</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Brands</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Business franchise</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Indication</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> US<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br> world<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Total<br> USD m</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td width="21%" height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="21%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="21%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;765</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;576</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;341</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Cosentyx</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology  and Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing   spondylitis and psoriatic arthritis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;674</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   2&nbsp;837</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;046</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 806</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;068</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;874</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 817</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 770</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;587</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 440</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;561</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 929</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;556</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Galvus</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;284</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;284</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Promacta/Revolade</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP),   severe aplastic anemia (SAA)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   581</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   593</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;174</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <I>Tafinlar</I> + <I>Mekinist</I></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and   adjuvant melanoma; advanced   non-small cell lung cancer (NSCLC)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     457</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     1&nbsp;155</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 521</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 578</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;099</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Xolair<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Respiratory</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA)   and Chronic Spontaneous Urticaria   (CSU)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;039</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     1&nbsp;039</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Entresto</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal   and Metabolism</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Chronic heart failure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   472</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;028</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Diovan</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 939</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;023</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Exforge</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;002</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Jakavi</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF),   polycytomia vera (PV)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   977</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   977</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 404</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 828</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Ilaris</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Immunology, Hepatology  and Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS,   TRAPS, HIDS/MKD, FMF, SJIA,   AOSD and gout)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     262</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     292</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     554</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Travoprost Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated intraocular   pressure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   323</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   517</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 464</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;654</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;292</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;946</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;736</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;946</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;864</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales reflect <I>Xolair</I> sales for all indications.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-29</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division product net sales &ndash; 2017</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Brands</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Business franchise</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> Indication</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> US<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br> world<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Total<br> USD m</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td width="21%" height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="21%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="21%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;709</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;476</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;185</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Cosentyx</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology  and Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing   spondylitis and psoriatic arthritis</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;275</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   796</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   2&nbsp;071</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;316</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;943</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;888</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;888</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 810</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;841</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 832</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;612</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 819</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 706</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;525</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><I>Galvus</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;233</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 515</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 544</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;059</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Exforge</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 960</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><I>Diovan</I> Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 87</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 870</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 957</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Xolair<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Respiratory</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA)   and Chronic Spontaneous Urticaria   (CSU)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     920</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     920</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <I>Tafinlar</I> + <I>Mekinist</I></div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and   adjuvant melanoma; advanced   non-small cell lung cancer (NSCLC)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     339</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     534</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     873</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Promacta/Revolade</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP),   severe aplastic anemia (SAA)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   421</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   867</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 407</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 401</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 808</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Jakavi</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Oncology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF),   polycytomia vera (PV)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   777</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   777</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Travoprost Group</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Ophthalmology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated   intraocular pressure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   216</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   589</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Entresto</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal   and Metabolism</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Chronic heart failure</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   297</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   507</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> Neoral/Sandimmun(e)</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology  and Dermatology</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   Transplantation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   450</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   488</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Voltaren/Cataflam</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Inflammation/pain</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 465</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 465</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;445</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;123</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 24&nbsp;568</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;412</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;298</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;710</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;857</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;421</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net sales reflect <I>Xolair</I> sales for all indications.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-30</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Sandoz Division net sales by business franchise</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> 2019<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2018<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change<br> (2018 to<br> 2019)<br> USD %</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2017<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change<br> (2017 to<br> 2018)<br> USD %</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Retail Generics<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;590</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;880</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;409</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Biopharmaceuticals</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;607</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;436</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Anti-Infectives</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 534</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 543</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 516</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division net sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Of which USD 784 million (2018: USD 826 million; 2017: USD 880 million) represents anti-infectives sold under the Sandoz name</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The product portfolio of Sandoz is widely spread in 2019, 2018 and 2017.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; other revenue</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate   (including eliminations)</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Profit-sharing income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 732</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 734</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 877</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Royalty income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 188</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Milestone income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 201</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 128</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 231</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;092</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 63</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Innovative Medicines  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Sandoz  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Corporate   (including eliminations)</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Group  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Profit-sharing income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 648</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 877</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 652</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Royalty income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 298</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Milestone income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 128</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 898</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;023</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-31</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001552740"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">4. Associated companies</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Net income statement effect</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other comprehensive income effect<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total comprehensive income effect</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG, Switzerland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 662</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 526</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 456</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 568</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 601</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 564</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">GlaxoSmithKline Consumer  Healthcare Holdings Ltd., UK</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;910</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   629</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;557</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   484</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies related to continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;482</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   565</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   5&nbsp;956</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   1&nbsp;071</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="20">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> In 2018, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 511 million was recycled into the consolidated income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. No Novartis share of other comprehensive income recognized by associated companies, net of taxes was recycled into the consolidated income statement in 2019 and 2017. <b></b><b></b></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has a significant investment in Roche Holding AG, Basel (Roche), as well as certain other smaller investments that are accounted for as associated companies. The investment in GlaxoSmithKline Consumer Healthcare Holdings Ltd., Brentford, Middlesex, UK, was divested on June 1, 2018, to GlaxoSmithKline plc, Great Britain.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Balance sheet value</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31,<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31,<br> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG, Switzerland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;445</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;195</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 199</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 157</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;644</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;352</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Roche Holding AG </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s holding in Roche voting shares was 33.3% at December 31, 2019, 2018 and 2017. This investment represents approximately 6.2% of Roche&#x2019;s total outstanding voting and non-voting equity instruments at December 31, 2019, 2018 and 2017.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Since full-year 2019 financial data for Roche is not available when Novartis produces its consolidated financial results, a survey of analyst estimates is used to estimate the Group&#x2019;s share of Roche&#x2019;s net income. Any differences between these estimates and actual results will be adjusted in the Group&#x2019;s 2020 consolidated financial statements when available.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following tables show summarized financial information for Roche, including current values of fair value adjustments made at the time of the acquisition of the shares, for the year ended December 31, 2018, and for the six months ended June 30, 2019 (since full-year 2019 data is not yet available):</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(CHF billions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Current assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-current <br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br> liabilities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-current <br> liabilities</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">December 31, 2018</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 53.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25.1</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">June 30, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(CHF billions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Revenue</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Net income</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br> comprehen-<br> sive income</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br> comprehen-<br> sive income</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">December 31, 2018</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.5</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">June 30, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">A purchase price allocation was performed on the basis of publicly available information at the time of acquisition of the investment. The December 31, 2019, balance sheet value allocation is as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31,<br> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of Roche&#x2019;s estimated net assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;404</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of reappraised intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 297</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Implicit Novartis goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;939</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current value of share in net identifiable assets  and goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   5&nbsp;640</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated equity accounting  adjustments and translation  effects less dividends received</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     2&nbsp;805</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance sheet value</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;445</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The identified intangible assets principally relate to the value of currently marketed products and are amortized on a straight-line basis over their estimated average useful life of 20 years.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, dividends received from Roche in relation to the distribution of its 2018 net income amounted to USD&nbsp;460 million (2018: USD 464 million in relation to the distribution of its 2017 net income).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consolidated income statement effects from applying Novartis accounting principles for this investment in 2019, 2018 and 2017 are as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of Roche's  estimated current-year  consolidated net income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     910</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     799</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     669</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prior-year adjustment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;125</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;67</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of fair value  adjustments relating to  intangible assets, net of taxes  of USD 24 million (2018: USD 40  million; 2017: USD 42 million)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">         &ndash;&nbsp;162</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">         &ndash;&nbsp;148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">         &ndash;&nbsp;146</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Partial release of deferred tax  liability recognized</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income effect</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 662</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 526</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 456</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The publicly quoted market value of the Novartis interest in Roche (SIX symbol: RO) at December 31, 2019, was USD&nbsp;16.9 billion (2018: USD&nbsp;12.9 billion).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-32</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">GlaxoSmithKline Consumer Healthcare Holdings&nbsp;Ltd.</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On March 27, 2018, Novartis entered into an agreement with GlaxoSmithKline plc, Great Britain (GSK), to divest its 36.5% stake in GSK Consumer Healthcare Holdings Ltd. (GSK Consumer Healthcare) to GSK for USD 13.0 billion in cash. As a result, Novartis discontinued the use of equity method accounting starting from April 1, 2018. The divestment transaction closed on June 1, 2018, and Novartis realized a pre-tax gain of USD 5.8 billion, recorded in income from associated companies. See Note 2. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">GSK Consumer Healthcare was formed in March 2015 via contribution of businesses from both Novartis and GSK. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At December 31, 2017, Novartis had a 36.5% interest in GSK Consumer Healthcare and had four of 11 seats on the GSK Consumer Healthcare board of directors. Furthermore, Novartis had customary minority rights as well as exit rights at a predefined, market-based pricing mechanism.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, dividends received from GSK Consumer Healthcare amounted to USD&nbsp;252 million.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consolidated income statement effects from applying Novartis accounting principles for this investment in 2018 and 2017 are as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of GSK Consumer Healthcare's estimated current-year consolidated net income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       119</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       589</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prior-year adjustment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of fair value adjustments relating to intangible assets and inventory, net of taxes of USD 1 million (2017: USD 1 million)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">         &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">         &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pre-tax gain on divestment of  GSK Consumer Healthcare</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   5&nbsp;790</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income effect</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;910</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 629</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name="anchorId001553915"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">5. Interest expense and&nbsp;other&nbsp;financial&nbsp;income&nbsp;and&nbsp;expense</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Interest expense</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;714</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;877</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;741</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense on lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense arising from  discounting long-term liabilities and capitalized borrowing costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;55</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total interest expense  from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;932</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;750</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Other financial income and expense</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 245</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency result, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other financial income  and expense from  continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     42</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-33</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001554220"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">6. Taxes</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Income before taxes</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;097</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;887</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;385</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 843</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;717</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes  from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   8&nbsp;940</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   14&nbsp;095</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   9&nbsp;102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Current and deferred income tax expense</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;186</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;615</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;462</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;961</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;988</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;451</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current income tax expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;913</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;93</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;305</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 447</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 428</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 615</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Deferred tax income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 354</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 308</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 310</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income tax expense  from continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;1&nbsp;603</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Analysis of tax rate</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has a substantial business presence in many countries and is therefore subject to different income and expense items that are non-taxable (permanent differences) or are taxed at different rates in those tax jurisdictions. This results in a difference between our applicable tax rate and effective tax rate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The main elements contributing to the difference between the Group&#x2019;s overall applicable tax rate (which can change each year since it is calculated as the weighted average tax rate based on the pre-tax income of each subsidiary) and the effective tax rate are shown in the table below:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(As a percentage)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Applicable tax rate</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14.3</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of disallowed expenditures</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of utilization of tax losses  brought forward from prior periods</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;0.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;0.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;0.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of income taxed at reduced rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of income not subject to tax<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax credits and allowances</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of release of  contingent consideration liability</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;0.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;0.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1.3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax rate change  on current and deferred  tax assets and liabilities<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;1.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;0.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     4.8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of write-off of deferred tax assets<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of write-down and reversal of  write-down of investments in subsidiaries</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;0.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax benefits expiring in 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of prior-year items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of other items<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Effective tax rate for continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17.6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><b> </b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Included in 2018 is the effect of income not subject to tax (-3.7%) arising from the portion of the non-taxable gain on the divestment of the Group's investment in GSK Consumer Healthcare Holdings Ltd. attributable to Switzerland.<b> </b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> 2019 is mainly related to the revaluation of the deferred tax assets and liabilities resulting from the tax reforms enacted in Switzerland in 2019, refer to Note 12 for additional disclosures.<br>Included in 2017 is a 4.8% impact related to the revaluation of the deferred tax assets and liabities and a portion of current tax payables. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017, refer to Note 12 for additional disclosures.<b> </b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> 2019 is primarily related to a non-cash, one-time deferred tax expense for the write-off of a deferred tax asset resulting from legal entity reorganizations.<b> </b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> In 2019, other items (+3.0%) include changes in uncertain tax positions (+2.6%) and other items (+0.4%).</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The utilization of tax-loss carry-forwards lowered the tax charge by USD&nbsp;11 million in 2019, by USD&nbsp;19 million in 2018, and by USD&nbsp;7 million in 2017.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For the amount of taxes attributable to discontinued operations, see Note 30.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-34</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001554969"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">7. Earnings per share</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income attributable to shareholders of Novartis AG (USD millions)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;797</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;499</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;732</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;611</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Number of shares (in millions)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Weighted average number of shares outstanding used in basic earnings per share</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;291</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;346</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Weighted average number of shares in diluted earnings per share</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;344</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;371</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Diluted earnings per share (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.06</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Basic earnings per share (EPS) is calculated by dividing net income attributable to shareholders of Novartis AG by the weighted average number of shares outstanding in a reporting period. This calculation excludes the average number of issued shares purchased by the Group and held as treasury shares.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For diluted EPS, the weighted average number of shares outstanding is adjusted to assume the vesting of all restricted shares, restricted share units, and the conversion of all potentially dilutive shares arising from options on Novartis shares that have been issued.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">No options were excluded from the calculation of diluted EPS in 2019, 2018 or 2017, as all options were dilutive in all years.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-35</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001555340"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">8. Changes in consolidated statements of&nbsp;comprehensive income</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated statements of comprehensive income include the Group&#x2019;s net income for the year as well as all other valuation adjustments recorded in the Group&#x2019;s consolidated balance sheet but that under IFRS are not recorded in the consolidated income statement. These include fair value adjustments to financial instruments, actuarial gains or losses on defined benefit pension and other post-employment plans, and currency translation effects, net of tax.</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes these value adjustments and currency translation effects attributable to Novartis shareholders:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value<br> adjustments <br> on marketable<br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value<br> adjustments <br> on debt<br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value<br> adjustments on<br>  deferred cash<br>  flow hedges</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value<br> adjustments <br> on equity<br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Actuarial<br> gains/(losses)<br> from defined<br> benefit plans</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Cumulative<br> currency <br> translation<br> effects</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total value<br> adjustments</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at January 1, 2017</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 349</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;915</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;642</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;212</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 50</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial losses from defined benefit plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;971</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;872</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2017, as previously reported</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   388</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;5&nbsp;064</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;4&nbsp;340</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 9 on retained  earnings and OCI<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;177</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;177</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to presentation required  under IFRS 9<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated value adjustments at January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;064</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;517</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial gains from defined benefit plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 320</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 320</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 415</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;423</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 744</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;452</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;45</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial gains from defined benefit plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;466</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;466</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;466</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 398</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;208</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 99</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;919</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;657</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Note 1 provides additional disclosures related to the impact of adoption of IFRS 9 Financial Instruments. OCI: other comprehensive income</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-36</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">8.1) The 2019, 2018 and 2017 changes in the fair value of financial instruments were as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br> adjustments <br> on equity <br> securities<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br> adjustments <br> on debt <br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value<br> adjustments on <br> deferred cash<br> flow hedges</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> </div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 208</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 227</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Debt securities sold</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred  to the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains reclassified to the retained earnings:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;140</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 99</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value<br> adjustments <br> on marketable <br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br> adjustments <br> on equity <br> securities<sup style="white-space: nowrap">    1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br> adjustments <br> on debt <br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value<br> adjustments on <br> deferred cash<br> flow hedges</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2018, as previously reported</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 9 on retained earnings and  other comprehensive income<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;177</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;177</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to presentation required under IFRS 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated fair value adjustments at January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 211</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 218</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred  to the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   13</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains reclassified to the retained earnings:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 227</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Note 1 provides aditional disclosures on the impact of adoption of IFRS 9 Financial Instruments.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value<br> adjustments <br> on marketable<br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br> adjustments <br> on debt <br> securities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value<br> adjustments on<br> deferred cash<br>  flow hedges</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2017</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 349</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 345</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Available-for-sale marketable securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Available-for-sale financial investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains transferred to the consolidated income statement:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;109</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;109</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred  to the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   13</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impaired financial assets transferred to the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 50</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Included is a  USD 18 million impact related to the revaluation of deferred tax liabilities on available-for-sale financial investments held in the US that were previously recognized through other comprehensive income related to continuing operrations. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-37</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">8.2) In 2019, cumulative currency translation gains of USD&nbsp;129 million were recycled through the income statement mainly as a result of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders. See Notes 2 and 30.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, cumulative currency translation losses of USD&nbsp;946 million were recycled through the income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. See Notes 2 and 4. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">No currency translation losses or gains were recycled through the income statement in 2017. </div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">8.3) Remeasurements from defined benefit plans arise as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Defined benefit pension plans before tax</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;119</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;482</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;367</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other post-employment benefit plans before tax</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxation on above items<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;313</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total after tax</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;467</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;466</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 851</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Included in 2019 is a USD -358 million impact related to the revaluation of deferred tax assets on Swiss post-employment benefits that were previously recognized through other comprehensive income. This revaluation resulted from the Swiss tax reforms enacted by the voters in 2019. Refer to Note 12 for additional disclosures.<br>Included in 2017 is a USD -272 million impact related to the revaluation of deferred tax assets on US post-employment benefits that were previously recognized through other comprehensive income (continuing operations USD-259 million and discontinued operations USD -13 million). This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-38</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001558042"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">9. Property, plant and equipment</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of property, plant and equipment during 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Land</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Buildings</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Construction <br> in progress</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Machinery <br> and other <br> equipment</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cost</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 696</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;135</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;155</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;028</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;615</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;655</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;678</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;009</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to right-of-use assets<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;127</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;23</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 630</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;474</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;551</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;774</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;409</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 512</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;463</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;350</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;674</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;999</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Accumulated depreciation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6&nbsp;328</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;18&nbsp;332</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 562</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;541</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;118</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to right-of-use assets<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to disposal group held for sale<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on disposals and derecognitions<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;674</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;846</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge<sup style="white-space: nowrap">&nbsp;7</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;447</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;898</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;345</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge<sup style="white-space: nowrap">&nbsp;8</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;51</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;205</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;43</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;726</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;14&nbsp;930</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 492</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;339</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;290</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;948</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;069</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Commitments for purchases of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 220</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Capitalized borrowing costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Represents the cost of assets and accumulated depreciation at January 1, 2019 related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Reclassification to right-of-use assets at January 1, 2019, upon adoption of IFRS 16 Leases. Refer to Notes 1 and 10 for additional disclosure.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Note 2 provides additional disclosures related to disposal group held for sale.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Reclassifications between various asset categories due to completion of plant and other equipment under construction</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Additions in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 23 million.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;7&nbsp;</sup> No depreciation charge in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 was recorded.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;8&nbsp;</sup> Impairments in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 2 million.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-39</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of property, plant and equipment during 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Land</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Buildings</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Construction <br> in progress</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Machinery <br> and other <br> equipment</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cost</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 720</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;064</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;368</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;858</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;010</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;309</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 538</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 931</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 407</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;774</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;212</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;457</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;291</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;504</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;887</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 696</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;042</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;155</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;028</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Accumulated depreciation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;485</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;17&nbsp;546</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to disposal group held for sale<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 56</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 161</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;574</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;140</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;717</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on disposals and derecognitions<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 412</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 595</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;324</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 361</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 479</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;43</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6&nbsp;328</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;924</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;18&nbsp;332</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 653</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;807</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;005</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;231</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;696</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value of property, plant and equipment under finance lease contracts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Commitments for purchases of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 289</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Capitalized borrowing costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Note 2 provides additional disclosures related to disposal group held for sale.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Reclassifications between various asset categories due to completion of plant and other equipment under construction</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Additions in the disposal group held for sale were USD 21 million.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Depreciation charge in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 15 million. For depreciation charge related to discontinued operations, refer to Note 30.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-40</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001559924"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">10. Right-of-use assets and lease liabilities</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Impact of adoption of IFRS 16 Leases</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Note 1 explains the changes and new accounting policy introduced on January 1, 2019, resulting from the adoption of the new accounting standard IFRS 16 Leases.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On transition to IFRS 16, the Group elected to apply the practical expedient to not reassess whether a contract is, or contains, a lease at January 1, 2019, the implementation date of IFRS 16. As a result, at the date of implementation, the Group applied IFRS 16 only to contracts that were previously identified as leases under IAS 17 Leases and related interpretations, and the definition of a lease under IFRS 16 was applied only to contracts entered into or changed on or after January 1, 2019.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impact on retained earnings upon implementation of IFRS 16 was USD 3 million arising from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group has entered into various fixed-term leases, mainly for vehicles and real estate. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The lease liabilities recorded in continuing operations on January 1, 2019, were USD 1.7 billion and the right-of-use assets were USD 1.6 billion. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Reconciliation of lease commitment disclosed on December 31, 2018, and lease liability recorded in continuing operations on January 1, 2019, is as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating lease commitments December 31, 2018<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;612</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating lease commitments December 31, 2018 related to discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;222</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating lease commitments December 31, 2018 related to continuing operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   3&nbsp;390</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition exemption for short-term leases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition exception for low-value leases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease arrangements with commencement date after December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;65</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Undiscounted future lease payments continuing operations as of January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   3&nbsp;283</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Effect of discounting</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;547</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Lease liabilities recognized as of January 1, 2019<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;736</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp;</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> As reported in Annual Report 2018 Note 27 </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> The weighted average incremental borrowing rate at January 1, 2019, the date of implementation of IFRS 16 Leases, was 3.5%. </div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The right-of-use assets of continuing operations at January 1, 2019, by underlying class of asset comprise the following:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> January 1, 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Land</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vehicles</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 147</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment, and other assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Right-of-use assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;554</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp;</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Right-of-use assets were lower than the lease liability at the date of implementation of IFRS 16 by USD 182 million, due to adjustments made for recognition of sublease receivables, prepayments and accrued lease payments and transfers from leased assets recorded in property, plant and equipment at December 31, 2018.  </div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The adoption of IFRS 16 on January 1, 2019 had an impact on the classification of the annual lease expense in the consolidated income statement, the recognition of right-of-use assets and lease liabilities in the balance sheet and the classification of the annual lease payments in the consolidated statement of cash flows.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The adoption of IFRS 16 on January 1, 2019 did not significantly impact the individual lines of the consolidated income statement.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the adjustments to the line items of the January 1, 2019, consolidated balance sheet, due to the implementation of IFRS 16:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> January 1, 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;101</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;554</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reserves</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;471</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provision and other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;212</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;257</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 268</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 267</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;524</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As a result of applying the modified retrospective method at the date of implementation of IFRS 16 on January 1, 2019, whereby the right-of-use assets were measured at the amount equal to the lease liabilities, there is no impact to the reported deferred tax assets and deferred tax liabilities on the consolidated balance sheet, as the corresponding deferred tax assets and deferred tax liabilities attributable to the lease liability and right-of-use asset relate to income taxes levied by the same taxation authority within the same legal entity, and were therefore offset.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The adoption of IFRS 16 on January 1, 2019 had no significant impact on the individual lines of the consolidated statement of cash flows, except for the principal portion of the lease payments (USD 0.3 billion for the year ended December 31, 2019) that is recognized as an </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-41</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">outflow in the cash flow from financing activities and the interest portion of the lease payment (USD 0.1 billion for the year ended December 31, 2019) is recognized as an outflow in the cash flow from operating activities. Prior to the adoption of IFRS 16, the full amount of the lease payments was recognized as an outflow in the cash flow from operating activities.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Current year disclosures</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of the right-of-use assets of continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Right-of-use assets at January 1, 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;554</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;305</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease contract terminations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;98</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of divestments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total right-of-use assets at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;677</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup> No impairments were recorded in the period.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Lease contract terminations also includes modifications to existing leases that result in reductions to the right-of-use assets, and reductions due to sub-leasing.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup>  </div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The right-of-use assets carrying value and depreciation charge of continuing operations at December 31, 2019, are shown below by underlying class of asset: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> December 31, 2019<br> carrying value</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Depreciation <br> charge<br> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Land</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 990</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vehicles</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment, and other assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total right-of-use assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;677</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 305</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The lease liabilities of continuing operations at December 31, 2019, by maturity are as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Lease liabilities<br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Lease liabilities<br> undiscounted<br> 2019</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less than one year</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="16%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="16%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 295</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between one and two years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between two and three years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between three and four years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 138</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 173</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between four and five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;081</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;419</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;485</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion of lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;295</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current portion of lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;190</div>
      </td>
    </tr>
    <tr>
      <td colspan="5" style="border-bottom: solid #000000 2px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At January 1, 2019 and December 31, 2019, there were no material future cash outflows, including extension options, excluded from the measurement of lease liabilities. The Group&#x2019;s most material lease with a lease term extension, representing a lease liability value of USD 0.6 billion, has a determined lease term end date of 2071.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, the Group completed sale and leaseback transactions for certain property, plant and equipment as part of its plans to consolidate sites. Transactions resulted in net cash inflows of USD 0.7 billion and the recognition of USD 96 million of lease liabilities, and USD 37 million of right-of-use assets. The right-of-use assets value reflects the proportion of the property, plant and equipment retained for a period of one to five years, with two five-year extension periods for certain right-of-use assets. The liabilities reflect the net present value of future lease payments. The net gain on the sale and leaseback transactions amounted to USD 478 million.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table provides additional disclosures related to right-of-use assets and lease liabilities of continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense on lease liabilities<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense on short-term leases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense on low-value leases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total cash outflows for leases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 339</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cash outflows for short-term leases  and low-value leases<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">   15</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Payments of interest<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 51</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Payments of lease liabilities<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 273</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The weighted average interest rate is 3.9%.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Cash flows from short-term and low-value leases are included within total net cash flows from operating activities. The portfolio of short-term leases to which the Group is committed to at December 31, 2019, is similar to the portfolio of short-term leases the Group entered into during 2019.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Included within total net cash flows from operating activities.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="4">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Reported as cash outflows used in financing activities net of lease incentives received of USD 33 million.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The net investment held and the income from subleasing right-of-use assets was not significant. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Note 30 provides additional disclosures on discontinued operations.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-42</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001560876"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">11. Goodwill and intangible assets</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of goodwill and intangible assets in 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div>
      </td>
      <td></td>
      <td colspan="13" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="13" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process<br> research and<br> development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Alcon <br> brand name</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Technologies</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently<br> marketed <br> products</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Marketing <br> know-how</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other<br> intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cost</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;700</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;980</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;253</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;412</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;960</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;253</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 69&nbsp;025</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to  discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;9&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;2&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;5&nbsp;369</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;4&nbsp;440</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;5&nbsp;960</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;572</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;19&nbsp;570</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale, net<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 342</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;550</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;914</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;069</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;069</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 265</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 259</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 767</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;544</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;436</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;055</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 335</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;825</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;429</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 884</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 43&nbsp;548</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 53&nbsp;419</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Accumulated amortization</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;406</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;758</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;21&nbsp;218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;906</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;30&nbsp;306</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated amortization/impairments  on assets related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4&nbsp;184</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2&nbsp;592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;906</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   128</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   8&nbsp;813</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization charge<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;42</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;657</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;137</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;836</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated impairments on disposals  and derecognitions<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   494</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   419</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   983</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;984</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;105</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;54</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;175</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;148</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;005</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;721</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;969</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;937</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;24&nbsp;632</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;579</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 621</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;787</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Represents the cost of assets and accumulated amortization at January 1, 2019, related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Note 2 provides additional disclosures related to assets of disposal group held for sale.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> No addition in the disposal group held for sale for the period from January 1, 2019 to December 31, 2019</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> No amortization or impairment charges related to the disposal group held for sale for the period from January 1, 2019, to December 31, 2019.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-43</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of goodwill and intangible assets in 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div>
      </td>
      <td></td>
      <td colspan="13" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="13" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process<br> research and<br> development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Alcon <br> brand name</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Technologies</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently<br> marketed <br> products</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Marketing <br> know-how</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other<br> intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cost</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;179</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;462</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;638</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;105</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;960</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;852</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 57&nbsp;997</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;276</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1&nbsp;116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1&nbsp;403</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;084</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;224</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;531</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;756</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 479</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 477</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 728</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 385</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;592</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;214</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;928</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;183</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;395</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;183</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;380</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;41</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;387</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;522</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;700</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;412</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;960</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 69&nbsp;025</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Accumulated amortization</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;429</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;268</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;19&nbsp;631</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;668</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;28&nbsp;000</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated amortization/impairments on assets related to disposal group held for sale<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   816</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   925</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization charge<sup style="white-space: nowrap">&nbsp;6</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;570</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;521</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;238</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;310</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;639</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated impairments on disposals  and derecognitions<sup>4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   209</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   791</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   257</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;257</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;825</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;049</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 152</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 200</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;406</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;120</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;758</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;21&nbsp;218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;906</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;30&nbsp;306</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;294</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;047</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;054</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 38&nbsp;719</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Note 2 provides additional disclosures related to assets of disposal group held for sale.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> No addition in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Impairment charges related to the disposal group held for sale for the write-down of the allocated goodwill were USD 183 million and for the currently marketed products were USD 37 million (thereof USD 9 million recognized for the period from January 1, 2018, to the date of reclassification to assets held for sale). For amortization related to discontinued operations, refer to Note 30.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;6&nbsp;</sup> Amortization related to the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 45 million.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process<br> research and<br> development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Technologies</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently<br> marketed <br> products</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other<br> intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;750</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;339</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;720</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 520</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27&nbsp;586</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;767</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 859</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;125</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;579</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 621</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;787</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-44</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2018:<sup>1</sup></div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="1" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div>
      </td>
      <td></td>
      <td colspan="13" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="1" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="13" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="1" height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process<br> research and<br> development</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Alcon <br> brand name</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Technologies</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently<br> marketed <br> products</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Marketing <br> know-how</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other<br> intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;551</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;377</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;228</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 431</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;042</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;837</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 419</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;115</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;875</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;899</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;851</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;054</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 363</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;679</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 123</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;294</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;047</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;054</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 38&nbsp;719</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Innovative Medicines and Sandoz Divisions&#x2019; cash-generating units, to which goodwill is allocated, each comprise a group of smaller cash-generating units. The valuation method of the recoverable amount of the cash-generating units, to which goodwill is allocated, is based on the fair value less costs of disposal. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following assumptions are used in the calculations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(As a percentage)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative <br> Medicines</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Sandoz</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Terminal growth rate</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discount rate (post-tax)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The discount rates for all divisions consider the Group&#x2019;s weighted average cost of capital, adjusted to approximate the weighted average cost of capital of a comparable market participant.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value less costs of disposal, for all groupings of cash-generating units containing goodwill, is reviewed for the impact of reasonably possible changes in key assumptions. In particular, we considered an increase in the discount rate, a decrease in the terminal growth rate, and certain negative impacts on the forecasted cash flows. These reasonably possible changes in key assumptions did not indicate an impairment.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">&#x201C;Note 1. Significant accounting policies&mdash;Impairment of goodwill and intangible assets&#x201D; provides additional disclosures on how the Group performs goodwill and intangible asset impairment testing.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the intangible asset and goodwill impairment charges for continuing operations for 2019, 2018 and 2017: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;669</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;591</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;506</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;175</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;841</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;652</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> 2019 includes an impairment of USD 416 million related to the write-down of IPR&amp;D acquired through the 2015 Spinifex Pharmaceuticals Inc. acquisition and USD 108 million write-down related to cessation of clinical development program MOR106 for atopic dermatitis.<br>2018 includes an impairment of USD 400 million related to a partial write-down of the <I>Votrient</I> currently marketed product.<br>2017 includes an impairment of USD 465 million related to the write-down of the Serelaxin IPR&amp;D.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> 2019 includes impairment of USD 442 million related to the write-down of IPR&amp;D related to the discontinuation of the generic Advair<sup>&#xAE;</sup> development program.<br>2018 includes impairments of USD 220 million related to the write-down of the allocated goodwill (USD 183 million) and the currently marketed products (USD 37 million) related to the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio. See Note 2.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the reversal of prior year impairment charges amounted to USD 37 million (2018: nil, 2017: nil).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Note 30 provides additional disclosures on discontinued operations.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-45</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001564398"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">12. Deferred tax assets and liabilities </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Property, <br> plant and<br> equipment</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Intangible<br> assets</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pensions and<br> other benefit <br> obligations <br> of associates</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Inventories</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Tax loss<br> carry-<br> forwards</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Other assets,<br> provisions<br> and accruals</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax assets at January 1, 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 191</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;233</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;188</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;722</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;175</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;782</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax liabilities at January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;622</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;805</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;558</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 915</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">At January 1, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 915</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net deferred tax balance related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;403</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;123</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 858</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Credited/(charged) to income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 605</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 308</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;818</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 298</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;166</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;83</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;313</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;289</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;45</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;282</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;141</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 787</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;271</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax assets at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;469</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;078</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;446</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;596</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;952</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax liabilities at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;390</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;610</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;291</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;287</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;910</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;282</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;141</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 787</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;271</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;909</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;867</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax assets at January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 137</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;287</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;090</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;786</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 97</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;380</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax liabilities at January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;613</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2&nbsp;985</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;455</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;003</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;319</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;476</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;331</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;061</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">At January 1, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;476</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;331</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;061</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net deferred tax balance related to disposal group held for sale</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Credited/(charged) to income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 378</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 368</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 582</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to equity</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;874</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 298</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;493</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;51</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 915</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax assets at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 191</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;722</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;175</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;782</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax liabilities at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;805</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;558</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;431</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;151</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 915</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;248</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;370</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;699</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;475</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.<b> </b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Includes USD 3 million net deferred tax movement related to disposal group held for sale</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-46</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table presents deferred tax assets and deferred tax liabilities, which are expected to have an impact on current taxes payable after more than 12&nbsp;months:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected to have an impact on current tax  payable after more than 12 months</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Deferred tax assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.9</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Deferred tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For unremitted earnings retained by consolidated entities for reinvestment, no provision is made for income taxes that would be payable upon the distribution of these earnings. If these earnings were remitted, an income tax charge could result based on the tax statutes currently in effect. </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unremitted earnings that have been retained  by consolidated entities for reinvestment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   61</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   73</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Temporary differences on which no deferred tax has been provided as they are permanent in nature related to:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investments in subsidiaries</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill from acquisitions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The gross value of tax-loss carry-forwards that have or have not been capitalized as deferred tax assets, with their expiry dates, is as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Not capitalized</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Capitalized</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One year</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Two years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Three years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Four years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 127</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">More than five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 435</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;684</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 648</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;986</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Not capitalized</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Capitalized</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One year</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Two years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Three years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Four years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 345</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 381</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">More than five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 522</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;288</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;810</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 996</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;341</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tax losses carried forward  that expired</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Deferred tax assets related to taxable losses of relevant Group entities are recognized to the extent it is considered probable that future taxable profits will be available against which such losses can be utilized in the foreseeable future.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The Basel-Stadt cantonal tax reform was approved by voters in February 2019, with parts of the reform retroactively enacted per January 1, 2019. The newly enacted tax rate resulted in a decrease of the blended cantonal and federal tax rate from 22% to 13%. This change impacts the Group&#x2019;s Basel-Stadt-domiciled operating subsidiaries. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Swiss federal tax reform was approved by voters in May 2019. The enactment of the Swiss federal tax reform requires the abolishment of the holding company tax regimes as of January 1, 2020. As a result, the holding company tax rate will increase from the current 8% to 13%, effective January 1, 2020. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The enactment of these Swiss tax reforms required a revaluation of the deferred tax assets and liabilities to the newly enacted tax rates at the date of enactment. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the impact on the revaluation of deferred assets and liabilities in 2019, as at the respective dates of the enactment of the Swiss tax reforms:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income <br> statement<br> continuing<br> operations</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Equity</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax asset  and liability revaluation</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized  in consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   234</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized  in other comprehensive income<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;358</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;358</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total revaluation of deferred  tax assets and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;358</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;124</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Related to post-employment benefits</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">On December 22, 2017, the US enacted tax reform legislation (the Tax Cuts and Jobs Act), which &ndash; among other provisions &ndash; reduced the US corporate tax rate from 35% to 21%, effective January 1, 2018. This required a revaluation of the deferred tax assets and liabilities, and a portion of current tax payables to the newly enacted tax rates at the date of enactment. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The enacted US tax reform legislation includes a provision that requires the US parent company&#x2019;s foreign subsidiaries&#x2019; unremitted earnings to be subject to an immediate toll tax on the qualifying amount of unremitted earnings (the deemed repatriated earnings). Previously, these earnings were taxable upon distribution to the US parent company. The toll tax amount owed is payable, without interest, in installments over an eight-year period through 2024. Certain of the Group&#x2019;s US subsidiaries are the parent company of non-US-domiciled companies, and as a result, USD 70 million of deferred tax liabilities related to these entities&#x2019; unremitted earnings, the majority of which were recognized in 2016, were reclassified to current income tax liabilities at December 31, 2017.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-47</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the impact on the revaluation of deferred assets and liabilities, and current income tax liabilities at December 31, 2017: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Income <br> statement<br> continuing<br> operations</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Equity</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax asset  and liability revaluation</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized  in consolidated income statement<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;440</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;440</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized  in other comprehensive income<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;254</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;254</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized  in retained earnings<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total revaluation of deferred  tax assets and liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;440</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;765</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total revaluation of current  tax payables<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total revaluation of deferred  tax assets and liabilities, and  current income tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     &ndash;&nbsp;474</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     &ndash;&nbsp;325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     &ndash;&nbsp;799</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Items previously recognized in discontinued operations amounted to USD 416 million</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Related to post-employment benefits and available-for-sale financial investments (attributable to continuing operations USD -241 million and attributable to discontinued operations USD -13 million)</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Related to equity-based compensation plans (attributable to continuing operations USD -66 million and attributable to discontinued operations USD -5 million)</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Revaluation of current tax payable attributable to discontinued operations amounted to USD -3 million.</div>
      </td>
    </tr>
  </table>
</div><a name="anchorId001567459"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">13. Financial and other non-current assets</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Financial assets</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;524</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;155</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;790</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;437</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term receivables from customers</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 164</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Minimum lease payments  from finance lease agreements<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   91</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term receivables from finance subleases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other long-term receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances and security deposits</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 254</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;518</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Note 30 provides additional disclosures on minimal lease payments from finance lease agreements that relate to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent considerations.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Other non-current assets</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred compensation plans</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 414</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 468</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid post-employment benefit plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 176</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 290</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 738</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 895</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-48</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001567727"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">14. Inventories</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Raw material, consumables</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 751</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 931</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Work in progress</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;087</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finished products</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;207</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;938</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;982</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;956</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the amount of inventory recognized as an expense in &#x201C;Cost of goods sold&#x201D; in the consolidated income statements from continuing operations: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.2</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the recognized amount of inventory provision and reversals of inventory provision recorded in the consolidated income statements from continuing operations:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventory provisions</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;752</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;603</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;416</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversals of inventory provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 218</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 216</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 172</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The reversals mainly result from the release of products initially requiring additional quality control inspections and from the reassessment of inventory values manufactured prior to regulatory approval but for which approval was subsequently received.</div><a name="anchorId001567906"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">15. Trade receivables</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total gross trade receivables</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;396</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;853</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movement in the provision for doubtful trade receivables:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;190</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;162</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of divestments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combination</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables charged to the consolidated income statement<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;89</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;119</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Utilization of provisions for doubtful trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of provisions for doubtful trade receivables credited to the consolidated income statement<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;190</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">  </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 30 million in 2018 and USD 94 million in 2017.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Reversal of provisions credited to the consolidated income statement from continuing operations were USD 44 million in 2018 and USD 60 million in 2017.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following sets forth the trade receivables that are not overdue as specified in the payment terms and conditions established with Novartis customers, as well as an analysis of overdue amounts and related provisions for doubtful trade receivables:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not overdue</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;763</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;916</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for not more than one month</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 296</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one month  but less than three months</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   123</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than three months  but less than six months</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   136</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than six months  but less than one year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   96</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   98</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 213</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-49</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trade receivable balances include sales to drug wholesalers, retailers, private health systems, government agencies, managed care providers, pharmacy benefit managers and government-supported healthcare systems. Novartis continues to monitor sovereign debt issues and economic conditions in the countries it operates, particularly in Argentina, Brazil, Greece, Italy, Portugal, Russia, Saudi Arabia, Spain and Turkey, and evaluates trade receivables in these countries for potential collection risks. The majority of the outstanding trade receivables from Portugal, Saudi Arabia and Spain are due directly from local governments or from government-funded entities. Deteriorating credit and economic conditions as well as other factors in these closely monitored countries have resulted in, and may continue to result in, an increase in the average length of time that it takes to collect these trade receivables, and may require the Group to re-evaluate the estimated collectible amount of these trade receivables in future periods.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the gross trade receivables balance from these closely monitored countries at December 31, 2019 and 2018; the amounts that are past due for more than one year; and the related provisions that have been recorded:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total balance of gross trade receivables from closely  monitored countries</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1&nbsp;588</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;729</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 97</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At December 31, 2019, amounts past due for more than one year are not significant in any of these countries on a standalone basis.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total trade receivables include amounts denominated in the following major currencies:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;466</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;510</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;384</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;551</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 466</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 658</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Russian ruble (RUB)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 247</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chinese yuan (CNY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 279</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 282</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">British pound (GBP)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 183</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Brazilian real (BRL)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 206</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canadian dollar (CAD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 136</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Australian dollar (AUD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 125</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 161</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 89</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other currencies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;655</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;693</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name="anchorId001568635"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">16. Marketable securities, commodities, time&nbsp;deposits, derivative financial instruments, and&nbsp;cash and cash equivalents</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Marketable securities, </font><font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">commodities, time&nbsp;deposits and derivative financial instruments</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity more than 90 days</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, commodities, time deposits and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 334</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;693</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides a breakdown of debt securities by currency:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 302</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total debt securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 325</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-50</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Cash and cash equivalents</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current accounts</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;247</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;121</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity less than 90 days</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;865</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;150</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name="anchorId001568877"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">17. Other current assets</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">VAT receivable</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 508</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 588</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Withholding tax recoverable</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid expenses</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Third parties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 898</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 811</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Receivables from associated companies</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other receivables and current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;165</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;360</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;680</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;861</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div><a name="anchorId001569003"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">18. Equity</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movement in the share capital:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Jan 1, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Movement<br> in year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Dec 31, 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Movement<br> in year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Dec 31, 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Movement<br> in year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> Dec 31, 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Share capital</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 972</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 969</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 944</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 936</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;80</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding share capital</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 896</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 869</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 875</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 856</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-51</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movement in the shares:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>Number of outstanding shares <br>(in millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br> Novartis <br> shares</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br> treasury <br> shares<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br> outstanding <br> shares</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> Novartis <br> shares</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> treasury <br> shares<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> outstanding <br> shares</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> Novartis <br> shares</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> treasury <br> shares<sup style="white-space: nowrap">   1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> outstanding <br> shares</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at beginning of year</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;550.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;239.4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616.8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;299.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;627.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;253.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="4%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;374.1</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares canceled for capital  reduction<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;66.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   66.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;10.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   10.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be  canceled<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;60.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;60.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;66.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;66.2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases<sup style="white-space: nowrap">&nbsp;4</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options  and employee transactions<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   18.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4.6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation<sup style="white-space: nowrap">&nbsp;5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon employees</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;23.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;22.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;66.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;46.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;56.6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at end of year</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;527.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;262.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;265.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;550.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;239.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;311.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;299.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="22" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Approximately 117.6 million treasury shares (2018: 121.6 million; 2017: 131.3 million) are held in Novartis entities that restrict their availability for use.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Novartis reduced its share capital by canceling shares that were repurchased on the SIX Swiss Exchange second trading line during previous years.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 Annual General Meeting (AGM) for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Shares acquired from employees, which were previously granted to them under the respective programs</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Shares delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="22">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">18.1) The amount available for distribution as a dividend to shareholders is based on the available distributable retained earnings of Novartis AG determined in accordance with the legal provisions of the Swiss Code of Obligations.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend per share (in CHF)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.85</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.75</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total dividend payment  (in USD billion)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   6.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   6.5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">18.2) The following table summarizes the treasury shares movements:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Number of <br> outstanding <br> shares<br> (in millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Equity impact<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Number of <br> outstanding <br> shares<br> (in millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Equity impact<br> USD m</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Number of <br> outstanding <br> shares<br> (in millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Equity impact<br> USD m</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be canceled<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;351</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;23.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;859</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;66.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="6%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;270</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;304</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of treasury shares</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;511</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;973</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;574</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 434</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 255</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation<sup style="white-space: nowrap">&nbsp;4,5</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 833</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 756</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon employees</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;450</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;520</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;56.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;707</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="16" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 AGM for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Shares acquired from employees, which were previously granted to them under the respective programs</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Shares delivered as a result of options being exercised related to equity-based participation plans and the delivery of treasury shares. The average share price of the shares delivered was significantly below market price, reflecting the strike price of the options exercised.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;4&nbsp;</sup> Equity-settled share-based compensation is expensed in the consolidated income statement in accordance with the vesting period of the share-based compensation plans. The value for the shares and options granted is credited to consolidated equity over the respective vesting period. In addition, tax benefits arising from tax-deductible amounts exceeding the expense recognized in the income statement are credited to equity.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;5&nbsp;</sup> Included in 2017 is a USD 71 million impact related to the revaluation of deferred tax assets on equity-based compensation that were previously recognized through retained earnings. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.3) In 2019, Novartis entered into an irrevocable, non-discretionary arrangement with a bank to repurchase Novartis shares on the second trading line under its up-to USD&nbsp;5 billion share buyback. Novartis was able to cancel this arrangement at any time but could be subject to a 90-day waiting period. The commitment under </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-52</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">this arrangement therefore reflects the obligated purchases by the bank under such trading plan over a rolling 90-day period, or if shorter, until the maturity date of such trading plan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2019, this trading plan commitment was fully executed and expired, and as a consequence, there is no contingent liability related to this plan recognized.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018 and 2017, Novartis entered into a similar irrevocable, non-discretionary arrangements with a bank to repurchase Novartis shares. The commitments under these arrangements reflected the expected purchases by the bank under such trading plans over a rolling 90-day period. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The commitment under this arrangement amounted to USD 284 million as of December 31, 2018. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2017, this trading plan commitment was fully executed and expired, and as a consequence, there was no contingent liability related to this plan recognized.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.4) Transaction costs of USD 253 million (2018: USD 79 million; 2017: USD nil) net of tax of USD 36 million (2018: USD 20 million; 2017: USD nil), that are directly attributable to the distribution (spin-off) of Alcon Inc. to Novartis shareholders and that would otherwise have been avoided, are recorded as a deduction from equity. See Note 1.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.5) The impact of change in ownership of consolidated entities represents the excess of the amount paid to non-controlling interest over their carrying value and equity allocation to non-controlling interest due to change in ownership percentage. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.6) Changes in non-controlling interests represent the impact on the non-controlling interest of transactions with minority shareholders, such as change in ownership percentage, dividend payments and other equity transactions.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.7) Other movements includes, for subsidiaries in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period as well as the restatement of the equity balances of the current year. In 2019, the amount recorded in equity related to hyperinflation accounting was USD 22 million (2018: USD 38 million; 2017: USD nil). See Note 29 for additional disclosures.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.8) At December 31, 2019, the market maker held 13 million (2018: 11 million; 2017: 12 million) written call options, originally issued as part of the share-based compensation for associates, that have not yet been exercised. The weighted average exercise price of these options is USD 63.90 (2018: USD 62.70; 2017: USD 62.17), and they have contractual lives of 10 years, with remaining lives up to four years (2018: five years; 2017: six years). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In December 2018, Novartis entered into an agreement with the market maker for its employee options to repurchase a portion of the outstanding written call options that are not exercised in exchange for treasury shares. During 2019, this agreement was fully executed.</div><a name="anchorId001571015"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">19. Non-current financial debt</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities to banks and other financial institutions<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 285</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finance lease obligations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total, including current portion of non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion of non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;190</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Average interest rate 0.2% (2018: 0.3%)</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All bonds are initially recorded at the amount of proceeds received, net of transaction costs. They are subsequently carried at amortized cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognized as a charge to the consolidated income statement over the period of the relevant bond. Financial debts, including current financial debts, contain only general default covenants. The Group is in compliance with these covenants.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The percentage of fixed-rate financial debt to total financial debt was 82% at December 31, 2019, and 80% at December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The average interest rate on total financial debt in 2019 was 2.4% (2018: 2.7%).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 29 contains a maturity table of the Group&#x2019;s future contractual interest payments commitments.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-53</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides a breakdown of straight bonds:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>Coupon</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Nominal <br> amount</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Issuance <br> year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Maturity <br> year</div>
      </td>
      <td></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Issuer</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Issue price</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<br> (USD<br> millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018<br> (USD<br> millions)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">5.125%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2009</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Securities Investment Ltd., Hamilton, Bermuda</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.822%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.400%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2010</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.237%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 998</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2.400%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.225%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;495</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;493</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.700%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2042</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.325%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 489</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 489</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.400%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2024</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.287%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;137</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.400%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;850</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2044</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.196%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;825</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;825</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.750%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.134%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 683</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.625%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2026</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.697%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 684</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.250%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2025</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.640%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 517</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 508</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.625%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 550</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2029</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.502%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 568</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 558</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.050%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 325</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2035</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.479%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 330</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.000%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2025</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.010%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;735</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;732</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.000%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2045</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.029%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;219</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;219</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.125%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.127%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;392</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;419</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.625%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2028</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.480%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 553</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 563</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.800%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.609%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 998</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2.400%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.449%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 996</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 995</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.100%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2027</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.109%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 990</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 989</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.000%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.133%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;396</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;421</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.125%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2027</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.874%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 684</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.500%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.655%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 837</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 853</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.375%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2030</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.957%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 838</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 856</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.700%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2038</div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.217%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 832</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 849</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total straight bonds</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td>
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;283</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables provide a breakdown of total non-current financial debt, including current portion by maturity and currency:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Breakdown by maturity:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;006</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;067</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;111</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;583</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;585</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;321</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;278</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;139</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;137</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After 2024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;353</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Breakdown by currency:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;889</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;964</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;861</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;028</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 184</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 272</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;421</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;396</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the comparison of balance sheet and fair value of total non-current financial debt, including current portion:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<br> Balance<br> sheet</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<br> Fair<br> values</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018<br> Balance<br> sheet</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018<br> Fair<br> values</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;701</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;438</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 377</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 377</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;889</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;815</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The fair values of straight bonds are determined by quoted market prices. Other financial debts are recorded at notional amounts, which are a reasonable approximation of the fair values.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the pledged assets:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total net book value of property,  plant and equipment pledged as  collateral for non-current financial debts</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     96</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-54</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001572683"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">20. Provisions and other non-current liabilities</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued liability for employee benefits:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Defined benefit pension plans<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;469</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;546</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other long-term employee benefits and deferred compensation</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 546</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 600</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other post-employment benefits<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Environmental remediation provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 634</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for product liabilities, governmental investigations and other legal matters</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 214</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 958</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 255</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 497</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total provisions and other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;632</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;319</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Note 25 provides additional disclosures related to post-employment benefits.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent consideration.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis believes that its total provisions are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities in this area, Novartis may incur additional costs beyond the amounts provided. Management believes that such additional amounts, if any, would not be material to the Group&#x2019;s financial condition but could be material to the results of operations or cash flows in a given period.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Environmental remediation provisions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movements in the environmental liability provisions:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 692</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 761</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 773</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;48</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;83</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp; 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;153</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 154</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 714</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 692</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 761</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current provision</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;55</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current environmental remediation provisions at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     592</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     634</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     706</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">  </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Releases of provisions credited to the consolidated income statement from continuing operations were USD 21 million in 2018 and USD 153 million in 2017.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 7 million in 2018 and USD 154 million in 2017.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The material components of the environmental remediation provisions consist of costs to sufficiently clean and refurbish contaminated sites to the extent necessary and to continue surveillance at sites where the environmental remediation exposure is less significant. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A substantial portion of the environmental remediation provisions relate to the remediation of Basel regional landfills in the adjacent border areas in Switzerland, Germany and France. The provisions are reassessed on a yearly basis and adjusted as necessary.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the United States, Novartis has been named under federal legislation (the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended) as a potentially responsible party (PRP) in respect of certain sites. Novartis actively participates in, or monitors, the cleanup activities at the sites in which it is a PRP. The provision takes into consideration the number of other PRPs at each site as well as the identity and financial position of such parties in light of the joint and several nature of the liability. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The expected timing of the related cash outflows as of December 31, 2019, is currently projected as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Expected <br> cash outflows</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due within two years</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 141</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due later than two years, but within five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due later than five years, but within 10 years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 258</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due after 10 years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 105</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total environmental remediation liability provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 714</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Provisions for product liabilities, governmental investigations and other legal matters</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has established provisions for certain product liabilities, governmental investigations and other legal matters where a potential cash outflow is probable and Novartis can make a reliable estimate of the amount of the outflow. These provisions represent the Group&#x2019;s current best estimate of the total financial effect for the matters described below and for other less significant matters. Potential cash outflows reflected in a provision might be fully or partially offset by insurance in certain circumstances.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has not established provisions for potential damage awards for certain additional legal claims against its subsidiaries if Novartis currently believes that a payment is either not probable or cannot be reliably estimated. In total, these not-provisioned-for matters include more than 3&#xA0;000 individual product liability cases and certain other legal matters. Plaintiffs&#x2019; alleged claims in these matters, which Novartis does not believe to be entirely remote but which do not fulfill the conditions for the establishment of provisions, currently aggregate to, according to the current best belief of Novartis, approximately USD&nbsp;0.9 billion. In addition, in some of these matters there are claims for punitive or multiple (treble) dam-</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-55</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">ages, civil penalties and disgorgement of profits that in the view of Novartis are either wholly or partially unspecified, or wholly or partially unquantifiable at present; the Group believes that information about these amounts claimed by plaintiffs generally is not meaningful for purposes of determining a reliable estimate of a loss that is probable or more than remote.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A number of other legal matters are in such early stages or the issues presented are such that the Group has not made any provisions since it cannot currently estimate either a potential outcome or the amount of any potential losses. For these reasons, among others, the Group generally is unable to make a reliable estimate of possible loss with respect to such cases. It is therefore not practicable to provide information about the potential financial impact of those cases.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There might also be cases for which the Group was able to make a reliable estimate of the possible loss or the range of possible loss, but the Group believes that publication of such information on a case-by-case basis would seriously prejudice the Group&#x2019;s position in ongoing legal proceedings or in any related settlement discussions. Accordingly, in such cases, information has been disclosed with respect to the nature of the contingency, but no disclosure is provided as to an estimate of the possible loss or range of possible loss.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 28 contains additional information on contingencies.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Alcon spin-off </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On April 9, 2019, the Alcon spin-off was completed (see Note 2). Under the Separation and Distribution Agreement that Novartis entered into with Alcon in connection with the separation and the spin-off, Novartis and Alcon each agreed, subject to certain conditions and exclusions, and except to the extent otherwise described below with respect to any matter, to indemnify the other party and its directors, officers, employees and agents against any pending or future liabilities that constitute either a Novartis liability, in the case of Novartis, or an Alcon liability, in the case of Alcon, with the nature of any relevant liability being determined based on whether such claim or liability relates to the Novartis or the Alcon business and products. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Summary of significant legal proceedings</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary of significant legal proceedings to which Novartis or its subsidiaries are a party or were a party and that concluded in 2019.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Investigations and related litigations</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Southern District of New York (S.D.N.Y.) marketing practices investigation and litigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2013, the US government filed a civil complaint in intervention to an individual <i>qui tam</i> action against Novartis Pharmaceuticals Corporation (NPC) in the United States District Court (USDC) for the S.D.N.Y. The complaint, as subsequently amended, asserts federal False Claims Act (FCA) and common law claims with respect to speaker programs and other promotional activities for certain NPC cardiovascular medications (<i>Lotrel</i>, <i>Starlix</i> and <i>Valturna</i>) allegedly serving as mechanisms to provide kickbacks to healthcare professionals (HCPs). Also in 2013, New York State filed a civil complaint in intervention asserting similar claims. Neither government complaint in intervention adopted the individual relator&#x2019;s claims with respect to off-label promotion of <i>Valturna</i>, which were subsequently dismissed with prejudice by the court. The individual relator continues to litigate the kickback claims on behalf of other states and municipalities. Novartis is engaged in settlement discussions to resolve the above-described claims, and recorded a provision in the amount of USD 0.7 billion in 2019 in the Innovative Medicines Division.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">S.D.N.Y. Gilenya marketing practices investigation and litigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2013, NPC received a civil investigative demand from the United States Attorney&#x2019;s Office (USAO) for the S.D.N.Y. requesting the production of documents and information relating to marketing practices for <i>Gilenya</i>, including the remuneration of healthcare providers in connection therewith. In 2017, the S.D.N.Y. and New York State declined to intervene in claims raised by an individual relator in a <i>qui tam</i> complaint, which continue to be vigorously contested.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Government generic pricing antitrust investigations, antitrust class actions</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Since 2016, Sandoz Inc. has received grand jury subpoenas and a civil investigative demand and interrogatories from the Antitrust and Civil Divisions of the US Department of Justice (DoJ), and a subpoena and interrogatories from the Attorney General of the State of Connecticut in connection with alleged price fixing and market allocation of generic drugs in the US market as well as alleged FCA violations. The requests are for documents related to the marketing and pricing of generic pharmaceutical products sold by Sandoz Inc. and its subsidiary, Fougera Pharmaceuticals Inc. (Fougera), and related communications with competitors. Sandoz Inc. is cooperating with these investigations, which it believes to be part of a broader inquiry into industry practice.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Since the third quarter of 2016, Sandoz Inc. and Fougera have been sued alongside other generic pharmaceutical companies in numerous individual and putative class action complaints by direct and indirect purchasers and Attorneys General for 54 states and territories. Plaintiffs claim that defendants, including Sandoz, engaged in price fixing and market allocation of generic drugs in the US market, and seek damages and injunctive relief. The actions contain product-specific complaints as well as complaints alleging the existence of an overarching industry conspiracy, and assert violations of federal and state antitrust laws as well as consumer protection laws. The cases have been consolidated for pretrial purposes in the USDC for the Eastern District of Pennsylvania (E.D. Pa.), and the claims are being vigorously contested.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Asia/Russia investigation</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2017 and 2018, Alcon and Novartis Group companies received document requests and subpoenas from the DoJ and the US Securities and Exchange Commission (SEC) requesting information concerning Alcon accounting, internal controls and business practices in Asia and </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-56</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Russia, including revenue recognition for surgical equipment and related products and services, as well as relationships with third-party distributors, both before and after Alcon became part of the Novartis Group. Alcon and Novartis are cooperating with this investigation. Pursuant to the terms of the Separation and Distribution Agreement, and subject to the conditions and exclusions therein, Novartis will indemnify Alcon in respect of certain fines or other monetary penalties that arise out of the investigations by the DoJ and the SEC at the time of the separation. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Lucentis/Avastin<sup>&#xAE;</sup> matters</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In connection with an investigation into whether Novartis entities, F. Hoffmann-La Roche AG, Genentech Inc. and Roche S.p.A. colluded to artificially preserve the market positions of Avastin<sup>&#xAE;</sup> and <i>Lucentis</i>, in 2014 the Italian Competition Authority (ICA) imposed a fine equivalent to USD 125 million on the Novartis entities. Novartis paid the fine, subject to the right to later claim recoupment, and appealed before the Consiglio di Stato (CdS). In 2014 and 2015, the Italian Ministry of Health and the Lombardia region sent letters with payment requests for a total equivalent of approximately USD&nbsp;1.3 billion in damages from Novartis and Roche entities based on the above allegations. In 2019, the CdS upheld the ICA decision and fine. Following the CdS decision, several additional Italian regions and hospitals sent letters claiming damages for an aggregate amount of approximately USD 330 million. None of these claims has been asserted in legal proceedings.  Novartis has filed a further appeal of the CdS decision. In 2019, the French Competition Authority (FCA) issued a Statement of Objections against Novartis entities alleging anti-competitive practices on the French market for anti-vascular endothelial growth factor treatments for wet age-related macular degeneration from 2008 to 2013, and is expected to issue its final decision in the course of 2020. Novartis continues to vigorously contest all claims in Italy and France. Also, Novartis is challenging policies and regulations allowing off-label/unlicensed use and reimbursement for economic reasons in various countries, including Italy, the UK, Turkey and Brazil.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Japan investigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015, a trial started against a former Novartis Pharma K.K. (NPKK) employee, and also against NPKK under the dual liability concept in Japanese law, over allegations brought by the Tokyo District Public Prosecutor Office for alleged manipulation of data in sub-analysis publications of the Kyoto Heart Study regarding valsartan. The charges against NPKK are subject to a maximum total fine of JPY 4 million. In 2018, the Tokyo High Court upheld a not-guilty ruling of the Tokyo District Court for both the former NPKK employee and NPKK. A further appeal by the Tokyo District Public Prosecutor Office remains pending.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">South Korea investigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2016, the Seoul Western District Prosecutor initiated a criminal investigation into, among other things, allegations that Novartis Korea utilized medical journals to provide inappropriate economic benefits to HCPs, which resulted in a non-material fine in January 2020. Novartis has received requests for information from the DoJ and the SEC regarding this matter, and is cooperating with their ongoing inquiry.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Greece investigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis is investigating allegations of potentially inappropriate economic benefits to HCPs, government officials and others in Greece. Novartis is providing information to the Greek authorities investigating these allegations, including the Greek Coordinating Body for Inspection and Control, and the Greek Body of Prosecution of Financial Crime, from which it received a summons in 2018. Novartis is also responding to subpoenas and document requests from the SEC and DoJ that it received beginning in 2016 in connection with such allegations, and is cooperating with their investigation.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Antitrust class actions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Enoxaparin</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015, Sandoz and Momenta Pharmaceuticals were sued in a putative antitrust class action in federal court in Tennessee alleging that Momenta and Sandoz engaged in anticompetitive and unfair business conduct with regard to sales of enoxaparin. The same allegations were made by Amphastar in a lawsuit filed in federal court in California and subsequently moved to federal court in Massachusetts. In 2019, Sandoz resolved both matters, with Sandoz agreeing to pay USD 85 million to resolve the Tennessee class action and paying Amphastar approximately USD 39 million to resolve the Massachusetts case. The class action settlement is contingent upon, among other conditions, court approval and the class participants not exceeding an opt-out threshold. Sandoz, Momenta and Amphastar were also engaged in patent litigation concerning enoxaparin that concluded in June 2019. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Exforge</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Since 2018, Novartis Group companies as well as other pharmaceutical companies have been sued by various direct and indirect purchasers of <i>Exforge</i> in multiple US individual and putative class action complaints. They claim that Novartis made a reverse payment in the form of an agreement not to launch an authorized generic, alleging violations of federal antitrust law and state antitrust, consumer protection and common laws, and seeking damages as well as injunctive relief. The cases have been consolidated in the S.D.N.Y. and the claims are being vigorously contested.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Product liability litigation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Reclast </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">NPC is a defendant in more than 20 US product liability actions involving <i>Reclast</i> and alleging atypical femur fracture injuries, all of which are in New Jersey state or federal court and in California state court, coordinated with claims against other bisphosphonate manufacturers. The claims are being vigorously contested.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-57</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Taxotere<sup>&#xAE;</sup> (docetaxel)</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz is a defendant in more than 2&#xA0;900 US product liability actions involving Taxotere<sup>&#xAE;</sup> (docetaxel), an oncology product, many of which have been transferred to Multidistrict Litigation in the Eastern District of Louisiana. The complaints allege misleading marketing and that Sanofi, as innovator, and several 505(b)(2) NDA holders (including Sandoz) failed to warn of the risk of permanent alopecia/hair loss. The claims are being vigorously contested.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Amiodarone</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz entities are named in more than 10 individual and multi-plaintiff US product liability cases involving amiodarone, a cardiac drug indicated to treat life-threatening arrhythmias that have not responded to other treatment. The complaints allege failure to warn, off-label promotion and failure to include medication guides to pharmacies. The claims are being vigorously contested.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Sartans and Ranitidine</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Since 2018, claims have been brought against Sandoz and other pharmaceutical companies alleging injury from carcinogenic impurities found in valsartan and valsartan/HCT film-coated tablets and/or losartan marketed or manufactured by Sandoz, including several putative class actions in Canada and a Multidistrict Litigation in New Jersey.  Claims have also been brought alleging injury from carcinogenic impurities in ranitidine-containing medicines, including several putative class actions in Canada.  All of these claims are being vigorously contested.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Other matters</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Average Wholesale Price (AWP) litigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Lawsuits have been brought, the latest in February 2016, by various US state governmental entities and private parties against various pharmaceutical companies, including NPC, alleging that they fraudulently overstated the AWP that is or has been used by payors, including state Medicaid agencies, to calculate reimbursements to healthcare providers. NPC remains a defendant in a putative class action brought by private payors in New Jersey, and vigorously contests those claims. NPC resolved an action brought by the state of Illinois for approximately USD 21 million.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Aimovig&ndash;Amgen Dispute</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015 and 2017, Novartis and Amgen entered into agreements regarding the development and commercialization of <i>Aimovig</i>, which the companies co-commercialize in the US and to which Novartis has exclusive rights in all territories outside of the US, excluding Japan. Amgen issued a termination notice in April 2019, based on an alleged material breach of the collaboration agreements, and this notice, as well as other ancillary matters, are the subject of legal proceedings between Novartis and Amgen. Novartis disputes Amgen&#x2019;s allegations vigorously. The collaboration continues during the litigation between the companies, and will remain in force until and unless a final court decision terminates the agreements.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Concluded legal matters</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">District of Massachusetts (D. Mass.) charitable foundation investigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2016 and 2017, NPC received subpoenas from the USAO for the D. Mass. requesting documents related to NPC&#x2019;s support of 501(c)(3) organizations that provide copayment assistance to Medicare patients who are prescribed Novartis medicines, including the respective accounting and tax treatment, as well as related to pricing strategies for <i>Gleevec</i>, <i>Tasigna</i>, <i>Zometa</i> and <i>Gilenya</i>. In 2018, NPC agreed to a settlement in principle to pay USD 23 million to resolve the investigation into potential violations of federal healthcare laws, including the Anti-Kickback Statute and FCA. In 2019, NPC agreed in principle to pay an additional USD 28 million to resolve related allegations. These settlements are subject to mutually agreeable terms and finalization of the documentation. Novartis considers this matter concluded for the purpose of reporting legal proceedings.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">MIVS platform patent infringement litigation</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015, Johns Hopkins University (JHU) filed a patent infringement lawsuit against certain Alcon entities alleging that the use of certain Alcon surgical products, principally by third parties, infringes a patent directed to certain methods of ocular surgery. In 2019, JHU and Alcon entered into a confidential resolution of the litigation. Novartis considers this matter concluded.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Summary of product liability, governmental investigations and other legal matters provision movements</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 340</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 351</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to  discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases of provisions<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to provisions<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 220</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;369</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 340</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 351</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;121</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current product  liabilities, governmental  investigations and other  legal matters provisions  at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">         200</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">         214</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">         230</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Releases of provisions credited to the consolidated income statement from continuing operations were USD 107 million in 2018 and USD 63 million in 2017.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 220 million in 2018 and USD 47 million in 2017.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis believes that its total provisions for investigations, product liability, arbitration and other legal matters are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities, there can be no assurance that additional liabilities and costs will not be incurred beyond the amounts provided.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-58</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001573684"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">21. Current financial debt and&nbsp;derivative&nbsp;financial&nbsp;instruments</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest-bearing accounts of associates  payable on demand<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;836</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;778</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bank and other financial debt<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 719</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 701</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commercial paper</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;289</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;951</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value of derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt and derivative  financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   7&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   9&nbsp;678</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Weighted average interest rate 0.5% (2018: 0.5%)</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Weighted average interest rate 12.9% (2018: 9.6%)</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated balance sheet amounts of current financial debt, other than the current portion of non-current financial debt, approximate the estimated fair value due to the short-term nature of these instruments.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Details on commercial papers and short term borrowings are provided under &#x201C;Liquidity risk&#x201D; in Note&nbsp;29.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"> </div><a name="anchorId001573842"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">22. Provisions and other current liabilities</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes other than income taxes</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 471</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 528</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Restructuring provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 507</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued expenses for goods and services received but not invoiced</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;046</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 970</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accruals for royalties</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 653</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 651</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interests on financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 156</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for deductions from revenue</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;595</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;262</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accruals for compensation and benefits, including social security</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;464</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;527</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Environmental remediation liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 114</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 236</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for product liabilities, governmental investigations and other legal matters<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued share-based payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 326</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent considerations<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commitment for repurchase of own shares<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 284</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 764</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 673</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total provisions and other current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;338</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;284</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Note 20 provides additional disclosures related to legal provisions.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent considerations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Note 18 provides additional disclosures related to commitment for repurchase of own shares.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Provisions are based upon management&#x2019;s best estimate and adjusted for actual experience. Such adjustments to the historic estimates have not been material.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-59</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Provisions for deductions from revenue</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movement of the provisions for deductions from revenue:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement charge<sup>2</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
      <td height="1"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Revenue<br> deductions<br> provisions at<br> January 1</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Revenue <br> deductions <br> provisions<br> related to <br> discontinued <br> operations<sup>1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Effect of<br> currency<br> translation <br> and business<br> combinations</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Payments/<br> utilizations</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Adjustments<br> of prior years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> <br> Current year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Change in <br> provisions<br> offset against<br> gross trade<br> receivables</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Revenue<br> deductions<br> provisions at<br> December 31</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans  and program rebates</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;883</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;5&nbsp;183</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;193</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   5&nbsp;474</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;981</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans  and program rebates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;625</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;2&nbsp;467</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2&nbsp;659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;769</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans  and program-related rebates, returns and other deductions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1&nbsp;754</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;166</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;11&nbsp;698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     11&nbsp;868</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1&nbsp;845</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;262</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;194</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;19&nbsp;348</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;220</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;595</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans  and program rebates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;4&nbsp;158</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;90</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4&nbsp;541</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;883</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans  and program rebates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;356</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;78</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;2&nbsp;182</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   83</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;555</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;109</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;625</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans  and program-related rebates, returns and other deductions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;726</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;51</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;12&nbsp;227</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;91</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     11&nbsp;956</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     441</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;754</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;672</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;18&nbsp;567</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 19&nbsp;052</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 332</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;262</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans  and program rebates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;461</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;3&nbsp;684</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   3&nbsp;875</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;590</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans  and program rebates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;020</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   131</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1&nbsp;954</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   80</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   1&nbsp;356</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans  and program-related rebates, returns and other deductions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;702</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;11&nbsp;814</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;127</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     12&nbsp;045</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     1&nbsp;726</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;183</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;17&nbsp;452</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;109</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;106</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;252</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;672</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="18">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Charges to the consolidated income statement from continuing operations were USD 18 248 million in 2018 and USD 17 772 million in 2017.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Restructuring provisions movements</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 507</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 222</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to  discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &#x2013;&#x2005;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 492</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 534</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;479</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;200</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;72</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;64</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transfers</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005; 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 507</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">   </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 521 million in 2018 and USD 186 million in 2017.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Reversal of provisions credited to the consolidated income statement from continuing operations were USD 31 million in 2018 and USD 59 million in 2017.</div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, additions to provisions of USD&nbsp;492 million were mainly related to the following reorganizations:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Innovative Medicines Division restructured its field force and supporting functions in Latin America, and following the <i>Xiidra</i> acquisition, its Ophthalmology field force in the US.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Sandoz Division initiatives to realign its organizational structures to improve competiveness. These initiatives include reduction in its headquarters, global functions and countries workforce, and the closure of its development center in Holzkirchen, Germany. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group-wide initiatives to streamline Novartis Technical Operations and implement new technologies, mainly in the Innovative Medicines Division and in the Sandoz Division, continued. In addition, Novartis Business Services launched the next phase of the new operating model to change outsourcing structures and transition activities to service centers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, additions to provisions of USD 534 million were mainly related to the following reorganizations:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Innovative Medicines Division&#x2019;s Oncology business unit initiative to streamline its organizational structure. The objective was to enhance agility and efficiency, </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-60</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;">resulting in an acceleration of operational execution. In addition, a program to reorganize the Japanese business model was launched. Region Europe transformed its approach to market in light of the changing product portfolio. The objective was to speed up patient access.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group-wide initiatives to streamline Novartis Technical Operations and implement new technologies, mainly in the Innovative Medicines Division and in the Sandoz Division, continued. In addition, Novartis Business Services launched an initiative to reorganize its organizational structure to achieve cost efficiencies by shifting activities to global service centers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">In 2017, additions to provisions of USD&nbsp;194 million were mainly related to the following reorganizations:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Innovative Medicines Division&#x2019;s Pharmaceuticals business unit adjusted a regional promotional model, which led to a restructuring of the sales force. It also streamlined the above country operating model to facilitate an even higher external competition-oriented focus. Furthermore, the development organization streamlined its activities to create efficiencies.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The former Alcon Division continued initiatives to realign its operations to focus on the Surgical and Vision Care businesses after the Ophthalmic Pharmaceuticals business transfer to the Innovative Medicines Division.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Sandoz Division launched initiatives to focus resources to gain efficiencies.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group-wide initiatives to streamline Novartis Technical Operations in the Innovative Medicines and Sandoz Divisions were launched.</div><a name="anchorId001575860"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"><b>23. Details to the consolidated statements of cash flows</b></div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.1) Reversal of non-cash items and other adjustments from continuing operations</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation, amortization and impairments on:</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;547</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;783</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;460</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 305</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;974</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;428</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;276</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;38</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 227</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-cash change in provisions and other non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;871</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 895</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 86</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gains on disposal and other adjustments on property, plant and equipment; intangible assets;  financial assets; and other non-current assets, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;1&nbsp;234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;902</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1&nbsp;077</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-settled compensation expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 758</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 673</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;659</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6&nbsp;438</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;108</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;295</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;603</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net financial expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 805</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 746</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 708</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;486</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;787</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Includes fair value adjustments</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> 2018 includes a reversal of a pre-tax gain (USD 5.8 billion) recognized from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). The net cash proceed of USD 13.0 billion from the divestment was included in the consolidated statements of cash flows in the line "Acquisitions and divestments of interests in associated companies, net."</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.2) Total amount of taxes paid </font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the total amount of taxes paid was USD&nbsp;2.0 billion (2018: USD&nbsp;1.8 billion, 2017: USD&nbsp;1.6 billion), of which USD&nbsp;1.9 billion (2018: USD&nbsp;1.5 billion, 2017: USD&nbsp;1.5 billion) was included within "Net cash flows from operating activities from continuing operations", USD&nbsp;38 million (2018: USD&nbsp;164 million, 2017: USD&nbsp;124 million) was included within "Net cash flows from operating activities from discontinued operations," and USD&nbsp;79 million (2018: nil, 2017: nil) was included within "Net cash flows used in investing activities from discontinued operations." In 2018, USD&nbsp;139 million (2019: nil, 2017: nil) was included within "Net cash flows used in investing activities from continuing operations."</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-61</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.3) Cash flows from changes in working capital and other operating items included in the net cash flows from operating activities from continuing operations</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">(Increase) in inventories</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;382</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;387</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;203</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">(Increase) in trade receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;544</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;655</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in trade payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 553</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 252</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 316</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;303</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 941</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;410</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other adjustments, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 199</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 576</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 332</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.4) Cash flows arising from acquisitions and divestments of interests in associated companies</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, acquisitions and divestments of interests in associated companies included USD 12&#xA0;855 million net of taxes (USD 12&#xA0;994 million before taxes) from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.5) Cash flows arising from acquisitions and divestments of businesses, net</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary of the cash flow impact of acquisitions and divestments. The most significant transactions are described in Note 2.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets recognized as a result of business combinations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;124</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;660</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;874</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value of previously held equity interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Receivables and payables contingent consideration, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 242</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 151</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments, deferred consideration and other adjustments, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;36</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows used for acquisitions of businesses</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;851</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;701</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;759</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows from divestments of businesses, net<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 91</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 45</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows used for acquisitions and divestments of businesses, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;760</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;683</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;714</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> In 2019, the USD 91 million included USD 4 million net cash outflows from previous years divestments and USD 95 million net cash inflows from business divestments in 2019. The net identifiable assets of the 2019 divested businesses amounted to USD 196 million, comprised of non-current asset of USD 159 million, current assets of USD 96 million including USD 11 million cash and cash equivalents, non-current liabilities USD 18 million and current liabilities of USD 41 million.<br>In 2018, USD 18 million represented the net cash inflows from previous years divestments.<br>In 2017, the USD 45 million net cash inflows related to the net identifiable assets from a 2017 divestment. The 2017 divested business amounted to USD 48 million, comprised of non-current assets of USD 29 million, current assets of USD 34 million and current liabilities of USD 15 million.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Notes 2 and 24 provide further information regarding acquisitions and divestments of businesses. All acquisitions were for cash.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-62</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.6) Reconciliation of liabilities arising from financing activities</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Non-current <br> financial <br> debts</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br> financial <br> debts and <br> derivative <br> financial <br> instruments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Non-current <br> lease liabilities</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> Current lease <br> liabilities</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;470</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;678</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 16 Leases continuing operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;471</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 268</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 16 Leases discontinued operations<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;89</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and lease liabilities related to discontinued operations<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;246</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;195</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;582</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments of lease liabilities, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;273</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest payments for amounts included in lease liabilities  classified as cash flows from operating activities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;51</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">New leases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 362</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 131</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations and divestments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;141</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification from non-current to current, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;003</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;003</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;156</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;031</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;703</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 246</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Lease liabilties recognized on January 1, 2019, the date of implementation of IFRS 16 Leases. Note 10 provides additional disclosure.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> In 2018, financial debts included USD 89 million for previously reported finance lease obligations of the Alcon business that have been reclassified on January 1, 2019, to lease liabilities, with the adoption of IFRS 16 Leases. Note 30 provides additional disclosures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Represents the financial debts and lease liabilities at January 1, 2019, related to the Alcon business reported as discontinued operations. See Notes 1, 2 and 30.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Non-current <br> financial <br> debts</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> <br> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br> financial <br> debts and <br> derivative <br> financial <br> instruments</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> <br> </div>
      </td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;224</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;308</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;856</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;366</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;681</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;48</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;462</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;93</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3&nbsp;190</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;678</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations.  </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations.  </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 1 687 million.  </div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-63</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Non-current <br> financial <br> debts</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> <br> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br> financial <br> debts and <br> derivative <br> financial <br> instruments</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> <br> <br> </div>
      </td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2017</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;897</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;905</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;933</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;187</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;755</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;140</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 744</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;359</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 359</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2017</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;224</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;308</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations.  </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations.  </div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 644 million.  </div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For net cash flows used in investing activities from discontinued operations, see Note 30.</div><a name="anchorId001577644"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">24. Acquisitions of businesses</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Fair value of assets and liabilities arising from acquisitions</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;550</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;531</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquired research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 342</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;224</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;223</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 381</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 195</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables and other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;107</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;874</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;325</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables and other liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;178</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;627</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net identifiable assets acquired</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;938</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;000</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 925</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;112</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;20</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;084</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 94</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets recognized as a result of business combinations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;124</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;946</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 999</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Net assets recognized as a result of business combinations in the consolidated balance sheet from continuing operations were USD 13 660 million in 2018 and USD 874 million in 2017.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Note 2 details significant acquisitions of businesses, specifically, <i>Xiidra</i> and IFM Tre, Inc. in 2019; AAA, AveXis and Endocyte in 2018; and Ziarco and Encore in 2017. The goodwill arising out of these acquisitions is attributable to the growth platform, the assembled workforce, and the accounting for deferred tax liabilities on the acquired assets. Goodwill of USD&nbsp;98 million from 2019 is tax deductible. No goodwill from 2018 and 2017 is tax-deductible. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-64</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001578024"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">25. Post-employment benefits for associates</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defined benefit plans</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition to the legally required social security schemes, the Group has numerous independent pension and other post-employment benefit plans. In most cases, these plans are externally funded in entities that are legally separate from the Group. For certain Group companies, however, no independent plan assets exist for the pension and other post-employment benefit obligations of associates. In these cases, the related unfunded liability is included in the balance sheet. The defined benefit obligations (DBOs) of all major pension and other post-employment benefit plans are reappraised annually by independent actuaries. Plan assets are recognized at fair value. The major plans are based in Switzerland, the United States, the United Kingdom, Germany and Japan, which represent 95% of the Group&#x2019;s total DBO for pension plans. Details of the plans in the two most significant countries, Switzerland and the United States, which represent 81% of the Group&#x2019;s total DBO for post-employment benefit plans, are provided below.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Swiss-based pension plans represent the most significant portion of the Group&#x2019;s total DBO and plan assets. For the active insured members born on or after January 1, 1956, or having joined the plans after December 31, 2010, the benefits are partially linked to the contributions paid into the plan. Certain features of Swiss pension plans required by law preclude the plans from being categorized as defined contribution plans. These factors include a minimum interest guarantee on retirement savings accounts, a predetermined factor for converting the accumulated savings account balance into a pension, and embedded death and disability benefits.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All benefits granted under Swiss-based pension plans are vested, and Swiss legislation prescribes that the employer has to contribute a fixed percentage of an associate&#x2019;s pay to an external pension fund. Additional employer contributions may be required whenever the plan&#x2019;s statutory funding ratio falls below a certain level. The associate also contributes to the plan. The pension plans are run by separate legal entities, each governed by a board of trustees that &ndash; for the principal plans &ndash; consists of representatives nominated by Novartis and the active insured associates. The boards of trustees are responsible for the plan design and asset investment strategy.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In September 2017, the pension regulations in Switzerland were amended, which resulted in a change in accounting from defined benefit to defined contribution for a component of the Swiss pension plans. This change resulted in a reduction to the defined benefit pension plans liability and in a corresponding net pre-tax gain of USD 225 million (CHF 216 million).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The United States pension plans represent the second-largest component of the Group&#x2019;s total DBO and plan assets. The principal plans (Qualified Plans) are funded, whereas plans providing additional benefits for executives (Restoration Plans) are unfunded. Employer contributions are required for Qualified Plans whenever the statutory funding ratio falls below a certain level. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Furthermore, in certain countries, associates are covered under other post-employment benefit plans and post-retirement medical plans.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US, other post-employment benefit plans consist primarily of post-employment healthcare benefits, which have been closed to new members since 2015. Part of the costs of these plans is reimbursable under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. There is no statutory funding requirement for these plans. The Group is funding these plans to the extent that it is tax efficient.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-65</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables are a summary of the funded and unfunded defined benefit obligation for pension and other postemployment benefit plans of associates at December 31, 2019 and 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment  benefit plans</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;179</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;210</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;073</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;115</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit obligations related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;662</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;385</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current service cost</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 378</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest cost</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 330</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 321</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past service costs and settlements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;168</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Administrative expenses</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurement losses/(gains) arising from changes in financial assumptions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;791</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;567</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;31</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurement (gains)/losses arising from changes in demographic assumptions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;193</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Experience-related remeasurement losses/(gains)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 184</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 264</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 283</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;374</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions of associates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;066</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;179</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 746</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;073</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at January 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18&nbsp;838</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20&nbsp;275</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 119</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Plan assets related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 257</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 249</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Return on plan assets excluding interest income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;656</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;805</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 304</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;310</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Group contributions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 420</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 520</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions of associates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 169</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Settlements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;193</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;810</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;838</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;341</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Limitation on recognition of fund surplus at January 1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;89</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income on limitation of fund surplus</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Limitation on recognition of fund surplus at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;68</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability in the balance sheet at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;321</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;409</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-66</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The reconciliation of the net liability from January 1 to December 31 is as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment  benefit plans</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability at January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;409</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;024</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;954</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;953</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less: net liability related to discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 238</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 345</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current service cost</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;336</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;378</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;77</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Administrative expenses</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past service costs and settlements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;507</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Group contributions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 420</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 520</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in limitation on recognition of fund surplus</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;321</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;409</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Amounts recognized in the consolidated balance sheet</div>
      </td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid benefit cost</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 148</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued benefit liability</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;469</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;546</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows a breakdown of the DBO for pension plans by geography and type of member, and the breakdown of plan assets into the geographical locations in which they are held:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Switzerland</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> United<br> States</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of<br> the world</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Switzerland</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> United<br> States</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Rest of<br> the world</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15&nbsp;106</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;552</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;408</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;066</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;263</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;348</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;179</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof unfunded</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 670</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 466</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 1&nbsp;136</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 649</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 491</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1&nbsp;140</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">By type of member</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Active</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 630</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;197</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;618</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 653</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;616</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;887</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred pensioners</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;205</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;517</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;722</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;131</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;531</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;662</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pensioners</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;939</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;717</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;491</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;147</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;645</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;564</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;421</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;630</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;457</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;042</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;810</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;160</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;208</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;838</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;649</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;241</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;366</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;793</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;360</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;341</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="18" style="border-bottom: solid #000000 2px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows a breakdown of the DBO for other post-employment benefit plans by geography and type of member, and the breakdown of plan assets into the geographical locations in which they are held:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> United<br> States</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of<br> the world</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Total</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> United<br> States</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Rest of<br> the world</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 658</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 88</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 746</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;001</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 72</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;073</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof unfunded</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 882</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 72</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">By type of member</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Active</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 157</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 270</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 295</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred pensioners</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pensioners</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 522</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 52</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 574</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 713</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 760</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;524</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;88</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;882</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;72</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-67</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the principal weighted average actuarial assumptions used for calculating defined benefit plans and other post-employment benefits of associates:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans  </div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment  benefit plans</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Weighted average assumptions used to determine  benefit obligations at December 31</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discount rate</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.6%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.5%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.6%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.4%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.7%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected rate of pension increase</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.4%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.5%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected rate of salary increase</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.8%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.8%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.8%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest on savings account</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.8%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.6%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current average life expectancy  for a 65-year-old male in years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   21</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current average life expectancy  for a 65-year-old female in years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   23</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Changes in the aforementioned actuarial assumptions can result in significant volatility in the accounting for the Group&#x2019;s pension plans in the consolidated financial statements. This can result in substantial changes in the Group&#x2019;s other comprehensive income, long-term liabilities and prepaid pension assets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The DBO is significantly impacted by assumptions regarding the rate that is used to discount the actuarially determined post-employment benefit liability. This rate is based on yields of high-quality corporate bonds in the country of the plan. Decreasing corporate bond yields decrease the discount rate, so that the DBO increases and the funded status decreases.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In Switzerland, an increase in the DBO due to lower discount rates is slightly offset by lower future benefits expected to be paid on the associate&#x2019;s savings account where the assumption on interest accrued changes in line with the discount rate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impact of decreasing interest rates on a plan&#x2019;s assets is more difficult to predict. A significant part of the plan assets is invested in bonds. Bond values usually rise when interest rates decrease and may therefore partially compensate for the decrease in the funded status. Furthermore, pension assets also include significant holdings of equity instruments. Share prices tend to rise when interest rates decrease and therefore often counteract the negative impact of the rising defined benefit obligation on the funded status (although the correlation of interest rates with equities is not as strong as with bonds, especially in the short term).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The expected rate for pension increases significantly affects the DBO of most plans in Switzerland, Germany and the United Kingdom. Such pension increases also decrease the funded status, although there is no strong correlation between the value of the plan assets and pension/inflation increases.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Assumptions regarding life expectancy significantly impact the DBO. An increase in longevity increases the DBO. There is no offsetting impact from the plan assets, as no longevity bonds or swaps are held by the pension funds. Generational mortality tables are used where this data is available.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the sensitivity of the defined benefit pension obligation to the principal actuarial assumptions for the major plans in Switzerland, the United States, the United Kingdom, Germany and Japan on an aggregated basis:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in 2019 year-end<br> defined benefit pension obligation</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in discount rate</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;787</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in discount rate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 837</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One-year increase in life expectancy</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in rate of pension increase</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 546</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in rate of pension increase</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;135</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase of interest on savings account</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease of interest on savings account</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in rate of salary increase</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in rate of salary increase</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;55</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The healthcare cost trend rate assumptions used for other post-employment benefits are as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Healthcare cost trend rate assumed for next year</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   6.5%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   7.0%</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   6.5%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rate to which the cost trend rate is assumed to decline</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4.5%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4.5%</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   4.5%</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Year that the rate reaches the ultimate trend rate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   2028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2028</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2025</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the weighted average plan asset allocation of funded defined benefit pension plans at December 31, 2019 and&nbsp;2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(as a percentage)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-term <br> target <br> minimum</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-term <br> target <br> maximum</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br> <br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Real estate</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alternative investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and other investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash and most of the equity and debt securities have a quoted market price in an active market. Real estate and </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-68</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">alternative investments, which include hedge fund, private equity, infrastructure and commodity investments, usually have a quoted market price or a regularly updated net asset value.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The strategic allocation of assets of the different pension plans is determined with the objective of achieving an investment return that, together with the contributions paid by the Group and its associates, is sufficient to maintain reasonable control over the various funding risks of the plans. Based upon the market and economic environments, actual asset allocations may temporarily be permitted to deviate from policy targets. The asset allocation currently includes investments in shares of Novartis AG as per the below table: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investment in shares of Novartis AG</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number of shares (in millions)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11.0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Market value (in USD billions)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The weighted average duration of the defined benefit obligation is 15.2 years (2018: 14.6 years).</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s ordinary contribution to the various pension plans is based on the rules of each plan. Additional contributions are made whenever this is required by statute or law (i.e., usually when statutory funding levels fall below predetermined thresholds). The only significant plans that are foreseen to require additional funding are those in the United Kingdom.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The expected future cash flows in respect of pension and other post-employment benefit plans at December 31, 2019, were as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Pension plans</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-<br> employment<br> benefit plans</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Novartis Group contributions</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020 (estimated)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 410</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Expected future benefit payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;201</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;116</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;106</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;096</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;087</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2025&#x2013;2029</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;270</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 231</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defined contribution plans</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In many subsidiaries, associates are covered by defined contribution plans. Contributions charged to the consolidated income statement for the defined contribution plans were: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined contribution plans continuing operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   422</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   443</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   307</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For defined contribution plans for discontinued operations, see Note 30.</div><a name="anchorId001581284"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">26. Equity-based participation plans for associates</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The expense related to all equity-based participation plans and the liabilities arising from equity-based payment transactions were as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense related to equity-based  participation plans</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1&nbsp;067</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   918</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   853</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities arising from equity-based  payment transactions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   326</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   273</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   261</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Equity-based participation plans can be separated into the following plans:</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Annual Incentive</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Annual Incentive for the Novartis Group CEO and other Executive Committee members (ECN) is paid 50% in cash and 50% in Novartis restricted shares (RSs) or restricted share units (RSUs). For the Novartis Top Leaders (NTLs), the Annual Incentive is paid 70% in cash and 30% in RSs or RSUs. Both the ECN and NTLs can opt to invest up to the maximum cash portion of their Annual Incentive to receive further RSs or RSUs. Any cash is paid out during February or March in the year following the end of the performance period, and the shares are granted during January in the year following the end of the performance period.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Share savings plans</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Associates in certain countries and certain key executives worldwide are encouraged to invest their Annual Incentive in a share savings plan.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Under the share savings plan, participants may elect to receive their relevant compensation fully or partially in Novartis shares in lieu of cash. As a reward for their participation in the share savings plan, at no additional cost to the participant, Novartis matches their investments in shares after a holding period of three or five years. </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-69</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Novartis operates share savings plans for which associates may only participate in one of the share savings plans in any given year. The most significant are listed below:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In Switzerland, Employee Share Ownership Plan (ESOP) participants may choose to receive their Annual Incentive (i) 100% in shares, (ii) 50% in shares and 50% in cash, or (iii) 100% in cash. After expiration of a three-year holding period for Novartis shares invested under the ESOP, participants will receive one matching share for every two invested shares. Associates eligible for the equity plan &#x201C;Select&#x201D; are not eligible to receive ESOP matching shares starting with the 2017 performance period.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Leveraged Share Savings Plan (LSSP) was available to key executives for performance periods prior to 2016. At the participant&#x2019;s election, the Annual Incentive was awarded partly or entirely in shares. The elected number of shares is subject to a holding period of five years. At the end of the holding period, Novartis will match the invested shares at a ratio of 1-to-1 (i.e., one share awarded for each invested share). In the United States, both the LSSP award and the corresponding match are cash settled.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Following the introduction of the new compensation programs in 2014, the Novartis Group CEO and the other Executive Committee members are no longer eligible to participate in the share savings plans. From the 2016 performance period onward, the NTLs are also no longer eligible to participate in the share savings plans.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis equity plan &#x201C;Select&#x201D;</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The equity plan &#x201C;Select&#x201D; is a global equity incentive plan under which eligible associates may annually be awarded a grant subject to a three-year, and for selected units a four-year, staggered vesting period. No awards are granted for performance ratings below a certain threshold. Executive Committee members are not eligible to participate in the equity plan &#x201C;Select&#x201D; effective from the performance period 2014, and the NTLs are not eligible to participate effective from the performance period 2016.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The equity plan &#x201C;Select&#x201D; currently allows participants in Switzerland to choose the form of their equity compensation in RSs or RSUs. In all other jurisdictions, RSs or RSUs are granted unilaterally. Until 2013, participants could also choose to receive part or the entire grant in the form of tradable share options.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Tradable share options expire on their 10<sup>th</sup> anniversary from the grant date. Each tradable share option entitles the holder to purchase after vesting (and before the 10<sup>th</sup> anniversary from the grant date) one Novartis share at a stated exercise price that equals the closing market price of the underlying share at the grant date. As the exercise price does not reflect the decrease in the Novartis share due to the Alcon spin, one-fifth of an Alcon share will also be awarded to the option holder upon exercise.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Options under Novartis equity plan &#x201C;Select&#x201D; outside North America</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the activity associated with the share options during the period. The weighted average prices in the table below are translated from Swiss francs into USD at historical rates.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Options<br> (millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted<br> average <br> exercise <br> price<br> (USD)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Options<br> (millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted<br> average <br> exercise <br> price<br> (USD)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Options outstanding  at January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   5.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   59.9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   7.4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   59.5</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sold or exercised</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 58.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58.2</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Exercisable at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All share options were granted at an exercise price that was equal to the closing market price of the Group&#x2019;s shares at the grant date. The weighted average share price at the dates of sale or exercise was USD&nbsp;89.9.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table summarizes information about share options outstanding at December 31, 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>Options outstanding</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total/<br> weighted<br> average</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number outstanding (millions)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remaining contractual life (years)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise price (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Options under Novartis equity plan &#x201C;Select&#x201D; for North America</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the activity associated with the ADR options during the period:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> ADR<br> options<br> (millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted<br> average <br> exercise <br> price<br> (USD)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> ADR<br> options<br> (millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted<br> average <br> exercise <br> price<br> (USD)</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Options outstanding  at January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   15.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   60.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   20.3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   59.9</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sold or exercised</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 58.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57.4</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 60.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Exercisable at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 60.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All ADR options were granted at an exercise price that was equal to the closing market price of the ADRs at the grant date. The weighted average ADR price at the dates of sale or exercise was USD&nbsp;85.1.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table summarizes information about ADR options outstanding at December 31, 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>ADR options outstanding</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> </div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total/<br> weighted<br> average</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number outstanding (millions)</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remaining contractual life (years)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise price (USD)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-70</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Long-Term Performance Plan</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Long-Term Performance Plan (LTPP) is an equity plan for the ECN, the NTLs and employees of Group units with specific targets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Participants are granted a target number of performance share units (PSUs) at the beginning of every performance period, which are converted into unrestricted Novartis shares after the performance period. The actual payout depends on the achievement of the performance measures and ranges between 0% and 200% of the granted amount. PSUs granted under the LTPP do not carry voting rights, but do carry dividend equivalents that are paid in unrestricted Novartis shares at the end of the performance period.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The LTPP awards are subject to a three-year performance and vesting period. Until 2018, the performance criteria were based on Novartis internal performance metrics. Starting in 2019, for new grants the performance criteria are based on both Novartis internal performance metrics and variables that can be observed in the market, which is the ranking of the Novartis total shareholder return (TSR) relative to a global healthcare peer group of 14 companies (updated in November 2019 from 15 companies following the acquisition of one of the companies by another company within the peer group) other companies, over rolling three-year performance periods. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">TSR for Novartis and the peer companies is calculated as the change in the company share price, which is translated to USD at the relevant exchange rate, including the reinvestment return of dividends, over the three-year performance period. The calculation is based on Bloomberg standard published TSR data, which is publicly available. The position of Novartis in the peer group determines the payout range based on a payout matrix. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Long-Term Relative Performance Plan</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The LTRPP is an equity plan for the Novartis ECN and NTLs. The last grant under this plan was made in 2018. The LTRPP performance criteria is based on variables that can be observed in the market, which is the ranking of the Novartis TSR relative to a global healthcare peer group of 15 other companies, over rolling three-year performance periods. The TSR for Novartis and the peer companies is calculated as described in the LTPP section above. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Other share awards</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Selected associates, excluding the ECN members, may exceptionally receive Special Share Awards of RSs or RSUs. These Special Share Awards provide an opportunity to reward outstanding achievements or exceptional performance, and aim to retain key contributors. They are based on a formal internal selection process, through which the individual performance of each candidate is thoroughly assessed at several management levels. Special Share Awards have a minimum three-year vesting period. In exceptional circumstances, Special Share Awards may be awarded to attract special expertise and new talents to the organization. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Worldwide, associates at different levels in the organization were awarded RSs and RSUs in 2019, 2018 and 2017.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, in 2019, 2018 and 2017, Board members received unrestricted shares as part of their regular compensation.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Summary of non-vested share movements</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table below provides a summary of non-vested share movements (RSs, RSUs and PSUs) for all plans. At the Alcon spin-off date, all RSU and PSU holders, who were not entitled to the dividend in kind in the form of Alcon shares received keep whole awards in Novartis shares to compensate for the loss of the Alcon value from their Novartis shares. These keep whole awards were accounted for as a modification. As they did not increase the value of the original grant, they did not lead to additional expense. In the table below, this is reflected by a zero fair grant date fair value:</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-71</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Number<br> of shares<br> in millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br> average fair<br> value at grant<br> date in USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Fair value at <br> grant date in<br> USD millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Number<br> of shares<br> in millions</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br> average fair<br> value at grant<br> date in USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Fair value at <br> grant date in<br> USD millions</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-vested shares at January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 25.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;981</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23.9</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 80.6</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;926</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Granted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Annual Incentive</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 109</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Share savings plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 349</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 348</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Select North America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 339</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 303</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Select outside North America</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 175</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 79.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Long-Term Performance Plan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 68.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 172</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 85.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 129</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Long-Term Relative Performance Plan</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 52.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other share awards</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vested</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;068</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;965</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forfeited</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;328</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76.4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;145</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-vested shares at December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 25.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;835</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 77.1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;981</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name="anchorId001582736"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">27. Transactions with related parties</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Genentech/Roche</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has two agreements with Genentech, Inc., United States, and one agreement with Spark Therapeutics, Inc., United States. Both companies are subsidiaries of Roche Holding AG (Roche), which is indirectly included in the consolidated financial statements using equity accounting since Novartis holds 33.3% of the outstanding voting shares of Roche (see Note 4).</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Lucentis</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has licensed from Genentech/Roche the exclusive rights to develop and market <i>Lucentis</i> outside the United States for indications related to diseases of the eye. Novartis pays royalties on the net sales of <i>Lucentis</i> products outside the United States. In 2019, <i>Lucentis</i> sales of USD&nbsp;2.1 billion (2018: USD&nbsp;2.0 billion; 2017: USD&nbsp;1.9 billion) were recognized by Novartis.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Xolair</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis and Genentech/Roche are co-promoting <i>Xolair</i> in the United States, where Genentech/Roche records all sales. Novartis records sales outside the United States.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis markets <i>Xolair</i> and records all sales and related costs outside the United States as well as co-promotion costs in the US. Genentech/Roche and Novartis share the resulting profits from sales in the United States, Europe and other countries, according to agreed profit-sharing percentages. In 2019, Novartis recognized total sales of <i>Xolair</i> of USD&nbsp;1.2 billion (2018: USD&nbsp;1.0 billion; 2017: USD&nbsp;920 million), including sales to Genentech/Roche for the United States market.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Luxturna</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, Novartis entered into an exclusive licensing and commercialization agreement and a supply agreement with Spark Therapeutics, Inc. (Spark) for <i>Luxturna</i> outside the United States. The agreements include regulatory and sales milestones as well as royalties payable to Spark on ex-US sales. On December 17, 2019, Roche acquired Spark.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The net income for royalties, cost sharing and profit sharing arising out of the <i>Lucentis</i>, <i>Xolair</i> and <i>Luxturna</i> agreements with Roche totaled USD&nbsp;101 million in 2019 (net income in 2018: USD&nbsp;34 million; net expense in 2017: USD&nbsp;33 million).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Furthermore, Novartis has several patent license, supply and distribution agreements with Roche.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis Pension Fund</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, a Group subsidiary provided an uncommitted overnight credit facility to the Novartis Pension Fund, Switzerland, for up to USD 500 million with interest at the US Federal Funds Rate. This credit facility was not utilized during the years 2019 and 2018.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-72</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Officers and Non-Executive Directors compensation</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, there were 15 Executive Committee members (&#x201C;Executive Officers&#x201D;), including those who stepped down during the year (there were 17 members in 2018 and 11 members in 2017, including those who stepped down).</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The total compensation for Executive Committee members and the 13 Non-Executive Directors (13 in 2018 and 2017) using the Group&#x2019;s accounting policies for equity-based compensation and pension benefits was as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Executive Officers</div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-Executive Directors</div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total</div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and other compensation</div>
      </td>
      <td align="right" width="5%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.7</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18.4</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.0</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.8</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26.5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="5%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.4</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Post-employment benefits</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 49.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45.2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54.7</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 63.9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 67.5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8.7</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8.8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 72.6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 76.3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79.1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="20" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, the IFRS compensation expense decreased due to lower cash buyout payments to new executive officers and the forfeiture of equity-based compensation as a result of the resignation of an executive officer. These effects were partially offset by higher equity based compensation of executive officers appointed over the last three years.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During 2018, there was a decrease in the IFRS compensation expense for Executive Officers, mainly due to the higher pro-rata accelerated vesting of equity compensation in 2017, required by IFRS, in accordance with the plan rules. This was partly offset by the cash portion of buyout payments for new Executive Officers. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Annual Incentive award, which is fully included in equity-based compensation even when paid out in cash, is granted in January in the year following the reporting period.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The disclosures on Board and executive compensation required by the Swiss Code of Obligations and in accordance with the Swiss Ordinance against Excessive Compensation in Stock Exchange Listed Companies are shown in the Compensation Report of the Group.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Transactions with former members of the Board of Directors</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, 2018 and 2017, the following payments (or waivers of claims) were made to former Board members or to &#x201C;persons closely&#x201D; linked to them:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currency</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dr. Krauer</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60&nbsp;000</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dr. Vasella</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;228</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;279</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Dr. Alex Krauer, Honorary Chairman, is entitled to an amount of CHF&nbsp;60&#xA0;000 for annual periods from one AGM to the next. This amount was fixed in 1998 upon his departure from the Board in 1999, and has not been revised since that date.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Dr. Daniel Vasella, Honorary Chairman, was paid CHF&nbsp;18&#xA0;228 in 2018, and CHF&nbsp;26&#xA0;279 in 2017, for reimbursable costs under his agreement with the Company, which expired on December 31, 2019. </div><a name="anchorId001583196"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">28. Commitments and contingencies</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development commitments</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has entered into long-term research and development agreements with various institutions, which provide for potential milestone payments by Novartis that may be capitalized. As of December 31, 2019, the Group&#x2019;s commitments to make payments under those agreements, and their estimated timing, were as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 809</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 442</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 319</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 724</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Thereafter</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;943</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;404</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-73</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Commitments for capital calls</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group holds investments in funds in which it has committed to invest further upon future capital calls. As of December 31, 2019, the total uncalled capital commitments for the Group&#x2019;s investments in funds amounts to USD 79 million.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 29 contains further information on the Group&#x2019;s investments in funds.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Other commitments</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has entered into various purchase commitments for services and materials as well as for equipment in the ordinary course of business. These commitments are generally entered into at current market prices and reflect normal business operations. For disclosure of property, plant and equipment purchase commitments, see Note 9.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Guarantees issued</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has issued guarantees to third parties in the ordinary course of business, mostly for tax, customs or other governmental agencies. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, Novartis AG is guarantor of the Group&#x2019;s issued bonds, credit facilities and commercial paper program.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Contingencies</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Group companies have to observe the laws, government orders and regulations of the country in which they operate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A number of Novartis companies are, and will likely continue to be, subject to various legal proceedings and investigations that arise from time to time, including proceedings regarding product liability; sales and marketing practices; commercial disputes; employment and wrongful discharge; and antitrust, securities, health and safety, environmental, tax, international trade, privacy and intellectual property matters. As a result, the Group may become subject to substantial liabilities that may not be covered by insurance and that could affect our business, financial position and reputation. While Novartis does not believe that any of these legal proceedings will have a material adverse effect on its financial position, litigation is inherently unpredictable and large judgments sometimes occur. As a consequence, Novartis may in the future incur judgments or enter into settlements of claims that could have a material adverse effect on its results of operations or cash flow.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Governments and regulatory authorities around the world have been stepping up their compliance and law enforcement activities in recent years in key areas, including marketing practices, pricing, corruption, trade restrictions, embargo legislation, insider trading, antitrust, cyber security and data privacy. Further, when one government or regulatory authority undertakes an investigation, it is not uncommon for other governments or regulators to undertake investigations regarding the same or similar matters. Responding to such investigations is costly and requires an increasing amount of management&#x2019;s time and attention. In addition, such investigations may affect our reputation, create a risk of potential exclusion from government reimbursement programs in the United States and other countries, and lead to (or arise from) litigation. These factors have contributed to decisions by Novartis and other companies in the healthcare industry, when deemed in their interest, to enter into settlement agreements with governmental authorities around the world prior to any formal decision by the authorities or a court. Those government settlements have involved and may continue to involve, in current government investigations and proceedings, large cash payments, sometimes in the hundreds of millions of dollars or more, including the potential repayment of amounts allegedly obtained improperly and other penalties, including treble damages. In addition, settlements of government healthcare fraud cases often require companies to enter into corporate integrity agreements, which are intended to regulate company behavior for a period of years. Our affiliate Novartis Pharmaceuticals Corporation is a party to such an agreement, which will expire in 2020. Also, matters underlying governmental investigations and settlements may be the subject of separate private litigation.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">While provisions have been made for probable losses, which management deems to be reasonable or appropriate, there are uncertainties connected with these estimates.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 20 contains additional information on these matters.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A number of Group companies are involved in legal proceedings concerning intellectual property rights. The inherent unpredictability of such proceedings means that there can be no assurances as to their ultimate outcome. A negative result in any such proceeding could potentially adversely affect the ability of certain Novartis companies to sell their products, or require the payment of substantial damages or royalties.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the opinion of management, however, the outcome of these actions will not materially affect the Group&#x2019;s financial position but could be material to the results of operations or cash flow in a given period.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s potential environmental remediation liability is assessed based on a risk assessment and investigation of the various sites identified by the Group as at risk for environmental remediation exposure. The Group&#x2019;s future remediation expenses are affected by a number of uncertainties. These uncertainties include, but are not limited to, the method and extent of remediation, the percentage of material attributable to the Group at the remediation sites relative to that attributable to other parties, and the financial capabilities of the other potentially responsible parties.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 20 contains additional information on environmental liabilities.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-74</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001583339"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">29. Financial instruments &ndash; additional disclosures</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<sup style="white-space: nowrap"> 1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018<sup style="white-space: nowrap"> 1</sup></div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at fair value through other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Marketable securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Long-term financial investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;158</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 802</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total long-term financial investments - fair value through other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;191</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 833</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at fair value through other comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;215</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;158</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at amortized costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables, income tax receivables and other current assets (excluding pre-payments)</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15/17</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;337</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;024</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity more than 90 days</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances, security deposits and other long-term receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at amortized costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;727</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;635</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at fair value through the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 366</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 353</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13/16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 286</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Associated companies at fair value through profit and loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at fair value through the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;323</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;310</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24&nbsp;377</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29&nbsp;374</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities - measured at amortized costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest-bearing accounts of associates payable on demand</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;836</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;778</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bank and other financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 719</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 701</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commercial paper</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;289</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;951</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;846</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;620</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities to banks and other financial institutions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 285</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finance lease obligations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;002</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;190</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Trade payables and commitment for repurchase of own shares<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;840</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities - measured at amortized costs</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 32&nbsp;623</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37&nbsp;930</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities - measured at fair value through the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration (see Note 20/22) and other financial liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;065</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 917</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities - measured at fair value through the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 975</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;822</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 38&nbsp;905</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Except for straight bonds (see Note 19), the carrying amount is a reasonable approximation of fair value.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Notes 18 and 22 provide additional disclosures related to commitment for repurchase of own shares.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-75</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Derivative financial instruments</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables show the contract or underlying principal amounts and fair values of derivative financial instruments analyzed by type of contract at December&nbsp;31, 2019 and 2018. Contract or underlying principal amounts indicate the gross volume of business outstanding at the consolidated balance sheet date and do not represent amounts at risk. The fair values are determined by reference to market prices or standard pricing models that use observable market inputs at December 31,&nbsp;2019 and 2018.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Contract or underlying  principal amount</div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Positive fair values  </div>
      </td>
      <td></td>
      <td colspan="3" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Negative fair values  </div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
      <td colspan="3" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
      <td colspan="3" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;779</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;823</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 96</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodity purchase contract</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Options on equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments included in  marketable securities and in current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   11&nbsp;057</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   10&nbsp;823</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows by currency contract or underlying principal amount the derivative financial instruments at December&nbsp;31,&nbsp;2019 and 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> EUR</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;373</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;760</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;646</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;779</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodity purchase contract</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Options on equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;665</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;057</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> EUR</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> USD</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Other</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;989</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;558</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;276</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;823</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;989</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;558</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;276</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;823</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Derivative financial instruments effective for hedge accounting purposes</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At the end of 2019 and 2018, there were no open hedging instruments for anticipated transactions.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Fair value by hierarchy</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As required by IFRS, financial assets and liabilities recorded at fair value in the consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. There are three hierarchical levels, based on an increasing amount of subjectivity associated with the inputs to derive fair valuation for these assets and liabilities, which are as follows:</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The assets carried at Level 1 fair value are equity and debt securities listed in active markets.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The assets generally included in Level 2 fair value hierarchy are foreign exchange and interest rate derivatives, and certain debt securities. Foreign exchange and interest rate derivatives are valued using corroborated market data. The liabilities generally included in this fair value hierarchy consist of foreign exchange and interest rate derivatives.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Level 3 inputs are unobservable for the asset or liability. The assets generally included in Level 3 fair value hierarchy are various investments in hedge funds and unquoted equity security investments. Contingent consideration carried at fair value is included in this category.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-76</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Level 1</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Level 2</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Level 3</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Valued at<br> amortized cost</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short term investments with original maturity more than 90 days</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, time deposits and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 224</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt and equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 976</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 581</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;557</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances, security deposits and other long-term receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments and long-term loans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 976</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;213</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 329</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;518</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies at fair value through profit and loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities at fair value</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;065</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;250</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Level 1</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Level 2</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Level 3</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Valued at<br> amortized cost</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 302</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 337</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short term investments with original maturity more than 90 days</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, time deposits and derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 337</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;099</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;589</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt and equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;186</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans and receivables from customers  and finance lease, advances, security deposits</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   512</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   512</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments and long-term loans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 698</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;135</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 512</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies at fair value through profit and loss</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities at fair value</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;917</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;975</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The analysis above includes all financial instruments measured at fair value as well as certain financial assets measured at amortized cost.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-77</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The change in carrying values associated with Level 3 financial instruments, using significant unobservable inputs during the year ended December 31, is set forth below:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="13" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="13" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Associated <br> companies at <br> fair value  through<br> profit and loss</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Fund<br> investments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Long-term <br> financial <br> investments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Contingent <br> consideration <br> receivables</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Contingent <br> consideration <br> payables</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> Other <br> financial <br> liabilities</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 145</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 251</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 488</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 396</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;907</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact from discontinued operations<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 163</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value gains and other adjustments,  including from divestments recognized  in the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     195</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     1</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value losses (including impairments and   amortizations) and other adjustments recognized   in the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;89</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;48</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments recognized in the consolidated statement   of comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 229</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;401</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash receipts and payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;53</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;64</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 581</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 399</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;29</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of fair value gains and losses recognized   in the consolidated income statement for assets   and liabilities held at December 31, 2019</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     12</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     106</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     &ndash;&nbsp;47</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><b></b><b></b><b></b><b></b></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="14">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations.<b></b><b></b><b></b></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="13" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="13" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="13" height="3"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Associated <br> companies at <br> fair value  through<br> profit and loss</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Fund<br> investments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Long-term <br> financial <br> investments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Contingent <br> consideration <br> receivables</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Contingent <br> consideration <br> payables</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Other <br> financial <br> liabilities</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 188</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 166</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 437</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 844</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;852</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;72</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value gains and other adjustments,   including from divestments recognized   in the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     93</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     213</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value losses (including impairments and   amortizations) and other adjustments recognized   in the consolidated income statement</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;100</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments recognized in the consolidated statement   of comprehensive income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchases</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 123</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;182</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash receipts and payments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;484</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;30</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payable related to disposal group held for sale</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 251</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 488</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 396</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;907</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of fair value gains and losses recognized   in the consolidated income statement for assets   and liabilities held at December 31, 2018</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;22</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     93</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     &ndash;&nbsp;5</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, there were several individually non-significant transfers of financial investments from Level 3 to Level 1 for USD&nbsp;64 million (2018: USD&nbsp;78 million), mainly due to initial public offerings of the invested companies.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Realized gains and losses associated with Level 3 long-term financial investments measured at fair value through the consolidated income statement are recorded in the consolidated income statement under &#x201C;Other income&#x201D; or &#x201C;Other expense,&#x201D; respectively. Realized gains and losses associated with Level 3 long-term financial investments measured at fair value through other comprehensive income are not recycled through the consolidated income statement but are instead reclassified to retained earnings.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During the year, the net loss and net gain recorded on associated companies, fund investments and long-term financial investments at fair value through profit and loss were USD 72 million and USD 110 million, respectively.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-78</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the pricing parameters for the Level 3 input were to change for associated companies at fair value through profit and loss, fund investments and long-term financial investments by 10% positively or negatively, this would change the amounts recorded in the 2019 consolidated statement of comprehensive income by USD&nbsp;100 million.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To determine the fair value of a contingent consideration, various unobservable inputs are used. A change in these inputs might result in a significantly higher or lower fair value measurement. The inputs used are, among others, the probability of success, sales forecast and assumptions regarding the discount rate and timing and different scenarios of triggering events. The inputs are interrelated. The significance and usage of these inputs to each contingent consideration may vary due to differences in the timing and triggering events for payments or in the nature of the asset related to the contingent consideration. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the most significant parameters for the Level&nbsp;3 input were to change by 10% positively or negatively, or where the probability of success (POS) is the most significant input parameter, 10% were added or deducted from the applied probability of success, for contingent consideration payables, other financial liabilities and contingent consideration receivables, this would change the amounts recorded in the 2019 consolidated income statement by USD&nbsp;267 million and USD 202 million, respectively.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Equity securities measured at fair value through other comprehensive income</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Equity securities held as strategic investments, typically held outside the Novartis Venture Fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Except for the investment in Alcon Inc. with a fair value of USD 382 million at December 31, 2019, these are made up of individually non-significant investments. At December 31, 2019, the Group holds 53 non-listed equity securities (December 31, 2018: 41) and 29 listed equity securities (December 31, 2018: 26) in this category with the following fair values:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Listed equity securities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 843</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 597</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-listed equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 315</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 205</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity securities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;158</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 802</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;</sup></div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There were no dividends recognized during 2019 and 2018 from these equity securities. In 2019, in accordance with the consolidated foundations Alcon Inc. shares divestment plans, Alcon Inc. shares with a fair value of USD&nbsp;976 million were sold, and the USD&nbsp;62 million gain on disposal was transferred from other comprehensive income to retained earnings during 2019. In addition, in 2019, equity securities that were no longer considered strategic, with a fair value of USD&nbsp;33 million (2018: USD&nbsp;21 million), were sold, and the USD&nbsp;33 million gain on disposal (2018: USD&nbsp;16 million gain) was transferred from other comprehensive income to retained earnings (see Note 8).</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Nature and extent of risks arising from financial instruments</font>
</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Market risk</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis is exposed to market risk, primarily related to foreign currency exchange rates, interest rates, and the market value of the investments of liquid funds. The Group actively monitors and seeks to reduce, where it deems it appropriate to do so, fluctuations in these exposures. It is the Group&#x2019;s policy and practice to enter into a variety of derivative financial instruments to manage the volatility of these exposures and to enhance the yield on the investment of liquid funds. It does not enter into any financial transactions containing a risk that cannot be quantified at the time the transaction is concluded. In addition, it does not sell short assets it does not have, or does not know it will have, in the future. The Group only sells existing assets or enters into transactions and future transactions (in the case of anticipatory hedges) that it confidently expects it will have in the future, based on past experience. In the case of liquid funds, the Group writes call options on assets it has, or writes put options on positions it wants to acquire and has the liquidity to acquire. The Group expects that any loss in value for these instruments generally would be offset by increases in the value of the underlying transactions.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Foreign currency exchange rate risk</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group uses the US dollar as its reporting currency. As a result, the Group is exposed to foreign currency exchange movements, primarily in European, Japanese and emerging market currencies. Fluctuations in the exchange rates between the US dollar and other currencies can have a significant effect on both the Group&#x2019;s results of operations, including reported sales and earnings, as well as on the reported value of our assets, liabilities and cash flows. This, in turn, may significantly affect the comparability of period-to-period results of operations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because our expenditures in Swiss francs are significantly higher than our revenues in Swiss francs, volatility in the value of the Swiss franc can have a significant impact on the reported value of our earnings, assets and liabilities, and the timing and extent of such volatility can be difficult to predict.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is also a risk that certain countries could devalue their currency. If this occurs, it could impact the effective prices we would be able to charge for our products and also have an adverse impact on both our consolidated income statement and balance sheet.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain countries have legal or economic restrictions on the ability of subsidiaries to transfer funds to the Group in the form of cash dividends, loans or advances, but these restrictions do not have an impact on the ability of the Group to meet its cash obligations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The most significant countries in this respect are Argentina and Venezuela, where the governments have </div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-79</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">implemented capital controls. The net outstanding intercompany payable balance of Argentina and Venezuela Subsidiaries were not material for the Group at December 31, 2019 and at December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Subsidiaries whose functional currencies have experienced a cumulative inflation rate of more than 100% over the past three years apply the rules of IAS 29 &#x201C;Financial reporting in Hyperinflationary Economies&#x201D;. The hyperinflationary economies in which Novartis operates are Argentina and Venezuela. Venezuela was hyperinflationary for all years presented, and Argentina became hyperinflationary effective July 1, 2018, requiring retroactive implementation of hyperinflation accounting as of January 1, 2018. The impacts of applying IAS 29 was not significant in all years presented.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group manages its global currency exposure by engaging in hedging transactions where management deems appropriate. Novartis may enter into various contracts that reflect the changes in the value of foreign currency exchange rates to preserve the value of assets, commitments and anticipated transactions. Novartis also uses forward contracts and foreign currency option contracts to hedge.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net investments in subsidiaries in foreign countries are long-term investments. Their fair value changes through movements of foreign currency exchange rates. The Group has designated a certain portion of its long-term euro-denominated straight bonds as hedges of the translation risk arising on certain of these net investments in foreign operations with euro functional currency. As of December 31, 2019, long-term financial debt with a carrying amount of EUR&nbsp;1.8 billion (USD&nbsp;2.1 billion) (December 31, 2018: USD 2.1 billion), has been designated as a hedge instrument. During 2019, USD&nbsp;44 million of unrealized income (unrealized income in 2018: USD 95 million) was recognized in other comprehensive income and accumulated in currency translation effects in relation with this net investment hedge. The hedge remained effective since inception, and no amount was recognized in the consolidated income statement in 2019, 2018 and 2017.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Commodity price risk</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has only a very limited exposure to price risk related to anticipated purchases of certain commodities used as raw materials by the Group&#x2019;s businesses. A change in those prices may alter the gross margin of a specific business, but generally by not more than 10% of the margin and thus below the Group&#x2019;s risk management tolerance levels. Accordingly, the Group does not enter into significant commodity futures, forward or option contracts to manage fluctuations in prices of anticipated purchases.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Interest rate risk</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group addresses its net exposure to interest rate risk mainly through the ratio of its fixed-rate financial debt to variable-rate financial debt contained in its total financial debt portfolio. To manage this mix, Novartis may enter into interest rate swap agreements, in which it exchanges periodic payments based on a notional amount and agreed-upon fixed and variable interest rates.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Equity risk</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group may purchase equities as investments of its liquid funds. As a policy, it limits its holdings in an unrelated company to less than 5% of its liquid funds. Potential investments are thoroughly analyzed. Call options are written on equities that the Group owns, and put options are written on equities that the Group wants to buy and for which cash is available.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Credit risk</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Credit risks arise from the possibility that customers may not be able to settle their obligations as agreed. To manage this risk, the Group periodically assesses country and customer credit risk, assigns individual credit limits, and takes actions to mitigate credit risk where appropriate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The provisions for expected credit losses for customers are based on a forward-looking expected credit loss, which includes possible default events on the trade receivables over the entire holding period of the trade receivables.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In measuring the expected credit losses, trade receivables are grouped based on shared credit risk characteristics (such as private versus public receivables) and days past due. In determining the expected credit loss rates, the Group considers current and forward-looking macroeconomic factors that may affect the ability of the customers to settle the receivables, and historical loss rates for each category of customers.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s largest customer accounted for approximately 23% of net sales, and the second largest and third largest customers accounted for 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). No other customer accounted for 6% or more of net sales in either year.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the Group&#x2019;s trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively). There is no other significant concentration of customer credit risk.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Counterparty risk</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Counterparty risk encompasses issuer risk on marketable securities and money market instruments; credit risk on cash, time deposits and derivatives; as well as settlement risk for different instruments. Issuer risk is reduced by only buying securities that are at least A- rated. Counterparty credit risk and settlement risk are reduced by a policy of entering into transactions with counterparties (banks or financial institutions) that feature a strong credit rating. Exposure to these risks is closely monitored and kept within predetermined parameters. The limits are regularly assessed and determined based upon credit analysis, including financial statement and capital adequacy ratio reviews. In addition, reverse repurchasing agreements are contracted, and Novartis has entered into credit support agreements with various banks for derivative transactions. To further reduce the settlement risk, the Group has implemented a multi-currency system, CLS (Continuous Linked Settlement), providing multilateral netting (payment-versus-payment settlement) of cash flows from foreign exchange transactions.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-80</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s cash and cash equivalents are held with major regulated financial institutions; the three largest ones hold approximately 12.6%, 10.4% and 8.3%, respectively (2018: 9.4%, 7.6% and 7.0%, respectively).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group does not expect any losses from non-performance by these counterparties and does not have any significant grouping of exposures to financial sector or country risk.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Liquidity risk</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Liquidity risk is defined as the risk that the Group could not be able to settle or meet its obligations associated with financial liabilities that are settled by delivering cash or another financial asset. Group Treasury is responsible for liquidity, funding and settlement management. In addition, liquidity and funding risks, and related processes and policies, are overseen by management. Novartis manages its liquidity risk on a consolidated basis according to business needs and tax, capital or regulatory considerations, if applicable, through numerous sources of financing in order to maintain flexibility. Management monitors the Group&#x2019;s net debt or liquidity position through rolling forecasts on the basis of expected cash flows.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has two US commercial paper programs under which it can issue up to USD&nbsp;9.0 billion in the aggregate of unsecured commercial paper notes. Novartis also has a Japanese commercial paper program under which it can issue up to JPY&nbsp;150 billion (approximately USD&nbsp;1.4 billion) of unsecured commercial paper notes. Commercial paper notes totaling USD&nbsp;2.3 billion under these three programs were outstanding as per December 31, 2019 (2018: USD&nbsp;4.0 billion). Novartis further has a committed credit facility of USD&nbsp;6.0 billion, which was renewed in September 2019. This credit facility is provided by a syndicate of banks and is intended to be used as a backstop for the US commercial paper programs. The renewed facility matures in September 2024 and was undrawn as per December 31, 2019, and December 31, 2018.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In December 2019, Novartis entered into a short-term credit facility of USD 7 billion, with a maturity date of June 30, 2020 with a syndicate of banks. On January 7, 2020, Novartis borrowed USD 7 billion under the facility with interest based on the USD LIBOR.</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table sets forth how management monitors net debt or liquidity based on details of the remaining contractual maturities of current financial assets and liabilities, excluding trade receivables and payables as well as contingent considerations at December 31, 2019, and December 31, 2018:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="11" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="11" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Due within <br> one month</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one year <br> but less than <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Due after <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term investments with original maturity more than 90 days</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   20</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   26</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   16</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   57</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   122</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 79</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;712</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;112</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;746</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;505</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;446</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;9&nbsp;150</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;11&nbsp;355</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;20&nbsp;505</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;130</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;402</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;031</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;373</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 103</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;237</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;073</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;938</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-81</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="11" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="11" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="11" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Due within <br> one month</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one year <br> but less than <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Due after <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term investments with original maturity more than 90 days</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   39</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   56</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;091</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   198</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   63</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="7%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   2&nbsp;447</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 142</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;571</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;700</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;271</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;650</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;831</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 198</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 167</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;964</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;025</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;13&nbsp;623</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;22&nbsp;648</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;319</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;118</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;327</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9&nbsp;678</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;583</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;713</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;791</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;782</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;323</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16&nbsp;184</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="14" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated balance sheet amounts of financial liabilities included in the above analysis are not materially different to the contractual amounts due on maturity. The positive and negative fair values on derivative financial instruments represent the net contractual amounts to be exchanged at maturity.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s contractual undiscounted potential cash flows from derivative financial instruments to be settled on a gross basis are as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Due within <br> one month</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Derivative financial instruments and accrued interest on derivative  financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential outflows in various currencies - from financial derivative liabilities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;814</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;624</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;952</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;390</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential inflows in various currencies - from financial derivative assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 807</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;656</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 922</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;385</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="7" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="7" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="7" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Due within <br> one month</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> </div>
      </td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Derivative financial instruments and accrued interest on derivative  financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential outflows in various currencies - from financial derivative liabilities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;305</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;949</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;598</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;852</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential inflows in various currencies - from financial derivative assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;328</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;974</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 593</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;895</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-82</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Other contractual liabilities that are not part of management&#x2019;s monitoring of the net debt or liquidity consist of the following items:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br> one year <br> but less than <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> Due after <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contractual interest on non-current liabilities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;36</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;428</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;531</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;439</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;434</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;181</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;622</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;081</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;949</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;222</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;202</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;424</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;582</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;383</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one month <br> but less than <br> three months</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than<br>  three months <br> but less than <br> one year</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br> one year <br> but less than <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Due after <br> five years</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> <br> Total</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contractual interest on non-current liabilities</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;113</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;459</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;667</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;755</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;994</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;556</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;556</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;98</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;470</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;339</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Capital risk management</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis strives to maintain a strong credit rating. In managing its capital, Novartis focuses on maintaining a strong balance sheet. As of December 31, 2019, Moody&#x2019;s Investor Service rated the Company A1 for long-term maturities and P-1 for short-term maturities and S&amp;P Global Ratings rated the company AA- for long-term maturities and A-1+ for short-term maturities. </div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Value at risk</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group uses a value at risk (VAR) computation to estimate the potential 10-day loss in the fair value of its financial instruments.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A 10-day period is used because of an assumption that not all positions could be undone in one day given the size of the positions. The VAR computation includes all financial assets and financial liabilities as set forth in the table on page F-75, except:</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Trade receivables, income tax receivables and other current assets</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term loans and receivables, advances and security deposits</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Contingent considerations</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Finance lease obligations</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Lease liabilities</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Trade payables and commitment for repurchase of own shares</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The VAR estimates are made assuming normal market conditions, using a 95% confidence interval. The Group uses a &#x201C;Delta Normal&#x201D; model to determine the observed interrelationships between movements in interest rates, stock markets and various currencies. These interrelationships are determined by observing interest rate movements, stock market movements and foreign currency rate movements over a 60-day period for the calculation of VAR amounts.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimated potential 10-day loss in the fair value of the Group&#x2019;s foreign currency positions (including foreign exchange translation risk), the estimated potential 10-day loss of its equity holdings, and the estimated potential 10-day loss in fair value of its interest rate-sensitive instruments (primarily financial debt and investments of liquid funds under normal market conditions), as calculated in the VAR model, are the following:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 355</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 337</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign  currency exchange rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   89</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   217</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity  market movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   31</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   122</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to interest rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 187</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 221</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The average, high and low VAR amounts are as follows:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Average</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> High</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Low</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 348</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 385</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 303</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign  currency exchange rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   143</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   195</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   86</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity  market movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   81</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   16</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to  interest rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   233</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   303</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   187</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-83</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="5" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="5" style="border-bottom: solid #000000 1px;"></td>
      <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="5" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Average</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> High</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Low</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 443</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 553</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 337</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign  currency exchange rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   324</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   473</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   217</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity  market movements</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   60</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   122</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   22</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to  interest rates</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   253</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   361</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   169</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The VAR computation is a risk analysis tool designed to statistically estimate the potential 10-day loss from adverse movements in foreign currency exchange rates, equity prices and interest rates under normal market conditions. The computation does not purport to represent actual losses in fair value on earnings to be incurred by the Group, nor does it consider the effect of favorable changes in market rates. The Group cannot predict actual future movements in such market rates, and it does not claim that these VAR results are indicative of future movements in such market rates or are representative of any actual impact that future changes in market rates may have on the Group&#x2019;s future results of operations or financial position.</div><a name="anchorId001590623"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">30. Discontinued operations</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Discontinued operations include the operational results from the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders, and certain other expenses related to the Distribution (refer to Notes 1 and 2 for further details). </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Alcon eye care devices business researched, discovered, developed, manufactured, distributed and sold a broad range of eye care products. Alcon was organized into two global business franchises, Surgical and Vision Care. Alcon also provided services, training, education and technical support for both the Surgical and Vision Care businesses.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Consolidated income statement</font>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019<sup style="white-space: nowrap"> 1</sup></div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from discontinued operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   1&nbsp;777</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   7&nbsp;149</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">   6&nbsp;771</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing segments</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;809</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;153</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;774</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;860</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;983</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;588</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 949</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;170</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;189</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;638</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;754</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;532</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;142</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;585</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;583</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;194</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income/(loss) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;234</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;73</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;27</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income/(loss) before taxes from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 58</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;260</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;103</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 307</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net (loss)/income from discontinued operations  before gain on distribution of Alcon Inc.  to Novartis AG shareholders</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     &ndash;&nbsp;101</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc.  to Novartis AG shareholders<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   4&nbsp;691</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The consolidated income statement amounts are for the period from January 1, 2019, to the completion of the spin-off.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> See Note 2 for further details on the non-taxable non-cash gain on distribution of Alcon Inc. to Novartis AG shareholders.</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-84</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Supplemental disclosures related to the Alcon business distributed to Novartis AG shareholders</font>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net income </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Included in net income from discontinued operations are:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;42</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;235</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;217</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of right-of-use assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;174</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;052</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;066</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets<sup style="white-space: nowrap">&nbsp;2</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;391</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;57</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;93</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. See Note 1 for additional disclosures.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="8">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> 2018 includes an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Balance sheet </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following were in the balance sheet from discontinued operations for the period from January 1, 2019, to the date of reclassification:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to property, plant and equipment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 113</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="14%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 519</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to right-of-use assets<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to goodwill and intangible assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 196</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="6" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="6">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019.  See Note 1 for additional disclosures.</div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash flows used in investing activities from discontinued operations</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash flows used in investing activities from discontinued operations include the investing activities of the Alcon business, and in addition in 2017 USD 140 million cash outflows for transaction-related expenditures attributable to the series of portfolio transformation transactions completed in 2015. </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments out of provisions for  transaction costs attributable  to the spin-off of the  Alcon business</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">       &ndash;&nbsp;29</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">       </div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Divested cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;628</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows attributable to the  spin-off of the Alcon business</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">   &ndash;&nbsp;657</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   </div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other cash flows used in investing activities, net</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   &ndash;&nbsp;502</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;1&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">   &ndash;&nbsp;775</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows used in investing  activities from discontinued  operations</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">     &ndash;&nbsp;1&nbsp;159</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     &ndash;&nbsp;1&nbsp;001</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;">     &ndash;&nbsp;775</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash flows from financing activities from discontinued operations</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the net cash inflows from financing activities from discontinued operations of USD 3.3 billion (2018: USD 167 million net cash outflows, 2017: USD 415 million net cash outflows) included USD 3.5 billion cash inflows from borrowings in connection with the distribution (spin-off) of the Alcon business to Novartis AG shareholders and USD 212 million (2018: USD 57 million, 2017: nil) transaction cost payment directly attributable to the distribution (spin-off) of the Alcon business to Novartis shareholders (see Notes 1 and 2).</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-85</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Intangible assets </font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Alcon Divisions&#x2019; cash-generating units, to which goodwill is allocated, each comprise a group of smaller cash-generating units. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The valuation method of the recoverable amount of the cash-generating units, to which goodwill is allocated, is based on the fair value less costs of disposal. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2017, the Alcon brand name indefinite life intangible asset was reported in Corporate, as it was used to market products of the Alcon Division and products within the Ophthalmology business franchise of the Innovative Medicines Division. In connection with the spin-off of the Alcon Division, the Novartis Group transferred the full rights of the Alcon brand name to the Alcon Division. As a result, the Innovative Medicines Division started the process of rebranding the products within its Ophthalmology business franchise and is no longer using the Alcon brand name. The Alcon brand name indefinite life intangible asset is therefore reported in the Alcon Division in 2018. In 2018, net sales of the Alcon Division products together are the grouping of cash-generating units, which were used to determine the recoverable amount. In the year before, net sales of products within the Innovative Medicines Ophthalmology business franchise as well as Alcon Division products, which used the Alcon brand name, together were the grouping of cash-generating units, which were used to determine the recoverable amounts. The valuation method is based on the fair value less costs of disposal.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The assumptions used in the calculations of fair value were a discount rate (post-tax) of 7.5% and a terminal growth rate of 3%. The Alcon terminal growth rate assumption of 3% is higher than the expected inflation rate of the medical device industry, and more specifically the ophthalmic sub-segment of the industry. The growth rates are expected to exceed this long-term inflation rate, as the aging population to which Alcon&#x2019;s products are prescribed is growing faster than the general population. The discount rates consider the Group&#x2019;s weighted average cost of capital, adjusted to approximate the weighted average cost of capital of a comparable market participant.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value less costs of disposal, for all groupings of cash-generating units containing goodwill or indefinite life intangible assets, is reviewed for the impact of reasonably possible changes in key assumptions. In particular, we considered an increase in the discount rate, a decrease in the terminal growth rate, and certain negative impacts on the forecasted cash flows. These reasonably possible changes in key assumptions did not indicate an impairment.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">&#x201C;Note 1. Significant accounting policies&mdash;Impairment of goodwill and intangible assets&#x201D; provides additional disclosures on how the Group performs goodwill and intangible asset impairment testing.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The 2018 intangible asset and goodwill impairment charges were USD 391 million, including an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc.</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Leases</font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the receivables of the gross investments in finance leases and the net present value of the minimum lease payments, as well as unearned finance income, related to Alcon&#x2019;s surgical equipment lease arrangements. The finance income was recorded in &#x201C;Other income.&#x201D;</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td></td>
      <td colspan="9" align="center" height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr>
      <td height="1"></td>
      <td height="1"></td>
      <td colspan="9" style="border-bottom: solid #000000 1px;"></td>
      <td height="1"></td>
    </tr>
    <tr bgcolor="white">
      <td height="3"></td>
      <td height="1"></td>
      <td colspan="9" height="3"></td>
      <td height="1"></td>
    </tr>
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"><br>(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br> future <br> payments</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Unearned <br> finance <br> income</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Present <br> value</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> <br> Provision</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br> Net book <br> value</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not later than one year<sup style="white-space: nowrap">&nbsp;1</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 64</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="8%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between one and five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 117</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;28</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Later than five years</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 48</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;35</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 229</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 213</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;65</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 148</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="12" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> The current portion of the minimum lease payments was recorded in trade receivables or other current assets (to the extent not invoiced).</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The lease liabilities recorded in discontinued operations on January 1, 2019, the date of implementation of IFRS 16 leases (see Note 1), were USD 286 million, and the right-of-use assets were USD 276 million, including USD 89 million and USD 75 million, respectively, for the previously reported finance lease obligations. For discontinued operations, there were no impairments or significant contract terminations of right-of-use assets for the period from January 1, 2019, to February 28, 2019, the date of shareholder approval for the Alcon spin-off.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-86</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net assets derecognized </font>
</div>
<div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table presents the Alcon business net assets at the date of spin-off at April 8, 2019:</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="20%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;858</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;906</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;121</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 732</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other non-current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 526</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;469</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables and other current assets</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;787</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 628</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;713</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current lease liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;269</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current financial debts</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;538</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables, provisions and other liabilities</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;751</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets derecognized</div>
      </td>
      <td align="right"></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;025</div>
      </td>
      <td align="right"></td>
    </tr>
    <tr>
      <td colspan="4" style="border-bottom: solid #000000 3px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td>
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defined contribution plans</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In many subsidiaries, associates are covered by defined contribution plans. Contributions charged to the consolidated income statement for the defined contribution plans were: </div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div>
      </td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined  contribution plans  discontinued operations</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">     33</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     104</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="11%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">     99</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="8" style="border-bottom: solid #000000 3px;"></td>
    </tr>
  </table>
</div><a name=""></a><div style=" padding-bottom: 10px;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In March 2019, Alcon acquired PowerVision, Inc. (PowerVision), a privately held, US-based medical device development company focused on developing accommodative, implantable intraocular lenses. The fair value of the total purchase consideration was USD 424 million. The amount consisted of an initial cash payment of USD 289 million and the net present value of the contingent consideration of USD 135 million, due to PowerVision shareholders, which they are eligible to receive upon the achievement of specified regulatory and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 418 million, consisting of intangible assets of USD 505 million, net deferred tax liabilities of USD 93 million, other net assets of USD 6 million, and goodwill of USD 6 million. The 2019 results of operations since the date of the acquisition are not material.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional information related to the distribution (spin-off) of the Alcon business to Novartis AG shareholders, effected through a dividend in kind distribution that was completed on April 8, 2019, refer to Note 1 and Note 2.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-87</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div><a name="anchorId001592172"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">31. Events subsequent to the December 31, 2019, consolidated balance sheet date</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Significant transaction closed in January 2020</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 23, 2019, Novartis entered into an agreement and plan of merger with The Medicines Company, New Jersey, USA. The transaction was completed on January 6, 2020. For details see Note 2, significant transaction entered into in 2019 and closed in 2020.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Increase in current financial debts</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 7, 2020, Novartis borrowed USD 7 billion under a short-term credit facility with a syndicate of banks. For additional information, see Note 29.</div><a name=""></a><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Dividend proposal for 2019 and approval of&nbsp;the Group&#x2019;s 2019 consolidated financial statements</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 28, 2020, the Novartis AG Board of Directors proposed the acceptance of the 2019 consolidated financial statements of the Novartis Group for approval by the Annual General Meeting on February 28, 2020. Furthermore, also on January 28, 2020, the Board proposed a dividend of CHF&nbsp;2.95 per share to be approved at the Annual General Meeting on February 28, 2020. If approved, total dividend payments would amount to approximately USD&nbsp;7.0 billion (2018: USD&nbsp;6.6 billion), using the CHF/USD December 31, 2019, exchange rate.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-88</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><a name="anchorNote31"></a><a name="anchorId001592243"></a><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">32. Principal Group subsidiaries and&nbsp;associated&nbsp;companies </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table lists the principal subsidiaries controlled by Novartis, associated companies in which Novartis is deemed to have significant influence, and foundations required to be consolidated under IFRS. It includes all subsidiaries, associated companies and consolidated foundations with total assets or net sales to third parties in excess of USD&nbsp;25&nbsp;million. The equity interest percentage shown in the table also represents the share in voting rights in those entities, except where explicitly noted.</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>As at December 31, 2019</div>
      </td>
      <td></td>
      <td></td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share<br> capital<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br> interest</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Algeria</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Soci&#xE9;t&#xE9; par actions SANDOZ</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Algiers</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DZD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 650.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Argentina</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Argentina S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buenos Aires</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ARS</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 906.1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Australia</div>
      </td>
      <td align="right" width="1%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Australia Pty Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Macquarie Park, NSW</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Australia Pty Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Macquarie Park, NSW</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   AUD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   3.8</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pty Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Macquarie Park, NSW</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Austria</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Austria GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vienna</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vienna</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kundl</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">EBEWE Pharma Ges.m.b.H Nfg. KG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unterach am Attersee</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Bangladesh</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Bangladesh) Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gazipur</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BDT</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 162.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Belgium</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma NV</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vilvoorde</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz NV</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vilvoorde</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon - Couvreur NV</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Puurs</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Bermuda</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Investment Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Securities Investment Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance Services Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Triangle International Reinsurance Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trinity River Insurance Co Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 370&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Brazil</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Bioci&#xEA;ncias S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">S&#xE3;o Paulo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRL</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 265.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz do Brasil Ind&#xFA;stria Farmac&#xEA;utica Ltda.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Camb&#xE9;, PR</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRL</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 190.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Canada</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Canada Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dorval, Quebec</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Canada Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Boucherville, Quebec</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.8</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CIBA Vision Canada Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mississauga, Ontario</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82&nbsp;886</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Chile</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Chile S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Santiago de Chile</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CLP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">China</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Beijing Novartis Pharma Co., Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Beijing</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals (HK) Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hong Kong</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HKD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">China Novartis Institutes for  BioMedical Research Co., Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Shanghai</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   320.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Suzhou Novartis Technical Development Co., Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Changshu</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   12.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai Novartis Trading Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz (China) Pharmaceutical Co., Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Zhongshan</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   57.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Colombia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis de Colombia S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Santaf&#xE9; de Bogot&#xE1;</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> COP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.9</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Croatia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz d.o.o. farmaceutska industrija</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Zagreb</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HRK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Czech Republic</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis s.r.o.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prague</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CZK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 51.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz s.r.o.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prague</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CZK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Denmark</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare A/S</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Copenhagen</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DKK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz A/S</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Copenhagen</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DKK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ecuador</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ecuador S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Quito</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Egypt</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma S.A.E.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cairo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EGP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 193.8</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.77%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Egypt Pharma S.A.E.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">New Cairo City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EGP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Finland</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finland Oy</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Espoo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 459&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>As at December 31, 2019</div>
      </td>
      <td></td>
      <td></td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share<br> capital<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br> interest</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">France</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Groupe France S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 903.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma S.A.S.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Saint-Genis-Pouilly</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CELLforCURE</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Les Ulis</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.A.S.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Levallois-Perret</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Germany</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Deutschland GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nuremberg</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 155.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nuremberg</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Produktions GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Wehr</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Manufacturing GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marburg</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz International GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1 A Pharma GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oberhaching</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">HEXAL AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Salutas Pharma GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barleben</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 42.1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Aeropharm GmbH</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rudolstadt</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Greece</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Hellas) S.A.C.I.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Metamorphosis / Athens</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Hungary</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Hungary Healthcare Limited Liability  Company</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Budapest</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   HUF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   545.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Hungary Limited Liability Company</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Budapest</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HUF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 883.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">India</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis India Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 123.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 70.68%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare Private Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Private Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Indonesia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">PT. Novartis Indonesia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Jakarta</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> IDR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ireland</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ireland Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dublin</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ringaskiddy Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ringaskiddy, County Cork</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Israel</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Israel Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tel Aviv</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ILS</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Italy</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farma S.p.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Origgio</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications (Italy) S.r.l.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pozzilli</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.p.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Origgio</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Japan</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Holding Japan K.K.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma K.K.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ciba-Geigy Japan Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz K.K.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Latvia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Baltics SIA</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Riga</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Luxembourg</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Investments S.&#xE0; r.l.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Malaysia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Corporation (Malaysia) Sdn. Bhd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kuala Lumpur</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MYR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.3</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Mexico</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farmac&#xE9;utica, S.A. de C.V.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mexico City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MXN</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 205.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz, S.A. de C.V.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mexico City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MXN</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 468.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Morocco</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Maroc SA</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Casablanca</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MAD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Netherlands</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Netherlands B.V.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amsterdam</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma B.V.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amsterdam</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">IDB Holland BV</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Baarle-Nassau</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz B.V.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Almere</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 907&nbsp;560</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">New Zealand</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis New Zealand Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Auckland</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> NZD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 820&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-89</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>As at December 31, 2019</div>
      </td>
      <td></td>
      <td></td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share<br> capital<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br> interest</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Norway</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Norge AS</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oslo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> NOK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Pakistan</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma (Pakistan) Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Karachi</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PKR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.99%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Panama</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma (Logistics), Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Panama City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Peru</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Biosciences Per&#xFA; S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lima</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PEN</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Philippines</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare Philippines, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Makati City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PHP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 298.8</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Philippines Corporation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Makati City</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PHP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Poland</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Poland Sp. z o.o.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Warsaw</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Polska Sp. z o.o.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Warsaw</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lek S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Strykow</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Portugal</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Portugal SGPS Lda.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farma - Produtos Farmac&#xEA;uticos S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Farmac&#xEA;utica Lda.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 499&nbsp;900</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Romania</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Services Romania S.R.L.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bucharest</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RON</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.R.L.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Targu-Mures</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RON</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 105.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Russian Federation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma LLC</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Moscow</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Neva LLC</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">St. Petersburg</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ZAO Sandoz</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Moscow</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Saudi Arabia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Saudi Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Riyadh</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SAR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26.8</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Singapore</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Singapore) Pte Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Singapore</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Singapore Pharmaceutical  Manufacturing Pte Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Singapore</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   SGD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   45.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Asia Pacific Pharmaceuticals Pte Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Singapore</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   SGD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   39.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Slovakia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Slovakia s.r.o.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bratislava</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Slovenia</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lek Pharmaceuticals d.d.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pharmaceuticals d.d.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">South Africa</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis South Africa (Pty) Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Midrand</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ZAR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86.3</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz South Africa (Pty) Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kempton Park</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ZAR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">South Korea</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Korea Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Seoul</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> KRW</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.55%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Spain</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farmac&#xE9;utica, S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barcelona</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 63.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications Iberica, S.L.U.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Esplugues de Llobregat</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   22.6</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Farmac&#xE9;utica S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Madrid</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270&nbsp;450</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Industrial Products  S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Les Franqueses del Vall&#xE9;s / Barcelona</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   9.3</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon Cusi S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">El Masnou / Barcelona</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Abadia Retuerta S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sard&#xF3;n de Duero / Valladolid</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sweden</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Sverige AB</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stockholm</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SEK</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Switzerland</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Holding AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International Pharmaceutical Investment AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Bioventures AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Forschungsstiftung</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Stiftung f&#xFC;r Kaderausbildung</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Mitarbeiterbeteiligungsstiftung</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Stiftung f&#xFC;r Mensch und Umwelt</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stiftung der Novartis AG f&#xFC;r Erziehung, Ausbildung und Bildung</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Overseas Investments AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japat AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 350.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International Pharmaceutical AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Services AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Schweizerhalle AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Muttenz</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.9</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Stein AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stein</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 251&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Schweiz AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Risch</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ophthalmics AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fribourg</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications International SA</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Geneva</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.3</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pharmaceuticals AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Risch</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 160.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33/6<sup style="white-space: nowrap"> 2</sup></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
  </table>
</div>
<div style="padding-top:10px; padding-bottom:30px;">
  <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%">
    <tr valign="bottom">
      <td height="12">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"><br>As at December 31, 2019</div>
      </td>
      <td></td>
      <td></td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share<br> capital<sup style="white-space: nowrap">  1</sup></div>
      </td>
      <td></td>
      <td></td>
      <td align="right">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br> interest</div>
      </td>
      <td></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 2px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Taiwan</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Taiwan) Co., Ltd.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taipei</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TWD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 170.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Thailand</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Thailand) Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bangkok</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> THB</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 302.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Turkey</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Saglik, Gida ve Tarim &#xDC;r&#xFC;nleri Sanayi  ve Ticaret A.S.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Istanbul</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   TRY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   98.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Farmanova Saglik Hizmetleri Ltd. Sti.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Istanbul</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.7</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Ila&#xE7; Sanayi ve Ticaret A.S.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Istanbul</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.99%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Grup Saglik &#xDC;r&#xFC;nleri Ila&#xE7;lari Sanayi ve Ticaret A.S.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Gebze - Kocaeli</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   TRY</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   50.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ukraine</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Ukraine LLC</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kyiv</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> UAH</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United Arab Emirates</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Middle East FZE</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dubai</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AED</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United Kingdom</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis UK Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.5</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals UK Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.4</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Grimsby Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Imaging Equipment Ltd</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vivacta Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frimley / Camberley</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.9</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ziarco Group Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;904</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Limited</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frimley / Camberley</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United States of America</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Corporation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 72.2</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance Corporation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ<sup style="white-space: nowrap">&nbsp;3</sup></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Capital Corporation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Services, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis US Foundation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Corporation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 650</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications USA, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Millburn, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">AveXis, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bannockburn, IL</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Inflammasome Research, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Technology LLC</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Institutes for BioMedical  Research, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cambridge, MA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">   100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CoStim Pharmaceuticals Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cambridge, MA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Encore Vision, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Endocyte, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Navigate BioPharma Services, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Carlsbad, CA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reprixys Pharmaceuticals Corporation</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Spinifex Pharmaceuticals, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Institute for Functional Genomics, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">San Diego, CA</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oriel Therapeutics, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Durham, NC</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fougera Pharmaceuticals Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Melville, NY</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Eon Labs, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Vaccines and Diagnostics, Inc.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Venezuela</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr valign="bottom" bgcolor="#ffffff">
      <td height="16">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis de Venezuela, S.A.</div>
      </td>
      <td align="right" width="9%"></td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Caracas</div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> VES</div>
      </td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div>
      </td>
      <td width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div>
      </td>
      <td align="right" width="1%"></td>
      <td align="right" width="9%">
        <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div>
      </td>
      <td align="right" width="1%"></td>
    </tr>
    <tr>
      <td colspan="10" style="border-bottom: solid #000000 1px;"></td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">In addition, the Group is represented by subsidiaries and associated companies with total assets or net sales to third parties below USD 25 million in the following countries: Bosnia/Herzegovina, Bulgaria, Dominican Republic, Guatemala, Kenya, North Macedonia, Nigeria, Puerto Rico, Uruguay and Vietnam</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;1&nbsp;</sup> Share capital may not reflect the taxable share capital and does not include any paid-in surplus.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;2&nbsp;</sup> Approximately 33% of voting shares; approximately 6% of total net income and equity attributable to Novartis.</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"><sup>&nbsp;3&nbsp;</sup> Significant subsidiary under SEC Regulation S-X Rule 1-02(w)</div>
      </td>
    </tr>
    <tr valign="bottom">
      <td height="10px" colspan="10">
        <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">m = million; bn = billion</div>
      </td>
    </tr>
  </table>
</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-90</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
    <a name="anchorId001731895"></a><p style="font-family:arial,helvetica,sans-serif; font-size:24pt; color:#000000; font-weight:bold;">Report of Independent Registered Public Accounting Firm</p><a name=""></a><div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">To the shareholders and Board of Directors of Novartis AG</font>
</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Opinions on the Financial Statements and Internal Control over Financial Reporting</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We have audited the accompanying consolidated balance sheets of Novartis AG and its subsidiaries (the &#x201C;Group&#x201D;) as of December 31, 2019 and December 31, 2018, and the related consolidated income statements, consolidated statements of comprehensive income, consolidated statements of changes in equity, and consolidated statements of cash flows for each of the three years in the period ended December 31, 2019, including the related notes (collectively referred to as the &#x201C;consolidated financial statements&#x201D;). We also have audited the Group&#x2019;s internal control over financial reporting as of December 31, 2019, based on criteria established in <i>Internal Control &ndash; Integrated Framework</i> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Group as of December 31, 2019 and December 31, 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019 in conformity with International Financial Reporting Standards (&#x201C;IFRS&#x201D;) as issued by the International Accounting Standards Board. Also in our opinion, the Group maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in <i>Internal Control &ndash; Integrated Framework</i> (2013) issued by the COSO. </div>
<div>
  <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;font-style:italic;">Change in Accounting Principle</div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As discussed in Notes 1 and 10 to the consolidated financial statements, the Group changed the manner in which it accounts for leases in 2019 in accordance with the provision of the new IFRS 16 Leases standard.</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Basis for Opinions</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in &#x201C;Report of Novartis Management on Internal Control Over Financial Reporting&#x201D; appearing under Item 15(b). The Board of Directors is also responsible for the preparation of the consolidated financial statements in accordance with IFRS, and for such internal control as the Board of Directors determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error. Our responsibility is to express opinions on the Group&#x2019;s consolidated financial statements and on the Group&#x2019;s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Definition and Limitations of Internal Control over Financial Reporting</font>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">A company&#x2019;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS. A company&#x2019;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with IFRS, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#x2019;s assets that could have a material effect on the financial statements.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-91</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</div><a name=""></a><div>
  <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Critical Audit Matters</font>
</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. </div>
<div>
  <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;font-style:italic;">Valuation of the dividend in kind distribution liability of the Alcon business</div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As described in Notes 1 and 2 to the consolidated financial statements, the shareholder approval to spin off the Alcon business required the recognition of a distribution liability at the fair value of the Alcon business. At the April 8, 2019 distribution date, the fair value of the distribution liability of the Alcon business amounted to USD 23.4 billion. The total non-taxable, non-cash gain recognized at the completion of the spin-off of the Alcon business on April 8, 2019, amounted to USD 4.7 billion. The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. The estimates used in calculating the Alcon business&#x2019; future cash flows depend on assumptions specific to the nature of Alcon&#x2019;s activities with regard to the amount and timing of projected future cash flows; long-term sales forecasts; actions of competitors (launch of competing products, marketing initiatives, etc.); sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition; outcome of research and development activities (compound efficacy, results of clinical trials, etc.); amount and timing of projected costs to develop IPR&amp;D into commercially viable products; profit margins; probability of obtaining regulatory approval; future tax rate; terminal growth rate; and discount rate.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The principal considerations for our determination that performing procedures relating to the valuation of the dividend in kind distribution liability of the Alcon business is a critical audit matter are there was significant judgment by management when developing the amount and timing of projected future cash flows (specifically the terminal growth rate, long-term sales forecasts and profit margin assumptions) and the discount rate. This in turn led to a high degree of auditor judgment, subjectivity, and effort in performing procedures to evaluate these assumptions. In addition, the audit effort involved the use of professionals with specialized skill and knowledge to assist in performing these procedures and evaluating the audit evidence obtained.</div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management&#x2019;s valuation of the distribution liability, including controls over the key assumptions used in the projected future cash flows and the discount rate. These procedures also included, among others, testing management&#x2019;s process for developing the fair value estimate; evaluating the appropriateness of the discounted cash flow model; testing the completeness, accuracy, and relevance of underlying data used in the model; and evaluating the significant assumptions, including the amount and timing of projected future cash flows (specifically the terminal growth rate, long-term sales forecasts and profit margin assumptions) and the discount rate. Evaluating management&#x2019;s assumptions related to the amount and timing of projected future cash flows and the discount rate involved evaluating whether the assumptions used by management were reasonable considering the current and past performance of the Alcon business, the consistency with external market and industry data, and whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of Alcon&#x2019;s discounted cash flow model and certain significant assumptions, including the terminal growth rate and the discount rate.</div>
<div>
  <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;font-style:italic;">Carrying value of the Innovative Medicines division intangible assets </div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As described in Notes 1 and 11 to the consolidated financial statements, the Group has intangible assets in its Innovative Medicines division other than goodwill totaling USD 27.6 billion at December 31, 2019, comprising in-process research and development (IPR&amp;D), currently marketed products, and other intangible assets. The Group recognized impairments of intangible assets in its Innovative Medicines division other than goodwill of USD 669 million during the year. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal that is used to determine if the asset is impaired. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. The estimates used in calculating the net present values depend on assumptions specific to the nature of the Innovative Medicines division&#x2019;s activities with regard to the amount and timing of projected future cash flows; long-term sales forecasts; actions of competitors (launch of competing products, marketing initiatives, etc.); sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition; outcome of research and development activities (compound efficacy, results of clinical trials, etc.); amount and timing of projected costs to develop IPR&amp;D into commercially viable products; profit margins; probability of obtaining regulatory approval; future tax rate; and discount rate.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-92</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The principal considerations for our determination that performing procedures relating to the carrying value of the Innovative Medicines division intangible assets is a critical audit matter are there was significant judgment by management when developing the amount and timing of projected future cash flows (specifically the long-term sales forecasts and the probability of obtaining regulatory approval) and the discount rate. This in turn led to a high degree of auditor judgment, subjectivity, and effort in performing procedures to evaluate these assumptions. In addition, the audit effort involved the use of professionals with specialized skill and knowledge to assist in performing these procedures and evaluating the audit evidence obtained. </div>
<div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the key assumptions used in the impairment testing of the intangible assets. These procedures also included, among others, testing management&#x2019;s process for developing the fair value estimate; evaluating the appropriateness of the discounted cash flow model; testing the completeness, accuracy, and relevance of underlying data used in the model; and evaluating the significant assumptions used by management, including the amount and timing of projected future cash flows and the discount rate. Evaluating management&#x2019;s assumptions related to the amount and timing of projected future cash flows and the discount rate involved evaluating whether the assumptions used by management were reasonable considering the current and past performance of the intangible, the consistency with external market and industry data, and whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the discount rate. </div>
<div>
  <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;font-style:italic;">Valuation of the US Managed Care, Medicare Part D, Medicaid and indirect rebates</div>
</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As described in Note 1 and 22 to the consolidated financial statements, the consideration Novartis receives in exchange for its goods or services may be fixed or variable. Variable consideration is only recognized when it is highly probable that a significant reversal will not occur. Rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers are provisioned and recorded as a deduction from revenue at the time the related revenues are recorded or when the incentives are offered. They are calculated on the basis of historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors. The provision reported as of December 31, 2019 for revenue deductions amounted to USD 5.6 billion, with a significant portion of which related to US Managed Care, Medicare Part D, Medicaid and indirect rebates. </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The principal considerations for our determination that performing procedures relating to the valuation of the US Managed Care, Medicare Part D, Medicaid and indirect rebates is a critical audit matter are there was significant judgment by management due to the measurement uncertainty involved in developing these provisions, as the provisions are based on assumptions developed using historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors. This in turn led to a high degree of auditor judgment, subjectivity and effort in applying procedures relating to these assumptions. In addition, the audit effort involved the use of professionals with specialized skill and knowledge to assist in performing these procedures and evaluating the audit evidence obtained.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to provisions for the US Managed Care, Medicare Part D, Medicaid and indirect rebate programs, including controls over the assumptions used to estimate these rebates. These procedures also included, among others, developing an independent estimate of the rebates by utilizing third-party information, the terms and regulation of the specific rebate programs, and the historical trend of actual rebate claims paid; comparing the independent estimate to management&#x2019;s estimates; and testing rebate claims processed by the Group, including evaluating those claims for consistency with the contractual and mandated terms of the Group&#x2019;s rebate arrangements. Professionals with specialized skill and knowledge were used to evaluate whether the policy is in compliance with government regulations.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">/s/ PricewaterhouseCoopers AG</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Basel, Switzerland</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">January 28, 2020</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">We have served as the Group&#x2019;s or its predecessors&#x2019; auditor since at least 1940. We have not been able to determine the specific year we began serving as auditor of the Group&#x2019;s predecessors.</div>
<div style="padding-bottom:10px;"></div>
<div style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
  <div style="TEXT-ALIGN: center; WIDTH: 100%">
    <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">F-93</font>
    <div style="padding-bottom:10px;"></div>
    <hr style="HEIGHT: 2px; WIDTH: 100%; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px" noshade size="3">
  </div>
  <div style="padding-bottom:30px;"></div>
</div>




<br>
<img src="x_coverback.jpg">
<br>
<br>




</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>2
<FILENAME>a20012920f-ex1_1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>

<html>
<head>
<title>EXHIBIT 1.1</title>
</head>
<body bgcolor="#ffffff">

  <div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">
<table id="z5497beb06e37450ab11a1bb36b8c8d5a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 12.48%; VERTICAL-ALIGN: top">&#160;<img src="deckblatt.jpg"></td>
<td style="WIDTH: 87.52%; VERTICAL-ALIGN: top">&#160;

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: right">Exhibit 1.1</div>

<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 12pt">&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div><br>
 &#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 12pt">Articles of Incorporation<font style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'"><br>
</font> of Novartis AG</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 486pt">February 28, 2019<br>
&#160;<br>
<br>
 &#160;</div>

<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 12pt"><img src="logo.jpg"></div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">
<table id="z0bf501f5dc854bb2ae47bdac1f9f8933" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Articles of Incorporation were adopted at the Extraordinary</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">General Meeting of Novartis AG&#160; held on October 15, 1996.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Alterations adopted by General Meetings of:</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">April 21, 1999</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">October 11, 2000 (extraordinary GM)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">March 22, 2001</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">March 21, 2002</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">March 4, 2003</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 24, 2004</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">March 1, 2005</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 28, 2006</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 26, 2008</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 24, 2009</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 26, 201<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">0</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">April 8, 2011 (extraordinary GM)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 23, 2012</div>
</td>
</tr>

<tr style="HEIGHT: 17px">
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 27, 2015</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 23, 2016</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">February 28, 2017</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">March 2, 2018</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">February 28, 2019&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">(The original German text remains, in all matters, binding and definitive)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left">Novartis AG</div>
</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4002 Basel, Switzerland</div>
</td>
</tr>

<tr style="HEIGHT: 16px">
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#169;&#160;February 2019, Novartis AG</div>
</td>
</tr>
</table>
</div>
</div>

<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z245b0a5f48be43b7b79bd0c3d9a66305" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 56px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BORDER-BOTTOM-COLOR: ">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 1</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 1px; BORDER-BOTTOM-COLOR: ">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div>
<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Corporate Name, <font style="COLOR: #0460a9">Registered </font>Office, Purpose and Duration </div>
</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">3</td>
</tr>

<tr style="HEIGHT: 33px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 2</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div>
<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Share Capital</div>
</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">3</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 3</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div>
<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Corporate Bodies</div>
</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">5</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">A. General Meeting of Shareholders</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">5</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">B. Board of Directors</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">8</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">C. Auditors</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">11</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 4</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #0460a9 1px solid">
<div>
<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Compensation of the Board of Directors and the Executive Committee</div>
</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">12</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 5</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #0460a9 1px solid">
<div>
<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Annual Financial Statements, Consolidated Financial Statements and Profit Allocation</div>
</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">15</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: bottom">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 6</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 60%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid">
<div>
<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Publications and Place of Jurisdiction</div>
</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 15%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #0460a9 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">15</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">1</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>
</div>

<div>
<div>&#160;</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<div>
<table id="z6bb05d6c9224478cbe759b75b72dbfd2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 1</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Corporate Name, Registered Office, Purpose and Duration</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 1</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Corporate name, Registered office</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Under the Corporate name</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Novartis AG</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Novartis SA</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Novartis Inc.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">there exists a company limited by shares with its registered office in Basel.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 2</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Purpose</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Purpose of the Company is to hold interests in enterprises in the area of health care or nutrition. The Company may also hold interests in enterprises in the areas of biology, chemistry, physics, information technology or related areas.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Company may acquire, mortgage, liquidate or sell real estate and intellectual property rights in Switzerland or abroad.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">In pursuing its purpose, the Company strives to create sustainable value.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 3</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Duration</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The duration of the Company is unlimited.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 2</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Share Capital</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 4</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Share capital</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The share capital of the Company is CHF 1,263,687,410, fully paid-in and divided into 2,527,374,820 registered shares. Each share has a nominal value of CHF 0.50.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Upon resolution of the General Meeting of Shareholders registered shares may be converted into bearer shares and reversed bearer shares may be converted into registered shares.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 5</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Shareholders register and restrictions of registration, Nominees</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Company shall maintain a shareholders register showing the last names, first names, domicile, address and nationality (in the case of legal entities the registered office) of the holders or usufructuaries of registered shares.</div>
</td>
</tr>
</table>
</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">3</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z976d490aa9f642a1a74aa878a947db30" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Upon request acquirers of registered shares are registered in the shareholders register as shareholders with the right to vote, provided that they declare explicitly to have acquired the registered shares in their own name and for their own account. Subject to the restrictions set forth in paragraph 6 of this article, no person or entity shall be registered with the right to vote for more than 2% of the registered share capital as set forth in the commercial register. This restriction of registration also applies to persons who hold some or all of their shares through nominees pursuant to this article. All of the foregoing is subject to Article 685d paragraph 3 of the Swiss Code of Obligations.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors may register nominees with the right to vote in the share register to the extent of up to 0.5% of the registered share capital as set forth in the commercial register. Registered shares held by a nominee that exceed this limit may be registered in the shareholders register if the nominee discloses the names, addresses and the number of shares of the persons for whose account it holds 0.5% or more of the registered share capital as set forth in the commercial register. Nominees within the meaning of this provision are persons who do not explicitly declare in the request for registration to hold the shares for their own account and with whom the Board of Directors has entered into a corresponding agreement.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Corporate bodies and partnerships or other groups of persons or joint owners who are interrelated to one another through capital ownership, voting rights, uniform management or otherwise linked as well as individuals or corporate bodies and partnerships who act in concert to circumvent the regulations concerning the limitation of participation or the nominees (especially as syndicates), shall be treated as one single person or nominee within the meaning of paragraphs 2 and 3 of this article.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">5</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">After hearing the registered shareholder or nominee, the Board of Directors may cancel registrations in the shareholders register with retroactive effect as of the date of registration if the registration was effected based on false information. The respective shareholder or nominee shall be informed immediately of the cancellation of the registration.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">6</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors shall specify the details and give the necessary orders concerning the adherence to the preceding regulations. In particular cases it may allow exemptions from the limitation for registration in the share register or the regulation concerning nominees. It may delegate its duties.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">7</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The limitation for registration in the share register provided for in this article shall also apply to shares acquired or subscribed by the exercise of subscription, option or conversion rights.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zee323b19d4694cbc92cd7adca538eb22" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 6</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Form of shares</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Subject to paragraphs 2 and 4 of this article, the registered shares of the Company are issued as uncertificated securities (in<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>terms of the Swiss Code of Obligations) and as book entry securities (in terms of the Book Entry Securities Act).</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Company may withdraw shares issued as book entry securities from the custodian system (Verwahrungssystem).</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Provided that the shareholder is registered in the shareholders register, the shareholder may request from the Company a statement of his or her registered shares at any time.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The shareholder has no right to the printing and delivery of certificates. The Company may, however, print and deliver certificates (individual share certificates, certificates or global certificates) for shares at any time. The Company may, with the consent of the shareholder, cancel issued certificates that are returned to the Company.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 7</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Exercise of rights</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The shares are not divisible. The Company accepts only one representative per share.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The right to vote and the other rights associated with a registered share may only be exercised vis-&#224;-vis the Company by a shareholder, usufructuary or nominee who is registered in the share register.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 3</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Corporate Bodies</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">A. General Meeting of Shareholders</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 8</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Competence</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The General Meeting of Shareholders is the supreme body of the Company.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 9</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">General Meetings</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">a. Annual General Meeting</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Annual General Meeting of Shareholders shall be held each year within six months after the close of the financial year of the Company; at the latest twenty days before the meeting the annual report and the reports of the auditors shall be made available for inspection by the Shareholders at the registered office of the Company. Notification thereof may be made by way of a publication in the publication organs set forth in Article 38 of these Articles of Incorporation.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">5</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zb00873bdddc54c179efbf3c369ad7f31" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 10</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px" rowspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">b. Extraordinary General Meetings of Shareholders</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Extraordinary General Meetings of Shareholders shall take place upon request of the Board of Directors or the Auditors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Furthermore, Extraordinary General Meetings of Shareholders shall be convened upon resolution of a General Meeting of Shareholders or if it is required by one or more shareholders who are representing in the aggregate not less than one tenth of the share capital and submit a petition signed by such shareholder or shareholders specifying the items for the agenda and the proposals.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 11</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Convening of General Meetings of Shareholders</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">General Meetings of Shareholders shall be convened by the Board of Directors at the latest twenty days before the date of the meeting. The meeting shall be convened by way of a notice appearing once in the official publication organs of the Company. Registered shareholders may also be informed by mail.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The notice of a meeting shall state the items on the agenda and the proposals of the Board of Directors and as the case may be of the shareholders who demanded that a General Meeting of Shareholders be convened and, in case of elections, the names of the nominated candidates.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 12</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Agenda</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">One or more shareholders whose combined shareholdings represent an aggregate nominal value of at least CHF 1 million may demand that an item be included in the agenda of a General Meeting of Shareholders. Such a demand must be made in writing at the latest forty-five days before the meeting and shall specify the items and the proposals of such a shareholder.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">No resolution shall be passed at a General Meeting of Shareholders on matters for which no proper notice was given. This provision shall not apply to proposals to convene an Extraordinary General Meeting of Shareholders or to initiate a special audit.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 13</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Presiding officer, Minutes, Vote counters</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The General Meeting of Shareholders shall take place at the registered office of the Company, unless the Board of Directors decides otherwise. The Chairman of the Board of Directors or in his absence a Vice-Chairman or any other member of the Board of Directors designated by the Board of Directors shall take the chair.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The presiding officer shall appoint a secretary and the vote counters. The minutes shall be signed by the presiding officer and the secretary.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">6</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z3354ebff2a1b46cdbb3152f0d7dd246c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div>&#160;</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 14</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Proxies</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors may issue regulations regarding the participation and the representation at the General Meeting of Shareholders and may allow electronic proxies without qualified signatures.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">A shareholder shall only be represented by his legal representative, another shareholder with the right to vote, or the Independent Proxy (in German: <font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">Unabh&#228;ngiger Stimmrechtsvertreter</font>).</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The General Meeting of Shareholders shall elect the Independent Proxy for a term of office lasting until completion of the next Annual General Meeting of Shareholders. Re-election is possible.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">If the Company does not have an Independent Proxy, the Board of Directors shall appoint the Independent Proxy for the next General Meeting of Shareholders.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 15</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Voting rights</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Each share provides entitlement to one vote.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 16</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Resolutions, Elections</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Unless the law requires otherwise, the General Meeting passes resolutions and elections with the absolute majority of the votes validly represented.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Resolutions and elections shall be taken either on a show of hands or by electronic voting, unless the General Meeting decides for, or the presiding officer orders, a secret ballot.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The presiding officer may at any time order to repeat an election or resolution taken on a show of hands with a secret ballot, if he doubts the results of the vote. In this case, the preceding election or resolution taken on a show of hands is deemed not to have taken place.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">If no election has taken place at the first ballot and if there is more than one candidate, the presiding officer shall order a second ballot in which the relative majority shall be decisive.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">7</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zdab45def94084f94bc4df43e736c4879" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 17</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Powers of the General Meeting of Shareholders</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The following powers shall be vested exclusively in the General Meeting of Shareholders:</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To adopt and amend the Articles of Incorporation;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To elect and remove the members of the Board of Directors, the Chairman of the Board of Directors, the members of the Compensation Committee, the Independent Proxy and the Auditors;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To approve the management report (if required) and the consolidated financial statements;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To approve the financial statements and to decide on the appropriation of available earnings shown on the balance sheet, in particular with regard to dividends;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To approve the aggregate amounts of compensation of the Board of Directors and the Executive Committee in accordance with Article 29 of these Articles of Incorporation;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To grant discharge to the members of the Board of Directors and to the members of the Executive Committee;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">To decide on matters that are reserved by law or by the Articles of Incorporation to the General Meeting of Shareholders.</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 18</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Special quorum</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The approval of at least two-thirds of the votes represented is required for resolutions of the General Meeting of Shareholders on:</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">An alteration of the purpose of the Company;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The creation of shares with increased voting powers;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">An implementation of restrictions on the transfer of registered shares and the removal of such restrictions;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">An authorized or conditional increase of the share capital;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">An increase of the share capital out of equity, by contribution in kind or for the purpose of an acquisition of property and the grant of special rights;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A restriction or suspension of rights of option to subscribe;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A change of location of the registered office of the Company;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">h)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The dissolution of the Company.</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">B. Board of Directors</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 19</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Number of Directors</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors shall consist of a minimum of 8 and a maximum of 16 members.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 20</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Term of office</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The members of the Board of Directors and the Chairman of the Board of Directors shall be elected individually by the General Meeting of Shareholders for a term of office lasting until completion of the next Annual General Meeting of Shareholders.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">8</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z88d067bf2fcc4c9da6790de821564c8f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Members whose term of office has ended may be immediately re-elected, subject to paragraph 3 hereinafter.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Individuals who have turned 70 years of age at the date of the General Meeting of Shareholders may no longer be elected as members of the Board of Directors. The General Meeting of Shareholders may, under special circumstances, grant exceptions to this rule.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 21</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Organization</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors constitutes itself in compliance with legal requirements and taking into consideration the resolutions of the General Meeting of Shareholders. It shall elect one or two Vice<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">-</font>Chairmen. It shall appoint a secretary, who need not be a member of the Board of Directors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">If the office of the Chairman of the Board of Directors is vacant, the Board of Directors shall appoint a new Chairman from amongst its members for the remaining term of office.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 22</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Convening of meetings</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Chairman shall convene meetings of the Board of Directors if and when the need arises or if a member so requires in writing.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 23</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Resolutions</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">For the Board of Directors to pass resolutions, at least a majority of its members must be present. No such quorum shall be required for resolutions of the Board of Directors providing for the confirmation of capital increases or for the amendment of the Articles of Incorporation in connection with increases of the share capital.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The adoption of resolutions by the Board of Directors requires a majority of the votes cast. The Chairman shall not have the deciding vote.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Resolutions may also be passed via teleconference, or<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">,</font> unless a member calls for an oral deliberation<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">,</font> in writing by way of a circular or electronic data transfer.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">9</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zfc23a4d44dae45b2a263546f61c0d96e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div>&#160;</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 24</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Powers of the Board of Directors</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors has in particular the following non-delegable and inalienable duties:</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The ultimate direction of the Company&#8217;s business and issuing of the necessary directives;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of the organization of the Company;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of the principles of accounting, financial controlling and financial planning;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The appointment and removal of the persons entrusted with the management and representation of the Company (including the CEO and the other members of the Executive Committee);</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The ultimate supervision of the persons entrusted with the management of the Company, specifically in view of their compliance with the law, Articles of Incorporation, regulations and directives;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The preparation of the annual report and the compensation report in accordance with the provisions of the law and the Articles of Incorporation;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The preparations for the General Meeting of Shareholders and carrying out of the resolutions of the General Meeting of Shareholders;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">h)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The notification to the court in the event of over-indebtedness; and</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The adoption of resolutions concerning increases in share capital to the extent that such power is vested in the Board of Directors (Article 651 paragraph 4 of the Swiss Code of Obligations), as well as resolutions concerning the confirmation of capital increases and respective amendments to the Articles of Incorporation.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">In addition<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">,</font> the Board of Directors can pass resolutions with respect to all matters which are not reserved to the authority of the General Meeting of Shareholders by law or by these Articles of Incorporation.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 25</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Delegation of powers</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors may, within the limits of the law and the Articles of Incorporation, delegate the management of the Company in whole or in part to one or several of its members (including to ad hoc or permanent committees of the Board of Directors) or to third persons (Executive Committee).</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 26</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Signature power</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors shall designate those of its members as well as those third persons who shall have legal signatory power for the Company<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">,</font> and shall further determine the manner in which such persons may sign on behalf of the Company.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">10</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z01aa4f96e0114eb5ae3d9033567abc9d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div>&#160;</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 27</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px" rowspan="2">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Organization and powers of the Compensation Committee</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Compensation Committee shall consist of a minimum of 3 and a maximum of 5 members of the Board of Directors.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The members of the Compensation Committee shall be elected individually by the General Meeting of Shareholders for a term of office lasting until completion of the next Annual General Meeting of Shareholders. Members of the Compensation Committee whose term of office has expired shall be immediately eligible for re-election.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">If there are vacancies on the Compensation Committee, the Board of Directors shall appoint substitutes for the remaining term of office.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors shall elect a chairman of the Compensation Committee. The Board of Directors shall, within the limits of the law and the Articles of Incorporation, define the organization of the Compensation Committee in regulations.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">5</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Compensation Committee has the following powers:</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Develop a compensation strategy in line with the principles described in the Articles of Incorporation and submit it for approval to the Board of Directors;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Propose to the Board of Directors the principles and structure of the compensation plans;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Support the Board of Directors in preparing the proposals to the General Meeting of Shareholders regarding the compensation of the members of the Board of Directors and the Executive Committee;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Submit the compensation report to the Board of Directors for approval;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Inform the Board of Directors about policies, programs and key decisions as well as comparisons of compensation levels at key competitors;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Regularly report to the Board of Directors on the decisions and deliberations of the Compensation Committee;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Assume other responsibilities assigned to it by law, the Articles of Incorporation or by the Board of Directors.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">6</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors issues regulations to determine for which positions of the Board of Directors and of the Executive Committee the Compensation Committee shall submit proposals regarding compensation, and for which positions it shall determine the compensation in accordance with the Articles of Incorporation.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">C. Auditors</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 28</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Term, Powers and Duties</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Auditors, who shall be elected by the General Meeting of Shareholders each year, shall have the powers and duties vested in them by law.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">11</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zf2b4cdd097e8421b9d4e395594af46ba" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 4</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Compensation of the Board of Directors and the Executive Committee</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 29</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Approval of compensation by <br>
 the General Meeting of Shareholders</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The General Meeting of Shareholders shall approve annually and separately the proposals of the Board of Directors in relation to the maximum aggregate amount of:</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Compensation of the Board of Directors for the period until the next Annual General Meeting of Shareholders; and</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Compensation of the Executive Committee paid, promised or granted for the following financial year.</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors may submit for approval by the General Meeting of Shareholders additional proposals relating to the same or different periods.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">If the General Meeting of Shareholders rejects the proposal of the Board of Directors for the total compensation of the Board of Directors and/or the Executive Committee, the decision on how to proceed shall reside with the Board of Directors. The options for the Board of Directors shall be to either convene an Extraordinary General Meeting to submit a new compensation proposal, or to determine the compensation for the corresponding period on an interim basis, subject to approval at the next Annual General Meeting of Shareholders.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Notwithstanding the preceding paragraphs, the Company or companies controlled by it may pay out compensation prior to approval by the General Meeting of Shareholders subject to subsequent approval by a General Meeting of Shareholders.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors shall submit the compensation report to an advisory vote of the General Meeting of Shareholders.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 30</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Additional amount</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">If the maximum aggregate amount of compensation already approved by the General Meeting of Shareholders is not sufficient to also cover the compensation of one or more members who become members of or are promoted within the Executive Committee during a compensation period for which the General Meeting of Shareholders has already approved the compensation of the Executive Committee, the Company or companies controlled by it shall be authorized to pay or grant to such member(s) an additional amount during the compensation period(s) already approved. The total additional amount for each relevant compensation period for which approval by the General Meeting of Shareholders has already been obtained shall not exceed (in full and not <font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">pro rata temporis</font>) 40% of the aggregate amount of compensation of the Executive Committee last approved by the General Meeting of Shareholders per compensation period.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">12</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z811626679b17461b9b86b643550c0396" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 31</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">General compensation principles</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Compensation of the non-executive members of the Board of Directors comprises fixed compensation elements only. In particular, non-executive members of the Board of Directors shall receive no company contributions to any pension plan, no performance-related elements and no financial instruments (e.g. options).</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Compensation of the members of the Executive Committee comprises fixed and variable compensation elements. Fixed compensation comprises the base salary and may comprise other compensation elements and benefits. Variable compensation may comprise short-term and long-term compensation elements.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Compensation (to non-executive members of the Board of Directors and to members of the Executive Committee) may be paid or granted in the form of cash, shares, other benefits or in kind. Compensation to members of the Executive Committee may also be paid or granted in the form of financial instruments or similar units. Compensation may be paid by the Company or companies controlled by it. The Board of Directors determines the valuation of each compensation element on the basis of the principles that apply to the establishment of the compensation report.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 32</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Variable compensation</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The variable compensation paid or granted to the members of the Executive Committee in a certain year shall consist of compensation elements from short- and long-term compensation plans (as defined in this Article 32).</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The short-term compensation plans are based on performance metrics that take into account the performance of the Novartis Group and/or parts thereof, and/or individual targets. Achievements are generally measured based on the one-year period to which the short-term compensation relates. The short-term compensation pay-outs shall be subject to caps that may be expressed as predetermined multipliers of the respective target levels.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The long-term compensation plans are based on performance metrics that take into account strategic objectives of the Novartis Group (such as financial, innovation, Shareholder return and/or other metrics). Achievements are generally measured based on a period of not less than three years. The long-term compensation pay-outs shall be subject to caps that may be expressed as predetermined multipliers of the respective target levels.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors or, to the extent delegated to it, the Compensation Committee determines performance metrics, target levels, and their achievement.</div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">13</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="zf1a41566f2f04687ac923927b67d20b5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">5</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors or, to the extent delegated to it, the Compensation Committee determines grant, vesting, blocking, exercise and forfeiture conditions of the compensation; they may provide for continuation, acceleration or removal of vesting and exercise conditions, for payment or grant of compensation assuming target achievement or for forfeiture in the event of predefined events such as death, disability, retirement or termination of an employment or mandate agreement.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 33</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Agreements with Members <br>
of the Board of Directors and <br>
 of the Executive Committee</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Company or companies controlled by it may enter into agreements with members of the Board of Directors relating to their compensation for a fixed term of one year. The Company or companies controlled by it may enter into contracts of employment with members of the Executive Committee for a fixed term not exceeding one year or for an indefinite period of time with a notice period not exceeding 12 months.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Contracts of employment with members of the Executive Committee may contain a prohibition of competition for the time after the end of employment for a duration of up to one year. The annual consideration for such prohibition shall not exceed the total annual compensation (i.e. base salary and annual incentive) last paid to such member of the Executive Committee.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 34</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Mandates outside <br>
 of the Novartis Group</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">No member of the Board of Directors may hold more than 10 additional mandates in other companies, of which no more than 4 additional mandates shall be in other listed companies. Chairmanships of the board of directors of other listed companies count as two mandates. Each of these mandates shall be subject to approval by the Board of Directors.</div>
</td>
</tr>

<tr style="HEIGHT: 81px">
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">No member of the Executive Committee may hold more than 6 additional mandates in other companies, of which no more than 2 additional mandates shall be in other listed companies. Each of these mandates shall be subject to approval by the Board of Directors. Members of the Executive Committee are not allowed to hold chairmanship of the board of directors of other listed companies.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The following mandates are not subject to these limitations:</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 14.2pt; TEXT-INDENT: -14.2pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Mandates in companies which are controlled by the Company;</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Mandates which a member of the Board of Directors or of the Executive Committee holds at the request of the Company or companies controlled by it. No member of the Board of Directors or of the Executive Committee shall hold more than 5<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;</font>such mandates; and</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 14.2pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Mandates in associations, charitable organizations, foundations, trusts and employee welfare foundations. No member of the Board of Directors or of the Executive Committee shall hold more than 10 such mandates.</font></div>
</td>
</tr>
</table>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">14</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table id="z2e3ac00e497941bc81758954d7a82663" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">4</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Mandates shall mean mandates in the supreme governing body of a legal entity which is required to be registered in the commercial register or a comparable foreign register. Mandates in different legal entities which are under joint control are deemed one mandate.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">5</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors may issue regulations that may determine additional restrictions, taking into account the position of the respective member.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 35</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Loans</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">No loans or credits shall be granted to the members of the Board of Directors or the Executive Committee.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 5</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Annual Financial Statements, Consolidated Financial Statements and Profit Allocation</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 36</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Financial year</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Board of Directors shall prepare for each financial year as of 31&#160;December an annual report consisting of financial statements with a management report if required and the consolidated financial statements.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 37</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Allocation of profit shown on the balance sheet, Reserves</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">1</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The allocation of the profit shown on the balance sheet shall be determined by the General Meeting of Shareholders subject to the legal provisions. The Board of Directors shall submit to the General Meeting of Shareholders its proposals.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">2</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">In addition to statutory reserves additional reserves may be accrued.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">3</div>
</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Dividends which have not been claimed within five years after the due date fall back to the Company and shall be allocated to the general reserves.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 6</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Publications and Place of Jurisdiction</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 38</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Publications</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Shareholder communications of the Company shall be made in the Swiss Official Gazette of Commerce. The Board of Directors may designate additional publication organs.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">&#160;</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: left">Article 39</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20.51%; VERTICAL-ALIGN: top; PADDING-RIGHT: 5px">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Place of jurisdiction</div>
</td>
<td style="WIDTH: 4.11%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The place of jurisdiction for any disputes arising from or in connection with the shareholdership in the Company shall be at the registered office of the Company.</div>
</td>
</tr>
</table>

<div><br>
</div>
</div>

<div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">15</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1
<SEQUENCE>3
<FILENAME>a20012920f-ex1_2.htm
<DESCRIPTION>EXHIBIT 1.2
<TEXT>

<html>
<head>
<title>EXHIBIT 1.2</title>
</head>
<body bgcolor="#ffffff">

  <div>
<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">
<table id="z5497beb06e37450ab11a1bb36b8c8d5a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 12.68%; VERTICAL-ALIGN: top">&#160;<img src="deckblatt2.jpg"></td>
<td style="WIDTH: 87.32%; VERTICAL-ALIGN: top"><font style="FONT-FAMILY: 'Times New Roman'">&#160; </font>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: right">Exhibit 1.2</div>

<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 12pt"><img src="logo.jpg"></div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div><br>
<font style="FONT-FAMILY: 'Times New Roman'">&#160;</font></div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 12pt">
<div style="FONT-FAMILY: 'Times New Roman'">Regulations of the Board of Directors, <br>
 the Board Committees and the Executive Committee of Novartis AG</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-SIZE: 20pt; FONT-FAMILY: 'Times New Roman'">(Organisationsreglement)</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 486pt"><br>


<div style="FONT-SIZE: 24pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 12pt">&#160;</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div>
<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-FAMILY: 'Times New Roman'; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div>
<table id="zfb18c78136dc4d6497e94c70c6f3f075" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left; MARGIN-LEFT: 108.15pt">Novartis AG</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; TEXT-ALIGN: left; MARGIN-LEFT: 108.15pt">4002 Basel, Schweiz</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 100%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 100%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; TEXT-ALIGN: left; MARGIN-LEFT: 108.15pt">&#169; 1 May 2019, Novartis AG</div>
</td>
</tr>
</table>
</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-FAMILY: 'Times New Roman'; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div>
<table id="z70a0ee492bfc4bdf82f3802ad30e915b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Table of Contents</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 1</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Scope of the Regulations, Organization in general</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">4</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 2</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">General Provisions</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">4</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 3</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Meetings of the Board, the Board Committees and the Executive Committee</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">5</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 4</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Board of Directors</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">6</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 5</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Executive Committee</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">10</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 6</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Internal Audit</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">11</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Section 7</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Effectiveness, Amendments</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">12</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Appendix I</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Board Committees Charter</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">13</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Appendix II</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Independence Criteria for the Board and the Board Committees</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">25</div>
</td>
</tr>

<tr>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 22.68%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 2.15%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 68.32%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: left">Abbreviations and Definitions</div>
</td>
<td style="FONT-FAMILY: 'Times New Roman'; WIDTH: 6.85%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; COLOR: #0460a9; TEXT-ALIGN: right">28</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">All references to individuals apply to both male and female persons.</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">3</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; FONT-FAMILY: 'Times New Roman'; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>

<div>
<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z728c3dfd33ca418db042333142ba427a" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 1</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Scope of the Regulations, Organization in general</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 1</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Scope</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">These Regulations govern the internal organization as well as the duties, powers and responsibilities of the following executive bodies and persons of the Company:</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#8211; Board and its Committees</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#8211; Chairman</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#8211; Vice-Chairman</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#8211; CEO</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#8211; Executive Committee (including its sub-committees) and</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#8211; Internal Audit</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 2</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Company Structure</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Company is a holding company which directly or indirectly owns a global group of companies that conduct the Business. To ensure proper functioning of the Business in the interests of the Company and its shareholders and to comply with various requirements imposed by relevant laws and regulatory authorities, the Board shall supervise and, where necessary and appropriate, provide overall strategic direction for the Business.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 2</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">General Provisions</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 3</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Duty of Care and Loyalty</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each Director or Executive is under the duty to carry out his/her responsibilities with due care and to safeguard and further the interests of the Group, the Company and its shareholders, including the creation of long-term value.</div>

<font style="FONT-SIZE: 14pt">&#160;</font></td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 4</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Conflict of Interest</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each Director or Executive arranges his/her personal and business affairs so as to avoid an actual or apparent Conflict of Interest.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">No Director or Executive shall participate in decisions and resolutions on matters which affect, or reasonably might affect, his/her interests or the interests of a person close to him/her (but he or she may participate in the discussion). If the Director or Executive is in a position of a permanent Conflict of Interest or any other non-solvable situation that hinders him/her in carrying out his/her duties to the full, he/she shall offer his/her resignation.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each Director or Executive must make a notification immediately, if the circumstances change so that it might affect or appear to affect the Director&#8217;s or Executive&#8217;s independence. In case of a new mandate, notification must occur prior to accepting such new mandate.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zbeadc73ef53a4f80a22b745cd305f197" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Required disclosures include (but are not limited to):</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a material change (or contemplated change) of his/her business or professional affiliations or responsibilities; and/or</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 26pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">any change of circumstances that may affect or appear to affect his/her independence or give rise to a Conflict of Interest.</font></div>

<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Disclosure must be made by:</div>

<div style="MARGIN-LEFT: 26pt; MARGIN-TOP: 3pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">the Chairman to the Chairperson of the GNCRC; and by</font></div>

<div style="MARGIN-LEFT: 26pt; MARGIN-TOP: 3pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a Director or the CEO to the Chairman; and by</font></div>

<div style="MARGIN-LEFT: 26pt; MARGIN-TOP: 3pt; TEXT-INDENT: -26pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iii)&#160; </font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">an Executive to the CEO.</font></div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Chairman, the CEO and the Chairperson of the GNCRC, respectively, must review the disclosures and inform the Board, respectively the ECN, with a corresponding proposal for appropriate mitigating measures, if any.</div>

<font style="FONT-SIZE: 14pt">&#160;</font></td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 5</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Confidentiality</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each Director and Executive keeps at all times strictly confidential all information &#8211; except information already in the public domain &#8211; relating to the Company and/or the Group which the member has learned during the exercise of the duties. This obligation and duty continues even after the expiration of the term of office.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Documents of the Company and/or the Group must be returned by the Director or Executive at the latest on expiry of the term of office. If required, e.g. in case of legal proceedings, the Director or Executive can access relevant documents at the office of the Corporate Secretary.</div>

<font style="FONT-SIZE: 14pt">&#160;</font></td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 3</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Meetings of the Board, the Board Committees and the Executive Committee</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 6</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">No Representation of Members</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">A Director or Executive who is not able to participate in a Board, Board Committee or an Executive Committee meeting may not be represented by another Director or Executive or any other person.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 7</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Quorum, Majority</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Requirements</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Unless stated otherwise in these Regulations, the presence in person, by telephone, by video conference or other technical means of a majority of the members is required for any meeting.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">If the chair does not participate, the meeting will be chaired by the deputy or, in his/her absence, by any member appointed by the other members as <font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">ad hoc </font>chair.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">5</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zc75c14fea6ed4702940adf277acfd7cd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Resolutions require the affirmative majority of the votes cast. If an item is, however, not on the agenda<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">, </font>resolutions are passed by an affirmative vote of at least two thirds of the Directors or Executives, present at a meeting.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">In the event of a tie on any issue, (i) in a Board Committee, the full Board decides the issue, and (ii) in the Executive Committee, the CEO decides the issue.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 8</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Circular Resolutions</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">A proposal for a circular resolution must be communicated to all members, giving a deadline for responding, and is only deemed to have passed if:</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt">(i)&#160; more than two-thirds of all members cast a vote or give written notice that they abstain (written notice can include email notice);</div>

<div style="FONT-SIZE: 14pt; MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt">(ii)&#160; an absolute majority of all members casting a vote approve the proposed resolution; and</div>

<div style="FONT-SIZE: 14pt; MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt">(iii)&#160; no member requests a meeting within the deadline for responding in relation to the subject matter of the proposed resolution.</div>

<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div>A circular resolution must be recorded under a separate heading in the minutes of the following meeting.</div>

<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 9</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Secretary, Minutes</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board and the Board Committees each appoint a secretary, who need not be a member of the body.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The secretaries of the Board and the Board Committees, and the General Counsel in case of the Executive Committee, keep the meeting minutes, which contain all resolutions adopted at the meeting and the key decision-making factors.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 10</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Application to other Bodies</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Articles 3&#8211;9 apply analogously to all other management committees of the Company and their members.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 4</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Board of Directors</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 11</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Independence</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The majority of the Directors have to meet the independence criteria set forth in Appendix&#160;II.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 12</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Duties of the Board</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board is the ultimate executive body of the Company.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">It shall resolve all Business matters which are not reserved to the authority of the General Meeting or to other executive bodies of the Company by law, the Articles, or these Regulations.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">6</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z4d3f0d3c0a254a4b8227bb6832b538d9" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="4">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">In particular, the Board has the following duties:</div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The ultimate direction of the Business, including, without limitation, the taking of resolutions and the giving of instructions or overall guidance regarding the following matters (where applicable, the duties of the Board are further defined and specified in internal regulations):</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The strategy upon recommendation of the Executive Committee.</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The entry into new areas of activity and withdrawal from existing areas of the Business; acquisitions and divestments of companies, participations in companies or businesses, or incorporations or liquidations of companies or businesses, if such matters are of fundamental significance to the Business.</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The opening and closing down of sites of fundamental significance to the Business.</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The initiation and settlement of legal proceedings of funda- mental significance to the Business.</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The setting of financial targets.</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The review and approval of corporate policies that are fundamental to the Group, as determined by the Chairman and the CEO.</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The adoption from time to time of further regulations and instructions regarding the organization of the Business and the duties and responsibilities of the executive bodies.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.38%; VERTICAL-ALIGN: top" colspan="4">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of the organization of the Company and the Group.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The manner of governance of the Group.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The regular review of the Group&#8217;s culture.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The review of the Group&#8217;s risk management system and of the most significant risks and how these are managed.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of the Group&#8217;s accounting system, financial controls and financial planning.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The review and approval of the annual report of the Company and of the Group, incl. the Compensation Report.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">h)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The nomination or appointment, removal, determination of duties and responsibilities, and succession plans of the following persons (subject to the powers of the General Meeting):</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Vice-Chairman</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Board Committee members and Chairpersons</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">CEO</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Executives</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Independent Proxy</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 2pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Such other persons as the Board may determine, from time to time, as having significant impact on the Business.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">7</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zed5385f792ba4c588b392920f6bd661b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The composition of the Board, including the appropriate skills and experiences to be considered in succession planning.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">j)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The designation of those persons who have signatory power for the Company and the manner in which such persons may sign on behalf of the Company.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">k)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The ultimate supervision of the persons entrusted with the management of the Business, specifically in view of their compliance with laws, the Articles, these Regulations and other applicable regulations, directives and instructions.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">l)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The preparations for the General Meeting and carrying out the resolutions of the General Meeting, including the preparation of the proposals to the General Meeting related to the compensation of the Board and of the Executive Committee and to the Compensation Report, as per the Articles.</font></div>

<div style="MARGIN-TOP: 3pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">m)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The notification of the court if liabilities exceed assets.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">n)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The adoption of resolutions concerning an increase of the share capital to the extent that such power is vested in the Board (article&#160;651 paragraph 4 CO), as well as resolutions concerning confirmation of capital increases and related amendments to the Articles. The adoption of such resolutions shall be exempted from the majority requirement outlined in article 7.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">o)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of (i) the compensation strategy and of the principles, structure and design of compensation plans for the Executive Committee, (ii) the long-term incentive/equity plans, (iii)&#160;the compensation of the Directors and of the CEO to be presented to the shareholders, and of the terms of employment of the CEO, (iv) the Group and divisional financial, strategic and operational targets and the evaluation of target achievement.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">p)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of the maximum aggregate amount or maximum partial amounts of compensation, in the event the General Meeting has not approved a proposal of the Board, as per the Articles.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">q)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The determination of (i) whether or not a Director is independent, based on a proposal by the GNCRC, and (ii) whether or not the ACC Directors meet the financial literacy and expertise standards.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">r)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The decision on appropriate measures in case of a disclosure in accordance with article 4 of these Regulations.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">s)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The approval of other business, if such business exceeds the authority delegated from time to time by the Board to the Board Committees or to the Executive Committee.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 13</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Delegation of Management</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Where not stipulated as a Board responsibility in the law, the Articles or these Regulations, the Board delegates the management of the Business to the Executive Committee, pursuant and subject to these Regulations.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">8</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="za6591fae7a844b8185b114f2f29e216d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 14</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Meetings, Agenda</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board meets at the invitation of the Chairman as often as may be required.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Invitations for Board meetings contain the meeting agenda and are sent out at least five business days in advance, except for urgent matters. Also, any Director may request a meeting for a specific purpose or the inclusion of a certain item on the agenda.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 15</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Right to Request</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Information</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Directors have full and unrestricted access to the management and employees of the Group in the execution of their duties.<br>
 &#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 16</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Independent Advisors</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board has the authority to retain independent advisors for any matters within the scope of its responsibilities.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 17</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Evaluation of Board Performance</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board conducts an annual evaluation of the performance of the Board, of the Board Committees and of the Chairman.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 18</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Board Committees</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board may establish ad hoc Board Committees and has the following permanent Board Committees:</div>

<div style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Audit and Compliance Committee Compensation Committee Governance, Nomination and Corporate Responsibilities Committee</font></div>

<div style="MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Risk Committee and</font></div>

<div style="MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Research &amp; Development Committee</font></div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The composition and duties of the permanent Board Committees are set forth in Appendix I.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 19</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Chairman</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">In addition to other duties described in these Regulations and the Articles, the Chairman has the following duties:</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Provides leadership to the Board in its governance role, coordinating the tasks within the Board.</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Coordinates, together with the Chairpersons, the work of the Board Committees.</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Establishes and keeps a close working relationship with the CEO, providing advice and support while respecting the fact that the day-to-day management responsibility is delegated to the Executive Committee led by the CEO.</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Promotes effective relationships and communication between the Board, the CEO and the Executive Committee.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">9</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z22abfe930a384b4788a97f5739fdd7f6" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Chairman</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Takes the lead in crisis situations.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Together with the CEO, ensures effective communication with shareholders, other stakeholders and the general public; and</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Works closely with the CEO in evaluating Executives and in establishing succession plans for key management positions.</font></div>

<div style="MARGIN-TOP: 3pt; TEXT-INDENT: 6.1pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 20</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Vice-Chairman</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">In case and as long as the Chairman is incapacitated, the Vice-Chairman assumes all of the Chairman&#8217;s responsibilities.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">If the Chairman is not independent, the Vice-Chairman will be tasked by the Board with the following duties:</div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Chairs the sessions of the independent Directors; and</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Leads the independent Directors in case of a crisis or matter requiring their separate consideration or decision.</font></div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Every independent Director may request separate meetings of the independent Directors if the need arises.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 5</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Executive Committee</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 21</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">CEO</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">In addition to other duties that may be assigned by the Board, the CEO, supported by the Executive Committee, has the following duties:</div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Overall responsibility for the management and performance of the Business.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Leads the Executive Committee.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Builds and maintains an effective Executive Committee and proposes adequate succession planning to the Board.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Represents Novartis, in coordination with the Chairman, with major customers, financial analysts, investors and the media.</font></div>

<div style="MARGIN-TOP: 3pt; TEXT-INDENT: 0.7pt">&#160;</div>
</td>
</tr>

<tr style="HEIGHT: 22px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 22</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Members of</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Executive Committee</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Executive Committee is headed by the CEO. It consists of such members as appointed or removed by the Board.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 23</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Duties of Executive</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Committee</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Executive Committee is responsible for the management of the Business. In particular, and without limitation, the Executive Committee has the following duties:</div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Regularly assess the achievement of the targets for the Business.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Submit proposals to the Board or to one of the Board Committees for approval for items, requiring such approval based on these Regulations or further internal regulations.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Implement the decisions taken by the Board or the Board Committees.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">10</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z02d410af7ae44fff842fb106ab064ba5" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top" rowspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Prepare and submit quarterly and annual reports for the attention of the Board or the Board Committees, and keep the Board or the Board Committees informed of all matters of fundamental significance to the Business and/or that are relevant to allow the Board or the Board Committees to fully perform their duties.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">e)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Implement modifications to the organization of the Business to ensure efficient operation of the Business and achievement of optimized consolidated results.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">f)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'"><font style="FONT-FAMILY: 'Times New Roman'">Ensure appropriate external stakeholder management, including an effective internal and external communication strategy</font><font style="FONT-FAMILY: 'Times New Roman'">.</font></font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">g)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Ensure that management capacity, financial and other resources are provided and used efficiently.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">h)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Deal with such other matters as are delegated by the Board or a Board Committee to the Executive Committee.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 24</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Sub-committees of the Executive Committee</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Executive Committee may delegate duties as stipulated in article&#160;23 above to other executives and committees and may empower them to further delegate their responsibilities and authorities. Each such delegation must be in writing, and clear responsibilities and accountabilities must be established. The CEO ensures proper reporting to the Executive Committee as needed.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 6</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Internal Audit</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 25</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Duties of Internal Audit</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.2%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Internal Audit has to:</div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">a)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Carry out operational and system audits, assisting the Divisions and Cross-Divisional Units in the accomplishment of objectives by providing an independent approach to the evaluation, improvement, and effectiveness of their risk management and internal control framework. All Divisions, Cross-Divisional Units and subsidiaries of the Group are subject to audit.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">b)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Prepare reports regarding the audits it has performed, and report to the ACC and to the CEO material irregularities, whether actual or suspected, without delay.</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">c)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Perform such other functions and audits as assigned to it by the Board, the ACC or the CEO.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">11</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z80c95b1384b3423b85b6e9bca483af9c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 7</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.16%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Effectiveness, Amendments</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.16%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 26</div>
</td>
</tr>

<tr style="HEIGHT: 97px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Effectiveness, Amendments</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.16%; VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">These Regulations come into effect on May 1, 2019 and replace former regulations of the Board, the Board Committees and the Executive Committee.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">These Regulations may only be amended or replaced by the Board.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 31.18%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Dr. Joerg Reinhardt</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Chairman</div>
</td>
<td style="WIDTH: 50%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Dr. Charlotte Pamer-Wieser</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Corporate Secretary</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">12</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zf51ae6e3578542f78cb66e6d12924414" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Appendix I:</div>
</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Board Committees Charter</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; TEXT-ALIGN: right">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 1</div>
</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="MARGIN-BOTTOM: 0px; FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; PADDING-BOTTOM: 0px; TEXT-ALIGN: justify; PADDING-TOP: 0px">General Provisions</div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">14</td>
</tr>

<tr style="HEIGHT: 25px">
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 2</div>
</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Roles and Responsibilities of the Board Committees</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: 1px solid; TEXT-ALIGN: right">&#160;</td>
</tr>

<tr style="HEIGHT: 43px">
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">
<div style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">-</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">Roles and Responsibilities of the ACC</font></div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">15</td>
</tr>

<tr>
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">
<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 12pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">-</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">Roles and Responsibilities of the CC</font></div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">18</td>
</tr>

<tr>
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: middle">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 1px solid">
<div style="MARGIN-TOP: 12pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">-</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">Roles and Responsibilities of GNCRC</font></div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">20</td>
</tr>

<tr>
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 12pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">-</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">Roles and Responsibilities of RC</font></div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">22</td>
</tr>

<tr style="HEIGHT: 40px">
<td style="WIDTH: 19.39%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 6.08%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 69.39%; VERTICAL-ALIGN: top; BORDER-BOTTOM: #000000 1px solid">
<div style="MARGIN-BOTTOM: 3pt; MARGIN-TOP: 12pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">-</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9">Roles and Responsibilities of the R&amp;DC</font></div>
</td>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-VARIANT: normal; WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM: 1px solid; TEXT-TRANSFORM: none; FONT-WEIGHT: normal; COLOR: #0460a9; FONT-STYLE: normal; TEXT-ALIGN: right">23</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">13</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zd04ce7b9d61e47edb425725b59b7e54e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 1</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">General Provisions</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">These General Provisions contain additional organizational requirements for Board Committees in addition to the rules set forth in the Regulations.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 1</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Composition</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The ACC, the GNCRC, the RC and the R&amp;DC each consist of a minimum of 3 members. The CC consists of a minimum of 3 and a maximum of 5 members.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board elects the Chairpersons of the Board Committees.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 2</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Independence,</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Qualifications</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each Director of the ACC, CC and GNCRC has to meet the independence criteria set forth in Appendix&#160;II.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each ACC member must further be financially literate, including at least one member who has accounting and related financial management expertise (&#8220;audit committee financial expert&#8221;), as such qualifications are interpreted by the Board in its business judgment.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The &#8220;audit committee financial expert&#8221; must have</div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;an understanding of generally accepted accounting principles and financial statements;</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;the ability to assess the general application of such principles in connection with the accounting for estimates, accruals and reserves;</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Group&#8217;s financial statements, or experience actively supervising one or more persons engaged in such activities;</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iv)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">an understanding of internal control over financial reporting; and</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(v) </font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">an understanding of audit committee functions.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 3</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Coordination between ACC and RC</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Chairpersons of the RC and the ACC shall generally be appointed as members of the other Committee. To the extent appropriate, the Chairpersons of the ACC and the RC coordinate the work of the ACC and the RC, in particular to ensure that there are as few as possible overlaps.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">14</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z5d4f751ec6a14e1487e3eba9f73a4034" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 4</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Meeting Participations and Interactions</div>
</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Each Board Committee may invite to its meetings other Directors, Executives and such other persons as the respective Board Committee deems appropriate to carry out its responsibilities. The Chairman may attend the Board Committee meetings in consultation with the relevant Chairperson.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Special rules apply to the presence of the following persons at Board Committee meetings:</div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;An Executive shall not be present during the decision on his/her own pay at a CC meeting; or</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Anyone with a personal interest in the matters to be discussed will be excluded from the ACC, GNCRC, RC and R&amp;DC meeting, respectively.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 5</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Advisors, Investigations</div>
</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board Committees shall have the authority to obtain advice and assistance from internal or external legal, accounting or other advisors. The ACC shall have the authority to conduct or authorize investigations into any matter within the scope of its responsibilities.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 6</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Debriefing to the Board</div>
</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The Board Committees regularly report to the Board on its deliberations and decisions and on the items set forth in Section 2 of this Appendix I. Other matters will be reported as the Board Committees deem appropriate.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Section 2</div>
</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Roles and Responsibilities of the Board Committees</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Roles and Responsibilities of the Audit and Compliance Committee (ACC)</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 7</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">ACC&#8217;s Mission Statement</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The ACC assists the Board in monitoring the:</div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;integrity of the financial statements of the Group;</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">External Auditor&#8217;s qualifications and independence;</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">performance of the Internal Audit function and of the External Auditor; and</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iv)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">compliance by the Group with legal and regulatory requirements.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 8</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">ACC&#8217;s Role and Responsibilities</div>
</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The ACC has the following roles and responsibilities:</div>

<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Regarding the External Auditor</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="VERTICAL-ALIGN: top" colspan="2">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Evaluate the qualifications, performance and independence of the External Auditor, including considering whether the External </font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">15</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z4c9909a0a961460b817fe189c7dce065" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt">Auditor&#8217;s quality controls are adequate and whether the provision of permitted non-audit services is compatible with maintaining the External Auditor&#8217;s independence, taking into account the opinions of management and Internal Audit.</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Ensure rotation of the audit partners of the External Auditor at least every five years. Consider whether, in order to ensure continuing auditor independence, it is appropriate to adopt a policy of rotating the external auditing firm on a regular basis.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">On behalf of the Board, which has fully delegated this task to the ACC, (1) select and nominate the External Auditor for election by the General Meeting, and (2) be directly responsible for the supervision and compensation of the External Auditor (including the resolution of any disagreement between management and the External Auditor regarding financial reporting).</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">On behalf of the Board, which has fully delegated this task to the ACC, pre-approve all auditing services, internal control-related services and non-audit services permitted under applicable statutory law, regulations and listing requirements to be performed for the Group by its External Auditor.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Obtain and review a report from the External Auditor at least annually regarding (1) the External Auditor&#8217;s internal quality- control procedures, (2) any material issues raised by the most recent quality-control review, or peer review, of the firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm, (3) any steps taken to deal with any such issues, and (4) all relationships between the External Auditor and the Group.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Discuss with the External Auditor the results of their audits, any unusual items or disclosures contained in the audits and the matters required by Public Company Auditing Oversight Board Auditing Standards No.&#160;1301, as revised, and request a formal written statement from the External Auditor documenting such discussion<font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000">.</font></font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Regarding Internal Audit</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review the significant reports to management, prepared by the Internal Audit department and management&#8217;s responses and supervise the remediation of open audit issues.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review periodically the adequacy of the organizational structure, budget and appointment or replacement of the senior Internal Audit executives.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.2%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.84%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">9.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Discuss with the CEO, as needed, the Internal Audit department&#8217;s responsibilities, staffing and any recommended changes in the planned scope of the Internal Audit.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">16</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z41f41dc414dc4a8fa44c35ccb09f9f43" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Regarding Financial Reporting and internal controls</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">10.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review and discuss with management and the External Auditor the Company&#8217;s and Group&#8217;s quarterly and annual financial statements (including the sections on Operating and Financial Review and Prospects) to consider significant financial reporting issues and judgments made in connection with the preparation of the Company&#8217;s and Group&#8217;s financial statements, including any significant changes in the Company&#8217;s or Group&#8217;s selection or application of accounting principles.</font></div>

<div style="MARGIN-TOP: 3pt">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">11.</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">On behalf of the Board, which has fully delegated this task to the ACC, approve the Company&#8217;s and Group&#8217;s quarterly financial statements for the first three quarters of each calendar year and the corresponding financial results releases. The Board remains responsible for the approval of the annual financial statements of the Company and the Group and of the corresponding financial results releases.</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">12.</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review and discuss with management and the External Auditor their assessment of the effectiveness of the Group&#8217;s internal controls, disclosure controls and procedures for financial reporting and whether any changes are appropriate in light of such assessment.</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt">13.</font><font style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'"><font style="FONT-SIZE: 14pt">Review and discuss (1) all significant deficiencies in the design or operation of internal controls which could adversely affect the Group&#8217;s ability to record, </font>process, summarize and report financial data, including any material weaknesses in internal controls, (2) any fraud, whether or not material, that involves management or other employees who have a significant role in the Group&#8217;s internal controls, and (3) any significant changes in internal controls or in other factors that could significantly affect internal controls, including any corrective actions with regards to significant deficiencies and material weaknesses.</font> </div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">14.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review such other matters in relation to the Group&#8217;s accounting, auditing, financial reporting and compliance with law and internal policies.</font></div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt">&#160;</div>
</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75%; VERTICAL-ALIGN: top; FONT-STYLE: italic">Regarding Significant Legal Matters and Regulatory Risks</td>
</tr>

<tr style="HEIGHT: 54px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">15.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review major issues regarding the status of the Group&#8217;s material legal matters, as well as major legislative and regulatory developments that may have significant impact on the Group.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75%; VERTICAL-ALIGN: top; FONT-STYLE: italic">Regarding an Effective Compliance Program</td>
</tr>

<tr style="HEIGHT: 52px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top"></td>
<td style="FONT-SIZE: 14pt; WIDTH: 5%; VERTICAL-ALIGN: top"></td>
<td style="FONT-SIZE: 14pt; WIDTH: 75%; VERTICAL-ALIGN: top; MARGIN-LEFT: 27pt; TEXT-INDENT: -27pt">
<div style="MARGIN-LEFT: 27pt; TEXT-INDENT: -27pt">16.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font>Review at least annually the processes and procedures used by management to execute an effective compliance program.</div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt">17.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font>Review at least annually compliance by Novartis associates with those Group policies falling into the subject matter expertise of the ACC.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">17</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z61bf6854f604495ca523a9cf0f2aa05c" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-TOP: 3pt">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">18.</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review updates from the Company&#8217;s SpeakUp office regarding whistleblowing activities and trends.</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">19.</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Establish procedures for (a) the receipt, retention and treatment of complaints received by the Group regarding accounting, internal accounting controls or auditing matters, and (b) the confidential, anonymous submission by employees of the Group of concerns regarding questionable accounting or auditing matters to the SpeakUp office.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</div>
</td>
</tr>

<tr style="HEIGHT: 23px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75%; VERTICAL-ALIGN: top; FONT-STYLE: italic">Other</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">20.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Annually review the financial literacy of each ACC member to determine whether he/she meets the applicable legal standards, confirm the audit committee financial expert, and propose to the Board the appropriate determination and its disclosure.</font></div>

<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">21.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Annually review and reassess the adequacy of Articles 7 - 8 of this Appendix I and submit proposed changes to the Board for approval.</font></div>

<div>&#160;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z835d37f1d81c454e8cccb34db6586bcf" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.67%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Roles and Responsibilities of the Compensation Committee (CC)</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.67%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 9</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">CC&#8217;s Mission Statement</div>
</td>
<td style="WIDTH: 5.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.67%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The CC assists the Board concerning, but not limited to, the:</div>

<div><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#160;compensation strategy;</font></div>

<div><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">design of the compensation plans;</font></div>

<div><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">compensation of the Chairman, the Directors and of the CEO;</font></div>

<div><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iv)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Compensation Report; and</font></div>

<div><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(v)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">compensation of the other Executives.</font></div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">Pay for performance is one of the guiding principles of the compensation strategy of the Group. The Group aims to reward those associates who achieve competitive business results and exemplify the Group values and behaviors. The compensation strategy strives to strengthen the performance-oriented culture and to reinforce entrepreneurial behavior resulting in contributions that motivated and dedicated associates make to sustain superior business results whilst holding executives accountable for behavior that displays innovation, quality, performance, collaboration, courage and integrity.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.67%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 10</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">CC&#8217;s Role and Responsibilities</div>
</td>
<td style="WIDTH: 5.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.67%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The CC has the following responsibilities:</div>

<div style="MARGIN-LEFT: 21pt; MARGIN-TOP: 3pt; TEXT-INDENT: -21pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Develop a compensation strategy in line with the principles described in the Articles, and submit to the Board for approval.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.4%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.67%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 21pt; MARGIN-TOP: 3pt; TEXT-INDENT: -21pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Support the Board in preparing the proposals to the General Meeting regarding the compensation of the Directors and Executives.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">18</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z57cecc9e6e2b48cab5bd861fbdb01b15" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Prepare the Compensation Report and submit to the Board for approval.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Propose to the Board the contractual terms (if any) and compensation of the Directors (incl. the Chairman) and the CEO.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Determine, upon proposal by the CEO, the terms of employment, promotion or termination of the other Executives (except for the CEO).</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Develop the terms of, and administer, the Group&#8217;s long-term incentive/equity compensation plans, including the weightings, payout curves and caps for the chosen performance measures.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Together with the RC, assess whether the Group&#8217;s incentives for associates below Executive Committee level are appropriately aligned to business performance and do not encourage excessive risk taking.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Determine the critical performance measures (financial, strategic and operational) that inform how well the Group and its Divisions are performing in relation to the business strategy for incorporation into the incentive plans.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">9.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">At the start of each performance period, review, after Board approval, the Group and divisional financial, strategic, operational and individual targets for Executive Committee members and direct reports to the Chairman. Incorporate these targets into the short-term and long-term incentive/equity compensation plans.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">10.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Periodically review and propose to the Board for approval a peer group(s) of companies for executive compensation comparisons.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">11.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">At the start of each performance period, approve the target total direct compensation levels and the mix of compensation (fixed/variable, short/long-term, individual/Group/Division, and cash/equity) for Executive Committee members and direct reports to the Chairman taking into consideration pay and conditions for the wider population of Group associates.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">12.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">At the end of each performance period, taking into consideration the Board&#8217;s evaluation of Group and divisional performance against targets established at the beginning of the performance cycle, approve performance results under the incentive plans, evaluate individual performance, approve the amount of compensation earned by Executive Committee members and recommend the amount of compensation earned by the CEO to the Board for approval taking into account the overall performance of the Business and, if appropriate, making adjustments to the formulaic outcome of any incentive plans, within the plan Rules.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">13.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Consider and decide whether there is a need for malus and/or clawback provisions to be exercised and, if so, the extent and form of the malus and/or clawback.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">19</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zf4ddfb9aa1804542afae972516f32c16" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">14.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Incorporate the recommendations of the R&amp;DC for the establishment of innovation targets under incentive compensation plans at the start of each performance cycle and measurement of achievement thereof at the end.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">15.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Periodically assess the effectiveness of the executive short-term and long-term incentive plans in relation to the Group&#8217;s strategic objectives, values and pay-for-performance principles.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">16.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Work together with other Board Committees, including the ACC, RC and the R&amp;DC to ensure that executive compensation is correctly aligned to performance and is not structured in a way that could lead to inappropriate risk taking.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">17.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Annually assess the level of Board compensation against the peer group and other relevant companies and submit to the Board its recommendations for the compensation of Directors and the compensation and terms of employment of the Chairman.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">18.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Establish executive and director stock ownership guidelines and stock trading policies, and monitor compliance with such policies.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">19.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">As directed by the Chairman, oversee communication and engagement on executive compensation matters with shareholders and their advisors, including shareholder voting on Board and Executive Committee compensation, and assess the voting results on executive compensation matters of the most recent General Meeting.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">20.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Annually assess the engagement and performance of compensation consultants or other outside advisors engaged by the CC and their independence in relation to any potential conflicts of interest.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">21.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Keep abreast of regulatory and corporate governance best practice requirements regarding Board, Executive Committee and other senior executive compensation.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">22.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Keep abreast of market trends and consideration of external factors that may influence pay in terms of design, structure, quantum, disclosure etc.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">23.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review and reassess the adequacy of Articles 9 - 10 of this Appendix I and submit proposed changes to the Board for approval.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">24.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Assume other responsibilities assigned to it by law, the Articles and by the Board.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Roles and Responsibilities of the Governance, Nomination and Corporate Responsibility Committee (GNCRC)</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 11</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">GNCRC&#8217;s Mission Statement</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The GNCRC assists the Board in fulfilling its responsibilities with respect to the:</div>

<div style="MARGIN-TOP: 3pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">governance of the Group;</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">20</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z94bfbf6cf1d04f02b6d5d13de12451bf" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">identification of individuals who are qualified to become (or be re-elected as) Directors or the CEO; and</font></div>

<div style="MARGIN-TOP: 3pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(iii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">corporate and social responsibilities of the Group.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 12</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">GNCRC&#8217;s Roles and Responsibilities</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The GNCRC has the following roles and responsibilities:</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">In General</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review periodically the Articles and the Regulations and recommend to the Board changes thereto in respect of good corporate governance and fostering shareholders&#8217; rights.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Consult with the Chairman in carrying out the duties of the GNCRC.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">3.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Prepare and annually review succession plans for the Chairman, the Vice-Chairman, Directors, Board Committee members, Chairpersons and the CEO, and make proposals to the Board for the election and the re-election by&#160; the Board respectively by the AGM for the Directors, the Chairman and the CC Directors.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Make proposals to the Board for the election of the Independent Proxy.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Recommend such other actions not set out below regarding the governance of the Group that are in the best interests of the Group and the Company&#8217;s shareholders, as the GNCRC deems appropriate.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Board Composition</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review the composition and size of the Board in order to ensure the Board has the proper expertise and consists of persons with sufficiently diverse backgrounds.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Determine the criteria for selection of the Chairman, Directors and Board Committee members. The GNCRC considers factors such as (i) personality, skills and knowledge, (ii) diversity of viewpoints, professional backgrounds and expertise, (iii) business and other experience relevant to the Business, (iv) the ability and willingness to commit adequate time and effort to Board and Board Committee responsibilities, (v) the extent to which personality, background, expertise, knowledge and experience will interact with other Directors to build an effective and complementary Board, and (vi) any disclosures made under article 4 of the Regulations, in particular whether existing board memberships or other positions held by a candidate could lead to a Conflict of Interest.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">8.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">With the participation of the Chairman, actively seek, interview and screen individuals qualified to become a candidate for the position as a Director, for recommendation to the Board.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">21</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zd4f69297226a440e9589d788b2b27129" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">9.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Assess and recommend to the Board as to whether Directors should stand for re-election. For its assessment, the GNCRC considers, among other things, age limit, contributions to the Board and the Company, and ability and willingness to commit adequate time to the Board and Board Committee matters.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Board Committees</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">10.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">With the Chairman, make recommendations to the Board for the creation of additional Board Committees or a change in mandate or dissolution of Board Committees.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">11.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">With the Chairman, periodically review the composition of the Board Committees. When doing so, the GNCRC takes into account whether a Board Committee member is suitable for the tasks of the respective Board Committee, including an envisioned quorum of independent Committee members, if applicable.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">12.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">With the Chairman, periodically review the chairmanships of the Board Committees.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Conflicts, Other Directorships and Board member</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">13.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review directorships and consulting agreements of Board members for conflicts of interest.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">14.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Annually submit to the Board a proposal concerning the determination of the independence status of the Directors and the corresponding disclosure.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; TEXT-ALIGN: justify">Corporate Responsibilities of the Group</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">15.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Oversee the Group&#8217;s strategy and governance on corporate and social responsibility.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">16.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Oversee key issues related to corporate and social responsibility that may affect the Business and the Group&#8217;s reputation.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">17.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Oversee the Company&#8217;s participation in the UN Global Compact.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">18.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review and discuss emerging trends with regard to corporate responsibility.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt">19.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Advise the Board and provide counsel to the management on corporate responsibility.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5.14%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 74.9%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 27pt; MARGIN-TOP: 3pt; TEXT-INDENT: -27pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">20.</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Approve the Novartis in Society Report.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zac0fc8255bcf450382696d17d714538b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Roles and Responsibilities of the Risk Committee (RC)</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 13</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">RC&#8217;s Mission Statement</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The RC will assist the Board in ensuring that risks are properly assessed and professionally managed by:</div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(i)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">overseeing the Group&#8217;s risk management system and processes; and</font></div>

<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">(ii)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">reviewing the Group&#8217;s risk portfolio and related actions implemented by management.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">22</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zd7bfbc9a410f434f8d4659592ec0949b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 14</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">RC&#8217;s Role and Responsibilities</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The RC has the following role and responsibilities:</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Ensure that the Group has implemented an appropriate and effective risk management system and process.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">2.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Ensure that all necessary steps are taken to foster a culture of risk-adjusted decision-making without constraining reasonable risk taking and innovation.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">3.</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Together with the CC, assess whether the Group&#8217;s incentives for associates below Executive Committee level are appropriately aligned to business performance and do not encourage excessive risk taking.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">4.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review with management and Internal Audit the identification, prioritization and management of the risks, the accountabilities and roles of the functions involved with risk management, the risk portfolio and the related actions implemented by management.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">5.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Inform the Board on a periodic basis on the risk management system and on the most significant risks and how these are managed.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">6.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Review such other matters in relation to the Group&#8217;s risk management as the RC may, in its own discretion, deem desirable in connection with its responsibilities described above.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 22pt; MARGIN-TOP: 3pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">7.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">Keep itself up to date on risk management best practices. The Chief Ethics, Risk and Compliance Officer, or his/her designee, is expected to update the RC at least once a year on developments in this area.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Roles and Responsibilities of the Research and Development Committee (R&amp;DC)</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 15</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">R&amp;DC&#8217;s Mission Statement</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The R&amp;DC (i) oversees the research and development strategy, (ii) evaluates and challenges the effectiveness and competitiveness of the research and development function, (iii) reviews and discusses emerging scientific trends and activities critical to the success of research and development and (iv) reviews the pipeline.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Article 16</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">R&amp;DC&#8217;s Role and Responsibilities</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The R&amp;DC has the following role and responsibilities:</div>
</td>
</tr>

<tr style="HEIGHT: 23px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">1.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">Monitor research and development and bring recommendations to the Board.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">2.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">Assist the Board in the oversight, evaluation and decision making related to research and development.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">23</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z57b9fd99c23644569b2fcc419217f656" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">3.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">Inform the Board on a periodic basis on the research and development strategy, the effectiveness and competitiveness of the research and development function, on emerging scientific trends and activities, critical to success of research and development and on the pipeline.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">4.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">Advise the Board on scientific, technological and research and development matters.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">5.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">Provide counsel and know how to management in the area of research and development.</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.15%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 22pt; TEXT-INDENT: -22pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">6.<font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #231f20">Review such other matters in relation to the Company&#8217;s research and development as the R&amp;DC may, in its own discretion, deem desirable in connection with its responsibilities described above.</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">24</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z663abc062f694192a21e30bf60b779a2" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: justify">Appendix II</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">Independence Criteria for the Board and the Board Committees</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #0460a9; TEXT-ALIGN: left">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">Independence of the Directors</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The GNCRC annually submits to the full Board a proposal concerning the determination of the independent status of all Directors. For purposes of such assessment, the GNCRC considers all relevant facts and circumstances of which it is aware.</div>

<div>&#160;</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">In order to be considered independent, a Director shall not have any material relationship with the Group other than his/her service as a Director.</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">I. Material Relationships</div>
</td>
</tr>

<tr style="HEIGHT: 27px">
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">1.</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">A Director will not be considered independent if</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director or his/her immediate Family Member owns more than 10% of the stock of the Company;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director has received direct compensation (other than for former service as an interim Chairman ) of more than USD 120 000 p.a. (other than dividends or Board/Board Committee fees and retirement or deferred pay for prior service, provided such compensation is not contingent in any way on continued service) from the Group within the last three years;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A Family Member has received direct compensation of more than USD 120 000 p.a. (other than compensation received for service as an employee other than an executive officer) from the Group within the last three years;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director is, or has been within the last three years, an employee of the Group;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A Family Member is, or has been within the last three years, an executive officer of the Group;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director is a current partner or employee of the External Auditor of the Group;</font></div>

<div style="MARGIN-TOP: 3pt">
<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A Family Member is a partner of the External Auditor or is an employee of the External Auditor and works on the Group&#8217;s audit;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director or a Family Member is a former partner or employee of the External Auditor who personally worked on the Group&#8217;s audit during the last three years;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director or a Family Member is, or has been within the last three years, employed as an executive officer of an enterprise while any of the present Executives serves or has served on that enterprise&#8217;s compensation committee;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">An enterprise has made payments to or received payments from the Group for goods, property or services in an amount that exceeds, in any of the last three fiscal years, the greater of </font></div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">25</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z7c681e1d798d43ca84d116d8676c8a6b" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt">USD&#160;1&#160;million or 2% of the enterprise&#8217;s consolidated gross revenues, and</div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;&#160; </font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director is a board member or employee of that enterprise or holds more than 10% of the shares in that enterprise; or</font></div>

<div style="MARGIN-LEFT: 40pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;&#160; </font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A Family Member is a board member or executive officer or holds more than 10% of the shares in that enterprise.</font></div>

<div style="MARGIN-TOP: 3pt; TEXT-INDENT: 18pt">&#160;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z383291138a4b40a39b27827d04fe3d4f" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">2.&#160; </font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic">In addition to the independence criteria set forth above for all Directors in Section 1, an ACC Director will not be considered independent if</font></div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The ACC Director or his/her spouse, minor child, minor stepchild, or child or stepchild sharing the ACC Directors&#8217; home, accepts any salary or consulting, advisory or other compensatory fee (other than Board/Board Committee compensation) from the Group;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The ACC Director is a partner, a member, an officer such as a managing director, executive officer or occupies a similar position in an enterprise that provides advisory services such as accounting, legal, investment banking or financial advisory services to the Group;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">If an ACC Director simultaneously serves on the audit committees of more than two public companies other than the Company&#8217;s, then the GNCRC must determine that such simultaneous service would not impair the ability of such Director to effectively serve on the ACC.</font></div>

<div style="MARGIN-TOP: 3pt">&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-STYLE: italic; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt">3.&#160; In addition to the independence criteria set forth for all Directors in Section 1, above, when making its assessment as to the independent status of a CC Director, the GNCRC considers whether the CC Director receives compensation from any person or entity that would impair his or her ability to make independent judgments about the Executive compensation.</div>

<div>&#160;</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; COLOR: #0460a9; TEXT-ALIGN: justify">II. Immaterial Relationships</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div>Unless the GNCRC concludes in its assessment to the contrary, a relationship is presumed not to impair the independence of a Director if</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="FONT-SIZE: 14pt; WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font style="FONT-SIZE: 1px; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director or a Family Member received from the Group, during the last fiscal year, personal benefits (other than the coverage of travel expenses incurred by a Family Member in connection with meetings of the Board) having an aggregate value of less than USD 5 000;</font></div>

<div style="MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;</font><font style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">A Family Member is an employee but not an executive officer of the Group, unless the Family Member is an ACC Director&#8217;s spouse, minor child, minor stepchild or child or stepchild sharing the ACC Director&#8217;s home;</font></div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">26</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<table id="z5c18094d2c9c4a6d80b51462407dc7d3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75.21%; VERTICAL-ALIGN: top">
<div style="MARGIN-TOP: 3pt">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;<font style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director or a Family Member is a board member or executive officer of a non-profit organization and the Group&#8217;s contributions to such organization did not exceed, in any of the last three fiscal years, the greater of USD 1 million or 2% of the organization&#8217;s consolidated gross revenues;</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;<font style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">An enterprise in which the Director or a Family Member is a director, executive officer or employee has been indebted to the Group in connection with a transaction in the ordinary course of business or in an amount that did not exceed USD 100 000 during the last fiscal year;</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; MARGIN-TOP: 3pt; TEXT-INDENT: -18pt"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">&#8211;<font style="FONT-SIZE: 14pt; WIDTH: 9pt; DISPLAY: inline-block">&#160;</font></font><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'">The Director or a Family Member serves on the board of another enterprise at which an Executive or another Director also serves as board member.</font></div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; MARGIN-TOP: 3pt"><br>
</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left; MARGIN-TOP: 3pt">The enumeration of relationships mentioned in this Section II is merely exemplary. The fact that a particular relationship is not listed does not mean that the relationship affects the independence of a Director.</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">27</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>

<div>
<div style="FONT-FAMILY: 'Times New Roman'">
<table id="zd1b5939b47ab4ae7a137c0f263ec54fd" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0" border="0">
<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left">Abbreviations and Definitions</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">ACC</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Audit and Compliance Committee of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Appendix I</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Appendix I to these Regulations which forms an integral part of these Regulations (Board Committees Charter)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Appendix II</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Appendix II to these Regulations which forms an integral part of these Regulations (Independence Criteria for the Board and the Board Committees)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Articles</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Articles of Incorporation of the Company</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Board</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Board of directors of the Company</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Board Committee(s)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any or all committee(s) of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Business</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Business operations conducted by the Group</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">CC</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Compensation Committee of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Chairman</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Chairman of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Chairperson(s)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any or all Director(s) who chair(s) a / the Board Committee(s)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">CO</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Swiss Code of Obligations</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Cross-Divisional Unit(s)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any or all cross-divisional organizational unit(s) supporting the Divisions</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Company</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Novartis AG</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Compensation Report</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Compensation report of the Company</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Conflict of Interest</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any personal interest, or the interest of a closely related person or company, that a Director or Executive might have in a particular matter which does or might be regarded to conflict with the interests of the Company or the Group</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Director(s)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any or all member(s) of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Division(s)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any or all global operating divisions of the Group, including its business units, if any</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Executive(s)</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Any or all Executive Committee member(s)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Executive Committee</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Executive committee of the Company</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">External Auditor</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Group&#8217;s external auditor</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Family Member</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">An immediate family member of a Director, i.e., including a person&#8217;s spouse, parents, children, stepchildren, siblings, mother-, father-, brothers-, sisters-, sons- and daughters-in-law and anyone (other than domestic employees) who share such person&#8217;s home</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">General Meeting</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">General meeting of shareholders of the Company</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">GNCRC</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Governance, Nomination and Corporate Responsibilities Committee of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Group</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Novartis and its subsidiaries</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Independence Criteria</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Independence criteria set forth in Appendix II</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Internal Audit</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The Group&#8217;s internal audit</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">RC</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Risk Committee of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">R&amp;DC</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Research &amp; Development Committee of the Board</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Regulations</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">These Organizational Regulations of the Company, including Appendix I and Appendix II which form an integral part of these Regulations</div>
</td>
</tr>

<tr>
<td style="WIDTH: 20%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Vice-Chairman</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 75%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">Vice-Chairman of the Board</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>
</div>

<div>
<div style="FONT-FAMILY: 'Times New Roman'">&#160;</div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">28</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>
</div>




</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2
<SEQUENCE>4
<FILENAME>a20012920f-ex2_8.htm
<DESCRIPTION>EXHIBIT 2.8
<TEXT>

<html>
<head>
<title>EXHIBIT 2.8</title>
</head>
<body bgcolor="#ffffff">

  <div id="HDR">&#160;</div>

<div style="TEXT-ALIGN: justify; MARGIN-LEFT: 0pt; DISPLAY: block; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"></div>

<div style="FONT-FAMILY: 'Times New Roman'">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: right">Exhibit 2.8</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">DESCRIPTION OF SECURITIES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">As of December 31, 2019 Novartis AG (&#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) had the following series of securities registered pursuant to Section 12(b) of the Exchange Act:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<table id="z6d5cca9e12164ce282f6e0c39d951b6d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr style="HEIGHT: 18px">
<td style="WIDTH: 30%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Title of each class</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM-WIDTH: 1px">&#160;</td>
<td style="WIDTH: 30%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: 1px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Trading symbol</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top; BORDER-BOTTOM-WIDTH: 1px">&#160;</td>
<td style="WIDTH: 30%; VERTICAL-ALIGN: top; BORDER-BOTTOM: 1px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Name of each exchange on which registered</div>
</td>
</tr>

<tr>
<td style="WIDTH: 30%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">Ordinary shares, nominal value CHF 0.50 per share</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">American Depositary Shares, <br>
 each representing 1 share</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 30%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">NOVN</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">NVS</div>
</td>
<td style="WIDTH: 5%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 30%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">New York Stock Exchange</div>

<div>&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">New York Stock Exchange</div>
</td>
</tr>
</table>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Our shares are listed in Switzerland on the SIX Swiss Exchange (&#8220;SIX&#8221;). American Depositary Shares (&#8220;ADSs&#8221;), each representing one ordinary share, nominal value 0.50 Swiss Francs per share of Novartis AG (the &#8220;shares&#8221;), have been available in the US through an American Depositary Receipt (&#8220;ADR&#8221;) program since December 1996. This program was established pursuant to the deposit agreement that we entered into with JPMorgan Chase Bank, N.A. (&#8220;JPMorgan Chase&#8221;), as depositary (&#8220;Deposit Agreement&#8221;). Our ADRs have been listed on the New York Stock Exchange (&#8220;NYSE&#8221;) since May 2000 and are traded under the symbol NVS. In connection with this listing (but not for trading), the shares are registered under Section 12(b) of the Exchange Act. This exhibit contains a description of the rights of (i) the holders of shares and (ii) ADR holders. Shares underlying the ADSs are held by JPMorgan Chase, the depositary, and holders of ADSs will not be treated as holders of the shares.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">The following summary is subject to and qualified in its entirety by Novartis AG&#8217;s Articles of Incorporation (&#8220;Articles&#8221;), Regulations of the Board of Directors (&#8220;Board Regulations&#8221;), and by Swiss law, particularly the Swiss Code of Obligations (&#8220;Swiss CO&#8221;). This is not a summary of all the significant provisions of the Articles, the Board Regulations, or of Swiss law and does not purport to be complete. Capitalized terms used but not defined herein have the meanings given to them in Novartis AG&#8217;s annual report on Form 20-F for the fiscal year ended December 31, 2019 and in the Deposit Agreement, which is an exhibit to our registration statement on Form F-6 filed with the SEC on May 3, 2001.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">ORDINARY SHARES</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 12pt">Item 9. General</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify">Item 9.A.6. Limitations or qualifications</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Not applicable.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify">Item 9.A.7. Other rights</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Not applicable.</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 12pt">9.A.5 Type and class of securities</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">Each Novartis AG share has nominal value of 0.50 Swiss Francs per share. The respective number of shares that have been issued as of December 31, 2019 is given in Item 6.C of the annual report on Form 20-F for the fiscal year ended December 31, 2019. Novartis AG shares are issued as uncertificated securities (in the sense of the Swiss Code of Obligations) and as book entry securities (in terms of the Swiss Act on Intermediated Securities). All Novartis AG shares have equal voting rights and carry equal entitlements to dividends. No participation certificates, non-voting equity securities (Genussscheine) or profit-sharing certificates have been issued.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify">9.A.3 Pre-emptive rights</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">If a capital increase is approved, then our shareholders would generally have certain pre-emptive rights to obtain newly issued shares in an amount proportional to the nominal value of the shares they already hold. These pre-emptive rights could be excluded in certain limited circumstances with the approval of a resolution adopted at a General Meeting of Shareholders by a supermajority of two thirds of the votes. Preemptive rights, if not excluded, are transferable during the subscription period relating to a particular offering of shares and may be quoted on the SIX. US holders of shares, or US holders of ADRs, may not be able to exercise the preemptive rights attached to the shares or to the shares underlying their ADRs unless a registration statement under the US Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), is effective with respect to such rights and the related shares, or an exemption from this registration requirement is available. If preemptive rights could not be exercised by an ADR holder, the depositary would, if possible, sell the holder&#8217;s preemptive rights and distribute the net proceeds of the sale to the holder. If the depositary determines, in its discretion, that the rights could not be sold, the depositary might allow such rights to lapse.</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">1</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div>&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; TEXT-ALIGN: left">Item 10.B Memorandum and articles of association</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.3 Shareholder rights</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">Because Novartis AG has only one class of registered shares, the following information applies to all shareholders.</div>

<div style="TEXT-ALIGN: justify">
<table id="zb1481fad4a8f46aab5d62da19bbe78b1" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(a)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">Under the Swiss CO, we may only pay dividends out of balance sheet profits or out of distributable reserves. In any event, under the Swiss CO, while the Board of Directors (the &#8220;Board&#8221;) may propose that a dividend be paid, we may only pay dividends upon shareholders&#8217; approval at a General Meeting of Shareholders. Furthermore, the Swiss CO requires us to accrue general legal reserves under certain circumstances so long as these reserves amount to less than 20% of our registered share capital, and Swiss law and the Articles permit us to accrue additional reserves beyond the statutory reserves. Our auditors must confirm that the dividend proposal of our Board conforms with the Swiss CO and the Articles. Our Board intends to propose a dividend once each year. See &#8220;Item&#160;3.&#160;Key Information&#8212;Item&#160;3.A. Selected financial data&#8212;Cash dividends per share&#8221; and &#8220;Item&#160;8.&#160;Financial Information&#8212;Item&#160;8.A. Consolidated statements and other financial information&#8212;Dividend policy&#8221; of our Form 20-F for the fiscal year ended December 31, 2019.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-INDENT: 14.15pt">Dividends are usually due and payable shortly after the shareholders have <font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">passed a resolution approving the payment. Dividends that have not been claimed within five years after the due date revert to us and are allocated to our general reserves. For information about deduction of the withholding tax or other duties from dividend payments, see &#8220;&#8212;Item&#160;10.E Taxation&#8221; of our Form 20-F for the fiscal year ended December 31, 2019.</font></div>
</td>
</tr>
</table>
</div>
</div>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z6c31b35c96a64450b45474f339166e15" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(b)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">Each share is entitled to one vote at a General Meeting of Shareholders. Voting rights may only be exercised for shares registered with the right to vote on the record date for the applicable General Meeting of Shareholders. In order to do so, the shareholder must file&#160;a share registration form with us, setting forth the shareholder&#8217;s name, address and citizenship (or, in the case of a legal entity, its registered office). If the shareholder has not timely registered its shares, then the shareholder may not vote at, or participate in, General Meetings of Shareholders.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">To vote its shares, the shareholder must also explicitly declare that it has acquired the shares in its own name and for its own account. If the shareholder refuses to make such a declaration, the shares may not be voted unless the Board recognizes such shareholder as a nominee.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">The Articles provide that no shareholder shall be registered with the right to vote shares comprising more than 2% of the registered share capital. The Board may, upon request, grant an exemption from this restriction. Considerations include whether the shareholder supports our goal of creating sustainable value and has a long-term investment horizon. Furthermore, the Articles provide that no nominee shall be registered with the right to vote shares comprising more than 0.5% of the registered share capital. The Board may, upon request, grant an exemption from this restriction if the nominee discloses the names, addresses and number of shares of the persons for whose account it holds more than 0.5% of the registered share capital. The same restrictions indirectly apply to holders of ADRs. We have in the past granted exemptions from the 2% rule for shareholders and the 0.5% rule for nominees. Under the Articles, the Board may delegate the power to grant such exemptions. The Board has delegated this power to the Chairman of the Board.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">For purposes of the 2% rule for shareholders and the 0.5% rule for nominees, groups of companies and groups of shareholders acting in concert are considered to be one shareholder. These rules also apply to shares acquired or subscribed by the exercise of subscription, option or conversion rights.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">After hearing the registered shareholder or nominee, the Board may cancel, with retroactive effect as of the date of registration, the registration of the shareholders if the registration was effected based on false information.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">Registration restrictions in the Articles may only be removed upon a resolution carrying a two-thirds majority of the votes represented at a General Meeting of Shareholders.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">Except as noted in the paragraph immediately below, shareholders&#8217; resolutions require the approval of a majority of the votes present at a General Meeting of Shareholders. As a result, abstentions have the effect of votes against such resolutions. Some examples of shareholders&#8217; resolutions requiring a vote by such &#8220;absolute majority of the votes&#8221; are (1)&#160;amendments to the Articles; (2)&#160;elections of Directors, the Chairman, the Compensation Committee members, the Independent Proxy and the Statutory Auditor; (3)&#160;approval of the management report and the financial statements; (4)&#160;setting the annual dividend, if any; (5)&#160;approval of the aggregate amounts of compensation of the Directors and the members of the Executive Committee; (6)&#160;decisions to discharge Directors and management from liability for matters disclosed to the General Meeting of Shareholders; and (7)&#160;the ordering of an independent investigation into specific matters proposed to the General Meeting of Shareholders.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">According to the Articles and Swiss law, the following matters require the approval of a &#8220;supermajority&#8221; of at least two-thirds of the votes present at a General Meeting of Shareholders: (1)&#160;an alteration of our corporate purpose; (2)&#160;the creation of shares with increased voting powers; (3)&#160;an implementation of restrictions on the transfer of registered shares and the removal of such restrictions; (4)&#160;an authorized or conditional increase of the share capital; (5)&#160;an increase of the share capital by conversion of equity, by contribution in kind, or for the purpose of an acquisition of property or the grant of special rights; (6)&#160;a restriction or an exclusion of shareholders&#8217; pre-emptive rights; (7)&#160;a change of our registered office; (8)&#160;our dissolution; or (9)&#160;any amendment to the Articles that would create or eliminate a supermajority requirement. As a matter of Swiss law, certain other matters require a supermajority as well, including certain mergers, scissions and transformations under the Swiss Merger Act.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">Our shareholders are required to annually elect all of the members of the Board, as well as the Chairman of the Board, the members of the Compensation Committee, the Statutory Auditor and the Independent Proxy. The Articles do not provide for cumulative voting of shares.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">At General Meetings of Shareholders, shareholders can be represented by proxy. However, a proxy must either be: the shareholder&#8217;s legal representative, another shareholder with the right to vote, or the Independent Proxy. Votes are taken either by a show of hands or by electronic voting, unless the General Meeting of Shareholders resolves to have a ballot or where a ballot is ordered by the chairman of the meeting.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">ADSs, each representing one Novartis AG share and evidenced by ADRs, are issued by our depositary<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'">, </font>JPMorgan Chase, and not by us. The ADR is vested with rights defined and enumerated in the Deposit Agreement (such as the rights to vote, to receive a dividend and to receive a share of Novartis AG in exchange for a certain number of ADRs). The enumeration of rights, including any limitations on those rights in the Deposit Agreement, is final. There are no other rights given to the ADR holders. Only the ADS depositary, holding our shares underlying the ADRs, is registered as shareholder in our share register. An ADR is not a Novartis AG share and an ADR holder is not a Novartis AG shareholder.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">The Deposit Agreement between our depositary, the ADR holder and us has granted certain indirect rights to vote to the ADR holders. ADR holders may not attend Novartis AG general meetings in person. ADR holders exercise their voting rights by instructing JPMorgan Chase, our depositary, to exercise the voting rights attached to the registered shares underlying the ADRs. Each ADR represents one Novartis AG share. JPMorgan Chase exercises the voting rights for registered shares underlying ADRs for which no voting instructions have been given by providing a discretionary proxy to an uninstructed independent designee pursuant to paragraph&#160;13 of the form of ADR. Such designee has to be a shareholder of Novartis AG. The same voting restrictions apply to ADR holders as to those holding Novartis AG shares (i.e., the right to vote up to 2% of the Novartis AG registered share capital &#8211; unless otherwise granted an exemption by the Board &#8211; and the disclosure requirement for nominees).</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">2</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="TEXT-ALIGN: justify">&#160;</div>

<div style="TEXT-ALIGN: justify">
<table id="z93a4bb2689404ec8889879f6c6f08e2a" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">
<div>(c)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">Shareholders have the right to allocate the profit shown on our balance sheet and to distribute dividends by vote taken at the General Meeting of Shareholders, subject to the legal requirements described in &#8220;Item&#160;10.B.3(a) Shareholder rights.&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z387189783de24d8ab242fe4f850969a0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(d)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">Under the Swiss CO, any surplus arising out of a liquidation of Novartis AG (i.e., after the settlement of all claims of all creditors) would be distributed to the shareholders in proportion to the paid-in nominal value of their shares.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="z3ba25b295cdf44b28b2b3bcf3cb5962e" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(e)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">The Swiss CO limits a corporation&#8217;s ability to hold or repurchase its own shares. We and our subsidiaries may only repurchase shares if we have sufficient freely disposable equity in the amount of the purchase price of the acquired shares. The aggregate nominal value of all Novartis AG shares held by us and our subsidiaries may not exceed 10% of our registered share capital. However, it is accepted that a Swiss corporation may repurchase its own shares beyond the statutory limit of 10% if the repurchased shares are clearly earmarked for cancellation. In addition, we are required to recognize a negative position or if our subsidiaries acquire our shares, to create a special reserve on our balance sheet in the amount of the purchase price of the acquired shares. Repurchased shares held by us or our subsidiaries do not carry any rights to vote at a General Meeting of Shareholders, but are entitled to the economic benefits generally connected with the shares. The definition of subsidiaries, and therefore, treasury shares, for purposes of the above described reserves requirement and voting restrictions differs from the definition of subsidiaries for purposes of consolidation in our consolidated financial statements. The definition in the consolidated financial statements requires consolidation for financial reporting purposes of special purpose entities in instances where we have the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities. Therefore, our consolidated financial statements include special purpose entities, mainly foundations, which do not qualify as subsidiaries subject to the reserve requirements and voting restrictions of the Swiss CO because we do not hold a majority participation in these special purpose entities. Accordingly, no reserve requirements apply to shares held by such special purpose entities, and such entities are not restricted from independently voting their shares.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-INDENT: 14.15pt">Under the Swiss CO, we may not cancel treasury shares without the approval of a capital reduction by our shareholders.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zfff68dab79864c1b923b600dbe3255ef" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(f)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">Not applicable.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zc0d63e6ca3874485805bde96adc3e678" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(g)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">Since all of our issued and outstanding shares have been fully paid in, our shareholders are not obliged to make further contributions with respect to their shares.</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: justify">
<table id="zbf9519b5b8eb4ed6b71e634b81ef7751" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 40px; VERTICAL-ALIGN: top; COLOR: #272118; align: right">(h)</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: justify">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118">See &#8220;&#8212;Item&#160;10.B.3(b) Shareholder rights&#8221; and &#8220;&#8212;Item&#160;10.B.7 Change in control.&#8221;</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.4 Changes to shareholder rights</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">Under the Swiss CO, we may not issue new shares without the prior approval of a capital increase by our shareholders. If a capital increase is approved, then our shareholders would generally have certain pre-emptive rights to obtain newly issued shares in an amount proportional to the nominal value of the shares they already hold. These pre-emptive rights could be excluded in certain limited circumstances with the approval of a resolution adopted at a General Meeting of Shareholders by a supermajority of two-thirds of the votes. In addition, we may not create shares with increased voting powers or place restrictions on the transfer of registered shares without the approval of a resolution adopted at a General Meeting of Shareholders by a supermajority of votes. In addition, see &#8220;&#8212;Item&#160;10.B.3(b) Shareholder rights&#8221; with regard to the Board&#8217;s ability to cancel the registration of shares under limited circumstances.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.6 Limitations</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">There are no limitations under the Swiss CO or our Articles on the right of non-Swiss residents or nationals to own or vote shares other than the restrictions applicable to all shareholders. But see &#8220;&#8212;Item&#160;10.B.3(b) Shareholder rights&#8221; regarding conditions for exercising an ADR holder&#8217;s right to vote at a shareholder meeting.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.7 Change in control</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">The Articles and the Board Regulations contain no provision that would have an effect of delaying, deferring or preventing a change in control of Novartis AG and that would operate only with respect to a merger, acquisition or corporate restructuring involving us or any of our subsidiaries.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt; TEXT-INDENT: 14.15pt">According to the Swiss Merger Act, shareholders may pass a resolution to merge with another corporation at any time. Such a resolution would require the consent of at least two-thirds of all votes present at the necessary General Meeting of Shareholders.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt; TEXT-INDENT: 14.15pt">Under the Swiss Financial Market Infrastructure Act, shareholders and groups of shareholders acting in concert who acquire more than 33<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">1</sup>/<sub style="vertical-align: bottom; line-height: 1; font-size: smaller">3</sub>% of our shares would be under an obligation to make an offer to acquire all remaining Novartis AG shares. Novartis AG has neither opted out from the mandatory takeover offer obligation nor opted to increase the threshold for mandatory takeover offers in its Articles.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.8 Disclosure of shareholdings</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">Under the Swiss Financial Market Infrastructure Act, persons who directly, indirectly or in concert with other parties acquire or dispose of our shares or purchase or sale rights relating to our shares are required to notify us and SIX of the level of their holdings whenever such holdings reach, exceed or fall below certain thresholds &#8211; 3%, 5%, 10%, 15%, 20%, 25%, 33 1/3%, 50% and 66 2/3% &#8211; of the voting rights represented by our share capital (whether exercisable or not). This also applies to anyone who has discretionary power to exercise voting rights associated with our shares. Following receipt of such notification, we are required to inform the public by publishing the information via the electronic publication platform operated by SIX.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt; TEXT-INDENT: 14.15pt">An additional disclosure obligation exists under the Swiss CO that requires us to disclose, once a year in the notes to the financial statements published in our Annual Report, the identity of all of our shareholders (or related groups of shareholders) who have been granted exemption entitling them to vote more than 2% of our registered share capital, as described in &#8220;&#8212;Item&#160;10.B.3(b) Shareholder rights.&#8221;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.9 Differences in the law</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">See the references to Swiss law throughout this &#8220;&#8212;Item&#160;10.B Memorandum and articles of association.&#8221;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #272118; TEXT-ALIGN: left; MARGIN: 11.35pt 11.35pt 2.85pt 1.35pt">10.B.10 Changes in capital</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">The requirements of the Articles regarding changes in capital are not more stringent than the requirements of Swiss law.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #272118; TEXT-ALIGN: justify; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: normal; COLOR: #272118; TEXT-ALIGN: center; MARGIN-LEFT: 1.35pt; MARGIN-RIGHT: 11.35pt">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: normal; TEXT-ALIGN: center">3</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; MARGIN-TOP: 12pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center; MARGIN-TOP: 12pt">AMERICAN DEPOSITARY SHARES</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 12pt">Item 12. Other securities</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left; MARGIN-TOP: 12pt">Disclosures under Items 12.A, 12.B, and 12.C are not applicable.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">12.D.1 Depositary</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">JPMorgan Chase has been appointed as the depositary pursuant to the Deposit Agreement. JPMorgan Chase&#8217;s principal executive office is located at 4 New York Plaza, 13<sup style="vertical-align: text-top; line-height: 1; font-size: smaller">th</sup> Floor, New York, NY 10004.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify">12.D.2 Provisions</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">ADSs, each representing one Novartis AG share and evidenced by ADRs, are issued by the depositary, and not by us. The ADR is vested with rights defined and enumerated in the Deposit Agreement (such as the rights to vote, to receive a dividend and to receive a share of Novartis AG in exchange for a certain number of ADRs). The enumeration of rights, including any limitations on those rights in the Deposit Agreement, is final. There are no other rights given to the ADR holders. Only the depositary is registered as shareholder in our share register. An ADR is not a Novartis AG share and an ADR holder is not a Novartis AG shareholder.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">The following is a summary of the material provisions of the Deposit Agreement. For more complete information, you should read the Deposit Agreement and form of ADR. The amended and restated Deposit Agreement and Amendment No. 1 has been filed with the SEC as an exhibit to the Form F-6 filed with the SEC on September 8, 2000, and Amendment No. 2 has been filed with the SEC as an exhibit to the Form F-6 filed with the SEC on May 3, 2001.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: justify">Voting rights</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">The Deposit Agreement has granted certain indirect rights to vote to the ADR holders. ADR holders may not attend Novartis AG general meetings in person. ADR holders exercise their voting rights by instructing the depositary to exercise the voting rights attached to the registered shares underlying the ADRs. The depositary exercises the voting rights for registered shares underlying ADRs for which no voting instructions have been given by providing a discretionary proxy to an uninstructed independent designee pursuant to paragraph 13 of the form of ADR. Such designee has to be a shareholder of Novartis AG. The same voting restrictions apply to ADR holders as to those holding Novartis AG shares (i.e., the right to vote up to 2% of the Novartis AG registered share capital &#8211; unless otherwise granted an exemption by the Board &#8211; and the disclosure requirement for nominees).</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">As soon as practicable after receipt from Novartis AG of notice of any meeting or solicitation of consents or proxies of holders of shares or other deposited securities, the depositary will mail to holders a notice stating (a) such information as is contained in such notice and any solicitation materials (or a summary thereof), (b) that each holder on the record date set by the depositary therefor will be entitled, subject to applicable law and the provisions of or governing deposited securities to instruct the depositary as to the exercise of the voting rights, if any, pertaining to the deposited securities represented by the ADSs evidenced by such holder&#8217;s ADRs and (c) the manner in which such instructions may be given, including instructions to give a discretionary proxy to a person designated by Novartis AG. Upon receipt of instructions of a holder on such record date in the manner and on or before the date established by the depositary for such purpose, the depositary will endeavor insofar as practicable and permitted under the provisions of or governing deposited securities to vote or cause to be voted (or to grant a discretionary proxy to a person designated by Novartis AG) the deposited securities represented by the ADSs evidenced by such holder&#8217;s ADRs in accordance with such instructions. The depositary will not itself exercise any voting discretion in respect of any deposited securities. To the extent such instructions are not so received by the depositary from any holder, the depositary shall deem such holder to have so instructed the depositary to give a discretionary proxy to a person designated by Novartis AG and the depositary shall endeavor insofar as practicable and permitted under the provisions of or governing deposited securities to give a discretionary proxy to a person designated by Novartis AG to vote the deposited securities represented by the ADSs evidenced by such holder&#8217;s ADRs as to which such instructions are so given, provided that no such instruction shall be deemed given and no discretionary proxy shall be given with respect to any matter as to which the Novartis AG informs the depositary (and Novartis AG agrees to provide such information promptly in writing) that Novartis AG does not wish such proxy given.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: justify">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">4</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Share dividends and other distributions</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">The depositary will distribute as promptly as practicable by mail, to the extent distribution by mail is practicable, to each ADR holder on the record date set by the depositary at such ADR holder&#8217;s address shown on the ADR Register, in proportion to the number of deposited securities (on which the following distributions on deposited securities are received by the custodian) represented by ADSs evidenced by such holder&#8217;s ADRs:</font></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">
<table id="za4dcfa775358400899997de8a53c6bf9" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(a)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; BACKGROUND-COLOR: #ffffff"></font>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; BACKGROUND-COLOR: #ffffff"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff"></font></font>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; BACKGROUND-COLOR: #ffffff"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-STYLE: italic; BACKGROUND-COLOR: #ffffff">Cash</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">: <font style="FONT-STYLE: normal">Any US dollars available to the depositary resulting from a cash dividend or other cash distribution or the net proceeds of sales of any other distribution or portion thereof authorized in paragraph 10 (&#8220;Cash&#8221;) of the form of ADR, on an averaged or other reasonably practicable basis, subject to (i) appropriate adjustments for taxes withheld, (ii) such distribution being impermissible pursuant to applicable law with respect to certain holders, and (iii) deduction of the depositary&#8217;s expenses in (1) converting any foreign currency to US dollars by sale or in such other manner as the depositary may determine to the extent that it determines that such conversion may be made on a reasonable basis, (2) transferring foreign currency or US dollars to the US by such means as the depositary may determine to the extent that it determines that such transfer may be made on a reasonable basis, (3) obtaining any approval or license of any governmental authority required for such conversion or transfer, which is obtainable at a reasonable cost and within a reasonable time and (4) making any sale by public or private means in any commercially reasonable manner.</font></font></font></font></div>
</div>
</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">
<div style="BACKGROUND-COLOR: #ffffff">
<table id="z79af11ac9d474212bceaf9d34eeb1283" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(b)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><em>Shares</em><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">. (i) Additional ADRs evidencing whole ADSs representing any shares available to the depositary resulting from a dividend or free distribution on deposited securities consisting of shares (a &#8220;Share Distribution&#8221;) and (ii) US dollars available to it resulting from the net proceeds of sales of shares received in a Share Distribution, which shares would give rise to fractional ADSs if additional ADRs were issued therefor, as in the case of Cash.</font></div>
</td>
</tr>
</table>
</div>

<div style="BACKGROUND-COLOR: #ffffff"><br>
</div>

<div style="BACKGROUND-COLOR: #ffffff">
<table id="z605ed95fc23f4c6b9df49191f0228094" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(c)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><em>Rights</em><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">. (i) Warrants or other instruments in the discretion of the depositary after consultation with Novartis AG if practicable representing rights to acquire additional ADRs in respect of any rights to subscribe for additional shares or rights of any nature available to the depositary as a result of a distribution on deposited securities (&#8220;Rights&#8221;), to the extent that Novartis AG timely furnishes to the depositary evidence satisfactory to the depositary that the depositary may lawfully distribute the same (Novartis AG has no obligation to so furnish such evidence), or (ii) to the extent Novartis AG does not so furnish such evidence and sales of Rights are practicable, any US dollars available to the depositary from the net proceeds of sales of Rights as in the case of Cash, or (iii) to the extent Novartis AG does not so furnish such evidence and such sales cannot practicably be accomplished by reason of the nontransferability of the Rights, limited markets therefor, their short duration or otherwise, nothing (and any Rights may lapse).</font></div>
</td>
</tr>
</table>
</div>

<div style="BACKGROUND-COLOR: #ffffff"><br>
</div>

<div style="BACKGROUND-COLOR: #ffffff">
<table id="za32242bf114f4ea49b150d1fc5329eeb" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(d)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><em>Other Distributions</em><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">. (i) Securities or property available to the depositary resulting from any distribution on deposited securities other than Cash, Share Distributions and Rights (&#8220;Other Distributions&#8221;), by any means that the depositary may deem equitable and practicable, or (ii) to the extent the depositary deems distribution of such securities or property not to be equitable and practicable, any US dollars available to the depositary from the net proceeds of sales of Other Distributions as in the case of Cash. The depositary shall endeavor to conduct any sales hereunder in a commercially reasonable manner.</font></div>
</td>
</tr>
</table>

<br>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">The depositary will distribute US dollars by checks drawn on a bank in the US for whole dollars and cents (any fractional cents being withheld without liability for interest and dealt with by the depositary in accordance with its then current procedures), pursuant to paragraph 10 of the form of ADR.</font></div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Deposit, withdrawal and cancellation</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BACKGROUND-COLOR: #ffffff">Subject to paragraphs 4 and 5 of the form of ADR, upon surrender of (i) a certificated ADR in form satisfactory to the depositary at the transfer office or (ii) proper instructions and documentation in the case of a Direct Registration ADR, the holder hereof is entitled to delivery at the custodian&#8217;s office of the deposited securities at the time represented by the ADSs evidenced by this ADR. At the request, risk and expense of the holder, the depositary may deliver such deposited securities at such other place as may have been requested by the holder. Notwithstanding any other provision of the deposit agreement or this ADR, the withdrawal of deposited securities may be restricted only for the reasons set forth in General Instruction I.A.(1) of Form F-6 (as such instructions may be amended from time to time) under the Securities Act.</font></div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Reclassification, recapitalizations and mergers</div>

<div style="BACKGROUND-COLOR: #ffffff">
<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">If Novartis AG takes certain actions that affect the deposited securities, including (i)&#160;any change in par value, split-up, consolidation, cancellation or other reclassification of deposited securities or (ii)&#160;any recapitalization, reorganization, merger, consolidation, liquidation, receivership, bankruptcy or sale of all or substantially all the assets of the company, then the depositary may choose to:</div>

<div><br>
</div>
</div>

<div style="BACKGROUND-COLOR: #ffffff">
<table id="z8dc69cfcb50b473bae8be4762c99f1f0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(a)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">issue and distribute additional ADRs;</div>
</td>
</tr>
</table>
</div>

<div style="TEXT-ALIGN: left; MARGIN-LEFT: 90pt; BACKGROUND-COLOR: #ffffff"><br>
</div>

<div style="BACKGROUND-COLOR: #ffffff">
<table id="z06f31dc8f57340e2acf13e9e188ee8af" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(b)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">amend the deposit agreement and applicable ADRs;</div>
</td>
</tr>
</table>
</div>

<div style="BACKGROUND-COLOR: #ffffff"><br>
</div>

<div style="BACKGROUND-COLOR: #ffffff">
<table id="zc4048eb3d6ff4389bf99b70b6527e9ee" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(c)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">call for the surrender of outstanding ADRs to be exchanged for new ADRs; and</div>
</td>
</tr>
</table>
</div>

<div style="BACKGROUND-COLOR: #ffffff"><br>
</div>

<div style="BACKGROUND-COLOR: #ffffff">
<table id="z914937c59c93474ba225ce1ff76a1504" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 40px; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">(d)</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">distribute cash, securities or property on the record date set by the depositary to reflect the transaction.</div>
</td>
</tr>
</table>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Amendment and termination</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The ADRs and the Deposit Agreement may be amended by Novartis AG and the depositary, provided that any amendment that imposes or increases any fees or charges (other than stock transfer or other taxes and other governmental charges, transfer or registration fees, cable, telex or facsimile transmission costs, delivery costs or other such expenses), or that shall otherwise prejudice any substantial existing right of holders, shall become effective 30 days after notice of such amendment shall have been given to the holders. Every holder of an ADR at the time any amendment to the Deposit Agreement so becomes effective shall be deemed, by continuing to hold such ADR, to consent and agree to such amendment and to be bound by the Deposit Agreement as amended thereby.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The depositary may, and shall at the written direction of Novartis AG, terminate the Deposit Agreement and this ADR by mailing notice of such termination to the holders at least 30 days prior to the date fixed in such notice for such termination. After the date so fixed for termination, the depositary and its agents will perform no further acts under the Deposit Agreement and this ADR, except to receive and hold (or sell) distributions on deposited securities and deliver deposited securities being withdrawn. As soon as practicable after the expiration of six months from the date so fixed for termination, the depositary shall sell the deposited securities and shall thereafter (as long as it may lawfully do so) hold in a segregated account the net proceeds of such sales, together with any other cash then held by it under the Deposit Agreement, without liability for interest, in trust for the pro rata benefit of the holders of ADRs not theretofore surrendered. After making such sale, the Depositary shall be discharged from all obligations in respect of the Deposit Agreement and this ADR, except for its obligations to Novartis AG under Section 16 of the Deposit Agreement and to account for such net proceeds and other cash. After the date so fixed for termination, Novartis AG will discharged from all obligations under the Deposit Agreement except for its obligations to the depositary and its agents.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: normal; TEXT-ALIGN: center">5</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Limitation on obligations and liability to ADR holders</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; COLOR: #000000; TEXT-ALIGN: left">The depositary, Novartis AG, their respective directors, employees, officers, agents or affiliates and each of them shall: (a) incur no liability (i) if any present or future law, regulation, order, decree, moratorium, fiat, the provisions of or governing any deposited securities and the Memorandum and Articles, act of God, war or other circumstance beyond its control shall prevent, delay or subject to any civil or criminal penalty or restraint or any act which the Deposit Agreement or this ADR provides shall be done or performed by it, or (ii) by reason of any exercise or failure to exercise any discretion given it in the Deposit Agreement, this ADR or the Memorandum and Articles; (b) assume no liability except to perform its obligations to the extent they are specifically set forth in this ADR and the Deposit Agreement without gross negligence or bad faith; (c) be under no obligation to appear in, prosecute or defend any action, suit or other proceeding in respect of any Deposited Securities or this ADR; or (d) not be liable for any action or inaction by it in reliance upon the advice of or information from legal counsel, accountants, any person presenting shares for deposit, any holder, or any other person believed by it to be competent to give such advice or information. The depositary, its agents and Novartis AG may rely and shall be protected in acting upon any written notice, request, direction or other document believed by them to be genuine and to have been signed or presented by the proper party or parties. The depositary and its agents will not be responsible for any failure to carry out any instructions to vote any of the deposited securities, for the manner in which any such vote is cast or for the effect of any such vote. The depositary and its agents may own and deal in any class of securities of Novartis AG and its affiliates and in ADRs. Novartis AG has agreed to indemnify the depositary and its agents under certain circumstances and the depositary and its agents have agreed to indemnify Novartis AG under certain circumstances. No disclaimer of liability under the Securities Act is intended by any provision hereof.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">Books of depositary</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: left">The depositary will keep books at its principal office for the registration and transfer of ADRs, which will be open for your inspection at all reasonable times. Such inspection shall not be for the purpose of communicating with other owners of ADRs in the interest of a business or object other than our business or other than a matter related to the deposit agreement or the ADRs.</div>
</div>

<div>
<div>&#160;</div>

<div>&#160;</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">6</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; TEXT-ALIGN: center">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>
</div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12
<SEQUENCE>5
<FILENAME>a20012920f-ex12_1.htm
<DESCRIPTION>EXHIBIT 12.1
<TEXT>

<html>
<head>
<title>EXHIBIT 12.1</title>
</head>
<body bgcolor="#ffffff">



    <div style="text-align:right;font-weight: bold;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Exhibit&nbsp;12.1 </div>
<div style="text-align:center;font-weight: bold;padding-bottom:30px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">CERTIFICATION </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">I, Vasant Narasimhan, certify that: </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">1.  I have reviewed this annual report on Form&nbsp;20-F of Novartis AG; </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">4.  The company&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f) and 15d-15(f)) for the company and have: </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">c)  evaluated the effectiveness of the company&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">d)  disclosed in this report any change in the company&#x2019;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#x2019;s internal control over financial reporting; and </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">5.  The company&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#x2019;s auditors and the audit committee of the company&#x2019;s board of directors (or persons performing the equivalent functions): </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#x2019;s ability to record, process, summarize and report financial information; and </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#x2019;s internal control over financial reporting. </div>
<div style="padding-bottom:15px;padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Date: January&nbsp;29, 2020</div>
<div style="text-decoration:underline;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">By: /s/ VASANT NARASIMHAN</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Vasant Narasimhan</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><i>Chief Executive Officer</i></div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12
<SEQUENCE>6
<FILENAME>a20012920f-ex12_2.htm
<DESCRIPTION>EXHIBIT 12.2
<TEXT>

<html>
<head>
<title>EXHIBIT 12.2</title>
</head>
<body bgcolor="#ffffff">



    <div style="text-align:right;font-weight: bold;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Exhibit&nbsp;12.2 </div>
<div style="text-align:center;font-weight: bold;padding-bottom:30px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">CERTIFICATION </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">I, Harry Kirsch, certify that: </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">1.  I have reviewed this annual report on Form&nbsp;20-F of Novartis AG; </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">4.  The company&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f) and 15d-15(f)) for the company and have: </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">c)  evaluated the effectiveness of the company&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">d)  disclosed in this report any change in the company&#x2019;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#x2019;s internal control over financial reporting; and </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">5.  The company&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#x2019;s auditors and the audit committee of the company&#x2019;s board of directors (or persons performing the equivalent functions): </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#x2019;s ability to record, process, summarize and report financial information; and </div>
<div style="margin-left:32px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#x2019;s internal control over financial reporting. </div>
<div style="padding-bottom:15px;padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Date: January&nbsp;29, 2020</div>
<div style="text-decoration:underline;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">By: /s/ HARRY KIRSCH</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Harry Kirsch</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><i>Chief Financial Officer</i></div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13
<SEQUENCE>7
<FILENAME>a20012920f-ex13_1.htm
<DESCRIPTION>EXHIBIT 13.1
<TEXT>

<html>
<head>
<title>EXHIBIT 13.1</title>
</head>
<body bgcolor="#ffffff">



    <div style="text-align:right;font-weight: bold;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Exhibit&nbsp;13.1 </div>
<div style="text-align:center;font-weight: bold;padding-bottom:30px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">CERTIFICATION OF VASANT NARASIMHAN, CHIEF EXECUTIVE OFFICER OF  NOVARTIS AG PURSUANT TO SECTION 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002 </div>
<div style="padding-bottom:10px;text-indent:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">In connection with the Annual Report of Novartis AG (the &#x201C;Company&#x201D;) on Form 20-F for the period ending December&nbsp;31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the &#x201C;Report&#x201D;), the undersigned hereby certify that to the best of our knowledge: </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">1.  The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">2.  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>
<div style="text-decoration:underline;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> /s/ VASANT NARASIMHAN</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Name: Vasant Narasimhan</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Title: <i>Chief Executive Officer</i></div>
<div style="padding-bottom:15px;padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Date: January 29, 2020</div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13
<SEQUENCE>8
<FILENAME>a20012920f-ex13_2.htm
<DESCRIPTION>EXHIBIT 13.2
<TEXT>

<html>
<head>
<title>EXHIBIT 13.2</title>
</head>
<body bgcolor="#ffffff">



    <div style="text-align:right;font-weight: bold;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Exhibit&nbsp;13.2 </div>
<div style="text-align:center;font-weight: bold;padding-bottom:30px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">CERTIFICATION OF HARRY KIRSCH, CHIEF FINANCIAL OFFICER OF  NOVARTIS AG PURSUANT TO SECTION 18 U.S.C. SECTION 1350,   AS ADOPTED PURSUANT TO SECTION 906  OF THE SARBANES-OXLEY ACT OF 2002 </div>
<div style="padding-bottom:10px;text-indent:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">In connection with the Annual Report of Novartis AG (the &#x201C;Company&#x201D;) on Form 20-F for the period ending December&nbsp;31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the &#x201C;Report&#x201D;), the undersigned hereby certify that to the best of our knowledge: </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">1.  The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">2.  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </div>
<div style="margin-left:16px;text-indent:-16px;padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>
<div style="text-decoration:underline;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> /s/ HARRY KIRSCH&nbsp;</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Name: Harry Kirsch</div>
<div style="margin-left:22px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Title: <i>Chief Financial Officer</i></div>
<div style="padding-bottom:15px;padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Date: January 29, 2020</div>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15
<SEQUENCE>9
<FILENAME>a20012920f-ex15_1.htm
<DESCRIPTION>EXHIBIT 15.1
<TEXT>

<html>
<head>
<title>EXHIBIT 15.1</title>
</head>
<body bgcolor="#ffffff">





<br>
<img src="x_pwc.gif">
<br>


    <div style="text-align:right;font-weight: bold;padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Exhibit&nbsp;15.1 </div>
<div style="text-align:center;font-weight: bold;padding-bottom:30px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="text-align:center;font-weight: bold;padding-bottom:30px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-171739 and 333-198706) of Novartis AG of our report dated January 28, 2020 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">/s/ PricewaterhouseCoopers AG</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">Basel, Switzerland </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">January 28, 2020</div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"> </div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><i>PricewaterhouseCoopers AG, St. Jakobs-Strasse 25, CH-4002 Basel, Switzerland</i></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"><i>Telephone: +41 58 792 51 00, Facsimile: +41 58 792 51 10, www.pwc.ch</i></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;">PricewaterhouseCoopers AG is a member of a global network of companies that are legally independent of one another.</div>
<div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;"></div>



</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>nvs-20191231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails" xlink:href="nvs-20191231.xsd#disclosureAcquisitionsOfBusinessesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingenciesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureOtherCurrentAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails" xlink:href="nvs-20191231.xsd#disclosureEquityDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfComprehensiveIncome" xlink:href="nvs-20191231.xsd#statementOfComprehensiveIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementsOfCashFlow" xlink:href="nvs-20191231.xsd#statementsOfCashFlow" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" xlink:href="nvs-20191231.xsd#disclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" xlink:href="nvs-20191231.xsd#disclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfIncome" xlink:href="nvs-20191231.xsd#statementOfIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:href="nvs-20191231.xsd#disclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssetsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails2" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails" xlink:href="nvs-20191231.xsd#disclosureEarningsPerShareDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/BalanceSheet" xlink:href="nvs-20191231.xsd#balanceSheet" xlink:type="simple"/>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/BalanceSheet" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Assets" xlink:to="lbl_CurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Assets" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="lbl_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Equity" xlink:to="lbl_EquityAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="lbl_NoncontrollingInterests" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Equity" xlink:to="lbl_NoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_EquityAttributableToOwnersOfParent" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReserves" xlink:label="lbl_OtherReserves" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_EquityAttributableToOwnersOfParent" xlink:to="lbl_OtherReserves" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_EquityAttributableToOwnersOfParent" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Liabilities" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Liabilities" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentLiabilities" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentLiabilities" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="lbl_EquityAndLiabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_EquityAndLiabilities" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_EquityAndLiabilities" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="lbl_NoncurrentFinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_NoncurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentLiabilities" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilities" xlink:to="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilities" xlink:to="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets1" xlink:type="locator"/>
      <link:calculationArc order="10.2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssets1" xlink:to="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:calculationArc order="17.2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssets" xlink:to="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxReceivable" xlink:label="lbl_CurrentIncomeTaxReceivable" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_CurrentIncomeTaxReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="lbl_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_OtherCurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_OtherCurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:calculationArc order="9.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentLiabilities" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="lbl_BasicEarningsLossPerShare" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_BasicEarningsLossPerShare" xlink:to="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_BasicEarningsLossPerShare" xlink:to="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="lbl_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_DilutedEarningsLossPerShare" xlink:to="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_DilutedEarningsLossPerShare" xlink:to="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="lbl_Cash" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashAndCashEquivalents" xlink:to="lbl_Cash" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="lbl_CashEquivalents" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashAndCashEquivalents" xlink:to="lbl_CashEquivalents" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredCompensationPlansAssets" xlink:label="lbl_DeferredCompensationPlansAssets" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherNoncurrentAssets" xlink:to="lbl_DeferredCompensationPlansAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:label="lbl_OtherNoncurrentNonfinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherNoncurrentAssets" xlink:to="lbl_OtherNoncurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaidPostemploymentBenefitPlansAssets" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherNoncurrentAssets" xlink:to="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="lbl_CommercialPapersIssued" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialLiabilities" xlink:to="lbl_CommercialPapersIssued" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="lbl_ShorttermBorrowings" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialLiabilities" xlink:to="lbl_ShorttermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialLiabilities" xlink:to="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="lbl_DerivativeFinancialLiabilities" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialLiabilities" xlink:to="lbl_DerivativeFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialLiabilities" xlink:to="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/StatementOfIncome" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLoss" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLoss" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromContinuingOperations" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossBeforeTax" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossBeforeTax" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossBeforeTax" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GrossProfit" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GrossProfit" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_RevenueFromSaleOfGoods" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromContinuingOperations" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossBeforeTax" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GrossProfit" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:calculationArc order="1.5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_RevenueFromSaleOfGoods" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_InterestExpense" xlink:to="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="arc"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_InterestExpense" xlink:to="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="locator"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:label="lbl_GainsLossesOnAvailableforsaleFinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_GainsLossesOnAvailableforsaleFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnNetMonetaryPosition" xlink:label="lbl_GainsLossesOnNetMonetaryPosition" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_GainsLossesOnNetMonetaryPosition" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:label="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:type="locator"/>
      <link:calculationArc order="5.5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:calculationArc order="9.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_RevenueFromInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromDividends" xlink:label="lbl_RevenueFromDividends" xlink:type="locator"/>
      <link:calculationArc order="10.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_RevenueFromDividends" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="lbl_OtherFinanceCost" xlink:type="locator"/>
      <link:calculationArc order="11.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_OtherFinanceCost" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeOnForwardContractsAndOptions" xlink:label="lbl_IncomeOnForwardContractsAndOptions" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_IncomeOnForwardContractsAndOptions" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Borrowings" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherInstitutions" xlink:label="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_Borrowings" xlink:to="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/StatementsOfCashFlow" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInOperatingActivities" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="9.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivities" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivities" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:label="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="arc"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="arc"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="10.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="11.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="12.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:calculationArc order="13.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:calculationArc order="2.5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="locator"/>
      <link:calculationArc order="9.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="locator"/>
      <link:calculationArc order="10.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="locator"/>
      <link:calculationArc order="11.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:calculationArc order="12.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="locator"/>
      <link:calculationArc order="13.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquityPaid" xlink:label="lbl_TransactionCostsRecordedInEquityPaid" xlink:type="locator"/>
      <link:calculationArc order="12.5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_TransactionCostsRecordedInEquityPaid" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:label="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:calculationArc order="15.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInOperatingActivities" xlink:to="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:label="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInOperatingActivities" xlink:to="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:label="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_CashFlowsFromUsedInOperatingActivities" xlink:to="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/StatementOfComprehensiveIncome" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ComprehensiveIncome" xlink:to="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ComprehensiveIncome" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:calculationArc order="2.8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ComprehensiveIncome" xlink:to="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="lbl_SurplusDeficitInPlan" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="lbl_PlanAssetsAtFairValue" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_SurplusDeficitInPlan" xlink:to="lbl_PlanAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LimitationOnRecognitionOfFundSurplus" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
      <link:calculationArc order="4.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lbl_SurplusDeficitInPlan" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_SurplusDeficitInPlan" xlink:to="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="lbl_KeyManagementPersonnelCompensation" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_KeyManagementPersonnelCompensation" xlink:to="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_KeyManagementPersonnelCompensation" xlink:to="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="locator"/>
      <link:calculationArc order="1.5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_KeyManagementPersonnelCompensation" xlink:to="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:label="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapital" xlink:label="lbl_OutstandingShareCapital" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OutstandingShareCapital" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares" xlink:label="lbl_SaleOrIssueOfTreasuryShares" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapitalMovement" xlink:label="lbl_OutstandingShareCapitalMovement" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OutstandingShareCapitalMovement" xlink:to="lbl_SaleOrIssueOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IssuedCapitalMovement" xlink:label="lbl_IssuedCapitalMovement" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OutstandingShareCapitalMovement" xlink:to="lbl_IssuedCapitalMovement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OutstandingShareCapital" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:label="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefits" xlink:label="lbl_OtherPostemploymentBenefits" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_OtherPostemploymentBenefits" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalRemediationProvisionNoncurrent" xlink:label="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationNonCurrent" xlink:label="lbl_ContingentConsiderationNonCurrent" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_ContingentConsiderationNonCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="lbl_OtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_OtherNoncurrentLiabilities" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:calculationArc order="1.5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPrepaidExpensesAssociatedCompanies" xlink:label="lbl_CurrentPrepaidExpensesAssociatedCompanies" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_CurrentPrepaidExpensesAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPrepaidExpensesThirdParty" xlink:label="lbl_CurrentPrepaidExpensesThirdParty" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_CurrentPrepaidExpensesThirdParty" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="lbl_CurrentValueAddedTaxReceivables" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_CurrentValueAddedTaxReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherReceivablesAndCurrentAssets" xlink:label="lbl_OtherReceivablesAndCurrentAssets" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_OtherReceivablesAndCurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReceivablesAssociatedCompanies" xlink:label="lbl_ReceivablesAssociatedCompanies" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_ReceivablesAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WithholdingTaxRecoverable" xlink:label="lbl_WithholdingTaxRecoverable" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_WithholdingTaxRecoverable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivableCurrent" xlink:label="lbl_ContingentConsiderationReceivableCurrent" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_ContingentConsiderationReceivableCurrent" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsUnderLongtermResearchAgreements" xlink:label="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:label="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:to="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangiblePurchaseCommitments" xlink:label="lbl_OtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:to="lbl_OtherIntangiblePurchaseCommitments" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IdentifiableAssetsAcquired" xlink:label="lbl_IdentifiableAssetsAcquired" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherAssets" xlink:label="lbl_FinancialAndOtherAssets" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_FinancialAndOtherAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="9.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="10.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:calculationArc order="11.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesAndOtherLiabilities" xlink:label="lbl_TradePayablesAndOtherLiabilities" xlink:type="locator"/>
      <link:calculationArc order="12.0" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_TradePayablesAndOtherLiabilities" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermRestructuringProvision" xlink:label="lbl_ShorttermRestructuringProvision" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_ShorttermRestructuringProvision" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="lbl_AccrualsClassifiedAsCurrent" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_AccrualsClassifiedAsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:label="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentInterestPayable" xlink:label="lbl_CurrentInterestPayable" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_CurrentInterestPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RefundsProvision" xlink:label="lbl_RefundsProvision" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_RefundsProvision" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="lbl_ShorttermEmployeeBenefitsAccruals" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_ShorttermEmployeeBenefitsAccruals" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionCurrent" xlink:label="lbl_EnvironmentalProvisionCurrent" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_EnvironmentalProvisionCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredIncomeClassifiedAsCurrent" xlink:label="lbl_DeferredIncomeClassifiedAsCurrent" xlink:type="locator"/>
      <link:calculationArc order="9.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_DeferredIncomeClassifiedAsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="locator"/>
      <link:calculationArc order="10.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="locator"/>
      <link:calculationArc order="11.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationCurrentPortion" xlink:label="lbl_ContingentConsiderationCurrentPortion" xlink:type="locator"/>
      <link:calculationArc order="12.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_ContingentConsiderationCurrentPortion" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentForRepurchaseOwnShares" xlink:label="lbl_CommitmentForRepurchaseOwnShares" xlink:type="locator"/>
      <link:calculationArc order="13.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_CommitmentForRepurchaseOwnShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentPayables" xlink:label="lbl_OtherCurrentPayables" xlink:type="locator"/>
      <link:calculationArc order="14.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_OtherCurrentPayables" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="lbl_NoncurrentFinancialAssets" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:label="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssets" xlink:to="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="lbl_NoncurrentTradeReceivables" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssets" xlink:to="lbl_NoncurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="lbl_NoncurrentFinanceLeaseReceivables" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssets" xlink:to="lbl_NoncurrentFinanceLeaseReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivable" xlink:label="lbl_ContingentConsiderationReceivable" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssets" xlink:to="lbl_ContingentConsiderationReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLoansAndReceivables" xlink:label="lbl_NoncurrentLoansAndReceivables" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssets" xlink:to="lbl_NoncurrentLoansAndReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsEquityInvestments" xlink:label="lbl_NoncurrentFinancialAssetsEquityInvestments" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:to="lbl_NoncurrentFinancialAssetsEquityInvestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAsstetsDebtSecurities" xlink:label="lbl_NoncurrentFinancialAsstetsDebtSecurities" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:to="lbl_NoncurrentFinancialAsstetsDebtSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsFundInvestments" xlink:label="lbl_NoncurrentFinancialAssetsFundInvestments" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:to="lbl_NoncurrentFinancialAssetsFundInvestments" xlink:type="arc"/>
   </link:calculationLink>
   <link:calculationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="lbl_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecurities" xlink:label="lbl_MarketableSecurities" xlink:type="locator"/>
      <link:calculationArc order="4.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialAssets" xlink:to="lbl_MarketableSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Commodities" xlink:label="lbl_Commodities" xlink:type="locator"/>
      <link:calculationArc order="5.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialAssets" xlink:to="lbl_Commodities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:type="locator"/>
      <link:calculationArc order="6.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialAssets" xlink:to="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="lbl_DerivativeFinancialAssets" xlink:type="locator"/>
      <link:calculationArc order="7.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialAssets" xlink:to="lbl_DerivativeFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="lbl_InterestReceivable" xlink:type="locator"/>
      <link:calculationArc order="8.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_OtherCurrentFinancialAssets" xlink:to="lbl_InterestReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtInstrumentsHeld" xlink:label="lbl_DebtInstrumentsHeld" xlink:type="locator"/>
      <link:calculationArc order="1.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_MarketableSecurities" xlink:to="lbl_DebtInstrumentsHeld" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInstrumentsHeld" xlink:label="lbl_EquityInstrumentsHeld" xlink:type="locator"/>
      <link:calculationArc order="2.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_MarketableSecurities" xlink:to="lbl_EquityInstrumentsHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInstrumentsHeld" xlink:label="lbl_FundInstrumentsHeld" xlink:type="locator"/>
      <link:calculationArc order="3.0" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="lbl_MarketableSecurities" xlink:to="lbl_FundInstrumentsHeld" xlink:type="arc"/>
   </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>nvs-20191231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" xlink:href="nvs-20191231.xsd#disclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails2" xlink:href="nvs-20191231.xsd#disclosureEquityDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfIncome" xlink:href="nvs-20191231.xsd#statementOfIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails5" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails8" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails10" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails10" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails5" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails3" xlink:href="nvs-20191231.xsd#disclosureSignificantAccountingPoliciesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSubsequentEventsDetails" xlink:href="nvs-20191231.xsd#disclosureSubsequentEventsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails6" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails13" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails13" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails4" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails3" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails2" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails6" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails3" xlink:href="nvs-20191231.xsd#disclosureTaxesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DocumentAndEntityInformation" xlink:href="nvs-20191231.xsd#documentAndEntityInformation" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactionsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails14" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails14" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails4" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails4" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails3" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails6" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails2" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails7" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactionsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails7" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails12" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails12" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails11" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails11" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails10" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails10" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails9" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails9" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails8" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails7" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails6" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails5" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails2" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingenciesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingenciesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails3" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails1" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails1_1df9063b" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails6" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails5" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails4" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails3" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails2" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails9" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails9" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails8" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails7" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails6" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails5" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails4" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails3" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails" xlink:href="nvs-20191231.xsd#disclosureAcquisitionsOfBusinessesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails5" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails3" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails5" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails4" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails3" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails2" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails" xlink:href="nvs-20191231.xsd#disclosureEquityDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails3" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails5" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails4" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails3" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails2" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInventoriesDetails" xlink:href="nvs-20191231.xsd#disclosureInventoriesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails4" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails3" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails2" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails4" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails3" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails2" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:href="nvs-20191231.xsd#disclosurePropertyPlantAndEquipmentDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails" xlink:href="nvs-20191231.xsd#disclosureEarningsPerShareDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails2" xlink:href="nvs-20191231.xsd#disclosureTaxesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails" xlink:href="nvs-20191231.xsd#disclosureTaxesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails6" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails5" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails4" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails3" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails2" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails12" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails12" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails11" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails11" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails10" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails10" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails1" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails1" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDisposalGroupHeldForSaleDetails" xlink:href="nvs-20191231.xsd#disclosureDisposalGroupHeldForSaleDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails2" xlink:href="nvs-20191231.xsd#disclosureSignificantAccountingPoliciesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails" xlink:href="nvs-20191231.xsd#disclosureSignificantAccountingPoliciesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactions" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactions" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="nvs-20191231.xsd#disclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementsOfCashFlow" xlink:href="nvs-20191231.xsd#statementsOfCashFlow" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfChangesInEquity" xlink:href="nvs-20191231.xsd#statementOfChangesInEquity" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/BalanceSheet" xlink:href="nvs-20191231.xsd#balanceSheet" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfComprehensiveIncome" xlink:href="nvs-20191231.xsd#statementOfComprehensiveIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails3" xlink:href="nvs-20191231.xsd#disclosureEquityDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails5" xlink:href="nvs-20191231.xsd#disclosureEquityDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails6" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:href="nvs-20191231.xsd#disclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails3" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssetsDetails3" xlink:type="simple"/>
   <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
   <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
   <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
   <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
   <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
   <link:definitionLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryMember" xlink:label="lbl_InventoryMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryAxis" xlink:label="lbl_InventoryAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_InventoryAxis" xlink:to="lbl_InventoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryMember" xlink:label="lbl_YearOfExpiryMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryAxis" xlink:label="lbl_YearOfExpiryAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_YearOfExpiryAxis" xlink:to="lbl_YearOfExpiryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentMember" xlink:label="lbl_BalanceSheetTreatmentMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentAxis" xlink:label="lbl_BalanceSheetTreatmentAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_BalanceSheetTreatmentAxis" xlink:to="lbl_BalanceSheetTreatmentMember" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationMember" xlink:label="lbl_IncomeStatementLocationMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationAxis" xlink:label="lbl_IncomeStatementLocationAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_IncomeStatementLocationAxis" xlink:to="lbl_IncomeStatementLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="lbl_ClassesOfShareCapitalMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="lbl_ClassesOfShareCapitalAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfShareCapitalAxis" xlink:to="lbl_ClassesOfShareCapitalMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypeMember" xlink:label="lbl_SubsequentEventTypeMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypAxis" xlink:label="lbl_SubsequentEventTypAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_SubsequentEventTypAxis" xlink:to="lbl_SubsequentEventTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisMember" xlink:label="lbl_FairValueByMeasurementBasisMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisAxis" xlink:label="lbl_FairValueByMeasurementBasisAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_FairValueByMeasurementBasisAxis" xlink:to="lbl_FairValueByMeasurementBasisMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_LevelsOfFairValueHierarchyAxis" xlink:to="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="lbl_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lbl_EntitysTotalForSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisionsMember" xlink:label="lbl_OtherProvisionsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="lbl_ClassesOfProvisionsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfProvisionsAxis" xlink:to="lbl_OtherProvisionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="lbl_PastDueStatusAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_PastDueStatusAxis" xlink:to="lbl_PastDueStatusMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="lbl_DefinedBenefitPlansMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="lbl_DefinedBenefitPlansAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_DefinedBenefitPlansAxis" xlink:to="lbl_DefinedBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeMember" xlink:label="lbl_ObligationByTypeMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeAxis" xlink:label="lbl_ObligationByTypeAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ObligationByTypeAxis" xlink:to="lbl_ObligationByTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionMember" xlink:label="lbl_ChangeInActuarialAssumptionMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionAxis" xlink:label="lbl_ChangeInActuarialAssumptionAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ChangeInActuarialAssumptionAxis" xlink:to="lbl_ChangeInActuarialAssumptionMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="lbl_ActuarialAssumptionsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="lbl_ActuarialAssumptionsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ActuarialAssumptionsAxis" xlink:to="lbl_ActuarialAssumptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsMember" xlink:label="lbl_AcquisitionsAndDivestmentsMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsAxis" xlink:label="lbl_AcquisitionsAndDivestmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_AcquisitionsAndDivestmentsAxis" xlink:to="lbl_AcquisitionsAndDivestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="lbl_BusinessCombinationsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_BusinessCombinationsAxis" xlink:to="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusMember" xlink:label="lbl_PastDueStatusMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingMember" xlink:label="lbl_NonvestingMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingAxis" xlink:label="lbl_NonvestingAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_NonvestingAxis" xlink:to="lbl_NonvestingMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersMember" xlink:label="lbl_MajorCustomersMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="lbl_MajorCustomersAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_MajorCustomersAxis" xlink:to="lbl_MajorCustomersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitMember" xlink:label="lbl_BusinessUnitMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitAxis" xlink:label="lbl_BusinessUnitAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_BusinessUnitAxis" xlink:to="lbl_BusinessUnitMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="lbl_FinancialLiabilitiesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:to="lbl_FinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="lbl_FinancialLiabilitiesCategoryMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:to="lbl_FinancialLiabilitiesCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemMember" xlink:label="lbl_BalanceSheetItemMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemAxis" xlink:label="lbl_BalanceSheetItemAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_BalanceSheetItemAxis" xlink:to="lbl_BalanceSheetItemMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="lbl_FinancialAssetsCategoryMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="lbl_CategoriesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_CategoriesOfFinancialAssetsAxis" xlink:to="lbl_FinancialAssetsCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsMember" xlink:label="lbl_FinancialAssetsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="lbl_ClassesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfFinancialAssetsAxis" xlink:to="lbl_FinancialAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsMember" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsAxis" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="lbl_MeasurementAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_MeasurementAxis" xlink:to="lbl_AggregatedMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesMember" xlink:label="lbl_LiabilitiesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="lbl_ClassesOfLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ClassesOfLiabilitiesAxis" xlink:to="lbl_LiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="lbl_AggregatedMeasurementMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationMember" xlink:label="lbl_ImpactLocationMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationAxis" xlink:label="lbl_ImpactLocationAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ImpactLocationAxis" xlink:to="lbl_ImpactLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorMember" xlink:label="lbl_VendorMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorAxis" xlink:label="lbl_VendorAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_VendorAxis" xlink:to="lbl_VendorMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:to="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesMember" xlink:label="lbl_PlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesAxis" xlink:label="lbl_PlansAndProgramRebatesAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_PlansAndProgramRebatesAxis" xlink:to="lbl_PlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis1" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_CurrencyAxis1" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LitigationCaseMember" xlink:label="lbl_LitigationCaseMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="lbl_LitigationCaseAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="lbl_LitigationCaseAxis" xlink:to="lbl_LitigationCaseMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" xlink:label="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="lbl_ShorttermBorrowings" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ShorttermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="lbl_CommercialPapersIssued" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CommercialPapersIssued" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="lbl_DerivativeFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_WeightedAverageInterestRateAssociates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateAssociates" xlink:label="lbl_WeightedAverageInterestRateAssociates" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:label="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails6" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" xlink:label="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:label="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:to="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialDebtsCoveredByCollateral" xlink:label="lbl_NoncurrentFinancialDebtsCoveredByCollateral" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:to="lbl_NoncurrentFinancialDebtsCoveredByCollateral" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:label="lbl_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:to="lbl_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" xlink:label="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:label="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageInterestRateOnLoansReceived" xlink:label="lbl_AverageInterestRateOnLoansReceived" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_AverageInterestRateOnLoansReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:label="lbl_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageInterestRateOnBorrowings" xlink:label="lbl_AverageInterestRateOnBorrowings" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_AverageInterestRateOnBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherInstitutions" xlink:label="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseLiabilities" xlink:label="lbl_FinanceLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_FinanceLeaseLiabilities" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract1" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract1" xlink:to="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximalAmountOfShareBuybackProgramm" xlink:label="lbl_MaximalAmountOfShareBuybackProgramm" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_MaximalAmountOfShareBuybackProgramm" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsHeldByMarketMaker" xlink:label="lbl_WrittenCallOptionsHeldByMarketMaker" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsHeldByMarketMaker" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsContractualLive" xlink:label="lbl_WrittenCallOptionsContractualLive" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsContractualLive" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsContractualLiveRemaining" xlink:label="lbl_WrittenCallOptionsContractualLiveRemaining" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsContractualLiveRemaining" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsWeightedAverageExercisePrice" xlink:label="lbl_WrittenCallOptionsWeightedAverageExercisePrice" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsWeightedAverageExercisePrice" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountRecordedInEquityRelatedToHyperinflation" xlink:label="lbl_AmountRecordedInEquityRelatedToHyperinflation" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_AmountRecordedInEquityRelatedToHyperinflation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxOnTransactionCostsRecordedInEquity" xlink:label="lbl_TaxOnTransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TaxOnTransactionCostsRecordedInEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquity" xlink:label="lbl_TransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:definitionArc order="2.2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TransactionCostsRecordedInEquity" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendsPayableAmountPerShare" xlink:label="lbl_DividendsPayableAmountPerShare" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_DividendsPayableAmountPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="lbl_DividendsPaid" xlink:type="locator"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_DividendsPaid" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/StatementOfComprehensiveIncome" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="lbl_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:to="lbl_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:to="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/BalanceSheet" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="lbl_AssetsAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="lbl_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_NoncurrentAssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="lbl_NoncurrentFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="lbl_CurrentAssetsAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_CurrentAssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxReceivable" xlink:label="lbl_CurrentIncomeTaxReceivable" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentIncomeTaxReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="lbl_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_OtherCurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_OtherCurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_Assets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="lbl_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EquityAndLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="lbl_EquityAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReserves" xlink:label="lbl_OtherReserves" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_OtherReserves" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="lbl_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_EquityAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="lbl_NoncontrollingInterests" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_NoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="lbl_LiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_LiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="lbl_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="lbl_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_CurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="lbl_EquityAndLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAndLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="6.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/StatementOfChangesInEquity" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="lbl_StatementOfChangesInEquityTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementOfChangesInEquityTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="lbl_IssuedCapitalMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_IssuedCapitalMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="lbl_TreasurySharesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TreasurySharesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="lbl_RetainedEarningsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_RetainedEarningsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="lbl_NoncontrollingInterestsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_NoncontrollingInterestsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementOfChangesInEquityTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_RestatedValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="lbl_StatementOfChangesInEquityLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_StatementOfChangesInEquityTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="lbl_OtherComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="lbl_DividendsPaid" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_DividendsPaid" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendPaidNoncashAssetsDistribution" xlink:label="lbl_DividendPaidNoncashAssetsDistribution" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_DividendPaidNoncashAssetsDistribution" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="lbl_PurchaseOfTreasuryShares" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_PurchaseOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReductionOfIssuedCapital" xlink:label="lbl_ReductionOfIssuedCapital" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ReductionOfIssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesOnTreasuryShares" xlink:label="lbl_TaxesOnTreasuryShares" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_TaxesOnTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquity" xlink:label="lbl_TransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_TransactionCostsRecordedInEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeMaketableSecurities" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:label="lbl_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseInNoncontrolingInterests" xlink:label="lbl_IncreaseDecreaseInNoncontrolingInterests" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseInNoncontrolingInterests" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="locator"/>
      <link:definitionArc order="24.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInEquity" xlink:label="lbl_ChangesInEquity" xlink:type="locator"/>
      <link:definitionArc order="25.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ChangesInEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:label="lbl_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:type="locator"/>
      <link:definitionArc order="26.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherShareSales" xlink:label="lbl_OtherShareSales" xlink:type="locator"/>
      <link:definitionArc order="13.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherShareSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployees" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="locator"/>
      <link:definitionArc order="12.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:label="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:type="locator"/>
      <link:definitionArc order="20.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/StatementsOfCashFlow" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceivedClassifiedAsOperatingActivities" xlink:label="lbl_DividendsReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="lbl_InterestReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="lbl_InterestPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestPaidClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:label="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="lbl_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:label="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:label="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:label="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:definitionArc order="23.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="24.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="25.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="26.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="27.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="28.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="29.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="30.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="locator"/>
      <link:definitionArc order="31.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:label="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="locator"/>
      <link:definitionArc order="32.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="33.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="34.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="35.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="36.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="locator"/>
      <link:definitionArc order="37.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="38.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="39.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="40.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="41.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="locator"/>
      <link:definitionArc order="42.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="43.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="44.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="45.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="46.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactions" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfSignificantTransactionsTextBlock" xlink:label="lbl_DisclosureOfSignificantTransactionsTextBlock" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfSignificantTransactionsTextBlock" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="lbl_DisclosureOfOperatingSegmentsExplanatory" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:label="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:label="lbl_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchasePriceAllocationAssociatesTableTextBlock" xlink:label="lbl_PurchasePriceAllocationAssociatesTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchasePriceAllocationAssociatesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:label="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="lbl_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:label="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:label="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:label="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:label="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_BuildingsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="lbl_MachineryMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_MachineryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FurnitureAndVehiclesMember" xlink:label="lbl_FurnitureAndVehiclesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_FurnitureAndVehiclesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="lbl_ComputerEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_ComputerEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="lbl_BrandNamesMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_BrandNamesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationAxis" xlink:label="lbl_IncomeStatementLocationAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_IncomeStatementLocationAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationMember" xlink:label="lbl_IncomeStatementLocationMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_IncomeStatementLocationAxis" xlink:to="lbl_IncomeStatementLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CostOfSalesMember" xlink:label="lbl_CostOfSalesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_CostOfSalesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CostOfSalesOrResearchAndDevelopmentMember" xlink:label="lbl_CostOfSalesOrResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_CostOfSalesOrResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDisposalGroupHeldForSaleDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalGroupHeldForSaleLineItems" xlink:label="lbl_DisposalGroupHeldForSaleLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisposalGroupHeldForSaleLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:label="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisposalGroupHeldForSaleLineItems" xlink:to="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_OtherCurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:label="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisposalGroupHeldForSaleLineItems" xlink:to="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsumerHealthMember" xlink:label="lbl_ConsumerHealthMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_ConsumerHealthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfReportableSegments" xlink:label="lbl_NumberOfReportableSegments" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NumberOfReportableSegments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfBusinessUnits" xlink:label="lbl_NumberOfBusinessUnits" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NumberOfBusinessUnits" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfFranchises" xlink:label="lbl_NumberOfFranchises" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NumberOfFranchises" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails1" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="lbl_AdministrativeExpense" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="lbl_DepreciationAndAmortisationExpense" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DepreciationAndAmortisationExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToRestructuringProvisions" xlink:label="lbl_AdditionsToRestructuringProvisions" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToRestructuringProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RightofuseAssetsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_Assets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDebt" xlink:label="lbl_NetDebt" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NetDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetOperatingAssets" xlink:label="lbl_NetOperatingAssets" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NetOperatingAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToInvestmentInAssociatedCompanies" xlink:label="lbl_AdditionsToInvestmentInAssociatedCompanies" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToInvestmentInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtsAndDerivativeInstruments" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:label="lbl_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="7.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="7.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_GB" xlink:label="lbl_GB" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_GB" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_DE" xlink:label="lbl_DE" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_DE" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="lbl_JP" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_JP" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCountriesMember" xlink:label="lbl_OtherCountriesMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_OtherCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR" xlink:label="lbl_FR" xlink:type="locator"/>
      <link:definitionArc order="3.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_FR" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalRegionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EuropeMember1" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_AmericasMember1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AsiaAfricaAustralasiaMember" xlink:label="lbl_AsiaAfricaAustralasiaMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_AsiaAfricaAustralasiaMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_EuropeMember" xlink:label="lbl_EuropeMember1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AmericasMember" xlink:label="lbl_AmericasMember1" xlink:type="locator"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitAxis" xlink:label="lbl_BusinessUnitAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_BusinessUnitAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitMember" xlink:label="lbl_BusinessUnitMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BusinessUnitAxis" xlink:to="lbl_BusinessUnitMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OncologyMember" xlink:label="lbl_OncologyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_OncologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PharmaceuticalMember" xlink:label="lbl_PharmaceuticalMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_PharmaceuticalMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_FranchiseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OphthalmologyMember" xlink:label="lbl_OphthalmologyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_OphthalmologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeuroscienceMember" xlink:label="lbl_NeuroscienceMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_NeuroscienceMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespiratoryMember" xlink:label="lbl_RespiratoryMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_RespiratoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CardioMetabolicMember" xlink:label="lbl_CardioMetabolicMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_CardioMetabolicMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMedicinesMember" xlink:label="lbl_EstablishedMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_EstablishedMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImmunologyHepatologyAndDermatologyMember" xlink:label="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductPortfolioAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_COPDMember" xlink:label="lbl_COPDMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_COPDMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecGlivecMember" xlink:label="lbl_GleevecGlivecMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GleevecGlivecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExjadeJadenuMember" xlink:label="lbl_ExjadeJadenuMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExjadeJadenuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VotrientMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KisqaliMember" xlink:label="lbl_KisqaliMember" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_KisqaliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LutatheraMember" xlink:label="lbl_LutatheraMember" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LutatheraMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KymriahMember" xlink:label="lbl_KymriahMember" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_KymriahMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TravoprostGroupMember" xlink:label="lbl_TravoprostGroupMember" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TravoprostGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SystaneGroupMember" xlink:label="lbl_SystaneGroupMember" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SystaneGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TopicalOlopatadineGroupMember" xlink:label="lbl_TopicalOlopatadineGroupMember" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TopicalOlopatadineGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MyforticMember" xlink:label="lbl_MyforticMember" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_MyforticMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExelonExelonPatchMember" xlink:label="lbl_ExelonExelonPatchMember" xlink:type="locator"/>
      <link:definitionArc order="32.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExelonExelonPatchMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RitalinFocalinMember" xlink:label="lbl_RitalinFocalinMember" xlink:type="locator"/>
      <link:definitionArc order="33.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_RitalinFocalinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherProductsMember" xlink:label="lbl_OtherProductsMember" xlink:type="locator"/>
      <link:definitionArc order="34.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_OtherProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PiqrayMember" xlink:label="lbl_PiqrayMember" xlink:type="locator"/>
      <link:definitionArc order="12.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_PiqrayMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TasignaMember" xlink:label="lbl_TasignaMember" xlink:type="locator"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TasignaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandostatinMember" xlink:label="lbl_SandostatinMember" xlink:type="locator"/>
      <link:definitionArc order="0.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SandostatinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AfinitorVotubiaMember" xlink:label="lbl_AfinitorVotubiaMember" xlink:type="locator"/>
      <link:definitionArc order="0.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AfinitorVotubiaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PromactaRevoladeMember" xlink:label="lbl_PromactaRevoladeMember" xlink:type="locator"/>
      <link:definitionArc order="0.8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_PromactaRevoladeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TafinlarMekinistMember" xlink:label="lbl_TafinlarMekinistMember" xlink:type="locator"/>
      <link:definitionArc order="0.9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TafinlarMekinistMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JakaviMember" xlink:label="lbl_JakaviMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_JakaviMember" xlink:type="arc"/>
      <link:definitionArc order="14.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XiidraMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GilenyaMember" xlink:label="lbl_GilenyaMember" xlink:type="locator"/>
      <link:definitionArc order="14.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GilenyaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZolgensmaMember" xlink:label="lbl_ZolgensmaMember" xlink:type="locator"/>
      <link:definitionArc order="14.8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ZolgensmaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AimovigMember" xlink:label="lbl_AimovigMember" xlink:type="locator"/>
      <link:definitionArc order="14.9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AimovigMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MayzentMember" xlink:label="lbl_MayzentMember" xlink:type="locator"/>
      <link:definitionArc order="14.95" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_MayzentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CosentyxMember" xlink:label="lbl_CosentyxMember" xlink:type="locator"/>
      <link:definitionArc order="14.97" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CosentyxMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IlarisMember" xlink:label="lbl_IlarisMember" xlink:type="locator"/>
      <link:definitionArc order="14.98" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_IlarisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UltibroBreezhalerMember" xlink:label="lbl_UltibroBreezhalerMember" xlink:type="locator"/>
      <link:definitionArc order="14.99" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_UltibroBreezhalerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SeebriBreezhalerMember" xlink:label="lbl_SeebriBreezhalerMember" xlink:type="locator"/>
      <link:definitionArc order="14.995" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SeebriBreezhalerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OnbrezBreezhalerMember" xlink:label="lbl_OnbrezBreezhalerMember" xlink:type="locator"/>
      <link:definitionArc order="14.997" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_OnbrezBreezhalerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:definitionArc order="14.998" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XolairMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EntrestoMember" xlink:label="lbl_EntrestoMember" xlink:type="locator"/>
      <link:definitionArc order="14.999" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_EntrestoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GalvusGroupMember" xlink:label="lbl_GalvusGroupMember" xlink:type="locator"/>
      <link:definitionArc order="14.9995" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GalvusGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DiovanGroupMember" xlink:label="lbl_DiovanGroupMember" xlink:type="locator"/>
      <link:definitionArc order="14.9997" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_DiovanGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExforgeGroupMember" xlink:label="lbl_ExforgeGroupMember" xlink:type="locator"/>
      <link:definitionArc order="14.9998" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExforgeGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZortressCerticanMember" xlink:label="lbl_ZortressCerticanMember" xlink:type="locator"/>
      <link:definitionArc order="14.9999" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ZortressCerticanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VoltarenCataflamMember" xlink:label="lbl_VoltarenCataflamMember" xlink:type="locator"/>
      <link:definitionArc order="14.99995" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VoltarenCataflamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeoralSandimmunEMember" xlink:label="lbl_NeoralSandimmunEMember" xlink:type="locator"/>
      <link:definitionArc order="14.99997" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_NeoralSandimmunEMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BeovuMember" xlink:label="lbl_BeovuMember" xlink:type="locator"/>
      <link:definitionArc order="14.6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_BeovuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XiidraMember" xlink:label="lbl_XiidraMember" xlink:type="locator"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_FranchiseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetailGenericsMember" xlink:label="lbl_RetailGenericsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_RetailGenericsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BiopharmaceuticalsMember" xlink:label="lbl_BiopharmaceuticalsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_BiopharmaceuticalsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AntiInfectivesMember" xlink:label="lbl_AntiInfectivesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_AntiInfectivesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductPortfolioAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AntiInfectivesSoldUnderSandozNameMember" xlink:label="lbl_AntiInfectivesSoldUnderSandozNameMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_AntiInfectivesSoldUnderSandozNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails10" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitSharingIncome" xlink:label="lbl_ProfitSharingIncome" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitSharingIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="lbl_RevenueFromRoyalties" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromRoyalties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MilestoneIncome" xlink:label="lbl_MilestoneIncome" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_MilestoneIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherRevenueOther" xlink:label="lbl_OtherRevenueOther" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherRevenueOther" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails11" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalRegionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USMember" xlink:label="lbl_USMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_USMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestOfTheWorldMember" xlink:label="lbl_RestOfTheWorldMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_RestOfTheWorldMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitAxis" xlink:label="lbl_BusinessUnitAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_BusinessUnitAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitMember" xlink:label="lbl_BusinessUnitMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BusinessUnitAxis" xlink:to="lbl_BusinessUnitMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OncologyMember" xlink:label="lbl_OncologyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_OncologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PharmaceuticalMember" xlink:label="lbl_PharmaceuticalMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_PharmaceuticalMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_FranchiseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OphthalmologyMember" xlink:label="lbl_OphthalmologyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_OphthalmologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeuroscienceMember" xlink:label="lbl_NeuroscienceMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_NeuroscienceMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespiratoryMember" xlink:label="lbl_RespiratoryMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_RespiratoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CardioMetabolicMember" xlink:label="lbl_CardioMetabolicMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_CardioMetabolicMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMedicinesMember" xlink:label="lbl_EstablishedMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_EstablishedMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImmunologyHepatologyAndDermatologyMember" xlink:label="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FranchiseMember" xlink:to="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductPortfolioAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Top20ProductsMember" xlink:label="lbl_Top20ProductsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_Top20ProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestOfPortfolioMember" xlink:label="lbl_RestOfPortfolioMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_RestOfPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GilenyaMember" xlink:label="lbl_GilenyaMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GilenyaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TasignaMember" xlink:label="lbl_TasignaMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TasignaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandostatinMember" xlink:label="lbl_SandostatinMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SandostatinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecGlivecMember" xlink:label="lbl_GleevecGlivecMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GleevecGlivecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExjadeJadenuMember" xlink:label="lbl_ExjadeJadenuMember" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExjadeJadenuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VotrientMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IlarisMember" xlink:label="lbl_IlarisMember" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_IlarisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TravoprostGroupMember" xlink:label="lbl_TravoprostGroupMember" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TravoprostGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeoralSandimmunEMember" xlink:label="lbl_NeoralSandimmunEMember" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_NeoralSandimmunEMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VoltarenCataflamMember" xlink:label="lbl_VoltarenCataflamMember" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VoltarenCataflamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExelonExelonPatchMember" xlink:label="lbl_ExelonExelonPatchMember" xlink:type="locator"/>
      <link:definitionArc order="23.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExelonExelonPatchMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CosentyxMember" xlink:label="lbl_CosentyxMember" xlink:type="locator"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CosentyxMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EntrestoMember" xlink:label="lbl_EntrestoMember" xlink:type="locator"/>
      <link:definitionArc order="4.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_EntrestoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AfinitorVotubiaMember" xlink:label="lbl_AfinitorVotubiaMember" xlink:type="locator"/>
      <link:definitionArc order="5.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AfinitorVotubiaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PromactaRevoladeMember" xlink:label="lbl_PromactaRevoladeMember" xlink:type="locator"/>
      <link:definitionArc order="5.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_PromactaRevoladeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TafinlarMekinistMember" xlink:label="lbl_TafinlarMekinistMember" xlink:type="locator"/>
      <link:definitionArc order="5.8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TafinlarMekinistMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GalvusGroupMember" xlink:label="lbl_GalvusGroupMember" xlink:type="locator"/>
      <link:definitionArc order="5.9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GalvusGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XolairMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JakaviMember" xlink:label="lbl_JakaviMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_JakaviMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DiovanGroupMember" xlink:label="lbl_DiovanGroupMember" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_DiovanGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExforgeGroupMember" xlink:label="lbl_ExforgeGroupMember" xlink:type="locator"/>
      <link:definitionArc order="10.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExforgeGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZortressCerticanMember" xlink:label="lbl_ZortressCerticanMember" xlink:type="locator"/>
      <link:definitionArc order="18.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ZortressCerticanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KisqaliMember" xlink:label="lbl_KisqaliMember" xlink:type="locator"/>
      <link:definitionArc order="18.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_KisqaliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails12" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalRegionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EuropeMember1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USMember" xlink:label="lbl_USMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_USMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AsiaAfricaAustralasiaMember" xlink:label="lbl_AsiaAfricaAustralasiaMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_AsiaAfricaAustralasiaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CanadaAndLatinAmericaMember" xlink:label="lbl_CanadaAndLatinAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_CanadaAndLatinAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMarketsMember" xlink:label="lbl_EstablishedMarketsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EstablishedMarketsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EmergingGrowthMarketsMember" xlink:label="lbl_EmergingGrowthMarketsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EmergingGrowthMarketsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_EuropeMember" xlink:label="lbl_EuropeMember1" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:label="lbl_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInAssociate" xlink:label="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="lbl_ProportionOfOwnershipInterestInAssociate" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ProportionOfOwnershipInterestInAssociate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="lbl_DividendsReceived" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_DividendsReceived" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:label="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContributionOfBusinessToJointVenture" xlink:label="lbl_ContributionOfBusinessToJointVenture" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ContributionOfBusinessToJointVenture" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatesSummarizedFinancialInformationTable" xlink:label="lbl_AssociatesSummarizedFinancialInformationTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_AssociatesSummarizedFinancialInformationTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AssociatesSummarizedFinancialInformationTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_CurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="lbl_Revenue" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_Revenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="lbl_OtherComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_OtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ComprehensiveIncome" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchasePriceAllocationAssociatesTable" xlink:label="lbl_PurchasePriceAllocationAssociatesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_PurchasePriceAllocationAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_PurchasePriceAllocationAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareOfEstimatedNetAssets" xlink:label="lbl_ShareOfEstimatedNetAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfEstimatedNetAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill" xlink:label="lbl_AdditionalRecognitionGoodwill" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AdditionalRecognitionGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:label="lbl_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:label="lbl_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementEffectsTable" xlink:label="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareOfCurrentYearNetIncome" xlink:label="lbl_ShareOfCurrentYearNetIncome" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfCurrentYearNetIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PriorYearAdjustment" xlink:label="lbl_PriorYearAdjustment" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_PriorYearAdjustment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:label="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:label="lbl_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:to="lbl_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:label="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:label="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:label="lbl_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:type="locator"/>
      <link:definitionArc order="4.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="lbl_AccountingProfit" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AccountingProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="lbl_CurrentTaxExpenseIncome" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentTaxExpenseIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="lbl_DeferredTaxExpenseIncome" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxExpenseIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxExpenseIncomeDiscontinuingOperations" xlink:label="lbl_TaxExpenseIncomeDiscontinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxExpenseIncomeDiscontinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeTaxExpense" xlink:label="lbl_IncomeTaxExpense" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="lbl_EarningsPerShareTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_EarningsPerShareTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="lbl_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_EarningsPerShareTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="lbl_WeightedAverageShares" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_WeightedAverageShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="lbl_AdjustedWeightedAverageShares" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_AdjustedWeightedAverageShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="lbl_BasicEarningsLossPerShare" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_BasicEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="lbl_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutedEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OptionsExcludedFromTheCalculation" xlink:label="lbl_OptionsExcludedFromTheCalculation" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_OptionsExcludedFromTheCalculation" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalFairValueAdjustmentsMember" xlink:label="lbl_TotalFairValueAdjustmentsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalFairValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:label="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_RestatedValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeDebtSecurities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeDebtSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeMaketableSecurities" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeEquitySecurities" xlink:label="lbl_OtherComprehensiveIncomeEquitySecurities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeEquitySecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:label="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfMarketableInvestments" xlink:label="lbl_GainLossOnSaleOfMarketableInvestments" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainLossOnSaleOfMarketableInvestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfOtherFinancialAssets" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:label="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:label="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:definitionArc order="14.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="lbl_NoncontrollingInterestsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_NoncontrollingInterestsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:label="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:label="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="lbl_LandMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_LandMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_BuildingsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="lbl_ConstructionInProgressMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_ConstructionInProgressMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="lbl_MachineryMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_MachineryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:label="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:label="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="lbl_DepreciationPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DepreciationPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:label="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:label="lbl_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:label="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsCapitalised" xlink:label="lbl_BorrowingCostsCapitalised" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_BorrowingCostsCapitalised" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:label="lbl_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:label="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:definitionArc order="1.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:label="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PresentationOfLeasesForLessesTable" xlink:label="lbl_PresentationOfLeasesForLessesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_PresentationOfLeasesForLessesTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PresentationOfLeasesForLesseeLineItems" xlink:label="lbl_PresentationOfLeasesForLesseeLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_PresentationOfLeasesForLessesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="lbl_GrossLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_GrossLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NewLeaseArrangements" xlink:label="lbl_NewLeaseArrangements" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_NewLeaseArrangements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UndiscountedFutureLeasePayments" xlink:label="lbl_UndiscountedFutureLeasePayments" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_UndiscountedFutureLeasePayments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfDiscounting" xlink:label="lbl_EffectOfDiscounting" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_EffectOfDiscounting" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="lbl_LandMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_LandMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_BuildingsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="lbl_VehiclesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_VehiclesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherAssetsMember" xlink:label="lbl_OtherAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_OtherAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="lbl_DepreciationRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_DepreciationRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:label="lbl_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfTheRightofuseAssetsRollForward" xlink:label="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="lbl_DepreciationRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_DepreciationRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseContractTerminationsRightofuseAssets" xlink:label="lbl_LeaseContractTerminationsRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_LeaseContractTerminationsRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalsAndRetirementsRightofuseAssets" xlink:label="lbl_DisposalsAndRetirementsRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="4.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_DisposalsAndRetirementsRightofuseAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesUndiscounted" xlink:label="lbl_LeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_LeaseLiabilitiesUndiscounted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostMaterialLeaseWithLeaseTermExtension" xlink:label="lbl_MostMaterialLeaseWithLeaseTermExtension" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_MostMaterialLeaseWithLeaseTermExtension" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLeaseLiabilitiesUndiscounted" xlink:label="lbl_CurrentLeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:definitionArc order="2.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_CurrentLeaseLiabilitiesUndiscounted" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLeaseLiabilitiesUndiscounted" xlink:label="lbl_NoncurrentLeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:definitionArc order="2.9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_NoncurrentLeaseLiabilitiesUndiscounted" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="lbl_CashOutflowForLeases" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashOutflowForLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RepaymentOfLeaseLiability" xlink:label="lbl_RepaymentOfLeaseLiability" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RepaymentOfLeaseLiability" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:label="lbl_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateLeaseLiabilities" xlink:label="lbl_WeightedAverageInterestRateLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_WeightedAverageInterestRateLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseIncentives" xlink:label="lbl_LeaseIncentives" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_LeaseIncentives" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOutflowsForShortTermAndLowValueLeases" xlink:label="lbl_CashOutflowsForShortTermAndLowValueLeases" xlink:type="locator"/>
      <link:definitionArc order="4.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashOutflowsForShortTermAndLowValueLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOutflowsForPaymentsOfLeasesInterest" xlink:label="lbl_CashOutflowsForPaymentsOfLeasesInterest" xlink:type="locator"/>
      <link:definitionArc order="4.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashOutflowsForPaymentsOfLeasesInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="5.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_GoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AlconBrandNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:label="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:label="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:label="lbl_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:label="lbl_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:label="lbl_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:label="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:label="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:label="lbl_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="8.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_GoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AlconBrandNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_UnallocatedAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_UnallocatedAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_UnallocatedAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VotrientMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SerelaxinMember" xlink:label="lbl_SerelaxinMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SerelaxinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CyPassMember" xlink:label="lbl_CyPassMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CyPassMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_GoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AlconBrandNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:label="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherProductsMember" xlink:label="lbl_OtherProductsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_OtherProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InvestmentsInSubsidiariesMember" xlink:label="lbl_InvestmentsInSubsidiariesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_InvestmentsInSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GoodwillFromAcquisitionsMember" xlink:label="lbl_GoodwillFromAcquisitionsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_GoodwillFromAcquisitionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentAxis" xlink:label="lbl_BalanceSheetTreatmentAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lbl_BalanceSheetTreatmentAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentMember" xlink:label="lbl_BalanceSheetTreatmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BalanceSheetTreatmentAxis" xlink:to="lbl_BalanceSheetTreatmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CapitalizedMember" xlink:label="lbl_CapitalizedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetTreatmentMember" xlink:to="lbl_CapitalizedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NotCapitalizedMember" xlink:label="lbl_NotCapitalizedMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetTreatmentMember" xlink:to="lbl_NotCapitalizedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryAxis" xlink:label="lbl_YearOfExpiryAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lbl_YearOfExpiryAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryMember" xlink:label="lbl_YearOfExpiryMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_YearOfExpiryAxis" xlink:to="lbl_YearOfExpiryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OneYearMember" xlink:label="lbl_OneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_OneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TwoYearsMember" xlink:label="lbl_TwoYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_TwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThreeYearsMember" xlink:label="lbl_ThreeYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_ThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FourYearsMember" xlink:label="lbl_FourYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_FourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FiveYearsMember" xlink:label="lbl_FiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_FiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MoreThanFiveYearsMember" xlink:label="lbl_MoreThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_MoreThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:label="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfTaxLossCarryforwardsExpired" xlink:label="lbl_ValueOfTaxLossCarryforwardsExpired" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ValueOfTaxLossCarryforwardsExpired" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:label="lbl_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:label="lbl_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:label="lbl_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:label="lbl_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureInventoriesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryAxis" xlink:label="lbl_InventoryAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryCurrentTable" xlink:label="lbl_InventoryCurrentTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_InventoryCurrentTable" xlink:to="lbl_InventoryAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryMember" xlink:label="lbl_InventoryMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_InventoryAxis" xlink:to="lbl_InventoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryRawMaterialsGrossMember" xlink:label="lbl_InventoryRawMaterialsGrossMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryMember" xlink:to="lbl_InventoryRawMaterialsGrossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryWorkInProgressGrossMember" xlink:label="lbl_InventoryWorkInProgressGrossMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryMember" xlink:to="lbl_InventoryWorkInProgressGrossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryFinishedGoodsGrossMember" xlink:label="lbl_InventoryFinishedGoodsGrossMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryMember" xlink:to="lbl_InventoryFinishedGoodsGrossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryLineItems" xlink:label="lbl_InventoryLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_InventoryCurrentTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="lbl_InventoryWritedown2011" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_InventoryWritedown2011" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfInventoryWritedown" xlink:label="lbl_ReversalOfInventoryWritedown" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_ReversalOfInventoryWritedown" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="lbl_DisclosureOfProvisionMatrixTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_DisclosureOfProvisionMatrixTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="lbl_DisclosureOfProvisionMatrixTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_DisclosureOfProvisionMatrixTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfDivestmentsOtherProvisions" xlink:label="lbl_ImpactOfDivestmentsOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_ImpactOfDivestmentsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="lbl_AdditionalProvisionsOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_AdditionalProvisionsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_ProvisionUsedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfOverdueAmountsTable" xlink:label="lbl_AnalysisOfOverdueAmountsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="lbl_PastDueStatusAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_PastDueStatusAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusMember" xlink:label="lbl_PastDueStatusMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_PastDueStatusAxis" xlink:to="lbl_PastDueStatusMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentMember" xlink:label="lbl_CurrentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PastDueStatusMember" xlink:to="lbl_CurrentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentMember" xlink:to="lbl_NotLaterThanOneMonthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="lbl_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:label="lbl_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="lbl_LaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfOverdueAmountsLineItems" xlink:label="lbl_AnalysisOfOverdueAmountsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_AnalysisOfOverdueAmountsLineItems" xlink:to="lbl_AnalysisOfOverdueAmountsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AnalysisOfOverdueAmountsLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:label="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_CurrencyAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CurrencyAxis" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CNY" xlink:label="lbl_CNY" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CNY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_RUB" xlink:label="lbl_RUB" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_RUB" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_BRL" xlink:label="lbl_BRL" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_BRL" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_GBP" xlink:label="lbl_GBP" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_GBP" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AUD" xlink:label="lbl_AUD" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_AUD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CHF" xlink:label="lbl_CHF" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CHF" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CAD" xlink:label="lbl_CAD" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CAD" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CurrencyOthersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:label="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_CurrencyAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CurrencyAxis" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtInstrumentsHeld" xlink:label="lbl_DebtInstrumentsHeld" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DebtInstrumentsHeld" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapital" xlink:label="lbl_OutstandingShareCapital" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_OutstandingShareCapital" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IssuedCapitalMovement" xlink:label="lbl_IssuedCapitalMovement" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_IssuedCapitalMovement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares" xlink:label="lbl_SaleOrIssueOfTreasuryShares" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_SaleOrIssueOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapitalMovement" xlink:label="lbl_OutstandingShareCapitalMovement" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_OutstandingShareCapitalMovement" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lbl_BorrowingsByNameAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:label="lbl_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:label="lbl_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:label="lbl_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:label="lbl_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:label="lbl_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:label="lbl_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:label="lbl_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:label="lbl_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:label="lbl_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:label="lbl_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:label="lbl_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:label="lbl_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:label="lbl_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:label="lbl_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:label="lbl_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:label="lbl_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:label="lbl_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:label="lbl_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:label="lbl_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:label="lbl_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:label="lbl_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:label="lbl_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:label="lbl_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:type="locator"/>
      <link:definitionArc order="23.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:label="lbl_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:type="locator"/>
      <link:definitionArc order="24.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="lbl_BorrowingsInterestRate" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsInterestRate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsOriginalCurrency" xlink:label="lbl_BorrowingsOriginalCurrency" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsOriginalCurrency" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="lbl_NotionalAmount" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_NotionalAmount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsIssuanceDate" xlink:label="lbl_BorrowingsIssuanceDate" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsIssuanceDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="lbl_BorrowingsMaturity" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsMaturity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsLender" xlink:label="lbl_BorrowingsLender" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsLender" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsPremiumDiscount" xlink:label="lbl_BorrowingsPremiumDiscount" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsPremiumDiscount" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:label="lbl_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanSixYearsMember" xlink:label="lbl_LaterThanSixYearsMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanSixYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:to="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:to="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:to="lbl_CurrencyAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CurrencyAxis" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CHF" xlink:label="lbl_CHF" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CHF" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CurrencyOthersMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisAxis" xlink:label="lbl_FairValueByMeasurementBasisAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_FairValueByMeasurementBasisAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisMember" xlink:label="lbl_FairValueByMeasurementBasisMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_FairValueByMeasurementBasisAxis" xlink:to="lbl_FairValueByMeasurementBasisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CarryingReportedAmountFairValueDisclosureMember" xlink:label="lbl_CarryingReportedAmountFairValueDisclosureMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FairValueByMeasurementBasisMember" xlink:to="lbl_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueDisclosureItemAmountsMember" xlink:label="lbl_FairValueDisclosureItemAmountsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FairValueByMeasurementBasisMember" xlink:to="lbl_FairValueDisclosureItemAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherNoncurrentFinancialDebt" xlink:label="lbl_OtherNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_OtherNoncurrentFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:label="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefits" xlink:label="lbl_OtherPostemploymentBenefits" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_OtherPostemploymentBenefits" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalRemediationProvisionNoncurrent" xlink:label="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationNonCurrent" xlink:label="lbl_ContingentConsiderationNonCurrent" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ContingentConsiderationNonCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="lbl_OtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_OtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="lbl_ClassesOfProvisionsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsTable" xlink:label="lbl_RestructuringProvisionsMovementsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_RestructuringProvisionsMovementsTable" xlink:to="lbl_ClassesOfProvisionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisionsMember" xlink:label="lbl_OtherProvisionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfProvisionsAxis" xlink:to="lbl_OtherProvisionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="lbl_RestructuringProvisionMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_RestructuringProvisionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesMember" xlink:label="lbl_PlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_PlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:label="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_RestructuringProvisionsMovementsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsRollForward" xlink:label="lbl_RestructuringProvisionsMovementsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_RestructuringProvisionsMovementsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="lbl_OtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_OtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="lbl_AdditionalProvisionsOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_AdditionalProvisionsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_ProvisionUsedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="6.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_RestructuringProvisionsMovementsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsImpairedMember" xlink:label="lbl_FinancialAssetsImpairedMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_FinancialAssetsImpairedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:label="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:to="lbl_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="lbl_AdjustmentsForSharebasedPayments" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForSharebasedPayments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="lbl_AdjustmentsForFinanceIncomeCost" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:label="lbl_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RightofuseAssetsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonCurrentFinancialDebtsMember" xlink:label="lbl_NonCurrentFinancialDebtsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_NonCurrentFinancialDebtsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:label="lbl_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLeaseLiabilitiesMember" xlink:label="lbl_NoncurrentLeaseLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_NoncurrentLeaseLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLeaseLiabilitiesMember" xlink:label="lbl_CurrentLeaseLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_CurrentLeaseLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtsAndDerivativeInstruments" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:label="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfBondsDiscount" xlink:label="lbl_AmortizationOfBondsDiscount" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AmortizationOfBondsDiscount" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPortionOfNoncurrentFinancialDebt" xlink:label="lbl_CurrentPortionOfNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="4.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:label="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="4.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="4.8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationFromNoncurrentToCurrentNet" xlink:label="lbl_ReclassificationFromNoncurrentToCurrentNet" xlink:type="locator"/>
      <link:definitionArc order="8.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ReclassificationFromNoncurrentToCurrentNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems1" xlink:type="locator"/>
      <link:definitionArc order="8.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_CurrentPortionOfNoncurrentFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:label="lbl_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:label="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="1.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherAssets" xlink:label="lbl_FinancialAndOtherAssets" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_FinancialAndOtherAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesAndOtherLiabilities" xlink:label="lbl_TradePayablesAndOtherLiabilities" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_TradePayablesAndOtherLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IdentifiableAssetsAcquired" xlink:label="lbl_IdentifiableAssetsAcquired" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_IdentifiableAssetsAcquired" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="lbl_GoodwillRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_GoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillExpectedDeductibleForTaxPurposes" xlink:label="lbl_GoodwillExpectedDeductibleForTaxPurposes" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_GoodwillExpectedDeductibleForTaxPurposes" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredCashAndCashEquivalents" xlink:label="lbl_AcquiredCashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="13.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_AcquiredCashAndCashEquivalents" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="lbl_DefinedBenefitPlansAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_DefinedBenefitPlansAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="lbl_DefinedBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_DefinedBenefitPlansAxis" xlink:to="lbl_DefinedBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConcentrationOfMajorPlansGeographic" xlink:label="lbl_ConcentrationOfMajorPlansGeographic" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ConcentrationOfMajorPlansGeographic" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements" xlink:label="lbl_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MajorPlansPercentageInGroupDBOPensions" xlink:label="lbl_MajorPlansPercentageInGroupDBOPensions" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_MajorPlansPercentageInGroupDBOPensions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:label="lbl_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanInterestCost" xlink:label="lbl_DefinedBenefitPlanInterestCost" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_DefinedBenefitPlanInterestCost" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:label="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="lbl_PlanAssetsAtFairValue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_PlanAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:label="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="lbl_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="lbl_SurplusDeficitInPlan" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_SurplusDeficitInPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LimitationOnRecognitionOfFundSurplus" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestIncomeOnLimitationOfFundSurplus" xlink:label="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:label="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaidPostemploymentBenefitPlansAssets" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:to="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:label="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:to="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeAxis" xlink:label="lbl_ObligationByTypeAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_ObligationByTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeMember" xlink:label="lbl_ObligationByTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ObligationByTypeAxis" xlink:to="lbl_ObligationByTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnfundedMember" xlink:label="lbl_UnfundedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_UnfundedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActiveMember" xlink:label="lbl_ActiveMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_ActiveMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredPensionersMember" xlink:label="lbl_DeferredPensionersMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_DeferredPensionersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionersMember" xlink:label="lbl_PensionersMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_PensionersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="lbl_PlanAssetsAtFairValue" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_PlanAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="lbl_SurplusDeficitInPlan" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_SurplusDeficitInPlan" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="lbl_ActuarialAssumptionOfDiscountRates" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfDiscountRates" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitAssumptionLifeExpectancyMale" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyMale" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitAssumptionLifeExpectancyMale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="lbl_ActuarialAssumptionsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lbl_ActuarialAssumptionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="lbl_ActuarialAssumptionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ActuarialAssumptionsAxis" xlink:to="lbl_ActuarialAssumptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="lbl_ActuarialAssumptionOfDiscountRatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfDiscountRatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LifeExpectancyMember" xlink:label="lbl_LifeExpectancyMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_LifeExpectancyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionAxis" xlink:label="lbl_ChangeInActuarialAssumptionAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lbl_ChangeInActuarialAssumptionAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionMember" xlink:label="lbl_ChangeInActuarialAssumptionMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ChangeInActuarialAssumptionAxis" xlink:to="lbl_ChangeInActuarialAssumptionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Increase25BasisPointMember" xlink:label="lbl_Increase25BasisPointMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Increase25BasisPointMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Decrease25BasisPointMember" xlink:label="lbl_Decrease25BasisPointMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Decrease25BasisPointMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Change25BasisPointMember" xlink:label="lbl_Change25BasisPointMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Change25BasisPointMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Increase1YearMember" xlink:label="lbl_Increase1YearMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Increase1YearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails7" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfHealthCareCostTrendRatesTable" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:label="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails8" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAllocationOfPlanAssetsTable" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInvestmentsMember" xlink:label="lbl_EquityInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_EquityInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_DebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RealEstateMember" xlink:label="lbl_RealEstateMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RealEstateMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlternativeInvestmentsMember" xlink:label="lbl_AlternativeInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_AlternativeInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndOtherInvestmentsMember" xlink:label="lbl_CashAndOtherInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_CashAndOtherInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:label="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:label="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanPlanAssetAllocations" xlink:label="lbl_DefinedBenefitPlanPlanAssetAllocations" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanPlanAssetAllocations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EmployerSharesHeldByDefinedBenefitPlan" xlink:label="lbl_EmployerSharesHeldByDefinedBenefitPlan" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_EmployerSharesHeldByDefinedBenefitPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:label="lbl_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:label="lbl_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails9" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpectedBenefitPaymentsTable" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="lbl_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:to="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:to="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationAnnualIncentivePlanMember" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:label="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationUKShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationUKShareSavingsPlanMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationUKShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermPerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationOtherShareAwardsMember" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationRestrictedSharesMember" xlink:label="lbl_EquityBasedParticipationRestrictedSharesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:to="lbl_EquityBasedParticipationRestrictedSharesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationSpecialShareAwardsMember" xlink:label="lbl_EquityBasedParticipationSpecialShareAwardsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:to="lbl_EquityBasedParticipationSpecialShareAwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:label="lbl_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAnnualIncentive" xlink:label="lbl_DescriptionOfAnnualIncentive" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_DescriptionOfAnnualIncentive" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="3.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="1.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.4Member" xlink:label="lbl_ExercisePrice46.4Member" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.4Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.7Member" xlink:label="lbl_ExercisePrice46.7Member" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice53.7Member" xlink:label="lbl_ExercisePrice53.7Member" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice53.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice54.5Member" xlink:label="lbl_ExercisePrice54.5Member" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice54.5Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.0Member" xlink:label="lbl_ExercisePrice57.0Member" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.1Member" xlink:label="lbl_ExercisePrice57.1Member" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.1Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.6Member" xlink:label="lbl_ExercisePrice57.6Member" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.6Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice58.3Member" xlink:label="lbl_ExercisePrice58.3Member" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice58.3Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.0Member" xlink:label="lbl_ExercisePrice66.0Member" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.1Member" xlink:label="lbl_ExercisePrice66.1Member" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.1Member" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="3.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:definitionArc order="1.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.4Member" xlink:label="lbl_ExercisePrice46.4Member" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.4Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.7Member" xlink:label="lbl_ExercisePrice46.7Member" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice53.7Member" xlink:label="lbl_ExercisePrice53.7Member" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice53.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice54.5Member" xlink:label="lbl_ExercisePrice54.5Member" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice54.5Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.0Member" xlink:label="lbl_ExercisePrice57.0Member" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.1Member" xlink:label="lbl_ExercisePrice57.1Member" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.1Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.6Member" xlink:label="lbl_ExercisePrice57.6Member" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.6Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice58.3Member" xlink:label="lbl_ExercisePrice58.3Member" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice58.3Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.0Member" xlink:label="lbl_ExercisePrice66.0Member" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.1Member" xlink:label="lbl_ExercisePrice66.1Member" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.1Member" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingAxis" xlink:label="lbl_NonvestingAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:to="lbl_NonvestingAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingMember" xlink:label="lbl_NonvestingMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_NonvestingAxis" xlink:to="lbl_NonvestingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestedSharesGrantedMember" xlink:label="lbl_NonvestedSharesGrantedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NonvestingMember" xlink:to="lbl_NonvestedSharesGrantedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationAnnualIncentivePlanMember" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermPerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationOtherShareAwardsMember" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="3.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="5.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:definitionArc order="7.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:label="lbl_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:to="lbl_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:label="lbl_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:to="lbl_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails1" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonExecutiveDirectorMember" xlink:label="lbl_NonExecutiveDirectorMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_NonExecutiveDirectorMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GenentechRocheMember" xlink:label="lbl_GenentechRocheMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GenentechRocheMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GenentechInc.USAMember" xlink:label="lbl_GenentechInc.USAMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GenentechInc.USAMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XolairMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInAssociate" xlink:label="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:label="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfContractsWithRelatedParties" xlink:label="lbl_NumberOfContractsWithRelatedParties" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_NumberOfContractsWithRelatedParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:label="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:label="lbl_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonExecutiveDirectorMember" xlink:label="lbl_NonExecutiveDirectorMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_NonExecutiveDirectorMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="lbl_KeyManagementPersonnelCompensation" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensation" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfDrBrodyMember" xlink:label="lbl_ProfDrBrodyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_ProfDrBrodyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfDrZinkernagelMember" xlink:label="lbl_ProfDrZinkernagelMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_ProfDrZinkernagelMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrAlexKrauerMember" xlink:label="lbl_DrAlexKrauerMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_DrAlexKrauerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrDanielVasellaMember" xlink:label="lbl_DrDanielVasellaMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_DrDanielVasellaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrJamesBradnerMember" xlink:label="lbl_DrJamesBradnerMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_DrJamesBradnerMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPensionFundMember" xlink:label="lbl_NovartisPensionFundMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NovartisPensionFundMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="lbl_KeyManagementPersonnelCompensation" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationDailyRate" xlink:label="lbl_KeyManagementPersonnelCompensationDailyRate" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationDailyRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:label="lbl_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationSharesAcquired" xlink:label="lbl_KeyManagementPersonnelCompensationSharesAcquired" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationSharesAcquired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:label="lbl_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:label="lbl_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityUncommitted" xlink:label="lbl_BorrowingsCreditFacilityUncommitted" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_BorrowingsCreditFacilityUncommitted" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:label="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:label="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:to="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:label="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:label="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsUnderLongtermResearchAgreements" xlink:label="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangiblePurchaseCommitments" xlink:label="lbl_OtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_OtherIntangiblePurchaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:label="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:label="lbl_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="lbl_ClassesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="lbl_DisclosureOfFinancialAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_ClassesOfFinancialAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsMember" xlink:label="lbl_FinancialAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfFinancialAssetsAxis" xlink:to="lbl_FinancialAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMember" xlink:label="lbl_CashAndCashEquivalentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_CashAndCashEquivalentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueMember" xlink:label="lbl_FinancialAssetsAtFairValueMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_FinancialAssetsAtFairValueMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="lbl_FinancialAssetsAtAmortisedCostMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_FinancialAssetsAtAmortisedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="lbl_CategoriesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_CategoriesOfFinancialAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="lbl_FinancialAssetsCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CategoriesOfFinancialAssetsAxis" xlink:to="lbl_FinancialAssetsCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:label="lbl_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:label="lbl_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="lbl_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableForSaleMarketableSecuritiesMember" xlink:label="lbl_AvailableForSaleMarketableSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AvailableForSaleMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtMember" xlink:label="lbl_CurrentFinancialDebtMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CurrentFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemAxis" xlink:label="lbl_BalanceSheetItemAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_BalanceSheetItemAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemMember" xlink:label="lbl_BalanceSheetItemMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BalanceSheetItemAxis" xlink:to="lbl_BalanceSheetItemMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquitySecuritiesMember" xlink:label="lbl_EquitySecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_EquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_FundInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_ContingentConsiderationReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:label="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:label="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:label="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="lbl_DisclosureOfFinancialAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfFinancialAssetsLineItems" xlink:to="lbl_DisclosureOfFinancialAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="lbl_FinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFinancialAssetsLineItems" xlink:to="lbl_FinancialAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="lbl_FinancialLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:to="lbl_FinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="lbl_FinancialLiabilitiesAtAmortisedCostMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialLiabilitiesMember" xlink:to="lbl_FinancialLiabilitiesAtAmortisedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueMember" xlink:label="lbl_FinancialLiabilitiesAtFairValueMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialLiabilitiesMember" xlink:to="lbl_FinancialLiabilitiesAtFairValueMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="lbl_FinancialLiabilitiesCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:to="lbl_FinancialLiabilitiesCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="lbl_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialLiabilitiesCategoryMember" xlink:to="lbl_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:label="lbl_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialLiabilitiesCategoryMember" xlink:to="lbl_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtMember" xlink:label="lbl_CurrentFinancialDebtMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CurrentFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialDebtMember" xlink:label="lbl_NoncurrentFinancialDebtMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_NoncurrentFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesMember" xlink:label="lbl_TradePayablesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_TradePayablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemAxis" xlink:label="lbl_BalanceSheetItemAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_BalanceSheetItemAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemMember" xlink:label="lbl_BalanceSheetItemMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BalanceSheetItemAxis" xlink:to="lbl_BalanceSheetItemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BankAndOtherFinancialDebtMember" xlink:label="lbl_BankAndOtherFinancialDebtMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_BankAndOtherFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommercialPaperMember" xlink:label="lbl_CommercialPaperMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_CommercialPaperMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPortionOfNoncurrentDebtMember" xlink:label="lbl_CurrentPortionOfNoncurrentDebtMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_CurrentPortionOfNoncurrentDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StraightBondsMember" xlink:label="lbl_StraightBondsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_StraightBondsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:label="lbl_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseObligationsMember" xlink:label="lbl_FinanceLeaseObligationsMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_FinanceLeaseObligationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:label="lbl_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="lbl_FinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="lbl_FinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="lbl_LeaseLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_LeaseLiabilitiesMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="lbl_MeasurementAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_MeasurementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="lbl_AggregatedMeasurementMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MeasurementAxis" xlink:to="lbl_AggregatedMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember" xlink:label="lbl_RecurringFairValueMeasurementMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedMeasurementMember" xlink:to="lbl_RecurringFairValueMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_LevelsOfFairValueHierarchyAxis" xlink:to="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="lbl_Level1OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level1OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="lbl_Level2OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level2OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="lbl_Level3OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level3OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValuedAtAmortizedCostMember" xlink:label="lbl_ValuedAtAmortizedCostMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_ValuedAtAmortizedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:label="lbl_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:label="lbl_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesShorttermMember" xlink:label="lbl_ContingentConsiderationReceivablesShorttermMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_ContingentConsiderationReceivablesShorttermMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_DebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquitySecuritiesMember" xlink:label="lbl_EquitySecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_EquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_FundInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalAvailableforsaleMarketableSecuritiesMember" xlink:label="lbl_TotalAvailableforsaleMarketableSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_TotalAvailableforsaleMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:label="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:label="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_ContingentConsiderationReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:label="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="lbl_FinancialAssetsAtFairValue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="lbl_FinancialAssetsAtFairValue" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="lbl_MeasurementAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_MeasurementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="lbl_AggregatedMeasurementMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MeasurementAxis" xlink:to="lbl_AggregatedMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember" xlink:label="lbl_RecurringFairValueMeasurementMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedMeasurementMember" xlink:to="lbl_RecurringFairValueMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_LevelsOfFairValueHierarchyAxis" xlink:to="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="lbl_Level1OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level1OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="lbl_Level2OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level2OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="lbl_Level3OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level3OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValuedAtAmortizedCostMember" xlink:label="lbl_ValuedAtAmortizedCostMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_ValuedAtAmortizedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="lbl_ClassesOfLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_ClassesOfLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesMember" xlink:label="lbl_LiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfLiabilitiesAxis" xlink:to="lbl_LiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPayablesMember" xlink:label="lbl_ContingentConsiderationPayablesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_ContingentConsiderationPayablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialLiabilitiesMember" xlink:label="lbl_OtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_OtherFinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="lbl_FinancialLiabilitiesAtFairValue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_FinancialLiabilitiesAtFairValue" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails7" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:label="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FundInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongTermFinancialInvestmentsMember" xlink:label="lbl_LongTermFinancialInvestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_LongTermFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_ContingentConsiderationReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPayablesMember" xlink:label="lbl_ContingentConsiderationPayablesMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_ContingentConsiderationPayablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialLiabilitiesMember" xlink:label="lbl_OtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_OtherFinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsCarryingValueLevel3" xlink:label="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:label="lbl_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:label="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:label="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseFairValueMeasurementAssets" xlink:label="lbl_PurchaseFairValueMeasurementAssets" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_PurchaseFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:label="lbl_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalsFairValueMeasurementAssets" xlink:label="lbl_DisposalsFairValueMeasurementAssets" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DisposalsFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationFairValueMeasurementAssets" xlink:label="lbl_ReclassificationFairValueMeasurementAssets" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ReclassificationFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:label="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails8" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:label="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneMonthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesAndTimeDepositsMember" xlink:label="lbl_MarketableSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_MarketableSecuritiesAndTimeDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommoditiesMember" xlink:label="lbl_CommoditiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CommoditiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:label="lbl_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMember" xlink:label="lbl_CashAndCashEquivalentsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CashAndCashEquivalentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtMember" xlink:label="lbl_FinancialDebtMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtUndiscountedMember" xlink:label="lbl_FinancialDebtUndiscountedMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FinancialDebtUndiscountedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaturityOfNetDebtLineItems" xlink:label="lbl_MaturityOfNetDebtLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDebt" xlink:label="lbl_NetDebt" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_NetDebt" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails9" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneMonthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:label="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:label="lbl_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails10" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractualInterestOnNoncurrentLiabilities" xlink:label="lbl_ContractualInterestOnNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ContractualInterestOnNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationLiabilities" xlink:label="lbl_ContingentConsiderationLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ContingentConsiderationLiabilities" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails11" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TenDayLossFairValueVARModelTable" xlink:label="lbl_TenDayLossFairValueVARModelTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_TenDayLossFairValueVARModelTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageMember" xlink:label="lbl_WeightedAverageMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_WeightedAverageMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WorstCaseLossScenarioMember" xlink:label="lbl_WorstCaseLossScenarioMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RangesMember" xlink:to="lbl_WorstCaseLossScenarioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TenDayLossFairValueVARModelLineItems" xlink:label="lbl_TenDayLossFairValueVARModelLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_TenDayLossFairValueVARModelTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputation" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputation" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails12" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorAxis" xlink:label="lbl_VendorAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:label="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:to="lbl_VendorAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorMember" xlink:label="lbl_VendorMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_VendorAxis" xlink:to="lbl_VendorMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestFinancialInstitutionMember" xlink:label="lbl_LargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_VendorMember" xlink:to="lbl_LargestFinancialInstitutionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestFinancialInstitutionMember" xlink:label="lbl_SecondLargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_VendorMember" xlink:to="lbl_SecondLargestFinancialInstitutionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestFinancialInstitutionMember" xlink:label="lbl_ThirdLargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_VendorMember" xlink:to="lbl_ThirdLargestFinancialInstitutionMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:to="lbl_BorrowingsByNameAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USCommercialPaperProgramsMember" xlink:label="lbl_USCommercialPaperProgramsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_USCommercialPaperProgramsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JPCommercialPaperProgramsMember" xlink:label="lbl_JPCommercialPaperProgramsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_JPCommercialPaperProgramsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OpenHedgesForAnticipatedTransactions" xlink:label="lbl_OpenHedgesForAnticipatedTransactions" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_OpenHedgesForAnticipatedTransactions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:label="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOnSaleOfOtherFinancialAssets" xlink:label="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostSignificantForeignExchangeLosses" xlink:label="lbl_MostSignificantForeignExchangeLosses" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_MostSignificantForeignExchangeLosses" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermFinancialDebtWithACarryingAmount" xlink:label="lbl_LongtermFinancialDebtWithACarryingAmount" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_LongtermFinancialDebtWithACarryingAmount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:label="lbl_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximumHoldingInUnrelatedCompany" xlink:label="lbl_MaximumHoldingInUnrelatedCompany" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_MaximumHoldingInUnrelatedCompany" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:label="lbl_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:label="lbl_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:label="lbl_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:label="lbl_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:label="lbl_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:label="lbl_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperNumberOfPrograms" xlink:label="lbl_BorrowingsCommercialPaperNumberOfPrograms" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCommercialPaperNumberOfPrograms" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityCommitted" xlink:label="lbl_BorrowingsCreditFacilityCommitted" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCreditFacilityCommitted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtEquityRatio" xlink:label="lbl_DebtEquityRatio" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DebtEquityRatio" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VAREstimateConfidenceInterval" xlink:label="lbl_VAREstimateConfidenceInterval" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_VAREstimateConfidenceInterval" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:label="lbl_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CounterpartyRiskAbstract" xlink:label="lbl_CounterpartyRiskAbstract" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CounterpartyRiskAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:label="lbl_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CounterpartyRiskAbstract" xlink:to="lbl_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityShortTerm" xlink:label="lbl_BorrowingsCreditFacilityShortTerm" xlink:type="locator"/>
      <link:definitionArc order="18.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCreditFacilityShortTerm" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountBorrowedUnderTheCreditFacility" xlink:label="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="locator"/>
      <link:definitionArc order="18.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ApplicableTaxRateExcludingExceptionalItems" xlink:label="lbl_ApplicableTaxRateExcludingExceptionalItems" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ApplicableTaxRateExcludingExceptionalItems" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="lbl_DepreciationAndAmortisationExpense" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DepreciationAndAmortisationExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToRestructuringProvisions" xlink:label="lbl_AdditionsToRestructuringProvisions" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdditionsToRestructuringProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:definitionArc order="1.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RightofuseAssetsMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherNoncurrentAssets" xlink:label="lbl_FinancialAndOtherNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinancialAndOtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssets" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAndNoncurrentFinancialDebt" xlink:label="lbl_CurrentAndNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentAndNoncurrentFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesProvisionsAndOtherLiabilities" xlink:label="lbl_TradePayablesProvisionsAndOtherLiabilities" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TradePayablesProvisionsAndOtherLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetAssetsDerecognized" xlink:label="lbl_NetAssetsDerecognized" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetAssetsDerecognized" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionRollForward" xlink:label="lbl_EnvironmentalProvisionRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvision" xlink:label="lbl_EnvironmentalProvision" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvision" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionPayments" xlink:label="lbl_EnvironmentalProvisionPayments" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionPayments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionReleases" xlink:label="lbl_EnvironmentalProvisionReleases" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionReleases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionAdditions" xlink:label="lbl_EnvironmentalProvisionAdditions" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionAdditions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:label="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionCurrent" xlink:label="lbl_EnvironmentalProvisionCurrent" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalRemediationProvisionNoncurrent" xlink:label="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails7" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="lbl_AssetsAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="lbl_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_NoncurrentAssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_Assets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="lbl_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EquityAndLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="lbl_EquityAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReserves" xlink:label="lbl_OtherReserves" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_OtherReserves" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAbstract" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="lbl_LiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_LiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="lbl_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="lbl_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_CurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="lbl_EquityAndLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAndLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:definitionArc order="0.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="lbl_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lbl_EntitysTotalForSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="lbl_SubsidiariesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSubsidiariesMember" xlink:to="lbl_SubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationAxis" xlink:label="lbl_IncomeStatementLocationAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_IncomeStatementLocationAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationMember" xlink:label="lbl_IncomeStatementLocationMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_IncomeStatementLocationAxis" xlink:to="lbl_IncomeStatementLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OperatingIncomeMember" xlink:label="lbl_OperatingIncomeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_OperatingIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_LegalEntityAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsAAAMember" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AspenGlobalIncorporatedMember" xlink:label="lbl_AspenGlobalIncorporatedMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AspenGlobalIncorporatedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TheMedicinesCompanyMember" xlink:label="lbl_TheMedicinesCompanyMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TheMedicinesCompanyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AveXisIncMember" xlink:label="lbl_AveXisIncMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AveXisIncMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteMember" xlink:label="lbl_EndocyteMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EndocyteMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalIncMember" xlink:label="lbl_TranscendMedicalIncMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TranscendMedicalIncMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelexysPharmaceuticalsCorporationMember" xlink:label="lbl_SelexysPharmaceuticalsCorporationMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SelexysPharmaceuticalsCorporationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReprixysPharmaceuticalsCorporationMember" xlink:label="lbl_ReprixysPharmaceuticalsCorporationMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ReprixysPharmaceuticalsCorporationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedMember" xlink:label="lbl_ZiarcoGroupLimitedMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZiarcoGroupLimitedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionIncMember" xlink:label="lbl_EncoreVisionIncMember" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EncoreVisionIncMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EliLillyAndCompanyMember" xlink:label="lbl_EliLillyAndCompanyMember" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EliLillyAndCompanyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKOncologyProductsMember" xlink:label="lbl_GSKOncologyProductsMember" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKOncologyProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKVaccinesMember" xlink:label="lbl_GSKVaccinesMember" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKVaccinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKConsumerHealthcareMember" xlink:label="lbl_GSKConsumerHealthcareMember" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKConsumerHealthcareMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKTotalTransactionMember" xlink:label="lbl_GSKTotalTransactionMember" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKTotalTransactionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CSLMember" xlink:label="lbl_CSLMember" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CSLMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexMember" xlink:label="lbl_SpinifexMember" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SpinifexMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdmuneTheraputicsMember" xlink:label="lbl_AdmuneTheraputicsMember" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdmuneTheraputicsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TakedaPharmaceuticalCompanyLimitedMember" xlink:label="lbl_TakedaPharmaceuticalCompanyLimitedMember" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TakedaPharmaceuticalCompanyLimitedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IFMTreInc.Member" xlink:label="lbl_IFMTreInc.Member" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_IFMTreInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PowerVisionInc.Member" xlink:label="lbl_PowerVisionInc.Member" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_PowerVisionInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:label="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_BorrowingsByNameAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsUSDMember" xlink:label="lbl_BorrowingsUSDMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_BorrowingsUSDMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsEURMember" xlink:label="lbl_BorrowingsEURMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_BorrowingsEURMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DetailedInformationAboutSignificantTransaction" xlink:label="lbl_DetailedInformationAboutSignificantTransaction" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DetailedInformationAboutSignificantTransaction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="lbl_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RepaymentOfIntercompanyBalances" xlink:label="lbl_RepaymentOfIntercompanyBalances" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RepaymentOfIntercompanyBalances" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill" xlink:label="lbl_AdditionalRecognitionGoodwill" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AdditionalRecognitionGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:label="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:label="lbl_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="lbl_PercentageOfVotingEquityInterestsAcquired" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfVotingEquityInterestsAcquired" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="lbl_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentiallyRefundableConsiderationFromAcquisition" xlink:label="lbl_PotentiallyRefundableConsiderationFromAcquisition" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PotentiallyRefundableConsiderationFromAcquisition" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:label="lbl_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractRightOfFirstNegotiationTerm" xlink:label="lbl_ContractRightOfFirstNegotiationTerm" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ContractRightOfFirstNegotiationTerm" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="lbl_RevenueOfAcquiree" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RevenueOfAcquiree" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueOfAcquireeFullYear" xlink:label="lbl_RevenueOfAcquireeFullYear" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RevenueOfAcquireeFullYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:label="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:label="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="lbl_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:label="lbl_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:type="locator"/>
      <link:definitionArc order="23.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:label="lbl_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:type="locator"/>
      <link:definitionArc order="24.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="lbl_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="locator"/>
      <link:definitionArc order="25.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfVotingEquityInterestsContributed" xlink:label="lbl_PercentageOfVotingEquityInterestsContributed" xlink:type="locator"/>
      <link:definitionArc order="26.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfVotingEquityInterestsContributed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionRelatedCosts" xlink:label="lbl_TransactionRelatedCosts" xlink:type="locator"/>
      <link:definitionArc order="27.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TransactionRelatedCosts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionRelatedCostsPaid" xlink:label="lbl_TransactionRelatedCostsPaid" xlink:type="locator"/>
      <link:definitionArc order="28.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TransactionRelatedCostsPaid" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="lbl_ImpairmentLoss" xlink:type="locator"/>
      <link:definitionArc order="29.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ImpairmentLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLoss" xlink:label="lbl_ReversalOfImpairmentLoss" xlink:type="locator"/>
      <link:definitionArc order="30.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ReversalOfImpairmentLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PreTaxProfitLossFromDivestmentOfBusiness" xlink:label="lbl_PreTaxProfitLossFromDivestmentOfBusiness" xlink:type="locator"/>
      <link:definitionArc order="31.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PreTaxProfitLossFromDivestmentOfBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:label="lbl_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:type="locator"/>
      <link:definitionArc order="32.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialReceivableFromDivestment" xlink:label="lbl_PotentialReceivableFromDivestment" xlink:type="locator"/>
      <link:definitionArc order="33.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PotentialReceivableFromDivestment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentFairValueOfContingentConsiderationReceived" xlink:label="lbl_DivestmentFairValueOfContingentConsiderationReceived" xlink:type="locator"/>
      <link:definitionArc order="34.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DivestmentFairValueOfContingentConsiderationReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MilestonePaymentAlreadyReceived" xlink:label="lbl_MilestonePaymentAlreadyReceived" xlink:type="locator"/>
      <link:definitionArc order="35.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_MilestonePaymentAlreadyReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FuturePutOptionToSellBusiness" xlink:label="lbl_FuturePutOptionToSellBusiness" xlink:type="locator"/>
      <link:definitionArc order="36.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_FuturePutOptionToSellBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentPutOption" xlink:label="lbl_PaymentPutOption" xlink:type="locator"/>
      <link:definitionArc order="37.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PaymentPutOption" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExchanged" xlink:label="lbl_InterestExchanged" xlink:type="locator"/>
      <link:definitionArc order="38.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_InterestExchanged" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="lbl_ParValuePerShare" xlink:type="locator"/>
      <link:definitionArc order="39.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ParValuePerShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalInTenderOffer" xlink:label="lbl_PercentageOfShareCapitalInTenderOffer" xlink:type="locator"/>
      <link:definitionArc order="40.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfShareCapitalInTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOfferPerOrdinaryShare" xlink:label="lbl_CashOfferPerOrdinaryShare" xlink:type="locator"/>
      <link:definitionArc order="41.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CashOfferPerOrdinaryShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOfferPerADS" xlink:label="lbl_CashOfferPerADS" xlink:type="locator"/>
      <link:definitionArc order="42.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CashOfferPerADS" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOrdinarySharePerADS" xlink:label="lbl_NumberOfOrdinarySharePerADS" xlink:type="locator"/>
      <link:definitionArc order="43.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NumberOfOrdinarySharePerADS" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfEquity" xlink:label="lbl_ValueOfEquity" xlink:type="locator"/>
      <link:definitionArc order="44.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ValueOfEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:label="lbl_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:type="locator"/>
      <link:definitionArc order="45.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherNetAssets" xlink:label="lbl_OtherNetAssets" xlink:type="locator"/>
      <link:definitionArc order="46.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_OtherNetAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="lbl_DeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="47.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="48.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentCostToSell" xlink:label="lbl_DivestmentCostToSell" xlink:type="locator"/>
      <link:definitionArc order="49.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DivestmentCostToSell" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:definitionArc order="50.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:definitionArc order="51.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:definitionArc order="52.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CarryingValueOfTheDivestedBusiness" xlink:label="lbl_CarryingValueOfTheDivestedBusiness" xlink:type="locator"/>
      <link:definitionArc order="53.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CarryingValueOfTheDivestedBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfProductsInPortfolioToBeSold" xlink:label="lbl_NumberOfProductsInPortfolioToBeSold" xlink:type="locator"/>
      <link:definitionArc order="54.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NumberOfProductsInPortfolioToBeSold" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:definitionArc order="55.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProformaNetSales" xlink:label="lbl_ProformaNetSales" xlink:type="locator"/>
      <link:definitionArc order="56.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProformaNetSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="lbl_OtherBorrowings" xlink:type="locator"/>
      <link:definitionArc order="57.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_OtherBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="lbl_DividendsPayable" xlink:type="locator"/>
      <link:definitionArc order="58.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DividendsPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:definitionArc order="59.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:label="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:definitionArc order="60.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="lbl_NetAssetsLiabilities" xlink:type="locator"/>
      <link:definitionArc order="61.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NetAssetsLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="lbl_FinancialAssetsAtFairValue" xlink:type="locator"/>
      <link:definitionArc order="62.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_FinancialAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="locator"/>
      <link:definitionArc order="63.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:definitionArc order="64.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:label="lbl_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:type="locator"/>
      <link:definitionArc order="65.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialMilestoneMaximumPayments" xlink:label="lbl_PotentialMilestoneMaximumPayments" xlink:type="locator"/>
      <link:definitionArc order="66.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PotentialMilestoneMaximumPayments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:label="lbl_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:type="locator"/>
      <link:definitionArc order="67.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalBorrowings" xlink:label="lbl_AdditionalBorrowings" xlink:type="locator"/>
      <link:definitionArc order="68.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AdditionalBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEquityInterestSharesReceived" xlink:label="lbl_PercentageOfEquityInterestSharesReceived" xlink:type="locator"/>
      <link:definitionArc order="69.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfEquityInterestSharesReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:label="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:type="locator"/>
      <link:definitionArc order="70.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="locator"/>
      <link:definitionArc order="71.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomaryPurchasePriceAdjustment" xlink:label="lbl_CustomaryPurchasePriceAdjustment" xlink:type="locator"/>
      <link:definitionArc order="72.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CustomaryPurchasePriceAdjustment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:type="locator"/>
      <link:definitionArc order="3.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialLossesFromDefinedBenefitPlansMember" xlink:label="lbl_ActuarialLossesFromDefinedBenefitPlansMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_ActuarialLossesFromDefinedBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationEffectsMember" xlink:label="lbl_CumulativeCurrencyTranslationEffectsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_CumulativeCurrencyTranslationEffectsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:label="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_RestatedValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails7" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CyPassMember" xlink:label="lbl_CyPassMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CyPassMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="lbl_IncomeTaxesPaidRefund" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefund" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails6" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:label="lbl_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="lbl_OtherAdjustmentsToReconcileProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherAdjustmentsToReconcileProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails3" xlink:type="extended">
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_LegalEntityAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKConsumerHealthcareMember" xlink:label="lbl_GSKConsumerHealthcareMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKConsumerHealthcareMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:label="lbl_ProceedsFromSalesOfInterestsInAssociates" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfInterestsInAssociates" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsAxis" xlink:label="lbl_AcquisitionsAndDivestmentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_AcquisitionsAndDivestmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsMember" xlink:label="lbl_AcquisitionsAndDivestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AcquisitionsAndDivestmentsAxis" xlink:to="lbl_AcquisitionsAndDivestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsMember" xlink:label="lbl_AcquisitionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AcquisitionsAndDivestmentsMember" xlink:to="lbl_AcquisitionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsMember" xlink:label="lbl_DivestmentsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AcquisitionsAndDivestmentsMember" xlink:to="lbl_DivestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="lbl_BusinessCombinationsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_BusinessCombinationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_BusinessCombinationsAxis" xlink:to="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalIncMember" xlink:label="lbl_TranscendMedicalIncMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForBusinessCombinationsMember" xlink:to="lbl_TranscendMedicalIncMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLiabilitiesMember" xlink:label="lbl_CurrentLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_CurrentLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLiabilitiesMember" xlink:label="lbl_NoncurrentLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_NoncurrentLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowFromNetIdentifiableAssets" xlink:label="lbl_CashFlowFromNetIdentifiableAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowFromNetIdentifiableAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:label="lbl_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReceivablesAndPayablesContingentConsiderationNet" xlink:label="lbl_ReceivablesAndPayablesContingentConsiderationNet" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ReceivablesAndPayablesContingentConsiderationNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPaymentsAndDeferredConsiderationNet" xlink:label="lbl_OtherPaymentsAndDeferredConsiderationNet" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherPaymentsAndDeferredConsiderationNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPaid" xlink:label="lbl_ContingentConsiderationPaid" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ContingentConsiderationPaid" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentAssetsDivested" xlink:label="lbl_NoncurrentAssetsDivested" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NoncurrentAssetsDivested" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="lbl_ConsiderationPaidReceived" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ConsiderationPaidReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashOutflowsFromDivestments" xlink:label="lbl_NetCashOutflowsFromDivestments" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashOutflowsFromDivestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAssetsDivested" xlink:label="lbl_CurrentAssetsDivested" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentAssetsDivested" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="lbl_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLiabilitiesDivested" xlink:label="lbl_CurrentLiabilitiesDivested" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentLiabilitiesDivested" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="lbl_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="locator"/>
      <link:definitionArc order="15.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:label="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestedCashAndCashEquivalents" xlink:label="lbl_DivestedCashAndCashEquivalents" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DivestedCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsAttributableToDivestedBusiness" xlink:label="lbl_CashFlowsAttributableToDivestedBusiness" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsAttributableToDivestedBusiness" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:label="lbl_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails14" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:to="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ListedEquitySecuritiesMember" xlink:label="lbl_ListedEquitySecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_ListedEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonlistedEquitySecuritiesMember" xlink:label="lbl_NonlistedEquitySecuritiesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_NonlistedEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalFairValueAdjustmentsMember" xlink:label="lbl_TotalFairValueAdjustmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalFairValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:label="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOnSaleOfOtherFinancialAssets" xlink:label="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfOtherFinancialAssets" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetAssetsDerecognized" xlink:label="lbl_NetAssetsDerecognized" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NetAssetsDerecognized" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="lbl_DividendsPayable" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DividendsPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionOfDividendToDividendBearingShares" xlink:label="lbl_DistributionOfDividendToDividendBearingShares" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DistributionOfDividendToDividendBearingShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:label="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCosts" xlink:label="lbl_TransactionCosts" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TransactionCosts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="lbl_ClassesOfProvisionsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ClassesOfProvisionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisionsMember" xlink:label="lbl_OtherProvisionsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfProvisionsAxis" xlink:to="lbl_OtherProvisionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsProvisionMember" xlink:label="lbl_LegalProceedingsProvisionMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_LegalProceedingsProvisionMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_IT" xlink:label="lbl_IT" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_IT" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="lbl_JP" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_JP" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CA" xlink:label="lbl_CA" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CA" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_KR" xlink:label="lbl_KR" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_KR" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NAGAndNovartisPharmaSpAMember" xlink:label="lbl_NAGAndNovartisPharmaSpAMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NAGAndNovartisPharmaSpAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FHoffmanLaRocheAGAndRocheSpAMember" xlink:label="lbl_FHoffmanLaRocheAGAndRocheSpAMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_FHoffmanLaRocheAGAndRocheSpAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaKKMember" xlink:label="lbl_NovartisPharmaKKMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NovartisPharmaKKMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NAGMember" xlink:label="lbl_NAGMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NPCAndOthersMember" xlink:label="lbl_NPCAndOthersMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NPCAndOthersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNCMember" xlink:label="lbl_NovartisNCMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NovartisNCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SolodynMember" xlink:label="lbl_SolodynMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SolodynMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnoxaparinMember" xlink:label="lbl_EnoxaparinMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_EnoxaparinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContactLensesMember" xlink:label="lbl_ContactLensesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ContactLensesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecMember" xlink:label="lbl_GleevecMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GleevecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclastAclastaMember" xlink:label="lbl_ReclastAclastaMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ReclastAclastaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TekturnaRasilezValturnaMember" xlink:label="lbl_TekturnaRasilezValturnaMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TekturnaRasilezValturnaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxotereMember" xlink:label="lbl_TaxotereMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TaxotereMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmiodaroneMember" xlink:label="lbl_AmiodaroneMember" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AmiodaroneMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="lbl_LitigationCaseAxis" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_LitigationCaseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LitigationCaseMember" xlink:label="lbl_LitigationCaseMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_LitigationCaseAxis" xlink:to="lbl_LitigationCaseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TennesseeClassActionMember" xlink:label="lbl_TennesseeClassActionMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LitigationCaseMember" xlink:to="lbl_TennesseeClassActionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MassachusettsCaseMember" xlink:label="lbl_MassachusettsCaseMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_LitigationCaseMember" xlink:to="lbl_MassachusettsCaseMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:label="lbl_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:label="lbl_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfSettlementInPrinciple" xlink:label="lbl_AmountOfSettlementInPrinciple" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_AmountOfSettlementInPrinciple" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalAmountOfSettlementInPrinciple" xlink:label="lbl_AdditionalAmountOfSettlementInPrinciple" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_AdditionalAmountOfSettlementInPrinciple" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfResolvedAction" xlink:label="lbl_AmountOfResolvedAction" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_AmountOfResolvedAction" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DocumentAndEntityInformation" xlink:type="extended">
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable" xlink:label="lbl_DocumentInformationTable" xlink:type="locator"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="lbl_DocumentInformationLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentInformationTable" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="lbl_DocumentType" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentType" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="lbl_AmendmentFlag" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_AmendmentFlag" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="lbl_DocumentAnnualReport" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentAnnualReport" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="lbl_DocumentTransitionReport" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentTransitionReport" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="lbl_DocumentShellCompanyReport" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentShellCompanyReport" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="lbl_DocumentPeriodEndDate" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentPeriodEndDate" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="lbl_DocumentFiscalYearFocus" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentFiscalYearFocus" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="lbl_DocumentFiscalPeriodFocus" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentFiscalPeriodFocus" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="lbl_TradingSymbol" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_TradingSymbol" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="lbl_EntityRegistrantName" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityRegistrantName" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="lbl_EntityCentralIndexKey" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityCentralIndexKey" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="lbl_CurrentFiscalYearEndDate" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_CurrentFiscalYearEndDate" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="lbl_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="lbl_EntityCurrentReportingStatus" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityCurrentReportingStatus" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="lbl_EntityVoluntaryFilers" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityVoluntaryFilers" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="lbl_EntityFilerCategory" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityFilerCategory" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="lbl_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="lbl_EntityPublicFloat" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityPublicFloat" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="lbl_EntityShellCompany" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityShellCompany" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="lbl_EntityEmergingGrowthCompany" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityEmergingGrowthCompany" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="lbl_EntityInteractiveDataCurrent" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityInteractiveDataCurrent" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="lbl_ApplicableTaxRate" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ApplicableTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfTaxLosses" xlink:label="lbl_TaxRateEffectOfTaxLosses" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfTaxLosses" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:label="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:label="lbl_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfCreditsAndAllowances" xlink:label="lbl_TaxRateEffectOfCreditsAndAllowances" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfCreditsAndAllowances" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:label="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="lbl_TaxRateEffectFromChangeInTaxRate" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromChangeInTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:label="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfWriteoffOfDeferredTaxAssets" xlink:label="lbl_EffectOfWriteoffOfDeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfWriteoffOfDeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromBenefitsExpiring" xlink:label="lbl_TaxRateEffectFromBenefitsExpiring" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromBenefitsExpiring" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromNondeductibleLossesInRegion" xlink:label="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageEffectiveTaxRateContinuingOperations" xlink:label="lbl_AverageEffectiveTaxRateContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AverageEffectiveTaxRateContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageEffectiveTaxRateDiscontinuedOperations" xlink:label="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="lbl_AverageEffectiveTaxRate" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AverageEffectiveTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:label="lbl_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:label="lbl_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:label="lbl_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:type="locator"/>
      <link:definitionArc order="21.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfUSTaxReformLegislation" xlink:label="lbl_EffectOfUSTaxReformLegislation" xlink:type="locator"/>
      <link:definitionArc order="21.7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfUSTaxReformLegislation" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="lbl_MajorCustomersAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="lbl_DisclosureOfMajorCustomersTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_MajorCustomersAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersMember" xlink:label="lbl_MajorCustomersMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MajorCustomersAxis" xlink:to="lbl_MajorCustomersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestCustomerMember" xlink:label="lbl_LargestCustomerMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_LargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestCustomerMember" xlink:label="lbl_SecondLargestCustomerMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_SecondLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestCustomerMember" xlink:label="lbl_ThirdLargestCustomerMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_ThirdLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_DisclosureOfMajorCustomersTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="lbl_PercentageOfEntitysRevenue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysRevenue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEntitysTradeReceivable" xlink:label="lbl_PercentageOfEntitysTradeReceivable" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysTradeReceivable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomersWithNetSalesOverFivePercent" xlink:label="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RealEstateMember" xlink:label="lbl_RealEstateMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lbl_RealEstateMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleAndLeaseBackMember" xlink:label="lbl_SaleAndLeaseBackMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lbl_SaleAndLeaseBackMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowForLeases" xlink:label="lbl_CashInflowForLeases" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashInflowForLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowForSaleAndLeaseback" xlink:label="lbl_CashInflowForSaleAndLeaseback" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashInflowForSaleAndLeaseback" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDeductionFromRevenueTable" xlink:label="lbl_ProvisionForDeductionFromRevenueTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ProvisionForDeductionFromRevenueTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesAxis" xlink:label="lbl_PlansAndProgramRebatesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_ProvisionForDeductionFromRevenueTable" xlink:to="lbl_PlansAndProgramRebatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesMember" xlink:label="lbl_PlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_PlansAndProgramRebatesAxis" xlink:to="lbl_PlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USspecificHealthcarePlansAndProgramRebatesMember" xlink:label="lbl_USspecificHealthcarePlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_USspecificHealthcarePlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:label="lbl_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:label="lbl_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:label="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_ProvisionForDeductionFromRevenueTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForDeductionsFromRevenueRollForward" xlink:label="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentRefundsProvision" xlink:label="lbl_CurrentRefundsProvision" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_CurrentRefundsProvision" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_ProvisionUsedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementAdjustmentsOfPriorYear" xlink:label="lbl_IncomeStatementAdjustmentsOfPriorYear" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_IncomeStatementAdjustmentsOfPriorYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementAdjustmentsOfCurrentYear" xlink:label="lbl_IncomeStatementAdjustmentsOfCurrentYear" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_IncomeStatementAdjustmentsOfCurrentYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInOffsetAgainstGrossTradeReceivables" xlink:label="lbl_ChangesInOffsetAgainstGrossTradeReceivables" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_ChangesInOffsetAgainstGrossTradeReceivables" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:to="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsAxis" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsMember" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractOrUnderlyingPrincipalAmoutMember" xlink:label="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PositiveFairValuesMember" xlink:label="lbl_PositiveFairValuesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_PositiveFairValuesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NegativeFairValuesMember" xlink:label="lbl_NegativeFairValuesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_NegativeFairValuesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:label="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:label="lbl_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:label="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:label="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstruments" xlink:label="lbl_DerivativeFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstruments" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:to="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsAxis" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsMember" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractOrUnderlyingPrincipalAmoutMember" xlink:label="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:label="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:label="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:label="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstruments" xlink:label="lbl_DerivativeFinancialInstruments" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_CurrencyAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_CurrencyAxis" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CurrencyOthersMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails13" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="lbl_MajorCustomersAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="lbl_DisclosureOfMajorCustomersTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_MajorCustomersAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersMember" xlink:label="lbl_MajorCustomersMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MajorCustomersAxis" xlink:to="lbl_MajorCustomersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestCustomerMember" xlink:label="lbl_LargestCustomerMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_LargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestCustomerMember" xlink:label="lbl_SecondLargestCustomerMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_SecondLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestCustomerMember" xlink:label="lbl_ThirdLargestCustomerMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_ThirdLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_DisclosureOfMajorCustomersTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="lbl_PercentageOfEntitysRevenue" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysRevenue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEntitysTradeReceivable" xlink:label="lbl_PercentageOfEntitysTradeReceivable" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysTradeReceivable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomersWithNetSalesOverFivePercent" xlink:label="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSubsequentEventsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypAxis" xlink:label="lbl_SubsequentEventTypAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_SubsequentEventTypAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypeMember" xlink:label="lbl_SubsequentEventTypeMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SubsequentEventTypAxis" xlink:to="lbl_SubsequentEventTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventMember" xlink:label="lbl_SubsequentEventMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_SubsequentEventTypeMember" xlink:to="lbl_SubsequentEventMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountBorrowedUnderTheCreditFacility" xlink:label="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="lbl_ParValuePerShare" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ParValuePerShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UndiscountedOperatingLeaseCommitments" xlink:label="lbl_UndiscountedOperatingLeaseCommitments" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UndiscountedOperatingLeaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShortTermLeasesAndLowValueLeases" xlink:label="lbl_ShortTermLeasesAndLowValueLeases" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ShortTermLeasesAndLowValueLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RemainingLeaseCommitments" xlink:label="lbl_RemainingLeaseCommitments" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RemainingLeaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesToBeRecognized" xlink:label="lbl_LeaseLiabilitiesToBeRecognized" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilitiesToBeRecognized" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RightOfUseAssetsToBeRecognized" xlink:label="lbl_RightOfUseAssetsToBeRecognized" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RightOfUseAssetsToBeRecognized" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaymentsAndAccruedLeasePayments" xlink:label="lbl_PrepaymentsAndAccruedLeasePayments" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PrepaymentsAndAccruedLeasePayments" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationAxis" xlink:label="lbl_ImpactLocationAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ImpactLocationAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationMember" xlink:label="lbl_ImpactLocationMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ImpactLocationAxis" xlink:to="lbl_ImpactLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementMember" xlink:label="lbl_IncomeStatementMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ImpactLocationMember" xlink:to="lbl_IncomeStatementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ImpactLocationMember" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:label="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:label="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:label="lbl_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:label="lbl_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:label="lbl_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:label="lbl_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails10" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails8" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:label="lbl_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:label="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:label="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseProvision" xlink:label="lbl_FinanceLeaseProvision" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceLeaseProvision" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceLeaseReceivables" xlink:label="lbl_FinanceLeaseReceivables" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceLeaseReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/StatementOfIncome" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="lbl_ProfitLossAttributableToAbstract" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossAttributableToAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProfitLossAttributableToAbstract" xlink:to="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="lbl_ProfitLossAttributableToNoncontrollingInterests" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ProfitLossAttributableToAbstract" xlink:to="lbl_ProfitLossAttributableToNoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="lbl_BasicEarningsPerShareAbstract" xlink:type="locator"/>
      <link:definitionArc order="23.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_BasicEarningsPerShareAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="lbl_BasicEarningsLossPerShare" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_BasicEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="lbl_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:definitionArc order="24.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DilutedEarningsPerShareAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="lbl_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_DilutedEarningsLossPerShare" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:label="lbl_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesMember" xlink:label="lbl_InventoriesMember" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_InventoriesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxLossCarryforwardsMember" xlink:label="lbl_TaxLossCarryforwardsMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_TaxLossCarryforwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherAssetsProvisionsAccrualsMember" xlink:label="lbl_OtherAssetsProvisionsAccrualsMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_OtherAssetsProvisionsAccrualsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossDeferredTaxAssets" xlink:label="lbl_GrossDeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossDeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossDeferredTaxLiabilities" xlink:label="lbl_GrossDeferredTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossDeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="lbl_DeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInDeferredTaxBalanceRollForward" xlink:label="lbl_MovementInDeferredTaxBalanceRollForward" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_MovementInDeferredTaxBalanceRollForward" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:label="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:label="lbl_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="lbl_ClassesOfShareCapitalAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:to="lbl_ClassesOfShareCapitalAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="lbl_ClassesOfShareCapitalMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ClassesOfShareCapitalAxis" xlink:to="lbl_ClassesOfShareCapitalMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="lbl_OrdinarySharesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfShareCapitalMember" xlink:to="lbl_OrdinarySharesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="lbl_TreasurySharesMember" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_ClassesOfShareCapitalMember" xlink:to="lbl_TreasurySharesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="lbl_NumberOfSharesOutstanding" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_NumberOfSharesOutstanding" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesCancelledForCapitalReduction" xlink:label="lbl_SharesCancelledForCapitalReduction" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_SharesCancelledForCapitalReduction" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeHeld" xlink:label="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeCancelled" xlink:label="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherSharePurchases" xlink:label="lbl_OtherSharePurchases" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_OtherSharePurchases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:label="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedCompensationShares" xlink:label="lbl_EquityBasedCompensationShares" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_EquityBasedCompensationShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployees" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOtherShareSales" xlink:label="lbl_NumberOfOtherShareSales" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_NumberOfOtherShareSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareMovements" xlink:label="lbl_ShareMovements" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_ShareMovements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesWithRestrictedUse" xlink:label="lbl_TreasurySharesWithRestrictedUse" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasurySharesWithRestrictedUse" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StockRepurchaseProgramAuthorizedAmount1" xlink:label="lbl_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="lbl_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lbl_EntitysTotalForSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="lbl_SubsidiariesMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntitysTotalForSubsidiariesMember" xlink:to="lbl_SubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lbl_LegalEntityAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SocieteParActionsSANDOZAlgiersMember" xlink:label="lbl_SocieteParActionsSANDOZAlgiersMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SocieteParActionsSANDOZAlgiersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozManufacturingInc.Member" xlink:label="lbl_SandozManufacturingInc.Member" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozManufacturingInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:label="lbl_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:label="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisManufacturingGmbHMember" xlink:label="lbl_NovartisManufacturingGmbHMember" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisManufacturingGmbHMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTechnologyLLCMember" xlink:label="lbl_NovartisTechnologyLLCMember" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisTechnologyLLCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInflammasomeResearchInc.Member" xlink:label="lbl_NovartisInflammasomeResearchInc.Member" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInflammasomeResearchInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:label="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:label="lbl_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:label="lbl_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:type="locator"/>
      <link:definitionArc order="10.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImagingEquipmentLtdMember" xlink:label="lbl_ImagingEquipmentLtdMember" xlink:type="locator"/>
      <link:definitionArc order="11.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ImagingEquipmentLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IDBHollandBVMember" xlink:label="lbl_IDBHollandBVMember" xlink:type="locator"/>
      <link:definitionArc order="12.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_IDBHollandBVMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CELLforCUREMember" xlink:label="lbl_CELLforCUREMember" xlink:type="locator"/>
      <link:definitionArc order="13.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CELLforCUREMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisArgentinaS.A.BuenosAiresMember" xlink:label="lbl_NovartisArgentinaS.A.BuenosAiresMember" xlink:type="locator"/>
      <link:definitionArc order="14.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisArgentinaS.A.BuenosAiresMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosS.A.BuenosAiresMember" xlink:label="lbl_AlconLaboratoriosS.A.BuenosAiresMember" xlink:type="locator"/>
      <link:definitionArc order="15.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriosS.A.BuenosAiresMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:definitionArc order="16.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:definitionArc order="17.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPtyLtdMacquarieParkNSWMember" xlink:label="lbl_SandozPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:definitionArc order="18.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:definitionArc order="19.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAustriaGmbHViennaMember" xlink:label="lbl_NovartisAustriaGmbHViennaMember" xlink:type="locator"/>
      <link:definitionArc order="20.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisAustriaGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaGmbHViennaMember" xlink:label="lbl_NovartisPharmaGmbHViennaMember" xlink:type="locator"/>
      <link:definitionArc order="21.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozGmbHViennaMember" xlink:label="lbl_SandozGmbHViennaMember" xlink:type="locator"/>
      <link:definitionArc order="22.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconOphthalmikaGmbHViennaMember" xlink:label="lbl_AlconOphthalmikaGmbHViennaMember" xlink:type="locator"/>
      <link:definitionArc order="23.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconOphthalmikaGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:label="lbl_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:type="locator"/>
      <link:definitionArc order="24.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBangladeshLimitedGazipurMember" xlink:label="lbl_NovartisBangladeshLimitedGazipurMember" xlink:type="locator"/>
      <link:definitionArc order="25.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBangladeshLimitedGazipurMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaNVVilvoordeMember" xlink:label="lbl_NovartisPharmaNVVilvoordeMember" xlink:type="locator"/>
      <link:definitionArc order="26.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaNVVilvoordeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozNVVilvoordeMember" xlink:label="lbl_SandozNVVilvoordeMember" xlink:type="locator"/>
      <link:definitionArc order="27.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozNVVilvoordeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCouvreurNVPuursMember" xlink:label="lbl_AlconCouvreurNVPuursMember" xlink:type="locator"/>
      <link:definitionArc order="28.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCouvreurNVPuursMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:label="lbl_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:type="locator"/>
      <link:definitionArc order="29.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNVVilvoordeMember" xlink:label="lbl_AlconNVVilvoordeMember" xlink:type="locator"/>
      <link:definitionArc order="30.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconNVVilvoordeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInvestmentLtd.HamiltonMember" xlink:label="lbl_NovartisInvestmentLtd.HamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="31.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInvestmentLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:label="lbl_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="32.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceServicesLtd.HamiltonMember" xlink:label="lbl_NovartisFinanceServicesLtd.HamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="33.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceServicesLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisB2Ltd.HamiltonMember" xlink:label="lbl_NovartisB2Ltd.HamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="34.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisB2Ltd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisB3Ltd.HamiltonMember" xlink:label="lbl_NovartisB3Ltd.HamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="35.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisB3Ltd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:label="lbl_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="36.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:label="lbl_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:type="locator"/>
      <link:definitionArc order="37.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBiocienciasS.A.SaoPauloMember" xlink:label="lbl_NovartisBiocienciasS.A.SaoPauloMember" xlink:type="locator"/>
      <link:definitionArc order="38.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBiocienciasS.A.SaoPauloMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:label="lbl_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:type="locator"/>
      <link:definitionArc order="39.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:label="lbl_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:type="locator"/>
      <link:definitionArc order="40.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozCanadaInc.BouchervilleQuebecMember" xlink:label="lbl_SandozCanadaInc.BouchervilleQuebecMember" xlink:type="locator"/>
      <link:definitionArc order="41.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozCanadaInc.BouchervilleQuebecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCanadaInc.MississaugaOntarioMember" xlink:label="lbl_AlconCanadaInc.MississaugaOntarioMember" xlink:type="locator"/>
      <link:definitionArc order="42.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCanadaInc.MississaugaOntarioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:label="lbl_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:type="locator"/>
      <link:definitionArc order="43.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisChileS.A.SantiagoDeChileMember" xlink:label="lbl_NovartisChileS.A.SantiagoDeChileMember" xlink:type="locator"/>
      <link:definitionArc order="44.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisChileS.A.SantiagoDeChileMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:label="lbl_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:type="locator"/>
      <link:definitionArc order="45.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:label="lbl_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:type="locator"/>
      <link:definitionArc order="46.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:label="lbl_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:type="locator"/>
      <link:definitionArc order="47.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:label="lbl_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:type="locator"/>
      <link:definitionArc order="48.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:label="lbl_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:type="locator"/>
      <link:definitionArc order="49.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:label="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:type="locator"/>
      <link:definitionArc order="50.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:label="lbl_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:type="locator"/>
      <link:definitionArc order="51.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:label="lbl_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:type="locator"/>
      <link:definitionArc order="52.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconHongKongLimitedHongKongMember" xlink:label="lbl_AlconHongKongLimitedHongKongMember" xlink:type="locator"/>
      <link:definitionArc order="53.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconHongKongLimitedHongKongMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:label="lbl_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:type="locator"/>
      <link:definitionArc order="54.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:label="lbl_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:type="locator"/>
      <link:definitionArc order="55.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:label="lbl_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:type="locator"/>
      <link:definitionArc order="56.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:label="lbl_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:type="locator"/>
      <link:definitionArc order="57.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisS.r.o.PragueMember" xlink:label="lbl_NovartisS.r.o.PragueMember" xlink:type="locator"/>
      <link:definitionArc order="58.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisS.r.o.PragueMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.r.o.PragueMember" xlink:label="lbl_SandozS.r.o.PragueMember" xlink:type="locator"/>
      <link:definitionArc order="59.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.r.o.PragueMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:label="lbl_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:type="locator"/>
      <link:definitionArc order="60.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcareASCopenhagenMember" xlink:label="lbl_NovartisHealthcareASCopenhagenMember" xlink:type="locator"/>
      <link:definitionArc order="61.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHealthcareASCopenhagenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozASCopenhagenMember" xlink:label="lbl_SandozASCopenhagenMember" xlink:type="locator"/>
      <link:definitionArc order="62.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozASCopenhagenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNordicASCopenhagenMember" xlink:label="lbl_AlconNordicASCopenhagenMember" xlink:type="locator"/>
      <link:definitionArc order="63.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconNordicASCopenhagenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisEcuadorS.A.QuitoMember" xlink:label="lbl_NovartisEcuadorS.A.QuitoMember" xlink:type="locator"/>
      <link:definitionArc order="64.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisEcuadorS.A.QuitoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaS.A.E.CairoMember" xlink:label="lbl_NovartisPharmaS.A.E.CairoMember" xlink:type="locator"/>
      <link:definitionArc order="65.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaS.A.E.CairoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:label="lbl_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:type="locator"/>
      <link:definitionArc order="66.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinlandOyEspooMember" xlink:label="lbl_NovartisFinlandOyEspooMember" xlink:type="locator"/>
      <link:definitionArc order="67.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinlandOyEspooMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:label="lbl_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:type="locator"/>
      <link:definitionArc order="68.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:label="lbl_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:type="locator"/>
      <link:definitionArc order="69.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:label="lbl_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:type="locator"/>
      <link:definitionArc order="70.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CELLforCURELesUlisMember" xlink:label="lbl_CELLforCURELesUlisMember" xlink:type="locator"/>
      <link:definitionArc order="71.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CELLforCURELesUlisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.A.S.LevalloisPerretMember" xlink:label="lbl_SandozS.A.S.LevalloisPerretMember" xlink:type="locator"/>
      <link:definitionArc order="72.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.A.S.LevalloisPerretMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:label="lbl_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:type="locator"/>
      <link:definitionArc order="73.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeutschlandGmbHWehrMember" xlink:label="lbl_NovartisDeutschlandGmbHWehrMember" xlink:type="locator"/>
      <link:definitionArc order="74.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisDeutschlandGmbHWehrMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaGmbHNurembergMember" xlink:label="lbl_NovartisPharmaGmbHNurembergMember" xlink:type="locator"/>
      <link:definitionArc order="75.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaGmbHNurembergMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaProduktionsGmbHWehrMember" xlink:label="lbl_NovartisPharmaProduktionsGmbHWehrMember" xlink:type="locator"/>
      <link:definitionArc order="76.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaProduktionsGmbHWehrMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:label="lbl_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:type="locator"/>
      <link:definitionArc order="77.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WaveLightGmbHErlangenMember" xlink:label="lbl_WaveLightGmbHErlangenMember" xlink:type="locator"/>
      <link:definitionArc order="78.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_WaveLightGmbHErlangenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionGmbHGrosswallstadtMember" xlink:label="lbl_CIBAVisionGmbHGrosswallstadtMember" xlink:type="locator"/>
      <link:definitionArc order="79.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionGmbHGrosswallstadtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozInternationalGmbHHolzkirchenMember" xlink:label="lbl_SandozInternationalGmbHHolzkirchenMember" xlink:type="locator"/>
      <link:definitionArc order="80.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozInternationalGmbHHolzkirchenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1APharmaGmbHOberhachingMember" xlink:label="lbl_A1APharmaGmbHOberhachingMember" xlink:type="locator"/>
      <link:definitionArc order="81.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_A1APharmaGmbHOberhachingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SalutasPharmaGmbHBarlebenMember" xlink:label="lbl_SalutasPharmaGmbHBarlebenMember" xlink:type="locator"/>
      <link:definitionArc order="82.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SalutasPharmaGmbHBarlebenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_HEXALAGHolzkirchenMember" xlink:label="lbl_HEXALAGHolzkirchenMember" xlink:type="locator"/>
      <link:definitionArc order="83.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_HEXALAGHolzkirchenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AeropharmGmbHRudolstadtMember" xlink:label="lbl_AeropharmGmbHRudolstadtMember" xlink:type="locator"/>
      <link:definitionArc order="84.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AeropharmGmbHRudolstadtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBusinessServicesGmbHWehrMember" xlink:label="lbl_NovartisBusinessServicesGmbHWehrMember" xlink:type="locator"/>
      <link:definitionArc order="85.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBusinessServicesGmbHWehrMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovistaInsuranceLimitedGibraltarCityMember" xlink:label="lbl_NovistaInsuranceLimitedGibraltarCityMember" xlink:type="locator"/>
      <link:definitionArc order="86.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovistaInsuranceLimitedGibraltarCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:label="lbl_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:type="locator"/>
      <link:definitionArc order="87.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:label="lbl_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:type="locator"/>
      <link:definitionArc order="88.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:label="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:type="locator"/>
      <link:definitionArc order="89.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:label="lbl_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:type="locator"/>
      <link:definitionArc order="90.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIndiaLimitedMumbaiMember" xlink:label="lbl_NovartisIndiaLimitedMumbaiMember" xlink:type="locator"/>
      <link:definitionArc order="91.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisIndiaLimitedMumbaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:label="lbl_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:type="locator"/>
      <link:definitionArc order="92.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPrivateLimitedMumbaiMember" xlink:label="lbl_SandozPrivateLimitedMumbaiMember" xlink:type="locator"/>
      <link:definitionArc order="93.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPrivateLimitedMumbaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:label="lbl_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:type="locator"/>
      <link:definitionArc order="94.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PT.NovartisIndonesiaJakartaMember" xlink:label="lbl_PT.NovartisIndonesiaJakartaMember" xlink:type="locator"/>
      <link:definitionArc order="95.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_PT.NovartisIndonesiaJakartaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PT.CIBAVisionBatamBatamMember" xlink:label="lbl_PT.CIBAVisionBatamBatamMember" xlink:type="locator"/>
      <link:definitionArc order="96.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_PT.CIBAVisionBatamBatamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIrelandLimitedDublinMember" xlink:label="lbl_NovartisIrelandLimitedDublinMember" xlink:type="locator"/>
      <link:definitionArc order="97.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisIrelandLimitedDublinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:label="lbl_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:type="locator"/>
      <link:definitionArc order="98.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:label="lbl_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:type="locator"/>
      <link:definitionArc order="99.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIsraelLtd.PetachTikvaMember" xlink:label="lbl_NovartisIsraelLtd.PetachTikvaMember" xlink:type="locator"/>
      <link:definitionArc order="100.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisIsraelLtd.PetachTikvaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OptonolLtd.NeveIlanMember" xlink:label="lbl_OptonolLtd.NeveIlanMember" xlink:type="locator"/>
      <link:definitionArc order="101.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_OptonolLtd.NeveIlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaS.p.A.OriggioMember" xlink:label="lbl_NovartisFarmaS.p.A.OriggioMember" xlink:type="locator"/>
      <link:definitionArc order="102.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaS.p.A.OriggioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:label="lbl_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:type="locator"/>
      <link:definitionArc order="103.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.p.A.OriggioMember" xlink:label="lbl_SandozS.p.A.OriggioMember" xlink:type="locator"/>
      <link:definitionArc order="104.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.p.A.OriggioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:label="lbl_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:type="locator"/>
      <link:definitionArc order="105.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconItaliaS.p.A.MilanMember" xlink:label="lbl_AlconItaliaS.p.A.MilanMember" xlink:type="locator"/>
      <link:definitionArc order="106.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconItaliaS.p.A.MilanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHoldingJapanK.K.TokyoMember" xlink:label="lbl_NovartisHoldingJapanK.K.TokyoMember" xlink:type="locator"/>
      <link:definitionArc order="107.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHoldingJapanK.K.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaK.K.TokyoMember" xlink:label="lbl_NovartisPharmaK.K.TokyoMember" xlink:type="locator"/>
      <link:definitionArc order="108.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaK.K.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CibaGeigyJapanLimitedTokyoMember" xlink:label="lbl_CibaGeigyJapanLimitedTokyoMember" xlink:type="locator"/>
      <link:definitionArc order="109.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CibaGeigyJapanLimitedTokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozK.K.TokyoMember" xlink:label="lbl_SandozK.K.TokyoMember" xlink:type="locator"/>
      <link:definitionArc order="110.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozK.K.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconJapanLtd.TokyoMember" xlink:label="lbl_AlconJapanLtd.TokyoMember" xlink:type="locator"/>
      <link:definitionArc order="111.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconJapanLtd.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBalticsSIARigaMember" xlink:label="lbl_NovartisBalticsSIARigaMember" xlink:type="locator"/>
      <link:definitionArc order="112.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBalticsSIARigaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:label="lbl_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:type="locator"/>
      <link:definitionArc order="113.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceS.A.LuxembourgCityMember" xlink:label="lbl_NovartisFinanceS.A.LuxembourgCityMember" xlink:type="locator"/>
      <link:definitionArc order="114.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceS.A.LuxembourgCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:label="lbl_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:type="locator"/>
      <link:definitionArc order="115.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:label="lbl_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:type="locator"/>
      <link:definitionArc order="116.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:label="lbl_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:type="locator"/>
      <link:definitionArc order="117.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:label="lbl_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:definitionArc order="118.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.A.DeC.V.MexicoCityMember" xlink:label="lbl_SandozS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:definitionArc order="119.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.A.DeC.V.MexicoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:label="lbl_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:definitionArc order="120.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaMarocSACasablancaMember" xlink:label="lbl_NovartisPharmaMarocSACasablancaMember" xlink:type="locator"/>
      <link:definitionArc order="121.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaMarocSACasablancaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNetherlandsB.V.ArnhemMember" xlink:label="lbl_NovartisNetherlandsB.V.ArnhemMember" xlink:type="locator"/>
      <link:definitionArc order="122.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNetherlandsB.V.ArnhemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNetherlandsB.V.AmsterdamMember" xlink:label="lbl_NovartisNetherlandsB.V.AmsterdamMember" xlink:type="locator"/>
      <link:definitionArc order="123.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNetherlandsB.V.AmsterdamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaB.V.ArnhemMember" xlink:label="lbl_NovartisPharmaB.V.ArnhemMember" xlink:type="locator"/>
      <link:definitionArc order="124.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaB.V.ArnhemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaB.V.AmsterdamMember" xlink:label="lbl_NovartisPharmaB.V.AmsterdamMember" xlink:type="locator"/>
      <link:definitionArc order="125.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaB.V.AmsterdamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IDBHollandBVBaarleNassauMember" xlink:label="lbl_IDBHollandBVBaarleNassauMember" xlink:type="locator"/>
      <link:definitionArc order="126.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_IDBHollandBVBaarleNassauMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozB.V.AlmereMember" xlink:label="lbl_SandozB.V.AlmereMember" xlink:type="locator"/>
      <link:definitionArc order="127.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozB.V.AlmereMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNederlandB.V.ArnhemMember" xlink:label="lbl_AlconNederlandB.V.ArnhemMember" xlink:type="locator"/>
      <link:definitionArc order="128.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconNederlandB.V.ArnhemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNewZealandLtdAucklandMember" xlink:label="lbl_NovartisNewZealandLtdAucklandMember" xlink:type="locator"/>
      <link:definitionArc order="129.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNewZealandLtdAucklandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNorgeASOsloMember" xlink:label="lbl_NovartisNorgeASOsloMember" xlink:type="locator"/>
      <link:definitionArc order="130.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNorgeASOsloMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaPakistanLimitedKarachiMember" xlink:label="lbl_NovartisPharmaPakistanLimitedKarachiMember" xlink:type="locator"/>
      <link:definitionArc order="131.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaPakistanLimitedKarachiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:label="lbl_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:type="locator"/>
      <link:definitionArc order="132.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCentroamericaS.A.PanamaCityMember" xlink:label="lbl_AlconCentroamericaS.A.PanamaCityMember" xlink:type="locator"/>
      <link:definitionArc order="133.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCentroamericaS.A.PanamaCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBiosciencesPeruS.A.LimaMember" xlink:label="lbl_NovartisBiosciencesPeruS.A.LimaMember" xlink:type="locator"/>
      <link:definitionArc order="134.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBiosciencesPeruS.A.LimaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:label="lbl_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:type="locator"/>
      <link:definitionArc order="135.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPhilippinesCorporationManilaMember" xlink:label="lbl_SandozPhilippinesCorporationManilaMember" xlink:type="locator"/>
      <link:definitionArc order="136.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPhilippinesCorporationManilaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPolandSp.ZO.o.WarsawMember" xlink:label="lbl_NovartisPolandSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:definitionArc order="137.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPolandSp.ZO.o.WarsawMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPolskaSp.ZO.o.WarsawMember" xlink:label="lbl_SandozPolskaSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:definitionArc order="138.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPolskaSp.ZO.o.WarsawMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LekS.A.StrykowMember" xlink:label="lbl_LekS.A.StrykowMember" xlink:type="locator"/>
      <link:definitionArc order="139.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_LekS.A.StrykowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPolskaSp.ZO.o.WarsawMember" xlink:label="lbl_AlconPolskaSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:definitionArc order="140.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPolskaSp.ZO.o.WarsawMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:label="lbl_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:type="locator"/>
      <link:definitionArc order="141.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:label="lbl_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:type="locator"/>
      <link:definitionArc order="142.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozFarmaceuticaLda.PortoSalvoMember" xlink:label="lbl_SandozFarmaceuticaLda.PortoSalvoMember" xlink:type="locator"/>
      <link:definitionArc order="143.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozFarmaceuticaLda.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:label="lbl_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:type="locator"/>
      <link:definitionArc order="144.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:label="lbl_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:type="locator"/>
      <link:definitionArc order="145.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.R.L.TarguMuresMember" xlink:label="lbl_SandozS.R.L.TarguMuresMember" xlink:type="locator"/>
      <link:definitionArc order="146.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.R.L.TarguMuresMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconRomaniaS.R.L.BucharestMember" xlink:label="lbl_AlconRomaniaS.R.L.BucharestMember" xlink:type="locator"/>
      <link:definitionArc order="147.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconRomaniaS.R.L.BucharestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaLLCMoscowMember" xlink:label="lbl_NovartisPharmaLLCMoscowMember" xlink:type="locator"/>
      <link:definitionArc order="148.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaLLCMoscowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNevaLLCSt.PetersburgMember" xlink:label="lbl_NovartisNevaLLCSt.PetersburgMember" xlink:type="locator"/>
      <link:definitionArc order="149.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNevaLLCSt.PetersburgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZAOSandozMoscowMember" xlink:label="lbl_ZAOSandozMoscowMember" xlink:type="locator"/>
      <link:definitionArc order="150.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZAOSandozMoscowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconFarmacevtikaLLCMoscowMember" xlink:label="lbl_AlconFarmacevtikaLLCMoscowMember" xlink:type="locator"/>
      <link:definitionArc order="151.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconFarmacevtikaLLCMoscowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:label="lbl_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:type="locator"/>
      <link:definitionArc order="152.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSaudiLtd.RiyadhMember" xlink:label="lbl_NovartisSaudiLtd.RiyadhMember" xlink:type="locator"/>
      <link:definitionArc order="153.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSaudiLtd.RiyadhMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSingaporePteLtd.SingaporeMember" xlink:label="lbl_NovartisSingaporePteLtd.SingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="154.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSingaporePteLtd.SingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:label="lbl_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="155.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:label="lbl_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="156.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:label="lbl_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="157.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPteLtdSingaporeMember" xlink:label="lbl_AlconPteLtdSingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="158.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:label="lbl_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="159.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:label="lbl_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:type="locator"/>
      <link:definitionArc order="160.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSlovakiaS.r.o.BratislavaMember" xlink:label="lbl_NovartisSlovakiaS.r.o.BratislavaMember" xlink:type="locator"/>
      <link:definitionArc order="161.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSlovakiaS.r.o.BratislavaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LekPharmaceuticalsD.d.LjubjanaMember" xlink:label="lbl_LekPharmaceuticalsD.d.LjubjanaMember" xlink:type="locator"/>
      <link:definitionArc order="162.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_LekPharmaceuticalsD.d.LjubjanaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:label="lbl_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:type="locator"/>
      <link:definitionArc order="163.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSouthAfricaPtyLtdMidrandMember" xlink:label="lbl_NovartisSouthAfricaPtyLtdMidrandMember" xlink:type="locator"/>
      <link:definitionArc order="164.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSouthAfricaPtyLtdMidrandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:label="lbl_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:type="locator"/>
      <link:definitionArc order="165.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:label="lbl_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:type="locator"/>
      <link:definitionArc order="166.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisKoreaLtd.SeoulMember" xlink:label="lbl_NovartisKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:definitionArc order="167.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisKoreaLtd.SeoulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozKoreaLtd.SeoulMember" xlink:label="lbl_SandozKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:definitionArc order="168.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozKoreaLtd.SeoulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconKoreaLtd.SeoulMember" xlink:label="lbl_AlconKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:definitionArc order="169.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconKoreaLtd.SeoulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:label="lbl_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:type="locator"/>
      <link:definitionArc order="170.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:label="lbl_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:type="locator"/>
      <link:definitionArc order="171.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozFarmaceuticaS.A.MadridMember" xlink:label="lbl_SandozFarmaceuticaS.A.MadridMember" xlink:type="locator"/>
      <link:definitionArc order="172.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozFarmaceuticaS.A.MadridMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIndustrialProductsS.A.BarcelonaMember" xlink:label="lbl_SandozIndustrialProductsS.A.BarcelonaMember" xlink:type="locator"/>
      <link:definitionArc order="173.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozIndustrialProductsS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconHealthcareS.A.BarcelonaMember" xlink:label="lbl_AlconHealthcareS.A.BarcelonaMember" xlink:type="locator"/>
      <link:definitionArc order="174.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconHealthcareS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCusiS.A.BarcelonaMember" xlink:label="lbl_AlconCusiS.A.BarcelonaMember" xlink:type="locator"/>
      <link:definitionArc order="175.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCusiS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:label="lbl_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:type="locator"/>
      <link:definitionArc order="176.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSverigeABStockholmMember" xlink:label="lbl_NovartisSverigeABStockholmMember" xlink:type="locator"/>
      <link:definitionArc order="177.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSverigeABStockholmMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisOverseasInvestmentsAGBaselMember" xlink:label="lbl_NovartisOverseasInvestmentsAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="178.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisOverseasInvestmentsAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JapatAGBaselMember" xlink:label="lbl_JapatAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="179.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_JapatAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalAGBaselMember" xlink:label="lbl_NovartisInternationalAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="180.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInternationalAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHoldingAGBaselMember" xlink:label="lbl_NovartisHoldingAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="181.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHoldingAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:label="lbl_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="182.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisOphthalmicsAGFribourgMember" xlink:label="lbl_NovartisOphthalmicsAGFribourgMember" xlink:type="locator"/>
      <link:definitionArc order="183.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisOphthalmicsAGFribourgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBioventuresAGBaselMember" xlink:label="lbl_NovartisBioventuresAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="184.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBioventuresAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisForschungsstiftungBaselMember" xlink:label="lbl_NovartisForschungsstiftungBaselMember" xlink:type="locator"/>
      <link:definitionArc order="185.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisForschungsstiftungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisStiftungFuerKaderausbildungBaselMember" xlink:label="lbl_NovartisStiftungFuerKaderausbildungBaselMember" xlink:type="locator"/>
      <link:definitionArc order="186.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisStiftungFuerKaderausbildungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:label="lbl_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:type="locator"/>
      <link:definitionArc order="187.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:label="lbl_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:type="locator"/>
      <link:definitionArc order="188.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:label="lbl_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:type="locator"/>
      <link:definitionArc order="189.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaAGBaselMember" xlink:label="lbl_NovartisPharmaAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="190.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalPharmaceuticalAGBaselMember" xlink:label="lbl_NovartisInternationalPharmaceuticalAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="191.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInternationalPharmaceuticalAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaServicesAGBaselMember" xlink:label="lbl_NovartisPharmaServicesAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="192.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaServicesAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:label="lbl_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:type="locator"/>
      <link:definitionArc order="193.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSteinAGSteinMember" xlink:label="lbl_NovartisPharmaSteinAGSteinMember" xlink:type="locator"/>
      <link:definitionArc order="194.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaSteinAGSteinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSchweizAGRischMember" xlink:label="lbl_NovartisPharmaSchweizAGRischMember" xlink:type="locator"/>
      <link:definitionArc order="195.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaSchweizAGRischMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:label="lbl_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:type="locator"/>
      <link:definitionArc order="196.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:label="lbl_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:type="locator"/>
      <link:definitionArc order="197.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozAGBaselMember" xlink:label="lbl_SandozAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="198.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPharmaceuticalsAGRischMember" xlink:label="lbl_SandozPharmaceuticalsAGRischMember" xlink:type="locator"/>
      <link:definitionArc order="199.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPharmaceuticalsAGRischMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconAGFribourgMember" xlink:label="lbl_AlconAGFribourgMember" xlink:type="locator"/>
      <link:definitionArc order="200.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconAGFribourgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconManagementSAGenevaMember" xlink:label="lbl_AlconManagementSAGenevaMember" xlink:type="locator"/>
      <link:definitionArc order="201.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconManagementSAGenevaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconSwitzerlandSARischMember" xlink:label="lbl_AlconSwitzerlandSARischMember" xlink:type="locator"/>
      <link:definitionArc order="202.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconSwitzerlandSARischMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalsLtd.FribourgMember" xlink:label="lbl_AlconPharmaceuticalsLtd.FribourgMember" xlink:type="locator"/>
      <link:definitionArc order="203.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaceuticalsLtd.FribourgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGBaselMember" xlink:label="lbl_RocheHoldingAGBaselMember" xlink:type="locator"/>
      <link:definitionArc order="204.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_RocheHoldingAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:label="lbl_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:type="locator"/>
      <link:definitionArc order="205.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisThailandLimitedBangkokMember" xlink:label="lbl_NovartisThailandLimitedBangkokMember" xlink:type="locator"/>
      <link:definitionArc order="206.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisThailandLimitedBangkokMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesThailandLimitedBangkokMember" xlink:label="lbl_AlconLaboratoriesThailandLimitedBangkokMember" xlink:type="locator"/>
      <link:definitionArc order="207.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesThailandLimitedBangkokMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:label="lbl_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:definitionArc order="208.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:label="lbl_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:type="locator"/>
      <link:definitionArc order="209.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:label="lbl_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:type="locator"/>
      <link:definitionArc order="210.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:label="lbl_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:definitionArc order="211.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:label="lbl_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:type="locator"/>
      <link:definitionArc order="212.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:label="lbl_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:definitionArc order="213.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozUkraineLLCKievMember" xlink:label="lbl_SandozUkraineLLCKievMember" xlink:type="locator"/>
      <link:definitionArc order="214.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozUkraineLLCKievMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisMiddleEastFZEDubaiMember" xlink:label="lbl_NovartisMiddleEastFZEDubaiMember" xlink:type="locator"/>
      <link:definitionArc order="215.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisMiddleEastFZEDubaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUKLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:definitionArc order="216.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUKLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUKLimitedLondonMember" xlink:label="lbl_NovartisUKLimitedLondonMember" xlink:type="locator"/>
      <link:definitionArc order="217.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUKLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:definitionArc order="218.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:label="lbl_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:type="locator"/>
      <link:definitionArc order="219.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:definitionArc order="220.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGrimsbyLimitedLondonMember" xlink:label="lbl_NovartisGrimsbyLimitedLondonMember" xlink:type="locator"/>
      <link:definitionArc order="221.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisGrimsbyLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImagingEquipmentLtdLondonMember" xlink:label="lbl_ImagingEquipmentLtdLondonMember" xlink:type="locator"/>
      <link:definitionArc order="222.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ImagingEquipmentLtdLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VivactaLimitedFrimleyCamberleySurreyMember" xlink:label="lbl_VivactaLimitedFrimleyCamberleySurreyMember" xlink:type="locator"/>
      <link:definitionArc order="223.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_VivactaLimitedFrimleyCamberleySurreyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:label="lbl_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:type="locator"/>
      <link:definitionArc order="224.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedLondonMember" xlink:label="lbl_ZiarcoGroupLimitedLondonMember" xlink:type="locator"/>
      <link:definitionArc order="225.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZiarcoGroupLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozLimitedFrimleyCamberleyMember" xlink:label="lbl_SandozLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:definitionArc order="226.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:label="lbl_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:definitionArc order="227.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:label="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="locator"/>
      <link:definitionArc order="228.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCorporationEastHanoverNYMember" xlink:label="lbl_NovartisCorporationEastHanoverNYMember" xlink:type="locator"/>
      <link:definitionArc order="229.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCorporationEastHanoverNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceCorporationNewYorkNYMember" xlink:label="lbl_NovartisFinanceCorporationNewYorkNYMember" xlink:type="locator"/>
      <link:definitionArc order="230.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceCorporationNewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceCorporationEastHanoverNJMember" xlink:label="lbl_NovartisFinanceCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="231.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceCorporationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCapitalCorporationNewYorkNYMember" xlink:label="lbl_NovartisCapitalCorporationNewYorkNYMember" xlink:type="locator"/>
      <link:definitionArc order="232.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCapitalCorporationNewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCapitalCorporationEastHanoverNJMember" xlink:label="lbl_NovartisCapitalCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="233.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCapitalCorporationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisServicesInc.EastHanoverNYMember" xlink:label="lbl_NovartisServicesInc.EastHanoverNYMember" xlink:type="locator"/>
      <link:definitionArc order="234.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisServicesInc.EastHanoverNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUSFoundationNewYorkNYMember" xlink:label="lbl_NovartisUSFoundationNewYorkNYMember" xlink:type="locator"/>
      <link:definitionArc order="235.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUSFoundationNewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUSFoundationEastHanoverNJMember" xlink:label="lbl_NovartisUSFoundationEastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="236.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUSFoundationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:label="lbl_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:type="locator"/>
      <link:definitionArc order="237.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:label="lbl_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:type="locator"/>
      <link:definitionArc order="238.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:label="lbl_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:type="locator"/>
      <link:definitionArc order="239.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CortheraInc.SanMateoCAMember" xlink:label="lbl_CortheraInc.SanMateoCAMember" xlink:type="locator"/>
      <link:definitionArc order="240.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CortheraInc.SanMateoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:label="lbl_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:type="locator"/>
      <link:definitionArc order="241.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionInc.NewYorkNYMember" xlink:label="lbl_EncoreVisionInc.NewYorkNYMember" xlink:type="locator"/>
      <link:definitionArc order="242.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EncoreVisionInc.NewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionInc.EastHanoverNJMember" xlink:label="lbl_EncoreVisionInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="243.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EncoreVisionInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteInc.LafayetteINMember" xlink:label="lbl_EndocyteInc.LafayetteINMember" xlink:type="locator"/>
      <link:definitionArc order="244.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EndocyteInc.LafayetteINMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteInc.EastHanoverNJMember" xlink:label="lbl_EndocyteInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="245.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EndocyteInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:label="lbl_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:type="locator"/>
      <link:definitionArc order="246.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:label="lbl_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="247.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:label="lbl_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:type="locator"/>
      <link:definitionArc order="248.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:label="lbl_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="249.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:label="lbl_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:type="locator"/>
      <link:definitionArc order="250.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:label="lbl_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:type="locator"/>
      <link:definitionArc order="251.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AveXisInc.BannockburnILMember" xlink:label="lbl_AveXisInc.BannockburnILMember" xlink:type="locator"/>
      <link:definitionArc order="252.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AveXisInc.BannockburnILMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:label="lbl_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="253.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:label="lbl_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="254.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozInc.PrincetonNJMember" xlink:label="lbl_SandozInc.PrincetonNJMember" xlink:type="locator"/>
      <link:definitionArc order="255.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozInc.PrincetonNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OrielTherapeuticsInc.DurhamNCMember" xlink:label="lbl_OrielTherapeuticsInc.DurhamNCMember" xlink:type="locator"/>
      <link:definitionArc order="256.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_OrielTherapeuticsInc.DurhamNCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:label="lbl_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:type="locator"/>
      <link:definitionArc order="257.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EonLabsInc.PrincetonNJMember" xlink:label="lbl_EonLabsInc.PrincetonNJMember" xlink:type="locator"/>
      <link:definitionArc order="258.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_EonLabsInc.PrincetonNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesInc.FortWorthTXMember" xlink:label="lbl_AlconLaboratoriesInc.FortWorthTXMember" xlink:type="locator"/>
      <link:definitionArc order="259.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesInc.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:label="lbl_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:type="locator"/>
      <link:definitionArc order="260.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconResearchLtd.FortWorthTXMember" xlink:label="lbl_AlconResearchLtd.FortWorthTXMember" xlink:type="locator"/>
      <link:definitionArc order="261.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconResearchLtd.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLensxInc.AlisoViejoCAMember" xlink:label="lbl_AlconLensxInc.AlisoViejoCAMember" xlink:type="locator"/>
      <link:definitionArc order="262.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLensxInc.AlisoViejoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:label="lbl_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:type="locator"/>
      <link:definitionArc order="263.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WaveLightInc.SterlingVAMember" xlink:label="lbl_WaveLightInc.SterlingVAMember" xlink:type="locator"/>
      <link:definitionArc order="264.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_WaveLightInc.SterlingVAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TearFilmInnovationsInc.FortWorthTXMember" xlink:label="lbl_TearFilmInnovationsInc.FortWorthTXMember" xlink:type="locator"/>
      <link:definitionArc order="265.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TearFilmInnovationsInc.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TrueVisionSystemsInc.FortWorthTXMember" xlink:label="lbl_TrueVisionSystemsInc.FortWorthTXMember" xlink:type="locator"/>
      <link:definitionArc order="266.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TrueVisionSystemsInc.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionCorporationLLCDuluthGAMember" xlink:label="lbl_CIBAVisionCorporationLLCDuluthGAMember" xlink:type="locator"/>
      <link:definitionArc order="267.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionCorporationLLCDuluthGAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:label="lbl_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:type="locator"/>
      <link:definitionArc order="268.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:label="lbl_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:definitionArc order="269.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:label="lbl_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:type="locator"/>
      <link:definitionArc order="270.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalInc.LakeForestILMember" xlink:label="lbl_TranscendMedicalInc.LakeForestILMember" xlink:type="locator"/>
      <link:definitionArc order="271.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_TranscendMedicalInc.LakeForestILMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeVenezuelaS.A.CaracasMember" xlink:label="lbl_NovartisDeVenezuelaS.A.CaracasMember" xlink:type="locator"/>
      <link:definitionArc order="272.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisDeVenezuelaS.A.CaracasMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalC.A.CaracasMember" xlink:label="lbl_AlconPharmaceuticalC.A.CaracasMember" xlink:type="locator"/>
      <link:definitionArc order="273.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaceuticalC.A.CaracasMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsAAAMember" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="locator"/>
      <link:definitionArc order="274.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NameOfSubsidiary" xlink:label="lbl_NameOfSubsidiary" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_NameOfSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="lbl_PrincipalPlaceOfBusinessOfSubsidiary" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_PrincipalPlaceOfBusinessOfSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:label="lbl_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharePaidinCapital" xlink:label="lbl_SharePaidinCapital" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_SharePaidinCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:label="lbl_ProportionOfVotingPowerHeldInSubsidiary" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_ProportionOfVotingPowerHeldInSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:label="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisManufacturingGmbHMarburgMember" xlink:label="lbl_NovartisManufacturingGmbHMarburgMember" xlink:type="locator"/>
      <link:definitionArc order="5.5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisManufacturingGmbHMarburgMember" xlink:type="arc"/>
   </link:definitionLink>
   <link:definitionLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:definitionArc order="1.0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="lbl_StatementLineItems" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="1.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="2.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetAdditionalInformationTableTextBlock" xlink:label="lbl_BalanceSheetAdditionalInformationTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="3.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_BalanceSheetAdditionalInformationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:label="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="4.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:label="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="5.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:label="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="6.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="7.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:label="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="8.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:type="locator"/>
      <link:definitionArc order="9.0" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:type="arc"/>
   </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>12
<FILENAME>nvs-20191231.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by MDD - e-reporting v3 -->
<!-- Created by MDD - Management Digital Data AG, Switzerland -->
<xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nvs="http://novartis.com/20191231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ns0="http://www.novartis.com/custom-units">
  <link:schemaRef xlink:type="simple" xlink:href="nvs-20191231.xsd" />
  <xbrli:context id="AR_I-CurrentYearEnd">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Alcon-3-April-8">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-08</xbrli:startDate>
      <xbrli:endDate>2019-04-08</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYearStart">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-01-01</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NoncurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:ContinuingOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CyPassMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CyPassMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NoncurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NoncurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:PowerVisionInc.Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:PowerVisionInc.Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-03-01</xbrli:startDate>
      <xbrli:endDate>2019-03-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-2-March-31_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4BorrowingsUSDMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:BorrowingsUSDMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4BorrowingsEURMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:BorrowingsEURMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-03-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-08</xbrli:startDate>
      <xbrli:endDate>2019-04-08</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-4-April-9_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-04-09</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongTermFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:PensionsAndOtherBenefitObligationsOfAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:OtherAssetsProvisionsAccrualsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InventoriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:TaxLossCarryforwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-08</xbrli:startDate>
      <xbrli:endDate>2019-04-08</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-04-08</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DiscontinuedOperationsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:CountryOfDomicileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">ifrs-full:ForeignCountriesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CommoditiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CommoditiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019RUB">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:RUB</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019RUB">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:RUB</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CNY">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CNY">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CNY</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019GBP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019GBP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:GBP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019BRL">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019BRL">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:BRL</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CAD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CAD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CAD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019AUD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019AUD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CHF">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CHF">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">nvs:CurrencyOthersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">nvs:CurrencyOthersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019CurrentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">nvs:ProvisionForDoubtfulReceivableMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019CurrentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019NotLaterThanOneMonthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019NotLaterThanOneMonthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanSixMonthsAndNotLaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanSixMonthsAndNotLaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019JPY">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019JPY">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AlconBrandNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AlconBrandNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AlconBrandNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019LegalProceedingsProvisionMember_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:LegalProceedingsProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NPCAndOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:NPCAndOthersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ReclastAclastaMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NPCAndOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:NPCAndOthersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ReclastAclastaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TaxotereMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TaxotereMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AmiodaroneMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AmiodaroneMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EnoxaparinMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EnoxaparinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EnoxaparinMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember_srt-2018LitigationCaseAxis_nvs-2019Q4TennesseeClassActionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EnoxaparinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">nvs:TennesseeClassActionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EnoxaparinMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember_srt-2018LitigationCaseAxis_nvs-2019Q4MassachusettsCaseMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EnoxaparinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">nvs:MassachusettsCaseMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfDiscountRatesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeInActuarialAssumptionAxis">nvs:Change25BasisPointMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeInActuarialAssumptionAxis">nvs:Change25BasisPointMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeInActuarialAssumptionAxis">nvs:Change25BasisPointMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17IT_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NAGAndNovartisPharmaSpAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:NAGAndNovartisPharmaSpAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17IT_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NovartisPharmaKKMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:NovartisPharmaKKMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:JP</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsAndNotLaterThanTenYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsAndNotLaterThanTenYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanTenYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableForSaleMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableForSaleMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AvailableforsaleLongtermFinancialInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AvailableforsaleLongtermFinancialInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:EquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AvailableforsaleLongtermFinancialInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AvailableforsaleLongtermFinancialInvestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:AccruedInterestOnDebtSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:AccruedInterestOnDebtSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:TimeDepositsWithOriginalMaturityMoreThan90DaysMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:TimeDepositsWithOriginalMaturityMoreThan90DaysMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4StraightBondsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:StraightBondsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4StraightBondsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:StraightBondsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LiabilitiesToBanksAndOtherFinancialInstitutionsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:LiabilitiesToBanksAndOtherFinancialInstitutionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LiabilitiesToBanksAndOtherFinancialInstitutionsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:LiabilitiesToBanksAndOtherFinancialInstitutionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FinanceLeaseObligationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:FinanceLeaseObligationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FinanceLeaseObligationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:FinanceLeaseObligationsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:CurrentPortionOfNoncurrentDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:CurrentPortionOfNoncurrentDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:NoncurrentFinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TradePayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TradePayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TradePayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TradePayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_ifrsfull-2019LeaseLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4InterestBearningAccountsOfAssociatesPayableOnDemandMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:InterestBearningAccountsOfAssociatesPayableOnDemandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4InterestBearningAccountsOfAssociatesPayableOnDemandMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:InterestBearningAccountsOfAssociatesPayableOnDemandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4BankAndOtherFinancialDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:BankAndOtherFinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4BankAndOtherFinancialDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:BankAndOtherFinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CommercialPaperMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:CommercialPaperMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CommercialPaperMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:CommercialPaperMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:CurrentPortionOfNoncurrentDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CurrentFinancialDebtMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:CurrentPortionOfNoncurrentDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationAndOtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:ContingentConsiderationAndOtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationAndOtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:ContingentConsiderationAndOtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetItemAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TotalAvailableforsaleMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TotalAvailableforsaleMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TotalAvailableforsaleMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TotalAvailableforsaleMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TimeDepositsWithOriginalMaturityMoreThan90DaysMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TimeDepositsWithOriginalMaturityMoreThan90DaysMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AccruedInterestOnDebtSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TotalAvailableforsaleMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TotalAvailableforsaleMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TimeDepositsWithOriginalMaturityMoreThan90DaysMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:TimeDepositsWithOriginalMaturityMoreThan90DaysMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AvailableforsaleFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AvailableforsaleFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AvailableforsaleFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AccruedInterestOnDebtSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AvailableforsaleFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AvailableforsaleFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AvailableforsaleFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">nvs:ValuedAtAmortizedCostMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialInvestmentsAndLongtermLoansGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019DisposalGroupsClassifiedAsHeldForSaleMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019DisposalGroupsClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis">ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:WeightedAverageMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ZiarcoGroupLimitedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-20</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ZiarcoGroupLimitedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-20</xbrli:startDate>
      <xbrli:endDate>2017-01-20</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EncoreVisionIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-20</xbrli:startDate>
      <xbrli:endDate>2017-01-20</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EncoreVisionIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-01-20</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AveXisInc.BannockburnILMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CoStimPharmaceuticalsInc.CambridgeMAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CoStimPharmaceuticalsInc.CambridgeMAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NavigateBioPharmaServicesInc.CarlsbadCAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NavigateBioPharmaServicesInc.CarlsbadCAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ReprixysPharmaceuticalsCorporationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ReprixysPharmaceuticalsCorporationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozInc.PrincetonNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozInc.PrincetonNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:OrielTherapeuticsInc.DurhamNCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:OrielTherapeuticsInc.DurhamNCMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:FougeraPharmaceuticalsInc.MelvilleNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:FougeraPharmaceuticalsInc.MelvilleNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EonLabsInc.PrincetonNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EonLabsInc.PrincetonNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisDeVenezuelaS.A.CaracasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHealthcarePrivateLimitedMumbaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHealthcarePrivateLimitedMumbaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPrivateLimitedMumbaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPrivateLimitedMumbaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:PT.NovartisIndonesiaJakartaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:PT.NovartisIndonesiaJakartaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisIrelandLimitedDublinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisIrelandLimitedDublinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisIsraelLtd.PetachTikvaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisIsraelLtd.PetachTikvaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaS.p.A.OriggioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaS.p.A.OriggioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.p.A.OriggioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.p.A.OriggioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHoldingJapanK.K.TokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHoldingJapanK.K.TokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaK.K.TokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaK.K.TokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CibaGeigyJapanLimitedTokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CibaGeigyJapanLimitedTokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozK.K.TokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozK.K.TokyoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBalticsSIARigaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBalticsSIARigaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInvestmentsS.aR.l.LuxembourgCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInvestmentsS.aR.l.LuxembourgCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinanceS.A.LuxembourgCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinanceS.A.LuxembourgCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.A.DeC.V.MexicoCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.A.DeC.V.MexicoCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaMarocSACasablancaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaMarocSACasablancaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozB.V.AlmereMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozB.V.AlmereMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNewZealandLtdAucklandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNewZealandLtdAucklandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNorgeASOsloMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNorgeASOsloMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaPakistanLimitedKarachiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaPakistanLimitedKarachiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaLogisticsInc.PanamaCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaLogisticsInc.PanamaCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBiosciencesPeruS.A.LimaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBiosciencesPeruS.A.LimaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHealthcarePhilippinesInc.ManilaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHealthcarePhilippinesInc.ManilaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPhilippinesCorporationManilaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPhilippinesCorporationManilaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPolandSp.ZO.o.WarsawMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPolandSp.ZO.o.WarsawMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPolskaSp.ZO.o.WarsawMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPolskaSp.ZO.o.WarsawMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:LekS.A.StrykowMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:LekS.A.StrykowMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPortugalSGPSLda.PortoSalvoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPortugalSGPSLda.PortoSalvoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozFarmaceuticaLda.PortoSalvoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozFarmaceuticaLda.PortoSalvoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaServicesRomaniaS.R.L.BucharestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaServicesRomaniaS.R.L.BucharestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.R.L.TarguMuresMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.R.L.TarguMuresMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaLLCMoscowMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaLLCMoscowMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNevaLLCSt.PetersburgMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNevaLLCSt.PetersburgMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ZAOSandozMoscowMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ZAOSandozMoscowMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSingaporePteLtd.SingaporeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSingaporePteLtd.SingaporeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSlovakiaS.r.o.BratislavaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSlovakiaS.r.o.BratislavaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:LekPharmaceuticalsD.d.LjubjanaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:LekPharmaceuticalsD.d.LjubjanaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPharmaceuticalsD.d.LjubjanaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPharmaceuticalsD.d.LjubjanaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSouthAfricaPtyLtdMidrandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSouthAfricaPtyLtdMidrandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozSouthAfricaPtyLtdKemptonParkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozSouthAfricaPtyLtdKemptonParkMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisKoreaLtd.SeoulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisKoreaLtd.SeoulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaceuticaS.A.BarcelonaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFarmaceuticaS.A.BarcelonaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozFarmaceuticaS.A.MadridMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozFarmaceuticaS.A.MadridMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozIndustrialProductsS.A.BarcelonaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozIndustrialProductsS.A.BarcelonaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AlconCusiS.A.BarcelonaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AlconCusiS.A.BarcelonaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AbadiaRetuertaS.A.SardonDeDueroValladolidMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AbadiaRetuertaS.A.SardonDeDueroValladolidMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSverigeABStockholmMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSverigeABStockholmMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInternationalAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInternationalAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHoldingAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHoldingAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInternationalPharmaceuticalInvestmentAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInternationalPharmaceuticalInvestmentAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBioventuresAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBioventuresAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisForschungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisForschungsstiftungBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerKaderausbildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisStiftungFuerKaderausbildungBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMitarbeiterbeteiligungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisMitarbeiterbeteiligungsstiftungBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerMenschUndUmweltBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisStiftungFuerMenschUndUmweltBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisOverseasInvestmentsAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisOverseasInvestmentsAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:JapatAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:JapatAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInternationalPharmaceuticalAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInternationalPharmaceuticalAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaServicesAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaServicesAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaSchweizerhalleAGMuttenzMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaSchweizerhalleAGMuttenzMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaSteinAGSteinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaSteinAGSteinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaSchweizAGRischMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaSchweizAGRischMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisOphthalmicsAGFribourgMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisOphthalmicsAGFribourgMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsInternationalSAGeneveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsInternationalSAGeneveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPharmaceuticalsAGRischMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPharmaceuticalsAGRischMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4RocheHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:RocheHoldingAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisTaiwanCo.Ltd.TaipeiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisTaiwanCo.Ltd.TaipeiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisThailandLimitedBangkokMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisThailandLimitedBangkokMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozIlacSanayiVeTicaretA.S.IstanbulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozIlacSanayiVeTicaretA.S.IstanbulMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozUkraineLLCKievMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozUkraineLLCKievMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisMiddleEastFZEDubaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisMiddleEastFZEDubaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozLimitedFrimleyCamberleyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozLimitedFrimleyCamberleyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisCorporationEastHanoverNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisCorporationEastHanoverNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisServicesInc.EastHanoverNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisServicesInc.EastHanoverNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsCorporationEastHanoverNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsCorporationEastHanoverNYMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AveXisInc.BannockburnILMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SocieteParActionsSANDOZAlgiersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SocieteParActionsSANDOZAlgiersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisArgentinaS.A.BuenosAiresMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisArgentinaS.A.BuenosAiresMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisAustraliaPtyLtdMacquarieParkNSWMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisAustraliaPtyLtdMacquarieParkNSWMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPtyLtdMacquarieParkNSWMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozPtyLtdMacquarieParkNSWMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisAustriaGmbHViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisAustriaGmbHViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaGmbHViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaGmbHViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozGmbHViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozGmbHViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EBEWEPharmaGes.m.b.HNfg.KGViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EBEWEPharmaGes.m.b.HNfg.KGViennaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBangladeshLimitedGazipurMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBangladeshLimitedGazipurMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaNVVilvoordeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaNVVilvoordeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozNVVilvoordeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozNVVilvoordeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AlconCouvreurNVPuursMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AlconCouvreurNVPuursMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInvestmentLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInvestmentLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSecuritiesInvestmentLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSecuritiesInvestmentLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinanceServicesLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinanceServicesLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TriangleInternationalReinsuranceLimitedHamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TriangleInternationalReinsuranceLimitedHamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TrinityRiverInsuranceCoLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TrinityRiverInsuranceCoLtd.HamiltonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBiocienciasS.A.SaoPauloMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisBiocienciasS.A.SaoPauloMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozCanadaInc.BouchervilleQuebecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozCanadaInc.BouchervilleQuebecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CIBAVisionCanadaInc.MississaugaOntarioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CIBAVisionCanadaInc.MississaugaOntarioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisChileS.A.SantiagoDeChileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisChileS.A.SantiagoDeChileMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:BeijingNovartisPharmaCo.Ltd.BeijingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:BeijingNovartisPharmaCo.Ltd.BeijingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsHKLimitedHongKongMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsHKLimitedHongKongMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ShanghaiNovartisTradingLtd.ShanghaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ShanghaiNovartisTradingLtd.ShanghaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisDeColombiaS.A.SantafeDeBobotaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisDeColombiaS.A.SantafeDeBobotaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozD.o.o.FarmaceutskaIndustrijaZagrebMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozD.o.o.FarmaceutskaIndustrijaZagrebMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisS.r.o.PragueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisS.r.o.PragueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.r.o.PragueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.r.o.PragueMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHealthcareASCopenhagenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHealthcareASCopenhagenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozASCopenhagenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozASCopenhagenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisEcuadorS.A.QuitoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisEcuadorS.A.QuitoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaS.A.E.CairoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaS.A.E.CairoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozEgyptPharmaS.A.E.NewCairoCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozEgyptPharmaS.A.E.NewCairoCityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinlandOyEspooMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinlandOyEspooMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisGroupeFranceS.A.RueilMalmaisonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisGroupeFranceS.A.RueilMalmaisonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaS.A.S.RueilMalmaisonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaS.A.S.RueilMalmaisonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.A.S.LevalloisPerretMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozS.A.S.LevalloisPerretMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisDeutschlandGmbHWehrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisDeutschlandGmbHWehrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaGmbHNurembergMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaGmbHNurembergMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaProduktionsGmbHWehrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaProduktionsGmbHWehrMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozInternationalGmbHHolzkirchenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozInternationalGmbHHolzkirchenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:A1APharmaGmbHOberhachingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:A1APharmaGmbHOberhachingMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:HEXALAGHolzkirchenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:HEXALAGHolzkirchenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SalutasPharmaGmbHBarlebenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SalutasPharmaGmbHBarlebenMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AeropharmGmbHRudolstadtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AeropharmGmbHRudolstadtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHellasS.A.C.I.MetamorphosisAthensMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHellasS.A.C.I.MetamorphosisAthensMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozHungaryLimitedLiabilityCompanyBudapestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SandozHungaryLimitedLiabilityCompanyBudapestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisIndiaLimitedMumbaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisIndiaLimitedMumbaiMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisManufacturingGmbHMarburgMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisDeVenezuelaS.A.CaracasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisManufacturingGmbHMarburgMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SpinifexPharmaceuticalsInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SpinifexPharmaceuticalsInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInflammasomeResearchInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisInflammasomeResearchInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTechnologyLLCInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisTechnologyLLCInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EncoreVisionInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EncoreVisionInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EndocyteInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EndocyteInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CELLforCURELesUlisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:CELLforCURELesUlisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNetherlandsB.V.AmsterdamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisNetherlandsB.V.AmsterdamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaB.V.AmsterdamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaB.V.AmsterdamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:IDBHollandBVBaarleNassauMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:IDBHollandBVBaarleNassauMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSaudiLtd.RiyadhMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisSaudiLtd.RiyadhMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisUKLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisUKLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsUKLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisPharmaceuticalsUKLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisGrimsbyLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisGrimsbyLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ImagingEquipmentLtdLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ImagingEquipmentLtdLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:VivactaLimitedFrimleyCamberleySurreyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:VivactaLimitedFrimleyCamberleySurreyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ZiarcoGroupLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:ZiarcoGroupLimitedLondonMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinanceCorporationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisFinanceCorporationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisCapitalCorporationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisCapitalCorporationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUSFoundationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:NovartisUSFoundationEastHanoverNJMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:PreviouslyStatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">ifrs-full:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:KeyManagementPersonnelOfEntityOrParentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KisqaliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KisqaliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KisqaliMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LutatheraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LutatheraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LutatheraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KymriahMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KymriahMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KymriahMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KymriahMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KymriahMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KymriahMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PiqrayMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PiqrayMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XiidraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XiidraMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4BeovuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:BeovuMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZolgensmaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZolgensmaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AimovigMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AimovigMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AimovigMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AimovigMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4MayzentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:MayzentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:UltibroBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:UltibroBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:UltibroBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SeebriBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SeebriBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SeebriBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OnbrezBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OnbrezBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:COPDMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OnbrezBreezhalerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:NeoralSandimmunEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:NeoralSandimmunEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:NeoralSandimmunEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VoltarenCataflamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VoltarenCataflamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VoltarenCataflamMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AlconBrandNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:IntangibleAssetsAndGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:DE</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019FinancialAssetsImpairedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:FinancialAssetsImpairedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019FinancialAssetsImpairedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:FinancialAssetsImpairedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019FinancialAssetsImpairedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:FinancialAssetsImpairedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:IntangibleAssetsOtherThanGoodwillMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:RestructuringProvisionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019LandMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:LandMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019BuildingsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019VehiclesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019VehiclesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019VehiclesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019OtherAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:OtherAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019USD">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalValueAdjustmentsAttributableToNovartisShareholdersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:RestatedValueAdjustmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-TheMedicinesCompany_dei-2019LegalEntityAxis_nvs-2019Q4TheMedicinesCompanyMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TheMedicinesCompanyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-11-23</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:IFMTreInc.Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-05-07</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:IFMTreInc.Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-07</xbrli:startDate>
      <xbrli:endDate>2019-05-07</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TakedaPharmaceuticalCompanyLimitedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-05-08</xbrli:startDate>
      <xbrli:endDate>2019-05-08</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TakedaPharmaceuticalCompanyLimitedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-05-08</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VoltarenCataflamMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VoltarenCataflamMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:NeoralSandimmunEMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:NeoralSandimmunEMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:NeoralSandimmunEMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:RestOfPortfolioMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KisqaliMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KisqaliMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:KisqaliMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TafinlarMekinistMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:AfinitorVotubiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExjadeJadenuMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GalvusGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SandostatinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RespiratoryMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:JakaviMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:PromactaRevoladeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:DiovanGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:NeuroscienceMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GilenyaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:OtherProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:VotrientMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SerelaxinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:SerelaxinMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:GleevecGlivecMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:IlarisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ZortressCerticanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:ImmunologyHepatologyAndDermatologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:CosentyxMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:OncologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TasignaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:EstablishedMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:ExforgeGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:OphthalmologyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:TravoprostGroupMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:RestOfTheWorldMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:BusinessUnitAxis">nvs:PharmaceuticalMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:CardioMetabolicMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:EntrestoMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:Top20ProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:InnovativeMedicinesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RetailGenericsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RetailGenericsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:BiopharmaceuticalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:BiopharmaceuticalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:BiopharmaceuticalsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:AntiInfectivesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:AntiInfectivesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:AntiInfectivesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4AntiInfectivesSoldUnderSandozNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:AntiInfectivesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:AntiInfectivesSoldUnderSandozNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4AntiInfectivesSoldUnderSandozNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:AntiInfectivesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:AntiInfectivesSoldUnderSandozNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4AntiInfectivesSoldUnderSandozNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:AntiInfectivesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ProductPortfolioAxis">nvs:AntiInfectivesSoldUnderSandozNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FranchiseAxis">nvs:RetailGenericsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-09-06</xbrli:startDate>
      <xbrli:endDate>2018-09-06</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-AspenGlobalIncorporation_dei-2019LegalEntityAxis_nvs-2019Q4AspenGlobalIncorporatedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AspenGlobalIncorporatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-11-11</xbrli:startDate>
      <xbrli:endDate>2019-11-11</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-AspenGlobalIncorporation_dei-2019LegalEntityAxis_nvs-2019Q4AspenGlobalIncorporatedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AspenGlobalIncorporatedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-11-11</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:SandozMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-04-08</xbrli:startDate>
      <xbrli:endDate>2019-04-08</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-04-08</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-06-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-06-30</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:RocheHoldingAGMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:OthersAssociatesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:RealEstateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AlternativeInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AlternativeInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:AlternativeInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:CashAndOtherInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:CashAndOtherInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:PensionPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">nvs:CashAndOtherInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:PensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:UnfundedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:ActiveMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ObligationByTypeAxis">nvs:DeferredPensionersMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:RetirementPlanTypeAxis">nvs:OtherPostemploymentBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice54.5Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.6Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice66.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice54.5Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.6Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice66.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.6Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice66.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice54.5Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice57.6Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice54.5Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">nvs:ExercisePrice66.0Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-AAA_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsAAAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-10-30</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsAAAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-01-22</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AdvancedAcceleratorApplicationsAAAMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-22</xbrli:startDate>
      <xbrli:endDate>2018-01-22</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Avexis_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AveXisIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-04-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AveXisIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-05-15</xbrli:startDate>
      <xbrli:endDate>2018-05-15</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:AveXisIncMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-05-15</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EndocyteMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-21</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:EndocyteMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-12-21</xbrli:startDate>
      <xbrli:endDate>2018-12-21</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-GSK-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4GSKConsumerHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:GSKConsumerHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-03-27</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-GSK-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4GSKConsumerHealthcareMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:GSKConsumerHealthcareMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-03-27</xbrli:startDate>
      <xbrli:endDate>2018-03-27</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-09-06</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:SandozMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-09-06</xbrli:startDate>
      <xbrli:endDate>2018-09-06</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:AlconMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4AlconMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:AlconMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">nvs:CorporateMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">nvs:OtherCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">nvs:OtherCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">nvs:OtherCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">nvs:OtherCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">nvs:OtherCountriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:AsiaAfricaAustralasiaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:LargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:LargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:LargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:SecondLargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:SecondLargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:SecondLargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:ThirdLargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:ThirdLargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">nvs:ThirdLargestCustomerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:LucentisMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">nvs:XolairMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:USMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:CanadaAndLatinAmericaMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EstablishedMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">nvs:EmergingGrowthMarketsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4ReclassificationToPresentationRequiredUnderIFRS9Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnMarketableSecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:ReclassificationToPresentationRequiredUnderIFRS9Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDebtSecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnDeferredCashFlowHedgesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4ReclassificationToPresentationRequiredUnderIFRS9Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:ReclassificationToPresentationRequiredUnderIFRS9Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:FairValueAdjustmentsOnEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:ActuarialLossesFromDefinedBenefitPlansMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:CumulativeCurrencyTranslationEffectsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">nvs:TotalFairValueAdjustmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:AlconBrandNameMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:CurrentlyMarketedProductsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">nvs:MarketingRelatedIntangibleAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:PensionsAndOtherBenefitObligationsOfAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:PensionsAndOtherBenefitObligationsOfAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:PensionsAndOtherBenefitObligationsOfAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:PensionsAndOtherBenefitObligationsOfAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:PensionsAndOtherBenefitObligationsOfAssociatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InventoriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InventoriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InventoriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InventoriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InventoriesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:TaxLossCarryforwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:TaxLossCarryforwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:TaxLossCarryforwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:TaxLossCarryforwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:TaxLossCarryforwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:OtherAssetsProvisionsAccrualsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:OtherAssetsProvisionsAccrualsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:OtherAssetsProvisionsAccrualsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:OtherAssetsProvisionsAccrualsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:OtherAssetsProvisionsAccrualsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InvestmentsInSubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InvestmentsInSubsidiariesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InvestmentsInSubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:InvestmentsInSubsidiariesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4GoodwillFromAcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:GoodwillFromAcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4GoodwillFromAcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:GoodwillFromAcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:OneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:TwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:MoreThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:ThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:OneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:TwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:ThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:CapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:MoreThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:MoreThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:ThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:TwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:OneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:MoreThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:ThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:TwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:BalanceSheetTreatmentAxis">nvs:NotCapitalizedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:OneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:OneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:OneYearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:TwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:TwoYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:ThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:ThreeYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FourYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:FiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:MoreThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:YearOfExpiryAxis">nvs:MoreThanFiveYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">nvs:IncomeStatementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">nvs:IncomeStatementMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">ifrs-full:EquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">ifrs-full:EquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">ifrs-full:EquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">ifrs-full:EquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ImpactLocationAxis">ifrs-full:EquityMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryRawMaterialsGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:InventoryAxis">nvs:InventoryRawMaterialsGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryRawMaterialsGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:InventoryAxis">nvs:InventoryRawMaterialsGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryWorkInProgressGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:InventoryAxis">nvs:InventoryWorkInProgressGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryWorkInProgressGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:InventoryAxis">nvs:InventoryWorkInProgressGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryFinishedGoodsGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:InventoryAxis">nvs:InventoryFinishedGoodsGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryFinishedGoodsGrossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:InventoryAxis">nvs:InventoryFinishedGoodsGrossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019JPY">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019JPY">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019CHF">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019CHF">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:CHF</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">nvs:CurrencyOthersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">nvs:CurrencyOthersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">nvs:CurrencyOthersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:CurrencyAxis">nvs:CurrencyOthersMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanFiveYearsAndNotLaterThanSixYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanFiveYearsAndNotLaterThanSixYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanSixYearsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanSixYearsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FairValueByMeasurementBasisAxis">nvs:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FairValueByMeasurementBasisAxis">nvs:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FairValueByMeasurementBasisAxis">nvs:FairValueDisclosureItemAmountsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FairValueByMeasurementBasisAxis">nvs:FairValueDisclosureItemAmountsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:USspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonUSspecificHealthcarePlansAndProgramRebatesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:PlansAndProgramRebatesAxis">nvs:NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:AcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:AcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:AcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:AcquisitionsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:DivestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:DivestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:DivestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLiabilitiesMember_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:DivestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NoncurrentLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLiabilitiesMember_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:DivestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLiabilitiesMember_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:AcquisitionsAndDivestmentsAxis">nvs:DivestmentsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NonCurrentFinancialDebtsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-3_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2016-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NoncurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:NoncurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">nvs:CurrentLeaseLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_nvs-2019Q4LifeExpectancyMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Increase1YearMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">nvs:LifeExpectancyMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeInActuarialAssumptionAxis">nvs:Increase1YearMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_nvs-2019Q4ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeInActuarialAssumptionAxis">nvs:Change25BasisPointMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationAnnualIncentivePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationAnnualIncentivePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationShareSavingsPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationShareSavingsPlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLongTermPerformancePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLongTermPerformancePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLongTermRelativePerformancePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLongTermRelativePerformancePlanMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationOtherShareAwardsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationOtherShareAwardsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:NonvestingAxis">nvs:NonvestedSharesGrantedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:NonExecutiveDirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:NonExecutiveDirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:NonExecutiveDirectorMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GenentechRocheMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrAlexKrauerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:DrAlexKrauerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrAlexKrauerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:DrAlexKrauerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrAlexKrauerMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:DrAlexKrauerMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrDanielVasellaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:DrDanielVasellaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrDanielVasellaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:DrDanielVasellaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrDanielVasellaMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">nvs:DrDanielVasellaMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NovartisPensionFundMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:NovartisPensionFundMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialAssetsAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialAssetsAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:NegativeFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:PositiveFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:PositiveFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:DerivativeFinancialInstrumentNatureOfInstrumentAxis">nvs:DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:NegativeFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:ContractOrUnderlyingPrincipalAmoutMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:PositiveFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:PositiveFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:NegativeFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:FinancialInstrumentsPrincipalAmountsAxis">nvs:NegativeFairValuesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:AssociatedCompaniesAtFairValueThroughProfitAndLossMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FundInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongTermFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongTermFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongTermFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongTermFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:LongTermFinancialInvestmentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationReceivablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:ContingentConsiderationPayablesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:OtherFinancialLiabilitiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">nvs:LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:MarketableSecuritiesAndTimeDepositsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CommoditiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CommoditiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DeriviativeFinancialInstrumentsAndAccruedInterestMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:CashAndCashEquivalentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:FinancialDebtUndiscountedMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GroupsOfFinancialAssetsLiabilitiesAxis">nvs:DerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4VendorAxis_nvs-2019Q4LargestFinancialInstitutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:VendorAxis">nvs:LargestFinancialInstitutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4VendorAxis_nvs-2019Q4LargestFinancialInstitutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:VendorAxis">nvs:LargestFinancialInstitutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4VendorAxis_nvs-2019Q4SecondLargestFinancialInstitutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:VendorAxis">nvs:SecondLargestFinancialInstitutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4VendorAxis_nvs-2019Q4SecondLargestFinancialInstitutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:VendorAxis">nvs:SecondLargestFinancialInstitutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4VendorAxis_nvs-2019Q4ThirdLargestFinancialInstitutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:VendorAxis">nvs:ThirdLargestFinancialInstitutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4VendorAxis_nvs-2019Q4ThirdLargestFinancialInstitutionMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:VendorAxis">nvs:ThirdLargestFinancialInstitutionMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4USCommercialPaperProgramsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:USCommercialPaperProgramsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4JPCommercialPaperProgramsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">nvs:JPCommercialPaperProgramsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4ListedEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">nvs:ListedEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4ListedEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">nvs:ListedEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4NonlistedEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">nvs:NonlistedEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4NonlistedEquitySecuritiesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis">nvs:NonlistedEquitySecuritiesMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4SubsequentEventTypAxis_nvs-2019Q4SubsequentEventMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:SubsequentEventTypAxis">nvs:SubsequentEventMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:EuropeMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:AmericasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:AmericasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:AmericasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2017-01-01</xbrli:startDate>
      <xbrli:endDate>2017-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:AmericasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:GeographicalRegionsAxis">srt:AmericasMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-Transaction-TheMedicinesCompany_dei-2019LegalEntityAxis_nvs-2019Q4TheMedicinesCompanyMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:TheMedicinesCompanyMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-11-23</xbrli:startDate>
      <xbrli:endDate>2019-11-23</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis">nvs:IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-01-01</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="nvs:ChangeOverPeriodAxis">nvs:PoPYEMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:RightofuseAssetsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2018-01-01</xbrli:startDate>
      <xbrli:endDate>2018-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2018-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2017-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_srt-2018RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_nvs-2019Q4SaleAndLeaseBackMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">nvs:SaleAndLeaseBackMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_I-CurrentYearEnd_srt-2018RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_nvs-2019Q4SaleAndLeaseBackMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">nvs:SaleAndLeaseBackMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:instant>2019-12-31</xbrli:instant>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DisposalGroupsClassifiedAsHeldForSaleMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:ContinuingAndDiscontinuedOperationsAxis">ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4RocheHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">ifrs-full:SubsidiariesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="dei:LegalEntityAxis">nvs:RocheHoldingAGBaselMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationAnnualIncentivePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationShareSavingsPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationEmployeeShareOwnershipPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationEmployeeShareOwnershipPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLeveragedShareSavingsPlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLeveragedShareSavingsPlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationNovartisEquityPlanSelectMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLongTermPerformancePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationLongTermRelativePerformancePlanMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationSpecialShareAwardsMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">nvs:EquityBasedParticipationSpecialShareAwardsMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:context id="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
    <xbrli:entity>
      <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114448</xbrli:identifier>
      <xbrli:segment>
        <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">nvs:GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</xbrldi:explicitMember>
      </xbrli:segment>
    </xbrli:entity>
    <xbrli:period>
      <xbrli:startDate>2019-01-01</xbrli:startDate>
      <xbrli:endDate>2019-12-31</xbrli:endDate>
    </xbrli:period>
  </xbrli:context>
  <xbrli:unit id="USD">
    <xbrli:measure>iso4217:USD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="USDPerShares">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:USD</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="CHFPerShares">
    <xbrli:divide>
      <xbrli:unitNumerator>
        <xbrli:measure>iso4217:CHF</xbrli:measure>
      </xbrli:unitNumerator>
      <xbrli:unitDenominator>
        <xbrli:measure>xbrli:shares</xbrli:measure>
      </xbrli:unitDenominator>
    </xbrli:divide>
  </xbrli:unit>
  <xbrli:unit id="Pure">
    <xbrli:measure>xbrli:pure</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Shares">
    <xbrli:measure>xbrli:shares</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="CHF">
    <xbrli:measure>iso4217:CHF</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="EUR">
    <xbrli:measure>iso4217:EUR</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="Year">
    <xbrli:measure>ns0:year</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="JPY">
    <xbrli:measure>iso4217:JPY</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="INR">
    <xbrli:measure>iso4217:INR</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="IDR">
    <xbrli:measure>iso4217:IDR</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="ILS">
    <xbrli:measure>iso4217:ILS</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="MYR">
    <xbrli:measure>iso4217:MYR</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="MXN">
    <xbrli:measure>iso4217:MXN</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="MAD">
    <xbrli:measure>iso4217:MAD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="NZD">
    <xbrli:measure>iso4217:NZD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="NOK">
    <xbrli:measure>iso4217:NOK</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="PKR">
    <xbrli:measure>iso4217:PKR</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="PEN">
    <xbrli:measure>iso4217:PEN</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="PHP">
    <xbrli:measure>iso4217:PHP</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="PLN">
    <xbrli:measure>iso4217:PLN</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="RON">
    <xbrli:measure>iso4217:RON</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="RUB">
    <xbrli:measure>iso4217:RUB</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="SGD">
    <xbrli:measure>iso4217:SGD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="ZAR">
    <xbrli:measure>iso4217:ZAR</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="KRW">
    <xbrli:measure>iso4217:KRW</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="SEK">
    <xbrli:measure>iso4217:SEK</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="TWD">
    <xbrli:measure>iso4217:TWD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="THB">
    <xbrli:measure>iso4217:THB</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="TRY">
    <xbrli:measure>iso4217:TRY</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="UAH">
    <xbrli:measure>iso4217:UAH</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="AED">
    <xbrli:measure>iso4217:AED</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="GBP">
    <xbrli:measure>iso4217:GBP</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="DZD">
    <xbrli:measure>iso4217:DZD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="ARS">
    <xbrli:measure>iso4217:ARS</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="AUD">
    <xbrli:measure>iso4217:AUD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="BDT">
    <xbrli:measure>iso4217:BDT</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="BRL">
    <xbrli:measure>iso4217:BRL</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="CAD">
    <xbrli:measure>iso4217:CAD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="CLP">
    <xbrli:measure>iso4217:CLP</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="HKD">
    <xbrli:measure>iso4217:HKD</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="COP">
    <xbrli:measure>iso4217:COP</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="HRK">
    <xbrli:measure>iso4217:HRK</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="CZK">
    <xbrli:measure>iso4217:CZK</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="DKK">
    <xbrli:measure>iso4217:DKK</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="EGP">
    <xbrli:measure>iso4217:EGP</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="HUF">
    <xbrli:measure>iso4217:HUF</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="VEF">
    <xbrli:measure>iso4217:VEF</xbrli:measure>
  </xbrli:unit>
  <xbrli:unit id="SAR">
    <xbrli:measure>iso4217:SAR</xbrli:measure>
  </xbrli:unit>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">12069000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">15696000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1677000000</ifrs-full:RightofuseAssets>
  <ifrs-full:Goodwill contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">26524000000</ifrs-full:Goodwill>
  <ifrs-full:Goodwill contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">35294000000</ifrs-full:Goodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">28787000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">38719000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">8644000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">8352000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:DeferredTaxAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">7909000000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:DeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">8699000000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:NoncurrentFinancialAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2518000000</ifrs-full:NoncurrentFinancialAssets>
  <ifrs-full:NoncurrentFinancialAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2345000000</ifrs-full:NoncurrentFinancialAssets>
  <ifrs-full:OtherNoncurrentAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">738000000</ifrs-full:OtherNoncurrentAssets>
  <ifrs-full:OtherNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">895000000</ifrs-full:OtherNoncurrentAssets>
  <ifrs-full:NoncurrentAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">88866000000</ifrs-full:NoncurrentAssets>
  <ifrs-full:NoncurrentAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">110000000000</ifrs-full:NoncurrentAssets>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">5982000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">6956000000</ifrs-full:Inventories>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">8301000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">8727000000</ifrs-full:CurrentTradeReceivables>
  <nvs:CurrentIncomeTaxReceivable contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">254000000</nvs:CurrentIncomeTaxReceivable>
  <nvs:CurrentIncomeTaxReceivable contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">248000000</nvs:CurrentIncomeTaxReceivable>
  <ifrs-full:OtherCurrentFinancialAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">334000000</ifrs-full:OtherCurrentFinancialAssets>
  <ifrs-full:OtherCurrentFinancialAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2693000000</ifrs-full:OtherCurrentFinancialAssets>
  <ifrs-full:CashAndCashEquivalents contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">11112000000</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">13271000000</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2680000000</ifrs-full:OtherCurrentNonfinancialAssets>
  <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2861000000</ifrs-full:OtherCurrentNonfinancialAssets>
  <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">28663000000</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">34756000000</ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners>
  <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">841000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">807000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:CurrentAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">29504000000</ifrs-full:CurrentAssets>
  <ifrs-full:CurrentAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">35563000000</ifrs-full:CurrentAssets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">118370000000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">145563000000</ifrs-full:Assets>
  <ifrs-full:IssuedCapital contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">936000000</ifrs-full:IssuedCapital>
  <ifrs-full:IssuedCapital contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">944000000</ifrs-full:IssuedCapital>
  <ifrs-full:TreasuryShares contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">80000000</ifrs-full:TreasuryShares>
  <ifrs-full:TreasuryShares contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">69000000</ifrs-full:TreasuryShares>
  <ifrs-full:OtherReserves contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">54618000000</ifrs-full:OtherReserves>
  <ifrs-full:OtherReserves contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">77739000000</ifrs-full:OtherReserves>
  <ifrs-full:EquityAttributableToOwnersOfParent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">55474000000</ifrs-full:EquityAttributableToOwnersOfParent>
  <ifrs-full:EquityAttributableToOwnersOfParent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">78614000000</ifrs-full:EquityAttributableToOwnersOfParent>
  <ifrs-full:NoncontrollingInterests contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">77000000</ifrs-full:NoncontrollingInterests>
  <ifrs-full:NoncontrollingInterests contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">78000000</ifrs-full:NoncontrollingInterests>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">55551000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">78692000000</ifrs-full:Equity>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">20353000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">22470000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1703000000</ifrs-full:NoncurrentLeaseLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">5867000000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">7475000000</ifrs-full:DeferredTaxLiabilities>
  <nvs:ProvisionsAndOtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">6632000000</nvs:ProvisionsAndOtherNoncurrentLiabilities>
  <nvs:ProvisionsAndOtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">7319000000</nvs:ProvisionsAndOtherNoncurrentLiabilities>
  <ifrs-full:NoncurrentLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">34555000000</ifrs-full:NoncurrentLiabilities>
  <ifrs-full:NoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">37264000000</ifrs-full:NoncurrentLiabilities>
  <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">5424000000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
  <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">5556000000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">7031000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">9678000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">246000000</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2194000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
  <ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2038000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
  <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">13338000000</ifrs-full:OtherCurrentNonfinancialLiabilities>
  <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">12284000000</ifrs-full:OtherCurrentNonfinancialLiabilities>
  <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">28233000000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">29556000000</ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">31000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">51000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:CurrentLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">28264000000</ifrs-full:CurrentLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">29607000000</ifrs-full:CurrentLiabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">62819000000</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">66871000000</ifrs-full:Liabilities>
  <ifrs-full:EquityAndLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">118370000000</ifrs-full:EquityAndLiabilities>
  <ifrs-full:EquityAndLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">145563000000</ifrs-full:EquityAndLiabilities>
  <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">9122000000</ifrs-full:AdjustmentsForReconcileProfitLoss>
  <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1486000000</ifrs-full:AdjustmentsForReconcileProfitLoss>
  <ifrs-full:AdjustmentsForReconcileProfitLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">5787000000</ifrs-full:AdjustmentsForReconcileProfitLoss>
  <ifrs-full:DividendsReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">463000000</ifrs-full:DividendsReceivedClassifiedAsOperatingActivities>
  <ifrs-full:DividendsReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">719000000</ifrs-full:DividendsReceivedClassifiedAsOperatingActivities>
  <ifrs-full:DividendsReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">987000000</ifrs-full:DividendsReceivedClassifiedAsOperatingActivities>
  <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">214000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
  <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">241000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
  <ifrs-full:InterestReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">97000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
  <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">793000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
  <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">816000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
  <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">697000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
  <ifrs-full:FinanceIncomeReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">28000000</ifrs-full:FinanceIncomeReceivedClassifiedAsOperatingActivities>
  <ifrs-full:FinanceIncomeReceivedClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">218000000</ifrs-full:FinanceIncomeReceivedClassifiedAsOperatingActivities>
  <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">33000000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
  <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">31000000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
  <ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">270000000</ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1876000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1506000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1487000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <nvs:CashFlowsBeforeWorkingCapitalAndProvisionChanges contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">14272000000</nvs:CashFlowsBeforeWorkingCapitalAndProvisionChanges>
  <nvs:CashFlowsBeforeWorkingCapitalAndProvisionChanges contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">13111000000</nvs:CashFlowsBeforeWorkingCapitalAndProvisionChanges>
  <nvs:CashFlowsBeforeWorkingCapitalAndProvisionChanges contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">11916000000</nvs:CashFlowsBeforeWorkingCapitalAndProvisionChanges>
  <nvs:PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">924000000</nvs:PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities>
  <nvs:PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">638000000</nvs:PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities>
  <nvs:PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">829000000</nvs:PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities>
  <nvs:ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">199000000</nvs:ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems>
  <nvs:ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">576000000</nvs:ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems>
  <nvs:ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">332000000</nvs:ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">13547000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">13049000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">11419000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">78000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1223000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1202000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">13625000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">14272000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">12621000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1379000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1254000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1325000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">857000000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">102000000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">91000000</ifrs-full:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">878000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1394000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">969000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">973000000</ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">823000000</ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">640000000</ifrs-full:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities>
  <nvs:PurchaseOfFinancialAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">302000000</nvs:PurchaseOfFinancialAssetsClassifiedAsInvestingActivities>
  <nvs:PurchaseOfFinancialAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">205000000</nvs:PurchaseOfFinancialAssetsClassifiedAsInvestingActivities>
  <nvs:PurchaseOfFinancialAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">354000000</nvs:PurchaseOfFinancialAssetsClassifiedAsInvestingActivities>
  <nvs:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1152000000</nvs:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities>
  <nvs:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">165000000</nvs:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities>
  <nvs:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">328000000</nvs:ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">60000000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">39000000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
  <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">40000000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">3000000</ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">9000000</ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities>
  <ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1000000</ifrs-full:ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities>
  <nvs:DivestmentsAquisitionsOfInterestsInAssociatedCompanies contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-6000000</nvs:DivestmentsAquisitionsOfInterestsInAssociatedCompanies>
  <nvs:DivestmentsAquisitionsOfInterestsInAssociatedCompanies contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12854000000</nvs:DivestmentsAquisitionsOfInterestsInAssociatedCompanies>
  <nvs:DivestmentsAquisitionsOfInterestsInAssociatedCompanies contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">29000000</nvs:DivestmentsAquisitionsOfInterestsInAssociatedCompanies>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-3760000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-13683000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-714000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">228000000</ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
  <ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">2440000000</ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
  <ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">580000000</ifrs-full:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
  <ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">2561000000</ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
  <ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">472000000</ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
  <ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">549000000</ifrs-full:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-1067000000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-4590000000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-2344000000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-1159000000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-1001000000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-775000000</ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-2226000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-5591000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-3119000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
  <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">6645000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
  <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">6966000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
  <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">6495000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
  <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">5533000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
  <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">2036000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
  <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">5490000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
  <nvs:ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">201000000</nvs:ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions>
  <nvs:ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">700000000</nvs:ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions>
  <nvs:ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">252000000</nvs:ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">93000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">2856000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">4933000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">3195000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">366000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">188000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-1582000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1687000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-644000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">273000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
  <ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">6000000</ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries>
  <ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">19000000</ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries>
  <ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</ifrs-full:PaymentsFromChangesInOwnershipInterestsInSubsidiaries>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">56000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">67000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">314000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-16884000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-4077000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-7318000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">3257000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-167000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-415000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-13627000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-4244000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-7733000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-2228000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">4437000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1769000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
  <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">69000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
  <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-26000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
  <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">84000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-2159000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">4411000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1853000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">7007000000</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:CashAndCashEquivalents contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">8860000000</ifrs-full:CashAndCashEquivalents>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">47445000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">44751000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">42338000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">53000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">82000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">43000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">47498000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">44833000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">42381000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1179000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1266000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1023000000</ifrs-full:OtherRevenue>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">14425000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">14510000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">13633000000</ifrs-full:CostOfSales>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">34252000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">31589000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">29771000000</ifrs-full:GrossProfit>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">14369000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">13717000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">12465000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">9402000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">8489000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">8389000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">2031000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1629000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1922000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">3426000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">2609000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">2137000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">9086000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">8403000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">8702000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">659000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">6438000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1108000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:InterestExpense contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">850000000</ifrs-full:InterestExpense>
  <ifrs-full:InterestExpense contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">932000000</ifrs-full:InterestExpense>
  <ifrs-full:InterestExpense contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">750000000</ifrs-full:InterestExpense>
  <ifrs-full:OtherFinanceIncomeCost contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">45000000</ifrs-full:OtherFinanceIncomeCost>
  <ifrs-full:OtherFinanceIncomeCost contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">186000000</ifrs-full:OtherFinanceIncomeCost>
  <ifrs-full:OtherFinanceIncomeCost contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">42000000</ifrs-full:OtherFinanceIncomeCost>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">8940000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">14095000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">9102000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1793000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1295000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1603000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">7147000000</ifrs-full:ProfitLossFromContinuingOperations>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12800000000</ifrs-full:ProfitLossFromContinuingOperations>
  <ifrs-full:ProfitLossFromContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">7499000000</ifrs-full:ProfitLossFromContinuingOperations>
  <nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-101000000</nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution>
  <nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-186000000</nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution>
  <nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">204000000</nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution>
  <nvs:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">4691000000</nvs:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">4590000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-186000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">204000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">11737000000</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12614000000</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">7703000000</ifrs-full:ProfitLoss>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">11732000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12611000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">7703000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">5000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
  <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">3000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
  <ifrs-full:ProfitLossAttributableToNoncontrollingInterests contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
  <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USDPerShares" decimals="2">3.12</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USDPerShares" decimals="2">5.52</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USDPerShares" decimals="2">3.20</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USDPerShares" decimals="2">2.00</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="AR_D-CurrentYear-1" unitRef="USDPerShares" decimals="2">-0.08</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="AR_D-CurrentYear-2" unitRef="USDPerShares" decimals="2">0.08</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:BasicEarningsLossPerShare contextRef="AR_D-CurrentYear" unitRef="USDPerShares" decimals="2">5.12</ifrs-full:BasicEarningsLossPerShare>
  <ifrs-full:BasicEarningsLossPerShare contextRef="AR_D-CurrentYear-1" unitRef="USDPerShares" decimals="2">5.44</ifrs-full:BasicEarningsLossPerShare>
  <ifrs-full:BasicEarningsLossPerShare contextRef="AR_D-CurrentYear-2" unitRef="USDPerShares" decimals="2">3.28</ifrs-full:BasicEarningsLossPerShare>
  <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations contextRef="AR_D-CurrentYear" unitRef="USDPerShares" decimals="2">3.08</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations contextRef="AR_D-CurrentYear-1" unitRef="USDPerShares" decimals="2">5.46</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations contextRef="AR_D-CurrentYear-2" unitRef="USDPerShares" decimals="2">3.17</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USDPerShares" decimals="2">1.98</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="AR_D-CurrentYear-1" unitRef="USDPerShares" decimals="2">-0.08</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="AR_D-CurrentYear-2" unitRef="USDPerShares" decimals="2">0.08</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
  <ifrs-full:DilutedEarningsLossPerShare contextRef="AR_D-CurrentYear" unitRef="USDPerShares" decimals="2">5.06</ifrs-full:DilutedEarningsLossPerShare>
  <ifrs-full:DilutedEarningsLossPerShare contextRef="AR_D-CurrentYear-1" unitRef="USDPerShares" decimals="2">5.38</ifrs-full:DilutedEarningsLossPerShare>
  <ifrs-full:DilutedEarningsLossPerShare contextRef="AR_D-CurrentYear-2" unitRef="USDPerShares" decimals="2">3.25</ifrs-full:DilutedEarningsLossPerShare>
  <ifrs-full:ParValuePerShare contextRef="AR_I-CurrentYearEnd" unitRef="CHFPerShares" decimals="2">0.50</ifrs-full:ParValuePerShare>
  <nvs:NumberOfReportableSegments contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="0">2</nvs:NumberOfReportableSegments>
  <ifrs-full:RevenueFromInterest contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">245000000</ifrs-full:RevenueFromInterest>
  <ifrs-full:RevenueFromInterest contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">292000000</ifrs-full:RevenueFromInterest>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">38000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-6000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">492000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">521000000</nvs:AdditionsToRestructuringProvisions>
  <ifrs-full:RevenueFromInterest contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">110000000</ifrs-full:RevenueFromInterest>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-227000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">186000000</nvs:AdditionsToRestructuringProvisions>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">15938000000</ifrs-full:NetDebt>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">16184000000</ifrs-full:NetDebt>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">71489000000</nvs:NetOperatingAssets>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">94876000000</nvs:NetOperatingAssets>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1474000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1774000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">55311000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">74013000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">767000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1592000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <nvs:CurrentIncomeTaxAndDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">8061000000</nvs:CurrentIncomeTaxAndDeferredTaxLiabilities>
  <nvs:CurrentIncomeTaxAndDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">9513000000</nvs:CurrentIncomeTaxAndDeferredTaxLiabilities>
  <nvs:AdditionsToInvestmentInAssociatedCompanies contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">55000000</nvs:AdditionsToInvestmentInAssociatedCompanies>
  <nvs:AdditionsToInvestmentInAssociatedCompanies contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">29000000</nvs:AdditionsToInvestmentInAssociatedCompanies>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">11446000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">15964000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">27384000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">32148000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="2">1.00</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="2">1.00</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2" unitRef="Pure" decimals="2">1.00</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">77701000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">1.00</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">98061000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="Pure" decimals="2">1.00</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">734000000</nvs:ProfitSharingIncome>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">877000000</nvs:ProfitSharingIncome>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">147000000</ifrs-full:RevenueFromRoyalties>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">188000000</ifrs-full:RevenueFromRoyalties>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">231000000</nvs:MilestoneIncome>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">173000000</nvs:MilestoneIncome>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">67000000</nvs:OtherRevenueOther>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">28000000</nvs:OtherRevenueOther>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">652000000</nvs:ProfitSharingIncome>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">298000000</ifrs-full:RevenueFromRoyalties>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">28000000</nvs:MilestoneIncome>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">45000000</nvs:OtherRevenueOther>
  <nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1871000000</nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities>
  <nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">895000000</nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities>
  <nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">86000000</nvs:AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities>
  <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-1234000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
  <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-902000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
  <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-1077000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">758000000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">673000000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForSharebasedPayments contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">612000000</ifrs-full:AdjustmentsForSharebasedPayments>
  <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-805000000</ifrs-full:AdjustmentsForFinanceIncomeCost>
  <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-746000000</ifrs-full:AdjustmentsForFinanceIncomeCost>
  <ifrs-full:AdjustmentsForFinanceIncomeCost contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-708000000</ifrs-full:AdjustmentsForFinanceIncomeCost>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-382000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-387000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-203000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-980000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-544000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-655000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">553000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">252000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">82000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-160000000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">316000000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
  <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-303000000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1167000000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">941000000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
  <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1410000000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities>
  <ifrs-full:OtherAdjustmentsToReconcileProfitLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
  <ifrs-full:OtherAdjustmentsToReconcileProfitLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-2000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
  <ifrs-full:OtherAdjustmentsToReconcileProfitLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
  <ifrs-full:IncomeTaxesPaidRefund contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1993000000</ifrs-full:IncomeTaxesPaidRefund>
  <ifrs-full:IncomeTaxesPaidRefund contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1809000000</ifrs-full:IncomeTaxesPaidRefund>
  <ifrs-full:IncomeTaxesPaidRefund contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1611000000</ifrs-full:IncomeTaxesPaidRefund>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">0</ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
  <ifrs-full:AdditionsToRightofuseAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">537000000</ifrs-full:AdditionsToRightofuseAssets>
  <ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-8">7000000000</ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners>
  <ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-8">6600000000</ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners>
  <nvs:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet contextRef="AR_D-Transaction-Alcon-3-April-8" unitRef="USD" decimals="-6">4691000000</nvs:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">139000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
  <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">14000000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">43000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:AmortizationOfBondsDiscount contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-29000000</nvs:AmortizationOfBondsDiscount>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-555000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">23802000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">44000000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
  <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">137000000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
  <nvs:CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3550000000</nvs:CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <nvs:CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2531000000</nvs:CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">342000000</nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">10224000000</nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">1223000000</nvs:AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <nvs:OtherIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">22000000</nvs:OtherIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <nvs:OtherIntangibleAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1000000</nvs:OtherIntangibleAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">60000000</ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">381000000</ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">8000000</ifrs-full:DeferredTaxAssetsRecognisedAsOfAcquisitionDate>
  <nvs:FinancialAndOtherAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">8000000</nvs:FinancialAndOtherAssets>
  <nvs:FinancialAndOtherAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">19000000</nvs:FinancialAndOtherAssets>
  <ifrs-full:InventoryRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">195000000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
  <ifrs-full:InventoryRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">20000000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
  <nvs:TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">4000000</nvs:TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate>
  <nvs:TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">90000000</nvs:TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate>
  <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1112000000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
  <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">20000000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
  <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">107000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2874000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">325000000</ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2000000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">14000000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
  <nvs:TradePayablesAndOtherLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">178000000</nvs:TradePayablesAndOtherLiabilities>
  <nvs:TradePayablesAndOtherLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">627000000</nvs:TradePayablesAndOtherLiabilities>
  <nvs:TradePayablesAndOtherLiabilities contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">1000000</nvs:TradePayablesAndOtherLiabilities>
  <nvs:IdentifiableAssetsAcquired contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3938000000</nvs:IdentifiableAssetsAcquired>
  <nvs:IdentifiableAssetsAcquired contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">11000000000</nvs:IdentifiableAssetsAcquired>
  <nvs:IdentifiableAssetsAcquired contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">925000000</nvs:IdentifiableAssetsAcquired>
  <ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">26000000</ifrs-full:NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate>
  <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">186000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
  <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">4084000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
  <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">94000000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">4124000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">13946000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">999000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:GoodwillExpectedDeductibleForTaxPurposes contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">98000000</ifrs-full:GoodwillExpectedDeductibleForTaxPurposes>
  <ifrs-full:GoodwillExpectedDeductibleForTaxPurposes contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">0</ifrs-full:GoodwillExpectedDeductibleForTaxPurposes>
  <ifrs-full:GoodwillExpectedDeductibleForTaxPurposes contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">0</ifrs-full:GoodwillExpectedDeductibleForTaxPurposes>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">146000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:AmortizationOfBondsDiscount contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-16000000</nvs:AmortizationOfBondsDiscount>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">870000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <dei:EntityCommonStockSharesOutstanding contextRef="AR_I-CurrentYearEnd" unitRef="Shares" decimals="0">2265008488</dei:EntityCommonStockSharesOutstanding>
  <ifrs-full:GrossLeaseLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">3612000000</ifrs-full:GrossLeaseLiabilities>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart" unitRef="USD" decimals="-6">1554000000</ifrs-full:RightofuseAssets>
  <nvs:AdjustmentsForPrepaymentsAndAccruedLeasePayments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">182000000</nvs:AdjustmentsForPrepaymentsAndAccruedLeasePayments>
  <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">30000000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
  <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12000000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
  <nvs:NewLeaseArrangements contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-65000000</nvs:NewLeaseArrangements>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart" unitRef="USD" decimals="-6">1736000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 contextRef="AR_I-CurrentYearEnd-1" unitRef="Pure" decimals="3">0.035</ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16>
  <nvs:LeaseContractTerminationsRightofuseAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">98000000</nvs:LeaseContractTerminationsRightofuseAssets>
  <nvs:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">6000000</nvs:IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-305000000</ifrs-full:DepreciationRightofuseAssets>
  <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">66000000</ifrs-full:InterestExpenseOnLeaseLiabilities>
  <ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">7000000</ifrs-full:ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed>
  <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">8000000</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
  <ifrs-full:CashOutflowForLeases contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">339000000</ifrs-full:CashOutflowForLeases>
  <nvs:CashOutflowsForShortTermAndLowValueLeases contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">15000000</nvs:CashOutflowsForShortTermAndLowValueLeases>
  <nvs:CashOutflowsForPaymentsOfLeasesInterest contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">51000000</nvs:CashOutflowsForPaymentsOfLeasesInterest>
  <nvs:WeightedAverageInterestRateLeaseLiabilities contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="3">0.039</nvs:WeightedAverageInterestRateLeaseLiabilities>
  <nvs:LeaseIncentives contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">33000000</nvs:LeaseIncentives>
  <nvs:MostMaterialLeaseWithLeaseTermExtension contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-9">1000000000</nvs:MostMaterialLeaseWithLeaseTermExtension>
  <nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-119000000</nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-482000000</nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1367000000</nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-35000000</nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans>
  <nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">54000000</nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans>
  <nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">76000000</nvs:OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans>
  <nvs:OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-313000000</nvs:OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation>
  <nvs:OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">69000000</nvs:OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation>
  <nvs:OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-592000000</nvs:OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation>
  <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3469000000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
  <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">3546000000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
  <nvs:OtherLongtermEmployeeBenefitsAndDeferredCompensation contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">546000000</nvs:OtherLongtermEmployeeBenefitsAndDeferredCompensation>
  <nvs:OtherLongtermEmployeeBenefitsAndDeferredCompensation contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">600000000</nvs:OtherLongtermEmployeeBenefitsAndDeferredCompensation>
  <nvs:OtherPostemploymentBenefits contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">612000000</nvs:OtherPostemploymentBenefits>
  <nvs:OtherPostemploymentBenefits contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">954000000</nvs:OtherPostemploymentBenefits>
  <nvs:EnvironmentalRemediationProvisionNoncurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">592000000</nvs:EnvironmentalRemediationProvisionNoncurrent>
  <nvs:EnvironmentalRemediationProvisionNoncurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">634000000</nvs:EnvironmentalRemediationProvisionNoncurrent>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">200000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">214000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent>
  <nvs:ContingentConsiderationNonCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">958000000</nvs:ContingentConsiderationNonCurrent>
  <nvs:ContingentConsiderationNonCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">874000000</nvs:ContingentConsiderationNonCurrent>
  <ifrs-full:OtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">255000000</ifrs-full:OtherNoncurrentLiabilities>
  <ifrs-full:OtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">497000000</ifrs-full:OtherNoncurrentLiabilities>
  <nvs:EnvironmentalProvision contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">773000000</nvs:EnvironmentalProvision>
  <nvs:EnvironmentalProvisionPayments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-30000000</nvs:EnvironmentalProvisionPayments>
  <nvs:EnvironmentalProvisionPayments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-48000000</nvs:EnvironmentalProvisionPayments>
  <nvs:EnvironmentalProvisionPayments contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-46000000</nvs:EnvironmentalProvisionPayments>
  <nvs:EnvironmentalProvisionReleases contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">83000000</nvs:EnvironmentalProvisionReleases>
  <nvs:EnvironmentalProvisionReleases contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">21000000</nvs:EnvironmentalProvisionReleases>
  <nvs:EnvironmentalProvisionReleases contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">153000000</nvs:EnvironmentalProvisionReleases>
  <nvs:EnvironmentalProvisionAdditions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">124000000</nvs:EnvironmentalProvisionAdditions>
  <nvs:EnvironmentalProvisionAdditions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">7000000</nvs:EnvironmentalProvisionAdditions>
  <nvs:EnvironmentalProvisionAdditions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">154000000</nvs:EnvironmentalProvisionAdditions>
  <nvs:EnvironmentalProvisionForeignCurrencyTranslationGainLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">11000000</nvs:EnvironmentalProvisionForeignCurrencyTranslationGainLoss>
  <nvs:EnvironmentalProvisionForeignCurrencyTranslationGainLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-7000000</nvs:EnvironmentalProvisionForeignCurrencyTranslationGainLoss>
  <nvs:EnvironmentalProvisionForeignCurrencyTranslationGainLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">33000000</nvs:EnvironmentalProvisionForeignCurrencyTranslationGainLoss>
  <nvs:EnvironmentalProvision contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">714000000</nvs:EnvironmentalProvision>
  <nvs:EnvironmentalProvision contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">692000000</nvs:EnvironmentalProvision>
  <nvs:EnvironmentalProvision contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">761000000</nvs:EnvironmentalProvision>
  <nvs:EnvironmentalProvisionCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">122000000</nvs:EnvironmentalProvisionCurrent>
  <nvs:EnvironmentalProvisionCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">58000000</nvs:EnvironmentalProvisionCurrent>
  <nvs:EnvironmentalProvisionCurrent contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">55000000</nvs:EnvironmentalProvisionCurrent>
  <nvs:EnvironmentalRemediationProvisionNoncurrent contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">706000000</nvs:EnvironmentalRemediationProvisionNoncurrent>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1949000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3485000000</nvs:LeaseLiabilitiesUndiscounted>
  <nvs:CurrentLeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">295000000</nvs:CurrentLeaseLiabilitiesUndiscounted>
  <nvs:NoncurrentLeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3190000000</nvs:NoncurrentLeaseLiabilitiesUndiscounted>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">-272000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">-358000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI>
  <nvs:EnvironmentalProvisionExpectedCashOutflowNextTwoYears contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">141000000</nvs:EnvironmentalProvisionExpectedCashOutflowNextTwoYears>
  <nvs:EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">210000000</nvs:EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears>
  <nvs:EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">258000000</nvs:EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears>
  <nvs:EnvironmentalProvisionExpectedCashOutflowAfterTenYears contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">105000000</nvs:EnvironmentalProvisionExpectedCashOutflowAfterTenYears>
  <nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="0">3000</nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases>
  <nvs:ProductLiabilityContingencyLossExposureNotAccruedBestEstimate contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">875000000</nvs:ProductLiabilityContingencyLossExposureNotAccruedBestEstimate>
  <nvs:MajorPlansPercentageInGroupDBOPensions contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">0.95</nvs:MajorPlansPercentageInGroupDBOPensions>
  <nvs:MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">0.81</nvs:MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans>
  <nvs:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">225000000</nvs:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
  <nvs:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments contextRef="AR_D-CurrentYear-2" unitRef="CHF" decimals="-6">216000000</nvs:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">4404000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <nvs:UncalledCapitalCommitmentsForInvestmentsInFunds contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">79000000</nvs:UncalledCapitalCommitmentsForInvestmentsInFunds>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-467000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-359000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">851000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">25000000</nvs:PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">565000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">5956000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1071000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <nvs:RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">511000000</nvs:RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies>
  <nvs:InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">714000000</nvs:InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions>
  <nvs:InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">877000000</nvs:InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions>
  <nvs:InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">741000000</nvs:InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions>
  <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">70000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
  <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">55000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
  <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">9000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
  <ifrs-full:RevenueFromDividends contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">12000000</ifrs-full:RevenueFromDividends>
  <ifrs-full:RevenueFromDividends contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1000000</ifrs-full:RevenueFromDividends>
  <ifrs-full:RevenueFromDividends contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1000000</ifrs-full:RevenueFromDividends>
  <ifrs-full:OtherFinanceCost contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">52000000</ifrs-full:OtherFinanceCost>
  <ifrs-full:OtherFinanceCost contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">39000000</ifrs-full:OtherFinanceCost>
  <ifrs-full:OtherFinanceCost contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">11000000</ifrs-full:OtherFinanceCost>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-160000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-68000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-58000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">22167000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">25283000000</ifrs-full:BondsIssued>
  <nvs:LiabilitiesToBanksAndOtherInstitutions contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">188000000</nvs:LiabilitiesToBanksAndOtherInstitutions>
  <nvs:LiabilitiesToBanksAndOtherInstitutions contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">285000000</nvs:LiabilitiesToBanksAndOtherInstitutions>
  <nvs:FinanceLeaseLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">92000000</nvs:FinanceLeaseLiabilities>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">22355000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">25660000000</ifrs-full:Borrowings>
  <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2002000000</ifrs-full:CurrentPortionOfLongtermBorrowings>
  <ifrs-full:CurrentPortionOfLongtermBorrowings contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">3190000000</ifrs-full:CurrentPortionOfLongtermBorrowings>
  <nvs:AverageInterestRateOnLoansReceived contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="3">0.002</nvs:AverageInterestRateOnLoansReceived>
  <nvs:AverageInterestRateOnLoansReceived contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="3">0.003</nvs:AverageInterestRateOnLoansReceived>
  <nvs:RatioFixedRateFinancialDebtToTotalFinancialDebt contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">0.82</nvs:RatioFixedRateFinancialDebtToTotalFinancialDebt>
  <nvs:RatioFixedRateFinancialDebtToTotalFinancialDebt contextRef="AR_I-CurrentYearEnd-1" unitRef="Pure" decimals="2">0.80</nvs:RatioFixedRateFinancialDebtToTotalFinancialDebt>
  <nvs:AverageInterestRateOnBorrowings contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="3">0.024</nvs:AverageInterestRateOnBorrowings>
  <nvs:AverageInterestRateOnBorrowings contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="3">0.027</nvs:AverageInterestRateOnBorrowings>
  <nvs:NoncurrentFinancialAssetsEquityInvestments contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1524000000</nvs:NoncurrentFinancialAssetsEquityInvestments>
  <nvs:NoncurrentFinancialAssetsEquityInvestments contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1155000000</nvs:NoncurrentFinancialAssetsEquityInvestments>
  <nvs:NoncurrentFinancialAsstetsDebtSecurities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">33000000</nvs:NoncurrentFinancialAsstetsDebtSecurities>
  <nvs:NoncurrentFinancialAsstetsDebtSecurities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">31000000</nvs:NoncurrentFinancialAsstetsDebtSecurities>
  <nvs:NoncurrentFinancialAssetsFundInvestments contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">233000000</nvs:NoncurrentFinancialAssetsFundInvestments>
  <nvs:NoncurrentFinancialAssetsFundInvestments contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">251000000</nvs:NoncurrentFinancialAssetsFundInvestments>
  <nvs:NoncurrentFinancialAssetsTotalFinancialInvestments contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1790000000</nvs:NoncurrentFinancialAssetsTotalFinancialInvestments>
  <nvs:NoncurrentFinancialAssetsTotalFinancialInvestments contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1437000000</nvs:NoncurrentFinancialAssetsTotalFinancialInvestments>
  <ifrs-full:NoncurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">164000000</ifrs-full:NoncurrentTradeReceivables>
  <ifrs-full:NoncurrentFinanceLeaseReceivables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">91000000</ifrs-full:NoncurrentFinanceLeaseReceivables>
  <nvs:LongTermReceivablesFromFinanceSubleases contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">66000000</nvs:LongTermReceivablesFromFinanceSubleases>
  <ifrs-full:OtherNoncurrentReceivables contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">104000000</ifrs-full:OtherNoncurrentReceivables>
  <ifrs-full:OtherNoncurrentReceivables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">3000000</ifrs-full:OtherNoncurrentReceivables>
  <nvs:ContingentConsiderationReceivable contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">399000000</nvs:ContingentConsiderationReceivable>
  <nvs:ContingentConsiderationReceivable contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">396000000</nvs:ContingentConsiderationReceivable>
  <ifrs-full:NoncurrentLoansAndReceivables contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">159000000</ifrs-full:NoncurrentLoansAndReceivables>
  <ifrs-full:NoncurrentLoansAndReceivables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">254000000</ifrs-full:NoncurrentLoansAndReceivables>
  <nvs:DeferredCompensationPlansAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">414000000</nvs:DeferredCompensationPlansAssets>
  <nvs:DeferredCompensationPlansAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">468000000</nvs:DeferredCompensationPlansAssets>
  <nvs:PrepaidPostemploymentBenefitPlansAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">148000000</nvs:PrepaidPostemploymentBenefitPlansAssets>
  <nvs:PrepaidPostemploymentBenefitPlansAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">137000000</nvs:PrepaidPostemploymentBenefitPlansAssets>
  <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">176000000</ifrs-full:OtherNoncurrentNonfinancialAssets>
  <ifrs-full:OtherNoncurrentNonfinancialAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">290000000</ifrs-full:OtherNoncurrentNonfinancialAssets>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">24000000</ifrs-full:DebtInstrumentsHeld>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">325000000</ifrs-full:DebtInstrumentsHeld>
  <nvs:FundInstrumentsHeld contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">37000000</nvs:FundInstrumentsHeld>
  <nvs:FundInstrumentsHeld contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">35000000</nvs:FundInstrumentsHeld>
  <nvs:MarketableSecurities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">61000000</nvs:MarketableSecurities>
  <nvs:MarketableSecurities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">360000000</nvs:MarketableSecurities>
  <nvs:Commodities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">110000000</nvs:Commodities>
  <nvs:Commodities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">104000000</nvs:Commodities>
  <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">61000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
  <ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2087000000</ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents>
  <ifrs-full:DerivativeFinancialAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">102000000</ifrs-full:DerivativeFinancialAssets>
  <ifrs-full:DerivativeFinancialAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">130000000</ifrs-full:DerivativeFinancialAssets>
  <ifrs-full:InterestReceivable contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">12000000</ifrs-full:InterestReceivable>
  <ifrs-full:Cash contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3247000000</ifrs-full:Cash>
  <ifrs-full:Cash contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">3121000000</ifrs-full:Cash>
  <ifrs-full:CashEquivalents contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">7865000000</ifrs-full:CashEquivalents>
  <ifrs-full:CashEquivalents contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">10150000000</ifrs-full:CashEquivalents>
  <ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">3000000</ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity>
  <ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">96000000</ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">395000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-42000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">10000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-116000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-118000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-69000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">52000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">107000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">70000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1230000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">220000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">93000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-1000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-6000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">2000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1369000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">340000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">351000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1169000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">126000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">121000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">230000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent>
  <nvs:InterestBearningAccountsOfAssociatesPayableOnDemand contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1836000000</nvs:InterestBearningAccountsOfAssociatesPayableOnDemand>
  <nvs:InterestBearningAccountsOfAssociatesPayableOnDemand contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1778000000</nvs:InterestBearningAccountsOfAssociatesPayableOnDemand>
  <ifrs-full:ShorttermBorrowings contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">719000000</ifrs-full:ShorttermBorrowings>
  <ifrs-full:ShorttermBorrowings contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">701000000</ifrs-full:ShorttermBorrowings>
  <ifrs-full:CommercialPapersIssued contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2289000000</ifrs-full:CommercialPapersIssued>
  <ifrs-full:CommercialPapersIssued contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">3951000000</ifrs-full:CommercialPapersIssued>
  <ifrs-full:DerivativeFinancialLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">185000000</ifrs-full:DerivativeFinancialLiabilities>
  <ifrs-full:DerivativeFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">58000000</ifrs-full:DerivativeFinancialLiabilities>
  <nvs:WeightedAverageInterestRateAssociates contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="3">0.005</nvs:WeightedAverageInterestRateAssociates>
  <nvs:WeightedAverageInterestRateAssociates contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="3">0.005</nvs:WeightedAverageInterestRateAssociates>
  <nvs:WeightedAverageInterestRateOnBankAndOtherFinancialDebt contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="3">0.129</nvs:WeightedAverageInterestRateOnBankAndOtherFinancialDebt>
  <nvs:WeightedAverageInterestRateOnBankAndOtherFinancialDebt contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="3">0.096</nvs:WeightedAverageInterestRateOnBankAndOtherFinancialDebt>
  <nvs:RelatedPartiesNumberOfExecutiveCommiteeMembers contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="0">15</nvs:RelatedPartiesNumberOfExecutiveCommiteeMembers>
  <nvs:RelatedPartiesNumberOfExecutiveCommiteeMembers contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="0">17</nvs:RelatedPartiesNumberOfExecutiveCommiteeMembers>
  <nvs:RelatedPartiesNumberOfExecutiveCommiteeMembers contextRef="AR_D-CurrentYear-2" unitRef="Pure" decimals="0">11</nvs:RelatedPartiesNumberOfExecutiveCommiteeMembers>
  <nvs:RelatedPartiesNumberOfNonexecutiveDirectors contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="0">13</nvs:RelatedPartiesNumberOfNonexecutiveDirectors>
  <nvs:RelatedPartiesNumberOfNonexecutiveDirectors contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="0">13</nvs:RelatedPartiesNumberOfNonexecutiveDirectors>
  <nvs:RelatedPartiesNumberOfNonexecutiveDirectors contextRef="AR_D-CurrentYear-2" unitRef="Pure" decimals="0">13</nvs:RelatedPartiesNumberOfNonexecutiveDirectors>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">24377000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">29374000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">35822000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">38905000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-64000000</ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets>
  <ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-78000000</ifrs-full:TransfersOutOfLevel3OfFairValueHierarchyAssets>
  <nvs:NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">72000000</nvs:NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement>
  <nvs:NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">110000000</nvs:NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement>
  <nvs:AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10 contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">100000000</nvs:AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10>
  <nvs:AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10 contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">267000000</nvs:AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10>
  <nvs:AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10 contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-202000000</nvs:AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10>
  <nvs:MostSignificantForeignExchangeLosses contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-8">300000000</nvs:MostSignificantForeignExchangeLosses>
  <nvs:LongtermFinancialDebtWithACarryingAmount contextRef="AR_I-CurrentYearEnd" unitRef="EUR" decimals="-8">1800000000</nvs:LongtermFinancialDebtWithACarryingAmount>
  <nvs:LongtermFinancialDebtWithACarryingAmount contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-8">2100000000</nvs:LongtermFinancialDebtWithACarryingAmount>
  <nvs:LongtermFinancialDebtWithACarryingAmount contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-8">2100000000</nvs:LongtermFinancialDebtWithACarryingAmount>
  <nvs:UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">44000000</nvs:UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge>
  <nvs:UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">95000000</nvs:UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge>
  <nvs:NetInvestmentHedgeRecognizedInTheIncomeStatement contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">0</nvs:NetInvestmentHedgeRecognizedInTheIncomeStatement>
  <nvs:BorrowingsCommercialPaperNumberOfPrograms contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="0">3</nvs:BorrowingsCommercialPaperNumberOfPrograms>
  <nvs:BorrowingsCommercialPaperMaximumBorrowingAmount contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-8">2300000000</nvs:BorrowingsCommercialPaperMaximumBorrowingAmount>
  <nvs:BorrowingsCommercialPaperMaximumBorrowingAmount contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-8">4000000000</nvs:BorrowingsCommercialPaperMaximumBorrowingAmount>
  <nvs:BorrowingsCreditFacilityCommitted contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-9">6000000000</nvs:BorrowingsCreditFacilityCommitted>
  <nvs:BorrowingsCreditFacilityCommitted contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-9">6000000000</nvs:BorrowingsCreditFacilityCommitted>
  <nvs:BorrowingsCreditFacilityCommitted contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-9">6000000000</nvs:BorrowingsCreditFacilityCommitted>
  <nvs:BorrowingsCreditFacilityShortTerm contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-9">7000000000</nvs:BorrowingsCreditFacilityShortTerm>
  <nvs:AmountBorrowedUnderTheCreditFacility contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-9">7000000000</nvs:AmountBorrowedUnderTheCreditFacility>
  <nvs:VAREstimateConfidenceInterval contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">0.95</nvs:VAREstimateConfidenceInterval>
  <nvs:MaximumMarginPercentageImpactOfCommodityPriceChange contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="2">0.10</nvs:MaximumMarginPercentageImpactOfCommodityPriceChange>
  <nvs:MaximumHoldingInUnrelatedCompany contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="2">0.05</nvs:MaximumHoldingInUnrelatedCompany>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1158000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">802000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <nvs:FairValueOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">33000000</nvs:FairValueOnSaleOfOtherFinancialAssets>
  <nvs:FairValueOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">21000000</nvs:FairValueOnSaleOfOtherFinancialAssets>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">6390000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">6385000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">4852000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">4895000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">-5434000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1036000000</nvs:ContingentConsiderationLiabilities>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">-907000000</nvs:ContingentConsiderationLiabilities>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">355000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">337000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">89000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">217000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">31000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">122000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">187000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">221000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">5994000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-94000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-482000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-37000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:WeightedAverageShares contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-6">2291000000</ifrs-full:WeightedAverageShares>
  <ifrs-full:WeightedAverageShares contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-6">2319000000</ifrs-full:WeightedAverageShares>
  <ifrs-full:WeightedAverageShares contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-6">2346000000</ifrs-full:WeightedAverageShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-6">28000000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-6">25000000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-6">25000000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-6">2319000000</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-6">2344000000</ifrs-full:AdjustedWeightedAverageShares>
  <ifrs-full:AdjustedWeightedAverageShares contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-6">2371000000</ifrs-full:AdjustedWeightedAverageShares>
  <nvs:OptionsExcludedFromTheCalculation contextRef="AR_D-CurrentYear" unitRef="Pure" decimals="0">0</nvs:OptionsExcludedFromTheCalculation>
  <nvs:OptionsExcludedFromTheCalculation contextRef="AR_D-CurrentYear-1" unitRef="Pure" decimals="0">0</nvs:OptionsExcludedFromTheCalculation>
  <nvs:OptionsExcludedFromTheCalculation contextRef="AR_D-CurrentYear-2" unitRef="Pure" decimals="0">0</nvs:OptionsExcludedFromTheCalculation>
  <ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011 contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">261000000</ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011>
  <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-5">2600000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-5">2500000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-5">2000000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-5">45200000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-5">47300000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-5">54700000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <nvs:AccrualForTaxesOtherThanIncomeTaxesCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">471000000</nvs:AccrualForTaxesOtherThanIncomeTaxesCurrent>
  <nvs:AccrualForTaxesOtherThanIncomeTaxesCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">528000000</nvs:AccrualForTaxesOtherThanIncomeTaxesCurrent>
  <ifrs-full:ShorttermRestructuringProvision contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">438000000</ifrs-full:ShorttermRestructuringProvision>
  <ifrs-full:ShorttermRestructuringProvision contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">507000000</ifrs-full:ShorttermRestructuringProvision>
  <ifrs-full:AccrualsClassifiedAsCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1046000000</ifrs-full:AccrualsClassifiedAsCurrent>
  <ifrs-full:AccrualsClassifiedAsCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">970000000</ifrs-full:AccrualsClassifiedAsCurrent>
  <nvs:AccruedRoyaltiesPayableClassifiedAsCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">653000000</nvs:AccruedRoyaltiesPayableClassifiedAsCurrent>
  <nvs:AccruedRoyaltiesPayableClassifiedAsCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">651000000</nvs:AccruedRoyaltiesPayableClassifiedAsCurrent>
  <ifrs-full:CurrentInterestPayable contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">98000000</ifrs-full:CurrentInterestPayable>
  <ifrs-full:CurrentInterestPayable contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">156000000</ifrs-full:CurrentInterestPayable>
  <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">2464000000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
  <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2527000000</ifrs-full:ShorttermEmployeeBenefitsAccruals>
  <ifrs-full:DeferredIncomeClassifiedAsCurrent contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">114000000</ifrs-full:DeferredIncomeClassifiedAsCurrent>
  <ifrs-full:DeferredIncomeClassifiedAsCurrent contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">236000000</ifrs-full:DeferredIncomeClassifiedAsCurrent>
  <nvs:ContingentConsiderationCurrentPortion contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">78000000</nvs:ContingentConsiderationCurrentPortion>
  <nvs:ContingentConsiderationCurrentPortion contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">33000000</nvs:ContingentConsiderationCurrentPortion>
  <nvs:CommitmentForRepurchaseOwnShares contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">284000000</nvs:CommitmentForRepurchaseOwnShares>
  <ifrs-full:OtherCurrentPayables contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">764000000</ifrs-full:OtherCurrentPayables>
  <ifrs-full:OtherCurrentPayables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">673000000</ifrs-full:OtherCurrentPayables>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-5">72600000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-5">76300000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-5">79100000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-5">24800000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-5">26500000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-5">22400000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-10000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">19348000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-220000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">20001000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-104000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-129000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">18567000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-98000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">19052000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-332000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">196000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">17452000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-109000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">18106000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">252000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011 contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">326000000</ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011>
  <ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011 contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">273000000</ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">354000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-83000000</ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-289000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">47000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-25000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">7952000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">5910000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">43000000</nvs:OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">8380000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">5319000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">-3061000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-6000000</nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">582000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-17000000</ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">77000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">2493000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-20000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">8782000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">7558000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">-1224000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">83000000</nvs:OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">2986000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">3341000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:ValueOfTaxLossCarryforwardsExpired contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">9000000</nvs:ValueOfTaxLossCarryforwardsExpired>
  <nvs:ValueOfTaxLossCarryforwardsExpired contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">8000000</nvs:ValueOfTaxLossCarryforwardsExpired>
  <nvs:ValueOfTaxLossCarryforwardsExpired contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1000000</nvs:ValueOfTaxLossCarryforwardsExpired>
  <nvs:DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-8">4300000000</nvs:DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months>
  <nvs:DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-8">3900000000</nvs:DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months>
  <nvs:DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-8">5200000000</nvs:DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months>
  <nvs:DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-8">6700000000</nvs:DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months>
  <nvs:UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-9">61000000000</nvs:UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment>
  <nvs:UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-9">73000000000</nvs:UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment>
  <nvs:ProvisionForIncomeTaxesOnUnremittedEarnings contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-9">0</nvs:ProvisionForIncomeTaxesOnUnremittedEarnings>
  <nvs:ProvisionForIncomeTaxesOnUnremittedEarnings contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-9">0</nvs:ProvisionForIncomeTaxesOnUnremittedEarnings>
  <nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">440000000</nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">254000000</nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">71000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings>
  <nvs:ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">799000000</nvs:ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities>
  <nvs:ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">0.13</nvs:ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges>
  <nvs:ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges contextRef="AR_I-CurrentYearEnd-1" unitRef="Pure" decimals="2">0.22</nvs:ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges>
  <nvs:ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="2">0.13</nvs:ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges>
  <nvs:ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges contextRef="AR_I-CurrentYearEnd-1" unitRef="Pure" decimals="2">0.08</nvs:ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">124000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">765000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">34000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability>
  <nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-234000000</nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">358000000</nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">39000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets>
  <nvs:OtherComprehensiveIncomeNetOfTaxDebtSecurities contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1000000</nvs:OtherComprehensiveIncomeNetOfTaxDebtSecurities>
  <nvs:OtherComprehensiveIncomeNetOfTaxDebtSecurities contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-1000000</nvs:OtherComprehensiveIncomeNetOfTaxDebtSecurities>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">1000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">12000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">2000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">50000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">44000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">95000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-237000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">352000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">315000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">2210000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">304000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-60000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">1986000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-47000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">13000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments>
  <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-514000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-346000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">851000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">11527000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12208000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">10540000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">11525000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">12210000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">10538000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">2000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
  <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-2000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
  <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">2000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">74891000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">2837000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">6495000000</ifrs-full:DividendsPaid>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">5574000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">255000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">612000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-2000000</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-11204000000</ifrs-full:ChangesInEquity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-406000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">6966000000</ifrs-full:DividendsPaid>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1973000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">434000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <nvs:OtherShareSales contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">263000000</nvs:OtherShareSales>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">756000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-284000000</nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">79000000</nvs:TransactionCostsRecordedInEquity>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">0</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">9000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-1000000</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">38000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-7803000000</ifrs-full:ChangesInEquity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-210000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">6645000000</ifrs-full:DividendsPaid>
  <nvs:DividendPaidNoncashAssetsDistribution contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">23434000000</nvs:DividendPaidNoncashAssetsDistribution>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">5511000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">210000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">833000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">18000000</nvs:SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff>
  <nvs:TaxesOnTreasuryShares contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">189000000</nvs:TaxesOnTreasuryShares>
  <nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">284000000</nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">253000000</nvs:TransactionCostsRecordedInEquity>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">0</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-5000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-1000000</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">0</nvs:FairValueAdjustmentsRelatedToDivestments>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">22000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-34671000000</ifrs-full:ChangesInEquity>
  <nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">129000000</nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement>
  <nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-946000000</nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement>
  <nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement>
  <ifrs-full:IssuedCapital contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">972000000</ifrs-full:IssuedCapital>
  <nvs:IssuedCapitalMovement contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-3000000</nvs:IssuedCapitalMovement>
  <ifrs-full:IssuedCapital contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">969000000</ifrs-full:IssuedCapital>
  <nvs:IssuedCapitalMovement contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-25000000</nvs:IssuedCapitalMovement>
  <nvs:IssuedCapitalMovement contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-8000000</nvs:IssuedCapitalMovement>
  <ifrs-full:TreasuryShares contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">76000000</ifrs-full:TreasuryShares>
  <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-24000000</ifrs-full:SaleOrIssueOfTreasuryShares>
  <ifrs-full:TreasuryShares contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">100000000</ifrs-full:TreasuryShares>
  <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">31000000</ifrs-full:SaleOrIssueOfTreasuryShares>
  <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-11000000</ifrs-full:SaleOrIssueOfTreasuryShares>
  <nvs:OutstandingShareCapital contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">896000000</nvs:OutstandingShareCapital>
  <nvs:OutstandingShareCapitalMovement contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-27000000</nvs:OutstandingShareCapitalMovement>
  <nvs:OutstandingShareCapital contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">869000000</nvs:OutstandingShareCapital>
  <nvs:OutstandingShareCapitalMovement contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">6000000</nvs:OutstandingShareCapitalMovement>
  <nvs:OutstandingShareCapital contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">875000000</nvs:OutstandingShareCapital>
  <nvs:OutstandingShareCapitalMovement contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-19000000</nvs:OutstandingShareCapitalMovement>
  <nvs:OutstandingShareCapital contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">856000000</nvs:OutstandingShareCapital>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-3" unitRef="Shares" decimals="-5">2374100000</ifrs-full:NumberOfSharesOutstanding>
  <nvs:TreasurySharesAcquiredToBeCancelled contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">-60300000</nvs:TreasurySharesAcquiredToBeCancelled>
  <nvs:TreasurySharesAcquiredToBeCancelled contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">-23300000</nvs:TreasurySharesAcquiredToBeCancelled>
  <nvs:TreasurySharesAcquiredToBeCancelled contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">-66200000</nvs:TreasurySharesAcquiredToBeCancelled>
  <nvs:OtherSharePurchases contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">-1700000</nvs:OtherSharePurchases>
  <nvs:OtherSharePurchases contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">-1200000</nvs:OtherSharePurchases>
  <nvs:OtherSharePurchases contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">-3800000</nvs:OtherSharePurchases>
  <nvs:ExerciseOfOptionsAndEmployeeTransactionsShares contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">5500000</nvs:ExerciseOfOptionsAndEmployeeTransactionsShares>
  <nvs:ExerciseOfOptionsAndEmployeeTransactionsShares contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">7800000</nvs:ExerciseOfOptionsAndEmployeeTransactionsShares>
  <nvs:ExerciseOfOptionsAndEmployeeTransactionsShares contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">4600000</nvs:ExerciseOfOptionsAndEmployeeTransactionsShares>
  <nvs:EquityBasedCompensationShares contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">9400000</nvs:EquityBasedCompensationShares>
  <nvs:EquityBasedCompensationShares contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">7400000</nvs:EquityBasedCompensationShares>
  <nvs:EquityBasedCompensationShares contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">8800000</nvs:EquityBasedCompensationShares>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-2" unitRef="Shares" decimals="-5">2317500000</ifrs-full:NumberOfSharesOutstanding>
  <nvs:TreasurySharesWithRestrictedUse contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">117600000</nvs:TreasurySharesWithRestrictedUse>
  <nvs:TreasurySharesWithRestrictedUse contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">121600000</nvs:TreasurySharesWithRestrictedUse>
  <nvs:TreasurySharesWithRestrictedUse contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">131300000</nvs:TreasurySharesWithRestrictedUse>
  <nvs:StockRepurchaseProgramAuthorizedAmount1 contextRef="AR_I-CurrentYearEnd" unitRef="CHF" decimals="-9">10000000000</nvs:StockRepurchaseProgramAuthorizedAmount1>
  <nvs:StockRepurchaseProgramAuthorizedAmount1 contextRef="AR_I-CurrentYearEnd-1" unitRef="CHF" decimals="-9">10000000000</nvs:StockRepurchaseProgramAuthorizedAmount1>
  <nvs:StockRepurchaseProgramAuthorizedAmount1 contextRef="AR_I-CurrentYearEnd-2" unitRef="CHF" decimals="-9">10000000000</nvs:StockRepurchaseProgramAuthorizedAmount1>
  <nvs:WrittenCallOptionsHeldByMarketMaker contextRef="AR_I-CurrentYearEnd" unitRef="Pure" decimals="-6">13000000</nvs:WrittenCallOptionsHeldByMarketMaker>
  <nvs:WrittenCallOptionsHeldByMarketMaker contextRef="AR_I-CurrentYearEnd-1" unitRef="Pure" decimals="-6">11000000</nvs:WrittenCallOptionsHeldByMarketMaker>
  <nvs:WrittenCallOptionsHeldByMarketMaker contextRef="AR_I-CurrentYearEnd-2" unitRef="Pure" decimals="-6">12000000</nvs:WrittenCallOptionsHeldByMarketMaker>
  <nvs:WrittenCallOptionsWeightedAverageExercisePrice contextRef="AR_I-CurrentYearEnd" unitRef="USDPerShares" decimals="2">63.90</nvs:WrittenCallOptionsWeightedAverageExercisePrice>
  <nvs:WrittenCallOptionsWeightedAverageExercisePrice contextRef="AR_I-CurrentYearEnd-1" unitRef="USDPerShares" decimals="2">62.70</nvs:WrittenCallOptionsWeightedAverageExercisePrice>
  <nvs:WrittenCallOptionsWeightedAverageExercisePrice contextRef="AR_I-CurrentYearEnd-2" unitRef="USDPerShares" decimals="2">62.17</nvs:WrittenCallOptionsWeightedAverageExercisePrice>
  <nvs:WrittenCallOptionsContractualLive contextRef="AR_I-CurrentYearEnd" unitRef="Year" decimals="0">10</nvs:WrittenCallOptionsContractualLive>
  <nvs:WrittenCallOptionsContractualLiveRemaining contextRef="AR_I-CurrentYearEnd" unitRef="Year" decimals="0">4</nvs:WrittenCallOptionsContractualLiveRemaining>
  <nvs:WrittenCallOptionsContractualLiveRemaining contextRef="AR_I-CurrentYearEnd-1" unitRef="Year" decimals="0">5</nvs:WrittenCallOptionsContractualLiveRemaining>
  <nvs:WrittenCallOptionsContractualLiveRemaining contextRef="AR_I-CurrentYearEnd-2" unitRef="Year" decimals="0">6</nvs:WrittenCallOptionsContractualLiveRemaining>
  <nvs:MaximalAmountOfShareBuybackProgramm contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-9">5000000000</nvs:MaximalAmountOfShareBuybackProgramm>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</nvs:TransactionCostsRecordedInEquity>
  <nvs:TaxOnTransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">36000000</nvs:TaxOnTransactionCostsRecordedInEquity>
  <nvs:TaxOnTransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">20000000</nvs:TaxOnTransactionCostsRecordedInEquity>
  <nvs:TaxOnTransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</nvs:TaxOnTransactionCostsRecordedInEquity>
  <nvs:AmountRecordedInEquityRelatedToHyperinflation contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">22000000</nvs:AmountRecordedInEquityRelatedToHyperinflation>
  <nvs:AmountRecordedInEquityRelatedToHyperinflation contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">38000000</nvs:AmountRecordedInEquityRelatedToHyperinflation>
  <nvs:AmountRecordedInEquityRelatedToHyperinflation contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</nvs:AmountRecordedInEquityRelatedToHyperinflation>
  <nvs:DividendsPayableAmountPerShare contextRef="AR_I-CurrentYearEnd" unitRef="CHFPerShares" decimals="2">2.85</nvs:DividendsPayableAmountPerShare>
  <nvs:DividendsPayableAmountPerShare contextRef="AR_I-CurrentYearEnd-1" unitRef="CHFPerShares" decimals="2">2.80</nvs:DividendsPayableAmountPerShare>
  <nvs:DividendsPayableAmountPerShare contextRef="AR_I-CurrentYearEnd-2" unitRef="CHFPerShares" decimals="2">2.75</nvs:DividendsPayableAmountPerShare>
  <nvs:TreasurySharesAcquiredForCancellationValue contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">5351000000</nvs:TreasurySharesAcquiredForCancellationValue>
  <nvs:TreasurySharesAcquiredForCancellationValue contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">1859000000</nvs:TreasurySharesAcquiredForCancellationValue>
  <nvs:TreasurySharesAcquiredForCancellationValue contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">5270000000</nvs:TreasurySharesAcquiredForCancellationValue>
  <nvs:OtherSharePurchasesValue contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">160000000</nvs:OtherSharePurchasesValue>
  <nvs:OtherSharePurchasesValue contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">114000000</nvs:OtherSharePurchasesValue>
  <nvs:OtherSharePurchasesValue contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">304000000</nvs:OtherSharePurchasesValue>
  <nvs:SharepurchaseOfTreasuryShares contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">-62000000</nvs:SharepurchaseOfTreasuryShares>
  <nvs:SharepurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">-24500000</nvs:SharepurchaseOfTreasuryShares>
  <nvs:SharepurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">-70000000</nvs:SharepurchaseOfTreasuryShares>
  <nvs:OtherShareSalesEquityImpact contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">0</nvs:OtherShareSalesEquityImpact>
  <nvs:OtherShareSalesEquityImpact contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">263000000</nvs:OtherShareSalesEquityImpact>
  <nvs:TreasurySharesMovement contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">-46200000</nvs:TreasurySharesMovement>
  <nvs:EquityImpactOfTreasuryShareMovements contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">4450000000</nvs:EquityImpactOfTreasuryShareMovements>
  <nvs:TreasurySharesMovement contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">-6300000</nvs:TreasurySharesMovement>
  <nvs:EquityImpactOfTreasuryShareMovements contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-520000000</nvs:EquityImpactOfTreasuryShareMovements>
  <nvs:TreasurySharesMovement contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">-56600000</nvs:TreasurySharesMovement>
  <nvs:EquityImpactOfTreasuryShareMovements contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-4707000000</nvs:EquityImpactOfTreasuryShareMovements>
  <nvs:SharesDeliveredToDivestedBusinessEmployees contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">900000</nvs:SharesDeliveredToDivestedBusinessEmployees>
  <nvs:NumberOfOtherShareSales contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">0</nvs:NumberOfOtherShareSales>
  <nvs:NumberOfOtherShareSales contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">3000000</nvs:NumberOfOtherShareSales>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear" unitRef="Shares" decimals="-5">-46200000</nvs:ShareMovements>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear-1" unitRef="Shares" decimals="-5">-6300000</nvs:ShareMovements>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear-2" unitRef="Shares" decimals="-5">-56600000</nvs:ShareMovements>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd" unitRef="Shares" decimals="-5">2265000000</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-1" unitRef="Shares" decimals="-5">2311200000</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">220000000</ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment>
  <ifrs-full:BorrowingCostsCapitalised contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">4000000</ifrs-full:BorrowingCostsCapitalised>
  <nvs:NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">79000000</nvs:NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts>
  <ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">289000000</ifrs-full:ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment>
  <ifrs-full:BorrowingCostsCapitalised contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">6000000</ifrs-full:BorrowingCostsCapitalised>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">37000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">0</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">0</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-8">8500000000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
  <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-8">8300000000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
  <ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-8">8200000000</ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod>
  <ifrs-full:InventoryWritedown2011 contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">-752000000</ifrs-full:InventoryWritedown2011>
  <ifrs-full:InventoryWritedown2011 contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">-603000000</ifrs-full:InventoryWritedown2011>
  <ifrs-full:InventoryWritedown2011 contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">-416000000</ifrs-full:InventoryWritedown2011>
  <ifrs-full:ReversalOfInventoryWritedown contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">218000000</ifrs-full:ReversalOfInventoryWritedown>
  <ifrs-full:ReversalOfInventoryWritedown contextRef="AR_D-CurrentYear-1" unitRef="USD" decimals="-6">216000000</ifrs-full:ReversalOfInventoryWritedown>
  <ifrs-full:ReversalOfInventoryWritedown contextRef="AR_D-CurrentYear-2" unitRef="USD" decimals="-6">172000000</ifrs-full:ReversalOfInventoryWritedown>
  <nvs:CurrentTradeReceivablesFromCloselyMonitoredCountries contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1588000000</nvs:CurrentTradeReceivablesFromCloselyMonitoredCountries>
  <nvs:CurrentTradeReceivablesFromCloselyMonitoredCountries contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1729000000</nvs:CurrentTradeReceivablesFromCloselyMonitoredCountries>
  <nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">61000000</nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear>
  <nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">97000000</nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear>
  <nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">-24000000</nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded>
  <nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">-44000000</nvs:CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded>
  <ifrs-full:CurrentValueAddedTaxReceivables contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">508000000</ifrs-full:CurrentValueAddedTaxReceivables>
  <ifrs-full:CurrentValueAddedTaxReceivables contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">588000000</ifrs-full:CurrentValueAddedTaxReceivables>
  <nvs:WithholdingTaxRecoverable contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">108000000</nvs:WithholdingTaxRecoverable>
  <nvs:WithholdingTaxRecoverable contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">99000000</nvs:WithholdingTaxRecoverable>
  <nvs:CurrentPrepaidExpensesThirdParty contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">898000000</nvs:CurrentPrepaidExpensesThirdParty>
  <nvs:CurrentPrepaidExpensesThirdParty contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">811000000</nvs:CurrentPrepaidExpensesThirdParty>
  <nvs:CurrentPrepaidExpensesAssociatedCompanies contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1000000</nvs:CurrentPrepaidExpensesAssociatedCompanies>
  <nvs:ReceivablesAssociatedCompanies contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1000000</nvs:ReceivablesAssociatedCompanies>
  <nvs:ReceivablesAssociatedCompanies contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">2000000</nvs:ReceivablesAssociatedCompanies>
  <nvs:OtherReceivablesAndCurrentAssets contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">1165000000</nvs:OtherReceivablesAndCurrentAssets>
  <nvs:OtherReceivablesAndCurrentAssets contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1360000000</nvs:OtherReceivablesAndCurrentAssets>
  <nvs:UndiscountedOperatingLeaseCommitments contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-8">3600000000</nvs:UndiscountedOperatingLeaseCommitments>
  <nvs:ShortTermLeasesAndLowValueLeases contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-8">100000000</nvs:ShortTermLeasesAndLowValueLeases>
  <nvs:RemainingLeaseCommitments contextRef="AR_I-CurrentYearStart" unitRef="USD" decimals="-8">3300000000</nvs:RemainingLeaseCommitments>
  <nvs:LeaseLiabilitiesToBeRecognized contextRef="AR_I-CurrentYearStart" unitRef="USD" decimals="-7">1740000000</nvs:LeaseLiabilitiesToBeRecognized>
  <nvs:RightOfUseAssetsToBeRecognized contextRef="AR_I-CurrentYearStart" unitRef="USD" decimals="-7">1550000000</nvs:RightOfUseAssetsToBeRecognized>
  <nvs:PrepaymentsAndAccruedLeasePayments contextRef="AR_I-CurrentYearStart" unitRef="USD" decimals="-7">300000000</nvs:PrepaymentsAndAccruedLeasePayments>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd" unitRef="USD" decimals="-6">5595000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">5262000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">4672000000</ifrs-full:CurrentRefundsProvision>
  <nvs:UndiscountedFutureLeasePayments contextRef="AR_D-CurrentYearStart" unitRef="USD" decimals="-6">3283000000</nvs:UndiscountedFutureLeasePayments>
  <nvs:EffectOfDiscounting contextRef="AR_D-CurrentYearStart" unitRef="USD" decimals="-6">1547000000</nvs:EffectOfDiscounting>
  <nvs:DisposalsAndRetirementsRightofuseAssets contextRef="AR_D-CurrentYear" unitRef="USD" decimals="-6">17000000</nvs:DisposalsAndRetirementsRightofuseAssets>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-3" unitRef="USD" decimals="-6">4183000000</ifrs-full:CurrentRefundsProvision>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">18000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI>
  <nvs:AcquiredCashAndCashEquivalents contextRef="AR_I-CurrentYearEnd-1" unitRef="USD" decimals="-6">1112000000</nvs:AcquiredCashAndCashEquivalents>
  <nvs:AcquiredCashAndCashEquivalents contextRef="AR_I-CurrentYearEnd-2" unitRef="USD" decimals="-6">20000000</nvs:AcquiredCashAndCashEquivalents>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">6948000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">12417000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">10211000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">521000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">186000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">31000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">18248000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">17772000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">8940000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">14095000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">9102000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:AverageEffectiveTaxRate contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.201</ifrs-full:AverageEffectiveTaxRate>
  <ifrs-full:AverageEffectiveTaxRate contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.092</ifrs-full:AverageEffectiveTaxRate>
  <ifrs-full:AverageEffectiveTaxRate contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.176</ifrs-full:AverageEffectiveTaxRate>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">59000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">7142000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">12797000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">7499000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">107000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">63000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">220000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">47000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions>
  <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">422000000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
  <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">443000000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
  <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">307000000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">-259000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI>
  <ifrs-full:GrossLeaseLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">3390000000</ifrs-full:GrossLeaseLiabilities>
  <nvs:EnvironmentalProvisionReleases contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">21000000</nvs:EnvironmentalProvisionReleases>
  <nvs:EnvironmentalProvisionReleases contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">153000000</nvs:EnvironmentalProvisionReleases>
  <nvs:EnvironmentalProvisionAdditions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">7000000</nvs:EnvironmentalProvisionAdditions>
  <nvs:EnvironmentalProvisionAdditions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">154000000</nvs:EnvironmentalProvisionAdditions>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1687000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">13660000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">874000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1471000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">268000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">593000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-185000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">61000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">3000000</nvs:AdditionsToRestructuringProvisions>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">52000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">208000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">853000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">122000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-42000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">591000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">61000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">916000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">270000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">117000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">2167000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">447000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">10000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">84000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">73000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">761000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">94000000</nvs:AdditionsToRestructuringProvisions>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">645000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">395000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">165000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">32000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">98000000</nvs:AdditionsToRestructuringProvisions>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">67000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">53000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">239000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">220000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1067000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">918000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">229000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">20000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-113000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">18000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">107000000</nvs:ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">632000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">592000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">506000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">249000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">7000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">100000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">239000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">101000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">60000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">1000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">952000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1075000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">283000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">285000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">110000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">122000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">247000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">41000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">17000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">2509000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">2214000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">315000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">366000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">12000000</ifrs-full:DepreciationAndAmortisationExpense>
  <nvs:EffectOfUSTaxReformLegislation contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.048</nvs:EffectOfUSTaxReformLegislation>
  <nvs:EffectOfIncomeNotSubjectToTaxOnDivestmentGain contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.037</nvs:EffectOfIncomeNotSubjectToTaxOnDivestmentGain>
  <nvs:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.026</nvs:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
  <nvs:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.004</nvs:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
  <ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">11000000</ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense>
  <ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">19000000</ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense>
  <ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">7000000</ifrs-full:TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">30000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">94000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">44000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">60000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">8097000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">11887000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">5385000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">843000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">2208000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">3717000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">1186000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">615000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">462000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">961000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">988000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">2147000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1603000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1913000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">93000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">-354000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">-308000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">-310000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1793000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1295000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">1603000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:ApplicableTaxRate contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.117</ifrs-full:ApplicableTaxRate>
  <ifrs-full:ApplicableTaxRate contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.143</ifrs-full:ApplicableTaxRate>
  <ifrs-full:ApplicableTaxRate contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.143</ifrs-full:ApplicableTaxRate>
  <ifrs-full:TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.048</ifrs-full:TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ifrs-full:TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.017</ifrs-full:TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ifrs-full:TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.031</ifrs-full:TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
  <ifrs-full:TaxRateEffectOfTaxLosses contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.001</ifrs-full:TaxRateEffectOfTaxLosses>
  <ifrs-full:TaxRateEffectOfTaxLosses contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.001</ifrs-full:TaxRateEffectOfTaxLosses>
  <ifrs-full:TaxRateEffectOfTaxLosses contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.001</ifrs-full:TaxRateEffectOfTaxLosses>
  <nvs:TaxRateEffectOfIncomeTaxedAtReducedRates contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.007</nvs:TaxRateEffectOfIncomeTaxedAtReducedRates>
  <nvs:TaxRateEffectOfIncomeTaxedAtReducedRates contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.004</nvs:TaxRateEffectOfIncomeTaxedAtReducedRates>
  <nvs:TaxRateEffectOfIncomeTaxedAtReducedRates contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.002</nvs:TaxRateEffectOfIncomeTaxedAtReducedRates>
  <ifrs-full:TaxRateEffectOfRevenuesExemptFromTaxation contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.000</ifrs-full:TaxRateEffectOfRevenuesExemptFromTaxation>
  <ifrs-full:TaxRateEffectOfRevenuesExemptFromTaxation contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.037</ifrs-full:TaxRateEffectOfRevenuesExemptFromTaxation>
  <ifrs-full:TaxRateEffectOfRevenuesExemptFromTaxation contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.000</ifrs-full:TaxRateEffectOfRevenuesExemptFromTaxation>
  <nvs:TaxRateEffectOfCreditsAndAllowances contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.023</nvs:TaxRateEffectOfCreditsAndAllowances>
  <nvs:TaxRateEffectOfCreditsAndAllowances contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.023</nvs:TaxRateEffectOfCreditsAndAllowances>
  <nvs:TaxRateEffectOfCreditsAndAllowances contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.021</nvs:TaxRateEffectOfCreditsAndAllowances>
  <nvs:TaxRateEffectOfReleaseOfContingentConsiderationLiability contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.005</nvs:TaxRateEffectOfReleaseOfContingentConsiderationLiability>
  <nvs:TaxRateEffectOfReleaseOfContingentConsiderationLiability contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.002</nvs:TaxRateEffectOfReleaseOfContingentConsiderationLiability>
  <nvs:TaxRateEffectOfReleaseOfContingentConsiderationLiability contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.013</nvs:TaxRateEffectOfReleaseOfContingentConsiderationLiability>
  <ifrs-full:TaxRateEffectFromChangeInTaxRate contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.014</ifrs-full:TaxRateEffectFromChangeInTaxRate>
  <ifrs-full:TaxRateEffectFromChangeInTaxRate contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.001</ifrs-full:TaxRateEffectFromChangeInTaxRate>
  <ifrs-full:TaxRateEffectFromChangeInTaxRate contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.048</ifrs-full:TaxRateEffectFromChangeInTaxRate>
  <nvs:EffectOfWriteoffOfDeferredTaxAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.040</nvs:EffectOfWriteoffOfDeferredTaxAssets>
  <nvs:EffectOfWriteoffOfDeferredTaxAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.002</nvs:EffectOfWriteoffOfDeferredTaxAssets>
  <nvs:EffectOfWriteoffOfDeferredTaxAssets contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.000</nvs:EffectOfWriteoffOfDeferredTaxAssets>
  <nvs:TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.006</nvs:TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries>
  <nvs:TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.000</nvs:TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries>
  <nvs:TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.011</nvs:TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries>
  <nvs:TaxRateEffectFromBenefitsExpiring contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.000</nvs:TaxRateEffectFromBenefitsExpiring>
  <nvs:TaxRateEffectFromBenefitsExpiring contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.000</nvs:TaxRateEffectFromBenefitsExpiring>
  <nvs:TaxRateEffectFromBenefitsExpiring contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.009</nvs:TaxRateEffectFromBenefitsExpiring>
  <ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.022</ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods>
  <ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.005</ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods>
  <ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.012</ifrs-full:TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods>
  <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.030</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
  <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">0.003</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
  <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="Pure" decimals="3">-0.001</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
  <ifrs-full:CurrentTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">1451000000</ifrs-full:CurrentTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">120000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">305000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">-447000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">-428000000</ifrs-full:DeferredTaxExpenseIncome>
  <ifrs-full:DeferredTaxExpenseIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember" unitRef="USD" decimals="-6">-615000000</ifrs-full:DeferredTaxExpenseIncome>
  <nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">241000000</nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019ContinuingOperationsMember" unitRef="USD" decimals="-6">66000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">0</ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">13000000</nvs:AdditionsToRestructuringProvisions>
  <nvs:AdditionsToRestructuringProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">8000000</nvs:AdditionsToRestructuringProvisions>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">9000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">93000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">71000000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">113000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">519000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">36000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">196000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="Pure" decimals="3">0.075</ifrs-full:DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal>
  <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="Pure" decimals="2">0.03</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">391000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CyPassMember" unitRef="USD" decimals="-6">337000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">79000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
  <ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">229000000</ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived>
  <ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-16000000</ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable>
  <nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">213000000</nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue>
  <nvs:FinanceLeaseProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-65000000</nvs:FinanceLeaseProvision>
  <ifrs-full:FinanceLeaseReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">148000000</ifrs-full:FinanceLeaseReceivables>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1777000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">7149000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">6771000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">32000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">4000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1809000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">7153000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">6774000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:OtherRevenue>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">860000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3983000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3588000000</ifrs-full:CostOfSales>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">949000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3170000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3189000000</ifrs-full:GrossProfit>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">638000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">2754000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">2532000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">142000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">585000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">583000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">15000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">61000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">47000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">113000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">126000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">194000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">71000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-234000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-73000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:InterestExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">10000000</ifrs-full:InterestExpense>
  <ifrs-full:InterestExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">25000000</ifrs-full:InterestExpense>
  <ifrs-full:InterestExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">27000000</ifrs-full:InterestExpense>
  <ifrs-full:OtherFinanceIncomeCost contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:OtherFinanceIncomeCost>
  <ifrs-full:OtherFinanceIncomeCost contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:OtherFinanceIncomeCost>
  <ifrs-full:OtherFinanceIncomeCost contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:OtherFinanceIncomeCost>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">58000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-260000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:ProfitLossBeforeTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-103000000</ifrs-full:ProfitLossBeforeTax>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">159000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-74000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-307000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
  <nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-101000000</nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution>
  <nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-186000000</nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution>
  <nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">204000000</nvs:NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution>
  <nvs:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">4691000000</nvs:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">4590000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-186000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:ProfitLossFromDiscontinuedOperations contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">204000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
  <ifrs-full:RevenueFromInterest contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:RevenueFromInterest>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">42000000</ifrs-full:DepreciationAndAmortisationExpense>
  <nvs:FinanceLeaseProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">-28000000</nvs:FinanceLeaseProvision>
  <ifrs-full:FinanceLeaseReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">80000000</ifrs-full:FinanceLeaseReceivables>
  <ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">48000000</ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived>
  <ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable>
  <nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">46000000</nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue>
  <nvs:FinanceLeaseProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">-35000000</nvs:FinanceLeaseProvision>
  <ifrs-full:FinanceLeaseReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">11000000</ifrs-full:FinanceLeaseReceivables>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">235000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">217000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">9000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">174000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1052000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1066000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">391000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">57000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">64000000</ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived>
  <ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">-5000000</ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable>
  <nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">59000000</nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue>
  <nvs:FinanceLeaseProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">-2000000</nvs:FinanceLeaseProvision>
  <ifrs-full:FinanceLeaseReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">57000000</ifrs-full:FinanceLeaseReceivables>
  <ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">117000000</ifrs-full:UndiscountedFinanceLeasePaymentsToBeReceived>
  <ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">-9000000</ifrs-full:UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable>
  <nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">108000000</nvs:MinimumFinaceLeasePaymentsReceivableAtPresentValue>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-89000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">246000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">40000000</ifrs-full:LeaseLiabilities>
  <nvs:DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-47000000</nvs:DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations>
  <nvs:DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-246000000</nvs:DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations>
  <nvs:DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-40000000</nvs:DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">0</ifrs-full:IncomeTaxesPaidRefundClassifiedAsInvestingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">38000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">164000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">124000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
  <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">140000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations>
  <nvs:CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-29000000</nvs:CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents>
  <nvs:DivestedCashAndCashEquivalents contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">628000000</nvs:DivestedCashAndCashEquivalents>
  <nvs:CashFlowsAttributableToDivestedBusiness contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-657000000</nvs:CashFlowsAttributableToDivestedBusiness>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-502000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-1001000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-775000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities>
  <nvs:ProceedsFromCurrentAndNoncurrentBorrowings contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3492000000</nvs:ProceedsFromCurrentAndNoncurrentBorrowings>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">212000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">57000000</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
  <ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">0</ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities>
  <ifrs-full:GrossLeaseLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-222000000</ifrs-full:GrossLeaseLiabilities>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-13000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-662000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-385000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-424000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-40000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-238000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">0</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">33000000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
  <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">104000000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
  <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">99000000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-345000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">4590000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-186000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">204000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
  <nvs:OtherNetAssets contextRef="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">6000000</nvs:OtherNetAssets>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">6000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:DividendsPayable contextRef="AR_I-Transaction-Alcon-2-March-31_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">26400000000</ifrs-full:DividendsPayable>
  <ifrs-full:NetAssetsLiabilities contextRef="AR_I-Transaction-Alcon-2-March-31_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">23100000000</ifrs-full:NetAssetsLiabilities>
  <ifrs-full:OtherBorrowings contextRef="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">3200000000</ifrs-full:OtherBorrowings>
  <ifrs-full:OtherBorrowings contextRef="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4BorrowingsUSDMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">2800000000</ifrs-full:OtherBorrowings>
  <ifrs-full:OtherBorrowings contextRef="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4BorrowingsEURMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">400000000</ifrs-full:OtherBorrowings>
  <nvs:AdditionalBorrowings contextRef="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">300000000</nvs:AdditionalBorrowings>
  <nvs:RepaymentOfIntercompanyBalances contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">3100000000</nvs:RepaymentOfIntercompanyBalances>
  <ifrs-full:Borrowings contextRef="AR_I-Transaction-Alcon-1-March-6_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">3500000000</ifrs-full:Borrowings>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-Transaction-Alcon-4-April-9_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-8">1300000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">424000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">289000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">135000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">418000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">505000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-Transaction-PowerVision-1_dei-2019LegalEntityAxis_nvs-2019Q4PowerVisionInc.Member_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">93000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">-28000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">-19000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">163000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-82000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-1403000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">123000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">217000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">248000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">39000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">4577000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-207000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">327000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">5000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability>
  <nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">13000000</nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">0</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:AdditionsToRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:AdditionsToRightofuseAssets>
  <nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-416000000</nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">0</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-194000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-166000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-28000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">0</ifrs-full:CurrentRefundsProvision>
  <nvs:NetAssetsDerecognized contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-20025000000</nvs:NetAssetsDerecognized>
  <ifrs-full:DividendsPayable contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-23434000000</ifrs-full:DividendsPayable>
  <ifrs-full:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3409000000</ifrs-full:DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed>
  <nvs:DistributionOfDividendToDividendBearingShares contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1273000000</nvs:DistributionOfDividendToDividendBearingShares>
  <nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">123000000</nvs:CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement>
  <nvs:TransactionCosts contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">114000000</nvs:TransactionCosts>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">-858000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">286000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">276000000</ifrs-full:RightofuseAssets>
  <nvs:RemainingLeaseCommitments contextRef="AR_I-CurrentYearStart_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-8">200000000</nvs:RemainingLeaseCommitments>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">2858000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:RightofuseAssets contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">269000000</ifrs-full:RightofuseAssets>
  <ifrs-full:Goodwill contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">8906000000</ifrs-full:Goodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">11121000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DeferredTaxAssets contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">732000000</ifrs-full:DeferredTaxAssets>
  <nvs:FinancialAndOtherNoncurrentAssets contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">526000000</nvs:FinancialAndOtherNoncurrentAssets>
  <ifrs-full:Inventories contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1469000000</ifrs-full:Inventories>
  <nvs:TradeReceivablesAndOtherCurrentAssets contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1787000000</nvs:TradeReceivablesAndOtherCurrentAssets>
  <ifrs-full:CashAndCashEquivalents contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">628000000</ifrs-full:CashAndCashEquivalents>
  <ifrs-full:DeferredTaxLiabilities contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">1713000000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">269000000</ifrs-full:LeaseLiabilities>
  <nvs:CurrentAndNoncurrentFinancialDebt contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">3538000000</nvs:CurrentAndNoncurrentFinancialDebt>
  <nvs:TradePayablesProvisionsAndOtherLiabilities contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">2751000000</nvs:TradePayablesProvisionsAndOtherLiabilities>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember" unitRef="USD" decimals="-6">54000000</ifrs-full:CurrentTradeReceivables>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">22000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">187000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">337000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">217000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">303000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">86000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">16000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019BottomOfRangeMember" unitRef="USD" decimals="-6">169000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">361000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">195000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">81000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">385000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">303000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">553000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">473000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019TopOfRangeMember" unitRef="USD" decimals="-6">122000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">7807000000</ifrs-full:PropertyPlantAndEquipment>
  <nvs:NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">79000000</nvs:NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">14135000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">6339000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-5983000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">56000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-574000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">180000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-122000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">115000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-6328000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">14064000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-5124000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">114000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">40000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">538000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">110000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">212000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-291000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">32000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">11463000000</ifrs-full:PropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">562000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">1170000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-447000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-51000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">1000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-33000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">3000000</nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">1615000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">24000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">332000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">112000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">1551000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">1774000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">355000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">630000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">9000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">8000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">2678000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-9000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">0</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-110000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-898000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">1674000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">0</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">2000000</nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">1541000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">13674000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-13000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">457000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">407000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">931000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">80000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">160000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">16858000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-9726000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">361000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">12000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-185000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">412000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-1140000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">101000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-11485000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">17155000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-504000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">5231000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">-11924000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019MachineryMember" unitRef="USD" decimals="-6">3948000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">15106000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">14263000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">6167000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">5618000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">8939000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">8645000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">14457000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">13470000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-649000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-793000000</ifrs-full:SurplusDeficitInPlan>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">848000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">795000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">780000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">33032000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="Pure" decimals="2">0.43</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="USD" decimals="-6">41972000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019CountryOfDomicileMember" unitRef="Pure" decimals="2">0.43</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-1366000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-1360000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3042000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3208000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1421000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1491000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1531000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1616000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1517000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1400000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">491000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">4408000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">4568000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">466000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">88000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">72000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">88000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">72000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">36000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">25000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">52000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">47000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-88000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_ifrsfull-2019ForeignCountriesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-72000000</ifrs-full:SurplusDeficitInPlan>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">809000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1201000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">46000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">246000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">295000000</nvs:LeaseLiabilitiesUndiscounted>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">3190000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneYearMember" unitRef="USD" decimals="-6">2002000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" decimals="-6">2006000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" decimals="-6">2067000000</ifrs-full:Borrowings>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" decimals="-6">202000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" decimals="-6">246000000</nvs:LeaseLiabilitiesUndiscounted>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1116000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">47000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanTwoYearsMember" unitRef="USD" decimals="-6">442000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember" unitRef="USD" decimals="-6">319000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1106000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">48000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember" unitRef="USD" decimals="-6">163000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember" unitRef="USD" decimals="-6">202000000</nvs:LeaseLiabilitiesUndiscounted>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember" unitRef="USD" decimals="-6">2111000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanTwoYearsAndNotLaterThanThreeYearsMember" unitRef="USD" decimals="-6">2583000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember" unitRef="USD" decimals="-6">2585000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember" unitRef="USD" decimals="-6">2321000000</ifrs-full:Borrowings>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember" unitRef="USD" decimals="-6">138000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember" unitRef="USD" decimals="-6">173000000</nvs:LeaseLiabilitiesUndiscounted>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1096000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">48000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanThreeYearsAndNotLaterThanFourYearsMember" unitRef="USD" decimals="-6">724000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">167000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1087000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">48000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">119000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">150000000</nvs:LeaseLiabilitiesUndiscounted>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">2278000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFourYearsAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">2139000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">11243000000</ifrs-full:Borrowings>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">-339000000</nvs:ContingentConsiderationLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">3755000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">383000000</nvs:ContingentConsiderationLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">-3439000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">13323000000</ifrs-full:NetDebt>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">13623000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">13490000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">57000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember" unitRef="USD" decimals="-6">110000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">3000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">170000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">11243000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">11355000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">11243000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">11073000000</ifrs-full:NetDebt>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">63000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember" unitRef="USD" decimals="-6">104000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">167000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">13490000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">1081000000</ifrs-full:LeaseLiabilities>
  <nvs:LeaseLiabilitiesUndiscounted contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">2419000000</nvs:LeaseLiabilitiesUndiscounted>
  <nvs:CommitmentsUnderLongtermResearchAgreements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsMember" unitRef="USD" decimals="-6">1943000000</nvs:CommitmentsUnderLongtermResearchAgreements>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">-126000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">8301000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">8727000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">-162000000</ifrs-full:CurrentTradeReceivables>
  <nvs:ImpactOfDivestmentsOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">12000000</nvs:ImpactOfDivestmentsOtherProvisions>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">1000000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">89000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">47000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">8396000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">8853000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">-95000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019RUB" unitRef="USD" decimals="-6">341000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019RUB" unitRef="USD" decimals="-6">247000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CNY" unitRef="USD" decimals="-6">279000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CNY" unitRef="USD" decimals="-6">282000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019GBP" unitRef="USD" decimals="-6">202000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019GBP" unitRef="USD" decimals="-6">183000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019BRL" unitRef="USD" decimals="-6">165000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019BRL" unitRef="USD" decimals="-6">206000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CAD" unitRef="USD" decimals="-6">129000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CAD" unitRef="USD" decimals="-6">136000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019AUD" unitRef="USD" decimals="-6">125000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019AUD" unitRef="USD" decimals="-6">161000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CHF" unitRef="USD" decimals="-6">89000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019CHF" unitRef="USD" decimals="-6">100000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">1655000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">1693000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019CurrentMember" unitRef="USD" decimals="-6">7763000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">-12000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">9000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">-190000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019CurrentMember" unitRef="USD" decimals="-6">7916000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">119000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">12000000</ifrs-full:ProvisionUsedOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">39000000</ifrs-full:ProvisionUsedOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">12000000</ifrs-full:ProvisionUsedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">53000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">61000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">76000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_nvs-2019Q4ProvisionForDoubtfulReceivableMember_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">161000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">296000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">123000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">194000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" unitRef="USD" decimals="-6">103000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" unitRef="USD" decimals="-6">136000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanSixMonthsAndNotLaterThanOneYearMember" unitRef="USD" decimals="-6">96000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanSixMonthsAndNotLaterThanOneYearMember" unitRef="USD" decimals="-6">98000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneYearMember" unitRef="USD" decimals="-6">150000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_ifrsfull-2019PastDueStatusAxis_ifrsfull-2019LaterThanOneYearMember" unitRef="USD" decimals="-6">213000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">3466000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">3510000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">1384000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">1551000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019JPY" unitRef="USD" decimals="-6">466000000</ifrs-full:CurrentTradeReceivables>
  <ifrs-full:CurrentTradeReceivables contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialInstrumentsAxis_ifrsfull-2019TradeReceivablesMember_srt-2018CurrencyAxis_currency-2019JPY" unitRef="USD" decimals="-6">658000000</ifrs-full:CurrentTradeReceivables>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">9000000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">23000000</nvs:AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale>
  <nvs:AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">21000000</nvs:AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">249000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember" unitRef="USD" decimals="-6">2980000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">5369000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">4440000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">5960000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">572000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">19570000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">1000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-4000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">186000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">342000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">3550000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">22000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">3914000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-9069000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">9069000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">265000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">243000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">259000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">767000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">75000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">544000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">436000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">-887000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">696000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">2042000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">34028000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">2368000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">720000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">34010000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">11000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">24000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">309000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">2000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">15000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">137000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">1000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-1470000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">7000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">1250000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">1774000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">7000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">21000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">697000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-16000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-76000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">21000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">512000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">1000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">26999000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">1350000000</ifrs-full:PropertyPlantAndEquipment>
  <nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">127000000</nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">5009000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">122000000</nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">23000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">10000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">12000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">655000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">44000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">57000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">1000000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">0</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">6000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-1019000000</ifrs-full:IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">1474000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">75000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">1001000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">3409000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">1000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">9000000</ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">61000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">1055000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-61000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">49000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">254000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">32000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">335000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">26825000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">7429000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">884000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">43548000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">1558000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">53419000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">32179000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">6462000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember" unitRef="USD" decimals="-6">2980000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">6638000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">34105000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">5960000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">1852000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">57997000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">9000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">276000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">1116000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">1403000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">4084000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">10224000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">2531000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">1000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">12756000000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-697000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">479000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">218000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">477000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">728000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">385000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">1592000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">214000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">70000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">928000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">183000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">1395000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-183000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-380000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-76000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-41000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-387000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-18000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-522000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">35700000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">16167000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember" unitRef="USD" decimals="-6">2980000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">6253000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">35412000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">5960000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">2253000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">69025000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <nvs:AdditionsIncludedInDisposalGroupToTheDateOfReclassification contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019GrossCarryingAmountMember" unitRef="USD" decimals="-6">0</nvs:AdditionsIncludedInDisposalGroupToTheDateOfReclassification>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-6">16280000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="Pure" decimals="2">0.34</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-6">14618000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="Pure" decimals="2">0.33</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-6">14135000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="Pure" decimals="2">0.33</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-6">28893000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="Pure" decimals="2">0.37</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-6">39082000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="Pure" decimals="2">0.40</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-882000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-524000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">119000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">134000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">713000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">522000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">15000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">18000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">270000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">121000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">524000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">882000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">1001000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">658000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019LegalProceedingsProvisionMember_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-8">700000000</nvs:ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent>
  <nvs:DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">54</nvs:DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">670000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3348000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3552000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">649000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">630000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1205000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1131000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">653000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1717000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1564000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">2311000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">2160000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-1241000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-1188000000</ifrs-full:SurplusDeficitInPlan>
  <nvs:AdditionalAmountOfSettlementInPrinciple contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NPCAndOthersMember" unitRef="USD" decimals="-6">28000000</nvs:AdditionalAmountOfSettlementInPrinciple>
  <nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ReclastAclastaMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NPCAndOthersMember" unitRef="Pure" decimals="0">20</nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases>
  <nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TaxotereMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">2900</nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases>
  <nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AmiodaroneMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">10</nvs:ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases>
  <nvs:AmountOfResolvedAction contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US" unitRef="USD" decimals="-6">21000000</nvs:AmountOfResolvedAction>
  <nvs:AmountOfSettlementInPrinciple contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NPCAndOthersMember" unitRef="USD" decimals="-6">23000000</nvs:AmountOfSettlementInPrinciple>
  <nvs:DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EnoxaparinMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">1</nvs:DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt>
  <nvs:AmountOfSettlementInPrinciple contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EnoxaparinMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember_srt-2018LitigationCaseAxis_nvs-2019Q4TennesseeClassActionMember" unitRef="USD" decimals="-6">85000000</nvs:AmountOfSettlementInPrinciple>
  <nvs:AmountOfSettlementInPrinciple contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17US_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EnoxaparinMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember_srt-2018LitigationCaseAxis_nvs-2019Q4MassachusettsCaseMember" unitRef="USD" decimals="-6">39000000</nvs:AmountOfSettlementInPrinciple>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfDiscountRatesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">-787000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfDiscountRatesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">837000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">546000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">-135000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">54000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_ifrsfull-2019ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">-55000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.15</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.40</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.27</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019EquityInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.28</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.20</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.60</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.35</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.36</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">24000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">24000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">302000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">23000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019DebtSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">325000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">55474000000</ifrs-full:Equity>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">0</nvs:FairValueAdjustmentsRelatedToDivestments>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">22000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-34668000000</ifrs-full:ChangesInEquity>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">0</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">253000000</nvs:TransactionCostsRecordedInEquity>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">0</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <nvs:TaxesOnTreasuryShares contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">189000000</nvs:TaxesOnTreasuryShares>
  <nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">284000000</nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">833000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">18000000</nvs:SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">210000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">5511000000</ifrs-full:PurchaseOfTreasuryShares>
  <nvs:DividendPaidNoncashAssetsDistribution contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">23434000000</nvs:DividendPaidNoncashAssetsDistribution>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">255000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">5574000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">6495000000</ifrs-full:DividendsPaid>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">10538000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">2835000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">7703000000</ifrs-full:ProfitLoss>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">74832000000</ifrs-full:Equity>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">6645000000</ifrs-full:DividendsPaid>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">11525000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">11732000000</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-207000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">78614000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">78617000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-7824000000</ifrs-full:ChangesInEquity>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">79000000</nvs:TransactionCostsRecordedInEquity>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">38000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-13000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">756000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-284000000</nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan>
  <nvs:OtherShareSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">263000000</nvs:OtherShareSales>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">434000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">1973000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">6966000000</ifrs-full:DividendsPaid>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">12210000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-401000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">12611000000</ifrs-full:ProfitLoss>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">74228000000</ifrs-full:Equity>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">612000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember" unitRef="USD" decimals="-6">-11202000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">74168000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019EquityAttributableToOwnersOfParentMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">60000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">59000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:ChangesInEquity>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-2000000</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">59000000</ifrs-full:Equity>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-5000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">22000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-1000000</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">21000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">78000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">78000000</ifrs-full:Equity>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">5000000</ifrs-full:ProfitLoss>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">59000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:IncreaseDecreaseInNoncontrolingInterests contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-1000000</nvs:IncreaseDecreaseInNoncontrolingInterests>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">77000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019NoncontrollingInterestsMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <ifrs-full:EstimatedFinancialEffectOfContingentLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17IT_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NAGAndNovartisPharmaSpAMember" unitRef="USD" decimals="-6">125000000</ifrs-full:EstimatedFinancialEffectOfContingentLiabilities>
  <nvs:EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17IT_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember" unitRef="USD" decimals="-8">1300000000</nvs:EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine>
  <nvs:EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17IT_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember" unitRef="USD" decimals="-6">330000000</nvs:EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed>
  <nvs:EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NovartisPharmaKKMember" unitRef="JPY" decimals="-6">4000000</nvs:EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="USD" decimals="-6">2656000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="USD" decimals="-6">2575000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="USD" decimals="-6">2617000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="USD" decimals="-6">309000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="Pure" decimals="2">0.00</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="USD" decimals="-6">144000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17JP" unitRef="Pure" decimals="2">0.00</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsAndNotLaterThanTenYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">5270000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <nvs:DefinedBenefitPlanExpectedFutureBenefitPayment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanFiveYearsAndNotLaterThanTenYearsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">231000000</nvs:DefinedBenefitPlanExpectedFutureBenefitPayment>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember" unitRef="USD" decimals="-6">1310000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember" unitRef="USD" decimals="-6">366000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember" unitRef="USD" decimals="-6">353000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">270000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">286000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">186000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">145000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">102000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">130000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">399000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">396000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember" unitRef="USD" decimals="-6">1323000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableForSaleMarketableSecuritiesMember" unitRef="USD" decimals="-6">24000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableForSaleMarketableSecuritiesMember" unitRef="USD" decimals="-6">325000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember" unitRef="USD" decimals="-6">1158000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4EquitySecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember" unitRef="USD" decimals="-6">802000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember" unitRef="USD" decimals="-6">33000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_ifrsfull-2019DebtSecuritiesMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AvailableforsaleLongtermFinancialInvestmentsMember" unitRef="USD" decimals="-6">31000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" unitRef="USD" decimals="-6">1191000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" unitRef="USD" decimals="-6">833000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember" unitRef="USD" decimals="-6">1215000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtFairValueMember" unitRef="USD" decimals="-6">1158000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" unitRef="USD" decimals="-6">10337000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" unitRef="USD" decimals="-6">11024000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">0</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">12000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember" unitRef="USD" decimals="-6">61000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember" unitRef="USD" decimals="-6">13635000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember" unitRef="USD" decimals="-6">2087000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" unitRef="USD" decimals="-6">329000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" unitRef="USD" decimals="-6">512000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialAssetsAxis_ifrsfull-2019FinancialAssetsAtAmortisedCostMember" unitRef="USD" decimals="-6">10727000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">6846000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4StraightBondsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">22167000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4StraightBondsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">25283000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LiabilitiesToBanksAndOtherFinancialInstitutionsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">188000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4LiabilitiesToBanksAndOtherFinancialInstitutionsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">285000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FinanceLeaseObligationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">0</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4FinanceLeaseObligationsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">92000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">2002000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">3190000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">9620000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">20353000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4NoncurrentFinancialDebtMember" unitRef="USD" decimals="-6">22470000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TradePayablesMember" unitRef="USD" decimals="-6">5424000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TradePayablesMember" unitRef="USD" decimals="-6">5840000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember" unitRef="USD" decimals="-6">32623000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember" unitRef="USD" decimals="-6">37930000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_ifrsfull-2019LeaseLiabilitiesMember" unitRef="USD" decimals="-6">1949000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4InterestBearningAccountsOfAssociatesPayableOnDemandMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">1836000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4InterestBearningAccountsOfAssociatesPayableOnDemandMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">1778000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4BankAndOtherFinancialDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">719000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4BankAndOtherFinancialDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">701000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CommercialPaperMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">2289000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CommercialPaperMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">3951000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">2002000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtAmortisedCostMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4CurrentPortionOfNoncurrentDebtMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtMember" unitRef="USD" decimals="-6">3190000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember" unitRef="USD" decimals="-6">975000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">58000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember" unitRef="USD" decimals="-6">1250000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationAndOtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">1065000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4ContingentConsiderationAndOtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">917000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CategoriesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_ifrsfull-2019ClassesOfFinancialLiabilitiesAxis_ifrsfull-2019FinancialLiabilitiesAtFairValueMember_nvs-2019Q4BalanceSheetItemAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">185000000</ifrs-full:FinancialLiabilities>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">37000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">37000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">1250000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">185000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">1065000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">186000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">186000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">1036000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">1036000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">29000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">29000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">185000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">185000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">35000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">337000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">23000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">35000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">360000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">2087000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">130000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">2087000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">130000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">12000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">24000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">37000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TotalAvailableforsaleMarketableSecuritiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">61000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">61000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">102000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4TimeDepositsWithOriginalMaturityMoreThan90DaysMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">61000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">102000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">37000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">126000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">61000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">224000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">976000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">581000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">233000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">1557000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">233000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">399000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">329000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">399000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">329000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">976000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">1213000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">329000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">2518000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">917000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">975000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AccruedInterestOnDebtSecuritiesAndTimeDepositsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">12000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">337000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">153000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">2099000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">698000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">488000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" unitRef="USD" decimals="-6">2589000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AvailableforsaleFinancialInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">1186000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">251000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">396000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4FundInvestmentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">251000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4ContingentConsiderationReceivablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">396000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">512000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">512000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level1OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">698000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">1135000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_nvs-2019Q4ValuedAtAmortizedCostMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">512000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialInvestmentsAndLongtermLoansGroupMember" unitRef="USD" decimals="-6">2345000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">145000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">145000000</ifrs-full:FinancialAssetsAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">907000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">907000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level3OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">10000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">10000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">58000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">58000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019LevelsOfFairValueHierarchyAxis_ifrsfull-2019Level2OfFairValueHierarchyMember_ifrsfull-2019MeasurementAxis_ifrsfull-2019RecurringFairValueMeasurementMember" unitRef="USD" decimals="-6">58000000</ifrs-full:FinancialLiabilitiesAtFairValue>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">74000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">390000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">108000000</nvs:GrossDeferredTaxAssets>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">10000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">31000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1000000</nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">476000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">613000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">137000000</nvs:GrossDeferredTaxAssets>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">282000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">431000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">622000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">191000000</nvs:GrossDeferredTaxAssets>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">-13000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">-42000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">1233000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">5384000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">4151000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">2141000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">1287000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">2985000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">1698000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">1000000</nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">378000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">2874000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">45000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">-39000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">1469000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">3610000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">605000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">8000000</ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity>
  <nvs:ProvisionsAndOtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">3000000</nvs:ProvisionsAndOtherNoncurrentLiabilities>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">169000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">148000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">475000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">478000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">11000000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:DeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">8000000</ifrs-full:DeferredTaxAssets>
  <ifrs-full:OtherNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">2000000</ifrs-full:OtherNoncurrentAssets>
  <ifrs-full:OtherNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">1000000</ifrs-full:OtherNoncurrentAssets>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">181000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">165000000</ifrs-full:Inventories>
  <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">3000000</ifrs-full:OtherCurrentNonfinancialAssets>
  <ifrs-full:OtherCurrentNonfinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">7000000</ifrs-full:OtherCurrentNonfinancialAssets>
  <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">841000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">807000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:DeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">2000000</ifrs-full:DeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">2000000</ifrs-full:DeferredTaxLiabilities>
  <nvs:ProvisionsAndOtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">4000000</nvs:ProvisionsAndOtherNoncurrentLiabilities>
  <nvs:ProvisionsAndOtherNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">4000000</nvs:ProvisionsAndOtherNoncurrentLiabilities>
  <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">25000000</ifrs-full:OtherCurrentNonfinancialLiabilities>
  <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">45000000</ifrs-full:OtherCurrentNonfinancialLiabilities>
  <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">31000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
  <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">51000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
  <nvs:AmortizationPriorToClassificationToAssetsHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">45000000</nvs:AmortizationPriorToClassificationToAssetsHeldForSale>
  <nvs:ImpairmentChargesRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">183000000</nvs:ImpairmentChargesRelatedToDisposalGroupHeldForSale>
  <nvs:ImpairmentChargesRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">37000000</nvs:ImpairmentChargesRelatedToDisposalGroupHeldForSale>
  <nvs:ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">9000000</nvs:ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019DisposalGroupsClassifiedAsHeldForSaleMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">-220000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis_ifrsfull-2019DisposalGroupsClassifiedAsHeldForSaleMember_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">37000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">9712000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">9746000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">14000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">20000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">3571000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">3650000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">40000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">39000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">4243000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">4243000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">130000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">4373000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">-5373000000</ifrs-full:NetDebt>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">5217000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">5217000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">16000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">814000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">807000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">5233000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">1583000000</ifrs-full:NetDebt>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">1328000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_ifrsfull-2019NotLaterThanOneMonthMember" unitRef="USD" decimals="-6">1305000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">2949000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">2974000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">65000000</ifrs-full:LeaseLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">-36000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">113000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">5222000000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">62000000</nvs:ContingentConsiderationLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">-5713000000</ifrs-full:NetDebt>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">4118000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">34000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">4656000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">4624000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">4084000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">4084000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">5556000000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">-103000000</ifrs-full:NetDebt>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">1402000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">29000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">1373000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">1373000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">56000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">75000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">9831000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">9700000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">26000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">79000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember" unitRef="USD" decimals="-6">1505000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneMonthAndNotLaterThanThreeMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">1400000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">3000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">3000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">9025000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">8980000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">9104000000</ifrs-full:NetDebt>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">198000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">198000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">6000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">9110000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">9150000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">9110000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">1667000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">-470000000</nvs:ContingentConsiderationLiabilities>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">622000000</ifrs-full:LeaseLiabilities>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">582000000</nvs:ContingentConsiderationLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">8980000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">8782000000</ifrs-full:NetDebt>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_ifrsfull-2019LaterThanOneYearAndNotLaterThanFiveYearsMember" unitRef="USD" decimals="-6">-1531000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">348000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">233000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">36000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">143000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">253000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates>
  <nvs:FinancialInstrumentsValueAtRiskComputation contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">443000000</nvs:FinancialInstrumentsValueAtRiskComputation>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">60000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements>
  <nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RangeAxis_ifrsfull-2019WeightedAverageMember" unitRef="USD" decimals="-6">324000000</nvs:FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">2627100000</ifrs-full:NumberOfSharesOutstanding>
  <nvs:SharesCancelledForCapitalReduction contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">-23300000</nvs:SharesCancelledForCapitalReduction>
  <nvs:SharesCancelledForCapitalReduction contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">-66200000</nvs:SharesCancelledForCapitalReduction>
  <nvs:SharesCancelledForCapitalReduction contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">-10300000</nvs:SharesCancelledForCapitalReduction>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">2550600000</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">2527300000</ifrs-full:NumberOfSharesOutstanding>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">-10300000</nvs:ShareMovements>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">-66200000</nvs:ShareMovements>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">-23300000</nvs:ShareMovements>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019OrdinarySharesMember" unitRef="Shares" decimals="-5">2616800000</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-299300000</ifrs-full:NumberOfSharesOutstanding>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-22900000</nvs:ShareMovements>
  <nvs:NumberOfOtherShareSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">3000000</nvs:NumberOfOtherShareSales>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">59900000</nvs:ShareMovements>
  <nvs:ShareMovements contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-46300000</nvs:ShareMovements>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-262300000</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-239400000</ifrs-full:NumberOfSharesOutstanding>
  <nvs:SharesCancelledForCapitalReduction contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">10300000</nvs:SharesCancelledForCapitalReduction>
  <nvs:TreasurySharesAcquiredToBeCancelled contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-60300000</nvs:TreasurySharesAcquiredToBeCancelled>
  <nvs:SharesCancelledForCapitalReduction contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">66200000</nvs:SharesCancelledForCapitalReduction>
  <nvs:SharesCancelledForCapitalReduction contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">23300000</nvs:SharesCancelledForCapitalReduction>
  <nvs:OtherSharePurchases contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-1200000</nvs:OtherSharePurchases>
  <nvs:OtherSharePurchases contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-1700000</nvs:OtherSharePurchases>
  <nvs:TreasurySharesAcquiredToBeCancelled contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-66200000</nvs:TreasurySharesAcquiredToBeCancelled>
  <nvs:TreasurySharesAcquiredToBeCancelled contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-23300000</nvs:TreasurySharesAcquiredToBeCancelled>
  <nvs:SharesDeliveredToDivestedBusinessEmployees contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">900000</nvs:SharesDeliveredToDivestedBusinessEmployees>
  <nvs:EquityBasedCompensationShares contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">8800000</nvs:EquityBasedCompensationShares>
  <nvs:EquityBasedCompensationShares contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">7400000</nvs:EquityBasedCompensationShares>
  <nvs:EquityBasedCompensationShares contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">9400000</nvs:EquityBasedCompensationShares>
  <nvs:ExerciseOfOptionsAndEmployeeTransactionsShares contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">4600000</nvs:ExerciseOfOptionsAndEmployeeTransactionsShares>
  <nvs:ExerciseOfOptionsAndEmployeeTransactionsShares contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">7800000</nvs:ExerciseOfOptionsAndEmployeeTransactionsShares>
  <nvs:ExerciseOfOptionsAndEmployeeTransactionsShares contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">5500000</nvs:ExerciseOfOptionsAndEmployeeTransactionsShares>
  <nvs:OtherSharePurchases contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-3800000</nvs:OtherSharePurchases>
  <ifrs-full:NumberOfSharesOutstanding contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ClassesOfShareCapitalAxis_ifrsfull-2019TreasurySharesMember" unitRef="Shares" decimals="-5">-253000000</ifrs-full:NumberOfSharesOutstanding>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">420000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">325000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">95000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">395000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Ziarco_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">25000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">67000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">456000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">366000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">90000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-Encore_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionIncMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">389000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">25000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="INR" decimals="-5">60000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="INR" decimals="-5">32000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="IDR" decimals="-8">7700000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">25000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">2000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="ILS" decimals="0">1000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">18200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">1700000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="JPY" decimals="-5">10000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="JPY" decimals="-8">6000000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="JPY" decimals="-5">8500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="JPY" decimals="-5">100000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">3000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">100000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="MYR" decimals="-5">3300000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="MXN" decimals="-5">205000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="MXN" decimals="-5">468200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="MAD" decimals="-5">80000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">907560</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="NZD" decimals="0">820000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="NOK" decimals="-5">1500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PKR" decimals="-8">6700000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9999</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9999</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">10000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PEN" decimals="-5">6100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">1.0000</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PHP" decimals="-5">298800000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PHP" decimals="-5">30000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PLN" decimals="-5">44200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PLN" decimals="-5">25600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="PLN" decimals="-5">11400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">2400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">499900</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="RON" decimals="-5">3000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="RON" decimals="-5">105200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="RUB" decimals="-5">20000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="RUB" decimals="-5">500000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="RUB" decimals="-5">57400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="SGD" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="SGD" decimals="-5">45000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="SGD" decimals="-5">39000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">2000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">48400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">1500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="ZAR" decimals="-5">86300000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="ZAR" decimals="-5">3000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="KRW" decimals="-8">24500000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9855</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9855</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">63000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">270450</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">9300000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">10100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">6000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="SEK" decimals="-5">5000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">10000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">100200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisForschungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisForschungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerKaderausbildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerKaderausbildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMitarbeiterbeteiligungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMitarbeiterbeteiligungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerMenschUndUmweltBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerMenschUndUmweltBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">1000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">50000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">350000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">20000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">18900000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">251000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">5000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">9300000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">5000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4RocheHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">160000000</nvs:SharePaidinCapital>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="TWD" decimals="-5">170000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="THB" decimals="-5">302000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="TRY" decimals="-5">98000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="TRY" decimals="-5">6700000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="TRY" decimals="-5">165200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9999</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9999</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="TRY" decimals="-5">50000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="UAH" decimals="-5">8000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="AED" decimals="-5">7000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="-5">2000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">72200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-6">650000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="DZD" decimals="-5">650000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="ARS" decimals="-5">906100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="AUD" decimals="0">2</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="AUD" decimals="-5">3800000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="AUD" decimals="-5">11600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">1000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">1100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">32700000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">1000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="BDT" decimals="-5">162500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">0.60</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">0.60</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">7100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">19200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">110600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">12000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">30000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="0">20000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CHF" decimals="-5">1000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">370000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="BRL" decimals="-5">265000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="BRL" decimals="-5">190000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CAD" decimals="-5">1200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CAD" decimals="-5">80800000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CAD" decimals="0">82886</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CLP" decimals="-8">2000000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">30000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="HKD" decimals="0">200</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">320000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">3200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">57600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="COP" decimals="-8">7900000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="HRK" decimals="-5">25600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CZK" decimals="-5">51500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="CZK" decimals="-5">44700000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="DKK" decimals="-5">14000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="DKK" decimals="-5">12000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">4000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EGP" decimals="-5">193800000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9977</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.9977</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EGP" decimals="0">250000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">459000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">903000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">43400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">9600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">5400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">155500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">25600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">2000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">26000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">93700000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">42100000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">26000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">23400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="HUF" decimals="-5">545600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="HUF" decimals="-5">883000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="INR" decimals="-5">123500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.7068</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="4">0.7068</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="VEF" decimals="-5">1400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">25000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTechnologyLLCInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTechnologyLLCInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">3</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="-5">12000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">4200000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">119000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">1400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">4500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="0">18000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="SAR" decimals="-5">26800000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">0.75</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">0.75</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="EUR" decimals="-5">22600000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="-5">25500000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="-5">5400000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="-5">250000000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="0">100</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="-5">2900000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">1.000</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="3">1.000</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="GBP" decimals="0">3904</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1000</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:SharePaidinCapital contextRef="AR_I-CurrentYearEnd_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="USD" decimals="0">1</nvs:SharePaidinCapital>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUSFoundationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUSFoundationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember" unitRef="Pure" decimals="2">1.00</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">388000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">-2000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">0</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">969000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">-100000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">77639000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">-4340000000</ifrs-full:Equity>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">89000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019PreviouslyStatedMember" unitRef="USD" decimals="-6">75000000</ifrs-full:RightofuseAssets>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">-177000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">237000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">60000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">3000000</ifrs-full:Equity>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">-177000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_ifrsfull-2019IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" unitRef="USD" decimals="-6">-177000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">59275000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-34557000000</ifrs-full:ChangesInEquity>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">22000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-3000000</nvs:FairValueAdjustmentsRelatedToDivestments>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">5480000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">4000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">207000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">828000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">18000000</nvs:SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff>
  <nvs:TaxesOnTreasuryShares contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">189000000</nvs:TaxesOnTreasuryShares>
  <nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">284000000</nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">95000000</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">253000000</nvs:TransactionCostsRecordedInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">82194000000</ifrs-full:Equity>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">6645000000</ifrs-full:DividendsPaid>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">11638000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">11732000000</ifrs-full:ProfitLoss>
  <nvs:DividendPaidNoncashAssetsDistribution contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">23434000000</nvs:DividendPaidNoncashAssetsDistribution>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-94000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-7814000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">82191000000</ifrs-full:Equity>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">38000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity>
  <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-13000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">16000000</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <nvs:TransactionCostsRecordedInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">79000000</nvs:TransactionCostsRecordedInEquity>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">752000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-284000000</nvs:IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">77876000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-11175000000</ifrs-full:ChangesInEquity>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">6966000000</ifrs-full:DividendsPaid>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">1960000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">430000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">9000000</ifrs-full:ReductionOfIssuedCapital>
  <nvs:OtherShareSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">261000000</nvs:OtherShareSales>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">12129000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-482000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">12611000000</ifrs-full:ProfitLoss>
  <ifrs-full:DividendsPaid contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">6495000000</ifrs-full:DividendsPaid>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">5538000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">253000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">607000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">7666000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">-37000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">7703000000</ifrs-full:ProfitLoss>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019RetainedEarningsMember" unitRef="USD" decimals="-6">81148000000</ifrs-full:Equity>
  <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">2600000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">2500000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">2000000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">63900000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">67500000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">70300000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">40600000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">42500000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">49900000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">20700000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">22500000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_ifrsfull-2019KeyManagementPersonnelOfEntityOrParentMember" unitRef="USD" decimals="-5">18400000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="3">0.065</ifrs-full:DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal>
  <ifrs-full:DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="3">0.065</ifrs-full:DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal>
  <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="3">0.015</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
  <ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="3">0.020</ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections>
  <nvs:CurrentIncomeTaxAndDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">8061000000</nvs:CurrentIncomeTaxAndDeferredTaxLiabilities>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">32148000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:CurrentIncomeTaxAndDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">9513000000</nvs:CurrentIncomeTaxAndDeferredTaxLiabilities>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">27384000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:AdditionsToInvestmentInAssociatedCompanies contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">11000000</nvs:AdditionsToInvestmentInAssociatedCompanies>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">15964000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">11446000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:AdditionsToInvestmentInAssociatedCompanies contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">18000000</nvs:AdditionsToInvestmentInAssociatedCompanies>
  <nvs:AdditionsToInvestmentInAssociatedCompanies contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">11000000</nvs:AdditionsToInvestmentInAssociatedCompanies>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">128000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">81000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">7000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">7000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">8509000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">8264000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <nvs:AdditionsToInvestmentInAssociatedCompanies contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">44000000</nvs:AdditionsToInvestmentInAssociatedCompanies>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">647000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1265000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">68000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">107000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">196000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">52000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">24000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1487000000</ifrs-full:RightofuseAssets>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">143000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">139000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">136000000</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">54000000</ifrs-full:RightofuseAssets>
  <ifrs-full:AdditionsToRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">454000000</ifrs-full:AdditionsToRightofuseAssets>
  <ifrs-full:AdditionsToRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">49000000</ifrs-full:AdditionsToRightofuseAssets>
  <ifrs-full:AdditionsToRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">34000000</ifrs-full:AdditionsToRightofuseAssets>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">46336000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">44593000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">8892000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">9712000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">19578000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">83000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">130000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">9632000000</ifrs-full:PropertyPlantAndEquipment>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">12664000000</nvs:NetOperatingAssets>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">13951000000</nvs:NetOperatingAssets>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">24007000000</nvs:NetOperatingAssets>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">10098000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1888000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">2159000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">2878000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">549000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">561000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1114000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">822000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">217000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">294000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">519000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">1086000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">23000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">662000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">7595000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1368000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-261000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">452000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">7615000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">774000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1027000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">204000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">691000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1124000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">351000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">71225000000</ifrs-full:Assets>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">55893000000</nvs:NetOperatingAssets>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">48474000000</ifrs-full:Liabilities>
  <nvs:NetOperatingAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">53999000000</nvs:NetOperatingAssets>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">3804000000</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">3377000000</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">1964000000</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">43683000000</ifrs-full:Liabilities>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">67055000000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">16468000000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">17328000000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">25971000000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">30677000000</ifrs-full:Assets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">35209000000</ifrs-full:Assets>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">15332000000</ifrs-full:Liabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">13056000000</ifrs-full:Liabilities>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">37714000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">34892000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">9731000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">9859000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">783000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">741000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">141000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">177000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-871000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-836000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">38497000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">35633000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">9872000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">10036000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-871000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-836000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1092000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1188000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">63000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">62000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">24000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">16000000</ifrs-full:OtherRevenue>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">10050000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">9870000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">5334000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">5530000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-959000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-890000000</ifrs-full:CostOfSales>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">29539000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">26951000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">4601000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">4568000000</ifrs-full:GrossProfit>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">5000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">656000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">6432000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">112000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">70000000</ifrs-full:GrossProfit>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">11617000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">10907000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">2218000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">2305000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">534000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">505000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">8152000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">7675000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1250000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:ResearchAndDevelopmentExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">814000000</ifrs-full:ResearchAndDevelopmentExpense>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1586000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">977000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">167000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">505000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">278000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">147000000</ifrs-full:OtherIncome>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">2069000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1475000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">749000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">622000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">608000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:OtherExpenseByFunction contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">512000000</ifrs-full:OtherExpenseByFunction>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">9287000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">7871000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">551000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1332000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-752000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ProfitLossFromOperatingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-800000000</ifrs-full:ProfitLossFromOperatingActivities>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">1000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">32278000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">10060000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">668000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">118000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <nvs:RevenueFromSaleOfGoodsSalesToOtherSegments contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-743000000</nvs:RevenueFromSaleOfGoodsSalesToOtherSegments>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">32946000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">10178000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:RevenueFromSaleOfGoods contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-743000000</ifrs-full:RevenueFromSaleOfGoods>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">898000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">37000000</ifrs-full:OtherRevenue>
  <ifrs-full:OtherRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">88000000</ifrs-full:OtherRevenue>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">8650000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">5800000000</ifrs-full:CostOfSales>
  <ifrs-full:CostOfSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">-817000000</ifrs-full:CostOfSales>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">25194000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">4415000000</ifrs-full:GrossProfit>
  <ifrs-full:GrossProfit contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">162000000</ifrs-full:GrossProfit>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">9887000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">2126000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1880000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1874000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.00</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1841000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1585000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1587000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.00</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1612000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1539000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1556000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">-0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1525000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1416000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1174000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.21</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">867000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.35</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1338000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1155000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.16</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">873000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.32</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1263000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1561000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">-0.19</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1943000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">-0.20</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1114000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">977000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.14</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">777000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.26</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">975000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1099000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">-0.11</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1059000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">755000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">828000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">-0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">808000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">480000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">235000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">1.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">76000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">441000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">167000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">1.64</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LutatheraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">0</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KymriahMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">278000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KymriahMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">76000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KymriahMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">6000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PiqrayMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">116000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1190000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">1139000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">887000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.28</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">14370000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">13428000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="USD" decimals="-6">12274000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">2086000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">2046000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">1888000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">0.08</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">433000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">517000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">-0.16</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">589000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">-0.12</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XiidraMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">192000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4BeovuMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">35000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">2030000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">1995000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">2144000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">-0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">4776000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">4558000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="USD" decimals="-6">4621000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember" unitRef="Pure" decimals="2">-0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">3551000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">2837000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.25</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">2071000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.37</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">671000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">554000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.21</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">402000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.38</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">1000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">1000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.00</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">4222000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">3392000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.24</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="USD" decimals="-6">2474000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember" unitRef="Pure" decimals="2">0.37</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">3223000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">3341000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="Pure" decimals="2">-0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">3185000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZolgensmaMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">361000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AimovigMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">103000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AimovigMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">8000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4MayzentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">26000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">60000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">80000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="Pure" decimals="2">-0.25</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">102000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="Pure" decimals="2">-0.22</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">3773000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">3429000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="Pure" decimals="2">0.10</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="USD" decimals="-6">3287000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">1173000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">1039000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="Pure" decimals="2">0.13</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">920000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="Pure" decimals="2">0.13</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">427000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">454000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="Pure" decimals="2">-0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">411000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4UltibroBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="Pure" decimals="2">0.10</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">121000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">148000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="Pure" decimals="2">-0.18</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">151000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SeebriBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">82000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">101000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="Pure" decimals="2">-0.19</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="USD" decimals="-6">112000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OnbrezBreezhalerMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4COPDMember" unitRef="Pure" decimals="2">-0.10</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">22000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">25000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="Pure" decimals="2">-0.12</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">23000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">1825000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">1767000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="Pure" decimals="2">0.03</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="USD" decimals="-6">1617000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">1726000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">1028000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="Pure" decimals="2">0.68</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">507000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="Pure" decimals="2">1.03</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">24000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">22000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">17000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="Pure" decimals="2">0.29</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">1750000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">1050000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="Pure" decimals="2">0.67</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="USD" decimals="-6">524000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember" unitRef="Pure" decimals="2">1.00</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1297000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1284000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1233000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1064000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1023000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">957000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1025000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">1002000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">960000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">485000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">464000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">414000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">0.12</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">419000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">463000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.10</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">488000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">417000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">445000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">465000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">2291000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">2587000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.11</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">2964000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.13</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">6998000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">7268000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="USD" decimals="-6">7481000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember" unitRef="Pure" decimals="2">-0.03</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember" unitRef="USD" decimals="-6">23344000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember" unitRef="USD" decimals="-6">21464000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="2">0.08</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember" unitRef="USD" decimals="-6">20004000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember" unitRef="Pure" decimals="2">0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="2">0.08</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">18750000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">5339000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">7000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">21720000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">520000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">27586000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">7767000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">85000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">156000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">859000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">-61000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember" unitRef="USD" decimals="-6">-442000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">-506000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">-249000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember" unitRef="USD" decimals="-6">-1175000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember" unitRef="USD" decimals="-6">-841000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember" unitRef="USD" decimals="-6">-652000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">25000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1125000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">7000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">76000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">76000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">18551000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">14377000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">6000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">11228000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">431000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">26042000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">7837000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">419000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">304000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1115000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">37000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">1875000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">8899000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">246000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">2980000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">1185000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">1851000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">4054000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">363000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">10679000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">7000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">5000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">118000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">123000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-669000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-592000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentConsolidationItemsAxis_ifrsfull-2019OperatingSegmentsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-591000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">202000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">301000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1345000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1482000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">157000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1303000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1547000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1783000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019PropertyPlantAndEquipmentMember" unitRef="USD" decimals="-6">1460000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">3974000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">3428000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">3276000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">2624000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">652000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">2836000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">2587000000</ifrs-full:DepreciationAndAmortisationExpense>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">1138000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019IntangibleAssetsAndGoodwillMember" unitRef="USD" decimals="-6">841000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="USD" decimals="-6">4120000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="USD" decimals="-6">3972000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="USD" decimals="-6">3484000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="Pure" decimals="2">0.08</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="USD" decimals="-6">2554000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="Pure" decimals="2">0.03</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="USD" decimals="-6">3124000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17DE" unitRef="Pure" decimals="2">0.03</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="USD" decimals="-6">2442000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="USD" decimals="-6">2505000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="USD" decimals="-6">2289000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="USD" decimals="-6">3933000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="Pure" decimals="2">0.05</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="USD" decimals="-6">3976000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_country-2017-2Q17FR" unitRef="Pure" decimals="2">0.04</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019FinancialAssetsImpairedMember" unitRef="USD" decimals="-6">-38000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019FinancialAssetsImpairedMember" unitRef="USD" decimals="-6">6000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019FinancialAssetsImpairedMember" unitRef="USD" decimals="-6">227000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">35294000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-429000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">23000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-406000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">4000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-301000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">26524000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019GoodwillMember" unitRef="USD" decimals="-6">-101000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-8813000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-2836000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">983000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-1175000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-24632000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-148000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">37000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">28787000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">200000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-1049000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">1257000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-28000000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-925000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-3639000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">-30306000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019IntangibleAssetsOtherThanGoodwillMember" unitRef="USD" decimals="-6">38719000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">1495000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-4758000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-570000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-107000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-4268000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-53000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">26000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">163000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-721000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-105000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-42000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019TechnologybasedIntangibleAssetsMember" unitRef="USD" decimals="-6">-4184000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-128000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-137000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-32000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">419000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-937000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-11000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">621000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">16000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-4000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">257000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-1263000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-310000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">-1304000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_ifrsfull-2019OtherIntangibleAssetsMember" unitRef="USD" decimals="-6">949000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">653000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-40000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">1000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-43000000</ifrs-full:PropertyPlantAndEquipment>
  <nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">26000000</nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">8000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-10000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-20000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">492000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-60000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-34000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">2000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">7000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-37000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">2000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">3000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">8000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-16000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">-38000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">4000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">1290000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfPropertyPlantAndEquipmentAxis_ifrsfull-2019ConstructionInProgressMember" unitRef="USD" decimals="-6">2005000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:OtherProvisions contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">222000000</ifrs-full:OtherProvisions>
  <ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">8000000</ifrs-full:DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">492000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">534000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:AdditionalProvisionsOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">194000000</ifrs-full:AdditionalProvisionsOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">479000000</ifrs-full:ProvisionUsedOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">145000000</ifrs-full:ProvisionUsedOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">200000000</ifrs-full:ProvisionUsedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">72000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">33000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:UnusedProvisionReversedOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">64000000</ifrs-full:UnusedProvisionReversedOtherProvisions>
  <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">-7000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">8000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:OtherProvisions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">438000000</ifrs-full:OtherProvisions>
  <ifrs-full:OtherProvisions contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">507000000</ifrs-full:OtherProvisions>
  <ifrs-full:OtherProvisions contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ClassesOfProvisionsAxis_ifrsfull-2019RestructuringProvisionMember" unitRef="USD" decimals="-6">153000000</ifrs-full:OtherProvisions>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">972000000</ifrs-full:Equity>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">3000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">25000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">969000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">-25000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">944000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">944000000</ifrs-full:Equity>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">8000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">-8000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019IssuedCapitalMember" unitRef="USD" decimals="-6">936000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-80000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-11000000</ifrs-full:ChangesInEquity>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-12000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">3000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">31000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">5000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-69000000</ifrs-full:Equity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-69000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">31000000</ifrs-full:ChangesInEquity>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">4000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-100000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-24000000</ifrs-full:ChangesInEquity>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-34000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">13000000</ifrs-full:PurchaseOfTreasuryShares>
  <nvs:OtherShareSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">2000000</nvs:OtherShareSales>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">4000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:ReductionOfIssuedCapital contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-5000000</ifrs-full:ReductionOfIssuedCapital>
  <ifrs-full:PurchaseOfTreasuryShares contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">36000000</ifrs-full:PurchaseOfTreasuryShares>
  <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">5000000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
  <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">2000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_ifrsfull-2019TreasurySharesMember" unitRef="USD" decimals="-6">-76000000</ifrs-full:Equity>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">537000000</ifrs-full:RightofuseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">-14000000</ifrs-full:DepreciationRightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019LandMember" unitRef="USD" decimals="-6">536000000</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">848000000</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">990000000</ifrs-full:RightofuseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019BuildingsMember" unitRef="USD" decimals="-6">-194000000</ifrs-full:DepreciationRightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019VehiclesMember" unitRef="USD" decimals="-6">129000000</ifrs-full:RightofuseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019VehiclesMember" unitRef="USD" decimals="-6">-87000000</ifrs-full:DepreciationRightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019VehiclesMember" unitRef="USD" decimals="-6">147000000</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019OtherAssetsMember" unitRef="USD" decimals="-6">23000000</ifrs-full:RightofuseAssets>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019OtherAssetsMember" unitRef="USD" decimals="-6">21000000</ifrs-full:RightofuseAssets>
  <ifrs-full:DepreciationRightofuseAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019OtherAssetsMember" unitRef="USD" decimals="-6">-10000000</ifrs-full:DepreciationRightofuseAssets>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">8019000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">6558000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">6558000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">7760000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">250000000</nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">12889000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">15964000000</ifrs-full:Borrowings>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">302000000</ifrs-full:DebtInstrumentsHeld>
  <nvs:DerivativeFinancialInstrumentsCommodityPurchaseContract contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019USD" unitRef="USD" decimals="-6">9000000</nvs:DerivativeFinancialInstrumentsCommodityPurchaseContract>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">13000000</ifrs-full:DebtInstrumentsHeld>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">12000000</ifrs-full:DebtInstrumentsHeld>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">7861000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">8028000000</ifrs-full:Borrowings>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">1373000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">2989000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">1373000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_currency-2019EUR" unitRef="USD" decimals="-6">2989000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-466000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-359000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">851000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9 contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-5">177000000</nvs:IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-7212000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">2872000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">2872000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-4517000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">81000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">81000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">0</ifrs-full:ChangesInEquity>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-16000000</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-4452000000</ifrs-full:Equity>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-16000000</ifrs-full:ChangesInEquity>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-4452000000</ifrs-full:Equity>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-113000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-113000000</ifrs-full:ComprehensiveIncome>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-95000000</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <ifrs-full:ChangesInEquity contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-92000000</ifrs-full:ChangesInEquity>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">3000000</nvs:FairValueAdjustmentsRelatedToDivestments>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-4657000000</ifrs-full:Equity>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-7212000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">50000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-237000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">2208000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">2872000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-4340000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-4517000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">25000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">95000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">320000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">65000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-4452000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-45000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">44000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">354000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-208000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalValueAdjustmentsAttributableToNovartisShareholdersMember" unitRef="USD" decimals="-6">-4657000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">329000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-5064000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">0</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">211000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">-2000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">9000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">218000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4RestatedValueAdjustmentsMember" unitRef="USD" decimals="-6">227000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:CashOfferPerOrdinaryShare contextRef="AR_I-Transaction-TheMedicinesCompany_dei-2019LegalEntityAxis_nvs-2019Q4TheMedicinesCompanyMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="0">85</nvs:CashOfferPerOrdinaryShare>
  <nvs:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="2">0.09</nvs:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
  <ifrs-full:AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate contextRef="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">33000000</ifrs-full:AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate>
  <ifrs-full:GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination contextRef="AR_D-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">14000000</ifrs-full:GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">361000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:PercentageOfVotingEquityInterestsAcquired contextRef="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="2">0.91</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">285000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">76000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">355000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-IFM-1_dei-2019LegalEntityAxis_nvs-2019Q4IFMTreInc.Member_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">39000000</ifrs-full:AdditionalRecognitionGoodwill>
  <nvs:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">3400000000</nvs:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment>
  <nvs:PotentialMilestoneMaximumPayments contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">1900000000</nvs:PotentialMilestoneMaximumPayments>
  <nvs:CustomaryPurchasePriceAdjustment contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">100000000</nvs:CustomaryPurchasePriceAdjustment>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">3700000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">3500000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">200000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">3600000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">3600000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">100000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:RevenueOfAcquiree contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">200000000</ifrs-full:RevenueOfAcquiree>
  <nvs:RevenueOfAcquireeFullYear contextRef="AR_D-Transaction-Takeda-1_dei-2019LegalEntityAxis_nvs-2019Q4TakedaPharmaceuticalCompanyLimitedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-8">300000000</nvs:RevenueOfAcquireeFullYear>
  <nvs:NumberOfBusinessUnits contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="Pure" decimals="0">2</nvs:NumberOfBusinessUnits>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">36000000</nvs:OtherRevenueOther>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">28000000</nvs:MilestoneIncome>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">186000000</ifrs-full:RevenueFromRoyalties>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">648000000</nvs:ProfitSharingIncome>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">55000000</nvs:OtherRevenueOther>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">24000000</nvs:OtherRevenueOther>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">201000000</nvs:MilestoneIncome>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">128000000</nvs:MilestoneIncome>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">732000000</nvs:ProfitSharingIncome>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">874000000</nvs:ProfitSharingIncome>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">104000000</ifrs-full:RevenueFromRoyalties>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">162000000</ifrs-full:RevenueFromRoyalties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">421000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">867000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">373000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">589000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">777000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">777000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">465000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VoltarenCataflamMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">465000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">38000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">450000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4NeoralSandimmunEMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">488000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember" unitRef="USD" decimals="-6">23028000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">8445000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">16123000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">24568000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">2412000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">5298000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">7710000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember" unitRef="USD" decimals="-6">21421000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1284000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">521000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">578000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1099000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">84000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">939000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1023000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1039000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1039000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">457000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">698000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1155000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">581000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">593000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1174000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">404000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">424000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">828000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">977000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">977000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">194000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">323000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">517000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">556000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">472000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1028000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">9654000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">17292000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">26946000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">2210000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">5736000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">7946000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">627000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1316000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1943000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1709000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1476000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">3185000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1888000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1888000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1031000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1841000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">832000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">780000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1612000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">819000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">706000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1525000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1233000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1233000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">796000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2071000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">87000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">870000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">957000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">515000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">544000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1059000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">920000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">920000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">407000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">401000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">808000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">339000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">534000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">873000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">446000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">10679000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">17967000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">28646000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">3110000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">5958000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4RestOfPortfolioMember" unitRef="USD" decimals="-6">9068000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember" unitRef="USD" decimals="-6">23925000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1765000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1576000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">3341000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1674000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">978000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1064000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">925000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">801000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1726000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">250000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">230000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4KisqaliMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">480000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1163000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2837000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1121000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1561000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2046000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2046000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">806000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1068000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1874000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">817000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">770000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1587000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">929000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">627000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1556000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1284000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1487000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">3223000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">929000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1263000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">481000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">857000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TafinlarMekinistMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1338000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">804000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1076000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1880000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1003000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">536000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4AfinitorVotubiaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1539000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">450000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">525000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExjadeJadenuMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">975000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1297000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GalvusGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1297000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">881000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">704000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SandostatinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1585000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1173000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RespiratoryMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1173000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1114000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4JakaviMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1114000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">691000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">725000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4PromactaRevoladeMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1416000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">332000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">423000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">755000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4DiovanGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">86000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1331000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">3551000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GilenyaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4NeuroscienceMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1736000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2220000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">12818000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">12296000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">11127000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.11</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">13789000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">11864000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">10857000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">8458000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">8097000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">7702000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">2649000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">2635000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">2592000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember" unitRef="Pure" decimals="2">0.08</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">28573000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">26258000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">24174000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">9141000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">8634000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">8104000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="Pure" decimals="2">0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-416000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4OtherProductsMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-108000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4VotrientMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-400000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4SerelaxinMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember" unitRef="USD" decimals="-6">-465000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2086000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">2086000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">334000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">13000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1012000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1025000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">304000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">367000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">671000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">169000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">316000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">485000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4GleevecGlivecMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">440000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">19000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">983000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1002000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">262000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">292000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4IlarisMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">554000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">145000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">319000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ZortressCerticanMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">464000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4CosentyxMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4ImmunologyHepatologyAndDermatologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">1275000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TasignaMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4OncologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">810000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">28000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">932000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4ExforgeGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4EstablishedMedicinesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">960000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4TravoprostGroupMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4OphthalmologyMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">216000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">297000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4RestOfTheWorldMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">210000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4EntrestoMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4BusinessUnitAxis_nvs-2019Q4PharmaceuticalMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4CardioMetabolicMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4Top20ProductsMember" unitRef="USD" decimals="-6">507000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="Pure" decimals="2">0.16</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="Pure" decimals="2">0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember" unitRef="Pure" decimals="2">0.08</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="Pure" decimals="2">0.09</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember" unitRef="USD" decimals="-6">8409000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember" unitRef="Pure" decimals="2">-0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember" unitRef="USD" decimals="-6">1607000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember" unitRef="USD" decimals="-6">1436000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember" unitRef="Pure" decimals="2">0.12</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember" unitRef="USD" decimals="-6">1135000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4BiopharmaceuticalsMember" unitRef="Pure" decimals="2">0.27</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember" unitRef="USD" decimals="-6">534000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember" unitRef="USD" decimals="-6">543000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember" unitRef="USD" decimals="-6">516000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember" unitRef="Pure" decimals="2">0.05</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="2">-0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4AntiInfectivesSoldUnderSandozNameMember" unitRef="USD" decimals="-6">784000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4AntiInfectivesSoldUnderSandozNameMember" unitRef="USD" decimals="-6">826000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4AntiInfectivesMember_nvs-2019Q4ProductPortfolioAxis_nvs-2019Q4AntiInfectivesSoldUnderSandozNameMember" unitRef="USD" decimals="-6">880000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">5115000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">4963000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">4633000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">2491000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">2754000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">3278000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="Pure" decimals="2">-0.16</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">1341000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">1363000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">1391000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">784000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">779000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">758000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="Pure" decimals="2">0.03</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">7111000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">7233000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">7383000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">2620000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">2626000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">2677000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember" unitRef="USD" decimals="-6">7590000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember" unitRef="USD" decimals="-6">7880000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4FranchiseAxis_nvs-2019Q4RetailGenericsMember" unitRef="Pure" decimals="2">-0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">19000000</ifrs-full:RevenueFromRoyalties>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">10000000</ifrs-full:RevenueFromRoyalties>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">2000000</nvs:ProfitSharingIncome>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">3000000</nvs:ProfitSharingIncome>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">30000000</nvs:MilestoneIncome>
  <nvs:MilestoneIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">45000000</nvs:MilestoneIncome>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">12000000</nvs:OtherRevenueOther>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">4000000</nvs:OtherRevenueOther>
  <nvs:ProfitSharingIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">4000000</nvs:ProfitSharingIncome>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">24000000</ifrs-full:RevenueFromRoyalties>
  <nvs:OtherRevenueOther contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">9000000</nvs:OtherRevenueOther>
  <nvs:NumberOfFranchises contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">3</nvs:NumberOfFranchises>
  <nvs:NumberOfProductsInPortfolioToBeSold contextRef="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">300</nvs:NumberOfProductsInPortfolioToBeSold>
  <nvs:DivestmentDateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">800000000</nvs:DivestmentDateFairValueOfTotalConsiderationTransferred>
  <nvs:CarryingValueOfTheDivestedBusiness contextRef="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">1000000000</nvs:CarryingValueOfTheDivestedBusiness>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">200000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:ImpairmentLoss contextRef="AR_D-Transaction-Sandoz-Divestment_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">200000000</ifrs-full:ImpairmentLoss>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-AspenGlobalIncorporation_dei-2019LegalEntityAxis_nvs-2019Q4AspenGlobalIncorporatedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="EUR" decimals="-6">300000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-AspenGlobalIncorporation_dei-2019LegalEntityAxis_nvs-2019Q4AspenGlobalIncorporatedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">336000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-AspenGlobalIncorporation_dei-2019LegalEntityAxis_nvs-2019Q4AspenGlobalIncorporatedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="EUR" decimals="-6">100000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate contextRef="AR_I-Transaction-AspenGlobalIncorporation_dei-2019LegalEntityAxis_nvs-2019Q4AspenGlobalIncorporatedMember_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-6">112000000</ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.03</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="Pure" decimals="2">-0.10</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="Pure" decimals="2">0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember" unitRef="Pure" decimals="2">-0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="Pure" decimals="2">-0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="Pure" decimals="2">0.00</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <ifrs-full:IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners contextRef="AR_D-Transaction-Alcon-3-April-8_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-9">3000000000</ifrs-full:IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners>
  <nvs:PercentageOfEquityInterestSharesReceived contextRef="AR_I-Transaction-Alcon-3-April-8_ifrsfull-2019SegmentsAxis_nvs-2019Q4AlconMember" unitRef="Pure" decimals="3">0.047</nvs:PercentageOfEquityInterestSharesReceived>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">662000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">526000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">456000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-94000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">75000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">108000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">568000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">601000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">564000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:CurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">32200000000</ifrs-full:CurrentAssets>
  <ifrs-full:NoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">53700000000</ifrs-full:NoncurrentAssets>
  <ifrs-full:CurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">23000000000</ifrs-full:CurrentLiabilities>
  <ifrs-full:NoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">25100000000</ifrs-full:NoncurrentLiabilities>
  <ifrs-full:CurrentAssets contextRef="AR_I-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">32300000000</ifrs-full:CurrentAssets>
  <ifrs-full:NoncurrentAssets contextRef="AR_I-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">53800000000</ifrs-full:NoncurrentAssets>
  <ifrs-full:CurrentLiabilities contextRef="AR_I-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">23400000000</ifrs-full:CurrentLiabilities>
  <ifrs-full:NoncurrentLiabilities contextRef="AR_I-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">25700000000</ifrs-full:NoncurrentLiabilities>
  <ifrs-full:Revenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">59500000000</ifrs-full:Revenue>
  <ifrs-full:ProfitLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">8600000000</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">-100000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">8500000000</ifrs-full:ComprehensiveIncome>
  <ifrs-full:Revenue contextRef="AR_D-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">31800000000</ifrs-full:Revenue>
  <ifrs-full:ProfitLoss contextRef="AR_D-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">8300000000</ifrs-full:ProfitLoss>
  <ifrs-full:OtherComprehensiveIncome contextRef="AR_D-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">-600000000</ifrs-full:OtherComprehensiveIncome>
  <ifrs-full:ComprehensiveIncome contextRef="AR_D-HY1-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">7700000000</ifrs-full:ComprehensiveIncome>
  <nvs:ShareOfEstimatedNetAssets contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">2404000000</nvs:ShareOfEstimatedNetAssets>
  <ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">297000000</ifrs-full:RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">2939000000</ifrs-full:AdditionalRecognitionGoodwill>
  <nvs:CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">5640000000</nvs:CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill>
  <nvs:AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">2805000000</nvs:AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived>
  <nvs:ShareOfCurrentYearNetIncome contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">910000000</nvs:ShareOfCurrentYearNetIncome>
  <nvs:ShareOfCurrentYearNetIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">799000000</nvs:ShareOfCurrentYearNetIncome>
  <nvs:ShareOfCurrentYearNetIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">669000000</nvs:ShareOfCurrentYearNetIncome>
  <nvs:PriorYearAdjustment contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-129000000</nvs:PriorYearAdjustment>
  <nvs:PriorYearAdjustment contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-125000000</nvs:PriorYearAdjustment>
  <nvs:PriorYearAdjustment contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-67000000</nvs:PriorYearAdjustment>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-162000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-148000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">-146000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets>
  <nvs:PartialReleaseOfDeferredTaxLiabilityRecognized contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">43000000</nvs:PartialReleaseOfDeferredTaxLiabilityRecognized>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">8445000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">8195000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:ProportionOfVotingPowerHeldInAssociate contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="Pure" decimals="3">0.333</ifrs-full:ProportionOfVotingPowerHeldInAssociate>
  <ifrs-full:ProportionOfVotingPowerHeldInAssociate contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="Pure" decimals="3">0.333</ifrs-full:ProportionOfVotingPowerHeldInAssociate>
  <ifrs-full:ProportionOfVotingPowerHeldInAssociate contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="Pure" decimals="3">0.333</ifrs-full:ProportionOfVotingPowerHeldInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="Pure" decimals="3">0.062</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="Pure" decimals="3">0.062</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="Pure" decimals="3">0.062</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">P20Y0M0D</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">16900000000</ifrs-full:FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished>
  <ifrs-full:FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-8">12900000000</ifrs-full:FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished>
  <ifrs-full:DividendsReceived contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">460000000</ifrs-full:DividendsReceived>
  <ifrs-full:DividendsReceived contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">464000000</ifrs-full:DividendsReceived>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">24000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">40000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember" unitRef="USD" decimals="-6">42000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax>
  <ifrs-full:DividendsReceived contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">252000000</ifrs-full:DividendsReceived>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">1000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">1000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax>
  <ifrs-full:ProportionOfOwnershipInterestInAssociate contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="Pure" decimals="3">0.365</ifrs-full:ProportionOfOwnershipInterestInAssociate>
  <nvs:ShareOfCurrentYearNetIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">119000000</nvs:ShareOfCurrentYearNetIncome>
  <nvs:ShareOfCurrentYearNetIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">589000000</nvs:ShareOfCurrentYearNetIncome>
  <nvs:PriorYearAdjustment contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">4000000</nvs:PriorYearAdjustment>
  <nvs:PriorYearAdjustment contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">47000000</nvs:PriorYearAdjustment>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">-3000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets>
  <nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">-7000000</nvs:AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets>
  <nvs:GainOnDivestmentOfInterestsInAssociatedCompanies contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">5790000000</nvs:GainOnDivestmentOfInterestsInAssociatedCompanies>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">5910000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">629000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">-557000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">-145000000</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">5353000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" unitRef="USD" decimals="-6">484000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">23000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">-3000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">2000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">23000000</ifrs-full:ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">199000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">157000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">33000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4OthersAssociatesMember" unitRef="USD" decimals="-6">16000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">22179000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">23210000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">336000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
  <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">378000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
  <nvs:PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-168000000</nvs:PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset>
  <nvs:PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-1000000</nvs:PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset>
  <nvs:AdministrativeExpenseNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">24000000</nvs:AdministrativeExpenseNetDefinedBenefitLiabilityAsset>
  <nvs:AdministrativeExpenseNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">26000000</nvs:AdministrativeExpenseNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-1791000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">567000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
  <nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">283000000</nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability>
  <nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-374000000</nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability>
  <nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-184000000</nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset>
  <nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-264000000</nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset>
  <nvs:DefinedBenefitPlanInterestCost contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">330000000</nvs:DefinedBenefitPlanInterestCost>
  <nvs:DefinedBenefitPlanInterestCost contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">321000000</nvs:DefinedBenefitPlanInterestCost>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">193000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-5000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3024000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">77000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
  <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">76000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">25000000</ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">2000000</ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">19810000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-3256000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-3341000000</ifrs-full:SurplusDeficitInPlan>
  <nvs:LimitationOnRecognitionOfFundSurplus contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-68000000</nvs:LimitationOnRecognitionOfFundSurplus>
  <nvs:LimitationOnRecognitionOfFundSurplus contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-89000000</nvs:LimitationOnRecognitionOfFundSurplus>
  <nvs:ChangeInLimitationOnRecognitionOfFundSurplus contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-7000000</nvs:ChangeInLimitationOnRecognitionOfFundSurplus>
  <nvs:ChangeInLimitationOnRecognitionOfFundSurplus contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-25000000</nvs:ChangeInLimitationOnRecognitionOfFundSurplus>
  <nvs:InterestIncomeOnLimitationOfFundSurplus contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">4000000</nvs:InterestIncomeOnLimitationOfFundSurplus>
  <nvs:InterestIncomeOnLimitationOfFundSurplus contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">4000000</nvs:InterestIncomeOnLimitationOfFundSurplus>
  <nvs:LimitationOnRecognitionOfFundSurplus contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-65000000</nvs:LimitationOnRecognitionOfFundSurplus>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3321000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3409000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">23066000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">18838000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">20275000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1256000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1263000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-169000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-169000000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1 contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">49000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1 contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">11000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1>
  <nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-257000000</nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset>
  <nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-249000000</nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset>
  <nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1656000000</nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset>
  <nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-805000000</nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset>
  <nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-304000000</nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset>
  <nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">310000000</nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset>
  <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">420000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">520000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
  <nvs:DefinedBenefitPlanSettlementsPlanAssets contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">193000000</nvs:DefinedBenefitPlanSettlementsPlanAssets>
  <nvs:DefinedBenefitPlanSettlementsPlanAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3000000</nvs:DefinedBenefitPlanSettlementsPlanAssets>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-39000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-6000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1>
  <nvs:DefinedBenefitAssumptionLifeExpectancyFemale contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P24Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyFemale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyFemale contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P24Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyFemale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyFemale contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P24Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyFemale>
  <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.003</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
  <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.004</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
  <ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.005</ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases>
  <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.028</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
  <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.028</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
  <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.028</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
  <nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.003</nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount>
  <nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.008</nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount>
  <nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.006</nvs:ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount>
  <nvs:DefinedBenefitAssumptionLifeExpectancyMale contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P22Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyMale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyMale contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P22Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyMale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyMale contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P22Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyMale>
  <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.010</ifrs-full:ActuarialAssumptionOfDiscountRates>
  <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.016</ifrs-full:ActuarialAssumptionOfDiscountRates>
  <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="3">0.015</ifrs-full:ActuarialAssumptionOfDiscountRates>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">11630000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">12147000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">2662000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">7887000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">2722000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">8197000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1136000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">1140000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-126000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
  <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-507000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-21000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">-64000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">10000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">5000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1>
  <nvs:PrepaidPostemploymentBenefitPlansAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">148000000</nvs:PrepaidPostemploymentBenefitPlansAssets>
  <nvs:PrepaidPostemploymentBenefitPlansAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">137000000</nvs:PrepaidPostemploymentBenefitPlansAssets>
  <nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3469000000</nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities>
  <nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">3546000000</nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">1.00</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">1.00</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:EmployerSharesHeldByDefinedBenefitPlan contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Shares" decimals="-5">2300000</nvs:EmployerSharesHeldByDefinedBenefitPlan>
  <nvs:EmployerSharesHeldByDefinedBenefitPlan contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Shares" decimals="-5">11000000</nvs:EmployerSharesHeldByDefinedBenefitPlan>
  <nvs:ValueOfEmployerSharesHeldByDefinedBenefitPlan contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-8">200000000</nvs:ValueOfEmployerSharesHeldByDefinedBenefitPlan>
  <nvs:ValueOfEmployerSharesHeldByDefinedBenefitPlan contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-8">900000000</nvs:ValueOfEmployerSharesHeldByDefinedBenefitPlan>
  <nvs:WeightedAverageDurationOfDefinedBenefitObligationYears contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P15Y2M13D</nvs:WeightedAverageDurationOfDefinedBenefitObligationYears>
  <nvs:WeightedAverageDurationOfDefinedBenefitObligationYears contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">P14Y7M7D</nvs:WeightedAverageDurationOfDefinedBenefitObligationYears>
  <nvs:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="USD" decimals="-6">410000000</nvs:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.20</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.17</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.17</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4RealEstateMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.05</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.00</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.20</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.15</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4AlternativeInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.16</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.00</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum>
  <nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.15</nvs:DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.05</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <nvs:DefinedBenefitPlanPlanAssetAllocations contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfAssetsAxis_nvs-2019Q4CashAndOtherInvestmentsMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember" unitRef="Pure" decimals="2">0.04</nvs:DefinedBenefitPlanPlanAssetAllocations>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">574000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4PensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">760000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">612000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4UnfundedMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">954000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">157000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4ActiveMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">295000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">15000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ObligationByTypeAxis_nvs-2019Q4DeferredPensionersMember_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">18000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <nvs:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">46000000</nvs:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
  <nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.065</nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
  <nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.070</nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
  <nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.065</nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
  <nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.045</nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline>
  <nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.045</nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline>
  <nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.045</nvs:DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline>
  <nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">612000000</nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities>
  <nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">954000000</nvs:DefinedBenefitPensionPlanAccruedBenefitLiabilities>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">3000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1>
  <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-7000000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
  <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-35000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
  <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">54000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.036</ifrs-full:ActuarialAssumptionOfDiscountRates>
  <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.044</ifrs-full:ActuarialAssumptionOfDiscountRates>
  <ifrs-full:ActuarialAssumptionOfDiscountRates contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="Pure" decimals="3">0.037</ifrs-full:ActuarialAssumptionOfDiscountRates>
  <nvs:DefinedBenefitAssumptionLifeExpectancyMale contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">P21Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyMale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyMale contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">P21Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyMale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyMale contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">P21Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyMale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyFemale contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">P23Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyFemale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyFemale contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">P23Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyFemale>
  <nvs:DefinedBenefitAssumptionLifeExpectancyFemale contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">P23Y0M0D</nvs:DefinedBenefitAssumptionLifeExpectancyFemale>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1 contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">2000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1>
  <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">74000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">6000000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
  <nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">10000000</nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset>
  <nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-8000000</nvs:ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset>
  <nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-3000000</nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset>
  <nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-5000000</nvs:InterestExpenseIncomeDefinedBenefitLiabilityAsset>
  <nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1 contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">1000000</nvs:IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1>
  <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">30000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">46000000</ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">119000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">162000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">746000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">612000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">954000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-612000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:SurplusDeficitInPlan contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-954000000</ifrs-full:SurplusDeficitInPlan>
  <ifrs-full:PlanAssetsAtFairValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">134000000</ifrs-full:PlanAssetsAtFairValue>
  <ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">0</ifrs-full:PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">26000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
  <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">34000000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
  <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">953000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">9000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset>
  <nvs:DefinedBenefitPlanInterestCost contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">29000000</nvs:DefinedBenefitPlanInterestCost>
  <nvs:DefinedBenefitPlanInterestCost contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">39000000</nvs:DefinedBenefitPlanInterestCost>
  <nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">22000000</nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset>
  <nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">32000000</nvs:ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset>
  <nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-7000000</nvs:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">-76000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">31000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
  <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">13000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
  <ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">34000000</ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">1073000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember" unitRef="USD" decimals="-6">1115000000</ifrs-full:DefinedBenefitObligationAtPresentValue>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">7400000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">2200000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">58.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">1800000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">58.2</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">3400000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">60.9</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">5600000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">59.9</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">3400000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">60.9</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">5600000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">59.9</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">89.9</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">300000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">700000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">900000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="Pure" decimals="-5">1500000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">P0Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">P1Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">P2Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">P3Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">P2Y1M5D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">54.5</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">57.0</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">57.6</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">66.0</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">2600000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">67.4</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">175000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">2100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">79.7</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">167000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" unitRef="USDPerShares" decimals="1">59.5</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">5300000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">64.0</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">339000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">3900000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">77.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">303000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">1200000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">2900000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">5100000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">P0Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">P1Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">P2Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">20300000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">5600000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">58.6</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">5100000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">57.4</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">9600000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">61.9</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">15200000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">60.7</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">9600000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">61.9</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">15200000</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">60.7</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">85.1</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:NumberOfOutstandingShareOptions contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="Pure" decimals="-5">400000</ifrs-full:NumberOfOutstandingShareOptions>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">P3Y0M0D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">P2Y3M19D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice54.5Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">54.5</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">57.0</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice57.6Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">57.6</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <ifrs-full:ExercisePriceOfOutstandingShareOptions2019 contextRef="AR_I-CurrentYearEnd_ifrsfull-2019RangesOfExercisePricesForOutstandingShareOptionsAxis_nvs-2019Q4ExercisePrice66.0Member_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" unitRef="USDPerShares" decimals="1">66.0</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
  <nvs:PercentageOfShareCapitalInTenderOffer contextRef="AR_I-Transaction-AAA_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="Pure" decimals="2">1.00</nvs:PercentageOfShareCapitalInTenderOffer>
  <nvs:CashOfferPerOrdinaryShare contextRef="AR_I-Transaction-AAA_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="0">41</nvs:CashOfferPerOrdinaryShare>
  <nvs:CashOfferPerADS contextRef="AR_I-Transaction-AAA_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="0">82</nvs:CashOfferPerADS>
  <nvs:NumberOfOrdinarySharePerADS contextRef="AR_I-Transaction-AAA_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="Pure" decimals="0">2</nvs:NumberOfOrdinarySharePerADS>
  <nvs:ValueOfEquity contextRef="AR_I-Transaction-AAA_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">3900000000</nvs:ValueOfEquity>
  <nvs:PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="Pure" decimals="2">0.97</nvs:PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">3900000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <nvs:PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="Pure" decimals="3">0.018</nvs:PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer>
  <nvs:ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-6">60000000</nvs:ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer>
  <nvs:TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="Pure" decimals="3">0.987</nvs:TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">1900000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">2000000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">2500000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">600000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:RevenueOfAcquiree contextRef="AR_D-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">400000000</ifrs-full:RevenueOfAcquiree>
  <nvs:RevenueOfAcquireeFullYear contextRef="AR_D-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="USD" decimals="-8">400000000</nvs:RevenueOfAcquireeFullYear>
  <ifrs-full:ProportionOfOwnershipInterestInSubsidiary contextRef="AR_D-Transaction-AAA-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsAAAMember" unitRef="Pure" decimals="3">0.992</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
  <nvs:CashOfferPerOrdinaryShare contextRef="AR_I-Transaction-Avexis_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="0">218</nvs:CashOfferPerOrdinaryShare>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="-8">8700000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <nvs:PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer contextRef="AR_I-Transaction-Avexis_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="Pure" decimals="2">1.00</nvs:PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="-8">7200000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="-8">1500000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="-8">8500000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="-8">1600000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:OtherNetAssets contextRef="AR_I-Transaction-Avexis-2-May_dei-2019LegalEntityAxis_nvs-2019Q4AveXisIncMember" unitRef="USD" decimals="-8">300000000</nvs:OtherNetAssets>
  <nvs:CashOfferPerOrdinaryShare contextRef="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="0">24</nvs:CashOfferPerOrdinaryShare>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">2100000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">2100000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
  <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">1500000000</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
  <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">1500000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">300000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:OtherNetAssets contextRef="AR_I-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">300000000</nvs:OtherNetAssets>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Endocyte-2-Dec_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteMember" unitRef="USD" decimals="-8">600000000</ifrs-full:AdditionalRecognitionGoodwill>
  <nvs:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="AR_I-Transaction-GSK-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4GSKConsumerHealthcareMember" unitRef="Pure" decimals="3">0.365</nvs:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
  <nvs:PreTaxProfitLossFromDivestmentOfBusiness contextRef="AR_I-Transaction-GSK-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4GSKConsumerHealthcareMember" unitRef="USD" decimals="-8">5800000000</nvs:PreTaxProfitLossFromDivestmentOfBusiness>
  <ifrs-full:ProceedsFromSalesOfInterestsInAssociates contextRef="AR_D-Transaction-GSK-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4GSKConsumerHealthcareMember" unitRef="USD" decimals="-6">12855000000</ifrs-full:ProceedsFromSalesOfInterestsInAssociates>
  <ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations contextRef="AR_D-Transaction-GSK-2-2018_dei-2019LegalEntityAxis_nvs-2019Q4GSKConsumerHealthcareMember" unitRef="USD" decimals="-6">12994000000</ifrs-full:ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations>
  <nvs:NumberOfProductsInPortfolioToBeSold contextRef="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="Pure" decimals="0">300</nvs:NumberOfProductsInPortfolioToBeSold>
  <nvs:DivestmentDateFairValueOfTotalConsiderationTransferred contextRef="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">800000000</nvs:DivestmentDateFairValueOfTotalConsiderationTransferred>
  <nvs:CarryingValueOfTheDivestedBusiness contextRef="AR_I-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">1000000000</nvs:CarryingValueOfTheDivestedBusiness>
  <ifrs-full:AdditionalRecognitionGoodwill contextRef="AR_D-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">200000000</ifrs-full:AdditionalRecognitionGoodwill>
  <ifrs-full:ImpairmentLoss contextRef="AR_D-Transaction-Sandoz-Divestment_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4SandozMember" unitRef="USD" decimals="-8">200000000</ifrs-full:ImpairmentLoss>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">382000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <nvs:FairValueOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">976000000</nvs:FairValueOnSaleOfOtherFinancialAssets>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4AlconMember" unitRef="USD" decimals="-6">62000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-2_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">88000000</ifrs-full:RevenueFromRoyalties>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">24000000</ifrs-full:RevenueFromRoyalties>
  <ifrs-full:RevenueFromRoyalties contextRef="AR_D-CurrentYear-1_ifrsfull-2019SegmentsAxis_nvs-2019Q4CorporateMember" unitRef="USD" decimals="-6">16000000</ifrs-full:RevenueFromRoyalties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="USD" decimals="-6">21099000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="Pure" decimals="2">0.44</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="USD" decimals="-6">20286000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="Pure" decimals="2">0.44</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="USD" decimals="-6">19033000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="Pure" decimals="2">0.46</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="USD" decimals="-6">8980000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="Pure" decimals="2">0.12</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="USD" decimals="-6">9763000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019GeographicalAreasAxis_nvs-2019Q4OtherCountriesMember" unitRef="Pure" decimals="2">0.10</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.21</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.22</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.22</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">2209000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.03</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">3066000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.03</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">9799000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">9460000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="USD" decimals="-6">9093000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4AsiaAfricaAustralasiaMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember" unitRef="Pure" decimals="2">0.23</ifrs-full:PercentageOfEntitysRevenue>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember" unitRef="Pure" decimals="2">0.18</ifrs-full:PercentageOfEntitysRevenue>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember" unitRef="Pure" decimals="2">0.19</ifrs-full:PercentageOfEntitysRevenue>
  <nvs:PercentageOfEntitysTradeReceivable contextRef="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember" unitRef="Pure" decimals="2">0.14</nvs:PercentageOfEntitysTradeReceivable>
  <nvs:PercentageOfEntitysTradeReceivable contextRef="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4LargestCustomerMember" unitRef="Pure" decimals="2">0.12</nvs:PercentageOfEntitysTradeReceivable>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember" unitRef="Pure" decimals="2">0.17</ifrs-full:PercentageOfEntitysRevenue>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember" unitRef="Pure" decimals="2">0.14</ifrs-full:PercentageOfEntitysRevenue>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember" unitRef="Pure" decimals="2">0.14</ifrs-full:PercentageOfEntitysRevenue>
  <nvs:PercentageOfEntitysTradeReceivable contextRef="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember" unitRef="Pure" decimals="2">0.12</nvs:PercentageOfEntitysTradeReceivable>
  <nvs:PercentageOfEntitysTradeReceivable contextRef="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4SecondLargestCustomerMember" unitRef="Pure" decimals="2">0.10</nvs:PercentageOfEntitysTradeReceivable>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember" unitRef="Pure" decimals="2">0.10</ifrs-full:PercentageOfEntitysRevenue>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember" unitRef="Pure" decimals="2">0.08</ifrs-full:PercentageOfEntitysRevenue>
  <ifrs-full:PercentageOfEntitysRevenue contextRef="AR_D-CurrentYear-2_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember" unitRef="Pure" decimals="2">0.07</ifrs-full:PercentageOfEntitysRevenue>
  <nvs:PercentageOfEntitysTradeReceivable contextRef="AR_D-CurrentYear_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember" unitRef="Pure" decimals="2">0.07</nvs:PercentageOfEntitysTradeReceivable>
  <nvs:PercentageOfEntitysTradeReceivable contextRef="AR_D-CurrentYear-1_ifrsfull-2019MajorCustomersAxis_nvs-2019Q4ThirdLargestCustomerMember" unitRef="Pure" decimals="2">0.06</nvs:PercentageOfEntitysTradeReceivable>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-8">2100000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-8">2000000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4LucentisMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-8">1900000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-8">1200000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-6">920000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_ifrsfull-2019ProductsAndServicesAxis_nvs-2019Q4XolairMember_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-9">1000000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">16280000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">14618000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="USD" decimals="-6">14135000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="Pure" decimals="2">0.03</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4USMember" unitRef="Pure" decimals="2">0.11</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">3433000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">3414000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="USD" decimals="-6">3350000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="Pure" decimals="2">0.02</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4CanadaAndLatinAmericaMember" unitRef="Pure" decimals="2">0.01</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">35684000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">33491000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="USD" decimals="-6">31557000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EstablishedMarketsMember" unitRef="Pure" decimals="2">0.07</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">11761000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">11260000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="USD" decimals="-6">10781000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_nvs-2019Q4EmergingGrowthMarketsMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">0</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">0</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">0</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">39000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">349000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeMaketableSecurities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">12000000</nvs:OtherComprehensiveIncomeMaketableSecurities>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">-13000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeAvailableforsaleFinancialInvestments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">47000000</nvs:OtherComprehensiveIncomeAvailableforsaleFinancialInvestments>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">-109000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <ifrs-full:ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">102000000</ifrs-full:ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">39000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember" unitRef="USD" decimals="-6">0</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnMarketableSecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4ReclassificationToPresentationRequiredUnderIFRS9Member" unitRef="USD" decimals="-6">-211000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">1000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">-1000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:OtherComprehensiveIncomeMaketableSecurities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">-1000000</nvs:OtherComprehensiveIncomeMaketableSecurities>
  <nvs:OtherComprehensiveIncomeDebtSecurities contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">1000000</nvs:OtherComprehensiveIncomeDebtSecurities>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">-1000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">-1000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">-1000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">1000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">0</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDebtSecuritiesMember" unitRef="USD" decimals="-6">-2000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">21000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">12000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">1000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">22000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">12000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">-3000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">1000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax>
  <ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">13000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">13000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">12000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">9000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">12000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnDeferredCashFlowHedgesMember" unitRef="USD" decimals="-6">1000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-142000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">33000000</nvs:FairValueAdjustmentsRelatedToDivestments>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">208000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-3000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4ReclassificationToPresentationRequiredUnderIFRS9Member" unitRef="USD" decimals="-6">211000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-5000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-16000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <nvs:OtherComprehensiveIncomeEquitySecurities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">18000000</nvs:OtherComprehensiveIncomeEquitySecurities>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">47000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">95000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <nvs:OtherComprehensiveIncomeEquitySecurities contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-94000000</nvs:OtherComprehensiveIncomeEquitySecurities>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">0</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-47000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-95000000</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">13000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:FairValueAdjustmentsOnFinancialAssetsSold contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">-16000000</nvs:FairValueAdjustmentsOnFinancialAssetsSold>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4FairValueAdjustmentsOnEquitySecuritiesMember" unitRef="USD" decimals="-6">99000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-5064000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-359000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-5423000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-359000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-466000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-5919000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-466000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">851000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">851000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-5915000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4ActuarialLossesFromDefinedBenefitPlansMember" unitRef="USD" decimals="-6">-30000000</nvs:FairValueAdjustmentsRelatedToDivestments>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">-1642000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">2208000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">-237000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">1971000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">398000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">1142000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">354000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">44000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">415000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">744000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">320000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
  <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">95000000</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4CumulativeCurrencyTranslationEffectsMember" unitRef="USD" decimals="-6">329000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:FairValueAdjustmentsRelatedToDivestments contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">33000000</nvs:FairValueAdjustmentsRelatedToDivestments>
  <nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">-140000000</nvs:GainsLossesOnValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeEquitySecurities contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">-94000000</nvs:OtherComprehensiveIncomeEquitySecurities>
  <ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">1000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">95000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">120000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">47000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeEquitySecurities contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">18000000</nvs:OtherComprehensiveIncomeEquitySecurities>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">-16000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">227000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeMaketableSecurities contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">11000000</nvs:OtherComprehensiveIncomeMaketableSecurities>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">-6000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax contextRef="AR_D-CurrentYear-1_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">13000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">-14000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">50000000</nvs:OtherComprehensiveIncomeNetOfTaxFinancialInstruments>
  <nvs:ValueAdjustmentOnComprehensiveIncome contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">395000000</nvs:ValueAdjustmentOnComprehensiveIncome>
  <ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">13000000</ifrs-full:ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax>
  <ifrs-full:ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">102000000</ifrs-full:ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax>
  <nvs:GainLossOnSaleOfOtherFinancialAssets contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">-109000000</nvs:GainLossOnSaleOfOtherFinancialAssets>
  <nvs:OtherComprehensiveIncomeAvailableforsaleFinancialInvestments contextRef="AR_D-CurrentYear-2_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">47000000</nvs:OtherComprehensiveIncomeAvailableforsaleFinancialInvestments>
  <nvs:OtherComprehensiveIncomeDebtSecurities contextRef="AR_D-CurrentYear_ifrsfull-2019ComponentsOfEquityAxis_nvs-2019Q4TotalFairValueAdjustmentsMember" unitRef="USD" decimals="-6">1000000</nvs:OtherComprehensiveIncomeDebtSecurities>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">15047000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-1120000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-2000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-1170000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">209000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-167000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">6000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">37000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-11000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">5424000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-2005000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-984000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">70000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AcquiredResearchAndDevelopmentMember" unitRef="USD" decimals="-6">-3000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4AlconBrandNameMember" unitRef="USD" decimals="-6">2980000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">14194000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-21218000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">152000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-825000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">791000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-19631000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-2521000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-816000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-20969000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">22579000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-126000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-2592000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-2657000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">494000000</nvs:AccumulatedImpairmentsOnDisposalsAndDerecognitions>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4CurrentlyMarketedProductsMember" unitRef="USD" decimals="-6">-54000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">-1906000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">0</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">-238000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">-1668000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">-1906000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfIntangibleAssetsAndGoodwillAxis_nvs-2019Q4MarketingRelatedIntangibleAssetsMember" unitRef="USD" decimals="-6">4054000000</ifrs-full:IntangibleAssetsAndGoodwill>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">-915000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">273000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">1188000000</nvs:GrossDeferredTaxAssets>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">-6000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">-313000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">308000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">291000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">1078000000</nvs:GrossDeferredTaxAssets>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">69000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">4000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">-836000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">254000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">1090000000</nvs:GrossDeferredTaxAssets>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4PensionsAndOtherBenefitObligationsOfAssociatesMember" unitRef="USD" decimals="-6">-787000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-2159000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">3786000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">455000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-3331000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-86000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-6000000</nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">2446000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">287000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">23000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-818000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-9000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">3722000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">474000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InventoriesMember" unitRef="USD" decimals="-6">-3248000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-273000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">0</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">273000000</nvs:GrossDeferredTaxAssets>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-1000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-113000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">75000000</ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-31000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-21000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">7000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">255000000</nvs:GrossDeferredTaxAssets>
  <nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-1000000</nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-113000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-298000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-88000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">9000000</nvs:GrossDeferredTaxLiabilities>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">97000000</nvs:GrossDeferredTaxAssets>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4TaxLossCarryforwardsMember" unitRef="USD" decimals="-6">-248000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-1271000000</ifrs-full:DeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">1983000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">1003000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-980000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-83000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">8000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-17000000</ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">368000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-1000000</nvs:NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">2596000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">1325000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">26000000</ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">12000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-166000000</ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity>
  <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">24000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">298000000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">51000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:GrossDeferredTaxAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">2175000000</nvs:GrossDeferredTaxAssets>
  <nvs:GrossDeferredTaxLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">805000000</nvs:GrossDeferredTaxLiabilities>
  <ifrs-full:DeferredTaxLiabilityAsset contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4OtherAssetsProvisionsAccrualsMember" unitRef="USD" decimals="-6">-1370000000</ifrs-full:DeferredTaxLiabilityAsset>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InvestmentsInSubsidiariesMember" unitRef="USD" decimals="-9">3000000000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4InvestmentsInSubsidiariesMember" unitRef="USD" decimals="-9">3000000000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4GoodwillFromAcquisitionsMember" unitRef="USD" decimals="-9">-24000000000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4GoodwillFromAcquisitionsMember" unitRef="USD" decimals="-9">-33000000000</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember" unitRef="USD" decimals="-6">0</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember" unitRef="USD" decimals="-6">0</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember" unitRef="USD" decimals="-6">2249000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember" unitRef="USD" decimals="-6">37000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember" unitRef="USD" decimals="-6">6000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember" unitRef="USD" decimals="-6">46000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember" unitRef="USD" decimals="-6">4000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember" unitRef="USD" decimals="-6">0</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember" unitRef="USD" decimals="-6">12000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember" unitRef="USD" decimals="-6">5000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember" unitRef="USD" decimals="-6">2345000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember" unitRef="USD" decimals="-6">2338000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember" unitRef="USD" decimals="-6">36000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4CapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember" unitRef="USD" decimals="-6">2288000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember" unitRef="USD" decimals="-6">522000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember" unitRef="USD" decimals="-6">345000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember" unitRef="USD" decimals="-6">996000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember" unitRef="USD" decimals="-6">65000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember" unitRef="USD" decimals="-6">27000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember" unitRef="USD" decimals="-6">14000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember" unitRef="USD" decimals="-6">23000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember" unitRef="USD" decimals="-6">127000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember" unitRef="USD" decimals="-6">16000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember" unitRef="USD" decimals="-6">435000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember" unitRef="USD" decimals="-6">648000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember" unitRef="USD" decimals="-6">28000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember" unitRef="USD" decimals="-6">28000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4BalanceSheetTreatmentAxis_nvs-2019Q4NotCapitalizedMember_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember" unitRef="USD" decimals="-6">14000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember" unitRef="USD" decimals="-6">14000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4OneYearMember" unitRef="USD" decimals="-6">27000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember" unitRef="USD" decimals="-6">14000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4TwoYearsMember" unitRef="USD" decimals="-6">28000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember" unitRef="USD" decimals="-6">39000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4ThreeYearsMember" unitRef="USD" decimals="-6">34000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember" unitRef="USD" decimals="-6">62000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FourYearsMember" unitRef="USD" decimals="-6">70000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember" unitRef="USD" decimals="-6">164000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4FiveYearsMember" unitRef="USD" decimals="-6">381000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember" unitRef="USD" decimals="-6">2810000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets contextRef="AR_D-CurrentYear_nvs-2019Q4YearOfExpiryAxis_nvs-2019Q4MoreThanFiveYearsMember" unitRef="USD" decimals="-6">2684000000</nvs:GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets>
  <nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember" unitRef="USD" decimals="-6">440000000</nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember" unitRef="USD" decimals="-6">440000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset>
  <nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember" unitRef="USD" decimals="-6">-234000000</nvs:ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
  <nvs:ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember" unitRef="USD" decimals="-6">474000000</nvs:ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember" unitRef="USD" decimals="-6">34000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4ImpactLocationAxis_nvs-2019Q4IncomeStatementMember" unitRef="USD" decimals="-6">-234000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">358000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset>
  <nvs:ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">325000000</nvs:ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities>
  <nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">358000000</nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">325000000</nvs:ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">71000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings>
  <nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="AR_D-CurrentYear-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">254000000</nvs:ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome>
  <nvs:ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="Pure" decimals="2">0.21</nvs:ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges>
  <nvs:ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="Pure" decimals="2">0.35</nvs:ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges>
  <nvs:ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment contextRef="AR_D-CurrentYear-1_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember">P8Y0M0D</nvs:ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment>
  <nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4ImpactLocationAxis_ifrsfull-2019EquityMember" unitRef="USD" decimals="-6">70000000</nvs:ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryRawMaterialsGrossMember" unitRef="USD" decimals="-6">751000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryRawMaterialsGrossMember" unitRef="USD" decimals="-6">931000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryWorkInProgressGrossMember" unitRef="USD" decimals="-6">3024000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryWorkInProgressGrossMember" unitRef="USD" decimals="-6">3087000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryFinishedGoodsGrossMember" unitRef="USD" decimals="-6">2207000000</ifrs-full:Inventories>
  <ifrs-full:Inventories contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4InventoryAxis_nvs-2019Q4InventoryFinishedGoodsGrossMember" unitRef="USD" decimals="-6">2938000000</ifrs-full:Inventories>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019JPY" unitRef="USD" decimals="-6">184000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019JPY" unitRef="USD" decimals="-6">272000000</ifrs-full:Borrowings>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019JPY" unitRef="USD" decimals="-6">11000000</ifrs-full:DebtInstrumentsHeld>
  <ifrs-full:DebtInstrumentsHeld contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019JPY" unitRef="USD" decimals="-6">11000000</ifrs-full:DebtInstrumentsHeld>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_srt-2018CurrencyAxis_currency-2019CHF" unitRef="USD" decimals="-6">1421000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_srt-2018CurrencyAxis_currency-2019CHF" unitRef="USD" decimals="-6">1396000000</ifrs-full:Borrowings>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">1665000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">1276000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">1276000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">19000000</nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember_srt-2018CurrencyAxis_nvs-2019Q4CurrencyOthersMember" unitRef="USD" decimals="-6">1646000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" unitRef="Pure" decimals="5">0.05125</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" unitRef="USD" decimals="-6">3000000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" unitRef="Pure" decimals="5">0.99822</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" unitRef="USD" decimals="-6">3000000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" unitRef="Pure" decimals="5">0.04400</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" unitRef="USD" decimals="-6">1000000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" unitRef="Pure" decimals="5">0.99237</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" unitRef="USD" decimals="-6">1000000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" unitRef="USD" decimals="-6">998000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" unitRef="Pure" decimals="5">0.02400</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" unitRef="USD" decimals="-6">1500000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" unitRef="Pure" decimals="5">0.99225</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" unitRef="USD" decimals="-6">1495000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" unitRef="USD" decimals="-6">1493000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" unitRef="Pure" decimals="5">0.03700</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" unitRef="USD" decimals="-6">500000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" unitRef="Pure" decimals="5">0.98325</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" unitRef="USD" decimals="-6">489000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" unitRef="USD" decimals="-6">489000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" unitRef="Pure" decimals="5">0.03400</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" unitRef="USD" decimals="-6">2150000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" unitRef="Pure" decimals="5">0.99287</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" unitRef="USD" decimals="-6">2139000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" unitRef="USD" decimals="-6">2137000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" unitRef="Pure" decimals="5">0.04400</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" unitRef="USD" decimals="-6">1850000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" unitRef="Pure" decimals="5">0.99196</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" unitRef="USD" decimals="-6">1825000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" unitRef="USD" decimals="-6">1825000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" unitRef="Pure" decimals="5">0.00750</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" unitRef="EUR" decimals="-6">600000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" unitRef="Pure" decimals="5">0.99134</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" unitRef="USD" decimals="-6">670000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" unitRef="USD" decimals="-6">683000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" unitRef="Pure" decimals="5">0.01625</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" unitRef="EUR" decimals="-6">600000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" unitRef="Pure" decimals="5">0.99697</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" unitRef="USD" decimals="-6">670000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" unitRef="USD" decimals="-6">684000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" unitRef="Pure" decimals="5">0.00250</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" unitRef="CHF" decimals="-6">500000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" unitRef="Pure" decimals="5">1.00640</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" unitRef="USD" decimals="-6">517000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" unitRef="USD" decimals="-6">508000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" unitRef="Pure" decimals="5">0.00625</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" unitRef="CHF" decimals="-6">550000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" unitRef="Pure" decimals="5">1.00502</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" unitRef="USD" decimals="-6">568000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" unitRef="USD" decimals="-6">558000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" unitRef="Pure" decimals="5">0.01050</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" unitRef="CHF" decimals="-6">325000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" unitRef="Pure" decimals="5">1.00479</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" unitRef="USD" decimals="-6">336000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" unitRef="USD" decimals="-6">330000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" unitRef="Pure" decimals="5">0.03000</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" unitRef="USD" decimals="-6">1750000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" unitRef="Pure" decimals="5">0.99010</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" unitRef="USD" decimals="-6">1735000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" unitRef="USD" decimals="-6">1732000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" unitRef="Pure" decimals="5">0.04000</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" unitRef="USD" decimals="-6">1250000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" unitRef="Pure" decimals="5">0.98029</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" unitRef="USD" decimals="-6">1219000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" unitRef="USD" decimals="-6">1219000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" unitRef="Pure" decimals="5">0.00125</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" unitRef="EUR" decimals="-6">1250000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" unitRef="Pure" decimals="5">0.99127</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" unitRef="USD" decimals="-6">1392000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" unitRef="USD" decimals="-6">1419000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" unitRef="Pure" decimals="5">0.00625</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" unitRef="EUR" decimals="-6">500000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" unitRef="Pure" decimals="5">0.98480</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" unitRef="USD" decimals="-6">553000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" unitRef="USD" decimals="-6">563000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" unitRef="Pure" decimals="5">0.01800</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" unitRef="USD" decimals="-6">1000000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" unitRef="Pure" decimals="5">0.99609</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" unitRef="USD" decimals="-6">1000000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" unitRef="USD" decimals="-6">998000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" unitRef="Pure" decimals="5">0.02400</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" unitRef="USD" decimals="-6">1000000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" unitRef="Pure" decimals="5">0.99449</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" unitRef="USD" decimals="-6">996000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" unitRef="USD" decimals="-6">995000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" unitRef="Pure" decimals="5">0.03100</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" unitRef="USD" decimals="-6">1000000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" unitRef="Pure" decimals="5">0.99109</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" unitRef="USD" decimals="-6">990000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" unitRef="USD" decimals="-6">989000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" unitRef="Pure" decimals="5">0.00000</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" unitRef="EUR" decimals="-6">1250000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" unitRef="Pure" decimals="5">0.99133</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" unitRef="USD" decimals="-6">1396000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" unitRef="USD" decimals="-6">1421000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" unitRef="Pure" decimals="5">0.01125</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" unitRef="EUR" decimals="-6">600000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" unitRef="Pure" decimals="5">0.99874</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" unitRef="USD" decimals="-6">670000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" unitRef="USD" decimals="-6">684000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" unitRef="Pure" decimals="5">0.00500</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" unitRef="EUR" decimals="-6">750000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" unitRef="Pure" decimals="5">0.99655</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" unitRef="USD" decimals="-6">837000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" unitRef="USD" decimals="-6">853000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" unitRef="Pure" decimals="5">0.01375</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" unitRef="EUR" decimals="-6">750000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" unitRef="Pure" decimals="5">0.99957</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" unitRef="USD" decimals="-6">838000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" unitRef="USD" decimals="-6">856000000</ifrs-full:BondsIssued>
  <ifrs-full:BorrowingsInterestRate contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" unitRef="Pure" decimals="5">0.01700</ifrs-full:BorrowingsInterestRate>
  <ifrs-full:NotionalAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" unitRef="EUR" decimals="-6">750000000</ifrs-full:NotionalAmount>
  <nvs:BorrowingsPremiumDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" unitRef="Pure" decimals="5">0.99217</nvs:BorrowingsPremiumDiscount>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" unitRef="USD" decimals="-6">832000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" unitRef="USD" decimals="-6">849000000</ifrs-full:BondsIssued>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanFiveYearsAndNotLaterThanSixYearsMember" unitRef="USD" decimals="-6">2137000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanSixYearsMember" unitRef="USD" decimals="-6">11353000000</ifrs-full:Borrowings>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">25283000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">22167000000</ifrs-full:BondsIssued>
  <nvs:OtherNoncurrentFinancialDebt contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">188000000</nvs:OtherNoncurrentFinancialDebt>
  <nvs:OtherNoncurrentFinancialDebt contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">377000000</nvs:OtherNoncurrentFinancialDebt>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">22355000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4CarryingReportedAmountFairValueDisclosureMember" unitRef="USD" decimals="-6">25660000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember" unitRef="USD" decimals="-6">25815000000</ifrs-full:Borrowings>
  <ifrs-full:Borrowings contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember" unitRef="USD" decimals="-6">23889000000</ifrs-full:Borrowings>
  <nvs:OtherNoncurrentFinancialDebt contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember" unitRef="USD" decimals="-6">377000000</nvs:OtherNoncurrentFinancialDebt>
  <nvs:OtherNoncurrentFinancialDebt contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember" unitRef="USD" decimals="-6">188000000</nvs:OtherNoncurrentFinancialDebt>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember" unitRef="USD" decimals="-6">23701000000</ifrs-full:BondsIssued>
  <ifrs-full:BondsIssued contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FairValueByMeasurementBasisAxis_nvs-2019Q4FairValueDisclosureItemAmountsMember" unitRef="USD" decimals="-6">25438000000</ifrs-full:BondsIssued>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">5183000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-193000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">5474000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">3684000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-62000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">3875000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">4158000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-90000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">4541000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1981000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1883000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1590000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-3_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4USspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1461000000</ifrs-full:CurrentRefundsProvision>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-78000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">2182000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">83000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">2555000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">109000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">131000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1954000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">80000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">2186000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">107000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-19000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">2467000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-2000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">2659000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">-1000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-3_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1020000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1356000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1769000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonUSspecificHealthcarePlansAndProgramRebatesMember" unitRef="USD" decimals="-6">1625000000</ifrs-full:CurrentRefundsProvision>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">9000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">11698000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-25000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">11868000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-103000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">65000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">11814000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-127000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">12045000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">145000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-51000000</nvs:AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
  <ifrs-full:ProvisionUsedOtherProvisions contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">12227000000</ifrs-full:ProvisionUsedOtherProvisions>
  <nvs:IncomeStatementAdjustmentsOfPriorYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-91000000</nvs:IncomeStatementAdjustmentsOfPriorYear>
  <nvs:IncomeStatementAdjustmentsOfCurrentYear contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">11956000000</nvs:IncomeStatementAdjustmentsOfCurrentYear>
  <nvs:ChangesInOffsetAgainstGrossTradeReceivables contextRef="AR_D-CurrentYear-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">-441000000</nvs:ChangesInOffsetAgainstGrossTradeReceivables>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">1754000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">1845000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">1726000000</ifrs-full:CurrentRefundsProvision>
  <ifrs-full:CurrentRefundsProvision contextRef="AR_I-CurrentYearEnd-3_nvs-2019Q4PlansAndProgramRebatesAxis_nvs-2019Q4NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" unitRef="USD" decimals="-6">1702000000</ifrs-full:CurrentRefundsProvision>
  <nvs:CashFlowFromNetIdentifiableAssets contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">4124000000</nvs:CashFlowFromNetIdentifiableAssets>
  <nvs:CashFlowFromNetIdentifiableAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">13660000000</nvs:CashFlowFromNetIdentifiableAssets>
  <nvs:CashFlowFromNetIdentifiableAssets contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">874000000</nvs:CashFlowFromNetIdentifiableAssets>
  <ifrs-full:AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate contextRef="AR_I-CurrentYearEnd_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">-33000000</ifrs-full:AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate>
  <nvs:ReceivablesAndPayablesContingentConsiderationNet contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">242000000</nvs:ReceivablesAndPayablesContingentConsiderationNet>
  <nvs:ReceivablesAndPayablesContingentConsiderationNet contextRef="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">-5000000</nvs:ReceivablesAndPayablesContingentConsiderationNet>
  <nvs:ReceivablesAndPayablesContingentConsiderationNet contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">151000000</nvs:ReceivablesAndPayablesContingentConsiderationNet>
  <nvs:OtherPaymentsAndDeferredConsiderationNet contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">2000000</nvs:OtherPaymentsAndDeferredConsiderationNet>
  <nvs:OtherPaymentsAndDeferredConsiderationNet contextRef="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">36000000</nvs:OtherPaymentsAndDeferredConsiderationNet>
  <nvs:OtherPaymentsAndDeferredConsiderationNet contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">36000000</nvs:OtherPaymentsAndDeferredConsiderationNet>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">-3851000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">-13701000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4AcquisitionsMember" unitRef="USD" decimals="-6">-759000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">91000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-1_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">18000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">45000000</nvs:NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities>
  <ifrs-full:ConsiderationPaidReceived contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">-95000000</ifrs-full:ConsiderationPaidReceived>
  <nvs:NetCashOutflowsFromDivestments contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">4000000</nvs:NetCashOutflowsFromDivestments>
  <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">196000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
  <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">48000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
  <nvs:NoncurrentAssetsDivested contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">159000000</nvs:NoncurrentAssetsDivested>
  <nvs:NoncurrentAssetsDivested contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">29000000</nvs:NoncurrentAssetsDivested>
  <nvs:CurrentAssetsDivested contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">96000000</nvs:CurrentAssetsDivested>
  <nvs:CurrentAssetsDivested contextRef="AR_D-CurrentYear-2_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">34000000</nvs:CurrentAssetsDivested>
  <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013 contextRef="AR_D-CurrentYear_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">11000000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
  <ifrs-full:LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013 contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLiabilitiesMember_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">18000000</ifrs-full:LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
  <ifrs-full:LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013 contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLiabilitiesMember_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">41000000</ifrs-full:LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
  <ifrs-full:LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013 contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLiabilitiesMember_nvs-2019Q4AcquisitionsAndDivestmentsAxis_nvs-2019Q4DivestmentsMember" unitRef="USD" decimals="-6">15000000</ifrs-full:LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-93000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-4933000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-1000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <nvs:CurrentPortionOfNoncurrentFinancialDebt contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-3190000000</nvs:CurrentPortionOfNoncurrentFinancialDebt>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">22470000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-462000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:AmortizationOfBondsDiscount contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-27000000</nvs:AmortizationOfBondsDiscount>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-5000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">10000000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
  <nvs:AmortizationOfBondsDiscount contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-25000000</nvs:AmortizationOfBondsDiscount>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-141000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:ReclassificationFromNoncurrentToCurrentNet contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-2003000000</nvs:ReclassificationFromNoncurrentToCurrentNet>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">20353000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <ifrs-full:ProceedsFromNoncurrentBorrowings contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-2856000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
  <nvs:CurrentPortionOfNoncurrentFinancialDebt contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-359000000</nvs:CurrentPortionOfNoncurrentFinancialDebt>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">23224000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">17897000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">6000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">744000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:AmortizationOfBondsDiscount contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NonCurrentFinancialDebtsMember" unitRef="USD" decimals="-6">-16000000</nvs:AmortizationOfBondsDiscount>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">126000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">140000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-3_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">5905000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">5308000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:CurrentPortionOfNoncurrentFinancialDebt contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">359000000</nvs:CurrentPortionOfNoncurrentFinancialDebt>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-366000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-1681000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-129000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">7031000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:ReclassificationFromNoncurrentToCurrentNet contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">2003000000</nvs:ReclassificationFromNoncurrentToCurrentNet>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">44000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">4000000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">48000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:AmortizationOfBondsDiscount contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-2000000</nvs:AmortizationOfBondsDiscount>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-93000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">9678000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:CurrentPortionOfNoncurrentFinancialDebt contextRef="AR_D-CurrentYear-1_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">3190000000</nvs:CurrentPortionOfNoncurrentFinancialDebt>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-187000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear-2_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">755000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <ifrs-full:RepaymentsOfNoncurrentBorrowings contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">-3195000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
  <ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">1582000000</ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings>
  <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">2000000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-11000000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">362000000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">4000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <nvs:ReclassificationFromNoncurrentToCurrentNet contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-156000000</nvs:ReclassificationFromNoncurrentToCurrentNet>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">1703000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4NoncurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-33000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-20000000</nvs:IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges>
  <nvs:FinancialDebtsAndDerivativeInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">246000000</nvs:FinancialDebtsAndDerivativeInstruments>
  <nvs:ReclassificationFromNoncurrentToCurrentNet contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">156000000</nvs:ReclassificationFromNoncurrentToCurrentNet>
  <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">1000000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">131000000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-6000000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
  <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-273000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
  <nvs:InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities contextRef="AR_D-CurrentYear_ifrsfull-2019AssetsAndLiabilitiesAxis_nvs-2019Q4CurrentLeaseLiabilitiesMember" unitRef="USD" decimals="-6">-51000000</nvs:InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_nvs-2019Q4LifeExpectancyMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Increase1YearMember" unitRef="USD" decimals="-6">848000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_nvs-2019Q4ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">62000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
  <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ActuarialAssumptionsAxis_nvs-2019Q4ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember_nvs-2019Q4ChangeInActuarialAssumptionAxis_nvs-2019Q4Change25BasisPointMember" unitRef="USD" decimals="-6">-60000000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">1100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">78.4</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">86000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">1300000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">83.9</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">109000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">4200000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">83.0</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">349000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">4100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">84.9</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">348000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">2500000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">68.9</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">172000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">1500000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">85.8</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">129000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">100000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">0.0</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">0</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">300000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">52.0</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">16000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">1900000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">67.7</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">129000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">1200000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">93000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationOtherShareAwardsMember_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">77.9</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">23900000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">80.6</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">1926000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue>
  <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">13300000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">80.3</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue contextRef="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">1068000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue>
  <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">10700000</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">90.2</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue contextRef="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">965000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue>
  <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">4300000</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">76.3</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue contextRef="AR_D-CurrentYear_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">328000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue>
  <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">1900000</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019 contextRef="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">76.4</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue contextRef="AR_D-CurrentYear-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">145000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">25800000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">71.1</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue contextRef="AR_I-CurrentYearEnd_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">1835000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue>
  <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="Pure" decimals="-5">25700000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
  <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USDPerShares" decimals="1">77.1</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019>
  <nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4NonvestingAxis_nvs-2019Q4NonvestedSharesGrantedMember" unitRef="USD" decimals="-6">1981000000</nvs:SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">4100000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">4000000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">4000000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">4600000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">4800000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">4800000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">8700000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">8800000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4NonExecutiveDirectorMember" unitRef="USD" decimals="-5">8800000</ifrs-full:KeyManagementPersonnelCompensation>
  <nvs:NumberOfContractsWithRelatedParties contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="Pure" decimals="0">2</nvs:NumberOfContractsWithRelatedParties>
  <nvs:NetExpenseRoyaltiesCostSharingAndProfitSharing contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-6">101000000</nvs:NetExpenseRoyaltiesCostSharingAndProfitSharing>
  <nvs:NetExpenseRoyaltiesCostSharingAndProfitSharing contextRef="AR_D-CurrentYear-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-6">34000000</nvs:NetExpenseRoyaltiesCostSharingAndProfitSharing>
  <nvs:NetExpenseRoyaltiesCostSharingAndProfitSharing contextRef="AR_D-CurrentYear-2_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GenentechRocheMember" unitRef="USD" decimals="-6">-33000000</nvs:NetExpenseRoyaltiesCostSharingAndProfitSharing>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrAlexKrauerMember" unitRef="CHF" decimals="0">60000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrAlexKrauerMember" unitRef="CHF" decimals="0">60000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrAlexKrauerMember" unitRef="CHF" decimals="0">60000</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrDanielVasellaMember" unitRef="CHF" decimals="0">0</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-1_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrDanielVasellaMember" unitRef="CHF" decimals="0">18228</ifrs-full:KeyManagementPersonnelCompensation>
  <ifrs-full:KeyManagementPersonnelCompensation contextRef="AR_D-CurrentYear-2_ifrsfull-2019CategoriesOfRelatedPartiesAxis_nvs-2019Q4DrDanielVasellaMember" unitRef="CHF" decimals="0">26279</ifrs-full:KeyManagementPersonnelCompensation>
  <nvs:BorrowingsCreditFacilityUncommitted contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4NovartisPensionFundMember" unitRef="USD" decimals="-6">500000000</nvs:BorrowingsCreditFacilityUncommitted>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd_ifrsfull-2019ClassesOfFinancialAssetsAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">11112000000</ifrs-full:FinancialAssets>
  <ifrs-full:FinancialAssets contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019ClassesOfFinancialAssetsAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">13271000000</ifrs-full:FinancialAssets>
  <nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember" unitRef="USD" decimals="-6">-110000000</nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember" unitRef="USD" decimals="-6">10779000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember" unitRef="USD" decimals="-6">10823000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember" unitRef="USD" decimals="-6">96000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember" unitRef="USD" decimals="-6">130000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember" unitRef="USD" decimals="-6">-75000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember" unitRef="USD" decimals="-6">-58000000</nvs:DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts>
  <nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember" unitRef="USD" decimals="-6">269000000</nvs:DerivativeFinancialInstrumentsOptionsOnEquitySecurities>
  <nvs:DerivativeFinancialInstrumentsCommodityPurchaseContract contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember" unitRef="USD" decimals="-6">9000000</nvs:DerivativeFinancialInstrumentsCommodityPurchaseContract>
  <nvs:DerivativeFinancialInstrumentsCommodityPurchaseContract contextRef="AR_I-CurrentYearEnd_nvs-2019Q4DerivativeFinancialInstrumentNatureOfInstrumentAxis_nvs-2019Q4DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember" unitRef="USD" decimals="-6">6000000</nvs:DerivativeFinancialInstrumentsCommodityPurchaseContract>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember" unitRef="USD" decimals="-6">11057000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4ContractOrUnderlyingPrincipalAmoutMember" unitRef="USD" decimals="-6">10823000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember" unitRef="USD" decimals="-6">102000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4PositiveFairValuesMember" unitRef="USD" decimals="-6">130000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember" unitRef="USD" decimals="-6">-185000000</nvs:DerivativeFinancialInstruments>
  <nvs:DerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4FinancialInstrumentsPrincipalAmountsAxis_nvs-2019Q4NegativeFairValuesMember" unitRef="USD" decimals="-6">-58000000</nvs:DerivativeFinancialInstruments>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">49000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">15000000</nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:DisposalsFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">3000000</nvs:DisposalsFairValueMeasurementAssets>
  <nvs:ReclassificationFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">10000000</nvs:ReclassificationFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">186000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">-15000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">24000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">188000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">22000000</nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:ReclassificationFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">-39000000</nvs:ReclassificationFairValueMeasurementAssets>
  <nvs:DisposalsFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">6000000</nvs:DisposalsFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">145000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4AssociatedCompaniesAtFairValueThroughProfitAndLossMember" unitRef="USD" decimals="-6">-22000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">93000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">166000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">22000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">12000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">233000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:DisposalsFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">30000000</nvs:DisposalsFairValueMeasurementAssets>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">28000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">12000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">93000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">251000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:DisposalsFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FundInvestmentsMember" unitRef="USD" decimals="-6">30000000</nvs:DisposalsFairValueMeasurementAssets>
  <nvs:DisposalsFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">25000000</nvs:DisposalsFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">488000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">-5000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:ReclassificationFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">-32000000</nvs:ReclassificationFairValueMeasurementAssets>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">6000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">229000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:DisposalsFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">53000000</nvs:DisposalsFairValueMeasurementAssets>
  <nvs:ReclassificationFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">-64000000</nvs:ReclassificationFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">581000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">6000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">123000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">-10000000</nvs:FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">437000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">5000000</nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4LongTermFinancialInvestmentsMember" unitRef="USD" decimals="-6">-6000000</nvs:FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">36000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">844000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">-484000000</nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">35000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">399000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">-32000000</nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">35000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">36000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationReceivablesMember" unitRef="USD" decimals="-6">396000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">-907000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">113000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">195000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">-401000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">3000000</nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets>
  <nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">89000000</nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">-1036000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">106000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">11000000</nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">-182000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">-852000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">213000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4ContingentConsiderationPayablesMember" unitRef="USD" decimals="-6">100000000</nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-2_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">-72000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets contextRef="AR_D-CurrentYear-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">62000000</nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets>
  <nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">-47000000</nvs:FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">-29000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">48000000</nvs:LossesRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">33000000</nvs:CashReceiptsAndPaymentsFairValueMeasurementAssets>
  <nvs:PurchaseFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">-5000000</nvs:PurchaseFairValueMeasurementAssets>
  <nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets contextRef="AR_D-CurrentYear_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">1000000</nvs:GainsRecognisedInProfitOrLossFairValueMeasurementAssets>
  <nvs:FinancialInstrumentsCarryingValueLevel3 contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4OtherFinancialLiabilitiesMember" unitRef="USD" decimals="-6">-10000000</nvs:FinancialInstrumentsCarryingValueLevel3>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">16000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">3000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">19000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">1230000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">1230000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">26000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">1256000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">1237000000</ifrs-full:NetDebt>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">2091000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">2118000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">27000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">-98000000</nvs:ContingentConsiderationLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">459000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:ContingentConsiderationLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">9000000</nvs:ContingentConsiderationLiabilities>
  <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">202000000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">181000000</ifrs-full:LeaseLiabilities>
  <nvs:ContractualInterestOnNoncurrentLiabilities contextRef="AR_I-CurrentYearEnd_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">-428000000</nvs:ContractualInterestOnNoncurrentLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">593000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">598000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">319000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">319000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities contextRef="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">952000000</nvs:PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities>
  <nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets contextRef="AR_D-CurrentYear_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">922000000</nvs:PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">8000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">327000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:NetDebt contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019MaturityAxis_nvs-2019Q4LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" unitRef="USD" decimals="-6">-1791000000</ifrs-full:NetDebt>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">2447000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4MarketableSecuritiesAndTimeDepositsMember" unitRef="USD" decimals="-6">122000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember" unitRef="USD" decimals="-6">110000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CommoditiesMember" unitRef="USD" decimals="-6">104000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">142000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DeriviativeFinancialInstrumentsAndAccruedInterestMember" unitRef="USD" decimals="-6">102000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">11112000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4CashAndCashEquivalentsMember" unitRef="USD" decimals="-6">13271000000</nvs:CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">22470000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">6846000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">20353000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtMember" unitRef="USD" decimals="-6">9620000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">22648000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">9620000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">20505000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4FinancialDebtUndiscountedMember" unitRef="USD" decimals="-6">6846000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">185000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GroupsOfFinancialAssetsLiabilitiesAxis_nvs-2019Q4DerivativeFinancialInstrumentsMember" unitRef="USD" decimals="-6">58000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <nvs:CashAndCashEquivalentsHeldWithFinancialInstitution contextRef="AR_D-CurrentYear_nvs-2019Q4VendorAxis_nvs-2019Q4LargestFinancialInstitutionMember" unitRef="Pure" decimals="3">0.126</nvs:CashAndCashEquivalentsHeldWithFinancialInstitution>
  <nvs:CashAndCashEquivalentsHeldWithFinancialInstitution contextRef="AR_D-CurrentYear-1_nvs-2019Q4VendorAxis_nvs-2019Q4LargestFinancialInstitutionMember" unitRef="Pure" decimals="3">0.094</nvs:CashAndCashEquivalentsHeldWithFinancialInstitution>
  <nvs:CashAndCashEquivalentsHeldWithFinancialInstitution contextRef="AR_D-CurrentYear_nvs-2019Q4VendorAxis_nvs-2019Q4SecondLargestFinancialInstitutionMember" unitRef="Pure" decimals="3">0.104</nvs:CashAndCashEquivalentsHeldWithFinancialInstitution>
  <nvs:CashAndCashEquivalentsHeldWithFinancialInstitution contextRef="AR_D-CurrentYear-1_nvs-2019Q4VendorAxis_nvs-2019Q4SecondLargestFinancialInstitutionMember" unitRef="Pure" decimals="3">0.076</nvs:CashAndCashEquivalentsHeldWithFinancialInstitution>
  <nvs:CashAndCashEquivalentsHeldWithFinancialInstitution contextRef="AR_D-CurrentYear_nvs-2019Q4VendorAxis_nvs-2019Q4ThirdLargestFinancialInstitutionMember" unitRef="Pure" decimals="3">0.083</nvs:CashAndCashEquivalentsHeldWithFinancialInstitution>
  <nvs:CashAndCashEquivalentsHeldWithFinancialInstitution contextRef="AR_D-CurrentYear-1_nvs-2019Q4VendorAxis_nvs-2019Q4ThirdLargestFinancialInstitutionMember" unitRef="Pure" decimals="3">0.070</nvs:CashAndCashEquivalentsHeldWithFinancialInstitution>
  <nvs:BorrowingsCommercialPaperNumberOfPrograms contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4USCommercialPaperProgramsMember" unitRef="Pure" decimals="0">2</nvs:BorrowingsCommercialPaperNumberOfPrograms>
  <nvs:BorrowingsCommercialPaperMaximumBorrowingAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4USCommercialPaperProgramsMember" unitRef="USD" decimals="-9">9000000000</nvs:BorrowingsCommercialPaperMaximumBorrowingAmount>
  <nvs:BorrowingsCommercialPaperMaximumBorrowingAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4JPCommercialPaperProgramsMember" unitRef="JPY" decimals="-9">150000000000</nvs:BorrowingsCommercialPaperMaximumBorrowingAmount>
  <nvs:BorrowingsCommercialPaperMaximumBorrowingAmount contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4JPCommercialPaperProgramsMember" unitRef="USD" decimals="-8">1400000000</nvs:BorrowingsCommercialPaperMaximumBorrowingAmount>
  <nvs:BorrowingsCommercialPaperNumberOfPrograms contextRef="AR_I-CurrentYearEnd_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4JPCommercialPaperProgramsMember" unitRef="Pure" decimals="0">1</nvs:BorrowingsCommercialPaperNumberOfPrograms>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4ListedEquitySecuritiesMember" unitRef="USD" decimals="-6">843000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4ListedEquitySecuritiesMember" unitRef="USD" decimals="-6">597000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4NonlistedEquitySecuritiesMember" unitRef="USD" decimals="-6">315000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis_nvs-2019Q4NonlistedEquitySecuritiesMember" unitRef="USD" decimals="-6">205000000</ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome>
  <ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare contextRef="AR_D-CurrentYear_nvs-2019Q4SubsequentEventTypAxis_nvs-2019Q4SubsequentEventMember" unitRef="CHFPerShares" decimals="2">2.95</ifrs-full:DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">17933000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">17259000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">15760000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.38</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.39</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.37</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">46103000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.59</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="USD" decimals="-6">55913000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.57</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.10</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember_nvs-2019Q4GeographicalRegionsAxis_srt-2018EuropeMember" unitRef="Pure" decimals="2">0.04</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="USD" decimals="-6">19713000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="Pure" decimals="2">0.41</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="USD" decimals="-6">18032000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="Pure" decimals="2">0.39</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:RevenueFromSaleOfGoodsThirdParties contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="USD" decimals="-6">17485000000</nvs:RevenueFromSaleOfGoodsThirdParties>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales contextRef="AR_D-CurrentYear-2_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="Pure" decimals="2">0.41</nvs:RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="USD" decimals="-6">29389000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="Pure" decimals="2">0.38</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="USD" decimals="-6">39082000000</nvs:SelectedNoncurrentAssets>
  <nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets contextRef="AR_I-CurrentYearEnd-1_nvs-2019Q4GeographicalRegionsAxis_srt-2018AmericasMember" unitRef="Pure" decimals="2">0.40</nvs:SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets>
  <ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents contextRef="AR_D-Transaction-TheMedicinesCompany_dei-2019LegalEntityAxis_nvs-2019Q4TheMedicinesCompanyMember" unitRef="USD" decimals="-8">9700000000</ifrs-full:PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">-101000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1554000000</ifrs-full:RightofuseAssets>
  <ifrs-full:OtherNoncurrentAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">74000000</ifrs-full:OtherNoncurrentAssets>
  <ifrs-full:NoncurrentAssets contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1527000000</ifrs-full:NoncurrentAssets>
  <ifrs-full:Assets contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1527000000</ifrs-full:Assets>
  <ifrs-full:OtherReserves contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">3000000</ifrs-full:OtherReserves>
  <ifrs-full:Equity contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">3000000</ifrs-full:Equity>
  <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">-2000000</ifrs-full:OtherNoncurrentFinancialLiabilities>
  <ifrs-full:NoncurrentLeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1471000000</ifrs-full:NoncurrentLeaseLiabilities>
  <nvs:ProvisionsAndOtherNoncurrentLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">-212000000</nvs:ProvisionsAndOtherNoncurrentLiabilities>
  <ifrs-full:NoncurrentLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1257000000</ifrs-full:NoncurrentLiabilities>
  <ifrs-full:OtherCurrentFinancialLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">-1000000</ifrs-full:OtherCurrentFinancialLiabilities>
  <ifrs-full:CurrentLeaseLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">268000000</ifrs-full:CurrentLeaseLiabilities>
  <ifrs-full:CurrentLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">267000000</ifrs-full:CurrentLiabilities>
  <ifrs-full:Liabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1524000000</ifrs-full:Liabilities>
  <ifrs-full:EquityAndLiabilities contextRef="AR_I-CurrentYearStart_ifrsfull-2019RetrospectiveApplicationAndRetrospectiveRestatementAxis_nvs-2019Q4IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" unitRef="USD" decimals="-6">1527000000</ifrs-full:EquityAndLiabilities>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear-1_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent contextRef="AR_D-CurrentYear_nvs-2019Q4ChangeOverPeriodAxis_nvs-2019Q4PoPYEMember" unitRef="Pure" decimals="2">0.06</nvs:RevenueFromSaleOfGoodsThirdPartiesChangeInPercent>
  <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember" unitRef="USD" decimals="-6">305000000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss>
  <ifrs-full:DepreciationAndAmortisationExpense contextRef="AR_D-CurrentYear_ifrsfull-2019ClassesOfAssetsAxis_ifrsfull-2019RightofuseAssetsMember" unitRef="USD" decimals="-6">305000000</ifrs-full:DepreciationAndAmortisationExpense>
  <nvs:DepreciationChargePriorToClassificationToAssetsHeldForSale contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">15000000</nvs:DepreciationChargePriorToClassificationToAssetsHeldForSale>
  <nvs:ImpairmentChargePriorToClassificationToAssetsHeldForSale contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">2000000</nvs:ImpairmentChargePriorToClassificationToAssetsHeldForSale>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-18332000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd-2_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-17546000000</ifrs-full:PropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">161000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-1717000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-324000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">595000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">20000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear-1_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">479000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <ifrs-full:PropertyPlantAndEquipment contextRef="AR_I-CurrentYearEnd_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-14930000000</ifrs-full:PropertyPlantAndEquipment>
  <nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">2118000000</nvs:DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment>
  <nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">26000000</nvs:DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment>
  <ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">2000000</ifrs-full:DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment>
  <nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">2846000000</nvs:AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment>
  <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-1345000000</ifrs-full:DepreciationPropertyPlantAndEquipment>
  <ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-205000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">3000000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment>
  <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="AR_D-CurrentYear_ifrsfull-2019CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ifrsfull-2019AccumulatedDepreciationAmortisationAndImpairmentMember" unitRef="USD" decimals="-6">-43000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
  <nvs:CashInflowForSaleAndLeaseback contextRef="AR_D-CurrentYear_srt-2018RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_nvs-2019Q4SaleAndLeaseBackMember" unitRef="USD" decimals="-8">-700000000</nvs:CashInflowForSaleAndLeaseback>
  <ifrs-full:LeaseLiabilities contextRef="AR_I-CurrentYearEnd_srt-2018RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_nvs-2019Q4SaleAndLeaseBackMember" unitRef="USD" decimals="-6">96000000</ifrs-full:LeaseLiabilities>
  <ifrs-full:RightofuseAssets contextRef="AR_I-CurrentYearEnd_srt-2018RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_nvs-2019Q4SaleAndLeaseBackMember" unitRef="USD" decimals="-6">37000000</ifrs-full:RightofuseAssets>
  <ifrs-full:GainsLossesArisingFromSaleAndLeasebackTransactions contextRef="AR_D-CurrentYear_srt-2018RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_nvs-2019Q4SaleAndLeaseBackMember" unitRef="USD" decimals="-6">478000000</ifrs-full:GainsLossesArisingFromSaleAndLeasebackTransactions>
  <nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DisposalGroupsClassifiedAsHeldForSaleMember" unitRef="USD" decimals="-6">-3000000</nvs:IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset>
  <nvs:CustomersWithNetSalesOverFivePercent contextRef="AR_D-CurrentYear">The Group&#x2019;s largest, second-largest and third-largest customers account for approximately 23%, 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). All segments had sales to these customers in 2019, 2018 and 2017. No other customer accounted for 6% or more of net sales in any year. The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively).</nvs:CustomersWithNetSalesOverFivePercent>
  <dei:EntityRegistrantName contextRef="AR_D-CurrentYear">NOVARTIS AG</dei:EntityRegistrantName>
  <dei:EntityCentralIndexKey contextRef="AR_D-CurrentYear">0001114448</dei:EntityCentralIndexKey>
  <dei:DocumentType contextRef="AR_D-CurrentYear">20-F</dei:DocumentType>
  <dei:DocumentPeriodEndDate contextRef="AR_D-CurrentYear">2019-12-31</dei:DocumentPeriodEndDate>
  <dei:AmendmentFlag contextRef="AR_D-CurrentYear">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="AR_D-CurrentYear">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:EntityWellKnownSeasonedIssuer contextRef="AR_D-CurrentYear">Yes</dei:EntityWellKnownSeasonedIssuer>
  <dei:EntityVoluntaryFilers contextRef="AR_D-CurrentYear">No</dei:EntityVoluntaryFilers>
  <dei:EntityCurrentReportingStatus contextRef="AR_D-CurrentYear">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="AR_D-CurrentYear">Large Accelerated Filer</dei:EntityFilerCategory>
  <dei:DocumentFiscalYearFocus contextRef="AR_D-CurrentYear">2019</dei:DocumentFiscalYearFocus>
  <dei:DocumentFiscalPeriodFocus contextRef="AR_D-CurrentYear">FY</dei:DocumentFiscalPeriodFocus>
  <dei:EntityInteractiveDataCurrent contextRef="AR_D-CurrentYear">Yes</dei:EntityInteractiveDataCurrent>
  <dei:EntityShellCompany contextRef="AR_D-CurrentYear">false</dei:EntityShellCompany>
  <dei:EntityEmergingGrowthCompany contextRef="AR_D-CurrentYear">false</dei:EntityEmergingGrowthCompany>
  <dei:DocumentAnnualReport contextRef="AR_D-CurrentYear">true</dei:DocumentAnnualReport>
  <dei:DocumentShellCompanyReport contextRef="AR_D-CurrentYear">false</dei:DocumentShellCompanyReport>
  <dei:DocumentTransitionReport contextRef="AR_D-CurrentYear">false</dei:DocumentTransitionReport>
  <nvs:ConcentrationOfMajorPlansGeographic contextRef="AR_D-CurrentYear">The major plans are based in Switzerland, the United States, the United Kingdom, Germany and Japan, which represent 95% of the Group&#x2019;s total DBO for pension plans.</nvs:ConcentrationOfMajorPlansGeographic>
  <ifrs-full:DescriptionOfPlanAmendmentsCurtailmentsAndSettlements contextRef="AR_D-CurrentYear">In September 2017, the pension regulations in Switzerland were amended, which resulted in a change in accounting from defined benefit to defined contribution for a component of the Swiss pension plans. This change resulted in a reduction to the defined benefit pension plans liability and in a corresponding net pre-tax gain of USD 225 million (CHF 216 million).</ifrs-full:DescriptionOfPlanAmendmentsCurtailmentsAndSettlements>
  <nvs:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">2028</nvs:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate>
  <nvs:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate contextRef="AR_D-CurrentYear-1_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">2028</nvs:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate>
  <nvs:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate contextRef="AR_D-CurrentYear-2_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">2025</nvs:DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Soci&#xE9;t&#xE9; par actions SANDOZ</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Algiers</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SocieteParActionsSANDOZAlgiersMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Algeria</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Argentina S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Buenos Aires</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisArgentinaS.A.BuenosAiresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Argentina</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Australia Pty Ltd</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Macquarie Park, NSW</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Australia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Macquarie Park, NSW</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Australia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharmaceuticals Australia Pty Ltd</ifrs-full:NameOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Pty Ltd</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Macquarie Park, NSW</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPtyLtdMacquarieParkNSWMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Australia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Austria GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Vienna</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAustriaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Austria</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Vienna</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Austria</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Kundl</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGmbHViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Austria</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">EBEWE Pharma Ges.m.b.H Nfg. KG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Unterach am Attersee</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EBEWEPharmaGes.m.b.HNfg.KGViennaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Austria</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis (Bangladesh) Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Gazipur</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBangladeshLimitedGazipurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bangladesh</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma NV</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Vilvoorde</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Belgium</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz NV</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Vilvoorde</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozNVVilvoordeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Belgium</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Alcon - Couvreur NV</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Puurs</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCouvreurNVPuursMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Belgium</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Investment Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hamilton</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bermuda</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Securities Investment Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hamilton</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSecuritiesInvestmentLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bermuda</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Finance Services Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hamilton</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceServicesLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bermuda</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Triangle International Reinsurance Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hamilton</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TriangleInternationalReinsuranceLimitedHamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bermuda</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Trinity River Insurance Co Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hamilton</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4TrinityRiverInsuranceCoLtd.HamiltonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bermuda</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Bioci&#xEA;ncias S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">S&#xE3;o Paulo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiocienciasS.A.SaoPauloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Brazil</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz do Brasil Ind&#xFA;stria Farmac&#xEA;utica Ltda.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Camb&#xE9;, PR</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Brazil</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharmaceuticals Canada Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Dorval, Quebec</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Canada</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Canada Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Boucherville, Quebec</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozCanadaInc.BouchervilleQuebecMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Canada</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">CIBA Vision Canada Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mississauga, Ontario</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CIBAVisionCanadaInc.MississaugaOntarioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Canada</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Chile S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Santiago de Chile</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisChileS.A.SantiagoDeChileMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Chile</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Beijing Novartis Pharma Co., Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Beijing</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4BeijingNovartisPharmaCo.Ltd.BeijingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">China</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharmaceuticals (HK) Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hong Kong</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsHKLimitedHongKongMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">China</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Shanghai</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">China</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Shanghai Novartis Trading Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Shanghai</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ShanghaiNovartisTradingLtd.ShanghaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">China</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">China</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis de Colombia S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Santaf&#xE9; de Bogot&#xE1;</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeColombiaS.A.SantafeDeBobotaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Colombia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz d.o.o. farmaceutska industrija</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Zagreb</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozD.o.o.FarmaceutskaIndustrijaZagrebMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Croatia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis s.r.o.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Prague</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Czech Republic</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz s.r.o.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Prague</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.r.o.PragueMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Czech Republic</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Healthcare A/S</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Copenhagen</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcareASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Denmark</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz A/S</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Copenhagen</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozASCopenhagenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Denmark</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Ecuador S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Quito</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisEcuadorS.A.QuitoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ecuador</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma S.A.E.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Cairo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.E.CairoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Egypt</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Egypt Pharma S.A.E.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">New Cairo City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozEgyptPharmaS.A.E.NewCairoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Egypt</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Finland Oy</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Espoo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinlandOyEspooMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Finland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Groupe France S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Rueil-Malmaison</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGroupeFranceS.A.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">France</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma S.A.S.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Rueil-Malmaison</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaS.A.S.RueilMalmaisonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">France</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Advanced Accelerator Applications S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Saint-Genis-Pouilly</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">France</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz S.A.S.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Levallois-Perret</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.S.LevalloisPerretMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">France</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Deutschland GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Nuremberg</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeutschlandGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Nuremberg</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaGmbHNurembergMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Produktions GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Wehr</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaProduktionsGmbHWehrMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz International GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Holzkirchen</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInternationalGmbHHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">1 A Pharma GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Oberhaching</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4A1APharmaGmbHOberhachingMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">HEXAL AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Holzkirchen</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4HEXALAGHolzkirchenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Salutas Pharma GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Barleben</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SalutasPharmaGmbHBarlebenMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Aeropharm GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Rudolstadt</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AeropharmGmbHRudolstadtMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis (Hellas) S.A.C.I.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Metamorphosis / Athens</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHellasS.A.C.I.MetamorphosisAthensMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Greece</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Budapest</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hungary</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Hungary Limited Liability Company</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Budapest</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozHungaryLimitedLiabilityCompanyBudapestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Hungary</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis India Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mumbai</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIndiaLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">India</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Healthcare Private Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mumbai</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">India</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Private Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mumbai</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPrivateLimitedMumbaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">India</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">PT. Novartis Indonesia</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Jakarta</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4PT.NovartisIndonesiaJakartaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Indonesia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Ireland Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Dublin</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIrelandLimitedDublinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ireland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Ringaskiddy Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ringaskiddy, County Cork</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ireland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Israel Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Tel Aviv</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisIsraelLtd.PetachTikvaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Israel</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Farma S.p.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Origgio</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Italy</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz S.p.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Origgio</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.p.A.OriggioMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Italy</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Holding Japan K.K.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Tokyo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingJapanK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Japan</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma K.K.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Tokyo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Japan</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ciba-Geigy Japan Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Tokyo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CibaGeigyJapanLimitedTokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Japan</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz K.K.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Tokyo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozK.K.TokyoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Japan</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Baltics SIA</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Riga</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBalticsSIARigaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Latvia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Investments S.&#xE0; r.l.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Luxembourg City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInvestmentsS.aR.l.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Luxembourg</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Finance S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Luxembourg City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceS.A.LuxembourgCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Luxembourg</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Corporation (Malaysia) Sdn. Bhd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Kuala Lumpur</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Malaysia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Farmac&#xE9;utica, S.A. de C.V.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mexico City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mexico</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz, S.A. de C.V.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mexico City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.A.DeC.V.MexicoCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Mexico</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Maroc SA</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Casablanca</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">2009</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaMarocSACasablancaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Morocco</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">2019</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">Novartis Securities Investment Ltd., Hamilton, Bermuda</nvs:BorrowingsLender>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">2010</nvs:BorrowingsIssuanceDate>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">2020</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz B.V.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">2012</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Almere</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">2022</ifrs-full:BorrowingsMaturity>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozB.V.AlmereMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Netherlands</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis New Zealand Ltd</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Auckland</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">2012</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNewZealandLtdAucklandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">New Zealand</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">2042</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Norge AS</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Oslo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">2014</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNorgeASOsloMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Norway</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma (Pakistan) Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">2024</ifrs-full:BorrowingsMaturity>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Karachi</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaPakistanLimitedKarachiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Pakistan</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma (Logistics), Inc.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">2014</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Panama City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">2044</ifrs-full:BorrowingsMaturity>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLogisticsInc.PanamaCityMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Panama</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Biosciences Per&#xFA; S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">2014</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Lima</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBiosciencesPeruS.A.LimaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Peru</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">2021</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Healthcare Philippines, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Makati City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">2014</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHealthcarePhilippinesInc.ManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Philippines</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">2026</ifrs-full:BorrowingsMaturity>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Philippines Corporation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Makati City</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPhilippinesCorporationManilaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Philippines</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">CHF</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Poland Sp. z o.o.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">2015</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Warsaw</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">2025</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">Novartis AG, Basel, Switzerland</nvs:BorrowingsLender>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPolandSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Poland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Polska Sp. z o.o.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">CHF</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Warsaw</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">2015</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPolskaSp.ZO.o.WarsawMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Poland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">2029</ifrs-full:BorrowingsMaturity>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Lek S.A.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">Novartis AG, Basel, Switzerland</nvs:BorrowingsLender>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Strykow</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">CHF</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">2015</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekS.A.StrykowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Poland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Portugal SGPS Lda.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">2035</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">Novartis AG, Basel, Switzerland</nvs:BorrowingsLender>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Porto Salvo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPortugalSGPSLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Portugal</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">2015</nvs:BorrowingsIssuanceDate>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Farma - Produtos Farmac&#xEA;uticos S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Porto Salvo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">2025</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Portugal</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Farmac&#xEA;utica Lda.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">2015</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Porto Salvo</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">2045</ifrs-full:BorrowingsMaturity>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaLda.PortoSalvoMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Portugal</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Services Romania S.R.L.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bucharest</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">2016</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesRomaniaS.R.L.BucharestMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Romania</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">2023</ifrs-full:BorrowingsMaturity>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz S.R.L.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Targu-Mures</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozS.R.L.TarguMuresMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Romania</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">2016</nvs:BorrowingsIssuanceDate>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma LLC</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">2028</ifrs-full:BorrowingsMaturity>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Moscow</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaLLCMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Russian Federation</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Neva LLC</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">2017</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">St. Petersburg</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">2020</ifrs-full:BorrowingsMaturity>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNevaLLCSt.PetersburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Russian Federation</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">ZAO Sandoz</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Moscow</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">2017</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZAOSandozMoscowMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Russian Federation</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">2022</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">USD</ifrs-full:BorrowingsOriginalCurrency>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">2017</nvs:BorrowingsIssuanceDate>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis (Singapore) Pte Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">2027</ifrs-full:BorrowingsMaturity>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Singapore</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">Novartis Capital Corporation, New York, United States</nvs:BorrowingsLender>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePteLtd.SingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Singapore</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Singapore</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">2017</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Singapore</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">2021</ifrs-full:BorrowingsMaturity>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Singapore</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Singapore</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">2017</nvs:BorrowingsIssuanceDate>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">2027</ifrs-full:BorrowingsMaturity>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Slovakia s.r.o.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bratislava</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSlovakiaS.r.o.BratislavaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Slovakia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">2018</nvs:BorrowingsIssuanceDate>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Lek Pharmaceuticals d.d.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">2023</ifrs-full:BorrowingsMaturity>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ljubljana</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4LekPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Slovenia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Pharmaceuticals d.d.</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">2018</nvs:BorrowingsIssuanceDate>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ljubljana</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">2030</ifrs-full:BorrowingsMaturity>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsD.d.LjubjanaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Slovenia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis South Africa (Pty) Ltd</ifrs-full:NameOfSubsidiary>
  <ifrs-full:BorrowingsOriginalCurrency contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">EUR</ifrs-full:BorrowingsOriginalCurrency>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Midrand</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <nvs:BorrowingsIssuanceDate contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">2018</nvs:BorrowingsIssuanceDate>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSouthAfricaPtyLtdMidrandMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">South Africa</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:BorrowingsMaturity contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">2038</ifrs-full:BorrowingsMaturity>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz South Africa (Pty) Ltd</ifrs-full:NameOfSubsidiary>
  <nvs:BorrowingsLender contextRef="AR_D-CurrentYear_ifrsfull-2019BorrowingsByNameAxis_nvs-2019Q4A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">Novartis Finance S.A., Luxembourg, Luxembourg</nvs:BorrowingsLender>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Kempton Park</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozSouthAfricaPtyLtdKemptonParkMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">South Africa</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Korea Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Seoul</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisKoreaLtd.SeoulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">South Korea</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Farmac&#xE9;utica, S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Barcelona</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFarmaceuticaS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spain</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Farmac&#xE9;utica S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Madrid</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozFarmaceuticaS.A.MadridMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spain</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Les Franqueses del Vall&#xE9;s / Barcelona</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIndustrialProductsS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spain</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Alcon Cusi S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">El Masnou / Barcelona</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AlconCusiS.A.BarcelonaMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spain</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Abadia Retuerta S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sard&#xF3;n de Duero / Valladolid</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AbadiaRetuertaS.A.SardonDeDueroValladolidMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spain</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Sverige AB</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Stockholm</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSverigeABStockholmMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sweden</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis International AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Holding AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis International Pharmaceutical Investment AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalInvestmentAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Bioventures AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisBioventuresAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisForschungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Forschungsstiftung</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisForschungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisForschungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerKaderausbildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Stiftung f&#xFC;r Kaderausbildung</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerKaderausbildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerKaderausbildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMitarbeiterbeteiligungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Mitarbeiterbeteiligungsstiftung</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMitarbeiterbeteiligungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMitarbeiterbeteiligungsstiftungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerMenschUndUmweltBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Stiftung f&#xFC;r Mensch und Umwelt</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerMenschUndUmweltBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisStiftungFuerMenschUndUmweltBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Overseas Investments AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOverseasInvestmentsAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Japat AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4JapatAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis International Pharmaceutical AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInternationalPharmaceuticalAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Services AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaServicesAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Schweizerhalle AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Muttenz</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizerhalleAGMuttenzMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Stein AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Stein</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSteinAGSteinMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma Schweiz AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Risch</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaSchweizAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Ophthalmics AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Fribourg</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisOphthalmicsAGFribourgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Advanced Accelerator Applications International SA</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Geneva</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsInternationalSAGeneveMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Pharmaceuticals AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Risch</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozPharmaceuticalsAGRischMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4RocheHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Roche Holding AG</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4RocheHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Basel</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4RocheHoldingAGBaselMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Switzerland</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis (Taiwan) Co., Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Taipei</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTaiwanCo.Ltd.TaipeiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Taiwan</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis (Thailand) Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bangkok</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisThailandLimitedBangkokMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Thailand</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Istanbul</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Turkey</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Farmanova Saglik Hizmetleri Ltd. Sti.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Istanbul</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Turkey</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Ila&#xE7; Sanayi ve Ticaret A.S.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Istanbul</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozIlacSanayiVeTicaretA.S.IstanbulMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Turkey</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Gebze - Kocaeli</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Turkey</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Ukraine LLC</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Kyiv</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozUkraineLLCKievMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ukraine</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Middle East FZE</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Dubai</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisMiddleEastFZEDubaiMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Arab Emirates</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Frimley / Camberley</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozLimitedFrimleyCamberleyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Corporation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Services, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisServicesInc.EastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharmaceuticals Corporation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsCorporationEastHanoverNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">AveXis, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Bannockburn, IL</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AveXisInc.BannockburnILMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Cambridge, MA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">CoStim Pharmaceuticals Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Cambridge, MA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CoStimPharmaceuticalsInc.CambridgeMAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Navigate BioPharma Services, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Carlsbad, CA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NavigateBioPharmaServicesInc.CarlsbadCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Reprixys Pharmaceuticals Corporation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ReprixysPharmaceuticalsCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Institute for Functional Genomics, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">San Diego, CA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Sandoz Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Princeton, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Oriel Therapeutics, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Durham, NC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4OrielTherapeuticsInc.DurhamNCMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Fougera Pharmaceuticals Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Melville, NY</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4FougeraPharmaceuticalsInc.MelvilleNYMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Eon Labs, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Princeton, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EonLabsInc.PrincetonNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis de Venezuela, S.A.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Caracas</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisDeVenezuelaS.A.CaracasMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Venezuela</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationAnnualIncentivePlanMember">The Annual Incentive for the Novartis Group CEO and other Executive Committee members (ECN) is paid 50% in cash and 50% in Novartis restricted shares (RSs) or restricted share units (RSUs). For the Novartis Top Leaders (NTLs), the Annual Incentive is paid 70% in cash and 30% in RSs or RSUs. Both the ECN and NTLs can opt to invest up to the maximum cash portion of their Annual Incentive to receive further RSs or RSUs. Any cash is paid out during February or March in the year following the end of the performance period, and the shares are granted during January in the year following the end of the performance period.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationShareSavingsPlanMember">Associates in certain countries and certain key executives worldwide are encouraged to invest their Annual Incentive in a share savings plan. Under the share savings plan, participants may elect to receive their relevant compensation fully or partially in Novartis shares in lieu of cash. As a reward for their participation in the share savings plan, at no additional cost to the participant, Novartis matches their investments in shares after a holding period of three or five years.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationEmployeeShareOwnershipPlanMember">In Switzerland, Employee Share Ownership Plan (ESOP) participants may choose to receive their Annual Incentive (i) 100% in shares, (ii) 50% in shares and 50% in cash, or (iii) 100% in cash. After expiration of a three-year holding period for Novartis shares invested under the ESOP, participants will receive one matching share for every two invested shares. Associates eligible for the equity plan &#x201C;Select&#x201D; are not eligible to receive ESOP matching shares starting with the 2017 performance period.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLeveragedShareSavingsPlanMember">The Leveraged Share Savings Plan (LSSP) was available to key executives for performance periods prior to 2016. At the participant&#x2019;s election, the Annual Incentive was awarded partly or entirely in shares. The elected number of shares is subject to a holding period of five years. At the end of the holding period, Novartis will match the invested shares at a ratio of 1-to-1 (i.e., one share awarded for each invested share). In the United States, both the LSSP award and the corresponding match are cash settled.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectMember">The equity plan &#x201C;Select&#x201D; is a global equity incentive plan under which eligible associates may annually be awarded a grant subject to a three-year, and for selected units a four-year, staggered vesting period. No awards are granted for performance ratings below a certain threshold. Executive Committee members are not eligible to participate in the equity plan &#x201C;Select&#x201D; effective from the performance period 2014, and the NTLs are not eligible to participate effective from the performance period 2016. The equity plan &#x201C;Select&#x201D; currently allows participants in Switzerland to choose the form of their equity compensation in RSs or RSUs. In all other jurisdictions, RSs or RSUs are granted unilaterally. Until 2013, participants could also choose to receive part or the entire grant in the form of tradable share options. Tradable share options expire on their 10th anniversary from the grant date. Each tradable share option entitles the holder to purchase after vesting (and before the 10th anniversary from the grant date) one Novartis share at a stated exercise price that equals the closing market price of the underlying share at the grant date. As the exercise price does not reflect the decrease in the Novartis share due to the Alcon spin, one-fifth of an Alcon share will also be awarded to the option holder upon exercise.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermPerformancePlanMember">The Long-Term Performance Plan (LTPP) is an equity plan for the ECN, the NTLs and employees of Group units with specific targets. Participants are granted a target number of performance share units (PSUs) at the beginning of every performance period, which are converted into unrestricted Novartis shares after the performance period. The actual payout depends on the achievement of the performance measures and ranges between 0% and 200% of the granted amount. PSUs granted under the LTPP do not carry voting rights, but do carry dividend equivalents that are paid in unrestricted Novartis shares at the end of the performance period. The LTPP awards are subject to a three-year performance and vesting period. Until 2018, the performance criteria were based on Novartis internal performance metrics. Starting in 2019, for new grants the performance criteria are based on both Novartis internal performance metrics and variables that can be observed in the market, which is the ranking of the Novartis total shareholder return (TSR) relative to a global healthcare peer group of 14 companies (updated in November 2019 from 15 companies following the acquisition of one of the companies by another company within the peer group) other companies, over rolling three-year performance periods. TSR for Novartis and the peer companies is calculated as the change in the company share price, which is translated to USD at the relevant exchange rate, including the reinvestment return of dividends, over the three-year performance period. The calculation is based on Bloomberg standard published TSR data, which is publicly available. The position of Novartis in the peer group determines the payout range based on a payout matrix.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationLongTermRelativePerformancePlanMember">The LTRPP is an equity plan for the Novartis ECN and NTLs. The last grant under this plan was made in 2018. The LTRPP performance criteria is based on variables that can be observed in the market, which is the ranking of the Novartis TSR relative to a global healthcare peer group of 15 other companies, over rolling three-year performance periods. The TSR for Novartis and the peer companies is calculated as described in the LTPP section above.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationSpecialShareAwardsMember">Selected associates, excluding the ECN members, may exceptionally receive Special Share Awards of RSs or RSUs. These Special Share Awards provide an opportunity to reward outstanding achievements or exceptional performance, and aim to retain key contributors. They are based on a formal internal selection process, through which the individual performance of each candidate is thoroughly assessed at several management levels. Special Share Awards have a minimum three-year vesting period. In exceptional circumstances, Special Share Awards may be awarded to attract special expertise and new talents to the &#xAC;organization. Worldwide, associates at different levels in the organization were awarded RSs and RSUs in 2019, 2018 and 2017. In addition, in 2019, 2018 and 2017, Board members received &#xAC;unrestricted shares as part of their regular compensation.</ifrs-full:ExplanationOfShareOptionsInSharebasedPaymentArrangement>
  <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;1. Significant accounting policies&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Novartis Group (Novartis or Group) is a multinational group of companies specializing in the research, development, manufacturing and marketing of a broad range of healthcare products led by innovative pharmaceuticals and cost-saving generic pharmaceuticals. The Group is headquartered in Basel, Switzerland. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The consolidated financial statements of the Group are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). They are prepared in accordance with the historical cost convention, except for items that are required to be accounted for at fair value. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group&amp;#x2019;s financial year-end is December 31, which is also the annual closing date of the individual entities&amp;#x2019; financial statements incorporated into the Group&amp;#x2019;s consolidated financial statements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The preparation of financial statements requires management to make certain estimates and assumptions, either at the balance sheet date or during the year, which affect the reported amounts of assets and liabilities, including any contingent amounts, the distribution liability recognized in connection with the distribution of Alcon Inc. to Novartis AG shareholders, as well as of revenues and expenses. Actual outcomes and results could differ from those estimates and assumptions. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Listed below are accounting policies of significance to Novartis or, in cases where IFRS provides alternatives, the option adopted by Novartis. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Scope of consolidation &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated financial statements include all entities, including structured entities, over which Novartis AG, Basel, Switzerland, directly or indirectly has control (generally as a result of owning more than 50% of the entity&amp;#x2019;s voting interest). Consolidated entities are also referred to as &amp;#x201c;subsidiaries.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In cases where Novartis does not fully own a subsidiary, it has elected to value any remaining outstanding non-controlling interest at the time of acquiring control of the subsidiary at its proportionate share of the fair value of the net identified assets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The contribution of a business to an associate or joint venture is accounted for by applying the option under IFRS that permits the accounting for the retained interest of the business contributed at its net book value at the time of the contribution. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Investments in associated companies (generally defined as investments in entities in which Novartis holds between 20% and 50% of voting shares or over which it otherwise has significant influence) and joint ventures are accounted for using the equity method, except for selected venture fund investments for which the Group has elected to apply the method of fair value through the consolidated income statement. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Foreign currencies&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated financial statements of Novartis are presented in US dollars (USD). The functional currency of subsidiaries is generally the local currency of the respective entity. The functional currency used for the reporting of certain Swiss and foreign finance entities is USD instead of their respective local currencies. This reflects the fact that the cash flows and transactions of these entities are primarily denominated in these currencies. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For subsidiaries not operating in hyperinflationary economies, the subsidiary&amp;#x2019;s results, financial position and cash flows that do not have USD as their functional currency are translated into USD using the following exchange rates: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Income, expense and cash flows using for each month the average exchange rate, with the US dollar values for each month being aggregated during the year &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Balance sheets using year-end exchange rates&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Resulting exchange rate differences are recognized in other comprehensive income&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;For subsidiaries operating in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period is recorded in retained earnings in equity. The subsequent gains or losses resulting from the restatement of non-monetary assets are recorded in &amp;#x201c;Other financial income and expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Non-current assets held for sale or held for distribution to owners&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Non-current assets are classified as assets held for sale or related to discontinued operations when their carrying amount is to be recovered principally through a sale transaction or distribution to owners, and a sale or distribution to owners is considered highly probable. They are stated at the lower of carrying amount and fair value less costs to sell with any resulting impairment recognized. Assets related to discontinued operations and assets of disposal group held for sale are not depreciated or amortized. The prior-year consolidated balance sheet is not restated. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Distribution of Alcon Inc. to Novartis AG shareholders &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;During the first quarter of 2019, at the Annual General Meeting (AGM) of Novartis AG shareholders, held on February 28, 2019, the Novartis AG shareholders approved a special distribution by way of a dividend in kind to effect the spin-off of Alcon Inc. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The February 28, 2019, shareholder approval for the spin-off required the Alcon Division and selected portions of corporate activities attributable to Alcon&amp;#x2019;s business (the &amp;#x201c;Alcon business&amp;#x201d;) to be reported as discontinued operations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The shareholder approval to spin off the Alcon business also required the recognition of a distribution liability at the fair value of the Alcon business. The Group elected to measure the distribution liability at the fair value of the Alcon business net assets taken as a whole. The distribution liability was recognized through a reduction in retained earnings. It was required to be adjusted at each balance sheet date for changes in its estimated fair value, up to the date of the distribution to shareholders through retained earnings. Any resulting impairment of the business assets to be distributed would have been recognized in the consolidated income statements in &amp;#x201c;Other expense&amp;#x201d; of discontinued operations, at the date of initial recognition of the distribution liability or at subsequent dates resulting from changes of the distribution liability valuation. At the April 8, 2019 distribution settlement date, the resulting gain, which was measured as the excess amount of the distribution liability over the then-carrying value of the net assets of the business distributed, was recognized on the line &amp;#x201c;Gain on distribution of Alcon Inc. to Novartis AG shareholders&amp;#x201d; in the income statement of discontinued operations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&amp;#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&amp;#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. These fair value measurements were classified as &amp;#x201c;Level 3&amp;#x201d; in the fair value hierarchy. The section &amp;#x201c;&amp;mdash;Impairment of goodwill and intangible assets&amp;#x201d; in this Note 1 provides additional information on key assumptions that are highly sensitive in the estimation of fair values using valuation techniques. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Transaction costs that were directly attributable to the distribution (spin-off) of Alcon to the Novartis shareholders, and that would otherwise have been avoided, were recorded as a deduction from equity. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For additional disclosures, refer to &amp;#x201c;Note 2. Significant transactions&amp;mdash;Significant transactions in 2019&amp;mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders,&amp;#x201d; and &amp;#x201c;Note 30. Discontinued operations.&amp;#x201d; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Acquisition of assets &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Acquired assets are initially recognized on the balance sheet at cost if they meet the criteria for capitalization. If acquired as part of a business combination, the fair value of identified assets represents the cost for these assets. If separately acquired, the cost of the asset includes the purchase price and any directly attributable costs for bringing the asset into the condition to operate as intended. Expected costs for obligations to dismantle and remove property, plant and equipment when they are no longer used are included in their cost. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Property, plant and equipment&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Property, plant and equipment are depreciated on a straight-line basis in the consolidated income statement over their estimated useful lives. Leasehold land is depreciated over the period of its lease, whereas freehold land is not depreciated. The related depreciation expense is included in the costs of the functions using the asset. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Property, plant and equipment are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the respective useful lives for property, plant and equipment:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Useful life&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20 to 40 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and other equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7 to 20 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Furniture and vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5 to 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Computer hardware&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3 to 7 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Government grants obtained for construction activities, including any related equipment, are deducted from the gross acquisition cost to arrive at the balance sheet carrying value of the related assets. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Leases and right-of-use assets&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;From January 1, 2019, with the adoption of IFRS 16 Leases, the Group adopted the following accounting policies for leases and right-of-use assets: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative standalone price. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases. For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease to end of the lease term. The lease term includes the period of any lease extension that in management&amp;#x2019;s assessment is highly probable to be exercised by the Group. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the Novartis incremental borrowing rate for the asset subject to the lease in the respective markets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The portion of the lease payments attributable to the repayment of lease liabilities is recognized in cash flows used in financing activities, and the portion attributable to the payment of interest is included in cash flows from operating activities. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease incentive received and any initial direct costs incurred by Novartis, and expected costs for obligations to dismantle and remove right-of-use assets when they are no longer used. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life of the right-of-use asset or the end of the lease term. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In arrangements where the Group is the lessor, it determines at lease inception whether the lease is a finance lease or an operating lease. Leases that transfer substantially all of the risk and rewards incidental to ownership of the underlying asset to the counterparty (the lessee) are accounted for as finance leases. Leases that do not transfer substantially all of the risks and rewards of ownership are accounted for as operating leases. Lease payments received under operating leases are recognized on a straight-line basis over the lease term in the consolidated income statement in either &amp;#x201c;net sales&amp;#x201d; or &amp;#x201c;other income,&amp;#x201d; depending on the nature of and underlying asset to the lease arrangement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to January 1, 2019, the Group applied the following accounting policies for leases: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Leases that transferred substantially all of the risks and rewards of ownership were recognized as finance leases, with the leased asset measured initially at an amount equal to the lower of their fair value and the present value of the minimum lease payments. Minimum lease payments were the payments over the lease term that the Group, as leasee, was required to make, excluding contingent rent. The underlying asset was accounted for in accordance with the accounting policy applicable to that asset. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Leases that did not transfer substantially all of the risks and rewards of ownership were accounted for as operating leases and were not recognized in the consolidated balance sheet. Payments made under operating leases were recognized in the consolidated income statement on a straight-line basis over the term of the lease. Lease incentives received were deferred and recognized as a component of lease expense over the term of the lease. The future undiscounted lease payments under operating leases were disclosed as commitments in the notes to the consolidated financial statements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Lessor accounting policies were not substantially different from those applied upon the adoption of IFRS 16 Leases, as described above. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2019&amp;#x201d; in this Note 1 provides additional disclosures on the impact of adoption of IFRS 16 Leases. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Goodwill and intangible assets&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Goodwill&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Goodwill arises in a business combination and is the excess of the consideration transferred to acquire a business over the underlying fair value of the net identified assets acquired. It is allocated to groups of cash-generating units (CGUs), which are usually represented by the reported segments. Goodwill is tested for impairment annually at the level of these groups of CGUs, and any impairment charges are recorded under &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Intangible assets available for use&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has the following classes of available-for-use intangible assets: currently marketed products; technologies; other intangible assets (including computer software); and up to the spin-off date of Alcon business, marketing know-how and the Alcon brand name. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Currently marketed products represent the composite value of acquired intellectual property (IP), patents, and distribution rights and product trade names. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Marketing know-how represents the value attributable to the expertise acquired for marketing and distributing Alcon surgical products.&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Technologies represent identified and separable acquired know-how used in the research, development and production processes. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Significant investments in internally developed and acquired computer software are capitalized and included in the &amp;#x201c;Other&amp;#x201d; category, and amortized once available for use. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Alcon brand name was shown separately, as it was the only Novartis intangible asset that was available for use with an indefinite useful life. Novartis considers that it was appropriate that the Alcon brand name had an indefinite life since Alcon-branded products had a history of strong revenue and cash flow performance, and Novartis had the intent and ability to support the brand with spending to maintain its value for the foreseeable future. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Except for the Alcon brand name, intangible assets available for use are amortized over their estimated useful lives on a straight-line basis and are evaluated for potential impairment whenever facts and circumstances indicate that their carrying value may not be recoverable. The Alcon brand name was not amortized, but evaluated for potential impairment annually. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the respective useful lives for available-for-use intangible assets and the location in the consolidated income statement in which the respective amortization and any potential impairment charge is recognized: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Useful life &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income statement location &lt;br&gt;&lt;/br&gt; for amortization and &lt;br&gt;&lt;/br&gt; impairment charges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currently marketed products&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5 to 20 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold"&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketing know-how&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold"&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Technologies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10 to 20 years &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold" &lt;br&gt;&lt;/br&gt; or "Research &lt;br&gt;&lt;/br&gt; and development" &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other (including &lt;br&gt;&lt;/br&gt;computer software) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3 to 7 years &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; In the respective &lt;br&gt;&lt;/br&gt; functional expense &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon brand name&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Not amortized, &lt;br&gt;&lt;/br&gt; indefinite useful life &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Other expense" &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Intangible assets not yet available for use&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Acquired research and development intangible assets that are still under development and have accordingly not yet obtained marketing approval are recognized as in-process research and development (IPR&amp;amp;D). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;IPR&amp;amp;D is not amortized, but is evaluated for potential impairment on an annual basis or when facts and circumstances warrant. Any impairment charge is recorded in the consolidated income statement under &amp;#x201c;Research and development.&amp;#x201d; Once a project included in IPR&amp;amp;D has been successfully developed, it is transferred to the &amp;#x201c;Currently marketed products&amp;#x201d; category. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impairment of goodwill and intangible assets&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;An asset is considered impaired when its balance sheet carrying amount exceeds its estimated recoverable amount, which is defined as the higher of its fair value less costs of disposal and its value in use. Usually, Novartis applies the fair value less costs of disposal method for its impairment assessment. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. In the limited cases where the value in use method would be applied, net present value techniques would be applied using pre-tax cash flows and discount rates. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Fair value less costs of disposal reflects estimates of assumptions that market participants would be expected to use when pricing the asset or CGUs, and for this purpose, management considers the range of economic conditions that are expected to exist over the remaining useful life of the asset. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The estimates used in calculating the net present values are highly sensitive and depend on assumptions specific to the nature of the Group&amp;#x2019;s activities with regard to: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Amount and timing of projected future cash flows&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Long-term sales forecasts &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Actions of competitors (launch of competing products, marketing initiatives, etc.)&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Outcome of research and development activities (compound efficacy, results of clinical trials, etc.)&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Amount and timing of projected costs to develop IPR&amp;amp;D into commercially viable products&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Profit margins&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Probability of obtaining regulatory approval&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Future tax rate&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Appropriate royalty rate for the Alcon brand name&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Appropriate terminal growth rate&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Appropriate discount rate&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Generally, for intangible assets with a definite useful life, Novartis uses cash flow projections for the whole useful life of these assets. For goodwill and the Alcon brand name, Novartis generally utilizes cash flow projections for a five-year period based on management forecasts, with a terminal value based on cash flow projections usually in line with inflation rates for later periods. Probability-weighted scenarios are typically used. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Discount rates used consider the Group&amp;#x2019;s estimated weighted average cost of capital, adjusted for specific country and currency risks associated with cash flow projections to approximate the discount rate that market participants would use to value the asset. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Due to the above factors, actual cash flows and values could vary significantly from forecasted future cash flows and related values derived using discounting techniques. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impairment of associated companies accounted for at equity&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis considers investments in associated companies for impairment evaluation whenever objective evidence indicates the net investment may be impaired, including when a quoted share price indicates a fair value less than the per-share balance sheet carrying value for the investment. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;If the recoverable amount of the investment is estimated to be lower than the balance sheet carrying amount, an impairment charge is recognized for the difference in the consolidated income statement under &amp;#x201c;Income from associated companies.&amp;#x201d; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Cash and cash equivalents&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Cash and cash equivalents include highly liquid investments with original maturities of three months or less, which are readily convertible to known amounts of cash. Bank overdrafts are usually presented within current financial debts on the consolidated balance sheet, except in cases where a right of offset has been agreed with a bank, which then allows for presentation on a net basis. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Marketable securities, commodities and non-current financial assets &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Commodities, which include gold bullion or coins, are valued at the lower of cost or fair value using current market prices. The changes in fair value below cost are immediately recorded in &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Marketable securities are financial assets consisting principally of equity and debt securities as well as fund investments. Marketable securities held for short-term purposes are principally traded in liquid markets and are classified as marketable securities within current assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &amp;#x201c;Other financial income and expense&amp;#x201d; in the consolidated income statement. Marketable securities held for long-term strategic purposes are classified as non-current financial assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &amp;#x201c;Other income&amp;#x201d; and &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Marketable securities are initially recorded at fair value on their trade date, which is different from the settlement date when the transaction is ultimately effected. Quoted securities are remeasured at each reporting date to fair value based on current market prices. If the market for a financial asset is not active or no market is available, fair values are established using valuation techniques. The majority of non-quoted investments are valued initially at fair value through the established purchase price between a willing buyer and seller. Non-quoted investments are subsequently adjusted based on values derived from discounted cash flow analysis or other pricing models. These investment values are classified as &amp;#x201c;Level 3&amp;#x201d; in the fair value hierarchy. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the Group classifies and accounts for its marketable securities and non-current financial assets in the following categories: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Debt securities are valued at fair value through other comprehensive income with subsequent recycling into the consolidated income statement, as they meet both the &amp;#x201c;solely payment of principal and interest&amp;#x201d; and the business model criteria. Unrealized gains and losses, except exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are recognized in the consolidated income statement when the debt instrument is sold, at which time the gain is transferred to &amp;#x201c;Other financial income and expense.&amp;#x201d; Exchange gains and losses related to debt instruments are immediately recognized in the consolidated income statement to &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Fund investments, equity securities of the Novartis venture fund and derivative assets are valued at fair value through profit and loss (FVPL). Unrealized gains and losses, including exchange gains and losses, are recognized in the consolidated income statement, for all fund investments and for equity securities of the Novartis venture fund, to &amp;#x201c;Other income&amp;#x201d; for gains and &amp;#x201c;Other expense&amp;#x201d; for losses, and for derivative assets to &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Equity securities held as strategic investments, typically held outside of the Novartis venture fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Unrealized gains and losses, including exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are reclassified to retained earnings when the equity security is sold. If these equity securities are not designated at date of acquisition as financial assets valued at fair value through other comprehensive income, they are valued at FVPL, as described above. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Other non-current financial assets, such as loans and long-term receivables from customers, advances and other deposits, are valued at amortized cost, which reflects the time value of money less any allowances for expected credit losses. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group assesses on a forward-looking basis the expected credit losses associated with its debt securities valued at fair value through other comprehensive income. Impairments on debt securities are recorded in &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For other financial assets valued at amortized costs, impairments, which are based on their expected credit losses, and exchange rate losses are included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. Exchange rate gains and interest income, using the effective interest rate method, are included in &amp;#x201c;Other income&amp;#x201d; or &amp;#x201c;Other financial income&amp;#x201d; in the consolidated income statement, depending on the nature of the item. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to the adoption of IFRS 9, the Group classified and accounted for its marketable securities and non-current financial assets in the following categories: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Group classified all its equity and quoted debt securities as well as fund investments as available for sale, as they were not acquired to generate profit from short-term fluctuations in price. Unrealized gains, except exchange gains related to quoted debt instruments, were recorded as a fair value adjustment in the consolidated statement of comprehensive income. They were recognized in the consolidated income statement when the financial asset was sold, at which time the gain was transferred either to &amp;#x201c;Other financial income and expense,&amp;#x201d; for the marketable securities held for short-term non-strategic purposes, or to &amp;#x201c;Other income,&amp;#x201d; for all other equity securities and fund investments. Exchange gains related to quoted debt instruments were immediately recognized in the consolidated income statement under &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; A security was assessed for impairment when its market value at the balance sheet date was less than initial cost reduced by any previously recognized impairment. Impairments on equity securities, quoted debt securities and fund investments, and exchange rate losses on quoted debt securities in a foreign currency that were held for short-term non-strategic purposes were recorded in &amp;#x201c;Other financial income and expense.&amp;#x201d; Impairments were recorded for all other equity securities and other fund investments in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Other non-current financial assets, including loans held for long-term strategic purposes, were carried at amortized cost, which reflects the time value of money less any allowances for uncollectable amounts. For these financial assets, impairments and exchange rate losses were included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement, and exchange rate gains and interest income using the effective interest rate method were included in &amp;#x201c;Other income&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2018&amp;#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Derivative financial instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Derivative financial instruments are initially recognized in the balance sheet at fair value and are remeasured to their current fair value at the end of each subsequent reporting period. The valuation of a forward exchange rate contract is based on the discounted cash flow model, using interest curves and spot rates at the reporting date as observable inputs. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Options are valued based on a modified Black-Scholes model using volatility and exercise prices as major observable inputs. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group utilizes derivative financial instruments for the purpose of hedging to reduce the volatility in the Group&amp;#x2019;s performance due to the exposure to various business related risks. To mitigate these risks, the Group enters into certain derivative financial instruments. The risk reduction is obtained because the derivative&amp;#x2019;s value or cash flows are expected, wholly or partly, to offset changes in the value or cash flows of the recognized assets or liabilities. The overall strategy is aiming to mitigate the currency and interest rate risk of positions that are contractually agreed, and to partially mitigate the exposure risk of selected anticipated transactions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Certain derivative financial instruments meet the criteria for hedge accounting treatment. A prerequisite for obtaining this accounting-hedge relationship is extensive documentation on inception and proving on a regular basis that the economic hedge is effective for accounting purposes. Other derivative financial instruments do not meet the criteria to qualify for hedge accounting. Changes in the fair value of those derivative instruments are recognized immediately in &amp;#x201c;Other financial income and expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In addition, the Group has designated certain long-term debt components as hedges of the translation risk arising on certain net investments in foreign operations. On consolidation, foreign currency differences arising on long-term debt designated as net investment hedges of a foreign operation are recognized in other comprehensive income and accumulated in currency translation effects, to the extent that the hedge is effective. The foreign currency differences arising from hedge ineffectiveness are recognized in the income statement in &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;When a hedged net investment is disposed of, the proportionate portion of the cumulative amount recognized in equity in relation to the hedged net investment is transferred to the consolidated income statement as an adjustment to the gain or loss on disposal. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Inventories&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Inventory is valued at the lower of acquisition or production cost determined on a first-in, first-out basis and net realizable value. This value is used for the &amp;#x201c;Cost of goods sold&amp;#x201d; in the consolidated income statement. Unsalable inventory is fully written off in the consolidated income statement under &amp;#x201c;Cost of goods sold.&amp;#x201d; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Trade receivables&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Trade receivables are initially recognized at their invoiced amounts, including any related sales taxes less adjustments for estimated revenue deductions such as rebates, chargebacks and cash discounts. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the provisions for doubtful trade receivable are established using an expected credit loss model (ECL). The provisions are based on a forward-looking ECL, which includes possible default events on the trade receivables over the entire holding period of the trade receivable. These provisions represent the difference between the trade receivable&amp;#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Charges for doubtful trade receivables are recorded as marketing and selling costs recognized in the consolidated income statement within &amp;#x201c;Selling, general and administration&amp;#x201d; expenses. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to the adoption of IFRS 9, the Group&amp;#x2019;s accounting policy for provisions for doubtful trade receivables was as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for doubtful trade receivables were established once there was an indication that it was likely that a loss would be incurred. These provisions represent the difference between the trade receivable&amp;#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Significant financial difficulties of a customer, such as probability of bankruptcy, financial reorganization, default or delinquency in payments, were considered indicators that recovery of the trade receivable was doubtful. Charges for doubtful trade receivables, recorded as marketing and selling costs, were recognized in the consolidated income statement within &amp;#x201c;Selling, general and administration&amp;#x201d; expenses. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2018&amp;#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Legal and environmental liabilities&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis and its subsidiaries are subject to contingencies arising in the ordinary course of business, such as patent litigation, environmental remediation liabilities and other product-related litigation, commercial litigation, and governmental investigations and proceedings. Provisions are recorded where a reliable estimate can be made of the probable outcome of legal or other disputes against the subsidiary. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Contingent consideration&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In a business combination or divestment of a business, it is necessary to recognize contingent future amounts due to previous owners, representing contractually defined potential amounts as a liability or asset. Usually for Novartis, these are linked to milestone or royalty payments related to certain assets and are recognized as a financial liability or financial asset at their fair value, which is then remeasured at each subsequent reporting date. These estimations typically depend on factors such as technical milestones or market performance, and are adjusted for the probability of their likelihood of payment and are appropriately discounted to reflect the impact of time. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Changes in the fair value of contingent consideration liabilities in subsequent periods are recognized in the consolidated income statement in &amp;#x201c;Cost of goods sold&amp;#x201d; for currently marketed products and in &amp;#x201c;Research and development&amp;#x201d; for IPR&amp;amp;D. Changes in contingent consideration assets are recognized in &amp;#x201c;Other income&amp;#x201d; or &amp;#x201c;Other expense,&amp;#x201d; depending on its nature. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The effect of unwinding the discount over time is recognized for contingent liabilities in &amp;#x201c;Interest expense&amp;#x201d; and for contingent assets as interest income recognized in the consolidated income statement within &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Defi&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;ned benefit pension plans and&amp;nbsp;other&amp;nbsp;post-employment benefits&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The liability in respect of defined benefit pension plans and other post-employment benefits is the defined benefit obligation calculated annually by independent actuaries using the projected unit credit method. The current service cost for such post-employment benefit plans is included in the personnel expenses of the various functions in which associates are employed, while the net interest on the net defined benefit liability or asset is recognized as &amp;#x201c;Other expense&amp;#x201d; or &amp;#x201c;Other income.&amp;#x201d; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Treasury shares&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Treasury shares are initially recorded at fair value on their trade date, which is different from the settlement date, when the transaction is ultimately effected. Treasury shares are deducted from consolidated equity at their nominal value of CHF&amp;nbsp;0.50 per share. Differences between the nominal amount and the transaction price on purchases or sales of treasury shares with third parties, or the value of services received for the shares allocated to associates as part of share-based compensation arrangements, are recorded in &amp;#x201c;Retained earnings&amp;#x201d; in the consolidated statement of changes in equity. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Revenue recognition&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;From January 1, 2018, with the implementation of the new standard IFRS 15 Revenue from Contracts with Customers, the Group accounting policy for revenue recognition is as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Revenue on the sale of Novartis Group products and services, which is recorded as &amp;#x201c;Net sales&amp;#x201d; in the consolidated income statement, is recognized when a contractual promise to a customer (performance obligation) has been fulfilled by transferring control over the promised goods and services to the customer, substantially all of which is at the point in time of shipment to or receipt of the products by the customer or when the services are performed. If contracts contain customer acceptance provisions, revenue is recognized upon the satisfaction of the acceptance criteria. If products are stockpiled at the request of the customer, revenue is only recognized once the products have been inspected and accepted by the customer, and there is no right of return or replenishment on product expiry. The amount of revenue recognized is based on the consideration Novartis expects to receive in exchange for its goods and services, when it is highly probable that a significant reversal will not occur. If a contract contains more than one performance obligation, the consideration is allocated based on the standalone selling price of each performance obligation. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. Revenues were recognized upon satisfaction of each of the performance obligations in the contract and the consideration was allocated based on the standalone selling price of each performance obligation. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which substantially all the risks and rewards incidental to ownership transfers to the customer were treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair value of the equipment, which approximated the present value of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements were approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements longer than 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &amp;#x201c;Other income.&amp;#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The consideration Novartis receives in exchange for its goods or services may be fixed or variable. Variable consideration is only recognized when it is highly probable that a significant reversal will not occur. The most common elements of variable consideration are listed below. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers are provisioned and recorded as a deduction from revenue at the time the related revenues are recorded or when the incentives are offered. They are calculated on the basis of historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Refunds granted to healthcare providers under innovative pay-for-performance agreements (i.e. outcome based arrangements) are provisioned and recorded as a revenue deduction at the time the related sales are recorded. They are calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data are not sufficient for a reliable estimation of the outcome, revenue recognition is deferred until the uncertainty is resolved or until such history is available. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Cash discounts offered to customers are to encourage prompt payment and are provisioned and recorded as revenue deductions at the time the related sales are recorded. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Shelf stock adjustments are generally granted to customers, primarily of the Sandoz Division, to cover the inventory held by them at the time a price decline becomes effective. Revenue deduction provisions for shelf stock adjustments are recorded when the price decline is anticipated, based on the impact of the price decline on the customer&amp;#x2019;s estimated inventory levels. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Sales returns provisions are recognized and recorded as revenue deductions when there is historical experience of Novartis agreeing to customer returns and Novartis can reasonably estimate expected future returns. In doing so, the estimated rate of return is applied, determined on the basis of historical experience of customer returns and considering any other relevant factors. This is applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that can be placed back in inventory for resale. Where shipments are made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue is only recorded when there is evidence of consumption or when the right of return has expired. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Provisions for revenue deductions are adjusted to actual amounts as rebates, refunds, discounts and returns are processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;&amp;#x201c;Other revenue&amp;#x201d; includes income from profit-sharing arrangements with our collaboration partners, and royalty and milestone income from the out-licensing of intellectual property when Novartis retains an interest in the IP through a license. Royalty income earned through a license is recognized when the underlying sales have occurred. Milestone income is recognized at the point in time when it is highly probable that the relevant milestone event criteria is met, and the risk of reversal of revenue recognition is remote. Other revenue also includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales, and is recognized when control transfers to the third party and our performance obligations are satisfied. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to the adoption of IFRS 15 on January 1, 2018, the Group accounting policy for revenue recognition was as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Revenue was recognized on the sale of Novartis Group products and services, and was recorded as &amp;#x201c;Net sales&amp;#x201d; in the consolidated income statement when there was persuasive evidence that a sales arrangement exists; title, risks and rewards for the products are transferred to the customer; the price was determinable; and collectability was reasonably assured. If contracts contain customer acceptance provisions, revenue would be recognized upon the satisfaction of acceptance criteria. If products are stockpiled at the request of the customer, revenue was only recognized once the products have been inspected and accepted by the customer, and there was no right of return or replenishment on product expiry. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. The total consideration was allocated to the separate elements based on their relative fair values. Revenue was recognized once the recognition criteria have been met for each element of the contract. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which Novartis transfers substantially all the risks and rewards incidental to ownership to the customer are treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair values of the equipment, which approximate the present values of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements are approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements in excess of 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &amp;#x201c;Other income.&amp;#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers were recorded as a deduction from revenue at the time the related revenues were recorded or when the incentives were offered. They were calculated on the basis of historical experience and the specific terms in the individual agreements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for refunds granted to healthcare providers under innovative pay-for-performance agreements were recorded as a revenue deduction at the time the related sales were recorded. They were calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data were not sufficient for a reliable estimation of the outcome, revenue recognition was deferred until such history was available. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Cash discounts were offered to customers to encourage prompt payment and were recorded as revenue deductions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Following a decrease in the price of a product, we generally grant customers a &amp;#x201c;shelf stock adjustment&amp;#x201d; for their existing inventory for the involved product. Provisions for shelf stock adjustments, which are primarily relevant within the Sandoz Division, were determined at the time of the price decline or at the point of sale, if the impact of a price decline on the products sold could be reasonably estimated based on the customer&amp;#x2019;s inventory levels of the relevant product. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;When there was historical experience of Novartis agreeing to customer returns, and Novartis could reasonably estimate expected future returns, a provision was recorded for estimated sales returns. In doing so, the estimated rate of return was applied, determined based on historical experience of customer returns and considering any other relevant factors. This was applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that could be placed back in inventory for resale. Where shipments were made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue was only recorded when there was evidence of consumption or when the right of return had expired. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for revenue deductions were adjusted to actual amounts as rebates, discounts and returns were processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;&amp;#x201c;Other revenue&amp;#x201d; includes royalty and profit-sharing income, and revenue from activities such as manufacturing services or other services rendered, to the extent such revenue was not recorded under net sales. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2018&amp;#x201d; provides additional disclosure on the impact of adoption. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Research and development&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Internal research and development (R&amp;amp;D) costs are fully charged to &amp;#x201c;Research and development&amp;#x201d; in the consolidated income statement in the period in which they are incurred. The Group considers that regulatory and other uncertainties inherent in the development of new products preclude the capitalization of internal development expenses as an intangible asset until marketing approval from a regulatory authority is obtained in a major market such as the United States, the European Union, Switzerland or Japan. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Payments made to third parties, such as contract research and development organizations in compensation for subcontracted R&amp;amp;D, that are deemed not to transfer intellectual property to Novartis are expensed as internal R&amp;amp;D expenses in the period in which they are incurred. Such payments are only capitalized if they meet the criteria for recognition of an internally generated intangible asset, usually when marketing approval has been achieved from a regulatory authority in a major market. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Payments made to third parties to in-license or acquire intellectual property rights, compounds and products, including initial upfront and subsequent milestone payments, are capitalized, as are payments for other assets, such as technologies to be used in R&amp;amp;D activities. If additional payments are made to the originator company to continue to perform R&amp;amp;D activities, an evaluation is made as to the nature of the payments. Such additional payments will be expensed if they are deemed to be compensation for subcontracted R&amp;amp;D services not resulting in an additional transfer of intellectual property rights to Novartis. Such additional payments will be capitalized if they are deemed to be compensation for the transfer to Novartis of additional intellectual property developed at the risk of the originator company. Subsequent internal R&amp;amp;D costs in relation to IPR&amp;amp;D and other assets are expensed, since the technical feasibility of the internal R&amp;amp;D activity can only be demonstrated by the receipt of marketing approval for a related product from a regulatory authority in a major market. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Costs for post-approval studies performed to support the continued registration of a marketed product are recognized as marketing expenses. Costs for activities that are required by regulatory authorities as a condition for obtaining marketing approval are capitalized and recognized as currently marketed products. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Inventory produced ahead of regulatory approval is fully provisioned, and the charge is included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement, as its ultimate use cannot be assured. If this inventory can be subsequently sold, the provision is released to &amp;#x201c;Other income&amp;#x201d; in the consolidated income statement, either on approval by the appropriate regulatory authority or, exceptionally in Europe, on recommendation by the Committee for Medicinal Products for Human Use (CHMP), if approval is virtually certain. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Share-based compensation&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Vested Novartis shares and American Depositary Receipts (ADRs) that are granted as compensation are valued at their market value on the grant date and are immediately expensed in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair values of unvested restricted shares (RSs), restricted share units (RSUs) and performance share units (PSUs) in Novartis shares and ADRs granted to associates as compensation are recognized as an expense over the related vesting period. The expense recorded in the consolidated income statement is included in the personnel expenses of the various functions in which the associates are employed. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Unvested restricted shares, restricted ADRs and RSUs are only conditional on the provision of services by the plan participant during the vesting period. They are valued at fair value on the grant date. As RSUs do not entitle the holder to dividends, the fair value is based on the Novartis share price at the grant date adjusted for the net present value of the dividends expected to be paid during the holding period. The fair value of these grants, after making adjustments for assumptions related to forfeiture during the vesting period, is expensed on a straight-line basis over the respective vesting period. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;PSUs are subject to the achievement of certain performance criteria during the vesting period and require plan participants to provide services during this period. The following paragraphs provide an overview of the accounting policies for the share-based compensation plans that grant PSUs. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For PSUs granted under plans that are subject to performance criteria based on Novartis internal performance metrics and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on assumptions concerning the expected performance against the internal performance metrics throughout the vesting period. The assumptions are based on the Group&amp;#x2019;s targets for those performance metrics, and the expected forfeitures due to plan participants not meeting their service conditions. The assumptions are periodically adjusted over the vesting period. Any change in estimates for past services is recorded immediately as an expense or income in the consolidated income statement, and amounts for the remaining vesting period are expensed on a straight-line basis. As a result, at the end of the vesting period, the charge during the entire vesting period represents the amount that will finally vest. The number of equity instruments that finally vest is determined at the vesting date. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For PSUs granted under plans that are subject to performance criteria based on variables that can be observed in the market, which for Novartis plans is the Novartis total shareholder return (TSR) relative to a specific peer group of companies over the vesting period, and that are conditional on the provision of services by the plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on the total fair value of the grant over the vesting period. IFRS requires that these variables that can be observed in the market are taken into account in determining the fair value of the PSUs at the grant date. Novartis determined the fair value of these PSUs at the date of grant using a Monte Carlo simulation model. Adjustments to the number of equity instruments granted are only made if a plan participant does not fulfill the service conditions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For PSUs granted under plans that are subject to both performance criteria based on Novartis internal performance metrics and Novartis TSR relative to a specific peer group of companies over the vesting period and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on a bifurcation into the components based on the performance criteria related to Novartis internal performance metrics and TSR, as described in the paragraphs above. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Measuring the fair values of PSUs granted that include TSR performance criteria requires use of estimates. The Monte Carlo simulation used to determine the fair value of the PSUs TSR performance criteria requires the probability of factors related to uncertain future events; the term of the award; the grant price of underlying shares or ADRs; expected volatilities; the expected correlation matrix of the underlying equity instruments with those of the peer group of companies; and the risk-free interest rate as input parameters. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;If a plan participant leaves Novartis for reasons other than retirement, disability or death, then unvested restricted shares, restricted ADRs, RSUs and PSUs are forfeited, unless determined otherwise by the provision of the plan rules or by the Compensation Committee of the Novartis Board of Directors, for example, in connection with a reorganization or divestment. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Government grants&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Grants from governments or similar organizations are recognized at their fair value when there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Government grants related to income are deferred and recognized in the consolidated income statement over the period necessary to match them with the related costs that they are intended to compensate. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The accounting policy for property, plant and equipment describes the treatment of any related grants. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Restructuring charges&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Restructuring provisions are recognized for the direct expenditures arising from the restructuring, where the plans are sufficiently detailed and where appropriate communication to those affected has been made. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Charges to increase restructuring provisions are included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statements. Corresponding releases are recorded in &amp;#x201c;Other income&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Taxes&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Taxes on income are provided in the same periods as the revenues and expenses to which they relate and include interest and penalties incurred during the period. Deferred taxes are determined using the comprehensive liability method and are calculated on the temporary differences that arise between the tax base of an asset or liability and its carrying value in the balance sheet prepared for consolidation purposes, except for those temporary differences related to investments in subsidiaries and associated companies, where the timing of their reversal can be controlled and it is probable that the difference will not reverse in the foreseeable future. Since the retained earnings are reinvested, withholding or other taxes on eventual distribution of a subsidiary&amp;#x2019;s retained earnings are only taken into account when a dividend has been planned. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The estimated amounts for current and deferred tax assets or liabilities, including any amounts related to any uncertain tax positions, are based on currently known facts and circumstances. Tax returns are based on an interpretation of tax laws and regulations, and reflect estimates based on these judgments and interpretations. The tax returns are subject to examination by the competent taxing authorities, which may result in an assessment being made requiring payments of additional tax, interest or penalties. Inherent uncertainties exist in the estimates of the tax positions. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impact of adopting significant new IFRS standard in 2019&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following new IFRS standard has been adopted by Novartis from January 1, 2019: &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 16 Leases&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;IFRS 16 Leases substantially changed the financial statements, as the majority of leases for which the Group is the lessee became on-balance sheet liabilities with corresponding right-of-use assets also recognized on the balance sheet. The lease liability reflects the net present value of the remaining lease payments, and the right-of-use asset corresponds to the lease liability, adjusted for payments made before the commencement date, lease incentives and other items related to the lease agreement. The standard replaces IAS 17 Leases and related interpretations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Upon adoption of the new standard, a portion of the annual operating lease costs, which was previously fully recognized as functional expenses, as a component of operating income, is recorded as interest expense. In addition, the portion of the lease payments that represents the reduction of the lease liability is recognized in the cash flow statement as an outflow from financing activities, which was previously fully recognized as an outflow from operating activities. Given the leases involved, these effects are not significant to the consolidated income statement and consolidated statement of cash flow. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group implemented the new standard on January 1, 2019, and applied the modified retrospective method, with right-of-use assets measured at an amount equal to the lease liability, adjusted by the amount of the prepaid or accrued lease payments relating to those leases recognized in the balance sheet immediately before the date of initial application and did not restate prior years. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Results of our impact assessment: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The undiscounted operating lease commitments as of December 31, 2018, amounted to USD 3.6 billion. This includes approximately USD 0.1 billion of leases with a commencement date in 2019, as well as short-term leases and low-value leases that are recognized from January 1, 2019, upon adoption of IFRS 16, on a straight-line basis as expense in profit and loss. This also includes USD 0.2 billion lease commitments related to the Alcon Division, which is attributable to discontinued operation in 2019. For the remaining undiscounted lease commitments attributable to continuing operations of USD 3.3 billion, the Group recognized on January 1, 2019, lease liabilities of USD 1.74 billion and right-of-use assets of USD 1.55 billion (after the reclassification of USD 0.1 billion from property, plant &amp;amp; equipment, and net adjustments for the USD 0.3 billion recognition of sublease receivables, prepayments, and accrued lease payments recognized as at December 31, 2018). For the lease commitments attributable to discontinued operations, the Group recognized on January 1, 2019, lease liabilities and right-of-use assets of USD 0.2 billion. This does not include the discontinued operations right-of-use assets and lease liability on finance lease agreements of USD 75 million and USD 89 million, respectively. There was an insignificant increase to retained earnings upon adoption of IFRS 16 of USD 3 million that arose from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As a lessor, the Group had no significant impact upon adoption. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For further information on the impact of adoption and additional disclosures of IFRS 16 Leases, see Note 10. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impact of adopting significant new IFRS standards in 2018&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following IFRS standards have been adopted by Novartis from January 1, 2018: &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 9 Financial Instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis implemented IFRS 9 Financial Instruments as of January 1, 2018, which substantially changed the classi&amp;#xfb01;cation and measurement of &amp;#xfb01;nancial instruments. The standard requires impairments to be based on a forward-looking model, changed the approach to hedging &amp;#xfb01;nancial exposures and related documentation, changed the recognition of certain fair value changes, and amends disclosure requirements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The impairment of financial assets, including trade and lease receivables, is now assessed using an expected credit loss model; previously, the incurred loss model was used. Given the nature of Novartis financial assets, the Group had no significant impact to its provisions for doubtful accounts or impairments from this change. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The new hedge accounting model introduced by the standard requires hedge accounting relationships to be based upon the Group&amp;#x2019;s own risk management strategy and objectives, and to be discontinued only when the relationships no longer qualify for hedge accounting. There was no impact upon adoption of the new standard, as the Group&amp;#x2019;s existing hedge relationships continue to be designated as such under the new hedge accounting requirements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The most significant impact to the Group upon adoption of IFRS 9 relates to the treatment of the unrealized gains and losses from changes in fair value on certain of the Group&amp;#x2019;s financial instruments, which were previously classified as available-for-sale marketable securities and financial investments. The unrealized gains and losses (to the extent of previous recognized unrealized gains), which the Group recognized previously in the consolidated statement of other comprehensive income, are from January 1, 2018, recognized in the consolidated income statement. This approach is applied to equity securities where the fair value through other comprehensive income irrevocable option is not applied. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group applied the modified retrospective method upon adoption of IFRS 9 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 9 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 177 million. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 15 Revenue from Contracts with Customers&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis implemented the new standard IFRS 15 Revenue from Contracts with Customers as of January 1, 2018. The standard amended revenue recognition requirements and established principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash &amp;#xfb02;ows arising from contracts with customers. The standard replaced IAS 18 Revenue and IAS 11 Construction contracts and related interpretations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The impacts of adoption of the new standard are summarized below: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Group&amp;#x2019;s &amp;#x201c;net sales&amp;#x201d; are derived from the sale of drug substances, vision care products, surgical equipment, and other products and services, where control transfers to our customers and our performance obligations are satisfied at the time of shipment to or receipt of the products by the customer, or when the services are performed. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Group&amp;#x2019;s &amp;#x201c;other revenue&amp;#x201d; consists of royalty income from the out-licensing of intellectual property, which is recognized as earned, and from manufacturing and other services, where revenue is recognized when control transfers to the third party and our performance obligations are satisfied. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized from these manufacturing and other services arrangements, nor did it change accounting for these royalty arrangements, as the standard&amp;#x2019;s royalty exception is applied for IP licenses. &amp;#x201c;Other revenue&amp;#x201d; also includes revenue from profit-sharing arrangements with our collaboration partners. Furthermore, the Group receives milestone payments related to the out-licensing of IP. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group applied the modified retrospective method upon adoption of IFRS 15 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 15 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 60 million. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;New IFRS standard effective as of January 1, 2020 &lt;/font&gt; &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 3 Business Combination amendments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The IASB issued an amendment to IFRS 3 Business Combinations that revised the definition of a business, which assist entities with the evaluation of when an asset or group of assets acquired or disposed of should be considered a business. This amended standard is effective for the Group as of January 1, 2020 and is applicable to transactions entered into on or after January 1, 2020. The amended standard allows an entity to apply an optional concentration test, on a transaction-by-transaction basis, to evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this optional concentration test is met, the entity may choose to consider the transaction an acquisition of an asset or set of assets. The Group does not expect the adoption of this amended standard on January 1, 2020 to have a significant impact on our consolidated financial statements in future periods. However, this will depend on the facts and circumstances of future transactions and if the Group decides to apply the optional concentration test in the assessment of whether an acquired set of activities and assets is or is not a business. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;There are no other IFRS standards or interpretations not yet effective that would be expected to have a material impact on the Group. &lt;/div&gt;</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForSubsidiariesExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Scope of consolidation &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated financial statements include all entities, including structured entities, over which Novartis AG, Basel, Switzerland, directly or indirectly has control (generally as a result of owning more than 50% of the entity&amp;#x2019;s voting interest). Consolidated entities are also referred to as &amp;#x201c;subsidiaries.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In cases where Novartis does not fully own a subsidiary, it has elected to value any remaining outstanding non-controlling interest at the time of acquiring control of the subsidiary at its proportionate share of the fair value of the net identified assets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The contribution of a business to an associate or joint venture is accounted for by applying the option under IFRS that permits the accounting for the retained interest of the business contributed at its net book value at the time of the contribution. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Investments in associated companies (generally defined as investments in entities in which Novartis holds between 20% and 50% of voting shares or over which it otherwise has significant influence) and joint ventures are accounted for using the equity method, except for selected venture fund investments for which the Group has elected to apply the method of fair value through the consolidated income statement. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSubsidiariesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Foreign currencies&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated financial statements of Novartis are presented in US dollars (USD). The functional currency of subsidiaries is generally the local currency of the respective entity. The functional currency used for the reporting of certain Swiss and foreign finance entities is USD instead of their respective local currencies. This reflects the fact that the cash flows and transactions of these entities are primarily denominated in these currencies. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For subsidiaries not operating in hyperinflationary economies, the subsidiary&amp;#x2019;s results, financial position and cash flows that do not have USD as their functional currency are translated into USD using the following exchange rates: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Income, expense and cash flows using for each month the average exchange rate, with the US dollar values for each month being aggregated during the year &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Balance sheets using year-end exchange rates&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Resulting exchange rate differences are recognized in other comprehensive income&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;For subsidiaries operating in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period is recorded in retained earnings in equity. The subsequent gains or losses resulting from the restatement of non-monetary assets are recorded in &amp;#x201c;Other financial income and expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Non-current assets held for sale or held for distribution to owners&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Non-current assets are classified as assets held for sale or related to discontinued operations when their carrying amount is to be recovered principally through a sale transaction or distribution to owners, and a sale or distribution to owners is considered highly probable. They are stated at the lower of carrying amount and fair value less costs to sell with any resulting impairment recognized. Assets related to discontinued operations and assets of disposal group held for sale are not depreciated or amortized. The prior-year consolidated balance sheet is not restated. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory>
  <nvs:DistributionByWayOfDivindendInKindToShareholders contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Distribution of Alcon Inc. to Novartis AG shareholders &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;During the first quarter of 2019, at the Annual General Meeting (AGM) of Novartis AG shareholders, held on February 28, 2019, the Novartis AG shareholders approved a special distribution by way of a dividend in kind to effect the spin-off of Alcon Inc. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The February 28, 2019, shareholder approval for the spin-off required the Alcon Division and selected portions of corporate activities attributable to Alcon&amp;#x2019;s business (the &amp;#x201c;Alcon business&amp;#x201d;) to be reported as discontinued operations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The shareholder approval to spin off the Alcon business also required the recognition of a distribution liability at the fair value of the Alcon business. The Group elected to measure the distribution liability at the fair value of the Alcon business net assets taken as a whole. The distribution liability was recognized through a reduction in retained earnings. It was required to be adjusted at each balance sheet date for changes in its estimated fair value, up to the date of the distribution to shareholders through retained earnings. Any resulting impairment of the business assets to be distributed would have been recognized in the consolidated income statements in &amp;#x201c;Other expense&amp;#x201d; of discontinued operations, at the date of initial recognition of the distribution liability or at subsequent dates resulting from changes of the distribution liability valuation. At the April 8, 2019 distribution settlement date, the resulting gain, which was measured as the excess amount of the distribution liability over the then-carrying value of the net assets of the business distributed, was recognized on the line &amp;#x201c;Gain on distribution of Alcon Inc. to Novartis AG shareholders&amp;#x201d; in the income statement of discontinued operations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&amp;#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&amp;#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. These fair value measurements were classified as &amp;#x201c;Level 3&amp;#x201d; in the fair value hierarchy. The section &amp;#x201c;&amp;mdash;Impairment of goodwill and intangible assets&amp;#x201d; in this Note 1 provides additional information on key assumptions that are highly sensitive in the estimation of fair values using valuation techniques. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Transaction costs that were directly attributable to the distribution (spin-off) of Alcon to the Novartis shareholders, and that would otherwise have been avoided, were recorded as a deduction from equity. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For additional disclosures, refer to &amp;#x201c;Note 2. Significant transactions&amp;mdash;Significant transactions in 2019&amp;mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders,&amp;#x201d; and &amp;#x201c;Note 30. Discontinued operations.&amp;#x201d; &lt;/div&gt;</nvs:DistributionByWayOfDivindendInKindToShareholders>
  <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Acquisition of assets &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Acquired assets are initially recognized on the balance sheet at cost if they meet the criteria for capitalization. If acquired as part of a business combination, the fair value of identified assets represents the cost for these assets. If separately acquired, the cost of the asset includes the purchase price and any directly attributable costs for bringing the asset into the condition to operate as intended. Expected costs for obligations to dismantle and remove property, plant and equipment when they are no longer used are included in their cost. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Property, plant and equipment&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Property, plant and equipment are depreciated on a straight-line basis in the consolidated income statement over their estimated useful lives. Leasehold land is depreciated over the period of its lease, whereas freehold land is not depreciated. The related depreciation expense is included in the costs of the functions using the asset. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Property, plant and equipment are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the respective useful lives for property, plant and equipment:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Useful life&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20 to 40 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and other equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7 to 20 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Furniture and vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5 to 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Computer hardware&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3 to 7 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Government grants obtained for construction activities, including any related equipment, are deducted from the gross acquisition cost to arrive at the balance sheet carrying value of the related assets. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
  <nvs:RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Useful life&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20 to 40 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and other equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7 to 20 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Furniture and vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5 to 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Computer hardware&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3 to 7 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock>
  <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Leases and right-of-use assets&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;From January 1, 2019, with the adoption of IFRS 16 Leases, the Group adopted the following accounting policies for leases and right-of-use assets: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative standalone price. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases. For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease to end of the lease term. The lease term includes the period of any lease extension that in management&amp;#x2019;s assessment is highly probable to be exercised by the Group. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the Novartis incremental borrowing rate for the asset subject to the lease in the respective markets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The portion of the lease payments attributable to the repayment of lease liabilities is recognized in cash flows used in financing activities, and the portion attributable to the payment of interest is included in cash flows from operating activities. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease incentive received and any initial direct costs incurred by Novartis, and expected costs for obligations to dismantle and remove right-of-use assets when they are no longer used. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life of the right-of-use asset or the end of the lease term. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In arrangements where the Group is the lessor, it determines at lease inception whether the lease is a finance lease or an operating lease. Leases that transfer substantially all of the risk and rewards incidental to ownership of the underlying asset to the counterparty (the lessee) are accounted for as finance leases. Leases that do not transfer substantially all of the risks and rewards of ownership are accounted for as operating leases. Lease payments received under operating leases are recognized on a straight-line basis over the lease term in the consolidated income statement in either &amp;#x201c;net sales&amp;#x201d; or &amp;#x201c;other income,&amp;#x201d; depending on the nature of and underlying asset to the lease arrangement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to January 1, 2019, the Group applied the following accounting policies for leases: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Leases that transferred substantially all of the risks and rewards of ownership were recognized as finance leases, with the leased asset measured initially at an amount equal to the lower of their fair value and the present value of the minimum lease payments. Minimum lease payments were the payments over the lease term that the Group, as leasee, was required to make, excluding contingent rent. The underlying asset was accounted for in accordance with the accounting policy applicable to that asset. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Leases that did not transfer substantially all of the risks and rewards of ownership were accounted for as operating leases and were not recognized in the consolidated balance sheet. Payments made under operating leases were recognized in the consolidated income statement on a straight-line basis over the term of the lease. Lease incentives received were deferred and recognized as a component of lease expense over the term of the lease. The future undiscounted lease payments under operating leases were disclosed as commitments in the notes to the consolidated financial statements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Lessor accounting policies were not substantially different from those applied upon the adoption of IFRS 16 Leases, as described above. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2019&amp;#x201d; in this Note 1 provides additional disclosures on the impact of adoption of IFRS 16 Leases. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Goodwill and intangible assets&lt;/font&gt; &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory contextRef="AR_D-CurrentYear">&lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Goodwill&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Goodwill arises in a business combination and is the excess of the consideration transferred to acquire a business over the underlying fair value of the net identified assets acquired. It is allocated to groups of cash-generating units (CGUs), which are usually represented by the reported segments. Goodwill is tested for impairment annually at the level of these groups of CGUs, and any impairment charges are recorded under &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory>
  <nvs:DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Intangible assets available for use&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has the following classes of available-for-use intangible assets: currently marketed products; technologies; other intangible assets (including computer software); and up to the spin-off date of Alcon business, marketing know-how and the Alcon brand name. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Currently marketed products represent the composite value of acquired intellectual property (IP), patents, and distribution rights and product trade names. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Marketing know-how represents the value attributable to the expertise acquired for marketing and distributing Alcon surgical products.&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Technologies represent identified and separable acquired know-how used in the research, development and production processes. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Significant investments in internally developed and acquired computer software are capitalized and included in the &amp;#x201c;Other&amp;#x201d; category, and amortized once available for use. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Alcon brand name was shown separately, as it was the only Novartis intangible asset that was available for use with an indefinite useful life. Novartis considers that it was appropriate that the Alcon brand name had an indefinite life since Alcon-branded products had a history of strong revenue and cash flow performance, and Novartis had the intent and ability to support the brand with spending to maintain its value for the foreseeable future. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Except for the Alcon brand name, intangible assets available for use are amortized over their estimated useful lives on a straight-line basis and are evaluated for potential impairment whenever facts and circumstances indicate that their carrying value may not be recoverable. The Alcon brand name was not amortized, but evaluated for potential impairment annually. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the respective useful lives for available-for-use intangible assets and the location in the consolidated income statement in which the respective amortization and any potential impairment charge is recognized: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Useful life &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income statement location &lt;br&gt;&lt;/br&gt; for amortization and &lt;br&gt;&lt;/br&gt; impairment charges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currently marketed products&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5 to 20 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold"&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketing know-how&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold"&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Technologies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10 to 20 years &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold" &lt;br&gt;&lt;/br&gt; or "Research &lt;br&gt;&lt;/br&gt; and development" &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other (including &lt;br&gt;&lt;/br&gt;computer software) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3 to 7 years &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; In the respective &lt;br&gt;&lt;/br&gt; functional expense &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon brand name&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Not amortized, &lt;br&gt;&lt;/br&gt; indefinite useful life &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Other expense" &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock>
  <nvs:RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Useful life &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income statement location &lt;br&gt;&lt;/br&gt; for amortization and &lt;br&gt;&lt;/br&gt; impairment charges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currently marketed products&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5 to 20 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold"&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketing know-how&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold"&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Technologies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10 to 20 years &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Cost of goods sold" &lt;br&gt;&lt;/br&gt; or "Research &lt;br&gt;&lt;/br&gt; and development" &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other (including &lt;br&gt;&lt;/br&gt;computer software) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3 to 7 years &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; In the respective &lt;br&gt;&lt;/br&gt; functional expense &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon brand name&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Not amortized, &lt;br&gt;&lt;/br&gt; indefinite useful life &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; "Other expense" &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock>
  <nvs:DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock contextRef="AR_D-CurrentYear">&lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Intangible assets not yet available for use&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Acquired research and development intangible assets that are still under development and have accordingly not yet obtained marketing approval are recognized as in-process research and development (IPR&amp;amp;D). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;IPR&amp;amp;D is not amortized, but is evaluated for potential impairment on an annual basis or when facts and circumstances warrant. Any impairment charge is recorded in the consolidated income statement under &amp;#x201c;Research and development.&amp;#x201d; Once a project included in IPR&amp;amp;D has been successfully developed, it is transferred to the &amp;#x201c;Currently marketed products&amp;#x201d; category. &lt;/div&gt;</nvs:DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock>
  <nvs:DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impairment of goodwill and intangible assets&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;An asset is considered impaired when its balance sheet carrying amount exceeds its estimated recoverable amount, which is defined as the higher of its fair value less costs of disposal and its value in use. Usually, Novartis applies the fair value less costs of disposal method for its impairment assessment. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. In the limited cases where the value in use method would be applied, net present value techniques would be applied using pre-tax cash flows and discount rates. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Fair value less costs of disposal reflects estimates of assumptions that market participants would be expected to use when pricing the asset or CGUs, and for this purpose, management considers the range of economic conditions that are expected to exist over the remaining useful life of the asset. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The estimates used in calculating the net present values are highly sensitive and depend on assumptions specific to the nature of the Group&amp;#x2019;s activities with regard to: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Amount and timing of projected future cash flows&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Long-term sales forecasts &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Actions of competitors (launch of competing products, marketing initiatives, etc.)&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Outcome of research and development activities (compound efficacy, results of clinical trials, etc.)&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Amount and timing of projected costs to develop IPR&amp;amp;D into commercially viable products&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Profit margins&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Probability of obtaining regulatory approval&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Future tax rate&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Appropriate royalty rate for the Alcon brand name&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Appropriate terminal growth rate&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Appropriate discount rate&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Generally, for intangible assets with a definite useful life, Novartis uses cash flow projections for the whole useful life of these assets. For goodwill and the Alcon brand name, Novartis generally utilizes cash flow projections for a five-year period based on management forecasts, with a terminal value based on cash flow projections usually in line with inflation rates for later periods. Probability-weighted scenarios are typically used. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Discount rates used consider the Group&amp;#x2019;s estimated weighted average cost of capital, adjusted for specific country and currency risks associated with cash flow projections to approximate the discount rate that market participants would use to value the asset. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Due to the above factors, actual cash flows and values could vary significantly from forecasted future cash flows and related values derived using discounting techniques. &lt;/div&gt;</nvs:DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock>
  <nvs:DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impairment of associated companies accounted for at equity&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis considers investments in associated companies for impairment evaluation whenever objective evidence indicates the net investment may be impaired, including when a quoted share price indicates a fair value less than the per-share balance sheet carrying value for the investment. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;If the recoverable amount of the investment is estimated to be lower than the balance sheet carrying amount, an impairment charge is recognized for the difference in the consolidated income statement under &amp;#x201c;Income from associated companies.&amp;#x201d; &lt;/div&gt;</nvs:DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock>
  <nvs:DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Cash and cash equivalents&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Cash and cash equivalents include highly liquid investments with original maturities of three months or less, which are readily convertible to known amounts of cash. Bank overdrafts are usually presented within current financial debts on the consolidated balance sheet, except in cases where a right of offset has been agreed with a bank, which then allows for presentation on a net basis. &lt;/div&gt;</nvs:DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock>
  <nvs:DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Marketable securities, commodities and non-current financial assets &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Commodities, which include gold bullion or coins, are valued at the lower of cost or fair value using current market prices. The changes in fair value below cost are immediately recorded in &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Marketable securities are financial assets consisting principally of equity and debt securities as well as fund investments. Marketable securities held for short-term purposes are principally traded in liquid markets and are classified as marketable securities within current assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &amp;#x201c;Other financial income and expense&amp;#x201d; in the consolidated income statement. Marketable securities held for long-term strategic purposes are classified as non-current financial assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &amp;#x201c;Other income&amp;#x201d; and &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Marketable securities are initially recorded at fair value on their trade date, which is different from the settlement date when the transaction is ultimately effected. Quoted securities are remeasured at each reporting date to fair value based on current market prices. If the market for a financial asset is not active or no market is available, fair values are established using valuation techniques. The majority of non-quoted investments are valued initially at fair value through the established purchase price between a willing buyer and seller. Non-quoted investments are subsequently adjusted based on values derived from discounted cash flow analysis or other pricing models. These investment values are classified as &amp;#x201c;Level 3&amp;#x201d; in the fair value hierarchy. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the Group classifies and accounts for its marketable securities and non-current financial assets in the following categories: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Debt securities are valued at fair value through other comprehensive income with subsequent recycling into the consolidated income statement, as they meet both the &amp;#x201c;solely payment of principal and interest&amp;#x201d; and the business model criteria. Unrealized gains and losses, except exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are recognized in the consolidated income statement when the debt instrument is sold, at which time the gain is transferred to &amp;#x201c;Other financial income and expense.&amp;#x201d; Exchange gains and losses related to debt instruments are immediately recognized in the consolidated income statement to &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Fund investments, equity securities of the Novartis venture fund and derivative assets are valued at fair value through profit and loss (FVPL). Unrealized gains and losses, including exchange gains and losses, are recognized in the consolidated income statement, for all fund investments and for equity securities of the Novartis venture fund, to &amp;#x201c;Other income&amp;#x201d; for gains and &amp;#x201c;Other expense&amp;#x201d; for losses, and for derivative assets to &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Equity securities held as strategic investments, typically held outside of the Novartis venture fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Unrealized gains and losses, including exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are reclassified to retained earnings when the equity security is sold. If these equity securities are not designated at date of acquisition as financial assets valued at fair value through other comprehensive income, they are valued at FVPL, as described above. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Other non-current financial assets, such as loans and long-term receivables from customers, advances and other deposits, are valued at amortized cost, which reflects the time value of money less any allowances for expected credit losses. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group assesses on a forward-looking basis the expected credit losses associated with its debt securities valued at fair value through other comprehensive income. Impairments on debt securities are recorded in &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For other financial assets valued at amortized costs, impairments, which are based on their expected credit losses, and exchange rate losses are included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. Exchange rate gains and interest income, using the effective interest rate method, are included in &amp;#x201c;Other income&amp;#x201d; or &amp;#x201c;Other financial income&amp;#x201d; in the consolidated income statement, depending on the nature of the item. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to the adoption of IFRS 9, the Group classified and accounted for its marketable securities and non-current financial assets in the following categories: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Group classified all its equity and quoted debt securities as well as fund investments as available for sale, as they were not acquired to generate profit from short-term fluctuations in price. Unrealized gains, except exchange gains related to quoted debt instruments, were recorded as a fair value adjustment in the consolidated statement of comprehensive income. They were recognized in the consolidated income statement when the financial asset was sold, at which time the gain was transferred either to &amp;#x201c;Other financial income and expense,&amp;#x201d; for the marketable securities held for short-term non-strategic purposes, or to &amp;#x201c;Other income,&amp;#x201d; for all other equity securities and fund investments. Exchange gains related to quoted debt instruments were immediately recognized in the consolidated income statement under &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; A security was assessed for impairment when its market value at the balance sheet date was less than initial cost reduced by any previously recognized impairment. Impairments on equity securities, quoted debt securities and fund investments, and exchange rate losses on quoted debt securities in a foreign currency that were held for short-term non-strategic purposes were recorded in &amp;#x201c;Other financial income and expense.&amp;#x201d; Impairments were recorded for all other equity securities and other fund investments in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Other non-current financial assets, including loans held for long-term strategic purposes, were carried at amortized cost, which reflects the time value of money less any allowances for uncollectable amounts. For these financial assets, impairments and exchange rate losses were included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement, and exchange rate gains and interest income using the effective interest rate method were included in &amp;#x201c;Other income&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2018&amp;#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. &lt;/div&gt;</nvs:DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock>
  <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Derivative financial instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Derivative financial instruments are initially recognized in the balance sheet at fair value and are remeasured to their current fair value at the end of each subsequent reporting period. The valuation of a forward exchange rate contract is based on the discounted cash flow model, using interest curves and spot rates at the reporting date as observable inputs. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Options are valued based on a modified Black-Scholes model using volatility and exercise prices as major observable inputs. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group utilizes derivative financial instruments for the purpose of hedging to reduce the volatility in the Group&amp;#x2019;s performance due to the exposure to various business related risks. To mitigate these risks, the Group enters into certain derivative financial instruments. The risk reduction is obtained because the derivative&amp;#x2019;s value or cash flows are expected, wholly or partly, to offset changes in the value or cash flows of the recognized assets or liabilities. The overall strategy is aiming to mitigate the currency and interest rate risk of positions that are contractually agreed, and to partially mitigate the exposure risk of selected anticipated transactions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Certain derivative financial instruments meet the criteria for hedge accounting treatment. A prerequisite for obtaining this accounting-hedge relationship is extensive documentation on inception and proving on a regular basis that the economic hedge is effective for accounting purposes. Other derivative financial instruments do not meet the criteria to qualify for hedge accounting. Changes in the fair value of those derivative instruments are recognized immediately in &amp;#x201c;Other financial income and expense&amp;#x201d; in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In addition, the Group has designated certain long-term debt components as hedges of the translation risk arising on certain net investments in foreign operations. On consolidation, foreign currency differences arising on long-term debt designated as net investment hedges of a foreign operation are recognized in other comprehensive income and accumulated in currency translation effects, to the extent that the hedge is effective. The foreign currency differences arising from hedge ineffectiveness are recognized in the income statement in &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;When a hedged net investment is disposed of, the proportionate portion of the cumulative amount recognized in equity in relation to the hedged net investment is transferred to the consolidated income statement as an adjustment to the gain or loss on disposal. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Inventories&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Inventory is valued at the lower of acquisition or production cost determined on a first-in, first-out basis and net realizable value. This value is used for the &amp;#x201c;Cost of goods sold&amp;#x201d; in the consolidated income statement. Unsalable inventory is fully written off in the consolidated income statement under &amp;#x201c;Cost of goods sold.&amp;#x201d; &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
  <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Trade receivables&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Trade receivables are initially recognized at their invoiced amounts, including any related sales taxes less adjustments for estimated revenue deductions such as rebates, chargebacks and cash discounts. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the provisions for doubtful trade receivable are established using an expected credit loss model (ECL). The provisions are based on a forward-looking ECL, which includes possible default events on the trade receivables over the entire holding period of the trade receivable. These provisions represent the difference between the trade receivable&amp;#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Charges for doubtful trade receivables are recorded as marketing and selling costs recognized in the consolidated income statement within &amp;#x201c;Selling, general and administration&amp;#x201d; expenses. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to the adoption of IFRS 9, the Group&amp;#x2019;s accounting policy for provisions for doubtful trade receivables was as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for doubtful trade receivables were established once there was an indication that it was likely that a loss would be incurred. These provisions represent the difference between the trade receivable&amp;#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Significant financial difficulties of a customer, such as probability of bankruptcy, financial reorganization, default or delinquency in payments, were considered indicators that recovery of the trade receivable was doubtful. Charges for doubtful trade receivables, recorded as marketing and selling costs, were recognized in the consolidated income statement within &amp;#x201c;Selling, general and administration&amp;#x201d; expenses. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2018&amp;#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Legal and environmental liabilities&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis and its subsidiaries are subject to contingencies arising in the ordinary course of business, such as patent litigation, environmental remediation liabilities and other product-related litigation, commercial litigation, and governmental investigations and proceedings. Provisions are recorded where a reliable estimate can be made of the probable outcome of legal or other disputes against the subsidiary. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Contingent consideration&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In a business combination or divestment of a business, it is necessary to recognize contingent future amounts due to previous owners, representing contractually defined potential amounts as a liability or asset. Usually for Novartis, these are linked to milestone or royalty payments related to certain assets and are recognized as a financial liability or financial asset at their fair value, which is then remeasured at each subsequent reporting date. These estimations typically depend on factors such as technical milestones or market performance, and are adjusted for the probability of their likelihood of payment and are appropriately discounted to reflect the impact of time. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Changes in the fair value of contingent consideration liabilities in subsequent periods are recognized in the consolidated income statement in &amp;#x201c;Cost of goods sold&amp;#x201d; for currently marketed products and in &amp;#x201c;Research and development&amp;#x201d; for IPR&amp;amp;D. Changes in contingent consideration assets are recognized in &amp;#x201c;Other income&amp;#x201d; or &amp;#x201c;Other expense,&amp;#x201d; depending on its nature. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The effect of unwinding the discount over time is recognized for contingent liabilities in &amp;#x201c;Interest expense&amp;#x201d; and for contingent assets as interest income recognized in the consolidated income statement within &amp;#x201c;Other financial income and expense.&amp;#x201d; &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Defi&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;ned benefit pension plans and&amp;nbsp;other&amp;nbsp;post-employment benefits&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The liability in respect of defined benefit pension plans and other post-employment benefits is the defined benefit obligation calculated annually by independent actuaries using the projected unit credit method. The current service cost for such post-employment benefit plans is included in the personnel expenses of the various functions in which associates are employed, while the net interest on the net defined benefit liability or asset is recognized as &amp;#x201c;Other expense&amp;#x201d; or &amp;#x201c;Other income.&amp;#x201d; &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Treasury shares&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Treasury shares are initially recorded at fair value on their trade date, which is different from the settlement date, when the transaction is ultimately effected. Treasury shares are deducted from consolidated equity at their nominal value of CHF&amp;nbsp;0.50 per share. Differences between the nominal amount and the transaction price on purchases or sales of treasury shares with third parties, or the value of services received for the shares allocated to associates as part of share-based compensation arrangements, are recorded in &amp;#x201c;Retained earnings&amp;#x201d; in the consolidated statement of changes in equity. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Revenue recognition&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;From January 1, 2018, with the implementation of the new standard IFRS 15 Revenue from Contracts with Customers, the Group accounting policy for revenue recognition is as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Revenue on the sale of Novartis Group products and services, which is recorded as &amp;#x201c;Net sales&amp;#x201d; in the consolidated income statement, is recognized when a contractual promise to a customer (performance obligation) has been fulfilled by transferring control over the promised goods and services to the customer, substantially all of which is at the point in time of shipment to or receipt of the products by the customer or when the services are performed. If contracts contain customer acceptance provisions, revenue is recognized upon the satisfaction of the acceptance criteria. If products are stockpiled at the request of the customer, revenue is only recognized once the products have been inspected and accepted by the customer, and there is no right of return or replenishment on product expiry. The amount of revenue recognized is based on the consideration Novartis expects to receive in exchange for its goods and services, when it is highly probable that a significant reversal will not occur. If a contract contains more than one performance obligation, the consideration is allocated based on the standalone selling price of each performance obligation. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. Revenues were recognized upon satisfaction of each of the performance obligations in the contract and the consideration was allocated based on the standalone selling price of each performance obligation. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which substantially all the risks and rewards incidental to ownership transfers to the customer were treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair value of the equipment, which approximated the present value of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements were approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements longer than 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &amp;#x201c;Other income.&amp;#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The consideration Novartis receives in exchange for its goods or services may be fixed or variable. Variable consideration is only recognized when it is highly probable that a significant reversal will not occur. The most common elements of variable consideration are listed below. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers are provisioned and recorded as a deduction from revenue at the time the related revenues are recorded or when the incentives are offered. They are calculated on the basis of historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Refunds granted to healthcare providers under innovative pay-for-performance agreements (i.e. outcome based arrangements) are provisioned and recorded as a revenue deduction at the time the related sales are recorded. They are calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data are not sufficient for a reliable estimation of the outcome, revenue recognition is deferred until the uncertainty is resolved or until such history is available. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Cash discounts offered to customers are to encourage prompt payment and are provisioned and recorded as revenue deductions at the time the related sales are recorded. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Shelf stock adjustments are generally granted to customers, primarily of the Sandoz Division, to cover the inventory held by them at the time a price decline becomes effective. Revenue deduction provisions for shelf stock adjustments are recorded when the price decline is anticipated, based on the impact of the price decline on the customer&amp;#x2019;s estimated inventory levels. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Sales returns provisions are recognized and recorded as revenue deductions when there is historical experience of Novartis agreeing to customer returns and Novartis can reasonably estimate expected future returns. In doing so, the estimated rate of return is applied, determined on the basis of historical experience of customer returns and considering any other relevant factors. This is applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that can be placed back in inventory for resale. Where shipments are made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue is only recorded when there is evidence of consumption or when the right of return has expired. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Provisions for revenue deductions are adjusted to actual amounts as rebates, refunds, discounts and returns are processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;&amp;#x201c;Other revenue&amp;#x201d; includes income from profit-sharing arrangements with our collaboration partners, and royalty and milestone income from the out-licensing of intellectual property when Novartis retains an interest in the IP through a license. Royalty income earned through a license is recognized when the underlying sales have occurred. Milestone income is recognized at the point in time when it is highly probable that the relevant milestone event criteria is met, and the risk of reversal of revenue recognition is remote. Other revenue also includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales, and is recognized when control transfers to the third party and our performance obligations are satisfied. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Prior to the adoption of IFRS 15 on January 1, 2018, the Group accounting policy for revenue recognition was as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Revenue was recognized on the sale of Novartis Group products and services, and was recorded as &amp;#x201c;Net sales&amp;#x201d; in the consolidated income statement when there was persuasive evidence that a sales arrangement exists; title, risks and rewards for the products are transferred to the customer; the price was determinable; and collectability was reasonably assured. If contracts contain customer acceptance provisions, revenue would be recognized upon the satisfaction of acceptance criteria. If products are stockpiled at the request of the customer, revenue was only recognized once the products have been inspected and accepted by the customer, and there was no right of return or replenishment on product expiry. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. The total consideration was allocated to the separate elements based on their relative fair values. Revenue was recognized once the recognition criteria have been met for each element of the contract. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which Novartis transfers substantially all the risks and rewards incidental to ownership to the customer are treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair values of the equipment, which approximate the present values of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements are approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements in excess of 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &amp;#x201c;Other income.&amp;#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers were recorded as a deduction from revenue at the time the related revenues were recorded or when the incentives were offered. They were calculated on the basis of historical experience and the specific terms in the individual agreements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for refunds granted to healthcare providers under innovative pay-for-performance agreements were recorded as a revenue deduction at the time the related sales were recorded. They were calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data were not sufficient for a reliable estimation of the outcome, revenue recognition was deferred until such history was available. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Cash discounts were offered to customers to encourage prompt payment and were recorded as revenue deductions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Following a decrease in the price of a product, we generally grant customers a &amp;#x201c;shelf stock adjustment&amp;#x201d; for their existing inventory for the involved product. Provisions for shelf stock adjustments, which are primarily relevant within the Sandoz Division, were determined at the time of the price decline or at the point of sale, if the impact of a price decline on the products sold could be reasonably estimated based on the customer&amp;#x2019;s inventory levels of the relevant product. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;When there was historical experience of Novartis agreeing to customer returns, and Novartis could reasonably estimate expected future returns, a provision was recorded for estimated sales returns. In doing so, the estimated rate of return was applied, determined based on historical experience of customer returns and considering any other relevant factors. This was applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that could be placed back in inventory for resale. Where shipments were made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue was only recorded when there was evidence of consumption or when the right of return had expired. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Provisions for revenue deductions were adjusted to actual amounts as rebates, discounts and returns were processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;&amp;#x201c;Other revenue&amp;#x201d; includes royalty and profit-sharing income, and revenue from activities such as manufacturing services or other services rendered, to the extent such revenue was not recorded under net sales. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The section &amp;#x201c;&amp;mdash;Impact of adopting significant new IFRS standards in 2018&amp;#x201d; provides additional disclosure on the impact of adoption. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
  <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Research and development&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Internal research and development (R&amp;amp;D) costs are fully charged to &amp;#x201c;Research and development&amp;#x201d; in the consolidated income statement in the period in which they are incurred. The Group considers that regulatory and other uncertainties inherent in the development of new products preclude the capitalization of internal development expenses as an intangible asset until marketing approval from a regulatory authority is obtained in a major market such as the United States, the European Union, Switzerland or Japan. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Payments made to third parties, such as contract research and development organizations in compensation for subcontracted R&amp;amp;D, that are deemed not to transfer intellectual property to Novartis are expensed as internal R&amp;amp;D expenses in the period in which they are incurred. Such payments are only capitalized if they meet the criteria for recognition of an internally generated intangible asset, usually when marketing approval has been achieved from a regulatory authority in a major market. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Payments made to third parties to in-license or acquire intellectual property rights, compounds and products, including initial upfront and subsequent milestone payments, are capitalized, as are payments for other assets, such as technologies to be used in R&amp;amp;D activities. If additional payments are made to the originator company to continue to perform R&amp;amp;D activities, an evaluation is made as to the nature of the payments. Such additional payments will be expensed if they are deemed to be compensation for subcontracted R&amp;amp;D services not resulting in an additional transfer of intellectual property rights to Novartis. Such additional payments will be capitalized if they are deemed to be compensation for the transfer to Novartis of additional intellectual property developed at the risk of the originator company. Subsequent internal R&amp;amp;D costs in relation to IPR&amp;amp;D and other assets are expensed, since the technical feasibility of the internal R&amp;amp;D activity can only be demonstrated by the receipt of marketing approval for a related product from a regulatory authority in a major market. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Costs for post-approval studies performed to support the continued registration of a marketed product are recognized as marketing expenses. Costs for activities that are required by regulatory authorities as a condition for obtaining marketing approval are capitalized and recognized as currently marketed products. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Inventory produced ahead of regulatory approval is fully provisioned, and the charge is included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statement, as its ultimate use cannot be assured. If this inventory can be subsequently sold, the provision is released to &amp;#x201c;Other income&amp;#x201d; in the consolidated income statement, either on approval by the appropriate regulatory authority or, exceptionally in Europe, on recommendation by the Committee for Medicinal Products for Human Use (CHMP), if approval is virtually certain. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Share-based compensation&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Vested Novartis shares and American Depositary Receipts (ADRs) that are granted as compensation are valued at their market value on the grant date and are immediately expensed in the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair values of unvested restricted shares (RSs), restricted share units (RSUs) and performance share units (PSUs) in Novartis shares and ADRs granted to associates as compensation are recognized as an expense over the related vesting period. The expense recorded in the consolidated income statement is included in the personnel expenses of the various functions in which the associates are employed. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Unvested restricted shares, restricted ADRs and RSUs are only conditional on the provision of services by the plan participant during the vesting period. They are valued at fair value on the grant date. As RSUs do not entitle the holder to dividends, the fair value is based on the Novartis share price at the grant date adjusted for the net present value of the dividends expected to be paid during the holding period. The fair value of these grants, after making adjustments for assumptions related to forfeiture during the vesting period, is expensed on a straight-line basis over the respective vesting period. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;PSUs are subject to the achievement of certain performance criteria during the vesting period and require plan participants to provide services during this period. The following paragraphs provide an overview of the accounting policies for the share-based compensation plans that grant PSUs. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For PSUs granted under plans that are subject to performance criteria based on Novartis internal performance metrics and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on assumptions concerning the expected performance against the internal performance metrics throughout the vesting period. The assumptions are based on the Group&amp;#x2019;s targets for those performance metrics, and the expected forfeitures due to plan participants not meeting their service conditions. The assumptions are periodically adjusted over the vesting period. Any change in estimates for past services is recorded immediately as an expense or income in the consolidated income statement, and amounts for the remaining vesting period are expensed on a straight-line basis. As a result, at the end of the vesting period, the charge during the entire vesting period represents the amount that will finally vest. The number of equity instruments that finally vest is determined at the vesting date. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For PSUs granted under plans that are subject to performance criteria based on variables that can be observed in the market, which for Novartis plans is the Novartis total shareholder return (TSR) relative to a specific peer group of companies over the vesting period, and that are conditional on the provision of services by the plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on the total fair value of the grant over the vesting period. IFRS requires that these variables that can be observed in the market are taken into account in determining the fair value of the PSUs at the grant date. Novartis determined the fair value of these PSUs at the date of grant using a Monte Carlo simulation model. Adjustments to the number of equity instruments granted are only made if a plan participant does not fulfill the service conditions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For PSUs granted under plans that are subject to both performance criteria based on Novartis internal performance metrics and Novartis TSR relative to a specific peer group of companies over the vesting period and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on a bifurcation into the components based on the performance criteria related to Novartis internal performance metrics and TSR, as described in the paragraphs above. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Measuring the fair values of PSUs granted that include TSR performance criteria requires use of estimates. The Monte Carlo simulation used to determine the fair value of the PSUs TSR performance criteria requires the probability of factors related to uncertain future events; the term of the award; the grant price of underlying shares or ADRs; expected volatilities; the expected correlation matrix of the underlying equity instruments with those of the peer group of companies; and the risk-free interest rate as input parameters. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;If a plan participant leaves Novartis for reasons other than retirement, disability or death, then unvested restricted shares, restricted ADRs, RSUs and PSUs are forfeited, unless determined otherwise by the provision of the plan rules or by the Compensation Committee of the Novartis Board of Directors, for example, in connection with a reorganization or divestment. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Government grants&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Grants from governments or similar organizations are recognized at their fair value when there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Government grants related to income are deferred and recognized in the consolidated income statement over the period necessary to match them with the related costs that they are intended to compensate. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The accounting policy for property, plant and equipment describes the treatment of any related grants. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants>
  <ifrs-full:DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Restructuring charges&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Restructuring provisions are recognized for the direct expenditures arising from the restructuring, where the plans are sufficiently detailed and where appropriate communication to those affected has been made. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Charges to increase restructuring provisions are included in &amp;#x201c;Other expense&amp;#x201d; in the consolidated income statements. Corresponding releases are recorded in &amp;#x201c;Other income&amp;#x201d; in the consolidated income statement. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory>
  <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Taxes&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Taxes on income are provided in the same periods as the revenues and expenses to which they relate and include interest and penalties incurred during the period. Deferred taxes are determined using the comprehensive liability method and are calculated on the temporary differences that arise between the tax base of an asset or liability and its carrying value in the balance sheet prepared for consolidation purposes, except for those temporary differences related to investments in subsidiaries and associated companies, where the timing of their reversal can be controlled and it is probable that the difference will not reverse in the foreseeable future. Since the retained earnings are reinvested, withholding or other taxes on eventual distribution of a subsidiary&amp;#x2019;s retained earnings are only taken into account when a dividend has been planned. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The estimated amounts for current and deferred tax assets or liabilities, including any amounts related to any uncertain tax positions, are based on currently known facts and circumstances. Tax returns are based on an interpretation of tax laws and regulations, and reflect estimates based on these judgments and interpretations. The tax returns are subject to examination by the competent taxing authorities, which may result in an assessment being made requiring payments of additional tax, interest or penalties. Inherent uncertainties exist in the estimates of the tax positions. &lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
  <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="AR_D-CurrentYear">&lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impact of adopting significant new IFRS standard in 2019&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following new IFRS standard has been adopted by Novartis from January 1, 2019: &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 16 Leases&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;IFRS 16 Leases substantially changed the financial statements, as the majority of leases for which the Group is the lessee became on-balance sheet liabilities with corresponding right-of-use assets also recognized on the balance sheet. The lease liability reflects the net present value of the remaining lease payments, and the right-of-use asset corresponds to the lease liability, adjusted for payments made before the commencement date, lease incentives and other items related to the lease agreement. The standard replaces IAS 17 Leases and related interpretations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Upon adoption of the new standard, a portion of the annual operating lease costs, which was previously fully recognized as functional expenses, as a component of operating income, is recorded as interest expense. In addition, the portion of the lease payments that represents the reduction of the lease liability is recognized in the cash flow statement as an outflow from financing activities, which was previously fully recognized as an outflow from operating activities. Given the leases involved, these effects are not significant to the consolidated income statement and consolidated statement of cash flow. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group implemented the new standard on January 1, 2019, and applied the modified retrospective method, with right-of-use assets measured at an amount equal to the lease liability, adjusted by the amount of the prepaid or accrued lease payments relating to those leases recognized in the balance sheet immediately before the date of initial application and did not restate prior years. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Results of our impact assessment: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The undiscounted operating lease commitments as of December 31, 2018, amounted to USD 3.6 billion. This includes approximately USD 0.1 billion of leases with a commencement date in 2019, as well as short-term leases and low-value leases that are recognized from January 1, 2019, upon adoption of IFRS 16, on a straight-line basis as expense in profit and loss. This also includes USD 0.2 billion lease commitments related to the Alcon Division, which is attributable to discontinued operation in 2019. For the remaining undiscounted lease commitments attributable to continuing operations of USD 3.3 billion, the Group recognized on January 1, 2019, lease liabilities of USD 1.74 billion and right-of-use assets of USD 1.55 billion (after the reclassification of USD 0.1 billion from property, plant &amp;amp; equipment, and net adjustments for the USD 0.3 billion recognition of sublease receivables, prepayments, and accrued lease payments recognized as at December 31, 2018). For the lease commitments attributable to discontinued operations, the Group recognized on January 1, 2019, lease liabilities and right-of-use assets of USD 0.2 billion. This does not include the discontinued operations right-of-use assets and lease liability on finance lease agreements of USD 75 million and USD 89 million, respectively. There was an insignificant increase to retained earnings upon adoption of IFRS 16 of USD 3 million that arose from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As a lessor, the Group had no significant impact upon adoption. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For further information on the impact of adoption and additional disclosures of IFRS 16 Leases, see Note 10. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Impact of adopting significant new IFRS standards in 2018&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following IFRS standards have been adopted by Novartis from January 1, 2018: &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 9 Financial Instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis implemented IFRS 9 Financial Instruments as of January 1, 2018, which substantially changed the classi&amp;#xfb01;cation and measurement of &amp;#xfb01;nancial instruments. The standard requires impairments to be based on a forward-looking model, changed the approach to hedging &amp;#xfb01;nancial exposures and related documentation, changed the recognition of certain fair value changes, and amends disclosure requirements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The impairment of financial assets, including trade and lease receivables, is now assessed using an expected credit loss model; previously, the incurred loss model was used. Given the nature of Novartis financial assets, the Group had no significant impact to its provisions for doubtful accounts or impairments from this change. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The new hedge accounting model introduced by the standard requires hedge accounting relationships to be based upon the Group&amp;#x2019;s own risk management strategy and objectives, and to be discontinued only when the relationships no longer qualify for hedge accounting. There was no impact upon adoption of the new standard, as the Group&amp;#x2019;s existing hedge relationships continue to be designated as such under the new hedge accounting requirements. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The most significant impact to the Group upon adoption of IFRS 9 relates to the treatment of the unrealized gains and losses from changes in fair value on certain of the Group&amp;#x2019;s financial instruments, which were previously classified as available-for-sale marketable securities and financial investments. The unrealized gains and losses (to the extent of previous recognized unrealized gains), which the Group recognized previously in the consolidated statement of other comprehensive income, are from January 1, 2018, recognized in the consolidated income statement. This approach is applied to equity securities where the fair value through other comprehensive income irrevocable option is not applied. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group applied the modified retrospective method upon adoption of IFRS 9 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 9 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 177 million. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 15 Revenue from Contracts with Customers&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis implemented the new standard IFRS 15 Revenue from Contracts with Customers as of January 1, 2018. The standard amended revenue recognition requirements and established principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash &amp;#xfb02;ows arising from contracts with customers. The standard replaced IAS 18 Revenue and IAS 11 Construction contracts and related interpretations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The impacts of adoption of the new standard are summarized below: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Group&amp;#x2019;s &amp;#x201c;net sales&amp;#x201d; are derived from the sale of drug substances, vision care products, surgical equipment, and other products and services, where control transfers to our customers and our performance obligations are satisfied at the time of shipment to or receipt of the products by the customer, or when the services are performed. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Group&amp;#x2019;s &amp;#x201c;other revenue&amp;#x201d; consists of royalty income from the out-licensing of intellectual property, which is recognized as earned, and from manufacturing and other services, where revenue is recognized when control transfers to the third party and our performance obligations are satisfied. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized from these manufacturing and other services arrangements, nor did it change accounting for these royalty arrangements, as the standard&amp;#x2019;s royalty exception is applied for IP licenses. &amp;#x201c;Other revenue&amp;#x201d; also includes revenue from profit-sharing arrangements with our collaboration partners. Furthermore, the Group receives milestone payments related to the out-licensing of IP. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group applied the modified retrospective method upon adoption of IFRS 15 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 15 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 60 million. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;New IFRS standard effective as of January 1, 2020 &lt;/font&gt; &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;IFRS 3 Business Combination amendments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The IASB issued an amendment to IFRS 3 Business Combinations that revised the definition of a business, which assist entities with the evaluation of when an asset or group of assets acquired or disposed of should be considered a business. This amended standard is effective for the Group as of January 1, 2020 and is applicable to transactions entered into on or after January 1, 2020. The amended standard allows an entity to apply an optional concentration test, on a transaction-by-transaction basis, to evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this optional concentration test is met, the entity may choose to consider the transaction an acquisition of an asset or set of assets. The Group does not expect the adoption of this amended standard on January 1, 2020 to have a significant impact on our consolidated financial statements in future periods. However, this will depend on the facts and circumstances of future transactions and if the Group decides to apply the optional concentration test in the assessment of whether an acquired set of activities and assets is or is not a business. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;There are no other IFRS standards or interpretations not yet effective that would be expected to have a material impact on the Group. &lt;/div&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
  <nvs:DisclosureOfSignificantTransactionsTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;2. Significant transactions&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Significant transactions in 2019&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On June 29, 2018, Novartis announced its intention to seek shareholder approval for the spin-off of the Alcon business into a separately traded standalone company, following the complete structural separation of the Alcon business into a standalone company (the Alcon business or Alcon Inc.). &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Novartis AG shareholders approved the spin-off of the Alcon business at the 2019 Annual General Meeting held on February 28, 2019, subject to completion of certain conditions precedent to the distribution. Upon shareholder approval, the Alcon business was reported as discontinued operations, and the fair value of the Alcon business exceeded the carrying value of its net assets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The conditions precedent to the spin-off were met and on April 8, 2019 the spin-off of the Alcon business was effected by way of a distribution of a dividend in kind of Alcon Inc. shares to Novartis AG shareholders and ADR (American Depositary Receipt) holders (the Distribution), which amounted to USD 23.4 billion and is recognized as a reduction to retained earnings. Through the Distribution, each Novartis AG shareholder received one Alcon Inc. share for every five Novartis AG shares/ADRs they held on April 8, 2019, close of business. As of April 9, 2019, the shares of Alcon Inc. are listed on the SIX Swiss Exchange (SIX) and on the New York Stock Exchange (NYSE) under the symbol &amp;#x201c;ALC.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The dividend in kind distribution liability to effect the spin-off of the Alcon business (the distribution liability) amounted to USD 26.4 billion at March 31, 2019, unchanged from its initial recognition on February 28, 2019, and was in excess of the carrying value of the Alcon business net assets as of February 28, 2019, and as of March 31, 2019. The net assets of the Alcon business amounted to USD 23.1 billion as at March 31, 2019. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;On March 6, 2019, Alcon entered into financing arrangements with a syndicate of banks under which it borrowed on April 2, 2019, a total amount of USD 3.2 billion. These borrowings consisted of approximately USD 2.8 billion and the equivalent of USD 0.4 billion in EUR in bridge and other term loans under such Alcon facilities agreement. In addition, approximately USD 0.3 billion of borrowings under a number of local bilateral facilities in different countries, with the largest share of borrowings in Japan, were raised. This resulted in a total gross debt of USD 3.5 billion. These outstanding borrowings of the Alcon legal entities were recorded in the balance sheet and financing cash flow from discontinued operations. Prior to the spin-off, through a series of intercompany transactions, Alcon legal entities paid approximately USD 3.1 billion in cash to Novartis and its affiliates. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;At the April 8, 2019 Distribution, the fair value of the distribution liability of the Alcon business amounted to USD 23.4 billion, a decrease of USD 3.0 billion from March 31, 2019. As mentioned above, prior to the spin-off, through a series of intercompany transactions, Alcon legal entities incurred additional net financial debt and paid approximately USD 3.1 billion in cash to Novartis and its affiliates. This additional net debt and transactions resulted in a decrease in Alcon&amp;#x2019;s net assets to USD 20.0 billion at the date of the Distribution of the dividend in kind to Novartis AG shareholders on April 8, 2019. The distribution liability at April 8, 2019, remained in excess of the then-carrying value of the Alcon business net assets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Certain consolidated foundations own Novartis AG dividend-bearing shares restricting their availability for use by the Group. These Novartis AG shares are accounted for as treasury shares. Through the Distribution, these foundations received Alcon Inc. shares representing an approximate 4.7% equity interest in Alcon Inc. Upon the loss of control of Alcon Inc. through the Distribution, the financial investment in Alcon Inc. was recognized at its fair value based on the opening traded share price of Alcon Inc. on April 9, 2019 (a Level 1 hierarchy valuation). At initial recognition, its fair value of USD 1.3 billion was reported on the Group&amp;#x2019;s consolidated balance sheet as a financial asset. Management has designated this investment at fair value through other comprehensive income. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The total non-taxable, non-cash gain recognized at the distribution date of the spin-off of the Alcon business amounted to USD 4.7 billion consisting of: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; April 8, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net assets derecognized &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derecognition of distribution liability&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23&amp;nbsp;434&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Difference between net assets and distribution liability&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Recognition of Alcon Inc. shares obtained &lt;br&gt;&lt;/br&gt;through consolidated foundations &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;273 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation gains recycled into &lt;br&gt;&lt;/br&gt;the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 123 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Transaction costs recognized in the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gain on distribution of Alcon Inc. to Novartis AG shareholders&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; See Note 30 for additional information. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;For additional disclosures on discontinued operations, refer to Note 30.&lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of IFM Tre, Inc. &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On May 7, 2019, Novartis acquired IFM Tre, Inc., a privately held, US-based biopharmaceutical company focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome. The acquisition gives Novartis full rights to IFM Tre, Inc.&amp;#x2019;s portfolio of NLRP3 antagonists. The NLRP3 antagonists portfolio consists of one clinical program and two preclinical programs: IFM-2427, a first-in-class, clinical-stage systemic antagonist for an array of chronic inflammatory disorders, including atherosclerosis and nonalcoholic steatohepatitis (NASH); a preclinical-stage gutdirected molecule for the treatment of inflammatory bowel disease; and a preclinical-stage central nervous system (CNS)-penetrant molecule. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The previously held interest of 9% was adjusted to its fair value of USD 33 million through the consolidated income statement at acquisition date. This remeasurement resulted in a gain of USD 14 million. The fair value of the total purchase consideration for acquiring the 91% stake Novartis did not already own amounted to USD 361 million. The amount consisted of an initial cash payment of USD 285 million, and the fair value of the contingent consideration of USD 76 million due to the IFM Tre, Inc. shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 355 million, mainly intangibles, and goodwill of USD 39 million. Results of operations since the date of acquisition were not material. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of &lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;"&gt;Xiidra&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On May 8, 2019, Novartis entered into an agreement with Takeda Pharmaceutical Company Limited (Takeda) to acquire the assets associated with &lt;i&gt;Xiidra&lt;/i&gt; (lifitegrast ophthalmic solution) 5% worldwide. &lt;i&gt;Xiidra&lt;/i&gt; is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. The transaction bolsters the Novartis front-of-the-eye portfolio and ophthalmic leadership. The transaction closed on July 1, 2019. The purchase price consists of a USD 3.4 billion upfront payment, customary purchase price adjustments of USD 0.1 billion, and the potential milestone payments of up to USD 1.9 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair value of the total purchase consideration is USD 3.7 billion. The amount consists of an initial cash payment of USD 3.5 billion, and the net present value of the contingent consideration of USD 0.2 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The purchase price allocation resulted in net identifiable assets of approximately USD 3.6 billion, consisting mainly of intangible assets of USD 3.6 billion, and goodwill amounted to approximately USD 0.1 billion. In 2019, from the date of acquisition, the business generated net sales of USD 0.2 billion. Management estimates that net sales for the entire year of 2019 would have amounted to USD 0.3 billion, had the business been acquired at the beginning of the 2019 reporting period. Results of operations since the date of acquisition were not material. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Significant transactions entered into in 2019 and closed in January 2020&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of The Medicines Company&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On November 23, 2019, Novartis entered into an agreement and plan of merger (the Merger Agreement) with The Medicines Company, a US-based pharmaceutical company headquartered in Parsippany, New Jersey USA. Pursuant to the Merger Agreement, on December 5, 2019, Novartis, through a subsidiary, commenced a tender offer to acquire all outstanding shares of The Medicines Company for USD 85 per share, or a total consideration of approximately USD 9.7 billion in cash on a fully diluted basis. The tender offer expired on January 3, 2020, and on January 6, 2020, the acquiring subsidiary merged with and into The Medicines Company, resulting in The Medicines Company becoming an indirect wholly owned subsidiary of Novartis. Novartis will finance the transaction through available cash and short- and long-term borrowings. As the transaction closed on January 6, 2020 the purchase price allocation is incomplete. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Medicines Company is focused on the development of inclisiran, a potentially first-in-class, twice-yearly therapy that allows administration during patients&amp;#x2019; routine visits to their healthcare professionals and will potentially contribute to improved patient adherence and sustained lower LDL-C levels. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Significant pending transactions&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Sandoz &amp;ndash; divestment of US dermatology business and generic US oral solids portfolio&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On September 6, 2018, Novartis announced that it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc. (Aurobindo) for USD 0.8 billion in cash and potential earnouts. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Sandoz US portfolios to be sold to Aurobindo include approximately 300 products as well as additional development projects. The sale includes the Sandoz US generic and branded dermatology businesses as well as its dermatology development center. As part of the transaction, Aurobindo will acquire the manufacturing facilities in Wilson, North Carolina, and in Hicksville and Melville, New York. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The transaction is expected to be completed in the first quarter of 2020, pending regulatory approval. As the fair value of the consideration (USD 0.8 billion) less costs to sell is below the carrying value of the divested business (USD 1.0 billion, which includes an allocation of Sandoz goodwill of USD 0.2 billion), an impairment of the net assets to be divested in the amount of USD 0.2 billion was recognized as a reduction to goodwill in 2018. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the Group&amp;#x2019;s consolidated balance sheet at December 31, 2019 and 2018, the business assets and liabilities of the Sandoz US dermatology business and generic US oral solids portfolio are separately shown as assets and liabilities of disposal group held for sale. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The disposal group, assets and liabilities classified as held for sale consist of the following: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Assets of disposal group classified as held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 478&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 181&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 807&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Liabilities of disposal group classified as held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions and other non-current &lt;br&gt;&lt;/br&gt;liabilities &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions and other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;There are no cumulative income or expenses included in other comprehensive income relating to the disposal group. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Sandoz &amp;ndash; acquisition of the Japanese business of Aspen Global Incorporated&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On November 11, 2019, Sandoz entered into an agreement for the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited. Under the agreement, Sandoz will acquire the shares in Aspen Japan K.K. and associated assets held by AGI. Pursuant to the agreed terms of the transaction, on closing the Group will pay an initial cash consideration of EUR 300 million (approximately USD 336 million). In addition, deferred consideration is due to AGI, upon fulfillment of certain conditions after closing, currently estimated at approximately EUR 100 million (approximately USD 112 million). &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;We have received all relevant approvals and this transaction is expected to be completed in the first quarter of 2020. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Aspen&amp;#x2019;s portfolio in Japan consists of off-patent medicines with a focus on anesthetics and specialty brands. The acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Significant transactions in 2018&lt;/font&gt; &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of Advanced Accelerator Applications S.A.&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On October 30, 2017, Novartis entered into a binding memorandum of understanding with Advanced Accelerator Applications S.A. (AAA), a company headquartered in Saint-Genis-Pouilly, France, under which Novartis agreed to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Novartis commenced the tender offer on December 7, 2017, to purchase all of the outstanding ordinary shares for a price of USD&amp;nbsp;41 per share and USD&amp;nbsp;82 per American Depositary Share (ADS), each representing two ordinary shares of AAA, which expired on January 19, 2018. The offer valued AAA&amp;#x2019;s equity at USD&amp;nbsp;3.9 billion, on a fully diluted basis. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As of January 19, 2018, the expiration date of the tender offer, approximately 97% of the then-outstanding fully diluted ordinary shares, including ordinary shares represented by ADSs (hereinafter collectively referred to as &amp;#x201c;the outstanding shares&amp;#x201d;), were validly tendered. On January 22, 2018, Novartis accepted and paid USD 3.9 billion for the outstanding shares tendered in the offer. On January 22, 2018, Novartis commenced a subsequent offering period that expired on January 31, 2018. As of the expiration of the subsequent offering period, an additional 1.8% of the outstanding shares were validly tendered. Novartis accepted and paid approximately USD 60 million, resulting in an increase in Novartis ownership in AAA to 98.7%. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair value of the total purchase consideration was USD 3.9 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 1.9 billion, consisting of USD 2.5 billion intangible assets, USD 0.6 billion net deferred tax liabilities, and goodwill of approximately USD 2.0 billion. In 2018, from the date of the acquisition, the business generated net sales of USD 0.4 billion. Management estimated that net sales for the entire year of 2018 would have amounted to USD 0.4 billion had AAA been acquired at the beginning of 2018. The 2018 results from operations since the acquisition were not material. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As of December 31, 2019, Novartis held 99.2% of the then-outstanding fully diluted ordinary shares, including ordinary shares represented by ADSs. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;AAA is a radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicines &amp;ndash; including &lt;i&gt;Lutathera&lt;/i&gt; (USAN: lutetium Lu 177 dotatate/INN: lutetium ( &lt;sup&gt;177&lt;/sup&gt;Lu) oxodotreotide), a first-in-class radioligand therapy product for neuroendocrine tumors &amp;ndash; and a portfolio of diagnostic products. Radiopharmaceuticals, such as &lt;i&gt;Lutathera&lt;/i&gt;, are unique medicinal formulations containing radioisotopes, which are used clinically for both diagnosis and therapy. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of AveXis, Inc.&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On April 6, 2018, Novartis entered into an agreement and plan of merger with AveXis, Inc., a US-based clinical stage gene therapy company, under which Novartis commenced on April 17, 2018, a tender offer to purchase all outstanding common stock of AveXis, Inc. for USD 218 per share in cash. On May 15, 2018, Novartis completed the acquisition of the common stock of AveXis, Inc. and paid a total of USD 8.7 billion. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair value of the total purchase consideration was USD 8.7 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 7.2 billion, consisting of USD 8.5 billion intangible assets, USD 1.6 billion net deferred tax liabilities and other net assets of USD 0.3 billion, and goodwill of approximately USD 1.5 billion. The 2018 results of operations since the date of acquisition were not material. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;AveXis, Inc. is focused on developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. AveXis, Inc.&amp;#x2019;s initial product candidate, AVXS-101, is a proprietary gene therapy currently in development for the treatment of spinal muscular atrophy (SMA) type 1 &amp;ndash; the leading genetic cause of infant mortality &amp;ndash; and SMA types 2 and 3. In addition, AveXis, Inc. has a pipeline of other novel treatments for rare neurological diseases, including Rett syndrome (RTT) and a genetic form of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of Endocyte, Inc.&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On October 18, 2018, Novartis entered into an agreement and plan of merger with Endocyte, Inc. (Endocyte), a US-based biopharmaceutical company focused on developing targeted therapeutics for cancer treatment. The transaction was completed on December 21, 2018. Under the terms of the agreement, Novartis acquired all outstanding shares of Endocyte common stock for USD 24 per share. The total consideration amounted to USD 2.1 billion. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair value of the total purchase consideration was USD 2.1 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 1.5 billion, consisting of USD 1.5 billion intangible assets, USD 0.3 billion net deferred tax liabilities and other net assets of USD 0.3 billion, and goodwill of approximately USD 0.6 billion. The purchase price allocation was preliminary at December 31, 2018, as the transaction closed on December 21, 2018, which was close to the Group&amp;#x2019;s year-end and therefore did not provide sufficient time to complete the valuation of the intangible assets, deferred taxes, assumed liabilities and goodwill. During 2019, there were no significant revisions to the purchase price allocation. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Endocyte uses drug conjugation technology to develop targeted therapies with companion imaging agents, including &lt;sup&gt;177&lt;/sup&gt;Lu-PSMA-617, a potential first-in-class investigational radioligand therapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC). &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Corporate &amp;ndash; divestment of &lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;36.5%&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; stake in &lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;GlaxoSmithKline Consumer Healthcare Holdings Ltd. &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On March 27, 2018, Novartis entered into an agreement with GlaxoSmithKline plc (GSK) to divest its 36.5% stake in GlaxoSmithKline Consumer Healthcare Holdings Ltd. to GSK for USD 13.0 billion in cash. As a result, Novartis discontinued the use of equity method accounting starting from April 1, 2018. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;On June 1, 2018, the transaction closed and Novartis realized a pre-tax gain of USD 5.8 billion, recorded in income from associated companies. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Significant transactions in 2017&lt;/font&gt; &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of Ziarco Group Limited&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On January 20, 2017, Novartis acquired Ziarco Group Limited (Ziarco), a privately-held company in the United Kingdom that focuses on the development of novel treatments in dermatology. This acquisition added a once-daily oral H4 receptor antagonist in development for atopic dermatitis, commonly known as eczema, to complement the Novartis dermatology portfolio and pipeline. The fair value of the total purchase consideration was USD 420 million. The amount consisted of an initial cash payment of USD&amp;nbsp;325 million and the net present value of the contingent consideration of USD 95 million, due to Ziarco shareholders, which they are eligible to receive upon the achievement of specified development milestones. The purchase price allocation resulted in net identifiable assets of USD&amp;nbsp;395 million and goodwill of USD 25 million. The 2017 results of operations since the date of acquisition were not material. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines &amp;ndash; acquisition of Encore Vision, Inc.&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On January 20, 2017, Novartis acquired Encore Vision, Inc. (Encore), a privately-held company in Fort Worth, Texas, in the United States, that focuses on the development of a novel treatment in presbyopia. The fair value of the total purchase consideration was USD 456 million. The amount consisted of an initial cash payment of USD 366 million and the net present value of the contingent consideration of USD 90 million, due to Encore shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 389 million and goodwill of USD 67 million. The 2017 results of operations since the date of acquisition were not material. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;For significant transactions in 2019 for discontinued operations, see Note 30. There were no significant transactions in 2018 and 2017 for discontinued operations. &lt;/div&gt;</nvs:DisclosureOfSignificantTransactionsTextBlock>
  <nvs:DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; April 8, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net assets derecognized &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derecognition of distribution liability&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23&amp;nbsp;434&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Difference between net assets and distribution liability&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Recognition of Alcon Inc. shares obtained &lt;br&gt;&lt;/br&gt;through consolidated foundations &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;273 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation gains recycled into &lt;br&gt;&lt;/br&gt;the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 123 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Transaction costs recognized in the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gain on distribution of Alcon Inc. to Novartis AG shareholders&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; See Note 30 for additional information. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock>
  <nvs:DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Assets of disposal group classified as held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 478&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 181&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 807&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Liabilities of disposal group classified as held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions and other non-current &lt;br&gt;&lt;/br&gt;liabilities &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions and other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock>
  <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;3. Segmentation of key figures 2019, 2018 and 2017&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The businesses of Novartis are divided operationally on a worldwide basis into two identified reporting segments: Innovative Medicines and Sandoz. In addition, we separately report Corporate activities. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Reporting segments are presented in a manner consistent with the internal reporting to the chief operating decision-maker, which is the Executive Committee of Novartis. The reporting segments are managed separately because they each research, develop, manufacture, distribute and sell distinct products that require differing marketing strategies. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Executive Committee of Novartis is responsible for allocating resources and assessing the performance of the reporting segments. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The reporting segments are as follows:&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines. The Innovative Medicines Division is organized into two global business units: Novartis Oncology and Novartis Pharmaceuticals. Novartis Oncology consists of the global business franchise Oncology, and Novartis Pharmaceuticals consists of the global business franchises Ophthalmology; Neuroscience; Immunology, Hepatology and Dermatology; Respiratory; Cardiovascular, Renal and Metabolism; and Established Medicines. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Sandoz develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. Sandoz is organized globally into three franchises: Retail Generics, Anti-Infectives and Biopharmaceuticals. In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form of anti-infectives sold to third parties. In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by Retail Generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Income and expenses relating to Corporate include the costs of the Group headquarters and those of corporate coordination functions in major countries. In addition, Corporate includes other items of income and expense that are not attributable to specific segments, such as certain revenues from intellectual property rights, certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations and sponsorships. Usually, no allocation of Corporate items is made to the segments. As a result, Corporate assets and liabilities principally consist of net liquidity (cash and cash equivalents, marketable securities less financial debts), investments in associated companies, and current and deferred taxes and non-segment-specific environmental remediation and post-employment benefit liabilities. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Our divisions are supported by the Novartis Institutes for BioMedical Research, Global Drug Development, Novartis Technical Operations and Novartis Business Services organizations. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Novartis Institutes for BioMedical Research (NIBR) conducts research activities for the Innovative Medicines Division and also collaborates with Sandoz. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Global Drug Development organization oversees all drug development activities for our Innovative Medicines Division and collaborates with our Sandoz Division on development of its biosimilars portfolio. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Novartis Technical Operations organization manages our manufacturing operations across our Innovative Medicines and Sandoz Divisions. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Novartis Business Services (NBS) is our shared services organization that delivers business support services across the Group, such as information technology, real estate and facility services, procurement, product lifecycle services, human resources, and financial reporting and accounting operations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Following the February 28, 2019, shareholders&amp;#x2019; approval of the spin-off of the Alcon business (refer to Notes 1, 2 and 30 for further details), the Group reported its consolidated financial statements for the current and prior years as &amp;#x201c;continuing operations&amp;#x201d; and &amp;#x201c;discontinued operations.&amp;#x201d; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Continuing operations comprise the activities of the Innovative Medicines and Sandoz Divisions, and the continuing Corporate activities. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Discontinued operations include the operational results from the Alcon eye care devices business and certain corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders, and certain other expenses related to the Distribution (refer to Notes 1, 2 and 30 for further details). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The accounting policies mentioned in Note 1 are used in the reporting of segment results. Inter-segmental sales are made at amounts that are considered to approximate arm&amp;#x2019;s length transactions. The Executive Committee of Novartis evaluates segmental performance and allocates resources among the segments based on a number of measures, including net sales, operating income and net operating assets. Segment net operating assets consist primarily of property, plant and equipment; right-of-use assets; intangible assets; goodwill; inventories; and trade and other operating receivables less operating liabilities. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; consolidated income statements&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales to third parties from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;731&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sales to continuing and discontinued segments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 783&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 741&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 177&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 38&amp;nbsp;497&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;872&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;498&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;092&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 63&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&amp;nbsp;050&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;870&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;334&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;530&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 959&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 890&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;425&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;510&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross profit from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 29&amp;nbsp;539&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 26&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;601&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 34&amp;nbsp;252&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 31&amp;nbsp;589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Selling, general and administration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;617&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;534&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;369&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;152&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;675&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;402&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;586&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 977&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;629&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;749&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;608&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;426&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;609&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;752&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;403&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Income from associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;432&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 659&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;850&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income and expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income before taxes from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;940&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;095&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net loss from discontinued operations before gain on &lt;br&gt;&lt;/br&gt;distribution of Alcon Inc. to Novartis AG shareholders &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;101 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;186 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gain on distribution of Alcon Inc. to Novartis AG shareholders&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income/(loss) from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;737&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;614&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Attributable to:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Shareholders of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 11&amp;nbsp;732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 12&amp;nbsp;611&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Included in net income from continuing operations are:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 245&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 292&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;952&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;075&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;247&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;509&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;315&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on property, plant and equipment, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;239&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;101&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on intangible assets, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;506&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;138&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges and fair value &lt;br&gt;&lt;/br&gt;changes on financial assets, net &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 18 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 20 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;113 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 38 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;229&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;492&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation of Novartis equity plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;761&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;645&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;239&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;067&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;918&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales to third parties from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;060&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sales to continuing and discontinued segments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 741&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 668&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 177&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;743&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;178&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;743&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;381&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;870&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;650&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;530&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 890&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 817&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;510&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross profit from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 26&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;415&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 31&amp;nbsp;589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 29&amp;nbsp;771&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Selling, general and administration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;452&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;12&amp;nbsp;465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;675&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;615&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;389&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 977&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;027&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;629&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;922&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;351&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;609&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;368&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;261&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;403&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;702&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Income from associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;432&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income and expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income before taxes from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;095&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;499&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net (loss)/income from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;614&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Attributable to:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Shareholders of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 12&amp;nbsp;611&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 7&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Included in net income from continuing operations are:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 292&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;075&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;916&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;117&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;303&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;447&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;624&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on property, plant and equipment, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;239&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;84&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;73&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;157&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on intangible assets, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;591&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;652&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges and fair value &lt;br&gt;&lt;/br&gt;changes on financial assets, net &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;42 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;113 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;185 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;227 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation of Novartis equity plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;645&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;593&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;918&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;853&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; consolidated balance sheets&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Alcon&lt;sup&gt;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71&amp;nbsp;225&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 67&amp;nbsp;055&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 16&amp;nbsp;468&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;971&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 30&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;209&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 118&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&amp;nbsp;563&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;15&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;056&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;804&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;377&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;43&amp;nbsp;683&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;48&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;62&amp;nbsp;819&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;66&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 55&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 78&amp;nbsp;692&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&amp;nbsp;184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net operating assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 55&amp;nbsp;893&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 53&amp;nbsp;999&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 12&amp;nbsp;664&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 24&amp;nbsp;007&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71&amp;nbsp;489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 94&amp;nbsp;876&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Included in assets and liabilities are:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;098&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;878&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 549&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 561&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;696&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to property, plant &lt;br&gt;&lt;/br&gt;and equipment &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;114 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 822 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 217 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 294 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 519 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 143 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 139 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;474 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;774 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;487&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 136&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2, 3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 454&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 537&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total goodwill and intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&amp;nbsp;336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 44&amp;nbsp;593&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;712&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&amp;nbsp;578&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 55&amp;nbsp;311&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 74&amp;nbsp;013&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to goodwill and &lt;br&gt;&lt;/br&gt;intangible assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 647 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;265 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 68 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 196 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 52 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 767 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;592 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total investment in associated &lt;br&gt;&lt;/br&gt;companies &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 128 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 81 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;509 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;264 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;644 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;352 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to investment in associated &lt;br&gt;&lt;/br&gt;companies &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 44 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 18 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 11 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 11 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 55 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 29 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents, marketable securities, &lt;br&gt;&lt;/br&gt;commodities, time deposits and derivative &lt;br&gt;&lt;/br&gt;financial instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 11&amp;nbsp;446 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 15&amp;nbsp;964 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 11&amp;nbsp;446 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 15&amp;nbsp;964 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts and derivative &lt;br&gt;&lt;/br&gt;financial instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 27&amp;nbsp;384 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 32&amp;nbsp;148 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 27&amp;nbsp;384 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 32&amp;nbsp;148 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current income tax and deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;513&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;513&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Excluding the impact of business combinations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Total right-of-use assets and additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows countries that accounted for more than 5% of at least one of the respective Group totals, as well as regional information for net sales for the years ended December 31, 2019, 2018 and 2017, and for selected non-current assets for the years ended December 31, 2019 and 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="11" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Net sales&lt;sup&gt;1&lt;/sup&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total of selected non-current assets&lt;sup&gt;2&lt;/sup&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Country&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 848&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 795&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 780&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&amp;nbsp;032&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 41&amp;nbsp;972&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&amp;nbsp;280&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;618&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&amp;nbsp;893&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&amp;nbsp;082&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;France&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;442&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;976&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Germany&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;972&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;484&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japan&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;575&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;617&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 309&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 144&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&amp;nbsp;286&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&amp;nbsp;033&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;763&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 77&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 98&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Region&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 17&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&amp;nbsp;259&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&amp;nbsp;103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 59&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 55&amp;nbsp;913&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 57&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Americas&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&amp;nbsp;713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&amp;nbsp;032&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&amp;nbsp;485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 29&amp;nbsp;389&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&amp;nbsp;082&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;799&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;460&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;093&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;209&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 77&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 98&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales from operations by location of third-party customer &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies, and in 2019 right-of-use assets recognized with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group&amp;#x2019;s largest, second-largest and third-largest customers account for approximately 23%, 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). All segments had sales to these customers in 2019, 2018 and 2017. No other customer accounted for 6% or more of net sales in any year. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively). &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; net sales by region&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;"&gt;1&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 &lt;br&gt;&lt;/br&gt; to 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 &lt;br&gt;&lt;/br&gt; to 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Innovative Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;818&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;296&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;127&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&amp;nbsp;789&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;864&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;857&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;458&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;097&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;702&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canada and Latin America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;649&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;635&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Established Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&amp;nbsp;573&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&amp;nbsp;258&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&amp;nbsp;174&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Emerging Growth Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;634&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;115&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;963&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;363&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;391&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canada and Latin America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 784&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 779&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;731&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;060&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Established Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;111&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;383&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Emerging Growth Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;626&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 17&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&amp;nbsp;259&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&amp;nbsp;280&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;618&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;799&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;460&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;093&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canada and Latin America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;433&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;414&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;350&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Established Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 35&amp;nbsp;684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&amp;nbsp;491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&amp;nbsp;557&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Emerging Growth Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;761&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;260&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;781&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales from operations by location of third-party customer. Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines Division net sales by business franchise&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 to &lt;br&gt;&lt;/br&gt; 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 to &lt;br&gt;&lt;/br&gt; 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;880&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;539&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;525&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Promacta/Revolade&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;416&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;174&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 867&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 873&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;561&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;943&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Jakavi&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 977&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 777&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;059&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 755&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 828&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 808&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Kisqali&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 480&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 235&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lutathera&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 441&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 164&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Kymriah&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Piqray&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 116&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;139&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Novartis Oncology business unit&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 14&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;428&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;274&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Travoprost Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 433&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Xiidra&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 192&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Beovu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;030&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;995&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;144&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;776&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;621&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Immunology, Hepatology and Dermatology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cosentyx&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;071&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Ilaris&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 671&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 402&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Immunology, Hepatology and Dermatology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;222&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;392&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;223&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zolgensma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 361&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Aimovig&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Mayzent&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;773&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;429&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 to &lt;br&gt;&lt;/br&gt; 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 to &lt;br&gt;&lt;/br&gt; 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Respiratory&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;173&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;039&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 920&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Ultibro Breezhaler&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 427&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 454&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 411&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Seebri Breezhaler&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Onbrez Breezhaler&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 101&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Respiratory&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;767&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;617&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cardiovascular, Renal and Metabolism&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Entresto&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Cardiovascular, Renal and Metabolism&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;050&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 957&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 960&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zortress/Certican&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 414&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Neoral/Sandimmun(e)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 463&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Voltaren/Cataflam&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 417&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;998&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;481&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Novartis Pharmaceuticals business unit&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;344&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 21&amp;nbsp;464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 20&amp;nbsp;004&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division net sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;nm = not meaningful&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Top 20 Innovative Medicines Division product net sales &amp;ndash; 2019&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Brands &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Business franchise &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Indication &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; US &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; world &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td width="21%" height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Cosentyx &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Psoriasis, ankylosing &lt;br&gt;&lt;/br&gt; spondylitis and psoriatic arthritis &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;220 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;331 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3&amp;nbsp;551 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Relapsing multiple sclerosis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;736&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;487&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;223&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Age-related macular degeneration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 804&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;076&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;880&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Entresto &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cardiovascular, Renal &lt;br&gt;&lt;/br&gt; and Metabolism &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Chronic heart failure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 925 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 801 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;726 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Carcinoid tumors and acromegaly&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 881&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 704&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Breast cancer/TSC&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 536&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;539&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Promacta/Revolade &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immune thrombocytopenia (ITP), &lt;br&gt;&lt;/br&gt; severe aplastic anemia (SAA) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 691 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 725 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;416 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRAF V600+ metastatic and &lt;br&gt;&lt;/br&gt; adjuvant melanoma; advanced &lt;br&gt;&lt;/br&gt; non-small cell lung cancer (NSCLC) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 481 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 857 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;338 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Diabetes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia and GIST&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 334&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 929&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Respiratory &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Severe Allergic Asthma (SAA) &lt;br&gt;&lt;/br&gt; and Chronic Spontaneous Urticaria &lt;br&gt;&lt;/br&gt; (CSU) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;173 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;173 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Jakavi &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Myelofibrosis (MF), &lt;br&gt;&lt;/br&gt; polycytomia vera (PV) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;114 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;114 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 978&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;012&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic iron overload&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 450&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 525&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Renal cell carcinoma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 423&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 755&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Ilaris &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Auto-inflammatory (CAPS, &lt;br&gt;&lt;/br&gt; TRAPS, HIDS/MKD, FMF, SJIA, &lt;br&gt;&lt;/br&gt; AOSD and gout) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 304 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 367 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 671 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zortress/Certican&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Transplantation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 316&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Kisqali&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HR+/HER2- metastatic breast cancer&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 480&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Top 20 products total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 10&amp;nbsp;679&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 17&amp;nbsp;967&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 28&amp;nbsp;646&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rest of portfolio&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;958&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;068&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 13&amp;nbsp;789&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;925&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Top 20 Innovative Medicines Division produ&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;ct net sales &amp;ndash; 2018&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Brands &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Business franchise &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Indication &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; US &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; world &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td width="21%" height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Relapsing multiple sclerosis&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;765&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;576&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Cosentyx &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Psoriasis, ankylosing &lt;br&gt;&lt;/br&gt; spondylitis and psoriatic arthritis &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;674 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;163 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;837 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Age-related macular degeneration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 806&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;068&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Carcinoid tumors and acromegaly&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 817&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 770&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia and GIST&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 440&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;561&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Breast cancer/TSC&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 929&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 627&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Diabetes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Promacta/Revolade &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immune thrombocytopenia (ITP), &lt;br&gt;&lt;/br&gt; severe aplastic anemia (SAA) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 581 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 593 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;174 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRAF V600+ metastatic and &lt;br&gt;&lt;/br&gt; adjuvant melanoma; advanced &lt;br&gt;&lt;/br&gt; non-small cell lung cancer (NSCLC) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 457 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 698 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;155 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic iron overload&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 578&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Respiratory &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Severe Allergic Asthma (SAA) &lt;br&gt;&lt;/br&gt; and Chronic Spontaneous Urticaria &lt;br&gt;&lt;/br&gt; (CSU) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;039 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;039 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Entresto &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cardiovascular, Renal &lt;br&gt;&lt;/br&gt; and Metabolism &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Chronic heart failure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 556 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 472 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;028 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 84&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 939&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Jakavi &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Myelofibrosis (MF), &lt;br&gt;&lt;/br&gt; polycytomia vera (PV) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 977 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 977 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Renal cell carcinoma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 404&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 828&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Ilaris &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Auto-inflammatory (CAPS, &lt;br&gt;&lt;/br&gt; TRAPS, HIDS/MKD, FMF, SJIA, &lt;br&gt;&lt;/br&gt; AOSD and gout) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 262 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 292 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 554 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Travoprost Group &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Ophthalmology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Reduction of elevated intraocular &lt;br&gt;&lt;/br&gt; pressure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 194 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 323 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 517 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zortress/Certican&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Transplantation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Top 20 products total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;654&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;292&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 26&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rest of portfolio&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;210&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;736&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 11&amp;nbsp;864&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Top 20 Innovative Medicines Division product net sales &amp;ndash; 2017&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Brands &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Business franchise &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Indication &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; US &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; world &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td width="21%" height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Relapsing multiple sclerosis&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;709&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;476&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Cosentyx &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Psoriasis, ankylosing &lt;br&gt;&lt;/br&gt; spondylitis and psoriatic arthritis &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;275 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 796 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;071 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia and GIST&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 627&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;316&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;943&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Age-related macular degeneration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Carcinoid tumors and acromegaly&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 832&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 780&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Breast cancer/TSC&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 819&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 706&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;525&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Diabetes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic iron overload&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 515&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 544&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;059&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 960&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 87&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 870&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 957&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Respiratory &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Severe Allergic Asthma (SAA) &lt;br&gt;&lt;/br&gt; and Chronic Spontaneous Urticaria &lt;br&gt;&lt;/br&gt; (CSU) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 920 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 920 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRAF V600+ metastatic and &lt;br&gt;&lt;/br&gt; adjuvant melanoma; advanced &lt;br&gt;&lt;/br&gt; non-small cell lung cancer (NSCLC) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 339 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 534 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 873 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Promacta/Revolade &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immune thrombocytopenia (ITP), &lt;br&gt;&lt;/br&gt; severe aplastic anemia (SAA) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 446 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 421 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 867 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Renal cell carcinoma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 407&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 401&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 808&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Jakavi &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Myelofibrosis (MF), &lt;br&gt;&lt;/br&gt; polycytomia vera (PV) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 777 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 777 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Travoprost Group &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Ophthalmology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Reduction of elevated &lt;br&gt;&lt;/br&gt; intraocular pressure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 216 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 373 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 589 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Entresto &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cardiovascular, Renal &lt;br&gt;&lt;/br&gt; and Metabolism &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Chronic heart failure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 297 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 210 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 507 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Neoral/Sandimmun(e) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Transplantation &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 38 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 450 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 488 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Voltaren/Cataflam&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Inflammation/pain&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Top 20 products total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&amp;nbsp;123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 24&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rest of portfolio&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;412&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;710&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;857&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 21&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Sandoz Division net sales by business franchise&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 to &lt;br&gt;&lt;/br&gt; 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 to &lt;br&gt;&lt;/br&gt; 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Retail Generics &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;880&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Biopharmaceuticals&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;607&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;436&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Anti-Infectives&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 534&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 543&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 516&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division net sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;731&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;060&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Of which USD 784 million (2018: USD 826 million; 2017: USD 880 million) represents anti-infectives sold under the Sandoz name &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The product portfolio of Sandoz is widely spread in 2019, 2018 and 2017.&lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; other revenue&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Profit-sharing income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 732&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 734&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 877&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Royalty income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Milestone income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 201&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 128&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 231&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 173&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;092&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 63&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Profit-sharing income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 648&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 877&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 652&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Royalty income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Milestone income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 128&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 173&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
  <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; consolidated income statements&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales to third parties from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;731&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sales to continuing and discontinued segments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 783&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 741&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 177&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 38&amp;nbsp;497&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;872&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;498&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;092&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 63&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&amp;nbsp;050&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;870&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;334&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;530&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 959&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 890&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;425&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;510&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross profit from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 29&amp;nbsp;539&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 26&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;601&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 34&amp;nbsp;252&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 31&amp;nbsp;589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Selling, general and administration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;617&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;534&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;369&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;152&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;675&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;402&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;586&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 977&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;629&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;749&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;608&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;426&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;609&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;752&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;403&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Income from associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;432&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 659&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;850&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income and expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income before taxes from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;940&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;095&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net loss from discontinued operations before gain on &lt;br&gt;&lt;/br&gt;distribution of Alcon Inc. to Novartis AG shareholders &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;101 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;186 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gain on distribution of Alcon Inc. to Novartis AG shareholders&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income/(loss) from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;737&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;614&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Attributable to:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Shareholders of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 11&amp;nbsp;732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 12&amp;nbsp;611&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Included in net income from continuing operations are:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 245&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 292&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;952&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;075&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;247&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;509&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;315&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on property, plant and equipment, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;239&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;101&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on intangible assets, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;506&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;138&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges and fair value &lt;br&gt;&lt;/br&gt;changes on financial assets, net &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 18 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 20 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;113 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 38 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;229&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;492&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation of Novartis equity plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;761&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;645&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;239&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;067&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;918&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales to third parties from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;060&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sales to continuing and discontinued segments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 741&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 668&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 177&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;743&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;178&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;743&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;381&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;870&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;650&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;530&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 890&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 817&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;510&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross profit from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 26&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;415&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 31&amp;nbsp;589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 29&amp;nbsp;771&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Selling, general and administration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;452&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;12&amp;nbsp;465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;675&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;615&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;389&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 977&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;027&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;629&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;922&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;351&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;609&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;368&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;261&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;403&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;702&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Income from associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;432&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income and expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income before taxes from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;095&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;800&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;499&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net (loss)/income from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;614&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Attributable to:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Shareholders of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 12&amp;nbsp;611&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 7&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Included in net income from continuing operations are:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 292&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;075&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;916&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;117&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;303&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;447&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;624&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on property, plant and equipment, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;239&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;84&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;73&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;157&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on intangible assets, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;591&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;652&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges and fair value &lt;br&gt;&lt;/br&gt;changes on financial assets, net &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;42 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;113 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;185 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;227 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation of Novartis equity plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;645&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;593&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;918&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;853&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
  <nvs:DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; consolidated balance sheets&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Alcon&lt;sup&gt;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71&amp;nbsp;225&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 67&amp;nbsp;055&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 16&amp;nbsp;468&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;971&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 30&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;209&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 118&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&amp;nbsp;563&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;15&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;056&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;804&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;377&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;43&amp;nbsp;683&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;48&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;62&amp;nbsp;819&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;66&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 55&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 78&amp;nbsp;692&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&amp;nbsp;184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net operating assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 55&amp;nbsp;893&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 53&amp;nbsp;999&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 12&amp;nbsp;664&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 24&amp;nbsp;007&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71&amp;nbsp;489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 94&amp;nbsp;876&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Included in assets and liabilities are:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;098&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;878&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 549&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 561&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;696&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to property, plant &lt;br&gt;&lt;/br&gt;and equipment &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;114 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 822 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 217 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 294 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 519 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 143 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 139 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;474 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;774 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;487&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 136&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2, 3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 454&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 537&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total goodwill and intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&amp;nbsp;336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 44&amp;nbsp;593&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;712&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&amp;nbsp;578&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 55&amp;nbsp;311&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 74&amp;nbsp;013&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to goodwill and &lt;br&gt;&lt;/br&gt;intangible assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 647 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;265 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 68 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 196 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 52 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 767 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;592 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total investment in associated &lt;br&gt;&lt;/br&gt;companies &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 128 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 81 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;509 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;264 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;644 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;352 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to investment in associated &lt;br&gt;&lt;/br&gt;companies &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 44 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 18 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 11 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 11 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 55 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 29 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents, marketable securities, &lt;br&gt;&lt;/br&gt;commodities, time deposits and derivative &lt;br&gt;&lt;/br&gt;financial instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 11&amp;nbsp;446 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 15&amp;nbsp;964 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 11&amp;nbsp;446 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 15&amp;nbsp;964 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts and derivative &lt;br&gt;&lt;/br&gt;financial instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 27&amp;nbsp;384 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 32&amp;nbsp;148 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 27&amp;nbsp;384 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 32&amp;nbsp;148 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current income tax and deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;513&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;513&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Excluding the impact of business combinations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Total right-of-use assets and additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock>
  <nvs:DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="11" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Net sales&lt;sup&gt;1&lt;/sup&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total of selected non-current assets&lt;sup&gt;2&lt;/sup&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; %&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Country&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 848&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 795&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 780&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&amp;nbsp;032&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 41&amp;nbsp;972&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&amp;nbsp;280&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;618&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&amp;nbsp;893&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&amp;nbsp;082&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;France&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;442&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;976&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Germany&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;972&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;484&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japan&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;575&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;617&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 309&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 144&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&amp;nbsp;286&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&amp;nbsp;033&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;763&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 77&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 98&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Region&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 17&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&amp;nbsp;259&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&amp;nbsp;103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 59&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 55&amp;nbsp;913&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 57&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Americas&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&amp;nbsp;713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&amp;nbsp;032&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&amp;nbsp;485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 29&amp;nbsp;389&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&amp;nbsp;082&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;799&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;460&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;093&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;209&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 77&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 98&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales from operations by location of third-party customer &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies, and in 2019 right-of-use assets recognized with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock>
  <nvs:DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Innovative Medicines Division net sales by business franchise&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 to &lt;br&gt;&lt;/br&gt; 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 to &lt;br&gt;&lt;/br&gt; 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;880&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;539&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;525&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Promacta/Revolade&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;416&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;174&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 867&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 873&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;561&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;943&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Jakavi&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 977&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 777&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;059&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 755&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 828&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 808&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Kisqali&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 480&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 235&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lutathera&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 441&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 164&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Kymriah&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Piqray&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 116&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;139&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Novartis Oncology business unit&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 14&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;428&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;274&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Travoprost Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 433&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Xiidra&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 192&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Beovu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;030&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;995&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;144&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;776&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;621&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Immunology, Hepatology and Dermatology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cosentyx&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;071&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Ilaris&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 671&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 402&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Immunology, Hepatology and Dermatology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;222&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;392&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;223&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zolgensma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 361&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Aimovig&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Mayzent&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; nm&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;773&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;429&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 to &lt;br&gt;&lt;/br&gt; 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 to &lt;br&gt;&lt;/br&gt; 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Respiratory&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;173&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;039&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 920&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Ultibro Breezhaler&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 427&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 454&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 411&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Seebri Breezhaler&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Onbrez Breezhaler&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 101&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Respiratory&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;767&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;617&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cardiovascular, Renal and Metabolism&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Entresto&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Cardiovascular, Renal and Metabolism&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;050&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 957&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 960&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zortress/Certican&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 414&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Neoral/Sandimmun(e)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 463&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Voltaren/Cataflam&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 417&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;998&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;481&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total Novartis Pharmaceuticals business unit&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;344&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 21&amp;nbsp;464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 20&amp;nbsp;004&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division net sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;nm = not meaningful&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock>
  <nvs:DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4InnovativeMedicinesMember">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Top 20 Innovative Medicines Division product net sales &amp;ndash; 2019&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Brands &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Business franchise &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Indication &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; US &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; world &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td width="21%" height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Cosentyx &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Psoriasis, ankylosing &lt;br&gt;&lt;/br&gt; spondylitis and psoriatic arthritis &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;220 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;331 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3&amp;nbsp;551 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Relapsing multiple sclerosis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;736&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;487&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;223&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Age-related macular degeneration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;086&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 804&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;076&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;880&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Entresto &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cardiovascular, Renal &lt;br&gt;&lt;/br&gt; and Metabolism &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Chronic heart failure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 925 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 801 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;726 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Carcinoid tumors and acromegaly&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 881&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 704&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Breast cancer/TSC&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 536&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;539&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Promacta/Revolade &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immune thrombocytopenia (ITP), &lt;br&gt;&lt;/br&gt; severe aplastic anemia (SAA) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 691 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 725 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;416 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRAF V600+ metastatic and &lt;br&gt;&lt;/br&gt; adjuvant melanoma; advanced &lt;br&gt;&lt;/br&gt; non-small cell lung cancer (NSCLC) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 481 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 857 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;338 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Diabetes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia and GIST&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 334&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 929&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Respiratory &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Severe Allergic Asthma (SAA) &lt;br&gt;&lt;/br&gt; and Chronic Spontaneous Urticaria &lt;br&gt;&lt;/br&gt; (CSU) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;173 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;173 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Jakavi &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Myelofibrosis (MF), &lt;br&gt;&lt;/br&gt; polycytomia vera (PV) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;114 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;114 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 978&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;012&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic iron overload&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 450&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 525&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Renal cell carcinoma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 423&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 755&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Ilaris &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Auto-inflammatory (CAPS, &lt;br&gt;&lt;/br&gt; TRAPS, HIDS/MKD, FMF, SJIA, &lt;br&gt;&lt;/br&gt; AOSD and gout) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 304 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 367 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 671 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zortress/Certican&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Transplantation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 316&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Kisqali&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HR+/HER2- metastatic breast cancer&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 480&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Top 20 products total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 10&amp;nbsp;679&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 17&amp;nbsp;967&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 28&amp;nbsp;646&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rest of portfolio&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;958&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;068&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 13&amp;nbsp;789&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;925&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Top 20 Innovative Medicines Division produ&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;ct net sales &amp;ndash; 2018&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Brands &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Business franchise &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Indication &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; US &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; world &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td width="21%" height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Relapsing multiple sclerosis&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;765&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;576&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Cosentyx &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Psoriasis, ankylosing &lt;br&gt;&lt;/br&gt; spondylitis and psoriatic arthritis &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;674 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;163 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;837 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Age-related macular degeneration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 806&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;068&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Carcinoid tumors and acromegaly&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 817&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 770&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;587&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia and GIST&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 440&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;561&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Breast cancer/TSC&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 929&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 627&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Diabetes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Promacta/Revolade &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immune thrombocytopenia (ITP), &lt;br&gt;&lt;/br&gt; severe aplastic anemia (SAA) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 581 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 593 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;174 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRAF V600+ metastatic and &lt;br&gt;&lt;/br&gt; adjuvant melanoma; advanced &lt;br&gt;&lt;/br&gt; non-small cell lung cancer (NSCLC) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 457 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 698 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;155 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic iron overload&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 578&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Respiratory &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Severe Allergic Asthma (SAA) &lt;br&gt;&lt;/br&gt; and Chronic Spontaneous Urticaria &lt;br&gt;&lt;/br&gt; (CSU) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;039 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;039 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Entresto &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cardiovascular, Renal &lt;br&gt;&lt;/br&gt; and Metabolism &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Chronic heart failure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 556 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 472 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;028 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 84&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 939&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Jakavi &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Myelofibrosis (MF), &lt;br&gt;&lt;/br&gt; polycytomia vera (PV) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 977 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 977 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Renal cell carcinoma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 404&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 828&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Ilaris &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Auto-inflammatory (CAPS, &lt;br&gt;&lt;/br&gt; TRAPS, HIDS/MKD, FMF, SJIA, &lt;br&gt;&lt;/br&gt; AOSD and gout) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 262 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 292 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 554 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Travoprost Group &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Ophthalmology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Reduction of elevated intraocular &lt;br&gt;&lt;/br&gt; pressure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 194 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 323 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 517 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Zortress/Certican&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Transplantation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Top 20 products total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;654&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;292&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 26&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rest of portfolio&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;210&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;736&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 11&amp;nbsp;864&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Top 20 Innovative Medicines Division product net sales &amp;ndash; 2017&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Brands &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Business franchise &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Indication &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; US &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; world &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td width="21%" height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gilenya&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Neuroscience&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="21%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Relapsing multiple sclerosis&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;709&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;476&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Cosentyx &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Psoriasis, ankylosing &lt;br&gt;&lt;/br&gt; spondylitis and psoriatic arthritis &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;275 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 796 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;071 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Gleevec/Glivec&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia and GIST&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 627&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;316&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;943&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Lucentis&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Ophthalmology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Age-related macular degeneration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;888&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Tasigna&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic myeloid leukemia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Sandostatin&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Carcinoid tumors and acromegaly&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 832&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 780&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Afinitor/Votubia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Breast cancer/TSC&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 819&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 706&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;525&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;&lt;i&gt;Galvus&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Diabetes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Exjade/Jadenu&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Chronic iron overload&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 515&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 544&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;059&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Exforge&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 960&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;i&gt;Diovan&lt;/i&gt; Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Hypertension&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 87&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 870&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 957&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Xolair &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Respiratory &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Severe Allergic Asthma (SAA) &lt;br&gt;&lt;/br&gt; and Chronic Spontaneous Urticaria &lt;br&gt;&lt;/br&gt; (CSU) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 920 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 920 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;&lt;i&gt;Tafinlar&lt;/i&gt; + &lt;i&gt;Mekinist&lt;/i&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRAF V600+ metastatic and &lt;br&gt;&lt;/br&gt; adjuvant melanoma; advanced &lt;br&gt;&lt;/br&gt; non-small cell lung cancer (NSCLC) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 339 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 534 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 873 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Promacta/Revolade &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immune thrombocytopenia (ITP), &lt;br&gt;&lt;/br&gt; severe aplastic anemia (SAA) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 446 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 421 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 867 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Votrient&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Oncology&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Renal cell carcinoma&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 407&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 401&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 808&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Jakavi &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Oncology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Myelofibrosis (MF), &lt;br&gt;&lt;/br&gt; polycytomia vera (PV) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 777 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 777 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Travoprost Group &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Ophthalmology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Reduction of elevated &lt;br&gt;&lt;/br&gt; intraocular pressure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 216 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 373 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 589 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Entresto &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cardiovascular, Renal &lt;br&gt;&lt;/br&gt; and Metabolism &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Chronic heart failure &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 297 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 210 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 507 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Neoral/Sandimmun(e) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Immunology, Hepatology &lt;br&gt;&lt;/br&gt; and Dermatology &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Transplantation &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 38 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 450 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 488 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Voltaren/Cataflam&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Established Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Inflammation/pain&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 465&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Top 20 products total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&amp;nbsp;123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 24&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rest of portfolio&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;412&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;710&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;857&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 21&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales reflect &lt;i&gt;Xolair&lt;/i&gt; sales for all indications. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock>
  <nvs:DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SegmentsAxis_nvs-2019Q4SandozMember">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Sandoz Division net sales by business franchise&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 to &lt;br&gt;&lt;/br&gt; 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 to &lt;br&gt;&lt;/br&gt; 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Retail Generics &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;880&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Biopharmaceuticals&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;607&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;436&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Anti-Infectives&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 534&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 543&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 516&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total division net sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;731&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;060&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Of which USD 784 million (2018: USD 826 million; 2017: USD 880 million) represents anti-infectives sold under the Sandoz name &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock>
  <nvs:DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; other revenue&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Profit-sharing income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 732&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 734&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 877&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Royalty income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Milestone income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 201&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 128&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 231&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 173&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;092&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 63&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Innovative Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Corporate (including eliminations)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Group &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Profit-sharing income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 648&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 877&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 652&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Royalty income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Milestone income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 128&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 173&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;266&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock>
  <ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;4. Associated companies&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Net income statement effect&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other comprehensive income effect &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total comprehensive income effect&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Roche Holding AG, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 662&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 526&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 456&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 75&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 568&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 601&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 564&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;GlaxoSmithKline Consumer &lt;br&gt;&lt;/br&gt;Healthcare Holdings Ltd., UK &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;910 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 629 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;557 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;145 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;353 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 484 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Others&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Associated companies related to continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 659&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 565&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;956&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;071&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="20"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="20"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; In 2018, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 511 million was recycled into the consolidated income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. No Novartis share of other comprehensive income recognized by associated companies, net of taxes was recycled into the consolidated income statement in 2019 and 2017. &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has a significant investment in Roche Holding AG, Basel (Roche), as well as certain other smaller investments that are accounted for as associated companies. The investment in GlaxoSmithKline Consumer Healthcare Holdings Ltd., Brentford, Middlesex, UK, was divested on June 1, 2018, to GlaxoSmithKline plc, Great Britain. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Balance sheet value&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Roche Holding AG, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;195&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Others&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 199&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 157&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;644&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;352&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Roche Holding AG &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group&amp;#x2019;s holding in Roche voting shares was 33.3% at December 31, 2019, 2018 and 2017. This investment represents approximately 6.2% of Roche&amp;#x2019;s total outstanding voting and non-voting equity instruments at December 31, 2019, 2018 and 2017. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Since full-year 2019 financial data for Roche is not available when Novartis produces its consolidated financial results, a survey of analyst estimates is used to estimate the Group&amp;#x2019;s share of Roche&amp;#x2019;s net income. Any differences between these estimates and actual results will be adjusted in the Group&amp;#x2019;s 2020 consolidated financial statements when available. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following tables show summarized financial information for Roche, including current values of fair value adjustments made at the time of the acquisition of the shares, for the year ended December 31, 2018, and for the six months ended June 30, 2019 (since full-year 2019 data is not yet available): &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(CHF billions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Current assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Non-current &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Non-current &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 32.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 53.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;June 30, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 53.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(CHF billions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Revenue &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Net income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; comprehen- &lt;br&gt;&lt;/br&gt; sive income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; comprehen- &lt;br&gt;&lt;/br&gt; sive income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 59.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;June 30, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 31.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;0.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;A purchase price allocation was performed on the basis of publicly available information at the time of acquisition of the investment. The December 31, 2019, balance sheet value allocation is as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of Roche&amp;#x2019;s estimated net assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;404&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of reappraised intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Implicit Novartis goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;939&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current value of share in net identifiable assets &lt;br&gt;&lt;/br&gt;and goodwill &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;640 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated equity accounting adjustments and translation effects less dividends received&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Balance sheet value&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The identified intangible assets principally relate to the value of currently marketed products and are amortized on a straight-line basis over their estimated average useful life of 20 years. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In 2019, dividends received from Roche in relation to the distribution of its 2018 net income amounted to USD&amp;nbsp;460 million (2018: USD 464 million in relation to the distribution of its 2017 net income). &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The consolidated income statement effects from applying Novartis accounting principles for this investment in 2019, 2018 and 2017 are as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of Roche's &lt;br&gt;&lt;/br&gt;estimated current-year &lt;br&gt;&lt;/br&gt;consolidated net income &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 910 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 799 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 669 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prior-year adjustment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;125&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of fair value &lt;br&gt;&lt;/br&gt;adjustments relating to &lt;br&gt;&lt;/br&gt;intangible assets, net of taxes &lt;br&gt;&lt;/br&gt;of USD 24 million (2018: USD 40 &lt;br&gt;&lt;/br&gt;million; 2017: USD 42 million) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;162 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;148 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;146 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Partial release of deferred tax liability recognized&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income effect&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 526&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 456&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The publicly quoted market value of the Novartis interest in Roche (SIX symbol: RO) at December 31, 2019, was USD&amp;nbsp;16.9 billion (2018: USD&amp;nbsp;12.9 billion). &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;GlaxoSmithKline Consumer Healthcare Holdings&amp;nbsp;Ltd.&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On March 27, 2018, Novartis entered into an agreement with GlaxoSmithKline plc, Great Britain (GSK), to divest its 36.5% stake in GSK Consumer Healthcare Holdings Ltd. (GSK Consumer Healthcare) to GSK for USD 13.0 billion in cash. As a result, Novartis discontinued the use of equity method accounting starting from April 1, 2018. The divestment transaction closed on June 1, 2018, and Novartis realized a pre-tax gain of USD 5.8 billion, recorded in income from associated companies. See Note 2. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;GSK Consumer Healthcare was formed in March 2015 via contribution of businesses from both Novartis and GSK. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;At December 31, 2017, Novartis had a 36.5% interest in GSK Consumer Healthcare and had four of 11 seats on the GSK Consumer Healthcare board of directors. Furthermore, Novartis had customary minority rights as well as exit rights at a predefined, market-based pricing mechanism. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In 2018, dividends received from GSK Consumer Healthcare amounted to USD&amp;nbsp;252 million.&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The consolidated income statement effects from applying Novartis accounting principles for this investment in 2018 and 2017 are as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of &lt;br&gt;&lt;/br&gt;GSK Consumer Healthcare's &lt;br&gt;&lt;/br&gt;estimated current-year &lt;br&gt;&lt;/br&gt;consolidated net income &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 119 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 589 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prior-year adjustment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of fair value &lt;br&gt;&lt;/br&gt;adjustments relating to &lt;br&gt;&lt;/br&gt;intangible assets and inventory, &lt;br&gt;&lt;/br&gt;net of taxes of USD 1 million &lt;br&gt;&lt;/br&gt;(2017: USD 1 million) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pre-tax gain on divestment of GSK Consumer Healthcare&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;790&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income effect&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;910&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 629&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory>
  <ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Net income statement effect&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other comprehensive income effect &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total comprehensive income effect&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Roche Holding AG, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 662&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 526&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 456&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 75&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 568&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 601&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 564&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;GlaxoSmithKline Consumer &lt;br&gt;&lt;/br&gt;Healthcare Holdings Ltd., UK &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;910 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 629 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;557 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;145 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;353 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 484 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Others&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Associated companies related to continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 659&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 565&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;956&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;071&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="20"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="20"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; In 2018, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 511 million was recycled into the consolidated income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. No Novartis share of other comprehensive income recognized by associated companies, net of taxes was recycled into the consolidated income statement in 2019 and 2017. &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory>
  <nvs:DisclosureOfAssociatesBalanceSheetTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Balance sheet value&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Roche Holding AG, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;195&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Others&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 199&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 157&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;644&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;352&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfAssociatesBalanceSheetTableTextBlock>
  <nvs:AssociatesSummarizedFinancialInformationTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(CHF billions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Current assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Non-current &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Non-current &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 32.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 53.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;June 30, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 53.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(CHF billions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Revenue &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Net income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; comprehen- &lt;br&gt;&lt;/br&gt; sive income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; comprehen- &lt;br&gt;&lt;/br&gt; sive income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 59.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;June 30, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 31.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;0.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AssociatesSummarizedFinancialInformationTableTextBlock>
  <nvs:PurchasePriceAllocationAssociatesTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of Roche&amp;#x2019;s estimated net assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;404&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of reappraised intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 297&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Implicit Novartis goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;939&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current value of share in net identifiable assets &lt;br&gt;&lt;/br&gt;and goodwill &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;640 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated equity accounting adjustments and translation effects less dividends received&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Balance sheet value&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:PurchasePriceAllocationAssociatesTableTextBlock>
  <nvs:DisclosureOfAssociatesNetIncomeEffectTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4RocheHoldingAGMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of Roche's &lt;br&gt;&lt;/br&gt;estimated current-year &lt;br&gt;&lt;/br&gt;consolidated net income &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 910 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 799 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 669 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prior-year adjustment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;125&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;67&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of fair value &lt;br&gt;&lt;/br&gt;adjustments relating to &lt;br&gt;&lt;/br&gt;intangible assets, net of taxes &lt;br&gt;&lt;/br&gt;of USD 24 million (2018: USD 40 &lt;br&gt;&lt;/br&gt;million; 2017: USD 42 million) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;162 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;148 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;146 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Partial release of deferred tax liability recognized&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income effect&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 526&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 456&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfAssociatesNetIncomeEffectTableTextBlock>
  <nvs:DisclosureOfAssociatesNetIncomeEffectTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019SignificantInvestmentsInAssociatesAxis_nvs-2019Q4GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis share of &lt;br&gt;&lt;/br&gt;GSK Consumer Healthcare's &lt;br&gt;&lt;/br&gt;estimated current-year &lt;br&gt;&lt;/br&gt;consolidated net income &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 119 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 589 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prior-year adjustment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of fair value &lt;br&gt;&lt;/br&gt;adjustments relating to &lt;br&gt;&lt;/br&gt;intangible assets and inventory, &lt;br&gt;&lt;/br&gt;net of taxes of USD 1 million &lt;br&gt;&lt;/br&gt;(2017: USD 1 million) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pre-tax gain on divestment of GSK Consumer Healthcare&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;790&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income effect&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;910&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 629&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfAssociatesNetIncomeEffectTableTextBlock>
  <ifrs-full:DisclosureOfInterestExpenseExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;5. Interest expense and&amp;nbsp;other&amp;nbsp;financial&amp;nbsp;income&amp;nbsp;and&amp;nbsp;expense&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Interest expense&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;877&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;741&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense on lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;66&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense arising from discounting long-term liabilities and capitalized borrowing costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total interest expense from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;850&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Other financial income and expense&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 245&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 292&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency result, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other financial income and expense from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfInterestExpenseExplanatory>
  <nvs:InterestExpenseTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;877&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;741&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense on lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;66&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense arising from discounting long-term liabilities and capitalized borrowing costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total interest expense from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;850&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;932&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:InterestExpenseTableTextBlock>
  <nvs:OtherFinancialIncomeAndExpenseTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 245&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 292&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency result, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other financial income and expense from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:OtherFinancialIncomeAndExpenseTableTextBlock>
  <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;6. Taxes&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Income before taxes&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;097&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;385&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Foreign&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 843&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income before taxes from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;940&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;095&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Current and deferred income tax expense&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;615&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;462&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Foreign&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;961&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;988&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;451&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current income tax expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;913&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Foreign&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 447&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 428&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 615&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Deferred tax income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 308&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income tax expense from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Analysis of tax rate&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has a substantial business presence in many countries and is therefore subject to different income and expense items that are non-taxable (permanent differences) or are taxed at different rates in those tax jurisdictions. This results in a difference between our applicable tax rate and effective tax rate. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The main elements contributing to the difference between the Group&amp;#x2019;s overall applicable tax rate (which can change each year since it is calculated as the weighted average tax rate based on the pre-tax income of each subsidiary) and the effective tax rate are shown in the table below: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(As a percentage)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Applicable tax rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of disallowed expenditures&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of utilization of tax losses &lt;br&gt;&lt;/br&gt;brought forward from prior periods &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of income taxed at reduced rates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;0.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of income not subject to tax &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of tax credits and allowances&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of release of &lt;br&gt;&lt;/br&gt;contingent consideration liability &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of tax rate change &lt;br&gt;&lt;/br&gt;on current and deferred &lt;br&gt;&lt;/br&gt;tax assets and liabilities &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1.4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 4.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of write-off of deferred tax assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of write-down and reversal of &lt;br&gt;&lt;/br&gt;write-down of investments in subsidiaries &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 0.0 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of tax benefits expiring in 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of prior-year items&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of other items &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Effective tax rate for continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Included in 2018 is the effect of income not subject to tax (-3.7%) arising from the portion of the non-taxable gain on the divestment of the Group's investment in GSK Consumer Healthcare Holdings Ltd. attributable to Switzerland. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; 2019 is mainly related to the revaluation of the deferred tax assets and liabilities resulting from the tax reforms enacted in Switzerland in 2019, refer to Note 12 for additional disclosures. &lt;br&gt;&lt;/br&gt;Included in 2017 is a 4.8% impact related to the revaluation of the deferred tax assets and liabities and a portion of current tax payables. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017, refer to Note 12 for additional disclosures. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; 2019 is primarily related to a non-cash, one-time deferred tax expense for the write-off of a deferred tax asset resulting from legal entity reorganizations. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; In 2019, other items (+3.0%) include changes in uncertain tax positions (+2.6%) and other items (+0.4%). &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The utilization of tax-loss carry-forwards lowered the tax charge by USD&amp;nbsp;11 million in 2019, by USD&amp;nbsp;19 million in 2018, and by USD&amp;nbsp;7 million in 2017.&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For the amount of taxes attributable to discontinued operations, see Note 30.&lt;/div&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
  <nvs:IncomeBeforeTaxesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;097&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;385&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Foreign&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 843&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income before taxes from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;940&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;095&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:IncomeBeforeTaxesTableTextBlock>
  <nvs:CurrentAndDeferredIncomeTaxExpenseTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;615&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;462&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Foreign&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;961&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;988&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;451&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current income tax expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;913&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Foreign&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 447&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 428&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 615&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Deferred tax income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 308&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income tax expense from continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:CurrentAndDeferredIncomeTaxExpenseTableTextBlock>
  <nvs:AnalysisOfTaxRateTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(As a percentage)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Applicable tax rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of disallowed expenditures&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of utilization of tax losses &lt;br&gt;&lt;/br&gt;brought forward from prior periods &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of income taxed at reduced rates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;0.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of income not subject to tax &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of tax credits and allowances&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of release of &lt;br&gt;&lt;/br&gt;contingent consideration liability &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of tax rate change &lt;br&gt;&lt;/br&gt;on current and deferred &lt;br&gt;&lt;/br&gt;tax assets and liabilities &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1.4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 4.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of write-off of deferred tax assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of write-down and reversal of &lt;br&gt;&lt;/br&gt;write-down of investments in subsidiaries &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;0.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 0.0 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1.1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of tax benefits expiring in 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of prior-year items&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of other items &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Effective tax rate for continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Included in 2018 is the effect of income not subject to tax (-3.7%) arising from the portion of the non-taxable gain on the divestment of the Group's investment in GSK Consumer Healthcare Holdings Ltd. attributable to Switzerland. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; 2019 is mainly related to the revaluation of the deferred tax assets and liabilities resulting from the tax reforms enacted in Switzerland in 2019, refer to Note 12 for additional disclosures. &lt;br&gt;&lt;/br&gt;Included in 2017 is a 4.8% impact related to the revaluation of the deferred tax assets and liabities and a portion of current tax payables. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017, refer to Note 12 for additional disclosures. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; 2019 is primarily related to a non-cash, one-time deferred tax expense for the write-off of a deferred tax asset resulting from legal entity reorganizations. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; In 2019, other items (+3.0%) include changes in uncertain tax positions (+2.6%) and other items (+0.4%). &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AnalysisOfTaxRateTableTextBlock>
  <ifrs-full:EarningsPerShareExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;7. Earnings per share&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income attributable to shareholders of Novartis AG (USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;797&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;499&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;611&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Number of shares (in millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Weighted average number of shares outstanding used in basic earnings per share&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;346&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Weighted average number of shares in diluted earnings per share&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;344&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;371&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Basic earnings per share (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5.52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.00&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5.12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3.28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Diluted earnings per share (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5.46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5.06&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3.25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Basic earnings per share (EPS) is calculated by dividing net income attributable to shareholders of Novartis AG by the weighted average number of shares outstanding in a reporting period. This calculation excludes the average number of issued shares purchased by the Group and held as treasury shares. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For diluted EPS, the weighted average number of shares outstanding is adjusted to assume the vesting of all restricted shares, restricted share units, and the conversion of all potentially dilutive shares arising from options on Novartis shares that have been issued. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;No options were excluded from the calculation of diluted EPS in 2019, 2018 or 2017, as all options were dilutive in all years. &lt;/div&gt;</ifrs-full:EarningsPerShareExplanatory>
  <nvs:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income attributable to shareholders of Novartis AG (USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;797&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;499&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;611&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Number of shares (in millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Weighted average number of shares outstanding used in basic earnings per share&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;346&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Weighted average number of shares in diluted earnings per share&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;344&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;371&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Basic earnings per share (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5.52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.00&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5.12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3.28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Diluted earnings per share (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5.46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;- Discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.08&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5.06&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3.25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
  <nvs:ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;8. Changes in consolidated statements of&amp;nbsp;comprehensive income&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated statements of comprehensive income include the Group&amp;#x2019;s net income for the year as well as all other valuation adjustments recorded in the Group&amp;#x2019;s consolidated balance sheet but that under IFRS are not recorded in the consolidated income statement. These include fair value adjustments to financial instruments, actuarial gains or losses on defined benefit pension and other post-employment plans, and currency translation effects, net of tax. &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes these value adjustments and currency translation effects attributable to Novartis shareholders: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on marketable &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on equity &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Actuarial &lt;br&gt;&lt;/br&gt; gains/(losses) &lt;br&gt;&lt;/br&gt; from defined &lt;br&gt;&lt;/br&gt; benefit plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Cumulative &lt;br&gt;&lt;/br&gt; currency &lt;br&gt;&lt;/br&gt; translation &lt;br&gt;&lt;/br&gt; effects &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total value &lt;br&gt;&lt;/br&gt; adjustments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at January 1, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 349&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;915&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;642&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;212&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 50&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net investment hedge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;237&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;237&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net actuarial losses from defined benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total value adjustments in 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;971&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;872&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at December 31, 2017, as previously reported&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 388&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;340&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 9 on retained &lt;br&gt;&lt;/br&gt;earnings and OCI &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to presentation required under IFRS 9 &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Restated value adjustments at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net investment hedge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net actuarial gains from defined benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 320&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 320&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total value adjustments in 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 415&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;423&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 744&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;452&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net investment hedge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net actuarial gains from defined benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total value adjustments in 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 398&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments related to divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;919&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;657&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 1 provides additional disclosures related to the impact of adoption of IFRS 9 Financial Instruments. OCI: other comprehensive income &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;8.1) The 2019, 2018 and 2017 changes in the fair value of financial instruments were as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on equity &lt;br&gt;&lt;/br&gt; securities &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 208&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 227&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair value:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Debt securities sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortized net losses on cash flow hedges transferred &lt;br&gt;&lt;/br&gt;to the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax on above items&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Realized net gains reclassified to the retained earnings:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments during the year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments related to divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on marketable &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on equity &lt;br&gt;&lt;/br&gt; securities &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at January 1, 2018, as previously reported&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 388&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 395&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 9 on retained earnings and &lt;br&gt;&lt;/br&gt;other comprehensive income &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to presentation required under IFRS 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Restated fair value adjustments at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair value:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortized net losses on cash flow hedges transferred &lt;br&gt;&lt;/br&gt;to the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax on above items&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Realized net gains reclassified to the retained earnings:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments during the year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 227&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 1 provides aditional disclosures on the impact of adoption of IFRS 9 Financial Instruments. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on marketable &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at January 1, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 349&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 345&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair value:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Available-for-sale marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Available-for-sale financial investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Realized net gains transferred to the consolidated income statement:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortized net losses on cash flow hedges transferred &lt;br&gt;&lt;/br&gt;to the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impaired financial assets transferred to the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax on above items &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments during the year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 50&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at December 31, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 388&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Included is a USD 18 million impact related to the revaluation of deferred tax liabilities on available-for-sale financial investments held in the US that were previously recognized through other comprehensive income related to continuing operrations. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;8.2) In 2019, cumulative currency translation gains of USD&amp;nbsp;129 million were recycled through the income statement mainly as a result of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders. See Notes 2 and 30. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In 2018, cumulative currency translation losses of USD&amp;nbsp;946 million were recycled through the income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. See Notes 2 and 4. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;No currency translation losses or gains were recycled through the income statement in 2017. &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;8.3) Remeasurements from defined benefit plans arise as follows:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Defined benefit pension plans before tax&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;119&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;367&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other post-employment benefit plans before tax&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxation on above items &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;313&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total after tax&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;467&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Attributable to:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Shareholders of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Included in 2019 is a USD -358 million impact related to the revaluation of deferred tax assets on Swiss post-employment benefits that were previously recognized through other comprehensive income. This revaluation resulted from the Swiss tax reforms enacted by the voters in 2019. Refer to Note 12 for additional disclosures. &lt;br&gt;&lt;/br&gt;Included in 2017 is a USD -272 million impact related to the revaluation of deferred tax assets on US post-employment benefits that were previously recognized through other comprehensive income (continuing operations USD-259 million and discontinued operations USD -13 million). This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock>
  <nvs:ScheduleOfComprehensiveIncomeTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on marketable &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on equity &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Actuarial &lt;br&gt;&lt;/br&gt; gains/(losses) &lt;br&gt;&lt;/br&gt; from defined &lt;br&gt;&lt;/br&gt; benefit plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Cumulative &lt;br&gt;&lt;/br&gt; currency &lt;br&gt;&lt;/br&gt; translation &lt;br&gt;&lt;/br&gt; effects &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total value &lt;br&gt;&lt;/br&gt; adjustments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at January 1, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 349&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;915&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;642&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;212&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 50&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net investment hedge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;237&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;237&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net actuarial losses from defined benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total value adjustments in 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;971&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;872&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at December 31, 2017, as previously reported&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 388&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;340&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 9 on retained &lt;br&gt;&lt;/br&gt;earnings and OCI &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to presentation required under IFRS 9 &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Restated value adjustments at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net investment hedge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net actuarial gains from defined benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 320&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 320&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total value adjustments in 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 415&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;423&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 744&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;452&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments on financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net investment hedge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net actuarial gains from defined benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total value adjustments in 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 398&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments related to divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Value adjustments at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;919&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;657&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 1 provides additional disclosures related to the impact of adoption of IFRS 9 Financial Instruments. OCI: other comprehensive income &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfComprehensiveIncomeTableTextBlock>
  <nvs:FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on equity &lt;br&gt;&lt;/br&gt; securities &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 208&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 227&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair value:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Debt securities sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortized net losses on cash flow hedges transferred &lt;br&gt;&lt;/br&gt;to the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax on above items&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Realized net gains reclassified to the retained earnings:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments during the year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments related to divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on marketable &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on equity &lt;br&gt;&lt;/br&gt; securities &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at January 1, 2018, as previously reported&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 388&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 395&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 9 on retained earnings and &lt;br&gt;&lt;/br&gt;other comprehensive income &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;177 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to presentation required under IFRS 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Restated fair value adjustments at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 211&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair value:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortized net losses on cash flow hedges transferred &lt;br&gt;&lt;/br&gt;to the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax on above items&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Realized net gains reclassified to the retained earnings:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments during the year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 227&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 1 provides aditional disclosures on the impact of adoption of IFRS 9 Financial Instruments. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on marketable &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments &lt;br&gt;&lt;/br&gt; on debt &lt;br&gt;&lt;/br&gt; securities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Fair value &lt;br&gt;&lt;/br&gt; adjustments on &lt;br&gt;&lt;/br&gt; deferred cash &lt;br&gt;&lt;/br&gt; flow hedges &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at January 1, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 349&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 345&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair value:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Available-for-sale marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Available-for-sale financial investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Realized net gains transferred to the consolidated income statement:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other financial assets sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortized net losses on cash flow hedges transferred &lt;br&gt;&lt;/br&gt;to the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 13 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impaired financial assets transferred to the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax on above items &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments during the year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 50&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value adjustments at December 31, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 388&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Included is a USD 18 million impact related to the revaluation of deferred tax liabilities on available-for-sale financial investments held in the US that were previously recognized through other comprehensive income related to continuing operrations. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock>
  <nvs:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Defined benefit pension plans before tax&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;119&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;482&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;367&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other post-employment benefit plans before tax&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxation on above items &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;313&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total after tax&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;467&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Attributable to:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Shareholders of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Included in 2019 is a USD -358 million impact related to the revaluation of deferred tax assets on Swiss post-employment benefits that were previously recognized through other comprehensive income. This revaluation resulted from the Swiss tax reforms enacted by the voters in 2019. Refer to Note 12 for additional disclosures. &lt;br&gt;&lt;/br&gt;Included in 2017 is a USD -272 million impact related to the revaluation of deferred tax assets on US post-employment benefits that were previously recognized through other comprehensive income (continuing operations USD-259 million and discontinued operations USD -13 million). This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock>
  <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;9. Property, plant and equipment&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of property, plant and equipment during 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Land &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Buildings &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Construction &lt;br&gt;&lt;/br&gt; in progress &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Machinery &lt;br&gt;&lt;/br&gt; and other &lt;br&gt;&lt;/br&gt; equipment &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 696&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 17&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 34&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;615&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;655&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;009&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;127&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 630&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;463&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;350&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 13&amp;nbsp;674&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;999&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;924&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;18&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 562&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;541&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;674&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;7&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;447&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;8&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;205&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;930&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 492&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;290&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;948&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 12&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Commitments for purchases of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Capitalized borrowing costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Represents the cost of assets and accumulated depreciation at January 1, 2019 related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Reclassification to right-of-use assets at January 1, 2019, upon adoption of IFRS 16 Leases. Refer to Notes 1 and 10 for additional disclosure. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories due to completion of plant and other equipment under construction &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Additions in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 23 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;6&amp;nbsp;&lt;/sup&gt; Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;7&amp;nbsp;&lt;/sup&gt; No depreciation charge in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 was recorded. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;8&amp;nbsp;&lt;/sup&gt; Impairments in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 2 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of property, plant and equipment during 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Land &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Buildings &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Construction &lt;br&gt;&lt;/br&gt; in progress &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Machinery &lt;br&gt;&lt;/br&gt; and other &lt;br&gt;&lt;/br&gt; equipment &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 720&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;368&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&amp;nbsp;858&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;010&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;309&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 538&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 931&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 407&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;212&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;457&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;697&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;504&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 696&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&amp;nbsp;546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 56&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 101&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 161&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;574&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 180&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 412&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;324&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 115&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 361&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 479&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;924&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;18&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 653&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;807&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;005&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;231&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;696&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value of property, plant and equipment under finance lease contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 79&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 79&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Commitments for purchases of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Capitalized borrowing costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories due to completion of plant and other equipment under construction &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Additions in the disposal group held for sale were USD 21 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Depreciation charge in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 15 million. For depreciation charge related to discontinued operations, refer to Note 30. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
  <nvs:PropertyPlantAndEquipmentTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of property, plant and equipment during 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Land &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Buildings &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Construction &lt;br&gt;&lt;/br&gt; in progress &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Machinery &lt;br&gt;&lt;/br&gt; and other &lt;br&gt;&lt;/br&gt; equipment &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 696&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 17&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 34&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;615&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;655&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;009&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;127&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 630&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;463&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;350&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 13&amp;nbsp;674&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;999&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;924&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;18&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 562&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;541&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;674&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;7&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;447&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;8&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;205&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;14&amp;nbsp;930&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 492&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;290&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;948&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 12&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Commitments for purchases of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Capitalized borrowing costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Represents the cost of assets and accumulated depreciation at January 1, 2019 related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Reclassification to right-of-use assets at January 1, 2019, upon adoption of IFRS 16 Leases. Refer to Notes 1 and 10 for additional disclosure. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories due to completion of plant and other equipment under construction &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Additions in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 23 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;6&amp;nbsp;&lt;/sup&gt; Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;7&amp;nbsp;&lt;/sup&gt; No depreciation charge in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 was recorded. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;8&amp;nbsp;&lt;/sup&gt; Impairments in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 2 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of property, plant and equipment during 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Land &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Buildings &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Construction &lt;br&gt;&lt;/br&gt; in progress &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Machinery &lt;br&gt;&lt;/br&gt; and other &lt;br&gt;&lt;/br&gt; equipment &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 720&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;064&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;368&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&amp;nbsp;858&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;010&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;309&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 538&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 931&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 407&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;212&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;457&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;697&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;504&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 696&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Accumulated depreciation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;485&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&amp;nbsp;546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 56&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 101&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 161&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;574&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated depreciation on disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 180&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 412&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;324&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 115&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 361&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 479&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;924&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;18&amp;nbsp;332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 653&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;807&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;005&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;231&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;696&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value of property, plant and equipment under finance lease contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 79&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 79&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Commitments for purchases of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Capitalized borrowing costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories due to completion of plant and other equipment under construction &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Additions in the disposal group held for sale were USD 21 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Depreciation charge in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 15 million. For depreciation charge related to discontinued operations, refer to Note 30. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:PropertyPlantAndEquipmentTableTextBlock>
  <ifrs-full:DisclosureOfLeasesExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;10. Right-of-use assets and lease liabilities&lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Impact of adoption of IFRS 16 Leases&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Note 1 explains the changes and new accounting policy introduced on January 1, 2019, resulting from the adoption of the new accounting standard IFRS 16 Leases. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;On transition to IFRS 16, the Group elected to apply the practical expedient to not reassess whether a contract is, or contains, a lease at January 1, 2019, the implementation date of IFRS 16. As a result, at the date of implementation, the Group applied IFRS 16 only to contracts that were previously identified as leases under IAS 17 Leases and related interpretations, and the definition of a lease under IFRS 16 was applied only to contracts entered into or changed on or after January 1, 2019. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The impact on retained earnings upon implementation of IFRS 16 was USD 3 million arising from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group has entered into various fixed-term leases, mainly for vehicles and real estate. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The lease liabilities recorded in continuing operations on January 1, 2019, were USD 1.7 billion and the right-of-use assets were USD 1.6 billion. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Reconciliation of lease commitment disclosed on December 31, 2018, and lease liability recorded in continuing operations on January 1, 2019, is as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Operating lease commitments December 31, 2018 &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Operating lease commitments December 31, 2018 related to discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;222&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating lease commitments December 31, 2018 related to continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;390&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Recognition exemption for short-term leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Recognition exception for low-value leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease arrangements with commencement date after December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Undiscounted future lease payments continuing &lt;br&gt;&lt;/br&gt;operations as of January 1, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3&amp;nbsp;283 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Effect of discounting&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;547&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Lease liabilities recognized as of January 1, 2019 &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;736&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; As reported in Annual Report 2018 Note 27 &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; The weighted average incremental borrowing rate at January 1, 2019, the date of implementation of IFRS 16 Leases, was 3.5%. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The right-of-use assets of continuing operations at January 1, 2019, by underlying class of asset comprise the following: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Land&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 536&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 848&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment, and other assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Right-of-use assets were lower than the lease liability at the date of implementation of IFRS 16 by USD 182 million, due to adjustments made for recognition of sublease receivables, prepayments and accrued lease payments and transfers from leased assets recorded in property, plant and equipment at December 31, 2018. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The adoption of IFRS 16 on January 1, 2019 had an impact on the classification of the annual lease expense in the consolidated income statement, the recognition of right-of-use assets and lease liabilities in the balance sheet and the classification of the annual lease payments in the consolidated statement of cash flows. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The adoption of IFRS 16 on January 1, 2019 did not significantly impact the individual lines of the consolidated income statement. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the adjustments to the line items of the January 1, 2019, consolidated balance sheet, due to the implementation of IFRS 16: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;101&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Right-of-use assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Equity and liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reserves&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;471&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provision and other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;212&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;257&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 267&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity and liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;As a result of applying the modified retrospective method at the date of implementation of IFRS 16 on January 1, 2019, whereby the right-of-use assets were measured at the amount equal to the lease liabilities, there is no impact to the reported deferred tax assets and deferred tax liabilities on the consolidated balance sheet, as the corresponding deferred tax assets and deferred tax liabilities attributable to the lease liability and right-of-use asset relate to income taxes levied by the same taxation authority within the same legal entity, and were therefore offset. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The adoption of IFRS 16 on January 1, 2019 had no significant impact on the individual lines of the consolidated statement of cash flows, except for the principal portion of the lease payments (USD 0.3 billion for the year ended December 31, 2019) that is recognized as an outflow in the cash flow from financing activities and the interest portion of the lease payment (USD 0.1 billion for the year ended December 31, 2019) is recognized as an outflow in the cash flow from operating activities. Prior to the adoption of IFRS 16, the full amount of the lease payments was recognized as an outflow in the cash flow from operating activities. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Current year disclosures&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of the right-of-use assets of continuing operations: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Right-of-use assets at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 537&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease contract terminations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total right-of-use assets at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; No impairments were recorded in the period. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Lease contract terminations also includes modifications to existing leases that result in reductions to the right-of-use assets, and reductions due to sub-leasing. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The right-of-use assets carrying value and depreciation charge of continuing operations at December 31, 2019, are shown below by underlying class of asset: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; December 31, 2019 &lt;br&gt;&lt;/br&gt; carrying value &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Depreciation &lt;br&gt;&lt;/br&gt; charge &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Land&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 537&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 990&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 87&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment, and other assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total right-of-use assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The lease liabilities of continuing operations at December 31, 2019, by maturity are as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Lease liabilities &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Lease liabilities &lt;br&gt;&lt;/br&gt; undiscounted &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less than one year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="16%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="16%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 295&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between one and two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between two and three years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 202&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between three and four years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 138&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 173&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between four and five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 150&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;081&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;419&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;485&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current portion of lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current portion of lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;At January 1, 2019 and December 31, 2019, there were no material future cash outflows, including extension options, excluded from the measurement of lease liabilities. The Group&amp;#x2019;s most material lease with a lease term extension, representing a lease liability value of USD 0.6 billion, has a determined lease term end date of 2071. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In 2019, the Group completed sale and leaseback transactions for certain property, plant and equipment as part of its plans to consolidate sites. Transactions resulted in net cash inflows of USD 0.7 billion and the recognition of USD 96 million of lease liabilities, and USD 37 million of right-of-use assets. The right-of-use assets value reflects the proportion of the property, plant and equipment retained for a period of one to five years, with two five-year extension periods for certain right-of-use assets. The liabilities reflect the net present value of future lease payments. The net gain on the sale and leaseback transactions amounted to USD 478 million. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table provides additional disclosures related to right-of-use assets and lease liabilities of continuing operations: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense on lease liabilities &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense on short-term leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense on low-value leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total cash outflows for leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Thereof:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cash outflows for short-term leases &lt;br&gt;&lt;/br&gt;and low-value leases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 15 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Payments of interest &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Payments of lease liabilities &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; The weighted average interest rate is 3.9%. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Cash flows from short-term and low-value leases are included within total net cash flows from operating activities. The portfolio of short-term leases to which the Group is committed to at December 31, 2019, is similar to the portfolio of short-term leases the Group entered into during 2019. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Included within total net cash flows from operating activities. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Reported as cash outflows used in financing activities net of lease incentives received of USD 33 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The net investment held and the income from subleasing right-of-use assets was not significant. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Note 30 provides additional disclosures on discontinued operations.&lt;/div&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
  <ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;11. Goodwill and intangible assets&lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of goodwill and intangible assets in 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Alcon &lt;br&gt;&lt;/br&gt; brand name &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Marketing &lt;br&gt;&lt;/br&gt; know-how &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 35&amp;nbsp;700&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 16&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 35&amp;nbsp;412&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;960&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 69&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to &lt;br&gt;&lt;/br&gt;discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;000 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;249 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;980 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;369 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;960 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;572 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;19&amp;nbsp;570 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group &lt;br&gt;&lt;/br&gt;held for sale, net &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 342&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;550&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;914&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 265&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 259&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 767&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;544&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;436&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;055&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 254&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 335&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;429&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 884&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 43&amp;nbsp;548&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 53&amp;nbsp;419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Accumulated amortization&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;406&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;21&amp;nbsp;218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;906&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&amp;nbsp;306&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated amortization/impairments &lt;br&gt;&lt;/br&gt;on assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 101 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4&amp;nbsp;184 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;592 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;906 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 128 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;813 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;657&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated impairments on disposals &lt;br&gt;&lt;/br&gt;and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 70 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 494 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 419 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 983 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;984&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;105&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;005&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;721&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;969&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;937&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;24&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;579&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 621&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 28&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Represents the cost of assets and accumulated amortization at January 1, 2019, related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to assets of disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; No addition in the disposal group held for sale for the period from January 1, 2019 to December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;6&amp;nbsp;&lt;/sup&gt; No amortization or impairment charges related to the disposal group held for sale for the period from January 1, 2019, to December 31, 2019. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of goodwill and intangible assets in 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Alcon &lt;br&gt;&lt;/br&gt; brand name &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Marketing &lt;br&gt;&lt;/br&gt; know-how &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;462&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;638&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;105&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;960&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;852&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 57&amp;nbsp;997&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group &lt;br&gt;&lt;/br&gt;held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;276 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;116 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;403 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;756&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;697&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 479&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 477&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 728&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 385&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;928&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;380&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;387&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;522&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;700&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;412&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;960&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 69&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Accumulated amortization&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;429&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;19&amp;nbsp;631&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;668&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;28&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated amortization/impairments &lt;br&gt;&lt;/br&gt;on assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 816 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 925 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;570&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;238&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;639&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated impairments on disposals &lt;br&gt;&lt;/br&gt;and derecognitions&lt;sup&gt;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 209 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 791 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 257 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;257 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;049&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 152&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;406&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;21&amp;nbsp;218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;906&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;30&amp;nbsp;306&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;294&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;047&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;495&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;054&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 38&amp;nbsp;719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to assets of disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; No addition in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Impairment charges related to the disposal group held for sale for the write-down of the allocated goodwill were USD 183 million and for the currently marketed products were USD 37 million (thereof USD 9 million recognized for the period from January 1, 2018, to the date of reclassification to assets held for sale). For amortization related to discontinued operations, refer to Note 30. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;6&amp;nbsp;&lt;/sup&gt; Amortization related to the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 45 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Innovative Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;339&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&amp;nbsp;720&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 520&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 27&amp;nbsp;586&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;767&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 85&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 859&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;125&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Corporate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;579&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 621&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 28&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2018: &lt;sup&gt;1&lt;/sup&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Alcon &lt;br&gt;&lt;/br&gt; brand name &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Marketing &lt;br&gt;&lt;/br&gt; know-how &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Innovative Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;377&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;228&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 431&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;115&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;875&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;899&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;054&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 363&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;679&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Corporate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;294&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;047&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;495&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;054&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 38&amp;nbsp;719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Innovative Medicines and Sandoz Divisions&amp;#x2019; cash-generating units, to which goodwill is allocated, each comprise a group of smaller cash-generating units. The valuation method of the recoverable amount of the cash-generating units, to which goodwill is allocated, is based on the fair value less costs of disposal. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following assumptions are used in the calculations:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(As a percentage) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative &lt;br&gt;&lt;/br&gt; Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Terminal growth rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Discount rate (post-tax)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The discount rates for all divisions consider the Group&amp;#x2019;s weighted average cost of capital, adjusted to approximate the weighted average cost of capital of a comparable market participant. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair value less costs of disposal, for all groupings of cash-generating units containing goodwill, is reviewed for the impact of reasonably possible changes in key assumptions. In particular, we considered an increase in the discount rate, a decrease in the terminal growth rate, and certain negative impacts on the forecasted cash flows. These reasonably possible changes in key assumptions did not indicate an impairment. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;&amp;#x201c;Note 1. Significant accounting policies&amp;mdash;Impairment of goodwill and intangible assets&amp;#x201d; provides additional disclosures on how the Group performs goodwill and intangible asset impairment testing. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the intangible asset and goodwill impairment charges for continuing operations for 2019, 2018 and 2017: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Innovative Medicines &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;669&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;591&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;506&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;652&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; 2019 includes an impairment of USD 416 million related to the write-down of IPR&amp;amp;D acquired through the 2015 Spinifex Pharmaceuticals Inc. acquisition and USD 108 million write-down related to cessation of clinical development program MOR106 for atopic dermatitis. &lt;br&gt;&lt;/br&gt;2018 includes an impairment of USD 400 million related to a partial write-down of the &lt;i&gt;Votrient&lt;/i&gt; currently marketed product. &lt;br&gt;&lt;/br&gt;2017 includes an impairment of USD 465 million related to the write-down of the Serelaxin IPR&amp;amp;D. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; 2019 includes impairment of USD 442 million related to the write-down of IPR&amp;amp;D related to the discontinuation of the generic Advair&amp;#xae; development program. &lt;br&gt;&lt;/br&gt;2018 includes impairments of USD 220 million related to the write-down of the allocated goodwill (USD 183 million) and the currently marketed products (USD 37 million) related to the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio. See Note 2. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2019, the reversal of prior year impairment charges amounted to USD 37 million (2018: nil, 2017: nil).&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Note 30 provides additional disclosures on discontinued operations.&lt;/div&gt;</ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory>
  <nvs:DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of goodwill and intangible assets in 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Alcon &lt;br&gt;&lt;/br&gt; brand name &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Marketing &lt;br&gt;&lt;/br&gt; know-how &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 35&amp;nbsp;700&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 16&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 35&amp;nbsp;412&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;960&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 69&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to &lt;br&gt;&lt;/br&gt;discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;000 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;249 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;980 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;369 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;960 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;572 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;19&amp;nbsp;570 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group &lt;br&gt;&lt;/br&gt;held for sale, net &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 342&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;550&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;914&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;069&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 265&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 259&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 767&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;544&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;436&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;055&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 254&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 335&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;429&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 884&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 43&amp;nbsp;548&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 53&amp;nbsp;419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Accumulated amortization&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;406&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;21&amp;nbsp;218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;906&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&amp;nbsp;306&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated amortization/impairments &lt;br&gt;&lt;/br&gt;on assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 101 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4&amp;nbsp;184 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;592 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;906 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 128 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 8&amp;nbsp;813 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;657&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated impairments on disposals &lt;br&gt;&lt;/br&gt;and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 70 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 494 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 419 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 983 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;984&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;105&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of impairment charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;005&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;721&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;969&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;937&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;24&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;579&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 621&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 28&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Represents the cost of assets and accumulated amortization at January 1, 2019, related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to assets of disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; No addition in the disposal group held for sale for the period from January 1, 2019 to December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;6&amp;nbsp;&lt;/sup&gt; No amortization or impairment charges related to the disposal group held for sale for the period from January 1, 2019, to December 31, 2019. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movements of goodwill and intangible assets in 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Alcon &lt;br&gt;&lt;/br&gt; brand name &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Marketing &lt;br&gt;&lt;/br&gt; know-how &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;462&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;638&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;105&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;960&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;852&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 57&amp;nbsp;997&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of assets related to disposal group &lt;br&gt;&lt;/br&gt;held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;276 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;116 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;403 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;756&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassifications &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;697&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 479&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 477&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 728&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 385&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals and derecognitions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;928&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;395&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;380&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;41&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;387&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;522&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;700&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 16&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;412&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;960&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;253&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 69&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Accumulated amortization&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;429&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;19&amp;nbsp;631&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;668&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;28&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated amortization/impairments &lt;br&gt;&lt;/br&gt;on assets related to disposal group held for sale &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 816 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 925 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;6&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;570&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;521&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;238&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;639&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accumulated impairments on disposals &lt;br&gt;&lt;/br&gt;and derecognitions&lt;sup&gt;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 209 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 791 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 257 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;257 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charge &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;049&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 152&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;406&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;120&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;21&amp;nbsp;218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;906&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;30&amp;nbsp;306&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;294&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;047&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;495&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;054&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 38&amp;nbsp;719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 2 provides additional disclosures related to assets of disposal group held for sale. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; No addition in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Impairment charges related to the disposal group held for sale for the write-down of the allocated goodwill were USD 183 million and for the currently marketed products were USD 37 million (thereof USD 9 million recognized for the period from January 1, 2018, to the date of reclassification to assets held for sale). For amortization related to discontinued operations, refer to Note 30. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;6&amp;nbsp;&lt;/sup&gt; Amortization related to the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 45 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock>
  <nvs:AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Innovative Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;339&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&amp;nbsp;720&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 520&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 27&amp;nbsp;586&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;767&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 85&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 859&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;125&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Corporate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 26&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;579&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 621&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 28&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2018: &lt;sup&gt;1&lt;/sup&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="1" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="1" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; In-process &lt;br&gt;&lt;/br&gt; research and &lt;br&gt;&lt;/br&gt; development &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Alcon &lt;br&gt;&lt;/br&gt; brand name &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Technologies &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currently &lt;br&gt;&lt;/br&gt; marketed &lt;br&gt;&lt;/br&gt; products &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Marketing &lt;br&gt;&lt;/br&gt; know-how &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other &lt;br&gt;&lt;/br&gt; intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Innovative Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;377&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;228&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 431&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;115&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;875&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;899&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;054&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 363&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;679&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Corporate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net book value at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 35&amp;nbsp;294&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;047&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;495&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;054&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 38&amp;nbsp;719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock>
  <nvs:AssumptionsUsedInTheCalculationOfValuationTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(As a percentage) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Innovative &lt;br&gt;&lt;/br&gt; Medicines &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Sandoz &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Terminal growth rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Discount rate (post-tax)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AssumptionsUsedInTheCalculationOfValuationTextBlock>
  <nvs:IntangibleAssetImpairmentChargesTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Innovative Medicines &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;669&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;591&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;506&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;841&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;652&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; 2019 includes an impairment of USD 416 million related to the write-down of IPR&amp;amp;D acquired through the 2015 Spinifex Pharmaceuticals Inc. acquisition and USD 108 million write-down related to cessation of clinical development program MOR106 for atopic dermatitis. &lt;br&gt;&lt;/br&gt;2018 includes an impairment of USD 400 million related to a partial write-down of the &lt;i&gt;Votrient&lt;/i&gt; currently marketed product. &lt;br&gt;&lt;/br&gt;2017 includes an impairment of USD 465 million related to the write-down of the Serelaxin IPR&amp;amp;D. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; 2019 includes impairment of USD 442 million related to the write-down of IPR&amp;amp;D related to the discontinuation of the generic Advair&amp;#xae; development program. &lt;br&gt;&lt;/br&gt;2018 includes impairments of USD 220 million related to the write-down of the allocated goodwill (USD 183 million) and the currently marketed products (USD 37 million) related to the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio. See Note 2. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:IntangibleAssetImpairmentChargesTextBlock>
  <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;12. Deferred tax assets and liabilities &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Property, &lt;br&gt;&lt;/br&gt; plant and &lt;br&gt;&lt;/br&gt; equipment &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pensions and &lt;br&gt;&lt;/br&gt; other benefit &lt;br&gt;&lt;/br&gt; obligations &lt;br&gt;&lt;/br&gt; of associates &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Inventories &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Tax loss &lt;br&gt;&lt;/br&gt; carry- &lt;br&gt;&lt;/br&gt; forwards &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Other assets, &lt;br&gt;&lt;/br&gt; provisions &lt;br&gt;&lt;/br&gt; and accruals &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax assets at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 191&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;722&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;782&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax liabilities at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;384&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;At January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net deferred tax balance related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;403&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 858&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Credited/(charged) to income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 605&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 308&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;818&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;166&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;313&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other movements &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;282&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax assets at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;078&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;446&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 255&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;596&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;952&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax liabilities at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;390&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;610&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;910&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;282&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;909&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;867&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax assets at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;090&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;786&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 97&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;380&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax liabilities at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;613&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;985&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;254&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;455&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;476&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;331&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;At January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;476&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;331&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net deferred tax balance related to disposal group held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Credited/(charged) to income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 378&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 368&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 582&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 77&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;493&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other movements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax assets at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 191&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;722&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;782&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax liabilities at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;384&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;699&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Includes USD 3 million net deferred tax movement related to disposal group held for sale &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table presents deferred tax assets and deferred tax liabilities, which are expected to have an impact on current taxes payable after more than 12&amp;nbsp;months: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expected to have an impact on current tax payable after more than 12 months&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;For unremitted earnings retained by consolidated entities for reinvestment, no provision is made for income taxes that would be payable upon the distribution of these earnings. If these earnings were remitted, an income tax charge could result based on the tax statutes currently in effect. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Unremitted earnings that have been retained &lt;br&gt;&lt;/br&gt;by consolidated entities for reinvestment &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 61 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 73 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Temporary differences on which no deferred tax has been provided as they are permanent in nature related to: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Investments in subsidiaries&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Goodwill from acquisitions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The gross value of tax-loss carry-forwards that have or have not been capitalized as deferred tax assets, with their expiry dates, is as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Not capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;One year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Three years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Four years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 127&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 164&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;More than five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 435&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 648&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;986&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Not capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;One year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Three years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Four years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 381&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;More than five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 522&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;288&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 996&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tax losses carried forward &lt;br&gt;&lt;/br&gt;that expired &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Deferred tax assets related to taxable losses of relevant Group entities are recognized to the extent it is considered probable that future taxable profits will be available against which such losses can be utilized in the foreseeable future. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The Basel-Stadt cantonal tax reform was approved by voters in February 2019, with parts of the reform retroactively enacted per January 1, 2019. The newly enacted tax rate resulted in a decrease of the blended cantonal and federal tax rate from 22% to 13%. This change impacts the Group&amp;#x2019;s Basel-Stadt-domiciled operating subsidiaries. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Swiss federal tax reform was approved by voters in May 2019. The enactment of the Swiss federal tax reform requires the abolishment of the holding company tax regimes as of January 1, 2020. As a result, the holding company tax rate will increase from the current 8% to 13%, effective January 1, 2020. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The enactment of these Swiss tax reforms required a revaluation of the deferred tax assets and liabilities to the newly enacted tax rates at the date of enactment. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the impact on the revaluation of deferred assets and liabilities in 2019, as at the respective dates of the enactment of the Swiss tax reforms: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income &lt;br&gt;&lt;/br&gt; statement &lt;br&gt;&lt;/br&gt; continuing &lt;br&gt;&lt;/br&gt; operations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax asset &lt;br&gt;&lt;/br&gt;and liability revaluation &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized &lt;br&gt;&lt;/br&gt;in consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 234 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 234 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized in other comprehensive income &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;358&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;358&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total revaluation of deferred tax assets and liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 234&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;358&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Related to post-employment benefits &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;On December 22, 2017, the US enacted tax reform legislation (the Tax Cuts and Jobs Act), which &amp;ndash; among other provisions &amp;ndash; reduced the US corporate tax rate from 35% to 21%, effective January 1, 2018. This required a revaluation of the deferred tax assets and liabilities, and a portion of current tax payables to the newly enacted tax rates at the date of enactment. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The enacted US tax reform legislation includes a provision that requires the US parent company&amp;#x2019;s foreign subsidiaries&amp;#x2019; unremitted earnings to be subject to an immediate toll tax on the qualifying amount of unremitted earnings (the deemed repatriated earnings). Previously, these earnings were taxable upon distribution to the US parent company. The toll tax amount owed is payable, without interest, in installments over an eight-year period through 2024. Certain of the Group&amp;#x2019;s US subsidiaries are the parent company of non-US-domiciled companies, and as a result, USD 70 million of deferred tax liabilities related to these entities&amp;#x2019; unremitted earnings, the majority of which were recognized in 2016, were reclassified to current income tax liabilities at December 31, 2017. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the impact on the revaluation of deferred assets and liabilities, and current income tax liabilities at December 31, 2017: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Income &lt;br&gt;&lt;/br&gt; statement &lt;br&gt;&lt;/br&gt; continuing &lt;br&gt;&lt;/br&gt; operations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax asset &lt;br&gt;&lt;/br&gt;and liability revaluation &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized &lt;br&gt;&lt;/br&gt;in consolidated income statement &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized &lt;br&gt;&lt;/br&gt;in other comprehensive income &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;254 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;254 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized in retained earnings &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total revaluation of deferred &lt;br&gt;&lt;/br&gt;tax assets and liabilities &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;325 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;765 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total revaluation of current tax payables &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total revaluation of deferred tax assets and liabilities, and current income tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;799&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Items previously recognized in discontinued operations amounted to USD 416 million &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Related to post-employment benefits and available-for-sale financial investments (attributable to continuing operations USD -241 million and attributable to discontinued operations USD -13 million) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Related to equity-based compensation plans (attributable to continuing operations USD -66 million and attributable to discontinued operations USD -5 million) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Revaluation of current tax payable attributable to discontinued operations amounted to USD -3 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
  <nvs:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Property, &lt;br&gt;&lt;/br&gt; plant and &lt;br&gt;&lt;/br&gt; equipment &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Intangible &lt;br&gt;&lt;/br&gt; assets &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pensions and &lt;br&gt;&lt;/br&gt; other benefit &lt;br&gt;&lt;/br&gt; obligations &lt;br&gt;&lt;/br&gt; of associates &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Inventories &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Tax loss &lt;br&gt;&lt;/br&gt; carry- &lt;br&gt;&lt;/br&gt; forwards &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Other assets, &lt;br&gt;&lt;/br&gt; provisions &lt;br&gt;&lt;/br&gt; and accruals &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax assets at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 191&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;722&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;782&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax liabilities at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;384&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;At January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net deferred tax balance related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;403&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 858&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Credited/(charged) to income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 605&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 308&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;818&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 354&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;166&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;313&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other movements &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;282&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax assets at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;078&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;446&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 255&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;596&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;952&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax liabilities at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;390&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;610&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;291&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;910&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;282&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;909&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;867&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax assets at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;287&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;090&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;786&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 97&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;380&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross deferred tax liabilities at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;613&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;985&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;254&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;455&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;476&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;331&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;At January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;476&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;331&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;061&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net deferred tax balance related to disposal group held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Credited/(charged) to income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 378&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 368&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 582&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Charged to other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 77&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 298&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;493&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other movements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax assets at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 191&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;722&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;782&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gross deferred tax liabilities at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;384&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;431&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 915&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;248&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;370&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;699&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;475&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net deferred tax balance at December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;b&gt; &lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Includes USD 3 million net deferred tax movement related to disposal group held for sale &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
  <nvs:DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expected to have an impact on current tax payable after more than 12 months&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock>
  <nvs:DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Unremitted earnings that have been retained &lt;br&gt;&lt;/br&gt;by consolidated entities for reinvestment &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 61 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 73 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock>
  <nvs:DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;13. Financial and other non-current assets&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Financial assets&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;790&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;437&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term receivables from customers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 164&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Minimum lease payments &lt;br&gt;&lt;/br&gt;from finance lease agreements &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 91 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term receivables from finance subleases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other long-term receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans, advances and security deposits&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 254&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;518&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 30 provides additional disclosures on minimal lease payments from finance lease agreements that relate to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 29 provides additional disclosures related to contingent considerations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;"&gt;Other non-current assets&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred compensation plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 414&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 468&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prepaid post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 176&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 290&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 738&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 895&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock>
  <nvs:DisclosureOfFinancialAssetsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;155&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;790&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;437&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term receivables from customers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 164&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Minimum lease payments &lt;br&gt;&lt;/br&gt;from finance lease agreements &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 91 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term receivables from finance subleases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other long-term receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans, advances and security deposits&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 254&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;518&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 30 provides additional disclosures on minimal lease payments from finance lease agreements that relate to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 29 provides additional disclosures related to contingent considerations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfFinancialAssetsTableTextBlock>
  <nvs:DisclosureOfOtherNoncurrentAssetsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred compensation plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 414&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 468&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prepaid post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 176&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 290&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 738&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 895&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOtherNoncurrentAssetsTableTextBlock>
  <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;14. Inventories&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Raw material, consumables&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 751&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 931&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Work in progress&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Finished products&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;207&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;982&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;956&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the amount of inventory recognized as an expense in &amp;#x201c;Cost of goods sold&amp;#x201d; in the consolidated income statements from continuing operations: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the recognized amount of inventory provision and reversals of inventory provision recorded in the consolidated income statements from continuing operations: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventory provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;752&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;416&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversals of inventory provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 216&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 172&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The reversals mainly result from the release of products initially requiring additional quality control inspections and from the reassessment of inventory values manufactured prior to regulatory approval but for which approval was subsequently received. &lt;/div&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
  <nvs:ScheduleOfInventoryCurrentTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Raw material, consumables&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 751&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 931&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Work in progress&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Finished products&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;207&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;982&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;956&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfInventoryCurrentTableTextBlock>
  <nvs:DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock>
  <nvs:DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventory provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;752&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;416&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversals of inventory provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 218&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 216&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 172&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock>
  <nvs:DisclosureOfTradeReceivablesExplanatoryTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;15. Trade receivables&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total gross trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;396&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;853&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for doubtful trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total trade receivables, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table summarizes the movement in the provision for doubtful trade receivables:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;162&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combination&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for doubtful trade receivables charged to the consolidated income statement &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Utilization of provisions for doubtful trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of provisions for doubtful trade receivables credited to the consolidated income statement &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 30 million in 2018 and USD 94 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Reversal of provisions credited to the consolidated income statement from continuing operations were USD 44 million in 2018 and USD 60 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following sets forth the trade receivables that are not overdue as specified in the payment terms and conditions established with Novartis customers, as well as an analysis of overdue amounts and related provisions for doubtful trade receivables: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Not overdue&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;763&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;916&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for not more than one month&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 161&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 296&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than one month &lt;br&gt;&lt;/br&gt;but less than three months &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 123 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 194 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than three months &lt;br&gt;&lt;/br&gt;but less than six months &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 103 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 136 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than six months &lt;br&gt;&lt;/br&gt;but less than one year &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 96 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 98 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than one year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 213&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for doubtful trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total trade receivables, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Trade receivable balances include sales to drug wholesalers, retailers, private health systems, government agencies, managed care providers, pharmacy benefit managers and government-supported healthcare systems. Novartis continues to monitor sovereign debt issues and economic conditions in the countries it operates, particularly in Argentina, Brazil, Greece, Italy, Portugal, Russia, Saudi Arabia, Spain and Turkey, and evaluates trade receivables in these countries for potential collection risks. The majority of the outstanding trade receivables from Portugal, Saudi Arabia and Spain are due directly from local governments or from government-funded entities. Deteriorating credit and economic conditions as well as other factors in these closely monitored countries have resulted in, and may continue to result in, an increase in the average length of time that it takes to collect these trade receivables, and may require the Group to re-evaluate the estimated collectible amount of these trade receivables in future periods. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the gross trade receivables balance from these closely monitored countries at December 31, 2019 and 2018; the amounts that are past due for more than one year; and the related provisions that have been recorded: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total balance of gross trade &lt;br&gt;&lt;/br&gt;receivables from closely &lt;br&gt;&lt;/br&gt;monitored countries &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;588 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;729 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than one year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 97&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;At December 31, 2019, amounts past due for more than one year are not significant in any of these countries on a standalone basis. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Total trade receivables include amounts denominated in the following major currencies:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US dollar (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;510&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Euro (EUR)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;384&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japanese yen (JPY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 658&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Russian ruble (RUB)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 247&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Chinese yuan (CNY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 279&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 282&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;British pound (GBP)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Brazilian real (BRL)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 206&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canadian dollar (CAD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 136&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Australian dollar (AUD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 125&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 161&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Swiss franc (CHF)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other currencies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;655&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;693&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total trade receivables, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfTradeReceivablesExplanatoryTextBlock>
  <nvs:ProvisionsForTradeReceivablesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total gross trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;396&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;853&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for doubtful trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total trade receivables, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ProvisionsForTradeReceivablesTableTextBlock>
  <nvs:TradeReceivablesProvisionMovementsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;162&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combination&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for doubtful trade receivables charged to the consolidated income statement &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Utilization of provisions for doubtful trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reversal of provisions for doubtful trade receivables credited to the consolidated income statement &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 30 million in 2018 and USD 94 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Reversal of provisions credited to the consolidated income statement from continuing operations were USD 44 million in 2018 and USD 60 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:TradeReceivablesProvisionMovementsTableTextBlock>
  <nvs:OverdueAmountsAndRelatedProvisionsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Not overdue&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;763&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;916&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for not more than one month&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 161&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 296&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than one month &lt;br&gt;&lt;/br&gt;but less than three months &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 123 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 194 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than three months &lt;br&gt;&lt;/br&gt;but less than six months &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 103 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 136 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than six months &lt;br&gt;&lt;/br&gt;but less than one year &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 96 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 98 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than one year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 213&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for doubtful trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;95&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total trade receivables, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:OverdueAmountsAndRelatedProvisionsTableTextBlock>
  <nvs:GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total balance of gross trade &lt;br&gt;&lt;/br&gt;receivables from closely &lt;br&gt;&lt;/br&gt;monitored countries &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;588 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;729 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past due for more than one year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 97&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock>
  <nvs:TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US dollar (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;466&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;510&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Euro (EUR)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;384&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;551&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japanese yen (JPY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 658&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Russian ruble (RUB)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 247&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Chinese yuan (CNY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 279&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 282&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;British pound (GBP)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Brazilian real (BRL)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 206&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canadian dollar (CAD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 136&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Australian dollar (AUD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 125&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 161&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Swiss franc (CHF)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other currencies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;655&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;693&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total trade receivables, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;301&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock>
  <nvs:DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;16. Marketable securities, commodities, time&amp;nbsp;deposits, derivative financial instruments, and&amp;nbsp;cash and cash equivalents&lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Market&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;able securities, commodities, time&amp;nbsp;deposits and derivative financial instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short-term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interest on debt securities, time deposits and short-term investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities, commodities, time deposits and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 334&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;693&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table provides a breakdown of debt securities by currency:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US dollar (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 302&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Euro (EUR)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japanese yen (JPY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Cash and cash equivalents&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current accounts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;247&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short-term investments with original maturity less than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;865&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock>
  <nvs:MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short-term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interest on debt securities, time deposits and short-term investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities, commodities, time deposits and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 334&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;693&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock>
  <nvs:DebtSecuritiesBreakdownByCurrencyTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US dollar (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 302&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Euro (EUR)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japanese yen (JPY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DebtSecuritiesBreakdownByCurrencyTableTextBlock>
  <nvs:CashAndCashEquivalentsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current accounts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;247&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short-term investments with original maturity less than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;865&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:CashAndCashEquivalentsTableTextBlock>
  <ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;17. Other current assets&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;VAT receivable&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 508&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 588&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Withholding tax recoverable&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prepaid expenses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Third parties&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 811&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Receivables from associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other receivables and current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;680&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;861&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory>
  <nvs:OtherCurrentAssetsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;VAT receivable&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 508&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 588&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Withholding tax recoverable&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prepaid expenses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Third parties&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 898&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 811&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Receivables from associated companies&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other receivables and current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;165&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;680&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;861&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:OtherCurrentAssetsTableTextBlock>
  <nvs:DisclosureOfEquityTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;18. Equity&lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the movement in the share capital:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Jan 1, 2017 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Movement &lt;br&gt;&lt;/br&gt; in year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Dec 31, 2017 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Movement &lt;br&gt;&lt;/br&gt; in year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Dec 31, 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Movement &lt;br&gt;&lt;/br&gt; in year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Dec 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Share capital&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 972&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 969&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 944&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 936&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Treasury shares&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Outstanding share capital&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 896&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 869&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 875&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 856&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the movement in the shares:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Number of outstanding shares &lt;br&gt;&lt;/br&gt;(in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Note &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; Novartis &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; treasury &lt;br&gt;&lt;/br&gt; shares &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; Novartis &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; treasury &lt;br&gt;&lt;/br&gt; shares &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; Novartis &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; treasury &lt;br&gt;&lt;/br&gt; shares &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Balance at beginning of year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;550.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;239.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;311.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;616.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;299.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;317.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;627.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;253.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;374.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares canceled for capital &lt;br&gt;&lt;/br&gt;reduction &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;10.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 10.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares acquired to be &lt;br&gt;&lt;/br&gt;canceled &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;60.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;60.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share purchases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise of options &lt;br&gt;&lt;/br&gt;and employee transactions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 18.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares delivered to Alcon &lt;br&gt;&lt;/br&gt;employees &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 0.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 0.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total movements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;23.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;22.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;46.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;66.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 59.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;46.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;56.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Balance at end of year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;527.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;262.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;265.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;550.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;239.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;311.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;616.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;299.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;317.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Approximately 117.6 million treasury shares (2018: 121.6 million; 2017: 131.3 million) are held in Novartis entities that restrict their availability for use. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Novartis reduced its share capital by canceling shares that were repurchased on the SIX Swiss Exchange second trading line during previous years. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 Annual General Meeting (AGM) for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Shares acquired from employees, which were previously granted to them under the respective programs &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Shares delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;18.1) The amount available for distribution as a dividend to shareholders is based on the available distributable retained earnings of Novartis AG determined in accordance with the legal provisions of the Swiss Code of Obligations. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dividend per share (in CHF)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.85&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.80&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.75&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total dividend payment &lt;br&gt;&lt;/br&gt;(in USD billion) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 6.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.0 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 6.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;18.2) The following table summarizes the treasury shares movements:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Note &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Number of &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;br&gt;&lt;/br&gt; (in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity impact &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Number of &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;br&gt;&lt;/br&gt; (in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity impact &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Number of &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;br&gt;&lt;/br&gt; (in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity impact &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares acquired to be canceled &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;60.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;351&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;23.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;66.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;270&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share purchases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Purchase of treasury shares&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;62.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;511&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;24.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;973&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;70.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;574&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise of options and employee transactions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 210&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 434&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 255&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4,5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 756&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares delivered to Alcon employees&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;46.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;450&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;520&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;56.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;707&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 AGM for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Shares acquired from employees, which were previously granted to them under the respective programs &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Shares delivered as a result of options being exercised related to equity-based participation plans and the delivery of treasury shares. The average share price of the shares delivered was significantly below market price, reflecting the strike price of the options exercised. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Equity-settled share-based compensation is expensed in the consolidated income statement in accordance with the vesting period of the share-based compensation plans. The value for the shares and options granted is credited to consolidated equity over the respective vesting period. In addition, tax benefits arising from tax-deductible amounts exceeding the expense recognized in the income statement are credited to equity. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Included in 2017 is a USD 71 million impact related to the revaluation of deferred tax assets on equity-based compensation that were previously recognized through retained earnings. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;18.3) In 2019, Novartis entered into an irrevocable, non-discretionary arrangement with a bank to repurchase Novartis shares on the second trading line under its up-to USD&amp;nbsp;5 billion share buyback. Novartis was able to cancel this arrangement at any time but could be subject to a 90-day waiting period. The commitment under this arrangement therefore reflects the obligated purchases by the bank under such trading plan over a rolling 90-day period, or if shorter, until the maturity date of such trading plan. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As of December 31, 2019, this trading plan commitment was fully executed and expired, and as a consequence, there is no contingent liability related to this plan recognized. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In 2018 and 2017, Novartis entered into a similar irrevocable, non-discretionary arrangements with a bank to repurchase Novartis shares. The commitments under these arrangements reflected the expected purchases by the bank under such trading plans over a rolling 90-day period. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The commitment under this arrangement amounted to USD 284 million as of December 31, 2018. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;As of December 31, 2017, this trading plan commitment was fully executed and expired, and as a consequence, there was no contingent liability related to this plan recognized. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;18.4) Transaction costs of USD 253 million (2018: USD 79 million; 2017: USD nil) net of tax of USD 36 million (2018: USD 20 million; 2017: USD nil), that are directly attributable to the distribution (spin-off) of Alcon Inc. to Novartis shareholders and that would otherwise have been avoided, are recorded as a deduction from equity. See Note 1. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;18.5) The impact of change in ownership of consolidated entities represents the excess of the amount paid to non-controlling interest over their carrying value and equity allocation to non-controlling interest due to change in ownership percentage. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;18.6) Changes in non-controlling interests represent the impact on the non-controlling interest of transactions with minority shareholders, such as change in ownership percentage, dividend payments and other equity transactions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;18.7) Other movements includes, for subsidiaries in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period as well as the restatement of the equity balances of the current year. In 2019, the amount recorded in equity related to hyperinflation accounting was USD 22 million (2018: USD 38 million; 2017: USD nil). See Note 29 for additional disclosures. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;18.8) At December 31, 2019, the market maker held 13 million (2018: 11 million; 2017: 12 million) written call options, originally issued as part of the share-based compensation for associates, that have not yet been exercised. The weighted average exercise price of these options is USD 63.90 (2018: USD 62.70; 2017: USD 62.17), and they have contractual lives of 10 years, with remaining lives up to four years (2018: five years; 2017: six years). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In December 2018, Novartis entered into an agreement with the market maker for its employee options to repurchase a portion of the outstanding written call options that are not exercised in exchange for treasury shares. During 2019, this agreement was fully executed. &lt;/div&gt;</nvs:DisclosureOfEquityTextBlock>
  <nvs:MovementInTheShareCapitalTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Jan 1, 2017 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Movement &lt;br&gt;&lt;/br&gt; in year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Dec 31, 2017 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Movement &lt;br&gt;&lt;/br&gt; in year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Dec 31, 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Movement &lt;br&gt;&lt;/br&gt; in year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Dec 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Share capital&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 972&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 969&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 944&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 936&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Treasury shares&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Outstanding share capital&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 896&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 869&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 875&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 856&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:MovementInTheShareCapitalTableTextBlock>
  <nvs:MovementInTheShareslTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Number of outstanding shares &lt;br&gt;&lt;/br&gt;(in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Note &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; Novartis &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; treasury &lt;br&gt;&lt;/br&gt; shares &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; Novartis &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; treasury &lt;br&gt;&lt;/br&gt; shares &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; Novartis &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; treasury &lt;br&gt;&lt;/br&gt; shares &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Balance at beginning of year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;550.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;239.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;311.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;616.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;299.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;317.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;627.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;253.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="4%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;374.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares canceled for capital &lt;br&gt;&lt;/br&gt;reduction &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;10.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 10.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares acquired to be &lt;br&gt;&lt;/br&gt;canceled &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;60.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;60.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;23.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;66.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share purchases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise of options &lt;br&gt;&lt;/br&gt;and employee transactions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 18.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares delivered to Alcon &lt;br&gt;&lt;/br&gt;employees &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 0.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 0.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total movements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;23.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;22.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;46.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;66.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 59.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;46.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;56.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Balance at end of year&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;527.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;262.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;265.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;550.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;239.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;311.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;616.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;299.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;317.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="22" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Approximately 117.6 million treasury shares (2018: 121.6 million; 2017: 131.3 million) are held in Novartis entities that restrict their availability for use. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Novartis reduced its share capital by canceling shares that were repurchased on the SIX Swiss Exchange second trading line during previous years. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 Annual General Meeting (AGM) for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Shares acquired from employees, which were previously granted to them under the respective programs &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Shares delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="22"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:MovementInTheShareslTableTextBlock>
  <nvs:DividendTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dividend per share (in CHF)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.85&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.80&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.75&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total dividend payment &lt;br&gt;&lt;/br&gt;(in USD billion) &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 6.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.0 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 6.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DividendTableTextBlock>
  <nvs:SummaryOfTreasurySharesMovementsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Note &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Number of &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;br&gt;&lt;/br&gt; (in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity impact &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Number of &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;br&gt;&lt;/br&gt; (in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity impact &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Number of &lt;br&gt;&lt;/br&gt; outstanding &lt;br&gt;&lt;/br&gt; shares &lt;br&gt;&lt;/br&gt; (in millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity impact &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares acquired to be canceled &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;60.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;351&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;23.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;66.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="6%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;270&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share purchases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Purchase of treasury shares&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;62.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;511&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;24.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;973&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;70.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;574&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise of options and employee transactions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 210&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 434&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 255&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4,5&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 756&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shares delivered to Alcon employees&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other share sales&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;46.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;450&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;520&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;56.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;707&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="16" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 AGM for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Shares acquired from employees, which were previously granted to them under the respective programs &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Shares delivered as a result of options being exercised related to equity-based participation plans and the delivery of treasury shares. The average share price of the shares delivered was significantly below market price, reflecting the strike price of the options exercised. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Equity-settled share-based compensation is expensed in the consolidated income statement in accordance with the vesting period of the share-based compensation plans. The value for the shares and options granted is credited to consolidated equity over the respective vesting period. In addition, tax benefits arising from tax-deductible amounts exceeding the expense recognized in the income statement are credited to equity. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;5&amp;nbsp;&lt;/sup&gt; Included in 2017 is a USD 71 million impact related to the revaluation of deferred tax assets on equity-based compensation that were previously recognized through retained earnings. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:SummaryOfTreasurySharesMovementsTableTextBlock>
  <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;19. Non-current financial debt&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Liabilities to banks and other financial institutions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Finance lease obligations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 92&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total, including current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Average interest rate 0.2% (2018: 0.3%) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;All bonds are initially recorded at the amount of proceeds received, net of transaction costs. They are subsequently carried at amortized cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognized as a charge to the consolidated income statement over the period of the relevant bond. Financial debts, including current financial debts, contain only general default covenants. The Group is in compliance with these covenants. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The percentage of fixed-rate financial debt to total financial debt was 82% at December 31, 2019, and 80% at December 31, 2018.&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The average interest rate on total financial debt in 2019 was 2.4% (2018: 2.7%).&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Note 29 contains a maturity table of the Group&amp;#x2019;s future contractual interest payments commitments. &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table provides a breakdown of straight bonds:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Coupon &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Currency &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Nominal &lt;br&gt;&lt;/br&gt; amount &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Issuance &lt;br&gt;&lt;/br&gt; year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Maturity &lt;br&gt;&lt;/br&gt; year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Issuer &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Issue price &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;br&gt;&lt;/br&gt; (USD &lt;br&gt;&lt;/br&gt; millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;br&gt;&lt;/br&gt; (USD &lt;br&gt;&lt;/br&gt; millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;5.125%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2009&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Securities Investment Ltd., Hamilton, Bermuda&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.822%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;4.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2010&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.237%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 998&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.225%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;495&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;493&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.700%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.325%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.287%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;139&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;4.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;850&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2044&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.196%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.750%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.134%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 683&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.625%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2026&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.697%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.250%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis AG, Basel, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.640%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 508&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.625%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 550&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2029&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis AG, Basel, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.502%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.050%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2035&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis AG, Basel, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.479%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 330&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.000%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.010%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;735&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;4.000%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2045&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.029%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;219&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;219&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.125%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.127%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;392&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.625%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.480%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 553&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 563&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.800%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.609%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 998&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.449%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 996&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 995&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2027&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.109%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 990&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 989&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.000%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.133%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.125%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2027&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.874%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.500%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.655%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 853&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.375%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2030&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.957%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 856&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.700%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2038&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.217%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 832&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 849&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following tables provide a breakdown of total non-current financial debt, including current portion by maturity and currency: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Breakdown by maturity:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;006&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;067&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;111&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;583&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;139&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After 2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Breakdown by currency:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US dollar (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;889&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Euro (EUR)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;861&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japanese yen (JPY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 272&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Swiss franc (CHF)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the comparison of balance sheet and fair value of total non-current financial debt, including current portion: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;br&gt;&lt;/br&gt; Balance &lt;br&gt;&lt;/br&gt; sheet &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;br&gt;&lt;/br&gt; Fair &lt;br&gt;&lt;/br&gt; values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;br&gt;&lt;/br&gt; Balance &lt;br&gt;&lt;/br&gt; sheet &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;br&gt;&lt;/br&gt; Fair &lt;br&gt;&lt;/br&gt; values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Others&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 377&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 377&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;889&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;815&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The fair values of straight bonds are determined by quoted market prices. Other financial debts are recorded at notional amounts, which are a reasonable approximation of the fair values. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the pledged assets:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total net book value of property, &lt;br&gt;&lt;/br&gt;plant and equipment pledged as &lt;br&gt;&lt;/br&gt;collateral for non-current financial debts &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 96 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
  <nvs:DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Liabilities to banks and other financial institutions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Finance lease obligations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 92&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total, including current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Average interest rate 0.2% (2018: 0.3%) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock>
  <nvs:DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Coupon &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Currency &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Nominal &lt;br&gt;&lt;/br&gt; amount &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Issuance &lt;br&gt;&lt;/br&gt; year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Maturity &lt;br&gt;&lt;/br&gt; year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Issuer &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Issue price &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;br&gt;&lt;/br&gt; (USD &lt;br&gt;&lt;/br&gt; millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;br&gt;&lt;/br&gt; (USD &lt;br&gt;&lt;/br&gt; millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;5.125%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2009&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Securities Investment Ltd., Hamilton, Bermuda&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.822%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;4.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2010&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.237%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 998&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.225%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;495&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;493&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.700%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2012&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.325%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 489&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.287%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;139&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;4.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;850&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2044&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.196%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;825&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.750%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.134%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 683&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.625%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2014&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2026&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.697%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.250%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis AG, Basel, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.640%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 508&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.625%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 550&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2029&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis AG, Basel, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.502%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 568&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.050%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2035&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis AG, Basel, Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.479%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 330&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.000%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.010%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;735&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;4.000%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2015&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2045&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.029%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;219&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;219&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.125%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.127%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;392&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;419&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.625%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2016&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.480%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 553&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 563&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.800%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.609%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 998&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2.400%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.449%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 996&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 995&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;3.100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2027&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Capital Corporation, New York, United States&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.109%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 990&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 989&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.000%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.133%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.125%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2027&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.874%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;0.500%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.655%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 853&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.375%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2030&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.957%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 856&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1.700%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 750&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2038&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Novartis Finance S.A., Luxembourg, Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.217%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 832&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 849&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock>
  <nvs:DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;006&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;067&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;111&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;583&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;139&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After 2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock>
  <nvs:DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US dollar (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;889&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Euro (EUR)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;861&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;028&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japanese yen (JPY)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 272&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Swiss franc (CHF)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock>
  <nvs:DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;br&gt;&lt;/br&gt; Balance &lt;br&gt;&lt;/br&gt; sheet &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;br&gt;&lt;/br&gt; Fair &lt;br&gt;&lt;/br&gt; values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;br&gt;&lt;/br&gt; Balance &lt;br&gt;&lt;/br&gt; sheet &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;br&gt;&lt;/br&gt; Fair &lt;br&gt;&lt;/br&gt; values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Others&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 377&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 377&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;889&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25&amp;nbsp;815&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock>
  <nvs:DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total net book value of property, &lt;br&gt;&lt;/br&gt;plant and equipment pledged as &lt;br&gt;&lt;/br&gt;collateral for non-current financial debts &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 96 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock>
  <ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;20. Provisions and other non-current liabilities&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued liability for employee benefits:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Defined benefit pension plans &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;546&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other long-term employee benefits and deferred compensation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other post-employment benefits &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Environmental remediation provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 634&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for product liabilities, governmental investigations and other legal matters&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 958&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 255&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 497&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total provisions and other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 25 provides additional disclosures related to post-employment benefits. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 29 provides additional disclosures related to contingent consideration. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis believes that its total provisions are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities in this area, Novartis may incur additional costs beyond the amounts provided. Management believes that such additional amounts, if any, would not be material to the Group&amp;#x2019;s financial condition but could be material to the results of operations or cash flows in a given period. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Environmental remediation provisions&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the movements in the environmental liability provisions:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 692&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 761&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 773&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Releases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 154&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 692&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 761&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current provision&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current environmental remediation provisions at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 634&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 706&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Releases of provisions credited to the consolidated income statement from continuing operations were USD 21 million in 2018 and USD 153 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 7 million in 2018 and USD 154 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The material components of the environmental remediation provisions consist of costs to sufficiently clean and refurbish contaminated sites to the extent necessary and to continue surveillance at sites where the environmental remediation exposure is less significant. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;A substantial portion of the environmental remediation provisions relate to the remediation of Basel regional landfills in the adjacent border areas in Switzerland, Germany and France. The provisions are reassessed on a yearly basis and adjusted as necessary. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the United States, Novartis has been named under federal legislation (the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended) as a potentially responsible party (PRP) in respect of certain sites. Novartis actively participates in, or monitors, the cleanup activities at the sites in which it is a PRP. The provision takes into consideration the number of other PRPs at each site as well as the identity and financial position of such parties in light of the joint and several nature of the liability. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The expected timing of the related cash outflows as of December 31, 2019, is currently projected as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Expected &lt;br&gt;&lt;/br&gt; cash outflows &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due within two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 141&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due later than two years, but within five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 210&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due later than five years, but within 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 258&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due after 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 105&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total environmental remediation liability provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Provisions for product liabilities, governmental investigations and other legal matters&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has established provisions for certain product liabilities, governmental investigations and other legal matters where a potential cash outflow is probable and Novartis can make a reliable estimate of the amount of the outflow. These provisions represent the Group&amp;#x2019;s current best estimate of the total financial effect for the matters described below and for other less significant matters. Potential cash outflows reflected in a provision might be fully or partially offset by insurance in certain circumstances. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Novartis has not established provisions for potential damage awards for certain additional legal claims against its subsidiaries if Novartis currently believes that a payment is either not probable or cannot be reliably estimated. In total, these not-provisioned-for matters include more than 3&amp;#xa0;000 individual product liability cases and certain other legal matters. Plaintiffs&amp;#x2019; alleged claims in these matters, which Novartis does not believe to be entirely remote but which do not fulfill the conditions for the establishment of provisions, currently aggregate to, according to the current best belief of Novartis, approximately USD&amp;nbsp;0.9 billion. In addition, in some of these matters there are claims for punitive or multiple (treble) damages, civil penalties and disgorgement of profits that in the view of Novartis are either wholly or partially unspecified, or wholly or partially unquantifiable at present; the Group believes that information about these amounts claimed by plaintiffs generally is not meaningful for purposes of determining a reliable estimate of a loss that is probable or more than remote. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;A number of other legal matters are in such early stages or the issues presented are such that the Group has not made any provisions since it cannot currently estimate either a potential outcome or the amount of any potential losses. For these reasons, among others, the Group generally is unable to make a reliable estimate of possible loss with respect to such cases. It is therefore not practicable to provide information about the potential financial impact of those cases. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;There might also be cases for which the Group was able to make a reliable estimate of the possible loss or the range of possible loss, but the Group believes that publication of such information on a case-by-case basis would seriously prejudice the Group&amp;#x2019;s position in ongoing legal proceedings or in any related settlement discussions. Accordingly, in such cases, information has been disclosed with respect to the nature of the contingency, but no disclosure is provided as to an estimate of the possible loss or range of possible loss. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Note 28 contains additional information on contingencies.&lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Alcon spin-off &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On April 9, 2019, the Alcon spin-off was completed (see Note 2). Under the Separation and Distribution Agreement that Novartis entered into with Alcon in connection with the separation and the spin-off, Novartis and Alcon each agreed, subject to certain conditions and exclusions, and except to the extent otherwise described below with respect to any matter, to indemnify the other party and its directors, officers, employees and agents against any pending or future liabilities that constitute either a Novartis liability, in the case of Novartis, or an Alcon liability, in the case of Alcon, with the nature of any relevant liability being determined based on whether such claim or liability relates to the Novartis or the Alcon business and products. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Summary of significant legal proceedings&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following is a summary of significant legal proceedings to which Novartis or its subsidiaries are a party or were a party and that concluded in 2019. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Investigations and related litigations&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Southern District of New York (S.D.N.Y.) marketing practices investigation and litigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2013, the US government filed a civil complaint in intervention to an individual &lt;i&gt;qui tam&lt;/i&gt; action against Novartis Pharmaceuticals Corporation (NPC) in the United States District Court (USDC) for the S.D.N.Y. The complaint, as subsequently amended, asserts federal False Claims Act (FCA) and common law claims with respect to speaker programs and other promotional activities for certain NPC cardiovascular medications ( &lt;i&gt;Lotrel&lt;/i&gt;, &lt;i&gt;Starlix&lt;/i&gt; and &lt;i&gt;Valturna&lt;/i&gt;) allegedly serving as mechanisms to provide kickbacks to healthcare professionals (HCPs). Also in 2013, New York State filed a civil complaint in intervention asserting similar claims. Neither government complaint in intervention adopted the individual relator&amp;#x2019;s claims with respect to off-label promotion of &lt;i&gt;Valturna&lt;/i&gt;, which were subsequently dismissed with prejudice by the court. The individual relator continues to litigate the kickback claims on behalf of other states and municipalities. Novartis is engaged in settlement discussions to resolve the above-described claims, and recorded a provision in the amount of USD 0.7 billion in 2019 in the Innovative Medicines Division. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;S.D.N.Y. Gilenya marketing practices investigation and litigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2013, NPC received a civil investigative demand from the United States Attorney&amp;#x2019;s Office (USAO) for the S.D.N.Y. requesting the production of documents and information relating to marketing practices for &lt;i&gt;Gilenya&lt;/i&gt;, including the remuneration of healthcare providers in connection therewith. In 2017, the S.D.N.Y. and New York State declined to intervene in claims raised by an individual relator in a &lt;i&gt;qui tam&lt;/i&gt; complaint, which continue to be vigorously contested. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Government generic pricing antitrust investigations, antitrust class actions&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Since 2016, Sandoz Inc. has received grand jury subpoenas and a civil investigative demand and interrogatories from the Antitrust and Civil Divisions of the US Department of Justice (DoJ), and a subpoena and interrogatories from the Attorney General of the State of Connecticut in connection with alleged price fixing and market allocation of generic drugs in the US market as well as alleged FCA violations. The requests are for documents related to the marketing and pricing of generic pharmaceutical products sold by Sandoz Inc. and its subsidiary, Fougera Pharmaceuticals Inc. (Fougera), and related communications with competitors. Sandoz Inc. is cooperating with these investigations, which it believes to be part of a broader inquiry into industry practice. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Since the third quarter of 2016, Sandoz Inc. and Fougera have been sued alongside other generic pharmaceutical companies in numerous individual and putative class action complaints by direct and indirect purchasers and Attorneys General for 54 states and territories. Plaintiffs claim that defendants, including Sandoz, engaged in price fixing and market allocation of generic drugs in the US market, and seek damages and injunctive relief. The actions contain product-specific complaints as well as complaints alleging the existence of an overarching industry conspiracy, and assert violations of federal and state antitrust laws as well as consumer protection laws. The cases have been consolidated for pretrial purposes in the USDC for the Eastern District of Pennsylvania (E.D. Pa.), and the claims are being vigorously contested. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Asia/Russia investigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2017 and 2018, Alcon and Novartis Group companies received document requests and subpoenas from the DoJ and the US Securities and Exchange Commission (SEC) requesting information concerning Alcon accounting, internal controls and business practices in Asia and Russia, including revenue recognition for surgical equipment and related products and services, as well as relationships with third-party distributors, both before and after Alcon became part of the Novartis Group. Alcon and Novartis are cooperating with this investigation. Pursuant to the terms of the Separation and Distribution Agreement, and subject to the conditions and exclusions therein, Novartis will indemnify Alcon in respect of certain fines or other monetary penalties that arise out of the investigations by the DoJ and the SEC at the time of the separation. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Lucentis/Avastin &lt;sup&gt;&amp;#xae;&lt;/sup&gt; matters &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In connection with an investigation into whether Novartis entities, F. Hoffmann-La Roche AG, Genentech Inc. and Roche S.p.A. colluded to artificially preserve the market positions of Avastin &lt;sup&gt;&amp;#xae;&lt;/sup&gt; and &lt;i&gt;Lucentis&lt;/i&gt;, in 2014 the Italian Competition Authority (ICA) imposed a fine equivalent to USD 125 million on the Novartis entities. Novartis paid the fine, subject to the right to later claim recoupment, and appealed before the Consiglio di Stato (CdS). In 2014 and 2015, the Italian Ministry of Health and the Lombardia region sent letters with payment requests for a total equivalent of approximately USD&amp;nbsp;1.3 billion in damages from Novartis and Roche entities based on the above allegations. In 2019, the CdS upheld the ICA decision and fine. Following the CdS decision, several additional Italian regions and hospitals sent letters claiming damages for an aggregate amount of approximately USD 330 million. None of these claims has been asserted in legal proceedings. Novartis has filed a further appeal of the CdS decision. In 2019, the French Competition Authority (FCA) issued a Statement of Objections against Novartis entities alleging anti-competitive practices on the French market for anti-vascular endothelial growth factor treatments for wet age-related macular degeneration from 2008 to 2013, and is expected to issue its final decision in the course of 2020. Novartis continues to vigorously contest all claims in Italy and France. Also, Novartis is challenging policies and regulations allowing off-label/unlicensed use and reimbursement for economic reasons in various countries, including Italy, the UK, Turkey and Brazil. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Japan investigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2015, a trial started against a former Novartis Pharma K.K. (NPKK) employee, and also against NPKK under the dual liability concept in Japanese law, over allegations brought by the Tokyo District Public Prosecutor Office for alleged manipulation of data in sub-analysis publications of the Kyoto Heart Study regarding valsartan. The charges against NPKK are subject to a maximum total fine of JPY 4 million. In 2018, the Tokyo High Court upheld a not-guilty ruling of the Tokyo District Court for both the former NPKK employee and NPKK. A further appeal by the Tokyo District Public Prosecutor Office remains pending. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;South Korea investigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2016, the Seoul Western District Prosecutor initiated a criminal investigation into, among other things, allegations that Novartis Korea utilized medical journals to provide inappropriate economic benefits to HCPs, which resulted in a non-material fine in January 2020. Novartis has received requests for information from the DoJ and the SEC regarding this matter, and is cooperating with their ongoing inquiry. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Greece investigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis is investigating allegations of potentially inappropriate economic benefits to HCPs, government officials and others in Greece. Novartis is providing information to the Greek authorities investigating these allegations, including the Greek Coordinating Body for Inspection and Control, and the Greek Body of Prosecution of Financial Crime, from which it received a summons in 2018. Novartis is also responding to subpoenas and document requests from the SEC and DoJ that it received beginning in 2016 in connection with such allegations, and is cooperating with their investigation. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Antitrust class actions&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Enoxaparin&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2015, Sandoz and Momenta Pharmaceuticals were sued in a putative antitrust class action in federal court in Tennessee alleging that Momenta and Sandoz engaged in anticompetitive and unfair business conduct with regard to sales of enoxaparin. The same allegations were made by Amphastar in a lawsuit filed in federal court in California and subsequently moved to federal court in Massachusetts. In 2019, Sandoz resolved both matters, with Sandoz agreeing to pay USD 85 million to resolve the Tennessee class action and paying Amphastar approximately USD 39 million to resolve the Massachusetts case. The class action settlement is contingent upon, among other conditions, court approval and the class participants not exceeding an opt-out threshold. Sandoz, Momenta and Amphastar were also engaged in patent litigation concerning enoxaparin that concluded in June 2019. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Exforge&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Since 2018, Novartis Group companies as well as other pharmaceutical companies have been sued by various direct and indirect purchasers of &lt;i&gt;Exforge&lt;/i&gt; in multiple US individual and putative class action complaints. They claim that Novartis made a reverse payment in the form of an agreement not to launch an authorized generic, alleging violations of federal antitrust law and state antitrust, consumer protection and common laws, and seeking damages as well as injunctive relief. The cases have been consolidated in the S.D.N.Y. and the claims are being vigorously contested. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Product liability litigation&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Reclast &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;NPC is a defendant in more than 20 US product liability actions involving &lt;i&gt;Reclast&lt;/i&gt; and alleging atypical femur fracture injuries, all of which are in New Jersey state or federal court and in California state court, coordinated with claims against other bisphosphonate manufacturers. The claims are being vigorously contested. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Taxotere&amp;#xae; (docetaxel)&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Sandoz is a defendant in more than 2&amp;#xa0;900 US product liability actions involving Taxotere &lt;sup&gt;&amp;#xae;&lt;/sup&gt; (docetaxel), an oncology product, many of which have been transferred to Multidistrict Litigation in the Eastern District of Louisiana. The complaints allege misleading marketing and that Sanofi, as innovator, and several 505(b)(2) NDA holders (including Sandoz) failed to warn of the risk of permanent alopecia/hair loss. The claims are being vigorously contested. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Amiodarone&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Sandoz entities are named in more than 10 individual and multi-plaintiff US product liability cases involving amiodarone, a cardiac drug indicated to treat life-threatening arrhythmias that have not responded to other treatment. The complaints allege failure to warn, off-label promotion and failure to include medication guides to pharmacies. The claims are being vigorously contested. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Sartans and Ranitidine&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Since 2018, claims have been brought against Sandoz and other pharmaceutical companies alleging injury from carcinogenic impurities found in valsartan and valsartan/HCT film-coated tablets and/or losartan marketed or manufactured by Sandoz, including several putative class actions in Canada and a Multidistrict Litigation in New Jersey. Claims have also been brought alleging injury from carcinogenic impurities in ranitidine-containing medicines, including several putative class actions in Canada. All of these claims are being vigorously contested. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Other matters&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Average Wholesale Price (AWP) litigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Lawsuits have been brought, the latest in February 2016, by various US state governmental entities and private parties against various pharmaceutical companies, including NPC, alleging that they fraudulently overstated the AWP that is or has been used by payors, including state Medicaid agencies, to calculate reimbursements to healthcare providers. NPC remains a defendant in a putative class action brought by private payors in New Jersey, and vigorously contests those claims. NPC resolved an action brought by the state of Illinois for approximately USD 21 million. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;Aimovig&amp;ndash;Amgen Dispute&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2015 and 2017, Novartis and Amgen entered into agreements regarding the development and commercialization of &lt;i&gt;Aimovig&lt;/i&gt;, which the companies co-commercialize in the US and to which Novartis has exclusive rights in all territories outside of the US, excluding Japan. Amgen issued a termination notice in April 2019, based on an alleged material breach of the collaboration agreements, and this notice, as well as other ancillary matters, are the subject of legal proceedings between Novartis and Amgen. Novartis disputes Amgen&amp;#x2019;s allegations vigorously. The collaboration continues during the litigation between the companies, and will remain in force until and unless a final court decision terminates the agreements. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Concluded legal matters&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;District of Massachusetts (D. Mass.) charitable foundation investigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2016 and 2017, NPC received subpoenas from the USAO for the D. Mass. requesting documents related to NPC&amp;#x2019;s support of 501(c)(3) organizations that provide copayment assistance to Medicare patients who are prescribed Novartis medicines, including the respective accounting and tax treatment, as well as related to pricing strategies for &lt;i&gt;Gleevec&lt;/i&gt;, &lt;i&gt;Tasigna&lt;/i&gt;, &lt;i&gt;Zometa&lt;/i&gt; and &lt;i&gt;Gilenya&lt;/i&gt;. In 2018, NPC agreed to a settlement in principle to pay USD 23 million to resolve the investigation into potential violations of federal healthcare laws, including the Anti-Kickback Statute and FCA. In 2019, NPC agreed in principle to pay an additional USD 28 million to resolve related allegations. These settlements are subject to mutually agreeable terms and finalization of the documentation. Novartis considers this matter concluded for the purpose of reporting legal proceedings. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;"&gt;MIVS platform patent infringement litigation&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2015, Johns Hopkins University (JHU) filed a patent infringement lawsuit against certain Alcon entities alleging that the use of certain Alcon surgical products, principally by third parties, infringes a patent directed to certain methods of ocular surgery. In 2019, JHU and Alcon entered into a confidential resolution of the litigation. Novartis considers this matter concluded. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Summary of product liability, governmental investigations and other legal matters provision movements &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 340&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 351&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 395&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions related to &lt;br&gt;&lt;/br&gt;discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;42 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;116&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Releases of provisions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;107&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to provisions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;369&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 340&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 351&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current portion&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current product liabilities, governmental investigations and other legal matters provisions at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Releases of provisions credited to the consolidated income statement from continuing operations were USD 107 million in 2018 and USD 63 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 220 million in 2018 and USD 47 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis believes that its total provisions for investigations, product liability, arbitration and other legal matters are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities, there can be no assurance that additional liabilities and costs will not be incurred beyond the amounts provided. &lt;/div&gt;</ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory>
  <ifrs-full:DisclosureOfOtherProvisionsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued liability for employee benefits:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Defined benefit pension plans &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;546&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other long-term employee benefits and deferred compensation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 600&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other post-employment benefits &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Environmental remediation provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 634&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for product liabilities, governmental investigations and other legal matters&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 958&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 255&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 497&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total provisions and other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;632&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 25 provides additional disclosures related to post-employment benefits. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 29 provides additional disclosures related to contingent consideration. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfOtherProvisionsExplanatory>
  <nvs:AccrualForEnvironmentalLossContingenciesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 692&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 761&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 773&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Releases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;83&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 154&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 692&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 761&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current provision&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current environmental remediation provisions at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 634&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 706&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Releases of provisions credited to the consolidated income statement from continuing operations were USD 21 million in 2018 and USD 153 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 7 million in 2018 and USD 154 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AccrualForEnvironmentalLossContingenciesTableTextBlock>
  <nvs:AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Expected &lt;br&gt;&lt;/br&gt; cash outflows &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due within two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 141&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due later than two years, but within five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 210&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due later than five years, but within 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 258&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Due after 10 years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 105&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total environmental remediation liability provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock>
  <nvs:AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 340&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 351&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 395&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions related to &lt;br&gt;&lt;/br&gt;discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;42 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;116&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;69&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Releases of provisions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;107&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to provisions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;369&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 340&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 351&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current portion&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current product liabilities, governmental investigations and other legal matters provisions at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 214&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Releases of provisions credited to the consolidated income statement from continuing operations were USD 107 million in 2018 and USD 63 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 220 million in 2018 and USD 47 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock>
  <nvs:DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;21. Current financial debt and&amp;nbsp;derivative&amp;nbsp;financial&amp;nbsp;instruments&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest-bearing accounts of associates &lt;br&gt;&lt;/br&gt;payable on demand &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;836 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;778 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bank and other financial debt &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commercial paper&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value of derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Weighted average interest rate 0.5% (2018: 0.5%) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Weighted average interest rate 12.9% (2018: 9.6%) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated balance sheet amounts of current financial debt, other than the current portion of non-current financial debt, approximate the estimated fair value due to the short-term nature of these instruments. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Details on commercial papers and short term borrowings are provided under &amp;#x201c;Liquidity risk&amp;#x201d; in Note&amp;nbsp;29. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt; &lt;/div&gt;</nvs:DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock>
  <nvs:DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest-bearing accounts of associates &lt;br&gt;&lt;/br&gt;payable on demand &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;836 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;778 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bank and other financial debt &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commercial paper&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value of derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Weighted average interest rate 0.5% (2018: 0.5%) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Weighted average interest rate 12.9% (2018: 9.6%) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock>
  <nvs:DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;22. Provisions and other current liabilities&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes other than income taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 471&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 528&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued expenses for goods and services received but not invoiced&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 970&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accruals for royalties&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 653&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 651&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interests on financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for deductions from revenue&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;262&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accruals for compensation and benefits, including social security&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Environmental remediation liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 236&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for product liabilities, governmental investigations and other legal matters &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued share-based payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 326&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent considerations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 78&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commitment for repurchase of own shares &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 764&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 673&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total provisions and other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 13&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 20 provides additional disclosures related to legal provisions. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 29 provides additional disclosures related to contingent considerations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Note 18 provides additional disclosures related to commitment for repurchase of own shares. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Provisions are based upon management&amp;#x2019;s best estimate and adjusted for actual experience. Such adjustments to the historic estimates have not been material. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Provisions for deductions from revenue&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the movement of the provisions for deductions from revenue:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income statement charge&lt;sup&gt;2&lt;/sup&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Revenue &lt;br&gt;&lt;/br&gt; deductions &lt;br&gt;&lt;/br&gt; provisions at &lt;br&gt;&lt;/br&gt; January 1 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Revenue &lt;br&gt;&lt;/br&gt; deductions &lt;br&gt;&lt;/br&gt; provisions &lt;br&gt;&lt;/br&gt; related to &lt;br&gt;&lt;/br&gt; discontinued &lt;br&gt;&lt;/br&gt; operations&lt;sup&gt;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Effect of &lt;br&gt;&lt;/br&gt; currency &lt;br&gt;&lt;/br&gt; translation &lt;br&gt;&lt;/br&gt; and business &lt;br&gt;&lt;/br&gt; combinations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Payments/ &lt;br&gt;&lt;/br&gt; utilizations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Adjustments &lt;br&gt;&lt;/br&gt; of prior years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Current year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Change in &lt;br&gt;&lt;/br&gt; provisions &lt;br&gt;&lt;/br&gt; offset against &lt;br&gt;&lt;/br&gt; gross trade &lt;br&gt;&lt;/br&gt; receivables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Revenue &lt;br&gt;&lt;/br&gt; deductions &lt;br&gt;&lt;/br&gt; provisions at &lt;br&gt;&lt;/br&gt; December 31 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;883 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 0 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;183 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;193 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;474 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;981 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;625 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;28 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;19 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;467 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;659 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;769 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-healthcare plans and program-related rebates, returns and other deductions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;166&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;868&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;845&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;262&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&amp;nbsp;348&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;590 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;158 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;90 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4&amp;nbsp;541 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;883 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;356 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;78 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;182 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 83 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;555 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;109 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;625 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-healthcare plans and program-related rebates, returns and other deductions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;12&amp;nbsp;227&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;91&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;956&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 441&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;672&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;18&amp;nbsp;567&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 19&amp;nbsp;052&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;262&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;461 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;684 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;62 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 3&amp;nbsp;875 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;590 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;020 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 131 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;954 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 80 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;186 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;356 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-healthcare plans and program-related rebates, returns and other deductions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;702&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;127&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;045&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 196&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&amp;nbsp;452&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&amp;nbsp;106&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;252&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;672&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Charges to the consolidated income statement from continuing operations were USD 18 248 million in 2018 and USD 17 772 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Restructuring provisions movements&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 153&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 222&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions related to &lt;br&gt;&lt;/br&gt;discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 492&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 534&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;479&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Releases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;72&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;64&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 521 million in 2018 and USD 186 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Reversal of provisions credited to the consolidated income statement from continuing operations were USD 31 million in 2018 and USD 59 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2019, additions to provisions of USD&amp;nbsp;492 million were mainly related to the following reorganizations:&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Innovative Medicines Division restructured its field force and supporting functions in Latin America, and following the &lt;i&gt;Xiidra&lt;/i&gt; acquisition, its Ophthalmology field force in the US. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Sandoz Division initiatives to realign its organizational structures to improve competiveness. These initiatives include reduction in its headquarters, global functions and countries workforce, and the closure of its development center in Holzkirchen, Germany. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Group-wide initiatives to streamline Novartis Technical Operations and implement new technologies, mainly in the Innovative Medicines Division and in the Sandoz Division, continued. In addition, Novartis Business Services launched the next phase of the new operating model to change outsourcing structures and transition activities to service centers. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2018, additions to provisions of USD 534 million were mainly related to the following reorganizations:&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Innovative Medicines Division&amp;#x2019;s Oncology business unit initiative to streamline its organizational structure. The objective was to enhance agility and efficiency, resulting in an acceleration of operational execution. In addition, a program to reorganize the Japanese business model was launched. Region Europe transformed its approach to market in light of the changing product portfolio. The objective was to speed up patient access. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Group-wide initiatives to streamline Novartis Technical Operations and implement new technologies, mainly in the Innovative Medicines Division and in the Sandoz Division, continued. In addition, Novartis Business Services launched an initiative to reorganize its organizational structure to achieve cost efficiencies by shifting activities to global service centers. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;In 2017, additions to provisions of USD&amp;nbsp;194 million were mainly related to the following reorganizations:&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Innovative Medicines Division&amp;#x2019;s Pharmaceuticals business unit adjusted a regional promotional model, which led to a restructuring of the sales force. It also streamlined the above country operating model to facilitate an even higher external competition-oriented focus. Furthermore, the development organization streamlined its activities to create efficiencies. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The former Alcon Division continued initiatives to realign its operations to focus on the Surgical and Vision Care businesses after the Ophthalmic Pharmaceuticals business transfer to the Innovative Medicines Division. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Sandoz Division launched initiatives to focus resources to gain efficiencies.&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Group-wide initiatives to streamline Novartis Technical Operations in the Innovative Medicines and Sandoz Divisions were launched. &lt;/div&gt;</nvs:DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock>
  <nvs:ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes other than income taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 471&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 528&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued expenses for goods and services received but not invoiced&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;046&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 970&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accruals for royalties&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 653&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 651&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interests on financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for deductions from revenue&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;262&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accruals for compensation and benefits, including social security&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;464&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Environmental remediation liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 114&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 236&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions for product liabilities, governmental investigations and other legal matters &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued share-based payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 326&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent considerations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 78&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commitment for repurchase of own shares &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 764&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 673&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total provisions and other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 13&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 12&amp;nbsp;284&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Note 20 provides additional disclosures related to legal provisions. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Note 29 provides additional disclosures related to contingent considerations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Note 18 provides additional disclosures related to commitment for repurchase of own shares. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock>
  <nvs:ProvisionsForReductionOfRevenueTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income statement charge&lt;sup&gt;2&lt;/sup&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Revenue &lt;br&gt;&lt;/br&gt; deductions &lt;br&gt;&lt;/br&gt; provisions at &lt;br&gt;&lt;/br&gt; January 1 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Revenue &lt;br&gt;&lt;/br&gt; deductions &lt;br&gt;&lt;/br&gt; provisions &lt;br&gt;&lt;/br&gt; related to &lt;br&gt;&lt;/br&gt; discontinued &lt;br&gt;&lt;/br&gt; operations&lt;sup&gt;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Effect of &lt;br&gt;&lt;/br&gt; currency &lt;br&gt;&lt;/br&gt; translation &lt;br&gt;&lt;/br&gt; and business &lt;br&gt;&lt;/br&gt; combinations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Payments/ &lt;br&gt;&lt;/br&gt; utilizations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Adjustments &lt;br&gt;&lt;/br&gt; of prior years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Current year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Change in &lt;br&gt;&lt;/br&gt; provisions &lt;br&gt;&lt;/br&gt; offset against &lt;br&gt;&lt;/br&gt; gross trade &lt;br&gt;&lt;/br&gt; receivables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Revenue &lt;br&gt;&lt;/br&gt; deductions &lt;br&gt;&lt;/br&gt; provisions at &lt;br&gt;&lt;/br&gt; December 31 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;883 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 0 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;183 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;193 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5&amp;nbsp;474 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;981 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;625 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;28 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;19 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;467 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;659 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;769 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-healthcare plans and program-related rebates, returns and other deductions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;166&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;868&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;845&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;262&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&amp;nbsp;348&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;220&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;595&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;590 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;158 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;90 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4&amp;nbsp;541 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;883 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;356 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;78 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;182 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 83 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;555 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;109 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;625 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-healthcare plans and program-related rebates, returns and other deductions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;12&amp;nbsp;227&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;91&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;956&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 441&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;672&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;18&amp;nbsp;567&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 19&amp;nbsp;052&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;262&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt;2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;461 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;684 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;62 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 3&amp;nbsp;875 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;590 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-US-specific healthcare plans &lt;br&gt;&lt;/br&gt;and program rebates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;020 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 131 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;954 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 80 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;186 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;107 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;356 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-healthcare plans and program-related rebates, returns and other deductions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;702&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;127&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;045&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;726&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;183&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 196&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;17&amp;nbsp;452&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&amp;nbsp;106&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;252&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;672&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="18"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Charges to the consolidated income statement from continuing operations were USD 18 248 million in 2018 and USD 17 772 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ProvisionsForReductionOfRevenueTableTextBlock>
  <nvs:RestructuringProvisionsMovementsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 153&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 222&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provisions related to &lt;br&gt;&lt;/br&gt;discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 492&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 534&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;479&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;200&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Releases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;72&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;64&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Provisions charged to the consolidated income statement from continuing operations were USD 521 million in 2018 and USD 186 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Reversal of provisions credited to the consolidated income statement from continuing operations were USD 31 million in 2018 and USD 59 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:RestructuringProvisionsMovementsTableTextBlock>
  <ifrs-full:DisclosureOfCashFlowStatementExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt; &lt;b&gt;23. Details to the consolidated statements of cash flows&lt;/b&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;23.1) Reversal of non-cash items and other adjustments from continuing operations&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation, amortization and impairments on:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;547&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;783&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;460&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;974&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;428&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;276&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 227&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-cash change in provisions and other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 895&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gains on disposal and other adjustments on property, plant and equipment; intangible assets; &lt;br&gt;&lt;/br&gt;financial assets; and other non-current assets, net &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;234 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;902 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;077 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-settled compensation expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 673&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Income from associated companies &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;659&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net financial expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 746&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 708&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;486&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Includes fair value adjustments &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; 2018 includes a reversal of a pre-tax gain (USD 5.8 billion) recognized from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). The net cash proceed of USD 13.0 billion from the divestment was included in the consolidated statements of cash flows in the line "Acquisitions and divestments of interests in associated companies, net." &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;23.2) Total amount of taxes paid &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2019, the total amount of taxes paid was USD&amp;nbsp;2.0 billion (2018: USD&amp;nbsp;1.8 billion, 2017: USD&amp;nbsp;1.6 billion), of which USD&amp;nbsp;1.9 billion (2018: USD&amp;nbsp;1.5 billion, 2017: USD&amp;nbsp;1.5 billion) was included within "Net cash flows from operating activities from continuing operations", USD&amp;nbsp;38 million (2018: USD&amp;nbsp;164 million, 2017: USD&amp;nbsp;124 million) was included within "Net cash flows from operating activities from discontinued operations," and USD&amp;nbsp;79 million (2018: nil, 2017: nil) was included within "Net cash flows used in investing activities from discontinued operations." In 2018, USD&amp;nbsp;139 million (2019: nil, 2017: nil) was included within "Net cash flows used in investing activities from continuing operations." &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;23.3) Cash flows from changes in working capital and other operating items included in the net cash flows from operating activities from continuing operations &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;(Increase) in inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;382&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;387&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;203&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;(Increase) in trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;544&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;655&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in trade payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 553&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 252&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 316&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;303&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 941&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;410&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other adjustments, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 199&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 576&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;23.4) Cash flows arising from acquisitions and divestments of interests in associated companies &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2018, acquisitions and divestments of interests in associated companies included USD 12&amp;#xa0;855 million net of taxes (USD 12&amp;#xa0;994 million before taxes) from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;23.5) Cash flows arising from acquisitions and divestments of businesses, net&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following is a summary of the cash flow impact of acquisitions and divestments. The most significant transactions are described in Note 2. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Note&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net assets recognized as a result of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;4&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;13&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value of previously held equity interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Receivables and payables contingent consideration, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 242&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Payments, deferred consideration and other adjustments, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows used for acquisitions of businesses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;13&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;759&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows from divestments of businesses, net &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 91&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows used for acquisitions and divestments of businesses, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;13&amp;nbsp;683&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; In 2019, the USD 91 million included USD 4 million net cash outflows from previous years divestments and USD 95 million net cash inflows from business divestments in 2019. The net identifiable assets of the 2019 divested businesses amounted to USD 196 million, comprised of non-current asset of USD 159 million, current assets of USD 96 million including USD 11 million cash and cash equivalents, non-current liabilities USD 18 million and current liabilities of USD 41 million. &lt;br&gt;&lt;/br&gt;In 2018, USD 18 million represented the net cash inflows from previous years divestments. &lt;br&gt;&lt;/br&gt;In 2017, the USD 45 million net cash inflows related to the net identifiable assets from a 2017 divestment. The 2017 divested business amounted to USD 48 million, comprised of non-current assets of USD 29 million, current assets of USD 34 million and current liabilities of USD 15 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Notes 2 and 24 provide further information regarding acquisitions and divestments of businesses. All acquisitions were for cash. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;23.6) Reconciliation of liabilities arising from financing activities&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts and &lt;br&gt;&lt;/br&gt; derivative &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; instruments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; lease liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Current lease &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 16 Leases continuing operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;471&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 16 Leases discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts and lease liabilities related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Repayment of non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;195&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;582&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Payments of lease liabilities, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest payments for amounts included in lease liabilities &lt;br&gt;&lt;/br&gt;classified as cash flows from operating activities &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;51 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;New leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 362&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 131&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations and divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair values, and other changes, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of bonds discount&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification from non-current to current, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Lease liabilties recognized on January 1, 2019, the date of implementation of IFRS 16 Leases. Note 10 provides additional disclosure. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; In 2018, financial debts included USD 89 million for previously reported finance lease obligations of the Alcon business that have been reclassified on January 1, 2019, to lease liabilities, with the adoption of IFRS 16 Leases. Note 30 provides additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Represents the financial debts and lease liabilities at January 1, 2019, related to the Alcon business reported as discontinued operations. See Notes 1, 2 and 30. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts and &lt;br&gt;&lt;/br&gt; derivative &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;308&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;856&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Repayment of non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;681&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair values, and other changes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of bonds discount&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;462&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 1 687 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts and &lt;br&gt;&lt;/br&gt; derivative &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;897&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;905&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Repayment of non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;187&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;755&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair values, and other changes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of bonds discount&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 744&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;308&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 644 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;For net cash flows used in investing activities from discontinued operations, see Note 30. &lt;/div&gt;</ifrs-full:DisclosureOfCashFlowStatementExplanatory>
  <nvs:AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation, amortization and impairments on:&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;547&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;783&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;460&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;974&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;428&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;276&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;38&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 227&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-cash change in provisions and other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;871&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 895&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gains on disposal and other adjustments on property, plant and equipment; intangible assets; &lt;br&gt;&lt;/br&gt;financial assets; and other non-current assets, net &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;234 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;902 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;077 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-settled compensation expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 673&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Income from associated companies &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;659&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;6&amp;nbsp;438&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;603&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net financial expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 746&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 708&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;122&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;486&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Includes fair value adjustments &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; 2018 includes a reversal of a pre-tax gain (USD 5.8 billion) recognized from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). The net cash proceed of USD 13.0 billion from the divestment was included in the consolidated statements of cash flows in the line "Acquisitions and divestments of interests in associated companies, net." &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock>
  <nvs:CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;(Increase) in inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;382&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;387&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;203&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;(Increase) in trade receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;544&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;655&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in trade payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 553&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 252&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 82&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 316&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;303&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in other current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 941&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;410&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other adjustments, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 199&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 576&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 332&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock>
  <nvs:CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Note&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net assets recognized as a result of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;4&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;13&amp;nbsp;660&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value of previously held equity interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Receivables and payables contingent consideration, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 242&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 151&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Payments, deferred consideration and other adjustments, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows used for acquisitions of businesses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;851&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;13&amp;nbsp;701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;759&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows from divestments of businesses, net &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 91&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 45&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows used for acquisitions and divestments of businesses, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;13&amp;nbsp;683&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; In 2019, the USD 91 million included USD 4 million net cash outflows from previous years divestments and USD 95 million net cash inflows from business divestments in 2019. The net identifiable assets of the 2019 divested businesses amounted to USD 196 million, comprised of non-current asset of USD 159 million, current assets of USD 96 million including USD 11 million cash and cash equivalents, non-current liabilities USD 18 million and current liabilities of USD 41 million. &lt;br&gt;&lt;/br&gt;In 2018, USD 18 million represented the net cash inflows from previous years divestments. &lt;br&gt;&lt;/br&gt;In 2017, the USD 45 million net cash inflows related to the net identifiable assets from a 2017 divestment. The 2017 divested business amounted to USD 48 million, comprised of non-current assets of USD 29 million, current assets of USD 34 million and current liabilities of USD 15 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock>
  <nvs:ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts and &lt;br&gt;&lt;/br&gt; derivative &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; instruments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; lease liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Current lease &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 16 Leases continuing operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;471&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of adoption of IFRS 16 Leases discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts and lease liabilities related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Repayment of non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;195&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;582&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Payments of lease liabilities, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest payments for amounts included in lease liabilities &lt;br&gt;&lt;/br&gt;classified as cash flows from operating activities &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;51 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;New leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 362&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 131&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations and divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair values, and other changes, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of bonds discount&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification from non-current to current, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;003&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 156&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 7&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Lease liabilties recognized on January 1, 2019, the date of implementation of IFRS 16 Leases. Note 10 provides additional disclosure. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; In 2018, financial debts included USD 89 million for previously reported finance lease obligations of the Alcon business that have been reclassified on January 1, 2019, to lease liabilities, with the adoption of IFRS 16 Leases. Note 30 provides additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Represents the financial debts and lease liabilities at January 1, 2019, related to the Alcon business reported as discontinued operations. See Notes 1, 2 and 30. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts and &lt;br&gt;&lt;/br&gt; derivative &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;308&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;856&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Repayment of non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;681&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of business combinations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair values, and other changes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of bonds discount&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;462&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 1 687 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Non-current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Current &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; debts and &lt;br&gt;&lt;/br&gt; derivative &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; instruments &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 17&amp;nbsp;897&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;905&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Increase in non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Repayment of non-current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;187&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in current financial debts &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;755&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Changes in fair values, and other changes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of bonds discount&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 744&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 359&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31, 2017&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;308&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 644 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock>
  <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;24. Acquisitions of businesses&lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Fair value of assets and liabilities arising from acquisitions&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currently marketed products&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;550&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Acquired research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 342&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;223&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 381&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial and other assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 195&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade receivables and other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 90&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;107&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;2&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current and non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables and other liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;178&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;627&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net identifiable assets acquired&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 11&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 925&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net assets recognized as a result of business combinations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 999&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net assets recognized as a result of business combinations in the consolidated balance sheet from continuing operations were USD 13 660 million in 2018 and USD 874 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Note 2 details significant acquisitions of businesses, specifically, &lt;i&gt;Xiidra&lt;/i&gt; and IFM Tre, Inc. in 2019; AAA, AveXis and Endocyte in 2018; and Ziarco and Encore in 2017. The goodwill arising out of these acquisitions is attributable to the growth platform, the assembled workforce, and the accounting for deferred tax liabilities on the acquired assets. Goodwill of USD&amp;nbsp;98 million from 2019 is tax deductible. No goodwill from 2018 and 2017 is tax-deductible. &lt;/div&gt;</ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
  <nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currently marketed products&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;550&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Acquired research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 342&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;223&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 381&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial and other assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 195&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade receivables and other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 90&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;107&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;2&amp;nbsp;874&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current and non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables and other liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;178&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;627&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net identifiable assets acquired&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 11&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 925&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-controlling interests&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 94&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net assets recognized as a result of business combinations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;946&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 999&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net assets recognized as a result of business combinations in the consolidated balance sheet from continuing operations were USD 13 660 million in 2018 and USD 874 million in 2017. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock>
  <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;25. Post-employment benefits for associates&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Defined benefit plans&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In addition to the legally required social security schemes, the Group has numerous independent pension and other post-employment benefit plans. In most cases, these plans are externally funded in entities that are legally separate from the Group. For certain Group companies, however, no independent plan assets exist for the pension and other post-employment benefit obligations of associates. In these cases, the related unfunded liability is included in the balance sheet. The defined benefit obligations (DBOs) of all major pension and other post-employment benefit plans are reappraised annually by independent actuaries. Plan assets are recognized at fair value. The major plans are based in Switzerland, the United States, the United Kingdom, Germany and Japan, which represent 95% of the Group&amp;#x2019;s total DBO for pension plans. Details of the plans in the two most significant countries, Switzerland and the United States, which represent 81% of the Group&amp;#x2019;s total DBO for post-employment benefit plans, are provided below. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Swiss-based pension plans represent the most significant portion of the Group&amp;#x2019;s total DBO and plan assets. For the active insured members born on or after January 1, 1956, or having joined the plans after December 31, 2010, the benefits are partially linked to the contributions paid into the plan. Certain features of Swiss pension plans required by law preclude the plans from being categorized as defined contribution plans. These factors include a minimum interest guarantee on retirement savings accounts, a predetermined factor for converting the accumulated savings account balance into a pension, and embedded death and disability benefits. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;All benefits granted under Swiss-based pension plans are vested, and Swiss legislation prescribes that the employer has to contribute a fixed percentage of an associate&amp;#x2019;s pay to an external pension fund. Additional employer contributions may be required whenever the plan&amp;#x2019;s statutory funding ratio falls below a certain level. The associate also contributes to the plan. The pension plans are run by separate legal entities, each governed by a board of trustees that &amp;ndash; for the principal plans &amp;ndash; consists of representatives nominated by Novartis and the active insured associates. The boards of trustees are responsible for the plan design and asset investment strategy. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In September 2017, the pension regulations in Switzerland were amended, which resulted in a change in accounting from defined benefit to defined contribution for a component of the Swiss pension plans. This change resulted in a reduction to the defined benefit pension plans liability and in a corresponding net pre-tax gain of USD 225 million (CHF 216 million). &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The United States pension plans represent the second-largest component of the Group&amp;#x2019;s total DBO and plan assets. The principal plans (Qualified Plans) are funded, whereas plans providing additional benefits for executives (Restoration Plans) are unfunded. Employer contributions are required for Qualified Plans whenever the statutory funding ratio falls below a certain level. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Furthermore, in certain countries, associates are covered under other post-employment benefit plans and post-retirement medical plans. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the US, other post-employment benefit plans consist primarily of post-employment healthcare benefits, which have been closed to new members since 2015. Part of the costs of these plans is reimbursable under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. There is no statutory funding requirement for these plans. The Group is funding these plans to the extent that it is tax efficient. &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following tables are a summary of the funded and unfunded defined benefit obligation for pension and other postemployment benefit plans of associates at December 31, 2019 and 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;210&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;115&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Benefit obligations related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;385&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current service cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 378&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 330&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past service costs and settlements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;168&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remeasurement losses/(gains) arising from changes in financial assumptions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;791&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;567&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remeasurement (gains)/losses arising from changes in demographic assumptions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;193&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Experience-related remeasurement losses/(gains)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 264&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;374&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Benefit payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions of associates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of acquisitions, divestments or transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 746&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 18&amp;nbsp;838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 20&amp;nbsp;275&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Plan assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 257&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Return on plan assets excluding interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Group contributions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 420&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 520&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions of associates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Settlements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;193&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Benefit payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of acquisitions, divestments or transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 19&amp;nbsp;810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&amp;nbsp;838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 134&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Funded status&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Limitation on recognition of fund surplus at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in limitation on recognition of fund surplus (incl. exchange rate differences)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income on limitation of fund surplus&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Limitation on recognition of fund surplus at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net liability in the balance sheet at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The reconciliation of the net liability from January 1 to December 31 is as follows:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net liability at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;024&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;953&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less: net liability related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 238&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current service cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;378&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;77&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past service costs and settlements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remeasurements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 64&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Group contributions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 420&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 520&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of acquisitions, divestments or transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in limitation on recognition of fund surplus&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net liability at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Amounts recognized in the consolidated balance sheet&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prepaid benefit cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued benefit liability&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows a breakdown of the DBO for pension plans by geography and type of member, and the breakdown of plan assets into the geographical locations in which they are held: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Switzerland &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Switzerland &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 15&amp;nbsp;106&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;552&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;408&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;348&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Thereof unfunded&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 1&amp;nbsp;136&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 649&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 1&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;By type of member&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Active&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 630&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;400&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;197&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;618&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 653&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;616&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;205&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;722&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;131&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;939&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;645&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;564&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;630&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 14&amp;nbsp;457&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;311&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 19&amp;nbsp;810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&amp;nbsp;838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Funded status&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;649&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;241&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows a breakdown of the DBO for other post-employment benefit plans by geography and type of member, and the breakdown of plan assets into the geographical locations in which they are held: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 658&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 746&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 72&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Thereof unfunded&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 882&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 72&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;By type of member&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Active&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 157&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 522&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 574&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 134&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 134&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Funded status&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;882&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;72&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the principal weighted average actuarial assumptions used for calculating defined benefit plans and other post-employment benefits of associates: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Weighted average assumptions used to determine benefit obligations at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Discount rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.6%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.5%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.6%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.4%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.7%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expected rate of pension increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.3%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.4%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.5%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expected rate of salary increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest on savings account&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.3%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.6%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current average life expectancy &lt;br&gt;&lt;/br&gt;for a 65-year-old male in years &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 21 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 21 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 21 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current average life expectancy &lt;br&gt;&lt;/br&gt;for a 65-year-old female in years &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 23 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 23 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 23 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Changes in the aforementioned actuarial assumptions can result in significant volatility in the accounting for the Group&amp;#x2019;s pension plans in the consolidated financial statements. This can result in substantial changes in the Group&amp;#x2019;s other comprehensive income, long-term liabilities and prepaid pension assets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The DBO is significantly impacted by assumptions regarding the rate that is used to discount the actuarially determined post-employment benefit liability. This rate is based on yields of high-quality corporate bonds in the country of the plan. Decreasing corporate bond yields decrease the discount rate, so that the DBO increases and the funded status decreases. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In Switzerland, an increase in the DBO due to lower discount rates is slightly offset by lower future benefits expected to be paid on the associate&amp;#x2019;s savings account where the assumption on interest accrued changes in line with the discount rate. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The impact of decreasing interest rates on a plan&amp;#x2019;s assets is more difficult to predict. A significant part of the plan assets is invested in bonds. Bond values usually rise when interest rates decrease and may therefore partially compensate for the decrease in the funded status. Furthermore, pension assets also include significant holdings of equity instruments. Share prices tend to rise when interest rates decrease and therefore often counteract the negative impact of the rising defined benefit obligation on the funded status (although the correlation of interest rates with equities is not as strong as with bonds, especially in the short term). &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The expected rate for pension increases significantly affects the DBO of most plans in Switzerland, Germany and the United Kingdom. Such pension increases also decrease the funded status, although there is no strong correlation between the value of the plan assets and pension/inflation increases. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Assumptions regarding life expectancy significantly impact the DBO. An increase in longevity increases the DBO. There is no offsetting impact from the plan assets, as no longevity bonds or swaps are held by the pension funds. Generational mortality tables are used where this data is available. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table shows the sensitivity of the defined benefit pension obligation to the principal actuarial assumptions for the major plans in Switzerland, the United States, the United Kingdom, Germany and Japan on an aggregated basis: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change in 2019 year-end &lt;br&gt;&lt;/br&gt; defined benefit pension obligation &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase in discount rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease in discount rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;One-year increase in life expectancy&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 848&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase in rate of pension increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease in rate of pension increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase of interest on savings account&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease of interest on savings account&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase in rate of salary increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease in rate of salary increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The healthcare cost trend rate assumptions used for other post-employment benefits are as follows:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Healthcare cost trend rate &lt;br&gt;&lt;/br&gt;assumed for next year &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 6.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.0% &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 6.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rate to which the cost trend &lt;br&gt;&lt;/br&gt;rate is assumed to decline &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Year that the rate reaches &lt;br&gt;&lt;/br&gt;the ultimate trend rate &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2028 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2028 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2025 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the weighted average plan asset allocation of funded defined benefit pension plans at December 31, 2019 and&amp;nbsp;2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(as a percentage) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Long-term &lt;br&gt;&lt;/br&gt; target &lt;br&gt;&lt;/br&gt; minimum &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Long-term &lt;br&gt;&lt;/br&gt; target &lt;br&gt;&lt;/br&gt; maximum &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Real estate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alternative investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and other investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Cash and most of the equity and debt securities have a quoted market price in an active market. Real estate and alternative investments, which include hedge fund, private equity, infrastructure and commodity investments, usually have a quoted market price or a regularly updated net asset value. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The strategic allocation of assets of the different pension plans is determined with the objective of achieving an investment return that, together with the contributions paid by the Group and its associates, is sufficient to maintain reasonable control over the various funding risks of the plans. Based upon the market and economic environments, actual asset allocations may temporarily be permitted to deviate from policy targets. The asset allocation currently includes investments in shares of Novartis AG as per the below table: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Investment in shares of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Number of shares (in millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Market value (in USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The weighted average duration of the defined benefit obligation is 15.2 years (2018: 14.6 years).&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group&amp;#x2019;s ordinary contribution to the various pension plans is based on the rules of each plan. Additional contributions are made whenever this is required by statute or law (i.e., usually when statutory funding levels fall below predetermined thresholds). The only significant plans that are foreseen to require additional funding are those in the United Kingdom. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The expected future cash flows in respect of pension and other post-employment benefit plans at December 31, 2019, were as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post- &lt;br&gt;&lt;/br&gt; employment &lt;br&gt;&lt;/br&gt; benefit plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Novartis Group contributions&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020 (estimated)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 410&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Expected future benefit payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;201&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;116&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;106&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;096&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2025&amp;#x2013;2029&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 231&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Defined contribution plans&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In many subsidiaries, associates are covered by defined contribution plans. Contributions charged to the consolidated income statement for the defined contribution plans were: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions for defined contribution plans continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 422&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 443&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 307&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;For defined contribution plans for discontinued operations, see Note 30.&lt;/div&gt;</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
  <nvs:DisclosureOfDefinedBenefitPlansTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 22&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&amp;nbsp;210&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;115&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Benefit obligations related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;385&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current service cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 378&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 330&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past service costs and settlements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;168&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remeasurement losses/(gains) arising from changes in financial assumptions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;791&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;567&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remeasurement (gains)/losses arising from changes in demographic assumptions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;193&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Experience-related remeasurement losses/(gains)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 264&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;374&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Benefit payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions of associates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of acquisitions, divestments or transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 746&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 18&amp;nbsp;838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 20&amp;nbsp;275&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 162&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Plan assets related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 257&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Return on plan assets excluding interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;805&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 304&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Group contributions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 420&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 520&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions of associates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 169&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Settlements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;193&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Benefit payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of acquisitions, divestments or transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 19&amp;nbsp;810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&amp;nbsp;838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 134&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Funded status&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Limitation on recognition of fund surplus at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;89&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in limitation on recognition of fund surplus (incl. exchange rate differences)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income on limitation of fund surplus&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Limitation on recognition of fund surplus at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;68&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net liability in the balance sheet at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfDefinedBenefitPlansTableTextBlock>
  <nvs:DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net liability at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;024&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;953&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less: net liability related to discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 238&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current service cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;336&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;378&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Net interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;77&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;76&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Administrative expenses&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Past service costs and settlements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remeasurements&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;507&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 64&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Group contributions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 420&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 520&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Effect of acquisitions, divestments or transfers&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Change in limitation on recognition of fund surplus&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net liability at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;321&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;409&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Amounts recognized in the consolidated balance sheet&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prepaid benefit cost&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 137&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued benefit liability&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock>
  <nvs:BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4PensionPlanMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Switzerland &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Switzerland &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 15&amp;nbsp;106&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;552&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;408&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 23&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 14&amp;nbsp;263&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;348&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 4&amp;nbsp;568&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;179&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Thereof unfunded&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 670&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 466&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 1&amp;nbsp;136&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 649&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 1&amp;nbsp;140&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;By type of member&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Active&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 630&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;400&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;197&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&amp;nbsp;618&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 653&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;616&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;887&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;205&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;517&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;722&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;131&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;662&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;939&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;717&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;645&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;564&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;421&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;630&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 14&amp;nbsp;457&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;311&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;042&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 19&amp;nbsp;810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;160&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;208&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 18&amp;nbsp;838&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Funded status&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;649&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;241&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;793&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="18" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock>
  <nvs:BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock contextRef="AR_D-CurrentYear_nvs-2019Q4RetirementPlanTypeAxis_nvs-2019Q4OtherPostemploymentBenefitPlansMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; United &lt;br&gt;&lt;/br&gt; States &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Rest of &lt;br&gt;&lt;/br&gt; the world &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Benefit obligation at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 658&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 746&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 72&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Thereof unfunded&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 882&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 72&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; 954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;By type of member&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Active&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 157&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 295&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pensioners&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 522&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 52&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 574&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Fair value of plan assets at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 134&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 134&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Funded status&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;88&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;882&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;72&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;954&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock>
  <nvs:ScheduleOfAssumptionsUsedTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post-employment benefit plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Weighted average assumptions used to determine benefit obligations at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Discount rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.6%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.5%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.6%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.4%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.7%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expected rate of pension increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.3%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.4%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.5%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expected rate of salary increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest on savings account&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.3%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.8%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.6%&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current average life expectancy &lt;br&gt;&lt;/br&gt;for a 65-year-old male in years &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 21 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 21 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 21 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current average life expectancy &lt;br&gt;&lt;/br&gt;for a 65-year-old female in years &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 24 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 23 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 23 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 23 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfAssumptionsUsedTableTextBlock>
  <nvs:ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change in 2019 year-end &lt;br&gt;&lt;/br&gt; defined benefit pension obligation &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase in discount rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease in discount rate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 837&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;One-year increase in life expectancy&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 848&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase in rate of pension increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 546&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease in rate of pension increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase of interest on savings account&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease of interest on savings account&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point increase in rate of salary increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;25 basis point decrease in rate of salary increase&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;55&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock>
  <nvs:ScheduleOfHealthCareCostTrendRatesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Healthcare cost trend rate &lt;br&gt;&lt;/br&gt;assumed for next year &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 6.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.0% &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 6.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rate to which the cost trend &lt;br&gt;&lt;/br&gt;rate is assumed to decline &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 4.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 4.5% &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Year that the rate reaches &lt;br&gt;&lt;/br&gt;the ultimate trend rate &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 2028 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2028 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2025 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfHealthCareCostTrendRatesTableTextBlock>
  <nvs:ScheduleOfAllocationOfPlanAssetsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Pension plans&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(as a percentage) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Long-term &lt;br&gt;&lt;/br&gt; target &lt;br&gt;&lt;/br&gt; minimum &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Long-term &lt;br&gt;&lt;/br&gt; target &lt;br&gt;&lt;/br&gt; maximum &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Real estate&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alternative investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and other investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
  <nvs:ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; December 31, &lt;br&gt;&lt;/br&gt; 2018 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Investment in shares of Novartis AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Number of shares (in millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Market value (in USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock>
  <nvs:ScheduleOfExpectedBenefitPaymentsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Pension plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other post- &lt;br&gt;&lt;/br&gt; employment &lt;br&gt;&lt;/br&gt; benefit plans &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Novartis Group contributions&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020 (estimated)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 410&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Expected future benefit payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;201&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;116&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;106&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;096&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2025&amp;#x2013;2029&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 231&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
  <nvs:ScheduleOfDefinedContributionPlansTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions for defined contribution plans continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 422&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 443&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 307&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfDefinedContributionPlansTableTextBlock>
  <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;26. Equity-based participation plans for associates&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The expense related to all equity-based participation plans and the liabilities arising from equity-based payment transactions were as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense related to equity-based &lt;br&gt;&lt;/br&gt;participation plans &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;067 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 918 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 853 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Liabilities arising from equity-based payment transactions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 326&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 261&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Equity-based participation plans can be separated into the following plans:&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Annual Incentive&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Annual Incentive for the Novartis Group CEO and other Executive Committee members (ECN) is paid 50% in cash and 50% in Novartis restricted shares (RSs) or restricted share units (RSUs). For the Novartis Top Leaders (NTLs), the Annual Incentive is paid 70% in cash and 30% in RSs or RSUs. Both the ECN and NTLs can opt to invest up to the maximum cash portion of their Annual Incentive to receive further RSs or RSUs. Any cash is paid out during February or March in the year following the end of the performance period, and the shares are granted during January in the year following the end of the performance period. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Share savings plans&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Associates in certain countries and certain key executives worldwide are encouraged to invest their Annual Incentive in a share savings plan. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Under the share savings plan, participants may elect to receive their relevant compensation fully or partially in Novartis shares in lieu of cash. As a reward for their participation in the share savings plan, at no additional cost to the participant, Novartis matches their investments in shares after a holding period of three or five years. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;Novartis operates share savings plans for which associates may only participate in one of the share savings plans in any given year. The most significant are listed below: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; In Switzerland, Employee Share Ownership Plan (ESOP) participants may choose to receive their Annual Incentive (i) 100% in shares, (ii) 50% in shares and 50% in cash, or (iii) 100% in cash. After expiration of a three-year holding period for Novartis shares invested under the ESOP, participants will receive one matching share for every two invested shares. Associates eligible for the equity plan &amp;#x201c;Select&amp;#x201d; are not eligible to receive ESOP matching shares starting with the 2017 performance period. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; The Leveraged Share Savings Plan (LSSP) was available to key executives for performance periods prior to 2016. At the participant&amp;#x2019;s election, the Annual Incentive was awarded partly or entirely in shares. The elected number of shares is subject to a holding period of five years. At the end of the holding period, Novartis will match the invested shares at a ratio of 1-to-1 (i.e., one share awarded for each invested share). In the United States, both the LSSP award and the corresponding match are cash settled. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Following the introduction of the new compensation programs in 2014, the Novartis Group CEO and the other Executive Committee members are no longer eligible to participate in the share savings plans. From the 2016 performance period onward, the NTLs are also no longer eligible to participate in the share savings plans. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Novartis equity plan &amp;#x201c;Select&amp;#x201d;&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The equity plan &amp;#x201c;Select&amp;#x201d; is a global equity incentive plan under which eligible associates may annually be awarded a grant subject to a three-year, and for selected units a four-year, staggered vesting period. No awards are granted for performance ratings below a certain threshold. Executive Committee members are not eligible to participate in the equity plan &amp;#x201c;Select&amp;#x201d; effective from the performance period 2014, and the NTLs are not eligible to participate effective from the performance period 2016. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The equity plan &amp;#x201c;Select&amp;#x201d; currently allows participants in Switzerland to choose the form of their equity compensation in RSs or RSUs. In all other jurisdictions, RSs or RSUs are granted unilaterally. Until 2013, participants could also choose to receive part or the entire grant in the form of tradable share options. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Tradable share options expire on their 10 &lt;sup&gt;th&lt;/sup&gt; anniversary from the grant date. Each tradable share option entitles the holder to purchase after vesting (and before the 10 &lt;sup&gt;th&lt;/sup&gt; anniversary from the grant date) one Novartis share at a stated exercise price that equals the closing market price of the underlying share at the grant date. As the exercise price does not reflect the decrease in the Novartis share due to the Alcon spin, one-fifth of an Alcon share will also be awarded to the option holder upon exercise. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Options under Novartis equity plan &amp;#x201c;Select&amp;#x201d; outside North America&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the activity associated with the share options during the period. The weighted average prices in the table below are translated from Swiss francs into USD at historical rates. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Options outstanding &lt;br&gt;&lt;/br&gt;at January 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 59.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 59.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sold or exercised&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 58.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Outstanding at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 60.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 59.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Exercisable at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 60.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 59.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;All share options were granted at an exercise price that was equal to the closing market price of the Group&amp;#x2019;s shares at the grant date. The weighted average share price at the dates of sale or exercise was USD&amp;nbsp;89.9. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table summarizes information about share options outstanding at December 31, 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Options outstanding &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; Total/ &lt;br&gt;&lt;/br&gt; weighted &lt;br&gt;&lt;/br&gt; average &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Number outstanding (millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remaining contractual life (years)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise price (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 60.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Options under Novartis equity plan &amp;#x201c;Select&amp;#x201d; for North America&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the activity associated with the ADR options during the period: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; ADR &lt;br&gt;&lt;/br&gt; options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; ADR &lt;br&gt;&lt;/br&gt; options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Options outstanding &lt;br&gt;&lt;/br&gt;at January 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 15.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 60.7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 20.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 59.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sold or exercised&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 58.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 57.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Outstanding at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 60.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Exercisable at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 60.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;All ADR options were granted at an exercise price that was equal to the closing market price of the ADRs at the grant date. The weighted average ADR price at the dates of sale or exercise was USD&amp;nbsp;85.1. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The following table summarizes information about ADR options outstanding at December 31, 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;ADR options outstanding &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; Total/ &lt;br&gt;&lt;/br&gt; weighted &lt;br&gt;&lt;/br&gt; average &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Number outstanding (millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remaining contractual life (years)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise price (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Long-Term Performance Plan&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Long-Term Performance Plan (LTPP) is an equity plan for the ECN, the NTLs and employees of Group units with specific targets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Participants are granted a target number of performance share units (PSUs) at the beginning of every performance period, which are converted into unrestricted Novartis shares after the performance period. The actual payout depends on the achievement of the performance measures and ranges between 0% and 200% of the granted amount. PSUs granted under the LTPP do not carry voting rights, but do carry dividend equivalents that are paid in unrestricted Novartis shares at the end of the performance period. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The LTPP awards are subject to a three-year performance and vesting period. Until 2018, the performance criteria were based on Novartis internal performance metrics. Starting in 2019, for new grants the performance criteria are based on both Novartis internal performance metrics and variables that can be observed in the market, which is the ranking of the Novartis total shareholder return (TSR) relative to a global healthcare peer group of 14 companies (updated in November 2019 from 15 companies following the acquisition of one of the companies by another company within the peer group) other companies, over rolling three-year performance periods. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;TSR for Novartis and the peer companies is calculated as the change in the company share price, which is translated to USD at the relevant exchange rate, including the reinvestment return of dividends, over the three-year performance period. The calculation is based on Bloomberg standard published TSR data, which is publicly available. The position of Novartis in the peer group determines the payout range based on a payout matrix. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Long-Term Relative Performance Plan&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The LTRPP is an equity plan for the Novartis ECN and NTLs. The last grant under this plan was made in 2018. The LTRPP performance criteria is based on variables that can be observed in the market, which is the ranking of the Novartis TSR relative to a global healthcare peer group of 15 other companies, over rolling three-year performance periods. The TSR for Novartis and the peer companies is calculated as described in the LTPP section above. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Other share awards&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Selected associates, excluding the ECN members, may exceptionally receive Special Share Awards of RSs or RSUs. These Special Share Awards provide an opportunity to reward outstanding achievements or exceptional performance, and aim to retain key contributors. They are based on a formal internal selection process, through which the individual performance of each candidate is thoroughly assessed at several management levels. Special Share Awards have a minimum three-year vesting period. In exceptional circumstances, Special Share Awards may be awarded to attract special expertise and new talents to the organization. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Worldwide, associates at different levels in the organization were awarded RSs and RSUs in 2019, 2018 and 2017. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In addition, in 2019, 2018 and 2017, Board members received unrestricted shares as part of their regular compensation.&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Summary of non-vested share movements&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The table below provides a summary of non-vested share movements (RSs, RSUs and PSUs) for all plans. At the Alcon spin-off date, all RSU and PSU holders, who were not entitled to the dividend in kind in the form of Alcon shares received keep whole awards in Novartis shares to compensate for the loss of the Alcon value from their Novartis shares. These keep whole awards were accounted for as a modification. As they did not increase the value of the original grant, they did not lead to additional expense. In the table below, this is reflected by a zero fair grant date fair value: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Number &lt;br&gt;&lt;/br&gt; of shares &lt;br&gt;&lt;/br&gt; in millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average fair &lt;br&gt;&lt;/br&gt; value at grant &lt;br&gt;&lt;/br&gt; date in USD &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Fair value at &lt;br&gt;&lt;/br&gt; grant date in &lt;br&gt;&lt;/br&gt; USD millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Number &lt;br&gt;&lt;/br&gt; of shares &lt;br&gt;&lt;/br&gt; in millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average fair &lt;br&gt;&lt;/br&gt; value at grant &lt;br&gt;&lt;/br&gt; date in USD &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Fair value at &lt;br&gt;&lt;/br&gt; grant date in &lt;br&gt;&lt;/br&gt; USD millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-vested shares at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 25.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 77.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;981&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 80.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;926&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Granted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Annual Incentive&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 78.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 83.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Share savings plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 83.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 349&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 84.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 348&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Select North America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 64.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 77.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 303&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Select outside North America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 67.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 79.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Long-Term Performance Plan&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 68.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 172&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 85.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Long-Term Relative Performance Plan&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 52.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other share awards&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 67.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 77.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vested&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;13.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 80.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;068&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 90.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;965&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-vested shares at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 25.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;835&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 77.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;981&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
  <nvs:ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense related to equity-based &lt;br&gt;&lt;/br&gt;participation plans &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;067 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 918 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 853 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Liabilities arising from equity-based payment transactions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 326&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 261&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Options outstanding &lt;br&gt;&lt;/br&gt;at January 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 5.6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 59.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7.4 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 59.5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sold or exercised&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 58.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Outstanding at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 60.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 59.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Exercisable at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 60.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 59.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
  <ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;Options outstanding &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; Total/ &lt;br&gt;&lt;/br&gt; weighted &lt;br&gt;&lt;/br&gt; average &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Number outstanding (millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remaining contractual life (years)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise price (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 60.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
  <ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; ADR &lt;br&gt;&lt;/br&gt; options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; ADR &lt;br&gt;&lt;/br&gt; options &lt;br&gt;&lt;/br&gt; (millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average &lt;br&gt;&lt;/br&gt; exercise &lt;br&gt;&lt;/br&gt; price &lt;br&gt;&lt;/br&gt; (USD) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Options outstanding &lt;br&gt;&lt;/br&gt;at January 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 15.2 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 60.7 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 20.3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 59.9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sold or exercised&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 58.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 57.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Outstanding at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 60.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Exercisable at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 60.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory>
  <ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory contextRef="AR_D-CurrentYear_ifrsfull-2019TypesOfSharebasedPaymentArrangementsAxis_nvs-2019Q4EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;ADR options outstanding &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; Total/ &lt;br&gt;&lt;/br&gt; weighted &lt;br&gt;&lt;/br&gt; average &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Number outstanding (millions)&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Remaining contractual life (years)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Exercise price (USD)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 54.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
  <nvs:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Number &lt;br&gt;&lt;/br&gt; of shares &lt;br&gt;&lt;/br&gt; in millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average fair &lt;br&gt;&lt;/br&gt; value at grant &lt;br&gt;&lt;/br&gt; date in USD &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Fair value at &lt;br&gt;&lt;/br&gt; grant date in &lt;br&gt;&lt;/br&gt; USD millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Number &lt;br&gt;&lt;/br&gt; of shares &lt;br&gt;&lt;/br&gt; in millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Weighted &lt;br&gt;&lt;/br&gt; average fair &lt;br&gt;&lt;/br&gt; value at grant &lt;br&gt;&lt;/br&gt; date in USD &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Fair value at &lt;br&gt;&lt;/br&gt; grant date in &lt;br&gt;&lt;/br&gt; USD millions &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-vested shares at January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 25.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 77.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;981&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 80.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;926&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Granted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Annual Incentive&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 78.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 86&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 83.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 109&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Share savings plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 83.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 349&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 84.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 348&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Select North America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 64.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 77.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 303&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Select outside North America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 67.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 175&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 79.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Long-Term Performance Plan&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 68.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 172&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 85.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Long-Term Relative Performance Plan&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 52.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&amp;#x2013; Other share awards&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 67.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 77.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vested&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;13.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 80.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;068&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 90.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;965&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forfeited&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 76.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 76.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-vested shares at December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 25.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;835&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 25.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 77.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;981&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock>
  <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;27. Transactions with related parties&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Genentech/Roche&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has two agreements with Genentech, Inc., United States, and one agreement with Spark Therapeutics, Inc., United States. Both companies are subsidiaries of Roche Holding AG (Roche), which is indirectly included in the consolidated financial statements using equity accounting since Novartis holds 33.3% of the outstanding voting shares of Roche (see Note 4). &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;"&gt;Lucentis&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis has licensed from Genentech/Roche the exclusive rights to develop and market &lt;i&gt;Lucentis&lt;/i&gt; outside the United States for indications related to diseases of the eye. Novartis pays royalties on the net sales of &lt;i&gt;Lucentis&lt;/i&gt; products outside the United States. In 2019, &lt;i&gt;Lucentis&lt;/i&gt; sales of USD&amp;nbsp;2.1 billion (2018: USD&amp;nbsp;2.0 billion; 2017: USD&amp;nbsp;1.9 billion) were recognized by Novartis. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;"&gt;Xolair&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis and Genentech/Roche are co-promoting &lt;i&gt;Xolair&lt;/i&gt; in the United States, where Genentech/Roche records all sales. Novartis records sales outside the United States. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Novartis markets &lt;i&gt;Xolair&lt;/i&gt; and records all sales and related costs outside the United States as well as co-promotion costs in the US. Genentech/Roche and Novartis share the resulting profits from sales in the United States, Europe and other countries, according to agreed profit-sharing percentages. In 2019, Novartis recognized total sales of &lt;i&gt;Xolair&lt;/i&gt; of USD&amp;nbsp;1.2 billion (2018: USD&amp;nbsp;1.0 billion; 2017: USD&amp;nbsp;920 million), including sales to Genentech/Roche for the United States market. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;"&gt;Luxturna&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2018, Novartis entered into an exclusive licensing and commercialization agreement and a supply agreement with Spark Therapeutics, Inc. (Spark) for &lt;i&gt;Luxturna&lt;/i&gt; outside the United States. The agreements include regulatory and sales milestones as well as royalties payable to Spark on ex-US sales. On December 17, 2019, Roche acquired Spark. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;"&gt;The net income for royalties, cost sharing and profit sharing arising out of the &lt;i&gt;Lucentis&lt;/i&gt;, &lt;i&gt;Xolair&lt;/i&gt; and &lt;i&gt;Luxturna&lt;/i&gt; agreements with Roche totaled USD&amp;nbsp;101 million in 2019 (net income in 2018: USD&amp;nbsp;34 million; net expense in 2017: USD&amp;nbsp;33 million). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Furthermore, Novartis has several patent license, supply and distribution agreements with Roche. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Novartis Pension Fund&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2018, a Group subsidiary provided an uncommitted overnight credit facility to the Novartis Pension Fund, Switzerland, for up to USD 500 million with interest at the US Federal Funds Rate. This credit facility was not utilized during the years 2019 and 2018. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Executive Officers and Non-Executive Directors compensation&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;During 2019, there were 15 Executive Committee members (&amp;#x201c;Executive Officers&amp;#x201d;), including those who stepped down during the year (there were 17 members in 2018 and 11 members in 2017, including those who stepped down). &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The total compensation for Executive Committee members and the 13 Non-Executive Directors (13 in 2018 and 2017) using the Group&amp;#x2019;s accounting policies for equity-based compensation and pension benefits was as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Executive Officers&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Non-Executive Directors&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and other compensation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Post-employment benefits&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 40.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 42.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 49.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 45.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 54.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 63.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 67.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 70.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 72.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 76.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 79.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;During 2019, the IFRS compensation expense decreased due to lower cash buyout payments to new executive officers and the forfeiture of equity-based compensation as a result of the resignation of an executive officer. These effects were partially offset by higher equity based compensation of executive officers appointed over the last three years. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;During 2018, there was a decrease in the IFRS compensation expense for Executive Officers, mainly due to the higher pro-rata accelerated vesting of equity compensation in 2017, required by IFRS, in accordance with the plan rules. This was partly offset by the cash portion of buyout payments for new Executive Officers. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Annual Incentive award, which is fully included in equity-based compensation even when paid out in cash, is granted in January in the year following the reporting period. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The disclosures on Board and executive compensation required by the Swiss Code of Obligations and in accordance with the Swiss Ordinance against Excessive Compensation in Stock Exchange Listed Companies are shown in the Compensation Report of the Group. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Transactions with former members of the Board of Directors&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;During 2019, 2018 and 2017, the following payments (or waivers of claims) were made to former Board members or to &amp;#x201c;persons closely&amp;#x201d; linked to them: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currency&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dr. Krauer&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 60&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 60&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dr. Vasella&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&amp;nbsp;228&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&amp;nbsp;279&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Dr. Alex Krauer, Honorary Chairman, is entitled to an amount of CHF&amp;nbsp;60&amp;#xa0;000 for annual periods from one AGM to the next. This amount was fixed in 1998 upon his departure from the Board in 1999, and has not been revised since that date. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Dr. Daniel Vasella, Honorary Chairman, was paid CHF&amp;nbsp;18&amp;#xa0;228 in 2018, and CHF&amp;nbsp;26&amp;#xa0;279 in 2017, for reimbursable costs under his agreement with the Company, which expired on December 31, 2019. &lt;/div&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
  <nvs:OfficerAndDirectorCompensationTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Executive Officers&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Non-Executive Directors&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and other compensation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="5%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22.4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Post-employment benefits&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 40.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 42.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 49.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 45.2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 54.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 63.9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 67.5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 70.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8.7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8.8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 72.6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 76.3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 79.1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="20" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:OfficerAndDirectorCompensationTableTextBlock>
  <nvs:TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Currency&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dr. Krauer&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 60&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 60&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dr. Vasella&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 18&amp;nbsp;228&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&amp;nbsp;279&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock>
  <nvs:DisclosureOfCommitmentsAndContingenciesTextBlock contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;28. Commitments and contingencies&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Research and development commitments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group has entered into long-term research and development agreements with various institutions, which provide for potential milestone payments by Novartis that may be capitalized. As of December 31, 2019, the Group&amp;#x2019;s commitments to make payments under those agreements, and their estimated timing, were as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 809&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 442&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 724&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Thereafter&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;943&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;404&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Commitments for capital calls&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group holds investments in funds in which it has committed to invest further upon future capital calls. As of December 31, 2019, the total uncalled capital commitments for the Group&amp;#x2019;s investments in funds amounts to USD 79 million. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Note 29 contains further information on the Group&amp;#x2019;s investments in funds.&lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Other commitments&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group has entered into various purchase commitments for services and materials as well as for equipment in the ordinary course of business. These commitments are generally entered into at current market prices and reflect normal business operations. For disclosure of property, plant and equipment purchase commitments, see Note 9. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Guarantees issued&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group has issued guarantees to third parties in the ordinary course of business, mostly for tax, customs or other governmental agencies. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In addition, Novartis AG is guarantor of the Group&amp;#x2019;s issued bonds, credit facilities and commercial paper program. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Contingencies&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Group companies have to observe the laws, government orders and regulations of the country in which they operate. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;A number of Novartis companies are, and will likely continue to be, subject to various legal proceedings and investigations that arise from time to time, including proceedings regarding product liability; sales and marketing practices; commercial disputes; employment and wrongful discharge; and antitrust, securities, health and safety, environmental, tax, international trade, privacy and intellectual property matters. As a result, the Group may become subject to substantial liabilities that may not be covered by insurance and that could affect our business, financial position and reputation. While Novartis does not believe that any of these legal proceedings will have a material adverse effect on its financial position, litigation is inherently unpredictable and large judgments sometimes occur. As a consequence, Novartis may in the future incur judgments or enter into settlements of claims that could have a material adverse effect on its results of operations or cash flow. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Governments and regulatory authorities around the world have been stepping up their compliance and law enforcement activities in recent years in key areas, including marketing practices, pricing, corruption, trade restrictions, embargo legislation, insider trading, antitrust, cyber security and data privacy. Further, when one government or regulatory authority undertakes an investigation, it is not uncommon for other governments or regulators to undertake investigations regarding the same or similar matters. Responding to such investigations is costly and requires an increasing amount of management&amp;#x2019;s time and attention. In addition, such investigations may affect our reputation, create a risk of potential exclusion from government reimbursement programs in the United States and other countries, and lead to (or arise from) litigation. These factors have contributed to decisions by Novartis and other companies in the healthcare industry, when deemed in their interest, to enter into settlement agreements with governmental authorities around the world prior to any formal decision by the authorities or a court. Those government settlements have involved and may continue to involve, in current government investigations and proceedings, large cash payments, sometimes in the hundreds of millions of dollars or more, including the potential repayment of amounts allegedly obtained improperly and other penalties, including treble damages. In addition, settlements of government healthcare fraud cases often require companies to enter into corporate integrity agreements, which are intended to regulate company behavior for a period of years. Our affiliate Novartis Pharmaceuticals Corporation is a party to such an agreement, which will expire in 2020. Also, matters underlying governmental investigations and settlements may be the subject of separate private litigation. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;While provisions have been made for probable losses, which management deems to be reasonable or appropriate, there are uncertainties connected with these estimates. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Note 20 contains additional information on these matters.&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;A number of Group companies are involved in legal proceedings concerning intellectual property rights. The inherent unpredictability of such proceedings means that there can be no assurances as to their ultimate outcome. A negative result in any such proceeding could potentially adversely affect the ability of certain Novartis companies to sell their products, or require the payment of substantial damages or royalties. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In the opinion of management, however, the outcome of these actions will not materially affect the Group&amp;#x2019;s financial position but could be material to the results of operations or cash flow in a given period. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group&amp;#x2019;s potential environmental remediation liability is assessed based on a risk assessment and investigation of the various sites identified by the Group as at risk for environmental remediation exposure. The Group&amp;#x2019;s future remediation expenses are affected by a number of uncertainties. These uncertainties include, but are not limited to, the method and extent of remediation, the percentage of material attributable to the Group at the remediation sites relative to that attributable to other parties, and the financial capabilities of the other potentially responsible parties. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Note 20 contains additional information on environmental liabilities.&lt;/div&gt;</nvs:DisclosureOfCommitmentsAndContingenciesTextBlock>
  <nvs:DisclosureOfLeasingCommitmentsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2020&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 809&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2021&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 442&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2022&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2023&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 724&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;2024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Thereafter&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;943&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;404&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfLeasingCommitmentsTableTextBlock>
  <ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;29. Financial instruments &amp;ndash; additional disclosures&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Note&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets - measured at fair value through other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Long-term financial investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;158&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 802&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total long-term financial investments - fair value through other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;191&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets - measured at fair value through other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;215&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;158&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade receivables, income tax receivables and other current assets (excluding pre-payments)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15/17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;337&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interest on debt securities, time deposits and short-term investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short-term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans, advances, security deposits and other long-term receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 10&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;635&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets - measured at fair value through the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13/16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 286&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Associated companies at fair value through profit and loss&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets - measured at fair value through the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;323&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&amp;nbsp;377&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 29&amp;nbsp;374&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest-bearing accounts of associates payable on demand&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;778&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bank and other financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commercial paper&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Liabilities to banks and other financial institutions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Finance lease obligations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 92&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Trade payables and commitment for repurchase of own shares &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;840&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 32&amp;nbsp;623&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 37&amp;nbsp;930&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities - measured at fair value through the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration (see Note 20/22) and other financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;065&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 917&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities - measured at fair value through the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 35&amp;nbsp;822&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 38&amp;nbsp;905&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Except for straight bonds (see Note 19), the carrying amount is a reasonable approximation of fair value. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Notes 18 and 22 provide additional disclosures related to commitment for repurchase of own shares. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Derivative financial instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following tables show the contract or underlying principal amounts and fair values of derivative financial instruments analyzed by type of contract at December&amp;nbsp;31, 2019 and 2018. Contract or underlying principal amounts indicate the gross volume of business outstanding at the consolidated balance sheet date and do not represent amounts at risk. The fair values are determined by reference to market prices or standard pricing models that use observable market inputs at December 31,&amp;nbsp;2019 and 2018. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Contract or underlying principal amount&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Positive fair values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Negative fair values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forward foreign exchange rate contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;779&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 96&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;75&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodity purchase contract&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Options on equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total derivative financial instruments included in marketable securities and in current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;057&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows by currency contract or underlying principal amount the derivative financial instruments at December&amp;nbsp;31,&amp;nbsp;2019 and 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forward foreign exchange rate contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;646&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;779&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodity purchase contract&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Options on equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;665&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;057&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Other&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forward foreign exchange rate contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;989&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;276&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;989&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;276&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Derivative financial instruments effective for hedge accounting purposes&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;At the end of 2019 and 2018, there were no open hedging instruments for anticipated transactions. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Fair value by hierarchy&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;As required by IFRS, financial assets and liabilities recorded at fair value in the consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. There are three hierarchical levels, based on an increasing amount of subjectivity associated with the inputs to derive fair valuation for these assets and liabilities, which are as follows: &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The assets carried at Level 1 fair value are equity and debt securities listed in active markets. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The assets generally included in Level 2 fair value hierarchy are foreign exchange and interest rate derivatives, and certain debt securities. Foreign exchange and interest rate derivatives are valued using corroborated market data. The liabilities generally included in this fair value hierarchy consist of foreign exchange and interest rate derivatives. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Level 3 inputs are unobservable for the asset or liability. The assets generally included in Level 3 fair value hierarchy are various investments in hedge funds and unquoted equity security investments. Contingent consideration carried at fair value is included in this category. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Level 1 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Level 2 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Level 3 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Valued at &lt;br&gt;&lt;/br&gt; amortized cost &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities, time deposits and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt and equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 976&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 581&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;557&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans, advances, security deposits and other long-term receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial investments and long-term loans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 976&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;213&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;518&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Associated companies at fair value through profit and loss&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities at fair value&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;065&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Level 1 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Level 2 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Level 3 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Valued at &lt;br&gt;&lt;/br&gt; amortized cost &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 302&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interest on debt securities, time deposits and short-term investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities, time deposits and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt and equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans and receivables from customers and finance lease, advances, security deposits&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial investments and long-term loans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Associated companies at fair value through profit and loss&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities at fair value&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;917&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The analysis above includes all financial instruments measured at fair value as well as certain financial assets measured at amortized cost. &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The change in carrying values associated with Level 3 financial instruments, using significant unobservable inputs during the year ended December 31, is set forth below: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Associated &lt;br&gt;&lt;/br&gt; companies at &lt;br&gt;&lt;/br&gt; fair value through &lt;br&gt;&lt;/br&gt; profit and loss &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Fund &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Long-term &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; receivables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; payables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Other &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact from discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value gains and other adjustments, &lt;br&gt;&lt;/br&gt;including from divestments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 12 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 35 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 195 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value losses (including impairments and &lt;br&gt;&lt;/br&gt;amortizations) and other adjustments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;15 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;89 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;48 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments recognized in the consolidated statement &lt;br&gt;&lt;/br&gt;of comprehensive income &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Purchases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 229&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;401&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash receipts and payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;64&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 581&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total of fair value gains and losses recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement for assets &lt;br&gt;&lt;/br&gt;and liabilities held at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;15 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 12 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 35 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 106 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;47 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="14"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="14"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Associated &lt;br&gt;&lt;/br&gt; companies at &lt;br&gt;&lt;/br&gt; fair value through &lt;br&gt;&lt;/br&gt; profit and loss &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Fund &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Long-term &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; receivables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; payables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Other &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 166&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 437&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 844&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;852&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;72&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value gains and other adjustments, &lt;br&gt;&lt;/br&gt;including from divestments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 93 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 36 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 213 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value losses (including impairments and &lt;br&gt;&lt;/br&gt;amortizations) and other adjustments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;100 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments recognized in the consolidated statement &lt;br&gt;&lt;/br&gt;of comprehensive income &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;10 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Purchases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;182&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash receipts and payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;484&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration payable related to disposal group held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total of fair value gains and losses recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement for assets &lt;br&gt;&lt;/br&gt;and liabilities held at December 31, 2018 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 93 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 36 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 113 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;During 2019, there were several individually non-significant transfers of financial investments from Level 3 to Level 1 for USD&amp;nbsp;64 million (2018: USD&amp;nbsp;78 million), mainly due to initial public offerings of the invested companies. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Realized gains and losses associated with Level 3 long-term financial investments measured at fair value through the consolidated income statement are recorded in the consolidated income statement under &amp;#x201c;Other income&amp;#x201d; or &amp;#x201c;Other expense,&amp;#x201d; respectively. Realized gains and losses associated with Level 3 long-term financial investments measured at fair value through other comprehensive income are not recycled through the consolidated income statement but are instead reclassified to retained earnings. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;During the year, the net loss and net gain recorded on associated companies, fund investments and long-term financial investments at fair value through profit and loss were USD 72 million and USD 110 million, respectively. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;If the pricing parameters for the Level 3 input were to change for associated companies at fair value through profit and loss, fund investments and long-term financial investments by 10% positively or negatively, this would change the amounts recorded in the 2019 consolidated statement of comprehensive income by USD&amp;nbsp;100 million. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;To determine the fair value of a contingent consideration, various unobservable inputs are used. A change in these inputs might result in a significantly higher or lower fair value measurement. The inputs used are, among others, the probability of success, sales forecast and assumptions regarding the discount rate and timing and different scenarios of triggering events. The inputs are interrelated. The significance and usage of these inputs to each contingent consideration may vary due to differences in the timing and triggering events for payments or in the nature of the asset related to the contingent consideration. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;If the most significant parameters for the Level&amp;nbsp;3 input were to change by 10% positively or negatively, or where the probability of success (POS) is the most significant input parameter, 10% were added or deducted from the applied probability of success, for contingent consideration payables, other financial liabilities and contingent consideration receivables, this would change the amounts recorded in the 2019 consolidated income statement by USD&amp;nbsp;267 million and USD 202 million, respectively. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Equity securities measured at fair value through other comprehensive income&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Equity securities held as strategic investments, typically held outside the Novartis Venture Fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Except for the investment in Alcon Inc. with a fair value of USD 382 million at December 31, 2019, these are made up of individually non-significant investments. At December 31, 2019, the Group holds 53 non-listed equity securities (December 31, 2018: 41) and 29 listed equity securities (December 31, 2018: 26) in this category with the following fair values: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Listed equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 843&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 597&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-listed equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 315&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 205&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;158&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 802&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;There were no dividends recognized during 2019 and 2018 from these equity securities. In 2019, in accordance with the consolidated foundations Alcon Inc. shares divestment plans, Alcon Inc. shares with a fair value of USD&amp;nbsp;976 million were sold, and the USD&amp;nbsp;62 million gain on disposal was transferred from other comprehensive income to retained earnings during 2019. In addition, in 2019, equity securities that were no longer considered strategic, with a fair value of USD&amp;nbsp;33 million (2018: USD&amp;nbsp;21 million), were sold, and the USD&amp;nbsp;33 million gain on disposal (2018: USD&amp;nbsp;16 million gain) was transferred from other comprehensive income to retained earnings (see Note 8). &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Nature and extent of risks arising from financial instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Market risk&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis is exposed to market risk, primarily related to foreign currency exchange rates, interest rates, and the market value of the investments of liquid funds. The Group actively monitors and seeks to reduce, where it deems it appropriate to do so, fluctuations in these exposures. It is the Group&amp;#x2019;s policy and practice to enter into a variety of derivative financial instruments to manage the volatility of these exposures and to enhance the yield on the investment of liquid funds. It does not enter into any financial transactions containing a risk that cannot be quantified at the time the transaction is concluded. In addition, it does not sell short assets it does not have, or does not know it will have, in the future. The Group only sells existing assets or enters into transactions and future transactions (in the case of anticipatory hedges) that it confidently expects it will have in the future, based on past experience. In the case of liquid funds, the Group writes call options on assets it has, or writes put options on positions it wants to acquire and has the liquidity to acquire. The Group expects that any loss in value for these instruments generally would be offset by increases in the value of the underlying transactions. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Foreign currency exchange rate risk&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group uses the US dollar as its reporting currency. As a result, the Group is exposed to foreign currency exchange movements, primarily in European, Japanese and emerging market currencies. Fluctuations in the exchange rates between the US dollar and other currencies can have a significant effect on both the Group&amp;#x2019;s results of operations, including reported sales and earnings, as well as on the reported value of our assets, liabilities and cash flows. This, in turn, may significantly affect the comparability of period-to-period results of operations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Because our expenditures in Swiss francs are significantly higher than our revenues in Swiss francs, volatility in the value of the Swiss franc can have a significant impact on the reported value of our earnings, assets and liabilities, and the timing and extent of such volatility can be difficult to predict. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;There is also a risk that certain countries could devalue their currency. If this occurs, it could impact the effective prices we would be able to charge for our products and also have an adverse impact on both our consolidated income statement and balance sheet. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Certain countries have legal or economic restrictions on the ability of subsidiaries to transfer funds to the Group in the form of cash dividends, loans or advances, but these restrictions do not have an impact on the ability of the Group to meet its cash obligations. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The most significant countries in this respect are Argentina and Venezuela, where the governments have implemented capital controls. The net outstanding intercompany payable balance of Argentina and Venezuela Subsidiaries were not material for the Group at December 31, 2019 and at December 31, 2018. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Subsidiaries whose functional currencies have experienced a cumulative inflation rate of more than 100% over the past three years apply the rules of IAS 29 &amp;#x201c;Financial reporting in Hyperinflationary Economies&amp;#x201d;. The hyperinflationary economies in which Novartis operates are Argentina and Venezuela. Venezuela was hyperinflationary for all years presented, and Argentina became hyperinflationary effective July 1, 2018, requiring retroactive implementation of hyperinflation accounting as of January 1, 2018. The impacts of applying IAS 29 was not significant in all years presented. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group manages its global currency exposure by engaging in hedging transactions where management deems appropriate. Novartis may enter into various contracts that reflect the changes in the value of foreign currency exchange rates to preserve the value of assets, commitments and anticipated transactions. Novartis also uses forward contracts and foreign currency option contracts to hedge. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Net investments in subsidiaries in foreign countries are long-term investments. Their fair value changes through movements of foreign currency exchange rates. The Group has designated a certain portion of its long-term euro-denominated straight bonds as hedges of the translation risk arising on certain of these net investments in foreign operations with euro functional currency. As of December 31, 2019, long-term financial debt with a carrying amount of EUR&amp;nbsp;1.8 billion (USD&amp;nbsp;2.1 billion) (December 31, 2018: USD 2.1 billion), has been designated as a hedge instrument. During 2019, USD&amp;nbsp;44 million of unrealized income (unrealized income in 2018: USD 95 million) was recognized in other comprehensive income and accumulated in currency translation effects in relation with this net investment hedge. The hedge remained effective since inception, and no amount was recognized in the consolidated income statement in 2019, 2018 and 2017. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Commodity price risk&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group has only a very limited exposure to price risk related to anticipated purchases of certain commodities used as raw materials by the Group&amp;#x2019;s businesses. A change in those prices may alter the gross margin of a specific business, but generally by not more than 10% of the margin and thus below the Group&amp;#x2019;s risk management tolerance levels. Accordingly, the Group does not enter into significant commodity futures, forward or option contracts to manage fluctuations in prices of anticipated purchases. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Interest rate risk&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group addresses its net exposure to interest rate risk mainly through the ratio of its fixed-rate financial debt to variable-rate financial debt contained in its total financial debt portfolio. To manage this mix, Novartis may enter into interest rate swap agreements, in which it exchanges periodic payments based on a notional amount and agreed-upon fixed and variable interest rates. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Equity risk&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group may purchase equities as investments of its liquid funds. As a policy, it limits its holdings in an unrelated company to less than 5% of its liquid funds. Potential investments are thoroughly analyzed. Call options are written on equities that the Group owns, and put options are written on equities that the Group wants to buy and for which cash is available. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Credit risk&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Credit risks arise from the possibility that customers may not be able to settle their obligations as agreed. To manage this risk, the Group periodically assesses country and customer credit risk, assigns individual credit limits, and takes actions to mitigate credit risk where appropriate. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The provisions for expected credit losses for customers are based on a forward-looking expected credit loss, which includes possible default events on the trade receivables over the entire holding period of the trade receivables. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In measuring the expected credit losses, trade receivables are grouped based on shared credit risk characteristics (such as private versus public receivables) and days past due. In determining the expected credit loss rates, the Group considers current and forward-looking macroeconomic factors that may affect the ability of the customers to settle the receivables, and historical loss rates for each category of customers. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group&amp;#x2019;s largest customer accounted for approximately 23% of net sales, and the second largest and third largest customers accounted for 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). No other customer accounted for 6% or more of net sales in either year. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the Group&amp;#x2019;s trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively). There is no other significant concentration of customer credit risk. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Counterparty risk&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Counterparty risk encompasses issuer risk on marketable securities and money market instruments; credit risk on cash, time deposits and derivatives; as well as settlement risk for different instruments. Issuer risk is reduced by only buying securities that are at least A- rated. Counterparty credit risk and settlement risk are reduced by a policy of entering into transactions with counterparties (banks or financial institutions) that feature a strong credit rating. Exposure to these risks is closely monitored and kept within predetermined parameters. The limits are regularly assessed and determined based upon credit analysis, including financial statement and capital adequacy ratio reviews. In addition, reverse repurchasing agreements are contracted, and Novartis has entered into credit support agreements with various banks for derivative transactions. To further reduce the settlement risk, the Group has implemented a multi-currency system, CLS (Continuous Linked Settlement), providing multilateral netting (payment-versus-payment settlement) of cash flows from foreign exchange transactions. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group&amp;#x2019;s cash and cash equivalents are held with major regulated financial institutions; the three largest ones hold approximately 12.6%, 10.4% and 8.3%, respectively (2018: 9.4%, 7.6% and 7.0%, respectively). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group does not expect any losses from non-performance by these counterparties and does not have any significant grouping of exposures to financial sector or country risk. &lt;/div&gt; &lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Liquidity risk&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Liquidity risk is defined as the risk that the Group could not be able to settle or meet its obligations associated with financial liabilities that are settled by delivering cash or another financial asset. Group Treasury is responsible for liquidity, funding and settlement management. In addition, liquidity and funding risks, and related processes and policies, are overseen by management. Novartis manages its liquidity risk on a consolidated basis according to business needs and tax, capital or regulatory considerations, if applicable, through numerous sources of financing in order to maintain flexibility. Management monitors the Group&amp;#x2019;s net debt or liquidity position through rolling forecasts on the basis of expected cash flows. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;Novartis has two US commercial paper programs under which it can issue up to USD&amp;nbsp;9.0 billion in the aggregate of unsecured commercial paper notes. Novartis also has a Japanese commercial paper program under which it can issue up to JPY&amp;nbsp;150 billion (approximately USD&amp;nbsp;1.4 billion) of unsecured commercial paper notes. Commercial paper notes totaling USD&amp;nbsp;2.3 billion under these three programs were outstanding as per December 31, 2019 (2018: USD&amp;nbsp;4.0 billion). Novartis further has a committed credit facility of USD&amp;nbsp;6.0 billion, which was renewed in September 2019. This credit facility is provided by a syndicate of banks and is intended to be used as a backstop for the US commercial paper programs. The renewed facility matures in September 2024 and was undrawn as per December 31, 2019, and December 31, 2018. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In December 2019, Novartis entered into a short-term credit facility of USD 7 billion, with a maturity date of June 30, 2020 with a syndicate of banks. On January 7, 2020, Novartis borrowed USD 7 billion under the facility with interest based on the USD LIBOR. &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table sets forth how management monitors net debt or liquidity based on details of the remaining contractual maturities of current financial assets and liabilities, excluding trade receivables and payables as well as contingent considerations at December 31, 2019, and December 31, 2018: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="11" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketable securities, time deposits and short-term &lt;br&gt;&lt;/br&gt;investments with original maturity more than 90 days &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 20 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 26 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 16 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 57 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 122 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments and accrued interest&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 79&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;712&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;400&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;746&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;446&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;402&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;237&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;15&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="11" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketable securities, time deposits and short-term &lt;br&gt;&lt;/br&gt;investments with original maturity more than 90 days &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 39 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 56 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;091 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 198 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 63 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;447 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments and accrued interest&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;571&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;700&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;650&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;831&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 198&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;490&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;623&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&amp;nbsp;648&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;490&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;327&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;583&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;791&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;782&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;323&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&amp;nbsp;184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The consolidated balance sheet amounts of financial liabilities included in the above analysis are not materially different to the contractual amounts due on maturity. The positive and negative fair values on derivative financial instruments represent the net contractual amounts to be exchanged at maturity. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Group&amp;#x2019;s contractual undiscounted potential cash flows from derivative financial instruments to be settled on a gross basis are as follows: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Derivative financial instruments and accrued interest on derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential outflows in various currencies - from financial derivative liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;624&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;952&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;390&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential inflows in various currencies - from financial derivative assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 807&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 922&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&amp;nbsp;385&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Derivative financial instruments and accrued interest on derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential outflows in various currencies - from financial derivative liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;598&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;852&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential inflows in various currencies - from financial derivative assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;974&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 593&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;895&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Other contractual liabilities that are not part of management&amp;#x2019;s monitoring of the net debt or liquidity consist of the following items: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contractual interest on non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;36&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;428&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;439&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;434&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;181&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;081&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;222&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;582&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;383&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contractual interest on non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;459&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;667&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;755&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;994&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Capital risk management&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Novartis strives to maintain a strong credit rating. In managing its capital, Novartis focuses on maintaining a strong balance sheet. As of December 31, 2019, Moody&amp;#x2019;s Investor Service rated the Company A1 for long-term maturities and P-1 for short-term maturities and S&amp;amp;P Global Ratings rated the company AA- for long-term maturities and A-1+ for short-term maturities. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Value at risk&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Group uses a value at risk (VAR) computation to estimate the potential 10-day loss in the fair value of its financial instruments. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;A 10-day period is used because of an assumption that not all positions could be undone in one day given the size of the positions. The VAR computation includes all financial assets and financial liabilities as set forth in the table on page F-75, except: &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Trade receivables, income tax receivables and other current assets&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Long-term loans and receivables, advances and security deposits&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Contingent considerations&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Finance lease obligations&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Lease liabilities&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;"&gt;&amp;#x2022; Trade payables and commitment for repurchase of own shares&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The VAR estimates are made assuming normal market conditions, using a 95% confidence interval. The Group uses a &amp;#x201c;Delta Normal&amp;#x201d; model to determine the observed interrelationships between movements in interest rates, stock markets and various currencies. These interrelationships are determined by observing interest rate movements, stock market movements and foreign currency rate movements over a 60-day period for the calculation of VAR amounts. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The estimated potential 10-day loss in the fair value of the Group&amp;#x2019;s foreign currency positions (including foreign exchange translation risk), the estimated potential 10-day loss of its equity holdings, and the estimated potential 10-day loss in fair value of its interest rate-sensitive instruments (primarily financial debt and investments of liquid funds under normal market conditions), as calculated in the VAR model, are the following: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;All financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 355&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Analyzed by components:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to foreign &lt;br&gt;&lt;/br&gt;currency exchange rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 89 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 217 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to equity &lt;br&gt;&lt;/br&gt;market movements &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 31 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 122 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to interest rates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 187&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 221&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The average, high and low VAR amounts are as follows:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Average&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; High&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Low&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;All financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 348&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 385&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 303&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Analyzed by components:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to foreign &lt;br&gt;&lt;/br&gt;currency exchange rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 143 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 195 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 86 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to equity &lt;br&gt;&lt;/br&gt;market movements &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 36 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 81 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 16 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to &lt;br&gt;&lt;/br&gt;interest rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 233 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 303 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 187 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Average&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; High&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Low&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;All financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 443&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 553&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Analyzed by components:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to foreign &lt;br&gt;&lt;/br&gt;currency exchange rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 324 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 473 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 217 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to equity &lt;br&gt;&lt;/br&gt;market movements &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 60 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 122 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to &lt;br&gt;&lt;/br&gt;interest rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 253 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 361 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 169 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The VAR computation is a risk analysis tool designed to statistically estimate the potential 10-day loss from adverse movements in foreign currency exchange rates, equity prices and interest rates under normal market conditions. The computation does not purport to represent actual losses in fair value on earnings to be incurred by the Group, nor does it consider the effect of favorable changes in market rates. The Group cannot predict actual future movements in such market rates, and it does not claim that these VAR results are indicative of future movements in such market rates or are representative of any actual impact that future changes in market rates may have on the Group&amp;#x2019;s future results of operations or financial position. &lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
  <nvs:DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Note&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets - measured at fair value through other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Long-term financial investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;158&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 802&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total long-term financial investments - fair value through other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;191&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 833&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets - measured at fair value through other comprehensive income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;215&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;158&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade receivables, income tax receivables and other current assets (excluding pre-payments)&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15/17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;337&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;024&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interest on debt securities, time deposits and short-term investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short-term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans, advances, security deposits and other long-term receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 10&amp;nbsp;727&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 13&amp;nbsp;635&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets - measured at fair value through the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 366&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13/16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 270&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 286&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Associated companies at fair value through profit and loss&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets - measured at fair value through the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;323&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;310&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&amp;nbsp;377&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 29&amp;nbsp;374&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest-bearing accounts of associates payable on demand&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;836&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;778&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bank and other financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 719&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 701&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commercial paper&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;289&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;951&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Straight bonds&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22&amp;nbsp;167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 25&amp;nbsp;283&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Liabilities to banks and other financial institutions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 285&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Finance lease obligations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 92&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current portion of non-current debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;002&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Trade payables and commitment for repurchase of own shares &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;840&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities - measured at amortized costs&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 32&amp;nbsp;623&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 37&amp;nbsp;930&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities - measured at fair value through the consolidated income statement&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration (see Note 20/22) and other financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;065&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 917&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities - measured at fair value through the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 35&amp;nbsp;822&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 38&amp;nbsp;905&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Except for straight bonds (see Note 19), the carrying amount is a reasonable approximation of fair value. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Notes 18 and 22 provide additional disclosures related to commitment for repurchase of own shares. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Derivative financial instruments&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following tables show the contract or underlying principal amounts and fair values of derivative financial instruments analyzed by type of contract at December&amp;nbsp;31, 2019 and 2018. Contract or underlying principal amounts indicate the gross volume of business outstanding at the consolidated balance sheet date and do not represent amounts at risk. The fair values are determined by reference to market prices or standard pricing models that use observable market inputs at December 31,&amp;nbsp;2019 and 2018. &lt;/div&gt;</nvs:DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock>
  <ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Contract or underlying principal amount&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Positive fair values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="3" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Negative fair values &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="3" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forward foreign exchange rate contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;779&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 96&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;75&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodity purchase contract&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Options on equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total derivative financial instruments included in marketable securities and in current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;057&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory>
  <nvs:DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Other&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forward foreign exchange rate contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;646&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;779&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodity purchase contract&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Options on equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&amp;nbsp;019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;665&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;057&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Other&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Forward foreign exchange rate contracts&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;989&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;276&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;989&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;558&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;276&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;823&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock>
  <ifrs-full:DisclosureOfFairValueMeasurementExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Level 1 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Level 2 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Level 3 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Valued at &lt;br&gt;&lt;/br&gt; amortized cost &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities, time deposits and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 224&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt and equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 976&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 581&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;557&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans, advances, security deposits and other long-term receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial investments and long-term loans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 976&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;213&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 329&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;518&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Associated companies at fair value through profit and loss&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities at fair value&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;065&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;250&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Level 1 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Level 2 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Level 3 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Valued at &lt;br&gt;&lt;/br&gt; amortized cost &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 302&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 325&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 360&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Time deposits and short term investments with original maturity more than 90 days&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;087&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Accrued interest on debt securities, time deposits and short-term investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total marketable securities, time deposits and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;099&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;589&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Debt and equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fund investments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration receivables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Long-term loans and receivables from customers and finance lease, advances, security deposits&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial investments and long-term loans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 698&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 512&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Associated companies at fair value through profit and loss&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total financial liabilities at fair value&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;917&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;975&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfFairValueMeasurementExplanatory>
  <nvs:DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Associated &lt;br&gt;&lt;/br&gt; companies at &lt;br&gt;&lt;/br&gt; fair value through &lt;br&gt;&lt;/br&gt; profit and loss &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Fund &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Long-term &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; receivables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; payables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Other &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact from discontinued operations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value gains and other adjustments, &lt;br&gt;&lt;/br&gt;including from divestments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 12 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 35 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 195 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value losses (including impairments and &lt;br&gt;&lt;/br&gt;amortizations) and other adjustments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;15 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;89 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;48 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments recognized in the consolidated statement &lt;br&gt;&lt;/br&gt;of comprehensive income &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Purchases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 49&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 229&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;401&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash receipts and payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;53&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;64&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 581&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 399&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total of fair value gains and losses recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement for assets &lt;br&gt;&lt;/br&gt;and liabilities held at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;15 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 12 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 6 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 35 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 106 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;47 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="14"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="14"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Notes 1, 2 and 30 provide information related to discontinued operations. &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;b&gt;&lt;/b&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="13" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="13" height="3"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Associated &lt;br&gt;&lt;/br&gt; companies at &lt;br&gt;&lt;/br&gt; fair value through &lt;br&gt;&lt;/br&gt; profit and loss &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Fund &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Long-term &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; investments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; receivables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Contingent &lt;br&gt;&lt;/br&gt; consideration &lt;br&gt;&lt;/br&gt; payables &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Other &lt;br&gt;&lt;/br&gt; financial &lt;br&gt;&lt;/br&gt; liabilities &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;January 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 188&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 166&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 437&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 844&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;852&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;72&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value gains and other adjustments, &lt;br&gt;&lt;/br&gt;including from divestments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 93 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 36 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 213 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value losses (including impairments and &lt;br&gt;&lt;/br&gt;amortizations) and other adjustments recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;100 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fair value adjustments recognized in the consolidated statement &lt;br&gt;&lt;/br&gt;of comprehensive income &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;10 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Purchases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 22&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 123&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;182&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash receipts and payments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;484&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Disposals&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration payable related to disposal group held for sale&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reclassification&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;December 31&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 145&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 251&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 488&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 396&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total of fair value gains and losses recognized &lt;br&gt;&lt;/br&gt;in the consolidated income statement for assets &lt;br&gt;&lt;/br&gt;and liabilities held at December 31, 2018 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 93 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;5 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 36 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 113 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock>
  <ifrs-full:DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Listed equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 843&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 597&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Non-listed equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 315&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 205&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity securities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;158&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 802&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory>
  <nvs:DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="11" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketable securities, time deposits and short-term &lt;br&gt;&lt;/br&gt;investments with original maturity more than 90 days &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 20 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 26 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 16 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 57 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 122 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments and accrued interest&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 79&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 102&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;712&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;400&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;112&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;746&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 19&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 11&amp;nbsp;446&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;150&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;355&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;505&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;110&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;20&amp;nbsp;353&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;243&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;230&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;846&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;130&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;29&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;26&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;185&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;402&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;256&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;7&amp;nbsp;031&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 5&amp;nbsp;373&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;237&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;11&amp;nbsp;073&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;15&amp;nbsp;938&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="11" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="11" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marketable securities, time deposits and short-term &lt;br&gt;&lt;/br&gt;investments with original maturity more than 90 days &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 39 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 56 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;091 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 198 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 63 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="7%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 2&amp;nbsp;447 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Commodities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments and accrued interest&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 40&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 75&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;571&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;700&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 13&amp;nbsp;271&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;650&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;831&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 198&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 167&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 15&amp;nbsp;964&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;490&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;623&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&amp;nbsp;648&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;980&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;490&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;22&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Financial debt - undiscounted&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;084&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;319&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current financial debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;118&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;327&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&amp;nbsp;678&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net debt&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;583&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 5&amp;nbsp;713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 1&amp;nbsp;791&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&amp;nbsp;782&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&amp;nbsp;323&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&amp;nbsp;184&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="14" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock>
  <nvs:DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Derivative financial instruments and accrued interest on derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential outflows in various currencies - from financial derivative liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;814&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;624&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;952&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;6&amp;nbsp;390&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential inflows in various currencies - from financial derivative assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 807&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;656&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 922&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&amp;nbsp;385&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="7" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="7" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due within &lt;br&gt;&lt;/br&gt; one month &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Derivative financial instruments and accrued interest on derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential outflows in various currencies - from financial derivative liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;598&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;4&amp;nbsp;852&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Potential inflows in various currencies - from financial derivative assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;328&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;974&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 593&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;895&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock>
  <nvs:DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contractual interest on non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;36&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;428&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;531&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;439&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;434&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;181&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;622&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;081&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;222&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;424&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;582&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;383&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;036&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one month &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; three months &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; three months &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; one year &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Due later than &lt;br&gt;&lt;/br&gt; one year &lt;br&gt;&lt;/br&gt; but less than &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Due after &lt;br&gt;&lt;/br&gt; five years &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contractual interest on non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;459&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;667&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;755&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;994&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&amp;nbsp;556&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contingent consideration liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;470&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;907&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock>
  <nvs:DisclosureOfTenDayLossFairValueVARModelTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;All financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 355&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Analyzed by components:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to foreign &lt;br&gt;&lt;/br&gt;currency exchange rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 89 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 217 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to equity &lt;br&gt;&lt;/br&gt;market movements &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 31 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 122 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to interest rates&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 187&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 221&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfTenDayLossFairValueVARModelTableTextBlock>
  <nvs:DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Average&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; High&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Low&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;All financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 348&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 385&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 303&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Analyzed by components:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to foreign &lt;br&gt;&lt;/br&gt;currency exchange rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 143 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 195 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 86 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to equity &lt;br&gt;&lt;/br&gt;market movements &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 36 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 81 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 16 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to &lt;br&gt;&lt;/br&gt;interest rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 233 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 303 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 187 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="5" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="5" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Average&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; High&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Low&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;All financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 443&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 553&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 337&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Analyzed by components:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to foreign &lt;br&gt;&lt;/br&gt;currency exchange rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 324 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 473 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 217 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to equity &lt;br&gt;&lt;/br&gt;market movements &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 60 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 122 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 22 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Instruments sensitive to &lt;br&gt;&lt;/br&gt;interest rates &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 253 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 361 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 169 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock>
  <ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;30. Discontinued operations&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Discontinued operations include the operational results from the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders, and certain other expenses related to the Distribution (refer to Notes 1 and 2 for further details). &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The Alcon eye care devices business researched, discovered, developed, manufactured, distributed and sold a broad range of eye care products. Alcon was organized into two global business franchises, Surgical and Vision Care. Alcon also provided services, training, education and technical support for both the Surgical and Vision Care businesses. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Consolidated income statement&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales to third parties from &lt;br&gt;&lt;/br&gt;discontinued operations &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;777 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7&amp;nbsp;149 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 6&amp;nbsp;771 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sales to continuing segments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;809&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;860&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;588&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross profit from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;189&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Selling, general and administration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;638&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;532&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;583&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating income/(loss) from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;234&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;73&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income and expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income/(loss) before taxes from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;260&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 307&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net (loss)/income from discontinued operations &lt;br&gt;&lt;/br&gt;before gain on distribution of Alcon Inc. &lt;br&gt;&lt;/br&gt;to Novartis AG shareholders &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;101 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;186 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 204 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gain on distribution of Alcon Inc. to Novartis AG shareholders &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income/(loss) from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; The consolidated income statement amounts are for the period from January 1, 2019, to the completion of the spin-off. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; See Note 2 for further details on the non-taxable non-cash gain on distribution of Alcon Inc. to Novartis AG shareholders. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Supplemental disclosures related to the Alcon business distributed to Novartis AG shareholders &lt;/font&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Net income &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Included in net income from discontinued operations are:&lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;235&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;174&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;052&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on intangible assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;391&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;57&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation of Novartis equity plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. See Note 1 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; 2018 includes an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Balance sheet &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following were in the balance sheet from discontinued operations for the period from January 1, 2019, to the date of reclassification: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 113&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 519&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to goodwill and intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 196&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Note 1 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Cash flows used in investing activities from discontinued operations&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;Cash flows used in investing activities from discontinued operations include the investing activities of the Alcon business, and in addition in 2017 USD 140 million cash outflows for transaction-related expenditures attributable to the series of portfolio transformation transactions completed in 2015. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Payments out of provisions for &lt;br&gt;&lt;/br&gt;transaction costs attributable &lt;br&gt;&lt;/br&gt;to the spin-off of the &lt;br&gt;&lt;/br&gt;Alcon business &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;29 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Divested cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;628&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows attributable to the spin-off of the Alcon business&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;657&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other cash flows used in investing activities, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;502&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;775&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net cash flows used in investing activities from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;775&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Cash flows from financing activities from discontinued operations&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In 2019, the net cash inflows from financing activities from discontinued operations of USD 3.3 billion (2018: USD 167 million net cash outflows, 2017: USD 415 million net cash outflows) included USD 3.5 billion cash inflows from borrowings in connection with the distribution (spin-off) of the Alcon business to Novartis AG shareholders and USD 212 million (2018: USD 57 million, 2017: nil) transaction cost payment directly attributable to the distribution (spin-off) of the Alcon business to Novartis shareholders (see Notes 1 and 2). &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Intangible assets &lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The Alcon Divisions&amp;#x2019; cash-generating units, to which goodwill is allocated, each comprise a group of smaller cash-generating units. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The valuation method of the recoverable amount of the cash-generating units, to which goodwill is allocated, is based on the fair value less costs of disposal. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;In 2017, the Alcon brand name indefinite life intangible asset was reported in Corporate, as it was used to market products of the Alcon Division and products within the Ophthalmology business franchise of the Innovative Medicines Division. In connection with the spin-off of the Alcon Division, the Novartis Group transferred the full rights of the Alcon brand name to the Alcon Division. As a result, the Innovative Medicines Division started the process of rebranding the products within its Ophthalmology business franchise and is no longer using the Alcon brand name. The Alcon brand name indefinite life intangible asset is therefore reported in the Alcon Division in 2018. In 2018, net sales of the Alcon Division products together are the grouping of cash-generating units, which were used to determine the recoverable amount. In the year before, net sales of products within the Innovative Medicines Ophthalmology business franchise as well as Alcon Division products, which used the Alcon brand name, together were the grouping of cash-generating units, which were used to determine the recoverable amounts. The valuation method is based on the fair value less costs of disposal. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The assumptions used in the calculations of fair value were a discount rate (post-tax) of 7.5% and a terminal growth rate of 3%. The Alcon terminal growth rate assumption of 3% is higher than the expected inflation rate of the medical device industry, and more specifically the ophthalmic sub-segment of the industry. The growth rates are expected to exceed this long-term inflation rate, as the aging population to which Alcon&amp;#x2019;s products are prescribed is growing faster than the general population. The discount rates consider the Group&amp;#x2019;s weighted average cost of capital, adjusted to approximate the weighted average cost of capital of a comparable market participant. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The fair value less costs of disposal, for all groupings of cash-generating units containing goodwill or indefinite life intangible assets, is reviewed for the impact of reasonably possible changes in key assumptions. In particular, we considered an increase in the discount rate, a decrease in the terminal growth rate, and certain negative impacts on the forecasted cash flows. These reasonably possible changes in key assumptions did not indicate an impairment. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;&amp;#x201c;Note 1. Significant accounting policies&amp;mdash;Impairment of goodwill and intangible assets&amp;#x201d; provides additional disclosures on how the Group performs goodwill and intangible asset impairment testing. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;The 2018 intangible asset and goodwill impairment charges were USD 391 million, including an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Leases&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table shows the receivables of the gross investments in finance leases and the net present value of the minimum lease payments, as well as unearned finance income, related to Alcon&amp;#x2019;s surgical equipment lease arrangements. The finance income was recorded in &amp;#x201c;Other income.&amp;#x201d; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; future &lt;br&gt;&lt;/br&gt; payments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Unearned &lt;br&gt;&lt;/br&gt; finance &lt;br&gt;&lt;/br&gt; income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Present &lt;br&gt;&lt;/br&gt; value &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Provision &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Net book &lt;br&gt;&lt;/br&gt; value &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Not later than one year &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 64&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 59&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 57&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between one and five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 117&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Later than five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 229&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 213&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; The current portion of the minimum lease payments was recorded in trade receivables or other current assets (to the extent not invoiced). &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The lease liabilities recorded in discontinued operations on January 1, 2019, the date of implementation of IFRS 16 leases (see Note 1), were USD 286 million, and the right-of-use assets were USD 276 million, including USD 89 million and USD 75 million, respectively, for the previously reported finance lease obligations. For discontinued operations, there were no impairments or significant contract terminations of right-of-use assets for the period from January 1, 2019, to February 28, 2019, the date of shareholder approval for the Alcon spin-off. &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Net assets derecognized &lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table presents the Alcon business net assets at the date of spin-off at April 8, 2019: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;858&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Right-of-use assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;906&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial and other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 526&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade receivables and other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 628&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current and non-current lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current and non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;538&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables, provisions and other liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net assets derecognized&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Defined contribution plans&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In many subsidiaries, associates are covered by defined contribution plans. Contributions charged to the consolidated income statement for the defined contribution plans were: &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions for defined contribution plans discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style=" padding-bottom: 10px;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;"&gt;Significant transactions&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;In March 2019, Alcon acquired PowerVision, Inc. (PowerVision), a privately held, US-based medical device development company focused on developing accommodative, implantable intraocular lenses. The fair value of the total purchase consideration was USD 424 million. The amount consisted of an initial cash payment of USD 289 million and the net present value of the contingent consideration of USD 135 million, due to PowerVision shareholders, which they are eligible to receive upon the achievement of specified regulatory and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 418 million, consisting of intangible assets of USD 505 million, net deferred tax liabilities of USD 93 million, other net assets of USD 6 million, and goodwill of USD 6 million. The 2019 results of operations since the date of the acquisition are not material. &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"&gt;For additional information related to the distribution (spin-off) of the Alcon business to Novartis AG shareholders, effected through a dividend in kind distribution that was completed on April 8, 2019, refer to Note 1 and Note 2. &lt;/div&gt;</ifrs-full:DisclosureOfDiscontinuedOperationsExplanatory>
  <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="AR_D-CurrentYear">&lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;31. Events subsequent to the December 31, 2019, consolidated balance sheet date&lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Significant transaction closed in January 2020&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On November 23, 2019, Novartis entered into an agreement and plan of merger with The Medicines Company, New Jersey, USA. The transaction was completed on January 6, 2020. For details see Note 2, significant transaction entered into in 2019 and closed in 2020. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Increase in current financial debts&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On January 7, 2020, Novartis borrowed USD 7 billion under a short-term credit facility with a syndicate of banks. For additional information, see Note 29. &lt;/div&gt; &lt;div&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Dividend proposal for 2019 and approval of&amp;nbsp;the Group&amp;#x2019;s 2019 consolidated financial statements&lt;/font&gt; &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;On January 28, 2020, the Novartis AG Board of Directors proposed the acceptance of the 2019 consolidated financial statements of the Novartis Group for approval by the Annual General Meeting on February 28, 2020. Furthermore, also on January 28, 2020, the Board proposed a dividend of CHF&amp;nbsp;2.95 per share to be approved at the Annual General Meeting on February 28, 2020. If approved, total dividend payments would amount to approximately USD&amp;nbsp;7.0 billion (2018: USD&amp;nbsp;6.6 billion), using the CHF/USD December 31, 2019, exchange rate. &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;&lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;&lt;/div&gt; &lt;div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
  <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="AR_D-CurrentYear">&lt;a name="anchorNote31"&gt;&lt;/a&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"&gt;32. Principal Group subsidiaries and&amp;nbsp;associated&amp;nbsp;companies &lt;/div&gt; &lt;div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "&gt;The following table lists the principal subsidiaries controlled by Novartis, associated companies in which Novartis is deemed to have significant influence, and foundations required to be consolidated under IFRS. It includes all subsidiaries, associated companies and consolidated foundations with total assets or net sales to third parties in excess of USD&amp;nbsp;25&amp;nbsp;million. The equity interest percentage shown in the table also represents the share in voting rights in those entities, except where explicitly noted. &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Algeria&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Soci&amp;#xe9;t&amp;#xe9; par actions SANDOZ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Algiers&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; DZD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 650.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Argentina&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Argentina S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buenos Aires&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ARS&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 906.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Australia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Australia Pty Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Macquarie Park, NSW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AUD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals Australia Pty Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Macquarie Park, NSW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AUD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Pty Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Macquarie Park, NSW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AUD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Austria&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Austria GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vienna&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vienna&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kundl&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;EBEWE Pharma Ges.m.b.H Nfg. KG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Unterach am Attersee&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Bangladesh&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Bangladesh) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gazipur&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BDT&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 162.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Belgium&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma NV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vilvoorde&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz NV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vilvoorde&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon - Couvreur NV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Puurs&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Bermuda&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Investment Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Securities Investment Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finance Services Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Triangle International Reinsurance Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trinity River Insurance Co Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 370&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Brazil&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Bioci&amp;#xea;ncias S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;S&amp;#xe3;o Paulo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRL&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 265.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz do Brasil Ind&amp;#xfa;stria Farmac&amp;#xea;utica Ltda.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Camb&amp;#xe9;, PR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRL&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 190.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Canada&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals Canada Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dorval, Quebec&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Canada Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Boucherville, Quebec&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 80.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;CIBA Vision Canada Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mississauga, Ontario&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 82&amp;nbsp;886&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Chile&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Chile S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Santiago de Chile&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CLP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;China&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Beijing Novartis Pharma Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Beijing&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals (HK) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hong Kong&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HKD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;China Novartis Institutes for BioMedical Research Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Shanghai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 320.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Suzhou Novartis Technical Development Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Changshu&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shanghai Novartis Trading Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shanghai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz (China) Pharmaceutical Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Zhongshan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Colombia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis de Colombia S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Santaf&amp;#xe9; de Bogot&amp;#xe1;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; COP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.9&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Croatia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz d.o.o. farmaceutska industrija&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Zagreb&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HRK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Czech Republic&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis s.r.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prague&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CZK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 51.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz s.r.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prague&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CZK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Denmark&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Healthcare A/S&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Copenhagen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; DKK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz A/S&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Copenhagen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; DKK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ecuador&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ecuador S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Quito&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Egypt&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma S.A.E.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cairo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EGP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 193.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.77%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Egypt Pharma S.A.E.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;New Cairo City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EGP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Finland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finland Oy&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Espoo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 459&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;France&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Groupe France S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rueil-Malmaison&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 903.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma S.A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rueil-Malmaison&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Saint-Genis-Pouilly&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;CELLforCURE&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Les Ulis&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz S.A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Levallois-Perret&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Germany&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Deutschland GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Nuremberg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 155.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Nuremberg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Produktions GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Wehr&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Manufacturing GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marburg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz International GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Holzkirchen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1 A Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Oberhaching&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;HEXAL AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Holzkirchen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 93.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Salutas Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Barleben&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 42.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Aeropharm GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rudolstadt&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Greece&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Hellas) S.A.C.I.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Metamorphosis / Athens&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Hungary&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Hungary Healthcare Limited Liability Company&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Budapest&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HUF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 545.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Hungary Limited Liability Company&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Budapest&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HUF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 883.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;India&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis India Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mumbai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; INR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 123.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 70.68%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Healthcare Private Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mumbai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; INR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Private Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mumbai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; INR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Indonesia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;PT. Novartis Indonesia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Jakarta&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; IDR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ireland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ireland Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dublin&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ringaskiddy Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ringaskiddy, County Cork&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Israel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Israel Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tel Aviv&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ILS&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Italy&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farma S.p.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Origgio&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications (Italy) S.r.l.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pozzilli&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 119&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz S.p.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Origgio&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Japan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Holding Japan K.K.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma K.K.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ciba-Geigy Japan Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz K.K.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Latvia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Baltics SIA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Riga&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Investments S.&amp;#xe0; r.l.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Luxembourg City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finance S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Luxembourg City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Malaysia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Corporation (Malaysia) Sdn. Bhd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kuala Lumpur&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MYR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Mexico&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farmac&amp;#xe9;utica, S.A. de C.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mexico City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MXN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 205.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz, S.A. de C.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mexico City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MXN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 468.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Morocco&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Maroc SA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Casablanca&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 80.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Netherlands&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Netherlands B.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amsterdam&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma B.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amsterdam&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;IDB Holland BV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Baarle-Nassau&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz B.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Almere&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 907&amp;nbsp;560&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;New Zealand&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis New Zealand Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Auckland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; NZD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 820&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Norway&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Norge AS&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Oslo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; NOK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Pakistan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma (Pakistan) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Karachi&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PKR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.99%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Panama&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma (Logistics), Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Panama City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Peru&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Biosciences Per&amp;#xfa; S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lima&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PEN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Philippines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Healthcare Philippines, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Makati City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PHP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 298.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Philippines Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Makati City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PHP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Poland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Poland Sp. z o.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Warsaw&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PLN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Polska Sp. z o.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Warsaw&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PLN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lek S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Strykow&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PLN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Portugal&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Portugal SGPS Lda.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Porto Salvo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farma - Produtos Farmac&amp;#xea;uticos S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Porto Salvo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Farmac&amp;#xea;utica Lda.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Porto Salvo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 499&amp;nbsp;900&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Romania&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Services Romania S.R.L.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bucharest&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RON&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz S.R.L.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Targu-Mures&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RON&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 105.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Russian Federation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Moscow&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RUB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Neva LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;St. Petersburg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RUB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;ZAO Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Moscow&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RUB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Saudi Arabia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Saudi Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Riyadh&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SAR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 75%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Singapore) Pte Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SGD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Singapore Pharmaceutical Manufacturing Pte Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SGD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 45.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Asia Pacific Pharmaceuticals Pte Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SGD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 39.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Slovakia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Slovakia s.r.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bratislava&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Slovenia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lek Pharmaceuticals d.d.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ljubljana&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Pharmaceuticals d.d.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ljubljana&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;South Africa&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis South Africa (Pty) Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Midrand&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ZAR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 86.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz South Africa (Pty) Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kempton Park&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ZAR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;South Korea&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Korea Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Seoul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; KRW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.55%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Spain&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farmac&amp;#xe9;utica, S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Barcelona&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 63.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications Iberica, S.L.U.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Esplugues de Llobregat&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Farmac&amp;#xe9;utica S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Madrid&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 270&amp;nbsp;450&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Industrial Products S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Les Franqueses del Vall&amp;#xe9;s / Barcelona&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon Cusi S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;El Masnou / Barcelona&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Abadia Retuerta S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sard&amp;#xf3;n de Duero / Valladolid&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Sweden&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Sverige AB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Stockholm&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SEK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis International AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Holding AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis International Pharmaceutical Investment AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Bioventures AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Forschungsstiftung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Stiftung f&amp;#xfc;r Kaderausbildung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Mitarbeiterbeteiligungsstiftung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Stiftung f&amp;#xfc;r Mensch und Umwelt&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Stiftung der Novartis AG f&amp;#xfc;r Erziehung, Ausbildung und Bildung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Overseas Investments AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japat AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 50&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 350.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis International Pharmaceutical AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Services AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Schweizerhalle AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Muttenz&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18.9&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Stein AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Stein&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 251&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Schweiz AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Risch&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ophthalmics AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fribourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications International SA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Geneva&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Pharmaceuticals AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Risch&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Roche Holding AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 160.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33/6 &lt;sup style="white-space: nowrap"&gt; 2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Taiwan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Taiwan) Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taipei&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TWD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 170.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Thailand&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Thailand) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bangkok&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; THB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 302.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Turkey&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Saglik, Gida ve Tarim &amp;#xdc;r&amp;#xfc;nleri Sanayi ve Ticaret A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Istanbul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Farmanova Saglik Hizmetleri Ltd. Sti.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Istanbul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Ila&amp;#xe7; Sanayi ve Ticaret A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Istanbul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 165.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.99%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Grup Saglik &amp;#xdc;r&amp;#xfc;nleri Ila&amp;#xe7;lari Sanayi ve Ticaret A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Gebze - Kocaeli&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 50.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ukraine&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Ukraine LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kyiv&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; UAH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;United Arab Emirates&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Middle East FZE&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dubai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AED&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;United Kingdom&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis UK Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals UK Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Grimsby Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Imaging Equipment Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vivacta Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Frimley / Camberley&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.9&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.0%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ziarco Group Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;904&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Frimley / Camberley&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;United States of America&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 72.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finance Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Capital Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Services, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis US Foundation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 650&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications USA, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Millburn, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;AveXis, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bannockburn, IL&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Inflammasome Research, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Technology LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cambridge, MA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;CoStim Pharmaceuticals Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cambridge, MA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Encore Vision, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Endocyte, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Navigate BioPharma Services, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Carlsbad, CA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reprixys Pharmaceuticals Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Spinifex Pharmaceuticals, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Institute for Functional Genomics, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;San Diego, CA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Princeton, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Oriel Therapeutics, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Durham, NC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fougera Pharmaceuticals Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Melville, NY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Eon Labs, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Princeton, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Vaccines and Diagnostics, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Venezuela&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis de Venezuela, S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Caracas&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; VES&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;In addition, the Group is represented by subsidiaries and associated companies with total assets or net sales to third parties below USD 25 million in the following countries: Bosnia/Herzegovina, Bulgaria, Dominican Republic, Guatemala, Kenya, North Macedonia, Nigeria, Puerto Rico, Uruguay and Vietnam &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Share capital may not reflect the taxable share capital and does not include any paid-in surplus. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Approximately 33% of voting shares; approximately 6% of total net income and equity attributable to Novartis. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Significant subsidiary under SEC Regulation S-X Rule 1-02(w) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;m = million; bn = billion&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
  <nvs:PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Algeria&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Soci&amp;#xe9;t&amp;#xe9; par actions SANDOZ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Algiers&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; DZD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 650.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Argentina&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Argentina S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buenos Aires&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ARS&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 906.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Australia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Australia Pty Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Macquarie Park, NSW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AUD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals Australia Pty Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Macquarie Park, NSW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AUD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Pty Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Macquarie Park, NSW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AUD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Austria&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Austria GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vienna&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vienna&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kundl&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;EBEWE Pharma Ges.m.b.H Nfg. KG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Unterach am Attersee&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Bangladesh&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Bangladesh) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gazipur&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BDT&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 162.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Belgium&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma NV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vilvoorde&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz NV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vilvoorde&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 19.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon - Couvreur NV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Puurs&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 110.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Bermuda&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Investment Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Securities Investment Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finance Services Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Triangle International Reinsurance Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trinity River Insurance Co Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hamilton&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 370&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Brazil&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Bioci&amp;#xea;ncias S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;S&amp;#xe3;o Paulo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRL&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 265.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz do Brasil Ind&amp;#xfa;stria Farmac&amp;#xea;utica Ltda.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Camb&amp;#xe9;, PR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; BRL&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 190.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Canada&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals Canada Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dorval, Quebec&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Canada Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Boucherville, Quebec&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 80.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;CIBA Vision Canada Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mississauga, Ontario&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 82&amp;nbsp;886&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Chile&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Chile S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Santiago de Chile&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CLP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;China&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Beijing Novartis Pharma Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Beijing&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals (HK) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Hong Kong&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HKD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 200&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;China Novartis Institutes for BioMedical Research Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Shanghai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 320.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Suzhou Novartis Technical Development Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Changshu&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shanghai Novartis Trading Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Shanghai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz (China) Pharmaceutical Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Zhongshan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Colombia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis de Colombia S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Santaf&amp;#xe9; de Bogot&amp;#xe1;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; COP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.9&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Croatia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz d.o.o. farmaceutska industrija&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Zagreb&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HRK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Czech Republic&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis s.r.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prague&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CZK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 51.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz s.r.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Prague&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CZK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Denmark&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Healthcare A/S&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Copenhagen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; DKK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz A/S&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Copenhagen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; DKK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ecuador&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ecuador S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Quito&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Egypt&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma S.A.E.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cairo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EGP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 193.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.77%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Egypt Pharma S.A.E.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;New Cairo City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EGP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Finland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finland Oy&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Espoo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 459&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;France&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Groupe France S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rueil-Malmaison&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 903.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma S.A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rueil-Malmaison&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 43.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Saint-Genis-Pouilly&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;CELLforCURE&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Les Ulis&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz S.A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Levallois-Perret&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Germany&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Deutschland GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Nuremberg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 155.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Nuremberg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Produktions GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Wehr&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Manufacturing GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Marburg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz International GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Holzkirchen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;1 A Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Oberhaching&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;HEXAL AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Holzkirchen&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 93.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Salutas Pharma GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Barleben&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 42.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Aeropharm GmbH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Rudolstadt&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Greece&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Hellas) S.A.C.I.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Metamorphosis / Athens&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Hungary&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Hungary Healthcare Limited Liability Company&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Budapest&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HUF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 545.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Hungary Limited Liability Company&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Budapest&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; HUF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 883.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;India&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis India Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mumbai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; INR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 123.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 70.68%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Healthcare Private Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mumbai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; INR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 60.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Private Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mumbai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; INR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Indonesia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;PT. Novartis Indonesia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Jakarta&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; IDR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ireland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ireland Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dublin&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ringaskiddy Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ringaskiddy, County Cork&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Israel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Israel Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tel Aviv&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ILS&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Italy&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farma S.p.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Origgio&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications (Italy) S.r.l.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Pozzilli&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 119&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz S.p.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Origgio&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Japan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Holding Japan K.K.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma K.K.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ciba-Geigy Japan Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz K.K.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tokyo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; JPY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Latvia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Baltics SIA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Riga&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Luxembourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Investments S.&amp;#xe0; r.l.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Luxembourg City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finance S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Luxembourg City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Malaysia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Corporation (Malaysia) Sdn. Bhd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kuala Lumpur&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MYR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Mexico&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farmac&amp;#xe9;utica, S.A. de C.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mexico City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MXN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 205.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz, S.A. de C.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Mexico City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MXN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 468.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Morocco&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Maroc SA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Casablanca&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; MAD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 80.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Netherlands&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Netherlands B.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amsterdam&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma B.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amsterdam&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;IDB Holland BV&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Baarle-Nassau&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz B.V.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Almere&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 907&amp;nbsp;560&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;New Zealand&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis New Zealand Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Auckland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; NZD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 820&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Norway&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Norge AS&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Oslo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; NOK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Pakistan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma (Pakistan) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Karachi&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PKR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.99%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Panama&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma (Logistics), Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Panama City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Peru&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Biosciences Per&amp;#xfa; S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lima&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PEN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Philippines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Healthcare Philippines, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Makati City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PHP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 298.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Philippines Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Makati City&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PHP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 30.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Poland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Poland Sp. z o.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Warsaw&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PLN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 44.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Polska Sp. z o.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Warsaw&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PLN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lek S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Strykow&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; PLN&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Portugal&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Portugal SGPS Lda.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Porto Salvo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farma - Produtos Farmac&amp;#xea;uticos S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Porto Salvo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Farmac&amp;#xea;utica Lda.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Porto Salvo&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 499&amp;nbsp;900&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Romania&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Services Romania S.R.L.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bucharest&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RON&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz S.R.L.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Targu-Mures&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RON&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 105.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Russian Federation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Moscow&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RUB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Neva LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;St. Petersburg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RUB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 500.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;ZAO Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Moscow&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; RUB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 57.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Saudi Arabia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Saudi Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Riyadh&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SAR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 26.8&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 75%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Singapore) Pte Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SGD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Singapore Pharmaceutical Manufacturing Pte Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SGD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 45.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Asia Pacific Pharmaceuticals Pte Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Singapore&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SGD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 39.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Slovakia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Slovakia s.r.o.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bratislava&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Slovenia&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lek Pharmaceuticals d.d.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ljubljana&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 48.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Pharmaceuticals d.d.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ljubljana&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;South Africa&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis South Africa (Pty) Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Midrand&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ZAR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 86.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz South Africa (Pty) Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kempton Park&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; ZAR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;South Korea&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Korea Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Seoul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; KRW&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 24.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; bn&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.55%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Spain&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Farmac&amp;#xe9;utica, S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Barcelona&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 63.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications Iberica, S.L.U.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Esplugues de Llobregat&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 22.6&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Farmac&amp;#xe9;utica S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Madrid&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 270&amp;nbsp;450&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Industrial Products S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Les Franqueses del Vall&amp;#xe9;s / Barcelona&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Alcon Cusi S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;El Masnou / Barcelona&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10.1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Abadia Retuerta S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sard&amp;#xf3;n de Duero / Valladolid&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; EUR&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Sweden&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Sverige AB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Stockholm&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; SEK&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Switzerland&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis International AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Holding AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis International Pharmaceutical Investment AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Bioventures AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Forschungsstiftung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Stiftung f&amp;#xfc;r Kaderausbildung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Mitarbeiterbeteiligungsstiftung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Stiftung f&amp;#xfc;r Mensch und Umwelt&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Stiftung der Novartis AG f&amp;#xfc;r Erziehung, Ausbildung und Bildung&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Overseas Investments AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Japat AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 50&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 350.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis International Pharmaceutical AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Services AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 20.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Schweizerhalle AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Muttenz&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 18.9&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Stein AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Stein&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 251&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharma Schweiz AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Risch&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Ophthalmics AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fribourg&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications International SA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Geneva&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9.3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Pharmaceuticals AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Risch&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Roche Holding AG&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Basel&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; CHF&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 160.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33/6 &lt;sup style="white-space: nowrap"&gt; 2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;As at December 31, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Share &lt;br&gt;&lt;/br&gt; capital &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Equity &lt;br&gt;&lt;/br&gt; interest &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Taiwan&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Taiwan) Co., Ltd.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taipei&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TWD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 170.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Thailand&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis (Thailand) Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bangkok&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; THB&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 302.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Turkey&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Saglik, Gida ve Tarim &amp;#xdc;r&amp;#xfc;nleri Sanayi ve Ticaret A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Istanbul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 98.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Farmanova Saglik Hizmetleri Ltd. Sti.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Istanbul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6.7&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Ila&amp;#xe7; Sanayi ve Ticaret A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Istanbul&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 165.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.99%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Grup Saglik &amp;#xdc;r&amp;#xfc;nleri Ila&amp;#xe7;lari Sanayi ve Ticaret A.S.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Gebze - Kocaeli&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; TRY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 50.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Ukraine&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Ukraine LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Kyiv&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; UAH&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;United Arab Emirates&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Middle East FZE&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Dubai&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; AED&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;United Kingdom&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis UK Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25.5&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals UK Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5.4&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Grimsby Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 250.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Imaging Equipment Ltd&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vivacta Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Frimley / Camberley&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.9&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100.0%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Ziarco Group Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;London&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;904&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Limited&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Frimley / Camberley&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; GBP&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2.0&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;United States of America&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 72.2&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; m&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Finance Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Capital Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Services, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis US Foundation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Pharmaceuticals Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 650&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Advanced Accelerator Applications USA, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Millburn, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 99.2%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;AveXis, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Bannockburn, IL&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Inflammasome Research, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Technology LLC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; --&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; Cambridge, MA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;CoStim Pharmaceuticals Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cambridge, MA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Encore Vision, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Endocyte, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Navigate BioPharma Services, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Carlsbad, CA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reprixys Pharmaceuticals Corporation&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Spinifex Pharmaceuticals, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Institute for Functional Genomics, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;San Diego, CA&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sandoz Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Princeton, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 25&amp;nbsp;000&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Oriel Therapeutics, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Durham, NC&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Fougera Pharmaceuticals Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Melville, NY&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Eon Labs, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Princeton, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis Vaccines and Diagnostics, Inc.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;East Hanover, NJ&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; USD&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Venezuela&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Novartis de Venezuela, S.A.&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt;&lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Caracas&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; VES&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="9%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 100%&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="10" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;In addition, the Group is represented by subsidiaries and associated companies with total assets or net sales to third parties below USD 25 million in the following countries: Bosnia/Herzegovina, Bulgaria, Dominican Republic, Guatemala, Kenya, North Macedonia, Nigeria, Puerto Rico, Uruguay and Vietnam &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Share capital may not reflect the taxable share capital and does not include any paid-in surplus. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Approximately 33% of voting shares; approximately 6% of total net income and equity attributable to Novartis. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Significant subsidiary under SEC Regulation S-X Rule 1-02(w) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="10"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;m = million; bn = billion&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Changshu</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">China</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Zhongshan</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">CELLforCURE</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Les Ulis</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4CELLforCURELesUlisMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">France</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Advanced Accelerator Applications (Italy) S.r.l.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Pozzilli</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Italy</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Netherlands B.V.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Amsterdam</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisNetherlandsB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Netherlands</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharma B.V.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Amsterdam</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaB.V.AmsterdamMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Netherlands</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">IDB Holland BV</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Baarle-Nassau</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4IDBHollandBVBaarleNassauMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Netherlands</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Saudi Ltd.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Riyadh</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisSaudiLtd.RiyadhMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Saudi Arabia</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Esplugues de Llobregat</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spain</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis UK Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">London</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Pharmaceuticals UK Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">London</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisPharmaceuticalsUKLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Grimsby Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">London</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisGrimsbyLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Imaging Equipment Ltd</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">London</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ImagingEquipmentLtdLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Vivacta Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Frimley / Camberley</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4VivactaLimitedFrimleyCamberleySurreyMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Ziarco Group Limited</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">London</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4ZiarcoGroupLimitedLondonMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">United Kingdom</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Finance Corporation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisFinanceCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Capital Corporation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisCapitalCorporationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUSFoundationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis US Foundation</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUSFoundationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisUSFoundationEastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Advanced Accelerator Applications USA, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Millburn, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Inflammasome Research, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisInflammasomeResearchInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTechnologyLLCInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Technology LLC</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTechnologyLLCInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisTechnologyLLCInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Encore Vision, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EncoreVisionInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Endocyte, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4EndocyteInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Vaccines and Diagnostics, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Spinifex Pharmaceuticals, Inc.</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">East Hanover, NJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4SpinifexPharmaceuticalsInc.EastHanoverNJMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">USA</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <ifrs-full:NameOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Novartis Manufacturing GmbH</ifrs-full:NameOfSubsidiary>
  <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Marburg</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
  <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="AR_D-CurrentYear_dei-2019LegalEntityAxis_nvs-2019Q4NovartisManufacturingGmbHMarburgMember_ifrsfull-2019SignificantInvestmentsInSubsidiariesAxis_ifrsfull-2019SubsidiariesMember">Germany</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
  <nvs:DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"&gt;Segmentation &amp;ndash; net sales by region&lt;/font&gt; &lt;font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;"&gt;1&lt;/font&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2019 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2018 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Change &lt;br&gt;&lt;/br&gt; (2018 &lt;br&gt;&lt;/br&gt; to 2019) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 2017 &lt;br&gt;&lt;/br&gt; USD m &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Change &lt;br&gt;&lt;/br&gt; (2017 &lt;br&gt;&lt;/br&gt; to 2018) &lt;br&gt;&lt;/br&gt; USD % &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Innovative Medicines&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 12&amp;nbsp;818&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&amp;nbsp;296&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;127&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 13&amp;nbsp;789&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;864&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;857&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;458&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;097&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;702&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canada and Latin America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;649&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;635&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;592&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 37&amp;nbsp;714&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 34&amp;nbsp;892&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 32&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Established Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&amp;nbsp;573&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 26&amp;nbsp;258&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 24&amp;nbsp;174&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Emerging Growth Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;141&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;634&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 8&amp;nbsp;104&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Sandoz&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 5&amp;nbsp;115&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;963&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&amp;nbsp;633&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;278&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;363&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 1&amp;nbsp;391&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canada and Latin America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 784&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 779&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 758&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 9&amp;nbsp;731&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 9&amp;nbsp;859&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 10&amp;nbsp;060&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Established Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&amp;nbsp;111&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;233&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 7&amp;nbsp;383&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Emerging Growth Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;620&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;626&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Group&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Europe&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 17&amp;nbsp;933&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 17&amp;nbsp;259&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 15&amp;nbsp;760&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;US&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&amp;nbsp;280&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;618&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&amp;nbsp;135&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Asia/Africa/Australasia&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 9&amp;nbsp;799&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;460&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 9&amp;nbsp;093&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Canada and Latin America&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;433&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;414&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&amp;nbsp;350&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 47&amp;nbsp;445&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 44&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 42&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Established Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 35&amp;nbsp;684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 33&amp;nbsp;491&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 31&amp;nbsp;557&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Of which in Emerging Growth Markets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;761&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&amp;nbsp;260&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 10&amp;nbsp;781&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Net sales from operations by location of third-party customer. Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock>
  <nvs:ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Operating lease commitments December 31, 2018 &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&amp;nbsp;612&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Operating lease commitments December 31, 2018 related to discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;222&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating lease commitments December 31, 2018 related to continuing operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;390&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Recognition exemption for short-term leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;30&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Recognition exception for low-value leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease arrangements with commencement date after December 31, 2018&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Undiscounted future lease payments continuing &lt;br&gt;&lt;/br&gt;operations as of January 1, 2019 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 3&amp;nbsp;283 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Effect of discounting&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;547&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Lease liabilities recognized as of January 1, 2019 &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;736&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; As reported in Annual Report 2018 Note 27 &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; The weighted average incremental borrowing rate at January 1, 2019, the date of implementation of IFRS 16 Leases, was 3.5%. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock>
  <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Land&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 536&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 848&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 147&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment, and other assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Right-of-use assets were lower than the lease liability at the date of implementation of IFRS 16 by USD 182 million, due to adjustments made for recognition of sublease receivables, prepayments and accrued lease payments and transfers from leased assets recorded in property, plant and equipment at December 31, 2018. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
  <nvs:DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;101&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Right-of-use assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Equity and liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Reserves&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;471&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Provision and other non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;212&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total non-current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;257&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial debts and derivative financial instruments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 268&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total current liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 267&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;524&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total equity and liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;527&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock>
  <nvs:DisclosureOfRightofuseAssetsRollForwardTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Right-of-use assets at January 1, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;554&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 537&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation charge&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Lease contract terminations &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;98&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impact of divestments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;17&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Currency translation effects&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total right-of-use assets at December 31, 2019&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; No impairments were recorded in the period. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Lease contract terminations also includes modifications to existing leases that result in reductions to the right-of-use assets, and reductions due to sub-leasing. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfRightofuseAssetsRollForwardTableTextBlock>
  <nvs:DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; December 31, 2019 &lt;br&gt;&lt;/br&gt; carrying value &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Depreciation &lt;br&gt;&lt;/br&gt; charge &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Land&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 537&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Buildings&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 990&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Vehicles&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 129&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 87&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Machinery and equipment, and other assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 21&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total right-of-use assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;677&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 305&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock>
  <nvs:DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; Lease liabilities &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Lease liabilities &lt;br&gt;&lt;/br&gt; undiscounted &lt;br&gt;&lt;/br&gt; 2019 &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less than one year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="16%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="16%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 295&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between one and two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 202&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 246&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between two and three years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 163&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 202&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between three and four years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 138&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 173&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between four and five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 119&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 150&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;After five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;081&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;419&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;485&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Less current portion of lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;246&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;295&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Non-current portion of lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;703&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 3&amp;nbsp;190&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="5" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock>
  <nvs:AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense on lease liabilities &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 66&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense on short-term leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 7&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Expense on low-value leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total cash outflows for leases&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 339&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Thereof:&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Cash outflows for short-term leases &lt;br&gt;&lt;/br&gt;and low-value leases &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 15 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Payments of interest &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 51&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt;Payments of lease liabilities &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"&gt; 273&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; The weighted average interest rate is 3.9%. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Cash flows from short-term and low-value leases are included within total net cash flows from operating activities. The portfolio of short-term leases to which the Group is committed to at December 31, 2019, is similar to the portfolio of short-term leases the Group entered into during 2019. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Included within total net cash flows from operating activities. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="4"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Reported as cash outflows used in financing activities net of lease incentives received of USD 33 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock>
  <nvs:TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD billions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Investments in subsidiaries&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Goodwill from acquisitions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;24&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;33&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock>
  <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Not capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;One year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Three years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 6&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Four years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 62&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 127&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 37&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 164&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;More than five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 435&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;249&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;684&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 648&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;338&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 2&amp;nbsp;986&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Not capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Capitalized&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018 total&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;One year&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 23&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Two years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 0&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 14&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Three years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 12&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 39&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Four years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 5&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 70&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 381&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;More than five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 522&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;288&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&amp;nbsp;810&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 996&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 2&amp;nbsp;345&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;341&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt; &lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Tax losses carried forward &lt;br&gt;&lt;/br&gt;that expired &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 9 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 8 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 1 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
  <nvs:CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; Income &lt;br&gt;&lt;/br&gt; statement &lt;br&gt;&lt;/br&gt; continuing &lt;br&gt;&lt;/br&gt; operations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax asset &lt;br&gt;&lt;/br&gt;and liability revaluation &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized &lt;br&gt;&lt;/br&gt;in consolidated income statement &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 234 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 234 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized in other comprehensive income &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;358&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;358&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total revaluation of deferred tax assets and liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 234&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;358&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;ndash;&amp;nbsp;124&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Related to post-employment benefits &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock>
  <nvs:USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock contextRef="AR_D-CurrentYear">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Income &lt;br&gt;&lt;/br&gt; statement &lt;br&gt;&lt;/br&gt; continuing &lt;br&gt;&lt;/br&gt; operations &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Equity &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Total &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax asset &lt;br&gt;&lt;/br&gt;and liability revaluation &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized &lt;br&gt;&lt;/br&gt;in consolidated income statement &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized &lt;br&gt;&lt;/br&gt;in other comprehensive income &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;254 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;254 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Items previously recognized in retained earnings &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;3&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total revaluation of deferred &lt;br&gt;&lt;/br&gt;tax assets and liabilities &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;440 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;325 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;765 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Total revaluation of current tax payables &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;4&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;34&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total revaluation of deferred tax assets and liabilities, and current income tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;474&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;325&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;799&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Items previously recognized in discontinued operations amounted to USD 416 million &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; Related to post-employment benefits and available-for-sale financial investments (attributable to continuing operations USD -241 million and attributable to discontinued operations USD -13 million) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;3&amp;nbsp;&lt;/sup&gt; Related to equity-based compensation plans (attributable to continuing operations USD -66 million and attributable to discontinued operations USD -5 million) &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;4&amp;nbsp;&lt;/sup&gt; Revaluation of current tax payable attributable to discontinued operations amounted to USD -3 million. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock>
  <nvs:ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019 &lt;sup style="white-space: nowrap"&gt; 1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales to third parties from &lt;br&gt;&lt;/br&gt;discontinued operations &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; 1&amp;nbsp;777 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 7&amp;nbsp;149 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; 6&amp;nbsp;771 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Sales to continuing segments&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 32&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 4&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net sales from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 1&amp;nbsp;809&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 7&amp;nbsp;153&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 6&amp;nbsp;774&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other revenues&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cost of goods sold&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;860&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;983&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;588&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Gross profit from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 949&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;170&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 3&amp;nbsp;189&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Selling, general and administration&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;638&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;754&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;532&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Research and development&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;142&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;585&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;583&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other income&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 15&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 61&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 47&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;113&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;126&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;194&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Operating income/(loss) from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;234&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;73&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;10&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;25&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;27&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other financial income and expense&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Income/(loss) before taxes from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 58&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;260&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;103&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Taxes&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 74&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 307&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net (loss)/income from discontinued operations &lt;br&gt;&lt;/br&gt;before gain on distribution of Alcon Inc. &lt;br&gt;&lt;/br&gt;to Novartis AG shareholders &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;101 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;ndash;&amp;nbsp;186 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; 204 &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Gain on distribution of Alcon Inc. to Novartis AG shareholders &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 4&amp;nbsp;691&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net income/(loss) from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 4&amp;nbsp;590&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;186&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 204&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; The consolidated income statement amounts are for the period from January 1, 2019, to the completion of the spin-off. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; See Note 2 for further details on the non-taxable non-cash gain on distribution of Alcon Inc. to Novartis AG shareholders. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock>
  <nvs:ConsolidatedIncomeStatementAdditionalInformationTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Interest income&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;42&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;235&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;217&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Depreciation of right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Amortization of intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;174&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;052&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;066&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Impairment charges on intangible assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;2&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;391&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;57&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to restructuring provisions&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;13&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;8&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Equity-based compensation of Novartis equity plans&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;93&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;71&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. See Note 1 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="8"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;2&amp;nbsp;&lt;/sup&gt; 2018 includes an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ConsolidatedIncomeStatementAdditionalInformationTableTextBlock>
  <nvs:BalanceSheetAdditionalInformationTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 113&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="14%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 519&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to right-of-use assets &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 3&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Additions to goodwill and intangible assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 36&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 196&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="6" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="6"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; Additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Note 1 for additional disclosures. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:BalanceSheetAdditionalInformationTableTextBlock>
  <nvs:CashFlowsUsedInInvestingActivitiesTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Payments out of provisions for &lt;br&gt;&lt;/br&gt;transaction costs attributable &lt;br&gt;&lt;/br&gt;to the spin-off of the &lt;br&gt;&lt;/br&gt;Alcon business &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &amp;#x2013;&amp;#x2005;29 &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Divested cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;628&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Cash flows attributable to the spin-off of the Alcon business&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;657&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Other cash flows used in investing activities, net&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;502&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;775&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net cash flows used in investing activities from discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;159&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;1&amp;nbsp;001&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;#x2013;&amp;#x2005;775&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:CashFlowsUsedInInvestingActivitiesTableTextBlock>
  <nvs:DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="center" colspan="9" height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr bgcolor="white"&gt; &lt;td height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;td colspan="9" height="3"&gt;&lt;/td&gt; &lt;td height="1"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt; &lt;br&gt;&lt;/br&gt;(USD millions) &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Total &lt;br&gt;&lt;/br&gt; future &lt;br&gt;&lt;/br&gt; payments &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; Unearned &lt;br&gt;&lt;/br&gt; finance &lt;br&gt;&lt;/br&gt; income &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Present &lt;br&gt;&lt;/br&gt; value &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; &lt;br&gt;&lt;/br&gt; Provision &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; &lt;br&gt;&lt;/br&gt; Net book &lt;br&gt;&lt;/br&gt; value &lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Not later than one year &lt;sup style="white-space: nowrap"&gt;&amp;nbsp;1&lt;/sup&gt; &lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 64&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;5&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 59&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="8%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 57&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Between one and five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 117&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;9&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 108&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;28&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 80&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Later than five years&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 48&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;2&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 46&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; &amp;ndash;&amp;nbsp;35&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 11&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Total&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 229&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;16&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 213&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; &amp;ndash;&amp;nbsp;65&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"&gt; 148&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="12" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px" colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td colspan="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"&gt; &lt;sup&gt;&amp;nbsp;1&amp;nbsp;&lt;/sup&gt; The current portion of the minimum lease payments was recorded in trade receivables or other current assets (to the extent not invoiced). &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock>
  <nvs:DisclosureOfNetAssetsDerecognizedTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Property, plant and equipment&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="20%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 2&amp;nbsp;858&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Right-of-use assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 8&amp;nbsp;906&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Intangible assets other than goodwill&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 11&amp;nbsp;121&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 732&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Financial and other non-current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 526&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Inventories&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;469&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade receivables and other current assets&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 1&amp;nbsp;787&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Cash and cash equivalents&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 628&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Deferred tax liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;1&amp;nbsp;713&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current and non-current lease liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;269&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Current and non-current financial debts&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;3&amp;nbsp;538&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 1px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Trade payables, provisions and other liabilities&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; &amp;ndash;&amp;nbsp;2&amp;nbsp;751&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt;Net assets derecognized&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"&gt; 20&amp;nbsp;025&lt;/div&gt; &lt;/td&gt; &lt;td align="right"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="4" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom"&gt; &lt;td height="10px"&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;td&gt; &lt;div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"&gt;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:DisclosureOfNetAssetsDerecognizedTableTextBlock>
  <nvs:ScheduleOfDefinedContributionPlansTableTextBlock contextRef="AR_D-CurrentYear_ifrsfull-2019ContinuingAndDiscontinuedOperationsAxis_ifrsfull-2019DiscontinuedOperationsMember">&lt;div style="padding-top:10px; padding-bottom:30px;"&gt; &lt;table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"&gt; &lt;tr valign="bottom"&gt; &lt;td height="12"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"&gt;(USD millions)&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"&gt; 2019&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2018&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;td align="right"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"&gt; 2017&lt;/div&gt; &lt;/td&gt; &lt;td&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 2px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr valign="bottom" bgcolor="#ffffff"&gt; &lt;td height="16"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt;Contributions for defined contribution plans discontinued operations&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"&gt; 33&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 104&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;td align="right" width="11%"&gt; &lt;div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"&gt; 99&lt;/div&gt; &lt;/td&gt; &lt;td align="right" width="1%"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr&gt; &lt;td colspan="8" style="border-bottom: solid #000000 3px;"&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;/div&gt;</nvs:ScheduleOfDefinedContributionPlansTableTextBlock>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>nvs-20191231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
   <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
   <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
   <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
   <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
   <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
   <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
      <link:label id="id_33621d8b" xlink:label="lbl_CHF_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Switzerland, Francs</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CHF" xlink:label="lbl_CHF" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CHF" xlink:to="lbl_CHF_labels" xlink:type="arc"/>
      <link:label id="id_2109f0bd" xlink:label="lbl_label554299581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Switzerland</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CH" xlink:label="lbl_CH" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CH" xlink:to="lbl_label554299581" xlink:type="arc"/>
      <link:label id="id_30237143" xlink:label="lbl_label807629123" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="lbl_DocumentType" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentType" xlink:to="lbl_label807629123" xlink:type="arc"/>
      <link:label id="id_bb438c4" xlink:label="lbl_NoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentAssets" xlink:to="lbl_NoncurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_7fdd0dd5" xlink:label="lbl_NoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</link:label>
      <link:label id="id_18b26df5" xlink:label="lbl_CurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAssets" xlink:to="lbl_CurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_2d4bde06" xlink:label="lbl_CurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
      <link:label id="id_e8d83cc" xlink:label="lbl_Assets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Assets" xlink:to="lbl_Assets_labels" xlink:type="arc"/>
      <link:label id="id_1c011115" xlink:label="lbl_Assets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
      <link:label id="id_17d32c44" xlink:label="lbl_TreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasuryShares" xlink:to="lbl_TreasuryShares_labels" xlink:type="arc"/>
      <link:label id="id_210754dc" xlink:label="lbl_EquityAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity attributable to owners of parent</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="lbl_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityAttributableToOwnersOfParent" xlink:to="lbl_EquityAttributableToOwnersOfParent_labels" xlink:type="arc"/>
      <link:label id="id_5c95b1b" xlink:label="lbl_EquityAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Issued share capital and reserves attributable to Novartis AG shareholders</link:label>
      <link:label id="id_6ada4c7f" xlink:label="lbl_Equity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Equity" xlink:to="lbl_Equity_labels" xlink:type="arc"/>
      <link:label id="id_217508c4" xlink:label="lbl_Equity_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
      <link:label id="id_202888aa" xlink:label="lbl_NoncurrentProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="lbl_NoncurrentProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentProvisions" xlink:to="lbl_NoncurrentProvisions_labels" xlink:type="arc"/>
      <link:label id="id_30c761c7" xlink:label="lbl_NoncurrentProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current provisions</link:label>
      <link:label id="id_70a3cca2" xlink:label="lbl_NoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLiabilities" xlink:to="lbl_NoncurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_46c178af" xlink:label="lbl_NoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
      <link:label id="id_37698457" xlink:label="lbl_CurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLiabilities" xlink:to="lbl_CurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_422c0184" xlink:label="lbl_CurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
      <link:label id="id_6a28968d" xlink:label="lbl_Liabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Liabilities" xlink:to="lbl_Liabilities_labels" xlink:type="arc"/>
      <link:label id="id_35c7371a" xlink:label="lbl_Liabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
      <link:label id="id_6baaabed" xlink:label="lbl_EquityAndLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="lbl_EquityAndLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityAndLiabilities" xlink:to="lbl_EquityAndLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_3794ff9e" xlink:label="lbl_EquityAndLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity and liabilities</link:label>
      <link:label id="id_5ecd50fe" xlink:label="lbl_PropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipment" xlink:to="lbl_PropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_5f7f6e84" xlink:label="lbl_label1602186884" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Goodwill" xlink:to="lbl_label1602186884" xlink:type="arc"/>
      <link:label id="id_78569540" xlink:label="lbl_label2018940224" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IntangibleAssetsOtherThanGoodwill" xlink:to="lbl_label2018940224" xlink:type="arc"/>
      <link:label id="id_600994ad" xlink:label="lbl_DeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxAssets" xlink:to="lbl_DeferredTaxAssets_labels" xlink:type="arc"/>
      <link:label id="id_76aa2451" xlink:label="lbl_OtherNoncurrentNonfinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current non-financial assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:label="lbl_OtherNoncurrentNonfinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentNonfinancialAssets" xlink:to="lbl_OtherNoncurrentNonfinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_2dffac3d" xlink:label="lbl_Inventories_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current inventories</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Inventories" xlink:to="lbl_Inventories_labels" xlink:type="arc"/>
      <link:label id="id_3b71d990" xlink:label="lbl_OtherCurrentFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current financial assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="lbl_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentFinancialAssets" xlink:to="lbl_OtherCurrentFinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_47798f64" xlink:label="lbl_CashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalents" xlink:to="lbl_CashAndCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_c46389d" xlink:label="lbl_IssuedCapital_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IssuedCapital" xlink:to="lbl_IssuedCapital_labels" xlink:type="arc"/>
      <link:label id="id_7fe108cb" xlink:label="lbl_OtherReserves_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReserves" xlink:label="lbl_OtherReserves" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherReserves" xlink:to="lbl_OtherReserves_labels" xlink:type="arc"/>
      <link:label id="id_62ed78ce" xlink:label="lbl_label1659730126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="lbl_NoncontrollingInterests" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncontrollingInterests" xlink:to="lbl_label1659730126" xlink:type="arc"/>
      <link:label id="id_40cd0a97" xlink:label="lbl_label1087179415" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other non-current payables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentPayables" xlink:label="lbl_NoncurrentPayables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentPayables" xlink:to="lbl_label1087179415" xlink:type="arc"/>
      <link:label id="id_314a7125" xlink:label="lbl_DeferredTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxLiabilities" xlink:to="lbl_DeferredTaxLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_15149ace" xlink:label="lbl_OtherNoncurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current financial liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentFinancialLiabilities" xlink:to="lbl_OtherNoncurrentFinancialLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_48a2d168" xlink:label="lbl_label1218629992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current non-financial liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:label="lbl_OtherNoncurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentNonfinancialLiabilities" xlink:to="lbl_label1218629992" xlink:type="arc"/>
      <link:label id="id_65fe4156" xlink:label="lbl_OtherCurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current financial liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentFinancialLiabilities" xlink:to="lbl_OtherCurrentFinancialLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_4f6a78d8" xlink:label="lbl_CurrentTaxLiabilitiesCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax liabilities, current</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentTaxLiabilitiesCurrent" xlink:to="lbl_CurrentTaxLiabilitiesCurrent_labels" xlink:type="arc"/>
      <link:label id="id_63598632" xlink:label="lbl_OtherCurrentNonfinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current non-financial liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentNonfinancialLiabilities" xlink:to="lbl_OtherCurrentNonfinancialLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_654cedce" xlink:label="lbl_Inventories_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
      <link:label id="id_288deb92" xlink:label="lbl_IssuedCapital_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
      <link:label id="id_b623bea" xlink:label="lbl_OtherReserves_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reserves</link:label>
      <link:label id="id_3c0375d2" xlink:label="lbl_OtherNoncurrentNonfinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
      <link:label id="id_5eaf97e4" xlink:label="lbl_NoncurrentProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and other non-current liabilities</link:label>
      <link:label id="id_48a98684" xlink:label="lbl_OtherNoncurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial debts</link:label>
      <link:label id="id_126c9e67" xlink:label="lbl_OtherCurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial debts and derivative financial instruments</link:label>
      <link:label id="id_4f2ac258" xlink:label="lbl_CurrentTaxLiabilitiesCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current income tax liabilities</link:label>
      <link:label id="id_42db4ec5" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions and other Non-current liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_45db5e46" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and other non-current liabilities</link:label>
      <link:label id="id_1abd43d3" xlink:label="lbl_label448611283" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document and Entity Information</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DocumentAndEntityInformationAbstract" xlink:label="lbl_DocumentAndEntityInformationAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentAndEntityInformationAbstract" xlink:to="lbl_label448611283" xlink:type="arc"/>
      <link:label id="id_3da2017e" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments accounted for using equity method</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InvestmentAccountedForUsingEquityMethod" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod_labels" xlink:type="arc"/>
      <link:label id="id_6c3d0a" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in associated companies</link:label>
      <link:label id="id_551c0fc4" xlink:label="lbl_label1427902404" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="lbl_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_label1427902404" xlink:type="arc"/>
      <link:label id="id_42437f89" xlink:label="lbl_label1111719817" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="lbl_CurrentAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_label1111719817" xlink:type="arc"/>
      <link:label id="id_6e6b7ee6" xlink:label="lbl_TreasuryShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
      <link:label id="id_47a37331" xlink:label="lbl_label1201894193" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="lbl_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_label1201894193" xlink:type="arc"/>
      <link:label id="id_131d39b3" xlink:label="lbl_label320682419" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="lbl_EquityAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityAbstract" xlink:to="lbl_label320682419" xlink:type="arc"/>
      <link:label id="id_7f542d" xlink:label="lbl_label8344621" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="lbl_LiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_label8344621" xlink:type="arc"/>
      <link:label id="id_622df1d" xlink:label="lbl_label102948637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="lbl_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_label102948637" xlink:type="arc"/>
      <link:label id="id_7ba5a5ef" xlink:label="lbl_label2074453487" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="lbl_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_label2074453487" xlink:type="arc"/>
      <link:label id="id_88ddaa5" xlink:label="lbl_label143514277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lbl_label143514277" xlink:type="arc"/>
      <link:label id="id_47732be6" xlink:label="lbl_label1198730214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lbl_label1198730214" xlink:type="arc"/>
      <link:label id="id_47bd73ec" xlink:label="lbl_label1203598316" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lbl_label1203598316" xlink:type="arc"/>
      <link:label id="id_bca487e" xlink:label="lbl_PropertyPlantAndEquipmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_PropertyPlantAndEquipmentMember_labels" xlink:type="arc"/>
      <link:label id="id_567bb83c" xlink:label="lbl_LandMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="lbl_LandMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LandMember" xlink:to="lbl_LandMember_labels" xlink:type="arc"/>
      <link:label id="id_16f548da" xlink:label="lbl_LandMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
      <link:label id="id_a7eb90b" xlink:label="lbl_BuildingsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buildings [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BuildingsMember" xlink:to="lbl_BuildingsMember_labels" xlink:type="arc"/>
      <link:label id="id_4d69998b" xlink:label="lbl_BuildingsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings</link:label>
      <link:label id="id_62ebaccc" xlink:label="lbl_ConstructionInProgressMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in progress [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="lbl_ConstructionInProgressMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConstructionInProgressMember" xlink:to="lbl_ConstructionInProgressMember_labels" xlink:type="arc"/>
      <link:label id="id_74f44044" xlink:label="lbl_ConstructionInProgressMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
      <link:label id="id_451f7511" xlink:label="lbl_MachineryMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="lbl_MachineryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MachineryMember" xlink:to="lbl_MachineryMember_labels" xlink:type="arc"/>
      <link:label id="id_50dda083" xlink:label="lbl_MachineryMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and other equipment</link:label>
      <link:label id="id_6f28e51b" xlink:label="lbl_label1864951067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_label1864951067" xlink:type="arc"/>
      <link:label id="id_7c438c3d" xlink:label="lbl_label2084801597" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_label2084801597" xlink:type="arc"/>
      <link:label id="id_5e0af6ee" xlink:label="lbl_label1577776878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_label1577776878" xlink:type="arc"/>
      <link:label id="id_345f7738" xlink:label="lbl_GrossCarryingAmountMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross carrying amount [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossCarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember_labels" xlink:type="arc"/>
      <link:label id="id_77df9cb5" xlink:label="lbl_PropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment at beginning of period</link:label>
      <link:label id="id_4145517b" xlink:label="lbl_PropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment at end of period</link:label>
      <link:label id="id_1f5560c5" xlink:label="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers from construction in progress, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:to="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_7baa32ee" xlink:label="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
      <link:label id="id_3eb55d39" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_31501db" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
      <link:label id="id_53833bce" xlink:label="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals and retirements, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:label="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:to="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_648c3365" xlink:label="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposals and derecognitions</link:label>
      <link:label id="id_5803c369" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_54f4afbb" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</link:label>
      <link:label id="id_f07d187" xlink:label="lbl_DepreciationPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="lbl_DepreciationPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DepreciationPropertyPlantAndEquipment" xlink:to="lbl_DepreciationPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_57f67848" xlink:label="lbl_DepreciationPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation charge</link:label>
      <link:label id="id_6a50bcb" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charge</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_4bc845d6" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, property, plant and equipment</link:label>
      <link:label id="id_6bc0d1d9" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_3cc1cda9" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of impairment charge</link:label>
      <link:label id="id_2b7f313a" xlink:label="lbl_label729755962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net book value of Property, plant and equipment under finance lease contracts</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:label="lbl_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:to="lbl_label729755962" xlink:type="arc"/>
      <link:label id="id_260ca259" xlink:label="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual commitments for acquisition of property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:label="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:to="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_34818382" xlink:label="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments for purchases of property, plant and equipment</link:label>
      <link:label id="id_54bcbe9d" xlink:label="lbl_BorrowingCostsCapitalised_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing costs capitalised</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsCapitalised" xlink:label="lbl_BorrowingCostsCapitalised" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingCostsCapitalised" xlink:to="lbl_BorrowingCostsCapitalised_labels" xlink:type="arc"/>
      <link:label id="id_555c8c31" xlink:label="lbl_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalisation rate of borrowing costs eligible for capitalisation</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:label="lbl_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation" xlink:to="lbl_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_labels" xlink:type="arc"/>
      <link:label id="id_4c298205" xlink:label="lbl_BorrowingsInterestRate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="lbl_BorrowingsInterestRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsInterestRate" xlink:to="lbl_BorrowingsInterestRate_labels" xlink:type="arc"/>
      <link:label id="id_4611e1b4" xlink:label="lbl_BorrowingsInterestRate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate on borrowings for new additions</link:label>
      <link:label id="id_3caaa61e" xlink:label="lbl_BorrowingCostsCapitalised_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized borrowing costs</link:label>
      <link:label id="id_5cb7a23f" xlink:label="lbl_CapitalisationRateOfBorrowingCostsEligibleForCapitalisation_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalization rate used to determine the amount of borrowing costs eligible for capitalization</link:label>
      <link:label id="id_556c754b" xlink:label="lbl_label1433171275" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementTable" xlink:to="lbl_label1433171275" xlink:type="arc"/>
      <link:label id="id_17e10fbe" xlink:label="lbl_label241915143" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementLineItems" xlink:to="lbl_label241915143" xlink:type="arc"/>
      <link:label id="id_556e2a5d" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_62e43be9" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:label id="id_7abef04f" xlink:label="lbl_PropertyPlantAndEquipmentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PropertyPlantAndEquipmentTableTextBlock" xlink:label="lbl_PropertyPlantAndEquipmentTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipmentTableTextBlock" xlink:to="lbl_PropertyPlantAndEquipmentTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_37009913" xlink:label="lbl_PropertyPlantAndEquipmentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movements of property, plant and equipment</link:label>
      <link:label id="id_611528f2" xlink:label="lbl_label1628776690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventories Disclosure [abstract]</link:label>
      <link:label id="id_7f461082" xlink:label="lbl_DisclosureOfInventoriesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of inventories [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="lbl_DisclosureOfInventoriesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfInventoriesExplanatory" xlink:to="lbl_DisclosureOfInventoriesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_6d592b5d" xlink:label="lbl_DisclosureOfInventoriesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesDisclosureAbstract" xlink:label="lbl_InventoriesDisclosureAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoriesDisclosureAbstract" xlink:to="lbl_label1628776690" xlink:type="arc"/>
      <link:label id="id_47e475f1" xlink:label="lbl_ScheduleOfInventoryCurrentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="lbl_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lbl_ScheduleOfInventoryCurrentTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1795799b" xlink:label="lbl_ScheduleOfInventoryCurrentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories by class</link:label>
      <link:label id="id_543a8d3d" xlink:label="lbl_label1413123389" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Current [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryCurrentTable" xlink:label="lbl_InventoryCurrentTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryCurrentTable" xlink:to="lbl_label1413123389" xlink:type="arc"/>
      <link:label id="id_781cb00d" xlink:label="lbl_label2015145997" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory [Axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryAxis" xlink:label="lbl_InventoryAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryAxis" xlink:to="lbl_label2015145997" xlink:type="arc"/>
      <link:label id="id_b0e25e5" xlink:label="lbl_label185476581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryMember" xlink:label="lbl_InventoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryMember" xlink:to="lbl_label185476581" xlink:type="arc"/>
      <link:label id="id_1b583e85" xlink:label="lbl_InventoryRawMaterialsGrossMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryRawMaterialsGrossMember" xlink:label="lbl_InventoryRawMaterialsGrossMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryRawMaterialsGrossMember" xlink:to="lbl_InventoryRawMaterialsGrossMember_labels" xlink:type="arc"/>
      <link:label id="id_2bb8c828" xlink:label="lbl_InventoryRawMaterialsGrossMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw material, consumables</link:label>
      <link:label id="id_9dcab16" xlink:label="lbl_InventoryWorkInProgressGrossMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in progress, Gross [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryWorkInProgressGrossMember" xlink:label="lbl_InventoryWorkInProgressGrossMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryWorkInProgressGrossMember" xlink:to="lbl_InventoryWorkInProgressGrossMember_labels" xlink:type="arc"/>
      <link:label id="id_696df603" xlink:label="lbl_InventoryWorkInProgressGrossMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in progress</link:label>
      <link:label id="id_5b4c39ad" xlink:label="lbl_label1531722157" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished products</link:label>
      <link:label id="id_2f569fbd" xlink:label="lbl_label794206141" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished goods, Gross [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryFinishedGoodsGrossMember" xlink:label="lbl_InventoryFinishedGoodsGrossMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryFinishedGoodsGrossMember" xlink:to="lbl_label794206141" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryFinishedGoodsGrossMember" xlink:to="lbl_label1531722157" xlink:type="arc"/>
      <link:label id="id_4819bb17" xlink:label="lbl_InventoryLineItems_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryLineItems" xlink:label="lbl_InventoryLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_InventoryLineItems_labels" xlink:type="arc"/>
      <link:label id="id_29f36af5" xlink:label="lbl_InventoryLineItems_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
      <link:label id="id_4b29af41" xlink:label="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of inventories recognised as expense during period</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:to="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod_labels" xlink:type="arc"/>
      <link:label id="id_2b41374" xlink:label="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amount of inventory recognized as expense</link:label>
      <link:label id="id_11cae639" xlink:label="lbl_InventoryWritedown2011_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory write-down</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="lbl_InventoryWritedown2011" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryWritedown2011" xlink:to="lbl_InventoryWritedown2011_labels" xlink:type="arc"/>
      <link:label id="id_1fa3a1d8" xlink:label="lbl_InventoryWritedown2011_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventory provisions</link:label>
      <link:label id="id_6f7b4a87" xlink:label="lbl_ReversalOfInventoryWritedown_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversed inventory Provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfInventoryWritedown" xlink:label="lbl_ReversalOfInventoryWritedown" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReversalOfInventoryWritedown" xlink:to="lbl_ReversalOfInventoryWritedown_labels" xlink:type="arc"/>
      <link:label id="id_56e8eb36" xlink:label="lbl_ReversalOfInventoryWritedown_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of inventory write-down</link:label>
      <link:label id="id_39ec1db2" xlink:label="lbl_label971775410" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="lbl_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EarningsPerShareAbstract" xlink:to="lbl_label971775410" xlink:type="arc"/>
      <link:label id="id_58dc47d3" xlink:label="lbl_EarningsPerShareExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="lbl_EarningsPerShareExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EarningsPerShareExplanatory" xlink:to="lbl_EarningsPerShareExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_20fad442" xlink:label="lbl_EarningsPerShareExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share</link:label>
      <link:label id="id_5ead42de" xlink:label="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5719e1f6" xlink:label="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share</link:label>
      <link:label id="id_531039b4" xlink:label="lbl_label1393572276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="lbl_EarningsPerShareTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EarningsPerShareTable" xlink:to="lbl_label1393572276" xlink:type="arc"/>
      <link:label id="id_6cb953c7" xlink:label="lbl_label1824084935" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="lbl_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_label1824084935" xlink:type="arc"/>
      <link:label id="id_1efe1d89" xlink:label="lbl_label519970185" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing and discontinued operations [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_label519970185" xlink:type="arc"/>
      <link:label id="id_26f22885" xlink:label="lbl_label653404293" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate continuing and discontinued operations [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_label653404293" xlink:type="arc"/>
      <link:label id="id_a503764" xlink:label="lbl_ContinuingOperationsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Continuing operations [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContinuingOperationsMember" xlink:to="lbl_ContinuingOperationsMember_labels" xlink:type="arc"/>
      <link:label id="id_64674183" xlink:label="lbl_DiscontinuedOperationsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued operations [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember_labels" xlink:type="arc"/>
      <link:label id="id_7aa601bd" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit/loss attributable to shareholders of Novartis AG</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossAttributableToOwnersOfParent" xlink:to="lbl_ProfitLossAttributableToOwnersOfParent_labels" xlink:type="arc"/>
      <link:label id="id_68d30e6d" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to owners of parent</link:label>
      <link:label id="id_5a4aec87" xlink:label="lbl_WeightedAverageShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares outstanding</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="lbl_WeightedAverageShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageShares" xlink:to="lbl_WeightedAverageShares_labels" xlink:type="arc"/>
      <link:label id="id_1d84ebe1" xlink:label="lbl_WeightedAverageShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of shares outstanding used in the basic earnings per share</link:label>
      <link:label id="id_4e4dd4b7" xlink:label="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dilutive effect of share options on number of ordinary shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_labels" xlink:type="arc"/>
      <link:label id="id_4486a95d" xlink:label="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options</link:label>
      <link:label id="id_627adbc2" xlink:label="lbl_AdjustedWeightedAverageShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjusted weighted average number of ordinary shares outstanding</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="lbl_AdjustedWeightedAverageShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustedWeightedAverageShares" xlink:to="lbl_AdjustedWeightedAverageShares_labels" xlink:type="arc"/>
      <link:label id="id_3ec2f3b5" xlink:label="lbl_AdjustedWeightedAverageShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of shares in diluted earnings per share</link:label>
      <link:label id="id_75396e0c" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share from continuing operation</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:to="lbl_BasicEarningsLossPerShareFromContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_35298166" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share, Continuing operations</link:label>
      <link:label id="id_4d75874f" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share from discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_57208e0e" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share, Discontinued operations</link:label>
      <link:label id="id_3bf5aca3" xlink:label="lbl_BasicEarningsLossPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="lbl_BasicEarningsLossPerShare" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BasicEarningsLossPerShare" xlink:to="lbl_BasicEarningsLossPerShare_labels" xlink:type="arc"/>
      <link:label id="id_51010c7c" xlink:label="lbl_BasicEarningsLossPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total basic earnings per share</link:label>
      <link:label id="id_48b2fef8" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share from continuing operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:to="lbl_DilutedEarningsLossPerShareFromContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_2cf2996b" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share from discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:to="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_4e26e1ff" xlink:label="lbl_DilutedEarningsLossPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="lbl_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DilutedEarningsLossPerShare" xlink:to="lbl_DilutedEarningsLossPerShare_labels" xlink:type="arc"/>
      <link:label id="id_28929982" xlink:label="lbl_DilutedEarningsLossPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total diluted earnings per share</link:label>
      <link:label id="id_3969c29" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share, Continuing operations</link:label>
      <link:label id="id_aa58d2a" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share, Discontinued operations</link:label>
      <link:label id="id_10d604a9" xlink:label="lbl_label282461353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="lbl_AssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_label282461353" xlink:type="arc"/>
      <link:label id="id_6b10381b" xlink:label="lbl_label1796225051" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of financial position [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="lbl_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementOfFinancialPositionAbstract" xlink:to="lbl_label1796225051" xlink:type="arc"/>
      <link:label id="id_40fad394" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfIntangibleAssetsAbstract_labels" xlink:type="arc"/>
      <link:label id="id_43e147c6" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible assets</link:label>
      <link:label id="id_56bb2315" xlink:label="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:to="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_51b234f9" xlink:label="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of intangible assets and goodwill [text block]</link:label>
      <link:label id="id_4c34e5bc" xlink:label="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Movements of goodwill and intangible assets [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" xlink:label="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" xlink:to="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_49099ca4" xlink:label="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movements of goodwill and intangible assets</link:label>
      <link:label id="id_73128ea8" xlink:label="lbl_label1930596008" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allocation of net book values of goodwill and intangible assets by reporting segment</link:label>
      <link:label id="id_4a2c58f" xlink:label="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assumptions used in the calculation of valuation [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssumptionsUsedInTheCalculationOfValuationTextBlock" xlink:label="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock" xlink:to="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_77ac0526" xlink:label="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assumptions used in the calculation of valuation</link:label>
      <link:label id="id_63728238" xlink:label="lbl_label1668448824" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocation of net book values of goodwill and intangible assets by reporting segment [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:label="lbl_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:to="lbl_label1668448824" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:to="lbl_label1930596008" xlink:type="arc"/>
      <link:label id="id_db941d3" xlink:label="lbl_label230244819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of IncomeTax [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfIncomeTaxAbstract" xlink:label="lbl_DisclosureOfIncomeTaxAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfIncomeTaxAbstract" xlink:to="lbl_label230244819" xlink:type="arc"/>
      <link:label id="id_21d3fbe0" xlink:label="lbl_DisclosureOfIncomeTaxExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of income tax [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="lbl_DisclosureOfIncomeTaxExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfIncomeTaxExplanatory" xlink:to="lbl_DisclosureOfIncomeTaxExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_3e9356c7" xlink:label="lbl_DisclosureOfIncomeTaxExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes</link:label>
      <link:label id="id_78295b76" xlink:label="lbl_IncomeBeforeTaxesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Before Taxes [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeBeforeTaxesTableTextBlock" xlink:label="lbl_IncomeBeforeTaxesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeBeforeTaxesTableTextBlock" xlink:to="lbl_IncomeBeforeTaxesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4c349cd3" xlink:label="lbl_IncomeBeforeTaxesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income before taxes</link:label>
      <link:label id="id_12bf41b8" xlink:label="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current and deferred Income Tax Expense [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" xlink:label="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" xlink:to="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_47b0c493" xlink:label="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current and deferred income tax expense</link:label>
      <link:label id="id_553ce855" xlink:label="lbl_AnalysisOfTaxRateTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis of Tax Rate [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfTaxRateTableTextBlock" xlink:label="lbl_AnalysisOfTaxRateTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AnalysisOfTaxRateTableTextBlock" xlink:to="lbl_AnalysisOfTaxRateTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3410484d" xlink:label="lbl_AnalysisOfTaxRateTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Analysis of tax rate</link:label>
      <link:label id="id_58de322f" xlink:label="lbl_label1490956847" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Interest Expense and Other Financial Income and Expense [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:label="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_label1490956847" xlink:type="arc"/>
      <link:label id="id_643ddbd0" xlink:label="lbl_DisclosureOfInterestExpenseExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of interest expense [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInterestExpenseExplanatory" xlink:label="lbl_DisclosureOfInterestExpenseExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfInterestExpenseExplanatory" xlink:to="lbl_DisclosureOfInterestExpenseExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_54a1e622" xlink:label="lbl_DisclosureOfInterestExpenseExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense and other financial income and expense</link:label>
      <link:label id="id_1f6de87d" xlink:label="lbl_InterestExpenseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseTableTextBlock" xlink:label="lbl_InterestExpenseTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseTableTextBlock" xlink:to="lbl_InterestExpenseTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6f7654df" xlink:label="lbl_InterestExpenseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
      <link:label id="id_3d171b85" xlink:label="lbl_OtherFinancialIncomeAndExpenseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Income and Expense [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialIncomeAndExpenseTableTextBlock" xlink:label="lbl_OtherFinancialIncomeAndExpenseTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherFinancialIncomeAndExpenseTableTextBlock" xlink:to="lbl_OtherFinancialIncomeAndExpenseTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_94ad887" xlink:label="lbl_OtherFinancialIncomeAndExpenseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial income and expense</link:label>
      <link:label id="id_4a94ff2f" xlink:label="lbl_label1934317586" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Deferred Tax Assets and Liabilities [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_label1934317586" xlink:type="arc"/>
      <link:label id="id_7354dcb2" xlink:label="lbl_DisclosureOfDeferredTaxesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of deferred taxes [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="lbl_DisclosureOfDeferredTaxesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDeferredTaxesExplanatory" xlink:to="lbl_DisclosureOfDeferredTaxesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_7f591b1f" xlink:label="lbl_DisclosureOfDeferredTaxesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets and liablities</link:label>
      <link:label id="id_1f4ff3aa" xlink:label="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_21fac415" xlink:label="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
      <link:label id="id_36d33958" xlink:label="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</link:label>
      <link:label id="id_59f2fa2f" xlink:label="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Differences On Which No Deferred Tax Assets Have Been Provided [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" xlink:label="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" xlink:to="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_73861c88" xlink:label="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary differences on which no deferred tax assets have been provided</link:label>
      <link:label id="id_34022912" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_1ccd7026" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross value of tax-loss carry-forwards</link:label>
      <link:label id="id_3232a79c" xlink:label="lbl_label842180508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SignificantAccountingPoliciesAbstract" xlink:label="lbl_SignificantAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_label842180508" xlink:type="arc"/>
      <link:label id="id_4b3b4099" xlink:label="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant accounting policies [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_3f1625ed" xlink:label="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant accounting policies</link:label>
      <link:label id="id_3d96e2f9" xlink:label="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Respective Useful Lives of property, plant and equipment [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:to="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_56feb2c8" xlink:label="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Respective Useful Lives of property, plant and equipment</link:label>
      <link:label id="id_8ac126c" xlink:label="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Respective Useful Lives of Available-for-Use Intangible Assets [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" xlink:label="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" xlink:to="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4312f4e1" xlink:label="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Respective Useful Lives of Available-for-Use Intangible Assets</link:label>
      <link:label id="id_16da82f9" xlink:label="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for subsidiaries [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_61c4e7e5" xlink:label="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scope of consolidation</link:label>
      <link:label id="id_2b17ff8e" xlink:label="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_57c3715e" xlink:label="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currencies</link:label>
      <link:label id="id_18360a81" xlink:label="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for business combinations [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_6b7df679" xlink:label="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of assets</link:label>
      <link:label id="id_9c406cf" xlink:label="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_634a44d" xlink:label="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property plant and equipment</link:label>
      <link:label id="id_785c05c7" xlink:label="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for goodwill [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_64f7217c" xlink:label="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
      <link:label id="id_5fb6702a" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for Intangible assets available-for-use [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_27c2e0c0" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets available-for-use</link:label>
      <link:label id="id_980511b" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for Intangible assets not yet available-for-use [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_31c63f04" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets not yet available-for-use</link:label>
      <link:label id="id_1a22e85b" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for Impairment of goodwill and intangible assets [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5ecba446" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of goodwill and intangible assets</link:label>
      <link:label id="id_35764af6" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for Impairment of associated companies accounted for at equity [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_547afa65" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of associated companies accounted for at equity</link:label>
      <link:label id="id_2741bbc2" xlink:label="lbl_label710888359" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="lbl_label710888359" xlink:type="arc"/>
      <link:label id="id_4c9d021c" xlink:label="lbl_DescriptionOfAccountingPolicyForMeasuringInventories_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="lbl_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="lbl_DescriptionOfAccountingPolicyForMeasuringInventories_labels" xlink:type="arc"/>
      <link:label id="id_2dc53cba" xlink:label="lbl_DescriptionOfAccountingPolicyForMeasuringInventories_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
      <link:label id="id_4f18679b" xlink:label="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for trade and other receivables [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_7ee3df7f" xlink:label="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
      <link:label id="id_5def73f" xlink:label="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for provisions [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_63d0690f" xlink:label="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal and environmental liabilities</link:label>
      <link:label id="id_7371c5cb" xlink:label="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for contingent liabilities and contingent assets [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_55214b7d" xlink:label="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
      <link:label id="id_7e49b25a" xlink:label="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_23e7bf92" xlink:label="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension plans and other post retirement benefits</link:label>
      <link:label id="id_f50de43" xlink:label="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for treasury shares [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_21b13d04" xlink:label="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
      <link:label id="id_7b5ef0a7" xlink:label="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue_labels" xlink:type="arc"/>
      <link:label id="id_4f9fa5aa" xlink:label="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognition</link:label>
      <link:label id="id_7912cc37" xlink:label="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_28239f2f" xlink:label="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
      <link:label id="id_20541755" xlink:label="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_6b599b81" xlink:label="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation</link:label>
      <link:label id="id_1cb64794" xlink:label="lbl_DescriptionOfAccountingPolicyForGovernmentGrants_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for government grants [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="lbl_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:to="lbl_DescriptionOfAccountingPolicyForGovernmentGrants_labels" xlink:type="arc"/>
      <link:label id="id_35eedb65" xlink:label="lbl_DescriptionOfAccountingPolicyForGovernmentGrants_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government grants</link:label>
      <link:label id="id_11f1b42e" xlink:label="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for decommissioning, restoration and rehabilitation provisions [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_40e153e3" xlink:label="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring charges</link:label>
      <link:label id="id_2726a264" xlink:label="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for income tax [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_13936f53" xlink:label="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes</link:label>
      <link:label id="id_4a557154" xlink:label="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for non-current assets or disposal groups classified as held for sale [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_7d2f6bd5" xlink:label="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets held for sale or held for distribution to owners</link:label>
      <link:label id="id_27c082e4" xlink:label="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_labels" xlink:type="arc"/>
      <link:label id="id_455ebc" xlink:label="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of adopting significant new IFRS standards</link:label>
      <link:label id="id_11c5047" xlink:label="lbl_label18632775" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="lbl_PropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipmentAbstract" xlink:to="lbl_label18632775" xlink:type="arc"/>
      <link:label id="id_7e2f70e6" xlink:label="lbl_label2117038310" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RangeAxis" xlink:to="lbl_label2117038310" xlink:type="arc"/>
      <link:label id="id_6a60d490" xlink:label="lbl_label1784730768" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ranges [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RangesMember" xlink:to="lbl_label1784730768" xlink:type="arc"/>
      <link:label id="id_64d1e224" xlink:label="lbl_BottomOfRangeMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bottom of range [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BottomOfRangeMember" xlink:to="lbl_BottomOfRangeMember_labels" xlink:type="arc"/>
      <link:label id="id_5e09e4ca" xlink:label="lbl_TopOfRangeMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top of range [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TopOfRangeMember" xlink:to="lbl_TopOfRangeMember_labels" xlink:type="arc"/>
      <link:label id="id_28553079" xlink:label="lbl_ComputerEquipmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer equipment [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="lbl_ComputerEquipmentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComputerEquipmentMember" xlink:to="lbl_ComputerEquipmentMember_labels" xlink:type="arc"/>
      <link:label id="id_2be121a7" xlink:label="lbl_FurnitureAndVehiclesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and vehicles [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FurnitureAndVehiclesMember" xlink:label="lbl_FurnitureAndVehiclesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FurnitureAndVehiclesMember" xlink:to="lbl_FurnitureAndVehiclesMember_labels" xlink:type="arc"/>
      <link:label id="id_613b73ea" xlink:label="lbl_FurnitureAndVehiclesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and vehicles</link:label>
      <link:label id="id_593b0650" xlink:label="lbl_label1497040464" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lbl_label1497040464" xlink:type="arc"/>
      <link:label id="id_42d9f411" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember_labels" xlink:type="arc"/>
      <link:label id="id_3c815062" xlink:label="lbl_BrandNamesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Brand names [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="lbl_BrandNamesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BrandNamesMember" xlink:to="lbl_BrandNamesMember_labels" xlink:type="arc"/>
      <link:label id="id_37b4dbd2" xlink:label="lbl_OtherIntangibleAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other intangible assets [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherIntangibleAssetsMember" xlink:to="lbl_OtherIntangibleAssetsMember_labels" xlink:type="arc"/>
      <link:label id="id_7fe96854" xlink:label="lbl_TechnologybasedIntangibleAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-based intangible assets [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TechnologybasedIntangibleAssetsMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember_labels" xlink:type="arc"/>
      <link:label id="id_2340963a" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketing related intangible assets [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MarketingRelatedIntangibleAssetsMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember_labels" xlink:type="arc"/>
      <link:label id="id_44d0b847" xlink:label="lbl_CurrentlyMarketedProductsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currently marketed products [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentlyMarketedProductsMember" xlink:to="lbl_CurrentlyMarketedProductsMember_labels" xlink:type="arc"/>
      <link:label id="id_796a6b5e" xlink:label="lbl_label2037017438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income statement location [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationAxis" xlink:label="lbl_IncomeStatementLocationAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeStatementLocationAxis" xlink:to="lbl_label2037017438" xlink:type="arc"/>
      <link:label id="id_bc5c8b8" xlink:label="lbl_label197511352" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income statement location [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationMember" xlink:label="lbl_IncomeStatementLocationMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_label197511352" xlink:type="arc"/>
      <link:label id="id_2aedaf69" xlink:label="lbl_label720220009" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CostOfSalesMember" xlink:label="lbl_CostOfSalesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CostOfSalesMember" xlink:to="lbl_label720220009" xlink:type="arc"/>
      <link:label id="id_2449d337" xlink:label="lbl_label608817975" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales or Research and Development [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CostOfSalesOrResearchAndDevelopmentMember" xlink:label="lbl_CostOfSalesOrResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CostOfSalesOrResearchAndDevelopmentMember" xlink:to="lbl_label608817975" xlink:type="arc"/>
      <link:label id="id_5073642b" xlink:label="lbl_label1349739563" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseAbstract" xlink:label="lbl_InterestExpenseAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseAbstract" xlink:to="lbl_label1349739563" xlink:type="arc"/>
      <link:label id="id_7fef39d4" xlink:label="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense due to unwinding of discount on provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:to="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions_labels" xlink:type="arc"/>
      <link:label id="id_1de5231e" xlink:label="lbl_InterestExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpense" xlink:to="lbl_InterestExpense_labels" xlink:type="arc"/>
      <link:label id="id_f4773bc" xlink:label="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income/expense arising from discounting long-term liabilities</link:label>
      <link:label id="id_5a15aac0" xlink:label="lbl_label1549022431" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
      <link:label id="id_7a288c00" xlink:label="lbl_InterestExpense_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Interest Expense</link:label>
      <link:label id="id_55d5704a" xlink:label="lbl_label1440051274" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other financial income and expense [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialIncomeAndExpenseAbstract" xlink:label="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_label1440051274" xlink:type="arc"/>
      <link:label id="id_1c654137" xlink:label="lbl_label476397879" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income on forward contracts and options</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeOnForwardContractsAndOptions" xlink:label="lbl_IncomeOnForwardContractsAndOptions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeOnForwardContractsAndOptions" xlink:to="lbl_label476397879" xlink:type="arc"/>
      <link:label id="id_545ae83" xlink:label="lbl_GainsLossesOnNetMonetaryPosition_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on net monetary position</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnNetMonetaryPosition" xlink:label="lbl_GainsLossesOnNetMonetaryPosition" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsLossesOnNetMonetaryPosition" xlink:to="lbl_GainsLossesOnNetMonetaryPosition_labels" xlink:type="arc"/>
      <link:label id="id_550f9fc0" xlink:label="lbl_GainsLossesOnNetMonetaryPosition_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monetary loss from hyperinflation</link:label>
      <link:label id="id_76a4da02" xlink:label="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_labels" xlink:type="arc"/>
      <link:label id="id_26393d9c" xlink:label="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency result, net</link:label>
      <link:label id="id_32d2b6d5" xlink:label="lbl_label852670165" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major components of tax expense (income) [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="lbl_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="lbl_label852670165" xlink:type="arc"/>
      <link:label id="id_66ab5be5" xlink:label="lbl_label1722506213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_label1722506213" xlink:type="arc"/>
      <link:label id="id_4667b9e2" xlink:label="lbl_label1181202914" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_label1181202914" xlink:type="arc"/>
      <link:label id="id_3f3ab48" xlink:label="lbl_CountryOfDomicileMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Country of domicile [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CountryOfDomicileMember" xlink:to="lbl_CountryOfDomicileMember_labels" xlink:type="arc"/>
      <link:label id="id_14841da" xlink:label="lbl_ForeignCountriesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign countries [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ForeignCountriesMember" xlink:to="lbl_ForeignCountriesMember_labels" xlink:type="arc"/>
      <link:label id="id_56fc0dcb" xlink:label="lbl_CountryOfDomicileMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Switzerland</link:label>
      <link:label id="id_7d96a380" xlink:label="lbl_ForeignCountriesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
      <link:label id="id_58ec016" xlink:label="lbl_ProfitLossBeforeTax_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) before tax</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossBeforeTax" xlink:to="lbl_ProfitLossBeforeTax_labels" xlink:type="arc"/>
      <link:label id="id_55d23fd3" xlink:label="lbl_AccountingProfit_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting profit</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="lbl_AccountingProfit" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccountingProfit" xlink:to="lbl_AccountingProfit_labels" xlink:type="arc"/>
      <link:label id="id_1207c251" xlink:label="lbl_ProfitLossBeforeTax_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before taxes from continuing operations</link:label>
      <link:label id="id_d3303df" xlink:label="lbl_AccountingProfit_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Income before taxes</link:label>
      <link:label id="id_5fb2cb43" xlink:label="lbl_IncomeTaxExpenseContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income), continuing operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxExpenseContinuingOperations" xlink:to="lbl_IncomeTaxExpenseContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_477ea68" xlink:label="lbl_IncomeTaxExpenseContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
      <link:label id="id_4390e563" xlink:label="lbl_IncomeTaxExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeTaxExpense" xlink:label="lbl_IncomeTaxExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxExpense" xlink:to="lbl_IncomeTaxExpense_labels" xlink:type="arc"/>
      <link:label id="id_c99559f" xlink:label="lbl_IncomeTaxExpense_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Income Tax Expense</link:label>
      <link:label id="id_750153b3" xlink:label="lbl_label1963021235" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of average effective tax rate and applicable tax rate [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:label="lbl_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:to="lbl_label1963021235" xlink:type="arc"/>
      <link:label id="id_5d2df8ac" xlink:label="lbl_ApplicableTaxRate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Applicable tax rate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="lbl_ApplicableTaxRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ApplicableTaxRate" xlink:to="lbl_ApplicableTaxRate_labels" xlink:type="arc"/>
      <link:label id="id_74bd6dfe" xlink:label="lbl_ApplicableTaxRate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Applicable tax rate</link:label>
      <link:label id="id_2c804df7" xlink:label="lbl_TaxRateEffectOfCreditsAndAllowances_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of credits and allowances</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfCreditsAndAllowances" xlink:label="lbl_TaxRateEffectOfCreditsAndAllowances" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfCreditsAndAllowances" xlink:to="lbl_TaxRateEffectOfCreditsAndAllowances_labels" xlink:type="arc"/>
      <link:label id="id_1d59fda1" xlink:label="lbl_TaxRateEffectOfCreditsAndAllowances_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of tax credits and allowances</link:label>
      <link:label id="id_682f727c" xlink:label="lbl_TaxRateEffectOfWriteOffOfDeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of write off of deferred tax assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfWriteOffOfDeferredTaxAssets" xlink:label="lbl_TaxRateEffectOfWriteOffOfDeferredTaxAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfWriteOffOfDeferredTaxAssets" xlink:to="lbl_TaxRateEffectOfWriteOffOfDeferredTaxAssets_labels" xlink:type="arc"/>
      <link:label id="id_514b6bd9" xlink:label="lbl_TaxRateEffectOfWriteOffOfDeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of write off of deferred tax assets</link:label>
      <link:label id="id_6710a9a" xlink:label="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect from write down and reversal of write down of invest subsidiaries</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:label="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:to="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries_labels" xlink:type="arc"/>
      <link:label id="id_175786ff" xlink:label="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of write down and reversal of write down of investments in subsidiaries</link:label>
      <link:label id="id_574b8256" xlink:label="lbl_label1464566358" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of tax benefits expiring in 2017</link:label>
      <link:label id="id_5de8eaa3" xlink:label="lbl_label1575545507" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect from benefits expiring</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromBenefitsExpiring" xlink:label="lbl_TaxRateEffectFromBenefitsExpiring" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectFromBenefitsExpiring" xlink:to="lbl_label1575545507" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectFromBenefitsExpiring" xlink:to="lbl_label1464566358" xlink:type="arc"/>
      <link:label id="id_536d84ea" xlink:label="lbl_label1131311877" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of non-deductible losses in Venezuela</link:label>
      <link:label id="id_4741211a" xlink:label="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate effect of adjustments for current tax of prior periods</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:to="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_labels" xlink:type="arc"/>
      <link:label id="id_3fc4f53a" xlink:label="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of prior year items</link:label>
      <link:label id="id_665323a" xlink:label="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of other items</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_labels" xlink:type="arc"/>
      <link:label id="id_dea5852" xlink:label="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other tax rate effects for reconciliation between accounting profit and tax expense (income)</link:label>
      <link:label id="id_ee48bb4" xlink:label="lbl_AverageEffectiveTaxRateContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average effective tax rate continuing operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageEffectiveTaxRateContinuingOperations" xlink:label="lbl_AverageEffectiveTaxRateContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AverageEffectiveTaxRateContinuingOperations" xlink:to="lbl_AverageEffectiveTaxRateContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_37da283b" xlink:label="lbl_AverageEffectiveTaxRateContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate for continuing operations</link:label>
      <link:label id="id_47841719" xlink:label="lbl_label1199839001" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate for discontinued operations</link:label>
      <link:label id="id_f9778dc" xlink:label="lbl_label261585116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average effective tax rate discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageEffectiveTaxRateDiscontinuedOperations" xlink:label="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:to="lbl_label261585116" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:to="lbl_label1199839001" xlink:type="arc"/>
      <link:label id="id_51bf64bc" xlink:label="lbl_AverageEffectiveTaxRate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective tax rate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="lbl_AverageEffectiveTaxRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AverageEffectiveTaxRate" xlink:to="lbl_AverageEffectiveTaxRate_labels" xlink:type="arc"/>
      <link:label id="id_4e4514d0" xlink:label="lbl_AverageEffectiveTaxRate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average effective tax rate</link:label>
      <link:label id="id_65d06a2f" xlink:label="lbl_label1708157487" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets and liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_label1708157487" xlink:type="arc"/>
      <link:label id="id_482aa0f2" xlink:label="lbl_label1210753266" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_label1210753266" xlink:type="arc"/>
      <link:label id="id_75d207b8" xlink:label="lbl_label1976698808" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_label1976698808" xlink:type="arc"/>
      <link:label id="id_1bb2f625" xlink:label="lbl_label464713253" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pensions and other benefit obligations of associates [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:label="lbl_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:to="lbl_label464713253" xlink:type="arc"/>
      <link:label id="id_6d0f55ad" xlink:label="lbl_InventoriesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventories [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesMember" xlink:label="lbl_InventoriesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoriesMember" xlink:to="lbl_InventoriesMember_labels" xlink:type="arc"/>
      <link:label id="id_7e43c96a" xlink:label="lbl_label2118371690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax loss carryforwards [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxLossCarryforwardsMember" xlink:label="lbl_TaxLossCarryforwardsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxLossCarryforwardsMember" xlink:to="lbl_label2118371690" xlink:type="arc"/>
      <link:label id="id_112eae32" xlink:label="lbl_label288271922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets, provisions and accruals [member]</link:label>
      <link:label id="id_4d44190d" xlink:label="lbl_DeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
      <link:label id="id_69dcdf60" xlink:label="lbl_DeferredTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:label id="id_65498be7" xlink:label="lbl_DeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="lbl_DeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxLiabilityAsset" xlink:to="lbl_DeferredTaxLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_46ad922f" xlink:label="lbl_DeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax balance</link:label>
      <link:label id="id_637b5bc7" xlink:label="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credited/(charged) to income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_labels" xlink:type="arc"/>
      <link:label id="id_50e2e919" xlink:label="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss</link:label>
      <link:label id="id_54101181" xlink:label="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax relating to items credited (charged) directly to equity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:label="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:to="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_labels" xlink:type="arc"/>
      <link:label id="id_8409b0d" xlink:label="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charged to equity</link:label>
      <link:label id="id_5e5bb1e8" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax relating to components of other comprehensive income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:to="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:type="arc"/>
      <link:label id="id_495f93f4" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credited/(charged) to other comprehensive income</link:label>
      <link:label id="id_22e658d6" xlink:label="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through business combinations, deferred tax liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:to="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_36e0af13" xlink:label="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_35a4b23c" xlink:label="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through other movements deferred tax liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:to="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_6e9211d6" xlink:label="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other movements</link:label>
      <link:label id="id_1e95490a" xlink:label="lbl_label513100042" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offsetting of deferred tax assets and liabilities within the same tax jurisdiction</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:label="lbl_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:to="lbl_label513100042" xlink:type="arc"/>
      <link:label id="id_7845a7b2" xlink:label="lbl_label2017830834" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary differences on which no deferred tax assets have been provided [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" xlink:label="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" xlink:to="lbl_label2017830834" xlink:type="arc"/>
      <link:label id="id_76d7af65" xlink:label="lbl_label1993846629" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in subsidiaries [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InvestmentsInSubsidiariesMember" xlink:label="lbl_InvestmentsInSubsidiariesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InvestmentsInSubsidiariesMember" xlink:to="lbl_label1993846629" xlink:type="arc"/>
      <link:label id="id_155fe654" xlink:label="lbl_label358606420" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill from acquisitions [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GoodwillFromAcquisitionsMember" xlink:label="lbl_GoodwillFromAcquisitionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GoodwillFromAcquisitionsMember" xlink:to="lbl_label358606420" xlink:type="arc"/>
      <link:label id="id_2439e7db" xlink:label="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deductible temporary differences for which no deferred tax asset is recognised</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:to="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_labels" xlink:type="arc"/>
      <link:label id="id_720fdd61" xlink:label="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary differences on which no deferred tax has been provided as they are permanent in nature</link:label>
      <link:label id="id_193f7081" xlink:label="lbl_label423587969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="lbl_label423587969" xlink:type="arc"/>
      <link:label id="id_6b884d65" xlink:label="lbl_label1804094821" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lbl_label1804094821" xlink:type="arc"/>
      <link:label id="id_37fff575" xlink:label="lbl_label939521397" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance sheet treatment [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentAxis" xlink:label="lbl_BalanceSheetTreatmentAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BalanceSheetTreatmentAxis" xlink:to="lbl_label939521397" xlink:type="arc"/>
      <link:label id="id_53909ff0" xlink:label="lbl_label1401987056" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance sheet treatment [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentMember" xlink:label="lbl_BalanceSheetTreatmentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BalanceSheetTreatmentMember" xlink:to="lbl_label1401987056" xlink:type="arc"/>
      <link:label id="id_439c0ffd" xlink:label="lbl_label1134301181" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CapitalizedMember" xlink:label="lbl_CapitalizedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CapitalizedMember" xlink:to="lbl_label1134301181" xlink:type="arc"/>
      <link:label id="id_4f2ca3b1" xlink:label="lbl_label1328325553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not capitalized [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NotCapitalizedMember" xlink:label="lbl_NotCapitalizedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NotCapitalizedMember" xlink:to="lbl_label1328325553" xlink:type="arc"/>
      <link:label id="id_2654c6dd" xlink:label="lbl_label643090141" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year of expiry [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryAxis" xlink:label="lbl_YearOfExpiryAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_YearOfExpiryAxis" xlink:to="lbl_label643090141" xlink:type="arc"/>
      <link:label id="id_4110ec53" xlink:label="lbl_label1091628115" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year of expiry [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryMember" xlink:label="lbl_YearOfExpiryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_label1091628115" xlink:type="arc"/>
      <link:label id="id_5e6070e2" xlink:label="lbl_label1583378658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One year [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OneYearMember" xlink:label="lbl_OneYearMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OneYearMember" xlink:to="lbl_label1583378658" xlink:type="arc"/>
      <link:label id="id_4ad3dc4f" xlink:label="lbl_label1255398479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TwoYearsMember" xlink:label="lbl_TwoYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TwoYearsMember" xlink:to="lbl_label1255398479" xlink:type="arc"/>
      <link:label id="id_5915ca9f" xlink:label="lbl_label1494600351" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Three years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThreeYearsMember" xlink:label="lbl_ThreeYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ThreeYearsMember" xlink:to="lbl_label1494600351" xlink:type="arc"/>
      <link:label id="id_7bb728cd" xlink:label="lbl_label2075601101" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Four years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FourYearsMember" xlink:label="lbl_FourYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FourYearsMember" xlink:to="lbl_label2075601101" xlink:type="arc"/>
      <link:label id="id_742ed8cf" xlink:label="lbl_label1949227215" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Five years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FiveYearsMember" xlink:label="lbl_FiveYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FiveYearsMember" xlink:to="lbl_label1949227215" xlink:type="arc"/>
      <link:label id="id_347afbb1" xlink:label="lbl_label880475057" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">More than five years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MoreThanFiveYearsMember" xlink:label="lbl_MoreThanFiveYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MoreThanFiveYearsMember" xlink:to="lbl_label880475057" xlink:type="arc"/>
      <link:label id="id_74c41296" xlink:label="lbl_label94266701" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</link:label>
      <link:label id="id_14f7a19b" xlink:label="lbl_ValueOfTaxLossCarryforwardsExpired_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value of tax loss carryforwards expired</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfTaxLossCarryforwardsExpired" xlink:label="lbl_ValueOfTaxLossCarryforwardsExpired" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ValueOfTaxLossCarryforwardsExpired" xlink:to="lbl_ValueOfTaxLossCarryforwardsExpired_labels" xlink:type="arc"/>
      <link:label id="id_6a5eff98" xlink:label="lbl_ValueOfTaxLossCarryforwardsExpired_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax loss carryforwards expired</link:label>
      <link:label id="id_70fd1364" xlink:label="lbl_label1895633764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax asset expected to have an impact on current taxes payable after more than 12 months</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:label="lbl_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:to="lbl_label1895633764" xlink:type="arc"/>
      <link:label id="id_522d9018" xlink:label="lbl_label1378717720" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities expected to have an impact on current taxes payable after more than 12 months</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:label="lbl_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:to="lbl_label1378717720" xlink:type="arc"/>
      <link:label id="id_2f7867e" xlink:label="lbl_label49776254" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unremitted earnings retained by consolidated entities for reinvestment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:label="lbl_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:to="lbl_label49776254" xlink:type="arc"/>
      <link:label id="id_5d6e151" xlink:label="lbl_label97968465" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for income taxes on unremitted earnings</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:label="lbl_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:to="lbl_label97968465" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:label="lbl_GainsLossesOnAvailableforsaleFinancialAssets1" xlink:type="locator"/>
      <link:label id="id_7db0af99" xlink:label="lbl_GainsLossesOnAvailableforsaleFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net capital losses on available-for-sale securities</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsLossesOnAvailableforsaleFinancialAssets1" xlink:to="lbl_GainsLossesOnAvailableforsaleFinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_27062936" xlink:label="lbl_GainsLossesOnAvailableforsaleFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on available-for-sale financial assets</link:label>
      <link:label id="id_71a78a3a" xlink:label="lbl_label1906805306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial and other non-current assets [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:to="lbl_label1906805306" xlink:type="arc"/>
      <link:label id="id_52927dd" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial and other non-current assets [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" xlink:to="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4f2bb8aa" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial and other non-current assets</link:label>
      <link:label id="id_67e73888" xlink:label="lbl_DisclosureOfFinancialAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAssetsTableTextBlock" xlink:label="lbl_DisclosureOfFinancialAssetsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAssetsTableTextBlock" xlink:to="lbl_DisclosureOfFinancialAssetsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_634e228d" xlink:label="lbl_DisclosureOfFinancialAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
      <link:label id="id_57b4381e" xlink:label="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current assets [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOtherNoncurrentAssetsTableTextBlock" xlink:label="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock" xlink:to="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6832ec2" xlink:label="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
      <link:label id="id_1f868b2b" xlink:label="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of minimum finance lease payments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:label="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:to="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2e528ce3" xlink:label="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum finance lease payments</link:label>
      <link:label id="id_6a1e58d8" xlink:label="lbl_label1780373720" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current assets [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCurrentAssetsAbstract" xlink:label="lbl_OtherCurrentAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_label1780373720" xlink:type="arc"/>
      <link:label id="id_574b2687" xlink:label="lbl_DisclosureOfOtherCurrentAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other current assets [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:label="lbl_DisclosureOfOtherCurrentAssetsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherCurrentAssetsExplanatory" xlink:to="lbl_DisclosureOfOtherCurrentAssetsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_2fe53b2a" xlink:label="lbl_DisclosureOfOtherCurrentAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
      <link:label id="id_2f9ef8c8" xlink:label="lbl_OtherCurrentAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current assets [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCurrentAssetsTableTextBlock" xlink:label="lbl_OtherCurrentAssetsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentAssetsTableTextBlock" xlink:to="lbl_OtherCurrentAssetsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6c3d724c" xlink:label="lbl_OtherCurrentAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
      <link:label id="id_229f76b0" xlink:label="lbl_CurrentValueAddedTaxReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current value added tax receivables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="lbl_CurrentValueAddedTaxReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentValueAddedTaxReceivables" xlink:to="lbl_CurrentValueAddedTaxReceivables_labels" xlink:type="arc"/>
      <link:label id="id_5dea7085" xlink:label="lbl_CurrentValueAddedTaxReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VAT Receivable</link:label>
      <link:label id="id_68e173a" xlink:label="lbl_label1024297901" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Withholding tax recoverable</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WithholdingTaxRecoverable" xlink:label="lbl_WithholdingTaxRecoverable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WithholdingTaxRecoverable" xlink:to="lbl_label1024297901" xlink:type="arc"/>
      <link:label id="id_3be22351" xlink:label="lbl_CurrentIncomeTaxReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current income tax receivable</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxReceivable" xlink:label="lbl_CurrentIncomeTaxReceivable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentIncomeTaxReceivable" xlink:to="lbl_CurrentIncomeTaxReceivable_labels" xlink:type="arc"/>
      <link:label id="id_47fe3c9c" xlink:label="lbl_CurrentIncomeTaxReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax receivable</link:label>
      <link:label id="id_7437ef3d" xlink:label="lbl_label905656156" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses - third party</link:label>
      <link:label id="id_6210dea9" xlink:label="lbl_CurrentPrepaidExpensesAssociatedCompanies_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current prepaid expenses associated companies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPrepaidExpensesAssociatedCompanies" xlink:label="lbl_CurrentPrepaidExpensesAssociatedCompanies" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentPrepaidExpensesAssociatedCompanies" xlink:to="lbl_CurrentPrepaidExpensesAssociatedCompanies_labels" xlink:type="arc"/>
      <link:label id="id_2201baf2" xlink:label="lbl_CurrentPrepaidExpensesAssociatedCompanies_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses - associated companies</link:label>
      <link:label id="id_61baeb33" xlink:label="lbl_label1639639859" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables associated companies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReceivablesAssociatedCompanies" xlink:label="lbl_ReceivablesAssociatedCompanies" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReceivablesAssociatedCompanies" xlink:to="lbl_label1639639859" xlink:type="arc"/>
      <link:label id="id_3ac7e1da" xlink:label="lbl_label986178010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other receivables and current assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherReceivablesAndCurrentAssets" xlink:label="lbl_OtherReceivablesAndCurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherReceivablesAndCurrentAssets" xlink:to="lbl_label986178010" xlink:type="arc"/>
      <link:label id="id_4072377e" xlink:label="lbl_OtherCurrentNonfinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other current assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentNonfinancialAssets" xlink:to="lbl_OtherCurrentNonfinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_e3db8e7" xlink:label="lbl_OtherCurrentNonfinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current non-financial assets</link:label>
      <link:label id="id_d18502c" xlink:label="lbl_label219697196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of marketable securities commodities deposits derivative instruments and cash [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_label219697196" xlink:type="arc"/>
      <link:label id="id_69021d0e" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of marketable securities commodities deposits derivative instruments and cash [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" xlink:to="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4984da50" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of marketable securities commodities deposits derivative instruments and cash</link:label>
      <link:label id="id_24a0b3b8" xlink:label="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable securities, commodities, timedeposits, and derivative financial instruments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" xlink:label="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" xlink:to="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_443173b3" xlink:label="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, commodities, timedeposits, and derivative financial instruments</link:label>
      <link:label id="id_34fe6088" xlink:label="lbl_CashAndCashEquivalentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsTableTextBlock" xlink:label="lbl_CashAndCashEquivalentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsTableTextBlock" xlink:to="lbl_CashAndCashEquivalentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1b8f74ee" xlink:label="lbl_CashAndCashEquivalentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:label id="id_808126e" xlink:label="lbl_DebtInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt instruments held</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtInstrumentsHeld" xlink:label="lbl_DebtInstrumentsHeld" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DebtInstrumentsHeld" xlink:to="lbl_DebtInstrumentsHeld_labels" xlink:type="arc"/>
      <link:label id="id_6e00ca4f" xlink:label="lbl_DebtInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities</link:label>
      <link:label id="id_22a6b8a5" xlink:label="lbl_EquityInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity instruments held</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInstrumentsHeld" xlink:label="lbl_EquityInstrumentsHeld" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityInstrumentsHeld" xlink:to="lbl_EquityInstrumentsHeld_labels" xlink:type="arc"/>
      <link:label id="id_724851f6" xlink:label="lbl_EquityInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities</link:label>
      <link:label id="id_419c6f6a" xlink:label="lbl_FundInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fund instruments held</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInstrumentsHeld" xlink:label="lbl_FundInstrumentsHeld" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FundInstrumentsHeld" xlink:to="lbl_FundInstrumentsHeld_labels" xlink:type="arc"/>
      <link:label id="id_53712316" xlink:label="lbl_FundInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fund investments</link:label>
      <link:label id="id_17079bd" xlink:label="lbl_label1789088932" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commodities</link:label>
      <link:label id="id_6c508a7b" xlink:label="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term deposits, not classified as cash equivalents</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:to="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_24ec6e77" xlink:label="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time deposits with original maturity more than 90 days</link:label>
      <link:label id="id_ef5ab87" xlink:label="lbl_DerivativeFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="lbl_DerivativeFinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialAssets" xlink:to="lbl_DerivativeFinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_4954716a" xlink:label="lbl_DerivativeFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial assets</link:label>
      <link:label id="id_57e2aa2d" xlink:label="lbl_InterestReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest receivable</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="lbl_InterestReceivable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestReceivable" xlink:to="lbl_InterestReceivable_labels" xlink:type="arc"/>
      <link:label id="id_6996ac87" xlink:label="lbl_InterestReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest on debt securities and time deposits</link:label>
      <link:label id="id_70ff77e4" xlink:label="lbl_Cash_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current accounts</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="lbl_Cash" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Cash" xlink:to="lbl_Cash_labels" xlink:type="arc"/>
      <link:label id="id_502a929f" xlink:label="lbl_Cash_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
      <link:label id="id_436c5591" xlink:label="lbl_label1131173265" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="lbl_CashAndCashEquivalentsAbstract1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsAbstract1" xlink:to="lbl_label1131173265" xlink:type="arc"/>
      <link:label id="id_20053f5" xlink:label="lbl_CashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash and cash equivalents</link:label>
      <link:label id="id_47b73cba" xlink:label="lbl_CashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time deposits and short term investments with original maturity less than 90 days</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="lbl_CashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashEquivalents" xlink:to="lbl_CashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_178a6550" xlink:label="lbl_CashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
      <link:label id="id_25a7d307" xlink:label="lbl_label631755527" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt securities denominations [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtSecuritiesDenominationsAbstract" xlink:label="lbl_DebtSecuritiesDenominationsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DebtSecuritiesDenominationsAbstract" xlink:to="lbl_label631755527" xlink:type="arc"/>
      <link:label id="id_6e4a0bf9" xlink:label="lbl_DebtInstrumentsHeld_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt securities held</link:label>
      <link:label id="id_3758e5ae" xlink:label="lbl_ComputerEquipmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment</link:label>
      <link:label id="id_487fbdc1" xlink:label="lbl_label1216331201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in deferred tax balance [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInDeferredTaxBalanceRollForward" xlink:label="lbl_MovementInDeferredTaxBalanceRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_label1216331201" xlink:type="arc"/>
      <link:label id="id_41df7536" xlink:label="lbl_DeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax balance at beginning of period</link:label>
      <link:label id="id_2e28206a" xlink:label="lbl_DeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax balance at end of period</link:label>
      <link:label id="id_4c171394" xlink:label="lbl_label1276580756" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_label1276580756" xlink:type="arc"/>
      <link:label id="id_767010e4" xlink:label="lbl_ContingentConsiderationReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Receivable</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivable" xlink:label="lbl_ContingentConsiderationReceivable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationReceivable" xlink:to="lbl_ContingentConsiderationReceivable_labels" xlink:type="arc"/>
      <link:label id="id_1c964d9b" xlink:label="lbl_ContingentConsiderationReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration receivables</link:label>
      <link:label id="id_1cc013c7" xlink:label="lbl_NoncurrentFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="lbl_NoncurrentFinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialAssets" xlink:to="lbl_NoncurrentFinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_47c06050" xlink:label="lbl_NoncurrentFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial assets</link:label>
      <link:label id="id_2038ebb3" xlink:label="lbl_NoncurrentFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
      <link:label id="id_7a406b1b" xlink:label="lbl_NoncurrentLoansAndReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current loans and receivables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLoansAndReceivables" xlink:label="lbl_NoncurrentLoansAndReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLoansAndReceivables" xlink:to="lbl_NoncurrentLoansAndReceivables_labels" xlink:type="arc"/>
      <link:label id="id_69fe82c8" xlink:label="lbl_NoncurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current trade receivables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="lbl_NoncurrentTradeReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentTradeReceivables" xlink:to="lbl_NoncurrentTradeReceivables_labels" xlink:type="arc"/>
      <link:label id="id_56c9fa84" xlink:label="lbl_NoncurrentFinancialAssetsAvailableforsale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial assets available-for-sale</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAvailableforsale" xlink:label="lbl_NoncurrentFinancialAssetsAvailableforsale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialAssetsAvailableforsale" xlink:to="lbl_NoncurrentFinancialAssetsAvailableforsale_labels" xlink:type="arc"/>
      <link:label id="id_7f86a75a" xlink:label="lbl_NoncurrentFinancialAssetsAvailableforsale_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale long-term financial investments</link:label>
      <link:label id="id_416abfec" xlink:label="lbl_NoncurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term receivables from customers</link:label>
      <link:label id="id_614e0e43" xlink:label="lbl_NoncurrentLoansAndReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term loans, advances and security deposits</link:label>
      <link:label id="id_2adc1935" xlink:label="lbl_label719067445" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current assets [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:label="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:to="lbl_label719067445" xlink:type="arc"/>
      <link:label id="id_372134b4" xlink:label="lbl_OtherNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentAssets" xlink:to="lbl_OtherNoncurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_36e85d79" xlink:label="lbl_OtherNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other non-current assets</link:label>
      <link:label id="id_3d890a89" xlink:label="lbl_label503420728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred compensation plans assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredCompensationPlansAssets" xlink:label="lbl_DeferredCompensationPlansAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredCompensationPlansAssets" xlink:to="lbl_label503420728" xlink:type="arc"/>
      <link:label id="id_5743c2dd" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid post-employment benefit plans assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaidPostemploymentBenefitPlansAssets" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:to="lbl_PrepaidPostemploymentBenefitPlansAssets_labels" xlink:type="arc"/>
      <link:label id="id_509c8962" xlink:label="lbl_label1352436066" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MaturityAxis" xlink:to="lbl_label1352436066" xlink:type="arc"/>
      <link:label id="id_36becdba" xlink:label="lbl_label918474170" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregated time bands [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_label918474170" xlink:type="arc"/>
      <link:label id="id_19bac06a" xlink:label="lbl_NotLaterThanOneYearMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not later than one year [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NotLaterThanOneYearMember" xlink:to="lbl_NotLaterThanOneYearMember_labels" xlink:type="arc"/>
      <link:label id="id_40351209" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year and not later than five years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember_labels" xlink:type="arc"/>
      <link:label id="id_26dc6723" xlink:label="lbl_LaterThanFiveYearsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanFiveYearsMember" xlink:to="lbl_LaterThanFiveYearsMember_labels" xlink:type="arc"/>
      <link:label id="id_678942b3" xlink:label="lbl_NotLaterThanOneYearMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not later than one year</link:label>
      <link:label id="id_65bceee2" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Between one and five years</link:label>
      <link:label id="id_2043ab6e" xlink:label="lbl_LaterThanFiveYearsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Later than five years</link:label>
      <link:label id="id_1c8984aa" xlink:label="lbl_FinanceLeaseProvision_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance lease provision</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseProvision" xlink:label="lbl_FinanceLeaseProvision" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinanceLeaseProvision" xlink:to="lbl_FinanceLeaseProvision_labels" xlink:type="arc"/>
      <link:label id="id_4a3761d0" xlink:label="lbl_FinanceLeaseProvision_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Provision</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="lbl_NoncurrentFinanceLeaseReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinanceLeaseReceivables" xlink:to="lbl_NoncurrentFinanceLeaseReceivables_labels" xlink:type="arc"/>
      <link:label id="id_5712ddf0" xlink:label="lbl_NoncurrentFinanceLeaseReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current finance lease receivables</link:label>
      <link:label id="id_3c5105da" xlink:label="lbl_IncomeStatementAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit or loss [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="lbl_IncomeStatementAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeStatementAbstract" xlink:to="lbl_IncomeStatementAbstract_labels" xlink:type="arc"/>
      <link:label id="id_3f03b5f7" xlink:label="lbl_IncomeStatementAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated income statements [abstract]</link:label>
      <link:label id="id_6acd9405" xlink:label="lbl_RevenueFromSaleOfGoods_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoods" xlink:to="lbl_RevenueFromSaleOfGoods_labels" xlink:type="arc"/>
      <link:label id="id_3a842f2" xlink:label="lbl_RevenueFromSaleOfGoods_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
      <link:label id="id_150c2b7f" xlink:label="lbl_OtherRevenue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other revenue</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherRevenue" xlink:to="lbl_OtherRevenue_labels" xlink:type="arc"/>
      <link:label id="id_127d952" xlink:label="lbl_OtherRevenue_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other revenues</link:label>
      <link:label id="id_2760bdf6" xlink:label="lbl_CostOfSales_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CostOfSales" xlink:to="lbl_CostOfSales_labels" xlink:type="arc"/>
      <link:label id="id_2b80a016" xlink:label="lbl_CostOfSales_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of goods sold</link:label>
      <link:label id="id_57c5a20d" xlink:label="lbl_GrossProfit_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossProfit" xlink:to="lbl_GrossProfit_labels" xlink:type="arc"/>
      <link:label id="id_526b4f9e" xlink:label="lbl_GrossProfit_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit from continuing operations</link:label>
      <link:label id="id_39d76e39" xlink:label="lbl_SalesAndMarketingExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales and marketing expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="lbl_SalesAndMarketingExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SalesAndMarketingExpense" xlink:to="lbl_SalesAndMarketingExpense_labels" xlink:type="arc"/>
      <link:label id="id_28a0f9b9" xlink:label="lbl_SalesAndMarketingExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Marketing and Sales</link:label>
      <link:label id="id_10d069b8" xlink:label="lbl_ResearchAndDevelopmentExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ResearchAndDevelopmentExpense" xlink:to="lbl_ResearchAndDevelopmentExpense_labels" xlink:type="arc"/>
      <link:label id="id_6d2fdc24" xlink:label="lbl_ResearchAndDevelopmentExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
      <link:label id="id_57c6dbd9" xlink:label="lbl_label1472650201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherIncome" xlink:to="lbl_label1472650201" xlink:type="arc"/>
      <link:label id="id_5f87ab8e" xlink:label="lbl_ProfitLossFromOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_ProfitLossFromOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_17803288" xlink:label="lbl_ProfitLossFromOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income from continuing operations</link:label>
      <link:label id="id_1fe0c0c6" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:type="arc"/>
      <link:label id="id_487c7d01" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income from associated companies</link:label>
      <link:label id="id_36251eec" xlink:label="lbl_ProfitLossFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from continuing operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossFromContinuingOperations" xlink:to="lbl_ProfitLossFromContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_6dd27571" xlink:label="lbl_ProfitLossFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
      <link:label id="id_706453ab" xlink:label="lbl_IncomeTaxExpenseContinuingOperations_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxes</link:label>
      <link:label id="id_1efbdca8" xlink:label="lbl_ProfitLossFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossFromDiscontinuedOperations" xlink:to="lbl_ProfitLossFromDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_1ee0d5e9" xlink:label="lbl_ProfitLossFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income/loss from discontinued operations</link:label>
      <link:label id="id_390e92f5" xlink:label="lbl_ProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLoss" xlink:to="lbl_ProfitLoss_labels" xlink:type="arc"/>
      <link:label id="id_62e876b4" xlink:label="lbl_ProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
      <link:label id="id_6b81cf74" xlink:label="lbl_ProfitLossAttributableToAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="lbl_ProfitLossAttributableToAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossAttributableToAbstract" xlink:to="lbl_ProfitLossAttributableToAbstract_labels" xlink:type="arc"/>
      <link:label id="id_1f2a4c4f" xlink:label="lbl_ProfitLossAttributableToNoncontrollingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="lbl_ProfitLossAttributableToNoncontrollingInterests" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossAttributableToNoncontrollingInterests" xlink:to="lbl_ProfitLossAttributableToNoncontrollingInterests_labels" xlink:type="arc"/>
      <link:label id="id_41604097" xlink:label="lbl_ProfitLossAttributableToNoncontrollingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
      <link:label id="id_68a67dec" xlink:label="lbl_label1755741676" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings per share [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="lbl_BasicEarningsPerShareAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_label1755741676" xlink:type="arc"/>
      <link:label id="id_4e036998" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations</link:label>
      <link:label id="id_fc632c9" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations</link:label>
      <link:label id="id_6d6e73d7" xlink:label="lbl_label1835955159" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings per share [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="lbl_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_label1835955159" xlink:type="arc"/>
      <link:label id="id_78a7e003" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations</link:label>
      <link:label id="id_2685ed2a" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations</link:label>
      <link:label id="id_506c062c" xlink:label="lbl_ProfitLossBeforeTax_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income before taxes</link:label>
      <link:label id="id_4ec1d679" xlink:label="lbl_label1321326201" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="lbl_DisclosureOfClassesOfShareCapitalAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="lbl_label1321326201" xlink:type="arc"/>
      <link:label id="id_28aa5281" xlink:label="lbl_MovementInTheShareCapitalTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in the share capital [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInTheShareCapitalTableTextBlock" xlink:label="lbl_MovementInTheShareCapitalTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MovementInTheShareCapitalTableTextBlock" xlink:to="lbl_MovementInTheShareCapitalTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_61f390ae" xlink:label="lbl_MovementInTheShareCapitalTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to movement in the share capital</link:label>
      <link:label id="id_696322e3" xlink:label="lbl_MovementInTheShareslTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in the shares [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInTheShareslTableTextBlock" xlink:label="lbl_MovementInTheShareslTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MovementInTheShareslTableTextBlock" xlink:to="lbl_MovementInTheShareslTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3b7d854" xlink:label="lbl_MovementInTheShareslTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to movement in the shares</link:label>
      <link:label id="id_21fc0b5b" xlink:label="lbl_label570166107" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:to="lbl_label570166107" xlink:type="arc"/>
      <link:label id="id_69f171dc" xlink:label="lbl_label1777431004" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_label1777431004" xlink:type="arc"/>
      <link:label id="id_66229f4a" xlink:label="lbl_label1713545034" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="lbl_ClassesOfShareCapitalAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfShareCapitalAxis" xlink:to="lbl_label1713545034" xlink:type="arc"/>
      <link:label id="id_6258cf3f" xlink:label="lbl_ClassesOfShareCapitalMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share capital [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="lbl_ClassesOfShareCapitalMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfShareCapitalMember" xlink:to="lbl_ClassesOfShareCapitalMember_labels" xlink:type="arc"/>
      <link:label id="id_45684f10" xlink:label="lbl_ChangesInEquity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in equity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInEquity" xlink:label="lbl_ChangesInEquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangesInEquity" xlink:to="lbl_ChangesInEquity_labels" xlink:type="arc"/>
      <link:label id="id_29e71b73" xlink:label="lbl_ChangesInEquity_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in the year</link:label>
      <link:label id="id_4ed5effa" xlink:label="lbl_TreasurySharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="lbl_TreasurySharesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesMember" xlink:to="lbl_TreasurySharesMember_labels" xlink:type="arc"/>
      <link:label id="id_17794e38" xlink:label="lbl_OrdinarySharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary shares [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="lbl_OrdinarySharesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OrdinarySharesMember" xlink:to="lbl_OrdinarySharesMember_labels" xlink:type="arc"/>
      <link:label id="id_b03287e" xlink:label="lbl_NumberOfSharesIssuedAndFullyPaid_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesIssuedAndFullyPaid" xlink:label="lbl_NumberOfSharesIssuedAndFullyPaid" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfSharesIssuedAndFullyPaid" xlink:to="lbl_NumberOfSharesIssuedAndFullyPaid_labels" xlink:type="arc"/>
      <link:label id="id_1d73737e" xlink:label="lbl_NumberOfSharesOutstanding_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares outstanding</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="lbl_NumberOfSharesOutstanding" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfSharesOutstanding" xlink:to="lbl_NumberOfSharesOutstanding_labels" xlink:type="arc"/>
      <link:label id="id_4825d127" xlink:label="lbl_label1210437927" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in number of shares outstanding</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:label="lbl_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInNumberOfSharesOutstanding" xlink:to="lbl_label1210437927" xlink:type="arc"/>
      <link:label id="id_4881ff43" xlink:label="lbl_NumberOfSharesOutstanding_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares outstanding at beginning of period</link:label>
      <link:label id="id_40051e5a" xlink:label="lbl_NumberOfSharesOutstanding_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares outstanding at end of period</link:label>
      <link:label id="id_3bcbca2a" xlink:label="lbl_NumberOfSharesIssuedAndFullyPaid_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid at beginning of period</link:label>
      <link:label id="id_733911db" xlink:label="lbl_NumberOfSharesIssuedAndFullyPaid_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued and fully paid at end of period</link:label>
      <link:label id="id_623febca" xlink:label="lbl_IssuedCapital_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Share capital at beginning of period</link:label>
      <link:label id="id_35d913cc" xlink:label="lbl_IssuedCapital_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Share capital at end of period</link:label>
      <link:label id="id_288f270c" xlink:label="lbl_TreasuryShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury shares at end of period</link:label>
      <link:label id="id_140833fe" xlink:label="lbl_TreasuryShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury shares at beginning of period</link:label>
      <link:label id="id_c7e7a97" xlink:label="lbl_Equity_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Equity at end of period</link:label>
      <link:label id="id_81b3b28" xlink:label="lbl_Equity_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Equity at beginning of period</link:label>
      <link:label id="id_102df8b6" xlink:label="lbl_PurchaseOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="lbl_PurchaseOfTreasuryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseOfTreasuryShares" xlink:to="lbl_PurchaseOfTreasuryShares_labels" xlink:type="arc"/>
      <link:label id="id_151d9a8b" xlink:label="lbl_SaleOrIssueOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale or issue of treasury shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares" xlink:label="lbl_SaleOrIssueOfTreasuryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOrIssueOfTreasuryShares" xlink:to="lbl_SaleOrIssueOfTreasuryShares_labels" xlink:type="arc"/>
      <link:label id="id_20b3b802" xlink:label="lbl_label548648962" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="lbl_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lbl_label548648962" xlink:type="arc"/>
      <link:label id="id_435514ee" xlink:label="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of events after reporting period [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_176c4f1e" xlink:label="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Events subsequent to the December 31 consolidated balance sheet date</link:label>
      <link:label id="id_34460981" xlink:label="lbl_label877005185" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Typ [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypAxis" xlink:label="lbl_SubsequentEventTypAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SubsequentEventTypAxis" xlink:to="lbl_label877005185" xlink:type="arc"/>
      <link:label id="id_72e1dec5" xlink:label="lbl_label1927405253" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypeMember" xlink:label="lbl_SubsequentEventTypeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SubsequentEventTypeMember" xlink:to="lbl_label1927405253" xlink:type="arc"/>
      <link:label id="id_1da2a9c4" xlink:label="lbl_label497199556" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventMember" xlink:label="lbl_SubsequentEventMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SubsequentEventMember" xlink:to="lbl_label497199556" xlink:type="arc"/>
      <link:label id="id_7f877b78" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:to="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners_labels" xlink:type="arc"/>
      <link:label id="id_7b380046" xlink:label="lbl_label2067267654" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and contingencies [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsAndContingenciesAbstract" xlink:label="lbl_CommitmentsAndContingenciesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CommitmentsAndContingenciesAbstract" xlink:to="lbl_label2067267654" xlink:type="arc"/>
      <link:label id="id_16b78de2" xlink:label="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of commitments and contingencies [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCommitmentsAndContingenciesTextBlock" xlink:label="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock" xlink:to="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4488d3fd" xlink:label="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:label id="id_2de2541f" xlink:label="lbl_label769807391" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant transactions [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfSignificantTransactionsAbstract" xlink:label="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:to="lbl_label769807391" xlink:type="arc"/>
      <link:label id="id_157aa47d" xlink:label="lbl_DisclosureOfSignificantTransactionsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Significant transactions [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfSignificantTransactionsTextBlock" xlink:label="lbl_DisclosureOfSignificantTransactionsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantTransactionsTextBlock" xlink:to="lbl_DisclosureOfSignificantTransactionsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_17fcde6d" xlink:label="lbl_DisclosureOfSignificantTransactionsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant transactions</link:label>
      <link:label id="id_60f273a7" xlink:label="lbl_label1626502055" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_label1626502055" xlink:type="arc"/>
      <link:label id="id_7edd823a" xlink:label="lbl_DisclosureOfFinancialLiabilitiesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:label="lbl_DisclosureOfFinancialLiabilitiesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="lbl_DisclosureOfFinancialLiabilitiesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_7e94d6aa" xlink:label="lbl_DisclosureOfFinancialLiabilitiesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current financial debt</link:label>
      <link:label id="id_594cd676" xlink:label="lbl_label1498207862" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of current financial debt and derivative instruments [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_label1498207862" xlink:type="arc"/>
      <link:label id="id_716dfcd6" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of current financial debt and derivative instruments [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" xlink:to="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4ab48078" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current financial debt and derivative financial instruments</link:label>
      <link:label id="id_3d80ff4e" xlink:label="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-current portion of non-current borrowings by type [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" xlink:label="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" xlink:to="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5bcb7f48" xlink:label="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of non-current portion of non-current borrowings by type</link:label>
      <link:label id="id_84597e5" xlink:label="lbl_label138778597" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings</link:label>
      <link:label id="id_77855829" xlink:label="lbl_label2005227561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:to="lbl_label2005227561" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:to="lbl_label138778597" xlink:type="arc"/>
      <link:label id="id_689e379d" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-current financial debt including current portion by maturity [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" xlink:to="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4824ba8c" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current financial debt including current portion by maturity</link:label>
      <link:label id="id_780939b8" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of non-current financial debt including current portion by currency [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" xlink:to="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_43204093" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current financial debt including current portion by currency</link:label>
      <link:label id="id_75f0b654" xlink:label="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of comparison of balance sheet and fair value of total non-current financial debt including current portion [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" xlink:label="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" xlink:to="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_18f19ce6" xlink:label="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comparison of balance sheet and fair value of total non-current financial debt including current portion</link:label>
      <link:label id="id_6962ebc4" xlink:label="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of collaerallized non-current financial debt and pledged assets [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" xlink:label="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" xlink:to="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1220efab" xlink:label="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaerallized non-current financial debt and pledged assets</link:label>
      <link:label id="id_4abca4e3" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of current financial debt and derivative instruments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" xlink:to="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1f8d2d9c" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current financial debt and derivative instruments</link:label>
      <link:label id="id_8188b7e" xlink:label="lbl_DisclosureOfLeasingCommitmentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Leasing commitments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfLeasingCommitmentsTableTextBlock" xlink:label="lbl_DisclosureOfLeasingCommitmentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfLeasingCommitmentsTableTextBlock" xlink:to="lbl_DisclosureOfLeasingCommitmentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_77b05f18" xlink:label="lbl_DisclosureOfLeasingCommitmentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasing commitments</link:label>
      <link:label id="id_6662e9d6" xlink:label="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of research and development commitments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" xlink:label="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" xlink:to="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3f2ee562" xlink:label="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development and other intangible purchase commitments</link:label>
      <link:label id="id_2a65b84f" xlink:label="lbl_label711309391" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasing commitments [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeasingCommitmentsAbstract" xlink:label="lbl_LeasingCommitmentsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeasingCommitmentsAbstract" xlink:to="lbl_label711309391" xlink:type="arc"/>
      <link:label id="id_1173f4bb" xlink:label="lbl_label292811963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule for commitments under fixed term operating leases [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:label="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:to="lbl_label292811963" xlink:type="arc"/>
      <link:label id="id_59b1ae19" xlink:label="lbl_label1504816665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule for commitments under fixed term operating leases [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:label="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:to="lbl_label1504816665" xlink:type="arc"/>
      <link:label id="id_a4d7aae" xlink:label="lbl_label172849838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year and not later than two years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="lbl_label172849838" xlink:type="arc"/>
      <link:label id="id_717d4be6" xlink:label="lbl_label1904036838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than two years and not later than three years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:to="lbl_label1904036838" xlink:type="arc"/>
      <link:label id="id_4d7a925b" xlink:label="lbl_label1299878491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than three years and not later than four years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:to="lbl_label1299878491" xlink:type="arc"/>
      <link:label id="id_3b47450e" xlink:label="lbl_label994526478" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than four years and not later than five years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="lbl_label994526478" xlink:type="arc"/>
      <link:label id="id_4b9f759a" xlink:label="lbl_label1268741530" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development and other intangible asset purchase commitments [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ResearchAndDevelopmentCommitmentsAbstract" xlink:label="lbl_ResearchAndDevelopmentCommitmentsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ResearchAndDevelopmentCommitmentsAbstract" xlink:to="lbl_label1268741530" xlink:type="arc"/>
      <link:label id="id_714a8ba3" xlink:label="lbl_label1900710819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule for commitments under research and development and other intangible asset purchase [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:label="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:to="lbl_label1900710819" xlink:type="arc"/>
      <link:label id="id_36fa2fba" xlink:label="lbl_label922365882" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule for commitments under research and development and other intangible asset purchase [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:label="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_label922365882" xlink:type="arc"/>
      <link:label id="id_5ab4de42" xlink:label="lbl_label632134259" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments under long-term research and development agreements</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsUnderLongtermResearchAgreements" xlink:label="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:to="lbl_label632134259" xlink:type="arc"/>
      <link:label id="id_2ceef672" xlink:label="lbl_label753858162" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current financial debt and derivative financial instruments [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" xlink:label="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" xlink:to="lbl_label753858162" xlink:type="arc"/>
      <link:label id="id_68d6c1f6" xlink:label="lbl_label1758904822" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current financial debt and derivative financial instruments [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_label1758904822" xlink:type="arc"/>
      <link:label id="id_797bb3cc" xlink:label="lbl_label2038150092" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest bearning accounts of associates payable on demand</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:to="lbl_label2038150092" xlink:type="arc"/>
      <link:label id="id_7b1552fe" xlink:label="lbl_ShorttermBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current borrowings</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="lbl_ShorttermBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShorttermBorrowings" xlink:to="lbl_ShorttermBorrowings_labels" xlink:type="arc"/>
      <link:label id="id_5020629f" xlink:label="lbl_ShorttermBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bank and other financial debt</link:label>
      <link:label id="id_13e39c07" xlink:label="lbl_CommercialPapersIssued_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial papers issued</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="lbl_CommercialPapersIssued" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CommercialPapersIssued" xlink:to="lbl_CommercialPapersIssued_labels" xlink:type="arc"/>
      <link:label id="id_4fdebda8" xlink:label="lbl_CommercialPapersIssued_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial Papers</link:label>
      <link:label id="id_46dd5b19" xlink:label="lbl_CurrentPortionOfLongtermBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current portion of non-current borrowings</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentPortionOfLongtermBorrowings" xlink:to="lbl_CurrentPortionOfLongtermBorrowings_labels" xlink:type="arc"/>
      <link:label id="id_7558c2a6" xlink:label="lbl_CurrentPortionOfLongtermBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of non-current financial debt</link:label>
      <link:label id="id_36b8e550" xlink:label="lbl_label918086992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit derivative, fair value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CreditDerivativeFairValue" xlink:label="lbl_CreditDerivativeFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CreditDerivativeFairValue" xlink:to="lbl_label918086992" xlink:type="arc"/>
      <link:label id="id_3a9947a0" xlink:label="lbl_DerivativeFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="lbl_DerivativeFinancialLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialLiabilities" xlink:to="lbl_DerivativeFinancialLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_6dcd1b42" xlink:label="lbl_DerivativeFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of derivative financial instruments</link:label>
      <link:label id="id_1dcb5ef8" xlink:label="lbl_WeightedAverageInterestRateAssociates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average interest rate, associates</link:label>
      <link:label id="id_2863fd2b" xlink:label="lbl_OtherCurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current financial debt and derivative financial instruments</link:label>
      <link:label id="id_5aca2f89" xlink:label="lbl_InterestExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
      <link:label id="id_74374cb6" xlink:label="lbl_label1949781174" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of components of non-current financial debts [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:label="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_label1949781174" xlink:type="arc"/>
      <link:label id="id_7edb9957" xlink:label="lbl_label2128320855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of components of non-current financial debts [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" xlink:label="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" xlink:to="lbl_label2128320855" xlink:type="arc"/>
      <link:label id="id_10bc1963" xlink:label="lbl_label280762723" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of components of non-current financial debts [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:label="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" xlink:to="lbl_label280762723" xlink:type="arc"/>
      <link:label id="id_300b69ab" xlink:label="lbl_BondsIssued_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Straight bonds</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BondsIssued" xlink:to="lbl_BondsIssued_labels" xlink:type="arc"/>
      <link:label id="id_1e4e0830" xlink:label="lbl_BondsIssued_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bonds issued</link:label>
      <link:label id="id_203f2415" xlink:label="lbl_Borrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total including current portion of non-current financial debt</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Borrowings" xlink:to="lbl_Borrowings_labels" xlink:type="arc"/>
      <link:label id="id_1bc6ed35" xlink:label="lbl_Borrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
      <link:label id="id_2e986311" xlink:label="lbl_CurrentPortionOfLongtermBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less current portion of non-current financial debt</link:label>
      <link:label id="id_355479bd" xlink:label="lbl_OtherNoncurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current financial debts</link:label>
      <link:label id="id_162b1eed" xlink:label="lbl_Borrowings_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">The amount of outstanding funds that the entity is obligated to repay</link:label>
      <link:label id="id_9d2aa80" xlink:label="lbl_label164801152" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years and not later than six years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:label="lbl_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:to="lbl_label164801152" xlink:type="arc"/>
      <link:label id="id_adae114" xlink:label="lbl_LaterThanSixYearsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than six years [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanSixYearsMember" xlink:label="lbl_LaterThanSixYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanSixYearsMember" xlink:to="lbl_LaterThanSixYearsMember_labels" xlink:type="arc"/>
      <link:label id="id_2050f0fd" xlink:label="lbl_LaterThanSixYearsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Later than six years</link:label>
      <link:label id="id_7e44b35f" xlink:label="lbl_label72836716" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Others</link:label>
      <link:label id="id_6a9e2b6" xlink:label="lbl_label111796918" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of the collateralized non-current financial debt and pledged assets [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:label="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:to="lbl_label111796918" xlink:type="arc"/>
      <link:label id="id_57bebc13" xlink:label="lbl_label1472117779" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of the collateralized non-current financial debt and pledged assets [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" xlink:label="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" xlink:to="lbl_label1472117779" xlink:type="arc"/>
      <link:label id="id_6cdc708" xlink:label="lbl_label114149128" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of the collateralized non-current financial debt and pledged assets [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:label="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" xlink:to="lbl_label114149128" xlink:type="arc"/>
      <link:label id="id_1ad42498" xlink:label="lbl_PropertyPlantAndEquipmentPledgedAsSecurity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, pledged as security</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:label="lbl_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:to="lbl_PropertyPlantAndEquipmentPledgedAsSecurity_labels" xlink:type="arc"/>
      <link:label id="id_4cf075ff" xlink:label="lbl_NoncurrentFinancialDebtsCoveredByCollateral_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial debts covered by collateral</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialDebtsCoveredByCollateral" xlink:label="lbl_NoncurrentFinancialDebtsCoveredByCollateral" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialDebtsCoveredByCollateral" xlink:to="lbl_NoncurrentFinancialDebtsCoveredByCollateral_labels" xlink:type="arc"/>
      <link:label id="id_cf0451a" xlink:label="lbl_NoncurrentFinancialDebtsCoveredByCollateral_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total amount of collateralized non-current financial debts</link:label>
      <link:label id="id_6e3a2d82" xlink:label="lbl_PropertyPlantAndEquipmentPledgedAsSecurity_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net book value of property, plant and equipment pledged as collateral for non-current financial debts</link:label>
      <link:label id="id_139c747e" xlink:label="lbl_label329020542" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:to="lbl_label329020542" xlink:type="arc"/>
      <link:label id="id_75a8b438" xlink:label="lbl_label1973990456" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lbl_label1973990456" xlink:type="arc"/>
      <link:label id="id_3e0c6c47" xlink:label="lbl_label1041001543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_label1041001543" xlink:type="arc"/>
      <link:label id="id_776f09d7" xlink:label="lbl_label2003765719" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_label2003765719" xlink:type="arc"/>
      <link:label id="id_227fd573" xlink:label="lbl_label578803059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_label578803059" xlink:type="arc"/>
      <link:label id="id_40a70df4" xlink:label="lbl_label1084689908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.25% EUR 1 500 million bond 2009/2016 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.757% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:label="lbl_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:to="lbl_label1084689908" xlink:type="arc"/>
      <link:label id="id_59ab4811" xlink:label="lbl_label1504397329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.4% USD 1 000 million bond 2010/2020 of Novartis Capital Corporation, New York United States, issued at 99.237% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:label="lbl_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:to="lbl_label1504397329" xlink:type="arc"/>
      <link:label id="id_57804983" xlink:label="lbl_label1468025219" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.4% USD 1 500 million bond 2012/2022 of Novartis Capital Corporation, New York United States, issued at 99.225% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:label="lbl_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:to="lbl_label1468025219" xlink:type="arc"/>
      <link:label id="id_7920acbc" xlink:label="lbl_label2032184508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.7% USD 500 million bond 2012/2042 of Novartis Capital Corporation, New York United States, issued at 98.325% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:label="lbl_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:to="lbl_label2032184508" xlink:type="arc"/>
      <link:label id="id_3ab016cd" xlink:label="lbl_label984618701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.4% USD 2 150 million bond 2014/2024 of Novartis Capital Corporation, New York United States, issued at 99.287% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:label="lbl_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:to="lbl_label984618701" xlink:type="arc"/>
      <link:label id="id_40a1b86b" xlink:label="lbl_label1084340331" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.4% USD 1 850 million bond 2014/2044 of Novartis Capital Corporation, New York United States, issued at 99.196% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:label="lbl_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:to="lbl_label1084340331" xlink:type="arc"/>
      <link:label id="id_78372e25" xlink:label="lbl_label2016882213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.75% EUR 600 million bond 2014/2021 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.134% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:label="lbl_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:to="lbl_label2016882213" xlink:type="arc"/>
      <link:label id="id_6e2b28f3" xlink:label="lbl_label1848322291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.625% EUR 600 million bond 2014/2026 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.697% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:label="lbl_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:to="lbl_label1848322291" xlink:type="arc"/>
      <link:label id="id_7c889c9" xlink:label="lbl_label130582985" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.25% CHF 500 million bond 2015/2025 of Novartis AG Basel Switzerland, issued at 100.64% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:label="lbl_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:to="lbl_label130582985" xlink:type="arc"/>
      <link:label id="id_1321f0b" xlink:label="lbl_label20061963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.625% CHF 550 million bond 2015/2029 of Novartis AG Basel Switzerland, issued at 100.502% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:label="lbl_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:to="lbl_label20061963" xlink:type="arc"/>
      <link:label id="id_66ae9900" xlink:label="lbl_label1722718464" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.050% CHF 325 million bond 2015/2035 of Novartis AG Basel Switzerland, issued at 100.479% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:label="lbl_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:to="lbl_label1722718464" xlink:type="arc"/>
      <link:label id="id_45d38312" xlink:label="lbl_label1171489554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.0% USD 1 750 million bond 2015/2025 of Novartis Capital Corporation, New York United States, issued at 99.010% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:label="lbl_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:to="lbl_label1171489554" xlink:type="arc"/>
      <link:label id="id_63c4e1e7" xlink:label="lbl_label1673847271" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">4.0% USD 1 250 million bond 2015/2045 of Novartis Capital Corporation, New York United States, issued at 98.029% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:label="lbl_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:to="lbl_label1673847271" xlink:type="arc"/>
      <link:label id="id_497f0505" xlink:label="lbl_label1233061125" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.125% EUR 1 250 million bond 2016/2023 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.127% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:label="lbl_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:to="lbl_label1233061125" xlink:type="arc"/>
      <link:label id="id_5233650c" xlink:label="lbl_label1379099916" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.625% EUR 500 million bond 2016/2028 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 98.48% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:label="lbl_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:to="lbl_label1379099916" xlink:type="arc"/>
      <link:label id="id_5f125bc1" xlink:label="lbl_label1595038657" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notional amount</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="lbl_NotionalAmount" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NotionalAmount" xlink:to="lbl_label1595038657" xlink:type="arc"/>
      <link:label id="id_4a9f133" xlink:label="lbl_label78246195" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, original currency</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsOriginalCurrency" xlink:label="lbl_BorrowingsOriginalCurrency" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsOriginalCurrency" xlink:to="lbl_label78246195" xlink:type="arc"/>
      <link:label id="id_3d3b01c0" xlink:label="lbl_BorrowingsMaturity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, maturity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="lbl_BorrowingsMaturity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsMaturity" xlink:to="lbl_BorrowingsMaturity_labels" xlink:type="arc"/>
      <link:label id="id_6970167" xlink:label="lbl_BorrowingsLender_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, lender</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsLender" xlink:label="lbl_BorrowingsLender" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsLender" xlink:to="lbl_BorrowingsLender_labels" xlink:type="arc"/>
      <link:label id="id_2d26d7a1" xlink:label="lbl_BorrowingsPremiumDiscount_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, premium discount</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsPremiumDiscount" xlink:label="lbl_BorrowingsPremiumDiscount" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsPremiumDiscount" xlink:to="lbl_BorrowingsPremiumDiscount_labels" xlink:type="arc"/>
      <link:label id="id_43d0ad58" xlink:label="lbl_label1137749336" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of liabilities [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:to="lbl_label1137749336" xlink:type="arc"/>
      <link:label id="id_5168eb51" xlink:label="lbl_label1365830481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of liabilities [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_label1365830481" xlink:type="arc"/>
      <link:label id="id_6ac35618" xlink:label="lbl_label1791186456" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of liabilities [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_label1791186456" xlink:type="arc"/>
      <link:label id="id_34e65236" xlink:label="lbl_label887509558" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LevelsOfFairValueHierarchyAxis" xlink:to="lbl_label887509558" xlink:type="arc"/>
      <link:label id="id_71bada1c" xlink:label="lbl_label1908070940" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All levels of fair value hierarchy [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_label1908070940" xlink:type="arc"/>
      <link:label id="id_7515173f" xlink:label="lbl_label1964316479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 1 of fair value hierarchy [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="lbl_Level1OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Level1OfFairValueHierarchyMember" xlink:to="lbl_label1964316479" xlink:type="arc"/>
      <link:label id="id_17ccd63f" xlink:label="lbl_label399300159" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="lbl_Level2OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Level2OfFairValueHierarchyMember" xlink:to="lbl_label399300159" xlink:type="arc"/>
      <link:label id="id_93d606b" xlink:label="lbl_label155017323" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="lbl_Level3OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Level3OfFairValueHierarchyMember" xlink:to="lbl_label155017323" xlink:type="arc"/>
      <link:label id="id_7c0df05a" xlink:label="lbl_OtherNoncurrentFinancialDebt_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current financial debt</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherNoncurrentFinancialDebt" xlink:label="lbl_OtherNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentFinancialDebt" xlink:to="lbl_OtherNoncurrentFinancialDebt_labels" xlink:type="arc"/>
      <link:label id="id_3aec21a3" xlink:label="lbl_OtherNoncurrentFinancialDebt_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Others</link:label>
      <link:label id="id_661a115" xlink:label="lbl_Borrowings_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
      <link:label id="id_45aae97f" xlink:label="lbl_label1168828799" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value by measurement basis [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisAxis" xlink:label="lbl_FairValueByMeasurementBasisAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueByMeasurementBasisAxis" xlink:to="lbl_label1168828799" xlink:type="arc"/>
      <link:label id="id_374d1399" xlink:label="lbl_label927798169" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value by measurement basis [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisMember" xlink:label="lbl_FairValueByMeasurementBasisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueByMeasurementBasisMember" xlink:to="lbl_label927798169" xlink:type="arc"/>
      <link:label id="id_5786569c" xlink:label="lbl_CarryingReportedAmountFairValueDisclosureMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying reported amount fair value disclosure [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CarryingReportedAmountFairValueDisclosureMember" xlink:label="lbl_CarryingReportedAmountFairValueDisclosureMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lbl_CarryingReportedAmountFairValueDisclosureMember_labels" xlink:type="arc"/>
      <link:label id="id_53a58f58" xlink:label="lbl_FairValueDisclosureItemAmountsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value disclosure item amounts [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueDisclosureItemAmountsMember" xlink:label="lbl_FairValueDisclosureItemAmountsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueDisclosureItemAmountsMember" xlink:to="lbl_FairValueDisclosureItemAmountsMember_labels" xlink:type="arc"/>
      <link:label id="id_5d4ffc36" xlink:label="lbl_FairValueDisclosureItemAmountsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair values</link:label>
      <link:label id="id_749b453a" xlink:label="lbl_CarryingReportedAmountFairValueDisclosureMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance sheet</link:label>
      <link:label id="id_670f6333" xlink:label="lbl_label1729061683" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="lbl_StatementOfComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementOfComprehensiveIncomeAbstract" xlink:to="lbl_label1729061683" xlink:type="arc"/>
      <link:label id="id_2d51324" xlink:label="lbl_ProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
      <link:label id="id_669b15d1" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_labels" xlink:type="arc"/>
      <link:label id="id_624c557e" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income never to be recycled into the consolidated income statement</link:label>
      <link:label id="id_543798f6" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, available-for-sale financial assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_6e3138d0" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on marketable securities, net of taxes</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges_labels" xlink:type="arc"/>
      <link:label id="id_f9a3fe1" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on deferred cash flow hedges, net of taxes</link:label>
      <link:label id="id_63d7965" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, financial instruments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments_labels" xlink:type="arc"/>
      <link:label id="id_57f5d574" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total fair value adjustments on financial instruments, net of taxes</link:label>
      <link:label id="id_4fc35e7b" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_labels" xlink:type="arc"/>
      <link:label id="id_5227f572" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_6b11bff3" xlink:label="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:type="arc"/>
      <link:label id="id_1e6e2048" xlink:label="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total of items to eventually recycle</link:label>
      <link:label id="id_485691e" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_labels1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_labels1" xlink:type="arc"/>
      <link:label id="id_6465e8d4" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_labels1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income to be eventually recycled into the consolidated income statement</link:label>
      <link:label id="id_2f7e508d" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:type="arc"/>
      <link:label id="id_7c43d9ec" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gains/losses from defined benefit plans, net of taxes</link:label>
      <link:label id="id_20ffa710" xlink:label="lbl_ComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComprehensiveIncome" xlink:to="lbl_ComprehensiveIncome_labels" xlink:type="arc"/>
      <link:label id="id_27277ccb" xlink:label="lbl_ComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income</link:label>
      <link:label id="id_5e2ce732" xlink:label="lbl_ComprehensiveIncomeAttributableToAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income attributable to [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:to="lbl_ComprehensiveIncomeAttributableToAbstract_labels" xlink:type="arc"/>
      <link:label id="id_5ce83165" xlink:label="lbl_ComprehensiveIncomeAttributableToAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attributable to</link:label>
      <link:label id="id_37725a9f" xlink:label="lbl_ComprehensiveIncomeAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to owners of parent</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="lbl_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lbl_ComprehensiveIncomeAttributableToOwnersOfParent_labels" xlink:type="arc"/>
      <link:label id="id_31bd4ac6" xlink:label="lbl_ComprehensiveIncomeAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders of Novartis AG</link:label>
      <link:label id="id_77aebdaf" xlink:label="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests_labels" xlink:type="arc"/>
      <link:label id="id_30557ca" xlink:label="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
      <link:label id="id_3783d7c" xlink:label="lbl_ContinuingOperationsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Continuing operations</link:label>
      <link:label id="id_411d9c7f" xlink:label="lbl_DiscontinuedOperationsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations</link:label>
      <link:label id="id_4c054c08" xlink:label="lbl_OtherFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other financial income and expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherFinanceIncomeCost" xlink:to="lbl_OtherFinanceIncomeCost_labels" xlink:type="arc"/>
      <link:label id="id_f2e2db3" xlink:label="lbl_OtherFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other financial income and expense from continuing operations</link:label>
      <link:label id="id_53dc86a1" xlink:label="lbl_OtherFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial income and expense</link:label>
      <link:label id="id_12f9d391" xlink:label="lbl_OtherFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other financial income and expense</link:label>
      <link:label id="id_76e0ee52" xlink:label="lbl_ProfitLossAttributableToAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attributable to</link:label>
      <link:label id="id_533d4513" xlink:label="lbl_label1396524307" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="lbl_StatementOfCashFlowsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementOfCashFlowsAbstract" xlink:to="lbl_label1396524307" xlink:type="arc"/>
      <link:label id="id_1706da9a" xlink:label="lbl_label386325146" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_label386325146" xlink:type="arc"/>
      <link:label id="id_23f6c7e5" xlink:label="lbl_label603375589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="lbl_StatementOfChangesInEquityTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementOfChangesInEquityTable" xlink:to="lbl_label603375589" xlink:type="arc"/>
      <link:label id="id_37845a12" xlink:label="lbl_label931420690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_label931420690" xlink:type="arc"/>
      <link:label id="id_ba7f520" xlink:label="lbl_label160680069" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityMember" xlink:to="lbl_label160680069" xlink:type="arc"/>
      <link:label id="id_3004ac5a" xlink:label="lbl_label805612634" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_label805612634" xlink:type="arc"/>
      <link:label id="id_4221701b" xlink:label="lbl_label1109487643" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interests [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="lbl_NoncontrollingInterestsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncontrollingInterestsMember" xlink:to="lbl_label1109487643" xlink:type="arc"/>
      <link:label id="id_6ac2ea98" xlink:label="lbl_IssuedCapitalMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="lbl_IssuedCapitalMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IssuedCapitalMember" xlink:to="lbl_IssuedCapitalMember_labels" xlink:type="arc"/>
      <link:label id="id_37852f90" xlink:label="lbl_RetainedEarningsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="lbl_RetainedEarningsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RetainedEarningsMember" xlink:to="lbl_RetainedEarningsMember_labels" xlink:type="arc"/>
      <link:label id="id_3014527f" xlink:label="lbl_label806638207" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="lbl_StatementOfChangesInEquityLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_label806638207" xlink:type="arc"/>
      <link:label id="id_7cb9019e" xlink:label="lbl_label2092499358" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="lbl_OtherComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncome" xlink:to="lbl_label2092499358" xlink:type="arc"/>
      <link:label id="id_14c74049" xlink:label="lbl_DividendsPaid_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends recognised as distributions to owners</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="lbl_DividendsPaid" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsPaid" xlink:to="lbl_DividendsPaid_labels" xlink:type="arc"/>
      <link:label id="id_55c8d5fc" xlink:label="lbl_DividendsPaid_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
      <link:label id="id_290fddfc" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase/decrease of treasury share repurchase obligation under a share buyback trading plan</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:to="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan_labels" xlink:type="arc"/>
      <link:label id="id_35016d1a" xlink:label="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:label="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:to="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_labels" xlink:type="arc"/>
      <link:label id="id_4817c0e9" xlink:label="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of change in ownership of consolidated entities</link:label>
      <link:label id="id_4d8eb67a" xlink:label="lbl_ChangesInEquity_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total of other equity movements</link:label>
      <link:label id="id_67a41ed4" xlink:label="lbl_label1738809044" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments related to divestments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:to="lbl_label1738809044" xlink:type="arc"/>
      <link:label id="id_63274027" xlink:label="lbl_IssuedCapitalMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
      <link:label id="id_403fccbc" xlink:label="lbl_TreasurySharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
      <link:label id="id_74d7e6ee" xlink:label="lbl_RetainedEarningsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
      <link:label id="id_b4d100c" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, fair value adjustments on deferred cash flow hedges</link:label>
      <link:label id="id_780100c2" xlink:label="lbl_InterestReceivedClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest received, classified as operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="lbl_InterestReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestReceivedClassifiedAsOperatingActivities" xlink:to="lbl_InterestReceivedClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_62d0936a" xlink:label="lbl_InterestReceivedClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest received</link:label>
      <link:label id="id_7b5cb6f6" xlink:label="lbl_InterestPaidClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest paid, classified as operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="lbl_InterestPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestPaidClassifiedAsOperatingActivities" xlink:to="lbl_InterestPaidClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_39ba29d5" xlink:label="lbl_InterestPaidClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
      <link:label id="id_1c3cdb2b" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_66b0d29c" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes paid</link:label>
      <link:label id="id_72973404" xlink:label="lbl_label1922511876" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows from operating activities from continuing operations before working capital and provision changes</link:label>
      <link:label id="id_2f19480a" xlink:label="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments out of provisions and other net cash movements in non-current liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:label="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:to="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_2fccc455" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in net current assets and other operating cash flow items</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:to="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems_labels" xlink:type="arc"/>
      <link:label id="id_7e94f37" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities, continuing operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_364038a2" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows from operating activities from continuing operations</link:label>
      <link:label id="id_2c0f5fb2" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities, discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_658b02cd" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flows from operating activities from discontinued operations</link:label>
      <link:label id="id_77c3c41b" xlink:label="lbl_CashFlowsFromUsedInOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInOperatingActivities" xlink:to="lbl_CashFlowsFromUsedInOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_4017c1c6" xlink:label="lbl_CashFlowsFromUsedInOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net cash flows from operating activities</link:label>
      <link:label id="id_668e4218" xlink:label="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_6c172e00" xlink:label="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
      <link:label id="id_79511d66" xlink:label="lbl_label2035359078" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lbl_label2035359078" xlink:type="arc"/>
      <link:label id="id_5310686b" xlink:label="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_4e39a447" xlink:label="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets</link:label>
      <link:label id="id_209f49b7" xlink:label="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of intangible assets, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_2fc66d2d" xlink:label="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of intangible assets</link:label>
      <link:label id="id_eed6ef4" xlink:label="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of financial assets, classified as investing activities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:to="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_7b96e87e" xlink:label="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of financial assets</link:label>
      <link:label id="id_674ec417" xlink:label="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of financial assets, classified as investing activities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:to="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_3a72549d" xlink:label="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of financial assets</link:label>
      <link:label id="id_4799c790" xlink:label="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of other long-term assets, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_5d62cc13" xlink:label="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of other non-current assets</link:label>
      <link:label id="id_4b05fa70" xlink:label="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of other long-term assets, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_2f0edb6a" xlink:label="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of other non-current assets</link:label>
      <link:label id="id_5354701a" xlink:label="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:to="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_2333df3a" xlink:label="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of marketable securities and commodities</link:label>
      <link:label id="id_8f147c1" xlink:label="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:to="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_c3ff34a" xlink:label="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sales of marketable securities and commodities</link:label>
      <link:label id="id_220d8b31" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities, continuing operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_1940f2ef" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in investing activities from continuing operations</link:label>
      <link:label id="id_bda8617" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities, discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_741f077b" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in/from investing activities from discontinued operations</link:label>
      <link:label id="id_34225142" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInInvestingActivities" xlink:to="lbl_CashFlowsFromUsedInInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_140f33b4" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash flows used in investing activities</link:label>
      <link:label id="id_643efdb2" xlink:label="lbl_PaymentsToAcquireOrRedeemEntitysShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to acquire or redeem entity's shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:to="lbl_PaymentsToAcquireOrRedeemEntitysShares_labels" xlink:type="arc"/>
      <link:label id="id_6226a1d0" xlink:label="lbl_PaymentsToAcquireOrRedeemEntitysShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of treasury shares</link:label>
      <link:label id="id_4f16d177" xlink:label="lbl_label1326895479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of options and other treasury share transactions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:label="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:to="lbl_label1326895479" xlink:type="arc"/>
      <link:label id="id_1e868ebc" xlink:label="lbl_CashFlowsFromUsedInFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInFinancingActivities" xlink:to="lbl_CashFlowsFromUsedInFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_2bab504d" xlink:label="lbl_CashFlowsFromUsedInFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net cash flows used in financing activities</link:label>
      <link:label id="id_5774a6d0" xlink:label="lbl_label1467262672" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lbl_label1467262672" xlink:type="arc"/>
      <link:label id="id_649add65" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_605d8076" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total change in cash and cash equivalents</link:label>
      <link:label id="id_153736f0" xlink:label="lbl_CashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
      <link:label id="id_354ffdea" xlink:label="lbl_CashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
      <link:label id="id_433b1725" xlink:label="lbl_label1127946021" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows before working capital and provision changes</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:label="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:to="lbl_label1127946021" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:to="lbl_label1922511876" xlink:type="arc"/>
      <link:label id="id_7f2f5c65" xlink:label="lbl_label2133810277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.125% USD 3 000 million bond 2009/2019 of Novaritis Securities Investment Ltd., Hamilton, Bermuda issued at 99.822% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:label="lbl_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:to="lbl_label2133810277" xlink:type="arc"/>
      <link:label id="id_429c1826" xlink:label="lbl_BorrowingsIssuanceDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, issuance date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsIssuanceDate" xlink:label="lbl_BorrowingsIssuanceDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsIssuanceDate" xlink:to="lbl_BorrowingsIssuanceDate_labels" xlink:type="arc"/>
      <link:label id="id_2669d99c" xlink:label="lbl_label644471196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency, others [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrencyOthersMember" xlink:to="lbl_label644471196" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrencyOthersMember" xlink:to="lbl_label72836716" xlink:type="arc"/>
      <link:label id="id_27412435" xlink:label="lbl_CurrentPortionOfLongtermBorrowings_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current portion of non-current financial debt</link:label>
      <link:label id="id_45c60d00" xlink:label="lbl_label1170607360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="lbl_DisclosureOfBusinessCombinationsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfBusinessCombinationsAbstract" xlink:to="lbl_label1170607360" xlink:type="arc"/>
      <link:label id="id_388165d3" xlink:label="lbl_label948004307" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_label948004307" xlink:type="arc"/>
      <link:label id="id_7de10318" xlink:label="lbl_label2111898392" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_label2111898392" xlink:type="arc"/>
      <link:label id="id_1b1dbf0c" xlink:label="lbl_label454934284" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lbl_label454934284" xlink:type="arc"/>
      <link:label id="id_1eb1092a" xlink:label="lbl_label514918698" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for subsidiaries [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="lbl_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntitysTotalForSubsidiariesMember" xlink:to="lbl_label514918698" xlink:type="arc"/>
      <link:label id="id_3d371bfe" xlink:label="lbl_label1027021822" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="lbl_SubsidiariesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SubsidiariesMember" xlink:to="lbl_label1027021822" xlink:type="arc"/>
      <link:label id="id_644266d7" xlink:label="lbl_label1682073303" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating income [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OperatingIncomeMember" xlink:label="lbl_OperatingIncomeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OperatingIncomeMember" xlink:to="lbl_label1682073303" xlink:type="arc"/>
      <link:label id="id_41ead269" xlink:label="lbl_TranscendMedicalIncMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transcend Medical Inc [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalIncMember" xlink:label="lbl_TranscendMedicalIncMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TranscendMedicalIncMember" xlink:to="lbl_TranscendMedicalIncMember_labels" xlink:type="arc"/>
      <link:label id="id_7cc6732" xlink:label="lbl_TranscendMedicalIncMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transcend Medical Inc.</link:label>
      <link:label id="id_5c37cd24" xlink:label="lbl_SelexysPharmaceuticalsCorporationMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selexys Pharmaceuticals Corporation [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelexysPharmaceuticalsCorporationMember" xlink:label="lbl_SelexysPharmaceuticalsCorporationMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SelexysPharmaceuticalsCorporationMember" xlink:to="lbl_SelexysPharmaceuticalsCorporationMember_labels" xlink:type="arc"/>
      <link:label id="id_26bb8728" xlink:label="lbl_SelexysPharmaceuticalsCorporationMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selexys Pharmaceuticals Corporation</link:label>
      <link:label id="id_f0f7125" xlink:label="lbl_ZiarcoGroupLimitedMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ziarco Group Limited [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedMember" xlink:label="lbl_ZiarcoGroupLimitedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ZiarcoGroupLimitedMember" xlink:to="lbl_ZiarcoGroupLimitedMember_labels" xlink:type="arc"/>
      <link:label id="id_74cc0f0d" xlink:label="lbl_ZiarcoGroupLimitedMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ziarco Group Limited</link:label>
      <link:label id="id_2cf9a6d0" xlink:label="lbl_EncoreVisionIncMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Encore Vision, Inc [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionIncMember" xlink:label="lbl_EncoreVisionIncMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EncoreVisionIncMember" xlink:to="lbl_EncoreVisionIncMember_labels" xlink:type="arc"/>
      <link:label id="id_14700202" xlink:label="lbl_EncoreVisionIncMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Encore Vision, Inc.</link:label>
      <link:label id="id_4323a92b" xlink:label="lbl_EliLillyAndCompanyMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eli Lilly and Company [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EliLillyAndCompanyMember" xlink:label="lbl_EliLillyAndCompanyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EliLillyAndCompanyMember" xlink:to="lbl_EliLillyAndCompanyMember_labels" xlink:type="arc"/>
      <link:label id="id_7d1163f7" xlink:label="lbl_EliLillyAndCompanyMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eli Lilly and Company</link:label>
      <link:label id="id_406cf0bb" xlink:label="lbl_GSKOncologyProductsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Oncology Products [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKOncologyProductsMember" xlink:label="lbl_GSKOncologyProductsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GSKOncologyProductsMember" xlink:to="lbl_GSKOncologyProductsMember_labels" xlink:type="arc"/>
      <link:label id="id_4dee8051" xlink:label="lbl_GSKOncologyProductsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Oncology Products</link:label>
      <link:label id="id_543b3534" xlink:label="lbl_GSKVaccinesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Vaccines [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKVaccinesMember" xlink:label="lbl_GSKVaccinesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GSKVaccinesMember" xlink:to="lbl_GSKVaccinesMember_labels" xlink:type="arc"/>
      <link:label id="id_50145ee" xlink:label="lbl_GSKVaccinesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Vaccines</link:label>
      <link:label id="id_258b2077" xlink:label="lbl_GSKConsumerHealthcareMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Consumer Healthcare [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKConsumerHealthcareMember" xlink:label="lbl_GSKConsumerHealthcareMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GSKConsumerHealthcareMember" xlink:to="lbl_GSKConsumerHealthcareMember_labels" xlink:type="arc"/>
      <link:label id="id_5cb81481" xlink:label="lbl_GSKConsumerHealthcareMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Consumer Healthcare</link:label>
      <link:label id="id_2c752dc" xlink:label="lbl_GSKTotalTransactionMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GSK Total Transaction [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKTotalTransactionMember" xlink:label="lbl_GSKTotalTransactionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GSKTotalTransactionMember" xlink:to="lbl_GSKTotalTransactionMember_labels" xlink:type="arc"/>
      <link:label id="id_366ab1d6" xlink:label="lbl_GSKTotalTransactionMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GSK Total Transaction</link:label>
      <link:label id="id_2144f8b2" xlink:label="lbl_CSLMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CSL [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CSLMember" xlink:label="lbl_CSLMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CSLMember" xlink:to="lbl_CSLMember_labels" xlink:type="arc"/>
      <link:label id="id_5f983746" xlink:label="lbl_CSLMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CSL</link:label>
      <link:label id="id_1961772e" xlink:label="lbl_SpinifexMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spinifex [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexMember" xlink:label="lbl_SpinifexMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SpinifexMember" xlink:to="lbl_SpinifexMember_labels" xlink:type="arc"/>
      <link:label id="id_7bf72331" xlink:label="lbl_SpinifexMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spinifex</link:label>
      <link:label id="id_72aed040" xlink:label="lbl_AdmuneTheraputicsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Admune Theraputics [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdmuneTheraputicsMember" xlink:label="lbl_AdmuneTheraputicsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdmuneTheraputicsMember" xlink:to="lbl_AdmuneTheraputicsMember_labels" xlink:type="arc"/>
      <link:label id="id_1b618d38" xlink:label="lbl_AdmuneTheraputicsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Admune Theraputics</link:label>
      <link:label id="id_2608381e" xlink:label="lbl_label638072862" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="lbl_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="lbl_label638072862" xlink:type="arc"/>
      <link:label id="id_6adf03f3" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion of consideration paid (received) consisting of cash and cash equivalents</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:to="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_29fb9219" xlink:label="lbl_label704352793" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent liabilities recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lbl_label704352793" xlink:type="arc"/>
      <link:label id="id_7589cc7b" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed_labels" xlink:type="arc"/>
      <link:label id="id_770a51dc" xlink:label="lbl_AdditionalRecognitionGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional recognition, goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill" xlink:label="lbl_AdditionalRecognitionGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionalRecognitionGoodwill" xlink:to="lbl_AdditionalRecognitionGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_159fb0c8" xlink:label="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:label="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_labels" xlink:type="arc"/>
      <link:label id="id_bb4840e" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:to="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_1f8e7785" xlink:label="lbl_label529430405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) recognised as result of remeasuring to fair value equity interest in acquiree held by acquirer before business combination</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:label="lbl_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:to="lbl_label529430405" xlink:type="arc"/>
      <link:label id="id_7a59b5df" xlink:label="lbl_label2052699615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="lbl_PercentageOfVotingEquityInterestsAcquired" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfVotingEquityInterestsAcquired" xlink:to="lbl_label2052699615" xlink:type="arc"/>
      <link:label id="id_3ce5a3b3" xlink:label="lbl_label1021682611" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:to="lbl_label1021682611" xlink:type="arc"/>
      <link:label id="id_4e581a" xlink:label="lbl_label5134362" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of arrangement for contingent consideration arrangements and indemnification assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="lbl_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:to="lbl_label5134362" xlink:type="arc"/>
      <link:label id="id_3ebaa53a" xlink:label="lbl_label1052419386" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of provisions and other current liabilities [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_label1052419386" xlink:type="arc"/>
      <link:label id="id_280373ad" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of provisions and other current liabilities explanatory [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" xlink:to="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_58be9555" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and other current liabilities</link:label>
      <link:label id="id_6f3dfdd7" xlink:label="lbl_label1866333655" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of acquisition of businesses [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:label="lbl_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:to="lbl_label1866333655" xlink:type="arc"/>
      <link:label id="id_74ec4e33" xlink:label="lbl_DisclosureOfBusinessCombinationsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of business combinations [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="lbl_DisclosureOfBusinessCombinationsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfBusinessCombinationsExplanatory" xlink:to="lbl_DisclosureOfBusinessCombinationsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_1fdc2fef" xlink:label="lbl_DisclosureOfBusinessCombinationsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of businesses</link:label>
      <link:label id="id_32cb811d" xlink:label="lbl_label852197661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_label852197661" xlink:type="arc"/>
      <link:label id="id_503f4b80" xlink:label="lbl_DisclosureOfEmployeeBenefitsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of employee benefits [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="lbl_DisclosureOfEmployeeBenefitsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfEmployeeBenefitsExplanatory" xlink:to="lbl_DisclosureOfEmployeeBenefitsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_4572e29d" xlink:label="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of provisions and other current liabilities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:to="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7df1458c" xlink:label="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and other current liabilities</link:label>
      <link:label id="id_330b4ffd" xlink:label="lbl_ProvisionsForReductionOfRevenueTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions for reduction of revenue [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForReductionOfRevenueTableTextBlock" xlink:label="lbl_ProvisionsForReductionOfRevenueTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionsForReductionOfRevenueTableTextBlock" xlink:to="lbl_ProvisionsForReductionOfRevenueTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2487cf91" xlink:label="lbl_ProvisionsForReductionOfRevenueTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for reduction of revenue</link:label>
      <link:label id="id_cda5e36" xlink:label="lbl_RestructuringProvisionsMovementsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring provisions movements [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsTableTextBlock" xlink:label="lbl_RestructuringProvisionsMovementsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestructuringProvisionsMovementsTableTextBlock" xlink:to="lbl_RestructuringProvisionsMovementsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_50653a58" xlink:label="lbl_RestructuringProvisionsMovementsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring provisions movements</link:label>
      <link:label id="id_51adf498" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value of assets and liabilities arising from acquisitions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" xlink:to="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_55fc13ca" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of assets and liabilities arising from acquisitions</link:label>
      <link:label id="id_43a17f70" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4ac74a65" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of the funded and unfunded defined benefit obligation for pension and other post retirement benefit plans table</link:label>
      <link:label id="id_7580bb7" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5d57abea" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of the net liability table</link:label>
      <link:label id="id_8f2e3e1" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Breakdown of defined benefit obligation for pension plans and other post-employment benefit [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:to="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_26221373" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Breakdown of defined benefit obligation for pension plans and other post-employment benefit</link:label>
      <link:label id="id_7b5fd886" xlink:label="lbl_ScheduleOfAssumptionsUsedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of assumptions used [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="lbl_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lbl_ScheduleOfAssumptionsUsedTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_83b4487" xlink:label="lbl_ScheduleOfAssumptionsUsedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal weighted average actuarial assumptions</link:label>
      <link:label id="id_5a767463" xlink:label="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of sensitivity analysis for actuarial assumptions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:label="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:to="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7c6a492e" xlink:label="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The sensitivity of the defined benefit pension obligation to the principal actuarial assumptions</link:label>
      <link:label id="id_40d21ce7" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of health care cost trend rates [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:to="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_28fc355" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The healthcare cost trend rate assumptions used for other post-employment benefits</link:label>
      <link:label id="id_37e4cfa4" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of allocation of plan assets [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_a47f671" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The weighted average plan asset allocation of funded defined benefit pension plans</link:label>
      <link:label id="id_14ebebe1" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of expected benefit payments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7cfc7cde" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The expected future cash flows in respect of pension and other post- employment benefit plans</link:label>
      <link:label id="id_5cc7b4f2" xlink:label="lbl_label1556591858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:to="lbl_label1556591858" xlink:type="arc"/>
      <link:label id="id_751ab231" xlink:label="lbl_label1964683825" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:to="lbl_label1964683825" xlink:type="arc"/>
      <link:label id="id_4f2027d2" xlink:label="lbl_label1327507410" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_label1327507410" xlink:type="arc"/>
      <link:label id="id_44180645" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currently marketed products intangible assets recognised as of acquisition date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_7b396a57" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currently marketed products</link:label>
      <link:label id="id_2a66227f" xlink:label="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired research and development intangible assets recognised as of acquisition date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_520a49db" xlink:label="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired research and development</link:label>
      <link:label id="id_79560b48" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other intangible assets recognised as of acquisition date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_2e2e2336" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
      <link:label id="id_2367c616" xlink:label="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:to="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_5161ba57" xlink:label="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
      <link:label id="id_62ae6b6f" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:to="lbl_InventoryRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_4affdfb9" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
      <link:label id="id_5c47e1cf" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables and other current assets recognised as of acquisition date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_59b962bd" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables and other current assets</link:label>
      <link:label id="id_13b05f40" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_33b144aa" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:label id="id_262ed31" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net assets recognized as a result of business combinations</link:label>
      <link:label id="id_7c2d8d71" xlink:label="lbl_label2083360113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill expected to be deductible for tax purposes</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillExpectedDeductibleForTaxPurposes" xlink:label="lbl_GoodwillExpectedDeductibleForTaxPurposes" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GoodwillExpectedDeductibleForTaxPurposes" xlink:to="lbl_label2083360113" xlink:type="arc"/>
      <link:label id="id_1e18b9d2" xlink:label="lbl_label504936914" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions and other current liabilities [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherCurrentLiabilitiesTable" xlink:label="lbl_ProvisionsAndOtherCurrentLiabilitiesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesTable" xlink:to="lbl_label504936914" xlink:type="arc"/>
      <link:label id="id_77fdfffd" xlink:label="lbl_label2013134845" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potentially refundable consideration from acquisition</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentiallyRefundableConsiderationFromAcquisition" xlink:label="lbl_PotentiallyRefundableConsiderationFromAcquisition" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PotentiallyRefundableConsiderationFromAcquisition" xlink:to="lbl_label2013134845" xlink:type="arc"/>
      <link:label id="id_240ec6" xlink:label="lbl_label2363078" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value of potentially refundable contingent consideration</link:label>
      <link:label id="id_5bb1899c" xlink:label="lbl_label1538361756" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract right of first negotiation term</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractRightOfFirstNegotiationTerm" xlink:label="lbl_ContractRightOfFirstNegotiationTerm" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContractRightOfFirstNegotiationTerm" xlink:to="lbl_label1538361756" xlink:type="arc"/>
      <link:label id="id_3eeb75f2" xlink:label="lbl_label1055618546" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue of acquiree since acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="lbl_RevenueOfAcquiree" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueOfAcquiree" xlink:to="lbl_label1055618546" xlink:type="arc"/>
      <link:label id="id_742dd0f8" xlink:label="lbl_label1949159672" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue of acquiree full year</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueOfAcquireeFullYear" xlink:label="lbl_RevenueOfAcquireeFullYear" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueOfAcquireeFullYear" xlink:to="lbl_label1949159672" xlink:type="arc"/>
      <link:label id="id_37ba66ca" xlink:label="lbl_label934962890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of business assets arising from contingencies amount recognized</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:label="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:to="lbl_label934962890" xlink:type="arc"/>
      <link:label id="id_53d61f56" xlink:label="lbl_label1406541654" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of business assets arising from contingencies amount recognized other than at fair value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:label="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:to="lbl_label1406541654" xlink:type="arc"/>
      <link:label id="id_6acd7a2d" xlink:label="lbl_label1791851053" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of business, contingent consideration arrangements, range of outcomes, value, high</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="lbl_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lbl_label1791851053" xlink:type="arc"/>
      <link:label id="id_c33fcc1" xlink:label="lbl_label204733633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of business, contingent option arrangements, range of outcomes, value, high</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:label="lbl_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:to="lbl_label204733633" xlink:type="arc"/>
      <link:label id="id_22e7f31e" xlink:label="lbl_label585626398" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of business, contingent option arrangements, fee paid</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:label="lbl_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:to="lbl_label585626398" xlink:type="arc"/>
      <link:label id="id_4739cf42" xlink:label="lbl_label1194970946" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="lbl_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="lbl_label1194970946" xlink:type="arc"/>
      <link:label id="id_7e1ee3b5" xlink:label="lbl_label2115953589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of voting equity interests contributed</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfVotingEquityInterestsContributed" xlink:label="lbl_PercentageOfVotingEquityInterestsContributed" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfVotingEquityInterestsContributed" xlink:to="lbl_label2115953589" xlink:type="arc"/>
      <link:label id="id_376f146e" xlink:label="lbl_TransactionRelatedCosts_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction related costs</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionRelatedCosts" xlink:label="lbl_TransactionRelatedCosts" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionRelatedCosts" xlink:to="lbl_TransactionRelatedCosts_labels" xlink:type="arc"/>
      <link:label id="id_2d34f9e9" xlink:label="lbl_TransactionRelatedCostsPaid_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction related costs paid</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionRelatedCostsPaid" xlink:label="lbl_TransactionRelatedCostsPaid" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionRelatedCostsPaid" xlink:to="lbl_TransactionRelatedCostsPaid_labels" xlink:type="arc"/>
      <link:label id="id_7a2e51fc" xlink:label="lbl_label690911032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="lbl_ImpairmentLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentLoss" xlink:to="lbl_label690911032" xlink:type="arc"/>
      <link:label id="id_67f3701a" xlink:label="lbl_label1744007194" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLoss" xlink:label="lbl_ReversalOfImpairmentLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReversalOfImpairmentLoss" xlink:to="lbl_label1744007194" xlink:type="arc"/>
      <link:label id="id_7cff95a1" xlink:label="lbl_label2097124769" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions and other current liabilities [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:label="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_label2097124769" xlink:type="arc"/>
      <link:label id="id_772301d6" xlink:label="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for taxes other than income taxes, current</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent_labels" xlink:type="arc"/>
      <link:label id="id_2dc3de10" xlink:label="lbl_ShorttermRestructuringProvision_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current restructuring provision</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermRestructuringProvision" xlink:label="lbl_ShorttermRestructuringProvision" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShorttermRestructuringProvision" xlink:to="lbl_ShorttermRestructuringProvision_labels" xlink:type="arc"/>
      <link:label id="id_5b202ec3" xlink:label="lbl_ShorttermRestructuringProvision_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring provisions</link:label>
      <link:label id="id_6d2493bb" xlink:label="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued royalties payable classified as current</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:label="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:to="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent_labels" xlink:type="arc"/>
      <link:label id="id_198471b1" xlink:label="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accruals for royalties</link:label>
      <link:label id="id_3eae10b2" xlink:label="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxes other than income taxes</link:label>
      <link:label id="id_4d2d81e4" xlink:label="lbl_ShorttermEmployeeBenefitsAccruals_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term employee benefits accruals</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="lbl_ShorttermEmployeeBenefitsAccruals" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShorttermEmployeeBenefitsAccruals" xlink:to="lbl_ShorttermEmployeeBenefitsAccruals_labels" xlink:type="arc"/>
      <link:label id="id_28ce7ee" xlink:label="lbl_ShorttermEmployeeBenefitsAccruals_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accurals for compensation and benefits including social security</link:label>
      <link:label id="id_72d5fdf0" xlink:label="lbl_DeferredIncomeClassifiedAsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred income classified as current</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredIncomeClassifiedAsCurrent" xlink:label="lbl_DeferredIncomeClassifiedAsCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredIncomeClassifiedAsCurrent" xlink:to="lbl_DeferredIncomeClassifiedAsCurrent_labels" xlink:type="arc"/>
      <link:label id="id_315adc93" xlink:label="lbl_DeferredIncomeClassifiedAsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income</link:label>
      <link:label id="id_dfd6824" xlink:label="lbl_ShorttermLegalProceedingsProvision_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current legal proceedings provision</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermLegalProceedingsProvision" xlink:label="lbl_ShorttermLegalProceedingsProvision" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShorttermLegalProceedingsProvision" xlink:to="lbl_ShorttermLegalProceedingsProvision_labels" xlink:type="arc"/>
      <link:label id="id_3dc37367" xlink:label="lbl_ShorttermLegalProceedingsProvision_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for product liabilities, governmental investigations and other legal matters</link:label>
      <link:label id="id_7364ea66" xlink:label="lbl_OtherCurrentPayables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other current payables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentPayables" xlink:label="lbl_OtherCurrentPayables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCurrentPayables" xlink:to="lbl_OtherCurrentPayables_labels" xlink:type="arc"/>
      <link:label id="id_53bd8e15" xlink:label="lbl_OtherCurrentPayables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other payables</link:label>
      <link:label id="id_16646c9e" xlink:label="lbl_label375680158" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions for deductions from revenue [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForDeductionsFromRevenueRollForward" xlink:label="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_label375680158" xlink:type="arc"/>
      <link:label id="id_236d2862" xlink:label="lbl_label594356322" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of other provisions [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="lbl_ClassesOfProvisionsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfProvisionsAxis" xlink:to="lbl_label594356322" xlink:type="arc"/>
      <link:label id="id_4ebad11d" xlink:label="lbl_label1320866077" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other provisions [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisionsMember" xlink:label="lbl_OtherProvisionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_label1320866077" xlink:type="arc"/>
      <link:label id="id_40fd93ca" xlink:label="lbl_RefundsProvisionMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Refunds provision [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RefundsProvisionMember" xlink:label="lbl_RefundsProvisionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RefundsProvisionMember" xlink:to="lbl_RefundsProvisionMember_labels" xlink:type="arc"/>
      <link:label id="id_134ebfe2" xlink:label="lbl_RefundsProvisionMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deductions from revenue</link:label>
      <link:label id="id_5e5b3081" xlink:label="lbl_OtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="lbl_OtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherProvisions" xlink:to="lbl_OtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_21da05f2" xlink:label="lbl_OtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Provision at end of period</link:label>
      <link:label id="id_3b690ec5" xlink:label="lbl_OtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Provision at beginning of period</link:label>
      <link:label id="id_7d787c31" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through loss of control of subsidiary, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:to="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_ff50d0a" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Provisions related to discontinued operations</link:label>
      <link:label id="id_5bf5caac" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through business combinations, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_2a95f348" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_27eafa" xlink:label="lbl_AdditionalProvisionsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional provisions, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="lbl_AdditionalProvisionsOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionalProvisionsOtherProvisions" xlink:to="lbl_AdditionalProvisionsOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_2c66d271" xlink:label="lbl_AdditionalProvisionsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
      <link:label id="id_fe1b238" xlink:label="lbl_ProvisionUsedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision used, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionUsedOtherProvisions" xlink:to="lbl_ProvisionUsedOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_36a5293f" xlink:label="lbl_ProvisionUsedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments/utilizations</link:label>
      <link:label id="id_359f477c" xlink:label="lbl_ChangesInOffsetAgainstGrossTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in offset against gross trade receivables</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInOffsetAgainstGrossTradeReceivables" xlink:label="lbl_ChangesInOffsetAgainstGrossTradeReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangesInOffsetAgainstGrossTradeReceivables" xlink:to="lbl_ChangesInOffsetAgainstGrossTradeReceivables_labels" xlink:type="arc"/>
      <link:label id="id_18735dbe" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_16f119f6" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_482a71cf" xlink:label="lbl_UnusedProvisionReversedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused provision reversed, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnusedProvisionReversedOtherProvisions" xlink:to="lbl_UnusedProvisionReversedOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_28d3a14e" xlink:label="lbl_ProvisionUsedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
      <link:label id="id_45b7ba0b" xlink:label="lbl_UnusedProvisionReversedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Releases</link:label>
      <link:label id="id_26660dfe" xlink:label="lbl_RestructuringProvisionMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring provision [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="lbl_RestructuringProvisionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestructuringProvisionMember" xlink:to="lbl_RestructuringProvisionMember_labels" xlink:type="arc"/>
      <link:label id="id_23d5363a" xlink:label="lbl_RestructuringProvisionMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring provision</link:label>
      <link:label id="id_79614e6" xlink:label="lbl_label127276262" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring provisions movements [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsRollForward" xlink:label="lbl_RestructuringProvisionsMovementsRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_label127276262" xlink:type="arc"/>
      <link:label id="id_51cb80cd" xlink:label="lbl_label1372291277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade receivables [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTradeReceivablesAbstract" xlink:label="lbl_DisclosureOfTradeReceivablesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_label1372291277" xlink:type="arc"/>
      <link:label id="id_2ea0d5c3" xlink:label="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade receivables explanatory [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTradeReceivablesExplanatoryTextBlock" xlink:label="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock" xlink:to="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6dd7d3e3" xlink:label="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
      <link:label id="id_2c1cad42" xlink:label="lbl_ProvisionsForTradeReceivablesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provisions for trade receivables [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForTradeReceivablesTableTextBlock" xlink:label="lbl_ProvisionsForTradeReceivablesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionsForTradeReceivablesTableTextBlock" xlink:to="lbl_ProvisionsForTradeReceivablesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3b131312" xlink:label="lbl_ProvisionsForTradeReceivablesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for trade receivables</link:label>
      <link:label id="id_2ef5991b" xlink:label="lbl_TradeReceivablesProvisionMovementsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables provision movements [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesProvisionMovementsTableTextBlock" xlink:label="lbl_TradeReceivablesProvisionMovementsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesProvisionMovementsTableTextBlock" xlink:to="lbl_TradeReceivablesProvisionMovementsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_77f758ca" xlink:label="lbl_TradeReceivablesProvisionMovementsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables provision movements</link:label>
      <link:label id="id_5d967f7b" xlink:label="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Overdue amounts and related provisions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OverdueAmountsAndRelatedProvisionsTableTextBlock" xlink:label="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock" xlink:to="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2b0e9f8f" xlink:label="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Overdue amounts and related provision</link:label>
      <link:label id="id_22339022" xlink:label="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables denominated in other currencies [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" xlink:label="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" xlink:to="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1c976f04" xlink:label="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables denominated in other currencies</link:label>
      <link:label id="id_3cb8d68f" xlink:label="lbl_label1018746511" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of provision matrix [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixAbstract" xlink:label="lbl_DisclosureOfProvisionMatrixAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfProvisionMatrixAbstract" xlink:to="lbl_label1018746511" xlink:type="arc"/>
      <link:label id="id_43d6f278" xlink:label="lbl_label1138160248" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of provision matrix [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="lbl_DisclosureOfProvisionMatrixTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_label1138160248" xlink:type="arc"/>
      <link:label id="id_4c9afaa7" xlink:label="lbl_label1285225127" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of provision matrix [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_label1285225127" xlink:type="arc"/>
      <link:label id="id_3182649e" xlink:label="lbl_label830629022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_label830629022" xlink:type="arc"/>
      <link:label id="id_5ff48884" xlink:label="lbl_label1609861252" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_label1609861252" xlink:type="arc"/>
      <link:label id="id_75e5081d" xlink:label="lbl_label123214748" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesMember" xlink:to="lbl_label123214748" xlink:type="arc"/>
      <link:label id="id_2e086500" xlink:label="lbl_CurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade receivables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentTradeReceivables" xlink:to="lbl_CurrentTradeReceivables_labels" xlink:type="arc"/>
      <link:label id="id_79f9d46a" xlink:label="lbl_CurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total trade receivables, net</link:label>
      <link:label id="id_3425f2e0" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for doubtful trade receivables related to discontinued operations</link:label>
      <link:label id="id_4ce7ed6d" xlink:label="lbl_AdditionalProvisionsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Provisions for doubtful trade receivables charged to the consolidated income statement</link:label>
      <link:label id="id_53792c91" xlink:label="lbl_ProvisionUsedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Utilization of reversal of provisions for doubtful trade receivables</link:label>
      <link:label id="id_74c340b1" xlink:label="lbl_label1958953137" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis of overdue amounts [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfOverdueAmountsTable" xlink:label="lbl_AnalysisOfOverdueAmountsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_label1958953137" xlink:type="arc"/>
      <link:label id="id_6ce050f6" xlink:label="lbl_label1826640118" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past due status [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="lbl_PastDueStatusAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PastDueStatusAxis" xlink:to="lbl_label1826640118" xlink:type="arc"/>
      <link:label id="id_3284c13a" xlink:label="lbl_label847561018" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past due status [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusMember" xlink:label="lbl_PastDueStatusMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PastDueStatusMember" xlink:to="lbl_label847561018" xlink:type="arc"/>
      <link:label id="id_21859e37" xlink:label="lbl_label562404919" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentMember" xlink:label="lbl_CurrentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentMember" xlink:to="lbl_label562404919" xlink:type="arc"/>
      <link:label id="id_36a38547" xlink:label="lbl_label916686151" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis of overdue amounts [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfOverdueAmountsLineItems" xlink:label="lbl_AnalysisOfOverdueAmountsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AnalysisOfOverdueAmountsLineItems" xlink:to="lbl_label916686151" xlink:type="arc"/>
      <link:label id="id_5fbcb687" xlink:label="lbl_label1606203015" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of receivables denominated in various currencies [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:label="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_label1606203015" xlink:type="arc"/>
      <link:label id="id_2efadcc4" xlink:label="lbl_label788192452" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade receivables from closely monitored countries</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:to="lbl_label788192452" xlink:type="arc"/>
      <link:label id="id_d85c974" xlink:label="lbl_label226871668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade receivables from closely monitored countries past due more than one year</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:to="lbl_label226871668" xlink:type="arc"/>
      <link:label id="id_5358f3b4" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade receivables from closely monitored countries past due more than one year, provisions recorded</link:label>
      <link:label id="id_7e49d670" xlink:label="lbl_label2118768240" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:to="lbl_label2118768240" xlink:type="arc"/>
      <link:label id="id_5081e337" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_172e52ca" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Group subsidiaries and associated companies</link:label>
      <link:label id="id_2f049798" xlink:label="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Group subsidiaries and associated companies [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" xlink:label="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" xlink:to="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_678c8520" xlink:label="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Group subsidiaries and associated companies</link:label>
      <link:label id="id_171309e1" xlink:label="lbl_label387123681" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lbl_label387123681" xlink:type="arc"/>
      <link:label id="id_7e6d2d55" xlink:label="lbl_label2121084245" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_label2121084245" xlink:type="arc"/>
      <link:label id="id_5b223713" xlink:label="lbl_label1528968979" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name of subsidiary</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NameOfSubsidiary" xlink:label="lbl_NameOfSubsidiary" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NameOfSubsidiary" xlink:to="lbl_label1528968979" xlink:type="arc"/>
      <link:label id="id_2bc20f05" xlink:label="lbl_label734138117" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal place of business of subsidiary</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="lbl_PrincipalPlaceOfBusinessOfSubsidiary" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="lbl_label734138117" xlink:type="arc"/>
      <link:label id="id_5cbe6246" xlink:label="lbl_label1555980870" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Country of incorporation of subsidiary</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:label="lbl_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="lbl_label1555980870" xlink:type="arc"/>
      <link:label id="id_77c5a25c" xlink:label="lbl_label2009440860" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:to="lbl_label2009440860" xlink:type="arc"/>
      <link:label id="id_64c53647" xlink:label="lbl_label1690646087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of voting rights held in subsidiary</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:label="lbl_ProportionOfVotingPowerHeldInSubsidiary" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProportionOfVotingPowerHeldInSubsidiary" xlink:to="lbl_label1690646087" xlink:type="arc"/>
      <link:label id="id_5c37870a" xlink:label="lbl_label1547142922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share/paid-in capital</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharePaidinCapital" xlink:label="lbl_SharePaidinCapital" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharePaidinCapital" xlink:to="lbl_label1547142922" xlink:type="arc"/>
      <link:label id="id_3c7cb5b5" xlink:label="lbl_label1014805941" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Societe par actions SANDOZ, Algiers [member]</link:label>
      <link:label id="id_1fee848b" xlink:label="lbl_label535725195" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Argentina S.A., Buenos Aires [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisArgentinaS.A.BuenosAiresMember" xlink:label="lbl_NovartisArgentinaS.A.BuenosAiresMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisArgentinaS.A.BuenosAiresMember" xlink:to="lbl_label535725195" xlink:type="arc"/>
      <link:label id="id_37e7fad0" xlink:label="lbl_label937949904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratorios S.A., Buenos Aires [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosS.A.BuenosAiresMember" xlink:label="lbl_AlconLaboratoriosS.A.BuenosAiresMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriosS.A.BuenosAiresMember" xlink:to="lbl_label937949904" xlink:type="arc"/>
      <link:label id="id_3ea304fe" xlink:label="lbl_label1050871038" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Roche Holding AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGBaselMember" xlink:label="lbl_RocheHoldingAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RocheHoldingAGBaselMember" xlink:to="lbl_label1050871038" xlink:type="arc"/>
      <link:label id="id_6ed1f5c4" xlink:label="lbl_label1859253700" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_label1859253700" xlink:type="arc"/>
      <link:label id="id_258b1d67" xlink:label="lbl_label629874023" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_label629874023" xlink:type="arc"/>
      <link:label id="id_d3021ba" xlink:label="lbl_label221258170" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_label221258170" xlink:type="arc"/>
      <link:label id="id_7226aa6a" xlink:label="lbl_ForeignCountriesMember_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Rest of the world</link:label>
      <link:label id="id_494ba6f4" xlink:label="lbl_label1229694708" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plans [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="lbl_DefinedBenefitPlansMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlansMember" xlink:to="lbl_label1229694708" xlink:type="arc"/>
      <link:label id="id_1d4af2d7" xlink:label="lbl_label491451095" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic defined benefit plans [member]</link:label>
      <link:label id="id_48d21535" xlink:label="lbl_label1221727541" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign defined benefit plans [member]</link:label>
      <link:label id="id_53109a65" xlink:label="lbl_ConcentrationOfMajorPlansGeographic_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration of major plans, geographic</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConcentrationOfMajorPlansGeographic" xlink:label="lbl_ConcentrationOfMajorPlansGeographic" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConcentrationOfMajorPlansGeographic" xlink:to="lbl_ConcentrationOfMajorPlansGeographic_labels" xlink:type="arc"/>
      <link:label id="id_6dd86874" xlink:label="lbl_ConcentrationOfMajorPlansGeographic_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of the major plans and the concentration of the Group's DBO by geography.</link:label>
      <link:label id="id_55c3f642" xlink:label="lbl_label1438905922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of plan amendments, curtailments and settlements</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements" xlink:label="lbl_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements1" xlink:to="lbl_label1438905922" xlink:type="arc"/>
      <link:label id="id_5774006e" xlink:label="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, recognized net gain (loss) due to curtailments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_labels" xlink:type="arc"/>
      <link:label id="id_1a9c795a" xlink:label="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Pre-tax curtailment gain (loss)</link:label>
      <link:label id="id_3ccdda27" xlink:label="lbl_label1020123687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plans [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="lbl_DefinedBenefitPlansAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlansAxis" xlink:to="lbl_label1020123687" xlink:type="arc"/>
      <link:label id="id_66c824b2" xlink:label="lbl_label1724392626" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement plan type [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_label1724392626" xlink:type="arc"/>
      <link:label id="id_1c17a6ba" xlink:label="lbl_label471312058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement plan type [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_label471312058" xlink:type="arc"/>
      <link:label id="id_2219e14f" xlink:label="lbl_PensionPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PensionPlanMember" xlink:to="lbl_PensionPlanMember_labels" xlink:type="arc"/>
      <link:label id="id_35fad562" xlink:label="lbl_OtherPostemploymentBenefitPlansMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other post-employment benefit plans [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherPostemploymentBenefitPlansMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember_labels" xlink:type="arc"/>
      <link:label id="id_2e4ea0d1" xlink:label="lbl_PensionPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension plans</link:label>
      <link:label id="id_67c584f7" xlink:label="lbl_OtherPostemploymentBenefitPlansMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other post-employment benefit plans</link:label>
      <link:label id="id_3d342709" xlink:label="lbl_DefinedBenefitObligationAtPresentValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit obligation, at present value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitObligationAtPresentValue" xlink:to="lbl_DefinedBenefitObligationAtPresentValue_labels" xlink:type="arc"/>
      <link:label id="id_22ca7a55" xlink:label="lbl_DefinedBenefitObligationAtPresentValue_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Benefit obligation at beginning of period</link:label>
      <link:label id="id_7de6506d" xlink:label="lbl_DefinedBenefitObligationAtPresentValue_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Benefit obligation at end of period</link:label>
      <link:label id="id_30925057" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current service cost, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:to="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_38d91a7e" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current service cost</link:label>
      <link:label id="id_2bef8750" xlink:label="lbl_DefinedBenefitPlanInterestCost_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, interest cost</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanInterestCost" xlink:label="lbl_DefinedBenefitPlanInterestCost" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanInterestCost" xlink:to="lbl_DefinedBenefitPlanInterestCost_labels" xlink:type="arc"/>
      <link:label id="id_6cf59b38" xlink:label="lbl_DefinedBenefitPlanInterestCost_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
      <link:label id="id_d5fe3e9" xlink:label="lbl_DefinedBenefitPlanInterestCost_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</link:label>
      <link:label id="id_4281521a" xlink:label="lbl_AdministrativeExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Administrative expenses</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="lbl_AdministrativeExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdministrativeExpense" xlink:to="lbl_AdministrativeExpense_labels" xlink:type="arc"/>
      <link:label id="id_603d3cd8" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses) arising from changes in financial assumptions, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_48f72a8" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement losses/(gains) arising from changes in financial assumptions</link:label>
      <link:label id="id_3f236d51" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses) arising from changes in demographic assumptions, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_78d171f" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement (gains) arising from changes in demographic assumptions</link:label>
      <link:label id="id_7a970ce2" xlink:label="lbl_label783050349" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Experience-related remeasurement losses/(gains)</link:label>
      <link:label id="id_783c6ad8" xlink:label="lbl_label220841955" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_45220e6b" xlink:label="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments from plan, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:label="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:to="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_1ebcfd45" xlink:label="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefit payments</link:label>
      <link:label id="id_6368b27" xlink:label="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contributions to plan by plan participants, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:to="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_481bb1bf" xlink:label="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions of associates</link:label>
      <link:label id="id_8f2ae87" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through acquisitions, divestments or transfers, benefit obligation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1_labels" xlink:type="arc"/>
      <link:label id="id_474719e9" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of acquisitions, divestments or transfers</link:label>
      <link:label id="id_26d72366" xlink:label="lbl_PlanAssetsAtFairValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan assets, at fair value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="lbl_PlanAssetsAtFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PlanAssetsAtFairValue" xlink:to="lbl_PlanAssetsAtFairValue_labels" xlink:type="arc"/>
      <link:label id="id_753e351c" xlink:label="lbl_PlanAssetsAtFairValue_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets at beginning of period</link:label>
      <link:label id="id_432fa1b8" xlink:label="lbl_PlanAssetsAtFairValue_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets at end of period</link:label>
      <link:label id="id_5996aa5" xlink:label="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense (income), defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:label="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:to="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_f38ab5e" xlink:label="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
      <link:label id="id_72396f28" xlink:label="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Return on plan assets excluding interest income, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:to="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_3dae186e" xlink:label="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Return on plan assets excluding interest income</link:label>
      <link:label id="id_66d6f9ff" xlink:label="lbl_label1273555602" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_37b55377" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contributions to plan by employer, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:to="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_12bfbc9" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novartis Group contributions</link:label>
      <link:label id="id_2adf4a42" xlink:label="lbl_DefinedBenefitPlanSettlementsPlanAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Settlements, Plan Assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="lbl_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lbl_DefinedBenefitPlanSettlementsPlanAssets_labels" xlink:type="arc"/>
      <link:label id="id_6615f676" xlink:label="lbl_DefinedBenefitPlanSettlementsPlanAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
      <link:label id="id_4cd3f00b" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through acquisitions, divestments or transfers, defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1_labels" xlink:type="arc"/>
      <link:label id="id_410b8f27" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of acquisitions, divestments or transfers</link:label>
      <link:label id="id_c41cf6c" xlink:label="lbl_label205639532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, change in benefit obligation [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_label205639532" xlink:type="arc"/>
      <link:label id="id_3bf9f9ba" xlink:label="lbl_label1006238138" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, change in fair value of plan assets [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_label1006238138" xlink:type="arc"/>
      <link:label id="id_290f00a6" xlink:label="lbl_SurplusDeficitInPlan_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Surplus (deficit) in plan</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="lbl_SurplusDeficitInPlan" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SurplusDeficitInPlan" xlink:to="lbl_SurplusDeficitInPlan_labels" xlink:type="arc"/>
      <link:label id="id_9610a9f" xlink:label="lbl_SurplusDeficitInPlan_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funded status</link:label>
      <link:label id="id_5aa411ee" xlink:label="lbl_label1520701934" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, change in limitation on recognition of fund surplus [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_label1520701934" xlink:type="arc"/>
      <link:label id="id_161add1b" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lbl_LiabilityAssetOfDefinedBenefitPlans_labels" xlink:type="arc"/>
      <link:label id="id_37321747" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net liability in the balance sheet at end of period</link:label>
      <link:label id="id_5bdc9111" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Limitation on recognition of fund surplus</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LimitationOnRecognitionOfFundSurplus" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LimitationOnRecognitionOfFundSurplus" xlink:to="lbl_LimitationOnRecognitionOfFundSurplus_labels" xlink:type="arc"/>
      <link:label id="id_76d185b5" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Limitation on recognition of fund surplus at beginning of period</link:label>
      <link:label id="id_1ada4e58" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Limitation on recognition of fund surplus at end of period</link:label>
      <link:label id="id_6ef6a13c" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in limitation on recognition of fund surplus</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:to="lbl_ChangeInLimitationOnRecognitionOfFundSurplus_labels" xlink:type="arc"/>
      <link:label id="id_203a6ebf" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</link:label>
      <link:label id="id_5d578703" xlink:label="lbl_label1566017283" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income on limitation of fund surplus</link:label>
      <link:label id="id_1c085865" xlink:label="lbl_InterestIncomeOnLimitationOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest income on limitation of fund surplus</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestIncomeOnLimitationOfFundSurplus" xlink:label="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:to="lbl_InterestIncomeOnLimitationOfFundSurplus_labels" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:to="lbl_label1566017283" xlink:type="arc"/>
      <link:label id="id_155f6c71" xlink:label="lbl_label358575217" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lbl_label358575217" xlink:type="arc"/>
      <link:label id="id_25ebb8ae" xlink:label="lbl_label636205230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, change in net liability [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_label636205230" xlink:type="arc"/>
      <link:label id="id_54f9f34f" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Net liability at end of period</link:label>
      <link:label id="id_56e703b2" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Net liability at beginning of period</link:label>
      <link:label id="id_4c3018ba" xlink:label="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense (income), net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_493d88c7" xlink:label="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net interest expense</link:label>
      <link:label id="id_58444b6a" xlink:label="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) on remeasurement, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_b032860" xlink:label="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurements</link:label>
      <link:label id="id_16e626ad" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through changes in foreign exchange rates, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_6f51c69e" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_3d05f86e" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through acquisitions, divestments or transfers, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1_labels" xlink:type="arc"/>
      <link:label id="id_594017b5" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of acquisitions, divestments or transfers</link:label>
      <link:label id="id_f5fa1d1" xlink:label="lbl_label257925585" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amounts recognized in the consolidated balance sheet [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:label="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:to="lbl_label257925585" xlink:type="arc"/>
      <link:label id="id_5b08b7db" xlink:label="lbl_label1527298011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued benefit liability</link:label>
      <link:label id="id_1ec53fdb" xlink:label="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit pension plan, accrued benefit liability</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:label="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:to="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities_labels" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:to="lbl_label1527298011" xlink:type="arc"/>
      <link:label id="id_1b1c172d" xlink:label="lbl_label454825773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Breakdown of defined benefit obligation for pension plans [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_label454825773" xlink:type="arc"/>
      <link:label id="id_574cbf67" xlink:label="lbl_label1464647527" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Obligation by type [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeAxis" xlink:label="lbl_ObligationByTypeAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ObligationByTypeAxis" xlink:to="lbl_label1464647527" xlink:type="arc"/>
      <link:label id="id_59c768c3" xlink:label="lbl_ObligationByTypeMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Obligation by type [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeMember" xlink:label="lbl_ObligationByTypeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_ObligationByTypeMember_labels" xlink:type="arc"/>
      <link:label id="id_e411de0" xlink:label="lbl_UnfundedMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unfunded [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnfundedMember" xlink:label="lbl_UnfundedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnfundedMember" xlink:to="lbl_UnfundedMember_labels" xlink:type="arc"/>
      <link:label id="id_206ca87f" xlink:label="lbl_ObligationByTypeMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Obligation by type</link:label>
      <link:label id="id_4964c411" xlink:label="lbl_UnfundedMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unfunded</link:label>
      <link:label id="id_15c93075" xlink:label="lbl_ActiveMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Active [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActiveMember" xlink:label="lbl_ActiveMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActiveMember" xlink:to="lbl_ActiveMember_labels" xlink:type="arc"/>
      <link:label id="id_4cc31394" xlink:label="lbl_ActiveMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Active</link:label>
      <link:label id="id_4cfa00d5" xlink:label="lbl_DeferredPensionersMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred pensioners [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredPensionersMember" xlink:label="lbl_DeferredPensionersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredPensionersMember" xlink:to="lbl_DeferredPensionersMember_labels" xlink:type="arc"/>
      <link:label id="id_452ea3f3" xlink:label="lbl_DeferredPensionersMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred pensioners</link:label>
      <link:label id="id_9ccd7d0" xlink:label="lbl_PensionersMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pensioners [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionersMember" xlink:label="lbl_PensionersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PensionersMember" xlink:to="lbl_PensionersMember_labels" xlink:type="arc"/>
      <link:label id="id_77f4d5bf" xlink:label="lbl_PensionersMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pensioners</link:label>
      <link:label id="id_41aa0977" xlink:label="lbl_label1101662583" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of defined benefit plans disclosures [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lbl_label1101662583" xlink:type="arc"/>
      <link:label id="id_70b19e47" xlink:label="lbl_ActuarialAssumptionOfDiscountRates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of discount rates</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="lbl_ActuarialAssumptionOfDiscountRates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfDiscountRates" xlink:to="lbl_ActuarialAssumptionOfDiscountRates_labels" xlink:type="arc"/>
      <link:label id="id_30e2ed44" xlink:label="lbl_ActuarialAssumptionOfDiscountRates_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
      <link:label id="id_228400f7" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of pension increases</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_labels" xlink:type="arc"/>
      <link:label id="id_5ba9eb34" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected rate of pension increase</link:label>
      <link:label id="id_4f7f1dac" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of salary increases</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_labels" xlink:type="arc"/>
      <link:label id="id_2cc2bb1f" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected rate of salary increase</link:label>
      <link:label id="id_1baffc03" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of interest on savings account</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount_labels" xlink:type="arc"/>
      <link:label id="id_56eba13" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on savings account</link:label>
      <link:label id="id_646262cf" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyMale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit assumption life expectancy, male</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitAssumptionLifeExpectancyMale" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyMale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitAssumptionLifeExpectancyMale" xlink:to="lbl_DefinedBenefitAssumptionLifeExpectancyMale_labels" xlink:type="arc"/>
      <link:label id="id_32829bee" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyMale_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current life expectancy for a 65-year-old male</link:label>
      <link:label id="id_d9d966" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyFemale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit assumption life expectancy, female</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:to="lbl_DefinedBenefitAssumptionLifeExpectancyFemale_labels" xlink:type="arc"/>
      <link:label id="id_5516dd19" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyFemale_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current life expectancy for a 65-year-old female</link:label>
      <link:label id="id_5918de81" xlink:label="lbl_label1494802049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lbl_label1494802049" xlink:type="arc"/>
      <link:label id="id_689d3554" xlink:label="lbl_label1755133268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lbl_label1755133268" xlink:type="arc"/>
      <link:label id="id_3e1a9660" xlink:label="lbl_label1041929824" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="lbl_ActuarialAssumptionsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionsAxis" xlink:to="lbl_label1041929824" xlink:type="arc"/>
      <link:label id="id_2737de6b" xlink:label="lbl_label657972843" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="lbl_ActuarialAssumptionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_label657972843" xlink:type="arc"/>
      <link:label id="id_70f6e61c" xlink:label="lbl_ActuarialAssumptionOfDiscountRatesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of discount rates [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="lbl_ActuarialAssumptionOfDiscountRatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfDiscountRatesMember" xlink:to="lbl_ActuarialAssumptionOfDiscountRatesMember_labels" xlink:type="arc"/>
      <link:label id="id_1b153ebb" xlink:label="lbl_ActuarialAssumptionOfDiscountRatesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate</link:label>
      <link:label id="id_761309a6" xlink:label="lbl_LifeExpectancyMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Life expectancy [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LifeExpectancyMember" xlink:label="lbl_LifeExpectancyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LifeExpectancyMember" xlink:to="lbl_LifeExpectancyMember_labels" xlink:type="arc"/>
      <link:label id="id_527cf7bb" xlink:label="lbl_LifeExpectancyMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Life expectancy</link:label>
      <link:label id="id_70b51d3d" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of pension increases [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_labels" xlink:type="arc"/>
      <link:label id="id_5b5a9ebb" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate of pension increase</link:label>
      <link:label id="id_47824990" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of interest on savings account [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember_labels" xlink:type="arc"/>
      <link:label id="id_32d0ccd0" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on savings account</link:label>
      <link:label id="id_742d5c34" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of salary increases [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_labels" xlink:type="arc"/>
      <link:label id="id_795db79c" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salary increase</link:label>
      <link:label id="id_72dd0a47" xlink:label="lbl_label1927088711" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in actuarial assumption [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionAxis" xlink:label="lbl_ChangeInActuarialAssumptionAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeInActuarialAssumptionAxis" xlink:to="lbl_label1927088711" xlink:type="arc"/>
      <link:label id="id_6778fca" xlink:label="lbl_label108498890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in actuarial assumption [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionMember" xlink:label="lbl_ChangeInActuarialAssumptionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_label108498890" xlink:type="arc"/>
      <link:label id="id_47ad1e48" xlink:label="lbl_Decrease25BasisPointMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease, 25 basis point [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Decrease25BasisPointMember" xlink:label="lbl_Decrease25BasisPointMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Decrease25BasisPointMember" xlink:to="lbl_Decrease25BasisPointMember_labels" xlink:type="arc"/>
      <link:label id="id_56d62cdb" xlink:label="lbl_Decrease25BasisPointMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">25 basis point decrease</link:label>
      <link:label id="id_3867e568" xlink:label="lbl_Increase25BasisPointMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase, 25 basis point [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Increase25BasisPointMember" xlink:label="lbl_Increase25BasisPointMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Increase25BasisPointMember" xlink:to="lbl_Increase25BasisPointMember_labels" xlink:type="arc"/>
      <link:label id="id_5197441d" xlink:label="lbl_Increase25BasisPointMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">25 basis point increase</link:label>
      <link:label id="id_1471972b" xlink:label="lbl_Increase1YearMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase, 1 year [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Increase1YearMember" xlink:label="lbl_Increase1YearMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Increase1YearMember" xlink:to="lbl_Increase1YearMember_labels" xlink:type="arc"/>
      <link:label id="id_4ce59d83" xlink:label="lbl_Increase1YearMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">1 year increase</link:label>
      <link:label id="id_290932d1" xlink:label="lbl_label688468689" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lbl_label688468689" xlink:type="arc"/>
      <link:label id="id_7dde43af" xlink:label="lbl_label2111718319" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lbl_label2111718319" xlink:type="arc"/>
      <link:label id="id_a6a337a" xlink:label="lbl_label174732154" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of health care cost trend rates [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfHealthCareCostTrendRatesTable" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:to="lbl_label174732154" xlink:type="arc"/>
      <link:label id="id_3aac73e2" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_labels" xlink:type="arc"/>
      <link:label id="id_6a35725f" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Healthcare cost trend rate assumed for next year</link:label>
      <link:label id="id_41b83777" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed to Decline</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:to="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline_labels" xlink:type="arc"/>
      <link:label id="id_4f8e05fa" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rate to which the cost trend rate is assumed to decline</link:label>
      <link:label id="id_6b154ebb" xlink:label="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Benefit Plan, Year that Rate Reaches Ultimate Trend Rate</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:label="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:to="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_labels" xlink:type="arc"/>
      <link:label id="id_1990f79d" xlink:label="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year that the rate reaches the ultimate trend rate</link:label>
      <link:label id="id_6d01266f" xlink:label="lbl_label1828791919" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of allocation of plan assets [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAllocationOfPlanAssetsTable" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:to="lbl_label1828791919" xlink:type="arc"/>
      <link:label id="id_546e2ee7" xlink:label="lbl_label1416507111" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_label1416507111" xlink:type="arc"/>
      <link:label id="id_351e0eb0" xlink:label="lbl_label891162288" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_label891162288" xlink:type="arc"/>
      <link:label id="id_124636b7" xlink:label="lbl_EquityInvestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity investments [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInvestmentsMember" xlink:label="lbl_EquityInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityInvestmentsMember" xlink:to="lbl_EquityInvestmentsMember_labels" xlink:type="arc"/>
      <link:label id="id_77cea25b" xlink:label="lbl_EquityInvestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities</link:label>
      <link:label id="id_1387f503" xlink:label="lbl_DebtSecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt securities [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DebtSecuritiesMember" xlink:to="lbl_DebtSecuritiesMember_labels" xlink:type="arc"/>
      <link:label id="id_3f4271a5" xlink:label="lbl_DebtSecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities</link:label>
      <link:label id="id_3fb49996" xlink:label="lbl_RealEstateMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real estate [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RealEstateMember" xlink:label="lbl_RealEstateMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RealEstateMember" xlink:to="lbl_RealEstateMember_labels" xlink:type="arc"/>
      <link:label id="id_3b683c06" xlink:label="lbl_RealEstateMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real estate</link:label>
      <link:label id="id_40e14f9f" xlink:label="lbl_AlternativeInvestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alternative investments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlternativeInvestmentsMember" xlink:label="lbl_AlternativeInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlternativeInvestmentsMember" xlink:to="lbl_AlternativeInvestmentsMember_labels" xlink:type="arc"/>
      <link:label id="id_63169a31" xlink:label="lbl_AlternativeInvestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alternative investments</link:label>
      <link:label id="id_2f33748b" xlink:label="lbl_CashAndOtherInvestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and other investments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndOtherInvestmentsMember" xlink:label="lbl_CashAndOtherInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndOtherInvestmentsMember" xlink:to="lbl_CashAndOtherInvestmentsMember_labels" xlink:type="arc"/>
      <link:label id="id_6087023c" xlink:label="lbl_CashAndOtherInvestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and other investments</link:label>
      <link:label id="id_36f85bd1" xlink:label="lbl_label922246097" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, target plan asset allocations range minimum</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:label="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:to="lbl_label922246097" xlink:type="arc"/>
      <link:label id="id_568969aa" xlink:label="lbl_label1451846058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, target plan asset allocations range maximum</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:label="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:to="lbl_label1451846058" xlink:type="arc"/>
      <link:label id="id_73a6e694" xlink:label="lbl_label1940317844" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, plan asset allocations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanPlanAssetAllocations" xlink:label="lbl_DefinedBenefitPlanPlanAssetAllocations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanPlanAssetAllocations" xlink:to="lbl_label1940317844" xlink:type="arc"/>
      <link:label id="id_7df88f41" xlink:label="lbl_label2113441601" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares held by defined benefit plan</link:label>
      <link:label id="id_638e4e2e" xlink:label="lbl_label1670270510" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value of shares held by defined benefit plan</link:label>
      <link:label id="id_1fe80675" xlink:label="lbl_label535299701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average duration of defined benefit obligation years</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:label="lbl_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:to="lbl_label535299701" xlink:type="arc"/>
      <link:label id="id_3b7d1376" xlink:label="lbl_label998052726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined contribution pension and other post-retirement plans disclosure [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:to="lbl_label998052726" xlink:type="arc"/>
      <link:label id="id_3dd16606" xlink:label="lbl_label1037133318" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined contribution pension and other post-retirement plans disclosure [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_label1037133318" xlink:type="arc"/>
      <link:label id="id_123e0aae" xlink:label="lbl_label306055854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined contribution pension and other post-retirement plans disclosure [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_label306055854" xlink:type="arc"/>
      <link:label id="id_f1ad7e6" xlink:label="lbl_label253417446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense, defined contribution plans</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="lbl_label253417446" xlink:type="arc"/>
      <link:label id="id_103a32b5" xlink:label="lbl_label272249525" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of expected benefit payments [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpectedBenefitPaymentsTable" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:to="lbl_label272249525" xlink:type="arc"/>
      <link:label id="id_3fa24799" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, expected future benefit payment [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:to="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract_labels" xlink:type="arc"/>
      <link:label id="id_7a2e1ca0" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, expected future employer contributions [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:to="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract_labels" xlink:type="arc"/>
      <link:label id="id_6e3282e0" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novartis Group contributions</link:label>
      <link:label id="id_723df25e" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future benefit payments</link:label>
      <link:label id="id_b004db7" xlink:label="lbl_label910647463" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contributions, next fiscal year (estimated)</link:label>
      <link:label id="id_489bf9be" xlink:label="lbl_label839490648" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected future benefit payment</link:label>
      <link:label id="id_20bc42c3" xlink:label="lbl_label549208771" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Past service cost and settlements</link:label>
      <link:label id="id_12ce3901" xlink:label="lbl_label315504897" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past service cost and gains losses arising from settlements, defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:to="lbl_label315504897" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:to="lbl_label549208771" xlink:type="arc"/>
      <link:label id="id_47519d57" xlink:label="lbl_label1196531031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, expected future employer contributions, next fiscal year</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lbl_label1196531031" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lbl_label910647463" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SocieteParActionsSANDOZAlgiersMember" xlink:label="lbl_SocieteParActionsSANDOZAlgiersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SocieteParActionsSANDOZAlgiersMember" xlink:to="lbl_label1014805941" xlink:type="arc"/>
      <link:label id="id_1b677399" xlink:label="lbl_label459764633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis of income and expense [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="lbl_AnalysisOfIncomeAndExpenseAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AnalysisOfIncomeAndExpenseAbstract" xlink:to="lbl_label459764633" xlink:type="arc"/>
      <link:label id="id_33287a64" xlink:label="lbl_DisclosureOfDiscontinuedOperationsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of discontinued operations [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="lbl_DisclosureOfDiscontinuedOperationsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDiscontinuedOperationsExplanatory" xlink:to="lbl_DisclosureOfDiscontinuedOperationsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_2e310112" xlink:label="lbl_DisclosureOfDiscontinuedOperationsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued operations</link:label>
      <link:label id="id_6868ef6e" xlink:label="lbl_label1751707502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of details to the consolidated statements of cash flows [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_label1751707502" xlink:type="arc"/>
      <link:label id="id_6b1bab45" xlink:label="lbl_DisclosureOfCashFlowStatementExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Details to the consolidated statements of cash flows</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="lbl_DisclosureOfCashFlowStatementExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfCashFlowStatementExplanatory" xlink:to="lbl_DisclosureOfCashFlowStatementExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_d3696d1" xlink:label="lbl_DisclosureOfCashFlowStatementExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of cash flow statement [text block]</link:label>
      <link:label id="id_5827fd3a" xlink:label="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for non-cash items from continuing operations [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" xlink:label="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" xlink:to="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4b12a0b7" xlink:label="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for non-cash items from continuing operations</link:label>
      <link:label id="id_31e67efa" xlink:label="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from changes in working capital and other operating items included in operating cash flow from continuing operations [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" xlink:label="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" xlink:to="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3971a54e" xlink:label="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from changes in working capital and other operating items included in operating cash flow from continuing operations</link:label>
      <link:label id="id_1118f1b5" xlink:label="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows arising from acquisitions and divestments of businesses [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" xlink:label="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" xlink:to="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4c64ba26" xlink:label="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows arising from acquisitions and divestments of businesses</link:label>
      <link:label id="id_4c022ee6" xlink:label="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from discontinued operations [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsFromDiscontinuedOperationsTableTextBlock" xlink:label="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock" xlink:to="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5bd72b36" xlink:label="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from discontinued operations</link:label>
      <link:label id="id_2f1afbf8" xlink:label="lbl_ConsolidatedIncomeStatementSegmentationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated income statement segmentation [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementSegmentationTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementSegmentationTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsolidatedIncomeStatementSegmentationTableTextBlock" xlink:to="lbl_ConsolidatedIncomeStatementSegmentationTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5cbbe15" xlink:label="lbl_ConsolidatedIncomeStatementSegmentationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated income statement segmentation</link:label>
      <link:label id="id_5a01c254" xlink:label="lbl_ExpensesIncludedInNetIncomeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expenses included in net income [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExpensesIncludedInNetIncomeTableTextBlock" xlink:label="lbl_ExpensesIncludedInNetIncomeTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExpensesIncludedInNetIncomeTableTextBlock" xlink:to="lbl_ExpensesIncludedInNetIncomeTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2004e8bf" xlink:label="lbl_ExpensesIncludedInNetIncomeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenses included in net income</link:label>
      <link:label id="id_10dd18ca" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToContinuingSegments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods, sales to continuing segments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToContinuingSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToContinuingSegments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsSalesToContinuingSegments" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToContinuingSegments_labels" xlink:type="arc"/>
      <link:label id="id_2d4849c4" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToContinuingSegments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales to continuing segments</link:label>
      <link:label id="id_398e8ede" xlink:label="lbl_label965643998" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_label965643998" xlink:type="arc"/>
      <link:label id="id_136ba9dd" xlink:label="lbl_label325822941" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SegmentsMember" xlink:to="lbl_label325822941" xlink:type="arc"/>
      <link:label id="id_211fcf4d" xlink:label="lbl_VaccinesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vaccines [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VaccinesMember" xlink:label="lbl_VaccinesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VaccinesMember" xlink:to="lbl_VaccinesMember_labels" xlink:type="arc"/>
      <link:label id="id_5b74f3f8" xlink:label="lbl_ConsumerHealthMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumer Health [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsumerHealthMember" xlink:label="lbl_ConsumerHealthMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsumerHealthMember" xlink:to="lbl_ConsumerHealthMember_labels" xlink:type="arc"/>
      <link:label id="id_56f765a5" xlink:label="lbl_CorporateMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CorporateMember" xlink:to="lbl_CorporateMember_labels" xlink:type="arc"/>
      <link:label id="id_18ef0ff6" xlink:label="lbl_VaccinesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vaccines</link:label>
      <link:label id="id_461a031f" xlink:label="lbl_ConsumerHealthMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumer Health</link:label>
      <link:label id="id_53139d8a" xlink:label="lbl_CorporateMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
      <link:label id="id_448d3c2a" xlink:label="lbl_OperatingIncomeLossOfDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating income/loss of discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OperatingIncomeLossOfDiscontinuedOperations" xlink:label="lbl_OperatingIncomeLossOfDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OperatingIncomeLossOfDiscontinuedOperations" xlink:to="lbl_OperatingIncomeLossOfDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_720983c3" xlink:label="lbl_OperatingIncomeLossOfDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income/loss of discontinued operations</link:label>
      <link:label id="id_72fd7ee5" xlink:label="lbl_IncomeTaxExpenseOfDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax expense of discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeTaxExpenseOfDiscontinuedOperations" xlink:label="lbl_IncomeTaxExpenseOfDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxExpenseOfDiscontinuedOperations" xlink:to="lbl_IncomeTaxExpenseOfDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_28dd046" xlink:label="lbl_IncomeTaxExpenseOfDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense of discontinued operations</link:label>
      <link:label id="id_1f5a1a52" xlink:label="lbl_ProfitLossFromDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income from discontinued operations</link:label>
      <link:label id="id_6a72e089" xlink:label="lbl_label1785913481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationExpense" xlink:label="lbl_DepreciationExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DepreciationExpense" xlink:to="lbl_label1785913481" xlink:type="arc"/>
      <link:label id="id_25726f06" xlink:label="lbl_label628256518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationExpense" xlink:label="lbl_AmortisationExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmortisationExpense" xlink:to="lbl_label628256518" xlink:type="arc"/>
      <link:label id="id_411f99ec" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_labels" xlink:type="arc"/>
      <link:label id="id_3b138d2b" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees_labels" xlink:type="arc"/>
      <link:label id="id_16efc802" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-based compensation of Novartis equity plans</link:label>
      <link:label id="id_1bd6fe9" xlink:label="lbl_IntangibleAssetsAndGoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember_labels" xlink:type="arc"/>
      <link:label id="id_1b76fc8a" xlink:label="lbl_IntangibleAssetsAndGoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
      <link:label id="id_7b8e06f2" xlink:label="lbl_PropertyPlantAndEquipmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:label id="id_199a6c29" xlink:label="lbl_FinancialAssetsImpairedMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets impaired [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsImpairedMember" xlink:label="lbl_FinancialAssetsImpairedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsImpairedMember" xlink:to="lbl_FinancialAssetsImpairedMember_labels" xlink:type="arc"/>
      <link:label id="id_430aa9fa" xlink:label="lbl_FinancialAssetsImpairedMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
      <link:label id="id_580bc98f" xlink:label="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:label="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:to="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract_labels" xlink:type="arc"/>
      <link:label id="id_12db58d" xlink:label="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation, amortization and impairments on:</link:label>
      <link:label id="id_7cae4caa" xlink:label="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for losses (gains) on disposal of non-current assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_7ed21581" xlink:label="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gains on disposal and other adjustments on property, plant and equipment; intangible assets;financial assets; and other non-current assets, net</link:label>
      <link:label id="id_353f4e60" xlink:label="lbl_AdjustmentsForSharebasedPayments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment for share based payments</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="lbl_AdjustmentsForSharebasedPayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForSharebasedPayments" xlink:to="lbl_AdjustmentsForSharebasedPayments_labels" xlink:type="arc"/>
      <link:label id="id_728a3fc5" xlink:label="lbl_AdjustmentsForSharebasedPayments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-settled compensation expense</link:label>
      <link:label id="id_71026a6c" xlink:label="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment for change in provisions and other non-current liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:to="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_7a811d6" xlink:label="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash change in provisions and other non-current liabilities</link:label>
      <link:label id="id_5215d26" xlink:label="lbl_AdjustmentsForFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for finance income (cost)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="lbl_AdjustmentsForFinanceIncomeCost" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForFinanceIncomeCost" xlink:to="lbl_AdjustmentsForFinanceIncomeCost_labels" xlink:type="arc"/>
      <link:label id="id_1e915c0" xlink:label="lbl_AdjustmentsForFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net financial expense</link:label>
      <link:label id="id_162e6aad" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInInventories_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInInventories_labels" xlink:type="arc"/>
      <link:label id="id_7b5bcf12" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInInventories_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Increase) in inventories</link:label>
      <link:label id="id_672b8eea" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_labels" xlink:type="arc"/>
      <link:label id="id_47cff5e1" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Increase) in trade receivables</link:label>
      <link:label id="id_543bdc2c" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts payable</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_labels" xlink:type="arc"/>
      <link:label id="id_4059a0ed" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in trade payables</link:label>
      <link:label id="id_b388f81" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other inflows (outflows) of cash</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_64e8a2fc" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in other net current assets and other operating cash flow items</link:label>
      <link:label id="id_63e2f9e4" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
      <link:label id="id_118bdd59" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents, discontinued operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_671e3a1e" xlink:label="lbl_label1730034206" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions and divestments [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsAxis" xlink:label="lbl_AcquisitionsAndDivestmentsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsAndDivestmentsAxis" xlink:to="lbl_label1730034206" xlink:type="arc"/>
      <link:label id="id_141b97fd" xlink:label="lbl_label337352701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions and divestments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsMember" xlink:label="lbl_AcquisitionsAndDivestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsAndDivestmentsMember" xlink:to="lbl_label337352701" xlink:type="arc"/>
      <link:label id="id_12050514" xlink:label="lbl_AcquisitionsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsMember" xlink:label="lbl_AcquisitionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsMember" xlink:to="lbl_AcquisitionsMember_labels" xlink:type="arc"/>
      <link:label id="id_7f5f8169" xlink:label="lbl_AcquisitionsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions</link:label>
      <link:label id="id_415fd821" xlink:label="lbl_DivestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Divestments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsMember" xlink:label="lbl_DivestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DivestmentsMember" xlink:to="lbl_DivestmentsMember_labels" xlink:type="arc"/>
      <link:label id="id_7b19873c" xlink:label="lbl_DivestmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Divestments</link:label>
      <link:label id="id_177d8886" xlink:label="lbl_OtherAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial and other assets including deferred tax assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherAssetsMember" xlink:label="lbl_OtherAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherAssetsMember" xlink:to="lbl_OtherAssetsMember_labels" xlink:type="arc"/>
      <link:label id="id_fdd065b" xlink:label="lbl_OtherAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other assets [member]</link:label>
      <link:label id="id_7f9f59b1" xlink:label="lbl_OtherIntangibleAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
      <link:label id="id_1a3864c5" xlink:label="lbl_TechnologybasedIntangibleAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Technologies</link:label>
      <link:label id="id_5b13ac00" xlink:label="lbl_BrandNamesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Brand names</link:label>
      <link:label id="id_7d41899d" xlink:label="lbl_InventoriesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
      <link:label id="id_50dd9de4" xlink:label="lbl_CashFlowFromNetIdentifiableAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net identifiable assets (acquired) or divested</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowFromNetIdentifiableAssets" xlink:label="lbl_CashFlowFromNetIdentifiableAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowFromNetIdentifiableAssets" xlink:to="lbl_CashFlowFromNetIdentifiableAssets_labels" xlink:type="arc"/>
      <link:label id="id_4169909f" xlink:label="lbl_CashFlowFromNetIdentifiableAssets_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow) from Net identifiable assets (acquired) or divested</link:label>
      <link:label id="id_6da3acb5" xlink:label="lbl_CashInflowOutflowCurrencyTranslationEffects_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow), currency translation effects</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowCurrencyTranslationEffects" xlink:label="lbl_CashInflowOutflowCurrencyTranslationEffects" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowCurrencyTranslationEffects" xlink:to="lbl_CashInflowOutflowCurrencyTranslationEffects_labels" xlink:type="arc"/>
      <link:label id="id_28a59cd9" xlink:label="lbl_CashInflowOutflowCurrencyTranslationEffects_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_6046e1a8" xlink:label="lbl_CashInflowOutflowCurrencyTranslationEffects_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_4ec913e7" xlink:label="lbl_CashInflowOutflowAcquiredDivestedLiquity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow), acquired/(divested) liquity</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowAcquiredDivestedLiquity" xlink:label="lbl_CashInflowOutflowAcquiredDivestedLiquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowAcquiredDivestedLiquity" xlink:to="lbl_CashInflowOutflowAcquiredDivestedLiquity_labels" xlink:type="arc"/>
      <link:label id="id_470c377e" xlink:label="lbl_CashInflowOutflowAcquiredDivestedLiquity_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired/(divested) liquity</link:label>
      <link:label id="id_50fcd8ec" xlink:label="lbl_CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subtotal</link:label>
      <link:label id="id_51ec5468" xlink:label="lbl_CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow) from Net identifiable assets (acquired) or divested, currency translation effects, Acquired/(divested) liquidity and fair value of previously held equity interests.</link:label>
      <link:label id="id_33a842e" xlink:label="lbl_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash provided by refinancing of intercompany financial debt, net</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet" xlink:label="lbl_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet" xlink:to="lbl_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet_labels" xlink:type="arc"/>
      <link:label id="id_cbc3f6c" xlink:label="lbl_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Refinancing of intercompany financial debt, net</link:label>
      <link:label id="id_2f2298e2" xlink:label="lbl_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash provided by refinancing of intercompany financial debt, net.</link:label>
      <link:label id="id_7e82bd81" xlink:label="lbl_CashInflowOutflowGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow), Goodwill</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowGoodwill" xlink:label="lbl_CashInflowOutflowGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowGoodwill" xlink:to="lbl_CashInflowOutflowGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_3c41ff79" xlink:label="lbl_CashInflowOutflowGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
      <link:label id="id_4f404f29" xlink:label="lbl_label1329614633" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Divestment gain</link:label>
      <link:label id="id_250b8244" xlink:label="lbl_label621511236" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow), Divestment gain (loss)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowDivestmentGainLoss" xlink:label="lbl_CashInflowOutflowDivestmentGainLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowDivestmentGainLoss" xlink:to="lbl_label621511236" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowDivestmentGainLoss" xlink:to="lbl_label1329614633" xlink:type="arc"/>
      <link:label id="id_48ec9225" xlink:label="lbl_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes paid and other portfolio transformation related cash flows</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows" xlink:label="lbl_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows" xlink:to="lbl_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows_labels" xlink:type="arc"/>
      <link:label id="id_69b7f35f" xlink:label="lbl_label1773663071" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables and payables contingent consideration, net</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReceivablesAndPayablesContingentConsiderationNet" xlink:label="lbl_ReceivablesAndPayablesContingentConsiderationNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReceivablesAndPayablesContingentConsiderationNet" xlink:to="lbl_label1773663071" xlink:type="arc"/>
      <link:label id="id_66ca8618" xlink:label="lbl_OtherPaymentsAndDeferredConsiderationNet_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other payments and deferred consideration, net</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPaymentsAndDeferredConsiderationNet" xlink:label="lbl_OtherPaymentsAndDeferredConsiderationNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherPaymentsAndDeferredConsiderationNet" xlink:to="lbl_OtherPaymentsAndDeferredConsiderationNet_labels" xlink:type="arc"/>
      <link:label id="id_7403ad6c" xlink:label="lbl_DeferredPrepaidPortionOfSalesPrice_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">(Deferred)/prepaid portion of sales price</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredPrepaidPortionOfSalesPrice" xlink:label="lbl_DeferredPrepaidPortionOfSalesPrice" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredPrepaidPortionOfSalesPrice" xlink:to="lbl_DeferredPrepaidPortionOfSalesPrice_labels" xlink:type="arc"/>
      <link:label id="id_7290427c" xlink:label="lbl_DeferredPrepaidPortionOfSalesPrice_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">(Deferred)/prepaid portion of sales price to cash flows (used in) provided by acquisitions/divestments of businesses.</link:label>
      <link:label id="id_55c25b5" xlink:label="lbl_label1423033786" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows</link:label>
      <link:label id="id_35ffff76" xlink:label="lbl_label905969526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration paid</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPaid" xlink:label="lbl_ContingentConsiderationPaid" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationPaid" xlink:to="lbl_label905969526" xlink:type="arc"/>
      <link:label id="id_344a7417" xlink:label="lbl_label877294615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="lbl_BusinessCombinationsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BusinessCombinationsAxis" xlink:to="lbl_label877294615" xlink:type="arc"/>
      <link:label id="id_2a937996" xlink:label="lbl_label714307990" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for business combinations [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntitysTotalForBusinessCombinationsMember" xlink:to="lbl_label714307990" xlink:type="arc"/>
      <link:label id="id_e12f433" xlink:label="lbl_Change25BasisPointMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change, 25 basis point [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Change25BasisPointMember" xlink:label="lbl_Change25BasisPointMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Change25BasisPointMember" xlink:to="lbl_Change25BasisPointMember_labels" xlink:type="arc"/>
      <link:label id="id_a3f5c53" xlink:label="lbl_Change25BasisPointMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">25 basis point change</link:label>
      <link:label id="id_375463d0" xlink:label="lbl_label928277456" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends payable, amount per share</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendsPayableAmountPerShare" xlink:label="lbl_DividendsPayableAmountPerShare" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsPayableAmountPerShare" xlink:to="lbl_label928277456" xlink:type="arc"/>
      <link:label id="id_43bd571e" xlink:label="lbl_label1136482078" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares acquired to be held</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeHeld" xlink:label="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesAcquiredToBeHeld" xlink:to="lbl_label1136482078" xlink:type="arc"/>
      <link:label id="id_57fc5a54" xlink:label="lbl_TreasurySharesAcquiredToBeCancelled_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares acquired to be cancelled</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeCancelled" xlink:label="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesAcquiredToBeCancelled" xlink:to="lbl_TreasurySharesAcquiredToBeCancelled_labels" xlink:type="arc"/>
      <link:label id="id_324c0bd9" xlink:label="lbl_label843844569" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other share purchases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherSharePurchases" xlink:label="lbl_OtherSharePurchases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherSharePurchases" xlink:to="lbl_label843844569" xlink:type="arc"/>
      <link:label id="id_4ae190e3" xlink:label="lbl_SharepurchaseOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-purchase of treasury shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharepurchaseOfTreasuryShares" xlink:label="lbl_SharepurchaseOfTreasuryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharepurchaseOfTreasuryShares" xlink:to="lbl_SharepurchaseOfTreasuryShares_labels" xlink:type="arc"/>
      <link:label id="id_191f6daa" xlink:label="lbl_label421490090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares acquired to be held, equity impact</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeHeldValue" xlink:label="lbl_TreasurySharesAcquiredToBeHeldValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesAcquiredToBeHeldValue" xlink:to="lbl_label421490090" xlink:type="arc"/>
      <link:label id="id_3ea88f28" xlink:label="lbl_TreasurySharesAcquiredForCancellationValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares acquired for cancellation, equity impact</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredForCancellationValue" xlink:label="lbl_TreasurySharesAcquiredForCancellationValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesAcquiredForCancellationValue" xlink:to="lbl_TreasurySharesAcquiredForCancellationValue_labels" xlink:type="arc"/>
      <link:label id="id_6fbbc8cc" xlink:label="lbl_OtherSharePurchasesValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other share purchases, equity impact</link:label>
      <link:label id="id_5d0bb4f" xlink:label="lbl_label97565519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_label97565519" xlink:type="arc"/>
      <link:label id="id_663e6f69" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in consolidated statements of comprehensive income [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1fe06852" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in consolidated statements of comprehensive income</link:label>
      <link:label id="id_72bd6f82" xlink:label="lbl_ScheduleOfComprehensiveIncomeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of comprehensive income [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfComprehensiveIncomeTableTextBlock" xlink:label="lbl_ScheduleOfComprehensiveIncomeTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfComprehensiveIncomeTableTextBlock" xlink:to="lbl_ScheduleOfComprehensiveIncomeTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3ec5912e" xlink:label="lbl_ScheduleOfComprehensiveIncomeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
      <link:label id="id_72f6c7af" xlink:label="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of share value adjustments currency translation effects [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" xlink:label="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" xlink:to="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_570bfee5" xlink:label="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of share value adjustments currency translation effects</link:label>
      <link:label id="id_55c48a63" xlink:label="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments financial instruments reconciliation [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" xlink:label="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" xlink:to="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_b6f9702" xlink:label="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments financial instruments reconciliation</link:label>
      <link:label id="id_56e22f6a" xlink:label="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of defined benefit plan amounts recognized in other comprehensive income [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" xlink:label="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" xlink:to="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_8052d36" xlink:label="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of defined benefit plan amounts recognized in other comprehensive income</link:label>
      <link:label id="id_639839a6" xlink:label="lbl_label1670920614" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_label1670920614" xlink:type="arc"/>
      <link:label id="id_46f3d26a" xlink:label="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_3abc74f9" xlink:label="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-based participation plans for associates</link:label>
      <link:label id="id_36b95a30" xlink:label="lbl_label918116912" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_label918116912" xlink:type="arc"/>
      <link:label id="id_4f551c1c" xlink:label="lbl_DisclosureOfRelatedPartyExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of related party [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="lbl_DisclosureOfRelatedPartyExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfRelatedPartyExplanatory" xlink:to="lbl_DisclosureOfRelatedPartyExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_2142f37a" xlink:label="lbl_DisclosureOfRelatedPartyExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transactions with related parties</link:label>
      <link:label id="id_21a37a9f" xlink:label="lbl_DisclosureOfEmployeeBenefitsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-employment benefits for associates</link:label>
      <link:label id="id_250e99ed" xlink:label="lbl_OfficerAndDirectorCompensationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Officer and director compensation [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OfficerAndDirectorCompensationTableTextBlock" xlink:label="lbl_OfficerAndDirectorCompensationTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OfficerAndDirectorCompensationTableTextBlock" xlink:to="lbl_OfficerAndDirectorCompensationTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_30161311" xlink:label="lbl_OfficerAndDirectorCompensationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Officers and Non-Executive Directors Compensation</link:label>
      <link:label id="id_332db2e6" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_5ba16f3" xlink:label="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of range of exercise prices of outstanding share options [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:to="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_23eec797" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of unvested restricted stock units roll forward [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4f141a24" xlink:label="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of share-based compensation, activity [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:label="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:to="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2cdc96dc" xlink:label="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of share-based compensation, activity</link:label>
      <link:label id="id_5c5154d5" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of unvested restricted stock units roll forward</link:label>
      <link:label id="id_44099e5b" xlink:label="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of range of exercise prices of outstanding share options</link:label>
      <link:label id="id_2a634859" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options</link:label>
      <link:label id="id_2b301a02" xlink:label="lbl_label724572674" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_label724572674" xlink:type="arc"/>
      <link:label id="id_499d66e9" xlink:label="lbl_label1235052265" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_label1235052265" xlink:type="arc"/>
      <link:label id="id_4bff5af2" xlink:label="lbl_label1275026162" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of related parties [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_label1275026162" xlink:type="arc"/>
      <link:label id="id_4175504c" xlink:label="lbl_label1098207308" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for related parties [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_label1098207308" xlink:type="arc"/>
      <link:label id="id_52e5607c" xlink:label="lbl_label1390764156" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel of entity or parent [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_label1390764156" xlink:type="arc"/>
      <link:label id="id_51571277" xlink:label="lbl_label1364660855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Executive Director [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonExecutiveDirectorMember" xlink:label="lbl_NonExecutiveDirectorMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonExecutiveDirectorMember" xlink:to="lbl_label1364660855" xlink:type="arc"/>
      <link:label id="id_77564460" xlink:label="lbl_label2002142304" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associates [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_label2002142304" xlink:type="arc"/>
      <link:label id="id_7f01623c" xlink:label="lbl_label2130797116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for associates [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_label2130797116" xlink:type="arc"/>
      <link:label id="id_2d55a2fa" xlink:label="lbl_RocheHoldingAGMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Roche Holding AG [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RocheHoldingAGMember" xlink:to="lbl_RocheHoldingAGMember_labels" xlink:type="arc"/>
      <link:label id="id_102c1151" xlink:label="lbl_label271323473" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Products and services [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_label271323473" xlink:type="arc"/>
      <link:label id="id_7a1d10b6" xlink:label="lbl_label2048725174" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Products and services [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_label2048725174" xlink:type="arc"/>
      <link:label id="id_4b6874" xlink:label="lbl_label4941940" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lucentis [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LucentisMember" xlink:to="lbl_label4941940" xlink:type="arc"/>
      <link:label id="id_4da120c0" xlink:label="lbl_label1302405312" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Xolair [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_XolairMember" xlink:to="lbl_label1302405312" xlink:type="arc"/>
      <link:label id="id_40080a70" xlink:label="lbl_label1074268784" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of voting rights held in associate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInAssociate" xlink:label="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:to="lbl_label1074268784" xlink:type="arc"/>
      <link:label id="id_4fef4e77" xlink:label="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net expense, royalties cost sharing and profit sharing</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:label="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:to="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing_labels" xlink:type="arc"/>
      <link:label id="id_5866119e" xlink:label="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, post-employment benefits</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits_labels" xlink:type="arc"/>
      <link:label id="id_32134034" xlink:label="lbl_KeyManagementPersonnelCompensationSharebasedPayment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, share-based payment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="lbl_KeyManagementPersonnelCompensationSharebasedPayment_labels" xlink:type="arc"/>
      <link:label id="id_40914b3d" xlink:label="lbl_KeyManagementPersonnelCompensation_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="lbl_KeyManagementPersonnelCompensation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensation" xlink:to="lbl_KeyManagementPersonnelCompensation_labels" xlink:type="arc"/>
      <link:label id="id_34c1eea8" xlink:label="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-employment benefits</link:label>
      <link:label id="id_24fee3be" xlink:label="lbl_KeyManagementPersonnelCompensationSharebasedPayment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-based compensation</link:label>
      <link:label id="id_5994538d" xlink:label="lbl_KeyManagementPersonnelCompensation_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
      <link:label id="id_a202e7c" xlink:label="lbl_label169881212" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genentech, Inc., USA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GenentechInc.USAMember" xlink:label="lbl_GenentechInc.USAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GenentechInc.USAMember" xlink:to="lbl_label169881212" xlink:type="arc"/>
      <link:label id="id_3ecec9c1" xlink:label="lbl_label1053739457" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prof. Dr. Brody [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfDrBrodyMember" xlink:label="lbl_ProfDrBrodyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfDrBrodyMember" xlink:to="lbl_label1053739457" xlink:type="arc"/>
      <link:label id="id_60abf97a" xlink:label="lbl_label1621883258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prof. Dr. Zinkernagel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfDrZinkernagelMember" xlink:label="lbl_ProfDrZinkernagelMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfDrZinkernagelMember" xlink:to="lbl_label1621883258" xlink:type="arc"/>
      <link:label id="id_707fbae9" xlink:label="lbl_label1887419113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. Alex Krauer [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrAlexKrauerMember" xlink:label="lbl_DrAlexKrauerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DrAlexKrauerMember" xlink:to="lbl_label1887419113" xlink:type="arc"/>
      <link:label id="id_5f1c0cdd" xlink:label="lbl_label1595673821" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. Daniel Vasella [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrDanielVasellaMember" xlink:label="lbl_DrDanielVasellaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DrDanielVasellaMember" xlink:to="lbl_label1595673821" xlink:type="arc"/>
      <link:label id="id_49199deb" xlink:label="lbl_label1226415595" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. James Bradner [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrJamesBradnerMember" xlink:label="lbl_DrJamesBradnerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DrJamesBradnerMember" xlink:to="lbl_label1226415595" xlink:type="arc"/>
      <link:label id="id_12139c9c" xlink:label="lbl_label303275164" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, daily rate</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationDailyRate" xlink:label="lbl_KeyManagementPersonnelCompensationDailyRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationDailyRate" xlink:to="lbl_label303275164" xlink:type="arc"/>
      <link:label id="id_34648bf4" xlink:label="lbl_label879004660" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, annual guaranteed minimum</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:label="lbl_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:to="lbl_label879004660" xlink:type="arc"/>
      <link:label id="id_475cd1c7" xlink:label="lbl_label1197265351" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, shares acquired</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationSharesAcquired" xlink:label="lbl_KeyManagementPersonnelCompensationSharesAcquired" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationSharesAcquired" xlink:to="lbl_label1197265351" xlink:type="arc"/>
      <link:label id="id_7d46110e" xlink:label="lbl_label2101743886" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, ownership interest acquired</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:label="lbl_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:to="lbl_label2101743886" xlink:type="arc"/>
      <link:label id="id_41061f2c" xlink:label="lbl_label1090920236" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in consolidated statements of comprehensive income [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_label1090920236" xlink:type="arc"/>
      <link:label id="id_2d82d11f" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments on marketable securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:to="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember_labels" xlink:type="arc"/>
      <link:label id="id_2c74381f" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on marketable securities</link:label>
      <link:label id="id_1315ebbc" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments on deferred cash flow hedges [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:to="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember_labels" xlink:type="arc"/>
      <link:label id="id_2feb765f" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on deferred cash flow hedges</link:label>
      <link:label id="id_41098a9f" xlink:label="lbl_ActuarialLossesFromDefinedBenefitPlansMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains/losses from defined benefit plans [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialLossesFromDefinedBenefitPlansMember" xlink:label="lbl_ActuarialLossesFromDefinedBenefitPlansMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialLossesFromDefinedBenefitPlansMember" xlink:to="lbl_ActuarialLossesFromDefinedBenefitPlansMember_labels" xlink:type="arc"/>
      <link:label id="id_66cb76c9" xlink:label="lbl_ActuarialLossesFromDefinedBenefitPlansMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gains/losses from defined benefit plans</link:label>
      <link:label id="id_2dc02a48" xlink:label="lbl_CumulativeCurrencyTranslationEffectsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative currency translation effects [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationEffectsMember" xlink:label="lbl_CumulativeCurrencyTranslationEffectsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CumulativeCurrencyTranslationEffectsMember" xlink:to="lbl_CumulativeCurrencyTranslationEffectsMember_labels" xlink:type="arc"/>
      <link:label id="id_167b29ff" xlink:label="lbl_CumulativeCurrencyTranslationEffectsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative currency translation effects</link:label>
      <link:label id="id_23f99baf" xlink:label="lbl_label603560879" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in consolidated statements of comprehensive income [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_label603560879" xlink:type="arc"/>
      <link:label id="id_525fbfa4" xlink:label="lbl_label98094011" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Value adjustments on comprehensive income at end of period</link:label>
      <link:label id="id_5f2ad26f" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net actuarial gains/losses from defined benefit plans</link:label>
      <link:label id="id_56084e2" xlink:label="lbl_label492438188" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total value adjustments</link:label>
      <link:label id="id_4f1abe21" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on financial instruments</link:label>
      <link:label id="id_44ea9064" xlink:label="lbl_label521267934" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale financial investments</link:label>
      <link:label id="id_172d7365" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities</link:label>
      <link:label id="id_1d877185" xlink:label="lbl_GainLossOnSaleOfMarketableInvestments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) on sale of marketable investments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfMarketableInvestments" xlink:label="lbl_GainLossOnSaleOfMarketableInvestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainLossOnSaleOfMarketableInvestments" xlink:to="lbl_GainLossOnSaleOfMarketableInvestments_labels" xlink:type="arc"/>
      <link:label id="id_67ba82da" xlink:label="lbl_GainLossOnSaleOfMarketableInvestments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities sold</link:label>
      <link:label id="id_2adbb944" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (loss) on sale of other financial assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfOtherFinancialAssets" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:to="lbl_GainLossOnSaleOfOtherFinancialAssets_labels" xlink:type="arc"/>
      <link:label id="id_24c923e8" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial assets sold</link:label>
      <link:label id="id_334897f4" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments during the year</link:label>
      <link:label id="id_36328be7" xlink:label="lbl_label909282279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remeasurements from defined benefit plans [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:label="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_label909282279" xlink:type="arc"/>
      <link:label id="id_598b1d0a" xlink:label="lbl_label1502289162" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_label1502289162" xlink:type="arc"/>
      <link:label id="id_42afb056" xlink:label="lbl_label1118810198" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_label1118810198" xlink:type="arc"/>
      <link:label id="id_4854e53b" xlink:label="lbl_GoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GoodwillMember" xlink:to="lbl_GoodwillMember_labels" xlink:type="arc"/>
      <link:label id="id_5a809ba7" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets other than Goodwill</link:label>
      <link:label id="id_6fcb9ca9" xlink:label="lbl_GoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
      <link:label id="id_789924e3" xlink:label="lbl_CurrentlyMarketedProductsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currently marketed products</link:label>
      <link:label id="id_6768eaf7" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketing know-how</link:label>
      <link:label id="id_1878d8ce" xlink:label="lbl_label410573006" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_label410573006" xlink:type="arc"/>
      <link:label id="id_5927b5e9" xlink:label="lbl_IntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IntangibleAssetsAndGoodwill" xlink:to="lbl_IntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_7c0ed12" xlink:label="lbl_IntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill at beginning of period</link:label>
      <link:label id="id_747bc8d6" xlink:label="lbl_IntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill at end of period</link:label>
      <link:label id="id_4eee4a8f" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_4295643b" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_fd8bae8" xlink:label="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers, intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:label="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:to="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_2975d791" xlink:label="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
      <link:label id="id_37bb77c5" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_31d55821" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
      <link:label id="id_4b244fff" xlink:label="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals and retirements, intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:label="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:to="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_c2fe7ed" xlink:label="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals and derecognitions</link:label>
      <link:label id="id_13c2a444" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_7e269b8c" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_3f53b387" xlink:label="lbl_AmortisationIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation, intangible assets other than goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="lbl_AmortisationIntangibleAssetsOtherThanGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_6e93cf7f" xlink:label="lbl_AmortisationIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization charge</link:label>
      <link:label id="id_4895c20f" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_31bd23bf" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charge</link:label>
      <link:label id="id_4c0505b8" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_3a8c745b" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of impairment charge</link:label>
      <link:label id="id_46823638" xlink:label="lbl_IntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net book value</link:label>
      <link:label id="id_71feba23" xlink:label="lbl_label1912519203" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment consolidation items [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_label1912519203" xlink:type="arc"/>
      <link:label id="id_76bd9383" xlink:label="lbl_label1992135555" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity's total for segment consolidation items [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_label1992135555" xlink:type="arc"/>
      <link:label id="id_e23d9e6" xlink:label="lbl_label237230566" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating segments [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OperatingSegmentsMember" xlink:to="lbl_label237230566" xlink:type="arc"/>
      <link:label id="id_4e99f014" xlink:label="lbl_InnovativeMedicinesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Innovative Medicines [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InnovativeMedicinesMember" xlink:to="lbl_InnovativeMedicinesMember_labels" xlink:type="arc"/>
      <link:label id="id_5cce9bca" xlink:label="lbl_InnovativeMedicinesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Innovative Medicines</link:label>
      <link:label id="id_62947297" xlink:label="lbl_SandozMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozMember" xlink:to="lbl_SandozMember_labels" xlink:type="arc"/>
      <link:label id="id_2d171b79" xlink:label="lbl_SandozMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sandoz</link:label>
      <link:label id="id_19f7b763" xlink:label="lbl_AlconMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconMember" xlink:to="lbl_AlconMember_labels" xlink:type="arc"/>
      <link:label id="id_82cbe5b" xlink:label="lbl_AlconMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alcon</link:label>
      <link:label id="id_40af0c2d" xlink:label="lbl_label1085213741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unallocated amounts [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnallocatedAmountsMember" xlink:to="lbl_label1085213741" xlink:type="arc"/>
      <link:label id="id_2f427f57" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Growth rate used to extrapolate cash flow projections</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:to="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_labels" xlink:type="arc"/>
      <link:label id="id_1f6b21d" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Terminal Growth Rate</link:label>
      <link:label id="id_6e31860b" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discount rate used in current measurement of fair value less costs of disposal</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:to="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal_labels" xlink:type="arc"/>
      <link:label id="id_59daa167" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate (post-tax)</link:label>
      <link:label id="id_32f31c92" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_6067b5a3" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible asset impairment charges</link:label>
      <link:label id="id_6697be1e" xlink:label="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of justification for using growth rate that exceeds long-term average growth rate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:label="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:to="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate_labels" xlink:type="arc"/>
      <link:label id="id_576cfb66" xlink:label="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of growth rate</link:label>
      <link:label id="id_645c105b" xlink:label="lbl_label1683755099" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_label1683755099" xlink:type="arc"/>
      <link:label id="id_86ca8ac" xlink:label="lbl_label141338796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_label141338796" xlink:type="arc"/>
      <link:label id="id_3cced209" xlink:label="lbl_label1020187145" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_label1020187145" xlink:type="arc"/>
      <link:label id="id_b0eee5a" xlink:label="lbl_label185527898" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based payment arrangements [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_label185527898" xlink:type="arc"/>
      <link:label id="id_7bf97c21" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Annual Incentive Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationAnnualIncentivePlanMember" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:to="lbl_EquityBasedParticipationAnnualIncentivePlanMember_labels" xlink:type="arc"/>
      <link:label id="id_2ae4d862" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Share Savings Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationShareSavingsPlanMember_labels" xlink:type="arc"/>
      <link:label id="id_6fae6c02" xlink:label="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Leveraged Share Savings Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember_labels" xlink:type="arc"/>
      <link:label id="id_4b1054ab" xlink:label="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Employee Share Ownership Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:label="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:to="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember_labels" xlink:type="arc"/>
      <link:label id="id_28d147a5" xlink:label="lbl_EquityBasedParticipationUKShareSavingsPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation UK Share Savings Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationUKShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationUKShareSavingsPlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationUKShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationUKShareSavingsPlanMember_labels" xlink:type="arc"/>
      <link:label id="id_43a6ccb8" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Novartis Equity Plan "Select" [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember_labels" xlink:type="arc"/>
      <link:label id="id_3073fb0" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Long-Term Performance Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermPerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:to="lbl_EquityBasedParticipationLongTermPerformancePlanMember_labels" xlink:type="arc"/>
      <link:label id="id_547a9da" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Long-Term Relative Performance Plan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:to="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember_labels" xlink:type="arc"/>
      <link:label id="id_1f01ff40" xlink:label="lbl_EquityBasedParticipationSpecialShareAwardsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Special Share Awards [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationSpecialShareAwardsMember" xlink:label="lbl_EquityBasedParticipationSpecialShareAwardsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationSpecialShareAwardsMember" xlink:to="lbl_EquityBasedParticipationSpecialShareAwardsMember_labels" xlink:type="arc"/>
      <link:label id="id_89e9c6a" xlink:label="lbl_label144612458" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:label="lbl_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:to="lbl_label144612458" xlink:type="arc"/>
      <link:label id="id_25616927" xlink:label="lbl_label627140903" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of method of settlement for share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:label="lbl_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement" xlink:to="lbl_label627140903" xlink:type="arc"/>
      <link:label id="id_7e605438" xlink:label="lbl_label2120242232" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of vesting requirements for share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:label="lbl_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement" xlink:to="lbl_label2120242232" xlink:type="arc"/>
      <link:label id="id_73de771d" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities from share-based payment transactions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:to="lbl_LiabilitiesFromSharebasedPaymentTransactions2011_labels" xlink:type="arc"/>
      <link:label id="id_41659fd5" xlink:label="lbl_label1097179093" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_label1097179093" xlink:type="arc"/>
      <link:label id="id_70e32ac1" xlink:label="lbl_label1893935809" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_label1893935809" xlink:type="arc"/>
      <link:label id="id_1e53f765" xlink:label="lbl_NumberOfOutstandingShareOptions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOutstandingShareOptions" xlink:to="lbl_NumberOfOutstandingShareOptions_labels" xlink:type="arc"/>
      <link:label id="id_71aeacaf" xlink:label="lbl_NumberOfOutstandingShareOptions_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of share options outstanding at beginning of period</link:label>
      <link:label id="id_5962c0d" xlink:label="lbl_NumberOfOutstandingShareOptions_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of share options outstanding at end of period</link:label>
      <link:label id="id_7fce5b76" xlink:label="lbl_label2144230262" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_label2144230262" xlink:type="arc"/>
      <link:label id="id_3d4fe5a6" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_labels" xlink:type="arc"/>
      <link:label id="id_18341635" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_labels" xlink:type="arc"/>
      <link:label id="id_1df4b58c" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_labels" xlink:type="arc"/>
      <link:label id="id_4c6be67e" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options exercised or sold</link:label>
      <link:label id="id_476e4360" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options forfeited or expired</link:label>
      <link:label id="id_3c8a636c" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options exercisable</link:label>
      <link:label id="id_18fcb954" xlink:label="lbl_label419215700" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_label419215700" xlink:type="arc"/>
      <link:label id="id_3e8e4697" xlink:label="lbl_label1049511575" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lbl_label1049511575" xlink:type="arc"/>
      <link:label id="id_2cfcdafb" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ranges of exercise prices for outstanding share options [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember_labels" xlink:type="arc"/>
      <link:label id="id_5fb4ce8d" xlink:label="lbl_EquityBasedParticipationRestrictedSharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Restricted Shares [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationRestrictedSharesMember" xlink:label="lbl_EquityBasedParticipationRestrictedSharesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationRestrictedSharesMember" xlink:to="lbl_EquityBasedParticipationRestrictedSharesMember_labels" xlink:type="arc"/>
      <link:label id="id_6a904dd3" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Remeasurements from defined benefit plans, total after tax</link:label>
      <link:label id="id_77782278" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, before taxes, gains (losses) on remeasurements of defined benefit plans</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:type="arc"/>
      <link:label id="id_5e993e53" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension plans before tax</link:label>
      <link:label id="id_70219b11" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, before taxes, gains (losses) on remeasurements of other post-employment benefit plans</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans_labels" xlink:type="arc"/>
      <link:label id="id_24653928" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other post-employment benefit plans before tax</link:label>
      <link:label id="id_2e31d75a" xlink:label="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, gains (losses) on remeasurements of defined and other post-employment benefit plans, taxation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:label="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:to="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation_labels" xlink:type="arc"/>
      <link:label id="id_258900b0" xlink:label="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Taxation on above items</link:label>
      <link:label id="id_7496cde" xlink:label="lbl_label122252510" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, shares acquired, price</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:label="lbl_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:to="lbl_label122252510" xlink:type="arc"/>
      <link:label id="id_77be955a" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value adjustment on comprehensive income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome_labels" xlink:type="arc"/>
      <link:label id="id_19d019b2" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Value adjustments on comprehensive income at beginning of period</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_label98094011" xlink:type="arc"/>
      <link:label id="id_53394b08" xlink:label="lbl_label1396263688" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) on value adjustment on comprehensive income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_label1396263688" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:to="lbl_label492438188" xlink:type="arc"/>
      <link:label id="id_5127c80" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total value adjustments attributable to Novartis shareholders [Member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:to="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember_labels" xlink:type="arc"/>
      <link:label id="id_11f1c5d1" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total value adjustments</link:label>
      <link:label id="id_4fa34414" xlink:label="lbl_label1336099860" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon, Inc., equity plan, converted, Novartis share options [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:label="lbl_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:to="lbl_label1336099860" xlink:type="arc"/>
      <link:label id="id_47c79757" xlink:label="lbl_label1204262743" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon, Inc., equity plan, converted, Share-settled appreciation rights (SSAR) [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:label="lbl_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:to="lbl_label1204262743" xlink:type="arc"/>
      <link:label id="id_5c4a8ca3" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of share options exercised</link:label>
      <link:label id="id_5368a3e4" xlink:label="lbl_label1399366628" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of unvested restricted stock units roll forward [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:to="lbl_label1399366628" xlink:type="arc"/>
      <link:label id="id_54d97aaa" xlink:label="lbl_label1423538858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-vesting [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingAxis" xlink:label="lbl_NonvestingAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonvestingAxis" xlink:to="lbl_label1423538858" xlink:type="arc"/>
      <link:label id="id_129e3bed" xlink:label="lbl_label312359917" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-vesting [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingMember" xlink:label="lbl_NonvestingMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonvestingMember" xlink:to="lbl_label312359917" xlink:type="arc"/>
      <link:label id="id_768fac4" xlink:label="lbl_label124320452" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-vested shares granted [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestedSharesGrantedMember" xlink:label="lbl_NonvestedSharesGrantedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonvestedSharesGrantedMember" xlink:to="lbl_label124320452" xlink:type="arc"/>
      <link:label id="id_2ded6718" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual incentive</link:label>
      <link:label id="id_5e84f23d" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share savings plans</link:label>
      <link:label id="id_47fd4dbd" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Select</link:label>
      <link:label id="id_779d196a" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Performance Plan</link:label>
      <link:label id="id_39c41311" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Relative Performance Plan</link:label>
      <link:label id="id_1cf8204b" xlink:label="lbl_EquityBasedParticipationSpecialShareAwardsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Special share awards</link:label>
      <link:label id="id_4b5d1837" xlink:label="lbl_label679367036" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value at grante date at end of period</link:label>
      <link:label id="id_569121e3" xlink:label="lbl_label1373999706" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested, fair value at grante date</link:label>
      <link:label id="id_6bf6969c" xlink:label="lbl_label766376780" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited, fair value at grante date</link:label>
      <link:label id="id_6a253a0a" xlink:label="lbl_label1695476906" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, fair value at grante date</link:label>
      <link:label id="id_5dafe477" xlink:label="lbl_label1571808375" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_label1571808375" xlink:type="arc"/>
      <link:label id="id_64b72c46" xlink:label="lbl_label1689726022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_label1689726022" xlink:type="arc"/>
      <link:label id="id_195ec04a" xlink:label="lbl_label425640010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_label425640010" xlink:type="arc"/>
      <link:label id="id_776b087e" xlink:label="lbl_label2003503230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material reconciling items [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MaterialReconcilingItemsMember" xlink:to="lbl_label2003503230" xlink:type="arc"/>
      <link:label id="id_13fb62a8" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods, sales to other segments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments_labels" xlink:type="arc"/>
      <link:label id="id_71f1654a" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales to discontinued operations</link:label>
      <link:label id="id_425f6b3f" xlink:label="lbl_label1113549631" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromInterest" xlink:to="lbl_label1113549631" xlink:type="arc"/>
      <link:label id="id_6ed59bdd" xlink:label="lbl_DepreciationAndAmortisationExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and amortisation expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="lbl_DepreciationAndAmortisationExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DepreciationAndAmortisationExpense" xlink:to="lbl_DepreciationAndAmortisationExpense_labels" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:to="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet_labels" xlink:type="arc"/>
      <link:label id="id_60788cbc" xlink:label="lbl_Liabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
      <link:label id="id_2bf65413" xlink:label="lbl_NetOperatingAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net operating assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetOperatingAssets" xlink:label="lbl_NetOperatingAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetOperatingAssets" xlink:to="lbl_NetOperatingAssets_labels" xlink:type="arc"/>
      <link:label id="id_3832e6c2" xlink:label="lbl_NetOperatingAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net operating assets</link:label>
      <link:label id="id_216a6d7c" xlink:label="lbl_PurchaseOfInterestsInAssociates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of interests in associates</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfInterestsInAssociates" xlink:label="lbl_PurchaseOfInterestsInAssociates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseOfInterestsInAssociates" xlink:to="lbl_PurchaseOfInterestsInAssociates_labels" xlink:type="arc"/>
      <link:label id="id_41f96a5e" xlink:label="lbl_PurchaseOfInterestsInAssociates_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions to investment in associated companies</link:label>
      <link:label id="id_5e202521" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, marketable securities, commodities, time deposits and derivative financial instruments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:to="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments_labels" xlink:type="arc"/>
      <link:label id="id_3b72597a" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial debts and derivative instruments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtsAndDerivativeInstruments" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialDebtsAndDerivativeInstruments" xlink:to="lbl_FinancialDebtsAndDerivativeInstruments_labels" xlink:type="arc"/>
      <link:label id="id_6e43b10" xlink:label="lbl_label1241182885" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current income tax and deferred tax liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:label="lbl_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:to="lbl_label1241182885" xlink:type="arc"/>
      <link:label id="id_2c7e10a7" xlink:label="lbl_label102429242" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales (in % of total net sales)</link:label>
      <link:label id="id_7f20a04d" xlink:label="lbl_SelectedNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total of selected non-current assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SelectedNoncurrentAssets" xlink:to="lbl_SelectedNoncurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_615b5ab6" xlink:label="lbl_SelectedNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies</link:label>
      <link:label id="id_46b9a3b0" xlink:label="lbl_label1358337308" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies. As percent of total selected non-current assets.</link:label>
      <link:label id="id_439913bb" xlink:label="lbl_label1134105531" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
      <link:label id="id_557072dd" xlink:label="lbl_label1433432797" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other countries [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCountriesMember" xlink:label="lbl_OtherCountriesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCountriesMember" xlink:to="lbl_label1433432797" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherCountriesMember" xlink:to="lbl_label1134105531" xlink:type="arc"/>
      <link:label id="id_7879a2ba" xlink:label="lbl_label2021237434" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical regions [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_label2021237434" xlink:type="arc"/>
      <link:label id="id_cd118fc" xlink:label="lbl_label215030012" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical regions [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_label215030012" xlink:type="arc"/>
      <link:label id="id_56b7dac7" xlink:label="lbl_label1638353244" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia/Africa/Australasia [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AsiaAfricaAustralasiaMember" xlink:label="lbl_AsiaAfricaAustralasiaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AsiaAfricaAustralasiaMember" xlink:to="lbl_label1638353244" xlink:type="arc"/>
      <link:label id="id_7ec1f871" xlink:label="lbl_label2126641265" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of entity's revenue</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="lbl_PercentageOfEntitysRevenue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfEntitysRevenue" xlink:to="lbl_label2126641265" xlink:type="arc"/>
      <link:label id="id_4a42fa89" xlink:label="lbl_label1245903497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of major customers [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersAbstract" xlink:label="lbl_DisclosureOfMajorCustomersAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMajorCustomersAbstract" xlink:to="lbl_label1245903497" xlink:type="arc"/>
      <link:label id="id_77148ff4" xlink:label="lbl_label1997836276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of major customers [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="lbl_DisclosureOfMajorCustomersTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_label1997836276" xlink:type="arc"/>
      <link:label id="id_3a785089" xlink:label="lbl_label980963465" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of major customers [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_label980963465" xlink:type="arc"/>
      <link:label id="id_7a5a32d3" xlink:label="lbl_label2052731603" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major customers [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="lbl_MajorCustomersAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MajorCustomersAxis" xlink:to="lbl_label2052731603" xlink:type="arc"/>
      <link:label id="id_54ab46d" xlink:label="lbl_label88781933" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customers [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersMember" xlink:label="lbl_MajorCustomersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_label88781933" xlink:type="arc"/>
      <link:label id="id_329eef9f" xlink:label="lbl_label849276831" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Largest customer [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestCustomerMember" xlink:label="lbl_LargestCustomerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LargestCustomerMember" xlink:to="lbl_label849276831" xlink:type="arc"/>
      <link:label id="id_3eacc0a0" xlink:label="lbl_label1051508896" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Second largest customer [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestCustomerMember" xlink:label="lbl_SecondLargestCustomerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SecondLargestCustomerMember" xlink:to="lbl_label1051508896" xlink:type="arc"/>
      <link:label id="id_54e36398" xlink:label="lbl_label1424188312" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Third largest customer [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestCustomerMember" xlink:label="lbl_ThirdLargestCustomerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ThirdLargestCustomerMember" xlink:to="lbl_label1424188312" xlink:type="arc"/>
      <link:label id="id_51bc0ac2" xlink:label="lbl_DisclosureOfEntitysReportableSegmentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of entity's operating segments [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="lbl_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="lbl_DisclosureOfEntitysReportableSegmentsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_76ba88df" xlink:label="lbl_DisclosureOfEntitysReportableSegmentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segmentation of key figures</link:label>
      <link:label id="id_596e3d72" xlink:label="lbl_DisclosureOfOperatingSegmentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="lbl_DisclosureOfOperatingSegmentsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsExplanatory" xlink:to="lbl_DisclosureOfOperatingSegmentsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_3d44b3a2" xlink:label="lbl_DisclosureOfOperatingSegmentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segmentation - Consolidated income statements</link:label>
      <link:label id="id_910173d" xlink:label="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments, balance sheet [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:to="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_f1f9461" xlink:label="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segmentation - Consolidated balance sheets</link:label>
      <link:label id="id_68241853" xlink:label="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments, by countries and regions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:to="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_8ba3eb7" xlink:label="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales and total of selected non-current assets, by countries and regions</link:label>
      <link:label id="id_6d6e90e5" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments, net sales by business franchise [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:to="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_11d66710" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales by business franchise</link:label>
      <link:label id="id_1b7ab5f2" xlink:label="lbl_label461026802" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_label461026802" xlink:type="arc"/>
      <link:label id="id_15494420" xlink:label="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of investments accounted for using equity method [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_2bcfd6a6" xlink:label="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associated companies</link:label>
      <link:label id="id_113707b2" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_38388c12" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to associates</link:label>
      <link:label id="id_27f02648" xlink:label="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates balance sheet [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:label="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:to="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_ebb669f" xlink:label="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to associates, balance sheet value</link:label>
      <link:label id="id_52795c5f" xlink:label="lbl_AssociatesSummarizedFinancialInformationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associates summarized financial information [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:label="lbl_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:to="lbl_AssociatesSummarizedFinancialInformationTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6a736cd0" xlink:label="lbl_PurchasePriceAllocationAssociatesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase price allocation associates [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchasePriceAllocationAssociatesTableTextBlock" xlink:label="lbl_PurchasePriceAllocationAssociatesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchasePriceAllocationAssociatesTableTextBlock" xlink:to="lbl_PurchasePriceAllocationAssociatesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_467a3bcc" xlink:label="lbl_label1182415820" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_label1182415820" xlink:type="arc"/>
      <link:label id="id_3a1d7e" xlink:label="lbl_label3808638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_label3808638" xlink:type="arc"/>
      <link:label id="id_6360193f" xlink:label="lbl_RocheHoldingAGMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Roche Holding AG, Switzerland</link:label>
      <link:label id="id_5e0c8ce9" xlink:label="lbl_label1577880809" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK</link:label>
      <link:label id="id_197b34b2" xlink:label="lbl_label427504818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GlaxoSmithKline Consumer Healthcare Holdings Ltd. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:to="lbl_label427504818" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:to="lbl_label1577880809" xlink:type="arc"/>
      <link:label id="id_49715fd2" xlink:label="lbl_OthersAssociatesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Others associates [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OthersAssociatesMember" xlink:to="lbl_OthersAssociatesMember_labels" xlink:type="arc"/>
      <link:label id="id_4dbe4327" xlink:label="lbl_OthersAssociatesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Others</link:label>
      <link:label id="id_54a1c758" xlink:label="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share of total comprehensive income of associates and joint ventures accounted for using equity method</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:type="arc"/>
      <link:label id="id_33c07958" xlink:label="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income effect</link:label>
      <link:label id="id_4b6b0442" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Balance sheet value</link:label>
      <link:label id="id_2f5ba89e" xlink:label="lbl_label794536094" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proportion of ownership interest in associate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="lbl_ProportionOfOwnershipInterestInAssociate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProportionOfOwnershipInterestInAssociate" xlink:to="lbl_label794536094" xlink:type="arc"/>
      <link:label id="id_5dfb85ae" xlink:label="lbl_label1576764846" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends received</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="lbl_DividendsReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsReceived" xlink:to="lbl_label1576764846" xlink:type="arc"/>
      <link:label id="id_404e569d" xlink:label="lbl_label1078875805" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associates summarized financial information [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatesSummarizedFinancialInformationTable" xlink:label="lbl_AssociatesSummarizedFinancialInformationTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssociatesSummarizedFinancialInformationTable" xlink:to="lbl_label1078875805" xlink:type="arc"/>
      <link:label id="id_53734bbc" xlink:label="lbl_label1400064956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase price allocation associates [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchasePriceAllocationAssociatesTable" xlink:label="lbl_PurchasePriceAllocationAssociatesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchasePriceAllocationAssociatesTable" xlink:to="lbl_label1400064956" xlink:type="arc"/>
      <link:label id="id_6e7640ef" xlink:label="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revaluation increase (decrease), intangible assets other than goodwil</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:to="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_20824625" xlink:label="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novartis share of re-appraised intangible assets</link:label>
      <link:label id="id_3ec70a2" xlink:label="lbl_AdditionalRecognitionGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Implicit Novartis goodwill</link:label>
      <link:label id="id_2f773be1" xlink:label="lbl_ShareOfEstimatedNetAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share of estimated net assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareOfEstimatedNetAssets" xlink:label="lbl_ShareOfEstimatedNetAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShareOfEstimatedNetAssets" xlink:to="lbl_ShareOfEstimatedNetAssets_labels" xlink:type="arc"/>
      <link:label id="id_7ae8d097" xlink:label="lbl_ShareOfEstimatedNetAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Novartis share of estimated net assets</link:label>
      <link:label id="id_df32051" xlink:label="lbl_label234037329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current value of share in net identifiable assets and goodwill</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:label="lbl_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:to="lbl_label234037329" xlink:type="arc"/>
      <link:label id="id_2274c64a" xlink:label="lbl_label578078282" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated equity accounting adjustments and translation effects less dividends received</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:label="lbl_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:to="lbl_label578078282" xlink:type="arc"/>
      <link:label id="id_4dcb8141" xlink:label="lbl_label1305182529" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated income statement effects [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementEffectsTable" xlink:label="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:to="lbl_label1305182529" xlink:type="arc"/>
      <link:label id="id_139af9b9" xlink:label="lbl_label328923577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis share of current year consolidated net income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareOfCurrentYearNetIncome" xlink:label="lbl_ShareOfCurrentYearNetIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShareOfCurrentYearNetIncome" xlink:to="lbl_label328923577" xlink:type="arc"/>
      <link:label id="id_9a810fe" xlink:label="lbl_label162009342" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior year adjustment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PriorYearAdjustment" xlink:label="lbl_PriorYearAdjustment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PriorYearAdjustment" xlink:to="lbl_label162009342" xlink:type="arc"/>
      <link:label id="id_78fa72de" xlink:label="lbl_label2029679326" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of fair value adjustments relating to intangible assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:label="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:to="lbl_label2029679326" xlink:type="arc"/>
      <link:label id="id_691026f" xlink:label="lbl_label110166639" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes on Amortization of fair value adjustments relating to intangible assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:label="lbl_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:to="lbl_label110166639" xlink:type="arc"/>
      <link:label id="id_7f5dcb1f" xlink:label="lbl_label2136853279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about provisions and non-current liabilities [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_label2136853279" xlink:type="arc"/>
      <link:label id="id_ff7eee9" xlink:label="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions, contingent liabilities and contingent assets [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:label="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:to="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_3d543140" xlink:label="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and other non-current liabilities</link:label>
      <link:label id="id_55d4757f" xlink:label="lbl_label1439987071" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:label="lbl_DisclosureOfOtherProvisionsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherProvisionsExplanatory" xlink:to="lbl_label1439987071" xlink:type="arc"/>
      <link:label id="id_5b6a3526" xlink:label="lbl_label1533687078" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForEnvironmentalLossContingenciesTableTextBlock" xlink:label="lbl_AccrualForEnvironmentalLossContingenciesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccrualForEnvironmentalLossContingenciesTableTextBlock" xlink:to="lbl_label1533687078" xlink:type="arc"/>
      <link:label id="id_60a92ef1" xlink:label="lbl_label1621700337" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies, fiscal year maturity [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" xlink:label="lbl_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" xlink:to="lbl_label1621700337" xlink:type="arc"/>
      <link:label id="id_345b34eb" xlink:label="lbl_label878392555" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for product liabilities government investigations other legal matters loss contingencies [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" xlink:label="lbl_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" xlink:to="lbl_label878392555" xlink:type="arc"/>
      <link:label id="id_48374a1f" xlink:label="lbl_label1211583007" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_label1211583007" xlink:type="arc"/>
      <link:label id="id_31459c86" xlink:label="lbl_label826645638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other provisions [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_label826645638" xlink:type="arc"/>
      <link:label id="id_2ad08cd6" xlink:label="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current net defined benefit liability</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:to="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_labels" xlink:type="arc"/>
      <link:label id="id_7487a2cd" xlink:label="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension plans</link:label>
      <link:label id="id_74710a33" xlink:label="lbl_label1953565235" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other long-term employee benefits and deferred compensation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:label="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:to="lbl_label1953565235" xlink:type="arc"/>
      <link:label id="id_26d5ce13" xlink:label="lbl_label651546131" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other post-employment benefits</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefits" xlink:label="lbl_OtherPostemploymentBenefits" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherPostemploymentBenefits" xlink:to="lbl_label651546131" xlink:type="arc"/>
      <link:label id="id_70976fa3" xlink:label="lbl_label304425068" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental remediation provisions, non-current</link:label>
      <link:label id="id_5e14a65" xlink:label="lbl_label98650725" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration</link:label>
      <link:label id="id_5b8272ec" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total provisions and other non-current liabilities</link:label>
      <link:label id="id_5ed0917e" xlink:label="lbl_label1590727038" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental provision [roll forward]</link:label>
      <link:label id="id_6aa8f98d" xlink:label="lbl_label448335871" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
      <link:label id="id_70108f36" xlink:label="lbl_label2143979670" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Releases</link:label>
      <link:label id="id_52a74241" xlink:label="lbl_label1560928630" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
      <link:label id="id_57e9d2a0" xlink:label="lbl_label42481781" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_5d09f298" xlink:label="lbl_label1902698328" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current provision</link:label>
      <link:label id="id_6048622c" xlink:label="lbl_label1615356460" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental provision, fiscal year maturity [abstract]</link:label>
      <link:label id="id_f98ea01" xlink:label="lbl_label1750372676" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total environmental remediation liability provisions</link:label>
      <link:label id="id_2ccb9fb2" xlink:label="lbl_label1351152500" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due within two years</link:label>
      <link:label id="id_78ad40b" xlink:label="lbl_label771700847" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due later than two years, but within five years</link:label>
      <link:label id="id_7cc5fad5" xlink:label="lbl_label1968177093" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due later than five years, but within ten years</link:label>
      <link:label id="id_6e61547b" xlink:label="lbl_label757561900" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due after ten years</link:label>
      <link:label id="id_4bc380f7" xlink:label="lbl_label1271103735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions [roll forward]</link:label>
      <link:label id="id_68422c0a" xlink:label="lbl_label1583004694" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions related to discontinued operations</link:label>
      <link:label id="id_efc629e" xlink:label="lbl_label1339267684" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
      <link:label id="id_6285ec7c" xlink:label="lbl_label1568927014" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Releases</link:label>
      <link:label id="id_3f37b15b" xlink:label="lbl_label1379712140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
      <link:label id="id_50e2f2bd" xlink:label="lbl_label1424862979" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_73b301e7" xlink:label="lbl_label252843510" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Product liabilities government investigations other legal matters provisions at end of period</link:label>
      <link:label id="id_29a7abc" xlink:label="lbl_label438797926" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current provision</link:label>
      <link:label id="id_2ace6c03" xlink:label="lbl_label1363494370" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Non-current product liabilities, governmental investigations and other legal matters provisions at end of period</link:label>
      <link:label id="id_39eddf10" xlink:label="lbl_label971890448" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal proceedings provision [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsProvisionMember" xlink:label="lbl_LegalProceedingsProvisionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LegalProceedingsProvisionMember" xlink:to="lbl_label971890448" xlink:type="arc"/>
      <link:label id="id_1f2f7122" xlink:label="lbl_label523202850" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Solodyn [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SolodynMember" xlink:label="lbl_SolodynMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SolodynMember" xlink:to="lbl_label523202850" xlink:type="arc"/>
      <link:label id="id_10d3ac94" xlink:label="lbl_label282307732" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Lenses [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContactLensesMember" xlink:label="lbl_ContactLensesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContactLensesMember" xlink:to="lbl_label282307732" xlink:type="arc"/>
      <link:label id="id_3e0809a2" xlink:label="lbl_label1040714146" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gleevec [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecMember" xlink:label="lbl_GleevecMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GleevecMember" xlink:to="lbl_label1040714146" xlink:type="arc"/>
      <link:label id="id_7edbae34" xlink:label="lbl_label2128326196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclast/Aclasta [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclastAclastaMember" xlink:label="lbl_ReclastAclastaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReclastAclastaMember" xlink:to="lbl_label2128326196" xlink:type="arc"/>
      <link:label id="id_2b94eceb" xlink:label="lbl_label731180267" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tekturna/Rasilez/Valturna [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TekturnaRasilezValturnaMember" xlink:label="lbl_TekturnaRasilezValturnaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TekturnaRasilezValturnaMember" xlink:to="lbl_label731180267" xlink:type="arc"/>
      <link:label id="id_6962e490" xlink:label="lbl_label1392715101" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NAG and Novartis Pharma SpA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NAGAndNovartisPharmaSpAMember" xlink:label="lbl_NAGAndNovartisPharmaSpAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NAGAndNovartisPharmaSpAMember" xlink:to="lbl_label1392715101" xlink:type="arc"/>
      <link:label id="id_13f125ec" xlink:label="lbl_label400121727" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">F Hoffman La Roche AG and Roche SpA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FHoffmanLaRocheAGAndRocheSpAMember" xlink:label="lbl_FHoffmanLaRocheAGAndRocheSpAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FHoffmanLaRocheAGAndRocheSpAMember" xlink:to="lbl_label400121727" xlink:type="arc"/>
      <link:label id="id_5ce126b6" xlink:label="lbl_label1365859055" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma K.K. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaKKMember" xlink:label="lbl_NovartisPharmaKKMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaKKMember" xlink:to="lbl_label1365859055" xlink:type="arc"/>
      <link:label id="id_4f6a2c55" xlink:label="lbl_label1494155554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NAG [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NAGMember" xlink:label="lbl_NAGMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NAGMember" xlink:to="lbl_label1494155554" xlink:type="arc"/>
      <link:label id="id_514c724a" xlink:label="lbl_label201735145" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NPC and others [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NPCAndOthersMember" xlink:label="lbl_NPCAndOthersMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NPCAndOthersMember" xlink:to="lbl_label201735145" xlink:type="arc"/>
      <link:label id="id_41e7b3b9" xlink:label="lbl_label770853776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis NC [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNCMember" xlink:label="lbl_NovartisNCMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisNCMember" xlink:to="lbl_label770853776" xlink:type="arc"/>
      <link:label id="id_51394769" xlink:label="lbl_label1362708329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability contingency, loss exposure not accrued, number of cases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:label="lbl_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:to="lbl_label1362708329" xlink:type="arc"/>
      <link:label id="id_241b918a" xlink:label="lbl_label605786506" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability contingency, loss exposure not accrued, best estimate</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:label="lbl_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:to="lbl_label605786506" xlink:type="arc"/>
      <link:label id="id_2225e7d2" xlink:label="lbl_label572909522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated financial effect of contingent liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EstimatedFinancialEffectOfContingentLiabilities" xlink:to="lbl_label572909522" xlink:type="arc"/>
      <link:label id="id_7a029719" xlink:label="lbl_label2046990105" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of nature of obligation contingent liabilities, number of legal questions referred to court</link:label>
      <link:label id="id_5477d4dd" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated financial effect of contingent liabilities, maximum fine</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine_labels" xlink:type="arc"/>
      <link:label id="id_4b15d12d" xlink:label="lbl_label1259721005" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of nature of obligation contingent liabilities, number of putative cases referred to court</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:to="lbl_label1259721005" xlink:type="arc"/>
      <link:label id="id_2dbbe7e6" xlink:label="lbl_label767289318" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of nature of obligation contingent liabilities, number of other cases referred to court</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:to="lbl_label767289318" xlink:type="arc"/>
      <link:label id="id_2ca8b224" xlink:label="lbl_label749253156" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of nature of obligation contingent liabilities, number of states with alleged violations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:to="lbl_label749253156" xlink:type="arc"/>
      <link:label id="id_5f79ad81" xlink:label="lbl_label1601809793" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of nature of obligation contingent liabilities, number of cases still pending</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:to="lbl_label1601809793" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:to="lbl_label2046990105" xlink:type="arc"/>
      <link:label id="id_206c121e" xlink:label="lbl_label543953438" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="lbl_Revenue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Revenue" xlink:to="lbl_label543953438" xlink:type="arc"/>
      <link:label id="id_16a8694f" xlink:label="lbl_label380135759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.800% USD 1'000 million 2017/2020 of Novartis Capital Corporation, New York, United States, issued at 99.609% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:label="lbl_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:to="lbl_label380135759" xlink:type="arc"/>
      <link:label id="id_37595e6f" xlink:label="lbl_label928603759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2.400% USD 1'000 million 2017/2022 of Novartis Capital Corporation, New York, United States, issued at 99.449% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:label="lbl_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:to="lbl_label928603759" xlink:type="arc"/>
      <link:label id="id_3742c395" xlink:label="lbl_label927122325" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">3.100% USD 1'000 million 2017/2027 of Novartis Capital Corporation, New York, United States, issued at 99.109% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:label="lbl_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:to="lbl_label927122325" xlink:type="arc"/>
      <link:label id="id_5358e820" xlink:label="lbl_label1398335520" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.000% EUR 1'250 million 2017/2021 of Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.133% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:label="lbl_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:to="lbl_label1398335520" xlink:type="arc"/>
      <link:label id="id_7779807a" xlink:label="lbl_label2004451450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.125% EUR 600 million 2017/2027 of Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.874% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:label="lbl_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:to="lbl_label2004451450" xlink:type="arc"/>
      <link:label id="id_2af5dc98" xlink:label="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transactions with former members of the Board of Directors [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" xlink:label="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" xlink:to="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3ade93c7" xlink:label="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transactions with former members of the Board of Directors</link:label>
      <link:label id="id_3e931ad0" xlink:label="lbl_TotalFairValueAdjustmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total fair value adjustments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalFairValueAdjustmentsMember" xlink:label="lbl_TotalFairValueAdjustmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TotalFairValueAdjustmentsMember" xlink:to="lbl_TotalFairValueAdjustmentsMember_labels" xlink:type="arc"/>
      <link:label id="id_5fef6f2d" xlink:label="lbl_TotalFairValueAdjustmentsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value adjustments</link:label>
      <link:label id="id_2b0a5355" xlink:label="lbl_CurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Provisions at beginning of period</link:label>
      <link:label id="id_7633694e" xlink:label="lbl_CurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Provisions at end of period</link:label>
      <link:label id="id_55d5426d" xlink:label="lbl_label1440039533" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current prepaid expenses, third party</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPrepaidExpensesThirdParty" xlink:label="lbl_CurrentPrepaidExpensesThirdParty" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentPrepaidExpensesThirdParty" xlink:to="lbl_label1440039533" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentPrepaidExpensesThirdParty" xlink:to="lbl_label905656156" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract1" xlink:type="locator"/>
      <link:label id="id_4ecd5cc2" xlink:label="lbl_label1322081474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [abstract]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract1" xlink:to="lbl_label1322081474" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:type="locator"/>
      <link:label id="id_3ada3bfa" xlink:label="lbl_label987380730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [line items]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:to="lbl_label987380730" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:type="locator"/>
      <link:label id="id_7e01564" xlink:label="lbl_label132126052" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for non-derivative financial liabilities [table]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:to="lbl_label132126052" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember1" xlink:type="locator"/>
      <link:label id="id_545eb47a" xlink:label="lbl_label1415492730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one month and not later than three months [member]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember1" xlink:to="lbl_label1415492730" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="lbl_LaterThanOneYearMember1" xlink:type="locator"/>
      <link:label id="id_7cfc55ea" xlink:label="lbl_label2096911850" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year [member]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanOneYearMember1" xlink:to="lbl_label2096911850" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:label="lbl_LaterThanSixMonthsAndNotLaterThanOneYearMember1" xlink:type="locator"/>
      <link:label id="id_22980743" xlink:label="lbl_label580388675" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than six months and not later than one year [member]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanSixMonthsAndNotLaterThanOneYearMember1" xlink:to="lbl_label580388675" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="lbl_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember1" xlink:type="locator"/>
      <link:label id="id_1f823f0f" xlink:label="lbl_label528629519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than three months and not later than six months [member]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember1" xlink:to="lbl_label528629519" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:label id="id_1d54f07" xlink:label="lbl_label30756615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not later than one month [member]</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NotLaterThanOneMonthMember" xlink:to="lbl_label30756615" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="lbl_OtherNoncurrentLiabilities1" xlink:type="locator"/>
      <link:label id="id_69518" xlink:label="lbl_label431384" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentLiabilities1" xlink:to="lbl_label431384" xlink:type="arc"/>
      <link:label id="id_7b946bcb" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past service cost and gains losses arising from settlements, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset1" xlink:to="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_11be10a7" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Past service cost and settlements</link:label>
      <link:label id="id_529b4b2a" xlink:label="lbl_TaxRateEffectFromChangeInTaxRate_labels1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect from change in tax rate</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="lbl_TaxRateEffectFromChangeInTaxRate1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectFromChangeInTaxRate1" xlink:to="lbl_TaxRateEffectFromChangeInTaxRate_labels1" xlink:type="arc"/>
      <link:label id="id_9416195" xlink:label="lbl_TaxRateEffectFromChangeInTaxRate_labels1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of tax rate change on current and deferred tax assets and liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss1" xlink:type="locator"/>
      <link:label id="id_753a14cc" xlink:label="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of expense not deductible in determining taxable profit tax loss</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss1" xlink:to="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_labels" xlink:type="arc"/>
      <link:label id="id_4ff9c19a" xlink:label="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of disallowed expenditures</link:label>
      <link:label id="id_72f99baf" xlink:label="lbl_TaxRateEffectOfTaxLosses_labels1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of tax losses</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfTaxLosses" xlink:label="lbl_TaxRateEffectOfTaxLosses1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfTaxLosses1" xlink:to="lbl_TaxRateEffectOfTaxLosses_labels1" xlink:type="arc"/>
      <link:label id="id_3858f2af" xlink:label="lbl_TaxRateEffectOfTaxLosses_labels1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of utilization of tax losses brought forward from prior periods</link:label>
      <link:label id="id_6100ccc9" xlink:label="lbl_OtherExpenseByFunction_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherExpenseByFunction" xlink:to="lbl_OtherExpenseByFunction_labels" xlink:type="arc"/>
      <link:label id="id_7b7f0633" xlink:label="lbl_OtherExpenseByFunction_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other expense, by function</link:label>
      <link:label id="id_295deb1d" xlink:label="lbl_label694020893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Par value per share</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="lbl_ParValuePerShare" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ParValuePerShare" xlink:to="lbl_label694020893" xlink:type="arc"/>
      <link:label id="id_223c2b0a" xlink:label="lbl_OtherCurrentNonfinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
      <link:label id="id_7418af90" xlink:label="lbl_OtherCurrentFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, commodities, time deposits and derivative financial instruments</link:label>
      <link:label id="id_7592952b" xlink:label="lbl_OtherCurrentFinancialAssets_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total marketable securities, commodities, time deposits and derivative financial instruments</link:label>
      <link:label id="id_6a995f9c" xlink:label="lbl_label1788436380" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxotere [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxotereMember" xlink:label="lbl_TaxotereMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxotereMember" xlink:to="lbl_label1788436380" xlink:type="arc"/>
      <link:label id="id_578eb571" xlink:label="lbl_label1468970353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amiodarone [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmiodaroneMember" xlink:label="lbl_AmiodaroneMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmiodaroneMember" xlink:to="lbl_label1468970353" xlink:type="arc"/>
      <link:label id="id_3bc6fd49" xlink:label="lbl_label1002896713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of equity [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfEquityAbstract" xlink:label="lbl_DisclosureOfEquityAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfEquityAbstract" xlink:to="lbl_label1002896713" xlink:type="arc"/>
      <link:label id="id_5120693" xlink:label="lbl_DisclosureOfEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of equity [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfEquityTextBlock" xlink:label="lbl_DisclosureOfEquityTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfEquityTextBlock" xlink:to="lbl_DisclosureOfEquityTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6726d861" xlink:label="lbl_DisclosureOfEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
      <link:label id="id_3dc60187" xlink:label="lbl_DividendTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendTableTextBlock" xlink:label="lbl_DividendTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendTableTextBlock" xlink:to="lbl_DividendTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_258e3af2" xlink:label="lbl_DividendTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to Dividend</link:label>
      <link:label id="id_cb435c9" xlink:label="lbl_label213136841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="lbl_AmendmentFlag" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmendmentFlag" xlink:to="lbl_label213136841" xlink:type="arc"/>
      <link:label id="id_5d388f3d" xlink:label="lbl_label1563987773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="lbl_DocumentPeriodEndDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentPeriodEndDate" xlink:to="lbl_label1563987773" xlink:type="arc"/>
      <link:label id="id_1e619d64" xlink:label="lbl_label509713764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="lbl_DocumentFiscalYearFocus" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentFiscalYearFocus" xlink:to="lbl_label509713764" xlink:type="arc"/>
      <link:label id="id_7fb4d619" xlink:label="lbl_label2142557721" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="lbl_DocumentFiscalPeriodFocus" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentFiscalPeriodFocus" xlink:to="lbl_label2142557721" xlink:type="arc"/>
      <link:label id="id_29f6dab9" xlink:label="lbl_label704043705" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="lbl_TradingSymbol" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradingSymbol" xlink:to="lbl_label704043705" xlink:type="arc"/>
      <link:label id="id_30c984d" xlink:label="lbl_label51157069" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="lbl_EntityRegistrantName" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityRegistrantName" xlink:to="lbl_label51157069" xlink:type="arc"/>
      <link:label id="id_387f1769" xlink:label="lbl_label947853161" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="lbl_EntityCentralIndexKey" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityCentralIndexKey" xlink:to="lbl_label947853161" xlink:type="arc"/>
      <link:label id="id_6f6c1fbf" xlink:label="lbl_label1869356991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="lbl_CurrentFiscalYearEndDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentFiscalYearEndDate" xlink:to="lbl_label1869356991" xlink:type="arc"/>
      <link:label id="id_6f81ea6f" xlink:label="lbl_label1870785135" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="lbl_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityWellKnownSeasonedIssuer" xlink:to="lbl_label1870785135" xlink:type="arc"/>
      <link:label id="id_593907e" xlink:label="lbl_label93556862" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="lbl_EntityCurrentReportingStatus" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityCurrentReportingStatus" xlink:to="lbl_label93556862" xlink:type="arc"/>
      <link:label id="id_a350bde" xlink:label="lbl_label171248606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="lbl_EntityVoluntaryFilers" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityVoluntaryFilers" xlink:to="lbl_label171248606" xlink:type="arc"/>
      <link:label id="id_1ebbff8e" xlink:label="lbl_label515637134" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="lbl_EntityFilerCategory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityFilerCategory" xlink:to="lbl_label515637134" xlink:type="arc"/>
      <link:label id="id_2df8f48d" xlink:label="lbl_label771290253" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="lbl_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityCommonStockSharesOutstanding" xlink:to="lbl_label771290253" xlink:type="arc"/>
      <link:label id="id_6a10c99a" xlink:label="lbl_label1779485082" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="lbl_EntityPublicFloat" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityPublicFloat" xlink:to="lbl_label1779485082" xlink:type="arc"/>
      <link:label id="id_60ad1327" xlink:label="lbl_US_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_US" xlink:to="lbl_US_labels" xlink:type="arc"/>
      <link:label id="id_45b4f0b8" xlink:label="lbl_GB_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED KINGDOM</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_GB" xlink:label="lbl_GB" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GB" xlink:to="lbl_GB_labels" xlink:type="arc"/>
      <link:label id="id_fa4133c" xlink:label="lbl_DE_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GERMANY</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_DE" xlink:label="lbl_DE" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DE" xlink:to="lbl_DE_labels" xlink:type="arc"/>
      <link:label id="id_4fab4920" xlink:label="lbl_FR_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FRANCE</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR" xlink:label="lbl_FR" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FR" xlink:to="lbl_FR_labels" xlink:type="arc"/>
      <link:label id="id_2409370a" xlink:label="lbl_JP_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JAPAN</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="lbl_JP" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_JP" xlink:to="lbl_JP_labels" xlink:type="arc"/>
      <link:label id="id_7e84627" xlink:label="lbl_US_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US</link:label>
      <link:label id="id_35cc0588" xlink:label="lbl_GB_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK</link:label>
      <link:label id="id_11499416" xlink:label="lbl_DE_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Germany</link:label>
      <link:label id="id_50732a2" xlink:label="lbl_FR_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">France</link:label>
      <link:label id="id_16ecebec" xlink:label="lbl_JP_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Japan</link:label>
      <link:label id="id_47d2ec01" xlink:label="lbl_IT_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ITALY</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_IT" xlink:label="lbl_IT" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IT" xlink:to="lbl_IT_labels" xlink:type="arc"/>
      <link:label id="id_3b372d9d" xlink:label="lbl_IT_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Italy</link:label>
      <link:label id="id_53d1a5ee" xlink:label="lbl_CA_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CANADA</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CA" xlink:label="lbl_CA" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CA" xlink:to="lbl_CA_labels" xlink:type="arc"/>
      <link:label id="id_68cbde64" xlink:label="lbl_CA_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Canada</link:label>
      <link:label id="id_87623f2" xlink:label="lbl_USD_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United States of America, Dollars</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_USD" xlink:to="lbl_USD_labels" xlink:type="arc"/>
      <link:label id="id_73a7c19e" xlink:label="lbl_USD_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USD</link:label>
      <link:label id="id_78126268" xlink:label="lbl_EUR_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Euro Member Countries, Euro</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EUR" xlink:to="lbl_EUR_labels" xlink:type="arc"/>
      <link:label id="id_70708ef7" xlink:label="lbl_EUR_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EUR</link:label>
      <link:label id="id_12746a38" xlink:label="lbl_JPY_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Japan, Yen</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_JPY" xlink:to="lbl_JPY_labels" xlink:type="arc"/>
      <link:label id="id_7b8f8056" xlink:label="lbl_JPY_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">JPY</link:label>
      <link:label id="id_7a7394c2" xlink:label="lbl_CNY_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">China, Yuan Renminbi</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CNY" xlink:label="lbl_CNY" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CNY" xlink:to="lbl_CNY_labels" xlink:type="arc"/>
      <link:label id="id_4d265dd0" xlink:label="lbl_CNY_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CNY</link:label>
      <link:label id="id_1c17f7c4" xlink:label="lbl_GBP_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">United Kingdom, Pounds</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_GBP" xlink:label="lbl_GBP" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GBP" xlink:to="lbl_GBP_labels" xlink:type="arc"/>
      <link:label id="id_1728da67" xlink:label="lbl_GBP_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GBP</link:label>
      <link:label id="id_436074ee" xlink:label="lbl_CHF_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CHF</link:label>
      <link:label id="id_1da98c1e" xlink:label="lbl_label497650718" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable" xlink:label="lbl_DocumentInformationTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentInformationTable" xlink:to="lbl_label497650718" xlink:type="arc"/>
      <link:label id="id_12b84aa7" xlink:label="lbl_label314067623" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="lbl_DocumentInformationLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_label314067623" xlink:type="arc"/>
      <link:label id="id_165ab5d4" xlink:label="lbl_label375043540" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_label375043540" xlink:type="arc"/>
      <link:label id="id_238135db" xlink:label="lbl_label595670491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityDomain" xlink:to="lbl_label595670491" xlink:type="arc"/>
      <link:label id="id_1d17e2f2" xlink:label="lbl_label488104690" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_label488104690" xlink:type="arc"/>
      <link:label id="id_1d7da856" xlink:label="lbl_AdministrativeExpense_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Need new ITEM here</link:label>
      <link:label id="id_751ef3e9" xlink:label="lbl_AdministrativeExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">General and Administration</link:label>
      <link:label id="id_20c355f9" xlink:label="lbl_IncreaseDecreaseInNoncontrolingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in non-controling interests</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseInNoncontrolingInterests" xlink:label="lbl_IncreaseDecreaseInNoncontrolingInterests" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInNoncontrolingInterests" xlink:to="lbl_IncreaseDecreaseInNoncontrolingInterests_labels" xlink:type="arc"/>
      <link:label id="id_71d21c6b" xlink:label="lbl_IncreaseDecreaseInNoncontrolingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in non-controlling interests</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceivedClassifiedAsOperatingActivities" xlink:label="lbl_DividendsReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:label id="id_7d6a6449" xlink:label="lbl_DividendsReceivedClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends received from associated companies and others</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsReceivedClassifiedAsOperatingActivities" xlink:to="lbl_DividendsReceivedClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_4bdcb2fd" xlink:label="lbl_DividendsReceivedClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends received, classified as operating activities</link:label>
      <link:label id="id_d7b5832" xlink:label="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance income received, classified as operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:label="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:to="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_7e7ea58d" xlink:label="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial receipts</link:label>
      <link:label id="id_44baadd4" xlink:label="lbl_FinanceCostsPaidClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance costs paid, classified as operating activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="lbl_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:to="lbl_FinanceCostsPaidClassifiedAsOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_68d65042" xlink:label="lbl_FinanceCostsPaidClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other financial payments</link:label>
      <link:label id="id_36d7aeb1" xlink:label="lbl_ProceedsFromSalesOfInterestsInAssociates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sales of interests in associates</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:label="lbl_ProceedsFromSalesOfInterestsInAssociates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromSalesOfInterestsInAssociates" xlink:to="lbl_ProceedsFromSalesOfInterestsInAssociates_labels" xlink:type="arc"/>
      <link:label id="id_df43529" xlink:label="lbl_ProceedsFromSalesOfInterestsInAssociates_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Divestments of interests in associated companies</link:label>
      <link:label id="id_789b89ac" xlink:label="lbl_label1718040268" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions and divestments of businesses, net</link:label>
      <link:label id="id_197c150c" xlink:label="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid to shareholders of Novartis AG</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:to="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_3ec8bcea" xlink:label="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends paid to equity holders of parent, classified as financing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="locator"/>
      <link:label id="id_7cc199f7" xlink:label="lbl_ProceedsFromNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from non-current financial debts</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromNoncurrentBorrowings" xlink:to="lbl_ProceedsFromNoncurrentBorrowings_labels" xlink:type="arc"/>
      <link:label id="id_2e7bd9f2" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of non-current borrowings</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RepaymentsOfNoncurrentBorrowings" xlink:to="lbl_RepaymentsOfNoncurrentBorrowings_labels" xlink:type="arc"/>
      <link:label id="id_106de250" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment of non-current financial debts</link:label>
      <link:label id="id_40f4d6a8" xlink:label="lbl_ProceedsFromNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from non-current borrowings</link:label>
      <link:label id="id_1bde8770" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) increase (decrease) in current borrowings</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_labels" xlink:type="arc"/>
      <link:label id="id_104baa70" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in current financial debts</link:label>
      <link:label id="id_367ad3ce" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing cash flows, net</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_2a649f3d" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other inflows (outflows) of cash, classified as financing activities</link:label>
      <link:label id="id_3f82a721" xlink:label="lbl_IncomeTaxesPaidRefund_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="lbl_IncomeTaxesPaidRefund" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxesPaidRefund" xlink:to="lbl_IncomeTaxesPaidRefund_labels" xlink:type="arc"/>
      <link:label id="id_53191c38" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund), classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_16a1607" xlink:label="lbl_label23729671" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfReportableSegments" xlink:label="lbl_NumberOfReportableSegments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfReportableSegments" xlink:to="lbl_label23729671" xlink:type="arc"/>
      <link:label id="id_ff1b344" xlink:label="lbl_label267498308" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Business Units</link:label>
      <link:label id="id_19aaa924" xlink:label="lbl_label430614820" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Franchises</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfFranchises" xlink:label="lbl_NumberOfFranchises" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfFranchises" xlink:to="lbl_label430614820" xlink:type="arc"/>
      <link:label id="id_4ccf5884" xlink:label="lbl_AdditionsToRestructuringProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions to restructuring provisions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToRestructuringProvisions" xlink:label="lbl_AdditionsToRestructuringProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsToRestructuringProvisions" xlink:to="lbl_AdditionsToRestructuringProvisions_labels" xlink:type="arc"/>
      <link:label id="id_3b0ef23" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions to property, plant and equipment</link:label>
      <link:label id="id_528839cf" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions to intangible assets and goodwill</link:label>
      <link:label id="id_40106876" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods, third parties and other segments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties_labels" xlink:type="arc"/>
      <link:label id="id_7458433e" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales to third parties from continuing operations</link:label>
      <link:label id="id_541cacbc" xlink:label="lbl_label1411165372" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods, third parties and other segments, as percent of total net sales</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:to="lbl_label1411165372" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:to="lbl_label102429242" xlink:type="arc"/>
      <link:label id="id_5aa03955" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selected non-current assets, as percent</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:to="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_6c200908" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selected non-current assets (in % of total selected non-current assets)</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:to="lbl_label1358337308" xlink:type="arc"/>
      <link:label id="id_6d471c75" xlink:label="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value of investments in associates for which there are quoted market prices</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:label="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:to="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished_labels" xlink:type="arc"/>
      <link:label id="id_6319607c" xlink:label="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in subsidiaries, joint ventures and associates</link:label>
      <link:label id="id_51c4430d" xlink:label="lbl_label1371816717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense, gross</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:to="lbl_label1371816717" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:to="lbl_label1549022431" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromDividends" xlink:label="lbl_RevenueFromDividends" xlink:type="locator"/>
      <link:label id="id_752e4898" xlink:label="lbl_label1965967512" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend income</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromDividends" xlink:to="lbl_label1965967512" xlink:type="arc"/>
      <link:label id="id_6b7200d3" xlink:label="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss on commodities and available-for-sale securities, net</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:label="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:to="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet_labels" xlink:type="arc"/>
      <link:label id="id_4fa6704a" xlink:label="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment of commodities and available-for-sale securities, net</link:label>
      <link:label id="id_6fd24c63" xlink:label="lbl_OtherFinanceCost_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other finance cost</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="lbl_OtherFinanceCost" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherFinanceCost" xlink:to="lbl_OtherFinanceCost_labels" xlink:type="arc"/>
      <link:label id="id_2d3e7598" xlink:label="lbl_OtherFinanceCost_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other financial expense</link:label>
      <link:label id="id_2b07fd1f" xlink:label="lbl_TaxExpenseIncomeDiscontinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income), discontinuing operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxExpenseIncomeDiscontinuingOperations" xlink:label="lbl_TaxExpenseIncomeDiscontinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxExpenseIncomeDiscontinuingOperations" xlink:to="lbl_TaxExpenseIncomeDiscontinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_671db01c" xlink:label="lbl_TaxExpenseIncomeDiscontinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense from discontinued operations</link:label>
      <link:label id="id_772c2e3e" xlink:label="lbl_label1999384126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect from non-deductible losses</link:label>
      <link:label id="id_199436bd" xlink:label="lbl_label429143741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation change in uncertain tax positions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:to="lbl_label429143741" xlink:type="arc"/>
      <link:label id="id_80d3caa" xlink:label="lbl_label135085226" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation other adjustments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lbl_label135085226" xlink:type="arc"/>
      <link:label id="id_2016529c" xlink:label="lbl_label538333852" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective income tax rate reconciliation change in enacted tax rate</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="lbl_label538333852" xlink:type="arc"/>
      <link:label id="id_2aa51152" xlink:label="lbl_label1640547073" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income net of tax gains/losses on remeasurements of defined benefit plans related to discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:to="lbl_label1640547073" xlink:type="arc"/>
      <link:label id="id_596243a4" xlink:label="lbl_label1689586548" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income net of tax exchange differences on translation related to discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:to="lbl_label1689586548" xlink:type="arc"/>
      <link:label id="id_1a035b8a" xlink:label="lbl_label436427658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business unit [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitAxis" xlink:label="lbl_BusinessUnitAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BusinessUnitAxis" xlink:to="lbl_label436427658" xlink:type="arc"/>
      <link:label id="id_7dfe6553" xlink:label="lbl_label2113824083" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business unit [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitMember" xlink:label="lbl_BusinessUnitMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_label2113824083" xlink:type="arc"/>
      <link:label id="id_1c8ae042" xlink:label="lbl_label478863426" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oncology [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OncologyMember" xlink:label="lbl_OncologyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OncologyMember" xlink:to="lbl_label478863426" xlink:type="arc"/>
      <link:label id="id_6b138679" xlink:label="lbl_label1796441721" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmaceutical [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PharmaceuticalMember" xlink:label="lbl_PharmaceuticalMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PharmaceuticalMember" xlink:to="lbl_label1796441721" xlink:type="arc"/>
      <link:label id="id_73d27a10" xlink:label="lbl_label1943173648" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_label1943173648" xlink:type="arc"/>
      <link:label id="id_578f16d9" xlink:label="lbl_label1468995289" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Franchise [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FranchiseMember" xlink:to="lbl_label1468995289" xlink:type="arc"/>
      <link:label id="id_7a3bb683" xlink:label="lbl_label2050733699" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ophthalmology [member]</link:label>
      <link:label id="id_29ccb106" xlink:label="lbl_label701280518" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neuroscience [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeuroscienceMember" xlink:label="lbl_NeuroscienceMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NeuroscienceMember" xlink:to="lbl_label701280518" xlink:type="arc"/>
      <link:label id="id_1b0191fc" xlink:label="lbl_label453087740" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Respiratory [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespiratoryMember" xlink:label="lbl_RespiratoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RespiratoryMember" xlink:to="lbl_label453087740" xlink:type="arc"/>
      <link:label id="id_43a1daf0" xlink:label="lbl_label1134680816" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cardiovascular, Renal and Metabolism [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CardioMetabolicMember" xlink:label="lbl_CardioMetabolicMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CardioMetabolicMember" xlink:to="lbl_label1134680816" xlink:type="arc"/>
      <link:label id="id_393ea837" xlink:label="lbl_label960407607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Established Medicines [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMedicinesMember" xlink:label="lbl_EstablishedMedicinesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EstablishedMedicinesMember" xlink:to="lbl_label960407607" xlink:type="arc"/>
      <link:label id="id_5bf06316" xlink:label="lbl_label1542480662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product portfolio [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_label1542480662" xlink:type="arc"/>
      <link:label id="id_38b2f5ea" xlink:label="lbl_label951252458" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product portfolio [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_label951252458" xlink:type="arc"/>
      <link:label id="id_77b41933" xlink:label="lbl_label2008291635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">COPD [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_COPDMember" xlink:label="lbl_COPDMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_COPDMember" xlink:to="lbl_label2008291635" xlink:type="arc"/>
      <link:label id="id_7bd53aee" xlink:label="lbl_label2077571822" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gleevec/Glivec [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecGlivecMember" xlink:label="lbl_GleevecGlivecMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GleevecGlivecMember" xlink:to="lbl_label2077571822" xlink:type="arc"/>
      <link:label id="id_b0600c4" xlink:label="lbl_label184942788" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tasigna [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TasignaMember" xlink:label="lbl_TasignaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TasignaMember" xlink:to="lbl_label184942788" xlink:type="arc"/>
      <link:label id="id_3f81d4ef" xlink:label="lbl_label1065473263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandostatin [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandostatinMember" xlink:label="lbl_SandostatinMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandostatinMember" xlink:to="lbl_label1065473263" xlink:type="arc"/>
      <link:label id="id_b64c3a5" xlink:label="lbl_label191153061" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Afinitor/Votubia [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AfinitorVotubiaMember" xlink:label="lbl_AfinitorVotubiaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AfinitorVotubiaMember" xlink:to="lbl_label191153061" xlink:type="arc"/>
      <link:label id="id_7ee4b441" xlink:label="lbl_label2128917569" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exjade/Jadenu [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExjadeJadenuMember" xlink:label="lbl_ExjadeJadenuMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExjadeJadenuMember" xlink:to="lbl_label2128917569" xlink:type="arc"/>
      <link:label id="id_28e14893" xlink:label="lbl_label685852819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tafinlar + Mekinist [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TafinlarMekinistMember" xlink:label="lbl_TafinlarMekinistMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TafinlarMekinistMember" xlink:to="lbl_label685852819" xlink:type="arc"/>
      <link:label id="id_67d8ca2f" xlink:label="lbl_label1742260783" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Promacta/Revolade [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PromactaRevoladeMember" xlink:label="lbl_PromactaRevoladeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PromactaRevoladeMember" xlink:to="lbl_label1742260783" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OphthalmologyMember" xlink:label="lbl_OphthalmologyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OphthalmologyMember" xlink:to="lbl_label2050733699" xlink:type="arc"/>
      <link:label id="id_647651d6" xlink:label="lbl_label1685475798" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Votrient [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VotrientMember" xlink:to="lbl_label1685475798" xlink:type="arc"/>
      <link:label id="id_2746717b" xlink:label="lbl_label658927995" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jakavi [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JakaviMember" xlink:label="lbl_JakaviMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_JakaviMember" xlink:to="lbl_label658927995" xlink:type="arc"/>
      <link:label id="id_72117eb7" xlink:label="lbl_label1913749175" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kisqali [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KisqaliMember" xlink:label="lbl_KisqaliMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KisqaliMember" xlink:to="lbl_label1913749175" xlink:type="arc"/>
      <link:label id="id_4dee8d50" xlink:label="lbl_label1307479376" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherProductsMember" xlink:label="lbl_OtherProductsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherProductsMember" xlink:to="lbl_label1307479376" xlink:type="arc"/>
      <link:label id="id_6a7a37e6" xlink:label="lbl_label1786394598" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Travoprost Group [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TravoprostGroupMember" xlink:label="lbl_TravoprostGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TravoprostGroupMember" xlink:to="lbl_label1786394598" xlink:type="arc"/>
      <link:label id="id_3e01b08f" xlink:label="lbl_label1040298127" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Systane Group [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SystaneGroupMember" xlink:label="lbl_SystaneGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SystaneGroupMember" xlink:to="lbl_label1040298127" xlink:type="arc"/>
      <link:label id="id_3ffa23d" xlink:label="lbl_label67084861" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Topical Olopatadine Group [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TopicalOlopatadineGroupMember" xlink:label="lbl_TopicalOlopatadineGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TopicalOlopatadineGroupMember" xlink:to="lbl_label67084861" xlink:type="arc"/>
      <link:label id="id_931b1f9" xlink:label="lbl_label154251769" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cosentyx [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CosentyxMember" xlink:label="lbl_CosentyxMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CosentyxMember" xlink:to="lbl_label154251769" xlink:type="arc"/>
      <link:label id="id_31cd0397" xlink:label="lbl_label835519383" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neoral/Sandimmun(e) [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeoralSandimmunEMember" xlink:label="lbl_NeoralSandimmunEMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NeoralSandimmunEMember" xlink:to="lbl_label835519383" xlink:type="arc"/>
      <link:label id="id_48585481" xlink:label="lbl_label1213748353" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zortress/Certican [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZortressCerticanMember" xlink:label="lbl_ZortressCerticanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ZortressCerticanMember" xlink:to="lbl_label1213748353" xlink:type="arc"/>
      <link:label id="id_d8aed9" xlink:label="lbl_label14200537" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ilaris [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IlarisMember" xlink:label="lbl_IlarisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IlarisMember" xlink:to="lbl_label14200537" xlink:type="arc"/>
      <link:label id="id_612117f4" xlink:label="lbl_label1629558772" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Myfortic [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MyforticMember" xlink:label="lbl_MyforticMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MyforticMember" xlink:to="lbl_label1629558772" xlink:type="arc"/>
      <link:label id="id_63153a75" xlink:label="lbl_label1662335605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gilenya [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GilenyaMember" xlink:label="lbl_GilenyaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GilenyaMember" xlink:to="lbl_label1662335605" xlink:type="arc"/>
      <link:label id="id_79c9c9f8" xlink:label="lbl_label2043267576" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ultibro Breezhaler [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UltibroBreezhalerMember" xlink:label="lbl_UltibroBreezhalerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UltibroBreezhalerMember" xlink:to="lbl_label2043267576" xlink:type="arc"/>
      <link:label id="id_39edf745" xlink:label="lbl_label971896645" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Seebri Breezhaler [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SeebriBreezhalerMember" xlink:label="lbl_SeebriBreezhalerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SeebriBreezhalerMember" xlink:to="lbl_label971896645" xlink:type="arc"/>
      <link:label id="id_3093cd1d" xlink:label="lbl_label814992669" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Onbrez Breezhaler [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OnbrezBreezhalerMember" xlink:label="lbl_OnbrezBreezhalerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OnbrezBreezhalerMember" xlink:to="lbl_label814992669" xlink:type="arc"/>
      <link:label id="id_61b9d990" xlink:label="lbl_label1639569808" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entresto [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EntrestoMember" xlink:label="lbl_EntrestoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntrestoMember" xlink:to="lbl_label1639569808" xlink:type="arc"/>
      <link:label id="id_ba5bf3e" xlink:label="lbl_label195411774" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Galvus Group [member]</link:label>
      <link:label id="id_4a18d85e" xlink:label="lbl_label1243142238" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exforge Group [member]</link:label>
      <link:label id="id_75a7ce71" xlink:label="lbl_label1973931633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diovan Group [member]</link:label>
      <link:label id="id_2e0075fc" xlink:label="lbl_label771782140" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Voltaren/Cataflam [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VoltarenCataflamMember" xlink:label="lbl_VoltarenCataflamMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VoltarenCataflamMember" xlink:to="lbl_label771782140" xlink:type="arc"/>
      <link:label id="id_5304aa12" xlink:label="lbl_label1392814610" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exelon/Exelon Patch [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExelonExelonPatchMember" xlink:label="lbl_ExelonExelonPatchMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExelonExelonPatchMember" xlink:to="lbl_label1392814610" xlink:type="arc"/>
      <link:label id="id_10a15386" xlink:label="lbl_label279008134" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ritalin/Focalin [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RitalinFocalinMember" xlink:label="lbl_RitalinFocalinMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RitalinFocalinMember" xlink:to="lbl_label279008134" xlink:type="arc"/>
      <link:label id="id_26f1359c" xlink:label="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation on disposals, property plant and equipment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:label="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:to="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_1c74ede2" xlink:label="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation on disposals and derecognitions</link:label>
      <link:label id="id_22aa91df" xlink:label="lbl_label1255943452" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated impairments on disposals and derecognition</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:label="lbl_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:to="lbl_label1255943452" xlink:type="arc"/>
      <link:label id="id_626451ea" xlink:label="lbl_AcquiredResearchAndDevelopmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired research and development [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquiredResearchAndDevelopmentMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember_labels" xlink:type="arc"/>
      <link:label id="id_d6a6395" xlink:label="lbl_AcquiredResearchAndDevelopmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired research and development</link:label>
      <link:label id="id_52b9d0b7" xlink:label="lbl_AlconBrandNameMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon brand name [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconBrandNameMember" xlink:to="lbl_AlconBrandNameMember_labels" xlink:type="arc"/>
      <link:label id="id_4db335d9" xlink:label="lbl_AlconBrandNameMember_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Alcon brand name</link:label>
      <link:label id="id_52290b49" xlink:label="lbl_label1378421577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross value of tax loss carry forwards expiring in future years</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:label="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:to="lbl_label1378421577" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:to="lbl_label94266701" xlink:type="arc"/>
      <link:label id="id_70e22198" xlink:label="lbl_label198642827" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales, change in %</link:label>
      <link:label id="id_330af3ff" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shareholders of Novartis AG</link:label>
      <link:label id="id_2b7d0eda" xlink:label="lbl_label729616090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative currency translation gains/losses recycled through income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:label="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:to="lbl_label729616090" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:label="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:type="locator"/>
      <link:label id="id_19f22bed" xlink:label="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impaired loss on financial assets transferred to the income statement</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:to="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax_labels" xlink:type="arc"/>
      <link:label id="id_2ac3f739" xlink:label="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on financial assets measured at fair value through other comprehensive income, net of tax</link:label>
      <link:label id="id_1bf8cda2" xlink:label="lbl_label469290402" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, available-for-sale financial investments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:label="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:to="lbl_label469290402" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:to="lbl_label521267934" xlink:type="arc"/>
      <link:label id="id_523cf50c" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, maketable securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeMaketableSecurities" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:to="lbl_OtherComprehensiveIncomeMaketableSecurities_labels" xlink:type="arc"/>
      <link:label id="id_64b0e4db" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities</link:label>
      <link:label id="id_37e931e5" xlink:label="lbl_FinanceLeaseReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net book value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceLeaseReceivables" xlink:label="lbl_FinanceLeaseReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinanceLeaseReceivables" xlink:to="lbl_FinanceLeaseReceivables_labels" xlink:type="arc"/>
      <link:label id="id_f9fb296" xlink:label="lbl_FinanceLeaseReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance lease receivables</link:label>
      <link:label id="id_18330ebd" xlink:label="lbl_NoncurrentFinanceLeaseReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum lease payments from finance lease agreements</link:label>
      <link:label id="id_5342799f" xlink:label="lbl_label1396865439" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for doubtful receivable [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionForDoubtfulReceivableMember" xlink:to="lbl_label1396865439" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded_labels" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Commodities" xlink:label="lbl_Commodities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Commodities" xlink:to="lbl_label1789088932" xlink:type="arc"/>
      <link:label id="id_2985d64f" xlink:label="lbl_OutstandingShareCapital_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding share capital</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapital" xlink:label="lbl_OutstandingShareCapital" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OutstandingShareCapital" xlink:to="lbl_OutstandingShareCapital_labels" xlink:type="arc"/>
      <link:label id="id_550535ae" xlink:label="lbl_OutstandingShareCapital_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Total outstanding share capital at beginning of period</link:label>
      <link:label id="id_75bd4d3d" xlink:label="lbl_OutstandingShareCapital_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Total outstanding share capital at end of period</link:label>
      <link:label id="id_551db3e0" xlink:label="lbl_SaleOrIssueOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares movement of period</link:label>
      <link:label id="id_736416f8" xlink:label="lbl_IssuedCapitalMovement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital, movement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IssuedCapitalMovement" xlink:label="lbl_IssuedCapitalMovement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IssuedCapitalMovement" xlink:to="lbl_IssuedCapitalMovement_labels" xlink:type="arc"/>
      <link:label id="id_58515153" xlink:label="lbl_IssuedCapitalMovement_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital movement of period</link:label>
      <link:label id="id_416f3b0f" xlink:label="lbl_OutstandingShareCapitalMovement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding share capital, movement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapitalMovement" xlink:label="lbl_OutstandingShareCapitalMovement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OutstandingShareCapitalMovement" xlink:to="lbl_OutstandingShareCapitalMovement_labels" xlink:type="arc"/>
      <link:label id="id_578dd06d" xlink:label="lbl_OutstandingShareCapitalMovement_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total shares outstanding movement of period</link:label>
      <link:label id="id_6cc370cc" xlink:label="lbl_label1824747724" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares cancelled for capital reduction</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesCancelledForCapitalReduction" xlink:label="lbl_SharesCancelledForCapitalReduction" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharesCancelledForCapitalReduction" xlink:to="lbl_label1824747724" xlink:type="arc"/>
      <link:label id="id_138eeec4" xlink:label="lbl_TreasurySharesMovement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares, movement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesMovement" xlink:label="lbl_TreasurySharesMovement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesMovement" xlink:to="lbl_TreasurySharesMovement_labels" xlink:type="arc"/>
      <link:label id="id_296c7c9b" xlink:label="lbl_TreasurySharesMovement_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total number of outstanding treasury shares</link:label>
      <link:label id="id_3fd2a1c9" xlink:label="lbl_SharepurchaseOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:label id="id_4f72913c" xlink:label="lbl_PurchaseOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares, equity impact</link:label>
      <link:label id="id_10472e97" xlink:label="lbl_EquityImpactOfTreasuryShareMovements_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity impact of treasury share movements</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityImpactOfTreasuryShareMovements" xlink:label="lbl_EquityImpactOfTreasuryShareMovements" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityImpactOfTreasuryShareMovements" xlink:to="lbl_EquityImpactOfTreasuryShareMovements_labels" xlink:type="arc"/>
      <link:label id="id_1cdf067d" xlink:label="lbl_EquityImpactOfTreasuryShareMovements_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity impact of treasury share movements</link:label>
      <link:label id="id_495f6f85" xlink:label="lbl_label903405960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average interest rate on loans received</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageInterestRateOnLoansReceived" xlink:label="lbl_AverageInterestRateOnLoansReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AverageInterestRateOnLoansReceived" xlink:to="lbl_label903405960" xlink:type="arc"/>
      <link:label id="id_57858aea" xlink:label="lbl_label1766025212" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ratio fixed rate financial debt to total financial debt</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:label="lbl_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:to="lbl_label1766025212" xlink:type="arc"/>
      <link:label id="id_10cf25f4" xlink:label="lbl_label1048419104" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average interest rate on borrowings</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageInterestRateOnBorrowings" xlink:label="lbl_AverageInterestRateOnBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AverageInterestRateOnBorrowings" xlink:to="lbl_label1048419104" xlink:type="arc"/>
      <link:label id="id_2aee42a4" xlink:label="lbl_BorrowingsInterestRate_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, coupon</link:label>
      <link:label id="id_176fa55a" xlink:label="lbl_BorrowingsIssuanceDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, issuance year</link:label>
      <link:label id="id_6ff69971" xlink:label="lbl_BorrowingsMaturity_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, maturity year</link:label>
      <link:label id="id_7a5c6046" xlink:label="lbl_BorrowingsLender_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, issuer</link:label>
      <link:label id="id_30da0d60" xlink:label="lbl_BorrowingsPremiumDiscount_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings, issue price</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationNonCurrent" xlink:label="lbl_ContingentConsiderationNonCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationNonCurrent" xlink:to="lbl_label98650725" xlink:type="arc"/>
      <link:label id="id_38f01585" xlink:label="lbl_label955258245" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Environmental remediation provisions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionRollForward" xlink:label="lbl_EnvironmentalProvisionRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_label1590727038" xlink:type="arc"/>
      <link:label id="id_26f523d7" xlink:label="lbl_EnvironmentalProvision_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvision" xlink:label="lbl_EnvironmentalProvision" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvision" xlink:to="lbl_EnvironmentalProvision_labels" xlink:type="arc"/>
      <link:label id="id_2f8c0636" xlink:label="lbl_EnvironmentalProvision_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Environmental liabilities provision at beginning of period</link:label>
      <link:label id="id_3ca05f15" xlink:label="lbl_EnvironmentalProvision_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Environmental liabilities provision at end of period</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvision" xlink:to="lbl_label1750372676" xlink:type="arc"/>
      <link:label id="id_5bf2bac7" xlink:label="lbl_label1542634183" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies, payments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionPayments" xlink:label="lbl_EnvironmentalProvisionPayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionPayments" xlink:to="lbl_label1542634183" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionPayments" xlink:to="lbl_label448335871" xlink:type="arc"/>
      <link:label id="id_1bbf0a1c" xlink:label="lbl_label465504796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies, releases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionReleases" xlink:label="lbl_EnvironmentalProvisionReleases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionReleases" xlink:to="lbl_label465504796" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionReleases" xlink:to="lbl_label2143979670" xlink:type="arc"/>
      <link:label id="id_30109c5e" xlink:label="lbl_label806394974" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies, additions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionAdditions" xlink:label="lbl_EnvironmentalProvisionAdditions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionAdditions" xlink:to="lbl_label806394974" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionAdditions" xlink:to="lbl_label1560928630" xlink:type="arc"/>
      <link:label id="id_6528e847" xlink:label="lbl_label1697179719" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies, foreign currency translation gain (loss)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:label="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:to="lbl_label1697179719" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:to="lbl_label42481781" xlink:type="arc"/>
      <link:label id="id_69c992c5" xlink:label="lbl_EnvironmentalProvisionCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for environmental loss contingencies, Current</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionCurrent" xlink:label="lbl_EnvironmentalProvisionCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionCurrent" xlink:to="lbl_EnvironmentalProvisionCurrent_labels" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionCurrent" xlink:to="lbl_label1902698328" xlink:type="arc"/>
      <link:label id="id_76c21b8c" xlink:label="lbl_label1992432524" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Non-current environmental remediation provisions at end of period</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalRemediationProvisionNoncurrent" xlink:label="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:to="lbl_label1992432524" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:to="lbl_label955258245" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:to="lbl_label304425068" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:label="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:to="lbl_label1615356460" xlink:type="arc"/>
      <link:label id="id_6deab0eb" xlink:label="lbl_label1844097259" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental provision, expected cash outflow, next two years</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:to="lbl_label1844097259" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:to="lbl_label1351152500" xlink:type="arc"/>
      <link:label id="id_54b46e40" xlink:label="lbl_label1421110848" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental provision, expected cash outflow, later than two years, but within five years</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:to="lbl_label1421110848" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:to="lbl_label771700847" xlink:type="arc"/>
      <link:label id="id_366842e4" xlink:label="lbl_label912802532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental provision, expected cash outflow, later than five years, but within ten years</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:to="lbl_label912802532" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:to="lbl_label1968177093" xlink:type="arc"/>
      <link:label id="id_53179e3c" xlink:label="lbl_label1394056764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Environmental provision, expected cash outflow, after ten years</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:to="lbl_label1394056764" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:to="lbl_label757561900" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_label1271103735" xlink:type="arc"/>
      <link:label id="id_5e9e598e" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions_labels" xlink:type="arc"/>
      <link:label id="id_1dcf084" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Product liabilities government investigations other legal matters provisions at beginning of period</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:to="lbl_label252843510" xlink:type="arc"/>
      <link:label id="id_71839c4e" xlink:label="lbl_label1904450638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:to="lbl_label1904450638" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:to="lbl_label1583004694" xlink:type="arc"/>
      <link:label id="id_53472504" xlink:label="lbl_label1397171460" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, payments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:to="lbl_label1397171460" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:to="lbl_label1339267684" xlink:type="arc"/>
      <link:label id="id_3e905f98" xlink:label="lbl_label1049649048" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, releases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:to="lbl_label1049649048" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:to="lbl_label1568927014" xlink:type="arc"/>
      <link:label id="id_61e84c26" xlink:label="lbl_label1642613798" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, additions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:to="lbl_label1642613798" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:to="lbl_label1379712140" xlink:type="arc"/>
      <link:label id="id_6c695b53" xlink:label="lbl_label1818843987" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, foreign currency translation gain (loss)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:to="lbl_label1818843987" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:to="lbl_label1424862979" xlink:type="arc"/>
      <link:label id="id_54a4e6a7" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, current</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent_labels" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:to="lbl_label438797926" xlink:type="arc"/>
      <link:label id="id_acc6217" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, non-current</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent_labels" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:to="lbl_label1363494370" xlink:type="arc"/>
      <link:label id="id_d93a8b" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateAssociates" xlink:label="lbl_WeightedAverageInterestRateAssociates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageInterestRateAssociates" xlink:to="lbl_WeightedAverageInterestRateAssociates_labels" xlink:type="arc"/>
      <link:label id="id_6be37912" xlink:label="lbl_WeightedAverageInterestRateAssociates_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average interest rate on interest bearning accounts of associates payable on demand.</link:label>
      <link:label id="id_1a1c62e1" xlink:label="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average interest rate on Bank and other financial debt</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:label="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:to="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt_labels" xlink:type="arc"/>
      <link:label id="id_1401b9c9" xlink:label="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average interest rate on Bank and other financial debt</link:label>
      <link:label id="id_7df4e11d" xlink:label="lbl_EnvironmentalProvisionCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Environmental remediation liabilities</link:label>
      <link:label id="id_19219108" xlink:label="lbl_AccrualsClassifiedAsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses for goods and services received but not invoiced</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="lbl_AccrualsClassifiedAsCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccrualsClassifiedAsCurrent" xlink:to="lbl_AccrualsClassifiedAsCurrent_labels" xlink:type="arc"/>
      <link:label id="id_2731b8ee" xlink:label="lbl_AccrualsClassifiedAsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accruals classified as current</link:label>
      <link:label id="id_1dcdc504" xlink:label="lbl_ContingentConsiderationCurrentPortion_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration, current portion</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationCurrentPortion" xlink:label="lbl_ContingentConsiderationCurrentPortion" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationCurrentPortion" xlink:to="lbl_ContingentConsiderationCurrentPortion_labels" xlink:type="arc"/>
      <link:label id="id_cecd050" xlink:label="lbl_ContingentConsiderationCurrentPortion_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent considerations</link:label>
      <link:label id="id_66cb3d62" xlink:label="lbl_label1724595554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for deduction from revenue [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDeductionFromRevenueTable" xlink:label="lbl_ProvisionForDeductionFromRevenueTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProvisionForDeductionFromRevenueTable" xlink:to="lbl_label1724595554" xlink:type="arc"/>
      <link:label id="id_62196d01" xlink:label="lbl_label1645833473" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring provisions movements [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsTable" xlink:label="lbl_RestructuringProvisionsMovementsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestructuringProvisionsMovementsTable" xlink:to="lbl_label1645833473" xlink:type="arc"/>
      <link:label id="id_5c0c0960" xlink:label="lbl_RestructuringProvisionTransfers_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring provision transfers</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionTransfers" xlink:label="lbl_RestructuringProvisionTransfers" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestructuringProvisionTransfers" xlink:to="lbl_RestructuringProvisionTransfers_labels" xlink:type="arc"/>
      <link:label id="id_2238ed4d" xlink:label="lbl_RestructuringProvisionTransfers_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transfers</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:label="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:type="locator"/>
      <link:label id="id_78c7fbb0" xlink:label="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification adjustments on cash flow hedges, net of tax</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:to="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_labels" xlink:type="arc"/>
      <link:label id="id_b7c54f9" xlink:label="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized net losses on cash flow hedges transferred to the consolidated income statement</link:label>
      <link:label id="id_58b3a333" xlink:label="lbl_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other payables and deferred tax liabilities recognised as of acquisition date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lbl_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_5a90c79" xlink:label="lbl_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payables and other liabilities including deferred tax liabilities</link:label>
      <link:label id="id_2856a2a3" xlink:label="lbl_IdentifiableAssetsAcquired_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Identifiable assets acquired</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IdentifiableAssetsAcquired" xlink:label="lbl_IdentifiableAssetsAcquired" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IdentifiableAssetsAcquired" xlink:to="lbl_IdentifiableAssetsAcquired_labels" xlink:type="arc"/>
      <link:label id="id_205b065c" xlink:label="lbl_IdentifiableAssetsAcquired_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net identifiable assets acquired</link:label>
      <link:label id="id_62f623d2" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property plant and equipment recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_59f5d7c5" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:label id="id_28728c08" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currently marketed products intangible assets recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_4dd002d2" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currently marketed products</link:label>
      <link:label id="id_3be633c" xlink:label="lbl_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired divested research and development intangible assets recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_3369d331" xlink:label="lbl_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Acquired)/divested research and development</link:label>
      <link:label id="id_44229a8b" xlink:label="lbl_TechnologiesRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technologies recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TechnologiesRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_TechnologiesRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TechnologiesRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_TechnologiesRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_3e9ce44a" xlink:label="lbl_TechnologiesRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Technologies</link:label>
      <link:label id="id_33f9a377" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other intangible assets recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_52667216" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other intangible assets</link:label>
      <link:label id="id_2879f83e" xlink:label="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and other assets including deferred tax assets recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_64556efa" xlink:label="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial and other assets including deferred tax assets</link:label>
      <link:label id="id_63e0564e" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InventoryRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_InventoryRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_7a3f0241" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
      <link:label id="id_4427bc74" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables and other current assets recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_5681fbbf" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables and other current assets</link:label>
      <link:label id="id_6359834c" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_47a6ced3" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:label id="id_4d854151" xlink:label="lbl_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current and non-current financial debts recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_3ea67aa0" xlink:label="lbl_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current and non-current financial debts</link:label>
      <link:label id="id_1be55693" xlink:label="lbl_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other payables recognised as of acquisition divestment date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate" xlink:label="lbl_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate" xlink:to="lbl_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:type="arc"/>
      <link:label id="id_65a5731d" xlink:label="lbl_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Trade payables and other liabilities including deferred tax liabilities</link:label>
      <link:label id="id_5d12057a" xlink:label="lbl_label1419113480" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Animal health [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnimalHealthMember" xlink:label="lbl_AnimalHealthMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AnimalHealthMember" xlink:to="lbl_label1419113480" xlink:type="arc"/>
      <link:label id="id_6ab963bf" xlink:label="lbl_label1790534591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from sale of business</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromSaleOfBusiness" xlink:label="lbl_ProceedsFromSaleOfBusiness" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromSaleOfBusiness" xlink:to="lbl_label1790534591" xlink:type="arc"/>
      <link:label id="id_2cda3a42" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in/from investing activities from discontinued operations</link:label>
      <link:label id="id_7f35ae76" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Financial debts and derivative instruments at beginning of period</link:label>
      <link:label id="id_5e88cc26" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Financial debts and derivative instruments at end of period</link:label>
      <link:label id="id_32b354fd" xlink:label="lbl_label1199806184" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in fair values and other changes</link:label>
      <link:label id="id_3eaf2bac" xlink:label="lbl_AmortizationOfBondsDiscount_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of bonds discount</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfBondsDiscount" xlink:label="lbl_AmortizationOfBondsDiscount" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmortizationOfBondsDiscount" xlink:to="lbl_AmortizationOfBondsDiscount_labels" xlink:type="arc"/>
      <link:label id="id_4b9e2882" xlink:label="lbl_label1268656258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial debts [member]</link:label>
      <link:label id="id_24db2ae3" xlink:label="lbl_label618343139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current financial debts and derivative financial instruments [member]</link:label>
      <link:label id="id_20254569" xlink:label="lbl_label539313513" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current portion of non-current financial debt</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPortionOfNoncurrentFinancialDebt" xlink:label="lbl_CurrentPortionOfNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentPortionOfNoncurrentFinancialDebt" xlink:to="lbl_label539313513" xlink:type="arc"/>
      <link:label id="id_4171dffa" xlink:label="lbl_label1097981946" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genentech / Roche [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GenentechRocheMember" xlink:label="lbl_GenentechRocheMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GenentechRocheMember" xlink:to="lbl_label1097981946" xlink:type="arc"/>
      <link:label id="id_21b59c45" xlink:label="lbl_label565550149" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of contracts with related parties</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfContractsWithRelatedParties" xlink:label="lbl_NumberOfContractsWithRelatedParties" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfContractsWithRelatedParties" xlink:to="lbl_label565550149" xlink:type="arc"/>
      <link:label id="id_140db491" xlink:label="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related parties, number of executive commitee members</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:label="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:to="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers_labels" xlink:type="arc"/>
      <link:label id="id_12cdd92b" xlink:label="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Commitee members</link:label>
      <link:label id="id_4d39a061" xlink:label="lbl_RelatedPartiesNumberOfNonexecutiveDirectors_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related parties, number of non-executive directors</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:label="lbl_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:to="lbl_RelatedPartiesNumberOfNonexecutiveDirectors_labels" xlink:type="arc"/>
      <link:label id="id_2b93879e" xlink:label="lbl_RelatedPartiesNumberOfNonexecutiveDirectors_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-executive directors</link:label>
      <link:label id="id_4c2ae7af" xlink:label="lbl_label1277880239" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, expected future benefit payment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:to="lbl_label1277880239" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:to="lbl_label839490648" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EmployerSharesHeldByDefinedBenefitPlan" xlink:label="lbl_EmployerSharesHeldByDefinedBenefitPlan" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EmployerSharesHeldByDefinedBenefitPlan" xlink:to="lbl_label2113441601" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:label="lbl_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:to="lbl_label1670270510" xlink:type="arc"/>
      <link:label id="id_2111657b" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Administrative expense net defined benefit liability asset</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:to="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_6b50d402" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Administrative expenses</link:label>
      <link:label id="id_2605ce0d" xlink:label="lbl_label637914637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses) arising from changes in expreience related assumptions, net defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lbl_label637914637" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lbl_label783050349" xlink:type="arc"/>
      <link:label id="id_45a2931c" xlink:label="lbl_label1168282396" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plan, foreign currency exchange rate gain (loss)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:to="lbl_label1168282396" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:to="lbl_label220841955" xlink:type="arc"/>
      <link:label id="id_329368f1" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through changes in foreign exchange rates, defined benefit liability (asset)</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset_labels" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:to="lbl_label1273555602" xlink:type="arc"/>
      <link:label id="id_5b9bb55e" xlink:label="lbl_label1536931166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years and not later than ten years [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="lbl_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:to="lbl_label1536931166" xlink:type="arc"/>
      <link:label id="id_7cbb695f" xlink:label="lbl_label2092656991" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="lbl_DisclosureOfFinancialAssetsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_label2092656991" xlink:type="arc"/>
      <link:label id="id_675e88e3" xlink:label="lbl_label1734248675" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="lbl_DisclosureOfFinancialAssetsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAssetsLineItems" xlink:to="lbl_label1734248675" xlink:type="arc"/>
      <link:label id="id_6f8cf207" xlink:label="lbl_label1871507975" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="lbl_FinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssets" xlink:to="lbl_label1871507975" xlink:type="arc"/>
      <link:label id="id_31c4b50a" xlink:label="lbl_label834974986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial assets [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="lbl_ClassesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfFinancialAssetsAxis" xlink:to="lbl_label834974986" xlink:type="arc"/>
      <link:label id="id_3b500f38" xlink:label="lbl_label995102520" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsMember" xlink:label="lbl_FinancialAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_label995102520" xlink:type="arc"/>
      <link:label id="id_5853963a" xlink:label="lbl_label1481872954" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at amortised cost, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="lbl_FinancialAssetsAtAmortisedCostMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsAtAmortisedCostMember" xlink:to="lbl_label1481872954" xlink:type="arc"/>
      <link:label id="id_15228c3a" xlink:label="lbl_label354585658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMember" xlink:label="lbl_CashAndCashEquivalentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsMember" xlink:to="lbl_label354585658" xlink:type="arc"/>
      <link:label id="id_2ea70" xlink:label="lbl_label191088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="lbl_CategoriesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CategoriesOfFinancialAssetsAxis" xlink:to="lbl_label191088" xlink:type="arc"/>
      <link:label id="id_5fa2081d" xlink:label="lbl_label1604454429" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="lbl_FinancialAssetsCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_label1604454429" xlink:type="arc"/>
      <link:label id="id_7ddd290" xlink:label="lbl_label131977872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities [member]</link:label>
      <link:label id="id_36737cf8" xlink:label="lbl_label913538296" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale long-term financial investments [member]</link:label>
      <link:label id="id_5632a636" xlink:label="lbl_label1446159926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance sheet item [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemAxis" xlink:label="lbl_BalanceSheetItemAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BalanceSheetItemAxis" xlink:to="lbl_label1446159926" xlink:type="arc"/>
      <link:label id="id_77e6aae0" xlink:label="lbl_label2011605728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance sheet item [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemMember" xlink:label="lbl_BalanceSheetItemMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_label2011605728" xlink:type="arc"/>
      <link:label id="id_39f42abc" xlink:label="lbl_label972303036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquitySecuritiesMember" xlink:label="lbl_EquitySecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquitySecuritiesMember" xlink:to="lbl_label972303036" xlink:type="arc"/>
      <link:label id="id_34461243" xlink:label="lbl_label877007427" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fund investments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FundInvestmentsMember" xlink:to="lbl_label877007427" xlink:type="arc"/>
      <link:label id="id_3c80f6bd" xlink:label="lbl_label1015084733" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables and other current assets excluding pre-payments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:to="lbl_label1015084733" xlink:type="arc"/>
      <link:label id="id_71d621f1" xlink:label="lbl_label1909858801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration receivables [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationReceivablesMember" xlink:to="lbl_label1909858801" xlink:type="arc"/>
      <link:label id="id_266ee04f" xlink:label="lbl_label644800591" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued interest on debt securities and time deposits [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:label="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:to="lbl_label644800591" xlink:type="arc"/>
      <link:label id="id_462cba41" xlink:label="lbl_label1177336385" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Time deposits with original maturity more than 90 days [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:label="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:to="lbl_label1177336385" xlink:type="arc"/>
      <link:label id="id_1ada2efd" xlink:label="lbl_label450506493" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term loans and receivables from customers and finance lease, advances, security deposits [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:label="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:to="lbl_label450506493" xlink:type="arc"/>
      <link:label id="id_7c347590" xlink:label="lbl_label2083812752" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Associated companies at fair value through profit and loss [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:to="lbl_label2083812752" xlink:type="arc"/>
      <link:label id="id_533b50d9" xlink:label="lbl_label1396396249" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsMember" xlink:to="lbl_label1396396249" xlink:type="arc"/>
      <link:label id="id_551fe4b1" xlink:label="lbl_label1428153521" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_label1428153521" xlink:type="arc"/>
      <link:label id="id_114f7584" xlink:label="lbl_label290420100" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:to="lbl_label290420100" xlink:type="arc"/>
      <link:label id="id_3b35b195" xlink:label="lbl_label993374613" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="lbl_FinancialLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesMember" xlink:to="lbl_label993374613" xlink:type="arc"/>
      <link:label id="id_68a64911" xlink:label="lbl_label1755728145" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="lbl_FinancialLiabilitiesAtAmortisedCostMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="lbl_label1755728145" xlink:type="arc"/>
      <link:label id="id_6d1d78f2" xlink:label="lbl_label1830648050" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueMember" xlink:label="lbl_FinancialLiabilitiesAtFairValueMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesAtFairValueMember" xlink:to="lbl_label1830648050" xlink:type="arc"/>
      <link:label id="id_27bb9ea8" xlink:label="lbl_label666607272" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Groups of financial assets/liabilities [axis]</link:label>
      <link:label id="id_7cf4bc91" xlink:label="lbl_label2096413841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Groups of financial assets/liabilities [member]</link:label>
      <link:label id="id_68ba85b6" xlink:label="lbl_label1757054390" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value, class [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueMember" xlink:label="lbl_FinancialAssetsAtFairValueMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsAtFairValueMember" xlink:to="lbl_label1757054390" xlink:type="arc"/>
      <link:label id="id_3cee5982" xlink:label="lbl_label1022253442" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="lbl_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lbl_label1022253442" xlink:type="arc"/>
      <link:label id="id_2d611cc9" xlink:label="lbl_label761339081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through other comprehensive income, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:label="lbl_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:to="lbl_label761339081" xlink:type="arc"/>
      <link:label id="id_2c7b189f" xlink:label="lbl_label746264735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="lbl_FinancialLiabilitiesCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesCategoryMember" xlink:to="lbl_label746264735" xlink:type="arc"/>
      <link:label id="id_153859c4" xlink:label="lbl_label356014532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:to="lbl_label356014532" xlink:type="arc"/>
      <link:label id="id_14968138" xlink:label="lbl_label345407800" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="lbl_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lbl_label345407800" xlink:type="arc"/>
      <link:label id="id_2576e32b" xlink:label="lbl_label628548395" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:label="lbl_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:to="lbl_label628548395" xlink:type="arc"/>
      <link:label id="id_5a840ece" xlink:label="lbl_label1518603982" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at amortised cost, category [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:label="lbl_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsAtAmortisedCostCategoryMember" xlink:to="lbl_label1518603982" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_label666607272" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_label2096413841" xlink:type="arc"/>
      <link:label id="id_4718921c" xlink:label="lbl_label1192792604" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current financial debt [member]</link:label>
      <link:label id="id_1748f73f" xlink:label="lbl_label390657855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial debt [member]</link:label>
      <link:label id="id_7d47f3b5" xlink:label="lbl_label2101867445" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesMember" xlink:label="lbl_TradePayablesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradePayablesMember" xlink:to="lbl_label2101867445" xlink:type="arc"/>
      <link:label id="id_1ed425bd" xlink:label="lbl_label517219773" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest bearning accounts of associates payable on demand [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:to="lbl_label517219773" xlink:type="arc"/>
      <link:label id="id_7fb53de5" xlink:label="lbl_label2142584293" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank and other financial debt [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BankAndOtherFinancialDebtMember" xlink:label="lbl_BankAndOtherFinancialDebtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BankAndOtherFinancialDebtMember" xlink:to="lbl_label2142584293" xlink:type="arc"/>
      <link:label id="id_36f483b7" xlink:label="lbl_label921994167" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial paper [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommercialPaperMember" xlink:label="lbl_CommercialPaperMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CommercialPaperMember" xlink:to="lbl_label921994167" xlink:type="arc"/>
      <link:label id="id_2993bf16" xlink:label="lbl_label697548566" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current portion of non-current debt [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPortionOfNoncurrentDebtMember" xlink:label="lbl_CurrentPortionOfNoncurrentDebtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentPortionOfNoncurrentDebtMember" xlink:to="lbl_label697548566" xlink:type="arc"/>
      <link:label id="id_7aa4522e" xlink:label="lbl_label2057589294" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Straight bonds [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StraightBondsMember" xlink:label="lbl_StraightBondsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StraightBondsMember" xlink:to="lbl_label2057589294" xlink:type="arc"/>
      <link:label id="id_2e89197f" xlink:label="lbl_label780736895" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities to banks and other financial institutions [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:label="lbl_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:to="lbl_label780736895" xlink:type="arc"/>
      <link:label id="id_3cfbed2" xlink:label="lbl_label63946450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance lease obligations [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseObligationsMember" xlink:label="lbl_FinanceLeaseObligationsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinanceLeaseObligationsMember" xlink:to="lbl_label63946450" xlink:type="arc"/>
      <link:label id="id_47b3aade" xlink:label="lbl_label1202957022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration and other financial liabilities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:label="lbl_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:to="lbl_label1202957022" xlink:type="arc"/>
      <link:label id="id_74b2144b" xlink:label="lbl_label1957827659" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of derivative financial instruments, by type of contract [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:to="lbl_label1957827659" xlink:type="arc"/>
      <link:label id="id_11a7e82b" xlink:label="lbl_label296216619" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instrument, nature of instrument [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:to="lbl_label296216619" xlink:type="arc"/>
      <link:label id="id_5a462aee" xlink:label="lbl_label1514547950" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instrument, nature of instrument [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:to="lbl_label1514547950" xlink:type="arc"/>
      <link:label id="id_75469247" xlink:label="lbl_label1967559239" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments, at fair value currency related [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:to="lbl_label1967559239" xlink:type="arc"/>
      <link:label id="id_3583f9fa" xlink:label="lbl_label897841658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, principal amounts [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsAxis" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:to="lbl_label897841658" xlink:type="arc"/>
      <link:label id="id_102b0f85" xlink:label="lbl_label271257477" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, principal amounts [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsMember" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_label271257477" xlink:type="arc"/>
      <link:label id="id_3f464064" xlink:label="lbl_label1061568612" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract or underlying principal amout [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractOrUnderlyingPrincipalAmoutMember" xlink:label="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:to="lbl_label1061568612" xlink:type="arc"/>
      <link:label id="id_24f6d45c" xlink:label="lbl_label620155996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Positive fair values [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PositiveFairValuesMember" xlink:label="lbl_PositiveFairValuesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PositiveFairValuesMember" xlink:to="lbl_label620155996" xlink:type="arc"/>
      <link:label id="id_42b35305" xlink:label="lbl_label1119048453" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Negative fair values [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NegativeFairValuesMember" xlink:label="lbl_NegativeFairValuesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NegativeFairValuesMember" xlink:to="lbl_label1119048453" xlink:type="arc"/>
      <link:label id="id_4c8abefe" xlink:label="lbl_label1284161278" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of derivative financial instruments [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_label1284161278" xlink:type="arc"/>
      <link:label id="id_5286c358" xlink:label="lbl_label1384563544" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial liabilities [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="lbl_label1384563544" xlink:type="arc"/>
      <link:label id="id_487fc207" xlink:label="lbl_label1216332295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="lbl_FinancialLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilities" xlink:to="lbl_label1216332295" xlink:type="arc"/>
      <link:label id="id_453bddb" xlink:label="lbl_label72596955" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstruments" xlink:label="lbl_DerivativeFinancialInstruments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstruments" xlink:to="lbl_label72596955" xlink:type="arc"/>
      <link:label id="id_397d852b" xlink:label="lbl_label964527403" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments, forward foreign exchange rate contracts</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:label="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:to="lbl_label964527403" xlink:type="arc"/>
      <link:label id="id_b3aed83" xlink:label="lbl_label188411267" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments, over-the-counter currency options</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:label="lbl_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:to="lbl_label188411267" xlink:type="arc"/>
      <link:label id="id_24aeca58" xlink:label="lbl_label615434840" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of derivative financial instruments, by currency contract [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_label615434840" xlink:type="arc"/>
      <link:label id="id_3d32bab6" xlink:label="lbl_label1026734774" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of assets [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_label1026734774" xlink:type="arc"/>
      <link:label id="id_3f252a8f" xlink:label="lbl_label1059400335" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="lbl_MeasurementAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MeasurementAxis" xlink:to="lbl_label1059400335" xlink:type="arc"/>
      <link:label id="id_59852144" xlink:label="lbl_label1501897028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregated measurement [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="lbl_AggregatedMeasurementMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AggregatedMeasurementMember" xlink:to="lbl_label1501897028" xlink:type="arc"/>
      <link:label id="id_640cd1b3" xlink:label="lbl_label1678561715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recurring fair value measurement [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember" xlink:label="lbl_RecurringFairValueMeasurementMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RecurringFairValueMeasurementMember" xlink:to="lbl_label1678561715" xlink:type="arc"/>
      <link:label id="id_6df52bda" xlink:label="lbl_label1844784090" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable securities, time deposits and derivative financial instruments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:label="lbl_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:to="lbl_label1844784090" xlink:type="arc"/>
      <link:label id="id_469d8a26" xlink:label="lbl_label1184729638" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial investments and long-term loans [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:label="lbl_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:to="lbl_label1184729638" xlink:type="arc"/>
      <link:label id="id_3e1a7df6" xlink:label="lbl_label1041923574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total available-for-sale marketable securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalAvailableforsaleMarketableSecuritiesMember" xlink:label="lbl_TotalAvailableforsaleMarketableSecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TotalAvailableforsaleMarketableSecuritiesMember" xlink:to="lbl_label1041923574" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableForSaleMarketableSecuritiesMember" xlink:label="lbl_AvailableForSaleMarketableSecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AvailableForSaleMarketableSecuritiesMember" xlink:to="lbl_label131977872" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:to="lbl_label913538296" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtMember" xlink:label="lbl_CurrentFinancialDebtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentFinancialDebtMember" xlink:to="lbl_label1192792604" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialDebtMember" xlink:label="lbl_NoncurrentFinancialDebtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialDebtMember" xlink:to="lbl_label390657855" xlink:type="arc"/>
      <link:label id="id_55c289f5" xlink:label="lbl_label1438812661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale financial investments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:to="lbl_label1438812661" xlink:type="arc"/>
      <link:label id="id_4af993b7" xlink:label="lbl_label1257870263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of assets [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="lbl_label1257870263" xlink:type="arc"/>
      <link:label id="id_5b807bec" xlink:label="lbl_label1535146988" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valued at amortized cost [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValuedAtAmortizedCostMember" xlink:label="lbl_ValuedAtAmortizedCostMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ValuedAtAmortizedCostMember" xlink:to="lbl_label1535146988" xlink:type="arc"/>
      <link:label id="id_6163f2e6" xlink:label="lbl_label1633940198" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="lbl_ClassesOfLiabilitiesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClassesOfLiabilitiesAxis" xlink:to="lbl_label1633940198" xlink:type="arc"/>
      <link:label id="id_39b2a3b6" xlink:label="lbl_label968008630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesMember" xlink:label="lbl_LiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_label968008630" xlink:type="arc"/>
      <link:label id="id_2dde0229" xlink:label="lbl_label769524265" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration payables [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPayablesMember" xlink:label="lbl_ContingentConsiderationPayablesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationPayablesMember" xlink:to="lbl_label769524265" xlink:type="arc"/>
      <link:label id="id_648479c6" xlink:label="lbl_label1686403526" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other financial liabilities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialLiabilitiesMember" xlink:label="lbl_OtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherFinancialLiabilitiesMember" xlink:to="lbl_label1686403526" xlink:type="arc"/>
      <link:label id="id_7d19861f" xlink:label="lbl_label2098824735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">China Novartis Institutes for BioMedical Research Co., Ltd., Shanghai [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:label="lbl_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:to="lbl_label2098824735" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare1" xlink:type="locator"/>
      <link:label id="id_6e8d8711" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends proposed, cash per share</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare1" xlink:to="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare_labels" xlink:type="arc"/>
      <link:label id="id_5643fad7" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share</link:label>
      <link:label id="id_65bb0a73" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends proposed</link:label>
      <link:label id="id_738a993" xlink:label="lbl_label121153939" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase/decrease in fair value measurement liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:label="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:to="lbl_label121153939" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:to="lbl_label1199806184" xlink:type="arc"/>
      <link:label id="id_7ebb8632" xlink:label="lbl_label2126218802" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, at fair value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="lbl_FinancialAssetsAtFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAssetsAtFairValue" xlink:to="lbl_label2126218802" xlink:type="arc"/>
      <link:label id="id_5083795f" xlink:label="lbl_FinancialLiabilitiesAtFairValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="lbl_FinancialLiabilitiesAtFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesAtFairValue" xlink:to="lbl_FinancialLiabilitiesAtFairValue_labels" xlink:type="arc"/>
      <link:label id="id_2d43301f" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, hedges of net investments in foreign operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_labels" xlink:type="arc"/>
      <link:label id="id_43e5ded1" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net investment hedge</link:label>
      <link:label id="id_72a89a91" xlink:label="lbl_label1923652241" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Australia Pty Ltd, Macquarie Park, NSW [member]</link:label>
      <link:label id="id_731902b7" xlink:label="lbl_label1931018935" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharmaceuticals Australia Pty Ltd, Macquarie Park, NSW [member]</link:label>
      <link:label id="id_1867bb0f" xlink:label="lbl_label409451279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories (Australia) Pty Ltd, Macquarie Park, NSW [member]</link:label>
      <link:label id="id_3d795141" xlink:label="lbl_label1031360833" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Pty Ltd, Macquarie Park, NSW [member]</link:label>
      <link:label id="id_5d546db3" xlink:label="lbl_label1565814195" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Austria GmbH, Vienna [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAustriaGmbHViennaMember" xlink:label="lbl_NovartisAustriaGmbHViennaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisAustriaGmbHViennaMember" xlink:to="lbl_label1565814195" xlink:type="arc"/>
      <link:label id="id_2234921c" xlink:label="lbl_label573870620" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma GmbH, Vienna [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaGmbHViennaMember" xlink:label="lbl_NovartisPharmaGmbHViennaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaGmbHViennaMember" xlink:to="lbl_label573870620" xlink:type="arc"/>
      <link:label id="id_7dcc65cd" xlink:label="lbl_label2110547405" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Ophthalmika GmbH, Vienna [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconOphthalmikaGmbHViennaMember" xlink:label="lbl_AlconOphthalmikaGmbHViennaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconOphthalmikaGmbHViennaMember" xlink:to="lbl_label2110547405" xlink:type="arc"/>
      <link:label id="id_6649a095" xlink:label="lbl_label1716101269" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz GmbH, Kundl [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozGmbHViennaMember" xlink:label="lbl_SandozGmbHViennaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozGmbHViennaMember" xlink:to="lbl_label1716101269" xlink:type="arc"/>
      <link:label id="id_2af5dc99" xlink:label="lbl_label720755864" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EBEWE Pharma Ges.m.b.H Nfg. KG, Unterach am Attersee [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:label="lbl_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:to="lbl_label720755864" xlink:type="arc"/>
      <link:label id="id_710ef91f" xlink:label="lbl_label1896806687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis (Bangladesh) Limited, Gazipur [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBangladeshLimitedGazipurMember" xlink:label="lbl_NovartisBangladeshLimitedGazipurMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisBangladeshLimitedGazipurMember" xlink:to="lbl_label1896806687" xlink:type="arc"/>
      <link:label id="id_33533709" xlink:label="lbl_label861091593" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma NV, Vilvoorde [member]</link:label>
      <link:label id="id_6bd26090" xlink:label="lbl_label1808949392" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon - Couvreur NV, Puurs [member]</link:label>
      <link:label id="id_471d9dcf" xlink:label="lbl_label1193123279" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon NV, Vilvoorde [member]</link:label>
      <link:label id="id_61e985d" xlink:label="lbl_label102668381" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz NV, Vilvoorde [member]</link:label>
      <link:label id="id_3d34517c" xlink:label="lbl_label1026838908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Securities Investment Ltd., Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:label="lbl_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:to="lbl_label1026838908" xlink:type="arc"/>
      <link:label id="id_2e061bfd" xlink:label="lbl_label772152317" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Biociencias S.A., Sao Paulo [member]</link:label>
      <link:label id="id_608a61f5" xlink:label="lbl_label1619681781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz do Brasil Industria Farmaceutica Ltda., Cambe, PR [member]</link:label>
      <link:label id="id_20501724" xlink:label="lbl_label542119716" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharmaceuticals Canada Inc., Dorval, Quebec [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:label="lbl_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:to="lbl_label542119716" xlink:type="arc"/>
      <link:label id="id_b170914" xlink:label="lbl_label186059028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Canada Inc., Mississauga, Ontario [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCanadaInc.MississaugaOntarioMember" xlink:label="lbl_AlconCanadaInc.MississaugaOntarioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconCanadaInc.MississaugaOntarioMember" xlink:to="lbl_label186059028" xlink:type="arc"/>
      <link:label id="id_3382e919" xlink:label="lbl_label864217369" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIBA Vision Canada Inc., Mississauga, Ontario [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:label="lbl_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:to="lbl_label864217369" xlink:type="arc"/>
      <link:label id="id_4aad4cdd" xlink:label="lbl_label1252871389" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Canada Inc., Boucherville, Quebec [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozCanadaInc.BouchervilleQuebecMember" xlink:label="lbl_SandozCanadaInc.BouchervilleQuebecMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozCanadaInc.BouchervilleQuebecMember" xlink:to="lbl_label1252871389" xlink:type="arc"/>
      <link:label id="id_467b0e02" xlink:label="lbl_label1182469634" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Chile S.A., Santiago de Chile [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisChileS.A.SantiagoDeChileMember" xlink:label="lbl_NovartisChileS.A.SantiagoDeChileMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisChileS.A.SantiagoDeChileMember" xlink:to="lbl_label1182469634" xlink:type="arc"/>
      <link:label id="id_4a31b636" xlink:label="lbl_label1244771894" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratorios Chile Ltd., Santiago de Chile [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:label="lbl_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:to="lbl_label1244771894" xlink:type="arc"/>
      <link:label id="id_61f8aada" xlink:label="lbl_label1643686618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Beijing Novartis Pharma Co., Ltd., Beijing [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:label="lbl_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:to="lbl_label1643686618" xlink:type="arc"/>
      <link:label id="id_344a1881" xlink:label="lbl_label877271169" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharmaceuticals (HK) Limited, Hong Kong [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:label="lbl_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:to="lbl_label877271169" xlink:type="arc"/>
      <link:label id="id_2c879a70" xlink:label="lbl_label747084400" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Suzhou Novartis Pharma Technology Co., Ltd., Changshu [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:label="lbl_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:to="lbl_label747084400" xlink:type="arc"/>
      <link:label id="id_44f2dcf0" xlink:label="lbl_label1156766960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shanghai Novartis Trading Ltd., Shanghai [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:label="lbl_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:to="lbl_label1156766960" xlink:type="arc"/>
      <link:label id="id_2b1815d1" xlink:label="lbl_label722998737" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Hong Kong Limited, Hong Kong [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconHongKongLimitedHongKongMember" xlink:label="lbl_AlconHongKongLimitedHongKongMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconHongKongLimitedHongKongMember" xlink:to="lbl_label722998737" xlink:type="arc"/>
      <link:label id="id_57ba8d14" xlink:label="lbl_label1471843604" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon (China) Ophthalmic Product Co., Ltd., Beijing [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:label="lbl_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:to="lbl_label1471843604" xlink:type="arc"/>
      <link:label id="id_252cd53d" xlink:label="lbl_label623695165" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz (China) Pharmaceutical Co., Ltd., Zhongshan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:label="lbl_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:to="lbl_label623695165" xlink:type="arc"/>
      <link:label id="id_65e89b36" xlink:label="lbl_label1709742902" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis de Colombia S.A., Santafe de Bogota [member]</link:label>
      <link:label id="id_1522bd0" xlink:label="lbl_label22162384" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratorios Alcon de Colombia S.A., Santafe de Bogota [member]</link:label>
      <link:label id="id_2d82460" xlink:label="lbl_label47719520" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz d.o.o. farmaceutska industrija, Zagreb [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:label="lbl_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:to="lbl_label47719520" xlink:type="arc"/>
      <link:label id="id_c60eb2a" xlink:label="lbl_label207678250" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis s.r.o., Prague [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisS.r.o.PragueMember" xlink:label="lbl_NovartisS.r.o.PragueMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisS.r.o.PragueMember" xlink:to="lbl_label207678250" xlink:type="arc"/>
      <link:label id="id_402474ef" xlink:label="lbl_label1076131055" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Pharmaceuticals (Czech Republic) s.r.o., Prague [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:label="lbl_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:to="lbl_label1076131055" xlink:type="arc"/>
      <link:label id="id_f1c4dd" xlink:label="lbl_label15844573" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz s.r.o., Prague [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.r.o.PragueMember" xlink:label="lbl_SandozS.r.o.PragueMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozS.r.o.PragueMember" xlink:to="lbl_label15844573" xlink:type="arc"/>
      <link:label id="id_6ea1eef6" xlink:label="lbl_label1856106230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Healthcare A/S, Copenhagen [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcareASCopenhagenMember" xlink:label="lbl_NovartisHealthcareASCopenhagenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHealthcareASCopenhagenMember" xlink:to="lbl_label1856106230" xlink:type="arc"/>
      <link:label id="id_2dbeb314" xlink:label="lbl_label767472404" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Nordic A/S, Copenhagen [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNordicASCopenhagenMember" xlink:label="lbl_AlconNordicASCopenhagenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconNordicASCopenhagenMember" xlink:to="lbl_label767472404" xlink:type="arc"/>
      <link:label id="id_1e75de5c" xlink:label="lbl_label511041116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz A/S, Copenhagen [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozASCopenhagenMember" xlink:label="lbl_SandozASCopenhagenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozASCopenhagenMember" xlink:to="lbl_label511041116" xlink:type="arc"/>
      <link:label id="id_574d51cf" xlink:label="lbl_label1464685007" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Ecuador S.A., Quito [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisEcuadorS.A.QuitoMember" xlink:label="lbl_NovartisEcuadorS.A.QuitoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisEcuadorS.A.QuitoMember" xlink:to="lbl_label1464685007" xlink:type="arc"/>
      <link:label id="id_679520f0" xlink:label="lbl_label1737826544" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma S.A.E., Cairo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaS.A.E.CairoMember" xlink:label="lbl_NovartisPharmaS.A.E.CairoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaS.A.E.CairoMember" xlink:to="lbl_label1737826544" xlink:type="arc"/>
      <link:label id="id_575ca2d" xlink:label="lbl_label91605549" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Egypt Pharma S.A.E., New Cairo City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:label="lbl_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:to="lbl_label91605549" xlink:type="arc"/>
      <link:label id="id_37f4e561" xlink:label="lbl_label938796385" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Finland Oy, Espoo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinlandOyEspooMember" xlink:label="lbl_NovartisFinlandOyEspooMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFinlandOyEspooMember" xlink:to="lbl_label938796385" xlink:type="arc"/>
      <link:label id="id_42a0d3e7" xlink:label="lbl_label1117836263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Groupe France S.A., Rueil-Malmaison [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:label="lbl_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:to="lbl_label1117836263" xlink:type="arc"/>
      <link:label id="id_7ba00702" xlink:label="lbl_label2074085122" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma S.A.S., Rueil-Malmaison [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:label="lbl_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:to="lbl_label2074085122" xlink:type="arc"/>
      <link:label id="id_d3dae7a" xlink:label="lbl_label222146170" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Laboratoires Alcon S.A.S., Rueil-Malmaison [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:label="lbl_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:to="lbl_label222146170" xlink:type="arc"/>
      <link:label id="id_3116dc5e" xlink:label="lbl_label823581790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz S.A.S., Levallois-Perret [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.A.S.LevalloisPerretMember" xlink:label="lbl_SandozS.A.S.LevalloisPerretMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozS.A.S.LevalloisPerretMember" xlink:to="lbl_label823581790" xlink:type="arc"/>
      <link:label id="id_6e409e90" xlink:label="lbl_label1849728656" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Deutschland GmbH, Wehr [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeutschlandGmbHWehrMember" xlink:label="lbl_NovartisDeutschlandGmbHWehrMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisDeutschlandGmbHWehrMember" xlink:to="lbl_label1849728656" xlink:type="arc"/>
      <link:label id="id_17634123" xlink:label="lbl_label392380707" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma GmbH, Nuremberg [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaGmbHNurembergMember" xlink:label="lbl_NovartisPharmaGmbHNurembergMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaGmbHNurembergMember" xlink:to="lbl_label392380707" xlink:type="arc"/>
      <link:label id="id_1cd787d" xlink:label="lbl_label30242941" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Produktions GmbH, Wehr [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaProduktionsGmbHWehrMember" xlink:label="lbl_NovartisPharmaProduktionsGmbHWehrMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaProduktionsGmbHWehrMember" xlink:to="lbl_label30242941" xlink:type="arc"/>
      <link:label id="id_401bb4ef" xlink:label="lbl_label1075557615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Business Services GmbH, Wehr [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBusinessServicesGmbHWehrMember" xlink:label="lbl_NovartisBusinessServicesGmbHWehrMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisBusinessServicesGmbHWehrMember" xlink:to="lbl_label1075557615" xlink:type="arc"/>
      <link:label id="id_3672a73d" xlink:label="lbl_label913483581" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Pharma GmbH, Freiburg im Breisgau [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:label="lbl_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:to="lbl_label913483581" xlink:type="arc"/>
      <link:label id="id_1fd8572e" xlink:label="lbl_label534271790" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WaveLight GmbH, Erlangen [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WaveLightGmbHErlangenMember" xlink:label="lbl_WaveLightGmbHErlangenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WaveLightGmbHErlangenMember" xlink:to="lbl_label534271790" xlink:type="arc"/>
      <link:label id="id_4649f215" xlink:label="lbl_label1179251221" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIBA Vision GmbH, Grosswallstadt [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionGmbHGrosswallstadtMember" xlink:label="lbl_CIBAVisionGmbHGrosswallstadtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CIBAVisionGmbHGrosswallstadtMember" xlink:to="lbl_label1179251221" xlink:type="arc"/>
      <link:label id="id_72338a4a" xlink:label="lbl_label1915980362" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz International GmbH, Holzkirchen [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozInternationalGmbHHolzkirchenMember" xlink:label="lbl_SandozInternationalGmbHHolzkirchenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozInternationalGmbHHolzkirchenMember" xlink:to="lbl_label1915980362" xlink:type="arc"/>
      <link:label id="id_2c6debd5" xlink:label="lbl_label745401301" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">HEXAL AG, Holzkirchen [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_HEXALAGHolzkirchenMember" xlink:label="lbl_HEXALAGHolzkirchenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_HEXALAGHolzkirchenMember" xlink:to="lbl_label745401301" xlink:type="arc"/>
      <link:label id="id_3b790099" xlink:label="lbl_label997785753" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Salutas Pharma GmbH, Barleben [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SalutasPharmaGmbHBarlebenMember" xlink:label="lbl_SalutasPharmaGmbHBarlebenMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SalutasPharmaGmbHBarlebenMember" xlink:to="lbl_label997785753" xlink:type="arc"/>
      <link:label id="id_5a59fba6" xlink:label="lbl_label1515846566" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1 A Pharma GmbH, Oberhaching [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1APharmaGmbHOberhachingMember" xlink:label="lbl_A1APharmaGmbHOberhachingMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1APharmaGmbHOberhachingMember" xlink:to="lbl_label1515846566" xlink:type="arc"/>
      <link:label id="id_63faa754" xlink:label="lbl_label1677371220" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aeropharm GmbH, Rudolstadt [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AeropharmGmbHRudolstadtMember" xlink:label="lbl_AeropharmGmbHRudolstadtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AeropharmGmbHRudolstadtMember" xlink:to="lbl_label1677371220" xlink:type="arc"/>
      <link:label id="id_53a147c7" xlink:label="lbl_label1403078599" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novista Insurance Limited, Gibraltar City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovistaInsuranceLimitedGibraltarCityMember" xlink:label="lbl_NovistaInsuranceLimitedGibraltarCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovistaInsuranceLimitedGibraltarCityMember" xlink:to="lbl_label1403078599" xlink:type="arc"/>
      <link:label id="id_2881adea" xlink:label="lbl_label679587306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis (Hellas) S.A.C.I., Metamorphosis/Athens [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:label="lbl_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:to="lbl_label679587306" xlink:type="arc"/>
      <link:label id="id_24c810e" xlink:label="lbl_label38568206" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories Hellas Commercial and Industrial S.A., Maroussi, Athens [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:label="lbl_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:to="lbl_label38568206" xlink:type="arc"/>
      <link:label id="id_20010fd1" xlink:label="lbl_label536940497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Hungary Healthcare Limited Liability Company, Budapest [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:label="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:to="lbl_label536940497" xlink:type="arc"/>
      <link:label id="id_3e0a5b35" xlink:label="lbl_label1040866101" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Hungary Limited Liability Company, Budapest [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:label="lbl_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:to="lbl_label1040866101" xlink:type="arc"/>
      <link:label id="id_866e747" xlink:label="lbl_label140961607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis India Limited, Mumbai [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIndiaLimitedMumbaiMember" xlink:label="lbl_NovartisIndiaLimitedMumbaiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisIndiaLimitedMumbaiMember" xlink:to="lbl_label140961607" xlink:type="arc"/>
      <link:label id="id_5d283d4e" xlink:label="lbl_label1562918222" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Healthcare Private Limited, Mumbai [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:label="lbl_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:to="lbl_label1562918222" xlink:type="arc"/>
      <link:label id="id_209ec8c8" xlink:label="lbl_label547277000" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories (India) Private Limited, Bangalore [member]</link:label>
      <link:label id="id_2bccb2e" xlink:label="lbl_label45927214" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Private Limited, Mumbai [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPrivateLimitedMumbaiMember" xlink:label="lbl_SandozPrivateLimitedMumbaiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozPrivateLimitedMumbaiMember" xlink:to="lbl_label45927214" xlink:type="arc"/>
      <link:label id="id_30564a91" xlink:label="lbl_label810961553" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PT. Novartis Indonesia, Jakarta [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PT.NovartisIndonesiaJakartaMember" xlink:label="lbl_PT.NovartisIndonesiaJakartaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PT.NovartisIndonesiaJakartaMember" xlink:to="lbl_label810961553" xlink:type="arc"/>
      <link:label id="id_bca100f" xlink:label="lbl_label197791759" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PT. CIBA Vision Batam, Batam [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PT.CIBAVisionBatamBatamMember" xlink:label="lbl_PT.CIBAVisionBatamBatamMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PT.CIBAVisionBatamBatamMember" xlink:to="lbl_label197791759" xlink:type="arc"/>
      <link:label id="id_4fcc5f83" xlink:label="lbl_label1338793859" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Ireland Limited, Dublin [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIrelandLimitedDublinMember" xlink:label="lbl_NovartisIrelandLimitedDublinMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisIrelandLimitedDublinMember" xlink:to="lbl_label1338793859" xlink:type="arc"/>
      <link:label id="id_74708b2c" xlink:label="lbl_label1953532716" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Ringaskiddy Limited, Ringaskiddy, County Cork [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:label="lbl_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:to="lbl_label1953532716" xlink:type="arc"/>
      <link:label id="id_169e129" xlink:label="lbl_label23716137" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories Ireland Limited, Cork City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:label="lbl_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:to="lbl_label23716137" xlink:type="arc"/>
      <link:label id="id_1a15ed68" xlink:label="lbl_label437644648" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Israel Ltd., Petach Tikva [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIsraelLtd.PetachTikvaMember" xlink:label="lbl_NovartisIsraelLtd.PetachTikvaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisIsraelLtd.PetachTikvaMember" xlink:to="lbl_label437644648" xlink:type="arc"/>
      <link:label id="id_79225a64" xlink:label="lbl_label2032294500" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Optonol Ltd., Neve-Ilan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OptonolLtd.NeveIlanMember" xlink:label="lbl_OptonolLtd.NeveIlanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OptonolLtd.NeveIlanMember" xlink:to="lbl_label2032294500" xlink:type="arc"/>
      <link:label id="id_572859e2" xlink:label="lbl_label1462262242" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Farma S.p.A., Origgio [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaS.p.A.OriggioMember" xlink:label="lbl_NovartisFarmaS.p.A.OriggioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFarmaS.p.A.OriggioMember" xlink:to="lbl_label1462262242" xlink:type="arc"/>
      <link:label id="id_51e555ae" xlink:label="lbl_label1373984174" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Italia S.p.A., Milan [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconItaliaS.p.A.MilanMember" xlink:label="lbl_AlconItaliaS.p.A.MilanMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconItaliaS.p.A.MilanMember" xlink:to="lbl_label1373984174" xlink:type="arc"/>
      <link:label id="id_39182a7" xlink:label="lbl_label59867815" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz S.p.A., Origgio [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.p.A.OriggioMember" xlink:label="lbl_SandozS.p.A.OriggioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozS.p.A.OriggioMember" xlink:to="lbl_label59867815" xlink:type="arc"/>
      <link:label id="id_23768229" xlink:label="lbl_label594969129" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Industrial Products S.p.A., Rovereto [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:label="lbl_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:to="lbl_label594969129" xlink:type="arc"/>
      <link:label id="id_46070173" xlink:label="lbl_label1174864243" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Holding Japan K.K., Tokyo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHoldingJapanK.K.TokyoMember" xlink:label="lbl_NovartisHoldingJapanK.K.TokyoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHoldingJapanK.K.TokyoMember" xlink:to="lbl_label1174864243" xlink:type="arc"/>
      <link:label id="id_30b5637" xlink:label="lbl_label51074615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma K.K., Tokyo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaK.K.TokyoMember" xlink:label="lbl_NovartisPharmaK.K.TokyoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaK.K.TokyoMember" xlink:to="lbl_label51074615" xlink:type="arc"/>
      <link:label id="id_2358b28" xlink:label="lbl_label37063464" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Japan Ltd., Tokyo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconJapanLtd.TokyoMember" xlink:label="lbl_AlconJapanLtd.TokyoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconJapanLtd.TokyoMember" xlink:to="lbl_label37063464" xlink:type="arc"/>
      <link:label id="id_90ace63" xlink:label="lbl_label151703139" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz K.K., Tokyo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozK.K.TokyoMember" xlink:label="lbl_SandozK.K.TokyoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozK.K.TokyoMember" xlink:to="lbl_label151703139" xlink:type="arc"/>
      <link:label id="id_2d24611e" xlink:label="lbl_label757358878" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Investments S.a r.l., Luxembourg City [member]</link:label>
      <link:label id="id_6373cce9" xlink:label="lbl_label1668533481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Finance S.A., Luxembourg City [member]</link:label>
      <link:label id="id_495a738b" xlink:label="lbl_label1230664587" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Corporation (Malaysia) Sdn. Bhd., Kuala Lumpur [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:label="lbl_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:to="lbl_label1230664587" xlink:type="arc"/>
      <link:label id="id_30ea85e" xlink:label="lbl_label51292254" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories (Malaysia) Sdn. Bhd., Petaling Jaya [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:label="lbl_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:to="lbl_label51292254" xlink:type="arc"/>
      <link:label id="id_2040f9e0" xlink:label="lbl_label541129184" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIBA Vision Johor Sdn. Bhd., Kuala Lumpur [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:label="lbl_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:to="lbl_label541129184" xlink:type="arc"/>
      <link:label id="id_23d9a520" xlink:label="lbl_label601466144" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Farmaceutica, S.A. de C.V., Mexico City [member]</link:label>
      <link:label id="id_7bc6228f" xlink:label="lbl_label2076582543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratorios, S.A. de C.V., Mexico City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:label="lbl_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:to="lbl_label2076582543" xlink:type="arc"/>
      <link:label id="id_77370b0a" xlink:label="lbl_label2000096010" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz, S.A. de C.V., Mexico City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.A.DeC.V.MexicoCityMember" xlink:label="lbl_SandozS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozS.A.DeC.V.MexicoCityMember" xlink:to="lbl_label2000096010" xlink:type="arc"/>
      <link:label id="id_7143fa4f" xlink:label="lbl_label1900280399" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Maroc SA, Casablanca [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaMarocSACasablancaMember" xlink:label="lbl_NovartisPharmaMarocSACasablancaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaMarocSACasablancaMember" xlink:to="lbl_label1900280399" xlink:type="arc"/>
      <link:label id="id_30236580" xlink:label="lbl_label807626112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Netherlands B.V., Arnhem [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNetherlandsB.V.ArnhemMember" xlink:label="lbl_NovartisNetherlandsB.V.ArnhemMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisNetherlandsB.V.ArnhemMember" xlink:to="lbl_label807626112" xlink:type="arc"/>
      <link:label id="id_1fa13a8d" xlink:label="lbl_label530659981" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma B.V., Arnhem [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaB.V.ArnhemMember" xlink:label="lbl_NovartisPharmaB.V.ArnhemMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaB.V.ArnhemMember" xlink:to="lbl_label530659981" xlink:type="arc"/>
      <link:label id="id_6a5dd736" xlink:label="lbl_label1784534838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Nederland B.V., Arnhem [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNederlandB.V.ArnhemMember" xlink:label="lbl_AlconNederlandB.V.ArnhemMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconNederlandB.V.ArnhemMember" xlink:to="lbl_label1784534838" xlink:type="arc"/>
      <link:label id="id_89b7931" xlink:label="lbl_label144406833" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz B.V., Almere [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozB.V.AlmereMember" xlink:label="lbl_SandozB.V.AlmereMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozB.V.AlmereMember" xlink:to="lbl_label144406833" xlink:type="arc"/>
      <link:label id="id_7ae0d9be" xlink:label="lbl_label2061556158" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis New Zealand Ltd, Auckland [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNewZealandLtdAucklandMember" xlink:label="lbl_NovartisNewZealandLtdAucklandMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisNewZealandLtdAucklandMember" xlink:to="lbl_label2061556158" xlink:type="arc"/>
      <link:label id="id_659fd8fc" xlink:label="lbl_label1704974588" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Norge AS, Oslo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNorgeASOsloMember" xlink:label="lbl_NovartisNorgeASOsloMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisNorgeASOsloMember" xlink:to="lbl_label1704974588" xlink:type="arc"/>
      <link:label id="id_53e6555" xlink:label="lbl_label87975253" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma (Pakistan) Limited, Karachi [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaPakistanLimitedKarachiMember" xlink:label="lbl_NovartisPharmaPakistanLimitedKarachiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaPakistanLimitedKarachiMember" xlink:to="lbl_label87975253" xlink:type="arc"/>
      <link:label id="id_2f1259ff" xlink:label="lbl_label789731839" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma (Logistics), Inc., Panama City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:label="lbl_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:to="lbl_label789731839" xlink:type="arc"/>
      <link:label id="id_51335372" xlink:label="lbl_label1362318194" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Centroamerica S.A., Panama City [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCentroamericaS.A.PanamaCityMember" xlink:label="lbl_AlconCentroamericaS.A.PanamaCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconCentroamericaS.A.PanamaCityMember" xlink:to="lbl_label1362318194" xlink:type="arc"/>
      <link:label id="id_240f2db1" xlink:label="lbl_label604974513" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Healthcare Philippines, Inc., Manila [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:label="lbl_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:to="lbl_label604974513" xlink:type="arc"/>
      <link:label id="id_2050b70f" xlink:label="lbl_label542160655" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Philippines Corporation, Manila [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPhilippinesCorporationManilaMember" xlink:label="lbl_SandozPhilippinesCorporationManilaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozPhilippinesCorporationManilaMember" xlink:to="lbl_label542160655" xlink:type="arc"/>
      <link:label id="id_5fffa6cd" xlink:label="lbl_label1610589901" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Poland Sp. z o.o., Warsaw [member]</link:label>
      <link:label id="id_74c896dd" xlink:label="lbl_label1959302877" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Polska Sp. z o.o., Warsaw [member]</link:label>
      <link:label id="id_712c39fe" xlink:label="lbl_label1898723838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Polska Sp. z o.o., Warsaw [member]</link:label>
      <link:label id="id_4ba5de33" xlink:label="lbl_label1269161523" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lek S.A., Strykow [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LekS.A.StrykowMember" xlink:label="lbl_LekS.A.StrykowMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LekS.A.StrykowMember" xlink:to="lbl_label1269161523" xlink:type="arc"/>
      <link:label id="id_520521db" xlink:label="lbl_label1376068059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Portugal SGPS Lda., Porto Salvo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:label="lbl_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:to="lbl_label1376068059" xlink:type="arc"/>
      <link:label id="id_c95dd37" xlink:label="lbl_label211148087" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Farma - Produtos Farmaceuticos S.A., Porto Salvo [member]</link:label>
      <link:label id="id_881ce5c" xlink:label="lbl_label142724700" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Portugal-Produtos e Equipamentos Oftalmologicos Lda., Porto Salvo [member]</link:label>
      <link:label id="id_1c2378c4" xlink:label="lbl_label472086724" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Farmaceutica Lda., Porto Salvo [member]</link:label>
      <link:label id="id_4a9bb1ea" xlink:label="lbl_label1251717610" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Services Romania S.R.L., Bucharest [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:label="lbl_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:to="lbl_label1251717610" xlink:type="arc"/>
      <link:label id="id_30d12469" xlink:label="lbl_label819012713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Romania S.R.L., Bucharest [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconRomaniaS.R.L.BucharestMember" xlink:label="lbl_AlconRomaniaS.R.L.BucharestMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconRomaniaS.R.L.BucharestMember" xlink:to="lbl_label819012713" xlink:type="arc"/>
      <link:label id="id_1a1b1a89" xlink:label="lbl_label437983881" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz S.R.L., Targu-Mures [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.R.L.TarguMuresMember" xlink:label="lbl_SandozS.R.L.TarguMuresMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozS.R.L.TarguMuresMember" xlink:to="lbl_label437983881" xlink:type="arc"/>
      <link:label id="id_620cd72f" xlink:label="lbl_label1645008687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma LLC, Moscow [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaLLCMoscowMember" xlink:label="lbl_NovartisPharmaLLCMoscowMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaLLCMoscowMember" xlink:to="lbl_label1645008687" xlink:type="arc"/>
      <link:label id="id_a4d4ccd" xlink:label="lbl_label172838093" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Farmacevtika LLC, Moscow [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconFarmacevtikaLLCMoscowMember" xlink:label="lbl_AlconFarmacevtikaLLCMoscowMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconFarmacevtikaLLCMoscowMember" xlink:to="lbl_label172838093" xlink:type="arc"/>
      <link:label id="id_4f8c203f" xlink:label="lbl_label1334583359" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ZAO Sandoz, Moscow [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZAOSandozMoscowMember" xlink:label="lbl_ZAOSandozMoscowMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ZAOSandozMoscowMember" xlink:to="lbl_label1334583359" xlink:type="arc"/>
      <link:label id="id_3b17514" xlink:label="lbl_label61961492" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Neva LLC, St. Petersburg [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNevaLLCSt.PetersburgMember" xlink:label="lbl_NovartisNevaLLCSt.PetersburgMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisNevaLLCSt.PetersburgMember" xlink:to="lbl_label61961492" xlink:type="arc"/>
      <link:label id="id_2d25f558" xlink:label="lbl_label757462360" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Saudi Pharmaceutical Distribution Co. Ltd., Riyadh [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:label="lbl_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:to="lbl_label757462360" xlink:type="arc"/>
      <link:label id="id_ef37254" xlink:label="lbl_label250835540" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis (Singapore) Pte Ltd., Singapore [member]</link:label>
      <link:label id="id_27535d56" xlink:label="lbl_label659774806" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Singapore [member]</link:label>
      <link:label id="id_73caa11d" xlink:label="lbl_label1942659357" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore [member]</link:label>
      <link:label id="id_5ac408db" xlink:label="lbl_label1522796763" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Institute for Tropical Diseases Pte Ltd, Singapore [member]</link:label>
      <link:label id="id_405feadd" xlink:label="lbl_label1080027869" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Singapore Manufacturing Pte. Ltd., Singapore [member]</link:label>
      <link:label id="id_5ad357d3" xlink:label="lbl_label1523800019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIBA Vision Asian Manufacturing and Logistics Pte Ltd., Singapore [member]</link:label>
      <link:label id="id_5654aaaa" xlink:label="lbl_label1448389290" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Pte Ltd, Singapore [member]</link:label>
      <link:label id="id_1f0269e9" xlink:label="lbl_label520251881" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Slovakia s.r.o., Bratislava [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSlovakiaS.r.o.BratislavaMember" xlink:label="lbl_NovartisSlovakiaS.r.o.BratislavaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSlovakiaS.r.o.BratislavaMember" xlink:to="lbl_label520251881" xlink:type="arc"/>
      <link:label id="id_3337da30" xlink:label="lbl_label859298352" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lek Pharmaceuticals d.d., Ljubjana [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LekPharmaceuticalsD.d.LjubjanaMember" xlink:label="lbl_LekPharmaceuticalsD.d.LjubjanaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LekPharmaceuticalsD.d.LjubjanaMember" xlink:to="lbl_label859298352" xlink:type="arc"/>
      <link:label id="id_24583ab1" xlink:label="lbl_label609761969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Pharmaceuticals d.d., Ljubjana [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:label="lbl_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:to="lbl_label609761969" xlink:type="arc"/>
      <link:label id="id_25162424" xlink:label="lbl_label622208036" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis South Africa (Pty) Ltd, Midrand [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSouthAfricaPtyLtdMidrandMember" xlink:label="lbl_NovartisSouthAfricaPtyLtdMidrandMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSouthAfricaPtyLtdMidrandMember" xlink:to="lbl_label622208036" xlink:type="arc"/>
      <link:label id="id_c4640a" xlink:label="lbl_label12870666" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories (South Africa) (Pty) Ltd., Midrand [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:label="lbl_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:to="lbl_label12870666" xlink:type="arc"/>
      <link:label id="id_44cecbf4" xlink:label="lbl_label1154403316" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz South Africa (Pty) Ltd, Kempton Park [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:label="lbl_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:to="lbl_label1154403316" xlink:type="arc"/>
      <link:label id="id_51e9e54d" xlink:label="lbl_label1374283085" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Korea Ltd., Seoul [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisKoreaLtd.SeoulMember" xlink:label="lbl_NovartisKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisKoreaLtd.SeoulMember" xlink:to="lbl_label1374283085" xlink:type="arc"/>
      <link:label id="id_2fbc9bcb" xlink:label="lbl_label800889803" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Korea Ltd., Seoul [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconKoreaLtd.SeoulMember" xlink:label="lbl_AlconKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconKoreaLtd.SeoulMember" xlink:to="lbl_label800889803" xlink:type="arc"/>
      <link:label id="id_3acd65c6" xlink:label="lbl_label986539462" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Korea Ltd., Seoul [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozKoreaLtd.SeoulMember" xlink:label="lbl_SandozKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozKoreaLtd.SeoulMember" xlink:to="lbl_label986539462" xlink:type="arc"/>
      <link:label id="id_2cb12411" xlink:label="lbl_label749806609" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Farmaceutica, S.A., Barcelona [member]</link:label>
      <link:label id="id_1788ee4f" xlink:label="lbl_label394849871" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Cusi S.A., Barcelona [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCusiS.A.BarcelonaMember" xlink:label="lbl_AlconCusiS.A.BarcelonaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconCusiS.A.BarcelonaMember" xlink:to="lbl_label394849871" xlink:type="arc"/>
      <link:label id="id_25c7e6c1" xlink:label="lbl_label633857729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Farmaceutica S.A., Madrid [member]</link:label>
      <link:label id="id_578d972e" xlink:label="lbl_label1468897070" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Industrial Products S.A., Barcelona [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIndustrialProductsS.A.BarcelonaMember" xlink:label="lbl_SandozIndustrialProductsS.A.BarcelonaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozIndustrialProductsS.A.BarcelonaMember" xlink:to="lbl_label1468897070" xlink:type="arc"/>
      <link:label id="id_6a673c57" xlink:label="lbl_label1785150551" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Abadia Retuerta S.A., Sardon de Duero/Valladolid [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:label="lbl_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:to="lbl_label1785150551" xlink:type="arc"/>
      <link:label id="id_6cfceac6" xlink:label="lbl_label1828514502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Sverige AB, Stockholm [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSverigeABStockholmMember" xlink:label="lbl_NovartisSverigeABStockholmMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSverigeABStockholmMember" xlink:to="lbl_label1828514502" xlink:type="arc"/>
      <link:label id="id_1784eaf5" xlink:label="lbl_label394586869" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis International AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalAGBaselMember" xlink:label="lbl_NovartisInternationalAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInternationalAGBaselMember" xlink:to="lbl_label394586869" xlink:type="arc"/>
      <link:label id="id_1cfce538" xlink:label="lbl_label486335800" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Holding AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHoldingAGBaselMember" xlink:label="lbl_NovartisHoldingAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHoldingAGBaselMember" xlink:to="lbl_label486335800" xlink:type="arc"/>
      <link:label id="id_523c2f36" xlink:label="lbl_label1379675958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis International Pharmaceutical AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalPharmaceuticalAGBaselMember" xlink:label="lbl_NovartisInternationalPharmaceuticalAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInternationalPharmaceuticalAGBaselMember" xlink:to="lbl_label1379675958" xlink:type="arc"/>
      <link:label id="id_31c15b81" xlink:label="lbl_label834755457" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaAGBaselMember" xlink:label="lbl_NovartisPharmaAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaAGBaselMember" xlink:to="lbl_label834755457" xlink:type="arc"/>
      <link:label id="id_6bb5d046" xlink:label="lbl_label1807077446" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Services AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaServicesAGBaselMember" xlink:label="lbl_NovartisPharmaServicesAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaServicesAGBaselMember" xlink:to="lbl_label1807077446" xlink:type="arc"/>
      <link:label id="id_151ca66f" xlink:label="lbl_label354199151" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Schweizerhalle AG, Muttenz [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:label="lbl_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:to="lbl_label354199151" xlink:type="arc"/>
      <link:label id="id_7888d993" xlink:label="lbl_label2022234515" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Stein AG, Stein [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSteinAGSteinMember" xlink:label="lbl_NovartisPharmaSteinAGSteinMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaSteinAGSteinMember" xlink:to="lbl_label2022234515" xlink:type="arc"/>
      <link:label id="id_46b0e62c" xlink:label="lbl_label1185998380" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma Schweiz AG, Risch [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSchweizAGRischMember" xlink:label="lbl_NovartisPharmaSchweizAGRischMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaSchweizAGRischMember" xlink:to="lbl_label1185998380" xlink:type="arc"/>
      <link:label id="id_175b3164" xlink:label="lbl_label391852388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Switzerland SA, Risch [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconSwitzerlandSARischMember" xlink:label="lbl_AlconSwitzerlandSARischMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconSwitzerlandSARischMember" xlink:to="lbl_label391852388" xlink:type="arc"/>
      <link:label id="id_6dde1079" xlink:label="lbl_label1843269753" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Pharmaceuticals Ltd., Fribourg [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalsLtd.FribourgMember" xlink:label="lbl_AlconPharmaceuticalsLtd.FribourgMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPharmaceuticalsLtd.FribourgMember" xlink:to="lbl_label1843269753" xlink:type="arc"/>
      <link:label id="id_2056dcf1" xlink:label="lbl_label542563569" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozAGBaselMember" xlink:label="lbl_SandozAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozAGBaselMember" xlink:to="lbl_label542563569" xlink:type="arc"/>
      <link:label id="id_c4607df" xlink:label="lbl_label205916127" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Pharmaceuticals AG, Risch [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPharmaceuticalsAGRischMember" xlink:label="lbl_SandozPharmaceuticalsAGRischMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozPharmaceuticalsAGRischMember" xlink:to="lbl_label205916127" xlink:type="arc"/>
      <link:label id="id_2bda8165" xlink:label="lbl_label735740261" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis (Taiwan) Co., Ltd., Taipei [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:label="lbl_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:to="lbl_label735740261" xlink:type="arc"/>
      <link:label id="id_1cc3a1bc" xlink:label="lbl_label482582972" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis (Thailand) Limited, Bangkok [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisThailandLimitedBangkokMember" xlink:label="lbl_NovartisThailandLimitedBangkokMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisThailandLimitedBangkokMember" xlink:to="lbl_label482582972" xlink:type="arc"/>
      <link:label id="id_1e10820d" xlink:label="lbl_label504398349" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories (Thailand) Limited, Bangkok [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesThailandLimitedBangkokMember" xlink:label="lbl_AlconLaboratoriesThailandLimitedBangkokMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesThailandLimitedBangkokMember" xlink:to="lbl_label504398349" xlink:type="arc"/>
      <link:label id="id_76d30813" xlink:label="lbl_label1993541651" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Saglik, Gida ve Tarim Urunleri Sanayi ve Ticaret A.S., Istanbul [member]</link:label>
      <link:label id="id_7653b21e" xlink:label="lbl_label1985196574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratuvarlari Ticaret A.S., Istanbul [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:label="lbl_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:to="lbl_label1985196574" xlink:type="arc"/>
      <link:label id="id_6083f415" xlink:label="lbl_label1619260437" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Ilac Sanayi ve Ticaret A.S., Istanbul [member]</link:label>
      <link:label id="id_2c3cd0a2" xlink:label="lbl_label742183074" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Grup Saglik Urunleri Ilaclari Sanayi ve Ticaret A.S., Gebze - Kocaeli [member]</link:label>
      <link:label id="id_775d02f4" xlink:label="lbl_label2002584308" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Middle East FZE, Dubai [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisMiddleEastFZEDubaiMember" xlink:label="lbl_NovartisMiddleEastFZEDubaiMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisMiddleEastFZEDubaiMember" xlink:to="lbl_label2002584308" xlink:type="arc"/>
      <link:label id="id_629f2d5a" xlink:label="lbl_label1654599002" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis UK Limited, Frimley/Camberley [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUKLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisUKLimitedFrimleyCamberleyMember" xlink:to="lbl_label1654599002" xlink:type="arc"/>
      <link:label id="id_24628050" xlink:label="lbl_label610435152" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharmaceuticals UK Limited, Frimley/Camberley [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:to="lbl_label610435152" xlink:type="arc"/>
      <link:label id="id_72101279" xlink:label="lbl_label1913655929" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Grimsby Limited, Frimley/Camberley [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:to="lbl_label1913655929" xlink:type="arc"/>
      <link:label id="id_41ed60da" xlink:label="lbl_label1106075866" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Eye Care UK Limited, Frimley/Camberley [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:label="lbl_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:to="lbl_label1106075866" xlink:type="arc"/>
      <link:label id="id_61fe5165" xlink:label="lbl_label1644056933" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Limited, Frimley/Camberley [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozLimitedFrimleyCamberleyMember" xlink:label="lbl_SandozLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozLimitedFrimleyCamberleyMember" xlink:to="lbl_label1644056933" xlink:type="arc"/>
      <link:label id="id_5fa82378" xlink:label="lbl_label1604854648" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Glaxosmithkline Consumer Healthcare Holdings Limited, Brentford, Middlesex [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:label="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:to="lbl_label1604854648" xlink:type="arc"/>
      <link:label id="id_4687124a" xlink:label="lbl_label1183257162" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Corporation, East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCorporationEastHanoverNYMember" xlink:label="lbl_NovartisCorporationEastHanoverNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisCorporationEastHanoverNYMember" xlink:to="lbl_label1183257162" xlink:type="arc"/>
      <link:label id="id_739f0d6b" xlink:label="lbl_label1939803499" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Finance Corporation, New York, NY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceCorporationNewYorkNYMember" xlink:label="lbl_NovartisFinanceCorporationNewYorkNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFinanceCorporationNewYorkNYMember" xlink:to="lbl_label1939803499" xlink:type="arc"/>
      <link:label id="id_6a2defad" xlink:label="lbl_label1781395373" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Capital Corporation, New York, NY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCapitalCorporationNewYorkNYMember" xlink:label="lbl_NovartisCapitalCorporationNewYorkNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisCapitalCorporationNewYorkNYMember" xlink:to="lbl_label1781395373" xlink:type="arc"/>
      <link:label id="id_2951cebe" xlink:label="lbl_label693227198" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharmaceuticals Corporation, East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:label="lbl_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:to="lbl_label693227198" xlink:type="arc"/>
      <link:label id="id_10d13d66" xlink:label="lbl_label282148198" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Institutes for BioMedical Research, Inc., Cambridge, MA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:label="lbl_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:to="lbl_label282148198" xlink:type="arc"/>
      <link:label id="id_2e63ddd" xlink:label="lbl_label48643549" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Institute for Functional Genomics, Inc., San Diego, CA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:label="lbl_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:to="lbl_label48643549" xlink:type="arc"/>
      <link:label id="id_13ee6af1" xlink:label="lbl_label334392049" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Vaccines and Diagnostics, Inc., Cambridge, MA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:label="lbl_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:to="lbl_label334392049" xlink:type="arc"/>
      <link:label id="id_5eea5c27" xlink:label="lbl_label1592417319" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Services, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisServicesInc.EastHanoverNYMember" xlink:label="lbl_NovartisServicesInc.EastHanoverNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisServicesInc.EastHanoverNYMember" xlink:to="lbl_label1592417319" xlink:type="arc"/>
      <link:label id="id_51dba865" xlink:label="lbl_label1373349989" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories Holding Corporation, Fort Worth, TX [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:label="lbl_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:to="lbl_label1373349989" xlink:type="arc"/>
      <link:label id="id_31a31f0b" xlink:label="lbl_label832773899" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories, Inc., Fort Worth, TX [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesInc.FortWorthTXMember" xlink:label="lbl_AlconLaboratoriesInc.FortWorthTXMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesInc.FortWorthTXMember" xlink:to="lbl_label832773899" xlink:type="arc"/>
      <link:label id="id_c4acd60" xlink:label="lbl_label206228832" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Refractivehorizons, LLC, Fort Worth, TX [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:label="lbl_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:to="lbl_label206228832" xlink:type="arc"/>
      <link:label id="id_48c065e" xlink:label="lbl_label76285534" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Research, Ltd., Fort Worth, TX [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconResearchLtd.FortWorthTXMember" xlink:label="lbl_AlconResearchLtd.FortWorthTXMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconResearchLtd.FortWorthTXMember" xlink:to="lbl_label76285534" xlink:type="arc"/>
      <link:label id="id_17312f5" xlink:label="lbl_label24318709" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Lensx, Inc., Aliso Viejo, CA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLensxInc.AlisoViejoCAMember" xlink:label="lbl_AlconLensxInc.AlisoViejoCAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLensxInc.AlisoViejoCAMember" xlink:to="lbl_label24318709" xlink:type="arc"/>
      <link:label id="id_305f2824" xlink:label="lbl_label811542564" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Inc., Princeton, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozInc.PrincetonNJMember" xlink:label="lbl_SandozInc.PrincetonNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozInc.PrincetonNJMember" xlink:to="lbl_label811542564" xlink:type="arc"/>
      <link:label id="id_1810f51f" xlink:label="lbl_label403764511" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eon Labs, Inc., Princeton, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EonLabsInc.PrincetonNJMember" xlink:label="lbl_EonLabsInc.PrincetonNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EonLabsInc.PrincetonNJMember" xlink:to="lbl_label403764511" xlink:type="arc"/>
      <link:label id="id_1c839601" xlink:label="lbl_label478385665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fougera Pharmaceuticals Inc., Melville, NY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:label="lbl_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:to="lbl_label478385665" xlink:type="arc"/>
      <link:label id="id_7af3c86c" xlink:label="lbl_label2062796908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis de Venezuela, S.A., Caracas [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeVenezuelaS.A.CaracasMember" xlink:label="lbl_NovartisDeVenezuelaS.A.CaracasMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisDeVenezuelaS.A.CaracasMember" xlink:to="lbl_label2062796908" xlink:type="arc"/>
      <link:label id="id_51d78d0e" xlink:label="lbl_label1373080846" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Pharmaceutical, C.A., Caracas [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalC.A.CaracasMember" xlink:label="lbl_AlconPharmaceuticalC.A.CaracasMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPharmaceuticalC.A.CaracasMember" xlink:to="lbl_label1373080846" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBiocienciasS.A.SaoPauloMember" xlink:label="lbl_NovartisBiocienciasS.A.SaoPauloMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisBiocienciasS.A.SaoPauloMember" xlink:to="lbl_label772152317" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:label="lbl_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:to="lbl_label1619681781" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:label="lbl_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:to="lbl_label1709742902" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:label="lbl_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:to="lbl_label22162384" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:label="lbl_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:to="lbl_label601466144" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:label="lbl_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:to="lbl_label211148087" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:label="lbl_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:to="lbl_label142724700" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozFarmaceuticaLda.PortoSalvoMember" xlink:label="lbl_SandozFarmaceuticaLda.PortoSalvoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozFarmaceuticaLda.PortoSalvoMember" xlink:to="lbl_label472086724" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:label="lbl_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:to="lbl_label749806609" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozFarmaceuticaS.A.MadridMember" xlink:label="lbl_SandozFarmaceuticaS.A.MadridMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozFarmaceuticaS.A.MadridMember" xlink:to="lbl_label633857729" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:label="lbl_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:to="lbl_label1993541651" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:label="lbl_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:to="lbl_label1619260437" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:label="lbl_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:to="lbl_label742183074" xlink:type="arc"/>
      <link:label id="id_5219f8cb" xlink:label="lbl_label1377433803" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments - additional disclosure [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_label1377433803" xlink:type="arc"/>
      <link:label id="id_7be99054" xlink:label="lbl_label2078904404" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in fair value measurement [table]</link:label>
      <link:label id="id_373151e5" xlink:label="lbl_FinancialInstrumentsCarryingValueLevel3_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value measurement, carrying value, level 3</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsCarryingValueLevel3" xlink:label="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:to="lbl_FinancialInstrumentsCarryingValueLevel3_labels" xlink:type="arc"/>
      <link:label id="id_3bebbf6d" xlink:label="lbl_FinancialInstrumentsCarryingValueLevel3_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value measurement, carrying value, level 3, at beginning of period</link:label>
      <link:label id="id_fde9a71" xlink:label="lbl_FinancialInstrumentsCarryingValueLevel3_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Fair value measurement, carrying value, level 3, at end of period</link:label>
      <link:label id="id_38539773" xlink:label="lbl_label945002355" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value gains and other adjustments including from divestments recognized in the consolidated income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:label="lbl_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:to="lbl_label945002355" xlink:type="arc"/>
      <link:label id="id_3f162228" xlink:label="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:label="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:to="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets_labels" xlink:type="arc"/>
      <link:label id="id_34d2b17f" xlink:label="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments recognized in the consolidated statement of comprehensive income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:label="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:to="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome_labels" xlink:type="arc"/>
      <link:label id="id_1f17c4f4" xlink:label="lbl_label521651444" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchases fair value measurement assets</link:label>
      <link:label id="id_712f0e18" xlink:label="lbl_DisposalsFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals fair value measurement assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalsFairValueMeasurementAssets" xlink:label="lbl_DisposalsFairValueMeasurementAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalsFairValueMeasurementAssets" xlink:to="lbl_DisposalsFairValueMeasurementAssets_labels" xlink:type="arc"/>
      <link:label id="id_6183f24" xlink:label="lbl_ReclassificationFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification fair value measurement assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationFairValueMeasurementAssets" xlink:label="lbl_ReclassificationFairValueMeasurementAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReclassificationFairValueMeasurementAssets" xlink:to="lbl_ReclassificationFairValueMeasurementAssets_labels" xlink:type="arc"/>
      <link:label id="id_21602cfa" xlink:label="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value gains and losses recognized in the consolidated income statement for assets and liabilities held</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:label="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:to="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld_labels" xlink:type="arc"/>
      <link:label id="id_d0e5228" xlink:label="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</link:label>
      <link:label id="id_28030b1e" xlink:label="lbl_label671288094" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monitoring of net debt or liquidity based on contractual maturities [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:label="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:to="lbl_label671288094" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:label="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_label2078904404" xlink:type="arc"/>
      <link:label id="id_2f39f660" xlink:label="lbl_label792327776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity of net debt [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaturityOfNetDebtLineItems" xlink:label="lbl_MaturityOfNetDebtLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_label792327776" xlink:type="arc"/>
      <link:label id="id_58c89014" xlink:label="lbl_OtherNoncurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-current financial debts</link:label>
      <link:label id="id_7d6c1038" xlink:label="lbl_OtherCurrentFinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current financial debt</link:label>
      <link:label id="id_2fc36503" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current financial assets</link:label>
      <link:label id="id_54e7be06" xlink:label="lbl_label1424473606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable securities and time deposits [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesAndTimeDepositsMember" xlink:label="lbl_MarketableSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MarketableSecuritiesAndTimeDepositsMember" xlink:to="lbl_label1424473606" xlink:type="arc"/>
      <link:label id="id_2cb9fd3b" xlink:label="lbl_label750386491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commodities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommoditiesMember" xlink:label="lbl_CommoditiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CommoditiesMember" xlink:to="lbl_label750386491" xlink:type="arc"/>
      <link:label id="id_31b4a926" xlink:label="lbl_label833923366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deriviative financial instruments and accrued interest [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:label="lbl_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:to="lbl_label833923366" xlink:type="arc"/>
      <link:label id="id_75dba3db" xlink:label="lbl_label1977328603" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial debt [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtMember" xlink:label="lbl_FinancialDebtMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialDebtMember" xlink:to="lbl_label1977328603" xlink:type="arc"/>
      <link:label id="id_24faa4a5" xlink:label="lbl_label620405925" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial debt - undiscounted [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtUndiscountedMember" xlink:label="lbl_FinancialDebtUndiscountedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialDebtUndiscountedMember" xlink:to="lbl_label620405925" xlink:type="arc"/>
      <link:label id="id_2e5c234f" xlink:label="lbl_label777790287" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than three month and not later than twelve months [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:to="lbl_label777790287" xlink:type="arc"/>
      <link:label id="id_106ff37d" xlink:label="lbl_label275772285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments and accrued interest on derivative financial instruments [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_label275772285" xlink:type="arc"/>
      <link:label id="id_7c18c756" xlink:label="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential outflows in various currencies - from financial derivative liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:label="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:to="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_4ab97cb3" xlink:label="lbl_label1253670067" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential inflows in various currencies - from financial derivative assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:label="lbl_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:to="lbl_label1253670067" xlink:type="arc"/>
      <link:label id="id_68a3968f" xlink:label="lbl_label1755551375" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments and accrued interest on derivative financial instruments [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_label1755551375" xlink:type="arc"/>
      <link:label id="id_6f45bf77" xlink:label="lbl_ContractualInterestOnNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual interest on non-current liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractualInterestOnNoncurrentLiabilities" xlink:label="lbl_ContractualInterestOnNoncurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContractualInterestOnNoncurrentLiabilities" xlink:to="lbl_ContractualInterestOnNoncurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_60f25e47" xlink:label="lbl_ContractualInterestOnNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual interest on non-current liabilities</link:label>
      <link:label id="id_26c3488c" xlink:label="lbl_label650332300" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ten day loss fair value VAR model [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TenDayLossFairValueVARModelTable" xlink:label="lbl_TenDayLossFairValueVARModelTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TenDayLossFairValueVARModelTable" xlink:to="lbl_label650332300" xlink:type="arc"/>
      <link:label id="id_3ecf37ac" xlink:label="lbl_label1053767596" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ten day loss fair value VAR model [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TenDayLossFairValueVARModelLineItems" xlink:label="lbl_TenDayLossFairValueVARModelLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_label1053767596" xlink:type="arc"/>
      <link:label id="id_1d7eaa93" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputation_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, value at risk computation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputation" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsValueAtRiskComputation" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputation_labels" xlink:type="arc"/>
      <link:label id="id_4d7520d9" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, value at risk computation, sensitive to foreign currency exchange rates</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates_labels" xlink:type="arc"/>
      <link:label id="id_bc6d63c" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, value at risk computation, sensitive to equity market movements</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements_labels" xlink:type="arc"/>
      <link:label id="id_7e591031" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments, value at risk computation, sensitive to interest rates</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates_labels" xlink:type="arc"/>
      <link:label id="id_1a9805f" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputation_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All financial instruments</link:label>
      <link:label id="id_2ef01715" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments sensitive to foreign currency exchange rates</link:label>
      <link:label id="id_74cd5fab" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments sensitive to equity market movements</link:label>
      <link:label id="id_3073f174" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Instruments sensitive to interest rates</link:label>
      <link:label id="id_69bd9251" xlink:label="lbl_WeightedAverageMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageMember" xlink:label="lbl_WeightedAverageMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageMember" xlink:to="lbl_WeightedAverageMember_labels" xlink:type="arc"/>
      <link:label id="id_301d16c7" xlink:label="lbl_WeightedAverageMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average</link:label>
      <link:label id="id_2a5fb07c" xlink:label="lbl_TopOfRangeMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">High</link:label>
      <link:label id="id_6654bf44" xlink:label="lbl_BottomOfRangeMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Low</link:label>
      <link:label id="id_405da1b9" xlink:label="lbl_WorstCaseLossScenarioMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Worst case loss scenario [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WorstCaseLossScenarioMember" xlink:label="lbl_WorstCaseLossScenarioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WorstCaseLossScenarioMember" xlink:to="lbl_WorstCaseLossScenarioMember_labels" xlink:type="arc"/>
      <link:label id="id_2e992db9" xlink:label="lbl_WorstCaseLossScenarioMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Worst case loss scenario</link:label>
      <link:label id="id_4ee2f2eb" xlink:label="lbl_label1323496171" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash receipts and payments fair value measurement assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:label="lbl_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:to="lbl_label1323496171" xlink:type="arc"/>
      <link:label id="id_2d2549bd" xlink:label="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Potential outflows in various currencies - from financial derivative liabilities</link:label>
      <link:label id="id_6773649" xlink:label="lbl_DeferredTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:label id="id_7a7f8744" xlink:label="lbl_Liabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
      <link:label id="id_5793c543" xlink:label="lbl_DeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax balance</link:label>
      <link:label id="id_786524e" xlink:label="lbl_UnusedProvisionReversedOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of provisions for doubtful trade receivables</link:label>
      <link:label id="id_6744ae33" xlink:label="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Publicly quoted market value of the Novartis interest</link:label>
      <link:label id="id_24696e1c" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current service cost</link:label>
      <link:label id="id_471bbf88" xlink:label="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net interest expense</link:label>
      <link:label id="id_1439e3a2" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Administrative expenses</link:label>
      <link:label id="id_2f35efb7" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Novartis Equity Plan "Select", outside North America [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_labels" xlink:type="arc"/>
      <link:label id="id_58a34798" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Select outside North America</link:label>
      <link:label id="id_5e36913a" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Novartis Equity Plan "Select", North America [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_labels" xlink:type="arc"/>
      <link:label id="id_49d8c8f7" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Select North America</link:label>
      <link:label id="id_7c2b7da9" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon, Inc., equity plans, granted to associates prior merger [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember_labels" xlink:type="arc"/>
      <link:label id="id_3be795e9" xlink:label="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_labels" xlink:type="arc"/>
      <link:label id="id_3e622c14" xlink:label="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited, number of shares</link:label>
      <link:label id="id_179f71dc" xlink:label="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Number</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_labels" xlink:type="arc"/>
      <link:label id="id_13e82d94" xlink:label="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested, number of shares</link:label>
      <link:label id="id_676b945a" xlink:label="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Granted, Number of Shares</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted_labels" xlink:type="arc"/>
      <link:label id="id_7c12048" xlink:label="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, number of shares</link:label>
      <link:label id="id_36172efd" xlink:label="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares at end of period</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_labels" xlink:type="arc"/>
      <link:label id="id_60b0a4e9" xlink:label="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares at beginning of period</link:label>
      <link:label id="id_3531edda" xlink:label="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:label id="id_5e461d76" xlink:label="lbl_label1581653366" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of unvested restricted stock units [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_label1581653366" xlink:type="arc"/>
      <link:label id="id_7874e637" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income from associated companies</link:label>
      <link:label id="id_32b80bd7" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity-Based Participation Other Share Awards [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationOtherShareAwardsMember" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:to="lbl_EquityBasedParticipationOtherShareAwardsMember_labels" xlink:type="arc"/>
      <link:label id="id_18282520" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other share awards</link:label>
      <link:label id="id_46ef7a38" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Alcon equity plans granted to associates prior merger</link:label>
      <link:label id="id_5f28436" xlink:label="lbl_EquityBasedParticipationRestrictedSharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Shares</link:label>
      <link:label id="id_68171cd3" xlink:label="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leveraged Share Savings Plan (LSSP)</link:label>
      <link:label id="id_33a3b55c" xlink:label="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Share Ownership Plan (ESOP)</link:label>
      <link:label id="id_48de40b0" xlink:label="lbl_EquityBasedParticipationUKShareSavingsPlanMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK Share Savings Plan</link:label>
      <link:label id="id_71e8eb1f" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for product liabilities, governmental investigations and other legal matters</link:label>
      <link:label id="id_68f6d949" xlink:label="lbl_ShareMovements_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share movements in period</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareMovements" xlink:label="lbl_ShareMovements" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShareMovements" xlink:to="lbl_ShareMovements_labels" xlink:type="arc"/>
      <link:label id="id_10047f77" xlink:label="lbl_ShareMovements_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total movements</link:label>
      <link:label id="id_5da2c69" xlink:label="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net expense, royalties cost sharing and profit sharing</link:label>
      <link:label id="id_1b2e9a2e" xlink:label="lbl_label2088768931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net investment hedge [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetInvestmentHedgeMember" xlink:label="lbl_NetInvestmentHedgeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetInvestmentHedgeMember" xlink:to="lbl_label2088768931" xlink:type="arc"/>
      <link:label id="id_6aadffe9" xlink:label="lbl_label1789788137" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written call options held by market maker</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsHeldByMarketMaker" xlink:label="lbl_WrittenCallOptionsHeldByMarketMaker" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WrittenCallOptionsHeldByMarketMaker" xlink:to="lbl_label1789788137" xlink:type="arc"/>
      <link:label id="id_29617d6b" xlink:label="lbl_label694254955" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written call options, contractual live</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsContractualLive" xlink:label="lbl_WrittenCallOptionsContractualLive" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WrittenCallOptionsContractualLive" xlink:to="lbl_label694254955" xlink:type="arc"/>
      <link:label id="id_b107ceb" xlink:label="lbl_label185629931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written call options, contractual live, remaining</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsContractualLiveRemaining" xlink:label="lbl_WrittenCallOptionsContractualLiveRemaining" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WrittenCallOptionsContractualLiveRemaining" xlink:to="lbl_label185629931" xlink:type="arc"/>
      <link:label id="id_292f5855" xlink:label="lbl_label690968661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written call options, weighted average exercise price</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsWeightedAverageExercisePrice" xlink:label="lbl_WrittenCallOptionsWeightedAverageExercisePrice" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WrittenCallOptionsWeightedAverageExercisePrice" xlink:to="lbl_label690968661" xlink:type="arc"/>
      <link:label id="id_1e74829a" xlink:label="lbl_InterestExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total interest expense from continuing operations</link:label>
      <link:label id="id_764458f" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in current financial debts</link:label>
      <link:label id="id_657faa04" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid to non-controlling interests and other financing cash flows</link:label>
      <link:label id="id_4f246ab" xlink:label="lbl_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and other liabilities including deferred tax liabilities</link:label>
      <link:label id="id_3f1c8d8f" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxes paid</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseFairValueMeasurementAssets" xlink:label="lbl_PurchaseFairValueMeasurementAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PurchaseFairValueMeasurementAssets" xlink:to="lbl_label521651444" xlink:type="arc"/>
      <link:label id="id_cca13ad" xlink:label="lbl_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxes paid and other portfolio transformation related cash flows</link:label>
      <link:label id="id_7ef7b9ed" xlink:label="lbl_OtherPaymentsAndDeferredConsiderationNet_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments, deferred consideration and other adjustments, net</link:label>
      <link:label id="id_47b366a2" xlink:label="lbl_DeferredPrepaidPortionOfSalesPrice_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred portion of sales price</link:label>
      <link:label id="id_547e2ca5" xlink:label="lbl_StockRepurchaseProgramAuthorizedAmount1_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StockRepurchaseProgramAuthorizedAmount1" xlink:label="lbl_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lbl_StockRepurchaseProgramAuthorizedAmount1_labels" xlink:type="arc"/>
      <link:label id="id_73838734" xlink:label="lbl_StockRepurchaseProgramAuthorizedAmount1_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased on the SIX Swiss Exchange second trading line under the share buyback authority approved</link:label>
      <link:label id="id_56c435e" xlink:label="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</link:label>
      <link:label id="id_12b02f16" xlink:label="lbl_DisposalsFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Disposals fair value measurement assets</link:label>
      <link:label id="id_26be22ce" xlink:label="lbl_AdjustmentsForReconcileProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reversal of non-cash items and other adjustments</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForReconcileProfitLoss" xlink:to="lbl_AdjustmentsForReconcileProfitLoss_labels" xlink:type="arc"/>
      <link:label id="id_2cafaaf8" xlink:label="lbl_AdjustmentsForReconcileProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total reversal of non-cash items</link:label>
      <link:label id="id_4b753731" xlink:label="lbl_AdjustmentsForReconcileProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile profit (loss)</link:label>
      <link:label id="id_38c3816c" xlink:label="lbl_IncomeTaxesPaidRefund_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income taxes (paid)/refund</link:label>
      <link:label id="id_156023e7" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income taxes (paid)/refund, classified as investing activities</link:label>
      <link:label id="id_4b858d4a" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income taxes refund/(paid), classified as operating activities</link:label>
      <link:label id="id_486e2543" xlink:label="lbl_DepreciationAndAmortisationExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortisation expense</link:label>
      <link:label id="id_bf2d3c0" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss</link:label>
      <link:label id="id_555a0937" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges and fair value gains on financial assets, net</link:label>
      <link:label id="id_498c02d2" xlink:label="lbl_AdditionsToRestructuringProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Additions to restructuring provisions</link:label>
      <link:label id="id_775477cb" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Equity-based compensation of Novartis equity plans</link:label>
      <link:label id="id_408b9f0d" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income statement effect</link:label>
      <link:label id="id_2a46b40e" xlink:label="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of income taxed at reduced rates</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:label="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:to="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates_labels" xlink:type="arc"/>
      <link:label id="id_55aa23f7" xlink:label="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of income taxed at reduced rates</link:label>
      <link:label id="id_17e76531" xlink:label="lbl_label401040689" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movements of property, plant and equipment [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:label="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_label401040689" xlink:type="arc"/>
      <link:label id="id_3d749f5d" xlink:label="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Disposals and derecognitions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherAssetsProvisionsAccrualsMember" xlink:label="lbl_OtherAssetsProvisionsAccrualsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherAssetsProvisionsAccrualsMember" xlink:to="lbl_label288271922" xlink:type="arc"/>
      <link:label id="id_5ac948f0" xlink:label="lbl_IntangibleAssetsAndGoodwillMember_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets [member]</link:label>
      <link:label id="id_6dbb9ba2" xlink:label="lbl_label1841011618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="lbl_label1841011618" xlink:type="arc"/>
      <link:label id="id_44d33d7" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, NonVested in Period, Fair Value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue_labels" xlink:type="arc"/>
      <link:label id="id_46c4badd" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Fair value at grante date at beginning of period</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:to="lbl_label679367036" xlink:type="arc"/>
      <link:label id="id_1c16a93d" xlink:label="lbl_label471247165" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Fair Value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:to="lbl_label471247165" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:to="lbl_label1695476906" xlink:type="arc"/>
      <link:label id="id_657887a0" xlink:label="lbl_label1702397856" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:to="lbl_label1702397856" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:to="lbl_label1373999706" xlink:type="arc"/>
      <link:label id="id_6cec499" xlink:label="lbl_label114214041" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeited in Period, Fair Value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:to="lbl_label114214041" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:to="lbl_label766376780" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSingaporePteLtd.SingaporeMember" xlink:label="lbl_NovartisSingaporePteLtd.SingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSingaporePteLtd.SingaporeMember" xlink:to="lbl_label250835540" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:label="lbl_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:to="lbl_label659774806" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:label="lbl_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:to="lbl_label1942659357" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:label="lbl_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:to="lbl_label1522796763" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:label="lbl_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:to="lbl_label1080027869" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:label="lbl_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:to="lbl_label1523800019" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPteLtdSingaporeMember" xlink:label="lbl_AlconPteLtdSingaporeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPteLtdSingaporeMember" xlink:to="lbl_label1448389290" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:label="lbl_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:to="lbl_label547277000" xlink:type="arc"/>
      <link:label id="id_3f303d9f" xlink:label="lbl_label1060126111" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spinifex Pharmaceuticals, Inc., Wilmington, NC [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:label="lbl_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:to="lbl_label1060126111" xlink:type="arc"/>
      <link:label id="id_7ab53501" xlink:label="lbl_label2058695937" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Encore Vision, Inc., New York, NY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionInc.NewYorkNYMember" xlink:label="lbl_EncoreVisionInc.NewYorkNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EncoreVisionInc.NewYorkNYMember" xlink:to="lbl_label2058695937" xlink:type="arc"/>
      <link:label id="id_71637428" xlink:label="lbl_label1902343208" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Investment Ltd., Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInvestmentLtd.HamiltonMember" xlink:label="lbl_NovartisInvestmentLtd.HamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInvestmentLtd.HamiltonMember" xlink:to="lbl_label1902343208" xlink:type="arc"/>
      <link:label id="id_631dbefb" xlink:label="lbl_label1662893819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Finance Services Ltd., Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceServicesLtd.HamiltonMember" xlink:label="lbl_NovartisFinanceServicesLtd.HamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFinanceServicesLtd.HamiltonMember" xlink:to="lbl_label1662893819" xlink:type="arc"/>
      <link:label id="id_682001cf" xlink:label="lbl_label1746928079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis B2 Ltd., Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisB2Ltd.HamiltonMember" xlink:label="lbl_NovartisB2Ltd.HamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisB2Ltd.HamiltonMember" xlink:to="lbl_label1746928079" xlink:type="arc"/>
      <link:label id="id_60c6aa6" xlink:label="lbl_label101477030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis B3 Ltd., Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisB3Ltd.HamiltonMember" xlink:label="lbl_NovartisB3Ltd.HamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisB3Ltd.HamiltonMember" xlink:to="lbl_label101477030" xlink:type="arc"/>
      <link:label id="id_4bc526b5" xlink:label="lbl_label1271211701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ciba-Geigy Japan Limited, Tokyo [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CibaGeigyJapanLimitedTokyoMember" xlink:label="lbl_CibaGeigyJapanLimitedTokyoMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CibaGeigyJapanLimitedTokyoMember" xlink:to="lbl_label1271211701" xlink:type="arc"/>
      <link:label id="id_518a9aeb" xlink:label="lbl_label1368038123" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis International Pharmaceutical Investment AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:label="lbl_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:to="lbl_label1368038123" xlink:type="arc"/>
      <link:label id="id_614bc25c" xlink:label="lbl_label1632354908" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Bioventures AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBioventuresAGBaselMember" xlink:label="lbl_NovartisBioventuresAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisBioventuresAGBaselMember" xlink:to="lbl_label1632354908" xlink:type="arc"/>
      <link:label id="id_8fecb9d" xlink:label="lbl_label150915997" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Forschungsstiftung, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisForschungsstiftungBaselMember" xlink:label="lbl_NovartisForschungsstiftungBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisForschungsstiftungBaselMember" xlink:to="lbl_label150915997" xlink:type="arc"/>
      <link:label id="id_600bda82" xlink:label="lbl_label1611389570" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Stiftung fuer Kaderausbildung, Basel [member]</link:label>
      <link:label id="id_6fd3a22a" xlink:label="lbl_label1876140586" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Mitarbeiterbeteiligungsstiftung, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:label="lbl_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:to="lbl_label1876140586" xlink:type="arc"/>
      <link:label id="id_2d8acaf0" xlink:label="lbl_label764070640" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Stiftung fuer Mensch und Umwelt, Basel [member]</link:label>
      <link:label id="id_7d992496" xlink:label="lbl_label2107188374" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stiftung der Novartis AG fuer Erziehung, Ausbildung und Bildung, Basel [member]</link:label>
      <link:label id="id_2bb02e62" xlink:label="lbl_label732966498" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Farmanova Saglik Hizmetleri Ltd. Sti., Istanbul [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:label="lbl_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:to="lbl_label732966498" xlink:type="arc"/>
      <link:label id="id_6c99f32" xlink:label="lbl_label113876786" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ziarco Group Limited, Frimley/Camberley [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:label="lbl_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:to="lbl_label113876786" xlink:type="arc"/>
      <link:label id="id_7dfa0e77" xlink:label="lbl_label2113539703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vivacta Limited, Frimley/Camberley, Surrey [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VivactaLimitedFrimleyCamberleySurreyMember" xlink:label="lbl_VivactaLimitedFrimleyCamberleySurreyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VivactaLimitedFrimleyCamberleySurreyMember" xlink:to="lbl_label2113539703" xlink:type="arc"/>
      <link:label id="id_5489f125" xlink:label="lbl_label1418326309" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis US Foundation, New York, NY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUSFoundationNewYorkNYMember" xlink:label="lbl_NovartisUSFoundationNewYorkNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisUSFoundationNewYorkNYMember" xlink:to="lbl_label1418326309" xlink:type="arc"/>
      <link:label id="id_1c9b37d8" xlink:label="lbl_label479934424" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corthera, Inc., San Mateo, CA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CortheraInc.SanMateoCAMember" xlink:label="lbl_CortheraInc.SanMateoCAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CortheraInc.SanMateoCAMember" xlink:to="lbl_label479934424" xlink:type="arc"/>
      <link:label id="id_32e0fe6b" xlink:label="lbl_label853605995" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CoStim Pharmaceuticals Inc., Cambridge, MA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:label="lbl_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:to="lbl_label853605995" xlink:type="arc"/>
      <link:label id="id_39cff8c0" xlink:label="lbl_label969930944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Navigate BioPharma Services, Inc., Carlsbad, CA [member]</link:label>
      <link:label id="id_196cf67c" xlink:label="lbl_label426571388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reprixys Pharmaceuticals Corporation, East Hanover, NJ [member]</link:label>
      <link:label id="id_72f336af" xlink:label="lbl_label1928541871" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ClarVista Medical, Inc., Aliso Viejo, CA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:label="lbl_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:to="lbl_label1928541871" xlink:type="arc"/>
      <link:label id="id_55c01a35" xlink:label="lbl_label1438652981" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transcend Medical, Inc., Lake Forest, IL [member]</link:label>
      <link:label id="id_4148f290" xlink:label="lbl_label1095299728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Triangle International Reinsurance Limited, Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:label="lbl_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:to="lbl_label1095299728" xlink:type="arc"/>
      <link:label id="id_75fcbca" xlink:label="lbl_label123718602" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trinity River Insurance Co Ltd., Hamilton [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:label="lbl_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:to="lbl_label123718602" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisStiftungFuerKaderausbildungBaselMember" xlink:label="lbl_NovartisStiftungFuerKaderausbildungBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisStiftungFuerKaderausbildungBaselMember" xlink:to="lbl_label1611389570" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:label="lbl_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:to="lbl_label764070640" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:label="lbl_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:to="lbl_label2107188374" xlink:type="arc"/>
      <link:label id="id_7fb34e52" xlink:label="lbl_label2142457426" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Syntek Ilac Hammaddeleri Sanayi ve Ticaret A.S., Istanbul [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:label="lbl_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:to="lbl_label2142457426" xlink:type="arc"/>
      <link:label id="id_48e7e2a8" xlink:label="lbl_RUB_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Russia, Rubles</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_RUB" xlink:label="lbl_RUB" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RUB" xlink:to="lbl_RUB_labels" xlink:type="arc"/>
      <link:label id="id_2b6714e7" xlink:label="lbl_RUB_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RUB</link:label>
      <link:label id="id_6b134c2" xlink:label="lbl_BRL_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BRL</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_BRL" xlink:label="lbl_BRL" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BRL" xlink:to="lbl_BRL_labels" xlink:type="arc"/>
      <link:label id="id_19bb001f" xlink:label="lbl_BRL_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Brazil, Brazil Real</link:label>
      <link:label id="id_26408b72" xlink:label="lbl_AUD_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Australia, Dollars</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AUD" xlink:label="lbl_AUD" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AUD" xlink:to="lbl_AUD_labels" xlink:type="arc"/>
      <link:label id="id_1c95476e" xlink:label="lbl_AUD_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AUD</link:label>
      <link:label id="id_547736b0" xlink:label="lbl_CAD_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CAD</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CAD" xlink:label="lbl_CAD" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CAD" xlink:to="lbl_CAD_labels" xlink:type="arc"/>
      <link:label id="id_5eb5601a" xlink:label="lbl_CAD_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Canada, Dollars</link:label>
      <link:label id="id_58b8f0b8" xlink:label="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_435d0149" xlink:label="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of associates, net income effect [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:label="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:to="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_71b428a4" xlink:label="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related to associates, net income effect</link:label>
      <link:label id="id_d71a4cc" xlink:label="lbl_AssociatesSummarizedFinancialInformationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associates summarized financial information</link:label>
      <link:label id="id_303f5b81" xlink:label="lbl_PurchasePriceAllocationAssociatesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price allocation associates</link:label>
      <link:label id="id_3ea56c51" xlink:label="lbl_label1051028561" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets/liabilities, expected to have impact on current taxes payable</link:label>
      <link:label id="id_549c77e3" xlink:label="lbl_label1419540451" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of deferred tax assets and liabilities, expected to have impact on current taxes payable [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:label="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:to="lbl_label1419540451" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:to="lbl_label1051028561" xlink:type="arc"/>
      <link:label id="id_686d8bfd" xlink:label="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of unremitted earnings retained by consolidated entities for reinvestment [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" xlink:label="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" xlink:to="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4726a0d4" xlink:label="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unremitted earnings retained by consolidated entities for reinvestment</link:label>
      <link:label id="id_2be0cf3f" xlink:label="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of amount of inventory recognized as an expense in cost of goods sold [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" xlink:label="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" xlink:to="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_26e57cfe" xlink:label="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of inventory recognized as an expense in cost of goods sold</link:label>
      <link:label id="id_30833089" xlink:label="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of recognized amount of inventory provisions and reversals of inventory provision [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" xlink:label="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" xlink:to="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3124df13" xlink:label="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognized amount of inventory provisions and reversals of inventory provision</link:label>
      <link:label id="id_4d23afdc" xlink:label="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross trade receivable from closely monitored countries [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" xlink:label="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" xlink:to="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5f55c02d" xlink:label="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross trade receivable from closely monitored countries</link:label>
      <link:label id="id_540d35ce" xlink:label="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt securities, breakdown by currency [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtSecuritiesBreakdownByCurrencyTableTextBlock" xlink:label="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock" xlink:to="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_295129f0" xlink:label="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt securities, breakdown by currency</link:label>
      <link:label id="id_22b42dd0" xlink:label="lbl_SummaryOfTreasurySharesMovementsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of treasury shares movements [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SummaryOfTreasurySharesMovementsTableTextBlock" xlink:label="lbl_SummaryOfTreasurySharesMovementsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SummaryOfTreasurySharesMovementsTableTextBlock" xlink:to="lbl_SummaryOfTreasurySharesMovementsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7493f0ce" xlink:label="lbl_SummaryOfTreasurySharesMovementsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule disclosing information related treasury shares movements</link:label>
      <link:label id="id_28836a6a" xlink:label="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" xlink:label="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" xlink:to="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_77bb4dc1" xlink:label="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities</link:label>
      <link:label id="id_63da54e2" xlink:label="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of liabilities arising from financing activities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:label="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:to="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_ea1dc4a" xlink:label="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of liabilities arising from financing activities</link:label>
      <link:label id="id_ecb4868" xlink:label="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of asset allocation, investments in shares of Novartis AG [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:label="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:to="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6d5c5887" xlink:label="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset allocation, investments in shares of Novartis AG</link:label>
      <link:label id="id_583fe5ec" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of defined contribution plans [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:to="lbl_ScheduleOfDefinedContributionPlansTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4176cd8b" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined contribution plans</link:label>
      <link:label id="id_5864530c" xlink:label="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of expense related to all equity-based participation and liabilities arising from equity-based payment transactions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:label="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:to="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_19e39c55" xlink:label="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense related to all equity-based participation and liabilities arising from equity-based payment transactions</link:label>
      <link:label id="id_12c92048" xlink:label="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets and financial liabilities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:label="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:to="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6a3159a6" xlink:label="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of financial assets and financial liabilities</link:label>
      <link:label id="id_5070bcfa" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of derivative financial instruments [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_5e4ef11c" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments</link:label>
      <link:label id="id_4b298c60" xlink:label="lbl_label1261014112" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract or underlying principal amount the derivative financial instruments, by currency</link:label>
      <link:label id="id_6bba442" xlink:label="lbl_label112960578" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of derivative financial instruments, contract or underlying principal amount the derivative financial instruments, by currency [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:to="lbl_label112960578" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:to="lbl_label1261014112" xlink:type="arc"/>
      <link:label id="id_7def025f" xlink:label="lbl_DisclosureOfFairValueMeasurementExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:label="lbl_DisclosureOfFairValueMeasurementExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueMeasurementExplanatory" xlink:to="lbl_DisclosureOfFairValueMeasurementExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_77677ae5" xlink:label="lbl_DisclosureOfFairValueMeasurementExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value by hierarchy</link:label>
      <link:label id="id_3e022541" xlink:label="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in fair value measurement [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" xlink:label="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" xlink:to="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_1b36ee5a" xlink:label="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in fair value measurement</link:label>
      <link:label id="id_fde92c1" xlink:label="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of monitoring of net debt or liquidity based on contractual maturities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" xlink:label="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" xlink:to="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2293ad67" xlink:label="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monitoring of net debt or liquidity based on contractual maturities</link:label>
      <link:label id="id_1cfe8d17" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of derivative financial instruments and accrued interest on derivative financial instruments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5ab7d205" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments and accrued interest on derivative financial instruments</link:label>
      <link:label id="id_36cdbc5" xlink:label="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other contractual liabilities of the net debt or liquidity [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" xlink:label="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" xlink:to="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_36a9094b" xlink:label="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other contractual liabilities of the net debt or liquidity</link:label>
      <link:label id="id_6873d3e4" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of ten day loss fair value VAR model [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" xlink:to="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_52a21cc6" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ten day loss fair value VAR model</link:label>
      <link:label id="id_5cc8b03e" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of ten day loss fair value VAR model, average, high, and low VAR amounts [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" xlink:to="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_13881ac7" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ten day loss fair value VAR model, average, high, and low VAR amounts</link:label>
      <link:label id="id_41e588b8" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of ten day loss fair value VAR model, worst case loss scenario [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" xlink:to="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7c01a973" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ten day loss fair value VAR model, worst case loss scenario</link:label>
      <link:label id="id_5ec493de" xlink:label="lbl_KR_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">KOREA, REPUBLIC OF</link:label>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_KR" xlink:label="lbl_KR" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KR" xlink:to="lbl_KR_labels" xlink:type="arc"/>
      <link:label id="id_685d93ad" xlink:label="lbl_KR_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">South Korea</link:label>
      <link:label id="id_25a8beb4" xlink:label="lbl_PurchaseOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares</link:label>
      <link:label id="id_43c445c8" xlink:label="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of change in ownership of consolidated entities</link:label>
      <link:label id="id_53037399" xlink:label="lbl_PurchaseOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury shares, equity impact</link:label>
      <link:label id="id_449dfef2" xlink:label="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments out of provisions and other net cash movements in non-current liabilities</link:label>
      <link:label id="id_5f336b49" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Portion of consideration paid (received) consisting of cash and cash equivalents</link:label>
      <link:label id="id_1ebe8e22" xlink:label="lbl_ReprixysPharmaceuticalsCorporationMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reprixys Pharmaceuticals Corporation [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReprixysPharmaceuticalsCorporationMember" xlink:label="lbl_ReprixysPharmaceuticalsCorporationMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReprixysPharmaceuticalsCorporationMember" xlink:to="lbl_ReprixysPharmaceuticalsCorporationMember_labels" xlink:type="arc"/>
      <link:label id="id_7c3b4ddb" xlink:label="lbl_ReprixysPharmaceuticalsCorporationMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reprixys Pharmaceuticals Corporation</link:label>
      <link:label id="id_37f79dee" xlink:label="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of release of contingent consideration liability</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:label="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:to="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability_labels" xlink:type="arc"/>
      <link:label id="id_7767d800" xlink:label="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of release of contingent consideration liability</link:label>
      <link:label id="id_3fbded99" xlink:label="lbl_IncomeTaxExpenseContinuingOperations_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromNondeductibleLossesInRegion" xlink:label="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:to="lbl_label1999384126" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:to="lbl_label1131311877" xlink:type="arc"/>
      <link:label id="id_7da827c0" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_45122075" xlink:label="lbl_AdditionalProvisionsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Provisions for doubtful trade receivables charged to the consolidated income statement</link:label>
      <link:label id="id_3b199e63" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_9457980" xlink:label="lbl_label155548032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax asset and liability valuation [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:label="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_label155548032" xlink:type="arc"/>
      <link:label id="id_1c2a973a" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law deferred tax expense income recognised in profit or loss</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss_labels" xlink:type="arc"/>
      <link:label id="id_44e2d573" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law deferred tax relating to components of other comprehensive income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:to="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:type="arc"/>
      <link:label id="id_31998635" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law increase decrease in deferred tax liability asset</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:to="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset_labels" xlink:type="arc"/>
      <link:label id="id_3ecc5b67" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law increase decrease in current income tax liability</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:to="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability_labels" xlink:type="arc"/>
      <link:label id="id_16a647a9" xlink:label="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law change in deferred tax assets and liabilities and current tax liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:label="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:to="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_549d9bf8" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Items previously recognized in consolidated income statement</link:label>
      <link:label id="id_5370a381" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Items previously recognized in other comprehensive income</link:label>
      <link:label id="id_584b4926" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total revaluation of deferred tax assets and liabilities</link:label>
      <link:label id="id_1d65bc0" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total revaluation of current income tax liabilities</link:label>
      <link:label id="id_67c3f632" xlink:label="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total revaluation of deferred tax assets and liabilities and current income tax liabilities</link:label>
      <link:label id="id_25c7d443" xlink:label="lbl_label633852995" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact location [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationAxis" xlink:label="lbl_ImpactLocationAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactLocationAxis" xlink:to="lbl_label633852995" xlink:type="arc"/>
      <link:label id="id_49f0b616" xlink:label="lbl_label1240512022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact location [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationMember" xlink:label="lbl_ImpactLocationMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactLocationMember" xlink:to="lbl_label1240512022" xlink:type="arc"/>
      <link:label id="id_2bcc20cf" xlink:label="lbl_label734798031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income statement [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementMember" xlink:label="lbl_IncomeStatementMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeStatementMember" xlink:to="lbl_label734798031" xlink:type="arc"/>
      <link:label id="id_5659c922" xlink:label="lbl_label1448724770" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase to retained earnings arising from first application of IFRS 9</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:to="lbl_label1448724770" xlink:type="arc"/>
      <link:label id="id_2a7f4c39" xlink:label="lbl_label712985657" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undiscounted operating lease commitments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UndiscountedOperatingLeaseCommitments" xlink:label="lbl_UndiscountedOperatingLeaseCommitments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UndiscountedOperatingLeaseCommitments" xlink:to="lbl_label712985657" xlink:type="arc"/>
      <link:label id="id_78817d05" xlink:label="lbl_label2021752069" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contribution of business to joint venture</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContributionOfBusinessToJointVenture" xlink:label="lbl_ContributionOfBusinessToJointVenture" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContributionOfBusinessToJointVenture" xlink:to="lbl_label2021752069" xlink:type="arc"/>
      <link:label id="id_77130f8a" xlink:label="lbl_label1997737866" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of income not subject to tax on the divestment gain on GSK investment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:label="lbl_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:to="lbl_label1997737866" xlink:type="arc"/>
      <link:label id="id_5b6d1716" xlink:label="lbl_label1533875990" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce current tax expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:label="lbl_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:to="lbl_label1533875990" xlink:type="arc"/>
      <link:label id="id_11cc9e15" xlink:label="lbl_label298622485" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to available-for-sale financia investments previously recognized through OCI</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:to="lbl_label298622485" xlink:type="arc"/>
      <link:label id="id_7418c9fe" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to deferred tax assets on US post retirement previously recognized through OCI</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI_labels" xlink:type="arc"/>
      <link:label id="id_12e2c645" xlink:label="lbl_label316851781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law effective tax rate after implemetation of new law changes</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:label="lbl_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:to="lbl_label316851781" xlink:type="arc"/>
      <link:label id="id_2bfd3952" xlink:label="lbl_label738015570" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law tax on unremitted earnings period allowed for payment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:label="lbl_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:to="lbl_label738015570" xlink:type="arc"/>
      <link:label id="id_34cb50dd" xlink:label="lbl_label885739741" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to deferred tax assets on unremitted earnings</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:to="lbl_label885739741" xlink:type="arc"/>
      <link:label id="id_73b04098" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings_labels" xlink:type="arc"/>
      <link:label id="id_75b59f04" xlink:label="lbl_label1713201135" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through finance lease contracts property plant and equipment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:label="lbl_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:to="lbl_label1713201135" xlink:type="arc"/>
      <link:label id="id_3eec7519" xlink:label="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal group companies materiality of assets or sales to third parties</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:label="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:to="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties_labels" xlink:type="arc"/>
      <link:label id="id_c93c456" xlink:label="lbl_label211010646" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other intangible asset purchase commitments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangiblePurchaseCommitments" xlink:label="lbl_OtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherIntangiblePurchaseCommitments" xlink:to="lbl_label211010646" xlink:type="arc"/>
      <link:label id="id_6759fd06" xlink:label="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development and other intangible asset purchase commitments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:label="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:to="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments_labels" xlink:type="arc"/>
      <link:label id="id_624861c8" xlink:label="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
      <link:label id="id_2f002958" xlink:label="lbl_label788539736" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial instruments - narrative [table]</link:label>
      <link:label id="id_684e1ed4" xlink:label="lbl_label1749950164" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Open hedges for anticipated transactions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OpenHedgesForAnticipatedTransactions" xlink:label="lbl_OpenHedgesForAnticipatedTransactions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OpenHedgesForAnticipatedTransactions" xlink:to="lbl_label1749950164" xlink:type="arc"/>
      <link:label id="id_38f600d1" xlink:label="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfers out of Level 3 of fair value hierarchy, assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:label="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:to="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets_labels" xlink:type="arc"/>
      <link:label id="id_24d61d6" xlink:label="lbl_label38625750" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount of change in OCI when pricing parameters for level 3 change more than 10%</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:to="lbl_label38625750" xlink:type="arc"/>
      <link:label id="id_8d1d7d" xlink:label="lbl_label9248125" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Most significant foreign exchange losses</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostSignificantForeignExchangeLosses" xlink:label="lbl_MostSignificantForeignExchangeLosses" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MostSignificantForeignExchangeLosses" xlink:to="lbl_label9248125" xlink:type="arc"/>
      <link:label id="id_75c586da" xlink:label="lbl_label1975879386" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term financial debt with a carrying amount</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermFinancialDebtWithACarryingAmount" xlink:label="lbl_LongtermFinancialDebtWithACarryingAmount" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LongtermFinancialDebtWithACarryingAmount" xlink:to="lbl_label1975879386" xlink:type="arc"/>
      <link:label id="id_189f8e8f" xlink:label="lbl_label413109903" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized loss was recognized in other comprehensive income and accumulated in currency translation effects in relation with this net investment hedge</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:label="lbl_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:to="lbl_label413109903" xlink:type="arc"/>
      <link:label id="id_19e141a6" xlink:label="lbl_label434192806" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net investment hedge recognized in the income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:label="lbl_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:to="lbl_label434192806" xlink:type="arc"/>
      <link:label id="id_7d454e3e" xlink:label="lbl_label2101694014" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Upper limit on holdings on unrelated company</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:label="lbl_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:to="lbl_label2101694014" xlink:type="arc"/>
      <link:label id="id_1ccfbaa5" xlink:label="lbl_label483375781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings commercial paper maximum borrowing amount</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:label="lbl_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:to="lbl_label483375781" xlink:type="arc"/>
      <link:label id="id_665a2289" xlink:label="lbl_label1717183113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt/equity ratio</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtEquityRatio" xlink:label="lbl_DebtEquityRatio" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DebtEquityRatio" xlink:to="lbl_label1717183113" xlink:type="arc"/>
      <link:label id="id_5597d347" xlink:label="lbl_label1436013383" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">VAR estimate confidence interval</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VAREstimateConfidenceInterval" xlink:label="lbl_VAREstimateConfidenceInterval" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VAREstimateConfidenceInterval" xlink:to="lbl_label1436013383" xlink:type="arc"/>
      <link:label id="id_42729374" xlink:label="lbl_label1114805108" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings commercial paper maximum amount outstanding</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:label="lbl_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:to="lbl_label1114805108" xlink:type="arc"/>
      <link:label id="id_6e4f3f5e" xlink:label="lbl_label1850687326" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings credit facility committed</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityCommitted" xlink:label="lbl_BorrowingsCreditFacilityCommitted" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsCreditFacilityCommitted" xlink:to="lbl_label1850687326" xlink:type="arc"/>
      <link:label id="id_40060c01" xlink:label="lbl_label1074138113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty risk [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CounterpartyRiskAbstract" xlink:label="lbl_CounterpartyRiskAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CounterpartyRiskAbstract" xlink:to="lbl_label1074138113" xlink:type="arc"/>
      <link:label id="id_16edbe31" xlink:label="lbl_label384679473" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of entity's cash and cash equivalents held with financial institution</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:label="lbl_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:to="lbl_label384679473" xlink:type="arc"/>
      <link:label id="id_367e78c8" xlink:label="lbl_label914258120" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vendor [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorAxis" xlink:label="lbl_VendorAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VendorAxis" xlink:to="lbl_label914258120" xlink:type="arc"/>
      <link:label id="id_45057e7f" xlink:label="lbl_label1157987967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vendor [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorMember" xlink:label="lbl_VendorMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VendorMember" xlink:to="lbl_label1157987967" xlink:type="arc"/>
      <link:label id="id_bcf5c90" xlink:label="lbl_label198139024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Largest financial institution [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestFinancialInstitutionMember" xlink:label="lbl_LargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LargestFinancialInstitutionMember" xlink:to="lbl_label198139024" xlink:type="arc"/>
      <link:label id="id_561f18c8" xlink:label="lbl_label1444878536" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Second largest financial institution [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestFinancialInstitutionMember" xlink:label="lbl_SecondLargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SecondLargestFinancialInstitutionMember" xlink:to="lbl_label1444878536" xlink:type="arc"/>
      <link:label id="id_cbf0fed" xlink:label="lbl_label213848045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Third largest financial institution [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestFinancialInstitutionMember" xlink:label="lbl_ThirdLargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ThirdLargestFinancialInstitutionMember" xlink:to="lbl_label213848045" xlink:type="arc"/>
      <link:label id="id_3a76e486" xlink:label="lbl_label980870278" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre tax profit (loss) from divestment of business</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PreTaxProfitLossFromDivestmentOfBusiness" xlink:label="lbl_PreTaxProfitLossFromDivestmentOfBusiness" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PreTaxProfitLossFromDivestmentOfBusiness" xlink:to="lbl_label980870278" xlink:type="arc"/>
      <link:label id="id_5810372f" xlink:label="lbl_label1477457711" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration transferred, divestment-date fair value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:label="lbl_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:to="lbl_label1477457711" xlink:type="arc"/>
      <link:label id="id_4121b29e" xlink:label="lbl_label1092727454" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential receivable from divestment</link:label>
      <link:label id="id_3cc9e79a" xlink:label="lbl_label1019864986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value of contingent consideration received</link:label>
      <link:label id="id_5b569e4" xlink:label="lbl_label95775204" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone payment already received</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MilestonePaymentAlreadyReceived" xlink:label="lbl_MilestonePaymentAlreadyReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MilestonePaymentAlreadyReceived" xlink:to="lbl_label95775204" xlink:type="arc"/>
      <link:label id="id_63dee19f" xlink:label="lbl_label1675551135" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Future put option to sell business</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FuturePutOptionToSellBusiness" xlink:label="lbl_FuturePutOptionToSellBusiness" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FuturePutOptionToSellBusiness" xlink:to="lbl_label1675551135" xlink:type="arc"/>
      <link:label id="id_7e35f229" xlink:label="lbl_label2117464617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment put option</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentPutOption" xlink:label="lbl_PaymentPutOption" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PaymentPutOption" xlink:to="lbl_label2117464617" xlink:type="arc"/>
      <link:label id="id_4b717d8e" xlink:label="lbl_label1265728910" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest exchanged</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExchanged" xlink:label="lbl_InterestExchanged" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExchanged" xlink:to="lbl_label1265728910" xlink:type="arc"/>
      <link:label id="id_8fd1ef1" xlink:label="lbl_ChangesInOffsetAgainstGrossTradeReceivables_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in offset against gross trade receivables</link:label>
      <link:label id="id_2ef82d23" xlink:label="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Benefit payments</link:label>
      <link:label id="id_7c796053" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Number of share options exercised</link:label>
      <link:label id="id_64515558" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Number of share options exercised or sold</link:label>
      <link:label id="id_79b0131b" xlink:label="lbl_FinancialLiabilitiesAtFairValue_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
      <link:label id="id_18855477" xlink:label="lbl_ClassesOfShareCapitalMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total outstanding shares</link:label>
      <link:label id="id_34b6a8cb" xlink:label="lbl_OrdinarySharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Novartis shares</link:label>
      <link:label id="id_20b38808" xlink:label="lbl_TreasurySharesMember_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total treasury shares</link:label>
      <link:label id="id_5dca543c" xlink:label="lbl_LiabilitiesToBanksAndOtherInstitutions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities to banks and other institutions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherInstitutions" xlink:label="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:to="lbl_LiabilitiesToBanksAndOtherInstitutions_labels" xlink:type="arc"/>
      <link:label id="id_3901e819" xlink:label="lbl_LiabilitiesToBanksAndOtherInstitutions_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Liabilities to banks and other financial institutions</link:label>
      <link:label id="id_551ca7d0" xlink:label="lbl_ContingentConsiderationReceivableCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration receivable, current</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivableCurrent" xlink:label="lbl_ContingentConsiderationReceivableCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationReceivableCurrent" xlink:to="lbl_ContingentConsiderationReceivableCurrent_labels" xlink:type="arc"/>
      <link:label id="id_15fc798c" xlink:label="lbl_ContingentConsiderationReceivableCurrent_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration receivable</link:label>
      <link:label id="id_249fb0f8" xlink:label="lbl_ImpactOfDivestmentsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of divestments, other provisions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfDivestmentsOtherProvisions" xlink:label="lbl_ImpactOfDivestmentsOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfDivestmentsOtherProvisions" xlink:to="lbl_ImpactOfDivestmentsOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_77b9898f" xlink:label="lbl_ImpactOfDivestmentsOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of divestments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:label="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:to="lbl_label788539736" xlink:type="arc"/>
      <link:label id="id_4241ab2c" xlink:label="lbl_GrossCarryingAmountMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross carrying amount</link:label>
      <link:label id="id_1264a0dc" xlink:label="lbl_label308584668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customers with net sales over five percent</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomersWithNetSalesOverFivePercent" xlink:label="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CustomersWithNetSalesOverFivePercent" xlink:to="lbl_label308584668" xlink:type="arc"/>
      <link:label id="id_2af199bf" xlink:label="lbl_label720476607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net cash flows used in acquisitions and divestments of businesses, classified as investing activities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:to="lbl_label720476607" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:to="lbl_label1718040268" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:to="lbl_label1423033786" xlink:type="arc"/>
      <link:label id="id_2cbb9926" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Impairment (loss) reversal of impairment loss recognised in profit or loss</link:label>
      <link:label id="id_eadbcd2" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquired cash and cash equivalents</link:label>
      <link:label id="id_36976720" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid benefit cost</link:label>
      <link:label id="id_1c757af9" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued share-based payments</link:label>
      <link:label id="id_79c38d68" xlink:label="lbl_Inventories_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
      <link:label id="id_1dbfe68b" xlink:label="lbl_CurrentTradeReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
      <link:label id="id_7bc2e092" xlink:label="lbl_label2076369042" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration receivables short-term [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesShorttermMember" xlink:label="lbl_ContingentConsiderationReceivablesShorttermMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationReceivablesShorttermMember" xlink:to="lbl_label2076369042" xlink:type="arc"/>
      <link:label id="id_1fd99bd1" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase of treasury share repurchase obligation under a share buyback trading plan</link:label>
      <link:label id="id_2da8b675" xlink:label="lbl_label329619167" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Options excluded from the calculation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OptionsExcludedFromTheCalculation" xlink:label="lbl_OptionsExcludedFromTheCalculation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OptionsExcludedFromTheCalculation" xlink:to="lbl_label329619167" xlink:type="arc"/>
      <link:label id="id_171116a0" xlink:label="lbl_label386995872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US commercial paper programs [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USCommercialPaperProgramsMember" xlink:label="lbl_USCommercialPaperProgramsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_USCommercialPaperProgramsMember" xlink:to="lbl_label386995872" xlink:type="arc"/>
      <link:label id="id_1fb8b12f" xlink:label="lbl_label532197679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JP commercial paper programs [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JPCommercialPaperProgramsMember" xlink:label="lbl_JPCommercialPaperProgramsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_JPCommercialPaperProgramsMember" xlink:to="lbl_label532197679" xlink:type="arc"/>
      <link:label id="id_68bfdd9c" xlink:label="lbl_label1757404572" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings commercial paper, number of programs</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperNumberOfPrograms" xlink:label="lbl_BorrowingsCommercialPaperNumberOfPrograms" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsCommercialPaperNumberOfPrograms" xlink:to="lbl_label1757404572" xlink:type="arc"/>
      <link:label id="id_4e21d3c" xlink:label="lbl_label81927484" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount of change in OCI when most significant parameters for level 3 change more than 10%</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:to="lbl_label81927484" xlink:type="arc"/>
      <link:label id="id_5ccfc0db" xlink:label="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount of change in OCI when POS for level 3 change more than 10%</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:to="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10_labels" xlink:type="arc"/>
      <link:label id="id_17ec29fe" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications (AAA) [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsAAAMember" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:to="lbl_AdvancedAcceleratorApplicationsAAAMember_labels" xlink:type="arc"/>
      <link:label id="id_4991ae50" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications (AAA)</link:label>
      <link:label id="id_69548c9f" xlink:label="lbl_label1767148703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Share capital in tender offer</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalInTenderOffer" xlink:label="lbl_PercentageOfShareCapitalInTenderOffer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfShareCapitalInTenderOffer" xlink:to="lbl_label1767148703" xlink:type="arc"/>
      <link:label id="id_5c76d079" xlink:label="lbl_CashOfferPerOrdinaryShare_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash offer per ordinary share</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOfferPerOrdinaryShare" xlink:label="lbl_CashOfferPerOrdinaryShare" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashOfferPerOrdinaryShare" xlink:to="lbl_CashOfferPerOrdinaryShare_labels" xlink:type="arc"/>
      <link:label id="id_741421fb" xlink:label="lbl_CashOfferPerADS_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash offer per ADS</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOfferPerADS" xlink:label="lbl_CashOfferPerADS" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashOfferPerADS" xlink:to="lbl_CashOfferPerADS_labels" xlink:type="arc"/>
      <link:label id="id_4236be0f" xlink:label="lbl_label1110883855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of ordinary share per ADS</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOrdinarySharePerADS" xlink:label="lbl_NumberOfOrdinarySharePerADS" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOrdinarySharePerADS" xlink:to="lbl_label1110883855" xlink:type="arc"/>
      <link:label id="id_471c5e7e" xlink:label="lbl_label1193041534" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value of equity</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfEquity" xlink:label="lbl_ValueOfEquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ValueOfEquity" xlink:to="lbl_label1193041534" xlink:type="arc"/>
      <link:label id="id_72ec4d21" xlink:label="lbl_label454367578" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximal amount of share buyback programm</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximalAmountOfShareBuybackProgramm" xlink:label="lbl_MaximalAmountOfShareBuybackProgramm" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MaximalAmountOfShareBuybackProgramm" xlink:to="lbl_label454367578" xlink:type="arc"/>
      <link:label id="id_6eb334f8" xlink:label="lbl_label1857238264" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of Annual Incentive</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAnnualIncentive" xlink:label="lbl_DescriptionOfAnnualIncentive" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAnnualIncentive" xlink:to="lbl_label1857238264" xlink:type="arc"/>
      <link:label id="id_5c74f412" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:to="lbl_TradeAndOtherPayablesToTradeSuppliers_labels" xlink:type="arc"/>
      <link:label id="id_5ba6657f" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
      <link:label id="id_7ae769dd" xlink:label="lbl_OtherCurrentNonfinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and other current liabilities</link:label>
      <link:label id="id_49cb7900" xlink:label="lbl_OtherCurrentNonfinancialLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total provisions and other current liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfBusinessUnits" xlink:label="lbl_NumberOfBusinessUnits" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfBusinessUnits" xlink:to="lbl_label267498308" xlink:type="arc"/>
      <link:label id="id_8b05ce2" xlink:label="lbl_label145775842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods, third parties, change in percent</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:to="lbl_label145775842" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:to="lbl_label198642827" xlink:type="arc"/>
      <link:label id="id_5eb218a8" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to deferred tax assets on US post retirement previously recognized through OCI</link:label>
      <link:label id="id_4b99efa9" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax on above items</link:label>
      <link:label id="id_5952def9" xlink:label="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Benefits other than equity-based compensation</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_labels" xlink:type="arc"/>
      <link:label id="id_389a5b52" xlink:label="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonCurrentFinancialDebtsMember" xlink:label="lbl_NonCurrentFinancialDebtsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonCurrentFinancialDebtsMember" xlink:to="lbl_label1268656258" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:label="lbl_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:to="lbl_label618343139" xlink:type="arc"/>
      <link:label id="id_6987695e" xlink:label="lbl_IntangibleAssetImpairmentChargesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible asset impairment charges [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IntangibleAssetImpairmentChargesTextBlock" xlink:label="lbl_IntangibleAssetImpairmentChargesTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IntangibleAssetImpairmentChargesTextBlock" xlink:to="lbl_IntangibleAssetImpairmentChargesTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_76ff2ee3" xlink:label="lbl_IntangibleAssetImpairmentChargesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible asset impairment charges</link:label>
      <link:label id="id_2dd3bece" xlink:label="lbl_label768851662" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of share capital tendered at the expiration of the tender offer</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:label="lbl_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:to="lbl_label768851662" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:label="lbl_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:to="lbl_label2363078" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentFairValueOfContingentConsiderationReceived" xlink:label="lbl_DivestmentFairValueOfContingentConsiderationReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DivestmentFairValueOfContingentConsiderationReceived" xlink:to="lbl_label1019864986" xlink:type="arc"/>
      <link:label id="id_4875601b" xlink:label="lbl_TransactionRelatedCostsPaid_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction related costs paid</link:label>
      <link:label id="id_5201dd1d" xlink:label="lbl_TransactionRelatedCosts_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction related costs</link:label>
      <link:label id="id_b9d0509" xlink:label="lbl_label770091111" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of fair value adjustments relating to intangible assets tax</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:label="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:to="lbl_label770091111" xlink:type="arc"/>
      <link:label id="id_55cbca11" xlink:label="lbl_label1439418897" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum margin percentage impact of commodity price change</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:label="lbl_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:to="lbl_label1439418897" xlink:type="arc"/>
      <link:label id="id_a88bf0e" xlink:label="lbl_label176733966" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum holding in unrelated company</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximumHoldingInUnrelatedCompany" xlink:label="lbl_MaximumHoldingInUnrelatedCompany" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MaximumHoldingInUnrelatedCompany" xlink:to="lbl_label176733966" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialReceivableFromDivestment" xlink:label="lbl_PotentialReceivableFromDivestment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PotentialReceivableFromDivestment" xlink:to="lbl_label1092727454" xlink:type="arc"/>
      <link:label id="id_2fe8aa88" xlink:label="lbl_CashOfferPerADS_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This expresses the amount of cash Novartis paid to the owners of AAA per ADS.</link:label>
      <link:label id="id_74cb8111" xlink:label="lbl_CashOfferPerOrdinaryShare_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This expresses the amount of cash Novartis paid to the owners of AAA per ordinary share.</link:label>
      <link:label id="id_4036843c" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This expresses a maximal amount.</link:label>
      <link:label id="id_64640b79" xlink:label="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This expresses a limit.</link:label>
      <link:label id="id_177cac6" xlink:label="lbl_ReclassificationFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This is a reclassification that can be debit or credit.</link:label>
      <link:label id="id_5fdbc2b7" xlink:label="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This amount can be a debit or a credit as the table discloses the fair value gain and loses on assets and liabilities.</link:label>
      <link:label id="id_314a813f" xlink:label="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">This amount can be a debit or a credit as the table discloses the fair value gain and loses on assets and liabilities.</link:label>
      <link:label id="id_4962d3fd" xlink:label="lbl_SellingGeneralAndAdministrativeExpense_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, general and administrative expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SellingGeneralAndAdministrativeExpense" xlink:to="lbl_SellingGeneralAndAdministrativeExpense_labels" xlink:type="arc"/>
      <link:label id="id_1f242104" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through other changes, equity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:to="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_labels" xlink:type="arc"/>
      <link:label id="id_5aa89188" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other movements</link:label>
      <link:label id="id_94ddbe4" xlink:label="lbl_label156097508" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change over period [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_label156097508" xlink:type="arc"/>
      <link:label id="id_4cdc11a9" xlink:label="lbl_label1289490857" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change over time [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_label1289490857" xlink:type="arc"/>
      <link:label id="id_501954f0" xlink:label="lbl_label1343837424" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change over period [member]</link:label>
      <link:label id="id_22153d9b" xlink:label="lbl_label571817371" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change to prior year-end [member]</link:label>
      <link:label id="id_dc043" xlink:label="lbl_NetDebt_labels2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDebt" xlink:label="lbl_NetDebt1" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetDebt1" xlink:to="lbl_NetDebt_labels2" xlink:type="arc"/>
      <link:label id="id_8969c68" xlink:label="lbl_NetDebt_labels2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
      <link:label id="id_641074d9" xlink:label="lbl_NetDebt_labels2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net debt</link:label>
      <link:label id="id_476a5a91" xlink:label="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_1548f70e" xlink:label="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of preparation</link:label>
      <link:label id="id_2c18deb" xlink:label="lbl_label46239211" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of preparation [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BasisOfPreparationAbstract" xlink:label="lbl_BasisOfPreparationAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BasisOfPreparationAbstract" xlink:to="lbl_label46239211" xlink:type="arc"/>
      <link:label id="id_2df428b0" xlink:label="lbl_label770975920" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selected critical accounting policies [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedCriticalAccountingPoliciesAbstract" xlink:label="lbl_SelectedCriticalAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SelectedCriticalAccountingPoliciesAbstract" xlink:to="lbl_label770975920" xlink:type="arc"/>
      <link:label id="id_2a3a2ba4" xlink:label="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Selected critical accounting policies</link:label>
      <link:label id="id_6b45f171" xlink:label="lbl_DisclosureOfEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of equity attributable to Novartis AG shareholders</link:label>
      <link:label id="id_2c2ab3f2" xlink:label="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments</link:label>
      <link:label id="id_4dd6c758" xlink:label="lbl_label1305921368" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal proceedings update [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LegalProceedingsUpdateAbstract" xlink:label="lbl_LegalProceedingsUpdateAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LegalProceedingsUpdateAbstract" xlink:to="lbl_label1305921368" xlink:type="arc"/>
      <link:label id="id_62d75963" xlink:label="lbl_LegalProceedingsUpdateTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal proceedings update [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LegalProceedingsUpdateTextBlock" xlink:label="lbl_LegalProceedingsUpdateTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LegalProceedingsUpdateTextBlock" xlink:to="lbl_LegalProceedingsUpdateTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_47116fe6" xlink:label="lbl_LegalProceedingsUpdateTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal proceedings update</link:label>
      <link:label id="id_6f65ab76" xlink:label="lbl_label1868934006" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impacts of adoption of new IFRS standards [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" xlink:label="lbl_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" xlink:to="lbl_label1868934006" xlink:type="arc"/>
      <link:label id="id_73aff3ab" xlink:label="lbl_label200796173" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impacts of adoption of new IFRS standards [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactsOfAdoptionOfNewIFRSStandardsTextBlock" xlink:label="lbl_ImpactsOfAdoptionOfNewIFRSStandardsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactsOfAdoptionOfNewIFRSStandardsTextBlock" xlink:to="lbl_label200796173" xlink:type="arc"/>
      <link:label id="id_9aad709" xlink:label="lbl_label162191113" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for available-for-sale financial assets [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:to="lbl_label162191113" xlink:type="arc"/>
      <link:label id="id_59f07686" xlink:label="lbl_label1508931206" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="lbl_label1508931206" xlink:type="arc"/>
      <link:label id="id_4a00f82a" xlink:label="lbl_label1241577514" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for Revenue from Contracts with Customers [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" xlink:to="lbl_label1241577514" xlink:type="arc"/>
      <link:label id="id_68958299" xlink:label="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for other revenue [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_68991831" xlink:label="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other revenue</link:label>
      <link:label id="id_5460feda" xlink:label="lbl_label1415642842" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated balance sheet by the adoption of IFRS 15 [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedBalanceSheetByTheAdoptionOfIFRS15TableTextBlock" xlink:label="lbl_ConsolidatedBalanceSheetByTheAdoptionOfIFRS15TableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsolidatedBalanceSheetByTheAdoptionOfIFRS15TableTextBlock" xlink:to="lbl_label1415642842" xlink:type="arc"/>
      <link:label id="id_5b4e8ef2" xlink:label="lbl_label1531875058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated statement of changes in equity by the adoption of IFRS 9 and IFRS 15 [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedStatementOfChangesInEquityByTheAdoptionOfIFRS9AndIFRS15TableTextBlock" xlink:label="lbl_ConsolidatedStatementOfChangesInEquityByTheAdoptionOfIFRS9AndIFRS15TableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsolidatedStatementOfChangesInEquityByTheAdoptionOfIFRS9AndIFRS15TableTextBlock" xlink:to="lbl_label1531875058" xlink:type="arc"/>
      <link:label id="id_e7f3472" xlink:label="lbl_label243217522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial instruments additional disclosures table by the adoption of IFRS 9 [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosuresTableByTheAdoptionOfIFRS9TableTextBlock" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosuresTableByTheAdoptionOfIFRS9TableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosuresTableByTheAdoptionOfIFRS9TableTextBlock" xlink:to="lbl_label243217522" xlink:type="arc"/>
      <link:label id="id_71771d90" xlink:label="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales by region</link:label>
      <link:label id="id_4f219465" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments, net sales of Top 20 products [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:to="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2b8de385" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales of Top 20 products</link:label>
      <link:label id="id_45ec2147" xlink:label="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments, other revenue [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:to="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7f01fd05" xlink:label="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other revenue</link:label>
      <link:label id="id_1894478a" xlink:label="lbl_AveXisIncMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AveXis, Inc. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AveXisIncMember" xlink:label="lbl_AveXisIncMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AveXisIncMember" xlink:to="lbl_AveXisIncMember_labels" xlink:type="arc"/>
      <link:label id="id_43b60602" xlink:label="lbl_AveXisIncMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AveXis, Inc.</link:label>
      <link:label id="id_6a7073ad" xlink:label="lbl_label1785754541" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retrospective application and retrospective restatement [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_label1785754541" xlink:type="arc"/>
      <link:label id="id_33459cb3" xlink:label="lbl_label860200115" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currently stated [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestatedMember" xlink:to="lbl_label860200115" xlink:type="arc"/>
      <link:label id="id_41804a67" xlink:label="lbl_label1098926695" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously stated [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PreviouslyStatedMember" xlink:to="lbl_label1098926695" xlink:type="arc"/>
      <link:label id="id_d0e08b6" xlink:label="lbl_label217930333" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy and corrections of prior period errors [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_label217930333" xlink:type="arc"/>
      <link:label id="id_4a438f95" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy, IFRS 9 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member_labels" xlink:type="arc"/>
      <link:label id="id_68a9252d" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment, IFRS 9</link:label>
      <link:label id="id_3803c2cc" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy, IFRS 15 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member_labels" xlink:type="arc"/>
      <link:label id="id_7f440478" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment, IFRS 15</link:label>
      <link:label id="id_6cbd5ed8" xlink:label="lbl_OCIReservesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI reserves [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OCIReservesMember" xlink:label="lbl_OCIReservesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OCIReservesMember" xlink:to="lbl_OCIReservesMember_labels" xlink:type="arc"/>
      <link:label id="id_37bd32c4" xlink:label="lbl_OCIReservesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OCI reserves</link:label>
      <link:label id="id_3071cdbf" xlink:label="lbl_label812764607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retail Generics [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetailGenericsMember" xlink:label="lbl_RetailGenericsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RetailGenericsMember" xlink:to="lbl_label812764607" xlink:type="arc"/>
      <link:label id="id_22d00e67" xlink:label="lbl_label584060519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Biopharmaceuticals [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BiopharmaceuticalsMember" xlink:label="lbl_BiopharmaceuticalsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BiopharmaceuticalsMember" xlink:to="lbl_label584060519" xlink:type="arc"/>
      <link:label id="id_74e760f" xlink:label="lbl_label122582543" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Anti Infectives [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AntiInfectivesMember" xlink:label="lbl_AntiInfectivesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AntiInfectivesMember" xlink:to="lbl_label122582543" xlink:type="arc"/>
      <link:label id="id_2e5631da" xlink:label="lbl_label777400794" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Surgical [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SurgicalMember" xlink:label="lbl_SurgicalMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SurgicalMember" xlink:to="lbl_label777400794" xlink:type="arc"/>
      <link:label id="id_5a63105" xlink:label="lbl_label94777605" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vision Care [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VisionCareMember" xlink:label="lbl_VisionCareMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VisionCareMember" xlink:to="lbl_label94777605" xlink:type="arc"/>
      <link:label id="id_33d2b620" xlink:label="lbl_label869447200" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumables [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsumablesMember" xlink:label="lbl_ConsumablesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsumablesMember" xlink:to="lbl_label869447200" xlink:type="arc"/>
      <link:label id="id_3fe1336c" xlink:label="lbl_label1071723372" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Implantables [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImplantablesMember" xlink:label="lbl_ImplantablesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImplantablesMember" xlink:to="lbl_label1071723372" xlink:type="arc"/>
      <link:label id="id_6d32d4c6" xlink:label="lbl_label1832047814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment/Other [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquipmentOtherMember" xlink:label="lbl_EquipmentOtherMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquipmentOtherMember" xlink:to="lbl_label1832047814" xlink:type="arc"/>
      <link:label id="id_9208315" xlink:label="lbl_label153125653" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ophthalmic OTC [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OphthalmicOTCMember" xlink:label="lbl_OphthalmicOTCMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OphthalmicOTCMember" xlink:to="lbl_label153125653" xlink:type="arc"/>
      <link:label id="id_3d77d223" xlink:label="lbl_label1031262755" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact lens care [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContactLensCareMember" xlink:label="lbl_ContactLensCareMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContactLensCareMember" xlink:to="lbl_label1031262755" xlink:type="arc"/>
      <link:label id="id_5ff6168e" xlink:label="lbl_label1609963150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top 20 products [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Top20ProductsMember" xlink:label="lbl_Top20ProductsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_Top20ProductsMember" xlink:to="lbl_label1609963150" xlink:type="arc"/>
      <link:label id="id_1bc8878f" xlink:label="lbl_label466126735" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest of portfolio [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestOfPortfolioMember" xlink:label="lbl_RestOfPortfolioMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestOfPortfolioMember" xlink:to="lbl_label466126735" xlink:type="arc"/>
      <link:label id="id_60f02df8" xlink:label="lbl_label1626353144" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="lbl_RevenueFromRoyalties" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromRoyalties" xlink:to="lbl_label1626353144" xlink:type="arc"/>
      <link:label id="id_132c5856" xlink:label="lbl_label321673302" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit sharing income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitSharingIncome" xlink:label="lbl_ProfitSharingIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitSharingIncome" xlink:to="lbl_label321673302" xlink:type="arc"/>
      <link:label id="id_dd742a8" xlink:label="lbl_label232211112" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Milestone income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MilestoneIncome" xlink:label="lbl_MilestoneIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MilestoneIncome" xlink:to="lbl_label232211112" xlink:type="arc"/>
      <link:label id="id_31af75cd" xlink:label="lbl_OtherRevenueOther_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other revenue, other</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherRevenueOther" xlink:label="lbl_OtherRevenueOther" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherRevenueOther" xlink:to="lbl_OtherRevenueOther_labels" xlink:type="arc"/>
      <link:label id="id_41473bf" xlink:label="lbl_OtherRevenueOther_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
      <link:label id="id_22e4d15f" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from operating activities, as a percentage from net sales</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:to="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales_labels" xlink:type="arc"/>
      <link:label id="id_3e5bb44f" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating income as % of net sales</link:label>
      <link:label id="id_15de3f6e" xlink:label="lbl_label366886766" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USMember" xlink:label="lbl_USMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_USMember" xlink:to="lbl_label366886766" xlink:type="arc"/>
      <link:label id="id_3761b8d8" xlink:label="lbl_label929151192" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Canada and Latin America [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CanadaAndLatinAmericaMember" xlink:label="lbl_CanadaAndLatinAmericaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CanadaAndLatinAmericaMember" xlink:to="lbl_label929151192" xlink:type="arc"/>
      <link:label id="id_35dc7c05" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from sale of goods, third parties, change in percent, cc</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc_labels" xlink:type="arc"/>
      <link:label id="id_2402bc9" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales, change in %, cc</link:label>
      <link:label id="id_11578a03" xlink:label="lbl_label290949635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Established Markets [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMarketsMember" xlink:label="lbl_EstablishedMarketsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EstablishedMarketsMember" xlink:to="lbl_label290949635" xlink:type="arc"/>
      <link:label id="id_1e6859ac" xlink:label="lbl_label510155180" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Emerging Growth Markets [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EmergingGrowthMarketsMember" xlink:label="lbl_EmergingGrowthMarketsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EmergingGrowthMarketsMember" xlink:to="lbl_label510155180" xlink:type="arc"/>
      <link:label id="id_395d61a2" xlink:label="lbl_label962421154" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rest of the world [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestOfTheWorldMember" xlink:label="lbl_RestOfTheWorldMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestOfTheWorldMember" xlink:to="lbl_label962421154" xlink:type="arc"/>
      <link:label id="id_2aeb33db" xlink:label="lbl_TreasurySharesAcquiredToBeCancelled_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares acquired to be cancelled</link:label>
      <link:label id="id_16be2f1a" xlink:label="lbl_TreasurySharesAcquiredForCancellationValue_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares acquired for cancellation, equity impact</link:label>
      <link:label id="id_14bac1b3" xlink:label="lbl_StockRepurchaseProgramAuthorizedAmount1_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase of treasury share repurchase obligation under a share buyback trading plan</link:label>
      <link:label id="id_10768f17" xlink:label="lbl_label276205335" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.5% EUR 750 million 2018/2023 of Novartis [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.5EUR750Million20182023OfNovartisMember" xlink:label="lbl_A0.5EUR750Million20182023OfNovartisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.5EUR750Million20182023OfNovartisMember" xlink:to="lbl_label276205335" xlink:type="arc"/>
      <link:label id="id_6c222bbb" xlink:label="lbl_label1814178747" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.375% EUR 750 million 2018/2030 of Novartis [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.375EUR750Million20182030OfNovartisMember" xlink:label="lbl_A1.375EUR750Million20182030OfNovartisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.375EUR750Million20182030OfNovartisMember" xlink:to="lbl_label1814178747" xlink:type="arc"/>
      <link:label id="id_42e49e27" xlink:label="lbl_label1122278951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.7% EUR 750 million 2018/2038 of Novartis [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.7EUR750Million20182038OfNovartisMember" xlink:label="lbl_A1.7EUR750Million20182038OfNovartisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.7EUR750Million20182038OfNovartisMember" xlink:to="lbl_label1122278951" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GalvusGroupMember" xlink:label="lbl_GalvusGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GalvusGroupMember" xlink:to="lbl_label195411774" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DiovanGroupMember" xlink:label="lbl_DiovanGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DiovanGroupMember" xlink:to="lbl_label1973931633" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExforgeGroupMember" xlink:label="lbl_ExforgeGroupMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExforgeGroupMember" xlink:to="lbl_label1243142238" xlink:type="arc"/>
      <link:label id="id_15727011" xlink:label="lbl_label359821329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Immunology, Hepatology and Dermatology [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImmunologyHepatologyAndDermatologyMember" xlink:label="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:to="lbl_label359821329" xlink:type="arc"/>
      <link:label id="id_86e5c43" xlink:label="lbl_label141450307" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Anti Infectives sold under Sandoz name [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AntiInfectivesSoldUnderSandozNameMember" xlink:label="lbl_AntiInfectivesSoldUnderSandozNameMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AntiInfectivesSoldUnderSandozNameMember" xlink:to="lbl_label141450307" xlink:type="arc"/>
      <link:label id="id_194d5f34" xlink:label="lbl_label424501044" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about business combinations [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:label="lbl_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDetailedInformationAboutBusinessCombinationsExplanatory" xlink:to="lbl_label424501044" xlink:type="arc"/>
      <link:label id="id_4f78aa77" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments on financial assets sold</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold_labels" xlink:type="arc"/>
      <link:label id="id_73e25c53" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_labels" xlink:type="arc"/>
      <link:label id="id_7e4ea322" xlink:label="lbl_label2119082786" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_label2119082786" xlink:type="arc"/>
      <link:label id="id_306dde36" xlink:label="lbl_label812506678" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy required by IFRSs [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:to="lbl_label812506678" xlink:type="arc"/>
      <link:label id="id_474e15ff" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets of disposal group held for sale</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherSharePurchasesValue" xlink:label="lbl_OtherSharePurchasesValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherSharePurchasesValue" xlink:to="lbl_OtherSharePurchasesValue_labels" xlink:type="arc"/>
      <link:label id="id_6ae68310" xlink:label="lbl_label1793491728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lutathera [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LutatheraMember" xlink:label="lbl_LutatheraMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LutatheraMember" xlink:to="lbl_label1793491728" xlink:type="arc"/>
      <link:label id="id_5ba5546c" xlink:label="lbl_label1537561708" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Kymriah [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KymriahMember" xlink:label="lbl_KymriahMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_KymriahMember" xlink:to="lbl_label1537561708" xlink:type="arc"/>
      <link:label id="id_6c54b8f7" xlink:label="lbl_label1817491703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of share capital tendered at the subsequent offering period of the tender offer</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:to="lbl_label1817491703" xlink:type="arc"/>
      <link:label id="id_a269182" xlink:label="lbl_label170299778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration paid for share capital tendered at the subsequent offering period of the tender offer</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:to="lbl_label170299778" xlink:type="arc"/>
      <link:label id="id_7317bbcb" xlink:label="lbl_label1930935243" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total percentage of share capital tendered after the subsequent offering period of the tender offer</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:to="lbl_label1930935243" xlink:type="arc"/>
      <link:label id="id_57adc4f7" xlink:label="lbl_TransactionCostsRecordedInEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction costs recorded in Equity [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquityTextBlock" xlink:label="lbl_TransactionCostsRecordedInEquityTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionCostsRecordedInEquityTextBlock" xlink:to="lbl_TransactionCostsRecordedInEquityTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_281ffdcd" xlink:label="lbl_TransactionCostsRecordedInEquityTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs recorded in Equity</link:label>
      <link:label id="id_2cc49159" xlink:label="lbl_TransactionCostsRecordedInEquityPaid_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction costs recorded in equity paid</link:label>
      <link:label id="id_7df5c0c1" xlink:label="lbl_label2113257665" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transactions with related parties [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionsWithRelatedPartiesAbstract" xlink:label="lbl_TransactionsWithRelatedPartiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionsWithRelatedPartiesAbstract" xlink:to="lbl_label2113257665" xlink:type="arc"/>
      <link:label id="id_5c1d5da7" xlink:label="lbl_label1309162706" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transactions with related parties [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionsWithRelatedPartiesTextBlock" xlink:label="lbl_TransactionsWithRelatedPartiesTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionsWithRelatedPartiesTextBlock" xlink:to="lbl_label1309162706" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquityPaid" xlink:label="lbl_TransactionCostsRecordedInEquityPaid" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionCostsRecordedInEquityPaid" xlink:to="lbl_TransactionCostsRecordedInEquityPaid_labels" xlink:type="arc"/>
      <link:label id="id_5de3849f" xlink:label="lbl_TransactionCostsRecordedInEquity_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction costs recorded in equity</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquity" xlink:label="lbl_TransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionCostsRecordedInEquity" xlink:to="lbl_TransactionCostsRecordedInEquity_labels" xlink:type="arc"/>
      <link:label id="id_154fa58" xlink:label="lbl_label22346328" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income recycled into the consolidated income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:label="lbl_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:to="lbl_label22346328" xlink:type="arc"/>
      <link:label id="id_7c9a09e2" xlink:label="lbl_label2090469858" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase to retained earnings arising from first application of IFRS 9 fund investments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9FundInvestments" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9FundInvestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9FundInvestments" xlink:to="lbl_label2090469858" xlink:type="arc"/>
      <link:label id="id_36de49a0" xlink:label="lbl_label920537504" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase to retained earnings arising from first application of IFRS 9 equity securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9EquitySecurities" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9EquitySecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9EquitySecurities" xlink:to="lbl_label920537504" xlink:type="arc"/>
      <link:label id="id_1e72baf" xlink:label="lbl_label31927215" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pension Fund [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPensionFundMember" xlink:label="lbl_NovartisPensionFundMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPensionFundMember" xlink:to="lbl_label31927215" xlink:type="arc"/>
      <link:label id="id_6d9924d1" xlink:label="lbl_label1838752977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings credit facility uncommitted</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityUncommitted" xlink:label="lbl_BorrowingsCreditFacilityUncommitted" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsCreditFacilityUncommitted" xlink:to="lbl_label1838752977" xlink:type="arc"/>
      <link:label id="id_60aed585" xlink:label="lbl_label1622070661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other net assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherNetAssets" xlink:label="lbl_OtherNetAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNetAssets" xlink:to="lbl_label1622070661" xlink:type="arc"/>
      <link:label id="id_25566515" xlink:label="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments from changes in ownership interests in subsidiaries that do not result in loss of control</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:to="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_labels" xlink:type="arc"/>
      <link:label id="id_73ce5e23" xlink:label="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of change in ownership of consolidated entities</link:label>
      <link:label id="id_68208ecc" xlink:label="lbl_label1746964172" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ocular health [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OcularHealthMember" xlink:label="lbl_OcularHealthMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OcularHealthMember" xlink:to="lbl_label1746964172" xlink:type="arc"/>
      <link:label id="id_7d654567" xlink:label="lbl_label2103788903" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">0.500% EUR 750 million 2018/2023 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.655% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:label="lbl_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:to="lbl_label2103788903" xlink:type="arc"/>
      <link:label id="id_a1b491f" xlink:label="lbl_label169560351" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.375% EUR 750 million 2018/2030 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.957% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:label="lbl_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:to="lbl_label169560351" xlink:type="arc"/>
      <link:label id="id_1f1416" xlink:label="lbl_label2036758" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">1.700% EUR 750 million 2018/2038 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.217% [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:label="lbl_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:to="lbl_label2036758" xlink:type="arc"/>
      <link:label id="id_63baf8ea" xlink:label="lbl_label1673197802" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications International SA, Geneve [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:label="lbl_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:to="lbl_label1673197802" xlink:type="arc"/>
      <link:label id="id_4bc832fa" xlink:label="lbl_label1271411450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications Switzerland SA, Geneve [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:label="lbl_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:to="lbl_label1271411450" xlink:type="arc"/>
      <link:label id="id_2658ed55" xlink:label="lbl_label643362133" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AveXis, Inc., Bannockburn, IL [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AveXisInc.BannockburnILMember" xlink:label="lbl_AveXisInc.BannockburnILMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AveXisInc.BannockburnILMember" xlink:to="lbl_label643362133" xlink:type="arc"/>
      <link:label id="id_358de13" xlink:label="lbl_label56155667" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications S.A., Saint Genis Pouilly [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:label="lbl_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:to="lbl_label56155667" xlink:type="arc"/>
      <link:label id="id_480bc7a" xlink:label="lbl_BasicEarningsLossPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per share</link:label>
      <link:label id="id_4f788787" xlink:label="lbl_DilutedEarningsLossPerShare_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per share</link:label>
      <link:label id="id_579c77e7" xlink:label="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:to="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_labels" xlink:type="arc"/>
      <link:label id="id_6e4a53e8" xlink:label="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets without disposal group</link:label>
      <link:label id="id_4c7ed954" xlink:label="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities other than liabilities included in disposal groups classified as held for sale</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_labels" xlink:type="arc"/>
      <link:label id="id_6f67d848" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities included in disposal groups classified as held for sale</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_labels" xlink:type="arc"/>
      <link:label id="id_41ef90c7" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities of disposal group held for sale</link:label>
      <link:label id="id_15dcecbd" xlink:label="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities without disposal group</link:label>
      <link:label id="id_6be52fb3" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, net of tax</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:type="arc"/>
      <link:label id="id_2cc5f4f3" xlink:label="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:type="arc"/>
      <link:label id="id_4201ce33" xlink:label="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total of items never to be recycled</link:label>
      <link:label id="id_3dedbea0" xlink:label="lbl_SellingGeneralAndAdministrativeExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administration</link:label>
      <link:label id="id_24ee551" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through business combinations, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_50cb4109" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_24ba2cbb" xlink:label="lbl_label616180923" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal group held for sale [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalGroupHeldForSaleAbstract" xlink:label="lbl_DisposalGroupHeldForSaleAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalGroupHeldForSaleAbstract" xlink:to="lbl_label616180923" xlink:type="arc"/>
      <link:label id="id_2e51c9a9" xlink:label="lbl_label777111977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities not classified as held for sale [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_label777111977" xlink:type="arc"/>
      <link:label id="id_54b5ab16" xlink:label="lbl_label1421191958" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities classified as held for sale [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_label1421191958" xlink:type="arc"/>
      <link:label id="id_620a76ae" xlink:label="lbl_label1644852910" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets held for sale [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsHeldForSaleMember" xlink:label="lbl_NoncurrentAssetsHeldForSaleMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentAssetsHeldForSaleMember" xlink:to="lbl_label1644852910" xlink:type="arc"/>
      <link:label id="id_35b1993" xlink:label="lbl_label56301971" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal groups classified as held for sale [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:to="lbl_label56301971" xlink:type="arc"/>
      <link:label id="id_775bbb23" xlink:label="lbl_label2002500387" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets and liabilities classified as held for sale [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_label2002500387" xlink:type="arc"/>
      <link:label id="id_76d4000c" xlink:label="lbl_label1993605132" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal group held for sale [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalGroupHeldForSaleLineItems" xlink:label="lbl_DisposalGroupHeldForSaleLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalGroupHeldForSaleLineItems" xlink:to="lbl_label1993605132" xlink:type="arc"/>
      <link:label id="id_511c252" xlink:label="lbl_label85049938" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets of disposal group classified as held for sale [abstract]</link:label>
      <link:label id="id_3a8a761b" xlink:label="lbl_label982152731" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities of disposal group classified as held for sale [abstract]</link:label>
      <link:label id="id_7ebdc3d3" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in other current assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets_labels" xlink:type="arc"/>
      <link:label id="id_196d02a3" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in other current assets</link:label>
      <link:label id="id_2004a2a3" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in other current liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_5c1266c3" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in other current liabilities</link:label>
      <link:label id="id_1b44e5e7" xlink:label="lbl_OtherAdjustmentsToReconcileProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other adjustments to reconcile profit (loss)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="lbl_OtherAdjustmentsToReconcileProfitLoss" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherAdjustmentsToReconcileProfitLoss" xlink:to="lbl_OtherAdjustmentsToReconcileProfitLoss_labels" xlink:type="arc"/>
      <link:label id="id_753e354c" xlink:label="lbl_label1967011148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in cash settled share based payments liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:label="lbl_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:to="lbl_label1967011148" xlink:type="arc"/>
      <link:label id="id_3fb8017" xlink:label="lbl_OtherAdjustmentsToReconcileProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other adjustments, net</link:label>
      <link:label id="id_45184c03" xlink:label="lbl_CashInflowOutflowNoncontrollingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow (outflow), Non-controlling interests</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowNoncontrollingInterests" xlink:label="lbl_CashInflowOutflowNoncontrollingInterests" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowNoncontrollingInterests" xlink:to="lbl_CashInflowOutflowNoncontrollingInterests_labels" xlink:type="arc"/>
      <link:label id="id_3e6c4694" xlink:label="lbl_CashInflowOutflowNoncontrollingInterests_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
      <link:label id="id_773be135" xlink:label="lbl_label1852230229" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount recorded in equity related to hyperinflation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountRecordedInEquityRelatedToHyperinflation" xlink:label="lbl_AmountRecordedInEquityRelatedToHyperinflation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountRecordedInEquityRelatedToHyperinflation" xlink:to="lbl_label1852230229" xlink:type="arc"/>
      <link:label id="id_73d5e167" xlink:label="lbl_label1851268028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions to investment in associated companies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToInvestmentInAssociatedCompanies" xlink:label="lbl_AdditionsToInvestmentInAssociatedCompanies" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsToInvestmentInAssociatedCompanies" xlink:to="lbl_label1851268028" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:label id="id_1341dbff" xlink:label="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through effect of changes in foreign exchange rates, liabilities arising from financing activities</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:to="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_346b395c" xlink:label="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_4b1ad4e8" xlink:label="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_2fcaf057" xlink:label="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_17118b46" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_1d85e3c0" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
      <link:label id="id_4b8f7d44" xlink:label="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and other assets including deferred tax assets recognised as of acquisition date</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:to="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_2918e43e" xlink:label="lbl_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial and other assets including deferred tax assets</link:label>
      <link:label id="id_5abfc6c6" xlink:label="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_40924196" xlink:label="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current and non-current financial debts</link:label>
      <link:label id="id_4016f674" xlink:label="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-controlling interest in acquiree recognised at acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:to="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_2ea65efd" xlink:label="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
      <link:label id="id_2375ce31" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, debt securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities_labels" xlink:type="arc"/>
      <link:label id="id_56d0df79" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on debt securities, net of taxes</link:label>
      <link:label id="id_4663183e" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale debt securities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="locator"/>
      <link:label id="id_40c6b8fb" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equity-based compensation</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions_labels" xlink:type="arc"/>
      <link:label id="id_3261fe4" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-based compensation, equity impact</link:label>
      <link:label id="id_cb4c548" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</link:label>
      <link:label id="id_2a76513b" xlink:label="lbl_TransactionCosts_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCosts" xlink:label="lbl_TransactionCosts" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TransactionCosts" xlink:to="lbl_TransactionCosts_labels" xlink:type="arc"/>
      <link:label id="id_19c4929e" xlink:label="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain on divestment of interests in associated companies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:label="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:to="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies_labels" xlink:type="arc"/>
      <link:label id="id_2500459a" xlink:label="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on divestment</link:label>
      <link:label id="id_198075f2" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments on debt securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:to="lbl_FairValueAdjustmentsOnDebtSecuritiesMember_labels" xlink:type="arc"/>
      <link:label id="id_3f9715cf" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on debt securities</link:label>
      <link:label id="id_76d81b48" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value adjustments on equity securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:to="lbl_FairValueAdjustmentsOnEquitySecuritiesMember_labels" xlink:type="arc"/>
      <link:label id="id_57bce160" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on equity securities</link:label>
      <link:label id="id_1fb67de2" xlink:label="lbl_label532053474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification to presentation required under IFRS 9 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:label="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:to="lbl_label532053474" xlink:type="arc"/>
      <link:label id="id_714a2d9" xlink:label="lbl_label118792921" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restated Value Adjustments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RestatedValueAdjustmentsMember" xlink:to="lbl_label118792921" xlink:type="arc"/>
      <link:label id="id_4587be64" xlink:label="lbl_label1595406142" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial assets, equity investments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsEquityInvestments" xlink:label="lbl_NoncurrentFinancialAssetsEquityInvestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialAssetsEquityInvestments" xlink:to="lbl_label1595406142" xlink:type="arc"/>
      <link:label id="id_2b6a8c9e" xlink:label="lbl_label858249235" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial assets, fund investments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsFundInvestments" xlink:label="lbl_NoncurrentFinancialAssetsFundInvestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialAssetsFundInvestments" xlink:to="lbl_label858249235" xlink:type="arc"/>
      <link:label id="id_6be6dda0" xlink:label="lbl_label1810292128" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:to="lbl_label1810292128" xlink:type="arc"/>
      <link:label id="id_ea4af2a" xlink:label="lbl_label245673770" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_label245673770" xlink:type="arc"/>
      <link:label id="id_341eabcf" xlink:label="lbl_label874425295" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_label874425295" xlink:type="arc"/>
      <link:label id="id_2ef67b59" xlink:label="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:label="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:to="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_labels" xlink:type="arc"/>
      <link:label id="id_2bbf6984" xlink:label="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities</link:label>
      <link:label id="id_5be6a6ba" xlink:label="lbl_label1541842618" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [axis]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:to="lbl_label1541842618" xlink:type="arc"/>
      <link:label id="id_5b1cb05e" xlink:label="lbl_label1528606814" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in equity instruments designated at fair value through other comprehensive income [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_label1528606814" xlink:type="arc"/>
      <link:label id="id_131c72f5" xlink:label="lbl_label320631541" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Listed equity securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ListedEquitySecuritiesMember" xlink:label="lbl_ListedEquitySecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ListedEquitySecuritiesMember" xlink:to="lbl_label320631541" xlink:type="arc"/>
      <link:label id="id_58943bff" xlink:label="lbl_label1486109695" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-listed equity securities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonlistedEquitySecuritiesMember" xlink:label="lbl_NonlistedEquitySecuritiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonlistedEquitySecuritiesMember" xlink:to="lbl_label1486109695" xlink:type="arc"/>
      <link:label id="id_466ea37d" xlink:label="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of assets of disposal group classified as held for sale [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:label="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:to="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_328aa9b8" xlink:label="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets of disposal group classified as held for sale</link:label>
      <link:label id="id_663782d5" xlink:label="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of liabilities of disposal group classified as held for sale [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:label="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:to="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5f98604f" xlink:label="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities of disposal group classified as held for sale</link:label>
      <link:label id="id_1786ac50" xlink:label="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory" xlink:label="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory" xlink:to="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_33784e41" xlink:label="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity securities measured at fair value through other comprehensive income</link:label>
      <link:label id="id_2785f328" xlink:label="lbl_EndocyteMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Endocyte [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteMember" xlink:label="lbl_EndocyteMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EndocyteMember" xlink:to="lbl_EndocyteMember_labels" xlink:type="arc"/>
      <link:label id="id_1ab891f2" xlink:label="lbl_EndocyteMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Endocyte</link:label>
      <link:label id="id_559cd899" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets, cash and cash equivalents [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_63b9b41c" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:label id="id_172750e3" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets, marketable securities, commodities and non-current financial assets [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" xlink:to="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_7ca31c97" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, commodities and non-current financial assets</link:label>
      <link:label id="id_447d705c" xlink:label="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net sales and selected non-current assets, by countries and regions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:to="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_36daedff" xlink:label="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales and selected non-current assets, by countries and regions</link:label>
      <link:label id="id_24f609b0" xlink:label="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net sales, by segements and regions [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:to="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_27432d26" xlink:label="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales by region</link:label>
      <link:label id="id_4192e6ea" xlink:label="lbl_label235032989" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of nature of change in accounting policy</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="lbl_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:to="lbl_label235032989" xlink:type="arc"/>
      <link:label id="id_457ba061" xlink:label="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Divestments aquisitions of interests in associated companies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:label="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:to="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies_labels" xlink:type="arc"/>
      <link:label id="id_49d2e101" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through classified as held for sale, property, plant and equipment</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:to="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_625c07b4" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of assets related to disposal group held for sale</link:label>
      <link:label id="id_6066a3c9" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through classified as held for sale, intangible assets and goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:to="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_580b40b6" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of assets related to disposal group held for sale</link:label>
      <link:label id="id_3af4fc23" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of assets related to disposal group held for sale</link:label>
      <link:label id="id_6cd0a23e" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net deferred tax balance related to disposal group held for sale</link:label>
      <link:label id="id_7f1eeac9" xlink:label="lbl_OtherShareSales_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other share sales</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherShareSales" xlink:label="lbl_OtherShareSales" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherShareSales" xlink:to="lbl_OtherShareSales_labels" xlink:type="arc"/>
      <link:label id="id_7be3c1db" xlink:label="lbl_OtherShareSales_labels" xlink:role="http://www.xbrl.org/2003/role/negativeLabel" xlink:type="resource" xml:lang="en-US">Other share sales</link:label>
      <link:label id="id_6d6afa95" xlink:label="lbl_label1359067097" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other share sales, equity impact</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherShareSalesEquityImpact" xlink:label="lbl_OtherShareSalesEquityImpact" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherShareSalesEquityImpact" xlink:to="lbl_label1359067097" xlink:type="arc"/>
      <link:label id="id_3b6caa8a" xlink:label="lbl_NumberOfOtherShareSales_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other share sales</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOtherShareSales" xlink:label="lbl_NumberOfOtherShareSales" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOtherShareSales" xlink:to="lbl_NumberOfOtherShareSales_labels" xlink:type="arc"/>
      <link:label id="id_6db1b7c2" xlink:label="lbl_NumberOfOtherShareSales_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other share sales</link:label>
      <link:label id="id_2d79675e" xlink:label="lbl_NumberOfOtherShareSalesEquityImpact_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other share sales, equity impact</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOtherShareSalesEquityImpact" xlink:label="lbl_NumberOfOtherShareSalesEquityImpact" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfOtherShareSalesEquityImpact" xlink:to="lbl_NumberOfOtherShareSalesEquityImpact_labels" xlink:type="arc"/>
      <link:label id="id_4f13fea7" xlink:label="lbl_NumberOfOtherShareSalesEquityImpact_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other share sales, equity impact</link:label>
      <link:label id="id_35d72bee" xlink:label="lbl_label903293934" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, debt securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeDebtSecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeDebtSecurities" xlink:to="lbl_label903293934" xlink:type="arc"/>
      <link:label id="id_269c946a" xlink:label="lbl_label647795818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, equity securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeEquitySecurities" xlink:label="lbl_OtherComprehensiveIncomeEquitySecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeEquitySecurities" xlink:to="lbl_label647795818" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:to="lbl_label1931018935" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:to="lbl_label1923652241" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPtyLtdMacquarieParkNSWMember" xlink:label="lbl_SandozPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozPtyLtdMacquarieParkNSWMember" xlink:to="lbl_label1031360833" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:to="lbl_label409451279" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaNVVilvoordeMember" xlink:label="lbl_NovartisPharmaNVVilvoordeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaNVVilvoordeMember" xlink:to="lbl_label861091593" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozNVVilvoordeMember" xlink:label="lbl_SandozNVVilvoordeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozNVVilvoordeMember" xlink:to="lbl_label102668381" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCouvreurNVPuursMember" xlink:label="lbl_AlconCouvreurNVPuursMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconCouvreurNVPuursMember" xlink:to="lbl_label1808949392" xlink:type="arc"/>
      <link:label id="id_20428b8c" xlink:label="lbl_label541232012" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Laboratories Belgium BVBA, Puurs [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:label="lbl_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:to="lbl_label541232012" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNVVilvoordeMember" xlink:label="lbl_AlconNVVilvoordeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconNVVilvoordeMember" xlink:to="lbl_label1193123279" xlink:type="arc"/>
      <link:label id="id_7f713e00" xlink:label="lbl_label2138127872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon AG, Fribourg [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconAGFribourgMember" xlink:label="lbl_AlconAGFribourgMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconAGFribourgMember" xlink:to="lbl_label2138127872" xlink:type="arc"/>
      <link:label id="id_3e12064" xlink:label="lbl_label65085540" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications USA, Inc., New York, NY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:label="lbl_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:to="lbl_label65085540" xlink:type="arc"/>
      <link:label id="id_749e4361" xlink:label="lbl_label1956528993" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CIBA Vision Corporation LLC, Duluth, GA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionCorporationLLCDuluthGAMember" xlink:label="lbl_CIBAVisionCorporationLLCDuluthGAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CIBAVisionCorporationLLCDuluthGAMember" xlink:to="lbl_label1956528993" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:label="lbl_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:to="lbl_label426571388" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPolandSp.ZO.o.WarsawMember" xlink:label="lbl_NovartisPolandSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPolandSp.ZO.o.WarsawMember" xlink:to="lbl_label1610589901" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPolskaSp.ZO.o.WarsawMember" xlink:label="lbl_SandozPolskaSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozPolskaSp.ZO.o.WarsawMember" xlink:to="lbl_label1898723838" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPolskaSp.ZO.o.WarsawMember" xlink:label="lbl_AlconPolskaSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconPolskaSp.ZO.o.WarsawMember" xlink:to="lbl_label1959302877" xlink:type="arc"/>
      <link:label id="id_6d8d3375" xlink:label="lbl_label1837970293" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Healthcare, S.A., Barcelona [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconHealthcareS.A.BarcelonaMember" xlink:label="lbl_AlconHealthcareS.A.BarcelonaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconHealthcareS.A.BarcelonaMember" xlink:to="lbl_label1837970293" xlink:type="arc"/>
      <link:label id="id_3892d07e" xlink:label="lbl_label949145726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Ophthalmics AG, Fribourg [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisOphthalmicsAGFribourgMember" xlink:label="lbl_NovartisOphthalmicsAGFribourgMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisOphthalmicsAGFribourgMember" xlink:to="lbl_label949145726" xlink:type="arc"/>
      <link:label id="id_5097f514" xlink:label="lbl_label1352135956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Ukraine LLC, Kiev [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozUkraineLLCKievMember" xlink:label="lbl_SandozUkraineLLCKievMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozUkraineLLCKievMember" xlink:to="lbl_label1352135956" xlink:type="arc"/>
      <link:label id="id_68b9cbd5" xlink:label="lbl_label1757006805" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Divestment cost to sell</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentCostToSell" xlink:label="lbl_DivestmentCostToSell" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DivestmentCostToSell" xlink:to="lbl_label1757006805" xlink:type="arc"/>
      <link:label id="id_3bde338f" xlink:label="lbl_label1004417935" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount of settlement in principle</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfSettlementInPrinciple" xlink:label="lbl_AmountOfSettlementInPrinciple" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountOfSettlementInPrinciple" xlink:to="lbl_label1004417935" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:label="lbl_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:to="lbl_label969930944" xlink:type="arc"/>
      <link:label id="id_54d2c7cf" xlink:label="lbl_label1423099855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of products in portfolio to be sold</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfProductsInPortfolioToBeSold" xlink:label="lbl_NumberOfProductsInPortfolioToBeSold" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfProductsInPortfolioToBeSold" xlink:to="lbl_label1423099855" xlink:type="arc"/>
      <link:label id="id_4f5a93ca" xlink:label="lbl_label1331336138" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying value of the divested business</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CarryingValueOfTheDivestedBusiness" xlink:label="lbl_CarryingValueOfTheDivestedBusiness" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CarryingValueOfTheDivestedBusiness" xlink:to="lbl_label1331336138" xlink:type="arc"/>
      <link:label id="id_2bfacba6" xlink:label="lbl_label737856422" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short term leases and low value leases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShortTermLeasesAndLowValueLeases" xlink:label="lbl_ShortTermLeasesAndLowValueLeases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ShortTermLeasesAndLowValueLeases" xlink:to="lbl_label737856422" xlink:type="arc"/>
      <link:label id="id_1638753" xlink:label="lbl_label23299923" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Remaining lease commitments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RemainingLeaseCommitments" xlink:label="lbl_RemainingLeaseCommitments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RemainingLeaseCommitments" xlink:to="lbl_label23299923" xlink:type="arc"/>
      <link:label id="id_3c454913" xlink:label="lbl_label1011173651" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities to be recognized</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesToBeRecognized" xlink:label="lbl_LeaseLiabilitiesToBeRecognized" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseLiabilitiesToBeRecognized" xlink:to="lbl_label1011173651" xlink:type="arc"/>
      <link:label id="id_46c00732" xlink:label="lbl_label1186989874" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right of use assets to be recognized</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RightOfUseAssetsToBeRecognized" xlink:label="lbl_RightOfUseAssetsToBeRecognized" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RightOfUseAssetsToBeRecognized" xlink:to="lbl_label1186989874" xlink:type="arc"/>
      <link:label id="id_5c114913" xlink:label="lbl_label1544636691" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net loss/gain recorded on equity securities and fund investments at fair value through the consolidated income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:label="lbl_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:to="lbl_label1544636691" xlink:type="arc"/>
      <link:label id="id_c04ac79" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on equity securities, net of taxes</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_labels" xlink:type="arc"/>
      <link:label id="id_5fb3768f" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) from investments in equity instruments</link:label>
      <link:label id="id_4dc28e6d" xlink:label="lbl_DeferredTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="lbl_DeferredTaxExpenseIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxExpenseIncome" xlink:to="lbl_DeferredTaxExpenseIncome_labels" xlink:type="arc"/>
      <link:label id="id_77e968c5" xlink:label="lbl_DeferredTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax income</link:label>
      <link:label id="id_2d4a780d" xlink:label="lbl_CurrentTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current income tax expense</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="lbl_CurrentTaxExpenseIncome" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentTaxExpenseIncome" xlink:to="lbl_CurrentTaxExpenseIncome_labels" xlink:type="arc"/>
      <link:label id="id_bbe9642" xlink:label="lbl_CurrentTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income)</link:label>
      <link:label id="id_5ac027e9" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income effect</link:label>
      <link:label id="id_2c40f598" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Associated companies' movements in comprehensive income</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:label="lbl_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:to="lbl_label757358878" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceS.A.LuxembourgCityMember" xlink:label="lbl_NovartisFinanceS.A.LuxembourgCityMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFinanceS.A.LuxembourgCityMember" xlink:to="lbl_label1668533481" xlink:type="arc"/>
      <link:label id="id_3d20cd78" xlink:label="lbl_label1025559928" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Endocyte, Inc., Lafayette, IN [member]</link:label>
      <link:label id="id_151d2726" xlink:label="lbl_label354232102" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tear Film Innovations, Inc., Fort Worth, TX [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TearFilmInnovationsInc.FortWorthTXMember" xlink:label="lbl_TearFilmInnovationsInc.FortWorthTXMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TearFilmInnovationsInc.FortWorthTXMember" xlink:to="lbl_label354232102" xlink:type="arc"/>
      <link:label id="id_1a32a075" xlink:label="lbl_label439525493" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TrueVision Systems, Inc., Fort Worth, TX [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TrueVisionSystemsInc.FortWorthTXMember" xlink:label="lbl_TrueVisionSystemsInc.FortWorthTXMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TrueVisionSystemsInc.FortWorthTXMember" xlink:to="lbl_label439525493" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalInc.LakeForestILMember" xlink:label="lbl_TranscendMedicalInc.LakeForestILMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TranscendMedicalInc.LakeForestILMember" xlink:to="lbl_label1438652981" xlink:type="arc"/>
      <link:label id="id_279b1df4" xlink:label="lbl_label664477172" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Baltics SIA, Riga [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBalticsSIARigaMember" xlink:label="lbl_NovartisBalticsSIARigaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisBalticsSIARigaMember" xlink:to="lbl_label664477172" xlink:type="arc"/>
      <link:label id="id_5e85347d" xlink:label="lbl_label1585788029" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Biosciences Peru S.A., Lima [member]</link:label>
      <link:label id="id_62d68d5f" xlink:label="lbl_label1658228063" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Overseas Investments AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisOverseasInvestmentsAGBaselMember" xlink:label="lbl_NovartisOverseasInvestmentsAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisOverseasInvestmentsAGBaselMember" xlink:to="lbl_label1658228063" xlink:type="arc"/>
      <link:label id="id_254382a8" xlink:label="lbl_label625181352" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Japat AG, Basel [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JapatAGBaselMember" xlink:label="lbl_JapatAGBaselMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_JapatAGBaselMember" xlink:to="lbl_label625181352" xlink:type="arc"/>
      <link:label id="id_4cd3abe4" xlink:label="lbl_label1288940516" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Alcon Management SA, Geneva [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconManagementSAGenevaMember" xlink:label="lbl_AlconManagementSAGenevaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AlconManagementSAGenevaMember" xlink:to="lbl_label1288940516" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteInc.LafayetteINMember" xlink:label="lbl_EndocyteInc.LafayetteINMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EndocyteInc.LafayetteINMember" xlink:to="lbl_label1025559928" xlink:type="arc"/>
      <link:label id="id_68b5f06f" xlink:label="lbl_label1756754031" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oriel Therapeutics, Inc., Durham, NC [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OrielTherapeuticsInc.DurhamNCMember" xlink:label="lbl_OrielTherapeuticsInc.DurhamNCMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OrielTherapeuticsInc.DurhamNCMember" xlink:to="lbl_label1756754031" xlink:type="arc"/>
      <link:label id="id_60eaa13f" xlink:label="lbl_label1625989439" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WaveLight, Inc., Sterling, VA [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WaveLightInc.SterlingVAMember" xlink:label="lbl_WaveLightInc.SterlingVAMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WaveLightInc.SterlingVAMember" xlink:to="lbl_label1625989439" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBiosciencesPeruS.A.LimaMember" xlink:label="lbl_NovartisBiosciencesPeruS.A.LimaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisBiosciencesPeruS.A.LimaMember" xlink:to="lbl_label1585788029" xlink:type="arc"/>
      <link:label id="id_5bdf673e" xlink:label="lbl_label1541367614" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares with restricted use</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesWithRestrictedUse" xlink:label="lbl_TreasurySharesWithRestrictedUse" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TreasurySharesWithRestrictedUse" xlink:to="lbl_label1541367614" xlink:type="arc"/>
      <link:label id="id_7fb088b9" xlink:label="lbl_label2142275769" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate effect of revenues exempt from taxation</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:label="lbl_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:to="lbl_label2142275769" xlink:type="arc"/>
      <link:label id="id_6108aeff" xlink:label="lbl_CurrentInterestPayable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current interest payable</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentInterestPayable" xlink:label="lbl_CurrentInterestPayable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentInterestPayable" xlink:to="lbl_CurrentInterestPayable_labels" xlink:type="arc"/>
      <link:label id="id_1fc5ed9f" xlink:label="lbl_CurrentInterestPayable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interests on financial debt</link:label>
      <link:label id="id_6b7c4e62" xlink:label="lbl_label1458816832" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitment for repurchase own shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentForRepurchaseOwnShares" xlink:label="lbl_CommitmentForRepurchaseOwnShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CommitmentForRepurchaseOwnShares" xlink:to="lbl_label1458816832" xlink:type="arc"/>
      <link:label id="id_5e285341" xlink:label="lbl_label130728687" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current financial asstets debt securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAsstetsDebtSecurities" xlink:label="lbl_NoncurrentFinancialAsstetsDebtSecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialAsstetsDebtSecurities" xlink:to="lbl_label130728687" xlink:type="arc"/>
      <link:label id="id_1f883fd2" xlink:label="lbl_label826017497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions included in disposal group prior to classification to assets held for sale</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:label="lbl_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:to="lbl_label826017497" xlink:type="arc"/>
      <link:label id="id_256b0374" xlink:label="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation charge prior to classification to assets held for sale</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:label="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:to="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale_labels" xlink:type="arc"/>
      <link:label id="id_4b6e3676" xlink:label="lbl_NoncurrentFinancialAssetsAvailableforsale_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total financial investments</link:label>
      <link:label id="id_2b3e006" xlink:label="lbl_label1209757713" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proforma net sales</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProformaNetSales" xlink:label="lbl_ProformaNetSales" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProformaNetSales" xlink:to="lbl_label1209757713" xlink:type="arc"/>
      <link:label id="id_2888ddc2" xlink:label="lbl_label680058306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Serelaxin [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SerelaxinMember" xlink:label="lbl_SerelaxinMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SerelaxinMember" xlink:to="lbl_label680058306" xlink:type="arc"/>
      <link:label id="id_4e4f9507" xlink:label="lbl_label1313838343" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CyPass [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CyPassMember" xlink:label="lbl_CyPassMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CyPassMember" xlink:to="lbl_label1313838343" xlink:type="arc"/>
      <link:label id="id_52281715" xlink:label="lbl_IncomeStatementAdjustmentsOfPriorYear_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income statement adjustments of prior year</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementAdjustmentsOfPriorYear" xlink:label="lbl_IncomeStatementAdjustmentsOfPriorYear" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeStatementAdjustmentsOfPriorYear" xlink:to="lbl_IncomeStatementAdjustmentsOfPriorYear_labels" xlink:type="arc"/>
      <link:label id="id_68901646" xlink:label="lbl_IncomeStatementAdjustmentsOfPriorYear_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions prior year</link:label>
      <link:label id="id_12f0be52" xlink:label="lbl_IncomeStatementAdjustmentsOfCurrentYear_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income statement adjustments of current year</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementAdjustmentsOfCurrentYear" xlink:label="lbl_IncomeStatementAdjustmentsOfCurrentYear" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncomeStatementAdjustmentsOfCurrentYear" xlink:to="lbl_IncomeStatementAdjustmentsOfCurrentYear_labels" xlink:type="arc"/>
      <link:label id="id_10001b20" xlink:label="lbl_IncomeStatementAdjustmentsOfCurrentYear_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions current year</link:label>
      <link:label id="id_53e07f22" xlink:label="lbl_label1407221538" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plans and program rebates [axis]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesAxis" xlink:label="lbl_PlansAndProgramRebatesAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PlansAndProgramRebatesAxis" xlink:to="lbl_label1407221538" xlink:type="arc"/>
      <link:label id="id_64c2e5e1" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through business combinations, other provisions and increase (decrease) through net exchange differences, other provisions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_359d5a9f" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of currency translation and business combinations</link:label>
      <link:label id="id_73fc698b" xlink:label="lbl_label1945921931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment charges related to disposal group held for sale</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:label="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:to="lbl_label1945921931" xlink:type="arc"/>
      <link:label id="id_6ee3c039" xlink:label="lbl_label1860419641" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment charges related to disposal group held for sale to the date of reclassification</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:label="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:to="lbl_label1860419641" xlink:type="arc"/>
      <link:label id="id_4ed2e3f9" xlink:label="lbl_label1322443769" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions included in disposal group to the date of reclassification</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:label="lbl_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:to="lbl_label1322443769" xlink:type="arc"/>
      <link:label id="id_7be11426" xlink:label="lbl_label1459075477" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net cash flows used in from divestments of businesses classified as investing activities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:to="lbl_label1459075477" xlink:type="arc"/>
      <link:label id="id_63a31bcb" xlink:label="lbl_label625103893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets divested</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentAssetsDivested" xlink:label="lbl_NoncurrentAssetsDivested" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentAssetsDivested" xlink:to="lbl_label625103893" xlink:type="arc"/>
      <link:label id="id_7f3ccd67" xlink:label="lbl_label654491613" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets divested</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAssetsDivested" xlink:label="lbl_CurrentAssetsDivested" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAssetsDivested" xlink:to="lbl_label654491613" xlink:type="arc"/>
      <link:label id="id_28fd0d0c" xlink:label="lbl_label2062437885" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities divested</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLiabilitiesDivested" xlink:label="lbl_CurrentLiabilitiesDivested" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLiabilitiesDivested" xlink:to="lbl_label2062437885" xlink:type="arc"/>
      <link:label id="id_217212a3" xlink:label="lbl_label1484079992" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and other assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherAssets" xlink:label="lbl_FinancialAndOtherAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAndOtherAssets" xlink:to="lbl_label1484079992" xlink:type="arc"/>
      <link:label id="id_3b6cb989" xlink:label="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities recognised as of acquisition date</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_411a4e68" xlink:label="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
      <link:label id="id_481dd512" xlink:label="lbl_label1209914642" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow outflow from net identifiable assets divested acquired</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:label="lbl_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:to="lbl_label1209914642" xlink:type="arc"/>
      <link:label id="id_2dad0e04" xlink:label="lbl_TradePayablesAndOtherLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables and other liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesAndOtherLiabilities" xlink:label="lbl_TradePayablesAndOtherLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradePayablesAndOtherLiabilities" xlink:to="lbl_TradePayablesAndOtherLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_1551e337" xlink:label="lbl_TradePayablesAndOtherLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Trade payables and other liabilities</link:label>
      <link:label id="id_29a54c7d" xlink:label="lbl_label698698877" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow outflow from net identifiable assets currency translation effects liquidity and fair value of equity interests</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests" xlink:label="lbl_CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests" xlink:to="lbl_label698698877" xlink:type="arc"/>
      <link:label id="id_72d7c22d" xlink:label="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from losing control of subsidiaries or other businesses, classified as investing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_469e951e" xlink:label="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Divested business</link:label>
      <link:label id="id_79d4ff23" xlink:label="lbl_label2044002083" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value on sale of other financial assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOnSaleOfOtherFinancialAssets" xlink:label="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:to="lbl_label2044002083" xlink:type="arc"/>
      <link:label id="id_f9b4624" xlink:label="lbl_label261834276" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable securities, fair value through other comprehensive income [member]</link:label>
      <link:label id="id_3f7b625a" xlink:label="lbl_label1065050714" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term financial investments, fair value through other comprehensive income [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_label1065050714" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_label261834276" xlink:type="arc"/>
      <link:label id="id_3373fda5" xlink:label="lbl_label863239589" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plans and program rebates [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesMember" xlink:label="lbl_PlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_label863239589" xlink:type="arc"/>
      <link:label id="id_52f984e4" xlink:label="lbl_label1392084196" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US-specific healthcare plans and program rebates [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USspecificHealthcarePlansAndProgramRebatesMember" xlink:label="lbl_USspecificHealthcarePlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_USspecificHealthcarePlansAndProgramRebatesMember" xlink:to="lbl_label1392084196" xlink:type="arc"/>
      <link:label id="id_3a1be35a" xlink:label="lbl_label974906202" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US-specific healthcare plans and program rebates [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:label="lbl_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:to="lbl_label974906202" xlink:type="arc"/>
      <link:label id="id_52817cee" xlink:label="lbl_label1384217838" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-healthcare plans and program-related rebates, returns and other deductions [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:label="lbl_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:to="lbl_label1384217838" xlink:type="arc"/>
      <link:label id="id_518b30b7" xlink:label="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation charge prior to classification to assets held for sale</link:label>
      <link:label id="id_611b2741" xlink:label="lbl_DeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
      <link:label id="id_35974485" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise prices for outstanding share options [member]</link:label>
      <link:label id="id_3da6037c" xlink:label="lbl_label1034290044" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">46.7</link:label>
      <link:label id="id_5698bfcb" xlink:label="lbl_label1452851147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 46.7 [member]</link:label>
      <link:label id="id_df65a83" xlink:label="lbl_label1098297979" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">54.5</link:label>
      <link:label id="id_26baf973" xlink:label="lbl_label1238972312" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">57.0</link:label>
      <link:label id="id_5d51017e" xlink:label="lbl_label1565589886" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">57.6</link:label>
      <link:label id="id_7925df2" xlink:label="lbl_label127032818" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 57.6 [member]</link:label>
      <link:label id="id_50442a73" xlink:label="lbl_label61576322" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">66.0</link:label>
      <link:label id="id_77b11616" xlink:label="lbl_label2008094230" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized income was recognized in other comprehensive income and accumulated in currency translation effects in relation with this net investment hedge</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:label="lbl_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:to="lbl_label2008094230" xlink:type="arc"/>
      <link:label id="id_13923e74" xlink:label="lbl_label328351348" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">46.4</link:label>
      <link:label id="id_26b025e5" xlink:label="lbl_label649078245" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">53.7</link:label>
      <link:label id="id_15297d64" xlink:label="lbl_label355040612" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">57.1</link:label>
      <link:label id="id_37ef180d" xlink:label="lbl_label938416141" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">58.3</link:label>
      <link:label id="id_7963b4c" xlink:label="lbl_label127286092" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">66.1</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.7Member" xlink:label="lbl_ExercisePrice46.7Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice46.7Member" xlink:to="lbl_label1452851147" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice46.7Member" xlink:to="lbl_label1034290044" xlink:type="arc"/>
      <link:label id="id_7638cc32" xlink:label="lbl_label1983433778" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 54.5 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice54.5Member" xlink:label="lbl_ExercisePrice54.5Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice54.5Member" xlink:to="lbl_label1983433778" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice54.5Member" xlink:to="lbl_label1098297979" xlink:type="arc"/>
      <link:label id="id_625d280f" xlink:label="lbl_label1650272271" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 57.0 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.0Member" xlink:label="lbl_ExercisePrice57.0Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice57.0Member" xlink:to="lbl_label1650272271" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice57.0Member" xlink:to="lbl_label1238972312" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.6Member" xlink:label="lbl_ExercisePrice57.6Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice57.6Member" xlink:to="lbl_label127032818" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice57.6Member" xlink:to="lbl_label1565589886" xlink:type="arc"/>
      <link:label id="id_7f8b8ef4" xlink:label="lbl_label2139852532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 66.0 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.0Member" xlink:label="lbl_ExercisePrice66.0Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice66.0Member" xlink:to="lbl_label2139852532" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice66.0Member" xlink:to="lbl_label61576322" xlink:type="arc"/>
      <link:label id="id_1c214787" xlink:label="lbl_label471943047" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 46.4 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.4Member" xlink:label="lbl_ExercisePrice46.4Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice46.4Member" xlink:to="lbl_label471943047" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice46.4Member" xlink:to="lbl_label328351348" xlink:type="arc"/>
      <link:label id="id_60064b00" xlink:label="lbl_label1611025152" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 53.7 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice53.7Member" xlink:label="lbl_ExercisePrice53.7Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice53.7Member" xlink:to="lbl_label1611025152" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice53.7Member" xlink:to="lbl_label649078245" xlink:type="arc"/>
      <link:label id="id_3d7bc5f9" xlink:label="lbl_label1031521785" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 57.1 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.1Member" xlink:label="lbl_ExercisePrice57.1Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice57.1Member" xlink:to="lbl_label1031521785" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice57.1Member" xlink:to="lbl_label355040612" xlink:type="arc"/>
      <link:label id="id_5312799d" xlink:label="lbl_label1393719709" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 58.3 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice58.3Member" xlink:label="lbl_ExercisePrice58.3Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice58.3Member" xlink:to="lbl_label1393719709" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice58.3Member" xlink:to="lbl_label938416141" xlink:type="arc"/>
      <link:label id="id_11afcf8b" xlink:label="lbl_label296734603" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price, 66.1 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.1Member" xlink:label="lbl_ExercisePrice66.1Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice66.1Member" xlink:to="lbl_label296734603" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePrice66.1Member" xlink:to="lbl_label127286092" xlink:type="arc"/>
      <link:label id="id_602d9a64" xlink:label="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisitions and divestments of interests in associated companies, net</link:label>
      <link:label id="id_1640eef1" xlink:label="lbl_TransactionCostsRecordedInEquityPaid_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs payments</link:label>
      <link:label id="id_4305d26a" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net cash flows used in investing activities from discontinued operations</link:label>
      <link:label id="id_1cb46ce6" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</link:label>
      <link:label id="id_45074031" xlink:label="lbl_label1158103089" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayments and accrued lease payments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaymentsAndAccruedLeasePayments" xlink:label="lbl_PrepaymentsAndAccruedLeasePayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PrepaymentsAndAccruedLeasePayments" xlink:to="lbl_label1158103089" xlink:type="arc"/>
      <link:label id="id_1787fdbc" xlink:label="lbl_label1284506961" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recycling of the Novartis share of other comprehensive income from associated companies</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:label="lbl_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:to="lbl_label1284506961" xlink:type="arc"/>
      <link:label id="id_7702ef73" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase of treasury share repurchase obligation under a share buyback trading plan</link:label>
      <link:label id="id_135f3eb7" xlink:label="lbl_TransactionCostsRecordedInEquityPaid_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs payments</link:label>
      <link:label id="id_1765273e" xlink:label="lbl_CashFlowFromNetIdentifiableAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net assets recognized as a result of business combinations</link:label>
      <link:label id="id_4a08e514" xlink:label="lbl_CurrentTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current tax expense (income)</link:label>
      <link:label id="id_71e76093" xlink:label="lbl_DeferredTaxExpenseIncome_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income)</link:label>
      <link:label id="id_608223c4" xlink:label="lbl_IncomeTaxExpense_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total Income Tax Expense</link:label>
      <link:label id="id_352bb146" xlink:label="lbl_TaxExpenseIncomeDiscontinuingOperations_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense from discontinued operations</link:label>
      <link:label id="id_6348f872" xlink:label="lbl_TransactionCostsRecordedInEquity_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs recorded in equity</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:label="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_label85049938" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:label="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_label982152731" xlink:type="arc"/>
      <link:label id="id_31ca37cf" xlink:label="lbl_label835336143" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization prior to classification to assets held for sale</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:label="lbl_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:to="lbl_label835336143" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:to="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale_labels" xlink:type="arc"/>
      <link:label id="id_43b1908f" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred tax assets or deferred tax liabilities related to disposal group held for sale</link:label>
      <link:label id="id_3b7e23ba" xlink:label="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accrued benefit liability</link:label>
      <link:label id="id_774651e9" xlink:label="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_5fb55436" xlink:label="lbl_TreasurySharesAcquiredForCancellationValue_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares acquired for cancellation, equity impact</link:label>
      <link:label id="id_71230227" xlink:label="lbl_DisposalsFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposals fair value measurement assets</link:label>
      <link:label id="id_757b03e4" xlink:label="lbl_EquityImpactOfTreasuryShareMovements_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total equity impact of treasury share movements</link:label>
      <link:label id="id_9217c59" xlink:label="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</link:label>
      <link:label id="id_eb62348" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment charges and fair value gains on financial assets, net</link:label>
      <link:label id="id_2ec0dcb9" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of acquisitions, divestments or transfers</link:label>
      <link:label id="id_48bf4d53" xlink:label="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other movements</link:label>
      <link:label id="id_1a35a04f" xlink:label="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interests</link:label>
      <link:label id="id_39d0eccc" xlink:label="lbl_OtherSharePurchasesValue_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other share purchases, equity impact</link:label>
      <link:label id="id_5209e6b5" xlink:label="lbl_SurplusDeficitInPlan_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Funded status</link:label>
      <link:label id="id_2a14e1da" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment charges and fair value gains on financial assets, net</link:label>
      <link:label id="id_74f13ac0" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on financial assets sold</link:label>
      <link:label id="id_180b00c2" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flows used in investing activities from continuing operations</link:label>
      <link:label id="id_aca6a21" xlink:label="lbl_ProceedsFromNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase in non-current financial debts</link:label>
      <link:label id="id_5e5a2737" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net cash flows used in investing activities</link:label>
      <link:label id="id_12daaf08" xlink:label="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Divested interest in associate</link:label>
      <link:label id="id_595a0496" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flows used in discontinued operations</link:label>
      <link:label id="id_6f1acb28" xlink:label="lbl_label1864026920" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long term financial investments [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongTermFinancialInvestmentsMember" xlink:label="lbl_LongTermFinancialInvestmentsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LongTermFinancialInvestmentsMember" xlink:to="lbl_label1864026920" xlink:type="arc"/>
      <link:label id="id_24014c8f" xlink:label="lbl_label1836731146" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecurities" xlink:label="lbl_MarketableSecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MarketableSecurities" xlink:to="lbl_label1836731146" xlink:type="arc"/>
      <link:label id="id_7323afac" xlink:label="lbl_label1544871888" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major plans percentage in group DBO pensions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MajorPlansPercentageInGroupDBOPensions" xlink:label="lbl_MajorPlansPercentageInGroupDBOPensions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MajorPlansPercentageInGroupDBOPensions" xlink:to="lbl_label1544871888" xlink:type="arc"/>
      <link:label id="id_192e72f5" xlink:label="lbl_label456555172" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Most signigicant countries percentage on group DBO post employment benefit plans</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:label="lbl_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:to="lbl_label456555172" xlink:type="arc"/>
      <link:label id="id_45e2937b" xlink:label="lbl_InterestIncomeOnLimitationOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest income on limitation of fund surplus</link:label>
      <link:label id="id_7686c3c0" xlink:label="lbl_DefinedBenefitPlanSettlementsPlanAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Settlements</link:label>
      <link:label id="id_4d6d4f53" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Past service cost and settlements</link:label>
      <link:label id="id_764909d2" xlink:label="lbl_label949739114" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncurrent financial assets, total financial investments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:label="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:to="lbl_label949739114" xlink:type="arc"/>
      <link:label id="id_2ba0d9fa" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on financial assets sold</link:label>
      <link:label id="id_751d39ac" xlink:label="lbl_label1964849580" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net income/loss from discontinued operations before gain on distribution</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:to="lbl_label1964849580" xlink:type="arc"/>
      <link:label id="id_3a463b8c" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed_labels" xlink:type="arc"/>
      <link:label id="id_2c57b1ca" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on distribution</link:label>
      <link:label id="id_291f69d6" xlink:label="lbl_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax on Pension plans previously recognized in OCI</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI" xlink:label="lbl_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI" xlink:to="lbl_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI_labels" xlink:type="arc"/>
      <link:label id="id_2f7fc540" xlink:label="lbl_RightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RightofuseAssets" xlink:to="lbl_RightofuseAssets_labels" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="lbl_DividendsPayable" xlink:type="locator"/>
      <link:label id="id_6acaf180" xlink:label="lbl_DividendsPayable_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend in kind distribution liability</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsPayable" xlink:to="lbl_DividendsPayable_labels" xlink:type="arc"/>
      <link:label id="id_34ce2448" xlink:label="lbl_DividendsPayable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends payable, non-cash assets distributions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:label="lbl_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:type="locator"/>
      <link:label id="id_484edcc4" xlink:label="lbl_DividendsRecognisedAsDistributionsToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividend in kind</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:to="lbl_DividendsRecognisedAsDistributionsToOwnersOfParent_labels" xlink:type="arc"/>
      <link:label id="id_7adfa754" xlink:label="lbl_DividendsRecognisedAsDistributionsToOwnersOfParent_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends recognised as distributions to owners of paren</link:label>
      <link:label id="id_590635ac" xlink:label="lbl_SaleOrIssueOfTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sale of treasury shares</link:label>
      <link:label id="id_2476e743" xlink:label="lbl_ProfitLossFromContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income from continuing operations</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:label id="id_1ffd83cc" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flows from/used in financing activities from discontinued operations</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:label id="id_6a49a8cd" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flows used in financing activities from continuing operations</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_labels" xlink:type="arc"/>
      <link:label id="id_59187aa8" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities, discontinued operations</link:label>
      <link:label id="id_1d15aff4" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities, continuing operations</link:label>
      <link:label id="id_100aa035" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net change in cash and cash equivalents before effect of exchange rate changes</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_labels" xlink:type="arc"/>
      <link:label id="id_50620c89" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</link:label>
      <link:label id="id_96ecbb0" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in cash and cash equivalents of discontinued operations</link:label>
      <link:label id="id_2334b78" xlink:label="lbl_label36916088" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of discontinued operations [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_label36916088" xlink:type="arc"/>
      <link:label id="id_76c64958" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sales to continuing and discontinued segments</link:label>
      <link:label id="id_36af0a7f" xlink:label="lbl_RevenueFromSaleOfGoods_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales from continuing operations</link:label>
      <link:label id="id_58501f6b" xlink:label="lbl_label1481645931" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">YoY [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YoYChangeMember" xlink:label="lbl_YoYChangeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_YoYChangeMember" xlink:to="lbl_label1481645931" xlink:type="arc"/>
      <link:label id="id_3ed48330" xlink:label="lbl_label1054114608" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:to="lbl_label1054114608" xlink:type="arc"/>
      <link:label id="id_43a1a553" xlink:label="lbl_label1134667091" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [table]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_label1134667091" xlink:type="arc"/>
      <link:label id="id_3045b2a1" xlink:label="lbl_label809874081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vehicles [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="lbl_VehiclesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_VehiclesMember" xlink:to="lbl_label809874081" xlink:type="arc"/>
      <link:label id="id_64acc522" xlink:label="lbl_label1689044258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [line items]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_label1689044258" xlink:type="arc"/>
      <link:label id="id_5367393f" xlink:label="lbl_DepreciationRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, right-of-use assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="lbl_DepreciationRightofuseAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DepreciationRightofuseAssets" xlink:to="lbl_DepreciationRightofuseAssets_labels" xlink:type="arc"/>
      <link:label id="id_4a6ffe17" xlink:label="lbl_DepreciationRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation charge</link:label>
      <link:label id="id_1b8dfafc" xlink:label="lbl_OtherAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Machinery &amp; equipment and other assets</link:label>
      <link:label id="id_2da47e8f" xlink:label="lbl_NoncurrentLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLeaseLiabilities" xlink:to="lbl_NoncurrentLeaseLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_5905e579" xlink:label="lbl_NoncurrentLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
      <link:label id="id_328c2a61" xlink:label="lbl_CurrentLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLeaseLiabilities" xlink:to="lbl_CurrentLeaseLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_543a77a3" xlink:label="lbl_CurrentLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
      <link:label id="id_234e965a" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, net</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_e7d4ee5" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
      <link:label id="id_7097e6f" xlink:label="lbl_label118062703" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation of leases for lessee [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="lbl_PresentationOfLeasesForLesseeAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PresentationOfLeasesForLesseeAbstract" xlink:to="lbl_label118062703" xlink:type="arc"/>
      <link:label id="id_171d0edf" xlink:label="lbl_LeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseLiabilities" xlink:to="lbl_LeaseLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_1c665876" xlink:label="lbl_GrossLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="lbl_GrossLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossLeaseLiabilities" xlink:to="lbl_GrossLeaseLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_2c03c1ee" xlink:label="lbl_GrossLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease commitments</link:label>
      <link:label id="id_1b0667c7" xlink:label="lbl_label453404615" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation of leases for lesses [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PresentationOfLeasesForLessesTable" xlink:label="lbl_PresentationOfLeasesForLessesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PresentationOfLeasesForLessesTable" xlink:to="lbl_label453404615" xlink:type="arc"/>
      <link:label id="id_72b5e1b" xlink:label="lbl_label120282651" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation of leases for lessee [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PresentationOfLeasesForLesseeLineItems" xlink:label="lbl_PresentationOfLeasesForLesseeLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_label120282651" xlink:type="arc"/>
      <link:label id="id_3a8f2f5a" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to short-term leases for which recognition exemption has been used</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:to="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_labels" xlink:type="arc"/>
      <link:label id="id_3f6e27d0" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognition exemption for short term leases</link:label>
      <link:label id="id_7a5f05cd" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to leases of low-value assets for which recognition exemption has been used</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_labels" xlink:type="arc"/>
      <link:label id="id_3ae50249" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recognition exception for low value leases</link:label>
      <link:label id="id_375e4cce" xlink:label="lbl_label928926926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New lease arrangements</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NewLeaseArrangements" xlink:label="lbl_NewLeaseArrangements" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NewLeaseArrangements" xlink:to="lbl_label928926926" xlink:type="arc"/>
      <link:label id="id_c8ad2dc" xlink:label="lbl_label210424540" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undiscounted future lease payments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UndiscountedFutureLeasePayments" xlink:label="lbl_UndiscountedFutureLeasePayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UndiscountedFutureLeasePayments" xlink:to="lbl_label210424540" xlink:type="arc"/>
      <link:label id="id_75283e38" xlink:label="lbl_EffectOfDiscounting_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of discounting</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfDiscounting" xlink:label="lbl_EffectOfDiscounting" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectOfDiscounting" xlink:to="lbl_EffectOfDiscounting_labels" xlink:type="arc"/>
      <link:label id="id_6ac0bebc" xlink:label="lbl_LeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
      <link:label id="id_6447e039" xlink:label="lbl_label1682432057" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about leases for lessee [abstract]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="lbl_label1682432057" xlink:type="arc"/>
      <link:label id="id_3e0ced0d" xlink:label="lbl_InterestExpenseOnLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestExpenseOnLeaseLiabilities" xlink:to="lbl_InterestExpenseOnLeaseLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_7693425d" xlink:label="lbl_label1989362269" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash outflow</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="lbl_CashOutflowForLeases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashOutflowForLeases" xlink:to="lbl_label1989362269" xlink:type="arc"/>
      <link:label id="id_26c71205" xlink:label="lbl_label650580485" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense relating to variable lease payments not included in measurement of lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:label="lbl_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:to="lbl_label650580485" xlink:type="arc"/>
      <link:label id="id_63dc6855" xlink:label="lbl_label1675389013" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis of total lease liabilities [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" xlink:to="lbl_label1675389013" xlink:type="arc"/>
      <link:label id="id_10622a16" xlink:label="lbl_label274868758" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis of total lease liabilities [table]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:to="lbl_label274868758" xlink:type="arc"/>
      <link:label id="id_24f1a439" xlink:label="lbl_label619815993" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis of total lease liabilities [line items]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_label619815993" xlink:type="arc"/>
      <link:label id="id_67bf33b0" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales to third parties of discontinued operations</link:label>
      <link:label id="id_327f346c" xlink:label="lbl_ProfitLossFromOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating income of discontinued operations</link:label>
      <link:label id="id_64213541" xlink:label="lbl_label1679897921" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restated [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentStatedMember" xlink:label="lbl_CurrentStatedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentStatedMember" xlink:to="lbl_label1679897921" xlink:type="arc"/>
      <link:label id="id_5ebed7b4" xlink:label="lbl_SaleOrIssueOfTreasurySharesNumberOfShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of treasury shares, number of shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOrIssueOfTreasurySharesNumberOfShares" xlink:label="lbl_SaleOrIssueOfTreasurySharesNumberOfShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleOrIssueOfTreasurySharesNumberOfShares" xlink:to="lbl_SaleOrIssueOfTreasurySharesNumberOfShares_labels" xlink:type="arc"/>
      <link:label id="id_22f85f35" xlink:label="lbl_SaleOrIssueOfTreasurySharesNumberOfShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of treasury shares</link:label>
      <link:label id="id_25cdb408" xlink:label="lbl_label634237960" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Detailed information about significant transaction</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DetailedInformationAboutSignificantTransaction" xlink:label="lbl_DetailedInformationAboutSignificantTransaction" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DetailedInformationAboutSignificantTransaction" xlink:to="lbl_label634237960" xlink:type="arc"/>
      <link:label id="id_7eb3758e" xlink:label="lbl_TakedaPharmaceuticalCompanyLimitedMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Takeda Pharmaceutical Company Limited [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TakedaPharmaceuticalCompanyLimitedMember" xlink:label="lbl_TakedaPharmaceuticalCompanyLimitedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TakedaPharmaceuticalCompanyLimitedMember" xlink:to="lbl_TakedaPharmaceuticalCompanyLimitedMember_labels" xlink:type="arc"/>
      <link:label id="id_6db37ab5" xlink:label="lbl_TakedaPharmaceuticalCompanyLimitedMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Takeda Pharmaceutical Company Limited</link:label>
      <link:label id="id_ff14c14" xlink:label="lbl_IFMTreInc.Member_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IFM Tre, Inc. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IFMTreInc.Member" xlink:label="lbl_IFMTreInc.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IFMTreInc.Member" xlink:to="lbl_IFMTreInc.Member_labels" xlink:type="arc"/>
      <link:label id="id_5b8c5fe7" xlink:label="lbl_IFMTreInc.Member_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IFM Tre, Inc.</link:label>
      <link:label id="id_33428670" xlink:label="lbl_PowerVisionInc.Member_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PowerVision, Inc. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PowerVisionInc.Member" xlink:label="lbl_PowerVisionInc.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PowerVisionInc.Member" xlink:to="lbl_PowerVisionInc.Member_labels" xlink:type="arc"/>
      <link:label id="id_7001a921" xlink:label="lbl_PowerVisionInc.Member_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PowerVision, Inc.</link:label>
      <link:label id="id_6bb5fe48" xlink:label="lbl_label1807089224" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for prepayments and accrued lease payments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:label="lbl_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:to="lbl_label1807089224" xlink:type="arc"/>
      <link:label id="id_10d3bb4e" xlink:label="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:to="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_labels" xlink:type="arc"/>
      <link:label id="id_e7bd10a" xlink:label="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average incremental borrowing rate</link:label>
      <link:label id="id_390e560d" xlink:label="lbl_label957240845" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions to right-of-use assets</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionsToRightofuseAssets" xlink:to="lbl_label957240845" xlink:type="arc"/>
      <link:label id="id_f3aa39f" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gains (losses) arising from sale and leaseback transactions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:to="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions_labels" xlink:type="arc"/>
      <link:label id="id_1dfe7c52" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gains or losses from sales leaseback</link:label>
      <link:label id="id_50d6583f" xlink:label="lbl_label1356224575" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other borrowings</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="lbl_OtherBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherBorrowings" xlink:to="lbl_label1356224575" xlink:type="arc"/>
      <link:label id="id_589c1537" xlink:label="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in dividends payable through change in fair value of non-cash assets held for distribution to owners</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:label="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:to="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners_labels" xlink:type="arc"/>
      <link:label id="id_1a2e3f6" xlink:label="lbl_NetAssetsLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net assets liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="lbl_NetAssetsLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetAssetsLiabilities" xlink:to="lbl_NetAssetsLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_4d789f55" xlink:label="lbl_NetAssetsLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net assets</link:label>
      <link:label id="id_7d2cba5f" xlink:label="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease of distribution liability</link:label>
      <link:label id="id_24596c04" xlink:label="lbl_label609840132" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential milestone maximum payments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialMilestoneMaximumPayments" xlink:label="lbl_PotentialMilestoneMaximumPayments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PotentialMilestoneMaximumPayments" xlink:to="lbl_label609840132" xlink:type="arc"/>
      <link:label id="id_3dc6ce5a" xlink:label="lbl_label1036439130" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of employees associated with the product transfer</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:label="lbl_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:to="lbl_label1036439130" xlink:type="arc"/>
      <link:label id="id_3954535f" xlink:label="lbl_label961827679" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional borrowings</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalBorrowings" xlink:label="lbl_AdditionalBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionalBorrowings" xlink:to="lbl_label961827679" xlink:type="arc"/>
      <link:label id="id_43740ee2" xlink:label="lbl_label1131679458" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of equity interest shares received</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEquityInterestSharesReceived" xlink:label="lbl_PercentageOfEquityInterestSharesReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfEquityInterestSharesReceived" xlink:to="lbl_label1131679458" xlink:type="arc"/>
      <link:label id="id_79732968" xlink:label="lbl_label2037590376" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Difference between fair value of distribution liability and net assets at the date of distribution</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:label="lbl_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:to="lbl_label2037590376" xlink:type="arc"/>
      <link:label id="id_431c3dd4" xlink:label="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution of dividend to dividend bearing shares to consolidated foundations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:label="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:to="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations_labels" xlink:type="arc"/>
      <link:label id="id_ff7c4c3" xlink:label="lbl_label267896003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aimovig [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AimovigMember" xlink:label="lbl_AimovigMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AimovigMember" xlink:to="lbl_label267896003" xlink:type="arc"/>
      <link:label id="id_4945ceaa" xlink:label="lbl_label1229311658" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities and Right of use assets Disclosure Abstract</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" xlink:label="lbl_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" xlink:to="lbl_label1229311658" xlink:type="arc"/>
      <link:label id="id_79212b70" xlink:label="lbl_label2032216944" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of leases [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="lbl_DisclosureOfLeasesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfLeasesExplanatory" xlink:to="lbl_label2032216944" xlink:type="arc"/>
      <link:label id="id_4b496242" xlink:label="lbl_ReductionOfIssuedCapital_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reduction of issued capital</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReductionOfIssuedCapital" xlink:label="lbl_ReductionOfIssuedCapital" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReductionOfIssuedCapital" xlink:to="lbl_ReductionOfIssuedCapital_labels" xlink:type="arc"/>
      <link:label id="id_211a2da" xlink:label="lbl_ReductionOfIssuedCapital_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reduction of share capital</link:label>
      <link:label id="id_610df533" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through exercise of options, equity</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="lbl_IncreaseDecreaseThroughExerciseOfOptions_labels" xlink:type="arc"/>
      <link:label id="id_169b45c8" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of options and employee transactions, equity impact</link:label>
      <link:label id="id_76378de3" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptionsShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase decrease through exercise of options shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughExerciseOfOptionsShares" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptionsShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughExerciseOfOptionsShares" xlink:to="lbl_IncreaseDecreaseThroughExerciseOfOptionsShares_labels" xlink:type="arc"/>
      <link:label id="id_4cd892b4" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptionsShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of options and employee transactions shares</link:label>
      <link:label id="id_1efc7c8b" xlink:label="lbl_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase decrease through share based payment transactions shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:label="lbl_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" xlink:to="lbl_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_labels" xlink:type="arc"/>
      <link:label id="id_1d05cf3d" xlink:label="lbl_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity based compensation shares</link:label>
      <link:label id="id_1a5eff2" xlink:label="lbl_label27652082" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayment of lease liability</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RepaymentOfLeaseLiability" xlink:label="lbl_RepaymentOfLeaseLiability" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RepaymentOfLeaseLiability" xlink:to="lbl_label27652082" xlink:type="arc"/>
      <link:label id="id_7a957c7" xlink:label="lbl_label128538567" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average interest rate lease liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateLeaseLiabilities" xlink:label="lbl_WeightedAverageInterestRateLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageInterestRateLeaseLiabilities" xlink:to="lbl_label128538567" xlink:type="arc"/>
      <link:label id="id_50834b9f" xlink:label="lbl_label1350781855" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movements of the right-of-use assets [roll forward]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfTheRightofuseAssetsRollForward" xlink:label="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_label1350781855" xlink:type="arc"/>
      <link:label id="id_4004db36" xlink:label="lbl_RightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets at beginning of period</link:label>
      <link:label id="id_63713767" xlink:label="lbl_RightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets at end of period</link:label>
      <link:label id="id_491fa8b0" xlink:label="lbl_LeaseContractTerminationsRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease contract terminations, right-of-use assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseContractTerminationsRightofuseAssets" xlink:label="lbl_LeaseContractTerminationsRightofuseAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseContractTerminationsRightofuseAssets" xlink:to="lbl_LeaseContractTerminationsRightofuseAssets_labels" xlink:type="arc"/>
      <link:label id="id_43e3ea12" xlink:label="lbl_label79581278" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase decrease through net exchange differences, right-of-use assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:to="lbl_label79581278" xlink:type="arc"/>
      <link:label id="id_750ea0e7" xlink:label="lbl_label1963892967" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares delivered to divested business employees, equity impact</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:to="lbl_label1963892967" xlink:type="arc"/>
      <link:label id="id_23a4b8a2" xlink:label="lbl_TaxesOnTreasuryShares_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes on treasury shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesOnTreasuryShares" xlink:label="lbl_TaxesOnTreasuryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxesOnTreasuryShares" xlink:to="lbl_TaxesOnTreasuryShares_labels" xlink:type="arc"/>
      <link:label id="id_2a977fac" xlink:label="lbl_label714571692" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease incentives</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseIncentives" xlink:label="lbl_LeaseIncentives" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseIncentives" xlink:to="lbl_label714571692" xlink:type="arc"/>
      <link:label id="id_752a730a" xlink:label="lbl_label1965716234" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow for leases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowForLeases" xlink:label="lbl_CashInflowForLeases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowForLeases" xlink:to="lbl_label1965716234" xlink:type="arc"/>
      <link:label id="id_56ca2a36" xlink:label="lbl_NetAssetsDerecognized_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net assets derecognized</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetAssetsDerecognized" xlink:label="lbl_NetAssetsDerecognized" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetAssetsDerecognized" xlink:to="lbl_NetAssetsDerecognized_labels" xlink:type="arc"/>
      <link:label id="id_1b28c052" xlink:label="lbl_DividendsPayable_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derecognition of distribution liability</link:label>
      <link:label id="id_32e2fa92" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Difference between net assets and distribution liability</link:label>
      <link:label id="id_5a5595b5" xlink:label="lbl_label1515558325" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution of dividend to dividend bearing shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionOfDividendToDividendBearingShares" xlink:label="lbl_DistributionOfDividendToDividendBearingShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DistributionOfDividendToDividendBearingShares" xlink:to="lbl_label1515558325" xlink:type="arc"/>
      <link:label id="id_76193299" xlink:label="lbl_TransactionCosts_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs recognized in the consolidated income statement</link:label>
      <link:label id="id_1fe7672a" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed, Net</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet_labels" xlink:type="arc"/>
      <link:label id="id_4fbc2a8c" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on distribution</link:label>
      <link:label id="id_1b6a6442" xlink:label="lbl_label459957314" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net provisions for transaction costs recognized in the income statement</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetProvisionsForTransactionCostsRecognizedInTheIncomeStatement" xlink:label="lbl_NetProvisionsForTransactionCostsRecognizedInTheIncomeStatement" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetProvisionsForTransactionCostsRecognizedInTheIncomeStatement" xlink:to="lbl_label459957314" xlink:type="arc"/>
      <link:label id="id_68457d8c" xlink:label="lbl_label1749384588" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows attributable to divested business</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsAttributableToDivestedBusiness" xlink:label="lbl_CashFlowsAttributableToDivestedBusiness" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsAttributableToDivestedBusiness" xlink:to="lbl_label1749384588" xlink:type="arc"/>
      <link:label id="id_4f1d6584" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other cash flows used in investing activities, net</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities_labels" xlink:type="arc"/>
      <link:label id="id_1bf16062" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other inflows (outflows) of cash, classified as investing activities</link:label>
      <link:label id="id_1d66e74c" xlink:label="lbl_label493283148" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and other non-current assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherNoncurrentAssets" xlink:label="lbl_FinancialAndOtherNoncurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinancialAndOtherNoncurrentAssets" xlink:to="lbl_label493283148" xlink:type="arc"/>
      <link:label id="id_2b5de5f3" xlink:label="lbl_label727574003" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables and other current assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssets" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradeReceivablesAndOtherCurrentAssets" xlink:to="lbl_label727574003" xlink:type="arc"/>
      <link:label id="id_54b5d55e" xlink:label="lbl_LeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current and non-current lease liabilities</link:label>
      <link:label id="id_5b8463eb" xlink:label="lbl_TradePayablesProvisionsAndOtherLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables, provisions and other liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesProvisionsAndOtherLiabilities" xlink:label="lbl_TradePayablesProvisionsAndOtherLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TradePayablesProvisionsAndOtherLiabilities" xlink:to="lbl_TradePayablesProvisionsAndOtherLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_cbbfa93" xlink:label="lbl_CurrentAndNoncurrentFinancialDebt_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current and non-current financial debt</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAndNoncurrentFinancialDebt" xlink:label="lbl_CurrentAndNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentAndNoncurrentFinancialDebt" xlink:to="lbl_CurrentAndNoncurrentFinancialDebt_labels" xlink:type="arc"/>
      <link:label id="id_2ce3e4d1" xlink:label="lbl_label753132753" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right of use assets Disclosure and Lease liabilities [abstract]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:label="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_label753132753" xlink:type="arc"/>
      <link:label id="id_7eea5c8b" xlink:label="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of lease commitment and lease liability [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" xlink:label="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" xlink:to="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_179a66c8" xlink:label="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of lease commitment and lease liability</link:label>
      <link:label id="id_61aad0c8" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_41e189f8" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets</link:label>
      <link:label id="id_74f2bff0" xlink:label="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Right-of-use assets roll forward [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" xlink:label="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" xlink:to="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_4b1c78b0" xlink:label="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Right-of-use assets roll forward</link:label>
      <link:label id="id_21983c62" xlink:label="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of right-of-use assets carrying value and depreciation charge [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" xlink:label="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" xlink:to="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_3cad94ea" xlink:label="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of right-of-use assets carrying value and depreciation charge</link:label>
      <link:label id="id_59a39235" xlink:label="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis of lease liability [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" xlink:label="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" xlink:to="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_16173223" xlink:label="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis of lease liability</link:label>
      <link:label id="id_349af9f2" xlink:label="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional disclosures related to right-of-use assets and lease liabilities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:label="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:to="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2b0fa89e" xlink:label="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional disclosures related to right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="lbl_GoodwillRecognisedAsOfAcquisitionDate1" xlink:type="locator"/>
      <link:label id="id_41a9be15" xlink:label="lbl_GoodwillRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill recognised as of acquisition date</link:label>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GoodwillRecognisedAsOfAcquisitionDate1" xlink:to="lbl_GoodwillRecognisedAsOfAcquisitionDate_labels" xlink:type="arc"/>
      <link:label id="id_5f4cbeb8" xlink:label="lbl_GoodwillRecognisedAsOfAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
      <link:label id="id_20d2348f" xlink:label="lbl_IncomeTaxExpenseContinuingOperations_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Taxes</link:label>
      <link:label id="id_24522acb" xlink:label="lbl_AdjustmentsForFinanceIncomeCost_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net financial expense</link:label>
      <link:label id="id_2dbe7019" xlink:label="lbl_AdjustmentsForReconcileProfitLoss_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
      <link:label id="id_665e2bc2" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fair value of previously held equity interests</link:label>
      <link:label id="id_2124eb92" xlink:label="lbl_label556067730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current lease liabilities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLeaseLiabilitiesMember" xlink:label="lbl_NoncurrentLeaseLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLeaseLiabilitiesMember" xlink:to="lbl_label556067730" xlink:type="arc"/>
      <link:label id="id_25d32b75" xlink:label="lbl_label634596213" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current lease liabilities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLeaseLiabilitiesMember" xlink:label="lbl_CurrentLeaseLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLeaseLiabilitiesMember" xlink:to="lbl_label634596213" xlink:type="arc"/>
      <link:label id="id_7905e1d7" xlink:label="lbl_label203360922" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Applicable tax rate, excluding exceptional items</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ApplicableTaxRateExcludingExceptionalItems" xlink:label="lbl_ApplicableTaxRateExcludingExceptionalItems" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ApplicableTaxRateExcludingExceptionalItems" xlink:to="lbl_label203360922" xlink:type="arc"/>
      <link:label id="id_65b2ed83" xlink:label="lbl_CurrentAndNoncurrentFinancialDebt_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current and non-current financial debt</link:label>
      <link:label id="id_2db983d5" xlink:label="lbl_TradePayablesProvisionsAndOtherLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Trade payables, provisions and other liabilities</link:label>
      <link:label id="id_71df6444" xlink:label="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flows Attributable to divested business before divested cash and cash equivalents</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:label="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:to="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_43e3fc7" xlink:label="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments out of provisions for transaction costs attributable to the divested business</link:label>
      <link:label id="id_4fb71438" xlink:label="lbl_DivestedCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Divested cash and cash equivalents</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestedCashAndCashEquivalents" xlink:label="lbl_DivestedCashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DivestedCashAndCashEquivalents" xlink:to="lbl_DivestedCashAndCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_74caa513" xlink:label="lbl_DivestedCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Divested cash and cash equivalents</link:label>
      <link:label id="id_3a16e3f2" xlink:label="lbl_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax on Pension plans previously recognized in OCI</link:label>
      <link:label id="id_5bc61768" xlink:label="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares obtained through consolidated foundation</link:label>
      <link:label id="id_32f424a5" xlink:label="lbl_label854860965" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customary purchase price adjustment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomaryPurchasePriceAdjustment" xlink:label="lbl_CustomaryPurchasePriceAdjustment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CustomaryPurchasePriceAdjustment" xlink:to="lbl_label854860965" xlink:type="arc"/>
      <link:label id="id_4b0dbe44" xlink:label="lbl_label1259191876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayment of intercompany balances</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RepaymentOfIntercompanyBalances" xlink:label="lbl_RepaymentOfIntercompanyBalances" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RepaymentOfIntercompanyBalances" xlink:to="lbl_label1259191876" xlink:type="arc"/>
      <link:label id="id_3ce6e6d2" xlink:label="lbl_label1021765330" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax reform impact on deferred tax on treasury shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:label="lbl_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:to="lbl_label1021765330" xlink:type="arc"/>
      <link:label id="id_1d9b087f" xlink:label="lbl_DividendPaidNoncashAssetsDistribution_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend paid, non-cash assets distribution</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendPaidNoncashAssetsDistribution" xlink:label="lbl_DividendPaidNoncashAssetsDistribution" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DividendPaidNoncashAssetsDistribution" xlink:to="lbl_DividendPaidNoncashAssetsDistribution_labels" xlink:type="arc"/>
      <link:label id="id_49b7a9d9" xlink:label="lbl_DividendPaidNoncashAssetsDistribution_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividend in kind</link:label>
      <link:label id="id_4f1253e8" xlink:label="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net gain at completion of spin-off [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" xlink:label="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" xlink:to="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_cd2ba12" xlink:label="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net gain at completion of spin-off</link:label>
      <link:label id="id_4a895e0" xlink:label="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of assets and liabilities of disposal group classified as held for sale [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:label="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:to="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_399cb44f" xlink:label="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets and liabilities of disposal group classified as held for sale</link:label>
      <link:label id="id_333e63f1" xlink:label="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated income statement, discontinued operations [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:to="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_2b60d5f0" xlink:label="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated income statement, discontinued operations</link:label>
      <link:label id="id_6f1a698a" xlink:label="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of items included in net income from discontinued operations [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:label="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:to="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6b21ae09" xlink:label="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of items included in net income from discontinued operations</link:label>
      <link:label id="id_4a52c922" xlink:label="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of net assets derecognized [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:label="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:to="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_54e8c608" xlink:label="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of net assets derecognized</link:label>
      <link:label id="id_68686f96" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value of assets and liabilities arising from divestments [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:to="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_74c77dde" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of assets and liabilities arising from divestments</link:label>
      <link:label id="id_3a5e6480" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:type="arc"/>
      <link:label id="id_2aebe53" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period</link:label>
      <link:label id="id_14e1d56d" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period</link:label>
      <link:label id="id_16d7d1ab" xlink:label="lbl_label383242667" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="lbl_label383242667" xlink:type="arc"/>
      <link:label id="id_364362e8" xlink:label="lbl_label910385896" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="lbl_label910385896" xlink:type="arc"/>
      <link:label id="id_3ff27324" xlink:label="lbl_label1072853796" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="lbl_label1072853796" xlink:type="arc"/>
      <link:label id="id_218c01ed" xlink:label="lbl_label562823661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="lbl_label562823661" xlink:type="arc"/>
      <link:label id="id_7e9fd619" xlink:label="lbl_label2124404249" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise price of outstanding share options</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:to="lbl_label2124404249" xlink:type="arc"/>
      <link:label id="id_726c27cc" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:type="arc"/>
      <link:label id="id_5f37a474" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement at beginning of period</link:label>
      <link:label id="id_88d7a8d" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement at end of period</link:label>
      <link:label id="id_4f1e5db1" xlink:label="lbl_label1327390129" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments granted in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:to="lbl_label1327390129" xlink:type="arc"/>
      <link:label id="id_738f9077" xlink:label="lbl_label1938788471" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:to="lbl_label1938788471" xlink:type="arc"/>
      <link:label id="id_236bf45e" xlink:label="lbl_label594277470" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:to="lbl_label594277470" xlink:type="arc"/>
      <link:label id="id_1e452462" xlink:label="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for leases</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory_labels" xlink:type="arc"/>
      <link:label id="id_19961677" xlink:label="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases and right-of-use assets</link:label>
      <link:label id="id_7213f224" xlink:label="lbl_DistributionByWayOfDivindendInKindToShareholders_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for distribution by way of divindend in kind to shareholders</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionByWayOfDivindendInKindToShareholders" xlink:label="lbl_DistributionByWayOfDivindendInKindToShareholders" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DistributionByWayOfDivindendInKindToShareholders" xlink:to="lbl_DistributionByWayOfDivindendInKindToShareholders_labels" xlink:type="arc"/>
      <link:label id="id_73c6a1d7" xlink:label="lbl_DistributionByWayOfDivindendInKindToShareholders_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution by way of dividend in kind to shareholders</link:label>
      <link:label id="id_3b0bcb35" xlink:label="lbl_label373468922" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aspen Global Incorporated</link:label>
      <link:label id="id_505899ea" xlink:label="lbl_TheMedicinesCompanyMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Medicines Company [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TheMedicinesCompanyMember" xlink:label="lbl_TheMedicinesCompanyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TheMedicinesCompanyMember" xlink:to="lbl_TheMedicinesCompanyMember_labels" xlink:type="arc"/>
      <link:label id="id_3d4865bf" xlink:label="lbl_TheMedicinesCompanyMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Medicines Company</link:label>
      <link:label id="id_26a553b7" xlink:label="lbl_label648369079" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Piqray [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PiqrayMember" xlink:label="lbl_PiqrayMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PiqrayMember" xlink:to="lbl_label648369079" xlink:type="arc"/>
      <link:label id="id_3dbe8202" xlink:label="lbl_label1035895298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Xiidra [member]</link:label>
      <link:label id="id_725b9be" xlink:label="lbl_label119912894" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zolgensma [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZolgensmaMember" xlink:label="lbl_ZolgensmaMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ZolgensmaMember" xlink:to="lbl_label119912894" xlink:type="arc"/>
      <link:label id="id_7679d6e" xlink:label="lbl_label124231022" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mayzent [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MayzentMember" xlink:label="lbl_MayzentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MayzentMember" xlink:to="lbl_label124231022" xlink:type="arc"/>
      <link:label id="id_18490fef" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through assets related to discontinued operations</link:label>
      <link:label id="id_c87ee03" xlink:label="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through reclassification to right-of-use assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:to="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:to="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment_labels" xlink:type="arc"/>
      <link:label id="id_479a229e" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Costs of assets related to discontinued operations</link:label>
      <link:label id="id_18f65009" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through assets related to discontinued operations, intangible assets and goodwill</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:to="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill_labels" xlink:type="arc"/>
      <link:label id="id_4ee2113e" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of assets related to discontinued operations</link:label>
      <link:label id="id_6422c211" xlink:label="lbl_label1679999505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated amortization/impairments on assets related to discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:label="lbl_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:to="lbl_label1679999505" xlink:type="arc"/>
      <link:label id="id_36a944c" xlink:label="lbl_DeferredTaxLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax balance at beginning of period continuing operations</link:label>
      <link:label id="id_f49321b" xlink:label="lbl_label256455195" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net deferred tax balance related to discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:to="lbl_label256455195" xlink:type="arc"/>
      <link:label id="id_59b158e6" xlink:label="lbl_label1504794854" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aspen Global Incorporated [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AspenGlobalIncorporatedMember" xlink:label="lbl_AspenGlobalIncorporatedMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AspenGlobalIncorporatedMember" xlink:to="lbl_label1504794854" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AspenGlobalIncorporatedMember" xlink:to="lbl_label373468922" xlink:type="arc"/>
      <link:label id="id_3dc8af6f" xlink:label="lbl_UndiscountedFinanceLeasePaymentsToBeReceived_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undiscounted finance lease payments to be received</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:label="lbl_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:to="lbl_UndiscountedFinanceLeasePaymentsToBeReceived_labels" xlink:type="arc"/>
      <link:label id="id_334ff648" xlink:label="lbl_UndiscountedFinanceLeasePaymentsToBeReceived_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total future payments</link:label>
      <link:label id="id_4ca139f0" xlink:label="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unearned finance income relating to finance lease payments receivable</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:label="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:to="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable_labels" xlink:type="arc"/>
      <link:label id="id_32f71aba" xlink:label="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unearned interest income</link:label>
      <link:label id="id_32d528ec" xlink:label="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum finace lease payments receivable at present value</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:label="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:to="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue_labels" xlink:type="arc"/>
      <link:label id="id_200aacc" xlink:label="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum lease payments from finance lease agreements, at present value</link:label>
      <link:label id="id_5e2f001b" xlink:label="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest payments for amounts included in lease liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:label="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:to="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities_labels" xlink:type="arc"/>
      <link:label id="id_270f5b37" xlink:label="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest payments for amounts included in lease liabilities classified as cash flows from operating activities</link:label>
      <link:label id="id_60c53887" xlink:label="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase through new leases, liabilities arising from financing activities</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_labels" xlink:type="arc"/>
      <link:label id="id_3255d072" xlink:label="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New leases</link:label>
      <link:label id="id_78469395" xlink:label="lbl_label2017891221" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from non-current to current, net</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationFromNoncurrentToCurrentNet" xlink:label="lbl_ReclassificationFromNoncurrentToCurrentNet" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ReclassificationFromNoncurrentToCurrentNet" xlink:to="lbl_label2017891221" xlink:type="arc"/>
      <link:label id="id_37080272" xlink:label="lbl_InterestExpenseOnLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense on lease liabilities</link:label>
      <link:label id="id_22d1162d" xlink:label="lbl_label584128045" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="lbl_LeaseLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseLiabilitiesMember" xlink:to="lbl_label584128045" xlink:type="arc"/>
      <link:label id="id_5bd2b859" xlink:label="lbl_label1540536409" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration payable</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPayable" xlink:label="lbl_ContingentConsiderationPayable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationPayable" xlink:to="lbl_label1540536409" xlink:type="arc"/>
      <link:label id="id_11db2be0" xlink:label="lbl_label299576288" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lbl_label299576288" xlink:type="arc"/>
      <link:label id="id_358bdb60" xlink:label="lbl_label2144120781" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) due to changes in accounting policy, IFRS 16 [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:to="lbl_label2144120781" xlink:type="arc"/>
      <link:label id="id_5776de2" xlink:label="lbl_label91712994" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, USD [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsUSDMember" xlink:label="lbl_BorrowingsUSDMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsUSDMember" xlink:to="lbl_label91712994" xlink:type="arc"/>
      <link:label id="id_37cf6b5c" xlink:label="lbl_label936340316" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, EUR [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsEURMember" xlink:label="lbl_BorrowingsEURMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsEURMember" xlink:to="lbl_label936340316" xlink:type="arc"/>
      <link:label id="id_4e1f7ea0" xlink:label="lbl_FinanceLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance lease liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseLiabilities" xlink:label="lbl_FinanceLeaseLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_FinanceLeaseLiabilities" xlink:to="lbl_FinanceLeaseLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_495a6466" xlink:label="lbl_FinanceLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease obligations</link:label>
      <link:label id="id_633ca478" xlink:label="lbl_label1664918648" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity based compensation shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedCompensationShares" xlink:label="lbl_EquityBasedCompensationShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EquityBasedCompensationShares" xlink:to="lbl_label1664918648" xlink:type="arc"/>
      <link:label id="id_79aa7a52" xlink:label="lbl_label2041215570" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise of options and employee transactions shares</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:label="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:to="lbl_label2041215570" xlink:type="arc"/>
      <link:label id="id_6d34d6c2" xlink:label="lbl_label1832179394" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of options and employee transactions, equity impact</link:label>
      <link:label id="id_6fef109e" xlink:label="lbl_label1877938334" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise of options and employee transactions</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExerciseOfOptionsAndEmployeeTransactionsValue" xlink:label="lbl_ExerciseOfOptionsAndEmployeeTransactionsValue" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExerciseOfOptionsAndEmployeeTransactionsValue" xlink:to="lbl_label1877938334" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ExerciseOfOptionsAndEmployeeTransactionsValue" xlink:to="lbl_label1832179394" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PoPMember" xlink:to="lbl_label1343837424" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PoPYEMember" xlink:to="lbl_label571817371" xlink:type="arc"/>
      <link:label id="id_347a007d" xlink:label="lbl_OtherNoncurrentReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current receivables</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="lbl_OtherNoncurrentReceivables" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_OtherNoncurrentReceivables" xlink:to="lbl_OtherNoncurrentReceivables_labels" xlink:type="arc"/>
      <link:label id="id_4871e871" xlink:label="lbl_OtherNoncurrentReceivables_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term receivables</link:label>
      <link:label id="id_4529bc84" xlink:label="lbl_label1160363140" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares delivered to divested business employees</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployees" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:to="lbl_label1160363140" xlink:type="arc"/>
      <link:label id="id_5b371f8c" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product liability, government investigations, other legal matters provisions, impact of business combinations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations_labels" xlink:type="arc"/>
      <link:label id="id_3787190c" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of business combinations</link:label>
      <link:label id="id_4001cae9" xlink:label="lbl_LeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Impact of adoption of IFRS 16 Leases</link:label>
      <link:label id="id_2f708bd6" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Financial debts cash flows from continuing operations</link:label>
      <link:label id="id_7a3ed482" xlink:label="lbl_label2050937986" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously reported finance lease obligation of divested business</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:label="lbl_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:to="lbl_label2050937986" xlink:type="arc"/>
      <link:label id="id_34924f0b" xlink:label="lbl_label882003723" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net cash flows used in acquisitions and divestments of businesses classified as investing activities from continuing operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:to="lbl_label882003723" xlink:type="arc"/>
      <link:label id="id_15f358a7" xlink:label="lbl_label368269479" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments, options on equity securities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:label="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:to="lbl_label368269479" xlink:type="arc"/>
      <link:label id="id_61acf165" xlink:label="lbl_label1591563240" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated financial effect of contingent liabilities, damages claimed</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:to="lbl_label1591563240" xlink:type="arc"/>
      <link:label id="id_49032bd4" xlink:label="lbl_label1224944596" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional amount of settlement in principle</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalAmountOfSettlementInPrinciple" xlink:label="lbl_AdditionalAmountOfSettlementInPrinciple" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdditionalAmountOfSettlementInPrinciple" xlink:to="lbl_label1224944596" xlink:type="arc"/>
      <link:label id="id_4b8a0c94" xlink:label="lbl_label1267338388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount of resolved action</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfResolvedAction" xlink:label="lbl_AmountOfResolvedAction" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountOfResolvedAction" xlink:to="lbl_label1267338388" xlink:type="arc"/>
      <link:label id="id_54d844bf" xlink:label="lbl_label1423459519" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Enoxaparin [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnoxaparinMember" xlink:label="lbl_EnoxaparinMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EnoxaparinMember" xlink:to="lbl_label1423459519" xlink:type="arc"/>
      <link:label id="id_29f14990" xlink:label="lbl_label703678864" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sandoz Manufacturing Inc. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozManufacturingInc.Member" xlink:label="lbl_SandozManufacturingInc.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SandozManufacturingInc.Member" xlink:to="lbl_label703678864" xlink:type="arc"/>
      <link:label id="id_1755f369" xlink:label="lbl_label391508841" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">China Novartis Institute for BioMedical Research Co.,Ltd. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:label="lbl_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:to="lbl_label391508841" xlink:type="arc"/>
      <link:label id="id_6dee5dc4" xlink:label="lbl_label1844338116" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Suzhou Novartis Technical Development Co., Ltd. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:label="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:to="lbl_label1844338116" xlink:type="arc"/>
      <link:label id="id_5443c473" xlink:label="lbl_label1413727347" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CELLforCURE [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CELLforCUREMember" xlink:label="lbl_CELLforCUREMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CELLforCUREMember" xlink:to="lbl_label1413727347" xlink:type="arc"/>
      <link:label id="id_4cf512" xlink:label="lbl_label5043474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Manufacturing GmbH [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisManufacturingGmbHMember" xlink:label="lbl_NovartisManufacturingGmbHMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisManufacturingGmbHMember" xlink:to="lbl_label5043474" xlink:type="arc"/>
      <link:label id="id_4471df2c" xlink:label="lbl_label1148313388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Hungary Healthcare Limited Liability Company [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:label="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:to="lbl_label1148313388" xlink:type="arc"/>
      <link:label id="id_424beb28" xlink:label="lbl_label1112271656" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advaced Accelerator Applications (Italy) S.r.l. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:label="lbl_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:to="lbl_label1112271656" xlink:type="arc"/>
      <link:label id="id_5fad9749" xlink:label="lbl_label1605211977" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IDB Holland BV [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IDBHollandBVMember" xlink:label="lbl_IDBHollandBVMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IDBHollandBVMember" xlink:to="lbl_label1605211977" xlink:type="arc"/>
      <link:label id="id_50283594" xlink:label="lbl_label1344812436" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advaced Accelerator Applications Iberica, S.L.U. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:label="lbl_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:to="lbl_label1344812436" xlink:type="arc"/>
      <link:label id="id_6345aa6d" xlink:label="lbl_label1665509997" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Imaging Equipment Ltd [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImagingEquipmentLtdMember" xlink:label="lbl_ImagingEquipmentLtdMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImagingEquipmentLtdMember" xlink:to="lbl_label1665509997" xlink:type="arc"/>
      <link:label id="id_2031baeb" xlink:label="lbl_label540130027" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Inflammasome Research, Inc. [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInflammasomeResearchInc.Member" xlink:label="lbl_NovartisInflammasomeResearchInc.Member" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInflammasomeResearchInc.Member" xlink:to="lbl_label540130027" xlink:type="arc"/>
      <link:label id="id_1af84be1" xlink:label="lbl_label452479969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Technology LLC [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTechnologyLLCMember" xlink:label="lbl_NovartisTechnologyLLCMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisTechnologyLLCMember" xlink:to="lbl_label452479969" xlink:type="arc"/>
      <link:label id="id_388a06e4" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Portion of consideration paid (received) consisting of cash and cash equivalents upfront payment</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:to="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment_labels" xlink:type="arc"/>
      <link:label id="id_3b18f468" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Portion of consideration paid consisting of cash and cash equivalents upfront payment</link:label>
      <link:label id="id_47a0c115" xlink:label="lbl_label1201717525" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Partial release of deferred tax liability recognized</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:label="lbl_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:to="lbl_label1201717525" xlink:type="arc"/>
      <link:label id="id_300e3078" xlink:label="lbl_label464719186" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities undiscounted</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesUndiscounted" xlink:label="lbl_LeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LeaseLiabilitiesUndiscounted" xlink:to="lbl_label464719186" xlink:type="arc"/>
      <link:label id="id_34d806ab" xlink:label="lbl_label1619923269" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Most material lease with lease term extension</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostMaterialLeaseWithLeaseTermExtension" xlink:label="lbl_MostMaterialLeaseWithLeaseTermExtension" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MostMaterialLeaseWithLeaseTermExtension" xlink:to="lbl_label1619923269" xlink:type="arc"/>
      <link:label id="id_53edcb" xlink:label="lbl_label5500363" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash outflows for short term and low value leases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOutflowsForShortTermAndLowValueLeases" xlink:label="lbl_CashOutflowsForShortTermAndLowValueLeases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashOutflowsForShortTermAndLowValueLeases" xlink:to="lbl_label5500363" xlink:type="arc"/>
      <link:label id="id_30ae4b2" xlink:label="lbl_label51045554" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash outflows for payments of leases interest</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOutflowsForPaymentsOfLeasesInterest" xlink:label="lbl_CashOutflowsForPaymentsOfLeasesInterest" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashOutflowsForPaymentsOfLeasesInterest" xlink:to="lbl_label51045554" xlink:type="arc"/>
      <link:label id="id_5a4733e9" xlink:label="lbl_label1514615785" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax reform effective tax rate after implemetation of new reform changes</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:label="lbl_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:to="lbl_label1514615785" xlink:type="arc"/>
      <link:label id="id_63ed288d" xlink:label="lbl_label1676486797" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax reform effective blended tax rate after implemetation of new reform changes</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:label="lbl_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:to="lbl_label1676486797" xlink:type="arc"/>
      <link:label id="id_3af42b4" xlink:label="lbl_label2021190939" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long term receivables from finance subleases</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongTermReceivablesFromFinanceSubleases" xlink:label="lbl_LongTermReceivablesFromFinanceSubleases" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LongTermReceivablesFromFinanceSubleases" xlink:to="lbl_label2021190939" xlink:type="arc"/>
      <link:label id="id_115b6ebf" xlink:label="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through liabilities related to discontinued operations</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:label="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:to="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations_labels" xlink:type="arc"/>
      <link:label id="id_64b9f08d" xlink:label="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial debts and lease liabilities related to discontinued operations</link:label>
      <link:label id="id_a7c0098" xlink:label="lbl_label175898776" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings credit facility short term</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityShortTerm" xlink:label="lbl_BorrowingsCreditFacilityShortTerm" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BorrowingsCreditFacilityShortTerm" xlink:to="lbl_label175898776" xlink:type="arc"/>
      <link:label id="id_3f8e8cf1" xlink:label="lbl_label1066306801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name of Property [Axis]</link:label>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lbl_label1066306801" xlink:type="arc"/>
      <link:label id="id_44dffa85" xlink:label="lbl_label1155529349" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name of Property [Domain]</link:label>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lbl_label1155529349" xlink:type="arc"/>
      <link:label id="id_7feaeddc" xlink:label="lbl_label167109794" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [axis]</link:label>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrencyAxis" xlink:to="lbl_label167109794" xlink:type="arc"/>
      <link:label id="id_2246514e" xlink:label="lbl_label2121837386" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe [member]</link:label>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_EuropeMember" xlink:label="lbl_EuropeMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EuropeMember" xlink:to="lbl_label2121837386" xlink:type="arc"/>
      <link:label id="id_4c9a1836" xlink:label="lbl_label849028726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Americas [member]</link:label>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AmericasMember" xlink:label="lbl_AmericasMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmericasMember" xlink:to="lbl_label849028726" xlink:type="arc"/>
      <link:label id="id_295e5e69" xlink:label="lbl_RightofuseAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_RightofuseAssetsMember" xlink:to="lbl_RightofuseAssetsMember_labels" xlink:type="arc"/>
      <link:label id="id_164ca513" xlink:label="lbl_RightofuseAssetsMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
      <link:label id="id_4947c6a9" xlink:label="lbl_label1229440681" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Beovu [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BeovuMember" xlink:label="lbl_BeovuMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BeovuMember" xlink:to="lbl_label1229440681" xlink:type="arc"/>
      <link:label id="id_22f028b0" xlink:label="lbl_ConsiderationPaidReceived_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consideration paid (received)</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="lbl_ConsiderationPaidReceived" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsiderationPaidReceived" xlink:to="lbl_ConsiderationPaidReceived_labels" xlink:type="arc"/>
      <link:label id="id_3dc9426c" xlink:label="lbl_ConsiderationPaidReceived_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash inflows from divestment</link:label>
      <link:label id="id_56521fba" xlink:label="lbl_label1448222650" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net cash outflows from divestments</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashOutflowsFromDivestments" xlink:label="lbl_NetCashOutflowsFromDivestments" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NetCashOutflowsFromDivestments" xlink:to="lbl_label1448222650" xlink:type="arc"/>
      <link:label id="id_1d2114e2" xlink:label="lbl_label488707298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents in subsidiary or businesses acquired or disposed</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="lbl_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="lbl_label488707298" xlink:type="arc"/>
      <link:label id="id_45aec51d" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through transfers and other changes, other provisions</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:to="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_labels" xlink:type="arc"/>
      <link:label id="id_6eb0eb0c" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers</link:label>
      <link:label id="id_6bada554" xlink:label="lbl_label1806542164" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLiabilitiesMember" xlink:label="lbl_CurrentLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLiabilitiesMember" xlink:to="lbl_label1806542164" xlink:type="arc"/>
      <link:label id="id_61717448" xlink:label="lbl_label1634825288" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLiabilitiesMember" xlink:label="lbl_NoncurrentLiabilitiesMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLiabilitiesMember" xlink:to="lbl_label1634825288" xlink:type="arc"/>
      <link:label id="id_2e9b8dad" xlink:label="lbl_label781946285" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities in subsidiary or businesses acquired or disposed</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="lbl_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="lbl_label781946285" xlink:type="arc"/>
      <link:label id="id_508846a9" xlink:label="lbl_CurrentLeaseLiabilitiesUndiscounted_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current lease liabilities undiscounted</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLeaseLiabilitiesUndiscounted" xlink:label="lbl_CurrentLeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentLeaseLiabilitiesUndiscounted" xlink:to="lbl_CurrentLeaseLiabilitiesUndiscounted_labels" xlink:type="arc"/>
      <link:label id="id_420e4c77" xlink:label="lbl_label1108233335" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current lease liabilities undiscounted</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLeaseLiabilitiesUndiscounted" xlink:label="lbl_NoncurrentLeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NoncurrentLeaseLiabilitiesUndiscounted" xlink:to="lbl_label1108233335" xlink:type="arc"/>
      <link:label id="id_5c23b63c" xlink:label="lbl_CurrentLeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current lease liabilities</link:label>
      <link:label id="id_77f7d595" xlink:label="lbl_CurrentLeaseLiabilitiesUndiscounted_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less current lease liabilities undiscounted</link:label>
      <link:label id="id_16b54793" xlink:label="lbl_DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense arising from write-down or reversal of write-down of deferred tax asset</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset" xlink:label="lbl_DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset" xlink:to="lbl_DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset_labels" xlink:type="arc"/>
      <link:label id="id_45e19527" xlink:label="lbl_DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of write-off of deferred tax assets</link:label>
      <link:label id="id_63e83d46" xlink:label="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment charge prior to classification to assets held for sale</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:label="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:to="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale_labels" xlink:type="arc"/>
      <link:label id="id_226b60a4" xlink:label="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impairment charge prior to classification to assets held for sale</link:label>
      <link:label id="id_557effd1" xlink:label="lbl_label1434386385" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax on transaction costs recorded in equity</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxOnTransactionCostsRecordedInEquity" xlink:label="lbl_TaxOnTransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TaxOnTransactionCostsRecordedInEquity" xlink:to="lbl_label1434386385" xlink:type="arc"/>
      <link:label id="id_5c1a2168" xlink:label="lbl_EffectOfWriteoffOfDeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax rate, effect of write-off of deferred tax assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfWriteoffOfDeferredTaxAssets" xlink:label="lbl_EffectOfWriteoffOfDeferredTaxAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectOfWriteoffOfDeferredTaxAssets" xlink:to="lbl_EffectOfWriteoffOfDeferredTaxAssets_labels" xlink:type="arc"/>
      <link:label id="id_59102729" xlink:label="lbl_EffectOfWriteoffOfDeferredTaxAssets_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of write-off of deferred tax assets</link:label>
      <link:label id="id_3df76505" xlink:label="lbl_ProceedsFromCurrentAndNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from current and non-current borrowings</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:label="lbl_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:to="lbl_ProceedsFromCurrentAndNoncurrentBorrowings_labels" xlink:type="arc"/>
      <link:label id="id_64441db" xlink:label="lbl_ProceedsFromCurrentAndNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs payment</link:label>
      <link:label id="id_11959a05" xlink:label="lbl_label295016965" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Uncalled capital commitments for investments in funds</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:label="lbl_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:to="lbl_label295016965" xlink:type="arc"/>
      <link:label id="id_12c8e5a0" xlink:label="lbl_label315155872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LitigationCaseMember" xlink:label="lbl_LitigationCaseMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LitigationCaseMember" xlink:to="lbl_label315155872" xlink:type="arc"/>
      <link:label id="id_73c71c69" xlink:label="lbl_label1942428777" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tennessee class action [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TennesseeClassActionMember" xlink:label="lbl_TennesseeClassActionMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_TennesseeClassActionMember" xlink:to="lbl_label1942428777" xlink:type="arc"/>
      <link:label id="id_17248af4" xlink:label="lbl_label388270836" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Massachusetts case [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MassachusettsCaseMember" xlink:label="lbl_MassachusettsCaseMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_MassachusettsCaseMember" xlink:to="lbl_label388270836" xlink:type="arc"/>
      <link:label id="id_23bc1d31" xlink:label="lbl_label599530801" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="lbl_DocumentAnnualReport" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentAnnualReport" xlink:to="lbl_label599530801" xlink:type="arc"/>
      <link:label id="id_34b5e034" xlink:label="lbl_label884334644" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="lbl_EntityShellCompany" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityShellCompany" xlink:to="lbl_label884334644" xlink:type="arc"/>
      <link:label id="id_481345ce" xlink:label="lbl_label1209222606" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="lbl_EntityEmergingGrowthCompany" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityEmergingGrowthCompany" xlink:to="lbl_label1209222606" xlink:type="arc"/>
      <link:label id="id_448d1a1f" xlink:label="lbl_label1150097951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="lbl_EntityInteractiveDataCurrent" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EntityInteractiveDataCurrent" xlink:to="lbl_label1150097951" xlink:type="arc"/>
      <link:label id="id_8e53da4" xlink:label="lbl_ProceedsFromCurrentAndNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash inflow from borrowings</link:label>
      <link:label id="id_39e22a7b" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Transaction cost payments</link:label>
      <link:label id="id_4f32f729" xlink:label="lbl_label1328740137" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross deferred tax assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossDeferredTaxAssets" xlink:label="lbl_GrossDeferredTaxAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossDeferredTaxAssets" xlink:to="lbl_label1328740137" xlink:type="arc"/>
      <link:label id="id_182b8b94" xlink:label="lbl_GrossDeferredTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross deferred tax liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossDeferredTaxLiabilities" xlink:label="lbl_GrossDeferredTaxLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_GrossDeferredTaxLiabilities" xlink:to="lbl_GrossDeferredTaxLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_3fcaf800" xlink:label="lbl_GrossDeferredTaxLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax liabilities</link:label>
      <link:label id="id_12baf088" xlink:label="lbl_label314241160" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount borrowed under the credit facility</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountBorrowedUnderTheCreditFacility" xlink:label="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AmountBorrowedUnderTheCreditFacility" xlink:to="lbl_label314241160" xlink:type="arc"/>
      <link:label id="id_24f2fc6a" xlink:label="lbl_ContingentConsiderationLiabilities_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationLiabilities" xlink:label="lbl_ContingentConsiderationLiabilities" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ContingentConsiderationLiabilities" xlink:to="lbl_ContingentConsiderationLiabilities_labels" xlink:type="arc"/>
      <link:label id="id_596ae769" xlink:label="lbl_label1500178281" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation case [axis]</link:label>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="lbl_LitigationCaseAxis" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_LitigationCaseAxis" xlink:to="lbl_label1500178281" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XiidraMember" xlink:label="lbl_XiidraMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_XiidraMember" xlink:to="lbl_label1035895298" xlink:type="arc"/>
      <link:label id="id_6dadd046" xlink:label="lbl_label1840107590" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="lbl_DocumentTransitionReport" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentTransitionReport" xlink:to="lbl_label1840107590" xlink:type="arc"/>
      <link:label id="id_287ed480" xlink:label="lbl_label679400576" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="lbl_DocumentShellCompanyReport" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DocumentShellCompanyReport" xlink:to="lbl_label679400576" xlink:type="arc"/>
      <link:label id="id_6eada512" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation, amortisation and impairment [member]</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember_labels" xlink:type="arc"/>
      <link:label id="id_b2dfb88" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation, amortisation and impairment</link:label>
      <link:label id="id_4be49960" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to deferred tax assets on Swiss post retirement previously recognized through OCI</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI_labels" xlink:type="arc"/>
      <link:label id="id_7d4d613b" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of new tax law income tax relating to deferred tax assets on Swiss post retirement previously recognized through OCI</link:label>
      <link:label id="id_4eb0928b" xlink:label="lbl_TaxesOnTreasuryShares_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Taxes on treasury shares</link:label>
      <link:label id="id_22a0ea85" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs of assets related to discontinued operations</link:label>
      <link:label id="id_15b36c9d" xlink:label="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease through reclassification to right-of-use assets</link:label>
      <link:label id="id_55dcd44c" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Recognition exemption for short term leases</link:label>
      <link:label id="id_7a35ce5" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Recognition exception for low value leases</link:label>
      <link:label id="id_40e677f7" xlink:label="lbl_EffectOfDiscounting_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of discounting</link:label>
      <link:label id="id_2d2e026c" xlink:label="lbl_DepreciationRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Depreciation charge</link:label>
      <link:label id="id_1ac53b1b" xlink:label="lbl_LeaseContractTerminationsRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Lease contract terminations, right-of-use assets</link:label>
      <link:label id="id_e5f5961" xlink:label="lbl_CurrentLeaseLiabilitiesUndiscounted_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less current lease liabilities undiscounted</link:label>
      <link:label id="id_7d7ce79e" xlink:label="lbl_InventoryWritedown2011_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory provisions</link:label>
      <link:label id="id_42fb2d2e" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current trade receivables from closely monitored countries past due more than one year, provisions recorded</link:label>
      <link:label id="id_4eb32c65" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of previously held equity interests</link:label>
      <link:label id="id_27322091" xlink:label="lbl_ProceedsFromNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from non-current financial debts</link:label>
      <link:label id="id_7e6f87d8" xlink:label="lbl_AmortizationOfBondsDiscount_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amortization of bonds discount</link:label>
      <link:label id="id_25b1f7fc" xlink:label="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contributions of associates</link:label>
      <link:label id="id_4de13945" xlink:label="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
      <link:label id="id_148d311b" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_67019b8d" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of acquisitions, divestments or transfers</link:label>
      <link:label id="id_f7a5847" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</link:label>
      <link:label id="id_6e294aeb" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation effects</link:label>
      <link:label id="id_4bbdbc8c" xlink:label="lbl_ContingentConsiderationLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration liabilities</link:label>
      <link:label id="id_45ca4585" xlink:label="lbl_NetAssetsDerecognized_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Net assets derecognized</link:label>
      <link:label id="id_42ccca61" xlink:label="lbl_label1120717409" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of entitys trade receivable</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEntitysTradeReceivable" xlink:label="lbl_PercentageOfEntitysTradeReceivable" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_PercentageOfEntitysTradeReceivable" xlink:to="lbl_label1120717409" xlink:type="arc"/>
      <link:label id="id_43ec36aa" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayment of lease liability</link:label>
      <link:label id="id_677ffa06" xlink:label="lbl_CashInflowForSaleAndLeaseback_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash inflow for sale and leaseback</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowForSaleAndLeaseback" xlink:label="lbl_CashInflowForSaleAndLeaseback" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashInflowForSaleAndLeaseback" xlink:to="lbl_CashInflowForSaleAndLeaseback_labels" xlink:type="arc"/>
      <link:label id="id_5bdc50eb" xlink:label="lbl_SaleAndLeaseBackMember_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale and lease back [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleAndLeaseBackMember" xlink:label="lbl_SaleAndLeaseBackMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SaleAndLeaseBackMember" xlink:to="lbl_SaleAndLeaseBackMember_labels" xlink:type="arc"/>
      <link:label id="id_73fe88ea" xlink:label="lbl_SaleAndLeaseBackMember_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale and leaseback</link:label>
      <link:label id="id_1b2ddb15" xlink:label="lbl_CurrentRefundsProvision_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current refunds provision</link:label>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentRefundsProvision" xlink:label="lbl_CurrentRefundsProvision" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CurrentRefundsProvision" xlink:to="lbl_CurrentRefundsProvision_labels" xlink:type="arc"/>
      <link:label id="id_6f9ec2d7" xlink:label="lbl_CurrentRefundsProvision_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions for deductions from revenue</link:label>
      <link:label id="id_782da91f" xlink:label="lbl_CurrentRefundsProvision_labels" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Provisions for deductions from revenue, at beginning of period</link:label>
      <link:label id="id_67f2691b" xlink:label="lbl_CurrentRefundsProvision_labels" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Provisions for deductions from revenue, at end of period</link:label>
      <link:label id="id_376d9857" xlink:label="lbl_label929929303" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative financial instruments, commodity purchase contract</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:label="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:to="lbl_label929929303" xlink:type="arc"/>
      <link:label id="id_4c17362a" xlink:label="lbl_DisposalsAndRetirementsRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals and retirements, right-of-use assets</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalsAndRetirementsRightofuseAssets" xlink:label="lbl_DisposalsAndRetirementsRightofuseAssets" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisposalsAndRetirementsRightofuseAssets" xlink:to="lbl_DisposalsAndRetirementsRightofuseAssets_labels" xlink:type="arc"/>
      <link:label id="id_328352cc" xlink:label="lbl_DisposalsAndRetirementsRightofuseAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Impact of divestments</link:label>
      <link:label id="id_5a93baa1" xlink:label="lbl_LeaseLiabilities_labels" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
      <link:label id="id_1917780" xlink:label="lbl_label26310528" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of income not subject to tax on divestment gain</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:label="lbl_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:to="lbl_label26310528" xlink:type="arc"/>
      <link:label id="id_6025ab0" xlink:label="lbl_CashInflowForSaleAndLeaseback_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash inflow for sale and leaseback</link:label>
      <link:label id="id_642f7fec" xlink:label="lbl_label1680834540" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Suzhou Novartis Technical Development Co., Ltd., Changshu [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:label="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:to="lbl_label1680834540" xlink:type="arc"/>
      <link:label id="id_14fc3a32" xlink:label="lbl_label352074290" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CELLforCURE, Les Ulis [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CELLforCURELesUlisMember" xlink:label="lbl_CELLforCURELesUlisMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CELLforCURELesUlisMember" xlink:to="lbl_label352074290" xlink:type="arc"/>
      <link:label id="id_372a8238" xlink:label="lbl_label925532728" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications (Italy) S.r.l., Pozzilli [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:label="lbl_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:to="lbl_label925532728" xlink:type="arc"/>
      <link:label id="id_12a3185f" xlink:label="lbl_label312678495" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Netherlands B.V., Amsterdam [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNetherlandsB.V.AmsterdamMember" xlink:label="lbl_NovartisNetherlandsB.V.AmsterdamMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisNetherlandsB.V.AmsterdamMember" xlink:to="lbl_label312678495" xlink:type="arc"/>
      <link:label id="id_495d47ae" xlink:label="lbl_label1230849966" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharma B.V., Amsterdam [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaB.V.AmsterdamMember" xlink:label="lbl_NovartisPharmaB.V.AmsterdamMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaB.V.AmsterdamMember" xlink:to="lbl_label1230849966" xlink:type="arc"/>
      <link:label id="id_3b55a7b7" xlink:label="lbl_label995469239" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IDB Holland BV, Baarle-Nassau [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IDBHollandBVBaarleNassauMember" xlink:label="lbl_IDBHollandBVBaarleNassauMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_IDBHollandBVBaarleNassauMember" xlink:to="lbl_label995469239" xlink:type="arc"/>
      <link:label id="id_33884b38" xlink:label="lbl_label864570168" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Saudi Ltd., Riyadh [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSaudiLtd.RiyadhMember" xlink:label="lbl_NovartisSaudiLtd.RiyadhMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisSaudiLtd.RiyadhMember" xlink:to="lbl_label864570168" xlink:type="arc"/>
      <link:label id="id_222bb2dd" xlink:label="lbl_label573289181" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications Iberica, S.L.U., Esplugues de Llobregat [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:label="lbl_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:to="lbl_label573289181" xlink:type="arc"/>
      <link:label id="id_10409dbe" xlink:label="lbl_label272670142" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis UK Limited, London [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUKLimitedLondonMember" xlink:label="lbl_NovartisUKLimitedLondonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisUKLimitedLondonMember" xlink:to="lbl_label272670142" xlink:type="arc"/>
      <link:label id="id_63d11071" xlink:label="lbl_label1674645617" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Pharmaceuticals UK Limited, London [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:label="lbl_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:to="lbl_label1674645617" xlink:type="arc"/>
      <link:label id="id_19392a8e" xlink:label="lbl_label423176846" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Grimsby Limited, London [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGrimsbyLimitedLondonMember" xlink:label="lbl_NovartisGrimsbyLimitedLondonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisGrimsbyLimitedLondonMember" xlink:to="lbl_label423176846" xlink:type="arc"/>
      <link:label id="id_7c7620c7" xlink:label="lbl_label2088116423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Imaging Equipment Ltd, London [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImagingEquipmentLtdLondonMember" xlink:label="lbl_ImagingEquipmentLtdLondonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ImagingEquipmentLtdLondonMember" xlink:to="lbl_label2088116423" xlink:type="arc"/>
      <link:label id="id_51082ea6" xlink:label="lbl_label1359490726" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ziarco Group Limited, London [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedLondonMember" xlink:label="lbl_ZiarcoGroupLimitedLondonMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ZiarcoGroupLimitedLondonMember" xlink:to="lbl_label1359490726" xlink:type="arc"/>
      <link:label id="id_70da7012" xlink:label="lbl_label1893363730" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Finance Corporation, East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceCorporationEastHanoverNJMember" xlink:label="lbl_NovartisFinanceCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisFinanceCorporationEastHanoverNJMember" xlink:to="lbl_label1893363730" xlink:type="arc"/>
      <link:label id="id_1a5c8917" xlink:label="lbl_label442272023" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Capital Corporation, East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCapitalCorporationEastHanoverNJMember" xlink:label="lbl_NovartisCapitalCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisCapitalCorporationEastHanoverNJMember" xlink:to="lbl_label442272023" xlink:type="arc"/>
      <link:label id="id_2db5a3fb" xlink:label="lbl_label766878715" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis US Foundation, East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUSFoundationEastHanoverNJMember" xlink:label="lbl_NovartisUSFoundationEastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisUSFoundationEastHanoverNJMember" xlink:to="lbl_label766878715" xlink:type="arc"/>
      <link:label id="id_5bd187f1" xlink:label="lbl_label1540458481" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Accelerator Applications USA, Inc., Millburn, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:label="lbl_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:to="lbl_label1540458481" xlink:type="arc"/>
      <link:label id="id_25dd15b1" xlink:label="lbl_label635246001" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Inflammasome Research, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:label="lbl_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:to="lbl_label635246001" xlink:type="arc"/>
      <link:label id="id_561808b5" xlink:label="lbl_label1444415669" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Technology LLC, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:label="lbl_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:to="lbl_label1444415669" xlink:type="arc"/>
      <link:label id="id_7ffed34c" xlink:label="lbl_label2147406668" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Encore Vision, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionInc.EastHanoverNJMember" xlink:label="lbl_EncoreVisionInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EncoreVisionInc.EastHanoverNJMember" xlink:to="lbl_label2147406668" xlink:type="arc"/>
      <link:label id="id_4458c6ff" xlink:label="lbl_label1146668799" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Endocyte, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteInc.EastHanoverNJMember" xlink:label="lbl_EndocyteInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EndocyteInc.EastHanoverNJMember" xlink:to="lbl_label1146668799" xlink:type="arc"/>
      <link:label id="id_68546348" xlink:label="lbl_label1750360904" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Vaccines and Diagnostics, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:label="lbl_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:to="lbl_label1750360904" xlink:type="arc"/>
      <link:label id="id_2d054e5d" xlink:label="lbl_label755322461" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spinifex Pharmaceuticals, Inc., East Hanover, NJ [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:label="lbl_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:to="lbl_label755322461" xlink:type="arc"/>
      <link:label id="id_75833aa3" xlink:label="lbl_label1971534499" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Novartis Manufacturing GmbH, Marburg [member]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisManufacturingGmbHMarburgMember" xlink:label="lbl_NovartisManufacturingGmbHMarburgMember" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_NovartisManufacturingGmbHMarburgMember" xlink:to="lbl_label1971534499" xlink:type="arc"/>
      <link:label id="id_3ce1ce66" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, net</link:label>
      <link:label id="id_7d5a543d" xlink:label="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payments for amounts included in lease liabilities classified as cash flows from operating activities</link:label>
      <link:label id="id_264ae6cd" xlink:label="lbl_AmortizationOfBondsDiscount_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of bonds discount</link:label>
      <link:label id="id_541ef56a" xlink:label="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transfers out of Level 3 of fair value hierarchy, assets</link:label>
      <link:label id="id_4edf1e96" xlink:label="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amount of change in OCI when POS for level 3 change more than 10%</link:label>
      <link:label id="id_2efc8f07" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of non-current financial debts</link:label>
      <link:label id="id_2d28f541" xlink:label="lbl_label757658945" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of US tax reform legislation</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfUSTaxReformLegislation" xlink:label="lbl_EffectOfUSTaxReformLegislation" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_EffectOfUSTaxReformLegislation" xlink:to="lbl_label757658945" xlink:type="arc"/>
      <link:label id="id_3c578d43" xlink:label="lbl_AcquiredCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired cash and cash equivalents</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredCashAndCashEquivalents" xlink:label="lbl_AcquiredCashAndCashEquivalents" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_AcquiredCashAndCashEquivalents" xlink:to="lbl_AcquiredCashAndCashEquivalents_labels" xlink:type="arc"/>
      <link:label id="id_25ec28ce" xlink:label="lbl_AcquiredCashAndCashEquivalents_labels" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquired cash and cash equivalents</link:label>
      <link:label id="id_4dc21030" xlink:label="lbl_label1304563760" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of impact on adoption of IFRS 16</link:label>
      <link:label id="id_284baaac" xlink:label="lbl_label676047532" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of impact on adoption of IFRS 16 [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:label="lbl_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:to="lbl_label676047532" xlink:type="arc"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:to="lbl_label1304563760" xlink:type="arc"/>
      <link:label id="id_7cee5446" xlink:label="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated income statement, additional information [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:to="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_43467410" xlink:label="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated income statement, additional information</link:label>
      <link:label id="id_47cec299" xlink:label="lbl_BalanceSheetAdditionalInformationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance sheet, additional information [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetAdditionalInformationTableTextBlock" xlink:label="lbl_BalanceSheetAdditionalInformationTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_BalanceSheetAdditionalInformationTableTextBlock" xlink:to="lbl_BalanceSheetAdditionalInformationTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_557771c9" xlink:label="lbl_BalanceSheetAdditionalInformationTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance sheet, additional information</link:label>
      <link:label id="id_6c2f9126" xlink:label="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows used in investing activities [table text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:label="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:to="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_6c013712" xlink:label="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows used in investing activities</link:label>
      <link:label id="id_cd95e1f" xlink:label="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CH Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities [text block]</link:label>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" xlink:label="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" xlink:type="locator"/>
      <link:labelArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" xlink:to="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock_labels" xlink:type="arc"/>
      <link:label id="id_5424fa1a" xlink:label="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock_labels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CH Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities</link:label>
   </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>nvs-20191231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails8" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails2" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails6" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails3" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails4" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails7" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails7" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails6" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails5" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiabilityTables" xlink:href="nvs-20191231.xsd#disclosureRightOfUseAssetsAndLeaseLiabilityTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails6" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureLeaseLiabilityAndRightOfUseAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails4" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails1" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails1" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactionsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDisposalGroupHeldForSaleDetails" xlink:href="nvs-20191231.xsd#disclosureDisposalGroupHeldForSaleDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactionsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperationsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperations" xlink:href="nvs-20191231.xsd#disclosureDiscontinuedOperations" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiability" xlink:href="nvs-20191231.xsd#disclosureRightOfUseAssetsAndLeaseLiability" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureLegalProceedingsUpdateQ" xlink:href="nvs-20191231.xsd#disclosureLegalProceedingsUpdateQ" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureBasisOfPreparationQ" xlink:href="nvs-20191231.xsd#disclosureBasisOfPreparationQ" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails12" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails12" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails11" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails11" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactionsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails14" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails14" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails10" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails10" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails1" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails1_1df9063b" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails13" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails13" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails12" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails12" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails3" xlink:href="nvs-20191231.xsd#disclosureSignificantAccountingPoliciesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails5" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosures" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosures" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails6" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails5" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails11" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails11" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails10" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails10" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails9" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails9" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails8" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails7" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails6" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails4" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails3" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails2" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails5" xlink:href="nvs-20191231.xsd#disclosureFinancialInstrumentsAdditionalDisclosuresDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails5" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails5" xlink:href="nvs-20191231.xsd#disclosureEquityDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityTables" xlink:href="nvs-20191231.xsd#disclosureEquityTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquity" xlink:href="nvs-20191231.xsd#disclosureEquity" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails4" xlink:href="nvs-20191231.xsd#disclosureEquityDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails3" xlink:href="nvs-20191231.xsd#disclosureEquityDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails2" xlink:href="nvs-20191231.xsd#disclosureEquityDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails" xlink:href="nvs-20191231.xsd#disclosureEquityDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails3" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilitiesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilities" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherNonCurrentLiabilities" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails6" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails5" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails4" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails3" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails2" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompaniesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompanies" xlink:href="nvs-20191231.xsd#disclosureAssociatedCompanies" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFigures" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFigures" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails" xlink:href="nvs-20191231.xsd#disclosureSegmentationOfKeyFiguresDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails4" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails3" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails2" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails4" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails3" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails2" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails3" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails3" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociatesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesTables" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedPartiesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedParties" xlink:href="nvs-20191231.xsd#disclosureTransactionsWithRelatedParties" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociates" xlink:href="nvs-20191231.xsd#disclosureEquityBasedParticipationPlansForAssociates" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncome" xlink:href="nvs-20191231.xsd#disclosureChangesInConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsTables" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatementsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatements" xlink:href="nvs-20191231.xsd#disclosureDetailsConsolidatedCashFlowStatements" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails9" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails9" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails10" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails10" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails8" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails8" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails7" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails7" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails6" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails5" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails4" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails3" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" xlink:href="nvs-20191231.xsd#disclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables" xlink:href="nvs-20191231.xsd#disclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompanies" xlink:href="nvs-20191231.xsd#disclosurePrincipalGroupSubsidiariesAndAssociatedCompanies" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails5" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails4" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails3" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails2" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesTables" xlink:href="nvs-20191231.xsd#disclosureTradeReceivablesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivables" xlink:href="nvs-20191231.xsd#disclosureTradeReceivables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails3" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails2" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails" xlink:href="nvs-20191231.xsd#disclosureAcquisitionsOfBusinessesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociatesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesTables" xlink:href="nvs-20191231.xsd#disclosureAcquisitionsOfBusinessesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociates" xlink:href="nvs-20191231.xsd#disclosurePostEmploymentBenefitsForAssociates" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinesses" xlink:href="nvs-20191231.xsd#disclosureAcquisitionsOfBusinesses" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilities" xlink:href="nvs-20191231.xsd#disclosureProvisionsAndOtherCurrentLiabilities" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfChangesInEquity" xlink:href="nvs-20191231.xsd#statementOfChangesInEquity" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementsOfCashFlow" xlink:href="nvs-20191231.xsd#statementsOfCashFlow" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfComprehensiveIncome" xlink:href="nvs-20191231.xsd#statementOfComprehensiveIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails5" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails5" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails2" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails6" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails6" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails4" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails3" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:href="nvs-20191231.xsd#disclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingenciesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingenciesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesTables" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables" xlink:href="nvs-20191231.xsd#disclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebtTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstruments" xlink:href="nvs-20191231.xsd#disclosureCurrentFinancialDebtAndDerivativeFinancialInstruments" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebt" xlink:href="nvs-20191231.xsd#disclosureNonCurrentFinancialDebt" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactions" xlink:href="nvs-20191231.xsd#disclosureSignificantTransactions" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingencies" xlink:href="nvs-20191231.xsd#disclosureCommitmentsAndContingencies" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSubsequentEventsDetails" xlink:href="nvs-20191231.xsd#disclosureSubsequentEventsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSubsequentEvents" xlink:href="nvs-20191231.xsd#disclosureSubsequentEvents" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/StatementOfIncome" xlink:href="nvs-20191231.xsd#statementOfIncome" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssetsDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails3" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails2" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables" xlink:href="nvs-20191231.xsd#disclosureMarketableSecuritiesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecurities" xlink:href="nvs-20191231.xsd#disclosureMarketableSecurities" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsDetails" xlink:href="nvs-20191231.xsd#disclosureOtherCurrentAssetsDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsTables" xlink:href="nvs-20191231.xsd#disclosureOtherCurrentAssetsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssets" xlink:href="nvs-20191231.xsd#disclosureOtherCurrentAssets" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsTables" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssetsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssets" xlink:href="nvs-20191231.xsd#disclosureFinancialAndOtherNoncurrentAssets" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails3" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails2" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails4" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails4" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails3" xlink:href="nvs-20191231.xsd#disclosureTaxesDetails3" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails2" xlink:href="nvs-20191231.xsd#disclosureTaxesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails" xlink:href="nvs-20191231.xsd#disclosureTaxesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" xlink:href="nvs-20191231.xsd#disclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" xlink:href="nvs-20191231.xsd#disclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails2" xlink:href="nvs-20191231.xsd#disclosureSignificantAccountingPoliciesDetails2" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails" xlink:href="nvs-20191231.xsd#disclosureSignificantAccountingPoliciesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="nvs-20191231.xsd#disclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="nvs-20191231.xsd#disclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="nvs-20191231.xsd#disclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilitiesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilities" xlink:href="nvs-20191231.xsd#disclosureDeferredTaxAssetsAndLiabilities" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseTables" xlink:href="nvs-20191231.xsd#disclosureInterestExpenseAndOtherFinancialIncomeExpenseTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpense" xlink:href="nvs-20191231.xsd#disclosureInterestExpenseAndOtherFinancialIncomeExpense" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxesTables" xlink:href="nvs-20191231.xsd#disclosureTaxesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureTaxes" xlink:href="nvs-20191231.xsd#disclosureTaxes" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssetsTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssets" xlink:href="nvs-20191231.xsd#disclosureGoodwillAndIntangibleAssets" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails" xlink:href="nvs-20191231.xsd#disclosureEarningsPerShareDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShareTables" xlink:href="nvs-20191231.xsd#disclosureEarningsPerShareTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShare" xlink:href="nvs-20191231.xsd#disclosureEarningsPerShare" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInventoriesDetails" xlink:href="nvs-20191231.xsd#disclosureInventoriesDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInventories" xlink:href="nvs-20191231.xsd#disclosureInventories" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosureInventoriesTables" xlink:href="nvs-20191231.xsd#disclosureInventoriesTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentTables" xlink:href="nvs-20191231.xsd#disclosurePropertyPlantAndEquipmentTables" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipment" xlink:href="nvs-20191231.xsd#disclosurePropertyPlantAndEquipment" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:href="nvs-20191231.xsd#disclosurePropertyPlantAndEquipmentDetails" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/BalanceSheet" xlink:href="nvs-20191231.xsd#balanceSheet" xlink:type="simple"/>
   <link:roleRef roleURI="http://novartis.com/20191231/role/DocumentAndEntityInformation" xlink:href="nvs-20191231.xsd#documentAndEntityInformation" xlink:type="simple"/>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DocumentAndEntityInformation" xlink:type="extended">
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationTable" xlink:label="lbl_DocumentInformationTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DocumentAndEntityInformationAbstract" xlink:label="lbl_DocumentAndEntityInformationAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentAndEntityInformationAbstract" xlink:to="lbl_DocumentInformationTable" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentInformationLineItems" xlink:label="lbl_DocumentInformationLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationTable" xlink:to="lbl_DocumentInformationLineItems" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="lbl_DocumentType" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentType" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="lbl_AmendmentFlag" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_AmendmentFlag" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="lbl_DocumentFiscalPeriodFocus" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentFiscalPeriodFocus" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="lbl_EntityCentralIndexKey" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityCentralIndexKey" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="lbl_EntityCurrentReportingStatus" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityCurrentReportingStatus" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityPublicFloat" xlink:label="lbl_EntityPublicFloat" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityPublicFloat" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="lbl_DocumentPeriodEndDate" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentPeriodEndDate" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="lbl_DocumentFiscalYearFocus" xlink:type="locator"/>
      <link:presentationArc order="2.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentFiscalYearFocus" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="lbl_TradingSymbol" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_TradingSymbol" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="lbl_EntityRegistrantName" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityRegistrantName" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="lbl_CurrentFiscalYearEndDate" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_CurrentFiscalYearEndDate" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="lbl_EntityWellKnownSeasonedIssuer" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityWellKnownSeasonedIssuer" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="lbl_EntityVoluntaryFilers" xlink:type="locator"/>
      <link:presentationArc order="9.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityVoluntaryFilers" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="lbl_EntityFilerCategory" xlink:type="locator"/>
      <link:presentationArc order="9.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityFilerCategory" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="lbl_EntityCommonStockSharesOutstanding" xlink:type="locator"/>
      <link:presentationArc order="9.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityCommonStockSharesOutstanding" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentAnnualReport" xlink:label="lbl_DocumentAnnualReport" xlink:type="locator"/>
      <link:presentationArc order="2.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentAnnualReport" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany" xlink:label="lbl_EntityShellCompany" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityShellCompany" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="lbl_EntityEmergingGrowthCompany" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityEmergingGrowthCompany" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="lbl_EntityInteractiveDataCurrent" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_EntityInteractiveDataCurrent" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport" xlink:label="lbl_DocumentTransitionReport" xlink:type="locator"/>
      <link:presentationArc order="2.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentTransitionReport" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="lbl_DocumentShellCompanyReport" xlink:type="locator"/>
      <link:presentationArc order="2.4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DocumentInformationLineItems" xlink:to="lbl_DocumentShellCompanyReport" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/BalanceSheet" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="lbl_AssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="lbl_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="lbl_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_NoncurrentAssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="lbl_CurrentAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_CurrentAssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_Assets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="lbl_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="lbl_EquityAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReserves" xlink:label="lbl_OtherReserves" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_OtherReserves" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="lbl_LiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_LiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="lbl_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="lbl_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_CurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentTaxLiabilitiesCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="lbl_EquityAndLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAndLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="lbl_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_EquityAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="lbl_NoncontrollingInterests" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_NoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="lbl_NoncurrentFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfFinancialPositionAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AssetsAbstract" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EquityAndLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="5.3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_OtherCurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="8.8" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="lbl_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="3.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_OtherCurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxReceivable" xlink:label="lbl_CurrentIncomeTaxReceivable" xlink:type="locator"/>
      <link:presentationArc order="2.6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentIncomeTaxReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="2.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:label="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:presentationArc order="5.9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="4.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="5.92" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentAssetsAbstract" xlink:to="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="4.6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="lbl_LandMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_LandMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_BuildingsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="lbl_MachineryMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_MachineryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="lbl_ConstructionInProgressMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_ConstructionInProgressMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:label="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:label="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:label="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:label="lbl_MovementsOfPropertyPlantAndEquipmentRollForward1" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward1" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:label="lbl_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:label="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingCostsCapitalised" xlink:label="lbl_BorrowingCostsCapitalised" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_BorrowingCostsCapitalised" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="9.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:label="lbl_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="13.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:label="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_DepreciationChargePriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="lbl_DepreciationPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DepreciationPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:label="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DisposalsAndRetirementsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:label="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lbl_ImpairmentChargePriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.15" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfPropertyPlantAndEquipmentRollForward" xlink:to="lbl_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipment" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lbl_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:label="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PropertyPlantAndEquipmentTableTextBlock" xlink:label="lbl_PropertyPlantAndEquipmentTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lbl_PropertyPlantAndEquipmentTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInventoriesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesDisclosureAbstract" xlink:label="lbl_InventoriesDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="lbl_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoriesDisclosureAbstract" xlink:to="lbl_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" xlink:label="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoriesDisclosureAbstract" xlink:to="lbl_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" xlink:label="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoriesDisclosureAbstract" xlink:to="lbl_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInventories" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesDisclosureAbstract" xlink:label="lbl_InventoriesDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory" xlink:label="lbl_DisclosureOfInventoriesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoriesDisclosureAbstract" xlink:to="lbl_DisclosureOfInventoriesExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInventoriesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryCurrentTable" xlink:label="lbl_InventoryCurrentTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesDisclosureAbstract" xlink:label="lbl_InventoriesDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoriesDisclosureAbstract" xlink:to="lbl_InventoryCurrentTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryAxis" xlink:label="lbl_InventoryAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryCurrentTable" xlink:to="lbl_InventoryAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryMember" xlink:label="lbl_InventoryMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryRawMaterialsGrossMember" xlink:label="lbl_InventoryRawMaterialsGrossMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryMember" xlink:to="lbl_InventoryRawMaterialsGrossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryWorkInProgressGrossMember" xlink:label="lbl_InventoryWorkInProgressGrossMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryMember" xlink:to="lbl_InventoryWorkInProgressGrossMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryMember" xlink:to="lbl_InventoryFinishedGoodsGrossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryFinishedGoodsGrossMember" xlink:label="lbl_InventoryFinishedGoodsGrossMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoryLineItems" xlink:label="lbl_InventoryLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryCurrentTable" xlink:to="lbl_InventoryLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfInventoryWritedown" xlink:label="lbl_ReversalOfInventoryWritedown" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_ReversalOfInventoryWritedown" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryAxis" xlink:to="lbl_InventoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:label="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_CostOfInventoriesRecognisedAsExpenseDuringPeriod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryWritedown2011" xlink:label="lbl_InventoryWritedown2011" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InventoryLineItems" xlink:to="lbl_InventoryWritedown2011" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEarningsPerShare" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="lbl_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareExplanatory" xlink:label="lbl_EarningsPerShareExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareAbstract" xlink:to="lbl_EarningsPerShareExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEarningsPerShareTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="lbl_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareAbstract" xlink:to="lbl_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareTable" xlink:label="lbl_EarningsPerShareTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="lbl_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareAbstract" xlink:to="lbl_EarningsPerShareTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="lbl_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareTable" xlink:to="lbl_EarningsPerShareLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="lbl_WeightedAverageShares" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_WeightedAverageShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="lbl_AdjustedWeightedAverageShares" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_AdjustedWeightedAverageShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="lbl_BasicEarningsLossPerShare" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_BasicEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="lbl_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutedEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OptionsExcludedFromTheCalculation" xlink:label="lbl_OptionsExcludedFromTheCalculation" xlink:type="locator"/>
      <link:presentationArc order="10.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EarningsPerShareLineItems" xlink:to="lbl_OptionsExcludedFromTheCalculation" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssets" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" xlink:label="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:label="lbl_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssumptionsUsedInTheCalculationOfValuationTextBlock" xlink:label="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_AssumptionsUsedInTheCalculationOfValuationTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IntangibleAssetImpairmentChargesTextBlock" xlink:label="lbl_IntangibleAssetImpairmentChargesTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_IntangibleAssetImpairmentChargesTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxes" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfIncomeTaxAbstract" xlink:label="lbl_DisclosureOfIncomeTaxAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="lbl_DisclosureOfIncomeTaxExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIncomeTaxAbstract" xlink:to="lbl_DisclosureOfIncomeTaxExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfIncomeTaxAbstract" xlink:label="lbl_DisclosureOfIncomeTaxAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeBeforeTaxesTableTextBlock" xlink:label="lbl_IncomeBeforeTaxesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIncomeTaxAbstract" xlink:to="lbl_IncomeBeforeTaxesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" xlink:label="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIncomeTaxAbstract" xlink:to="lbl_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfTaxRateTableTextBlock" xlink:label="lbl_AnalysisOfTaxRateTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIncomeTaxAbstract" xlink:to="lbl_AnalysisOfTaxRateTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpense" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:label="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInterestExpenseExplanatory" xlink:label="lbl_DisclosureOfInterestExpenseExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_DisclosureOfInterestExpenseExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:label="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseTableTextBlock" xlink:label="lbl_InterestExpenseTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_InterestExpenseTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialIncomeAndExpenseTableTextBlock" xlink:label="lbl_OtherFinancialIncomeAndExpenseTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_OtherFinancialIncomeAndExpenseTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilities" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:label="lbl_DisclosureOfDeferredTaxesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_DisclosureOfDeferredTaxesExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:label="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" xlink:label="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" xlink:label="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" xlink:label="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" xlink:label="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SignificantAccountingPoliciesAbstract" xlink:label="lbl_SignificantAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SignificantAccountingPoliciesAbstract" xlink:label="lbl_SignificantAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForSubsidiariesExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="lbl_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForTreasurySharesExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:label="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="locator"/>
      <link:presentationArc order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="locator"/>
      <link:presentationArc order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:label="lbl_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:type="locator"/>
      <link:presentationArc order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForGovernmentGrants" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="locator"/>
      <link:presentationArc order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquityTextBlock" xlink:label="lbl_TransactionCostsRecordedInEquityTextBlock" xlink:type="locator"/>
      <link:presentationArc order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_TransactionCostsRecordedInEquityTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="locator"/>
      <link:presentationArc order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="30.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForAvailableforsaleFinancialAssetsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="31.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" xlink:type="locator"/>
      <link:presentationArc order="32.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" xlink:label="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" xlink:type="locator"/>
      <link:presentationArc order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionByWayOfDivindendInKindToShareholders" xlink:label="lbl_DistributionByWayOfDivindendInKindToShareholders" xlink:type="locator"/>
      <link:presentationArc order="3.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DistributionByWayOfDivindendInKindToShareholders" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:label="lbl_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:type="locator"/>
      <link:presentationArc order="28.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_DescriptionOfNatureOfChangeInAccountingPolicy" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SignificantAccountingPoliciesAbstract" xlink:label="lbl_SignificantAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:label="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" xlink:label="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="lbl_PropertyPlantAndEquipmentAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_BuildingsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MachineryMember" xlink:label="lbl_MachineryMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_MachineryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FurnitureAndVehiclesMember" xlink:label="lbl_FurnitureAndVehiclesMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_FurnitureAndVehiclesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComputerEquipmentMember" xlink:label="lbl_ComputerEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PropertyPlantAndEquipmentMember" xlink:to="lbl_ComputerEquipmentMember" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BrandNamesMember" xlink:label="lbl_BrandNamesMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_BrandNamesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationAxis" xlink:label="lbl_IncomeStatementLocationAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_IncomeStatementLocationAxis" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncomeStatementLocationAxis" xlink:to="lbl_IncomeStatementLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationMember" xlink:label="lbl_IncomeStatementLocationMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CostOfSalesMember" xlink:label="lbl_CostOfSalesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_CostOfSalesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CostOfSalesOrResearchAndDevelopmentMember" xlink:label="lbl_CostOfSalesOrResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_CostOfSalesOrResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SignificantAccountingPoliciesAbstract" xlink:label="lbl_SignificantAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseAbstract" xlink:label="lbl_InterestExpenseAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InterestExpenseAbstract" xlink:to="lbl_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InterestExpenseAbstract" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InterestExpenseAbstract" xlink:to="lbl_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InterestExpenseAbstract" xlink:to="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialIncomeAndExpenseAbstract" xlink:label="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeOnForwardContractsAndOptions" xlink:label="lbl_IncomeOnForwardContractsAndOptions" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_IncomeOnForwardContractsAndOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:label="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnNetMonetaryPosition" xlink:label="lbl_GainsLossesOnNetMonetaryPosition" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_GainsLossesOnNetMonetaryPosition" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesOnAvailableforsaleFinancialAssets" xlink:label="lbl_GainsLossesOnAvailableforsaleFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_GainsLossesOnAvailableforsaleFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_RevenueFromInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromDividends" xlink:label="lbl_RevenueFromDividends" xlink:type="locator"/>
      <link:presentationArc order="2.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_RevenueFromDividends" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:label="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:type="locator"/>
      <link:presentationArc order="6.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceCost" xlink:label="lbl_OtherFinanceCost" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherFinancialIncomeAndExpenseAbstract" xlink:to="lbl_OtherFinanceCost" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="lbl_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccountingProfit" xlink:label="lbl_AccountingProfit" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AccountingProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:label="lbl_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="lbl_CurrentTaxExpenseIncome" xlink:type="locator"/>
      <link:presentationArc order="1.55" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentTaxExpenseIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeTaxExpense" xlink:label="lbl_IncomeTaxExpense" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="lbl_DeferredTaxExpenseIncome" xlink:type="locator"/>
      <link:presentationArc order="1.65" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxExpenseIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxExpenseIncomeDiscontinuingOperations" xlink:label="lbl_TaxExpenseIncomeDiscontinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="1.8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxExpenseIncomeDiscontinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTaxesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:label="lbl_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="lbl_ApplicableTaxRate" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ApplicableTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfCreditsAndAllowances" xlink:label="lbl_TaxRateEffectOfCreditsAndAllowances" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfCreditsAndAllowances" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:label="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromBenefitsExpiring" xlink:label="lbl_TaxRateEffectFromBenefitsExpiring" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromBenefitsExpiring" xlink:type="arc"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:label="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageEffectiveTaxRateContinuingOperations" xlink:label="lbl_AverageEffectiveTaxRateContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AverageEffectiveTaxRateContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="lbl_AverageEffectiveTaxRate" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AverageEffectiveTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageEffectiveTaxRateDiscontinuedOperations" xlink:label="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AverageEffectiveTaxRateDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss1" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfTaxLosses" xlink:label="lbl_TaxRateEffectOfTaxLosses1" xlink:type="locator"/>
      <link:presentationArc order="3.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfTaxLosses1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="lbl_TaxRateEffectFromChangeInTaxRate" xlink:type="locator"/>
      <link:presentationArc order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectFromChangeInTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="locator"/>
      <link:presentationArc order="16.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="locator"/>
      <link:presentationArc order="17.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:label="lbl_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="locator"/>
      <link:presentationArc order="18.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:label="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:type="locator"/>
      <link:presentationArc order="4.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfIncomeTaxedAtReducedRates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:label="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:type="locator"/>
      <link:presentationArc order="5.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfReleaseOfContingentConsiderationLiability" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxRateEffectFromNondeductibleLossesInRegion" xlink:label="lbl_TaxRateEffectFromNondeductibleLossesInRegion" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:label="lbl_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="19.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:label="lbl_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:type="locator"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfWriteoffOfDeferredTaxAssets" xlink:label="lbl_EffectOfWriteoffOfDeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc order="8.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfWriteoffOfDeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:label="lbl_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:type="locator"/>
      <link:presentationArc order="4.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TaxRateEffectOfRevenuesExemptFromTaxation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:label="lbl_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:type="locator"/>
      <link:presentationArc order="19.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfUSTaxReformLegislation" xlink:label="lbl_EffectOfUSTaxReformLegislation" xlink:type="locator"/>
      <link:presentationArc order="19.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfUSTaxReformLegislation" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:label="lbl_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_PensionsAndOtherBenefitObligationsOfAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InventoriesMember" xlink:label="lbl_InventoriesMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_InventoriesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxLossCarryforwardsMember" xlink:label="lbl_TaxLossCarryforwardsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_TaxLossCarryforwardsMember" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_OtherAssetsProvisionsAccrualsMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="lbl_DeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInDeferredTaxBalanceRollForward" xlink:label="lbl_MovementInDeferredTaxBalanceRollForward" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_MovementInDeferredTaxBalanceRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:label="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:label="lbl_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherAssetsProvisionsAccrualsMember" xlink:label="lbl_OtherAssetsProvisionsAccrualsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInDeferredTaxBalanceRollForward" xlink:label="lbl_MovementInDeferredTaxBalanceRollForward1" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward1" xlink:to="lbl_DeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_DeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="1.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:label="lbl_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="1.1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems1" xlink:type="locator"/>
      <link:presentationArc order="2.6" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:presentationArc order="2.8" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossDeferredTaxAssets" xlink:label="lbl_GrossDeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc order="2.55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossDeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossDeferredTaxLiabilities" xlink:label="lbl_GrossDeferredTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.75" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossDeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementInDeferredTaxBalanceRollForward" xlink:to="lbl_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:label="lbl_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:label="lbl_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:label="lbl_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:label="lbl_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProvisionForIncomeTaxesOnUnremittedEarnings" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" xlink:label="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InvestmentsInSubsidiariesMember" xlink:label="lbl_InvestmentsInSubsidiariesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_InvestmentsInSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GoodwillFromAcquisitionsMember" xlink:label="lbl_GoodwillFromAcquisitionsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_GoodwillFromAcquisitionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:label="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:label="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAbstract" xlink:to="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentAxis" xlink:label="lbl_BalanceSheetTreatmentAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lbl_BalanceSheetTreatmentAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetTreatmentMember" xlink:label="lbl_BalanceSheetTreatmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetTreatmentAxis" xlink:to="lbl_BalanceSheetTreatmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CapitalizedMember" xlink:label="lbl_CapitalizedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetTreatmentMember" xlink:to="lbl_CapitalizedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NotCapitalizedMember" xlink:label="lbl_NotCapitalizedMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetTreatmentMember" xlink:to="lbl_NotCapitalizedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryAxis" xlink:label="lbl_YearOfExpiryAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lbl_YearOfExpiryAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_YearOfExpiryMember" xlink:label="lbl_YearOfExpiryMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryAxis" xlink:to="lbl_YearOfExpiryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OneYearMember" xlink:label="lbl_OneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_OneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TwoYearsMember" xlink:label="lbl_TwoYearsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_TwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThreeYearsMember" xlink:label="lbl_ThreeYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_ThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FourYearsMember" xlink:label="lbl_FourYearsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_FourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FiveYearsMember" xlink:label="lbl_FiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_FiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MoreThanFiveYearsMember" xlink:label="lbl_MoreThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_YearOfExpiryMember" xlink:to="lbl_MoreThanFiveYearsMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfTaxLossCarryforwardsExpired" xlink:label="lbl_ValueOfTaxLossCarryforwardsExpired" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ValueOfTaxLossCarryforwardsExpired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:label="lbl_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssets" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:to="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAssetsTableTextBlock" xlink:label="lbl_DisclosureOfFinancialAssetsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:to="lbl_DisclosureOfFinancialAssetsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOtherNoncurrentAssetsTableTextBlock" xlink:label="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:to="lbl_DisclosureOfOtherNoncurrentAssetsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:label="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" xlink:to="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureOtherCurrentAssets" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCurrentAssetsAbstract" xlink:label="lbl_OtherCurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory" xlink:label="lbl_DisclosureOfOtherCurrentAssetsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_DisclosureOfOtherCurrentAssetsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCurrentAssetsAbstract" xlink:label="lbl_OtherCurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCurrentAssetsTableTextBlock" xlink:label="lbl_OtherCurrentAssetsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_OtherCurrentAssetsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCurrentAssetsAbstract" xlink:label="lbl_OtherCurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables" xlink:label="lbl_CurrentValueAddedTaxReceivables" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_CurrentValueAddedTaxReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WithholdingTaxRecoverable" xlink:label="lbl_WithholdingTaxRecoverable" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_WithholdingTaxRecoverable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPrepaidExpensesThirdParty" xlink:label="lbl_CurrentPrepaidExpensesThirdParty" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_CurrentPrepaidExpensesThirdParty" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPrepaidExpensesAssociatedCompanies" xlink:label="lbl_CurrentPrepaidExpensesAssociatedCompanies" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_CurrentPrepaidExpensesAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReceivablesAssociatedCompanies" xlink:label="lbl_ReceivablesAssociatedCompanies" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_ReceivablesAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivableCurrent" xlink:label="lbl_ContingentConsiderationReceivableCurrent" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_ContingentConsiderationReceivableCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherReceivablesAndCurrentAssets" xlink:label="lbl_OtherReceivablesAndCurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_OtherReceivablesAndCurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherCurrentAssetsAbstract" xlink:to="lbl_OtherCurrentNonfinancialAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecurities" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" xlink:label="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtSecuritiesBreakdownByCurrencyTableTextBlock" xlink:label="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_DebtSecuritiesBreakdownByCurrencyTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsTableTextBlock" xlink:label="lbl_CashAndCashEquivalentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_CashAndCashEquivalentsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:label="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtInstrumentsHeld" xlink:label="lbl_DebtInstrumentsHeld" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_DebtInstrumentsHeld" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInstrumentsHeld" xlink:label="lbl_EquityInstrumentsHeld" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_EquityInstrumentsHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInstrumentsHeld" xlink:label="lbl_FundInstrumentsHeld" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_FundInstrumentsHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecurities" xlink:label="lbl_MarketableSecurities" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_MarketableSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Commodities" xlink:label="lbl_Commodities" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_Commodities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:label="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_ShorttermDepositsNotClassifiedAsCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="lbl_DerivativeFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_DerivativeFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivable" xlink:label="lbl_InterestReceivable" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_InterestReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="lbl_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" xlink:to="lbl_OtherCurrentFinancialAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="lbl_CashAndCashEquivalentsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Cash" xlink:label="lbl_Cash" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CashAndCashEquivalentsAbstract" xlink:to="lbl_Cash" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashEquivalents" xlink:label="lbl_CashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CashAndCashEquivalentsAbstract" xlink:to="lbl_CashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CashAndCashEquivalentsAbstract" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtSecuritiesDenominationsAbstract" xlink:label="lbl_DebtSecuritiesDenominationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DebtSecuritiesDenominationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtInstrumentsHeld" xlink:label="lbl_DebtInstrumentsHeld" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DebtInstrumentsHeld" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis1" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_CurrencyAxis1" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrencyAxis1" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsEquityInvestments" xlink:label="lbl_NoncurrentFinancialAssetsEquityInvestments" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAssetsEquityInvestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAsstetsDebtSecurities" xlink:label="lbl_NoncurrentFinancialAsstetsDebtSecurities" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAsstetsDebtSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsFundInvestments" xlink:label="lbl_NoncurrentFinancialAssetsFundInvestments" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAssetsFundInvestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:label="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAssetsTotalFinancialInvestments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="lbl_NoncurrentTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinanceLeaseReceivables" xlink:label="lbl_NoncurrentFinanceLeaseReceivables" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentFinanceLeaseReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivable" xlink:label="lbl_ContingentConsiderationReceivable" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_ContingentConsiderationReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLoansAndReceivables" xlink:label="lbl_NoncurrentLoansAndReceivables" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentLoansAndReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="lbl_NoncurrentFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_NoncurrentFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentReceivables" xlink:label="lbl_OtherNoncurrentReceivables" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_OtherNoncurrentReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongTermReceivablesFromFinanceSubleases" xlink:label="lbl_LongTermReceivablesFromFinanceSubleases" xlink:type="locator"/>
      <link:presentationArc order="7.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_LongTermReceivablesFromFinanceSubleases" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:label="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredCompensationPlansAssets" xlink:label="lbl_DeferredCompensationPlansAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:to="lbl_DeferredCompensationPlansAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaidPostemploymentBenefitPlansAssets" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:to="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:label="lbl_OtherNoncurrentNonfinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:to="lbl_OtherNoncurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherNoncurrentAssetsAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/StatementOfIncome" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="lbl_IncomeStatementAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncomeStatementAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="lbl_ProfitLossAttributableToAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="lbl_ProfitLossAttributableToNoncontrollingInterests" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProfitLossAttributableToAbstract" xlink:to="lbl_ProfitLossAttributableToNoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="lbl_BasicEarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="lbl_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="18.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_BasicEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_DilutedEarningsLossPerShareFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:type="arc"/>
      <link:presentationArc order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossAttributableToAbstract" xlink:type="arc"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_BasicEarningsPerShareAbstract" xlink:type="arc"/>
      <link:presentationArc order="21.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DilutedEarningsPerShareAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:presentationArc order="9.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProfitLossAttributableToAbstract" xlink:to="lbl_ProfitLossAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:presentationArc order="13.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:presentationArc order="3.2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:presentationArc order="1.65" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="lbl_BasicEarningsLossPerShare" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BasicEarningsPerShareAbstract" xlink:to="lbl_BasicEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="lbl_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DilutedEarningsPerShareAbstract" xlink:to="lbl_DilutedEarningsLossPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:presentationArc order="16.5" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:presentationArc order="16.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSubsequentEvents" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="lbl_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lbl_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSubsequentEventsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="lbl_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypAxis" xlink:label="lbl_SubsequentEventTypAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_SubsequentEventTypAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventTypeMember" xlink:label="lbl_SubsequentEventTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SubsequentEventTypAxis" xlink:to="lbl_SubsequentEventTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SubsequentEventMember" xlink:label="lbl_SubsequentEventMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SubsequentEventTypeMember" xlink:to="lbl_SubsequentEventMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:label="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountBorrowedUnderTheCreditFacility" xlink:label="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingencies" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsAndContingenciesAbstract" xlink:label="lbl_CommitmentsAndContingenciesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCommitmentsAndContingenciesTextBlock" xlink:label="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CommitmentsAndContingenciesAbstract" xlink:to="lbl_DisclosureOfCommitmentsAndContingenciesTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactions" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfSignificantTransactionsAbstract" xlink:label="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfSignificantTransactionsTextBlock" xlink:label="lbl_DisclosureOfSignificantTransactionsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfSignificantTransactionsTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebt" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:label="lbl_DisclosureOfFinancialLiabilitiesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfFinancialLiabilitiesExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstruments" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" xlink:label="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" xlink:label="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" xlink:label="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" xlink:label="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsAndContingenciesAbstract" xlink:label="lbl_CommitmentsAndContingenciesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfLeasingCommitmentsTableTextBlock" xlink:label="lbl_DisclosureOfLeasingCommitmentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CommitmentsAndContingenciesAbstract" xlink:to="lbl_DisclosureOfLeasingCommitmentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" xlink:label="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CommitmentsAndContingenciesAbstract" xlink:to="lbl_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:label="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeasingCommitmentsAbstract" xlink:label="lbl_LeasingCommitmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LeasingCommitmentsAbstract" xlink:to="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:label="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" xlink:to="lbl_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:presentationArc order="1.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="1.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:label="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ResearchAndDevelopmentCommitmentsAbstract" xlink:label="lbl_ResearchAndDevelopmentCommitmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ResearchAndDevelopmentCommitmentsAbstract" xlink:to="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:label="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" xlink:to="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentsUnderLongtermResearchAgreements" xlink:label="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_CommitmentsUnderLongtermResearchAgreements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangiblePurchaseCommitments" xlink:label="lbl_OtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_OtherIntangiblePurchaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:label="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:label="lbl_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" xlink:to="lbl_UncalledCapitalCommitmentsForInvestmentsInFunds" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:label="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_InterestBearningAccountsOfAssociatesPayableOnDemand" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermBorrowings" xlink:label="lbl_ShorttermBorrowings" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_ShorttermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="lbl_CommercialPapersIssued" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_CommercialPapersIssued" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="lbl_DerivativeFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_DerivativeFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateAssociates" xlink:label="lbl_WeightedAverageInterestRateAssociates" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_WeightedAverageInterestRateAssociates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:label="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" xlink:to="lbl_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:label="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherInstitutions" xlink:label="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_LiabilitiesToBanksAndOtherInstitutions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:label="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_CurrentPortionOfLongtermBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageInterestRateOnLoansReceived" xlink:label="lbl_AverageInterestRateOnLoansReceived" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_AverageInterestRateOnLoansReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:label="lbl_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_RatioFixedRateFinancialDebtToTotalFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AverageInterestRateOnBorrowings" xlink:label="lbl_AverageInterestRateOnBorrowings" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_AverageInterestRateOnBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseLiabilities" xlink:label="lbl_FinanceLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" xlink:to="lbl_FinanceLeaseLiabilities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:label="lbl_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsAndNotLaterThanSixYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanSixYearsMember" xlink:label="lbl_LaterThanSixYearsMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanSixYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract1" xlink:to="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:to="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CurrencyOthersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesAbstract1" xlink:to="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:to="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems1" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CHF" xlink:label="lbl_CHF" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CHF" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis1" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesTable1" xlink:to="lbl_CurrencyAxis1" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrencyAxis1" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails6" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:label="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialDebtsCoveredByCollateral" xlink:label="lbl_NoncurrentFinancialDebtsCoveredByCollateral" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:to="lbl_NoncurrentFinancialDebtsCoveredByCollateral" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:label="lbl_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" xlink:to="lbl_PropertyPlantAndEquipmentPledgedAsSecurity" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:to="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lbl_BorrowingsByNameAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:label="lbl_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:label="lbl_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:label="lbl_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:label="lbl_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:label="lbl_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:label="lbl_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:label="lbl_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:label="lbl_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:label="lbl_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:label="lbl_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:label="lbl_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:label="lbl_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:label="lbl_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:label="lbl_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:label="lbl_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:type="locator"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:label="lbl_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:type="locator"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="lbl_NotionalAmount" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_NotionalAmount" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsOriginalCurrency" xlink:label="lbl_BorrowingsOriginalCurrency" xlink:type="locator"/>
      <link:presentationArc order="3.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsOriginalCurrency" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:label="lbl_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:type="locator"/>
      <link:presentationArc order="16.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:label="lbl_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:type="locator"/>
      <link:presentationArc order="17.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:label="lbl_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:type="locator"/>
      <link:presentationArc order="18.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:label="lbl_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:type="locator"/>
      <link:presentationArc order="19.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:label="lbl_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:type="locator"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsInterestRate" xlink:label="lbl_BorrowingsInterestRate" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsInterestRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsIssuanceDate" xlink:label="lbl_BorrowingsIssuanceDate" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsIssuanceDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsMaturity" xlink:label="lbl_BorrowingsMaturity" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsMaturity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsLender" xlink:label="lbl_BorrowingsLender" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsLender" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsPremiumDiscount" xlink:label="lbl_BorrowingsPremiumDiscount" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lbl_BorrowingsPremiumDiscount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:label="lbl_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:type="locator"/>
      <link:presentationArc order="21.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:label="lbl_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:type="locator"/>
      <link:presentationArc order="22.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:label="lbl_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:type="locator"/>
      <link:presentationArc order="23.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:to="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BondsIssued" xlink:label="lbl_BondsIssued" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_BondsIssued" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherNoncurrentFinancialDebt" xlink:label="lbl_OtherNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_OtherNoncurrentFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisAxis" xlink:label="lbl_FairValueByMeasurementBasisAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_FairValueByMeasurementBasisAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueByMeasurementBasisMember" xlink:label="lbl_FairValueByMeasurementBasisMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FairValueByMeasurementBasisAxis" xlink:to="lbl_FairValueByMeasurementBasisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueDisclosureItemAmountsMember" xlink:label="lbl_FairValueDisclosureItemAmountsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FairValueByMeasurementBasisMember" xlink:to="lbl_FairValueDisclosureItemAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CarryingReportedAmountFairValueDisclosureMember" xlink:label="lbl_CarryingReportedAmountFairValueDisclosureMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FairValueByMeasurementBasisMember" xlink:to="lbl_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/StatementOfComprehensiveIncome" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="lbl_StatementOfComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfComprehensiveIncomeAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:label="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="locator"/>
      <link:presentationArc order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc"/>
      <link:presentationArc order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="25.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToAbstract" xlink:label="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:type="locator"/>
      <link:presentationArc order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="lbl_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:to="lbl_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAttributableToAbstract" xlink:to="lbl_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="1.6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="locator"/>
      <link:presentationArc order="2.3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxCashFlowHedges" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:presentationArc order="4.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="locator"/>
      <link:presentationArc order="1.9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract1" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxDebtSecurities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/StatementsOfCashFlow" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="lbl_StatementOfCashFlowsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfCashFlowsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="lbl_InterestReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="lbl_InterestPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestPaidClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="17.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="19.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="21.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:presentationArc order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="26.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:label="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="locator"/>
      <link:presentationArc order="32.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsToAcquireOrRedeemEntitysShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:label="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="locator"/>
      <link:presentationArc order="33.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="38.5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="39.5" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="40.5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems1" xlink:type="locator"/>
      <link:presentationArc order="41.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:presentationArc order="41.5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:label="lbl_CashFlowsBeforeWorkingCapitalAndProvisionChanges" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceivedClassifiedAsOperatingActivities" xlink:label="lbl_DividendsReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:label="lbl_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:label="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="7.2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceCostsPaidClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:presentationArc order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceIncomeReceivedClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="31.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="locator"/>
      <link:presentationArc order="35.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="locator"/>
      <link:presentationArc order="36.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="38.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:label="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:label="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="locator"/>
      <link:presentationArc order="37.6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsFromChangesInOwnershipInterestsInSubsidiaries" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:label="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:presentationArc order="24.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="29.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="locator"/>
      <link:presentationArc order="34.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="38.45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="38.35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="locator"/>
      <link:presentationArc order="39.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="39.3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="37.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/StatementOfChangesInEquity" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="lbl_StatementOfChangesInEquityTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_StatementOfChangesInEquityTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="lbl_NoncontrollingInterestsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_NoncontrollingInterestsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="lbl_StatementOfChangesInEquityLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityTable" xlink:to="lbl_StatementOfChangesInEquityLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="lbl_OtherComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="lbl_DividendsPaid" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_DividendsPaid" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ChangesInEquity" xlink:label="lbl_ChangesInEquity" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ChangesInEquity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="lbl_StatementOfChangesInEquityLineItems1" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems1" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:presentationArc order="10.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="lbl_IssuedCapitalMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_IssuedCapitalMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="lbl_TreasurySharesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TreasurySharesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="lbl_RetainedEarningsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_RetainedEarningsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseInNoncontrolingInterests" xlink:label="lbl_IncreaseDecreaseInNoncontrolingInterests" xlink:type="locator"/>
      <link:presentationArc order="10.1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseInNoncontrolingInterests" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="lbl_PurchaseOfTreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="6.2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_PurchaseOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="lbl_StatementOfChangesInEquityLineItems2" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems2" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:label="lbl_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:type="locator"/>
      <link:presentationArc order="9.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="locator"/>
      <link:presentationArc order="8.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="locator"/>
      <link:presentationArc order="10.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherShareSales" xlink:label="lbl_OtherShareSales" xlink:type="locator"/>
      <link:presentationArc order="7.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherShareSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeMaketableSecurities" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="locator"/>
      <link:presentationArc order="9.75" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_RestatedValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquity" xlink:label="lbl_TransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:presentationArc order="9.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_TransactionCostsRecordedInEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReductionOfIssuedCapital" xlink:label="lbl_ReductionOfIssuedCapital" xlink:type="locator"/>
      <link:presentationArc order="6.3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_ReductionOfIssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="locator"/>
      <link:presentationArc order="6.9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="locator"/>
      <link:presentationArc order="8.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:label="lbl_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_TaxReformImpactOnDeferredTaxOnTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendPaidNoncashAssetsDistribution" xlink:label="lbl_DividendPaidNoncashAssetsDistribution" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_DividendPaidNoncashAssetsDistribution" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:label="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:type="locator"/>
      <link:presentationArc order="9.9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesOnTreasuryShares" xlink:label="lbl_TaxesOnTreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="8.8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_TaxesOnTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:presentationArc order="9.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityLineItems" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilities" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinesses" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:label="lbl_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="lbl_DisclosureOfBusinessCombinationsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:to="lbl_DisclosureOfBusinessCombinationsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociates" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:label="lbl_DisclosureOfEmployeeBenefitsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_DisclosureOfEmployeeBenefitsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForReductionOfRevenueTableTextBlock" xlink:label="lbl_ProvisionsForReductionOfRevenueTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ProvisionsForReductionOfRevenueTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsTableTextBlock" xlink:label="lbl_RestructuringProvisionsMovementsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_RestructuringProvisionsMovementsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:label="lbl_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfAcquisitionOfBusinessesAbstract" xlink:to="lbl_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAssumptionsUsedTableTextBlock" xlink:label="lbl_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:label="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfHealthCareCostTrendRatesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:label="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedAbstract" xlink:to="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" xlink:to="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_InventoryRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IdentifiableAssetsAcquired" xlink:label="lbl_IdentifiableAssetsAcquired" xlink:type="locator"/>
      <link:presentationArc order="10.2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_IdentifiableAssetsAcquired" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="locator"/>
      <link:presentationArc order="13.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:label="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="8.7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems1" xlink:to="lbl_DeferredTaxAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherAssets" xlink:label="lbl_FinancialAndOtherAssets" xlink:type="locator"/>
      <link:presentationArc order="4.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_FinancialAndOtherAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="8.3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesAndOtherLiabilities" xlink:label="lbl_TradePayablesAndOtherLiabilities" xlink:type="locator"/>
      <link:presentationArc order="9.8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_TradePayablesAndOtherLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:label="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="lbl_GoodwillRecognisedAsOfAcquisitionDate1" xlink:type="locator"/>
      <link:presentationArc order="12.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_GoodwillRecognisedAsOfAcquisitionDate1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillExpectedDeductibleForTaxPurposes" xlink:label="lbl_GoodwillExpectedDeductibleForTaxPurposes" xlink:type="locator"/>
      <link:presentationArc order="13.6" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_GoodwillExpectedDeductibleForTaxPurposes" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredCashAndCashEquivalents" xlink:label="lbl_AcquiredCashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="10.8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" xlink:to="lbl_AcquiredCashAndCashEquivalents" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForDeductionsFromRevenueRollForward" xlink:label="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDeductionFromRevenueTable" xlink:label="lbl_ProvisionForDeductionFromRevenueTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementAdjustmentsOfPriorYear" xlink:label="lbl_IncomeStatementAdjustmentsOfPriorYear" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_IncomeStatementAdjustmentsOfPriorYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementAdjustmentsOfCurrentYear" xlink:label="lbl_IncomeStatementAdjustmentsOfCurrentYear" xlink:type="locator"/>
      <link:presentationArc order="4.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_IncomeStatementAdjustmentsOfCurrentYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesAxis" xlink:label="lbl_PlansAndProgramRebatesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionForDeductionFromRevenueTable" xlink:to="lbl_PlansAndProgramRebatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_ProvisionUsedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="1.55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesMember" xlink:label="lbl_PlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PlansAndProgramRebatesAxis" xlink:to="lbl_PlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USspecificHealthcarePlansAndProgramRebatesMember" xlink:label="lbl_USspecificHealthcarePlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_USspecificHealthcarePlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:label="lbl_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_NonUSspecificHealthcarePlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:label="lbl_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PlansAndProgramRebatesMember" xlink:to="lbl_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ProvisionForDeductionFromRevenueTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:label="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionForDeductionFromRevenueTable" xlink:to="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionForDeductionFromRevenueTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInOffsetAgainstGrossTradeReceivables" xlink:label="lbl_ChangesInOffsetAgainstGrossTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_ChangesInOffsetAgainstGrossTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentRefundsProvision" xlink:label="lbl_CurrentRefundsProvision" xlink:type="locator"/>
      <link:presentationArc order="1.3" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward" xlink:to="lbl_CurrentRefundsProvision" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForDeductionsFromRevenueRollForward" xlink:label="lbl_ProvisionsForDeductionsFromRevenueRollForward1" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsForDeductionsFromRevenueRollForward1" xlink:to="lbl_CurrentRefundsProvision" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:label="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermRestructuringProvision" xlink:label="lbl_ShorttermRestructuringProvision" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ShorttermRestructuringProvision" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccrualsClassifiedAsCurrent" xlink:label="lbl_AccrualsClassifiedAsCurrent" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_AccrualsClassifiedAsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:label="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_AccruedRoyaltiesPayableClassifiedAsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentInterestPayable" xlink:label="lbl_CurrentInterestPayable" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_CurrentInterestPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:label="lbl_ShorttermEmployeeBenefitsAccruals" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ShorttermEmployeeBenefitsAccruals" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionCurrent" xlink:label="lbl_EnvironmentalProvisionCurrent" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_EnvironmentalProvisionCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredIncomeClassifiedAsCurrent" xlink:label="lbl_DeferredIncomeClassifiedAsCurrent" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_DeferredIncomeClassifiedAsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationCurrentPortion" xlink:label="lbl_ContingentConsiderationCurrentPortion" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_ContingentConsiderationCurrentPortion" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommitmentForRepurchaseOwnShares" xlink:label="lbl_CommitmentForRepurchaseOwnShares" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_CommitmentForRepurchaseOwnShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentPayables" xlink:label="lbl_OtherCurrentPayables" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentPayables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentRefundsProvision" xlink:label="lbl_CurrentRefundsProvision" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_CurrentRefundsProvision" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RefundsProvision" xlink:label="lbl_RefundsProvision" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_RefundsProvision" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="lbl_ClassesOfProvisionsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisionsMember" xlink:label="lbl_OtherProvisionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfProvisionsAxis" xlink:to="lbl_OtherProvisionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestructuringProvisionMember" xlink:label="lbl_RestructuringProvisionMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_RestructuringProvisionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsRollForward" xlink:label="lbl_RestructuringProvisionsMovementsRollForward" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisions" xlink:label="lbl_OtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_OtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="lbl_AdditionalProvisionsOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_AdditionalProvisionsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_ProvisionUsedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsRollForward" xlink:label="lbl_RestructuringProvisionsMovementsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward1" xlink:to="lbl_OtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestructuringProvisionsMovementsTable" xlink:label="lbl_RestructuringProvisionsMovementsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" xlink:to="lbl_RestructuringProvisionsMovementsTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsTable" xlink:to="lbl_ClassesOfProvisionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PlansAndProgramRebatesMember" xlink:label="lbl_PlansAndProgramRebatesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_PlansAndProgramRebatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:label="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsTable" xlink:to="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProvisionsAndOtherCurrentLiabilitiesLineItems" xlink:to="lbl_RestructuringProvisionsMovementsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="6.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsRollForward" xlink:to="lbl_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestructuringProvisionsMovementsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTradeReceivablesAbstract" xlink:label="lbl_DisclosureOfTradeReceivablesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTradeReceivablesExplanatoryTextBlock" xlink:label="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_DisclosureOfTradeReceivablesExplanatoryTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTradeReceivablesAbstract" xlink:label="lbl_DisclosureOfTradeReceivablesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsForTradeReceivablesTableTextBlock" xlink:label="lbl_ProvisionsForTradeReceivablesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_ProvisionsForTradeReceivablesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesProvisionMovementsTableTextBlock" xlink:label="lbl_TradeReceivablesProvisionMovementsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_TradeReceivablesProvisionMovementsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OverdueAmountsAndRelatedProvisionsTableTextBlock" xlink:label="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_OverdueAmountsAndRelatedProvisionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" xlink:label="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" xlink:label="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTradeReceivablesAbstract" xlink:to="lbl_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="lbl_DisclosureOfProvisionMatrixTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixAbstract" xlink:label="lbl_DisclosureOfProvisionMatrixAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixAbstract" xlink:to="lbl_DisclosureOfProvisionMatrixTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixTable" xlink:label="lbl_DisclosureOfProvisionMatrixTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixAbstract" xlink:label="lbl_DisclosureOfProvisionMatrixAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixAbstract" xlink:to="lbl_DisclosureOfProvisionMatrixTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:label="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="lbl_ProvisionUsedOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_ProvisionUsedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems1" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems1" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_UnusedProvisionReversedOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="lbl_AdditionalProvisionsOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_AdditionalProvisionsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfDivestmentsOtherProvisions" xlink:label="lbl_ImpactOfDivestmentsOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_ImpactOfDivestmentsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="locator"/>
      <link:presentationArc order="2.8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfOverdueAmountsTable" xlink:label="lbl_AnalysisOfOverdueAmountsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixAbstract" xlink:label="lbl_DisclosureOfProvisionMatrixAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixAbstract" xlink:to="lbl_AnalysisOfOverdueAmountsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusAxis" xlink:label="lbl_PastDueStatusAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastDueStatusMember" xlink:label="lbl_PastDueStatusMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PastDueStatusAxis" xlink:to="lbl_PastDueStatusMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentMember" xlink:label="lbl_CurrentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PastDueStatusMember" xlink:to="lbl_CurrentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AnalysisOfOverdueAmountsLineItems" xlink:label="lbl_AnalysisOfOverdueAmountsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_AnalysisOfOverdueAmountsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AnalysisOfOverdueAmountsLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:presentationArc order="1.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_PastDueStatusAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember1" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="lbl_LaterThanOneYearMember1" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanOneYearMember1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:label="lbl_LaterThanSixMonthsAndNotLaterThanOneYearMember1" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanSixMonthsAndNotLaterThanOneYearMember1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="lbl_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember1" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentMember" xlink:to="lbl_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentMember" xlink:to="lbl_NotLaterThanOneMonthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="1.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AnalysisOfOverdueAmountsTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionForDoubtfulReceivableMember" xlink:label="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_ProvisionForDoubtfulReceivableMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixAbstract" xlink:label="lbl_DisclosureOfProvisionMatrixAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:label="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:label="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsAxis" xlink:to="lbl_ClassesOfFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeReceivablesMember" xlink:label="lbl_TradeReceivablesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialInstrumentsMember" xlink:to="lbl_TradeReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CurrencyOthersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="lbl_CurrentTradeReceivables" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivables" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:label="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixAbstract" xlink:to="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_ClassesOfFinancialInstrumentsAxis" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CNY" xlink:label="lbl_CNY" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CNY" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_GBP" xlink:label="lbl_GBP" xlink:type="locator"/>
      <link:presentationArc order="3.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_GBP" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CHF" xlink:label="lbl_CHF" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CHF" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_RUB" xlink:label="lbl_RUB" xlink:type="locator"/>
      <link:presentationArc order="3.6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_RUB" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_BRL" xlink:label="lbl_BRL" xlink:type="locator"/>
      <link:presentationArc order="3.65" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_BRL" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AUD" xlink:label="lbl_AUD" xlink:type="locator"/>
      <link:presentationArc order="3.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_AUD" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_CAD" xlink:label="lbl_CAD" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CAD" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis1" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_CurrencyAxis1" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrencyAxis1" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:label="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixAbstract" xlink:label="lbl_DisclosureOfProvisionMatrixAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixAbstract" xlink:to="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfProvisionMatrixLineItems" xlink:label="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" xlink:to="lbl_DisclosureOfProvisionMatrixLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountries" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:label="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfProvisionMatrixLineItems" xlink:to="lbl_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompanies" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:to="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" xlink:label="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:to="lbl_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract" xlink:to="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="lbl_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lbl_EntitysTotalForSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="lbl_SubsidiariesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSubsidiariesMember" xlink:to="lbl_SubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NameOfSubsidiary" xlink:label="lbl_NameOfSubsidiary" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_NameOfSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="lbl_PrincipalPlaceOfBusinessOfSubsidiary" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_PrincipalPlaceOfBusinessOfSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:label="lbl_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:label="lbl_ProportionOfVotingPowerHeldInSubsidiary" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_ProportionOfVotingPowerHeldInSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharePaidinCapital" xlink:label="lbl_SharePaidinCapital" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_SharePaidinCapital" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lbl_LegalEntityAxis" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:label="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lbl_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SocieteParActionsSANDOZAlgiersMember" xlink:label="lbl_SocieteParActionsSANDOZAlgiersMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SocieteParActionsSANDOZAlgiersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisArgentinaS.A.BuenosAiresMember" xlink:label="lbl_NovartisArgentinaS.A.BuenosAiresMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisArgentinaS.A.BuenosAiresMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosS.A.BuenosAiresMember" xlink:label="lbl_AlconLaboratoriosS.A.BuenosAiresMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriosS.A.BuenosAiresMember" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAustriaGmbHViennaMember" xlink:label="lbl_NovartisAustriaGmbHViennaMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisAustriaGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaGmbHViennaMember" xlink:label="lbl_NovartisPharmaGmbHViennaMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozGmbHViennaMember" xlink:label="lbl_SandozGmbHViennaMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconOphthalmikaGmbHViennaMember" xlink:label="lbl_AlconOphthalmikaGmbHViennaMember" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconOphthalmikaGmbHViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:label="lbl_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBangladeshLimitedGazipurMember" xlink:label="lbl_NovartisBangladeshLimitedGazipurMember" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBangladeshLimitedGazipurMember" xlink:type="arc"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaNVVilvoordeMember" xlink:type="arc"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozNVVilvoordeMember" xlink:type="arc"/>
      <link:presentationArc order="16.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCouvreurNVPuursMember" xlink:type="arc"/>
      <link:presentationArc order="17.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconNVVilvoordeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInvestmentLtd.HamiltonMember" xlink:label="lbl_NovartisInvestmentLtd.HamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="18.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInvestmentLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:label="lbl_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="19.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSecuritiesInvestmentLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceServicesLtd.HamiltonMember" xlink:label="lbl_NovartisFinanceServicesLtd.HamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceServicesLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisB2Ltd.HamiltonMember" xlink:label="lbl_NovartisB2Ltd.HamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="21.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisB2Ltd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisB3Ltd.HamiltonMember" xlink:label="lbl_NovartisB3Ltd.HamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="22.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisB3Ltd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:label="lbl_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="23.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TriangleInternationalReinsuranceLimitedHamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:label="lbl_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:type="locator"/>
      <link:presentationArc order="24.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TrinityRiverInsuranceCoLtd.HamiltonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBiocienciasS.A.SaoPauloMember" xlink:label="lbl_NovartisBiocienciasS.A.SaoPauloMember" xlink:type="locator"/>
      <link:presentationArc order="25.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBiocienciasS.A.SaoPauloMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:label="lbl_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:type="locator"/>
      <link:presentationArc order="26.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:label="lbl_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:type="locator"/>
      <link:presentationArc order="27.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozCanadaInc.BouchervilleQuebecMember" xlink:label="lbl_SandozCanadaInc.BouchervilleQuebecMember" xlink:type="locator"/>
      <link:presentationArc order="28.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozCanadaInc.BouchervilleQuebecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCanadaInc.MississaugaOntarioMember" xlink:label="lbl_AlconCanadaInc.MississaugaOntarioMember" xlink:type="locator"/>
      <link:presentationArc order="29.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCanadaInc.MississaugaOntarioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:label="lbl_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:type="locator"/>
      <link:presentationArc order="30.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionCanadaInc.MississaugaOntarioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisChileS.A.SantiagoDeChileMember" xlink:label="lbl_NovartisChileS.A.SantiagoDeChileMember" xlink:type="locator"/>
      <link:presentationArc order="31.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisChileS.A.SantiagoDeChileMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:label="lbl_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:type="locator"/>
      <link:presentationArc order="32.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriosChileLtd.SantiagoDeChileMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:label="lbl_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:type="locator"/>
      <link:presentationArc order="33.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_BeijingNovartisPharmaCo.Ltd.BeijingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:label="lbl_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:type="locator"/>
      <link:presentationArc order="34.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsHKLimitedHongKongMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:label="lbl_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:type="locator"/>
      <link:presentationArc order="35.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:label="lbl_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:type="locator"/>
      <link:presentationArc order="36.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:label="lbl_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:type="locator"/>
      <link:presentationArc order="37.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ShanghaiNovartisTradingLtd.ShanghaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:label="lbl_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:type="locator"/>
      <link:presentationArc order="38.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconHongKongLimitedHongKongMember" xlink:label="lbl_AlconHongKongLimitedHongKongMember" xlink:type="locator"/>
      <link:presentationArc order="39.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconHongKongLimitedHongKongMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:label="lbl_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:type="locator"/>
      <link:presentationArc order="40.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:label="lbl_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:type="locator"/>
      <link:presentationArc order="41.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisDeColombiaS.A.SantafeDeBobotaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:label="lbl_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:type="locator"/>
      <link:presentationArc order="42.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:label="lbl_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:type="locator"/>
      <link:presentationArc order="43.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisS.r.o.PragueMember" xlink:label="lbl_NovartisS.r.o.PragueMember" xlink:type="locator"/>
      <link:presentationArc order="44.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisS.r.o.PragueMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.r.o.PragueMember" xlink:label="lbl_SandozS.r.o.PragueMember" xlink:type="locator"/>
      <link:presentationArc order="45.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.r.o.PragueMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:label="lbl_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:type="locator"/>
      <link:presentationArc order="46.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcareASCopenhagenMember" xlink:label="lbl_NovartisHealthcareASCopenhagenMember" xlink:type="locator"/>
      <link:presentationArc order="47.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHealthcareASCopenhagenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozASCopenhagenMember" xlink:label="lbl_SandozASCopenhagenMember" xlink:type="locator"/>
      <link:presentationArc order="48.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozASCopenhagenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNordicASCopenhagenMember" xlink:label="lbl_AlconNordicASCopenhagenMember" xlink:type="locator"/>
      <link:presentationArc order="49.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconNordicASCopenhagenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisEcuadorS.A.QuitoMember" xlink:label="lbl_NovartisEcuadorS.A.QuitoMember" xlink:type="locator"/>
      <link:presentationArc order="50.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisEcuadorS.A.QuitoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaS.A.E.CairoMember" xlink:label="lbl_NovartisPharmaS.A.E.CairoMember" xlink:type="locator"/>
      <link:presentationArc order="51.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaS.A.E.CairoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:label="lbl_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:type="locator"/>
      <link:presentationArc order="52.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozEgyptPharmaS.A.E.NewCairoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinlandOyEspooMember" xlink:label="lbl_NovartisFinlandOyEspooMember" xlink:type="locator"/>
      <link:presentationArc order="53.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinlandOyEspooMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:label="lbl_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:type="locator"/>
      <link:presentationArc order="54.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisGroupeFranceS.A.RueilMalmaisonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:label="lbl_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:type="locator"/>
      <link:presentationArc order="55.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaS.A.S.RueilMalmaisonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.A.S.LevalloisPerretMember" xlink:label="lbl_SandozS.A.S.LevalloisPerretMember" xlink:type="locator"/>
      <link:presentationArc order="56.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.A.S.LevalloisPerretMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:label="lbl_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:type="locator"/>
      <link:presentationArc order="57.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_LaboratoiresAlconS.A.S.RueilMalmaisonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeutschlandGmbHWehrMember" xlink:label="lbl_NovartisDeutschlandGmbHWehrMember" xlink:type="locator"/>
      <link:presentationArc order="58.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisDeutschlandGmbHWehrMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaGmbHNurembergMember" xlink:label="lbl_NovartisPharmaGmbHNurembergMember" xlink:type="locator"/>
      <link:presentationArc order="59.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaGmbHNurembergMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaProduktionsGmbHWehrMember" xlink:label="lbl_NovartisPharmaProduktionsGmbHWehrMember" xlink:type="locator"/>
      <link:presentationArc order="60.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaProduktionsGmbHWehrMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:label="lbl_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:type="locator"/>
      <link:presentationArc order="61.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaGmbHFreiburgImBreisgauMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WaveLightGmbHErlangenMember" xlink:label="lbl_WaveLightGmbHErlangenMember" xlink:type="locator"/>
      <link:presentationArc order="62.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_WaveLightGmbHErlangenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionGmbHGrosswallstadtMember" xlink:label="lbl_CIBAVisionGmbHGrosswallstadtMember" xlink:type="locator"/>
      <link:presentationArc order="63.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionGmbHGrosswallstadtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozInternationalGmbHHolzkirchenMember" xlink:label="lbl_SandozInternationalGmbHHolzkirchenMember" xlink:type="locator"/>
      <link:presentationArc order="64.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozInternationalGmbHHolzkirchenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_A1APharmaGmbHOberhachingMember" xlink:label="lbl_A1APharmaGmbHOberhachingMember" xlink:type="locator"/>
      <link:presentationArc order="65.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_A1APharmaGmbHOberhachingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SalutasPharmaGmbHBarlebenMember" xlink:label="lbl_SalutasPharmaGmbHBarlebenMember" xlink:type="locator"/>
      <link:presentationArc order="66.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SalutasPharmaGmbHBarlebenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_HEXALAGHolzkirchenMember" xlink:label="lbl_HEXALAGHolzkirchenMember" xlink:type="locator"/>
      <link:presentationArc order="67.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_HEXALAGHolzkirchenMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AeropharmGmbHRudolstadtMember" xlink:label="lbl_AeropharmGmbHRudolstadtMember" xlink:type="locator"/>
      <link:presentationArc order="68.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AeropharmGmbHRudolstadtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBusinessServicesGmbHWehrMember" xlink:label="lbl_NovartisBusinessServicesGmbHWehrMember" xlink:type="locator"/>
      <link:presentationArc order="69.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBusinessServicesGmbHWehrMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovistaInsuranceLimitedGibraltarCityMember" xlink:label="lbl_NovistaInsuranceLimitedGibraltarCityMember" xlink:type="locator"/>
      <link:presentationArc order="70.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovistaInsuranceLimitedGibraltarCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:label="lbl_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:type="locator"/>
      <link:presentationArc order="71.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHellasS.A.C.I.MetamorphosisAthensMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:label="lbl_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:type="locator"/>
      <link:presentationArc order="72.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:label="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:type="locator"/>
      <link:presentationArc order="73.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:label="lbl_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:type="locator"/>
      <link:presentationArc order="74.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozHungaryLimitedLiabilityCompanyBudapestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIndiaLimitedMumbaiMember" xlink:label="lbl_NovartisIndiaLimitedMumbaiMember" xlink:type="locator"/>
      <link:presentationArc order="75.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisIndiaLimitedMumbaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:label="lbl_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:type="locator"/>
      <link:presentationArc order="76.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHealthcarePrivateLimitedMumbaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPrivateLimitedMumbaiMember" xlink:label="lbl_SandozPrivateLimitedMumbaiMember" xlink:type="locator"/>
      <link:presentationArc order="77.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPrivateLimitedMumbaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:label="lbl_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:type="locator"/>
      <link:presentationArc order="78.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PT.NovartisIndonesiaJakartaMember" xlink:label="lbl_PT.NovartisIndonesiaJakartaMember" xlink:type="locator"/>
      <link:presentationArc order="79.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_PT.NovartisIndonesiaJakartaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PT.CIBAVisionBatamBatamMember" xlink:label="lbl_PT.CIBAVisionBatamBatamMember" xlink:type="locator"/>
      <link:presentationArc order="80.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_PT.CIBAVisionBatamBatamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIrelandLimitedDublinMember" xlink:label="lbl_NovartisIrelandLimitedDublinMember" xlink:type="locator"/>
      <link:presentationArc order="81.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisIrelandLimitedDublinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:label="lbl_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:type="locator"/>
      <link:presentationArc order="82.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:label="lbl_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:type="locator"/>
      <link:presentationArc order="83.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesIrelandLimitedCorkCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisIsraelLtd.PetachTikvaMember" xlink:label="lbl_NovartisIsraelLtd.PetachTikvaMember" xlink:type="locator"/>
      <link:presentationArc order="84.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisIsraelLtd.PetachTikvaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OptonolLtd.NeveIlanMember" xlink:label="lbl_OptonolLtd.NeveIlanMember" xlink:type="locator"/>
      <link:presentationArc order="85.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_OptonolLtd.NeveIlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaS.p.A.OriggioMember" xlink:label="lbl_NovartisFarmaS.p.A.OriggioMember" xlink:type="locator"/>
      <link:presentationArc order="86.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaS.p.A.OriggioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.p.A.OriggioMember" xlink:label="lbl_SandozS.p.A.OriggioMember" xlink:type="locator"/>
      <link:presentationArc order="87.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.p.A.OriggioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:label="lbl_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:type="locator"/>
      <link:presentationArc order="88.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozIndustrialProductsS.p.A.RoveretoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconItaliaS.p.A.MilanMember" xlink:label="lbl_AlconItaliaS.p.A.MilanMember" xlink:type="locator"/>
      <link:presentationArc order="89.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconItaliaS.p.A.MilanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHoldingJapanK.K.TokyoMember" xlink:label="lbl_NovartisHoldingJapanK.K.TokyoMember" xlink:type="locator"/>
      <link:presentationArc order="90.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHoldingJapanK.K.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaK.K.TokyoMember" xlink:label="lbl_NovartisPharmaK.K.TokyoMember" xlink:type="locator"/>
      <link:presentationArc order="91.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaK.K.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CibaGeigyJapanLimitedTokyoMember" xlink:label="lbl_CibaGeigyJapanLimitedTokyoMember" xlink:type="locator"/>
      <link:presentationArc order="92.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CibaGeigyJapanLimitedTokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozK.K.TokyoMember" xlink:label="lbl_SandozK.K.TokyoMember" xlink:type="locator"/>
      <link:presentationArc order="93.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozK.K.TokyoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconJapanLtd.TokyoMember" xlink:label="lbl_AlconJapanLtd.TokyoMember" xlink:type="locator"/>
      <link:presentationArc order="94.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconJapanLtd.TokyoMember" xlink:type="arc"/>
      <link:presentationArc order="95.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:type="arc"/>
      <link:presentationArc order="96.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceS.A.LuxembourgCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:label="lbl_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:type="locator"/>
      <link:presentationArc order="97.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:label="lbl_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:type="locator"/>
      <link:presentationArc order="98.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:label="lbl_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:type="locator"/>
      <link:presentationArc order="99.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:label="lbl_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:presentationArc order="100.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.A.DeC.V.MexicoCityMember" xlink:label="lbl_SandozS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:presentationArc order="101.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.A.DeC.V.MexicoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:label="lbl_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:type="locator"/>
      <link:presentationArc order="102.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaMarocSACasablancaMember" xlink:label="lbl_NovartisPharmaMarocSACasablancaMember" xlink:type="locator"/>
      <link:presentationArc order="103.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaMarocSACasablancaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNetherlandsB.V.ArnhemMember" xlink:label="lbl_NovartisNetherlandsB.V.ArnhemMember" xlink:type="locator"/>
      <link:presentationArc order="104.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNetherlandsB.V.ArnhemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaB.V.ArnhemMember" xlink:label="lbl_NovartisPharmaB.V.ArnhemMember" xlink:type="locator"/>
      <link:presentationArc order="105.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaB.V.ArnhemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozB.V.AlmereMember" xlink:label="lbl_SandozB.V.AlmereMember" xlink:type="locator"/>
      <link:presentationArc order="106.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozB.V.AlmereMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNederlandB.V.ArnhemMember" xlink:label="lbl_AlconNederlandB.V.ArnhemMember" xlink:type="locator"/>
      <link:presentationArc order="107.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconNederlandB.V.ArnhemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNewZealandLtdAucklandMember" xlink:label="lbl_NovartisNewZealandLtdAucklandMember" xlink:type="locator"/>
      <link:presentationArc order="108.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNewZealandLtdAucklandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNorgeASOsloMember" xlink:label="lbl_NovartisNorgeASOsloMember" xlink:type="locator"/>
      <link:presentationArc order="109.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNorgeASOsloMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaPakistanLimitedKarachiMember" xlink:label="lbl_NovartisPharmaPakistanLimitedKarachiMember" xlink:type="locator"/>
      <link:presentationArc order="110.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaPakistanLimitedKarachiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:label="lbl_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:type="locator"/>
      <link:presentationArc order="111.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaLogisticsInc.PanamaCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCentroamericaS.A.PanamaCityMember" xlink:label="lbl_AlconCentroamericaS.A.PanamaCityMember" xlink:type="locator"/>
      <link:presentationArc order="112.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCentroamericaS.A.PanamaCityMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:label="lbl_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:type="locator"/>
      <link:presentationArc order="113.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHealthcarePhilippinesInc.ManilaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPhilippinesCorporationManilaMember" xlink:label="lbl_SandozPhilippinesCorporationManilaMember" xlink:type="locator"/>
      <link:presentationArc order="114.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPhilippinesCorporationManilaMember" xlink:type="arc"/>
      <link:presentationArc order="115.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPolandSp.ZO.o.WarsawMember" xlink:type="arc"/>
      <link:presentationArc order="116.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPolskaSp.ZO.o.WarsawMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LekS.A.StrykowMember" xlink:label="lbl_LekS.A.StrykowMember" xlink:type="locator"/>
      <link:presentationArc order="117.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_LekS.A.StrykowMember" xlink:type="arc"/>
      <link:presentationArc order="118.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPolskaSp.ZO.o.WarsawMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:label="lbl_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:type="locator"/>
      <link:presentationArc order="119.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPortugalSGPSLda.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:label="lbl_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:type="locator"/>
      <link:presentationArc order="120.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozFarmaceuticaLda.PortoSalvoMember" xlink:label="lbl_SandozFarmaceuticaLda.PortoSalvoMember" xlink:type="locator"/>
      <link:presentationArc order="121.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozFarmaceuticaLda.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:label="lbl_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:type="locator"/>
      <link:presentationArc order="122.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:label="lbl_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:type="locator"/>
      <link:presentationArc order="123.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozS.R.L.TarguMuresMember" xlink:label="lbl_SandozS.R.L.TarguMuresMember" xlink:type="locator"/>
      <link:presentationArc order="124.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozS.R.L.TarguMuresMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconRomaniaS.R.L.BucharestMember" xlink:label="lbl_AlconRomaniaS.R.L.BucharestMember" xlink:type="locator"/>
      <link:presentationArc order="125.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconRomaniaS.R.L.BucharestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaLLCMoscowMember" xlink:label="lbl_NovartisPharmaLLCMoscowMember" xlink:type="locator"/>
      <link:presentationArc order="126.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaLLCMoscowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNevaLLCSt.PetersburgMember" xlink:label="lbl_NovartisNevaLLCSt.PetersburgMember" xlink:type="locator"/>
      <link:presentationArc order="127.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNevaLLCSt.PetersburgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZAOSandozMoscowMember" xlink:label="lbl_ZAOSandozMoscowMember" xlink:type="locator"/>
      <link:presentationArc order="128.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZAOSandozMoscowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconFarmacevtikaLLCMoscowMember" xlink:label="lbl_AlconFarmacevtikaLLCMoscowMember" xlink:type="locator"/>
      <link:presentationArc order="129.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconFarmacevtikaLLCMoscowMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:label="lbl_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:type="locator"/>
      <link:presentationArc order="130.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSingaporePteLtd.SingaporeMember" xlink:label="lbl_NovartisSingaporePteLtd.SingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="131.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSingaporePteLtd.SingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:label="lbl_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="132.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:label="lbl_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="133.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:label="lbl_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="134.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPteLtdSingaporeMember" xlink:label="lbl_AlconPteLtdSingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="135.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:label="lbl_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="136.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconSingaporeManufacturingPteLtdSingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:label="lbl_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:type="locator"/>
      <link:presentationArc order="137.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSlovakiaS.r.o.BratislavaMember" xlink:label="lbl_NovartisSlovakiaS.r.o.BratislavaMember" xlink:type="locator"/>
      <link:presentationArc order="138.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSlovakiaS.r.o.BratislavaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LekPharmaceuticalsD.d.LjubjanaMember" xlink:label="lbl_LekPharmaceuticalsD.d.LjubjanaMember" xlink:type="locator"/>
      <link:presentationArc order="139.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_LekPharmaceuticalsD.d.LjubjanaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:label="lbl_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:type="locator"/>
      <link:presentationArc order="140.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPharmaceuticalsD.d.LjubjanaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSouthAfricaPtyLtdMidrandMember" xlink:label="lbl_NovartisSouthAfricaPtyLtdMidrandMember" xlink:type="locator"/>
      <link:presentationArc order="141.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSouthAfricaPtyLtdMidrandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:label="lbl_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:type="locator"/>
      <link:presentationArc order="142.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozSouthAfricaPtyLtdKemptonParkMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:label="lbl_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:type="locator"/>
      <link:presentationArc order="143.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisKoreaLtd.SeoulMember" xlink:label="lbl_NovartisKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:presentationArc order="144.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisKoreaLtd.SeoulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozKoreaLtd.SeoulMember" xlink:label="lbl_SandozKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:presentationArc order="145.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozKoreaLtd.SeoulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconKoreaLtd.SeoulMember" xlink:label="lbl_AlconKoreaLtd.SeoulMember" xlink:type="locator"/>
      <link:presentationArc order="146.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconKoreaLtd.SeoulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:label="lbl_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:type="locator"/>
      <link:presentationArc order="147.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFarmaceuticaS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozFarmaceuticaS.A.MadridMember" xlink:label="lbl_SandozFarmaceuticaS.A.MadridMember" xlink:type="locator"/>
      <link:presentationArc order="148.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozFarmaceuticaS.A.MadridMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIndustrialProductsS.A.BarcelonaMember" xlink:label="lbl_SandozIndustrialProductsS.A.BarcelonaMember" xlink:type="locator"/>
      <link:presentationArc order="149.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozIndustrialProductsS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCusiS.A.BarcelonaMember" xlink:label="lbl_AlconCusiS.A.BarcelonaMember" xlink:type="locator"/>
      <link:presentationArc order="150.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconCusiS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:label="lbl_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:type="locator"/>
      <link:presentationArc order="151.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSverigeABStockholmMember" xlink:label="lbl_NovartisSverigeABStockholmMember" xlink:type="locator"/>
      <link:presentationArc order="152.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSverigeABStockholmMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalAGBaselMember" xlink:label="lbl_NovartisInternationalAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="153.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInternationalAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHoldingAGBaselMember" xlink:label="lbl_NovartisHoldingAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="154.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHoldingAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:label="lbl_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="155.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBioventuresAGBaselMember" xlink:label="lbl_NovartisBioventuresAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="156.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBioventuresAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisForschungsstiftungBaselMember" xlink:label="lbl_NovartisForschungsstiftungBaselMember" xlink:type="locator"/>
      <link:presentationArc order="157.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisForschungsstiftungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisStiftungFuerKaderausbildungBaselMember" xlink:label="lbl_NovartisStiftungFuerKaderausbildungBaselMember" xlink:type="locator"/>
      <link:presentationArc order="158.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisStiftungFuerKaderausbildungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:label="lbl_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:type="locator"/>
      <link:presentationArc order="159.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisMitarbeiterbeteiligungsstiftungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:label="lbl_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:type="locator"/>
      <link:presentationArc order="160.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisStiftungFuerMenschUndUmweltBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:label="lbl_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:type="locator"/>
      <link:presentationArc order="161.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaAGBaselMember" xlink:label="lbl_NovartisPharmaAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="162.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInternationalPharmaceuticalAGBaselMember" xlink:label="lbl_NovartisInternationalPharmaceuticalAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="163.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInternationalPharmaceuticalAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaServicesAGBaselMember" xlink:label="lbl_NovartisPharmaServicesAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="164.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaServicesAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:label="lbl_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:type="locator"/>
      <link:presentationArc order="165.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaSchweizerhalleAGMuttenzMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSteinAGSteinMember" xlink:label="lbl_NovartisPharmaSteinAGSteinMember" xlink:type="locator"/>
      <link:presentationArc order="166.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaSteinAGSteinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaSchweizAGRischMember" xlink:label="lbl_NovartisPharmaSchweizAGRischMember" xlink:type="locator"/>
      <link:presentationArc order="167.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaSchweizAGRischMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozAGBaselMember" xlink:label="lbl_SandozAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="168.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPharmaceuticalsAGRischMember" xlink:label="lbl_SandozPharmaceuticalsAGRischMember" xlink:type="locator"/>
      <link:presentationArc order="169.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozPharmaceuticalsAGRischMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconSwitzerlandSARischMember" xlink:label="lbl_AlconSwitzerlandSARischMember" xlink:type="locator"/>
      <link:presentationArc order="170.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconSwitzerlandSARischMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalsLtd.FribourgMember" xlink:label="lbl_AlconPharmaceuticalsLtd.FribourgMember" xlink:type="locator"/>
      <link:presentationArc order="171.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaceuticalsLtd.FribourgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGBaselMember" xlink:label="lbl_RocheHoldingAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="172.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_RocheHoldingAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:label="lbl_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:type="locator"/>
      <link:presentationArc order="173.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisTaiwanCo.Ltd.TaipeiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisThailandLimitedBangkokMember" xlink:label="lbl_NovartisThailandLimitedBangkokMember" xlink:type="locator"/>
      <link:presentationArc order="174.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisThailandLimitedBangkokMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesThailandLimitedBangkokMember" xlink:label="lbl_AlconLaboratoriesThailandLimitedBangkokMember" xlink:type="locator"/>
      <link:presentationArc order="175.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesThailandLimitedBangkokMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:label="lbl_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:presentationArc order="176.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:label="lbl_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:type="locator"/>
      <link:presentationArc order="177.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:label="lbl_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:type="locator"/>
      <link:presentationArc order="178.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:label="lbl_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:presentationArc order="179.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozIlacSanayiVeTicaretA.S.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:label="lbl_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:type="locator"/>
      <link:presentationArc order="180.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:label="lbl_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:type="locator"/>
      <link:presentationArc order="181.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratuvarlariTicaretA.S.IstanbulMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisMiddleEastFZEDubaiMember" xlink:label="lbl_NovartisMiddleEastFZEDubaiMember" xlink:type="locator"/>
      <link:presentationArc order="182.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisMiddleEastFZEDubaiMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUKLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:presentationArc order="183.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUKLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:presentationArc order="184.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:label="lbl_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:presentationArc order="185.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisGrimsbyLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VivactaLimitedFrimleyCamberleySurreyMember" xlink:label="lbl_VivactaLimitedFrimleyCamberleySurreyMember" xlink:type="locator"/>
      <link:presentationArc order="186.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_VivactaLimitedFrimleyCamberleySurreyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:label="lbl_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:type="locator"/>
      <link:presentationArc order="187.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozLimitedFrimleyCamberleyMember" xlink:label="lbl_SandozLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:presentationArc order="188.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:label="lbl_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:type="locator"/>
      <link:presentationArc order="189.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconEyeCareUKLimitedFrimleyCamberleyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:label="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="locator"/>
      <link:presentationArc order="190.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCorporationEastHanoverNYMember" xlink:label="lbl_NovartisCorporationEastHanoverNYMember" xlink:type="locator"/>
      <link:presentationArc order="191.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCorporationEastHanoverNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceCorporationNewYorkNYMember" xlink:label="lbl_NovartisFinanceCorporationNewYorkNYMember" xlink:type="locator"/>
      <link:presentationArc order="192.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceCorporationNewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCapitalCorporationNewYorkNYMember" xlink:label="lbl_NovartisCapitalCorporationNewYorkNYMember" xlink:type="locator"/>
      <link:presentationArc order="193.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCapitalCorporationNewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisServicesInc.EastHanoverNYMember" xlink:label="lbl_NovartisServicesInc.EastHanoverNYMember" xlink:type="locator"/>
      <link:presentationArc order="194.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisServicesInc.EastHanoverNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUSFoundationNewYorkNYMember" xlink:label="lbl_NovartisUSFoundationNewYorkNYMember" xlink:type="locator"/>
      <link:presentationArc order="195.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUSFoundationNewYorkNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:label="lbl_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:type="locator"/>
      <link:presentationArc order="196.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsCorporationEastHanoverNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:label="lbl_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:type="locator"/>
      <link:presentationArc order="197.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CortheraInc.SanMateoCAMember" xlink:label="lbl_CortheraInc.SanMateoCAMember" xlink:type="locator"/>
      <link:presentationArc order="198.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CortheraInc.SanMateoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:label="lbl_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:type="locator"/>
      <link:presentationArc order="199.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CoStimPharmaceuticalsInc.CambridgeMAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionInc.NewYorkNYMember" xlink:label="lbl_EncoreVisionInc.NewYorkNYMember" xlink:type="locator"/>
      <link:presentationArc order="200.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EncoreVisionInc.NewYorkNYMember" xlink:type="arc"/>
      <link:presentationArc order="201.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:type="arc"/>
      <link:presentationArc order="202.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:label="lbl_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:type="locator"/>
      <link:presentationArc order="203.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SpinifexPharmaceuticalsInc.WilmingtonNCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:label="lbl_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:type="locator"/>
      <link:presentationArc order="204.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozInc.PrincetonNJMember" xlink:label="lbl_SandozInc.PrincetonNJMember" xlink:type="locator"/>
      <link:presentationArc order="205.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozInc.PrincetonNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:label="lbl_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:type="locator"/>
      <link:presentationArc order="206.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_FougeraPharmaceuticalsInc.MelvilleNYMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EonLabsInc.PrincetonNJMember" xlink:label="lbl_EonLabsInc.PrincetonNJMember" xlink:type="locator"/>
      <link:presentationArc order="207.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EonLabsInc.PrincetonNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesInc.FortWorthTXMember" xlink:label="lbl_AlconLaboratoriesInc.FortWorthTXMember" xlink:type="locator"/>
      <link:presentationArc order="208.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesInc.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:label="lbl_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:type="locator"/>
      <link:presentationArc order="209.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconRefractivehorizonsLLCFortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconResearchLtd.FortWorthTXMember" xlink:label="lbl_AlconResearchLtd.FortWorthTXMember" xlink:type="locator"/>
      <link:presentationArc order="210.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconResearchLtd.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLensxInc.AlisoViejoCAMember" xlink:label="lbl_AlconLensxInc.AlisoViejoCAMember" xlink:type="locator"/>
      <link:presentationArc order="211.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLensxInc.AlisoViejoCAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:label="lbl_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:type="locator"/>
      <link:presentationArc order="212.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesHoldingCorporationFortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:label="lbl_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:type="locator"/>
      <link:presentationArc order="213.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:label="lbl_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:type="locator"/>
      <link:presentationArc order="214.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ClarVistaMedicalInc.AlisoViejoCAMember" xlink:type="arc"/>
      <link:presentationArc order="215.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TranscendMedicalInc.LakeForestILMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisDeVenezuelaS.A.CaracasMember" xlink:label="lbl_NovartisDeVenezuelaS.A.CaracasMember" xlink:type="locator"/>
      <link:presentationArc order="216.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisDeVenezuelaS.A.CaracasMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPharmaceuticalC.A.CaracasMember" xlink:label="lbl_AlconPharmaceuticalC.A.CaracasMember" xlink:type="locator"/>
      <link:presentationArc order="217.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconPharmaceuticalC.A.CaracasMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:label="lbl_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:type="locator"/>
      <link:presentationArc order="167.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:label="lbl_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:type="locator"/>
      <link:presentationArc order="167.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AveXisInc.BannockburnILMember" xlink:label="lbl_AveXisInc.BannockburnILMember" xlink:type="locator"/>
      <link:presentationArc order="204.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AveXisInc.BannockburnILMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:label="lbl_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:type="locator"/>
      <link:presentationArc order="55.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_NovartisAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPtyLtdMacquarieParkNSWMember" xlink:label="lbl_SandozPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:label="lbl_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaNVVilvoordeMember" xlink:label="lbl_NovartisPharmaNVVilvoordeMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozNVVilvoordeMember" xlink:label="lbl_SandozNVVilvoordeMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconCouvreurNVPuursMember" xlink:label="lbl_AlconCouvreurNVPuursMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:label="lbl_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:type="locator"/>
      <link:presentationArc order="16.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconLaboratoriesBelgiumBVBAPuursMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconNVVilvoordeMember" xlink:label="lbl_AlconNVVilvoordeMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconAGFribourgMember" xlink:label="lbl_AlconAGFribourgMember" xlink:type="locator"/>
      <link:presentationArc order="169.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconAGFribourgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:label="lbl_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:type="locator"/>
      <link:presentationArc order="204.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" xlink:type="arc"/>
      <link:presentationArc order="212.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CIBAVisionCorporationLLCDuluthGAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CIBAVisionCorporationLLCDuluthGAMember" xlink:label="lbl_CIBAVisionCorporationLLCDuluthGAMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:label="lbl_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPolandSp.ZO.o.WarsawMember" xlink:label="lbl_NovartisPolandSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozPolskaSp.ZO.o.WarsawMember" xlink:label="lbl_SandozPolskaSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconPolskaSp.ZO.o.WarsawMember" xlink:label="lbl_AlconPolskaSp.ZO.o.WarsawMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconHealthcareS.A.BarcelonaMember" xlink:label="lbl_AlconHealthcareS.A.BarcelonaMember" xlink:type="locator"/>
      <link:presentationArc order="149.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconHealthcareS.A.BarcelonaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisOphthalmicsAGFribourgMember" xlink:label="lbl_NovartisOphthalmicsAGFribourgMember" xlink:type="locator"/>
      <link:presentationArc order="155.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisOphthalmicsAGFribourgMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozUkraineLLCKievMember" xlink:label="lbl_SandozUkraineLLCKievMember" xlink:type="locator"/>
      <link:presentationArc order="181.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozUkraineLLCKievMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:label="lbl_NavigateBioPharmaServicesInc.CarlsbadCAMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsAAAMember" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="locator"/>
      <link:presentationArc order="218.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:label="lbl_NovartisInvestmentsS.aR.l.LuxembourgCityMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceS.A.LuxembourgCityMember" xlink:label="lbl_NovartisFinanceS.A.LuxembourgCityMember" xlink:type="locator"/>
      <link:presentationArc order="200.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EndocyteInc.LafayetteINMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TearFilmInnovationsInc.FortWorthTXMember" xlink:label="lbl_TearFilmInnovationsInc.FortWorthTXMember" xlink:type="locator"/>
      <link:presentationArc order="212.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TearFilmInnovationsInc.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TrueVisionSystemsInc.FortWorthTXMember" xlink:label="lbl_TrueVisionSystemsInc.FortWorthTXMember" xlink:type="locator"/>
      <link:presentationArc order="212.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TrueVisionSystemsInc.FortWorthTXMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalInc.LakeForestILMember" xlink:label="lbl_TranscendMedicalInc.LakeForestILMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBalticsSIARigaMember" xlink:label="lbl_NovartisBalticsSIARigaMember" xlink:type="locator"/>
      <link:presentationArc order="94.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBalticsSIARigaMember" xlink:type="arc"/>
      <link:presentationArc order="112.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisBiosciencesPeruS.A.LimaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisOverseasInvestmentsAGBaselMember" xlink:label="lbl_NovartisOverseasInvestmentsAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="152.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisOverseasInvestmentsAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JapatAGBaselMember" xlink:label="lbl_JapatAGBaselMember" xlink:type="locator"/>
      <link:presentationArc order="152.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_JapatAGBaselMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconManagementSAGenevaMember" xlink:label="lbl_AlconManagementSAGenevaMember" xlink:type="locator"/>
      <link:presentationArc order="169.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AlconManagementSAGenevaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteInc.LafayetteINMember" xlink:label="lbl_EndocyteInc.LafayetteINMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OrielTherapeuticsInc.DurhamNCMember" xlink:label="lbl_OrielTherapeuticsInc.DurhamNCMember" xlink:type="locator"/>
      <link:presentationArc order="205.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_OrielTherapeuticsInc.DurhamNCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WaveLightInc.SterlingVAMember" xlink:label="lbl_WaveLightInc.SterlingVAMember" xlink:type="locator"/>
      <link:presentationArc order="212.1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_WaveLightInc.SterlingVAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisBiosciencesPeruS.A.LimaMember" xlink:label="lbl_NovartisBiosciencesPeruS.A.LimaMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozManufacturingInc.Member" xlink:label="lbl_SandozManufacturingInc.Member" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SandozManufacturingInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:label="lbl_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:label="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:type="locator"/>
      <link:presentationArc order="1.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CELLforCUREMember" xlink:label="lbl_CELLforCUREMember" xlink:type="locator"/>
      <link:presentationArc order="1.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CELLforCUREMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisManufacturingGmbHMember" xlink:label="lbl_NovartisManufacturingGmbHMember" xlink:type="locator"/>
      <link:presentationArc order="1.85" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisManufacturingGmbHMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:label="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:type="locator"/>
      <link:presentationArc order="1.87" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:label="lbl_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:type="locator"/>
      <link:presentationArc order="1.88" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvacedAcceleratorApplicationsItalyS.r.l.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IDBHollandBVMember" xlink:label="lbl_IDBHollandBVMember" xlink:type="locator"/>
      <link:presentationArc order="1.89" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_IDBHollandBVMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:label="lbl_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:type="locator"/>
      <link:presentationArc order="1.885" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImagingEquipmentLtdMember" xlink:label="lbl_ImagingEquipmentLtdMember" xlink:type="locator"/>
      <link:presentationArc order="1.887" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ImagingEquipmentLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInflammasomeResearchInc.Member" xlink:label="lbl_NovartisInflammasomeResearchInc.Member" xlink:type="locator"/>
      <link:presentationArc order="1.86" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInflammasomeResearchInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTechnologyLLCMember" xlink:label="lbl_NovartisTechnologyLLCMember" xlink:type="locator"/>
      <link:presentationArc order="1.855" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisTechnologyLLCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:label="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:type="locator"/>
      <link:presentationArc order="36.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CELLforCURELesUlisMember" xlink:label="lbl_CELLforCURELesUlisMember" xlink:type="locator"/>
      <link:presentationArc order="55.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CELLforCURELesUlisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:label="lbl_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:type="locator"/>
      <link:presentationArc order="86.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNetherlandsB.V.AmsterdamMember" xlink:label="lbl_NovartisNetherlandsB.V.AmsterdamMember" xlink:type="locator"/>
      <link:presentationArc order="104.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisNetherlandsB.V.AmsterdamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaB.V.AmsterdamMember" xlink:label="lbl_NovartisPharmaB.V.AmsterdamMember" xlink:type="locator"/>
      <link:presentationArc order="105.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaB.V.AmsterdamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IDBHollandBVBaarleNassauMember" xlink:label="lbl_IDBHollandBVBaarleNassauMember" xlink:type="locator"/>
      <link:presentationArc order="105.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_IDBHollandBVBaarleNassauMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisSaudiLtd.RiyadhMember" xlink:label="lbl_NovartisSaudiLtd.RiyadhMember" xlink:type="locator"/>
      <link:presentationArc order="130.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisSaudiLtd.RiyadhMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:label="lbl_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:type="locator"/>
      <link:presentationArc order="147.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUKLimitedLondonMember" xlink:label="lbl_NovartisUKLimitedLondonMember" xlink:type="locator"/>
      <link:presentationArc order="183.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUKLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:label="lbl_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:type="locator"/>
      <link:presentationArc order="184.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisPharmaceuticalsUKLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisGrimsbyLimitedLondonMember" xlink:label="lbl_NovartisGrimsbyLimitedLondonMember" xlink:type="locator"/>
      <link:presentationArc order="185.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisGrimsbyLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImagingEquipmentLtdLondonMember" xlink:label="lbl_ImagingEquipmentLtdLondonMember" xlink:type="locator"/>
      <link:presentationArc order="185.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ImagingEquipmentLtdLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedLondonMember" xlink:label="lbl_ZiarcoGroupLimitedLondonMember" xlink:type="locator"/>
      <link:presentationArc order="187.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZiarcoGroupLimitedLondonMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisFinanceCorporationEastHanoverNJMember" xlink:label="lbl_NovartisFinanceCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="192.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisFinanceCorporationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisCapitalCorporationEastHanoverNJMember" xlink:label="lbl_NovartisCapitalCorporationEastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="193.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisCapitalCorporationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisUSFoundationEastHanoverNJMember" xlink:label="lbl_NovartisUSFoundationEastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="195.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisUSFoundationEastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:label="lbl_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:type="locator"/>
      <link:presentationArc order="196.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:label="lbl_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="204.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisInflammasomeResearchInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:label="lbl_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="204.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisTechnologyLLCInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionInc.EastHanoverNJMember" xlink:label="lbl_EncoreVisionInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="200.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EncoreVisionInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteInc.EastHanoverNJMember" xlink:label="lbl_EndocyteInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="200.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EndocyteInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:label="lbl_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="213.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:label="lbl_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:type="locator"/>
      <link:presentationArc order="203.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SpinifexPharmaceuticalsInc.EastHanoverNJMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisManufacturingGmbHMarburgMember" xlink:label="lbl_NovartisManufacturingGmbHMarburgMember" xlink:type="locator"/>
      <link:presentationArc order="1.852" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_NovartisManufacturingGmbHMarburgMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="lbl_DefinedBenefitPlansAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_DefinedBenefitPlansAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="lbl_DefinedBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlansAxis" xlink:to="lbl_DefinedBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConcentrationOfMajorPlansGeographic" xlink:label="lbl_ConcentrationOfMajorPlansGeographic" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ConcentrationOfMajorPlansGeographic" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements" xlink:label="lbl_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements1" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:label="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MajorPlansPercentageInGroupDBOPensions" xlink:label="lbl_MajorPlansPercentageInGroupDBOPensions" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_MajorPlansPercentageInGroupDBOPensions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:label="lbl_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="3.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:label="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="locator"/>
      <link:presentationArc order="24.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanInterestCost" xlink:label="lbl_DefinedBenefitPlanInterestCost" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_DefinedBenefitPlanInterestCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward1" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward1" xlink:to="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="locator"/>
      <link:presentationArc order="25.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="lbl_PlanAssetsAtFairValue" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_PlanAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward1" xlink:to="lbl_PlanAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:type="locator"/>
      <link:presentationArc order="26.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LimitationOnRecognitionOfFundSurplus" xlink:label="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward1" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward1" xlink:to="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_LimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="27.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_PaymentsFromPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="lbl_SurplusDeficitInPlan" xlink:type="locator"/>
      <link:presentationArc order="25.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_SurplusDeficitInPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestIncomeOnLimitationOfFundSurplus" xlink:label="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_InterestIncomeOnLimitationOfFundSurplus" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanSettlementsPlanAssets" xlink:label="lbl_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="-0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lbl_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:label="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_InterestExpenseIncomeDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" xlink:to="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:label="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:label="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward1" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:label="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:label="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_CurrentServiceCostNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:label="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:label="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="4.9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward1" xlink:to="lbl_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaidPostemploymentBenefitPlansAssets" xlink:label="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:to="lbl_PrepaidPostemploymentBenefitPlansAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:label="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" xlink:to="lbl_DefinedBenefitPensionPlanAccruedBenefitLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:label="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:label="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="5.9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:label="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:label="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanChangeInNetLiabilityRollForward" xlink:to="lbl_ChangeInLimitationOnRecognitionOfFundSurplus" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:label="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ForeignCountriesMember" xlink:label="lbl_ForeignCountriesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_ForeignCountriesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeAxis" xlink:label="lbl_ObligationByTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_ObligationByTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ObligationByTypeMember" xlink:label="lbl_ObligationByTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ObligationByTypeAxis" xlink:to="lbl_ObligationByTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnfundedMember" xlink:label="lbl_UnfundedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_UnfundedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActiveMember" xlink:label="lbl_ActiveMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_ActiveMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredPensionersMember" xlink:label="lbl_DeferredPensionersMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_DeferredPensionersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionersMember" xlink:label="lbl_PensionersMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ObligationByTypeMember" xlink:to="lbl_PensionersMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SurplusDeficitInPlan" xlink:label="lbl_SurplusDeficitInPlan" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_SurplusDeficitInPlan" xlink:type="arc"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_DefinedBenefitObligationAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PlanAssetsAtFairValue" xlink:label="lbl_PlanAssetsAtFairValue" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lbl_PlanAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:presentationArc order="2.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_BreakdownOfDefinedBenefitObligationForPensionPlansTable" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:label="lbl_ActuarialAssumptionOfDiscountRates" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfDiscountRates" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreases" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitAssumptionLifeExpectancyMale" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyMale" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitAssumptionLifeExpectancyMale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:label="lbl_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitAssumptionLifeExpectancyFemale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:label="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="lbl_ActuarialAssumptionsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lbl_ActuarialAssumptionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:label="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionsMember" xlink:label="lbl_ActuarialAssumptionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ActuarialAssumptionsAxis" xlink:to="lbl_ActuarialAssumptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="lbl_ActuarialAssumptionOfDiscountRatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfDiscountRatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LifeExpectancyMember" xlink:label="lbl_LifeExpectancyMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_LifeExpectancyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:label="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ActuarialAssumptionsMember" xlink:to="lbl_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionAxis" xlink:label="lbl_ChangeInActuarialAssumptionAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lbl_ChangeInActuarialAssumptionAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInActuarialAssumptionMember" xlink:label="lbl_ChangeInActuarialAssumptionMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeInActuarialAssumptionAxis" xlink:to="lbl_ChangeInActuarialAssumptionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Decrease25BasisPointMember" xlink:label="lbl_Decrease25BasisPointMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Decrease25BasisPointMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Increase1YearMember" xlink:label="lbl_Increase1YearMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Increase1YearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lbl_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Increase25BasisPointMember" xlink:label="lbl_Increase25BasisPointMember" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Increase25BasisPointMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Change25BasisPointMember" xlink:label="lbl_Change25BasisPointMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeInActuarialAssumptionMember" xlink:to="lbl_Change25BasisPointMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails7" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfHealthCareCostTrendRatesTable" xlink:label="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfHealthCareCostTrendRatesTable" xlink:to="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:label="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:label="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails8" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfAllocationOfPlanAssetsTable" xlink:label="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfAllocationOfPlanAssetsTable" xlink:to="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_DebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityInvestmentsMember" xlink:label="lbl_EquityInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_EquityInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RealEstateMember" xlink:label="lbl_RealEstateMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RealEstateMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlternativeInvestmentsMember" xlink:label="lbl_AlternativeInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_AlternativeInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndOtherInvestmentsMember" xlink:label="lbl_CashAndOtherInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_CashAndOtherInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:label="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:label="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanPlanAssetAllocations" xlink:label="lbl_DefinedBenefitPlanPlanAssetAllocations" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanPlanAssetAllocations" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_EmployerSharesHeldByDefinedBenefitPlan" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:label="lbl_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_WeightedAverageDurationOfDefinedBenefitObligationYears" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EmployerSharesHeldByDefinedBenefitPlan" xlink:label="lbl_EmployerSharesHeldByDefinedBenefitPlan" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:label="lbl_ValueOfEmployerSharesHeldByDefinedBenefitPlan" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails10" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:to="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails9" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpectedBenefitPaymentsTable" xlink:label="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansAbstract" xlink:label="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansAbstract" xlink:to="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeAxis" xlink:label="lbl_RetirementPlanTypeAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:to="lbl_RetirementPlanTypeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetirementPlanTypeMember" xlink:label="lbl_RetirementPlanTypeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeAxis" xlink:to="lbl_RetirementPlanTypeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PensionPlanMember" xlink:label="lbl_PensionPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_PensionPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefitPlansMember" xlink:label="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetirementPlanTypeMember" xlink:to="lbl_OtherPostemploymentBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:label="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:to="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" xlink:to="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" xlink:to="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:label="lbl_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfExpectedBenefitPaymentsTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:label="lbl_DefinedBenefitPlanExpectedFutureBenefitPayment" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:label="lbl_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsAndNotLaterThanTenYearsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatements" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfCashFlowStatementExplanatory" xlink:label="lbl_DisclosureOfCashFlowStatementExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_DisclosureOfCashFlowStatementExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" xlink:label="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" xlink:label="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" xlink:label="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsFromDiscontinuedOperationsTableTextBlock" xlink:label="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_CashFlowsFromDiscontinuedOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:label="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsImpairedMember" xlink:label="lbl_FinancialAssetsImpairedMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_FinancialAssetsImpairedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:label="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="lbl_AdjustmentsForSharebasedPayments" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForSharebasedPayments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:label="lbl_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract" xlink:to="lbl_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:label="lbl_AdjustmentsForFinanceIncomeCost" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForReconcileProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RightofuseAssetsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfComprehensiveIncomeTableTextBlock" xlink:label="lbl_ScheduleOfComprehensiveIncomeTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ScheduleOfComprehensiveIncomeTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" xlink:label="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" xlink:label="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" xlink:label="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociates" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:label="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedParties" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="lbl_DisclosureOfRelatedPartyExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_DisclosureOfRelatedPartyExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesTables" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OfficerAndDirectorCompensationTableTextBlock" xlink:label="lbl_OfficerAndDirectorCompensationTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_OfficerAndDirectorCompensationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" xlink:label="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:label="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfSharebasedCompensationActivityTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:label="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:label="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonExecutiveDirectorMember" xlink:label="lbl_NonExecutiveDirectorMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_NonExecutiveDirectorMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:label="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="lbl_KeyManagementPersonnelCompensation" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensation" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfDrBrodyMember" xlink:label="lbl_ProfDrBrodyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_ProfDrBrodyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfDrZinkernagelMember" xlink:label="lbl_ProfDrZinkernagelMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_ProfDrZinkernagelMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrAlexKrauerMember" xlink:label="lbl_DrAlexKrauerMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_DrAlexKrauerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrDanielVasellaMember" xlink:label="lbl_DrDanielVasellaMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_DrDanielVasellaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DrJamesBradnerMember" xlink:label="lbl_DrJamesBradnerMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:to="lbl_DrJamesBradnerMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="lbl_KeyManagementPersonnelCompensation" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationDailyRate" xlink:label="lbl_KeyManagementPersonnelCompensationDailyRate" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationDailyRate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:label="lbl_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationSharesAcquired" xlink:label="lbl_KeyManagementPersonnelCompensationSharesAcquired" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationSharesAcquired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:label="lbl_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationOwnershipInterestAcquired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:label="lbl_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:type="locator"/>
      <link:presentationArc order="8.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_KeyManagementPersonnelCompensationSharesAcquiredPrice" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityUncommitted" xlink:label="lbl_BorrowingsCreditFacilityUncommitted" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_BorrowingsCreditFacilityUncommitted" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPensionFundMember" xlink:label="lbl_NovartisPensionFundMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NovartisPensionFundMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:label="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="lbl_NoncontrollingInterestsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_NoncontrollingInterestsMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:label="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RemeasurementsFromDefinedBenefitPlansLineItems" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:presentationArc order="4.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ActuarialLossesFromDefinedBenefitPlansMember" xlink:label="lbl_ActuarialLossesFromDefinedBenefitPlansMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_ActuarialLossesFromDefinedBenefitPlansMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationEffectsMember" xlink:label="lbl_CumulativeCurrencyTranslationEffectsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_CumulativeCurrencyTranslationEffectsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems1" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:label="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:label="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_RestatedValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:label="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:label="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems1" xlink:type="locator"/>
      <link:presentationArc order="1.6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfMarketableInvestments" xlink:label="lbl_GainLossOnSaleOfMarketableInvestments" xlink:type="locator"/>
      <link:presentationArc order="1.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainLossOnSaleOfMarketableInvestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfOtherFinancialAssets" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="1.9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:label="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems1" xlink:to="lbl_ValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalFairValueAdjustmentsMember" xlink:label="lbl_TotalFairValueAdjustmentsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalFairValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:label="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:type="locator"/>
      <link:presentationArc order="1.97" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:label="lbl_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:label="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:type="locator"/>
      <link:presentationArc order="1.965" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="1.99" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnDebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:label="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_FairValueAdjustmentsOnEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:label="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_ReclassificationToPresentationRequiredUnderIFRS9Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestatedValueAdjustmentsMember" xlink:label="lbl_RestatedValueAdjustmentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_RestatedValueAdjustmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeDebtSecurities" xlink:label="lbl_OtherComprehensiveIncomeDebtSecurities" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeDebtSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeEquitySecurities" xlink:label="lbl_OtherComprehensiveIncomeEquitySecurities" xlink:type="locator"/>
      <link:presentationArc order="1.55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeEquitySecurities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherComprehensiveIncomeMaketableSecurities" xlink:label="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="locator"/>
      <link:presentationArc order="1.52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_OtherComprehensiveIncomeMaketableSecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:label="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_GainsLossesOnValueAdjustmentOnComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsOnFinancialAssetsSold" xlink:label="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="locator"/>
      <link:presentationArc order="1.57" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsOnFinancialAssetsSold" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRelatedToDivestments" xlink:label="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="locator"/>
      <link:presentationArc order="7.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" xlink:to="lbl_FairValueAdjustmentsRelatedToDivestments" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="lbl_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:label="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComprehensiveIncomeAbstract" xlink:to="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_GoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:label="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:label="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DisposalsAndRetirementsIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems1" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems1" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AlconBrandNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="10.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:presentationArc order="12.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:label="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:label="lbl_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AccumulatedImpairmentsOnDisposalsAndDerecognitions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:label="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:type="locator"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:label="lbl_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:type="locator"/>
      <link:presentationArc order="12.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:label="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:label="lbl_AmortizationPriorToClassificationToAssetsHeldForSale" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:label="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:label="lbl_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="8.5" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_GoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_UnallocatedAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AlconBrandNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:presentationArc order="6.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_UnallocatedAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:label="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsAbstract" xlink:to="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnallocatedAmountsMember" xlink:label="lbl_UnallocatedAmountsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_UnallocatedAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:label="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_DescriptionOfJustificationForUsingGrowthRateThatExceedsLongtermAverageGrowthRate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VotrientMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SerelaxinMember" xlink:label="lbl_SerelaxinMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SerelaxinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CyPassMember" xlink:label="lbl_CyPassMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CyPassMember" xlink:type="arc"/>
      <link:presentationArc order="2.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:presentationArc order="3.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:presentationArc order="4.1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GoodwillMember" xlink:label="lbl_GoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_GoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquiredResearchAndDevelopmentMember" xlink:label="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AcquiredResearchAndDevelopmentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconBrandNameMember" xlink:label="lbl_AlconBrandNameMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_AlconBrandNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_TechnologybasedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketingRelatedIntangibleAssetsMember" xlink:label="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_MarketingRelatedIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="lbl_OtherIntangibleAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_OtherIntangibleAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfIntangibleAssetsLineItems" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:presentationArc order="0.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherProductsMember" xlink:label="lbl_OtherProductsMember" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_OtherProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="lbl_GrossCarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_GrossCarryingAmountMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:label="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_LiabilitiesFromSharebasedPaymentTransactions2011" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="4.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:label="lbl_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ExplanationOfShareOptionsInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationOtherShareAwardsMember" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationAnnualIncentivePlanMember" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationLeveragedShareSavingsPlanMember" xlink:type="arc"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermPerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="arc"/>
      <link:presentationArc order="14.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationRestrictedSharesMember" xlink:label="lbl_EquityBasedParticipationRestrictedSharesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:to="lbl_EquityBasedParticipationRestrictedSharesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationSpecialShareAwardsMember" xlink:label="lbl_EquityBasedParticipationSpecialShareAwardsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:to="lbl_EquityBasedParticipationSpecialShareAwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:label="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationEmployeeShareOwnershipPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationUKShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationUKShareSavingsPlanMember" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:to="lbl_EquityBasedParticipationUKShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfAnnualIncentive" xlink:label="lbl_DescriptionOfAnnualIncentive" xlink:type="locator"/>
      <link:presentationArc order="4.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_DescriptionOfAnnualIncentive" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="arc"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.7Member" xlink:type="arc"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice54.5Member" xlink:type="arc"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.0Member" xlink:type="arc"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.6Member" xlink:type="arc"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.7Member" xlink:label="lbl_ExercisePrice46.7Member" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice54.5Member" xlink:label="lbl_ExercisePrice54.5Member" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.0Member" xlink:label="lbl_ExercisePrice57.0Member" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.6Member" xlink:label="lbl_ExercisePrice57.6Member" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.0Member" xlink:label="lbl_ExercisePrice66.0Member" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:presentationArc order="2.2" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:presentationArc order="1.2" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:presentationArc order="0.7" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:presentationArc order="0.2" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.1Member" xlink:label="lbl_ExercisePrice66.1Member" xlink:type="locator"/>
      <link:presentationArc order="10.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.1Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.4Member" xlink:label="lbl_ExercisePrice46.4Member" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.4Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice53.7Member" xlink:label="lbl_ExercisePrice53.7Member" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice53.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.1Member" xlink:label="lbl_ExercisePrice57.1Member" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.1Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice58.3Member" xlink:label="lbl_ExercisePrice58.3Member" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice58.3Member" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:label="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_ExercisePriceOfOutstandingShareOptions2019" xlink:type="arc"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract" xlink:to="lbl_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.4Member" xlink:label="lbl_ExercisePrice46.4Member" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.4Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice46.7Member" xlink:label="lbl_ExercisePrice46.7Member" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice46.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice53.7Member" xlink:label="lbl_ExercisePrice53.7Member" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice53.7Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice54.5Member" xlink:label="lbl_ExercisePrice54.5Member" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice54.5Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.0Member" xlink:label="lbl_ExercisePrice57.0Member" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.1Member" xlink:label="lbl_ExercisePrice57.1Member" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.1Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice57.6Member" xlink:label="lbl_ExercisePrice57.6Member" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice57.6Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice58.3Member" xlink:label="lbl_ExercisePrice58.3Member" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice58.3Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.0Member" xlink:label="lbl_ExercisePrice66.0Member" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.0Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExercisePrice66.1Member" xlink:label="lbl_ExercisePrice66.1Member" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesOfExercisePricesForOutstandingShareOptionsMember" xlink:to="lbl_ExercisePrice66.1Member" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfReportableSegments" xlink:label="lbl_NumberOfReportableSegments" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NumberOfReportableSegments" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NumberOfBusinessUnits" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfFranchises" xlink:label="lbl_NumberOfFranchises" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NumberOfFranchises" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsumerHealthMember" xlink:label="lbl_ConsumerHealthMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_ConsumerHealthMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfBusinessUnits" xlink:label="lbl_NumberOfBusinessUnits" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="lbl_DepreciationAndAmortisationExpense" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DepreciationAndAmortisationExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToRestructuringProvisions" xlink:label="lbl_AdditionsToRestructuringProvisions" xlink:type="locator"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToRestructuringProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RightofuseAssetsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_Assets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetOperatingAssets" xlink:label="lbl_NetOperatingAssets" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NetOperatingAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="lbl_IntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_IntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtsAndDerivativeInstruments" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:label="lbl_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_CurrentIncomeTaxAndDeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="6.7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="8.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDebt" xlink:label="lbl_NetDebt" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NetDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToInvestmentInAssociatedCompanies" xlink:label="lbl_AdditionsToInvestmentInAssociatedCompanies" xlink:type="locator"/>
      <link:presentationArc order="10.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToInvestmentInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="6.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="6.75" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssets" xlink:type="arc"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CountryOfDomicileMember" xlink:label="lbl_CountryOfDomicileMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CountryOfDomicileMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherCountriesMember" xlink:label="lbl_OtherCountriesMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_OtherCountriesMember" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_GB" xlink:label="lbl_GB" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_GB" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_DE" xlink:label="lbl_DE" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_DE" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="lbl_JP" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_JP" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_FR" xlink:label="lbl_FR" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_FR" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssets" xlink:type="arc"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalRegionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AsiaAfricaAustralasiaMember" xlink:label="lbl_AsiaAfricaAustralasiaMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_AsiaAfricaAustralasiaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:label="lbl_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_EuropeMember" xlink:label="lbl_EuropeMember1" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EuropeMember1" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AmericasMember" xlink:label="lbl_AmericasMember1" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_AmericasMember1" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="lbl_DisclosureOfMajorCustomersTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersAbstract" xlink:label="lbl_DisclosureOfMajorCustomersAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersAbstract" xlink:to="lbl_DisclosureOfMajorCustomersTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="lbl_PercentageOfEntitysRevenue" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="lbl_MajorCustomersAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_MajorCustomersAxis" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersMember" xlink:label="lbl_MajorCustomersMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersAxis" xlink:to="lbl_MajorCustomersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestCustomerMember" xlink:label="lbl_LargestCustomerMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_LargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestCustomerMember" xlink:label="lbl_SecondLargestCustomerMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_SecondLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestCustomerMember" xlink:label="lbl_ThirdLargestCustomerMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_ThirdLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomersWithNetSalesOverFivePercent" xlink:label="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEntitysTradeReceivable" xlink:label="lbl_PercentageOfEntitysTradeReceivable" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysTradeReceivable" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFigures" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="lbl_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="lbl_DisclosureOfOperatingSegmentsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:label="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:label="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompanies" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:label="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfAssociatesBalanceSheetTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:label="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:label="lbl_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AssociatesSummarizedFinancialInformationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchasePriceAllocationAssociatesTableTextBlock" xlink:label="lbl_PurchasePriceAllocationAssociatesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PurchasePriceAllocationAssociatesTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:label="lbl_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInAssociate" xlink:label="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="lbl_ProportionOfOwnershipInterestInAssociate" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ProportionOfOwnershipInterestInAssociate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsReceived" xlink:label="lbl_DividendsReceived" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_DividendsReceived" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:label="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContributionOfBusinessToJointVenture" xlink:label="lbl_ContributionOfBusinessToJointVenture" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ContributionOfBusinessToJointVenture" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatesSummarizedFinancialInformationTable" xlink:label="lbl_AssociatesSummarizedFinancialInformationTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_AssociatesSummarizedFinancialInformationTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssociatesSummarizedFinancialInformationTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssociatesSummarizedFinancialInformationTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="lbl_CurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_CurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Revenue" xlink:label="lbl_Revenue" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_Revenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="lbl_OtherComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_OtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="lbl_ComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="6.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchasePriceAllocationAssociatesTable" xlink:label="lbl_PurchasePriceAllocationAssociatesTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_PurchasePriceAllocationAssociatesTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PurchasePriceAllocationAssociatesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PurchasePriceAllocationAssociatesTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_InvestmentAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill" xlink:label="lbl_AdditionalRecognitionGoodwill" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AdditionalRecognitionGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareOfEstimatedNetAssets" xlink:label="lbl_ShareOfEstimatedNetAssets" xlink:type="locator"/>
      <link:presentationArc order="-1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfEstimatedNetAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:label="lbl_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="0.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:label="lbl_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:type="locator"/>
      <link:presentationArc order="0.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:label="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementEffectsTable" xlink:label="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesAbstract" xlink:to="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ConsolidatedIncomeStatementEffectsTable" xlink:to="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareOfCurrentYearNetIncome" xlink:label="lbl_ShareOfCurrentYearNetIncome" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfCurrentYearNetIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PriorYearAdjustment" xlink:label="lbl_PriorYearAdjustment" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_PriorYearAdjustment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:label="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:label="lbl_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:to="lbl_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:label="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:label="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_GainOnDivestmentOfInterestsInAssociatedCompanies" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:label="lbl_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantInvestmentsInAssociatesLineItems" xlink:to="lbl_PartialReleaseOfDeferredTaxLiabilityRecognized" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilities" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:label="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsExplanatory" xlink:label="lbl_DisclosureOfOtherProvisionsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfOtherProvisionsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForEnvironmentalLossContingenciesTableTextBlock" xlink:label="lbl_AccrualForEnvironmentalLossContingenciesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_AccrualForEnvironmentalLossContingenciesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" xlink:label="lbl_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" xlink:label="lbl_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:label="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_OtherLongtermEmployeeBenefitsAndDeferredCompensation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPostemploymentBenefits" xlink:label="lbl_OtherPostemploymentBenefits" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_OtherPostemploymentBenefits" xlink:type="arc"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ContingentConsiderationNonCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="lbl_OtherNoncurrentLiabilities1" xlink:type="locator"/>
      <link:presentationArc order="8.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_OtherNoncurrentLiabilities1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationNonCurrent" xlink:label="lbl_ContingentConsiderationNonCurrent" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalRemediationProvisionNoncurrent" xlink:label="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionRollForward" xlink:label="lbl_EnvironmentalProvisionRollForward" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionAdditions" xlink:type="arc"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionRollForward" xlink:label="lbl_EnvironmentalProvisionRollForward1" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvision" xlink:label="lbl_EnvironmentalProvision" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvision" xlink:type="arc"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward1" xlink:to="lbl_EnvironmentalProvision" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionAdditions" xlink:label="lbl_EnvironmentalProvisionAdditions" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:label="lbl_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalRemediationProvisionNoncurrent" xlink:label="lbl_EnvironmentalRemediationProvisionNoncurrent" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionCurrent" xlink:label="lbl_EnvironmentalProvisionCurrent" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionReleases" xlink:label="lbl_EnvironmentalProvisionReleases" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionReleases" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_EnvironmentalProvisionRollForward" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionPayments" xlink:label="lbl_EnvironmentalProvisionPayments" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionRollForward" xlink:to="lbl_EnvironmentalProvisionPayments" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvision" xlink:label="lbl_EnvironmentalProvision" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:label="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:to="lbl_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:to="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:type="arc"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:to="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:type="arc"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:to="lbl_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:type="arc"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EnvironmentalProvisionFiscalYearMaturityAbstract" xlink:to="lbl_EnvironmentalProvision" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:label="lbl_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:type="arc"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:type="arc"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="arc"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward1" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsTable" xlink:label="lbl_DisclosureOfOtherProvisionsTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:label="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" xlink:to="lbl_DisclosureOfOtherProvisionsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="lbl_ClassesOfProvisionsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ClassesOfProvisionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherProvisionsMember" xlink:label="lbl_OtherProvisionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfProvisionsAxis" xlink:to="lbl_OtherProvisionsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LegalProceedingsProvisionMember" xlink:label="lbl_LegalProceedingsProvisionMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_OtherProvisionsMember" xlink:to="lbl_LegalProceedingsProvisionMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="lbl_GeographicalAreasAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_GeographicalAreasAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GeographicalAreasMember" xlink:label="lbl_GeographicalAreasMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasAxis" xlink:to="lbl_GeographicalAreasMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOtherProvisionsLineItems" xlink:label="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_DisclosureOfOtherProvisionsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SolodynMember" xlink:label="lbl_SolodynMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SolodynMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContactLensesMember" xlink:label="lbl_ContactLensesMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ContactLensesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecMember" xlink:label="lbl_GleevecMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GleevecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclastAclastaMember" xlink:label="lbl_ReclastAclastaMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ReclastAclastaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TekturnaRasilezValturnaMember" xlink:label="lbl_TekturnaRasilezValturnaMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TekturnaRasilezValturnaMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="3.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NAGAndNovartisPharmaSpAMember" xlink:label="lbl_NAGAndNovartisPharmaSpAMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NAGAndNovartisPharmaSpAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FHoffmanLaRocheAGAndRocheSpAMember" xlink:label="lbl_FHoffmanLaRocheAGAndRocheSpAMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_FHoffmanLaRocheAGAndRocheSpAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisPharmaKKMember" xlink:label="lbl_NovartisPharmaKKMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NovartisPharmaKKMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NAGMember" xlink:label="lbl_NAGMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NPCAndOthersMember" xlink:label="lbl_NPCAndOthersMember" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NPCAndOthersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NovartisNCMember" xlink:label="lbl_NovartisNCMember" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_NovartisNCMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:label="lbl_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:label="lbl_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentLiabilities" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilities" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:label="lbl_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxotereMember" xlink:label="lbl_TaxotereMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TaxotereMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmiodaroneMember" xlink:label="lbl_AmiodaroneMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AmiodaroneMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="lbl_US" xlink:type="locator"/>
      <link:presentationArc order="0.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_US" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_JP" xlink:label="lbl_JP" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_JP" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_IT" xlink:label="lbl_IT" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_IT" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_CA" xlink:label="lbl_CA" xlink:type="locator"/>
      <link:presentationArc order="0.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_CA" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_KR" xlink:label="lbl_KR" xlink:type="locator"/>
      <link:presentationArc order="1.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalAreasMember" xlink:to="lbl_KR" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfSettlementInPrinciple" xlink:label="lbl_AmountOfSettlementInPrinciple" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_AmountOfSettlementInPrinciple" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:label="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:label="lbl_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:type="locator"/>
      <link:presentationArc order="5.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalAmountOfSettlementInPrinciple" xlink:label="lbl_AdditionalAmountOfSettlementInPrinciple" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_AdditionalAmountOfSettlementInPrinciple" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfResolvedAction" xlink:label="lbl_AmountOfResolvedAction" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsLineItems" xlink:to="lbl_AmountOfResolvedAction" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EnoxaparinMember" xlink:label="lbl_EnoxaparinMember" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_EnoxaparinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LitigationCaseMember" xlink:label="lbl_LitigationCaseMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TennesseeClassActionMember" xlink:label="lbl_TennesseeClassActionMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LitigationCaseMember" xlink:to="lbl_TennesseeClassActionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MassachusettsCaseMember" xlink:label="lbl_MassachusettsCaseMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LitigationCaseMember" xlink:to="lbl_MassachusettsCaseMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="lbl_LitigationCaseAxis1" xlink:type="locator"/>
      <link:presentationArc order="4.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOtherProvisionsTable" xlink:to="lbl_LitigationCaseAxis1" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LitigationCaseAxis1" xlink:to="lbl_LitigationCaseMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="lbl_DisclosureOfClassesOfShareCapitalAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:to="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="lbl_IssuedCapital" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems1" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems1" xlink:to="lbl_IssuedCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasuryShares" xlink:label="lbl_TreasuryShares" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapital" xlink:label="lbl_OutstandingShareCapital" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_OutstandingShareCapital" xlink:type="arc"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems1" xlink:to="lbl_OutstandingShareCapital" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares" xlink:label="lbl_SaleOrIssueOfTreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_SaleOrIssueOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IssuedCapitalMovement" xlink:label="lbl_IssuedCapitalMovement" xlink:type="locator"/>
      <link:presentationArc order="4.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_IssuedCapitalMovement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OutstandingShareCapitalMovement" xlink:label="lbl_OutstandingShareCapitalMovement" xlink:type="locator"/>
      <link:presentationArc order="4.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_OutstandingShareCapitalMovement" xlink:type="arc"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems1" xlink:to="lbl_TreasuryShares" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalAbstract" xlink:label="lbl_DisclosureOfClassesOfShareCapitalAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalAbstract" xlink:to="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="lbl_ClassesOfShareCapitalAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:to="lbl_ClassesOfShareCapitalAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="lbl_ClassesOfShareCapitalMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalTable" xlink:to="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="lbl_DisclosureOfClassesOfShareCapitalLineItems1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfSharesOutstanding" xlink:label="lbl_NumberOfSharesOutstanding" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_NumberOfSharesOutstanding" xlink:type="arc"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems1" xlink:to="lbl_NumberOfSharesOutstanding" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeHeld" xlink:label="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="locator"/>
      <link:presentationArc order="8.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherSharePurchases" xlink:label="lbl_OtherSharePurchases" xlink:type="locator"/>
      <link:presentationArc order="8.4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_OtherSharePurchases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeCancelled" xlink:label="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="locator"/>
      <link:presentationArc order="8.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesCancelledForCapitalReduction" xlink:label="lbl_SharesCancelledForCapitalReduction" xlink:type="locator"/>
      <link:presentationArc order="7.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_SharesCancelledForCapitalReduction" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShareMovements" xlink:label="lbl_ShareMovements" xlink:type="locator"/>
      <link:presentationArc order="8.67" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_ShareMovements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StockRepurchaseProgramAuthorizedAmount1" xlink:label="lbl_StockRepurchaseProgramAuthorizedAmount1" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfShareCapitalAxis" xlink:to="lbl_ClassesOfShareCapitalMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OrdinarySharesMember" xlink:label="lbl_OrdinarySharesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfShareCapitalMember" xlink:to="lbl_OrdinarySharesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="lbl_TreasurySharesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfShareCapitalMember" xlink:to="lbl_TreasurySharesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesWithRestrictedUse" xlink:label="lbl_TreasurySharesWithRestrictedUse" xlink:type="locator"/>
      <link:presentationArc order="9.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_TreasurySharesWithRestrictedUse" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedCompensationShares" xlink:label="lbl_EquityBasedCompensationShares" xlink:type="locator"/>
      <link:presentationArc order="8.51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_EquityBasedCompensationShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:label="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="locator"/>
      <link:presentationArc order="8.46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOtherShareSales" xlink:label="lbl_NumberOfOtherShareSales" xlink:type="locator"/>
      <link:presentationArc order="8.63" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_NumberOfOtherShareSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployees" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="locator"/>
      <link:presentationArc order="8.55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendsPayableAmountPerShare" xlink:label="lbl_DividendsPayableAmountPerShare" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_DividendsPayableAmountPerShare" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPaid" xlink:label="lbl_DividendsPaid" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_DividendsPaid" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails4" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeHeld" xlink:label="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TreasurySharesAcquiredToBeHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeHeldValue" xlink:label="lbl_TreasurySharesAcquiredToBeHeldValue" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TreasurySharesAcquiredToBeHeldValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredToBeCancelled" xlink:label="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TreasurySharesAcquiredToBeCancelled" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesAcquiredForCancellationValue" xlink:label="lbl_TreasurySharesAcquiredForCancellationValue" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TreasurySharesAcquiredForCancellationValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherSharePurchases" xlink:label="lbl_OtherSharePurchases" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_OtherSharePurchases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherSharePurchasesValue" xlink:label="lbl_OtherSharePurchasesValue" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_OtherSharePurchasesValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharepurchaseOfTreasuryShares" xlink:label="lbl_SharepurchaseOfTreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_SharepurchaseOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="lbl_PurchaseOfTreasuryShares" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_PurchaseOfTreasuryShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOtherShareSales" xlink:label="lbl_NumberOfOtherShareSales" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_NumberOfOtherShareSales" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherShareSalesEquityImpact" xlink:label="lbl_OtherShareSalesEquityImpact" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_OtherShareSalesEquityImpact" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TreasurySharesMovement" xlink:label="lbl_TreasurySharesMovement" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TreasurySharesMovement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityImpactOfTreasuryShareMovements" xlink:label="lbl_EquityImpactOfTreasuryShareMovements" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_EquityImpactOfTreasuryShareMovements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="locator"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedCompensationShares" xlink:label="lbl_EquityBasedCompensationShares" xlink:type="locator"/>
      <link:presentationArc order="11.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_EquityBasedCompensationShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:label="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="locator"/>
      <link:presentationArc order="11.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_ExerciseOfOptionsAndEmployeeTransactionsShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="locator"/>
      <link:presentationArc order="12.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharesDeliveredToDivestedBusinessEmployees" xlink:label="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="locator"/>
      <link:presentationArc order="12.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_SharesDeliveredToDivestedBusinessEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="locator"/>
      <link:presentationArc order="11.25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_IncreaseDecreaseThroughExerciseOfOptions" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquity" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfEquityAbstract" xlink:label="lbl_DisclosureOfEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfEquityTextBlock" xlink:label="lbl_DisclosureOfEquityTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfEquityAbstract" xlink:to="lbl_DisclosureOfEquityTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfEquityAbstract" xlink:label="lbl_DisclosureOfEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInTheShareCapitalTableTextBlock" xlink:label="lbl_MovementInTheShareCapitalTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfEquityAbstract" xlink:to="lbl_MovementInTheShareCapitalTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementInTheShareslTableTextBlock" xlink:label="lbl_MovementInTheShareslTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfEquityAbstract" xlink:to="lbl_MovementInTheShareslTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DividendTableTextBlock" xlink:label="lbl_DividendTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfEquityAbstract" xlink:to="lbl_DividendTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SummaryOfTreasurySharesMovementsTableTextBlock" xlink:label="lbl_SummaryOfTreasurySharesMovementsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfEquityAbstract" xlink:to="lbl_SummaryOfTreasurySharesMovementsTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitAxis" xlink:label="lbl_BusinessUnitAxis" xlink:type="locator"/>
      <link:presentationArc order="2.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_BusinessUnitAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitMember" xlink:label="lbl_BusinessUnitMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessUnitAxis" xlink:to="lbl_BusinessUnitMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OncologyMember" xlink:label="lbl_OncologyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_OncologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PharmaceuticalMember" xlink:label="lbl_PharmaceuticalMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_PharmaceuticalMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:presentationArc order="2.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_FranchiseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_OphthalmologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeuroscienceMember" xlink:label="lbl_NeuroscienceMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_NeuroscienceMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespiratoryMember" xlink:label="lbl_RespiratoryMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_RespiratoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CardioMetabolicMember" xlink:label="lbl_CardioMetabolicMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_CardioMetabolicMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMedicinesMember" xlink:label="lbl_EstablishedMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_EstablishedMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:presentationArc order="2.4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductPortfolioAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_COPDMember" xlink:label="lbl_COPDMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_COPDMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecGlivecMember" xlink:label="lbl_GleevecGlivecMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GleevecGlivecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExjadeJadenuMember" xlink:label="lbl_ExjadeJadenuMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExjadeJadenuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OphthalmologyMember" xlink:label="lbl_OphthalmologyMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VotrientMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KisqaliMember" xlink:label="lbl_KisqaliMember" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_KisqaliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TravoprostGroupMember" xlink:label="lbl_TravoprostGroupMember" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TravoprostGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SystaneGroupMember" xlink:label="lbl_SystaneGroupMember" xlink:type="locator"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SystaneGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TopicalOlopatadineGroupMember" xlink:label="lbl_TopicalOlopatadineGroupMember" xlink:type="locator"/>
      <link:presentationArc order="16.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TopicalOlopatadineGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MyforticMember" xlink:label="lbl_MyforticMember" xlink:type="locator"/>
      <link:presentationArc order="21.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_MyforticMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExelonExelonPatchMember" xlink:label="lbl_ExelonExelonPatchMember" xlink:type="locator"/>
      <link:presentationArc order="32.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExelonExelonPatchMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RitalinFocalinMember" xlink:label="lbl_RitalinFocalinMember" xlink:type="locator"/>
      <link:presentationArc order="33.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_RitalinFocalinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherProductsMember" xlink:label="lbl_OtherProductsMember" xlink:type="locator"/>
      <link:presentationArc order="34.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_OtherProductsMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImmunologyHepatologyAndDermatologyMember" xlink:label="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LutatheraMember" xlink:label="lbl_LutatheraMember" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LutatheraMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KymriahMember" xlink:label="lbl_KymriahMember" xlink:type="locator"/>
      <link:presentationArc order="12.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_KymriahMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:presentationArc order="2.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PiqrayMember" xlink:label="lbl_PiqrayMember" xlink:type="locator"/>
      <link:presentationArc order="12.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_PiqrayMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TasignaMember" xlink:label="lbl_TasignaMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TasignaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandostatinMember" xlink:label="lbl_SandostatinMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SandostatinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AfinitorVotubiaMember" xlink:label="lbl_AfinitorVotubiaMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AfinitorVotubiaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PromactaRevoladeMember" xlink:label="lbl_PromactaRevoladeMember" xlink:type="locator"/>
      <link:presentationArc order="1.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_PromactaRevoladeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TafinlarMekinistMember" xlink:label="lbl_TafinlarMekinistMember" xlink:type="locator"/>
      <link:presentationArc order="1.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TafinlarMekinistMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JakaviMember" xlink:label="lbl_JakaviMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_JakaviMember" xlink:type="arc"/>
      <link:presentationArc order="14.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XiidraMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GilenyaMember" xlink:label="lbl_GilenyaMember" xlink:type="locator"/>
      <link:presentationArc order="14.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GilenyaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZolgensmaMember" xlink:label="lbl_ZolgensmaMember" xlink:type="locator"/>
      <link:presentationArc order="14.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ZolgensmaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AimovigMember" xlink:label="lbl_AimovigMember" xlink:type="locator"/>
      <link:presentationArc order="14.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AimovigMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MayzentMember" xlink:label="lbl_MayzentMember" xlink:type="locator"/>
      <link:presentationArc order="14.95" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_MayzentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CosentyxMember" xlink:label="lbl_CosentyxMember" xlink:type="locator"/>
      <link:presentationArc order="14.97" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CosentyxMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IlarisMember" xlink:label="lbl_IlarisMember" xlink:type="locator"/>
      <link:presentationArc order="14.98" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_IlarisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UltibroBreezhalerMember" xlink:label="lbl_UltibroBreezhalerMember" xlink:type="locator"/>
      <link:presentationArc order="14.99" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_UltibroBreezhalerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SeebriBreezhalerMember" xlink:label="lbl_SeebriBreezhalerMember" xlink:type="locator"/>
      <link:presentationArc order="14.995" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SeebriBreezhalerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OnbrezBreezhalerMember" xlink:label="lbl_OnbrezBreezhalerMember" xlink:type="locator"/>
      <link:presentationArc order="14.997" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_OnbrezBreezhalerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:presentationArc order="14.998" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XolairMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EntrestoMember" xlink:label="lbl_EntrestoMember" xlink:type="locator"/>
      <link:presentationArc order="14.999" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_EntrestoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GalvusGroupMember" xlink:label="lbl_GalvusGroupMember" xlink:type="locator"/>
      <link:presentationArc order="14.9995" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GalvusGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DiovanGroupMember" xlink:label="lbl_DiovanGroupMember" xlink:type="locator"/>
      <link:presentationArc order="14.9997" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_DiovanGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExforgeGroupMember" xlink:label="lbl_ExforgeGroupMember" xlink:type="locator"/>
      <link:presentationArc order="14.9998" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExforgeGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZortressCerticanMember" xlink:label="lbl_ZortressCerticanMember" xlink:type="locator"/>
      <link:presentationArc order="14.9999" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ZortressCerticanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VoltarenCataflamMember" xlink:label="lbl_VoltarenCataflamMember" xlink:type="locator"/>
      <link:presentationArc order="14.99995" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VoltarenCataflamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeoralSandimmunEMember" xlink:label="lbl_NeoralSandimmunEMember" xlink:type="locator"/>
      <link:presentationArc order="14.99997" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_NeoralSandimmunEMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BeovuMember" xlink:label="lbl_BeovuMember" xlink:type="locator"/>
      <link:presentationArc order="14.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_BeovuMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XiidraMember" xlink:label="lbl_XiidraMember" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="lbl_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsHeldByMarketMaker" xlink:label="lbl_WrittenCallOptionsHeldByMarketMaker" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsHeldByMarketMaker" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsContractualLive" xlink:label="lbl_WrittenCallOptionsContractualLive" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsContractualLive" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsContractualLiveRemaining" xlink:label="lbl_WrittenCallOptionsContractualLiveRemaining" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsContractualLiveRemaining" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WrittenCallOptionsWeightedAverageExercisePrice" xlink:label="lbl_WrittenCallOptionsWeightedAverageExercisePrice" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_WrittenCallOptionsWeightedAverageExercisePrice" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximalAmountOfShareBuybackProgramm" xlink:label="lbl_MaximalAmountOfShareBuybackProgramm" xlink:type="locator"/>
      <link:presentationArc order="7.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_MaximalAmountOfShareBuybackProgramm" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountRecordedInEquityRelatedToHyperinflation" xlink:label="lbl_AmountRecordedInEquityRelatedToHyperinflation" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_AmountRecordedInEquityRelatedToHyperinflation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:label="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TaxOnTransactionCostsRecordedInEquity" xlink:label="lbl_TaxOnTransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:presentationArc order="7.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TaxOnTransactionCostsRecordedInEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCostsRecordedInEquity" xlink:label="lbl_TransactionCostsRecordedInEquity" xlink:type="locator"/>
      <link:presentationArc order="7.1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfChangesInEquityAbstract" xlink:to="lbl_TransactionCostsRecordedInEquity" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtsAndDerivativeInstruments" xlink:label="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems1" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_NonCurrentFinancialDebtsMember" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:label="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:type="locator"/>
      <link:presentationArc order="1.9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:label="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonCurrentFinancialDebtsMember" xlink:label="lbl_NonCurrentFinancialDebtsMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:label="lbl_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="1.98" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLeaseLiabilitiesMember" xlink:label="lbl_NoncurrentLeaseLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_NoncurrentLeaseLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLeaseLiabilitiesMember" xlink:label="lbl_CurrentLeaseLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_CurrentLeaseLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="1.86" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="arc"/>
      <link:presentationArc order="1.865" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationFromNoncurrentToCurrentNet" xlink:label="lbl_ReclassificationFromNoncurrentToCurrentNet" xlink:type="locator"/>
      <link:presentationArc order="1.995" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ReclassificationFromNoncurrentToCurrentNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPortionOfNoncurrentFinancialDebt" xlink:label="lbl_CurrentPortionOfNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:presentationArc order="1.997" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentPortionOfNoncurrentFinancialDebt" xlink:type="arc"/>
      <link:presentationArc order="1.9975" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_FinancialDebtsAndDerivativeInstruments" xlink:type="arc"/>
      <link:presentationArc order="1.998" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems1" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:label="lbl_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:type="locator"/>
      <link:presentationArc order="2.998" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:label="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="1.3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="1.83" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:label="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="1.85" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RepaymentsOfNoncurrentBorrowings" xlink:type="arc"/>
      <link:presentationArc order="1.8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmortizationOfBondsDiscount" xlink:label="lbl_AmortizationOfBondsDiscount" xlink:type="locator"/>
      <link:presentationArc order="1.95" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AmortizationOfBondsDiscount" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LevelsOfFairValueHierarchyAxis" xlink:to="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="lbl_Level1OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level1OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="lbl_Level2OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level2OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="lbl_Level3OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level3OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="lbl_MeasurementAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_MeasurementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="lbl_AggregatedMeasurementMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MeasurementAxis" xlink:to="lbl_AggregatedMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember" xlink:label="lbl_RecurringFairValueMeasurementMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedMeasurementMember" xlink:to="lbl_RecurringFairValueMeasurementMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_DebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:label="lbl_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:label="lbl_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FinancialInvestmentsAndLongtermLoansGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_FundInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalAvailableforsaleMarketableSecuritiesMember" xlink:label="lbl_TotalAvailableforsaleMarketableSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_TotalAvailableforsaleMarketableSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:label="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:label="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_ContingentConsiderationReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:label="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValuedAtAmortizedCostMember" xlink:label="lbl_ValuedAtAmortizedCostMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_ValuedAtAmortizedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="lbl_FinancialAssetsAtFairValue" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfAssetsLineItems" xlink:to="lbl_FinancialAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquitySecuritiesMember" xlink:label="lbl_EquitySecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_EquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesShorttermMember" xlink:label="lbl_ContingentConsiderationReceivablesShorttermMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_ContingentConsiderationReceivablesShorttermMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="lbl_DisclosureOfFinancialAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:label="lbl_DisclosureOfFinancialAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsAbstract" xlink:to="lbl_DisclosureOfFinancialAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsLineItems" xlink:label="lbl_DisclosureOfFinancialAssetsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="lbl_ClassesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_ClassesOfFinancialAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssets" xlink:label="lbl_FinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsLineItems" xlink:to="lbl_FinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsMember" xlink:label="lbl_FinancialAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialAssetsAxis" xlink:to="lbl_FinancialAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="lbl_FinancialAssetsAtAmortisedCostMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_FinancialAssetsAtAmortisedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMember" xlink:label="lbl_CashAndCashEquivalentsMember" xlink:type="locator"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_CashAndCashEquivalentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:label="lbl_CategoriesOfFinancialAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_CategoriesOfFinancialAssetsAxis" xlink:type="arc"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_DisclosureOfFinancialAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsCategoryMember" xlink:label="lbl_FinancialAssetsCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CategoriesOfFinancialAssetsAxis" xlink:to="lbl_FinancialAssetsCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemAxis" xlink:label="lbl_BalanceSheetItemAxis" xlink:type="locator"/>
      <link:presentationArc order="5.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_BalanceSheetItemAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemMember" xlink:label="lbl_BalanceSheetItemMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemAxis" xlink:to="lbl_BalanceSheetItemMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="lbl_DebtSecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DebtSecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquitySecuritiesMember" xlink:label="lbl_EquitySecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_EquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_FundInvestmentsMember" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_ContingentConsiderationReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:label="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:label="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:label="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueMember" xlink:label="lbl_FinancialAssetsAtFairValueMember" xlink:type="locator"/>
      <link:presentationArc order="0.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialAssetsMember" xlink:to="lbl_FinancialAssetsAtFairValueMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:label="lbl_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:label="lbl_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:label="lbl_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialAssetsCategoryMember" xlink:to="lbl_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="5.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialAssetsTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AvailableForSaleMarketableSecuritiesMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CurrentFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableForSaleMarketableSecuritiesMember" xlink:label="lbl_AvailableForSaleMarketableSecuritiesMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleLongtermFinancialInvestmentsMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtMember" xlink:label="lbl_CurrentFinancialDebtMember" xlink:type="locator"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:presentationArc order="1.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesAbstract" xlink:to="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="lbl_FinancialLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfFinancialLiabilitiesAxis" xlink:to="lbl_FinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="lbl_FinancialLiabilitiesAtAmortisedCostMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialLiabilitiesMember" xlink:to="lbl_FinancialLiabilitiesAtAmortisedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueMember" xlink:label="lbl_FinancialLiabilitiesAtFairValueMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialLiabilitiesMember" xlink:to="lbl_FinancialLiabilitiesAtFairValueMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:label="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesCategoryMember" xlink:label="lbl_FinancialLiabilitiesCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CategoriesOfFinancialLiabilitiesAxis" xlink:to="lbl_FinancialLiabilitiesCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:label="lbl_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialLiabilitiesCategoryMember" xlink:to="lbl_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:label="lbl_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialLiabilitiesCategoryMember" xlink:to="lbl_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CurrentFinancialDebtMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_NoncurrentFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesMember" xlink:label="lbl_TradePayablesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_TradePayablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemAxis" xlink:label="lbl_BalanceSheetItemAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_BalanceSheetItemAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetItemMember" xlink:label="lbl_BalanceSheetItemMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemAxis" xlink:to="lbl_BalanceSheetItemMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:label="lbl_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_InterestBearningAccountsOfAssociatesPayableOnDemandMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BankAndOtherFinancialDebtMember" xlink:label="lbl_BankAndOtherFinancialDebtMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_BankAndOtherFinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommercialPaperMember" xlink:label="lbl_CommercialPaperMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_CommercialPaperMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentPortionOfNoncurrentDebtMember" xlink:label="lbl_CurrentPortionOfNoncurrentDebtMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_CurrentPortionOfNoncurrentDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StraightBondsMember" xlink:label="lbl_StraightBondsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_StraightBondsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:label="lbl_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseObligationsMember" xlink:label="lbl_FinanceLeaseObligationsMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_FinanceLeaseObligationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:label="lbl_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_ContingentConsiderationAndOtherFinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BalanceSheetItemMember" xlink:to="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesTable" xlink:to="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilities" xlink:label="lbl_FinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialLiabilitiesLineItems" xlink:to="lbl_FinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentFinancialDebtMember" xlink:label="lbl_CurrentFinancialDebtMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentFinancialDebtMember" xlink:label="lbl_NoncurrentFinancialDebtMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="lbl_LeaseLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_LeaseLiabilitiesMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:to="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsAxis" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsMember" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractOrUnderlyingPrincipalAmoutMember" xlink:label="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PositiveFairValuesMember" xlink:label="lbl_PositiveFairValuesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_PositiveFairValuesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NegativeFairValuesMember" xlink:label="lbl_NegativeFairValuesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_NegativeFairValuesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:label="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstruments" xlink:label="lbl_DerivativeFinancialInstruments" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:label="lbl_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:label="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="locator"/>
      <link:presentationArc order="2.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:label="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="locator"/>
      <link:presentationArc order="2.75" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:label="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentAxis" xlink:to="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:label="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentNatureOfInstrumentMember" xlink:to="lbl_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsAxis" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsPrincipalAmountsMember" xlink:label="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsAxis" xlink:to="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractOrUnderlyingPrincipalAmoutMember" xlink:label="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsPrincipalAmountsMember" xlink:to="lbl_ContractOrUnderlyingPrincipalAmoutMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:label="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstruments" xlink:label="lbl_DerivativeFinancialInstruments" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstruments" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_AllCurrenciesDomain" xlink:label="lbl_AllCurrenciesDomain" xlink:type="locator"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_EUR" xlink:label="lbl_EUR" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_EUR" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_JPY" xlink:label="lbl_JPY" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_JPY" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrencyOthersMember" xlink:label="lbl_CurrencyOthersMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_CurrencyOthersMember" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd#currency_USD" xlink:label="lbl_USD" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllCurrenciesDomain" xlink:to="lbl_USD" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CurrencyAxis" xlink:label="lbl_CurrencyAxis1" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" xlink:to="lbl_CurrencyAxis1" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrencyAxis1" xlink:to="lbl_AllCurrenciesDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:label="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:label="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="locator"/>
      <link:presentationArc order="2.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DerivativeFinancialInstrumentsCommodityPurchaseContract" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesAbstract" xlink:to="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="lbl_MeasurementAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_MeasurementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="lbl_AggregatedMeasurementMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MeasurementAxis" xlink:to="lbl_AggregatedMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember" xlink:label="lbl_RecurringFairValueMeasurementMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedMeasurementMember" xlink:to="lbl_RecurringFairValueMeasurementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_LevelsOfFairValueHierarchyAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LevelsOfFairValueHierarchyAxis" xlink:to="lbl_AllLevelsOfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember" xlink:label="lbl_Level1OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level1OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="lbl_Level2OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level2OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="lbl_Level3OfFairValueHierarchyMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_Level3OfFairValueHierarchyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValuedAtAmortizedCostMember" xlink:label="lbl_ValuedAtAmortizedCostMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AllLevelsOfFairValueHierarchyMember" xlink:to="lbl_ValuedAtAmortizedCostMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:label="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis" xlink:label="lbl_ClassesOfLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_ClassesOfLiabilitiesAxis" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesTable" xlink:to="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesMember" xlink:label="lbl_LiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfLiabilitiesAxis" xlink:to="lbl_LiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPayablesMember" xlink:label="lbl_ContingentConsiderationPayablesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_ContingentConsiderationPayablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialLiabilitiesMember" xlink:label="lbl_OtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_OtherFinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="lbl_FinancialLiabilitiesAtFairValue" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems" xlink:to="lbl_FinancialLiabilitiesAtFairValue" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails7" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsCarryingValueLevel3" xlink:label="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:label="lbl_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:label="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_PurchaseFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReclassificationFairValueMeasurementAssets" xlink:label="lbl_ReclassificationFairValueMeasurementAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ReclassificationFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems1" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems1" xlink:to="lbl_FinancialInstrumentsCarryingValueLevel3" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:label="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:label="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:label="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FundInvestmentsMember" xlink:label="lbl_FundInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FundInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AvailableforsaleFinancialInvestmentsMember" xlink:label="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_AvailableforsaleFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationReceivablesMember" xlink:label="lbl_ContingentConsiderationReceivablesMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_ContingentConsiderationReceivablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPayablesMember" xlink:label="lbl_ContingentConsiderationPayablesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_ContingentConsiderationPayablesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherFinancialLiabilitiesMember" xlink:label="lbl_OtherFinancialLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_OtherFinancialLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:label="lbl_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:type="locator"/>
      <link:presentationArc order="5.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CashReceiptsAndPaymentsFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PurchaseFairValueMeasurementAssets" xlink:label="lbl_PurchaseFairValueMeasurementAssets" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalsFairValueMeasurementAssets" xlink:label="lbl_DisposalsFairValueMeasurementAssets" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DisposalsFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:label="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongTermFinancialInvestmentsMember" xlink:label="lbl_LongTermFinancialInvestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_LongTermFinancialInvestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ReconciliationOfChangesInFairValueMeasurementAssetsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails8" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:label="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaturityOfNetDebtLineItems" xlink:label="lbl_MaturityOfNetDebtLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:label="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GroupsOfFinancialAssetsLiabilitiesMember" xlink:label="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesAxis" xlink:to="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:to="lbl_MaturityOfNetDebtLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MarketableSecuritiesAndTimeDepositsMember" xlink:label="lbl_MarketableSecuritiesAndTimeDepositsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_MarketableSecuritiesAndTimeDepositsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CommoditiesMember" xlink:label="lbl_CommoditiesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CommoditiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:label="lbl_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_DeriviativeFinancialInstrumentsAndAccruedInterestMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsMember" xlink:label="lbl_CashAndCashEquivalentsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_CashAndCashEquivalentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtMember" xlink:label="lbl_FinancialDebtMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FinancialDebtMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialDebtUndiscountedMember" xlink:label="lbl_FinancialDebtUndiscountedMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_FinancialDebtUndiscountedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsMember" xlink:label="lbl_DerivativeFinancialInstrumentsMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GroupsOfFinancialAssetsLiabilitiesMember" xlink:to="lbl_DerivativeFinancialInstrumentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneMonthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetDebt" xlink:label="lbl_NetDebt1" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityOfNetDebtLineItems" xlink:to="lbl_NetDebt1" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails9" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="lbl_NotLaterThanOneMonthMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneMonthMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:label="lbl_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:label="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails10" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:label="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" xlink:to="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationLiabilities" xlink:label="lbl_ContingentConsiderationLiabilities" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ContingentConsiderationLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractualInterestOnNoncurrentLiabilities" xlink:label="lbl_ContractualInterestOnNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_ContractualInterestOnNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails11" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TenDayLossFairValueVARModelTable" xlink:label="lbl_TenDayLossFairValueVARModelTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_TenDayLossFairValueVARModelTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TenDayLossFairValueVARModelLineItems" xlink:label="lbl_TenDayLossFairValueVARModelLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangeAxis" xlink:label="lbl_RangeAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TenDayLossFairValueVARModelTable" xlink:to="lbl_RangeAxis" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TenDayLossFairValueVARModelTable" xlink:to="lbl_TenDayLossFairValueVARModelLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RangesMember" xlink:label="lbl_RangesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangeAxis" xlink:to="lbl_RangesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageMember" xlink:label="lbl_WeightedAverageMember" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_WeightedAverageMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="lbl_TopOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_TopOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="lbl_BottomOfRangeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_BottomOfRangeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WorstCaseLossScenarioMember" xlink:label="lbl_WorstCaseLossScenarioMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RangesMember" xlink:to="lbl_WorstCaseLossScenarioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputation" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputation" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputation" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:label="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TenDayLossFairValueVARModelLineItems" xlink:to="lbl_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingAxis" xlink:label="lbl_NonvestingAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:to="lbl_NonvestingAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestingMember" xlink:label="lbl_NonvestingMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NonvestingAxis" xlink:to="lbl_NonvestingMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonvestedSharesGrantedMember" xlink:label="lbl_NonvestedSharesGrantedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NonvestingMember" xlink:to="lbl_NonvestedSharesGrantedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationAnnualIncentivePlanMember" xlink:label="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationAnnualIncentivePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationShareSavingsPlanMember" xlink:label="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationShareSavingsPlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermPerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermPerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:label="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationLongTermRelativePerformancePlanMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" xlink:to="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:type="locator"/>
      <link:presentationArc order="16.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:label="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward1" xlink:to="lbl_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationOtherShareAwardsMember" xlink:label="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_EquityBasedParticipationOtherShareAwardsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:label="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityBasedParticipationNovartisEquityPlanSelectMember" xlink:to="lbl_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:type="arc"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward1" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:label="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward1" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:label="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ScheduleOfUnvestedRestrictedStockUnitsRollForward" xlink:to="lbl_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:label="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="lbl_SharebasedPaymentArrangementsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lbl_SharebasedPaymentArrangementsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:label="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SharebasedPaymentArrangementsMember" xlink:to="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:label="lbl_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:to="lbl_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:label="lbl_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" xlink:to="lbl_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="lbl_NumberOfOutstandingShareOptions" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward1" xlink:to="lbl_NumberOfOutstandingShareOptions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:label="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable" xlink:to="lbl_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" xlink:to="lbl_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosures" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:label="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementExplanatory" xlink:label="lbl_DisclosureOfFairValueMeasurementExplanatory" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfFairValueMeasurementExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" xlink:label="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory" xlink:label="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" xlink:label="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" xlink:label="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" xlink:label="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:label="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationAxis" xlink:label="lbl_ImpactLocationAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ImpactLocationAxis" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactLocationMember" xlink:label="lbl_ImpactLocationMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ImpactLocationAxis" xlink:to="lbl_ImpactLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementMember" xlink:label="lbl_IncomeStatementMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ImpactLocationMember" xlink:to="lbl_IncomeStatementMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember1" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ImpactLocationMember" xlink:to="lbl_EquityMember1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:label="lbl_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:label="lbl_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:label="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:label="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:label="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:label="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:label="lbl_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:type="locator"/>
      <link:presentationArc order="7.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:label="lbl_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:type="locator"/>
      <link:presentationArc order="7.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DeferredTaxAssetAndLiabilityValuationAbstract" xlink:to="lbl_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SignificantAccountingPoliciesAbstract" xlink:label="lbl_SignificantAccountingPoliciesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantAccountingPoliciesAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="lbl_ParValuePerShare" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ParValuePerShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:label="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UndiscountedOperatingLeaseCommitments" xlink:label="lbl_UndiscountedOperatingLeaseCommitments" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UndiscountedOperatingLeaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ShortTermLeasesAndLowValueLeases" xlink:label="lbl_ShortTermLeasesAndLowValueLeases" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ShortTermLeasesAndLowValueLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RemainingLeaseCommitments" xlink:label="lbl_RemainingLeaseCommitments" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RemainingLeaseCommitments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesToBeRecognized" xlink:label="lbl_LeaseLiabilitiesToBeRecognized" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilitiesToBeRecognized" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RightOfUseAssetsToBeRecognized" xlink:label="lbl_RightOfUseAssetsToBeRecognized" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RightOfUseAssetsToBeRecognized" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PrepaymentsAndAccruedLeasePayments" xlink:label="lbl_PrepaymentsAndAccruedLeasePayments" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PrepaymentsAndAccruedLeasePayments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails12" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:label="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OpenHedgesForAnticipatedTransactions" xlink:label="lbl_OpenHedgesForAnticipatedTransactions" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_OpenHedgesForAnticipatedTransactions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_MostSignificantForeignExchangeLosses" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostSignificantForeignExchangeLosses" xlink:label="lbl_MostSignificantForeignExchangeLosses" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LongtermFinancialDebtWithACarryingAmount" xlink:label="lbl_LongtermFinancialDebtWithACarryingAmount" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_LongtermFinancialDebtWithACarryingAmount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:label="lbl_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:label="lbl_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_NetInvestmentHedgeRecognizedInTheIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:label="lbl_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_UpperLimitOnHoldingsOnUnrelatedCompany" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:label="lbl_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCommercialPaperMaximumBorrowingAmount" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DebtEquityRatio" xlink:label="lbl_DebtEquityRatio" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_DebtEquityRatio" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VAREstimateConfidenceInterval" xlink:label="lbl_VAREstimateConfidenceInterval" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_VAREstimateConfidenceInterval" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:label="lbl_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:type="locator"/>
      <link:presentationArc order="9.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCommercialPaperMaximumAmountOutstanding" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityCommitted" xlink:label="lbl_BorrowingsCreditFacilityCommitted" xlink:type="locator"/>
      <link:presentationArc order="9.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCreditFacilityCommitted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CounterpartyRiskAbstract" xlink:label="lbl_CounterpartyRiskAbstract" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_CounterpartyRiskAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:label="lbl_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CounterpartyRiskAbstract" xlink:to="lbl_CashAndCashEquivalentsHeldWithFinancialInstitution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorAxis" xlink:label="lbl_VendorAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VendorMember" xlink:label="lbl_VendorMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_VendorAxis" xlink:to="lbl_VendorMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestFinancialInstitutionMember" xlink:label="lbl_LargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_VendorMember" xlink:to="lbl_LargestFinancialInstitutionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestFinancialInstitutionMember" xlink:label="lbl_SecondLargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_VendorMember" xlink:to="lbl_SecondLargestFinancialInstitutionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestFinancialInstitutionMember" xlink:label="lbl_ThirdLargestFinancialInstitutionMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_VendorMember" xlink:to="lbl_ThirdLargestFinancialInstitutionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:label="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:to="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:type="arc"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:to="lbl_VendorAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFinancialInstrumentsNarrativeTable" xlink:to="lbl_BorrowingsByNameAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USCommercialPaperProgramsMember" xlink:label="lbl_USCommercialPaperProgramsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_USCommercialPaperProgramsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JPCommercialPaperProgramsMember" xlink:label="lbl_JPCommercialPaperProgramsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_JPCommercialPaperProgramsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCommercialPaperNumberOfPrograms" xlink:label="lbl_BorrowingsCommercialPaperNumberOfPrograms" xlink:type="locator"/>
      <link:presentationArc order="9.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCommercialPaperNumberOfPrograms" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:label="lbl_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:type="locator"/>
      <link:presentationArc order="5.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_MaximumMarginPercentageImpactOfCommodityPriceChange" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MaximumHoldingInUnrelatedCompany" xlink:label="lbl_MaximumHoldingInUnrelatedCompany" xlink:type="locator"/>
      <link:presentationArc order="5.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_MaximumHoldingInUnrelatedCompany" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:label="lbl_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:type="locator"/>
      <link:presentationArc order="11.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOnSaleOfOtherFinancialAssets" xlink:label="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="3.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:label="lbl_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="locator"/>
      <link:presentationArc order="6.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsCreditFacilityShortTerm" xlink:label="lbl_BorrowingsCreditFacilityShortTerm" xlink:type="locator"/>
      <link:presentationArc order="9.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_BorrowingsCreditFacilityShortTerm" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountBorrowedUnderTheCreditFacility" xlink:label="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="locator"/>
      <link:presentationArc order="9.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountBorrowedUnderTheCreditFacility" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:label="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:type="locator"/>
      <link:presentationArc order="3.7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:label="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDerivativeFinancialInstrumentsLineItems" xlink:to="lbl_TransfersOutOfLevel3OfFairValueHierarchyAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails13" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:label="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersTable" xlink:label="lbl_DisclosureOfMajorCustomersTable" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialInstrumentsAdditionalDisclosureAbstract" xlink:to="lbl_DisclosureOfMajorCustomersTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="lbl_MajorCustomersAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_MajorCustomersAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MajorCustomersMember" xlink:label="lbl_MajorCustomersMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersAxis" xlink:to="lbl_MajorCustomersMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LargestCustomerMember" xlink:label="lbl_LargestCustomerMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_LargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SecondLargestCustomerMember" xlink:label="lbl_SecondLargestCustomerMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_SecondLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ThirdLargestCustomerMember" xlink:label="lbl_ThirdLargestCustomerMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MajorCustomersMember" xlink:to="lbl_ThirdLargestCustomerMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfMajorCustomersLineItems" xlink:label="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersTable" xlink:to="lbl_DisclosureOfMajorCustomersLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="lbl_PercentageOfEntitysRevenue" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysRevenue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomersWithNetSalesOverFivePercent" xlink:label="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_CustomersWithNetSalesOverFivePercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEntitysTradeReceivable" xlink:label="lbl_PercentageOfEntitysTradeReceivable" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMajorCustomersLineItems" xlink:to="lbl_PercentageOfEntitysTradeReceivable" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails1" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_CategoriesOfRelatedPartiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CategoriesOfRelatedPartiesAxis" xlink:to="lbl_EntitysTotalForRelatedPartiesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_KeyManagementPersonnelOfEntityOrParentMember" xlink:label="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_KeyManagementPersonnelOfEntityOrParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonExecutiveDirectorMember" xlink:label="lbl_NonExecutiveDirectorMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForRelatedPartiesMember" xlink:to="lbl_NonExecutiveDirectorMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GenentechRocheMember" xlink:label="lbl_GenentechRocheMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GenentechRocheMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GenentechInc.USAMember" xlink:label="lbl_GenentechInc.USAMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GenentechInc.USAMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XolairMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfVotingPowerHeldInAssociate" xlink:label="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_ProportionOfVotingPowerHeldInAssociate" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:label="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_NetExpenseRoyaltiesCostSharingAndProfitSharing" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfContractsWithRelatedParties" xlink:label="lbl_NumberOfContractsWithRelatedParties" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_NumberOfContractsWithRelatedParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:label="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_RelatedPartiesNumberOfExecutiveCommiteeMembers" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:label="lbl_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lbl_RelatedPartiesNumberOfNonexecutiveDirectors" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails10" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitSharingIncome" xlink:label="lbl_ProfitSharingIncome" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitSharingIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="lbl_RevenueFromRoyalties" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromRoyalties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MilestoneIncome" xlink:label="lbl_MilestoneIncome" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_MilestoneIncome" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherRevenueOther" xlink:label="lbl_OtherRevenueOther" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherRevenueOther" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_FranchiseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RetailGenericsMember" xlink:label="lbl_RetailGenericsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_RetailGenericsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BiopharmaceuticalsMember" xlink:label="lbl_BiopharmaceuticalsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_BiopharmaceuticalsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AntiInfectivesMember" xlink:label="lbl_AntiInfectivesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_AntiInfectivesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductPortfolioAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AntiInfectivesSoldUnderSandozNameMember" xlink:label="lbl_AntiInfectivesSoldUnderSandozNameMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_AntiInfectivesSoldUnderSandozNameMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:presentationArc order="4.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails14" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:to="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:label="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:label="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:label="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:to="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ListedEquitySecuritiesMember" xlink:label="lbl_ListedEquitySecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_ListedEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NonlistedEquitySecuritiesMember" xlink:label="lbl_NonlistedEquitySecuritiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember" xlink:to="lbl_NonlistedEquitySecuritiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOnSaleOfOtherFinancialAssets" xlink:label="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_FairValueOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GainLossOnSaleOfOtherFinancialAssets" xlink:label="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems" xlink:to="lbl_GainLossOnSaleOfOtherFinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:presentationArc order="2.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="lbl_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:presentationArc order="2.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeTable" xlink:to="lbl_ComponentsOfEquityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityMember" xlink:label="lbl_EquityMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ComponentsOfEquityAxis" xlink:to="lbl_EquityMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityMember" xlink:to="lbl_EquityAttributableToOwnersOfParentMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalFairValueAdjustmentsMember" xlink:label="lbl_TotalFairValueAdjustmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAttributableToOwnersOfParentMember" xlink:to="lbl_TotalFairValueAdjustmentsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfSignificantTransactionsAbstract" xlink:label="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:label="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:to="lbl_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:label="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:to="lbl_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" xlink:label="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:to="lbl_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:label="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfSignificantTransactionsAbstract" xlink:to="lbl_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails11" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitAxis" xlink:label="lbl_BusinessUnitAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_BusinessUnitAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessUnitMember" xlink:label="lbl_BusinessUnitMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessUnitAxis" xlink:to="lbl_BusinessUnitMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OncologyMember" xlink:label="lbl_OncologyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_OncologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PharmaceuticalMember" xlink:label="lbl_PharmaceuticalMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessUnitMember" xlink:to="lbl_PharmaceuticalMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseAxis" xlink:label="lbl_FranchiseAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_FranchiseAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FranchiseMember" xlink:label="lbl_FranchiseMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseAxis" xlink:to="lbl_FranchiseMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OphthalmologyMember" xlink:label="lbl_OphthalmologyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_OphthalmologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeuroscienceMember" xlink:label="lbl_NeuroscienceMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_NeuroscienceMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RespiratoryMember" xlink:label="lbl_RespiratoryMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_RespiratoryMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CardioMetabolicMember" xlink:label="lbl_CardioMetabolicMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_CardioMetabolicMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMedicinesMember" xlink:label="lbl_EstablishedMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_EstablishedMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImmunologyHepatologyAndDermatologyMember" xlink:label="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FranchiseMember" xlink:to="lbl_ImmunologyHepatologyAndDermatologyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioAxis" xlink:label="lbl_ProductPortfolioAxis" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductPortfolioAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProductPortfolioMember" xlink:label="lbl_ProductPortfolioMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioAxis" xlink:to="lbl_ProductPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GleevecGlivecMember" xlink:label="lbl_GleevecGlivecMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GleevecGlivecMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExjadeJadenuMember" xlink:label="lbl_ExjadeJadenuMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExjadeJadenuMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_Top20ProductsMember" xlink:label="lbl_Top20ProductsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_Top20ProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestOfPortfolioMember" xlink:label="lbl_RestOfPortfolioMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductPortfolioMember" xlink:to="lbl_RestOfPortfolioMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CosentyxMember" xlink:label="lbl_CosentyxMember" xlink:type="locator"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CosentyxMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LucentisMember" xlink:label="lbl_LucentisMember" xlink:type="locator"/>
      <link:presentationArc order="0.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_LucentisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TasignaMember" xlink:label="lbl_TasignaMember" xlink:type="locator"/>
      <link:presentationArc order="0.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TasignaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandostatinMember" xlink:label="lbl_SandostatinMember" xlink:type="locator"/>
      <link:presentationArc order="0.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_SandostatinMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IlarisMember" xlink:label="lbl_IlarisMember" xlink:type="locator"/>
      <link:presentationArc order="7.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_IlarisMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VotrientMember" xlink:label="lbl_VotrientMember" xlink:type="locator"/>
      <link:presentationArc order="7.85" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VotrientMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TravoprostGroupMember" xlink:label="lbl_TravoprostGroupMember" xlink:type="locator"/>
      <link:presentationArc order="8.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TravoprostGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NeoralSandimmunEMember" xlink:label="lbl_NeoralSandimmunEMember" xlink:type="locator"/>
      <link:presentationArc order="9.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_NeoralSandimmunEMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_VoltarenCataflamMember" xlink:label="lbl_VoltarenCataflamMember" xlink:type="locator"/>
      <link:presentationArc order="9.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_VoltarenCataflamMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExelonExelonPatchMember" xlink:label="lbl_ExelonExelonPatchMember" xlink:type="locator"/>
      <link:presentationArc order="9.9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExelonExelonPatchMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:presentationArc order="6.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalRegionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USMember" xlink:label="lbl_USMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_USMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RestOfTheWorldMember" xlink:label="lbl_RestOfTheWorldMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_RestOfTheWorldMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GilenyaMember" xlink:label="lbl_GilenyaMember" xlink:type="locator"/>
      <link:presentationArc order="0.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GilenyaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EntrestoMember" xlink:label="lbl_EntrestoMember" xlink:type="locator"/>
      <link:presentationArc order="0.85" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_EntrestoMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AfinitorVotubiaMember" xlink:label="lbl_AfinitorVotubiaMember" xlink:type="locator"/>
      <link:presentationArc order="0.95" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_AfinitorVotubiaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PromactaRevoladeMember" xlink:label="lbl_PromactaRevoladeMember" xlink:type="locator"/>
      <link:presentationArc order="0.97" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_PromactaRevoladeMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TafinlarMekinistMember" xlink:label="lbl_TafinlarMekinistMember" xlink:type="locator"/>
      <link:presentationArc order="0.98" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_TafinlarMekinistMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GalvusGroupMember" xlink:label="lbl_GalvusGroupMember" xlink:type="locator"/>
      <link:presentationArc order="0.99" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_GalvusGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_XolairMember" xlink:label="lbl_XolairMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_XolairMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_JakaviMember" xlink:label="lbl_JakaviMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_JakaviMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DiovanGroupMember" xlink:label="lbl_DiovanGroupMember" xlink:type="locator"/>
      <link:presentationArc order="4.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_DiovanGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ExforgeGroupMember" xlink:label="lbl_ExforgeGroupMember" xlink:type="locator"/>
      <link:presentationArc order="4.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ExforgeGroupMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZortressCerticanMember" xlink:label="lbl_ZortressCerticanMember" xlink:type="locator"/>
      <link:presentationArc order="8.4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_ZortressCerticanMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_KisqaliMember" xlink:label="lbl_KisqaliMember" xlink:type="locator"/>
      <link:presentationArc order="8.6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_KisqaliMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails12" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsAxis" xlink:label="lbl_GeographicalRegionsAxis" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GeographicalRegionsMember" xlink:label="lbl_GeographicalRegionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsAxis" xlink:to="lbl_GeographicalRegionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AsiaAfricaAustralasiaMember" xlink:label="lbl_AsiaAfricaAustralasiaMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_AsiaAfricaAustralasiaMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodAxis" xlink:label="lbl_ChangeOverPeriodAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ChangeOverPeriodAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeOverPeriodMember" xlink:label="lbl_ChangeOverPeriodMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodAxis" xlink:to="lbl_ChangeOverPeriodMember" xlink:type="arc"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPYEMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ChangeOverPeriodMember" xlink:to="lbl_PoPMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:presentationArc order="1.4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_GeographicalRegionsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_USMember" xlink:label="lbl_USMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_USMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CanadaAndLatinAmericaMember" xlink:label="lbl_CanadaAndLatinAmericaMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_CanadaAndLatinAmericaMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EstablishedMarketsMember" xlink:label="lbl_EstablishedMarketsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EstablishedMarketsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EmergingGrowthMarketsMember" xlink:label="lbl_EmergingGrowthMarketsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EmergingGrowthMarketsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:label="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_EuropeMember" xlink:label="lbl_EuropeMember1" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_GeographicalRegionsMember" xlink:to="lbl_EuropeMember1" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPMember" xlink:label="lbl_PoPMember" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PoPYEMember" xlink:label="lbl_PoPYEMember" xlink:type="locator"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureBasisOfPreparationQ" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BasisOfPreparationAbstract" xlink:label="lbl_BasisOfPreparationAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BasisOfPreparationAbstract" xlink:to="lbl_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLegalProceedingsUpdateQ" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LegalProceedingsUpdateTextBlock" xlink:label="lbl_LegalProceedingsUpdateTextBlock" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LegalProceedingsUpdateAbstract" xlink:label="lbl_LegalProceedingsUpdateAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LegalProceedingsUpdateAbstract" xlink:to="lbl_LegalProceedingsUpdateTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiability" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory" xlink:label="lbl_DisclosureOfLeasesExplanatory" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" xlink:label="lbl_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" xlink:to="lbl_DisclosureOfLeasesExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperations" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory" xlink:label="lbl_DisclosureOfDiscontinuedOperationsExplanatory" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_DisclosureOfDiscontinuedOperationsExplanatory" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:label="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:label="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BalanceSheetAdditionalInformationTableTextBlock" xlink:label="lbl_BalanceSheetAdditionalInformationTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_BalanceSheetAdditionalInformationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:label="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:label="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsUsedInInvestingActivitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:label="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:label="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.92" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ScheduleOfDefinedContributionPlansTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:label="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.91" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DisclosureOfNetAssetsDerecognizedTableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="lbl_DisclosureOfBusinessCombinationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsAbstract" xlink:to="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="lbl_EntitysTotalForSubsidiariesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lbl_EntitysTotalForSubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SubsidiariesMember" xlink:label="lbl_SubsidiariesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSubsidiariesMember" xlink:to="lbl_SubsidiariesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationAxis" xlink:label="lbl_IncomeStatementLocationAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_IncomeStatementLocationAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncomeStatementLocationMember" xlink:label="lbl_IncomeStatementLocationMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncomeStatementLocationAxis" xlink:to="lbl_IncomeStatementLocationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OperatingIncomeMember" xlink:label="lbl_OperatingIncomeMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncomeStatementLocationMember" xlink:to="lbl_OperatingIncomeMember" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_LegalEntityAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdvancedAcceleratorApplicationsAAAMember" xlink:label="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdvancedAcceleratorApplicationsAAAMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AveXisIncMember" xlink:label="lbl_AveXisIncMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AveXisIncMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EndocyteMember" xlink:label="lbl_EndocyteMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EndocyteMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalIncMember" xlink:label="lbl_TranscendMedicalIncMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TranscendMedicalIncMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SelexysPharmaceuticalsCorporationMember" xlink:label="lbl_SelexysPharmaceuticalsCorporationMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SelexysPharmaceuticalsCorporationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReprixysPharmaceuticalsCorporationMember" xlink:label="lbl_ReprixysPharmaceuticalsCorporationMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ReprixysPharmaceuticalsCorporationMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ZiarcoGroupLimitedMember" xlink:label="lbl_ZiarcoGroupLimitedMember" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_ZiarcoGroupLimitedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EncoreVisionIncMember" xlink:label="lbl_EncoreVisionIncMember" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EncoreVisionIncMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EliLillyAndCompanyMember" xlink:label="lbl_EliLillyAndCompanyMember" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_EliLillyAndCompanyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKOncologyProductsMember" xlink:label="lbl_GSKOncologyProductsMember" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKOncologyProductsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKVaccinesMember" xlink:label="lbl_GSKVaccinesMember" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKVaccinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKConsumerHealthcareMember" xlink:label="lbl_GSKConsumerHealthcareMember" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKConsumerHealthcareMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKTotalTransactionMember" xlink:label="lbl_GSKTotalTransactionMember" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKTotalTransactionMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CSLMember" xlink:label="lbl_CSLMember" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_CSLMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SpinifexMember" xlink:label="lbl_SpinifexMember" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_SpinifexMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdmuneTheraputicsMember" xlink:label="lbl_AdmuneTheraputicsMember" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AdmuneTheraputicsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TakedaPharmaceuticalCompanyLimitedMember" xlink:label="lbl_TakedaPharmaceuticalCompanyLimitedMember" xlink:type="locator"/>
      <link:presentationArc order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TakedaPharmaceuticalCompanyLimitedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IFMTreInc.Member" xlink:label="lbl_IFMTreInc.Member" xlink:type="locator"/>
      <link:presentationArc order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_IFMTreInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PowerVisionInc.Member" xlink:label="lbl_PowerVisionInc.Member" xlink:type="locator"/>
      <link:presentationArc order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_PowerVisionInc.Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:label="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="locator"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RocheHoldingAGMember" xlink:label="lbl_RocheHoldingAGMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_RocheHoldingAGMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:label="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OthersAssociatesMember" xlink:label="lbl_OthersAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_OthersAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DetailedInformationAboutSignificantTransaction" xlink:label="lbl_DetailedInformationAboutSignificantTransaction" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DetailedInformationAboutSignificantTransaction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="lbl_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="lbl_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ContingentLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:label="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionalRecognitionGoodwill" xlink:label="lbl_AdditionalRecognitionGoodwill" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AdditionalRecognitionGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:label="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:label="lbl_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="lbl_PercentageOfVotingEquityInterestsAcquired" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfVotingEquityInterestsAcquired" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:label="lbl_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DescriptionOfArrangementForContingentConsiderationArrangementsAndIndemnificationAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentiallyRefundableConsiderationFromAcquisition" xlink:label="lbl_PotentiallyRefundableConsiderationFromAcquisition" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PotentiallyRefundableConsiderationFromAcquisition" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:label="lbl_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:type="locator"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AcquisitionFairValuePotentiallyRefundableContingentConsideration" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContractRightOfFirstNegotiationTerm" xlink:label="lbl_ContractRightOfFirstNegotiationTerm" xlink:type="locator"/>
      <link:presentationArc order="16.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ContractRightOfFirstNegotiationTerm" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="lbl_RevenueOfAcquiree" xlink:type="locator"/>
      <link:presentationArc order="17.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RevenueOfAcquiree" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueOfAcquireeFullYear" xlink:label="lbl_RevenueOfAcquireeFullYear" xlink:type="locator"/>
      <link:presentationArc order="18.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RevenueOfAcquireeFullYear" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:label="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:type="locator"/>
      <link:presentationArc order="19.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:label="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:type="locator"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="lbl_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="locator"/>
      <link:presentationArc order="21.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:label="lbl_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:type="locator"/>
      <link:presentationArc order="22.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:label="lbl_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:type="locator"/>
      <link:presentationArc order="23.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_SaleOfBusinessContingentOptionArrangementsFeePaid" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="lbl_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="locator"/>
      <link:presentationArc order="24.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfVotingEquityInterestsContributed" xlink:label="lbl_PercentageOfVotingEquityInterestsContributed" xlink:type="locator"/>
      <link:presentationArc order="25.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfVotingEquityInterestsContributed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionRelatedCosts" xlink:label="lbl_TransactionRelatedCosts" xlink:type="locator"/>
      <link:presentationArc order="26.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TransactionRelatedCosts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionRelatedCostsPaid" xlink:label="lbl_TransactionRelatedCostsPaid" xlink:type="locator"/>
      <link:presentationArc order="27.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TransactionRelatedCostsPaid" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLoss" xlink:label="lbl_ImpairmentLoss" xlink:type="locator"/>
      <link:presentationArc order="28.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ImpairmentLoss" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ReversalOfImpairmentLoss" xlink:label="lbl_ReversalOfImpairmentLoss" xlink:type="locator"/>
      <link:presentationArc order="29.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ReversalOfImpairmentLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PreTaxProfitLossFromDivestmentOfBusiness" xlink:label="lbl_PreTaxProfitLossFromDivestmentOfBusiness" xlink:type="locator"/>
      <link:presentationArc order="30.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PreTaxProfitLossFromDivestmentOfBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:label="lbl_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:type="locator"/>
      <link:presentationArc order="31.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DivestmentDateFairValueOfTotalConsiderationTransferred" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialReceivableFromDivestment" xlink:label="lbl_PotentialReceivableFromDivestment" xlink:type="locator"/>
      <link:presentationArc order="32.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PotentialReceivableFromDivestment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentFairValueOfContingentConsiderationReceived" xlink:label="lbl_DivestmentFairValueOfContingentConsiderationReceived" xlink:type="locator"/>
      <link:presentationArc order="33.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DivestmentFairValueOfContingentConsiderationReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MilestonePaymentAlreadyReceived" xlink:label="lbl_MilestonePaymentAlreadyReceived" xlink:type="locator"/>
      <link:presentationArc order="34.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_MilestonePaymentAlreadyReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FuturePutOptionToSellBusiness" xlink:label="lbl_FuturePutOptionToSellBusiness" xlink:type="locator"/>
      <link:presentationArc order="35.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_FuturePutOptionToSellBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PaymentPutOption" xlink:label="lbl_PaymentPutOption" xlink:type="locator"/>
      <link:presentationArc order="36.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PaymentPutOption" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InterestExchanged" xlink:label="lbl_InterestExchanged" xlink:type="locator"/>
      <link:presentationArc order="37.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_InterestExchanged" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="lbl_ParValuePerShare" xlink:type="locator"/>
      <link:presentationArc order="38.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ParValuePerShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalInTenderOffer" xlink:label="lbl_PercentageOfShareCapitalInTenderOffer" xlink:type="locator"/>
      <link:presentationArc order="39.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfShareCapitalInTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOfferPerOrdinaryShare" xlink:label="lbl_CashOfferPerOrdinaryShare" xlink:type="locator"/>
      <link:presentationArc order="40.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CashOfferPerOrdinaryShare" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOfferPerADS" xlink:label="lbl_CashOfferPerADS" xlink:type="locator"/>
      <link:presentationArc order="41.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CashOfferPerADS" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfOrdinarySharePerADS" xlink:label="lbl_NumberOfOrdinarySharePerADS" xlink:type="locator"/>
      <link:presentationArc order="42.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NumberOfOrdinarySharePerADS" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ValueOfEquity" xlink:label="lbl_ValueOfEquity" xlink:type="locator"/>
      <link:presentationArc order="43.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ValueOfEquity" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:label="lbl_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:type="locator"/>
      <link:presentationArc order="44.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherNetAssets" xlink:label="lbl_OtherNetAssets" xlink:type="locator"/>
      <link:presentationArc order="45.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_OtherNetAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset" xlink:label="lbl_DeferredTaxLiabilityAsset" xlink:type="locator"/>
      <link:presentationArc order="46.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DeferredTaxLiabilityAsset" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="47.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentCostToSell" xlink:label="lbl_DivestmentCostToSell" xlink:type="locator"/>
      <link:presentationArc order="48.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DivestmentCostToSell" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:presentationArc order="49.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:presentationArc order="50.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:label="lbl_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="locator"/>
      <link:presentationArc order="51.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CarryingValueOfTheDivestedBusiness" xlink:label="lbl_CarryingValueOfTheDivestedBusiness" xlink:type="locator"/>
      <link:presentationArc order="52.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CarryingValueOfTheDivestedBusiness" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfProductsInPortfolioToBeSold" xlink:label="lbl_NumberOfProductsInPortfolioToBeSold" xlink:type="locator"/>
      <link:presentationArc order="53.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NumberOfProductsInPortfolioToBeSold" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:presentationArc order="54.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProformaNetSales" xlink:label="lbl_ProformaNetSales" xlink:type="locator"/>
      <link:presentationArc order="55.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProformaNetSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="lbl_OtherBorrowings" xlink:type="locator"/>
      <link:presentationArc order="56.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_OtherBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="lbl_DividendsPayable" xlink:type="locator"/>
      <link:presentationArc order="57.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DividendsPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Borrowings" xlink:label="lbl_Borrowings" xlink:type="locator"/>
      <link:presentationArc order="58.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_Borrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:label="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:type="locator"/>
      <link:presentationArc order="59.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="lbl_NetAssetsLiabilities" xlink:type="locator"/>
      <link:presentationArc order="60.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NetAssetsLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="lbl_FinancialAssetsAtFairValue" xlink:type="locator"/>
      <link:presentationArc order="61.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_FinancialAssetsAtFairValue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="locator"/>
      <link:presentationArc order="62.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:presentationArc order="63.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:label="lbl_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:type="locator"/>
      <link:presentationArc order="64.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PotentialMilestoneMaximumPayments" xlink:label="lbl_PotentialMilestoneMaximumPayments" xlink:type="locator"/>
      <link:presentationArc order="66.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PotentialMilestoneMaximumPayments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:label="lbl_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:type="locator"/>
      <link:presentationArc order="67.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NumberOfEmployeesAssociatedWithTheProductTransfer" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalBorrowings" xlink:label="lbl_AdditionalBorrowings" xlink:type="locator"/>
      <link:presentationArc order="68.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_AdditionalBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PercentageOfEquityInterestSharesReceived" xlink:label="lbl_PercentageOfEquityInterestSharesReceived" xlink:type="locator"/>
      <link:presentationArc order="69.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PercentageOfEquityInterestSharesReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:label="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:type="locator"/>
      <link:presentationArc order="70.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DistributionOfDividendBearingSharesToConsolidatedFoundations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="locator"/>
      <link:presentationArc order="71.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_ProportionOfOwnershipInterestInSubsidiary" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CustomaryPurchasePriceAdjustment" xlink:label="lbl_CustomaryPurchasePriceAdjustment" xlink:type="locator"/>
      <link:presentationArc order="72.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CustomaryPurchasePriceAdjustment" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RepaymentOfIntercompanyBalances" xlink:label="lbl_RepaymentOfIntercompanyBalances" xlink:type="locator"/>
      <link:presentationArc order="3.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_RepaymentOfIntercompanyBalances" xlink:type="arc"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_AspenGlobalIncorporatedMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TheMedicinesCompanyMember" xlink:label="lbl_TheMedicinesCompanyMember" xlink:type="locator"/>
      <link:presentationArc order="1.7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_TheMedicinesCompanyMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AspenGlobalIncorporatedMember" xlink:label="lbl_AspenGlobalIncorporatedMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="lbl_BorrowingsByNameAxis" xlink:type="locator"/>
      <link:presentationArc order="6.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_BorrowingsByNameAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="lbl_BorrowingsByNameMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameAxis" xlink:to="lbl_BorrowingsByNameMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsUSDMember" xlink:label="lbl_BorrowingsUSDMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_BorrowingsUSDMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_BorrowingsEURMember" xlink:label="lbl_BorrowingsEURMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BorrowingsByNameMember" xlink:to="lbl_BorrowingsEURMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:label="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:type="locator"/>
      <link:presentationArc order="3.2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDisposalGroupHeldForSaleDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalGroupHeldForSaleAbstract" xlink:label="lbl_DisposalGroupHeldForSaleAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisposalGroupHeldForSaleAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis" xlink:to="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:label="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember" xlink:to="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:label="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember" xlink:to="lbl_DisposalGroupsClassifiedAsHeldForSaleMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalGroupHeldForSaleLineItems" xlink:label="lbl_DisposalGroupHeldForSaleLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_DisposalGroupHeldForSaleLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:label="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisposalGroupHeldForSaleLineItems" xlink:to="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="lbl_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_OtherCurrentNonfinancialAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:label="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisposalGroupHeldForSaleLineItems" xlink:to="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_OtherCurrentNonfinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" xlink:to="lbl_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="lbl_DisclosureOfBusinessCombinationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsAbstract" xlink:to="lbl_DisclosureOfBusinessCombinationsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetAssetsDerecognized" xlink:label="lbl_NetAssetsDerecognized" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_NetAssetsDerecognized" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DividendsPayable" xlink:label="lbl_DividendsPayable" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DividendsPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DistributionOfDividendToDividendBearingShares" xlink:label="lbl_DistributionOfDividendToDividendBearingShares" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DistributionOfDividendToDividendBearingShares" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:label="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TransactionCosts" xlink:label="lbl_TransactionCosts" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_TransactionCosts" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfBusinessCombinationsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails1" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="lbl_SegmentConsolidationItemsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentConsolidationItemsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentConsolidationItemsAxis" xlink:to="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="lbl_OperatingSegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_OperatingSegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="lbl_MaterialReconcilingItemsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForSegmentConsolidationItemsMember" xlink:to="lbl_MaterialReconcilingItemsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="lbl_SegmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_SegmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SegmentsMember" xlink:label="lbl_SegmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsAxis" xlink:to="lbl_SegmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_InnovativeMedicinesMember" xlink:label="lbl_InnovativeMedicinesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_InnovativeMedicinesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SandozMember" xlink:label="lbl_SandozMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_SandozMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CorporateMember" xlink:label="lbl_CorporateMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SegmentsMember" xlink:to="lbl_CorporateMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdministrativeExpense" xlink:label="lbl_AdministrativeExpense" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="17.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="lbl_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="18.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:presentationArc order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:presentationArc order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="lbl_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="22.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_ProfitLoss" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsThirdParties" xlink:label="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsThirdParties" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:label="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoodsSalesToOtherSegments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="lbl_RevenueFromSaleOfGoods" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromSaleOfGoods" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="lbl_OtherRevenue" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherRevenue" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CostOfSales" xlink:label="lbl_CostOfSales" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CostOfSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossProfit" xlink:label="lbl_GrossProfit" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_GrossProfit" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_SellingGeneralAndAdministrativeExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="lbl_ResearchAndDevelopmentExpense" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ResearchAndDevelopmentExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherIncome" xlink:label="lbl_OtherIncome" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherIncome" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherExpenseByFunction" xlink:label="lbl_OtherExpenseByFunction" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherExpenseByFunction" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="lbl_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:label="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProfitLossFromOperatingActivities" xlink:to="lbl_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpense" xlink:label="lbl_InterestExpense" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_InterestExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="lbl_OtherFinanceIncomeCost" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherFinanceIncomeCost" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="lbl_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:presentationArc order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossBeforeTax" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="15.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxExpenseContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:label="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:label="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="locator"/>
      <link:presentationArc order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProfitLossFromDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ApplicableTaxRateExcludingExceptionalItems" xlink:label="lbl_ApplicableTaxRateExcludingExceptionalItems" xlink:type="locator"/>
      <link:presentationArc order="20.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ApplicableTaxRateExcludingExceptionalItems" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="lbl_PropertyPlantAndEquipmentMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_PropertyPlantAndEquipmentMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RevenueFromInterest" xlink:label="lbl_RevenueFromInterest" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RevenueFromInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationAndAmortisationExpense" xlink:label="lbl_DepreciationAndAmortisationExpense" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DepreciationAndAmortisationExpense" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:label="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:label="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionsToRestructuringProvisions" xlink:label="lbl_AdditionsToRestructuringProvisions" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdditionsToRestructuringProvisions" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssetsMember" xlink:label="lbl_RightofuseAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_RightofuseAssetsMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Goodwill" xlink:label="lbl_Goodwill" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_Goodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="lbl_DeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinancialAndOtherNoncurrentAssets" xlink:label="lbl_FinancialAndOtherNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinancialAndOtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Inventories" xlink:label="lbl_Inventories" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_Inventories" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradeReceivablesAndOtherCurrentAssets" xlink:label="lbl_TradeReceivablesAndOtherCurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TradeReceivablesAndOtherCurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="lbl_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="lbl_DeferredTaxLiabilities" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DeferredTaxLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAndNoncurrentFinancialDebt" xlink:label="lbl_CurrentAndNoncurrentFinancialDebt" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentAndNoncurrentFinancialDebt" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TradePayablesProvisionsAndOtherLiabilities" xlink:label="lbl_TradePayablesProvisionsAndOtherLiabilities" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_TradePayablesProvisionsAndOtherLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetAssetsDerecognized" xlink:label="lbl_NetAssetsDerecognized" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetAssetsDerecognized" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_SignificantInvestmentsInAssociatesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForAssociatesMember" xlink:label="lbl_EntitysTotalForAssociatesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_SignificantInvestmentsInAssociatesAxis" xlink:to="lbl_EntitysTotalForAssociatesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AlconMember" xlink:label="lbl_AlconMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForAssociatesMember" xlink:to="lbl_AlconMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsAttributableToDivestedBusiness" xlink:label="lbl_CashFlowsAttributableToDivestedBusiness" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsAttributableToDivestedBusiness" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="10.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:label="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestedCashAndCashEquivalents" xlink:label="lbl_DivestedCashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc order="7.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DivestedCashAndCashEquivalents" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:label="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:label="lbl_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:type="locator"/>
      <link:presentationArc order="12.5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromCurrentAndNoncurrentBorrowings" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="13.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PresentationOfLeasesForLessesTable" xlink:label="lbl_PresentationOfLeasesForLessesTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:label="lbl_PresentationOfLeasesForLesseeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeAbstract" xlink:to="lbl_PresentationOfLeasesForLessesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLessesTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_PresentationOfLeasesForLesseeLineItems" xlink:label="lbl_PresentationOfLeasesForLesseeLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLessesTable" xlink:to="lbl_PresentationOfLeasesForLesseeLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GrossLeaseLiabilities" xlink:label="lbl_GrossLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_GrossLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NewLeaseArrangements" xlink:label="lbl_NewLeaseArrangements" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_NewLeaseArrangements" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_UndiscountedFutureLeasePayments" xlink:label="lbl_UndiscountedFutureLeasePayments" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_UndiscountedFutureLeasePayments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:label="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_EffectOfDiscounting" xlink:label="lbl_EffectOfDiscounting" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_PresentationOfLeasesForLesseeLineItems" xlink:to="lbl_EffectOfDiscounting" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsAbstract" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="lbl_ClassesOfAssetsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_ClassesOfAssetsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="lbl_ClassesOfAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsAxis" xlink:to="lbl_ClassesOfAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LandMember" xlink:label="lbl_LandMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_LandMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BuildingsMember" xlink:label="lbl_BuildingsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_BuildingsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_VehiclesMember" xlink:label="lbl_VehiclesMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_VehiclesMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherAssetsMember" xlink:label="lbl_OtherAssetsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfAssetsMember" xlink:to="lbl_OtherAssetsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:label="lbl_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_AdjustmentsForPrepaymentsAndAccruedLeasePayments" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="lbl_DepreciationRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_DepreciationRightofuseAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfTheRightofuseAssetsRollForward" xlink:label="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:label="lbl_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MovementsOfTheRightofuseAssetsRollForward" xlink:label="lbl_MovementsOfTheRightofuseAssetsRollForward1" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward1" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseContractTerminationsRightofuseAssets" xlink:label="lbl_LeaseContractTerminationsRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_LeaseContractTerminationsRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisposalsAndRetirementsRightofuseAssets" xlink:label="lbl_DisposalsAndRetirementsRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="4.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_DisposalsAndRetirementsRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="lbl_DepreciationRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MovementsOfTheRightofuseAssetsRollForward" xlink:to="lbl_DepreciationRightofuseAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" xlink:to="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:label="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" xlink:to="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseLiabilitiesUndiscounted" xlink:label="lbl_LeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_LeaseLiabilitiesUndiscounted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MostMaterialLeaseWithLeaseTermExtension" xlink:label="lbl_MostMaterialLeaseWithLeaseTermExtension" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_MostMaterialLeaseWithLeaseTermExtension" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.7" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLeaseLiabilitiesUndiscounted" xlink:label="lbl_NoncurrentLeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:presentationArc order="2.8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_NoncurrentLeaseLiabilitiesUndiscounted" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLeaseLiabilitiesUndiscounted" xlink:label="lbl_CurrentLeaseLiabilitiesUndiscounted" xlink:type="locator"/>
      <link:presentationArc order="2.6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_CurrentLeaseLiabilitiesUndiscounted" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_InterestExpenseOnLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashOutflowForLeases" xlink:label="lbl_CashOutflowForLeases" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashOutflowForLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RepaymentOfLeaseLiability" xlink:label="lbl_RepaymentOfLeaseLiability" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RepaymentOfLeaseLiability" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:label="lbl_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_WeightedAverageInterestRateLeaseLiabilities" xlink:label="lbl_WeightedAverageInterestRateLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="11.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_WeightedAverageInterestRateLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_LeaseIncentives" xlink:label="lbl_LeaseIncentives" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_LeaseIncentives" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="locator"/>
      <link:presentationArc order="1.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="locator"/>
      <link:presentationArc order="3.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOutflowsForShortTermAndLowValueLeases" xlink:label="lbl_CashOutflowsForShortTermAndLowValueLeases" xlink:type="locator"/>
      <link:presentationArc order="2.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashOutflowsForShortTermAndLowValueLeases" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashOutflowsForPaymentsOfLeasesInterest" xlink:label="lbl_CashOutflowsForPaymentsOfLeasesInterest" xlink:type="locator"/>
      <link:presentationArc order="2.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashOutflowsForPaymentsOfLeasesInterest" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc order="3.2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutLeasesForLesseeAbstract" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:label="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:label="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsTable" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowForLeases" xlink:label="lbl_CashInflowForLeases" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashInflowForLeases" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:label="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_GainsLossesArisingFromSaleAndLeasebackTransactions" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RealEstateMember" xlink:label="lbl_RealEstateMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lbl_RealEstateMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_SaleAndLeaseBackMember" xlink:label="lbl_SaleAndLeaseBackMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lbl_SaleAndLeaseBackMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowForSaleAndLeaseback" xlink:label="lbl_CashInflowForSaleAndLeaseback" xlink:type="locator"/>
      <link:presentationArc order="1.5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems" xlink:to="lbl_CashInflowForSaleAndLeaseback" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiabilityTables" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:label="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" xlink:label="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:label="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" xlink:label="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" xlink:label="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" xlink:label="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:label="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:label="lbl_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:type="locator"/>
      <link:presentationArc order="2.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" xlink:to="lbl_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails5" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="lbl_MaturityAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_MaturityAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="lbl_AggregatedTimeBandsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_MaturityAxis" xlink:to="lbl_AggregatedTimeBandsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="lbl_NotLaterThanOneYearMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_NotLaterThanOneYearMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="lbl_LaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="locator"/>
      <link:presentationArc order="5.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregatedTimeBandsMember" xlink:to="lbl_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:label="lbl_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UndiscountedFinanceLeasePaymentsToBeReceived" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:label="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:label="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_MinimumFinaceLeasePaymentsReceivableAtPresentValue" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_FinanceLeaseProvision" xlink:label="lbl_FinanceLeaseProvision" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceLeaseProvision" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinanceLeaseReceivables" xlink:label="lbl_FinanceLeaseReceivables" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_FinanceLeaseReceivables" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="lbl_LeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails6" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsAbstract" xlink:to="lbl_DisclosureOfOperatingSegmentsTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="lbl_AdditionsToRightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfOperatingSegmentsLineItems" xlink:to="lbl_AdditionsToRightofuseAssets" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails7" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="lbl_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" xlink:label="lbl_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" xlink:to="lbl_StatementOfFinancialPositionAbstract" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementOfFinancialPositionAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RestatedMember" xlink:label="lbl_RestatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:to="lbl_RestatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PreviouslyStatedMember" xlink:label="lbl_PreviouslyStatedMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_PreviouslyStatedMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_RestatedMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember" xlink:label="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyAndCorrectionsOfPriorPeriodErrorsMember" xlink:to="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_FinancialEffectOfChangesInAccountingPolicyMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:label="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember" xlink:to="lbl_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="lbl_AssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="lbl_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_NoncurrentAssetsAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Assets" xlink:label="lbl_Assets" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAbstract" xlink:to="lbl_Assets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="lbl_NoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_NoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="lbl_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_EquityAndLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAbstract" xlink:label="lbl_EquityAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Equity" xlink:label="lbl_Equity" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_Equity" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="lbl_LiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_LiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="lbl_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="lbl_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_CurrentLiabilitiesAbstract" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_Liabilities" xlink:label="lbl_Liabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LiabilitiesAbstract" xlink:to="lbl_Liabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="lbl_CurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="lbl_NoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ProvisionsAndOtherNoncurrentLiabilities" xlink:label="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_ProvisionsAndOtherNoncurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="lbl_EquityAndLiabilities" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAndLiabilitiesAbstract" xlink:to="lbl_EquityAndLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="lbl_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc order="0.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_PropertyPlantAndEquipment" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="lbl_RightofuseAssets" xlink:type="locator"/>
      <link:presentationArc order="0.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_RightofuseAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="lbl_OtherNoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="0.7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentAssetsAbstract" xlink:to="lbl_OtherNoncurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherReserves" xlink:label="lbl_OtherReserves" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EquityAbstract" xlink:to="lbl_OtherReserves" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="lbl_NoncurrentLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_NoncurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="lbl_CurrentLeaseLiabilities" xlink:type="locator"/>
      <link:presentationArc order="1.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_CurrentLeaseLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_NoncurrentLiabilitiesAbstract" xlink:to="lbl_OtherNoncurrentFinancialLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="lbl_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc order="0.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CurrentLiabilitiesAbstract" xlink:to="lbl_OtherCurrentFinancialLiabilities" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails7" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDiscontinuedOperationsAbstract" xlink:label="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDiscontinuedOperationsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="lbl_CarryingAmountMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lbl_CarryingAmountMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lbl_IntangibleAssetsAndGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsAndGoodwillMember" xlink:to="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentlyMarketedProductsMember" xlink:label="lbl_CurrentlyMarketedProductsMember" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_IntangibleAssetsOtherThanGoodwillMember" xlink:to="lbl_CurrentlyMarketedProductsMember" xlink:type="arc"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:label="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="lbl_ProductsAndServicesAxis" xlink:type="locator"/>
      <link:presentationArc order="4.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ProductsAndServicesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="lbl_ProductsAndServicesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesAxis" xlink:to="lbl_ProductsAndServicesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CyPassMember" xlink:label="lbl_CyPassMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ProductsAndServicesMember" xlink:to="lbl_CyPassMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:label="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:label="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_CarryingAmountMember" xlink:to="lbl_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails4" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsAxis" xlink:label="lbl_AcquisitionsAndDivestmentsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_AcquisitionsAndDivestmentsAxis" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsAndDivestmentsMember" xlink:label="lbl_AcquisitionsAndDivestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AcquisitionsAndDivestmentsAxis" xlink:to="lbl_AcquisitionsAndDivestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_AcquisitionsMember" xlink:label="lbl_AcquisitionsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AcquisitionsAndDivestmentsMember" xlink:to="lbl_AcquisitionsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DivestmentsMember" xlink:label="lbl_DivestmentsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AcquisitionsAndDivestmentsMember" xlink:to="lbl_DivestmentsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="lbl_BusinessCombinationsAxis" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_BusinessCombinationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_BusinessCombinationsAxis" xlink:to="lbl_EntitysTotalForBusinessCombinationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_TranscendMedicalIncMember" xlink:label="lbl_TranscendMedicalIncMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntitysTotalForBusinessCombinationsMember" xlink:to="lbl_TranscendMedicalIncMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="lbl_AssetsAndLiabilitiesAxis" xlink:type="locator"/>
      <link:presentationArc order="4.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_AssetsAndLiabilitiesAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AssetsAndLiabilitiesMember" xlink:label="lbl_AssetsAndLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesAxis" xlink:to="lbl_AssetsAndLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLiabilitiesMember" xlink:label="lbl_CurrentLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_CurrentLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentLiabilitiesMember" xlink:label="lbl_NoncurrentLiabilitiesMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AssetsAndLiabilitiesMember" xlink:to="lbl_NoncurrentLiabilitiesMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="5.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashFlowFromNetIdentifiableAssets" xlink:label="lbl_CashFlowFromNetIdentifiableAssets" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowFromNetIdentifiableAssets" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:label="lbl_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ReceivablesAndPayablesContingentConsiderationNet" xlink:label="lbl_ReceivablesAndPayablesContingentConsiderationNet" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ReceivablesAndPayablesContingentConsiderationNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_OtherPaymentsAndDeferredConsiderationNet" xlink:label="lbl_OtherPaymentsAndDeferredConsiderationNet" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherPaymentsAndDeferredConsiderationNet" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:label="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc order="8.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ContingentConsiderationPaid" xlink:label="lbl_ContingentConsiderationPaid" xlink:type="locator"/>
      <link:presentationArc order="9.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ContingentConsiderationPaid" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NoncurrentAssetsDivested" xlink:label="lbl_NoncurrentAssetsDivested" xlink:type="locator"/>
      <link:presentationArc order="10.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NoncurrentAssetsDivested" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ConsiderationPaidReceived" xlink:label="lbl_ConsiderationPaidReceived" xlink:type="locator"/>
      <link:presentationArc order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ConsiderationPaidReceived" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_NetCashOutflowsFromDivestments" xlink:label="lbl_NetCashOutflowsFromDivestments" xlink:type="locator"/>
      <link:presentationArc order="12.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_NetCashOutflowsFromDivestments" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentAssetsDivested" xlink:label="lbl_CurrentAssetsDivested" xlink:type="locator"/>
      <link:presentationArc order="13.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentAssetsDivested" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="lbl_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="locator"/>
      <link:presentationArc order="14.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_CurrentLiabilitiesDivested" xlink:label="lbl_CurrentLiabilitiesDivested" xlink:type="locator"/>
      <link:presentationArc order="15.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CurrentLiabilitiesDivested" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="lbl_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="locator"/>
      <link:presentationArc order="15.5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:label="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails3" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="lbl_LegalEntityAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_LegalEntityAxis" xlink:type="arc"/>
      <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="lbl_EntityDomain" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_LegalEntityAxis" xlink:to="lbl_EntityDomain" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_GSKConsumerHealthcareMember" xlink:label="lbl_GSKConsumerHealthcareMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_EntityDomain" xlink:to="lbl_GSKConsumerHealthcareMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromSalesOfInterestsInAssociates" xlink:label="lbl_ProceedsFromSalesOfInterestsInAssociates" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromSalesOfInterestsInAssociates" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:label="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails6" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="locator"/>
      <link:presentationArc order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:label="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:label="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:type="locator"/>
      <link:presentationArc order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:label="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:label="lbl_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:type="locator"/>
      <link:presentationArc order="7.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ChangeInCashSettledShareBasedPaymentsLiabilities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="lbl_OtherAdjustmentsToReconcileProfitLoss" xlink:type="locator"/>
      <link:presentationArc order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_OtherAdjustmentsToReconcileProfitLoss" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:label="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="locator"/>
      <link:presentationArc order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails2" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementTable" xlink:label="lbl_StatementTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:label="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" xlink:to="lbl_StatementTable" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_StatementLineItems" xlink:label="lbl_StatementLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefund" xlink:label="lbl_IncomeTaxesPaidRefund" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefund" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="locator"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementLineItems" xlink:to="lbl_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="lbl_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_ContinuingOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:presentationArc order="3.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_StatementTable" xlink:to="lbl_StatementLineItems" xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails8" xlink:type="extended">
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="locator"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" xlink:to="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_AggregateContinuingAndDiscontinuedOperationsMember" xlink:label="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_ContinuingAndDiscontinuedOperationsAxis" xlink:to="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_DiscontinuedOperationsMember" xlink:label="lbl_DiscontinuedOperationsMember" xlink:type="locator"/>
      <link:presentationArc order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_AggregateContinuingAndDiscontinuedOperationsMember" xlink:to="lbl_DiscontinuedOperationsMember" xlink:type="arc"/>
      <link:loc xlink:href="nvs-20191231.xsd#nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:label="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="locator"/>
      <link:presentationArc order="2.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" xlink:to="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:label="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="locator"/>
      <link:presentationArc order="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="lbl_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" xlink:to="lbl_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc"/>
   </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>nvs-20191231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>
<xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nvs="http://novartis.com/20191231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" blockDefault="" elementFormDefault="qualified" finalDefault="" targetNamespace="http://novartis.com/20191231">
   <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
   <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
   <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
   <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
   <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
   <xsd:import namespace="http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2019-03-27/full_ifrs/full_ifrs-cor_2019-03-27.xsd"/>
   <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
   <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd"/>
   <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd"/>
   <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
   <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd"/>
   <xsd:annotation>
      <xsd:appinfo>

      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvs-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
	  <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvs-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
	  <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvs-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
	  <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nvs-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
	  <link:roleType id="documentAndEntityInformation" roleURI="http://novartis.com/20191231/role/DocumentAndEntityInformation">
            <link:definition>0001000 - Document - Document and Entity Information</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="statementOfIncome" roleURI="http://novartis.com/20191231/role/StatementOfIncome">
            <link:definition>1001000 - Statement - Consolidated income statements</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="statementOfComprehensiveIncome" roleURI="http://novartis.com/20191231/role/StatementOfComprehensiveIncome">
            <link:definition>1002000 - Statement - Consolidated statements of comprehensive income</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="statementOfChangesInEquity" roleURI="http://novartis.com/20191231/role/StatementOfChangesInEquity">
            <link:definition>1004000 - Statement - Consolidated statements of changes in equity</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="balanceSheet" roleURI="http://novartis.com/20191231/role/BalanceSheet">
            <link:definition>1003000 - Statement - Consolidated balance sheets</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="statementsOfCashFlow" roleURI="http://novartis.com/20191231/role/StatementsOfCashFlow">
            <link:definition>1005000 - Statement - Consolidated cash flow statements</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePropertyPlantAndEquipmentDetails" roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails">
            <link:definition>2400900 - Disclosure - Property, plant and equipment (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePropertyPlantAndEquipmentDetails2" roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails2">
            <link:definition>2400901 - Disclosure - Property, plant and equipment (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePropertyPlantAndEquipment" roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipment">
            <link:definition>2100900 - Disclosure - Property, plant and equipment</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePropertyPlantAndEquipmentTables" roleURI="http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentTables">
            <link:definition>2300900 - Disclosure - Property, plant and equipment (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInventories" roleURI="http://novartis.com/20191231/role/DisclosureInventories">
            <link:definition>2101400 - Disclosure - Inventories</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInventoriesTables" roleURI="http://novartis.com/20191231/role/DisclosureInventoriesTables">
            <link:definition>2301400 - Disclosure - Inventories (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInventoriesDetails" roleURI="http://novartis.com/20191231/role/DisclosureInventoriesDetails">
            <link:definition>2401400 - Disclosure - Inventories (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEarningsPerShare" roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShare">
            <link:definition>2100700 - Disclosure - Earnings per share</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEarningsPerShareTables" roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShareTables">
            <link:definition>2300700 - Disclosure - Earnings per share (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEarningsPerShareDetails" roleURI="http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails">
            <link:definition>2400700 - Disclosure - Earnings per share (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSummaryOfSignificantAccountingPolicies" roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies">
            <link:definition>2100100 - Disclosure - Significant accounting policies</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInterestExpenseAndOtherFinancialIncomeExpense" roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpense">
            <link:definition>2100500 - Disclosure - Interest expense and other financial income and expense</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTaxes" roleURI="http://novartis.com/20191231/role/DisclosureTaxes">
            <link:definition>2100600 - Disclosure - Taxes</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureGoodwillAndIntangibleAssets" roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssets">
            <link:definition>2101100 - Disclosure - Goodwill and intangible assets</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilities" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilities">
            <link:definition>2101200 - Disclosure - Deferred tax assets and liabilities</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
            <link:definition>2200100 - Disclosure - Significant accounting policies (Policies)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSummaryOfSignificantAccountingPoliciesTables" roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesTables">
            <link:definition>2300100 - Disclosure - Significant accounting policies (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInterestExpenseAndOtherFinancialIncomeExpenseTables" roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseTables">
            <link:definition>2300500 - Disclosure - Interest expense and other financial income and expense (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureGoodwillAndIntangibleAssetsTables" roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables">
            <link:definition>2301100 - Disclosure - Goodwill and intangible assets (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilitiesTables" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables">
            <link:definition>2301200 - Disclosure - Deferred tax assets and liabilities (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantAccountingPoliciesDetails" roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails">
            <link:definition>2400100 - Disclosure - Significant accounting policies (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails" roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails">
            <link:definition>2400500 - Disclosure - Interest expense and other financial income and expense (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2" roleURI="http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2">
            <link:definition>2400501 - Disclosure - Interest expense and other financial income and expense (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTaxesTables" roleURI="http://novartis.com/20191231/role/DisclosureTaxesTables">
            <link:definition>2300600 - Disclosure - Taxes (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTaxesDetails" roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails">
            <link:definition>2400600 - Disclosure - Taxes (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTaxesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails2">
            <link:definition>2400601 - Disclosure - Taxes (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTaxesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureTaxesDetails3">
            <link:definition>2400602 - Disclosure - Taxes (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureGoodwillAndIntangibleAssetsDetails" roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails">
            <link:definition>2401100 - Disclosure - Goodwill and intangible assets (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureGoodwillAndIntangibleAssetsDetails2" roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails2">
            <link:definition>2401101 - Disclosure - Goodwill and intangible assets (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails">
            <link:definition>2401200 - Disclosure - Deferred tax assets and liabilities (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilitiesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails2">
            <link:definition>2401201 - Disclosure - Deferred tax assets and liabilities (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilitiesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails3">
            <link:definition>2401202 - Disclosure - Deferred tax assets and liabilities (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilitiesDetails4" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails4">
            <link:definition>2401203 - Disclosure - Deferred tax assets and liabilities (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantAccountingPoliciesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails2">
            <link:definition>2400101 - Disclosure - Significant accounting policies (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialAndOtherNoncurrentAssets" roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssets">
            <link:definition>2101300 - Disclosure - Financial and other non-current assets</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialAndOtherNoncurrentAssetsTables" roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsTables">
            <link:definition>2301300 - Disclosure - Financial and other non-current assets (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialAndOtherNoncurrentAssetsDetails" roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails">
            <link:definition>2401300 - Disclosure - Financial and other non-current assets (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialAndOtherNoncurrentAssetsDetails2" roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2">
            <link:definition>2401301 - Disclosure - Financial and other non-current assets (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialAndOtherNoncurrentAssetsDetails3" roleURI="http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails3">
            <link:definition>2401302 - Disclosure - Financial and other non-current assets (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureOtherCurrentAssets" roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssets">
            <link:definition>2101700 - Disclosure - Other current assets</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureOtherCurrentAssetsTables" roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsTables">
            <link:definition>2301700 - Disclosure - Other current assets (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureOtherCurrentAssetsDetails" roleURI="http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsDetails">
            <link:definition>2401700 - Disclosure - Other current assets (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureMarketableSecurities" roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecurities">
            <link:definition>2101600 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureMarketableSecuritiesTables" roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables">
            <link:definition>2301600 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureMarketableSecuritiesDetails" roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails">
            <link:definition>2401600 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureMarketableSecuritiesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails2">
            <link:definition>2401601 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureMarketableSecuritiesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails3">
            <link:definition>2401602 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebt" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebt">
            <link:definition>2101900 - Disclosure - Non-current financial debt</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactions" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactions">
            <link:definition>2100200 - Disclosure - Significant transactions</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCurrentFinancialDebtAndDerivativeFinancialInstruments" roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstruments">
            <link:definition>2102100 - Disclosure - Current financial debt and derivative financial instruments</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCommitmentsAndContingencies" roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingencies">
            <link:definition>2102800 - Disclosure - Commitments and contingencies</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSubsequentEventsDetails" roleURI="http://novartis.com/20191231/role/DisclosureSubsequentEventsDetails">
            <link:definition>2403100 - Disclosure - Events subsequent to the December 31 consolidated balance sheet date (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtTables" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables">
            <link:definition>2301900 - Disclosure - Non-current financial debt (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables" roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables">
            <link:definition>2302100 - Disclosure - Current financial debt and derivative financial instruments (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCommitmentsAndContingenciesTables" roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesTables">
            <link:definition>2302800 - Disclosure - Commitments and contingencies (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsDetails" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails">
            <link:definition>2400200 - Disclosure - Significant transactions (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtDetails" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails">
            <link:definition>2401900 - Disclosure - Non-current financial debt (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtDetails2" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails2">
            <link:definition>2401901 - Disclosure - Non-current financial debt (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtDetails3" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails3">
            <link:definition>2401902 - Disclosure - Non-current financial debt (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtDetails4" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails4">
            <link:definition>2401903 - Disclosure - Non-current financial debt (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtDetails5" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails5">
            <link:definition>2401904 - Disclosure - Non-current financial debt (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureNonCurrentFinancialDebtDetails6" roleURI="http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails6">
            <link:definition>2401905 - Disclosure - Non-current financial debt (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails" roleURI="http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails">
            <link:definition>2402100 - Disclosure - Current financial debt and derivative financial instruments (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCommitmentsAndContingenciesDetails" roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails">
            <link:definition>2402800 - Disclosure - Commitments and contingencies (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureCommitmentsAndContingenciesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2">
            <link:definition>2402801 - Disclosure - Commitments and contingencies (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSubsequentEvents" roleURI="http://novartis.com/20191231/role/DisclosureSubsequentEvents">
            <link:definition>2103100 - Disclosure - Events subsequent to the December 31 consolidated balance sheet date</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType>
		 <link:roleType id="disclosureProvisionsAndOtherCurrentLiabilities" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilities">
            <link:definition>2102200 - Disclosure - Provisions and other current liabilities</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAcquisitionsOfBusinesses" roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinesses">
            <link:definition>2102400 - Disclosure - Acquisitions of businesses</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociates" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociates">
            <link:definition>2102500 - Disclosure - Post-employment benefits for associates</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherCurrentLiabilitiesTables" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables">
            <link:definition>2302200 - Disclosure - Provisions and other current liabilities (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAcquisitionsOfBusinessesTables" roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesTables">
            <link:definition>2302400 - Disclosure - Acquisitions of businesses (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesTables" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables">
            <link:definition>2302500 - Disclosure - Post-employment benefits for associates (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherCurrentLiabilitiesDetails" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails">
            <link:definition>2402200 - Disclosure - Provisions and other current liabilities (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherCurrentLiabilitiesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails2">
            <link:definition>2402201 - Disclosure - Provisions and other current liabilities (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherCurrentLiabilitiesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails3">
            <link:definition>2402202 - Disclosure - Provisions and other current liabilities (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAcquisitionsOfBusinessesDetails" roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails">
            <link:definition>2402400 - Disclosure - Acquisitions of businesses (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails">
            <link:definition>2402500 - Disclosure - Post-employment benefits for associates (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails2" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2">
            <link:definition>2402501 - Disclosure - Post-employment benefits for associates (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails3" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails3">
            <link:definition>2402502 - Disclosure - Post-employment benefits for associates (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails4" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails4">
            <link:definition>2402503 - Disclosure - Post-employment benefits for associates (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails5" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails5">
            <link:definition>2402504 - Disclosure - Post-employment benefits for associates (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails6" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails6">
            <link:definition>2402505 - Disclosure - Post-employment benefits for associates (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails7" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails7">
            <link:definition>2402506 - Disclosure - Post-employment benefits for associates (Details 7)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails8" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails8">
            <link:definition>2402507 - Disclosure - Post-employment benefits for associates (Details 8)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails9" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails9">
            <link:definition>2402508 - Disclosure - Post-employment benefits for associates (Details 9)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePostEmploymentBenefitsForAssociatesDetails10" roleURI="http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails10">
            <link:definition>2402509 - Disclosure - Post-employment benefits for associates (Details 10)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivablesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails3">
            <link:definition>2401502 - Disclosure - Trade receivables (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivablesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails2">
            <link:definition>2401501 - Disclosure - Trade receivables (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivablesDetails" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails">
            <link:definition>2401500 - Disclosure - Trade receivables (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivablesTables" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesTables">
            <link:definition>2301500 - Disclosure - Trade receivables (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivables" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivables">
            <link:definition>2101500 - Disclosure - Trade receivables</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivablesDetails4" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails4">
            <link:definition>2401503 - Disclosure - Trade receivables (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTradeReceivablesDetails5" roleURI="http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails5">
            <link:definition>2401504 - Disclosure - Trade receivables (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePrincipalGroupSubsidiariesAndAssociatedCompanies" roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompanies">
            <link:definition>2103200 - Disclosure - Principal Group subsidiaries and associated companies</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables" roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables">
            <link:definition>2303200 - Disclosure - Principal Group subsidiaries and associated companies (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails" roleURI="http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails">
            <link:definition>2403200 - Disclosure - Principal Group subsidiaries and associated companies (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails2" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2">
            <link:definition>2403001 - Disclosure - Discontinued operations (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails">
            <link:definition>2403000 - Disclosure - Discontinued operations (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsTables" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables">
            <link:definition>2303000 - Disclosure - Discontinued operations (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperations" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperations">
            <link:definition>2103000 - Disclosure - Discontinued operations</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsDetails4" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails4">
            <link:definition>2402304 - Disclosure - Details to the consolidated cash flow statements (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsDetails3" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails3">
            <link:definition>2402303 - Disclosure - Details to the consolidated cash flow statements (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsDetails2" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails2">
            <link:definition>2402301 - Disclosure - Details to the consolidated cash flow statements (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsDetails" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails">
            <link:definition>2402300 - Disclosure - Details to the consolidated cash flow statements (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsTables" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsTables">
            <link:definition>2302300 - Disclosure - Details to the consolidated statements of cash flows (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatements" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatements">
            <link:definition>2102300 - Disclosure - Details to the consolidated statements of cash flows</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFigures" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFigures">
            <link:definition>2100300 - Disclosure - Segmentation of key figures</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompanies" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompanies">
            <link:definition>2100400 - Disclosure - Associated companies</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureChangesInConsolidatedStatementsOfComprehensiveIncome" roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncome">
            <link:definition>2100800 - Disclosure - Changes in consolidated statements of comprehensive income</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilities" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilities">
            <link:definition>2102000 - Disclosure - Provisions and other non-current liabilities</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociates" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociates">
            <link:definition>2102600 - Disclosure - Equity-based participation plans for associates</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedParties" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedParties">
            <link:definition>2102700 - Disclosure - Transactions with related parties</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosures" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosures">
            <link:definition>2102900 - Disclosure - Financial instruments - additional disclosures</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresTables" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables">
            <link:definition>2300300 - Disclosure - Segmentation of key figures (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesTables" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables">
            <link:definition>2300400 - Disclosure - Associated companies (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables" roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables">
            <link:definition>2300800 - Disclosure - Changes in consolidated statements of comprehensive income (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesTables" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables">
            <link:definition>2302000 - Disclosure - Provisions and other non-current liabilities (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesTables" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables">
            <link:definition>2302600 - Disclosure - Equity-based participation plans for associates (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedPartiesTables" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesTables">
            <link:definition>2302700 - Disclosure - Transactions with related parties (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresTables" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables">
            <link:definition>2302900 - Disclosure - Financial instruments - additional disclosures (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails">
            <link:definition>2400300 - Disclosure - Segmentation of key figures (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesDetails" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails">
            <link:definition>2400400 - Disclosure - Associated companies (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails" roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails">
            <link:definition>2400800 - Disclosure - Changes in consolidated statements of comprehensive income (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2" roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2">
            <link:definition>2400801 - Disclosure - Changes in consolidated statements of comprehensive income (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails3" roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails3">
            <link:definition>2400802 - Disclosure - Changes in consolidated statements of comprehensive income (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4" roleURI="http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4">
            <link:definition>2400803 - Disclosure - Changes in consolidated statements of comprehensive income (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails">
            <link:definition>2402000 - Disclosure - Provisions and other non-current liabilities (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails">
            <link:definition>2402600 - Disclosure - Equity-based participation plans for associates (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails2">
            <link:definition>2402601 - Disclosure - Equity-based participation plans for associates (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails3">
            <link:definition>2402602 - Disclosure - Equity-based participation plans for associates (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails4" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails4">
            <link:definition>2402603 - Disclosure - Equity-based participation plans for associates (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails5" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails5">
            <link:definition>2402604 - Disclosure - Equity-based participation plans for associates (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails6" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails6">
            <link:definition>2402605 - Disclosure - Equity-based participation plans for associates (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails7" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails7">
            <link:definition>2402606 - Disclosure - Equity-based participation plans for associates (Details 7)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails8" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails8">
            <link:definition>2402607 - Disclosure - Equity-based participation plans for associates (Details 8)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityBasedParticipationPlansForAssociatesDetails9" roleURI="http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails9">
            <link:definition>2402608 - Disclosure - Equity-based participation plans for associates (Details 9)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedPartiesDetails" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails">
            <link:definition>2041200 - Disclosure - Transactions with related parties (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedPartiesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2">
            <link:definition>2402701 - Disclosure - Transactions with related parties (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedPartiesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails3">
            <link:definition>2402702 - Disclosure - Transactions with related parties (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails">
            <link:definition>2402900 - Disclosure - Financial instruments - additional disclosures (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureGoodwillAndIntangibleAssetsDetails3" roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails3">
            <link:definition>2401102 - Disclosure - Goodwill and intangible assets (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureGoodwillAndIntangibleAssetsDetails4" roleURI="http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails4">
            <link:definition>2401103 - Disclosure - Goodwill and intangible assets (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType>
		 <link:roleType id="disclosureSegmentationOfKeyFiguresDetails2" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2">
            <link:definition>2400302 - Disclosure - Segmentation of key figures (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails3" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3">
            <link:definition>2400303 - Disclosure - Segmentation of key figures (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails4" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4">
            <link:definition>2400304 - Disclosure - Segmentation of key figures (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails5" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5">
            <link:definition>2400305 - Disclosure - Segmentation of key figures (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails6" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6">
            <link:definition>2400306 - Disclosure - Segmentation of key figures (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails7" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7">
            <link:definition>2400307 - Disclosure - Segmentation of key figures (Details 7)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails2">
            <link:definition>2400401 - Disclosure - Associated companies (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails3">
            <link:definition>2400402 - Disclosure - Associated companies (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesDetails4" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails4">
            <link:definition>2400403 - Disclosure - Associated companies (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesDetails5" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails5">
            <link:definition>2400404 - Disclosure - Associated companies (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAssociatedCompaniesDetails6" roleURI="http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails6">
            <link:definition>2400405 - Disclosure - Associated companies (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2">
            <link:definition>2402001 - Disclosure - Provisions and other non-current liabilities (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails3">
            <link:definition>2402002 - Disclosure - Provisions and other non-current liabilities (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4">
            <link:definition>2402003 - Disclosure - Provisions and other non-current liabilities (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5">
            <link:definition>2402004 - Disclosure - Provisions and other non-current liabilities (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureProvisionsAndOtherNonCurrentLiabilitiesDetails6" roleURI="http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails6">
            <link:definition>2402005 - Disclosure - Provisions and other non-current liabilities (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquity" roleURI="http://novartis.com/20191231/role/DisclosureEquity">
            <link:definition>2101800 - Disclosure - Equity</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityTables" roleURI="http://novartis.com/20191231/role/DisclosureEquityTables">
            <link:definition>2301800 - Disclosure - Equity (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityDetails" roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails">
            <link:definition>2401800 - Disclosure - Equity (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityDetails2" roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails2">
            <link:definition>2401801 - Disclosure - Equity (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityDetails3" roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails3">
            <link:definition>2401802 - Disclosure - Equity (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityDetails4" roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails4">
            <link:definition>2401803 - Disclosure - Equity (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="statementsOfCashFlowParenthetical" roleURI="http://novartis.com/20191231/role/StatementsOfCashFlowParenthetical">
            <link:definition>1005010 - Statement - Consolidated cash flow statements (Parenthetical)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails1" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails1">
            <link:definition>2400301 - Disclosure - Segmentation of key figures (Details 1)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureEquityDetails5" roleURI="http://novartis.com/20191231/role/DisclosureEquityDetails5">
            <link:definition>2401804 - Disclosure - Equity (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsDetails5" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails5">
            <link:definition>2402305 - Disclosure - Details to the consolidated cash flow statements (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails2" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails2">
            <link:definition>2402901 - Disclosure - Financial instruments - additional disclosures (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails3" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails3">
            <link:definition>2402902 - Disclosure - Financial instruments - additional disclosures (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails4" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails4">
            <link:definition>2402903 - Disclosure - Financial instruments - additional disclosures (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:labelLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails5" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails5">
            <link:definition>2402904 - Disclosure - Financial instruments - additional disclosures (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails6" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails6">
            <link:definition>2402905 - Disclosure - Financial instruments - additional disclosures (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails7" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails7">
            <link:definition>2402906 - Disclosure - Financial instruments - additional disclosures (Details 7)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails8" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails8">
            <link:definition>2402907 - Disclosure - Financial instruments - additional disclosures (Details 8)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails9" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails9">
            <link:definition>2402908 - Disclosure - Financial instruments - additional disclosures (Details 9)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails10" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails10">
            <link:definition>2402909 - Disclosure - Financial instruments - additional disclosures (Details 10)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails11" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails11">
            <link:definition>2402910 - Disclosure - Financial instruments - additional disclosures (Details 11)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails12" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails12">
            <link:definition>2402911 - Disclosure - Financial instruments - additional disclosures (Details 12)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails13" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails13">
            <link:definition>2402912 - Disclosure - Financial instruments - additional disclosures (Details 13)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDeferredTaxAssetsAndLiabilitiesDetails5" roleURI="http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails5">
            <link:definition>2401204 - Disclosure - Deferred tax assets and liabilities (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantAccountingPoliciesDetails3" roleURI="http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails3">
            <link:definition>2400102 - Disclosure - Significant accounting policies (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureBasisOfPreparationQ" roleURI="http://novartis.com/20191231/role/DisclosureBasisOfPreparationQ">
            <link:definition>2010100 - Disclosure - Basis of preparation</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSelectedCriticalAccountingPoliciesQ" roleURI="http://novartis.com/20191231/role/DisclosureSelectedCriticalAccountingPoliciesQ">
            <link:definition>2010200 - Disclosure - Selected critical accounting policies</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsQ" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsQ">
            <link:definition>2010300 - Disclosure - Significant transactions</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSummaryOfEquityToShareholdersQ" roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfEquityToShareholdersQ">
            <link:definition>2010400 - Disclosure - Summary of equity attributable to Novartis AG shareholders</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsQ" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsQ">
            <link:definition>2010500 - Disclosure - Financial instruments</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLegalProceedingsUpdateQ" roleURI="http://novartis.com/20191231/role/DisclosureLegalProceedingsUpdateQ">
            <link:definition>2010900 - Disclosure - Legal proceedings update</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsQ" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsQ">
            <link:definition>2102900 - Disclosure - Impacts of adoption of new IFRS standards</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSubsequentEventsQ" roleURI="http://novartis.com/20191231/role/DisclosureSubsequentEventsQ">
            <link:definition>2011100 - Disclosure - Subsequent events</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresQ" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresQ">
            <link:definition>2011000 - Disclosure - Segmentation of key figures</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSelectedCriticalAccountingPoliciesPoliciesQ" roleURI="http://novartis.com/20191231/role/DisclosureSelectedCriticalAccountingPoliciesPoliciesQ">
            <link:definition>2020200 - Disclosure - Selected critical accounting policies (Policies)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSummaryOfEquityToShareholdersTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfEquityToShareholdersTablesQ">
            <link:definition>2030400 - Disclosure - Summary of equity attributable to Novartis AG shareholders (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsTablesQ">
            <link:definition>2030500 - Disclosure - Financial instruments (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsTablesQ">
            <link:definition>2302900 - Disclosure - Impacts of adoption of new IFRS standards (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTablesQ">
            <link:definition>2031000 - Disclosure - Segmentation of key figures (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSelectedCriticalAccountingPoliciesDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureSelectedCriticalAccountingPoliciesDetailsQ">
            <link:definition>2040200 - Disclosure - Selected critical accounting policies (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetailsQ">
            <link:definition>2040300 - Disclosure - Significant transactions (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSummaryOfEquityToShareholdersDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureSummaryOfEquityToShareholdersDetailsQ">
            <link:definition>2040400 - Disclosure - Summary of equity attributable to Novartis AG shareholders (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsDetailsQ">
            <link:definition>2040500 - Disclosure - Financial instruments (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsDetails2Q" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsDetails2Q">
            <link:definition>2040501 - Disclosure - Financial instruments (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsDetailsQ">
            <link:definition>2402900 - Disclosure - Impacts of adoption of new IFRS standards (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsDetails2Q" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsDetails2Q">
            <link:definition>2402901 - Disclosure - Impacts of adoption of new IFRS standards (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetailsQ">
            <link:definition>2041000 - Disclosure - Segmentation of key figures (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails2Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2Q">
            <link:definition>2041001 - Disclosure - Segmentation of key figures (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails3Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3Q">
            <link:definition>2041002 - Disclosure - Segmentation of key figures (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails4Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4Q">
            <link:definition>2041003 - Disclosure - Segmentation of key figures (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails5Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5Q">
            <link:definition>2041004 - Disclosure - Segmentation of key figures (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails6Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6Q">
            <link:definition>2041005 - Disclosure - Segmentation of key figures (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails7Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7Q">
            <link:definition>2041006 - Disclosure - Segmentation of key figures (Details 7)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails8Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8Q">
            <link:definition>2041007 - Disclosure - Segmentation of key figures (Details 8)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails9Q" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails9Q">
            <link:definition>2041008 - Disclosure - Segmentation of key figures (Details 9)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsDetails3Q" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsDetails3Q">
            <link:definition>2402902 - Disclosure - Impacts of adoption of new IFRS standards (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsDetails4Q" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsDetails4Q">
            <link:definition>2402903 - Disclosure - Impacts of adoption of new IFRS standards (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsDetails3Q" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsDetails3Q">
            <link:definition>2040502 - Disclosure - Financial instruments (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsDetails4Q" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsDetails4Q">
            <link:definition>2040503 - Disclosure - Financial instruments (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedPartiesDetails1_1df9063b" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails1">
            <link:definition>2402700 - Disclosure - Transaction with related parties (Details 1)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureImpactOfAdaptionOfNewIfrsStandardsDetails5Q" roleURI="http://novartis.com/20191231/role/DisclosureImpactOfAdaptionOfNewIfrsStandardsDetails5Q">
            <link:definition>2402904 - Disclosure - Impacts of adoption of new IFRS standards (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureTransactionsWithRelatedPartiesDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetailsQ">
            <link:definition>2011100 - Disclosure - Transactions with related parties</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails8" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8">
            <link:definition>2400308 - Disclosure - Segmentation of key figures (Details 8)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails9" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails9">
            <link:definition>2400309 - Disclosure - Segmentation of key figures (Details 9)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails10" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails10">
            <link:definition>2400310 - Disclosure - Segmentation of key figures (Details 10)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDisposalGroupHeldForSaleDetails" roleURI="http://novartis.com/20191231/role/DisclosureDisposalGroupHeldForSaleDetails">
            <link:definition>2400202 - Disclosure - Significant transactions (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureFinancialInstrumentsAdditionalDisclosuresDetails14" roleURI="http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails14">
            <link:definition>2402913 - Disclosure - Financial instruments - additional disclosures (Details 14)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsTables" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables">
            <link:definition>2300200 - Disclosure - Significant transactions (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails11" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails11">
            <link:definition>2400311 - Disclosure - Segmentation of key figures - Top 20 (Details 11)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSegmentationOfKeyFiguresDetails12" roleURI="http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails12">
            <link:definition>2400312 - Disclosure - Segmentation of key figures - Net sales by region (Details 12)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedCashFlowStatementsDetails6" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails6">
            <link:definition>2402302 - Disclosure - Details to the consolidated cash flow statements (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsQ" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsQ">
            <link:definition>2011100 - Disclosure - Discontinued operations</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsQ" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsQ">
            <link:definition>2010600 - Disclosure - Lease liabilities and right-of-use assets</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedStatementsCashFlowsQ" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedStatementsCashFlowsQ">
            <link:definition>2010700 - Disclosure - Details to the consolidated statements of cash flows</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsTablesQ">
            <link:definition>2030300 - Disclosure - Significant transactions (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsTablesQ">
            <link:definition>2030600 - Disclosure - Lease liability and Right-of-use assets (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedStatementsCashFlowsTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedStatementsCashFlowsTablesQ">
            <link:definition>2030700 - Disclosure - Details to the consolidated statements of cash flows (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTablesQ">
            <link:definition>2031100 - Disclosure - Discontinued operations (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetailsQ">
            <link:definition>2040600 - Disclosure - Lease liability and Right-of-use assets (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails1Q" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails1Q">
            <link:definition>2040601 - Disclosure - Lease liability and Right-of-use assets (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails2Q" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2Q">
            <link:definition>2040602 - Disclosure - Lease liability and Right-of-use assets (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails3Q" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3Q">
            <link:definition>2040603 - Disclosure - Lease liability and Right-of-use assets (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsDetails1Q" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails1Q">
            <link:definition>2040301 - Disclosure - Significant transactions (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetailsQ">
            <link:definition>2041100 - Disclosure - Discontinued operations (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedStatementsCashFlowsDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetailsQ">
            <link:definition>2040700 - Disclosure - Details to the consolidated statements of cash flows (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDetailsConsolidatedStatementsCashFlowsDetails1Q" roleURI="http://novartis.com/20191231/role/DisclosureDetailsConsolidatedStatementsCashFlowsDetails1Q">
            <link:definition>2040701 - Disclosure - Details to the consolidated statements of cash flows (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAcquisitionOfBusinessesQ" roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionOfBusinessesQ">
            <link:definition>2010800 - Disclosure - Acquisition of businesses</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAcquisitionOfBusinessesTablesQ" roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionOfBusinessesTablesQ">
            <link:definition>2030800 - Disclosure - Acquisition of businesses (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureAcquisitionOfBusinessesDetailsQ" roleURI="http://novartis.com/20191231/role/DisclosureAcquisitionOfBusinessesDetailsQ">
            <link:definition>2040801 - Disclosure - Acquisition of businesses (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails1Q" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails1Q">
            <link:definition>2041101 - Disclosure - Discontinued operations (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails2Q" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2Q">
            <link:definition>2041102 - Disclosure - Discontinued operations (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails4Q" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4Q">
            <link:definition>2040604 - Disclosure - Lease liability and Right-of-use assets (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails5Q" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5Q">
            <link:definition>2040605 - Disclosure - Lease liability and Right-of-use assets (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType>
		 <link:roleType id="disclosureSignificantTransactionsDetails2Q" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2Q">
            <link:definition>2040302 - Disclosure - Significant transactions (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails3Q" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3Q">
            <link:definition>2041103 - Disclosure - Discontinued operations (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureRightOfUseAssetsAndLeaseLiability" roleURI="http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiability">
            <link:definition>2101000 - Disclosure - Right-of-use assets and lease liabilities</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureRightOfUseAssetsAndLeaseLiabilityTables" roleURI="http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiabilityTables">
            <link:definition>2301000 - Disclosure - Right-of-use assets and lease liabilities (Tables)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureSignificantTransactionsDetails2" roleURI="http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2">
            <link:definition>2400201 - Disclosure - Significant transactions (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails3" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3">
            <link:definition>2403005 - Disclosure - Discontinued operations (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails4" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails4">
            <link:definition>2403003 - Disclosure - Discontinued operations (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails">
            <link:definition>2401000 - Disclosure - Lease liability and Right-of-use assets (Details)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails2" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2">
            <link:definition>2401001 - Disclosure - Lease liability and Right-of-use assets (Details 2)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails3" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3">
            <link:definition>2401002 - Disclosure - Lease liability and Right-of-use assets (Details 3)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails4" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4">
            <link:definition>2401003 - Disclosure - Lease liability and Right-of-use assets (Details 4)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails5" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5">
            <link:definition>2401004 - Disclosure - Lease liability and Right-of-use assets (Details 5)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails6" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails6">
            <link:definition>2401005 - Disclosure - Lease liability and Right-of-use assets (Details 6)</link:definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails5" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails5">
            <definition xmlns="http://www.xbrl.org/2003/linkbase">2403004 - Disclosure - Discontinued operations (Details 5)</definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails6" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails6">
            <definition xmlns="http://www.xbrl.org/2003/linkbase">2403002 - Disclosure - Discontinued operations (Details 3)</definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureLeaseLiabilityAndRightOfUseAssetsDetails7" roleURI="http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails7">
            <definition xmlns="http://www.xbrl.org/2003/linkbase">2401006 - Disclosure - Lease liability and Right-of-use assets (Details 7)</definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails7" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails7">
            <definition xmlns="http://www.xbrl.org/2003/linkbase">2403006 - Disclosure - Discontinued operations (Details 7)</definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType><link:roleType id="disclosureDiscontinuedOperationsDetails8" roleURI="http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails8">
            <definition xmlns="http://www.xbrl.org/2003/linkbase">2403007 - Disclosure - Discontinued operations (Details 8)</definition>
            <link:usedOn>link:calculationLink</link:usedOn>
            <link:usedOn>link:definitionLink</link:usedOn>
            <link:usedOn>link:presentationLink</link:usedOn>
         </link:roleType></xsd:appinfo>
   </xsd:annotation>
   <xsd:element abstract="false" id="nvs_ProvisionsAndOtherNoncurrentLiabilities" name="ProvisionsAndOtherNoncurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" name="NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_StatementTable" name="StatementTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_StatementLineItems" name="StatementLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PropertyPlantAndEquipmentTableTextBlock" name="PropertyPlantAndEquipmentTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoriesDisclosureAbstract" name="InventoriesDisclosureAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfInventoryCurrentTableTextBlock" name="ScheduleOfInventoryCurrentTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryCurrentTable" name="InventoryCurrentTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryAxis" name="InventoryAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryMember" name="InventoryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryRawMaterialsGrossMember" name="InventoryRawMaterialsGrossMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryWorkInProgressGrossMember" name="InventoryWorkInProgressGrossMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryFinishedGoodsGrossMember" name="InventoryFinishedGoodsGrossMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoryLineItems" name="InventoryLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" name="ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" name="DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AssumptionsUsedInTheCalculationOfValuationTextBlock" name="AssumptionsUsedInTheCalculationOfValuationTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" name="AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfIncomeTaxAbstract" name="DisclosureOfIncomeTaxAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncomeBeforeTaxesTableTextBlock" name="IncomeBeforeTaxesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentAndDeferredIncomeTaxExpenseTableTextBlock" name="CurrentAndDeferredIncomeTaxExpenseTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AnalysisOfTaxRateTableTextBlock" name="AnalysisOfTaxRateTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" name="DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_InterestExpenseTableTextBlock" name="InterestExpenseTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherFinancialIncomeAndExpenseTableTextBlock" name="OtherFinancialIncomeAndExpenseTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" name="DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" name="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" name="TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SignificantAccountingPoliciesAbstract" name="SignificantAccountingPoliciesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" name="RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" name="RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" name="DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" name="DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" name="DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" name="DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FurnitureAndVehiclesMember" name="FurnitureAndVehiclesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MarketingRelatedIntangibleAssetsMember" name="MarketingRelatedIntangibleAssetsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentlyMarketedProductsMember" name="CurrentlyMarketedProductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IncomeStatementLocationAxis" name="IncomeStatementLocationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IncomeStatementLocationMember" name="IncomeStatementLocationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CostOfSalesMember" name="CostOfSalesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CostOfSalesOrResearchAndDevelopmentMember" name="CostOfSalesOrResearchAndDevelopmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InterestExpenseAbstract" name="InterestExpenseAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OtherFinancialIncomeAndExpenseAbstract" name="OtherFinancialIncomeAndExpenseAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncomeOnForwardContractsAndOptions" name="IncomeOnForwardContractsAndOptions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncomeTaxExpense" name="IncomeTaxExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectOfCreditsAndAllowances" name="TaxRateEffectOfCreditsAndAllowances" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectOfWriteOffOfDeferredTaxAssets" name="TaxRateEffectOfWriteOffOfDeferredTaxAssets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" name="TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectFromBenefitsExpiring" name="TaxRateEffectFromBenefitsExpiring" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AverageEffectiveTaxRateContinuingOperations" name="AverageEffectiveTaxRateContinuingOperations" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AverageEffectiveTaxRateDiscontinuedOperations" name="AverageEffectiveTaxRateDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember" name="PensionsAndOtherBenefitObligationsOfAssociatesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InventoriesMember" name="InventoriesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TaxLossCarryforwardsMember" name="TaxLossCarryforwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" name="IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" name="OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" name="TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InvestmentsInSubsidiariesMember" name="InvestmentsInSubsidiariesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GoodwillFromAcquisitionsMember" name="GoodwillFromAcquisitionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BalanceSheetTreatmentAxis" name="BalanceSheetTreatmentAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BalanceSheetTreatmentMember" name="BalanceSheetTreatmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CapitalizedMember" name="CapitalizedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NotCapitalizedMember" name="NotCapitalizedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_YearOfExpiryAxis" name="YearOfExpiryAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_YearOfExpiryMember" name="YearOfExpiryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OneYearMember" name="OneYearMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TwoYearsMember" name="TwoYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ThreeYearsMember" name="ThreeYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FourYearsMember" name="FourYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FiveYearsMember" name="FiveYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MoreThanFiveYearsMember" name="MoreThanFiveYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ValueOfTaxLossCarryforwardsExpired" name="ValueOfTaxLossCarryforwardsExpired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" name="DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" name="DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" name="UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProvisionForIncomeTaxesOnUnremittedEarnings" name="ProvisionForIncomeTaxesOnUnremittedEarnings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" name="DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" name="DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfFinancialAssetsTableTextBlock" name="DisclosureOfFinancialAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOtherNoncurrentAssetsTableTextBlock" name="DisclosureOfOtherNoncurrentAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" name="DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OtherCurrentAssetsAbstract" name="OtherCurrentAssetsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherCurrentAssetsTableTextBlock" name="OtherCurrentAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_WithholdingTaxRecoverable" name="WithholdingTaxRecoverable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CurrentIncomeTaxReceivable" name="CurrentIncomeTaxReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CurrentPrepaidExpensesAssociatedCompanies" name="CurrentPrepaidExpensesAssociatedCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ReceivablesAssociatedCompanies" name="ReceivablesAssociatedCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OtherReceivablesAndCurrentAssets" name="OtherReceivablesAndCurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" name="DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" name="DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" name="MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashAndCashEquivalentsTableTextBlock" name="CashAndCashEquivalentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FundInstrumentsHeld" name="FundInstrumentsHeld" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DebtSecuritiesDenominationsAbstract" name="DebtSecuritiesDenominationsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MovementInDeferredTaxBalanceRollForward" name="MovementInDeferredTaxBalanceRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationReceivable" name="ContingentConsiderationReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfOtherNoncurrentAssetsAbstract" name="DisclosureOfOtherNoncurrentAssetsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DeferredCompensationPlansAssets" name="DeferredCompensationPlansAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PrepaidPostemploymentBenefitPlansAssets" name="PrepaidPostemploymentBenefitPlansAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_FinanceLeaseProvision" name="FinanceLeaseProvision" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_MovementInTheShareCapitalTableTextBlock" name="MovementInTheShareCapitalTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MovementInTheShareslTableTextBlock" name="MovementInTheShareslTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SubsequentEventTypAxis" name="SubsequentEventTypAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SubsequentEventTypeMember" name="SubsequentEventTypeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SubsequentEventMember" name="SubsequentEventMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CommitmentsAndContingenciesAbstract" name="CommitmentsAndContingenciesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfCommitmentsAndContingenciesTextBlock" name="DisclosureOfCommitmentsAndContingenciesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfSignificantTransactionsAbstract" name="DisclosureOfSignificantTransactionsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfSignificantTransactionsTextBlock" name="DisclosureOfSignificantTransactionsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" name="DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" name="DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" name="DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" name="DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" name="DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" name="DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" name="DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" name="DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" name="DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfLeasingCommitmentsTableTextBlock" name="DisclosureOfLeasingCommitmentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" name="DisclosureOfResearchAndDevelopmentCommitmentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LeasingCommitmentsAbstract" name="LeasingCommitmentsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" name="ScheduleForCommitmentsUnderFixedTermOperatingLeasesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" name="ScheduleForCommitmentsUnderFixedTermOperatingLeasesLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ResearchAndDevelopmentCommitmentsAbstract" name="ResearchAndDevelopmentCommitmentsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentTable" name="ScheduleForCommitmentsUnderResearchAndDevelopmentTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" name="ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CommitmentsUnderLongtermResearchAgreements" name="CommitmentsUnderLongtermResearchAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" name="CurrentFinancialDebtAndDerivativeFinancialInstrumentsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" name="CurrentFinancialDebtAndDerivativeFinancialInstrumentsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_InterestBearningAccountsOfAssociatesPayableOnDemand" name="InterestBearningAccountsOfAssociatesPayableOnDemand" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" name="DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" name="DisclosureOfComponentsOfNoncurrentFinancialDebtsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" name="DisclosureOfComponentsOfNoncurrentFinancialDebtsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember" name="LaterThanFiveYearsAndNotLaterThanSixYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LaterThanSixYearsMember" name="LaterThanSixYearsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" name="DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" name="DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" name="DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NoncurrentFinancialDebtsCoveredByCollateral" name="NoncurrentFinancialDebtsCoveredByCollateral" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" name="A4.25EUR1500MillionBond20092016OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.757Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" name="A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" name="A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" name="A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" name="A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" name="A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" name="A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" name="A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" name="A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" name="A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" name="A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" name="A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" name="A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" name="A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" name="A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BorrowingsLender" name="BorrowingsLender" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BorrowingsPremiumDiscount" name="BorrowingsPremiumDiscount" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherNoncurrentFinancialDebt" name="OtherNoncurrentFinancialDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_FairValueByMeasurementBasisAxis" name="FairValueByMeasurementBasisAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FairValueByMeasurementBasisMember" name="FairValueByMeasurementBasisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CarryingReportedAmountFairValueDisclosureMember" name="CarryingReportedAmountFairValueDisclosureMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FairValueDisclosureItemAmountsMember" name="FairValueDisclosureItemAmountsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments" name="OtherComprehensiveIncomeNetOfTaxFinancialInstruments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" name="IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueAdjustmentsRelatedToDivestments" name="FairValueAdjustmentsRelatedToDivestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" name="PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" name="ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" name="PurchaseOfFinancialAssetsClassifiedAsInvestingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" name="ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" name="ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges" name="CashFlowsBeforeWorkingCapitalAndProvisionChanges" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" name="A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BorrowingsIssuanceDate" name="BorrowingsIssuanceDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrencyOthersMember" name="CurrencyOthersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OperatingIncomeMember" name="OperatingIncomeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TranscendMedicalIncMember" name="TranscendMedicalIncMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SelexysPharmaceuticalsCorporationMember" name="SelexysPharmaceuticalsCorporationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ZiarcoGroupLimitedMember" name="ZiarcoGroupLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EncoreVisionIncMember" name="EncoreVisionIncMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EliLillyAndCompanyMember" name="EliLillyAndCompanyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GSKOncologyProductsMember" name="GSKOncologyProductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GSKVaccinesMember" name="GSKVaccinesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GSKConsumerHealthcareMember" name="GSKConsumerHealthcareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GSKTotalTransactionMember" name="GSKTotalTransactionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CSLMember" name="CSLMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SpinifexMember" name="SpinifexMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdmuneTheraputicsMember" name="AdmuneTheraputicsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" name="DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" name="DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfAcquisitionOfBusinessesAbstract" name="DisclosureOfAcquisitionOfBusinessesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" name="ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProvisionsForReductionOfRevenueTableTextBlock" name="ProvisionsForReductionOfRevenueTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RestructuringProvisionsMovementsTableTextBlock" name="RestructuringProvisionsMovementsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" name="FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfDefinedBenefitPlansTableTextBlock" name="DisclosureOfDefinedBenefitPlansTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" name="DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" name="BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfAssumptionsUsedTableTextBlock" name="ScheduleOfAssumptionsUsedTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" name="ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock" name="ScheduleOfHealthCareCostTrendRatesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock" name="ScheduleOfAllocationOfPlanAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock" name="ScheduleOfExpectedBenefitPaymentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" name="AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" name="AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" name="CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" name="AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" name="OtherIntangibleAssetsRecognisedAsOfAcquisitionDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" name="TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PotentiallyRefundableConsiderationFromAcquisition" name="PotentiallyRefundableConsiderationFromAcquisition" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueOfAcquireeFullYear" name="RevenueOfAcquireeFullYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" name="SaleOfBusinessAssetsArisingFromContingenciesAmountRecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" name="SaleOfBusinessAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" name="SaleOfBusinessContingentConsiderationArrangementsRangeOfOutcomesValueHigh" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" name="SaleOfBusinessContingentOptionArrangementsRangeOfOutcomesValueHigh" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SaleOfBusinessContingentOptionArrangementsFeePaid" name="SaleOfBusinessContingentOptionArrangementsFeePaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PercentageOfVotingEquityInterestsContributed" name="PercentageOfVotingEquityInterestsContributed" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionRelatedCosts" name="TransactionRelatedCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionRelatedCostsPaid" name="TransactionRelatedCostsPaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProvisionsAndOtherCurrentLiabilitiesLineItems" name="ProvisionsAndOtherCurrentLiabilitiesLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent" name="AccrualForTaxesOtherThanIncomeTaxesCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AccruedRoyaltiesPayableClassifiedAsCurrent" name="AccruedRoyaltiesPayableClassifiedAsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_ProvisionsForDeductionsFromRevenueRollForward" name="ProvisionsForDeductionsFromRevenueRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ChangesInOffsetAgainstGrossTradeReceivables" name="ChangesInOffsetAgainstGrossTradeReceivables" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RestructuringProvisionsMovementsRollForward" name="RestructuringProvisionsMovementsRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfTradeReceivablesAbstract" name="DisclosureOfTradeReceivablesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfTradeReceivablesExplanatoryTextBlock" name="DisclosureOfTradeReceivablesExplanatoryTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProvisionsForTradeReceivablesTableTextBlock" name="ProvisionsForTradeReceivablesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TradeReceivablesProvisionMovementsTableTextBlock" name="TradeReceivablesProvisionMovementsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OverdueAmountsAndRelatedProvisionsTableTextBlock" name="OverdueAmountsAndRelatedProvisionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" name="TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AnalysisOfOverdueAmountsTable" name="AnalysisOfOverdueAmountsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AnalysisOfOverdueAmountsLineItems" name="AnalysisOfOverdueAmountsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" name="DisclosureOfReceivablesDenominatedInVariousCurrenciesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries" name="CurrentTradeReceivablesFromCloselyMonitoredCountries" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" name="CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" name="PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharePaidinCapital" name="SharePaidinCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_NovartisArgentinaS.A.BuenosAiresMember" name="NovartisArgentinaS.A.BuenosAiresMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriosS.A.BuenosAiresMember" name="AlconLaboratoriosS.A.BuenosAiresMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RocheHoldingAGBaselMember" name="RocheHoldingAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ConcentrationOfMajorPlansGeographic" name="ConcentrationOfMajorPlansGeographic" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" name="DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RetirementPlanTypeAxis" name="RetirementPlanTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RetirementPlanTypeMember" name="RetirementPlanTypeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PensionPlanMember" name="PensionPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OtherPostemploymentBenefitPlansMember" name="OtherPostemploymentBenefitPlansMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanInterestCost" name="DefinedBenefitPlanInterestCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" name="IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset" name="InterestExpenseIncomeDefinedBenefitLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" name="ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanSettlementsPlanAssets" name="DefinedBenefitPlanSettlementsPlanAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" name="IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward" name="DefinedBenefitPlanChangeInBenefitObligationRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" name="DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" name="DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LimitationOnRecognitionOfFundSurplus" name="LimitationOnRecognitionOfFundSurplus" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ChangeInLimitationOnRecognitionOfFundSurplus" name="ChangeInLimitationOnRecognitionOfFundSurplus" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_InterestIncomeOnLimitationOfFundSurplus" name="InterestIncomeOnLimitationOfFundSurplus" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward" name="DefinedBenefitPlanChangeInNetLiabilityRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" name="IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" name="AmountsRecognizedInTheConsolidatedBalanceSheetAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities" name="DefinedBenefitPensionPlanAccruedBenefitLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTable" name="BreakdownOfDefinedBenefitObligationForPensionPlansTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ObligationByTypeAxis" name="ObligationByTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ObligationByTypeMember" name="ObligationByTypeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_UnfundedMember" name="UnfundedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ActiveMember" name="ActiveMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DeferredPensionersMember" name="DeferredPensionersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PensionersMember" name="PensionersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleOfDefinedBenefitPlansDisclosuresTable" name="ScheduleOfDefinedBenefitPlansDisclosuresTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" name="ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitAssumptionLifeExpectancyMale" name="DefinedBenefitAssumptionLifeExpectancyMale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitAssumptionLifeExpectancyFemale" name="DefinedBenefitAssumptionLifeExpectancyFemale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LifeExpectancyMember" name="LifeExpectancyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" name="ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChangeInActuarialAssumptionAxis" name="ChangeInActuarialAssumptionAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChangeInActuarialAssumptionMember" name="ChangeInActuarialAssumptionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_Decrease25BasisPointMember" name="Decrease25BasisPointMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_Increase25BasisPointMember" name="Increase25BasisPointMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_Increase1YearMember" name="Increase1YearMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleOfHealthCareCostTrendRatesTable" name="ScheduleOfHealthCareCostTrendRatesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" name="DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" name="DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" name="DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:gYearItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleOfAllocationOfPlanAssetsTable" name="ScheduleOfAllocationOfPlanAssetsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RealEstateMember" name="RealEstateMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlternativeInvestmentsMember" name="AlternativeInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CashAndOtherInvestmentsMember" name="CashAndOtherInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" name="DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" name="DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanPlanAssetAllocations" name="DefinedBenefitPlanPlanAssetAllocations" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_WeightedAverageDurationOfDefinedBenefitObligationYears" name="WeightedAverageDurationOfDefinedBenefitObligationYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" name="DefinedContributionPensionAndOtherPostretirementPlansDisclosureAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" name="DefinedContributionPensionAndOtherPostretirementPlansDisclosureTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" name="DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleOfExpectedBenefitPaymentsTable" name="ScheduleOfExpectedBenefitPaymentsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" name="DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" name="DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" name="PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" name="DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_SocieteParActionsSANDOZAlgiersMember" name="SocieteParActionsSANDOZAlgiersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" name="DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" name="AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" name="CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" name="CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsFromDiscontinuedOperationsTableTextBlock" name="CashFlowsFromDiscontinuedOperationsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ConsolidatedIncomeStatementSegmentationTableTextBlock" name="ConsolidatedIncomeStatementSegmentationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ExpensesIncludedInNetIncomeTableTextBlock" name="ExpensesIncludedInNetIncomeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueFromSaleOfGoodsSalesToContinuingSegments" name="RevenueFromSaleOfGoodsSalesToContinuingSegments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VaccinesMember" name="VaccinesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ConsumerHealthMember" name="ConsumerHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CorporateMember" name="CorporateMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OperatingIncomeLossOfDiscontinuedOperations" name="OperatingIncomeLossOfDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncomeTaxExpenseOfDiscontinuedOperations" name="IncomeTaxExpenseOfDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" name="AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AcquisitionsAndDivestmentsAxis" name="AcquisitionsAndDivestmentsAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AcquisitionsAndDivestmentsMember" name="AcquisitionsAndDivestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AcquisitionsMember" name="AcquisitionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DivestmentsMember" name="DivestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowCurrencyTranslationEffects" name="CashInflowOutflowCurrencyTranslationEffects" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowAcquiredDivestedLiquity" name="CashInflowOutflowAcquiredDivestedLiquity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashProvidedByRefinancingOfIntercompanyFinancialDebtNet" name="CashProvidedByRefinancingOfIntercompanyFinancialDebtNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowGoodwill" name="CashInflowOutflowGoodwill" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowDivestmentGainLoss" name="CashInflowOutflowDivestmentGainLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows" name="TaxesPaidAndOtherPortfolioTransformationRelatedCashFlows" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ReceivablesAndPayablesContingentConsiderationNet" name="ReceivablesAndPayablesContingentConsiderationNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherPaymentsAndDeferredConsiderationNet" name="OtherPaymentsAndDeferredConsiderationNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DeferredPrepaidPortionOfSalesPrice" name="DeferredPrepaidPortionOfSalesPrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationPaid" name="ContingentConsiderationPaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_Change25BasisPointMember" name="Change25BasisPointMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DividendsPayableAmountPerShare" name="DividendsPayableAmountPerShare" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TreasurySharesAcquiredToBeHeld" name="TreasurySharesAcquiredToBeHeld" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TreasurySharesAcquiredToBeCancelled" name="TreasurySharesAcquiredToBeCancelled" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherSharePurchases" name="OtherSharePurchases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharepurchaseOfTreasuryShares" name="SharepurchaseOfTreasuryShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TreasurySharesAcquiredToBeHeldValue" name="TreasurySharesAcquiredToBeHeldValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TreasurySharesAcquiredForCancellationValue" name="TreasurySharesAcquiredForCancellationValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" name="ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfComprehensiveIncomeTableTextBlock" name="ScheduleOfComprehensiveIncomeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" name="ScheduleOfShareValueAdjustmentsCurrencyTranslationEffectsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" name="FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" name="ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OfficerAndDirectorCompensationTableTextBlock" name="OfficerAndDirectorCompensationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" name="ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfSharebasedCompensationActivityTableTextBlock" name="ScheduleOfSharebasedCompensationActivityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonExecutiveDirectorMember" name="NonExecutiveDirectorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RocheHoldingAGMember" name="RocheHoldingAGMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LucentisMember" name="LucentisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_XolairMember" name="XolairMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing" name="NetExpenseRoyaltiesCostSharingAndProfitSharing" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GenentechInc.USAMember" name="GenentechInc.USAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProfDrBrodyMember" name="ProfDrBrodyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProfDrZinkernagelMember" name="ProfDrZinkernagelMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DrAlexKrauerMember" name="DrAlexKrauerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DrDanielVasellaMember" name="DrDanielVasellaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DrJamesBradnerMember" name="DrJamesBradnerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_KeyManagementPersonnelCompensationDailyRate" name="KeyManagementPersonnelCompensationDailyRate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" name="KeyManagementPersonnelCompensationAnnualGuaranteedMinimum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_KeyManagementPersonnelCompensationSharesAcquired" name="KeyManagementPersonnelCompensationSharesAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_KeyManagementPersonnelCompensationOwnershipInterestAcquired" name="KeyManagementPersonnelCompensationOwnershipInterestAcquired" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" name="ChangesInConsolidatedStatementsOfComprehensiveIncomeTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FairValueAdjustmentsOnMarketableSecuritiesMember" name="FairValueAdjustmentsOnMarketableSecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember" name="FairValueAdjustmentsOnDeferredCashFlowHedgesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ActuarialLossesFromDefinedBenefitPlansMember" name="ActuarialLossesFromDefinedBenefitPlansMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CumulativeCurrencyTranslationEffectsMember" name="CumulativeCurrencyTranslationEffectsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" name="ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_GainLossOnSaleOfMarketableInvestments" name="GainLossOnSaleOfMarketableInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_GainLossOnSaleOfOtherFinancialAssets" name="GainLossOnSaleOfOtherFinancialAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RemeasurementsFromDefinedBenefitPlansLineItems" name="RemeasurementsFromDefinedBenefitPlansLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InnovativeMedicinesMember" name="InnovativeMedicinesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozMember" name="SandozMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconMember" name="AlconMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationAnnualIncentivePlanMember" name="EquityBasedParticipationAnnualIncentivePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationShareSavingsPlanMember" name="EquityBasedParticipationShareSavingsPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember" name="EquityBasedParticipationLeveragedShareSavingsPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember" name="EquityBasedParticipationEmployeeShareOwnershipPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationUKShareSavingsPlanMember" name="EquityBasedParticipationUKShareSavingsPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationNovartisEquityPlanSelectMember" name="EquityBasedParticipationNovartisEquityPlanSelectMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationLongTermPerformancePlanMember" name="EquityBasedParticipationLongTermPerformancePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember" name="EquityBasedParticipationLongTermRelativePerformancePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationSpecialShareAwardsMember" name="EquityBasedParticipationSpecialShareAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" name="DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationRestrictedSharesMember" name="EquityBasedParticipationRestrictedSharesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" name="OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" name="OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" name="OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_KeyManagementPersonnelCompensationSharesAcquiredPrice" name="KeyManagementPersonnelCompensationSharesAcquiredPrice" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ValueAdjustmentOnComprehensiveIncome" name="ValueAdjustmentOnComprehensiveIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome" name="GainsLossesOnValueAdjustmentOnComprehensiveIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember" name="TotalValueAdjustmentsAttributableToNovartisShareholdersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconInc.EquityPlanConvertedNovartisShareOptionsMember" name="AlconInc.EquityPlanConvertedNovartisShareOptionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" name="AlconInc.EquityPlanConvertedSharesettledAppreciationRightsSSARMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" name="ScheduleOfUnvestedRestrictedStockUnitsRollForwardTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonvestingAxis" name="NonvestingAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonvestingMember" name="NonvestingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonvestedSharesGrantedMember" name="NonvestedSharesGrantedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueFromSaleOfGoodsSalesToOtherSegments" name="RevenueFromSaleOfGoodsSalesToOtherSegments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" name="ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetOperatingAssets" name="NetOperatingAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" name="CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_FinancialDebtsAndDerivativeInstruments" name="FinancialDebtsAndDerivativeInstruments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CurrentIncomeTaxAndDeferredTaxLiabilities" name="CurrentIncomeTaxAndDeferredTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_SelectedNoncurrentAssets" name="SelectedNoncurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_OtherCountriesMember" name="OtherCountriesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GeographicalRegionsAxis" name="GeographicalRegionsAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GeographicalRegionsMember" name="GeographicalRegionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AsiaAfricaAustralasiaMember" name="AsiaAfricaAustralasiaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LargestCustomerMember" name="LargestCustomerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SecondLargestCustomerMember" name="SecondLargestCustomerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ThirdLargestCustomerMember" name="ThirdLargestCustomerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" name="DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" name="DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" name="DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock" name="DisclosureOfAssociatesBalanceSheetTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AssociatesSummarizedFinancialInformationTableTextBlock" name="AssociatesSummarizedFinancialInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PurchasePriceAllocationAssociatesTableTextBlock" name="PurchasePriceAllocationAssociatesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" name="GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OthersAssociatesMember" name="OthersAssociatesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AssociatesSummarizedFinancialInformationTable" name="AssociatesSummarizedFinancialInformationTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PurchasePriceAllocationAssociatesTable" name="PurchasePriceAllocationAssociatesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ShareOfEstimatedNetAssets" name="ShareOfEstimatedNetAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" name="CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" name="AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ConsolidatedIncomeStatementEffectsTable" name="ConsolidatedIncomeStatementEffectsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ShareOfCurrentYearNetIncome" name="ShareOfCurrentYearNetIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PriorYearAdjustment" name="PriorYearAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" name="AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" name="TaxesOnAmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" name="DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccrualForEnvironmentalLossContingenciesTableTextBlock" name="AccrualForEnvironmentalLossContingenciesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" name="AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" name="AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation" name="OtherLongtermEmployeeBenefitsAndDeferredCompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OtherPostemploymentBenefits" name="OtherPostemploymentBenefits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_SolodynMember" name="SolodynMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContactLensesMember" name="ContactLensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GleevecMember" name="GleevecMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ReclastAclastaMember" name="ReclastAclastaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TekturnaRasilezValturnaMember" name="TekturnaRasilezValturnaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NAGAndNovartisPharmaSpAMember" name="NAGAndNovartisPharmaSpAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FHoffmanLaRocheAGAndRocheSpAMember" name="FHoffmanLaRocheAGAndRocheSpAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaKKMember" name="NovartisPharmaKKMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NAGMember" name="NAGMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NPCAndOthersMember" name="NPCAndOthersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisNCMember" name="NovartisNCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" name="ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" name="ProductLiabilityContingencyLossExposureNotAccruedBestEstimate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" name="EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" name="DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" name="DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfOtherCasesReferredToCourt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" name="DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" name="DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfCasesStillPending" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" name="DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfLegalQuestionsReferredToCourt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" name="A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" name="A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" name="A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" name="A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" name="A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" name="TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TotalFairValueAdjustmentsMember" name="TotalFairValueAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentPrepaidExpensesThirdParty" name="CurrentPrepaidExpensesThirdParty" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_TaxotereMember" name="TaxotereMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AmiodaroneMember" name="AmiodaroneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfEquityAbstract" name="DisclosureOfEquityAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfEquityTextBlock" name="DisclosureOfEquityTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DividendTableTextBlock" name="DividendTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseInNoncontrolingInterests" name="IncreaseDecreaseInNoncontrolingInterests" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfReportableSegments" name="NumberOfReportableSegments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfFranchises" name="NumberOfFranchises" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdditionsToRestructuringProvisions" name="AdditionsToRestructuringProvisions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueFromSaleOfGoodsThirdParties" name="RevenueFromSaleOfGoodsThirdParties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" name="RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" name="SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" name="InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" name="ImpairmentLossOnCommoditiesAndAvailableforsaleSecuritiesNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxExpenseIncomeDiscontinuingOperations" name="TaxExpenseIncomeDiscontinuingOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" name="EffectiveIncomeTaxRateReconciliationChangeInUncertainTaxPositions" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments" name="EffectiveIncomeTaxRateReconciliationOtherAdjustments" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" name="EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" name="OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlansRelatedToDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" name="OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationRelatedToDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BusinessUnitAxis" name="BusinessUnitAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BusinessUnitMember" name="BusinessUnitMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OncologyMember" name="OncologyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PharmaceuticalMember" name="PharmaceuticalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FranchiseAxis" name="FranchiseAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FranchiseMember" name="FranchiseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NeuroscienceMember" name="NeuroscienceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RespiratoryMember" name="RespiratoryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CardioMetabolicMember" name="CardioMetabolicMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EstablishedMedicinesMember" name="EstablishedMedicinesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProductPortfolioMember" name="ProductPortfolioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_COPDMember" name="COPDMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GleevecGlivecMember" name="GleevecGlivecMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TasignaMember" name="TasignaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandostatinMember" name="SandostatinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AfinitorVotubiaMember" name="AfinitorVotubiaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExjadeJadenuMember" name="ExjadeJadenuMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TafinlarMekinistMember" name="TafinlarMekinistMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PromactaRevoladeMember" name="PromactaRevoladeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OphthalmologyMember" name="OphthalmologyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VotrientMember" name="VotrientMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_JakaviMember" name="JakaviMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_KisqaliMember" name="KisqaliMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OtherProductsMember" name="OtherProductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TravoprostGroupMember" name="TravoprostGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SystaneGroupMember" name="SystaneGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TopicalOlopatadineGroupMember" name="TopicalOlopatadineGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CosentyxMember" name="CosentyxMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NeoralSandimmunEMember" name="NeoralSandimmunEMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ZortressCerticanMember" name="ZortressCerticanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IlarisMember" name="IlarisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MyforticMember" name="MyforticMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GilenyaMember" name="GilenyaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_UltibroBreezhalerMember" name="UltibroBreezhalerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SeebriBreezhalerMember" name="SeebriBreezhalerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OnbrezBreezhalerMember" name="OnbrezBreezhalerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EntrestoMember" name="EntrestoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VoltarenCataflamMember" name="VoltarenCataflamMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExelonExelonPatchMember" name="ExelonExelonPatchMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RitalinFocalinMember" name="RitalinFocalinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" name="AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions" name="AccumulatedImpairmentsOnDisposalsAndDerecognitions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AcquiredResearchAndDevelopmentMember" name="AcquiredResearchAndDevelopmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconBrandNameMember" name="AlconBrandNameMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" name="GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" name="CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" name="OtherComprehensiveIncomeAvailableforsaleFinancialInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeMaketableSecurities" name="OtherComprehensiveIncomeMaketableSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProvisionForDoubtfulReceivableMember" name="ProvisionForDoubtfulReceivableMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" name="CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_Commodities" name="Commodities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OutstandingShareCapital" name="OutstandingShareCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_IssuedCapitalMovement" name="IssuedCapitalMovement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OutstandingShareCapitalMovement" name="OutstandingShareCapitalMovement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharesCancelledForCapitalReduction" name="SharesCancelledForCapitalReduction" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TreasurySharesMovement" name="TreasurySharesMovement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EquityImpactOfTreasuryShareMovements" name="EquityImpactOfTreasuryShareMovements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AverageInterestRateOnLoansReceived" name="AverageInterestRateOnLoansReceived" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt" name="RatioFixedRateFinancialDebtToTotalFinancialDebt" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AverageInterestRateOnBorrowings" name="AverageInterestRateOnBorrowings" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationNonCurrent" name="ContingentConsiderationNonCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_EnvironmentalProvisionRollForward" name="EnvironmentalProvisionRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvision" name="EnvironmentalProvision" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionPayments" name="EnvironmentalProvisionPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionReleases" name="EnvironmentalProvisionReleases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionAdditions" name="EnvironmentalProvisionAdditions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss" name="EnvironmentalProvisionForeignCurrencyTranslationGainLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionCurrent" name="EnvironmentalProvisionCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalRemediationProvisionNoncurrent" name="EnvironmentalRemediationProvisionNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_EnvironmentalProvisionFiscalYearMaturityAbstract" name="EnvironmentalProvisionFiscalYearMaturityAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionExpectedCashOutflowNextTwoYears" name="EnvironmentalProvisionExpectedCashOutflowNextTwoYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" name="EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" name="EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EnvironmentalProvisionExpectedCashOutflowAfterTenYears" name="EnvironmentalProvisionExpectedCashOutflowAfterTenYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_WeightedAverageInterestRateAssociates" name="WeightedAverageInterestRateAssociates" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt" name="WeightedAverageInterestRateOnBankAndOtherFinancialDebt" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationCurrentPortion" name="ContingentConsiderationCurrentPortion" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_ProvisionForDeductionFromRevenueTable" name="ProvisionForDeductionFromRevenueTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProvisionsAndOtherCurrentLiabilitiesTable" name="ProvisionsAndOtherCurrentLiabilitiesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RestructuringProvisionsMovementsTable" name="RestructuringProvisionsMovementsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RestructuringProvisionTransfers" name="RestructuringProvisionTransfers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" name="TradeAndOtherPayablesAndDeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_IdentifiableAssetsAcquired" name="IdentifiableAssetsAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashFlowFromNetIdentifiableAssets" name="CashFlowFromNetIdentifiableAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate" name="PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" name="CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" name="AcquiredDivestedResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TechnologiesRecognisedAsOfAcquisitionDivestmentDate" name="TechnologiesRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" name="OtherIntangibleAssetsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate" name="FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_InventoryRecognisedAsOfAcquisitionDivestmentDate" name="InventoryRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate" name="TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate" name="CashAndCashEquivalentsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate" name="CurrentAndNoncurrentFinancialDebtsRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate" name="TradeAndOtherPayablesRecognisedAsOfAcquisitionDivestmentDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AnimalHealthMember" name="AnimalHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProceedsFromSaleOfBusiness" name="ProceedsFromSaleOfBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AmortizationOfBondsDiscount" name="AmortizationOfBondsDiscount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentPortionOfNoncurrentFinancialDebt" name="CurrentPortionOfNoncurrentFinancialDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GenentechRocheMember" name="GenentechRocheMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfContractsWithRelatedParties" name="NumberOfContractsWithRelatedParties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers" name="RelatedPartiesNumberOfExecutiveCommiteeMembers" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RelatedPartiesNumberOfNonexecutiveDirectors" name="RelatedPartiesNumberOfNonexecutiveDirectors" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DefinedBenefitPlanExpectedFutureBenefitPayment" name="DefinedBenefitPlanExpectedFutureBenefitPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EmployerSharesHeldByDefinedBenefitPlan" name="EmployerSharesHeldByDefinedBenefitPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan" name="ValueOfEmployerSharesHeldByDefinedBenefitPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset" name="AdministrativeExpenseNetDefinedBenefitLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" name="ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" name="IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" name="IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CashAndCashEquivalentsMember" name="CashAndCashEquivalentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BalanceSheetItemAxis" name="BalanceSheetItemAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BalanceSheetItemMember" name="BalanceSheetItemMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquitySecuritiesMember" name="EquitySecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FundInvestmentsMember" name="FundInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" name="TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContingentConsiderationReceivablesMember" name="ContingentConsiderationReceivablesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" name="AccruedInterestOnDebtSecuritiesAndTimeDepositsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember" name="TimeDepositsWithOriginalMaturityMoreThan90DaysMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" name="LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember" name="AssociatedCompaniesAtFairValueThroughProfitAndLossMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DerivativeFinancialInstrumentsMember" name="DerivativeFinancialInstrumentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GroupsOfFinancialAssetsLiabilitiesAxis" name="GroupsOfFinancialAssetsLiabilitiesAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GroupsOfFinancialAssetsLiabilitiesMember" name="GroupsOfFinancialAssetsLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TradePayablesMember" name="TradePayablesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_InterestBearningAccountsOfAssociatesPayableOnDemandMember" name="InterestBearningAccountsOfAssociatesPayableOnDemandMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BankAndOtherFinancialDebtMember" name="BankAndOtherFinancialDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CommercialPaperMember" name="CommercialPaperMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentPortionOfNoncurrentDebtMember" name="CurrentPortionOfNoncurrentDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_StraightBondsMember" name="StraightBondsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LiabilitiesToBanksAndOtherFinancialInstitutionsMember" name="LiabilitiesToBanksAndOtherFinancialInstitutionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinanceLeaseObligationsMember" name="FinanceLeaseObligationsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContingentConsiderationAndOtherFinancialLiabilitiesMember" name="ContingentConsiderationAndOtherFinancialLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" name="DisclosureOfDerivativeFinancialInstrumentsByTypeOfContractTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis" name="DerivativeFinancialInstrumentNatureOfInstrumentAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DerivativeFinancialInstrumentNatureOfInstrumentMember" name="DerivativeFinancialInstrumentNatureOfInstrumentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" name="DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinancialInstrumentsPrincipalAmountsAxis" name="FinancialInstrumentsPrincipalAmountsAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinancialInstrumentsPrincipalAmountsMember" name="FinancialInstrumentsPrincipalAmountsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContractOrUnderlyingPrincipalAmoutMember" name="ContractOrUnderlyingPrincipalAmoutMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PositiveFairValuesMember" name="PositiveFairValuesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NegativeFairValuesMember" name="NegativeFairValuesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems" name="DisclosureOfDerivativeFinancialInstrumentsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DerivativeFinancialInstruments" name="DerivativeFinancialInstruments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" name="DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" name="DerivativeFinancialInstrumentsOverthecounterCurrencyOptions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" name="DisclosureOfDerivativeFinancialInstrumentsByCurrencyContractTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" name="TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinancialInvestmentsAndLongtermLoansGroupMember" name="FinancialInvestmentsAndLongtermLoansGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TotalAvailableforsaleMarketableSecuritiesMember" name="TotalAvailableforsaleMarketableSecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AvailableForSaleMarketableSecuritiesMember" name="AvailableForSaleMarketableSecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AvailableforsaleLongtermFinancialInvestmentsMember" name="AvailableforsaleLongtermFinancialInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentFinancialDebtMember" name="CurrentFinancialDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NoncurrentFinancialDebtMember" name="NoncurrentFinancialDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AvailableforsaleFinancialInvestmentsMember" name="AvailableforsaleFinancialInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ValuedAtAmortizedCostMember" name="ValuedAtAmortizedCostMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContingentConsiderationPayablesMember" name="ContingentConsiderationPayablesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OtherFinancialLiabilitiesMember" name="OtherFinancialLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" name="ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" name="IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisAustriaGmbHViennaMember" name="NovartisAustriaGmbHViennaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaGmbHViennaMember" name="NovartisPharmaGmbHViennaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconOphthalmikaGmbHViennaMember" name="AlconOphthalmikaGmbHViennaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozGmbHViennaMember" name="SandozGmbHViennaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EBEWEPharmaGes.m.b.HNfg.KGViennaMember" name="EBEWEPharmaGes.m.b.HNfg.KGViennaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisBangladeshLimitedGazipurMember" name="NovartisBangladeshLimitedGazipurMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSecuritiesInvestmentLtd.HamiltonMember" name="NovartisSecuritiesInvestmentLtd.HamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" name="NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconCanadaInc.MississaugaOntarioMember" name="AlconCanadaInc.MississaugaOntarioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CIBAVisionCanadaInc.MississaugaOntarioMember" name="CIBAVisionCanadaInc.MississaugaOntarioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozCanadaInc.BouchervilleQuebecMember" name="SandozCanadaInc.BouchervilleQuebecMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisChileS.A.SantiagoDeChileMember" name="NovartisChileS.A.SantiagoDeChileMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriosChileLtd.SantiagoDeChileMember" name="AlconLaboratoriosChileLtd.SantiagoDeChileMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BeijingNovartisPharmaCo.Ltd.BeijingMember" name="BeijingNovartisPharmaCo.Ltd.BeijingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaceuticalsHKLimitedHongKongMember" name="NovartisPharmaceuticalsHKLimitedHongKongMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" name="SuzhouNovartisPharmaTechnologyCo.Ltd.ChangshuMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ShanghaiNovartisTradingLtd.ShanghaiMember" name="ShanghaiNovartisTradingLtd.ShanghaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconHongKongLimitedHongKongMember" name="AlconHongKongLimitedHongKongMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconChinaOphthalmicProductCo.Ltd.BeijingMember" name="AlconChinaOphthalmicProductCo.Ltd.BeijingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" name="SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" name="SandozD.o.o.FarmaceutskaIndustrijaZagrebMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisS.r.o.PragueMember" name="NovartisS.r.o.PragueMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" name="AlconPharmaceuticalsCzechRepublicS.r.o.PragueMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozS.r.o.PragueMember" name="SandozS.r.o.PragueMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHealthcareASCopenhagenMember" name="NovartisHealthcareASCopenhagenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconNordicASCopenhagenMember" name="AlconNordicASCopenhagenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozASCopenhagenMember" name="SandozASCopenhagenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisEcuadorS.A.QuitoMember" name="NovartisEcuadorS.A.QuitoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaS.A.E.CairoMember" name="NovartisPharmaS.A.E.CairoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozEgyptPharmaS.A.E.NewCairoCityMember" name="SandozEgyptPharmaS.A.E.NewCairoCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFinlandOyEspooMember" name="NovartisFinlandOyEspooMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisGroupeFranceS.A.RueilMalmaisonMember" name="NovartisGroupeFranceS.A.RueilMalmaisonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaS.A.S.RueilMalmaisonMember" name="NovartisPharmaS.A.S.RueilMalmaisonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LaboratoiresAlconS.A.S.RueilMalmaisonMember" name="LaboratoiresAlconS.A.S.RueilMalmaisonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozS.A.S.LevalloisPerretMember" name="SandozS.A.S.LevalloisPerretMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisDeutschlandGmbHWehrMember" name="NovartisDeutschlandGmbHWehrMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaGmbHNurembergMember" name="NovartisPharmaGmbHNurembergMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaProduktionsGmbHWehrMember" name="NovartisPharmaProduktionsGmbHWehrMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisBusinessServicesGmbHWehrMember" name="NovartisBusinessServicesGmbHWehrMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPharmaGmbHFreiburgImBreisgauMember" name="AlconPharmaGmbHFreiburgImBreisgauMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_WaveLightGmbHErlangenMember" name="WaveLightGmbHErlangenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CIBAVisionGmbHGrosswallstadtMember" name="CIBAVisionGmbHGrosswallstadtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozInternationalGmbHHolzkirchenMember" name="SandozInternationalGmbHHolzkirchenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_HEXALAGHolzkirchenMember" name="HEXALAGHolzkirchenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SalutasPharmaGmbHBarlebenMember" name="SalutasPharmaGmbHBarlebenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1APharmaGmbHOberhachingMember" name="A1APharmaGmbHOberhachingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AeropharmGmbHRudolstadtMember" name="AeropharmGmbHRudolstadtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovistaInsuranceLimitedGibraltarCityMember" name="NovistaInsuranceLimitedGibraltarCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember" name="NovartisHellasS.A.C.I.MetamorphosisAthensMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" name="AlconLaboratoriesHellasCommercialAndIndustrialS.A.MaroussiAthensMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" name="NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozHungaryLimitedLiabilityCompanyBudapestMember" name="SandozHungaryLimitedLiabilityCompanyBudapestMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisIndiaLimitedMumbaiMember" name="NovartisIndiaLimitedMumbaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHealthcarePrivateLimitedMumbaiMember" name="NovartisHealthcarePrivateLimitedMumbaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozPrivateLimitedMumbaiMember" name="SandozPrivateLimitedMumbaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PT.NovartisIndonesiaJakartaMember" name="PT.NovartisIndonesiaJakartaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PT.CIBAVisionBatamBatamMember" name="PT.CIBAVisionBatamBatamMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisIrelandLimitedDublinMember" name="NovartisIrelandLimitedDublinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" name="NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesIrelandLimitedCorkCityMember" name="AlconLaboratoriesIrelandLimitedCorkCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisIsraelLtd.PetachTikvaMember" name="NovartisIsraelLtd.PetachTikvaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OptonolLtd.NeveIlanMember" name="OptonolLtd.NeveIlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFarmaS.p.A.OriggioMember" name="NovartisFarmaS.p.A.OriggioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconItaliaS.p.A.MilanMember" name="AlconItaliaS.p.A.MilanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozS.p.A.OriggioMember" name="SandozS.p.A.OriggioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozIndustrialProductsS.p.A.RoveretoMember" name="SandozIndustrialProductsS.p.A.RoveretoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHoldingJapanK.K.TokyoMember" name="NovartisHoldingJapanK.K.TokyoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaK.K.TokyoMember" name="NovartisPharmaK.K.TokyoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconJapanLtd.TokyoMember" name="AlconJapanLtd.TokyoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozK.K.TokyoMember" name="SandozK.K.TokyoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" name="NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" name="AlconLaboratoriesMalaysiaSdn.Bhd.PetalingJayaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CIBAVisionJohorSdn.Bhd.KualaLumpurMember" name="CIBAVisionJohorSdn.Bhd.KualaLumpurMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriosS.A.DeC.V.MexicoCityMember" name="AlconLaboratoriosS.A.DeC.V.MexicoCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozS.A.DeC.V.MexicoCityMember" name="SandozS.A.DeC.V.MexicoCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaMarocSACasablancaMember" name="NovartisPharmaMarocSACasablancaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisNetherlandsB.V.ArnhemMember" name="NovartisNetherlandsB.V.ArnhemMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaB.V.ArnhemMember" name="NovartisPharmaB.V.ArnhemMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconNederlandB.V.ArnhemMember" name="AlconNederlandB.V.ArnhemMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozB.V.AlmereMember" name="SandozB.V.AlmereMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisNewZealandLtdAucklandMember" name="NovartisNewZealandLtdAucklandMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisNorgeASOsloMember" name="NovartisNorgeASOsloMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaPakistanLimitedKarachiMember" name="NovartisPharmaPakistanLimitedKarachiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaLogisticsInc.PanamaCityMember" name="NovartisPharmaLogisticsInc.PanamaCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconCentroamericaS.A.PanamaCityMember" name="AlconCentroamericaS.A.PanamaCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHealthcarePhilippinesInc.ManilaMember" name="NovartisHealthcarePhilippinesInc.ManilaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozPhilippinesCorporationManilaMember" name="SandozPhilippinesCorporationManilaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LekS.A.StrykowMember" name="LekS.A.StrykowMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPortugalSGPSLda.PortoSalvoMember" name="NovartisPortugalSGPSLda.PortoSalvoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaServicesRomaniaS.R.L.BucharestMember" name="NovartisPharmaServicesRomaniaS.R.L.BucharestMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconRomaniaS.R.L.BucharestMember" name="AlconRomaniaS.R.L.BucharestMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozS.R.L.TarguMuresMember" name="SandozS.R.L.TarguMuresMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaLLCMoscowMember" name="NovartisPharmaLLCMoscowMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconFarmacevtikaLLCMoscowMember" name="AlconFarmacevtikaLLCMoscowMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ZAOSandozMoscowMember" name="ZAOSandozMoscowMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisNevaLLCSt.PetersburgMember" name="NovartisNevaLLCSt.PetersburgMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" name="SaudiPharmaceuticalDistributionCo.Ltd.RiyadhMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSlovakiaS.r.o.BratislavaMember" name="NovartisSlovakiaS.r.o.BratislavaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LekPharmaceuticalsD.d.LjubjanaMember" name="LekPharmaceuticalsD.d.LjubjanaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozPharmaceuticalsD.d.LjubjanaMember" name="SandozPharmaceuticalsD.d.LjubjanaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSouthAfricaPtyLtdMidrandMember" name="NovartisSouthAfricaPtyLtdMidrandMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" name="AlconLaboratoriesSouthAfricaPtyLtd.MidrandMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozSouthAfricaPtyLtdKemptonParkMember" name="SandozSouthAfricaPtyLtdKemptonParkMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisKoreaLtd.SeoulMember" name="NovartisKoreaLtd.SeoulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconKoreaLtd.SeoulMember" name="AlconKoreaLtd.SeoulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozKoreaLtd.SeoulMember" name="SandozKoreaLtd.SeoulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconCusiS.A.BarcelonaMember" name="AlconCusiS.A.BarcelonaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozIndustrialProductsS.A.BarcelonaMember" name="SandozIndustrialProductsS.A.BarcelonaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AbadiaRetuertaS.A.SardonDeDueroValladolidMember" name="AbadiaRetuertaS.A.SardonDeDueroValladolidMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSverigeABStockholmMember" name="NovartisSverigeABStockholmMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInternationalAGBaselMember" name="NovartisInternationalAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHoldingAGBaselMember" name="NovartisHoldingAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInternationalPharmaceuticalAGBaselMember" name="NovartisInternationalPharmaceuticalAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaAGBaselMember" name="NovartisPharmaAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaServicesAGBaselMember" name="NovartisPharmaServicesAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaSchweizerhalleAGMuttenzMember" name="NovartisPharmaSchweizerhalleAGMuttenzMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaSteinAGSteinMember" name="NovartisPharmaSteinAGSteinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaSchweizAGRischMember" name="NovartisPharmaSchweizAGRischMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconSwitzerlandSARischMember" name="AlconSwitzerlandSARischMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPharmaceuticalsLtd.FribourgMember" name="AlconPharmaceuticalsLtd.FribourgMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozAGBaselMember" name="SandozAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozPharmaceuticalsAGRischMember" name="SandozPharmaceuticalsAGRischMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisTaiwanCo.Ltd.TaipeiMember" name="NovartisTaiwanCo.Ltd.TaipeiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisThailandLimitedBangkokMember" name="NovartisThailandLimitedBangkokMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesThailandLimitedBangkokMember" name="AlconLaboratoriesThailandLimitedBangkokMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratuvarlariTicaretA.S.IstanbulMember" name="AlconLaboratuvarlariTicaretA.S.IstanbulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisMiddleEastFZEDubaiMember" name="NovartisMiddleEastFZEDubaiMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisUKLimitedFrimleyCamberleyMember" name="NovartisUKLimitedFrimleyCamberleyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" name="NovartisPharmaceuticalsUKLimitedFrimleyCamberleyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisGrimsbyLimitedFrimleyCamberleyMember" name="NovartisGrimsbyLimitedFrimleyCamberleyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconEyeCareUKLimitedFrimleyCamberleyMember" name="AlconEyeCareUKLimitedFrimleyCamberleyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozLimitedFrimleyCamberleyMember" name="SandozLimitedFrimleyCamberleyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" name="GlaxosmithklineConsumerHealthcareHoldingsLimitedBrentfordMiddlesexMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisCorporationEastHanoverNYMember" name="NovartisCorporationEastHanoverNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFinanceCorporationNewYorkNYMember" name="NovartisFinanceCorporationNewYorkNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisCapitalCorporationNewYorkNYMember" name="NovartisCapitalCorporationNewYorkNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaceuticalsCorporationEastHanoverNYMember" name="NovartisPharmaceuticalsCorporationEastHanoverNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" name="NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" name="NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" name="NovartisVaccinesAndDiagnosticsInc.CambridgeMAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisServicesInc.EastHanoverNYMember" name="NovartisServicesInc.EastHanoverNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesHoldingCorporationFortWorthTXMember" name="AlconLaboratoriesHoldingCorporationFortWorthTXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesInc.FortWorthTXMember" name="AlconLaboratoriesInc.FortWorthTXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconRefractivehorizonsLLCFortWorthTXMember" name="AlconRefractivehorizonsLLCFortWorthTXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconResearchLtd.FortWorthTXMember" name="AlconResearchLtd.FortWorthTXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLensxInc.AlisoViejoCAMember" name="AlconLensxInc.AlisoViejoCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozInc.PrincetonNJMember" name="SandozInc.PrincetonNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EonLabsInc.PrincetonNJMember" name="EonLabsInc.PrincetonNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FougeraPharmaceuticalsInc.MelvilleNYMember" name="FougeraPharmaceuticalsInc.MelvilleNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisDeVenezuelaS.A.CaracasMember" name="NovartisDeVenezuelaS.A.CaracasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPharmaceuticalC.A.CaracasMember" name="AlconPharmaceuticalC.A.CaracasMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisBiocienciasS.A.SaoPauloMember" name="NovartisBiocienciasS.A.SaoPauloMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" name="SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisDeColombiaS.A.SantafeDeBobotaMember" name="NovartisDeColombiaS.A.SantafeDeBobotaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" name="LaboratoriosAlconDeColombiaS.A.SantafeDeBobotaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" name="NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" name="NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" name="AlconPortugalProdutosEEquipamentosOftalmologicosLda.PortoSalvoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozFarmaceuticaLda.PortoSalvoMember" name="SandozFarmaceuticaLda.PortoSalvoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFarmaceuticaS.A.BarcelonaMember" name="NovartisFarmaceuticaS.A.BarcelonaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozFarmaceuticaS.A.MadridMember" name="SandozFarmaceuticaS.A.MadridMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" name="NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozIlacSanayiVeTicaretA.S.IstanbulMember" name="SandozIlacSanayiVeTicaretA.S.IstanbulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" name="SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinancialInstrumentsAdditionalDisclosureAbstract" name="FinancialInstrumentsAdditionalDisclosureAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialInstrumentsCarryingValueLevel3" name="FinancialInstrumentsCarryingValueLevel3" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets" name="GainsRecognisedInProfitOrLossFairValueMeasurementAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets" name="LossesRecognisedInProfitOrLossFairValueMeasurementAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" name="FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisposalsFairValueMeasurementAssets" name="DisposalsFairValueMeasurementAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ReclassificationFairValueMeasurementAssets" name="ReclassificationFairValueMeasurementAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" name="FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" name="MonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ReconciliationOfChangesInFairValueMeasurementAssetsTable" name="ReconciliationOfChangesInFairValueMeasurementAssetsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MaturityOfNetDebtLineItems" name="MaturityOfNetDebtLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MarketableSecuritiesAndTimeDepositsMember" name="MarketableSecuritiesAndTimeDepositsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CommoditiesMember" name="CommoditiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember" name="DeriviativeFinancialInstrumentsAndAccruedInterestMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinancialDebtMember" name="FinancialDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FinancialDebtUndiscountedMember" name="FinancialDebtUndiscountedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" name="LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" name="DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" name="PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" name="PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" name="DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContractualInterestOnNoncurrentLiabilities" name="ContractualInterestOnNoncurrentLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_TenDayLossFairValueVARModelTable" name="TenDayLossFairValueVARModelTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TenDayLossFairValueVARModelLineItems" name="TenDayLossFairValueVARModelLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialInstrumentsValueAtRiskComputation" name="FinancialInstrumentsValueAtRiskComputation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" name="FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" name="FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" name="FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_WorstCaseLossScenarioMember" name="WorstCaseLossScenarioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets" name="CashReceiptsAndPaymentsFairValueMeasurementAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" name="EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" name="EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" name="AlconInc.EquityPlansGrantedToAssociatesPriorMergerMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward" name="ScheduleOfUnvestedRestrictedStockUnitsRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquityBasedParticipationOtherShareAwardsMember" name="EquityBasedParticipationOtherShareAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ShareMovements" name="ShareMovements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NetInvestmentHedgeMember" name="NetInvestmentHedgeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_WrittenCallOptionsHeldByMarketMaker" name="WrittenCallOptionsHeldByMarketMaker" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_WrittenCallOptionsContractualLive" name="WrittenCallOptionsContractualLive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_WrittenCallOptionsContractualLiveRemaining" name="WrittenCallOptionsContractualLiveRemaining" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_WrittenCallOptionsWeightedAverageExercisePrice" name="WrittenCallOptionsWeightedAverageExercisePrice" nillable="true" substitutionGroup="xbrli:item" type="num:perShareItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PurchaseFairValueMeasurementAssets" name="PurchaseFairValueMeasurementAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_StockRepurchaseProgramAuthorizedAmount1" name="StockRepurchaseProgramAuthorizedAmount1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectOfIncomeTaxedAtReducedRates" name="TaxRateEffectOfIncomeTaxedAtReducedRates" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MovementsOfPropertyPlantAndEquipmentRollForward" name="MovementsOfPropertyPlantAndEquipmentRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OtherAssetsProvisionsAccrualsMember" name="OtherAssetsProvisionsAccrualsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" name="SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" name="SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" name="SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" name="SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSingaporePteLtd.SingaporeMember" name="NovartisSingaporePteLtd.SingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" name="NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" name="NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" name="NovartisInstituteForTropicalDiseasesPteLtdSingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconSingaporeManufacturingPteLtdSingaporeMember" name="AlconSingaporeManufacturingPteLtdSingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" name="CIBAVisionAsianManufacturingAndLogisticsPteLtd.SingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPteLtdSingaporeMember" name="AlconPteLtdSingaporeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" name="AlconLaboratoriesIndiaPrivateLimitedBangaloreMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SpinifexPharmaceuticalsInc.WilmingtonNCMember" name="SpinifexPharmaceuticalsInc.WilmingtonNCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EncoreVisionInc.NewYorkNYMember" name="EncoreVisionInc.NewYorkNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInvestmentLtd.HamiltonMember" name="NovartisInvestmentLtd.HamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFinanceServicesLtd.HamiltonMember" name="NovartisFinanceServicesLtd.HamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisB2Ltd.HamiltonMember" name="NovartisB2Ltd.HamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisB3Ltd.HamiltonMember" name="NovartisB3Ltd.HamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CibaGeigyJapanLimitedTokyoMember" name="CibaGeigyJapanLimitedTokyoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInternationalPharmaceuticalInvestmentAGBaselMember" name="NovartisInternationalPharmaceuticalInvestmentAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisBioventuresAGBaselMember" name="NovartisBioventuresAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisForschungsstiftungBaselMember" name="NovartisForschungsstiftungBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisMitarbeiterbeteiligungsstiftungBaselMember" name="NovartisMitarbeiterbeteiligungsstiftungBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" name="FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ZiarcoGroupLimitedFrimleyCamberleySurreyMember" name="ZiarcoGroupLimitedFrimleyCamberleySurreyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VivactaLimitedFrimleyCamberleySurreyMember" name="VivactaLimitedFrimleyCamberleySurreyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisUSFoundationNewYorkNYMember" name="NovartisUSFoundationNewYorkNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CortheraInc.SanMateoCAMember" name="CortheraInc.SanMateoCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CoStimPharmaceuticalsInc.CambridgeMAMember" name="CoStimPharmaceuticalsInc.CambridgeMAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ClarVistaMedicalInc.AlisoViejoCAMember" name="ClarVistaMedicalInc.AlisoViejoCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TriangleInternationalReinsuranceLimitedHamiltonMember" name="TriangleInternationalReinsuranceLimitedHamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TrinityRiverInsuranceCoLtd.HamiltonMember" name="TrinityRiverInsuranceCoLtd.HamiltonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisStiftungFuerKaderausbildungBaselMember" name="NovartisStiftungFuerKaderausbildungBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisStiftungFuerMenschUndUmweltBaselMember" name="NovartisStiftungFuerMenschUndUmweltBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" name="StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" name="SandozSyntekIlacHammaddeleriSanayiVeTicaretA.S.TuzlaIstanbulMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock" name="DisclosureOfAssociatesNetIncomeEffectTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" name="DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" name="DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" name="DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" name="DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" name="GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DebtSecuritiesBreakdownByCurrencyTableTextBlock" name="DebtSecuritiesBreakdownByCurrencyTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SummaryOfTreasurySharesMovementsTableTextBlock" name="SummaryOfTreasurySharesMovementsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" name="USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" name="ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" name="ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfDefinedContributionPlansTableTextBlock" name="ScheduleOfDefinedContributionPlansTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" name="ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" name="DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" name="DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" name="DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" name="DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" name="DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" name="DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfTenDayLossFairValueVARModelTableTextBlock" name="DisclosureOfTenDayLossFairValueVARModelTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" name="DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" name="DisclosureOfTenDayLossFairValueVARModelWorstCaseLossScenarioTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ReprixysPharmaceuticalsCorporationMember" name="ReprixysPharmaceuticalsCorporationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability" name="TaxRateEffectOfReleaseOfContingentConsiderationLiability" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxRateEffectFromNondeductibleLossesInRegion" name="TaxRateEffectFromNondeductibleLossesInRegion" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DeferredTaxAssetAndLiabilityValuationAbstract" name="DeferredTaxAssetAndLiabilityValuationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" name="ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" name="ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" name="ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" name="ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" name="ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImpactLocationAxis" name="ImpactLocationAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImpactLocationMember" name="ImpactLocationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IncomeStatementMember" name="IncomeStatementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" name="IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_UndiscountedOperatingLeaseCommitments" name="UndiscountedOperatingLeaseCommitments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ContributionOfBusinessToJointVenture" name="ContributionOfBusinessToJointVenture" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" name="PercentageImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" name="ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" name="ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" name="ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" name="ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" name="ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" name="ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" name="AcquisitionsThroughFinanceLeaseContractsPropertyPlantAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" name="PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherIntangiblePurchaseCommitments" name="OtherIntangiblePurchaseCommitments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" name="ResearchAndDevelopmentAndOtherIntangiblePurchaseCommitments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OpenHedgesForAnticipatedTransactions" name="OpenHedgesForAnticipatedTransactions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" name="AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MostSignificantForeignExchangeLosses" name="MostSignificantForeignExchangeLosses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LongtermFinancialDebtWithACarryingAmount" name="LongtermFinancialDebtWithACarryingAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" name="UnrealizedLossWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement" name="NetInvestmentHedgeRecognizedInTheIncomeStatement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_UpperLimitOnHoldingsOnUnrelatedCompany" name="UpperLimitOnHoldingsOnUnrelatedCompany" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BorrowingsCommercialPaperMaximumBorrowingAmount" name="BorrowingsCommercialPaperMaximumBorrowingAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DebtEquityRatio" name="DebtEquityRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_VAREstimateConfidenceInterval" name="VAREstimateConfidenceInterval" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_BorrowingsCommercialPaperMaximumAmountOutstanding" name="BorrowingsCommercialPaperMaximumAmountOutstanding" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_BorrowingsCreditFacilityCommitted" name="BorrowingsCreditFacilityCommitted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_CounterpartyRiskAbstract" name="CounterpartyRiskAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashAndCashEquivalentsHeldWithFinancialInstitution" name="CashAndCashEquivalentsHeldWithFinancialInstitution" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VendorAxis" name="VendorAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VendorMember" name="VendorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LargestFinancialInstitutionMember" name="LargestFinancialInstitutionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SecondLargestFinancialInstitutionMember" name="SecondLargestFinancialInstitutionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ThirdLargestFinancialInstitutionMember" name="ThirdLargestFinancialInstitutionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PreTaxProfitLossFromDivestmentOfBusiness" name="PreTaxProfitLossFromDivestmentOfBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DivestmentDateFairValueOfTotalConsiderationTransferred" name="DivestmentDateFairValueOfTotalConsiderationTransferred" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_FuturePutOptionToSellBusiness" name="FuturePutOptionToSellBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PaymentPutOption" name="PaymentPutOption" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_InterestExchanged" name="InterestExchanged" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LiabilitiesToBanksAndOtherInstitutions" name="LiabilitiesToBanksAndOtherInstitutions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationReceivableCurrent" name="ContingentConsiderationReceivableCurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfDivestmentsOtherProvisions" name="ImpactOfDivestmentsOtherProvisions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfFinancialInstrumentsNarrativeTable" name="DisclosureOfFinancialInstrumentsNarrativeTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CustomersWithNetSalesOverFivePercent" name="CustomersWithNetSalesOverFivePercent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" name="NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContingentConsiderationReceivablesShorttermMember" name="ContingentConsiderationReceivablesShorttermMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OptionsExcludedFromTheCalculation" name="OptionsExcludedFromTheCalculation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MilestonePaymentAlreadyReceived" name="MilestonePaymentAlreadyReceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_USCommercialPaperProgramsMember" name="USCommercialPaperProgramsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_JPCommercialPaperProgramsMember" name="JPCommercialPaperProgramsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BorrowingsCommercialPaperNumberOfPrograms" name="BorrowingsCommercialPaperNumberOfPrograms" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" name="AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" name="AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsAAAMember" name="AdvancedAcceleratorApplicationsAAAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PercentageOfShareCapitalInTenderOffer" name="PercentageOfShareCapitalInTenderOffer" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashOfferPerOrdinaryShare" name="CashOfferPerOrdinaryShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashOfferPerADS" name="CashOfferPerADS" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NumberOfOrdinarySharePerADS" name="NumberOfOrdinarySharePerADS" nillable="true" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ValueOfEquity" name="ValueOfEquity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_MaximalAmountOfShareBuybackProgramm" name="MaximalAmountOfShareBuybackProgramm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAnnualIncentive" name="DescriptionOfAnnualIncentive" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfBusinessUnits" name="NumberOfBusinessUnits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" name="RevenueFromSaleOfGoodsThirdPartiesChangeInPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonCurrentFinancialDebtsMember" name="NonCurrentFinancialDebtsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" name="CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContractRightOfFirstNegotiationTerm" name="ContractRightOfFirstNegotiationTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_IntangibleAssetImpairmentChargesTextBlock" name="IntangibleAssetImpairmentChargesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" name="PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AcquisitionFairValuePotentiallyRefundableContingentConsideration" name="AcquisitionFairValuePotentiallyRefundableContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DivestmentFairValueOfContingentConsiderationReceived" name="DivestmentFairValueOfContingentConsiderationReceived" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" name="AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MaximumMarginPercentageImpactOfCommodityPriceChange" name="MaximumMarginPercentageImpactOfCommodityPriceChange" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MaximumHoldingInUnrelatedCompany" name="MaximumHoldingInUnrelatedCompany" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PotentialReceivableFromDivestment" name="PotentialReceivableFromDivestment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_ChangeOverPeriodAxis" name="ChangeOverPeriodAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChangeOverPeriodMember" name="ChangeOverPeriodMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BasisOfPreparationAbstract" name="BasisOfPreparationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SelectedCriticalAccountingPoliciesAbstract" name="SelectedCriticalAccountingPoliciesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LegalProceedingsUpdateAbstract" name="LegalProceedingsUpdateAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LegalProceedingsUpdateTextBlock" name="LegalProceedingsUpdateTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImpactsOfAdoptionOfNewIFRSStandardsAbstract" name="ImpactsOfAdoptionOfNewIFRSStandardsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactsOfAdoptionOfNewIFRSStandardsTextBlock" name="ImpactsOfAdoptionOfNewIFRSStandardsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" name="DescriptionOfAccountingPolicyForRevenueFromContractsWithCustomersTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForOtherRevenueTextBlock" name="DescriptionOfAccountingPolicyForOtherRevenueTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ConsolidatedBalanceSheetByTheAdoptionOfIFRS15TableTextBlock" name="ConsolidatedBalanceSheetByTheAdoptionOfIFRS15TableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ConsolidatedStatementOfChangesInEquityByTheAdoptionOfIFRS9AndIFRS15TableTextBlock" name="ConsolidatedStatementOfChangesInEquityByTheAdoptionOfIFRS9AndIFRS15TableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialInstrumentsAdditionalDisclosuresTableByTheAdoptionOfIFRS9TableTextBlock" name="FinancialInstrumentsAdditionalDisclosuresTableByTheAdoptionOfIFRS9TableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" name="DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" name="DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AveXisIncMember" name="AveXisIncMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" name="IncreaseDecreaseDueToChangesInAccountingPolicyIFRS9Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member" name="IncreaseDecreaseDueToChangesInAccountingPolicyIFRS15Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OCIReservesMember" name="OCIReservesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RetailGenericsMember" name="RetailGenericsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BiopharmaceuticalsMember" name="BiopharmaceuticalsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AntiInfectivesMember" name="AntiInfectivesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SurgicalMember" name="SurgicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_VisionCareMember" name="VisionCareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ConsumablesMember" name="ConsumablesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImplantablesMember" name="ImplantablesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EquipmentOtherMember" name="EquipmentOtherMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OphthalmicOTCMember" name="OphthalmicOTCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ContactLensCareMember" name="ContactLensCareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_Top20ProductsMember" name="Top20ProductsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RestOfPortfolioMember" name="RestOfPortfolioMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProfitSharingIncome" name="ProfitSharingIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MilestoneIncome" name="MilestoneIncome" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherRevenueOther" name="OtherRevenueOther" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" name="ProfitLossFromOperatingActivitiesAsAPercentageFromNetSales" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_USMember" name="USMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CanadaAndLatinAmericaMember" name="CanadaAndLatinAmericaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc" name="RevenueFromSaleOfGoodsThirdPartiesChangeInPercentCc" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EstablishedMarketsMember" name="EstablishedMarketsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EmergingGrowthMarketsMember" name="EmergingGrowthMarketsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RestOfTheWorldMember" name="RestOfTheWorldMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.5EUR750Million20182023OfNovartisMember" name="A0.5EUR750Million20182023OfNovartisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.375EUR750Million20182030OfNovartisMember" name="A1.375EUR750Million20182030OfNovartisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.7EUR750Million20182038OfNovartisMember" name="A1.7EUR750Million20182038OfNovartisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_GalvusGroupMember" name="GalvusGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DiovanGroupMember" name="DiovanGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExforgeGroupMember" name="ExforgeGroupMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImmunologyHepatologyAndDermatologyMember" name="ImmunologyHepatologyAndDermatologyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AntiInfectivesSoldUnderSandozNameMember" name="AntiInfectivesSoldUnderSandozNameMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueAdjustmentsOnFinancialAssetsSold" name="FairValueAdjustmentsOnFinancialAssetsSold" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ProductPortfolioAxis" name="ProductPortfolioAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherSharePurchasesValue" name="OtherSharePurchasesValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LutatheraMember" name="LutatheraMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_KymriahMember" name="KymriahMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" name="PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" name="ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" name="TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TransactionCostsRecordedInEquityTextBlock" name="TransactionCostsRecordedInEquityTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TransactionsWithRelatedPartiesAbstract" name="TransactionsWithRelatedPartiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionsWithRelatedPartiesTextBlock" name="TransactionsWithRelatedPartiesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionCostsRecordedInEquityPaid" name="TransactionCostsRecordedInEquityPaid" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionCostsRecordedInEquity" name="TransactionCostsRecordedInEquity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" name="OtherComprehensiveIncomeRecycledIntoTheConsolidatedIncomeStatement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9FundInvestments" name="IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9FundInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9EquitySecurities" name="IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9EquitySecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPensionFundMember" name="NovartisPensionFundMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BorrowingsCreditFacilityUncommitted" name="BorrowingsCreditFacilityUncommitted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OtherNetAssets" name="OtherNetAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_OcularHealthMember" name="OcularHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" name="A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" name="A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" name="A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsInternationalSAGeneveMember" name="AdvancedAcceleratorApplicationsInternationalSAGeneveMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" name="AdvancedAcceleratorApplicationsSwitzerlandSAGeneveMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AveXisInc.BannockburnILMember" name="AveXisInc.BannockburnILMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" name="AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisposalGroupHeldForSaleAbstract" name="DisposalGroupHeldForSaleAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisposalGroupHeldForSaleLineItems" name="DisposalGroupHeldForSaleLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ChangeInCashSettledShareBasedPaymentsLiabilities" name="ChangeInCashSettledShareBasedPaymentsLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowNoncontrollingInterests" name="CashInflowOutflowNoncontrollingInterests" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AmountRecordedInEquityRelatedToHyperinflation" name="AmountRecordedInEquityRelatedToHyperinflation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdditionsToInvestmentInAssociatedCompanies" name="AdditionsToInvestmentInAssociatedCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate" name="FinancialAndOtherAssetsIncludingDeferredTaxAssetsRecognisedAsOfAcquisitionDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities" name="OtherComprehensiveIncomeNetOfTaxDebtSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TransactionCosts" name="TransactionCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_GainOnDivestmentOfInterestsInAssociatedCompanies" name="GainOnDivestmentOfInterestsInAssociatedCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FairValueAdjustmentsOnDebtSecuritiesMember" name="FairValueAdjustmentsOnDebtSecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_FairValueAdjustmentsOnEquitySecuritiesMember" name="FairValueAdjustmentsOnEquitySecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ReclassificationToPresentationRequiredUnderIFRS9Member" name="ReclassificationToPresentationRequiredUnderIFRS9Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_RestatedValueAdjustmentsMember" name="RestatedValueAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NoncurrentFinancialAssetsEquityInvestments" name="NoncurrentFinancialAssetsEquityInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NoncurrentFinancialAssetsFundInvestments" name="NoncurrentFinancialAssetsFundInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_ListedEquitySecuritiesMember" name="ListedEquitySecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonlistedEquitySecuritiesMember" name="NonlistedEquitySecuritiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" name="DisclosureOfAssetsOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" name="DisclosureOfLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EndocyteMember" name="EndocyteMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" name="DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" name="DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" name="DisclosureOfNetSalesAndSelectedNoncurrentAssetsByCountriesAndRegionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" name="DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies" name="DivestmentsAquisitionsOfInterestsInAssociatedCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherShareSales" name="OtherShareSales" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherShareSalesEquityImpact" name="OtherShareSalesEquityImpact" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfOtherShareSales" name="NumberOfOtherShareSales" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfOtherShareSalesEquityImpact" name="NumberOfOtherShareSalesEquityImpact" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeDebtSecurities" name="OtherComprehensiveIncomeDebtSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_OtherComprehensiveIncomeEquitySecurities" name="OtherComprehensiveIncomeEquitySecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" name="NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisAustraliaPtyLtdMacquarieParkNSWMember" name="NovartisAustraliaPtyLtdMacquarieParkNSWMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozPtyLtdMacquarieParkNSWMember" name="SandozPtyLtdMacquarieParkNSWMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" name="AlconLaboratoriesAustraliaPtyLtdMacquarieParkNSWMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaNVVilvoordeMember" name="NovartisPharmaNVVilvoordeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozNVVilvoordeMember" name="SandozNVVilvoordeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconCouvreurNVPuursMember" name="AlconCouvreurNVPuursMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconLaboratoriesBelgiumBVBAPuursMember" name="AlconLaboratoriesBelgiumBVBAPuursMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconNVVilvoordeMember" name="AlconNVVilvoordeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconAGFribourgMember" name="AlconAGFribourgMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" name="AdvancedAcceleratorApplicationsUSAInc.NewYorkNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CIBAVisionCorporationLLCDuluthGAMember" name="CIBAVisionCorporationLLCDuluthGAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ReprixysPharmaceuticalsCorporationEastHanoverNJMember" name="ReprixysPharmaceuticalsCorporationEastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPolandSp.ZO.o.WarsawMember" name="NovartisPolandSp.ZO.o.WarsawMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozPolskaSp.ZO.o.WarsawMember" name="SandozPolskaSp.ZO.o.WarsawMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconPolskaSp.ZO.o.WarsawMember" name="AlconPolskaSp.ZO.o.WarsawMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconHealthcareS.A.BarcelonaMember" name="AlconHealthcareS.A.BarcelonaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisOphthalmicsAGFribourgMember" name="NovartisOphthalmicsAGFribourgMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozUkraineLLCKievMember" name="SandozUkraineLLCKievMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DivestmentCostToSell" name="DivestmentCostToSell" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AmountOfSettlementInPrinciple" name="AmountOfSettlementInPrinciple" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_NavigateBioPharmaServicesInc.CarlsbadCAMember" name="NavigateBioPharmaServicesInc.CarlsbadCAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfProductsInPortfolioToBeSold" name="NumberOfProductsInPortfolioToBeSold" nillable="true" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CarryingValueOfTheDivestedBusiness" name="CarryingValueOfTheDivestedBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ShortTermLeasesAndLowValueLeases" name="ShortTermLeasesAndLowValueLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_RemainingLeaseCommitments" name="RemainingLeaseCommitments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_LeaseLiabilitiesToBeRecognized" name="LeaseLiabilitiesToBeRecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_RightOfUseAssetsToBeRecognized" name="RightOfUseAssetsToBeRecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" name="NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_NovartisInvestmentsS.aR.l.LuxembourgCityMember" name="NovartisInvestmentsS.aR.l.LuxembourgCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFinanceS.A.LuxembourgCityMember" name="NovartisFinanceS.A.LuxembourgCityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TearFilmInnovationsInc.FortWorthTXMember" name="TearFilmInnovationsInc.FortWorthTXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TrueVisionSystemsInc.FortWorthTXMember" name="TrueVisionSystemsInc.FortWorthTXMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TranscendMedicalInc.LakeForestILMember" name="TranscendMedicalInc.LakeForestILMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisBalticsSIARigaMember" name="NovartisBalticsSIARigaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisOverseasInvestmentsAGBaselMember" name="NovartisOverseasInvestmentsAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_JapatAGBaselMember" name="JapatAGBaselMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AlconManagementSAGenevaMember" name="AlconManagementSAGenevaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EndocyteInc.LafayetteINMember" name="EndocyteInc.LafayetteINMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_OrielTherapeuticsInc.DurhamNCMember" name="OrielTherapeuticsInc.DurhamNCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_WaveLightInc.SterlingVAMember" name="WaveLightInc.SterlingVAMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisBiosciencesPeruS.A.LimaMember" name="NovartisBiosciencesPeruS.A.LimaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TreasurySharesWithRestrictedUse" name="TreasurySharesWithRestrictedUse" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CommitmentForRepurchaseOwnShares" name="CommitmentForRepurchaseOwnShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NoncurrentFinancialAsstetsDebtSecurities" name="NoncurrentFinancialAsstetsDebtSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" name="AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale" name="DepreciationChargePriorToClassificationToAssetsHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProformaNetSales" name="ProformaNetSales" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SerelaxinMember" name="SerelaxinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CyPassMember" name="CyPassMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncomeStatementAdjustmentsOfPriorYear" name="IncomeStatementAdjustmentsOfPriorYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncomeStatementAdjustmentsOfCurrentYear" name="IncomeStatementAdjustmentsOfCurrentYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PlansAndProgramRebatesAxis" name="PlansAndProgramRebatesAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" name="AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale" name="ImpairmentChargesRelatedToDisposalGroupHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" name="ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification" name="AdditionsIncludedInDisposalGroupToTheDateOfReclassification" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" name="NetCashFlowsUsedInFromDivestmentsOfBusinessesClassifiedAsInvestingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NoncurrentAssetsDivested" name="NoncurrentAssetsDivested" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentAssetsDivested" name="CurrentAssetsDivested" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentLiabilitiesDivested" name="CurrentLiabilitiesDivested" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialAndOtherAssets" name="FinancialAndOtherAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" name="CashInflowOutflowFromNetIdentifiableAssetsDivestedAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TradePayablesAndOtherLiabilities" name="TradePayablesAndOtherLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests" name="CashInflowOutflowFromNetIdentifiableAssetsCurrencyTranslationEffectsLiquidityAndFairValueOfEquityInterests" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueOnSaleOfOtherFinancialAssets" name="FairValueOnSaleOfOtherFinancialAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" name="LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" name="MarketableSecuritiesFairValueThroughOtherComprehensiveIncomeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PlansAndProgramRebatesMember" name="PlansAndProgramRebatesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_USspecificHealthcarePlansAndProgramRebatesMember" name="USspecificHealthcarePlansAndProgramRebatesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember" name="NonUSspecificHealthcarePlansAndProgramRebatesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" name="NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" name="UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice46.7Member" name="ExercisePrice46.7Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice54.5Member" name="ExercisePrice54.5Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice57.0Member" name="ExercisePrice57.0Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice57.6Member" name="ExercisePrice57.6Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice66.0Member" name="ExercisePrice66.0Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice46.4Member" name="ExercisePrice46.4Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice53.7Member" name="ExercisePrice53.7Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice57.1Member" name="ExercisePrice57.1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice58.3Member" name="ExercisePrice58.3Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ExercisePrice66.1Member" name="ExercisePrice66.1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PrepaymentsAndAccruedLeasePayments" name="PrepaymentsAndAccruedLeasePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" name="RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" name="AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" name="LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AmortizationPriorToClassificationToAssetsHeldForSale" name="AmortizationPriorToClassificationToAssetsHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" name="NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LongTermFinancialInvestmentsMember" name="LongTermFinancialInvestmentsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MarketableSecurities" name="MarketableSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_MajorPlansPercentageInGroupDBOPensions" name="MajorPlansPercentageInGroupDBOPensions" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" name="MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NoncurrentFinancialAssetsTotalFinancialInvestments" name="NoncurrentFinancialAssetsTotalFinancialInvestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" name="NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI" name="DeferredTaxOnPensionPlansPreviouslyRecognizedInOCI" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfDiscontinuedOperationsAbstract" name="DisclosureOfDiscontinuedOperationsAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_YoYChangeMember" name="YoYChangeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PresentationOfLeasesForLessesTable" name="PresentationOfLeasesForLessesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PresentationOfLeasesForLesseeLineItems" name="PresentationOfLeasesForLesseeLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NewLeaseArrangements" name="NewLeaseArrangements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_UndiscountedFutureLeasePayments" name="UndiscountedFutureLeasePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectOfDiscounting" name="EffectOfDiscounting" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" name="DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" name="DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" name="DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentStatedMember" name="CurrentStatedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SaleOrIssueOfTreasurySharesNumberOfShares" name="SaleOrIssueOfTreasurySharesNumberOfShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DetailedInformationAboutSignificantTransaction" name="DetailedInformationAboutSignificantTransaction" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TakedaPharmaceuticalCompanyLimitedMember" name="TakedaPharmaceuticalCompanyLimitedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IFMTreInc.Member" name="IFMTreInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PowerVisionInc.Member" name="PowerVisionInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments" name="AdjustmentsForPrepaymentsAndAccruedLeasePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PotentialMilestoneMaximumPayments" name="PotentialMilestoneMaximumPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NumberOfEmployeesAssociatedWithTheProductTransfer" name="NumberOfEmployeesAssociatedWithTheProductTransfer" nillable="true" substitutionGroup="xbrli:item" type="xbrli:decimalItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AdditionalBorrowings" name="AdditionalBorrowings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PercentageOfEquityInterestSharesReceived" name="PercentageOfEquityInterestSharesReceived" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" name="DifferenceBetweenFairValueOfDistributionLiabilityAndNetAssetsAtTheDateOfDistribution" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DistributionOfDividendBearingSharesToConsolidatedFoundations" name="DistributionOfDividendBearingSharesToConsolidatedFoundations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AimovigMember" name="AimovigMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" name="LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughExerciseOfOptionsShares" name="IncreaseDecreaseThroughExerciseOfOptionsShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" name="IncreaseDecreaseThroughShareBasedPaymentTransactionsShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RepaymentOfLeaseLiability" name="RepaymentOfLeaseLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_WeightedAverageInterestRateLeaseLiabilities" name="WeightedAverageInterestRateLeaseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MovementsOfTheRightofuseAssetsRollForward" name="MovementsOfTheRightofuseAssetsRollForward" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LeaseContractTerminationsRightofuseAssets" name="LeaseContractTerminationsRightofuseAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" name="IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" name="SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxesOnTreasuryShares" name="TaxesOnTreasuryShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LeaseIncentives" name="LeaseIncentives" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowForLeases" name="CashInflowForLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetAssetsDerecognized" name="NetAssetsDerecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DistributionOfDividendToDividendBearingShares" name="DistributionOfDividendToDividendBearingShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" name="DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetProvisionsForTransactionCostsRecognizedInTheIncomeStatement" name="NetProvisionsForTransactionCostsRecognizedInTheIncomeStatement" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsAttributableToDivestedBusiness" name="CashFlowsAttributableToDivestedBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinancialAndOtherNoncurrentAssets" name="FinancialAndOtherNoncurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TradeReceivablesAndOtherCurrentAssets" name="TradeReceivablesAndOtherCurrentAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_TradePayablesProvisionsAndOtherLiabilities" name="TradePayablesProvisionsAndOtherLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CurrentAndNoncurrentFinancialDebt" name="CurrentAndNoncurrentFinancialDebt" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" name="RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" name="ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfRightofuseAssetsRollForwardTableTextBlock" name="DisclosureOfRightofuseAssetsRollForwardTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" name="DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" name="DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" name="AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NoncurrentLeaseLiabilitiesMember" name="NoncurrentLeaseLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentLeaseLiabilitiesMember" name="CurrentLeaseLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ApplicableTaxRateExcludingExceptionalItems" name="ApplicableTaxRateExcludingExceptionalItems" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" name="CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DivestedCashAndCashEquivalents" name="DivestedCashAndCashEquivalents" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CustomaryPurchasePriceAdjustment" name="CustomaryPurchasePriceAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_RepaymentOfIntercompanyBalances" name="RepaymentOfIntercompanyBalances" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxReformImpactOnDeferredTaxOnTreasuryShares" name="TaxReformImpactOnDeferredTaxOnTreasuryShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DividendPaidNoncashAssetsDistribution" name="DividendPaidNoncashAssetsDistribution" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" name="DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" name="DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" name="ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" name="DisclosureOfItemsIncludedInNetIncomeFromDiscontinuedOperationsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock" name="DisclosureOfNetAssetsDerecognizedTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" name="FairValueOfAssetsAndLiabilitiesArisingFromDivestmentsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DistributionByWayOfDivindendInKindToShareholders" name="DistributionByWayOfDivindendInKindToShareholders" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TheMedicinesCompanyMember" name="TheMedicinesCompanyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PiqrayMember" name="PiqrayMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ZolgensmaMember" name="ZolgensmaMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MayzentMember" name="MayzentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" name="DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" name="DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" name="DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" name="AccumulatedAmortizationImpairmentsOnAssetsRelatedToDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetDeferredTaxBalanceRelatedToDiscontinuedOperations" name="NetDeferredTaxBalanceRelatedToDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AspenGlobalIncorporatedMember" name="AspenGlobalIncorporatedMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue" name="MinimumFinaceLeasePaymentsReceivableAtPresentValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" name="InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ReclassificationFromNoncurrentToCurrentNet" name="ReclassificationFromNoncurrentToCurrentNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationPayable" name="ContingentConsiderationPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" name="IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BorrowingsUSDMember" name="BorrowingsUSDMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_BorrowingsEURMember" name="BorrowingsEURMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_FinanceLeaseLiabilities" name="FinanceLeaseLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EquityBasedCompensationShares" name="EquityBasedCompensationShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ExerciseOfOptionsAndEmployeeTransactionsShares" name="ExerciseOfOptionsAndEmployeeTransactionsShares" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ExerciseOfOptionsAndEmployeeTransactionsValue" name="ExerciseOfOptionsAndEmployeeTransactionsValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PoPMember" name="PoPMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_PoPYEMember" name="PoPYEMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_SharesDeliveredToDivestedBusinessEmployees" name="SharesDeliveredToDivestedBusinessEmployees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" name="ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" name="PreviouslyReportedFinanceLeaseObligationOfDivestedBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" name="NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivitiesFromContinuingOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities" name="DerivativeFinancialInstrumentsOptionsOnEquitySecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" name="EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AdditionalAmountOfSettlementInPrinciple" name="AdditionalAmountOfSettlementInPrinciple" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AmountOfResolvedAction" name="AmountOfResolvedAction" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_EnoxaparinMember" name="EnoxaparinMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SandozManufacturingInc.Member" name="SandozManufacturingInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" name="ChinaNovartisInstituteForBioMedicalResearchCo.Ltd.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" name="SuzhouNovartisTechnicalDevelopmentCo.Ltd.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CELLforCUREMember" name="CELLforCUREMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisManufacturingGmbHMember" name="NovartisManufacturingGmbHMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyMember" name="NovartisHungaryHealthcareLimitedLiabilityCompanyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvacedAcceleratorApplicationsItalyS.r.l.Member" name="AdvacedAcceleratorApplicationsItalyS.r.l.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IDBHollandBVMember" name="IDBHollandBVMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvacedAcceleratorApplicationsIbericaS.L.U.Member" name="AdvacedAcceleratorApplicationsIbericaS.L.U.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImagingEquipmentLtdMember" name="ImagingEquipmentLtdMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInflammasomeResearchInc.Member" name="NovartisInflammasomeResearchInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisTechnologyLLCMember" name="NovartisTechnologyLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" name="PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_PartialReleaseOfDeferredTaxLiabilityRecognized" name="PartialReleaseOfDeferredTaxLiabilityRecognized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_LeaseLiabilitiesUndiscounted" name="LeaseLiabilitiesUndiscounted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_MostMaterialLeaseWithLeaseTermExtension" name="MostMaterialLeaseWithLeaseTermExtension" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_CashOutflowsForShortTermAndLowValueLeases" name="CashOutflowsForShortTermAndLowValueLeases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashOutflowsForPaymentsOfLeasesInterest" name="CashOutflowsForPaymentsOfLeasesInterest" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" name="ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" name="ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_LongTermReceivablesFromFinanceSubleases" name="LongTermReceivablesFromFinanceSubleases" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" name="DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_BorrowingsCreditFacilityShortTerm" name="BorrowingsCreditFacilityShortTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_BeovuMember" name="BeovuMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_NetCashOutflowsFromDivestments" name="NetCashOutflowsFromDivestments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CurrentLiabilitiesMember" name="CurrentLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NoncurrentLiabilitiesMember" name="NoncurrentLiabilitiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CurrentLeaseLiabilitiesUndiscounted" name="CurrentLeaseLiabilitiesUndiscounted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_NoncurrentLeaseLiabilitiesUndiscounted" name="NoncurrentLeaseLiabilitiesUndiscounted" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale" name="ImpairmentChargePriorToClassificationToAssetsHeldForSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_TaxOnTransactionCostsRecordedInEquity" name="TaxOnTransactionCostsRecordedInEquity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectOfWriteoffOfDeferredTaxAssets" name="EffectOfWriteoffOfDeferredTaxAssets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ProceedsFromCurrentAndNoncurrentBorrowings" name="ProceedsFromCurrentAndNoncurrentBorrowings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_UncalledCapitalCommitmentsForInvestmentsInFunds" name="UncalledCapitalCommitmentsForInvestmentsInFunds" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_LitigationCaseMember" name="LitigationCaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_TennesseeClassActionMember" name="TennesseeClassActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_MassachusettsCaseMember" name="MassachusettsCaseMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_GrossDeferredTaxAssets" name="GrossDeferredTaxAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_GrossDeferredTaxLiabilities" name="GrossDeferredTaxLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AmountBorrowedUnderTheCreditFacility" name="AmountBorrowedUnderTheCreditFacility" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_ContingentConsiderationLiabilities" name="ContingentConsiderationLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_XiidraMember" name="XiidraMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" name="ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_PercentageOfEntitysTradeReceivable" name="PercentageOfEntitysTradeReceivable" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashInflowForSaleAndLeaseback" name="CashInflowForSaleAndLeaseback" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SaleAndLeaseBackMember" name="SaleAndLeaseBackMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract" name="DerivativeFinancialInstrumentsCommodityPurchaseContract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DisposalsAndRetirementsRightofuseAssets" name="DisposalsAndRetirementsRightofuseAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain" name="EffectOfIncomeNotSubjectToTaxOnDivestmentGain" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="true" id="nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" name="SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_CELLforCURELesUlisMember" name="CELLforCURELesUlisMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" name="AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisNetherlandsB.V.AmsterdamMember" name="NovartisNetherlandsB.V.AmsterdamMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaB.V.AmsterdamMember" name="NovartisPharmaB.V.AmsterdamMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_IDBHollandBVBaarleNassauMember" name="IDBHollandBVBaarleNassauMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisSaudiLtd.RiyadhMember" name="NovartisSaudiLtd.RiyadhMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" name="AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisUKLimitedLondonMember" name="NovartisUKLimitedLondonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisPharmaceuticalsUKLimitedLondonMember" name="NovartisPharmaceuticalsUKLimitedLondonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisGrimsbyLimitedLondonMember" name="NovartisGrimsbyLimitedLondonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ImagingEquipmentLtdLondonMember" name="ImagingEquipmentLtdLondonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_ZiarcoGroupLimitedLondonMember" name="ZiarcoGroupLimitedLondonMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisFinanceCorporationEastHanoverNJMember" name="NovartisFinanceCorporationEastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisCapitalCorporationEastHanoverNJMember" name="NovartisCapitalCorporationEastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisUSFoundationEastHanoverNJMember" name="NovartisUSFoundationEastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" name="AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisInflammasomeResearchInc.EastHanoverNJMember" name="NovartisInflammasomeResearchInc.EastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisTechnologyLLCInc.EastHanoverNJMember" name="NovartisTechnologyLLCInc.EastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EncoreVisionInc.EastHanoverNJMember" name="EncoreVisionInc.EastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_EndocyteInc.EastHanoverNJMember" name="EndocyteInc.EastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" name="NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_SpinifexPharmaceuticalsInc.EastHanoverNJMember" name="SpinifexPharmaceuticalsInc.EastHanoverNJMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="true" id="nvs_NovartisManufacturingGmbHMarburgMember" name="NovartisManufacturingGmbHMarburgMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_EffectOfUSTaxReformLegislation" name="EffectOfUSTaxReformLegislation" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_AcquiredCashAndCashEquivalents" name="AcquiredCashAndCashEquivalents" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
   <xsd:element abstract="false" id="nvs_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" name="DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" name="ConsolidatedIncomeStatementAdditionalInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_BalanceSheetAdditionalInformationTableTextBlock" name="BalanceSheetAdditionalInformationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock" name="CashFlowsUsedInInvestingActivitiesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
   <xsd:element abstract="false" id="nvs_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" name="CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>x_pwc.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_pwc.gif
M1TE&.#EA50!* /8  !X;'"$='B(?("8C)"DF)RDG*"TJ*S N+S$O,#,Q,S<V
M.#@W.#LZ/$ ^/S\^0$-"1$='24A'24M*3$Y.45)25%9665=86EI;7EU>8%]@
M86%B969G:6=H:VIK;6UN<6]P<W)S=75V>7=X>WE[?7U_@7^!A(&"A82&B8>)
MBXB*C8V/D8Z0DY&3E967F9>9FYJ<GIR>H)Z@HZ*DIJ2FJ::HJZFKK:RNL:^P
ML[*TMK6VN;>YN[J\OKV_P;[ PL'#Q<3&R,;(RLO,SLW/T<_0TM'2U-77V-;8
MV=K<W=[?X-_@XN/DY>;GZ.?HZ>KK[._P\?3T]?CW]_?W^/?X^/___P
M
M
M                                                 "'Y!
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M@11&, #Q:> <2GB!!BIP@L\5 W_#TQ__-O4$#E0P<AM0@B"V9X"+^< )&PA
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M '_T9 AV5@ &S.H037!!!5Q'@*)JK0(FX$$998&_W,WM C*PD@Q\0'RS0?S
M2BY0Z2-W$)46\ <31IA!"DI0&!;4X A$- 4Q0WA,"QDDK4S-'P%$$(5EF69T
M"(@>7.VJHQ,P4:]\O<03=, "W!E3 BFH 6D"2P@E@* !#7B 9"7;@ KT@+&(
@@,(3H,#9SFIVKY@-K6A'2]K2FO:TJ$VM:E>+G$   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>deckblatt.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 deckblatt.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0I ,(# 2(  A$! Q$!_\0
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MT9(]1G/--G>^BNHX(Y8V6=FVNZ\QX&>@^]^GXU5Y\VKZ$^[8T%544*H"J!@
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M+:1);L\$=P710,1,P)C'IGKCZTK)*_4?4ACNX+J9(X[1V:)OFWQ[?)./?O\
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M'\7X4_KM'N_N8OJ-;M^*/)Z*]B3X-6#HK?VK=KD9PT2Y%+_PI?3_ /H+W/\
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MK)69.RV+Y]/6HK2'[+9PVY8,8T"YZ9P*8T<5_;J9874@Y ;Y60^Q'3\*AT^
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M276G137T$GD@HQ/G8. W'&X=^:IM-[DJ]MC05E=0RL&4C((/!I:0    8 Z
M4M9&@4444 %%%% !1110 4444 1SQO)$5CE:)\Y#  _F#VJI8-=7.9IYE 5F
MC$<:X!P2,G.3V_\ UU;G>2.(O'$92.J@X)'MFJ]I>+<M^XMW6$$[G8;?FSR
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MH)88_0_G4,]XMG,WF6S[9" LD:[M[>A[@_7BFM9;">BW)9=US DEK<!3]Y6
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M8>>W*W4* G(9,[E(J'3;06=H(_+57+,6QWY..?IBIT2*UN5Q;6:(EX+V3>Q
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M(5:Z(CE!VHCX$H^O4CZ4ZTCA@>2&&=G"8_=%MWE^P[CZ5)=VZW-I)$R*V5.
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M5HA2>*ULT9;66*')RH3[@]2!T%)#<6\]LT=M"\ENJ84J,*P]%)Z_R]ZNEE!
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MU/Y5!-:P7EPXEN'?R\$1*^WRSZ\<Y^M/W6Q:I%BXF:! XA>1<_-LY('KCO\
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MS,QF1&.#QGKU7GTQ3L^;5]/T%?31&G13418T5$&%48 ]*=61H%%%% !1110
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MF??]*EU*\6SMU/FJLA=0 >I&X;N/IFIM\?VX1[/WGE[MWMGI4-Q<V]G<M)-
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M\GDAAOQ*0<;EVG /J,XIVUU8KZ:(EG6.\$<8NML;@DK&PS(/8^GTI;6(6[/
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MPSLKO&%4;5P&(SCN>*N3M,L1,"*[C^%FQD?6J]I>2W;;EMS'""5)D8;BP."
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M27,XD:X:,&5GRS=,X _H*E9+Q;==LT;3*<MN3"M[>WUYJ.SDNKRV%P[)$LJ
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MK7FT)TMJ7D18T"(H55&  , "G4U RHH9MS <MC&:=6)J%%%% !1110 4444
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MZXIJ[>B%LMRZBE4568N0.6/>G4U"S(I9=K$<KG.*=61H%%%% !1110 4444
M%%%% #7D2, NZJ"<#)QD^E0P)':CR/,!9V=P">3DDG^=321I+&T<B*Z,,%6&
M0:IZ;9+:1.3'B0NWS$Y.W<=HSZ8QQ5*W*2[W)_+3[<)=_P _E[=GMGK4-Q:Q
MWL[1RW#E5 /DH^W![$XY[<?2HO\ 3OM?VS[,FP)L\K?\^,YSZ9]L_C4FI62W
M<"D19E#+@@X(7<-PSZ8S5K1K4EZIZ$L#I%$$>Z$OS[%9B,D^G'4TMLD=JBVP
MD!;YF )Y()ST_&GFV@-O]G,*>3C&S;QCZ56TVT%I:\Q8E).XYRS<G')]L5.C
M3*UNB=8D%\\H?YS$JE/0 L0?U/Y5#-:1WD["2YD(C((CC?;L/8G'.?K42"^6
M\:\:V38Z+&8@_P Z@$G/H3ST_6GZC8I=&%O*#.)%#$'!*9Y!]1[52TEN2]5L
M3P2(L**UTLI8E5<D98CMQWIL8CM+-;87"JT40^9L9  QN(J62V@DM_(:)#$!
MPF.!]/2H--M!:V,2M&%F9!YI/)9L<Y/>INK7*UN1I9QVTB7"WD@>1@&9W!$O
MH,=/IC%6'2.XEC<2#-O(20#GG:1@^G6J]KIT4%_/*(%5>/*]%XYP.W-+>Z?'
M<W5O(80PWXE/3<NTX!]1G%4VF]R4FEL6F,=Q:L5D4QNI&\'(QZTPA8K$!9Q&
MJH )3C &.OI3;L3&'R+>%3O4KN8X5!_,_2BS$P@$%Q"H\M0H93E7'3ZCZ5-M
M+E=;$4=G':3+*EW(&D8;_,?<)3CT/?Z8J=UBFFCG$JX@9@<'C.,$'TQ4%EI\
M=M=W,@A51N B/7:NT9 ]!G-)=:=%/?02F%67)\WT;CC([\U3:;W)5[;%]'61
M Z,&4C((/!I:.@P**R- HHHH **** "BBB@ HHHH CGC:6(JDK1-U#+C^O:J
ME@;FXS/<3@[6:,1QKM7@D9/4YXJW.\D<1:*+S6'\.[!(]O>J]I>?:F_<V[I"
M"0SO\OS9Y '?G.3_ #JU?E9+MS$&R[^V?8_M9\K9YF_:/,QG&,]/QQ4FI7BV
M\0CC=C/N0[$4LVW<-QP.V,U8\T?;A#L&?+W;OQQBHKJ[^Q2%Y+=C$V!YD8R=
MQ. ".O4\?TJD[M:$O1/4>S"]MU>UN=O.5=,$?0CT]JAT\W%S%]HN)N6W*(XQ
MM48.,^N>*E\VX2W\T6>&+9:,.-V/7T)]OUI+.[^U?-#;LEOSAW^4DYYPOYTM
M4G8>ET5T6[-ZUFUV?*C19-X4!V!)&">G;J!3]0OE@:.-'8R"16=44L0F>20.
M@JRLP-])!L&Y8E?=ZY+#'Z?K4-Q>?8Y3YELY1R CQ@$LWH1V/Z4UK+86RW))
M,W4"2VMSM_B5UPRM[$=Q46GO-+:I>7,X_>1AM@&U$'7ZY]\U(99XK=9/L@SD
MEXT8$@>H[$TRWN6NX"T-MBW*?N_,.W?^'8?YQ2L[#TN1VVHQ2WTRF4^6Y40%
M@0K\<[3WYHNOM<-S$L-R EPY4ATW%/E)ROY=#FG1WS7$WD+9N)$(\T28"I]#
MW]L?I2SWS03B.6TD9F;$)3#!CCI_LG&>OYU5O>T0KZ:L=<Q316H>&Y??"I/S
M@,'_ -[_ .MBEM"ZVWVFYN,[U#GHJ(,=O_KU*9'6T:26,!@A9D!R.G3-)N,M
MDKI$K%D!$;' Z=*B[M8JVMRK9ZA'-=SHTAVNX,&Y2H==HSMSUYS27 NX[R.&
M*ZQ'<,W+("T>!GY3_CFI(KTW4WE):.#&P$IDP!&<9X]3SV_.DFOFAN!%)9NT
MK$^24P0WX_P\=<_K5V=]$3?35EU%V(J[F; QENIIU-0L44NH5L<@'(!IU8F@
M4444 %%%% !1110 4444 1S310)OE=43.-S' J*$V]NWV9)078M)M)R>3DGZ
M<U8(# @@$'J#533K-;*!T$:(6D=OE'8L<?IBJ5N4EWN5O(L/)^U_;'WYQ]I\
MWYL_W?3_ (#C'M5ZZ2*2W F<JF]#N]PP(_7%1?8D_M47?E1_ZK;NQSG/^%-O
MH+J[_<QF.*(%7\QAN)(((&..X'.:NZ;6I-K)Z%J6>*!5:614#-M!8X&:AA-O
M;C[(DWSJ"^,Y8 G.?UJ2(22P%;F) QR&4'<I%1:;:"RLQ%L1#N8G;WY./TQ4
MZ)%:W*H@L%C2Z6[?>Q %QYN6?_9]"/;%7KE(G6+S7*@2*5]VSP*B2Q1-5ENQ
M%&-T2J& YW9.?TQ^5-O(+NZD58S%%'&ZNK,"Q8CG&.,"J;3:U)M9;%J6>*'8
M)9%3>=J[CC)]*CMC!"JV<4@9H4 VYR0.@S3E5I[;;<Q("P(9,[E-0V-L;+3(
MHEB7S4C&Y5.-S8YY_K4Z6*UN2Q)$MU<,CDR-MWCTXXIDCVTTH9IE#6K;F&X#
M;P1S[8-0P0WT5T\[^2XF*[XUR-F.,@]_R%27EBES<VLK11MY4A+%AVVG^N*=
ME?5BUML).;6[$"R7!\N7.U VT2^Q]?I3K-+>&26&WF+*F 8MVX1^P]/I4MU
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M[_/V\[<XQMZ9]\_A4NHWBV5LK&55<N@&[N-PW<?3-7KS*PM+.Y(;"V-N(/*
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MN%/EI@R94'G.<=>U%P;V*[CACN%V3LV&=,M'@9XQP?Q_6JUYM'T)TMJ:  4
M   = *6FHI5%4L7(&"QZFG5B:A1110 4444 %%%% !1110!'/(\41>.(RD?P
M@@''MFJ]I>+<L1;V[B$$[G9=@W9Y&.I.<YJS)+'"H:5U12<98X&:B@$-L?LZ
MR@N[-(%)&3DY/X<U2M;8E[E7[8N/L?\ 9[^;C_4[1LV^N>F/U]JMW4JPVX=X
MPXWHNWW+ #\LYHV1_;A)O_>>7MV^V>M0W%M;7ER8YYB^U0WD!]H'^UQR?_K5
M6C:%K8L7$KPQ[TA:7GE5(SCU&>M06MTMTI^SV["WP<.PVACW '7UIT$T$, !
MO!(F_8KNPZ_W<]S3K<0VX%JLH+C+;21NP3GI^-*UEL/=E47BOBS%@_FJ 6A*
MC8J]CGICCMSQTJW<RK$L1= ^Z15'L2>M"QQB^DD#_O3$JE/0 M@_J?RJ":VM
MKNY<33LYCP1$)-OE^_'.?<T_=;%JD6+B9X$#K"TJY^8(>0/7'>H[.Z6Y4&&!
MDMMHV.PV[OHO7%$$\*01@W:RAB521F'S'TXX-(A@MK7[(MR%:&( DD%E &,D
M4K:6L%];DD4JO=7$80!DV[F_O9%03WP@G$<UK(6+?N2J[MYQV/8XSUQ4:6MI
M \<\=VRR2, 9#)GSO8YX/X=.U69/(GE1_.7-LY9@&'!P1SZ=:=E<+NPR:=H4
MCN)K0G .\KAFC']1]*?:S"X+3+;F-& VNP 9QZXZX^M2,T5Q:LPD!B=#\X/&
M/6F-LBL !/Y:+& )>.!CKSQ2TM:VH^MQ895DGN45 IC<*Q_O':#G]<?A5>:^
M$4XCEM)3-D^3M ;?]#VXZYQ21VMK;31R17+(\IYS)N\[ZYZ_45,YMY95G\]?
M]&9@WS# .,'/I3LKBUL6$+%%+KM8CE<YQ3J:CK(BNC!E89!'<4ZLRPHHHH *
M*** "BBB@ HHHH 1E5U*NH93P01D&J>G62V<+@1*CM(QR!R5W':,_3%69XC-
M$561XVZAD/(/]:IZ>)Y@9[BX9RK/&$4;5X)&<=SQ5KX7J2_BV&[+_P"U?;/*
MBP%V>1N^;&<YW=,^WZU+J5FMY;J/*5G#H03U W#=S],U#Y-Q]M^R?;)/(V>9
MT&_KC;N]/U]Z?J-V(HQ#"9&GW(VR,%F"AADG'3@'ZU>O,K$Z6=RZ88C#Y)B0
MQ8QLVC&/I573K065GM\I5DRQ;'4\G'/TQ4A*7UN'M[ADYR'3J#Z$'^1J'3A-
M/#]HN)V=FW*%4;5&#CIZ\>M3KRN['I=#$COUNS>-%$0ZJAA#?,J@DYW=">3Q
M^M2ZA8I=B$F%'99%)+#^'/(^GM4*17)OFM&O)# B+(. '.21@MZ?+]>>M/U"
M\$;QQ1&1Y%D5I%B4L53/.<>U5KS*Q.G*[EQX(I(3$\:-'C&PCC\J@TVU%I80
MQ&-5DV#S,=VQR2>].?%[;K);7)3NKIR/H1WJ'3VD:T2]NK@DR1AB/NH@QG@?
MU-1KRO4K2XMM81P7]Q,((U#;=A '''./3FB]L([FYMI#"C['.\D#E=IP#Z\X
MJ.VU!'O9=[2+%(5$#.I"MQS@GW_.ENTN8[J%8+ID2X<JP90VSY2<KGIT[Y%7
M[W-J^@O=MH6+Q9WB\FW1/G!4NQX0?3O26:SQQ>1<(G[M0JNIX<?3L:;<P21V
MH:&XD62%206.X-_O ]:+4F*U^TW-P6+H'8M\JH,= .U3]D?VAMG81VUU=2+#
M&@=QY9 '"[1D#TYS1=6$<]_;3F"-@I.\D#GCC/KS3+2^5[N=9#(JR.#!YBE0
MPVC.,^^>*2XCN8[R***[=8KAFW J&*8&?E)Z?CFJ][FU>MOT%[MM#2HIJ*$1
M5!)P,98Y)IU8F@4444 %%%% !1110 4444 1SM*D1:&-9''\);&1]?6J]I=R
M7;92V,<()#,Y )8'!  ]\\U8FGCMX_,E;:F<%CT'U]*AMY+6)OL\,H9F+284
M[L9.<\=.M6OAV)>^X_SO].$&T?ZO?N_'&*BN[N2S?>UL9(3@!HR-VXG !!QW
M(JIY>E^5Y_GGS=V/.WGS=WIZ_P# <?A6A=")K<"=B$WH<^^X8_7%.R36@KMI
MC/,NEM_,%LGF;LF(/SM^N,9_3WIMG=O=_.EN8[?D N1N)SZ#MUJQ-<16Z!YG
M"*3C<>@^I[5# ]M$#:PR[BH+$+\Q7)S_ %I;K8?7<>LV;^2#:/EB5]W<Y+#'
MZ5#<WDEI+\UJTD;D*C1D9+'L0<8^M5EBTL(DZ3'S6; E#DR,WH>Y^GZ5?N1$
MRQ><2 )%*_[V>*=DGL*[:&&2ZCMUD^S(SY)>-'Y ]B1@G\J9;7,MW 9([=4A
M9,Q>8>6],@=!5B:XBMPIF<(&.T$],_7M4=J]NBK:02!O)0# .<#MD^M+I>P^
MNY#%>S3S^0+,J\9'FEV&U>_&.OZ4MQ>RV\ZQO:-(7;$+(PP3C.#G&. :GB6$
M75P48F0[?,'IQQ^E1RSV;R@R3*CVS;B&.W'!&>>W-/2^PM;;DIDD2T:255WJ
MA9E4Y'3IF@.\MFLD:(79 P5C@=.E5[EK.Y$'GR,(I,[5;*JY]_\  TZR6UC>
M6.T<E%(RBG*(?0>GT%*VEPOJ-AO9;F<Q"T*>6P$ID884XSQC.>"*2:]FAN!"
MUF7=R?)9&&UA[D].*L0+$)[DQDERX\P>AVC'Z8J*2XLVE\V2=5:V8Y#'&"1C
MD&GI?8-;;EI-^Q=X ?'(4\9IU-1Q(BNN<,,C(Q3JS+"BBB@ HHHH **** "B
MBB@ (R,'I56PM!9P-&$1<R.WR#'!8D?I4T\*SQ%&9U[AD8@@U3TZ*1P9[B>2
M217=%W?*  Q'0<9..M6OA>I+^(F^R+_:8NMB?ZK9NQSG-,O;>YN_W221Q0@J
MV[&YB0<CCH!D#_ZU0?;A]N$_ES_9/+V>9L.W=GKCKCWQBI-1CD1/M-M/)'(6
M1#M^8$%@.AXR,]:I)J2N2VFF6X1*T.VY6/=T.SD$?C_*HM/M19VBP[44@L3L
M&!R2:4V*?9Q$)9@0VX2>8=V[US_3I[5!IR.8?M5S-))*=P^;@* 2. ..W6ET
M=F/JB9+15U.2ZV(-T2ID#G()S_,?E4=W;W5U( DD<4<;!U.TL68<\],#_/%0
MI??Z>TYCG%J\:HLA0[=P)R<=0.1SBGW\,J.DMO/+$TLBHX7YA@\9P<X/O3LU
M)7%=-:%R-9)+?;<I'N((95Y4_G45G;M9Z;%"B)YB1@8' +8]:&LD^SK&DLR,
MARKAR6SZG/7Z&H=/@::R2>YDDDEGC&_)V@ CH .G\Z6EGKH/J$-M>PW+3M)#
M)YQ'F(%*A0./E/?\>OM4MU:+<7%K(41O)D+$L.<;2./Q(J"WMY&O98Y;B9X8
M"IC4G&<C/)'+8]Z+N"5;J$07$T:3R%90IS_"3D9^[T[57VMQ=-B[<PB>VEB*
MJV]2,,..E,BB>VL4BB1-Z( %SA<XJ.YD2TM/(C61I&4K&JY9B<>I_F326KK=
M6GV>594D5 LBME6!QU!'\P:BSY?(=U?S&V]M>07#RM)%*)F#2*%*[3@#Y>N>
M .M2W%HLU[:SE$/E%LDCGD<8_&J]I!*UW,)[B:1+=P(@QQ_"#DXQNZXYI+FW
MD6]BCBN)DAG9C(H.<<9X)Y7/M5?:WZ"Z;&G13401HJ+G:HP,G-.K(T"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>logo.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X0O 17AI9@  34T *@    @ !P$2  ,
M   !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (   $Q
M  (    <    <@$R  (    4    CH=I  0    !    I    -  "OR    G
M$  *_(   "<0061O8F4@4&AO=&]S:&]P($-3-"!7:6YD;W=S #(P,3 Z,#<Z
M,34@,#DZ-#@Z,#       Z !  ,    !  $  * "  0    !    R* #  0
M   !    (P         & 0,  P    $ !@   1H !0    $   $> 1L !0
M  $   $F 2@  P    $  @   @$ !     $   $N @( !     $   J*
M     $@    !    2     '_V/_@ !!*1DE&  $"  !( $@  /_M  Q!9&]B
M95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ ' "@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MFB_,Z=@-R<*BUU0>Z[T[7^F[T[[:L<4VM]-GOV>K?59;_HT!"1)';3=<<D0
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M,_X.JS]$NEZ#Z?[*Q_1];[/Z;?L_VC9O]+:WTOYC^1^_^E7.XO[,^PX'VO\
M:?[#]1GV;[7Z/V?G]3^T^C^O?9=_I_9_M?ZO_-^M^C1A\TSO'](']W_OOW49
M-88QJ)$>B0W$O^\_??_9_^T04%!H;W1O<VAO<" S+C  .$))300E       0
M                     #A"24T#[0      $ !(     0 " $@    !  (X
M0DE-!"8       X             /X   #A"24T$#0      !    !XX0DE-
M!!D       0    >.$))30/S       )           ! #A"24TG$
M"@ !          (X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F
M  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M      $X0DE- _@      '   /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z   .$))300(
M       0     0   D    )      #A"24T$'@      !      X0DE-!!H
M     TD    &               C    R     H 3@!6 %, ( !# $T 60!+
M "T 0P    $                          0              R    ",
M                     0                         0     0
M &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ",
M    4F=H=&QO;F<   #(    !G-L:6-E<U9L3',    !3V)J8P    $
M  5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N
M97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<    C     %)G:'1L;VYG
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M=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*
M    #     (_\        #A"24T$%       !     (X0DE-! P     "J8
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M_JW-Z#?;TWZU9?3KL=V%1U1OVK&H<YCMKVB+=OH.?4WU-MO_ &U6K7^,&?\
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M[Q_2!_=_[[]U&36&,:B1'HD-Q+_O/WW_V3A"24T$(0      50    $!
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M  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8
M 0    #3+4A0("
M                 !%C<')T   !4    #-D97-C   !A    &QW='!T   !
M\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+    !1B6%E:
M   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #3    (9V
M:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H   $,
M  QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT97AT
M $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0
M9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$              !)S4D="
M($E%0S8Q.38V+3(N,0
M                        6%E:(        /-1  $    !%LQ865H@
M                 %A96B        !OH@  ./4   .06%E:(        &*9
M  "WA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE
M8RYC:
M      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O
M;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M        9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG
M($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M         '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A9
M6B       $P)5@!0    5Q_G;65A<P         !
M     H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9
M !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '< ? "! (8
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M949#!5M?20Y"&DKX)7A9Q(L<T;$:74FMY87^W2K!N%E-!,5U!9$9&*DD @,
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M/R>9R=?38O&XG']L;"K<GD,G6U"4E'CJ&@IL_+55=?5U4JQ10QHTDDC!5!)
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MV0RO:?8%=3[1V+3XZBD(.0GH<WEHZZ6%;LU+22FUE/L(\C[$G,7,^U[=<8L
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M:DDY/J>L4?NY\J\L;USG[]6>\<N6%W:0;I$L236\4J1J;C<05171E12$4$*
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MG6VY7W/LO$;\KTT87*; W74)_=3=R9!XFIE@H<O18Y,N ZG'$3B1M,?KYO\
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M?]FT_O?_ '=\/V=1_P >)_<'_?X_WUU6T_P_]_[7R_V=7N&/?'Z?^J4?U?\
M5KZ?QQJ_?/C^%32?]Q_IOU_']/#[M&KRKUDG]UWZS_7 F^@_KI]9],=']7/I
MO'KJ7_<SZS_%?I?7QNSQ-'G3I!_!7[C^X6P_[C?[,%_<+["#[CQ_PS_9>?-Y
M?^:9_P"S%?\ .2G]P?#_ ,!/M?V-&K_=OLF]GM?[FV;]T?OO]S:!6FC]V5K_
M ,1/WG_NT^FI\&CMI7\70D^\5X7]9.9/ZQ?U9_K)XATU\3]]TI_Q/_<G^Z+Z
MRO\ :>)WUI^#H</D]X_X-DO[P_WR_N_KQOVG\<^Y_P!#'F^XI/-_>G_1=_QD
MSP7_ $?>_P"3_=:?%Q;WCS]]'POZO;Q_6S^L/]5:V_A?6>)_5+7KBU_O+^K?
M_(BT?P_5_H?4:?!Q3H%>R^K]X6?[I_=_[UI)J\'3^]Z:6I]-^\O]UU?7P>_P
MZZ^A)^./V_\ H]C^T_T0_;??R^#_ $-?Q3^ >+P4^G^+?QO_ '+_ -X+?Y_[
MC]W3IU<^Y@^Z'])_K3Q?0?U!^B^J;1_5/ZGZ'3HCI]5]9_C7UW^_O'_5TZ-6
M>@?[N^+_ %K;Q_W_ .-X0U?O;P_'KJ:OA>#^EX'\'A]M=5,=#[[RFZBWI*[Z
M^Q_N9NK^)_=_P[^[^6^]^Q_O']U]M]E-Y?%_=#_?T?H_5]A_E6F_C]5O:JRU
M_66OA4\3Q%I712M?^&=G^]=OKT@W7POW9?\ CZO!\%]6GQ*TTFM/!_5_YQ]U
M.&>J@OY</^CW_2UV[_=__93/XI_?3<'A_P!E7_V:#^(Z-&7\W^G7_2;_ +\_
M^_\ XK^7[C]S[CR^+]S3[EGW#^O_ '5M/C_O7PO!7_<WZ.GX?]QO!_4\+TIB
ME*XZQU]F/W/_ %AYB^D_J]X_U4E/W7^\]7XZ_7?4_H_44XZLZM6G-.K(_EC]
MM_LM?=OWG^AO[3_1UN/[K_9A?XK_ *%/MOLG\_\ I(_@7^YO^[7BOY?L_P#*
MM6GQ?N:?<=\K:OZQ[+H^LU_4)3Z73]16N/!U=NOTU=OKCJ:?<#1_4GFCQ/W;
MX?T<E?WAK^BIIS]3X??X=..COK33FG2MZ&^R_P!!O3/\-_NO_#O]%'7?V']R
M/X__ '+^R_NAA_M?[H?WK_W]/]U_!I_A_P#$O]R'VGC^X_>U^TF^:_WWO'B>
M+XGU4M?$T^)7Q&KXFCLUU^+1VZJZ<4Z,.4_"_JMRUX/@>#^[[?3X'B>#I\%*
M>#XOZOA4_L_$_4T4U]U>JFOYOW]U_#U[_>__ (;7_@W\*K_)_LY_^F'_ $L^
M;[Z3Q_Z+?]!O^_\ ?[JZ=7W_ (OV/NM&OG1[E3VF^IK?_2?UC\;4/^2?]/X'
M#_1OJ?TM?\-<Z:T\^L?OO%?0:=G_ 'C_ %)^F\-J_OGZSZNNH_[B_0_K^%_O
MRG;KI7-.BW?%#_1A_LQO2G]P_P#AM3[G^&X_[S^]W^S??Z:O'JD_[)G_ -F1
M_P!Q.CR7\'V'[OA_VBWL1<T_O+^KV\_7?UCTZC3P_H/I_P#J,^D[OMU8K\^@
M7R!^XOZY\L?NG^I.O0M?&_>_UM,_\DW]X]G^E\/.GY=;)OO'7K-7HD_\P_\
MA'^RE=C_ ,=_V7O^%_Q7KC[C_9I/[[_Z%=?^DO:/VO\ >C_1S_O\/N_N_'_#
MOM?1_$/#]Q_DWF]C/D#Q?ZU;?X'U_BZ9:?1>']1_8R5T>+^G2E=>K\%=/=3J
M,/>+Z?\ UOMY^K_<_@>);U_>GC_1?[DQ4\7Z?]:M:>'IQXFG7V:NCD9;P_PK
M)_<>7[?^'UOG\'WWG\/VTGE\/\,_W)>71?3]O^_?_-^NWL(15\6/335J%*T]
M?GC]N/7'4DW&GP)]==&@UIJK2AK33W5]-/=Z9ZIB^%?^CK_9R^X_X%_LJ/\
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MWS^&E.[HBG\MS_1O_LP>_/X+_LB7\4_B$GVG^R>_[-=_?K7HWCK_ -,O]_\
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K7;JTUSUCA[:_N#^N_)?[J_J7XW@9K^^?JJ4;_DE?O']*E>&GNT:Z8Z__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>deckblatt2.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 deckblatt2.jpg
M_]C_X09N17AI9@  34T *@    @ # $   ,    ! ,(   $!  ,    !!"D
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   >    M $R  (    4    TH=I  0    !    Z    2  "  (  @ #J8
M   G$  .I@   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q
M.3HQ,3HR." P.#HP,#HT.0     $D   !P    0P,C(QH $  P    '__P
MH ( !     $   #"H , !     $   0I          8! P #     0 &   !
M&@ %     0   6X!&P %     0   78!*  #     0 "   " 0 $     0
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
M  !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE
M5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    $@!0 '( ;P!O
M &8 +0!% &D ;@!S '0 90!L &P =0!N &<       IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q 6             IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ !@
M 0 " &     !  (X0DE-!"8       X             /X   #A"24T$#0
M    !    !XX0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      T<    &              0I    P@    D 9 !E
M &, :P!B &P 80!T '0    !                          $
M     ,(   0I                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   0I     %)G:'1L;VYG    P@    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $*0    !2
M9VAT;&]N9P   ,(    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !     $X0DE-! P     !00    !    '0   *    !8   W
M!.@ &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( *
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M ', : !O '     3 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P "
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M(#P_>'!A8VME="!E;F0](G<B/S[_[@ A061O8F4 9$     ! P 0 P(#!@
M             /_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$!
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\( $0@$*0#" P$1  (1 0,1 ?_$ 2$   (" P$! 0$
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M1X)(93SH.V982]C,@I()>M=<Z4RG/YCI:><D+54T?>%:>IRSP_1GSWT\V
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MC1<JM].O4&JGH0$^9/U=-8NY\S7GB94//1ZI.6%B:Q)VNM+(UR+X^>^GF@
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M1*@W<2 M5&7Q;L7%N5SIYRK:I,7FU967=1Y^05VO[Y,T%C'A:LUP^B<#?V@
M   )-NI3NQA0[TSQVFNG<3KM!;FH,4-QQJ7%29"W*N_SUJHV,17NU^?O?H[Y
MK>F     $BYGUY?HNU&\D2>)>QXYJOEF@OHUZA-^>Q)%6*V_URQ\W1T=(-_/
MXW+XP_H9L    !2DA3KM6G]/!OC,VY>G.H7?51WL*]*&C*P6U_O.OW$NR\@I
M:,UYZRU[JS[6GG:4R    !$<K5=I4_.QP5A86=85[5+GL(IRR,RXH7/*W-X8
M^G/.FBG42Y',2\O;$U@    !+L5::UZD9;S)"KU\J;"5:SE_6]3.1Y>*EM-M
M(RSF[??''/L:!2T(</+Z+^8^FGP    $J[GUO>HQ<OE_I>I.E<1MFE!>Z]BY
ME_K[U6EY.P0I>CYFZECOYWH]0(D_F]</Z"9     1Y(4F]4<*U^K+F#(2I>O
M?9:UBJM#/8>=QYQ N0/U7CS2UH[G:MT\EEXN?"^@F@    .:&"L-?/1;=%ZS
MKEG4]*L;ROM/YFP\?;L.*TAS<Y9J_CNN2'6YNAL9RK9S;X     CV*U/:]"%
M]4&%?<J/I']E^]6G.<>,ZRGRH70R=_GC?1U]?"KJ96B3GTM\C];+@    )5O
M/K#1HS4?B#E\,]>> \>>^S/!^,YE\6XCJ%N5>GSUZH['G"+H8W,[?WSWT\T
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M]?'^B,;=ZZ\J?;4]M?._0WSGT/1WJW[Y->?*G+R(]TI;ANAO(LG+DS=*;
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MI5VG@W[E[G13ZF7U4:>1]#XNCAXD776./TC:SAJT)?SUPJWD#7Y=.#I38
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M+(M[)W)"IU U>J%W/N?Y[0\G+GOC%6L(&Y@=E2U)>##5NUQKT+W^=^AF
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M-EGSIYZUU^;C8Z   ')OU<?XS_V5_6'^7?UK^%']Z_S_ /A*_2S\W],(
M        -D\_[P?S1_2'^YO\&_O'\*_[U_G_ /"/^EGYOZZTGDL)Y]GCNSQ9
M\\>O+53'SS*&;V>#"6(BE\     V3S_O!_-'](?[F_P;^\?PI_O?^?\ \)/Z
M5_F_A#V_/@OMZIU\I9^H^<ZK#IH7;4R;5-:V?=?QGU&%W/[\_4H7[_X?&.4
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MRWG;N\;J,_.*5F'3[[]+_-?2S
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M_-_(NI2)X7DP_52GR#%-4E"+V8B=DA<*CTQ[H9F.):1>3E3Q6MW._/4MB_\
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MK<F*KN[$2&K8.]]JT>-]I<$RU%9;,93?%?/9?/9?/9?/9?/9?(YV2^.<C?\
MLKE$B=90!PI%5,2OHZ\*<L=0_E:B!QN;5(RNJ:\'[(U 5QD0@[RQ (X1( I6
MB!,)E+!8/,8(!%&- "YGHU-;(CK*I*B:VH.0:L%G_*JZZ55LJ@B-KZHV.&O$
M)26FJY9W7=26.LJ2NCKZ4HN*GKR9VW($\#9$GD8#3$DQ>C7"O^)C$(2&:?\
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MO^H2MA(6N$!:MG7"-=/5#M@!JP98ZT$+YV0 B*2)#'", (]GHU8!4BG!FN9
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MO0:C?=.HM%5LM( /0U6FJLE3X;9<[L"/R_VW?I^]FS<>:U^RK,968;7\[L!
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MIY3J=KMZ7']+K=+T;9:SJ.4TFI(Z3FLSS8[:75=S_IM9LMGJ=/UC/:NK@-$
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MRH[Q)?EXKE:J2>(KW-1?=/N3S[D\^Y//N3S[D\AFB^W_ &^+D=_3Q\Z7@/\
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M5NOOZBMU%QK*<;=#8;,?RE/E: .HT=E35FAOPRPK$7T+W/T6HK>/<S#QU?\
MX)9Q>G]=#WVJ''KP.BY7C?.1\AFJOB=$#U3IXG0]24^GJ>F97D6/DP'.<DSI
MU5K^D\EHM3J^@<_S^EQ>*SH/.L-B8.FTNOWG'Z&\Z! /"'%Z&HK;JUI^4']&
MTOC^QY]O5^L6'0\P-)D=NS-\;L-YJ0*[LU"?USI9O1<L:;EMM%E^9$;K<8[*
M3=3MMANC.H4&GV&E&YU@\3I1^AX/$E=1O]CK3.IT^QJP)@*_T-7;65+48#H@
M&S+_ ,10/AO;T#.T.MO[2AJ,)O0=P&+T(&P?M+ROH1]GH;',!\VW@^Q!S][7
MV.NTW41LW>Z74F9VOY_HA=<1E+\*WT.BZ@RDOZJ<P@#T+N_H\X'F1\MD)DJJ
M=.@[7&XCH.IR^FRF>HL@F6R0XE)2C]"T>'Q&ZT^9TV8"S]:1D\=CJK$\ZS9]
MU_*6FMBS<[KL<6E91<WHL-SW'7EA+BKZVK+.ON0/0,#"MPN.\SKN=TJ@=A79
M=HYP%T/,/S.;FH>,<^CYOBJJMZ^+M^N<KJ-[!:97.W%)QG"1<\YQBN24N8Z%
MT;D]-LM;T@/8'TW-0MA4U'..2TV-V.[Y+0Z3H'HZBBGT=)R4?7WK5H-JF^['
MOX:&ND*K.G93CC-5I*>KH]P[HO7^EQ4Q%G(SI&9Y&9?%8W%=9KK'H&^"WM3K
MMUE;JMQW/I)Z#&<]Z@)8[7756YJ-U6!1U@7H:<O25=+@-]>[F=VG1.@[[H%_
M@)UT/1A<QS7?6N[\&TS9^D['I-YA+0F[Z15YW%;;2=!SU%TW3ZB\UG3=)DKX
MBYN <6/96MOAL[TS2[+0:#J.GS^BK$LUK_0T&MH\C7Y"XY[3E?I/[?UJM]%G
M2LSI-CG<B)E;/#T<(%%P,87:C9LH;2:_.Y-F!L<16C9X?+1["]U?,[*WV1_-
M=C#S4;G].?E8,W#H[K6\K/MJNT@N /0GC:^'DV$$YYGEP(2=;Z;E-SMX\]!H
M"J+DF'&YSC:S !A=:Z#E>A;(NL&NKC,\YR97.^69?&]5H=1O<#7ZW3[7.C:G
M)4=%88WG>2QG4,QI-=S\2_Z!Z.GS8^EJ>/T5Z8Q>I-7H'8ZB[! DY74/S7'*
M^U(IJWJ\O^(O4LSH*LHGFX3\OR/.V&AP>.R%\3ON@9+2":[:W //,?A;,7?X
M_"9'2$[/7XV\AWU55CTX'_UK_]H " $" @8_ "D+ N@4AUIIZ>$*(4PJ0J0@
M$(1!W"%$(800#&[T3?.)#":B9'\VI%<#U0!YQ<\@% $0$ B1<IEU[15,;G/W
MN;(8UQ9M#"27(7 *N0W*9:K%_EG,>6ECOE"E6V[C@DQ-0$S*#&'6[SRUAQ$T
M.H52#U>^'6/,W70BX(LP I)-1B=2(%ZS>+K9( 4(04!0GJ2= ,3',*UQVVG.
MEB@3.N0@V[K]JJA$^\+2E95G!L[UNBNE"E<B)I.>,HLW$/$OK3/26D/+[VUK
M&DF6XH BH)I.8E*:A%CRKA2X3) 9G(Z=1'6(-JV\E[2AP"Z!<I*)2UERUPM/
M&#V(<)]VD7+URZ6V[0&[A61D  2A.Z060*DJ/1;6D;JS2>@KEE!>\(*3SQ2I
M-)>$/\P#9NT7<GN6'MY8O;=^Z4S2;4*?Y/VN$0&W$-_&@GE*I QE#KMZV&EY
M 2A4(#C22@DS&"0  K-VE4'LBVVT7-:OU2%U730R6L.V[=^T26>-9(O=A#'W
M  TG%.M2,DP)7JB_^),I*I&V@^7 5"8?:G#"UJ@Y)6>9TQQE#0UH4'[M>M/;
M&Y.,%<$7U*-(NNYEY+2J[B$PV[0) YX=L--NWN#DFLA(DK.0&JK2I3T;3/:G
MKG!Y5W)DV_FW;RN[:BIM1?#%(%T;BUK7459M< A2OMR@6M4Z2B[?M@@$-!7-
M /9#[#>3<VT)CC)*H N(I03$7BY3NMEN(KV9QYHH(?=GL-%Z@%[4BU;)/ 3U
M%2M,8OL*\00)G,>WPCS39+W @@*0 [-47LF)T.!N>26.)4A21NHJ[5[)"5,[
M>Y9":QS-DJ0X!,E!W9=\_1-V&8IT\,X9:M-MMM2<C6HA.V9U,Y(H !)*H'7'
M6K9YVGF;1OV@  KM5=O#\RIC#KO,/:UH:X*073<T@R1")S#@1U0C"QS=4>US
M3F%-0:+VPZS9M,9RP*AK6ALR&J24"F1P% JQ<)MVOQ;G;77 P!SFH@<" "'(
M4520%E.+WF7 QC[;F*1)7A*2D.P:B'"V6D.!#@X!S7 K6N?4<90+5FVUED)M
M#0&A9*J 5S0=M8LL9=:YUM04IQ%9+,B80ST)BZ76K;]C#MW &O"E/E0TF2M8
M*[767#B:X;@9X":=9!GA*&V[8:VT%VM #0 M9 =Y $R@4Q:99O-=Y4BBC&9"
MDXXS!61BZX,:ZZQHV$M!(0X*/JB8*E"29T]$U[CP+X=ZZQY-HEUQ02< #-HK
M4#M2>D&]Y;MJ^$IU5.E(=RUU[F.<"0X E-H+G"M2T.KXT+ A;:[TUF6A:9>R
M'<J'N=S#$4D! '(0 AG59 U1< ;QM.#%GU44A5'$<L%RB_:O7RUC6%Y0+PMF
M[/+KT-(;YZMME9B::U!/21A]AI+GM<A)"3E*I!1:IX%8;<M7"YCP-JB@'#,R
MI3#M18N7+CW-%L%SD"J D@20A5)A#/M#+=MKB":(J 8J40=,HN6KC'!HP,E"
MU4*H7I6&OMO<XO$EJ!D4'S*",%GD8NW[EQPMVQQ !9.!:HGGUTICZ+;N ."T
M)RKZIP#=<T'"=4[>TG"#<%T?ATKN"51.O#Y47!8++5QK7;2A-)-.N2G36-H<
M-U1@NE9$:3C==<T.D$K)9F5&]:Y*##K[KI*C,)H@I(&7"DY"+VP3VE:?*:]W
M?!8UX\RHFB^X@"%NN'G$]J8$@%!+*6JQR]UWRO7P,\?=&^R&EA$RH""LYF9"
M9BLJ&'LMW0#US2LJZ2* A02!#;=ZZ'7,JD"LS[.XD18N.F+@*:4UUT@/M%IM
MD3.X "2E54T[<T'HD *@^Z X-H ,\!ZJ0^T%0/W+V;4Z81<O;6^8!)9IFF-"
M9*!JD*RV0<:G.AH!/2'7=J%R)V(,M(;R[G2#]V-$ 2F/MC]S8W/((<27%6N*
MN"<(!HCJR0@5@%C2!+HL\X<X@D$S2M5JE)9RAEMUH!K)!#14!%%I(Y^,7V ?
M.T &B%:^WL2&OHE!V=L$F8)7 'O0'Q@--D-#0 ,T"2,IA5,Y&I"QS%IH)\S:
MB8(5]$UMIJ'-5\"(:VWL%D(48&M&XHI* S,Y'!*D+#N5%\$EV^5%V[=JJJZH
MF"+*"RZ+9Y8M)(> YJH2"AJ=P$EG.E1^):\^=19=R)30=ZQY=LM')M(+&,#
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M+-IY(V;IY[CQ88Q?MAR[P :YJNIG\0HASA9'G-H2-VU4)03;N G,BHZH#GM
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M$[&N34(#CD*ZSLO+0A$IB:2]F,/M6.4<X70*(=02<.TA*F7H@*=OMPAI#G$
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M/<X-#"X[0JAH4@;EGDH'9!\QC@P@B2J*S14QE,HE! M6VEQ!F3)9 @ #"8P
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M 3QF,5PB]MN%H\MP:M-Z2()'^2>$S*QYS#.AZM1)>R8@D.!8#PI1)43$3KV
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MHIZX?>NVM@>0 "4,D7A)446>%%K!X>#LR7U1;_#L0AP5 )G)Q$TS4)F8<YC
MJ E.VM9R*@:(3#+K[8"E$,O BFE>R+S;SMUL@(" &M1J< ^5J I*N)=6#L82
MQV2'U:8T.<"T$+B1)1UG(^$;  ' FM%!H#%ZWS?$QTT<&HTH@V(*)@*&:J23
MM9:4.ZDD%J*:+7T:J4 3PG)$68[H/+&V[[>Y3\Z(FW:B))%1)+C#GV[CO+VN
M! 59M<E6HH*)*M90U@=QK7'U0;P<3;  "T4(H&5<JP+(M.#05!)4[D28#4(
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M+0 *-&V90J1@LT;4!"25D[ECS+3>#MR?Y*=:89]\&W=MVWV4)VO"B37$3+2
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MFFZ07+<H 5/&0)AK'EOGBK0519@$A<"M NHG%BX51^Z66TSQP$%]I[=@522
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M;'+@2W$JZ:D2 P'5*H Q@\P.70[MB+*B[MM*314QW+.'/NFVWEPTJYY#0"A
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M'X#\*W\(B[<5KNW5KCE*-S+1>0URA:@M(.&1*=PAX:%0*9 H,ZSZH-T6SL)
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M,#,F$9;)#A))K+PQ.$-EQ+3K-%A"T$J5!I+O/LCRN8LM-M@X0&ANR00-0 @
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MW5%O;B"LA\Z."D >BVAP7UZ8^J"]X0"0U2J8I4KE-$@^8FP.TJFFD7!R^\/
M7A*%$/V4)2<AZA ;<#?-Q$EZB40N2LDG1(=<O-#7/( $E.W:"<"DI#6F:(/+
M5<*H.VD6Q;)#=WU2!UDD3GCK@3#@US2\-!.'0]:5$-=<(:"5&ZLA5 9=IEUQ
M<=>8C *D@K3Y41233N,X6S;W->,$D1-"M)!)XRK +6S72O7],;DX@5P1?4O5
M.+KKS4 S-2@(#4130+B9(H,#RFAS'XR+1B5*JU$Q!G)%EZ-KTX4'O@\J[EEY
M<A5W'<'TW9(F":IA'F@$M:UT@HJQP%1TT@6M4Z2BY?8T@$-$^H#V1^';RA%@
M(A+BNY "YTDRDB9C 7]TPZVYN./9!N ?+TRA]Y#L-%Z@%IBD<O;<3P%W:I!R
MCF+32K7M3JGU:K'G.L[W@J)D-!S,B2<5*I@(WFT67"5)!)!.8)!<!I+(T6+%
MHN(# [MW$+A',6FN)W ?Y)7+T3-C4<$Q622").J>Z&VK=NVVT' HQH:%($U
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M2J4CAM$- )K)= 9)#G[4+DE+"4BD>65V[E\ #AC!<RT-Y%2IE4R&'=J8!#$
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M&'.N'A)5:X@:2$,:RT&ALFT4"2SF3Q+Q#OF5NVP"&N %1@20I3OI+T3"P_O
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MHJ:B/,O7$:TJ@F24UD,E0=8K!N6;BM<:$(09'J/6APF:Q:MW+G$%W("%IM)
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MO^>LNS((YVZ0@4D%7R*! 9JX@H!([7?QK^?>3_ZV]NZ_G [/'"-K/XU_/B\
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MI$*AN6["6%H"9=X"]0( RJ8?RPMJYFTEY,SNFB!0VN07(R,#F#8(<LPG%M*
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M0:^B&ZG2AZ+!)59UG[8MAKSY=4P7];/2&-:"9X:$=<5/RCU"'7'E7$5).H1
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MX0[SZ+THG? _#C/I,F!N(F>[HL-+J?#7T0%MI(ZQ[8)N,0]8BV-AVJF'?3.
M6_,#ZR%AULE'IU^,.N7+1(I5F'?TPCY"&8$[8!<U%E7Z8_W099>U>RG9&[G&
MSGE[".^$#3+4>^&MMVSM-9LT6O2<?[B"YQPD/Z2P?QP+7#"1_HI$FS&H]\-;
M;MG::E62IZ([:_#2)(!\8MMV!55=/C)8:YI"J#XC2 6]*1N(P,(6C<JX3RZ&
M< G.?AI' BY9]%@[L<.@AS<.@@@!>@C<G24*1V0YN"E/5!:&J?AZ+]]=(71W
ML$ 6[ZFM'>Z+?[SC08.I],,WWP)Y.T[.E,(\YEY;>>UVF86'V;/,*]H5$?UU
M1/&/+%[]YU/]R8QOYF\!;2I#M-"?;DL W^8VM/W7GU"".7YC<!DU_M$-+;\B
MN#NY$E[8.Z^A;]UVFDXXW8>Z.%RE-8:6WU!6@=XREVP2>8FW1V*8)/T6VY7"
MOLAP:,3]J&.^\G97+Q6-KDJ,\QK! '"DZ]T.:TT2A*D8HO7 6NZ?3VRBV74#
M@9]8E7IE!#AXNI[>T0T-&>?M6'I0]9HFHAI"2.NFI@!8(647/LDX=FN,-=EU
MZ#/T7"9+V^N-UQY5>F,-N6V+: S%:4)@6N7L[KBYM&(Q,H-I[T>11#73"'7[
M@F0BDZ4K*!<#";8*B;:G1?9%MG*6-UP.!JT43[4H1MQ4T(3'&$?=XE*R=GVP
M\GES/5DL)^V&)9QG-NGJA6-5P2.)LTGC#]W+U/VFRIX]W=#6BTBKBW3N[I:^
MB05[--(E2"S=AX]VL$U\,H50L<5)IT2"Q?5[M?")!0>S*,C\.Z*3RRARB8KV
MIT,!*X>$$KTE!./PAP("A5\(1)FGA7T3GFYP#%':06<O>W.'W7#/$@1Y%RXC
MUIM=ID/;VP+EXHS/BTRC>RZK.ITJ+A40;5F[N=^B1XE(V!_@[33VF&@NFOWH
M#^8NEHZG'+(&">6N[JA4</6!#UO<74[%-( N<RCOT+AR^[#3S#]O83ZEASK#
MEK@1EF!%Q.8F#D_33U0 [F.+]%^FGHG%Q1B3K\8N>6@<GWIUPUIX4ACJ'MS7
M.&-67TMZ$Q(BD_F6@E2'L;\R2KUJG01NTU]\('FGN@^95,S/N1('E(FI,N]8
M5RUKQ3GU>^!O:I&K_9ZX+;PE3HB0EF77]),*3Q*57= . /WM/1/MXD:Y]8]<
M/N72T*@J#66#_=#;CN61E)EH*9H4[H8"$?+3$+.0@V;EU"1D>W'IG#KCWS29
MFO4B]7O2";G+%HI5ND_7 -QJ3SPEE&WE2>P..6)7I6">:<=Z8M>%]7=IC!\I
MSBGW72S3"ND-++;R,4:=#UP&\FQ7',@#KXH(YQB.&H(.O##YDY2=X>^&[6/F
MJHUVG2D4=^J[W11WZKO=%'?JN]T4=^J[W11WZKO=%'?JN]T3(["#ZC_+P2/9
MI&XM092AML#Q"K^K6 6,%<Q-2,47Q@()]FFE-8<7-3M&D$)AF/=6),!!.8TT
M'M@8IU>Z%H.R71(<K:&=,4T]D-:UH5W5*FD!733O,?-#U !!(PTT@,:T!>K!
M/N^B6ND_#AI'"V7\[W0&FV=Q=2??\M.E(#G-5LL\QIG$FJW^=I]VG?UQP#A_
MG>Z-FPBXN3I4TI# X*%U]T*6\,EJO]'Q\8X6G;//]GII!'O]T %I4?I5E258
M#T*9]/H@O0IGGTS@CW^Z "TJ.O2DOH]$G3#2&M)4D],(MDGBRGUYYPQKE3=F
M<QBIA54@)X)!8NM4/JE!(.&OO@JXRZY4U@ 4/T:0X$]):07"Y4KC@FO=X0%=
M30Z5@+2)02'&:Y^^ [=,+GHOHM/AK"]/7#'X HDJ5&/3*&HZ80X25)5R@LIP
MCU#6'N$I8KK!<[Y3))2IK G-=*=_C"&GPU@RZ2@D.]7[4M%AI!X>S2O%GVQP
MU,$.KT]T/<)!="@DJ3\8!!EC2=/O>KT01TY:CUSU@O<[I+7UPUB25<%RRZ9I
M#4$RF6"3IE#B#4+WSASS0BG8<^FL$>,M-.FD-"5.8,I:>V.$])0"<O;#F8=G
M[/<L-(%982IH%@;>[H1!+OHA[449RG_D]T-VBOZ,D33T0#6]DE\!! ;PK[M(
MM@CB2L]!EG#"Y2W=J9RT]NH@E*@'U0[:U&@2ZRL)CV^Z%+2G;64J=,H/#+X0
M$$D,%&3[?=W0&EA7"NGW8"Q*D.+6S77W:0&;"7&E9T^[Z*?2FD!JJ3[>R&DW
M#NW5GW?-2 USD;+/,:YP!A\-((-/AI#G[R79J[3[U-(8KL=<#UP :'Z-((!I
M]&D%P=/M@DFG7I !)3+Z>Z"U93AYW3GGI .Y".O3T4^E-8Z:IC#7@T3#']:J
M>,!K'XY# C51&GPU@^/AK!+2.J7[4#:X;0<AAV^P1.GPU@A.DM8>7$3ZL,?F
M]L,-<Z4E]Z HI$A!)=PNT%9(/F\(:[<$'5I7BS]%5$Q'Q@N<[IWQ;;MX:8(O
M=I]$!UMLE&5"6Z>N)$K\-8:YWS3[!WYPI;+.2+W0TLJ2F"8:=,H^<H/HP6/F
M*)TDL$.)V@KZC.<X".DO3'IG!"S^$"<T@M+J$^/;&T.,S[CG+T2 #U0Y!PS]
MBX0QFSBW:HF:I +@"%&>8TCA"GX>, I*:=$CRRQ'SST&71(:'-DNONCA"]!$
MQTE!1GC";57Z)4,$I(?1%$!$7$ [.S2 $F?HT]%2OT:0&@J5'2D6W$\2:TPQ
M@&X1M)UT&?<O7 .[A7W=,X#,1VY:1NQ[??#B\S3736 %Z2Z""U88A2>N8KB>
ME(!W4ZX)-4A14P',>A7[VE9P-SY]NF'HJ])1T]\,=O"*B(*5JL- ,QH)3;K!
M0+TZXR/36%-P3-$%%&J],("&A&7OA.F&L.&/PUAY! !T'[4YPPAP(QII]Z &
MF1@AW3U0]P< N@_:ZB@AC@FT=6*?>[O1 DTI/Z8+B<_9K#&%QV5K]--(M@-4
M+ZB((!P]0A]VX27)B>L2GTHD;5)8-:4UI 15'J@))*)+]GIC!W$J:^['NA "
MAIK\>N 02%D4[-8&8IX:PN)!7W5EA'RD TZ2@$.(7WC4>B")ZO9!EPK[1I%L
M P'$*%ZIJU,(+BV:#U"+@>.%/?II$A,Q3A/9EI (FO8OKZ4C< DCE_HP%%-<
MX:T-5QUZM(U^&D&<_AI E0],_;#6 *XT\-,O14Z2@- 7Z>R&*9[M5GVKTI #
MRK%&>8@2E\-((Z>J$:9KJN!SAH<Y)ZQI\-((%.FD&4^FD$$S'T:0%$I=/=XP
M4$I]/?X0ZJ^S#"/FF/HTFOHE7I*)G'Z,X;=#^!$H/7NAOEW"BY#[IJ70N'PU
M@@]/'6-X?PF5-<]W5. EU!(B0TG\T(LD]::P0G3OA3\T^E8!28\:0)=#!E"X
MS^-8!V_337T4Z=*%8<XJJG6G;%LH=M(!8JK@=0N(@ JF'7+MA5*YUIV]46Y%
M*=.G;#0TE5"H<"1K :)$$3G(Z$.*PXN<KRLRL_\ *AQ*[!13_I80#-"9SZM8
M< )GZ(:"*"'&:!4GU:P*[2JSZM<?1 -RZ802:?#2&#"N/3V0'!TU'K&A@;>E
M-(.%?9I# ) %?=##N^L.Y1I V.XAU=U8)<Y%7[/O^,7&;E2FM-( 21^C2"1T
MI ).$7&JJ?0N$!H XC[M/14Z2T@ ""UHFGTY05$_ATUB<F])]# :) ?1I!:!
M,=,H=ND>I5I$@=OPATI$>[3IG!0'NZNGKA2)CZ.GMA4E\-()P3IA$AG[.GMA
M9J/H]$H/26L5Z3UC<7<6?<(XG=):P2/FQK[X 6?36%W*<^["!/'IC"BOPUCB
MZ>,/.?T:P#E]&L)0?#6"%4?"58><S[M8:X]*:^B5P'^5X<0@DS*G[5.^<,>T
M<)*I@O5NAC6B:YZC6-J*")UR$/N JXU)#M1FM,H+A2O;U+I 1M)]*QQ$89C*
MDVQ57%5/$?:Z)B1E+2&N(K(]4JS@*>(4.N$U$'%QJ<_%T ;9$YK3 PTH9U\$
M7B2N7HAL>A73QT@ESL=/>L,MM* >O]7*&O:BGWCJ/M@@W>/^;ZMV&?C#GO?P
MD(@ RK4DT2"P%4'3#6 CJRZ?3"LN+V#NJ[M3X![[B"> -.HCW1,TAC BGZ-#
M"DS/M['0H-!A\&I XJ'U].J&L!"E?!#]E/1% O0:0@I!:6\2T[M.F43'CU:1
M3I*"C>F,;4F,.[1/" $QZ80W:*=.F,$;>'HJ=#!&(QS\(0B?PT@';+/HD&4N
MDX<">+II!"<7PT]$M#\-8KTGKE!<#ATQT@@E?#*)NG .GL$;@>G?!W%2/HZX
M4E8"22 1\W36 <1XTU@@U(@#$0"*S@'$?1K+T3V_5(7&4\0L7-K>))UI/%<!
M[S*&NDBIKG &V8(QS(U@M*(F4J=<%0DJ]XS@$I,IK%OAD'CN4:A<(5Q"=,08
M[^E8N/V@ ^'5Q''W1; %#/HOAW5A!4CI\((-1%QP;CT^L<33LBV1GU^"S4^B
M>UMRHP E/KA[[MR2)1O>9^OM,-"T*^*(M>E(&Q=Q.'6-##B,0.E(<YQ4$2&&
M.FD-R5>G=69BW.6X*@P":=7OA >G4B^N%.*]GA#F$G:LC-#FG".J&(9'HM,H
MW TA29F+EM3,R,PO5PYC.+;6FO@B' =7HN!D^L::0T[.%?N]N$6V8)TPAA"E
MOJ^5))].L29(:C3%/"L%;? 5Q'NC:>GA!<1TE"ADNL::03LX4*&7N@@,( K,
M!#W>V<)Y?5,3H4^58*C#W1*?L@M%LHA!H.SY5RC:+5:)MG3[OP]%Q5QK66D(
MT>L^R+9W<1=GU:Y:>^ TE$(]8UCB./WM-(1%:)_6TTZH'%-:YTZ4!AHU[_&!
MNH?TO=!:VG;F-(>@FNND3$QJ=( -/ATUA[10=HPAZ"?;I"FHZ]/1-W(8<,X8
M\-4>V69AK 4G7M:G>8<H$P((1#CX^R-X !(\>I=( $DARB8]PAHE0PXA\S61
M[JPTN(4:'37UP6&@]G:V P (>F;H)#U6LCI*O5#7.10==-?1-)D,X<25AA:P
M^6"BX+^KGK#7 I/UD3T3,06S^4>H07.*N(TUA T[>FFL*'3,NGC!SS[H:DR6
MF"#<) ZO&?C"-N$ _HZ:B-H*T0)/#0Z0A*54)] A'7"0/T=,%, -ND KEIJO
MHE8WBZQII"[$;UCJR@@VQUJ$]4X7;-<QI]V.!GB/="[$"9CW0 ZUQ K4)4:>
M^ C15*CJ^SE"L8I&"CPEZH5UNJI3JJ!#]P&T4I[H"6E!ZAEI&X,D-1II"E@0
MTF--(N$B0,J>Z$;;'6H PT]%Q5[=-(1HKU]F$':)D?>@AXXDUZ>V%^IV^ZFL
M(TKCCII" 3_G0526ITT@%)']+32#(E!K[H! JJ?-ZDZ802ZHZ]*2BG"FONA0
M.%%QTT7U0"W%0/F]TH).%?FTT]$"O24(<U[H80[BIW=F4\X: BK[1K$^E( Z
M_9#';@JD?0)3QU$,4S!'K$3Z4@@=*1YJB?7A+[4_;&Y4(GCIK":"$.$*#,G(
M]6<$JA;/ZV.7HJ2^$"?$?IZH8BI5.OMIX0UC6J21X$:0G3"!NJO=A%L[N&O:
M4U]T-:P*053J(T,ZZRCII"F9]4.)4,)02&$M,_C <+A#=-O7GF*RZH42<!"X
MIUP-[2 24I*@3#H*0XAW 2%"!,-5$]/1<#9]FFD-<0 %TP[(;:#12DJI3Y>G
M7#7,MK/,9M^[U:0$:%[$P^[&XLX9XCW>Z-NU99CK3Y4->B0$MJTR%!.4OE@%
M!NZQ[NF<*&^K/&0\(=P@$'3'L^&,!H97JE33KI$W3]L?-#CY8"&=-*2RS@,:
MP*=1@A^SEEZ(K3*<J:81P#U^Z&M+9[DQ7U>U8:7A6J,\Q!)!3MTT^,'8/Z6F
MD%@MJY3+B7"LNF<,+F276%>J+6?C+J@BV9!<_=!3V^Z$<)C]+093Z3@.(E+J
MGGTE!<VGAV0?I]T3!4?I9@2E/O\ 13,_A#6N2O5[(MN)XLI]><,:20%UF98[
MISA5"@#U 906%%^)@D'#7WP07&7766LX19'Z-(()3H-():\J:R/J7NAI+IBE
M=-8GTI"#I2'G?,UKIK#2'!>W%-?1$GI36%Q^.L6W)((/J]8-=886.XL$3, X
M]8]\%B8>R'.^L4$SUB"YP1IPX<QTSU@;7'<LT2G? !$OA!DI/T04/#V=R$]-
M8".*8TTU@@"9^B-I;,02#(4H>O&%)X36FDJ]-/1('3\,.^ \E.G7# &B6*MZ
MLH:6B93+ C3*"0Z6V'O-"W7J\8(+1UR]T-"(I&5/U:0)S^$+6'J.'"8TI+.&
MAC0AZM-/& 6T$'=T]</*<*RIX2A&-"'&6GW5\/1%NTD_#2&@"2CU]46V$<2:
M^[&L-\SY0:\55!RQAQF 0HE#P!)*H@]_?.$Q[==(FTTUK*5/"%V'HDZ>Z'!K
M.#X=,HDWBG]J77*$+9]LZ4E!!'$80"<2854_:[J=<3;/^=.E)>BF>DH#3CTR
MPAETO.Y56?<BY0 XI2<\P<^J!K]&D$$RG[-(W.N$O773[T &BZX4QBLS]&D%
MIK\-(<]M3UZ)CI$S,=?TP&K+U^J"U5'OZ:0YPJ9X_M9RB;N(=>GHBO2FL+C%
MM^'4*KUY0UMMXVKDW-NJ^WKC[OPU@KT\8<\2$\![\NR&@$!"N&F"F*2^$$D3
MZ>^%<9Y2EA#9^K372!*#*"7&?9+U0#NZZ:?>]$$<A'2<^^"XGI+6+;$X>RO=
M#7L9CF,VZ*8D>+X:^$-<ZLTTI.LX(-,Y5[O&&EN)3"5-/"L%#Q?#6%)G.67C
M#@ZFFV:S]GQAK0DS]V5)T\( 6:09TAZT'5.FGA#0!(_HRIZ)H#5,NN'(TI#+
M7E\2Z]:T[8#G!9B4] M,?""@4_#2<!!*?;X0;>Q'3STT2&[FR7[WN@I7X:3A
M4EGG! =3K[,(V%AG2O[,BG00' */$07H@,/8P3!G,_LYI :YA4TKI]WX>B37
MW:0&JM.E,HMO7B371<<*0T7#PK][ @9K*/FDL!A,Q]"80HP&OO@J[LG*BGYA
M &[I*' F<;FW#,K]8K37X0-S_7I!)K"@SAI#RI,ZE9XS/?X0#NIU^BZ::PN/
M36+;@^62"E<X#0Z8(RS&L'IEK &/QQA5"Y2TU]\--2",J95@2E\-8<HG\-8>
MX. [!VIQ=,(8=P03PI*O% #:&"'8+#D< >S'(;L^Z&$.!;V:(O%GZ('<A!J/
MC!<YV<-;O**O;3.&!H.'@6G."AP'J&L.<YV'9B*06DDA/NZ0&M;-<$I+.)./
M1(!<9H8( 1II2?AF8!:)&ORZ=/;";CT3!8)#BIJ?H7JU@J$!/T0T[RGPU\?1
M(T FN4$ 27W1; $X#B.%?&2>/5!);/:,=!I#CMX$TUT,;5GV]U/; 5G#("9K
M+[JB"0.DH!22&"-L^W/JTC:&*"4J:R^X@K'32*SCU].K* PLF:>&GHDZ8:0E
M>G5#"73W@XKZU3M[(:'NX5&=%$#+X:01EVY:0U'J5K-54:PT[I=L#(_1I*"
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M9!J0.P$#(I VCI*"HZ2TBX!/+PT@ B733K@G#X0":)%P">7A :@Z(?14Z2@
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M$0RF2G5Q0D]IJF--4KGZ(;'3E3:G;.G?#B79I)OO7OBV!U^SI* 09K[1I2"
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MTH1M*@K,(BRFL?\ #N3J=D.F9H%,.M6OROFB_F/E'EA?W<W2112B*<HN7O\
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M[2?R._*[EII<""-S6%OS*55CEE*D?@.9_*;!ODGY;=DL^8NQM*AQ$A Y;_\
MY_\ E6Y:GD.7JE%V^RL></X!_)"W_P!#97#[D3_@G^']W_H[2?\ AP7'^"?X
M?3_T=K^[]D%EO^ /RGK/(\OH$DU.X5ANW^ /R1:?\#9\>" 3_#_Y:2J_\/:T
M_P"S@I_#WY:!_P"GM>ORU@M'\ _D8 J3R-K]CO@?_P!"_D*?^BM2Z_W?NC]Y
M_#7Y>>KE[/[ C]W_  U^7@Z\O8_8,.'_ /H/Y& /_P"#:G_D2UA!_ OY"G_H
MK4NO]W'_ $S^7_X>S^Q'_3/Y?_A[/[$?],_E_P#A[/[$?],_E_\ A[/[$?\
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MO\Q__)X\'?YC_P#D\>#O\Q__ ">/!W^8_P#Y/'@[_,?_ ,GCDCT__%'(S_\
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MB319%:Z:8UEG4JN5KOY$X,7*L[EW'V?J]8Q75R)_NPTWNZ 51O3]3CB///\
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M=+3(^L;(58AA8NM<H]L66Y7")GBG>T<D)]?4D6\X<7K.<//4(XG.[6\LQ[I
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M_JD;$OZV%^WP1.-[NC+GFGR#M:]Q5G+GT*0B'1A,MZ?^>@RY.*UHAM \??\
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MW]O4)[.[++[&37$+]X03WGI]S]^ZN7=NGR?KVWB($M8:^5NP:2:>A*/UU+I
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M#H!]FMC$[?M&J[.\2U2L)<)L%1[PA^)Z.<C"8QKF93[5RF-J&;5NHU@OXVV
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M]6M;!-,F^\*U'KA?*RF?QSPP#7V(1J.KUKFMFF$JE-Y_:"&Q S41X([R;7D
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MB2O&'[#T[&ZQY#FHG2O6JY^GCI3-!H@)]A%Y:,9\>C)!UW51RJB$X=O[&V-
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MO6TUXDA-AKN8/8#)6O([8&^2>"-<(2'R(<TU5WK.IV(J.P;Q2VHAW9 T)6S
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M1R4XBERO?()6:VY:KUDH-O7FHF7LC:Y4C:N%1$\>6?R_0S%YQ1HS%7E8MBJ
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M9NN,@!>R%K)9$U[7M9H]GB>M$.'=+^Y(VJJK(KE61[LY7JY+N@XY.=&C]DV
M19^-?= LZ"I'1J:7KR&8P2G8HW]7N%;R^@7I<W&4;SRFI@-=^3=@I:]\AD-E
M0M!>$"-A)ZWVD(\LWV69*Q>6%25\:_ZTA,M1RY8U/#BE1;9LVDK5DJMM$[*W
M2%IK$3G)+U?M7+C*_P"+]#8LZN$IGBM=[4:,L%7C5O4416R-C)R0RLB)=+4Z
M5=EJ*OCX+PZ4=H]S7=3KVCH\F7V"T,K$)]E"&I0AH8*#AY9'JUIJ*VKB+GM8
M][%5K554Q%I_H(D1NI+LBE?M\>]=F46G+QY]7_BSPA*SHET]JEIP*E7+:W=#
MN/R; =.0 1(DD%.V-;:UMDL8J)&YDKNASUZN>>.\0Z&&C/.+MEGT^#9VI?<
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?E(?5;4JNL3NM/5C<-;UN<JO>K43&55.7+E__ 'O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>x_coverfront.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_coverfront.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" 5/ \$# 1$  A$! Q$!_\0
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M4\>A6:)!"B33!9F@@W2M*N14$B@43Q2#&:4#9'<U* 61V-,*S:@@]0!Z@#U
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MR: -5)"OQ#- ":DI!P!0!H:9%<NS.34BFI H U/:@&)J) R*9BFA)/<TH&*
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M&BCS02U1HKO00)K_ !4\>BN78F>],0(GO0!@]C0 F.] &#^*@#"J -55* P
M#W%# P4ISVJ410F>YJ I&*8K,$#':@@TV@^E &CB0 ,"@AB=!!@DBGCT!C)I
M@-A[TK[&,$GWJ -<#OBG%/8H \KM0!K0!Z@#U 'J /4 :4 >P/:@#!'% &*
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ML?2AD(;+!W=C31Z%EV:X/M3$";@/M00A/%!)JH>4\4 :4 :+["@#0H*N<&I
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MWTJT!:NE'3;373:T22_%TY;6H*7U#:I]:<EQTCTWK4M6/3=CTJQ<&=NW864
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M3/&F2LC2H"?BAZ&6'X?/@FO>@],W^\W6WNZLMUQ0JYEHK96XXD+0GPTI&TE
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M[.V)#X*U *6?W/"4IW+/L$FA-D.$5S1]?FT>$A+7C*=V)"?$5W7@8W'ZGO\
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M$E/26+-!8M[+SV/$<;:0$)*L<;L)&<4Z6U)%4I;FV28&!4BB@[4%JZ--A^E
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M"4@X2!3)4(VWV6".PH(*XZV?#WTJ^(*PM6+J7IWYM43<8-PC.>!-@J5^(LO
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M Q4@>H W':@!4=JJ+3>@#).:"*$7$ >;-2B)=&E2(>]*9 8(S4@>VB@#VT4
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MH%/ IH]@)&G Q0!B@#4]Z /4 -_6@#<I !XH TH ]0![=B@#51"L&@21H>]
MAB@#U 'J /4 84<#B@#3<?>FB2CVY7O3C%[UR#JGJ /5!)X\]^:9"L1>:!Y
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M1Y+*PI)(/(*5IY'T(-4FGLL3XD>OM_\ B,ZDJUY>(8M[+4&/ @V]#FY$5M"
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MUKN;K?/.Q3L<I_H15F7X*L/R5=_9K@N?%/;&RH^>PW5/ZMH%1B_$3F_"5/\
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M/'>K[1E^:/@3<I,>;=IDV&UX4>1*>>9;QC8VMQ2DIQZ8! _*J#4=5?$@W/\
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ML^UGQ6-LCX:NJ;&Q.U.E[@$IQP,(X_3 _2M<_P +,6/\2/B)))##Y'<-K/\
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MI1#-:D@]0!J5)QWHL!.E PKM4Q[ 1(JP#50![T$&I'/% &M!)Z@#U &%?A-
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MPE2@, 8!(J=JJB$VN2+M/1'HU9;E&O%EZ3:-@3X3J7XTJ-8XS3S+B3Y5H6E
M*5#T(.:-L5\$N3?R$U_TQIW5EJ=L6JK#;KS;7U(6Y#GQ42&%J0=R24+!22"
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MH 34K;Z4 )K.3F@#6@#4K X./UH ]XB?<?K0!CQ$^X_6@#&Y/\P_6@#- 'J
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M$]@]ZD4\$ '.: -J /4 >H ]0!Z@#U 'J /4 >H ]0!Z@#U 'J /4 :E ]Z
M$%':?>HZ)2LU\4\\=J+"C13Q/&VI[%NF:^)]*BB=Q[?]*91L-Q@ND>E&P-Q[
MQ3_+1M#<)K<W\8HVAN,^*?:C:&XP720>*%&B'*S3>?:F(,%6[TH U)Q0!C=]
M* ,'F@#4KP<8H TH TH ]00W2-5G S3)4+N$E**JE<BRD:DD5-"V:*Y-2N"#
M% 'J $RLX[5%@:$YIMH"95DXQ0HT!A7:F U)Q0!C=]* ,'F@#U &BC@T >H
MU7^&@!-7:@671K05F"<4 8)S0!B@#U 'J /$9&* -=@]Z ,*3M'>FB2C6G&+
M\SY\5QSJF%]A0!H4@I)/I0 @KO0!B@#Y\_VEW6OJ[TLZAZ(MO3?J1?\ 342?
M8),F4S;99:0\ZF44A:ACDA/&?:DDW99!)]G'7_=>?%)_[7_6_P#[\S_V5%L?
M:CW_ '7GQ2?^U_UO_P"_,_\ 91;#:A>!\7/Q0N3HK;G7W6RDK?:2H&Y'!!6
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M_#Z5R:.G8@M(SC%0,)K&.!V-0 F4)/<4R1#8FL *(%0R4?,+^UL_^BAT]_\
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MJ-[&])'0W3/^T3Z.ZGZ57S7NMH[VG+SIL-)EV%MT2'9JW20U\D3M+H4I)!W
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M!_@S^!KHGJ[H+9^H'5C29U%>-8,KG,^+,?91!B%:D,I:#2TX64IWE9R<J &
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MO5L'P4R5,^:'QS:\L?47XHM:7W3<UF;;8KD:TLR65!3;YBL(:<6E0X4GQ L
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MIH=BS? F2,=ZMX*Q%5*!HKO0!B@#U 'J /4 >H U6>!@T :4 >H ]0!Z@#U
M&E!!JY^ U*(ET(X/M3%9D?6@#58!(XH 34WDYJ4A68QCBI S0!@]J $\4H&J
M^U3'L!.K /4 >H 34/,>* ,8/M0!Z@#0=Z -CVH UP?:@#W;O0!Z@@T6.>U
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M3:$;DA0".V#7HN%T?)G:=,V3^$4$&: ,CO02;4HQ[O0!L!B@#.3C% & ,=J
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M^2*2,+0K\6.*<!(\^E &""* /4 >H UP: ,4 >H PKM0!B@#W>@@U6G!\V:
M/ I"0<\4#7P8)'?(_6IHK<C&6QSN%0&X\%)5V- 6>(3]OO4I$2-"IM')54L6
M+IFGS4;^<_I2666=%5R#KGJ $G>XI62A)223D5=CZ*Y]B#[9P3D<TS1"8T6=
MG>ILCY&%QN-NM$?YV[7"+!CG_EI3Z&6_^LL@?UI1NR.M>L]'7Q_Y:RZNL5Q>
MSCPH=TCOKS_NH63_ $HLDF22DE*DD$=P1@B@@P5>U "$R9%@1E3;A+8BQD?B
M>D.I:;3]U*( _6@"/M.KM)7Y\Q;%JRQW)\''A0[FP^O_ *J%D_TH[))<I()!
M&"."#Z5-$&* $W7F8[9=D/-M('=;BPE(_,\5 ";-PM\E?A1KA$>7C.UN0A:L
M?8$F@!>@!E=[[8]/MAZ_WNW6M"N0J=,:C@CZ%Q0S4IT1+E&EKOEBU&V7-/WV
MVW1">5*@S&I( ^OAJ.*FT5CY"=H[YS4@>4L).,5%DT)*.5$BI(,*Y %!*,9X
MQ0%&*!C50W#% "9;(^M+0&I!'<4 8)Q10'N] &#WI@-"%>XH P5@C'-.(:$9
M%%-\(F*3=,1=F1X;#MUFJ\&-!27G5+('E2,_^:J<THZ>#<W_ !'T.')Y+41Q
M88T[Z?R<$]=NI+%\U/-OEQ>1)F3/*TP%Y;C,)/[M ]1@<GW-> U^M]?)\T?K
M+Z+\ O':-<4^+?RRE[E=)-P9.7ANQR$' _(>E<J"2R71](ABA''LA\_S*GU-
M^V+-+-TCK64$\H)_K7K_ !WI9\?IOL\+Y/'G\=D>7&GM-;=KZ--"6Y(VK'!!
MQC-:<N@ECY@[,N'S6'7/;+A_F2:IT=3GB+*'$'ML]*R/%-\1M,Z#U&1<1JE\
MC9W6"K TKY<99/*TY\WY4Z\7#4<Y5R,_,3T&*3E5&;!UFC(N3,Z)+5#E-. H
M6@D*!'8\4D_"R@KQM&#3?6&@\E_^FSTT^.3O7H!\1=GZHVS^[VI),=^\I04*
M"R-LP8[G/8_:JXRRXEZ69<?<\']1?3V/297J]"KC^1'=;OA+TIU!CR+SIA@6
MVZ!LJ#2&@65D=\>HK9BR3C)*+X/.8?(Y\&-S;Y7P5'-^$Z\=)H>G=372=&DN
MWIS8F,PG+C6!G*AV K1J-])66:'S^HUZDLO%4BZ]).BW1FO#4I+B %?O!C:1
MZ5CQRV3Y$\C"&; VNSJ;1]^3J#3L::@E;B4!*\8].*]-@FLF-21\DU<)8<\L
M<D3N"D8/>K2D]009'>@DV[THQL!B@#- 'J %$;=O.:E(!0(21FIHBS4AOD'-
M%!R5LB_28W5*[Z6?2XEI<2)+B*[)6E*2E](_Q!1:)],*HC'=()>V(9FX08@#
MTUXM)\(O$)3N44#@XI,LUCX;'Q8Y9'P@!U!U6<$5W]E1W&8[64QT1FBX\H>I
M\90 2?MFLTM0E\FN&E<G5%87W4]Z9AF?%2R9)W+,!Y:W"01@K6OU4>W>JWD4
MUP7QPN#::*<_;[\-+J'[([;0IQ2QA_Q4$D\GOD#Z56V:(P-F]1'P#*3*AR&@
M<*5DC;]#FJV[-,(TA@;WI"_+5&N3\-WQ$D(4T^1CW!QSFI2L'1!O:"L%K0Y-
M@2WW83_F*%K*MF?3((-6IOHH>."=D4U<DP4$:=G.36%/*C&))>,IE*P.4EMP
M'S?3(5[$U;'?\,SY&ND14C3M@U2A;#5K1:;PM)(2RX4)=_W HXSG^'.16EY'
MTRF.*/P0,&ZZCT1)>@3BI32=S2O%0%I^K;@/X<]MU5RCZG T9>F^1QJ)=HU'
M$8N,!H*C8)?WJ_?PG?4-*[D#U2?I5BA&*$E<G:)[0>O[Y;=MAEW1;JU-+-JN
M+2E)$D 94PL^^ #CN,?6J9PW-47PDMK3.D^A'Q6?M9N'ISJ!,:D/D>#'FDI2
M"DG" L?Q'/EW#VYP:OQRXVLYF; U+<CIUN2O*42(+T9:N0A;01E..%#G&#3.
M+15O3-@^VH!6X8/UI5R&Y&JR!S[TUBB8%,11DY]*8#Q&1]: -2DF@#4@CO0!
MB@#U 'J /4 >/:@!-2"#NS0!C('>@5NA/Q$CN>]30*5GE/LI[N"C:R;0G\['
MW;=XI>5\!:%D2FB  :E<BN:0W5<&03R>#3*#8;T:"YM9Y4JHDG'KD9NNS9<]
M@I.":3=7+(W+L0_:+><)))^E,GNZ(WH59F>(K&"/O3QB_G@1Y%+H5FJ0&=RR
M<@<42]I(#7Z\)C.*PEQ0 ';%5^I*J7!6YIRV@?-UE*8656VU)>5GE:E=OO6#
M+J,R? Z:;H9*Z@86$28K"%GOSD9I?WV,?Q/DTK!-_!(Q-41U(2Z;@VD$C@YH
MCKH7;8L\3B@@B:D86T2U-0O_ *0K5_B&GJ[,;4A9G4A*LMKW*'\(4,_YU9#5
MX<GX60I-/DF(FH"L!+@(^YK=M]NZQMZ9*-/B0G<"*KW(D6V>7FILD3VGTJ-R
M QM-&Y >P:8!.@#/>@#VPGC- 'O"/N*BP&[[R6!SS]J;C;NLB^:&+EU_E2<?
M6J]ZJ[%W)#&1>-I(5N'OVHCD@_\ 4@W7\#1V\.(<"-I.>1A0HCGQMU8KMF6+
MP'B,*Q]S1ZV.KW(1._@D(L\)<!*QQ[FIAD63\'(]*/+$)U]2@E*E@#WI7D<7
MS%AN3&J+RAU)*5E7VIM^Y"KGH3_:'^*HLFI?8ZPKE';/4 :+1NQSBH:LE.A-
M2=IQFKL?17/L1?\ PTS%1RM\=?Q7R?AMT5;[7I!N,]K75!=3;3(0'&H$9O =
MEK0>%D*4E"$G@J))R$D%).N!X1MGR(UEKC6W4N]N7S7>I[MJ2YR5\O7"0N0L
MJ)X2A)X2/0)0 /0"JR^J(J99KGI^2VFXV:9:I)'B-!^(N,X1_,G<E)Q]10!V
M7\#_ ,;6N]):[LG2CJAJ27?=(WV2W;8<JXO%Z1:)+A"62EU65*84LI0I"B=N
MX*3C!!9,245VCMWXNOB?M/PQZ ;NB(;-RU5>EN1;%;'E$(4M 'B2'L<^"WE.
M0,%2E)2",DAFZ$BMQ\@>H_5CJCUNU$;OU"U7==1SY+H0Q&6I19;*CA+;$9'D
M0,D )0G)X[FJ^RU)(C=2=.NH'3ER',U;H34&EURO-#>GVQZ$7".?W:U)3DCO
MP<B@FTSK?X./C\UCHC4=MZ<];-12;YI"X.HAQ[M/<+LNS+40E"ENGS.QLD!0
M62I .Y)P"DM&5"2C\H^H%WOEDL$5<^_7JW6R,@%2GYDMMAL =SN6H#'YU8RH
M^:G]H=\8.C^J%IB]%>E-W;O%FCS43[W=V,_+2G6L^#'84?\ :(2HE:ECRE00
M$D@$U7)V6PC7+*\_LRPD?%;;B$@?_*[>/3_VTBH783Z.E/CX^-G4?2J[GHOT
M@GI@ZB^60_>[TE(6Y;D.IW-QV 00EY2"%J<(.Q*DA(W$E+2?P+&-\L^<42V=
M0.KNJ#'AP-0:TU%-W.E(0]<9;O\ ,HYW*P,\D\"D[+>$+W33?4SHQJ1A%WLF
MI-#WYH!]@N,O6Z3@'\:%#:2,^J211T1:D?0[X#?C@U'U+O;717K'<$S[\ZRM
M=BO:TA#L_P -)4N-(Q@*=V J0X "L)4%95@FR,O@IGCKE'=*E;CFF*UP:U*(
M9ZI(-:!SU!!DC% )V8H T= (R.,5#0".,U"=$GAQ0^0,'O3 8/:@!*G$-7/P
M^W/?V^M+-.2I <[_ !B=:(6D-.Q>GMNEAJ\7+;(EI!Y89YPE0'?=P?RKS7U!
MFBX>CC9]C_99].O7:G_$,ZJ,?[\'!\R2S<)94MY3KBE%:U9SDG_(?2O'K<E;
M/TC#TINX==?R,3_"91EE*NWH:C%<GR79JCS$B97R]QC*:D-)4%#;A0KIZ=3Q
MY-\68<V7'GO#.-E;:FT.Y&4J=; 0E(R4 =J]5HM=";J?9\_\U].SQR];3<$!
M;KW*B+^6D.*">QS71GCA+E'$T7ELNFEZ68+&;0W,1\XIX/M+&2GV^E<_)JWA
M>VCTT=/#6XWE;]OR"=YTFZW(,J!&V@JSY:VXM1&4>3R.M^FWO]?2=#G26K+_
M *7O#,R++?8?96%)4@X(Q49\<,N)Q:)T7D=3ILGH:CF+X/HWT%^(-/473[;%
MSEG]L1$@/IW8"@!@'\_:N!DW8'Z3Z^&<[SG@HZ7.M9A_ ^U]NRUF[G:KDXIM
M\-EX84TIP;PE7T![4RDZ29YB:VN4L?R0NJ56Z&P7W8S:7&TE2BC@*!]:6?+X
M&P3DHOU K^'6\7"XO7=$9"EP66TJ:)/!/J!^==OQZFH),\;YUX7EDX]EWMY*
MLJ.<^M=:=5P>7PWN]QM2EAX<D4 * 8I1C- &"0.] &I6!]: -T.@"IL!5+PP
M./ZT611@*2K(/ HLDKWJ(W TOX&M+PM*'[>H?+I4=JG0X-BDGZ%.W\T@U1ES
M>GR6Z;!+(Z9S;UH^)FWM7.3'L4])?V)<4RDY2V@#&=H^OIGZUCENSOD[6*,-
M.E^1R?J/XL]02;@MM<IYT-Y0EUZ:4@Y]"VE( K3#0J2,LM>H3,6SXE%7&8VU
M=6E0@$A(DMN+#&?3>1^$?7FFEH_37 0UT<DG8<VKJ['F2/D'WE.2% *,.2L;
MEI_F:7^%23]\UFEB:9ICFC+H7E+LM\D);MTR7:9*N24K&Q)^J3P34;*+4[1$
M/V^_[W(\&_M275JP5NLH1OQZ)QS3*(C;0K8+G=X$]VWB6A4MK/C6]Q1PM7\J
M5'@'[XIU$J;Y)-^R0;HVO4=D@F/.;RB>PGC<?3>.PQZ*':F0C5\BUEAQ]26I
M5EU$1*>B;E1I>/#>3GOX@'\:?16>11-DXZD:7*S25QS$EO\ SC[#9;#KJ?/(
M1_"A1[%7L33PD$\:*[F,7*%<9U^T_&4(+^&[A;5'&W'"E(/<\XR.X..XI]U]
M%$HT>MQBJWVV3=U1&I.'(C[GE:4_GRI5G\#GLK@*[&I5$)T.+VBYV&0FZS(C
M,9"7?#F1H[?^P>/:0V,\)<[K'8GD8IZ*Y<EO]./B"U7I]QBV/ZPO#D>.TIIN
M,7TOA(QY24N)5XB >P.#Z58K:,LX*^CI'1GQ-VBZ-"+U B1K._L3X5U#N(,T
M@>;!P?!7V\BN,]C1&KY*90:Z+1BZIL$N/&FQ+W ?C3.6%HD!07] 1P#]":;8
MNRNW]B8!&T$G:KV]#]C2= G9L.3C%,,;;?K0![;]: -%IY'- &FWZT >V_6@
M#QP.YQ0!JE:#W5B@#VX'\)S0!DI*DT$"+R" ."<FFB1)6#UZNB(""MP[0G/K
M1)T570%7+7D!H^(9B4) YW*P<U5+5>GP([;X(F-U,MCTP,LN/O$\;FTY3^M5
M/6K[!MD&$?4[:FT%"7"2!PK -++5Q2L9)T14G6;33ZFQL)Y[N>M8Y^34>"S:
MR'G]5Q;BD2DI4E1PK:>0*Y>?Z@>A>WLMQ87E0E(ZN65<13D?Q5JX\M:L/FGG
MAZL%<OL)FP-*D0O^FRV1E)\9#K14L(Y.<9]:NCY:4O\ J*C(K@Z"ZU=0+7(2
ME]%ZCE*@#A2\&MV'4X<_X9=%LYI)$U,UU9DQO&?N;0;0GE6[BK9ZV&$G>FBH
M]9]>M(P%O-PXTR<XI.WRHP@?]*L,_*P<JH3;?)3$KK;-N$[Y>'F*RXKELJR?
MUKCZS49<CN!?H91CD]Y+P+U\R[XS<@E1Y(5S7F-7KLN+L]/*>%QX)EO4LEQ!
M8WH '? K+#7Y<D6D<+526[@RB:IY*E)F.MK \N%5ES9M7CC5F;<ADQ<+_"FH
ME1+DZ"3C).1]J['A<^>61;BG))46]HZ]W66$?.L%9*1@[Z^DZ?)-XU95%IO@
MMFS96WE22C&/KFM2Z+>B;66@D#>*8!/;D;DX- & /IS[4 :!&<Y.*<#7:GWH
M Q@4 >2GFH9!EP;4*/TI0L&+O<4LY!0M2MN0 .,?>JLB]MMBR[*MUIU$%G;4
M%995Z JYK@>0UD<<*BR8QL&;5KU^^QU(3/V.>O.:YVDSN<%*^QFDB/E7U3,T
M(D7I23_OT/,XR[))Q=YN+2/%:GMJ YRE>:NRUBC:D1*GT*Z=ZD?,3#">7O<2
M< A?)-:=!Y6-^C%^Y]&:6.=V^B>7>WY&\RXQ0D'@!>2?K7;ADF^9N_Y!^A*V
MN\041E*4PI&1W4:T>OCVN_@(Y'C8I^W(7\[?_7KF_O\ B^Y;^\/['9]-1V3U
M0T!ZH 1=_%^560Z$EV-'W#@C XIFR$CYV?'W\*WQ#]=^ML+5/3K1S5VL,'3T
M2WM.KNL6/M>#KSCJ0AU:5=UIYQ@_E22399"22Y-O@+^#'J1TFZJ73J!UKT-$
M@KMUK#>GUF?&E[);C@#KH#2E;5I:! 4<8\16.:$ON3*5K@*/[4_6O3]GHW;=
M#7B1$EZRFW:+.M+!(7*AQD;O'?/\3;:TGPQG 65<9VD@D1#L^9&B+5<K[K73
MUDLS3CL^?=X4:*AL9475OH"<?F<_E2%KZ.@/[1C7TS6WQ4:EMCDA2X6D6X]A
MB()X24MAUY0'NIUY9/V'M4MVQ8*D'_\ 97]-[3J?JYJ3J#=H;<A>C;6S^SO$
M2"&IDIQ2/%'^)+33H2?3>2.::"L7+)Q1] OB0Z<6KJWT1UAH:[QD/F3:I$J"
MM8W*CS66U.,/(]E!:0,CN%*'8FG<>"F,FF?")!2ZTE2T\.(!4GZ$<BJ34=E=
M=X74WXC/AD^'G4.G-%7_ %9/M%OO%JNCMNMSLQ3;L9QAA"G-@.TK0R#D]R#3
M/E(KBTF[.4]6Z&UKH*<S;-<Z1O.GIDAGYAF/=(3D9QQK<4[TI6 2G((SVR#2
MEB:?1T=_9G$)^*JWD]O[O7C/_BD4T>Q,G$2K/BQ=N;WQ-]47+N5?,_WIG [N
MX0%X;_+PPC'TQ4/LF/2.Y/[*!C2;72O6D^"F.=2JOR&;DKCQDPO 08R?<-E?
MCGV*@?4"G@D596^@N_M.VM)R/AJ3*OJ8_P"UX]^@BPK5CQ0\I1^82V>^TL;R
ML#CRH)YQ4SJB,5[CY;=/=53M"Z]TWK2VO*:DV*[P[@VI)P1X;R5$?FD*!^A-
M5%[5H^_Q4VX2XU_LU^9'^Z>1_3%7T9+,5)!C)H)HQ0,>H \3F@BCU!(FZ< #
MWJ& F!P34 :[C4T!BF2%LT*SVXJ:)LT&]:BA&,^F:(^Y6*OQ-?8C-1:DM>DM
M,W/5MZDH9BVQLO *X\7CRH'NHG'%4:_.M'C<X]F[PF@R>6U,<%=OX_4^9VM]
M17/7EZN.J;T5RYDUU;V]?)2#V1^0Q7RG49Y2U#<I=G[2\)XW%X/2XM/BCVD
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MA[FE+4H+'"SR16'68%ECP5J3?R0\&PWR\*4]#4=A/\2CBO':OQFIS/9%NO\
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MHSC326&4M)VJ7YCD)R<^I-*XVQE-K@KL_P!DKTR S_IEUA_[[8=1M)]1B?\
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MCCW'ZU-@;(?3C\0_6BTP-P\#V51P![Q?K4,#/B&H 4\;TR*FP/;D_P P_6H
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MQ^59-YIRK>*371G!4/K5,I&N$2.<VK6,$&L\G9L@ALZUWQ5,B^)$O6P/O'/
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M'IL6J*"=L\YZ>M*G5N%#GAC([5MADC&-L2261V6?T_Z02+U.8>>AEQ Y.Y/
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MZ/;BH.1G$;>>#6K2YHYI)(IR7% U$OJ'Y24Q=Q"CS]*ZFJQ)PY*M[1:&B)C
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M[$CZTT*Z8>I?!&VW57]WYX5)0E3!5@[>>*TZ=[9\$N@]@=1]-*DI%IF%+SH
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M>;VM%97^\-/S%)#AY]<UZC2X/37)B=R!J8%J0MT%? SWKHXU&QU'[D#\ZO\
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M,442F:*6D*P*C@!!TH-,)\C-WN*5DFA0HCM0!D)*?M4 *-=S3(!9-2*SQ)%
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MIMES;N[$>M;=+HWNMDMVJ 5]F05&2%E14<UZ'&XUM,$X--OLS"M<FZ2$L(&
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M  A'ZU9P:>3KNN<=P7: ]J9$,\Y0R$)#M0AC1;14HG-0P$2@@D9H"D8V'WH
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M7]QI<F6&T*W ' )Y%=;3SE*56$7&N2D^H!8#SJU-  <\#FO6Z->WAG/R*\G
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MYS^M+O\ R%_>9'V%0-QP3BL9ZFQ9MS!*!VJ0[-\8YSWH ]4H#4]ZA@8J /4
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M<;S:H:6$.JDS&FE%0R/,H<4\8XL&/W+EFK10;SH^CSXVK=2GRMI64MI_E2,
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MECB]R1>>G]),QFP@Q@D#&,"N<]T6-FR1ET3,J!'2 C:C [TK*(39$3(3*<E
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MQ42.A41LE*OQY'<5"F4.-/@@W;(&6\?AQWV]Z+3(K[DQIJ Y<ID>VH3N6XX
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M<E*"A\C[YSP24URNOS 'XN;\-4=4DPXJO$9TY;8]KW)5G]X,K6/R*L?E7O?
M8O0T45+L_)/UWK(ZORDGCZ7]RK[;<'V6DL% ]@?45U9*^3R,':H77<Y86I/C
MN8QC\7 J4/''SV-Q<%LX#O[P=]V,<U&T7(_@L_IWKZSLM(@3G5-J2X,*(XJM
M\%49)<%Z,ZHM$MI*H+I5A(R,<5FR9MO1?"2^2)69URD.J"E%)X[>E9_53*?Q
M WJNQR%L$QV%)6@9P/XJIDUW9+DX($;= )4MM\N=^4GM3PDD9I7+D=7&"TJ&
MME+8(QR2*N4OL,HLAF; $M_,,L)4DXW>7/:KXS;&VDUIO2T"Z79#LV(A2FQE
M(QW_ "K1CBGVQHJN"QYNG+.]992%VV.VI*/*4-#CCWJR:2196WFSFK6UN;:E
MO("D!"%$I ]#[U7C;)DTU8'1H*W7-JD Y]<U?9E<_L$L/2;[S:5I9.U)R3BL
M[S)%Z?Y&T[2[J$[&V=^?8&B.:+8Q/]/-/KBK(N,91"E9"L=JN]2(/(TJHL>\
M6U9B>(S#2IEL9&3^*L\IJ^&4[^2MM0P8:PMX,E![*3GL:(S?P.E8QT=/:L=]
MBW#P%J##@44^F,]\T^Z^RO*JX.^NGNO=+ZET^W*A7!H+:;'BM9PO/V-,LD)<
M-T:,+>*'0 ]7KQ:KJ\@1E)5X7XL^@K!K<JM*+&R-25LH&_6)F5O6AL*6HY2-
MO;Z55BS)+EE,I+(J0$R+!<(CBB6%C!S@?Y5LCFQRZ9F]/(GRA*4N>Q'*%-N)
M..,IJU--\#J$ES1#^$H#<\V0H\YHI671R-+H1?8"D^5.3C(-6#1J2Y'5DD38
MKR6$@E#O?Z&EG$JDZ+?T3"8D,);4]^^4#N"A]>*SN-.R8I278IJR3!MJ$Q76
M@AP<9![U97 BC<JL@^E+;ERU89;8+_AC8H ?AY[TR44:\:X.H#'1"LJU!/F"
M#D>]8<[<4Z0SK=1SUK"W)OER4VXT $J5P1WKE^M.+LT**8]TATJ:D+:=4TDA
M2P.$UDR^2E%M!.*@K1T%I;0<*UL(=3' *1@Y'>O'ZW52R3HSRA\DS,C18J,D
MI&!VK)",XNES8B=JP:NFJ68"%H;*?*,GS5T<6C<UR68\O-%>7G7LIZ0KY5Q6
MT<@@]ZU+Q>%_B7);DG[32T=0)S"MTU1QZ>:LN?PF&71A]3D)HO4-N0 H/H S
MSSV%4Z?Q,XND62R$PUJ!F<T?'6D@CR\_BKUFAT,L4::LSN7N*RZH6]AZ-X\9
ME*,^F<Y-=?'C4"U.RB6(#D>8LJ0495DH_P#/5\I)J@?!+>3_ )K^M9R+/M]D
M^]=$](;(/)J&!E2B.U*!CQ/?%,@-5/$'  HL#0N$G.!46 EXGIF@#3/UJT#8
M* YS2RZ \5@^M(!NEP*&">WM18&<H]S1P!HO;G@FGCT!HI\(&..*FP$5R#WX
MJ+ :KRH9)J$0)9]S3BB3BQC%2NQ9=#9Q[T!IA;-4/>N:*L+%0\%<DG\J-H6;
M!P8[TKX9*-5GBH C)2R3^M61$9'/K*3QCM5J*QN5E7>I(,H[F@!9OUH =,C
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M_P"+%-,=6[C#0S$GL.2$K "MIQS[TV++-+DS234K4N!OU!Z@,7-7[*LZ%J)
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MG_=]\U)?!BX/B/&4O^4'_*GTL'DRT5>1K#'U/L(:$1'UMIN9'2X$3&GB$%1
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M))KD:SQ^34?A0;C>Z=6[$VE26YA<X. !G-<W#X?/"=R*IYD-;!K9BY20XT,
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MTXVYXC1SGCFD4/N,K3$?[P2_<?K3[$3;/OHM "?+Q6 ] (E&/KF@#3PN<XH
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M+0FO[X14@%(X3/90DDI7C^(#)!]>U<O7X5G7JXU^I[[Z(^H\WT_K%BSRM/\
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M);K@2ZA:%8!*5<$9J45RG7M1)J:+<1$$2#X+3A=#). %^I^M)RGS$7<Y+O\
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MQ#4 *M'<G/UH R3S3(#ROPU# R /:H SBI ]4@>J0,8'L*@#.,=JA@>P/:H
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MQS+'5E=S+9%AW!QD-DJ1D#BNQCS3GC3;/1XLGK14?BAY:;,MY?BIPV@'S%7
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M)A13O>6G [*&*C'FDL[2^0PZ=9G:78/NZPDH.]E2=@^M;)R-Z\:OD2<U#.D
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MD@]O%% :GS'(H W2@X[T4!CPC[BF UV&HL@R4D8P<8IER[$R<JD0^LK-%O\
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M\'0?6H:)3LSOSR%?UHH+-@<BF0&"!["@!.@BK,$<5*%DN.#7!/:F*^3V".]
M(S02*(6K;^(U%$VS<*)'>B@MBP)QWI2PR%JS^(T$BF3[T +->_JGD?0T6UT*
MP.ZT:1;UQTGU)9TMA4DPS)A\<B2Q^\21]< C/UKF^7T_J:1XJY[/2_1WE%XS
MR6+77Q=/\W\GS7TI">7;[YJ*4D?.7-YNUQ1ZI\P*\>W=(KP&M<:QZ6/ZO^!^
MK<<U*;S3ZBFOYJT='"$_(GVVR(3EF$RVES/\P2-_]<_I7*>.&;/'$EQ'LY&G
MRO#BR9Y=RZ G7EX_:>HE1V25Q(8\)HDYR ,9_.DU^>.63V]<4>A\-I'BTR<_
MQ.VR-@NH0PED?PIQ7"R-RGN.G.'-OLGK6T5J\=1R.U(H48LTDN$.%Q4*?)0K
MS>E$G7!5&;2Y/:C2XW#MS91QPHCZYKL2:C!,J\<[R3K_ )V0S[S7[12S-0I3
M:V?%P._"C29H^I5=]&N<%EALAW9R?UVO]MOG4N2;8/$B6UGY8+/;<#E6/H5?
MY5]A^EM)^Z:!*J;/RO\ M,\N]?YR<=S:QI+^-4Z_4JQ+"'E[BM#3BG,D[20V
MGMV!R>Y.![5Z;XH^:1ZOX8M?9TU$7Y*//<)>4$_N8VUF0U_,K/.<>PS5<97T
MRZ*4?Q+_ .1W;HCB&4AI: G;M^I-623I_P RJ$MTTE\\?Q"SI188]\UPPQ>$
M%R+":,EU'=*U [49'KR?Z5YWZGUDM-HGZ3J3Z_H?2?V5^%AY?SJ]2%XL=N2^
M'P^_XG3[>D+%%0V[&92V6SD%(QBOBLO(:C):E*[/UKBP1QR;BN61UY1&N:'(
MC6'%(& 3R15^EE/3M3?"9O4(RC317MRLZ8CZ@Z"5']:]-IM7N7#.7FT\(-[@
M>N;ZH:5.!"@E/O78P+UW1RM3+T^4"<Z;)FO*+940?X<UV<6&.-=' S9IRE[1
M!N&XLA*B4DG)%6.22*5AE/Y'R6/EB%)XSWQZU5N4C9CCL-UR%;3M?!QV2?2H
MCBIVD6[DEPQNN].Q5*V[P?O5KPQ:J2,>36/$^6PGTKK-V/(2F02I(Y&3Q7*\
MCXJ.2/LX.KH->W)6^ S5J%%Q4E:"$@>HKSDO&STZ;[/2_O&/+"UV$]JN+:FP
MVM:5K SD>U<?/@FI7TBR$UTV$=O?;<"M_.,8S6#4-0HF;2'ZBV4\)&*S;T^"
MN[Z$TA'XMHJ=[7 ZDXH59>*5'8<4K:?9-J9+*6AQA+8 W^BO6LJ;VNC$TL<V
MW\@+UBT7_?K0,NV,;1.ADRH&1W=;!)'V4,C\Z]7](>7_ ,/U:WO\35_HZ/$_
M6_@8^9\?D]MRBFU^J.'I&Y#92M9;6V2@;>""<Y(_,5]S261?DS\IM3CD>.^8
M/_?E'970+JFG7FB@W/.+Q9RW&EG.2ZWC]VZ3ZD@8/U%?#_J_PC\?KWFA'V2Y
M_(_3_P"S_P"H5]0:-8)/_,A%I_[,L./*7,F[ H[3V&>*\IEC%0W)4?1=1!X8
M07R2:W@VWX6>4CFL7XN451BIR;8S00M[)&:L?"++?0[SL:)_2J;=I"]NF1L>
MS,RGU2'U[P23A7.*U2U;QK:D0[AS%T3<5V%;D_ZV$@#W%51?K/VHIR1GD7L8
MPNVM;"EM4?Y]*5*!"0#6B&@U.[<DZ%Q:22:E+DKR7H?35P4Y<I>O8<-MTE1"
M$E;B?L.U>HT?D<N)*"PMM$:F6?+[8KC^A".P>G%L4M#6K;G/6."4(;0/ZYKI
MO+K\Z7^4HHIPX\KE&,LE)=!#:(%GO\!R%;IDH1WD%M]N6A"D.H/IY1Q^=<K-
MJ)Z+.IR]OZ<&G48,>JQ9=+JXK*I+Y_0H/5>BIND;S(M$T+2A)6MA]:>'FB?(
MI)]3CC\J^I>,\EBU^GC/'*WTS\7?5/T[G\#Y#+CFFH6VO_7Y$*I92PDO_NUA
M(Q@]_;-=%-MTD>8A*.:.Z;VUU^9"3_$>= <R23R#6B*K@BI22<E3&*T(9)\-
M <^X[4_71%?84C15R3N;)'/I42X0RMAQ:X16VEI&U) !)/\ 6N9ES^F[+%C]
M7V-A+T^TOI74/4"':M9B6NQI2N;+1&X<D(0.& K^ +44@J]!G'.*YNNU[T^E
MEE7?1ZSZ0\#/ZA\I#0Q__*_T:X_J==Z?U+;$PVE6AF) BPFDHC08P"4,-CLV
M@#^7U/<GO7R36^0RY,N_-;:?#?P?JC3^ Q^,Q1T^.-)*F-Y2GKA+>ERE^(X\
M?$4K.0<]L5Q=3GGGGOD[9V-/Z>+&L<%2(N3AHE>!@4BMRY-F/B/(T(CW&.Z,
M %LY5]ZOYPM-$MM= ]-'^M(FGDH&S=ZX%=/%D<H.#.GAK:FA!^PHN*TR)*0C
MD' '>K,.J].XH)I/\0R1':BS%-".6P#P0,58YRG#EV87R]M#W4$5B7$BR7TI
M4&5I;=61SL5P?^%6Z/(\=QA^O\C0YK&E)]?/Z M>^CS<ITNPF6E)<&_=MY]L
M5TM']4>F]N1G,U7C])GDWL7\@3<Z,RXL@.&&WM&<X&*[/_U+CDN&8(>%T^^_
M35?H'.D= 6LD1G-/E1'\>-PS7&U?DL^=^S(T;WX[18%NM_SX"*]VZVZ.M[A;
MCI2X]^Y2@)P25\ C[>M9-'I<VMU"4W:1Y3ZS\[I?#^*R3NW--)?T(NP1W)>4
MR"0",)/L/I7MLF2.GBHQ7"/QEZTM7GFI_+X)<+@,.X6H<>M*Y[UPB;BN*""U
M7^ULIVMD*)]ZQ9,7/*X(;5=!/$D0I;8<V)Y'?%8I9XXG0*F!^M[% DQW@AE)
MWC'E'(K"M?.&;\7!=MBUP@0TATWM2G0X_&"E;N2I.2*U:WS>2$*4F6X\<7V@
MXFZ+LD!L+BLH!QR=M<K2>1GFG[C0\4:X0PD:?M3S1"FFP .3M%>GTLY2:VRH
MRSC0"ZFT=:)++KT=24!D^@KT>#(X^UE227P5Y%N-YTM?X:K(^H J(4VA6 H9
M]:Z^&3[1+;+^L^L=-W"$B0\'?G2DX2HY -;I23Z+(9-RIE&]2=?2;?>GE-RG
M2A!/[O=P?RJAX]_ZF?)CENN^ $NVLV+S 28RBI:@=ZO7[56L#BR8JBJ;HXXN
M8KPQM&?2M\>J-&*JMC;_ %CZTP_L/T5)=3G!(_.N19UCRW4@<$'[&IL&-)DD
M  9':@4C/'=6O:V>*BPXH:7AW;$6EPA)QW/%,(4MKR\*=2JW)3NY(R!FH4MI
M5(Y6U_IJ]JU*NX38KA0);;[;V"?*"./TKAZO$YS3HKLNS3>IH3\=$<)Y2G@G
MUKJJ?,1HNNRI>L^L53-?RU1,$PFF8HVG@[4<_P"=>7UNI:S2HL2L0Z;W6?==
M50 YPE*P5_:M.BSMM6*X<G:>C[PQ"B%*'$A.?55>HAS%,G\)':LZA1K*M3JG
MQ\RKA+6[DI]\4LI)!=CW1FMW)8;+VU*EDJQNSWH1*9:=OGB2E*\C!'O0RZ+0
M^44XX(J!SQQBI(-<?2@4R!SVJ0,*3NJ ,>#FI)2$G8F[G-0R:0V<BX':G715
M)<C9QH-\U(HV*#SS3T)N8GC'K4 WP8*\=Z$)=F/%'M4T![Q0>PHH!5M>4]O6
MADIBH5QVHHFQ9)&T5 ZZ-L'VH)-5#((H T#>300U9N&P#G%39&T\I/TH3%:H
M36.W%20:[L460;I.0* '((P.:4M1D=Z"16@!9GU'^$_Y5#[7ZH*M/]&*A?@+
MAHR/]IXA!&?3M_PQ]:?)&.7)+=U5?U*_=AQXL<.[W?S1\]]6Z8M6G>J']QH!
M"XD"]29+I0=P("RXK&/;A/Y5\JSIQ\CD?:BFC]<^&RSU7@,>>?XLE?T=!ZBY
M&U::GZDN/#\K>F./\2JHP85BADU'SS_L.X_O&KQZ2'2JRHI#I=>4M:AN/?!K
MSU-GO8)0BDB4L\)Z21M[$<4OI?<S:C,HA;"B%*<8["G>/C@Y&7+R-%O>'+#?
MN16":]Z+&O\ +;)#5;&]B(H@[=F16W5RV1BO^?!C\5D]TZ_YV#FJ$,0M//7K
M>$?*1EN*4?0 &M&AC++JL<*[:#6:_P#<<4\S_P!//\CA20Z].+DV6Z'%R7%H
M2K&,A)R/\Z_0.EQ+#AC%?9'XM\EJ9:[79,\G^.4OZ-F^G7W+?=FI\932'XH4
MAAQZ-XS8=4. 0>,D9[\#BKH_BLQ4TO3^Q'W&?)U!=FHKMTERHUO0I#;4MH(#
M2E'*DI"?0'M458[]BHD/"5&CJ4K!4,=AQVJ;]R7\"N4-F-Y%VG9='032=GN-
MD>U%+2?F9KZ@E:2<^&G@?_!9-?*?K7R.2&98,?P?J;]D?B(^.\4_)M>[+POX
M<_[EJSW$P&BE3@Q@]U5X3$GD?1]FQU$@H<A"G7%?S>U=&>/VFI12C8A=X#3[
M:G<@*Q4Z?*X22,6>%VP O$9+KACE/&.*]9I,WI+<<7404_:P-D662P^K9^$\
M\5W\6H4XG R:.2EP-U.^ 3D<@>M716\C_I*AE-N[@1X:1Q5L,27)S-1K7C7!
M%KGK5S[5?M.7+7S;,IEK>/--\$K62R=DC'D(;2% <CFJW#?V='%EI$K&OSRA
MX2.#COFJ'IXKEG1Q:^N$R7M-]N<1U)+V$9]ZP:OQ^/-'A&W#JLEW8>6;72F-
MA+@5@^85Y74^#[LZ^+5[E4GR'D"]1YC29"%#S<D9]:\QGTL\,MK-L)I\CQR6
MAQ&Y'!JI8[[+^&N#1N1X:0M1Y/UJ7BO@F*KLEH4T*9\0CM6;+C]-TOD3+C61
MICB+*9F*RG&\=@:JGAG#F)3FDL2IJSC+X@]%Q]"=0Y/R<<MVZZ@S64XX2M7X
MT#[*)/YU]X^D_++R?CXP_P!4>/Y<'Y6^OO _X)YAZC&KADY7Y-VVOX-@_P!(
M==2-$Z[@37'MEOF+^5E 'NVOC)^QP?RKH_4/CX:_12QM6XK_ ,F#Z'\OD\-Y
M7'DNHN24OXM';-FF.1T+DK4E8?.6L<X1Z5\#U>&/NQKXX_B?KY5JFII\4G_,
MD')'BN%7M6)XMD(_F50CVQ!^[Q(396\H;A]?2IAIYY'44+*<4N07OVO6$H4F
M*KSCZ\5U])XF4FMZ*E.,N@>C]59UN.U>UT'^'/:NK+Z=QY58N3+'&J;LB-4=
M6)MS 07 PT>/+WKI:#Z=QX';1B>M27/" I[44^4Z4P@HD<!P]U?K7H8:'#BJ
M4^C-/R.1S4,7\S5F+?KF=LZXO)0>=B!DGZ<4V2>DQ+=!%;CJ\S]\N/MP61H/
MIG$G),J:E3/E\J2DY6<^M>4\QY^<4L>!?)U<.G>!1R32#9;5SM;1M=FTN0@<
M*>S^+V->=3AJGZN>?/V.I[<C61T-[GHY>I;?^R=305R4D%;"DH/B1U$8"DGW
M'M6S1^1EHLJEI[KY_,X/U1]/>,^I=,\69+<EP_LSF/7FG+WH+43EBU I"7&O
MWD9T)*$N-GL<'UQW'O7USQ?D(:_ I0/QK]2_3.;P>NEAR)M?%<K\N@9?F+:4
M>2O![X[UUH)+HX4E*+J?9B @SI0C'().<>M,Q5&PJ8MD5E "$Y4KLD>M9I3;
M1"JZ)6&I3B4M,^5>0E(/;[D^P[URLS47;":E)5'LZHZ1=/\ 3VE>A=TUMJ&,
MVJY:O)BQ9*S@MPT+&S:#VW*!.?I7E?-:S_)<8=_8^\_LO\3..KQY(JI)J5U\
M+XLQ9+9%L;+TI:BH*.UL]_)W_J37S?699:J,4N^;/T/GR_O.9JOA"\#6MOG3
M_P!G*248X&>*2>@R8<?J%632>G[B9D)CE(4GM@]ZP)R<C/";E*@7@2MMQ4RG
M. KM[UT<L/\ +MFR=11&ZZ>FP4)9BQ\MR#E3G\M;O%0ADMS?*'PY7:@EP_D=
M6::N0QR,D<'/I5&?%LGP73DUPA)V,XN0MQ8X'TJ7.E2*Y)W9AU6Z#)9(R/"4
M>1["KL&39--D2ENQN(2L3DMLMI !PD?_ 'HKE3Q*>1R*]H\:F1%8\9I"L^Y%
M,LM6BC*GMX8.:_UK'TG;6U0$H2]*W!"4XX('<8]:[GB=%/73I'E_J#ZATOTU
MIO6U/+^$5*C4]UU--%QN<A92T1X2"D@CW[^N<U]!T.@6AN#[/R[]8_6$_J7-
MZT.(?"^W5_SHF+GK.+#BA+.$[,#@XK3CT>^3W'C9UGJ6/AHK2?U3FO3ML0\$
MX[_6NI#01B@VDWIO5UW^<2XYG85#/VK!J]-%)DJ')>&E=4M&.CQ%I*B,XW"O
M#Z_%+U.#1&"-M5ZI08RU-E(.,5GPZ)Y)<EFU(&=+:S=83A>0-QY-7ZKQJF,G
M1(WC5=RDE+<(]E956O0>*A%<DO+2 +4?52=8&GTNL%9YR:]/H_%7*T9YY$5J
MYUJF2BZTRDI"CY@:]'CT"@+?%L&[CKV5XPFIQE)X /-;(X5%"M[N$3<?K>F)
M"5LB/>,#Y$'^$^AS5D4D,L;B^"M[[J2ZWZ0]-D*Y<43C--%).RU5=2(R-)DL
MI*LD9.*EDSA%ND;!2W"5KH0G"X1CCWHY"V??%S4:$^8*"OL:YNTZFX6CZD:P
M5<=O>C:F2IT)2+RB4?)C(XQ2N*(<K$H4S<X0'DA0_ASS2]<$KA$9JRZH6TIC
MQDJ4._--8K8,V;3S%[EI)84K^8@>M*G3'C"R8U+TQC2+>ZW(MK*T%)X'<C%6
M-[BK)B.0.J;=PZ1WP,,L+=B3 IR.Z%$I0!W1]Q7G?(:C+HLLFBMP4D4P9LN9
M/>N$MW<MTEU1^I]*\V\\LD_499%? ==,9BH%P-T=&T#@D]L>]=3Q\DYC/@N)
MSJLQ9+2_<'5(60E7A(S^-9_#QZUZ9ZKTEMC\E4EN G3TZZZCGINVJ;DXY/>X
M(2<AM).4H'V%9L?OG9+JJ1?^B+2(09"-Y'XLJ'/-=.*H(]%T:??6 AK'E4.3
M4V6QZ"=G'(2<U!:+@C(YJ -U+3C@THYA"\G!J;L#>B@,GTJ0,4 :.HW 4$-D
M=+:]*DJ&Q8([BK+%H16T H$T)\D27 DML$TQ2D:^$!G H[&1JE.TGZU QL.]
M2B&+).1Q3"BB5#%5M<EJ? L'$X[U%$V8R/>F R#S0!L2!WH ]WJ& D[ZU*%D
M(C@5*X*SU2 Z21M'/I2EJZ%*"3*/Q"@!P@[3FI2O@64MJL<Q&TNRXX6."M"L
M^V#G-599?Y4HHF$-\TW]CYY].X,O4^JM2:FE$[T3WXT<X_#O>4I7ZX _.OG"
MQJ.24/ORS]<3S/3:#!CCUM7]%P/>K^IVT/-:<@K2$P!L(SV7CM7/UK<)[%T=
MKZ;T2V?O$^V#>E],R;FE$N2%(0!E6X8!KFY(>G*D=7/Y#;)Q2#R%#CL(2U%0
M!@8&/:JY0W'*R9/4YD2P:#,51/! .:$]L&8[WY$ \J65S@E)R=P[?>L6./J9
M#T4<:6.F'%[DL&QP$K1G]P/-Z<9J/,0>V+7Q_P"CRNAA+'JIQC\E(?$)J]=H
MZ6FVVTMF5>I:(:L_\U@J7_D!^=>U^B])+5ZCU'TH_P"Z/$_M,\IE\3XUXYO\
M;K^C.2[K&9;=;0A*E>"0K"DG&2/0CM7U^"II?8_,<_\ )PRDOE_[A'9K1;6]
M.F3=K[<S&7O5-@VJW+5(:0.4/%P@H('/J"._/:DM6V_Z%V._3C7V^0?T_!W"
M3+)>)?65I\9>Y92>V3[X[_6F714U<B2D,*N<^+9604JE.):*_8JX_I6?4Y/0
MP3S+M'1\3HLGE?(8?'XU>]I?S=?[G55CL%JTI9H\"U!IIIAA*<I]58&3^9S7
MY_UVMS>1U<LF;[L_</A])^X:/#HZI8UM_DJ(?4++D[+A<'%6Z62Q\4=['!3Y
M!UF3+8?2RRDJP> *Z3C&4;8CE-2VHFG6W'(GB.I(4?0]ZQ)I3I%DTVN0;E6T
MNKWK2OOY<#N:ZF'-Z:.<\"F[9%R+).""5QU%*@0"!6[#KHI]F*6"2_$@;N=C
M#;"BILA0SQBNSI=9OEQT<S/IDO@%)L'PT%10H#ZBNQ":FSS^ITW?!&HCMJ60
M/>KW*27!RXX,;ER+AAM R#M%$7N[-'H8X\HU4".4C--1$U71HB06^WK4M<%4
M,OINT2$2Y+ *!W/;[U7*%G1P:UU0]:E/,*WK<.X\\54\.Y&S>WV%]DU<N/X:
M0[^OO7!UWBUELZ^EU>RD%K6LE%OEQ)6>PSS7GY^&VNJ.K'4*:['#6K%/=QD>
M]9Y>,VFO'EBPPTO>6KDRME:QOQPGUKAZ[3RQ,B$]S:(Z;?'+)=U>./W9/!/
M/YUJP:3]XPW'LHE_ERVRZ #XAQ%UQTR<O+37BSK(YXR-G=MLJ"5?T/\ 2O2?
M2CEXOR"P2ZG_ 'IL^=?M+\7BUOAYZO$^<--?_O-*1S1T\TVK6&M[3IU2R$29
M*?$5WPVDY4?T!KZ9Y76K0Z/).7=?['P/Z<\:_+^5PZ2/*<E_*^3OA*8\)IMM
MHI\-I(:0!Z) XKX!ER2S3F_NV_ZG[&Q+T(1PKJ*2_DJ("\ZP:@*=;"AO_A.:
MW:?QCSQB_@JGEVP317UWU--G%1+XP:]/H_'QQ+HQ2R-\@Y*FO*;(2I:B.^VN
MOCT\8O<S%DMNR.#=QDG]S@?YUKWXTN2I0G/\(_MNCY,IT?,A1R?45EU'E(07
M#(QZ&4I>X-[?TW>+:0A(&>RL5Y_-]0QBVCJ8]&H+@.-+Z"B6Y:%N,;G/YR.*
M\[K_ #+S\)FJ.+'#EKD//DI(2AM@I0$CN*XD<C3W+MD;TN1*#<KA RPZZI02
MKL"/^-:5"4WN0T]+'*MP<Z=N_P ZI+(8+A!!_#^'ZY_X5MQ3RP>T\UK\'H3I
M$9JQJT3'W&=2Z;LU^"E%+1FPDK#2?;)YQ6W%Y7+HY>UT89^!TWE8?YJ "Y='
M/A\O*OFI?3"+%>5YC\L\\RG/V2KBN]@^K-3'EL\_F_9WXW*W&>+^/W +7?P\
MZ#DQ&Y?3!4FQW-LE*8LB2IV.^?Y=Q!4V?8_K71TGUFE/;EZ_Y^9Y[S/[)82Q
MN6BE3^W_ ,(I!MF]INRM*FR27;[X@8,-IE3CP>*L<;>3D<Y[5[+][Q9,7K*?
ML/A>3PNHT6K>CEA;ROBZYLOWI%\,#TDK<ZJ3BVAL%:+3#='C*4>R7E_A;_W1
MD^]>3\GYS'-__IG:79]$\!^S?42P^MY!5?*7\?T+ ZOLHA6!=N:;\)B%'1&C
MM!7E:0E/  [?GZUX?'K9ZORS@_\ N/T/X#0X-%I5#%Q2&23(=TO;ARE9BMJ/
M_5%<;(XK5S3^)/\ N=K3N4YN3^: Y#13>$*<6%$'CFNQ)W@X-NI_,LN(Y\U&
M#9/\(%>8:VS.=W*QLF+%B.[MF'%>OO5LY2E&AV)7^*BX6TM*2=WM[U9I)>E.
MR(Q2[!"V3#%N28@_ _YE'V-=?+CWPW_8VQG;_4(Y'G2<'.:Y[[)G&T15V?;@
MVJ2ZLC*D%('N3Q6O30>3*DBI5"+;',*ZQ#& WI"B!QGGM5&?#/<,YI#"X7/Y
M4^9:?,#@59AP.71DG%R3O[HB7-.N:VTM=[PT MVQ2FEK1C.8ZTJ"S]TJV*_*
MO9^&2TDXK[H^/?M@T$]7HXY(K\*_\@K<U1+='<.,J (.3ZUZS"G)GYAFG)VR
MI-2WQ<ETLM*6E.>2/2NQAAM19BX9%:?M+LVX,,[5* )/:K,V58X#W9=EETPL
M1D*6TI/EXR/6O,9]0K:%:):+">MZMZ04D>M8)/<0N!*XR7'_ "NN \\CV%6X
M\._@L4B1M=I2^PCGR$@YKFZS(\4J&4@ACV<(:<6O\:^0/<8K3I<UHANU13W5
MJUN,Q%;4D%7IBO7:":DBE*G92+T)3K:$->521R:["98G:&K\$CR$@J'>K&R;
MHRW *L*V]NV:7<)O,%DI#B"V@$^W>ELC<-UQBL;?SIK&4Z8F65<IV*\OM3)V
M/O\ DU\$_P M38;SZXCJC;VVDK;NS2RZ,( 5WKAK41?3.KL9M$ZB>"A3KLY'
MF.,!6<4T<Z^Y$H,5E=3"8RDQIC>Y1_FP>/:HGE"*KLT@=3+9'8\15S\5XDA1
M!/!]J2.:/RQFT+/=18+JFDN2VP5*VX4KG)[4_J1%?/1;_3A]KQ@'$@%20L>Q
M!^M72IQ5$PDP\N\EIZ*ME0 )21GVXJ(2VKDMER<D_%=8HEST1\RF.D.0Y;9:
M<'<C'F'YURO-0]; IUR9_DXXCNK3*4A*=R>P%>*E-+CX&CV&%L;E)A_NO+ZD
M ]ZZ.C;A[@F#6IKS<A(2A3Y\-I0(1G@FNQAFYOW%1=O2MZ/=&F)4\;%I R ,
M^GTKJXDDN"4T=':2>86A"BO 'T]/2MF.5KDEM)EC6NXQ4A)0[Z>HQ3M,MBT$
M$>YL#_E1S44RS<AZW-:7@A7'V-%,-R%O':QG=2N+0Z:9NAY!.<G]*A,&Z['"
M.1D=J:T%H]D5'?06>R*E!9X\X(J2&-GVMQ)^M2A&F(+2D]J:B+0W<;"J@'35
M"?A?2FL5Q-2V .U,A&OL)!M()J;1&UF=B*"&J,[?;M4D&OFSBHHFS?S5'1*M
MGMQJ"PRE9S0!MDJXH 53VQ2L#1Q"E'@5*8K5B?AD=Q3\,1JC9*!BI(% A7M2
M%J%:"39*3G/I0 NCD8IHNF5S'L1.V5'/J%) !/!![\_:JE%M.3Z+)2VN,(]M
M'#=LM,_0-IO"FREAZ%.E[DJP=[ZW5A )]PG_ #KY]J(RCDD_D_4N@S8M;BP.
M;]K2_DJ_W!2UZ,5)7^V=4K4TI1W@*.Y2U'GMW[UY_+*4LGO/83UD<4?3TO*"
M]NWS7$MH;A_+M#\(R 2/M6;/E@Y>TR>OB2YE;)>-8_"8^9<&T)X[U5#<^S#/
M51W;8D)J:_P[?"<BQW-[Z^R<?\:JGEA6VS?I-+EG-9&N (M <F3RHIR0<YJ-
M+CDYQK[G>U.:./%R%LUU4JP,H63Y4E QZ8)S3ZZI8VW\/_<XF->AJ-]<?^3E
MWKW?%7?5L33S?,>P0PMS'JZKD'[XKZQ]%:-Z70++)<R/SM^UGRLO)>2>A;X@
M[_O_ .2K8UOD762EM+#JU.JP$-I*U*'KA(Y4<9P*]?)OM'RB,5+V3Z#[J:U-
MAZ88MS9U*Z92$0+-(:"(D=VW) 5(;<0E(4LI.!MR022<YR*7)RKY+8U#V@@S
M"9@L!"""4I *AZG_ -,?I3-J"5BJ-LFNG&FT:CU&N6[+=83 22R4(R/%6-HR
M?U->4^K/(RT."*Q\WVOYGV+]D?@O\0\A+7SXCAYO\^&D69&D7/3TWY::^X\T
MDD*W'/'8&OG66./68]^-'Z9A+TL_-M2Z_7Y"&1(9D,$M'/'M7,A"4'R=?#Q'
MD;1+<T74O <GFKYYZ5"Y(QB]P]?@.R/W21@?>LZS1B[*)9%\B3-@<;<!4C</
MO5LM7&4:3*G)?!()M0)#9;&TC/(]:QO.US95*3;HV>T9"DC>N.E:E#"O2FAY
M;+A?M8CA&O<N2)NG2K3,R*XF2TH9_E41C]*VX/J+50FF9,GC<.?AHJV_]+H4
M5U2;#)=4I)(+3AX_(U['0^>EDBGG5(Y6I^FXXUOQ/C[ K<])7FWM[I$124^A
M&#7;Q:_3Y^,<CCY_%3BKHA'(3[1 6DC-;E)/HYTM/-=B"HRRG*1G'>FNN3,]
M-)KVHV8;5O[8HNRS!C:8\658P3RGO2W1LE*C:.^XRH. TK5]CX\KCRR2A7EU
MI7G43SQ5.3 F=#!JVNPDC70*"2@\*]^*Y>;3?D=..IE_I"+3UV6S.2KQR@9Q
MD5Q/):*\?".CAR\A=J!F->HA4%^9"20>V:X&AE+39%"7R;-3C67%^:(UFUV@
MV.5;WWT_^J+*HI2L]RH$=OSK:\NHEJ8S@N8O^AQ]?HL.7Q\L.7\,D_XM_P#L
MK#X==$(T[)OE^NR-LQEURW0MPY(0<.J'YX%>A^JO(/4PQX</,?G]?C^9\M_9
M=].2T6JR:S5*I)N,5^G;_GP7!/O$A,;<3^' Q[<=J\=ATT5,^W152E*?3 *\
MRW9\I:DDD9XKU&DQ+%#DX\M^U0E\$8F&\Z< '%:O6C HV-D_8-%NW-Q+CHPV
M/KWKEZWRL<-QB^2S'IU-AM"T/ 8  9!Q7GLGF,K?9MAAA'HE8^GHB2%!L)4"
M.,=ZPY-9DEVQY8T^:"1AAMN.$^$ 1W^E<QMRGV3%<TQ_%!&-H[53D23Y%R>T
MD=P4H944X]^*19-BX,[3[&T/2=UOET_<++,8$%Q\G 'VSWKOZ;(UCMHC5>2A
MI\6U=A<[)@:=:,2UOME21APGG>KU.:5ZE+E]G$QPRZ[WR7R"5QN;DM3GF"B.
M>]<^664I[I='<T^ECCC0'7VZN1V%*8=5XA[CD#/M72T\7*5-<'1V;<:4NOZC
MK1NGM1Z@?9?OBW(=K4K]Z^O"7%(_E;!Y'WK0XZ+'.F_Z7_\ )R==Y:&&#AIH
M;G^=]EK#073V RN3I^_PX,B2$M2'72/F7VA^%"W!S@>@!Q[YK7EU$)_Y./*]
MGZ-'A\,\L-5^\YM*I2^]+_P+-VJ/I1*7;==HEQ96H>(ZEP%1'N1GC%<K6:5X
M(-Z:>[K_ )R==:J7D)/U8N+^%7!3W775EO,&XBW2FY+;<<O..(.0DCC']:W>
M-T>_7K*ERY<?F=[01CXSQV7/J>*7^PYG3V8FGX*UN!*?E&R/^J*Y$=/.>KR*
MN5)_W-^EEZD?4AT $2XB1<O$"\I*O+7H,N!PPTT6YFVN2T[,[AM*B>Z<5Y'/
M6XQVH]CR4VE36Y0\X_#2Q]SI$XW?9$IN3P);<9SCBM+Q+X99)T"EV8S<E*0/
M#,58)QZC-=73NL=/Y+L+M-/X)AJ3XD4.DG"NQK'*-3:^Q==Q [6EWD(DQK6@
M I=4%*Y]!_Z"N_XK3J47F?2,V2;WJ'P;MR$1XZ'GU$$ $BJ<F/U,CC JS2BN
M9 E=]9B5/+3"B4HRGD>M=[3>*<<5R7)SL^LJ$F@_Z4:C#%GU1#=QMF6]95GM
ME*2>_P"E#@\.7&I?<X?U1IX:[PLYS[VE%:EU,Y<62AB0=RAYL ]_6O>XL&SL
M_&<YXYVX=6_[@U&@O/IRZ-V.Y)[UIF^.!(<%K=,=',22W(=0G>"/45P?)ZEI
M5$;:X]EUO6%B/$2VVUR*XCN5,E-,BIUF3\NH*3@D9IHIV))HKB[-R$7-++8\
MJE8[^E;\4E\"QER65IBV>)&1'X*D^F?6J-;IO4CN1*DR;+ 9SXB?*CRYKDPO
M&J'2=@7K;3K-VCJ);2H*!&?:NQHM7+'V/*-K@YOUWHR;8)!<;04L*Y"MPQBO
M5Z750S15/DKV.* UIY*GMRE9 ]?>M[3H7E=CT*6EDG;2)H3FAKR IU8YW;1]
MZ?@CL;NO)2<GB@:,6Q)#H658/&*;H=Q:1[:*+"SK>WZ0ZM.-#Y6WNI1G \0<
MI^@KQT=)E9W=X[M?37K;;[C\[\IXR'#AT%U1P@^PQWJR.GR0?(;K)V9IOJ(E
MX2'+<XE+0\I2OD8]#FMLL$W K;*<UY>M7V*>OYIF9!+BM^Y2B$DGUR./2N/G
MP34[L+(VU=6+[ :#DE]4@-+"@MQ7./<5..>9<(1R/H)T ZG?WGT;:9[DC<I<
M="#C\60.17H=--R@E+L(ODN"\ZKCIM7B>/A9!3@GFK,E(N;.>NN&IXLJROV;
MQPO>C?M_Q 5Q_)ZB+Q[$5[?DY/MC27)[N1P%FO%Y8-$Q_$'T"*$Q 5$8(P*Z
M."6V-$3*^UC 7XRBWW"LUT\,J5B)78?]*;\_"=;6MP)V)"=I]:W0S[2$J9T3
MIC6$1YXK+^P!(X/O6[!E3Y9$WR&MIU(;B?#C%9;0,E78"N@I)H:+H<MZL4E[
MPT34D XSG@5%HMW!%;M;JER?E$/@J'?V-3:(L(HFH6R?#\3+G\M*^1U(F$WE
MO:ELG*CSY:51Y)E*T2<:>DI!5D U+B$6/ \A?(X^]15#W9[<,9S4@)J</<=J
M $G%*7V4!0 F5#!JPJ$2H8I00FIP"F2!L34ZG'/%.D5;A/*?<4;2=S-DE..^
M:*HANS.1Z5)!KZ_G4_!"[-J1EL3; J!C  )P* -TH*3DD4 ;IJ&!FE P4DG.
M*9,5JS(3QVJ;#:;#M02;[#]*"39(P,4 +M8]:AD)6QW 6ARXLE>/#0H*6#V(
M'/\ PJ<LO3Q.R,<?7U,4O@Y&UM<&43Y,CY=$B3)E.R4M$>516LD.$?8#'VKY
MGK\]S;;/U']/::M)&,N*7_$0]NM[KD@3YA2[('*0KE(_+TKSF;-<CNYI[8;(
M=!#&C!3P4\K/!4HGL/I5+<6K.=.;VT@&USJ^2Z\J!;%>$RUE&]/=1'K5#RTS
MN>(\=ZONR &4NOJWNN*4H]R:KE)2Z/2PQK$J)F!'5;8*Y:0,8Y]Z?'E<>49L
MFW-D]/[C>Z:H:M.D)UQ4H$V\*6H9[X25<5U8Z;]\U&+3K_5S_9G'\KGCH<4]
M5D_"HR_FEQ_4Y%GZBE78NW6:T!,NCZG%*)_%G&T#/?BONV#2QT>*&*'5'XQU
M_D\GE=3DU65VV_\ V&>AK'<8T-.HU1+XTV^^FW6V7;%MM!4Q79"G%J3A)2%#
MRD$GU%6Q^YAKD&ITNT7G4\FY0;$_;FH2UQ$LR;DJ8YXXX>7N_"G<H=D^V>32
M[4[I#R=4VQM>DLM-<*"2O*B,_AXSW]?O4IQVN4O@7)"<LD80^2YNC.D+?;]+
MQ+PMEQ,F6DRG5*/?)\O'^[_G7Q3ZP\M/4ZZ>"/2='ZV_9OX1>(\!'(U[\JM_
MU0KJ!M,Z6Z02G*B/T)K'II>GA43ZSEP5I<<WVE_L-X,AQILISN'K1DBFQXR]
M.-!)9VU/I"L #T![USM0]MF7)FM,(8UNW8X%<R>8R2F2;-N:'X@*S2SM%,LC
M^!0Q6$D>7D4GJRD+ZK,F.A0X[^U+O:?(KR2(VZI3&BKW<<5LP7.29HP-LJ\2
M2;\H["I(61]#7JUB?H6OL:,K;:HE-2NP9L3]VA*@1CL*J\;ZV+)RQ/0]54RO
MY6GHSA.6@>.,"O6Q\DT<S+XR/V(:1I81F]X:X)K7B\EZDMIS,GC7C^""EVUM
M"BE*<&NKBS[D8,FF2X(YUM;9VK3A/I5J=G.R1<73$"?X<_6G*F_@W;6>-OZX
MH9=CF2D5W.P+<XSGBLTX6=+'*^V$MKEI;VDJR0:Y.JQ.2.GAR4$\>^&.D(>)
M*#PKZBN'+0*<N.SJO-MQM#8QT7=:T%3A(4/!*<A223W%62E^XJY&6>..LP>C
MD[^ RGB)$M+=OCEEA,1*?#>(\V\\J4??)XK@PGDU.;U)73^/[&W2>/QZ3%[:
M5?/^_P#Y!N(9]\<<8;:(^74$N@=D9_B)]C[UT<T(Z>*DRR63U?;U7:)./HUQ
MY\A#)<P0"4\BLN7RNR*YHIS)7[4$36A8K*!XC&U1&<&N5/S$Y/ABJ,28MEF3
M%2EAMG"4^N*PYM4\GN;(32=$RU;PCTK!++98FD+B"V.R>:AY6R=YNAL!6PH-
M0NQ,C:BY1[/.#S#:,X(. <5,>7R0G<;D%U@TTOP4S+@LSEN'>VRQA:4I_P 1
MK7&.&"3:/.:OR$H2<8\+HEKHSJ1]D1HEJ^5CA)X"T#]>::4<F55#HQ8LVG@]
M^ZY /.CQ("EINFH+)'7G)2[,!4/TIX>,RS5H[N'4Y<T=[A-5]E2_J"LS4%C4
M2S%F+F$$A'R3:CD_[QX_I6B.AGBYG_4Z>#)#)VU_^]_Z%(LFYH;"X.DD)?6,
MB;+4''1_NI/E3]\9K2]1I\<-NY?P*<FCQRFYRR6OLNO_ "+&VZHGE2[EJ)QI
M./*AKG'WR*Y\_(8(NH0LT0R0PK;&"$V=*M/'_7+S<7?;:L(']*6>O>/F$41D
MGF:ILE8NF;3&;*&F5*W=RXM2]Q^N36/+Y/-,RWD?$NBM.LNE'EZ9N+%F0?&<
MB'R9_$0<D#\A7IOI_6;LT)3?^I%7D\4M?XS50QKW4_[#J B7JO35E7$)6A,-
MMM?/(4$ '-5YFM%J\KGVY-_S;+M!_P#RV-+[+^Q#/V:;99H\5O*0K/EYQ6]Z
MB&HQTC7D;V\EBV:8DLM85G(':O*:O%4F9LD;Y"$%+B E7)Q6+&]K%@ZX/?)M
M 9*!S]*N<F6.2!C4L !U#K2?]H-J_J?2MVER_#+(2IV1L.2D0'!SEDD'-7RA
M>7]2^+I%;2;BFX7]WQ%%3<,E*3[YKU^+ ]-I=OWHYZDM[7V-+S>U)97R0WM(
M3[YI=+I-T[,NIR-W8"1RMQ\* *E.'''N?6O3RJ&,YL8[JB_U_D'=MO/[*TQ<
MV$A(<DQC%8]"XZ3R!]DY-<G!II:G5QF^D[_@>1^O_(Q\3X2<E+G+:2^WR 9L
M&$)#:0K*C^'[U[-9.#\GRJ,FD8?MKS"=Z48+?!%3NLMBK#+06N(]E_<O*;2K
M/<USM5I/5'RHN2T:VA7&,-KR7<\>4@UQ\VCGB:=%27 XN=R86P0%#S"B/':*
M)*17UPB+7.2^V$D(4"<^U:8M/A"1;3Y#'2ET8;D*"MZ2H\9ILG,:-$.0_AV9
M5T;+310=PR37,6+=+9]RR::=H%-36&7;6E[D;FP%*R/IWK<O&3PK>3%V4MU(
M,.1;EQW"A7DX!^H]*Z.@C-2MCM%!Q;6/V@4;3X8)P!7H=W!2^7022;,4V]+G
MA[#ZA1YI$+7 /SV=A2&QV3S_ +U6H2ALUIV?/2AV.PM2G.PP:+1;!R7 L=*W
M*&LHFL%DD<;@>:-Z)=LV_8#_ +?UJ-Z%VL^WL7I1;T!*3$2D8SC'K66$U'X.
MY+'^8Y_T<VMM"DJ9 ./2FE*+^!5&@5U)T\MKD5;28S1)/!P?^VJK)I%?Z@Z-
M6*^01$F6QA:@,>9O<"/SJ)XL.;M<B-<\'*?7OX5'K*\+WIB.I# 2$NQD(.$C
M.2K.?Z5S\N"6'\/(LE87=)W9VA(<"(TVLQ5-AQ"D*X22.Y'I3X-W<B$6]J?5
MZ%*80'U)2ML.*&>U&JS)(=2.?]?ZJ9E7J0XX\K8E)P2>!7F<KGFR;$/*7!3]
MCU,E=Z=;\3RAPC.>]6Y_'-0NRA9:D6_ EIDQVPTX"!6&,7%[2R]P*ZGD-M25
M)< P?7-;H/=20J>T>Z.EAA1>2I)!. *>5P([#X:X59FR[A.Q('IWJY:EXHVE
M8DDV[).V?$):9+*[-*6[$#8YV)Y>^QK9IO(>KQ)41S'FAK>^O[4"*EV+$^6:
M_"E+BP5J ]3QQ5TM:DZ1;%IDMICXF[7*C)CPT(+ZN"^I83_3%$=?;JB6JY#:
MS];+4AS"Y:GY*^Q2KA-;89DR%*_@L.R=0T24-J2Z-SAP%J7V_*M"E?0S=(*6
M]7RVG0A;Z%I "LI<_P#-3/\ ,F,DPEM&LV) VEW>00#YNU%*73'W4%D*:B4V
M'$*&"<=Z27!8G8Y==2@8[U"Y1#=.AN7B3FI"Q(N_^F:LHJL36_QMV]_K0D#=
M(24K'.:>J*G*S4K!]*E,4U)![8%,!C>4]C2L:)D+)&=]02;A7;UIET+?)GQA
M[?UJ&AE.CP<&>](/N-BX$\BI2LAS-DN^O>IVD>H*-N;L\4LHT-&5F^[Z5%$F
M0>.^**)%$J&.V:*"T>QGFBP%=OUH P.:D!0 D$ XP,U*[Y(?3(_4=WBV#2-\
MO$UT,ICP7,+*L'<H;0!]3FLGF)^GIVT=/Z3TW[[Y&&/Y;_D<BMW!+CSE[O)2
MV]*.8[2CR&P !QZ?;ZU\F\CFYX/U5BP>E%:?'U'Y^YA-[3G(.W\Z\_//R:?W
M-OFQ5W4(3 ?"%^=0V]ZCU')%<-%6:WT $Y!*]RN<>E":;Y/5:>HQJ/!M$BB0
MO8V.WTJA3VOD7/.D3LN-XMK<;V;0EI6?7/%68I_YD>/DYT,CAE4OS*$ZVR;A
M:.GCZD;D)N$MB'W[A1\Q_0$5] ^D],M5KUF?^E?^3QW[4O)QT7TWDQ1_%-I?
M_P!292L)Q4V]B$@8:C;6FP "5JQM 'L>:^LN;;MGY)C!<QC\,L35,DZ,LCUL
MN.E[:%-LB!)M5QNWB*5)6?)+;9;X6E)&2 <'C)!%3*#CW_+_ ''C)4 L1EJV
MQ&(2"A* .5(3PI7J<]^?K4QJ"W%652R_Y<?UO_86M<-6H]36ZPMQRXW*?#;@
MW<EO'G/VQ7)\MJHZ323R-GJ_I3QDO*^3P:9+YY_))?[T=3-140+.([+(80V@
M(0G.< # ']*_/N3-^\ZAY).VS]GZ3%#&H8L:J,>$@,<B2I3JO!8).X\UVHY(
M8U[F>DR;)X]KE0\LVDY"5A<QT(&?PE.<UGU&MAU YL\]\T%+%M9C$);2*Y4\
M[GPS+.>Y$JRA24@[*QR5],S28Z1R. <U0XN^2IFI&/Q'%-%$B,MU3+96C@@9
MS5T<:ERQH1WNBO;]J*2_,<BE6Y/ [_2O2:311CC4SK8M/'%'=8A B-["OP<J
M5SNILF65TGP$UNY$[S:@RVE$=)'.3ZU;I<[3;D[$AD6,AEP5\I4>3]*W^H,W
MO&LV*KP=@021ZU;AR;9W91EPJK0,S[('2I2FSGZ"N[I]:HJCCZC2;N:!^?IV
M7G]RTMP#Z=JZN'6XVO<Z.+J=!),B7;'+;(6I&WTY'(K5'40F_:<Z6CFG:&A9
M6VLI6HX%77:*MDHNI"[02. O[4KO[%\)U\#R-,6TX$9_/-59,2R(VPS-.@VM
M2&KM;MJ3N>2,[>^37F]5*6GRI5P=[2N.HQ5\H7L:+A#F*E+E?N6TG#1X\W8?
MH>:JU>3%GQ[&K?W+M#CGZOJ;N%\$M.>6]$VDEQ8[#Z^]<O3X]L^>$;=3*37!
M(Z;LEW0/VJTXLKX'RR4X2XCU2H_Y55K]9CG_ )*7\3F2QYF_4AW]OAK[,LVP
M76T26"S&:1&>93^]CJ.%MD>X_P"->0U>DSXWNERG\A#(I=</[?*)1I"99#I'
M!X!(]*Q3]BKY'YH=?+(;'DQ^E9_4;[%4_N)*;&>V:L3LM3,D8&1Z41[(BR'E
M37D/*2D8^OM6_%C3-V/$G&S NL&"T95X?983G:G<OE6?3%3+3Y)RVXT8=4XQ
M^:1JO6]Y<"8^G;#(\(?A=SL;Q[_^@J_'H(KW9I_P,TM-C=-J_P"G_/Y#:5;-
M<7]O9==9O1FCSX<5H!20?0+/_96W_$-/IHU#%;_-C+388\Q3B_R?_E&D?0%@
MV^#.;>GK2-P7+<*R3_E66?E]1)W#VK\@GC66GE>ZON3B8T"W14ICM-M% P$M
M)"<5DEFR9'<G8Z5*EPA%-S>7PH)(''/?\S5<L?-C**0[\9LI!/&?K5:@AFI?
M<60ML#>%)('.>U([W;1'#<A5,IESRMJ0??!I<D-O:*7C<'N(+4\=,F"I9X/;
M'Y&MWC\KADBE\%^GBX.<+_%?]J*SZ,:@1XMTTE*REZWRG4- *QE))4./L17J
MOJ722ECQZN'SP_X)'/\ $ZEY(ST\G[L;:K\OC^A)WJX")>G(,G<4N')W'\-8
M])IWFPJ<7T=Q16WEDK9Y*4* 0G" <#FL&JQV^2EI.(6PW?*%E7!%<B:VF1+:
MR20X'  D5,DU%-#N-_(TND3='"RC=L\WZ5&&3<OL$9J+2*ROER3:V+BC^)!S
M@'&<UZG1:=ZC)!HU3R**;^Q7EN;\."9SBAEQ9W#U[]Z]5K);Y+&ET<V,:Q^H
MW]R"O,EZ1(##7(4?*,]ZZ.@PI1N7!RLNJ>1;HKKO\C1'R]MA2ILUPM,Q4[W7
M-O;V ]R?05;)2SSV11R_(^8T_BM.]7D?'POO]_T^P/MZ_DW:X,_,);3%C9\%
MM/&,_P 6?4GC^HKNX/'QT^+CMGYD^JOJ7/\ 4&NED;:QK\,;NN?N%-MO\*8V
M&G!YCGD'%#Q23/%8HN2MDJN,VN$M2%!6!D>N:CHVP5%<ZD2['D[6P!GVK7CJ
M7),_<26F+_<;.E!;DJ4G(\N<4N7#'()'CAA*GJ.^U(\*5(5M/?S=JR3T<6N"
M)T@SLFK8$]@;ADXSDJKESPRC*DC+D_(*[))BOOMJ; ./8T+'*7!?A+VZ?.P6
MF"Z\D#)_"3]*V:?17[GV:)*R'ZQS;1"TG=)OB;5)CKV 'N2,5V<6+V^_D(4G
MT<'W[4[KPVNN*<"!M&35D,,4[1$WRR M4U1E^(1G/.*::*TK88K=3.8*EMH"
M<>7[U4D+0/&*%OJ#@X!R>*=O@(QJ5G0W2/2MFGQ$27HB20$J2",XI;+FT$/4
M?1VG783K[T9 ="3L*1CG%42R4Q<C44J*-_8-M_YI7_7I=PF]'VCF:A82#M?
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M]HR/6B1*=&R72>]*3N/%9S10;A1+AVBB@W"P5D YI:'W&_BF@G<>\0CTH&%
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M-C'<UL>)S:CC.1K/(:;01>IS/;"/XOS /4FL9NI7U08RELV]"DJ0TH845)&
MX??()Q7HM'I(X8)R[/S=]7?56?S^H>SC%'B*^$OG^;[(IL/M9*$@#.!]*V-I
M\'B8QV)MDA N<F,\A&XJ23V-$XQHI@BR;-)DOP$!+A[CC_A7.RHUQ0.:D;6^
M]O4I06#V':K</16QFR\MM("AC'-6]E;=$;-FE3ZE8R3C\JM457)5*5B]NNE]
M$E#%K6\Z5D)" .3]*JEAC(50<F=2=-;#,MMM0Y/94N4\A*CCL/I]Z5:5+LO2
M^Q:5M;O##0$9C*C_  G-:(XU!47*J!3JQI'6FHM/OQ6EI;RTHJ;3G)'TS5R@
MVB%**9Q%>_FH$]^WW1A3,AE9;6@]P10D))6V)VU2PZ'$ 'Z4LD*@XCEA+2$J
M=.[U0/0_2J!J$K<EM^<6E[0HDC:KVQ2M@XG1/39*[3:([RL9>3C [ "E;X*9
M)V,NJ%ZDJB%O8K"B0"GOVK--6T2[:Y*6WO?S2/T%3M8'TRU7KQ^ 5,.RTH*E
M  [?2I>>"='749-64WKO7,BV1'Y#$\.K6#M&WL:Y>LUBBN C&3=%"3.K&I&W
MU./NJ 43CV(K@+7:C)*K_H7;()<D5(ZNW5A:941Y2' KD@U=&6I;W7_0K]JZ
M+&T-\3EQ(1;;ZP%M$;?'1^(_<5T,>NS07^8_Z Z8;S==MZCB%$#*XP.7%E.%
M ?\ ;56HU+R]#PB@1OEPCQ+4^ D[2#W//:L#DTT@FZZ.:M1A^^7A:&T[DI/E
M3[UZ'2[<6/@Q9%O?)8.A;# 9CH5<6RA8_#@XKFZG,Y2HNQI)469:W8H26T%*
MDIX [XKESQK=9:G1 =08#<RW(:""2IS(Y[5ITZ]-W$JRNZ"CHWTT9^61<;@T
M'5/@AI.?P_<>M=W!BCG5R%LN:\],[.W;0M<,$%O]X<_Q8XQ[5IAI8R337 O#
M9ROU CQ=%:W=;=EM-  .H0M7(S[#UKG1I9-I$U2X+'T;J6RW>V(?B.?O4'_9
M<<GW(]!71AE470%S:*L4.YQFA.4T#P?*-I)K;-*4:(W.^"XH'3NW3;:VTED8
M4!P%8H@O351_KR7QC?8 =3_A]M=^A.1Y$#<E0SO'XD\=\U$\$,JY13-RAT<+
M]3.D.JNF]Q?ENQ%OVY"]K3R<E:!GC(]JY,\4HLL_$K'^A=:?,)8B2I3Z/#6$
MJ*3Q_P"F:G!/;:$C^9U3TUNH4PPA 6]S^):\'-='%)R+7M2+^TQ.6ZAI"P$<
M=ASCGWK3M^XJEQP&K*EX&.P%*^"3<H*N]%L*$E(]*$W84J$EIQPFGW,4T4%#
MN:%[NP,*)5C/I4[4%FA%32!\F,"BB*,]JC:B3?Q5XQQ1M0&F3[TQ%&2HFA\@
ME1ELD*[TNU V+H<6>,U$E0)F^\^II23="QCDT42D*I<0!^*BB:0JTX%<$U#L
ME4+X;QGUI6V/2, YIE2[(4K%T$!)SC"N*F#J5HC*_97WX_F<>?&7JMU.L(&G
M8DI15"M3++@'=+BBI1!^N,5X#ZA:RZER1^E_V1>/]+QN]K_BI'-%J>?1/;:G
M$E(43GL>?K7GM0D\=Q/L$LCJH_)9(U#&CI;2PL;0V!SSS7FY:=R;LY[Q7,;I
M><O,E8)REO!&!BGBEIU:+LD4HHEK7*0ZA41P^9H[3]JJSW+EE,V]MH7@W6*X
M\4'"0DXY^E9)891DK'R8GM)]Z_L08R'!'6_N]$^E=3'F]*.V'9R,NEED>W[G
M*76S4"-0:^N,S.\0('RP0<[4+4<G@?3%?7/HS!/%X_U9_BD_]^#\]_M9UF++
MY3'I(._25?Q:394D*4&X39>AQGT*>*L.)\N?=('...Y%>RK@^1N;<^?GG^ P
MM;ZE37G=D9 42D!E.U.![?3ZFI455B2ES1./1V46]<I(Y0D[B3W'L*52IIOH
MLG&L4MO;5%K].XEUL^D&/!B%PS<N.E2??M_2OEOG<N+5>0:D^OS/V=^S?QTO
M%>#PZ6,/=6]_GO2:%[M"4EXJ\);:=V2!Z5ET^IE+&E9ZC)C67_.7%\C+YE4?
MRQ2I 5R<'O5SPK+S(23V_@$7I4Y8(1XBN._)IH8<>/F15//,S;=/WNXNA32'
M %'\1/ _*HRZ[2XE7R4PC.;W(LC273YV,429_G5Z9/'Z5Y;R7EMWMQFS'!QY
M8>FWIC[0D\@8P*\]+(Y<R+XY&^&*,Q$E16L'/I2/+\ \E=&EW2G]FOM@>4I.
M:NTDG+,@Q>Z5LII;@9E%2AV5Q7OI13Q4CH.6U$];7[G/!0A6Q'^[7%S8L<.3
M)/,IW2H/;/;LQ@M[.[WS7 U$ZEP4O+2HE$-1VAYW *R^JI=1*[DN"/EN0P[A
M4A('Y5?BW]J)?%R4>1M\];VS@R4G'VJ]PG+_ $B.:?;%VKC$4/W;@7^@JC)B
MG]J(5/Y,.R&5_P"T<"3[?2IQK8^BZ*H;+$!W*%+2K[U=)S?NCP$W-ND^ +UK
MI>W7!I199!7G)P*[_B/(YL#ILIR:/#F5R*QNVC7XJBMILY X^E>SP^6QSI29
MPYZ&3L;6BT2%7!$=U*A@>(HIXP$]_P!35FKU,/2;BPT6CE/,H/KM_H@YC-/.
M$J2A?/;R5Y+-DA?+_J>EW8\806734B0^'2[G*2-I3BN;JM=&,-J,V3)N7M)V
M5TZ;N"$!^0M&TY'F/]*PX_-RP_A2_D9\D5+AF\#ID;>LR(<Q1</&Y1)Q49O.
M/4+;-*OT*\<5BZ9)CI_&FH*;Z^_+ 20E*GCM&?I[UD7F<F!_Y%+^ U[OQ\D2
MI5QT1+4N:E<BSIP$/;RI;  _C]Q]>];MV'RN-;.,OS\)_H$,DL:J7,?O]OU_
M((X>HHUS<:;MSJ5I=2' X.1M/(KE9M!+2IRSKHOE%*-V3"GFD?B<"?OZUSXP
M<GPBAQD14^<WOV%0 /K[5MPXK-6.%+\RHNJ/5FZ:>'R6F$-K=_Y1Y:<A)^E>
MW^G_ *<Q:G_,U:M?"NCB^=\EGT..],K?YE96SK!K@N^++G>,I1Y2I(P!]*]9
MD^FM!)5&%+]3S6@^H?(3=97?\ WLG6*Y/K0B0L)/KE(KC:GZ7PI-XU_4]1H_
M*>OQE#J+J1^_1DJ,Q)1@CCBO+:C02TDJ:Y.J\>.:4HC^TS(T5I+25 J23S^=
M8LT)3=D[U5"EVU&S:F#(?(5NY %&ET,M3/8A);8>YE4ZAO[U[DJ>*\ Y& ,#
M%>[\?H8Z."5&#+GE*Z!1^(580G859SR,\UW8SKDY4L7K?B"O2S3,=: ZE'U&
MWBO/^5<IQ=':\=A4'M9<NEKG"2VB*%Y '"<U\_\ (8LDWND:\\$\C94OQ.V-
MR2JU:F@I/C6]S:LCT0OZ?<5['Z)U#K)@G\T>%^K]%.4<&?"N<<G_ %H)-%W%
MK7'3/Y?\4B,T<HSR%)[?UK!Y?$_'>3]2/$6SU7B=?^_:?U)?BK^I'Z8NH0 V
MZK"VU$$?:M/E=/OJ<?E(VX9+9R3NK]:6NTVM"9 +BG!R$\&N=XKQ&749+7"%
MU&6.GC;^0&C:S@Y+EJ=<:)[I62KG\Z]1+Q+DJSJZ_@9L>NA(:W2X2I"%/RYC
MCB1^%&[@_7%6Z328\;VPB3-XVG*1!029+OSI&YAE"CC&,'WKJS:A'8<S39HZ
MC*_B,1)\&0[\PX=G!)S@!*1W4?3 JG$O=M@<K7ZK&HSR-U"/-_IS16>IM0R[
MV\Y%C*/[/2KRC."LCLI0]/<#TXKTNCTL,$5DDN3\\?5'U9JOJ'.\,)5BC^5?
MER^+&%O;&1O03MX!)Y_6M\ON>#RS4W2Z1,JBM> " 1D\Y-)96UP81'"9+80G
MC(I9=!&*3#VQ/AEM*$IQZG?P,UCF7I\#>ZMMO.^+L\V?3M30;70C0.7+""0V
M<'T)K1$JDD0C;3CLC*05'.-P3GO]*LX,]4Z.FOA[Z5,35)N\V'O<"<-J4< *
MR/2K<'#LM=_!UM8>EB(C"'E1"2OS#G@5<V71A:"&PZ1VW3+D882,8],4O?(.
M-<">MM/Q6H;KP0$[$D).><GO30Y%E%(^5G6>7%E=3+X_'&6C.6,Y[X '_"EN
MQTB'@I\-@O-H/?(^U+VR%%%S].-.P9EL1<)#:G9$AQ3B=R,@)3SM^_UJJN"9
M*B,ZA6%%KFQKBB.6?F$%2E)[#\JJ?(J=$QH;JDY;H[%IG-AQIM6$*V\_K4/@
M65/H*K_?6+^-R4)+2 5D#@XQ[U7)<E=%?_M6V?\ ,'_KTQ.TZXUAJ^%<IJRM
M3:_"/\V*X<\\;.ZI4BG->:LB_+/E"T#(P/-FN3JO\^2C$5346REY4^9=7OE8
M,-R0ZHY"&4DJV^IJZ&D6+EE4I[W1*6'I'KF^.*4]!7#8*MR"\KS*3[XK?#"V
MTT*UM+9TO\/UEB%"W+W-7,(!4D@! /TS6B6A]54%L.[5H[^[P?:0\ZLXVG<.
M#6"6B>)-OX+(RLKKJ%<C'M3C2!M4M7!'I7+PKU<M?8,C*BM4=,BXK<!W+SP:
M[.63QP*(+<6,'6V+>AIY&/+G([YKC1DYY!DZ="%CU 6G'4H<R<<<\]ZV+#?(
M]DS<;LM^"\J8H(2R$N(*OXE9[4T,>TJF^BT.DFI66VD*4^A2$J*L9_":ZNCR
M;> 2+9NFLXCL)3:4_N2@JP?^44*W1S)-Q#;R<8=<$2M1WB=J&0V$%*BTD$=D
MCL*XB=Y^ R=45=I;4-PT[<V9\28ZV&GDJ6A*SRCU%;)1<795&7P=N=*=?V.]
M1(TQZYH0$D%("O,3]:V0R\),MC'DZ4T7U"L\KPV&97B%!]_I6R/(\I[66-F'
M>X?FPH+XY]J%+:RQPWQ*JZH],[9=H;YE,AQ"D%I2 C.]!X(/VH2CF317..U'
MSSZ@]*Y/3O7$BT$2$PGE>+&7V249[?E7+G@>*=,IB]SM%N=.+E*C--143"7P
M=PRKG:<8K=B]D2UP='3^@+N\XTR'U$+">1^=7*6Y61%5$N& Z'66SZE(-#8P
M\(% "1 />I!B*P >U2Q1-P$@8J8@)[33@8*":"&S(0!W%!%GMJ?:@@QX9H)L
MSM3[4$'MJ?:@#P '84 9R1V.*AA=&05'N:4-QNE6!@F@9,R%\_BH"S=M9SG/
M:FV@I$;JW5T+16F9FJ;P'5QK:E"WDM=_#4M*2XKZ *S^5+27++$]W")Z*XEQ
M2%I<*VU-(P3ZGN#^8(J<^/;T5QDQ\C8%))&4H4%D>X3YO^']*KV[,<IO[,MA
M%YIP@O\ N7]SYV=5=1IZ@=1KYJ0HW-R)CCB"?HHI _( 5\IU>>63+*WVV?M3
MZ6TD/%>+Q07RE_9 ;*MX>4'D) QWQ6.<MJIGHHIQ;OY&O[YMP-(1E/?\ZRM)
M\E.7V*T%^FUEA"G%)VJ4.:Y6K_'2,D\M]C-5U7;KZI0!#;RB2!ZBKHXO4Q?F
M7QBG&QV_'=(6ZSD*<!4C'ZU5N3DDS92H4LVJKE';4Q\LR^^D>8/'E/N:MRZ.
M.Y3O@ISZ>,H[FZHX\U9?Y-WF7R]-(#;%SN+KA7N(*@%$8'T[5]_\;ACIM)CP
MK[+^Q^&OJ749-=YC4:MOC<TOX-H8PGY'R"WS$MRPTWX:%*42X >>!BMTJ32^
M_)Q8)RC?_;Q_N-=-,-NH6K*4Y43A(P!]J9=%<N9<A,Q:79TNWV]N4G$J0VV=
MY[ JY_I6'69/2P3E^3/0?3N@_P 5\KIM(^I3C?Z71U'&A!N*S:XJD+2RTA*%
M([9 Y_RKX1FS2>6>>?W?]S]U:6$='BQI=16U_HE2)5.G8D^)NELH4I0SR*YD
MM9EQSN'14LCQ06)_!#N=-;$%EPI>5GD@'BM</.:A*BC;!.^Q-.EK5;SL;9#F
M>,D=JL7D,^;\3)]-1^"3@0(L50WH2$_:L>?+*=T^1G%11/-38P0$I4"1VK \
M4KMD*.[HV,N.3N60GZU+BY+:A98]HFJZ1V^ YD5'[O+[$K'8A*E-38CK3*LK
MVGRUHTV-X\B;'A';*BI)B/ DNA]H)*%$FO<8Y;X*C<U[;D/H6LK3 C!2W4I2
M!S@UFEXO-GEP8LGD-*D[8TN77MB,R6;8UR 1S5^'Z0<Y*61G%U/F=/'_ *?]
M0$NW6S5LX*;:>#2%#&4CO7HL/TWH<3XB<#5?4&2;J/ /.]0-3/Y+ER7^5=&/
MB=+%?A1D7F\S5-B"M:WTD*$]S^M-_AFF_P"U"/S&3NQ9CJ!?V#Q-61]\4D_$
MZ:?428^;R19-6_JE=T>5V2O.>V>*Q9? :;)\'4TWG'+ALG[?U17G=(=&X'G'
MM7.S_3::K'T=3'YJ^+09VGJ'9Y[:4*?;#F>RO6O/:GP.?"[B=7#K8Y^$^334
M-ULUM9,R?*:2%\A(6#FG\=H,V>=+X&RY\6F@YY&E_$%-,W9$V7)NL<!3;;B6
MD9'!QYJ['D-/+!!8W\F?P^JCF>3)']%_<N73%VMDUAOYII"%GN=HQ7@M?@R8
MV]K-NHFV%[$:WNI"VT((]P*X<IY(\-F!R;8]0RTD>4 UFE)B2;-7@-O(J8MD
M1L9.N'&W<>*T1C\EGIMC21%^<8=:D("FU<'(R#6G%F_=YJ4>RS'47R5;<;T_
MT[NCPMK#4F.\25M?Q-#T*1_*/:O8Z73+S>->MVA9REA:VJXOM?*_3\B=TWJ"
M1K"0F2S(*H[(&_:,#?Z"N9Y#0Q\9%JN6:%.&1W!VO]_L*:RF(ML=U]Y90A*#
MS[FE\5IGJII1+7.,>9.D<^W^>W/DN2$)RDDCGG-?5M%BEAQ*"/*:K4+49'$%
M'XX2O=G'FQCVKHQ<JIGG,V%1R4/H2RG"4X.!SFHYKDZ>E;CP@PL%WE0=A;>"
M?7 -<'6Z2.H;;1W-+FDD&47427&@XM6QSW'K7G,WCU%T=:,E-6^"*O\ >Y,M
M&U;BE)'8'VKH>/T4<+W449I-=@TX^\4Y;3C[5W)14UP8)MR5(V8BN!8>=)R3
M^'VJN<Z5(3%C:=LEV=S)#GB$"L&6"R*CJ8T\?NL+-.W)QM]"RLI5C KSGD-,
MJ9TH8O4CO"#6L-G4^F)(VDJ\+'Z'/_"N=XC,]#K(OX_]&358<>3%*,T5YTBG
MN::U6;4ZI0B32._9>[L*]9]1X(ZW0O417*.#X[%^[9FH]/H7OJ38M87.W8\B
M'0ZC'HA7.*C1):S0PD^ZHZ7JJ.64?C@?-1K?J%0CS4;U!(*2?3[5AEDS>->Z
M!ICCCF=30-W?1MPL*U3P@AC<2%8]*[>D\OCUT=GR<W-HY89.2Z(BXW%8#$AI
MGRMJ\#[*(X_IS70PXMMV8\[EM]J_+^+'$9MUE@,16\O33PD=]@YS^=9L\E.5
M?8HS/#^[+#E=5W^B^2O]:ZH^>=59+84K:1^[=DH5D.+SRA/T]_?M7=\?HE#_
M #)'P/Z\^KUK)2T/C7_DIJ_S_O\ F9MW3F_2(*9JHSC+2D9\XY-=><E%6?*T
MYY'LZ3[(21'DVZ48[B>4G&:E<JRC*]C4/L.FWEN@(6:K?#&@]Q*6ZVR92@XV
M,I0H)_,TDI%O19%GT9-CL-OOJ)WX/-9,DATR*O,)460IO:O=SY,4T9%38+2[
M8J2E0/;=C\JN4^"M\EA]%= 0[LX\\ZE"U-K&-PSCWJR#LKZ.N>EFGX5JG!H!
M(0"$A([=Q6B/!I2X.I[/;H[\9M*=N @42=FB#5&YL[$13KH !]ZA2HFE)E,=
M;[\W9K%)>0\E*FVG'L9Y(2,5?CEP4Y('R.U+-?G7N9-=)!?D..$?=1I8]$(-
M+-9T?LEA2VPX7&=_-)\DH/="ZC>TR_\ L>*VA;+IW)"C_L\]P*63VA)6@FUZ
M6+O:G'GWT!30 ;1]/853?)37P#'3WI7?M:N.2(<0A#)/G ]?;\J=1<B5%+LG
M=7Z)U#HB&Z;B'6VMI3XG\W'X3]ZKG%I\CRBDK*I\1S_P(?UHHBBSM::T<BNE
M*G\Y.3@XS7BH:66>6ZV=1LKQB5==97AFW-N+::?< *QVQ]:ZL,$<$;[*9ILZ
M1Z4Z!LD&V'PPE,TN%)>'XE8^O<"M>#&I\LB,:+->@MV^"B5(4 IA6U"U#/ K
M5&.*,;FZ0TY4Z$X^OM#_ #&!?4.26L;F&QYE'VIHY].O^DVW_$7<QQ,OL6ZM
MR7X\1Q*EM[D(5W ^OUJG,G.,F_D5RHYSZJSELCP3'4,Y ->?T^!PRN1#G8"Z
M>5XKS;J1M(4&SCC)]ZVZA6A8EAO)2J(DJ]$$?TKCI[9ER15=VO7[*F.-AXMD
MJ\I!Y)]J]'I\&^-E<I4PQT-IS5'4I!4^5H@M;<G<?-WQ_E2RPVZ2)C]R_>FW
M3"9;7FXKC"V4A7E).=X]ZMQ:66-[F/9T-&Z5Q+C9%-*;\.2E)*'2/+70E&,H
M*21$4V<H_$_H^;IC3NV0EL2D2"PDH2 '&U<A1QW-<_5;8952"4+.76XZBYO2
MD'</;TI&S.E;)JU7F]Z16)T1;_A9R$D$)_I1%-O@NZ1;W3[XF7HDA$2XOHCJ
M& -B=H/_ $C6Z&62_$)'DZMT1U[BRH"%&\1BGA6')0/^7-6[\3^2US:19S74
M>SWRU^,Q*C.N*&%!E940/KFGT^R_:P<[7)4/5FP6K4Z;?*>:#BX[BN2,^7OC
M[4V2-ODJC+G@"K;8+<Q*8=1&#*B =P3CC/:HI#6RZ=(,)0XPZVO<@@<CUIHH
M:+X+?L2E$^"5$[NW/:ADD\ILX[FD18Q%39W#FF*_D3<04G-02)+4$C)J2&C"
M'$JSP*FV09R">U%L#) SV%#; U(&>U,NB;1ZIH+0FK\0J2LS0!Z@#"JE$,QD
M^]32%-T\CFE:&1F@D72!M&!Z4 -KG:+;?[?<++=F [!NT9R#(1@'<VM.TCG[
MY'U J?D:#J2(#HP^]_<N/:IDPR)=B<<LLMY:RLN+BK+9<R>3E(0?^E49T\FQ
M+XY8N&.R>6_FZ_F/.KFMV>GW3BYWAQ[9*=9=@P&L96N4YQG/? 2K-<;S&L6#
M!*2?XO\ X/8?1GAI^9\GAQQ7$?<_T3LX9?A+CPV_W* 5'<LC\6['K7RR619<
MK:/U]I<4&_3;X22$FX+2BKQ. K&,53EDTCH12VJ%]'F+>PE9;2D')SG%<G-D
MFG=F6<:=-DG$LBE%:DJ(&*SO*Y49''W$!JVPN,-MOMK5G'<&NGH\E\,U8VDK
M1C3]Y_:4$M'A;?E[\\5&KTWI9K71KZDF--<RXVGM$7^]N )D,07%MJ PHJVX
M'/YUI\+NU'D\./N.Y6GT<'ZKUCTGA]3F3K;"31QU,EN_)1(3Z$@!&X@< $\&
MOOJ]L(H_#SR?O&JR3^'_ .Q<NN,6-Y/CQDM_@RML%95CU]1]*=\LHQ2:@XO[
MBMA2IJ&@H0-QY!QP:*:#>G\!ET\MS5RUDQ(EG<W 96^MM7X=QX1_4G]*\[]2
MZGTM&X1=-GU3]DOAWK_.QU4N8X^?ZHNFV7>X09:I$&,LL[BK:H\#WQ]*^5YL
M,,F.IOD_6&7.I0:QQX#"SZH5=$A):\-1'*>V*X^ITOI/L%&+;BUR38DA0V9Q
M6+TGV#PI='G8Z0"1CCFK;VB[A+Y-M]!YQ2N=,5Q3&ZV$1N1R>U%N0<1Y0W<"
MW>Q/'-/&HE<KD15U?5&0#[^U:\,=[%W./9BU3%>*ES*O,,'FFRK:J+82_P!0
MTUA:=Q$YI(PYC=Q6KQ^J?X&S9!VZ "X=,G-0 OVVXK9#A*E-8XX]J])B^H(Z
M1+'DCU\G"\AX-ZB<I8Y;4^0/O.@9]E&X_O\ W.*]!I?+XM6EMX.#J/!SPK[@
MNN,K"DK2H%)]ZZ]HXT])P]R$C$6!@$X/K37P4O25P8^7(P :+)6F^QY<51[8
MXH4Z$RZ>O@;*8<0<U*=F)X9KE&NY0Y)(--96Y3BS=$J4C!;>(QVYP:5I/M(L
MCJ\T/PR,N2I,@9DO+=Q[J)J,>.$9<102S9,CN;LL?0KS$/32'Y#Z&D%YP^;C
M/(KS?E-//-FJ)[[Z;RPT^CWY'2MD^SJZWQ%AR#=6RL?P^+D?I7,?B,DU4HG4
MS>8T76Y$_9^K3[+@+DQI2 ,8["N?J?IJ4E<(\E;\AX^4+<J#FQ]3[?<4XD26
M4^V%>M><UOT_J,/.TKQ9--F?^7+^H3,:EMDC!3)2K/;"JXL]%EA_I-'[I.-K
MX8^PAP>(D@I/(JJ/+J7!4\BQ/TURR.O=Q$*WN+3VP>U:,.G63,HIEV.,D[D4
MK=;HNXWH%II+SKY\- ([5]!TNC]#!W5$:J2;6SEE@P'K1H6RHBR'T)4/.\L
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MHJ=U"N;LJ=(\*'')P2C<%*],>]<3%BKA&VRRH_2Q-I:>=:E-/MMH*]BV0@H
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M+DA(00R5 *^U8)XU=BJ=(LFS=,8,NULS=AW.@'&/>M&#3)JV5;F^@=U% O\
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MKZKZ489B3%K97M"%!M"D\YP><53J,"Q1<F5JVSFO2=E6RE2I!!*5J04_4_\
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M>;!<$MK##2RDCT0:9JBR,&!2]&.-2A<G4D*2<X(J!GCKDE5:V&FREM2=RC@
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M&[AU\GK4I,6WN =PL]_TJMYW+@7=^8*7/K-K.1N^78"4GL<<U*D2I@A=-?\
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MDG;;_B;-!CEJ-3'"UVRRSTV@6'J+MDY<=@V5MAM('"M[AQ]@-O:M#3AB6/\
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MT^AJVC-)UR%?0"^29=WCRE (VI \0\9QZ5*X8'5-SZFB!;%(EH.Q#:P#NQG
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M7&EY+4:B5ILM>./V().J8<4%;1PM1\Q![?E70C)Y(>]D4D,W-:AMQ:VT!_\
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M('O48\UNF0U16\A"TN+R.-U=&,MR+H-51HTC<XE..YIW))$M\%F:6M3#L?\
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M!X?X?^VEC\C2^#E?INX'.IURXY#R*Y^'_K2-N9UAC1TYA/\ (/TKHF'<<_\
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MC[P!NKJ^*U:QR,V1$%(VI6G81C/I7JY:U>FV9G$=6YG8LN+ P:\5Y7R<Y/;
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M4@D^E219NA"CP% ?<T4,F8)4#C)HHG<A0K&*"!+(*Q]34-DQY94_61?AVV4
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M:?'"&Q!==;X+P[!0P0I#$< '/<^M<GR&I>14T8,&D>FDY?=C":XZ &VCM*^
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M>9=A-QVVWVW M*7D(X;="3E*E?XAD\UKQ9WC@XJJ_J63QV.8<P1G]P0D9.<
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MVCR2R1<&)JL>Q*41[ E(FLIC\;^U8\^#]WDYFC39O56V1Z=9+C$44,L%3CJ
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MM/X26ICN%]11"AB#XC0&WG&:B7TG*;M ]2D8_90)2I*,$^M+'Z3FG3(6H3'
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MGSXU.)4O:SKGIK+1>;*5J1N;V@8^N*^;^;\+OGO1UL.4>7'3JXDU+\5>TK4
M<'O7)GX^2AM+W)=A3;M.ORX2$J7DXR$FH7@<V2%DJ:)2T:1GL))C, D')!]J
MY\O!9L<K<;'>1)$G-5)B0UAV LJ;'(QP:SY=)J<?M6-_U%WIE8W%Y,R<=\5;
M96KD8J,.DR-U-4*Y)!.BVL?L]/@KP=O(/>M4O%R_$Q'D0*SXB$O*0$C&*T8M
M.X02$4E)T"UT:;8?3M3C/?%7J+&<4A6'J'P1M(XI/W)SE91.:#2RW^)(CI3\
MP&R.YKT&DFL$-C,,G;(36%RMSKFQM86?4U>WN(!B)+:0LEK&?J>U0\?R"Y9'
M:LELLQUJ<+AW#/'85NTV,:7"*R=F>=3@=R/MVKJ*%*C.N>1 STD\*IM@R="4
MF2'$  \TRA1$I6&FB'XD=#)<<#6XY5GUK'J?LB8*RSV+O9)@2A#S9P>V!7(]
M*>/DOM(A[Q98DE:GX6P.=P0*>&=ITP<^"&V*<RVX[^'BM,9WR"F,9EN;\(E:
MDJ'H#Q5ZR_ SD#=R=<;*FVD* 1P,BM,>2MLB%E[ >5DDG&/:G^ 056)UAM00
MMW"B1@#U^]5R+HEG0)[+=LV>. K [5E;Y-#GM12G5]?S6Y:%^5KA8]S73T/P
M8LL]Q2Z$>,ZI!&>>*[5TAEPE066RW+;;0GP^XS6+).W1;&-!'; 2\AI PI)%
M9YO@NBBX+6/DK:,\'9D5BF^2SI%0ZVN3R;H9$=TH<0K<E0]#SS6O3QLY>KGM
M ^2MR4\EVX2RI3Z\KD.+)*/J>Y56VMK,<7OY%I!M\&6EJVW%4I*>%N[-@)]T
MI/)%3)6#1(B8X2VKQ#_YJRR@);-]Y6XGPW#WI6N"5=EB:'\%;>71ES^:O/\
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M"9+KP!.5GBHG?X8A'AA[9K(HMIW<\ \UW?&^,CE]TXI_J5Y)OX8;V.S)) (
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MV:\NK4+>R"E*EY&5\Y ]. ,5ZOP.#"L;S8XI-_D?G;]J^OROR./1N3N$%?\
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M;"EJ/;@5I>H2X*XHB)^DY$):G_EEK8' 4.Q-/#4H:<>"/>M2XX2O:=H'8_\
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ML"-8+I,L,@\,+4&L\9;/*3^8-?=/%ZO_ !#28]1_W+D_%'U'XS_!O*YO'O\
MTMI?FONOR*_ND.W+<=0@#<MK<DCT(-=3L\Y^!T@N@:^N=Y@6NWW^89+5D93#
MA)[".P/X1C[FDFW+ACPDET6?HGJ1977!95/84U@I)XS1MW*@FZY+<M?4BQ[
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MFW9HP9-&DE!H]UJ<?D(/W=$,'KO'7XOG0 ?4G%:I1QY(M',<];CEO)RV:NU
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M[K2L8)QSS2;$=#'Y*<'R2L>\*?'*2G'?!QFJ98OD[NG\HLBJ1+PHXN8XD>$
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M93(2E[&,YP?6L&HNN#3C5EQVE5M?B)P$D # ]J\GK,<W(Z&.DC2:F&M02E
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M,7%!;K'!--HXJ;4OA%LVEP&34)M#8:6R0E W* .24CD@?4C./K7I-+L<KO\
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MA&9*U$Y;1PD\^YR?L:^M^#T\M/HXQGV^6?C3Z^\K#S'G<VIQ+V6E']$DO]B
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MIQ(2M25!*NQQWI6BI13-HTCPE9!.:C:1*-DY%EM.-A2SC!JB4"$J)2WO-O2
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M7U,8:_%O^49,+E@GMK@NZ]:7$^&F<A1EQ74>+"=2<I"2/XCZ'%<A7CX-[DI
MRG3=@;#JKLM^.Y@!(2-^3CU'M]:;U9=H66&+5C*3:G&HJV[8XZXA3JE;0T0-
MI[$>^:-SEV(EMX1$N6^2E;;$JVO.H[K26S@'ZU:LBCPF3[>Y)_H:/:)_;C@C
MP[6W& .5J2K:<5/[Q*/^JR'AQ9N(QVD@>B\1<<(42>.QYHCK<M\"RT6&*J;<
MG_ @[MT,4$_ZH-OY5I6N:_%R5QTJ_P#V5+]2"3TGG1'?,VM'/'A@C^OI1+7J
M?:+<2RZ9WB=#Z/T\U"$J1&D/(2?5:MQ_KS5?[S#['I-']1^7TU*.=U]K$)&E
MNH5GR^+8BY-IXQMY^],IPR\71V\/UOK\+_S7N(%&NWF756V?"E09 4=R%(XP
M/:K(Z&,N5)2_0ZV']H6DR>S6XG7WK_RR8MFJ[),4D2;P<$<AP8&1Z<BLV723
M7X8GK/&_4/@=7RIJ#_.E_N$D5^QRHY<C2(ZEGC 4 <_:N?+%GADIIGI]/Y70
M3CMQY(R_-/\ H"U\M9F24E6 $GL/XOO73Q2VI;CF>1T*UC4KX'=KMORP6H-$
M>P"JKS98OHG!I5C@HQ?]11]A^*A8;25NK[$5.Y21JR1>.#I\D8--39?E?2HI
M4<J'8U;Z\(+VLYO^%9-7#_-^1_:].L,%9>4"A&-RAP,^@^HJK)JG)4NS=H/$
MXM/>YCF<6U$-(& . />EA*3Y:-N:<(K:F(0$(:?+C2"0CS+QZ8[4^1W'DR:?
M)CA)N^PQTS'(@HDRD*)DE2DCW'M].QY^M<749'+6QA#E&WR.2.D\%J-3)U49
M?PI?T,V?I5$7$D24-[%*=+F,=P3G\Z]G"3<%9^-]1)3SRFOEM_U"B7TQ@76W
M-(:1D[<9 [X[T.7V*I(Y@ZB::5IO4LN,#O;<=&TCL<5NPR*U)],5Z<(2;HHJ
M(X%1GX#_ %HNF2641VW$J2"$\<U@:99*AA(0B3X:HYVGUK!E_$9Y*^B0?CN,
M6Y0>5RD8(/H<5E7,^!TJ13\]*7]1MJR"$N8KO8^,97:W%_Z5T^X;(#X.4EHD
M9'(XK.\2F[+)9*Z8 7734E4QM+4,^(%G>H*QNYJOF'"#<FK;#*VVF7;HC*AE
M)P#M]JRRQ>K+W((Y$OD?Q-4W2WSFP7=H['-<_7>-QZJ#BT:\.IDG9:%@U9*B
M0GC'7@RV]BU#L:\'KM#^ZWAKL[6'/NC:(*=='=Y85WR2#[YK+#3_ ",\MJ@.
MU S((<?;0I2@,X S7I= ]T=C9AU";7!!R[Y=+$RRBX1W8KCJ=[8=3M4I/N ?
M2O18,$NT<V62F#]]U+<9T4GYEU23QS73PK;P(IN3L&8>YU25KW$E7KWJ[(N#
M=BD$Z+LJVNI=:6$J2/>L<L6\,DON2T7K%?;:E#4=Q2P.^[TIL>%P,&22;X)%
MSK%>EM!2UJ\WO3N,M_ L::Y)70_4>==+Z\)!R !D5SO+9<FFPO+'X*<L-_M2
M+HEZN89LYD.N[ $8RD^M?,\^;+K\FRN;*YZ>5+@Y8Z[:\5=5KA0Y!7G(4"<\
M5]$^F?%_N<-TE39NQP]J156F;2X_*3L!Y SQW->IU&2C=CQT=)=,--)V)\4X
M(]ZX6>=RX-^&-%I36!$C8'9([UF_4W5P5SJN0TB.L$C<23C-785R8\ZX VRJ
M6Y.*DI*1D8^M:9]&2/!8%N964;5'&_O7*U ]-AQ88.Q@*4K -9XXVW;16ZZL
MCM5L!&XH4.015D8I,IDD",2T+>8RM)P3^M;H0W+DSS0/ZF2S''@!.W .<U=C
MBUT9Y)+LI;6T-$@EQ'*<]QVKK:6;CPQ$KY0#.Q&VCYU 9[9]:Z>Z^B]?F)PI
M0C2B01C--D5H3)&U9:.F7V)B6DN.-Y4C&U1[UQM0I*Z1EM7R$-TL$1R/A'\0
M].U98:AITR6K(73^D%/3#&\)8W'WQ5V74^VB(8K?);MNZ2W5N"A;4%M84/*=
M]<N>3))\19JA&*(V[Z*U-:5!28B2<9&QRK(1F^TS3"44^QHE_4:(;K,NV2-H
M3R0LXQ2/ MULZ6-Q:[*,ZB$+EE924Y4203G%>@T'$4D9-4E? *V^*7Y"5;3M
M/8UT,DJ5F'(VHT6-#TZJ7"2MDE1/&4\XKCY-5MER4>CN7MY&3MONEC>\BSA9
M[D58IPS*A5BE"2X)S3%^,FZQHLD;B5#FLV?3I1X.E@I]G46G].P';:VZIA"E
M;<X7]J\_DPRE)HV/&JLU_8$/_P "9_6LOH_F5;44/_H(<;N())<XP"XD )^H
MQW/UJ7]7IP_"8X8FBS]&]*HEJMFS]\J3OR2K&TI^E>4\G]13U;44J1JA&@CF
MZ=3$::2T%E\G)&!LP/?ZUQL&KWS;GT7+@=7)C33>A[:W;HDB-J6).=:EK!_<
M28J@%(<4/^<0H$#'O7<]339,#OOX)MH'42'EE3K@ 6?,K[_]M8H));'T-!\C
M.=JA5L96XH!:\G KIZ+QT,_?1MC"U8'7[5LV0VMU:E-)/(X->HT?C<>'\)7D
MPWR5%J:]39<HN,J#@1R4D9!^E>LTN*.-='*R0DP2>A/KCNRUEA+A4 &T9"CN
M.3^G:NCCR+IE/HNNA)4-U+25KV@'DY4/+]_;\Z99(Q=B>A-?!LBW+<("B$Y&
MX<YR.<?K@U$LJ7(8\,Y-DQ:K6PPH2% .)4./:LT\YT]/H+YD.EVQF03&6ZEE
MI\%"G-F?#!]:2.5IFO+HL=<]D8S9%'YB,=JO$"0E9P,!)[_G5[U"2.<_&Y&[
M@*N6);*=X3O!Y'M41U*+)^&S15L,NFNH'[%=&4!?AA"D^7T//:N-Y;3+58Y+
M\BN.EEC='4VGM71Y333:G$A"4[\?7%?*O)>+RXY>Q&['CDB1@]7TZ&N@U!"=
MB/+AI7NCOHWM/H4"E3:Q[$'TYX%;O"^-S8<GJ-=IK^97D3?#.4>M'4=S5$MU
M$%:F$94E"$9\,()R$I'?C..:^E^)T"QK>S!FR-^TJUJVS3.%J=CN-2BHH\)X
M>&H+ S@[NW'O7?7=)F*5]AKI#48A0649WK&4D8["N9JM-NEN%Z= WJEX2KL4
M--#<H_B'<^M;-/';C5C);G8MI^,@.A\D$$X"N^[[>]5ZB=]&O3P<>RQK&AUR
M0VX%E(0.?7%<34[4;,SX+%T5=G;9<VIS\=+X:7N2%_A5P>X_.O/ZQ1[,,?Q!
MF+P$Q!AQ(659)3D#'V_/^E>6EAC+-NHZ&-I(C5:C7&D?N9 (/Y5;+01RNY(E
MY$3]NU7)<*"%Y4",8KD:K11Q](TQ>Y!Y9=2R%/AQX$^V:X<H>E/U%\%L52HF
MKGU"G6UI3JXX<;;&4HSS7IO$?4KQ34''_G\A)XDRK;_\7L/3LEQN?97DA*B!
MSD']*^K^/U,];C4DER<C-'9)C*-\<VC'1_K<6:W]DDC_ "KHK'DB^C,YR9*0
MOC2Z9O8#KCJ0?XE1U #^E'I-D/))<$JS\6/2J;P-0MHW?PEL@']!4+'L>X/4
METQVU\0_32:VIQC44+:E6U6Y1&#]C0Y+[!O9Y76KIW(2=E^@*4>V%4J;NTJ!
MRW*F7+\/$J-J2!=-3VR1&,*2?V6AT\@G.Y9'VXK)JLC:.GX_$BV+IJ'3-D0Z
MNY:C9:2T?#!0,!0 [US/@ZFWD$9W6'I? !$N\.2R.Z6UY'ZBJW9:D@?F?$OT
MKMA/AIG/#/"1N5CZ<"JV_BA]T5\C"'\572M;RWWF[@RK&,_)@@&D8;HOIB3_
M ,3'2"4Z')&K)3..Z1!SG]*5^E]W_49?J(_Z>^D=R_<PM6S%+7P,V\TB4;]O
M8[JN6+0M1Z)N+2G8U^>45*QYXA0,_D*L4I(K:BQZS;FY*5*@O)?"OKC'ZU9N
M<NQ*HC[I8Y:XRV9-N#K2LA7DW<?E2MDT<X=4>C=TLEV;UYTYN+UIO<(^*&T#
M:EU [I4GUS[&M.#+3K)S$SY<%?YB'73_ *DZ?ZT[M*ZU9CV36T8<(!V"2E/\
M8/97^[39=,H^_%^'Y0N+.[J096\2+"^JP7EHM.(Y:<7V6/3!K-#)%JD6L'.J
M/3:!KZU.-1D);O,-!>CN8Y6<9V5;BRSQ.OAE,H;@(Z=WB]Z:C)L\EQ:X,L>
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MV6Y;*FT%G#K2B,G<.W'_ &UKA"4,O KFFBG->3I4_5,BY720X^^^05N*[?8
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ML:(JY=3]7/,JD-:5G>$$DY#1*L8]!5>]EBQJAJWU0U;;-J6]*W%;CN"$NM8
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MW6EH 3V^];(:A9%:-.-**"!&KNH+VBIW3N-?G6=/W64)<V,VD),A03@)6O\
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M@,J]#G;^E5.)8F-T1VF'4.B$AY]L8;5R< ]QWHI$V2,>WSKPXDS(*"TGG;@
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M-*J%<$QH_:K6ZL[0G'V%71U,X=$;$(_W>MF<[$9_W13O6YONQ4DF*_W;M6.
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M^?S&_>$-W/A\L2O,(6/O42\)I7VK_P"?J,M0J$A\/EI PB$,54_!:3_L_O\
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M73%]DL8L^C'79;^Q _9[N&TA.25;5BB+3^XDG3Z 27TCCS(DJ7?],Z-3\N5
M)9M[Z=X!QD87VJU)7P5[E\H5C]#[2TPA4+36DDN* (Q"<)3GUPM7-6;N;&M?
M")V%T]D6YF7'>DV"&B,M.?#M+9"O48!![TDJ;L-[1ZW]-ILQI4A=ZM3*GGGU
M!;5H9"@DC@$X'8\U-KX%W6/1TU1'3'8D]19R'D1\N*APT-;$CNH$$^N!FI38
M*J%;?TY@0&W9%\U[J:4MQ3:RVJ0EI+?/D3A(Y)[YSZU.[\B*0RU-I/3J+#<0
MW?K_ /-*1)6"+LX"A7A^W/(HW$.'%@ZF!^P[7IZ$NXONNJMS*)Q4H[=[A!!
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M&[/>7':C:!LSM4-I')]:<#9UMM*=N.?>H :EC)SD8J: ]\O]10!JIG;0!@H
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M!R*843<X.!0!E#FU&V@#13O)YI6!IWJ ,&@#7)H ]0 K';;=<#;BP@'^(^E
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MQ:R1?(_">?2MDNS%#H;NYYJ"1%6<4$,T4K:/O00ANMXCWI>1C5M[<=I[_6H
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M=0QODXEOEQDNV]"D/%T..!+84$^5!2KDI';WIX<RLHFW5'8"DX*D^(',*/G
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M\GL"@C:6+M45<"KBLPIM!'/<?2@!/UX]* %$I)\P[4 >4IP<I[4 ;(<4KA5
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MB0/SJ:86(>,CWHIDV*-/*2.:@>S.\4$/DPI0!S4TQ>C*'4[N30N M"BWFRG
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MHH8W0\XCDG&?K11#="GS:OYA0+N+)!*SC&!6@J-TH SDT )K0 >#0!Y((Y%
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M5D?[7(4,?TQG%9T_49;'HE[]TD7>9QF6I,B+)\(G>QR@D=OSIE[73Z$;478
M]6)>H^G6GOE=07%Q3KB1X1.05<=RD?Y]JG#B_>)>TC)_DKU&<NW*^W*_3")3
MSA!)/E<->BQ8(Z>*;1Q\NIEJ95%AQT[T"]<Y'C2%G">4'&[D=N/6N?K-6NHF
MS3:9QYER=.Z/TZG3UO9*;>'9DPI#33+)+IR>YS^$8!-<N,K[-[5=%CZBU9;^
MG.EWIEREL+FNH*4H)PM*".$D>IS2N$INHCJ:@K9QI?;O<==:A=D3)JW\.$(*
MQNW G/8]@!V^M;8R]*/!BE>21;F@]):#MD!3\@MMN;0&4)2%.>*0<DY_]!6&
M>:<Y&J&)05CX:96U8HXL]P@S(+[*DRD/C"HR=^?Q=]^23^8J5+[DU]@CLO3W
M3Z7W4*0T]OP!O;!R,<=Z9MODCA.B9MNB;;&DNHTK8B9B 4/OI:(2%>HX]*W:
M;&YG+ULU$>Q^F6O4^=%M4!^+CC-=7FCC;V_@<%_66F@6WK4M"1W42<"E;7V+
M5.5"[.II3S*EJ:_>]\-K()J+(<K-[7=M0R'PXS:7'$).<;N]0VQH--T3RGM9
MOA+L'2LE(*/-AS /ZU%O[#TF"TZ[:IA32FYZ:F$=QA>[ J+8\52%VM1QI#3Y
MG0Y<-+*-P2L9*_H*C<R6@'UP-/ZKD/.-15Q6U(R&UCS)X]?_ $]:.Q>F4M?-
M 6-)*_FGLYW=JBJ)L&XM@A0YT><S+VI8<2ZV2GRJ*3GUX(XYIG:(27P7/?G[
M]\2.OM'W;65MM<&W)EQ; @VA"&%K;_&X0@'>I6P'S'@4F6=^Z0^&%2VH[5L]
MJMT9F!IK1]F664J0Q'B-(W!IIHD;=P_'P 2H^^>]8YY-[I'047!>YC'KYIIW
M7^@[O:]/7-^)+B-[S#W%##[J<K6P^4X*R0G/FR.!3O%N7#*8M7R?./2C&J-=
M:E:T1&M;\F=='-[3KJ"?#7DDEQ0X2E SG_"!31BJHLEP=%1^@^F^D\/_ $@W
MJ^?.1(@2E$V6UX28ZSQO2UW<6H9+8'/8^M"BNQ-U$%=?B6F71!M6DF188S7D
M:EN JDR&Q^%1'*4$CD@YY]:HRQOHOQ3^X+WJX:OULMAV]:AEWII (8:D/)4T
MTI7<I2,!)/KZU3<DJ9?2ER1T;12KE*=LD:R-M.1&@^I9/."<8S]ZASD&U=$>
M/A\FZ@N[K LDAWPDE:G4=DCW/H:MAJIX_DKGI5)] W.Z<7?IO=XUSL+A6R'@
MIUA:CDD'MCMCWII:GUEM:&6*4$6C?.JEWU.B.;I(B1E)9#:68[26TH ],)P"
M?KWKGY(4^#7'KD'7E6.XHE,7"\ML);9+@_>K;6XKT0DH!.3]J6.Y/H64DB!M
MO5>]:>@KL@U.ZS&DG>4M/*2E0'&% 'G@8YK<L4Y+A%*G%_B8M%^(299CX[-S
M<<;2,A+:RGC\J(:#43Y1,L^&/#9*,_&S>8<946',G!*^?#Y4!^M6Q\7J7(I6
MLQ+Y-(?QU:_<2OYYHK=&4H?;&UW;Z J'-79O$RCS)_U*H>1<I;4B.G_$1U@U
MDL^ X(;;GE6^X204GO@>E43P8\4>R]Y)2:9>_P ,,JXQ]4LKU#+:?:GH?94K
M (R$A6<?E5>AS7F,GD\7J8TT=$7B7H\3$)DP(3Z$]PIM*<#W!Q7::C->H<V2
MVS45]C#+6AG]Z+.U!AI6//\ O02KZ I%+4?@5[OD -36KI\V^XVJ##4Z3A2G
M'%'=]15,L..01<@5F=-.E<_]]^SHBEN !1;D%(^V*J>EQL??(9/]&>F"8NYF
M/+0__$42=R/R]:KGI8I<"[Y6"5ZT?IBRLJ3;I#@(."%G-4+ BU-D-%BP9"BC
M*R@<J*FL@#W-)&#0UB%R>L$!]*;4ZT^VI/G*62GS>U1*+"/9,V*;9;D\Q'DN
MMLI6M*%+<'E SZ_2K\2KLEODN[475'3S%B:T7;KO;9C+3(:4\V2IM7'X<* _
MRJZ6515$[=RLY]ZAV&R/PUM(:MZ!@E/RS24XS[X%9%/DE1*A3I>X)65M6T3&
MQY4[L^O;%:(S!QL=V2Q2;;+\"X05-/I("$.J(./J/\J7)*T(X,.U:9;E-AQ+
M<9/'/[S!JA(LCPC1K23;0"5MQE8.<*<.#SVIJ:(;)/5-LA7IN(U:M/VV*U&:
MVI1"04>;U)6"2O'U-/N$7 (2>G]P?0M09=;'\VX\4>JH\D2Z 6^:;OMI?4/.
M6_0\]ZT8\L9$)-D;#_;164@K) ]SQ5DI1+(Q'42UWB:K:ZE:LG)PHTK<1]A-
MHMTZ*QA#1&/<<YJMR5C4TAB]<KI#.P(_BXIDDQ&6[8^G$DZ0;UK>M:6NVQGF
M"41 O>ZHXSG![&A17R/\45ZUU%O,8[6FMR <?<5/IQ8K)NV]<+XK9$N9N'RC
M:D_NTNJ5Y<\X23C.*78D5A](ZT].),=:;59Y:6V^ 9ZD./.*QR2E(VHQZ $T
MW'^D16N65W.ZLV=5P<#,%.P^@2,5#4QMR#C0M[TWJ9 2Y!8 R K<VD]_RJN4
MY0_$3%V'+&B-$)E)=;9C)<3Y_.PDIY^F*3F?06 74OIY8I\EI]^:PH%64I0V
M$H3]AV%"R2A[;(=42ND^G.CD6W?*^7=4$CE>":64I/Y%B^0?FZ0T/;[\D>!#
M*%*'.T9[U/J3^Y:U'X1==AZ<Z2D6]#L=J,E11QM2.]:H*,E;1FG:)MCIRL)V
M1'=C9XW#C%6)?812'Z.BVHU(^8CW0.#&[9NYH>*4D6*:0PE]/->PT+4VEQ2?
M0MIW'\ZI>&0V^))672&L5QMTR*\L@\;TXXJIX)$.2',RV7F(? =A'<D9^V:E
M8618S<EW6,V$F.,CW&34RQ6J+$U0U5J&>.%16_\ JUEGI[^!;$F]0S$.APVQ
M83G\A28],T/ZI$7WJ='LZ/W\=0.:;)BVJV2LECS2_4FP7D@/Y22?:EA&+^"7
M)H-E,:9>V.^.OS5KCIUW0OJ-BOR>F?\ GE_K3_N\?L&]E$.-=&HNUR/%MB1G
M*3\V3N^E4R]%/HGD,M%:7TW?;3<=60;=9(MCMS2E29<E9\(G^% 4KC<3Z=Z'
M/3P7*(YZ(N!U'T('5N085I=4VP4J:<9\N?>LV34X(]1&VL F^IVF86HVY+S"
MT-I.[<PR4I1SV'T^M9OWC'NW;1J=%FJZT]/[C&5-N$IIQUI("#(8RXL8X^]:
M7Y#226V<?^?S%V,CKG<M!ZCM4>[.,1VXTI>Q#C32,[Q_,.Z?N:9/19%Q_P _
MJ1[D0+[ND[4VJZ09#9;WXW&*0"1W (XS5;_=8.HD\LF(W5[3%JM_[3,1Q;0[
M$CRJ/MFKI:C&GT13&L/K_I-R0AWY60TXDDX2WG^AJ'KL<5Q$(QMT%\7XE-)+
M;!39YS[J1CB.D<>]8LGG,6-U)C^A8NGXCH2N6;/<]H[!I" ?SJ'Y_3R7N?\
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M\%I(Y&Y2.%YO42PXTUT=G3>EEVN,=(-S9:&5);SG*AW[CT.16C'%J$H/X?\
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M=J0@>?GWS]ZZFEON#HYNL@I+D)=;]5^G/2MQI.NKC%BSWD[TP5!1F):[AU:
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ML-\Z-]:+D=,W-V/&U/ %X>1'7M\(J6=XY]-^5#UY-=2626HQ;XG+EBCBR[9
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M0.C^M76C1D9IJ?I5Z5#X27&4*0M0'OFICEDB=@073XK;Q*2IB;I2<VH _N\
M ?<^E2\S9'I) 3"^(V\-7!UZ1;),9DK[>)N./MZU6LC3&V&VM>N]FUE&5:Y-
MHF%"T!"U)V)7GW&?2IE-2&C"BG]3:DU1+D)#5WN<EEH[6$2I2E>&WZ)QG'Y5
M"IODF4?L!EW1,6^9TB:B4XO_ )$*)V'&,X[5=&BIQ9)V324>Y14DWMA"T(&X
M.I).?88]*)3KHF,"S]"=/XK;(5)N$50QPKPCS^M4N98E18^DNDUGU/?F[>I^
M*6%#SJ\'G/VJ4U+@KDVN2R]0_"?TG8MB75IFA]?&YA>W'U&?6K'A794LTBO5
M?"6Z\MU&DYMP<;5V$J2V3_VTKPOX+89%\@=JGX;>I^G',H=05=MRWCV/IFD]
M)V7/(DK!G_13U&AYDR[+(?CI_%X3Z03]LFE>-HA9$R-,;5=I6H+LETC,@^7>
MV58_,<4E4-9I_>>8VK8J1(0L<GN,?E106+IU@^\UX1FE>WMO3S^M(X7RAURA
M$WWQU .*:X_%G'-1L9-(92Q;I2O%?WH/LT@'/ZTRDQ:1(Z4U:O3$DK;;(84?
M-EOL/OZ5:I5R0XIHO/3/Q%:?M4='C+(5@<I4<C]:9:EHI>*P_L_Q@Z \9MM^
MX/I4!@A2,@5;#4[G3*Y86EP$[_Q(:0NJ@JWZD:&1PE*PD_G5GJHKV21K_IMG
M(2!;+IN"U?B4X*5Y%V.DUV2$WK'>;7;S<)U_A[4IW87CGZ<\U/KALL!$_&9I
M]N6Y%N/R1VJPI2DE.?S[5/[RDJH5X'=BDWXB>FUS2'Y:HX0KG!2#W]OI1'41
M^42HR0R5U)Z2N NQ),-A8&04@8!^U1<1VID='UKTUDSA)CS[>F4DY2LHQD_4
M"BXKD1J1/V/K3%M$]IERY6]Z-NP A'(/I4>K0RQE\V;J1T_U%;T&X+B%9&%9
M/"OUJQ9(OL5PDNAQXO27_P 'MG_534WC"IGSAUUHAMYM#6GK:Z^(K?[QYE&0
M$CU/KQ7'>>$2[:5RS89:4X6XHNY_&G(*D^V*;]Y@ER@<!.5IN9,<0;6IH/H!
MR59._GZT0U4(JB-C"NVWC4=@CQXJ8ZRUQXRTGU]1P#D50]DI;DPIK@O'I[KZ
MPQ+<M,ZZ!#B\ ^,YM_X5JQ:B.,C:V%:[EHB[J7*>UL]#+396@-KW)6?8$'M5
M^^$O=9%-?!%SKGI%+ 9B:V6F3CA:9RPKWXY[U#E&N&3S]AC&UOKRW(<1:M;7
MAV$/,ZO8MTE/KN4E)S692DB?X$6[JJ(U<9+T>[3EE0!?D(;6TM2CZ86/>H<I
M=DTY<!=IG55T>A?+LW&=X*SRM+"]_P"9 P::,I,1JF/Y][<985'B72Y)D$82
MI3*B2?H/6G;E\ X,#'XNO+K(5&6_JC '!;CNH2X/M_QJF3F&TVL]P^("W2%L
M0+IJF.TS_LP6'%C'H.4G_.L\Y9K]K'CPAQ+U1\2+WBOKNNKEX3C]Q&4"5>V-
MO%5/)J/N-_ 3C=1?BBBQFH#8U&U@Y+J8REDY]%<=ZL6;*O@5IAAIG677B6M7
M[9N&JW4%80VA%L7A2CV&0.*WX)Y)\M$-,O/3]ZUK9'HK&I)$YG>E*PVXZ"H@
M]\E)*1CVSFMFZNR$I/HMK^^4BT6%R].HFN-,MA3:$I*G'U'@!"?7TJ)R25HL
MPP<IU(?:1CZ\G3(EXF:K\6#,95\];>%-L*/*$IR,@\\GWXI%N?-ELW&+JBF(
MK]YU5JFY2+G'<N-T5*=:9BNO*2RWL60A:0#_  XSCUK+.;NS5C2H1NVITZ8U
M]IV3:V2Y=0X6[L@?@([ $>O\1P>U4*=LT.'!!V:QW7^[^IYMV:7'>N%T/R9=
M2?WOAN*40D^HP0*?;\B;S306HYL.]2D+/R;3S"XQ*A_,,'OZU*M"RIEJW"VS
M-&:;>OKTAEBVVF.F9*4AS!2TCD*P,C(!))]:?D2TP9N^K[%>4,ZAM]R1.@W&
M,I,6:V$)$C<G*2HIY'Z<D5'R3TN 5L\5[Q/GI,MN7)2O84(/#8/ (^H-39"=
MEW:6L-F8M[,14,.2I:3X;RE%*65$<DI'XB>V3[TT9"9+7)%WF'JF:[*@*TY;
MG[BMQ:;9"B/*WRT-IRI2B?PG 2/_ )-658BKL$;]U'<MZ1;E:;4B5(@(^8;=
M!9\-9&3M_F"3QGU(-1N&<:Z"KIG<;?JVUJD2ID@/QVPVM*$)0D*W9![<^V,U
M"2E\D.4H](F.H.CF7V&[I9&3:YD4E3TAES:."-NX)X.?0^GK2S7PAL<_N5S>
M]"7#5%M>NVH[Y AW)7[B$7W4-EXCG!P>#_BQFD28\I)D_P!%[\\FXR-'Z@D1
M7DQD!;:GGR5_7"SZ?05?&<NF9IXUVB\Q:M+I@_.)\-6 C)0Z% 9^G>K=U<LH
M<&^!*1;;*J&M<@-)8 R?$2DA?TP00:EY$U5!&#3X.9?B^Z362T=&=2:YT9:K
M+ U!8_ D,S8Z"V^MI3@"U%*<)/XL8P<8S6:<$N4:\,FW3./M6=0>I?3-Z/*T
M;/=NUK=CM.H;FD[\J0DJ!4GZDTE1GPV;'NCR@.OOQ8=<+@Q^S[58X\5:^5*0
MXXM0^PJ8:+"WN<RF6HR+V[+!"+*Z^=65OH5K*6VMA0"[<)):=2/Y@WW4G\ZT
M2>FPKJRE8LN;\AR]\,&N;DA+EROCDIPG]XA:UJV'UX4<U6_)J*I15#+0-OLC
M9_PWO6M9:?N;A(YR D'^E+_C,^MHW^%)\N0RE]"3%8$A-S<4G&3N1D_YU9'R
MT[I()>-C]R2F?#/JAFS1;[IRYLRGWN0RH[2D_P#&A^63>S*J1'^'/&MV-\A5
MH?J)KKI,VN-U.T'+?LRE);\1IH>11X!P.XK+GP8=3[H,NQ9,N+VR1:-JO6F]
M2V2\S-":GEJMMX4I$R&?W:XBL<\]P#]*PY,;PKW<?QNS2G?12/6V!:M+V:WB
MQ-.*7'5B2X!^'/;'J<UTO&7F?)BUGLCP4_":=DJ:M,%)\:4O>\H<E*"<J->I
MS95I<&V/9YK!@>MU/J3Z71]3_@#UY9/]&D_I>S$8<79U)FPMHV+6TZ=KH)'I
MOV_K7G<.HR9Y2G=;3NZG"L.%)*SI/J!J"'HK0MXUC<;?"A,Z>MS]P5YB=J6T
MY!'N=VT 59S^\JS,I[L)\P?[.[1L[J5\2]SZER%QVQ867[RI3I"A\W)<.S;G
MN1N5^E=#-:@Z^W]RB$DY)/[_ -CZBWR!I:\-O:<6Q(4RY$+C@5Y"^Z.?R(5[
M5R\?^6S9-.1SA>/A\N=YESW].+N)7&)=7&>8_<I1_OYS_2GWN<NJ*W!+Y*UM
MANUCO+L&0A ;&6%!"PHMG(\V#S_\FF17*)9ETM\VU6-K3@BS8^G+K-1<4.$+
M:#A &0LI_$C<"=N/6I:X&QO^8ZUOH;IYJK55GFZ'U.&4,89O";0TM*$J6.&E
M$X.%'UYQ5<Y*^"W%B<NRQITZ)TFT._JZ*VS,F.N,6V+&?<V)\19P0H[>0$@_
MA!*NW%)+GDM:VO:B)MUH%\7*U9?6GD16W%3GOF$X4L)& X4DX0D !*$\D#OS
M4+V\@O?QT&=FNHDZ<=U5?U)2V^I+C:D_CR.4M(1[4G?+)7M=(@W8VN9FC[AJ
M3Y2.6I,AI#3;@VA+:G!A0R?,1WP1BI3<5:1$Z? CKU-P7(G6J/,%UM:VDROF
MVW M4*0A('GV]AN/Z&FS1:@VN1-ZDJJCD[6>CKMK35;<K6LV7:++;6U*G7>,
M\$M-.)[#(\Y!'? KA>-QR6IFWQQ_N2U:H)+?J*#'TPA>D;V]<(#$CP6993@O
MI_FP?-CZGO7'\EKGIW.),N50G;-1ZAL=^;OLBS)D0R<!:P3D^H I/&^0R2QQ
MC%69'':R0O&KI.K-0L*TO8D6"-%'BO;72I;CN1^\)(P/7@>]>[QW&*75D[VU
M30%=9>FG2VVNV_J%/N?SBKD\&]0VCQ$LESG]V6#ZJ/J.^3Q5^73224DRS'J/
M]+1S5>-%(Z@ZNN5OT+H.0BW^=3$1I8<4RVD>8K6<;2!WS5*G*'3LO45,9VW^
M]NE='W[16E-+6F1_>)"$2IKT%,F<VT#A33;F#X23@9*>:MAG;=MT4YM/NYHJ
M>5IS44&0%2+:\%;B00C 216^&:$U3,KQ2AS0M_>?6#-LCV,Z@GIM\596W$#Q
M" L^NSL5?4U#QP[1*RRZ+NT3JG0VG^C%RONI>H4QW6TAPM0+0@E2T#T*O3%8
M<NGADE&N.S9CU$X1?R+Z+ZE]=]:Z)N<EWJ/:[;I^RH"GV7%AMYY>!Y6TYRL^
ME)J,3A[8\EF#)ZCW,E.GFH>I'4\M6ZV,R9SB3L=88"@2@=E.'V^E<[/BC"6U
M/DVPS??HG7D:EA7_ /N'+L9?OTU7^I6Y#6Y)0>%./G_DTI'(%8Y:>3Y?!ICF
MC+B')=MLTLWTZTNY;HLI3L^9A<Z6ZI/F7C (/? [#Z4ZE&,=K%Y;!+4>OXUF
MT^WI'14T.SY/%REMJX;4KA2$D=\^]5SDG&BYI222'FDG/V*B(RPA"%;4)4K!
M.X>HQGUSD_6J\>=PE;(RXE)IKX(CJOTR1J:6YU+79A<&EQ392'5*_P!55G<E
MQ('\1Y'L*]EXS%B6AFWRZO\ D>)\WJ-1#5P<?PWROU^?X?8JZ+TUL;=AGIN#
MDAM]#9*7'5 D$#L.U>7EJ<GJW7%G85>DG'EE26M<P.*81'\7PG% ;$Y4H#Z=
MZ[$JDE11",H\R+'L>CKQ(LC6J'V&E191VMLL)\60D^A4D=A6>2KD=-=$CH>^
MZ5T_,E/W2#$5<XKA(^92I#B>.U(TY%BH((G4CIIJ"Z?,Z@A;WVO*#(&]A('N
M.^*B,7$G@S=8&FY>I+?=;##,& M80X[&;\-L GN"><U5N;E16DD7WHWX8>FF
MMH NC.IKG\VHY)W)<!^^1C%:_0I+D'.N!'7'PL?W'<=O^E+O;;A*+12A%S8"
M@"1Z)'ES[''%++'MYLF+3.2;U;+ZBZ2S(>\)XN$.)9\H)!YQC@?D*BZ+;H9>
M%>8Z5[9+^U*<[BK<1^=2DD(^2PM)W?0S-@2[J!IZ1/2@[?WIQ^GO54D[X",5
M\D !8+O)<;BJ2RI:LIW#8!_TCWJ-TD-4?L$&GY=NTY<VY'S\?='/F&[*<C_.
MD4I;NADE1>ELU+IF="1<IE]*I0&0CYC"0,?RXK7"5KDAQ08Z5Z?VO7D;]J0;
MB&G">Q92O?\ ?/:KE4BEK:)ZU^'#5MT+;NFIUN:6T/Q/,(VD_7BDE!M<$)HI
M:]?";UDN-P<G2%VIY6=H+/DX^P%5^G/[#IHA9_PL=7H"0ZNUL.]_]DX,_P#P
M7_"C9,;<@-N/0;J0VXXIW1MP?4@?C2D+ ^G%%R1%IB!Z/WRVVU<B59[U"E$;
ME)0T< >G%0VWR2DJ()4R=:UIC&Y7"/)0,*2^O: ?MZ4C;)VA=IKJ%<K>E#$&
MY*6^O&YUXC*3Z[3[4JFTR7!,L_3G6:Y+'RU_7)6TGE+J%E63]1[5>M1**Y16
M\"?0<Z;^).QZ?E)3(CMN#=RM;1WC[4ZUL?L5O231.ZL^*;2M^M_RD5"4/*&$
M_N0>?S%.M7%](2>"=4RF(MUU;J._JVRK>U%)WY"5!6,_I2[]Q,8[2>N^I(5D
M8,.YO+<4@'<G "557DKX'Y^Q$6"+HO4T@K$5I!=\I*FTG!_.JD[?(7()4=#-
M"(2Y,GRD.HQG;X.T?JFK'!)=DIRJP)G=(-#WB\F%:5>#E9 PK('ZTJ2?R++)
M)? .:X^'PZ:B*N5FOKLIM/*DD%/WIY)1Z'C)R!>WZ#N=YB QG ES'E2MS(4?
M8U4FVZ2)NF9<Z/:L<24%ME9/9*%C-6[)_8:R+N/2?6MM;5NM:ECZ$9 ]ZC;)
M=H64N"$3HK5C \1,$GW*584*.1+-VF=26Y6YQVX(4GT^8X%))OH9-,<2-3:D
M4RN*[+6Z'0$@.J"\_0#TJ$E\L9-(A+EIK4D"*B<_:7UM+Y3XB,Y'VK1&J)W#
M2%#U9<3X#%AG/([ HC+X'TXJQ13*W(*H73O5K<93DG3UP:PDGSM+'_"EVLG>
M@;<LFHA-6Q;[5<''TG'AI2<TM7P1:'B+=KNWN)=-DO"%#_VRK_LJ=A*:)6!J
M?J/;B'&D71D Y/BM*(Q]*246AJ3);_2?U%_\(?\ _%*I?<12/I+<^G/0<^)\
MM9;2'-A 4$K8('W'%:/1TTN:*5Z@$QM"])8SBVY]KMDM@J\A<<2[@^PPE*OU
MJAZ?!/BBQ;@HC]+?A_N,7QSINVEP#:<0E^OUH_=-.B-TAQ:NE/0#3$@72+8(
M;2D\X3%=//O@Y%2L.GCQ5DU*7(6,73H1-4$3+-;ED#!+MJ&3]\(IU'3?]HK4
MT2D;3W0Z:@KAZ3MPR" H6Q.U0/KVS4^AB?*%N0F=-]%$Y5_H_AJ4!C(MJ,G^
ME'H8T'N(?YGI]9Y)%KT-(C!9PE3=N2C'Z#-2U#[#4_N2J[ET[F(1^T-+E@8R
MMQZ%A)/^(D=ZB48-51,4T^QDSU Z46=XQ(UI:41Q^ZC '_(414(E<HML53KC
M0DN0'6=+/R"DY!1$R4_F1_E31E#[%C@Z[)=SJ/I6*T,Z0N))/"BPHD#Z5+<'
M\">FW\DG!U[87V0[&TU+2A7_ #C'F_RH4HKBB5C_ #-W]6VT%#2-$SW4/^;>
MEO ^]*]K_P!).S\R0A3;4H;8]B+/N".?S^M3+:UQ$-OYC344,WB +.W993,5
M3H6OP'E)4KGL<'D57OE%;4N"8QBG=B2M+V6!*;DQH:U^(E#89>1^(@CCV_IF
MH;HMC3*LN#5\>ZP7)R^7B5:_E74JM:7%^&AMHI PVD#')SZ&JIR=\FC&EMX+
M/9ZA62PZ>_9STU3]TBH>6EAQ(5)DN Y0C QDJ..1V%71FJY,TX-R*]T;>E=-
M]-W;J7JRVR6+B@NN1XIQM<DK)VL))'F/.3C\(!-4RC2MFE<TD4JQ=]5/QKKU
M@?6<Q[F)1;2E(3O!2E0 (Y"4J_/-9HQYLU2:J@GO.HIFIK*VJ1)<\5M 1&2%
M80TCNE20/XCGD^M:*M&>Z!X0WXMO^9E34K>:>47$$945Y/\ 3M11.XMK64J:
MQI^T:7E/EUMV'\WX89W!;;B< .#^(;APDU#ZH1/FRO=:);E:2_9S\6/#?A(0
MIIV&T&V4LI[CR\;@3^&E?0R=NB2Z)6J->&E)\=D/*="@P 2\^$CC!/ ]S1'D
M)>TN2^E";FQ:H$M4**4LN...L*6XL$X5X>,8*3S^56J/)2VV@?U'J:^6:-#8
ML[;04[>VH+ER:6-ZXAY(SG(4L]\8QM%/)N*)BD^QMK#0)U=KMVZZ@<3M$1+,
M)ML*64>$!O8P/XB=RN?YJH;W,MBU%!/TX3IQL^#I*,P81R'T[2%MD'!"L_Q
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MSGED>$XK^5I R2.235:W-VS;+TXQX)&ZR9&J)'R%C=?CV:"HNW&>[QXJ2?\
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MT47_ )TI-_E13JOVB^4E_P#RN**_6_\ 869T3IME"T.ZHU(]NY4'9RT!1^R
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MT6/%LJ-:K1;+S;!,7DJ++<8-,J<3SPH9"N  5'NK-.G[HLIR1W09Q_U<MG[
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M!QV^U8UJLV#VS?)IE@Q95N$+'\%+=T=$AW5R(S Y\K@+A^Y]34/R65<*-_\
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M'[]J6=5P-&+H#F+Q=@X'[E8'6V^Z=KB2<>E4)6-M![4/5.?8K@8$V&VGU:2
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MAS*FW>1=T62ZQODYZVDN"-N"CVY&0<'G->3G<9,]1!J4>#2UVTS-1*@7=KP
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MEU7?QXAX:8FN/-CUX3C(-2TER(VWT$B.JI96U'@KFNLK(3AYE04?J=P%1O\
ML2H?<+H=]B*;2_-CM1WE?A4H]QZ=JANNQJOH>-SU3E+"X;:T)'XE#*2/H*+L
MC:D1<R'I@I>7/MT=P+R=J4I2=WZ5*EP1LC8.HD:4:_?L6R&IY/"7%,I2L?\
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MU9;=%V=<=%WLSZH97QX3!.#[X]J64:)C3Z!JXJZ(7A$BWRK4N6S&X>8$/RM
M_P 1(&1CO2U$9II$=JWI%I.]Z">/2="(KJEI+<IE]0V >PSWJR6-5[2B$WNJ
M0RT;HW7,>U"++:82[&',I+AW$CU/'>D47'LU1<6^0=^);HU<-5])&46Z T]<
M+0M<N.@%*"XMU7[W/&2.Q ],&NGI-9DP1N7*./K]!CU+>WAG%VOND&I>FNB$
M:ZO3\5RVMW!-M<\'<5-.K3NP01V]*[FF\OCIMIGG9>'SN;BVN?S?Q_ JPZKT
MX!O3*?.<\>"KN*WKR>!*[!>(U?7'\S3^_5L1E30></H C!_0TK\UBB^$R9>#
MS/B30C(ZF73;X-LA-,'MXKWF7^G8?UK/E\[F:K&J+</T_@B]V9W^2Z!>YW6X
MWJ0'[E-<<6.RO1'^ZGL*XNHU&7,]TW;.W@TV'21VXHI+^_\ $: H 'GP@ A)
M(/(]S5?ZEW-]<F,'.,?7\JE438JVZ]'<0_%><9=00I+B%E*DD>H(J+MD1==G
ME27G%'QUE6]16I7\2E'N2?6K8991X%<4^4'_ $MZ@3-&7UB:VL[4*3N'\R<B
MM,,FY.)RM3A<)>K#^)UGJ>PSNHC%MU]HJ7 C.. ^+XS"E'(X)2M.>Q]!VS7%
MUVE<);K7)U]%FWPIF+#H#JZX['ULNS2+E/B+\-#092$N(' \Q//YBN8\<HLV
MJ:EP)ZQTO?\ 5U_9&MNESL>XN) ;1'0@*/U*TX _.I7/:)_"@UTI\*VIY%IC
MW*XW:Z"R<K;MCFP%*A_CSC^E6>G9+DDQ5SX>^EDR:Y\[>;G GI[M!05@_;'-
M0L2;!Y&D:7#X9>C,V;'=_OV]!?;Y *$(2H_XL_\ ;3/&E\E?J2^P6:;Z/?#F
MII^)*U$U=)K2=JE-R0V-WL A0HE&"1,9S;Y0.7WH9T3;8E2H<N?$6L% \%Y9
MP/<Y)!%1Z2J[+5(Y\U'TN_NNN3==/:X@2HK&5('B$.'W&/4_I5;CP3N";I_T
M#OG4"TL:ATUKBRM3%+#CC<DG<!GL<&HQXFV)*='3FDNB%R@VY#6HX]JNSFT
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M#84X#DJ;2"2L'U/'%9)VI<#KE<A9I^TW6+$3JF=.4S$;2W'D(;\ZR,]D]N_
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MX/"E+(R&4@C@!1&:K<:Y#=? !]0NIFIM*S1/2['9NJ[TF"RB.L.+844G>E)
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MRE3-.:=LQ7,&'EBWK<#WU)' JQ2D^@=#Z5KGXDOV>N9%;AH5XH<>2T@[2GU
M1FF;R"K:$UMZK]>TVY2G+-;0VXD)6H+&X'W(]*-TQ_: &I^M74#43C-IGWQE
MIEEPI4EG .1P0?I5:G+<5RB<Z_%0KJ!9_P!E:=NE\?DZ5D._M"+%*@MMJ24X
M4HD=S@C@^U=3&E+AO@H:7?R<^,M./*2TPRZMQ1"4I;3O4H_1(Y],U=+;$2K8
MG@_\H.?7C!IN'T,U7"/ X/%!%69*L-E(X/?-"_,BO=9U!\*/PAV7KOHS5'47
M6&NFK19+(F1'\-*%!8E)9\0.J5V<;2.2A.2>W'>J9SE.22ZNBR<HXXTES1S1
M<VH<6X28UNG&9%1(6F-)4R6B^P"=J]AY3D ''I30;$JOC_Y&Y.*L%,;OI1=$
MT;I=VK2K.,?UIX3%<+31VIT!^)?I_I7X6IN@M23EQ=06W433\-.WQ%2VW594
M?\+:0,*^N*KRKU(T^Q81]*6Z/195U^(&7H6/;YMIC"ZV^>V' =J2VE)[8..X
M]JQ:J\'M-6GDIJS5_P"+&Y6IQZ1_<Y#L=]D9"D;PE6.^ "0*Y\-0T^C:X1:&
M&EOC;B+>D0]46^2S!<.&4M(W;,^_M5RG]RJ4?L6SHOJUH"\$3PW"2P\?]O)5
M@I^I[$U;!ILJDF&LRY=(+];UEV-;WR\DI\1'X/KW'_&B:BP3:*BU3T&Z?7,J
MO.AKO+A7%M)*41'D>&H_4>G/KFJI8DU:'63[E-P>I']PW9VCM;7.09;JBAJ0
M\!GU''?/IGFJTVN&/V*Z>T#T:U&MQ5UNDQF8Z%.*<2[M:42.^#QGZ9IXP5<D
M-LM?I1:^A_3^,]:WG3)?<22VXDJ\17KD?2FQJ*[%EN?1+:KUQH.-;"]IGJ-*
MLJE+VE"W=S8_WDDC_.GDX_#(2?RBN[-U'OTFZ.VZS=2ENN(&Y*G!O;6<]@G/
M'ZTB;^XS2^Q,.]>.M%OE*MWSEL=:;_Y4M]_R(H<YE:BF/I_Q9:[TZS'_ &KI
M]B<D_B4V@!)_7BEED=<EBB"M^^/*_OW!FWVS0R7GU=VTE()^G&:LCF="O&K%
MYWQ,=3)C0<:Z07!"R@K"FFO$*3CU 35;F[Z+&EP3>A>NO5J]L!RY=,6E+5D-
M!UQM!2/\04K(/Y4RG+[#22H)K _KS5UZ<1KC1=NAQA@H4R]N./0<$#^E13D^
M2M;4BQV[)H949(EZ;9+[*AE2FPX<_?-6J*(LE'F+%(CMVZ)#^7!&?$#:<#Z8
M_P#/345\W8$WJR:DM\:4'M,6B]1D)4 VVWM4I./0<Y/TJMQ8Z:LKR/IWI#?A
MX;UI<TK<]Q#JE-> 4GW"L$4D8H=R:Z"K3N@[%'AI#=T;N;"%84\5-E6/N"%5
M=%)%>]MD_>+!&M.GG9,2*U=86<*98?&\#T'XN?M3.*H$[?(*6:SZ"B-%YC3[
MUL6\=[R'6"@$GOG_ .32[(KH=/[A/IO1V@6YBKG 4TWN.2VVZ<9]\>]5N"+-
MP<6VQ:3FLON-N*CE'X5[MN?SJ8XTQ99&N 4U3T]7<@?V;?9;V3P&G0:EP*]U
M@V]TGBJ0I,Z[W5I21V)'/'?M1M"P4UEH^\:.M[=PL+4RY1DC>XL@[TI]2 .]
M*TX\H9<@*;%U%UA)$O1VI+>TVI)#D6<DH43[4KN71-T3]JZ9=1&XJ6[YI2TR
M7TG.YI1Y^N[%0L;?9&Y()H72_P -:;E,TFXB1M.[P'DDIQ[9JQ8J^"-Z*IUM
MK&_,7G^[3%AO$-"O*'FVR@GGN5'@U7/C@=4T:Z+T#8K%?G+WK+4\D-S%!0;;
M7X>W_>SG)JN*YY*Y/['1EGMO2)R #$U2ZY(2D86X22?TXK4E&BNY$/<(6FYC
MY>M.I4N.-DI.Y(/;^M1Q\#*P7ONA6[B=R4P76U<9;7C/ZT2Y(7 .L]'HWBEQ
MBVEA7_.(>!Q^AI-@R9/:;Z36UF5X\FX3<H."%2"L'\C31@,Y&VIM/VV[*D6*
MTRF6)24'87@H9/W%-**?!&ZN2J_]%/43_GX'_CG:K]-C;T?4)6FWICFU#2%H
M/.[@G^@J;;(I(T6R+:H0GT(7MYXY%%WPPZY0XN+T^=;3;XTD1$+&"II(W8]N
M:;M$)\V1S(F6=E&7 ^A(V)25 *)J%%5RP<VWPA!<W4"[@W'=LZ6&WR-CA=P*
MBD,FVB:5I=X*#CT@8"OWN% D?:E<GT,J9(-62W)8VIE/%?H-]1=D.)%W"#-C
M-NK8E-'RGR2,8/Z5:VT*DF1<5Z]) 5+8@1@.X43A0]"*A-O@:E'E$H)[B&$N
M[F'$@\^'4-41N_(P;M#D%"7%X&>R"=P'KQ4Q8LN1B+SIY<>1/>E%J-$"EOOR
MMS2&TCU*B,8]_;V-3NHE(!5]?>COBJAS7KC(:4K:$IM:W65D=E GG%5/,B[T
M6T5#UAZF*U5>/V?:53G;0R\V^PX^Q\JTV4#E+;:?,I1'\:^V. *S99[C1AQ+
M'R#ULD)6T_?KJA3K#8\1A2S^\)3R$D^OWJM)%K;&D?7#.I+FN=.C+AR)K+94
MTI844GVW=B*G@KY&\BZWBSW%"X$LO-J6!X:SP<GM0-M"/65^5?="ORMS,%Q&
M6VPY)2'%/HYX;!W8!'XL8-/2JQ7'X&<._3=36* BXJ#BIK329$US_DU!("E_
M<XJ.P4:Z"9<K3UGCSM/QMMSAK?CNN3$?[0A')0!VQZ]J*0T41UCU&]<8Z+]>
M$./-7*?\E%85P5!&=REGT&-OT[T*/W(;:Z ?K_K']B,.VRUQ8\N5% ^95%>2
MYE]P#PHN1QY$X6L^Q">]#=/:2KDK9R++_;-XULIB.B1+GSP"M 1DK<]2D>X[
M8I62N"'ONL+K9&'K,J7(:CN+*'&%*4DA8_A4@^M-BP[^6-+)2H.?AEZZ=/\
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MB*TXX\\YRA*PK.T#L3_6F<_@5\>X8=24:EU;H=C4#&GY_@K=0X\^E*0UM Y
MQSQ5<\:7N&Q9G-[6#'39,F' 7^(>*2E17W S5#Y-%4P1U_;XJY5PMCMO7<W
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MNILV>XQ%<VH=;>*01Z$<=OSJ8T_Q [^ TUGJGHE:H;:M.:7U%?V92.5QWG'
M"?3@^E2]JX%6[Y*STOTKUIJZZ39MJT%=K=8=BEH,Q\1RO_=4HY_6JW!]C-I<
M$WHWH7>7Q<VY^F&V'6W$B._*N">!Z_A/F^YHV.@C-$UHC0/3FX7Q_2]Y6IB^
M,':ZXQ+.T'W&.#^E$8INB)3KDL6P_#%H:TW)Z[:CGS)EN=X:6_)\@/U 2/\
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MCLD[CH;2O6KXA9^DOA[9%IT]<RM<(2@H!AEIK+JBD94HJP<('))Q1.7I1==
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MOF'$$(\?W SD>U,I)<,6:<N4SF'KMT_U=TOO4&=>6FE*U&\E_P 0HP$.9W*
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M)38[2BZM24J4^S#0E(2,=E(&15^WVE$6/^F74J\0I:)-OGM-%"CXZ2<H> /
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M\)V_0GO4/GA!7-B^F+WI[3VG5,7%H25D )PWYD#VIDE7)7*3LA+GU5BKN?\
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ME\N6#QQLP>Z::..^F+*5E]:-U3J'64*%"O46'',%E.P,M["0?11JO+RB4[?
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MBJE!Q+E-2X++D:S@VJ&JZZ@T_<5NH! >;CA*=Q_#D^U.K[9#=] ]>+YU"U-
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MPMI:[@; V<I^G>K%!]IB7&*IDP=;=9+A",73?Q0Z3O%T7C,'YSPUA0XPE;B
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M=%PF+W:O##S-V;;2U"4W_P"VGU@%?VVTB4F^![C5,2L6G^IUXU=^RKC;=+R
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M_.FJD*NP3ZLR-=ZOTM+TJJTB7#ES6''Y"%%UMM <QN;0CA!(X)%2Y2JB579
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M_P!<F%_K./8K(V#CZ9HDW)VB<>*-<@Y>>H&IKY)>B!$B],LH*U1GW4^)X8Y
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M[:&;<AI#;8<=BMK2G ;4L\N(SV5[U>JODIDG\&EQF_)VU#L.'(#\N;X<5#C
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M2(83">C*]'([2,@J]PO.153XY"Q[(UE<-/@2=5R[1.MQD%H3[G:RAY"N/Q[
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M@^P7<EYN*7?#4D_P#MD?4XJ5C;&GDX#=K2&K6[TW<(6IF)<2VNE<=5X86\5
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M=JB.X%)/H=VO5D2TNJ9>:8?2RHK<<45)+H5SGM_2IMLFT1VHM;7?6$IFWVU
M+2!LB1XS9*W"3V  R:FK[(W<@UJW3>L=)*0Y?[3,MJWF@M"'V\*V$<* JQ12
M[!R;Z"/I+?K7#N*1>)*&MRTE"G$$Y&>?M4K\R&^"^5:JL=PD)=MCX5&0=NY*
M3Q3R::X*U%W90W42WLP-:.W")$9E,NCQ0A_(0H^F:2,DAVOL"[ETDW*Z3G+E
M%B[I>-S49.Q* D<;!VSZ$TSDB%%FK6E-.PVH]XFB6J6MU1+*24-I3VVC/<#_
M +:941),AW[GJ#2-U\1B/XHO!4Q&>4-RF\_A*,?A/89_2I5%?*.M+M/B-=+[
M/;X]S\2Y!)F/NQTA*P2.6UK]1OSQ4SZ)B^3G;J")BHH0ZZAU"U\+"\K3[\8S
M5*_,L^+*>N,Z?:IWA.K<0HC*%YVDC_C6F&-2*G(<V2)>M52BIA*@@#"E[2HG
M["HE&./\0ZDWT&]QZ;Z]Z73X<#7L)ZW0;PG=&DET%*G",XR.QV\X-53@MMH%
M)W1Y$9V.%FR2W9DA:BVVAO+CCGJ< ?:JJV]B[K(^5JB[7V!_=&3=85OB"4',
MOD!TK[$^^!S5R3K@5L@=7:6M]DU;_=O3.HD:E0M#:Q)CMD'Q%C); /?:>,U<
MWM!-L-^F6FM<:6Z@L6ZY:7N3CK;:9+\)U!;WL'LK)]*J;38]\'0]SU;'8NSL
MNS6A=K@R'$)5#:D*4GQ,#S;O:EE5\$8[(V8UIFZ:PB-:_?\ !L=PD)$N0TG@
MI'?\ZJ2]Q9)NCG;JKHG2ENUW>[?H:Y-W&T&0INW29!VG9Z<'L:UQEMX*=E]D
M+IG1$Z_75C3D2TJE7!]2664LK "UGL"KM4N2?0;&B=8Z3=1O[SS-,VFU/+U!
M8G%*F14D;F0CDD'LK ]JK<DN&.H\<$7J'4^NDWM<R[:@N*K@HH0Z^7RVIM(&
M-@*3SV[4W#Y%=HA;MJ"5J&.%R;:RS*'F=?6UYU*R<9QZGBGVJ/+(_$;VJTZF
MGR@IMZ,&2I+3A>1PC/ICO42R11#B6KT]M6E-$W.X3]6Z%;UHRY#6Q$+2_ :;
MD'L=IY5BJXS7;5HFG5 -JVV0(Z79$^VS;6X^K]S%99V1R1R4J/<D#T-2OR&1
M'6V(+S/1'<VSF\)P'%;-F?Y0>V*:Q&2ULA0F)JVX]JFOS/$*&"VTE]*P/X><
M&HN^B*9'.V:3J*6XC3=DGW=U!)D,L1_,R <'(';FIBV#1'ZVZ>WG1S\1NY0W
MK:+A@;TOA:T $%04A)W @<[3BKXR:8M)<A5HZY] ]%7Q-_G:COVJ9(2/!:>M
MJVVF_P#G"I!(\1.>V2.U.XOM*Q=R+(1\0'2N,ZW'TG#FS'91.^-&@NAI"2.<
MI*CZ>B>*K<)MVT-%IK@;Z>EZ#U'J>1*T=#NJ;M\NHJ<@0I"%,)]E G!2/MG-
M*U]@=CK4=WF:1V);MFI[]=7W0IMJ\)5;8SHXX"UD;_R%0DURT)N71 7KJ?-:
MD#2_4V5>-'H=<3)99C6R+/8Y[!+F2H8'%6[92X9#FER._B7Z.P=/Z:M'4Z]7
M74.HTST(B19K"HS:&!MR IK;E61]1BHQ2J(\[?!0%]Z@ZLF6C3UJ?EO6^!8F
M'(UN,9H1W%I4K)4M:#E:O3G@"M$8+BV4*.V^#-BM.D)%MF3[MJMA5R4XR(MM
M2VM1E;G/WOB.C/A@)R=P!)I)RV\#XVW\'1'0'J0IV_Q^EW3K3]F_9[CC\F4B
M7,=>&XG\3+JL%?;&TIXK/*T_R99*CI!VV1H$5I^^0((F.@GPX48N+"<\;E8!
M_+THX9#37)$W31D205O0+G<V _L:5;' GY9Q?\R=^2E1^A]*E*N!-UD/JGIU
M*U'"8M=ZTO$:0T\%MNOQPM;*DC 4!@#T[#O4N,F&^)O"TG"Z;1Y&J+AJAZ+"
M+(\7P;<6XY<]2I.\X_I]JA+;R-V@#U!U5T?;'47)>N=/W1<DY\+>\)(CCNK#
M8+8'W]>]'?R1?P ENZUZ'N-WDN7/3S:DK5X$5R.E1D%.?*XOD $_2HV_=%E%
MVZ0N>I%0E%ZW2(@D(& [*2M"6R,I)\Q':FIQ0KH!>HO46+TSM:XT"TV>&Y=)
MCDEI9?+S,E:.ZU;<J3COR!]*1V@7(-:MO%TUC'A:.N=WOU[D7A#=P:&F+$N.
MWX"L8RXI6]:4G)SCG%#BY<#1='15AL;73;1#=ZU+U#GOP=C+3TJ^E2%!:B$(
M2I)X1Z#D?4U<H-*[*F[=) V.L72RWZE=L]]UA;(4YO:N-$ML54Y,LD>I:: S
M]$DFH=)\L9+@5E7WJ/IVXM*MNBHMQ@3&2]'*0J/(&>0I33Z@IH?XL9J'NC\"
M.-JQ];;AK+4,5\:MZ?M1RRIU:D_,+F$ [2W@H&[)&:N6Y]HJDU\,"6]::/N'
MS5SUQI.7I?CY)A$^P**#C&Y;9"=Q(V\9X.:H;OF2HLBG'A#RSO:7U#J&78H5
MFL3DAG:MZ2+<VT0LHRVD!?D.4\Y3CG@U%INBSKDW5T^N^F)\MZP08K#-\::;
MO%KEMCY18"N7FUIW>"H D; "%!7OBHVOX)E.T-M9:08ZBZH:5?VH,*R0'RB1
M*M*RTB<, (A2AN!;2 ,A9SQD9SQ0X6^2(R:&%AO>HNBW4./>IVD;F]H=N(U;
M&VX<DONL;LJ#[*,E12 0 E785"6V5UP.YIJF$VM=6:2U6U,F:<U9>[2(RL9N
M:V$2GSC)(\3*MN#@ K'VIY5+IE,6T^2M]&:AF7N3$GL6U=P996XI$D/-K4MK
ML6ELC\1..XSCTJI%S?%C:9JS2:[A*;-AF6BX)6H,^(V0AL9X\F>/H,4.A.7T
M3]CU?)\5EBX3 IMT [X[!#COT2G:<J_PU"+.2R(5QZ=VTHMVI61=4 !+?S86
MRXDKY"U+&-I!IVHU3(]PQOEBL%PD34PGW'H2(ZI$Q^(4J<;;]%$ *46T^I]N
M])Z:9.]DGIN##MPV:8B?M(LL(?>%M8\K2"."5(RDDCDYY^E6QBHE<IMH-X+M
MD3$^=9F?+NJ*2"8SB"VY_*I8PHG[CBI:7P+&379.:C0IRSQ[LBSN/S4@MD1V
MTEQTX_$-^-_?MWHKCD'*WP5-??VPN$J$N!>)DK)?:89C+8R >QVY0#_G15HE
M.C-LZEVYZSL6O5&F-2V*Z[@E*9S3FUU/T5P"/TJ+OAASV,KMK^SZ:1,M=XN$
MI+"BEYAQYAV.%I/HEQ22E7M@&H?'#!7+HE+7U&T5IUE,"?>'H$>Y\LDQVUMJ
MS_#@*SM_2K$DB&FP<N/4WI]89[4^)=XL\E:Q*#T'"64XX\-0<0D9]2<\>]5S
MJ*LGE\!I;.HND+KI\ZBMUIAIA/8CR)SBO]4"3_C3G;@\>@R:$[5A0SC:6LUU
MDJ5,?1%BN)"H_P NZD+3GDE*MV>P' ]#4JI Y-=$RO04MQIM8L\?4-E4"7(@
M6J+)?4KC8%^9"\#D'*>:ETOS(3;(JXZ*M=KM;MOO#5YMK$10,>3J"&5IB@]F
MQ)94'%!/LI) HVIH*E8!ZAOEVT/'8O"]0::O]F4\(SEPMCKCKT4GLTMG"7#G
M^;8H<]ZKE<>1XJ^![J;6UOD_W?:MD^:AV*KQVEQ)7[]E*CY@XWA7B-^FU0R.
MV*G>N**ZY81Q-3H1>&]0Z7;<C30G#Z)+CS3:QZY0H%)S_AJR^;1%7PR=>U3;
MM8VBY6KJ!HN?;DV)/SC%PLHDK#S)&24+;1O"AZ]QCTI6W+AHL@HP[8%W:]:?
M5;+6G2.HKM=(MQ6$MJ<OJ<(![GPGBEU6/7=VJ*;7 LFDR6AR[G-O$6XO:=FJ
M;LS;C+SL.&AAMA6-K97N5N6%@\%.033)/Y(37P-[2B<HR%MW^.Q':*WHECD(
MCN/I2,ES(SOSD9QDX J8JQNNQG8EZ+UI?6;U:NH*F+F"J.&X<\*8.T\MN,N9
M0>2?0'ZTR2;[%;"E<K4]FNSK+ND;K<($;:\)=K;;0DKQW2DKRE8[>7BAIWT1
MN2X&[/471UWU>O3=V8E6._RV/%CKE0'$)+>/QE:B$'ZG<>:7\3H+I62UJTKJ
M/3]U3*L-U8=CHRIY^.VZ4NE7\)(.U0Y_BS16WHG<I+D:V^/<Y=YF3K-86''X
M:]LIH36$/_=+,E*5@'T*5%/UJ.'T-T3#+#?45OY:5;W&%MI*'&)4=!=3Z9_<
MJ*D_0C!]JE*+[!MH&=3/=1>E\'Y*SQK?J*"MU*'(]WGJ>DQV>Y7X2@AYU(P,
M)RHC/K4IUQ'D5>[LC+%<;AK"X*DRKEH1QP.A32X,Y42<R#_@>0AQ(&/PJR#Z
M9J&U\D-">I^GKSEW^<O>B-17[PPIU$NU7*&J*ZD#^-IP@J5GW_(TM*7),6TA
M6%HZQWVT&W2KGJ*QJ"1_JSL=J26S_+X:,''T"B*:,+X8DI-$A$Z+Z!7:6H5S
MTC$N#S:E%-R<T^(LC<KC<5!>3M[I)/!]*)02XHF,F^;']EZ":*1,(:U#=I$I
MAO8VY*E!;Q3CU01@_P!<50Z3+DY"DOX?=+R@XU-U??G@[RL% !)]MR2,??TI
MY1BOD'N^PX?Z96F!8D6%M+ZX:SM(F-..J4!SG\1SVI>.BJI-@G)Z7IOC;UKT
M_,L[D,^1^+,M[T8J^F!@$?7O45?1<N%R1U\Z0:JMEOCN-1]/,N1BD"5&!==8
M0#PD)5D%/V /UJ7%BI<C/^['47_V>(_]]TFGM_<FOR+LZF7RP=2)CM_BP)-J
M@2VTBT!M."5)X4>?X:QR5FQ6N"DV]0FWZ@D:9E/[WHA'[Q7&\GVS6:2HT)\#
MN[N2WW''V$[BTCD8-9Y6.BN[O<7XD]B6<H4O((4?0]Q4P;7 _ SO=ZFWJ*M%
MSDA45'=C&4G' [C@XJ^,F52(6-+1'TY->A3E^10"(KJ\-)SV4 #R:?<1\%?R
M+E<T+E.27U$K[$'R_;![5**V&?1BXMR[+>X-PN-M:M[7G4)D!,K*U=@A7"P<
M^U:;V\(ILE>CW45&D=4*M$U*;S$NJEMH(86RAI7KA"N^!1?%DKET7-?[-:[O
M?(\Y-QG62/X?AARW!H+))[K*TJ\OTQWQ2XY>X;8@\T1\)BNH+,QQR[W1[#96
M+S=PCPTC!QX>" #]AS323;*Y[44GJ;X<+GI2]N76-J#2O@PEJ3)BNOJ+Y2/^
M41R1N/;%3O:)4$P27HS7<>WW*V].M2V^):=0.H5.@"0%-KP<C!/(Q['M3P;?
M17D6T(]$=#[;'MR Q?I%QFR5EQ;CVU;22E0 ;92.Y!]3@8JYXE1G65IEEN=*
MHMD$F!=NI]HM<QU +WS"TC(([(*<X_.A8DNV2YM\I 0UT/M$7?(:GF9&+FTI
MC#=)E+]FT]R/J*C8D1N=D]"TEHS3,9N]7_3FK=,S@C<VB,?F I /"CG.P^X%
M344K=H;W/H2MO0_1NI$WYJ+J*_1[6\EF7)DS0D.+>6K<$H0K"G$]^3VJG)%5
MP/!N^2*N?2BTVB:Q;HTM_4K.]*EK86&U*9SG8I0_ 1_$!R?I52Q67[^*!K7V
MJ;98;G!T;'T&F)N<"V83S:T*63^%U9!V\_?-3*"7%$+\B.OVBIL"%'O/[5LS
M#LM2U2+:TOQUQRCMD9R > !R:78@MAWT%T])A3?G[G;GK%<[BI28TYR-L6VV
M,;@VDG"<Y[DYI7&F6+E%F]5/A^NC_P"SW9[#RD7OR07Y:E/.+QV/<G[&AJ@4
MDRA.H6CKUTQU:SIUZ8PZZPA*W/$CX*3ZIP1G(I&Z+*1*Z;Z@JA,I95!1*WN#
MLT!W..PHW<!Q0QZFB/$LHNK3JFI[#_[UET#RCTP/:JURQ7P 6F]16V*S.O%R
MTTQ/D)BDQU?,%KPU;AE1]S]*T1C:$<Q%S4IZA76$TZXZW'CE2MK?X4DG.W<<
M#G%.T+NLMB]Z)@0-/6O53ER2MQQQ+*;?'*2\T4\I*\_A'/I1TK%[9+*L-QN5
MK;G3K<IX0=D@1&G0CQ$@Y.X)[\5#Y"BH>H,9C5]XEW'0#*FE,QU+D0'' E"E
M9\WAY\RB/:HX?0WQ162+1>=6.1K&(2Y<G<I+*TMGQ<@<_>K8SH1Q(2QR=56>
M<[&M?[0267?"7X;"BD+'\.?4_:K91QS[93%N)TRFZ=<OB'L^FM)ZZT\J#IW3
M*_F&7VF4Q')KZ4%*"ZZOGD8!JO)**C0T8^[<5*]IKJWHW73UPCZ>D6:4AUUM
M@)D)<#1SC 5GS9'.3Z5+E%1L(]B3G2;6-QN_S6HG&P%J"W"S(0IPG.<8]!S2
MMVB8\R9V#T)^&S1,#3B;W*T0X_=;HZEF"DNE3J%#&5* _"DGD'-4IN^1^AAU
M@G:VD]7)VGK.\P38(:+=O93XJ1X8RI:5=R!G'/&133DV^!XI;; *_:"UIIC3
M,+7=SO@N]JO$LQ]RB04OC^$<4E.K&A5T1DP&-:V[I.MTE5M4LH#;HWI+WJG/
MOFE2:98Z*_6C3]PU$)$UN#$8<6&]H45(;&?,H@<\"K$5NB?M5BTU)DS[A9]5
M6RVIM@WL%:U-.2E \>#CD'UYQVIHJQ;+#Z5]*+;JAZ_:G;UE)C/Q8XF3I[D@
M@KR#P5$\GZ55.#DN W) -I?3,'4&HG-/6"Y6%)O2O <E79D*4S@X*DE7;WR*
M:-H)4RO5Z"O]KU>[9T(A*;CS5I^83+'AN%)QX@'/?C JQS:%18O5'H:[IK3E
MAZB2-;0KC+O6],@>.$&*\GLH!) Q@CO]:EUPR$[8,:<U1H'2UE\#4-MC:BN1
M>*G)ID.AS'LDI4$C'UJ'1+&#+<;J-<?V<Y<H\;3T4NR$L/K6XMIW'&"@$J5_
MAR34+@#:$Q"?"+9/T-(DKBXVRD)69("?YR.4@_4<5+D10ZMMQZ?3I+K\XS[(
ME(\)I<-U3S"5#\06>#NIHM,&F;Z7U,[TDO+VKK1:Y%YB3GW&XLM<K8A31[+"
M,<J![%0[U*>UV*U8.Q-0Z3B:G7>[U9;GJ'QG%278TH9+KJCE2BI*N?Z5%\V@
MV[@PN=LZ)2YD;?H1AL3D)D>!^^_>K5V1E));QZ\>U.I_!#QE1:OEVK2VM(;G
M3FT7K2TF YXCBA<"\\E>>%-IP,)[#'/UJ_$^-WV*IQVA3 Z==:OF)/5!^RWE
M<C_OIZ;-?:AH=:/<N94"DGW'?O4/=D?1"DN@"U3=_P"]-Y^9N]]NCLI&&R')
MWSW@Y_A2LGE(^U#<8JF+3W,0NV@;\PAF98;5?+I'('B/?LIYMM&!V23G(/O5
MT)Q7"0D^>V35M=ZS:F8CV14;5$BVLX6@B&ZI,8 8W!..X'.>]5SQPAT6J5]E
MTV>Q:;M'3]"=3:'MEHGOA2TWR]N'Q;J0.#O4E0BK]D+3A7;UJE-2>U#[5VP(
M:ZSR&H,73732T:;TE,:66;A?)#$=#\A2N,MK""AM."<E/]*>,9K\3X%G.,4!
MFB;/JUOJ"Y:M)+;O5PB2 AV5;%*DL86O_:EP 822>5' ILBM**)QRW\_!T3U
MMZ@VG0\:-TZU);;NYJ!ZWIDFX0;BZT&U*R!A([8QV['WJEPVNF-NW=%>=*[X
MO4]M9TO'TQK345SC .SI4>_R4J4SN."AE(.T>YS5BBI*DK8KXY([J#KME5KE
M:<L]SU)#N$1U86+A.0L*0%$>$2H!8V]LC)XI4O@6BNY$W7<N&5SES+W;V. E
M?BR6A@9Q@<)^YJUJ-"6TP]Z5::T#=[Y%TGJ_7CD7]NI;3^S+#;U3W' L$I:<
M4.4D$>9 !(JM;;Y?\BRG5T6Q>?A@Z(Z-G"TZKU?J&]SI*"ZS"80M+K#&/*7$
MM(44CT&2*F2BN&P4VRV8'3/3>J]/P[/8T3+:S9FV]K8804A!3P'$2$YQ]0<Y
M]JATE9#DT[ GJ=K3HYI<38.JX6EM07>V(*8ENFV%2%/+5@);/A )3D]CV-/O
MBUR"39)])=;Z_;T)+F:PT5 T_$4TIMF,W;"TRQ'7V2-CN_!P . *5.4%;^2)
MI)]DC>K K7VCI-DU+;V+9&EJ:,>,\@2581RAU"0H9&>VX]^X-%-KDC=3X"73
M&G+E9(%F#+SAE0L0U7&0M#;J&R.X#?"01Z#M5FYI")IR%+-;^FNGKHZQI7PI
M%]N3A<?<<<4ZM\Y]5.E2RD'D8/%46KX[+I77)*VQF;(G2H%T>?@R'&ES#X#V
M6W6DJP2,XYS_  GDU:I/IF=K[&('[51!N(C7ZYW.XN-+,.#/MRF8K:&T\^&@
M9W+_ ,965>V*-[KL=1 N&QU1,!+4Z- @V\KWR)!2XPE)XPM2DI)./4GOZFJ_
M<6<%E1=+1Y5K<CR9D'8XT@?.0XFX7 *(SN!]O0GOZ5:D5R8 _P"CRZM7&_/Z
M@UA8+K8GV$1[>Q<6TQY$'"R%M^"C\:5). LG(JMK[L:+Y&MBT7=M*QI=MLUL
ME7>SR)0=C2HT4(\!D-A"HJU;MRD<=QWI>8]%JJ78XDRM36R*WHRR].8UILC;
MI4(WR268X*AYBOQ<E2CD9)SFASETD"A'LB+KHI4FQ28C>E+>RIIDR/E8BPP'
MPCNIO&//[8(SBHJPE44#5BG=-+DJ-%_O%JF#/9<0&C+AO$*<(_ ^R\G#JD]L
MI5S4W$K2=DV=!Z$_?QI%Y;M=ZBJ$UJX./OQX\KGD!#@* D>H0H%/TJ-J'W,1
MEVZUS6H_S?@K6TX52#&O*)D5Q&?*XE:E)6#[<_K1P-N!O4-WTKI*[,V=QHIB
M3BI$M-N=:CRT^OF<22M(/KN'-#:BR4MP_P!/:WL5MEEJ-J+65V'A>#&;\5N.
MBVD?A2EQL;EJ_P 1],\5.]!*' 1:,^(2\IO[]BN=UL;#3;64N7E<ATO)'=2W
M$-XS]< _>ICDYY*WC+!F=;=(.+ML=_7FDMX64NK@W19\,8_Y/> 0?OQ3N2?R
M5M.(33%:<>MS-SM4E]^#*4&T7%Z?O0X^3PA.TXR??M4MI=!%-]B.MM>=,=,V
M?]B=1=50[3=K@P'8<:8PXAUULG;N3E)!3QW/%3NBOQ,AQ?P4];.MFI[4J#IN
MY](;=J2U2&G#&E1[LQ/CJ9"CM<>*$*\$8QPK[4OJ-<58T8WRF)3^M?0^#+C+
MNW0A+3*@4OR8EF86\F0.R$<I*DG^;FD=1[1+4ON/5ZZ^&?K6%:1:M<K3]VP?
M =FVTQ6FQCN=BPA6/91YIG&$XE:WQ9%7;0,KI-8R[8>J&B)MLP2Y-?EBVK2K
MT2"WO0H^R5=_:D<=G3+5+=VAKH;JTNXVI:-065IJ0AI3C$^-X24R&T_Q@+/A
MA1]E)&?SI8RKLF40WL'6U\Z:F:AM]VE&VQ/W)N,C3H4TR[[.H0ZE! [9! S5
MD96K%:K@KE>F= W[4S-UU%U7UH+G?"5H;>MT:)#=!Y!C.K>4EL'TR3FEVQNF
MQU)T12M"=(;+K5[3&I>J>MK1-97OC?M> AI(!P1MEA*M^<\8P,5#A&Z;)W.K
M1<73KI9H"1(F-:?ZJW/485(24B'<F4OMK/="EH1N7G^; ..,5*QJ^&0^N2 O
MUSUC8[ZYIA%L?<:9>\-AO4=H?0[M'\3$QC<PX@_^W,*^U0VUP2HKL!9?6J)8
M;\PNZ%W33S3QCB78)<D*:R< OM[]FS_$$<YI?4I_8=P3(&\6:R]25N0ICMTC
M:NN,Q<JW7!]I(F*1@C8IT^7PE@9!R._:C\7ZB.*706L2%:"TT),F^7.Q7.UQ
MTL2[3X$E3;X2003*6HHPH=R"D8.!3W2$KD'IETT(_&:U5_<&U664VRN2T79R
M5,7%:E$N,%:T>7<.P\8>N,U%KNB>>K"_0%HTLSHPKU'U Z<Z3?NS)EP;+*PJ
M1""C_LY#O_*9QY2>P([U;%+;RTBFVI=-D>?[PO7E%DT?:;#-N$9(<;$"<Y,0
MX<=R0H(9'U&:2_A%SC?+"RY6[J<NS,K,BYINBV4B1;X]O_:+*5^K;9<!2<=\
M#N:ES:%VHGM*7'K)I:TM2I'3MB2VL[9*E6U5M? _Q1TA;95] 033+<ET1[7\
MBFNNH-X=@(?D6V7;9L0CY8P%OHF[/5"06E-KS_(2!Z"EE(L2X--'=1[%.<;D
MZW@,R!+9*V+T&4ID>&CNS(CX0ZVM)&?PX^M":?96[^ UN6L]#71;-LMFK=*W
MF&XT"F%)G-_,[R.%)0H%>4_RYS[ T_"Z8JO[%4ZWL6KK[J"+J3IC<M,0+G:A
M\M,@SGTS(LH'L5JV%;:L9R%!/>E<7)VBQ-53&=BM7Q(7^ZKL4ZPZ7T% ^80]
M^U[-!,P27!V"3OV!)]<XXJ'&=TE1-Q2+J=Z:R##+-_N]OOTR.DI#YMB8RE.#
M^<H5COZCFFVOY$X95MWOFN] R42-2:.;B69UWY=JZ1+A*<C$_P I25*\-7T*
M:AN48W)"U[J0[N^LM=V"R.ZIT[+1>F$\BW_*I4X!Z8=0A#B?T-9)YXQ9?%,G
M=$]2=?:_TNS<[7I&UOW0GSVQ,Z0S*:4.Z2'60DD>P/-:(3E/X*W-+L-+7=-=
M3(L=%SB&W712SXOS[:UM!H<X;  !/&.2*L<T_;7(JKM$M<FG)$EU;3PD8#:R
MO&QG<>Z1@GD4KB,I$<Y;[^J0E:X:/EE))46W""![\'_.C:PW(:XD?^&R/_SM
M').Y W<=3:DE:G8U%?-.L,VFWH2VS'9.UO">, 8XSZUB<[?*-NRBCOB(6N3=
M&M=62$JWL'A6TE7/?/:JW&V61? /6'XC#;+(W;[S;E277CX>Y&,D>A]Z26)#
MK*!6IM;17G_GXA4ZQN\3PMQW))[^E(L02R#J-U)M3]H<M$:WR)$M]:0-K6=I
M/I]:LV)%4LA:_3SX5^J'46*B=)C6VP6Z3M=\2<]Y]H&=P:'FR?M1L8RR<&G4
M/X2K_I20^S?]2168I0%QG(L=3I?^P.,'Z59"%]B2G]AKHKI5T\E:<DV&9>46
M&?)3X$9<EXJN*B3YB=@VIW'C'<?6M-1KDJY":S]&(&C].W5ZUW-R\2;>KP3)
MDCEO^9ME1 WX/!6>3VJMNE0T582=.+ J]/,3Y5S@L0&G$)>2MS>^H#D^3T&1
MZ\4L%3LEMHN3477BWVNV*THU.G1K8V=J$L,M,^(?3GDJ_*GE)"1A;ME;ZFOG
M2:+$+UTL]^FS+M'P^T\Z&$D9/)41G'V'YTE1&>XI.X6:R:6U7:YNFY#\YZ6[
MXC%I:/BH2WG!"SW-">QV@:W*CH^1TQC:1@,!Q^3&OVH4?ZG$A/;D10M.5 !2
M1M6K/Y5I<E7YF3TVW^17TGX,U*D*NVJ+S>)H6P9/A16]KF0>6BI0.5_057^I
MIM-46)H+I58[[(MUETSIV-$GL*2E[QGE2;FVR#R-KF&VQCN1FGW)KA"N*3ML
MM*]]-6XT9R9*CHLP0DA2G+BW)>4D<<I3V!/HE.?K5>]OM#4D4CU%38+2['O+
M=JE1Y41.\W.*_M:4$\!3B71@ 9].>:5OFV-%6P*TGJSIXB2N1:[<CYV2]XLI
MT3\2?&&2E2"KA*5'O@U8FJX%>%M]E9=6=56?4]WMETBZ,?M]]A34KN#LB09#
MLA /"?97';'%5-V71C2+>A=0M!V'0TZ^6SI@TO5%U>,6"I^+@L+('[_D?B_E
M2G'ODU8DDK^1).F.M6ZL1I>!9]%ZN84V[(@IN+KB1A],EW!0!GD @<\^])DX
M=,F,MRM [=?B/U?8I<"\PWWG';=M0P5+#NS/JGOC]*H<F6;4T >H;Q<>O.I#
M=K?(D2+GXI=FR9!S@JX )3[FA>X5^T<NVIS0MHN";M;%Q9UGF>$^IS@I44Y2
M0/4>H-#C3H%+Y*%U'U)BSW2P(S[DQQU7B/N*W I/J<'&#Z5;#$N[*Y9"*B_[
M?PW+@VLN\I:!R3GT _[:L;VB-7R6STCTE(TYJ.0UJ")(?M\Z!F*TED*;4ZHC
MRJ<[) &<D GVJ;^Z)2_,O5R)IAB-(D7* RJ.R[FS6^#Y$I('GD.+/F4V",#<
M!N(]*5I=C77!5FO+OJ"[N*-LEM6Y@(#[D2,Z4((]QZY(Y(SWI&R;'UD@6"99
MX N=G,1N.D*0M"")#RE'*E$]]I]*1,F@BZ?P=-:@ZGI98MBG4*3X?A2' CP^
M<#PU#\!],\T4YO@.BR[CHZV:6-\D0)=MA/6%U28\1;84MMY2<[6\?B.>-ZLF
MGDJZ%:4B/TWU.9,/]FZEL#,=3!\1Z6#N>6G&<#=P/RJI-7R61:2H!>HNL+=K
M;4EK;T?9,J3N\1<O:5RGE'\7'X0!P!S33>^DA(QVNQQ=+.QI"&4:MT[*DSI3
M80Q(W>&TRL\GRX(7QCN:M7X:8M<VB!MG5#7&GEK>5>;C&;R4(>BN;<I'"4[?
M0?:DE(;@'+MU!DV:Y/3!<9:'Y+:P5ISN<![I4O\ ].])$)<D!K/JQ?\ 5>E(
M%E>E*C0DO)#38\J 4_Q!/\Q]ZMK@2+H87JZZZNNDF+7<[H^Y:K>]\PU'!P0H
M_P 61WQ4W\#?F"-L>MH0N1,4^7>5A"",$GC!-2J$=FC'B,N!*GMX<) :<;YY
M[$<9_2BTB;']QN&I6(2[$W=)+;3X"2PP%)X]-X'^=01V@CN7374FDM.V/7#]
MQ9?7=F%J:;;?!=:">"%>U,^A0&NB;NM+MXMUW6PDE(4AP@KR3C*?I3Q2H9.N
MQV[>]03M,HM5]NTN3&:>4XPA20I)/8Y]NW:EX#<&G3/H?J;J;:KQ?-,,V]"+
M1',I3!)2Y(2D95A!XX]:FG\(G<EV#D"ZZK9N<.79'%PVFW-Z&!M:2@H/X_#P
M,JX[\TK]W))8O3SK--T+<+G?+[:;7>9]QW(>5(?V/(![+..3CVI5QR#*RNT]
M:YL^;:;Q;FX,J29!?=:R0XK\01Z?^G:I7V(;X(95PEW M&.AJ:@C8EM;GGR.
M20.P'L*:A$["2TR(UKN\,WN,;-ELO,/S6%.LN*[! 2D8*CGC/''-%#K@ZOU?
MH5&CNCK.L^G4B$B]R5QHZWY26&&93CHSY .1C)&3_2BGV@;1RCJC65YUS,=T
MO(T"XG4R'-C#D!G?(D/(.%;7",^&#SY>]7I/JRF3MV2"+YU@A7V!TUZC7-^\
M,.%#<S3]WX2I.,I0ZLX4,<=C@"HR3E^&AHQCV@^A]0M(=.ITBQ/Z-T'I)<5"
MVT2'83DU6_&0G" 2<]@3Q]:B.3A1:Y"4$N;L![=\6?5N[7>/8[7IJSSR\_X$
M9AEE; ?]L84-I/?'I5\8R2X9GG3^#HC3,WXC)@;M5_TII[3S3P4M4U%U,IR/
M@<?N2-JC] :1QDG[@N#Z O5WP]=2==RHAZ@]2HE\M$*892H?[-^34M/L7$9Q
M],TKE2]O8Z:0TUO\,O3)VRNHLFB[W;I#(5(BS[1*1/WG'*%MN*!/Z"HWVN%3
M_F$5S; "RWW66AY)L'2_1E_M463%'_J=<8K27'Y.<>,\ZO\ >+23SL' ]#5=
M\W9HN*^"0N_36-:GQU*^(CJ);[VXZTE*+=%7XCCCG\,<E*DG:GV1@#L33^I)
M_B5B."[0*:EN]]NFF)>KNDW2RXZ(TQ"9^5N]RAN%(E*6>RE'D([ %/KGFFC"
M?XDJ0CDNF5396OFKDEQ8:<65>*X'W#M6@944J5W!.,9'O32Z%4MSH[RZ)WCH
M_*TZF/H741LZYC:9LFRIF)6MA]21N\-+H!40?3)JN*;;J5#NDJ:#6-9+6W=G
M)X=8@W!S :DM-1V9A/;(4/-R._J:>JY*FKZ UZ\]3X&IA'F:'@1].-R%"3*N
M.IPB>ZRA1PMMIOS '&0DI.:C&MW*Z)DU']0?UU)ZIZHU,Q;^E74#2>G(C(/S
M*W[OX\IQ:CY?W1;';M@#[XIY;ERJK]284^T*Z1^&U.G]02-?]5+@[U!U$\I+
MC*YZ\-1R/X@D*\Y]@0 !V%*H_P"I]BRRUPBQ;IIS0LF%&F72S66&N.YXD=M]
MOYC:H<@EOZ$D_F,5"B[M\D*Y#:!8[QJ:Y/OV?6ZTEM!*66(R03CDCS@J2,=@
M15RWSZ0K2CV**-MTS,89U?J6-;G9""MA]]]MAQ]7HDI& 2.W(I'[>)$I?*)1
MVXZ:AJ1)BW2+&2A ,F5&:94MU/J%$;2D_5-1&B92;^"/L=WF:MGS9&G85SD-
MLN>*B;,91\H2GL$)<4%N*P/0 5-OX%X79-7C4##MCB6B#?TKFN2-D];!3%*%
MK&=K:5*)2?SYHNUP,GSR8AZ:?L<67-N-RN$R$SA3BIA>V.I([92,D>A!X(HV
MUR3NOA$2J.[J1N';K1<%+@S"MI:/"V(1G\+;*5*R .<$8I:W<(&2VGM'732[
MDJ.Y%M"F%LMM14JBH;E>(%>93BEDEUI7;TP:E0:(LBM46G6]X2O3]R6I<827
M)*7436H2$)7C#80D#>D>BL]J64&R5))\$7$T5 <?D3G].0Q9&&4M*DIN<F;,
M+R?QX;Y3CM[5"@AW)H(]%6"Q3[5+A6NVJA1-SB9.8_CKR0/-E2L@X X'8TR2
M0KEN(3J+HN:O3OAZ2:N2$E2%L-R2E[>?JRK.4J[X!2KV-1+E< EM?(.0-57*
MS3;9.8@RIEN7_JDFW$K4Q%<'=10O#\<D_P P6BH7!'8;7B]V5ZT)G7'3EH9A
ME6$/RK&N8E"OX02QW /K_E3/D%%WV$73JPZ&C,*U0JT:2<N$M&UT-6U;OB'U
M46WB2WD>E"@DKLL5IT,Y72CH\W;Y=BL.I4:7EW%9>6(<A#I2LJSGY=15N3G[
M8%(HQZLMDVUT -YZ>:;-X?MMOZJ,W!#$3Y9;9MKL0J6HC=N)24*'U!^PI)4G
MV"3^4"!^%)-MU#<W(FB[)J!MJ-XK9MSS<QQU.W.YQ@J2O'IBB*KXLJR=FDKI
MMUKC:10FVV"[673S2<JL4)YLMNHSE0+!)6@D\\*X-0U)K\B8M)D=9-+];-:3
MX]STXU?K+O(MSSBKFT)L=D*SE]#Z5'8.?PC!]J:.[M"R:;IH,=2="^MNG]/N
M6VUC1]WC10IF,V):(D[8OE2ROPD!W).<$X^E6.,J$WJ+Z*SD]&NL\535[N/3
M]-[##880PB>W):; [J\-LCS?[M4RC.7(W#^2OY=G&IYTYV\F/IR"P/#>:M%I
M,QQ"AW+C4EQ+B5?;O[5&YU1*BX]<D_H_J'T<B:658=408-P5;WB(+TZTSC,<
M&"/%\%AP-)*>^-V13Q46K8DI2ND3FFM&:.U58Y<+3_5:SZO?E K$";"7'4?9
MD>.WC<.V"X">.:1\\%D6WVJ(73>F]:-NWOIFBYW3ILRH%<6%="6[5<7%']XA
M25;V3QSG?[8JU*4571$DNR?%NM_1RP-M=8-.7'6EH@2D?L>9;;\VQ\JA?!\)
MD92M&[C(4<9[5"KN8O-7$$M1=4NH5HN0DZ8LFN(^FYR5I<AZNA)GMIR>$MJ"
M I*<'@8S4N3CU_4A.Q;2%ZZ06K4#%U;T=!1(*5!Z)#N<JVR7'_1Q*',=CZ"E
M3BGT7M-KLNZ-UTOC#P.DY]ZFQ&&0W(MMZD,NK94.P2\@I6I)_P"E]:=2OHKV
M_<@KMU8T3U?DVZUS^DL)=^BO'#;\V,S!6ZD_@?#F%)"O0YYXJ=T9\5R14H_/
M O%TSI._ZS/]U]#6S0>K;;%(E:<NU\2+3=X3R3YHTELX0ZA7T'!YS0XJ3X5,
MB+<.6[0^LVDK] U:G3/4"X7O3L*2%R6HC(%QAQ$!&U'AS&/$"TJ/=#S?(]N]
M*E3ICVI*T,/]#6I+U-EO=-Y^AKW:U+,>:Q:IJ6 EWD*_=J*=J\'E)20"?2HV
MMOVD2:BN1U<[5U Z2VJ1,B:2\/<6FEP0M@I(;_A274%+F1Z(5Q[4WN@BM14F
M*Z6ZWZ;U["NDJ/TCMTB3:"ARX,SG40ID5O."XTD-@NI'KBC\:L>]O 6:YZH:
M<1H*=#T?IZXW5)4C,:U:D=@R6UJ3N)4D)WJ ]DG%5SCQPP4N>2D-.=9-1QF6
M;6Z_-T[>9+19B7%=X<1'DIS^%YMQ1;>QZYVJ^M"DUP"2;+.O?5J9#TTT[&B6
M?6MX2T4O16GMD91 \Q2 2E1_P[P3Z4SD_P!2S;:8)6[7VA;%I5NZZZC793FH
M(:VG9RW6U)A..9 ;;C.J!0$>F_/(SGUJ5*,5R5;6WP"&J-"Z1D:=BS>F-AN>
MH)ZTK:?N+-K:@RT)_@=*@2PZ#VR@I54TFO:,FUV1>E]:ZANFI6[/JBQ]03<+
M9&4U *04*80D %"P "XE7H2I13S2.VZ9/"Z#C^\RGKB;''U=/LDEJ,IQ]H,/
M19K.1^!#C@\-:B?Y@?H::#V<65M7R-;1JWX@+5)F1&M?:IO3#:4*A*<M\93[
MJ#_-XHV* ]<*%2IS1*41]<.IW6IS,N\VNVWL; 5QS#7%7L/!.]AQ3.\<Y"@#
M]:KS3FXCQVBSQUE,TRZMNW7AB6ZVIQ+%OBLN.-@]@'"K=V]Z\WF<Y9*-4:HI
MNU:8ZM05KO.D]5/W-]GR/6_4*W8\J.KOA"5*VK/^))'VKU&*>[HQ22B6QIKJ
MUU@N=D<T;?--6M-R*/\ 5'8&I B2%CDE*)!<;)P#Y<<\^M3)-L7A.T2*OB"U
M3H:UQ)&M;+JFVM\L*6B.VIM6/XE%IU(!/IE(%3&5=DM?8VLWQIVQ^\N*?M<F
M)"C<*D7?4*(V]/T8P5$_0%5-<?N1M;"S_NWNE'_U?C?^_%__ .-4V['_ -Q&
MR?V&YU9?X4D6R[20\PE[.P@D$$URCJ,>WZ- U'9I%E4P'6I.2C><);)')_[*
M&R(\ 78?A78E2X,RS]2+$RXZ5-K8NL52"D'CRJQ@_<5:H6NQ-],G)7P06*RA
M4:_]6K+\JVKQ5.07E[R@G.W!'/K2;*?9.Z_@)H.CND/3=^$YTQN*)D]L 2)4
MF&5N+]PA:\A(^PIY**Z$Y^3H;1#EFG::E:^GB+;OE_W:6G9 "I+H_E1427&X
M:+:]H!]<];1-6Z-=:NR2XM:2W'=22D)&.P I8RM<A*-/@YILMF5IUN%>[!I:
M- DNMKC_ #;),F4Z?INR4G[4[?V%19MBU8]^R4C5T]J#$A@[3)5O4H'\02S@
M%2C[D\'FHO[CH#K1J&Y(E2X^C0W'@ONJ*/&0 \^DG^8^N<8';%"?V!CLV?5-
MUUO:;@=#/WA$##CL9;Z<[_4C) ]*B5V1&B?NNF-7:^UBX\[HZ=';>6&UKENM
M[8I]$)R>V.>*.6P;2+EZ9]&-/],;W&O^HE1TW5T%N'>!M4VR#W;;2KR[_0GF
MIV-.R%-.(?WRSZ$N4:2K]MRV@L^%)DH9\1Y?NIM2P=A^U-M$<J(F'+3I:UF/
MHV^WNXR$GY>,W<Y1>2TV?^4!&,*^_:GBFN@J^P"U7K70NA.HT*\R+I:9%WDI
M\.=^RV5_.*)X()259S[T-)2Y)7,2<?ZMZ9AW-&J=0#4,-A+>V+%3 0VI[CC&
M_E9^^*'%1Y(MM4AE/T\UU9METUCK73]PAV!#!0Q;W)B6'I8/J6SC:GU/Y45N
MY9-[>$4Y+Z5=/9%SCZDLTMD3;84^%%N2FEIP#P%%O\0'U%&U5:'W?<)+EHGJ
M]"NYU=%LFFKC;9$-,?PVFFFR&\?\GE.>/?O45*[%]1=$!I71FL]27%-NEW5F
M*F-*2\PR\^EU;92/*>WIDU,;(E),#^K5MNNE^J-G?MKXU)>VMRY,FX/>)XN!
MP@-@$)2D>IJF;]Q=C7M5%9:GTUK.X715VG:8<<;F.+FJBL'P A(5^% X)'M2
M[6QNBV>C=QN>G]7&]6?IC(@6YZ*VT69)\&,-O*G2H_C&15F&+3Z*LO5!#U?T
MT]U37/U'=7(8GSG?+M<"D)P $C"3@@ 8Y]*G)&W8L*2HJ2X=#TH@>+J" @S&
M6U9-O82EMML#A(;& 3]3S4;MO8LNR+Z>](; I]^[W#2\CY-*"A#\Y:&UA6>^
MP<@8S0I)]A-.N"[[1H-NU65<C3D:2F(TUXB&T K0K ()W+SC .?84]TN!$F!
MVJ$ZFU*XY9(]O;M]E0T'+I=5O@.7 -@'PV\#A(  P.YS2M[BU*AYTLT1<-3_
M +3U(QI=J1".&(?SKO@MLD]B2KD@8[>M0E?(-H)M6]#M6:AN#5_7>I#5N2RF
MWA<=H-!+K8\K*4D>8>N><BAQ&314+VG>I^G)=PDR+"F-\JK"9R'$H2[SQM4/
M7Z>]1T,>LW4>.U#D1;] NTK4<B2V$)).TD'O]32O\P)/5\C6VLKXU;W=-&RK
M#"-[;P*-S8'"CGW]:2N2 LL6F+78W8$^Y--RGV%!80RG#0QZI7W)S3I4*V$G
M66[6[7.F(5GM=ODQ7XS?S3CZ'2Z7'!CR@>B<#[T\GQP)&[=E&]23I*0NQ1]*
MS[BB2A(3=/F6RAM+A&?)[C/O5;I]#"&M$-3(.DM,VU#$F9*#B77FN0MQ2P$[
MSZ<4(GX 1S3]JCZG;LE^\<(BSDMW3_FO*O!PK^$8]JN2^Y6B[.M'4CI+!@.:
M*Z:61GY)R$A$EZ(5.,%92, *7YBKOG'K4S<>HC*ZY*'+)D,(!CQ<*2=JB0"H
M)/TJ"&.6KW*D-M1+G$BR1&(2VXE6QQM([#<*CD LTAJR7:=2Q[["MEO?:;2H
M/QI+9<9(QC\9P:$Z=A5C*YQ96I+Y(EWN/*>9<4I4:,"4I )SY#VP/2JW+D:B
M+D:2MJGFC9]-32F.5)EJ<=_>J42"G:CUQ@TZE9%!EI&R]+KHPW:8DF6+T^2%
M_.E37@JS_"D>4X]S3<"TR<M'2WJ:S-N<;3UZBR&'VBRI,:3L=<1[$\#^M3SM
M&XKD"["=(Z#N=RTUKG2]SN4@.!MY./WD4@]F'4G 'N.:1]42)ZLTW:[@\F]Z
M-T9=+?:"UY_G%AQQ7U"R<XJ7^0]!;<= ].4=,U3D7N;;IA\-]JP/,[DR%@>9
MQ*\?YU/%%;397-O9N$6X2;W9HEM@B%'#D=;*POPCV45!0]JA-D;:&^K]0ZKE
MW)B)=X\F=*9<;=VNI\L=!3N&$@825)]3SBFMWR1WT3NN-:0M8&VVZ%+GZ?N\
M-32D)??<<9!&-H;;!X)]S4MJ[$5]%FZITSU 19&)=WF76\-VUMM]R2AAFW7<
MIQDI:<22 WZ9R21WJ93E)K\BR$5!<E$:TU MB=_>>P61QM]0<96_=[H+B^5G
MNILG!:4!QNP:MB_DKDOL"-OZI:ZTR7!$O0"YC2FU./PTNGPE#! 6H'(P:NQX
MU+E=E,I?#+-Z(],NE.N=./7^\Z6ZD7!-N<(F/6=;#K2'B?+L2DAU(]3C)^M)
MDW=),MA-73+DM&G>G+X".GG63J/:BRC:]MFN.[%#^'8^GA7T!I'*;?M%<:[1
MII^TV*QZK7<;I?.KO46X-A17$_9"UQ'&R",*!"4>ON131C-*VF_X$2?'V#.^
MZ_LG2'3\-_4O3V]:9LTK<[&99BMRU-%7_.^&<M9^IX-0W2]RHF*W=%!=1.K-
MWU];WM:6#II98T"QW)J);KO=I15/\91\A0@J&[)[C&T#N:A;5[J'?!2VM9FL
ME:YEKZE-+?OA<2[);E*2!@X4D#82G:0!^'TK1+'?ZB/*FJ0ZU)K[6.H5RHDA
MZ5:+=/4DIM<9"V(BMHPDH:5P0/>D]T54A5]B#=M\VVL,RKK;'H;<@!ME;S:D
MAW!//^(?:ENQFMH6=+-=W/16H$W&RSK6S(?3X;TJXP1(3&1_S@2<J2?]W!J)
M1^Q#=H4UC/N?4/J0VJQ7*9='[B]':8>@6_Y!;CI4-Q;1N.![$GGN<5"Q]V3&
M5'3\W2^MK+U0L/5?4=]L5I@Z<MZH#R]57IF4\XHI*2DI8"=O'IE1![&FQPXW
M1X_4G)*+5!M8NN?1^2%HLNL+5'O4LX0N/:G"TKW*'G&L8/;DTJM=R$^ OO3M
MTD_+.Q8K9=?2%EUIY+BE)Q^,JQM%6-%';*HU+\0G1[1<I35R5+N%S9=P[X#7
MC^=.?*2,('/?DXJ(27-%[C)45_HOXF-"W:]3KUJ2RJ^8GJ*&[5:;8L,N 'RJ
M<E)W.NJ^B1CTJ+=VV.H/HM;2/4F/$UA#OEULFC],:7\!:Y#L]+PNCRCD)0AA
M>5')QYMJ:6G=L6<:5"6I=1ZGU0P\KH[TNO$V,^LB=>;](,*-%2>ZD)6I)*?7
M=G&/>GB_^U%3X_$R9C:"U[=K/ <N+>D;C#<0DF1%FS7%*VXR$(<(:4..ZB1[
M"FDG7P&Y$ZW8-(/3T&=8VT2''!A)MC3V5]AE6/;G/>B*C0-L)VU.6*'^R;A>
MI\U;1W-%4Y2DH2>$I\+)4G''?BBJX8MWS0E+@W1J,K%R:GN24>9AR(G#7.0H
M+&"G&/3'WJ&FAHM-D5(>?D2DNW":PN2-J%OAGQ_%3V\)/<) _P!ZELLH7UFW
M-G1X<YK2$A2DJ2RIE*%&2AL< [<[0DCZ$U,NNA%P^PGN#2[;:HB+=)6')C(#
M#<>WK!C+ \Q<R2,]LG:.U3UT2^>QGI:-&NC;!=4XJ7!<4MR4RDAM:L^H!Q^M
M*^2(\$U>XJ(4-5U3#E3 @*45( 2L'U  \V/L"*A#3YX*L;T;"UJMYVQ:N1&<
M:>#Y@A@O("P<IRO*7&L'^3G&14[=W3%NNS= NNC6BC5.D+E)<7O$V?HYE;Q;
M43Y%J:>PI/'?N*C\/?\ 0>[(ZVZWM#5X_9=XU_#,AAQ7A(O<%%JEEE?8+*DA
MM_V!"T_:HNWV.G0<6>S],K.A5R=TE 8DS%Y<G)B!+;F>R"^A2PD*^I S3;8Q
MYH;<W\A!;FM3V"_($6!"F6MY(5'9<@-C]E@]P,I49&>#S@C'!Y-(TTR-UHUU
M5I#J1=)29[G5Q^UP.5&WPK<P"]GL7'LX(_P8R,4CC)_(*4?L1EE3U AO2HMV
M_9]QAL)2(DYE(2^YQR'&^$@)[ I)S4)2&W0)-YB_)BN7%B_MV66I&$R?DDR@
MH>F$**0!],T_-$1VMT1;.O-06B1'COL?M.-X!\:X--H:6ZO/K&.!_P!5=$9M
M$Y(Q9-0[LF5$5.5<GHZ'5;RU(B;'%?X1S@4]E%%;=2+-8=27%R9JK2UFNMK2
M$!=PNBU92 > I*&R<#W)X[TK=.VBR'!)6KH5T)ONG5KTQH&P369:,/N6I277
M5?\ NM95N3]3Y?2H:<OPHKE*I<E6ZGZ :=TFX[\D-:PFF3O2T]81(84"?P*?
MBE2R?8D$CV-&U?)<IV@.;>CV+Q(.GNINM=)"2HA,/5MO#MKE 'EM$M20$*]4
M[TCV(JQ-/A-K]>A9?FB0M7]S&[G-M.O=)Z7U2^E)>A/VTMP;GM4GG]P"F.^H
M=\M$*['!I)*I4^1E^'@--']?]3Z<U.--ZDTEK"XZ9GM,LV2X7&&V)GBI!RA2
MU+VJ]@"0>!1ODN&4[(OE$U>=67"%?572=I*'=8B%(^2FW..U;KC'=5SX"T.(
M*'OHXE0!HDVBRN!?6\[0%JTX;WK7HE<G=J2X9D"%'F)[<8=CN#:??@4R22N2
M*^6Z3*C3K'H?U!0NUP.A^O=0R)& KY"WA#K)3^']Z2I0 [^M1<)?#'>[[E?:
MQM+4JY2(5WG/0-JD%N'<K5<''(X0G:@_/!H;EXX* D)S5<D-9>?3'0UZT;:(
MVI+)T?F/MR@%-S;5K-YD/ C!<<0X0=Y]!@ 4\8M*TOZB;TW5@GUMZ+S).HV+
MEH/0>K+1=;L@+FVVX36Y&]1P2ZAUESQ"3]4G/K2SQ\\(>,K7)OH3H%K_ %U/
M2SU0TE>F;;;VMT)I4\P3N'\24K R?L3]JA0E_J0-I=#_ %OT,O-DFP(6E="7
M"\BXN?(B3<K^IURVE0SXGB1U86WGNEQ./3'%.XTN$)=]C[2/0#K=I9TKUI<(
M,RV!*DNFSCQ)#>!C<DA:0H ?I]:K<9)\ANB^B6TWTZN^GWY#5XM-QU+:"<L?
MM(!"&?;Q RRX%?GBK(QKL5_D5CU"_8C-T><Z8:<O4_4+F[;;+,IYYAH)/F\1
M*6FBD>V5&E:Y]J+$^.6 B>N:X5[2UJ'I_9UWD!+$U-RC.QWTJQ@I6I9.01Z$
M5*3[:%+,L'4[4=ZT<=':,B:@@282ML.'8G8T^.I&2?#2C(*0 58P,\XI-\H\
M(C:F[8A&NLI;[-@UI.EFY-J\:-'NP;9B-MGA25H2M*T.DX]<&C=?#&K[&YOU
MKTG?7=+W'5&A[-)=<2N5&FB3N6R1D)"O&4V00>U,FEP*TV$>H6.G+LFWQ=%V
MN=<&VF2I2;;J@P65+(R5)!5A0SSM!IG7P*K^1M!TSJR<ENX0-52&[<V\'D1K
MK94R/#P>6U.M*W?](JQZU5-R2?V&BU89W^Y3FK8_)G62*U(E-ASYAF0IMA 3
MQ@*4@D<<\D_>N/*?O-<.B(TVX_>+<N5:-;WF3$;8W>(Y+;G)&/Q;F@C<$@=E
M'.>W'>NQBW17!GR-63-^L4/2MH@ZPU7=&KC8D,_-J>C,PG'V2D]T(0CQ$'M^
M*K>;3?012:==BD'JITUZD6B7!LZ#<_W"DR%W",IAQUM>/*I>-AP/=-,\B*G!
MHJMN#T9TM/DVC2<33;Y+@5,B,1&Y<EI)[D/*0=@'M2;DE2&2;['?R71;_G8O
M_BV__C=&Z)/N'UX5+$Q<@/!QMAS:M>.Y]\=JYW)T0ML^I;<S:FD&WMOAQP9?
M6O:KR\D!)XHL5K['M>:RGZXNL%^QVB(B/$2&6H:'\K2G'F))X3DC-6;VQ%"@
M=NJ);4>,[<;FA")"L>!'EB0XDY[%* 2*C\Q_U)B%<;1"2Y$BO$S&H_B!+@&
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M>)?;=<)+/@*9EMQ'RE[/#.T!"B?T-/')CZ(<63ULZC_$U>-4IT_9.G%HA0W
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MOV*JOEACP)LB"BXF8A+Y3'?4W@R![[3^'[5=":F43CM$XT9YV,MU];+ B_\
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MM:Y*K3-=&6Q*XRW);3KLN2[E04.6R?>D[!'4W2[3MQTM;LW27"?@3TAM3*G
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MZXN5LL%QAQH3*EK:4XK<@X/\1'!_*JU'FBU2X#S36D?]$<A&I=46F#(FO_[
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ME'3 CE.%/(+;N><E"1CM3[701DF!GR&HM+F/K5?5.;;K7/C%3<2W1E.+1M.
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81ODL+]EZR_YZY_\ OP:_^)KD^FS3N/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>comp_0001.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0001.gif
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M\/3T]/CW]____P
M
M                                                 "'Y!
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M&!P $$2LNA\#&" E39O1DPD'##!( ('FH1F$9]<>3BA8$F,2<E1(<,3U%!(
M8.PE7ME*BP0$-% 9@D!T<2Q,'AAH39UZ,",M$62XR*"UM20*#MPM3]V*"P+X
M9&/9$,(UCP$8K$4?<49 YL$$ _2 !1))3$8(# "<,-V :-DP@ ,_^#" "EC0
MT%\A5I00&86U9?*$!P",4,44!TR !0X,9!24!@ @0V)M/BR0%1963,# %/_-
M)P@3#1! U80W'OYD!0L!-"#:%20$\(01 -A02 X$2"!DDGEEPH0%!!F&A0H
M]-#$ANID0B8)6R'))34]'-# 4X(TU8(5#%30IB!D<OAF92X ( %26^D P 98
MA#  4IF$"("?;O[9BQ4\P;#55D<,(($5 QV)18&/NB:I2D]8,-52433@P!1"
M1*>.#?CA,.IA/""0@#2_8#%%!0 P,04!'Z@S4(#?S<I.HV1:X$0A&HR'1040
M=-:4"7N.!@Q;UF(AQ0:/,@/E **=@,!L))U0;! .DA8I-4](I6!5T%$UPP!%
M\ B=N6Q)@0(  :XK2Q1"W&"##3NHE2YB0N#CW2!6A% 24P!0-44'KOX2\@0(
M%:Q@0P4_JL3$!P8 $,!#(@\ P0A$=":J7EC,$  &P@5600%4X0  #5BT6\"[
MP6!9PF0A+"#C(T\<[$D4)Y3U31!)_' #"B= )D ")2R\LC*!DG"M(%%80(!H
M1 "  A9)/*! .L$TC !5@NP@@)6'&,VC"0-(LPR/,BA @ IB&F**"KP6X$$/
MPAU+)F.$$&F :$\<0 (61.B&MB!#.( !*IG,Z]=W3V"@P7=7.%R"OXPP00$
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MZP!"/":?#*  )42R,?2Y A=GJ0XF,*  =LL$"72CT%P9(3M[8H+^$,#.3+"
M  EXP+*V8KH#** "*C,1!P:@ *M];U:"$8#NEC*$+$T."S(H0 ,4.OZ()X F
MIC<Y@(V$-8 &(&"636B 5!.@.BP,03PS_*@@K, $)LAM.($!$PP'83,-I,L'
M!B@2,G+UA-2@,#P).$!_6*<# CR  #% WA.@J0$"V%**^#" 0;D2E!UX@ $#
MR%(!![2KW!DB4#];2A*@68#$7N,!^@G, _)3NY8%( 05B,!?<J:> CW@6E<$
M  ,0\#E%6&$()5!  ""@ AB4X'_+\F<R H.;I^"6BRDHQ!0FH  #)'88'%
M"JUP@>T50%8F"H$ =L!&\B3L<Q!R+G@J(( 66*  .#P)$4BP   DP 5$& 9P
M5EF>*5! /AKM'  H*0P/'*  :B1$H*2QE?[;&$ (%'!1)HZ0  &TA@'*[-
MI!,% I1@$'%:0!&LD(!/[FZM-("  !@0@AP$U40'J(!RDS'=@%:%" H8P&;5
MX0)[:.U:K>)0)HB @ 8\H57O8L(")! 6<1DFE;OX@ )0804R7>XR!VBMKF"
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MVML^@8RL7?.8&), TF$$!PC@!8MP C3CC?KEOBAZ+X*&O0_QA+"3M/;32$(
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>comp_0003.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0003.gif
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M]/+U^?;Y^O____CW]_#O[^#?WP
M
M
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M!($00?X 7.&* )C@%4D0@"KV0+QF'-2'+)1  5;0![H2H1EF ( JVIQ)&?@
M&G<@GC%:D  74P #TG#E&)#L %4(LP+ZRR$T)$!?'QQ:#P 8Q"L,@  'LR'4
MS0C!ZWX0 /FY614>UL,P/@B-"E3 ?P*8(VL#$()"A)D-T5 U-(  @&,D(0##
M8 4 UN"\'3L;8H% 0  :Y\KBQM$%RC6 WSRW7@P80+.="T!KZ,QL:#SN!PQ<
M@ 5^\(,$-. 5"\ V-&1@ +!-XP ;G;<!CA$-,(M@ ""L@ A8,6T_K@$(&1B
M(*;7N!0' GFM>46$0_@]/@9@#)^-P0]:P#@&-QP ?5C% /Y(\ ,(AP :*UC
MRT+0 (NG 8TJM8 0./ELF U;GM+$P"I4,8 2>'H &VA& RPP$'H[< &YA88:
MA+N&Y GDB7SR)C06U[A7I.$'$C# -)IN5#( TPT*)D@,).J#$(2:#1G80(X?
MT%9HI&$ +?B!"P!PA&&\<H)Z,,(&A@@-'QB@&7$, ;N!K@I:0R,$#D @!D)
M\",;XPY""($ W-#F0RL= %9RA1I^4 $%N"+11G6% 7Y@=S%,8P""][L$:G9J
MHP[#H&C<?.=;H5\WC&$ IJRY[AG&!@&L &RO3_H@--UWSR<J%6M@Q6+G$FZC
MTID-#$1MT(>1@!"P00UZV,,K$OX@;WK;VP"6ET$!IO%$,?1A $2 QA@6((0#
M^"U-KFB !-: O(5CC\Z#"'1K6C%Q/E&809)V94IP-&N@"HMC!O8$<JI086J@
M!O&%<@O@0"QF,]LC$-/ !BBU +FW>R4A! &@!\:@2#8C-PVH!TO& "; )MX7
M#0UP<I>W"ER7)BT0@<T@=8"@8H&G!QXX#*>F66,  *X =E8B,EMV &2@!F[@
M!M.@!AN@=M#  +R5!A^4!FN@!ZG@05?0#!#0 $=3<#EP ',%=]=W!X.P"H:W
M 0^0+.MW! 7@"LT@ 5RX!A](: *Q=(+0"@:P 7FW9J"'1@- >@$@!JXP "9P
M?7Q0//YU&':OYP.CIH=*Q2 6L (AP%L<6(D)DPH#T !'4 9&<%;$-@:#4 $#
ML#(R, #3\ PA$ )I9  GMR9BH#G0\'SFE@!R>#DDD !;] .ODW![L ;CPTWQ
MMP![, BL> QP!PU-!T*NX #+1!##9P8 I#F?<'^8-STQ( @<ASL3%@ K( @Q
MH&#,8P0.X@+#L#BO<X-Z\ P+\ $9% -G10('(($+  VNU +@XP!Z P1K9HDF
MD28N!0@>(P$5, RM$ -[4&))-V^/!0W7LP>M( $Q%FB:96X'8 PUN +0D&)Z
M &J!($/(=FI6\H.L, T4I0J9(P@XQ ;&H 8^@&?2L  N2/Y7.7 ,@Q #K. *
M^S4-=/<,'M8X,"  :F ,%B !T] *,G '0L< @U & R !"-0*ZS5+M_,,2@
M=X"38K5TJ< '(!=4:]9T&R (+N4&=A=P1.D*,G Z"Q4 (I *L<:5>^"5K6$&
M#G4Z0\./> DF:3(&"" !YD1KTI #"C  #W!6:0($"> W@_  @[D!)714!E U
M>P!>@K!2,'  ;R0"!3!,1E4(#A  &6 "#6!OU5<!6-8:1F  #2 ##H [?:=B
M_6,"!E !,I!9(M=P!J WWV4 ,*")(=0 .6   P $?,(&"V  !B #T4",C4.,
MO50(6:< &^ W+N  #D0"3BD-)O[PA\] ;PQ@63J6EQ9!5E;2+:Q0 090 !GP
M"K>%D0+Q QHX02U@  <@ 49E!@9@5- 0 PY@#-'@ #$ #<2X!L=@ 0>P 3&P
M *ZP!M,%#6: F=# !TF&50*A!/1I $H0+#$D 2DH$'S   =0 "W0#*]P ')U
MF1"0 PC0.(#@ .LT9>F)/K&X &P9 A80,/-IEWX' 3*P &L@>G,$#?$D",<0
M31DP=J_P53Z0 +$5#:YP )G4"A90 (/#/ZQE #/8I,.P >?3HS1S# LPFN(Y
MIF32#,: 1<T@- -!0@%CIFW2"H^Y)\;P)M+P#%A41COTF,;0"O_B0X/H P:$
M0!W$0O[2< QK8* I1!!;Q$**XI]JXJC&Y3>0FB@=,ZAEI I@$S_",J<#<9,#
MX:8JY$-,Q$!O1*8D$3_W0GMR(@VD%*H$X0JL$"QU^D"]8Y&/RB>DTS%S:J>+
MXD-U=$8GU*K](T%=!#;5)2BO(*F"4JAKHJH#<0Q6BF>42A"O$#FV"JF:FBBM
MH*MHTC$$*:?=XJQLLG2#D&QO2C<&U%WY9JKLRB_A:3$+8'D)H0JJV4M:\JX%
M@:_MNJ\+H:\EP08*,#L)H4[3R:\&*YZVNA!I>K ,BR5WZ6RHNA#1($$-6[$6
M>[$8F[$:N[$<V[$>^[$@&[(B.[(D6[(F>[(HF[(JN[(LV_ZR+ONR,!NS,CNS
M-%NS-GNS.)NS.KNS/-NS/ONS0!NT0CNT1%NT1GNT,.NO2'M*2OLP34LFJM(G
M!T$KN%*UK&(U<Y*O](*U\=*UGQ*U6NLJ4G,IVD(G9/LMN6*V98NVD4*V:<NV
M;INU<ANW<#LK9ZNV;UNV>5LK=DNW>CNW?_NT#?L,Q5 ,Q$ ,A5NXC50,QJ"X
MB%L,Q_"XAUNXD>NXE"NYCUNYAHNYB6NXE6L,A_NXBONYH=NYC82XH#NYB7NZ
MC%NZJQNYQY"ZQ& ,6<2YD&N[D:L,"7$,L>NZHXNZONNYP*NZO]NZQ"N\QBNZ
MPCN[AQN[M6NYMPN]FJNZTVN[H_YKNJ2[N(WKN:]+#!0K)\Y "[5 "[@POK5P
MONB+"^5[ONJ+ON([ONMKOO#KON=+OO0[O^B;O[70ONF+"^^[O_/[O_V;O^K[
MO^5KOP+,OO&[O[E0P/4;O^]+OK3@"PCA"YG0"1C<"9J0P1J,P1O,P1G\P2(,
MPB,,PAY\PAW,P27\P2;,PBX<PC",PBD\PRG,PB2,PC9<PR:,PS+,PYT0"9H@
M"9(0"9(0PS/\PC*,Q!VLLJ<;NKS+NTX<NHT$NY';O%3LQ%=LQ5,LQ5@,Q<TK
MQ4]<Q4ULQ5X\QE-<QF)\QFD\N0V4Q5N,QO2#$,\P#&T,QD\<Q5TLQFD<QGA,
MQGILQ_Y>+,9T#,5H[,:$K,=N#,AHS,6+W,2\&\<'X0RS,,F47,F43 N6G,FS
M@,F9S,F6[,F5#,J=K,FD3,JB7,JE?,JC/,H4?!"^P B0\ B/$,NQ/,NV3,NR
MS FRC,NT# F\?,NV_ BZ#,R]_,N\[,NS7,O$O,S&S,S [,S"O,O$C,S-7,O#
M;,S4S,R^O,W<[,S5[,V/( DI^PQ\S,5?;,[HC,Z;R\6=.PRKF\[P',_NO,Z(
M6[KJ',]LW+CX;,ZQFQ#U',\A",]TO+WS[,[NO,\(;<Z@^\[QG+CT0\?#4,^*
M6PP1G=!23,^3R\6Z&\FHO,J;;,J;3 LBC<F@C NAG,H?#?[*))W2LV#2D^S2
M+4W)+@W3+UW*--W1'ZW)LM#*!O'*D<#-OLP)/^W+0\W-1?T(F8#4R)P)D1 )
M2)W4D0#5D.#44AW54TW50)T)1+W-6KW-14W474W47UW4/UW44"W49#W51*W4
M5/W47BW+7>W41@W40#W6=+W57@T)71W6/QW7OLS7:KW-XIRR;;S&O6#.CFO1
MZ S1A4O'&*W8Z'P,]$S14DS'D(VX$ W9PX ,<LS%EIW9^QR"CMW8%-T+CWW9
M^-P+ARW/ ]T+#;30$1W1B8W:\;S1!B')ETS)LF#)LK#;J.S;I S<.#W<'2W<
M,8W3,'W3Q)W3QVW2/%T0/GW7TOY]UVW]U[N<U+*<W;7<UL.<U'JMU-.MS&$=
MWL4\W4Z=S-D]WD:=S$Y]WEW]"%$MRUA-WG3]U?1]W_@=">-LSO3C#,JPQO]<
MV8N=SA9)T,K0#,L;NA5]V8Z]X,1PT,=PX)M+SV7,SHSKX C=SU/+Q6F:IOXM
MX.I,2(2TO<9PX+)+VR"NT<Y@N*<]N\H0@LK@# 'MN@>-XO',V9%,"I:\"\&P
M"[H@T[L0Y);\"S/]"SVNR;@@Y!ZMRI.LTC*=Y+D Y":MW,N=R;C0P+.0"[Q
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M<,3H'LAF+.M-G%X"#$\,H<(03<*8^Y$LOM@D#":6"$.21_9&) O;LL@B# 9
M\&21+'K(HK7Z[#L^><#N&[!YYY^'/GKIH<ETH%+3"( /"RP8YADV ,@  0$@
MZ&4- "Q88'Q78 % !FC^  "+9UH ( 1KC=DC@#2<P?+%#!X00 F(X0H(Y,D
M,'A&&?X*$ ,('& 5RG"! 3(P@!^0:D<Q6  ,#F !9 AB !$ @0#2\(P0-, 8
M@A!  T(@@#) PP<#"$$ [I" $#Q#%   0C2JMZR#- L_SR!(,88! 0<, QJJ
M2$ &G$&& 5@  17H!2P,(($'#$ !>_!%!23@@@#XP!GHZX4K,K#! 03A&7H
M7_H:P"HLJ0$ %;#  03AB@% H(H#T,,S[C" )TH  ; @E3+2H  (+& !JMC#
M 2*  !(9  ,("( (AH&,%V)@@2@*0 D D(1GN(J'RO+A7IPABXC@ A1!: ,P
M9L$ #%QB 1_8Q2XP48 77.()-1@ &G+!@!$  QB4"$ 1?OXQ"Y#%(0!M&$$$
M2+$+/!"@ @P@@+EB<8 '%'  <)C% $80#&#Z !@U"$ &&M  4C!,F""+6!&
MT8$#7$ ! <A!,";!@ 4T0 !G0(L!*+  "(0B%O6$P  $  <_+, !"7@#%@"0
MAR@ ( [)>$$ 0/$&!3P3 I=XB<_RTQ?Z0.(""R!:9FQ0  HD8 *)>,0"(O
M PQ "J78P@$0  $&), 0MN%$;S2A@@)\+1,V&$ %#N"!372! !P8  Z:0(!R
M#> $%"C  )K@B<Y9(:F9 *@!"M"$4LR!GA&0:BFF<( )-" "AG@$ QH @:A2
MH0D):  #YM"$ &PA!0- A"8>X/X 3>#  !5(@ =,@Y@M#. !%BC %N@P&T]8
M8 "-"(, F "& 4B  P?(@B;X:59.@(  #:   M3#@0: (+#S45YJCR>)Z;76
MM:^%;7^>L<-C(*.$SS""  8!C34(( ;#, ( _K ' ;@ N #@@RL,  1H!$(
M9$#&$?@ #20 X!.!T%\GG2&$ (CA&=6-$!%4\8P2(& 8&6  +"9U"S< 8 W0
M* ,  J$,#RF !-/X!!^&\0<C%*,7"Q !"2%PIR3X=P$@@ 81!&""0BCC!P.X
MA1D$( I,K>F3!'%2G))T"PDLH 4N@   RO * ?@ &BB\0B\8  %8$%<(A=@D
M,0*!IOX01, 8P?T#-(X @$$,8@ H&$9UU3!;8Z@!"R<& !*&L=86E[@9$FC
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M!X[@0KQ'D84!L$ 1Z8$$&+9@&-6JMJ/Q85YLU;YVM@\(B 1!1BH,0()47$$
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M8$B7. B&#NB 1HN#2OBKTTN #JB%B-"+C?*+=$. =4.,)1@ +^@."+  1V@
MDWN$TLJ$".@ ]L"! WB$D3* &1"-$S  ,"B%)3  #JB "C  &\ YVO"$A]L"
M4S@!!H $1U@ #R"<N\$!36@ #N@.$(J$7"R,4C"%+^"G4ER "W"$"-!%2'B
M#G@YFYHY LB"2$" &6"" 4B$)C  "Y@ H6*![L@$1> !#MBG$S@%&F" )>"
M$V !$)@ 30!'#K@ JENY"8"$F1N S'H$T3J%&3B  H" +/YPA+(3R/K(A+8S
MR(-$R#Q+"&<0@P(HP01(@ I0!C1B,_,9+LCCK0#8 \(S,?A1@U4 @!:X!3<2
MA$$(@!7I']V"!HK\'BP8!AE(@%9H!5$8A!U#@OBZ U:@R2HCAEM8A4+X@Q@
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M)( 2$L""+(F!!H"!*R !.]F15_"!Y!4#)VD%'Y" /5B#$)CE-%CD9_@$$6@
M"SA,0=@ *;:P2+8>VAPENJ"$$WB!$1B!#YB!B3@#"VA#@OZ9B#S( #C0"BB
MLA&H!)ZAP2"XBH7I@">@A [ ITGX &Q"@2'(A5AXZ&"P PR8@"A @2@(AB>
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M 1Y \@ ""T!P  - =G4( PMT<, "AFRBP@ >3$  $YLXXL4#"2@"R04#6$M
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M$%8T>I$"'3A W?@OEP%48(Q\29L)C@1LFK ! 490@0!X@08!J(,G&O" 2'#
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M:&@7P-@$OW8!AF3KP@$F4 ='',(32[#R*>I0."TU@LD;'( 5+EN'+W1!$8N
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M0YT.6C&(H:G(Y#E^HSER!(CFH6NV9ES]Z?Z5QE^.Q#*00D+8PD78 M9<A$!
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M#CS !/X\  2 0!C,S02$,&6*;D?ASO1* OAZ 0/L@.=HPC5!P 1T< .$ 0M
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M!540[7AB%SX@"H!A%I8!"S! *)^ !&Z $H(!"^) &$BA""Z!%R@!"G8!#UX
M!:" 3K!@$FX@#H(!#U#@!MH  V*!%(( !73@$H1"%H(  G" $G[!#CX !<[
M+*_ 7^-@%V0A%_R@#<Y@!&H@%.Z$$F9 7VL!%_KU!?"@$BX@ [#@%RCA!DR@
M". R#]K@#6Z )VQA/MY.+67!,/ZSD"T>(3%+ 1)0 01LH!04 01 X *R8!1
MP M*X0M P!%&P9-*H0><%@0601-HH F@=A-8X ).@ 9 P!/"H - 0 .R0!,>
M4359LQ%4H ,TH <V(1%2@&LA0 K B@DNP -P( 4< 1 SQ0L@  )L0!/6%@0Z
MH M&P0ML8 <X(!%8@ <N8&I!8 (6ERT<(07:=@=&@0UWX (NX N,<P9 @ -L
M(!.:-@LF8/- P /<UA,0X0)V  0BX&TU@0T]P /"8'3;$!)F('-MH -\A7(]
M8 :XQ0:R &H!T4$"0Q("80!< !96(08 (!" 0  :+@,6 !K8(  :( -6X0<
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M5N$!5@$6;H&(H6$#.O(3*J 9=*"+H4$-/!D65"$!8.$'5O[O%1[@%:!!#&(
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M"CMXXH@F'&SQQ06;3( B)U_$><$,F&:1Q28=9*$)DI#LRBN&O/X*+(:1##(
M$)[Y(( @JC!0 31Z , '2S\$H$8T1P!0R!X L '-&M"FXL,PT,0P@"L2;,"2
M'H%0R&Z[[KX+;[SRSNO9,?8>\\P/.41SRS-7K/",!7NP%$@@S\0@AD(6Y&LL
M-*VLT4P&:[ $1,(N<!4($BSM 4$S*@F203'%()-!M-  (LH:$T.C%S01Z,%2
M"TD,TX J+(D@QC,5?-),+Q:L<D4J+%6@ARH1N> #2V2@VX(9SE1@R3//0./,
M9IH=0_Z,,>T^,PS6P]!$!C19]_*,&2XX8XPJ#O3B#,M)7P$$#.N2X<) @K!D
M1-T5#,+2+; ,(O0S,LCP3$YEY:0*!%I#HTHKRF1PMR@5- .#&,XTLT8(+0GB
M3.6,6]"*OX3OS9(KJI ,&3$94+8Z-+T88[75QO32&86@B48:%,', @P*3\C2
M@"S) '/))<!$\4(-NP3Q'C,OO  ,,SI  8P%>.02S U# !/,)!"0\L8OP(3"
M "71Y7))!9?L\L$;P"1C!P6[;(!'>+/(LDL;&  SX .7#!$$9O!O$O[!0X*"
M,00=+$,'-TC&+V;1@%# 802ZL$4N?O&+Z#R(00OJX((DU/XN"_WJ 5[01*DN
M4*L(A $5J-A4F4#0@TV  (6H8 $(6 B"'9@"1YK0! B6<(I3"$H3-%@$*CS1
M@"YLPA%+LH$G'L"%(+* !I!X0"*P!(%'?$&%FN!!!""AB5&,(HPVF $JMK@)
M5* )$G#JTY<440H>L& 4D-A3GS:Q!"_@< E@B-,FML"!4DP@"Z@0)(HFL @Y
M36"%J.!"&';D*45D,5&E*(4B&* (+ER@%#E4XPXVV4E4A"$+H^! K8"%RE2B
M4A*  $ ,H!$-:$QM#P,(@ 0<L(!N 0!FT/!! BK0@ "0(!K1<,$ )"  @;PB
M 0D0@0%DH! #+""8O*27-:^)S?YLMJMKQ!C&,V 0 ZX]@PP8"00$C  $"-RM
M!1HSIS%<80$87 $":GB&.9$ A JHXAE(:, :7%$!%X@A TAP1DX& 8%BJ 2A
M1A"" U8AB 88X0H5V ,R+" ")/B@ J$K0P6:0H)N0J @PWB *M+@ #$(P0*N
M*,0#FA$#"Q@!"0X86 G*\(P'",(@O9!)[$YRC,6QJR18:X8$<D82;UZ!!%QK
MQ@]$D!2H-(,5"R"!,9XA!A$P96]J8 # V  !/O"AIGM @!X*$0++Y404$7B=
M,H 0@D&0P0'[S$ +6)$*!D1C!4C@VC!"\(-!_" #T3!!$A@7@59 (PE&60,$
M], '"/ZLX1D."(0RC.$ 0$!C RU8Q4A^:K7:><89"L+?!8H0C%C\X@4G6$9S
M_("&!E#B%Y<80!&6@08!Y $81>A )<X  1;@ @(&S,4D&H &/(1@ ;,( 0H(
M@08*A$([N+@$ R[Q"SA 0 YV@$ ;=L$ .^@B-/B30P**X ?>[.(2S_'#"&X0
M# C8X8 UN,'X(! %/X! @6C P ,]"& .>K!!$V*7A7SUB 7DB!&;T, .T#2!
M'H!@D9[H @&Z< H<,. 1B(+ $G   @T\H@*XXD07(K #'$R  TOR, LX\(@D
MC6(&,S!%%B#0 Q9<8!&):, 5$1&!1)0B"Q/P  \NX(@D/?["$9[(P@)BJ.(E
M@* #B)K )C*1"!668@<I* 4G)N %'4GI 3O8P2*],(%#$;E,%?BP!E*@B :$
M 8Q;>  .9@"!,"Q"A9OH<1@\ 8(?1AC"G@C#!'"@8E4E8@(SP$$#2(E".JIR
MTJLTAB 4ZYE5_/,50AN&(([!$E^J8@U\B"5+!&&&N[&D&7H@ ]]8,@R534.;
MM*ZUK=W%-:\18Q6>[=HK O$U6(R!#*YHQC$\@@Q7?-H8MU"#&%+A#*FTH@QD
M>,5(AJ$'07A,#5>P*#&*\4Y!B*P8RH %M5VAC'*300P[[07DU$#LL0A"#&O(
M&C$&X8J1",(5SIAW&5J1[$$8(_X5KM #$E9QV52(!=^P^S;60%L2E6P-:_8R
MAAH@DU1E#,(-D0&W&6#P@].I) U[N*P@*'(,-;#S#W=(-Q]@ (.2*V,/,' !
M&8H1$V.TP@PR,089%(/P8HCB!X*X!1F,H:[(O#-O1\C)'0+1C%<0NQF!T(/+
M8;X'8Z=!+"F'13,^\0/+^A3B)2D&[=I%6M'DX@S@F04O\H &7.0""R^X 26.
MDPLH5((7EX""+6@QBR?<  W_"P7ASY?>&^0!"Z$9 @MN0$ &R>(*R]D%'IXW
MWUQ< 1/1"4W^4/ &% Q!%KC0Q25J\ (HY&+NE]".+O 0!UWD A,Z6 'C<T&)
MN-LBP/ZSV*"# %Q@"HF05YS*!"0X$88Y%[H'D=K$KL!0*D2$@1.0V 08F/ %
M3K@I#(HPOB8,P0,J-"(,F=!$%WK0A$50'Q*1H(,AJF\(]!__$6"(,2-01(<_
M%QH"J?0"%SBA"5[0)G*2"&# *UT0)<G7)\67))H0!DNP!&'09P;("8M@@&S$
M!(^4!5J4(6#T@$Q0*AQH?%_P")F0"5G  U_@?(I@@)7"?(DP9R:4!3OP9YD
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M3#AQO/YL#$10]ZLP.:FP )_0%1 0#25P!="@#$[N^G$H 4!0#.,4Y!0P,:T
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MA%W8 FL)F 5"&H"+2C2@#9-  ?X$@/$"'3#C%QDHRT]&6E()Q.(#?F#&+AA
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MV !1Z 41*('3*X1F\ $+@ $8@!8UB $>:840< 'RJX!4 /Z"?W$&'XBA1)E
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M*X$%'V@!(W@%-B(#:/@#)!!+-Q!N9:B +;*27DB"%I"!5"@75U^!),#,'(
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M"!WXF5@H@A8H>EX(!2R  Q1@ 4I@6;5'@3/0-S2@A%_ @Q<('#84V;C FAI
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M,V$E$9P!BBRD %-$$,M<$L$EP-"R.2AP0$ **7C@,4F+M,CR(J@RAIE)(A!
MT@0+-)2BP1:E7+"%*1YD@<H4%Y1RRA87; )))HI$H,@FI_1PPB@5@*&)(Q0@
MLJ@FGE2/#A&0@B(>H8A2]& &IE!$ PQ1BO<MXA%TX),I0%"^*#TB$5U  "1
M4(52E&(*/P+!#E Q@QV,@A&1N-0*-96I3E6/4C#<5*4>U<(93DH2J]HA#WOH
MPQ^NJB6N(@:Q?I !") A)AE8 1*:$8TKQ,!7:FB&!%*!C&$4HQEBV  $?.",
MU/R@:3]P5@5>H8Q>&!$":3CCMO[ Y<8W@NL8,PO5,SC2BVB0X C-:(8/CK 6
M(HA "#&(8AE:4"]8(,&+KG!+&5I1@5XHXP\."*,,9""(1$;#%<C8@,R(<8P-
M""8$:S@C,3(0B&:TQ05J$(0%C'$+9:@A!H5H)5N>\8Q6P""/(2B#4 9Q,9I5
M8)$_.,(S7"$!5=PB!KKD)6&,H8PU(, ') C9"D3@@Z81@1AZ",'&4((UK<EB
M%V_HP"_R\( :W""=>+@$!6(!&\P%(W"YV 4*L/"+NOTB"$$ 1B4FH(LSC" 7
MOT"#"-33 =1=@!3L)$4N,%&!4%2@$K@@Q2Z"D0L,Y,$6+QC!$$+P!/W@81=:
M*P((@OYP Q0 XP9%$,8O;O $#!4N&'BCFRS*.8(*9( 2=ZM!,!Q*"MBTX:!#
MP  I*C&"$=2 %K)Q4:BH%Z9-@& +,^A""L!P 49H @-9*$4'I% **G" $YH
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M(PY0" 8&*#$$E#)#!U  1@;RL O8O0$"N&!&'$9 H"+\XA<U>((M'$"*OZ$
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M2VRB!:A",22X"41#SQ@&'QC!#S0 +%R!#&2$< )3*TQ[&HC"M&@$,C3#"I!
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M^""821[(PPX\*IDE"!V6"882"H)! X5=(*@D%UITPD667U" (AA9=*'@(!2
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M[& !X& 21L R=X%H\$ P(< 67OY@"!"R!8)@&5A@!/P@"@K [68B%A: 3X<
M!1@ $W;A Z P""B %U*(%WX!#2Y )&N $*)@ 8H@&/)@ (* H5911#/ #[#@
M!'\! N) 3ASB1RJ@"14N*8 3JV841[$2.7-5"]>L"[=B.8%46%/G,:242>LJ
M,FPNQV"G.H_U,:+46*$U,08+&:+E\@K*#J! 2W1A$FH@""CA#,Y@%J! 1IP$
M"NR@"6\0!4Y&%W0!#P 0"N[(J=Z@[4+A"28A0Q 0#O# *& 1#>0 #\)$%J!@
M" HV"BZA(F*A"%I@"/)F$BJ06RLP%(:@!O!@$HH@)IX  G-A7Q%0%1^P(M#
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MDB[$>H0F.(%,8T(B$9#T2X("$XE!!  )2!G$!ARP@4! XQ4;4$,,E""(>&X
M H,@PP)"T J/J-,!&7 G$!+P@ WT$QJNV( 88K  &1P#H2UP@ ..\ PCB& 8
MT%##!EPA@Q\@80$^6,4ZQ<"106"@ 2' 5A_B&0('D)0("8# !C":/1/):!C1
M(($0H$$R9P0B$,\(1 E<$((_-$,5*S#!!]( #2R80 @9$ $LXG2_JEK52 *+
MWD! 8@P(W&%DO5"&'E;1#%BT@ 3Q?(8@8"#"0.3@&4@P0OX.+  #8ZP, CEP
MA0_40(%!*,$,S5#&'W10O@SP 1IW( )<Y4K7]MTA R% @@4*\0H8W"(&.#(&
M#%8A!C8\(Q4BR  12%"&9K1 %<IX10LDF 03F$ &O>BAS\H4L3OY)']Z:HHM
MG@B'4%#B%[L(101"H8M?Y.$!P7C"$)XQ!"Q0X@7)^.*F=.&'#RR-;*2 X@>*
MD(M<G*$#)!C!)80!@B&P@ +<[8]^Z&A'/Z)M4F9CKZ4XM3]HU T2C(" (4ZQ
MB4U0:!,]T!L/4I")+-! $YN0P@Y*D0(P-*$!%*!"%T[@H$>  !$6VD069E @
M,)P@P1<  0A6&88.@$ #6<A$"OXBH $Z-*$'HY@!#TXP 1M$0A--F  (=L""
MPK"@ 1SHPB9VH $0I, 1G8/$!!"AX2)W !$61D0IFI "2,Z@"V%(P29H ,T:
M9_(+&N  #1H,JTPLP<0COILFO# !"!P8!#90P01FL(DN</D"D*"#B8-,("IP
MP ,CF!5>'@$X!64B$ :P0 Q<L()IM$( (MB#" 3PBE<,8 $0<(,; & !(S3
M "T0 @!D  UNJ6( (9"T %0QB <X( T/C9\"#F $4?\ &BY80"K2  !!\ $
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M"!6*!X!B$A68! 8F\8)+^,$/BB+% [PHAP?H @LW (8N*D")632 $LQX0A&
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M"\$ #-L5#!2 !LL #$,P K\P"^ [!&>@"]\;"QS %+O@!P^ "\D@"Q\ "@^
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M 51P"BNV!022!05 >ZC7*ILP P<P*Y#@ 2"P!!.  X4S 4O  AK@DA6PK#0
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M.)*1W9C!DS"=3> "*YP!/;P U,P$1-B$'JB 2NP!):RW(2'.&<"!/Q),1[B
M+'@OI?[3A$[<A$<0S29 !2,\!86 @#"(3DW0A$28 $0HA1U@@4K"S#" .4UH
MG:B#MTWH34B( )+;!"] !!J8@4U8A$=0A/485L1,3 Y8A A A$Y95T685DYP
M3B^X $]XA%-0@1[P@@D8!4CP! QP+HLX3TM!GH4UE?6$V .+GO>D6!!1NYQ@
M"F40! 80A-;+ &B  0E0A6$@@;HS A+H!1=3@V<H 2$8AD% @%9( Q& !C4
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M#GH&#W(K$A"V)\6%(,  #'@"U]@%/*!)7/"#$; K<Y&%51N!$?@ N]$%*,B
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M@84=)  A)M(#@#&B:6&  R3 4?Z&!X088!4,%E@@@VC(.""! \2 II4#@'
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M!1^X!/XPT->!HMQ@!#7 P"1X$8L/H. %&+C$+H;P@2%@X W > /[0K"+)U3
M!2^0P*VHEZNU[! C;M%2L)*3"42 BRZ<<$0%O! !+IPB89K@! TXP(();,$1
M$Y 8(B[@"!Y<  >M,84-0, !''P! A# @28TX(5$:$!<(!#9(SR1!0A\C%R0
M"(,=-3 #$(" +GN<007"L D/@& &%^@ )$0&-$C0PF") 4Q=/)&P46AB%(A8
M ")&,04-[!$1IZ#!9!"Q1PU(01,L:, %YM $)H A!<,*PPDV004.>. $B"!6
M8N;0@$0,RQ$-:(+*5@8).C1@$9DI!02FH!I%QD82@1B "/[80(8* & 58@@
M*Z11@0Q PP<#P( 9I/$) [3 %7T @!&F<00 ",(56O-!*HQ&@D!@( !(X,,
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MG $<0 9H5. !/S@= (8AA  @:1@#R $T?C" $[EB $*8Q@!<,!$W ( /W#1
MCQ8@ FA(0P]&$,$ R@ -"5A@(A(@P2T&  2*1..>)OB!# "09_X 80#_D< V
M6P$ ,BQT!3^ 0:95Q 8@!%2A:Q,!&:)!YR- 0Q !6,,Q%+""B7!:!CXPP7T$
M<3@1F*%'O_)1[HB1ABB(00Q(@(4QP!IM:8NU(LL34R"PC>U> $_:W:8JM2W"
ME5V,( B7F$0E.E"$8,P"#4-X 05R45>GV&$(.GA 'GYA@?Y)Y (7&*C$"[ 0
MC%CP>Q85N,$04DN"2DR %K((1@W431);H,#@<0#&$U@0#%*01184H 2_+_$
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M$$$S-K  ,N@A (E>]#.B(0$30/H'$]$0'P( !#6P00^"H$B<*40"-@ :5B$
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MYV3A%WAN*GZ.AT9BZ.""$0RC"78@.C+AB,)@%,)@ @:,ZGK@Z@*/"QY!ZRY
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M()(+$/Y!ET1F$3K&-HAO9 0!;!:$1'*@ +P,/X!@ :B/ 4"2#!! :\;@=1)
M<L!O /KL!QK ,1^ !/0)S&2  ;J&;FK' @3-%3Y@  Q !"YD$!K  +KR/_C#
M"!+@1!3U0PY "5K2 0Z@H([!&$+@ "I !A:@$%RA @Z  2!@$$1R:7Q@ =S
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M^:J_6J-UR*J].I:Q.JL9FYF+6:OEDZ1%FA>>&6B"FJ?ANBX8P:<S>V"&FF#
MN;/3>ILY6[2+SZY1.[55^Y+[VOY[)[JUM1>4RZ2Y.EJP2WJ7&3N705JR!_NJ
M(9NP?5ND$WNW8SFE@<6%96,S+BPPB 4U:#:M-\&F9<.<QQEHD!NMR=&T[\6E
ML^RY]?FS$XFZ%:FH5;N\S=NH;Q"VO=>I35>]8]LR?V49/'HM/IHK\+=7@%L4
M,>$&#E@6J&<7X& (X#,CFIF9?YNK$1NX#SL4=X6D%SPCC'NE96,3QMCP:O;Q
M'F&S=?:,@MJ%2QL2%,'R+LQ;G/&,Z *;OP 'V&.S;T,3LB <99HVQ#NY[X+&
MD^.R=_K&W>.1,@$,5/R-HH-AFB"T;SR+9V"76)J\SWO)F1R2F=6]I763C0W*
MM?>OF?Y+*G [)@X1/N-G%X+A*8(A&'(E3[R\E7LB&$+A"=[7RW<Y%_( #7(A
M)Z"S)I Y&' BP1_<L9<YLO-;P1L[OTU:HR/\NN]B$W:V6R(A$18 7#9A%):%
MPB\@,V!#G!M]Q/<B"P[ 60C#$Q#41BD)02O 9S)A%-IY+SQ!QE+@&+%[QB%F
M+Q!#,0HL$E2CG3W!T<-YTFT/GZE;U_LYO JCG[G4$=@Q!4S!$VQCO#R!9& &
MD6.#H.6ZR:$]VOF:RJ>5O1<D,:D]6:T<*?)@"+#@@&4""X8 #W("$RH!#][*
M%IX "F["#T(A#H:@77&A#>, #OAD)M ="D@!%T*A$OCD$O[>( C\X"EPH=W^
M=T]JH;<S>JN#N[?S.[$3W+F>^;-9(PLX81.\*S.\  >88!'BB ,\@<$0Z0L.
M05VRP :R8+I=%&83K\-0/@LX0%W"  =>O /4!1%ZH ?>3A.\@ 92W 94W:49
M@1:(O"X480OJ@@L2P1/ 8 >6X(H=H0L4@0FJA0EVX._L* QRV!!TA@=V@(@,
M0PILX O @%YX+Q,2 >SFH)]_% QL .N/#@>68!$T01&LB#T^6R.E?>_Y'JJS
M?3*99%G3^^\-4[:3!#-W 0HN  MJH )(018R0 ?0P +\"@T0H B&8 )>( HR
MX 6 X08D8 B>H '0(!ENP )&X/X,+F$!<"$.," .=$ "A,%[J!,"GL )&. U
M&58,;N  *D$7+F'A%;[/&WXM^'SXEUFP;3LF6!BZ"/TN!,Q9-@&]3*&+MD!<
MXD@#9'$3IK\'?C$;">G8IU%F>\#8OP!O=^##/*$+&J!")P $I&P"<AYF2^$[
M[+;]+9WX(H$12*$3VH.. 2)"&$]A&CS*,F$*#@V0$D4  0)1BAD(=Y@"@</3
M)@]+,EU8(J4!%TV0(&F:P:')C -@ODS89&@"#B80J)SB\< &S26GEDS(@L-#
M)D43$&4JB32I4DB2H#E]"C6JU*E4JUJ]BC6KUJU<HSX[1@PLL;%DRYH]BS:M
MVK5LV_ZZ?0L7[3%C58_9C8LWK]Z]?.,6(X:,JC-9LV;A(A4!$S!@0R@]89$,
M6"@'L]Y8" 8, Q9FDR $J\$"V#(X$(#5&!$L&*8)NXJ$X 4L#ZTS(Y;=J)%L
MV8LHE![H2B;KP25*#4+A*HR\,"WDQPTK1[Y\>?+IU*DWGQ5]^O+FLGA1]<4H
MZ=&DF@HN2O3@D*8LD% =>G!0PRD0/4IM I$ES$M3FAZ$(0F))S;0@,H7%T"R
M20=,H'**#1>4TD$6I33X('VGH-(#")HT$,8IHW" PRA+C3A>)$CA(LF(CXPR
M X$]S%"*?Z?,UX,F"V1Q"B019&'*(UV4,@,/&IW0A"(('/YRRB%S'*7)'!%
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M NYS<-O7C9GY9]]8CH%VCIBW7IT9CN*7CC7  &U :NDW C?P C< "KD@ 7X
M"@J !KR !A*P"Y/0 ;BP#"@ !<   350"Y2P #+Y '# "W#P +SP1[^0 97
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M)1$W\G!$DUYB=\2,WB6Q70[I[=#=CSP<KS@5U_KB  +&[(F1"&2\0 I3/)D
MC$,U,84*#5!;PI13MJ"@,R].Z2 +1[8 C04:3 %#@U$VT:"+,!K@I)12//L"
M HFST.!3VII !8P%($%%A1U.N: ++RY C0G0E@!ADT<6 ?3@6?;D+8L)..&L
MSE$A<$0K1B: =&E&_*(Y"PZR[$$*+SQ8 DD<N+2AAQD0V:W55.M.59):\]9[
M;[Z5*\]8P ,'W#QCCA/\<,1U+8:89(=;EEF/((@#OP,P 2:9)U[0Q5I<8L$E
M@S>"D?Y%P!O\8.$--% (AI((+LGE0I?RM1=R$F>G7:5X2]*71%E\,4XGGC()
M@X$"I-CSD1ACYB*33(;V@@--V.J $Z^U4N0!2':@H<I&.*DBM0EV*&6+"Q[1
MY (POO=DD5%H"$N#3-B"OB=---ABE.<Y2Z$'H;DH^GP0I$ %6]H$#2Y@%IQ!
M@A1_FLPC-D$UK8QJ J-Z@%H*]8!$V&P3CM#$H3AC"#HD(@5AJ$ C.D %4]
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M%F,$;7L^<HLAHCNWZ0O"O>$X[MLQJ#,/82E"'9.\L=N(7*"$!HB%8$@&**"
M7-B%"X #)%,]C/@%4  %)@N&(- !T=&\4, %L=L%4*@MC7 ]7<@%=0DN6D#
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M$CQB<OZ 3/"$%,B"]DD!3>"""* #36 ""NB2 ^@"Z@(!4]@!+O$$$& "3X@
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MXB"6CGD]8A]ZM^*(!G1>IWU]-5.>B5VHO"@0$/K(WE  !3^@!5O0A3S  C_
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ML?08RD[VLI>[,L\L?P7-Q$"RF+739DB1^<E>87-V'EA$V($XOZS=,T/Y+-]
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MS$)IB@%!OS):#+2"@I* $H@!":1"'XB &0A!#C0#- Q#OI)!N,JK##B:(,C
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M4WAU24DL4USKAA9V@@)V8SMV50B"&K3N#VNK&,1 "\1 X *!"\B -$/##\1
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MFOLP-+0"'[3 )R@!\$+#'EC ;/?!KJMS*BB!$L#[(SN\<U_[U@>K+*\PT,;
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MR* A!YIAY_QM$#9@,-( M<J%V; .)UYI,GR !%,F!L@@ URA#V*@#%;@&')
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MYC9B#(Y("?3 #! )D=P@9+<X!DJ"9Q<5>'SF>BQ@&)0@"F& [E0A">[@&%R
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M#;&2D*FP$-<!+0E#!B@C,L!! K<I#9^@<O4(#4H0"&[P',^0?WS0$*^@9%>
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M&T4I#;#8!_EH!.5U!5RX"D 0(4S8 M(@N:T@;5=@##&P!ZF@+#)0"#R1A-$
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-?NB(GNB*ONA4'A  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>comp_0024.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0024.gif
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M^>?P]_/S]//W^O;Y_/____CW]_#O\.7@W0
M
M
M
M
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M$Z1!BQL1+ A" J5,\,!S7"C[!0 <]$: D@1(8%< JB02@ IT2% P!@C00@<
M:$ 2  IT3!#LPQ6LH( !'YP 0 EV)3 '&  ([  !(Y PG206)*!%*0:58L &
MM+@ P"5C ##&' B(0,L' CCP 2,(?"#)"4B#0(!"%# 0* !WU%%!FW[%N,%^
M1#+R00"VC!$  Q,PHH6R6R!@0/XIC@A@ B(5+.P% AHTQ= < 80Q 0HL2" &
M (J,C (;6TP7X1]FL$=+PQYP04>$ B")>!I&MZC" %RL40( :(/K^NNPQRZ[
M2.,Z64LIB,@A0@!L0"* 6+2(@,!R9JR[!@ LK"$$ $+0XL!LM$R2&(*E1"TL
M '70PJ-!DM 4 @%$<Z! +2(<H(JL8*PQ @"(L %Y"P3$H@(!7[ A OMI  #H
M!P<\AT (I2  !]A@!@-,H!;;H\6 :"$KX,BD! C@#VP4E@8U5 !C)PA 4TJ1
M@ :H@'3!4X!",!"LY7V "W=PBBD(P *#8.(.;-C  "1QO!;28@(3,,C\5,$"
M&*D. /YRJ 4!9M00.03 #2N8@ 58$"]%K$$ '/! "$XP!D1   (HL( ""B*&
MTP2 "YX0@%D0D;-2"("()#C !SQ0@A-D;W9PC*,<Y_BZVM$B%B)0  @RN 9)
M $ +!A$>T9K&"# ,P ,>^$\::J6B!<E$# *   8D0 #J+- I'T! *6KQ 07T
MQ@"J$!X(/&""$RC"%@1H@060]H$$A("-)5!$\8+8R5BHXG^.*  &// !%&3!
M-A:H12P<@+02'(!H"Y&# ,"0@.$\X &C1 $*X+,W@T "40)XP*$4\!P2JL>+
M@.1>KVA1BA&1( 0!D(0:@&@0"EB,@00PA0G4R,83("* ,_[J"^+8@(@#'*!]
M $B$=)"D"C!,HBU$LP #:N&%%M:B,<[Z@"7:0KI*&N1Q39$$& 1#QXYZ]*,@
MQ8J#"I0( )@E?V^01  J1(OC:6!'!$ $(P P'-+ Q%;(7)!W3% "$["G%M^3
M1"PJ$"P1)" OG20? F*!LQ0J8J.T\, #%""PAGV.$5ZHA=S<,#5NXLL#M1"/
M0<9 JP<XIE9((P$![K 76T!@ @IPD@<2H! Y&$9X,)$$"6C2L$3DB@Z*4  %
M:*$%)*V" 1;P"0$"TS2NJB  EEAG>I(& !&P0 $B+-YJ"JD*9RFJB$ZK10(2
M0 N,"BN;"$B OP0@ 0TXP "U</Z?) D@AEIH@"L5<%JR:.87#V13 !;@:$B'
M2]SB&I<C&P" DTP!@01@P ( ,,-,6U 7-E3  RL0P&H>^P #.  F(0"  YZC
M($8$P ,Q44'.+.&  RQ  (;9@ !@L@$"1#4 FY3O P(PJ"<!@ $*L04'(AF
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M!Q0J TJ9!#%@B9L0 Q,JF54PIGO AG5!!#F0C,;Y":* !# PHDHP U4PI7N
MDGWZIOY3.INTT -6P <[X(54&)DPL >9, 2*20N 20BA(*EX" 4V, -%0 N'
MT)W ^)82UP,Y, ,C&H<ZH*.V^)666*HVL*II*@NM.7$YD -P,0ND.@,X.@LY
M@ ,4MP<R@)UE206T( HSX)V$L)&$< A#T)ZTT 1^"J=&Z01E.:)\D)2CL >
MD*I6$*>D$ />R9RJB:LV, NA, -$,*93ZH8X, I%8 4E294,.J\$QP<_@)*L
M$*6'6@/SZ .!J0<_ )B<\ K'NI0QX 0-,01#@ 4S,(TJJ@.ON@E!69,SL ,V
M  N?,+$T:I2T<*,&,01$@ 4QX(M6<*!2296S8 ,Y< -88/ZD,3 *^<JE!C$(
M4-"(,M"R#&$(,U"I""JSM)"LJFD0>:F4P*J:M3FB1[J,#,$*-^"=HG #/?",
MLR *7GBDT[@05OL04) #GWJJ$:$$WEF3_=FB!F$(02D+F7<#0]"3H$D+5" #
M;6L0:ED%.!"V<8D#,\"3K$H+.+"R>ANK4'NKM9J&:TH%.)"+O(H#TZF$UTJF
M>K"S#<N7$XJFLRD*44"F3J"?#-$$-Y #.T +B4FF!I$$@6F:X$H+I*"O&<N3
M:SJA#/&F RJ&R?JC]%J[[B8+40 #5C +QED73C"IM*"DF8"@.P"(>A #"GJ)
M,4 %9@NO-1D#>S #%CJQ50"CTO[+G3-:HQWKH\6ZO(4@ \[KL1(7I+-0 T>@
MI*3PE:Q@MBW;<#J+ SN0 S9 IM];!3[@G#D@LUTJ ^,YG4.+NC.@H$-0 VEX
M!$1:JSV@C1)+K+.0GLWI!+-YI+6: PE,"WTZP3J@C;*0AK:X"9E0")D0PA]<
M".U("X50JK!PK<Z;NCR:KVL+"#) K+ P!#'@M6Y+E09LBU:)!#2Z"41IB3;
MP[Y)HPT)M081E\[IM@)ZI+:8N(O+$-:IFD5K THP"@>;LCOPQ M!K9Z;O[;8
M!#3 G'O@H.-*"T,P \?X":=+"Z0K"]8YHIN@H_EK _"JPW5A"#$PGEAHNWPL
M.YK0 _Z6.0NLZ;/#.;RTT)MLR =SV;<U@ 0,49M [)K;6P@8R0=Y*[:94,F7
MO+$VFI3;^XPXT -P49M.V1!]*J0W@ 3_"04?.0KLZQ!8J@-0  5-,*+-^ZE6
M0 0^FYAZ7*8SR<8UH E-JY7'.LM1\,3UNQ"$$ 4ZH)%9*9E,  5.<,P67,RL
MK,4,$9,9*0/<K)%U:J,Q0 ,CFI=Z !<L_(LWT*FOH*?RJYM>"YTO;*9Q: -#
MD*]-( 5IBJ ^D*],0*.A4)R2+ O).0N\ZI>AVX>#*W%%6YW]69M[4 --D+(Y
M( L21ZU*  5/$ 5B"*VD< 3S&ZP+0;IIS*9"NZ><2[@[._[+34"["_&]Q-K'
M,$UGA%"Q'#L+.L"O'WL#T]B;AKP)56 %F3 #"#MQ_CH$15 #,\"&-FD(5IFJ
M/+G437T#/,G)8CNB'VK4=<F&1_L0Y'L#/D"Q@$D*^>J7!D$(1D#",@"9+1W#
MM( $*KO+NDN3I/R=CZFK!L$$,:"-$R@*,DJ.>N"+@Q# %AP#BWC7A$T1FP#"
MFE (A;#8F< )&%B>4,"'GXJSW\N3 -RIZSD%AV"3H D7,XT#1= #,>#( GV<
MC^NOS_B6%#H#/7 #CE@#QXF!?4L+[SO:^HK$4KC0P$H(L\ #J>J=9QR.K+ $
MXYFY2DL+3_"RQNJO0<O&:&RZ8?Z;NDZ0 V&KQD,=A9]Z!3'=W<6U"350 U5P
M"(!@E+59GXH<MH<< \,[!4L B$B9E7"A"3,P!+.,U\1JDT:Y!R IE+6YW_U-
M"S"L!)M@",T\"L9JWT^ URYIDU0P"!#.J)$Y Z)0OBAJTS=0 ZOXNU&P"8>
M S(P"FMZ!! .X;.@D\0:QX$[L^!+D\SYRZ10 S9PL7<] WH X8!@J+SZU88
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M ;)80 L4H)$ !%@C&P00+3 0(!&U( $!(+@%6@A! #8[B @$  E5), #$Q
M!"97!P<@H  B,%04T?<J-B" ! P0 .HLD+]W<0 #B4" _R!!0%J0P  (:, =
M%$*'!QR  "$PE!@@>(!QE4(!'JA  #RPA3>.RPT($ $F,?Y0"E,H0 02\  B
M$E"J8$*  %R@!0>"* 0ENG)<JLB  !B0@03<K04SJUXX=R0'!%R1 0J8A"4"
M@#()&  ,8]P +4S008"Q4 ($>&<F:V$!!"A"#@0LA=+DV4$X $!-!/#?0<P0
M@ W((9<M8 ,!.$ +"SQ %9(@0 IH<0(0W \ :T $ ,80"RZ4"@+G4H4"/N!!
M DS "Z:#91H 4(>0BJ$67GA51#R@  @X@  )L 0C )"]48J@%A#P@ /&$((T
MU"$%P!O(!@R@B.U-@!9C$$ +%#<01"#  R-46BE:\-%24  "-DN#!2ZAB@-X
M@!9>%(JC')"!6CQ@ @<)(0GDT/[.6+ @ "+8JP%B ;!K<0$ C/ $!:+U-UIH
M(0"3"Z0 )&&*!#! #5L 0 MJ441)@"$ :G $ +;0UP"4XGH5D(,( " 'DW&@
M:!5@0"TRP !:> $ EA # .A@BPL\8&]M4T $)"&& $1L5Y[0@D%MD3\VH"
M%YA#!0H0BSD(( )UL&T+4HJ #]"AGL/20BW  ,T+*( 6+@@ ".1 L#4!0 R*
MH)HD +9&<=8W1W(H@ 508 (2F&(2V*,%!*Q*BP>\2Q5I4 $&GAG@ 3_ M01
M6:AJ@5&4'3C!SXP%0DTETVN9TA:T4(!K$6"!$E21MK%(PPHP,  NE"(!!J@
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M -B,!0*P! AH2XN%SBL-,+-ON&<D!P'83WL"&!<$*A"J!_YL(!854( 7TA
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M> !%L/XM,/ 5%E"%-0"!4@ VU6.#%$2 "9@#6I ;0(&]!+ 9PV*#-0$7+8
MN+$@10 # /B"2P" $) $%P  -<@PMRJU2"&!TJ(# 9@ .K M%HB% E@ICQH#
M1F" 1;D_2X"]\P* -EF! /"$1- F#&   V"$[5FRW2/%%ID#!%BCND%%6I@
M99L #JB%*GH $5  @9& CJ. >+H$"RB  E ?2TB <3&!E2,!@+,%!1B7@U #
M [@6 0*4=L,6"R"  X" 2CF!E:-%/NL *U( /DJ#!!" #X" #D(!!6B9.6"
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M>-(BB?[2FIC2KW%23]D)E8F(6I@Q%\(6**T(3/@M)(W1*C7,)JT*-M@ "\"
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MJ$L+0/XYBBILE)* C$$!L]&;IDB#GBM9BMI9#%B4#2@5=5T69)T#'P^5+/@
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MK018 TMP@PR]A#L8XQ(  5.XA CX/ ;XMG($=P)0DS1H (-9@25Z>E;T@EA
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M(8@KCUKP%:R4@ ,K0-&C=\0!+O E%@[ 3 @(Q08*E.5%"_[Q@)+G:UQ:D$!
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MQH(!= @_0TY@^Y<0@ 5WP( $Y& &!:P"$PAX#[R]JPH$C-\!9F $A-&"&A#
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M3( ;R$$%E(!"(-;#Q2I8H$!:8/X:(DQ *?08P$VJWDX)"S  %X!!!EC .SZ
MP_6M)=0" H0 "Z  !&3F[SE &LS!</&6TB(" %#H"J" )-3"!$Q9"\!M0EC"
M I#&">1)'YK"_>TI+1QLI<9"CW$!'6C DHR!.)J!.(IGF8B &ZS!!+@7"8B$
M(DB !PR7;D! <HXJYSD6)<II%E# '(R!AIG!Z*F!!&R *DR 9^!%6F* (JB"
M I"%+5A 0"[$N4J$ KA +!R !\@!&#1 H'R QGTN:4#"TIVH_[E(:QZ))*B
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M198-;,F6F[REM8<,;CD6!N37V?P5</72U0S7)137<:5\8<Q=02\&!EAP7X!
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M%,-:>>P!8NI8&&3D@0ETR6*_J@P<-ND&$!'+(FQLBA8T"1$6H< DJA@5/2$
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M<"LM2) <B*@ *P]!@PVC69F%]O>A)_ H6U[*@F9-P*T5F!0&UH*!1/R!3[8
M9A&]Q5XOT&$+^<R"#4$,$9AD)3NED, MK"("$;BVAYCDP+$8P-Y53H*Q#8'I
M!SBB@<O\A5%-F0,"/*."#="5K[3P M]$=90)H  .'E! C0S  CJ<H (\\M5B
M4E!554@ 1R%PCJ+,,(<)"*$KI/L '5S@@%B,Y YB4  +:OX! 13\@0L4H(4%
M.AR9J=B31;08SACDS#0.$&<5"E@2\"B0!8<=0 YF4( ;_*AHJT#@9Q:X !+U
MQ0$"H8 %;L@ \!A2!RU ]21TIM08%L &1%CF16RH@PC6I@7G@ $";E"# ^K
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M$SQ%<_X]R;,]S1,^>5,^U9,XV1,ZYQ,_XU,_[W,\EW,R/5,Y;[,[7Q,Y33-
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M%.!&7DZ!#?Z07B3AKUC#$M@+(ARA6E6G"$]#$L0@#=BU6<=B#@2N_+3E$LP
M#3JA*R A$1 A$4I#$JR'Z@;6%(CO.OXPOZ9"#B;*6AW6A6JA"./U82.N%!)/
M1M05(DA@ K@E7+8%@^2U*8S$ R867IY.MU@#!0P B>SH7"&5%HAG*U3/4"'"
M! :B Q1@R6A6-M;,%!B! 8#G ?XZ1 P>X 1*@ '. %L4H (R8)0JXJ:PJ\[
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MS* 6%,  ?:I;_"E-IL*3TB>(J2MRA*-0KH<%3JI"OH9[,_Y6OY&5#M*+*\"
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MMF"/A\-7\#B1<#8)EW"/D !N^80(B+!ZIT"2O>,)IN,)M2 )"S "_*=/%[
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M(.\QK0IJH (4D*%W* 0;$  FH/X& E "7_ %:/!XC, %('   GP*:Z "%0
M8\#28D +<BT)I]  &=#>&7#NZ>X)%2 !^R0!%5 +..R'*4C;H,*QCB"%7E +
MOE0++0  +M 5KJ !C9S.F%0!$I[<DMC<_0'=RCW=GA#R:&:275X+\4T!PJL*
M%" !L0#B)R '8JW?PEO<[(T ($"7?X (CW  (I"J<8L& Q $=QP"2(T*&0X!
M^70!<9L&!!#@!3 "RA/JG_Z?6J_6#'\&(J<!#S!&I_#J%V"7/GP!#6 +*S
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MA[I"%8JHE:T<&DH9;>42MU*%*VS!4U4(\!08-98+5\&(F6[THM()T$K_4)9
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M[D57%XI?%UY8.6@-;RT!#?B #- 3WE4%#U@#X<W@DBT!5:A7-: %,"G?+-@
M*\X (%[81!B9#B:,+'B2?V6$"KCA<"T%.:A72TB*<P6!-? ",-98+;B#<$WC
M;U4!8[H$#B@%2:B #^  $G@G-7[9$B#C<#T%$6#7.F"!;X4J6L@".@#>4B@!
M6I"#&W99+8 8;^4I6M""-S;71/  $/" ,\975>@/>]4",_!6-E!D,^" $/@
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MX+!VM83WI@5&* 41>.1R/:J-EN*<;M?F#FP:-MI:0(7EJOYJAU:%"J!J6K
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M=4>WM*B01@=<@(^(&/7MWFT&#DE2@B,$[73:![%X$D(M7*@@!H0GI*B"'"B
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M(<T!&"#O'=QN@43O0ZSN\KB608X!!3A":<D!&D :T+J+:EH"@L&?F#R@IF%
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M_RX$/?[$UQ"$8RD7E[@!"W1+"[# _ST"1&B!'_94%LB!'# (S3X'<S]$9&A
M'<@!Q)4 #/TWA!C?'$C[M \.)\6"@*E67WW!3[19!LB]J?346/G.A4]X"UR"
M"KA V(^5*BR+29"%&GC WU_*=DS-CX1 Z$*4&?S5T+E %EC _2;$]33'=I2
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MB04:1G)"N9BA-E![(0I"R(4YT.$P<TB!%K1H"UJL04B(N4,MLG""*BHB89;
MBR18P"J#,(H6:, B5T[@ E7,(2>24 .LQ'""B2P.!6#8R1Q4$+_SU<*!*&!3
M+;3  C6LQ2",C$49Z6B=.I0R%N(CRA9>DBDNG&!Y8T#!%U:FBM"H825KB"".
MW&")M5@B-). 7+)N$QHY3,(2(<0$"V9&BTFPH"ZTV (+LN :DJ3AB'=QPQWN
MX B*@/ZSC-VL0UGRHP7^E2(T!L&$%BK(@HP Q8*(@"$Y'VD" .[$!2UP@0O\
M>#,43 29"_*)%U2@ACK$XC\T6] D2J&(1)0L+!J-Y/]L48OS2((LA-Q" A'!
M)B\((6BU0(1(MJD"N=1!<3N)G'78T (Z//& H:3%'$0 AA,H4 U?_$D*7!#(
M-.2D%"T PQVN*(=:G$EZ6=7J5KG:5:]VAPM5_.I8R<I5G945K6F]SEG%T[>L
MLC5Z<%4K\^A@D;EJE04_U*H<BNH!6&ZG%@<LI%R;IP6;;"<$RSS(E^[:6,<^
M%K+9(>STB+*2R8H*>I?5"6 WZYV=:!:STB,L:#T;V>W,HOZLI/U.+10['M6:
M5K+=>6VF ME8N;+UL]I113A#R]GME&(.M>T.(C[)G=5]AQ&\Q4XISAH+X<(6
MNM&5[G2-2UWK1G:VU]4N9;>[5=)FM[OA)2MXQ5M>\YX7O695*WE76U[VJE>[
M[TUO:N\JW_G>%[_YU>]^^1M>^_87P $6\( )7& #'QC!"5;P@AG<8 <_>+K_
MA?"$*5QA"U\8PQG6\(8YW&$/?QC$(1;QB$E<8A.?&,4I5O&*6=QB%[\8QC&6
M\8QI7&,;WQC'.=;QCGG<8Q__&,A!%O*0B5QD(Q\9R4E6\I*9W&0G/QG*49;R
ME*G<70E7&<M9UO*6N=QE+W\9S/YA%O.8R6Q@^5Z9>6@N\YK9W.;SJKG$<';S
MG&&LBC&PP 4A[.R>M;.R\)C!#.-9"#U%E13N:J<6*[L#'].J""SN1!%L J,<
MPOG<[23BC-.[['&ULX;VA84-A?IJ(K@0SO8HU;LZXX*>FP?>V=9)N8_DSZ'I
M7.OSJL(" 7!  @ @HE(X0";=^;5JPL, !LRV%F, P*<E 0"PR)8M#/")" !
M:*_NI 4 & K+)$   DQ +I:80 4@4!8U<("T;A   JKXAP3D,SL?P(]V)J
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MWH\+ B!D*J "."  $N _4$ !2,#;5$,%$, G0N#8YL0 %( !,,4%!*#O0D
M+($.$( $&$  #@L,CA !MD G2OZ  !+  3A"!19@! J  %2# I[08QQ !3#!
M !+"$0B@8$C@_@8Q.^X  @D@!-Y"#(P0 ;YD:SR@ @+  [3 VU* %EI  40
M$5UC:TA@ CR@"),K[QP  1*& V@P"Q+ $@G@2U0A P2  3(@ 2(O3)9/&1NK
M* (   B  F2C#@Q@( R. #@ F30@"QX' '".&BT!$PB !&(A[H)+ +BD!0(@
M(1Z !BT  7 '&,/BW]( $S! XM9   1%"P @1@( X2Q@XR2! !+"'1%A#@B
M;NP/#HXN $I!#@!@C! 2$0! E$Z  &P( )*K!22#WZ9G:\[$ (:""P! 0>+.
M#"0A ?Y$@ 'F8$+$H 5JJQ02H (4"0"^#Q"1Z;/&( "$P!3H  !* !-<
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M(&!EW    HT6+  RLR  Y$)G?#+04@ Y;V,_DP0"C&X-6$ #$C%)J# LLD
M+',"&& E*F#L1H0&5R  R@(%+K(%". P/L#>:$$"/R !\(-'??0BYM GT:(%
MZV +>M0ZV*\$MK/:>-2=5(  .OZ!%HJT$Q!@*,"@1W<13Q0 0"O +Z]#.9<'
MH>34%!0 !%3A #P'/?_C! 3 %'A4<1PA %I@0><M'24!$0@  3  7Y($,H4@
M -BD!>8P W?"#%:U%K:H.6MUK P'B[* 0E4A'FL! BI@)R ! 2H CE:55Q,"
M#00 F,3 #!#A#ER0900@(2#@ MZ30!E!TFA! B+ ?>YS*(DTL02@.0A@ \
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M%87YFWU"!0S  BR! 609#:Q8)U"@  X  ;Z %JZ0(W\" M1/!#RQ^Y#P-AC
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M$:T[GD[!(WS(-FW!2L$$> OMH*VN7ZXL $/V.G*M)N\%1X(%M  F*XC0YH"
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MY3Y&;K>?E?9\"4Z_G?M77Z']=OX""0#=1\#+V6]Z!I1? !6X0.C-SX$)]%\
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MX'W]38_*)@9&R0+@M^)<WN6>IFL5T# (=VPP(0G=EB!"(!A< *\-D04.@''
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M6MB ,(& +*F%192UAFBV1&S$YIH$":@%#4 T[$"L+#B-1&P(#I"#,?A#6I@
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M.;BPMC0(6X" 55 !$VB(-9@+3W2]_XB]$E@!5MO$3FR1#5B#4E" 1(@%,$@
M\2(!$+@T0%1#JI"U&\T.6D@!IBN%$YR_6DB GJH%!6B0G% I8TR$_BJ!^1.#
M"Z,^#1.#!ZB%N&0MWX* +HT 50"#-SN-@10!1&O$4JA-6D@$!Z@%,/A#1BA0
M.F@ V)C#AK"%K9O+OSQ)!>BI"DC'FDJ[%A@N$0@-"+"Z[M3433T4"<C4S; Z
M!3"ZO.)/E'+&$QF!#] J=FL(2Y"YAG"$+(4((9  (>  #8");,R""6 Q.F
M$6@!#/Z BP+4PQ)P@0<(+,9< 2T@ 0=0(,QJLPU, P=P@11P #D[BRW@50[P
M@ "3 &"M@+2S *5@ 09HC!"P@,Z+O1: BX;P  UP ??TCAMK$ L(#2ZE!5MP
M/E6H &-] #:S@!'Y@'3]@,BZA =0@190L^V[M'%M" P8$3F(K1:H@)VX##D
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M9EY^9FPVYF;V9FV6YE^FYF3>YG)69F<^9V >9G7N9F9FYG 6YF0V9G8&YA"
MYW..9V_^Y70N9G"^9EVF9X!F9US&9W=N9X+6YW_N960V9WT^Z'Y6:(?FYGU>
MZ(+NYGK.YXL6Z(A^:(N>:(1VYV?>YX%^:(XN:8;VZ(:F:)26:)4&Z7F&:&C>
MYI2V:'E>YY@.:&B^Z6JFZ9;FYURV9V(F 4L@ZDL@ZJ.VA$E ZJ5F:DLPZJ)N
MZJA6:J2>ZJB&:JNNZJ5^ZJO>ZJP^:J^VZJ1NZJVFZK#6:OZS/FNG5NNO1FNR
M9FJP1NNP=NNH?NJZCFNH)FNCGNNCUFNLONN_#FNX3NNQEFNFGFO!1NJ]+NO$
MCFO$5FRME@2Z3NQ+0.S 7NK*)NK*5FJXKFJ[+NR[?FRQ-NO0YNRVMFS ?FO3
M]FO49FVV'NW6'NQ9ENW9INT69.-\4F1WZ>2 N295GJC<!FZ,*B=Y"N7A=N5S
M>A@U=J[=EF3E3B?D/FZ"263FQB?JEA;<IBC=KI:"Z>U=^NU1IF3IANY--N[J
M+NYX:>[IWNZ!<>[:=N_WAF^:LVZ.0N7XIF_?MN_MK.]#SF^0V6\[B>3^_A$)
M42HJ*X4LB6)Z:I :'!*T*@6+'?Z) P\)23 1G, (H[J(!W<1L>P3HN((!VR3
M!/<-29 PVD@(ER#QC+ $" .85E6J1+@#E&*$,0A+B)@#,?A4D !Q>]&"(BL%
M-0DO\;HJB&BNB+B#P!+PD?#=IH/PBU KML( !C"14:F^S8#P]UJ%S>R(O1J9
MO;J(B70I$FB0%M"PZ)X7Q1(6(7ABB=B11LR1BT $9IP('J0%#5BP(BF!_9T(
M#O@"C5HOK56*1/#A-D[DAXI:54[N_V ZB3B!4.*"0PSD"."2B3 %$F (K_6(
MJ>6W## 3NI  % @!!XA0"[, $:B OG0(5;!TC1 !Q[((%] ^F! !]E"%$,"
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M!@4M%_Y?)(D06@<"[OSZ]_/O[_\_@ $*.""!!1HXX DD9#"1+1HXM% +&6P
M'QT10' ";I(P ((((CA D!H5M*0!+2A@Z( JC# @B2TL(%#+'?BYT( EL63
MU@-FP$@ =@NIPD$6JMBB@ B,U%)!4+1 H(@J"GR$0AH_!CF11AZHA0!+MM&R
M@"6JK!0+%P],$LL&+3!D"0-/IE&+!&+0XH@#F$D 1BV*,*!*%B$TQ,)"&,BA
MB@<NJ%(+!'30<D<$'TV4 1>TK'(G& I($@L'*M!"@@BQ>.F&)!+00MA")/#Y
M@4>2-( A!FE80@ <8(HXA@2FK$*"IXGQ5<L#JEC2P!VUP/Y:RPF'J3*!&J5
M,!L;&-!R0@D4<5"+'!$L]$%:/DZP1BQI2(!)+2R,MU (&92BB@-!6;"&:K$B
M0B(M&MS601BV@*""*I(@P$8L8'BJ!@28Q!(L+1^@B\@$.!'0@B.UI:':!+,M
M=,=X&RS,@ JK,** K@PD J8!8DTT!@%C6&*)!&+)80$M(-,1BQ?X:?%!7\VZ
MI% ("ROBJ2H5I!'+%^FIP($ME%H:0@6EK!+!PA,EPFX'8-!"M-$0K&$* W?D
M2P D#,GQ@"6U9'$!+8Q 8.0)%D1]6P;3#6M)*02HD#!#'U2 :0AFILR 80M_
M"G,MEL@QAY$,.;(D41NH$LL'&/Z6L*(M)%CY01:Q.  'M W4PA0M/RHD GRU
M3$0"AD+% H$7M#P0W$06L$$R(FB18 DBB"R$ID('VGX[[KGKOCOO^8GP!0<$
MI2%"%B#0XH65ET;>P@>F9-@ %V&(@<(&L<B1GF96LF"I ]W"1XLM#L3R!P4:
M?2\$"YTRQ %+#('@IBI<]\G2D8G48L$'(H/KYIF>LL"""]C4F AX@A83"$X+
M0L<%$EQE%1;P@/[H4+"%_(\1M:)(++1@ EHX0 QJ< ,'K!0"I]%B"WHZ01:$
M8@&GK0("J_!"LPK2+ <4,'.E2(2G$K@0%'*P=D*HSP;6,(D)6I 6'N ?(\ F
M%$RX@?X+#5 %%^HSNQ8ZK"=>L, <U, & WC"#0YHP1PF(HD+J:$Q0JD 9C8P
MG86(Z2H>  \(S( F-ZAA:Z4SQ1S,$ $W>> +M"A!"G&X$/5Q@'\4&8HDUI""
M@@UN(2IR0QKD  $M"$45>82 FR0PB85(P!)B@-E"(&"5A8AA/&#(RP<-8(DT
M),]TGI0B"S"DAO'40A)L8,$$)G*!.9P'9@\P#R3P(P(2DN I5%)%'<PP@=*%
MP(^7&D,:.L"0"*1E(A\H72C'%('&A ";.J':&NH( 2ZLHGNXX<#[Q  &="TD
M%G5P@0.XL@)0IJ$R".B:CWBBI.!0Y#<EH"0M,.& /XH!#O[8H\4FZ>  %<@!
M,25@($-"8"DJK2$"@<$5/\GC)C:$((M:6$,(2X>)!6RR=R8]*4I3JE+^3"2.
M:>  +=C'!3U9@ 5LN.5 N3""_$!"? R10!J\,A0SP'1['/Q7 (<B@5603R.A
M4T$+U+>0#=R$2A_PHY<Z,;^%6. .M #3!QC@IFOB)@-R>!T)T@ S51S+@)AQ
M00SABIN9*D -<T!94K2 @CN@3"A9P! #LJ"%+8S!JR%H%"T\(8%26,!A"]%
M"FWA0B](\:^U<( I/+<0@IEO(BC( JXR>QX@"K%6G#VB(_NZD"V@1 X5,(4+
M,'3,!Y2"2AK! !>TX 4U."\1*OZP0-%4XP(.\.J,AE(=+69!"PF@SHAA6 @'
MU, (!X!!"UP8@R0D> (U@,!I3;L46Q212UJ(ESQMR$PM2I"!+=3S31+P'!T>
MX 7KFL%CAYK "=(P0EI$ '6+S0(#4X>9B8 !E%JP0&ZY$"4Q!)@651&#GIQ*
MBS20*+T9T$(]/V*!H!38=+W!B3 1V\VK$*P$PWO*8<%E!@A?!0.RF^H8J'1
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M>NNYHJOMD.NXLBM+N>NLBNM)B2J\"DB]+NN] DB^EJN\ANJ^+NB_TD; #L7
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M*[XJ[A"_NPX[_U8R:+Z6LOI/%CD60*,6AY![CSQ(%C# A(%:XHX@5SK(X*
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M E7..&"$!0@0(H0!%ECCYPL08  -[&L"%]! =."@" 0LX  J<)8K('&!!2!
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MB!0DPA(\_(,L3E  "7P!$AM0P2Q8L$]/;'-;Q_,$(YH%/# B8 *GP&DLA
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M104@$%<DXX@@LA R(F@AB0.(P!(%*$&.U><);\9U ?*5P#XUT #_((06+1@
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MH:S)NJS+.JI[1:U!5*U#1JI[!43;>J[7&D03P:KM1:NW>JOK.J[]^JO_H!'
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M3N!2$0(!! (3D[@%)AS1B>HQ-' )U6=362" ."PB!8$8Y_5VM]1[@JL271
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MS7.*ENOC0-;H+"+:6JGH0@!,T I,K.($-@:%!D;0B454( AU:("INT")#SC
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M  \@"1*P ($ 2G? !LK5 )2 3F-07"/ 09,@"7>@!EQ@79*P 2<V!7+@"BP
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M4Q  )Z *E> *B\0"KW ""I %!/ &=&  %M !'% "W!<!$A W;.  $% "%J
MEO!0Q$5OD8 );/  #Y"3JB@)*9!N!' &I= %%H   1 $9%  &< !'D "69 *
M:+ !"C  &4!T*2 !:-0&#\4%KA "!X (DY!Y=9  $^ !,)D"D2 !$5 =$8"%
M,\A,4S0'&GD+MY ":&<' 6 $Q_X59R00 &5@894@ @K& 0:P"+-@$*E0!P=
M 8.3"G%@ .LH"8&51[<0"0NP 74  0]@ A>0 )0PB%Q0"1G  " 0 @/@!F@P
M %JP"CB4!BE  '-P.#]" 0S@ ;A6 G5@ 1(86% U18$P @]   R0?0]0(R 6
M<X,3BG6@ @0 0W6@ !+PEB2@ G*  !\0.(;#""3U 6*HC/<7.!7P &85!H(6
M0]L(G_&).?+Y>[J3!1?%"I:@"BY@<Z#  !D 2@@  JY0!@) !KN3!16   /
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MH 6=X $$8 >1< '$NCN!$ )V4 O*) 8H, !I  H<P "+0/X!"[!-VD<)*$
M<1 X$;!O-[2GV+H(#M !6C@%M, " < &*,IGPCH 8R )&*"4UDB?JD0V=44P
MX-A[_-I*TJ*O6Q-J@5<&B/ %--H(DN  #Q (.#<"K\ % 9 %F. "*."9## !
MJA "!F"/#" !KK (". !GD!V0:2AI1!T:I (%D  (0H #TD ), *<D  *Y!_
M"M "&4  );!6<?,&,!5'#2"MUV(! ( "]V0&![  ##  8- )#."<=T0 $( !
M#H  ' @ 8+ ( A "QY6G!*!W#G  1PD %A !!W '-?8 %V  4Z **T  5IL
M=W '"I  X08"D5<!$H  =8!#%?[F 0-P!Y.0 !%0"G:  $L[ '2T:C/2  -9
M!PRP?I^5!@D08 < !N\( $%@C;I#!@HP1@*0 >Z3 2PD  /P@JFP"!S 0@-P
M "W 3T1(@0-0@6=  &OK  ;P"&[*!8RP  M@ 46;!FZZ! 2:M: PK.[' 9T0
M"&$) 5P+"FR0 &!+ ?&:"C-2NAC0 !"0""MK $S+ JF@!@I@7P90!K P @
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M1" NNY[ MWL*PI3G=M<7*, ( AV)5(#  ,E.-BA2C@E'I+RU..\N<0&GJU3
M714A*$#<1VV)121@!*,8K25R!<R'&W>H,J9XM^X6<8AWMQ,/H, H_.=R4&#"
MOZFXA8R-.]KCHI97,LYL;'F,-T^L00$'4  !7'"+0# @! QHP2O((('==E #
M TC  "C0B%)T@0 )., !SC#R-JQ> 0-(@2K,D  1(" -JS@!"'(+B@P\@(C)
MEH,!.*!K4'Q  %T Q2C*,( -@%\$!6A#)^+N!7P?P VI58$ P)"*GGH9%&!
M@ <.</[G2GB#,UB$,D"V3@@$,FB$,^B"0  %.B"#!JP#,E@$72N#%AB#WS(!
M ]@X_]H  KB#20 #.G"#)7 #3* $3W #(R"#2,"@,6"!-  M!%R$-&! 4%B#
M"'@ %CR#;2,#0J.$-CB#"!J#%K"#PB*OYDJNH5M")FQ")URG73N! D" "% >
M!;" 6S"%*5@!4.@" .!",A" $/"$!!BX J #,,@ 79L@3)@$,RC"U+(#!I"
M-FC!2J ##%B +@ ^.L@"(XB#-AP#. B$,= U,. "/SB#.FBM.C "+E $3*B#
M#%  +4@$S0L^ =BQ-;"#1N@",("<"FR!,Q@Q"-0U+S"#HOXK@R"XLTZ0P$63
M@S&(A#9P  F(1<AY0$:P@SDPA3OP0S;0/#N( S_H CLXK5N0 R&P@SL0 T;P
MA$1HMHVCH A0 #J8A T8 #1$@%=( 0E(!0HX U(8,J/:-2X @!0 A10 @#TD
M@ N0A$!P  9H00E(@$7D  &@ Q&X@%JP@!-0MT70/RX0 #LH!?_2N3KPONX2
M! : @!8<J@I(@$X#!1$8 #8@!93;  = @P%  5U1@0"PL:L"!0YP #L@@!/0
M%0\H  I   'H@%3(@G[KO0>HA#(  #)XA1, @#J(! 9   PP@!%(A1(H@#HX
M+4S0  .X@SLH  @@MP-(@UMP@?X">  #<(! ZX #F("R<X4N"( )2  !> !)
M( $$8( ("(0(: !)>  'J(1&*(#TXP #T,J@S((+"+1]*K G5"Z];"Y(*B<E
MW$N("DR4ZDN  H4R8($(<  @'  7. $+< %'  4,2( &[(0):(!(<( 6"(0"
MB(,*J(-7 (73\B]'N  $D( "\ !0Z( $:+I% X460( &:( Z.(, B  *,  S
MF(34-,M*T  !<(!U(P%8* ,#B  &< !'F (#&#<V@#90  %.2P4-.( ( ,OT
M"X0$2 !W8X$Z ( 0< 4["( I6 0&2 #5; %7: $ 2 -7& $ " 01.( %J(!_
M+(4@$/Z # " ,5B#X;2  AB#2E" A22  >B"5+"# T  "%   TB$.V" !8@
M RC$77,# 2 ![#(# #""-"  2@B!#B ##7"%G"NOQO*;92.!0)@%,   +JC)
M,E"6=&R#.AB $= 5.Q  %T@!"+B%!YB"$% !66"6.& ^@H2P.$!(7D. "X@@
MU.* STRMB6P#3Z@$1#@ $3 %"(  1S %CQPXISI !!"!5,A!M!N! <B"2*@
M!(@$,!@ $*B$$@B -B"# " #5U ! JB#0#@!.DB%"E@ 4)#".3!*I%1*]4P$
M,!  %4"$ 0B!6TB#",A3_WR%%="X,1B #ZB$$Q  ,C@%"OZ(@ B2  @ !180
M #\8 P!@ S*PR5=@ 8TS@0 0,<',U;E:0L+4U9EBPM]RA0M@ )I\S@W8@ #@
M@$Z0@ 9@!-3:  1 P 9X@!1H@1%@@PL(@?>2A%+85#.X!2.P25!X@(1#LNF,
M5E(  ZBC P(0@4F @ -H@4C S11(A2Y@ODI(@ VXA3LX $KE  2P1$B@)@MH
M5E#P  (@OQ' TUZCP,4$!0U8 #M=._^C@U&0ND (2#MP!1/@-$N @ JHIM_J
M@@*H@#:0!#%0 7XM@!#HA >5 SDX@ Q(A0N 2$FP@ 1(A Y0 $4 A0K0OM82
M@P"(,4QP@W;%OAQ,@PI@@Q2@@/Z!>RKEB5KUP3LR>,U(J#\C[$*;?(,O)"XY
M(( 14(0(B  ,4-HZ\( ,:(-2H(,#L+ZA,D@#Z !0N 1!J%!9ZP0+.  ZL-(!
MV+$N'( 5J(,.&( SV,:/Q+_!^MO [0 "& -7" $#" 17$(&U X./G(4RP-,Q
MV%-7<($! #DMT  *8  &D 04^-,;0\I " 0"( %78-<5V%P;PX154(7ZM(#'
M&( R. .!@U%11852O1M4Y34!F (/,(!.(($#J "^*( EP 20 ZI>+:?\FMZS
M8BSQ<JFP.JJRJE[F\EY?=3,,>MON'5^":L%AK83-+0%E85-)7(!%T+D,L,Q4
MJ(.=I/Z -D  +J@ N?TM#D@ 00"%.2  $P %!Z" (II.RZPU%<" W12!2F
M"B@%5<B" %"#6WA+\)S+QTB "0"%$+#,XK($"F@ 2+@%#E" N,/-+@@^T5V
MF2L#@90 #HA@"VBMFK2#FDP#59!"#*,\*>W"  @#50"\%;@ "C@ UF0 "^BN
M!LB 2G@ +%0%%-!;9K6+!T" H@2%,Q" <[0$-A@ ]@7"2@@"$E@!" "# L@U
M+X-7!$@ EH6VH9*$.Z6 .F"%%!" X],T #B#. @ CJR$,"8!57B$-#A8+M
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MHO )?"O![[1@11,43PL^'&'B6L]O)C#NA"?@G0^,![O48;'Y(S A"OVN>A1
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MVGT?KN5@:UJ8'@CE8LX ,_9ELXV"#>0 +40!#-Q )YZ8.L9 T.'7)T@F+>C
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M^@"?%M]R5N$,+&YYDD)]WM>*QA5%FILAV*D^%8$.W^YR^JH/"&(=\IP2Q!5
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M- #  2PW@"4(G( 1O+L6B+BO"EH=NU54MQ2Q< ,!0*"* SC8XRP@ 0#N4(H
M)(#> #!#[-0@]5<'H 2MDX0!,A [$ B #K68!,1C(8( A'T2$$@ +=Q@=66_
M'>YQ7R*SG=W7+#"=%L;E0BD,4.X[!( +C " %VC!" (,%Q&(N(,M-$WNBV1
M 9(HA?Y]8Z&" &2A%K&8  -JX0@!B-B_C6X9!P[@  88  !@$+P+2I'>+)0"
M 1"8Q$5<$(  ;P !K^4" !3!; ^\5MVGA0 #"K]N6LB!$:KPN"/"R^XR   1
M&6\T(G+\ 05 HA3]UBXM5 'Q!C"   2HPRH.P-]$T"$68P"\*A#0=44$@,:T
M\()X$1& < ?Y %V_R =*WP #!*"S^,\!_ \ 7$T. D +;$ON%I !&[!DZD
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M#_58(!8<( %$( &H31+VJ_  8+C8P/\\0 $*4=P   ,N@@X(@ )(X+YH(00
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M!3(/ E2!$61-#M:+%E!8 Y!P+\  !!C!AYD, RR !4KXU:Z8!3  #=@. S:
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M48]1"!Q  U[MDO>*!3(T$0X@16,! W"7^YAVU3)M*[W %L#R!+2WE;N/%DB
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MTL?#30OSQ,(!ED$,=UID(IN0(-P8\!8$[H ("#1)$@Q811H44@H(T.(+.'O
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M\S%=$G E/MA^*A +#4 O ;(P:8 !'] D06B,G18!*^%1G3$B&. !%G!Q8,
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M 2#0 I&P[@._]WS?]X\^\WX?^(+OZJ P!F00[FVP D$ ]6$=]4'0!MK.!2H
M]950!V!_XY9,"9U0!R.P 8W0">5.!W'P"&"]R3O=S&'-Z;PNZH$0!\!^"T:0
M (% ZIV^ZZ>/Z:$.ZIM^^Y0@!W60X+H."=,.WJ .[+K\Z:)N\('0!2[ !IC@
M"*!0!REP^#:=!HR@[U<="63  ESP"-H."H0Q!6Y@[)* "8W0!2QP^:"0!B<
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M(X@TZB#CLD7*,((.ZN2+0 $Z*MF @#O 0."5%"0P90(S;H%D/E"Z $ %4%(
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M2( @%NH ( 15T !@"J 5Z!T+8-$" *0!%B((0"!$@#P*U P3+@A !@) AI9
MP (%&$,E%E 3 Q# !:8X@P$0 ($%&" 0@6@  R)@ #& 8A*88,, 2/ 9.P3
M"$.B1 @Z (8-V*(4.>N(<RH1)?[&V($$?IA%&3*BQ$*E@F-MJ,, 1" :.P!
M""F  "@:T(43K$ 6MXG# %) "IY<QBT<Z(0EZG  #-2M$QPHP+5.I+1.7$)V
M(U %!"# %JJ!@8P_L00BMG8627R-$<.Q@P$DT($-(*  <'#! "X  H) H!((
MK,-AG-(HG6QR)$G)W.-$28G$C5),G#!E*E79E5*NTDJH=.58IO25S;%F$@<
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M  *2:  &R( "!&# #.F)0R0H4)XR5* #)MJ  @2QLP*4 !3;?!1C^@F*1JC
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M; H# FR -[B]#J@$!8B W$B "C"%-V" )WR !%@$+D! ,I  #P!!CNF &Z,
M3;F,$" !6^B "HB# K"#&Z&$4OZ0-$G+"Y+( IK   N @$(AB!((@0 8 <^8
MB3XT *XI#@D@ U)H@!,H@P*0!#*H$<\#J$#(@!0(A9W8F0]X@ ?P@.HKN1;
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M\ "2E 0/, %+6 1^R4D.!(4@H!X.H(.KZHD6V+T0:*TA8H00N)5$T(!ENJK
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M84L Y1<FY34>Y1J&XB/V8CZ&9%[^8U[V8A-6X]&@82V>8Q3^8A<.8V$N94P
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M!I!J:@L#8(()"S1A8*HI!=0UW(,;,$#+"0;44H(!GM"R@0)M,42 !"%P@(
MD[ !0%=: #"):A3,H4HI"'Q 6P BT&() >]:0$ +ETA27BGFEF!*!@=P)$1!
M"<R& 0)T6*) !;24$$ BM9C P2H23  1 QLLQ,4 &(20@8NQ9!' )*6TD- &
M!R0&U2D:&(")0K$X(.>6:XVT @!R*(0( @[D"N5(>G$  OX% (10RU\>?.#
M1+3, < 6@TH]-=556WTUUEEK36BF"XE@ $V6%'"")0*D *\7_ND<"P(JQ*(
M @;PY(AL*4W @ 430 #V6Y,H!,$$\PK0@E-@DM7! 2EDD7*1@E6@]WI9#)!0
M&AQ8X  #MIAR@ FU3$(7+6($0(<$Q=V=-P0'**+0'3I>8($'89J P 434"!
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MP(X6(@" #T%$FTK18@M'5$@&EC0+6D@  36Y)ALL,)L3 ,!D=4H#W#B%  6
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M*&?D0 '*K*";'%0!O2?L -O.*V&(FF]9Z$T86Q6I%F9/-V3&XW ,?)86IE
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M5$"82/X"!;C>FR@@64A"!4  !P@!UTU %B3"':2!!8C62'! K72C4TP [(5
MX+  !/U>+2""3FD! TQ"+&P $4& SI@!:\R!!&"",&V SLS!!33%&'"D+80
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M0Y2%4 +L&H!=!W@502ZK$'"!%H2!(M#! WS!%G"!&5C"(P2.,)6I0GP >D"
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M+V'0H7?5Q03<5UG@!0.XY7: P20DP $'#I3&C 3XS<:]!(]^EE JQ%;>44*
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M)83,H/Y%!F1!!=0%%TS %K0 !G3 [V6%"RB &BA"H:I<001<%B!E+*2N%I@
M \R!%] 0F/K6/S>%"$@ "[1  X3)P)6K _"$%T" "WQ K##"^"Z$*6Q !:
M!J#'*:[PP:E !"3$&#" _)DG)BC ![@ 7C7&!^RA-X> !RP :Z) !*0 "SP
M62$N!0"< W"2&!1'&F_UGW1A4Y2 QF! !;# "G#B^5  ;5VM]&3(O$A "62N
M5XV$&B  %[0'4[Q=8>#H^4R $]ZO'"Q "[@ !+21<<(!]G@"T;9 J^Y4<(C!
M [@ "C  635%5 J3(IC6@%:R)?A0&B R)F!$+;"!&.M2+?[<@3 APA;X<8=E
MTBZEP1:H01DE@L.Q45.8@AATQ:LY@F9UK^V. ;OH$$]L-E)PF!QH 7IX"AL(
MDVWC]EHX@FG-@9P(-^\HQ5@H BJ( 1@\WG+3 B-( KBU1L2X;!FYP1;0)AT4
M5"V,I2)H27I+0BR(EBKHT@IQ 8=AV7TQ@FXG6W'3ID)X@!G(01846$9\ 1AH
M!R.\:P!7+J+0)@;@MB^5 G4OQ!W,A+@Q @98 H(W1B),XPJ+01K<G2* @1=8
M)"+4@1P \4+4(%>O^)Y(0KF5PFZXX!IP@<.A-@5/F*EAF1?\&AW\P?YPT&Z
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M.2.24P/AN@T(XACUP@P"*,   PH H(U..A#@  0$P(#S  @HH  " K!@U @
MV"!D%P(HP^>N.FG$@ ?N+*4+ /Y@-V"  %Q@ P $$#A @ <"800!V D0P $_
M%DF @/4'<,!N.]]CM^G\GJ[?_@B7GI]^"?7O#\I4(L$ #4#E! <P  $\P+4N
M)*![#VB#*KK@@ A\H!*IZ$ 74N$6PJ&K%!\80 0<QK430( 1RR,<7J1"B7!M
MZT(B\H0G'.$(4)S@ 4,#RP,P,"IO38M)VI**KL*E0F%M*T,GP="I+M !DWGH
M5*O"UH4,TBN\0.4D7>&75R1W@?4UX R=B 0&),!%5,2! H\+BXA.@H(##,
M(J#8Z=97 3J@I!$8^!T#R) *.4!@ A((!"NXH,0+/4!X'I+:& Z@@<E5(@4
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MH@S)HP0"E+@(!7@ % DH0R4,((<,C$$6JNL4"A"0@ 1D 10:2  #&D"'R*W
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M1 ""!OYD@!&*@.\4N+ ! *B EPU80K !$(0R ("]Z9K3<97[3&8B+=K5OA$
MGPN55#3B 00(0>3*4  &O#<0J:!A!C90A@TPX@1<T XHOC!L28@  &R@IP3F
ML!SL<" !LV.!!1Y!AP"4X,@'V(#6!M"!.Y1@ "BX10,L@ DU$, %;>WW5RR!
M@<2"P@,#&$$=,#" .KQ! K-[0 0Z$0$(I$(% N@M ,BPB D@0!)="$ ;5D$"
M O@AOQ.80W1NL00".$ %C9B"!1)QAP&$H!-/C8(6"K !573@QVQP@ (680("
MU,$1A,2$)&XQ!@&H "IO&$ )(J'A!8!A V.P0PD8.ITMW_YB4M@RDJ?^8 $!
M^($% 1B#CK, @!$'@.R=,+L)Y)  #S# #A7P0Q94(,_!BH!;7!LL=#L1B 10
M0#F0Z$0&#E"'78E  &R85!@&D&</$. -KEBU5DG4B 5,8"N8D<2L(V>' SP@
M Q(PP <P<8<&**!W"0B!)!8Q? 8J( 21>(30@O@F:.-H^LFM/E^N?_WZ:)\L
MW ^+]\$"?@'%/@%*W-8BNK"!!,0<XF280JDIY@4C1*("8X@ "!Z  @""H@,)
M$(0>&RX5'H ">H5K1" !;B82QB %-,  0N 3&B "+L$6IB  T& 5&J$ 5. .
M", "/N #GH<50@ !AJ8Y)N !)/ZA%#R !%]!# 0@S]B !1;O 4#!K^3@ E9)
MRCHA%98M#<I  )K,! S #T ! BJ@7G2,"P*@"US!(^S !3;  #R@$AR@ E(!
M$W8-$XP0%,CL .A@ AR  _!OG79%[%:@[#PN%0)!!>* ##B@#!9@!!: #AP!
M.SS@ C @ RC@#*T(# S("TPA!0; #&@E\,9 >_"J$^)@ $0@%=A !0*A!%2@
M!"2  R1 <@Z NRYDG^3  *#K0BK  -Y %4R!#G!K*SI!!&!L6S"I>Q3  $[
M%5+ [VR!4K"C8EX-%("E5T;K$7;%#E#+%4"!S\3 $1@  NX $8:F$Q;A&.\@
M$6ZF(/ZF941:Y/NHS=IX1/RP<4BTD4$4I!O!\3$P)!"P"Q18@.!F(1((X .4
M$ QBX19 8  X"1-D(0A$H T,0!6"P &PI@,0(!%<00X(X 2:#M8TY0,2@&MJ
M+ 72( % H!(8  ,N 1.\( "60!9.:P4X< -<8 K$K!-   $>P1.VPA,R8./Z
M;Q%<0>R\P L&P /2X +XD1Q)8 $BK0$JP!( "0!\, #88!:TS@\J 0(LH!2
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M$J%>;L'')*OC2( .,&#O/H   OXA$!C@ 102 1C@PD@@>1HS 2A!FT8 #!@
M >SF 1A #*9$>F#.9QA  C#!#%ZR$QB  KR( 2X@%;A  (Q0 ;#.!$(M$DX
M!=ZM S#+#H:O$?B*!3@@%BS  RCA ,J@%/SE4BAE5/;I##P3!59@!-J EQ2
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7_0HVK-BQ9,N:/8LVK=JU;-NZ+1L0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>comp_0025.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0025.gif
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M^O____?X^0
M
M
M
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M&Y=L\LDHIZSRRBQKE$87,&=Q21>2*-LQ&VSX5>VT%TLF61?\_:)&SJ)QBZU
ME&"1B1:4 #/+8RU'!$8: LV21=,[_\(&U6:]DL4K84VB12^>Z4S0M U=3"Q7
M<(Q==E_4]GPLM&>[MK5KL\3:K/[6:T3M-Z[ 4#   PT4 (8&63BD@08B 2/
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M$["Y";"@$P:R@ DR,0!*D"!WOY#%&^3  LP5@(\1..4$?O&*7@J$!(S3A *
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MH %D4ZY L-  @7# !$:X@!90$()?:. %$>#C+](P@2$ @0)M* !_*  $%FQ
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ML$"+7L;!!+KPBTR8 **:8$,*@"$+$TPBW!"5"9@@ ID #"CP!L#0 R&0"5V
M 1LP!$WU;UTP IVF!E<6!%FD F0#!$:0"2(@ N7W!BQ0;28 "] ##''  1=@
M20)A AO  A/ /-4&!#J0.+"3,PEQ"Q&P B.  ?[S!BJH [<P!$$@$&"P F33
M!:BU0RE -9A  IDP"WGU"RN0!G%P 3B ?)@P NF'0<!%@2:$6ED0@4%0A+\
M!X:T [4P!$(P@"-@!2PP"Y*P 5; ?L[7!K_0!10P?<,'?'Z8'%PQ! .0$&\0
M 0WP0/Y_.!Q<@0%UA!#6)7(*L0L"('.)6(F66#%F@Q"4P#S44G]7<Q!H,S>@
M.(JBR$.5B#$CHS8'\1_%PA5RT 7CA!#   :=9A"^98O9DC9UHXNY2(JE>(G
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MK\!:HX#&0'RI=5P0!'NPH4RZI7H*8@  ,S # C &GN  &P %"M "I[ %&R
M@N #"  %,X  @4#)G\ *8M  "_ZP!:P "KM+"HE0"J' "*7 "-F=FY[ HJR0
M")G,"B&0 ;BKQZJLL:TLON%+S1X[ 1Y@"'^ !T=@ PM0 D@0!4Q0 #*0!!UP
M %20 1.0!#:@ +5,J[^:IM^[OKDZO;,ZO? -RWY0 1Y@RU6 !#!P #)P!'@0
M PJP!$[@ 0J0!S&P #: !!(@ 7Q0 15@X >0X+1:SQ6Q%:^0Q#GT  F  Q@
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MBI82ZB$!#"ZXP(&.>KDBA DB0( 2F7#XA80",$EH" !,Z 68#G?$H  ()F%
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M B_H12PR,0$.U" !&"D 6 5P!DHHX $=,( 1@/&0%83F 7, 1O&$D(4"N#$
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M>]3?;/@"Q GRADH<&Q:I2,0F>H%"-]3B%;EVB'8ADNZ%>-?#X)W8> N9%T$
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M/E_QE7[<1/WCKK60&!NDF&F<F/"RF(B$QEVZR(ST,)G+"T80NX4@NW$4R?D
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M^(((&/Z 5Y # )B (5!A2H ##&@ #1B"5S  " "&ZU$ '%#A20," 'B "WB
MF8#9-7XJ%&5:U#P(3! !$)" 'P &*'@ #," 3<"" ^B$+,ACI:H#"J@!+::
M4= $"3@#7AC%_5/'I7UC_>L%$K  $E  '5BA%Y" "&@"8%B!$?@ !.@!7U@#
M"@@4M&H "/B!*S !-T O$Y"4#Y@ ('#!LRA&/_JN.HW(N-7!Y,S*NH6"0)@
M%F" "0B$4FB!!W@ 'S@%0=B "9@ ,PB%"VB!(1L#2W$ )=B"TH  .C %"U "
M.N"8#1 $J%'&J<'<$*O5WC $*<B .X"$"N@ *B  )H $*O[P7QD($"HXA "=
M@&8JPSO( "=X!!EH #QP !AP!$)(Z#]-:#PH@"AX!(B6@@CI@Q.   :P@2E@
M@"A0! ^0@3R8' AP BHH@!@[ 0F0@&;B#N[%2X6PFVU\RT- @@YH!$)@IB2
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MH  YP@ .B 4=<(!9^($'& 4N\&TWZ )@V=&HS-*H&2^]L,JX* 5!*( K"(0
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M  FX@EE( TUQ "C@@@38A$Q1 0?HE ! KEH( 1Q@ 1(@%ULFRA>R]T?L!1%
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MN.PDRP0*O(')!0!DDA$.KZ11@ ; F)" );]$E 9& &312P0)"$$)#@ $09(
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M#P$4 <4!GH!R 0* L*($ R4P (4IKY5FBWF&'JJ'(4L8$($#!V"@2!(*1*
M#844TM]_'DCI!R&%*(*' @Y T  ##$(P.0A]7"D!"(W0D$ &A!>B.1X$.Y!!
M'HZ<4,!^4C!0@0)^&B %'Q-4<'L>. +YQQ\[]JB'[H?VP68!#S@@@ R-P.!
M! TX0?X(G!#XH0<#&/IAN")V1/Y Y'P$'H&>AMMQYB$>,'#! DZ,7DCI$C"
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MK!HFA%+##BL.D$"I_A *M$P/_?X"'"1 "'  !NR OI* !AC!"D" S[[$$$1
M$.Q  X#!WFK $/QM!$F,XC(N_@$#W_HMX(Y$#D3 #HA Y;X"!&A "&C "*CI
M+\0!!.  $#S W)*NZ4* $13$*UR "0@![*JJS/U"%@! !*V:IES #JB,+KS$
M"[@M#F# W9K  +0NDLW"Y^X [&(5&SB #@0!YHZ$Z@(!ZZ(JWRYNY1[E$"Q
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M8L0$_((6[( FK,':EG$$:#%6B?[ %<@"!+CU+XQ #TU '0 #5F7!RL!=)D2
M'%  *%, XCJO9-2!&@0U!$- Q_X"7@/#)+B%7H<!6LE" F!")[2U7D-T#W7U
MDLF!5O\"5#-E+W  )8"L2\A"&J2! T30!!3V+[#!D2GE%VR+%O^" Z2T!.2U
M5^DU6KB5_X:>:K-VX )#&[3!!6C!+YR!!!RE!12Q2\S"!/@K5JZ WL:O R@K
M88\U&[1Q)A!U5]%JK[F$%7!0 >CMM9#Q)"0 !JAI'   $/0"&V0QW3; !31
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MYL +K*KRBD!#*_<XMY5+4(("] (B9X&30[G-N<3MEG(*!("0SX($.(#(FK4
M_"T-BT"&UL$ M#(F%( $+$"(]L 2GX%$C 0F", / 'M;+S)"./$ /'2K_0(.
M'$L3# $PB( :I $+U$+,?(&2@\$*Q,'$OX(#8'0(M2V]I@ <:( FR$(K2SS%
MQT$J0  ++(8*4'P= '4<D$ =9((): (#=$&G=\$.+#L'], 77 !@?0 <#$'K
M6L .? $&A';HN<0/*+E2PL%YJRMKOX(NY$" _T)6+$PM&,$+:,#4Q\07#*^F
MST(3L  &;'TOA+W6ZY\N-$'6!_XXDLGV"F"5$7C!M!? D?_"%3A &*S!"T1
MK91W&*C!WNNM'"B %;1!#UC -&\[P?>0+I [4\)":[\$)?R[:"NY2X2!H1LE
MYW+ 5$V^OX[$&^Q ".P 5OD]&[# ],)=+5@!"V@ 3/M0#@Q6"CSP+PS17"DZ
M85'^2)@ ![3!%YB  [B* W"^#QG&2\"!#H2 "8^>Q8,R,&C L?0 "C!E"K00
M%#G F\,$& @Z&+QQ6^!^\;\"(A1 #KC%&3B FNM;M[,*_,X"!30 $F=! 3@
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M\=F_^_[SYQX""B!WJR)P>^]?'_WR'S_YE<_]PJ__]L_X I  VP_^F*\ G^\
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M<7,@;L68 VP""*14:D&&3/NC%SB@:62!0%( K+AJ.C7 YM;71]( ?1='@(7
M6#@ !29!D>+7AZ$4K%+@NX* /],@9@2X#GJH"_0%&$AX!S1!5JX@!51($VCI
M!?)&43BBF&>#;RPA*X!B(#" -( + _A"%ZP@"UX@%H'9;GL!A;_@"R: EI_X
MEJW "#!A"-)6#;JX%J*W%^ @>$M'/_[-1]Z82-&#"^"2GS>BKO+-!'2!DL_D
M5?A,27OA!<3"!"3A#':@%_CY%6CB!7( &$Q $S! $F9! _)8$M( &'! 92E
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M-?AY()1Y* J6 [  EQ9'(7# !&8$!T@""-Z V=Q\G=P@"[! #51#I_BQ(*[
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M!4:P!FT0$F^P(CU )24<$FH .W,493D@!"H0+IJ  S6P [-0-?(AA370"<!
M3?(!!#7P G0&623P+!G2!%I@!.*8 SE@B3JP5$  !Z%13_Z:Y2W)L<%C:19_
M.@0Q["%6\ -?4%!IL )_FC*R( 0;025PH!I-51*S(%/2F@9:X"=:P!T-_ L/
MS"0<]04U:2\UX*C X,:++*Y;_ *U0 DCP#[A(GM ! R64#P3; G>D@HO@ ,[
ML!\Y #QQQQN3QP(8]040M0)H,A0H@ *G:#A9.KZYK,L &WZO( 0KNUY!(V]7
MR&H5UEVF(P=8 VLXQVJ%AQM:T 7WRQT:9U?A5V3,IF1>61;&C&EFU\U!8VN
M5VC,7,VRIF3[U5U6L0*6P%AP$!SG[&J\QLW@7,Z[;,_W'+":,(03QZ+?MD97
M %C>UL_>_*][AS"MA34#;6L*C7#/#>W0#PW1$2W1$TW1%6W1\\;0%ZW1&\W1
M'>W1'PW2(2W2(TW2)6W2)XW2*:W2*\W2+>W2+PW3,2W3,TW3-6W3-XW3.:W3
L.\W3/>W3/PW402W40TW416W41XW42:W42\W43>W43PW542W54TW5)AT0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>comp_0006.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0006.gif
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MK[&OL+2SL[BWM[FWN+R[N\"_OX&QUX2UV8V[W(FWV9.]W9B_W8&LU,&_P);
MWIG!WYW$X*+&XJ7)XZO,Y;#.YK/1Y[;3Z+W6ZK_8ZZ_0YL3#P\C'Q\C'R,S+
MR]#/S]#/T-34U-C7U]C7V-S;V^#?W\3;[,C>[N#?X,S@[\_B\-3E\=SJ]-GG
M\]#A[^3DY.CGY^CGZ.SL[/#O[^3N]O#O\.?P]^WS^>CQ^/3S\_CW]_+W^_CW
M^/7Y_/___P
M
M
M
M
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M!1?T3"<&$BC!!E0'JCN$#G1Y8,7%\G""%4P@%I$8GP5P%8LW5, "&*A3!1;
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M!(M4NHQ%"![WA@>FX:!S$F\;.A +!JR@#&5@ Z\$0@00Q*(5+6O )5[QBDO
M,@39JJB=S# Q"%2"R''8 "44< 8<LX$26EU3L+2,@@HT0!21@( (WA "U<G!
MGYFEQ/X:+K8F$9RA#IU]@V@'(@%>E8(,&TC "@5R@>0]8!020 &.TX"'2#R
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MD#:^0@(D( ,)AOD& Y!@!0]0=!E$^X@%G. $"J!@=RM A@G4RM H0,'78S%
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M!RC0)F2P2Q0U!F6 ,([PA6-@)W?P "B@/JR0!BJ ;VO@4"'S"F^@ C?S;FE
M"I0@"G?P/*( H+A""1FP 3LF!_:),65 !I= 0WHB"F,P!E5)403PHW* *@E#
M!F- 5Y<@!RI0"J) H@+A"*3 !BKPHWB@ FDP)F 6"2F0/*('I9%%! \0!VM2
MI6> I5CFH Q4!Y2@)Y%@I6/B"!,P NT#"41@!E?#$#>" \JF"@+A!RY@!*<
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MBX4\ I$"!]4 :+1ZKW-=MU<PNQ=>L)(Z3]HPE+,^*'<).^8!*^ ^/7.A Z$
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M 1X  O&36>U#@+H6:JZ" 6V :!% ?U]&$)<P 0\P00GC &82 NA$:1PP @]
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M ',@T,4;"R,P0@-U0MM]":2@.[,L ;,8 ;^# 4F#NF8P 76"<[FB N3]50:
M2KR#":*  2<$ L=B:V:R!K@T 1A X ^@Q :P3&<P ,@477(0765P (LTB0E@
MBCZWH1:.K*32!@M0!F.0 -F"Q:40Q]6" 21 "BE@7J^  =FRD;& DJD "H4
M"YDP4S/P!8'*"$<  WO "#P +SNP"'O +T!P"(*J131P"%Z44HR@!RX0!8S
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MA_?XH04XJ"<,0$%!3KRB!RTP1"R2T(586.$&?8B%$Z*P3QL\284M&EI/*!$
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M27SBH]DB8HT#;X@$)5%4DPQ@0 0A^%937^>!I8T !:^(Q .$Z8!2>"!;#?B
M"&2\-/Y1<" "#:@;F*Q6@B6*N"9F<  )0B "$L"0>A-80*5"8 96-*!:L3A!
M&DK1@%*,LE]Q(&(=*%"3$*3A#1S8<$U($8(,I""UL8B Y&(QV2]FZ0U$) 6+
M/9"E SE" XY 01O20(0ST)0$,@Z!'$JAPQ. 2YB41,&)H7R"P4+@%6]8@)!E
M3 D1Y.W0Z-,+=ZB3BA^\@ >Q2.XI/J$?57 "!J< %JH8<>KDPB"@>W@!#IH
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MI<>,RO#8%>IH!!? B1K@E?!HCO[EB UU^HY=49]@>0)5,"^K!$S!A(OXD -
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M!2Z!3G:$2V %"(!@"<::#2C%"[: .?"V$'B##Y@X-)$<$'8M'4J!"H@#4=
MRG($,UB ,Y"A(L6#2" %-A"^&BX3.7CF"=!0>K$ NKF$":"*[)TX!S"74I #
M$0"8U'W'6SF$%R"6U[U85\A8"U)3,=Z[+7@!CO)B>881'OZ0@5CX-54 @A\P
MA,)3!56(C>6UH$,X@K1\7O^J8S8 0%9P@(S#DD-A '<C@@7($C-HN!  I W
M&C.@5160VB(RF@:( ZF @%)L +B"7THX@')*K)N( PEX!4H8YS%CA>FUB0<(
MHG\MMQ5I@QUV!!,(JJ35HJ"J(U$X@&SA6UZ-CU+( &H."A)X@!4I WKQI8DS
M $H0SEA  \'BU9HX 5,Z@,=Q!,LMDSK(ZJD[ %:@@PM@!;8=K+4N!08 7RK+
M ,I2@'^3C^_(*%= !%=X7548A#+UA'=L D'(@OG:@2E0A2MX@2U0!260 E7
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MRH*/=VEWBPGHOS)Y P"H<[=<7%AO"^3<R1WV%TFU^;K  Q% @060@!,0 4N
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M,0EHJ@,5X, 'ZO4]"7!@>M/17T:6@X<Z#.H-L2E%!BZ0@0JP+7<26( #'I"
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MHEA#!"XQ"0<$\P$IH,2<[G"),#:M 8Z0PP(\H!M2J, CK_XH008@@29P7D(
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M76$ *1P)4AB+?1!6;&C*UUA 64! !X@ !7J,:DT 1I";1$R (YR !+C?")P
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M[<8%1,(=<&,=W ?S. )$V@?>Q((# $<#D,$=;$#SZ08>K$L=*  ;L(*[_<U
MO$$"1((E)$0=<( "6 (E&(#T,%R&X<$**$PI+"4I'( /O@4  2%+':.UL,($
MR $):!CDN,8;B  VC0&JE853*/Y-6ZI ;A%'\EU"&\@!)=CEB$V+7O98"(!
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M_220!>TB!K#!%9X&!WS'YI)$GT#6SUS"!E!=!9!!'&#@Q:9!\[T"&9P )B3
M&91!&;3!:/GMCN+4?[9>F/E38 QIW0@BVV" D@CM4[V!7:8 T_F2?9@K931<
M65RN?T!/*93%OX@>&\QI1BP )"B+9AS.&Q1.W$U$PX  $&%$"H2 \!$ 1DA,
M9WS&9V%M":0D)D!'S1KOC ;N>_*LBZ2!JGJ !42$!W3O>B1 "9P;22A Y"I
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M]$8,NO#0+B5+_'%S5, C#? <+/[F X2U!4@;:)! "L3U\-#U&,B!,W8P;#*
M@(S"N:;K>OA$3+Z%&2@A [#!&4@ !3BGN>:S&[QBQ_315*IJ9Q"<!0 -X!GV
M5=R!>%0 [UX !H3 7CJ&(W&9&92!!XA()/B$!43I?C)I4N,4C+)"R!+>6UP
M!8@ "'3 ?NBKQ#S"*Q"V*$# NSDN[=DP&0SE"9  *WB "*;D)12/?5!"B$A$
M!FP3:,@67-1;S/E=++@!.))" H0 >]+)&PR ))3">9<""L5"#N,VI+&"&U"
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MJ,: &$=V)(==2T0D9'S(["52*_X\3CEOW52  E3 !$0;'I3'1XS=&BP $7B
M!%C;"+BP!!B+)"@ #2\ @)0!1"[)5;!" G0A)!@^"CCN6US0 X@ !O#CB%G
M!U2<2J3!S$0 2;!'<T"(U1-'X41PTQP P$#" ;"(=JP %+L&"73:#07J!T!-
M_'#&&23'Z\>^$5N;"1R.>93" 7" ^SRP9D3 &"C1S<E)$H]!!*C$%3: "HQ!
MR$+"<^N&"B@_!F1 AWHZV]MV0<ED'=S!'=0!*<22'KL&%B^(1AK?(!?R16R-
M.K%)RF F0X/T'9B!&XP@[94!0%"*%4M4I(&12,5BY8B@I(&0$BZ,1>E2K%=U
M&,:*5/[GU40S;5@-C(6G3!V1 RE:=!12E$./;$*R@M3QDL!8D%BQDD0J#4R1
M>,C,&4C*X,!2:\ID%"EJC5!'EZ">!"KT9%6K5[%FU6IU1E>O7\&&%3N6;-FR
M,LBB-9MV[0P81[;&S=I1;EV[=_'FU;N7;U^_?ZNV%3S8K-JOA@DG%BP#[EZZ
M>!^?C!QW<M7*%K=>EJQ7L];.5RM_ODQ7\V? ?16G5KV:M=FWIV''ECV;=FW;
M@,<B;FU8=VO?B6F\OCV\MFGBQY$3_SVC]W+GAU4+3SZ=>G7KU[6N;OZ<^W;"
MTB%['C@YM,B%(<=;[GBBHDB(FZN>D8/9*LT0(\>([(@G?_Y]R__Y@X^T_P8B
MHPWZ'HM$%,GH,H,-!+'J3 5(Z--/)%(HA,_"\1PQ)98STDB/+DA4R(N[$U%4
MC0;&L+.*% 72RTH!"NF* (\*-]N@OZQ$,2.6-2RH<(T*^&*#2..LBN,.K"J@
MRBHYENSK 9,BO.F!NQ984 XJJYH#@KR\2U',,;L"SRX\5&"CHT@R>BH61T1)
M8PQ,?DKSL3=0F ^6-1I8(R$TUR MC14NF2##D1Y(02!6TE ACZI"2*,.%#*"
MI#TX;XJ%C0U0RK,-3A^[0X4T0JH)DCQ%H@2%.-[0X"0X07PS!:7<4&&^6"Y9
M$,XU5*C(D0A*,.B5-U2(8Z!+Z/[<M=>J'%GAC(0PR>@2"BNXPXT4VF-TA259
M&>.!-T)"\XQ2%'J*##/(E:.!,D@1I3UBW^BH#B+Q8HO,>[MKK*Z.S*B #1$X
MT.@ 42A1@,X&,!CC! 4JB:5?-D8(.!8/-DC#@A!804$!$N*<@ T20,V @S(X
M0& 2S-A8@(,[2)&@A#0@.",]$AY0H8P$YL/ QU@FD$,4 V)Y X-8ZE" #!4:
M^. D%2B0HX2 WRA !3(4\+&.!<A8H0$/3H+  C,LJ. $(@XPZ((/Y$@XE@Y0
MB.6!KTE8H)0W&-B (PP\D".#%28^(18(*C"#! 82ZNB."-Y(80%6VJ"7#$XO
MJ&",%?YFC(4#$]YHP Q2/&! !5;,@$ .%(8FY0 /S,!@:*I#N.2$^S;@0 X.
MVJYC A/QS9U,%N\21>Z!))@O#0XX,.D5!HR-)0046$D@H5@DN",/!P9BA82<
MKF1E@5& OP./+PDRP*:!+&#H]8$P4>!YY96.18XO.0@Q%@SH((6!6-K( /HW
M!@*9/CE"0HD%N"\" WE#D";@AH&40'\U,A8>$C 0#J A%LEK7"Q&0(2_\>]O
M2\* 25AQJS<0B00E0MQ (K"DCJ1! B'!R1OTYS"E16!G*N": N8CD4A08"!S
M()?O2L$*ABE$ >1ZP().T+;DR4$"1+M=O73GFS"U98IE"?Z.ONIR!P6(P ,A
M\-A 'D"O5T2@(J]@0P<BD0 NAB!X9KC/8R[!@(6HL8MM5%I(** 4GG'$ FUX
M14<DP)".?$!-N&K Q.3W05(,\%.Q6(! 7J&WDUQ"!!_PP)?> *I,QJ(!E.B(
M)$42R(L$Z14@\-$=NH@!3HF ;Q$(1/=B80$..B*5KAI!B21P(YZIT"(B<( $
M0B2T@9B!:Q-XA$5L%XL[/  "&VC8'21 $Q)\( 0/($4I') 0432 %*QX@$%.
M4((W=7$#0ZL##Z$81=54\5Z\LTLD%A?$:P;- QG@WRL>8),SA& 3"F!%$$7!
M*$X-) ZL$,65!%@*4QA4H"+YYOY)*/ H#NS,D9",Q0=V)L!8;.!!L:P#*0[9
MR 84A0VNZLB+VE"*4C11F$'3GP,RU%+@W6A> _' &BAQ@)4$0G^LA)XN)W C
M"]!A) G  RP<,;020B]*$X@20122!P7, 91IX%KT"'J!5RSH$F,XI"-NQPH&
MI*$4KYC /QVP(%(\H*Q'C$4)B' ) ]R!%9&X -'H=9?<L9.=N6DG%NM2@17H
M! (428"[#F")6##@ ^["82P_1XG"EF(!<3B* K::@#N\ @.1+:PH-%L*,P#
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M /_R&XLQE$'SU9>-P/=:[]\0W-D7R$ :VL.!CGJ @@N!(=?2$$,6UB$.<A#
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MUN 2%$#+/$ !+B$-I O/)F ,.E ,!^(,[@H2'@ %4* !3OZF<C1  U;  PC
ML&#NKDHQ%D@A R#M @ , CB #"Q S/!P%OU-#_?0[+2"%=Z #*B$$HPN)2HA
M#9;D#D0AN$ZB#LH@2@AF():1(-(@#9X'$E#!(M[ # HB)QBB&9=1E^;G08:%
M%VDQ'+/#%L4""5<#]!9P!"S@##Z@ G).'.$Q%LA1[/A0+AZC-'!$0_)Q0]1#
M'V,$#]( 7/@Q'@E2'A6#!LP"(5E#(5>#(<?"(<4"(F>@[ JR(BU2))A#+6
M,6 @[&1@.]#B(\M1+4 R(Q>C*TC2),M1)3TR)=W"".(1WBZ2 7.@)FL2!W(
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MJGI&H+$Z(FD54!(^:BAPQ>C@]B30*T,H0;S0(Q#BEN>^0A,6]F1AX1!@  A
M(3U3(59/X11DX <>-Q9.00EDX!0\ 7%=00I@( <282!2X0E<  BL-18R00=@
MX E4(18\P1-@00?H$1=)08]$8@+2X(]$ 0*6Q!$@X&FX)A*NA!0L  3*;$$F
M@)K^D%\@  0>($1$ <LZ8/?<IP$XH)KNK"-*00.XZ&#Q( )$(!:E+P$DP%@6
M5 0N /YZGT("%H#5!N("/, #:B8$,  "=$5\+\!O6$$#/* $:C!H)J $'B _
M/# *Y6"E:(;!NLP#," G-@ $JJF,B*8!'"#3V$ "V&@(2P#+'H"HXNQ;6$%^
M'3@AWN>WVD8$%*!\1K@#/@"X^NTP$%<D5,$(7L +,N$'=B 6%,$%/D$58( +
M<E@'>!@&3B$6P  +8H$37L /8F$+CN 40"$&/$$5<D (8H$07. 48($)IB ]
M>R!FD7 )JZ)E ,!'(@,#%H "*N  Q.E'J*0!".:K)FVC[DP![JQY"$9]<.6L
MH!#/J _!".( ME>9!DA3<.*A>.9&*&!?TX!>"(QH@N0D'O[ 1^0@N7CF01X@
M0R; $2BA"4,@/W0W%DR!^E"G$,%E  )%>?KC!,:@$NSP#3*B(U9 G"@A 2K"
M%!: (4+B#7BV#O1' CP@)$2@"55 G,;@ZA8'!C$HTV*!"-[8<%&2$V*A"Z)
M"U3A$Q"2"OA 83/!B$^!.9Z@FU47!E;A%*94%3QA!B97!CH2!F#R$PSA$&)!
M%>""<5^ $5P64QFN'B]A  " MJI"L"B!320 9^M !4B $2\!_S1B!4Y@ 339
M)AX $\Q :>B"%1J PE2@RX@7,T( C15" ]YN22 A$5%@!1A E(VG([#+H2CA
M#O(*>/A,NCJ #43A %0 !8C  ?Y*)!)68!,M>0$T8 P2XI1C(0/B !46H"-:
M 0)$( 548 ."A ,>  2X9" 4&N8X)226JB-.^3&"RB(T6*HYX(F()00:((C(
M$'I"0 54H .J4)J90V%I@ 5:8'27P(D'X0E@(1.V&)T+(1;^P*^_614PE@;4
MV8@AMG&9 "8](4BQ8 HX-1'05&%?-N5\;3! ;W3FE6>,E0V^Y(5]Q@(HXDK6
MP %D[V5BP0&$):U8D":PZ0W<5D& %Z2;]DW*0,(0T1&DQQ?+*VXSL"/(4*:K
M @(>10XF6?Q$00&$%@]\,7-P"@7Z@Q3B  3DZ /D1ZE+H0'0X[]J^Q(ZPA',
MP&C28_ZK'1$S;@DS/@!?<246*$"%(" -\N .(N$26 %O[N 2*("M*V*^X?:^
M8_A;J7D0 ,$0TE,'SE(&FJ"<)U>Q54$&GJ"<SW(B50$47( /8L$+D, 58,$&
M/,$5@. '#,$+9*!;IZ +$CQF?X.,Z\+%VN42),!O#(!"+H$ ".9^,(!O7J$!
M'F2D;(XB&/$F_.D#G+D,0&(!EN1G"IGIM#H+'8!*$"T"YH,NVB "0B(.#DD.
M9OIODIM>)LAMJ&($*(G-H,='*B C!H8$V"RG?6AQ!F($S#P@ZV"@4H<^4" $
M7@$1!:*Y!<E]'*"7"ZC(%N@^?@3 !H!<[N  <J+^SD=37/Z.KF5@$3Q\(#C!
M=+T %F!!$4"!$=#5$X)8TSD]$V0 %-9Y!D!!$TR6GC&W"4YWAD^!"5P@"E[7
M$S+!BEE\^V;V,C9  2#@ 1H@!#S$#"3@ VQ(R)KH>SX@B29@>H5% @QB#2*
M R" ?T1!=3#@]&)A#AQ  [S(&PE"=3A  B@$>#>  N!.!:;J)$Z@ L:=(>;@
M$0<BS8E&NK3[)B1@ RK@ UX!>/]7!?#W#1Z  RB S8@7 TB  NB@%+S+*#;
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M)YZ<R4,LAK@ @YE%P #>6'P89Z50?.ZK9T0W7<(!! _@$0L&;$QDP1R"8?"
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MD,,&5$6"#H)D A7X405,, 8$<-8$&V@#!R8]!@6L2 4,V, 92G& 1UD@!&F
M0)@[0((WE$@X>6-R27T)4M 9 /X D^ZFHC9@&PZ\802JXH"G6W$!$W3 (A)
ME(X$DX%VUB'CE)Y()()E@$^10@$MKH F%7 [DR>*LRG P$8>P>B^4&[DHG"$
M:0 $B5<D@&"EB$0I7CL1.$-BY@808"MB,8:)QV(4"3#%'"# N-2N2K02$&P"
M5$,*9CNB-Q$@6 00Q;$U<!Q3+O0(HMY @0F&F2)^1F$"0'.&2RR (@SX5/]
M)EI1-. 5:P"2*$[PB@8$AA5Y"8Z_#X_2R,J1 0 @PD4F4)L.;(@5'I#@!CP=
MBPT*$"3X$<7)+I&R-[C<FV^XP$80\P$/2. PBXM%)" P72*]06@B>,T$/"V!
MF)G" _X/:#N,UA "2L4B H)U38@X*X<'0( #(DD '$,@ 3<0"R85*"VIUY!.
M"4"B#A-ZA>@K4H<)3*3JI7" =%L'J:2/8 &EE4"!M8^XV$^$!*J:2P@P(.QL
M5V0",;O#CEY!;_A3>R$  9/1 )\B8W*T=Z633AJD?!OP,(@U$XCW47AC7)>0
M9!110:QP 6@0?!O@>)?W$1UP D R.@O0&XZP.7)@@HR3<32B2:2P>I2P:+&0
M=914<:*@ *5@"JQ "IE1?:P3"Z500(&Q$6Q@@@W 9B2@&A@0"3[(.B=0 7(W
M"I#R*$A($1# 8!SA$1.AA-S'.$ 27E2W( V0&:(P&QL@ OZJ46BQ( &V)0&2
MD )KYWT31 :4< !XT J.,"$)"!(5$#-XD'8<D0:.  &0\@JB "D)%#MK1PH]
M@@*3]A%R4 HOXF$O87@4B'@0H7@L@6BQ$P"<=0$=A $J00(8XP$C4!$K< &B
M( JPIBO_1Q' LD<&0"@J< "E0 D* !)W5@8ID "V<0$HP J4$ %Y 0%C4 IP
M!"D5!R-O$ !S4 IE 'L/P ;4-0!W( H&X BOD'RQL &S0PG:ARQU@%X L'DH
MI "/4 HIL",7%PMMD'8@40>K$PL-X BD4".LPXL2T#EW, !U%" 3X0!YP"@+
M<@+B%P)C  D*X(.\QPHC "$@ ?X!4'4'K><!*^ QY(4'$N!YP?@*)$ "<I0
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MB4I<*4H33*<:*= Y9V !JN$!"F".>  D&- &E'<"I' )#^!&.R('#*"()*
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M>FE@)"DC1YE!:IB'N^LZO920,A^P!C0B!W%@M&D0!R9(**5P=R!@(H #(*5
M AU0!W&0!@00(0Y !CF&5I4@!RK0(W' <2P8"PZ@:M\'$E7G@C02!^8; 2K
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M$\ U%6B .[B#&*.;,< ^!N, 5F  @VN;5WB %+B#$@  X7.$ #@!%$B!":B
M5Q"%!2@#/,B N?DSD_" *5N &#P! D",- " XU L$PL!/$B!","R T@+$\L
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M6)@=VF'15+B"%[@"53 )0Y !(P"%W5(%;EQ0T=!.V?C42W  $N" MWJ%#5
MA1*%"1 D-52+!N  $9A%T2&!!O[ @[HJ ;GILR/JI T @0UH ,"!! DH 0^8
M&TJ8@!%X %$P@P20 %K,"Q&X@!#8L4N0@ 7X )3#@P@  0PHIM>3!)R#@%*X
M. \0JJZ$ !" @,]9"7Z% ,0X@0L@ 0@8 3Q2 -(Y 0S0)"&+A5&P@'?% -?
M@"F:@/>AA I LPS "!6H@)N: Y!8  \HA42*HP@(@0D0"5& @,!J@,(S"3F@
M@"\D@TB84D!EV#+  !+@*U&P@ 7H %*@! EHI"X;A0@0@0V @!7X *Q0SYQH
M&'=ZT5@0!!^H)RF(@0+EKFM*@BF(A2O0+D\0 CV(A2< J"70@3VXI] H3J0@
M7.&$M?ZC<8#[*8 JP@/L$84'P @- *(0N+W6ZIL% *L2P(@U((L&N!\/\PL0
MX,/&B*G.E45*$ 4!H#71,3ACBBDG'(@H? E6< !%LH"(4%><:X!2J .VXAR+
MJ(P(907#X*']*H'W(04!0 P5J"H2<-HTB(!8V#N3*#D=R[%84(!+2 .A,H,T
M+0&_>*18P ,@DP"O2H =8@4A8P4#D!^+<#T3RS%6X*3#H*.J2H"WZ,$B4KWZ
M-;&J, #FG:^2S8S_>(I/,(3?@@47((18*((7*% L8 %R4H*ZC8(HB 4L< %Z
M(4:3T 0O $=CK1C$K8D'J C0^@N66M:;80 I4P&4O811)/X(OC$("%,!$M#>
M94V.>JRD!L"(.K#A!+ $3""^6*  13*)#. ;OT@V%'P)2(AA-WB?!P"<4G"
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M##)HB5@X/<T0"F$%@D7S@A<HA'*R 7+:@E6F8+NE@78Z@GG"@C[PA""(+E#
MY1!F3F1M3<6M*R+#GDM@@,KH +8H@\?@  YPA#8@@*K0W5A(14L"W<X$ <U*
M 3@R:/IRL?I2C0CH2 ?#B#C 'O'U)0B@-3.*!;ZZ20(@7HBMI"*$BP1@A97"
M"#E8@/Y7X)]]WJ&$:HLF+ ,*D BELJJ(\#>3@ !(4 'LQ8 UP -*2H&8$D6_
M$&CR YP;A 136( ]90  >@4,^+<[JST(N+U+F  [?<$\V.8*L$<4< 3UK8PQ
MJ"'<&]1"<Q<*V;]/8 (7>()4B 4ED )5L((7T )56((H4 4L> $I2&[8<0I6
MA853@ *C/FJDV.76C !,T%HB>S!6P( (< @+P( ,P"J3""J!(Y6_B=@/D"(1
M^-?.W%<EFC"K@@ /4 $0R.\F-(D5&*G .8$*X  WG@.(E20)X("8)<H%,"D)
M:-CV@@E/Y8 '.",*8'#=(P$QE@!G0S=I4J('>(M2V( +T/X ;Q.=?].<2X
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M!<679'\A5S-<( W1,Y" #Y@ /?[CB0\@))0A >:[#E1-#0Y0 *ZTD'4)CZ$
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M3%\L1,*(L,(9$$W5)>$RSL 2(@XK4, *:, $8(HH>$ %/%PE1!P)J),*6(
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MJ9S>*9_&J9X":J%F@IL6JJ#Z*9TR:J3NZ:/VJ9X>JJ!6ZB)H IMR:J?^E O
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M"M0!R90"'K0!!+1&"1 )!%2""!B(26R4'!"-'.S?V-33'?0(S6!-CDC,YBS
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M% 4,$F2-%2(A-BIGOT"B%- #/$H!%6!!$FT#$D$1=JX%6[2%7.;E),K"!;!
M%:S /\YB0/[#3<[%)<K%9,S"*(#DS-!B&\U"^?:$&)G01$X@ 2RI23;( RI
M!,)1'*7G4SX%"]%B5&R$5>JQ#]L1'T'B$DKL62"!'_,1'^M1( >R&TOE'@$2
M(3DF(1=R(!O2(9'D(!=2(B<2(!_R(0NR(>^%(C>2(]O1(N=D4#!23MXD(CO2
M)$\24_X^4B55TE*^$25?$B;Y9"5G\B%+DDNPA1UCTD5R$B%ITB<'TB5U4BB'
M\D5^TBAC*RCUXPU"( 38@"=7A!3,D2+PYE#DXPWT(APE83U(IA148#V>4AR/
M4BS])/E6A!4J0 +,8-60<$\F(0& ZJ VQE&DBDER10Z\#EM   /> RR9,"3'
MDB8UDD3"#R0P( 1N(U8<YW78XR'0(P\Z!S,H 3TL[2,,C17N ',TYR$ZYR&@
M!U9" F]F)38H@9'NH#1J47?P*1(BP<'@@SDXIS2"$6]2YUGJ@%HP Q):,Q(-
MASE>X0[PP')LA3I$80+:8#PHP8E L100+R'?1"0!\TB>T_YD@G(418(5%$#2
M/J+C1LV_8@$$UH 4*" $.( #V@J,&@!Z+. #2& "] *,($84*H \*X 4*H&C
M.F !#B8-% ?LPN@!WFH,(* #/L !9.T51, P)T 2+@D#2*#K2& #%, N('2E
M&, UA/"/-N CLHB2UJ,-** $K.C3IB\#2( !1 YW). #,, #/H)%_R@#MH\A
M4&@#%H $;8@$/L#"5@#N5,.@""H!\B@6OB@$(& ]4J #+&!A)I)5I%,Z_S)2
MML(E24$" ( !%^(2E HDDDH4[D A<JH4/( $1XU?%. $!,,1+HH#2' !2D P
M.("D2  \"T N'.&AUL#"/.#]8OZA MI % Y@- W $L8DYQ9"#@9FI6XC  P#
M!1(J!&XK%LJ  HSJI11 $E[!Z\AK DBP%%ZH#2SL *:K,L8DJ+82 U[H 41M
M 5RCD0B@,2C! /#"SV(! I!J 6+# Z1O/#!@%=\@ CX"$A3@%51@ 1JQ.:$3
M65O%+2YA  "@1P\C 4HLJ1JC 4;A &.A35- !2P 8 J4(B)A!5!@V/[+,1B@
M,8[3SLR/BS3 Z<;T ]K/PCZB A;T(SH  U0@!4A@Z4* 7S8! AX08,04=AJ
M%?1O(2C#-\P !>23(18@ S!L1(F5 V95-!R (MY@8! V%GAG3!QM3"8 /^Y
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MUWV=!X1]V(4=V(.=UW>]V)']UYD=V(M=V7N]V9V]V:&]VHG]V;'=V+-]UWO
M"7(=W!/O@,:=W,O=W,\=W=-=W=>=W=O=W=,]W.-=WMNQ;5#'WN\=W_-=W_>=
MW_O=W_\=X ->X >>X O>X \>X1,^W^==).Z #-+ #,S@#")>XBO>XB5^XB<^
MXC-^XYLI'CDNGN,QON,W7N,U7N1-_N-)'N11/N0SON0]_N5'_N0]WN)9'N1K
M'N9O/N9GON-+?N=3WN9M7N6%GN==7N:!GN:'GN91GN*UF.&?'NJC7NJGGNJK
MWNJO'NNS7NNWGNN[WNN_'NS#7NS'GNS+WNS/'NW37NW7GNW;WNW?'N[C7N[G
;GN[KWN[O'N_S7N_WGN_[WN__'O #_^D# @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>comp_0005.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0005.gif
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MY^CGZ.[M[O#O[^/M]N;P]^SS^>CP]_3T]/+W^_7Y_/____CW]_#O\
M
M
M
M
M
M                     "'Y!       (?\+26UA9V5-86=I8VL-9V%M;6$]
M,"XT-30U-0 L     '8!N   "/X 5ZU258D0(E4"5W&JE"IA0E*%"'5*:*I2
MI4R5.#E<U0D1J8>'2FT4N+#A*D^(3"F\F GC1(&G$&E,>#'A*8L6-U4BE>K0
M3((S!19$9%(@04L(!^+,Q,DDJ:49'5K$&'1JRTJG5EG%F#5GI4U%'7(B9.BC
MP%)3=V[<1"A144Y$2<;%2'6DW;MX\^K=R[>OW[^  V_D9"2&X2";!"Z9$50@
M'AN&9W!!:&A&C1F8JR1=U21&E8&KO+P(!-JADQB)5UF!88@SYA@S7F !W27&
M#Y.F;O1(^@<&#1N77W3A%(,*R1E(!';J?#AH(LR5!*;:86,&[""(5N&)4=WP
MD(2I?/Y<QKR$E"KQL&/S6=7C,FP8>U;Q&#_C1W2'6JQSSR,P3XSQ-F2!$"E,
M&!:##XD(!$4,F0AD10R'K/(#9I@I\9)@&&:HX88<=BB=$#%L48EH.32T6&-[
MP""$(8<T 8,7JQ@2 Q2)&,($#(((54,/-YCE!0R V,7$#*D]V-J07/R1!QX1
M#C3$#C,0(I I.OR0U"9XY"$>'GA48HEG GDR@Q(#$1%B)5S \)V#-=@PVRK3
MZ2"((5O$D)Q_5"B)!VG2]6"#%WM$ 8,5[-V AYX:^9GEDHGQ.&>=0CB49A.)
M$,*#"U+N$8,5AP1R!(ZK)!$#&)O\04,-B2V86A402E@#H/Y2P&"<A[36:NNM
M@ &R:4*'"*+2B0X%0:1R-^"PRB&C.@:#E*MP44-M088&PWHC#5ED# D.V9A
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M!VX@$)!@ B'P!@(Q!W9 !AVP>ZM& 7-0 8V0$&T  B9P@F/0 ";P"9, !W:
M JL@"BT0 F% ?@XQ NTG$&X  B<P>J+0!HHP B,0"1^8 B"@!IE' B$ !P(A
M"F$0 BT ?'+&"A# ",37>(N  "=@!R5  :LPAR9P!R: AY, ?ZMP!AJP"J@
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M 2FP 6+)" P !Y_P 9OGC0(!I=OI9A50!+%G!P7 "BP@ 9$P"1(@@POP>G"
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M 6?0 NC'")-9JK1X!F%PFR@\514PPHTW >3( G.  8W0"*8X!\:: JPP"1<
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M:2 **H"'<%  ,:W,5#4&[+D1 RD*J) !NZ>#!DT&HI & K (Y2B&;B"6*I
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M?2(0?HW7""$P 0<M$'40?VO@D:^]"I*@W"V^ ;OGP'#0?HU'PS4>>Q\M56X
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MQU4<N1(2F9!DI9'Y&D%E)E;@( ,.$QFQ,4>8(#GA Q,8B?X)DC;,/'"F14P
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M21A"9MX"A$(4"YB4$!])L \EE,.,& "#.[ &?ZYB!9&<Q)WVUC-VV2%?1T*
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M/#Q)Q;)) 1*YG86<O3"X@ KX@#:2/QTA [@Y*12HO-^KD1-P'9O"2/AKD%9
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M:"43J/X 0+R1#G #$N@C2'  A,& $8@5,F"%Y#D29($#"#B#%& Y2IF 1I
ML@&=(XD %B"#!V@:X-( ,(VC,=  ^9J#?RJ#B]L X6*O#> < *&O@FM0._BG
M:(F)% "T!;@60T(%.'BQF'*#:!(%5V&$!B":.HBG9C&!!.@C14#2F+@ -!@%
M)0*U'&, 4!HT2.@F%YNN"PH%TC!+H6L @.*Q\7+'"@F%Q_0Q3X*FF'*5F BA
M4#" 2-W)8W*$2;" -9C2JK ##"@ H-),3UH= Q$%/(H)?SO+#YDL5D  NKPQ
M_HP)2E@ 5" !'@L#5<&VF#B!$J 4PD2 ,PFFOUJ.?&&!I_XB@U2K@WJM [SI
M@'U"!4A1@14P@08MD5%PS^EZG&U%A7:5)T SHYZ!&*AR@ K(L80=(#B A&AZ
MLYF0DQY3@XX"%%3P& MH VBB*U Y4I>!@$]@!*^T*7M9! F0@(E<!0MPG?<"
M@8'L +*148RY+$; FP:PP04@ 1 @ 0D@L9^LV?,K%0G(T)EH(42B4U$3HEMZ
M'4AHA-J!"9#[UM4CEM5! ];J(A# 26%EV0L@U9!I'U%C!>,1@1&(@YJ)@"$I
M&V3Q&]O"R%#X23TBD@N   T@C198  ?(,7*,"398KT[3G"D"(\YA@7VZV%#Z
MA+81!45H@#9PM]&R T< V1K32?XOF80(L  ".8$&O0 U@(3<.B95L3:7B0"9
MI5EH8H4DF82"6@4.6,=08(#K$MK)&EO^**<Z ($5:!2+4AB%,)MS@@E&.")'
M^81),$K[<9<SJ*DT*(!AL9U/!2@2"(4)6Z0RVQ'B)980"":.C8F\714XF+B2
MHI(TJ*D3F8!'T)\)X%$*D(.LN3&OHK@&74Y6J(.:28Y/6 ,$^(0P"E-[S ]&
M2%91X+9(D8 D2:F^B205:)Q/N["(Y2ET"X4%&)(T^"=#JR3#S(#GF80*@,JP
M91='0 "@:K=58 0&$).=U$F9K=3::8!1@81FB@,'2 X3$*ZB(SJRE)"<89=0
MZ:96#?Z50JJ 2+!> <$ 'H,$!("$*;XP]&&$O3F3 "A4)M*@NCP +\F OSF6
MIM%+'-$ (FHA!0B3!9"Q,8BF%6" 81G93X" QQJGA[(# 9 :,JB MOD 4#$!
M0#L7(YDH5I@#KZ2 6T(%*DJ52)E>_E"E"'B>F+@=#" !@A&-5.JVY$"%#S ;
M$\  # @!@ID##,B #?"21$,412N;#JB "5@#,D#D$P&N&2:2#L@ 43F1#S =
M5A"?26 L2.@4.[B #; AT[J +HT=3%0!3/154C:ML $H,9D$W[& U3%F >&=
M#'A6(OF ]F&LF$@G"D P"(4HAI, MSTI@VM=E[F *;N1%/[X2#;(@#)Q@V<V
M2$2A@+H1A1'   M 8E:H+T!) <Z!2.<I$[L E#.@@ P(@Q#0.5"!!-2I@%LR
M@V$9 <TID:8[$:QLCU%HF9IXCU8@$92MBK:)D5"X/9+.$9=&#Y@ND.(4/I$&
MG.A#:?6@:?=@:?0(ZM+ O'ALSP#Q#P!DW"0ND?5(R$T$2'.)/W2DZJJVZJO&
MZJS6ZJWFZJY6/F6<1K"61K'615<$R%D\ZU)T1F TZ[#.$[:&:[)6ZUH,1KCV
M1;DF1KKF15^DE%C4/;UN1K[>Q;9.1L 6;,'&Z\0F;+;VZL9V; E!0S=X@S=
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M"T\KLOX("RS!D?DGE*]BAQV-L'!WKY"LH *V.ZN +"IAJ"#O*FT4088H+*
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MP$#ZBM"".7P"D8SIP+:*A@80G($%&ID#"_ASACFH( 5F8($B3F"IR6T@.RL
MU0K20(8TI !_=FA#'*[(D#  #?ZE*D#!&38J34MEX#HL^(0)JA<[,KC!!#0A
M:AC@T#:#6(>6'#$!6L: +98U8I0CL,/$X* 4$X!JBJM@6>_:4+$PH"^.T1I#
MZ-XZ"5:8@ QK,6?\_K6*1<0.%2:PF-[8D(+#PK0-WIH7_-S@!CB881527 4J
M0 "[]+4!#J&#Q,F@-U)6E'6.#/F$!4.P+<T1\3\L8 0D3%""3[A!*37+GT=X
M)P)I-B**NP%F*'9;A_QI0&]*44EJ"8LL^:E$!9.86!S0,-PL^A61*H $X.S
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>comp_0007.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0007.gif
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M]/CW]_'V^_CW^/7Y_/____?X]P
M
M
M
M
M
M                     "'Y!       (?\+26UA9V5-86=I8VL-9V%M;6$]
M,"XT-30U-0 L     /\"F ( "/X /3%J](C@(U*>_$PJQ;!4PD8$(3IDQ*@3
M0X&,/)6"-!!B(TFE(OG16&I3'T\"&U%4N:D4J8:>^N!I])*ARH(%135D& G/
MGI8[>_+YY+*4I($ZC0Z<Z!&DRYL>-4KDZ2=I3SQ &W(D"8D@Q4>/2O:QR' 3
M'CP++S**U'#JSK=M&75ENW,2'CU939*]V"=M*5$R&3&<U+?AHZIP$RM>S+BQ
MX\>0(TN>3+FRY<N8,VO>S+FSY\^@0XN6C(>&#1FH:0"&(66G'M.H9:CN0T-&
M%897:-# 4PJ);MDPIO26085A'!A_ZL"@<>,&#1A67/>(O<3B)AR_:_=I**I)
M;1D[]OXP[/X=AQV&573S+K6$>4S8,FP4[Z3#1NWG=TCID%&'X1(9D)02Q7<W
MG%?6?G"XY(-L-IRFVG%R,/0&#JE1\1)M-S3BT@X]U,28)SO8)]L1%HDR(&HX
M1%C*<0DVQ(@,3##$QW2HQ=@(#3_HY(<,1XSFXX] !BGDD$06:>212":966E(
MT ''DZ7T$4-KI+RTAPQ(V/%D@GS0@(,0#"'A'&^^7>'D&]OY1L-VQ]TAR1MP
MZ'!#'&\(9I.7=#0B10P]=H*##G#"\4963L# 1!]RU###0H4RP0@>T^E12GHV
M1%&2#O4)),,0=+RQ(&]_;AG')*+L0,,.+?TGB1\P*&$2#OXU "6'ET0P)(<<
M3M"@A),KQA!A'3'XH(<?24 7I7U);-BA8R#><(4<2L0 12E0P+#$(G@L>,>*
M,"18TXLQ1H(='(P\\4(3U,(081(R;*?DN_#&*^^\]-9K[[V:X2%#:Z[)8&E#
M?/C[UAXT'&'#))W<<,1NO='@%T,&X_ #MP:6P@,.214%A:\-'2'#03;XD-@D
M-/B0E!U*0+))R4GIFZP5-A#10REXV&"$#9K&6 H=,-QV P]O>:*#J=.R:Y:A
M&G4""4E(^""%##0Q9(>QII3RAKJE_$"#AI?B8 HC-/ @PWDZ+-L8B#IH% D-
M2&QB0P\D!=QC'#&TR!"XI5#1[?Y%3A0G2<Q]R( NOH07;OCAB">NN+TUE]V#
M#0E>Z411I;PV].,)ZIMK'J4Y(0.9I^Z@PP\:&:'#%3#D(0<,YY$B2@\WD-00
M$32P]5(5,-!1"@XX'*$$$MLRA$<,DWM(,_%%>8+##J5<84.NDU"QPQ(XOWA$
M5TQ@7=\..^ 0HR<V'.'Y(TW(0&H/,,C0@Q1I3;)O'SU768H=,42GT]5VD&(#
M#R^]Q&XDC8C!%(R @TWTP&P?PA0?(E$%XBU"!D^ 2?=* 8>]N0A&P]&0\2:%
MH]HM[H,@#*$(1TC"Q)6&!TUH@A)XHX<I4>XU*%0A;ZX$!Q_TC0=P^%S#E- $
M)D!!)_Y(.)@/?'"%&!B(%#R(W5N$X,&70(@4.+A!#Y+HK>--CG(TD\$5'3*T
MYM' #C20@Q&8\#2!P(='7/2>"J_@D!L8@61/\%R 1 $M',3@!@&*0[M*H0.@
M2:U^1<&?*/:7L?]$XA'UVT//AK"#C"T&1"("#V$$5Y12X8"">Y-?(S"X,*Z]
MI1-B*TX)1TG*4IKRE*A\C+ZH!+ 8_$M&^QH8ZZC@@Q](X0XP$(]O'M8;&X@B
M8$.@@>Y<DD39,<1S%5/"'FTPA V6@F0_J,D=D- '2="@F0S948^J #4B)$$'
M=J""##1%33PPXB6>N('(=J*\(7#0![7K0QS(0H48Q"%K./XB( WX(+6>!1)K
M/K!!@!SR.%%LLC5'6![_'&/).^QA#QHA&0^2 K9:06@G>)N"!4WAA"8DI7S;
M<68J1TK2DIKTI$4JS1'N8(>61JE@>+"#'":YTI:>)V!VZ(-]^H#+/_3R#2R5
M@V""V)(GZ*8_#+F8(Z.DOC](X@HRJ-4G<(!-N#"!>)'X0PYB$)8EL&82C/A!
M#/(P*?.]P4N=&) G-JDSF"S/IG8@%57_\@,;W$ 2<0#"$A#6!!CH@61#Z.A_
MIC6_&-S&B5@[#A(:,8F^3NN!K6G$#0C)+-$9LQ1-(-XD&D$$UEE-BS&E0R?8
M6HH;X<!->DO6,?>(TM:Z]K6PC?ZM8_05FQC P"3+B<$,7E"%1>@V!JB!@23Z
M\(((U8 &I9##"WA#!!G,  :[C> /9-"22=A11:3800V62L'3R" &0UB()VB
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MAJ8TAA>'AIDQ"O)#"EEX)&JH;7/(AG88<G>8AWJXAWP(;HG@!8#P<H\Q!UZ
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M$EL*)+ !)E !B("X#T "H& !@^ %"U !OBD!I( !FX@!@E ($W"U<LL06-
M%0"+)Z"Z$U"5KJ@!(1 "'="+&_X@ B10 2(Y"AP0 BA@ 9B) 2(@ AJ0 89H
MLZ7P!0-; 87)F"30 !C0FQ"  B#  -$(")Z; >C*$&:0 2&0 9GXL!J KF$P
M 1\KF2L0 H^KJKWXM7B[!8/P !" !95@P!Y0 5CPLB)9"F%0 2D M*6 !IX;
M @RP!I>  0\0 GW:GA4P ALPKVT  1!PO*70M",  G)Y!F.+"1W@ 2_KD"N@
M 20  E1;"FH@ 2RP <U:"1%@JJ#  2 @ AM@B,OKNI K!AYL 6# $"M@ 24@
M >1H 6E*"HXI!@PP 6>0EJ @ :RIJIAP"!50 AM@EPWA!0T0L63K 2M0 ::H
M B@0P/YRC) D6@(D  %F:0+P*Z8F6P$OX0%VJ:JC$ 0M< @RW *7( $D4,AT
MS!!K(  IL!-H  !;3 ($H DH, "7P 8 H :   !C20(%@ DL0 !/VZ^CB *"
M68E>X+M0*Y@;T+HB$(Z5. </8(B)D)<J8)9J@ &@  'A.0H58 B)0 #DN*S'
M>;*9B+)<H+*>R "260J\2@HGT(M;,*]8H):E  :".0&!X %;O*SA.0@0,)D
M/)GS7,X,$08B^1*6P  5F@:P&,5;6@:(D)>G>IF$@+)&[)4@,)8,(*:5H  2
M6XF(< !5B0D,8 B&( &]> @<710B,*^'0 #XB,O+:HJ#$/X!I8 (!3 &+F$!
M@  "7<"8$K"3%H"/%K")Z>B6AID!@U#0M8B7B7 &#-"+#P"Y:3#/9(  %0H(
M"I#.&UP&:GD&]3P!@8@!2&D(#T"6@HFQHS !BHP!T,L0&!"-.\H0,=R-(O#-
M* "Y$*"2H)#1A\ "#"$"65 *$H"N'@"Y$C (B@ !AJBJP7G)6VD&#&"(6Z"6
M$^"36+VR:&  YU@!T"O60ET*B6 !H; "#U"+AQ !#8RR)T#7+/#("5#2T1G7
MAU )$*"7JCVI!LT%8\L&8-L0$U"8'0"Y+4#'E5@&T5D*9?#4:#"VF<P06S"V
M*P"RZ4L!](J/E?  Z]G$#7$"<OZ;VZ70N&7@E8D0 ;5XR9B !A)0B6N@EA4
MD'U="AP@L6?@E2W)P1II =%8"AL BROK 1)K""OP$BGPR2E@EI/+$!M@MPJ
ME(?  )HP"A+@D/TC <N) 2)9!F.K HJI!2,@G P@X ;-$&K@R899B25@ "2@
M AH  &?0RFB@FJ"  AZN AL@XE@P +5LRXIQ M3Y$EDPX:60!8+I "G0 EB
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ML&XY:E=C <_7!L&$ ;,P(8$4_Q8RXP)7)QBIJ@J^6"B#N%HH@<%$&!#C$!)
M/<,@%,YD[:X5(%"*"PPP28#.-A0 !9,'_AH)A;AETHH%$4AA )"N?=+DV34
M[\_4"O@#Y !#K&)[;',SX!@#_EAC8]%2-)#5A)/05#D%E2U8O84V0'' P^U(
M<2#<JD#)8$!")B"SQ5*P^"!&"#"ZY/FJU%"  004$( T+ XPP ".VT!@@K]*
MR8)[ U)@\0"SNF2_????AS]^+E.(FRLN2KZ_%$4PX*#_FA?JP@1&,($C'>4
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MT2M.N?X$$8B+GS"5D9@,1:BKL"@%-K" #:"34-B3GT&! DF$+R2# JD91)
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M ]PXRM'ABA%@ <SJ#)@B&X,(2,/P@'&A#$PL@:X9GT-8C0N0#A&8#U 8G?P
MBT1  ]\ !14@!1+X KKT#$SXKX4H@3,!N96$S,B4S-[C !(8!"P0@()D 4-
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M]JJ)5[\$+PB"6Z\ HKA(7V<004!.-Q .N4($"R!S+S L,?YH >'VC"S8@L$
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M4I4R)* 29/!?: 9F@38X0@%OFD-B_EL?Y(Q=4KDL18*9-@<S1'P+8^IBN[@
M "PH A%G   '1L$ RJF>*JO'#0.TMH(CDV  #P %!18PB"V@GB_%K$@A"G
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M"E@ !H &*8C SY!""/R,"F! !@C'*)# !IR &FQ EZ" !7"""\B%(X" !F!
MQ!C" R&"*HD6"<A*!AA/583 <')-",2;D7SAF\Q@*:Q!/4H(+>;?"EC 5TG
MFX"!!6P ""C%**S !6# "L!@(B 90MA5"%1")2!("YQ!4<[7 @0>;IS !IA
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M;(0(.$\)&((7R(612O2;B(#QN/X!G9:"%D2/5V!! Z@Q'&+ '_F'"23")93
M%F  C?!B!H  19T &62,EUAI<QR"!X! 4U\""11T%59"IG"!"YR !""<-7N
M!:# "; 7$TK %B#"W!72FZS!']D.FHB-5T3K T@IGEII%6:!66""!]Q&&U#$
M?$Q<1[RH!<C%@'  4GQ<PGG !OQE1;1!<D& "ZA!(7W,D60 (*H &5  &ZR
M 4II]F1 !F30&D" AE@$-I((:XL *61I*%8,(;ST!CR&]T L"0PG2V%/&'"5
M"WBW;ZF &%B ^-"-S;WR)9P CTR  :UHK^Y0&[  %FA )90 B6CK!A0UX%0
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M)21Y2/D.%GRYCQHYX>-K*(B7&9R=M1YT_ID-B9Z &[#!%BQ H93!$-<'"YP
M9U2+"@R,5OB'^VAP15#P W@!&P "4>I+/'5RT'#"YV,"()A!WN?%7WH!!C#
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MP0P00O( #,P<"&."RS80L842OZ*)E @<X:("+ES(0@Q+1I% D0T&&82!+;#
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MLD"$,DIH =5*).#$JQ586(Q,F3%1HR#?(!AEWX@L .2$UTJYY$J1)%#+MY\
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MI?#"UC R 4,X E&'H(@+>E(*-_1$>!C!P&%*(0A ..( LSE4*;C / XFJ2(
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M3C0A#+  $_$0$\J 5=B1"Z0P(WPH$&"Q$AWR(2$R(B6O8#""#19"!$)@##"
M!ZMI"ZR$.R) P! A#2S@#$)@:[RBPLK !3)@+S:@!<3@O5 E!; C!(;""Q3
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M!124[O4& 2)4@Q0PX08- >^HV%#: ^[0J!+: .JXC12X(R) H0(,,3D&P1$
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M  (@H 4J00,4]1#6. 02744XB00J@ -49+B$O(5*?/(<5T6X %%.@$<:I@W
MR710A1 (P&(<00$.(1$(8 P8AC^%QTT\X@P(H- 0Y8:\()90H'C"8,M$ @4$
M!1 @!@P2 )U>:_%+(0U<9S BY8EF0U,0 11*P",.R0/H5P3 H!(.0% 6@R9
MP(<THA08("0N@6E;@$<XH05&X8;LPS7A:@YE+0PP2KBG0BKV N-=>#)48%<&
M@2*R */V S'#J#6)XA!<H$/0-2JJA2G8H\IP"*1*(1",(XR&?#8"+)*D>S,N
M@@SZ:_XQ^R(E%N(,#(!Y)H KEBDU)D!"N2@C9@.+\*(G0*$%0&%A6(*20, X
M=#<+ :)4FPFEUCS(4LJ#%TX.-)7*8*:4&0:52F794"IC*0F#V"BH>+$4"1(9
M460!96 +J5(F6&14T4)D13(92F'A4(I4"U!F:I8Z@Z'4ABVE$+G06 I"F5*7
M&""LD"9C!C8HQ90"Q6 -)@@5*T4 Q29!Q2U!1Y3(Z"'H"1495["EX#+4@S9"
MR2 U\[44( :E6%Q >S14J4$,0)4"H\8FR4L(L&2TX"5CAY@55I0:]0 0UD%%
M$P#*B32TZ-&D2YL^C3JUZM6L6[M^#3NV;-*C2J$@N7(+R?Y26T+4)67!@@K.
M&@-5 .TA3*((&C?8+55AD.[+HR14XC*A2PLL!Q*!$9%Q"XA287"NS,@32PB"
M7L!?AI HC/M1\,-XR!@$O&"%I2I]P6+!60\<<EE&A$BPTH'G@0+!"EALL0%.
M$A"2DP2&& (!!U@DHA<%*ZEA02DA$%4*"!YL@04*?(WQ0 A?&*91")&5<@@$
MH)!B!A8B3#!*)3:>@5&,7R3B5 M</+ %(A+T%1,$*#S8@08;<9:!!2D$$MHA
M6[@  1<B.B8B!RBJP  F&E7P&9 9@5"&&5VZL,4!@Z#A4RD4?'8!&J608:)5
M$V!)'D:7A(%%!N,=N($+B)0BPOY06)!9R03$D8'1>>A9]R )H$Q0B8\.053*
M&$&646E&$Q2B1I"4;O291HI 8"8I%)SP( @A8D)H!O<=(H$&+1!(@J,L) "*
M&@R P(5#&6$(HPE88,( %BYT,0$+#'*2$:UK.,!%"ULDX$8;0?U4DP2MGE%3
M!25DT1M!%K"1T06).9=1;20<51L%@P1A62DJ6+82*1[,2I=B_7%5U -FEH)&
MB!@D5HH%<[01XDH;P#M;QAIOS''''G\,\FHHC%!@%N[U5@H'85RU1@L,+%6;
M<06"H!QS&6GPG 72[4:*!)9LH4$@9[#!F1>^\>:;?4B!8@$);0 2(A>X;13?
MU!+$-_Y>*4&09%ARE3S@PB!@D/3 HJ5P HHA$@@V"(_H01#&&F@ DL@HDEXV
M 868E%$" XD00E I((KH9<HH '*&&X88%A\'%1A6FXL9'1(!)AJ(P$8@%Q@&
M ADGK%R@BT2NH48:@51D 2 ;< 8W&V< LN@$GXW"A@L,@ %:&1!XD4@*CHVX
MY@F F-'&XAI-, >Y:)5!!II#"Q*J>:7(7@H&>@XR!AF<19>1&!Y< @$+@Y#Q
M 7IFH*  (B:4@#@;AFC"449EX"0:"5R44 D)7G102B(08 NJ5>TI2!FA "'4
MX!-2)65VH-"$(V"5$0EXH0VO2T0B)+""09CA/E<Y PH2</Z($XP <6THA&$J
M$0802&!AS"I)%B[1@#24#A"7J(0$8*0"%ZA!=F=8PR!(D89QG4%*YLJ(&J0T
M@2U0$! $DM=CYF67\]RK0&AR 5M*D8)^:<0-6(B63<[BHXH@PD89.4.(\O08
MQ2WI,72Q5,C>",<XRG&.=!S-2D0(&I250@N^V< 9Q'#%VQ2H$'+JCP(N9+-2
M:( HB$C ( #Q ,.LH0"5& 09*W$"I(5G/&# 2&U*(0ABE:(,#SA,F4K!!KZ$
MX92I+(71,A((!URB?PNXA!>.4XH3C&<R:^+" VMSH-JLQ -@\L)2XE>*"" "
M!5:!3AD<P0"'K. XR H/_>: !?Y2:, 0I8 6-U<R OK=1!$)F.49'E ;-F"@
M PO+2 B\!(&"M0!Z6-# ;D!PE,/8!0*(X%M&7'"?VGP !8]!2 @0XDHIZ24F
MQTO3N+PF2Z9D<@STFU[R*J"GT& P(QS@ AH@D)$68.0$N*M>&("2D4&XQ ,N
M20A.#M'.@DP@DUN08%'(:(&EB"HCJ_JDI! HOZ"0().Y5 $H'J L$ER1#&9(
M0REM$A04S&@#7E #+E6:LL^0@@&M2DI40.$ QTS@#/@)!"@.0%:YK*$I%>$$
M"D81Q#(&)017%$%02D#044:F FMX8O6:F1$S($@O?'%+1K)8H#.XYPLA:@%X
M?&2)C/Y4H*0<B(D%HA*QQ,"E$EXP0%?K"-K0BG:TI!V-"KC&F]UL 3P>((,F
M)N !$>BK0)8, 0DF$!-!4$ C!@'!"20 KQ-40 0BL)!%)% ""1!EM1EY)6'<
MLR8.G, %$V">!$1 @@<LY0O7%0$$[/+*E7"! B68 .X480$1G* %$!@$)BY@
MH@R,PA 36$DA*/#)_F#  QZP0$7N9C=$  ("(_# !LPD6Q*  ",AZ )H2- T
M"22FIB7  %$S4F$1A&!"(MK ="U (@FPI3:U$0%1VG!=#(1 ,(@X .@JL=\/
M6(!#^F(:!VZK58%(X 0H0 %!2D BD4088I)-DT)EY$KD3O[@*&+@7Y%+L0(%
MZ&D4Y]% "!J% 5!@P@(A6&\$ &%)$7P  [,T005(( &R(F("(&B4;SS E@4Q
MX L"20"'+FBF%BB@#:F2'P&A8X@^CU)0&_" K3!A0V5A(@,< ,$$$ $*%7NY
M#34* 0@P4!$4G%D"2P%#!$J0@=W41@T0$,$(*H 004P@!!KH "F\$H(1-*U[
M$"BO9=3T$RDEH@(>" $'RH>)#6Q@/9S!0%^KEQ@L*""*;6G:6/W54A6XI#:<
M$'9Y$[,&!;0 $Q*892D,48$0#-LP#Y-*8BYQ@@R 00,8*ZV[WPWO>,L&$^W4
M,GK,= G#@ (06D&*<<#"S<MX._XCE7 #*/*=4JI<XCR)4$-%SK8P>Y?"$AS2
M""D$P9E*C*(+) A%&AP1'A( \>$2ST@BUE"1E7!B#HM2A)E&X88YD-C;I!@X
M>N8 B$]>0N<KP00;YB"8G 3"$*.8)29@E-)^9\01:B .:$#PA4NH86$7UQO(
MM^+TC!Q=ZSY$"L(S0HJ)Z5R8@)AZ:"K1!C&2 FU(,<1:0[/PJWA[Z_U;0\5+
M'O=1)"*F3!G%(-RP(-CU9Y:<8$,;D.[V@1>+Z!4A%-P-0XJ%%5TCB.#$Y.7N
M=5+4'#TT!X3!,V)S4@"B#9_<-X$Z=17#(_[M!%<#H)!2"8># D9@^6$I'-%M
M0+R^/_YJ,-O!.8\>]VT^)Z.'T=>_C@B^'T(-WI9XR7,B"(=K!/4/#[[3CT\*
M4'A!WP_@3'[E#?[PBW_\K1'$&@LTVI5T(6L%6K]&OD]^V9BX-+410P/R&G_2
MNC$T\!\-&VQ.?OVG,?OG(P"X?_DG&RB  9K&4 CH@ \(@7)T@*!0?;,A@*RA
M"2FG$9@061<(=AUS@*(1@J:Q?_UG"2]7&HX /2$S@J?1@F_T@A'H@>C'&@<8
M@@>87Z2@"+$Q@ZT1@Z\1@XG0!F83@45HA$>(A$FHA$O(A$WHA$\(A5$HA5-(
MA:[1@U6(A5FHA5O(A5W8&C?BA57X@V%(AF5HAF>(AA]C*?YK2(,K(4PH( $$
M,@I4QG_H=QZD\'UY"!HB:'&EX89($3!(41LG\!Q]^'V:!X@?R(?OMX>C08<I
MPTUTR#2(X A2\@4D80@1T8BA,0)T)DRC408$XCDTV(>AX49_V#\<$'2?R(=W
M6(J*"(OU$HL6UX*N*!%$B(B#Z"5X"(N(^'XK<0:[88KYQ8I@-XA$$3"GN!(@
M\%EIZ(S/"(WAAPBG!$=CZ!K#M(OPUGVAT0:D8 BEE A8$@8A8AJ#4'&E(0%Z
MX@45!1LK\8U(%X'/=H"#0(2K,08U88VB08^H,0%M%(W_") !^1JC( : 8 +,
M6"]<  (K4!&*0 : 4 *.H (0T/X"%>$%OK4HI! &AE "AD (9P &'# 'AM!E
M"R,&V/49BC &:N!;#T<()0 "S40*"JD"%5@*;E "(? <9] &-[$45W$39P "
MD;$295<&'K 3>J$&9W!%%WD"W!0&Q$$Z/X&2.1$&;G"0S0@()" "460!:J "
M(% P9  *E/-M_^<!$L %A_ %G[21H-%U80 (NI0\&B$&#_ !AR &(0 D6  C
M%ZD"YSAQ8R ((U 18  ")E (-')#W=0"(' 2H<$&&I88PY,1B( [A9"38Y 1
M<[,%1 E+.0DZ&F$()B "7E ;7U 1VF<F1G,"G$$&$""6>F$"(0 Z1$,>;I "
M'E P(?YDFQIA!AV0!5S 0=T#""K@ <=V&"&  HN"*X-  I>@>]V$!0OY<)6
M B"@!AA %U<HD-\)GL\8"@VP 6L0!@K &2.A"%T0%(-@ "#0!9C@!0\ !J!0
M AXP"/-9$0Z  =L&!@9 !F/  "$ "(UF$?ZU!@AB" 00-@LV& \@!JKF$B5
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MKU?A2O=A 8'@!6Q1:B,!//%C-TZ'"290619 9\9UO<G4LJ7T!?=!!@JE-J3
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MNLRZM>K5KF"U7G5)2BO6EZ3 <BT;\^M8KG#9;H6I=JY5L/Y?X](-ZW6O6+^
M!?O%*K=OVK5E$Y\E2W/L6<AMZR;&>_<M7[AZ"V.FJ]CR8LEIK3+&JAEMY[9Z
M#Y_="G?UW,9>#1OF._DS[)>L99>EO?;J;\NC.0-'6W7V<,*KY7H^7?DTZ=Q_
MI=_5;;>Y=>7(-6??'GKWX+QSH8LVR[EV<<2W3U-.?9PLV>I^7S-GC3UT]<S3
MU[NE;'WJ?P #%'!  @LT\$ $$U1P008;)$JWI6)S<,+_B(.00@PSU##!"VN2
MT,,-0Q1Q1!)+-/%$%%-4<4466RRQ$C$$::H2+BKAZ4,7&TS$"S#(( .,+A1!
M9 ['D&)ME#,TJ:G#&X=BTC&M#/YIPR8<?3IDRJ>N+,4-0TI1 Q.G6%/C$E#0
MJ+*-+B.C"1!"<%+#1IM <0F00E"SLQ1 !IFI2B.7DM-+.'LBJTP^^8Q)MU$,
M[4D-1UY*9 TCJP+EC#]E4M1- $JXTZV<JL)"@D1* 0. ,#:]*\<0!P'A! @>
M.,&#0[CPP%0_,SB$*/AD>A*I1#( TXL3:,6UE"XVH)7/7;<*@X12/,"B% 8
M:6[)H1X8I!(&*I7IA"]PJBJ$%H1]8$H)JVICUE)"8$'8JD18]])#19.JRJH
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M(+.JH+34N9\KVHHO"">7D !IF0,M6 $&0 1"B(#H& ,(2/Z YZD*1. "+'@
M,JB$!P@%AR,#.-L"%^B"=4.+-K@ 4B ![2,$"P.#>PDWCJJ*,$"7+%0PL3$$
M<H-"E]C""ZNA09@ 'O0"+(" EE"=G1J%2W@CO6J+J-*UZIF 0]C"JK@AYSG!
MS"E ,)B5@C$$0?+!%5" ?ZF*@MNR\WDX-'@ +W !+D@ 2+DA%9"  X 44)B
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M+%"J+0BG#"@R_=R*%D4;-BJ$LTQ++*B 1$@RC!E&ER@!9H$ L]2*02 S-V@
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M$V!%")@Y#." $)A7EUB#J(V),-#$"7B>2]" +,ZN4HAE),W06<F #1@!#[@
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M+"Y%8H,7#"H8,_  0I&)!B1 !2%AT,2*4@\\9.& H=2@!Z Z?_:PI507"V%
MC"B5J$*7%@P442REA4,I$!-<G&" */@@":6V8#0>)/GR$AW 8. 2O-0$,Z6\
M($B+ 8T8#Y@R0 C"J0)J#A8J&O3"8,.@,@Q6N%!@-)"$%BPD#%)*"QR44<$)
MI?"7!0L75/70"1EXD<&!\FT "/X@$E3@12DF<! &!EB4\@4$'IA0"@H=8I!%
M*95,4$(+&%!04"F@)#=")65(L,4(&*3E( 9>6"!:%AX8Q$()W+DWR H5:* =
M"AMX"&(8"ZB !0-E8+(!!"QP$MP&06""""+ C3(!&*54$(:)*(+(R08A;/&
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M(1*JQ2A8PA:VA1BZX4.P(1DN8(^\11>N!1MN(2C$(5N0 A;F!1T&QQ]JGT&
M M $19<X89P%!2EHH5IP@AKV11^NR!XB8EV@X5Q<PAZV85M05A."8BB*XBA6
M!"'P$G,T#R7^A2K2BR!:D!NZ(OZ[Q*)!L*(?MH4KSF(><D4%U2)<]"(&Y:*\
M_.(H$F,Q&N,Q(F,R*N,R,F,S.N,S0F,T2N,T4F,U6N,U8F,V:N,V<F,W>N,W
M@F,XBN,XDF,YFN,YHF,ZJN,ZLF,[NN,[PF,\RN,\TF,]VN,]XF,^ZN,^\F,_
M^N,_ F1 "N1 $F1!&N1!(F1"*N1",F1#.N1#0F1$2N1$4F1%6N1%8F1&:N1&
M<F1'>N1'@F1(BN1(DF1)FN1)HF1*JN1*SDO:J!2*#2.+!>,S!DY,LN1-XF1.
MZN1*8@'V5(0JUF(<"N5#7 *^/ ??#>4:TB(6 .)V@%U'J%0O(II!"&+@7,(>
M4>5:P/ZB&T[E+K9%&Y095:Z 4?(*^85E(VIE4)Q!UJA%'\(BKSP$*&32":A
M"81 6,8B?,R1&X8""Y!E4GHE6M+B(10$&\R&6[H%5]JB8&;E0SA"1U!BX+
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M B:409>8J!DXA<-@0H"(A1J P39M0:7\IAAP05,MR(@B A>$ =!PPL)P@1G
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MI "Q /Y")6! !-0*94B&F%G 91C&.T7 920"IAS9<K@1KYQ'/3V =S2 F#
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MJ8L$N/X7(9Q,"5@.(J#9E)_$* WU0: -DP=HV31'Y5'+"9"UV)^Y!GB'EDN
M&7#"@3VANQ."UP4%5"M45 \"JF%/"]2*"72U4FW'5RO"#U48*"C8D%E802!"
M%S" (UP K1(7I";"^AB$&'#-7">U57Q=SU=%&CR0&<0(L3_2J$7 ):KP<E0
MJ;<3$LX-LU;"&00V$XW'+C_0&5# VN\Z0^UR9YMYK%>0!)1*/I/J(HO!!!1$
M%AR(M* SB$Q -!E" B3"&9 X\1?'$3:1:(!!!0#-!G#H4D.WGQ""D G"R;B,
MK#& ACC 351$2U>%"1")<L#X'/6?1R3 (22" ACV]'3 ;/Y8U:-(#"5TF_,;
MUP0 Q*52#-24:F. $*('HTH->E *#81*I5!P*%6!2ZE+&!*)L5"*(HE29$"5
M(E7*BT64%AT$*I5!!!H2"3"!V0#2R\T3($"2\%+J 2"0)DNUP&"H31NA&+"4
MJO2@8%"0$81J"(&FA()#0XFV6<"P%(8MI3!E(%2)0<E2$MJ4,O.QE(>,##DI
M.)NV%"(&I=@\2%2*!8:P3<L.0EL2D0-2F!BX*15&,*@-$]H^9=,0 R:B+C*<
M]&""XH.))BRB$%VJA,46&AAZ.+'V,L,5'DHY4N#2Q$,2+'KREK"FE(4L(S^V
MN%GJA!?&A0P^.,F0#01'I28 7_X[B 5/3!)4E"*Q F0)\*1.MN! RI$#S6A)
M;<%0,H3("E]*@6* R$L&D"B:#NW0?;LPPA(#)!=$T @"-$HQQ )2U*@ )$T2
M7- "4-I@8*(6#M L0@<*VJ)"[PX<RC6R&&!C$ 8PX<0"GB@X Z0S("R%$PA@
M/*3"-28 20T)2@&$@;^X&I+((HT\$LDDE5R2R2:=?!+***6<$H2"//@+% \0
MX6J+"C+PX))$-A ($0PJ<82##2P@L)0N-;BRE/A$:%$S13 (H105RBAE#0PV
MR$"H0CPX2= %OVSA"PTN 6&KH=S3X .!/*@DD4%!2B1-"P0L)0L)0FBAA#S)
M**52S?[ :*%-"SBP8([:,L 3C1:Y +72DP[YX*0N+/AR(DPUL&"N$S#(@(.)
M'E#PI#*Z*T79N PI)10O4!BD@DK40 $D,[ %15@,3"@)A&>Y"D.""BJ@X+U*
M//CUIU) & 2D=TWZ8EH+X#UI*$$X $L1#C(0CE0/U)*7#9'RW/,D4#1 Y!(.
M2E*WI# LV*!8ISKX=;A*.BC)$8'SE*"2-D)M4X.A )G8 @6'&F4%## XH204
M0!CA @ZFDYD$#&PVJ65O.8GSWH8D *\+"4!P8812L&AW:7>%$H.!-0 1B905
M+LB !,TD7K6@H3#Q8-\1A (:DPT\2($,"S#9(B.EN^"*D/X)6."$@_4\^-DH
MK'\.1.<*^FM9 Q$X!.F2$/X=JQ03NO;"!9 $\=."/0O.%_(]VZQ@@Q9"$&BH
M%B2 UR@,LN;J$A$RJ&"X/"?X#CP1VOHQ:9 &R4#-4=LP&) #00%!@\&G_!WX
MX(4?GOCBC4^2DXF(6AG?2M0""13E2]D #*>2C!Y?(T?A,/LAHU?2>:XX>?YZ
M1[H'"Q1-0.K>>^E!"M]KZ540%\E*1@?$ ?*'Q,3W)BW1GRN6$-R/'M _(_WO
M>/5QGU, ^"125()](,&$0$XR@J9,AR$D"(+UN*() Q8)% UDT@2Y$CVP- D3
M#(G@D_C'E0>JSVN<(](E1#@D^/X1Z8'D(V&1LK?#&>IPA3B\80*)6$0C'A&)
M22SB24PPJN"=T'A!5"(.2TB_)+G' QBP3@*ER 4,>, "6YRBD:1(Q/*\[23E
MR4@9CPA%D+AQC%($"QR'PL8QNO".>=3C'OG81S_^$9#$ \4E[%C$018RD%-$
M9"(9V4A'/A*2D4SD(L=(1TF:\9*9')XE-9DD2G82E*$4Y2A)64I3GI*/GT3E
M*EG92E>^\HB50,0A:'F(&DYID% :12#.8,7A64*51<3$ OF8O"D2LH3$))(Q
M@6>)#R)I$&> %R0SP4DD82(-:I#A\'(Y)1\BZ8%D^9D@MPE+<YYSBAEX  8L
M8($)//Z+?=F+YY&\8 :#[ B<0T*$.SW@ !$$DT@, 04$GK4"<=5S2-8,:)1.
MX@6>)!1X;I3HD$X"!MIH;TF()(4$A(*O0TA A.1YS$6/Q!!,J,!W)Q4("?JS
MI$ID0 (>>,#=E*30DD(426.H7BDHX!@Z!C$,#=" !AA@N2>60@R"&02JZJ,"
M94*4"[3!5Q K 0%2H& \5,3CRH:$A<N003#+VRHZR5K6WU5@3R$,!9( N-8B
M,20$3>GF5@%("@CP!EH2P-9S]$<*L+BUCG\="C!A Q(1H I?^AM%2.OHO7F^
M$2<\ 6 -01'$J3HV21:M#T4!J]6W<A*91$$$!-1""OU%3/XE.'P>6MS'6N\,
MY[1%JL#(PH*G-,(1+.P;!?LJ2U'O4;0D)U$!U2YQ0@!"\21J0, TVT  YB1L
MH:78K6^E.Y1<LL%')OK+;3%;BCE@:[-O=0H$, &*<89W99R<+D@P(*"YC@*W
M9I7O?)=4 7MR)1$B$$@6"%0)$5!L;(/PEP>VPH+7S4\-#IC %RJQ E"00!'[
M,00H_KN!L8%$#!" ;"'85(8,9, $FMG"%D@P 39XH0(@$ C;2LR&+J18,RFH
M1!88@($VK.$!$QC+(#RP@1!,9R0:V("#5\:"+VQ@ X-(P03 HQ$24*PMB$A!
M%R9P@D& 8 ("<F@6+-"!+;F%=OXJ*,D6Q!""#6(!R1L<RAI:X ()>*%/%G )
M*%30XY]@P8F!Z Y#+ HB#C3*#$(6,U=8( 8/H XD+#B#!=+ J0\W[@R-^U%W
M5K 5,%C  UFHP,_.L $-I* DH%C!;%7PT"&UH0,> ,%T2,  #TSSP0S80"54
M8 (55+DD@MH "+Y\DC7@Q5;T(5D&7-#0+9A  FGP2,5:( 80^$V")D!R06B=
MDPI<AEL<T ";PL !#H"F#1"80%-80(A2J,'3(YC('%C Y0T("207T$)U2S$&
M093B$""@G5"J;0$1$$($$\C('%;0*2RX80/7_E$6+*&!!Y"@$BE@@ ;NO05/
M(PX4*/Y ,HP,0Q%M[W0H95#5%B8 "C(0B T4^S%./@R>2^BI L\ZP<91\@#[
M'H*I^<D D<.0A5N3X);T%3HZ=;8"%23'L-,JX$OH,X@)3) !"MJ"CS#@Q DT
MV@,H( 7^7K+C!X"" S\9! 4F<I(34(VK:GC (4AQ MI\@ *7* ,!O! *#*#*
M W$_ ]U)P92!$.(2$@A#"#\ LTIP]#$W64,%-&,"O(*$ 25@V0':@);+;" C
MA7AZ(@@P> Q(0!%L2 "S#' &4K3@(VR(.W+ $P(%D $3;M!P*#3@T\<8(!"(
M4( (0A$$"&D!3Y@@KQEF- +P,(0,!S #*5Q @7M:(D_=P?[7 XJ5F%%!X )J
M&$46,' )3(C%$2KR#G@<,(@Y-, 0BWH(("8P$15@:P49 $4A(( G*(*" JW"
MPH'"W8;L 0("+N,$)H!A'F!/). RSD _B*(%:,.-0,3[ALP[1&,-"" +2.$S
M2@$",D 1%.$!J@<$FB(1)B 1+H$ N( 4ON A+"XOU.:C).4G2$"_-! 0#H$!
M H'Y+J 4]HX-1D$$3(T3&.#"K$L"JB<-&J 2,,$ MB 49,H0!@$!,($-!H -
MGJ(#.,$+-*P,( 0,*H#M!B$"&NT+SJ,4.( ^0H W*J$"S TE]",1.((H@&00
M,($$%  YL.4!+J,%NL,+VH\3_/[N $*@+;[#*2A@$$#![\[ 1\  9$#A T)E
M!1C $#1!X,1JZ"Z1K#  !+8 "UK B;($ N %2 "A#0C! <P@#"YJZ\K0<C"@
M($2@*=B/6?3#!5@@$820#0SA 7XB@T"#2.1"@M1#!#+B!94F:3S@)PX! @0"
M"T0B LRM EH%-38(1 BA#=S  !*!!$J $ #!"QA@JB3 )3P,)#B@#- B*0P!
M KR@JDKB!,!CH"Y!#(X#%!S ?DI@$  A#$;OL$#B$!S !=Q +?CLHE*F% )A
M1[9G$,J  > E%-?B+Q@B#.A1-$J !/(Q#!3@>29@;+: -B( .#9*&@$A EX"
M1MYI+?X0H03ZPR%$I!  00P2 !0FP#%*@0LL@K<480Y(@#8.#_J&XO F0H-Z
M LXB8!"4(@':0C9,C2L04'8>X@0:IZK^0K,HP#J\ $P:8 W<X! JP 5 8>D2
MX2%^S0L&085  2G\;@7 JP(*0066Q:X080T6T STXR088YH@2^2( @2X "P%
MP@4,YIW8(*PV@$"4L1320#_: "XT00+^ G4&81!&31,(P@T, 0-2 "36P &X
MX!"YX@2612]*807 @P,\X R4QP)@Q"D.X1(>8$O0 @TN,P->8P,$Y P$HP)8
MTP:+ KQ40#,!"A.',Y/LB]Z&(BNV9 T@  M6@ 6TP!%: /XTGF<#6K$@+.A'
M=F0[7HH0 L$!L( %6& +@H8+/D*D "%4JDZZ1B$"'&$$DE$"-*,9XP(^Y1,T
M".HB+B-Q4 4+_&8%7* +, $$/* YL4 ,GN=SD.HX-J"7&* Y5V +#.$0(J D
M3*!Q) 03PL#^-LH01(! 5P +!$0$T&A!4. "6H(HOJ @@4,6B>\$R. "A$(%
M@J -4JL4O@!/UDH""($$.*! !V\H#!$DR*!D)F#.'D!<#F$%IV4!)2#?V@41
M?"0$.J! Q^#PV) ,2,JZ0 #S6H G*J$]N>+P_H*E#.L+RD "FK,%MB B1Z(D
MJ\L02( 3$I14H%(J'Q,E:*,"QOZFTVRP!<(S"PR#O$@E C1C)R> \>P$!#1T
M@U;@-7AJ$$A@+$J" @"A3T"B#(X#)+*L/LIC#<C (MSQ*Y>Q*%Z#% :S,$=%
M'7=0,-C  DQ* K:$ DJ@!4!4#0R! ?YT!;3@=7Z$!"A@ J;C)$+P?32L-&G$
M(Q=@+"2@5<#B\ 1"2?^TW=J" ZH'#02#6=_'.?80)-Z2.+_5G%:32+B !!2Q
M3CEG#4!!1M['(FZS/B  .$1@+ "A DZB!$JM%#R0<]B@32TA ?:$(4X3.1XU
M1>(D&9].:40"&?$-8;$@5"3@62HU/)IB+TT"1E! ,YVB:T!"2,M )3R@#.I1
M>=9 EOXF8*VBLCXD0.[PZ199YE$MH2!"X&T@@C570+)* 0P>2HM^!$((HCXF
M %X$+ 0LAR'& )_"#Q1 A7 V5@,M!P5$PDC9:U,\ M^^K5T(,#!Y9"^45B,*
M(G*Z5:JX0@RR2[,<067%%&2\HS]\8A"RZ]Q@J#X8X"=.@@0^(@/:I0QV9"6=
MHOUNE"<D@$U60"0<H%$J[_ T(Q$D8!3"8&S::P5&I$R]]2(,H0LNJA(: !30
M+5MN E^^<9P4@0  01?58C?CL11<P%0IX!#FLAQ'!3'10#]<58+P= /:Y1
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MG)^%!-IX#7Q$'9<& NS)!![U!%[#*K\7HDFI#<: HLD #"XA'R7(#$IB#59
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M18T;Z$H&!Z5TL8%L<4I@ 1J@> 'R*!P\Q<!B*A0WE;_HD?X '" 5D3$L:Z6
M(-HA#Z2!<05GI#QR*1N(@32^:AR T52CE! ")J!(,%,:#CB"TB47-+;& 6J0
M(D*-VT7% 9U3%<+ I*>!8@ *F+2A0%)$4V5!N RX,4H*&90B@= T8E() Z 8
MTL!)?&^-0 B!A3&!(YQX(+$%!(YG]\P;9J[YYIQW[OGGH&.8 00045[* V0
M<D@(-3Y@:"DDZ,I!6)<0_@7("$N0E!@:#.244HD XO/$87E 1B(/1%4F*"&<
M4(@@8#"@_"@3"%+*&+TC?<;@@+1!$628&,(&!1N1D,$9CI@]QD 8M*&( UZ1
M D$8@1@R @B#8P%(42@9(D%1)OY8P: D8!A-'((-%9A)![J M*>DK5I@,)9=
M:@2!Y20B$8>H"!=*%)D6L(I_&P"#)<3D!D-,H#%3"</10+$P,,2I%"V8' G6
M<(FHB, +EX! 48 &.Q(8 A!B2 "L+&"&1$2E# _XPB"B,H@P@.%@&!"!3J)R
MI8$, @+4Z\(@"G&"#=3.*\LKP\C.T#?8<0$3#*#/1+26L.)4(@+5\<+4&,"&
M.1QB5G&I!"!* #(56* ,1BR%2AR2K G I104X((@"I&"NT51#?E!R1HV-:A+
M#((+%2%C*4J0!7.12V6EJ(!90KF%00QB!:=R@!I%4!SEM>!(9+C;5$"@*^7]
MS@R4G/Y,*+,P"$(("R5O7($;O,*J_(A@"X!XP"#:,(@$ ,(%$BM%*!:# 0*Y
M(%FL@M61!K4<[SR@.J6PP"$S2(H_)7,0;A@$ PX9NG:Z\YWPC*<\,50!I2DO
M52I@@0JPL 922, E-M35'Q$6"@A4P@L<K!HAW-(!W\'% QSH @K:TH&-E*)E
M@*@6*6;& 1"X0 5!$ /_J)>4,.!N VE0)Q96L((L%.*.(@A#10?U!0\PP" ;
MH).<W#>!J6 B BG0)Q;0,)$36  "28D*(?ZWR>)H @**0,0%0A &#T!&*)4X
M$Z<$]84/#$2.IW/)S"@2KQ>RH 6%@  I0@&[+R"B 2MMZ?[KOA GMOXS#"]T
MP9$N$00.+& C(<!A!(I"UA!T( @Q"T-1JNJ ;;)!!"8+Q1E"$(+88 (+&V#
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M(%!4FOY%D,?!Z72&.<LESE 1MQ@K"P(!Q;[(<+03)*L";AB(!G1J"$%4 B:
MD!Y*U' W1R2@.AFT2._([0!BH^#>)T':E ^Q/P8<* .-0<DK2S$'"+ UG+%!
M26V^>S1-;L"BB !*5-H0<LN00@$7%P,Y!R(T+N .,7(2&A:.A.DNX,X0(+@G
MB0?B 5U1)0)RF@-%9J8&<MWXZ5"/NM1#]X I(XPJFMW"RTKQ[>" H#6)D  +
MQ!"!F8 +*N>R"R6)IK8Q;$>''<B,;TLUGA-,@!3X' .%@Z.EI("!DAAXDPLD
M, 84/& 46R!:%BC04 Z<SX]V2:(*"-"&1 C\( S@ A<6 /X(021@"SJS9YD<
MP%81&$03#*C$%PR9^ X4Q0L&$.M .F67H_6D%&R @.8MCH@%E$D!6-C"CDIA
MU#*HP "0P8($Q*""A05'# 9(01DL<*2"!7\!!F' "<X @BAOX5*$9< H,#&!
M$Y!! @*[P!E6,"RMB\$+2$585# !@1)P'UXH8  6PL  .KG! 5K@!>M4:1)
M!BE0$6-P-V: :CW3'=1"!BH0 0(Q%0%#$ Q0'981+Q$0!BW@:9WR!8R5""1
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MQ@8J<$8#80E;H (1)TGT\8H#$8L'H0);H$9FT )N@ EA0!_,MP66$!0L, B
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M<%$)%3 (":&0WY4"+%D*G. %*J"-;- 053DH:L!6G- %*OX@-"A!"FH@8HJ
M!7")>_FAEU\P*8<@FIP8F[(YF[2Y(,I3FYF("5K'3K@Y(9AC(;/4&KTYG!!R
MFY^CB%-GG,2YG,S9G!4"-1&BG*.9(+?)7].9(-!9%](IG;_Y6E"A/+>Y4=IY
M=0HBGG71G=ZI(-8Y*%C FR@Q,^'YGM+YG=HY%<:YG@ABGM<9GMTYG^GYGP":
M)5)Q%DEQA><YGO\YG_XYH ABGPB*.:1PGP):GN.)GN89H1/*H/+G(,;IG[_I
MG^!YG>1)G<'1E$4AH0WZ6O%)HAS*( OJG# :HS(ZHS1:HS9ZHSB:HSJZHSS:
MHS*&GSX:I$+*.2\ZI$9ZI$B:I/Y*NJ1,VJ1.^J10>F/H&:546J56>J58FJ5:
MNJ5<VJ5>&B&(< B(,*9D6J9B6J9H.J9GBJ9KFJ9AZJ9LZJ9MFJ9S*J=V"J=O
MBJ=J>J=P6J=TRJ> FJ;^60E^2J:%:J:!&J=ZFJ=]NJAF>JB,BJB)*JEZ"JF4
MVJB.JJ:0ZJ>%NJF.6J><NJB'8*F&ZJE_.JF&^JFGJJAX2JJE6JFH:JJPFJF6
MZJJ:.JNLFJNKVJJ[FJJX^JF'"@;".JS#ZD3$:JS%2JS*NJS'JJS(*JS/RJS2
M&JW4*JW6"JW.FJW7.JW:FJS;RJS5ZJU?61=JX 7@VJW8^JW+&J[>:JWL"JU?
MD*[N&OZO[=JL8!"MZ'JO^<JMZYJN[WJO](JOSDJO\FJO ENO^FJOVRJPQMJP
M"QNP"[NO"7NP!9NP",NOVNJP"@NO\4JQ\+JQWNJQ_^JQ%SNQ%4NM$'NM84"P
M%FNP*INO)%NQ_GJRW1JS2O.E.)NS.KNS/!ND,W.%(1JBP0&A#EJT0ZNB2/NS
MH^F@5Q<52ANT$^JT2_M:]FFT4'NT46NU34NU6"NT\*FU6LMW4:NA#&*?4"NT
M: NV72NV2*NB8=NVV=FA#!JW!SJB:7NT5XNV6>*@0HNU @J??\N@?0NWY*F<
M4ANX>\NV?(NX1,NU\0FA=CNV5P>X^XFXA^NWERN>4@N>T_YSG5^+MQ4ZG9";
MM(*+H(=+N:*;NHF[N0*JMU2[N)$[NJX;HDI;N6L;NA/ZN8=K6FU[MU#!M(C;
MNY*[NX6;N\7;L\B;O,J[O,R+B46:B<];MQ82O=/+LU.J(=9)O< YO=?;O O2
MO9JCO0T"OCY*OIECOIB(OMZ[ONS;ON[[OA12"6>@!M"Q1!@R"F008Z!S"66@
MOP[2!BT8OV70*^KK((!0!IP@; 4,3VP08SI)(4 "3Q&,(107E&1PP64@!I!Y
MOG$1P!)2"5VP F P*9RC$_F9HNZD/,$3H#0&"JBQP@K2!IH0"N58+FQ0I( @
M+60[(3!L(8NT(8YP8@TBOA]\E/X9NCE;U*($$8P3T@:1I"&7Q ES\,02<@8"
M0  "$  #0 + 6YP3 0!Q0L31B7L T!C;21 ?(4T,P  ?-\9A   ZI9[%&15!
M,  &@ @G   RTALL+$\3T  DS :",L8:,!-B+"%145D+X@$' Z+9)68#80$3
M<#\A<!YR[*(+\F*E$ @80+U3P08,$ )8,#IL=+_E<@%)T0(242K9(4]1 09E
M5"&'/,3&X2ED$,;YB0&$,#AJ%!66-RD6.A$-X +CZILQ<3=$3$4"M*)C7 ;>
M-9]3 0A>99O;:P9>M<"(;&T2T[EU 0H;8!AGP( 48CFS'!R#LP*<T %$99E]
MC" -X_X!9+D! #!*@E,N;N9TH) (O2P&*%D)D D*15$))-S-CM#+13$:=5$)
MI  ( K#***$)Z7./!% BI$ !%4 *EZ!& U$)^%P4DW)$ 1 ;6H,2H2#0Y<)?
MCB!B>#?0%L  +E$(;Y((!/!"WA%(,S9<T=0&PT*8Q ;04C$S10$"=")B\05,
M@4#"4T$P:A30A&"<AG"+TA0519EN50.;B6"_4I$48*4\.3:BH$#"I+#4@_#$
MEK34RA,*4S$"^\561)W48XT@F*  #E0*(B!!I: (@\ _ 8T>I% (2ST*E6 8
M?0U&_$,"6T8"$N.1@C#0'('5[VD<?C$(F$,PD51>?DT0AOZ00C4R"$[7V,IS
MT II"/Y[CX( U)7$T^A),",==@<]$* @")@@GD7!VH@ 3JR=:I*-(&5 293)
MV>5"$+^))I]8AD=S&/Y[")D-3 PV$.G2S:-@"/11"?I["8! +E'!":- &P/!
M"6!4"7D=%!3PE7NMG8(P:E%M")](,."T5@N9(U)!"IKPW0A"W>3"7Y@@WX-B
M/2R%(*]-+JFR&&DP,KX]$*$P".E-$"*& 6>&DE!AX+]]",-="8+ /VJPT_P#
M7/U3"."K!@.@:V^L*R=P  >  =5A=RIP  JP$6T@ 0ZP.!S18J7@"!Z0  G0
M 0VQ$"%  ! @Q#'!  F@ *U1!OX,P (,8 #;1(7:YS"3NP(*@  3  C4HP *
MX &C( $3$ (%  $YR0$B+AIR @(FX%HQT>$04  E4!09=0"?QQ$/< (80  8
MT!!IG@"Z4@('L,:'0"V%< %2/C(JP  -H #N"4\80 810" K/A HH $>L &@
M<$?YE2R$4@D@8 9I\$*'@ $B%@088 (68#TJ80(:  &!<0(F$ (8< &]$F?K
M 0)%00*QL0$G  (0D *EL (,@&>E@ (88!H-D0@8<!\=T!8HT=4)30$+-0(S
M,0A390%A(085  *B1-?D <]JP "ZAP@9  H9L!P;0 B'4 %W.!,STUT"2MVR
M<0$@@/X!12(")-!BJ 0!2:8"[@[OHX,>&( (:X#M6W &#A !05X!O-&"+=#K
M&F#>$W,"'B !8# "%J !DT((S8X1VJX"P5Y5$G D8H !*+ !>B$;&! "&5 =
M*\#K E3)'J !I@@['=!;#;$"%F\0+!#R(U\7AA#R%D#QF10G@4 !G*$!ZY,!
MA& )$[ ""U\<K>45I@("-1\5B( !#. !H) &X@YJ',$!+0 !@GT6U(<!F5&&
M?<,\)<$!#<$\N,$! N$%G6X!J%$",D,0&? :%R!<$D#L:G\"SP%#8^$"DX1[
M%F 86#!5&* (:L$ ^(,2(9 "'E !'. 53[_N;J0!BN\ &/Y1"1L@ AC0%FM@
M+*! $AW  5H#$B9P 1:0'Z]\ 4:E<R!0 A=0 =4Q"!6P >:#B&96]3.Q+A90
M"&X@ 2FP 0Y ()^Q[JUQ"5BO3"AA$R%P 1PPC!F ZMUQ"1F  A[P !G'$LE_
M""KF ,L? LP$ 1 @,2C04:7/(&I  *>!2P#0!ET0 &N@" VP*200 " @!@I
M."VM"6L  A<$ *2R 02P!@#!A@ '4A((M-@BP$,IAI@FG"AU D"E,@$FD,$
MP% ; ", 81"0I=2H4EL ;#$D(4&E-08\' )E@<"*A!Q*;5"0R,T %Z4D%*C
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MB <\X&X:.0, T"4V0*Q@ #("! #F]R$)[,D,*M5$ 2 R"OX)3& 4K-1 (@Z
M@1:L@ M@",X$ZL2I (2H$@D(P1D&$((6($0-B2  @4Z6A;2)@ 4MX$)W,.
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M8(I#48ESMH$,-C%!3QK5RLGL5 +JG8 )V'!'[C*$1H,PD'="L 8Q$-A?<[&
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M0/B\N<  1CJ!PIB AO$"%WP ==*3,SB51  /0.@_##"8/TD#(@D#4*H+-1"
MPEBM2]   DB  <"*8CLV ^"$+Q@ !V" _D$$ 8"(Q3L !'B !H* ;*.9N#BQ
M Y@ #A" 0."9+QDW$LD  3" #2  :YD4#B  !3B _0&! 'B.,K0,". 5\2B
M,"01"$A L"F%,1B( Q" "N@F,CB  R  .5.$ 5"X 5 -,D  !+C$T+" B8N(
M 4@2$   "[@$F8  !, DD(/%N:@  KR)O\@G#3B!#LR4ORB0!SHB'(DGN3B$
MAT@!%?YX@$0@ P@0@5S4#A&P /^  /<XA H0@1# @*\9HV<:0?<@ 08($@_(
M@%R<E<7SCV>4"YR0@ B0  4 !$"( ,TX/P8[@0SP@%#8C I0 0G "AH)@5R$
M$B]  # (H#TAA $8'S6 @'F$N;A(! N0@ YP !#8DYG;@!.0 "@IH-F@,BU
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MX=W@RR7AV[.C2<+8TD7;%V9@VTU@1DSAQ85? ,;A'-;A'>;A[853':T+4'
M1."$--C:2L 3!M",+5@(Q@4!\' C<*G:-H#7J9.-&P8YR^""#B#='O;B+P;C
M,!;C_AT%-##1+:.<.BFH1.C6\-@RP_%*$D !NF,(,T@24$ J_4 #39!3%C@H
M4N@"$D@#$.@"N?@D#E@#4O#;%2 !L#L$%:@P0P:G1YT4[0"$'@$%P5H#RID4
MSO "DAB$-E@#N&@(+!B!+]B305B#3AD$_UD!S1@$D2V@/?&"IS.!$I!60 "G
MB,HZ3_[.D$2 Y+$HT5HF@S+E%$1@@<.8@UO^5M)BB#.HTS((!!)0 1<=XVO&
MYFS69AXF!06PA"\P "^@D=< GW0BO=P(9S5P *D3@[PP@PD@8#_IBP# #1)@
M 41H %#0 I,B!3&HBO(K9%"^  \($@D @358@?$((#)XP \N/^!H%U+Z"PW
MBA#@@#9@ 7UYE18PA&7TC 00@?V!C@W@:!* ""\(9R]@@!!0@PT0#'!V@37
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M G /0/X@DT10@-@)=7O:#<LP 0V0C$T9A09 !-([T ^ B R9HH4 A %0VPW
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M92DE9#%E*66,P>2/I51"P0;#A1#!<4AZR-5HU[EVFF6%!%$3"?>5 48IAT#
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MX0*R9, &"C&(^T#L2U@(PP@FX").K  3+8!F(=0PIE&T@'JPNY+H6&@3-1A
M B#H@ ( -@@ 4&T- "##/&56 @!4H@7T7 $ 4% *$ P 0_X54( W$> X0 1@
M!04"V-8,@QD4C* 42/." @"!B0NPH!0K<- E+" TFI1!8C):PX(X00(0#.T
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M@!"@4$ E# $!9E7LL:=T! 4,48D8EX(#O*P).R<  A! 0 *(L.I]-ER*"D@
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M!+*+*8P&QIF) Y"""E#-);C::YVB!:D!!B"" VAD++H!]6G',K[C SA()7#
MZ6U9+[%*)3P *9# G= $!K3!'&@<Q&B<RT& )E@&P0!@(+&!!6 "R'6,"J#!
M_]&$1B*5*3[@<71938#!0D)730 64E4"*8"B!ZH,5KH Z20""F   YS*:(#*
M$2D"S:! (@@ JV"! "10M5! C(V" MCD*2I EQ# ()REC22" ;!*&V@!AH
M 6#,$P9&IT';ZFU!Q!&E-&V5S& &1CU6#Q)"CRE-&JJ5&Q2,!W14F!2,Y-7$
M<>:A1?T8&X1>":C MM4$%1J"!/XPC0>$@<I,2@A@025, &:\(92HP0&@'RDP
MP$PP@&.50@C<!RB6 ;O4U"=RXMMU@!ETG.CEW2F>R@GTX"6<B@5 2RD80IM
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MXAJ=!-!A"20 ((B!QGD "*2!"S  %E2+CC+ *(0JX$I O^ 6&7R3IHQ&!U
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M4M:  (0. #[,Z*.13EKII9D.3/ZI,#X+52E#EYN*SE(X&(,4!LH:)81$VI!
MJ3D0""6+$A)J%NN>#)@C(0QR+*4$%QJ,5K)!%%"D20A*60'M4LK(8*0Q_E0S
MLT$B*.7;4EIX+_!2'CA#HP?**D$RML)8X"1W$4FH D "@2"44@(Y !0N1$AH
M!11TQ,B L#1@L)03B.-:(P; 2,LL! 1)ZX%!R)B9,CT5F0"A$/[F@#S*$[)
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M@&*(,#! C&;A0!#(T(;1?(I(^-/?YSP'D;MD8(EA6*<8/A.!,_ADQA])1 0
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MD< #/S:2"I G#/IK?RE&@Q]4$N0 6Q<BE0"V3^5/!!'46\,#3@(+9.5C0,$
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M!>!1!:#E$)XQ,A)"*<P@!$Y  V -%$!@ DP .4KA,CJ@ OZ>YP3( !,T *_
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M(K: I]: $/A,9C* S[" #$*@ F3G(\I R%= *1)!!#@ !"+U$L[1N$<"$+C
M"SXC$4*  T0@,\:67W*$#?@,#<ACW1 G57 QRA%=3=@D;A(B"SJ  Z E.L1@
MRU?](P"V YHV(<M@P1,""VK]*;&B!3P2LXEC$+#@RSU@T#;@ 4H B<6 5 H!
M,FJ<%,R$ [B'H\?@(ZU"!8 E4AE<H,& I^ADC#@<%:TO(8(G ^@&$,*RN\/#
M SH@!6H""WS.#(!7 K" $^8*O_GEIU?% QY !$8A") #R_Z+<@2D?,99V0/(
M P*,9/H\PN ;1.'9FD$6(#/P=A3<X'<N@0-F! 0LX! ,80&F2T@;@"XR $N\
M3C,4H TN 0-(B0,P9 ZPQ1 &P'O(UI_\L!3>C1,0(>9!=HN 8@-^9@%(X!+0
M0 $X8?K,P,$-P"<NT '\)^_VHY)$0_,(  T*086:+SH^0\A.HFX]E0M& 1 (
M%Q-*X#/ @ !<(!!( 0LV_A(84DUFIH/"H\RPII(T^B-"@0$@@@P&D'M Q, 4
MP L4H>01YR0P#%<X8(D9X'F@; (D!PQ0,2&X #/>+7<@P M (0PRI1((X(<S
M8 45@!3.8 #" !-6X.]J:G96@_X$* <1'&"B"3=:Z"8$B..X48(?64E-D @E
M)0,V*D$.\33@]$;5CTPSU@DH1("4:%]WSH  6@"(+"!'"%M-/,@Z2"$,1K)K
M*\@J1" $&CLMV(,3?F_&(B,^-0,\]F@[AKT-%, CE&+;.J<#D- "#,'K<F<"
M+F#^'Z#%08!^I!<3$H 4 ((- 3.:0(0HY66"H%(5.%S"8H!,I0=D2I4X4>K0
M!$2@#+3 Y.5!*4 0RH J1:H4&0NE0$D0I,F"BTNE:@ZB  H"F%(D5)0*(^%0
MI0T?%50JY8($I@>&2H'84LJ"A#&*2IG@4*G2 E!E6"+:6#/L3PF 2F%Q *B2
MA"ZE+OY\*87&0DJQ=.O:O8LWK]Z]?/OZ_0LXL.#!=BLQ"%1*1(E2F"2L"'0R
MK,O'G$IQFI"HE",)HY[6O-2FE <O-3V\'543]0@OET2$J 3FX!80-;>04,1@
MT*!$$<9L#E5JD 2QG#0A.N- $2())P=-0%T3Q-N7*"%4"L.AIB8'B):7.K%"
M=)A2'\1,C)Q!S->::C)8UG0(C0-"I20,*@7=PAJG6+0_P$0&!F&9X1X8%22B
MVP&)D.%!*8E(0!,)&[!QE%@J^ 3"3IA<4D@)M(D07D:<D8)))8%8P)8$H962
MQ4$0''(&9KHE4%9-*M:$2")EN)?2!F$LA4DI*F!$2@2*G/XA($H/))*""(D8
M8D8"5@51$PG]55 "()R@A@DFAG@!P4D9G*%2@Q+L-])P%K!14P4KEA**)I4(
MDD%_)V"@1B5SU80)?%] H E^I9A104UF2(!(((8@,,@:#)#!T4\-EF);*1.P
MR0(*-:5D!DNE0:6!&6*!PDDB;$ 06@5JU*1?6'%6,D@&+C!$YD_N55!K&!N
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M"1K<PP9/X<E80(0*Q&Q"B<;01"V:<$EF!#6!M[1E/QNH2/!PF1),8$ "_=E
M0<'5,GQ5"P632IX%V6B6Q5 6#37J0+7FDA*$H88%>V2!"Q(QV)JTP7^(+*YQ
MCXM<C TB 4=)R0GDIH 6K,$#1')0TZ;[R=>5 03I4@0$L' &"*Q.D37)P%LP
M<-F:B( !BEO 4+,P*2W4;@44.,,*' "*0C@@)8)P@%@V4((UL& !7S $ U C
M"'26R_ZTS[H/*1@ 3A2<(00$2,0A&' 2+ C A56L'IY60("=.$ %8JA H3A
M@C6T8 ']R4U:PS7/%J!A OWAG*#&$%$.?."  O*"@(1H DQP0 -K<$$%(I,2
M+02 36UP0!ER&D80]*<4AE  I2JPABY,P .CB("^N #A4J"EBAY00PB2)-$'
M@"$,T!*-!]8 @MH=H@$G*<$G>96(-1Q !>UYHUI6<(8*8 0$+8C.K.ZW!A&(
M@!2D38,)%$"F#AR(#(4"UQ?$\(!5/6!%J"J7%\[D!0IH0#1XRL($@M221I]
M :)"#:7# @(.J&$$A0)S&<8  4$X0@%:^ (#W@B!_6R! ?X85&\'$JT!U%A3
M+"+P !NPX+E2!-M&^SD)[M3PA0ID@!0;F,!%&>!"#.C5UZ'Y]!FP0#-,2(FD
M@YI <!(PJPF0:0V2!$&UNO" ,FB! 8? A )*9QB:0(",0>7 LQV $1%,H'W!
M><!<V@" 0@?B 5P@ P3(Q1,#-"4,$<"V!014 5&E) P**(._03$&!9"A#"JZ
MA-S*50@%A$<%0T6!OTB  32<P*;)[;G/?PYT0U0,?15)A M.\ 7@A,41*/W"
M23"!A1880@TG8?H)T+0&?6:]%!,22R%JE09]%F)%AOC@&4Z A:-<HE:8$%58
M,+&%J U"#)A8&6/<+M&FF,%_9_Z@R26"< )!I&%;;E=$&"(3+?R @01J: -]
M#K$"+DR=,7$WA"'>TG>QH*%":3O!JJC\0?1]'A1>,($]J8PF0%2N%%\XP6_I
M<IW(M&$%8  %P0!QOK:GA PJ2,,ENG")-10""RHXGQF.$HHOF)ZB-2D$$1>"
MDC"8P.F,.<-) %$C=XVQ#5M3>N=KU8;SA?]?62@!%RJ#"!>D?0VB2@06#.&(
MSSL_!><[0X7L+Y8RJ  -F. "3<)P BV07@ZB?H[0!GB'"&@2?2; !9&Q!BB
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M+1XYE]-I7"S@;A-( &H("H9 48H3*950%>4""H? ?)701.6""6I8$^:Y)Z!
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M4CC!P ,4.'"+#090**''NLAP2OX$9$F(BB4U')"6 A]!L""%#F2KQ((13(C
MD4H>J"F1!X RZ!((DCH7T0GR(J$%J<C$X$M#'@BE+H>"4"$#$2J9 (05)(A.
M*S,2V*+==]T="(,5(I@0-R\8X( #!< PB(L)6ABWE'8!:^'(6 =Q@X$0&N97
M0(PA@,@$XDHY@3AQ7;B N! X<$&%":):08$VVC 7@Q!.D""O"N(LQ8(XQ:L$
M@PA D, "P"QA&@5940 4DP>0(\,U% K"1-$Q2ZE I!84^!*-!);RHE,+5GS2
M A8DH&L^P ,7?'#""S?<O43*0*,FK08) [GB2D,9,%(.*66+$R[Y O+ UA@#
M,)0?@_[L,5+:"".OXM)HPTWD*IF#%$R2"HJ,U0U"I-#;QQO%C3%0-PB3,\XH
M5!'2$6&I$L!RQ\3'H&K*'11 0!_$<M-.QXV-,1P93WGF*6'+C+P& 2S50G%S
M1(S:)_^=^>I1CWV\2''C)'C&*P"D#3.( H7Z0\HH#9"L5((,;!!/^]8GEYK$
MKSAF* /C<N>FK$ /= ;IW_^R@@C]2:X4ESB#F A1B4M,$!1G0(,"'4&&,HCN
M@,C[S@11AL+L@&(-;0 %\T:8PJ)(CA0:M)UX1F@&QK&P%,M#8.3&,P@S7 )Z
MJ1,#YQIGN4.P9(=:F4,8>*B52IC!#"XTA/4"8[Q26 )TEOY#@P<P$09!X&8.
M8I"<$(4(B## :E-J $4E7$2*Z"D0%&IHH%R($I0_:H44@1@#( JXQSZJ3TA9
M(:(0#\%('^5ND* SA(N$%$?<P)%ZA^-D)SWY25"&$CTLP0((1$F> IY2E>IQ
M 0.Z(*?W""1P$(#5*FUY2USF4CXL,8-LQI-*7>)2EL$D9C&-F4M@ O,\E2C-
M, 6IGE0J<W#2E.;ADEE-:)8"$&X8Y7JP:9Y4$J)\J"2/,P,CRF^Z1YGI!&<[
MGPD?=IZ'FO'!YCS5<PGJ)3,]4H2G.LL33_:8\YVX >@Q#7I0A"94H0ME:$,=
M^E"(1E2B$Z5H10574(N>TZ "O?XE1C/Z49"&5*0C)6E)37I2E*94I2ME:4M=
M"DI^"C*:19FI04H@$O&,0@0^8HDY"]A3<KYSIL <)BE\:DZ!;&F3!4Q$^H!:
M'DW0T2"R9 DB=B.G$XSAG$159E;E-,PU:,\@1@6G,V,ZUID*U*P%'(3OQJI1
MFLI%!.4CJ^X&.M"V;@\#!3$++(LR3#:P[ZQOA>M+#7M8Q";6F )1@Q-!X0 G
M/I04."3H6\BD'D0P0%[C(<0#G+F&0KQG#98D3P1J54R6D !0[+G..'?YE,34
M!5/MJ4!T.*I8W.96M[L]3QE($(3L)*(%)] /(>9PAA&(P78L(*Y>?&2)%J
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M-O  $EBPRSD2LXB 0PB#$2B%4##"+]0;%ABVK  !,$B$X,B*$. "19B(P)
M%PD##CB!92L%,8B+-F  $@@!$=B +TDE1)" QT@$$@ !%(  1'"$!-@ #! =
M$' ^"8BOB0B!5QJT\5/#2O"R4M@P@;" -2"%8J$ZK- *0/X  1$@ =G@@-4
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M%,@ #3*$ #4(0+P$6S.$$30-#\4$$]B-4=" !LB+$_  /&* M  !9.$0X<
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M-CB#!%@-8 *0:6*^J!@F-RVLNPV!.HZ/2A T]4@5LJU.;)* .CL-URJ<!W!
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M  '[ L#. @S("@T(@:YVNG-"@PH0!"UX\U$^ 51SBC1P@#: Z4NX! 7@ !/
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M30$F84 ;-'$"ZRB$#9W)3B%%] 6?5 (##5&!$'&C$!'0R@T'0$0;T)((#E2
M?"P 14U 08)<A4 I+<!7:MC5DRV 0@R=00$&?%6!5V'@!*0H0[FD [K/:0$4
M7F! DQ@PLM!<8A 0$ 0I&! &3FPA &.3"$M=6@9.[.5JH\! ;<Y@@#+LS$AA
MD, [-Y %NF"" 62H! AL8H(DE4!$$'A/:T:QAKB<J@2<<('*2F$"=1J" 6H
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MA$ +4( A>  #:( B( (&>( %&/X9*(3 %C# ()Q!"*  !*R %V  !(C$185
M!J1*(7@ "VC  ^1/'SG7;Q1"!GRDL"D$(FQ "%A ;4R,34* S2@"!\0D#XH
MA4!."-R;Z="$7;"!<JS "8S !'B 170 (F ! U2 S0C24%J$"7Q02W! 0H2+
M1:C 6$E W3Q 2230O8F(&3@ !-2&!:  L)@.%GBD";) $,@D7;@  TR &B1"
M7&[  R28O65 DK#$%V0 "5C .X'2T\1&(0P"!HB !;P*CF'!9!A"!63 8FDB
MX!Q%)7B)8X1C"6! !J@9<UC 1]I,(G@ JCGF.C$ !IQ63H2 ZD! DIC!!&S
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MN,!,7,+"T45?*@0'H!0#)$1-./Z"M=H,&FCK8J91&-Q0FE:" G0A Y0(&Q
MG$G 3TR,75E@!1A98;6$(VAL>^$%)A@ F4SGQIU 1AP" <#&"6 '!M!E!0P"
M)D1 &LT'*+"(0'3HYX2*)3" (^8L(!@ 6TB'&A" ^:"!/JV!!4B'&'2 1B#$
M5:Q 3ER-<N%%&PP &5P%!>0$&1  6U2 R7" U-X0&AB 0*#:<,SJ!+ !*$2
M0!S"!%R%=+A FU0D5$ .(C2 (QX N%642QP%*&2 N)R E*B!!;(*5+QD,6FM
M@MP0!]2&(92 1'SGL&K$45B != C2[  !)#*!BC%!N2*B46K<IP<!Q@9&R0
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M@6K <C)S@"+T#Y"(P6U[06[+SMN0@G3DVG*@ "L5\XU< D3?- HU<T:U!R#
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MP MA2(!*O& !-FSA AM?B0).8(8-' @%O]MZUR$@'"](P Q98( C-/$ 64$
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MDBYA 31!!9NK L:T0#O@$@B!CE&"=I)B"PZ (LP""\(%#K&  BX!%-:5BT3
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MRVKK^L\7WOFTAV$"#5^00(Y$D,[)F<V.9YA ^@22 :)U,3B)B(#75D"&,I"
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M )1O:H@"#Z!-:K >&_$3</(?6/  *D ""E )KU<V#+ :]_:-V&A3%M "(K
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M6@F(<$S!B9_#62R$X 6$4 E(4@@D8PB-H@C%8@A>, B5,%F 0 ;.&1=C$!.
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M""%ZH*" !H P"!#%@(HK2E@ '$L3$8H "CW1!A(*2F- H(4H!G_;*"$0294
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M0 6E0,0!LK(%$E3B :4( P=$!"V"8$(#*+"?:=8P@15L@$:EP((%6E !YX0
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MAD. H@5^V<* #F$@"'VA% R@% ;$4(D$[*N6!YG <!#""0<D!@-Z>8!SPK
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M4;HU38 0KBJJA< "$G"$"""(83L()3,(RW,[AM"" 9& M#"]QQJ.#FRL@N
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M@\@ ](& -)B#?$R A5D#!- $3;!)KUB!"H@1-<BN3 H2-; L%2BO(PF#47"
MM,"$$*A!!X2O%G"L%2@2%WG()?4)%J"19GLA+RB22N  #<@ $) 8@W"!![
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M$WN5Q@OH@ LP@84  PFX"FOS@ KXG0M2@2X A0J0&% ( 0S8@#O2IPG@ !)
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M40, 3F3/-F" @LT.YQ<ZX!,P & @\[1H(@;@F4-)10 ]9(D8 " &4 C ,PE
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M8((!B/[1"*# (%BC G@!&CB 4K3! V!,2%D1!9Q!(D3  Y" <8P"".P;TF0
M!"A%)7A !9! "'C&"31*3I3"&:R (ES("E" !Z3 =WR!"^R$%JA$&VB "%C
MX&P!A:P!!H" !2A'I50""(  !LS*"&2!!&""(VA !UC ;.R%(9" %DC )3C"
M!G2 ;.R$&$@ !K0 "%C<A;@!;*S ;(S %TB 4I" !F! 348'!F  "F3 ?; $
MM4B 6@ E!UP U>U$"VQ!!H"-&F" !V3 N;'@0IQ !F# "3!$(G# !HR+5V*
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M! "%B(  A $9#(!"F,  <( 94,  5((9'*NUBE$_8L(*%  )) (B (!GE(
M4-P;5?Z &/@?!\S:0CA O V 4GB!C8" &%7" XA1!HA!G90"!XP!(CR+VYP%
M"&2$"PS=">2$!VR.&]C(%FC'!,@,&IP(2V!!36H"!%@"(@P %O#?!6!,)4R
MM_D0 03!&E[ X-RL(RB" K2%%Q  )@3"V=5>!PP) WA >7SL3G" S!@I1!1
MP.I% I5"<+R'&\")3HR  X1;(DA Z'!,*2CF"5R(!^1$!:B$(C@ RV5 Z)2L
MA&  0W3E6U"*2G*$_VU&N9(!O2'" =Q'(7S*)4# :'B'ZW#!\4& (@3" ^Q$
M";#'I/B?G.#0L)0"&@R )9S! 8R&"5"("IP("+C=!(B@(/X,;@EJ0'E8"'@,
M#@B\1"(XP"B8@,P,0@1PH@\]@ <> @2T!0HH0!N0@AK 2(78B!E\+BDX &R0
MP=DIGP4XC@I4@.-00.M @( 4(+1\1PH(K^.P!!HD0%OD9BFT@%-(!6R<@ 2
MPB$0@ B6@'9L !@LA 443T,\A M8(@G A@MH0$QX@-%H0%N(@5.,[7N80$X,
MYD),@!B0@@$,Q!HP " Y0@2\!Q9D $N4@ +NA!I4P&J@@-LA0N2F0;=4P.#
M*4-@!E^,P-1XP'T80$T2Q5^6P@8,"1LDP'NT@/!A@79@A5I,0!OXBR 1R>+=
M;4TZP.#PHB$0A?2>@97$B+NHDOY)E"A+H(!"L, #0$<&Q*4J?2H$2  I@((#
M?,<9!,!LH  !9 $:D   J ',3<W:M$4(($",#$(;N, !=(D*$$!Y9.L:M $
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M*$" Y/2S=X,'8E^" X!"$)S("BBWI_Y&?2\%!#S$\JE%MNZ((&0!*"P?_92
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ML#0$"?XO# LBLHR#B=20D004##(#L192,(@%)#$A10T TF(  HH6@/ 0!@#
M"(0!'!# NS  (,,@$0(8*H0!-&E!@ DR0* V,@@  ) S $AH"P(8,$ "16:Z
M$C#G,C"@@@P$P (4 $@(20P )@I! ,L0.*D-!3!- (U21"#  @,$N(L, ,K
M)(!&'V@J$2XS+*4%1J&:4=99::W5UEMQ]4R""B7TS!0&'"$$@HH 26\-!EI
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M*H$2-H #!.$0+* 05F ++*XKQ/ZO!3 KI_JB$D"A#2IA"XQ*#4Y #0;A(2H
M)$:A#%0@#+C( @ZA!;) ?BIA^PXJ![M"$]K $%0@+L!@!< *$[I !;Y"+D+
M$%# AO"C("J@;T "$(A'J 0#$ZK0E-K@_[( BT;A#%+ !TNA.%H)K%0O"RQ!
MI]+(!5H CRX!;,K0(-3@)*)HFE2/_&P%!J>HE69OGS" K]8P!<  F<R@#2V(
M$&9O* "! DC $J-B^Y;($-#@!'0+!8.@!0I"N/B#KRH!$ 9!!1XQLU;Q"RP(
M%+Q !2YI$ Z!#<; 521@F68$$'ZH($"O![FH"E5Q\HRQT$ ! C0 !!"!A\I
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M)%?_,)<"!D$-SI$C,%@-?H)*+_X! L84 U"/52MA C)G>T !98* #&2"(TJ
MI+R#!+:@$J#%WN"0 CA#!#J@4=J  B8RU)"GB!(! N0G-4@@>;\&(K+, N0#
M%"J@ T1 !#B#? (!#O?W*^^"PSBA:+82+R<B9RVA @ZJ$AR %%: ;;HF0$3D
M"R)  DH %'+6:!%##9"#(]C2#7Z"(VA+!3""(UX$"S(DX"J Y+J">0VB#4RR
M V3B*$!@ 2)O;"4YO"AX*))Q.S !$T9!/Q*X*\B8)>9G#$H3"RH,"%T$)+0
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M S1A2SABZV)E"RS@3S% .$Y@ SA!#09 #7"$Z[P  KA@!1[H.D!"(DAA#!Q
MC@>@!5XP 939.E*C2<J.<!H :5) :$9!*+8$$$)!!7["# 1@]&!;+FK#;7!D
MA%= ?O)1B"LA 9S\4H8B KY@#1F %,Q =P(D>4D)7-4 0KB@I$'! [@ %!+@
M*\[ A(YB#EH;?LQ4)4P2%(9GBS "$(145*O0"^9FT$O#526 "TA!OBWCMR64
M%## 4-?@ !+"NN5X 49A#"07$S8 24K X4X@+61##1C@(5C <1:@5$B@*=J
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M-\YV[]L1Z$VM87AD67H@!BD,.&UQK!$X'8H$3D/P,*&5'X]\\LIWZ04$6'B
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H!"^XP0^.\(0K?.$,;[C#'P[QB$M\XA2ON,4OCO&,:WSC'$]U0   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>comp_0008.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0008.gif
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M^/7Y_/____?X]P
M
M
M
M
M
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M#^  #3$)!/  *ZD8:H  92 *A0  (6!LEJ  !(  !R  !F"4O)@%#'"-)0
M"$D9MY:(7)  UT@V@9  ;CF3C#$) ; !B]&)>4D(HG & ) %HA"0,JD" !"2
MBR$"$Y"($W  ,+D8?[   9   U  %0DO'<  GF )#D  91D9.9F1FI&(A9
MC*D& - "GF@("A"; + "G[&)(1  $X (J8B.\'(" ("2,ID("P $$@D 5M"8
M#>D)"0 !2*F(#%$" 0 !]9B4+O[  !1  5D)DX+ DY, GHW $)90GJ)0"3PI
M"H(@"-[8G9!H"0Q0 :)@";MX"-DI"I,0".LIEH)0CNHID=<("E\  %J@C&-
M".>9B*,PGB(I"/GY:9WP !*0")1P!@=  9#8G@SA"2H0 &DP"H4@!N0(G)90
M"0QQ"('@C?8I"OCYH)DI"IT "(=@CY/PDX( DYWPH6E0CA8Y!@%P!9DY"8#
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M8YJ9HQ"O+$&DXBD!$' (CJF2#^ !5D"7*"L!&) !G1F1$& !2*L 9R *))
M3VFG+AH!!Y  #A"2$S !V+H 7&L"#  " V  S2D*5F  !V  7%"?'V  "/
M@0"U#! "!#  65 (".  !N"4"6 %8B  $9D% S"E$I"V&7"F]HABG>  $H"N
M&2H*B$ !:7L!+5D #V  :I %"( (:6  *K"WHA ";NL <B **:  (D  "; %
M%1  #X"0:<  "%  )*"?"> !$A  #H (9$  >DL&52F6"L  !Y "HI %!I
M!["V9>"Y!, %69  ))"66F !NOY;"/)9 J*  1/  0)P &"@GQ5@  J@ ']P
M!@6@MVCP!\LK"ER  ,JK F.J !Q  ;J+D(G( @?P 0HP "<P"A5PIZ*@ 1%0
MCI_K  IP"!SP !LP  ?P!?J) 6A; <"9B&40 "?0$(#P!:%Z N2; &N+!@<@
M @P0K280  8 P1D0 1S@P(PY"1)<OF'9 @D@ @8P "HP"0KP >FI &4YBUX
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MYJD WGG")Z &#Y  GI & * "A1 ""& )+7"QG2 !C2O5:@ !"6 )7U"M&1T
MH.J_HA# V_L EG (!F"\7:E1E@ !<RL"%  !;  *&.  EH (!T "GF "!% &
M'@H G#L #, "AY % ? 'G8 !#R *'WH":,  !#"-S.D)!N !G8 & 4 &EH
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M09\ "" *5Z#BF,WJLEFV%0#.0@\ A6 % >#/33VO > ":R  &T " ^X!EF
M93D)!?#T>#^@,?D' ?[/!1 "(Y#@7.#XM"D*MWV-%A !^HG#A5^6%H"5;^W4
M:^ "]DV?DHV0BNF21&OVA _S]6D VIN(:7J-@A  += ) ^ "8H#0*>D!I"D*
M[IV(%B !D\  $A#TC9R97+"8*/Z+LJ&J 0P DX[/!8#@_"XP #4Z 9>] 0X0
M[   O*6O[EP[M"'9X8G@^&B R$-9 N#.GKAOMI%9GPQPTO/)$QQP .59YAI
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M@4P! @,":(09J%*)+(# $RJII3%A-X$$"*)]FU.EVY@E%0 4C05S&^ D#J$
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M^8!PJ1H&,  '01\+Z# 1V0 56ZJP&P %N( '>!DN8"D2V,S\1,00\ P( (!
MZ 0(H$0'0 "W @ 'N( $F(L?<X!@.X$ > #[<AT/("KN< %_N8^3,A(&4(!.
M0(&Y@?X4[20 OE"!(XJD-+"$!( -_HF*!S" DDLAJA"#!7  $9B$#V@K4- 2
M.?2<#> ;K1&<#6 ! OB,DVJ!\E$F"4@ #'C/ 9" "R  3V'10C740]5%M@J=
M-; "2T@$-;@$-?@32Z@6,_@#S"@!>1$%#F@;W;HWG4H VJ"34&"8JBR 1K
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MZ!*LDOZT% A+4?B" ," $ZZ:*\4-N<4C<D&  <B$*RV$W/@ %[!3!&$ %<B
MH*+45G*9JAE2!);2V"6J!P"30V   IB1G0",+>;3MF*E!Q"! LB _*!$#0"
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M[$N#%2<)-4@#J^,"#)@]R2 S"W"G8B<)0!#TXH.U/2^),ECQ)$\2APF[Q:N
M2B;OE4$_4$@#0\>/P+,$7_<R7T<#E/B42= ZK$,+7T\# OZQA.J=--].DC*8
MF9((#MH3S;@< X.S!#.8E_L@=@PA]- Y=[";EG8>" F8-$&@==B9/DL(CH,G
M"4I0<B"XKAW?:,TCB0?H7@SP $!Q@0LH 0J(1(7A @WP %HA 3J=@,!I+!CZ
M PE0:!$(+[M R\AAK1-H-XG@ @I(@0]@@#](C?>0X'J/#!6PM*NH"FNE"PH(
M 1*@@%;UA, D@0A@HD,XCQ#P ":T@*J_>GIA  LH"S3%PXTK.0M  0IXZHD
M 2T0A1+P !30<(C$ !$0 0U =NQ22PHP U$ @27NN!&0@*@G@P>0@)?( @HP
M 0I(0RDF^83) @LX 0H8 U!H-_X-0(02*!HUF( 3V(#K>OP2F( !';D.8+IC
MRS9$6 $,.($.@  1$7W2OZ[QIH 2^( '4 J/V( 2D(#3$ .2!8%"<! 2N(0*
M"!TM@'P*>(E#B( 2"($'8!W1Q( 0$ $*0(1#,!81F#0T@  )J)H,^( 2L( -
ML H2X(#,IVPT@(XAM(0_&/WVGP@T9@$*Z!+%Q(#BL(HL  @'%,JD@7#B P,R
MHB9E(#%"@R51$B<]$(5& @H0#,2(.D3A XD,'D11$&0%A4046=9@$(7H8\@.
MHDA<D?C!BR@5&%A8 ".*3 91H$2MH2 1PPJ7$CJUV%F!8R$+*3QDZ"11E"4-
M(DA@H/XD:L.'$A)4D/  X9 H#B!(<) PR=*#B"<PB"7C"4(AB1K*=,JP-<,D
M46H@K*7@0NC5Q(H7,V[L^#'DR)(G4ZYL^3+FS)HW4\;@P8J5#1) >5& =@T$
MJY,<Y$W,)0%:2RPD9@DA*LQ(45[42(1@2.)0,AI$"9+@2=0@V((K<ADM:@4)
M40\0+83@"5 6B1ZXB-J.>'7>!QP]+;"D98-$,2/2?I%8 HLH!SX],<AKX8\H
M+1]$71@CJ@4+A4@PD001#?4!=PD$]D<9B3U0TU=7>**"1%Z,Y!T#@&"E $Y7
MJ=""*( X$)$E#@B"F!@'Y 7(@%BE9LE2HH20W0.M50"((?X,1#0)!IUT$N-5
M,$9$@FU?<0?!(!)9D(8HQXVA0&""*.")%RV)\L<#H)2AHD1I!"7*!((<HJ,H
MEYAH20(G"N+ <4.%D)0H6:#GY55#M0"G!%I(Y, A8J GF)5"3;!&G"*((H&&
MHF" 1DX2 27*"04JMD&#8CA@%1=!A6"%1"Q0.!0B%:'!P"6B9"K*!W!^@-X$
M.$(PE%MHM)2J1"$$)0*$'N $IQDM/2J1)Q(<8DD&(.@V$H4662#*%5]R$=A0
M)8 HBA4G@,GI&@8$QD%-%%@[TPF@L%G&!!(5PL"$%!(2 :2S46N"*! T>->T
MG-E[+[[YZKLOO_UNYID5+7 1T?X5T8G"@K7'>?!%)QRH5>A5B+B@ @7P>L'!
M562H4 )KB7V  1=9'$ H($81-V 6!F]AZ -H(>)6B"NHX$![W@UE"0._29 7
M*!(@X@%'0[EH@@HKB'0HSV&2Q"07(]5&4B%>1-!"T0IH.!0(>K+P@*Z*37#(
M4&"@-XD5*EBPW@=?"(@8"7J",M0)2;E@Z'$B9'><A;1!T$(*+"0 B"40!!:"
M%X@HX&D+#WCAA6W'311!8%=- KF,>HHR A>)+. I"Q%P>MP7M@T5I@C<P5I(
M&>@-5<:7$QCBQ7['D9!%X* ""0I>$H4J2AJ!2J1""A*5)+P@)V0@\PDC(E:P
M*#<FPOX XA(D1;9.(Y' J= 29<"1&!C_Q"H)17L0:"(5E>%]ZJ)$(,A0: Q7
M :%A"K+L&,-!P+Y%+=&D'4Z37*'"T7XE$1)\00TM(,$D"+B0+ !0)I.P  5*
M<**K4$ $*E"!!Y9E =ZPQ#V'H0!^>&<!N("B!#49B@76@ @(B&)B8!*!S,:W
M0D_8B4*.\Q<.<ZC#'?*PAY<9B&*R8*C_1&<H&P #*-2@!D(]C2@.X$(AOF"H
M+^0&!!Y( [%XMI 'K& %+L! = (Q@:$4QU1%RL)Z!.<B4#1'#(@X 7>Z)A&<
MY44"2>H9(M*&F$+<A0R ^$,A)@$*I?7,/KS)PGX.@0% M/XD"QH0A!S$9!6L
M<6$HAP##!40GD:])Y L?*(0#M" (,>PG;8=@UP"S<Y43@.@*QCH.".YV+(EH
M(0."^(,@#.&)2< L!,]RP!\!40CS[&<H?.2E@0@4$1' 1T:_#*8A(B<*3R)F
M H5H&V(@@ @RJ"Y_FRP$&$9R'%_"Q2JGM$IO)K@[6=7I.7"B *' 5(@3F$ 0
M;!@$V")V@3^T!)1_^(,P)U&(!V1!$&C 6 F L!A*B4(,PVDH>B3PA3\6@CH3
M,=^7_'2H"9YA.!3@#0NN !J(;E0B9KB5*H&VFBL((@WH>=3;1%$&$K  $"';
M@"40X0"6J@%C0V&#%1; J*%0P/X+_ZRHHABEA@H,D%,5"&'O @<I$!&521A0
M0P=.- $N4'02H7(<U7PHUK&2M:QFO<P$VD-#B5RA2&NBCB 8D(@@%ND*5@J!
M;;B  1HJ0$T)^,U0M! H0"3 $\4A(PL121O;,(!08$! 6A1Z%YQPP'0+44!>
M[B<4;8J! L>Q0E!  "<@<$2SN#N1!!2BA=R0P +9$<0# C,)$4RR.X6CP%"P
ME!@(N(L"8A!#N69RH2R(BTF(2 !.8EJ"$W@"E'DYUV_PEIN!RC8$NXRM*&)Y
MJ ;-1!"3J ]Q=+0:BUXT+R%HYHP.I1!12! Q8U".&A@ "C+$2 SL^D(WR^#9
MC7[WN?X,. 1%S)F:51;I!,8JPP7:F0(2C"Z>$C!H<-> DL2@0 +<\81O!U@(
M-+!0%"C0'U43<P&<B,%*)8:4P;1@69W*U,3Z*R('AC,!W@CB AM RXE)4,3Q
ML3<ZDU  &M;@ (FL8%ED\)TE,) !4!0G.F2HR,$2K )W?:9).1EBR$BB5).1
M $05,!@'6B N3ZPA+A8Q,W -MH(B95D"."D1B-@0D;/2N<YVOK.^-, 1X)@*
M7D/Q @4\ $3$#(4+\%H(!D!0@BR$Z1 /L(T6*! "%^CX*D>T\B#3@(@+D'%9
M7C 8%Z+#!:[-I1-_F  (/E0!3RCP9L(2A05X=H&\J. "&?[,RR0VH&L.4 (4
MLQ;*KUN0H3$,L0P*L"@8). !B2)F)CA!0: GL%ZA8" $'P,!*(CU 1-DX<$J
MX,Y%-A"2]EQE5(?IK <FL.=.&FHH8E#V5A=2@8B40$^"H  '+L#<AD;;/Y[X
M ">%XHEE6T(%JCS!:RG0@0N8H$W\9HL$N-L""PA:0V+0)"(FX %09,#B&J>
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M 7@ !R!DG @ !3# WQP* DB  0! O3@E9F:F9I:5)2" H6  F:R   S,!A1
MP1& )7!! +1&L#S <6#  7C"'P  3AQ" KA%&@3 "DQ" %@+(   [:"E65Z%
M!A1 "R!"(0R ;P8 IV0!HUP! + D )2!):C!(2#" -@&)2! 4&3  ; !)3!
M<&TF>9:G>>*+NP& "J1!" 2 ?YS  -#: '@? '3/>"*" 90 6P% (?PF3N"G
MCQ& "Z0! 5" !%   H3 )!P 0UZ%!:#+3Q2 @4Y  HS$&H1 !4@ 7%9= !
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MJ8$79$$&H  $9D$9V JC% *$L/ZD4&#!!W@ HP1"B[0/"ZV!%PC6":#3Q7!
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M<47#!>7  Y8 @.Y"H( AP $SHAZL;T]&E(@#E41E< "JD/Z# PL46$.4"21
MJ)(%)A"%! 4\&&  [$1AP8 $"KAB- XF9( -!1D<0  K"CG  0.NF,0 %\0
MX+TL A#$D <.,  #KL2;8((, )#@"@0$T* 33S@@8$0+2TC  P(&6$&444(8
MP$@#L&MA  8.""&3"11(( -1S%! @0,TV$@""S9P0! #7#N$ !52>^TU"LJ@
MZP$21)I)C0Q"P. ]OE:XC0(.-D+$@P\PL$(4040 @H)"/G! @TG&8+,0#32H
MP*9!)&*!A1#^#'30# PMQ(,6,G@ #2 =X("GF6H295(.,(!,%"XR "$#1,38
M2Y0S7"OC @XRB.H0#CRPP,+21/[8( ,69 JAA0TH&(.$"4+P!!01K-A@@KU
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MK(.@X.8:'I (B6T)5,F\GP2\-XD%%,(2"OB#*,CPUTDXH")_$)D+-F"M#[#
M$RH@P26J,I.8):^5=)J$ A!A!=? M!,>N)\H+&!&!N"N#$XE02?(,HB+3< 3
MO?/D"OX2T$T6)(!V:Z" 2,0@5 Z$:K820,]R:2=/2F; 6NL"!0O.ULZH(*(L
M:W" )UN07+YX(&&AE !&-H =%-S/.)[XPP"XD!6KD=<38+  042@G=><8 "
MH.8#*J(>@CQ  Z"(P"8?H%82(,"3&WC *$!A!A1LX  2H< $0M$5%WJ3  <A
M@0$Z<8(2_X0"#@@!Y " "!4,X" E,( GU@  R!2" %+<@ 1*><H#4.#%"6#
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M8'QD\@ 1/C@]6QK! 2HBYX4/X J 8$ '/\P4!1#LRSPAP0$\(6:>3"(-DZC
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M)JQ ;$+@6+ %\MAD$BQ !,) !^OC"NCM4%B. HB" N3@+B3 "CCQD<;@!!A
M28 L#=2*()3)#)(*#,!-"R; !=8 C40! ^@C[HZ#WC:+B!I'00QE)K3 <T3"
M!++@3MJ$ E ##0HM!)CH(Z[F"CC@KA(N) AB$"(@&LM K022' 4A##I()#)
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M"T9 %'325?1,8CHAK0@B#985(4H@)?8S;7!'20Q@(^1)%) .7'W"Z;A 5D2
M3;9HXAC 8BR  B8A U2N CSG L -%"Q (CXMA*AG9+)$!"[ <Y2%*21@2U:@
M7R&OV6:% 0S@U.X"!6+$ >A#!1C@JZ!)<T@$JTS'!!+@MLK% (;,Y-XB/#%
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MV$J"(D9#P#1B0,(.#"KZ) "!"SX17$LBGEUE(W:B*^)O+BI:.<@E(3SA"\B
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MQ H<0/[A<C.\U7N];] 22H !/#NZ@<0#@, "'H^]\3N_F1L4>$V_GUN_ 3S
M!7S U?N_"9PA#%PF$KRYM^B!XNF7K4(\(?PE8B\M(FF; ^._'PC#(TFX(7R8
M?6(-CGO/-%S"(SR]+UP\3!S!:S+%%^*!UB ,ULXN$GS!%US%3SP\=1S!7[S'
M77S%K6)?-_S'9S;'>1S'?=S"2?S(#[S)G?S)H3S*I7S*J;S*K?S*L3S+M7S+
MN3S*;[S+P7S*OSS,(6G,3QPHI-S,DUS U1S%R?S-X3S.Y7S.Z?PU0,' ZCS/
MU3NNQ>,[(JFF]3S0!7W0"?W*K4408H4R>J(02, "R/DOAOZIR),Y;)T"!$(@
MTGTB:JB#R?D"T@6C?)AT)A!+0")=)@0!@(U<\[0WR6E5E1,"PR(<S4'<*N3H
M*I>[U#O=I?D;*)5<QZL"$5#]+4X@XSY\#9!'P65#%,8@'X.\9X3B.S!=TI,\
MPPE"!2#C$/Y UA=">6QI [R= U@2:Q08!%B"!$(2(G@]&BUA1EZ<VHL\+;:
M LZ]QT%!#2@ $=$\?!!QLWO]+73(SPL]X 5^X-5;D'A=(3@@293;:Q&S 3V
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M&2"@((HA#UC!!082'"59O?;>BV^^^N[+;[^-N1! LBVLAP@ ,:D! !>B3/#
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M@;-X $L\280GBC>0*^3RK EAP05PXK]J32*%)2-#B#QPTOD2J#?3XZ8H+/&
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MB9 )J9!==A%RH%#?I41D( ;?Y?X)&/$0?_","ZF1&\F1'>F1'YD89C  !C
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MH15JH1>*H1FJH1O*H1WJH1^JD)ZPEB!*H@99 B8Q"2.BC]]XBLIH"6D@$5Q
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M5W !$L& <_B= VN #O!0W/*L"I-"7K %NW<27# !8H %^(5;7^ "'0T*7.
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M!39&%#6,312' ($&0O"33JQ C?YLI!$& /$'R1AD!3\!C@920!0JZL83*M@
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M)W&]/8(3,6"1,5  =LJ ,0B$F1 6=O( I/ $+<" 'P1+_B%-8W0]4H( WW
M,[J>5/* ,-@-,\ ?44"!0G 2@X"1TTB G_@"_*D(4)B Q?"$QQ@=5MI#"5 _
M@N@)Y&0+"=B8XC& M2 #Z0&#Q/&"A/B"!1"1$Q@! Z2 LZ($""@$_(L*0ST-
M!3!!!DB!Z*(>V,B?LS"!<S$*4"B!%?")3B4$"C ]0Y  F#B!4+6(!_" 0^A!
M#/") 6"GKQ2%"C@K0;">[4@*2S"623" ;DE-M#"T$)","8"\H<  ,0"%,6
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MV D">@@PV D,R%]1T "A$ /3L S;60$'=D^%:H$3H0NBF/X$Z4G=(N&.V3T
M0*"E+^""*SB 3E #$S !=L( (CE8016#+'B;;CF6\)",DJ63$R"HDQU3(#@.
M9QJ#]'L 0NP$"'6 I9(64$ #(4&##6 .2^"(P]T-,7@0CKB ;@DWLMB)TT4+
M!] "+O@""D@0SZJL$GA67C,TM/B"*T"9,;$F#CBK,\@2%?AB%G"!K7B(*^(+
M#S@K-!B<F&@=.<(1R_)*@[@ +.*(BB@E@UB#K[" $_ "+CB!Z'4YUWL $?@
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M^4-A8)H)HBA=\&#BP9J!)D^B3*ER)<N6+E_"C"ES)LV:-OY/6D)TTE,A48=
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M/P_T$']@*8$#+=@8"7#/:2)<(A.;Z$2X@<("+3#$%P" P@A,0A 6R$ G#J$
MW7F@!(@XPP,"8XD(<.$05J  */X*P0#L5 00#T"!"B2@ E%@0"^B(($("*6
M%GB" 4@9A0,TN(%"=.($*GLB(QOIR$>Z:Q*(RD(62F(%#[! $"0(A"BRX %+
M>"(%&_# 'U!RB!!LH 0-F<0*"#.02X!!$#GK9'DF80(._4$$EFB!JE: GT(
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MXUH<@AB,P1B( 994A D8@"5\@,EL %Y>(P#(P8:2@6-VX39^@248@'\6P@"
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M?*,%6/[ !Y" 6: G 0P  0! *2U%&L"D ]R1!'@$*/RC&/!H)3!BC01 D J
MYAP" =Q1T=9:1T1 "## DTY O3%MX?GGF%2$%R2 !OA9L,YJ"6B2&CRI(&!
M"+@/R7# -VT@<>#K0) !"$# )[F*&%1 "7@!=U*KA2P$':G &>Y(@%:<*!R@
MK_UB^*%)OV& :>*%$%[?(0B$)X"":$S"!%@"!,A@MJ+!&HRLAU0 ] V$!?Q&
M!HR!KY&.JR!"?K*!1^CN%_AGM2;O;W2 !ZQ "G"?*$RK"71A)\SFF6H;& 1N
M%DC ,JT %E#)P=J>?P)114P@\.@N^+:)!.P'*/QBTYG'G_YQQ2^"+Q8,A&@<
M @.T@ JL !!L'%Y\ 7'T;FAP0/>R !> PAGP'" XP KXCPO\P<UA!P5$"QI
M7==AC<4>#T0L!4N: !>J  M\S]15!"(44/E2Q9T@$6Z@P9-J;+<(0@),0 9@
M  800)N8+&Y P),")VY$@#62  'PB -,@"= 0*LF@']6@-BAS$;(:$^4P %X
M C8."1=,I0A@9HTXW@D8@!<?0"?HFUXP;4( 0@)@P .$U@(47> I1E,@0A\C
MAZY!P 4D *T.0$^T   ( AL$0!FP+5-FP=M6@@&TD(=VH84*K%**P@(\*;T1
MAITD@+"-"0^-UN\:SQ5XP!VA /ZQX9$+;,B0."OXLK(HC$'P<(&@Z)U),,#&
MW<GHX@8*4P^?U@B^O:,HF "(4@\#@((8E*<+?1,:F$P&2"H$?#!26NL:($()
M44!?B.<D4'/WE 0%9,Q_(H4)3 \BR)QY:!O*;(8( $BU5@0&_,8)W-% % JX
M(@U3'.PQ@T(8!.X9" 1'$,9?#@3AX$4/2<#41H!9C$";/"^U'@(:H%L-NJ*K
M $]%3.L>^0V_?LAJNM[TK(%2KL#T6(F56&/,P9F4T' (;]P#.-Y_]H0<=FXI
M!I(EO*I)%$H)J"L-@X(&?%,9>,0%C,% N,"B]O"VD( 5<<4 I X#F PHV.P"
MW XH)/Y \'Q! !S  R#  H ""0@ "PY \CA JWZ$ =R.+O;$!P# #%T  5"
M &1 &R7  F   $ $"*2G*-AU,QD  !0- (@ ;E  .:[0 $Q 8-.<2Z   &B;
M"RF  F1  +10&0#  U-  "@ !)SC)   #18" &@.-@Z &JQ  'P !["U*#C
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M _!"(>@F"@E, #5E"  +))0&0/YT\(-4\@07!D"<I & >AGLX18B$"!1: $
M8! $ &C5& "L@"-IX *G!%&(^ATD! 9(@!;E)8JI]>H* %"+!PR0B+\I0 *>
ML,310@" GLD/CG&4XQSI",>IB>$@6)"8($! @DY,X *3>%46,D$ "33H >G:
M#P ^Y($ A&%JM))2%D"A(C6P 0-^HT !N+ " O3)4P085_! 48( X$4$2Z,
M QKQJ0V(X@$/,$A+*B (,5#@#VD8P!<JL8$#_.F5!@DC&"QD*C4 8 $NL((#
M2NB)PY1@!0P0 " L@8 23"*,@F@! @B"" )@X ]_6$-K=@@ "GA@ @%HDR@X
M *J#2/[*$BZ;Q#%C54=[WA.?^=0G;\2 OX2T0 %VFLD?)I  !9" ("U@0,@V
M "91'"("0/A;"!B%4%&,85V%"0$"$K"!Z !BDQX0005:59P5*$ !$,!C"[8D
MBA5(X#Z!,0$'0B"*ABI$$!7@Z E:=5(%/  -AV 03;[P@#,<Q L.* D9+'
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M0('U">(!7C #!;#0%P1X80P,(*8#.J&"$1RD!&HA0XWUW&QG/_MLB'  7M3
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M.L%6$J"61&&'64!-$F2$#. !3&"71 $"8$/:4!!U#H $/,$#/I8"K(P.TT
M.+3K7D,0[$(0#H$ %H +(.3"!O[  M8 0B8W(0KA97DG -0 $1X 65*(AR>!
M @C@"E9@ !S@"SA 08FV ";A$ Q  ;C@! " QQ)  M8@06?/C28ABRYA# !@
M AXL>;SCQCH! B2L!.0"$)Z$6-!@D$U$4B=A#40 /+OEF%S@$B3(4*\@IYQE
M0>)5 #XDEB],<[F@5+1G;G[D9_\ <!@CD=5'6A@( )SL("Z  %3%$AP  R;A
M,M* 0*_ RRJ$KA1D4-!J437$PN!3#;8/1J3%$G@H!;YM #[ F1P@1!Y#%"Q
M %  7/KO("X! AB@GU? $C@X V3K^3( $/BL A!!#("H:;"$#-(@5;Z  @0
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M$JQJW.+D@RS/670!KN<AL.#X-\#@%&8$O/JEZ]D#I&D-3D@4,N%H&>"EE1
M_"="#NZ41$#D ][9&8,2", %#(%Y#B(1 O8!TG])"0 @-%RQLN(/&@ N++4
MD&:2@!.B! FPXND!@1 3"$ 4Q9%C(0(>.)X8($@4%RNB3! H),J3! FB# U8
M(4H+0U&@1'4@, G1 !.B"@6P8FD ADE> (A1 \"+J#0J+)51*BH, #2B*#!@
MXVF"!$^B3BA(\$44"I*BO%CI!$)%T !N<W:<2[>NW;MX\^J=FS.- 00A1;E0
M2NE# $19 A2R9(#"'Q(!N# .(?X*$0$4HC D4 .*@@-1DPYD$&7A0:>.)L:J
MP<FQ=";0!SR 2J0"T)\*@%(>UL! U-0)(!@<*+0& !??#+, 8(G!0"=  $H@
MFF1 1*<$%";]&4#9 H/3%B+(M:1@PB1  T98.O"A8T[R% 1-2L !U"05:]8'
M3@,@BR@6 Q@BB@01B)+! J)8 < ?HK0@ "(;(" *)0I0(,H? 8B "%-<>)*
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M0A@*;#17(09PP)$E&Q" P ")DE# (2U! -.R--GT(T<<%-#3 "4$-1.0"!Q
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M%RC(P(5.ZC 19XA6!@;!R"P,#"< )<,#RI!N?G<$$!HO@7]<O>V>^_SG,W[
MCFS-EW]G6\82 +*'!%$&AB=H1G1;C?A>R$@&3#$G)' +1ZX@IR\06Q17N,"
MUC7HU4B@#$#7U0I,8 D&-*PBDQ@$N0<I 1:H0 *($,0%(+ "% D" Q$X+P4^
MP (-9" G)N@ %BJ@XIR4X0%:4($&:I>"B! @-RTH@24>T/Z"+$R I!/P@ 4
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MP4:> (*9> (D4 (04!(YX0E90 (D\ "+!"(H( 8D, D3<!ID0 (F\ !M @%
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M0B@*('B.<A&%DO05$+!*1:1:)_ L'' <'!$_< DD4R((##,=?/.*B# !8/$
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M $Z!;KTYHB3Z660P&F@P 12PHJA3&1GP0AZP&DM4!A77$1@@HZ!Q 2M: 1"
M=HB0 94HCJQ1!B&!!K4W%QY@;?ZB&923J087R%M$"@I)>0A'^B8DD $98#QE
M8"UO= $9Y@$"X@D>0"YH0 $9@ %4E1-D< $>D 7<]286@)T9 !:@X@$L8&N3
M\ &=5%,68*<CT%->4'L@H&(JT"8<4 EE4'FLT0)AF $>4"*>0 (8D $F(%\Y
MX0)\J047X*AQ(P9QX2M'> @;D $6X!^&(!M<20%35 (8P)"G 0BM"E[92 $,
M5:*V>JM<!0H;X$\;LP83$).YX@D9H$FXNA>6D%RWHFU[(C]QQ:QV<:PR9!^Y
MA*QST0G*RD>051?0.A?76JS>^JTS-0F1IC&%,*XQ]1S@BH? .D/KFJ[N^J[P
M&J_R.OZO]%JO]GJO^)JO^KJO_-JO_OJO !NP CNP!%NP!GNP")NP"KNP#-NP
M#ONP$!NQ$CNQ%%NQ%GNQ&)NQ&KNQ'-NQ'MM9[1I8!ANR$DNR0V:R'QM=**M'
MG;"R*?NRG0:S"X8&#\"*J/< _C$*C&6+K'5+#! 7/$LCDB0&XX< >YH[0>L\
M2].SJ\41G5 &*R4*(K !+;NS=>$%%+  G#<T+M:T3-MCJQ6T/34*F>@WK%%;
M%8:T%6:U0ANV:7M9<E$(1'LA#^ 4&-6V;GM+8E 2@%"W+1%BM656?\@1&!6X
MB9,!(.A:MHBV:TLC'M:UC@NVER6YLB6T(: !?VBXT+*W=OZ%MF-+)=38LS+F
M"1I0<9K[M7D+5FIJ #MRMW?;N'A[MO/#N6*+$Z$ &M8GL^R:(A3  0H@&A7
ME[G"+12F5PG"*<.V4;:B @"@;WGA"0,0&%G[6PLA 2B  0"0?2Z+*X@@5&BP
MO:AE$LVK*,7;5 "0*/Q1OC(E 0G@!=0:9!.P -EZ%X@  #K6K@<AO'71"0S@
M='JD!A- K#$T"0" &7MA"&AC6[J[,1B@ /*3"5D@ EMP&H6@<5Q@&UI0""Q
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M#Y,%E[ LE2H(S-()8G!/'D  " < 6V (I.<3^^F", %HBP8YY"$!/]ANAT
M\%UG@I,4)7'LE-'NQ6%O3V(&04,!7LX:0N$?2*\[B^(O3*/:EH >_?DO2M1Z
M!; C?RT(#@((G4#I8R( (@!0==8S9R#S\F("H\#E9M )?W 1HO#798'6H  (
M:'?W^SDR#.(9AS(WXD@=(= )V.(W.KP@0 ( 9( MGX<BU/X1$I9  F10'/X1
M]-GW /&3" 80 I0@(I- *B8A  S20KL, &P )"1@K0.@G$J%"&(@81*0A")
M #O"U0WR.PKR]613(E8@) DD80<P)7=4W&(@,QT "F;0'YUP+]"B,_K1"8>0
MQZSA!92"" ; V@>!$CD1YR5R!2Q /;>6W)Z@,JM!-M)$ #0A" @0C#1V$P?A
MO@/PJ;X>0US=,"=P !0  0!!@8&8-0"^B!*E@D A410HB"H4@(4E B0:1@ E
MJH($47\\2,! 8(6H%@($)0R J&0A4)84?*!D8(2H2090B,JX@D B480$C%10
MPHH!2CA%64KP >&%!QDM6#C$ /Y"! @3*%A"* 9 "Z.!Q$S*\*"3)T !LOP!
MP$44"P*(1$G@B"$"PC$ S% J$<$"@PJB,CCP) K# U%?!I1AH )AQC4!N%IX
M8 F4(+.  &A!F#G#@DZBT!B@ $$"!!">LEB5< !1IQ $ #A(PR9MQA '+'5@
MT%D#X3(/ A (@564FMFB0ACPY 7 FN$ LHB272:+@0H0*#C8(LAY9H1EK0PW
M"SV %U!9'*:>9/GYG_%&-P#V#$"," 2AK__ALAQAIP</KP3X Q1/'L# $@8R
M0 BM[[((@*&]0!D$A @N.& F#A+ JH,'$&%@ ^[6,&""!T;S(#,/%)"LD %:
M*&2KQ?XZ"N *[AAD Q10)*#@D@-%\62!$2C[3I0-&! EOS]$66& 24+ ,".$
M!"& !>XRLV0%"2QP@+ 0$)A$%! 4\&3+24!!2RU1.G%  Z/.))!'!SQ$0P.0
M!O "$8E$H8R+259$R((, #E@M-$V<#(_->R44A !9'03@S4%63$C%09 Y 0#
MNJ2O$T0(. '/ 6XR[H!)1D'$ !/V3&%*55=EM5577X4U5EEGI;566V_%-58,
M%.@R"P#2 &62-2Q!(X"#D"3@)(<@$J %2PRPJ+K *+# D@,J\.20 :1L80!"
MD*04# #0@"@ %2XY( 11$#G@IHQ:"( ,4>J2404')BB12OX%U/5++%$LH" 3
M!C#PQ!-! '%R$@46.&F2!P"8A 0"NM0*#<NV6(N 0]Z:P"\N17$! $!$&&!C
M'$71P('.,.#(P T2.-+)/P3XKC6WM"I#.RYLS.P]K"A3H25 "LDO#%%2F)B0
M-"@)Y($(!AF@4U%$!(4#!K#*0 )+TA"DD2L \ *A0@20^CI1M !P. &P *^,
M,N2C:8U)V'O.25$ 610\&=6(EPR#P)T$2%$:"QNA#@PP1!1?UTB2)434Z(1!
MYMBT0!2M#IJD@!!&88"#! 4 0A0L!CCI @@L>>"!2RZ!5I03N^1 90H(6\N$
M0@@P 91.!#D)(10:%"4-@R(*$OZA3=4=Y0,NA ][D@-  ,4!!'4<(1$"E+KD
M 0A$V2* -+PTP!)X3R)C@TFTY6IPAC(J062_'!!%A 1X^D !47X'1/'V,KHN
ML!9(0)VC.L$ $$PB "5BCQ@0,0#%* HS"G" (,1@ /,9( 0"XIU1E+.&!8X$
M4FSK$P,"8X40'.( ^>+  3Q1@@-L3'Z>V%0#18*0%K@/+5EXEF+LEBL>]M"'
M/P1B$(4(JP@(H!$T<8 #6D !7KW-3"8 P$D> +]! $ %E@! B1Z0@,"DSA)9
MTD(' - I7S'@#RL  "&^F  50,  A<!B!T1Q" !8)",G , #/)"  S!D$ HH
M@+R<Q/Z? :@K-9D0!0064"0 B$ ABLG,& A0 ";&J",$F( *#" !3Z ! #+"
M(T,80*0,@(9D$_"$" 20!10,8"X3"-];&'#' 51@AP49"2 *D,D#0*"3GYP2
M!6(IBA$P, 0"0(-64& %!@1@$N(Z 1@.H"82C-$#8)M:+"> HBUZ@00!8 [[
MK)D648B+ 6I "U>$QX511$ !+,! ']'B@C5!I  &. L I"2\+WCR!%=@   0
MD<[F8"8C'@A1" KP $\4 C0L&)$GOO:],R5@+IT0I@HH0#I/$* O@P/ 2&IX
M) @@X!),U$(( * 4#"A), 00A=\R( ( E$ 4)P@ "KX9MOZ,%.( #U!! AQ@
M"<OH,#,I $ (,O"WC%)  $?:I2@N40!'<0  '-BH_83G  PD@%+L>H )"  8
MYQG 60%P%$)4   KL,  "7!=2H0T #(%X $=<,!V,E(&M%:3!*!  $<Z,<U*
M4"<+&$@+'4UP-Q>MX0$#F%U?5A" $Y1@  9E9!H4RUBN[+6O  #!6NI(4ZY<
M,W$=$( ED!(E[2QV70I@P H8P"M$U'2(M\5M;G6[6Q]F006=$44C4( !$IQ$
M$"8X4DQ/T"4KR&@2)RA#)U0 !E%<P049N<)W_O !#IRA!6(X2A9"((@TG, M
MDU"!!4@PB*.H(&R64,$8C$(&%?ZDP0,>F-R-KC:E-9" *UEH04:R8(6,E"\#
M6@@,=P!Q@@V$H Q&$80(,,""+A7B!&H011E0P-SO9(T+&3#!QB8QW"]PX;I;
M:$%@!IP1K7S';H<X ;GP).$55/C"4](""Q)<'@QT0%ZFP4 +RJ "BFW  C7F
M$1<PP($'<T_'BN,*>BVP 1DCQ!-*9O)^LB "0$S"!-^S\)'0BX$0',G"&)X2
M&4;PA4J!^01'RD(&5C#D223B!&Z.F2@X\( /DX A>"*!!5#@EO)N#"<M>,Y1
M6' !+I]I!1B;8XR#MUS%2:D0(=@ &:R@%BZL "M<2+%G.I"!G>'$"QG8 'BY
M4P@27/Y !6XY! JJO)A39_DH+2#SD3K!@N=X@@5J>2X&2BPE47AA U:@;X5;
M?46$G($$S[$"1Q!2)0QH 0PK ,47F.V%%72F#!L0 1I4,#F$V+?:&>'UH=6"
M!@Y\0-QJL 1TUW7AR0#B$*" @*- X04-;.!8";(=)4X@+SM3%"%J^  &LA 8
M4(!! QI0M;:QPNW.H&$$64"OO!!BB!-8X 0B5H'&>3MRDI?<Y"='.:[$X(
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M&+K"0;0$0TO$H^ )D *"P+"4*43"6:3%6K1%I1N#!;"@-LD !.F$"%"72=B
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MZ?E/A-@7:\$ %W !+OB"* P+FC  E 29 *"[_830!]A!R)BC F@!!N"*"F
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M@"LX+M?*"!"(RC4H! D@ T#(@+#Q @A  S)@ )2T #.1@#28A.WA2(QG:U'
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MH#67 T4%(@7%%3P0@M^0 00>N$+EYBZFUXBAO6) TVG,T D11!(A(O  &;*
MB!B%X,PFN) +%#8OT>?'#-<ZB"!&4$I?M@#RDK<$%\KP@=&#1P*5FR'DDY,%
MXB-?!.66.PG0) @2>  +U#R("?Y88 4+&QB'4 I,KFTSQS* H#-KSZDE4*\;
MYF%A$G2R9N9- A=X5A;\A,\!$[N8@?N12($ !0ET@!54CB#8S@2>Q1^$@)R!
M ;0PV@JL'^6)PA@PCNN07P2F!1G4V/])W@D@PKPD"R#T&R"(67*X&QAP@.:!
M!PJ00!G\00H(D>FU0&IDP5Z@ <$!X5EPP6\8PLA806H(0CZ=A26<P!;02<MX
M%Q?D!R7H7QJ87MX=A!H0'".]#1?,3Y/9A@> P$=T0E.)0B=<P5"@@:#E!AF,
MR$O\1AFXA,]E 9T,A1H2'A%.@AJ\'QI\$VV@8=(=(B(FHB(NHG(9A N$P"$
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M07R!482 !+"@Z$B(()R+:;H* ;R)<AC%(0S 1YC =9S 7AQ"L7Q!G4F*48
MD)  %\R-02""!"0*7P#)>A0"W6"'9S! @Q3"3H@ 9$B 1%4 LDV5"[0KF=G5
MVQ5+>O H84" " S%%S"0&/#&0?Y$P"&$GL]*D'8-!1 ,%0GXFS7NB KD!Q6)
MS@14#N<"3I.M1J#8B(1D[YE8%"!<@@%D06JL@/Q"0&IDP$F00%NA0+E @$L8
M!V1DW*I\+AJ0BAE($P:0!Y7-TN?RAUE) &PR@"&D0?%^P6EBK0JOL$U^1B)
M(2BT@)Y4#@>0P2&T">_,$@)S0; <4B%D00LPV=($B00< B5(!]N=108H8X>]
MS?O9$'!XUN"* OF"Q+KT'D@([%GX[E!D@=O8AFPQ0!:X0!8\ &%4#A=DB4%8
MS>U=@60EA34EQ^A D=MLYA=,PF0<Q >0!R+$D!<'"1G\T7X<TTAQR@/L%W]*
MP!AG ?X"U!36U&CE8( :V&U@. W-6)-Q8 $90T"Y9*8CU@9"K,H-6X+*6D'H
M(<@YA<"# (%A]HJ:P-0&N  J<N[:#95>: D$9&891-%D?$#H9,8@?,=YC P6
M%&8"3-#?,< 5  $60  3-I15F$$4L<]VG(2?FK(';,#<6,4)E$MF6 W&\L<&
M%/,*)$!:.L >IX;O-(@)E OX',3&_"Q(6 (%I 9NLC ^YS-30D 9$L72,0H-
MBP&LH =A<%0G9(&>& 0$A-D#("'U\!41CRT<,H]!>)/K  86V11$T\Z(1 !K
MB,8D\-11[%5FQ=!M'(06E !,J4$95%R_B *^6(75X"X:E/X!ONF3@4@3$&1)
MY;#1]5#39I 9-5L'*&# ")0!(& $;2"3(2-'H62"%O1(&:2!F'"(6A6*66B!
M"HC!=?Q1<@R%-3$42[OT6@"!^&J1>4I )G1:3?_!3QR5'I] 3=M7\DR '+#A
M&)A @\GQ@-%R^9 9 H.$)VR SX3S'G^U( CS+'4"-Z5!&:@!:Y2 %GP&&IB!
M2W,Q2! V:5C ?3!.!&Q!6Q^"(.R'HCBI**0 %[BQ<DC%8Z/EA-!&!%C".D_0
MCQE-_ER!O_VT/N\V;\.B08 ! OQ&%BB )S#F4&SM)'2808A 07,)[0Z%&CA*
MFQ[$DY3'7GA"!*C=&5B S>1&\_X=1!"_#624&9K<,D=;-TC<+2 L@!K ULNX
M3KK ]+0)AI#\Q@J #4 )2,@%QH !0KD\AAQ+T^B:12(@[T!7$V3 BEE<P0E8
MP@%$AJ,LM>8R1C7YA -43B>@37*$0&.00*A,P@;@!W^]RH7G, 34E"9Y HL:
M!+L.2F 3+U^TU1= B?.ZB: XG4P7 @O$S2\#5%]+R-GXK/@BPH-G1%* ZMIA
M0-5\TP3\P<$"A5]DKZ:!MR!0 N22V0%DW(6KADOTQ=I]P<KMT"7(ZXZ,2@?L
MQ1>02B',S :$)0,, KC\! ,3A6V7Y@*402&0@'2,26_WN9\K8A8D+05 @$1E
M@:GNF?ZHO$P.VVTG? '7A  $ZP;7J$ )8  ]7[<PF0L)#5L&<,#M(8@:/  P
M20":\(TH1 Z8@,T$J!T;;( U%2<;8L $=,+^,+4000"FB@!>.;H(A( 0>X((
MA% $, X(1))6H;2I3@!Y#,)7Z1.L# 469 D(;%@+7%KXNHE13$(&S&P&F,76
MB( $^(>%;KM"O.6^[A47!$^G\05DJ &N5ZRA.,!Z0I'XPDI:3Q$7?4 %[,4[
M[XZP4V+^" *N>T"W)P<8U$88#-4D: #8[>8P:X )M( %$(8)8 "XH\D?3$"P
MBX!!F( %0#IG9>\?>-BV=T(B2( ]$VS$6\!KM("C60(&</[ !U  (>@&!(
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MBP YT $#R!"E! (X ,!52Q( @5 &%'@ 6U%.<-:  # L9 $"'GA@ %<%$L,
M!Q(HPY(*$H"   A-,*#;/S!0P ( %#@!VAX'*H.  R28X !+6@!@D$(4P* "
M ,1 %P )$I"@$S0&N,!?!@ZQA  ,-UA %!8 **0% QB(8(T$,A %$0%(D-7G
MGX$&BU8'D@*%"P#(4(-C^V)>0_Z%3CQ1(.=,K2-#  \060& !2TRM1)/*%
ME!8&V.#-21)HT=1)0*$@ 4]:", %1#(@P!(4 OC#D@X,V,@34.*S(F]15!B@
M. \0& 4( 310HY,-"E!C#0,@0,0*I"T"90(&)D'D 00LN0( 1+0 ((U.R!#D
MMXZ/!N0/ 3:P1(T 4NCD@ ]F=%GP03?@'-T! O76PZ")+]YXE89.ZF7372A
M8PH"2)$+#RA   -1U@# "U'(>%"4,K86:!(#>A9%]$(N+]%+!$BPA'R!SA>\
MN!4(0*2#!P3Z8O0O##A@ U&L(*,+,$!C$B"1Z(PD"@LX0!3N,X$HQK T-1V@
M1>BRF_[\/!> <!5'$"?0@*_2 (BE>>(!%YC$[7(G"A<$@'<,2,H? # &$3C
M/\>SX0UM2"M;Z<E<E+A" *0$"#7$20!BL 0$+" *I8&!>P&P3AD"D*T&)J #
M E$! ";A@@&H3TT)* \".&#% #1B=X2SFPGRU@D/&.X/*EB!=:Q@.%%D8 %K
M$(00.T&V$F& AB<L@2C $$,O*4 # O&  3(1P$!8XBA9,  &"L&X0DAH#2*\
M0@,5$+L$X(Y& &3AC!AHD0EPX ' PN$I49E*$AZ  A18UR4%L3(UI$ "B-
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M.J0+P#!L>*@KP3+U4SLB3PD2!T-L4S,5P42U!-2G5#E5P3[U5(=BP_[K#[C
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M1D$P>_Z+ B  )M9 4[)G>^RI$1)8%"J S0 I5SB =3G Y0Z!8I/) #I@ T3
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M(.H\(0/4X NLH$I0D< X.0L(E=)21TWRG2 6KGVYH$OSX^=QR@L^OLTLX0^
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M$&$AG/ %! J&L%\G$Z !2@(A6)'!!J(4LM\53OWGQ0-6J/[@0 NB("2&"AR
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M<H"-%/)(1'1B 6C(H,9P) (EB2($2MJ "O9J@2NF9FA?6!R/QOJ!+ZRA+98
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L-XNS.:NS.\NS/>NS/PNT02NT0TNT16NT1XNT2:NT2\NT3>NT3PNUVQH0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>comp_0009.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0009.gif
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MZ.SK[/#O[^/N]O#O\.;P]^SS^>CQ^/3T]/CW]_'V^_CW^/;Y_/___P
M
M
M
M
M
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M/!:(?O2!$FQ:@R%0L*PO"4JH^O0G9D5%#-ADC S TX>=P$!8N3I%*5+$BBO
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M0 1.<(*+K> #$"QS!602 @:=, 4--'$*'$QW$(F1@>N6@ ,1(O,0,[!"*ZR
M TZ8(@DW$.<>_#[PIX"!-,H<Q2J4T.UB;[MROEER84X#MB025087%T07 L0)
M&EA"%3T8 BL. 0,.7>(*." 7%X"PO"[P 'Q!P!0K^B"$X! ""B*!82N(A0A
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M&U#1B/X(C &5$VA$:$5&8C(X@A(!&$,C=H4'-RQ@%8XX7"@N<"H&>* 1<$B
ME29 ADBP@,-LR  E(D$!VXTR G! !0HB>88(-&(14[3B!9+W $]0 @&M>,,
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M*#4-Q"/(&_**"@<HSP1*+2V6.BX0YK9" R6]) 4XKCPY$ _6B_@2Q^LP"4^
M@ 0<+\-H\T2YH?YM#"0P>0@8\25JO<&>WT*%)S!,W0:T$ */$,@85H")!4R"
MY@[0EVBYQ0 X4,)- E&#/4L@ CM0PEN,\)8G)( P[98*Y4,J03<7 0'W<O@#
M*J@$)7AVF"&] > ^&PCC!@R!7D$ $V^H@"<D$8E)"N3+,AG8Q$M@@E7$8>W4
MPO"(/0#S00'0FZ(5<"0\$0$V@/Y"O .YP,&$+1#*A4 %[HW D%*0;L*C E*-
MF&LKK.OX2;1\('- Q03:0(E*I !GR:);)$[ R F<D WVI)LGSBQZ#KOA^' P
M7P18X BBVP%9(*H#P%N@K4A;J;#.@AE4X7@Y2HB-!>E>Q:DF4,A(/ "0YUK5
M^237_,E=7@1I8 0VBX3V@X0[L "!J /BF3^P(QXK\83G:IJ$.31DF8"SH9\,
M2X'7:P45>#TCV8#C:2N!Z#C%BHDRB"1/< !#X;CM^JQ)\ ,$R"I4: "A:C<.
MF+@0*"D-4*@6:@404"IEN0 3P),^ Q%'>( )P!:"(#A4B2F!N( [* )W*X$3
MX**!H/Z DGH8.)@E$4 Q@KB##$._%2"<5@B%"0 %93D#4GF 2C"D!S"456"$
MO]$ .U"63*.$"!"35: Q/8D?!E@#4'" $IB\:VJ%20"!"7@ =LL_;O&6,>"L
M/[N !=@C*^J (4E $2B#"  MJ$*%"*"$(3D#%F@$!A S$SB!/%B%"? #@<"#
M#8B "\"6(:&$"V@$$ZB#%DB#2,J_2)" 2.F ^?E%;1D!R4&[(6&$M=. #9BX
M$R@#(O2+9GL Q!$(TT.<"( Z5& S,Y"XR5,!SQD2#1B_AZD#D4D!_AD(1S@]
M++&BO&H%4%H A4*5#QBN5:"$"I@#!SB!05R$<E.2"L"#5?YP@$]<A4G@L!!
M V8KF58P 13K1)J+I3$XOS+3$PB@!#,8 47!QA%81I33DQ3(@'(D%1P;DCA@
M)#S @ \H@PDPK0QC@TH$(_/QA!&@ $D[M LH' KQ! MH +<9B#%   W(@ 8X
M/H%X@XZ2M7S\.$-, T4AL$=0%D_PK2=<A004B! @)OZK@P/L03:0 WP<Q$FH
M@^^+ V21R%6X V1)%Y1<P P(F+'4/;=9!4!LA0P4"!-8 6K1@(#Q #. $PO
M@Q>:F%9PQ%7P! B(%!1<!;F:N(5LGPAHGB'ARE9X@.L:"!,@%269 "S$$A/
ME_E!$:(+( <0*Y,[N#R I8' +?Y428-T7 4$$!D1&#]!<8!NFD8$B*91$K#S
M0;$'P!9LY,E5:X4,0 .2.T '^,T-0(79B82]T;5DHH1)*"0U\)8AT2G6:T3*
MFQU)&*#^(1546(#T*1E[&0@-* (]N0 N:AR!< 1#F0 SJ8->X2IM$8$1D#%A
MLAVTHQ^H"L92F9\A"0&16<30>ILO0A?% $V" ,0!FP!(T!--E ,,& A&4)+
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M.$  HP&%+&J$!'!&$F&V B @G[HW,(N %*B#6&J2$'" ,B S$1L!!MBL$OB
MXSDU$$@#%E@ ?A.Y#9 #-&  KP-16HJ . @IW.J !WB#.%@ D+I6-F" @RDP
M.Q@#WF&#Q6*#S*D$^K*#^&1%,,2#QF$!1BK7XO*80U, M?ZI !6H ^Z* T8P
M4:+9@&-ZO1'(@#F0(DZ9 !F*@P1X SL()&I1 P$(E VPO\FYTDI( /PYO[(!
MO%9 @0A -@8PQBN--#.8@PEPU +QA (8L 7H&DKMD@HH@3H0@0M0I 48@Z?*
M@"M)@00H@1$PUH")! ;H@#08 P:H+3VI@ ^P S-H,50I 09@@WLD1WLD@[#"
M'"5Y*YC!NC=P@&C2@"]"QRL9@0.2*D\H@T%+UP\0!09(S05P&_BJ@Q @GCG(
MES=H4A=B@#H0T\X!A0R -?@RN9OUR328A 1H!37 N%43A8Z] Q.0&3Q(@*64
M59A1 (+(@&:!S+S: !"8 [LAS/X:JX,*B"0,:X,XP+I6<("S@2.!Z(#Q>]U6
MH .Z*Y7QVP /J(,3*!DX@"J-.S0&B(,V< #B\0 0B%IP*Q7*BET\<( E>H"
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M&Y[VJJF$JX%H!&Y/IF^!NDO" [/+$]#D:9-^D'7'$CN6 TR*],F).7U*;H&
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M*YX\ $JY(YC6[-BS^F'@*HP8&%0**7!&UK<1>)57*&:DP $%K93A.G224ZZ
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MU*$!=5/! @[BEA/,*G4.6(4:*-4KGHS!=>EYCNI6<8+=G, $'YHB+&,)2S8
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MY&M1<I -M$'0 I(HWRVY1Y0%-E"!+SE"\15(0;DFH)(+-*_;O?D *1Q(!70
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M=AXT?5E>)$#S4,(1C@!/.4((6/[?1+!!':2 7,A!\*T!!81B&W! F&64!D!
M"B!D!EB*::1I(ZS!A-@!WK8"'GA PN$%&VR J=A!!%" OGC"VWJ%)YB!'6B
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M"@Q(R%&"I[P%"1P8(N(!&B &RBFJ=AF%'2PJY8'.1-3-BYSX XA"P32+J8S
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M$3ZA NXP(30 !(X((]*@ 29 #NQ -53 #4&  1)""<>@ M(C#AI#(<J&!")
M2/!@ E#  QHG#1@@74#! F3P G"B'"6@#A:A 4SQ KJE>X"$.C*  TY  R@
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M)U*#(SC@13(@LE8!>M* 6E9A G0D2E.L*U?C131@#M)@[[1U[< T9F4VQ=3
M, I"!#X$ BRI##0#Y@Y $D['(?[2@@TJ0!*T=1)0002JTJN(AB$F@5@,423L
M,\3N0 6NI2-"X5#'4ZE:M%%-L!60=%)-(,-,X  70*OP #18Q+X>(,)2()X6
M@!$<@?QP8@.N(P+8P!$:@1(8L&[HJ4\TH#5FE6%L%: NX XBP@RV"C14,S^(
MB2$*X@1Z0VHV0V=EK6<P@"-8 #08 0+L; 1  "SF( &2QP[*9 44(U!Q@A$*
MY'4XP@0*1$U1(10(1BR)D(Z0Y/6DSQ%NA>22AQ0<  _.($R80P->Y#+9("W6
MH#<P('E X0$^;B36!I(4I &\ A4.]BR8@P$<5FKBTE(BX8DT8E0^0"0@H2>+
ME%'!]OY%TD _Z]$O%H9D(^\V"D(W.6(#O@YL&R\M)^,#U#71%FY; AC)D'5F
MSRPB!"2%(@%[IV;'*H 2* $/(H YK*5! \,!$L(3.@ 5[(!WVC?R2N4":L0F
MONX:"4)9&X(!NHIV.V,%.J @3, TC&3,,J UX* O0@1$QN!.&B(%"C$.I'1D
MOV[BR.<"/J3M6,F(2P(P<K%&>JHV?M)X*X8!7((M)D#Q2/9=!50U\L!%*< .
M4($!6,E:',%-<>)?/6&37FT53. "-& #<,(1\K$M'.![[#%'0*,,@L->)D #
MGK@53L"-(<*K)MBV*F #)N ,;&M-6\&!$!D-& 8P"B(4-OX1D=F"&86P?;-U
M C;@ DJ 8DZ@ C2@]R:C C(@!#[ .$'1 OQ8D5$A SH* ]2R%<Z@)2Z@HRZ
M0:)1 _"6&R6 #9E#%#H ?% C SC".C!"!2Y@ U9G0+). P0D#WH6*$UC!%S%
MFANYC]?1@+D93,40D;L#%#!@3@JB#>KX>V9B,QBB#IB"5[0Y.]2" C:  CQP
M/31@%3!!!RU 1#1 J=IQGA',(!1R)$9 !SN *CA C:MC(.H ,%B@*EF@1CY
M _ZG51>!B1LB/Y?0 SYD$C(@ P:5(]B  ?YJ! 2Y,SH F.R B4%@("BA+\:
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M 0,<K8 MK X(H ,V8%6Y[B=T2%,WH!SW.FY"0$#,0&2AA!$80 -.@ + )^6
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M.E[F 3: [V9%S:V-U3'^^+;JX@]MOVNL$5:OU'HLXTGL#0# 93#"#H9'#N!
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MP03BH 8 UL$!<LC1!$ !!P2L 14*H 0J+F"".&@ -W;8"W3,^I(2,* %8W@
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MM@(%S6J$(^@R@IH8$15VX%<=%E(8&.ND@'P2XAC HDRZP/[A@9\"[8M5_&2
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M,-M(8!!!!'F$!C) !TI<, 4L(*G=3<#KWQPZ+,!^HQT>D8(5D-03*E!!(^Q
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MJ0M -_X1 @H "B\T&7YUA!E0$PU .@YP:__H3FJP3\8F@B- "7G@48V1 &S
M"&>PN< K@NZ% (M "2MP  _A,AYP/I.P *1P'$RV &S' :"@NB9@3L8A?U"V
M)J/K.'3Q"/I#">5Q'L;Y$N0("92@ $J: ,VC/Y60 DU)%QQF@&G0123@ 92
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MX*=)$C CE 7\:N2!5N98J(4-.VQE 4=:D2/"EB(AC,.W4O)M1QY[C"DE,P
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M" H&2 )4E#BA2BA AH2T)5NA>4,'.J"6"M03#E/Y2P>6DI2%V.$!W%L *,[
MD_7!C5089:)&5<4J5YVF=VMJ11D\@0=MFK"4SF1I2UC@K$B\!@$Q0D5%&^&
MDO1Q%1FK8$H>09["1(@4?CN72B;Q$P^,,(M^*8->0."J,]1& [Q+D8,B $R5
MG("A%?X05TI 9IN%:*!?2&**$%MQ OF0X3S[6<5R.-?$\W0@#G*PU!@( X*?
M).4G#<B#2B[ "+?V+J\M)6QN>.B7%:#@*>!IPWD\<<4&..E1D[ #,S,"B@64
M) V $Z32=#2&T E'51%:60K>%@? .8"<#O ('C*P@?"P(3G1005DG@(!N:B
ME"F9@Z!DVPH(S$$ET#N)2N1@@:3@;A%ON!KCF$0&5"B@,BBJPT)$H%PX@,)5
MGLB*>OY2 KVTX@,(66EAS2N3FR3';!CX@ DBX!$5:(HE)KC "21 +0\X8!)C
MV)"&6L&(!Y  !!-HC -JY[0#3$#!LHIG4>3@-T<$>,"A8?Y#!$YP 9XX8FDH
M> ! [X  %%PM-*$ <8(D[#*6A$(##_" @FN7@@N@0 (_:8%>U.B1.@"NGS?V
MJ%A-DH"SY '(F'& "3+0@9*D@ +NQ=UY6XH*#6S ! ^ 0RM0<($4P)A*+*C
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M\$VC& $U$"E&H 22[#G!NX.4T$H6&!5CE*Q&>,>V9 'U:/Z#^P#*DW&$#-"
ML@"%%B !^(N$16"$MY =%F !5) #$1 NB^0>X3 !A, ,Y4FD=W2$K^2YG,N4
M>EH$1W@#$8 _+H6#$*BR5JC#.! 74)@2-S [$S !K%(#$N#*0.H /!@!.5V)
MW2R!,RB)2<"#11@!Z!(//XU3OTB!P\ #[TH#/75&2.-(2E@!$R!3V>$O8$(%
M,A@!/]  X4H).YB #V $.]" /!"!._5*[21#!CF FFD +YJ;/YJ -IB#Y+N
M0AJ!!U !-E" .'& #G #FU&/$@"!.U !6#F #SB,8UV$^@K%4?$ !^F $6@$
M$]"+,5" :1$%Q8$#$"B @K@ %OZP@PT K<0L@U P PU8!"73D5!@ 0<@ U"
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MF=R CP25HK KE2"#-'D YR*!+\$:-IC*%6J E5"M?TD(W+@-56&N!-#+\-B
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M'Y\^,I"R"HB0$GBD2$H!+<>I%" OL?GQ"ZB#4!B,$PC)-GA$'7$B1MF<0-*
M$7"H.36=#*B#.[B/DL@ J\42)I(#!K#K$=  QF&@"$">*C$#*;, A*@ <K*
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MH9I(X%9J;$%%)!JY"@[DAX*C:A<J(!"*1E2 9#-))WI68?Z&$FA7(93PYR-
M:L3)@"(25V.N>5?K3T>@(@UC#>]YM1L;>RTBNY%H;RNV=9D.Q"$4)13P&^UP
M@*CYU"4F*-%,+G >PDXDA]]%3SI_M)H)M,L3CH@06P1,$^22[;VH:$/"*MC;
M#R<7%8]0#7I/4M[MPG<FC["H3$ Q&?6^P:YSR.ZH$C2)%$N&L! @Q4DF06.2
MJ>;$8:2$KTH(BABW8@23<RU;9"(*?ZK7J:;\0 =.$@<$$+D5Z?WA*MK%9!XR
MER9&_J$G9@KBDX0"RG*(; 51$6-#_OC#![BFF?BD'-S*Q!,3]:!,)/%;?6K7
M$P[(ZP72(-TGJWFF/23+3")!Z/Y()7>ZF\(58=T9$TI'LPB)2@%,1E""$$P@
M88SH,EXJ8"^9] 4$&'!(*)*R:%!XZ@(Q)(E[T@ "$U@ IZNX0"C8L( (J*$_
MK#NK!\:$B@>$@A%_P4"[UL:625S@ NTY02L:]B$->. "06,$!3@P@0?AH<OU
M(2IX0#"!*3D" R"@@$-6D8(,;, #0IP$!K3-@2C)A WG&7:E'+$!5&B $BQ8
MP 3P$(D(J" ##CCJH2(@UA&!8 03X #O*M !"QQT Z*2;B3,9X*LGL01"4"M
M3%IP$<[.,6(9. %EWX4*$:2Q Y&+@/G&D $17*!^*2"!QC40.4=<8 /T%AJ^
M-Y K3_YDX (A$-Q,?.Z!"I@/Z1NH0*)LV($)5.H-(QB!8![8@4;#;0(;X$FD
M,*8!B$&'!0_P1"BB'H)F5XT!AI)))"JK =DH9,X=J(!P/<  #, 77QKX0.3@
M]X">L. "%TNN!U+0@0BP8004,'HKSH !$1!^1 X90PA0 ?7?B* $%+B $!LQ
M 0<[*Y6>2("OSD9D,EA@Z_6+5PHF, * <>0W)1@!9=>"BA P:@27^?4'(H"\
M#7S@ B<8I 4TOPA/4, !C ?!N^S@\0FXQ!,?TX #QB83E\4DT/6C!+<ND *9
MA, $'HA &DI0 6+C6@47L  ;Y@]>\8-""2S !3B"C8 ?M/Y<0 =D@/B@ MEM
M0.G-!!Y0P-JY!"AT  @(SBKD'_D5T$F  EIE("@X0"B 0KYA0 GP2 5P  5P
ME3(MF$* @$-4'\DP ",TPGV@@@0<% NX04PX@(TE@ GD2@=@BP;T!(_<QQC\
MX%>HBX^L@@>8P2K<P7W4059=P-LT "A(6ULX!BC,W4DT2M4X ,1<0( A@$R8
M01QLA*8HFB?@08*TPAM<Q'PPA[J$ +>%PGE(C_U$B0:(BB<\ +<1EE5)@ET(
M7RLX8<.M0B,@0&&T 1Q&3P?\UYBT@@,02 1<QB)80 5%0$G-Q,)=3 9TF8[0
MA'W(4, AP%JXP9/@P8-U2RM @/YZ26)_$54'')R9K$H$K HH0  EQ(%@=%X(
M? 7$A(+O=1CMO8=&1,"QW,II),<C_%0<#( =A (J4,"K89@GD%#C8&(:3,X#
M,-D F$&N_!KK)%9,/,"K1<H!K HE* !R"8ER@ 0E@&-;C!4)G,<#>, DK(+=
M*(0:--5D/("ZL$$!!(T$Q,%S10X;N <(L($<"D]"E, %7$8%P 3F5<T"P 3,
M[=)T/( 3R0$$"-&=U(=W^,1YU$%"H(!52(A7W(5"E,#A1(!CA(("T 8PZLL3
MYDH<7,2.74;#A4(-KA8)H4)G,(=EG$2YV,0%/ @J7$#;3$"42",DM (%N$0!
M^(X)7/X)*KQC4(9"*$3 6KP6&Z1"'=P0M4@(>+7""?B9-KY+)(R@',B-C @7
M.QZ*8<D$',SE! B7 ZP"&X2&"5!"4+X+)CA 87 D*,E$"LREE&&$UF2 '3C"
MCDB 6/)/&JB 5:0"2RI:&: !;Q 5CR1("T ,2D1)/7X 3. !C]$,&:A')6IA
M@CC"?;!!0(K9$J*$AV3 JFR !:Q 8=@!) K+'83&&P@&"T" "6A-'5R(1FC5
M[Z4!"@@);I:!ATQ&!3Q"&[2 \FF O4! T$Q 82P"'+H>#[&!NL5>5,A!;;!!
MZ1Q ^BA$!%!<3%R&"OA/'>"GHM#):I@B#IG!?#W 6M!,&?XXP+%  %6*0AR
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M]%Z M/XPBCY Y^(4K20("ZCE"E=BT+PJ'(#HNSKKKHA@;+K/ LA5*U1%"9!
MTF($'#BE!FAIC+1!<EX >)$"!JA- CY&5&8 >-6%RV1 -7)+"3B IMQ! ["U
MYM)$!'!;) S%0:\%"#@ @] )(^QGXR3 >6Q 1+?"!KA$[Y6 !/A9X T@<DQ.
M=TQ !$S UY(,96_ !3" )ZY0&C@?"00?'#P 8X( ZX4ETBZ85D9"E6I&G93
M]I#,Q93  _C.(CP /AJC3*!"L6CI@]@'9(" ET1E[W9>E\G$'#B BG">W)I
M!!S."N3IO9E Z$Y&(X@5"9QC)(_*4$_D"&AW"4R 8P#BS/YLL0A<-5.[CP?\
MM0,,EIE\4QR$1@>HP:T$]Z)1;T8NQDAH<S;7FPE4  MX !KPK"BM @DPP-K9
MZ"J,P%]'@._@Z@6W B18U0I(  D8MKW<E >, )[(R,F$IX6P]>LB+PFDP DX
MP!V L >L0@70AQE$I5N)H1!1P@C.A(6HX'601 24 *;\Y$4K1 A$X1*RP(/I
MX$8(409H:RNL@%FT NB5  3 A"=4@(P'UTS4AI8ZAI$S9K[M]VV:5VW,N0<
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M"-1X@_<\'"A(C@@BBOT.1Q!8(8X,'C+]#3LJ</#LS@I* P$A. ,J-,""/(
M!0UY@!G:5P26W.P-#OC4 CCPA@U$H QL2,!:%K !"V)0@VO)P KR$(*:I*$
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MZBT1L) <#&=#H%1/ \F<Z66)*@=Q$B04C75#2B>WRPCLY_X$SG3$5@3*$ M
M*@W.C,"G6C$'\8" 4*TXZN@8 HKY%$0%A(I#4PVRT(A<H"EI("T;8C,!1JW
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MH]9M46DK#3XE65< .BAA\RBA!&A5/4ZC QRA$6K.]U1* [8/(5!!!0(-!$Q
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M0E=^Z[=_JA=?GC=].6-_V0,E^M=^ UB !YB "PN "QB!$UB!%YB!&]B!S^:
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M 6B/R]CY 392!&J")2DA $S #OK3#)@/-T'! =[ $V33[7)J, )V$NQ+\Q:
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M+9!0,S R$-<2"0> $R3P?P[@)1/@,2'P%WOG49EG OS'!AGR=A[X@2 H&IZ
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MP0*DUP%><HKXV:F>VF(2DP(9($9 I#LIP 87X!(Z:1$?D@$W<CX1X $K, *
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M"<"SX:4"7D)=?50)*N"+1"46*/!_UU4'43)?'G MS$$NGOYP2LOU6:\I%G>
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MP"IK-OZI;P,7%U#NQ<&L2H<;<7 6MO,6CE V9["K[9X"3:A&.ST&CLBG,(Q
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MOP4WW#?E%+=<<1UI((TT/G# $4<<&,,,!A;Q) '_$I UH_XT'$A#A0:DBD0
M#'>%5UXX6F%!@C16.(#0[6)"!0$/[[OLOMA(N&!="]P+0;/,0CE! S98>, Z
M".9@T4X/5F@%XW4OF$TD%K),XP&M1CBA2'Q-L*Z5$JQCXX&%'0!%CKMF9F'?
MFW=CPP$T6/CW,%0R("$-"G[#DEISM^:Z:Z^_!CML;QT9XPU4Y#"6$OJD0J4.
MD5"YK!&03%N!#%!@DN/0XHI@8>Y6Y$#6$:GRGJD.O>\X%/&7XE"!#:KD4&&,
M[E9YHRY/V&AEHML\3'3QQIU*88PY4O#076QC,UTE8Q%E@8SN/!$MA1;J0/:E
MU!E907*94.FWXE7L$$5LX8<GWOY;I402*8V><5T5)J>8HLK)E\AU"H]6G9=3
M^L-PBOYY<F6"_OOHL0=_>N?+-__YF$1J8X3TA_^^^)Y$&F%YHTBP7W[]]^??
MZT@:D0D'SK"][XBD!!B*7_^.,@G'B.UXY\M>IM8WD_$=AGHZ$1_TT%<3Y,F$
M$0 4'_?.]T$"@N^""D1A"E4HE$;8H0T=8,0D1I""NT6B-*@@@P?D  *#*"45
M:G"):6)CAQ&48'6K,,,(5- =RM1A8"^)A E&@+G3: !2JSB#$@_E"!&8  \,
M:L4=B@A FDC"!"$@TZ@6888.@#&*4WP)&^Z&"L<]X@YVR @J6A ",SBE#HU(
M@P?:\/X2":E+-F, P1B(\XCZX>%@CKC#'7ZC1SXJA0TXXPP>BCBQXH@F%&,8
M01&"N$)2EM*4IT2EFI)7 #:P80$?B ,']#*&#+2B(DX\0/-><H$![F4.=9@
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M- A@#26L1 -"\!)&^R6>H5# '1QA @10(@W78DHD<AD)%M3R!)#!C<9/4&B
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M#M@ %G"/13 (3SB!#O  _!,7C%$!$%BVT6H%,]@3"W ?K#H!%7" 5JF #:@
M.Z $";B0"?"$X)J ,\ -M-J 1*(FQU* %%"!!7A!6TK"K'"L!1"S",@9.1#$
M%"!$QTH.RBHY+\00/XC#$HB X %!!\" ..@H#QB#.#P,3^@ !S !5!B#"&"!
M%$@ LF"!K,B @1$)%9@ #<"0,<@*#?@-.5@61E.#$M"+IKD .@ F5&  J3 2
M')I%EO[9'99@J9G9C)AX@-F[ &A3OVB41I^(A#)0+/.P PN(!$HHNQ(*DQ8
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M KB#5?#05;@#0C74!:!,U!@!X6@ U(&9KK(4K5"*2PF%10C&54@#JSL,/'
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M.0'])H@3!@%/>(VIDC%9G<@2R/X93V" 4% 2E:"01VC*Q4(-=32+!R"3"/
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M8%IRR$ H'D"*Y3P@%)28@.".1S>214!8H&C *E:0+C>2LYQA"DDE$6)'E92
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M1@:FJ:Q"!J1 (Q0%*D#@,KU!&<Y$3:# !2P"',0$*"3 )FK !+3 +IU ?X&
MY\Q>.%T (TQF< CA83[ *IS! ]B!&@S &(W! ]Q!XQS$(@P =<E! ]1!.VI0
MF+%+')R?W61-&C""!S#%&VS(V)4& K"$2ZR03*Q!38R 2Y3! Y &(R3 &+4
M!2R"'#" >L@/(RA%=[3$2[ 03?Z@T79VYR*@@N/<'E.TP@,T30%XP"*P036F
MEADP@@@0D@ETU"(<0!PX0@C,S\ )IH$*2BC@7@K$AAR, "A$ DLVPFBE00?D
MXW(PV%? 00J@@!21P"+,7WB,@4RD@0=8J,W@G@D\CE"^ 1OH!RBD0(%@*!I]
M$D/T8&YXA2>HP 9X@';E3+F0@4I$ N*Q07" @L/,D\V4P4$T D_* 6F\*&^F
M 0JPG > 0'_9# MT0(JJ2!V0QK5TAB.,%D&!0%.A ADPT1U 'AI0PBK$# B
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MA)U @*$"BZE7:G31'9R1ZBC8&*V"V7X @'7L7Y( <CE"AB%'*%  SMP!!#R
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M,'_,DOX==-%($H3=G5)0IA9_5%LH,$"7VL'0>,)0E88#V$$=+-E \7 K8 #
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M Z2!)X"U"3C"-<&!!H(/"C)"SP(L?U [82 3)7Q _#4EU),."TP"&524'0S
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M#04XX0,N0 GFV.=XH#&((QQTFMJ5@%H75!Y:(F$"@YB@-W5(0 LH823RR<%
MH;G# GIS%CB4(3.A.B('P1A&,8[1=2D8CDPH@[JSH&*%%.& 62@S 651)!1J
M/$N^3$<3"YRH=@F<R@K/D('AE: NK2!%#Q-XE@3&B5S-HT@BAU<9-H)F0IU9
MI(LJB:.:) Z2,/&+\:H"F#&0 'DHHE5])D0\2)*1E:UTI?CHX  (I&P"8\C
MNBC"@A.VH#,:F.-^(.*)$&0  UUJ!7(\X"N1J& ,?\%#!?XLT *)H"4.%\A
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5<S$9LS$=\S$A,S(E<S(I4S<" @ [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>comp_0010.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0010.gif
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M\._P\>[S^?3T]/CW]_;W^/CW^/?X^?___P               "'Y!
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M/(@G'*D'O2W]]-17_XN_")!@A!!&D*#  ?Y"[(&! 1\(HH,!#]C1 H[32('
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MN1MLK89\NX'A"#>YXO\M"2E,0 ,/<( &)) %((!@'Z80I 3:X8&R?#T3>9"
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MB+BHP(%4F"\.?O3P\."-!QX%]P0I,&8>@S%"&@25$*:@CPV41&08H@$$(2L
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M\*@!O&48SR,!45("F@@"5%$$@S:$5E80=J",A"""=A"(C25\5)&)?-$#=I
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M)@/W%D=@!5ZB3!SP8"+P 1A03/7R(9#P$:&')YAAE!,  A3A 0!"CA61G$
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M0 I[Z$$$&%!>":1Y#QMPLR+>(%Y?PD$+ZJ6-&K;PW>_FX;M[ $,6U@.1/OF
M!'NXPGQSOO-$C('FYAVOFK@0FT2HP0KJ#<&86:[TF^=AO#A_@]!-DX6YS GG
M-2?/%GX!DVY\=PM-7\33Y[L&J"]B"Q&8+QBXD B(J&$"W]4LI<$.$]JP?.B7
M#OQV!GN&"H3@3A9( !M,#85N2. !5*"V 52@!PE(@ XY-T *\-!C,&@@ 0F@
M !7T8 ()G.  "N"&"2)@ M2KO@%?P(,'*, A%"1  0V8W0D*\&(62<#,!G@
M$WB] ="+'@\\:/Z  Q#0 BR?  $'L( 6EARB$C"@ 0LP AZD((';=R -8#C
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M$$ ;+8 !'U !8+ &%7 (+? 1% $&4F!G$W 8@K>*V>%0'(('1$  &X '&8
MN$8'(6  5+ '4A  +(!R"& %>@ $ @ ",(8'/=  5+ % U 3(A  'R $#*
M;E " : ,#)  ;S "!O %A49R4L  /_ &$N  >( "T49K%5  +< $UR<'0,
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M3_ ->U#,6[ &&H" >> !L6$'"@ &;^"J\[O/2!$>6Z  V4A@"D &X'  !$
M'D!E=-"++* '8) ! V#0+'!9 "L#!=  &_[@ !F@!Q6\$0JKG]'VG@90!E"@
M  $ L@_P!DUP>Q=@ 0J0!@:ZP@DJ 14P  ; #2YP81F- >XZ  ^@ !N0!F>P
M 02   0@ Y?E!F10 080 0>@ G3 G0_@ 0?0 D(KHTG\ !Q0U60P "/ +#Q*
M%D.0  A0 !+0!85G !#PU!%E<)%  8<1QW#JG&5Y A@0 N9! @I@ 9:G ;1!
M!,4ZO8F0F#:5!!# AAXP38&H BQ@<D+@R' Z9I"\ 2-XJTHPO6.* 6\P 70)
M#!-  B;P (=QV:X\ A?P!A^  2DP 62A!!!P G>!<V4P 2&PB%FP!A)0 BB@
M @\P!B1 %GC(V/X2D 1&(*H2P&<Z( $H, %PX0004 *IK5YBT@(1 !*%P<<5
M<(,3T!K0_*79'0(3D'9J0 $DL-L/L 4&K (:,(B(@(F'H 87$(86@ :X^JR]
M+ (^* 'BNJ?VP(6(P ,0D (:4!,< )O\?.!&@2-=L.!?T. >8@=?P 14,&0<
M<@9;0 9#)@=4@ 33%QX:W@1L0 9=P 9@T 4J4N(D;N+6U@5%I@3%M@7_V05*
M  9IH 5J( 9:X"-LT 5BD 9*T'L J@1I(.+MI@5&  7F8BYE[&M)PBM28 18
M@&5N  5(SN-L,';<1N5N\ 5@<.5B<&S,Q@;"I@2S9EQR\.11GA!:J_X&.+<&
MW[4&.MAQ27"3BK &.G/G@YT$7O F:D >:Z $4\ >=B %&Z$&96 'J)'/>] &
MZK4&Y37H-*=T96 (.9=968>D1V <?$SI7I" 21"]:S#GC& '4: $B?X$OQ &
M25X/A-YQARYQ;(X(89 $FO[GL[$(<*!TCFX:3W#K'?=PO1Z_KB&HY34&9$LG
MG6L'P=[>K=2Y5J $Y64/F?4.\V7L5F /NX[@VCX4#H5EWI[4_PE8+%5E(N)L
M;)PDNA(BA(5EH34'H45KSK(BVE)EEM4LSL)M4MX&W&8NX](B=?7N+C('>*!A
MJ+#%2*H+2F)"_-=N[,9M],[PEG59[ YD)OXE[JC@; B*$$NZ[5_"\1[/SV45
M2*N 4EW"6LB5)&JDXZNU"C[B8:QU(TS""@7W)#B2(RRO1A"B6E?"(T_B48W$
M6D ?]#A"(4E1:?[07I(0**>$#T;O"4V_]!\?]9"Q(U'Q"OU'4PY5];@05PMU
M\K9 4UR?9:X041,R8@6Q!D2EYE*_]FS_\0%B"U;U]A+B"98"*ABR6&O27L1T
M]((2*'N?'L\9^/,$^&U?^)4@][.04HC_]I?!"7]?'F'E78Z 'L+N+UL'">;B
M'F"0[/J<'FYN^('WS@2Q^*1?^E>E"4\@#X$Q7EMP =EK ; _%V @ @W  !Q@
MF(J@!!.Q2GM@!/X/(!-6, &_.$OS) 5\IFF:/BGH\086,)KV8 02L+N\[_>(
M,!J"OYCBR@A&T(*>D7,E$ *!C A;(*YE@ )21QL\@):.< 48, $2P %S\08=
M,!?V  2%D046D &NGXJO8I6+D 2 (%*RM5>FP\/3\Y.UU]A#V-CXYO+!8Q<9
M=A*2%+F7&7+4*7E1MK<F(C$Q\=3(4H$!6V&UE\<S43&!<MD90IC7^0M,"QPL
M2EL\_*OFL3O<B"PL6CP=_1R9)&(-C?P;#&U=#6[<'4G>R>.SURPNO2=54NYL
M+-[3H]T>#ZV6\98,O:;D5PDI\MCA\[;'"@EB>Y)\F >Q$9N)%"M:O/Z(,:/&
MC1P[>OP(,J3(D1/[12PX[,@ !"8X *B04$ ##!9JOBFC@("($SF=B*K@\UL$
MGWM&K$ Y;D^(%NJ<P#DI2@V#"$\;;2!P!6J['ASFY2F3"R4/"4Z ()AUA0$0
M)P]XJ"M#X<2>,1!\6/&0[0V$,?.R' #R9LV)!GG>+ @S;,6&/4\89+ERQ<J:
M2':L(. 4K$>$)V;#K&'1PD4+ T2- %CBS$X%$U,\=&C$A4$/)Q%T- (C^TGM
M>"X6VI% 8LT;(P5F85 1QDH6*_U*0-CR9HP&#*(D$-2*'7N9!NNR>]<ZYOKW
M\>0A_C*A@KP2F.-_G4"!U+N=)=\Z28'0J/Z"DO+"G%! 6H%XV)%$8($&'HA@
M@B2Y09X=$"#@12,J$&#%& + TXD( !C1B!4'3%!,%@_L(H0(+O1#Q ,GA)$%
M!1[X](8.(@@1S!@JB,")%19LX),3=B0!1B-21,$8"2=$&$D9&V P1(>P$&2'
M#R2T,%D64CSA@CHZA-##)4"0X(0'0!0SQ08*V"8- U,T@D(V&KBUQQ8,Y&'%
M!@MDJ4)ZZDC B >V09,!"\Z(D$4>#_#U2PL>[!&%!! %@8$"K/QBQP-!NL-(
M)"L((:0&&^PW3 \:1 *!3QQDN0<8"TS6 :JXF=2(!*CIP%XCZ.RA 1"B7(&
M&IT\T&0P%C@AX_XL>\1(0I=:DJ!#'(V4L0()G'0"+0E-TB($"2R44H8$3WFA
M@K2-)#%&"U9(8>P:1$0"AA-*?!"%8"=,QE@))LS21+I&!%,&D>@&\0&'XXZ
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M"P!!<[8QP0;4(*I"0" /:6! $C2'FEN8H/X,C[-55WZ1! +X($4O"L%BDO"
M+40! G80 N3V<,)A&.$_)UB $9*0 )_02@I 2, :G&  +NT!!"O2Q![,T  C
MC,$"G!#B()D2NR=$07:=L  +U% "N:! >"<8U3!: "PE*& _'S@!&%00 FLX
MH0%*& ($NB(%"BXR"V%@0#]ZX($\4, '8." ;5"0'AY4( I#<  C+# !(QA!
M 5%PD!.L<+]AK$$!=I " 700!0O(A5(L@ "-.( !)0!! :40!!A6L,)$,4!:
M=IB "^X2RB? Q H4E$(%6+'&[\QMGO2LISTGLH:ZM<,( 0C NCKQ! #(110>
M8H "%#  ']A! ?X5N,0O2!" 6?S"!:\)0P-,,H%0R*(1S'+>&=>  #N40%"I
MTE4);/.;,H0A IX 40;W@((1*+-V$D",!, P@2KLX0J7<(*CA/"?/1CA;'9P
MBQ!>!H2'%"-/$7D#"2;PAC<T@"_YF18+X&,%!L2K!P9H$A!@DL;;*2!]&WL
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M0ZKE*$ION@<*> $(\'G ?$7@VV&H88DFZ/Z!%!;S@#4Y@0,D* %,@!#*/;3
M-WGX!:(;\0.^66,%US.&7EEP"?<M=A6M2(&08"&$#W#*!]2Q ZSL .!&[T$)
M7$ U8A*UJ"<X*B)T_845[-@('R0:"$J6P07 H",:1F(#/U#''DIPE# . RA[
M\.6R]_,+W$R& TQI<Q;VLP%=D8/4("3!0H)1@4P983$N,X$'0KF&$$Q  D50
M"@:\+ (1P.J'$;# +*2 EQ-,8+9DS,.+56 !MU! HL?F 5@Z<827:6 _7'#4
M&DC@ 15\[Z1PL<81FE<"&32B!#Q0PW=5G?!&#.$!)@ !Q&?Q[PO89@L;D,!&
M711O$.BI$>,NP?X'%N74=5?L%RA@"N]FXX 2@$ $'A#/<QOAA%%5H ,QAP\/
M3N!<WE4 S7C.PPI:\ 8'O.$7(=X#!HH6!9@XH0(2X("O?M$&W#[A;$LXFZTI
M< D,$.4"5A@EU3M D%]8CZ/5]GH4:KR'"Q Z!"&0BQ/PXQTA*W[QC*_(2<90
M"F-8@ "@ @$ GF A*/<#!0! TQ(&X':A3B!.W]V#&OIA[XW;ABN1X$L(X!2&
M=)# +>4D1 O&MJ8'\-57MY- 95#;;@AD :2$T)SC$AV$EQ5U#T&0]*,[P0*%
MB8((%> ]<I\UY5:D9SG/.#H*%B*,$*Q0':390P,0<XD6/"1V)_F4,OXA0*]0
M-T(#%0O""$1  @E8(%A[D(&#,:A@."85'22 #&!?DL  A$ $#- ,&K 0!98D
M!Z Q(,4*D?!.MD("5K  _> 0"?$+68  ;\!4M!!YQP()02 !&F9Z(+)G>\ "
M+Z,"MD$!>9<0'M "?_(+(5=EG  &CG(!J*(!!'$7-VAQU84J)X W#<![1K %
M3V!)2U K?-$"S>."MF$L1.  C#4MLQ4)=N4K3_ :V;,'7*  C:,")'4"/,!.
M2=(,%@ J0C JC?46J<(!/M!9&#(7(L,4#1!Y0+ 8%3 M+K,&EW("*+0';N![
M47 V3D"%'7)&&H :7C<%5S!KA= ,>Z=HV?[0"):B(UYW+7; %T!@2=G1>*5H
MBO6D3]]Q!0H0 !;P  #P$%40  >  +5X *TV 0 P 1@P  J0*;>CA'O@ <&A
M!'P(0=<! DRA%SZP!K22$ WP!+@##R6@ 7S1 (2 &QSP"SU  6#0<)%E>MF'
M =_% ,R1 %:@!B<0@GZ8-!+0 V_  H[2 R_#>N0@,SOE<WL0!P9P DG@ SV0
M%4ZP $T !A50:2>P$!Z2!#GT,I E5.-C"@\ +T_@(L>" *\F,J/B! QP$A4@
M,!+" 30& 1M6AI('CL?R #I0!B=0 ;\@!0N@!& @34("DV%P 0/%/Q7S 1(@
M/R0@CMF6"#I "/YF43I&T  XV0@0@ %;D 4+, 5950:UM&\5@ )O( 6(TTI)
M\'"AI P), 1P0&IOP !.\!D'  9J &$O9I4/L! 24#2-$ (/@ :=8 3LX9%Q
MPI$:T )V0 0'P%YQ68)[< 3_$0(\0P(WU ']@@!,$U1Y8 %4$@3XH0/\, 4/
M4 )OD !!8 =!,'I'('R#Y!8NJ5UAX %D]&YO8 4.@"C'!A_'EAX5P )K( 02
MD#B.$P') 0&0 T85DCM^I0"S, :!)!B+80*=M0%E( 4-0"0:$&Y@0$I^,052
M WZFL !VP'ZK%E2-D 6;M > Z#H*I@+J@CC#@ +YY7%#(!BCT@2.LOX$NE<&
M>KD'>99XITB?]9D@J?@=8[ "&; !RC(&)H ")R"@4W0L/# =*D!5G0 "Z0"/
M&P "QN("5"4$1#$&)"!"O"<%'[ !73,&'] DC]0*_A,$', !'WDL6-<0VL8"
MB*$$J)4%.G $5F!9<U$"&U "OA(%EI6CHG $'!(&\-<(:2 S)N<!H.($&_ F
MQ="C'>(!&E"58[AO#8$FD; &*H !'A1EX7D-R257\\ #OVA:'4 4(@@KP:"&
MH@ Z&& "5/8$2(HW*[,!&?"F=/DR>>"'&4"@CA-O^%=T0N(!&, !H2 */* $
M7M1NCA-Q8) "4O &)4"B%6@%&HIIG; \'/X0 HCQ!,,HHT!@!RQ00"S 0%L0
M'#QP*7KW,I%@!7!RIA(S%R.P"4]P HERJAWB%D, *F^D#CS  1[ "JE*I2TA
M NC' I7 !22@!ESP 99Z*4?  =DF"D*0J"KP!'9P B2*-$(U+;B:CAL0 HO5
M"*)8 D> 8TG0 1Q0;(WP!*T9)UZD OU@!*&P,!O JU;1 R908"VZ 5!'&9XZ
M.8TP-*(@([4 "5]J"H78K18'CF 0 AS0KF.()DK0K/;@7(&I%?9IL1<K$OC)
M'QM[&__'L1\+LORA!OD8LJU0,26+LBE[$A\ IBKKLAMKE1!0@>6QEC/[LC>+
MLQ]+ 9&8LRX+!/XD.R 8*[1#BQ%$]AT(D0_RT&-4:@Y:T;1>D13QP#8100U1
M.[4;LP[D4+4G80YKL+56Z[)+Z[3AD!UP8!*J%@U/*[9+B[3"T&-MNPU)VPAA
M@ $XUAZ_0+=VFQUMZ[92RS9KZPQB:Q!6&[=^>[7.T ($!+:'R[A7^[3SL ;=
M4;%$2[E$J[$]B[F9J[F;R[F=Z[F?"[JA*[JC2[K&4+FGB[&7N[=QR[=^JVJ_
MX%_W +7<(+6QJ[8%41_F4+CBH+6SVPZ[R[OX<!"N2[S:\ W'*[73P VT^[O#
M2[;>\;6EN[<@B[;2:[TX^[;7.[FHR[WTJ;W?"[[AV[F"*[[E:[[GB_Z^*-N]
MZUN*JNNT5B $1F [;. $4? $3>,$8Z &21!Y^QLD=0<[4> $02+ L,.HG? &
M36._L),'^YLN^L,H]1L% LQ[=N $0J"5<[N0SX($:D &^ L[9+D%26 '94 N
M71@%;:# $_P$<X"F0S $^V/!&&Q]6; $4A ,6= $!%$&3> $)C$&3N C2D->
M"XR_DM$T]PL%3A &:E!"+$P09K $+/P$8]84^2L)0EP*4K#"3J &%KP$MO,&
M3] $6XR_4<![6Y#$]TL(7!S 5&;!0"!(QF '*N#"=!S#C: $_N,=![RW3@ )
MDI $1JL59; _TB"YSP &9&5ZM04,S: &Y/[5"$$ *A !$,UPP$] OD)"91Q+
MOM^P!5CVLEL &/-@!6R0OGO OJNL>.Y[$F_@ 0$P  %  %DR!  P  5@  /0
M>;=L64<  $>Q ;+<3P  #PM   0PRPPP758@  0  /T4 &/P!@I0 (Q0 @#
M*0PPR[@, $VR!;G(RPU $"VP(=_ZS2N RP9@  (  $Z0S6% !0"0:&,0 !N0
M!;D<S0$  -[J @1 S";P"UZ0BP!]&8WP 0%@ (3@( &P7$ 0S143 K)<!F,
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M 0)==2XH5BD04"% 8 "UD@4%P#E1,"27H 0!4 )9$  /X2 /4,57,AD20 !
MH 9&(  0U@.@W0A"\,UJX 3#- %<; <D, "$  $7Q7P;4@9)9@6Z7?Y,:@0
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M!"(=GP]0 8OA C.!'T&  !PP)U.  !Y@ &8P!@3 -WQ=R59Q )%WR\56#$0
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MM 4!=8FWP0 3OZ2#%0!8OL?=MX;PE00?,/Z0!0=A G"%"!A<[4.:931SB P
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M0]0X,DD,G&0D3J#C$(P@!2!Z[9.@_)K91DG*4IKRE&Q 6RA5 ( /6*$)$A!
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MV#&71R9Y""G 9 ]&@@L4W.  I>1!!YX-I?YZS8/*]KKWO?!%SQJ^MY_QJ*T
M%YD(62IP  ;]X)8Q 8!P/$   PR   "0# ,F^X8%?'</QD3  "8, # \ 0 <
M<!6&(7<  @R@ ([SC@<&<)&4&<(%!Q!  !#@HSV8X0 D"T$ WL(=\1E"'PCP
M,(+C9P@C,. B!OBC&3B@X@!(8&(A,( =FB#@P_3."FLP@$=8   U!> QS $
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MD%*\Q5>$D #$M00P,0$M, ;&@0L/, ),<!A0$0+0-#-!8 46\ Y&,/Y /M
M,7>8:T  )_ $'& 3%:$#3R !MR(!,#<&WE6!)$<"'# &.G +1& !8* #7;44
M*+ %(@!'??NW@5L)'H *#^ 4+3!5AS $-N$!MP(!CJMH;T !0& %<9$*4P!4
M>\  @"$%P  "^A.,49 &#)"V'N NL^, +6 '+  !#YH 3J(#U-H#&$ :9L
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M ),=)VPQ*7-C?/"#EMA\J"NE;Q#!G1#,V='"!AQDEU@*'O"010AF)8%")%;
MB()*07"GY;79FJ5&$/+T8H<+TBYAWK<;J* 2'"OT!\D3'9 010\]:+G'%2%!
MTD.7HD1A@J(E;!""FWF4,.:+)$CA@P]@#/Z\QQ"K)5&E%1]PX &PD:RQ\ ?
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M:P<M0"T=^J>BC&VL?"Y*MZ1L  3 X@'-U" S)W  K=AX PHX0-F5Z( (&MC
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M!1-XPA(PP.8]:  ()[  )DZQ9]<8&@-&) '(=B**+,BO!T@CE9/=Q?X!7>O
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M2T!P82/U$$8@.4XD I0(+$3" X[A ^'@ )(B!(O8B/!" AN@ R<0#A^0C"B
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M ?NP^;3/(W#PCNFN!D.@^7"O! AJLE*R465@!&V@&?A5&Y6?!V;PN-:T$5N
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MX4.+"<M$\,@]086'V"I\ESE0"4C)<SHP( 2R!P3-%A][H%Q2_@,+Z'M,<+
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M( P<2!P*'[ &("SGA;OX7]ZXL0$.!$<$%#!#!(X!A)=M8@C_ 5TB?#"U391
M!JQQDR+<=!T5G$ $T/H $= 0 5CE01R&T,"/4*A"$1 !# Q8@0E8 (&)?4 "
M'I!,).P@ 36H0 @E> /9PA"L,KSE4" P!!"F9H@)&,I8)0G#Y"RP'"<\  ,J
M:!^@3D "(1F"!P_80 ]ZUP,4>,!-?)32"4K0 $' 9WE!*,,"U,C&Z80  G$,
M11C<M D1  $%&%@!)9-& B#L)2Y#B(T$RO[  B&0:@)PV000(- "$ZB  96
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M!81 Z3(0QYKJJ\ F>FG5N$0TA7!!)UP4$00&L$,"AA+I(1S0 S5( 1)6>)B
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M!2M';U'P %(PA#3A 0RQ! B7!<'2JB;A 7 P!A3@4 LP FJ0<W.0,S[PFT!
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M&=S$/<'B;R@QQAY9\)P$6':,D3?.HN.W\P$D@'7" 0A8L<<0%!< @1':Z+!
M"$$PT*_L>KC 0  "/,##'F5<($&V=O#P  $&3$#$[ R$  3N#!1Q+@L,#$"
M PWO\0$#++B 0 (29*'-$ Z,[,($:G.S!0<($*! "(>#<  ##1Q0A0X#2-!#
M _W>5#07+,P &&"=&B;P "&DCGQ[6((!%- ""3Q0!7KHA@0(4( '-&\//%#
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M 0M4@ ,>* $7DN<"M31!I:4$P@ > $(%$/[8P!_8P!BR*SDB/S6=#U"R!3S
M@;6)@  4(-4(V.L%:3)T#V H@03L& "OXG?/XBE=$9^6RAYH8PU@L!>90?77
M SCA"4-@71G.J('$ L%7!]A@"Q[XAGE2UK**UD861E8S.TS@QJ#EP.R$W('E
M@2H*TEP;QM1)*C4\H  ^!0$];4O:W Y."EQ0:<G* (8RF,$!!(BRH@1W@. !
M-,87?.C6"IU4(>]A"DZ5PA $  &BC8$+AUNS5O? U0M\U0"R$]42[/ &\"7
M7FCEL[N=16>>G4XL>]@6 WJ0! H P*LJ@!VB1V:%9#Y "F7P0 ! H(9 0W1_
M1_ ! P10@GK[>_X/1.[T5Q$ S1,$+,H8D*5H/08'( A  1N0 0T/T%%3$N
M)WA"$Q% OC4_@ -?SJ"W*MX$B I  MYH  !8 "T#_!,L@KN?"DK @ )XH*#<
MXD$2+*"QI&9PNP>UPP)\K 06L*MFWMXJ/?>@K 5,P =%   !@/ &'5CR;>]N
MNW6V0(#RZL0.)-BBV3&0.1, @ &@BFH GF 'T (  +X, QJ6%>4Q:$#" #!
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M GG  AQ@ A" N$L0 2" S-E"RJ;L4]L0!LW\RH*F+A_@ 7,S!A7P "10-59
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M3   1@ % , #=! "!I &02!%)Q &0P  2) & V "8"  )* '\EP&5,!B7P
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M!#>D!!F@#1(0.6<.=A.0!]Z@#1/ .A 0/': NQ UV>%R )DC0WG@! 7 .F#
M )D#+6'P! ;@[ H0["9.<0V@<J7T!A)P."3  S9E[0WP*0<@L5?@ %4CN[.#
M4D^@9]L0!3 S!@U@[6RN :%F MYB!+JNV&"A,-3GUG:00PX+[I8LM@;0.3J
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M@R>*"P5.PDC8H\$WP >1*NWI(6*;G0HEIE@1Y$-[CQ%['(S; Z02)RD3MO$
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M!!L]Y-%$1$&@A@4]6+&$%1M=\ 1+V]KA! L*6*'@"LLT,@4^%EC!#% ,Y?&
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M0@>"B$+Y@O$&!B0'.%:P@P/@!0&K*-! =63*5O8EPO+!["FP$ (1I> NJUC
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MF$,@#T_@ %,0!4I$ BTP!NW#/CY9 ?R ('"F 0;" [XPHSD%"290 ?YF 2T
M!B@ 7#X*FF&  #*P!6(E!!@ !O"1F3'4 T= !$-@<@.A W7T('>C!B= (ESP
M $6P!16 $0H@10NP!E;P*VL !NUC 4*2%V^@ B.@!F!Z"IQ0E5['"6DC!5(
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M#48X%<93;FL@02G@@R6T;&%["20R 7+E"Y:  ; C!% R"RXT!D]Q 5B3'PR
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M8\ "W!,&#5 $8< !H.X1&P &1-  ,^$ \Z#V"0P"JO0*[/$*>G66[<X)2I
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M"9+@ ;U$P@DB*,&)UX  "=*$OD[0O34JH,)H(R.6U3C""$H@03T8P0HF2,Q
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M$M "4R ""% WD$@!9;"1<[ '$;!_GV0(12 !3V"*3I ')4 !3K!((" %.M
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M$66 @-9 )-!2<TK0F\TC 1H@!2/P #S@!(>U!_>9GP[ GPFP# J0B0V@#U>
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M ()QC"MT!6*B3AT@!(W'LV!P5S3! $\@L Y'M)'  07Q49/2 :2Q!+'D!!D
M=Y/!$8;AI6MP $+90!MP%D=J"[VQ ;A1%7E  K4X6\\0KWO0!KNPG6&0L&[R
MI\@W3M3) $]Q*1&I-";+ R4 =]HE @P8259E.0^QD=<@G;5@-UFP %_"!:/
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M- 2X9ETS80ARL  EP ,NH ,7 @;-("91L*I&4 8AT)JX=J0SD0$D$/X&*T
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M4Q^%E44+3@&QP1XDZ$!1"[AP <%T.U[X5/X^;Z3P20DR.(G/$4-:N15?19T
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MH+E&6 :]*[BC-[B^"PIAD 0H8(1V( 0Z$ 91,!V9&P8>AP<9][D#8V^AFPI
MH (#A@])H )%H ><X 3@^[=)X04^8 =/AVP#,P4KT(B84 8WB )$\"I#( -@
M4 :\E[W7=@CLZ[Z8$$8L #'=AZ9VD 1>  9$LP8]T -K8 7(5#]8%9?0LL -
M_#&C:P>CJP8NX +,^V]*H"Y*L 9@<*=90")/T!]18!U@T*9A@ L(J?X#6Z &
M0X#!BT(&J."(AZ &DZ,&.J"VB* $0#,=SP@MDR,%09 '4O"XTUD&/<QFDK#
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M 1@@"AI +1. "URJ J=SJBAE C;6-2=C?"?J!9UREBS@ Q/ "R@SD"V@Q\J
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M)6'1@,,&="1")>CDC$US0,/X0P(A"N$ I;$ S)#'@#S,(2OKD,86%#")/'"
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MI1J  ;&P!8SE!-=6/&60?DPQ"3QP;?G2 NL$H5XQ!.V! J$"I_@""ESZ 1,
M9"C  1P@$VJP(#ZI ;SQHD"  A2PBM$P!A] =MSB XEJ'$  !,LC4$\0 1,
M!&K0 DE0 6] !$W@2$#@<I]0!@C%!>-B*AU0!EF@"6_P=AOP9CHP!"%  7VA
M0APPBE+0 W%E!R=P;?8!JD1 IO(0!<&J)\3* 04&!%;#%F,  AL0 JXA!8S'
M;@BH 0]@ N?P!BWP 4B!B/82%*+B %X2!:JQ!.VR!&@0%5'@+1Q@A8<0!-H3
M(E*P<)IG!A40K?X6$ M64 QEP P=<'T:\ ,D4 '=\090N@&Q8 <LP $;,$A2
M,+$I8(!J$ (=8+"@P -+%!QK  %M($ >T %MJ@-IJ@1'("4.<YD9ZHL<*K/9
MEYH\N  ?H 9G%0L,8*MYX *FMC9&L 4.4"Q P%5>-09C,!A>,P'](@+%< ('
M9P6+8J!)UJ,6D+0,D"0;D!:?EC@G, (&V@+)P0(LL!Y.4!#2H 1I>ZH^^4&A
MH />\@87L+/TJ0((\ 28%5T"X )O< 1;,@8%(04-D 5V8 +>$@\.DUMQM2Q)
MX@#0DS@C0#=K8"WQX0'Z9)A060\($)GN8 5T=1 ^:0$MA '%,#EA8/X&#?!P
M;Q !0Y '/F ;^AE,Q4 "$("ZJCLM(_!$!D "20(",I C&U &!Q$%)14*3S 1
MZR</ #(M]+D%&D8*(84 S\4AQ@42 C0 .C )(; >%A1$!.!<2S"]3I"]V]N]
M3=LRDY(!L4 !,G$$4:$$!/ $5.44X08&U@,M(/02H> $%[0%^D!N_85!*O,0
M*\ #0M #>5!)T2 ((4@+"8*ST: E/# JJI$$*N(!(>(2_A)E9?  #2$" D40
M>R $41$&%/!$R/(I(F0B(Y0Q1J!2=C (H_!_&C$M:5$!L50/JF$,L@FSO#BS
M01QH-?N!,^0I3D%:&>$E/.8YNO(&8# 1'/ZP04\@%AZ@ F/ !4$@'1# .2WP
M7FOR8^N000.<!@PP$&,@ ;>U'&<8"F.K V6['DD0G]'@!&(1"B2P 4Y@A1!
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MLKQ4<@H,BQ7Y &:5DG51GHI"["RRRH++(J[@0MH!\L1.*7#YG(31H2)KF19
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MT( P&V "%CP >%N80 M*H($N3:$!7<J#-/>@ @SHP +/ P(F/("!$Z#@ :X
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M4V0%9BMG"IKU"F8Y%J$D 4M@!F" !AR1 I8(!BK9=]FI!"GQ+K&8&GGT"F,
M=WOP 48$05Q0!A5C!,"(<Q"@!.AI!AQ1&X\!=S!):Q(0!7G  JX@C1,0!D1P
M?(*UF1]@E_DY!Q.0!&K !0@:'>68!8\H%F4@"1-P!"%:!G  !@FW"*WP"D.
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M\ 19P'Q1X%1$Y0&'# M69EP<@ $A,07#7 %T%P3#K,Z,@&E#10(KH/X'MBO
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ML'#""CM@,N<>(XBFPD(C5+!7*K;]"6B@@@Y*:*"^'8IHHHHN.@QPNJBP%"M
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M>S3Q !%",&#.!OXB1.$!1ELX0.U!&700A0R0<.W"$A/XMX%8#.0UP0E.A#!
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MT, 8\A"2/:SA"$H@KAW,L 8C?$,*3:Z4$HC JC&HJBZLL$,:X' $SMHA,%*
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M8B%!"#XO5L5S@-R>L+WD)_"-KZU@ QC)PP<\P ()>(((%>A B=2&@A T  S
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M R5B76EBE)0P)?X?<!S]9&.8 !:6B23=$9',$072(A+5DA4?  1<LUXV!A-
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M1CJQU ? [.%!$-U]4H$X=KSQQA86#($-!$F"DN::%@#C@0^8>) $(9B\X0!
MGU@0R59"]8 )F'M@6080$A2X6CT$0B#.'EN ,<92<[))9@2'!"5$:WO0M081
MJ[UAAQI1/!!&&1!< P8$I#7%6 ="X2G!I!*4H8)DE#YWD*EF! %K$: .L1H$
M4V"BPZ.83 "&&A X$@:L)6Q@A:GUP+*'"]5)<,D>;\"QAA22[D%!5A*$@0*O
M;Q0T@1!FK+$"??Y!O>;('AL8\80$:EB:0!@J(+8'"3S8P8 58;2!@3L8@#:&
M!'F\(4$:Z4"PA!I!X:CQQAQW[/''"P$I\L@DEVRR1O=&9,<$^-6S6@2]K/%
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M<<M)<  !!RF#[/[[\,<O_R<GUV___?AO)*1$0F=E@@KNZ<7O"L(8^ECA R<
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M!Z_X >EG)4*A 2A0 210 B)04]NS&Q)I A4I#A#P8PQP 5,0!0XP 8923BU
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MP-2A(@'&+0*E]0EJZ0A@H # X#E^9AL=@,QDG,H;0-Z.X$CY45H2 !I[, (
M=-#H$ :P, 0LE 2TYY?:K&' [)>78 <BT+?E6P*C"1M(D!?-H:Q#L/X8S8$6
M4 ,WMH,4W:&?BR48Q!4YK3&1F" "B1L&.[0'1;  L?()BH4))$ /GB(K8>
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M @Y(("K1 0@<@@JV$MZ"##D(87WW-!AAA>L5B&&&&FIRH(64E#&?AR)>DH=
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M[& MRU5 "BV0*%7>,($5#&$#K3R!G8 P 2.T0 (%P0 &?, #!B"4!1:P @L
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M<X\RU8#0J> $>4! Z @,5I9E8 ]N[5-V]R #C#U!T9*X<YI=E6I)L& $>ZC
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M 1; 0I:S 1L0)9/#<2H0*%]":R5P A=@ BS& :%$!#2B*BIH C*A6$EB!RB
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?+,_S3,_U;,_WC,_YK,_[S,_][,__#- !+=#^' @ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>comp_0012.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0012.gif
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M]/'W^_____;X^@
M
M
M
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M*B  =[ *I/  !; $":@*41  %B  :[ & 1 !'E  "$ (+ND ,U  (& *(I
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M( F%@*F:N@J&D  ,  $.  $$H 2QL*BI:J('>+*RH ($$/ZJM5D!"5 *K+
M'N *&%";&:@(+^FG+9N.!U *21  :] +;% !6I@ DA +A  'JC #!# (Z5@
M^RD U[JE=?@&!@ "*5H*"5"SLSH(/%>$5Z@_8SF,<HJ6W:<5=)&G^N.OX/-A
MKF " / &LM & N !.N   # (KAD&@4@*)S  #I !!E (+LD ,<  #* (I+
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MOF00 63@ A*P"[Z@ 39@!A)0!\"PX5S@X9ZP"1)  70 "@N W&X #+[@ )Y
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M%FT##T !T<X'"^ "]DL!K-SO0I')\/NN.,_GJ9X+7&"_#/ )H! !"SSROK#
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M[!8-<@3F%D S@*N]AWQ*:[B,+,)(S9R"&6$3A-#0  4Y;&C"%U!AU.2&3&#
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M5",!?W6 B141$#!&\8!H @,%JJEFJ5PERX0$(YMLR^8NHCF!0:+EFY[ACG-
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MP,0%-C$"7_!!@PC1@P,0DX,-  ,3#]#$<&#P@+F(0$LC@ LF;ND'PH@ $[Z
M $ORL)>$< !!=2"!?S,@&1' )0(L^0V0,NR"!-3A> M C!O$ZXD [960]0E;
M(W7BB?X'! ,3)$T/ 1"$!@;\A0"#=,$(@.& 0<)D+A<8Y!A",!G5QFNSP(A
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M8X*1,G .0AL##O@X46F!,8@ ! $W 5DJ!_B]!<@1WB.#%UB .O $!<"!,9
MW4 !5.& +=LV"C"#%^"_""@#+M" #? %!] $4&@ +_B"$F"T%NBG\7 ,A*"D
M%N0K-?$KGT !)VF5!;# %@.W'S2S\3 SAON"%C@ 4!@%!^B"840Q&"@22TH
MD"@4A(B ')$!J.F #!L,&^B"4X0R4HD OV@!!M"$/,A&.?X  %*A 0HH Q&0
MMP@)N3.LD!$!-*NH*)4#E^QC( TA+A%IKMC9&3DL@QJQ)#D0@UH A3SPA7+2
M@R_8A%V@@UQX,(58#K_A-%DA(9V (\31! &I!2[0G([(Q=T:25?9!%# @QS8
M+5L@@S+P!4T B5$ @R8@*R/) 1M9B#S8@3$0$#[X@DSP!3JXA4QH(4_X CL(
MACP(.@U*"SDPN%N0 .E[%79JQIH*()_@@[P;.D\(!CZPI(/9K5H8I&"@@R\
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M5?AG5PB#!6" "'@#5Z@!"W  %9 $53"!&5 "#U"%13 !!DB!%% !HI@!!["
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ML=P10!2WK1&+) F8D$8 :;"B"@8.2%)!!*:4P@IM8<@2A@!K](+$=&S4MFX
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M@@3DT 0*B, 7#G@: T#A"088B?X!9%, W1;0PPC<H PN4  FR-"!EJ'  3L
M P/8R%0SN" !?" # \C !3<"B@-FX #8(C*"#+@!!AL !@I"((<;.  'P%C
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M+O:QDSUR73\[VM-^=G5S_2T.^_YZ6&I! PUH@ 8,C8@GM#S0?_^[*G9 00L
M/P(VXKOP+4/X+>3D"QN,HN"'MTHMM*:!)D18X4Y'N >[P$9;\%<DF(>ZX_GN
M>*/58@=Y'/W3LX+B'=3!@;XH0Q<&RPDNQ"P87:P**"ZX;TXT'A@$'D-4:F@&
M+@S6$USHHNWUG:,6H/#SH$>Z V^!@PB;0==]![W"'_]YXCL_^V5W.<5QKO;Q
MSY?\.&^[/N&>^JJ\@@$MV/$*@CK$!G$AI4BW"@PD0 <RF&$,,5/+63E)#EQ0
M5[1?"R#9!4Q5TYF(35F1@*S,Y Q5Y:5%!XC &'" $MF"!+0 KM&![UV &5P
MDZ%!\_[9! Q@C<KYPEX!0QTPP Z\  /(B08&"@,HQ"> H @" QK,D59X1 XL
M%*0\12X,"@J0C*1$@,;<W_>]7+69G\F1W]8]#/K]G/CM7'Z(A4=\ $U]Q <
M R8\0!<$ QC P"=P@0X1U!>8 <N4"1T$A4?8 !5QF!\<Q2UD@D>  HZ-F"9T
M 1D1E(A<V=E< "8$ RC8'BX(B.*9@959A0BL@$WD@@2D3(GM00U=F!?(!!V(
M@<74 BCL82WXPAC(@4?4PBT$(B:@V ,TQ4EU0>N1F!E"WB=X(BC208 4&1FP
MS";80AEX8"9P7U'8@AB(HBOJ$"=BF2\HXO]5!1^L$(C(2?X+T-0>+  PB %%
MP,! =<#=?9 (D, &[0$7)-B@\,T L-$"N$%$O  * (,+* D?2.,8_(P,_ D'
M!)]5>$(7H,%1V P*B,B+F4$75)@G0 GWB9 M?$&72=@&C<(&94(7'"0HA-"@
MN, 7=,+QV40O'J2$C0'PV00?<$&,584>:)Y-[((B=M$%V%0PV,$W1L0GV((F
M\($M5-A)C=@20EQ]5.%B02'$3"%/ZF3%?1S;S<=6V,&3Y<@"/(V1), M8-4'
M>((9-  .[$ "0(@?2, 7W( &Y$(P1( (: #-V$ ))!X@TA%%R)$71L!5:H#%
MC($$@,$(4,4.I",PO, -W,(&0/X %^P" XS""\R160'#!=  &-S(H.3" C1(
M@/C"4;A !XS!!I3$)A@ 74; "MQ 5P(#&21 #K1 TC1!!&!-8^8"!SS &<F
M^]F"'%! &92 7+Y 3&E E@Q*&2!5"U1 "WAFDVB"!'1!#E  0T7 !W !!8S
M"6942 4*Q40$#%C$!@A*&3C !U#$",B &=2@3U3%Q.3!+<A!!QS% Q2-1SQ
M)^@$H-"!1M);55+ 0,G !ES@%OJ$+W2 !YK!W8%E30V*T]0!1Z" >2K.5<@!
M6KJ 4831!/S)BT5 #I@!8;Y !.R #22 )]B" ;2 %U  1(R! NX 1'"!_JU
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M5LJ)D,A!E70 ![Q "Y" 4;S8 @!)1&R"+S1!3QS%")0!"'E$2_G$RJQF1&2
M3841H60)&B@@R/H")BP .L+ 7I7! \  X,W,H(Q!E2CKZ%+ +D! "3PC!Z1C
MGLS$GXJ ',#$H)2 &;B! \@ "KB X"S-H)C! UR ##S1B)D!!1P%"-E4# [*
M%]4,&\$ 'Y0 &H!!.@8(#=  ,"31QJR 2]D$O@J(0BG>3]F$T=Y"'@2#^*Y
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M<L@7#3ZA"%:&S+@!F!'<  83"+C@A(.&()((#84G(B,"@"VR"%:%'I+#AHB
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M8  SZ!\JHA  !U@  0E8!"DB4( ."" "%CP !DX@@"6(ZX8"6$ $",  "C!
M !APQ2 .4 $3"( )LD@# #R@5R3$H@(-2,("',"*, #@#+V8 0 (<08 1$
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M @[J%E!  AY JAZR(B3*'U'@"YCN6#"! 7AQ!41@#[;1%P["%VR@ VX@ \0
MT\J)Z;;KF^QO(#"ASBJB=TQR#/[R /C0('WJX $]H01&X 84T!8:4 [L#QA^
M;_@6\ %V02.GS 4F;Q0FS1<.Z@/)TE"BK0 *018\@MN4P!4DX0X*@1 (( ;$
MQ15F0*MB 0,2@!1Z 0D   Z<, U@(@4*P!!4(=-BX0X$( G>  !JH!?LBA
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MJE(.0@ 8)F !(6 K06'*RN !ZT#ZRC)2S3)-5@$# D"-QO[%1C*@ &;  Q
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M !3H( $VMW.YH.W,X $;M4@5  ^ 00-RX!;*@ #0X-:L\@%K%Q@<(!.,3'M
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MAZ6[451\Q8,[K)^%.M7"^RI&=H+!QPK"%S)!DE\FPGTI(CA!U76GU"59$R8
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MH#@ S!=E +/+ [5X8E5!#/P4D?Y9I 'CBP2UR($ )HFA49XF#(QRW *V@#(
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M< ,&' I/(Y0 @):U D\L0 Q<( ,#T" '[$%$#N5I FH@\@$T0 TBP9" F>2
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M@2UDD <7Y*!/-_$$PF3 A1W4 F$:< $8P!"==79@.GM@S W MI.W?&!0G]-
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MP :&#1 D#WDT6 %FPH<!@*T$4_]>R= S H7@@@%*(0!].J>'8+PB>6\C0P*
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M9Q8YH2)H"QG!G%RC":T)"G3@!TF3&(@9F?:9![<4#'Y0!YJY"70 >+RI!Y]
MFMTY$L'0FK9P1,57$*_ FK>1G3]J!R%:F4:6GEA"HRG!!R=ZH=M2!]&9H-29
M:,=Q"_S)>P2Q"^H)%4T ;+N0!\2Y)?=9F!E:$'KPHE"QFOZ00CG!D*3ELHOT
ML2SH\:/EDFNI*:8U"@H-LBV D@-HE9=_-3]ZV:?V\Y=X26V%BFU0\H&#J:B+
MRJB)A5. -X(A&*F+.JDF:*F-^FV5BJF;RJF=JJB^A*(Y:2:>BB6:FB6F2JJI
MNJEWU*BHJJJJF@M!\ZJ*^FY3Z9*8>@O;: ,/<!UD<!M  C\7:&U+,JA PI>
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MJ130.-/KJ,Y"4I[J/O'CL<Y6K#L\L\+JPTH"0.";JB58$#B'";?G"4RS-V,
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M"%P?'? *7. F>>  ,G +95  +3 H)# ;.P ;75 7OD '%6T'+E04'> '7R
M>0 * _[B2V,P3JPT0G*A">-X' G@ GLPAMLR(-PD!WU\%!QE!W2P 'QP<#+
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MYF@1<T295Q)LDJG54@2'%B%A@(KP*6;!"WJ ;6IIAZ $6YD6!$4A@@XP-!-
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MNLB#'\R?8+B 7IDP7^$B?^L$#6BO!,H#70D?#N@ZJIDHB;D #KB )KN!$>"
M9W,!)W0],QA"H$.!P3$(+F"(3KB ,)0Z"@B_"XQ#.;R\$52\D$L\$5R\XOLV
M^M$^.4$%#?RX$N2W6\@$!&2BO@J&W/B"%9 27]@$VSF(]J(($6B-$?B82?R;
M8,B16]"$-C2(3DS$1Z2_@U 6VRJ>E)$4@\C$F" !.,L%92D! &J01Z2X@SC
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M#E\XS1W N%N038/( )@ !1S( TXKM-0TB [(@SS @;D@ 3H0)#'P FOZ HL
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MN^CA=!T58%B 9V-,>"T9Z?F,WZF%+F&<96J/"'BW+^A1(P.%$0!6,JT6Z=6
MS[ #"F"<8 (-I5"+Y0WBI2@!.,84:,F!KQ !:($!+@ 0B,!-3F"(104KH  Z
M,O"13IRQCIH4#ZDG<$0),[B:PIB.:9NF$)BW"[B7XMA7>2*(+[A+3Y@ B5!6
M3&H"B=D:CD#@>CK6M>0# V@--*"G"?YE"M;@Z=M@#$8?LU7(#8Y("_Z3M*75
M?O,%0[L!%Z&#=@6&%,:$!W"!%OZ@ (PSB#J( !K0 $#Z@ R @0]@D ]HC3$P
M@,5P$1= @20ND+H0)QJ( +I$P<<= 1NX 0BH S & [_ 9HR@@!;>#WL)@0S@
MBAW(9A2@X2R^2NEY !AH@0<0,@<8!3"F7(B@ !F8(9G8A 1H@6!(XT"*@.62
M  01@0VP@0D0BRI"@>/2 +.JA0+(F9%6%AA8@/A[@.7E:8,0 0VP 0K(6IQ$
M@3KBC@L("0L"!9\F 0Z  0> B4Y8 )A&KB^2$I;(D;K8 7\D9Q1XD544@0K1
M@Z<.R=WT"ULH  WC P=P <R\GO8@@XJ\ 8EPV@<A#SDP  .2G#(%!C=@$%^@
M(RX@@?[O* $*!&;$1LBQ511E#EO?:^QESI-26%NVY8/J&(5P2;%(M 4Y\ 0B
M;I-:H(.:TC]-8%(-^9)Y$4G2L9W/-@A/D(/HX0.EG C+UA!0\ 5.S!'.W@1?
M<$8-T;\\$!5-(!U6N07;L074E@-(XXI]PNVUL9TZ:#(9\"&#&(5)<1Y0M*'6
MQH3.KFX>1.Z"> 4'P>Y]9.Z_>1B9@,N-G0B?G40]R .*\ 7T[K"8LL:-U02?
M;A-$SHS6/@@_J.]5=$9/J(,P!._?!D4ZX!'CKHAW&Q$#-_#4#I?>QAO;<:B"
MH(U;X)#$WG#%[D#LJS[(]KVT-;Z/8T_$]@,>3+XZ@ "ZIOX WP;F'5@ %XR4
M%<X\/8  &YC8KUHW+J  #]D93# :#A_R."1FT MQPSHY9#9R)D\YP7)FRHNZ
M]KS \K,%G/U$LH,]*7\33?@[W'L\*]\#+&\L4+ #3)AR(D]SV?O R(8?93[F
M544YXO/P^U%S.[]S/,]S/1<\\L1#B/3@Q6[S"T:Y$(X\IS,[M -F--_SV=L\
MO&-T2-\W809T#X9S./_@#L9T0?_P3/]#Y5OT2 ]U1V?;"'Z4F1%U5(<32M]T
M567UX%LY:O.#"2!+#M" XSU8L<OU7? "^7!&'WR!&?3K?QQ#&7# 8""!'7^]
MZT&0GC,_L3MT_4#V\SOT9U?VJ_Z;.J +AA)P0#M ;[@[N^-B)&='])JKBSJP
MP@2R.0<I@5YQ$$_H@'A,.VIO=FMWNEVP _JC=K/;!138 -89A>">'"4)NS:)
MM B@@ H8$SJ@@%KG@ B LSRX  J0 !&(GJVSN7&O"UL8 5(4E5<@GG0W68GH
M CB#=DQB0&QWDW;#I*CQQEP']Z_;A/9M.W(?.U#W.$WG].SCP/.\]"4?'T&9
M\PH6%+ESDUOP@T\8@0YX*V#P@K_T*P1K 0B@"#!P #P0 RN^!3(P@ JQ@8(=
M@P98[V (>T@Y1Q1,.@<(=GC;<GB+4H-07WY;)E_FMS)(4L8B%IFX!2&G/%NH
M';+SSOXVJ8/#:8$S)$(*((%7P"D'G9P=Q(1,B#^356LBQH$B_;=7@."QRP/O
M<1-04 H70(O 0TQX^YF">$V'F^<H#.;00_)*)]M);TCVT<,F[[S8M[<<1PDO
M< $\& $R<! ]^"0'Q(0$<) (R)E.,BD&.1&>MMHOZ8)?74H_V($6>#=?& /"
MKY!;+8@Z^*3<J(4Z\(,5B#7NH($6Z#HT6 %7*@A;.!Y,D%^#<!L<L-M=1P$P
M& X_< $8*!:1&@,8^H0<WS&  .;'!8Q,P(#9:M)"C"]@>CR1,8,01PL_%S0!
M"P:,SH,6!C?):%'GH)Y.921N>B$#$YV#H&RTL .L%@H)8_Z"C:+10L[!GL'(
MM,!1"UBG/75(@-$(+ ^),F)&]#P(-,=08*]NK. )+$.='2LP[LJCT8_*3< R
MY3E8B^>H&S$/[L$$IL4H32B^],3DX@7&6W4PM; QE,L#'*" R6EQXU/4F3E:
MH$'88@*970=MN8@ !A@,+FY&M 3FZ\L*A@<UBHD0]0L78%U$- [F@*=2%%"C
MFG%Q8Q0P3WHPX=!()VC5GI]@V-@CX18P33!@8 )VZT6$+[F Y;YQ^-4>SCD.
MUE'\ZF"N'2C\<- 3U9;Y,AI!Y<F#HDO#@[=@0/CBJX.<+BBB.[938W[X808)
M6@4CQ@I?6!9?1FC8 DH'&F@E&OX=FSS'&#"@N%6A'"20P8=!P-BAV&&-H9BB
MBBNRV)@I+\(8HXPSTCCC*37&>,J-.)JR8X\R^@ACD#P2.2211R*99)*HK!@,
M%UPH%95&,+0@&C!D*#!&'@R,@1@%?L@AP8D(::*1+PMHH@D$&0&SB0,-U?*
M+Z!$4%\9$O@D 0=TB+& )\",4$(M.<#V!51C1. )':IY,L -?'0 FR</@,%'
M!#L (\,(G'"Q0482V,!4 IVP.<8&H' !@48<O( )"1QL]$ ==#@@4PD.M,!'
M+1&@@4D&D7%4AQP)\ %,!%R,(D)K).":%@4TR'? GP?EX0 ,H'RR@!V<2% L
M"@WD^OX* V+8P4$#P(PB@1F99"!',"U((,<N%Y3AB69L M.""*-PT0$P:"
M1AX/M&8& W:,T0 *IP'CP@>C=.$O*!!XP<<$-P!#P0=Y<+' G DX),$>>$0
M"B9O I,#"KY(0(8F&G39 @-TX,  # -WL90$>N21J"T(P,#'"/Z*P< .OM!Q
MP2=@.'"=1KMVP0<'-@3S @1HU'=?!&4 8\,#: RKG@@P>$)E5!]@&J5&7US
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M8"A?L!^ZZM,U,=YB ;?@PQ-[DH<G%O$@*P"#)E0C&@:P<2N;D1(PQI  $70
M>+EXI3&;PX#$-?(L9JQ60W0YK0[D3",P.0@?%@ ,#F .&%^ E1XR<!!-,$<3
M#@A&'CP% TPM@!,'Z< 8AG@07S"@6!K9P0ZO60L^5  \3QP+%B^@R(P9#I.<
M\!B;;O[PQTPU85)*B6@W._ !#7'!@_9A@$*!(8*<L5$QP,#F05K0&@:8!5#?
M^:#^BEI4&PFI@#\"DO^4ZE2F/E6 49W1 6O4/P;&YBP&2(!!/C@E"FK$"WWL
M@@N"T8 2E  %RFK,#1S@!HWD 4\:Z80#F+.K^_GB!1=H 1DD*1H):,A02_G
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M+.>% NRG+;2$!3K1GVA.(&>. ]J +83G&&3 !SAN#C) !WB"'? $%YA!"U3
M6<=8"8C "%@1&,P906=$#A0E3X2G=$3F+-L"!/BL#=AN=-2!"(2 ##0$%Y2F
M1+!-"62S7[K4D6'"!$3 =\A!.&EE5'B"8^_S3+3 !X0 @!R$VYKL^XZ:2D9L
MI-K>'4L':4_M5[$)&4S<+5Q AN% 8BT9.0*=1GA"&49.3]"57051:[$=2/O$
M _#D)BA L73 9M3!%WW!#G%!8C%Q+GB" )#!6GZ116J2:?X"PP?D#"90P"T
M:AW<P@T0P!CG0&(-,LQ^C2]X 0YQ@0;4PBM0P!XM0!G8 B9(P%"TP'<PW]"Z
M%3!L7.;43@E<."AH63WF  +4@D !W04 MR.+ >0T0";X @R$ ';<3C9=L7L
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MDP@@Y145I8,$CO0%'19F!"/(PPB8U($+U,(,<&R24W80 3HDTQ:@"*!L<E
M%(A@!!W($ 4RA(:#>,&HR41)3O/ ,6!L0@%>Z*6;^&" +L1M)[=8@ [[,X9C
MVD\@,=5 %UYP@*)X\ 8KI2,9XD3/KP8/#>G)B7XT$;P2",4+"_B2 7:@'@C(
MH0FT P8)Z%2".''DL'^1[!B>Q48PF&$!=5 K1'2S$0=LXOX6!1 !'6@0@5T
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M#$!AT991>$0M-DPE A/Q:>J =X[P2KQ@R];/&B?P #E"#I)$%W%#$WP($T@
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MFN,!=K,P;B' %J8DZ,#E3-$X7?[.%B* .R\&J-:.>L9@66X@8<: .7PR)<Q
MZ5:0\?A1+ENI!_>1($60R#;/\X)*)A;@$ANL;4R$ MZ""U+D WA$($*@4"@@
M2?" JCJ 29("!1A@!'(!#,8C D8 !S+@6J#*DHJB!#+@!DJ @H#!#2KJ Q3B
M"X $0K\ !A2"- NC$R1 !M;K+%#@ RY #'CB TH@!^2F2!B !&X!!BX@6(=5
M#BJ@"S[ 30BG!#: )3AB#!Z@:C@*&, G)2PF%R2 !KI@ GX"PVZ  Y[E"QA
M P[T*UQ@ 4:@%C2!FV#@(R!4 E1-C/Q%)B# $QJL"T2 +<.# 38 *48@!,B
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M OB@PA*$7:0F;D#I8W(BB'&"!N)$#BBE!=X1&$3 VI9J#V($7GPA 7ZYC5I
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M*F$@J -Z@AT  PPA'\5?@-E:Z?Y+0; \@#_@"*P'4\*C$8#E4% +6),+P&3
M ,:A24,4>8#5\>6PMNW;N',#,V7J%._?P(,']RV\>'%5QXTK[[U\./'?SYM+
M!XY\N/7IV)DS1Z6[.S 1.6M%D*A00@@*>("1N=L"K=!;(CZX,$-A$Z@+'S*\
MJ VJPR[U-K FEB\=@.)+?"_0YXD-:#3T@ALM<? !!9&5L1I])72AVB<=U.8+
M"AQH\ )M#[+E$!?X%4A0"1+<8H,9#<$ 8R<:3)B3)QT(55LF%'#@P@4-TO&
M9A_<\LD%(]@ A@:VB-!)0Q]P LP7*]7"@5 H1&!+'1)D: ,)P/#!P!=6"C6*
M W8\Q/Y!!Q?L8!L8#,067PMF7+#)#F2P50L,-]AQ@504?*"!1+5<$ (PF(DP
M04X.U5+C47D.E><('=!Y04J&T@;E6@UY,8&@:]DP::5F:!!;"Q&,U((&'(Q@
M4T-^/+#9%_AMX(EM+^C%161',?;)FA?< ,PK&B#:D6UH2-"!#!U8Q %MMSR
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M8 P7\B"":35$R9C-P:V"<8-;[&%@(G! "WSA!G !8PR)*;8&GE2Q$# U-Q+
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MBS(\X&X#^,(M=B !DDA +"UP$^UKD8?@CP %L6X(6?R0BQ=T10\.R$.Y]/
M;<D@ IP !0/ 50)A:4("\%-_,.P F.P.P NYX,(#@%'F]#, +7G5&)7U"0\0
M:QS0(*%E>0Q@$0, $EPP7)O  %91 EV! @&R"?!W"PUX"UT0&GS@ . B!ZCA
M $R5!Q(0#!> %FC $&SA>8V1*AK8!+?@!?N7"0N ": P @Q &T)1*HWQ ')!
M "6@+2M(2W<6%!< (4"'* )@!_Z?P  ?4 L=*!H)H >W\ '552JTE&+7=PMU
M4 !;U85?N%6/Y6[/!PP/ !9=, "(P!9TT'P3T &OX <)L'#N%B>W< /%XH/
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MP( "9B QH+ )GI!UEK<+H*!SF6"366&6L@4,F^  .Z43E/[Y@9A 6B9#(:
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MQ7(!'Y<!#?N>.4$;ET)5#3$&8 *Q\8-YG1.>++$3C[B>I'=;4%H" ]&IGM
M-D #7<I;ON, /=(!!3 M,R5Q $J@R<%<.LL;!MJSPE$*K;!+:_1P*# 0F6
M&<&>[R<:G>BM7H"9)'$+>C"0+G!00M&H#3$",$*3#5%P86<3%$!0DN&(#H&-
M* ,Z+#$&/@H&+E +!Y 1T.H1."!YP,"U*I$W*+ 9:]D8Q)<5"8 ^<:(3$C *
M.:4C%,!;C^D09-!\%W=2:OD)GY   ]2I)#D2!G5FM2$#3_ZK"3)P$29C=+0*
M#'3 G06'$'E# 7: "72EEGPPE8H:&K?9&.LBJ0U! =P" U#:$#9 =*. $;9J
M0%'9 N JJ(UX/&.!O&,Q6;Y4!V;)K-DU7"^ 62Y@/PX@ECOX D3G I&1@*/E
M !813]D5&CO@HYT  R%A,IIP..+*K+9:&D/VM>4+#'K@N&&B/0\9G@=QKJ.P
M?SE ='[0DLZ98V\:+3;! 3D&"FL!=?;+$G; @D;J;J%Q SZ*"68YI\.R"< X
M0T@W>QR<$PTP0YI@"YBP?X%188ARC_,&#-79A^\X%W4@KSD )D43/R+ *W7
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MM/$)"O">)SM4)7!G+8  M]"X>W"C'2*0IE, ([P ,T'.;7D#)K@9'4@'7;
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M'*7 5@VT!XKM"3C0!5Z8$A:G!R]0!YB@4G00JY>#"=>IV 1A!C:@![7P!<'
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M<8M,;6"WZTBUW2#OP%NU;^6=3C[8'C1Y054,%AI4]UR^^G\:R).*0#'#-X5
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M J%'@,$+%C 7Z]U@!!VHB 8^< ,.7$!C%.C""#+P'09D  ^VB  *)F +.4!
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M3#GOKOY Q1UH: X"T)H6* \8 ZO%!%#PQ$D2%3T"(:NC4?#J$?C:HU0"R0W
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MBO"%3, !V[J ;6$_A8@MW"$<D' !HA.(#R +.@ JCI. 'YG"AFBDG<J#XFN
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M@? #!WB+/+B #UV(_A$!&?B .>F""A"!"T@)&S"=6S _8$ #G0$%6+L HOL
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MX<)8!4+0  \  1#P  R8 58@!<9@=48>)4EX T((=<.X SC(#((?A%4HA A
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M@!?4X0,=V(X#R&"&!2"H ;Q:0!DP08$)20 X!^'"%&$G@F!0H M\N,#MZL"
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M\,:'P& @P'A 1H+Q@%?@X 4$@=)#4  #(F7@%@QXQ:#JD D().H!HP"%2]
M$F", ;@12"8$/(%>BDR8#*9CP'> L=KSX4$"!:F 23203(+8H+O;>8#E?/0
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M$$F AL&8&<!:&2@$ ]@*!=S.09A!()W.[:C80ZS Y<ED"=(6L8'"(BJ)L+P
M1K8 1A+$#524)[A$Z^WC" 1# IA$+?1.JK@'* 3?'MV+21@E%VC ;MB ]TG
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M,,#$2\3$^1SGJF3L*RQ ,)#4)^0AC^D(>%+1ZS0!!9S7 H"*!I"1'12 L'"
M"Y"$.>'K&WW" X@,!9C./B44%^P"&B@ +@'##JS4+I  VAY* MB"+90 "RD;
M0=A!!9QG L! >(B:+UPM01R4)]C"0YZ.:+W"/P(##'S +6R" ^1!,!@ R-0!
M"\F Y*;EA#R &,1C ""(RD $:+ "%(  (?A%#4# "82!ZMX!!\"!7ZS5*<X
M 12"68"  W@ [:X"AZ: 7T1%ZUI "BR"*RQ""EC AM85')R !R#O&61 #$C"
M"43!*K! #$1%#(RH,PY"*6  !/[TS6E<(V@@:=Z@+^ LJ58X:4[<@!;]$2+8
MPG9Z0DS40G :40G<@@T@6##0 ()Q@A250%%PP8202@LLS_8 9**TP(!A0@B0
M !V8P0V\ M'R!AC0CE#<P@MT0 >021UH0$9X@0?CW4:N 'QAG2^  >DR" <\
MI+TPB >/P'Q(GP>3B1V(\/G8 AH:T@C<PFH"(6]T@.'(@''T"#"L(0?(0$X>
M:QG 0*[NAB_ P 9PP+$<!!^0 1$U[8#I 1D9F_<9,8N]@O1MQQ?SP1=[0@;S
MWRA]0@EP  E 2 Z@&4MXL.!:C@B, !K(07>!PAO3,(4]Q1@T$#"8@5#4PH"A
M,4$H,OX=C X:?\$4[X8M^&FMO3! RH<ON( (< $FC$ MY$"2[ 2=Z8$=J]D3
MF0$=O, DQ_![=  *>#$D4[+T[<8. " 9T-IZ?, K<X$7^()_90)7@D+_L:0-
MV,H-V(IU_-Y[$"TP'T="X,Y[E@%-G ]LUD$D@X<,E$<9O/ 7%X14,I2E@,(F
M3W%YI,03E8$=O XF:,!*\$$(@#-![((9^$$=3-$-\$D*<H ((/- %68&O !.
MW+.G01(FO(!P**8F2.="4  8:,NBW/'AOG 3',0''&&P*LD.<$"E!9L(=, '
MN%8.O+"<=4((:, 7Y("W"6@D2FA4N((JN%Q6O'1;N (3"/Y #-3 UOC%*G2B
M*[!"2_]B:L3"R0DU8PDU*S#<7[@"2[L"4YM"3SNUS$ U*V1  2#!"L"-*^3<
MS:DODTH%^3(I9C&%6(\U6?_=2@A;B'5$Z98U6[=U3MB"&15RZ+AU"8 ,K/*S
M4:RU6^\U2DSN UPQ7T^$7G=$"PA+]OQ<8"<V61\$&;0 ]G% $W $#'[78)_$
M,UG7202=6N]U:6BU*7BV9WL&%&# !,R (GSU9^=-:$<%:(>&5H.V-$K"#&!
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MLN>\SA/ZF)O&:DA[LU<6M4>X^0:]-3XXC*LY!:"1!%04#&!Z'?C70;@!"LC
M ^# &&S  Z3(*(3 &Y.1+Y3 KR%4,+S !X@ K1\L +T ^ !#)^BS>UK.".3
M!(P '7S  ]#:7G[ _M(0#*" ! "7'#! !'3SX!<^@US !UR 4.'  O311]C
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M-/P@O8($%,9 !I:%#V3 "RI1#UZ!"VI!#AS@"_#B$W+ !L*/V?( P#"!#UX
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M@5@[]>[XH%<\04%.B#L:(">$(P_,%6 Y90<R@^M68C8,(+QRA6LZP(6 08*
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M2U7$SAJB;C5ODD-D2VNL2Q4"U4!B$_C.(V2 ]"X&@;[ +("6)X(+%)BC%C+
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M+_WVT'%CG76$>GVV)=X*Y9WWWEOZ_7?@>/<M.."#\UTXWWO[E+CBC1....2
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M@ P9@,$M2&+D$DB7(+>(@"8BP%HYT.$&%QAM2^C0 1& 4P]F((@=>L*)%HQ
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M,R1 !72536SJ&N*FX!4_\-FE0WSA BB 6UX" ^.T$6.0 '8 "A*P<B*  \%
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MM<  =% +F <,,- "]T@!Q!42%' +M8!IP" !3? *7Q  E<@ IM4!T!2#?"
M9E +'6!,$6!/)  972 !?/"")? !."A;-K  ?'!8/9%UX$@"P& #0)@1;O:&
MQL@ P/ "JC4![=0$4PD#>@<,H,  2?8![20!'. )>6  0#:/GC ""U!MP% !
M@H$"I/$%$<","? !HD@#A,4'$OX0#,UECCM  KF0"1(P910 A6,PDWP@63?
M :# !PD ;[^!%#U5  N@  @P %&@"F] "))@ @- "&T0 &W !@$P"(,0 $O0
M"Z20 !Y0" @P [+0!J'9"S-  (K 5$8Q 0?0!JY0"F\P")*@ @,P"&H0F[V
M!   !TD@ '?0"V$@ &L FS- "LI7 W<  "H !W?@-$92/K/D(B"6&_N'%&C$
M$64     32>!8BJ&B,#0!2Y0"POP":!P"Q!0:@@A DP&#+0E;GQ%!DR88CM@
M Z_@ "4! SG@"6L&#&>F9/DH2 _ !:"P$9[PH 21![>  J\F F8PD9[@GQ%
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M$#!*$%P@ UU( RT  S)@4< @ KS&"0\0#&-P 3) ;!<:#!K "9@@6QOQ!2[
M";5EH1=8EV6Y A3@ /$H6YVS: 31N9YH R[0E9C0 >&V";+5!3&Z VS*N1V@
MB"RZ&"T@9(*W-RYK!E-I$1<@$V,PE<  !BW0"0M  _4( Y):E@EP 1S  06
M") H9NI8!K4  1OQN<#P!9\EIL @ ^': H3E:@7!I$"&H9U0IP\ 3G^SES:
MN0/G @2* L8VEDHFA7Z0 ;X@ ;M !O^&N?=:$)P(OQU:IQ$03W_3!82U$2A
M!GF I/X+.$<NT 6*-A,M, 9Y %((09DX4'>J^A)C$ $(# ,T $X[H $,H(<$
MH:Y=5WD,H(@O  .84 ?IN!%YL&9?L%D;X0)?H ?UBA 4<!=Y0$UHJH[4^@$K
MI\4$(0&;T ),-D>=@,0ND+EVP!&;T &N5L;#RA$:D G!0 )A',8NJ0E[4*]=
M5Z_29KL]P0>B6AG&1 <CX:<C65DYH $W0&XCR4TC^046&D@!"XX<< -NA[]D
M*:+4*@*5M:P4A0DP(&3!8 L14%,:=P$,4&J%O*X/4&V)[ +_> O;" JCP  O
M(+Y\P <O@:GQR &UL+*651J;*;2%( MS%0MI  !1\ M(4/Z=8,M)+" +=#L#
MO; (!P "AC  *2 +U/FU84L(5644$% !E> *SJP$OY $ 4 (;"  8="VQ+<&
M % "<. ! J &A!";LG"<A3 (4> T($  A0!7A%NX1#1&J)&X!+$+LYL0E\L1
MDDN_,& +&D$0G%!3(="B=: !GZ"#]Z2O)8 #FV66U<:G EQC];H3B^$);@P,
M;B !'EEM-^ )+<!UZH@&KUAMFQ ,T NB4L@%A+8"7,"2P$!9,I6H(RED+7!<
M9AD,U<L0%96DGS4&+>#3BMM07M !%2N"QD0"&M5E)CIG%TB_3L@%=7"S+NS%
M;.< E7C6LH6QN"8'>J"O(ZO4K_YVQI*L9(0)#-1*6!%8$+-:$!.P"2RY$9^P
M6QG :W* !LD:J>VVJ29($(&1";M%Q'H@PP3!@IZ]62"MJJ*J";= !W=T"PD0
M3P0!E)-; C";2$KF"Z!6$'2LJ12%!WK@CK-X%W3<97)P>8EH;&.LK)[0!;Y5
MEC8 @PGG";$-#!$ 3<"@ :6M .#D"050"S=PBS* 4MCJQV_V ;O :Y?)9M14
M$/Q:H?5*N@?[!9FP  A1!R!E WHH UW@H07A:#?0!:>($'90KS904E1YBS=0
M61H@J1>@"5^ W)S  -5F"[R6"0E ;R4+ 7J4VIAA"W6*R\$0UXJ+;10)"@70
M"9B04_X-T&W:%AR9)%2OEQ6LT+4:$ ,.L)JR< <)4 !PP JG8 ("< (6@ !P
M8 H.,  .(.-(T M+$  )T ;F[$FFP IP,  8$., , C.' :]$ 4 H :R@ 33
M=P($$ :Q<)HG$ $#< >P&0%+D  5<'^9E)ZX<5<JY']#L0*(B! 0-[F;Y0(;
MX ==8-D(@0(.@ 9Y\(F[BJPMH !<Q@<#$&XPP &8P 6RS*1=4 <5L&:@L  Y
M4&V@D !>8,:$Y>A^P 5;^0&O-J4CJ0%^X 4-S@D*( =V0 %;>9ER8 8'L*$Z
M:I; 2@&DL1!"",%BX =O*%B[71 :\ &W0 ;N^ 7JK0%\\/X%#)!PP-  /8$0
M?(  ZMBB:5D+"H 0GJ"C/TCK!I #F]"49P:Z([!R;$< *!J"2J:C>>  ]:0
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M73:@":6["08P!IA.7-O(!9G@D/;T "6IPZ3& %S6]R/H )W !U((!A*P!V5
MD<"126F !(M0(JE@"JO !B:@ X.@ X3@"H6P !% /]H'5!BV"H00 S,P"$N@
M7Z00!C- "%L1!6%@%*NP!B8@_DL0?N+/"H/ !(5@"&HP",T, &O@16%@ BD
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M9@G&D L*H* $G Q&!,!B"PE\H@4+$ $0@Z$!%TS5$Q#PSQ\[\8#K-J )1)%
M"5Q  1A(A<B[%-L8_N@"$=S  :2QBR<<X!M@D/86%[#%*_XRL(L0H'(7)6#
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M@OQ01V#H@#HP XER !FP@1VX "Z9)9PQ ]B#@$\(!C&D QYC !BP1W%[1PE
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M-"J_Z/Z$';@!") /"K@UHW(B8QL24%B &[#'"<.;6_@"7J(Z/W" 76(B,6B
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M+KMP3_,CV2#\ DQ 0>^[SUD"A@G@A#U@@#+A@J2CLN3+!!M(.J,!!5!H@-7
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MY98J/WXL3Y/(@0N0Z#*F "OBA).^ *AJ*CF!Z:3A@@30@XI# 1D8,5OH@/=
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M-#%?>B,"(("10"((TB!9*!H0:[:%HAU0F%'K)=V(H+-)'.%UO]A" YW0RT>
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MN+*X/BM/YC10>M"Y.8W\%8P@$ZH$L]"#7U#/H:SD 1!Y ;5?&&]UE)@C,'X
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M"+S !^R"1G2"'V!")OA!;SYE"T0 0C3!L])&PE+K;.  Q&H""HC!)K0 )G3
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M*01,; 2 0BU0+S"@P0&XJ[A^P&)2P(4" RA\A4%P0!?PRRAT0%U<JPO0A4B
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M=W:7]X%/.(-3^'0?=S7?-H-T)477<SPS=5-XR.^.>(N[N$O,,Z=<L&Y;R,F
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M1X "%SAE'9B&+W!!"+3 %&="BRXF,,@!YW[N+N  KHK I6(""I0 N .L#(@
MRF\H9-Y"%_B"+91!'HQ "]"N+0@]T<=%"XP M?*!!&R ;=S"#I# "U2J##@
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M!XALH86W7@LFQ=4$DH,#%VPX$?X4"&SZP@5-)%!IC!& B8"3R"38!)@Z-H"
M YL6O!//G*9[)9A:MN-" X048N@%&@3"Z 8[;D@I C\O$J&##U:T4Z!<J%L
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MO>EMU7C9^UG->M16N#H:A2!Y2/D)Y9SE5&<[DVG._%+4HNT,<'_CB4[_[K?
M$56E@HLY40;K=\ (9B6#)RSA!5LXH0^F\(7SN^$,4U2_!_[^,']!#&#)V.7"
M%JVP>EE\S/:"\KLR?:]XOU+?F=Y8O%+9:8MY?-'M$F6B\!1RCXF,R47>]%:;
M?3$AEYQCI^SX)[ L\I2I7&4K"\V^,U8R_&+:Y-+&&,=,@;)/2%"L[6A" 7-
MZ$+1 !+G&!2?P&CS.PFR$ IH1L@_OK*!\C""#^S +K[HP@=6@.=:N* %KQ!(
M'@KV$TW@D0]EIJ);9-"!&[AQAG:1 R[VW.F@L53+'(5OJ#G;R#!G^<BG/JU0
M.E  XDC&!@+ 3T\<X(<A*\@!V7KE9 (5#$PTQ],.XX,#\L")$>P'&"58W1<8
M !(1H$$.'WL+RG;BBTU(H 7 V/[# NB B0C4QR,V\$0+3O0W3LB )GE =K#9
MS2K/OL_+I%8UJ$U;"E,,I<RA B$'.B &@="!!"L 4C"\, (9^$D,#]@C,+A
M@B5JA($D4 PHNL"0.LA%#GS@0@<&^.\2H&#@7'R!9EI7 EOOH04D<!DH/B !
M+]3&)K:P@0CJ^ HS]+D%( EA">K8;J1()@<D$ @F%@",3## +BT0#@5L<0L<
MV>!*/=&$"!Q0GQD*Q \,  88,B:0".1A/L#H,S!"H!D]^QSM2)&W2'%:RGB'
M=,P]N0_34]BBMHAA Y_@PP0TLP+>C$$#P; >";T0@EV,00*]W$0$]@"*#0PP
M UWP7?Z;1L  .@Q;(630@"?\\"9@-+ 38E" +3#Q !IJ G:OF("M7T"!/?B"
M>L"8P X\88,, ,,32N)$";XE D!S,.U(L45"ZC"NS>1,,G(XD0;\D(D.D.<B
M/I$,%[+--2:>:5B?:@G%N) #.L"+VL$7?W3<]^XDFUK4639__9",9/FN?2EQ
MY\D%,%$"[6B #RA0"& 8TH(7V&(!:@$C(D Q?@08FB #/B$8<*%A2F O?*$O
M]DT#;.8D6",/SH3_5H(W?./?%(@";,T6_,06LD/.BB48&D4.9B8D]N 5J&7Q
M$,(%:L$RQJ\H1N$#'' "7B,'U$0R\N V,"%2-.$%^" './Z@/G@I/7RABIR'
MEYJ  6R- _PM/_:##.0F0 )D0&A0"]5N?F2,RZ[B[= /O-ZM*N1O)RA $^P@
M!&KA3$* BAI@!68$!=" #QA@2E# 7"3 U@[P AI@+S+B S[ !6;$!@1C1$1#
M!,Z($SXB DJ 2DJ #L^$?R@@6VI!=7+@ L[##$SP 6J!^E1B!,K@%2) ,EY0
M-2;  3IN"X%" W2G-VIA#'*&(>C@1%2B#G(@#[Z% RA((,P@ R+E G+H3UQ@
M@2  !1Q%!#R%(6! .((!(W+@%ML"55:1&H-"##L*S)PL#-NNR[3Q:<Z"LCK
M!O;"#?^"CZ)E6NSB$S "#<6.T_Y\ 6ZV@P3:HEG$3@2^X%M )B6 00_.) *
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M$T2@!$C !0; 949  \1@-@6B \8@$7'OA!O8@4F-_8P2.<44QAYIR:#W)B[
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M.("A*_N+>&XQW&SU,,&?04B/1Q$R.*$[1T A7* M7O &D(T3M,X,:M$+5-,
MX,2->TP&]H(#7L-Z4N05.V$#4(!4 B<9@4("/C)&MR.X&P(%." 34& 3N A%
MX9K*)#AAF3=78BR+\SJG? 4&\B#C)&,7FL!%7&=-"'8"LJ4+]N,6]*@%&J 6
M/,&Q53,/<$0$HNX$-<,,3K@#[& 3%@ &2L %(H .QD!*+#P"/&$4;0(3)$ "
M1L#L+N(!/LX%ND0@:&  (",8) !"RX $4*]%7@ "Z. +&/XF(\+$3N2@!&#@
M <[#!;[W!3O 9;#D 4#!#80NA=2$D2D !L+/O"0##33@%G+A/H"A]%*D%A@
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M3ID:.+ 5L(,($RI<N#"8+X80@3F,Z,L+AX@1;SU$&,Q61%L;%>;:!3'8 T_
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M)$C?2Z>*G5=%KXG05"+/8M6**#8S*Z@P(@7*D!)?7* +FE@ #)96P$_D4 ,
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MKORF2FP?]]:-!L'P!5U !W+ !ZHDQ;ZPP'@SKC*@G@^M]AXQ!\D$KCG@"W5
M-V+@ GL% YHI!SE@!ZK,/B-P]W1C!RZ  [90"ZP##'H 0BC_^L0O$V3%"7A#
MPI9J!V.@"=JS"7C3Q":NM\7//BZ@V1<N Z[DGS"PLZR3!W5!5GH0_'1#!V14
M<0EAUBX@H9[0LDO[47H@ SG@$9[02VC@GO,__@ !R@PP/OYZ<N"P,0;8K1TP
MT #SQ>4%'8([?(WA4@<,,#)R[( *Q@4&13F@@)FY5>?%C5? 7+ZT@P?8EUK
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MP2&!M:MB[8I7MW)5J5:A@@P TXZP02-M[/2?1P[H5EP:932E.4UJFJDUJ\@
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M0(<#D(9#XGD0,9:%B:,@BQ@$5I>N2$, H" +$QS $+%@Q %2D-PSR&(5*4#
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M 5J[&6_3=I=0@0B4H(0EY&^)2\S?$O&/O_WEGW_]VY___/>__I._^KN_^0-
M Q3  -P_ 3S ^2/ _2."O\,/2OB!+*B$ 5S #-2_!MQ !.P_#J0_#>1 $/3
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M!0&%H'@)7^  M'A0:9%(^]@%.M@%8'B!,L#(%"4-PB3+]) "]00&.:" #;T
M+U"P::&PT$B,%^V,+G@ 3?C0;DD,$JG(3-  8/"$%N@"^Z@#]YP67T"!#+B.
MY"Q"'G#.\N ""M@ #:  &XB1BV20+V"+#SB,(1W(!F'3\J"+U[1/V6RF_(Q-
M[;2HK 2-[U0..7  #DC3[^B QO[(C@<@DPD53US4EDWPA#%0 $W0A+UX%Q?A
M4<_( RSECE%8 /C !+2 #D@83H^,1;H84T_0!#Y(@,;P#EQ8 !!QB5M8 %$M
M#5B55=/X !FE #YP 2X !DP8 =*@"SY05/A43CH%!F(TQO00@1( !4I] !G
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M!? %3E@ /MB$".C;76T03T@ PX"!T]V$\MT$"3B,$;"!6A !%-A1"L"$.I
MC$4.C?W*'H $8@4&/7@ NO"%".""6A@!#RT!!C ,YR6#/.  !^ +"4 #3="
MMFT!"<B)EU@ 3JB% ; !/AB!KP6%!_@"/Y  V+T!$?"$+[@ OC!A%/Y:,&"
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M5/1  Q*0;\[H@B?>40Q& 0^%B,*E]I?XWU?8<4_8YA;  8\F U X:6"H!5\
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M#X9;4 "%((%A[H#+!@9-8( ZJ 7P)@U]1XXCR=&7R($H5?Z0W/>$#AAG+2^
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M)YYPPFM*):6",.G!"UZMT8M+ZI?CWQX.[M+'9VO\6,Y^5&GPU5]U-<)U&&"
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M,%7(*S  $7G" @!#'8 309A!+%;(#B!DLL& AXQ &VH$_#S+F6%12%S !Z!
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MA044((D8", !!3!!*1@  6HQ8 *Q",,!%%" #)2"$ *8@2S6 ( TG $!###
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M8!=V@ YNH G$X%L=$F9]@0,VL[ >E<-N(0*PE02B200V !@<\"-W84R#@>^
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M48L1DF%V8:E% HP#AA6*(2T[N( -;A"_,72@ WS+PP,H  9@>(($'7!!<O1
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MZ,P+U<L# <; 4O_) 'MET, M=@%:MTR@"[XH P. (0<(>"*CV*/! CR1AP+
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MP'0]X@ML"%%<\ (L(P)K! P?$ (W  ,W( 9QV 4<P  ZAT/L=Q"; ( 2 %C
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M= ^0'+4 E^ U A'@:H/V ;NSBTIT 9B@3>&1 7Q0A"ET=ZJ1/&N)%RZ5"Q#
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M97!9L\@!(F,#&9 '-O  "',!'0 *@,<%=1 !V_0 =? %"< D?90 .4"KR[8
M:A4,5#8X=> &'$"F(>!-JK4#8PHY$<$'A10:=N  ;E &#H [U4H>=A!T!_$)
M U +MN  )( &8+  W>,+'W!6.)  1)0'!E &>4 !)<,!QA$69N  =" &"U ]
M>,  9F &"X!"*  ^'S ">D "!S0&6]< 5I<'$UNQGZ8!>9 #"  W8;$"ZC$*
M$+ #>-!0!D9_Y.%#!=8 DX=9=E<1)*D')7! ['@#!KL^%?ZQ":=V$%P0 77
M!0M@"YO  'OS 0Z0"RC@4-XY!C;9/6,Q H&31GO !1/@"[@  4-+ ;C%!PQ
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M6$MMYT]^<(>Y4 :>D GGLPF.Z+9/5VG!4 8O@ .W80LK:L>;(,1 ;".;H)[
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MLPL0(/[/@EZTP+!74DT6R=&O(W #>0>T-T !)? "+C"\0%OH)> "IKY@\K0
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M6N,A \_Z&?@2:W'H?RNP1IY0 7'Q[MK6]A0 ]Q:/+RDI/E"CM#?P C:P )V
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M&'! %^@KM:"#,0*&$+"^QP*56\ ZC.,BP[J%!<"$D-, R2(A$T2(37" /^N
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M\RF"R)WX6LA[Y -;("$ZJ"&#V/X! ^@ #G"L0-R#0-0$/9!#.OR/$4@>&]"
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M!]/#@1DGRNGT4,\#/KX*RN&#\:$M!A<?<OAR(2$P/A$P>BJ0"=B&,0*!Y>
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M@;_ ^!&!#")P<),+'=P@@:YY.  ## OH6L<#+[0@+S 3\$'' A04^. M'*
M0P1+[3!!F@M$=\,'7##P*[V>+'!++@^@($,$E&)D ^&??"&!#"@LX%O#-XR
M.49[=/X;C ,Z4<"V5COQZ*./1>*/__T_[K]C__[G+X !5,62"NB=B3WD G(8
MQ0"X@Q&0 8,+ZA-!K#Q!@.B\(%8:$-<*QE"+ ; ,&"+0%0-\$XP/>*(33A$A
M"<?RLI$\A% [64&L' ##"6SB%03PS2Z8MPER9<0G67H(@SX1 ;9<0">86*$(
MNM( @DGI4TSQF708T((=Y* #L?*#PS(&#"]HJPXM",8#;D4!3+Q"2W*HGI02
MX(M:1, A-L"<+_;S%#!HX&2.$D,('L*'!L '!ICK  >XD ,4=  E%R@#,$:A
MJQ)XX2F?:(#3*,!(=TW@ 1( 0X6RHA ';.(6!JB*)F#6 OZ314 G.Q@;,"!
M1;;8P%&@2$!T-@$S3WP$&"B8# T<A9&K%4L"D_F &S02,V"L@&:-I"6;%@ ,
M,N112HZ[101&)X-HEH$"P"!!)#.4++9@ I#%\L0H(F"U$1'M(688$00?P!*F
MY*$6"T")+3I@"U]$H$%\>!,PB*5+'.QD!Q5D $K(B E,$( C"HE 7"3PEPYT
MSI,=< ,PT% Y,&#N JQ< 5B T01**:=G7O*#';0)#$\XC@_W,D,>B14,"!#L
M G8 Q@<P5(MOR4Z=VGS20UK@'P;HA!-C(4OU?)$ G8""C:8A#E0JUP)'22"$
M(WP*^^S2 .N H@40>, 'ED(_ ?[&Z']@'2M9RVK6^AFI1:5 A0&7E =MWL0+
M+S!(DGQA13*T8 $.F:HG)' 3+L2* 1F\009>X DM/>0#=#A<DO@02P9@" (<
MP:?0@"'#IY @!YY0P U>@ ,'F $4(V)+"<P@ABC=)$XB?, (9MJFAU#@+WSH
M)6A;B1]@:" /K_!K>QI@@R^ @0-C\T($<  #&R3 $R/0E7(PP8#.YL !9+CI
M,S''%@EHXA8/<,@G+C"!%MS6<AMHR0,6!H,$Q"5+;%'=V+(EAB^XX (.R<,#
M-& #E.SAMI-TVB*?XATZ'. C;/'"G6Z"@B_<HFH/:\MD<C"V,^)JJ ^)Y4G-
M62\+8_XBE@_X" V211()@"('96@!-<?#+#K(;#*(L; 72<!)ME# #[YX0%R>
M$AK$;)=5,KA!"*2"D18\0 08\@2&1_2";E(7!EVPA0)L  ,</  ,<E@3?!+<
M(#V\Z;"?H4,&6@(52HUA33=1LA_RR)8$3VT!3L9!!'+@"P<XI ._LBC9,$>!
M/ B$ BB(I0BB>5(I/F67"MF*'\K\D#I\8!3D8@L.'"73S.FJ%CG^RRT B0/_
M ,,&-'BF SK A5TDB7JYN)Y#; $!A[!E%Z[*M"_[<R(9P.!LL0I1^XY&DD_(
MX !Q4<Y9@60__OF:2&+M]9!^;:.TFF+8.&)K6QOK,*C @/ZN)%'4 [R @R\\
M0%<?Z J1"9*#9#% #Y[0Q"=\P=B'"-D3$$"*+\+G&1<P\@%5P2='V)*']BT@
M#YYH0"<VP8ER;^+90BY#N\S5E6"4A0%F*"<2=>)N7\"@*_)^"AE> (9-*\<6
M#5"H+0I0BS%P8!28\,1%1+#"Q6B"WYM CR\.^\QV/<15)19(1+Z0 ):PI4D/
MV8,#NH #,$#@(S2!3VW3A2\!^X(/,'C _ JB '])X%<<J"P8NLR6,?21+2;7
M[DT^H:53GE0#>O"Q+QK@55@ZRH@W<;D9'I":&TS&!OXQ%#!@P 47W"(T[?+B
M8QC\%(- 2$N"CKDF\%D:MD@&Q_Z[D( ;/D%N?]5,#@_H@J3/67<5@X)92KY%
M^5;^B6"@02ILZ80O<A&!5WAYGP4C2N@#2BDSB%Z78#"T=.+8.$VL/$*V8'KF
M,&0&;5UN*W@&AB5!\7BY>-(\3WX*=E5?K _8(OER%SY-*5H+"-SB L-O'%1\
M.?V!Z&$$_/0R2D?] 'INURY,O4&K;V!7/W "/:@>EW).M D_W DCC/=OCXJD
M;&43"2KD#P >2?^A50$"$++IR/_A3[,E"1FYT/NH6Y)XVE,T@39U@%,<5D(X
M&)Q@F@W8 59@Q+;U$X8P&2B, ,'D0@/HRD8(Q ,HE&4QP"B\0B=\@-5)P$SY
M0@F POXK($"7?$("?$)2<80FN!$9P)P,R !U 4,$C 7K*,0#= 4HM0<'7,"M
M\ 3S/,7[-,Y%>(*@-,E--(%42,!8!$,)D!S,R($!7 0=P,PK,,!(H$ W78"N
M/(2].,0(Y PP@,%1J-0GU,(74@ 2?<1-E,"F.51&H AZ[$0$P( O!(,<%,!(
MD( &@%HP: #&%00"<<(\9=[:-0 RJ9CQ7!(G. "H/84,C(TG !$HA"(*@%0$
M3(8J6H4?.$"R?$'TU(L:YA$*S$M!.$!"@ +,T!=!H,%1O,RML 7"<*!4R,#B
M1-"+,4GE<($(^((!C(0-,(LV$L0.Y!$$<45/88+$L 0G)/[ +=A5>-'$36B
MR03#!8@!S7T9XS  5J%('KS)F3G 161 5[2%'^3"O6@ )]$!8FU E$C \-V
M^GQ!)"E'(;U@'J2<0]0!L^#CH;V)!'2%+2P P7 .4WQ$3P0#%VB+#:R)$C[$
MCOD"!%Q$)RQ ,/@;1G3".09DJ4F-7;Q/IL6*3@)#4(#&\&5$ KQ%,'3!2^+"
M :P0)AB 3/Q%LA6) !I@KQ$@L E;L$5E EXEL07)C* "O3B@E&B "%" R6B"
MCZT&4['%!L+ KW@"!R1$%SB*+?08![0+)YAE"U"4)H1EIEP'!?P)%V1 /=4;
M!]3;N$C 8<) 16C"!80 !0!4P/ZY0 AL$A$%R@3,U"V(P ;<X-1H %N,BA_T
MU5_*%V%ZV0N,UT[< E,E%B,UR0A(@+BDR@=HP$ALP@5\P 7XAR>\B1EHU =$
M ,L$ PE44W>%P :4 'MHP%A( ,44Q/EU @,<I@2\0$4LUU-T >8LR@@,S#;-
MVD-XP@9$  5PB6E(2@=,P''NA-^()8: @@9T79?10#P"0QX80$5P 2NM#P-P
MP7?<1'N>% 60@ QX 07D B8L0$>91@1@B"TZ!"B\21W<"0T(&#"\0@;TIWM&
M4*!< 'ZL  P^Q0[@10=<P&25@ 9DB[_L8%AN*%2P%@P(B@0ATHBF#<%\YVW"
M@+W]S?YK]I2'ULH%= !<<,!M8AI&> &FO95VZ@H>P%Q&:,!%@ ('B"BE? =!
MC,$"8(AKML">T=1?^$(+F&@B[00H9,L%^%+9B, %6$<>" HPZ(&@: (%0(D(
M1-('L P9*( <^,(%$(0+F.@'H,0.=!2@6HX$N&97K,#<U4L%Y$*>.L0M6,E.
M# XH@ $4&9+;=,#'T LF3$ %2, %>!4F7, %<$ $,-(K*(!,+&!9W<C^K.JP
MK>H!"LE4:F55*B"0,-M7[H0O<()6>&4PL ?-!0.(3-L=*@A\!*MI>(+3M)QQ
M^->@Y:HO_*I )"M(2 #"C<XND%Z89FNSWL)Z%4=W&.M6B/[+3M#+L2K$)A %
M3WB"L7("BK8,FZ"B=+1$)\#03N0!9/PJ)"H$M)8KO7S&>92&&:S03MC"*WCE
M+7""T^2J)VB%:M =6RRD:<BH54"KLSJK+Y1;1J3:KX:KESU%KPZK=WSK:I!K
M1G0"O8!"O>[$*'"":M3'H!G'R'9 HDCKZ)S'_#2=2WCGZ'BL:812R#:KM=H%
M1NR"<D3(QUH%*,0@6:#>:FQKT)H&)URBQ19MLXZ"RH*(<MS")A2&5_[KT%H%
M09CKV'I"TR9)+?!L0;3LCZ'>6<GJK&XEK19;W,)MJIK"K>)JWNKMWO)MLXW>
M^/6M W)&_CF@5UJ%X>Z$&:C/WO[J0;H&[N$"0R9$*] ^KG1T0 3 T"LX4.5R
M;N=Z+L51P$4@[N>2;NF:;L^>;NHFR2VT#54Z9=T*T-O";NR"%:O""-ZJ;MZ.
M;NXJB>.F+ESL+NGZ*N\2;^76PN06;_(J[_(R;_,Z+^E:Y>SZ7ZTBX.MB95:Z
M+NWJ3UBY".X^[_>";_B*[_B2;_F:[_FB[_C"K>Q*KU;*[OTP(%B5@BFD;_W:
M[_V:;O#JK?[B;__Z[_^FK]V.%?QFI>U:+_8*,-W.[0+++??B#P$!< 1+\ 1_
M+O)2\ 5C< 9S[@&WKP.3E:Q.)0A+KZQ",-]V[)($+UOD )[1G9*<<+/"\ -B
M!!VH&/[B]JH+B"[DNG"]C!'J<H'/C,#2ZC#0@NP//X4GD, +#W$,-RL7F.%7
MFNNT.3'EGNT[N4!AEJQ5> $CL44F1(FB<( 5^N,.ZP% H:Z8[B03>YD2'RL,
MG$46$S'JPO$<QS#(8@0G^ 8H6",5[Z[6M@ J&FX+:_ @/P2L=O A(W("SVX)
M@R\'#"SQ#ABM0+$#M$W>_I ,?\!'V-'GRNE3V((=>BY;C("*5>XHJW')TH%)
MN9/? D,)?!,PV($"2,D"\ 'K)L C)TD9C%>Y @/ZD&XJW2\LC<TMF '_MI4\
M-1TA*[.2,' B._,S:R\"S@@CYZT<P, 8^((M#)\FM$T\%?Z%#>3 1=P"'X!"
M$QBC"VC""# 2*.R #>P!N?*!)_R<HL" 5]W"%\@ AFC".P5#Y^R$',@ &% I
M'8V!#*"!<KP*#BQM,%! )H"!#=2K'<  &/PJ*/R6'@PBXW"!#;Q3"3B%C.W!
M3VP"2VC"#83S3-C"%T1'29\T$;6 %W.2:9Q))NR!"U"45>2!#'!!1828#7 I
M&<B &1C8&-!!"SC0+6P?RXP<&KP =\B!"V""6SQ$3B-81H3T3DL'#+QFGNH!
M/L-0,)@!#(SK0QSJ4\#.,W79SJF+56#""]!!&:RI)Y@T1WP"!XB ==A"%\C
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M*>T%9(!K7  78)FNO !K]8L!? ")09,>Y, &W$0'D  =E$ ">%5&4( -& M
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M,K[@!.KJP!7?<"4"_/'$ D:!0F#8@0#%RT'P0($YYA31!O[6DD.9?$-'91G
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M6H +/OY  @@J&%J@"QB0H"@#%+C@*_A@!=YB!QB  A0"##+@ED@M.TB !#A
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MR";  # "$A1JH2?,8#("Q$\X8+1:X (*0P**AP%2 A0,X!;( "/^:"108 Z
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M\#0/P*!=0*V<4QNUZ!)%"E@0\_)_"UC)VCF>YZRW5)O"@.$+P!7+./DM&H5
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M/&JPP5NGRBK>NE)( ">X4AVMN;JB/?>CQO)& 6G$TMKT?%J)V00%2 W,'@T
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M!9]%!TZ4"PL0D5=3@"TCE5CI "KC!9_5 >](C\BX-B5Y"PMP81#@"9I@:[X
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M-@^P C0'"KO  5,>6.BQ"2U$D1(P C)8,QW0 6HK1W20 &, "A<P'BC0,65
M 200 47C"Q^ Z;O0 73_ 2)C!P\@ H^WJ+?P 77_"H8O0C59?RC@M1=@"QQ
M5IW/ :4G,C* 3Q(PECMU3R $;"A@ SMP^APP,VC@WXE# *F:&#9  >,A!Q)0
M A6 D/XB\ "Y8,D3#; :@*UG5P<9 +# X 9\9_@J,T(N( ==]^QRD$^HI7,W
M4 $E( &0HQ@R@')>P %DD ?\";,^I 'OMWZ+46N:SP$7I@&E]7")00< 00)8
M+0T=2HQH 6P3!1$77  #=<$71 H36UP0X4)#,$\8.82X!4PDL(L9-WZ*P$$&
M!SK -& 2*>.+2YC .,#TA*(%'8DC@:%P4$N/")%UB'84H:%%,)^V%I01Z6L$
MAP\<1@';(:&$!*BU*'0(U@&3+PHAO8;D(R('&*(C.XR8^B$D4@TK@-DJ*[+#
M'F!V*&PE(Y),A(P7,M5B$)*IF0\C-T4(.>9!APT2:GYA</XA0HA:P#YE"%&U
MLTA/?V%TD5!KA)ZH*#0D!>53CX01$L:(+"''YV[>O7W_!N[3U'!3ITB1*D7*
ME"M5PR65:FY*$O'CQ5<16N1JNJE5I@@58F[J^"GCI4RQDD3HE'CBXLV;*B5I
MU1H+4129$#!HU?/AR+G'+\654@@A1!565C&AAEC:*^6]Y=)39$'N2%'$..62
M&RX^5MZH[[X !A%0/.7@0TZ5$SP@Y T$3A!PNE,P5$4514A1Q95"!E'$E?:(
M0R4XWWQA2J1@)A()E$V"C,HG4&+SY98A?6H2&"*!\423*9,<R1=-KAK)DTVF
MO&6B*8$4Z99,0A+2EBX]\>D63?YV"09)TJS$4LHR/9G(EB'E](3-D5[!!$V?
M@M'DE9%VX23/)X6\,@\)>ENTS#-'"L;))\>\BXN)0$F,4DPQ"0P8-RX 9M%%
MHQPH$S5W6U+*D(@T59/.K@3F%DQRB=/.J(*,=58A-XFMSBG[U)503N0DC4TB
M?<&3S#&9FG(78#0!HZ@*=@M&SV*7!;8W6CTY=B1;,%G555VC!48..T2R(:$@
M*>#CEB,IU2187>]UL]R[K'1VT"OAC&H33^1D5M]@.)D72D]""C/7D8Q$5DI5
MLXS81XLO]FU'4V*,CKB.-R:./.)6Z6X]XESI;CA5UA-9Y91;-@65]IHK)04%
M#E @#/X!8]288^A(+F6506+HF4%55E'%P5-*;LYDE8=+P8 #%@CC8YF?7@4.
M"*3VH)#N.@;;Y%68<["]4S!&.VVUUV:[U+;;KOAMGV!8H ZWY>9-AKHD,",X
M6S[X8 0*-,&[<,,/E_L6$3[8"A'$$>?D@A)$\XD#/@R/^_&UX\Y<\[<U!CUT
MT45W>G33BW.%E$("/)TX!VN<.?2R6]]8P-5UE#UIE!=9!&G:34>E<\^')[YX
MXWNK9;3A;=%$T.! Z836XZ>GWD=0$JU^<V)W<S)[[[_W_/?62Q>__.%\-S]]
M\WD^/>F-4U9_QQ[!I[]^^^_'/W_]]^>_?_^!"QWY2"= T_XU"'0PBU_H:)9
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MU+;2(/XAP)# 4Y\(C OHQA:A'%XP*!F<.I"JGO9\6A(\ ((TN&(1*5B#8J-
MG"5D( P>2$!!5]$&$&B@!M-9Q65!L(98M,$""P#!(&9@@ HLP:(16 X<3C39
MT,[@#2=@@22BX($D@&P)&% !(6P4 S4H-@FN> ,$4*N?&.[HCJ?+8W0#N#9?
MY$ $+0C6)D;P 3N (1AY: DPZ( '<GJ"#VX0B2;$ (PZD$ $MPE&!"CY"1=\
M  <3X0,:QJ !&P3C$QR(@*9$8@?T*J1:=3C(4$4 E1VHZ19<R 4P^% "$80J
M*A>@0PL^0-Y@<,'!FAJ# T2@USQTP 5FJ @P,#&Y+A#1#?YTP($&JC40&'P
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M@@-88 FKN.B&!@""&0A@!K(X@0 J4 $$0* "#@A &F)Q\B54( &*X'@"GAZ
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M%YBJ,8B 3< $!F"\D8@ "OB"72B!MR(!$@ %.AB OJ$-3T"#!/BK")"U,>"
MOG@ 0>D$!D@4#6@)!P@!3Y"#!'"2!_ "4)"! F EIM"$!<@#3>" !B G]%N
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M/# L7V  3] #R "%6C" (:Q-8' !+Q!.-.D KM1 4/"%*7F%EA2)#P #6X"
MB7@V]GH4B!"^.H!-?@.&## S,[A)M\D!&1 )"FBR5>("$EA*/D@ :6$*J63.
M,< $21R%6DB 3<@#I&J8;M(-.NA &)@J8( !+^ $X7M/8^H+"A@)G>*"$?"%
M6O # P"&Q1.)6NA.#I@#D5BJ\PRO_0)&_&F/T*H "(A')5B$F9.%E5L"1IBY
MCP*!!""%]5B%)5@  2" )2"$ XB (L6 #EB%&"  X2J$ OY(@05IT4J(  :(
M  O(  HHA!@8 $-8!0? @%AH1B10@P&@ *>3 ($<@!20!4) @*-34D* GQ:Z
MH[)K( *B2(O1 P:0@19X@1?PA"Z8RB&1@%T 5)&@@1L AJ%D4"_ A XTOA#@
M@@Q8I >H!2^( +N" 1C(A3$XP"]@O#)H#"21@2[0A)\"A>WJ @T(C 4K/#9Y
MA0C(A1'H !C@4VX;"0GPDS&X29T:B A0$PK@BY'0@$6J)IL0I/@B')$@ 063
M S&HNXDHR[9L,I'@@+Z9$C/0 !BX 0HM X%@BOES&Q< @TSH0#N$ ,6Q&P?P
M$T_@.QM U/@"!3EH"S(@B@A(5OXT.,">3-82( .-)),6" P)V"J!Y:M"&S,'
M*($IL87)X0(.6,V:D(!/T%4[J3RW^8"A<J=TD3@^T "RB W7G-B)N  4=(!V
M<0$8L 48<#62^(*Q(A,8R$50: $*< "[D4&R8@H8^ +NG @_N!8Y0"=0X#LZ
MZ,C<G("D,HJ[R8&0=,O!@8%LO3L<*!=-D @*L 4Y*%D^E0$JXP '&(&0X( #
M13_%%(D7^ *.=9L-D% Z:(R)R( \N($+H%4%?<7%!%%;F( ^ ]%:R%MMZD H
M2E'-&1E#$( 3Z 5]#(-"D-%!0( E((4"T #M<( &4(2CN8,P4(12\( "( 0%
M ($2&OZ$.X@%%EC26" $)UV0"8B 56A'23#=-W"%%.#<58B +^V# >#'BY,%
M4GB#0B@$ E#3TSTZ%D  X6)(.XJ?B&S(!-HCM&%7(F&E,NC(V^NPA_B)0615
M/A@!&JB6#UA0$M -231/VP0&6\-)QE//W< $49L)[\4-J @D'XP-=D7*Q?0%
M5A*2SXP)]VP 0V+7D*  1?N)N,0\YES04=A,MUE6D3A+/:#0GEP7P@L25P0&
M3M@!4#" JR@-75Q/O(I!%1.!%^@;GV@U$0B)"2BT.G@4&(A+"8C MMA)8!B!
M!16RNZ& K>I-'UP77W" 12+8MDRF"V"-.@@6"0@,BZ@[YOZL%I]L2T_(@P?>
M!0=(5F!X@04=PW0)U>@\0 H@S@<63O-ZX&EAT)5U 45D@-'X #%8NZYTR@]M
M #0>@UK(/#QX%*(MDO$L6HGC4[OC21Q8T Q(*B[F NLEE-WX "\0B-EP#%_0
M S_1 *X,VW1)T,5465_0/X@P %*T@_ ,A@8 A2ZP"XEYQ>4$T6"X6)'P Z;2
M #/CP,"U'X]1! 5P@!F@@  H(P P@1D%@!@8.0 H4@(@J%-@!3@(  I(@@6H
M %9(@@!8K !8 EE8 @%(@#<PA048@!-0!9P;9@*  !48NE@X@0 HD 6P@%B
M@UV.!1,8 !.@@ & @T( @!/09?Z*0H( 4( U *B/>2FS<<B'1"'S6!LZPP0O
M2 Q?>  N\ ,4N$_[I ,S,(#:U #XTH &4!,9Z !.* ,&>(%@8 !*DMM,: 'T
MTS.1X((ZI(,$,#-A/>-7[(!-, ,&2(@.J!8-0 $^0($"\ 5.X4\*6%"18  -
MT ,T6 !6VH":;H$"N,H1,"097  YR(,+<$JA'0,_N(#%9(I#SLZ9R%9-&#21
MR  N'(E/< #^E( =X&@SP 07. !/&+.18( IEF$'H)4]$("XK ,KM ,':(D;
MT-\%^ 0W@,U6K@4]'#3K%0D'J D1R$4^B  2:($(Z!L&Z+,&@ D.Z !;V($'
M\ ,]T/YLMVD"#=@$-'B F_S!PX:)"+@!3( ! 9C-2%L ,] ##DA#;!4)+Q"
M0G, QZE$3'@!UK8)%,@$&WB4$EC,$JC-0<L$49R)!&B"3;@!=&(*.M,$+QB
M5&. ',B#KDT7PP*%-)2#!_[NNZ"*%>"  V2*+G  UGB )OM,'N:"3&BTW0"#
M # SQM$$&Q ^+T JQEZ7#]B 6E!ADEA0%Z !78P %%@!J&0*/2  ', $%.A
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M6E&$B@Z% JA\:@X5TA$1VJB..H\5"JB-62@2RJ>O*2'$_QH1BM/F@O-[&I\
MHATZ;_ZBBVS[S5>2,5@ NGH<+KCH,?0JW]C>3RB#H.!\^V&*_=J$5$YI_O&%
M\OL$'+@ )*&#,%[]B1L=\U".]2B;XX4/!S$@T1%^X=<B,4K^#$%^.OT=YY>I
MY:5\S(>K/@H&\Z,4*9HE/P)<<&(GMW&E4@)_=<I^:O(D9BJB2HH8)/$$$N!+
M\P\G\D<D-W !%YC6(KH%+[!PP(I_]#\DI@"(8, &$B0H$-C!@@<7&FS8,"%"
MAP4'"DQ8<2+%C!DA8L0HYX4+/!B#<9Q(LB/'DA 9=AR5H\6.6@4[E=%H<Z1"
MDSD[\NSI\R?0H$*'$C5E]"C2I$J7,FWJ]"G4J%*G4JUJU?[H*:):MW+MZO4K
MV+!BQY(M:_8LVK1JU[)MZ];GU;ARFZJB6G?JJ;E0\^9EVE?I7Z=9N;)$^?:P
M3L0]2PIE7-8QSY,J(^Z4J/BR5\AB-3>.C'GL2LHY.7_N236PWM1TXZ)NO?2N
M:M2F9 O&6OHV[MRZ=_/N[?LW<,Q[51,O;IRI*MFTC\_F6H=+ERY<QI2TA0:8
MICR5>?HJ<TNKKUT#[6P2K77R0%^^@-4RXQ,R:8IF;"T&9MUSXH&Y#JH?Z(;^
M5J%-= MC$&DBPR<$;?)%=%SL01 F,J#0Q7? Z.$'0:"X=]-XF!"5DDZ>T.'3
M+67$AU-]/1'84(GK8=2?91'Y8OY&0IN82) ;HWR8V'[ B A40G* 8EB*0<4G
MAW8#W4*&=%^4-Y G#$J7)(>]+;4<<UEJN:5>KJ'"E00<X$"###NXF%$F# ##
MA0CF^>3+"$,2)<<( W4 1GY?"00#%]B14.58<'KB9D&<,'#B1!SP,9 -32#4
M0":$;B>4HC_EXL .WPFT@P$YV"!# CL DP<#8MB!0@3?C0!#1'4DX-,-UR$:
M5!D: /K)".O-^M4M%,A4$"BYZL2%#4"!LH"FP) !@!P$-:"'I$/E,L&0=KP0
M+481V('M3[NVE( $+G8R  PWN)! #@.-40 .,MBP *O!%<3E58%AF11L4.5+
M[US['OYUKU%?;G5!'1AY8H><FD@ S!<MI,<''P+=4N$M+LHD7C 5Y\&)07Q@
MX@N  W6Q@4PCR%&+';D0=/"O%-5RT"WBV5+'H.E=J.L(,O@2C,J^Y#*SC@.]
M4D<MN9P9C"V^\/$DE'6\DE[,'(LW4'85(L0')YU(P%@F>5AMBQT<VR<!C<"4
MX,)Z$CSYB=/IY5)+'NOYH0E!ONP1L9*^8(*W+1+<6- F=E2(R0,)$L1%G0+I
M\>H(H@ID,C HX!!1'@\,9 L>=!>T,]5XA'QY,'Z4![?5G=0A)S"^X%&+'!\\
MC'=!/4^,!^J@#R23+Q,CG+<M-6N"A]6>U&&X)@XL6G'OP/ZH?/4>+KZ PO*@
MG%[0W*!$L#PP8U @@9P4+ K,*#3?#O-WONC1/$+T;>)+)P_L(=#4OW\^4.
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M#!1H9/Y-@K'#%HS@>A'I@@RX4$%@2.!!9:" 246E@3 JJF\RP")[+O#,3M!
M 1SXA!YLE8,/X, !!3M(#CI0UH*I$P87X,!Z=J"!%EX'!S%-I PX8%(,T>$"
M.9  *@ERBP^(H 44&%0.1*#7B6!R#"& T@+H TX49,]65#- ,/1 @1S\%#B
M"2%HGP*PUS1EM%@YCL!T@HD#',!#$.&  S2PO5<43V7'LL4F:/@%&V[ G<"
MP0MVX0#V38!5-TAD T;QB0,,JG)K<AW#:!B1'@YD!%8$1D [$0&!>")<!)%!
M(O.@ 5] H!,(F8 G^&"Y1Y:G!7W2! W+\ "!X("R#,"0+_X:T"SN$@!#MUC
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MU8081$ )D,U$>((!A!$F2  )7/X JR04J1X6B27 &(!"!2A+9Y*!J 5#%W"
M&8R (W8"!*S "$A 098!K\*0LE 60ER ><G !11K>?A"2!748G[!RKT3!6QJ
MLPSK"!CK0)2?=M!! O3)!="-&?!J! 21&3 =!SS()G1:&QD>!]!'!CQ)!M!-
M#BB 2!S$#:0K!41*+5" U1"@#0D$'VR7+_1J"%! "%1(#CA !CR "'Q'X(W
M!WQ LKS EYG4IEX'06B A^3!\K5 3:@3^D'3+5S !Y3 "(C:+2C6!VS TW3>
MPM3!-;EC0928")B45T:MZ\B .]$7!9! !$#+>:* Z0W$+MD"#A3D*,01G'"
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M-W<S=W3O=A( ]W@K 7AK=W)+MW"WMW5#-W53]W"WMW/3=Q)@MW([=Q@XAAF
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)Q[JL+W-    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>comp_0014.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0014.gif
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M\>SS^>?P]_3T]/CW]_?W^/CW^/;X^_____CX]P
M
M
M
M
M
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M:6@8)9@!6&""G/ T"_"3OX@ T2@&4FD7E\   RD7F]  B8@8?_  U#@L@M
MCUB"90 !>C$*!P"&;.  >7$& I &"$$""$"%%E"55.B" H$!&)"&HY !$]"-
M#7$!52D094  1BB#7W !)UD8)( "3Z,"%0D8AZ  -#DLJ2"94",(#B"95WDA
M);@&O1B%"*"42V,%>(D0'K "6F !'$ (J* (+4"%9\ !&X "KXD*9[ !QYF&
MBC "&Q "B<@&'H !): )J- "#OY@ 0O9 L Y"BV@ 1NPBJAP"2W0!B!P 5;
M@EQ0!IO) ;;8!650!AO0A%^P 1J0!9S(!<R)!2<8"22P 2#PAW.X A=  ILP
M"B70 !G@!:B0!L99 FF)"H+  0[@ 8)0!A20!AN  >2)"F+  1JPE<VH" [
M!B2  <,I$(<0 A[@ 8%0C T@B)MP ATPG@(A!E_P!1BP ;:8"EB0 1G0!0@Q
M!B*ZD (Q"BJ  2= EJ;0$'_@ 1Q  @-9HSVJA:A0!AR0 2K0A.!Y""40!*B
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M6K@%99 %%N !;0F1J& %#]",)*  7%"4>"D(!3 *I9D&%9H!S?B-I%N=Y=D
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M&K"0J0#?R\J)%FP(D5#G)G@"KGR"(H"8J( %D!X"F]B("?"BK7H @3 *&[
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MD04NF<@$XSP*(;.&K  L!!0F"D2!$?\XY)+<%!D# [D\($%$$O%:;B+:(G+
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MAR', OXE)N!V11F%!!C@**?V%30.\( *'F "3^+N !3(L .^A $#0, !#W"
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M'+$"!P"7Q?@##]  $@BK(/@#-DK5CP"#134:O<D %"F#@C@!A&-5".D\%]V
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M*4O,50T(@JL(@F'=/_8<, +PBB\XD*2U6[SX @[8 ".]&!< 5#" .@YP !!
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M02MH -C;A,L*A"Y8*L;A8B\VC#21@''"'>$:A:&; !8X1,)MWC^NN> :$0F
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M$MB1=]&"\A)+VW+2K>U:C^""#/_HICY>!B ]B> $!ZB,@S@ZNPAO&TL%1H(
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MH#(D0#<*6,[PO(4%1:4B FQ(Q0*00A=,94$_C&/#* Z PRPD8#R*0$U2VI!
M&$)$ FE(Q>Y0@0@4H&84"\"A^000B%0T '(&V,079(0)TZVPA PB7!>N!1$3
MV<Q:%T%=B?:6@$BT)!$3^ TJ2."M$*"@31#HV"5,D I%'/[@1Z-!5""2)8;J
MK' FN0.,\&3GD(R, 5-[,T!N+$ T$)A@$P=XV!I$HP)J;4)^22'!!R)RQJ0H
M @-$(\%,N! @%9 H(Q50R<9008<+R8<+E\#?3%2@*, <HG4/V\Q#J(8:#!SP
MC:B8TD,VD0 <EJ%\#22:!YYB 1>TB02IP(*['G+*$0B1#>6S2@E(M E;3:^)
M26'#,B70, 00#0Q4DD^S_$3!ASA >I-Y2!="5@:[<"&!H"'1!E*GMXFNK $R
M4=DV49$&!0AR 9$90P)(T(('I#,I8C# !JS& $$J($@0N6%2K%"F$7Q1HP@X
MB1@^PRT)*#,"%[G$!#; @@=$B?XU!@"7[2BP@15(H"2HN  %0J""!A25.E)E
M #F_(#7)-* %)B#! JC4 @-$27G#$0$*&! 98#GH!&R2J5=+H  PX \NC&@
M!D: @@38K L*X)X"7C:"N63$FJCX @.XQX#E=!(B9? D_DX2B)O>Z00J.,$$
MYB(!F[GS)"=PP'H@X!#RF: $"1 B1+)0 !)-( L104 J(FD"%92  C>)G 54
M]1 5.$ %'A#M*"3 @17\+6DN"%FM1O@0A(% !4WKC )*8((%U(\K#?13 MZR
M/U20+R-9L(LB&,"!$H @*!I9 $NIY )$Z>XCCRW!"3YH$@Y,8 48F(!#N)
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M'1LI\-[>]$L9K( 5]&090$ (W/X*&XQ'&6C"&*@ :BF""ZP X6Q"&FQ"%JB
M<AFF7S[$)ZS!28R"%JS @F@,:HV"%_36"(G!"@2!@]"!?6#!2?R!7#)"86:/
M"KB J"E""T!&8C3;"J3=WH3 <3B1"Z@ PD%$&SB$@91!"O@<1/0E%L2<:JI
MOR@"YK7 "B2&((B !'3!*-S-)H!05US1MC#<%WR!&"!@8!;@8F#!"K"$28C!
M6]#!CQ@(&ZA %SQ/;8[0)5BE%C23P(T"%ZR <[;8\LTE1,B*(JR "V"+?*I
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ME&7;!)1!798':D0 .0'I<B" 3#>9!V1 &EA&;2!" 6Q(",S$']PK;E. +Q.
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M![W0#WT).F%+?N+1:R05NF1( K'3YZ'34R0(6, %> #3,7T:KZ%&<N0>MB%
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MEQAX2,4  RH3 D:I('!(4X,->0.T '/@@)@6 ,1L"F!BU/X6 ($.(<"!,50
M@(M+&KA+()#B0T4""5"AH+1  D!L-@W** ._4:SH(I4&RL/$@.PB*.V/%1 I
M3L4566S1Q1=AC%'&&9\2Z O\2-G @$T."<"%@4H9913R4$E% 1!,86"#41R
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MB'6!\DH@()!-6OAQE E.2RCEE5MH(:\=4UG@/38,O$0 $C9A@X1##@$ SD
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MX0>.DXP$,@J2%$D0>-%(1C;Q"8+8)A%C"=@ ':*(0)!B(/\[8)$@. J7.&R
MJ8#@)3 1$P'&I( C<5TB_A"1@^!%)>-+WD#2D   '"  "F@#*E8   ($0
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MAE1 H%%,^D JOG2 " 2B.PW@Y@*\8 $!2  OC+@ Z0*'"@M<P ,"2$ ;RF"
M!AP@#9B@@ ,6P #LQ1,F0)0.*AAP@4LD8%T\LP)6+!#-5!R@F(G1ESSA&5:Q
M[B2'-T1%&QB0 *H2- $FF("R3D!&#E3'<PU @ %08)X#-&"=FYB '<<:V'VA
MP@L* -985.  ER:D!2 0PUHNP0$&E( $D1H%"AK@ #I]P; 2P$PJSF,I@&DF
M 5H)P"&8!2>!;*(!$?@(5LHP"@HP(#, \$(@M"9;U8&! (VB)UL X#T3$& 3
M*^@2F?[*P 4 H&\"$T %"@!P@C(HH !>$"AB,+#.0Q0@KQ0@@!7$0  ,;,($
M!9B+%?Y3W+SE)!7WP8*;)G>0Y:!"# !0300<H(CT-$BP_?4O3@12(.JI8$D\
M\\(F$G  $*PA#=$-! C*1(H$!$Y#8[C$4?^0BD,T +#_[6\@+/ M3%Q'# V&
M$PBV6)N,9J$$ 7"N" R0!O^(X1 72$ +7E(V7U$P%0VQ@@!08+$N;&(-SU((
M01@@@5,XY!!:(($1-U$!"!4)- \:2 2X<P(!7 )<)#C!!O!3M#)8@0"7R*Z6
M*   1;1  "*1@'/=Y()-(, "*#C!J$9Q 0<,9 (0^C%>ROXP  5H@ M.>R(&
M1K,!$' 2 P @@2D$$8#X*L( 9D$%&"Z9A@((=0('(**'01UJ5!1H#1PI0PLV
M0  L*">A;$Y1I,?PAP!TX 1*?(\&"J60#(LZU"HH@$$V(8A 8.$ G2.! %2C
M",D-!$^*.  'TB &!#P A\1UB+-$X) 0.& 3_2QU!!,@@8\X*SM<&X 'RL !
M!6Q"0A(1Q,LD\"\)9+G,*R" "[+@A2^4KP$A0'2$')"%+'S!"YA0#UXD0 %5
M^6@3&1,6L49A ==&2.$N:/- _F %,%M:D1/   8L4!N'!.(TW\9$ AJU+ "P
M8""8]I6&O5"&(D<4K+RV^?L"#/Z 4H]B PD KP"LL D"9 <5_;14?6.-G2QL
M 0R6T@ $;AYJ@0 J(5Y@@ 56D(#.P3@AE(ZO!# @B -8H .T9GD*JLD12Y)
M#,=45A "X $5: DQ]]& &+B@  .4KQ224D2Z$E!;+Q"" 75\D$ @H/#S7((.
M20-%&4@@$A44QBHM"( :. 0R%"S30<XE!)MTN@!%8 (%;YF  Y;<9U18/NA6
MH(!':(63=!6 !%QHP5M.D#0V>-> F+;*"AJ00FI*,>K%QZ. '26 8MYHU03(
M]D%&MP$'$"!7!ZC--BV% 02,P=#&'ZM 2F" ##? N<HQB[%$D@JP6*$$!<@
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M0  VR0*T0N1(8 $<P  BJE^8:@4*(!# X!<=A:H&H@V2)A $@+X@0!'BS3C
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M<R3 F1* :"1-$RMM4#S  ;2@!+@@$%@ 5O-"EPXAR1I6 $X@>?Y@T$XB $!
M$=!+#"[! H(O%=)  E#">_\7)OKL91R@(2SO RYY &86 -!-IBS10/P0 -B
MW;C %$"  $RA"P!@@Y]K#8?D +Q@F$H@%1[ .;Z D2(ADSEDB<3W <I G\1
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MN V-!0C@H1:@7J([ J<["P(@ BV.$<@DHNJ+#5+'LX]-$\)[;,G[/30A 4H
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M[-N[?^^]U*:B%3--WM308?[9^OO[?R[(0*?8-Q!_^#DTV4"C$/B))@,=6&"
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M?(ZK_D C-9V),I-I R3OLX87;<*1;Y( 'WW$TP*E(3\= .4FV/"G5, T.R=
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M!2[  1V5!JS!:KL%8ZHQ"FFP3R!P!FQP>(FW )Y!)@O@*0PP(JKW)E8U$&R
M 9L@ 0VA"#!A@]K2 5/F(4$P@(C1 G\  6R0!FL@"![19 :Q"6-  H$E" Z
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M?Z!T1K)X T%8J* "'/ D$. 9B7 (B, %%J 5!!$! ?*)&4E^&Z=DIJ@(A]
M'H%K7QD!'D(($N"'-30*Y_8@$#!E$\ C81@()-  NBAQ9;!//(<8 PAT-#<9
MUK<)!] 01-E-$G<&3L<&KRB!T$@!@(15=8D*6)!U^W@("K )+@!V6"!Q*I !
MV,$(#I F)P!'HR "O"$!MW@(@1"3BB!F&P "D]$"$  "YE47$)")IVDK/C=J
M SA2(?Y@9AZB@"?A(6<  2$P7:G03M37 A& ""$ !MTD 9AF LA) 1X  K1G
M*SP6$ACP 1S  ?^68!6 '6P@@^P$ 9.Q A0  NX46AY@ 3^A:VO 8%CP 1M
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M)TA2NW$(N%84(\!^#4!H\84&3D<0&2 0NVTDJ+%C W'2M^+Y;4># ^$%$-
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M%'5,12(+*IZ80&0@00($!HH--UA!M>($X(IZ^3;D@J&APD -(E?<I 5B"Q&
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M\,ZV<*,%#&3@;>\Y00@P4 **C,($&," 1D8! D\=8@,>L,(7-I"*-D@ #(J
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M+A@!PNJNMG"-#C"0%E*C2UC0&_4/%F  +MA+D_A*4J@ 2]D @TD 46R PW
M-L"."0A R9&5$,""5#0(.3J!!4V#!%"0!M""30 !!U"!45 011"4FKB(VQ !
M?N0 1$J#!H!$"\"0"5@!*R"@^J$(#YH;.?2 ^[2""(D(#.@ 612$F$@(";"B
M"TF%", 6H#@+6TF(!J"6AJ" [<""%D*%S>$.^S$!;3)5\:A3*S$!13B$C]J
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MB!-ZB(B8B(J EHS8B*"H69&XBOU@T:MDB6%ZB01(A)EH"0C@A)S8":_8U*$
M#':YC5&8 !AI@<Q9@4<4@1% 30X821+X@#="&,_('R\(@1)P@#%A PF@@&S=
M@,/R /[5:0@1H RT"),S&)F>X (5^ ,7T->F[*U1"(+&<(!>1 $(L "I,XDV
M$($2L "&$D?+! .E8@,+B Q.6%:%.(2'><7<6($'L  L("<4<(R.:$EWN2$2
MT(#46!P*. 'H$9+6$=C(:%SI$P&;]->5(1,1D "06)/R4(AM'85M00$VP!,O
M&)4D(5D=NX0/J !5V80)2(,0Q("](!/O;(@60-(_.(1 4 $VV*3D%%\ >:D!
M.0 #01 5"(*F<! G:M2#J1!4:(&UR!"S&(U+V!40$1'Q""BAJ "*6!'SB! ,
MV-?]P$42$$\; 0P-T)&$6),?"9(6*H,&. '2#=]A4@ 9A/X2*2$3!]"$$L62
M(:F)F/V#K)27#*2 <<$<^ V!G.F45&"?3ND4%,J5B&":#"B/$KC0G[ "T4'<
MAN" /+F-$3"+/V")#3@AB]@$1?" %6"#-%@!#T@$;56![<@ 1-!&/J$,BN#3
M BH#7E&I-V*D,$&547@ 5 F$F#V!/-H/;!D%.J" ('B6+[@$3,C*[T4%+=T$
M3.B4H<+%0J2 //D J=/>^JG!\L@ U-F/,V!&D"%#CPA'@ETK5$B15-!:5G18
M_5VMP:# AJ!$$.@ #'  #[ 2.*22T9#%W]2GQ(UEX>"73_D7(/X"<S%7@YE@
MHJA9%VB8A_$8DRB5!HT5EB#$$OX]$8VA9I 1&9,@! 9 @\9,&;>B@#;@@,Y<
M0M%0(Q=UB E(8DT8#2OPF4M@ Z&1"6;4)Q$8A4B8@*19FKUYF@(8@ZF)EE.
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MA1A4SA]TB]YX  I@PER@%P=XP!I,6A!F54N1P$R!Q1=\@!:(@<M< !B4@ <
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M6V9E3\KE@H3E@4PE7/JE7O+E6_)D7_JD@ABF2")F8BKF8FZ0"CCF8T*F8ZY
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MQ7BM#!^V1J<P.)]O.6W"+3=W(8.S#]-S!*NR-X/V!#OW9_X;-T[;LT?#LL6
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M9X/PI!]Z-/<PX((VV\9Q-'\M*-!!"*#!*#!S($="!PP  <+M*,S!! R  !3
M!T "M*/QWM8M7G]""QA  PQ"UNM]BG\S#\-]0%^")RR" .R)]*[OYD," VQ
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M9P+U%K"G4&?_*C0%/M.I#@0N@1\\,A0Q6L IE%**6V@DU!H2#+J/WBL+E)#
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M88!-ER83X#1#S"[!@0&DX N!. 600< %-9RB# (X@1JZ:H(_!. "6#A#8C=
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M2: "%B 2(@$%'(  $. , $<"#/Y  +1 # @  S)@ \KH%-0' 02@ ^8F#PG
M -8@I;@@;0K@41P  P0A 21  [X0!2+A#$O#Y4S!E2@1)PKA $;@+;1K#AH/
M+2[A%/9J-!3A#_9#$-   +8 +2P  A*+X;)@#98%%;J*#D+C"]"B57!B$18@
M U"BXTSA AH $A3K 3SA#.;%!!Z  A2K 11!L2* XSY@%#3A+18A 3@ <!K
M D[  $S $Q:@/([# Q; &[-@<$S@ #Y0 Q@@\-A  &()LSQ #;#.$$< E$!
M 12A+5H@ @J@ #C'+3H  12P#Y^(#4 !%-1  () 5%9* -) +R"@ L8# SP!
M$AI X_[6@ ,20  J(!/^@ !6 "U.@ $TH-*\0! "X$+\L6$FJ<528<S*H#C(
M)P#4(%D$0!&\0"/> @00X!!4XP JH!-'8 4@023MQ0$ZH.T^[S1"HM/H  $J
M8 ,R0 10( ZO9@ DX! >Z/\:B$NRI!/2C\+T2R&,)$B&K_A$Z(0Z;"]"*+\0
MC+\4K,5(B"8*XH+TTOB([\ NB"C.Y,&^A,4,K$F& C+_Q/V>1#%3C#(=T_PP
M$_XDTRE HC(?,TC\ZTBBPH1PX@S" #H@ 00"( VZB@WR#+D$X1_?L23'PP-<
M[U:X( 4U,@@&H:A2 Q02@0,:X ,Z8  *02D=\.S8P! &X/[S+D$"@.(2&* $
M/ #1!@(4N@!T3H#O/@&LL$/MTH "*B NM.T++J$ 5B #GBH$$& #,  $1$ H
M,R$1'  !P& 1RBT!!"$5UD !7*[D&$"H1D$,TF 3JA,622  # $5,&#HRF#6
M:JT$_J8$ J 04"$#&F 16F#RFBX%!$0O0"<0G.X2OD 0V  %%F&\!D 0@N#=
M_D  5" T1L,$#$!_[$B2*&!GR&"!7*X_*N %L:R((L !%.<"#N 2!NX*8&(4
MV*  0DH1=@L!;C$ Z&<43J H42&JUB T5N 2/F  6I&>HA2I&$,14/(4PO$4
M.M0;,2 "$BT!/,$4[.BUI#$4,/X  CK! A0@$31!*A5! 1S* #( %0KAUUPO
M'B/R/R]AS5 A.D] EAA@$>PE @R >@;@ Q2A $( %3PA#-;@%#P  0;A$ZQ@
MIA8! 7@JL3R@[,X.N:Q  "YJ$Q1AQQ F 52 RG;26"80 T#A)$.@$$[@#[P4
M -C -DT@2L5I:-I0\2YD#0:@84!'$;8CTRC5#+"K4+0 $@ZP\V;M+>*S$$8!
M$NX.%1!40:]2DO". 50O$1A@!$!ADBZ!NDQ%#-B@6.< %:Z@LU@D-8>H2WB$
M_?22P^JKP([#2RP,A19B_"@H4"K33+;/*)9/,&\B^0*%OPRB)@[L,PF,@]*D
M8@76+?Z;KR;J4F0]","(#R%.%DP20F57%B]=UB^32$16%B?H*V,'0KT ( 4@
M 1+JZ@\N+PT.80 @@ LPX#8;(%A/<J : *M\L^[\D6H2 "@.00%40"F1ZP0$
MX!"\8-:JD V,=I$R00(NX#10@ $4P 708B 80 (F[@!T, (4@ TRX0(,P#5_
ML.L$@%\[X*_P[8DN0A"\(!%" C080  ,(  6@ S<-K?H#!3$8$HAX,Y& :1@
MT0L&0"PAZQ+HX@L4(0!"(!4TEW,W +(@ 04 0 ,LP  8$  F8-]:X!180 !B
MQ@#H !4+%0%N[@0 8 /R=@WH M^\3G_2JPP,H $LEY\>X/ZD/.$!'. 3!$$!
M N!88/$,$&!Y"6 TS   :/<@1H$+ -$AI>L/S@  GG038.8 )$  \N(0'$
M-C$ P+0 (("7#F -+BX1HK)-F>H4)N  O)$"$F 46D  +D #$. !1J$"!MB!
MZW0-$$ !&F"KK H#1D'I-&"I1H#),KCDH"H #& .0&"GE!8$4$&NN*=?0( !
M3("03F$+N*(!+,U+!:  _J":%/@A>P(4%JNQ.@M9U4 OQ)< '$ !$D!<2B M
MAVP1(!4H((&U+L$!HNQ=-P4" , #+N$![BZWM* E*#488^G*^+$S!@L"#* 7
M!P'@3,9KNVJ5QDX "B$NKLX!'/Y@NSPA 2!@(!+ 1Z_.I P@#=ZQ@<&@(A[
MW1:44QW@Y4("_5C,26*%_# 3A'26_4J,2^IRA\CO1^Z$PDY'(;)DAHQDB0BB
M^TR#PKIOQI0H4 X,012LPH"C^:1/Q X,E@>L+5FLE5WY3^X2_F99/33,EM_R
MEP'LED=H$Q9AJ0Z@ -[W%#+" 7T& E3@ !#I "; 7%EK$PX-%:KIW4*#4KF
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M5N !).&0(& (48@**K );, !+( !7G )6_@!>/8'6ND!QO[U!Y@H LEHA'_
M!8"X!@ZP JD !O=79!UW"-7EA$#'3I=0C-2$722P<5:P78+  :,P 4)&BP2'
M"AMP""%P!A?V!6+@ 0"U!NS5<*C0!2V@"!)P6\F%"A/@=AK0BK5F :A @Z@@
MCES@9H(@!IYY:!206R!0!J.@ D>&!:F0@&N@;ABP"0FXC:@P=Y>P!A?&;1@G
M"*1YG_M9!AZ&"F< =:\V ;UUG"N !OO)!FD ;E/7!JC  LQ97:;W"13 !I=
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ML*QG (X.@,+M:KB*L+AD* 9<T 74) )"=\56L :'F&C1"%!GT*K%* 96 +J
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M7 P<O!I'AAB6<IDG76R C(E0K,O6K^$K >26"L5M@1*& E^@ BC79S@, HC
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MD,BJF210 J/P!QAP AY0;60(8!U+BQ\@ B->3?:GE).N?#V(!1.6\VG ;5Q
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M!19<$A;Q:" (' @#*LH 2))%IR\DX$ J5* (4!)2$2MH00D.U@(KA( ,@H
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M0! K* HJ/+#/,WC !1R83!GVZ )4!&$$*M  (T81@IET(!4G2 46XI*!OXC
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M"I$/(*4,?Y@ ([) KC*$8!2$H,!"0,"334R@)B)0 Q:L<(H>L4$$T>',"M+
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M[\A"HV !-  [''2Q[=LX&^0+;5.)N+""+)!#3I"C$SB8%;B6L5B*/V ]TK,
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MF$T6 P XSN\Y #=37Q<+@* 2@+I$&$(" (<TO 0@  ,P@*(0! 8  05(C2]
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M@(#*4VL)6( $.,8&D( (6(#P ?Z "3B #N@V!5" I=#L!R@ 5SR! %" ""
MS'$ "#@*!4B  U  O[8  W   N",,"  #'   9" 2V $ < <.E" !E  !U (
M'4\ !#B BS2 !D" -FB!@$8! % (#4@ NR$ "!  LUL "Z" LYZ0,Q" ,G@
MQ"D# ,@,+GAI+@CIS?6"Y'(-,2CRP4[<-<^,<V: !,@C%2  #5_' V  !DC<
M '  !TB 3&. WJ  40. 0+0 !;   0@ GF@! <@  PB %G,! #@8$1  KU&
M Y   G _H6[IC ( # Z #%"  &@ U&F! 6   8@EO6'QRX9.1S<    X!&"
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M0) @ %C !A"C.;%%#PDR7)@ @(T7 (D/"T+E0.TF!AA0K0& !D3A#ZLQ3 A
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MTX (%" -B@  AT*'LAG2L(8VO"$.<ZC#KYP! WC"@%=2@84NK65*'2*!;JQ
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MJEKW4R+GQ'65=;5(&@[0@C0>(),Z_2M@ RO8P1+V06FX  /&*4, +98_A-(
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M;8(5B(!'XI4H,L !2  # $#V?$  2( #!("^= \(!( (V/Z&\+S0"6C" #A
M"A! "!"* D# %[R0=R3-!TA  21& ^Q.3))+Z$P 9HA0;1R"42J" .33OJA
M=3R+!XB!CH@15HZC6JXE6Y),GSRC"ZB2^B2,! S J\@D*AP 0\3D6!  !@1"
M!#04%X0&BJ@/!DC :[P0Y1! 3UX(!$#  #3 /1Y2]D# !42C5FQ" .C(9@%
M!ZS-+$$  U2 !93A'^S.3A), S# ?<3(*#Q  T0,9_*&*$X  US")B3 ;IB
M  R$!OS.!_0566#'LOQ+ !B"%>)F\* "&Z3.(1A "QP")A)$ GQ+\#Q3X%@$
M)Z3%5ZP! Q@ :   "[2+ >B("_XX@ 7\@060SP.H@$P$1@&VI7S.)WWVQQG,
M#@!LYJ-83V]02B@NQ]., HZ 0"I,!RH<!1J Q0 $D %P0!QER!ALPB789+P8
M2TB9B !P%'2PD_54!3>"A7U(A'>(IEMP@&1PP/)<Z"%X 6.,T"4,1<+\CS^*
MH@-40$5 P&Y$#$R00 (P@@38Z(R4AF9F@;@P50M,0 5H5"E418^X2PN(!,8
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MV$C:1("UOBF[MNM:AH"I5@0*R(9V_(%TAL A:,QR-(!:V$L(%.AN+$L)!8(
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MF(R%&*3 5(2!"KA%&X  !E@!J20J%B1A"V  %HC!"KC%%X3$**1 C^0/!GA
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M6&E%1D*#;$"1<&!ER# $O*,)C&U%3"!-';(';.]_& HA"/Y"(,!$3"F(3+0
M0 ,*BAS"ICP(: W6"< +R5R0@U[T#&' 0"$(OB3"@\C$%W"+*7 T*D2$D716
M@I1!!+#T5[ C?X !MT3UL%J (AQ"&B0 :D#T@@C"!HB 1*'"^%9$&8Q "9Q%
M&43*O]P'"G2D3)#!(;B M$A !PS$&"1.%I2M)5M$W(S &IZ!".@C<V9 &H#
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M"20 %W!3+]E]&4Q ]DS !*" )%(@&WB :B9&(#A [[2  E/$FZ#"!6@!(61
MV\?$R&_$U-;,(71!!OP!$&I";FY \W+!Y@/A8A^"\-I'"(0 &UB!!' "&QC
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MH$U.X$ %"OB:0)%44@F# X_63D53[NAZ8+"4(E/!"D6<+-5L"]3[&)5 ,I"
M O'H1-?8@290%(,_P$@, A!(&"&$4*/ZHS^VQW :A8UA.BLE"4@K%Q41,"!!
M:!(")*'DYR8 (><07AK( @PLN A:U4< @:_#O_!IH%%6V$ %#,0L00NV-WE@
M)&93"7F3#,0&87G2,& #D0E(P4 \+S10G;?/(>5  @G$%J@-#@)1X0LNLK!B
MDP8JS_*+42# )!5$Z,\9A"Z6AH5#?>%BJ7#!"@+A))1Q+"H86,,:;B:"$7Q
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M!LPH-B X@1@(^0%!D,)(-,+$0HZB.!HM#A59& $JV,!05*1GDU.95)W6< A
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M6K  -MSM"17@+I@9#:Q@J_0JNZ3Y =*@QWR"F:T/,U@-!;8D @)A#?2-,++
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ME"@[%]]=<L(&7.C>F"(IJ$ ""26,(-4A(MBDFA??I;))&9=4P-0F*GA  E/
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ML 4%,&&,@ 'G$PB32$05@"X'L"A2TP(<@ %X,1<24":(H_X8/ @&!B ]*=@
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MA+8!*@ ?TN$0(-$"*9 ^ Z$)"?Z@@Z#Z)7+C.R][4]TT$!Q !EG9$%)XGA\
M!HK! 8;AEPP"MO(%B*C "*HRL4HA+%8 !I[71 C1N581N3"3:SX"MF3!!1>!
M<OB$ 5G"(011:20P&<TG%C2A?8(P%%80,&F  A$[$&L0/?^D=S12). )!JHC
M 0QB$@HJ!OEA)=);GC=*K45B F]!3^+C*)=0:2J0N^RA%N%Q"6W &L4S$"70
M%P^[GX(  5O6 .8+$R*+!?_T+>7B>KTY+:4% 3."EQY@&&O 9R+[!S]I!17*
M!J3!>=\Y"G_ 9VIG4]X[$G_@ (0V ;]TK2)+(!7TDZ-0 0Q1 ?#B?$KA6Q4
MFK%[%/X3,8*C\ 6=<PBHFU(-("GH^X6H0 @-< JM(U$#(08=$1:1,:WF@Q <
M('8>H+0G(+W-H@@(,!""4!6!E["5YD")*S&7ZX!CB\5*FH%>D 49, &P* %8
MD 4^:!5A/,9ETBP$X6]<\ #AH0("P!3IX06J)P&88"XWXADEP $0)'<.40%=
M0 ( ,@H+D!0T@0$W6B#1,0%<T&\, 08!,!$>H)8FH80+4!8?. H4,)\@8 "7
M( @:LP80D 46JPC+Z 5;\":*X+V@5ZGB0P%=8 */6C0OHPA:T !<@ 5@VQ 1
MT$P4T' 2,!E/^SYI^@%E224;H*X0EJ 0(,:($F)=< */FOXBJ6LE"9"##) *
M7N  N'S%)K$ICL%G7D :,+$!#?!\''!A4*@Y#K ;M)80X]H%$T E*M  0< %
M#I!?,Q@$8UP&J>"9YA$!7X %&( !%0$OO-P9IT,"!D"3-Y)R&% "#@L?0?-1
M8E"95E)IHY  ^.("8G$V3 %(!%)*S.<!)2 &*& <6> H*/ 6H=@8'E"T^^C)
MUK@!6-&6WS(*_>=A*I *91 !7; "7WPF4^6/7P W< <N% $N)GD",W8 (\$)
M-]/$!< (6R@A$@ =$! (RRH&8# !&4".?:$>-^4"!S,@B>S-#< A"W$?5@#(
MKM@T#;>KKFS4$P "6:DSBB"$AOZ6Q7U-6?&3!JD@!IN@%5^P JK# 6-@V.EH
M<+,D;_Y*N?(60']@!8%]@7H]%X:-*KT)CVL0@ RV!C75!A,\$FG  EP@-YL0
MV"$5V3TU$3G8::K!"5EP$Q"KVF82!%8PP5;0SV- 2%R0"G\P$FSPV9T6*L2[
M=2ZP:L-[$9M V[+S!X6L$ETM!EY@OIBT*)2K"%9@!=)=!BO0!:HAW .AB48G
MAO#R!RZ@VQDD(IB=H.8[W:XC!E^0%(+@ FEP" %\:EO&!2O F^I;!H':$-M]
M$P/1.F,WCE_P+Q?AN*G0WX+PBC11WI/2W_23$ZMQ"/#8TPDZ+0,1"&61!JJ!
MM4L;*OX?3N%9< FUPA,]Q11@D+L]C4QEL D[,KQ=LMJ;D"6"P-B"  8FT08!
MV"610)XT(08XM@F1&^)SD>2;X*^( +$)FU%I,!&*H-Y,D0JA'5*5C8&-S1N\
M]1UT0-HT<0A<=Q&*('KL% A<8 * "CIE8 5B^ 7L%"HA'CU^;>=)20'RM*5_
M=>=]+EDF 52Q00J;K5A9$ %\;DZ=XN< %3F+[NAA2U12_E&2SM=355_AQ=>O
M=C>@55_MQ62>+F9#55A*-5BVD>DZA1&:9E,P\0<YINFHQ54=QM=$%$"F+E>;
MGE6X$>NUL>MK13=?91*$4":]_NC%;NS'CNS)KNS+SNS-[O[LSP[MZ'3JT4[M
MU6[MUX[MV:[MV\[MW>[MWP[NX2[N61Q6N#[N@?7IYTY<ZEY.TVY.[FXW\,[N
M\T[O]6[O]X[O ]4%(E""CF,"HY!-OMX:]I0!./CJ1P98J-5J&'%*4!7J:+7=
M6-5^H+[P7C#D7J(%(R,P&3];H(5)KB94[Y,&MPOLPTMW6O55K@$K[%;KLIY6
M7RE6H$[L%$&P- 'S*FCE<57J#Y]!+J"#:F4]/Y]3@<" GI[RMH[T.V\^&K[N
M=<4%WDEE^+0X9[GJ"9IMZ)[P&-$"X1+U^?,:JM$&J",BJB[O^=X:(\\%"E "
MCY0UB.X:99  6+ &7)  UAOOYOXT"A^(3C.X&F>P:W:S9#!Q!@ZP B(0:V70
M (5/I[/QPDY&0+.Q!K!Z-V>234TC,67OXS\I[2>Q%%+#J7 !'0JU"49)&QVT
M8LO5/N2%>^E>&QEPN\BU D?9FVMJ-WSB6Z\QB;'!!:2A!;5N]@DU >2Y 6=
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MD0I$B:E3/4 W): 6%BY"OT"8$A45> @JZL4(!T#D3B'PV7;RM<&12  A4/%
M,2>6J1 \) $KQ  88A>3P1AP+ X8A0A2X,<O7% F9KF@DQ*RA@="*R$JH)8#
M8+3"A&"@+1R(5!FZ1(&SH4($L3F ;2J03Q$X#"HVW(D78$B!-(Q"5\\2@:;&
ML(DR)40##V% +R%2@E@9TPK80OZ;SR"6$"ULT &1$4,P46$!*<9I2;=)Q1I,
M*L-.H6*E6.M=.!.2!0M-8*%HX!])(GJ(8%KADG^@E@2\-SZ<6  5&$!C""(5
M@BRDKB6?S$N79.+)_655JUOEJOWZ]S__&68-;&@ K$P @99 10Q(?8H@4F&!
ML[F/FUB@UB@H )@T*'4#D7G0CQ9& A)\,! 54,CX\BJEFR5$#,9R)RH>H!42
M0" #.E3!11 " HLNA@0FH( *4@&[P/Q!G('X419BY0 1D* $O_/E)<304 >,
M0+54$FU''-(1DV @ W<Y1 9V2QDN., "*RB*!Q:*@5Z-#RK[=")"4 "P443
MM5TB5/X%1#"0ZOX%%5V(E ,2 15%<"US#!H+"AP@2! %ACD:4"J33$ "$40@
M%2JP@N52\04'P.H$-UR!0$]@E320"[]F=< ?5$ D^$)@O@!+!175I."(''9C
MN(UA^U!Q@7Q6X ]I:  *-@N!-2AB A, 04PX!BL21. W)JD !3P0DR)5A LN
M&@54*I:ZTV"A51?>R0?G-($/C&44(9"L-=6@5+8,E)M6N.5&48$&!U2@!#>Q
ML1788 45!.($!VD 8$U@@19D;4 / &P),$"M@4I *UR062HT0!$ZE("S%]E
M&6J+D"S(#%&4400&)N"!G;A@QR?P&0?*D(I4$&("HYC 0/Z^8"$6I@X1F\"
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MR1=6*?Z"J)H W7@3+)B\0, J94M !5S $VDLJ+" J4HB7),B1<B [D %%V
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ME)X1Q4C0A >(C%;4FSD4 [F)1:A3.E1H)M.0 %,)G1YA@\="!81BD$^LQ9'
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MP  -V/X 14@%"L 8#@)."^B KN@""_ MD; :B/@#_104#.PE*]"C2T"9R\R
M"]"(+SC0#?B*"$T(*WB(( &!UA09P:2P3?" #4@%$@@0$=B)0-!/"QB>%]T
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M<%D/U?X-I#7;[;A+W$($Y3VGOEE2O"@!RX0@S>G>0V!=.=NG$1%=\T61+_
M#C"!KN""V=5"D4"##]" ZW0*1%",-! +RM#:F;D+P8T*OKI6^;U<%F:1/T@
M+HCA+$BLW4C+YT7!2-%=14   MD(F0D#&)9A1[HH"N@"+> ">?2E/>4"+?B"
MP46OEU6!DI@ ZB"!'1P10>B=W:"@BDU:9A*HA&"!-&E@5" $ ZC<_1$#!A +
M,$@ ^\T?"QABPNTJ5I&IKQC<HT4%%6@HI[ " &41,3"5;64#K/H#!A"#[TB
M [:" 0!CB, "V(W=,D" &$;B\4TV+HB - B$%8@H"@"!+O[8 B8N"2NHJ#7
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M<98UP/X7O=Z(0CV=L0 !"F@!3J4E!C@;!DB\!MB #8, 7@H8W:P:@D 6?JF
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M6,%"*' &13! 6(NCE *$=88#P$8WJ*B 4%JPD 28U0"7"(2Y",*%L([B$A[
M% 7$@PHLG&I:HF(.*O[PR#(XX ]TJ*0@6EJ&01T@79B"#@7>EH@&_($1!-C(
M'Z*E/OY>;F 4E1P*"2HP.T1 0"@4:,$E+_D\$%! $)M80P48("T?HD(0"FA#
M*KZ0152D(;"HF, 9].B!JU2 "^UL9HT8 #O9BJ$TKD-GZ-*9QNMB-[O:)0I@
M$W,!"*3A$&,!;FLN@8$6I,(#TDH%"C"@ 1(8Q@48V, &8&/8C7S! ALPD<DT
M$+(6V.8,XS4*U Z%"BU((#$5,)!IJ$00&X%%.1K8  $)T@()B& %K5F!"D*
M 1!0Y 1D.-MQP_(6#L F"^"=2P2$DH8*:, "#E:!!3S0 A%$YQ(=@.4H3) !
M#*" %'K<R% .D0$/L, +%QC%"4(@ @RHES8*A')C5K"5BOYPP0(:Z "/Z-B8
M8&Z@!&+ P!^L8+:V<:@#AE%$B2LBB,2 #4 /M;(%-L&I)W/@CQ<(P1=(8 6H
M&>82/#E!(Z,SA@DD!@7]R<(%(M*8/V"  Q;(R2A(D $-G" 5:W!(&;0UBA"
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M<I&$(G!!9:8/98;,(01CV#6&3(D!0PZ%($P $GH!"2@"&9+$)K1FWVE'R%C
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MK$'$G!^K5H0&;$6-R1CG^$ZVHOY(B^;HJ !8*MG%":6(%GQ%1FR ( 7-"5C
M"H0  Y1:;@5.CSRD?UP-E53 'XA!"^S.!E!E P0+:!C&%JP'J B%ZX#2!,Q$
MI&2!"31)&I1&L *7!+2 "8CL&#B "HA3\SP "%P ^XUD25+)"8! %CR %FP"
M"#A +DDJ%U1J*HC! V# <PC&4%A! W  &RA,"90DC%C!!&Q _0#7=A /L_Q/
M;5B$"F ! U#)P6D?^F#1@34 ARE <6$!L)Y  HA&>BEN-U9)>J$ %BQ F.1/
MN;J&C6E MS"K!S  )GR!!'# 0KQNX6T *0R5"9R 0J  ?17/!F!!L@R%-L$N
M"W" N_ZN1 -XY;RF0+WF5CRMP+Z1!"*<!$GX*VTX0,#V:?;ZRXOI3_[\%<)U
MRQ=L# :\Q2$< $60@$V P8D@QR8(PC_910,4&P88(5P,3$U5A+6@@G,1101@
MA).\T";85DPH@B!DP*X]SRCXT1I("B8L"$EHA**4 <%5A(TH#J9TP!>^G)O)
MU7+,R'B]5(-41,Z04%3R!1N0(QLD@HU(2P4(8UA@R@/\4$CE+UAT@5-IP<8<
M\/=H2T<44T540$[^K@-(@-3XAWCL!&TX1-FF@CFZ1M^@4,HYP%N$P-L4!'9(
M0,N8AA'FET?P! DQAP>(AQ6< /["!9&9@&U@4$5$0" 4$OY)(<"<"L+]E&/W
MT2Q,Z-<*S--68,% ?H$ A(T#%-<E "Z&;(47E(P ;T(82$H:; (;U,4*?$D$
MP$P*_ 0$S(8%V(8"2 VF;LO . ",%,O92 KVCL(#L!R? 1 =DX3A,$3^8&.Z
M/$!^<L$I%84D5T0)8,&HU>8?-'&IG01I'%BWN !\,0"/2, /70(I <B<GM2)
M'$(@Q(5A% PJA')%",@:R$5N&4"'H-0F "U7*)<BD0"FI(*GM(%3*? L;HTU
MS_!.DEG&.!47K$<&6.-6A8]>9!%!!+%=9($%$+$1:^] -\6?2BT)36\9=(O&
M"%9A84Z(>)H5H(4#< *DH8*0<?[ 5M O\0BS0H,(7J""=@Y%&D! !9  RYV)
M"$7'MV2&?RC)Y>I&"5!%13AP7W2$_DQ K_ %%V!*LE:)U/:K(MBD>4U WA9$
MF FJ:J0"K#P*;)2 W.;$W>A&[GJ,76&*!!@"=$Q @P+QE[)0*G@!ID#  L6)
M.0/(G5H \VW"%Q@ 5>:6N\0'>,Q$*I  [)1&.&'G*;?!LC0'ND3-<!D,>IA'
M7GK$VV0.PHP;8.S7*+ !&6U:/JD6'1 $JOK@R&J &\ZQ81"$*3A 8UO&PX0T
M3$RQFP4."E! !K2 QEE*?*" 1DT&=H3 6Y )1GA !&S 1G"OB""'9K<)'"F*
MMCSP</XUMETHR1HX@ 64<6%9S1N6P AP$RJ\3D70@0-$!^T(R\N(V@-P A:
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M84(7]801CH!RD2-MU.\I,R<(F,W.Q%DJ<.S9#),)&*&"*$P9/(PFV)1=24
M60&04, =Q5898*7&$80<$<4"8<A,. "57'B/=$Y?O)%K=!/+P4;I$ _H>,3Q
MQ(;>H@(CD,$6B= *L$ 3?\H99  X]P?]A+2!60#,V @C$$28,,>]0D<%/! "
M0;>,U.VD5+B.^\?]P KQ74("Q*4@&$ J_$E%7"M6,/8&C$4$7,BJQ$]IS/M?
MG0 G@ L0;Y)?V 4;>(!K^SO$\_Z$%URK;->.72!,%M0<&U^"@&<-22P*?@B9
M"8R)DG3!!DPY#A%$"'C,GE.6G_<)*G2!@FJX:Z0!(]SY:A8122PZD#>'X)KX
MT'?FP&CMP;2 4%_"W23,]F4$9P6.2J&"O9.07 E" & $&W@*"^>F5!W,5@1(
M(#2QW=D(3"#.5.GYSR1  3,'XB04T.Y%L:T!!VBVR(C 57#0214;&Y1?1HW'
M.@H"42F. )S,,-E8190HU%)$%H $XUJ) 2C"%X3E"?Q$7]W$!J0J*FS!QNQ2
M13Q ]TT %YP"/6,93Z1 "!!$":SC6BWG)61! O3%!)3 TW06B;^N77A8<X1.
M;(>Y2OX(P@'T#8Y^P1\0?V,W6:4<P$9@,EF$ENO\! H\P(F< $^T  <(&0IH
M02>-$#_=A 1H2U AOMY"*H<"<I5\2T!>DB8H0E"^40N@E.=^ 04\CPNL1ZO"
MD@J@3_> ?0/,AM=@RA\ 1(-#J+Y 0-4"!"I4'+@$DH!*10E4'DZ8VD2!"RH,
M+5(I4M "%8-("KE4V)3J1(A-#OZ@.L0@E: &BD8I$(2JS(&!'EIL@GA"H<)4
M$ *AZC+AI H.!T>@2A44E94%;#8)@I "%18+HQ0QX'*H@4\Q%5 Y0(1J5(-+
M@AQ$#:'02L(2&,2X2)!&X1\'EU")H> 4E5Z^8R:@VJ2! O[?5 ]NIG*@R..A
M5%T$;.+B0:@%+:@4-?BCR,$H5"1 IE5TR4'1/QM$/_60I6Q15$2A8CS%90/)
MW"E /"W1!7 J"R%.:TEP*=4$$I=&_4FP9I.8IU"I5[=^'7MV[=NY=_?^'?SV
M-F^S;%$DH0,&"B!5*%>A8C1>0KVS8D'EQ<('+BA6' JQ0KTR",)L.I?H.T2#
M#"P( ZT.%*&N# LVH. +5+@ Z9 -,J  #%0"2<A"$E+AX,$(-<" #:A&(2$#
M#.!#)0T+-+A@#8+@.X$,J+R8((,6/+A$$<P0V6 ##$YX"HL*-" 1IPM>:X&$
M%3%8\D%%$K0 MJ#$@,^#@5+YP/Y+DA[X(PV@< )J%!,PP"!*J!@!80(*,&@)
ME4M"D'."C():<8,2Q)@3"SU;R$@0"S P080*GQJ%@S@IH$ "1BY9DX40\ )!
MME12P""#-E$ @00,-E ,!4Y#X(J!@1129 ,/5/CB@DM(H!.$ELJ0<X5: 4.D
M@D<I@*!&0320@,?&-J!3JPQ^=*J%"B[@@"]4!,'@@CRI4R0"T<2P((,,;KH$
MA&Y!:"ZA+*PP+(060>*L11)(V&S4H(*84J6^*IA0#+1"P&"4;4'@0@43<'K
M"U0H*&JZ5$!0U8H+,@B!KPNMXX)8"58PQ3 0*D"!A(Q<D-&"HIAD%)-#,/N"
M!86^6/Y!H3)*8 .$?)^R0D(+Z%1(JPUL5L@$S)SRX,%4NKR/@@Q6\&"3,E
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M9"CU2$H5'N*#U4%E$B^QF=,)POY_L#R=(L'3R3^&41$'R,A35( 5/D*E0%G
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MA182E&0,X-=:3^$"64DPD$# YP\>T/-9% $"\RK.PQG@0$O^L$$)!<U"#K!
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M#."I): $%4!@]U8J) R!+< J<2ZA!A4A ZK*[1IH^@:JYHA($ KC$ Y@$UB
MR-2B9=RMJCA1-#@!$=:  Y8F SK+I8"##?XB"R3 "U1E3RZAT/[""IA)HLJ
M+[2/=]: +(2"$P0A#2*@]PQ"(?Y0* N:PD+>HL0TL0W8H@P:S-]<P![Q\0M
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M@ T98,,HON!HF; A$%\(@07?4OX&$IQ /$I=SN9Z/)2!? $$8E"!"Y VD$V
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M*.J%"OX1>$!6$OC$'PC@@C)DX))L:$"=)2"=PP:B,A-H]02&[A,'K$ 17&!
M%\K0 .1\P<]B\"I63L!.N$3D>V707!J*AA(P%*W&(B!$"[QTB*RC00(B$L$$
MQ!"&!!QB-*A A 3$P(8*I($-V[),3S(P9E.3IP%=$,,%*"#."7B@#$$(#NB]
M@-TL0( 3),R" ZSP: C\8?'D@X %3HT&!XQ!# S SADFD(8SL%T0;4Z#MH[/
M *F%KC(C:(#4%1!;06A  VE +0K*$(*G7V("7&##!A:+"D8P@"TM<, G#A%R
M*#E@8*W!<:)2 F5@ @<@")?0,4[1 /ND %D@-)OQ%EA@>OY=X ""< @;4"!,
M)'Y[)A.34P98@ !<P#$XP05/AP$J< @F@!DJD !?4 919QUSUP4*X!45D 5_
MT &;D0;BYWA5LSET)1,=4""BHP@;@8,>("(MH #%=@D.H"H:@!PM< !80 84
MP (A(S8,D$"CH  =( 98L !C QN\T@7:-()1,0:;8 4/H 6,)@%G( 8.@$YA
M<0*;H 4'\ 5<T  B, 9*81PM$ @>4%%P00$RD0!"MP(/('"^DX)@H !<4 8.
MP#-B0 %L4 :X\DPK\"(0]1.HP %O8AF<&%<_J(E,@DE>8  N0 89@!U<X"4B
M  *"L#NHD 80<&K8MP'] P%9\/XNK>$%!S "//, N@@"^R4&"A!01 <83#80
MQE<E%)$2E3%_ ^$%5.("I"4EZ*<(_U=C7* MIF,RXF,!OD0B@3,=3Q<D<R$?
MJ,!<V9$S$% \)< R;A$"*_86+<  'I Z7A(&4O(ECX<0,W%YJ# "D8-WQO$D
MJ/ !8* (0T,"G66+G@(G3509I+ )"; ))A Y:="-!Q$U R$!A^"0('(!'7%(
M)R4X=N4:RC4BM&$!!A(F%T0;+N S+" B?]  J+$)_H$28N S+C80NB95+B B
M)X-/3AA7E^04# !."?@AMK()>6(L*. 9$R I99(*#! (EQ !^&$L*I SJ$ (
M)5-K#OY 05B '5B@<90%,BZFE1]2%*)R%1J@.:CA8#=R&>?5&@V " ,Q!H'
M!<25"J,Q"AMP2_]8$0B% :V& 6P !F@Q"HB@ *F !4_G$0(Q"BM8-SY3?PR
M"B?@&3OR%KRB14'Y $8H':-@;OF12HP@)0^@15^ %FJ7'=44 ?6Q(ACP8J@0
M">LH$PY " ,1 0EG =*1!=MU9U"3!BA1=:%$ G03%\=A,4ZC $H5 >RB)!L0
M52S07&_Q=\;# +;F)?"Q!GDR*N?E&:P1GMY4-+!5BV7R;<L8&":@ ![@ 0D@
M(AS'':X")QCU'$+2 BQ#&?B1(]?R/CMR"%*R(IMP AV@ OYS5QLU4AFC0"(K
M %]P<0J6V(X(M2-&(@(B, +G8XKAY!J7DVAPP0;_=U("DIBUF#Q+,9>X=A >
M$(W*H0C;8D,C( (A<$DH$#:580410 (AX'6*8"O<H0@4(' IPATBF34#T0(3
M  $M0#99$QN)T#DJ$ &HT:1P(@C<40;P" (@"@(BPED^64O$]!:069!/D@I#
M^18J@ *$R2XX6I!&5:0A@!,HH:3A5)5[\Y54DCAP0@C1XA&9\0==*:B@F07<
ML0GJ@A4NP1VID 8!BAFD&00;@ (7D 5.B!^I8 4:AP4G, H3@!]BH#HA@!8J
MT%DJ\&(0\#YN80) 4:3$9 %MP/Z?T--;@-(6&+ &+C !1#H"IB2JX40U)Z!B
MDB,BN)92I7,!RF@BI9$*6_ B?(.L&\ C7/ !V50=KS&M@6,BZ8,%/;%UJ&&I
MKN$!$D!]+V6(J$"<G.% !X%!("*66= 3#E"DL1B!*%&3,W4)!K$)"X !': !
M!R 0*[ !GV<CR,$&6: %!M*=^20@0H02%" (8N E:\ !(E "2XH*3S80)989
MMX82N)*Q6$$N/E$UWY99\PD7>Y-%@O %#Y 9>78&0H(!>98&E8&-3A$JW9)Z
M!9D%"GHLE>$!)X 2(: YYB@E*1 $'C!";\&.198=F %79&%"@G  _J,"E7$"
M445"2_[W%FT82J,A'9<@),UQ0F\" C8J!G@R, II,E R')M!7@.1" ,3BF0"
M%RDR$'&3-1-U0A"@:HP@ 2@A 3R3&0)QE<D1@2;P(A( 6A[1$2H0!&-)/IM0
MI*'TDP01@27PIEBQ D:9)W>* F$[0HQ0EC7Z&C8#FIYQL:!R$%SJNDY1'6 [
M$*L+3O+C'^0UFBCA(RZ  ?AA!9MA7 31$(?  5O (VS  !TA"$]'.P.Q BQ@
M)!^R0>0J9W,9-*%R$%A -[HX$!E@9R7GESYK'110@CQ";+4V/_/G):1YEEG1
M(0XV 3CA!3R2!4NIH-R!M7P"-9BRO:E0 7*R!AF %"!&&OYR80$R(9(>D8E3
M>YSV>DD/\"R%!%0'X)=16AU*TE?:Q +[))8@4HI8T0(E]Q9=T)FU\6A[BF)D
M$2KHN5DB8I G02,H.Q J:W;,07\ONQ=8D)@)($ Z21G5(8>24DO[]"*"L "-
M)A15<FI?X!M_4+.I\7\@0 )(DP!68 JD03*;PP LLPDI@$,2L *;$ 35-'GM
M6 %]%0%M<1#YV 5KP ()@!HG( %98 59$ 1-@5<MD 96R $"IP@+L%KUN3 .
MH'T8P#(9$(H9T 6&O(!ILC(>@0%-(Y58< A64!EKP !MP$RF=1 Z.1,-,))
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MN5B1!A^ S]&8!K?$ 1Z09W!!!G0E94'S.(\#:YNS%!L0BG !<2?P!UAP.6R
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MPB5$L#BMG& $!W'5%[P2 A0((@07ZN0A+- !]8QD!"QYR GP5P:8M"!D@,*
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M 'OJ@HMU"#80<S$0 2MB P/HL8A+ Q=X.Y]B4_K6"&PWBX[<(<3@;T:#  T
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M0@.DHH55DH !@4C(0DCQ@"\D(@L&"$0X%\*!F_24$R"8:.0X>10(?$$162C
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M8,]]GLJK_P""2%.HB[ 4@X8B**)-G  E:VAQ()XCPNR((3 _,3:&*LD%#8A
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M+FK4)3B 4;B  82:"&1&_5!("J7" :P (X@! P357XW7*,Q&%SI'2[(H&RA
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M3_P'7&I/&Z2 G5Q-1(RC1/@%0+H1QIQ!K/3/5&#+RHR"(:0!!#R= XQ"&S2
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MZ1S@ !X#F8\M, #O]-AC5&B 258@@$T*2 $)I&(3*9# !+!0"IT$X@,.X #
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M,/+%!4 O]O1P#YDL$ X@ !B  [P@:ZS V3R# 59@ A8.%13  #9 X1C. "H
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MPH",P-I8AT9,C@-)CM!(POJKD2YA%.;(PYQ8X[2XTNKGBJ/,C_THD+'LP<H
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M0!EAD']):3]7)P9JQH%4,OUU! LF80CAA"(N%:2!@-HICN,R132J<"!4J/
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M""!$-)F=P&,<^A07TV 1@FG$ ?[J;$!V5$"@,XG!;()@ "D*>@(K; )9EU"
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M"C^4B&_9$FWYE4W2$6W +T/9,%G0 DXS)5?I)(!ID&$Y/:, !BW !379/)O
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M+SH1 OV1 8> !9X2(XIP'A9@,D3& ;4#-A)6D2>@)JQ7'HJ@ 5UK,HP3 A+
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M!@$%!G6I"%Y@!4I-/5A<FR-S&BJ@""UP!NGE :&#.TO%* =R"6.#N,^D$1I
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M$Q4GL!!KW?M>^,8W1SEIB9/X1TWAF)4I^R4)-(,S"AX&IPVSZ6!^'3*N,FQ
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M%YC,KJ-^(@)X"1':.?^Y!,& 3>B"YR"2E*" K&N!,U. ,_J"=2N6BTF%0R"
M+#@C7SD($L W!^"*+J RD&"3["& JU $!: F N +5(B 0+@$!I";0^@^3"@
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MCE2H $4A"33PO9'  %R;/(?8@#+H @/, BFY!"ZPC1;8C7"9#Q'@ BY8@09
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M@#^2X,K]\@ Q* @R^((RV+XL&/Z!@]B9^D*%#4@!,?#--5)"IF!.$FB70XB
M$SB#+& .[SB(+%"!%B0#,* .$Q*$S" )$? "+F".E(A"@-2*XUH6$R@.RE@!
M!T =DF O5!"=E(#%T(C.48"P,C (5/" J0#"G9A/*\@R)X&)+O"RE" !+1B:
MC1*$6MN)%A2#[DP#CX* %F #MIB5,(,(T' (%.A%H' G0<B"0_ "VSB($%"$
M$B"+YE+*'"J^PTG.,Y";L*!*D2B640"#"2B#[EP##0*8,I@--C@*+H#)/^"
M/] "XLHRM/B Y/2J<<D Y/N#"[@$N20)SNP,=FJ:TP )=5$$+-@ 3SL(K[")
M!4+-D?XH0,513#=]T\1L00MM@3T\.@]-0K+@ @IHB!.@@-'@3!=POL>< !>X
MA#(P .0#'P[\#+D!@PS0*!B)3:AHQ C@E@^(-U[3#J9(ES]PEE3P%^%$B.1
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MJ#R7+3!>"Q!.5AS9['$ #DB%([43#W@.KBS:>S*<9FD\UU@^$6#.0% 8$-
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MH+2%0'W5#Y<%R!L.V(G/V 1-"?Z$,IR;DR@#!F P@; ?!D $0F" H1N(-'@
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M@8+J%&44AT;:^&-RA@YLP JV0^\A0D#/[5!O^_%*U@G^T((RL*'X[7]_3=+
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M!8C 7YD &#&?VV! !-Q*%_S!$'J!!5R?"%" 1AW"&)+ 47 !1G!!&]AK!F2
M0!E*KS[A"KB&(("/E83%%WP !U@C G% )\8$'>B&%8!!"'!9@1"%8K@$%F2!
M!8# =H -H]J$"\I@MQQ"-OY!!(C';F3!"$Q 6EZ0_H@$Y(W 1";*]JV Z7&!
M V! 6 1""'A ",C3&'#-?#PB%U@C&VQ?"JP)!T"  -Y1"PSCX_P!^E%M*JA
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MC$(72$ @V-$/7P(;' "FU=.9/DH'"-BR) "'+$=66L"C!/Y8M)#R& C 0"3
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M"N30(53'4M'()JPO Q0C03Z'G!+,L3=WG% A08J7!-")"K0 ($IM&D#$%JB
M;I! CZP G@H-1%GX"11$!:@14:"  ==+%J?7SN 1GK3 ;CL6"CC6% \-!D#J
M"F3!$$L9&X3 !#320G=\8\ *2;85UB&>6MMF-J%HN5A "'!-"WR!4Z[ \W*"
M^&0 S9^/&*!400#'4$MDHK2%"XQ),&ODM:[!!3R34H5RM!C<(W6R;8H B_P!
MT'"I!IAZ"K! %R 2!*L C62 J6.\F *:"EC!:J6U@92!!91 %T PKB"-FW#
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MY!*6*1=11B&]Y;SG(BW(719&L0G+:&%L@AE*&1;$1**481,U5$2Y$%&N0ZQ
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MA!<:\$<)K($465A(&A[PATMLX 2;: $&PG-I5(RA*X>0@#M+C(HEH8<" E$
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MB$(%*OY #%* ,\CL-A(@$HZ#!,! !/(D%30@!#""([A&QA[ 9\H@ ;8 5[1
M#$9  6H" S1 $:#,C"# "[B >% !_LR" 12!#1* 3@BE- (O^WX0"(-0"#$J
M%<1@*KCH(+R@!1"C?G[I!'XDGUI@"P;(.&;)+_X@!58 @^)/"S9I* +A!+"
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M8C"X('7OS#,NH0'8K3XW@1!J)#^&@@T\@ RJ:R3X@R#BH@+FB1 8 5&TH%?
M&A4> $D> PMF)/2*(@UP R$ J_Z>X6*+'$ +#L$0N@(W".(" &E!ZDXMBKO7
M%6$J8G8#IB(#L  1""'3O;X_%($.F"4-:*JZ8:,#R&"F^WK8P8(4G&\DMMQ
ME@/&4>'A$&&S39P48*8^*4/-.4\04MGQX!P_N%LX?L-MNXD1XB(1),!D(F -
MOH R# '1FGTJSEU$QT "PBZJ%82J+">042HG.$*@C[,"F@+G0 ^.VV AQ$+<
MV2#.-T,B4X$#7D,1(N!W+:\REL8*L(X$'$0BK*#UW%O?:% DV*#A1B42J((
M+@$1T/C30&!LVNQ'<&4H.LYM94M-P((##&/]E<^2E6Q>.KA4)N E%J F L$
MLMT!$/Z"$):&>MD0($XP0%5&PB9462R@ D%BDZ*#J"*BH@!FU"$'HU I0I"Q
MBP)47S9$]")R0AI4J1@\=' )U84LJ#9)$(,*PI^(7S1$O% &E2 (-7L>.M &
M504NHQ0U0-7"0T82)%"-:!&1!-4S&25:125A340);#@U\!HHP:@3*[AR(6A
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M)88TD*(_.ASG)AB$B"]X!24S3L,#UC"*'D>$$39>X"A$'$+YHEA 'DB!?:R
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M (QP&1'AA)$@"!B!(+XF <&6!OEQ"0:Q$ 6T ><EB<KI)5R@$ #4G+#74QN
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M.:. :%U),!+ "&UJ&VRPIQ^S%ZB0 E1!@4O(E!(1H&> B(@:F3H;"8F$?%F
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MMYN"P#X)V.B"@4TVR38-!M8P!8%+@%JA# Y&D)" %L2@ (6$K*"@#2XJV-"
M$[X P<(V"EB__0T1 ,$L%#8H8X4)1@E!6%0D^$,7)M &+_Y88!3)HE6O%+A
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M:AI#H_Z])-G*0W VA+B$@8U:-I,T;E6@5#@TAS#%OQ*!O/@##/" T8%5+FB
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MV@NE@PKXL+H J8.H (9^+T'P K4P"=+"B:3! )DS!2L"@=GPK,7\L52"B1&
MM(2X@*8 7S1Z$."PHBG' *X8A3+@@KAYG3!&A3$P)=<EW0D@)B#5@!) @ZRI
M@"IK;>AA3]YIQIPY&Q%H)2.Y! ;P AWOCTFCF;H0@0IH 1$%E3+P .O1FAS_
M@@,XA#.H*(%(:E?]GT/XM('0CPE@@2[P@A%0&PKX=*@1&:FL"!$@@?+"* BP
M O!,FVA3A#( @0-("3!2B.DR!8P[@3%(RTT0 ]/[G0H0-@QH PD2@RW8\>/(
M.BQ8"Y+"C14X51YSB-U A0ZP#OY9AX F:@&/>J4R<#MA$3??T,>'N',MJ&LN
M0P5$)EZ"8 -"D)@@8"0L8(TM P%.=8@N(.8T^*["4\3"O",-. .7#@,NZ (#
MV 0A5YJ&"#;RAND+YO@"N(0N6#2[C !C)FWR(-.E]BT^ A4&T.MGIPF8:7!I
MMBXZVJ<RT*)991I&V!]4V(*-B0 ?R@@O>!@0Z(('C(XD:>U+LP@W2]R0BX!)
MA7'&D(#N[N</H2LV@  QZ((O6 -&@%4??Z]-B$0P4'=VTU327@,6D( YX;=#
MU@^<:)&&H_B#H  B1A\5L("PP(!VY'(XZ[:#$-L0J$MWMX@?;QJ@.;EB2HA\
M3PHN*/X0*G*(;T($#$ $ T*$"2@!>X>)I$:(1WJUE!@%+R !>%F(=T>:5]L9
MZ-%K15"SIU:$2(<TQD\*,?B"+RB)@] 3OQ.(,U"!!CC5,$D(ED0<L@<#'8EU
M<JL 19#3'D*2IOF)";""WR\##4H#%;#5K) <J6R(\O+WFS"A@4A$I$H(#D.%
M GKV>)\8*\" 8TF(@%.!-%@!80DR"_Z#"P0(,5[ I+GD18*5-AS28'(P*A6J
M("I0I8((9@.J4:A:E$#%X0M%5"(W37B(RDI'!YL(25!1Q@4*5!C&B,Q01B1.
MD8(DH'AY I5-5 \4H=("0N2%-BPC=D3E0@4C"#@WW,S)Q?X#JC(7,J+"(B(G
M&@LA09S)DD%,%S%K1F4)@6J#EY,MRKAM<9:+VE%:OD+,Z2!0R!(F4*G8A),%
M!U05XD),TX!4SB^7<$)8<\E!152''*#B@E$CE\1]487(@DJ1A,E>444XI$CJ
ME\0@O""2@,H4JMBH)ORA2 $P3@Y=;N\.Q"G"Y)S*ES-O[OPY].C2IU.O;KVZ
M!#0A@P)-LZF!QJ[)<7K@@FJ-V/,,1(ZAX'2P4Q2CCF9,,.I025060*(ZT1$"
M42>1X!M@:6" "@)$;<+ 9""8]L<$&]&7AE0>\&=A2*A\=XA(&)@W A89=IB&
M2%\H<* 56)T'@48@A-!"5^FMX/Z642&)@5$J$B@B1H@2BN@A1?.YQ8 @J/RA
MP"@KK-&A&)H\@ H)IJ$B@A:I.,!A9XJ4885(5H!PR5>:,3#:)0;0))($8"C"
M69>CB)$83B*$L()(% BB" .&;2+!)B+TR,89E[AUF@*CG=: )JA@B$H:#%#P
MT -MC#0!%JD<$)=(%82(0D=D\DE"@ U(&MB J(  (P4DHG(!&Y> )Q(6FU!0
M%02].;"D8C#BI$@#D:!YTZ(X?:* JONAPAD+])$P$095!34>1"NHN*Q,-P'8
M&7T8L'&(;2AUV=$$5ER2A@&XXL3%4:YB60$8&5["8$8*K/&';5UVY=9'FFT
M HEI1/YHKQ:#*H<!?-^!Y "=(H4P8 7\'<* E"%Q\%-&#+"!B@28DC"@(@M@
MF::(I9W&)RI9?"7!(9=(Y056(&B!2@.]O64:;R)- !Q$66@@TA_@72(!)M<)
M/33111M]M'4/W 11LTQV]L )&8 0'DY6)% &O2-90,(**-R*Q0@BM3 @"12H
MD$%'.VFTDPDB6*#)* X$:(5;.?;F+RHF9+"""A;$A$4"8@@BU2@:@(!"96]A
MNL%P.8G!TP8A0!0"E\I50")$&W V"@<>H""!JET(P"%+*JQ0PI4LAW1D":9
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MI M'>=@*4A$EXBQY.B18TA<.1!T\Q?HZC,C3<]:$ N!VQ@4"A9=T) "2\55
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M$,B<AL@$YOS&L22'!MRG3)R %W2!"E"B^"E*NX# N(E$(A2=>)53&>#C3YP
MG5@ 8#S )@@"<09"!:3"M73&3[  'ZE*.4E W&'!@+3&GG00!?2&R=[C5SB
M%7!!;(A&5Y2BS!+ )7Q!F'!!"7!+ "8L%M0-*GR >3R;<J2!!)2 1KQH2)S
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M0 8.\8<+M)(P&&J!"D10 0Q@)018D !AK'"!;<Y$!12PYLU0$*Z5$281&]@
M!=X#@OX&8$ 1:SC!)C+PB;%L8!,A$$06&$#)/[1P$QNX3AH> ($5H.(+P;3
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M  N*.($)VMX"M(&!"YATBHNC/*,_<*$$7\P=*KQPL@=8H0M?\(#K1G$&+F3
M]1L0J)T9Q,L9-NP$X8R(%QH6"0D,! L04('L"2("DW.> OY\\8#)41$!1(C
M:_%&A?H)LH$R7,(!NNK\N5%!#)PF"S1&B%"! IH% QI/!?Y&_RRD!?Z&(](@
MX"!F# !(E>JNWPXA#1Q #+@ #! @(2 @3V@B$+8JN-"@[JS+ZSAE!0N"$1Q
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M>A,E00 %." ",JP!5*H!RB4-(B %GH\4I*W7R. "R2  .&4"KN0$&J"=TH
M,"< $\ *+F$"3@!/>4PJ(^(2M@D++*!9K$ "4. "'I84,H "VB(5N&N6U'$-
M0JD,%._)&M<"^*H@VB "4  $".L #\,"VLD@-D "&"$IR_XP E9@!49  I;(
M D+@9CFN 9XB"RA@0-(@ 5*)"ZSV[XB"JOP#@"P7!1X #6B0,.1W+!! +B&@
M!$3@SDBA\&C"B$Y F,YB _(6HCP !<Q4TMR&)E2  >[% 9KE]1Q R_;.-2>@
M B8@R)9D5F\,YD[ <2O%6>VO;#<@7Q;M:D% 2AX @2#@\HZ.; Z((WX80U1
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M@&43L&! -H$+0@BZXP@+D!NW23N[M=M )GN[XVX%<'>,1_[' 4K H+0" D1
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M)D]9CK(%W.42;I^NHO81IYZMW!(51J ;#X$)*<"9 H\^N/ZL+Z+]407*RD#
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MAC]X3Q!BP GW!/*%'D%YT(0N]!"YD#D=::$W,MS)&@)@@ (((  9*")/6I"
M-T.%#0!@DP>M ( _K $ R3&R!!: "CH0@ P35@$ 1-@0"H!E$QX0@  (L *'
M<.$ ! @ !BA6!@98P&-9,U'_$@ D0RM[V<Q6W1\( (#RC"(![WG*LT-PB4.0
M  !SZ=\:Z-"138B@ &M#A2E$C8FUI $VR4,%('7R!T$&((:_6\,EN!" /X B
M#)FX'?X;N)<=-JQA%%V8=[I180@[QX4 9682 %34@F@+8@,!.,0A K"!U02
M.Q.8F0'2(*OBG<  !V^VR4^.\AV#J0&RULL#,C *-B@O$&O0Q.\(B K\40WD
M\!9 "?32  :08@P$8$ "5M6% C3@ #)7P $:H( O]R\# W"  0I"@@1X@  "
MJ!<(!+  #QC -*.2@  >L $!U'D 84"%"P1P  H@&Q44P$ @%+#T%HQ" P2P
M>A"")("&6T'M=?, )PP" #J .GXK,D#BYG* -)1@:P(! P#4PN24:W[SG.=)
M<4H3 *V, @(2L$ !#* KGQE  0D@PR@4H)M+' !-*"#  OX,L#<F": U#MG
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M F)@ 8,()IWV!0T0>NB7'!X  /!G #\7 68R:AT@""P0:LQR *3@ @#0<%T
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M";7<,6F@"20@ ?7' AC !E:P(!&T 5:0!MNJ!0%M!42""0E@)6 @!A.@%1.
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MC"_T/2@0 [A0I(M2V8 @R-^.%..2>Q%:N24&7@H!A$3>5$#>E%HHZ@+VL)"
MA1,8H..0!@RJV",%>K2"KIRZV@"%2]*H&2LL#E'A@%%NOA "-D9Q(%(N*$@E
M! \NN02"-C[&J2 P)+@. PQ&V>#9[>2ZP" ,OA#;BTNXB"N-.P_IH-24%%%
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ML(=];/YD)_O4RF9VLYNMY"T;V]G3IG:UK>UL..<YT3!NY4'^\!)!S''/0>J
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MR(($4 3M\(@)X((RF("V\8P5T(VI20,/& A":  LZ (+:/X]@T B,0B>ZT@
M#SB!.J&9E^B74?B" \ "+VC+]W  +\B"!M"-O@.9BD"%"," $!"$P^L6 J .
M#'B9!?B"#1,$/#*(<8*T'FH#.J"8"<B/#AB(#0B!+S ! E $3%@ $_@"#KB*
ME4"%!AB)W_1  5"$35" XVPS5, "!WA"GV$#$)@^@W" -M@$ R"!+TBF27,
M+O "'D$%5Z3,\_2*!N "N^@*1_D"H-2\ECB/,2@8$"@F0.."ANB2MF0#"^@1
M5_1*2(F,#3A!$0@G[]H "P"#-B%/;FP)H:*/<S((+8"1:GDCR6@ C3H$#JB
MV)  4'R \7$ +& ##+BA#&B^@O[XG#)  U[!21ND#!!(@37  "M2@:*P40MX
M0@X@RFZ1@!4#ED @ *VT !,P%0=(2;J[2Q5IS16@ $!T@ P0@;&<TL64@$\@
MO/>("RU@ !1A%D]B@Q7HB"42@S10#3]B#[8"N*M(RZ=@ (0DR[)0O,=, YQ$
MA1!042YH@%$Q 9#B !FRCQ"0 !"J  [X A5P (F@@!4PJRRXA$3= B")%72J
M@#4( @@@I94,U<' @G%!A4\8" <YA4D2! 58%@WH+:R2ID/1 .MZ43\=E348
MC2^XBD! S%&( 'TA@8&  (O@DTE[@$+I" G IA)0B_5D"VQJ4U00@8 [A,OH
M@!3A /[CZ0@2Z"W6PXJ7X)/R"Q+=*0'H>@]DM8\&("41L )-F$NVH(APE !2
M\*RMZ HC-8@3* K@FR'=&!N#((K^DH]1<))+&+F]2P4?JQ*^^ ,%\ "(!0$%
M8(\0X()#F)G@4 3_H(XC<3N6D!%!P-@'. 0ZN0ASP0J)X(#S(A>VL(#Q:0#J
M:)-4B":$&)7V3+))&XT6-0@M0@4-X*\LV!8E:8B"?8G&BC0 _0Y]:5:'T(P(
M> FW\@II$J@\XP)4:9-C,1?(DXWB"Y)!P8I&B0PK$"@3Y)LUJ8! *$F#4 %4
M:<W-$Q:WE8!S"E<M*(AVL0)4F8"ZS8[W0(T_O(@'P(1R2?[6BT!,@QB#HE $
MTPL!EF@ +U3<FPB!+!"-?400+O"[&>( ZE C1="*F66/>.*099F )2D65(@$
M0@F!X2F#\-N$!0A)*_J^CL@ CF+9E%@#[X@ ;)( 01@%;)I-W&4+1'@,FMI<
M:!-5Y$T)K(J(@WB( ONYR# \\DB%)!(!$3"+W5#$F96X_,C517$2@5B+(UD(
M$4B?C,6*62'0+[P 37B A6 S]:&*A/2 A6B(,F%>@XBG^!@#17B,V:.)KB !
MDQF-()" $3B+#$"?'DF%1#";@QA7>>,"$5 $S(6)R80 4O "H4@%)CR/5A(#
MH8  LQ@!E?44-?*("E"$$A@#>/[KBEE\3"G5*$48#3H#PY3(J5LM@W&1B,^Z
MA B0-T18F1+XV$/0X99 A<]J$HE0!"=IDG#D  GHUY2@ ":! .I0A G8A!")
MJO9TDDFS@%0(D58*W@F@7[1!%68A@08(@1"X3%3HTVY3! 3B@KT)V XP@0I8
MN0)%!1T<$8D 3!*HN6V[3A'H$B,!W%%0@0G "[%8BVV:0*\8#?X[XM,H" =)
MA0J8%2[XHPM0BPQ OHDHJ!.0@!XA! R8  R8E4/   FX@%%S ;1D90L8M4V&
M,)XX@< 5A-:X$G*1FSSK@G$I@[V)X!"67R71$PXF <I%IX;( N4X&%,@ 0E0
MU)88I_Y1C@T." -"6 K5M=4LF.:X.@B-6HZ[Z(F?($^"8 2#W8 H7I.#((,,
M* @Q9L]9&0,_^4U4&(-X/JD?YN-IUL?D#>B48-N#8 ^7C1%$^+"#V  R,(@,
MN"$(VXV&W@U, 8%145^W:Q7L$9N+6A1 E !LF:2<59H+$!OL& 5T&<V36H!9
MJ154Z !<N1P_8BT/X-^.\( ,M8@TJ):5RP(6H954Z #^"@3/L%N,Y;\!X;2O
M;1.Y6)<.QHYWX1A]06E/H;@06 $K& 420&<4V "-6('\2 //,[2$?)2"P&$1
M,)FD6101&I E%F(0$81R*0A.8(!$&)#=B0!2\&.6-3$%P/Z>3!Z1*TXR3DVO
M T/;M2F4T:  ;'H1]C034B"4-BF#-6 #+(B+,U  ("E?G.B"@@$3,1D(YPV$
M0E,+AW6/[_*+24$%33CD)C$%*\ 8;DD),3B!%N [2;:B@M""X:F MJL(,(@
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M@O-12U1X@+!9 #%0KZ21)$4(! EH""1#'1SF#TDZB%%  (GR@,P(!$ZZJ(*
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MM "0'/ZRB%W*'S3))1/$BHT$%AQ3M5!-S+@ 5A '*B""OW5!#6H,I7P!"JW
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M[F6>MF !&UPS%BC+(=0S-7K M@="!4Q $.0*LV'!%V2 !R"<"Z"&K7B&3$G
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MPSH1*B>A5@9.:N,2$B8UJ8%-Q/!@0) @6M.!C5 9X30/3@-!HN'X%"AB]"1
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M$ *A ;A #!S@-+A@ 70" ;(@#3: >C2 >$Z"0(C% -2F+QI@"\8  N!CHQI
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M; )< "?+0 RP  -.H%;3P .>;SA@^9=J6"KHY L0 @(>H@U8%@5RZ +DUZY
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MAJD.X;$!0F "+ !M%J\-.&"9W?YM)4[  PX!U=;@$D1@6U)B#1X ##;!!1R
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MI%2*X$4@B$.78%01"2 \U!0J&;3X4P-'&DB""%Q$Y %%6OZ(X! 757HPQE%
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M0P)2D*@R_($Y)"&$(C!@@D/\@0 FD%GN-G$(A 0B ES A!5D9(4+'"+D>=^
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M#6"D$?( '& %*T !=528J, "-ZID(J$(;OH0@C !#9$%"N "8G "!S JC'
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M$( "(<  \GDJG<HO&I &++1->'$;<L$Z[.J[@<",M?*T8?%4#@&X+>#%4O$
M^,L (!&T(2! ;"L2CE2N@XL*)J !7PP2\E,"(M!.)*$"*( !G""X.$?&0[L)
M/O('$Q#!H]!+(2$JV]0]63B2$D &M:(?(S(*37P"%( )7/X@)XV( H], ?/A
M N#AP.N& 9IP'B(@0!D0@!.0SQ(06AQP.:_RPQF %YIWRV'B 0T0 OK(1<]"
MHS[Q, )I/>N" B*0"E"3"@R@6)3J$UO1 +9C AB0 AX  1M2!A.0 @>;01?
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M[ TP*^  D^(!$@ "J(4*Y;&"U8$R58)_/G$3:= A(D(C&B*)+;$7;8 !IO
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M^J*!B"K@C%S.2K"  YC<XCI,YBJ\A(,-,"#!E&JS5B0#$$S(8H)#2&";7\3
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MPPDVL0E)OI%T6&B #BE@$LA(@#-G@Q)-/J#$$QB*!%YP& 50""DO8< "&Y!
MEU Q FQ.H %L&$18OD6BG$Q  _X4" $G4$$"!T@@ A)H0* D8@(.A& #%MC-
M"0Z$@CQ**8(22$1&LS=5JE;5JM0;WDD6>!)0$&B!"WP=CZ1W2(DTQ"UC+0^!
M=)J*L>:))B<A!(BTVAGTL+6LFQR,5Z5B/U0DPB]UA8T@,,$^0J!5JC<BYE:U
MFJ>MVE5<K9KK*K4J2R_MAD".G4BX3I*(F8R"K6--Q5;=2A/*#D805CK))0SA
M%D:@MK, ,@3?0IL> (VB N%2[%\ORUC1NL6SBN*1K#CRUL&XAS.*Y0AET;/
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MF D %$ %*T#44 0C3(4S\*SM$SS8^8,R$A<($ P7B XN> R)("*[B X/X#4
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M@"]0 <GP@M;0@*!Q@ WH@NM,!;9 M@?@ BY@ -3XB35PJA"@J(D( 0D(OPG
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MW(V 3?X8A0>(!.UJF [!.#TZ <4SUX5,C_Q\Q[+Z+E#*X-_5BRSXJ1.X+)?
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M2RO @$7ZDP%+:+L@NI-(J4V F8*(YT-:6[.8"1;X#PU(@4O8%J]I@*,#%[/
MF3(@!4MYG8DZ%'^LEA'8A.ON9*?SNK$ZS4V SK(Z"!,(@39G $AQNJ$3'A+@
MZIW" !<8@2&/A'@)A :HM1-P"C$( #&XA""@ %KF@DTH P,8/\@LV;U0@+RV
M$&0L@P,@D16XH9DFG3\  *?@ AGFFL?P  ;0BS2 F#/5%?YE?:O:: @%2(46
MP(!+X*-%Q!, @5K!,(C!FEM$:  EPQKI^8#I;;E:>1,,X 1#D( 0((4_4( /
M:H UT 0M.(#H!8&@400"P((V=,.5,  O )4&, 76&PP+:#A95[FK $!"P(00
MZ)V373 &P) /&(% -NX0:"\'* ,"Q&._:('_L !#N8"(Z  ." (0*,]O*0--
MX(+2\  1V(31M!H(<$=U<8! N 1Y'JJZ$Q>"I_./L8+6&*NL4#E889W1:9FM
MI.C9( $L$.H4-O(S-XE-=XL..(&Z1 !>](H-")H&.-OYV'0L0"H5&0.[[(A=
M&@7;RZ@RT$W=1(@.V(0$.%@7B/Y:K[/G"G=(+Y5*+>KDK.6<40AZNQ#C,42+
MWOD#^=F  VR!^ZI[<2&!%BK!41B=[LHWFL C%[ "$@F$#I#$V7 !U#"!XUI\
MFOB",?@#VKX$C8<23 "!YKH/MR"#],W1#5"!K2+[2T!A?2D::=* #; :Q,BN
MH!=]M*5J+#C],L("WDLM$?";-?@4%7"0(SX)-%C7/U I[D4%3- XIA&<900+
MZ?2P-9 :"S#($V@>0]8 A4(VCPR<<(F0#_@",5C\^V@#[DJ%!8C>&_$ $-C^
MZ% $C!J,M4=;[H+.#%"I*A4U+." $\ W-A"#.IF(#D"=F!L%Y &(#"U0,?*P
M"15"A/Z*2(Q"N.G$P8<'V6S0(.)20E1<.'CH<$(0PE$G/+1@XT%1*A4>4JW9
M *),EH&I$&(I@TH0B \;/&18@VKF&@Q8,' (A"J0BH272&3@\ ?5GPH(OVC8
ML&)4JE0N,F3X@O /!J\)P7H-Y$%#"(P)Q6A!51*A"Y^HTG"Y-$'140X90N"]
M5&(#!BX(Q6!XFG!,114-H8)8+*A#!A"(4,',Z-!$!@QB0J+ <$$P0D98$%X2
MX2&-92Q5MR!D,S#CPPP;4*>Q@@K+&50G\.K>Q,8VJBQ<L_QTT0'%GQ"!O-A,
MN*D$B50I#B%<8UO,AA%I6F3A9&*FY?#BQY,O;_X\^O3JU_ZS;^_^_&+TX-^'
M/%\FQ*A1(4[\I(]POGH ^C?@>Z18MHD&A*0B1@3Q)21@?_(I8@4&!%IXX7D0
M8JA>&A-$.!YXFW06H8;KE2@>(AJ@E 4%&0EHBGSF&9CAAC36>"...>JX(X\]
M6GCB>*.XP $'*3@88(U AJ?DASY21N0'(+T'X4PM5&!(>4S2IR62[LVD)97D
M?=ED(/S1J$@(ACGY("I@=- !"+RQ.2"7Z=6Y)IYYZKDGGWT2.*9E=_(IJ)^%
M7JAD5DL"2.B6ACKZZ(V,0CHII95:RJ.DETZ:J:8)44?@*'(Z>62GI9IZ*JJI
MYC@3)R0<!"@JB 0"7J*!"H*!;?ZP-OEAB8@V*6 J7IR0Q4%?H=""J+O.^2"P
M_XDYWW,>'#G?*&R0FE%#5MC$:*W]]=I?&BXHJ^%\&AX"DE\-+2I>M8OIRJNS
M\2)T;GABD(!0&">T,-E_PGH!WB4J@ ;50:-D\*EE:*JK["4;@#23%F!LL@%'
M('@0UD]85$#!!5Z R,9!7P@VK8LE0[@"&_*6F^5,++"1"@AJT:J1;8JH">@A
M9B+$1:X_S<SF?"Z@YFV@R\J[;" (?]@N*BHT-^ZZ('X;==%&OZLJUCV.TH!:
M;&X!PGDB*#8I"!M\ 8(%#7WA !<M.*"TDS.E(4&QXVW2 'H=C(9G%Q7^V'12
MAS# Y?XH#%S+7I4F+"T!2"J$9<7;/WG P1<[_92!O<0=T@%6&H4@GB )8%+>
M(0)4T#D)**2"QAHG.+!&&=2!4 $;B*3!P KC.8#7"?=::,%F P*?2A><B-<&
M:EYP,%X;$&3TQ]!VHJ*!8)P634+/EEV"-V4/9_T]^!MNXD(+@E# ""J'M+""
M46ABT-P7 COX!P4E"'+)'Q,V5(8*6314K2)6X#$Q?"0\9T"!_^:BED 8A1$N
M6 %(3+&&36"!.C/Y P(2\H TI*(!4FJ!!Q(RBC(XYBF7L((*C#(8%6BA(;XY
MX2A.B++P'&(%+:#.4MY'+2ZHP"NIR ($B(4(PPA"2@2DP_X(NG (-:5A,9<8
MFB ,LP:\C*%_BTF#"K!0MY#P4 PS\0()RB065%!0!:AY8D*:B(HOH"!X"3'$
M!C8P10H(@@56*);ZD.4B+T  "W@)A T_-4$N/$40*.#"$A&2B!;<,'T<F$U&
MYO83!J@E! ,1@P02 H$U7,("1]D *DB0LH9LKVO]$40#8OB'/YR@"P 21%58
M@) 3)&4P?J/,X)1R "EE!),MN,0#TU "-+1F$U_PB2+6A[ _K, *H\O(!C:C
MB#' B)E6P$@:U(+&C'SA!'\ P6;^T!!$K*""*5/$(3 1 AVB8@TK< %>Z)<1
M=$)%$6T;19F:DS\PG( ."/& 6/[.(#\RLD$0)UC##U>@312J\ ^(Z.93 A$9
MGXQ""RK8C"F J(5-' )]<\EBL:9HA17P!HM:A T; GC2%]ZQG2IH*4+*<((T
M_($Z@S0*(1C)FTV,-'KA^RF!-D&!%'!A X8+! /$4 8)* *.%! ,"$*P!A+H
M+!4=FLT?$O !_JP  _S$P"9&H0 0;,$"N+(")3/2U3"@@ *D"$'N4$&!;$I
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M8K<(X8!@&D (5'C!WLSMSR%2^4\O',)##=<P0L9P 50 >#R*P,"ZQR 513I
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M@5  (;!!A9S/VN A"12&LZA "J0"(AQ;*BB"!& "!7@ &'J XBB%N&V""H"
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M]G70IU" 5TR 42!?RESI)G "1@!3B^1'YS2FL(;'?/[!):   8R"![!  29
M6V@!?NG;)2Q%^&4$\<V%J@KH+]V.(I#" DQ&%BR/7#V-MCZ1?1X% WP C)P!
M! C")I! 4IQK1K!! (A!&HB!_(52!MA,Q3E+O[%C&CA (+RK"C!" BC"):1
MN^D6N_W!)VC!/E((.DU 6_0-MK#-)LSG)JA?&9!"I2[1 N1.!7QG&0A %RRI
M N3JO0G=*#Q ",G8(5Q""XA."?YX@":,X;9T&01L@B)PP.F(@0 L5A"TR*FV
M07]VP)(F@%= I1=L0I2Y2Y)F "*\W8(J@$90 ,)N0%N$2%*-0@5L5!D8P&9L
MTKPX@'=.@"O>Q254EUM@@-+\@?/H9ET< @9T(2:<X25D0;7.!)DR*6/QK&_)
M[,((P@%85<^50<^]F+\1' "(RTRPV+U)0&Z) 0,,Q!]TGANRS2BHP"/>"V(-
MA@08PB7 E6YX0'%20'/,A 5PF0I '0IP0'%6@$UDUHZ*4%U= A@$@$TH0"2T
MZ@E8P05 70N #9\)PM:4P29X 0$( HHZBPN 36"@ B%4JPI0%@@PSB5<@$@*
M1@:L /XFP"TC,*Q*#D3+;4(;"*PFF(#B: !K%!IQD,!).!C/8@ %OAU17NL&
MH$!? 1;%J5 #*$+-NJ#D)@217M,9*  F( +^_9,)X$\#O!P70( +J$!249QA
M9$&,*4)77$("K,$HN.FPAO!XE $&L*B%*L('B"=ZI<(EH"<J:,$&E  ;G( ;
MV1UJ"$(MQ1U3<, H-3 JG,'>L(":H (F[/!BDH ;B8$&:(!BI((/.TL:>( '
M4,P&4,<HK(!9U9UE0(!G==D2>QC!:0 )K($*=&HS4L8&9( 'P(T5+#%HK,%_
M>@I/I.9/D.BU:2\6>(4B@  &M(#0(,1_08A,(<0*!$\89/['=K30":1QZQ6'
M!YP &Z3)'U@!A7Q 2:4Q1+P8!^ 13W@ +\W+!A"+"9#2"32$%F2 !C3R3PC'
M)6S.!W2!&(@=!/4')W!!&F#8SJ!R"\P$G@6!BUA R@3"!V3&+L]+!UA !R ,
M3RGG2&Q&"_"'(A@$ 8L=('W%:RC$"<P'$H-+7"6$%EQ JP4/&Q@6-V& (I0!
M:(A,DC[%3%"%5:A+I5&/9;Q%*H@ 2+0 5PS,?C3)(5R,%;3 R_GP*'3!&-!!
MBX@!<8PN?U $.+6-(N@,*I !<?SQ0S>$&$#5"O3B5=@P&:$9).4,0F3!&+CA
M"6#$&"QQ)G\B0JAT(,CS"G" "OY$\E-4VBADP>R>@&P,S6[,DB*,@@D !A;,
M!R%<0!9H0$^@PD.'R E416[,"Q8@0@D(Q@D@S 2F,B#'D2>+L%;K"8RT!Y/
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M/TBL$]FS/;_K\[KL\PA"/NOE$#; 4K9 +W$I(:R""U"M(=ZP 0B(/@>B!:S
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M XCS@O8""V@("T"3Z!;E3:V %-+ 2S  2G\%-YI3(;=Q+V1J QH2%=H@;*R
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MZ!@&0I"&+$B %&5P@!C$T #$A( #:;"" # XE&H]!4&HX!I8MB (!J2A#!N
MP$ATX@$7A PR6,C4%RS0PQ+44 %<4(0"IB43!8C@#"W8DR(2@(HL4& -\>/
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M& %# AQ0=F+S()P0'6E@ 2"P >A6 AI  LY4$Q6T >-1!A-0 N>*$G8I BM
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M>5\!&9"C&D3%&7'*7*J* 2<@+Q0@%*.E$"O '!>A@[1"-54A 4K&96G".($
M10D1 E4T*GGZ$US >091OV,0+0\TR5&H!:G0 =8$.E'H 96'%QN0'@EA&V)P
M;%^P+(S#L)Q1 MZT&@) %B(@*S+AOV7 T@05+>0R0;MW*A,DQ*LC4K%7!@V1
M$!G0E?XJ0Q,),09KH4<@49IJ@Q<@8"CDY@4K$+115I4P@AB"@#,0@!(5\")G
M\!4E>[)ID"$^[2QFY0 N(#%"M D70*L.Z5S'D2=-HQMI\Q.7T6@?1"A:HR#/
M$[$LR@4.L %8D J8((54!Q+(*D?Z9!"JW4,]FM.MT]LA, &M1F0J, %WT7]@
M89W#[0%3O3$-8 );4 (-$!-C ,WM<3&.BQN,\"AXX0&BIZJ)JQ 6P*2-RRTD
MHQ"W@@J3"],:9!#>(2) &<T*@089 @)A0"W^.Q1!H)'5JPA=  %'33O>02T&
M(0)>L# (% B<<4&H0 9?H04%+C$*0 @[35<,,XJ&0 $7D?X&%& "+. 9=!@G
M6- "7. 6(4007" FHY$0(* Z"#M-:; "3JF>$8 T7'!L%/42+1 <'#V0D9(!
M5D!@075NM;0 [Y'2P:,OJ9V@H^+:$I ;+H Z0T'(&,.-$E!E<9(0]2489-%_
MY7(1?T"Z?S!_(:8R7"#+">%4EZH;'-!R1B0&-=,%6?T3I$-@A! BJW<!E;?3
MU)(E)N R=DD1_GL($R3C"L$(-'&OJV,_JW,(?R P8F.8P#P4;RT!%L8QFW &
M:Q%R$?$3!(H!)<"DJC'7/Z&I(00&BF %YY0;93#9;;!3*'79&&@!9C4!A/ '
M@8 (1X6"VHH7H\UDF! !(+FK-_Y1UP?6 %^@"%F0 EDS'!L@ FR@*@](5\K"
MR5X-%>H' 9N0 :GV!TB^ <V2 ;U5HDHS)FB.Y'@13EUP"%R0)AK W\$-?@OB
M9U'F %:P MV4%-HM*3$C)U-9<*0DWBE3JCTD>JY3+F%$'7FG)@4RN8RP0BIC
M$"4P,5I3FU@S@!C#*8]I=JZL)0.> 8DE"(@PKQ\_06(]$SG$6)"I"*4393?!
M!1C Z^I\1F--YJ1("%RZ @*@1$5^$!MP0(J  24?,C6S 5]"RWENVYLP&2"0
M,D*;; Z0",J!Q8^Q!@',PC3A @V!"B8P0?.\4DHDWIS2DU1O!=Q#-K2!*9,Y
M-0DO(?Y<94AG<@@&H"A6I B8WAX9++$AT %LX 6.T_+M 3HA< G[L=(EL)P)
M<<)X 08?OA &P055"30UPV88*'$XL0+&(A3E=!$ML!:)(A,1]<;DTB1?\"@N
M\)6H3>683# 4H )LT (1)6[$K!B=HQZCD08&L)D_G!AG$!VV@@%LE"=G\)52
MS!Y_<$7 =-Z$,@$T>I>K8[(/H\9*P3!C)!A:K%,M #))="9C1 H0?PE,-B\,
M8&&!( "&$ 0U@Q99,Q>;< !/P08T-2\G2DA7Y 'S10'I<4E8 ! >4*'Z8@45
M!C$#,91)Y6 -JDL*+FGA,+#@0%2I4+78,+!#B8,)4640,_Z*P1]4APR4R8AQ
M Q:,+C"@$B,!XT!2#(*@(C7A"\0,&!3=U/@APRA4)4*@VN "%:$#@0XY0)5%
MX(86J$91$,$4C"((&@-!0!6(@9@U&RA@U"B(P294)RJ@$H$!:0J!&@>:O83J
M# %%BAKTO10B%1<+ UDP0!4B"RH)8+0R.$1"!4\)C\50&#5U:.%47M:B<L%
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M#@GDM$L"H36U2P8O.VVR,4I]H-5CI:N+3=9$_'!8'6_S1;Q%SWR3K" :3+5
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MPQHT@H@)1'>ZX^Z:%AQ @:&A( ,GH$"H),""#X#GC2AHT0I$D-[B8$ %(+C
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MC$2"*FF(P E"<!91_N'P'N# *!0A :0$XL(9#L%16D*(M[A8*3"ZC%A%T-9
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M@DW9MVRZL"Q@@*%(@]%XFKDIC@M3N62I@(1@ ;B(D*HX1!4 CRQJ@0B "XU
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MOQX(=,$.HW2!"%@QSLSN&)8 "9@ *AR(%B@>06[,)J. OOXP@0?XFPI0%T4
M@8A#A'#<BKXX:[<5!$$ :C>=E52HBVAY$?'0[KB*EIX,FE0(OPX0/\D=B CG
MS3&BHAD9CS\84HR8./)N@('FF818 _-6["HI@UL)OW91O0$Y&@-)FQ,H&O34
M"Z$;@4D!K%20:MH9;! 0CC-@$"L #PLXG*19&HYK;/H $W=A"(5NHWNL7-RX
M#8T D@&1K:24FJSY"35!A418P3%8"S$(DZ?9E.J%$BEAA"JI:31/'^%(G:UQ
M2MH1'1K:&M-!G^T X012!"3\I-Q9)@Z2<;T!'+?I'[*!(&5RI21:LOEA<]0
MH&LB&QI*"5:*-*TX!(W('C"3&_X,$;)'3Y[2@0M.$ [2D?/M<?2),1@\4J%S
M&0ILBIT^QY"9<;&PY039BAX*HITU#P081A 38J0"DG0(49Z]R1Q?]Y="K_/=
MZAZ.%9YX2H5#L*Q-,(5'+Z"[.9](B_/^TA^XF?,[IZMIWXY%,R#?8217&G=P
MQZ%*K_0#ZA_2*2#MOA1.LI<?HO/4VIXN&),0< I'I_0!ZO;]629'E_=($(1
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M01)LD 8=>"DB@15<2. %*E8D@(46#/A;\ $D9,$!6W],\/XA!&5D8<&=$FB
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MP@DLD+<H4F -:YC %[!0@4V,P@$< ,%7ZF(%W&F (2U("$^RP+J&O"T$7L!
M\ ["!2Q X"\4  -#)! @ J" "Q0P 2D,N()-A$ "'#@#(0AUB0E@X0L3044)
M2( &##2J(X=@0!?*, &0@  "*%- "#,@ BU\@)6>:D$#5+ ),3# "E?#"!9(
M]T-3,&0A]U/(0L:&"@8$8A,/N$X&\,*%#&PBE3\Z@P/*X 4*<$(1$,B8Q[KI
MS6]ZAOXP#-G$"M3B$BOL#P.D<8 F#F$(AI .%1AP 4-,@@H(N"0+5&% J@Z!
MFWCJ<7850,4(HD@(O&#ACE98T$("P0"SR.00$I@=4#:A,N]A)$FL$\- &>(
M02@B 3?R0%,NH8"MM,!P)&DBLBAWN" PQ .D^@E#*)"J!!&,(Q,HPR4F>H&L
MM>!S(%!>"G8W&88$0BQ>8)WD)' )0G0@(2L8"1KJ"3\,P+0XP@M$*KAD3Q!D
M= -G2!10+M$ 5+@@>!D9B02F(P%!!.)U"FD <]2ZAIUTQ"9;T<19K1 BLH(
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M0$@4H6(%.?5HB21@"@F$,!5B(-A0.=F"A0A"!"+@6P7OV! 1A*$+7R"!(C8
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M,,9>[!$%O$5#6 &76 %^,)$&T/Y&(R;)!G# !HQ =?UH?F+!&G@!P:RI?V&
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M/!W+Y'S."@#K(8@ .VNY0V1 _Z7!1&T9G(:[ *7*6\%70_3Y0F!!\&" ?$?
M=19R&*DUCGC6==94&Z1" CAK=?/.2#0 ?A2=0UA ?UD!ZWR4' 7/P!\*_%0
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M6>&D2QCX(CL(..E)I1-:P$0"H"[2H@)%+L%@K3(F.# -!T"3<R,(V!A% B^
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M AC@F!I48.$#>\P""%(1@7(:Z '\=% 6.@ AD^0E!"+APEL0=)$_ "!/W,G
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M>&A#!9FM,(%4G,8#R6/)"40@@1(8Y .C$(,*4E"!,Y-F@1<X$T>^ "J6H$>
MI-$ V^XCB!)@03&*F#0&T( @%<+N(Z,XP08V@#<P-,!180,! &WG@150P )9
MR4)R^>0YL]DI%19HP5N#I[X-B$ DFP!!!4@P@I%"D05#N=;O5' )8(>@ 9(J
MSZL/;?Z@RFV@/RL0 60VIUL4].T$4BI!%R;P$11L[<US[IT%T#._K?WY$!5P
MP,1($.WV<&0,&1@@:+"@ A-,X$:DR8 %4+"!K4(9 HJX0*=1L88B24 %8M
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M1XH.-\(!-L$+DBOA+@$"2. +-,$B$- ]%$$%R1(+?@2N-OYB"RPL.A3#"EI
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M 3;R4C/5 3Z!K#:"*$=A!6KDY [D#S;NAZJ.$1*K>06A)Z<B>\YRMABQ><6
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MNU; !$2UI2XAP5J:)S30G#W (/SX#^Y/ S/3;@R3@T0 76PGJF/((!J 5D6
M ZQ !22 !9A#-"A2!%I 8!"D!#0@^*9;77S4PB[BZEP* U8@%0X@L#H%<$]Z
M28!B!=Z"!"".!1J )S9@.+Z@G =H% BA 1CJ!#+ !51@ EXH!/[D3[T$XE"
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M"%TJ-)' 50E$"*T3I6R@!7_ZG_JZKT#F>_SZKP ;L/U)"@XJL+^Q.2F !1*
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M!D-5<U: $&?ANU>1'FEPG:9C!0_!"8Z,$^<T5*/P"6D:I3/X!U2L$)O@BIO
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M)Q "#% L!;X"49U-#1!X(%%-(% "%# >6% !*W !2$%?(, !7'V:9,W4_&)
M07V7W$H!(R "&< !BU%:C!,X4P1J?894B! !%=X N\%>#A !6G#)-CD*FTT"
M&E "3@;4$,P"(K !+CX1$8 (NIJ8F\W5WZ9)=26E9;T!5[? U!U,A^ ]!G<"
M"@X?OL9'%"#B;7(P)1#:L5W3>EX0+F%:%O8%'&<G1"<;!^#D'#>'2G@B\W%3
M#3$Z@5 9 R2 E>$E!)$"7[<&:G5?<U(T"S'>'/13%% &YG1M?\ %UO8%F_;6
M<_(L OY4%%PP;7=) 9D22:BP ?ME?@'&PE\!+L>U"<972\7D "R" 2^A59VD
M4#"!8OFU!:C0V 2! :*' #KR!R&<$"HP'H>@ "?!9NG!+[MV[3*IZ2#@3EME
M!3KR<3\H@(Y5$%-"6S]U 6UP"#H$1B?2 GD$ 7A!8X!>B/E[%<3$$PX R%M6
M$E %$_PX"A90%":Y%>X8;"L@ 1 #!F%'JLN%$!T .VFW;N,53'I)$!$ 'VG,
M1S[(!3#,1YFRCZ/P!PKP$&)@:PQ#$"50=R 1 HG)!BLO)I6A!4-UET ^$>-+
M$!F (2I T1-C!2IEW+AW!C<E$4B5R MQ!@<PTA31  Q[ ?XO@5.GC0J0E>PK
M 12;F@!'.'Z)W2:$8  8\PD!3Q 7H#\-H#^Q1!.A#A*R[@$OL8&LLJN;MH$P
M#!33!NV;4 #HP4$<6R=B4$)ELFD@P 6,P "<W "'@ D(<!+BR+][GK8?4"R*
MHU$P7 +F<8(ND)]=DP";$ 1D(DILT  N<.T6A>BMQ!.D(&4>,%#/I+'=TDAX
MZI? TRAU>&FZD@&B/C%#T@(K0 (F1O?'Y0%X>C!#UXN.CWLG4FW-?@*V-9%&
M<F8$[_P[_  @\!*3"15*8NQ<M66;\Q#Z=3!QX04A(,?_,0%V:UIY5!FI(&'I
M(?P.@!0%0E1:< *,X&ULP 7DS?XC !%BPJA1("2(2(-*H<)4J-)@0'6(00L5
M+22T0.5!0HB$J%J80.7%@8N*"OZ4R*(0DX1-"Q4RFM 0%0J,#B[1R>!R81D'
M'T*$\) 1"ZJ&5D+HG&E%(2<(EU")64&B*2H.7E"=@6A!Q(H5(":@PM!10QFJ
M5B]AH%#B#U*%4$DX&,4&(BHV%E!16*/PCUV7#4%P0;6&;QN^4$L\4(3J+])1
M34FATH("U28N*SI<0&6%!*H,9*F6$=2 9 L&9:R<8#CAD,Y1$YRBRK(90F)%
M$49M>I#JRU$N&S:(0=7TT%=4@H@O;$A":2 )"ME0((J*"PA4$E:+"9KQ2W2&
M%B0T&/Z%Z@^#T0ZTD )?)JA,O5\;>@EQR3TJ$E@V.4#UA7I^#JA"@-$/E?!$
MR&(3"1I29""V%F2P00<?A#!""2>DL$('0; *+X7N>RVZ$S 24()16@ A$#8"
M.20503;X(Z<T(A"DC3\.V>0/Z"XX0Z%1'-C$ \\"B4DG+"800Q$2@).IJ,TR
M4\&XZ*P003H4OD -@R#^8(.0Q#S8+LF,QE#H$ C\\R -3#(@Y*ZUL(C2@3*P
M).225"1(<\[5*EA+IX8.\8*"$P1IKJ'I@E-$$.CH@BC!ED#X0I$Q%>(B/MLB
M.K O5"J*:-)#(D %# @:74$IFM@ZI(,LOF"CA1#82*4"$_[84.2"3QH*A L'
MAF+/(8@.<> /&0^1$Y5:'5!J!=2ZL,!$%$<)(:7)6-+IDDIG6@&5$RH#3,_)
MTMBDBZ-4V"PYC')%0:G)FN) A#48N< I+J^"B (NL#PD,0QR!(NL=QMJPXH%
MR,IU@Q#6N,2"&OD2[*Z\Q.-+I\76.)2-"J@"(8VS$EM,3PD$48BKQEKXXP^(
M-$-E S 4VN",0" (Y-=-6D!-H0D084V"U["0S2EI6_(1(50(22,-15*)X))#
MFA/V.)>42[JA/^;+XB@) GEJ X4X.%DG"-+ HK\_'FAY1J="$*,$SQ@2%FGI
MXE-[A +Q^R([+SI0[ OL!/2/B_Y-( @/$1$M!#QPP0<GO'"V.!C*!:LS6]RE
M-.#*SX!1_H#\D!+\PF [31R@&A41+OFC.2QR@@TB#K(C802D+-!"0 > T\D*
MU3/;S(&$]B;KK S6RF+Q,C#:P"J'-VCHA*,2X/@0!!*+("$LJ ,!1"O(@L 0
MHJJO+HU<B^.+#0A(D8"L420 [H%$%%F@)12@4\0!C%,B/\0R+N$[HN^1,N&$
M5,0,CU?%5%"(!%)2 OVQ12"'X,0%-("*2""@(658P%/VTS5+I8$"HT@%!<"$
M"A,<X@S9R<("P96*]B6&6:,00Y"RD(#PH.T2!CC9?1(BB ILH"4ZN<]:=I2C
M0RB 8_Z"4,!JD.,1:&D! YM(0$O8D$14:" E9X#."HX2DJ%8P#-6;&+KN**0
M$(!H(9LX@%/^@ !3/$<A:_B*"O9#@D,-L0-#@=@9+3"*!"0F$ E@!%6PD*NB
M3. /95! %A"1 (5H84Q0XDS6-" &4O1*(9_[0P-:(@8#)*8O#%!**B:P'0:L
MY0L,:(D%0;"]QBAB4[12&]J8QIR&C$]\X4/% S@&AL5MH$O(B<!J7I<]A92
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M @,P!2S(#C%0"@R '2OX.!( (#IX# [4P1WDP1[TOS6P&F89*)Y"+_7"@@H
MCA,()L>2$Q$80H[Q$3[#@ VXL$NXA ;8/A_4PBWDPBX,/':+""6K%P'I-(X!
M-C3+E6/#,R]DPS9TPS>$PSB4PSFDPSJL$+BSPSS4PSWDPS[TPS\$Q$#T.CP<
MHD)D"_Z,VQ[V0$1#M!2T:41MX3D)4<2+.T1(5#%#7$1'9,1-?,0'F<1(O#I+
MS,1+U,1$K$10A)!//$5++,55'$53#$54]$1.I$58)$7->D56I$5-G$5>U$5?
M5,5'S,5.W,5;1,6W6\56C,5;#$9FI,27*\915$91=,5?-$9!Q,9LU,9 _(-
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7TS$ETS(UTS-%TS15TS5ETS85O(   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>comp_0026.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0026.gif
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M^OCW^/;Y^____P
M
M
M
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M<-(#M(8DYPA.J->RTD/0(6 H16Q#B!0&=++>R+4'A#O5"1GRB#[,!!C2=(2
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MSOF<KSD)*L "*J "-O )BMF;^?XT"R= !N''F$NI"2, !RJ1E0)A R\0#+U
M"=BY)M-7GLP7!P4P"<'0"6/P!9'0$)'@!6= "P@1!]<I$+2P!P*A!@5 ">8'
MG0JZH"K'"S-0 IH@$+_P C;0F1SQGN,G$'$@  T0 0\0 !&@G*3Q"0'  @D*
M&I$  !6*H9MQ 0T0#+Q0 "9J&KP0 2 0#'BP  >   ' !0)1 P'0  7P /0Y
M!@_  @^ G230!0@! 2+ H% :I2QW!P,0 !4*HPU  :MA!S+*"[Q@ P 0!L%
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M@*\,\0D4@  1$ !?$ P0, '!8 L(<*.8B@L=L  -8 *;$/X  5L( " &M!
M'7  (Q ,)U  $UNG#&$# 8"@7" & @$""."@ 9"?P6 "!0 +(G "OW  =E "
M<] 0<   \^JL6)NUH$0+"] "81  J%JM$>"B > %]1D!"E !!. %O]  %<"F
M : "P" ""' ! U #"%$'"% !)S ""7  G= "":"<'O  O\ "LQH,+1  I;"A
M)T +<&"EM+"PP?  O\JU)2 >FV #G1 ,'?"B,B  8@ +'5"T9P  9  ,/HNO
MO1 ,+!  DP ,+" "O' !&#"R#Y"Y'1 !P0 +"K "]8D ,A ,D1  9D +#[
M>5JUY/D%1QL,%'<""-"< L$+,?X  #$0#"6  .T9 S\["1%0 2K@!B*@"2
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MH %%?+HMX 8+$ &]X 8%( %>0 (>/+,FJ@(&< 9N$ $^ROX0,Q  ;Q '#8
MO;"XX K M%"\&& #$Z"B,!H,;@  *C &!# !OP "+DO417P!#@ ,7-L 7S +
M#=  +W ! / %,QO%FH  'Q '+4 !G<L0;A  4WL!^RH"&M !M$ +$8  -@#2
M'\L0LQ !G1"C;I ##W#*L'NB[YS7>CT:7P  7M )GQ ' 3 "OQ ! U "-C
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M,DN\V D,N$\+J$H+84#Z F$)9/Y\S[30!6% "1=@Z3=/GKV+"8#/\V.:\Y(
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M\E \/ZP 4D;P!A'$ A00F,74&.)HI-" "RSH<.\BW E!$F1SUIG!D#-H5BY
ME0M+6!?.@Z&"^*5"F7.-A+EY$8GNO6&_<!CO'/6F@6 &@P-XH 52*"$"%^"7
M-"_(@1&!40?QQ0$#JX9%+UY0 X)HT8%>H4,K8WVD^)T 41.XC0\G >N<6SUY
M&6]*+.+0 *FL1!,.J ,O-*&] #:R _C=D0W(XY'L$837(#!3,&8<C C<A@8T
M *)'9B"#QPS= E\@5C L031+L/[.%M'BQ<D)$DJF(<2#!%$\B+H25X*X "87
MZ"1ZN/R]@H2Y:)^P(D'Z]09;;#H8!4(*U%(A.X)P 8846,LO+ #0LMMBE"_0
MWE][,@%;H#919C"XN]2 =(^ ( ZTZEUID<+18%B ,I8.PP$K4])0U]_^]R\.
M!)HS$0Q$OO\@\@Q)P(#JN(H+ #T\4 !:& ,,@(5)6  ( I3G*+A): !,^(0.
MT)LL(PB6LPPVL*N/4*<ZR(4O,)0XF(!.H(7< J0D0A3=2H5\H@61"@:UR8]9
MB(,!8 P(L ->> ,. (82<(%>L)\.FP@U."A@Z  ;R(5)@ #>((@6\!1-(*Q@
MF %ZH?Z%K2J("! !I*B#"= $7K !;!D<]*B!7(BD2)@%!/@"6J"I>/.(%O!"
M6K@68/, 6(@%#A"T9 F&-_"@$C@=%Q@!+H. 98*#KJ$E&N"%/Z,$!EJF-!,!
M+[FE"%@+$HB!7+"$"- D!VR8,4B YF@!$Q@E"4@2%2"[OH" 3:"%%EB 96*\
M"&B=PN%!]'D#]+FS\ @1:HH$/(" @["!HE& +*) 2K"%!OB%.8 UUSF*0C"2
M27@ 3*"%&$  S6@AC\B%"UB(.E@ 7N@"#8"%2$B O]"G&$"L,;"%(INR!X #
M6'B!!T"/^] BRIB(0F@ 8GD!5[P#^'@(^) N6Z"$!D@2F?Z@0$T !0WH'AHB
M" ZPB@1P@5G8!'/[E2[(A4)8FC# @*$H@2[0A&<2F)GY,5Z@! N A4YH $F@
MA248@-9;+Z&(! B0"L:)-0CP@BZ(@';Y&6!X@P*PA$LD"$D(F*0QJ!>@!#S0
MA(P\&1MH %OH%U+Y@D%)PB5LPF_JNPC@"Y*P!+[C+X^9%-% @%Q(!35DPP8
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M)$(-&ZB#,( A_2*!,_""&?B$%2")33 K-_ "6O  @^& AOD"#Y@5%^B/&>"
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MGCN(@X'A N[=U;DN@6ET)Q7X(TO YSG @,+XA!=0&:2P@SHX@X91 TD6$5O
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M/0"!7RL[!' !/&AP.-B[@]  *C\CD(" .Y 0AP$P2U BY/Y)=NM0@#B(A B
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M"3"=3+! %X "%^"'=^1 '5Q0'9Q ]M&<29A!2K'>KV6@!FX@!R[(&W# 4F#
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M8  <L, (1%0DC.6""-$)*([I:?X1]8P &Z3"!US 68R?1]Q&(= !&Z@-+,3
M".0 ,@:#&0P?#M7!!70 &WR""%@ %^3"&5"""E!")PR(!L3!"XB 5B!?[_&"
M%_#"&41 "6C%)*Q "7Q2+(B.XMDD;=:F;=XF;FX4+%1 &$S""=P)#8@ *-1!
M!: ? 7Q!(8R _)2$T]@ )11"!-!!)'! C=@ 7-25)KQ,2X#C 'R!27E '7"!
MI)3&%TS""\"('4A9'6# 5T0"0VF"!P 5"  59'7 "DC"+TP "^"!%TP')50
M'L#G)UU)@11"'31 (1A52;B!9XC &="""U!.+;7$)^"9&2! #+P!+6A Y<U
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M!@R;4;48R\P ;WQ!KL6!9%R'296$"'0++&19+EA #A3""MP)K=(!9 K')$
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M"<X$$^-YQHN#7<YRF'%PPF 29(*-T=X%%A[6"V=$96[1!O[+A1XFDLJ-8!J
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M!$PF&:T.K.&>09SR@AP 8P)IH]=--K,'[4S'-W=@5E(@4 <[*!,6<+A (>R
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M*R;A#C23%H(-%SL &,22,B1!63_B#1Z 2"( I&B!5UR2)I"B/DXQ?(!2$^H
M)C+P76U2#VF!%G+@)C;!#E0S W/A#O2U&>MROFAA*&#!GBB#1A>B$Q"6,O"@
M*BWV4O3$*7)! G 3ASS27O^Q$![F&L_N)E!VII8%$ G6)0FV2BG#$M[-+,(
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M\@[B"USE @:#%L!O2NS"#"9IA*T#7%6@!3J 1TSS!#C@+ J,##J@(-,J EC
M%CC@B2W 6V;  V3@ O9@BB-@!?YGD#[ !3[@ H:F$.H9..X+O"@Y J KK5[
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M&RFWQ:!E*=S@U-,W663@;CXN/@I2*E1Z*<Y@! [MQ9>E M1I=?J"U/^<)$7
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M0#!=[)7K"L%T%TP$FP1#P1X' 0.JJ#WMQPLO$RCTPB>61"#9+&!RL:O&9S3
M4QT:B]!G!<M%0$=5C*I10K(7-)M:IA3H=AM9%NOI1J8]G7!2,+A+=\=!,FB2
M2KL+\!3) [R\D'4P6+]U9//./P]]]-+_: D&*KQ@PVPEE+GDDV-40 (+%Y1^
M$"T5V')<,%S$(.YA(N3'KF7.-C#&+R=X4 (&Q+YEQ@)J5"^>S/3B!!TH@05R
M=! \3. "&H# <EQU@1-HX"NS:E3JEE2F"Y2 @'KZA 9.\/Z"'$Q $V<(5[),
M^(8%Y.(\8:B !$=S$#)<@ 4DF$"98*$!#[S  QBY "8.P@(/J( $%Z@2+#Q
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M EEC!P<(#'>0&1H@ BPP1![Q 65R'"DQ ^EWL?\A"1X0"Q&@ BK  AT0'2(
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M:DL3!XOV ,"P!"8\"QU0*_MZ$"6 )B^@Y='"47_.Z>'O(W9@ 59+')-P,%_
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M#?B"(!5*(M@(#PN"68%#//CV_G\ !E"  [3='-1W*@_480_QFY/ZO*"78'0
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M.6"@P<P%P=N(R6Q<UJ"!,3'%!>8% !%B'6D[+A@2B]BF+YB!&> -EZC8C>
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M3Z1(N5*FX\8(]T^ H$ _<\B8@5U9^<7 ,)QP@150"8* >80P@3+Q)^TV<\>
MC&)J#*6:$U[R #0Y@:?8BQG @"WO  LX"/CQ@!S  +AX@:F8@7 6)(>TH4^0
M$Y^@B;+0A%@P@<4PO: /#J&E#(((=8><H=F0\5FZ%G[YE%Q8N$J!#D"I2.H,
MK&D1EO[(:IB%<3!_CP-B]A2\,JSI"+!5"9,&J0'NK96*:1;&SY1-L!^$:?Q,
MH07_(=OR8)9+\7QOP7N# ?S-WY1<F)=QR_ME:1:\FA0:H"_3I*]NH1;.S_M@
M&:K4IA2N<Q;-APJC-2[?=PG1WXC*/_T).(MFZ9=B"8;PW?WA+WW)'U&VH8,/
M. YI'*J'::E+"0.4^0!R3JU,<8,Q4989X-(I5YJI<HE4\&^969OU7QJ-H(,)
MT&6HT824ZP#?JJCMMQ@9R'Z ""9P(+!@>RK8&*APH<""#!]")'CB4S"'$1^2
M^2#"0Z2+'BUZ#"ER),F2)D^B3*D2)<B1O%;"))DK)LV'O?Y>JFQ9<R?/GCY_
M*M0)-"0OH4./0C2*%":MI4Z?0HTJ]9?4FDJ3]KS:\NI'DTVKFN1%%2S9LF;/
MHDVK=BW;D0['-@Q:46Y0BW$D,2P8)J% 7A]2!?M%52=7D%S=QJ4D(B[<N2U=
MN*E8>"[=@FQ>4(Z;]Y<(37/'J'#\T,Z=8)U O#3\$!8($+,Z3 I,5R"M,[8>
M&E5:4*AA&Q$Z$LPL?+A%AWCJ6'P98XGHX,/;0H\N?3KUZM9#BB#S/ >+N;8B
M@*HN:8+)$6-VAB%1<D)L@9\\0Z3Z@D8P2Q%(WKD@,-+,B[P@X!05!!3Q5!!W
M#&G2R74+,MB@@P]"&(PF;]0Q0OX+L A4APHGQ"$0&Y;,\$8P>&S883!NX&&#
M"' $$T<%((A(20LG>$'5$BW,Q0L%"J820PE? %-0'2R<(.(8\,U11S"1;,CB
M0':8>&0PLWPAH0LG</$2+#&88,-7 YFA@@H=1:(?,%Z<T )\L\Q0@@VWS57"
M>;EP<<(+%.%A8AU*OG$'%R"H(1";)'@9C!@JJ &"#3A]4<*=[K%00AT:Q%:0
M)AW"8<>?9RB$!P8=N+&)!G24L *!EA#)Z4"?D'!!EF_04MLD*LS"RPPGS!!+
M,#5(\,*:7_0R8F3!F.%9G2UL$LP7& :C!B7!C%$"L@MMTD()7E240P2^=GJ"
M"2;RDOX#"3%@&,L8P<)RWIY?@!!&,)-PH,$9M5%RPBR1["&0&2>P8(E 9_ +
M7(0#$URPP0>'9$<!-=P1@WYV1$"))1;$UL$$-%!22 5X4,(!BQU@4,<;"V@R
M"08L1 (+!'& 0@*V-N H4"X3I&(+!L6V$$,P=T2L206:S! S!9%04L$=E( J
M6QP4!$,+ CD$<T8'_[D!2PE<! ,"%Y^L$)I#7G#0"1X5\%)T,%V,\,D8%OS"
MRP5+2"+#!P&2<)X(+Z3";C VE""0"RX$,\($=,S10"2_:&!#)"U@T&P#:HP-
M=0LL:'*&!KSP4@$7>+20@&=4A=%!,"5$L&<#I5%E"0@D1/[R20,VX,&"Z)I8
M,(<E(K@KZ P7Q/$+!)/ <D )7?"BP@R?S+#8&1&,P6PN$.!5 GFY/##+"R>
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MCY"@O$" @O&"+OQB!1.Y PB"L8DVUN$^=1#=&TK0"PCXDA<=0&5!9( 9@41
M017HCT T8")+W $/^A$(H&A!@9=(0C\Q6&0P9B"#8'!!9RI+E@"A]@!*T((7
M(/@"SPJ1Q&"),*$*72A#?3*'Q;Q$!&>810E&8 />!:,#<ZA(!T; @H_2!P1.
MNB$CQ?X RAJ 0 8CT!G,!C(S6ER4!2L (BA@<0(1V  #D;G )KB0D Z(X*,L
MH,%N@J$"-RQA2!U+Q2]LH$82 (X6+,# ! (UD$B(X 0VH$ J+%%"?&H@ CJ;
M00S:!HP3N"M8=6N6!U@0@RMRH3OU7.1: P>'+[0 & @UE D$$H9^/< %'SW!
M'KK  F!0!39S*64P3)"[$[Q0(/.L#]DD1!X3=$"F;KU-03PI$ M8 A84&,LO
M7H !YIF19G&I V%S, 8UV*!*<6CK##" N0E(]0V?>$ +9JH"$5&E;FT+A@;N
M\(L)*&@@$[ $8@72*% "8P9>FL!,)&$! ?)E/GL[;"HJ\/Z5Y62RMRQ %+$X
M, $5D+.AZETO>]L[D#JL,Q@4F(2;!$(")7G 1"!0E82RYB08,3)07&@<M'26
M \ 51$>YB-9 _"4">A9I;S8XP;-$<!Z!P$<@<> 7+_ :&C&L\PR8^>.[&L L
M8*R,ETK4CY*"80L([,&SO%12(-DP"P50!!;Z$:+?%BE(@90 #G60I$!F (PS
M] U:+)A% -U#"S7P,3 1\!=5&(O65+K+(2_ VL1>XK-@N( OP<"$0N80Y5Z*
M=B:_:'$G%O )6E2@,;0@00OLH(D5C  4M%B OWB!@6"UX LDL(7W< *+#L[@
MF\&( !PK )B!:,!)>SB#Q@;R ?X;<['2,>!+#&JPMT5VUWS!D$$.@/& K\!B
M%H68"2\T@$KWPCK6LCX8'A*@N-WI4 63.$,#Z',!J]+O#9'  -1^+1 ,<.H$
M': $&RA B3I\*A<T.(%L<M& 3^2" EQ8G.A88())J*$!,_B%)A) [25!P V1
MX("G!V*+!U"[$ $(U!G8,ZD.S((",Z"$&2S0GU]<H N2Z ("Z&")!P1C!1R0
MQ!TF((E>7$!Q+_" 13PPADS287%\MD,#Z "'!2RR R_\ ) BOK@KZBT87N C
M"T 0B3,,B!<1^$(A7D" 9^EEEUH3B /C0H,*1$(3#_!R R14/ZS*M2!O6"<$
M* &+!OZD1@,KD,0;<!M*+HA:("]00%,FT$PFJUL&"\@7'@I 3QET(!)N^)UL
M/C&!,41B!"LPXP/",Y XE(YG]GM!))9 3)ESH0XB0+A;!<("S' A G=X^E<.
M'PP::* 0;WB )KX0@4*4*0ZQ(($;9^WYSX-^+8)W U0Q- L:L" .E%CD&9XE
MD$)X2U5F<'WK3>."C8YA!5] 7BHD/Y!??,%\/7+33&#*@C< [25>P(-LF/3C
MA9BA-'02-1ET_PD::((6,BB5O\XGV#W4P0NPJ!(POG""$VPT&+%HDPW2RX:.
MW&$%,] $&>@M)SC\\?T>RA>;2D"#IA0"&^R' "I+"?2+0/YTP@J0P!R0P:,M
M":>@B$"X0;X,Q):X02[4R)1\P4N@"@E$ED!8PH4M"RT B4#8 @VP#W# 00LX
MX+M@2]38P7ZXE26PP7G\0@YT'[2P#UXHA"982PEV6.>%T0DX22Z(BPPP2[W(
M@!V<1QRTF!,V#0V0 2]X 4Y (;&DX+^<0 EP"BPL2NB!81B*(52XR!B:X1FB
M81JJX1HZA26$05%IQG,X!&$X!UQ,AERHQFPL1''016/081S*1A[&AQP^1W#P
MAAX"8B+BQD4<1D0(8EXHQ%CPH7,\1&,4XG-8XB4J(AXZ1R.RX2>"8BB*XBB2
M8BF:XBFB8BJJXBJR8BNZXBO"8OXLRN(LTF(MVN(MXF(NRMH<EH4GZN(OFJ(O
M N,P$F,Q&N,Q(N,'T<$7C $;F,$8C,&:$4A(U$%RP40UPH18B$11G$4L.$E)
MW$&&+>(F1@0W>@0M?&-)6$J+,0@OP$$Q+<0G;%0D\.!0\((;!(A%#)<ZPN-*
M>"(VNM2AP0*<!-U 8 Y1C(&(N%2&B.-JI.-"<.,D,%](""-6:$)IU$%#"@0L
M.$DQ@00<?,D=Y.!*'(TF)N-)5-_6?4 +M$ O8(!5C>.Q148_FL0)L.-)%,0+
MF(%(>,!(@H5B^&)!#)1)FD1!V,"K*870Y6-)C,$NP41%P@0HG-HBOD$)%9XG
M0B4L?/Y YQ7$&.@,4398E"V%1;RD8WC IUC >>3 "0 8,+# -"[B1=F!0WQ"
M!Q1$!US8(D:">D#$!SQ+&- 3)?Y$%S03"T1&2U!",\$"!]!D,$#/7,006#JB
M /'72?+$!4SD]MA!)U @;2S00H@4;2R>0N#+0#0%+<#"2]#"'7P%0C7%)+C>
M?O390F0,5>0"H9SF&S4%+W#,1E; '. $)0A,8. !16#.EQQDTRPD;0B$).R!
M17P""D$D*#4-!4X"?-P&+#RG0)S A?%F<@'#2^Q!4W1"/=9'9F8G'KQ$\;P
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M!G1")$S !.A,!:D L@4#*'Q RY& H7U !)0 +'P"!Q@NUPX$'A@K!BP2'G3
M"X# !+P0%W3 Y>;+^;5 JC:%&E" 1[VITJP 'GR!@L1"XW3"W#030\#7"7
MZT5 !;Q:+.2L", ""]!9!W1 4^2'JU9))%Q1M)1 DCW> V# I'5'I+0 !=A
M#'S !#R+.H'L"VZD!SBK"#2%M;0 QGY)NO;LYNK0>7#!!?Y(ZP7 0B=H "V4
M  2(@"7P0E;=+X94P+-0!609! 9,+-8\G@>85@R^P.VVZ[>20 1@"PNXR^:J
M@ 6<0$%\P=>&K4:*:D3LK6RHD4!,P(AR4&!8@#7FE\P!!C!4 "QHBD!X (N
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M*'7";F&()7A."X\$!6P457A BWU '40"!'C!43Y H. U7T/ %P!VH$P"%]1
MB@6Q0.3 5QK6]HC(!%PJ59. &Q0$E0Y$6;, B4DP+TQ 2/O)"W@Q&&_/U0C1
M,U= <I$!CJC!+JE EC4-!4B;&,@ +5A 4VA"%_@&)45 =PY&,)A-&(QQVBV)
M?I2 577"?>Q0__!V%[S/5\4 UNA(*JC "'#!8SN 45T8"Z"2=H5!!?QU%R@
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MS=$0[ 757H$_+NR2BP/@5 ]XD= ;[ %-<C"AH"X0D^&$@FAPX1<(@IDAP6!
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M0FJ'&,L<^JZ@RW<+$B$DK$M@P8*+%/I$@PXZX+D@7E0@21,?:($*YC.3;W&
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M(,IH3#K #3X!!#2F:0LR-BB #.J #B)A$RC%!O#@#2+G#%"#:T'&+\3%0<=
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M^-#56<6%-O"Q$QX (33AJR @]#CF4UH 1\: 42<A!WH!N OB 5Q/K#\=5A<
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MXPPE((%M',F""I@L%1X I<TLX8$73( 622(E"R:4))YIH 44($-01G "%G2
M(A2P!"]&H((2W+-;ST0803:!@1>0  )?&$@,/%"""TAB%A:@R PH%HP.?*L_
M)X! !SHQAU!ZX)H7X.2M@!&##ZA  QQ1P1@D$3:R8* N>9G#!6+0@;MUX XD
MC 0>"NJ!)?#L?BQ@F$Q?X($<!.,-!17!!"3FAH_2@@0DR*8&0?()#D3@!.C4
M0 E L )&V>$"+^@ P^+@G1C0H#!Y^2I1&=:+?JK@ F-1@?X)AD0537!@JR=8
M2!R"= &?UN$#\P,K",X:A@=<8 R\R*8)0%"7,%1I L)RU7<N0(L)2*@#29E
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M$'C !3$  1P!%2!A"4=S!A!P F-0)IK@!3:@.HI&";S@ 1KP A@1"4<#$F9
M,5^S<YMP-"1 -L%  9\P!C, "R_P;6. ,*F1:Q1Q!O>#?Q7P!1NC )3P7%S
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M;TX(%:)H%R,P7974"W50AV"QG'%021YQ@$8Y$ >(4.'F+B10B" 1"[]PB,$
M57&P"1PP%BF8-5T@G,09#)I0F2 @)B !!Q$0 RT0 P^ 2!W0<J($![$4#*3H
M!A2E;P!* G>PDAJH"1>0%R 0>!]0!X.D'74P"4*Q<YDX ;&P!Q. !W0PH;1
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MX(, "X$'"C=N8V$)#L +A=@"*O<&9 ,2G25O]'8WRZ0 N!$)"L=O['-6D9$
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M=)!5I?[ 8T$\&<&H&DM,9J8!;R5/1WI2"%.W%?9/=0M5'-:$5;:Z,4!9<[
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M?V(@,AT0 UNZ'76 72*?Z6=_81F?^JJ_^F_^G)+T-L,W"P^0$RPP"T>Z$)O
MA@-! 91 "?K"<HH&,'H-#"X\$"KP!5O[-PW@96HD @B04&N(%A2P!['0 2S
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MD(1HX_D1,=3'!A_AA0?H]0 7S6!3.<; &6@!-4WDP@9D8<, QF#ENO""#1$
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M"I!./%" G5%'J2@!"N"Z"'@639 !#C#*9A&!!JB#.2B,V%B"&7!$M^JM+\"
M&7B#BYD.MN( %LB!'/ "VRB6X;.!Q.&%+GB6')"!FR2(CFP!Z+F>HI2>+_@,
M" B+' @#/!A)^1&G#K"#28" +LB!)1@#3;"$"IB(+]2-"C")B0 QP^"/1;F
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MD010"%*YVXD.\"9;?9]O$97F(_Z(7P !<NDU3=")N+2^DV@ F\I-^SP/T'+
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M**)CQC @BT+3();X@&<&,@,9#.037R##=QA&BTE8Q0U>H)TE>&&'27R" R]
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M(*MIPO  Z,1 FQ?@)QXJT 4:=& 6K+F #5KP ".AQ -UBP )<B""#H@4&!,
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MX6&9@ ,MH$$$G$D'"WSA!2!X\0-.D/H1? 0")9B$)<0^@PD #Q80,+C&B+>
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M+4  7%A SY!!A 1#(53?!,!%&P9/!'C$'0C$!(B.!W 5!8Q'(!9> _Q@'*E
ME^"!X!#/FOR>1C251\1! F@ !F! !9#5#$2 -7D ]<'" SC7 _PB8$! HI#
MLD0 +-1*QT! +TR>.#D*!X2, +Z(C&FB8,S"4FH 6(:!1'D$)1C,*P85P[3
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MQ@QD$2W4&2<JHJK% N".+ X-6S!8P&K\QBQ(6]V@9[4ZRK#^BP?8 AZRA@P
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M4T7%:[H('GQ 7IT!!,P%,'0 L*0"!XB&1^3 !9#!$C2 D0#W]) ;)K.QH;P
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MR@"&<@7@QMAX0)D/1!S F@L4WL9UP D([A<4@B%6!%85XMR<KD-,0GH%0PU
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M3KQ842Q]02PG+-A]22 ]WG]$:&M@GE&]2= "X>>9S;L132"]2,R"XJ?2Z$3
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M] ']+70$%-+ 0%I @C!TX"49@< =/M&)K7B'?:F @"9LT8$8>.$""9E$!6I
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M7F()"6("\(PS9X U"X$OFLEC6(#/%L(& L3U<H$75"! (B$A'$+_/(4GFR]
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MR;$<6R"<!+R3%JR3/PBO!&C #FC%#4J]TMQ@#U*Z?V6=('XA34%<$]Z@#DH
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M$AK@3PR\YF?<  ]?)(K$T<25D0N0Z 0@P,T9(* O$JA@$OYFH!$3OT")&'C
M0&WCU00"W84E' 4$'\"#&QJ01EZ,($XM6,(K@TB_0I!-4I]HP!AX,:M(;/,H
M)XA '<[*L]^<H)5N@, GLAC [E(B,9,002+'4($](.8H&'C!'EZ0@!&V !9A
M()4-"J O6F @!Y2P ?6"Y 8$C($2*GB-)2+@AGYG)*&4.*LDSL"8.30@#L
MUB\P8(.*7Z 7FT!<,##1@'+]9Q(5T!>N1- ;&US #I(HP6DI0B)XGD!?!9V$
M!7@A"0O\AG%PH,0,%$ )[L8QYV:80"0Z!Y+?^#('O& !N520(F5+0I7!"D8J
M?C0#+D/ $F/ @";J0($2\&(S'OX*<0,F$0G+? (6&#C!"SA@&!IP0!)T(%ET
MM.(8#UFW)]FA41W0.@>M3:(!;IB+7BZPU0^T(#MA"08E$,!E*'X] L632,=T
M-DX/Q>DN)^A"TC0A GAJ  ]+2"2D'639,-0$ 7>0!#?WL*'&X^&5:-5+#AZF
M!@AHRV.9MC5X0)"B#N"-BB5F 2T:<(=)M& !1EQM!Z[F 3+ (@%JT 0-<CO>
M!]1A$B]00"?.0( Q3.($-VE2R$%P7S8P /JB,R,P"?4V'7I!"1 0<B30(2)
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M(H ')B #6P0+7IAIMV0&(X!8P/[P!2,9$W;P 750 F:&->*F K$P!R20:;G
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M G4P UHC<1MW+W?Q3'  !V<  DYE QGQ!4,'!Q%@7;M]![UM71Q@ 7,@ Q!
M:HF1,B0P!V3P 'QT4Y3@!06LSJ>H B5@!U]  &E4%A0@ G,0$9*V I3P!1WP
M"X&1 W4P @\S(W=9 ;0Z 4N7 RAM"080SA+T!CF@>0^P!R9#%A#0 1DD:,'
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M.&-P!U_0<T/!*UT !UTPO\I/%"[ '[AGIGCI/B*@ C)@%\[C%!<5 3E3 F$
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M#SJSIOZ7A!: @< &3=2@@)<Q@MS1Z A(@ ..$4SSL $W[K@@.@ZZLZWR@TA
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M0K=M.X, R!@R4*T2R)<[1=64M5-H61Q$=55;<X,7 %FHF 06L!6?/8YW*S=
MQ8,T^M2$>('6 (8+F !ZC52$^ ($6( "0(  L Y-N  "P%D5B"HW@(  "( %
M4+_3]2'3G;(  !M)11@ Z([7@84!.)!)& $(N(#)@0HUN( '*('!8X,)D)H8
M])?"I5A?A04(0( KB80%0( V<37(W:$-6C$U^(# +3:<D(@*.+0O"(!(Z 4;
M*,+[N/Z 82K8 +B2^9BQ9KD# )B<-P" M%A8#)L!CM'% G :^8"% V"H0G@S
M^XC?L)./": )-^@" ^:S!8B0^.!;W;V/,P" C#F!LL61!.A73J,?%8Z;%P
MD#T(KFT6LY6P/)N$SL4U6@B [ON%"U@2A N# 3@!+^@"+K J$A@ -9@$%P
MC+@;"#@#..@  .@9.=& !< /_[4/$6!<A+ ! Z %6ED &;B  !@,,P@ $+"!
M!(" (#. .F@!FCB##G@V2@@ L759HWF !X" 4LR!!$B ')C3%_ZQ70D 9+DJ
M ! D$&@-2O@ /*"%$YB<"[ .8%B"62+;2)!D)QF!P:4 ;?XR&A:(@!>0 1?X
MX@:( !!@G1. .DV0@5'B!<JBG ^8  U(%1)(Y5%"D!+HA3Z9G+R*!!<X UB
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M"+# 7T#Q!TCJBDX(!""!7VB #@A##6"R#HXKHM4$/   7=& "-"$ #@![40
M$=@#.BB "%"!"9#?PHCQ2&@!#""J!9@ ,^B  ;"$65  "? ""!B 69#PZ4D
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M 416@028F8.8A %X@ 88 TTH@!.(@PE8$E&'@!?0 !)6)KZ !0)@@;5H !D
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M+2]H*P#,D8_I8%$#_ #(+P<#@!CLH#(S)( 2>P  '/QR%5A<"ETD\(T)(K
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M!2C!\G 2# H(;2TM"$!%/@ ?^1 D=V98SB\&YK^UK&  E@C&# ! "5JDD1?
MN( %(G(!#HB3 PBI0XW"=$6$C$$ -KA#'>H0B5@@H !WL 4E%D";U(A $[20
M&P92U $(P**+*)(, GAQ$?&DY@QH;,&I3/ ;!7Q!$S:H2)1BH9_0L:8!")Q%
M!1(PAOZ,5 0$!=@#+V)@E9H$HQ,1 (8*?'6!J%P@5AV<+6UK:]O:PD(!,: %
M!!3 A4GA,4L(B4.-;-6RSP6@  (0@+#,A8$ V)4OL " ;B*P$SL8X$02 ,MT
M7_ ) .1+$P"0RRH;P (-4("<P1CJV:(4/JH&( $5,,"4+C" $DP  JD !@8
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MQ1CXBGJMQ2=@U 5] @4$7DO&YCMV@#M=  5HP'UJ "S00@=X  M8  .= 02
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ME0"&X(<FS$ 8=( &C!\;S<N'NO[K"%2 &@3#"I")"WW"&(S$#,2!!M1(#GQ
M!_A/W'S!"UR 7'S"#(A!R41""5@ R/Z&"(" "5Q&'=@ %V" ",!")Z ."\S1
M"6!(C73IFL3!!X@ "Z )+;3 "LFKU:Y0Z&AH3=  "7P ?9AI8_("#8P "-"'
MHHR!"52 0;F$!HR %V" I2*$#6B "G"!T1B%U-"$';C;ZS01V)) ^(S!&;3
M#)36&'C !6P=JHI "ZR1#8S!"51 @78""7@ "(Q?&!CLR[*%"D3%+TR +-:M
M<+!&^'S CY"3)82/.)&NB8X!!Y2 )/CGRT["A>15FD7 ":!)#*PK09@H'%R
M)GP!)_[=+@F(@(38@)RA#!SLC1IH0OI0!NE20L2"0.3]@@V P <<J?:"P!=$
M1"J<@-3B1R_8P+@:C;\.J-'P@KN2[PM80 Y$1"2,*^^6G@U@  G0@I=,P L\
MZ1R(  G8;Q=\00N\UEI<K@;D@ A\*$(XKP6,@9=8+ :,'QML+^*JSQ>XP 7(
M@#URP8#*+XSY[&WPP@E 0%[MW0R,P <PA_T,;>7>#\;J!=.XP$@4P@O<*K'J
ML)I8P@7\ @88S0OD!0N<P"QT @7$021(JK:2&65!T01\GM78 "Q$3BXT+)*
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M-ZYB_HPB%B1!U'YC#DX%(B:+MK*0GS NK=!I.A@H%W:0_!J#4NR@ J()TW(
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M+%>CK,X.RK4W@H%COH4\+" &O" HK%"DL@,^'X)1I^1>K?Z.!4"Q*"Z $MR
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ME)JI?_&<S_D^'81P_H)U4:QKSDT!*$$2%)D%8D./:\H[-OZ(GWEW A;SO"?
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MPS DW - \7CK0P1B#01@G3M:H"FZX"<LXVU'H%WHNRNXP/+ .29\65-6'2%
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MV2H0)I10!W%@ EXP:X0ZV6%BQ'%0 C>W'IT@ RR@$["P%5_ "QT !Z6V';E
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M Y !.%B!SI@$Q7N@J_* "GB!0J"%"#@#2_B ,_@$$C@3'?D$,+*![ *42!@
M+F@BNN "#9@$-[BCGT$V"80 /)"$"B 6NZ"$$;",5#H#Q7,#2ON$$\  -RC*
MA@([')LA,3 RM_. %X"%+N ($=#7W^)2F^B/CJ"G8/  L  6W>V(&C /\CV2
M1[2).,"4$0"1,3J!"' #-]B1Z?XH@4@(@PX A@[P+#$H ,2H R=$,.F@A2VN
M"[V  !"(@RY(-8%] 4GX! LX@T+P  )Y SS[.D"I  QX 4OHA+NC! Q(.16"
M8 *2A!B@B^D1 SCP@ D05..Z@#JH@PN0C@EHX"]X %BX PI(P52X@-\# =Y[
M ;2) UI(@!-X@QQ(CSI @+2-BCOP#SP B6HIR4B8 43J"#K8YB\0K"3ECY!3
MU8<H$:0-AEE(@!9X PZX@#XZYOBQUVUED@50@SCHC?B1 4WH-PA@ SBX@,Z(
M! N(@]:Z*GR.@Q:( !MX@[O+%!:(!/J30 -8@CCH@$^S@0D@@YH@#W:D!!_3
MT(K^A/XO6( R6N$6!H$Q (42D))@<($5B(1(?#8;F ,6, !@H %$<H&2((_<
M&8-. Q$0J  X #IB*0$2F ,;V#*/F(0">($W>($*Z 5*0(!%^06IJ@,OH( 3
M>8&460BGJ@ WV(.;IIMP@9 P  %*\ (]4@M->(!9^(4OB( OH 47J( W<(,%
MB*X*,^0.$)U<_ 0%R P]@4&)\*ZOC0#RH($62(4'H /'J)8)T(!JU80.2!E-
M6 "YH*^9"$X++E(N )2..+;V.I))8 &!.P-,\0"]" MK]>>,#8L)X 4RP"8)
MT 1*,(U@F 0<L@0\BH!S4D]0.)%9X(#,TH <B!3U6]^@<OZ#*/W!F]BQIEB!
MNVC29WD!\T Y-J:+O[C*&0 @IEP"")".*TXE%V KI:B9!Y W+S@ XO6(G8&#
M1U4+T".J,=B.5  6#(@#)PP&&;C8GWD)\;#<ER <M>A;GB$O84:KZY@/&(L?
MRPL#"*F 'YH%[J&%$E!8&W ).K" 7^B%7&@ 4."2]M,6C^" ,U +GOYE5N'.
M#[@J&J"+7I $!Y@.PJFM34J<(?&(U4J%!M@#8&BJ)>.%7T"/Z#(N(BFO]N :
MM  &.O TNK")%8Z++W@<#- /<SD#M4K0M2)ND1CS;8(ZD X5+R"/V8X?5M*$
M8HJ!:XP T04&9Z$$YI $3.F$K?[BMQ%H$6SLK^XIC%S "AG0DC. D#NC!6"1
M@#U@\[NDB=S)!6"P /74TKM4V5 !%5&QK0I@);40M':Y #L A6,J5RD/!A;8
M7;XKE1<8B,LYC@^8@8XU=.X9#A=7UF^JFO^VE>'  .0AC^P)!B_8XPY:#5Q<
M$@K7 $N@!6VB!3Z.BL.R ;W0!)0( PS0IEU'[2(M@4H$E@^@@TGX#F A 3(@
M@15ZM))@UY;L@@^(@0_(#HN%&/>* 1MP\KC*LV6*V (A@1.H&U!87W_,BA&0
M 0O(K%08 0NP@.4LK[0H$)10]U12BSDX@!$0@0K %#!*BRV""@I(K2^ $/.V
M"1E %?Z<D 0+*(&3C#F1"(;NE@VZ*H0.B+G?X4I;T0 1^( $R$_RN$Z\6,$'
M&)H52 @,YK:IG@- &0/QV(0)^(420!/X4 '>LYN]<';;* '**1$6L 4,F(26
M6?I@L("[<7(:$($9T #> ZZ&F(#*,7J6R%I@B 7@' ^$(!F7 ',;CY\I.0$-
MJ)Q' P9R":P[TI^<!;1@T("K<M0*$ %:8(,Y)9H2^$]"80\842QUF0 7H(^O
M%H',W*FXX((GQ@#N9 /M4P&.D&^A-H_3'QJ.D)^_(1C%'YE',R7;4)_)8);Z
M2)L\L;)E>B#BOB-^C &*X;V'C03H*XF_(>.S-H\P( %@F/X#WCF!%1 !0[8,
MX:DG(-H#C$J3K3OKDA"!C\5D(8+YKPB&R;B0\Q>#3Z"9.>@,X5F9^]E)$/B
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MIKBJ+:[PB%>\TW/0:#!R$0>#V" LO6C-!VYI\IHK.^*@(,&+.%X8;B?%"Q(
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M7$F$)/Y-":P<R_U"*$7"'J@!I!7% !5%)='"H>@&77"!!OP,>KA77B!%#.3
M#,"&DB&A8A$1-:I 8:U=9=#"&>"$.BX'7=5&9-T!"[1 K5#B"=!!"9#+&)BD
MVL5'(OI%)Y" !IC!O1T)1P&5#4R #=!"-<)!"82!0\R!0=C"$JC %V3$'>:A
M4="!0=P!%A*80-CC%-9$,'AE"[Q),+"!=23?)\R "I"+'43"7*QC;VC !^R<
M*\: WK   @K$)\C 6U9@8^ !&T"?"QYF?$3 S5@"!-2> C1:"5 ")I4E1[1
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M* HS!OX#%P2%#+R(D(R%X@I$"6#5[%[/D4R"&SRB!4$ "WQ,00L$"4B'#&&
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M":Q1PKP%,%1 PV#,'JB0)'S"'CD$'4  \W2 JHPU'6C"")11!$2)&@'W>;R
M!M@'!#%F>$G'6,\!)AQ&2FB )7BK%^YP!T@"+8"F)@#%>+ U#6Q"'72(#6B
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M!2M)A0HDHYR$>*!)E- 0"80TAOZ8?8$R7" #"RR@E4B8]WXV6$%.5[ 26)P
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M/>@17.\#38J 9B.Q@$_D.0SPB^'V1-"?"7A +1$XS<(;?AJT?786:H  +\Z
M$>$T99C%+ \(<L$+$9R&"QB H04P<I.R3+$!,Z !#5X0"8P/$Q@=*,$G)K&
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M0?ML0 -L8 9LX MR810SXH1HZ1=DH -J@/NVH@BYH 6 (0+,YQ=X2CB$Y".
MY"[8  ->X PP0$@HX"0I@,K@X!> 01,.,B'<0 -:4@.:@BMF0/C& @.<IP*
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M#82P6?*N*[?NA'BA TY( K>NVA3@)K!T [EB(;-I#S+M I!)TN0+&V?DNB
M$=EC(IKB#A!@%GY/(>C@%]A@(SY1$2G! CZ165*!,3"@7@XU0J(P(50 %EF
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M/^Z@ ;K T*YB:7]"2#@@:+O 3W.X*DK #"ILA,#1>;D-%A$VB958(>JM0[B
M#HVQ2)GI,RBA7N*I66!D!NK@!9@%#P!G#F8@#,8"%A"Q$$ZR#L;B%\A@!BS)
M$NI%$^H%#BBE$SY,GDCE$\0@T^K%$N+P@NL 3X"!#BQ0 Y E]+J  2F%#A+C
MBC6!!@AR<I)O# "E$^ D?+H@%?'@,1112,QG_/#@),_@CNL8#_ @%?3+268
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M-E3@ 52@3AJ@21YVHB*@RDC@ 03-#$[S$P+@_6[B!2;V:V. !B:@!,"&# #
MD6(@ (*&YP+E BI !4K@WRA33<X   +D)GB!!"H YM(\(4C0.$^@ :0%%!:
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MPR2# 0<5 $.S)Q!!@CSPB4], !B9W:QI@:&!&)0  RH8S@<ZH5I^O> 3%X@
M"RS1@1*1X%4#^8 F8M&!&5 TE/XQA)(&YK")%%Z %F;@RA*:-9*E.B<2!G!#
M@DCPL6!VZ &%DD0!"K$'?9V!J%WH0$=HX(*@J2IOL8@$!/I'!@0L+QAAX,!M
M^AN,#K#O MMQ0 N0UJ()?,*6 NE";6PH$ STZ@$6_40#>'$2D7!!*(?M2%0H
MAAD)!\,+#26!%"DQ #:> "05.-(%JI:9AGYA7 J&V5/P@ !$W88%TZ5D0UF0
M,!78RP4S $8J(I +6%1@DF-H* 8*%@P,A&\"">J$!8#QA@9HA 8EX1@O'!L,
M-DBQ!11(D VBYX()]._,P7A!=!84'?@\ !9<F*0F*  ,&K Q%A$ +5$+HH%_
M\2*>-/X :T'HL ! <8&H,\!+F[^ FIU 0"DM* K'ZI" IUQ *'N @)_T58?H
MR:#+:8QR'2Q&JDY0V09XT4 +; ,!U$T ++2H0"[.,+X9X(\&K]; )($1 2@[
MQP92!,8)4-*%FMD@!T<620?N8(D*=&0/:_' &WX1 3;20J#!6$!P>#&!:U-@
MOA6(Q23NRU0$+*TC7XB +7BQ *4\%8P$5+,F#&"&!(T@#J,4R0E&-L#1+B$8
M;X!8,&C0/#PX>@16(0$).F*!-P#;)Y9( !L*@H=7\\6[Z":!&S3QV1*8(1@1
MT 0H)K 3C9?@8Q&H"P;^57)8H/P,+W&#!SKR@8]1HB8%F?X )6:!@(+5(0+N
M:FZ 9F #,KR:!'!P@45=+88PO*#/!,%#9V(!@2Y\80P<B$$D]!6,#]2AJ@)1
M@Q2?JZ [1( ,7B!# ^;0!4?_@@)/ 1/:A1.!68B ?1K8CH(-\HL*T-H-7N
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MN; @LV &+1B>IP8CDR I]D$+#[\1<' &<QAE?50'JRX07O[010-A QK0+'B
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M"1:G @T5R6VH\(@@[)B[)$[DN!"VK@?R"S\]*/] 1HP'R AF#@IF.$$#TKC
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M17]3(5OA54LLGQA8,-[PI"UVZ1-X<-YT@U$(.W8@-3^-W1DP#(O2_J(0++B
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MX?L%+[@+$#@27"(-% 2VQ: %$'@]_8$ 6(B2=2&!$3B@"'"#,^ 5AZB/O*&
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MA=/3! Z9!0@=(#IPW[G3W9CYA-KU65I0@]N-MTF( S5@DAF[7M)P@Q'\6S(
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M#C@3C"N!&>B D7D!$% 0XW0+K>"M&7"!!OB2W7BG"K 0Q6",.ZC'RO+".)B
M"QC?"# !#Y@%#1BU$GB67]" OU.!"X@:-[B )2@!![FLS.*4@NCL;B;DH*(!
MF0P&-8" L'ZGR<B@&>B" 6JA$N"+-\@-DV;94Z9;-<B-+PAFXM&$2I:@TUL
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M!:ZT\PEI<8"!=6I;G4SW!0R H .,T4X.*A2,,6#@ QYH6QT,RX4<D*ZV;*#
M=CH EZAQ!18_U0E-9$6"#VB@3=J5XG:#,0L/\ (6TO* "4X)BQ'0M"5C<(%
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M+HCBUJ $+V@"+P6,-IY2.[XCKX0+,:D!0R[*&&S"4O#*KFC"KM3!&!#3&%A
M)/R", F$)8P!C_P"K+F!1#4&&0BAK;E 9P6#!]2!'8P!K=!"*@SC0L3C&SC%
M+X!B+@J$+9S!'-C"UMB #6A"&.CBLM#")##D+Z@!UN1"3H8),$#E&RP$4)E&
M)]A"##P9*F(-,,#!/_J82U&"2_Z>CUD&0RZL6AWT0IAD6RR< =; PA@4@L-Q
MQRT*!S"\005( B]8 @6X054-"RV< 1N49;/!P1D<&ZR58[/5HS\EWB:,@1BZ
MIAM\H7:D@CSN"JS%@1H8#U[&08DY'0;X4SL6@G;0)#R^YJIL0@50HB5J)WC
M 5H<A%/D0 EH0E TQTD@UQ*  %/< 064@&;951A\0--DR$6DE;VQP!C,H$Z
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M_,+K8%$PS<(/C2<P:!0+@*I%<$&)OL"4'!P73( -5(0+*/Y&XXSG&V% SDC
M"?R7530758S ;DQ 2[PG".2 C]W5#$0 'E "!GQKOP!D!"C'!"!HOUC* [A
M#$2 3[S0"\Q O&Y'C"X!!H"CH9[ )X3! WA .X[ TEE #+1 881<4WB :$3*
M"2"I@OJ&#'1 #5P 4WR!5;#!!>0 "6@(+&@ 2T1 #Y8DTP!I:Y  +&X$+6C
MIW@ !K#:!9C.#'1 .G*92=$ G@$2T[A4MF'G=EKM>' !G72%&J %!A08I^3*
MKDQ )UC"_?@,.:)%#FA(ALX?"WP!+S2 \[3.F9J&)[V'WUB%&J1-!,R")B0
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M O1M$<Z!Z"K2!,3RG<8% L ".>TW! Q&AC(*K;S!@V#( S@$"50 5WR >#6
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M8%(P"6&#1>@$IP*O7R\>A(08; *E60\*!2L$ =8L"'N"W7E 2T*=A@@HP8K
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M$\9K,. @Y,3D8@Z6>$$,J):*"=2P$S1H@</F0 DNJ. XE(@682&B"?[9(2S
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M!"( PA9@."! !-[ !KSOY5J #E@ !((! S!$KV#A!49@$G(@Q+X@ KA@%L9
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M5?5W(' GF$J 3/: ,4O #9QW<Q: %B1!)U+'[]B@>S.8-$-W;9;S+<A ($Z
M3/B13\D"-N/@<CT 0TH 6[RR ?C"%A02%BQ FKCS03[B1]["<;)6DON" +Q
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M[&B@#NR@CV C(JS%!L@@8BSA!$2 !'8/&'+@:L) !$2@U+R@J*!0PR7!!N8
M#TY#QA.C"\;R!$A@*'+@1B9AE;Z O<Z HH)!#42@ TJ +#JA63457UG'$D#*
M:CLC#OH+Q)J<2#\AROW*1$:@+NR !$0@!T8H:0\7,<9 0-@<JLI<!:CF.4C
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M!^)@ PCP(@R5N8!W@E&!.O2B C1P@PDZ9(D&H D!8W #!/["$(P6?  .71B
M[$PR P_4@0YS2% D"N %.%P ,SF@@,1($!Y-Y( $>^A">C11 3S$H7F:L, +
M)/&)"G2A#AC %4_"H#+5U&$";( #!.X0# V,80\7X*$-1("'+W"@1A P2PO2
M\P4)N.$OWOG%!.I ,/Y< $A@H0$+8D !D]1(!&3 PP4BD29> .,#+'@#"Q2
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MQGVD"*RP#D7^!95[%^C>^_[WU/LO02X@B4FHC.(-P(DFTN-5@D@:&'LF"-^
MH9<I/?[@3!5);I$*LK92$Y @DJ" PPCB K>4^G)/BX2*)B N]['VURLDP1M
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M=8  ,_ +#1 &)'-D!?$%71%-,= ).O0)L/)]+#198Q OZH4EHO&.X^(U=9
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M@G$!<P ,:^$&PN-E[!3#KK0'+D$Y\0I33?*Z*C3#<P,Z>H.8AIS+NBS D^
M60H')N'(OY!]*T@0$% R*B _!,$"BF@9BFN"+3 1C\%I!5$'I_QB7\$"7T!J
MWP'+!8$!R18,%4,5$##(NWS.Z"R_88!9\44+P0R,93$1G7$"\-$"3R0=B4P0
M(" P$Q 8H'P@)I #/$@"*@,*#S #.9 #,V P-P(*H,".7L9G%R Q1'0! BUI
MN)S.&KW1[]L%-Q<'$G !"? 4%/X 5Q6Q@T!QFL1X 5&3J1$* 99P&'/VSRJA
M =K<!</B-:   3%  XYH,,XQ"[-  ;#CS<-'T:^D 6'0!:.'RT;,T5 =U=E;
M!Q*0$[_ ;12P4":!D+^;1\&@ G,&02$Y!@L  A[P;I\\ \  N]2,,:=L0BJA
M A# R8'TRKA1$^ ,%N/\*N4LU7[]U]Y[(TW[!@. $Q5 L<&P"0@P?F_ 4L%
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M29XHE]H4<H$' _KFO]$)8["DN-ODT*C>MA"%6*YH=L#FR$'I#O$))0S8FD
M\&$2+3 =3$(<V_,=&!#HR#$#"0Z@52L</D+F)9H#\%H<)V#HQ2%>:2,<*D!'
M8^"9P3$&#P#6%^ !9W(&F%4:R>RXMXPH!>$!F&$2D;  RH[LAYD8+* AMV0:
M960#$VTC9PV.R$T]+[!AMUL!%S!F&$ !"WXG"$06&J!M%1&QP= AD9 >H@.]
M]L4QPE$:%!,,MJ !IH(<FU  JZ4O:^6.!2D&$. &#!;JR*Y62I-]."7;FH !
M<T2!,VB)6:HT(U&0 QH,(. %>_[;)#%-N :A(C4QS+]  EPP*(MA$CO\%;2
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M@]%@H_X*?**E@DB P6 .8+KX4\Q@(R@A5!=:7<NWPGCI  Y@W*C (34*?:,
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MN4%E*ZE# 6@1B<(%8P:4@$4"[D"5PHV!-2>X7PSPAI!/&$ -OUG )N:@-5H
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M^0*"$?X;?9&=];! ._B$PA$#<<J(5@D\.*" 62P)6^@2#W"C3P .%<A* 8J
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M0"JX>.X"S8B(,8 ,E:882\!I#^"+7.B($8@ +@"&":$_X44(&7B ><P,$?B
MQGW''XFH@1'(] TI$("%31CL+_$0Y8)(D\J)#F ,LF !8IJ!,[CIG/[$")B
MF3MI$HB38-*0IVH!R:H3$?@$4/CO"$ L\T.*"/@"&U#IF+@##G@)GR"47_CM
M$9 .AS@!+I" /; #]<&##E@!#OA7<?;Q6<$#]%.#! @O OY0@UD AA-8B3NX
M#[/@!5I(@-#@@HZJR#OX)9%H"6<N@5_Y@J()(YFA!4G@$Q*8G8D.!A/@:Q#8
MB 9H@7/E:P&UO+:0! 08O8-0 2>1A%\Q@;S@A65\)VV2'R3NDPR"C&"@@(U
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M06*CX=D0)5QPT(%;H\%202H2<='01+! X,89:M3!6D1CX,9?"UP09=0G5+W
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M" !S 8ZTH ,QF$!X"C&!%I0  YH)+'L7!))3YH!#D=!I"?XZP M)''8&+)@
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MT"(2ZHG$'&YM&D7O9(:.[! <XN!*2D1F$PWCDJ9]\CM>Q$':(Z&%ICL1!U!
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M]F*>:8]F5*%ZT$"BS&!($!\'"OY4$<[! Z@,R+A2# 2 )$2$#2S "9  "8!
M8OQ"^2 (!70 . ;+)WB !WB%)U)("0R+W]A" ^#3"[A>0]!  *B8>G2! IS
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M?TP4EC$$FP:#'9P %RB$#=!')WS "'3 X8Q&'<Q9!TQ :MR63]Q&!X"+&UR
M![S !=A('%2 ![0 ")C&I)! :S;$GX@ Q>:0>H!"!T3 ,\&""(# 4N7&'9Q
M;T%%F6K T@1##>"J!T1&*JPL!Y#,'5S #'A !$AG1+@!!ZB !G#A'H27T([@
M&QPMS3X&T@ZJ3O "TEJ*2X0!%UC"!* 6+8  4YR!!HB !@!;)/S>R::&)@!5
MKP(-!?[L%AR$P7*.Q"RPP=Z@RDBHZ4 ZS@A,P+"0P4=PSO2 PB9 !"V4  B
MP*?.0 L$E@BXWZR^5@6H&"^PP*K.CQM   4,BS;:; <XDV8P;F!]P*A%  5
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M<D')6\+)]$B), >#)#@O!=3*&) ,A]V0&GB!A3WU&RG2"%A:!8S %Z0A'@C
M&<R! O[XTR6QP<L>" '5P1S 0:W\RF6XP0S)JB8,P-^! -Z.!+>% :ZR!X^Q
MP!B  HXEJZKH24V6@"8H@&N2DAG<0<$T1$_3@?U]VB0<P):0P+!,QTAHM)^
M3'G1A_A50"&0 *HBQ@6<VP-P]!E<0/ )X!NP<]), A=KSQB$06QS09C8A"3$
MRTAX@";<002H 6\K0"1\]%4$R6C$1C\R1T/0007M1(C$P7$O2@-8#RW\QP5(
M2UMT2'/TA.N\4AV(P0FXQ!WT1"&L[]78P1BD=]+XV1[0SL<&0R$0B8"!,GT
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M%&M#Q (%Q,*U\<?(&$M$S '^(/[.!;@ '&R3";$'&5C,JGP+ER134_A.YD"
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M#P['28E)3(47^\N?\. 93WG.DY[R9$@' @0AA;T@!A,@H3Q[X:8)F2%.*L"
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M8D[@ SIA!2#@!&!A!(8CXVP  IZ%(3H!,6CDU6S!.KX  [Y !$SB$SC !E[
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M<H#1?/$\<H\^<X$6/, "2, ]I"4&7L %*O(-YO99^@E7UY(&8'9F0%$4&V+
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MU:I/#2(,TF(,, !Y+-%%@\X"GF4/%H,$*D(%7F!K>[<7BLPB1D 3[*PSW,
MW+-!%XTE."(2'@"/D/)35- V-*$.*N!3W*![5T\#-($7)/[! SS9#8 B!DJ
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M4 )]YO0HEM! @![; 1J<( )WF?Z!!VRP2XJ<80(N\-"X9M !I1I&!1DD 1E
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MP.M@$0%@1$(#.GN!2[E@J;JJX.1JN$H#$B*)/:1G%F6]8P-X88G'/Y$"P>!
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M,7$0 5RIC,'@ 7C"EG8@"<8&.KS ?VR98@\(>!.! 5C7 @T&$3 #?E9Q5UV
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MJ?"*2Y'P +'0"1CW6(9AC!DR"1<P BP1 R?P"\!P G'& AB0$+\:#/ $.@D
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M@S<Z@0#;2#!S2 018 $FE0K0\L"-3]"; X*S]CIC F F@>P,#< T8X;4[T#
M#5MFB0$R32#XE)+GOGA.!#$:BO[E@4_)S/X[MF+II &G6!!LA##BBS^"N30Y
M( XX^CQALD\@R+J$*RTF&+.80+@B@1 *7 <W+S@!7DQ0EC?\)B610( 9<D&+
M,10 >B>HSPG&8 >AM2!>9RA/I6B1 +>XH0&\H(6(_O9"&,90AC.D(;)L, $,
M5, --MA4!S3D 5IHK 0V. HL/$":7  Q%A\@P0O&@('OY,8%'T#;!]Z@B?)$
M8C*;Z( '5*"")9B%3ZU:@54L,I<S7  $&' A0FCA/@]<( :&88%(W( !$6"
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MX+)!.8)FA(1! ;.H6L!FP0L7G("%'1(:H;?<NV"\0 6TF,66#4,"!&PD&(6
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M-RB@ QRXN"TTT9:4!(\63PN&)5"8@QT5O@,+8',+6O6&!@"^5E?JWX:W^0#
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ME!D  ?X32+,])0X-^(Z@PR$R&,TSR*6R(P&.L:<S4(,9>,2$H '2X 7?BP2
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M"!!0B7 ("[ #+'J+O?B N[E-+JBFN0@&+G"#$]" ZJ6$$?  YCD@#PVL7Z4
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M%?@%,/$ \(TL2ZC-W"@Q'/6.3)V,.S@!E>0,K^$"GNZ N< -$@@86C^#W(H
M$<&+.? E$\@!@)AT(5BP,"""G<A!,)*-3Q!^$7S1J447@L B\2)#,%6#66IX
M$900)QB&2,%HO"!X@DNP"; L7?X %LP+BQ*I"!(42+!3!)R2:+'I0'#6 UB3
M*A \(_1"G:1D:$' .6G6&PX$:3VPA#-8"R_!*%T J0FI"QHX"VU5$8:@BC'!
M(GP*E@H"+S<D"'IH>I1KRF!XD&IH&FP6I6 73&ZU@Y3@!3J_*L B"-'-P&#
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M'.%^]/X"'HF 22R!!AS2186!")  5L4!!6@ Q&W%\R4<B<3!!&C  @[*+X"
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MY!M.8( *^!(-: 3/$D31NBMNS@ 7_$+$LD]LN [=U8$:S$X$FP>"$<22R 3
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M0G9H0KY><7Q,@"4\1EQ0\K%10KQ, %I<L'U<=$$<Q =$%.1M6!?(@ E\C><
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M#B]4H($3L, #\1*7&SI0 @P(9"D>)<%89E$"$'0@!G]Y0T<_.A@0I-%K>,!
M7EH0HTW@+!ADR,'_:,"!"<PA&&.PP41J>,,+U&"/]]R)"'0"!VL&XP4Q8L$(
M2'""JG !91Z87C!RX"X0""UU-KL TBPB2 S$ 1AS)($)<@&,$WQA G"1 09&
M\(*"<5 $'X!8(Q_IHV#4@(OAT<0%=#B!X_%B!2#P ,3BPX:&$<B=.V'!!SZ@
M@JK8P 4KF$ 8<G"SE/!H@J%-C?X-"G:&!L!% W>X0PLLH@$Z!(-HAKI 5>8
M32XDP Y]"^9.-  '8/ Q&*F P"0T48"8C & )X 8+%3@,!=8A 5#11DO[C"
MBH@@8 N8P2]H$0''E: RA2@.&3! J"Y \PL/>,@)-F85+@@Q&!$0W0-2$@<$
M1*I_Q@L&!#[1B0((1 T->T%::*$"6O#B G2 CPH$8@D+W.<7+*!!551 $DL4
M1PT%B$/8'J"3.A0 %JF8P$,F@0&I46!Z+Q,*)2 0/$+&3":62$ )4K8K,I#
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M^F#!#<+ NX)!L;B 68+A Q8IOFAA#+9M#"1N\0ZE[>#*, BMX9ZE$SH@\KC
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M1JRO*FH 8A[ @H30:TB H0H!@&J@?X@C7K;M"U8@&.KB.Q8@)7+![&#A >H
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M&+Q B"A!HAK["UCS?YXF-E@W./3EO"U"$AB2-#J@(ES@M3I#!H:*Q2=[)BK
M D@ !"  Z5Y886#C+^R ^OSC#2 F%BA'-)#67 HE3SN#@^IVI"S"#B[@ X9R
M(#JH!?ZJ0A+6J&HNX 32QM=\10Q !Q9*8-4^U#2B92RZALD?/+0BB+_/PQ;2
MYK:]3"*D9R9H0:29A\9EXA,D]#P<O3\\@A>L!Q8L72:"PY^;1H ,IVUT?" 2
MX\(%1Z1+>R(>:U14=:NL!TJ8)#Q8 &+D$Q3Z9D3'HWTH_;P[@6F  7%VPGR*
M<2?^PB/_(CGT>#%R9@;0$VS,*'B4AG;@;R2UYG3X146F'<QF*U_Z9M/C8LK^
MP@,JL\LDA-<#)ZKW>S"VW=.;_%J$2XA8.QB.QBHVX=T-'6A4)-2[[!?$1E["
M8]L'_D!&@ V*173B0HY3_4&BV"(H#D<%@A(FH!?,("U X/ZU2& 2]J/7M59M
MTZ*H*=UP-">HNB7**/@,XC@O@+TSJK<L3H ,0MTL?IS0<04/3J"G*B!A:&$%
MNC'/H$IE*Z"Y6$#KU #I<D&L.T"15* "O@ZK3N #A*876  #2J %H,F81$"-
MV)"T,*"=@B$&SDW6QA,$M#$&0-<%F@OV5("+8/>3:L*'@(@U>>%+0>#G$P*.
M.B&'!.JL+0*Y%BLU+\*3TM1[T AU)Z)BV$">:&# +N#,)T$#.F".*+ 3/D B
MSM,B1N 3;  .Z@ ")L +-N%A]RAA!"O?N("#2> AC,FBHBNX2,"D&.L<02 L
M)]-O+L>"06<&W  //I\+*MJ(+O[@G$K@%V*AG&KF^>")*41 (MQ1L6JB#H)I
MF';Y^)$N;TJ@8RTB![P^!OQ,?D 'FX3I]F!! R" SV'ABSH OJ:W QJQ$R+!
MUN%%!2*!#!Z@ B";]D M;<3)BE@J)HH3($I@(!/,1IA@P6:<"19)PP@.=(+1
M.D'"0XQ?"#,&JS G&$8W$X*%R1&,30>!>()9^G"B@Y=@A4[8T$!!#<,3-6BR
M0<A& P@-A1B6"$9&Q0L-&&!)HC#!12X1M"R1J-$A0IU@L$!T4*'BY8<Y<5P@
M_"2"E\9@.3J  /$IV!D5,31<Z!0L BR%"..PR'BA;;!9$(BJ"$;)++ <7(*U
MB(-GQOY9A%S4LN5% D('30C'>)@A%U.P7"I >* !+-B>#B<TN DVQD2PRAX^
MQ3C!XL((6QEAB2@!PK&E$0CQJ.!E(D*'3S).M+@ @E:P3B) <$B<L?3CZ]BS
M:]_.O;OW[^##B]>(I\!5/ ULS6F!4,-5#B=X\7I "4X'A!W>(,S50$RP&@_
M,A\ELWR $ TO!!-9+Y1A$,P)72 $0AS!]!+,3[0 0P)[(E10V"008(8'!+R<
M<8%9+E @$@)UT$))!<[AH8%B"<ZB C!Q5(!0"Y0@!$P$GVQ2P!UN61!,:91
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MJZP&,'*I3*D@,8Z<7$B$B)" B42W>P !D6; ,RV60)L6NH E5(<0-V2J-&*
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MV0M$$ M-1 !5(-@)9410>%H8YLOG$Q4R@^?/8%  ,YI0^-4S$@..CN$^DY@
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M!1<P PR9$7@P3C/0 ANU-D]1 B=V%9T@ 4XG$M2G)2I1 20X 98 #!Z@ C9
MCG&@!EO"7ATP$9KV)A62$-C(&7NA%3*@%8." 4#( M1A HD1!Q0P R10%FMS
M-  XEW3Y?W0@ K!P!FC$3F] +FCT"<[Q'('9 :&C)QBA.V7D')\P8PSA'+3@
M6+RP9+3 !G# + @A G"P!YN5F/X:(5%?)0F8$2HFY1?+<P8],A9G$#1NY@9G
M0)HK1(>A22=G40>;U0G,$@EG &[!84FYL"V8L6_! )ACX1Q6UH#%*1%SUPF!
M^0FF% F6$YNA.2C129M^<0?V(WH(L0=!PPLT- EFP$UG8" 32!>?8#^@"0S
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M=^ !'F"9I=9JWE$:,;E$$E"IF%HZ<9$#(C "H(I3I?$&$T #+N!%W4$++/
M>_D=@U5"%%"8J4HZH9AV'=!@VL$++_  $!JL 9@G&7$'\S9J8U !-L "&("(
M ',"-(D0=A"=X!$)'U MS#JNY%JNYHHZ47$D<BF7CP$+JOXY'NOZ&.QJ">3"
MKF<AEVC3E]AAK_R*.NQJK]LQ"6SPIK"ZIF\0!S+ZKQKQ"W-PFO>Z';PP!VPP
M=^K*'0KK(P^[-OL:'G*I0AE1"&[ 31@KKW4@LM=QL=71'0 [LMD1KQGA(B.;
MKOTZJMO1"0<+JKP0!]XJ'J4!"^W9LH_AL1N;L3Q+4RN[LB=[KDJ[M$S;M$[[
MM%#KM#.;LE%;M59[M5B;M:/V"Y(@M-G!G:\Z:C +K_V'A*9FMG4IEY%PE(-B
MLAJK$8NZ';"@FZ,3M^,*#.PZF:YY'0/*KE6J$;.PI/=3EYVPLT1;9.-!"6@J
MKQE!(%0['I, @8^Q+6^KM99[N?Y8V[,7\#0R4'#7 0LCA[1)ZQTE@!EV('U*
MVP6Z(KJE\P5;,K6G PLDL$Y4.P%[61KU=7O9D;M >P:I^!W@%2&OLKC9(0D
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M"&:#QL%?%#J)B&%FC)M(J2;0:MD2V 5)P?9PH/77(D81:AHV;NBFQ0,O'$7
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M+AEZ>4 ,,GAT,)@[Q (0A#JX0.V,.V"IH).&N.C0@S<(<C0Q6B@9T+ !?YS
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MPFTSD !#\ "!&,"Q8Z]!W0G4,H$S\ ($)'#+'-YE@1:TH%$* R,&UJ(&"+#
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M *T8H.91K#(M&V@L*:^!PQI7_L=HJR!J2?E"E30! ?$63 550CRUAI-ZB5F
MQAX\0]J*P@L3B"0.8AFV&7BAB/" RKFVZO,^I"@!#FB:@K$!Q\ #H5F*'.@
M$0"!$_X( ,?0FM>(! F<M"_XB%]3 99"MA.(-:)@@09TBC& CCM0K+5S@Q"B
M 0U(&X2@!$E@&Q0!!I<  2["G 4;J%;I+%AH/^7"L00C"O$B@2$IK$+#G(@8
M Q$(-EZ ,HZ(,QR#A<S[CBNTPES#G-@SBN]HLMK#,2OLK$^H,B>$!:2I@(L9
M-&##(*1I-A=8"TT8$"SCL>^0,Z+XA-#CA8MAK8C(!1=#BD_ F]?8CJ+8PY8H
MPXFY@-?0 $F@!=3K!&3+E4UPM4)BMAR B^_8A-6P!0G0JQ3ZA-63PXCXA4U
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M\8#:@K074 %>L@$,T #!VH,../X!#M"8-,(+#0 0H<S*61B*&F"($Z !$IB
MW8F(.(@ A!(0?YR >;&!KN@)$OC*H8@%$R@!?]H:(9& !-/)#FB=8& #M>R
MX(L.%?"AHK(!-B@$B2D$N!"#"A0!Y^B"3L( #Z#+B.@$#HB $J"%!3H!"N!(
MP^  $>" Y^,(/&B!A0F&2-  $>@ Z,$#0=* "JB<.7@A-;"!#IR #M&$"^0
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M@,]@4  QZ,D'J$9WI80!J!P\6/Z 67@=F$0K$NB0*>HS$OB"!8N52;FE];*
M];)"2^T\!=@#8# )"<D9<5G8AK $!&@:2X" >V&_.3*8606&6C48OLF!M;!
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MLHUIG5K:HPK^ @1@ER78EQJ@OCU8$0Q(DV!@P#:"@S-X@P4P0)>PCH:(@PF
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M[$%$K0 M>(!YG&1W_$0D&!LE6,#XQ$$$?$ -Y,(OF"-A6/Z"=*)I'5)"49"
M0-3%0[W!?T2&!/!"2$4*X73%&6!3!32+&8"J)JS !^@G"U  +&@.$\4 0G!>
M>.#@3TP =<Z =0X26>9J@]3!H/T"'M@ ! ")K]K 0=5!<4#D5^&!MF!**8U7
M,.2 1N6 +3W '2SK[0#* AC,)C0 +\#"*WI$"WRD)2B 81%&%U2FTP6#")P
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MH.E9=%" HXQ@\WU G-1 67Q3020/!Z@ 88! %T3" U#D#<*!@23$!_P$+W3
M5=(='B" <'S %_0"UXR ;3@47M0!!/0"!ANEY49 +K0C4<8)+"1Q]42" ?P&
M)20Q,*-?"4B>500#!, ".IH')10 'E "9.3 T^7 =7P!!=3!&T" *1+&&'1
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M@A=4(*&D-RIHH8,5?LGA@0[JX&4$$EZHX(Y@PNA A.HZF($%"_(#1H41<L#
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M! T<\!8B!2,"#2L!K68 !V!,(&"P>$!%)D"'5VF@)%^X2_$&X@6CX2M;7^#
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M #!  A: O '"000($C0Y4##BP(I@; *<*76@A2]8N0PB/*#B5XV(%!)HHG.
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M!^ $+R3 @4HT@ (6L$ $*) *#4Q@71B@0"^0)X;2Y0(3"/A*+F97B$$$@ O
M@,4L>!&'*2' !)K@10@@\(F2"& 0P<!%'4AP@0H4@ W!\, #8&$0!DJ) I-P
MP,J"H8(&R"($Y/, !$P8C&!X3B,#X%TI'#""4BB =+Y8 0(V,0('I,)A%:Q
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MY.#V6YW^:E.1]0FPCBHIBPU"90$)>  "V, +O\PB&"<X0"4XH*Y@>"&RP:@
M"";P@F"XH "BH\0=-!$=7M @ !$H 04"P )<X*(44QH!+W)Q'"Z 80%+R 5A
M@7$I,8R!P[1@ P#44(H G. 7J0#&CJ6\  5\XC)SZ-@8E@  ,= A 2/ !08:
M8(87+* .HVI!(3 @QF;100P &$,<;H/$V.6B 1/XA0Q:^P4'R  I8L0%E'K!
MI@F0H7>^N)@,9C<"T@) -6K,10@0$ <S_(0W A@!+&0 @(^!2@5PP   >"@"
MY)0"I340@P-B3 <'%$ "$Y@ +/XT@ !:(*\#7-AU<W#A"0= P'H>*T4"#C""
M%02 !+SH ,.01P(R<& #M @K!\!P@$&-(0 6N(-MJC2)!0B@H[@8 0+"D!8U
M5$( )"A$0BX1F6,5<[V0A-'C\FLDO^G(6+,H)MYVV:,'R<A$II1FX Y97.?<
M@N$"Q^8F =[OAG.204^3)=W<-EX"#1/C_C80S_:#W?H0?-_PN<6&"EYP"D_<
MDN,=>2<G9[5I[JTY*Z=E+4YN75/V?)K4<;EW8(Y*6<Q\YU+ST225WF4T?R$S
M=@S!+" P@ ^XP#+ $/4)OI" B )C=@>XPR\*<0 /G $$%,"QL7)AAA!0@ -B
MB Y%NOX  CU03Q8V\,L,C-6"%\PB%YU0001>T(7T%0($=DC%"+Y@IDZL0 *(
M-\%B5-!K&\1B%GVGP HT41$62. "8J %+\YP 0G U!>:6(%?:D"+.X# 26$@
M06-7$(/E+($"$Y"!5E_0 EC@X@4OT#T'EM"[Y7CA]5I=O!M\(8O)=((%\ZI!
M\TO @4ZH8025B X77&P&$M#!%X4@@0<PP8LN6& "+O@$+1I:!UB(P &SJ,$*
MJ ('#DS@!*"?3BXJ80(2T %QT N?8 )<( ,1L *;$ SSUPF]D'\2, *%@ NY
M$ <>( $G@'Z?\ (:  >7  (@1@O^@BK/(0-8P06PP L1R/X!<< +!7=+%,9R
M 8<Y+K=,R11+-G=?:>-,GD-)DJ1=.><U-N,V0#@>/W*$VH0X%K)O*](<-MA+
MM'1QT81(3CB#3X@TVJ$=N/*$%+<B%_9@8-A+.DB#32AP4%A-8=@Y40AA6EA>
MJ="%E"1>^B6&5NA=92B%59-<-D "G7!DL^ "*J )+5 #-A !X*(<9H !$L "
MG"!DE# "N>=8=_ !JE<'N= <D@$,RH$+O\ >)[2),><+N8 +P+ <OD ]@^<+
MM/ +OK"*N0 ,T8&*)N<+N- +ON")N+"*IG>*0C:*LJ"+IK>*LC"+O# 1P8B,
MOX +T[*+KK@<FUB*N# +SDB,OOY0<+R C>?Q"\H1BY,1BLP!B^5EBNMBC$(6
MB\U!/:[8"\N1"[W "[8P"] 8B[E08CDP ^O6"^<T"\28CLNX'!3AB=A8<+]@
MC.2H! @P ==(/=MH'=CH6)CH6*-("YMX'<88&<VAC*6X'04ID!X2A"C'<<;U
M<0$G'T 7-B?BA';H'+RD;_IQ'BRY-2Q9<"ZYDCN(.=P1<TPSDDIW.!]G7Q2'
MDG2X-3GYDX=C=)LD'T7Y7=;5=+JD<[+D=$>'-NYE<3[9(4#)2<"X@_^6DJET
MAW=X<T$IE0XG<CV)<O;%E*JX'9+AC,:HC*18<+-8B]%'"[?XCP6)BC'WC]1A
M,Q4B&?XAZ3DV(QFS$ NQ8#.P8"RRT)>S8"PF1!TY^8__"',S2829.)G,(1E\
M29>(&9F> W.":2RU  M$(IB3^9?+P9A[J9J*^9B2"2 F="RPB9BX4@,:H %*
M !TF5'!JY#GZ07"F"7/#UP%T$!GX,0O&>9F,:9DY"9N1N8^JF9I!<YJ2Y&#=
M\9PVB970A$H3)R0SV71ZPS-Z*1W*52*34U[.(9[,09[3!8:@A)VH](E=:7$3
M-I(@^9X&=RSRF9V+M)4HYYTBIS>=%',*!Y0IEY\,!I),N''[P9W^:21?B* ?
M]Y\7%J A,J"A-')'DI*RE)G2L7F#J6_'\I?3$7.C"9HB^OY(>AES*XH=I\FB
MQAFBZ:EO!?>AGXB:,]JB.*JBXHET(>HA*'JC/GJ:L= A,DJ7.!H>+!JC06J=
M-RJ>P3 ]GJBD.%H=M:"D/8J-+YA-/;JB7<JD7@JD.OJ?6I6C/HJ>,1<+4DD>
M+'JEW"%)4PJDIYD=9M*C"T*F2VJFST&G>>JF>QJC%NJ#-BJF3"I-<(J::*JF
MTK&B."*>K3FH9OJFA'JHRY&F3;JF3GJF_A&I9NJBWMF:1/BE03JF92JC0YJH
MF(FI?UJ3Z$FHG?JE$[JI/.JE/[.;^Z&BHLI,I(H>0VJ@'\*FK,JE.-FJNYJJ
M*YJF=2JC+&*H7"H>S)JJF,JCG/ZJE\YU'4@7K7":B53*J1^2I,BJJW5Z2]:1
M-7^9GBM:K52JHO5QG,MA"SDZH6!:I80II+1PK/_5KF]8I\ :I&AY2.7JH\UA
M"_<ZJ2+JJA,6IW+:K-H:A9V:K#I:<8K4L) 9L/J:L$K*K_[1L <JJ,3*'A/[
MK!1+E%3HKP4RL8[$L/"Z3$ SI?E*"QZKL,6Z8,7DKWH)L )[L 5;IOM1LMIQ
ML@.;-@VRLGGJLBR+KCI7-R,;K=;9I>1ZFHB)F(8)"U"K1H7IM&IDM56+F+-
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M&YI4/&2B$H?HHE75(( T=K)GG?04H_R%R$(2UI/R4E-I?!=)FV4/5$FZU]6
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M@ ?PA"=:(%:#)=$9@0=XKQDH@ 4(@30Z P10@ R8@5) @P+P !08 0$@@4J
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M3OR ,?@"-%"#3*"  EN%+Z#!%FP +Q0 -$"$,-0@D"*!%EP 2N $-ZB!#0
MT-,#+AB! #B!,P"Y,0@#-$BN0?B"%5@ "#"?P2Q,,&C&+]@%%4  YHJ +E.
M#EA+-#@#22R[H+M!-QB ,-C%@%* $5B%78@! < #.0@ &V"A)E(_G[R%2JB
M"_B$ECH$8-@%6EB%2X  !TA$G1*X!UJ%G>("7<B$!V!$!Z" ,S@CKPH Z6N
M"=C. '"#.+@N6O@K-( ].= %2E"#0P"!!@ #MAR#2AC(2O[PA0I$@U(LA4M
M QK(@/&CODOH)3<XA ?H@%6@!1L( ,04 -FC! C(@#!@2_>$ +$+'#FP.PE
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MK5%B&?XVGNT5G0U)(BTN!'B!+]  @A6_$_@")"J;"7@ -- #"-A-VR.N \B
M/#BC,?"$#@B 04@#!=H%]3P$ K@ .2 !&BP%"FNX \ #[4. 3&C,"'T C .\
M4J@$%5@ !E" $G KT#F!!0 D3SB$#4   D.I]BH@/9@ !?" $9B 3'"#!3B#
M2W@ &-BY"4A#$FBW-E P!TBO0\  !7" "6 P.9B -A0!]8)$+BPJ-8" !G"
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MH^Z(6B)H(NC"*V1  S1"&V2  T! &H3"!N# *9P""H3 *1 "!SB !"B!,*8
M"IA"(VR $JR! \QK&^QE,&;CB!(AP0:AP1KA7X;"0H*%)A3 "5B%F%9J)'3
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MR7H >/IM,,#!^D9P,+@!!H3!!9AQ'$MO!\"""LS +&A =]*"!Z F%SQ  ZS
MEO8(MR) &A#"%B! !C2"!(0 (:"  #3""70H(0P #)B"!#C &MQ  "B!*3A
M!9@"(11 7G+  B@!(2AL.D(B,9*H,8:D?EA" D# !51  ;  5F@ ]=(  '0"
M' # &UB"!WP!,&@ !$3"%P3 \TZ  IQ!"QR !G@%*"Q !<Q!"TPG+\#F"[
M *!F5L"!\P8#"10 "=A  81P#@A '-C! :"F5<!" TP ';AS'>P! ,#HW@8#
M"#Q )/Z,00#X[0,D0 1P02P\P EH@@@40"^X 0#L 2R,;3#P)!X<P!=8PNL&
MPZ]NPA@P<AU0ZD=+*9#N 1D$@!OP0@"PP"?$0 GP @9$0"?(-"QH)@;T[ &8
MP P$ /9Z00"P 1XD ,2:0 !\@ 5/ "R\  *\P')>11WP[1O0@@8@P K$0 "4
M0#"$00"<P1XHP%I;12S8;@7L)P@(Y0JXM1H$@ D$PPD\P"20 0#002H<P#J3
M 2U([QF40 &(P%58KP?4 0D$P"3@@7N207Y2 @&HP&F -"S$  "D0AP$P.M&
MPAL$P!A$0@-XP-<"P NXP0!@ "_,P &P0"0X; ?,00D\*?XL(,"PGL%@UX'1
M5NIHC,%KCT$$%, =P,( G$ DD( "T,(G(  &%'( P$(- ( F:$( =, 9=$"I
M!D,%3$ D<$$! T,$+, 9K$ !^&@P=$("7$ =G   X $O*$ "Q$!R2F96Q$$!
MG $E)$"?.C4*0T "T&1H:, %6((- ( E?()LG\$'#(#O%D!K>_!H3&\P1, %
M=,(7>  LU$$"/R_@?G, D"D%)( 9M  "7 !9*/8)=$( $.^/!@ _%T!XGO<%
MV( $#  M'+=+MD  T$(A%, 74$+I!L,*,.M5]'(N3(( /,#DCNFN1H ;@
M8,(DS&<D$#4PB $ 5( -3,  ;/["'4  !<2!ZX:P!R0 ,#2T&SBI&U#U$?^(
M@8:  L3F #S &KP"1*X!!QR 1 ; &J1!A[9! *2!*X2"!&Q *%# !E2D Z3
M+MQ  >AE,6NZ7PXC$?YABFJ%)52W#=B ""Q "</"'L1!"0A '=!T!]C <UKO
M"1SJC9,GV49 CL)P 0>#8I, /.LF+U2U5D# 8P?#"$AW,'1 !- "L;*!&TQ
M ;"N9LY!,-A" SPV!)0 **1VA). &Y"! 6@ +_#P5WX"'K@!!Q0 *(AI)' [
M>UH%)N"!&%@N+WR ,X\!2M9! &! #<0!,'2"8[N!&10 !KCN [S &<1",'@
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M"A,T;,22V"7 GL 2+@1[ :'+@$^4"GB82R,,+0@@@@'[= '""Q.JWP# LRJ
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M8  23*0W><%7\#@0@34]BS4=>,,8-!"<+:7B2(@+1@M4(QU&R2  =^ %"!8
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M "URH=+E% !3T K X#YP ,]TP'J:@$ "(!" +E"$!@:( '8BPHL+R%$M"'A
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M7]3@^T0@<C*F#DIS 0C@-MD( ((G&'B)0W)+-0L  #23(FH   Z(W-Q@ 0R
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MC(VW6"!%OOE(YN"P9@ 6!( $8 %?\F(!WOD39"55='=ENV #:4$]N  67@
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M3%Q9@J&($&:+R&!>NN,NU&U__J16)H+&\Q[U0GHXF+4+[/[@J36L$.8^&"[
M F!! B+@#())>BI !39)7 1/,-S, 0X(;>#J/YXPF%K$!,['$@+%$X#>!E=$
M7Y:KJV@)#MS"O^' 03>+B18;M-[Y Q3@"6,?S%T@ *1^@PH@!]#E,!A\0B(@
M<X8'=BBJ42S T2,GC,:$TN?C0A9UL/!ETX_6.[R+Q4EG$@R@TY%, _A"B6.H
M7%@R61ZC/1Z %LS@SF3[,9>U & T381,J1;@V8/A:@P2C28#('A-N/ K&)X
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M"1I@1O[CV ("&1D)_]0XGRI=(#3!:,$"*%$<35P  0<HHT946  %M, V9VA
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MOO"'3WP8$SOD ^:[R9ML\I,[I]EVT(MM0'$'6E " J0406YR.(%<3(!1P?C
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M"]OXC@M %,CR+:"0 $M@ :ARCFA6BP 9D )Y9R)74KS(:P<I@@;)''%(&9W
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*D!S)DHR! 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>comp_0016.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0016.gif
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M__CW]_#O\
M
M
M
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M-HB+_R,"$7-Q! P5X0R3(9\B%\G(1CKRD7Q*VW;2QSQ&+4)Q-[F/$,  AB]
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MACX(9]CP]2OE@E,((7R2$@,A'^ H3K3,X" :8.C.%QC^\X6.#!":H Y?!J'
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M05#B@O[F4.<._;I2-H%1XET^J0+MP>XL(A!%E/0!.+4 AH;H0 $'Z@ .F+!
M2_S0"QRHTP8ODL_B6N)"4DBL)6[0CS41O*_LX5:]DXL DXX4,';Y(ITKTL'#
MQAF!H)P"M_:L)V:<DH4#R"T%"R!H)$9  *$5X@ :*,0("K $0Q1@!$TK --6
M,( 02"T15AM %CH1A4@_@0$9Y6@3(@&)0>/A$0Z00"6R4  6* (!#F#!! ;0
M!$0,( 6-070*"J.WG?;:U[_>#"1DY@?O^'<![8F '4+K"TW&YE@(^4 =:/&
MH!RW/ TP4AU&I(+IS $XP-BFL6C(3!CPJTEHVLE'ZO"DH?Z,JCP00(@HX&V#
M#)8 <_(IA0*0)8@%T (0$3B1#@@D@AUB22=\0'<-BBD"P<9A6170B2#4\P":
M^($ HF"7?!KL9M/N@@)SV$4#@ F(#K31 [\B!0)B<P<&E.SDDSO *>I03!R(
M &;GHH6'L(0"N4+ 01WX52HN<(H\/$D^>UC0+"! $SXTP!?KGE+DD-XM/=C
M.NSZU7U^- KS(&<&=OH >C,0&Y2XVQ<6 $0B3R@(>/_B! M"0<G8KB)ZM<0X
MF/B%"M2C@E^)R0VT8  7&W"0"GQO%@Y0$4H $:%=C'?9.H! *&C!RA>UH0&8
M2 4?#@#,CSLG0W50ZTZF(V3X4/[ Q"6 3RTVP"FS5H &H%=/#-0Y@P-'8$BF
MQ])!&L"K$@R)%AL@1+IXI8< C*LF3_J$ O20KAP[O0T=^$4M,K @.&2 )3"
M _.',BPY^<[-3YW D)+M"T @P!<U,-4,9B"4!M,&PLR2DG]]\?RH/@#!#?B%
M'2Y@BYT\,B4(X(-   0^V 5MHX5?0* "TQ,;X X8("T:0(#(P3,\TPQ(T((0
M:  &:((F" %*@(I"D 1)B ((D("=@0)$P("\*00,:(*F"0$(P )*N+0EP "I
M>80HD  &V  \J 0LV(M'> I$>X00> P\H( HJ(0F($$:?()$T("\B8('@("=
MB0)*N/X,7PL<8--"OE$$2C <^6N#3*$?*?B5.:  UNL%GMB%' @3&^ 50>B
M#_@ _4$(.M@ $)C#4ZF '8(!$)B!6"*%-C"3Q1(LA+"##O  &* (/_@4^2L?
M.I@%%, WZ^B%&MB #L !'PF%"\@!#\B ,+&##/@ VZH)+4$)&-"?.D!$7*J)
M@.F#OD/%U;".0/" $I@#.)B!4U !^3B%>JF)#@ ZA/@$#\!#"42(2/R #)"3
MXD  _9D%K-H S.$#+'N6QDH)^_,O3"R!#"B963@!#^@ 9.$#=9*0]2L/$$!'
MXR)'%3 )03!'' "$71"!$LB!W)F%&# )9C*)/(C#$]"06OY  7!$%NT*R Z
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M!3]82L6$ ]VM )S,@3O( 5/)/.H(J^E!%A0@#SBPCE\0@1J CZF+#SUHHP?
M%Q70@5:0$A#HN]?Q!0I CE\(L3DHE@MP$-Q B3A8D/HA$)4QJP68G^^PD\5+
M" @@!?"8'CU0RH2(@(.8 1'X'OZA#(H<N!):6(#$$^K45NW5OM2DMBFCODZD
MOBG'G9GQDY ':(,<4)=0@#=H^YX&NQ(;()"C8X#Y,P&$:(/PD#@WR('UJ109
MF ,(V"'*A;9WR0&#B ,20.X T)\3B#8/$)^3L( -@(,:*"P)\@4YJ( [T($,
MB)'(BX_UF8,'F ,IF !:@ /]D(\.N\420!,5R( [*!X?N8/%5@$06#<"@8-B
M @$^00$$GTR$Z(, 2-]B>SL!?Y(2&"O6YO .]W#4% W8%G'%#6"9^02#-04W
M@(,3H:Y\J8]:00E32,E9J##].85B29,W4"]:H ,=T!^,B[=[W@-1F 5G# 1/
M?<53C?Z/L:,#-] 06^ 40' #4=@%/0"&3X@BU4(/*7 #Y! $<*J(-Y@R/J@/
M/L@!.D#06>@O/\@!0- 5V@#R7C#S4ZT5^3 %.C3S.;B23X#H#_?S/U?M$6=6
MV<970L<,1V@$VD;C=/%3.1T$U@/T2)?T20=60;?TI/#?>UUJ[[39.=U40$74
MH@ $O-53^%Q33CT)P 7556?UDZ7T5X=U^[WTSGCC6;].I^CT6-?U7>?U2+?U
MSP#VHTY51"=7J.WU8T?V9(=UOCE7I#;T7^?F?57V::?V:D]M:,=V9M?"$K?V
M;O?V;R_<;!=W9E5T>$6)7CAW__+4=9<_= =5=_?4 1**<_Y/]WAW]WFW]P%*
M=WQO]WR'=VFB]_[)]0F\]X)G=WDW>'57>(0_^(1G^'Z?=XCG]XC_=WMG]X&O
MV84/>(JO=XG?^(ZO]X87>8T?^8<W^82/=VL?]Y4O4VD']Y>'^9B7V&Q_=KXA
M]OR%=I=_UTT @S#P^9\'^J 7^J#O^:$W^J-'^J17^J4O>J,_ U674UXX@Z6G
M^JJW^JO'^JIG R_P!%_E^:P'^[ 7^[$'>C3 >-;>C&<W])IG^9J!5IUG5Y1
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M8'@=R(- 2&$NNGF-+G=:6$F:,Z22T&)H!?03&TF#'3C6)HYOC$W.#.*'#"R
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M08M80=*/;6@#-G^AAT&,%"*[ZI^>AMF142!@#K8 !AP( %6'5.0" '/(+!X
MJKD@DZN3"2MXP]L2 $E%#P"H6VQS0 M 1. !4F#1#6<@Q3KH 1,Q@ .H!A$
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M<VOWW(T (FL. -"Q-P"@6QF P"^ L8!X_F(4R*/FNW 0 "D*Y [P=C;/)@Q
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MQ,%DO4$?B<()5,T'HHM I((,H  ?K%@MM$&LY $(Z, >X-(OQ$&[N")'6 @
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MP#" #>@  ]3)'5# &Z! ![P(#8  '72 R=S! BSF NP!+8! !.! 7Y8"#LB
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M>>EYJ+(H0K(B\)MQ]F6\J6)KZ.XZ=O3JV@.8I$UE@ QLP+WP0?5L@"^,@@6
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M;9N&* !"!-ZG\X]%[!67:)<H:?>E29X" D0@H!Z[>6*)"@P= NA!=K'(+^B
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M: ,.ZO5'E0VD#1< !!PHP$<0B';"681+EFB! #ZB4P6 P$$#XF"*!OA"% N
M QP6\$= /& .<VB Z]+G"S&8T46^H(, 2#'<EFR6J"49X0SJ<(,%M*:' S$!
M'$[1 #W40000L 4*+,*4B_'A!(11"0T>X :QG><$B;3#1 0!@3G0H0%$!@$?
M4&";3;+O:#SM4@*ED $/=* # >7(!R[0(4&H0",$/DXOGO[KM/H(H<?4-?1*
MN)MH1>_$NT-1A%-;P@L^Y" '?? 7+?1 A\6%0@<XT.0%+$"(&]C!7Y;2PQY.
MK8<>C<6M-"RT1GK!!XR<HA:3%83.]("#0=1B#K_X!(H$<1Q:S '&&O'#9.,3
MAQR8HA1ZH$5 !6$#/H@"V:'0XJ(H&[N87.")F+'=?EH!AQE((5B$R'%^Y?0)
M'-1A%W<PA2CD=)LZS( .38(!'/H@ QAC MNG&$1D<6"#>/?B#C/HM7Z$2\"$
M]O35;<689.MP &8W0!2[. 4$(J.'"<P) <AF97V&>FB1'S4GC=:)R4L^E.TN
MVB<HM^ZC.04!B'0J#3S@V\BGV_Z7(.1")J@X@*X.&B1\(4W*R_$I4V1&=/N9
M$I5%9@H(Z "(=GGD/'SH=GP>,-E/T$ &K4$E2G >=D_-TN4LA^6I;%F_G[;/
M#WU@"@!AO9>W\@?N4](Q9YX:=[S;?2LSXL] 8[*+6A"5Q_H)]-X1;QG+!&*R
MI*EQE3J)-)ZAD@3K] 4PE,RV"\CA$U?I@UPQ'PKY!$(0948@R!LN=N::G51E
M9[V!)J%ZO,]=]D#5N;8[M=G:&Q4T-.V4FT_Y-!6TY0/=48DMYE!0"+B.#W+=
M10-*<8H%3+86:T(@2@Z_^["_OE3<]SY/(%'[&=Y<^ZG,%\]_[XMOE__CONC]
MW?=3RO[@.ZT$,TB%*&#6BFGF@)%63PTM'D"-], ")J $K.^ I(O]Q.[[_H,!
M9\D14@^5T*":%+"5; 3]CJ;P*C"!DJ[-[.?-GH8IB@SO7 !YF.(A=H$0&L!?
M6@$!1 D5T&*/X$]+!BT"-_!IB,+U3LX!>3 ITD[U9LB:;E#0? 'P,A!@AA"!
M$@YI& Z!.B CMH(4%J -2"$4/("/?L$"1$ 0 B$#P@@0,FD7HN/KEB8)<:X'
MA4(2T'""8&[W!,P&S? EC##W$&,&XU _.,GW.(6GF"Z!X""@2J(47, #0$ '
M@*L6;*!>VL!?]( $<FJ:$)#0[O#0<.*!$DT'7PD3KRMK9/YO_";1 ^>04W3O
M$S<%Z7A@9B0/!$F1!D]"$E=Q]=9PJ6+QE10A]MS0YEZ14V8, W,/H7)12Y9P
M#S]P_HJJ[IC+"T+N%X%J%IG1NB!-[()0&;7D IMF_:01X=B,"57Q&CTC ;GQ
M@)!"$[E/'%\OEL!+]6CO&T>C"'>N&GU1'??B_>#P,I8+'@.C%>?1'F&"5-20
M&<F1'*FF#6MO;]JG[Q O8+(B+0QR[Q12[[*D(1/O(!?R(>T.(?&NC'!/4PSC
M'2V2(252[R"R(R-R)!.R(DO2(4\2)>,N&#NE'E/R)$,R)2GR(*DD)-$B)C]R
M)'6R)%$B(_7Q:)JQ&5VN'P5D$OX>+1^5KN;([R=E(A0WQ1J94B8X"16%4?[L
M,"H'PANQ4DN"T@&)<D"^$B?"4B<401)J$2D]D$M8 19>H2W=\BWA,B[E<B[I
MLB[M\B[Q,B]OX0N$P"<U)1>$P MPP17RLC -\S 1,S'A,A8X(1N/QC0X@2T5
M<S(ILS(1<R^- "VW<B"\#R"[TC^^4A+,\A*T#PUVX =X(#55<S59LS5=\S5A
M,S9E<S9ILS93LP>,0!>:1A>$H =L\S>!,SB%<SA5<P>P1#.9(@U.DSB9LSF=
MLS9],S6-(/LV$S\"9"QG"3L_\U/,4B!ECQ,8P1$683S%4SS'<Q',DSS/$SW5
M4SW3L_X]V?,]V?,\S3,]RW,]YS,^\?,]ZY,^\Q,^[W,1,D$S8<T^_1- #]1
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M-WW!]_Y\R;=]W;=\W]=[G0 + JT7_$ /\#?5]!?5\G</^!=__;=_]3=_ ;B
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MN[R%=?XG6A>JM[4?V75>,?5>,96]KV91A7NX;T(2:A==-Y5 KIM@&]6\ 3S
ME54GU! *4F $F@!K4%:]<2(1#&&Z%SQ?[YNJR?HF'+PLI5I=VUK"\97#W]40
M$I;!P[HL$V$%G@ 2+KR]94DT;;17!V(6<  0_4 'W*#&W2 '3H$/I. -V@ .
M6,@7](#&V\ -?ES C?S(K['D$D$#!H !&(  ,* 0($$2(*$1&)HL*Z$%%J 0
M**$L,5=;IYS*;^(1BOH1JEP1R'S*%2'+%\ 0* %32Q?,J]QV%7;.*T%@S1*_
MJ_PFIMS**P$+#. )[AQ Q%S,'V'0"X$ 0J 37F#+IWQ4^O[\E8C292]#O_)&
M)=+K  A  1(   0!!?9+?LZ&(  @ 11   0 7J 7R5F]U0/V72MA!0: !41S
M"0I@!"JA$/"@$>!X)Q)A! [@";!&$K  "PP!$A2A$ JA$;2@$2*A$(Q=V:T\
M$; @"XKBUP_ "K :V8L=:QI!UQL!CQ_A$1!AU_$ "Q0<$@RAVL?]VPM!$;1
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M(1(\H(A#&CSB0%R-0/*"  Y,\&)=#&B!AP8O#$8 "X4\HLB"&F&!P 65I$!
M"%<PB,<3!DR Q0H%+-'( @_@L40!+50BP9._&1<"'E84$$(3#AC@;0%+0E$
M119--X"NHC6 P$4DN4EO2XK )-4G!$2  @HBS.&+*008Q5X G\1TW@D ' SG
M!Q;\LFC$$D],<<467XQQ52<I4LD3&"1P  5/0 ()"P]HNH($B$C"\I194'#
M%4\PL$ *%XRPH ;S-H)%"UEH\  DAFB P (8X $)'A@L\$0EO2)"- (;:)I"
M2 LL</YK$SLZ0%LBE;Q<] IR::!!29(DLL$"+3RB600K.% (%@L8^<0"%#E
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MD04\&&($!$B6TY%3@"LLH>^=@(( GH"' K  $;8A#:UY:,A:<S&]$U4G  #
M7C@IF)Z%F\4#8% #&L"@P!$(^4PJT =2.!0GLT#!!>)] 64+%@>[:$"\8U*!
M/_@"!_X?R(,>I "(#X@ V3$9!00J9P,ZP>#$^:,%+4P! Q3@^[$_ =@$)O>+
M"<Q"#C>9.>-F\8M3S$''I*  G$Z095\(0L>TX&H@(( *4\CU%'VJ0P9F48K[
M9M07*BC!)V@!,;O@?*.0 ?_T<LYW"C+P."C .!#S+_B6>4$G@1.H%@H2!1)
M 8X6!726-P11".T"'"'  !:$!TXW"9"0-HK !!*  1L0(IVP 100!:AQ$)L&
M--?1=K,1 L5! %!@'241 1+P"'/! B:"++9A).AR!2T0)!TQ(P:  1.  1K
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M"_!D,:$#C 45?E !)$EP&,<G#W P'L!\G_  ?0(Q.F 'NU !O6 *#1<3I_
M)ZD"C+-\:35^,3$'TF<"_'4"'$8!>=@+%# +<* ",<%CLW  ]!0*%Y ?.N8G
MC--?7OD ,O<+7/@)>^(+,3 #@@"4OO )];,+== GLX  M. "-<=_EG@*>J"2
M=+" C^43NR "-E #>&*-B:F86&$[9\, #+ "%(!VA:!G$!( @N$L]G@U@@1,
MFY$M2"<)CWE=@]8;!%$)DI ""K !G98%%S( #  !#\$1!V  +6 =BM  #N H
M4)@R ?Z@!3ZU)$X0 ,0Q*6]W +C!=QHP 0: !41UA5\40UI!"QEP 7'0!@@
MC =0 I&H BZ@23;0 #DP!R70 /LA".$F$Q%P 3D0B0 3C3'@!QO0?:+0 &Z@
M!P_ 83Y1"G[E"R)@!SAPF.=A QT@"#J@?3_1@#$!" \0"'K@ >9' B>7<'+@
M"^5).;\F"@M0!W2  #G0"P] !X$  P@@"O)7BC9'!W[P .SE 3+P"3J  '4@
M" AP!X)P 0#3 2H@""I ,#'1 26 "6Z@8Z'X"7,0 8_#;I_@ ("P!R 0 ;^
M?C,Q!PH@68MII5>*$R>1-"NP G@0!5=@=%<@-%\Z$E%0&_Y7T 0$%"$L<%O1
MXQ9<6@A$LB9VL2MR<5ON CNSA0=.,#*/T#.])0E0  469%TBL@2I(R*1@ <O
M8 B%  5X@)"QP1U.D (M@ <P]9Q;! E>\0MU  ,S, BD9 =O0*IN\ ;U(P@S
MX )P<)*GP%\]H0=PT 9O( 6F5PM2@ )V ">E, ,P$ @S(0J3XPNS8 -M8$HQ
MH0<PD -F& C"*A. , -T0 MQ@ J"@%6 L!]Z\&2]H >:! @PH >8@&RA4*RS
MP =^L MY,!.!\ ERH (RYPNUT 8V$ JA\%B?T*L(QB=P  -P<*R[P*\X0&6_
M8 <TX >SX :TT ?T!*W2.@>E(/X(SNH+/8>E%6NQ*,%4)/4ZE4!4S=-"#T(R
M'20:#(E3!M0\I_D@P$( *T!,F]*R&MM2I3$O#V(2&8M(4$47'!LA=@:%0?4@
M%RE5CE!%CE!1%ELHM% '$0!C1LNTUCA !T1+R=0HN602AO :YS4OL5,(2^ $
M%32U]F(245M+1B2UQ41I2[ "4""VF3I']U*T50$Q"76B>H0_A7.B^#.W\X.8
M &508)A6E>>W]I,_@QL_?QM0>(*W,5$Y$)=6AQMD>A2X8#AA-O"J36NY$ZA%
M(.4=FLNV-T6SG0M-E'>YHTNZI5N!6 BZ]/)XF0JT+7%>%4D7;SL5C-NW70%Q
MLBL@A_[K/[K;/Q(%N#/!NU_QMGD4O%N!NZ9[,:FKO,O;2-&)O,\+O=&K,<Q+
MO7+4NNCE%;N0B"<P!Z94"^)DEEM!"#J0 SF@ S406,4+N5(A@)03!R=9NSBQ
M"W%@8\^VOGK[MQ8E$WEP,, P2BYYO(HK%<,;KW0P31554:% 6(XK;],8O_>;
MOU!6.0'G!Z/T"X*@!R0Y"W<@7SDQP/H+O ZGK_/#;0Q5!WV(,!BLP1PL$[<'
MPJ3D!ND'MR_\P3%!"W3 .8"P)V(DN^E$O#)1!R4<P)15O45LQ+<VQ#9L 1[@
M>QX@C3%Q 0<C!22W%3,  <:6 S6 PF#A$WE ;;LP9=)Y ?X>H =V  $")A80
M@P,AUU=!60&V "#X0PH-<*S"ZPMST*-]RP=WPA^S  %4YE\VH (6$$K ( (?
M$ ,/$*JSX $YX $,BU9@40=Y+% ^YPMQ< $XT '=1Y@>$ ,0\*NU\ $YT 'Q
M!JV%=<D5(+%JT0H[EU@P$,D 0@$RE\1$?,2WC,O=(;I9T7\S(0)7.8KL!0<A
ME@<E3 M\  B5TPJ]\ F<YPLUH)?Y8PJEB H08PM\$ APT@IZT(?GY@O.YPM2
MT &GT MB53^U0$\7W =H!@,B(!-=A56DD ?X03FS0 M[0&6?X <0@X#K+%!]
M" P0XP;C_ N!$ &$T"=]N<6A4/[,.(& >Z!)?J"6O@ ,?I#,,1%M@' PJ- '
M3T8*&5#1@243H]#0WYQ)?:C"E6<'*O +>D#/,2$(>W"2<' !IQ!^I6B&M$!/
MNX#,G!-P??@+]LP'6TQP$+  ]-0 OPI@=&(#[CRQ#Z!.-Q$#  ,"\B%&J) '
M(FT+Z#S/,D$+>M"7[NP3M" #"-!PIC"2,9$![(4#3LT'#> +=7"5,_!8(H ?
M8E0+>R (\.,",1!0H7 ']%P+ME *>B!?T28(S>8+MI#39MB7A. 3LT !< PQ
M-. &M9 '))D*>C#1NP (%8PGA?W2]J4'DM4+*>T+'1"J#G<'6&7/LQ *.BT3
M]%=9D?YW$K:=R[D=M-(T'D1-T5^H/Y^P ,#0!@W0 :)0!Q1  R[0 'ORT33P
M8?>3 3!  8'E$Z+WS<"PD2*0932 <*5@ 33 9$_!!Q10 Q[P.%(@8#2@ [-P
M 1%@ \ P :T0 ^E7 @!3 B=@ Q> 'P'8 .D;V7"L QF  Q9P8JFH@)GL AGP
M.'8P 37P 1]0 S   6669+5@ 6=5"RH 'ZVP?CGP ?<6SAF@ Q:@KGB2W#8
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MX$@%$,9D^-87Q85L2<@CRY;I@ADN+FTI+#6B87'':.D@AE!2R0#+]_2   Y
M+G 67](MVD40&QK8A0\(]* %P94(J:7P4P)1.4^3JA:D@ZL3-?YXY)-7WA=&
M)9GT>>@=A7YZA12A)%I$ 4G CU]^\6-[BR8@TXU1W1"LA/X<+,)ACVIYBI:&
M$X@VI93DX&#L@DU/P$%] ", L!8&G,(.&< :!?9G!_ 0K#^#R( (:K$O\+C&
M:!H)A +(] L<4,<4#?B5*!I "[Z9! ;? L8#:$&'?K&D7)XJP;3N0,  /4 E
M%.!#5U PE ?8QQ0H\-MG^G4!@'TB KZ  0TLHH,ZZ&1AURE+'FCAD0 QH!2I
MR&& !&.'LHUB:KX8Q! 'D;F-*.!7?J".'C14G5CMX0*],(D;'@ @%!B+B+'R
M11OHX(L* *@7+@C%+"# %E- H'A"BT K@(& &@+I.G&(CR^D $.+J* E%3B%
M*6K4& 0D9P\+V(C*%',=%%C%%_X>X$KQ!"$56C0@*2)IR1PFX#<WG#&2+;E
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M )@8 ,B!6?B$#A" I.A#4BS%R].X0/Q#(T._+20L 1"OQD@ )CH, E"U#Q
MFQ& [0( -] # + L&P  01@%'/ ;4SQ&9/0[5;3"%X0>K .40A0ODT %602)
M$[A$&/  !L"43U  _(&#"A#&._X(@!.P@QQ8  6@A1A BF1L1W=TNV64/"P\
MLA3LB4]X19 PB5.H1HNXQ@X @0=@@!KJL08X@ -X +Z( P5H  0X !H*$$!H
MPG><2(H\N4E)NRF,Q]5SO4"Y1U@,$ 2X#HU  0+@B5- @*0I1!/8M%W0B#D
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MRU)3:C6>-M5(U?O,R8P!&-C.5OX8B3\1"3NB@S=(B@HPD>*9 #[XA40*"0K
MDE.XF@N8%LS"SSN" 3>H&E,H 6"H!>"J #AHA1P@("%J T;[A <H!5L (E]@
M@/.P P;XA5(0@#8XA1@ CPS %#PB$_\YIJR  R\,#Q'X!$!8@% I@1K0BAII
MMXWP%!CYA%HH@<0P"=,0A%WP@"J!@PW0M0BP!508HE!(6 H#K0R  V"8@TNB
M :M(TVJ]S6O5S83JS0_U!3L   !(HFA!B5$+B0<X 1A@,([]B&BQ@#[0HD'J
MG(NX+ZZ@A1+H W!#@$^P!11@*QWH@SGP *  B3F #2&IH2&A%EJHA5TXA0[
M%+'IBOX). 54 )HUJ8T2,)%1DI-4L*:?\(4XB">+B(#'P0&8R!=:N -/B0.%
M<4P7H &UX8,&:,P(<(-62!M$C$XA0@6>Z0O!/04/V)0(\!-@F(!?88VF_5U#
M,;NG=8@8)0CS$PA%>+Y X9L(*#2+ (8&<!I@@X,_DZ% PUEJ@=Z6*)Z->5>+
M:(,&2*(_J0FL61,8" 4+Z*5OX2>K8(L3T*4*()*0. ']Z( DHH"M8I5*0M90
MJ T2$-\.(),:^  <4(&< -D[JP"XX!>MZ(#-R(#/Z  (@(D2^ #ID($<T)<=
MLH ( !A,^  5: ,*&(HAJH43$($HW10*:(UNB8-/F$7@C?YAL1M> ]1(WLL^
MP\0(6K"Y2'*W4TC*$KK3=&D /8.#>PK7"GB@;<K+-?FHV'#4VR@%0>"*.8 )
MDZB#HZ0 .<F  [.($I OW B/_*4D5*@ C0@%J0 !N*$GO;((.L@).6".JYF
M9<**;E()4B @/U"3"  $''BJ7:"J4SBM/1BB!V"?E6@U3U$!48*!3?%=D\"$
M$I !C95A2QXRXX2Z%ZTW\HR(&Z8\WZN%]JH#.6B K-A'%8"5FN"2PLF#MTP*
M23[;#ZJ%5]21&4@*"D !V+%3";&*5*"G+X%5&P@%&( -:R$S&_@ 4JB#!X )
M<^J*D3"%!VBMU,V!"A"$-A!%0OYX $RPCMJ0 [Z=B0X(!#U8@%* WCSXA!A
M@%+HIT] FE#XUCGXA U(68UH!01X P(E"S0A!3<X@#I B0WK %+0C9QX@%'L
MQU>Z9(:V"!I&3OE+GET 615()%N @QS(Z(PVQDXM 1U0$U10K\:<@UZ@01W
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MVFN][JN]^NN]?D*_ BS [FN^%NR__JO!YBO!XNO ,NS!ZNO !FS$(JS$ZJO
M]FO"*JS"5FS"8NS$(BS(-JR_8FS#<NS(6BS)<JS'BBS$GBS%BBR_7NS,!JS
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M[HI"TB-  A.;,6U-$NEJL1>S<1N[\8W&\ N,P K,L1/H'_'VKNSJL4\6 AX
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M=KJCO7__^__<_$\2^*__ O#_#A !#]  H8U&TJT!%S !(S#=)@'=]J\!&1
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M@N? ,N! !.J !F[ (FH!!U  !^@B$ 3!#I0*&-K@!$B8C[".<0C@"H0K;QZ
M 2)!DJ"@$0P@! R! "+@!1!  RHA!!3@ 1*@$$YD01S@ *X V@J! $+ 1P+@
M"9S@:S1  7!) A!@ AY  %:@$T:@ "3G !:D $9 10R@$& $ BAV YH6[>0/
M/]5"C>V@LP0! 4H@#@IO()3B#IJB#40 &.(@9W8B6#Z!LURC!"# !D+AF$3A
M%"K )TH@H/@  41A%CK@3TB! @+!%#S H0BA ?@@$#*@71>B!$2,D5LX G)
M0 <A OZJ-P\6X X6!F+J (+:XBYVHA00X-=RP"I^80/@P-=(Y9CTX!,^ &9
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MX"6!:, @/I&3CYR" 8 H!0P0\),+Q&!YH[0 #'X1A[V]042V>2$$NG*24@B
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M&(1,N();*(9D2(:CE(-?>(57^'U@R(90M(9#"(1H^(5J 0@?\&9MB"1#&&C
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MJP6!6O( @: Y2"BI06 >J&.77?[#J(\&?4&*( JNNLJ7'$KP98\-,2IE%U\
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M-%^@A4\0Q^(8B4_024RPN5\X**)2D5WXA*PD"#J F4\ JO[^$ 7,"X6@M!0
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M_AB%!""4/J@5NMF.J9&C]+F T?$%K)).F(D H9BP<VF _4R36@B%!M ,/2
M6J #$BD%"KB($EB.")B,"?.#62  )QF.L9 /6F"_)ZF#![@(&CB.&' 24:@5
M&9@Z3.@-"U"-7U"<S\@#!*BAZ^C/9J*#:RDE;4J2!DB26FB $?J,.FB BW@
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MB8.M4 _W()6(( 'Y>"?Q:0/5%?Z>3\V(!H"<X$F_S2@D/3@76&$20EG=X,D
ML?J$ABB!SB@)5H&!]B@3W(7A&'9'$N6KW@U1&UZ8:71,".BW"LB1'- 8"NB,
MJ-73X'F/&3!/\M#<)]W+>;U:A"B!&E@=/3"%"?#:ACB%_(39]HL )#X!A_D%
M%$B("7"H(^X ^>@%NZF9$6JA&"!<2+H66LB "]@%%=A/0*  ))8/JOB,46B1
M$XR!$_" B[A<7;J6:;,!D5F.42  L@D$!NW-E+F#"G"!&(@EST !\\S2_KB
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M)Q$$ 9B:7A!O D?QL9[O%:^+U>YF K" 5H(  =@3:YL% ;@6LU( _XI 00"
M$D_Q(!=M!53ON-YJY@;MM?@$ 2!8/0  B)B##,CC@P4!)U$QW @$$,CCI\HE
MS8@/6X"!!>ABC'B#!7B $ABAV:@ N;.!'- #%/ T.\@!"K #JPJKC! !A\*<
M5O@$ %@.4X !"NB \'-*(3=TP&9Q>DP8FA;)(UQR9)L%&P" .@@$ '#S)S\%
M ) /'   4R $  "!J! 2 % 6$#@ 6F@#!+" V"D1"&B H8,# * !*0@ ^:"
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M7VHKRJ+1/^K4OJ*3;HM:N .,3Y\ZL %1$ 0^^ QC/Y3/F 4YJ $_.(V>(X0
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M2U1EBL5=(U2:^IZJ6.%GTQD[\# KK;7:>BNNN>JZ*Z^]^O[Z:ZU(9(I4+#\
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MAM 7=*PC:7*(1SW2<GZ]\R!.5$"!##R@ A0X0?@DN+M?2$$EPL0)!$DS!Q@
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MO%)/_$(#"!8<Q  "6-7A4  @'%E.\<0,G"!#_,(#L&0&H/Z4(#3 '7R"#BS
M-,T , G$)QP ^ %%W9G-;.0=*;X/)-Q2X"'%DGT"#MC>>L183\Q"**225^ZA
MNZ!1+0S>0<S" JA$24A42^U"("04!=P!(]'"'N@!(IW"+I2"5:$"+=3!- F"
M'CC4+O#!'405+0!"8"*$*-@!0YZ:'O1!KM%""=! = D"'4BD+]"E7?H",)R
M"E!&*-!!8]("3&'$&B%/+W0 38ED39Q!:=W8N3T%2O+$+TR 1 G$9)YE'8#:
M0?P"("2D+W0 J-$$+7S")X3"(G%F78J2*=#!+.# #93&! SCM97"#<0 :>"
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M(ZD '4 6:9PF3U16"2 L")1=3^P8+-&-X?S$+)2"*9A"*;A4/98?FM4C!<P
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M9$ $!.H#8%Y7P<$,- !&N,%Z,00J)$"'<3/]Z@0?(, <^/Z"#3R>3_1/9E[
M-E_5!HA !M"4*>!HP4&<+5BK!\  2,Q '6"4!PA$#M#:+GA *YC"!5@L'&3
M+)05,3.D'UQ "5A XQ5L!S@T/>F 8]'""2R9';AME'E !Z@ (PE"POG"5Y?
M!>"6'I@J:$'S_PST3U2S7=R!X^:$0*A "QXM+9! _B:%/4'L'%71T8)&!T"<
M0,# .IT""(# !L#>*7A "<S <T$=(?Q"!O2"'$  9U- X\$ !(H 38Q"!GR
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M?,#,.90+V$$MH#(F_)E6410PE<#+V3H=D "TP0$M-$#NZOX!"RY;V.$:,$3
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MUZT?:'PQ5#B18D6+%S%FI,A058],$35B9'AFB*Z0"$]54"$CPB=?=R+@@/&
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MS5U/D*-28*<721Z.'R*<XSV8,L;3I,63YG !YDQE%I>Q12O.G.8IY2 #LX2
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MM"Y#TS*WTQQKP'PE%3?-&0) HZ<)(@-&:W:!C0!,B>)BK 1XB5Y/(.[:Z""
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M H$(D?Z[_*;"#6P;%TV!$,3K!!Z+\:+0F#/@ ZXB!B!@? N\ V0 .P"!KBR
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M3T$[?6QDB*,04(0,>T)ET/.AA*F"=,!3/VC* P4=P. 0*B&(+W.0,!U*-)R
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M<D<$&Y+J2R@41'09'6IU((<O-JAUD!L9E!+*!&*64$$HGRP08&4@P#!+*0C
M,8N$UXE BRD7?&+0+C=D$,HN$/YT0,<N<X"0\ 4VBO!6'1[XHD<$?$@4UAP'
MM'%*!=;!@3$J"_O2@ JGW+$ +:50X,9F HGR0""MG "#+SAD($I&&XB9T0D.
M M( *JT(X,8L-&0 5P."H%+" SD- H% NUR@AR]N8%J' C9\8@H!*&=0P2=Z
M+&"+05EFIO8L-H@V1P6DD%68"S7\,@@%(!/01RH;V.!+'Q$H:L(;IS1@U@PV
MS!*!*+N@8-I%)]3@2VB^I'@= ?-5((@>&>QR2@2SS*+ "6''48$ID9%4PEMN
MB(!1&Q8P',,)K43&, 47S#$I:2K&(,,O@E1 "UYB=<#'*36[.T,M$7SR"PPX
M^#(# OYMD%(*8[-4<!^RYI^/?OI'/<M^^Y*T;UMMN/66$T-OD(18 [34T4'S
MI" PBU-0P"RUV,4L @$!5/@B K10ER]*8*9=R*1R!?&#!1Y8JV!]! ;6$44$
M=E:!7DR@#XV1@0D4\J6!3& 0)8E 'UI!BQE@*ENSH$,%,G,N7YR (J:  &;:
M$+3%-4:&OIC JWI!@3-=@! *.8%I')(7/H"@(3!22 ^!41 <T(!R9BF%7&2P
M/5^(@FJH  0@>C2(")CE#A>HA2E,<8!3]$$TMF(@]Q"WBPF(A2%S,X4=2S&!
M7I"N(*,(A65"<0I:6* .@/B8+^J NU90 #,NH,@%J%.!4_[4  :TF(4?&)"1
M LXB7)W[& U4D =:#) 6NZC%)R 0"EHTH%,58*'8I@@#$8C"31\!1%U. 8'-
M0$<M%.!61F  AUTT0!2)[(!U9F$+4X# .AL86>QPH ):I (0"/ %#6)0$%0T
MP ZM^,5DU(?.=*K3?/!CBB.4);^GO*^=]*3*/!L1SZ900EK>G$%)?D&!6K2A
M C:(P0QN4 L!1B00'5"!&V+G"PC08@YJH04..M  BC#$>IT2Q00>:(>"E""D
M!^$@7$(HQC9&  8SD $-"F,02 Z$ F*QGD%=6I@Y;( &.:": #=S@CN9@GG0
MD4%$61H#&H@IB3,=A2\NX)>+>/Y 3.:<P"G\X,B#=* P$O3%\@PR!Q5(TBSU
MD@A%?%&*"]H!!!^ :2 ^*#8*%%1RM+@#_FXFD!F\91<4(,5!^D@!@92">1/P
MZR\8\HD'T$ &,YB!*/1 @O%$-A44F!0*K),#')2":B< P3=GT(;'U&$#,Y#"
M!7Y!BX7%0! UT(-:".&!B5C D /TQ2XB<":0X6X7;>C  ]YR$#_4Y1.!%<EG
MVL81%\2A%0WX[ P" 0P4W<XZ;:#!*42C @_4(*EO :U!1'&""NCM-.LLKWG/
M>YC<W%,WZZVG>]_KE'W>1$!3S(S^\I!5A@V6(0WPB[8F=:XY!.T. CD%  \R
M ;\\DOYJ(RV("0I#$!>X(:4,"85H!IF9^;CD#ICZQ7A]@>%3G,(4"-B,A7$8
MMZ#:R@*C"AH%;#EB$)^I%Q;PZ\L.$@/$948R?,"=0J:J$&!V!P8Y&)]@!6<'
MJBU*+AH1Q 1$(ABX//*$:*TM3VU;@3UZ52ZHJ.W-?)$!;H&,#L!@3$%"\8L\
M8.J1F$H99F#0)U&(P ;6F0'G;/NJ@AAX4@HSBPQ0,&$7E&!D$ @;F$DQB]H^
M=4/0P=0=L$B+!1C61Q^K!00Z55!?[*XAR.S% UJ!IS?!R[ND$ $.5)1IVS+,
MNW I40[JB]Y8RWK6/H&OK>F9SUM+11%>T0DM(J #0:"  /Z3NL ,,(&"CTDO
M![;PP-ET@("0+N!1F** "D3AAM.Z)&1\T$//?.&!6H6[([ZH 6Y#(1DQ-@!D
M$.!#'QK Z HB( ^_>$!N]0"!/NRAO[MX0!T$X8(%B"+2VR-!GTJAOVZ1!-]]
MZ,,#-M2 W"X3S"28#T. ":D+;*\.2CY(!BPP@Q@ VET=$(0;&(AP@82B 0R)
M0090<(*.IV<!#.F%!U3P"1C@[3-H+8LO8$ #VS9 + ()1#?#U\5U P(">WCW
MAFYP 4' 07_\H\_':*%8B5CG<PN85.K:((@.^%,@M(# ' 31/;_H(0 !@L$"
ML"@"&(BB#0A8+N0*<@<( *(.#?[ G0=(8*> &H0/@O.%#C(@B#@\0($0")!
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CN9$KN9-+N95KN9>+N9FKN9O+N9WKN9\+NJ$KNJ,+LP$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>comp_0015.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0015.gif
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MZ.SKZ_#O[^+N]O#O\.WS^>?P]_3T]/CW]_7Y_/____7W^>_P[P
M
M
M
M
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MM1"!Q"23@ &$%KE$<D@70G!QR"&X,+D*+4(@D0IS/C $D2Y*_! &)6'XH,2
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M*2"S.8@&-,"(^KH2(0"N?=>!$JB%7OL*:\"M(L )Y8JCDB&%<W"U")2!W8I
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M &=@"[=0!P3P"9K0 .+*!Q' K6V  2'0N2L!"O+J&Q10NYN0P2M!"G]+*;A
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M";F@"?_<!W0P"Q1 KY@P RH@NG1  2/0L]&= O6,$8>]!C8 Q3E!!_W,R[G
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M0ECA#W&( B$ T8&I(48M'H#!'Q#P D7$C2Z 2$!:#%$!""SB!0B(RURN$(<
MR* 2@D"+(A0'F0IT8'*2N6KFM!J9K&[5JY3Y#$=;@8$"V8(#(&B(&Q[@LEQ$
M0(P9HP$*?H()#HYB%&9HEE)Z@_X0DF@"F:TCR1SL$$:E5 =YT<&.!%&0O#ZT
M"PVYH)Y0E+*"M^(&%8=R@X_,- J2K& '-J !268 !R[5X$&Y^(0MR!6*!O0,
MA1 HT"828 LWT"@7U20)+"#PBEF@8 :8V$0+4/ [OHJH-1G@A%(BL+KID,*%
MK_K$"V%$DC*,T$:V!<&.,D$3"C"7 Z2H5@8? #I0)&!!&\)ACD:4BQ:P 187
MP%<.BFF+"[2B#E[*Q0-<<8.WZH@D>_#1)^PI'O@5=CHQPF(N5# '3#0HC;F@
MP5LC+,,8<>X"R<L%"$"QA_7@(@/0D58*9I"'4 BW%;IUF2A>80<<:8"0K+M/
MAD$!BOX0Y2":N;@ B#5,8Y+D0 4\SD4.:'"&:/5U8*$B5I$?S(=A,?E'P!D:
M25X!S O<(@3DLD5'N),+5%@ %R%@;A\>"XH2Y ")3%%!,?<P+-<H[(I2;D"4
M^*#9FG2L.#X*'\](L@8^N#D790 GBWA0T2D4<P1UR-@,"GNE@[6@F/I[ZP@P
M$8HHE0%!KK$%!D8!DP[F(@TT,AJ3P]GI-2P,!S,PW@Q8.3#0 :68' 6-(2 #
ME0X4( $)*  #GI"7#R" !1LP !:R$( ..,$!%F!$$PK0@0T$( I_"( )%L&(
M)\SM#PU 3+.=*H,"-  +<GO"(TA@ !98@ !74(0#)N"4!?Y(H*M?U6KEX#WO
MR0QB<QSE8ZLS 8#0CH<":G"#!W86' *,P#4HZ/>/")!##\ A5Z[!!( RFP<[
M-  3HGA &_C@@8: X'2Y",'I,+""5HS@L;@  9C^C"D$K" -9:!#;MC T!VT
M(@%KP,0-K#N'!M@!$QQP@QE"@ DY0( &F0*%*" P<Q#@ ,>_;<.626*&"ZR@
M!1&(Q1J0#(KZ,7ED,VC K2#PG5(YH P>B=(#?N(:$.@ $F9(P!Q"X8!7;<(!
MN5C#R>;P@!NG <D7P$,N^@"@$.  $F=( !Q$07>2H*'J5W>%&Q#T #KEPB45
ML0X:7M$ ?,U@)[9H;1X08 8^I/Y@8?8DB1TH8 >3,+<$#>"L*"*0!CZ((+00
M*!,=]C4")(+ !GS0 6W2'!WCA0 %_13!#3"!AMJ5H5%"V9%2;F!>_%14!Q[@
M0QL>, H&M;5,KBE!#2"A!@:LH0\)H ,F2F \\(L_#>7'1-PS40(S:"+NZC][
M!-# !Q1\IP\-: .+R(51T#_^^XX\8)&!81%26 !;< 4*V+\0J %82 !<T ,(
MH ,$=(-9:(!<:H!;*(HZ"!CL<(CQ.IX<"H$;D T =)DY\) 10 %(4#W.<HT3
MB($^"#Y7L  ^TX$$P(0\\)$RX( ]<(,&$ 51:  XL(,XLH4*7 ,8J0,,$ %;
M2 $1T/X$5XB ,BB]#;D![%L#!' 7B[ Z3%B#!3@#V7*#3%B!G<"T!_B$7# #
M#="#O=,$6V" HV&1,]" /9B#R^.# %@='4" WT$#",B#/L" /$@#0=DHIW&*
M1AB$1H@"&:#$)_"#O(!$)^@ %L "14"$.&"!#G@!0%"$18@"$B"!*V"$/Y !
M*6"<.'B!./@# W"!)NB )U"$1B $)W !/_"#K%B$07 "#^#$O' ")W *)W@"
MR*&W9G3&K4($>VM$I8"%"E$*-R 7GFB!%$ #MO*T/6@\1U(*G*N1.>"$:B2)
M5@"Q.VB!&#@4B%H!$IR#*)E'X[ !4;"#*,D##,,$.X"%,OYPHAR CDV@@7@,
M#AI0@1TH$*7(@QA8-5LP QJ8@U'@@5=@@]_YA(+$,%C@@16@@3>4%@>,D?K:
M!.;"#1M8 0PSCAAS@PJ[(AN(O-_!.YG\D1RH@3[ A#-XA5;B$!!S Q0H SU
M--?0!.9J@U#X$>AH!9O$29WDR99QA9_  %+@A-59 YE< YI)/4RP!36PB#Q0
M$UQ( UN0@Q5PDA[ ESIX,6.:@1:(OCH!L7*I@57#.\X"!7G\"5CH@80L$#MX
M,3LH$TZP@1BQ"%?0 1K8@TP0%#>XD&RTB$T L3D@%>^@@>K8!#G(!3;@+)+1
M@1K@ TTH)CY0-31 HU> ECT S?XZF0$5Z$;57($S>!51N &7<XU;8 ,>$, !
M1$G2S 51P#!1N(]84(-7&879/!U;L$;1;(&1@(7A]*>Q%#Q58PWJVA!<, -Q
MY EPQ 4VV &7N4L(*8,5B(%UD18SJ)C=^(0:P %.L ,W& 4,FX,5F($0*2 T
MR(,[$,M760,:N,@=<(51L $U(879/ .+N 4T> X[>$N.I($\  7CR015*P.V
M\J96HP/Y_(E92 -<>$^2N- 9* Z(W W(-) +P8XZP!A8ZRC)>(06;=%@?$07
MS0NH<%%%& 1#D%%9@QNG6(0692H6J 1&> 1#B,06K8I'@%$9O5%&*!P<E81G
MA-(HO?Z<>U/1*K72*\72+-72+>526!LK<[0!$9C&+B73,H6U#I$#3L@!$!C3
M+5V#83'3.)73.:73.K53+W4#"*B\.^73/O73.JVW01!40?6H01T$1(#$067&
M06@,(KW1IR"$1@ $&*B"1#6$SAA41WV*3'7469/2*)6W3]6<-JT1CH(4T"!5
M+6W$5"6)574:SH'5I2#5C7+55D55T "%&YB!'EA(IIA57ZU2-$I55GU5I4 C
M4,B!:FHU8BU5636.Y&G34W76:;72W(2U6C769BW6;+U59Q566P56:FV-:<16
M;KU26K758;7543!+<^U64PU78=+65K567!C36-56=(774OYEU7[-5Q5EUA6U
MC%"EMR)-&X_B*LMA1E%-6(9]1GO[TXB5V(FEV(JUV(O%V(S5V(WEV(Z]6"A]
M-\IX5(<EV2A]MY"5M<I@'&GTV);EV(!U656%V9BEV9IMV9FUV9SE4\XHV9[U
MV9^5#(B]5GX=UQHY57PMVJ,EVG0%UUB%56F%%*6%6F.=6GLUVJ9=VJO-6JG%
MVE:M6J?MVJ1-UZ]EVJVM6J:=6JQ5VF:UVK0EVXJ%6JY%VK:]VKDE6ZYEV[M%
M6ZVU6Z*U6KX%5[%=VV_%5[ 5V[H%W+SUV\$MV[^55IWU4\V 1*"EW$>L7"AE
MV6 ]UWA]U\#U7'>=UWTUUU_MW/YYQ=9R9=MM!=UO+=W//=W-%5?.-5W5W5A_
MC=W895W-I=9[I=W9_5S7E5W<#5[?E=W7%5WAA=R(O=S(0=GE=5[+"2NGF81#
M.(1(H-[KI5[KK=[LQ5[NW=[OU5[LM5[M#5_P[=[RO5[R]5[Q7=_T;5_U/5_S
MC5_NA5_V_=[NW=[Z==_[M5_\'=_V]5[T#6  EE_]I=_W)6"<)5-5* 3^+6#_
M'6 'EM_Y-> )[M_XK> */F )AM\,MF #%N -%F /YE\2+@1*2-Z=?=Y/;=X5
M-EFH:5,M ((?H.$:MN$;QN$<UF$<GN$=]N$?!N(@MN$>%N(B-N(C1N(@)F(@
M7N(D]OYA(5@%B76-0_ !(7#B*\;B+-;B+6[B+?;B'18"(/""%+[3S&GA>3MC
M%U;CR C5S 6-+T""5)#C4Y#C.K;C.[9C.L;C/>;C/O;C/^9C/0;D0=YC02;D
M0P9D0T;D/U;D06[D10[D5" #(I %BI4$(9B$4WAD/]YD2(;D3O;D.@;E2 [E
M4OYD4Y9C4S"","!C.[6,R:4,6-ZJ-%[C6K8<-V8*+4""5N;E7O9ED@@#(:CD
MB8T$(%"%7T;F9$95(1AC9>Y2R;%ES*#E6/ZJDX72RIEFIXA>9]7EKOU;K<U7
MPO76PEU:6C7G;#UG;G7;<O9:=';7;WY<</[FHBW;=E9G6?Y-9W"F9V\69\^%
MYW]UW,9MYV >YC]UC6(^!7CNYW!VYX;>YWV.YWE&VH?^YWPNYX7.YXCV77*F
M6GQV:(H6Z,1]6I*@!2, @]!UYBK-YFAFZ<@AV&>D4M#HYI2FZ9JF6(*VY!](
M!9ON905N65H0@I/FZ2MEV)6&9BDUZI8&*UC3 B48ZJ>&ZCC%Z8F5!" XA:C&
MZHX%ZI/VZ61F7C,>6:46ZZV*Z5S>Y:SNZJQVYJF66$G0:;6&ZXLM::&.:X']
MV:Y*ZK&^G+R6#((M:UN=Z;H6[*AV#;;V4]=PZYU.Z\%F;*>9:Y3&:KT6:[X6
MU8]BZK..:DUP@SIHM3NUA4[+4OY;0,K&GE/#_E.$)NW4EM.M;FS)UBK*=NW+
M^&NE:.JHW@44J+H2< "3-%/70 /LF(V9G0UO[%W('FS3YM.#!H*=5NWF[M+'
M7FQ?1NK8/FKJUN;+CFH5& &7X0,$V%-P80I8(.Y2A0^EP*V668K.EC*G\4;U
MYI!&=&_P]J>-NH7XING"%F9+MFKC=N[^9@K69FSK=EC8)MDTMNQ;#6R>!@4&
MT*@>PY$>.(,9T(!>:8T;"($00"+YR2P^F 7A H''VJ(+2(-6N T[\"$-" &[
M% $.N($&K9$2RX4[L($=0/$.0@4IX@#2DHT0$(&ANX@;T $*,(,#:1Z\X_$9
M&&^:QO[IZ ;87$AL_X9R*P7PP=[K6@Y9 A?5%L;RR)AMDDAPFXY"IC")X^$@
M6"B!T+J!(AN!D8" $GB),U!!7%B?6""/5X"-7&@#!K"7%(@6#>A&34  D]R$
MV' #!=CSG>  ,\BR!^@("-@#7&@)LDP 4'"%!J"!6$ #FDB25^&!IN'I8*X%
M*7;RY8[R4N<HZ*9RO=[R:QYPK?HH<LV%+T]IU] ],6>1PTHC:SD)!=5N_ @1
M7&B%/%B#CP@=BM $'UD#LFN#%GA \+ ='O&1GR$)-XB!44C  43.#0D>.Z@#
M["J38Q^/$;.#- @[GL;O@H[8JE9L4V=WDC;IUA;P>"_9SO[8YEQVZJ<&A08H
MD%[B@5!!@=7!!5$8B@O@ 3,P S8@)([8,PW8@3L @:2@@6+:!&17 9)(@QGP
M"&?'/$Y@D36P+36HS'WA'!X(K5>)1PTAB321#0_I/S,H@S6X@R1?Z_R.6.5F
M[G9G=]9F<E[.\K"6=^O&Y:60]9H> =M*(P10$Q0H,C=0$@Z8SDR@DPL(D08H
MC@CHH!9 (G!/]CW[#@Q @UO8! 9 M."(]HK'.SEZ@$Z3JTQ(0)P!A0_R'S7)
M!!_9@7Z+!=ZV:>3N4[>^:IS/^7??^58NZE?^>;VN=Z''[*%^!1"X (1L #40
MK0O8@3)X@!W!A C0@1RX/$TAB?X6H#\=N("&,(,%F -0 ! TP!'(6IB2TX ;
M$ '2>DP 28.*0H.%88,+",^!HX$0, ,0B);:9QW+%QA8X( 6* ,)>"QSSP6]
MMU/$WF^_-_4I%^P7EC59+GS)7>-%8.I[C^H]./C-/!XWR(,RP$Y22 ,U.)A,
MP)?6J(.+=(7 @W1[B9&C:)'D(B37 +,:L87Y#Q'Z3R,S  @YMW(1S&-F#T%4
MFPAF>I4+EB:"MN"864CP(L:,&C=R[.CQX\<P0F2!+ E2$I!4)E>R;.GR)<R8
M,F>RI"4$3"Y<-'?R]&CH)]"@0H<2_3FHD:&C2(LR1<3TZ=*G4J=2E1JU*M:A
MB'1NU/Z"I"=8L%Q%I F[<<:(-2U"V#+K]NU.D23AYLP5*27=O'KW\HU)RPC.
MOH(W3KU:U##01H.4#LKJ^#'DR)*I.A7JU!%7C#J]#NZ;F>&HNADS?Q;-DD^:
M.6U7EC9=LG5GL;GD[D5YRG7LW+IWM_P;F#??R849(Q9>M?)AHLB-4V8>%%%'
M+4J 4Z]NO3IMNCHE_;A]_3OXP39QP@X_4W)QY^K7LV\?%+/&S5_-T^]HJY7.
M\O7!9X>[':]^^PDXH$?CX4:@2^XIN"!6Z3'8W'O1S8=@?9F@0"%].O5'%W?>
M8?@AB+GX%N)+#PJWG(*-.&AB>X,L$MUT)'ZW20HR?K<A7/ZVV;AC?2,&R"-!
MAA2W8E8HLFB(D4<JR11\74T(9&YYI( "!2G0L!J4L8E4RUYWJ90EF+P9&"9'
M2PY%9&%F,H5FFI8]YF)YG)$YV"N@V%%"**',Z=EL(^7UGX=["IJ7CX,&J2:B
MB;IIHB,P&MK7)B(\RA>.;W5XX*29PC3FHXIZ^BF#@S2ID9R:PN7*':;256E8
MVW6G*JR;WI0IJ,ZQ62NC$L:ZZX :^JG778'R.BQ'A1J**V2WLI>DD$(IRUZC
M'$E'++7AL6H6=RJU]F.U@XXXZ8+/-HNL5HF*.VI&I7:[[F[7AA7LI*Y@J>DH
MW!8[J[T[DKLOOU6A2Y!\'9710_Y\ !<\6BZV;#(0#WE@*EHKG!"T@\,&([R1
M+32$9C%NL.EDRPP;7]SQP0EK,F^ GWF<BQYFC'R13J3<D(L=4V#ZF2BBY!+*
ME3"_?%$K*>C <4>^SN6?74 $J@D*''" AF;; EP#*+ELXM!% Q'$1AVN9<8U
MR2-+K=$H(MC2!AT)_SRVS[#D,,O/1.<RA\L)MP )0SD0!(L*?&1TAM,H6)3+
M*S8X38-#MK@!RAQZ;\2VB/AVFMQQD8G;KW&7_Y2DB[INA H%$8@<$RH1;)W)
M1SK-,0)!;:#NDBUFN#+3+6>T M8KIIN5!NLE@?) +I#  9).-^R0RRAIY%L7
M#R/,SOZ2NV!E6Q<?"9RQ21X4U+ 2&CISX+#*N:S  T<ZM3#T6RVXO(+C/+7B
M "PMZ63' P-!0@#Z-UR8BQL)M "S"C2@!TU,(0$1<04%6I")3*C@ K  !0CT
MD L*5,TEWYH<YC*HP7]=9%H;04,-<F"SAVPB%#S !/_,$#^"T*%A! G%*!AW
MBS500 ZV& 4L;#$'.]@A#[=37 \D^(H:? ]YSZL##U)%PE%,P0U:RP@H<&$+
M38B"!WAS@QD<(HI1;,*%!'D%&LH@L5Q$46&P8 ,L-M$*-,@A%WS@P2<N@HD>
M.'&)9:AC&RC@!H?,H0=*W$@>Z-B6&&J"8A?Y!,7:4".,!/[2#:MYA1G8H D,
MX (6.M/$[7*!R9V9 0VA 44)4H")6U0MAIDP)$'XL(,^@$)DH!A!"S2ADSOP
MH&NYF(4FSKC"BT1O)SJ!5T[T>!%2<, AL$A#&5[7$#=,86.@L$4F,)"#.,[-
MCP2A01E,@X=:7A,->=#!Z]S8@S:T!16M9 -!^J #/H!"9S3SXD5RIZ<:H$&=
M*'QA&<RP,528P0QZ(@@M[7 16* A#9_ P"YSX8HP5K"5>=C!/?<6@3CR8 8I
MT D'; F".7C@G_3+3 [T5H/>$20$ FV#0&<PM,R L0P-'<4>=!!1 RU/1AK4
MG 99%"TG<42 D+@ 0321@!OTP/X"*>A!"D) D!2D8 TAV!X:(H "'MBB!A&X
MP2M&P(97S" '-!C R3A@ SIP8 ZB&,$%LCF"LDQI#2/8GB884 ,S9&![HWE
MSH;*@PL<-04<R,4:&G"#*5" ?*"( !K<@(&%-"!/#4"!"EIA@1*4@0,CR,$.
M'J"G-'"@#32HT2<2,%<,T  7.(B #5S!@Q3,@0-VS4@.0$"'&<P@%VQ80 _*
M\( VY"(/$2C##BA06Z[H  1UH$$,<D$*"N# #![  &!!D(L0K($@&K##*S#
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M4(G"!<S.)F@ !I3 0I0&*-# #*A !@"6"A#$&E2@!&S,_6&$*-1 #$A@+HC
M\.""]O[E O3Y'CJ%8-?P  5H0 \,1 T,#2<DFQLL$ANT0"M<P"VTQ0WDG$[8
M@-[TP/^TQ>V9'VQL26TH#4,\@"T\D<D-G0K0@ 6410;$T2W@@71E -X8%T%
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M=56,1N:"#J /9@GCK'0&"*Q4;_V;#E  !U" ]8D"!OB7&=A5'CA 1.@$'N0
M-Q&&-9:GHBA"G#R)\NWF132 'H""!.A$"M@,+#R *VAD'BB.D/5:780"7>9"
MUJ&">VD"'[A"&TQ@*X! ],'!!53-"+0!+$  'NA0!$R1[FB"Z>@!0A#$+4"
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MI-7%#+A,&-$ "*C [&2""*! &EP@KZDO"H3&)_PL"$S:&G" Z0X>1IB!O.9
M6Z!!"OYR<$;,@>>Y[]#80@HLQ('9 @J@CBWD0 9D0 1?Q"A(( :DP.C8P@4\
MXQG K@;G@AKDG)0)(V \S%O<0@CH  :T11W\%2@D@']U8"Z@ 5_>&=QHGR84
M7U#5P.! (XM0(\FNK'.LGLMJHTRL6TQT)4<DE$;P0=V8Q!EX'AJ;<4O <4?L
M$A^$6-:4Q-UEQ"U0'GQQA>V*K-I@Q"V@\4?,@ 096\II!"$?[U<2C\^PA)=$
MGB1?A"7VGD?P\48L<MP0A VD2BL@XD60<4:(@M%>1%>>,AKG<4Y@,H?*<4_
M<5%J!F 1:FE8<D=P"DAD0AXD;1Z,$4Q@0"BX'\3^U03+W/X#9*80NF^--"Y
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M5'MU(9J=0@#4# 17M$((,%4(S,ZPJP (C #<R)?F$LPG]/H!JCNHXT(//(
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M(Q?T4$ #*RBE]+&$,GBXH0&,[LJ!@A5"*BZ7DU)2#;6R(@$B)C,]\X^_'-!
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MS&!$-U8 )0)(]N!C$U= P< T&D*@ Q41!N-@QQY78%0%R#@0Z8)=RX+#@C5
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M<SF)$SF)$SJ/<S=QTS>5BCFMTSFQTSB7TSN5\SG%DSK),SNC4SN=4S@S<UH
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M)4:A#4K-#FH@!7"!#M!@%#+9>G !C',A!I"D!NY MUN]TQ*/?$I@(7' !FH
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M*3 "#?Y$ Q 0 EHR$K-0 VI).CMP!BL@E"KQ"E>9+2U /S.@EF-2(W"  :"
M"B<0F_B!!JM7!D!2FB-  VA8$X+H:C>V:\RV?2T1E^*4 B+@'@]@&!P )*"
M ?!!%74 /PU@&'>7"Q1@4T-V!K=A"Q3 (%S8"K$0 >+'"0.@2WG0 *[@2)^@
M.'>Q!@?@!CXWH%/G 5$$"A" $7K'!V?! 4-" $\D M'1 P93AZX@"@0P36B@
MDG=  :$PFCGBGZ.@1BKA"A@P37T ?2,@!YRT'IOP *"P"12@";BP YGT"B*
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M$@)R"= "D( ++3!&D/ ?-("1**!+]\H80((3YBFUO&9V[*F(WP>U*$ 'HO
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M@(89@$"-'J'!'#CPD%O=5A0C@,H%8J%I5UR75!3H 0\@ (I1>&8*&*B+HLW
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M.(KL6(_1L(/%:P4(B P4D+O!@(4I0H.M&XT<<( (LZ<2T/Z#'="#.4"!(^.
M3%J#.4 %CC P=/J$;"FT7* ^@Q K3$"G7'B%!X"%'L V/="F@U"!-I#"I@ %
M53J(%A IGP"*/' Q"B"%0U(*"L"%*=@Z48# %6BW7'"H')"[![H]@W"_7."
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M"A:!D6C!Z<D#"J@([-39Q7/>2N0A/4  3,@U" VMW N%5T  2LJ$*%L*<(D
MZS@#D:(#"UI/53D\N%G"4\F%'A"!CN S6U V7$@#!K!%G $)KT"#3PB[Q-"6
MC+N%(<X.=\V].F# %51!$'%%%V$(,Y +6#@!V+V#51V-/HA67." '(@%3&@
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ML),H$? QW 6XW) "+*U<4,<KM=DR!V>?#+!#)K9@L$8L=A!01RX.C!+* '7
M8D8&IE$PRBLMD%?"'*X\(- :J!5T"P2?P))"#JV8MP8!>L#2 UUV<.#3#7&E
M$($=K=CB#"$@Q2@@D =;U $TH!B #DJ7 @VT(@\$:,,K1&"C$L!A0G1A@P(T
M 0L4V" 7.AC!*UR! 3C$@@(8LL,(*$*1194P!&=H!03PTH(SP(("FF@3"'+A
M!@&LP5=H:4$-7 $*!L@!%FJX0"[RH(&=Z  '&QD."+1S 1N\8A,-: 4J"' #
M3."B!&O(Q2@P,+L+E,X.(1 +*OX>H!U,S0*-3?0 K#B0E!(,)0(AX -9<K$"
M0=W.%BDH%2G,N D(# 0%>XC%#&C0"E \ "L(P 0L6M""7(1@![O01 +&.!!2
M$* 'K\ $ T!ABPNLS(EM&H :/I$+'6H" INP!=R:& %1O"(&$)C*)B@ "5NP
MP4"O!,5F3,.S$40E#SHCB YDR2H#F6&92\D%!GXI@3G8@@\0>(4-0KB&!)3N
M6 W*10MRT((0< !#$R$-*M"" 3[88 UL<,,K8E,0%+DB%BFX 2[DH(%13 <'
M+6CG:AI"GCP,X S[2H$-8'%$-.#B FS"1/Y 00$^!(T@&4B!*T+1 $Z<T@VV
MZ$,$&/Y$D3P$8 ZP<,,#;$$'%/"%$YL C0AO0)OEK8&)<W!.&DJ "SID8!13
MP4 ?]((6$2")(GL@ !\I,()6S &1=6!4!C!QBPBH% Y,Q84&))*))S*D=6(=
M*UD]HKJRDN1U":G#!40QB@NX(1<]N*3:8J>=7+BB%6809BY D(>(W8F) QE!
M7&4'"L$>-A<I\&2D9#1&,?85753!P+X*:AXUJ( @$4!%"VBPASRDH0&Y4$'C
ML(*::!)$!'5H16D&(I1< ,\G:+BD+4:1!QXPL4 #<8/.2CH65+1! Y#(@QX2
ML,,&4<!7O8QL+BPP"SED8+AZ0, HYH OJN0K;9RPP$  V_Z"&? A#VMH0&=P
MACX,N)*:G*"A3R"9ASSPP0)KL$,UX9N 3;3B#&EX5PM8(P(^V &5]ET9+#)1
M!PV4B@(K*@@?-/ K+#[@O7RX@. B< ,[6&5F!L4*HUY*NZ/0(&9DI(!75K"&
M/%B@#WC@0P) D0?GY"(##K'30+IG Y&-N+S!L4H]X1 !#Y:F#CRSGQK421 :
MI"W'DB+N#;:'@4WDH8<#4<$:0N'@&V@(%L(A2 LBL*\Z4, J-H@+13:Q@C*$
MH@6<& $1"T+4@:"B-!1-3B[*4(.!W (5>CA#:51)E-H=;@V8B$ ?[L"'!N3D
M @ [" CL"0),\ '&,TA;4J),$/X-Y.05?3!>3CB0$S/R0(I\V80>KKL&G7W5
M(![@ R<@P(/<%<32BHVK*\),%$S,(0*\<?#(^* )W!GZ 5,+4$=0<E:TQ@0F
MR%YVZF("((6LP*DCH, )B!6CH[PB @+Q2@X>XA,4P$$4@L7#7GS2@KA* !6@
MR VLF+A8M3D8!6.T PI(P8'TW.("^XH!CBF2AA FY<DJ.',/T/"N%+"A+J85
M80A]H@(VD(*)%'EW*"Y0%##EH@:A"FXN3CV0-%PR J3 A7F^98:JN6'1*1RY
MJ<B#AAS@J<Z2ZD$9VK!2G2%G?[G@Q)83FZ8R%)P.4U$C13!0NEST!15;S@0$
MSD!S-?Z  C<G-P,]0T&#&K &0:Y@8AJ Q(,RL $5F]! #-RP KT9'3FW"&H*
M,!$*")B!YFLHG2MV,(()L G++>?P;E.0PJ/8H%1)"<7V]&>&.5"8YFQH!1VT
M4O1/M&",/M& )B)/D59TB2"U)@56,' #.H @$[0SS77K$ ,*J*"\-%@#+G#1
M"@N\0@,W #H:<I*!3\ !IOJ+"VQHL D;N($&ZVF!C9(2@ISD4(@$J8$F-)0+
M#1CY IMH_69L 0D8#Z0,PL\%#SC  V/=HF]CL36Q3DR!N-=<J'U!B =>I8%,
MT $U/M%!8]JD%9_ AP\8J(%U-;(&W^_%"K"&3S1:J0T$&_[ 5!]H ')DA%S@
M  <DUT;(V@G$5<3@@AYD /_MD1HI7 F$U_G17!LH'T)\Q+$QV^F8X D:@K*I
M8$H\&T*X0G9T5P/ 0A[0!5H #0=(#_>YP80]1TFMVT"(PB[5V+M0 "F PO;D
M@B;0!1Q8G"W8 %VD0%S90@GTUS@E!V6]A80$C!*VD8.(&@(I5L)1Q!R@QAT(
M5BY$P":4D7E062Z( @;L1!GD@"LD +SDEC#IEKL,A!D(V@WR2U)0! AD4,?U
MD.C00%S=@1)B12ZT <ZM1T%Q @8D16+QP/;9 K+P"_I0WD!@ "C$UI]9Q5_U
M01IBTT&D0 P(B@T2Q+NH@*@A'/[2'5U!Z$ -J$!51 !9Y$$K\,&[U!EJU$#:
M@ )W9<5 %*.DP.$#Q-4G-<!=:< =6%0KZD(QCDS451MLM509"%,>T-18F)$:
MODI?P(($F(96[(!7-, .)47O#,0><!=A"6%L4!XH()(G:L0(Z<T,X 068LIS
M7( KY0$C;@0F&$@*2$\(E$Y2H("$W %=\ $=K0</Q$@K),!.9%L3\<Q@"4H!
MM<$HM!:_Q((M4$!1I(=?#00(]$$!F0<?5AH$4,0MN!$'B$B,C8TKE, *# 6[
MR,<#O,(=.$<.9%:D&42CS8$]N<\XR1H*Q!4ID(<&+"/E%1!V8 (IU&.;]%%"
MM& *MO[@5C9;?;#@1PS"(B $1?0 ]FF C:1 ":#(0_ !!4S!#D0 DJ0 "J !
M"(30H!$$#F@ &M0  KR+ Y ")T1 4C!='[J(#?10"*A!P"  Y_7 G3W' V"(
M"@@*R3FB ]S &5R H)@0#9R!!.A-")2*3[B!E+5 ":1!" C?)D328.D-/18%
M#^3*!>0 &MA ;; !^J !:HQ'#_# &OI1"-3E+1)$;_8 <,J( UC%.:%!",#4
M;A[$&32 '$"23[!F56C #)S!^6U$+D " ^C 5:T,+JSA*+14P%# &=" !0C$
M#(  &NB)>;@05A  G[S%>XJ 5K2!!:A!&8! "&S&@A7$)OX$0%0XXOG5P$AJ
MD0YTW5"DP0*XP2B(5FD>(!VYP@B4BPB,45)0Y4*N@ ?X! UXP&ZBAAO 6 1
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M'YENV8Z(A.1!#_@B&<$!+(A""%@&)A@.[[:CVV+7':# )P!OHZ!!*,S"V^Y
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M&\O!_3V \N7!,E[P#+"&VC(P!YS!56+ RDP+1[@" ]CG$K9!KK7 ' SM#E#
M',!!#R0 )MA" M!N::)/0?3 GF8"&B3 "$\R1>@D0[1!3O# ""AL $-"274U
M,[ML+NS K> .1PBE'\6%:J]V#X10+IQ!"F>P&:RT0HC).&E".'-$@&$P+$BJ
M7%# #J0!!>C-+(" B8U 9K4"!["!!Z32]J'Q"CB2Z:!U#7<W-#]K-1?$)Q -
MK=A!&53Q*#P2Y;H"8F)4.K4!&EAD.YF&&50Q06Q"#9:!$/ZA AH<[D" E!Y
MPBB(P QLPBW02MV:@3J-PBALPM8>!!Z4ZT! P@7HK=RB32O\WR;TP,_VM_,4
MA"M$0&D/A C4K@[$ $'D0(H_ .?5A0/\Z\XE@,)Z7(.XP8*KC2O4"X-$[2?M
M2]WFMMK  B18RBCDK>C>01G84QNDGNER@HL3Q.R00@G,0/:>QR:\ AJXP<TD
MN3VU@ENIU [(35)L M4=Q<+4@2B(0BO@P1FXGAE\:Q]<=5+8 B?T-QP<A2N@
M@;CBMQG( ;[)@1D0V.OZ1!Z@]T!\.501A"C,Y<K QAR$+IX%NO+53P;DQ(GP
MP;K6Q2S!05&4N1M8!B=077K$@O[I@@*?B#H<W$P=3'A#O((FO HN0+;:\$E4
MHX'A1'4::,<HK$ )K(PHV,(K@ (H3,&WZM4<M$)ZP4LLT($9**S:BM2FVT*G
MMT)B\$$9P#.KC\((?&MM%:X9P#/0.LERT!LIF 'E\DL9S(WI>E!#F+G*<@ "
MQ!7QJ4TD'2U!N%$>0).@E("<&(2<O^TF<, .Q'@S(QLCE[58?7=,)#Q9A642
MWX$%@$ ;X((*T"71_ JUW8I<A$"VP (&I$ 9H,!>B'R^3&$&Q(A7J$ &S,P#
ML$E\E0&/+I0'A$!16@ 'S %K$@4'8!U<Y8(:.  /A.K;#L0,J&4(/(0:0  *
M_&P:+/Y])D25T.]I+F!"LG:?Z(IX:5,$!TB>"-&58CV$&ZD- [@X1?SU?"X'
M+'C :ES 4)P-C#! *]S ;9< &]@"!]0F!N3$"G" "+0!YAEL7+^%O(5*Q[E,
M R")2&*N6F+"!6C &%$$)+4 #YP,1=0 X:>-&T0 "MS 5R=W50,)#7# 3FC
M"(# )N0 !8@\GB;PN_" !L !/S?$I?: !ES2)FPF#T# RKA!!J@!#:3 S<Q"
M"-CU!;!!+(C])PQF#HC1W6#%YM. 5_!!!CQ^7Q',"EA 3XA #71=M' H"E!
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MXD&H5E"0I'1'!"F T/;=F8/JIX!/JGH)5.R0/5@/:!,F3@H/;F6&:,5, SP
M0>0-DHGJGUQ)&(38;, @6F$%0@ $VL5)S&0*$L(55&!3;J\J0& %YJ &S@ 6
M4D O0D\OB ($<B I7"$%$'"C6@)90B %5"H7,D$#,$L3$/"\<B$/;D T+$E$
M7H]-!D0./" $4*"<6N(54N $Y$0!S>#E-+!R#K HDA !?<LR<$'L# (6E-"
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M0P$4YB !1B$3%N 30F$3K*\E9OZA$_MR#@BK-QI&'?G@ >: #RP 36 ! W*
M#V8 !*0B_MJ #S1@6S"! S[! Q"Q#"CQ&$$@- @F<7+3$;?D1TO5,TLC.94S
M50UL58=4-9IS*_0  T0@/$+A!KI/+_B #^8 368G!>X #C;%%7) !5[%%FY
M G0 LUKB%N! $VH@!0A)%&YU34;A_MS 2M) .SYL#1(C%@C%#2A@!?3J^"*
M$?ME!5H $8-#%A60.RA !3:!;XRD#/0B#VAB$S"$"UMA#OI !6;@!V%A!U*
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M!NSE =I@#U"@ 7"!%$"%$^8,%G0 BODR<S/Y+CE7-G"C+!.L5073-HH49V;
M8\O)%3IX @6%L%I(#D!@,$8A ;2*A$<$S0P"![1(RX;5,'* !LW !K2T)6H
M360G3Y2+ [!E*_[#(P@I#X9#!;)GF0=$:ZE&*Z(L.MI ZQC81[X#RSR@)31
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M)5!!H?8 9J=7NO_D_I*B#P2:N_4GC/+% J8/ ]9U5_4E3F9A.*+-(""@%>H
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MCN "$< ""<  ,N" _;$!'= !!^  45!_CJD %> 'E<"7+_[  %F  0W@ !N
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M%6  T^4 #F (,&  5T ($7 !>VD %" #@G %"> !DN, %?[P!T]0 "_ "!:
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M'Z$)(B !&$ #&P(*$ #+9V"/MQ ",: "+4 !!)80&4!B;A*$?[  %\"">DL
M$?"V!( %E>!_+O (A4D XON=B] !$; (\UL)5E  3? ("5(!%= (TYO4'?
M+_ "%E  ?_ "!9 %E3!^"< "V5D TJL(%6 !@[ !#D (V3D 46 )C@D(CQ !
M&; ?6= $)K  '; (7GU*$= !@/#6E= (A* (48  )  #I_Y& O77"!<@ 880
MUU%P!07 G3*0U)6P 4<MVD]0"88PV2]  '%0"8'PUHE@ ' M!7)="29@ (3@
MERSP B00 %L-'^L6H/F[)6UP>"+0OQ[P$1*P8"5P&1>P(;[:"BO@!B<!"O88
MQ1<P$&?@EFI0 Y_P &?0 V@0 2J9$'R0 2LP$#; KR B!R^""B6<"U;,EBJ0
M @$W"ALWEW?0PJ(0 ;H! B=VKJ@Z WG:'!'P9"#2IB&M>)<!(B"2 G @"N1M
MWL-W43&,>#8@"A* K9HXX6Y@RO8-K[=0!S&ZE:  Q8]6HXBW%( \ SIF!IIX
M$A@P"FYP 6C0 V:0 *! !Y'**?ZY@ +8+1UM8 $[C@8^?@.O^ALZW@-GD "<
MT *RT716: 8Y,*#,*)32L593D"-T\  D_ F9X,P5$0L@D@DED@.S)XX:, =S
MP)$50<1KA0&;8 L4\'JY(,M;L@.]F!"A  <00'4"O:2YP %1^X>=D2>P,)*C
MD DCH!%">0%F00.=4LEUP"(U *\8P ES$*E/00-IP >)V&04XB:NL +9F N-
MS@:CH DE@)"P8 9XD DW0.IH(*5(6P8TP,JNP,I)V=T<0 -E$*.'UV3X6,DS
M4*5I6-][[F&O8):D[!UYP.L4$+(70&2MD 8\8'"'7AL>D <GP0>1J@'$'J,F
M:08YDOYH44$A(.(5!SJ0"#&V7#EWJ:$'*/  L&#A0V%T'&P6%]"U32;*4T*V
M=*DJ=,O6NVF:CC"_BQ '"-#4C. "?^D"#:#75&W5>UL)HKW5_5(!%[ (T[O6
MJ"T#N/L$A. ""1 'KO8'"4 "V1F]CZ (&R !*%@!MA8% A %>[FW@_  &\ (
MC<L"4C !N^O5_=+8?X  +,#5I1,%!F ",M $3U %3=((7@W652#7HGT%88T%
MC(#:CW"ZJST(,DCQL3W;+/#8)I"=!""]>MO;!O ")X\%S *@$Z8A";$".;+A
M\9H+%HP01)X+FWP=%. *EKZ)!-O #XP&,GJ(-O )%+ '=_Z0!YJ@YVU8%;^A
MK?=HT6)L$A;@89H YUO!!Q @&U$, 68!S'DBKEM"%3G98PO>''&6'6[ KR&
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MH%DB")4&Z$= 3X/@YH@@DTPX"+P&ZKXBM0?H!<(V5%@HT&-5-YAB@ Z!X&#
MEE$."(XH%L )4BC.%JXH0P/<TQ&C!,YA&K@%*A:X.4SEHE(=6H03'$"  IC
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MA,#V4[S/P[$M*S$ID3S[P#'/F_ZT04 $+:,/U*,/$)S 4$*]XGL\R=LR()O
MQ:O 2CDR',.C4-K XM- %'S!"Z+!^H"R%NS '.R0(%Q!Q7O!&$1!2LN_",P%
MKZ,_)73"_@L_6,B(]DO")[3"]ZM")<Q"]]O"\,.%+F0_,-3"*R1#*L0_3, $
MOE- ,83 %N3!$CPR%50\SWL\-XQ#-\1#X8O!/-S#&,S UJ/#/!3$.@S$09Q#
M0Q3$2BO#163$1G3$1X3$2)3$2:3$2K3$Q--!("1"/]S!"SQ"0=3$#CG"4+K!
M4!3%#?3$&H2]'-3$0@3%4T3$6(S%05!$,Y0/-KS$7-3%7>3%7O3%7P1&2IQ
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M32B#9XL(=IL%4$"%,Z #C],$,R .@<@#,ZB?JQB%32B#/H@(.S"#N\(%-Z"
M.B@/4$"#-3B=37@%-U#39+L ,WA VAC24,&%*;Q3R$"%4:B#7+@)V*"8-'A3
M/VW30<4-+(6?TYG2*LT$*L7%ZX342)74296/+6.$+&B )W(!1S !!(B 0EF2
M_NR2Z<."!H" !G""/_B/":#,+*@$&4  "4B #X!!)UC02GB!$WD! L""QNL
M!_B#)OYX 0?8 -R#O@Q HQ]3!"M@@3BH!+N4R !P@K>4@0*P@BMP@0U8@$%H
M%+RL!!@P@!>YCR9 @$7: $"0  <@A$%PS$=P@G*%4&X5@">H!"=(@ AH$A34
M21D5)4RA"4V(@!C@@1!X.TR  +MI#@EP!8+!*P[8"@L(##2  ![8@080"H^P
M!<\!A02H 1ZX@*24*.$$ 8B8@1(P@Q (GC5X@!W@@0;0GQQ( 3; @!VP!1J
M !IHA8=A@X'E%L+J 13@@%M(@P= @3U@H%?HK#*(@,!X@-O EEMP@P@H 1S
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M[M<*VH0!&!X^> !8H N)Z)5D:?YP.K@ H[N!P!'.\C5LC[B%#OZ$W_Q@P>$
M-,"%ZA6%SN$#6Z"#"4:#%7:[7(  H1B%!<<63< %"*B?/$" ^! 6^Y6N_DTG
M.Z  HZ.!MXL .(B%,TB 7%@#!]+@;8-9G%N!Z]AQ#0:%SM&#6YB#CD&!NN&
MED$%#A %&J"(FA"/N1KM,T?S-)= 2[V""NBC1;@""ZBP*J"1"VB"N)R\06"!
M"7 "0+B 1_&#"WC=.+#<!Y"!"V*!#NB "]B WI8$+/A5"6C+1NL _5R$;"4A
M4?21)HBA&))T0F,!!W" /Q%<&,@ */:#7QUU0M# ,/M5MF0\0SA5S/T#+X:
M:;4"-_[/RP_ 4!@PQJ-NP9Z4"TZ8@1X( 0T0BDTP;#@@"Q1P!5&8YGGAIZ>
M Z"4 Z"<B11PA5%XNPD[ZZM  1'P .+@@Q P]_BX=@%#CST  1'0@/M!&0^
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MKEQQT@$:<+$_")5 %SGXH2M"8 98+#$4 LC#*U @'@RT 19N.  JBF.+':
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M.Y 5G RC'X.%"F&A@AS$(@\1@,4*<@ +3$# %7/ J(_@P <$I#<YR462+=;
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M! @*&$\+X$ NC((#\(&(O4=PG,#TH(2G 56OB4*Y@<"[V?Y;LJ# ]'C */#
M#>6"*(1("#8;1T2 OIB,0+"!? R(TM&.4MH"4PI$XU2@<BR<0/3 9:&$8@A$
M&Q3+&J1 E>2!QFT"[@3(OPC$71D$HK456TF39O2!]D$&]N5"&A@:"-0'#90!
M*D@A4-9:"Y!" ]B+57I4G&Q6*\#!F^7 &F#"]*! =H4(+#A'=T5=*Y2 D^1"
M#91!*_2:W(F+ ]"-+3S '&Q"C^3"*U! *W@B0[*D*P2(RFV6.H[ )M3!DK2
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M<5(+8!BM&MA&K07(!4!"GNS>NQHG ;@)#S" +D :*-B!.O+ 90%L"K2 ?&A
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M30=&B["T2@<U*QDS,N^T41\U4B>U4B\U4R?U3TNT4'.%.V9T5+\2Q?A$'M1
M.4-$3]=S3@0*5^>;FX )#J03A@@)-_.S/=>S+>3 '*^U/1,T0WRU0N3!S FT
M6E?S>,FT00P3$FWU.(<+91BT6C>U81\V8@N%6IQT*@%U53^V5[3>7#,$"B0
MOG5U5E2+1)C!'=I"#[!O+=\"#Z13+;]+OA7&37O$&MR:3=B"PZY)8L>V;,\V
M1[L(5,.28SM,;D.V5RA9:@.2R2#8+7 "%J_!LH!)&Z0!2QB*1]C"?W:-'LS9
M0(Q"&K#!^:)!9RYGY')$&Z!!E_ZH;Q_@K(&XA"V8#QKD5"NLP1H4TB;8@AW
M3BN@ 1LL2Q^80>=F G:7GQN@093V"IU\0GS/03F[@GH'1=?P@70;2QJL@;T
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M"\9V.IMRD)5F0 #LH,0-]*H="!4L< #M.=N;K4&NM0:.3/[!:9(V#?B@1=R
M0]Y!KF' 9"[)56  *8C" ]C+)CR0!W3FU0*H&E#<]-R >+0!2A1]8DA('MS"
M#A1G'BCEZY#" SP$)Y!=+GC HU&GI%R;*/D+W81E!,Q<'N#'K8- B)2EOT3*
M? A5"S@DNN("W;,!K%'@0%# 6+.::\<*!^0!+"1 "MO"VCDET K5A0H$',S*
M!12&)CR0'EPCI%G+!=0'>6["MG!$H90)@G[<PY>^Z8-TBDP\Q:_^611U0>0!
M 1#  GH$)B! #>" !@B5XE.'XO?8"(C #) [9>4; "#1 .)"<[2"!;1 #-#
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M"O8N\H1%:0*;Q,?>!0-I%:QE?5@:#& 5(X(L55X*6Y6=;O&Q8P2)8$"8!PT
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M]*8PK)8H%^Q@ .C@%=( 6-H@)W !+2H").C# W!C#G:K;M(D?UR!6F*"*FR
M?F( 9C[A G#!%1!@!O@ %S@@$S!! @@I5,@#%1H %_*  /C@%51#*6!A5 2B
M)BB/ 43!0E:G#"CB+3( !5IA#1#@#ER!8ZJB!RK$(/2  /+@%6R@! Y"J$H
M#=S0#%P!%"1%)1@&(EX!%"! #Z+O%>; ^W)!WLHG =I@%.P +'3@-5XA ](
M%UX%%NY@ !8();HQ0#9/'E,E\N#@%=Q %A=CO_B.:WKIE_[PZ),:JG-N @
M0 ;O(@0>( \@@'S0P ,R00_TX !>80UN) =0)RPH8'4",%0H0"!0@0)\0@+0
M("V\HD%68R!28 Y&X0'X0 ]PQ@U&A@?V8(<<+ ;J8)P4@@88)D(ZYQ4P 0YZ
M)13 @B# 8@XB  TTH4@<@CP>Y&:20@5VJBT& @1.Q$HP0A/L( -8H@9@9A/
M(@6N8B B@""U @ZDY%I080ZT0@ZH,0>LY<3J  ,ZDE]  2//(!/>0BQ11"M
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M0#;E9-Z+1"'D8'_9J%%?X^<10Z1F  XTC);7!)ADWN8KU[]R_B[<P) "::G
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M629 (*(34&04*3@G@*<P.#S B \!G<%;YB""%>%B%CI8@P@T0+DR@((.$-"
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M$I!B#SLDF!0'L@(CT06'U%H#24.04Z.0 8_C5FB "9BP SR0 9AR!LS2 Y@
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M8<FH"5Q8!C@% 5&S G; .*$R ]WH!@2@!Z/@ *"0"1QP&X;S"@3@!J]0 RD
M"REP U/3/Y"  E:3-T'2"G2 2@-Q;[;0C7>  )G@"B!E"QA +: &(\ET<A#0
M7!B0"1B "YB0DZ/0 &S@"C<0;%<A 9P "RM (A=P%YD@ ;F  2"P![.0%%^$
M"2702$DT"@E0 YE@"QQP%S5@!OK8!K"@!BH@._S81[XQ BB "1: +43T1FS
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M"2C !\K)!WD@, 9A:(UP"#(J'3":'9PK<@U!"B"0B@=!G@2!<D5$"AG@&BM
MI!>6"VR0 SU2!CS0 ]J2 GFP*#<0+XF!"B6@ FN@ E;) ;& "[@P W P R^"
M @J!"1Q  W"0LVS0'TFAGHXV$![@8,$W13H@ A% +5Z9%#G@*;@@"D"& F:Q
MI;D@ IHP WR0!APPE3CG"AP@7G4V$)# 0$GQJ'80 YNP/0.1 R38 ]6;+^"2
MJ1H@7GG@'H%! ]Y* VI@!SW0>[90I/8;M72RJLT2-'IP; 0!!QJ@ VW@'BV@
MN[=@!_XM$ KHT0;]\PHH@ *TMSB.>Q4!S &;,&4ZX*/'PQX/P ;\,@4\8(:K
MTP,W<+RM  *SX &A@ M]8",70+X\@ 9W ;/Q,0)J@0OZ.&R[<B:Y0+NVFP:N
MH <J8*H%$0*<D <QH ><0@&D4!\B:':4$PH/( (B  (0,##DT@)VX+]'&"\E
ML <Y8 =V-)4]X 9)T0,C  &4PZ*Y$ ,)]80#(0*94 ,H(,2: 0H<0"YH"RS&
MU'X6D *)$;.Y<,-.99@$A8,<@ H[.Q [D!4SL@-EX 9S,0LBD <] !8W< >P
M,#*,DU]T\I6Q0RZW>FL8((UN]JK>,G8%@0DS0 %':P<7MO["@6$+XH8&-N I
MM$&WSL(#9@"R\7)C%]8#97 'H984731/1#1T'6,>U1L+'* '%S"59K@)'K )
MV(N>L5J=?\<!4*$X F0X)K(#/= &G#@0A@:ZGHM"I3@2&J RCW91U-D".X2=
M?+ )[-,&-B ^9(<+*+!!@N8>N= 'H(=_6O$ ZY8!S?PBTTC*08.#;;!D-5!_
M:> &2Q(C*2 *>-@#;"Q/N> &[',':I,"S#+42#(#G/*WUG>?%'&^Q:$)T"D[
M"6D+** "3D(N,F,>E>K3=)*10J+ A9&0 X$!5P*\7S$"%X4)(Y!'XC4*DT(#
M4M0*8C00KA !]X5.'B([0AV".OZ@ P#GHFD0TM';N 3!"><X"Q$P06ZVK[:P
M/ 4S0<6A,)D2TN1Q"W-:!R/33JX2-4G1PD-BIV4W;23RB+GPFZD2"[:0 BJ
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M^@11!A6Y**-P!J%B!XXA"IRFC7J MSL 2P1#Q9']"AK1_>-1+EUUP&"T!SP
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ME<HKNOX%@U9@T0J45]B8 S1,SD@\+C- :0&.YEZ90R1,T$B,(#;8B&6@6]R
M Q,0N&/)%C?6T.J5TU-?'5@Z8LI=CZMLR6GW7.Z8=#Q07%F#ISI6R@646.XX
MZ+<YT$@*EE!&87R3$EV9BV_ZZ[?_?A<%?W/PP/NG=N&4P<@&(V #"*+'%CB
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M02-SD8,RQ()VN4C!'$ 1 ;9< "9K"",%9G$&'N0" DSAA 9(<0&VV.("K]#
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M0C#&\6D #9MPK1)!8 -<P$(%)=A!&]9Z3C,SI0[!1 'RUI +%7PEC* (00A
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M>F$+4*" SFB^4I,^_4$0O),\33(\7-$ VF&)$A")T",]3&@ 2'@%'<@ @K@
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M!&,4B!A+&Q28@]Z$!#[0A A@@V2!A:!BBAHX)_J0 RH=!6]< ^Z"A-YABH%
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M/,@#/B3%W*J#@5'DP)'Z$1E"*+"#B41)!=ZC6W[V@#LWG$$!F:@# '-1@C:
MXG.>V80K$. &6X BC+G0@*[$M_[$7.0 #:^ P%*H<XO/. P#MIC!%F=!@5$
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M(9FTQOXL;%A@#M30!SMO0@68J"WR.) 3%-3'#BIHQ05VP(<>K ')G$Y6Q>V
MB5G0P'NV^&4^ WT+#$C'%K.8@@?<L FWWB%MN+###1PP\#0I5PI(AQQ05"Y
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M'IC-&L!""*P!)GQ2!LUL!&1"'D! &;Q"C?'!#8C #6N ,%_D [A7!,P!'#S
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M@Y85N(5U>BCE VIV.#,\8 UYX $#Y'T&A]:@![A0"?%F<#0T< *"+,(R!LR
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MA0Y$X#*0,IKN<BT?911L( 5FH#CL0 3JJC/<DBR5\BO/\B\?4R[+$FQ0!)S
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M CP@!F(  P@H27\B!$+J,WK K'K#%>HF S8)!7"R@1R@#OJ 7=!2MUY4FNP
M % "+3X! !P%+$/@67A#!59F,R#A3S=#.?X1#>;O)S ! #0#+:;  C1A#0!L
M,U;@649 *^+ROY:R!U( !1) !3IL#0:,'D=!( WR)R#A 7;J4=8  (JQ8&2F
M2C?C!%PR+!VR%5SEK99F%)1+]BZ@#_XQYGH#+:!.4)$T%^A )X+U2U]R3+M5
M3%U3-<I4FC!@2R&@&$%!RH"0,OY;84M30+4V82]G\!78P-%F 1.TDC.HM3DQ
MX51[H#K8IHKV,@T<310P@3?.L$(S@2'/BLH\H@PB8 -M 1."(WDZ8CNL<[4R
MP3D[ A3X,/$ EBDS(;&@PQ8RX7 TP17DH$,.IP9P@(",I@0. V"A Q30"2WD
M:XC.(A-*D62?:+XZ8\QX@XPD]G#8E3.:!(HT 9VR)/Z:))ENZ$_*"S$]PA4P
M882@0BRS9\#.K2,V(6D\(A36"6 WP1!GH5K0HF1GU"-BP6!'R">XSV:^%@B/
M,F(V@0+(!HQ$X08[@A/J:A0R@&:G]A6>0RS9"8HX@$0_H:ZB\FE?P6J%5&9"
M8$NA!/X3-A0.GF2U7&EGST)=#]9HR&03  ^:S@(3U'9;<],>O55UO]4T8N_T
MG,,C(B!!6N $WH^FM&(4S"(-SH,#ZJ33;$$$5J $R&,63@ $5H!\<D$/." %
M.,!+H:7^?$(34,Y\-($"'L#FJ,(&6F &+* Z>BH7L+ %1@ 6;"%[X,DCW$!4
MN0-Y=^^!'.7DFI=91LEC9*0%?.W].( #;*'<;"L%1. 5<L !/&!J;0;E0*!G
MVN"//( #8 $74N!XWV\S;,$"4"$$BF8DZ (.]"8Q4" ")&0&\* ,&N#</BOL
M4*(-]) \+L!+?P(4L*LCV, #;H"!XV\-0" %0B!9FG(&1OX@!UZA!"#X#&ZA
M!$@-%5 @6?K@(7+@!C#@#J9@,"]@!@['#<Z#KD#A B! VCSBD<8,BC @ODJ@
M!$# L7(@!$Z ?)\*"\?-(WC  3@@$S[!BG650S&@!&9  U!!^5"@!F8!!4H@
M!!P%,J)J44I $V+  19M!&9@!8QLVE0@!5*@!7"A1PAE!%0 C,B"=X'O)T+A
M_42  MQ# TQ6T8H',>0MZ/;@#CA !3C@,FPM!&8 =G\B#S1@!CB@:'[B.Z+J
M!/B7>37 #EBI:4/ @GB@!CB #<"N!!;92B2+$SP@!30@ T_W-O417+,&-5;L
MFE<W-+:YF\0UFC+@ MV@!F*@$_X=:P7NX ;8+@UNX(7' @[NI03R !,V,'#*
M8$YL00-"$YY"H7H\(PW8!8#L:D70X$GTX%)&H#I@X0%B885F08Y68%H:8 >N
MJ!4@H0=F !-<4GW-P(;J8 :DJCF29A2J)P7T;8M'( 3GRP/L !1"X!4<X"?.
M@* ^K3/,P#U:X4+40+\RR@Y^R2= H#J.TB&B2HY:('=LZ $.HP\4PEVS8^0N
M0-X<I!7D@ $T 2U"8"8Y(Q0B(#C8@ ).Y4W?R5?F!"TH[;=B8+UN3*>=1P.2
MA0]6I 4T0"M6H)$6CV,C@/ORP (.380>A>G^*K!2Y0;( Q<\@!/LX YS@ 9:
M(0%DYOX,)A6T4H(C!$;*FJ-H/@$!4,$.$N"W:,#B0( .= =N;$&.\PLZ+D!&
MJJY),,'BS@T6,, 5(&P-^. EM&(/?G84#H C-$$L;@P4'(N7V@ \2(&N]E=Y
M3T!BO"@3'OM1<."W^$"RSMH&."O^/("@9F% 5*!G#/-1;L "DN4&'$T$W(!R
M0.!9]=ETJ9DVN=F]78.;[Q/$-."/:( "V"X$8F1\:@ 2)&L$-L$,T.4G D=#
M&I",(H 4YCGXHBP"UL ,TJ !"O@GHK<C^L"@[R4-GN1E$(-!.( 4[F@=VT"*
MIN4"U+:Y\*P%/H@L:(!*@D[&;B LUJ ,(!P4;B "&J!)3OX $]A I3X%?8(N
M W"@KC" 6#T"$GJJH%7J!MSFIN9 5B'9#LS@0?PL,%)*,.(/%>YE!=;#1S@!
MDH+."GVJ!"3D.L//JX/0XG+ 1C' P7F 23HB#7KE<WC@P54;<'Q" XJCEOTL
MI$AU7!3G#/XU)4;!#N:O(RZ !^Q@!F &<?6H.5$@I% !CCDE#PP]O4)AU_"E
M(S#=(T1 %.3*:/SF\%J )6#!!G1@.FKFG7Y" Y*&>JZ(%-: !R(@$V#AO&S@
M FZ H-; H7*! YZU 44%1P:(H&*]!T1-OJ)*!^X ,,R@!RA@#X1=<C<C#\P
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M<]K38OZH!2,4"KV.("$"4DWBM$(#0@6=;,%\54O2O0<M[H J>*/5(X? EJQ
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M! LW,&4/TVY!#Z93@X)?8'NMT$$,VG"W&=0@I:U8 0;HP GSVN$3MK!#)G8
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MD  I4&D:((4C  &Y< ,SD DW8/X09A !<  A=@ )$5!2BK$&"5 8#H #=?
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M;$,Y!QJ0?5KR:@B1:NDT/RB0"660'7,@ ?;X (US:E1!0"O '2@  319 FD
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M%9:S!FI: G9 "E(SC0UR%ZA0F!SP"1*Q XH;,CN1I5#!%'&T>1[EEAXB$:X
M"I@@HS$I"@]P1"6@N&IE"SE0 CDPE BA 110 ]OC'#>0!SQ0!P#W 'R+ J&0
M V=P&MO#!IPR N-!!^A+ ]LS!R_A!H<A!^*Y&W6P,OZ7)/YH0 <1<+$T^PHA
M@+PL,;0<<!SBN1Z&-$.U$R\>.P,9$7TI@ .(.P7QM0:@  $7^S+XN@E,809/
M<6HC$ J@D'*0@ H/  L!FAXA\9DK80=]:@L\0+X8$$<^4P9F0 <I0%FV4%K#
M%+!0',5W4CV+ %2C$#XL0;ZBE9:Y4 <U<(/66$H!8K*DN1$A@ O;^B.@L +F
M]1/:Z:*L@0MV8 ,Y\#T)&T.SH(U=#(Z;NGRFT0J8(+0;<@*&8Q*HP2H\0 KQ
M1$NBB12;$ )>L0F!BJ%\, -[E#%(\1H/&@H6P!*ZP;M^\1*N@ )G@!4 $R#W
MU\4S0'M-NP:)@5XKP0-S, KYBOXUC&<TDQQP\(07>M>R81(;=(.X-^ &>F !
MP=0#<( *L 8VN:#(4A(9=2!_5P8=6VAS!W$6!W&RC=(#6$&D*7P74,>A,@D*
M-'!_MB !KH *%=$*#C W.&BCGFP+<T 7F!P2'20UG+"%#G*X$W)F(."1H9D+
MH<  W.0!+!*-+$$*## W%"!.=J V%&!>N= "3Z$!RJH8-[ "3)$"F2 *)1$W
M/BP9-'!X-; ">$ ?4<&M-Y &JE,L>2 !KY$&9H *:!0W=NJ'7 :KN7 "<R">
M41%^51$7/( &F)"O IT+(3!+&X83/[@1'# +(6!D=9 ).O"9#4(H=14"_FP+
MFL 48/YF!X490V[S1KE0 ^(ZI2QQJOAZ$'8  *%1 D=4%#&<JR7 %"VP;$=<
M!D5-5Q< @LHCQ<P$V"584]'#5,43"O*;!W-@ 6-C"Q<@G19A Y]0!IH& CVA
M.G#P"3G0EV?@ 9Q !P[@"LD*%>-2$"&!>SGCJ^FU$E/@ 9MP!Q& "B6P&7.0
MKPF[LGN0<G; KP<Q% :3 HUR:AS "?-$"I\09LJ5 &:P"360(+%=)33P"6:
M&7A E2T)JQ@P!9@@ ICQ*:IW&VX@ 9K0!Z)9 PF0(SV0&"VP8C#A 8Q1P1&0
M"1P6"GP0 3J0<BQA R!P R/ 'BH0 YR0!AF MPT@00W0>/X2!PHL\L*)P9TE
MT0)7@AI]0 $YP*^?(;G6,8LP 0*0RQ*L9A%[I %D_1EWD0,&X:*;UP>;D (O
MZAO8R0EF$ *9P ,'\ JC, %X\0 JG@(68*HML EH8!VJ&4<1P =S0 !W,!Q@
MAP&J<Q>MT&;SF8,1P'Q,\0H]B4]LD ?B\AHMJ0-YP 8/L#5\D  ]P =E  +
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M0 ,'2J !4;3A 1?(PQK64(>UY$(';LA!'GC0@!!@H@1W0L&N"((!/:0,1KG
M1!THT HSQ*P$H."!P&BBB1'4  044$@K1E "$# +$_ZJ00MF8 $;V&($$%!!
MI6H0@A&@8!9N>  %O)6+')0@!2.HX!I D (0N (4A2S!)T8 DCS8  Z8@@0'
M4( !./[DBP,IT$ M0\(&#92  SMC@S[/DHLY>& %&-#$'#Z9.ESJ,P-S:$4(
M9L('%>3"!MU< 2XX@8)M"H8.S\) H^J@@4@*# -_^:B\J)6"<\X@%Z.@@  I
M H(6A. ,N6C!^,@&BQ*4( 33&D&CTO# $&SDGR#0GAXN( (:O'2#&(# 6G(
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M>$4><X$!4J2 .A88R V8Y4CDP (",KR)!48A8S:D !,UL,490K8)! @L#Q'
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M@T/C0U?@@!Q@/0TH@SS8L7K!%*)+P!FH@\QI/%#(@1IPA1:@% [$A.Y9-!Y
M S[0*S,P@[S#L!WC !F:A1#@ PV "I"H@8FX,30P@S5X .K8A#2X@9FK@PCP
M((+P %'(@TKR13/@O$S8EQ.QC 7Y#,)#1Z1@(POY"@S8E6/4 <;QFI ( 39
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M$4 _4"BOFBB#"Z VMZ##',B!@ &!3<"%_PW@L5.!%L@ 6% # 711#ZB!'=
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M!%'I](J= 00:!11HJYO"@1AHB5NP@RNK@5= !7F7TU!1"^VI=5MP@Z&F#4@
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M0">!4?YI!B0*^23&MNX2K]00M2+ +>R C>E &>R/F#( 'V3"O.9"'Z#!#41
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M ^1!*-P <@8@LAPUNTPN+!"C L("#/<% BC+/;JN! Q&#>! =+D!+!B,*S"
MB>3!>462!ZQG'%>V&^/*?4+ L2T.#4AI><6BS-3!];1S6OYHP$2$0D;6"R.O
MJ])R  [@@'^65P-8H&!(+5_P  ;,  9DJP)R@ W4T-!&@ K,0 9,Q"9$ "F9
MMH&\4+R(PDFN  ?,PBA@  V\-@4(5P/ A0K(#/O2  8XTUKP;;-H! >X!P<<
MB^HF!BNVP"T :U%<P$>LCW?;V V:-OX0!1_X'1H,B397Y 7H]H6U3SM3 +IH
M@@6TP QHH4V!0!JA@ IBB]WH0 8X$RH<0(&T @>LP I4&Y%LW@STY T\@'P8
M6 N$  U0@&F= 7)_N"O I*:- @'\"T;-P B,@"T<MPO;1PA0)U" R# /$(WO
M86*, !U\,@8<N00XD[LR2@2@"_Y)U  #M8((0)$8D43\_/8XKP%U8T "&C/]
M*@8#I<%_>R!_#4 ;0<)_E$ (Q,(!/S*D7(#Y*-^'%YT-V%@-K(<=+ !]DP5C
M_QPF?D146ZS7M4"U14@4D78:4  -C,#?>1H%#*26UP#Q"<@B<Q_2(2!84$ ,
MG  (B!$/-(!(T,W<5;4*AD;RF6HNY$!>?P@;_$?R.<1D@T@(U( .<$ "HL!<
MBM]W64!5T( &"$FH*@H(K,"V6L!OMC%T6+:R$UDIYAPJ"!4HV(%&V0)L--S5
MV %]O8+,OAELS +X^N^+5-F=QT8K#$8K ,JY$ZD=V%9:; (#V0(H8+$M:*VE
MZ V]V_X';(![EOPD371P+H3"%)4[8?26"4][E=W"L>%"'O"0M\L&BM8:NK=:
M'0R7@6CD?F@"5.H!3\!"H86"'8 4)MA!P<4"MML"^"I$!FP")-1B6O1!54CC
M<KN6@^A!$WV"1KH"H'Q"PBV+R*>%S2.\41Q;*[@6+&RN0L0""A3:C>."OUU-
M;Q5]VJ7%T./"*&":F4T7$.+!S@=,7]C!SKO='C2$U6C$Q^\2^)K\5)K(*$Q\
MSG!]+L3"'8Q6/='$= V]I=@!^&*-T]<2]+H"S/%!:[T$K-W!'9B(+? !** ]
MS=A!A"G*V(-"V"^$&:8%',AL52O$+-P!=('"R4>[N0+*)O[4097! M9/%RE@
M^RX56B:\.U_<N(GP 1ZX%B?L;&S< A]@C %_XK+O?G;9%4'1@07<@ IXP+$5
MQR;T([<A?TP=E"A@0 O4P 4(:G' ^6W@*J$*U'-5E_8?"@;8P E "(#1ABN
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M*"%TJ%X=(H"'5LP  V[@&0TPX*@6I( 39BA!+CZ1 !3HP!8Y"($=TD" #.4
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MH#D(&-(6&#1AP'+!@Q5VDY0SB$%!^  Z+4$@3CJ@02Y L">-B$!0H6BJFRB
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M)T%$# >5JHV"7T6(&SI'J(+4X'<7X%%LG8F![?0@!Z]@0'A:@2<*MS0#M[C
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M#^###!"B;EPE%VQP.SAA!D8 !=P&(;Y0(?YFWU#   L"#E!@#0E"$^0H\G0
M!QP&!6P@$\[ #6:!!S2B%6IP!I;%%GI@!-Q'E5+ "G/!#'AD#MX00'1PFJX0
M!3#!%GA ,%QA@MP 2C!!!4H@_1Q.:$3  -<@!79@$VY $^I $FUA!VY@-'#!
MAU+@O\R@B@@"$U*@#W2!!R#B%7H (N;@!$K@5"BG!W)K!I9FWQC(84B0<G2
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M%X2S#F;!#$  %1I'E%#@ D*A#@@@#48!!)15+ DB%![M7"<F HQ%!.[ %B1
M!;V14?[7"P5.">3X( (PH15H-71:HHY-R&;LYH\<P U"P1;0@ -  1<@@!,(
M)7<>CH7F@ !XY[O* !<^0<KL8 #F !5Z )S@ '1&U@M?JW+XQH!Q(1,N0!1N
M 0?L$)%0P<Z [#-$( ]<:% *!7R$@P("Q@UFU)K-*B%6P(T@ 9PVH55L8:'Y
MI''.P!5<@0'08!360 )P=Q9@X:8H9PTT #LH !)F@0#L=@T*!0-SQ]!@P:91
M :?#"0+Z8)! AP),*@.@)%+#%YA08!3,  'L .'J !<R@(NX%1?LS Y&- '6
M !3,R!:8B@_, W3 IDZ"2'-RP ;H#Q8:9PI:00\2  ]0(?X&FNDS:,"/-L$"
M0,1Q3RC2VOD"UN 5\" "4&$6#F *1D$%(D 3-($!,N4 VJ 5.HN,QTD''D"2
M+D!S-("+UN"'[(R5;P"IT$Z.+>!B-& $1&$3&D#SYL "0L%#7E$.1$4P$.(\
MGLSP(F*)+:-(C=1="6))<Z 'DFT15X@@T&T4DID@]#4D^+5!\B !8D0#M#<$
M*"!&F&Q$*(#,BH_51F&P;"'61J0E3F">'P 3^D"<*AD"S* 2#:(-** -PAG/
MZ,469H$^,F!94&"DP!?&P&D-@,QQ]]<;5\"&%424;L$"&L:3;G&<RJ58+4 ^
MTJ!-$F(-($!SZ&0ULP471"!F>/Y 41F821+B%2[@%98/%$XK^0HB EZA#$XI
M!0"$K>-%X)0U#Q#,A$!A2<L $@!G1D4! K[E7-D@#X(N=$:!?&JDWNP  D*A
M:P$6%S9L$S!A#AA@%O".(#K;(TH 0#0 #4R-!T W(7"@34K 7$H@!6'(5>HR
M$SH+%U"! GJ@#[H0I%54,$3<9?!8$W( ] 2C#V94=F^.SBE@%FX!%CB!]C+A
MSR%XG&R@'@$V%SQ 4&*A%?K@<,%W@CX#U#!!F6A@#;H1RE5;4![J0^7+3=@M
M!W[G%BGG F:A#6Y OH2J<M+D8H!-E6RT1EXA$]@ O?IDF@@]@@HB!F@D K;C
M#) JC?ZA_%]%Y;=R(0?\**M."18DW8ARCS]RH&0?(#WHX)(2B2!$@(MX"JM<
MX9=B-R'>4A/:0 *>-;=UVR9Y&S-4D]/>JB!PX :("P7@(!3^M4^00T2:6S#N
M %WQ#$!*(KB&:S1J (*:R0/L@+L*8@VKC@>8?;V=B08T@ )L,0]6@ )&8#LL
M+IQ H%S&O(]9*'PUH;__&UT<JB!:( 0)P@;X[SKTF3\(C,'E:.(&P@Q@%:%"
M0 1X)!/BBIPBX+V<#* &3H2"0X/X ^C6H'-"  ZVS(0V 10P2@/R:P5&H QT
M ,A6@.  "@00(C[5I@8XP-OX!-"8!0)X0 =TH PV00[:!/XB,L_@ HH&W$ #
M(&:%H",%2D#M>< -7,$"POD6[(!LNPQ ,JP.Z@1%DD,P1J&% =8"4.$",NZ:
MR',$&& 9%Y$#<H!I!T)M<?.?C)L.<$%%MT,4FD<#[EH'IL 'N0;T-.#002:F
MLE2$9J -.* /;FX[5+2+TH"XE)L/<&$&0F *F+#2#>+#' ;T6J -L!3B=> ,
MNAGPP3<'GZJ+A"PX4H .ZF<&^, #<"&XO&0$,F28"(+\&R0--" 'V$ #,"@^
M&3X7V."'(*(.62TFRN"L3(@3PHJ%@A82%L74 2)7KAPY<M$(P:/,B%RV+FP:
MR"-6!%NX</'1D N$'8$@[@C,A?X!4L59%&!IRO!1X!H.-]IH()4RYD=#-&O:
MO(DSI\Z=/'$VZKD3$="A.G\2%4HTZ<Y!BV1^;!6A5:Y;N'+1X? Q B=0&&1R
MR.,5SM1<=[K&Y"#6*08\ M.@R86IQ J/-&P(S#0C5PHXL2!\Y ,K#Q^!-UKD
MJKKFE4 ,<D ^',%#X%Z]:\;.>*OI0JXU*U1VIB!V5 ,Z*6V4F9KA82X.=02Z
MP;HB32Y1&!2CR7MKJH@S*6]% )O+S,*J(S;6@"5P1PR9KS!(U4LA;XZ\N5H]
M4%R"!XU<;#3G<I,BUXJWN>F46 R*#W >*,:Z:9_+U42!F%K5\6[+ :PY)W(]
M .Z<)OX4?(2"+5-L)Q!8'&R4"WLIG3!'6Q2 8,LL#K3Q$0U8'2:"#<OEDL8(
MMMAR2P[PY3** LB]8D$N?'B42QDBI 3"8*)<$ N*FHT08768I)0'" )QD DL
M%B!'R@6W7$!:+AJ 8LN1N: RX!GAS=89!YOPX5<N=BQD0P\I>;"'BQX(%,,:
MH0R8H"VQ7(#<#9%5-R :_:&X0E4"F;==&2CL4)T%BHW@41TA"'3'H0*]PH!4
M4>8F4 EOY5)'#Z%$\!$'<]Q"@2O!(:C!)IETZ1\I?&!%D$ YF*&) P+M<6A#
MGN:@0RX1J,:#"AD!%X)'5:5@AD!]#*@)1A_%PH HAUE@B_Y3,2D%;;323DMM
MM=9"ZXB>,HV2 "J]H;""&R+DA0FF,65@00HHA'!:+A2P<9A5#\A$067:?I1'
MO6<\H%H*&%35R@4[N!%!92&\Q0,&;-Q 02Q\,("&&QB(514/$K21!@6@Y!("
M!Z"@D0$<9F!0 BXCO%55#Q#8 8JK:"P4W(R@: ""AFGEMD*MMSR@B4!\U(M&
M!'WD,D*PH5R72P_MY98' #2HH$(*#]GQ@!D[/+"Q0!I$R$/!.5 0BGB-5?7*
M Z,(U,H X;F"00YM8#!I&@ ,A@D$;JR!0@2CK"!F;GTT, 4NMVK"@!EN: !O
M;FL(614:%+21 P2OV,& VR#DM?ZX>"BXP0,$M:YP@ALGM-><#6\79 <$:Y@1
MP7EZ>N!&O!PDT"P?#:300PD0G-TX &S92G$NG!!P-D,8\.!&#0W8L0D#4\#!
M@6QZII !)JXT@)QHMXQ:QAH/D*9G'MY%  DLV*/8 "XTE "'RCJTHA_ZL=BB
M00T2BRGT*!"PP48*6-N @WBY"RQY:)%>(M,"$+AA!1P8D050\(H:W$ @J-"/
M+3A@OPS,22"P2 "@FO:C5C3 4RVX0";*(I ZF(4A&LB!&V[@@-CEAA,4,(/W
MZ!("-[0@!+BXGE1R)9 (: (3!*A!&T80'CNTR 8(LL$-7#&!-;1A!0_(Q))&
MX(KI?/ZG7CW06"XNT!J0M"8WH*! ]R@0H3Z8JRJW ,$-7OB RCAK)M>JHQV3
M8I0[TB2/>H064^Z5$EO8H5DIP84;<M"C5P G)7QP@R/;,)A<Y$%9:(,1D"CI
M%$[L@ =A$T@+Q$0V,^0@DGSH9!YR@(8<Y>(3/,C!(A.D QUP0B"D2$/8Z-"#
M/LR"#;C 1"<9P@9(V,(CH("$0$#QHXU)I00]NHMJ\J"88VZRDYC8F"WPT"QD
MQBL4<W#DW3R5"TWD@ ?%\UGQ^)"#'L D.+5B(S8_@HE(PN(,H_S(*^B@ITR4
M80ZVF$,H-)$U@> A=GGP%"AZX,J4B"*2/EN58G38AQND)?X4@[$%&\H "E+$
M+A=SP,%&<P$+-"24/CAH0WH8B4E2A#$^(ET#<C[B"GXRI Z$3*&WT&8&-+P"
M$QL)!4(9!-,U@ (7=LC-,)OETQVHYBG @>8M\M"L:U:D#5/X1"O<,(L\&!6J
M#!%I4[VUB3*TP19T ,4GEBI)3[4".)B8I55P *]CI@$6FU"-+;AJ"S7DP)+X
M4I8@JW+79KU"J*[0 P7+!-,SG,$5F@ JBJ:@@YZE, =L,.H=FL6)'TD2%J[
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M"H>EP?:92,,H:" ;(*F!^,\6?_[QL%\'-S3+%<5KQ4U;T09\L4H80&.ML :
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M T?["8^8CT/S$2$ /CZ#$<W"!NUQ 9]0>NV!"R= !ZT GKD0 VRP!GG1+"O
M!C>2(%BA J$5+I_0%54!?RIF S7  8:A G(4&R!1=;B  5&HDCPP0;BP!C0@
MDJ% )1.& 9Q %770&2J@GT03.\VB?'-  Z"03GQ@!I&!"QK!'5?R'B*Z5&R
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MU#HQBLG&F;, "6R""0-B!G[W":R:"WUP'G"@ <TB4C(!"R'P$K.G%;D "24
M"P\P-'R  !MCU2D!<4\*$K'S"B*0Q;)'$H9U/;:0 K42J94QD?KS$)B@="HP
M)QA &N5Q 5)Q ^>A ;*AF6!AGKDPG@*QH;!  !$"SJ/0"A/P(WQP':*A@"N
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M 4!8A-4PR]4X2^.HC;,<!$)@A"@ @"A@A$2=B46(@A<(!$FE5$M-#=< U=<
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M\  ZR(492%>2,1D-P 3-N]:6I?Z(5Q");RT#&E@9"$"%7+ !C!U-R+Q6A."
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M,%RHP V810 L,(1'B(("> %&L/Z !X@"#T  0,B"V[X""6"!1WB! G !$P@
M)_"# W  !G""28T"0"  !B"!FI6!.+" 0@6$* B ^,6 !' "$OA>1I@ !.B
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MX-XHR (_:  +((1*>(("D(+33_[]1JB "7@$&$" [97]*\"" &B"2AB$"=B
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MB$0B:Q".P%-27L$)*>D06QDI 1YV4#BO0, 6MR@!#PH7 O[EI(1 &-B@&6H
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MX8 )&/["PKB")(<[[.$/)VL1>!K% 5P!W(Q 8D<@N D(W#"<'KC! C?I00
MQP,/S,$,%U#!+4(0@E&@03 \T  <;E N,[RU#"@<31E2T-4<<*MP!ID"!^:
MA@N(:"E*9NT"^, '"*PA#0_XSBLBX"-[YD($VDD)EG;P@#6 P@$\BL :=$
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M0 AF (+5&F03%#A#&R(0L!S4\D<70,$K;K!/&L@N S1PRP4U8@.B@V T=B!
MEV#A@1K(@0/&M$-6YNZ!"XZ@2_Y+R3@/1O$ ZC(<%!"80MD78K3M:O=7BK!"
M%#I_!4!8JA&-D((+9  (\P)"!BQX B$,L0@LO  &=P1$%+(@>C\\ 1!_V-05
M7'"%131B$%=H@NZ?X ?@7^$%,OB#I:I0A0Q'H0J-!/&P'DG]ZWO867>RQ1S*
M<H>,O,(]? A%1OC0OE:4 0==R@@JN#E3'O0!%FO Q2C.T(I07"4/-T##=CZ1
M75"LWSIU!/JYD]&8&A_,PAJH%2A<A29\AR;HP [ 5"Y80/;\UH3  AJ402B
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M42)E4BKE4C)E4SKE4T)E5$HE4;K!!=2!&T3 AR1E#92 '9@!!8C"5&[?&E"
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M0SC04B#.NU9H'W  YJF!'2Q<P^')"'P?NK;G&JP$4UC ]QE1#FC:0U+ D%Q
MF!I1"ZP ON;0!?#!A4!D&V3+0P[KS.YG(PGKC HHM/0%:=P$'Y1J^;%!R(+"
M&F0/][F!:L2"H.;!:( "&TR(=&#"&D0J!;Q"F15J#M0=A7A41MA!&]3(*)2)
M+;0/++@!'81:!BP%+,!!]V6$*-C"'<A!-H["*[1!^^3!'-A3USZ)V]8!V]8!
M!>0!9!6$!! D/H[&+,B!'*A5*/[8 AU\Q]"JAI;2;?OH 1R,QBO8PBLD72BT
M @I05HRL+>5$;3)JQ":L 2DL5K6L07/$0AEP0"88Q.AFA*J"@B:TPBSTP4K
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MD<T #8CR*SP:#2@S#=2 " @&"A!M!&2 TU+ I0V-#MP "&R'#IP2!Q#D05B
M<46 %/KS%!#%*(  !10.#_QSK<Z "'  &^0 I84 "M  #8Q9+E"%'4! #M3
M Q1/'60 #Z0 ]/"!!IA!"N1=1N"!!6! &HQ"!-# #5R CU1%#NQSC2Q%,/LS
M1FNT>]S8#GA X?2!2F.R44& "E1A*$!:1?OS"63TF.E&"]@ ")S 4E#9:?A(
M+H, &N#C!9C!*VB #9Q!!FP&!Y1 #I0 !\3"#3Q "@140=G:7<06![R3*6<
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M<4V)7+=T6MB$"]<K#'=A1:1@"]0%#2U Y:IQQ@Y6D2/NC$!1PP9:5Q3RYM*
M"1((A7E&A(7%N P/G;$N=.:@1R&(/CPTU*!!(T).QB7<Y+( :2,LUB'X8 +1
MZC)D/AY@78!%PXV.41EUY(C[*M<KUB+RW,*%"2N?5KD,U;=_'W]^_?OY]_?_
M'\  !1R0P +K<V0CG11L!8+*<H$E 5C00 $54$9I!9:-(/ZY@8,\<+)PE%BF
MX( /6VJH8Y0+-L+D ITV>64%-A1"H;G%(" EEU PX,#!7'"8P<4$8D&AC%%
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MW*($.LA%!-(G!Y&]A4$BH8$&;0&!5\1*?32HS'%F40,@>08.NT,@)TH IYO
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MX58&EP>',4!"(;!%,V?PS(A$P'PUXIT.=& +!\PD#P/8Q!J*F L>)-.$"LD
M)OB@ ;7YTPP7H,,:&@ 3A<PB GS A0:XJ0$^;**0>5A!Z@J3"S. 0"0V$$IU
M,H("\_P,)G!H0%MN $H?F>>.Z?YIT,/:0(<,*,8..2G=?Q0Q4YO>%*>?<X3J
M%.0*#N!((26 RQPT,((.Y8(.&B@!!MK""1"(0 ,PT00'4+ #-)2@#RC0"2A"
M, (-M(4&<.&(6',Q"J-BX QE -)&U$ !#6" CSJ9@@9$P+V=\&H6*P@!"&*
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M&$%EA)R7&DP9!>BQ@0?6&XI6,+"X3V7H8G+P5!543P25D:\M,M'<'4C3)'/
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M^@ #\( .5FR#A(H'((#/RFC2&N(L\Z .,,!MUE$P!Y,PL\X=#Q,QB0\(YP
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M(_0@!&Z!3BDT!?[L/PO54-&1/PPT/PHT=.!1=!PU]-H1015$%*@N G]$,F.
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M!6[  RA@*^S HS!@!N@I G HQDJ !AAC!6Y !2R ?<K@MW$H0<S  PS/3^[
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M%C=0 ]HQ"TM"4'>Q; KA"F'S639I7'W#"2(@ I\U"U)R SBP:O5( VAP"["
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MH0(T8"M[60<'8 9S< %3  LT8 %L<(UFH %V8*2C\ H,4/X"-O"5$10!H?(
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MT! 6P$VSPUEP$F4QD *[2J]&>*W"4C(5)"AA0@JX< MR4!PP2 .'U1.H$,!
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M@0Y$$),I@* $[LP%'SB@ @P,B0<UF $'.# Z6[3@GC002"A", (--*L,#[B
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M!.B<!EP)&R@?#<"$5I" E)(B.M"<&B! ?+$!,Z W7J$#$9B%[<J%5R@R@L"
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M!7EQA01(DE#0M2QLN'%1@8NY 3H;" _H TR00!C*GQH LQ4H'UYY!6*"A4P
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MB?&M 5-5L0OX65 )6-XXV"W.CD<\"E' B4UX/+YIPF#<$86K'0X1$G@S%#O
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MR!K>] H1R($^%@M%*%34BA&,!7TS($FMOM2&DYE')@;)0P,RI[<XY6('?KK
M_T(R@@R!X$.Q*L@%1K0@$M7J4+;@0P-(X1U2_&T4-.R!IBZ G*7]+1<MV%HN
M5M"&5YCI.Q/46P)N5I SW(0'?CH)+BA0P?7PR"0:, -(0@ *KX#D7U8L0T%
MD;>%R.$!)]%!<>  OSDXJB BF/[#U2*UIQG )Q02 )R<WH*+"_C'%J"KPXEJ
MMYSF;*(].N"1I?ADH8)$H!5WH)WMKB8CIJUI+/'+!0AX0) 1@((N(;E )D:1
M.5?$"WN^_"4P@ZF9U(1/?,8\)C*UQRS/Q,8Q;+B *S3!@1'(J 8)^% K*-"&
M49QA3V686"[< ,U-<" $L*A2#G1 @;&4@0.@V 0&,J0E"K!A%&7( $@<@K-<
MP0$79CC1/W%#@U%(Z68+N0,$-L$)$?CQ#"?*00(,"*11S.$!G#@:CQP@BDU
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MM%,,R,@MZ  '3-H1SL(-A$ )*/Y&'5" !JQ1&41 "/0!*&A &X3 "&R5@)6
M/.616T /*>2 2?3 H0C8".@&/!%$'C3)2C &0E#C-&*8"&Q5.H[ .H8$!NA&
M2*3!H<B7"*R ?XA"&;B!!N@ )\2 !AB0'JP!&G" "@C)/*YC&[0!#FA #RQ$
M.I9 #L@(4.2;49P!! #A)O3$+'R9');!'*P >YQ$'OB1G+%6+K#!"(Q !;6!
M&]R !O2!:9U'+D2D3?(!(>FD2:T!!(2 'O2!!60 HHV"FB%8+NQ!DZ#@2;Q"
M[YB!"B":+>0 A?5+&D"CP^C!BH%$&]B!#<B?&:!!!JQ!'Y1 "" ')MB%2;:
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M!LR5'$0 +*BHJMT$)%" '4R0+6Q,)MP"#>  +D!"<<Q6'HP"#8Q P&( ZM%
M"NR'8>1"!F" &\@/0?"  RQL"6@*#4 ')+C(;$D0""@-D=A"H\A$8H1""SB
MBA"$'."09XX%#O15**B13XA"+(T"C/! * @E0X! *[Q""<AEV)'GVW$B*(:&
M(OQ;'N3.*UR 7FI L)V$!B#'XI3';40 '9#I#"P(0:@!"(3")F0" L!"&ZQ-
M!I&4?_Z@BJJL2MR8$4ZPUIEP ')H81[-*X: [0"!!(F%A'2<P6WT '0<3_R
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M+(".&\S ZFE )H1+,+-6"[CD"F#O#8#  [0'+-X +()$%B?(#,2G06 I1F!
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M]7=!3'4NW$$B%L0>.$<;1DH$E0HLJ<$M3 B6R$_PU@N#[C"?/.>)C( !L?,
MHXF%&;"L<O<MS '&P))+%@0(C#A+4XPK3] G=%XK.("0A$ =\,#:W !)N"L.
M5$=6$9 =$*^<N BL!!H?^# #*)$E 3(XM<*;,'6M1,#;*H=:>\="Y,#); +
M-*M!)$0FR.$9+*OE[K ME(&J<$*,>$<)8%&_ULLHI1/.V/A/%/0SVT(*J(DM
M&+C*O89X>J*S6?:ZT?$8T<F%\(@&E$ .#<D(C$* H@IYX 4;K(&9AH0M]".)
M8$09P$\9D,<:4( <H$$#Q&T-,?YX#K#@;K112#S).[$D)N@50JT!J\NA091
M"PSPQ. ")A! AN1!!+3!&MQ*F>("*4A #\S!!?#("MAB#45 'GR"VVR"7F4B
M#SA/)&[*"%C %.Q  _"(NS[[IK$L2+3 6-A**ZSO#A"2IC!-NS=T+HS IY7
M&=B" ^1 ':R +%+ &01& WR(DR"/H]S3'/! $+U4?^:I2C* C0*6?^P!<UGG
MA[BI4?5%&<0$"O#(R@,R1B3&P8.  (XS2]CF"G# +;R"!>1 >X^%2=P =O+
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M@ M;:& %":T!!W+ @1748 8/N% /.'"&$8A3$Q"@ 0TB(,Y-8("N&.C:'##
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MN?7+101" 0L*5.4"1BW!2]9 S%QD(MXK@#0E_PN3/>,A OY5@0/;"Y()ZVM
MQ;F@0"9(<7;[*>[F6@<P\SMD!.B@%>IO)G*A!J2D/3Y(=L8#^* $ZF9O#5##
MXG;!%AA T#PMX!!D-O*@?G9 _&:@!USA ;@)%1( $[1/V9AM#:QO#M2"@9@B
M 9P"!-YC#3;OJ!YHW,QM!W<D3RQ(13!!2V8C!>!@#8"-!F[ WM8@!G"E#5BL
M _$BH.*KZ0K"XYJM*LK JJ*B!E"@?C2!NS1! [CM+*:##R @!V@ !]"DD6K@
M!B+@Y,H@ D2 Y3(C D#@!F !%Z0*"4$@ON)P!/IF>>[P+%)@(4(A V8!%\S
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M6(P#TH3#-&%0]Q(".!("-H%4^(X& ,<.$N!$#@PE, !!Q#,S3E-(;0$"N,E
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MP+&O9!/0(,X+@@Y4@D6X/=W0U -NHW\.,"219)(O &T@IB2A<TOXP,^.Y!,
MCENO'6H 9C9T0)P890YRR=OU/23J0$MJ90>.]6%&@*2\Y!4P0#PR/>)WD,F3
MA/PD Q;PYEP:PD5HP'9(90908!0@H0%NHP[L*A1"@']$ 3QMP';:0$HD!7VE
M)45'8?[>+V35(2$40,"JZF $LK0F;. ]4 4#SGU%,#Y)+J!W\;Q%,* F'*9Z
M<@$/3M-*9L, EZ5,7%52\B 2PU%9>@O@E(2=UGWIDR0D9O%(:),6C^?";^"
M5.1PJ 7N(XVLB-Q%S%E,R,<@4&;3A43-M5SBSXU%+AH%;,"H$&\$3HY^W" $
M2H B-HEBF_$B>D!#W. BSJ $3N B;*$,ABD%"B1%JT[,4H @0J$,%O^C;:$%
M(J %9EL-)'HAP(MVWU'_*L(^-. D7$%G(4'K[F &<&$$X+L@F%D5;<$6<F $
MW!HF7N$!NL<#$$0#4B[W \]V<  .1&$=)1VK4* OS  "1/X@DW-A#]:@C5?
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M3F=RV;K!H0>-Z;=ZO-0SUV8A@)(+#Z$!J%$*(*P1PATW\2%""6Q,P5(F*8Q
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M3FG0C&7 4J/'6"V! 7:P!A;Y5@/1  L3B[D@ 7P0"PT0%&EP 7-@!@] ("I
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M M!$ Q@@0G;@7T&3"VF@ 3R0ZO,A%DH1"_2H 6(7 R(0\G^A!Q!P ]C^%Y"
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M T3: V;+ 4*T!1UH49P8A3* @Q_5%E?+ 8 Q YJXC4B)&!YXDB)MT<N<%5S
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M1/^+A5?(A!8HDGQ% 3K 6H6PVW*S@#.> \#[XA: D7\- 4QY6B/)P>%@#.)
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M\K.]'C3@!.2D: F)C <8KP++"S^Y $@(-86@@+69@1Y(@=NHSUQ A65I$1V
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M\&\=2"U8B  ><(,,H)OBR('^4]@ZV($&: -0( "MYP"O2/[A.D@!%;B-/0@
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M _S!()A  S2 "0 ",5I Z)E !RP"#&S "S0 !#@!Y0U"!WP "R1 !63!ELD
M,W[ ,[X !C3!!&!!!S3  W1 (\1!!SB  \# 9G2 ";A !T1!!<A !3A %,A
M.&+!WYF  S1 !_B!(G0 ";   UP %BR"(!RD [  XL7!!C2  SR!(D"8(C2!
M RP W56"%$S %53",?[!"RR  U0 (/B!.SY $_B=% "D!#S!(_B!!+Q !RS
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M%F0!(YB  4# 199K%$2! 71 )9@  OP!(VR  RP""Q0 /UZ  6A9[%3  ;#
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MQ.3"@@3,(1ZP;0GHP1VTGY;:@0!:( =H @? 6AO,P"U( %7400+@H2UD *Z
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M'IQ 8M@"!3 (#^R )CB'#I@A"KP'#_3 +2# C#C=8VAK(## !B "(Y   1Q
M!# ""Q@ 2OH! K# (U0". *""S# 'RQ"!T1 O2) ')1D 33![ U"!51 (R1M
M ;3C3#X!!@3 2A8 2BX"("0 "U1"%!3 $U2"(>#S(&!  P!"0B^T):#S(SS
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M@ [<1POD[<G,@1E$P"BXP=;E@/XZ"=T*2Z@>S,'\Y@ ;V(%"9 4'N,8:V,4
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MZQF"!53 ( SUT>XT2A+L3_?Z(US[(X!>([Q /#/"'S0C(/@KP?-TN1+"K;$
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M[RC<."<0.&RSA/>NP FX@1Q@!/[U#_@*VQR@8(#WV\&@N2;\>^[I L2M7+E
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M92' @OY1A0J#&$4I$*42"P9_&CGHL$A"A$> $I!8)'U0(PD;%%5P\,?/ A*
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ME0=@>70@-T29HU2!:# CEQ*L;10-5SB(B,>!4* CESM6<(6!@> H0:-/_,0
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MP0K2F*@&]#!I.>#!"C  BS:L<P8^.V<.+C OC!$D8J"@0 IN@ &0@,(">-'
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M/I,K;^#1@O 7X='Z3O 1L"  =OY2/YZQ]G*'Q-P'0K #"PH@0W[ON:9Q]^+
M 1+@ 0K@ YK'/R( /,=KQ9"G$2"@  J  1(  4P$NSJ@ "   2+ #QZC ")@
MAIY ]P"A PB@-UQ  -RC-'KO&Z>1];ZQ]\ Q&:6@0D@,'%7P)S,Q%J\/$T@-
M=4*@3@!E% [@9 8B! HN^B*@*NI@[L+O#IIPN<JF$=, + 1B2J"O"E% 4NJ1
M#4Y@+I>K#<1(!G.A!:PE$YC%7FY-#WXT#THG=;X-W'CS,%; 9]!R#S#@;2 I
M'Y,/%B# =#QM!VT@!&[%+HAD!@X")'SJ 8AT!>J@!5!@!S4 +&?QPP@A,UQ@
MO BA(OX;+,>>( ZRH I #! R@P7@PP!> "6OH.^NX 6<@!!.A#I,( !@PS]H
MK "T!PL8A!$"E &8X[[^X HH"""K(P!@8$(*H"1#J!$(P0(:@!!DH  2  )T
M3 !>P,,ZP %"4!$0U0EP\@DX+,1*S I@P D H1(") KV#E>[BQDK%!9/IQ7Z
M !-ZIC?K*>LT 13JP Y:8<[DH ;60$7L8 ;R8 6L="#FH@1 (A?X22G.H :8
M!1,>;1.>P@YNH S&A ]&(0U.(@)ZX!4V04?@P :X-2=: 1,V 61$P:R$Q1;4
M%<OFH&$&PN;RP'1*+C=KX$=P 3@QP0,B#1?8H : : ] 0?X'>* J-L%SOE4H
M]( 4RN!7&'8K6B%P7H%9[N &ID!'UJ!4<,$6>H "8&T.:D -"J->UX C5&0.
M;$!S@#0C9H&4SB0/8(D/4*5G$<U-=D!DP8T/,F%;L;!H,V*T*F),1"%B<,%-
M<L -; $-;@"K,N$&>$!(D&4@Z.!?<T(3;D '?H4/&*[DY@ L7J$,;&#=FM8,
M; T5=@ 'IM 5^  3?+9S." %X@X4>"0%-J$5@,8B )84=B 'NE G9&5>7*$%
M..#?[" B!C91\D 3G*(&K*78(.<&=D!(9F -VF &UJP59L!-*^T50DXI:F43
MUI;LNI;-=&04SF035N)70&$3^/X@(UR!!VY@S0:"#UKW5_H %&3W*5Z!#SBA
MGHY-%&BB<W! !X3$#I[(#FP!%IKWT6*A#'*@#SC@B63NUC;!#68@_T8A 4PG
M D2A#@+F%2Q&2QB 6J/DN RC9PT%I?RD#&H@8CZV#'  JSXA!W:@Z?1/]K!@
M AQ@ EH#-R0H QHA#@K@ @C ! @O#OC3 9Z /"I@ N#S"A[!!0B 5BU $)QG
M$7ZC$2IA->(@AH;C4K<C"IS@ 9CC\0@A KX#O9(1"V3@#U;H":(@ *) &F5
M *0 "YZ@ QA $*Z A2KA!;J',QCA!0@@51O@#RR  4PQ4\%8C LHBT.D$F"
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M$N"'4N!QC.F:,<&.TL!72B C(OY*%$ @#5C[*9[:#4K  J0.7&P  MK #!Y
MVV !$C3+NNLI40BB5G#! R!A$P+F7%4W%W0@!/@@_C3"V#*@!["I3C* 3HSK
MUC" #M:  VBT_?SP$:1@ +"C"5C(.I[ .!S@"OZ/.K08.^*@ 3+ $$!$!OR
M-2I!BYN Q-"K$AH!!@K //@G$)XKAK"@$ACA =B#$,"X %82- !A48LQ"A@
M @:!5:6 ?!RD$K;'0P"A 2#@"I[@.PUU$;!  .P#"SH "P(D"ZR@ *3 #P3
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M%2*"!N8%%T/AJ03G#EH $GJ@!W!!((P((&C8R;,B5Z@9*V* R(4B3ZY<MC"
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M$,!")8]\8$ <C3!B @. &))%'(0\PD(#Y3)R1:>5$.("JB944 $)E;S;1"6
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M00.X2--WXNDFG+:B!C3 A0;0,(HR#  ZC!'%&$, "Y:,X@X.B(4;$K '5(B
M=A30&D5TT HV8.!*-&A )G9&A_Y63($!KEA#^(#BTB[FH!5MN, M2I"RU(S@
MKG,H* I0&H$YM"('*MI$ TY8 L JY0)I&X4%+),)D?F$(H#%VRP:@Q8$;"(Z
MMZ# 1')@@\E((!=H $$H\@D*.7BD!#= !1ULA 8/C (3#! %#U  "C,0P!9N
M6 $?+/"*Q=W %A88RD/RB8E1C* -HZ!<'19" Q2T0@W'J>Y 5<"0&[2B#AS0
MQ /T\(H<U  5,13.!=R "GOFP@U:P<L/(X +423 .U=+B79&P;HU<" 4F6B
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M:WSXB?RH,/&("(ZR"1U3BO,VBQ"!BHU2D G)* IIBPU9: _Y$+9P V '%'3
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M5[("Q5AWWX$4%*#$>M 6:B>=#P +#A(*-$%%/?!AQ(<WG_Y;RQ2Q K? !@F
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M\6RP!@UP%9K0!H?.%1K0 Y]5!TBO].ZCC!SN,%6;]5R?X<DLH1$0%SLA0Q<
M!T/.4''^%?=9 BL@!R6QW_ !%/YV%ZMQXV90 FZP!G/P0"60>YN "19@]EYA
M"RF@,W60/_^% @ND]Z  "9(=7/X,,86@, 4<@+T5.@H/MQ1H<0-L<*'1L0EF
M4\H/X08UX&-RL 9>$=\UP^9P4 .?@!JMGPD3%!==4;LC*$,8P ,=P0F9;MJP
M@'.U3A$+9&7$F=,IA0FO90>YG/=PD EWL!!  1LER EG,;)XPP8W7 -L0 ,T
MT 96ME:SH--7I-5<S;@J@@&P'B@>(?LG1P,/D,\CT >SOR5M0 <GE -TLC7
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MG,*L[!^-@(:]+4(Q%S:0^YUR5R"8)9,1<VEC!E#FAV-&-S#(@8.&3TH @."
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M$+ #'I .,V" -5B#!AB%3:B\@+J%$L" -D"!##"#*8  7! 9J/* +0&%$GC
M4*  OJ. /(H $6@;"ZP\,[  #;E.-'@ 5$ *DKD -Q D]<$ /> !%5@8CKB8
MXT0!## #,WB 6RB#8ZF\4' B-*  'QND'J  6 "2"]$6-V@!7*  ,\@##O"*
M[1RZ&_Z# #KHP%>8 PC(@5\* 1J A2D( 2R1#C5(@!Y@@PA(EPN(DQ*(@3ZP
M *A0@QGYBAB(BQ7@'0A  121#C<8)!YH@""YA5!( 5/BA ?( 1[E'1[8D!@(
ME%QHBSQ(@P)AL]RYE#IH@,X4(E0X@!P T!18 PTPP$FY37-$ 3U9 SMX $VP
MSES8 PJ  P!U!3A( #1@@P9H$+T;)#2X@%'(4#*Q0+^QB1C@ 5L0@1X8/A4P
M@Q'I@1'8P3D0 3:L@889 1LH 11P,)BT@+Q:&5AI4S= @TRE@_(!A1Q@D!G@
M 5=8 0N8@UY1E_!*@+JD !1@ Q!0F K"A*? @!"()0Y(@_YYB@H*@%+IR($(
M0(,U> "OT%7/J(,(B %0^%*4V28Z<( 5()=<G55>]=464!9;>(!1R .OX0#]
M0Q%82  58(,4D(XN&H@:P ,.\HRRTP,<J(DTR  XJ('!R &#:8$:" HVF(L2
MN %N4H$Y*(%1R8$5T(,00,8' )T5N"<4I#/\8++WF,'S2#C(5(]KLS:""[3N
M> 6OP(5% 06P60,:0 71<84',"UNK0K_R)Y,78.WX!%S6IF<@M U<)<5F ,^
MH "L>I&=R(-PT0 <PHI8R !A00PV.!625#^AB( (LYL+\%D4X)U<2, RR843
M"!@, (6RRH5,L!;Y%)C.X .A'?Z%IU&7/M"EUA"L#+@++@F%O'B4\'2#&+B%
MMZ767(@ F0N%MLJ DL   ($ #CD- \& 3+C-6-$ !CT7<2(:7PR!B"RI"&-5
M"I ,5Q@GN^B0G4",.8 -?;((.D !I\ <!NTAGOV)GHJ!('&,6*#-6 $!4+
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M6Y ;%:F($L@#4;H #]"$5JB25RB!"P"!NWKB*<ZUBI5B71N$/[O8CHTT-M"
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M"-B$/%!^/4  .N@;BQ@!CKB#X04!'N@N"(ESX.@65V"1.8&4!!@%''  -;V
ME_!YRBF\4&Z%9>5QZC:)[5_W"(H _02!4%B# AA[?!T!#5,!6P (!3Q&L:&0
MJ\:.7/X7UK0R<R(7KEPY0K1J)4&4C16MZCRP94.'0H9F4J"B8"N7+0UJ4/4
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M(,:J)T7)76^*14&*Y?QVDC(X# (Y?!@-'("F"YS@%AJ@%40HD =7-*!^:\C
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M J6!!3QG@((+HT4#$, !E4-  ?X')<R>%&-PKT?@"N[HP ,7J%(9;M""#*C
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M'  JV%@+KD'M\0$N< "3T$%FY((&. @'Y%(A\<&-T0 ;P (!H$$KX!YKS '
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M7034 1W,00F< 2SL7S)%P!SP055B0!V$@NJ5(!*F 2?D0 W$ @ID @W, !S
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MZK7I5_X+?%*C+)\MG,%KE8 =U%8NH U/K$ :9$+PN4*U;"H:3($==$D(%.1
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M*T0 +J1!Y/I1.X5$+LP23[3E+HP73^# ?8& AYX =HFNZ8:S.!L"E3;5!>@
M#\R%3M1 #5@GX3[ 9+@! [ -)CCL_=V"&6!@#L$""-# ;&36J>E B3U(#30
M!W" !2 K3X#90C$ !F! !BSC0OY$";!B!-# _4%6^MZ!]:(S*?&P\&E #LQ
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MN.&"O2[@&(<(T& +$=Q@#AH(R@@RT (_(20%+> #"H*2@_X0S $%*X!><^;
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M54F=FXM^Y8">%*"1C0K"&TWT-K"_:2QC3X-M;6_;,LY+B8RDP@D.7* $6,.
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M V*@!=:N(& !!]@/ V[A!MQ@)?J@W&(N.OJ !U["%C(@^7"A#T+ %C# %E:
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M-+<'%DSM##*APR[OZW""OQ[S%4S-#$@M/ 23ES;A ::@&)6# NK %;#0(#!
M$UKA ?: %%+@ 4QJ!42A# [ %@AM$TA!! P%G2Z $UJ! NC@,#N$("P@#6RA
M'PD" S[!'?%S!! P%YI,;72'$R2@!S@!DM8*%AR #W),!T(!DDB& N:@%79
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MUZ))M/ZPTZBC259(!$!Z*$:A!-N8!SK7C:OML$2:VTZZL(*YA-,U)>Z  T+
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M7 78A .2I@1\PB+H( *(PR]*  4HXF[>W"#28 1.@$KJ' 50@ [G8 K8T@U
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M"#26:U *;K3BP:<[Y,'!**#H\<"Z!A%X$+^YJ&%?>W4LQ$E9>Z#@2@24B?)
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MF*$!<, $I&#Q $UXD!.%6P--0& U$' .!.290\8BBX*;UJ !F% !!.;0A@=
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M8&I#!2G/5@<[8 &V, ,H@1ZB<#LIE4L8@ 9VL (0\ F\$?Z L7 '$4 ':X
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MD8GR2]B4"Z' 6K! 'G5P*J.@ S3P,9H@*JX0,D4R"VC0 GIH'1+6"J684E,
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M'A?0"BZ4$E/P +&2!Q=0 R#@*6P  B/@*1/D!K8PO3P0%;Z4$C5P7VM8)"7
M6CD0 Y9R@%W1 K,P*Q8A92F1'V2HK;EP JG6+QG@%=7B!OR\ A3P"25@B!@P
M"S50 OX[,$ZM$ $T$ ,/@"M!70,<$!%YD %F1R-OT<\8$#+MT4E')C &E\L&
MD@."C0')A@(8,"CU40.>=08.  +:10$ZL *#T08AL ,4L)?EO ;50P,H% MG
M\--R@E4K4 (SX'T/>P(U( )140<@4 (U< LMH *!K<*1AT*SL&=_Y %KX0 J
M<(_!70(T< &<< L Y]J_U\T0T%$9L,BZP0<8@ ,@@!(Y4 (@D+P&$0LA, ,1
M: MY8 $VD()PH@,U?=F%>J:!_#Z #)R#'#]G>R1X0#6MDC,8,($9  LE8+@$
ML@84P"9KL%"T1\" 97)KD#$AD =IP /=MRXR17L%#@LHH/ZL=$'A,94 "W4"
M_)LQ=[ 0#Q",IH98!>$&!T:HLJHJ;1$!KE"&!L$#=<!$TXPJ(_ *$7 JFY
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M!P5U%[DP"R<05(.%V2E 6Q=P6\K%FBJ0!GS  (BB%0@"9VSR/61D$&B@,!R
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M! U,H$;D"I%'XBM4Z).H!3O2,/YCDPM T>234'!);XHV<JD+/E!@,4,'ES2
M)3([UEB!DTQ (>45#A(B*9<T:.A+$S0:R$2B/KY"P0Z).! %A3O^0V4-%35P
M)9<\4,!DL1I;0>' $%_A 0>)1JFI(Q7@Z"T'P^"8H8Q-,@DE(8E2H#&7%%;
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MP/(+0;Y[#M-+/Q,\0<3AOKUA@Q>I&RRZ-[YYO 34P*[;KJLHCEBKEV;1C!N
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M %R8 [&XA3S*@989A1#+(W5,T,]3/WC,J$ULT.:0Q^)0S!T@!328@/=X $R
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MT965BS!F#]J0.AB!44 L':@!>XZ+VEB#'*"#)V$QO!BU-;F@3?@<!BN;HO.
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M":"0B)>Q S-@DUR8 P"@$:UY;PJH 4QH1N'0@3L0SRT2ZY_B0N_!'#L@@(B
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M( 44: 4/'C "PM'  T25H$F[&M-TWJ &B/M$[,XP AU$ )D+(04(<I""R*6
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M1>YW4 ;++ZL.#PCR'+)L$AJ4P=&RY !DZI#R(*-A#Y$;!0=F88&QH$(!,F%
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M+KC"!<""%KH"!Z33BN5 !G13T.0"'?38V<Q FGE$"I#" MH! !"2+:@!#HQ
M3#7/0?YD&T+H@!R" AW$0&IP4X8$ST="0"8$Y$&H ,_I0>2@0@_<@"L*H%+
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M6IA$&VC "J!!":R!LZ) !CC.TD7 *-Q T:' )L0"*GO #03-E)W C]H !M#
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M"-+B?&8 ').8!$S$11H(?5N@ ,%]ABM,4F:TP5C62,_'Q2B(^D(<&ES( >*
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M:10A<[5*,T>$"HYS\M1P"',%*(+B9[2Q>#H%4$!9 84=4OH,!1JXXR K2%)
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M4F(-F"03&B<%TB!R^F?%;!+C0F $:  #5BHE=@ $\* [<OY!%"# P@@"!%*
M(]Q@ #C" FSJ%D:@!O!@! BK)Q!@!NR 0-:E#4(K#>R  NS %AZ@!_*@!#+$
M;B@@)'B@)J='!>B#](3E#E)  L**/7"G 5(S!L8C50ABQ_ @!SR )VS  Y83
M62@@*E8Q#^9  T#K MZB#)#EH02I(%&@!T8A!2RL5.Z #C1@/8Y-(NRH!@!1
M!P: .5)"ONY@!^RH!5@K,F%! LS #C!@-]#LCS3"L$X"%^I&(@+@/B=M#\_
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M!EHE)5KA%OJ@M(K4='#A#N[ PFZADL\J%TAA#A(9J":%( Y*M3&!W/P*%_+
M1:LI=OJ LBT,(BX3$SK;)6 !%G;)KTJ !SP;/<*6(#[I%=@#(BJK#XP//<(G
M%#@"HO>9%.B@9?5 -H6BFC N74YYO.M@Y:AI;]%#KQU;\#3#EHY;7JL)L^S@
ME$.!#E[ADX[[DQ2\EK3%)9A&2O"V+T:AY,@#!7( /51[Y:[5#DX/VO[;)2+\
M.%V!EHE*1T!A#L9Y%N@ %!K9=/Z&R%R35DJN53?[PA7H +B 2@4L\M->H9O!
MB@ZL!3TV06V+W!5HI5,?P@Y8SUI@X9-6P")MP72B*L?) \9<QB6>D">TW)Q
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M [Q=0/X.(Z"-&D1#FW".PG9U. %5('"U/#Q T*OI8@I:@8"68"+),\A0*T(
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M^-"N1P "'.3B#/$\ YG6P($2>"!%5*$#YH.9BS5HH 0@^ 1'--#'(=T@#Y#
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M M=A"R/ &L"%!C@P7Q+A=WS7C_Y(+/SX*W3TC\0B+8)'%5P5,;:P">B4$'F
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M, W0!Y@ %2.0 6Q0 ^1! 6S0 P3 @;!@ Q&0!NIV-^*7"Y B>V0"$J(B&3>
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M&PB%;3IS"Q0P"GT5W+1R&[80S4/$ SN@&JR!?+#0 B?&&:/0 [@4N3?55V@
M"G,P Z<V$=T^BFZP ]XL$:0@*QAA);04OEXG$13P"C0P=ULD DW, =+Q &YQ
M"R\&.!)Q TC(.1BY.,;1C$+'&J!0IZ%PVAH "G4 AS>0!IC@<9#@*;2!T[G
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M:U$*]WG 8JJ!RW"%$W"?&E@!#$@@V00!-)B%$8  %4B9L0(!]&B!'1C-*+F
M""@##MS!$RBBD1 D^9B%%A@!#OX8B5[,A3*(B1D0S0LPLQ42NOA@"QO  !1P
M&1H8 1!XC1RH$CO@@#J["A[(@18(*M"X P_(,%+8A.9TLUR A1/X2U08@1PH
M 0H8B5F8@?;<M$W   @H@SG0@14HE!L0N@2J@QFX@0PH 9>I@=MJ$#?PFC4
M+?6D PBP #K(@P;) _X4@:OH@1N( 03*!5=  10  3-S@Q<J"S3P !"( ;M
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M@ED!,]L(/CT(D++$EKRF!\ S4&@ 4L"$:<& 5G"#!\B(#+ #3"#&F;6#5X
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MKKJZ !LX/YOE888:'AL8"3ISEF^MG(XCUW(]!$00U[+3M2KN$->+$!UPKDT
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MJ*LNN8PI>C"N%B!KG (?G?+I5A*0R( ]H)D3U 0(V,R7]?XJ;J&#&!@)37B
MYPW0%>AO*U)-5,B7[-G,W]  /!$%K7#97.@#-2$C)<D7:'SU+#$G4ON$"$@2
M_Z69L%4<"GB%"#]5-W"O3IF#&LB#30C%8,(%OUH-]*MK\XD 7("#;?Z3,L$%
ME2Q-K= LG@%U-G@E-$BZ$NBJ['UG6(KSQBD!.,@#&X#6NC00+32+]1H>8(F
M6Y@!*QH!2+B Z**/V)4/,W@EL\@,+,. 4;"#4*2Q4<"E7)"#%](F;^X#.MCH
MX:&!A;D FEB!.GAJE8 #47 N. "G,*&#B>$!+),B=5E\.[#I,\!;I=@$@R6A
MTK19 >E]&'H%%.@!6,@#!<"K.OX8 >*<D[+@ T[!%^AYZD@MBSMX %PX <3@
M<#2>C\WW[QI(@S9(K]>A@9!9G 12"A"(KHYA[9F\C"H%?&=1 U08_%,KBS,X
M_Y['&SP B BY<J#(E8M'C39Z#%+0! E$+CL7#.;@D8M#IERV--C2$R+7*!"C
M&MS*E0<BB#RY<!ELZ=*@(4.(8M*L:?,FSIPZ;3;:Z?-GS9Y AQ(M:O2FHY<N
M;850P8,#AUP@%D(8E0O3Q%<48+WB0..&!5>;(-BXT8#3FA6Y[C1 TQ+5 QJN
M0-B8$@,#)@VM#+8: 8*'WE<:9MR0H"G7"+TT./  8286!:NY,E'HT:/$B%88
M]H*:>/Z'0HX:"^88A,6AAET*FPQB@H C!P97<R+8F!%A5HL+.FA@L#7V!FQ2
ML"#,> 6B1H\9%R!IL!IJ(I\$:3)IR$5C1(\<$>RT6+-R<H0<+4"(NI#13(F-
M(G:4* @' X\=&GJ@H6%PQII0#X!C0)5"CG4B\& !:260EHL&F+14PWH6 +A&
M02UIU<(K&(@"$@6Y;!(!#BWHE4M)D"2P1AHS&#0'?(#M4*)!-J Q"@0U[' !
M*FZD0 H%._2 @@:PK-& 'FVH54,(,[J1"PI'7I1)#R%D%\$<=8SPW2PAM) #
M!:+<<0$/3^4P6PTZ1(!'+B',, 4-%/ ! @@[I##E&C/$ OY!+BMXI\(%H^"7
M2PT<Z("!&;: @ (/&2B9RV9PI$#1#AKE0L<%.XQ@WQHJ4*3#0']=X%T.?V'@
M70P]9,H#!FSD,DL*C'&@("X16(3>=WQ@\)T; ;3RB4"8(, F!P_0<9%W)7'@
MUDHGK%!&#1%D@H,9?#RP0Y^VC(+!#8N]TE(&"IZA%BP6S%(&8UBJP4EX.#Q0
M1BXZ:+ #?""N!8$.T9H!6@H3B8D##A&TXFR\',P"2@,Y3*M##ROD"8*"L5CP
M2B@-Z#"M+2FH@&P$?)1PAU(9'[4QQQWC))3'1X$<\E%)96S0+7+,\0HHN8 "
M2RZ<V*+1)RM]4I(M<[@!<RZAN/XQRBBVN'+A9*NU% H?N< B1]*8C (*2[8D
MS=!>.;?!,RQYS)S'&BKAL@(G+8GB1LU\V (*SBWG\HD:GXSB2DNPS-'T7GRU
MP4;=F,#!\"VAP(('&SR[TL8:=8N2]"QP[#'9TS.?;5 FF]@2]EITX"(*)V^[
MY H;I,%B]&2P@  *'+]"#H<KMO31BF2C[#4X&ZBX?&TN>ZRA-BBT@S)S2WS<
M;M#0+XW"QRV[@PAU+JVT<:!+FFSR"M&3N9$Z'ZP;Y'HNK[BQAE4L@^3&:F;G
MP@<IT!OD>\VYB*+[UG/80LHFL(3B$BYUX&V0)FZ08@LF:]P "AK4EC.5:"(4
MHWC%'/[F4!+KK484<+.%UC0WOC6 K@YJR$A+.($+\^6"%'4S""C6L)!<N&)^
MN4"%9/I P=ZM$"1UZX,:C#9"1!F- C5#A=J4ED,-X<(W&LD$'_C0!]W!S2"A
MB-X -?0VJXAB#3LKC1ODP#L0SJP5\\/%)UC"ASG,HA4*&L4:,&&]JZCA,"X!
MXQ/'-P=8M.R OJL;&GD&BCZ0$ X*X@,;9X;%DH "$SZ\!1TPM@E1A"(6)WM)
M448&%$62K)% F0E1&.E(FDAR)XY@R2$SJ<E-<E(I+2A!&3S0J$Z>R@ZD/"4J
M4ZG*4]J" A]<)2QC*<M9TO)DE:HE+G.9,99TJ@PE:(%)-/X0 UT2LYC&/&8N
M)DE)93*SF<XDV24SB<E33G.5U7P)']J@H)9<DWZ;["8W=WFR:H+S)>5,Y3G#
MJ11<9$*/WI3F.#F93GEV<I[?,><W-6G/=2:O9=?LYC[Q^4YJYE.=XFQ))MJP
M.)<I$)D#?:@J_\G/@QY2HA-UZ#,SJM&-ZJ22/X&D30:Q"(>2M*0F/2E*4ZK2
ME;*TI2Y]*4PWR5&-*A*D,[UIR0(:TWOR=*<^_2E0@RK4E>ITJ$8]YE \BM.E
M&L6F3,6)R8XJU:E2M:I6O2I6LXK4I^K$J5S]ZB1%6E"#6G2@_YSF-6&Q MKA
MXIJA"-LF&E56B (4%S5X93Q7@OZ)61BDK0*%J#HU82*#HFQ!L8"#&=PUUW66
MTZ^$[2M=\:D)8!*VL7^E*&2YR1(TF#*RERTL2$!WS4^T *V8Y>EBP9E.EF!2
M8#VM;#5OT8(KWM.BCLWK8S_;T[I2I&:JS6U+U( QWHUB!>[\[%D-<H<<:,0&
M+2@N[P!Z6G).9I2D5*HSO0K6[=)$NQZ+9E!MT0:^*J4D:1AF'J*BRPB0XI01
M*&(M1W$H349@%)D@$U5;,=^6KL M18WG'$KP6KL=]0([I*8;\%I5#$PMHKEH
M ;&@6!)9;H(TF*# *U[1A@GG,@_5.25W&XG=$#,5$8=LA28T<8,#8<(5X+M*
M#LY@2/Z7Y: -FPA;]=  ,SKDP'2V0(,.II8)'9R!9_B;3"C6D(/VLF04*@!!
M'_B @DRLN"5VN('IWM(#'L@N>V?0 1U5UXHTH ($06R)UER"BBVWS X4,,->
M]$!D\O+!!G?(Q(5LH>1MLF84;<C!A3['N#^;\!9KP $D#((!UXUB%IC8! Z8
MMUSFM>06?1C%%,H ,U @C32M*(,.!%B&'G B:9EHA1USH8D<H(&\=LB!&Q98
MAAVL9A9AZT,HRJ!I@_3A!G8H8*77H .5K.302>-#ES$Q/SS@ $!7:84<$LT'
M'9CA6C-0@TOZD ,S\ P2OM9$RV[!AAPL[A6/AC4)%R/('?Z4 ;X^S 0HW)"#
M'=HB#3D8(1]<H8:]_+G!<X U2V[Q9_SV]<^=%=\KIJ8''*R!)68V0P^,K!%[
M$QL4['ZE)G QBDWD 0>N&$4.ZJ ^CM^ =3KX52P6"HJ,X!KBM.,#PSGLDCWD
M8 TS$\4F^% #8L/"##D '1Q";A S*\WG&(S(#?C08CSB3VTLJ<$:[%"#U?@P
M%V[0@<AC@6L=I&'"H6 W[6)A=!+NS@8:T$/5^9"#-,SL%D$7>?,N#A)-],$&
M^&W%#M1@!P&#.,0CONG?2;P3190S.BY:%V(TD()/;*D-ZK)%*")PAA\Q-P(C
MF($M>( ".H"R3CFP@P3HT!D[ /Z&=["(0"Q04*H:],8@G!A!!NB0B0=P/0)M
M2-?F42"J)F> #6O0RRTN4 8[:$ 3MZ" "&B "@_P@0*RR\0%IC@+#K!!#A#8
MA!L>4 /Y7L ..E#+'"BPABD0@#0G^)(&,%82%%#@#&6 0"N@CZ0W]R "\T/!
MESB ,0R;X0:C.$ .J$$$I,%!&$@*6)=!M)((E @'X,(:0$"2M(+PK8&:2 4-
ML$$(",0*9$ * !$&S $/3 D<@  >J(!Q>4 :S,$#@,(F9$@$E, :M$=$B%\9
M',#M/1T-V $&$" *8)D&\ $/V,!*6$ HJ($(T,$*X$"=8$ *8$(=4( =],"B
MQ "VE?Z$'%# '>S(6HB?&2" =Z3 BG& '9 " MS &D@ &K1""6! &X!"!M3!
MO-!."^;"#(B?=O",+7! #N !!RP.!H# "K3"#-3 '(# D=C ".3!"HC*#<3
M'6@ NI2$>#QB8JG&^ @$&FB D @8!\ @"O"=1H  #J07'[S"!= !&KA22U
M*=A! GP9!=  &C@ '^1! IB!#L0B&CQ 'K0"!91$&13$!8C &J3 1Z2!!KC!
M=4R10?R>,GX$'21 &:0!+6Z$#K !!)A2"Z2 &X0 IJR*-;+!!9"&&6B D@T
M**C &1B$!A";0>S FZ7! VQ"*] )#ZR '7! &<1" Z1 &OZ4P*)H @8@%@C8
M0A[F #;R@92\P@J('R@(1!NPX0QX0"Y(X1V  *:4A!Y$0!V@P4>X8@]08QY
M!@^@009$""D)GDKZA'=M3$MVS$Q$E3?U0024A"M @"V<@$7DP@68D0I<W4[N
M ',]0-)T!DO$0@28QI' PBCH(,Q(3FEP@"V@P.TA2KCE AO4P/A,!%86!P5$
MC2I:1V+E@E#:PD*I@*GP(D/$0@VX10Z@2X9UT0.$#?9@P+4PW29@ "YPP-2$
M0![PP4?D0A]D0$OH7HOP "A A&'FP@WT & :!"1$Q06\PAKPP"AD2"[,P0K
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M"O &:63 M=A";$#"1VB !VF XCT*!5P #MC"+6! R[2"#:Q "X0 LXY"2=B
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M"IB*AIB9>C5?G9"&+5S )G0J+,!"GN4!!&@"S(P""NB *$ $RHY"=8@ W(6
M&N-">[E"&8Q &RQ*$K<7#YS!<WDQMIIP"QR(/B8Q1&#O=V3RK"+&@83 '-R!
M@"5Q*VR"B=[!"5B=6HP"2VR"!9@I)T3%#"@)V1I$'E! RZ!!8D6H&ZPRMNYF
M!C^HI5R(*Z!!@8)(]Z2!!9RL560""#Q'2]3!^+9,X?+,'D1 RZR!&:3.VEQ
M55Y$*\P!,.7AA:R((FJ$VAY$M:E7&G3N:KQ""$#?A,W &?[@0AV_#V;F0@RL
M::#R0!KPP!1<CQ[< =;2T B  L'PQ<(8&$,DC4"OP('5P%CN75=(2_:L 0:$
M @D;A ?T02(&;AWG@*B<4![<P:+<P9N*1/09Q!A:!2RT003P3@G@ ,R *YL:
MA!F8P13LY!X<="=M#/_V+U&3C$A)EZ[,@2OPP! 3VPVD0"M @C:[ @7H0!FX
MB@##S<D6V1R$P"M B7BAP.^UPK[R' 7,P@B8$BY<0*WF C**@H :!!LL"@=P
M&QUX ._H8"@T;Q[,@51R @24P?'MQ2W87RZL 0-@C$MLPCS: @-'@!NT4A[
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M2$#0T/ZPNS@?%<^"!;3,#9B!'11$*[5,1> "458W,,EQ]G1F"]3 *VPW7JU
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M!)X" P3" 3XA%\X@ ''@>D3A 30' PKC D( !33!%3! !]C WG(! U!@#6C
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MM[+#)7!@9S:AOT!!XF[@+?/ QQ:B!"[ H2@@!6YA8^H*6C;A :8C%%#!%2"
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M1/+ R7EPPU\.ZH)^0A15)1=N(*S$!PY$X2GM !/TAB?6@(90P [08 YF8!1
MP A?80U*% V\C3YO 1?<H"QQ@0)( 10H$Q-\# 7J "5 H?X.3P#2=@AB8F *
M8L(EEJNYXC(7PE.!V$ ^+P 48H:&<*$$X%0A: "E-@$#GF[TWJP%#(0G4 ($
M<& &F7$4-.$!9J %6B!2688",* XP(<&5B &/$ _T  %:N "KFM;%2($\FLA
ME#$I,D O7,(-0&<*3@!7&8(WVVH46+ %PJL%I@54R<W'5"!=6^!W8H -6",I
M<&$.G"8#N#47ZH E)!!F)P<%Y. D9^!?.8 .ZN!Z8N9Z[  $?$*_E"4F($$4
M-J$U7&(.4, 5ZBL'\I0LZA-T<$$'/H8L1H$_[:-DMK85:"8%[+4$;@#^<C8&
MJL7!)LX"-HT&U(L&]LT!RA9C4?XBXBSN*1) %%I <'B" ZYB#5+ !C!@9S)
M-6$&%UXA ]HD:7'!)>Y ;W;@KW21%ZU5XFS@8S1 +/2G\UJ@!&H@67]O(6XJ
M!5!C;_N@/%]17VW@D/@ ;$O@>FS #%!"/8\#=G&- FQA!U#J8,Y@<7.A@$ A
M+D$@$T@S!EK ;-F 9=NJ!(CN:5# !C0 I?BV7<UG3O4&:I/">B7 %7#!%23@
M%AJTK;0E%'Q,!%BL#_X5!?KS O0":FU!8A:W#^(R;A0B/OX$5V;,FAY/FSHE
MQ3;##.Y48?B@5,6G#D1! A9"!T;(#6B !A1M!^3S%D*##6YU)C.@D&H <FDF
M6,TU%_Y&3GPD51,L0"ZIC&]S80:<0BC8EH,SX.D.LTI'R *D8@ZN%"J3PB6V
MDH,QP"6,\<?L0H$^]=%V\PKWBR=0!160%01Z #!M08$<1 =$P-4J+1?4ERJ'
M*A9PHC@5(@,VCTP'(DH10"IB(D 5H@?B4@6F(!=F 1=<C0]4H')^C+D4:%-:
M8 U>X;D\J(,NX(_8X'HP0%GL8-)2  Y@ 0)B@8EG00Z&]#PD<G(68@5*5"$:
MH X&.2;0 +G4ABV*@V9 P6G-8E%;X@+VTVF<UG2<=F4N0 ]P88E=X<9>X19N
MX16$ZQ5(+H6UDLZ*=%=;<"$TP8 7@@+R0 ?R5"$D8!320/X#-J4,$D(##"@&
MF"L74.&2[4,M[?!W>"!A= *"7>X$O*T&4$H#SJY\;D&525,N^* P1@!1-+&7
M0:%^.H4G0B$%W,(E,,$!E$43G,8&@GG!,/E^^G0'@CDR%^("E,7#G.85(@ 5
M% B6[V"#W/0J>"(-,"!8T"!/2;AW(<8E\D!O/)DM/H:(<H$$JY2S%$(&<8L_
M]P@2<>$36,(6,&!3@)DDR8,./*"DJX)290PH<=H0]->9KR94(J .:A5TJ#2W
M>G<'C/0>&R0"Y),/$, I)NP5.%)L"% /(F *IJ")'.P6GO$QJTSB6N "/J%]
MBB,E4:$."N J8B %0,4E6N!C,/X!QZI"!UZA#QZ@,)"Z#38(7V."!E" %!K3
M)1HS%_8@ N(L!V!SI)WZQY!"!'( %C:A9.8 6-$E84:@L1^;%&H@!ORH 7I
M_)",#QK5%52@@R" JAH5*]R L$,A!P8 07NW!>R@#FJ@ 91EL O;VVYA!+0+
MM O;+5 @(3CW%2Y1BE%@%-(2)PJ3'ZL"-4H@=3E!;<?E=.S'%QM-8VO@R%"
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M(+[04: '^  %6D$'7*X-/* $TO[@!B3LY:DO%^"@BV&B!I*C!'B@KM9 /VX
MC',A"4/ />,B!Z@E._3 7JQU!!X^/,0-+-YE!3ZU##AW#UJ #P8T!T!@T]D"
M&,-KJ]A 4I,,\5M'(41A!$#%%G#@73XXW<V V!<"%FP !79@[)/NNW1-EW$@
M%]P@%VN^A,M-X9LF!!S?QD8@V2",!O2 !G!B#4  &B=4\$5 4FN_3OF@TH?)
MF;8(1'8:*"3$,+Z#!^P" VL-*):^K?QC^YW#_!VB,1!Q,M"?/4B,^U6#(23@
MI\ZB_17#_O<C,Q1*!_!_5-B_HP BE\"!! GB*H@PH<*!!PG>6IC+%D2)$'/1
MT!%Q8/X-C!05=E38D.!'@Q5++AQI$N'#A89:NGP),Z;,F2\;T;R)$Q'.G3QG
MVNP)-.A-1RF+&ETXBD8)$69*'N1A!^31J52I-@Q9U2A6A%NS(ISQR6O1KF++
M#H3URJS47"O'BB6KUFJN-6L8YE)3-Z[>O66%^OT+.+!@F3\'"QZTB*]:N(H;
M.WX,.;+DR90K6[Z,.?- PYQA%NX,.K1HF(X8:SZ-NB+9JPYSF?;:-K7LV;1K
MV[[M=;3NW;QUZ^2)^#7NX<2+&S^./+GRV7\_]\;I7'3TYZ")Z@6%1SCE6WE
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M2FP"84">0*^4*I"J H$2P:VYO/Z25D$?83"E0+8 Z^RB,6"T209 ?O0L26M
MD"PF!8AB2P02#K1) @ZB"0)"OQ9$JD@"DCG0+!$X*A *Z0YD2T/"5@3K0*10
MH*NRR3I;:AT<1#L0M,>.-$,:N2"8ZD>P0+N@#8I&I'"P@QZ40PYF:E+# '3D
M HH#?.!BQP,+GM%"*Z-P@LL=)>2B@ANYQ !C0JULG$O'!>4PZ4&XC(MOPLJ6
MF@<&E2XM&:>@#=+(IIN^Y*G3G4'M7' *;3)#&5C.(= =((PP@G=N[$!#"YM<
M(,$,N8A2P@@>T&C+#&M<H(D9.;1 P1P]W+E@'R&D  (>)*<)@@4PVD)#""#D
M\% H9/Z#$-5 .CR@@1VXX%#""3-(!+<(',!Q"PH0E(U+#2* <,-#/*0APA0#
M\8 YG6B 8&1Z/* Q@NP'S0&!!6B @D$/(%!@>"YHA##""L;F$D%4%.4AZP/]
MYM)"T _=T@ F ]VR0PDHM.#J%$!CH *2<]S)0P;D_7Y!0=Z)TC %KK2"@N,.
MWY*"*+G @@);Y*$&.>! !KPGD%BDX $@& 4/1I:+&N@A%S/H 0HHP .!K,$#
MS&M%*#1 @1;$8@;DZ</8.  C4:R@#"&@ )UB5(,6V  #*' 5_D8 @A_E@@<C
M0,$*T@**$'# !B,X0R[< (+\?2E8*?!34^P0@0OL8"![0/X#!L"6 [<)I 1&
MI $=.-&K--P@%SU8 RA:H+,F>D!1>*  !3QVD#Q$$2-U&!P(RF0&,Z1 3';R
M0 Y4$)8VC T%KQ@%""*@@H$Q;9%ZL9I,JF:(J;6D$8. 6DPHZ4C!0%*2D:SD
M9[26D$T,  ZVZ,,"7#&*"RPH#^E: P+JT(I;I&$$HLH &]X6 ?L\0 6;P$7^
M8,&' =3!%B/(( I@A FE;8( >;C%&I1&@Q78(A8<L)D&[@ D#(P+%IFS!1]0
ME0L1@"T#:\!%*!X "E!0(!2WN($T;5&"*:H@E\:"10:&.0<++*@,Z5H!!/A@
MK%G$( >S $4"[G +-\2O#O<J@_X-8M2*!Q#-5Q(H00M:4 *P84"' _% 71X"
MB9GE @6W5 $'1.5"5SA $[A8 P&\\Y <K&!8=LA#)H9&@!V XA8@: HJ*(!-
M"(3%%1"(A1T*T(=;M($"'?D$!<)2@KR  &P1&)$H3LD'"4"(!RC !1R>E L*
M9 (6#[ /)B#0"E<08 ZVF ,%"%(##X@* S0*@<UL@0%1!%$@*5!#+C* !EQD
M(@&W1*?RC-B0$,BN%1=@:PUJ\+R1VFP$#I.(#MQV@232T!;$XP,'--$"4KRG
M(")0DRLV:@L;T,!8ML@B+&SAI5S 802YN$$#\H"L?^)B#]_*1 8DLH:9TD$#
MUV.D<?[%$LE,!B9JG%0N=9@+$P\EY""^'<@([-"&:\YA#@=XQ1I2,! XS(P/
M2A.(&=P6@2^AX$>BP,!#RA"T3<RA!LHL[R<P8 L*^"\BK]@$!.P !SDZJB$<
M*-/_\K!4.X3BK:^:!6-O<0L)[%<3;TV!PPJB >^-P&8"B< K9D O@E@L%YHH
M;R@LD(L4M, .<S!# R@2T8D>BP)F@(,;UE F#7"XHWD1""P0?(&ZJ."6V(/#
M', KD N\+Q<X0*-L.0""!,!B%!$X""<8/!?P7L [KJ# +.8 SEQ8 (% NH"K
M4I"7$8R,5P+1 "A '*M<Y"$$20[%'&9VD!2P 186. AC)?[RD!C0RP9H>,4#
MYB '.UP@@Z_(@QLPP 971& @+5!4_H9'D%!,6B!NH*T./&:0$OQH!'61" ]B
M,)<O:<"(>9@!'^9PAB-;.$::7@D<Z,R#,;:E!V-T#2;@H(*9$5 @=KA7+D
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M 5PU K@ <"/@"E>6 S>P90;H,%A1C[ 0 BW  WUC@(XB<\K# '!0CBI79;$
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M/T#F!6'? T$)/C#CN5 (/E (IP $72 0@W[A!Z'D!;X%0/Y@"8(N!&#P Y,
MX3X0"9/@ Q<>!INN'EJ^"K4@!%H0WD6@!#1.Z'>NZJN^')8 !'L^$+I@W[4@
M$$.^!;A "YT>"89^Z[F>ZM4]!D!0"+@@"TYN"KF@!$AP"D* Z!&!!$I !4EP
M$%H@! Q>W8U."V9>ZFM^$)'@ V+0N*PN[N..&GE.!G=KW^!M"4) !#CNX[1
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M$Q$   /:"$(W ""5EDQ +'*1@_Y"JM$".&R2!^YH"P1<0")V4, IT[8#2B8
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MP)]) 8($+!* K=   AKP #WD0@,<4 $]W9"  YQ  AP@R!H4,,\<Y,(&"(!
M5(>' 0<<, 8 @$0F$@#F>F, !+E0P\(1X'!R*T#=91!Y QR@@5RT@0$-0$ .
MH-N %0@]%RUH  4(\.=(T8  #D@ TWFP@!7X,P:YV(.^'R  "><B!+U$ "XR
M(0&&A^ 5>1" &W(Q![B^@@,(2( &CJ<)"@P@ R)(P!XAY0:/)P %N."#OB$P
M !#@5KSD'<@9 ##N'"+@U)D(@ U:<8#1#X"MD"H!!4I02$Z^(@0>9T >,#&
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M#,B#&IC'\ H SH.46(P@4%" "U@#- "!>6P%!,  J/2 .;H4% B ',@$$!
M5.@##3 R"  !,,R 3!N 5ZB! ."#4;B !L %+P,@L6N%47@ $,@N4(BP4+ %
M"H  4<@$ CB!^S/) Q*%",C+ERR '<@#!YBS&8 T6)@ .(,42_LS@:&#!"2
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M+0$ E<>1P@5=:( [@H( >, ?30%8:(!#;06OPP ;(#(TF 'I@X4S"("[ H4
M@ )B?"-<H "T'('B0R _$X@38(!;H $]:H :N(4&^"0:@"I0>( .E#D!R"X)
MK $-$( \V(0O[8,:A1OQ.J7GR@4:9<H%J#4%>( =P 50N%:&>P =L)02<( "
MF['@P80R4(%>I=8!  4.O(4'.#5';8,  *"92R8(.+7AB0"6(SVF2\X$@(45
M. #^RH4($ %:98#]&8$(X%0*F/X!&H   N"A&<.OYX(%:@R %:B#.8"#X\&
M!G PN(&O.U@A-[@!#AB .0B% .BH-*C7;(0 5Y" 0XTF3-BV3,(F6(BFUU&#
M2LT%"H L6RA+#PS8^WN^"SA4'4  [X$;*WR=@?(>6XJY2>$ !H@MN(D%X6H
M#'"##X( 'QS''+"!&A@F&UV#%?BY2QD%.?@N.R@]@:#1_+RT<JRS2^&] %!
M";B N[3/7$@#H_2H'%@ &T DBQB<#E" +" $0*BB..C5*]C#+*@$#.B #MB
M2GB"#ZT$1*B "HB#!'@!2SC1)TC11&"$%LV7%VW1>EF$A.@#.[)3 %"#7("#
M!$C43?YPLQ!H _+A10ZX@/T1A5Z5 QKU(7R#TH/H@0'8(VP"H/2"A2DM S8
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MT( #R@$&^(1[DTB!*,H(\J2K%8A7^,OI#8 Z$(66S852S01< ($( &3(BCH
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M'>?F@0@%!YB\@RB!?*WW.((J% B!#"!" (C25Q@HKHZD40"!C_Y RNJ!!*"
M([N 4]L$#9B^$?">%!CW@B@#WXM)F7U)JL>H T" !RA9@N"!!H"E$2"E.G"
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MLH8T'$03,RC!&@ZB@0S,4P=% 04/HH:)%HB !T7)0P 2H,)</" $JN&#;WH
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M@H2L8=HI@"N=.4" ".@"% @(@0X( ,2#M (!$"# "EZ!  J<X0&K+C,%-$"
M"=B"#P&X@ H6$ "*9F ".XC !5:RU@",@ 8 R($M2L" "ZPX%QEX@'(T\(!I
MHA1.N/   F:Q@P#P5Z, X$0/ )#RS7Z"!Q;@! +R((),R"9!F @I0EK1 !YD
M(@<8"-XU5R#0'I1 (3&8P2OLP(%<D(( /( $""Z0ASF<,)!SV$0+3*>&)O?
M=.?%!-9'H0D,Y-1I<!@Z#1Z@!TQ H ZYX( .-E&&".#"#HS4+D)"T*0+]" 3
M.D! )OYP 5]4]#07;N" *_1@XH240'X[6H,%VK"&RS< 3BHH@>71P)J$C.(H
M*: M!^0P@Q"L./0(2<&[*P>".J @!.G#!09R-YZ8PB("KLD]C@YR!PKP01,<
M,(,M3IF'U-2@!)F 0P+D=TP[Y#9Z?7@@'2+0ASQ<0)-YR, F0/'Z7&@ !'VP
M P-&T0I@AN\! ^3F <'L_@*64R&<0.,9() !4#R MLN.2@0XJK)<I  "1,4<
M$!\(, #_<11"W$$ U $G $ ,\$$FK%^?[8&Z+4 /P,$#,(!;+,!8_1I"V  %
MU, >@  F.)#\C,<F!( LX0+#Y<(:/%%"V-#,O (?B,(H+/Z1+IA! .B +MC"
M!#!2+H#  \5  F!"*[P  .0$ .#2<X2" %P>!%P *$0 V@PA=-Q0+J!" UP3
M*!" #=B" GS;")1?+ER ,R5$"F14''50+M3  )!"#1P )KC"# # 3;@"!$R
MX,0"'X0"*I3  < "&@1 ^MB  (Q"#2# 7/!  (#"'=P0=#$A0MP"!:R:&P)
M*Y " %Q/25# RB"$""3 *Z "'V#"*6+"47@? *!!+M#   @.+I0! /2!#@P
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M@ .$ /Z.8,0(Y&,.;,( -!H3'H2SX<(9! ",C8? -<DKV( $@  &), NE$$
M",XK, #:Y((*/( MA, #J$P(8  G[)"P.<D%H$ )Z  (Z$ "I(\'9!0F!$"3
MM,+9Y$)QWH M),"W#:%$@  %C,=!E,#'Q5$ 1 T/"  HG  76@ (:$!+,4#_
MP$(.@!&6#.*CY>( C,(*G% NR,$=F@$!<(YWMB)#,$"$L0$M@@( 9-S<42?X
M9903#<   $ !S(6DN1)"Z #*(<0-W.$LPM@-,.@F90 F-, <,%^ ) G<(:,%
MG 8H+&.2*:@'0(#\),0BT0 /8( MH,(%\(0.R-(M7( HM/Y /TF$!FA"'9P
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MFK2""!R \N =)R0 !<2  9!$*!   4S!)O;/06 " #P +GQ0_EP  N!"*!R
MU,$""!TG +3 +& ;HB+ :5S  MA%#0# ./(  ,#)9HF"*"C V"0 !QQ%%#59
MGZ'5 P2 *\QK+FQ61=C  */  4#"+7   L0 !22 3C#C"*W1"RUQC$(,!@P
M""!  R22;E   #0  U1Q1=BA!D3  ,@=+DB<!D#  !0C*$1L+EA #+3 T%WR
M^O'248@"=89" S3ETX% "O !'#P>2%! &_"!#1BAS_&$#9 -XA*%+_)!Q)EI
M \#!'#P V4# N4I XYR/X(S'VOYU%%_.<"X,$Q_<  ;@PAP,G1I$@!VL 0',
M# :L$PX<G#>W !_HP-Q"<![L 09T1DGPP .4@1N4  5L1!D\W4'< @,T#@CT
MIT4P0 GT #3)73.Y@1YXP-$D $-#DU4>Q-K=P36>5"CP\QUH  [DC ,\LP,P
M);S.41Y80)/L 1IJK@?HP1H<0)!9@-R5V(K>CS/5P0/@P35>DRK! ?:UX@4P
MY07<@;2%%PHDP/K%+_V*DU,'"P.UBQG(W2B4 9JT@8,Y#PZYP1I(!"C<0 JL
M00P!#QLL$RB40=1P@@V4P Z\+D+8W4T4E@IXM=U0%3+B$$CD0 ITI&7, >NA
M"224@?YR(40>0%7PB#4?F,$L]$$9/$0[\<%&?.E!@ (.I$ :'(5A?\_?*,0M
MH$'ZH$(99) ;I,%XZ %4X4(,]X09Y,$M4+7BQ9?B"=LKH($.P (FE$$I$694
MB,)>GP%SS,(91!DNP($*I(%BWW89T =AOL(FY$%%[&!EQ *$Y<"TY@(DT "4
M(41HMS!(F,$*S)"QK,L:H $:F,$9F(%6P,$*U$#*(00<M$![PZU5CL+2S<4=
MX-(TJH%UL$%3- DHI$_QK< ,<%$0 1DH4*DMU#4?1 X;E-(HX, *+%,>U*@>
M=$8;Y(8;S 4HY #.C,<G*%4>/)*(K[8*[ !/K!="K,$*V/Y!'41-*^2 "EP=
MCMA"&1C=5<Q!"[2 52I$'F1W&5Q%)N"MBN/('+BW0L1"&DR!#O! #I3J)M#
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MJC;0@ I00($+N':$)XG*"-=&NOXV2.L\F4 #!'X28"""@@X(%(4.2G-#'N7
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A)YJB*]JB+QJC,UJC-YJC.]JC/QJD0UJD1YJD#20@   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>comp_0021.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0021.gif
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MZ/#O[^/N]NCO]_#O\.SS^>?P]_3T]/?Y_/____3W^0
M
M
M
M
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MIR6*$?X98GZ%^H.&&GV%^G\]4*B*>J@_2(6(RJB.FJB5RB0 ,B&/NBB-FB$
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MQ-F9?/Y^K)>!S,<3P;O$NPB-4,=U?,)>/ @=',1SG B)7 B)X,@FC,>8G,=
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MW*"  Q* EC"! S4P'1$@"K@0"D.M'9X@ ><1 G,@';8@ 3)='6;0 A.1WZ;
M';E  <0\ 7K=WW3I" I ![9P"WVPX-,Q"Q"PS-D! C^MRM@"$V?@W[<) N#-
M"A&0(J 0WX>EPZRKV KP!XU0"!WPS8T@"#'0 2[P!U)K!2;0 3'@R(D !29@
M E;0"(#P E;@!$[P!R_P!T$.!4W0 4V@"%5@ 0]  G%@Y%<0SDW0V*0-XTX
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M"S@#/CB!L.@,![HE]N$ /8"#",@@"LB!/"@!Z+B#]R.WB*$/(G. '= #-X"
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M@K0MB2=H791X B=!22Y@(B9&"2:ZFN(="2M0X.NLFYH)7R[XG=&)@AZP8J!
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M49IFB>%D+N D0M 0E$5$*& /'8@*:#Z)+5QC$HI)%XZD&6YA 2I)".P1]\@
M#6! "RP;"HA "'C00. !#I0E!WB9I8A "P#,+>" <O9$#;R!!@B=+=  !ZP
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M'="!'OXL5N6X@2$-AR><KA[4 1LL@'>!!![(ZP<]!08(2"=QAPRH4 O@S7"
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M'^# '3#H4Y0 'N"))F3 !N4<IV3"+KNP$ZTQ0DP6+K^/]W+/0@3&*SC"!=1
M'<S(<)A%'+%"P,H*5D3!IKQ!B%*R]HTTQ4#$!(A"[W7";Z" X9S!&N1!5<I
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M0Y;J]+8PVU%(!@#@00T 8 9<Z""-:0B #'"!AQ4 H :>&,$*;&"! HB$+W0
MP K00( 00 < *7@#!"1@"SVH(  4D<$ VO & LS 5WS)Q81F@;_O9"I]^$L4
M+B9EBT*9JB!\L<7\9F@TOF2" 02X 60" (?O3 I6K+B**7&!@P HY!)LF!0K
MTL<75U3.%IH$SF]RP09+K#$ %[E#E QT2X, C"]X"  -]%. 09H%F:XJIOE\
M50('G(HTHM33*^CCBM$XQ!;6*<C;/O>]>\4,3@8\%O!" $=<-" %ME! "@IR
M P& H@876( ^<:$)!>R0-#S00/Y34+  6Z#  4VY P#LD .#PI$!-"B(#A2
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MSW +!D  #CU>)KWX<H<!M( -4<XP".KPB@6L(!0OOH4 =M ' *PA$Q'  "Y
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MR!,: /XVG'QG?/'O_$7P  7<X<ZU$D4!=@ 7)@ &)( -;@$#*" /M(\5T*
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MI)@H!%Q! 5+OHG0 BNHK!0A !T8 SSRA "Z #48@ (B$_G#FSL2DJK;J%B2
M A9)  AB!P*@IFQA#SOA! # %,S@P0KBO&C %;+,%%* NM+ QW"!RU3 #1Q
MZEPL"NQ@DC(A =S@$RC.%O!K&P& !E@!M9Z+^;*Q#6Z! )+*#MP+8"ZQE'"A
M#12N#Q!@D%K! @@@V_(  '  #Q1@D&0@ '*@!  @ %5  '@@-7YMF:C,#B01
MYU @ 7)!'3WJ! 2  BY  4+!"\W $4K@"=^)GD#GV4 &<>IDC,XC!4Z@!$(
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M "# !CKA#OY+-P#@$U(0%/K '7'A,VWX>DJK#[Q0!'XD B:E#Q1 !@85 B8
M#AP,%-KS$C1AYAB%6-6@#@(@OTH@ DS!CZ0Y 'JX -2*6$> #OCB%10 !!QA
MCOC@$@@@ F[ $R@@ S0ARS)!U !C!7!YQ&1 #\Z*20*FM/*"!CC  W3 !MB
M#W9 (?C"Q>PC B0NRMQ ,*9- O[6@DAA(042('D'  0*^8T<@0,&ZMB2S1U#
M0 *6Z<B&%A<2!IZ>[8SA!'C.[/AV0 !"X17>X!)L(1LG8S\18VT50(M H*X6
M8(52\",%@ VT*B\N(0!V-@]T  5 [O'@*)IG3114X $"[AM9 0,40 -XP)V
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MLMUIQ^UTTG[W#7C3@C]-^-^#&U[XQP)N.?'%K38>'^/Q7A5)#T'X<#GFFOO
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M6O+P47,@$YG 00INP0$^9%83=&CT#OS0AQ38H@5HR$6X0\$!4%P" [G@00A
ML0,9Q,@3(V"PH'&>41O4P18CX $(3F @$91*!VRX! W>8(8T7.(29\(0>=P
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MNL1KN9O[N[1KO*:KMJ/;NM,[NMTKO#-(MF=",5G5/TZK5A%S;Z[ !Y;@")8
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M"G0PW+3B93.Q6TS]"IEP"WTQ"W2 %FM7 [GU";)F$BW@&>3!!Q( VG0 <*P
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MQOMR985;')&A#JUQN?ABB?>'N'\4 =!_#QM1QJ"G$D_L8 <Z<$-E^)"V3-#
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M2PNST!%%'BK8,BJT+@TJ4B8WI' +!WZ(PD$G='R[@Q]]J)!+"VG88H,;H6@
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MPZ32 "!6^ L4GZEG1%X1@L_@H0!GP 4'$L(#ZM!! W%A0Y]@H8&'4.^D/""
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M%LA[:^! V" "%?1)$P_V@"6F'*()@ (-Q*)!"DHPUQT0RQ$S*%8F4@0*$*@
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M@H*KH?Y!Z3A42GHEI3EC$N*03 XC30*-&U!'8.F!_+Q"#83"'8" #%" /HY
M"JS 6=" #/"2U<6$#;P0'R"/'HP G'W&:*1 "]S"&XQ #5Q >PAF"MR2U;6"
M!>2![J2.D%S'*[ "9(+ +>' "8B '2 2!6R(1G[E:;)5-*HF-SZ-62X,'G&
M&Z@!!=A$"21$":Q(XJ1("A#17$5 '; CT^E ":2!&8Q 'VQ%0M  6]250OA!
M'2 ('Y1 +K@-+M! >UP='EP !JP 7[#!=N  '<R"!#P$!LR"'=Q'*QS+&R#3
M&_"2.*)F?.H(6:YF?>80C243'ET #^# )HD1+J" ;+3"!?ZPPBQ@  _P0 O(
M0-ED74SHC!KH  :0FW-9@@QT0FYD17$VA(5B@!F800E,#M9YP@U< $?D3V0
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M !SH 1M<0BOL !KH00.[09JZ@@Z8 @Z$PH'E@![@@!VX@2W\ZAMHB UD @Y
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MYWUW=YLW=*-W<]=V+.ZH;\,W\C7)<+=W?=OW?0--8L=W?/YO80VW01L<&!L
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M= K!BH8C'"!Q]>F.(A<N&(ZB]]'3 A=6< "ECCO28*H/.#P9C0T[,JF##SU
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MKK&;$X1(Z\**X*70#!*5"BB:11A(72M.MC@9EW+A.XSTI?Y(F7C%7331!IV
MP@UQ8D4;#F*+-ZBL;ZU0&"SJ@BI3N2(7VC(,;J7"!UL4R7>INXL=T'"@K,@K
M*[9XH50^X:];V L7H:B*UNA@!C/:I5J=DDJ0%*O8)ZUUKVU]DD=O1CR@VH%6
MK!C2)7" $%H%$!=ZT$1^]/#:/NC$%7IXH4XB]0H^L"(-=L#**W+ !^J\0L"U
M4BTK:'4+D[&B#Z:ZA"5N4:1(9>)DCHB-$%M@AU?\1A1Z>%HG+,$*XY+X06S
M;1_\%:)+T  4.. ##C2! S_<0!/6*8Y47H&)D]'X5'I8K2@ND1]7T#@7B&(3
MZEYABUR\ B6CI?"[^,"S3_2!9_Z[FH4G?&>)09D"%ZVX!*D:6-Q!L:$&IF+#
M2#8X%S[$:;QZ,%4F^C"7/E K4JYP!8H^T65TK: 3#-.$RO#49]W1N,,!,M4,
MZ-4"6W2"C*X(!9C?D -<^)!04[2%!%2V@Q*\@K>LR(4>T&R*3-@"Q'-Q)II
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M#M2 )\[P#?JGDJXI5W0@#SQ(0=1 %&ZB!/G@1@;IZ=:#330@1UPAB7 @%$K
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M :[27"!S$H12)F8'F#.([@Q&ZHU-'H0+45C %5X#F]@6<L.'X $[:C'/ASQ
M!UNXPA:M<!B,S*!!7+SB I1ZA6IT8(.27(!850H83IZBKW[YI(UN+ 0<XUBO
M.=(Q*%%1H^8JLA 48"8CI1%!#FSA"0P$S2!V2( >7($&C'SE%IV(0 [(@P(*
M8.A<=' %'2(P"SU$ !2=2!,N\" !>%$L<W>H3NW<8(D(W*(5*2C(*R!@AUS(
M &V@>/[ +?R JSQ, &*XH$-U6B"=O-P %RF0@2LZL8!,Z $C.@@!*_B0@"I"
MX ZN>$, _) +"[S!%MZR10Y&  M;5"5).2@!HRP@ ];D(0*AZ-O$+I"'6W!
M!NK#E1Y^-,H?8>!Y/"@9*R#@BE!$@ ^NB,@L'N (6[#A *+PUD.>B8M+1,!9
M)>$ B>0F 3_ @@TN60,810$"C)2@!JR@ P%(H@$TN((/"WB1!-I@BQW4J08H
M>(4)D0<!F<RBIR7I9N9V(!D/( \7((##21:9!BB!H VXB,!<=*" 6WSB 99P
MA1D"T(I,L&0$PA'!6': @33@P $A,8@:,%"3%>A@)7> Q?X:6+(#$;#"%!S
M3 LLX E7C !)XWS%*T9PU(70( 6@8,6K9@$'"O1L(6E U._N8(M4WN(.$DBL
M"AR "SM(0!2=D$ 91W #5V2BF3"I@RWPP %@LN(!]CF!#4P; =],B9.N@P N
MWB"1%,@J#=<KR1L2$!(90.!%!DU(*'2K!@ZPPA4IJ @%?(,+"V1N(8X0B,D
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ME%,QDJ80>E?T$+DP'T#Y?",I>SR8%!IYFV[4D3?A""& =W)C)I9  [F@ A'
MCVKP%QJ04PI17R&@,Q'I!NVU!@^@ 7#B!H_V(F>@/CR 8&<@*EIV 03Y$&<0
M 1B@!]JQ QK  ?#""BE :C%F=-V) GJ@ A;P1P]X BN ,R21<7"V%JPP VR@
M.C?0"8X@ 11@!GS0/[:@ ACR$ @F AZ &6D  1BP1&<2 1=@!WW  3R@ 1K
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M.E""<K*@!T5H0A5JPGTVU*';C"! .RG.4,:'+JYT!1S*A >@)9$.TLMA)VY
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M$ &:NJ($*VC!"-+%@Q'40 )Y< 0%*&"=[5E@VY;!P+!OE!L]:,D5*$!!"S
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MI&-,"11@2 S #00$"\/A#5!P@'I9H8*  5MP YTP PB IP-<0 QH/UR@ =_
M@9JKJI3P! @8"DL@@*;(@ 6!"1JX$<K#A3LH0.&@ )=BQO[<H '%LTHAHTI6
M@( WL 09B  )TXD[8#O?J!M7T("C,,K,4(%GX8'#](J9F V\$@Z"T(&:RXSO
MF840  %;T(1P8T4)("D9<(7^2XD6^(\1@+^UH(#9NP4,H &"<04,,(\5J(%V
MN@4S(+3<\( \T 3HXX/"V@C-,(5;($ AL[T(0PHDH0,+: ]/0 $.N 6J*<GG
MA$YR2LF47$FR0D16O#0:@!0+A#_E2X$+6,64H('SLP0,6 $<T(&I" &@\0!/
M8 4-(!@U^!XXN( 4^"%&$;53 X%)<PE)X8".\;WX0($1*($0B(L:,(^-2(,+
M* %!RX@V^\Z',$%;V0$.2($,L/Z(5^" E,(!E, %AL"%JE")%5B!RQ@\/A$.
M/K&%?3L!#H"/'<  8Y,4/H@ QDH)/\C#Q[K0K3N+(%P!$4 !$(B7&IC 3#R+
M^M2 &_$$#CB!$P !>V&#!R@)6]& 'ML(4Q !)L6 %B 8&O!#.- 2FBB!/M"$
M,+4$M<N<5^$ "Y"!23.X$O  %Q6.!\" "[@ &4@7M8S./>739II.[/O3ZH2@
MZSR7N'@%E_*F5[ $'/N(]LH$^'$I!5FP!7NO@K $%LH$0GJIF)H%!7&OM= $
M;&&4EQ*%7"L;4.@?F/(FFBA5=(*%9XFIC\"83M6$5?2#"[B%7- ;7:4)34@J
M5O #E_YI#UMA,9BZ5$Q")T](JG9*+)M2K[7(!+YAQ55*B4X%&4N8G5CUKS[9
M"'.YA9%9BU?H!.Q25-UIP?90I+?JTW5E5R7ZTWP"5&L25##JIG9])H-\M@O(
M,'OEUW[U5X2BSG=MN4+,)I,+)V(R6&=*V%!XU']UV(>%6'*:5V&9V&:)U^/"
MV'<EU(CEV([UV(\EJ#(JLXH5V TB6&9Q29!5V95EV995II(M69(MHXUUV9JU
MV9O%608R%@J26>0Z69@U%IK-V:$EVJ)]6*!UJ)\%VGHUVJ9UVJ>U5S)"R9XM
M+J056JC%VJS56N%"VJ[5)3 JLZO=VK$EV[*]I^6B6J\-IOZ4-=NV==NWE:9?
M4=JSJLZTM=J$A=N\U=N])2&UY16[;2A_FE>QY=O"-=S#I8F8]=NS(ES$==S'
M;=MJ ER1E2 Q&UB\A=S,U=RA7=S.Q2:FW=S0%=VM;;G)]5P):MS15=W5_5BP
M/=U"P"#391:43%W6M=W;[=?9[2<R"Q;9'42VK0NT-%C,12CBU5SCA4[D95V_
MG=O7]:+:Q=WHE5[H_%I^6I;F=5[=[5UZA2-+B((!8@,T.(-9Z(.G*B%/R $8
MV($K0R'E51=KA0/L,B'+DH'?4J*-\(2HLE99_28ZL!=;6%4>>H-; (6H*B0B
MPIA<>(.1N25M12,Z8-02.:)<>/ZDZ5LB_X'@9 HD!V:4 4JG!>+@'%*];L7?
MV:.)^+4C6['6/@"E@"J3SOK4;R(C[/TB[74HW^V^8A$$X!6.('L #\B!-E4!
M#RVA.W  )FR!!]"=;]H(1\B[%&CA.SJ!"U #-:" *%,B/5"*7("+AJ0I]T6A
M%K"($K7@$G$ 15T!BIH!SVB%$I!?$((#+ 8A6W@  $L)4- )DUM1(RHA.VA$
M7' \<,J!$:)#-*" /3"A$8@O'1K%7( %#DB7U:L+*/Z@1XZP\TPH5CCC>,I>
M0[3<:Z)9$8"]%G@#ZT(G5\!-QED /=*!O-N8L3D*3\"K/HB7HS %/:#45U:7
MH^ #4?Z%!3U(*D_  ^2XA:9$#G2Z981ISHT1U8TX ^C[B >(&%L YEW6#>0(
MA8A99EHV$_S2"(+Q! KH@UQX!1!( XW9FGRIYGS1&%M8L%MF*D?(,$W0 ^+D
M5E<( 3.(L%G0 VFEB4OP@UG @+C0&U9(LI<99XU(%T^XFQF#NA'@@71!ITOH
M+UQXU5:XKGRAMM\LB%2^%?#*!0U8&DO0 \K;#4_ F%<HL<PYBLHXBDY(H%S0
M W+QGTX]:)H@:5A- Q 0!5M80_!:"T_(Z'!5B8IF13QPEY+)!7+A@[%YA;(Y
M5%MH 1IH!06!A1;0 ;TA:73B9Z!1.C=8,/Y:,!>[!=UI!?ZH5I<((QA,F  _
MR(4Y: %7T(-XT1M>3BJ(J(A;&$]64#";T@-1A2F" 1@\0!C"Q.42R8/?-!=J
M3JJF]J!?!AI6R !7X)B7*6F+'FOO:D'@W# D8DF@]24<WM[+/24/J!6"D8$0
MJ($1N #DX ,:A+4^8@."\%3X8 414 $5X&FDJ#;&L $4P ND:% 4H("98(60
M6($2L 53N  :4(%6@0@/J $1().K&+4J-04/D( 6F 7]JD,:/(RN:&X5F "Y
M3 D*H*FR,86XN(0V<11;8 75/ $,B (OR1/)IH'YYH$6\  ^P0,GHH%;HYL'
MT( %'@%H$P&@H\$2P*&-L ,4;?Z#Q, ##@B3_Y@%1VD! \V,$+"!"8 A!<$]
M.H  #&@#5I#N?7NI82LV"H %2R (/:!P#8")%7TV#*!$#A"[;Z3!$VB!8I8
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M+%8LP)VN@1.XE"/JY'U'W4 R;:SC\Q H"0K %@6DPQO@"@_"9&@G-!D@-%9
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M=LA),H0MA,"A(*):6*19,(0:"%9)5EM9L,&/+(4=\($])OY%*W@ @F  !U#
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M >2 )>3 ^-R!!(C0'5  'TP(@"S7"&#"'2R )^#.&SQHK>"! +B!)8R 3<A
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MS43@N!P=QD8LR T0^00DW"WP 86HM#7U5)6TA2?H&0_0"QX\Q##FC_YA@!\
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M;S-HN".4^CK9OON7'M\!%#?TD(D[O"$%:5!<^U;0@G9U@@8JD DN+'$'LL%
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M@V&9(@0H2 $'B 8!#2"//(NCEB9,U((4W,(,ZM:#'>S$"OX1J& %(&B<#41
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M#)'EG$" 3X(08AQ,#W3 !O:#)"3H#<K/30H"%&Y"!EQB(VZE U. .E[B%=)
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M!-HE2\W *N# )3R <W# $AP!'>T#(G8 )MD !W-@6#R B<K%91;' C3'/7C
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M  [Z,$-<C,!63T+;0=YP@37@X *NV,$*#)*"-82" FI8PP7BH@$UR<T648C
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M!F62$)H@ ;"'"PMF$*\@ 0UQ"PGF&K>  Q3P"@5H(@9A ?!'>XQ" R@P"Z]
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M?@F!!CUF!L5#5FB$)RG ;#DPEYIY$#I0.9VD(P?X"BN0*X/A!Q30": @ S0
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M$;)R+==V3$ )B% !"+<!%3 (6J.K%<F.B" !OTH")R4($M !Y#0! A.2@?
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M 7AC"^AS$W9@ 0-D 7)C"A!0@C7 .)XC&5N:$#30B0?A"2B  WS 2"C "J;
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M!A9P65#2AC+@"IW@55X= J*PI75@"1 0NW%E"W60+ 9!91JN![9P 6Y@"WZ
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M*[C  R-@_"V@!YXPO%*:0]#O*Q]R',N!(8L@'(MP(00B"(V@,/$A'N_1""8
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M^7ST/4VO$2H,B"$BE["*Z"%SKVH$B@"@H"2. UR@9!"X&24E3E/$$PS0@1A
MP & " 3@G$ " S"!$55PP0$V4(BO=< $"X  >! A!P5$( 8^@T(C.E" &+R
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M@%?X</YV&0@C7  %"4"OL/"#L\L$!7 %^:, 51I "< %%) 1#/B$V> #.-
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M")"-$3@Z>=O#$I !8@/$+PHC&C"V,\*! ;2 6T@#/_B*$C KL,B$ OR*5T@
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M:>+)D^@!&VP$2K@"'.C &5P"1X "P;;J&V!%'O  #]Q!E4(E(G1  23  1!
M U"!(CRJ(B3"39+D3S*D3S)D6"*"(>1FG39"#$  ("2"B/;G@@+JJ6JGC/IH
MBYKM<H(E==:H2&2" "2  B1  $C QIHL+D  !+A$+G! "W"$!Q1 *T@I+I@!
M .B!1X1  'BL2X  "ES% ER 20R%'0"  M M &@ X1*K'@# &9!F+F0  8Q
M4?!! "3   3  *3 1JP  $#L[^$"'RQ XN;M<]A" F  ;(J$+3B  UPL+M !
M  @ TOXB  #L !P 0 ,L0-V"@"O8 @0(  $(0  X0"=X NH.@     >TK$_D
M@@;(0,*F@?6.;%&@00!8JR500 $4  0D;B[00 $T[PBX@BMP  9(0+CZ@0<P
MK%-<0@(D@!D\12@X@!JXK/"! @2D 5FT0 !0 +"B1 A +BZ40 !(L$EX @4
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M6T( @'!:9#)6!+ *M.Q06(( J( G6((* $ .X'*M7C(NW"^\WC'&2JQ2O $
ML$'P@L(Z.XG'GG,I6RM(>((\L\)&>$+CNH+'>O+'6DGCOD(N[_'W7G)5V (R
M>P0K:((M4  (?(0I7((_>RPHK/[R55" !6"%''N"!S  'QCR&P1 &KQ"*,@
M - !+E" !(AT&A! "Z2Q"'1")M0  #3P4- R+FB"+DMR)FS$/Q<%*WPO'\_L
M+("L.5^T X3 (<?Q)<0J+L!""2C )3R)'XC  C0 )3M  ]@Q!$@ +GBN&;Q"
M.[]!'2@ +J0 Y(+ 2M>E)M!Q+IQ! +1!\,YN .! M.("'TMP.;]"M.8"4%]R
M49B"/)_N#;QP+%\ *V %]AY%*URL+L<R!A#N"CC 2?=R1WQ".A,%"!" &\AQ
M!   *SC" -1 **#VQNX  -A *[A"#K"V2MBGT28 (%!"(U"  PQ"##3  S"
M"PB"!/YL '!:P 8H@A5$  ,LP <@PA\HP M0@A44 !1 P0%$P )0 2/ J*:.
M*'MJY]H:JE3ZZ77:Z7>;MWYB,16_;4AH0@*@ !NG00$DKALH@ ,H@ K<0BN
M0 1$@ (DKB-( -W"0%74P0(4P A<P!]S!!TL@'W;P"V\0@2,  @,0 2$ZU"
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M6$(?$  (]X$ Y'H-]+D#Y/H3'/[ F,N  [#""#2  VC 5[R! S  G.-"#B2
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M(EC! 0!4!@Q<=@#<":5@P8Q+= #LR%0B@)J;N'( L&.*@X)7EA*@ )5+I*4
M,K:.2-"J1@!7= )$T,%JAX!,L"Y@P*4# !Q-$CC<8D/@C/XK'@#HL I1X%4=
M 79-[0"0Z=6.D&CA< #UJL#+# 7.6)J@P!8. "LLJ0!@B=4"!2W\6 )  R^
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M%PP>\"23 TZPA8*R["") @T^P45,'/2   )<<!# $U<D"&$KJH#":20]$GA
M@ 0":R4!2+="(8$8Q1MUU$),+021#AQP0 $'.I!#D3^<<,&"!*[XHP GFB!@
M$"@,@(*20BS8((X$7J#$B@.:H.2% _Y(1)!3I9V66E,7$621; 7!=MMLJ_T6
MW' +R?9::K$55UI#T/WV6F^K%0012DGM) $0]- C+Z!>><,&#030(Y,"%N#
MC%PLR5$&&0(HX1( SA#I@@LH/0, /W"!!8(1#"P!%UMFV^J6"'2$:(&'1I"
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M+3+F"@>4X!:M<$ +1@*+".BN! Z(T@@HD#(,:)./L$A+ - @$C6L10\<D(!
M&,"*6YS 9]!<P00F\! 4%(TB(3'1)W8P@!J9(0 AD5?'*  I6T1@01A;P2<*
M@ )\WH%2>>"(2#P!@!J<36\:<(6=V-"2-X@B #H02=>(Q!LM#9*+N*#*'5HA
M ,%M12TT2$L",H"+&4#&;QW#P 2T28?&9.!SH+"8'/$ 3@N(Y X R,/3I(,3
M2YRA!/ZKV0H."' #/J P=B;*!.T(!X TN")P(L'! #SANP3,K047H($#\!@
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M,@,$2&Y";0 $6J#%1L4.]@8#,( #*, 3+,&"]$>C%K9E%?Z69L],%$Q8/$9
M%GEX<%3@\R!V%M1Q<-27F#*! S!  RA-)$I@A_4 4HA2 S2  RR 7"G%%&C@
M!%2 %T7"#$J@!-!&/%B!!DH@!2RF8WC@!G" !EJ,#DZ@! Y1;$<%%$!@!&06
M)V3 #D*A,)Q8#=BICG"!!IPG>B^H<#TA! JWAR^H#>:F7]'B!K2BD0WW8M9
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MFT;"!L@O$R9:!U,@!?XD%$3@ LR@168A!T3@#53 #6RARL_@1]< >)L-RD,
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MKC6-!BZ.!& ;42$<X.!0;)CK@"FWY(*" *"PDH (H(!"$TND[E =;R! H!D
M?6BT P#;N1)!!G<1I0< 1]T"0@&LH*" QB$LX H*"T0[BP. 9I5"#DCED1$N
MGN^'!RZ7G$!19G>E 4(--5P8,2ZSP.K2":]0,,LMM_CQ(?X(>Y"K02>7D-C'
M?9=<4"9T)XJ"BRL4V&+##K<<'\*,-=YXJPZXVZ*!*"640(,,,O! +@T<2. 8
MH;8Y"SJ,&/2M41\ZF1+!\1H110>1&M%P\!D2V%9_:/B[U<%8DH?[7.!\K(B
M)S3BB@F0Y!:>(!(=1A ?^^ B%[>8@1M,02170"L%XG%4\<B%"QJXP1,0L($,
M:#"#/KQI0#+!Q0CHX"Q1<*!,L+  ^+[G!G]=\%:VL4!F/$BK"_'! [;@@"AN
MP8,0J-!%P1(%!&H /AGH@144@(6-B/0*"R@/%W  P01:H,4=R: $.@@!&SJ%
MN[N<@ UI(Y0CB *'U=PB#36H$OX5O]<'-ZQF0"/HVY;2DP(S8, /N)$*%F_1
M@C00!5.M<)ALU'<)AJ6 81I)H%#RQ+%.:F5EH QE* W1%E&:LF2&(!5>]A2
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MT 2>'%$_"]#53_>A0^9V$BF*TL$4%R"*#-" @FBQX5$1N L(*-5.C83B%:'
M *D\T2<9',6=%(@/!NXZBU#(KTPA<(P$8KDI6]3!CB50@T3H$*D\="18N:BJ
M1D#Q"E;,"A=ONH6L2)6':/4F9D2AP5%QL(9;S-,ZES"#;'"!*@QMQS+JV@$-
M<E$>W+*B#_92TG-;HH%=Q2@3N:" (HG$@X.%0@*[L80"8OZID1%(1 5FB!XN
M-('>B>3+D_C5R"G90LK]^O>_8>DO@ O1LJP<SFAQ6L $9+  #>1B!@#(00X
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M1C,@(/Z RGYA-!=P5QJPK+>@!SK@ )V ![&LP3;@ 7; "B5P";4C%)T0 8Y
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M-( ""\(*&C!1!NUFU,XPK( !D?0*&J!WMK "(=#O[%6\QJT!*$#!2H@5;/
M;U 2.342N>"R)\ !<O5(':H"I&LXTRYV7#/,MS#8N#4F(K " X("^&D),2H#
M,=,*L_[")RV0 S>PN0UO"V*+"VHP[A?@XZ(  B,@ B6@ZVQ@]O$'"@=0?*;
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+T((7Q& &\1<0 #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>comp_0023.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 comp_0023.gif
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M]_3T]/CW]_'V^_CW^/;Y_/___P
M
M
M
M
M
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M;#@#9C!\(@2CB?FO3!$-6#M")E &4WQA[87@ 1Y@!O]G"FWP 1[@!0C!!FD
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MHE (%8 "B9 &$)!\$/ &A6"*7(D!@J &"8 (J(>9IF ")J )7Q!ZA*$% 0
MF;=ZBK  5FD!!9!YFC"&8/"%IA *$4 *'# &"'$)#4 *7, !"+$%(" 1$E (
M@F !"&$&8ZD!)5 (:!<2'%"";?Y0 :+0D(MP"2)@CPTP"!)1 :39 26HDZ0
M!AF $(7@CJ90 F8H"A!P":'PC(5@ 87' ;?X 6>@?!(1?R+0@Y=@!L698*((
M  "0@[!7"!"@":1P <+)E8: CJ]G"BH@CB2@@8M "HJP LAI!A. $'\G"O>I
M"8BP 5M@"A  ?J8 !AY@"LWY!A)P"8L "0I@>U6YE1LH"-LI$1TP!MVY">,X
M ON7"&\PH@CQD5KP 39JDA@JCE%J"A2@ H5@HH8G"I> F8GG 6B0?.UY ;&I
M" Y@"AG HQF@!JC'!AB H1E0!]=)& @I 8_(C,XXAQ) "J'@ *2@!1%)"J)0
M 9JPD?YS1Y^:P 5_6@(M *BFP %I\)S1N0$K> (6T !:V*AL,'>%0 'H6 (E
M8 (G8 :D( $=NG^S5P&9.G?U"0;VZ(84H'DBD(.Y::,"Z (8L)^%!YQIL 4G
MP*@(L0$<8 *?J@7E=V"*4 $.@'XAT0()H $:((,\::$2(0@8$ H5P BDP +A
M6 )?. 8QNH%CB DAP $MH $K:IYSEP;M.0&&8 8/< (D< (H@'ZCB@B^V@4@
M *BDH (M$ H/@ FFT (/2)2)P 8QBG=GJ@(6< (E< (JL*\L@! HL *0"'H.
M$']F@ $DH 6(UZAC0 IIT*828'NYJ0D:H*9YN)5MQP;P:/X*I>@ #SLA;W<7
M^*=_H<  T_B6^PAW;)  IA "78 0B=  +FL"" $&R(D0#X (;P"=+^H!HA!_
MIF ("K!V;:<!7V"$H0<!I&EXBC"J=4H*%3![(&"&AE><76"D&.B2ID "*YJ;
MH="8"!$"\><!$^H!:< &3DL*2+FQ$J&L&':?BR<!:1!]A<  C$"AER !RZAY
M', %(9"496H*:A"CWDJB$7":D8NA04NXR;F<["H(2MJ)IT>5N @&&2D1>A@*
M#QJP#\B5B> &\&D*#K (6]"J;HBA+2"Q:>B'-=@ E_!\FN=ZIK !F1>RIJ !
MMU@(?'JF"($!:["F[2FU-TN#KOZ2" 8 "0@1"@CP!J2@ (M@"BQ  1\@ HS+
MO&/ !A*0@RH0N7I: >:(@%'( %Y@!A*@ :00 2?P!EO G1(! A!@!FK0 (D(
M!A PB@R@@@I@C$#9B0X !FTP 6;8 M]ZF&WG 2Y@"IB ERR@ 6\@!@Y@CQF0
MM7GX!:1@ 2K0!B%0?%#I!6Q0 10K8@8:$A4@C@P ?0JPC&W'!0&0>6[0 #NX
M ?4Y!BVK"#[+!8!8EAX0"H WBCEJ"@V@@AH@ FV@ L3;=FUPL6F F(U*Q2K
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M(46(2[-@@+N0EP9A6(K2$*;%(A,JKG8!R8P.2$J)0*(X0S#!B7X"L*;FQH#
MC$58N*LGB<[H: )#)#*# T@<$"1$1,R"ZB<+WJBIC <D;,$%K+0:JS,',),H
MDP;"4Z0!4]I82Z(Q1II(A3?(*,&4%K:H200M:J*@D$+^HN@-#"12 8,T-/'
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MN4YVMI.3+DA;2WXROY5XX"K23- E=(3'1$0 G^X$:$!#*8@0>* %G6*#&;J
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M:8(F0$-'5MHE<,(F%C@!/%2C=-RE;V)'=@H%$_@ ?6.Z+_[9)OX" YKH%!(
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MDH"Q &%YRT'0!$IS@2)!A.!2QE!8 ,NI #1A &&9Q3!2O7FA"?5J509(&0S
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M:9K2L!.TL)0G(2'!$[NP!5,@KYL]R< &1" 8300+ RH@Q0D88 &9L  #&O
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M5IUCC2G!,VNTB$40KP2&%,4$TD "0_)>%&\PP/,E  )1$$5) _4 8B! 7IQ
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M8'& 875(OM!$T95 2W%'4V3":)C2B("!!,!;D4#14.W+OVU'C7#FD!69-"H
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M5E$)A]"GP%6-BU@J?IK9[<P$""S%!5@Q099-*+R';U9 Q+'!)'U 3*M+2(A
MVP:B-$* _&R5^PV$"1R1S+ !R#2(;D=D26+.\AV2*'/$&* $Y%9O61]A4)5
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M>4 9G$ ";#;A$J,7((P7+$X"?/[!&#! WH !!) !O3CO0)2! YQ (3 @OT[
M:FR _L$!&!B OCF "(R!!2RK-"X 3Z2!8=>S(&@ 8HA:"!C' G36NHU!!;C2
MDXK!%BC^!"^<!JA &Y!7@Z1!W+/K@&A =)B+K12 DSWIF#Q0U<]^. $?"@Q5
M"S0."O8413A O@K:+*'UQXW.%GQPY,ICZX!=QX4$3YJ"-R<EDK3:0&P![D!
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MB0L++BED @]$46$$Q*Z"8 M%P@C@NI'<X(L-!P111(.=5(@*I!!,<<,!%52
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M#05R IVQX 0_^9<F?@(&OI" DWOL G$NU #-F($#(P$#FTADB@UPYQ*3HJ)
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M\_"1MH!-NN<_X$ !< (%)@ %-( $.B__!L(%\H4"T,,#SOY# E:B!#01 SS
M!$B  :X#"TFQ 7Q#$?+E!"Z +"R  P:M*P:A K3@ RZ (DA@ [K  A), QR@
M!(;*-[3  J!L)Q:!TO+PQB*C!4B!DU:@>3)D4M+@)51@ E8@ SJ KT(#*=Y
M$"1 #TEA!& *S$I( DA R]CL)R[! X*QN_A-!#  $W0##B8@ H( $R! !$Z
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MHTP!R0EB!9"PO4CX-S#$ NYJJ]W@+10RIPU71<C"ABSID>;8% RAP^HG$0)
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MA@0&*>* *%I@,'H76E:  A<3Z&2!!Q7D:!<$B'@!HBEI-*#""0R\C,($*Y3
M "*,.-!KWII8<(+J'E70[42%- !K R*H4$%;I(3 P0H0--3&!"V(X $IFDA/
M?5LJ,.!!(L@B H%!:5A@2@@?!$'!LAY*T(4((1RD@50-_.J5-G3 #)HS!0$G
MH@@*;4!(8JC=1":P+!6PH7,3T00#+E$(!O3( R30$@-( ?Z&]IE"$ PPA0HZ
M2!$*=0$#$V%!!U\W$1)XC $N$44#>D*!<YFP+2-T@.T<Z+[:>4 %$\% &@8Q
M@0I"($H&*8$63 &&VH&!8"E#V0=0$"(S)")OIF #"\^0)=F98G"Y600"LO0
M-VC" #DRA0BX8(H&#&(B'^!"*-A8%>:9H@4K6(0/8>* )@G)%$XTQ02(2),B
M:0D"&$F#",? PA. 8"(A4 H$>D6!)YWM!"PP105<8I ,UHL!.KE$"<=@)*>$
M(!1D- 4'JJ2 4C) (A+ " J(.($W*.H,:LC D21@HS'T)!3$4X0")/(4L A"
M 1#@(?5.4((2.&PMIM  C'SR+?Z]F& %U*IF&@I!Q1 TY!(4V@(1^R(!16B
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MD?:583D1%O &#=DC;[ !&<"/EV "X)@C:8".&+ !.J&+$Q$&"CDBND&(=W4
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M711^8J %AG )9V,&,@VY8* )6?,2;( 1;O!\;/"QHB &$I@&7Z ";E(3:8"
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M@$P6X0!5C2]LH2%(&!*0I:N80@P(>(,H"H%',30@-"<PWP=0,*XQ+*(!*$%
M2+IBBC!XP"("L<B %*"D,VP+-OZ+, !++J& ?1' "Z$I 9],@0(2B.)JIOB
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M6N?+E$TH$J<!"&1@?0_-^ E6<!F!&0#/89CULB(@ O>5:FLF4$$U$:&("83
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ML8 / #0"#2O!,QF3Z(*D8@,'4(%[80,&4H0.#0,7Q0@SN/XB-IB )X,14="
M$W #$GHL,' #'J6N!D@#+6  %$B#"!"($5B ,%!2C'"@-W #"MB-!]  -N@"
M!=@M-1N#G*0 +4B$4"D."3 #6:J)WWF#^G.C C@!-IB;%&D#!T #-I" ,;B.
M,JT]"'"C"1 #0>@ @4B#;A*$"+@$,#"@PRF$"&B#-Z@ /*N "<C.-J  OV@
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MXZ-.B++FUOW5,!9(A!; ,RU( 5+H@I"X#J'6:B?N&9M@@[$.8C(C#BWH!%-
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M K!'O-%/GA( UZK !@P/K<S$F'1!7 B?S';3&W".V1U0@.H=  # X(R%&J@
M ^!8VEY"!)"+)KS!&$AH0B+; +I!<Y@&&9CM!X@!(MS;":A J.69&=CBTVT!
MK** R*GR_$[ %\"0>#?$WYV %@SD@90 49D"<)17!+P!&_Z\ 0(,0@OL#,.8
M@@]##)=8 !/.B9R@ 7^'I"FX6Y(UA-7@VGZ_05\+0LJ1QE.P7F2-@<]L 2W'
MR#&9*(9:U_>^Z(E6:229"@N4 '^0RXEW*1II@DE0WM\D*B4J&P2$!"(LW02@
MP!E@ $ 6* *SEP!>3UIH,=V9@@B:0"&<P!A(BWO'D+U(0)%W0=?X2EZ0  2
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MZ$N'/A2B?4F$02=*BN @(A0MR !V0.#"$"@I RP@Q2(JP"S?A$(, 6 6!%
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M=P(/:,"%*AC#6DS! @UD@)P+042 !1Q'@13" U0!@Q@,88*1F?&OJZ8IA\:
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)LU,[ER,@   [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>cogo_0002.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0002.gif
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M]_3T]/CW]_+V^O7Y_/____CW^/#O\
M
M
M
M
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M+61#TB/:"4C7HP,+(+!!*:B0(!8&M*Q!@ (6F"5'7 H@2,!Y(L_!L<RTT&R
MR.4V(#DJ&!162A[:IB#0&AZ(F?3PQ!=OO%%+!RS5@:NQ!P 'L#2P@ ++F_(<
M I?@H2T'=.DH!R1E:E#)(Y:@H*L:M#! K0INE5&F!P)9$E<#9M4"2RF7W)&K
M 2?$7ET9 GE#F39 BPU4QPW[>4,;\'"'\(T/$^9# !K<8@O,(4!9\IM>*3Y0
MG38,9%$$D(,9#D,"MWC..BLS3!T@ 3/QD0\%@VF#)>CE !",H0X7.IX.=\C#
M'H[D$?Z^,<![&&:!"C   2*P1&<<D,.3&2 ]9,,$!J8%BS:L#@$ "   6@6
M$IX' 9)SBOL0@ (,G8=^M,##!R!    8H $%*&,'=,6K!B*  [68P& " 1^!
ML,$\6-0B%T4PD(VA<3002T >,)  !/"Q("OXGPIT!$ QZFAF*KP96+*XQ?8\
MS@.&(D"I5L <'YKRE*CL(2P@9@!"/N4U*]!6""ZQQ O5P@*-?,\)"-."!QC@
M<6TH .E4<((3K* %*'@#N.+2EH*XSP!EI$4I.,. _[ G 1]X@QETU;]%&2 .
M JG#]FA1N&K!ID<-:@-A*K""$Z! !2U(@0<%LC$&+.Y X?Z"!"/O<DX4&*
M9XBE >;BE")<,H4%J,-ZANE.>*9@8;6H0PDL !8&**R/J<RH1C>:M!:LS@!4
M"Z?Z#,"W"&3.6I98P/06UT &-*!GL(K$YPJ)B4LTY3P+:"8MQAC-:7(,%KM$
MP#P%",T4[DH@=PB+<>PVT/@Y@ $< **9"GD)%@T$5(-9&"V2^E.K-?4I%A"8
M&ARF@8+$(G<%P%5UZH"),H&.GI? A)'4((?%J4)K)>2H7O?*5R>E @((R)8%
M2K"!1AX1?F,8P (L\ A)<" Q>86%'AF MPMQ@# DB$0=)("  *3G.0S0J1G"
MPCYI8JX!0 W+&&I1"0MDKHQ=0OX .+<J%@*NQZ5J>$2N!M _#5Q-LYP-P'M>
M$Z7I*: ,:8  M>"'AS@U( Z84 '*(A"?-R8@!''P@,]V1(O8@M.W"LCL9K'X
MB#=L<7.T2(.N?-?7]KKWO;>1!!L+4P #"  $&    6$1@E;IR%(6,(5;5""T
M )2P()A@8WW90X#KI&(P!O@,+<80  'H2YJ#08 J\"" L#2@90:F1<,"P*LZ
M" !0 AD#@Q<L ;-8@HWL6?!U"JF  N - */3UL1VRAYM%4"8REJ!T P0  )0
M (NMX5< //AB45K*4M>!1<,,L(">C6YY\,VREK><E5(4P0(.:, $6E"+,51@
MQK5( _X&UE*!,:C"()'0@ <T8"T,L: "#H# !D0VF@]PH /UPPX&-'"&_?C9
M PUZ YXAX ));& #963!!C20'EH\0@,;*"TMZK"!!SA@ BH(="GN[( ';&"V
M)0K!!D10MS!O0%D%J0,'PBR!$W#G*6>80 ,@L(8Z:$ #"UO!I*TU:CR;#-6H
M^/)3)2 "J922R]".MK17DHI2T @AIBC%LUW"N8[4 A6QN0@JK(W1IZ1"*0TI
M!=$*26Z$W._:"ZE%MQM3;7A/^][XSC=-7K)MC/9;)/U6SD9:(G"(_%O?"$^X
MPK-\\(4[_.$0C[C$)T[QBEO\XAC/N,8WSO&.>_SC( ^YR/Y'3O*2F_SD*$^Y
MRE?.\I:[_.4PC[G,9T[SFMO\YCC/N<YWSO.>^_SG0 ^ZT(=.]*(;_>A(3[K2
ME\[TICO]Z5"/NM3Y.@N%5'TD5Y=(UAVR=9AT/21?7TC8,S+VC91=[!$YNTG4
M;O:T@X3M%X'[0>1."[J#?>UNG[K>]\[W\8@B%*#0Q"<&3WC""W[P@6_$)A;/
M^$UH8A.?<+SA!Z\)P3/^$Y:/O.,;S_C':Q[SA0>]Y1L/^L(+?O2+1SWH+W]X
MR5.>\JK/?.HY/_O(QU[SD&]][D-_>MPOOO231SWG/2]YUD=>\X^G/?$/7_K*
MXW[UR*?]YC_/_-<+?_>F7WWGG_Y_>]M/'O.WA_SLE2_^\/]>]\"WON^Q'_SU
M=[[\W#_^^(</_]>#/_[BWSSYJ<][[1L_^\)G?MCG>LT7?M&W?\5W?O''?P"X
M?NDG>NY7>PG(?IKP"B77"#-0 QJX@1S8@360 U(0!5$0@B)8@B9X@BB8@B5(
M@BK8@B;(@BXH@C 8@S,8@RE8@S9X@CBH@CMX@SGH@CWX@SPHA$/X@T&H@T3H
M@TF(A$8HA$=H@T^XA",HA2_HA%9(A3*(A5G8A%Q(A$Z ""9'"#-@ V18AF9X
MAIK0=VJXAKDA!F-XAG X X?@$7:'=A!1AW4H$'EHAPU!=WNHAUC7$7XX$7OX
MAPD!=_Z#B!&&R!"+.!")F'>$^!&("(D6T8@7MP5O"(=D* -\4'=L^(F@^!=2
MD(EG. -;$(JHF(IYX0I&0(ID6 -1H(JR.(M7(0H^<(8UH 262(N\V(LAH0D[
M4 -D. ,^L J^>(S(:!.(((PU< .?D(S0&(TKX0<R4 .+((W8F(TB475=T(G:
M^(W@&([B.([D6([F>([HF([JN([LV([N^([P&(_R.(_T.'7\YHD$YQ*7T4=
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MTU8AH $,4!3K*IQCX*B0J@+\P1B58  7\ ABN:JI@  3H/X49P  8U *!$!
M [&MUL*;>("L*G"EBQ,+>-H@>-!%DA  #6L)5JFK]5@09@"SCWD"8S &J+!+
MP(F:H1, *^  '%"C:I )8@$  F"G)%  &. !>B0RFQ$HI%,0-GL0E5  (L
M8W"U(4  E[!+[4&UDQ 7G 11J[0 ^K&MCW ) _ !'J  XD0"DB  W ,++- "
M8Z EF^$ 2F$*]5(*%= 9"S  Z%,0Y+E%#4L+:G 86E0=Z(,& ( '2RLRWHJU
M&J  \+,&VK*< % @8O&=[*$"0\LW!=&G(H ),SL;VSI$2[L&-X-%RRD5$I
M&L !#2 !C&$";30 $R">2#N/J_[)/I%P'@!0/@%0!CF+%S6Z!F\P !LP &E0
M"@5@ 4I9-6+K >?Q'G)@M;"P 00@.23 K091"0.P A]0 1)  B@@ )<0P-X[
M!WA!"0:@OB'B'_$J8#U*G:4P "*PKB<3 I6 8K!@ 0S F@<",2]""[34LGHD
M B7P 946/VK 00/ EP @ G+P!K2Y,(STKP+P.*OK > * K30!@:&!W1 ![2
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M)12&$/Y+&D^!M' N=!4"8A%G.&V3LBPROTI@G(%TI E)\((OT6 J0EAD%\'
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M&PX\\/XS4$*^.M EOL'!%H2<.E"8$OB@4X&,N5B!&O1"!Q2)$D"!%9 @2%
MN6 !PUBP(ULQ%$"8,RP!")"GC!(J"6*%"=  6& !-"R/G1 )$O@@B"E#"$P%
M'PR!.;.MQNDH*B2.U?J@+-Q"D,D+"D 8T[B$YFM#,H2?PS/%4T1%G%H//9DA
MH(*%.K E4+R#W( %6TH(3*@#4U (6-!%A; $,%2(2 #&/?G%6*R#2YC%K*D#
M6$H%;*.%2L@16$ (6+@35("%6K E6+#&-*#%!Y 6A<@$/,B-.[$E;+S%.M!&
M9^2)G6 %6S!'G; E28C&];@4W*A'7"P16X)&W,@$;61%/?XIA67<Q6RTI8 ,
M+WO4KMQH 1?:MGI,B%6DCEP<2(6XA$#(C4NH18"\B,C Q=K:$U-H"=RX1EL$
M)W&DR$?@1<-:@5<LQ82I@X.$A;YJ"H(\1X],A9=,B%GPI&UK"7.,A4= EE)8
MN_ RR%WL29+T1W-LQH2<I4=@A5G*2-RP)5/ 2:&B+#RX"(Q$A8G"A,S*FK7#
M2NK(C5*8%!P;1FN$QS/"ME^,C'*T)50(KX[<$U0(A*RLQ2^*C)BLA'=LR+1$
M2YZXR$>X%(RD29ZHRJ5$A;#4RHE*Q<9TS,>DGYUH 3.:B[G#J3]BO)E@S/I1
M@0M0 ?GPD\V$S)JJ ]%\3-,T0_[*1,W1C)_5K)_5=$W6E,W9I,W:Q+)4F*$_
M6D74A,T]B<V$44>%X,U#N00\@"7?%)3?#,WDY)/%*Y3?5,Y!Z<WG_!/71$W<
M%#SDU)/89,SI;$[$TTZ:$DWKK,[RI$[I!,^:XDY B4[;=,_WA,_XE,^<:L_Y
MM,_[Q,_\U,_]-,7Z/,6):D__3,_OY$]#(<_61%#SQ#(!S1\%+= 'A= (E= )
MI= *M= +Q= ,U=#&G*AK$T[A]-"FZ$[;"D\2I8X\,4WGO$4/. ,#.0&'O!?A
MA$T 31CA2 44F+<_B0/740A4< $-P  3:,D/C0-?^B(:W8DU^ ^=>"B!8-+M
M3-$/S?[.*2W1*4W2)571&A4J%"A' O7-B4*@*B70WZL%.7"A+YH%W&B!'!67
M;'G2 :52  T3A#'1.J52*;T-&C53Y"1$6'"!'-D3*+*M2G#3S1S1B7%0P6.I
M$O5.$873.,53.^W.$=W.K!&.1R@=.[W3#>74F1H1C[2M3]U41-D).AO52I4(
M9WP# "B=G5 ]S#R4;4J%(G!(Q-. :MFV"=BA1Q@!!AC2N5"!07/-.-!,A:@
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M"3C3N;2M-WB ,4"!!*$4#' ##Y"+2QB)"Y0$%QBT$[" $EL /$"%%ARNO<2
M,4@#!K"6Z*OBGJD%$W8!$!"<,7  %"CACM  (*V#,Z@ -?" 0%( RF@(6@@0
M"WB$%ABT$9B3#5!="TCA5(@S/(B ,E !PWF$!$ !B)J.+QJ#3O: #ZB%$OX
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M01^46" !"," _T@UA6L!!R&15).Q!OB)E5.5Q7GS6:J &9GT"F@QR9E,6N@
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MZ8T>1/XZ!BSN;B(M<G FD25^5X_!!AO\Y"!8*8/ @0IQ>*#&?+188H$*L'0
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MM[W!&*A !+S!<VC G_2/[:G<&0@?'HQ!Y+W&&=@.JJ%!Z!U&) 0>6*R!!FS
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M@L :0&,+8 (OFD4(;.)!Q*6%V/Y<): B&J""4MI-4\)"&1@ &Z"""RS L1@
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M2;A'!4R"9(#N[4S UK; &:2""VBH043""5@ 5Z0"!GS &I3 \G; V+1&Y;(
M"SRI0Q!:S1C<)2B2C$;(I;1K>QQ$!< K+;#"2E0/O<*JI39*&>S/"6@ 5+C
M&T0"!/YP+0N8@0ER&BW8P@1XA^GR3.JZ0/IV:)7\1!K50@0TE2YY %.NP-X"
M!JZEP0<P -%^K _SEQJ\2I:60B6@[5E,P*%YP%D]72JT# ;\R'L$0B3DAAF0
M)AT>;<KL"D)@'?&.06-.$A;;3<11CPN@@*G,7_'P3R2LP=/9WR6$1QU8"R1<
M1*^&@ KL#\ ZSXE]43:"1@'@ 1A]A\UX0$U: -4$;FYD+D)$P)3B!0<,R\4<
M!&0<1)B(ZT%@PJ&9B+-2<JYN@"5 @![33CO%@4%P@+F,05<D9$YHIT2LDK7R
MU)Z5@16/[60<114?!"0<[<E\!KFXL >TK1Z/1DVB[0F4P?Y;9$=88 )L\D_2
MY,8C# LML %$H!D)H&L=$$ *\L<*C($L%T?R\FP++"\L4,!/Z,\C3,WVJ(9K
M]"J>3@A-&$ I3$ .L4#D(#"2++ Q'<2.7)T>T\+Z3FL+U $1/8GTSC)G/+)#
MV-"I(L4;^*^$4(@$C/$*\ @$S#-*V+,",W O0W"]PH)%2 2")(P5#UZPH-HC
M>,?)B#-)*M$E@/)!8$6'CC,E0#"HH-H&M,$)2 \FX$&PL%@IA*3Z*,#+_3!1
M@\Z4SB7.3I(#X!0$2, '>$ %M,3!(35G]$H<M( $H,!LI@P J0$'F.-94- ;
MH !<M "2J !*2, )>#582X0(*/[ XMF1'(A,=N1>0JR &C2 >6S 7%+ 8<R9
M*C: =BB "3R<>;P! #R+"E1 &X3 PB#3 IR "C# 9QSU<T0%!2CI5/@E!_OJ
MCXA)+7C-"30 'I2">E:/ YQ!"S0 )F2" ZQ &NBUFWR;'*1V598"'D2 9E3
M:4 $>@2>B^C$J;4 !+1!"P2M6RL "/@= SR?,>K/JV0M%@J1):@K5Z]U![2U
M9J $RY0NEBYV;[^'9J/L&%2" 93 &FQ <UG" \"VBX"+F,2B!:3!X%;;!D3
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MKSI@S@+BJ@4%+%$"4K8 <QJ@P_[R++&\/9F'%@HHRR4:H"8HI1(/;_#4'11
MNXFJ@!()@ XJ&& )&0[$ 3+*A&A\LX:!K."9D5O3T4BP4(#:,UIE,)X$(H&"
M9]*"#A;0W%],$<H2TL(,YTE%@2H 4P^LDHE-Q ^(1-#$"BQ$ R48R#^[B8<4
M#/4-9WA$QR8@5:H.! ^X8AXM5I!5#\B4(&O 7 O61HL3%&&@J3F!YO!C@3JD
MH9FTR(,"3MH 25C@H;2@J$4MPX:_]-4,6:W#!20Z$!6@0!*9%"<E01M:T<ID
M(49C%6;3U8$XR TO-_( !Z[RVJ>JQ04JN-\(2# !2* O%1$H14'9ZH$Z#%$$
M)X! 'O[*$"A:L "8VNG,&QP0AS>\ 3@K4*X!!W)--273+"480RT*5! V%+<!
MCS@K-#4 /=H&JCP4. %N)1#1#RP (NZDA04\$-L.I ("T'FJ?_M+BS60U[S&
M*RT*D/= P2:E I' P)[PT#' T0("F%#O0.Y@ 5@\H$>/$)+@""R][$95 FJI
M@^Y8F[XX6&(">(GF'7'%*1(LT@6U"'!O?RLN3GD+%>$MPWEHX4T-["D5%AC#
M _&B 3Q @HDARM$$'A$!$A37 N8, 00P4):"6. "+3B! :(U85H\HL5!KL.0
M+8->64[Y!%6V$):U#)L'J.4.3+0O1, (UZ%>C04\[,H;4O[,@A:8 9CI2K$'
M6& !M408?/BQ!()]2 LGG[D4N82F[@B7X=%NFM.=)HEI(PQ-X1(NR'?@ !M@
M(9547!,_*FB!".>5BC&%=[9BGH,'G*@*3Y0".EX>"'.#2=<N>6LA+%"N!0(G
M2Q]UX(Q0XL :@#R0$G @HA[PI_'.'$'\T-0LYHDU=";1QC,,1)BTJ$"05-WC
M1M$: K XP0:JO612&PU?CZ">N(PXB1M!LV.!7-XE8-$ _*RVT7N9=KR+4.@-
M2L*W WD#!_) Z@L$"'.P<%8E5" !B$"WISR\<17%7 =2JYNI6;WO(SB@Y4*R
M 9WWO7;)GZQ.29C"0*DPE=_4L_Z02#A@1V_8@%?%O-MNUH$#7ER3)#H5P4F,
M:=7.*@7.!Y(*!PR\8^7NBEV7J]RKC<$$ X%%).0 4!*8X87\)H@&TE !. $:
M%@VGM^>>5%E#:]OA'CAO$U'K:;WOG>\-J40"6#4!:(*M 5JI0P >P;&%7*VB
ME2G% AYAM(C*(01T3T4.?6<9#5@ O&7!A(9;X%6XGF<#++@(&P3?FQ5TO905
M^ L)1#0!.:#T4+7 8!Y08P$SS 4!=2 S- 6O 1YB0@'/U+D#U!0'-\H>I='B
M@#G38(%8P-4I]\E1 SQQ?5MH8#'.\3UV%H('!BRDANFKC!P(<"S,PF(#3*P
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M'T%$,@P#5" $1*,%+$ #0  54*$"5H #*& UXL "?$@2:O[! T[* TR!%DH
MOX!-$C1@ S# #6CA#&P##9Q"#AX@YZ8)! G"%<TB;31 1-: ]=[ Y,Y F@H"
M$C#  \;@#!BQ#$4$$U!QQG8/(N1 $S$ $]J@T-H@J^3 523P$2LO"3_QI#J@
M5C#@ \8@#4  #Z(-KC2 !)1/#C"A C!@##Y@/D9Q"+V*!,1E#"! 3D1  R[
M*5C!$Z_/6L8L',=Q VH!#2I@ PSG>T9@\X;C#BH D!8,%D(  R;% CC@_<PB
M%3R@ U  T/(@!#YQ*N:1!5BOG@!R#7B(%D0@6ES@$4E@*B!2 Q;Q$2J!0502
M)6TN!#0  RH#%?81 T+@PSA -/X$2 ,>007V)'\PH!9.0$9>$@.RZA#K200P
MP">K\H>&$H)(H"=M P4"9RQ6D!4'@BSC  ,V -Z")RTMP(O,8#6*!Y J0$:
MTB'KJ0.V30-&8!TWB 4*L9ZZ$@.*8,Q& $I,#A 1,S'W3H.D12VT#19NR#)B
M#"%2014,XGM* A;40BDL;I . C+U(E<,XV!8XS/5@CDV$R%004ATPQ8N\\,2
MPN80X@30)2E.T^MN,T>$I*\P\S-[LR!0H4.B#C8G0C.#8C(;PA0B4]9$PC@/
M8M4*@CF?TS4YXF"0XC=G!'.PTT420A58,S8C4S'%<SS]$"G8#SGSPD/2$R1P
M Q,HX/X#B-,DA)-#(F(^ZS,A?"0W*B0/&,0S:L(^X0(EYA- Z<,D'J$_,X)
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MX5/5-_Y9B14A7O56WY=]W3<AL+5]G;5;Z7=Y[S=^][=6]?=9US> XY=_R16
M QA^):* Y==_[3=6^1=9?35_V_=]'YB"&?B"\7=^)=B"_S>"#1A8.]B#[Q>!
M0WA^1^$'P+8/L%03RM=Z?6 5MC>&G701=F &;& &^."#G101R+=\=^ 39#B(
MD50@"$%Z=^"&<SA+^4 &K)=L$4&(H=A(P\"&J1>'=?A)NX"*K]=YH[B+?111
MLX")S3>)M=0*Q'@&O."*O7B-8=05G$"+JYB,M70);I@*V/B.<S04HK>%K1@C
M(-1"_Y,]:^(5>( )\/B0;900Q+A\K?B!I3041@&1)7E&%_[A!GHXCBFB7C;
M ](R%P6P MH -C@ !"S! S2 V3A ]SJ%DU.Y1C:  TY1!$3#$C9 )&$#*Q_$
M J@P%N E/%-CD_'#$2G!,C[  V#!##3 E$5 #A;"#LFB CB@C5 QHM9  _YF
M_VAA#C2  ](2!31JDL$92T'!!^#8!FI CB5"$@@@ 1[@ 1B@8R)A !A %50
M ,H %B0  A3  !R  5R@#0"  2! GU? $@8@ 29  @J  ";!$@A  ,Q)$@+@
M@=9D 02@L+;F.1#"!0)  (9I P @$')$ 1  %D0  !Q  @P@  ;$GME  1[
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M 6KS1-8\T+$]DC2A!E38D0E"$@:   !@W F (J$;#P* V@<B!+H\G@! W ,
M . - (P'Q-O@$N2=W   !"@AWW.$ 0B @0(@W@%@!HM[("I<!08[  8@ !#
MBSP   0   (  L2%IU=2$@#@2SB% 0!@I1M -)Y[)4$Z0DJB%,:@#,I@#-8
M5_# /+CZ(=+ !=8;Y56^#%I^3?Y27N7Q8/H*HA+(T 7F8YI<X"W+@.8'0@Y<
M0.77 $XB004> 15VGN6A Q*67N7'('" G@2*(*+PX.JQ'CHDP05& .EIP>IO
MOG4&(@]40 3&H-JS'9$%P@O$ "-0(0[D(._EH Y0(>\SI [:8+U%$#\P(;FG
M6PX\[ U@ZA+6H!*F9?'7@+77@"C8BKKJ ._G( ZBY5G4GA9,X0UD)!7>8%\$
M_PWF0 ZH!E$:/[L4/U?6P 5R'C;68)C'[ W0,R3BN0#P.P F8"I6(  ,8 $J
M?KTC0=R'*O<)@  "P 'P)  6>N#ADR!&70 80  , $<^X-WQN]UI 00 0/<!
M( &\Z/ZYWQ[X[WOY48$-OI_A <"-%&0 %"#=;_W=%UK<RT3W&6  EGT5/_[\
MU^8- $)  @@!$$RBA3"APH4,&SI\"#&BQ(D4*UJ\B#&CQHT<.WK\"#*DR)$D
M)<ZB%89/R94D:X$\R5*ARTH&-L""10+ HT< +%RJ=2; !H0M$#B0 (L6S0VE
M4IT H*:4 0V7(GD T )A)@4*\-#"DT"!*A0#WJ0JA2DIK1($WI12@R !K#<
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M4&-X8$"$HF'RA@<#J!=JO?;>BV^^G)XTH[[^2C23 1TD=08 8]P!  >V/#B
M!JE$D( !!"A@0!VE%' F+4_A<4E-9\U')RV7(-! );1,LF@I*O3'T D#R $+
M'0P84$H< Z+7 4+S/>*F"U>B@E^<D7QE  1)47* >I@856DE#1R BLUET&*+
M! E84O[!!)?0\@@!U_X+=MABCTUV1K&5778D QB00 )K>R4"  Q4(  "E=AL
MPB67 .M!)88A5.H;EP1@  (#&%9*0D$A4,&.H85 GY"_@0   @8$0,"@A8UQ
M"0!?ERH'70<4'H &M*0A@ $3&% 60I)X7EL:A%NPXQF$ < "0AH @$D+ "B
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M6Y_P?,\_+31!!8A01?-6-C&G*7T  SH >)SP BHQ"S?@!+00!#+@ S<0 U]
M"U,@ [1@!3=@ S+  S>P"0IA!2\0@;00"C(P R/H!#E "U00 SW  S$@!34R
M"CTP TMP S0 "K3@!3%@!$M @R@X S$@"+0@"#$@ Z-P"#&0 T @ SU "U40
M T$0!#PP!;0@!#'P![2P!S"P"IH@ TP @TD@3D$  QBX!_XVL ,@6 .'@ @O
MP FTX 0QL 1;J =(" -", NS, -9&!*. ()+, ,ZT H^"(1"" 42& 0(804;
M2(56R -4(($SH 1!$ -9H(4PT(5?*'938(()(02<Z',QT'1UR 0_$ .'L I.
M> 1!  2:T"))* 1-< ,S, JBX(1!\ ,[$ J;$ -*$ 4Q8(8P*(F4^']%N'DO
M"(1&, -"X!*HB(F&0 LY, 0(H04Q<'ZT@ @RD 4S,']<ER(P: 3.* 17]P*;
ML EC"(-(@(0OH FC\(R %T5U=A%&5!M+Q$.U\0A,\@%WD(\ZE$1$Q!"S@0*N
ME! @,#4N@0=,$D0.\4/Y. ?8]/Z/ 3D21N $-W"$C1 #?J A.Q %M/ #2X 0
M4B #KK %-6!X56 #GR4*/! %-Q **+@#,Q"!4@ $4V@#?+<',4"-,%(%,A!]
MHY #?/ *,5 %",$',* (JW #/6 %'.@#-C *B! #F]>$B= %*JD01E #.3 +
M?G"2?2 #LL@(8?!^AP"!YX@0AR #<T@+31@*AP #1T@+43 #KG (-3 #8D +
M.Y"4(2$$/\!WG^ $F]"*@>D'+[ (?F"*M& #24D%.&!X".$#)$D+.C@+3?"5
M88F+M" *-]"!,TD+1U #/!"6)]F$73@+2F %HC #>2B.,7$2A'"5_\>%KM"7
M"O$%,?XP@HR @5FPDPN1!4(@!,C(DGRG!S @"E9I<ZT9@2.)$%Y0 ^]'=380
M"C?0A9R2G#['G%89"GT0 V:)@8< CD& !+,90D_U&G5  ;>6"2SA$I+@ /\E
M&A5@ -$F!WS%$4AF,G40GROQ"3)P"$A DIP0 \\)DK3  YBI"#&@E5PYA37P
M<7XP XVPFZ%0 U@ CE3  U,X WRW"C,0F"_" TJP<+0P"#$P=",*!JM@ U'@
M ZL0!%!0 U7IDZ[@!3#0"%T@ T9PB2/H SC9!80@ V&H@D'P!?0(!4K0A+)X
M=>.)$+89"M]HG5;9"'M9!3- "D" C!\Q"C)@=:+P"4V7A/Y#!YM>T(J#H DQ
M@'E;"J1!,((_$ 2(0 A 8'0_( 4]4*0R,),6BJ%^.0M#V@-;4 @R\ I7D)<*
MH:% P 1!H(DM8IMAH A5L .Y6 ..&@17T'<S, -!('H@J@1!BA WX 5>8 /O
MMZ6$@ A,T 0O6)T+<00VH 1,$(+"1PN?@ ,R8'3JZ1JKVJI&0'0Q0 J:X*F@
M.GJ$4(@RL A5Y&L5D0JUH@:YP08BX +8E!AU$ )S@ HK< *),P>34 8B,!@I
MA@?Q^0@G< )>D1AX$ )CP K650(H0#^2< (E$ @+80K2VB4I( %I\%^UL $E
M8 %)(0=?4P<E< (F\P8!6@>0H/YD)# &!HL)9E!@#J "F/ (\9D&$@M?'D&=
M*'&2P*@2KK #-0@$*-IW,8 (71"B"+&EE8D02, $M( $C2B/A5 %QYF351"K
MKE #@/@B.T"2-/('M\EV,] %KQ";/M '/N %N-B--N"I2<FA59 %5#"3DZBL
MU-ETHN %1B #.> *NNF7-1"IM@F7MOD)6!"KW!@#B]"-FA $5A $7^H1*8B!
M?% #,J '3;B,(ZJ)/P %7G #?+>E6#L%,QD$,_ #,X #(SB)?S #U#F31E"S
MEX@07$L#4;L*/DN/-U<#31![WL<BR@H$/2 #23D*HQM[>0B:8>N$L_"-58 %
M5#""B_X@ YO0IM2XI3]P S+@D5;PM@D1!#= !500!#9P?J) M*8:!5J@*2>Q
MI3[  \*+A#$PAZ,@NV#9A%+@ WQH1?T6$;!0 2N0!QHP K0@ A[P""S 5X%
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M^&$&,SA$ PENA1F )XGNU,L68J#B_;%8!H;\ @P84;I%3,$&51 DC6L0"B&
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MD'0W6E@!%B!2BJ@#)Y4#%5" -JB#@R0G%2@"*:6%0Y6 :',!_[, $9@#.=
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MA!<8!5+L*$'P=99(]A?1G1AXPV8O'6BW3&FW7 FW"CR8 !&0A%3 @UJ0 TE
M 13HW4= @1- OTNH SP@@3'HMC5P>77# VYZA!0X 9HD599(A2(X 39POPD(
M 9J\A!8H@;O8^ ^@R4JX>:* !3F(A!)( UA0 Q$@"H/PKJ9_>A5(@5* A160
M #/X-N_2=(K(A**_"Z<?^13HW3<( 3D 7/C*"JB42I$0!3VPRN'4RD^(SU'H
M35%(3/Y76 7&%(4^L$/OM,/B7$N\),L^T(19V$NRG,N+CPV[WX*K% E$P (O
M $M&:)M0V*=5Z(-99 E$R(+-+\X.)9 ^"/>+,81$\<_,)$L_*,MAQHW4] *P
M*6$]J()!N Q"T,H.F\OX7(55T$]18$S!-WSU% E&H$S,^@,^<'RR+$L_J)')
MK]SQU8H\F  /J(0[F !82  1J ,2@%0\F$D\B(!2>(0!:($<?4 2H-@3.%@*
MJ(-)8 #75?]'*%**Z( 6L 2 L-""DH0/D& U2%,)PYM*$#Y(JB0A3IT)>6HE
M""$'@X4S9AB@DOCFSH1'&$/4(6$!U@H':BQ-D(.GP1Q:M?YHH7J@9N$;6AE3
M4J!51D*=,0I:T$JJ="G3IDZ?0HTJ=2K5JE:O8LVJ=2O7KEZ_@@TK=BS9LF;/
MHDT[5@P?6K.N>E!#JXX&6 XJT4KU(-4E2S8KX)$D(2G=2@]@)2V3JD.=4GAK
M 8Y48:F$,[1@8:+E84W>2$E/G-#,AM:&,DG9:*#U &^9U+0H1"(Q)JF:U'?S
M.F E*>@E!H]HE2JE-)5G6B=6T+J=*@(F"9*2>E!A<^O;IM75*KV^5#OV[MZ_
M9^6>?:IV\53-@^>*/GS8]>G?PX_/54R?K''G8H 50?CR4K!.>) "!($\<@%A
M'L2!P64WT8(!';4 J,* CTPV7?XE&D1@ 1Z:I6'3&1N@@ %R',AU 0<CA/#!
M":E((%P9)"1U01T>;("BBJ6TF!<$J$@R 6)R5""!!\(I90:(&" %@7"E4("'
M!*DDY0(*\E%9I9578IFEEEMRV:675KW%UE4W?2!7'?GMEU<$L*@('1Z16$ 8
M!X\,1ELJ&^!!@@E)<?!FG$FI,DE2;S! "PBCE4$!8F5(U\%H&'!V62FH2' )
M+6; V. CFR4%RZ0YL@B+)).5DAF$&TQG1@6(C<$"+4KF10%!F1DG'8-?XIJK
MKE6ZMZNOOP(;[%1?U-<K4QJ8,9>B#'B2%T@>H%#+' BLX21A$S2X BIK+  +
M!G6(D/Y"+7(@T :=2J'"@!JPQ $!+1]\ (NJHD[@@68@P"*' Y&4PL$8M3!@
MZ1CVTB+!(WCL6\H&LP7L;"J5*)!''0H\PM('J:XD& BH-)")LZR4X$$J=1A@
MJ[ GHYRRRBNSW'*P8;2%E1D;2C(&2U#"HH*G(GS QATG/#(;+9(@9<H)&T!$
M2Q&2I"+"H3\'G=1-DH"P@0>_1;)!'+2HX($+DHB 224;]!3'!@M?I@*4<W1(
MR]>TO,$!VCFCDG;=+H20[]DE$'D9"U['!DD+.*N 2LX8L*!&3RXSWKA55!AQ
MQ!%5K$(+Y$$8 41;AQAQ Q*+T#+*$DT$H00A28U"!0\_B/[QEB,_G#[+$E_0
MLHD3.OC@1U)09&%Y$Y)33HL4O8NAA"Q*B;'$*DP$P003/RPQ2Q2]0WY$YIMW
M_KGCVW.OY5LP=Q^^^.-_V4,.7E0APQ*T^'##%EM$L<@K,DAQ"!(QB"**#$%0
M(40,A]""!S30PQ9B0 5:""(&.J@<#@X8!!\<@@HO.!T/DD +\WEA"S*P BUR
M, 3+R>!X2:'"#%9Q!2G80 ?3FT4/+-B^+62!"O*3@1,0<;]0D"^'.CP+^+!R
M*ZD]Y58_!*)2?BA$J0SQB$L9XA*9PL0B$K$I2H1B$W=H16%!+RE.N $MLJB4
M1L3 "[1P!2-DL8H9Z($69^S"'_YBP(BD="$&JSA$#6YPP!M@@18S8,+Q&H%#
M'ZP/D$GY@138IP1:5*$&QWM+(ETQR/4E19! @&12.!'&,3+B%5?<)">Q$H8]
M=#*4HAPE5(+ @RU0X09_H$40:N#*'#C2"3'8WR!"-X/Z90$&?VAD4A01@T70
M,0PS6,0/#N@%&<1@!UYXBP^8P,H:!.$&-]B$(2VG2*4D<I$^.&12)OE,&]0Q
MEC&( >Q(:<Y1BLE88'EB5]AYSG?"\RE!L $4A% #170Q"(@@! "3L@D]&"$&
MAEA%'7F0@RT@<@::I,4A8L )1,0 %$M(0C%1YP<IQ. * 5S?#X*@"$4< 0G5
MI,(UD_Z2S4A:L)L<U2<_E;*)/03T=/&<Z?CH0].;XG1E7A2D()7RAQMH@A:@
MD $@7"&#-"K%$#&(F1-F,(M#R& 4H*!!#;:PBAOH;A9 $*D@O9B^5S0/D39X
MQ2P<B04;B-"+7>0H)6E!"*#2XA.7S"E=5Q:FF&DE%;^IBB748(M(F (L>G7*
M(_I6U\.2KP<?I$42=$ +(<C E3+X@BMR, ,EW, &HUC%"VAWG2C$P)0QT-T?
M8!#4+;R@"K180@R,\ ,9K-*#K)2!-&.@6ME.(08VL($,&G&%&%1'MDF1K?]J
M8(,84-:RF+T!*!#K7&$1RRU704%/ZE"GJ7C" 2> !0?D,/Z=K=RD#JAJ8@6V
M)L6A7<PIDDBO5XYX N^Z\[GRK8HA$I&41?SAJ7[XPQ_XT A:O((/5 C#*,;(
M!VHRY1!;Z,(GDA(*/C@RP&]\*A:V$%1:U)>A?_ #'T"'80 N8K]_Z,,J-*&[
MI!#"ODG)L"%$W(?_!I@*7Q#%?&N<JQY>90/).A,M+*$*I<"B$K9@"AZP=1D@
M6P(Q24'%).HVG4P8ME128Q LFIP4#<!7*98@$AX@H.0@<UD"/[Y,)9Q\$U18
MBA:7<#*9V7P92\0B*1NP#)FA9.,[XSG/>D[+]_!:E30P0 )O>,0$5J !!]R!
M%GBXP <LD.52:* !'$@%"1[1!OX0G, "%6A6@E2"!UALX&\.,$TM4H"!L\%B
M4[3HM 7JT* LHP($'L  "B#M )%A @,DN  :4''H2<,)!!7P[AE$< ((M* ,
M&(! 'A1M@49[UPPA.$$%*I"*-01Z#9; @ @JT+8]@WL[XY$*>HPEGNH8*[Y,
M>0MWU!GN=Y<%QU;Q !H4G8#GF$$#M7 .+3(Q@;[E80(_!DP:'( 8#B#% \^1
M@[X3,)I(*.!2KCF!"PC]KH4K" -99H."('2)2$Q@R"S@3"D,3NA:4.HY.(K%
M&!Y0"U,8(%DNZ$#!5"Z!6HS!R[1 ^,XM\P&D6&*[\!XZT8N>YT^.23-F^E,=
M.' '!_ZXX0QO4$!/;@*)"F$@$&4(#2U:$!I8X$$-']@ +&"%B@BD @,U.3(>
MXE2+L(,@-1J?CB4@$((T".?J2I$$&UK"Y,'4P0%OD'H"\+#URTP +W+P ,+>
M8(8W%-X,7/?ZSN7RA@:<X U*-OK0U<WYSY,RG7!9NISF( $YL*$-=^@;)"9P
M$PP\0O))68%T,*"1-W@ %;!:3BHLD.A:A!<#M;"]'-Z0&BPO)15J"($")E$)
MUQL' VIXA 52,0ELR>'T:FA#'6KA@CW!8@+/><,'K(MZ[L/"!5Q?06CNT^/6
M3,#-H#^L*T8A0J6(HG))<84HJF-&1[J"_HW1*KQ%*T38*_X@X"K(0EFY0BLX
MX"S,PBJXPBNX0H1)8 #>W_QI();8%%:0R%PPG0:4')&4@7!8706\7AX<'BVL
M@ M$0J'0PAKDQ^YYF0IDBAF@P"/T20,DQ1K$R=S=1!G(!2V$0 LT!TX@ %Y8
M0@/ 0B0,QB4X )'8C/K1@BU( %[$P:1%86*D']>Q0&ALP&B00'$X@*MM(%VY
M0A7,P S<@"'<UP^LX1(4F 8=D.7,@&HAP0RTA2L$P0P40A=%P29$U@[<0$;U
M00S<P X<%R$H0AW5 !NZ A.XTG'1SAE:8GS<5=*Y0 +4@<7-!;:D 02L  :
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MN+UL5,#BD7W+\_T0!?Q&"VP '8C@7B1%V^U;*;B J\P("8P=+2#?9?#;W+6
M!$@ "]3N!(2 !Q# (]1!!&3E(T " T#"=-#L))R &H#OE$1A+4R 9\R=\7I7
MZZKO^MX9D&IGU\'(341 )%A"URI%!?Q&+6B !^"+ ]"*#/[20@F8@0=8@B4D
M %[DP?&E+RQ0@%]H0&,L2060FJ(9;6"0  E@A*M-#0((RDW 0G2PP260  AL
M2(N0+UX<+_+)*?NR< MOTIM2128X0!RP1)P@(Q$YP%Y5P@!,A@ILP+<Z@'?A
M@0*$P#$N@%*&@ ,,W^+4 LZ^1AVDP;]YBV7<A >$QDT\@@&@PAL@P$X8GV\L
M!0LD88,$1;H(1P.8Q@4L3GFY<!N[,3QUX%5$P@=HP D(AR4@QU(\['2H@:O@
MG 9TEU*0P-JI 0< #0K(@1GD+]QH@"64P6^,P08H;IQ]QG-XZ@DTFWA9  =4
M0AO@A5) 0@G<Q!ET""JH#2,[\OY>%8%,OG$KN[(.9>(KR_(LTW)3R&NG6H5U
M3F<055$N1U$OK^H*U_(P$_.7O&XQ(W,RPRO<*G,S._.['K/*"/,S4W,UXTHF
MNJM6H((':Z?\&0YVP$):2L4VAP4Y6_,YHS/R^-F0.I$3_= &!$+;_?)WW00>
MN,9T<( &/]&GTD:S"2D1,8@TJFYVW@H'U,0^1Q$_?U<J5(!AI?-#*S,SG\7K
M>9>U1H7?6FSZ5H4&?-O[<B-HGJ]7Z)Y#0W1)%W,T/P4>?  'Z PLC,'BS9TD
MF($,>D#C-H9IT,(8:, &I*\:>  '=(AXO0$&U'3J0L+8K<"8)84<<( 'S,8;
M.( %]/Y$&OQTATA"&7"<!V1&#8^!":0 +=S!!W1 2X]!891""$C? ]<""72
M02P%2WB ![B:'*B!"U1 "B &S6X&!8RJ2?LU,8./2I;<<X! LAQ "&!"'20
MQ : &91"&3B \>+!(SP U_PPQ$5"D87S%4I" 92!*92!NSRP[OT&"ZSB34#A
M)7@+#6. S@#)9E=") C &Z3""-A+Z*;"'"2 S3@ 82=+ G17*53 &*2"&0R
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M=?JTY"Q:8?A M7H5:U:M6[EVU4IA#"I3(3"4'#CF0TVF9]-")#G&@UJBF.1
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M80(U(($ *J G#"A<*5*PO!-@ !4.P$@E'" W%D3.#$QTH@6@R!<\&* %:GB
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M!MZ@!A%ZY .M:H'X+#&)%Z\+R?Z*;8QL8>JC$S JPV-(Q20DBP$\D$"XP-F
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MTJ 6-. $8 '#B@H6\$=)#:!)"?XB!52@%!(@#U+!! I ZV!41N. ,A;@N"S
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MKZGC,2@$T*.\*XZQ%MA@V2H DU"$($J@#BSAI?-(@70-G5 ! QK@ R9!!%@
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M<@EC*! MX!PH5TEW<1(?L!_ TB00 "*5@ II "%<4DX?D#*E6 <A0 ('L0'
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MJJ5<2J,_VJ)?>J54FJ57>J0Y&J9/"J9%*J9>"IW=QB!0(0EQ<&B9$ <@ @M
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MF+1  =;4$JJB 7=@"1B0"0Z@ E'E3)!P% _A 95$40O8$ZW4!K*"4SJ4'$7
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M=')@5&70 !Z@FG5P"6E0M&;$%M#3 H0($:5P HT$'K -8[ZC&"B !M[<$BS
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M 110^9=P_,$O 0HP!Z N^Q+   &(]/7KS%=A9UC!$"<0 I8@<):P.GLC"07
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MM--8(T?>!FA!DA4 N&!C $BHY T&#+@$$P'&P(,  R)188!,4""= P%$L(0
M$_RK\;D$@3* .IA*($"%-=+HZ/X- 4 8/HTYK&:^>>>?A_[!K -+;>L;3\L+
MIC=PVLO2ZE\#GRZ8Y-  %@?J'7\#5!B 9843:&F#>\8B43V   ! H!(&!@A$
MRL%5@0 !['<_Y[C    (@ %Z5(L3"#  "% .3()S-+$!  .C4D  SB"1.QG
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M#2"!-\" *VL!!_  ,U"#!A"!4EB!%* $ WA""0BJ-7  -1B#!,")%MF -;P
M%H %$J"W/JH 2," B" T6H@#"6 #=I,$">@?3&@ 6 @!#W@$$%@8#:@ #W@#
M@&L!6*B \-( /$ V*G3%5X1%B?""*\Q"+12][H&6!3B4-%@:JZ*%#9 +-0J!
M*"N*Q?XR@_Q*E<Q8@1:@!)OZJOR2@.@( ;F "34@L:)P $^H!&2<BPF@!$M
M@%3 +UJ @.AH 12X-5J1BAE\QOE:&'5"1@Q8)ZFHA>^K$/*+1=C+QWT$$5F@
M EJLQ1G80I3K'%I(@0I0"!&P@%1X,6@IQ!###JA['QR1 +I91DE 1@+[LE*
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MSAU1JZ@TX  2R#C%PB@'&,(:B?XQ;VT 2X.)#5".2Z" $RB"!T"1\*R+.H@
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M!#J%)4J@L=* A3C0=4QX!.V0"$P@)4D@]J\J=<KXX%1H=5)*]1S)A$^*!))
MA37HB*)0]97*D4J8@S1RO#+PP':GBTI@3.^SG%]GS$K@I:*(@S9 !6\'=RV2
M U4HA9$Y.C-HP4*7PD5 !(RGB^!LO46)N_X+W 2%+4;Q  ]@@S7G^)5G>7Y!
MOM5X).@[/MRB^9''Q2\RO,,3W)JG>>/3V_1&OCJH\9<G>>XK^I+WB]9P5@6-
M/*1O^:>'^JB7^JFG>O1;YJK'^JS7^JWG^J[W^J\'^[ 7^Q>Q)_NR-_NS1_NT
/5_NU9_NV=_NW!]&    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>cogo_0026.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0026.gif
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M\^SS^>?Q^//T]//V^O;Y^_____#O[^#?WP
M
M
M                     "'Y!       (?\+26UA9V5-86=I8VL-9V%M;6$]
M,"XT-30U-0 L     '8!? $ "/X IPD<2+"@P8,($RI<R+"APX<0(TJ<2+&B
MQ8L8,VK<R+&CQX\@0XH<2;*DR9,H4ZI<R;*ERY<P8\J<2;.FS9LX<^K<R;.G
MSY\GI4T3*A2HT:-(DUXLRK$H4Z50HTIEZ92AM&C.F"DC!NS6K5*EOH+U2DR8
MLF?1'#Z=RK:M6[4)HRD#5BI4HSAMP'21<D0($" [=.C(<:.PX1N$!>_8,63*
M%B]CUL1Y1 J7LK0(B;[=S#GIVH'1B)5Z!$<,E2$[<M@X7#C'8,&N!<N>31NV
M#M:%=Q"AXL5,'%"6.PL?SO.S-&&B%I&A$F3PC=4W:DN?3GWZ#]J$#><((@5,
M'$^WE/X9_$R\O/FF!:4%"Q5'S)';K6-?KTZ_OGWIA5?GV"%ES2-<SXQWWH $
M6A0-+H^04<1M-L1VWX,/%B;8?/91F%\.0W3Q!BC""%C@AQ\^%<TMC9!QA&J(
M0:BBBEJ  1]T*\J&H@[]@2(>B#B>]Q0QF9 AA&$QTM9@D-/=P(PG-;3A2!QK
MA(%$=,X%F5L7<93B#$'DY:BE9[C,T84.JQ$I'1Q2Q$B8@X+=(,8T1MAPRS3$
M.",4*+=UT4A@1!HF1!B9#+/EGU!%$PH;)Z;X8&*W43?$-'#8\)H-^LDVI*-I
M'B&&%CDX> ,NH30H3"@U[!"$&=/,4<,<TR@F9IHW[.#%(_X= BKK34Q)4TH:
M1;068Q%=W- %,4= .1B:F0ZAQ0YSD.)(<X(U$DPPGO1PFR/.W#+,+4+ IL4T
M6D3G#"B4UD *,35\@DL-8:XJVY2.!#-0EK/&>](M< 1K:(PWQ#&-KZ48 =L-
M0Q21:0YMT)%D-*2$\H@TMQ16RC!?>'$+,#<4,0T8-/"@C"/1U1 *+M'M( T<
M-&1:0R^WU(#+)U\\8L9LSPU)I&HY;/'(C?+F?!(QBU"AZZJ^3B-%8=?=D$0I
MRBB#"Q(>#U.#%]/$44,-:^[0Q30YT("N-&+L,,TC2!"&I\5B1&=Q*7"D\04F
MTYAQPS#*@ (*PVF"T4B]L:&I8OYAHXH"K\Z 6R2-*&'<IK>4^^4031LUW(*)
M#4$P$TH20IBBC UP/'/#ME.XA@2;<433""2??#(-*#68H8PTWRYXPR+*N):#
M%-,$ XPRSB@3QPU 3-/(U%=K80/;D( 2C=LZ'!$$I'G><$0<[@8NO47#+/)D
MR/7)3-T-:9@5BC*?T# *,#6\$<W KN90QC0["'&QV=S&(0TCB\3QAA?O14<%
M&TKO%TVC/[@!U*10 QVD!C&?"UORN'4#1W1A!C-X@S,($XQ'N"$44I"=]NZC
M&AUX(115F9X(%5(*,^S@7O79P2-N@2?G!"8Z:F*4$M8@#?+!01HV\ 3%)&6#
M;2VH;?XAX]K5LF8#&KA'#+C000UF0*H;T!!/-UC?B603P#4-X39DD$80$".%
M+FRA3SD @C.<00I2(,$,M^ "'+@ P\-5IS!(< 3.1DA'@4C#$SX3UO9H<P2!
M@ &&6G@8,=90F%N,HH#E2]75@+"(9^Q',&8(0Q#>%XTW1"<'TI!:,(BA!"'H
MBPM"< 8NZB"'9X!J&(][(1S8A*8;P&&"MXF#,VQ@AF@$XQ:B,&4-KL:XYX1B
M&J$HQ332D ,Q/$E%J@F"&X!11^D5Q1E@VR!U=L"%V<QN&,_XA*.D( U'*(%4
M;JC!,SCV@QRXCPM>V\LTNE"#YTQC$3:8QAMJX Q/..H&M_Z@@PV$,(IG*&,8
M9=.!$%9XB]U=;4%IBH,P*"08&X0B&#?X00YO88-Z1H<&MWA$#4(7FQU$PQ,W
MJ $DGE$*7'0S;Q"*3AA(\:YFQHL9D<B5'JN3@U&\TP;7R0$7P.>,'=@@83,H
MXB/8APM1V !/_ZNHJ3XAC2:10AE#N $IW' #,U1356D:@A$0A2+#]*(4E))-
M"]?EB$7 D!B=\ET[NR"-,(BK88.Y6J$>X0RFO6$:A6I?IB)T@RV(PJ6S&@8<
M?@2A$]*U;??L@C/"\+Z-H4&'N/ $#^3'H#Z"*AA@U4$<@$$,4 3+-A*:CFL8
MJH/Y>,%?]C%4#LP !AN4X1FW"/Z%3<U@ V4T J<V:"1LF/$[#^(U!XY@AC!N
M008W;L]7?P5LB 2B##CXU+AO9"O;J) I,$1C!W$[&1D7T87 )"$(U:("$F\1
M#!N0X65@RE18*X0G"EWG!ZF9T-Y<<X,@D.&/CPB%^P)Z V" :X%?LD$CF'$#
M(=S"##U(@S2\ *6]UJ<P6_BE<@GTC$4(8;TQ>L9WI'%A,SBC@3BD@S1""BEF
M2$T+M\B=''CP'D11A[3..0RDGA,S&MOX,!6"61N!8(8K"A2(-VB#-%Y(C$_4
M0+TVF$%&$9,#+6@A4?4A#!= ,>'RB*X(&(Z1#1XQC!O8+G4$WI87<*",7FRA
M"J%@1OYS"-.<F8J50H2!CH2 ,(0N0L8,;7@#'.:PB#XO@L^.B(3]VI &,G2!
M"WUYH790"..&RB8(;[BBFRBJ@R%PK0>F& :G/"$-,]2 "L'(W3 8S$$;>$&8
M5=Z,-#)QA"QG[SG$NIH4>B"-18!A&)EB!NJ.0(K<A6*K4;8Q8[;@&T=\0A2W
M(,9E,'*5K=R"%(^(0QFZ< 0@,"BT6*5-@QU1!L*T(56?B(87NE &3HO*&:40
M @]NF$&^EB%Z?TOU3HI""I]!MTA%,)<H?&9-9F@4:N !4R.N>YL@^)0V+<S.
M=L0+!TP\##,*J8IF[-C2H31$&L\ AB@<888NM#E=VZ/O&_Y$48-/!74&GR@%
M#1HAC=?40!GVC X0L+V]'<"!&?*&RC#<AM(H9^H(RLC$&<+-Q@EM61E@(A7(
M=% $*L@HVX?9 17\@XLK908BTGA*UA^2)6?T A1Q"(/K4%@;^I(A&I P R0N
M5G)[*L8,;K#!&X9QK3^F5@@LS[E1:MT#-^L8.UK@0@U* 0JMU8 8!$\3%Z;!
M!<+,80WWEE 1P#"'4<RQXNF!!C2248QBS"(6K5 %*D9/"4H,8A"!*(9 H"$(
M0A""$IH8O2I>$0M:^*(8R8!&O+&$BTRD00HG3-%8UR6%1SQB#=,(IS+F$-$
MAC1T:4""'*31!=G1AS!(0+7><_Y"[V/2M QF:"4PD!0-,O1@#L$81>&L*0PX
MM(KF.G95(WH!<<S;D1K%H,4K4$$)00@B$'\0@ (8@(!0@( 0"('0!ZHW#<V
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M/3W "/4W#3"\OS+LO),KP :IQB7[?WU " >,)82I1_7U!HN@N[]D+:!0!8V
M= *&5_ZU$4 [\*N&^@Q_F3V-0#[)=*45$Z"'4QAF4+$"<0R:\)W=2HML+(N9
MS+QGW,FS"+T+.!#/8$ET7!CN4P8U4 1P\":>MCYE$%&BY;K%>;OGRRJWD5$X
M)5%NP#XQAI=2D%Q%<;%:Z,DE^J+C28O_^['$W)DQC+Q_D HJ*Q"W8+.Q><6,
M@"XU  Q":#&/0V-%<E<O*12X4+\/9BE%4"[$$#*S(PT"@Q\YX)).$0L1N,R>
M_*TV#+DF"K)_T K+$**6O)XBNPIKP0C6"S-20 RBL%G,T,00U0.-  I;X'<_
M4 /K\Y*D("T/MDK3$ T[F7Q'ME%(AQ];L)<#40R7*::93/[/ #BJQES/K H-
MLG#28DJ!<5P4Q/"J,+,#9[!*8E #;--J,#M252H=-A &4DQ'(&4?-G $XN8#
MI? ,.+"VF? %CM!60/PZ$X<,J "!GWK#7CW G*S2L/C,BTL+H-H'E!#-TP )
M6Z1CQ% &0.J^.I!),Z %TM!N(GTE1QTXC5#+L@&#C+,?FI8ZH78+T;HN74#2
M B'/9KS&Q)S29IK&GCG "B@0HY<, F$,D+V%!1@+3P$QPG(=.Z"C.?"JU$($
M-I!4VR,%A5I'0M'7',2);1!1.=!'2&*_1+,N.< (!8$,7RK6&_NXM.BQS?"*
MF]W2_0L(E" 0Q< '@- 'LR 0 ?ZIR5$)RHW8US,5?@=U [U EVR *6_$O:D&
M3S058X41"M% S@($1#R(!'4[%(S=TL"-TJ(9UO,-@)T+KJH@"'P0"Y;=S)"[
M"O*)"_PFNHNW/$0@#?-4=HN8G2X%J+S:!;> "[VR \3PNW6#6C!C!ATJ$,E
M"13XV/>=S/=\S&T\<90I$,T@LMU:P LH%)6$0K?*0D;B=O?1 PY.1Q[,A.O"
M!=(03$%:!#].*4"\ VN7I*_ U<<-W,8-T))-JL@KIGW@W]/@I6,X"U]*C !N
MHECHV>7[(RVT Z+P3W65J-8D!%%,1XU"'3\H&#WP"5*30\"IP3_+@WIYK930
M!]MZR?Y1OLQ36:9G_+@<2(;/C0K2  V7^0>870Q++I5I37'#,*P6 @9NT,X0
M L)/ZTQUCA]]_"- -PSX>*O.8 2IXP5ZPST3MPL ^*G)V^B3G;E/SN2KX.&V
MF( <2 M]H H"00ONR8M;[JV D-]V9,%I8L5%LH>:[@@,>@-48$M]9\*T)1AG
M^0RP"3.[:7'2L I<G<_WC:[V[.I7J[D"3KRH( N[S@=@:<. @ S%,-V2BPKR
M^0A0QD&S>QM'$(6 @PD-5B3<! P\,#R,1]M#  G>6%H%1LC3X-LAWNU@".[,
MC(O=[IXI:Q"#D J+#8&S7N40Z*EBRHN#$,VWD 2P##3WGOXS<^+7M[%X-.XW
MGS7O:2(%'5(49KWG.9RY3<[P'<O2?=[BZUH,T7#HJ] 'Z>Z%'$@-!RAZ@J#G
M'5^ PCX-THGRY=SAL]*G]R%15T,*.(!/S\"80F*)!/$*2E_S?([S4$GB9(^%
M%$@( $@( B$+?= '&:\*BFY'LH#)74VJ6"C024I;C;8W73#&6\)"UZ=MC!4*
MK1(,0RTI^F)QT) *?7#WU#W?XNGPW\[D5RL(0N';AI[P< _?F,WK_T<)T( ,
MJ%>:?Z )\KGCHH6<9# K_HXOK1\*.( ?LJSP'4_SQQOY\VW?J-KJ)*KK!9$*
M_3T4ERD4FI" &;_5NJ^+@H#91?Z1"5!/'R68I#FB#):NJ-FS!L_0.=@A80+A
M"R9+HED8[F1_GF7(^WL.^9V,UK+@Y<70E4(_%)1@Z*K !Z)'>VP<FB]^C6?+
MX/Z?P0"Q:)JT:04-'D284.%"A@T=/H184-J6&SHL7L284:..'#LP_KC1H]1!
M67\"G4294J5*0(!:[9HU"-!*FC5MWL1)4Q!*0']\_NS9LUA!:']F_D3J<^;)
MG3F=/MW9IX\L:)123:,5"%G!08($#2J8B@_-I3C_R#K82XC%BALYNL5XPU-$
MNG7MWHUHINW%''#]7@29!-C @J_Z/%T)B- RB9K^-$6,LVQDE$W_]%$::)"F
M5*MBT?ZB5<Q8,F3("!(MG>Q8,9BR5J6BU-605*.4;:N,NA/5M&B7MR;S>:R@
MJD"$3-[^LTKB-&%);OSX&_T&*;S5K5]?2##.WNC===R0,HSP-%6/;P<21' 5
MJJ_&S[_'??*G9E2K0B.#=AJ[1&G(BM%:3Y">:H/OI,EN F2H8@@9"IH^8BF(
M%C]DD6:5 Q'[0Q6""%(&">Z\TV@'8L;;KT03&2+H$QO@Z@O$BVZ@XAF#I$GE
M.-L$.6L:6?A092AI9+FPP)QV&I"^6(I91K\3'9*&FF)B044FGX1\:BB#5A&$
MJ#YVFP893=RS[0]*]&.&BAL\8O&O&Y!P9DDWWYSFEA:]F_X3+AAE)(H2\RA#
MBI9IH($&(4V"K(E0IW92:A!5:#$-SNKZHT450H*BLM _4 EME3Z2*8@20 *=
ML15#;1*0$%"G<::*#]VJ,Z,;PG TUNN&$:)5O^:TE:T8"8-&)N3LBT4Q4*&)
M19- 5[&QTOBD$@331F7=#U+VE(),R)EP](D/M'3DP\I9&"P(E62=F@F000(E
M*)HNN*LSUXQ BH-$:.=%<5T7-ZKS3H-Z'?<I0'PQ"#A"7D$E$#\$"70096GR
M29!5BCF5WA.A*6:50::L5DBO ($0&CY>B? RL*:)94_*S&W&('57O?>&4"2&
M6:$W5KS7+QC;)*A7FP@5\%*B"O[:Q:A5G"P(603/:_AA)6-VDV(L,5M8/E0(
MT80H^689SJB6*!-0$,8*<L;,FC/B83"F8P:%Y8S<W>CF?7T]F9#2H"E8N&FP
M-*@95 Z+^K >(SX[5FF*2240OBOM696"" D$D*NF 0X03:+L-Z>6M@);"K7I
M/*+-P.<-!LTT0;Q!"&;>'M6F/ZQ$AF]0&8>MI\8K]8D0JCYG&AI9C*O\/!PU
M4>5:= 71A!J#:#DP]<8%2;D@98[8_%:+;"@#=UFET9POB]B.3H@1<X;[MG,'
MTJ1Q0C84I(]K_34KPV*6ME[BP5.1O=+Z.9TF%4(D,B;08I3'#2 09A!:C2TN
MCY!7_/Y*I(;HL0HN.[C%VTSVE,<0(GU<@H97^J <6F2L0"9I!>84B#MDM,)P
M"QL35OJ N6+XX0];004 63+ @A!#" W\RPZ",<(388)F!M3(= @3C4G9!A"S
MR!DM_M"*@B3C,,3K'7($$0O \?!SQ$K?R6Q"">3M;QH*TI:.)D@6W/S!5(2Y
M172XMZ9H6!$[PQ#=O7)U@T\<1%Q&- :)D/&'781L=E1ZS.W<R$/=G=!:1MF-
M-![4I9253'8>-!0@*(&N::2-3FUKPR#Q0A OX!!$-FC$>%)QN)M,23X@*P9Z
MO+7"+VIQ)8@*1"S:J$DW%C**E!F$-*1!"#]P:1K&005Q;O[Y2I\9I!$_7%MW
M;@ *6MK%$<C$E_;\8H,U',1HEIM%,2AA(!B:9'5_4@R0 .F2*C9SA- PX3!W
MAI(^^ D9J[ @Q?@ L#_5*#(X4AQAW.!)N/1 /.9\2"^ V+8N'"06??!@8KPX
MB[%HA63FJ5H& Z%.RV7H:P"E)3+*$R09-JZ/A1$0E]XWC1A*1B5_@)!!PL!/
M@F*T(=C#E?1N=833 :UW06*4[0;1!Q_M;4M=ZF@IP>52@"Z(HJ5,!2V2$0N9
M5.V7Z8$&<OQ4D&AD3YH:F>-<B)H0.$ 3(]S#Z@YZ89!C')4G"0(J)23BFF.9
MM29&V=96,2J+B<(G*'XH!C4"(?X<)P;*4W@DC#!X,#J_^%.N!C$%2Z7SLIPE
ME&';; D?"[)'Y9#$K?')4#D/JTEHE*= .^&4Q=2#"F@81X"V$:$H%.LJ,&Q6
M&D@8:$9L,(<9_34G/DL&( #$AZGND1"AH85CUFD607QTLUO=!8X<ZY2ID,P/
M((.& "4))L0H9D/3F,-J,6(#K;J4((OPJ@%OX(7Q7-- .YMJH)#WA]X:+C/O
MR>QQ-]M94IY,$-&0ABJVI2<K=9!/^2S(2M7HEAXH8ZO$B".=<B4$ Q=$%O65
M#-8&8AP<3;49"FM*4.43B*G*][A9T3!/4MC$#?XLM_=L+D&< 3WQBF&KG?P+
M6%\T"OZ#&,.M JKLG]S#VRXMUREBTJR'B4HW"/MK$$J-E$O^M,B26"XEWRR(
M0 GK%I<ET(HI^E!,O?,#&\2+*#ZNR0:?)!%QJ>)!X0M32H6\9D?>*"A]H%AZ
MR),E9(0X$)1\Q%YD_-4BP,^-SUA+;-E24(/<$4.#T)_A*BL-3LT"P@!4KI76
M/.E47C8E(YOBGP1QC*(8<<33@/'89FME'JY!NVYAL$%*%ID'G88X6SJ--$J*
MG$E.VM9$$>YM +&50?"!,:\(Q*SON42#**-6!MR!,)HIIQ@GLVW,) AP(I,<
MHB"O.'W0!&ER;9L2W]K;=[/T1*^2#$ULI1@$2LQM\UB04/YDV3NO:F87; 76
M=GVG>N@C5V5T65+'5>4XIPU3A[]]:R4B1\UW*PN8R3) @NR3L+:Z 8VO/(UV
M7W5L0I 10<JC<)Y4;8\H25E).$Y&20_<V_\#.(9ZA(Q73,8D+>&X /_P.-YX
M2(X<.8*?<2>-([AKSQ>Q 6._>%G)A>LQ[<1*N)<G0I-_&QG*/>^0II0L<B;#
MLU!A+QIQ.$='N/&8W0'K#<RPKY'C)E!T,\E6KH[B,S:]Z:4M,DZJU1, @YLE
M"+JHP\>V@YHJ4!E!&)NMB( G\KCU#PKC0XZ3$:@3<^U2.G>[K66M],:5!RW+
MD-LO98BC1/+F"%\E'1Q(#3."=/X5]#(-HM#/75U!O(]8&]1/,<I>F<='WO8T
M0NCLS:>CJBGR*@4?TE$Z7/&Q\>"?UD.PH+_36JM%!JT&264@6-&*60>U#W6W
MO=OSB]#_3H,:N];1;LZM\,E04B_-#F(UXU<&M?W\(B/*&NL'PBB)J((/INQ^
M]O5/'NY75ZTMO(JH>I(;RQ"#8(9 PZH8VR'<"8:?XYY1(XC5BSJ<4(Y8X /=
M.I[;P*?]XT#S.I0_X)14X!)QF0]6,ZY,.+4;J![<.3\'\HXCF"7-JRXKT92=
M(JVDXYKKX\ ='*6R,Q<EV8E5D(56N)B42!V&FP:QJ9D<P(71<Q2"" 8@RA>A
M>[![POX<:6"%QQ"@6. )J.B#5("\'30Y5#"$D1,02D@&75(%8YF1M1.04F*B
M@KB%S6$;> L<,PBOEH&5G,DW S&*#NN@H\A!5 A#,1PX68N[/S)"Q2@.Z)LJ
MV_JQK2 (]@N\)F2:Y$O *6,+^,N?,5(=T @$'@$5:B@8VS"$\S%$,92&(N23
M!IF&6? #Q?$%3RP47U*&./HY%3R;-? J]V,+-B ,"207IZ*O0+ 28?07&DK%
M'<R@E#L4OX(02J S190[GB*,[#*@'2K$$R$&Y;.(!OLE7)*T!>&#6$ &:B07
MIEM&#JPSVP@4' $4@ $.K_ 75.2-(N">.<HDF'F#U8(X+_Z;AFKH/\LY"E5H
M'FD(%ETKN77<062\+3]Q-+4J&FI9"D-)G[CZA.>HF1T 1VAA!L!#/Q81 IQ9
MQ:/AB4&XHY8 Q$0,,X%;QU@CC.L:C^N2R<.:!;,2H+/+-%I *%G0DZ9XPYN@
M)"3PQ>D1/7KY.F?[I*XCB"8S"P,9BD TG&.0AM(Z&59@R*Q$%HX[PZUX.C-3
M!>.ILY$K,2Q[BS2IDR#H.UGI.4&#08E0N$'XEA\D"@MYH5X)*DG:QNS[A#A8
MA+\$S,"<@\ D3$>(!&9R+3TA(R-L'$ (IL/#GR_:FD.Y,X.P*A>Q :9\PFDX
M!3JTN"!"H()8M9OH@UK0D=.2M/YD& IJL+0@VT$JJ('8E,W9I('9M$W9)*_C
MBBJ38@ILD;!]*0:%2;>5H#:"(+Y[R3EHL9>;XPLCF*7=S(E "::J$$6#,KR%
MW"H_TP]=HHM.^H12( 52$ 7Q#$_R+,_Q)$\4) ,/<T@$449:( 0P?*CJ,IZ"
M4$(7J3(X(0A<R)46V3-0(@S#4+@-J4I!I K=Z2@<.;BL[*2.I(MAL $7\S !
M9<RW\A-M,HKKPY(BDCH .T[2@958:4$I'(+G/!1 6(73():Z6@K#^S2,8H8R
MD-$R$(,QF-$;+0,;G=$:E5$Q6$"%\ (;^![^F)$BG9%@N $7VTM:HJZ;Z)J-
M8@J?:/Z&]MP9$=*"MO!%3G239T@P41,(@AC-G-#!?;$0._L4N8+0V+R!-8U-
M&VC3&G#3.+4!-JT!&I X(+T!9;L+8+"!]12RZ/+!E< <#KTMQ2$(2\I$B[,!
MT5O2NLBS2W*+(, 3:?!!,)2%R$2&PD$QE\0H90 #,/""(="!(0#54O4"4#U5
M+_""(M"!($#5L4H(3LI3O B&")TT)3)#([2;67!&R3A(?*P9(HC!)>&"4YN3
M&V!4,>)-E%"8^ J7CBI #P.#&I#0AN@J*8"(3M+3ETJ(6JU6(5N[X>()*RF)
MR207Y2"(I,3,.G(3_A2T9),(X;R-PZ"B=HP,U\2H+K"!UO[2.8)X@QI  H@
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MTU+J(W'9B5H+65*!LFE@,1?) ::^"V<8@E;Q3YD:93!5IT'07VBHA1@J!F1
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M U%@;*4F:BIAZEB@!<Z6:[Y87R;EVHQE6TW&$#4$9,9DA= E2&S"768F3EY
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M5MWY .H!2 !94$,U&,()1.H"%, "# 1U4L,'!( "%( "F$ >&,(=D "D*@
MF$!9G$ !$, (J&9!5 4T2(/,L@(>A, !Y&L"!( &Z.PP78L$*6>=<E&I]4%X
M2&A:-(/?V4L.\-1'_$).QJDM*OYK(AS<AJ03-,C"_T5A?E&BPF4/M@[ R_X,
M:]K"!PP  PP "%RJ"@! XI) -8!$+(# J : 'YS; .'K 3PM6=0""D1JXBZ
MPYE2"L'@H7@*D=A,2NI99D1<.!)&NWG$,72 Q\IM.U; %51%ABZ&'_W$?+:9
M#@%J 4A PJ+1" S  @3 '1A%1!Q"H Y "1Q&)$T#-3R  1Q !$"H5N"KTV)N
M\:C&*F@ \A)LC#80:;Z$6M;=4KYDZ9:)K1*$)\Q/E<S>Q7C$,[" >=KNW%8
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M6OLEO?YBVY%B*."/,1W1- Q!H04(  2&Z)DT"/$!<1; G=,0 4( D)Z^"-$
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M@:72!6#QR:%CY@^JD/O<,9]YAPMS6OO%[YE;YPQFZN '\>X%*4+QB$;$P0S
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M &$9@G --0\:(I 0^B 0+"<,3P40-D:O"BH8UH#[=* &/"$.\(T*G(E[(N0
ME\+Q5 ,JK( A$N0&V07*4*'HI$$6;B(^FH\-,='H4$$0\OX*.&0A_IIL=6Z"
MW:8A%!"/&.*@!DC/#QUA!G#!$?A0!T(&G!+AMU#C\<JO6"R##ENB#PAA_::!
M%@8A#M4FRC+Q&.EKMOJKZ* AF_1I=?[@&'0"\>)@&L@@!VQ ")S!#&J@%.#
M!H#@!L* 1Y2A Q 15#B)?!IB%9J.,AXP C6!&&=B I&Q'J.&*N(#$%;!7I+A
M-4+1]S@P21JB%#PFWJ9!&3XM%&J@"*)AK[X%%/+M)!** QSO'!L*K=8N_@)!
M!RN"!XM0#JEF%.UQ))E',H*$)59B%L@J&(?19=)H&L  \72@"'0 "1;!$\Q@
MYI2!:WI""+9,0J;!$I#B'*G$ OXF@2&"Z7P 017LY0(S@P-?CB2E4E[2;I@R
MXQ?]XQ/;D0.-JQ<0KPV :AI 80=J@"="P1&NT T0!1I:@ L5;)-6S2'**#9H
M8AG](Q8T4FT2ZP.GLB]KA"K^42MH8LTVQB&:<3(<<;$DB2=*SPRD(0VV( V&
M01JDP#.LCEL*#%&N@-_$[S0L@!/219M8PA>!41CCT.4J+R+]<C4M(IB,:1<;
M!!!>P5Z* 0[E<$%LHR&4@0<*BAC4@ :PD<!*H=Z^)0O!I"  JPL+A(30KAW[
M8! @,,DHX2/7SAA9\SJ_(FUJHI&>[@']@Q8*X30I8QB5HR#<@$F @!F.8 =V
MH/2ZP/X9HJ^@Y U:FH S#_%D+@!U!@+YZ"H6^F,(J1/"Z!$["12M^FD..\\J
M^H 2.K%8\'(E**,0'.,9@"![E($.5%$';  ,E.$S?DI>NDPU$-'G+. )FO-=
MEI*&#/,,N81:;H(2+J] ,U$:I&7EIL7N*D]%A3 5Q%-!RW,:%L$&ID *5/$&
MUF :XJ ';D (A@$6@\(&WD UH\DMJ:0B_VT:ZJXN4:%U@B,6GA*%MD)&Q?0A
MV'&_T# Q-=(_D\PVK2(WI^$9@L &N <4J #KHO0@I4$40,,%H:4@]& "8A"X
M2A3MXI T+8(6*E&B;H*QQA0[7>WNYB\F_@ ZOS-17Z(/T/X)#GAB!\R &/2O
M"VI@!]1@#F+224HM1DOBU$:T7"Q /[$T$!BU!J>3%SFP7<JP4?W2>3)MR:(H
M^)B115W"N(:AZS+E!LX %Z8!%[S ^C*H**+&"LB%*,W% IS ,,DMQHB05N]J
M0'$5&?'1*FV"6CA0'_F1".406PJB[X:B^JB@*(3!#.(S4[0 <L!/.9<B/SGB
M O]@*\_H#RBA6_U2&LRU:EY3;8Y0@C12%B)P$/@@20J"&'B36\R@$>! "&J
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MH*$^2X<%I-&P^'5ISTQUK%>+[ZD@DH%NSV>8ZC:_H$P@I?XA&F#/F<Z2#V]
M#*9!"L16\5 U-P#Y*29@#W2A CI@ A:1!2J@-6# +:'"1*="A1]146L"&!7Y
MGHJAKJYXY7BU:F1C%^DH;'OB!VS@$T@A5#.%&4JUH,!&IK80S#C)"I ! RC2
MH9Z  B2A%F/0 CRI("+WU42S76(UEQ&I&,)0AINHE@DV_M")ZKC%K]K@ZFI
M#)RA!YPD7&2J(+* YU17B:U@ BR@ PX,4#'@H,&,!7*N3%?8'<O9G)F'%F"3
M+F_4D6="E&A"(*>A(;/'"FN@&G$A#A1/70O*KT)9/505]Q;Q"6!@ =LW?CD@
M!CG)1 L"&N1*[?K5:2&Z?5JA1_X/N5H2^ :;K(:GX0W>S0N$81BXD0M(01AN
M06\M)3/IJR!@T"E:V2&NP'U=0 ;BEXBA5Q(8@NF>[/>6KU08I ]2X:1W^B2D
MH0?/*# WD)'J3_]\UB?X(Q0^0?\L]OH*4G2,CBW=UZI=H E@@ (L8 (L(1IR
M@06LN2DR@ .2:?<*N:'_@!"X=:W7 QH( 4(/F:E<%()4CI0<(AIH$BAJP!%$
MH09L@ I<$ YN-C1F#^F&RAR?(H\Y(!%R(08XP ,2019L$2J:X"'LBVV9]C)P
M&;,CQ!@L=5V(Y"1Q%S,&@:A)NB>2X!-RLO1RH!H_P6-L((B5;HCA%S0K(1J<
M8 (J@/X7CD*F"4MZ)SOJWCHGD!M,9 $Q11&8Z1:N,6.02Y%)9 XB0\$&<H )
M;4 +ND![^$.M@7)HWW<#H@$**" &G&%<C@'!WC<#DJH@9F%+M!4:F3*^UZ.M
M3W/#7_9YNG>,'4(9+OGJKF\'N*<4CB# K-!)#@KSJIHI.&D3$D&$84 7E.$7
M6, "?MOL;H.A&SI])A5V/1PRDF$0"KFV*AHJ+4:T':)O;Z ('@$87O$(:H +
M7% .""ITVA &K#G,6H 7]. %]  :*H$%*& )F&#,;3QZ':-UB_Q(  &^D]PL
MO'3#Z</)<[,@-#4'PD :E"$4G!7 LGL:@"%B@T(TB$\H3_[#?=&E&;+9 EIC
M$B@@9)<3K-6VSLNZ%S6A,/-\.5ZC16O5[CB0CDPQ!Y!@&MS-ZH3 $US]ZKA@
M$3)H/C/O8_G-FE59&CR  EH@\C:A$Q0A=<',PAG"1\:ZL\_H)NY\U$V"%BS:
MTZ$,G80!GXGB%NK-!A2/"W( WIP$[(HOI6W\ E[@"B;@":*!%UZ@9'A!$FS/
M"V% #5NM]\S:D*UE-*T6VCL2%7R:VM'H2QR#"S95&B9I*)@!%*+P,W( 6=E/
M$H;2J"AR J0X$4Z7!28@N#T@L&W< H+;,8A<G$,I!Q%\3"<Q_OJ7N$%[HDK)
M(?J.)X0 )@O2$XBA:VY@#J14COZG82+)C@,N  L"VII/MQ.:8<%9 X6'^]0;
M&B6Q<M1K\]]7AVT,6(51I;,>H8KFP'I.<.&+V09  9XSA0IR_IZ. 7\SX#Y'
M""DX8 )<0!>D8=\LH+$'ZRAK&M/XO%_)T,,]\C8!<FV7BB7X<AH$ZEN>X1-H
MH-M%#?JDX1OC=0?XM/T* N)C$ ,>&P,L( NF8;$G0 :6 "HVJ4HRP%7A;YO0
MK[8FPQ8N&VZAH164UM1=%Q :KA>Z3N; 8!J.  =Z81IR<L5O85CM3?$JL"#2
MFYHN0"KT@ )>@!<V>AGV#2K&QIHMP 6PA)&=_-Z'SH&B4Y$G<;G]_M/]]P]\
M@2&>P?YZ"NH6AE,(-D@8/.$3HD$9D*!WQ['DF4<9VO+LRUT/G*#-IX$39, #
MKJ#H 6+"%406.&S8P,%"#&?3&A;[$RBBQ(D4*U($9'$BQHP<)?891$M:PY$D
M2YH\B3*ERI4L6[J<)HU6H3X=:W+<& BGS8L2_] BV>6&CJ$Z;E"9YN7&C3"C
MB!%SU",'T:$[E+V\BC7K24X7#![\NL%"P6>=*ES84 '6$D33KF#PBK "DX8B
M:4'<B3<C($J#[N:=^#&DUL&$"VN-.8CFW\5Y!>F,Z#C0'UDDS0B=JL,&*&)"
ME7K&7/23X=&D8;8M"/8@API-IGGHFK"2,FE-)AC$\'7U$_Z2M/H(8KQ8&C15
MCQ?_$20+6NGES*]"DY4XT&_@U&]F%-0G%MUI<&Q,_:%CAXXBTRR+!SWTAIGF
M[*^*C($:MVJ%TQ)RF-!:EPL+'3A@^)];!5:8-DTL?E7'41_%C&0@@I()T@HR
M[4W('C*O"/)'<<!I^!>'.6'8"DF.7$;4#38(98,CSDB%7E%21$-AC"H9X\%;
M\GUE02Z;>)#!@)-8, &0!=VXP5L5Z$'2*GX5YV%'&*JRG9+3(9@A*L6()&.6
M+TE3#"J '.A@F(!,6=&3VS5RPWE$S6&*&51%$P>)F.T0C)9VDF3)D*EAP((E
MKDAXQ00>))*+*TR@EMIJ;(VDY/YB348$B'+4B#0(1AB!R=@??Q 2BX1W?CH2
M,K'TA6F8'3TJG8=_0&G:)W(6=<LMGG11@PXUM#&-$.C=(!JH6HIT!:)$4F!)
M-$M0L(0TRNRQAS16()I:!9(0V$JIU?D$4S73(#/F'YJ(^B6"CD&$"BW*^1HC
M-+2@(AED&YJJ44V7LMI0**_:$ <N-M1P1"G$E&&#,IAX1]0/-KA!(+I9,E&!
M?WO&X$(%'D2S20834!"#-#!T!99\%VQ"8"R*.>B8)@WMLJ L?:R*93*$X/5H
MN*J8J_!RZJHBF;4VD0GO7W^LLETI.(!V@S"+T(!P*:%,<T07TVA!X@U<8%ES
MELKL!_X7CAM<@$4T',!VP2]6-)P:0AA<8 E)*O.\X3+30$.)2*CT\<IVTZ2"
MJL_DSN)IU5@A(PN[FDIW;;@]Y_4S2:2H.=4-<4PC#'<WU,!,&S6$$A11/0SC
M=Y8BY9(!0F6OIL@F$_2'00?1/%&!!0?=:*,%TV(YRW$(9M>0*JB\W<=/TR13
MEV^'$_XE((2LXLNYG9\$C2^K$%(\O+$L0\N'C.6MT6]_A#B2**_F<**);3QR
M1 TU>!&-KCJP6!0IR]LI"=F)"KB,6!=,,$DT&<1@R7]P^8\!"R2"0+VI#B!V
M]SL^+&@5VID&+20$#7<-3R.#.UXUD$$UA4D#&;1X7LZPM_Z3WU#F;9K0F41
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MA>UTO#-OP?01[%N*,(; +\XAX?XR/1 &,XJ 'GP5NVI7L#-"+N"Z9[MW-4Z
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M.. ,H_Z@%.<S#>Q$-%?7D7-9,R(A":%TESO( <U9 2Z DB-1#(4&+X.3"K2
M(2/T5<5W9,5P6- @;]E&$\H1"X( :J*BF-/@CL>G+E$Y'.9""%92#8&P"APT
M0M)@(-ZTC=_D7STAE*:FC4-Y:B.Q-I"R)&RSFG#U(+XS$K= !98W SA$!34
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MZQ$*.\!8YK1^1FTBWP5#63V^TH %8H%Z,[UZ7],P3\ )$>B2K>!IXAQ@$&U
M;?T*P',2I6 &0 "LTLR6TR '2< ,E_L&O: 4IB -/*"1-1@&H"S8G;L),/!^
M0H38"/[!S18@ WO RB41C]441GF%;VLM)F"D";%P#,6I#(WPH'3=(C;P84+
M [? #&M #"[B!BWRSU,+L:]-K,_P+".*V*<\UAQPTRFA+C!;1\+-1\VD=S1S
M$LJ0"6% C,Q=%+^*&3= #*1P(MJ-!%)QU5\0.=R]QEBR"<=ZV,\6UF'-G,U)
M 5RUW7V5#(&#(3@\4>KM4AGBH[* V8[=$,X0"F2 N?2='A4<#*3PH!>&U-,
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LBN94IQ65TDUW^E.@(J4KTAAJ48J:$Y\&5:E+96I3G?I4J$95JE.58$   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>cogo_0005.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0005.gif
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MZ^CGZ/#O[^/N]NCO]_#O\.;P]^GP]^SS^>?Q^/3T]/+V^O7Y_/____CW^
M
M
M
M
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M P%   84Y$(L\FMLP0D)' @@PF*U( #2N=  *@"4-$!S/@5XP&9RT8%=.J<
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MX8D@#2!*Z%'J!=3PI7WUBVP&N?[$+ W0"4T,( $4P(0K3D I\O0!A[<! 6!
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M5/^!@_XM<;K29/$! 0?X "] 8"L'<&L@KD4F1<XL5 $;8 X",>G9>&$"Z;1
M()\P@0E:T,%)3:8/SB&N50MPJEBDN T&N4!T[L +"%Q(1)U(0-'$*QT1[0L!
M**O#S@QP,(44;%(7P 1=>*$"Z3 T(26M%9&H<V:4GB;%,PK)@D\<LU!U  XI
MF%1V<M6!:\6-#Q/@-(6G3>UJ%R<-MLSRO 9BX0*D*R1V@,X&<@%9OM B3@@6
MR 8@9*3/*<!> ;6J ?H 0Q6'9+X$4,,G(D16!WB +;+UHY"?<[H/&(  >>!#
M<QC%BT_P-!=PD"6#> &+!@S)?@T/501B,9!,L" #\,0O*/Z23( !'<#?=^:%
M)@X@<('L* $/N,3G;H6]4&63%R&0SX'$528"'(4B>[ 5 CJ1@?3(SVV>$BH'
M(/0=:76'YK>*3I8OAH Y$7;$17X.IQ78FI!<;-XSO-73>30 T=P6PPVY!!]"
MX)P%=*C6!@B?>132!P>HZ0"G>N20#I#R./EP(,,&-"]P3( !@ AMDY0U+V98
M "M5Q]J0C[SD:<+%-/%!(T3WP 9:88+GT)@7>-#0!FC1-@4 +L6Y6G?C5[RF
M%*&;#\,VDD%8(!^H72($)CX  6*\5MP:Q%H&^ XOK(5P/9#55ZCZ7 )B(8>2
MBW-$B'4[5C[' * 8H9$%J$ +0/Z97UCBWHNV#,678B;,+WG"4P_X _6YQ[T*
M4 "KSRV ZUH[/K()Q,(*V/B"%2 !]E.@ A. "?66+=)25 S ?A/@?AG@"MPW
M)Q80'<(G5T?6:9,R/: $=B83 ?Y7 1#@"7<@2W)V)1[' M*&8I1R*@91:PMU
M$I-U(13 %I4Q/IQF'DBD);G""X$W$)U@ A50 29P";RR .+'"YIF /\Q>4B8
MA$K8$BK%(Q1P%R.020C "VL@'1/'"]AF "3 "XC%4B:X4>H&(5;R.?.&:"*$
M (L$(?87%^3C"I[ +)U0!] S ';@"=!! 4(&(7%C< 6 !YU@2TK$"W]0( \P
M>-+Q?/ZO\#M#:#5!:"^M("0QIV"4TPG+\@E[8P<6D!VNLU8*P !#&'2X]0H0
MT",8)Q0\ 40GIB[CTU]60T6K1"CH80"G8S4_@7//T2JO$ (=,#)6M0 ;,R+Y
MDD 8(Q":AG5SIG6\,&D1E7$*< "@4&@&L(RTR!-S,  '0%P(L0<L! %700&?
M9C6T9FN=40?-,G@!T!TJ8!+/134>4F=748R Y@I]L E5EE5J@CXH-BF_N(3\
MV(_^R!!W$  L P%IT 8#PQ]ST0D'($+9H@D.0"39XFXIA6ZI-T\KYBD40&9
M5#EX$0#\MQYU,"0(\ H?($MY!U\$8 >@\%T&X0$L-P)&(OZ!FD)UZ?(*'. T
M@M$&AXA%BO@EO+!N9;@)0H*'*2-"!_ )(P!-@L<"S_%2*C=;R)4Y%\(@)M <
M)< 3;! !['.,J4@09 (Z&' 68Z19XO>!"5 !Z[$'W(,^>+!5#G )N5!'E>)A
MMR4"6"D!6VE5" "##TAD<P8A6U=8>^ )UI( $+!%.48!? %M"8@7&D)@SN(
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MEQ0@:J .7AP :B5/(GB%EPGZ@"^/GAAHA0413GJ# 5[J6, 57OB0BBD&<NG
M0@\RR&\I"KQ[1;X'7[)C($\>Z%"EMCQ@@(()'.ADPY/Z6.H"[W@1@8/V"I0P
MA LY.>D".WX$,TPQQR2S3,S&B&$,T4@SC8DHF+@AB%UTZ?X!"%[ D,&W0=+D
M!0@:;*!!AB5&V\&)*X*X8H<R9""$EST;T<6&(:#K@10;F!#BAET6&6.TE2J0
MHR>5*LC !!,HJ&L/!MY(XXT$[NA$J@V^;._+!\"*)0*3.G&CA0;\<\ 3IAQH
MY:0TWM-D@@7-9+99!MN:\,4$0(E $U%3:@,!%EA8X"H/-6EK E Z"-6^HMZ(
M;(T#0RBA 4_D*"$3Q?I(@P5>_HC ,&'+C!"$"%A(H0!:5\J C8@Z3%! /B[H
MY8%.3JJC UXDN 3B$3[I-@03)E##68\_!CEDD5]Z1(8F3KIEBBIN,6VV6G#H
M@9=':.CAB"!F@(*71$#C!3=4=OZY(@9!>"G4$1MLF&*1& ;A)0D:A#@"!^IZ
MOH&7,62X88=;5EJC7"E9FL"_DQ+HXY('^+@##T1RN40JM$[*P%:37B&RC@?<
M\ 0$"Q\0MA4'7.1E#61C'+EPPUTB["02/KC VI4N0$$..%IX0, ),CDI@D\^
MF#)!7M ]J0T-<@'%E6(]Z8 %//I(P8.*8^&EDS08 +Q,O]EX8XX0-F@I@W)/
M2M:OI1[ Y"0X>+^@W!9&:.6K5EIQI<C#IZ>^>NMK:B*&*AR1X@4IJ)Y-%IAY
ML4(&*:RP8H?K%H%!3=QF>R2&+H@>0I4>9"C$$1@2484&(-!G@@R^0#5=Z(((
M-MB!+OZN((1:L$5"/.$% ^X0.Y5$X$L"PL ;>L$ 8?5B!>LIRMMJ=2&P^.05
M%^@8+R+@GP>8A!<4*)<%KI*)REW/AA\[P5IZ0H$"@.(5%G)@'_"#D@5\J0$5
MNQ H[  ! 8U@ 9_C'2\^X8"*70(# O+  UKQBJ.<! +^:<4"P&(F-BSE))XP
MP"=>$:H(\8(K)VG+)Q)@+1$4I00?B,@$>*<J.<CA 2084(%>@8$_W-"0AT0D
MR%3!A!G$@ 9,N,4N?" ;7MA"-:K 01!8TQH8-$)_:O+!#53!"U&8CQ<^" (O
MH""#5+!O$8*  =-X@8H;$(%E.+ %+QI! Q_<H@DT6 5*6OZ!D E(+!0*"$5*
M+.A $%S%;B:PP(GZ(!4- !$#7PI61![@"CQ$8$(@R  77=@'!XQ@!.#)XP5J
METAV,F@-6.)%'R"P'C.>1 UKZ45; ,:+#CR,GP]+ 04VP(+#V $%*.$#J2C
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M&#R'%Z.@00Q&+1HBP& *HO'!#(R:$E D@ ^:R 0FN.1F7O[<X8E/FI%;T.W
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M,=JP6"W8@BH@.92(A"HX@BD@LET0 RW8&EW0@C&H6#4YB4>0 D@8!2EP-C"
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M/#B,-*@ E+(6<#T!#" >MFB+8X2W%T($![V $J@ $&$!@Z  AMF#!LBS>+(
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M-#" +$>)$-B/BDND$8B 3'"%/D" 8M9+$T!R;N'L,K_S3(=Q#:@I.*@8Q;H
MU*O(QD10:TG-#9"/5S@6L>.#=P$B&[H$!"B6ML"#L.[NB%4#MYJ#+&0L6L&$
M>L6#3K@#P-$$/U K%B@!'\&#3U"#BK&#+)QP39=V(M\# QB!.O#03_$. 0G8
M7+";3+ #9>D$4F&H"&@!U.$\$'" $! ;&[)MF2!T%<B#VOXQ@0SP!!:PB 3
M' \HBKAH!:?FCS?@ZC?X@UF5@ H8 5#  PKH!#7(MVF'^"#7A)1<@ X@[*\Y
M0 5H!?_2)LRA[XA HC20&!"P=1LR 4:.B3[ Y00P@9;N$"8= 8BLB%;H Y[8
M ZGX! BH[K_\@[XX/7NB -@!A2&/^*(OZ@EW!0GH9)7XFL=+@+8: 0\X@0?
MG"Q4Z1[- "VAZC"WGIV@MU9X]3,;,$U   NY! \P"*FP Q#X@U&U Q;0ZWT<
MZWN\@!&@" ]XA0J .//^3*/W>QB/BXA]]\=A(PD9B BPQ\;ANIVV [BD@\,H
M8ZZOGDXP ,,RPY70A 2H'0[@O/Y"ER)A=84>Q8-,* $/<)PT6&2&&H%$EZ(L
M/8E.Z!"_4?._I_WA5@,&V -/V(,$L(-06/HB]8 [D ,06("'\3UX+( )ZFA)
M)A)0\&%^TFYW3X ZR 0V, "&,@$.%XM+  4-1# $N(174 $$L!8G*I8'P-<M
M=.U,8("]*H'#<(!"XCIU:@J0JOW[-^PZV( ,\!W$&(&T H@U'CQ\:!&*%Z],
M'D#<L6."EZ<.;GBEV9!"DXA,<O0@[.CQ(\B0(D>2+-G13@8*&_KPRA7"D\=<
M:C)@Z,"2UYT.(_JH6<-K3PJ$:>IXI,"F8Y\-&5*\XJ4"9DL6&3*T,6GU*M:L
M6K=R[?[J]2O8L&+'DBUK]BS:M&K7LFWK]BU<M*WJ.&C:*R[>O'KW\NWK]R_@
MP(('J\TU\B[ALX@/&PZY>&2="7NV/DYL^3+FS)HW<^[LV61EL'=#?WY+^N/I
MTJI7LV[M^C5LSHT=@]T%.W5)W+%W\^[M^S?PX,*'@R9N_#CRY,J7?]JC1\^>
M.U _@MJS!P\FDJ4T]?[3"J&KF[PZ<?H8ZE+'2Z 0YNJ3ZU+3CJEU+Z]O_S[^
M_(3OKD  8D,'%]@1D@H'?-!!!!- ]5@O;V2052L=Q&?9!2L@Y 8 W/%BE'R\
M7() 4[DD\ %"?2R02P79@>3*!J[H]R*,,<HXHUIWJ3""2?XK@- 2+R50T%$N
MGC3VQHY">@3*=QXUY8D#W\TV&!L8(#3"!56YPL!T=^7B $M\7-"B4R'PV-$G
M\7WBP"=D)@ED8YY,2".<<<HY)W(W>D2:"B3>]4H"Z.%A00<4X,$+'!>D4,$$
MG?#R2@@9& J1!VE$T D("V#0R0?H\=+"4?35B- E#.3R"@9P=/!3!*CQT@$+
MO*#0@@<L54#4!IZXD@$+&CA E <,7,#="#0]Q L(:SR01RX9>%"!"G0Z^RRT
MT7J6Q@(';O#!FQWEZ5$$>/#)728GUK% FB6(.4*KJ];A2@!I+ G!>BJ(T-(#
MF0262P.:]"$A!$X]5%D;4E:@"?X+:?#20)H/:/+* 'GP@H<#$#T TPE!$5O5
M QNL!^NB(:PI+<@ABSQR6H:M<($?=^"![$>&;=O1 WS(<2I"&MAA!\UOD.A
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MB@(<Y7BQ0T@=!+ >BB"@,0IKA:@@(K1<+# 4K1BA"1Q@KP=H"@\,2(&/TF3
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MT@/_=C.'. WR7OQ5EB'R2:\" 6U#"'0G'0K+YZ5MA _W)^3.-F! O:^MP,G
M.UGSPK3"A9MP?9!]X<)(F/LSOR]M:@^P"A=FPOIQ)PH:?*&83? !_4T1%."
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M&,3 #&SD$\# VLD"#?@ +TQ!D]% #"1?>[X *4#!HM$ G'E$),A #$CC*,Q
MYO$")+S &*S"HLF ##S!2PT"F_7 #.! [!&"A07!#-# 5C)H?]XB@BH!+_S
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M!" O7($-]$"9\H(IY-JK3D(,E/Z!>GXL*C!!#)C?*MC #JS=(,! %=P"#>P
MRED>>QK=#31!.:(;]PG!#8S"+G2L(#Q"AK94PNHC+R#!#MR ^/&"T=$ $U1E
M#(P8##2!/EY!J=8"#2CN7D*@5:C"R,;>LBX=N!J>*@B!#*!"[B4!+TQ?XF;N
M#8A"+XSG& @NZXHM\&H=+^  $NB"#NP MXW!$$Q@$M@:],G"+@B"#(S!+MS"
MWO)NS[*>*@R!#(B"S=;H+8R"#$PM9MAG+,K"U]D"*? HM_VH]>U N^H"#OR
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M##""S/[1<D=(P0Q\02$ 0MYIKQ040B 4PFZ/Q1^KPB&/:F\?<PMGK51V00Q
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M0A#T+CCN(I METHP(T3"# !!>4(TAO."+#@"*ECT$F2Q%F]%(U0U3$D")-.
MOP."85="#!@"Y-_ (@1!H$N;Y6^EJC?\+?0B$( H0ENYV.Y"*C3"$6N>XS)"
M&<A PB^K&4@BZ#:U'2:UX#Z!+9BW9&<&5N_E%QP!$NL^RY^=+.C"#1P!$NA
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M>"$5MD#<ND9#B#%LY8I?>.E+;S&(,>A"$&L5:Q<>@0HM$"\17E#7+B!AA2@
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MN"<(^H5E5HB<=*=F/@0'-.810H4&AH!XE)"<FDH5=F *00@^@& &-$)#1*5
M9, 4F  '%W UF@ ''T<*!(A&%C"41 %6,DA&(B%4;& ([L/%;N",AD ]:N$+
M[X-VO.;1UA '<0"F>.$)V+!V)N$(;D!29&,R() -90 5]/XC<\PK*-#G"TH"
M$@L$!Z9&$G#P,G1!"&R "#.Q#4=A4,HD*B(,!FC$_V3( 751=5!!!VA # +!
M@9HO%0M!"-JC7!2"%ZQ !PEA8OIP3R"&2^9F% )E_80@#,1@$KH@#  F#*Y
M%;B@:\#@"Z('5()@',- T';Q"0(C$2H)A,0@!I)@$<) !GZ 94S&1U#D4!*%
M!I0B"4K0%F: "61!"\* 1KK@"D;!$+K@"5A$M1JE![[@"[H $";%!KH '9T/
MYV30!LII(Y: _>3.!W["BZ1 #(8@!GZ)%T@!1&A#!V4A!1]C$.A'%.)C!\A
M#("@)B9!!I  #*2@0MC)=@B!)OYE@!3BHP=R<B?[ZT=8Q%^TX IL( @H4A;<
M@@O&L0LDI?YHX K&8 EBP MN<B+#X#*20 8,(1)T  92@3.$ "BYZ4;&A!%.
M1 =JX18\2%50809B(GE(#E>:@ :LX M^@&X"\PHF\@JDRFIX(1)B0%D.4PS(
M\18(07'>8Q6I91&:  9 R"VF  R$0#0TY2DGP@;NT2VL0#*[H!8H 46JI1$R
M A*Z("B18"+_<A=Q<R.\Z&-\9 @>04.,:")2B I$15F$H =F(! 2L =H0!8:
MP2-QH!?"D7A2D H:CVWHPPID@'C,JR%RTR1ZD@F$#*QT84ZV<FX<X1%F8 >L
MXPL.Y/Y0JH0IXB,(9D 2;&%3F"0(=H#Q<L8,4.4(TF((;& C<ZXD J%$9B#*
M@F8&IJ('?D(,8&!K= $)MG,CE$/+B @)1$$+9"#*[ 8);8"7 $%Q4O 'FV &
M4F%!.,E'9  )0Z(D1E30I@ '')*K4F%-3"(D6P@M E-=>G(*="$D (T(@*=>
M)$$7..,'W4(4AL ?ER4&!@$L8%!"<D/2F& '91 ';J$'M<U?NJ:+T"A/N*HD
MRH Q2Z([IJ9><$!+>U I.,,*)J('<$ 7!H']?H)+T0(5"P05( $&. P2J.4[
M!35.\L1&O(=5B$=L;J 7JF 'FD (1L$&JF &FG$&I, &&O[A"GZ@"<QC;HB'
M%*J4/G2!;=AJ&87F*4:!0 AD!II0_)2'7((--YZB)!9!9RK!4FU %(Z@"8)
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MX0N8P I:M3G*H+(631;*  JJ@+A.H0L"3"8 H0LNXQ&P<DFPK,1V(1U5(0S
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MP@4$4T4.DG*0'-P"/;",020<]I&EY. P/$(D2E1V"QED@44RJ,467C +0+P
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MH@]?3IXF',!D_CZD%[D [PDF(&(*(+D.* "S@SELAR(?;2*NH$"!>[&"'C^
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M;L +&1 !>5 '"  *FG!^#R& O! *"X!V_H4 +' )&_"3$Q"1:Y<)"\ +;V
M) !DG)@\=D !Z\=P$>&2%;@ KX '7K@'#H!D#- !?9 &#.!M%Y!EO1 *!Y )
M=D!U;Q !GL '#Y +H#  *G )'Q"8#L &N3"/?. )%,!D13:/[L4">O@0)1 !
M=X '"%"3$>!Z"<@+'#!F/:8"-98!Q5=%)F1OM6<Q:A!G,J8&(9<'$_ '?3 !
M\=4 $?XV "> ""-@D4AG!WF0 $-6 NOV!A9Y!P9 ?[Q@ 2;P!R5@ "8' 2:
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MS+QA$0H&P&TF*!'XV1 74*0(X/X'%4@!$K8!&+<"O,L"ZA?"$<$&NV>[#[$
M&KI>KO  O9 &,]P"?1=MEY#.$OQROL()!\ ":I &:5!\;["71UP L)8&#O#'
M+6 !G= '#,!D"V"S"J!?#O &K7 "(4<!0<J8P'@"">!_#\%\E98 0FD"" !]
M-4P!>V '$= *?MMK"+H P @*)_LSR\@&,LT"GY +(G"'AC?6O#"/EP *(Y
ML*>$$QAQFU9TH-  <G8'XGIU'\ ';TG"&/EF/2<!;> *:U  -'9^SZQEUJIE
M1/, U0?/" #,K.D0>%  60H'EIH)#\"(#<!RO?D0$@"KBFQE$Z &KO &!8 '
M5R=C3/Y9@0I :2G  :^P!PS =?.% 9_&!@C0!GW  @< ;SO:$!WP!I<@E9I
M;KQ =KR VNGF ,#8/""P :@;<BP0I+S  A8I8W:0 ,#\ )? MUG6CW:;8Z#@
ME2/@O/*: +.M @8 "H'-:9/V"2P@ /&% 1Y8@P_ <B/@ '6P@[KHA0WAHFQP
M 3'G &<JC'8[:FKW8%2!='N@"<:J":X0 K3 7@I0 NU78KG ?P;* @8 ;UCY
M"FQ0 3'W &SVM1%Q9S*6"T^&!WM@ 2%'H 7F"IJ]!A3@XI4G =U7BCYGF$/C
M"BG @R,@ EPG!R^9Y"30Y-3L$)37 =2<"RT@85FNIR&P ?XI(&%L@&X6@[I<
MV ;I_!!JD+@$V $80 +^UP;XU0;HI@9DYPDE  IR@,OOV1!#&X^^T@9+/@(?
MT FY<(L1(0=E=P<>@)UJ< >7\&E\ &3-W1!OH%YEAZ_8Y@HJ@ $9\ 8R]@D0
M%^I[R+V%G0:MH)-]\&FY( %1/32SFW6O0+1XL-JRGIUU@)5<F ;N)=(TR :?
M.&=9U@DC$ )[H ?OV9VH3I$?D'@I@,F:P&(/40=69C%\X '_S7)R\'A".8H(
MZ0DGD EWP&2[3I%D6D6R?@$F4&!I@&0FM <E^PDJX.%)2,=X^'4L(&,]"<P7
M6 ?4'((C< EO( >=D):>  *$Q_X&T'<)'4#&86;)<J !&& "JZ8&NE;QX!VT
MMM@*;+!_^/[-W4D6O>" &0 "&Q8*)E!P?<Z#8MEE(."$<E!\F> !0\8"'[ &
MM@@*;W"I\\R%L*<!&:#EZ>;QK] ",I8&&5\"GV"0H("*E6;)=E7A#B%T$?#=
M[)5F99$+')".J44'4#P671]@$ $".Q\6'A#0Y13U&N(*&X##7['V;7\K42]C
MB,#(8Z%N=Q@T,H9IA[; V?;G1@H1H; !F X1KQ>VM&99AY\+</\KSC5=CW_X
M?S\1C(]>%&'XR//XXJ7YW?5=?G\5B^_W]65"T07Z6G1=U>7XX246E^]9AP;X
MG$;YV/Z%%2F7]ODE9V%1^NA4^[.U^UC17V$/_(D?_!ZB7;WO,WR&8,.O77U?
M7)Q?V2!B_'L5_6HQ_4/38-5?=</?_%R!_=KO_;+__3ZCZOUN!W.0<Q"A"790
M!W)P![%/%7Q AY#O5_M8!W- Q@]1"G=0!_L_E9P&_[X%$+'LN.)5T*#!5W?J
M+)3#J==!@P]Y\7D%$:)$BQDU;N38T>-'D"%%BO3$YR#%C9I,7LR8:R7+D3%E
MS@1YZ9)!E[DV]KGY\5,?F@5[80Q:U"A(-AQ '+ 0(D3%@R(4C "!@8$GCD0/
M]GJU )1&K4?%CJ4Y88*($ P^6+PS( 0(#PGDM&30B>Q=O/YY#]8!L";CPST%
M0 S>@*<C@TQZ%2]F+)(-@)<,@&J\@*#51U ,H#;F+)+HAP&?"H)2L!FB*P04
M0-Z98#&LT,ZQR^[1."*%00\F>.DLR)N7JTR^>8&RR^M5!%>@ODK,I<FT)M&]
M?PN77=TB!3L%N_J!R)K7PSH.I..,@)77ITO4K:\_NHO7!A48U!?DT_J@;]^M
M.N6:D/AW8M]>P60^]@JTSHT')H!J@IO"ZB.#$=3 B9=.2CG(DT\^B4"G7G(A
MB)=6-.&0P]UZT^D3$0T4RX0'/!CM =,.:B.$#6CKK9=.HBM(Q#TP*-'#@EH9
M<#?U>&LE.!6MB^ .C4*X3:<-)/[, *A>,KB)C0I"L$"3W4BX0(,+7.'O! \<
M8(&72RY(80,&#/LD P\PN.V5#5APX)+7DF1L@CH,@B [W_"PCY<W+N EC=MX
M68$-7A[ BH4+2MARI#SUE*T3!UZ98#*+]H@ (A&RX\4#VMB(H ,3(N#RC0@X
M&.&"K^:@( 0*.+7TUKP>0K0$$+Z+H*?OHC*B#_M 4;.#!MHHR 0*/!CA4Q9,
MP$ W2$&XH)57*+@LC0X*VN 2.2X0X5=<9?*@4$8]R=0U7BC@0XU>?\L@A0X<
M2(.K#2[X (0,#C5!@Q%X4:,"$"QHY1(?1SVSE0I>"?=96\O-"X(\8#O(! 8V
MV,"!#?X*FL#&"#;!9(*'^# TC7YY.4&W!.:@, $T"[#K#=4TF(L7#0Q#( 4"
M)<:K A/NL*,$S81Z2 \$,@"S+EY4**&@$LYTX)-7/J@H#1)\UAHV%IYF(>",
M^$A:@PI4X"6#FRO@XY,%+K-C@% ^24"T/@IH!10(*M*$@IZW]MNC-'1# *@'
M$&DI KL>N.D3 VCK@P%>YK!O!9A38-H.0WFIH^,+^@1A@E@T?*6!Q.YXXV^/
M.JBCDP->*65=BS:)H!=/8#3N ,,N44#E>/-M6@$N][#@(3PZ=@"47"KHU@X?
M&;AI#[]0'XOBVCRXA(\^-&BAW94F\"2-"N180PT#6L' ,/Z$( C%N$PO48V7
M/BYXA0$UV'B8E^.EU^N""TQP4D>#X,$!?>##)5+0KV@M*PV-PLHKZH EW>@/
M5Q%(P272L !:9&0/ R1@8CIPLPM<X@UK>0@$6K&Y8$W %7*(@!S4\ 8$ $N"
M,[1(&@(F!P?P1X8&V<,"\$ LLX%B0^=Y "] $#U0%-$$9N/%"#8 !S:TX "\
M:(,)7%&"$_1A#KU*50I>0D/8G(L7)?! *]:EE19L*@\*8%(K;.?&;$T&#Q;@
M10I.L"RTL2$-!J#%".A@P!&TP@2,2@$$3& C,-+D 17+B),,PH<%\.("M.&/
M)UBP 3[, 0_I49N)<O$ T;SB ?ZQ<!]]PM0 .=BA#GWXQ"<!F,B@3$!4&O%.
M;Q#0B34\C1<FV)X#2H$W%5R"#4^K%"P9\X<%E. #)5C + _B*8AL (2(F)%!
M(A */"2,%WDK5"8W&2-CHDXG:="E!@Y(I8CP@E8D"$$'/A4*VWU"/!]0%HB4
MN$ CCB"3>;A))VS6!CZP@ 2BNH01(@ V8XKQDVMH6$8HP($0C* "+G(C04J1
M-P859 ^&.@$3E<D'.NCA)G4H01KXP(8W;, \EU!#!.(53I$X@)%4@TT([J@3
M$U2@773@A2<0  H^O*\59TI!" JR!A'@[S*B?$4IX:?3"HCJ#4!QP/I@6I8^
M\284PO[!PZ>.=H!<J,%%[9)0IMB0.1. K9A7'<M#1J";A[# 1ZYP!4:@B9$H
M_28!E\!$ W1RB0(@CP%R>(4:"O"*3#Q )Z]@ 3C9NC6L%204$4#,< [B"J;M
M1C*BS* \J9@R.<",EP5Y0\HZ(2%U5@ 3K\B ?$#1 9UD8@%K_9L8X;> "+PB
M%Y>1R.,,T@D$N$*4L "1>$+ 1!/0L:,%"==HC""O##0U2^?Q0$4ZD8"^/=8@
M#T!?!)QI @.8Y0$4X)(<&#""$C3@)LQ" 024Q=H.E. !F\!?*-MG'V+Q0A,1
M:"<%Q#0U[<:$3P>9@!SL6@ *1& "J.QIBTP@ 0DQ(&X1,/Z!'2' )=H&."BY
M<%ZP-(& 7+2@6P'\U$D8$((2.( V$C4!"!R0&$]TX )OJ  G>-$""D;@3!K>
MFJX"IA,Y", 3G5! +()%8^F,8 2O6!<H<EBE#92@ T6,FE!"T+\'N(P7:UB
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M R/0C6J'USX1(UK(@ ^(9FUZ.!X/ 0^H%X+0BN<VB PP:0K8A, 1"N08TX*
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M 2IIQ0-@H;L0>.)X!CFT3%+0@?X3.* /N4BAMH:3BPC<Y166-D%7-9R<D(2
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M"6C@SXW ?50?"ZA &GQI"^#7I(DG":#$'H  H:2 4P02"TP$*!!9"+2"[XR
M*[2!?3"&JU9 &G3 >%T IY# &Y# \57NY3[5,%V &G" 1?R!VT+?'60 "4S*
M& 52+MP!=%X =HR ?;F:)J"N2M1N"DR P@BN' !N"D@ R0D<4^X'D_"*VY+
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M*$#F!"BKI)! )JA;!W3""EA$Z7"+-;T"!KA"!CB*+\\Q1O F+^@V!;W.'&1
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MS0\>#/ZQ*W3"1'@"1*< 1T?U!_BX@\S1+E1W(NOD624E"+B&"FSN&ZCT&Z!
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M+=(##S3A$R+ %7KA6F:P=-1 91SB#PS"%1Y@#QY.,@PB$S"@(>9@)"C 3>J
M(B C5I@0&J-1&J>QKS+A U: #=H"-TRC!9S0!"Y!#5K!#NS@V "/!;XI!3)@
MAY#B!#Y C$["",+F&SVA L!HQ7AA!5+$7P2$=WB!!%CC ]QD(](@8=A@-%1
MX7B-0Q#C UB./E*D__)@+4!! T:@-^)@1Q R(.7"'5NB!9 B!;J#!3@!)').
M!=A !54PRG9"4@5,@WXZ(0-4X*)4YB17H!/08CML!P1 ( 0>CO<R8$=XZ0,*
MQ1.T*!=VL-4^0 ,PKW0V@ ,@BP]V9 \X0 0\H"@\(!?H@)NHD2N[TBNA,2
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>cogo_0027.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0027.gif
M1TE&.#EA 0-* O<   ,! 0D%!@L'" X)"A$-#A,/$!81$AD5%AL7&!T9&B$=
M'B,?("8B(RDE)BLG*"TJ*C$M+C,O,#4R,SDU-CTZ.CLW.$$]/@ R;P U<@(\
M=@,_> H]=P M;$(_0 5 >0E#>PA =Q%&?2E/>T5"0TE&1DU*2TI'2%%.3E)/
M4%524UE65EI76%U:6V%>7V)?8&5B8VAF9VIG:&UJ:W!N;W%O<'5R<WAV=WU[
M>WEW>(!^?PI+A0I9EQ5/ARM5@2A8BC)=C#EFDP!>JP%6I@!CK@=DIP!FL !K
ML@MMLPIUN!MWN!UZN15SMA%MLR5\NTEQFEY\G(%_@"N!O"6 O3*$OTV(M7N9
MIF^0KUNANQ6&Q!.,R!:3S1F6SQ*4SCF)PBZ4QP:BV0NCV@ZIWA6GVQ>HW!FJ
MW1FDV26LW3*LV ZIX12LX#>TX2>PXD.-Q%::R5>:RDF2QF:CSFFDSW6KU'6J
MT$N[Y%*BQUO"YF_)Z86#@XB&AXF'B(R+BX6'B9".CXR.D9&/D(^1E(J6G963
ME)F5E9.5F)R:FYB8F:">GZ&9EXB9HH2:HY2>J*&?H)FBK*2BHZBFIZNIJJ>G
MJ+"OK[&OL+2SL[BVM[R[O+>WN*ROL\"_OX2UUXNZVH6UV).^W8^LQJR[R8>_
MX,"_P)C!W[?$T)77[Y#1ZZG+X[G3Z+?3Z*G8[K;D],3#P\C'Q\S+S,?(R=#/
MS\S/T,3-V,[0TL;1W]'3U-C7U]77V-;8V=O;W-O9UM#/T.#?WN#;U\7;[,K;
MZMO?XN#?X-WAY-/D\-CK]<_K]N3DY.OKZ^?HZ?#O[^3M]>KN\NGT^?/S]/;W
M^/7Y^_____CW]_#O\.+@W0
M
M
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MD3*K0 O>M1+S>M8.;??=>%O%3/X#H>%&P*6A"!1EBP*-@%N!6N5!0  &"!"
MQ([DZ]TQ%3!N9[E0$AGR TU.,- )"1AP<*=YEV[ZZ4%!(T@>>>B11Q^6-*85
M)3G\49TE>.1@K$"9U( "#)!H]0H4>*@FD#&"L% "\+/?T$=CM>!1PW,"P7
M F.CKOWVW/_61P4-%(!F]^27;_Y*6EVW&FL%J<\^:^X+Y)K\KC46I;!.GZ__
M_OQ754PKK:A;_P9(P (:\( (3&"(2*? !CKP@1",H 0G2,$*6O""&,R@!C?(
MP0YZ\(,@#*$(1TC"$IKPA"A,H0I7R,(6NO"%,(RA#&=(PQK:\(8XS*$.=\C#
M'OKPA_Y #*(0ATC$(F:K-PP\2!(GLD0C.A%]\HLB!IOH$2I^QXI/S*)1H)$)
M2BSJ>)3(A  38HE"8'$AR*B$);3"B$H]I!5V^<T9$V@,6/VB@L50HR7V:(E,
M5"(7^RO&9R2 #&@1R7A2/)X,7@!(8R   /29WVLF^;Z!M$(TS,@$  @ R$>D
M8!")C"(S'C$ [_S&-JS Q5N.$4?3)08W+U!B*&=9OD(  #3-"LV65H/$4/(F
M-NT;4S$<L*X<_.H #T"D000Y *=!(P8C "0P(2*\!#C &,<800L:<P, L$ A
MA6"  ;*'&:T8(P8-(,  %L ":59$*ZQ(0 246;H1)* !5OYKR!SOIA5+D$ %
M)J!:!U0P NJ53RO%:,"$%. T2A1@3@+)Q2,*00F[0(,2#DB (U3)BM@%;!6%
M> 0B:V&)8A3#$8YHY3$D$5+CO>( $+6$AHH!@P&LH!7%8,4JXE@,2\CB&;D8
MY_HN8XP*#.  '2C!GR00Q_@Y1"N9($ ^?QDT>!* !"@(P"/6QPQ('"(7/56E
M0'#QB$/DCW^Y6%<D",(U1'@4.I:H15<+(4U<6((68XTK7$E&";'FPA%F%=,Q
M&.  )J'@&0YU@&H*<8"^5< 8KP@  QH @!) @P&Y>08N2C  W"2 >C=: 64Q
M1AE6/"  !!"  J;3"@0P@!FL$/Y  IC! CTE  "5Z   !"$0%@# 44$E)V9P
M("OZ/",3#-CE0(J!EX AHS&XH(6UC.&T51A L<O512N?\=QG'(,RVNHF%/80
M@ ()1$8" $ "2 " &&P(7_J:P3ZK^HQ:B'.K_71  !QG@ET\(P\X&L$F$S =
M'-!((-U<P3/*MH(=/6</!_";?$DT3 0X0@(#J,0JI&H,8URO$K0%@*\HT8 $
MB#0:]]+-";Q9BT/\:3HI4 \.\,"W/CS# @#80YP"0()GM/:US%(L,F(P !7@
M]0\!J%%"FU;?4@ZU,LB  &D(0@M+Y&\7*6B< F[0&$$0  ;A2H %Q&J(=#(
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MBI[1!R6%VKQEBZ7B&)"_C&^<&8/P^(A@38!G=>8%^%2-(Y1Z- /\NL1.Z](
M6%&) 1!2*^0MP3,*YJMG\)D&SPA%"QJ   <H0 (&.@"0KZN:'"A[-;Z%1 X
M8./YCN4_:TJ9FQJP /9 (LD"27<#6.[TLKN<SRT0B"&DVE6\/^,5"G  -&X&
M+V>X/3PR&, )5L$*%7A\F ?(WQYV:8$$!/IZ@]IN^6S!@ (X&E+K.AD" M"*
M00! 8L\H1)\7# "8 R"6>@B U OG6E2IFW @0J@#*OX,2)1Z :^5!  :P AH
M].%+T&E YH7-.59<$KO/N$%YG_Z1 A%7[[?%.$ !MA8*CX4=R%(M^]FU<O<7
MD"!5PDFW 1RQH0I8P  1R/Z;)  !C0% %X8  (<5>P(P M!@ @&@8SXF=LS@
M)A#P@/<" *WP"K("2(_W'<?P '\2 )ND  C@-)MF8U,G (-V @-P [C "K6P
M@A>(,%J1"Z7G:'CP.+G0"K10"Z_P#.15([$W .<Q@^:E?;@7  /X#"@P #F0
M@C<H5R-2#/?R+,_  J6F>-,22]!@>6"R9(708?<R'5)F8[4@ 0'P'"HP %47
M P$ (1AC%WA@;09B3; %-64G "<@7<0A 82R>\'!#!/ :02A..QQ P-  H;P
M.A.5<OZ&5P@%J"(!\"3+HB[0X&F$F =_,%'4E2ST)"IQ]@!]8 B#( @18 ".
M\GQ7TGF"QG(TTAB4T *\M3]I=0!KY6,%\  Y" LS@'6T!GL=ER-ZX'1[U#.Q
M=#$2HQ6N=P*JZ *M*"*"! "5D@N?<0 F-P"7 @$/\'J%DUXJ  VWI1N4L'H0
M<%LMH!4WXBA1"  SP P,(  14 $0D&<^QCBPA1JJ 0D"T"3Y<P,'8 "*%AR)
M,P *@ .L! D>R![CMG)<0Q]]\#@"40@N%WDET!@S4&K,8 E]UAC&0 GT85W)
MA# W8EX-$B4/T!B%L&DL4 ,!4!K,L *HX0  ( !N=#ZU4/X  $!_6C&#R=(D
MCE(V:"((  !VM(  ZN0QUE@V/18PM'%:F34BS* '-^!.D' #>F 7E/ "*? (
MKS ]8Y4'-4 ?3/E%M( #), "CL 5CE #W@$)-: ;KS #*8 'N( '>< ,QG #
M<5D,4%E(Q8<#-V \AS H8B4<S%"&_LB2%D!,C>%;$  #7B)U %:4KL<>S$(
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MQ@W7<IW<;UW7>=W<S;W7?/W11_[0!9PP#$)S#*V "33M!X  V9+]W=]-V1G
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M](F$<Z:4)-Z)0 +)9)51$,%14D*5Q0X=-;[B-!%W%0\I/=<Q"(,P* CNK8)
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MB-=8@D"<D]\T94+@81+Q '8":@V"3]LX9CVSW4 .X3'@7BNH:D3>M9V%A5P
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M]8VAW*=]YGC*J-MU2*1/=.DZ'*OOL9H3&73A9!]=>0$KWW"M#CMB$9W&>EB
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M!!G_Y(Y'E2)C@-XN%DP_Y9XHDF(\LD07G"#I'1* (9*3()8319\Q3M@%O5Q
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M*QS  4@ -# #!"   N3]2Y   DB\RNT]-+1"#D###7R[JQM^)8S['[""T?.
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M (A $!, F/QXEBPQNZ2=:S%;$$\1_YZM3WQ@'H@?/J&(&4HD<&0/ %@XI((
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MD2!A%>9'$A)N!E@A , C##$J/^9G7")B%QZA<=#%$7S&5O) %QCL&0B/",G
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M 1C !"#!!>Q$!B"@ F['!!J@[9P"<VJAY\3L*RI!+)X!\/) G8NYI7G#&=1
M#,9@#,) #<JJ90[  5+@ B%Q4_X29OA0Z;HJ ))V6@&0008HT 0"(/@2QU86
M#3V<J*#TP!#*>?L -JURLQ\5[T;Q#$60H1C,[VJQYP1H(0>HI4PRY!'FM4-8
M>C>,(06<U",@01#Z8!5ZAI\0":;'@ C%@)DEPOC:TP$4H!8V10$2 !),H  N
MP0(.H 8&@01QP"MO( %:85O;$P! %'-:92<*(6' !"5JI1B8UZ5)&W?68*_)
M0 QL.E:&&C\RQ&PH 4^A085))P!N($+P\;5W @_M=6B.X04N[@;P QKZ@-&P
M8A> 4A-7]*S8F0C3E").P  \!0\"  %<40% 4@$$P)FO%6@50!&+!)%^,B*@
M[1<+8?X5@F8/,%E]CEFFQZ"O)T*<5J &6  !;F!"3@ B#(,9;B  =B'3^F!!
M7@"OHWL7C$$!%E:SV\.3Y)$1'.$5^DX0]  _2KO"N\89QN +"OJ@)4*='F8$
M%8(S#^B8RC*#7H  /MRV<0 G:U*ANT8\#<$05(#+B*,B!,X0J))N$6F0#=J0
M)2(7$*!#5R$']D /ODS,*J&A$" %/@*(&R#!VVC4/L(1M,(DBF%R>+&M.Z.]
M9[JON3H/&Z-E%, 0!H 3&Q,'!@ 8,FVE<8"Q)20S"VH!H'QHU@,2J@I,(>(/
M"! :*L?"_=QF2N$.!/T.2@&AP=(!8  !!OL@ NW1P/(!8/[@ )SD!7B/>T9
MQ\U$B2T!<8:/*C+A=@ZA:LGMK%1AT 6]%RZM1D90T.A3 0X@5/3P(U8A 0J
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MF,'D)468P:_YS >:V"L&A1(RG_YB\,N9W.RFU"@B%&9*2YS1\29,;I:01\B
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M%R6@!S?P20BA!\BZ(O\G"2QP"(PYJ<_@ BO2LC!P H4@IH^V!S@0/P59.2^
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M;8$OE?Y0^("A"[B #'!$">[A^%K5=DMB51)D+WY'"X] *+G0^:KO%;5 C*L
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MB4H;)X]['N2CB1MWW+9B'#! D(HH86"!AW*1 ( $=L7AH$@0"&"  "!X2 4
M DX!  L,@N0  0!@X $ #GF&! !@:   7'"1((!="3CVF1&,/:AX09XQ 8 2
M#@!@@ <&J@4"7@TXP0"F+L(# #Q&6IV  0;(@2 ' *CAF?X. /A\^Q$B\-6
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M*<0)<X&+G1:"&3D @ .>\:\GCH  R'W&2H-H5@, 5P4#J"HS*C" Z:[B 0$
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M#,_Q!$_P_*?L3,_N!,SMY,[S=$];6,_!5,_WK 58&,N_E(5;R 18X$Y:N 6
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MT#\@@*IRK^$A,8Q2E(O@FX!9A8\0A%(!"CPX!DZ=CTT( B0-5\ -7&\M@BK
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M=&WB=SW3=6UBQC7/,D7<]$3<Q_XUT\E]82Z5A4FX"T-6AAR A%\X2R.FTQO
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MN 4Y-09;V-=!3>PFN8A:6(#N>6VQ8H"KN $5@H T>P3->OZ!"J@R"$ N1W
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M47+U"[HLO7,1DTZO?CW[]N[?:]3<*@")CJ8QWH=604%H_!XU'V/ "!=I1@D
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M#AB  12 'BB, AC %F6+!!C  3Q +11#EG"*Z C6""@  *3 /Q791Q' *J1
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M!"<@5W*9DGK.R!)P1B*21QA"U7,HXK;)0C#   S863#<0B1 @33,!0S,DD%
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M) "QJ@ M!$ *F(N(KD<QA*QFW !BY "8$0@>,$.FV90H:6O3'A OIMG;>(>
M,@DP!OYD"#E)#+B"0%C",-$ U[P%!ET"#(Q",.QA1LY%W-GKVKZ$? " #E7:
M-NH!Z<B4[V3""A  )$!.8A[(,_@.A5;/#0! "11# E3 (70 !$@# T38,Y1
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MT8 08#', "VP0N]" B1DPA'5@EBB!"<L,G ,P13TA8G3*?-F>##R-_2R^*I
M;[A:>)5GN'MGI-NH^$!NN=7 PBBH "44Q"74P)ZB "X< @V,@B"\^26;<8^G
MWX'F:T9,#QZ8" H_PRXX0FA(PF1=7X'P\-P*@IILRAY(0X%S1$Y%>!1$K79[
M>5)-,9W&4I-<;96[=Y=OG"=O]_Y[FOFG)Z)&EO$F:[J'>[HO4JTMN (?C "[
MZI(DC,(,H, O:.HO *TEM U=JK*>CU\*/=-%A*@$C("IHD  ] X .,(QK);V
MR4HNM$*F"<)6FDXYSG&]!4<1-$'&B7B*LS<FBWF*D[I=K-TO@K?SRFF7:W=\
MZYE=P*6;LKLGFWN*B^MVRX(QX ";MX(,Y,4OQ, KN$)E7%";XOD9$[OW0::;
MC!HK[,$$"< ,^*@DK$  T  DJ)&D.Q\TU  >X$ 6%8,>_,P@T)4@G+9'K,BW
M3X&XP_J6C[F^SRG:;C>%PRFJ5SAYS_N]?_G/JSI_>_A[ GVIA_A<!,,,8,(Q
M&((?[/Z"+OC2*VS0*,3 UMBE"#5\^1THM_@Y"SB !1R # 0G"U1 "U1 "BS
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M( $*@,$SZFJ! >"5$@10@ (&T H]$&"M $A!7L/:53T\(_X% ZC  $CPC#P
M(!/&@, !*A" &A0V (@-0 E< 0 6/,.O7?0@5R:S!T/T02^UP .(\ND(6AAC
M#ZPX1!J]@J+*H!2[V4UA$;J0"YNXAZ7ND0GV:O.9F]I$%KNX 20( 05+!$,6
MK9 !+7*!BQC(PA4S?$$K:.*05T85P)AZQ68/<(  %(*R!JC$+%=0"  ($@8!
M:(4@_DIA8E9  <6HP .*T8H P( 27GT&# ! BQ808 ;(@$*% 7!A!N " A'0
MWP%JF0L"_.$9N3! "Y[A"!&3N!464( Q<&&!0O2AQ<:H0 *,H0("4.(5!E *
M /+P#$, (!(4;D4;N]B" :PB OX0F'$M2=" 8UA  L/]RAX@<8P^.+?*DUE%
M(9"1A^@:XA5[Z,,RO4*W(?A.NR=D) I/6@0V>'<DEWQI3)L:FO"$1C_YZ8A^
M(O*+&+A $I=P 26.80@_, @6,( %+7[A"AD<XA>P<$GV MSJ3+V" +7<$&69
MS(P$L$ / 5B,EI'<BC\ H(LG8$ K'O" "E1  BRX@0$J  $*0  2*C" 2/'P
M5\-VL00,T 4#1LN,!HP I 7PJ(YYO.P*1 #9?X" ":2"HFH'F\DH4  R;,V"
MUW;1$@#(@6$SH8($>'0/ OC# VKI[=8.8@![.  ." ,-''@61)40I& @D8D^
M'(,5"/X.2]T(0FCL>CS0BSR(2E]B294LVD<V$LEL7&JCD$2ZIN:113!<0(AC
M! ,2-SC&#$(!D5##XA>& #$0T?M?5Q_=2Y-Y!0),T)!77/0$0V;& E@ "0"X
M@!669866*3Q'81<CQL8PQB'F#  $6[ 8*<BP:RL<@#G*6\D&H,0?!E!+"8PV
MQP;XK8//;HA:2. !/"V!(/;@=M0.6>W&8(8"6N#C03SC$68?Q%]G$ "_R("L
M(WBR( 90@F<4@P&"=0Q:F"$)#I61!AWJ0R:D4HPJ0^'S>Z N5S3QYT6"/.2Y
MSTP+43->EY\\/;/1"44N69%$QY BP< #(X*!<SR,H@:IIOY%J&_AB!P$XQ@_
M^XS1D=[]$;%"  0(@   < !FC&  QH & 2CPC!SL%?VL>"TKS/K&$02 &8X(
M@ 5(8'9H5$#*#D#,.D  /,JOZ,^-GN'^MHD""* #%D %\LWT'J,! . %F $
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M3AI? !*>(1-28 0$Z1 8H '*Z 8*@1EPH! ,@03V8#(*801N0!!N !EZ99^
MRRVR" ^.@8V*L7;'XI"Z%C,DMAY]3R5&XF)]#T"T]7CG4/[X,@F\P% ,R99Y
M;@$3"J$8HH$0"*%H;, 21F$/5N 6;D!+=@Z4,.)P$1>JE,X 4.  ',$0$N $
M"  7) $ 9& B!8$9"H"S9" %&J 2K@@:5J'N:B  ]N 1%( !9@ 7"& $C.$
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MB@-8 !&&,(2=2J  Y"V 58XX@ *08J@_($M#N"  &0%  U8$ "IZ $ K_@
MZWPO?'4"UBJH1983=#%Y)]@4 XK!LU! (P(6T-]_;A #C.#A!MX!@!Z ];$4
M#( 6)#@ +FJ! !S0<14E,  S<D& &N!-6;79R2$Z1+<],.49J\1(+40(%6GT
M 26;"/X"Y%#(R[@,@48S!)UE>A29(;DK2/?2(6-B",,;7<:8>;E$)'X% UA
M8C.)@0$N]D (9@0#8#D<3!.G2,YRFO.<MB$5 0 0  "(<@2*8H8!+/",8S0
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M0YA= M XP0$4FX 4K"( !*T%ONM9,JHU0 5XJ\%M$W "F>4A#P2P"G"2!SE
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MH20![(,?#/".\7@ACW( 7[$+!FF K[2%X!,#11<J V A1#<  ]!U5),#W6@
M>/  C_ *XU..-GF3.#ECQE +%?2.VX(1[H,1Q8!<R(,1+U !E@!Q!$4UM+!N
M9'=4&)$+S841QG!4/TEV*@(-(P,-/ODWR&"53:D1N5 +R^(S>U25/?DLJ)8+
MRX)JB/4,;NB4.3F7=%F7--8*%I  "@ #W.)]LV%C'8$,-U @)&%DMN:7=IF8
MBKF8O#-E%61MT39XC#F9E%F9=X68$H.9EKF9G-F9GOF9H" 9FJ(YFJ19FJ9Y
8FJB9FJJYFJS9FJ[YFK 9F[(YFT 8$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>cogo_0030.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0030.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MGSJN9,?9D^-(*8J"#V5E:-Z? #NDD^N-^UR!Q\Z6*[&;Z""):^!)YY%2BR^
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M=9_I,3RKM]#9IQ*F4AH+);:^K0#E1"0-AD[UZ6,(0CMBCYWDSY<V1Y,LK?\
M0=K+]H:WY4&5)W)&4(B28J !GV16:K9TOT@BXLA,E!)QDXI'P1*PBB,@H';M
M4L%%2Y-I0PI..56+H5\"[PB@*.NGI"E6QK'/%5>30OJ6;LXI4)0--'[$E]1>
MTHZ42'?_ '*L95#L9)MX7%5L :9*Q93V<%?]Y!C)3O3J!3+/1[;U"M78,5-H
M5FX+S%U4\H =I Y5-H/>"R4JQQ8Y5!R0'V2KM%!JU05V8.U=TL:3Z0M6WOHI
MT^MZ;=-,,IG7*0RV3%C.J5PACK.UPC)QW"N?ZC@K!7D[GH6:M3N\,Q]+E(B/
M,B>HML\?"M?=OVUY2*MTSW<GM5H;9BK>S%;5"D(6RZV2E3?NG;M\:T>VDN!,
M$Y3D(E[8B/,%SB(XD;<2L);[]NW-!1='32KD&6A#,5Y/5.E:@/>2K%!Q8SBN
MV#M;Z@A,%B&G"' DNE(.23XUIGC32:.#+*]SQKH/Z M#L?3+][G(/K%U'&V3
MV,I/LC\B:[_IN#9CWOR>+_B#5/-G]F/40A8N:OZC73/.#I9CAYL^5(P1^QDR
M(ZH1F\=J16?R=-?4%7)Q2I2$GLWI)#1+[;BB@'-0!5N#A+2DFG70D@#34(-V
MF@!;F?Z:1Q2+X.U1=NGV-51*G89="UI?>2[X.&F97 -78 BFAR4YNP6A(XN'
MLJWHR/Y/DL-M]PH_U"^%P'+0TDD%2<[TKG72#':^QD(4&E*) &*HR9/;==FR
M$'-6:_\ I+>DO:>B:T/::T_<69.K)B"&VD85ZDV1_%7V ]PYD[\JWZ?3/+)2
MET9\N98XNNS%OH%MQ+_T>=(;3S@7?9%^]:DR5G+CO$V"WQ'F1D* \ZI]2QIW
M"/1N]-S^Q.,Y_P!QKNW4S79ELF1P%94T\VKFAP<\]WPKP6;'*$^>SZCBV9L2
ME%_%BG.DRK;:?HQ+RVDLD]7PDFK(.^S/#^5*XF*K[T@3US6V<<0C.<2TE1]O
MX5IC!>30];Q]3Y'U)J.[R7'FBVPT.92DYH^W%%6;U%M51^0U-ERE.S%$J6.!
M3JO:(0!OCNVJ0<I.C%:47,V-CR84G3$-RV2F'X:X;9CNM*!0M/ /:'A_>O80
MQ>S%1E_8^9ZG4>]EE->0+8L\2A^,T64)/R.EH_C-^8I&,DDT9+AC,5!/8FL[
M[.@OJ"+@?\4CSQ2/DB=((-[(%$%LK3@.K53(CY W FAN8M#7IO\ RYG^FC(M
M@7+E]E5409=,6])X,QX'?ZPT650#5WYT\"K-V#FP.+.*M,J[+3#:U*VR0G<@
M=HI)-M5$"?/(H:\])?H3Z'HR_P!\-;PD3$[B#&(?DJ..7 @Y3_RQ5F/#DKDL
M4X_@U5Z2OVG5TOJ)-GZ)M-)M;;J5,HNES/6/<1Y*;:2>$8_$36C%HX;MS7(9
M9^*LU/<U9=[K=9-QU'+>F3I;BG'Y*U\:GE$[J)KH0;AP9LGS=LVB_9Z:^1:N
MF"^:0DN\+&H;<'V03S>9.?\ XE58==CM<&K32333-T^DKHS:U:PJYVAY%NOB
M <.*3AN0!_*YC\E=E<#4Z&&J^<>STGI7J^71+V\G,37"[3[E"N#MBU' <B7"
M,#QL/)PKA^^D_P Z?$5Y[+AE@EMD>YPSQ:Z'N86)$+2]G=G/W&85N*D.$-GA
MVX?"E;:Z&6+?R02I%JL3<I:Y(880K/&LXPG^]6P39DE@W.K'#H-T_*UVU=->
M.6MV-IR!#E,6UY\<*KA(ZM7$ZE)_TT]A[37;]*TS>3?)<'G/7=:L</9Q=FFW
M1;Z1W2%T10TVR(\F[6!2EI7:Y:SPH/$<J:7[S9V\C7J\F&.9'@%*6+[>39_H
MB]*3HMUN^F%,N1T_='-O5+DM*$E7X'?=5\<&LKP;>A][?1LK9"APL.MN(<0O
M!XDX*3W<*N1'E6:45'SR6Q;;,FPP/54;?RUD?9TOTH"W( 3$@?\ F]**7VO<
M%$A!- ZI6U,@@7 [J@1JTW_ES/\ 34D- O7'/J;@'/%!M<62=I.A=T<I/K3V
M1_J&IDB^WP589KIA;4LF#;XJYERG,0XR 5.//K#:$@?B5M3XWOXCV+E2C]C6
MSI-]-;H>T EV-8KBO4]R2"E*( X64G\3IV^0-=&&!M?,Y[[^)IITP^G!TM](
M"'[=!NRM/6QPE(B6M1;*D]G&Y[RC\0*MCCACZ!5O]S6Z?>)=P=+LF0I2W%96
MM:B23WDGG1<OP6QQWVRVPH*>B"(\EQ(&Z@K(SG>F3$:&-N]1XR'49XW4^RV/
MU-6;N 1[Y,A>CAK5S1?35I+5,A\H2S<FFGM]BTX>!0\O:%4Y4Y0:+\7WH[/L
MR/6&@HJ!]D94>X#G7*VN#I'1E)./)BOI4T[H_I"9:M-QB//3(ZB8MPCN]4_$
M5VE"QS'X3M2:C2QS*V:-#KLNAE<7P:X](FA=7=&$)B\+N1U!9G9(BH<CQBF0
MR\KW X@>]G'O#MKAZGTYPYB>S]/]>CJUMS<,I:0]'Z5JVY1M4=--R<CP7/K&
M-/PB>L4@'(]97R1G;V!OWXK5H_3F^9=',]2];]N3ABY9M5.^B&=&RX]@0TS#
MCVYUB.PRD)2RD-'" !L .ZN]BQJ"J)X_/.623E+MG$\!PM+6!D!YSB!Y>]S%
M=3&N#FY/W!\B*'7<I.$K&Y[E"I**8J'_ *)O24Z5NB.0W^[FI'),%M6%VZ:2
M_&4,[X!W1YI(JJ6*.1;6&,W%[D;_ '0C^T"Z)M=M1K-K?CT?>5)#9]85Q0G%
M=Z7A[@\%CXUS\VCE%W$WXM5&2IFQ#DZ%<^JN%NFL2XKJ IMYAU+C:AWA2=C6
M#(I/AJC5%QH*-$! S3Q@MO MIOD^2^'J-J"NN2.O (X4]U$ Q:;(^CF=_P"6
MI(L@7K@"8CF,9 SX_"A^X9*S63IK])1WHE;F6G1MOC3[\ 0I<C^!&\P/?/@=
MJZ6'TZ65;\IR\NL2>V*.>'2GZ0W2;TGSI#NL-5W"6M"SF*MS@9:\$-I]G%;-
ML,:VQ17NGE^1C"1>I#X 4LC;NQ2N5\$C"V#%/+63D_&JV7QKR>2E2N8YU.&"
M2_!-%BAI76LJ4V2=^$XSYTRLC06BE/9DJ[33HK:KD/1)+D8)D-*(6UA:2.P@
MY!^=.E? 4ZFF=7M+]-*M;=&&E#8)W%+O%L9>FO).5-J"0DMY'(DI)KGRC;=G
M1C&U8_:2A2&@TB:XAPN#!R,5)2I51-CN["NI;"T[%#3&66TJS[)R2KOJE)52
M&W.WN9CEZ J//5;8[G$4X*E=N3SK0JB51W-,%/SING-<'3KTDJBWJTRSP=A=
M2V>$_+:FQJI_U#E6Z''@Y1Q$YBRARQ)<'_<:Z&-<'*R=@J=MQ85A*L@X/.@T
M"K**V2T$A(P,9Y4-I-U$:7%A>,';NVJ< I-VD/>@^EWI-Z.'$JT3KBZ6E(/%
MU+3Y4R?-M64GY4LL<9<-!N2YNS9KH:_:':[&NK+I?I8BVJ399V(KMQC1NID,
M.%0 =5@D*&X!&.6XK'FTD%_<TZ?4WPT=$%K2Y'XTXX5#(QRQV8\*YKAL>UF_
M<I*T#J  YIPCZ/CC\-21;#H]ZLN/T1IJY78D 0XSKV3WI22/SI\4=\U$7(]L
M6SF%K6?(NTJ5(F*6^[+6IQQ2CDA1WQ7K%&L:BSS[=S<D:M:YCK@:DX\<+;P*
M%>?8:YN55,V8OJ!#Q9(/*JBP\%O?-0A] P<@\N50A>94E;:5 8[_ #IR%J(H
M()R>VBNP/H*MN$MX[Q3+AB/E&Z?[/[53$NTWO2\U*77K>\EV.%'<-[G;/963
M)PS?B=P-[6D-!3$ICW%8.W9FL]VBQ%N\20MI*4'(YFA#O@62%"SVH+N,FXOH
MSQ*]D&K;KE@B_ EZY3ZOTCV^2>%>;7*4WM[OLFK8>&'],D<J4)03.X4X"I3J
M@.[VC71Q^3CYNQ;N77)<4M "A]TU7/L:/1%UG61LD8)4!CNIET)+LIJ!XB/&
MJ_)8NBPQQ @GLJSP5)?(IW)XB]6T-J(5]8<CLY8/SJK*^8HN@JC)G;7H3O[F
MJ^AG1]^<)4Y*LT<N$G)*DIX"3YE)KCZA5D:.CC^B&;![C5(X6L+H3!82.810
M?/0\))< 'ILDO-=$NJ%,$\9MZ\8Y\P/T-:-&F\\0:AUBD<W]7/M6N(VZ3E1=
M'%Y8KU>26WD\[!/;R:]]);;4Z6XXWN%;I([*YF9.[-F*22H2&7NL9#B@<YX5
M>8JDNLF1@G!HT"S\Z@@9%2B6B>(H;H^-08E0O"Z*%ET%&G/8!S3/EV+'A<F=
M/0UU@C2_35!B/+ CWAM4584<#/9232O<^C5IIKF#\G4NPR"J.]%4H*,<[>1Y
M5BXZ--\A!X)7Q%Q0R!C'CBD7#Y!)-E6WMI7'*L)RE79VT9NT!1:9B#I:F"VZ
MPC7%9(2S99RSY)02:T8_DDD3]+.5]N7QQWED^^LJ^9S71Q<JSD9U\J -S)"R
M!WU7-\CQ3HK(!+2!^(J-,GP(X\E=1P\ >W:D\C>"W)'5,)6GMJQ\<B1Y="^V
MZI_44=).0A./+)K.Y*60O<''&U^3KIZ"6L6]2>CS M2G_P#$Z:E/VQT#GU95
MUC>?@H_*N?K8O'EM^37IYJ>/CP9]XWON)K)8^Y'VTR.KALD\N'<]PJ(9.F+?
M35?8L#HJU%(E;),4M@$_S*(P*U:/&Y9XM>/_  349%[33.:.MY#TFUE]2^)*
MR2"#V9KTN7F)P7=JC!=TF=8\ME:^()Y5SY.^#<N&*[?LR)3'>0XGPSSJE%SZ
M+#2O; [J80MN("D[5"(A1EL9&YJ%A[*QQ)(Y$9J"OH)1E\38_2F0@;TG>W=-
MZHM5_95PJ@RVW<^ (S2S5JBW"]LK.QF@+RU>%-RD.!3<^WQY:%#D0I._YUER
M1VR9N[2?Y'E;*2'=AG(YCPJA<R"#+1[,J1%4=TJ*L=R>R@POHP+Z5\L6:"]<
ME*X +%=&TG./:+6WZUJT[M_V8CX@SF):R4P#GGO70Q\1.5EYD!;@K+BJ278\
M>B($=2HXY;"BNA'V561UBQYTJ[#X+-S7PQ ,>[5L_J4XW\Q6LCA>U$M9Y(X4
M_G6&#O(;LGU.@O[.#6BX>L]4Z"=7EF[6],]E&?\ 595A1\RA5378[CN*])/G
M:;X_6_>_.N'O.C[9[M["3"9"BHCASMX5:GM[#LMFJ7I?=(DHN2-&1)11#@XZ
M](/\1XC)SWXR*[OIV+9'WF<O5RW/VT:H:@?+VD\I.2EM6*Z,_I9ECRTGX-?7
M7W>M4M1S@^T*YKER:JYLHONI^DHSG)+R5-'SYBE\EG99;3];C)S1L#5%T;)Q
M3"$6,&@^"Q,@95NMM6V%93Y4$PM<!&*O QG:B)M+:R.J([#13(^%1T_]#S7!
MU9T::,GO.=8]";D662<[!39R@'S!-9LRIF['+>J?@V@>5@\0[:S)46 5UPQ;
MTR_CA2^2VH_#:BU;&\&MO[0%UR'T3-W-LX*W512>[K  1^568>),KG*HLYOP
MU\$$ CF,UTX_6CDMVP),/$ZHU7)\ED>B-9Q'\P31O@6K97@'+OQJ1Y8LG19N
M^S!2.P;5;D^I7C^XI:;4?7Y+Q'O2.'/E7/Q/YV;LOU1M%Z'^JQI7TA]'35.E
M#4R4JWNG. 4O)* #_P N&M>IAOQN)DT\E'*F=7_5_P"OY"O.>Q/\':]^)39N
M;,"T>N27 AJ.T75J.V$I'$3\@:?9[TE!>2;]L&V<V^G?7*-4:NNTYL%#<^0N
M0V@G<))V_+>O5)+'CC!'!;<IMB"ZX9%@ZKMP0:9OX C]C!]U8+4EPC8A1[:Y
M\D:T!;J>%AN2G +3J%'PWWI&6()MJ"WTK'([T4!EH$TZ*GP1J)I66(J.$A[B
M'?O0&+S*\$=QIB%]*P4[#.U0#7%FW/H$:W>@R-1Z.6\0EE4>],)SCW%AMW'_
M !4#235HOP/HZ2YZU(X5C) (\<BL7DT(":K<,.+'DG_3D-@?$T9<(>'+-;/V
MBDQJ/T&1V%;+D7MA#8[=DJ4K^U:,,>V9<TJX.<*E\$9"1W5O7".9-U0&D;K/
MXCBJI%\>CQ(40UCP(H^ +L@@?Q4GO.]2!7,LW=8 QGE5N3HKQ_84; L)9ZTC
M'6/N*&3XXK!C7R.AFX1DC35W?LEUMM]C.%#L&2S)01V*0L*'Z5ODMT&CGXZC
M)29T@_ZT-*_>_.L^R)MLL>E9TI?N?T>6O2\&3U4[4\I$96.8C@@K^9P*P>GX
ME+(I,MUDI0C\6:/],+CD.XHN$<*X$G@7X#LKN:CAVCF8[*&G[HU/M:DH.58-
M+BENCR/);7P8AU:[B<ZXC(2VL@@5BR-WP:8]"Q=)27(;C:5\14G/RWJF3=&B
M*0:MKP?BLOYW*4_I5L>D43M-H(<?A5A4[(BHY.]*-=$"_>S0H9-EELC 3W;B
MIT.6V7#D)!HJF+)LROZ-6IAI?IEL3SC@1&N*G+:_DX!2\DI&?CPT53?R&@VN
MCKG:'+A<X-M=8= 4AEOK-^T8S7-E=\&Y.NR/I'/46!;P.2V^TX?(*%6Q2DN1
M;:?!IY^TNU#_ .G]#Z<"B#,DOSU^(0A* ?F35^!]F;/X-#WE_5<)/N\JV,Q-
M*7?Y!3JN)T)^[O599T>'U9&#49%V1P\)>3Q'"<[GNH18))%:]327G%\&&D(.
M%=BL#?%-EDZ%QI;T+%L;<>B-.\? TA.W?G.]8HNC;E5\#Q:7_6(H03[HP*Z.
4*3HYF2"WM!'UF1]Y7SI]@+9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>skill-x.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-x.jpg
M_]C_X01G17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR-B Q-SHQ.#HU,@   Z !
M  ,    !__\  * "  0    !    $J #  0    !    &0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M259N/__9_^T,<%!H;W1O<VAO<" S+C  .$))300E       0
M         #A"24T$.@      \0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    2 %  <@!O &\ 9@ M $4
M:0!N ', = !E &P ; !U &X 9P      "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!2
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 $@    !  ( 2
M  $  CA"24T$)@      #@             _@   .$))300-       $
M>#A"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-!         (  3A"24T$ @      !      X0DE-!#        (! 3A"
M24T$+0      !@ !     CA"24T$"       $     $   )    "0      X
M0DE-!!X       0     .$))300:      -+    !@              &0
M !(    + %4 ;@!B &4 ;@!A &X ;@!T "T ,0    $
M         0              $@   !D                      0
M                   0     0       &YU;&P    "    !F)O=6YD<T]B
M:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G1L
M;VYG          !"=&]M;&]N9P   !D     4F=H=&QO;F<    2    !G-L
M:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)
M1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M#$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M"D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<    9     %)G:'1L;VYG    $@    -U<FQ415A4     0
M &YU;&Q415A4     0       $US9V5415A4     0      !F%L=%1A9U1%
M6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%
M6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX
M   '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG
M;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O
M;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/
M=71S971L;VYG          QB;W1T;VU/=71S971L;VYG          MR:6=H
M=$]U='-E=&QO;F<      #A"24T$*       #     (_\        #A"24T$
M%       !     0X0DE-! P      TT    !    $@   !D    X   %>
M S$ &  !_]C_[0 ,061O8F5?0TT  ?_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( !D
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M "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %  : !O '0
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M041"10)   !M;G1R4D="(%A96B 'UP #  ( "@ ' "EA8W-P
M                         0  ]M8  0    #3+6))0T.<;32EK:1%]A1M
MF+!1#!)M                                          EC<')T
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M96XO96-I4D="+G!H<    &1E<V,         "F5C:5)'0B!V,@
M"@!E &, :0!2 $< 0@ @ '8 ,@     *96-I4D="('8R
M
M %A96B        #VU@ !     -,M8W5R=@        *\    "@ 5 !\ *@ T
M #X 20!3 %T : !R 'T AP"1 )P I@"P +L Q0#0 -H Y #O /D! P$. 1@!
M(P$M 3<!0@%, 5<!80%K 78!@ &* 94!GP&J ;0!O@') =,!W0'H ?(!_0('
M A$"' (F C ".P)% E "6@)E G ">P*& I$"G *H K,"OP++ M<"XP+O OP#
M" ,5 R(#+P,\ TD#5@-D W(#?P.- YL#J@.X \8#U0/D _,$ @01!"$$, 1
M!% $8 1P!( $D02A!+($PP34!.4$]P4(!1H%+ 4^!5 %8P5U!8@%FP6N!<$%
MU07H!?P&$ 8D!C@&309A!G8&BP:@!K4&RP;@!O8'# <C!SD'3P=F!WT'E >L
M!\,'VP?S" L((P@["%0(;0B&")\(N C2".P)!@D@"3H)50EO"8H)I0G!"=P)
M^ H4"C *30II"H8*HPK "MX*^PL9"S<+50MT"Y(+L0O0"_ ,#PPO#$\,;PR/
M#+ ,T0SR#1,--0U6#7@-F@V]#=\. @XE#DD.; Z0#K0.V []#R$/1@]K#Y$/
MM@_<$ (0*!!/$'80G1#$$.P1$Q$[$601C!&U$=X2!Q(Q$EH2A!*N$MD3!!,O
M$UH3A1.Q$]T4"10V%&,4D!2]%.H5&!5&%705HQ72%@$6,!9@%I 6P!;P%R$7
M4A>#%[47YA@9&$L8?1BP&.,9%QE*&7X9LQGG&AP:41J&&KP:\ALH&U\;E1O,
M' 0<.QQS'*L<Y!T='58=CQW)'@,>/1YW'K(>[1\I'V0?H!_=(!D@5B"3(-$A
M#R%-(8LARB()(D@BB"+((P@C22.)(\LD#"1.)) DTB45)5@EFR7?)B,F9R:L
M)O$G-B=\)\(H""A.*)4HW"DD*6PIM"G\*D4JCBK8*R(K;"NV+ $L3"R8+.,M
M,"U\+<DN%BYC+K$N_R].+YTO[# [,(LPW#$L,7TQSC(@,G(RQ#,7,VHSO301
M-&4TN34.-6,UN#8.-F0VNS<2-VDWP#@8.'$XR3DB.7PYUCHP.HHZY3M .YP[
M^#Q4/+$]#CUK/<D^)SZ&/N4_1#^D0 1 9$#%029!B$'J0DQ"KT,20W5#V40]
M1*)%!T5M1=)&.$:?1P9';4?52#U(IDD/27A)XDI,2K9+(4N,2_A,9$S133U-
MJTX83H9.]4]D3]-00U"S42-1E%(&4G=2ZE-<4\]40E2V52I5GU845HI6_U=V
M5^Q89%C;65-9RUI$6KY;-UNQ7"Q<IUTB79Y>&EZ77Q1?D6 /8(YA#&&,8@MB
MBV,,8XUD#F2091)EE6889IQG(&>D:"EHKVDT:;MJ06K(:U!KV&QA;.EM<VW]
M;H=O$F^=<"EPM7%!<<YR7'+J<WAT!W26=29UMG9'=MAW:7?\>(YY(7FU>DAZ
MW7MR? =\G7TS?<I^87[Y?Y& *H##@5R!]H*1@RR#QX1CA0"%G88ZAMB'=X@5
MB+6)58GUBI:+-XO9C'N-'HW!CF6/"8^ND%.0^9&?DD:2[9.5E#V4YI6/ECF6
MXY>-F#F8Y)F1FCV:ZIN8G$:<]9VDGE2?!)^UH&>A&*'+HGVC,:/EI)FE3J8#
MIKFG<*@GJ-ZIEJI/JPBKP:Q[K3:M\:ZMKVFP)K#CL:&R7[,>L]VTG;5>MAZV
MX+>BN&6Y*+GKNK"[=+PYO/^]QKZ,OU3 ',#DP:W"=\-!Q S$U\6CQF_'/,@)
MR-?)ILIURT7,%<SFS;?.B<];T"[1 M'6TJK3@-15U2S6 ];:U[+8B]EDVC[;
M&-OSW,[=JMZ'WV3@0N$@X?_BWN.^Y)_E@.9BYT3H)^D*Z>[JT^NX[)[MA.YK
M[U/P._$D\@WR]_/A],SUN/:D]Y'X?OEL^EO[2OPZ_2K^&_\-__]865H@
M    IG@  %'^     %A96B         ME   FB   !%=6%E:(        "+)
M   3X@  P=#_[@ .061O8F4 9$     !_]L A  ! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,#
M P,# 0$! 0$! 0$! 0$" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P/_P  1"  9 !(# 1$  A$! Q$!_]T
M!  #_\0!H@    8" P$             !P@&!00) PH" 0 + 0  !@,! 0$
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&O?NO=?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>skill-g.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-g.jpg
M_]C_X03817AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR-B Q-SHQ.3HU-0   Z !
M  ,    !__\  * "  0    !    %: #  0    !    &          & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M,  X0DE-!"4      !                      .$))300Z      #Q
M$     $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN
M=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M      MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P
M3V)J8P   !( 4 !R &\ ;P!F "T 10!I &X <P!T &4 ; !L '4 ;@!G
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0%(            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      !  2     $  @!(     0 ".$))300F       .
M     #^    X0DE-! T       0   !X.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-)Q        H  0         ".$))30/U
M      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(
M   ! %H    &       ! #4    ! "T    &       !.$))30/X      !P
M  #_____________________________ ^@     ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@  #A"24T$         @ !.$))300"
M   $     #A"24T$,        @$!.$))300M       &  $    ".$))300(
M       0     0   D    )      #A"24T$'@      !      X0DE-!!H
M     TL    &               8    %0    L 50!N &( 90!N &$ ;@!N
M '0 +0 Q     0                         !               5
M&                      !                         !     !
M    ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !
M  !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M&     !29VAT;&]N9P   !4    &<VQI8V5S5FQ,<P    %/8FIC     0
M    !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO
M;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'
M96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M!F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M     $QE9G1L;VYG          !"=&]M;&]N9P   !@     4F=H=&QO;F<
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M# P,# P,# P,# P,# P,_\  $0@ &  5 P$B  (1 0,1 ?_=  0  O_$ 3\
M  $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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M "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %  : !O '0
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M041"10)   !M;G1R4D="(%A96B 'UP #  ( "@ ' "EA8W-P
M                         0  ]M8  0    #3+6))0T.<;32EK:1%]A1M
MF+!1#!)M                                          EC<')T
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M96XO96-I4D="+G!H<    &1E<V,         "F5C:5)'0B!V,@
M"@!E &, :0!2 $< 0@ @ '8 ,@     *96-I4D="('8R
M
M %A96B        #VU@ !     -,M8W5R=@        *\    "@ 5 !\ *@ T
M #X 20!3 %T : !R 'T AP"1 )P I@"P +L Q0#0 -H Y #O /D! P$. 1@!
M(P$M 3<!0@%, 5<!80%K 78!@ &* 94!GP&J ;0!O@') =,!W0'H ?(!_0('
M A$"' (F C ".P)% E "6@)E G ">P*& I$"G *H K,"OP++ M<"XP+O OP#
M" ,5 R(#+P,\ TD#5@-D W(#?P.- YL#J@.X \8#U0/D _,$ @01!"$$, 1
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M[U/P._$D\@WR]_/A],SUN/:D]Y'X?OEL^EO[2OPZ_2K^&_\-__]865H@
M    IG@  %'^     %A96B         ME   FB   !%=6%E:(        "+)
M   3X@  P=#_[@ .061O8F4 9$     !_]L A  ! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,#
M P,# 0$! 0$! 0$! 0$" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P/_P  1"  8 !4# 1$  A$! Q$!_]T
M!  #_\0!H@    8" P$             !P@&!00) PH" 0 + 0  !@,! 0$
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L^K75U)G]1]M_</[G\0_5>/\ 4?4>'%J^JI3QO#T>%33^GX6CP_ _1IHZ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>cogo_0029.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0029.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MJ90;X7_)EZ_0XM-H<>6*J3?]J.DF/E2*[(]F-DZ0<DX S10#-)!SBH0Q>25
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M^U3&SE+L1]32L^IQP?QHM62-1Y3-^Z$^WSUSTH&H]_EP-4QFS\0N#&U]2?\
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><K9US=84-G$H"%!"L#@BKBG\$6__ !'\ZEB\'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>skill-m.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-m.jpg
M_]C_X1#117AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR-B Q-SHR,#HU-P   Z !
M  ,    !__\  * "  0    !    &J #  0    !    %P         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
M @$ !     $   $N @( !     $   ^;         $@    !    2     '_
MV/_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.
M  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="                  #V
MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ %P : P$B  (1 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,
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MW/Z(=&1PG7.Y/2;^OO9FY#!ALI+78+7-_3>US;/6R=6O9N:W]%B[O9O]2_\
M2?HV=$EP#;B]7;^M^[Q)]R6IX/18]5_H_O<#_]#L^L U=<JR3CU9;?1K;74^
M]E3FVBRST7^G<1ZF[?\ H?\ A5'.SK'9>([/Z15]J8^</U<J@/W'V_HFN/Z3
MW;?[:^>4E9%U&^&^'3^>XN'_ *GZ6E*N*?#[G#Q>JONW!Q_]6];]*CJ/7)'^
M2"!.I^T5+57RJDF>B_\ )[?ZZF3];PG^>NQ_XFXO^\?_V?_M&-I0:&]T;W-H
M;W @,RXP #A"24T$)0      $                      X0DE-!#H
M /$    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
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M;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B
M;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U
M8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M          !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M              !2<VQT56YT1B-0>&Q 4@            IV96-T;W)$871A
M8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&
M(U)L=                %1O<"!5;G1&(U)L=                %-C;"!5
M;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC
M<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M    #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<
M     #A"24T#[0      $ !(     0 " $@    !  (X0DE-!"8       X
M            /X   #A"24T$#0      !    '@X0DE-!!D       0    >
M.$))30/S       )           ! #A"24TG$       "@ !          (X
M0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M  $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M     '   /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H
M /____________________________\#Z   .$))300        "  $X0DE-
M! (       0     .$))300P       " 0$X0DE-!"T       8  0    (X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #2P    8              !<    :    "P!5 &X 8@!E &X
M80!N &X =  M #$    !                          $
M !H    7                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<    7     %)G:'1L;VYG    &@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG    %P    !29VAT
M;&]N9P   !H    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!0       0    ,.$))300,
M      ^W     0   !H    7    4   !S    ^; !@  ?_8_^(,6$E#0U]0
M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(                  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                        9&5S
M8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'
M0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &1E
M<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V
M,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ                                  !V
M:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,
M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1"  7 !H# 2(
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MEJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#T5N1<>OOQMY]$8C+
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M29Z+_P GM_KJ9/UO"?YZ['_B;B_[Q__9 #A"24T$(0      50    $!
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M0YQM-*6MI$7V%&V8L%$,$FT
M    "6-P<G0   #P    BF1E<V,   %\    >'=T<'0   'T    %')44D,
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M('8R           * &4 8P!I %( 1P!" "  =@ R      IE8VE21T(@=C(
M
M                6%E:(        /;6  $     TRUC=7)V         KP
M   * !4 'P J #0 /@!) %, 70!H '( ?0"' )$ G "F +  NP#% -  V@#D
M .\ ^0$# 0X!& $C 2T!-P%" 4P!5P%A 6L!=@&  8H!E0&? :H!M &^ <D!
MTP'= >@!\@'] @<"$0(< B8", ([ D4"4 ): F4"< )[ H8"D0*< J@"LP*_
M LL"UP+C N\"_ ,( Q4#(@,O SP#20-6 V0#<@-_ XT#FP.J [@#Q@/5 ^0#
M\P0"!!$$(00P!$ $4 1@!' $@ 21!*$$L@3#!-0$Y03W!0@%&@4L!3X%4 5C
M!74%B 6;!:X%P075!>@%_ 80!B0&. 9-!F$&=@:+!J &M0;+!N &]@<,!R,'
M.0=/!V8'?0>4!ZP'PP?;!_,("P@C"#L(5 AM"(8(GPBX"-(([ D&"2 ).@E5
M"6\)B@FE"<$)W GX"A0*, I-"FD*A@JC"L *W@K["QD+-PM5"W0+D@NQ"] +
M\ P/#"\,3PQO#(\,L S1#/(-$PTU#58-> V:#;T-WPX"#B4.20YL#I .M [8
M#OT/(0]&#VL/D0^V#]P0 A H$$\0=A"=$,00[!$3$3L19!&,$;41WA('$C$2
M6A*$$JX2V1,$$R\36A.%$[$3W10)%#848Q20%+T4ZA48%485=!6C%=(6 18P
M%F 6D!; %O 7(1=2%X,7M1?F&!D82QA]&+ 8XQD7&4H9?AFS&><:'!I1&H8:
MO!KR&R@;7QN5&\P<!!P['',<JQSD'1T=5AV/'<D> QX]'G<>LA[M'RD?9!^@
M']T@&2!6(),@T2$/(4TABR'*(@DB2"*((L@C""-)(XDCRR0,)$XDD"32)14E
M6"6;)=\F(R9G)JPF\2<V)WPGPB@(*$XHE2C<*20I;"FT*?PJ12J.*M@K(BML
M*[8L 2Q,+)@LXRTP+7PMR2X6+F,NL2[_+TXOG2_L,#LPBS#<,2PQ?3'.,B R
M<C+$,Q<S:C.]-!$T932Y-0XU8S6X-@XV9#:[-Q(W:3? .!@X<3C).2(Y?#G6
M.C ZBCKE.T [G#OX/%0\L3T./6L]R3XG/H8^Y3]$/Z1 !$!D0,5!)D&(0>I"
M3$*O0Q)#=4/91#U$HD4'16U%TD8X1I]'!D=M1]5(/4BF20])>$GB2DQ*MDLA
M2XQ+^$QD3-%-/4VK3AA.AD[U3V1/TU!#4+-1(U&44@92=U+J4UQ3SU1"5+95
M*E6?5A16BE;_5W97[%AD6-M94UG+6D1:OELW6[%<+%RG72)=GEX:7I=?%%^1
M8 ]@CF$,88QB"V*+8PQCC60.9)!E$F659AAFG&<@9Z1H*6BO:31INVI!:LAK
M4&O8;&%LZ6US;?UNAV\2;YUP*7"U<4%QSG)<<NIS>'0'=)9U)G6V=D=VV'=I
M=_QXCGDA>;5Z2'K=>W)\!WR=?3-]RGYA?OE_D8 J@,.!7('V@I&#+(/'A&.%
M (6=ACJ&V(=WB!6(M8E5B?6*EHLWB]F,>XT>C<&.98\)CZZ04Y#YD9^21I+M
MDY64/93FE8^6.9;CEXV8.9CDF9&:/9KJFYB<1ISUG:2>5)\$G[6@9Z$8H<NB
M?:,QH^6DF:5.I@.FN:=PJ">HWJF6JD^K"*O!K'NM-JWQKJVO:; FL..QH;)?
MLQZSW;2=M5ZV'K;@MZ*X9;DHN>NZL+MTO#F\_[W&OHR_5, <P.3!K<)WPT'$
M#,37Q:/&;\<\R G(U\FFRG7+1<P5S.;-M\Z)SUO0+M$"T=;2JM. U%75+-8#
MUMK7LMB+V63:/ML8V_/<SMVJWH??9.!"X2#A_^+>X[[DG^6 YF+G1.@GZ0KI
M[NK3Z[CLGNV$[FOO4_ [\23R#?+W\^'TS/6X]J3WD?A^^6SZ6_M*_#K]*OX;
M_PW__UA96B        "F>   4?X     6%E:(        "V4  ":(   $5U8
M65H@        (LD  !/B  #!T/_N  Y!9&]B90!D0     '_VP"$  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$" @(" @("
M @(" @,# P,# P,# P,! 0$! 0$! 0$! 0(" 0(" P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __  !$( !< &@,!
M$0 "$0$#$0'_W0 $  3_Q &B    !@(# 0             '" 8%! D#"@(!
M  L!   & P$! 0            8%! ,' @@!"0 *"Q   @$#! $# P(# P,"
M!@EU 0(#!!$%$@8A!Q,B  @Q%$$R(Q4)44(6820S%U)Q@1ABD25#H;'P)C1R
M"AG!T34GX5,V@O&2HD14<T5&-T=C*%565QJRPM+B\F2#=).$9:.SP]/C*3AF
M\W4J.3I(24I865IG:&EJ=G=X>7J%AH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>X
MN;K$Q<;'R,G*U-76U]C9VN3EYN?HZ>KT]?;W^/GZ$0 " 0,"! 0#!00$! 8&
M!6T! @,1!"$2!3$& "(305$',F$4<0A"@2.1%5*A8A8S";$DP=%#<O 7X8(T
M)9)3&&-$\:*R)C495#9%9"<*<X.31G3"TN+R565U5C>$A:.SP]/C\RD:E*2T
MQ-3D])6EM<75Y?4H1U=F.':&EJ:VQM;F]F=WAY>GM\?7Y_=(6&AXB)BHN,C8
MZ/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@ , P$  A$#$0 _ -U^
MCWCNB3YD;BV ^;JVV52_&;9N\:;;A2F^QAW17]I[[PM;FTD$ K/NZG$XVG@8
M&4Q:(ELH:Y(K>QM!R-;;F(!]>=VEB+YJ8Q;Q.%XTH&8GA7/'H)IN%X>>KC:3
M,?H!M,<H3%/$-Q(A:M*Y4 <:8X=&9]A3H6=<#)&'$1=!(REQ&6765!L6"7U%
M03]?I[W0TK3'7NN?O77NO__0W"]Y=@;+ZJ^879W8W8NY,7M#9&S_ (6[)S6Y
M-R9F?[?'XO'TW<O9&J21@KRSU$\K+%!!$LD]3.Z11(\KHAD2QVV_WCD?:=LV
MRU>>_GWZ54114LQM8/R '$DT"@$D@ GJ.;[<K#:.?-TW/<[I(+"#8(V=V-%5
M1=2_M)X "I8D  D@=*S8GS<Z8W)MCLK/[_.X_C]D^HL/3;M[!V7WMC(-D;PP
M/7N<>9ME]A_PO[W()D=K[VIXPE&U+)-50Y3R8FJA@RL$]%&AW#D'?;6ZVJWV
MX1;E%>N8X9;1C+&\R?VL.J@TR1'+:@%,=)D9H660F&W\_;#=6V[3[@TNW2V*
M"2:*[7P9$A<5BFTDG5'*,*5)(D#0L%F5D!6=\_&7=G\P/,[>[L[-VXG16V=@
MYK9VX/C/M[-;8DINZ*J3;6]\%O"/LGNNIIJ_$9W 4.4I<9/'@=@M4B'&_>FO
MSL<V1\>.QHOV[FRS]MH+C8=INCN%W<I(E\ZR VH#Q/%X%J"K(Y4L#->!:OI\
M.W*Q5EE"&X<IWGN1<V^_;O:C;[.V:-K!'C_QJJ2I)]1=95TJ%/@VA:D>KQ;A
M3,%CBMG]PUU,O7__T=K#Y10';ORUV7O_ "76G6?<.+3K?K##[8VINSOGK[J[
M,8+MR@[9WI4=<9M=I[XK:6'=4^7R.=DAV[((ZITSE&?M8Q51I(DN<I,+KDN_
MVV/=;JQE^JG:22.TFN%>W-M$)T\2)3X854!F%5!B;O.@D&(>;A])SIM^YR;5
M:WT?TD")%)=P0,EP+F0P/HF8>(69BL-%;]5>WO (9NYNU9<EV;T9D>^?A+T_
M'VU@=T5%;\?(^Q_E=\?\5O"?==4:7'2)U_B\W4T=?N/(K655*T=/3PU7AKQ3
M3QHM3'!(JC8MF$6T\PQ<N\_7IV:2$"\\#;[QHA&*M^LR A%H&J6*U36I)0L"
MFW[>C+NW+LO,?M]9C>HYZV7C[A8K*93V_H*[!G:I%%4-1]+ !PI!ET[N^6[2
M1*WPAJDC>:%)9/\ 9CNJ6\,+RHDT^@4VJ3P1,7TCEM-AR?84.P<ET8CW 6M#
M_P 0KG)I@?GPZ%@YAYT)4'V]< D5/UMM@5R>/D,]')N?Z?B_U'U_I[ W0\QZ
#]?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>skill-o.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-o.jpg
M_]C_X00L17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR-B Q-SHR,#HS-@   Z !
M  ,    !__\  * "  0    !    %J #  0    !    %@         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M;W-H;W @,RXP #A"24T$)0      $                      X0DE-!#H
M     /$    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O
M; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E
M;D)I=&)O;VP     "W!R:6YT97).86UE5$585     $       ]P<FEN=%!R
M;V]F4V5T=7!/8FIC    $@!0 '( ;P!O &8 +0!% &D ;@!S '0 90!L &P
M=0!N &<       IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL
M=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !     !
M   2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB
M<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP
M     $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN
M=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P    !29" @
M9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@(&1O=6)
M;^            !"<F1456YT1B-2;'0               !";&0@56YT1B-2
M;'0               !2<VQT56YT1B-0>&Q 4@            IV96-T;W)$
M871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15
M;G1&(U)L=                %1O<"!5;G1&(U)L=                %-C
M;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L
M  YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<
M        #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO
M;F<      #A"24T#[0      $ !(     0 " $@    !  (X0DE-!"8
M  X             /X   #A"24T$#0      !    '@X0DE-!!D       0
M   >.$))30/S       )           ! #A"24TG$       "@ !
M  (X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8
M      $ ,@    $ 6@    8       $ -0    $ +0    8       $X0DE-
M _@      '   /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z   .$))300        "  $X
M0DE-! (       0     .$))300P       " 0$X0DE-!"T       8  0
M  (X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #2P    8              !8    6    "P!5 &X 8@!E
M &X 80!N &X =  M #$    !                          $
M     !8    6                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<    6     %)G:'1L;VYG    %@    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    %@    !2
M9VAT;&]N9P   !8    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!0       0    *.$))
M300,      ,2     0   !8    6    1   !=@   +V !@  ?_8_^T #$%D
M;V)E7T--  '_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  6 !8# 2(  A$! Q$!_]T
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M?=Z;PW?^_P"HOF=)2"^%C-<7U\7ZJ27RJDHV1__9.$))300A      !5
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-! 8
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M0U]04D]&24Q%  $!   'R$%$0D4"0   ;6YT<E)'0B!865H@!]<  P "  H
M!P I86-S<                                     $  /;6  $
MTRUB24-#G&TTI:VD1?84;9BP40P2;0
M           )8W!R=    /    "*9&5S8P   7P   !X=W1P=    ?0    4
M<E120P   @@   6$9U120P   @@   6$8E120P   @@   6$<EA96@  !XP
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M0B!V,@
M                      !865H@        ]M8  0    #3+6-U<G8
M   "O     H %0 ? "H -  ^ $D 4P!= &@ <@!] (< D0"< *8 L "[ ,4
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M   175A96B         BR0  $^(  ,'0_^X #D%D;V)E &1      ?_; (0
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0("
M @(" @(" @(" P,# P,# P,# P$! 0$! 0$! 0$! @(! @(# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\  $0@
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<MHCB \.N@@Z&"ZJ4U%JG3J*C! J;7V%.C_K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>cogo_0028.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0028.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M=7MS\1KI*NA4)62B!E /I0<#Z;1%?$:5(:DE#:]J9&*L3*4ET1Y"D/FY=[<
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MG; H7-=!J(I]V'D*C>@]H]0X3M2Z1+;/E*(&.N:)*B8MV.C3L<*9[0C%"6X
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ME/-SMG(_3I2FMHY4^6-;5W$B'8(K[]S6ZM\82W':^-Q7^E"HIL=&;JB-+#Q
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M'@'VFU8[%C&_:A.P5G&$]:G_ !(-)KL9'5S3VOHY]ZM8N*'X<23)4XJ2M0Y
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-G4[G@_XPK*IEZD?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>cogo_0032.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0032.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M-HS)C ^8&E9Q%L65R,K3I\-/EZ0X:.5E0.!D[9B$JQ'OGB_9UA,J_BE595,
M>5HD!)]U<H1M+DLQX)SX*C_ZEZO=9F?^$)J39:9<" \MLJ;(('(\B8"E;-:T
M5('3?'2Z))SY&;O2G(F5;D_+Y*?H(LW"/3T9G>/%V2+"3.&1J;.K27@D(./8
M0RR45O3V-- OV@74D&0GFT31&7)=W(6#Z=XT0RJ7!DR8I1#OB]MXM_H4U^3*
ME9*08)#$X=)V.8 0C(J*0$XSG;(@@"?R,O--X>3](K;&43D23$L/(D( A7R6
MI41)N:0E12%#'O"A(8F_#"B$@1+(0YJIN+YG;MF(&@8_/'IL?>(2R-_$%_\
MV?K$)9L'66TK;<)'3$<JZ=EV0I&O)"*F\D<C_O'3Q.XF>0TV@L^&D=L0N2*8
M;H>D+46XS."3&3M$=Q <.51%P3L^P$-@Y "3OGM!3D^$1\(US^*GXFZ=P>HS
M<K3W"[59H:9:7QYCE6-9';TB2;C^HUZ? LO*-9[/LJ_^-)7<=]/S/@39+C8?
M3C3OL$ <ACI&2>JQQX3/18/&9)_9HLF5L*H4 ?PFB,I3+,Z6T@'1R'/WBK^<
M2Z-[\:]O(KWSP]NN9:==I#"67 ,*4G=;BO>+%K(^S)D\9-](KFV+DNZU+@10
M+V0'Y*</@HF$I_LU'H>X/*+5GA-=G/R:+)B?*&.O3U3L:Y&)Z1FGTMG#K#J%
M9&D[\_3KZ0T6TK,$\<7:9L]POO=/$2A-S$N$NS["0V^E!^^?QX]8Z.+):Y.5
MEQ.,BRZ=:U5FPG4WX23RSSB]M(I:H8)*QI=!S-.J/L83<RQ8[#*Z%(RLO]FP
M@!.\#Y)=#K##NQ2K\^S3WDE*21U @,'70O3]P.S*"" VG'3G"L*;? .9FT*P
M2XHDGJ8 Q+6M2D GM! #W]9!(,!A!SX<P8(*(^'(&YDHV6K']BN.673*2KP!
MJCV>\=/%^E&>0P6NM2$)TG&X@3 N1]9)+8S&>?8T>CHL *($*,"+CJ**?3UJ
M62GQ,C4.20!DD_2!DG\<;+=/'Y)[6:/M<-G^-'%.=XBW,VMVERLV6Z:TO=*T
M-[)4?3.8X.LU.67UAV>Z\5H<.);\G7HV$IE.1*L)EY5M*?"&-., #TCGJ$[Y
M.YN@NB5,26M)Q+)UJRK.GI%VUT+O ,\P$M* \JL:0!M%,MQ;:165SVW)SFKY
MR4;5A7B).@$!0W$".6<))IBY<4,D':*ZO9;<\PR@--K2VX6'V>J4YR%I/0CK
MZ1ZO3S^7$F>!UN+XLS&7X<+AF;#XKR$F_P#9RU2/RJ\G[-U*_NJ3GM&V"HYF
M:I&_B76VM\ >IZQ8TVS%5D&>N6ER /C3+>W0$0U4'?:%.K<2&@DMRK>H$$9/
M2)8K$FH5QZHOEUYPG'+80&% V9>44E0R?2 Q]M&&4==5IP@\X!!C;;F'6DX&
M,""*?+E5);PH;P2$"882!R@!(O@#L(ED-AJLK+2]^D<W:6392E<)_BK_ /YU
MC=BNBM<L/VS]WZC]H:97['UG/@ Q2U9&Z,*W=*B#"T$K[C;5'Z;9<PJ4'VCR
M5H3CH5)TQ3G5P-^A2^9-@FV+0DK5M&GTI#02ZF5;<=4!MD[G]XY,E2;/889.
M4U&^#JP94O$E].1G&(R0FO9TYXY+HRKF6UY"#R21F+9231(1?0JU=U#!))SD
M;[9CGY9\\'0QP;7(N+2B9);<2-.=6^X^L#&TW3!D^J$Z]N&E,^3F*](J<:=<
M;*GV@=ED=1'J=)'9!'D?(*.2;I%%)NYZ6J-,90[ARG5!MYI9YH.H9 /2-^^T
M><R0<+1O?,7C5Y]I"A.:4J2D@))!&0(N3.?+CH%./OODE:BHD[DG,0)T5+E8
MP3DQ"6B5)T5<QA(ZP6@V@NU:2UM^;3^4#L%LR-VVF6(("3WVB42R=\MI2$A(
M&!!2$<C#--A#1! S!(FP&[NM6=]X4L71CT(_"(@2Z*K,8:7DX^L9&N!4[*BK
M:PJH.D=_]8O@J0Z#MLN:4\\^809]%?L=TO'P1[16B-<F!2M2B8!!2XFH8F:#
M*RLR-07/-;#F G>*\BLVZ-U*T2*VT'$$-' =:3]!'+SJFT>KTC^JD*#L@ZRM
M09PK3U,<YP2Z.[#)O5LY;:F'%!*)=)3V)Q]8.UO@=4G=B]4WI-$TZQ,3#0QN
M,K ^D9<N*V:HY$D+TP[3PZ V\A9.X"5 G](D,;BT59)J:/KA>!H#R3NGPR=)
M[8YQZ33SN"1YG40_U&T:?7.RPJ9FIN1=*'I-Y+R3C[Z=7F3CZ1KCPCB:F-\F
M[U&6J<I$A-H5J2_*LN XY@H!C4<1K[!B6:)P.<.)9.\ LG&D[^D0%C+0Y4+0
M-QF!(D6-;,H&T#..45Q;LN25 FH(T:L#.8M7)7('>&I0Y02M$2?04-G(@#(7
MW?[17O +5T=( 2V*RHEHZNT9?8D>BJJH0)QX$]8NB.&[:5Y=OQ"&]%7L>6-2
MVP"#B*FRRB4U*@F$9*$?C0P]+6>NH,(R)&8;>=T??*3L<17+)NX-6D^F2OR)
M]_UAM$G*NS=R)I,F99)6\MP-E&V1DGK&/.KG2/6^.5XW*12+?$&UI>J.N6_Q
M)EZ^\P=2T(F=1SVSR5](Y^HQ3QJXHZ^DR0U$G!,L27O=$W9:[M07&VVF%*6V
MYLH$<^<9)2G5-FN.-)TE931JLM<[J)ZNHJ:P^I2V924W4M W)SL <1?BA.4E
M%<E.?;&#R25(A27&/A*J<52:73:Q33(."65,S+:BWK.X"E@QNR:5PILY^GUV
M+/%PCZ+7I\TS4*<D+2EQL@)(2=04E7(YZQ="<6J79GS0G&7[&KG$.VZA3KVJ
M%'IH+@+FI!0,Z0L;9C5CGMC]CF:K3RG/;'_+-RN%ZA/<.J ZY.L33C<HAAUU
MDY3K0,8WW[1IPYEJ(;H^CAZ_1ST.7X\GOH>J?2CL2DQI1S6@A-4Y6C.GEO!
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MU;C$%,6B#5FEAA>0.7>(V,D);B@'% ]X%C'76F)82XZJX$LJ!'2.:BTJ"NK
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M#&FHY%M90G/'*STJX(\8G.,'#Z2KE06!5)?^J5%.?[Y P5?]PW_./+^1T_\
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MPA).#@9*C^4>C\'B^74K(_29RM7/;B-)^#^3;"YD_>FZE-.G/7<#_2/6:/\
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M>LCW]8RNV27#5&A/QDW$VB<%":4OPI5HNNI2K&5KZ?D/UCVW@<6S2_*UR_\
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ALMG/S=-EU$_X@@ _J#'D=3!0RN*/0X'>-,8]"XH+3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>skill-z.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-z.jpg
M_]C_X03Q17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR-B Q-SHQ.3HR.0   Z !
M  ,    !__\  * "  0    !    &Z #  0    !    %0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M']#;_J3_ /_9_^T,^E!H;W1O<VAO<" S+C  .$))300E       0
M             #A"24T$.@      \0   !     !       +<')I;G1/=71P
M=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L
M<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M     0      #W!R:6YT4')O;V93971U<$]B:F,    2 %  <@!O &\ 9@ M
M $4 :0!N ', = !E &P ; !U &X 9P      "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 $@    !  (
M2     $  CA"24T$)@      #@             _@   .$))300-       $
M    >#A"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          CA"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-!         (  3A"24T$ @      !      X0DE-!#        (!
M 3A"24T$+0      !@ !     CA"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      -+    !@
M%0   !L    + %4 ;@!B &4 ;@!A &X ;@!T "T ,0    $
M             0              &P   !4                      0
M                       0     0       &YU;&P    "    !F)O=6YD
M<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE
M9G1L;VYG          !"=&]M;&]N9P   !4     4F=H=&QO;F<    ;
M!G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '<VQI
M8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE;G5M
M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M
M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<    5     %)G:'1L;VYG    &P    -U<FQ415A4     0
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M &\ 8@!E "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %
M: !O '0 ;P!S &@ ;P!P "  0P!3 #8    ! #A"24T$!@      !P (
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M(" @(" @(" @(#P_>'!A8VME="!E;F0](G<B/S[_X@?824-#7U!23T9)3$4
M 0$   ?(041"10)   !M;G1R4D="(%A96B 'UP #  ( "@ ' "EA8W-P
M                                 0  ]M8  0    #3+6))0T.<;32E
MK:1%]A1MF+!1#!)M                                          EC
M<')T    \    (ID97-C   !?    'AW='!T   !]    !1R5%)#   ""
M!81G5%)#   ""   !81B5%)#   ""   !81R6%E:   'C    !1G6%E:   '
MH    !1B6%E:   'M    !1T97AT     $-O<'ER:6=H=" H0RD@,C P-R!B
M>2!#;VQO<B!3;VQU=&EO;G,L($%L;"!2:6=H=',@4F5S97)V960N($QI8V5N
M<V4@9&5T86EL<R!C86X@8F4@9F]U;F0@;VXZ(&AT=' Z+R]W=W<N96-I+F]R
M9R]E8VDO96XO96-I4D="+G!H<    &1E<V,         "F5C:5)'0B!V,@
M        "@!E &, :0!2 $< 0@ @ '8 ,@     *96-I4D="('8R
M
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M65H@        IG@  %'^     %A96B         ME   FB   !%=6%E:(
M     "+)   3X@  P=#_[@ .061O8F4 9$     !_]L A  ! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(#
M P,# P,# P,# 0$! 0$! 0$! 0$" @$" @,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1"  5 !L# 1$  A$!
M Q$!_]T !  $_\0!H@    8" P$             !P@&!00) PH" 0 + 0
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H<G^Z#ZGZ;QFU^/XGB^)1:ZO$_#HT>'X?Z/A:/!_3T]'$]@KH8]?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>cogo_0025.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0025.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M4IY3I<6ZX.N%'HCFYB$C:O08<2BE1XO5ZF>9U)VO^#R<HA:DD9WZUL[I_JC
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MJ$'? .]2#X$S7R&-R>\#E..LA'^=1D.KFSX90\!]XY@:DN.2X\\#[D9U)9A
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)7\8_6D6%1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>skill-w.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-w.jpg
M_]C_X1#N17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR-B Q-SHR,3HR,P   Z !
M  ,    !__\  * "  0    !    %Z #  0    !    &0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
M @$ !     $   $N @( !     $   ^X         $@    !    2     '_
MV/_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.
M  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="                  #V
MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ &0 7 P$B  (1 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,
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M_P#F[,.GL?I5_@\?S?XG"__9_^T8]E!H;W1O<VAO<" S+C  .$))300E
M   0                     #A"24T$.@      \0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    2 %
M<@!O &\ 9@ M $4 :0!N ', = !E &P ; !U &X 9P      "G!R;V]F4V5T
M=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--
M64L .$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO
M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
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M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M $@    !  ( 2     $  CA"24T$)@      #@             _@   .$))
M300-       $    >#A"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          CA"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M     0 U     0 M    !@       3A"24T#^       <   ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H   X0DE-!         (  3A"24T$ @      !      X0DE-
M!#        (! 3A"24T$+0      !@ !     CA"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -+    !@
M            &0   !<    + %4 ;@!B &4 ;@!A &X ;@!T "T ,0    $
M                         0              %P   !D
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   !D     4F=H=&QO
M;F<    7    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<    9     %)G:'1L;VYG    %P    -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_
M\        #A"24T$%       !     XX0DE-! P     #]0    !    %P
M !D   !(   '"   #[@ &  !_]C_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[0 ,061O8F5?0TT
M ?_N  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3
M$Q43$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+
M#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,#/_  !$( !D %P,!(@ "$0$#$0'_W0 $  +_Q $_
M   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M,=^C]/=^C]3Z'IU)+823]?=_1O\ YNS#I['Z5?X/'\W^)PO_V3A"24T$(0
M    50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <
M !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@    $
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MU@ !     -,M8DE#0YQM-*6MI$7V%&V8L%$,$FT
M                    "6-P<G0   #P    BF1E<V,   %\    >'=T<'0
M  'T    %')44D,   ((   %A&=44D,   ((   %A&)44D,   ((   %A')8
M65H   >,    %&=865H   >@    %&)865H   >T    %'1E>'0     0V]P
M>7)I9VAT("A#*2 R,# W(&)Y($-O;&]R(%-O;'5T:6]N<RP@06QL(%)I9VAT
M<R!297-E<G9E9"X@3&EC96YS92!D971A:6QS(&-A;B!B92!F;W5N9"!O;CH@
M:'1T<#HO+W=W=RYE8VDN;W)G+V5C:2]E;B]E8VE21T(N<&AP    9&5S8P
M       *96-I4D="('8R           * &4 8P!I %( 1P!" "  =@ R
M  IE8VE21T(@=C(
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MBS#<,2PQ?3'.,B R<C+$,Q<S:C.]-!$T932Y-0XU8S6X-@XV9#:[-Q(W:3?
M.!@X<3C).2(Y?#G6.C ZBCKE.T [G#OX/%0\L3T./6L]R3XG/H8^Y3]$/Z1
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M^6SZ6_M*_#K]*OX;_PW__UA96B        "F>   4?X     6%E:(
M "V4  ":(   $5U865H@        (LD  !/B  #!T/_N  Y!9&]B90!D0
M  '_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! 0$! 0(" 0(" P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M __  !$( !D %P,!$0 "$0$#$0'_W0 $  /_Q &B    !@(# 0
M   '" 8%! D#"@(!  L!   & P$! 0            8%! ,' @@!"0 *"Q
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$KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>cogo_0031.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0031.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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ML?-FBD597:^[5D>KRMO$JZE$QNA4$<7/-SEPB/3,LE"PAQ])"/$^\KV6T_\
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&81- ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>cogo_0035.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0035.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M$.)4A#"/(ELI'OZY-94>PI;$E.*:?36V*GS?PB5K<0T#L3CS+4#[^]*5VE'
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MIWJJ[6F[P5C4D]#3;N[9'<"5)SWVD^]"R0M=L@EC:YJ]9NC%S8O'3^U7./\
MCMDF.AQ(G$>.D=L*Q]><UT6.\NC7-YC0'[)\G/K5AQ!X5<7W6' 5) '>A*(+
MX< "DF*S3ID-<.$?E4ZKE<6U!2<#WICNF'*V)P<4R*E@\TDX6[20<@^M.$BJ
M\_$[I[4%RM[KMI#0CL)*UK.?(O.!G'K[?K6%U,.;;ET/2]+FAI*H?JEW5]ON
M3:+K.84EIP-I P%JYS\O?%<V07#4NHB<R,Z*34UBB/>&4(4X')&XK*=W(S]/
M2CC.E!+ZU*?_ $^?"T_UPDVV])0TY<K6]%B JQA04%!(SWSBKDIUQTJ\0T2;
MA6OZK6.7%U7%N<6W+FN>(LM1$KVI<=VY2"KL.U9\9M^GL5U6/_FL;6Q/NONF
M^O.K'4BU.G2^A--VYZWOKBSH=RF%4IM7;S)'&T]P1P0:V8X&M]+1:H396#@S
M&+/,@/\ IKZ)J]2-']6H-Q7-DZ'T]'26O%7AT[!W&<G&W.TX%)V+K/I!4G\4
MZ2/E<2/HH3TGU*U%JK5QT4QI-667"EV;%>RRRL'L,]_RS4<V,V%NH)XY#E[M
M!#.Q/"FS5ME3:7PSXH6H,)4\OV..:I1O+D.6UI9V54NIFN-&Q+UJ^(_N7<E,
MA3))2&E(0@;TDGLKD8'K6KCPO-.*YG(S&-MG=0C"@-W!H/*5@N>8*2?X8]C4
MT_%*G .248_PQ/\ #94N6"H_(0.X]0:HO< K3=D^='Z&>1.:DR[HS%C%M04=
MFX@XXQ4=WPG<^ANO4CX5'[A)Z,Z=>N[JW99AA)6H=T)4H(/Y@9KH,04Q<YF/
M#G[*7ZMJFOJ2(+ZDF*^I)D+=/[L_45-=J A<6.P^])".2MU_,:92+FLJ!X--
M:2ZQE[B :<)R$SNM>DKOJSIO>;;IX)_:H;;?C)4K;XP0L+4@'_,0"!GO5/-B
M\V,N]E=Z?.Z*4 \+SJUTTY>#,NRHB8RPI2'DNIVJ2H#!2K'.17'R'2_2NXA!
M<S7RJ\W&1-:O:V(7+:!E;BA@X]:7*C<*=LGQHOJ!,T#JJV:SA1TN2+<064N)
MQN4!R?OC-3-:2*M1O/\ ,%Z5VR5;NH]OLNK[0XEZ-<DM3VL<XW)Y''L20155
MS'1R?FMS$F'DES3_ '276.F).E[T-3Z9:6W*D-):D>!AM3B4]@3CD#GOS6W'
MD:  X6?=6\67&S(C'FMU'L5#?4]>J;HRXT[+N4I$E #C<QU2DIY/'E[@9XJ5
MV4 .5)#B=&PVEWE%Y[;FOV23HWH9JQ7!N?,:2VTUE;AVA*0D#. /:L?+F<\G
M2HG9#IG>K8>PV"4=:=5Q[9I^;='%;#)!#9SR?:FQFV:69G2[+SQ:NUXD3=63
M7OP*EWHK9"G\E30!XVG[?K70DB,-_)<@6ZWN)0ZRRY<1]+<AY/AIPG>E?950
MR"]U,TULG:NZO(:;<7+"@H[4$+&2:I/9:LM<.Z<.B6M2W/4D:T-S_P 672GP
MV=N\G/ICWI1,U&DIZ I>NOPZVJZV+I?:;9>&BF0EG>#X@<!3D@ *'' XQZ5N
MXK35%<[DN:7;!28:LJJOJ2(+ZB#;%H"[>E]Q2TI6A2SEO-2!0N7)CL/O20CD
MK=?S&F4BU*<\YIJ276.V <Y-.BM*'6T/-%I2<A0*5C/S TJ!2:2;7G?UZTS_
M (:ZE7B'(9>1;WE.N$J1Y5.J.<?3\ZX_.QSYA(7:8&4!$&E5^F1+%<''I+*6
MFI"70TIGU( [U4;L**ORD.=;4S[_ !GT.-QEI(225Y]C[5:C(59P) 4Q?"5\
M6G_Q(^- ZZ=<5IZ1)*X4C!48+BCSD=RVH]\=CS4\D0D&L<A#CY!BMAX*]!'^
MI6DIUJ9GHN45UE0#@6% A0(R,?3FH@\UPM/']3JM1EK?6]EFO)2U*BEE9&0@
MCA/UH'>H[!:)<R./E,"[:_AJF*;ALE$1I'AJ*>/%![@#ZTFQ6-UG39ENV4+]
M8+[<]4RX\125(:;"E^%GY4@<$BI6-$:IS/,JJVX&8J)KSC87A:RHX[')Q5US
MKI90:!:'6RU*<E)0I7 6E9(X'(R*)QH*,#=/:'I2.9)0ZYGPUAS;QR@\Y'US
MQ55SE,UM\*4>@FI-$:?U0W<[K:7)\],A#;6"0&0#W3@94OVQ3PNIZCG::7I]
MT3UEIG4$2Y6BQ.E*H3OB+CN+/BLJ<3NVK2>4?:MO&D#B0%AY419ZE)@V'LKC
M J<BE5:;7QQGBDC"U*@GO4C>%$[E:^,W[T5(;0M]:4H"1ZTD)7)EQ.X)%),W
M=="M)4:9&OMR?:DDMVG #@4DDK;4C@^M".X3O.PI15USZ>:+U%IVYWK4*4QF
MT,I7,?;224A .%#')5GUJADX[' DA:6%D/%-M>7%ZL$9S4TR18I$@PFG E+D
MMLMK6.Y(] /UKF)  =EUL+A5=T%O[K*P%2"$M;PC"CDT41)*>5N@44P'X*&]
M0 /A22E0.WVR#S^=7V&V;*@_YJ*O-T-MKFH^C]J,U:C-MRG8;J3SE*%>7/Y&
MJI?3B K\3/0">42GZ<B1W"IJ*E)/)QSG^M%YKD7E@BEB+8VD(7*$8K= \H4/
M7Z4X<:LI_)8 FA=]*/27I$MQLN.KSXBO8?Y10N=JV2;'2K/K70TV'.N$.*RI
M3*]RU) _E*O2K+)6N^94I8#9\L)KPK:_;9"5.)<!*=JDJ';'85.:<J@-&NZ)
MPTN7.7(0B6\WX8+C;A.$  <BHG--T$3'B]THL&K)MH.^Q/I5<2XE2'T ;D[3
MG\C]:A(+2C-.^9>B'P$6/4-OLTW65YE+D+OZO&45$J.1D$J)[GZUK8-&W%8O
M4K%-'"N+XR4,I4GCC-:8%C=9;CI^5)%75(7LW#^E.0U"'N)6)$\>"3NYHF@4
MDXFT,_::_<45!!96[[CA1\N33 ("5R8=6,%2>_%$ F:=ULY)6%'":5([64O.
M*&<4#ANE:ZMO*!Y33)K2M+OE'I14I.0DEUMUMO=NDVN[1DN1I32VG4$9RE0P
M?SH'QZVD>ZDCD,3@[V7E%\1'3C5'2OJ%<K7<TNSX;KQ>B.O H;?9_D4".,@8
M!'N*Y/(@,+RP]EU^+DMF8)6[VHJ7?;"W#8\<(,AE:BXP<X![@_6HFL/(5E\H
MK=!M.V6YZIU2S+>3_P"6_D;1RK'88JTXB-FD*!@,LEKT<^'30AB:!5!F(4W(
M#RW4K'&0>>?>J+3;BM)HH4G1+TRAPX<4P5*X2"G&*-& D\C2J&$ML..(!6"H
ME/H!3W03Z+*:5\LBF%-B-$6ZC<=K2$^9:O\ BA-'A"XZ-E!G5!=@TJ9^Y]F7
M<WD[W=A!0P.^#]NU:>-TC*?%YSFTU<MF^*^FX\_X-L@,A]B-OR4 7*^Q'5R%
M.)!2I*EI( RKCG%73AAC XK-9U9SY'1MY2C2EOO5X::_9<$M14_*XXG@^_%;
M/3NBRY+M=;>ZY'Q#XSQNFL\L/MWL$^HW2FTSBR^ZH0I2'$*<6T.'1D;@4\#D
M9YK;R/"L.2TF,T[[+@.G_%;.Z=)IF;YD9YN[ _+@?U7I9T)U'TZG:;A6C24J
M/&>B,(C_ (%S"'AM3R0GU&<\UBS=%GZ>TA[;_/LO1>D>,.G>(2),62G=VFM7
MT&^RE"2L!D@)Q_O^?M5=NS>5OR'4;JOW^J$16P_))4,TZB"5S8@#)*4XHP-D
MY.Z"_AS]:= CLAGR\>U,A(7!EHC&?>B"$#=9<;&X\4Z*E@(IB$86[;>3WI@$
MDH#:<?-A/K06;KNG%<@[=U%?4_KC8=$AVU68)N=U],*_=-'_ %>Y^E;&#TB7
M-=J?LU>>^)_'V)X?88<8A\OV_8CZ*H77/6=VUY:'5ZLDMR$A16VRAE(()[[/
M:M?J'A7&E@TMV/OR5PGACXF]9'43)/3FNY%  ;JIVH=!K1$3.@VR44R%EMD^
M&K(]_2N+=X>R(W4&V%[9%X]Z=/Z2\!W??C[*1^B&@)4.^P[U?GBQ$MN5+W@Y
M(QZ8'?%7<GPOD'%U1CU=UC8_Q3Z;A]3K+=_E50H$V;_($\+T;TD[8VM(QM36
MZ8RNU,Q0LELC<&R,Y^_-<9^$>7:8^>_T7K[\^*%HR7GT4"+V^;W0H:VZ92&1
M)>OK(W'LH96>>!@=JE_"2..G2;_0J#_$73@"6S-I-?5/5SIQ9GI"477\1+;1
MNV(940!C(&0,"M&#PSU#( (9M^H_:US74?B;T/!<Z+SO4.VEQO\ U52@_5O6
M&^ZI_P"SL\8VV&62EYT*!<Q_EW#&./:NXZ;X2Q\(B23U'[?TW7C?B7XHYW58
MC#C#RFG:KMWZZ@ 0HM_9#5S<<8DY>#N?$*CG=GTKH_PD1J,C8KSV3J,T9\[4
M=7OW39B=(+.;DITE?A-'RM').#Z9]JHMZ# )K[>RW9O&V;^'# =_=/UBWMP&
MFX[;:4);3@!/I6RZ(-(8T4 N-DR'9#C(XV2MBOPS@''M0.< X,0ANI%K-J"9
M;Y*)$66\PZW@I<:64J2?N*4E.&F065"6R0'7"XM/Y&OV5K^B7Q#IU#X6EM<R
MT&2X0W#E@;=RO1*\>I]ZYOK'1!&P2X_U7K_@SQV<EXP.K.]7\IXL]@:_/W4Y
MPN9BO0?IBN7D :  O5FG6[?_ ($7E-YC9]Q2'*F?L$#\+[4:KVBL@@)[C&*C
MHJ;9<&5(P/,.].VTP M;+*2H\BBM$M3@<^E(%):I^?/OR*7=+A1?U]ZG?X-L
M2=.VA]35VN+95O0?,TT<^8>V2*V.D]..0_S2/2"O-OB#XH;T;%_"0.J5XL5R
M >#]E4*YWN/;&E/RU;W%\@9Y5]:] BC:UFIX7SG#BRYLGI^I3:B,/ZFG*D3>
M6@>4D?*GVI%WF$DK8ED;TV+1%RG4J!"4AMI<9);9(V)(X%%YC8V40L$3R@EP
M=N>4V>I=[;T?HZ=.B-I3(D;8K"0.[KAVC^F2:Q.NY;<3#?)>Y%#]5V'@+I<G
M7NNP0.W:TV[\@%)<>]/:1Z"V32Z%^$'X6Z1@_P B-JC_ %S7G/AJ&/S)<^3A
MGWNPOI;XGY\LF-C>'<8^N>K_ /:&:3]Q?90_/7=(EH5J-"F$,H2I2%J.5N#.
M!@ 8[D5*_K><YYD:\@>W900> ^AP8PQ70AQ&Q<>3^>R#Z5F/:E<DQ5JQX#B0
MH#L0H9!/O79]"S7]0AU.YM>+^->D1>&<[RXMP18_V1^[K;90+="( R-Z_51K
MH9-SI"XW$!>?.E^B66> 0T7E(Y(.!11Z=1+@J^7/ZM(72UQ=[[SV.0<8--$[
M6XD(,J72UK5RG@-2 %)&#C- XT2Y' =3-EP# *';@\=K*.Q/L*&%K7%TSN.R
MEUD$0MY*#-7=J42N-RC_ #>BJK"7U:SNM)V(Z+9_*)V^_.0GVWFW"DH((4#R
MDCL14D9,SB7\*L[&<TA[#3@;'ZJ]WPZ=1E=0=(),MU#MQMNUF1SRI' 2H_4\
M_P!*XSK6"W%R=;?E/[KWCP-UV3JN 89]Y8]C[UL 3^JE^<L(9<.1A"2!6*PW
MNNZEKLFG^.5[&BLJO262+@I2,[N*,E, N<6=N/S?I0DJ1J[F: H^;]*:T=+5
M<T8SNX')I6D0;OL%Q=NK42.Y)>4/#82IQS)_E )_M11#6X-'=0Y,@QXWRO.S
M19_0"RJ:]4=;.ZMU+<-22%YCH);BI[;64D[$_K7HO2L,XL8C=]?U7R=XHZP[
MQ'U=\[3;;INW\MFOW41QX\K4-S4\L$@G/T2*V9-MT\DD>! &C_\ 4](,%J!'
M3'93V[J]S5=H"YJ>=T[R]R5+QMQ[_I2E/90#E0MU>N[U]ZC:/Z<V^*XZI4I,
MV0<>4'/E!/8\9-<)XPRB6MQVCC=?1/P/Z+3Y>JR'YCH'Z"B2I.ZDSQ=9*[?
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M0D'W\10!_3-8W7)-."^N]#^I7>?#?&&1XB@+A8;J=_0;?=-WX8;8(N@IEP(
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M8[ $LN*41XX3D81R<>AJ.6+20>RKXY,C[]T__@I:7*ZW1)@.Y+$:0H_FG_\
MM974C_TCZ[C_ &7H7A^.NJ0;<'^Q7H3*2D@\>U<;PO6*2/:GVI)DR? 6]A6*
M9Q*!B*Q;:CPQE([5$7'W4P:WV29VUA;N$I!HQ:8<IO\ 4J&Q9M"7*2X4I6^D
M,H'^HD'_ &!K9Z# 9LYA]C:XWXA9@Q.@3L)K6-(_6P56B<4.1UY]3Y@:]6<S
M4".R^5H;:\+:U/!V.4A0(0=OY5 YMML<!#E,TOOW2\#BF#/2JA6A&!GF@#"
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MGG^%#1M!]EJ/_%9N,?/R2X\!=CGD8G36Q=W'[!/2]RT1H@8!\R^2,^E:.1*
M-"YK"B,DFOV0:++#0VLH\ZN >]5(A5VM*6+4;<=E]J4J@Z;>DOG]ZH$#[D8'
M^]/F/T0E-TVI\T,;PIH^ *UA_7MTGNM _A+8>3Z%:@,US/4Y"W& ]UZ9X:C$
;N>7?]H!"O8^=S>[.<XYKFW<KT75:24*5K__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>cogo_0034.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0034.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MA.ZV5# %03HUHBK.211)Z!8LAL*60C'2BL%CBY#4V$E(]J,!A-864C -*8<
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M_P Y'RH7Z$.V1[U)Q+=R9!85GI6=>PK(CU.SY,]PJ&,@_E5N#LCX%.A7D(=
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M(WTPVEF_NM<NQ-6&FXB63-;$L_!MYVVJI]MC%5;%*D-J'* "*CK06CRJ.TH
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M:5QM,QWV\%MK/*Y+^15NE!]LFJ6>3R2I%G#'JM^EXKQ.4<1V2%=.92=N7?\
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=]2MOGVKKN3L"6HH)_P#$-Y_^[/\ ^NAZ(G[A_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>cogo_0033.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0033.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MIR]A:V2$^[A)P,"H^RR'Q!]P<XI[7A'.BBB79(^_1^44UA+,+2E,GERS5J[
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MM2*KX!STR9:6^(T)EV'IFK5 )<%-#H&3L5:4?L H^54S[-,/B,KB,S1P[U;
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MXO?B=Y6D]_+)/A_,TSU _,OF>0KZ-XGPN+214I?/_@^7>7\[DUCK'\/Q^?\
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J**:!TJUN1;:N;<W.%:_A3R-(U798B,N+4I0 3MTK.^R]+@1W9\A4(?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>cogo_0038.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0038.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MI0ZIRGC=Z5SLL,D%R:<<HSDRRMA_"K\JSV:?+1C3M0OXLEK:?>_<[BI7JKH
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M.G%5=A]$!J-3S24-(ZN ) SU)-)R>GD9B]3Y)VW+3$NRXK2E -,I8(QQP/\
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M:/R5$("N1G)SUJ!'*9"65)D;4JQ\*N/ U1"0W'N\)/0Y2H^(]!5D.7CWK (
MSX^M4PHED=@6L?<[!J?0;[I"7)T>X,(\%#!2K]0/SK9X=2U'\^1.K;>!A[.<
M6I1!&.OD/ZZ?UQ7IF<%]D7(8"1E2N?'/]?UCUI,AT>B_/9_O"'>R/M M[RO^
M#M,L\GP*3BO+Z^.W4<?S@[VEENP)F#T+ ?0H)_ASQYFA78,N+H<%!4 /%1S_
M +T3%H$TGO94V43GO9"B/D.!_*EAOH:2BEN1G&!D$U4BT=A:2L):5QT/H<U2
M1<B,G2F(FHF5K5@1XSBSZ$]*3D_S%^!V-5 ;6N.N6KWMO=M*LD*\O2CCRQ66
-T@H[QS_'INU&?<S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>skill-l.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 skill-l.jpg
M_]C_X04417AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,#HP,3HR." R,SHQ-CHU.0   Z !
M  ,    !__\  * "  0    !    &Z #  0    !    &          & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M[0T<4&AO=&]S:&]P(#,N,  X0DE-!"4      !
M.$))300Z      #Q    $     $       MP<FEN=$]U='!U=     4
M4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P<FEN
M=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !       /
M<')I;G10<F]O9E-E='5P3V)J8P   !( 4 !R &\ ;P!F "T 10!I &X <P!T
M &4 ; !L '4 ;@!G       *<')O;V93971U<     $     0FQT;F5N=6T
M   ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M     $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N
M=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M    4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L
M("!D;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD
M(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%(            *
M=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P
M  !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M       $    'CA"24T#\P      "0           0 X0DE-)Q        H
M 0         ".$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ !
M *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M   !.$))30/X      !P  #_____________________________ ^@
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@  #A"24T$
M     @ !.$))300"       $     #A"24T$,        @$!.$))300M
M   &  $    ".$))300(       0     0   D    )      #A"24T$'@
M    !      X0DE-!!H      TL    &               8    &P    L
M50!N &( 90!N &$ ;@!N '0 +0 Q     0                         !
M               ;    &                      !
M         !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG    &     !29VAT;&]N9P   !L    &<VQI8V5S5FQ,
M<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M       '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E
M3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E
M5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M !@     4F=H=&QO;F<    ;     W5R;%1%6%0    !        ;G5L;%1%
M6%0    !        37-G951%6%0    !       &86QT5&%G5$585     $
M      YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
M 04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!
M  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]'R^K4T6'&H8[+S(TQZ=
M2/ WV']%CL_E6N5&]V8VZMV=U1F!E62<?&K#74@3_P!J#< _)W?0W;L;])_,
M(G5L,4VUYF"\X>9D75566L +7AQV?K-!_1W[6_1?_.L_TB#DMOLNK_:'21F9
MC 11;20<=X^E^G]8_H-COS,AEWO_ */ZEBG@(T".HUOAX[_P_1P-7)*=R!O0
MCAKC]OA/^R_6>Y_S$^/U^NM[:.IFJBQQVLR*WA^/88'T;)WT/_X+(_[<M6MN
M'B.)^2Y#J72]XSJ<RNDN&'ZM&/C5AE3;7FRBK<Z/5R7M<UCOTFRO_@5;^V9>
MS?N]O[*YC_M1N]*/^W/;M3CCA<9"JUXOW?EXEL<V3AE$W8KA_?\ G]L\3__0
M],ZAAG,QS6UYJM:YME-H$[;&'?6[:?IM_?9^XJS<WK#&[+NG>I:--]-M?IN/
M[P]9U=S&_P#6U\SI*2/R^KAJ].+B^OR,,_F]/'Q5ZN#@V_1XO=]+],8_3K+S
MD7]4:Q]F6P5&AFK*Z6ESFU>I#'V6;K'/MM_[;^@B?L3I6W;]G;M]#[+$F/2G
MU/3Y_P!)[_4_G%\QI(^OB\/_ !NN'_U7_AK?U7!UXO\ Q[BX_P#U;_U-_]DX
M0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ',
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M(%A96B 'UP #  ( "@ ' "EA8W-P
M     0  ]M8  0    #3+6))0T.<;32EK:1%]A1MF+!1#!)M
M                              EC<')T    \    (ID97-C   !?
M 'AW='!T   !]    !1R5%)#   ""   !81G5%)#   ""   !81B5%)#   "
M"   !81R6%E:   'C    !1G6%E:   'H    !1B6%E:   'M    !1T97AT
M     $-O<'ER:6=H=" H0RD@,C P-R!B>2!#;VQO<B!3;VQU=&EO;G,L($%L
M;"!2:6=H=',@4F5S97)V960N($QI8V5N<V4@9&5T86EL<R!C86X@8F4@9F]U
M;F0@;VXZ(&AT=' Z+R]W=W<N96-I+F]R9R]E8VDO96XO96-I4D="+G!H<
M &1E<V,         "F5C:5)'0B!V,@          "@!E &, :0!2 $< 0@ @
M '8 ,@     *96-I4D="('8R
M                                         %A96B        #VU@ !
M     -,M8W5R=@        *\    "@ 5 !\ *@ T #X 20!3 %T : !R 'T
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M;0B&")\(N C2".P)!@D@"3H)50EO"8H)I0G!"=P)^ H4"C *30II"H8*HPK
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M P,# P,# P/_P  1"  8 !L# 1$  A$! Q$!_]T !  $_\0!H@    8" P$
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'7W:ZYZ__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>cogo_0037.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0037.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M*3T='I#Y-%PBK=)4Z-E#O1::]"NL?!5N\;W<!02H#TJV#*\L95:![;Z21E.
M.OK6[!_*CG9_QC;,;\TS%MK-R97AYMT92.XKK1PKU'"Y&7LJ9L\&-<(SRVI7
M(M]'BA*NJE ;*3Y'J,>E=K#N%,\MGCUG<2R+.OQ;5$SGF,=)SZXJ=>K,JR*;
M:"45DH^+]:#_ *"25S0R@CFH5^P77A@R[XVXZFH]"LFL,GJKO0&C9)*>7:I0
M:9\P/*BD ^\OTJ$&S(\ZP%I\4L)!-!C(3M4N_P!U=R>]""=DT5LI65YS^\*W
M1\$D6-I+=E.?*DGZ)$;FVQX1)(Z5FF[+EH#WN6S!;;==<0D(RIQ2R$@)_,5'
M88J-VJ1?QHOO;0HZJXO:7L5I2I%R3<+@4<H1$3X@;QW6>@VK!.'[/1QG7B*P
M=]H_2JE*:OMTA(D<A*$H>3D^6:R9./W9T.-S/M*J,_\ :EIBZVUV6W<(J4%L
MJ&7 %\P'2L,\,H2T=W!EADC;(%VXSZ39A(F"[LDJ:',/& ",#?.^/UJV/'ED
M]$S\S%A6BI[_ ,=X#TM:+=<&7"#S*0E#B]CN#E.U:H<.,?3ES^ISR.H()V?C
M38Y,9*;NQ*\3<J<0UD;;C88(J^'$MW%F?+SE%5-;/J^-.F+PE,*$Q=KF%*PE
M$:W+)3_U&M^+$XNFSG9^1')&U%_],Q1JK5TN<F*-'W*WPD(7(;E3$I3A#8S@
M@'()Z;UMA-0C;.1+#/D3ZP.B=":AMNH].PY<!24E+:4N-*(YFU>6U3'FCGOK
M\&3F<++P)+[GR,)STZ5=#9BFP%/EJ\?P@#CFJR2T4J3;&>Q1"ZE!([>552+8
MV,:8O(,!.?M2)EJ1ID)2D=J(:(K&.>F7@K])6!Y"B*'O *=^4US5(OHUO)/)
MBF;L5JA'U8"([FU71\$CZ5VYU'^:K8^#S+$TDZ R,$=*297 <6_C;220>9./
MM5-UX6N#]D_=?\"%K^V)OM[M=KO<9J5IRXLNL76&\,(<2"%(PI)R%9QW[5S<
M^9\?-'],]-](QX^7PLR?\TXU_P"[*AC\,[M:K+=+'HCW:#=6;A,C-N2TE]EG
MF(Y7%)/;PSM5?(FILZ7#75+NJ_1SY?N O'Y6HEN.WR-(MS2@" RP"M6.F,;)
MST^M->%8]>A6/DO+;?XC_P +.$T^/K 2=7PXSO+;%.3 VD%OGSAO'8'K^E8L
MV51AHZW&QO[KM%'<<;!=+?Q.EP=-0&$PW%H<;2ZWE*4D8.4CKN/M5^+-WPIL
MR\O%UY+_ ."6?9^XK*L$&Z:?U0+/*>RN6M$L!*TE61\)Z#&V,5HQ<CCN-26S
M!R.)RNREBE2&2)H?5-MBHB7F7$O+@+9:EI0$K"L[I41L1ZTJRQCN/@\\+E%*
M7I<-HEI0TQ'3&:97@>(&T@?THXI=Y663Q_XW%BQQKU?/TZD:=A3&,79*'&3S
M'G* ?C"CVP<5LY>7[4.J,7TSAK--S?O_ .HM/V<+8[#TU>YKK!3^)7@O('-S
M#D\)&Z?(9S4^E2<E.7[?_P ,7^J^JGA@O8QI_P#9;;ORGZ5UHGDV ?#+LK"1
MD!6:9^ 18%BC\K22?(51+TTQ>@PL!*%>M*M ] EP7\>!OM5B%9A$2K8J213
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MS_<0VS Z3F8_>HK(AE9K>TQ+;;.<[T?N(86;Q;)4,C.?.FA*R,EZ>:NDAP>
M5;^6:D\J6BIC:W8;X\D$2RDGJ":SRY2CIH2,.ST0K_(8T=#<N.I=0L6Z*GHY
M)>Y>;_*#N?M5L,KGXB2ZQU(H[5WM7Q8O/"T3 >N2@KD]YEY::)\TH'Q*^];H
M\-/JV9^_[#EFU5K;5?L]7C5.JYJ'GKC>C'9;:;Y$-M-M[X\QS$]?*N?]4I*D
M>A^A8TLEO]$?@1Q(_']$S]-3G4K<M4EZ(E:B?D0K('V!%>;G^,SV^+_)!-?
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$AT?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>cogo_0036.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0036.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MT(/N IY/3I2CJ=]C=3B=N<U";D:H<3BE8RDC!> .,"@&S1R3QT%&B6ANXXC
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MO&ACV7=I$>ZV92C NK*9C2B /&/"ZG XZX/WHOVM271&GDBV M00&;E$1/C
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M$^@KT\I-NSB))#2=WZ$,SVQXXYW$#S2?F'Z4K^0H>K4ET(=;5E*\$8\P>E$
M[4@]QTP:C'0V2C8K&>*48<9;6@MK2"E0P1BB 394IEP1WSN6M.&E?S)']Q0_
M(@L\H,@(5RH^E$AEE8"=P/GTJ(@09>& D'&>M, ?Z+U=*[-]=VW63!_<LO=W
M+;''>QU<+2?MS]0*22Y4AHOAQ/2O1^HX5Z@17F)0D0YS(4VO\JVEC*5$^N#^
MM&:I\"0?"..;I8RW='[>NS7*>Q&NDNWER9*[E)0Z#@XSC:", =:Z<9;TG?\
M0];"W'[?R[^?)#7X,:$(S[EDL+66X[BP[<"3EM196"<^25"C5AF]OC\OUHMC
M\)>JUZ>UQ,TD1#::N+2I#;<>7WH[UH[%IVGD90$G[5AU6-2:FCCZ['2W'6=^
MA0]30>]CJ >;!(R>169<(Y2MOD\[?Q;Z3>T[VG+N!:*/VM&0^3CCO4\*/UP!
M5LK=2(^416,^+MI^.\.5!&/H15\'NB9NF (:"V^XR1SM4/MU_M2KX"PBSM>8
M "LJ%6+E"^15I@=T_&*<I<0K/OE-%JXM"X_O'OX';F;?V]Z0_>8_\13&/U+;
MB/\ \KDYG_=Y_D;H/^\H];OV--]:X^Y'1Y/&&6D!XG'TKTK.2(H(4K:HC;C!
M!Z4K&CR-;(]W9>A/ DPW249ZEM7*?[TD7S0S2#"'%.;MZLIQQ5@KX8@%!1VC
MD"@"V+ !*AN'&*'0YNMI#R$H/!!R%>:3ZT: )M*4OO$R!^\1P??W'M0":MJ"
M221X?2@0>L+YX\Z9 ,S&4R&%)QDXHOHG1TW^#KM1#UID=G%WE?Q-J/>PR3RN
M.H^)(_Z3_0FEQU>UDKFQ'M,M336N-0!-B<DJ4MNYAV7.[ME+C:P3M3Z8/7VK
MHX[]/B_@]/HWOQQW5\_S16VH68[MRDPVF=*,,N.RFD [E^%U =3_ /9/Z5:U
M3\_!;*+<E=?ZCW3.H6-,ZRLNLFING@N)=8[Q##"TK4T^V K:K'FI)'O6;/'V
M<%6HQ+)CE='=EP0]!6U=K,HK8< 44YR%I4,@^W6L$E5<'EHM],YP_&GI]K4O
M9Y;]7Q61WUFEI3(&/$&G!M_0$?UJU7*''@:%)M,Y0T9)#L&3;SQW2CCZ4^%\
M4437NX,H06[DH*'"T\'^E-Y%$8SA3@I/7@FFB!\,,P]I4%!6?(U8A.N2._AS
MN"=,]NUJD E'[.U1%W?Z0I_!/Z*KDSBI1G#\_P!S9RIQF_@]NOB(W_J5P]IU
#+/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>cogo_0022.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0022.gif
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MK[&OL+2SL[BWM[FWN+R[N\"_OX.UV8FVV8NYVX2SUY.^W9B_WL"_P)G"WY;
MWIS$X*+&X:7)XZO,Y;/1Y[;3Z+K4Z;[8Z[#/YL3#P\C'Q\C'R,S+R]#/S]#/
MT-33T]C7U]C7V-S;V^#?W\/;[,K>[N#?X,W@[\[B\-3E\=SJ]-CG\^3CY.CG
MY^CGZ.SK[/#O[^/N]O#O\.;P]^SS^>CQ^/3T]/CW]_'W^_CW^/7Y_/___P
M
M
M
M
M
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M0(4G_GL(-"L"!TN @DU?L)X]W  *P5&C@P=,@T"X(A'_">!C1^F\*KB@#ZY
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M7@?D[NBI$ >5X!2LX CU'NR38  8H $:@ $C,.NF/N)X$/X!>#$!$; !&O
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M[MF 7#2!!K@5 CJ5!S"B!L"SGG  A<  V)@E8&HO%2"!"E",GH@W'#H*-F
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M,DB!J?B$,4B!YCV(.3@!,N")!S(!=1&-1]CC!5T!,G W3"8!FMCDU?@$2YN
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ME<!#,PC/,X"6P(D -B #:ERS$< #8G2%.4" #V0%>Y$G!&C=+C,#.W ?5Z"
M"E@#%E  D9!*-2"! ^AS.8@ 42!(3O85.Q@!T$S7 3*(%-@=%@!$M)R1CMB
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MBN[FD [0#1@1B9*R4Q'!;-TH X]K":P?BDU+GE3H@,^;"%MBOPC   QH@)@
MK^,9@U%TN)2X T,DH/!9 "/#=%> O*GQO2L9#;Z?Z"24-H/HH=6H\+Q+I!*H
M@)A8 ;%? 18H#L-@A0]VA0?(A/XA@0"BR,:,3D)7^  U8 756JEU4;(64+..
MN0^XTZNQB(,(B(!"*BF1H(3I)(/340B*P$.86H 1.!++*74DQE]E_U8X.#4,
M0!(S $0S*(';4PA4XQ 28 &;":M4\*KC&#>I_(AW<MHXM)D\KZO9"G'G$ H(
M)(CSM\4*:1(H0ZYR:83@!X$0T& "%G[[EZY*H@2PG:-U 8@)CUR1Z6!B0AI7
M$21]BN"*E:M/&B)4L./J8JH('D"$X&#"59P.(S2,<.5@$BN(KB1-2.5J4@27
M$$.DJ;2 !$<,:ES)$:DAA$E)#WL^O/@(!(@1+2\R;>KT*=2H4J/FB?#ADZM6
M#QZE=/YUX<W%#FPNGJ&00<V%1A=909"4LLX&5Q,ZA @ATM6*$JS4.!C!L<(C
M.QE<J7)5 8^K.A@>CCB3B@'/Q2 [6%H0 H2("VS8Q'6IP2)3#6Q8-11%^H&H
M5"D,0KCCB@4)E1!%GQ85,4*H"QPXWEW[ #&K5!/,?'*0*B4>"J[LB.R@P=4<
MR6LZN]H@IZ@K-1U*4&!AN [$"XSB/'?)X3K$.A5<,5HJRD.$"7"FTJ]O?VJ:
M")6RG\#[\34+DD# % DMN/+ ?J+HY\H(9G0PB2O)7?1!0I\\D(H&8+DB"@.L
MI+#"12*4(0I6GYCP'$2?E%C"!JE<Z$HE#A!$0E&?9/ &"/[L/<#4)[:54(8'
M$-XW))%%&GDDDDG6!\=)/.5H1HZNG$%"C$QML!.!9CPDT$,1?#("&34R)8F,
M%\5!21O/772!'2&M:5%[V7GP)GL3N *"EF]P<%$E#E72@$L1I<+&8BD&JI!:
MKCQ"AUQJL3)!)2U@@%4*"44P24,R03A*'0GL=U$$B+F2RB=V+""4'3E&P(A1
M=63Z4DQ,C9 &A\=M* H>IRXWYU87J1%7B@M<ETH%ARIY+%-X/,!J:&BLM8"0
M8K%GVT,.4"L7LVFZ(D$=#Y'V6@JNP*'<19FP(H>:AEETAP47C8 &*S(J9F8'
M')IVJQP7,#6!J!=I<%U#H=S&BOY!MG5@$0OAJN3*O[>5"$$J%\0QZK=,/9"H
M*RF D,H"U+(1) (#/3)8'?KRM-Y%$U@$D1F0NF(&B!8PZE4><:;<+41VM,L(
MRD*EPD@" R$[-%,0D5&!*)#,Y6%)&9=4 0N?R,% )1PGN  EKC2RP']V[,BP
MEI\LD$H=#CQ2R08TYC<)'@6H(<D!C8A21%P7 2WW&'$YD,8D)AS@2@M1NIN
M11&O4&H$63_"0$FBJ' MT9%+/CGE3D'$1@2B3'+!!:F44??G<D4-AP!C=47"
M!I2PPL! JU/2" .,?$)"25T95"H"D[C(QB=I7'B&FA%TFP=DP(/:+2"0<3"&
MN VH]?Z) G&PXD$)GS#R@"2I., [&Q.,4I09%$PRR0,[,9 H Y2D\($HL*>P
M^MEC$Q;!&*(L;@GX%5!2R5=X-*"Y!B@@BI9-@A(/X)T"7#()^4'$ P82R2<:
M<1([_(\2&VA)"RY0B4<XH&X124 C/L&" V2M<D;B& GJ\(8W# 0/A*-$!W($
M$9V\; %GTT )UD(0"FPP OI*PP0F40D-A(D%%GB$<(@#AYC P4X7@4"WZN 0
M5WB #*E  $B<V$0&7>41JV)% WB'!@"(:C;5^T0";%.95&"@?G0PP$[& !@=
M:L $*EJ P-#(BC<LY!,=8!Y$5I<".,"!# :P" D\8 G8X?[A$0KX1"5 @!HY
M.-%%:OB$&@2P,E>, 0/VBT (A#,QN<@A7FG I":+,@>'; TQ%S"!*"AA-A,>
M2S4=6 $C/% ).6#I#14B 08XP*I4P')4Q71% [JUDG 1I%NB*.8;-) !%D!$
M-1<8 QDF%LT,@ !_*H&#-$&0-3Q@P -L"%<<$E(4/&SL(J(8R0;ZY0" >0 K
MM+PG/O-)'U:PH ,I8,0')(&',ERD#@2MQ ?:6 1E7D02&DB("3YU@JRA2P,G
M^!Y31'$"#'RFH1[(P <@9-"+I& @D^B/'<+D"A68M#]FF,.&2! ;@FC@$\3D
M*$Q?\M$@.>4,&<B EER! B&=H/X2[ZPB'NJI J.:0"64^( &,'"=II@A T2\
M2 LZ< )&B  QP -J1$S@$A,%4DH3&\5&&\:*,1@$#R.PR HN0((T$)0IY F!
M';")'7U*110A\, &.H"!L?"$<R>0"2=%1:@+I,!8_+S K%2:!JN. 2*46)XK
M* $"#'1 +8SPSD58JB@57,0,X*%1(T#[V5&E0 ,9,HH&+F &T28+ W1@10F^
M]\Q44,(#'E"#'(#B1]!>A)RE+(%MGFF;-5BU" OS4 <XL)LRLH"C\WG9!DR
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M0D1"REQ:-,K)1;@!Z3U "[!!&WR OD1 )!3'CWUC1J7"!SC+12 (>=S)*2T
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M2LS8OO+GGF@ EN !3$'HJP2>\ZQ)(]RFHG1(-&6DEC" D*B!)80 ,SV4RYY
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M@'09O4;M@  %B+)#=.-%F  *+$<$G("#VD8*+( =V(&=?$(%C( )0(!:P+1
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M-$+I<.4&L (;0 #(4H!NO](D3/ZNR'2(!8R% 9B )+!!8]K!^4!"!C@11&2
M'5P/9+(/2V"]FGR HR9&3- G)%!"!I3 )#1" )1 '*A"!Y !I[3$(P2 [YJ
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ME>J"$?# @PT$2-RWJ@_257C<AZMB8U2I/ !AU30B:*22$:1LR@24%!9OU <
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MFTJ$0 )I:.9,4N  G73 !,P9SOY.[#"!.+!A K9Q@ 9@)#F^@. 1:M +"!P
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MM N';.0"=- 5/D!6RD#8/@$#$J):-* "5F4#ABNB_$97YOX@4^I@*#[A C2
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M!2:C#"J@!%J =N)O!"Q =$3!!#I@ [ G#S8@ TQ@]N8GOWYP)P)\\O[H/CP
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MXO$ 9BPCQ7,WW/06:FP QM'3'A$!]#4"P7(!OTIZ$> D*9," Z(5*Z*9KK
M/O0)!U 5;E!5)7H2N<$W&. 36@$?$] M[.(3\>I)C>"FXL0 J3 ))1>W7#$E
M#^!.!G 3$7!N&<$"'5$8>U$ ,90 <[H=3,(EA21,W3,'9-2Q**$L,_L3=7"I
M*( 7C]VQ%* ?E=!6/T$>9O0("" *]5LF*,8*#0 N*- 4&D \;HH'8Y [!OH:
M3TC.M?Z=BV@0 1,  23 (6SP0%%'*Y!9!E)*">+Q!L LI\BS22- CQW0 27
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M56$ECDHI!$X#-E@!;H)')*E E FR?/>,$/X>51(V(E@AA:\K<06-#A@PP=>
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MC<HXP((2>&L29V/(*!10"4"DYR2B<)9T$O 3X(S@0:YH7@0,MH$W54^0'YQ
M$$-%IBRYH@PD<$0";H('2):@!?Y.65H$&@&_+'VB 9DT PA<QDI7/L!_8'*%
M %V! @".R0RLH)UTBF.'2N$N2V'<@!M2 8%,-HDAE!MA,YWY3&A&TU"22  (
MV#"""IAD QY@PP:J4H;$ (<2"\@2>MB0@MQAR&AEJ(HKJB,;W(3 #2Q8@!D^
MIS<%;&D%;'@ K<80@7,V0" :Z!9N0/ &>I;AGF/)YW;(H 8+.,!7HFB Q#P
M00X4044 58% *:& QS&@H!2H0!K(L( EV8<AGYB "M@P 8&E 0"ET@\"+3 "
M-H1@  OIP ;8X($+I*(#&$ H!;($G Z,TA4><!-*X<#""5RH$0NX7@<C4 %(
M<<<5)/[PGAU QH@%4.(1')"E3D+R@#1(8@P "%(",FD"#DS"#@PH50DV(%<
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M/0TK;FCY,^@PW3!4>E7PX  YO $. B[#!:(?!T:(0G+2P9LKTN IX#@2/6F
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M!*T4.V"A3$G-=)*=#]B -VB$VT$EEK@F!9@$]%G&^'((2O!3W"$#'K,#DKF
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M'@>),HD<\AT$ AJL.+#0"&8PXD C=C2"@!T(Z7I0)>LU4@%#%P"2R@,&B?+
M;A&(,OY>*0>]D<&J0[HR!ZFN;,#6)]NR(LHC</#(+EMRD#K!LV8UX(H*PKFR
M0@H)I1*B"9FF # +=C$PKBLF##R<&228Y:U"#JC2@@:PSE' 3I&"'++((Y-<
MLLDG6T2E0N#*X8%"KER QPC#&D1E'>O"(>5P>%CP%06[LC(I' ^TL (+:0B%
MT!L@.!!"*A$\PLI7KJ#ALD$HL&!@*E\9+<<#8QB=QE2N0"VU*,4R0@%#/Z?B
MP%Z?.""*MI]44I#4=EA+P;Z8'J1!&ZY0\@ K>$Q  AL7S.&*!HSQ'4$C9CO
MBL 'I3"P?B-DT (9I%9..0MG;^W*&)8?1,8(K'P"P4YPI_Z20E<K%*$ARK/3
M7KOMM^.>.T0.U/3) AL^<% JOZ/1 :\+I"*'SCDGE.!!%>SJ"@6//!+\070L
MQ H94R<P"0A-N<+&&)($>M $<J2"P%07O$')>@?-,>Y7&X!?QY8\,V0!'MKN
MEGHJ3U>"6#41TPA6M2]U'80#;*'$EB+ %NF5!0-#XEL'0,.3X*D@8@D;#H=L
M@C -GH8!<5&<I[XRAC!]PE*\@0 KU&"\@Z!+=S*<(0UK:,,;>N0K)IA &490
M@",AP 1IJ$ !15$!$G3)06Q0FRO:H+:I#2@%K(B 9ESQ@&>-X )I$$N*?*.&
M%4P@%9)PP!C,P(!=D0 #:O  !_Y0QX .G($$$]@-"2RP104-!Q)D5 \=3&0]
M3>T/ ?U+P/\6P!(V1" -*8A )60TF =-X" 78,PD$B F-;(  @4DP0,840<(
M",H!+% /<T@0IH>98#CN,T,:0+" 1Z2 8@^C6!D>D(85'$ X4WL# M(@B@3L
MY)>?4,4%0) &"H1I:CA<)C.;Z<QGCHP5;2 #)?8'!P\T(@4/5,@7HV<)5=&)
M(7A@"QX^5LZ#R&$%C&'(''SRL4^0@04CG,\*'OB)Z95Q-^A4P3H3 D]Y'B04
MT4-(.5EA!X.DP@YW6\@C8J+/<YHE>H!H9$*_\@8R2$(4?Q,%&S(:/7BV8(22
M&.!($_XR"3*T(15UD,0D!DB]YJ1@I0,L51R>=5"%W'0_*W@D-'OJTY\"-:@I
MX<_(*D%(H2(UJ4I=*E.;2I*OA$@Z"9%:193I$*HVQ*IHFNK4DO<5K6IUJAB9
M&E@?0M:L(F1JK;AJ6L7JUK"ZE:UQE:I3ZVK7N^(UKWK=*U_[ZM>_UNZK9^4(
M7"-26+T>%K"*72QC&^O8NGXBL8^=+&4K"TTVC( $(RA!(^9:*L^:D!*L2,%N
ML(I6C'X6K3RQDVH3TBO/IK:M##%M;%E0$[@6MJRB8,$H/BN*%;"BH;P9H6U+
M%5:P*K,,MW4%)"J0/<M"-[K2K>%SV/!%!'16LA%YP!U8\?XSBER1K@YA!/@D
M\A5&1'(Z8X!$2'ZY%X2( @&I> 1H'I'>]7*$-*Y0A2M0 +#I CC  C;9!M*
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M! ]U3OX &> !'J! !8C""1X$"6 GKXF)!W9.$83)Z2&$"%S(SJ[*KJ3-093
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M?\ C5,(DCX$#'&22^[K?G5>F[,C4>%GZ#)"[P; 91(B@</89\8:J^%/PT(&
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M(0D*A/Z #2-H 1J%,X%)A" .BWE:-:^IAI2 X TFD,0(ZH"!S[5@ W$D2O2
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MFB<%KH,@,F0#_ 9H-L.I+L3[7/Y! P9" ]YF#@SBJ@[B$<YK$H:.*"I!3$A
MEB9@7U"L$20ALX;0KCJB UQ&#E9L>!Z) ][F#.Z',SYI*XS*0QB@8]+*%3!
M19;HER"+$3Z)$3Z% JB/A$2C>6!L\+!"#2B ?92B(](@D2SAAAY@M&IM)X!B
M(]* 6^"D4LI0&J?Q01X!#C>D ]3 7EI";8*#%33 920AK4K@/L0E C*A CQ
M!$9@ ]IH!4R %=X* S+& 1XAI,[0%5# Y<C  >I(,?P$#A8H_NB)&]N@#15#
M SP+$ \C#KS1G%JB T1 !#9@,PY"$E 0*QAA-'Y",2P #_( AEAA WZ&$M(J
M!7:H@OZ4H@P6R 'P(!6*JZ0P(D-.DBA280(I0 \/(@3(8!L9QZ1<S2#P( (F
MP$9<X0)9P9T.)QJID2F;LBXPQ$ NRP2&RP$<$;(T(&/\KR@ S"-4:0+D0!3"
M4BD*QP]U(P,&(@+LBA*:!P4VAA6FBA7Z EFR GZ&@@PVI@+NH+*X3JBFYR#
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ID1-9D>LD!1?9D1\9DB-9DB>9DBO9DB\9DS-9DS>9DSO9DS^Y3@(" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>x_cg001.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_cg001.gif
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M^>CP]_3S\_'W^_7Y_/____CW]_#O\
M
M
M
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M! P0P,8!E##7'@#4> ?$"/#&PL8']#A"!+.>>1PQ*=1H<@%9BOH)  A4F(
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M 6,-(PXK.D =1(:: +!@&#-#  0\2 $EF>9!"SC  U(0!UQ4 $]].%4&*$0
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MKW(^AL]/_&8 (U:TO.<=E95IASOX!D\ -.!!_WCGJ\$R89/'-[I@SPZ5C!Y
M=T<U*_/TJ)+GL?5 "($  R3  *(-=@8@" ("*/&]2Y,;=_Z,YI[\C% @@!B
M%;&XPP-0H"""8,^L:G97#\R%&",(@'N^*B($7&P%<%M  )8%BEFYIV;!KH"Q
M7GT>;MJ[.PMP0+ @!5QZ6_WJ1^$# F8CN]1$8 -UR*UI#%0S)2IU:4!%^A[<
M,#H*  ,0PD( D.XBBAM^50*?V "+3@B84&S@XE]MP JF.@P2:,X"(%=VUU/S
M  VT(&1S&40"((" <6V@0A@PB-]WC@ 'N('P'Z1-V3,0BOF6H(@>H*,'=HZ:
M%$#P%KI)P*$'T@>FJBT!'0@9UG?/>Z$L^!:YN(7PA0_R$X6"#WP0Q8!*,8A/
M5.;WSQ\^H3[1AS6#B/@(,04@^O[@". "8_@&^7WPAU]\_DA?7^ _R"D&$8A/
M>+ @P*"^'QB9[%*@XOU[ L0>! %<\@]I%-LW"+K7>P18@$5!8B.!@$IA(@;8
M@ Z8%@BH@ DA@>%'$S<W@1-Q@1'!) _8@1[X@2 8@B(X@B18@B9X@BB8@BJX
M@BS8@B[X@C 8@S(X@S18@S9X@SB8@SJX@SS8@S[X@T 8A$(XA$18A$9XA$B8
MA$JXA$S8A$[XA% 8A5(XA518A59XA5B8A5JXA5S8A5[XA6 8AF(XAF18AF9X
MAFB8AFJXAFS8AF[XAG 8AW(XAW18AW9XAWB8AWJXAQ,D#(+AAP@!B'PXB(18
MB(;8$/Z=@ B/H B/@ B1, L(X0MD< :"*!;!8 9D$ S"T(B:8!"ST 6&, R;
M@ B*X O"< 9DX L&H0E>4 F'^(HX(04P( ,O\ (R( ,W@ @%X8>&X (N$ G#
M4(D,(8P<08S!N(L+88P"88R Z(>/X(N+( PRX )@<(S'N 4N  .S@ 8N\ *Z
M0 F^&(I>8 1I(!! X (V((C*"(OL>!)<0 ,U  0_\ ,U4 ,OT(D%H0I#, 2Q
M4!:QL(^KX L\( -D8!"4T -2$ QK( ,U, NS, 1"H K#<(Y=(!!HD ,%N8[M
MN)$EH04,N0G!X N&4 ,RT 6^H JO, RQH F^D F=Z NKL/X*P_ *BG ) J$*
MB' )@N@+E: (D]"/P0@+JB ,+3D+0JD+ N$+KZ *JC@,LZ *_:@*$NF4DZ (
MG)"/C_ (^"@,0DF4D  )D#@0PJ )CT )8:F2JH"4/3F5PQ ,F: (DI"2;:D)
MF2 ,NJ #,H &OK (D("4P] +E2"1:,"0L3"6F1 ,_R@#60 +PC +E2 + Q$+
MD+ (;#D,W^B3M,"1FLD16<"0L" 0O4"26T )+V #:2 #0( (MZ@*E0 #.C &
MM/@"9K &L_@"62 0FN #+P #,$ #:S ,M$"29K $,$ )/_ "6" 0:_ "#2D0
M90 #2G &,! %PX (-\";+Q %D/[H"U0PC=V8D+I DEB@ [-H _BX"DJPFS!@
M [\Y#$\  U<@B[>H",, "T.@GC(P!L-0";=8"<*P S(@!3S@ C*  YDP#&?
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M&. 600KX:Q@/;@1$2YF(D: #ET<(@-T6/@8&D ,0$V2 /J1.P(1A)#"*CP$
MP86/FX89I "B$Z  %%Q8.("Q"S*P!1<W , C0+482 'I$H:^98'#<&D!ZZ]M
MH=L5X 9X Y=2$C#JDP+X *:4]&;"Y8!!1'($ <8:0/T.!42YQ71<@&D @D]L
MH0 !/'!)(0$B"W"#R R,LJ6"$G*^ P%1@"'$=<>31@&74#08X/4$7@.A@!(
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M]0D!#$*:"P#-+061NP XLS>?P(7^QM6";8JD P"2PU,F9@IB#&( 9:H?,?:
M $'DHA0#@%$)'% *!P[@-R,8@!UP$<K78.!&Q=B &Q<VTH4]+0$!N,T)11*(
M BAH& \L"07^&)?61:M;GOK C41"FV&8H)_#"$5+OP:YK&7M :\II$XW$A-
M("!G>XAA"^ HDE/XC0X.D DSTR*OF24 ,0C I)D*X"1@((!="'B=2$(0@F%D
MH 0R$86;+D 8"\A-)'%(P$@0,/X0!/AA*P4X!2H&X)UA/& X 0KH3!*@$01$
M!Q<%@-%,*&"=83B%7./: $L$J4Z1X$(!-OW$ F:GE4$0\A,(L,QB17(""VSI
M +9 GTB ,4.18&"-DI')"C0PD]K(Y!3=<Z)&/##5QB"5D1BXU6Y+!$1B4/->
MN)692/AP@ 4M0"8LJ,!,4K$KF9@ 7:% +6PV8%<QRL0-$^BI<H$JNP"U+CHF
MPD@#<OF M^XT"3+I&S'N("61C.!&)?!48@H0RWLM8 5%G8DM"$ 1D5Q ;@TX
M["D2 ",#(]@$NWU@3'J+78P= !AZ.$"9U!*2!IP P9(%T(70I38GW>$I;OCI
M+59 #/Y1^)&+N8RC=77W) 2DC )27,%/0W CU:I5J2+)P >F93P.I'@L@"4&
M MPD$A(B1B23W4@!<N9/*NT(*@C0;PQ%@C^QN"0.,7RLE3?PUE-$-HWLX@"Z
M1)(7,7K'#F(N:RXO($5&?HS**AU&*B)[BPBDC*N &4X#G-G?N[@!CB[Q@-SH
M(%"+AF0@Q=V(&8<QB@.DXK$B[FEK02#2"QCE AK8<M9(NFIII3$ !;!RF8<!
MB@#@V!: " 1#I!EBD:3O+R[Y P)NI=0(L,N_ 2+A;RX&"*PXC#'$> "[AA&!
MG82$&&W90 86D+,[AP0$#>B !C20@2.RX"XNH1F,W. I._[PD299<TFV)%N'
MQV9 W%>Y2P,:![$*$&8!>+A8(*PK"-F5-:VET+(@QAB@#+"K/R XL@8LA(!-
MH>( 7O//?2O[Z%M120*D$?<%#D#8I*7U$PF8'6@&^1=?$V,!#"Z!_+Z<EE*4
M8 -N27&I:9* "VQ W!&0P*DN'"#>W08N;ZJO+39S[T/AQCH0 X8"*,([/1!C
M;?PAAL5M(;0 I4#.+@E$ H3I$CU8UY.$#=":17+G *T CAKPDK@Q@$NYF+4E
MP A$((R(& <,AT@4)](P; %9KO?W1FMM+T,#Y(<%)$ "*Q"F;R=\KPLA%\)4
MI>0P_M#L _?T+GU80$S>(*4/-/Z  ^+F'O]&< "[;"H0 '.8JD52 ;:J^*6B
M50I6_^FX7H?)%@? ,2"LVUN96" I/[8]I)VC>/ZPX$:GJL#3UVL+"/C]7@KP
MZP$"<3%<0- _YFJ Q881!REU"BH>+H$.9<*! WYMXU3E]3 T8-=!?$ #'2AA
M6RT4$CH4(%*!O) $\+DV&@"-L !;P84-0 !PBS78& 00T  /*"%B@#7>NX4$
MB)8AH8/66C>9Z("WNJKF6\ *T AB.)'S2POVP05"8"^R4X!A"Q *((Q0F(#V
M& &78K4<G(E22(';2!A@2 #FD@DX\!M7 #Z1"(61"[P^>,$A"Y!B&P82H)*0
MZ#Y"@/X-4)BT"8FVG:*LYZ  /LBB!D@+/ B]88# 4/B$3RB%6HJ#G\H8!4D%
MIX(3A'&Q)YD;.KB% ^@#4/@$4,BBQE B2U.0?@-$RALDO?J;33&% G %5"
M57L )0H0FVL)E]BS84  'T0%R!(+&4P7CAL!'9* $T!#4"@%V&JOSY(8!4BY
M&'&J\[N?Z"@!Y4J? <&@3[B%-W"C4E..!+@#/@0%5-@RETB!<RNPVU  C=B
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MEG."0:Q@8!Z<P :>0HP3T,0$@T@"!31 $V"0=AAQL(,>*':>80PB Q-XPQ[
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M"& #VT< .W/!KD#<@0+$'(8)&@"(</]^GI^  P#HNUT?:B4"=!CJP^W0,84
M4FQ  [  ()S  $!-KM#!)RB==NF$D$13824 !'! FCV+OKE! =0(":2$0$B
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M YA4[5F)IB((H6R3*"! J8G"!U@2"5S&@>R,!%B'L<S.&\PJ06B3<&2E*"3
M!HQ'""R'4.9O%&VM3QS'+8QE'40M'$RM0!!""V1 "A)$<Q #:T!01T+K0$CK
M)4+E O[LP3"U@ +G02K*$\.XQ  8)D@E*+EIKW(&1@:\!9JA!G@<F1]T%@&0
MQY? 1F"8JN%JH\6@!@M<AF:" /VHE,(NATY  $-EP,=\@@!4A;,< !&' @8P
M%'5D[ ($@B#TID[005W0 >C!GT.&3@G@S4  0P0DRW'0BUIH".6FQ(7H98&8
M0!B+ @&@SRG@HF[4;AY<(L.8)RM.4F^EK \RGU2L1*-\1E8D  1!Z=0(@O]
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M360?)X!-IH8-,1%="L0%9(H\@=0R=IC&U46[4A)87, F[L2!3O20,?'.[/)
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M0I1GWRUHYM?$ 5ZP+7D;H%1P0 2PY0J<,"$ 0!VXPO3V;J[\"5782  @]S"
M5HT,#&D@ %;( 1*APA[<1$$ PP40W:Y=0 8HP"EL(VG8@?ZP6/< >!FO\8$^
M"0!8= #16>6HZ@04 H)Z'^/.#'@IE((&''A;)%%7/  ;M9R$@$ $:&X+#, )
MX#J>A 985 "*9(#TX4$>_$4)C/M,#8 >EAL==.C@P=\"$,(I<.!3,+I E, D
MCLXM?![-R0$PA,"?E 1!L.JVLOD*/  %W,$(R'L'@#*PZ=S:7("^.#S(1 "*
MC,#@$ ,+.  AFD !/58$1(!B L@#M(0H7, #A( >Y.4M#-;BF@ $1$ &!/,I
M= !\\4$?1 !':?(*A),=/( #?( =1!E!V(&^2  C'A4BA0*6R<M3?$(%5, &
M?$(+:  N?'V&84 Q_CPJ7( &5/Z Q^L,UWL]F5X ,-B"D>/"'J 3+HA[!'A
MQB(?5&3 KU. &]M(!3@ !>"!!Y"''DR]O^S7 WA9WK>\!^Q%*60 TQ!#!X 4
M')!OY2/*BV4I2.&"PV] )1LER:>L&XQ/P3\'Q8! *"QJVEG1+61 44Q4 SS
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M=MR<<I-AV%<*&/0 BE!J19R,()">@#.L@X8*%2AL='M!3Z (HHBM<-!GF(9
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M#F:Q%F\Q%T&@""/@42;  40@**3DK1"@#X#!J3+ #4!I+W A B[ #0C18NZ
M )IJ! ( :0R%% N0 F[A%J0D W8"*QI@ DK 5!;@I<21G[QH\L*()N"/ "F@
M C "_CQ@_B1@+$9@:QI@$ "! #3@ TZ %P<B%!;  UJ C<9"Y32@ 2(F(NN@
M Q[@%E#! Q2  U8"#S@P"5"'0BI  EK@ Q+ 8N F;P@@**H1%VZ& S+D)550
M%*:((S4  1>@!W^0_'(%&#)  /X: /5*@@# SA3HX [J "EL 0$^H#<V)"/@
M<1A ( 0R0H>&(04*P#W@ $!R"*42R-LNL=@.Z70VAF8&PA00@&3X (D&(0!
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M).)JK(TR BDWY =EXG(8  %S*@,!((8/K ?\-F"&+JR'[OX4_&2H,1X$ DA
M90"!!=ZI@[YJ*UJ@OOA(#OR@#P+AA31'#OZ 53= CUA C^0$(XCAB!J$0W)C
M$ 33QD!PS;[C 2KO .( 5#L AX0# 2X #C:)?L;BC_ D.03A#M@(Q![D=MP
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MO60%)W@A0D01B%2DX#O >$,*JG>*))C@<@/A72@6F$&>'/"."/&#"># OHX
M0PZ;=(HM6F""4;P!+D8SS2WV$,JME&( COA8*0[@@09X(( )\$ +*D"!A6R
M PAI !R&,8(%9& $(1B (A$2@?[1T:\$$E"> DK@A@C Q19M8P$"H(B04QR@
M B$ 00),H '&E& @;DC &]Z0@&?V80 ;&$$) N 88G1  G-(0<*F(H$)I, #
M$(" 3U*P /LA0(L(HT (0O!.#9S@ $D;!D238%"/ 6( &B"!"6HU##I$( (C
MV(E/5@#'% 2@#Z$ @"G,)@ 7(F %;D# /%>P@ JD !BH$*8;+G !@61 F"9
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M#!%$X TE&(#'^J" KE8 %[>8@ ;BL($$A-);&J  '5*0@)#L<P,D^.<S*[L
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M"X-0!Q20<X#@:6-G;"[4:4PS 3@F$(#@$EDW"'S@!WL0 *# ?'GR 1TE" A
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M8]I-GK>QI'D'014!$M E#S"RHV@V"S<5&M#*$NF:9X*@+]H7V+H9M-79)?$
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M CH0@A(,H$3#N&(*$A AAU1 A_Y'R0 %+N" 3Q"C Q%@P0@0,"A $$ ^27B
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M;$T#Z&J"=.9B&'PH  C:&($3(&F  @%&!@(PQMD,H@#=0OX%'>QPA[;9XH>
MB0"4!"*!(X% AQ^F8PH* "W) B8U!^!,*:P[C HLKC4'&%0)XF"E P"C+G53
MV0!P<8L"V.L4)ZX+Z1" "EPTX%\&(;!\6"  #"&@2WD$CPEXR4GW4)67;@B
MO001@-LEH*[#,$$%AC$(!>0"& GP<"BLLV:Y)"#!RQN *U0ZU8,4(#H_80%Y
MU&@OGID--,,0Q +4XS@&Z^$.=K##P#[P'8'(P= "(28Q!.%0@<3!S&[FL2T&
M,"B#,."1@(#F0#Q@KTH:; !=Z^LM3!& #K4:#P@ 3%"  8K4TL$]I0BF0/9
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MACD +I((P@V0Q1+TOSP"A=K#P6!KP='#"Q/3@&=SC &0G($0HMAS%'XQ1X,
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M-3L )#T%0;+,^9E,!'&# Y"#.NB  VC;'8R H7"$0=,#AY.]>^.99R,&#3@
M0,"CASEBDC.0J@B$ 9 =+-VUHC08_!*% 1"!60R ,JD.YY*P(.E<\, %#C"T
MQ8(F."  '4, .Z8*$&X-$!@W3Q.)4W"]9>T6I\R)#/B H>A.+F0(&;X%",@
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M &CA7DJ5@!+IJSLQ+D+L51?&!>?[U,:L"[EP*8/H P& $OYXW^(0!0DX@ 9
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M!J$(D("!*84'",3\?FSPP ,'R),G%(BJC0,?8XJKI8]UB?Z 2EP BF$!0\H
MP5X<"4A0&&\1M;: !2B1B[P+O]8 &K^ #$BRU/R;!JB QWZ9))< !W@4PC9L
MSC@%F_B$2^N=.DHGB"H3#:B;3W@ "<@ -B,)?]( #) ##3"S"R@UZ-R<XYZ
M#N@ ( (8!E!16;R:?S$%!!@8M-F #;@#9-+-X1[7=)IOA7AMII. $*J#;;I(
MV)T $7CLIL(1CB@!)FUO"" !8%@ S6D4?U13[T"0'%=3#>L:0(AS0=@ )F*!
M7":(.#J)!-#O";C.MB,.@P@@2BOO#.\6B[Z=#LBR80BI8+?UONMH$<@ .X #
M377#%(J8"8B@U?8/#^?P# >!A/[UZ@HIA4%X$?G00(+0=AV1('\<0+^,($*H
M;:7P=@V\TF\%C%00D]8@1V]OWH$ A4$82E 0!.7YP7,\E7FW\B&YA52UDD&
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M BF<5ILP99784"AW,*2' RTBEZ..._+8HX\9E0+'<05YD %!?"" 8U@,B=+
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MM!0@H'L@>(#Z"'**"BS@ 28 !@0\6  3(&V(W(&B04H1@*]UB"W &$$#-/"
M#M0D%+5#X@7TT+L"!(\.2HR A/[:T[0*4$!R=5A0!$"P >^-@"%N6( '*! !
MV-SBCB)H@.D$T<,'T,$6!+@0+BX0 0VLB" CJ  (*+">:RUD ;HK" 894H<%
MW)$"WC&%Y214*5QD( (9:, )&$("#91  .]:0 ,:M#Z*-2Z7NMPE+S>S #L0
MA 5&0@4",K"P /AA&!1(0&]PD;QA]"$ (+B9* ; 0APF*1!):AI^ I& 6QT
M!):I0P$ZDP"B#4,/ DAF2!Y(D$ (@"S#",$$AC&* GQM&"FP (9BQQ8)G!(!
M'K",'@APBUL(E* #N 4NSD<0:5GF 0(:!ATD, Q0+.!4]2* ($KAT14\ #8C
MN "V$OX@E3@(@%/#.,&T3E& /)'3.QTH@!UPP1 *",@E'3#2,#Z! )LV '3#
M^,, 8".!$+00 *&PQ4\1>DT7WH(8K"0('00@H R8KJH.HB0T"4 :8&R@/@8!
M!OP6%-2V!8 T*X@ 0S@(3"L5 ),&P: 6)2""883H!&9] %L$.(P\"&!?;S@
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M8J7BV/Y"4*T "%3$'6QE!FR "0259=Q.!I@ $I$&'I03Y25 "8# 2YU$"@
M?;49L 2  8&" %3,"#Q !-3!!,190=3! %@ ,! 5=,3!'0[#.Y; "!R /#%$
M*8#DQ]D" -0!G5Q3* # *6BF> @ ::1  <AA!HS;+41 !;" 5T9F*-A/6?0!
M %Q+,0R @*!" U3 "? 0;+A!4(5 "!" %,;! 9" "$3F-C8E0YP  7Q ER5
M,@U" *00 1CD*0A K A" G0 WA7(*!05#A& '&K QT!$ 81 J24 G%0 4K5
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M%$ J-_Z W,#!LC'50/U5 3"4@]V*$^)Q:CC )LU!V45EM"^;>QFD'!"6"G6
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MT I - (0!<5A>ZG =QX0 0P$K@(4P 4Q5M  !="P+*@ 004V0((%&&AD+F'
M'LS$O!*Z(9 NN44">H01!  P<!(@BRU L( $2(!"+.!<WO@ B 48CX,90(&
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M.F %0$ $"@ 0/B4#0F $"@ H@"$"+N!Z). !4H(]*. $*H"!A@$4!, 62D$
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M!!X 1"3@_A!@1R!L X+' :YK)H!F=UBD 2K@!"K"0$X  4R@+S[C#1I 6D2
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M87]59/Y+ML;ZU60O,F13EF5;UF79"1A:( (8 BKHP!(Y%A?L[!,Z0#(5%1=
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M%(!A *<MS"Z&6(IDEEI@9@9(#Q#@%("A#B8(-W3)>XXF$ 0@!$HAVZ;"/E8
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M<&&#'X2W5F1P$\H-,(1\.F1(<0LA,3D:--!)2 Q.2#D)"7G L($/PE0E,FB
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MT* +D4 $W&:!"2G[@A(V>$'U]B4#(J A%F"HHS J(0,:5$(8J]AO444V#%@
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MU+=V"%B0 SPPV,) !CW@ \ \#*\ 8C=8AZJ@!&OJ"UB  SW !@ ]#%QP:(A
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M((6,/%&"7\'D0 PW$"SI8A8OJ%P:*D>9@-Z'"*9IRD"T,!A":F<C&0760G@
M4BX,1CG:Z4)^B#:<"N%E%0PIQ"N^D@;>: 8Z@),,_,0@G?Z!/.%7+SEA@X91
MB(R(H0>Y6L4-[@>+'W3AH,(,6 U(=![3P<(7!@01)7HAU6H-1!%VT<774G*#
M\O1E&&S@Z3!JQSZ4^$(*040*OH;1&H;,(@T#R<+?8OC$N?J@KG<=QA-3HPHI
M1&$1 _%B0F,S&#38@$2QP '@<$(#LZRE-#PPV9LXT1WUX.!H"'F%OP92P=N\
M8)\\V$L7X#-:&0AC$F&4"4\($JU9_( -L\'->)@FC!M80C-,$(@F9  ;JMGG
M:IST:YX8$@PT:(M6I@PL9/H4+<0Q1"?.3-HPT@ 824G(-SCA =.& 8E*A,1%
MP$H-0V11!>W(D7L[T8\,7CH0B?YVIU )60@6P$;5=.)($5Y(PR'2T 7Q]LBA
ML_"%.'LQBUF0L[\/AG"$?12U%V"A$&;@ 0Z$*A,@:$<2+T #);IP(BPLP3B&
M@$$A,)$&[]!"!FJX!!HB-Q<3_:!2+@B=QUX AECT @:S4@4,2E.&-$8""CS8
MQ5=H80,L4*(0,LB,=<X@XA-- BJWX0$0U$")+=R@-.PS Y4S0HD7P"\2+U!$
M)<A0!"%DA D]*,0PU""#0T2"3"&4! S2@ E#R$ B:!BN+SCQ@FN2&1&5,(,0
MVJR9',"$Q8:PLS4/PB4B2$$*@1Q&%H@R#%K@ &P!@\$+7V#"6<"@*'TV!"6H
MT(.[P/Z@CU? P2.Z A=:W6 1DO#:@(:0&C5,!J^-6<,-B$ $+G2X/TI([S!Z
MT8,H1 )QO\H$#(: D"=@Q1= 8,(D /4K2;B =#^0 8VB "8V3(9=.O0"#BI]
M!<D.1 I#J,0BL# #,$"D0B>#@4'FC @[OZ!E*>$!%E8G!1D\(A8VR)^J<3"6
M+@3*V80*36L9TG!%1&+8I<.""UP4"QB@I 89%<8+1K(+)@!AUTQ@E7'(#(8!
MR@ YC3W(L".Q"!PD^]?&B<4-FER(%T1KV5&P1"%^8(/2,,$'D,@A@'R<B6#
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M'&*H&O[(QW+* IO#$8JASQQA'LOQA1TPT'1RJ7+"K*4 J=8$*L+3!2KPIH/
M MFZD<'4.YJPS P]"%ZP#5X-U5"=A"'0@2I8"5]0@X%RO%X8@U@8OZ^XOQ_(
M E]X+57  B.(TC")5RK(L1M1 C1X%)FT@2;A1";P@JX,F"I@ BZP#4A(!$R
M@C+$D54 &6\<"#3H!$A@ BF(H54H&E@H U60$3;,$5VP/=^A#R  @BS0@A\
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MJ!J0BC4@NTG8 AC8"RZX@2[P!#-X@?.,B2H@9Q@> MQ3!!DX+%\8 BA\Y?*
MA!N@@D5PT[U0!!@0XH;>BQB>X4?PE1*9GJR0@36HA(8K#5]@MDGHB@0A4I30
M"4/HA"PPY(2H@DO8Z/-R-\"AA1L @TY( UA""!T57"VVI(]D'BS(C"<  C.
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M0OB!#ZK@DB6(80L\P($91L+086B""7":!$0?A,N YC0BQ4/#N(01A:!V!PQ
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M)QCU[,)6:] L%>D"SS0Z-(H(':$_CT037G@)&CW]Y[0,$D*2@!%U]SR&1?%
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MS\_T'WS!$BM R"I8@N6UFB9H0CVMPAA2@MXT!Q"\%IGDA"9D MO DN6EA1(
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M2SCQC;:A#5BCMYS*_ W2ZU*XA\A @,4"#/2X#.C*^F8)V8Y!#[P$&=2$+MR
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MT>J"T& (FI@%%_CS$TK 0!.^.!1"T'"#3.@B$C"P4!ID,&U(6!LN3)B%+L
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M7(*BCJDA;P(21RDBM+4B(N&3+ @+F&T.06*=;  K 408T@ ,T* 0U( +@%-
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M@Z+#!62  U.:'N]'!C* %92@ U>&!0=D>$*0!OTR%AOL@X(C&Z/]4FU+!5P
MK*\!"S<0!6Z! W*8-C@V!K-=5$9 W(;K"T,0!6E !4)0L@F1!A-)/@+RW])W
M ]EB'5@ !$00-DWC!5$ BA<QD?TB&-9Q!4 01*MP=A1F1#W  U5@9=!6!3B
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M$:] 5JIP!<LU#$^ Z.*A [O!XBRR9!2E7IAP">;X8:.B,Y/0WVH($H:H"YP
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M05_X 7&9FUE8A'X<CHFX G<,#W2\2(R$&RZ0@1J0 5G P?K; :"I 1K(&Y6
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M!!XH*;%\*APXI#*0 8CH!?<:!D0(*HWP@2HU@X/;FRY "*ZXO,E""S32#+,
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MCH"H0@A!@ET:G1>(0 0F;.0*'W,1$0Y$!18.! WJ*Y] $"$:@8P!<UUX3Q
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M0>O%@A<H@?@EQ.W"!!@@VB1\P20(@_J:$C4=3FY=E>$B[$ZH B-(X/WR+U)
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M,'A!3_[K65CYB2S(@+PE-TS W#"4P6]BVXBRHFC<1##L0*E$@?+S'?:P]-4
M4KIP@M8GA$?M0%$NID!,0>X5SGY0V)-X(EK9_ML) [M412:<[13D6%.6"HT-
M1!8\CG0O!.@)">D3&/L Q"Q(P\ 0&790D3!5,F8=#$;CT; L0PX.&V)F&!",
MPV9%JGAPB*%A3\14[$)E&*1#%6MP&M;E1L-AD1@>//-C&!L@%3'9&+;&Y\$U
M+V)]C$6FHA2D778>5-)E),J#4G@(^VAI344;EX;50'10F TLPPP%)?N"EJ\:
MF6;J.$BIQK!8,E1IS5H&1\4H6X:EJ71P%@U=(\]\-'P8<?YBQ8L9-W;\&')D
MR9,I5[9\&;/DP#5>4%(LC(>2,F.Z^(BR:QB5(870I#$#XY4ONL-^B)04%\OJ
MUJ]5]9*A*Q,615DLBM2!)4UK+#)\Z8@8K*UA6#3JTLYZT 8E73+*)&<TQ*#T
M%QM!HAEF56TF83)B;:(!_>"/2ZI>I/%^PSR0K\-TU:C+188J_HIO/S*>.$@3
M&WPYZ))#S+AAOX,DL4$8JRPRCS]%S)#BAJ*Z4,+"82XII L;H*HHF!H\$NV\
MC-@8!J[!R,"!M=9@R 21IH0)QH:Z5&QQ#9R&6:*,%I7 R! A6]1I&$UF\*$+
M2RK:0@8IT"AJF"E*.D^'2H2IH?Z+Y-*0PJR/9JE!EX5:0Z,0'*X8!A$9E"!#
MDX-4N0%*CX8Y@Z(*A[GB32K&@HX(C!1Y@0@RV#+LAZ]JV"*Y-:2(:QA?%E&#
M"AGJQ$**8:![Q"VKT,!)"B)8<PV&6*B RJI8:"@J1!C3Z$(&\SAM\8DQNO+(
MJD=X."R82ZN@:RY:6M3B32F(LRJP6'JAH4Y$=(".$AJ&4>17/\=0XJ4#K9*"
M"\ 0,8.)&P9[HK#,U%V7W7;=?1?>>.4]R) BNHC5L+"N\U2&PDI5XXPST%!$
MEF&40*._P2*)BPHB CY##44:&D*2-="898@SC3T.X#/6@,07&R;Q%$8=8HW%
MO_@P_/ZR$EID( -B,PSQS"@96"7F/!O^:I4A5:R5I*EA>JFA%T1Z,*000PZ9
M)!:U-D&PA@6;]$(&XM2JT^"-#*&($AR0JP0(3,ZS2A&W6IRB,#1NV *1GEX9
M1@QN.1*BT$JZ(*XBM3R;@M6,"H$1S9=\0"-@-1"A)9&@>?21UY^$9+'77Y40
M":R<FM*E$"QN$&(P$<E0 @:1E-A2F"Z_Y*+C0B+!=QA9:IA%DWX+/X2K859!
M0XH7QJK4$,V!".8,N:W:HE- 6RSTH%AP?X&*6(=P%'4S/(Y(D1NP,&03'KC"
MXLV#'J'P(#4HDD()-:0?6)<H=&VU!E@^4J4')M# 1(HBL_[HU"HF=*W!,^@B
M,;M%D+C!%0J1/4[,93!6Z4*GGM"W,S5-!FQ1!/C@0I:@#:,,%!'#@:;"EP=Y
M01&5L$%#F)"N>9WPA/ Y##%8AT(7OA"&[M*!>8+QK4Z-@0D?V815$"$%0W1J
M)G$Q@]SL)"HL8($M4C #!Y>@AHHHA#8F1 , >8:E(:Q,9,.(8$5T43 NY@ I
MAK&!)"J"AE\EJ4G,.0@9?((()35I&*J(VD$*09%%="X6,*#%*VKP"R[1+ OA
ML@'E>-0Y!/W&+L-X@9Y^\3JX1>$@9LC+0;C %POI+4M;RHA(*E$#'OZJ(JH0
MQBIF,Y,7N,\&>G+<099@0E\ X?X10##D0=B $TC(Y$N3F,4B*L(&MSRA2.>I
MP5]LH(B\O>TPM'@=+VJ2/%T(PY@'@05[(H&E8=P@$IF0P4> 8)XK[&X8#KN6
MA>;BOHH,(1&;1-$JNI*&BMR %<.X5:],=A T:)"#"'H)$3$A V-5! M$C((3
MM0#$840!#!EQHDU 61$>F- &FPC&%IWR)C%0Y"";((HO:, 61(!R$G'9A!I9
M"94N3*%%JPK&"SH!F#E&P80QE"EE@L&(+'S!"VJ0R3#LYH4L=&% ,Q7J4(EZ
MF"_%] H4<9D9=$$+*0S!*KP 0G8.LC#^R("ILJ""#]@WA 61X07[J80,[K@*
M&X0K3OZ9Z 4E;L #%7)$!H8H"A!,6 -CFD%3NJC$"\B('B  (1*(4(0B$#$R
M,_"@:8J0@=BDL#LI]$ -7>!!IV815U_$@@DY+$30E)61*.C"%W$*1HZ2QYZ#
M\. K-D"#,%1%-,,,00JZF,488)"5&ICALEMXP5\DJ0EA'.)5N[#$#:0@M4K)
M8$7AL@H.LH*)%^C2%SC8PBQF 9,%E>$&8_!"%'HT#!HTSHRLE((H;3*#$WT$
M*,-X;--BIXI8N. 0OM!%0(?QH%70@K:>4:QV8F<>,O3U(+*0@?NV@ -5Z$(2
M,' )#:H VCCY @LX@(4O1OH7'U1A%KH 0PUXH5[\T08C-_Z@PBQ\H0@:[-1%
MPY#$<]-T XST8 N^F 498&#,*T"2AY3:TT[FHH:F1H$B]$$$A8<PX!8-8T89
M7H0,O"",+'C+8.%*1 376H,?.(\*,G[-5[#0@UCH8BAC6458?:$*)6QTBX^0
M 25\00DU9O;+:#!M%Y:@EW#)8 V^>,457E GR!45T(B1110.\<Q>1(()=5'#
M%D2I$"^0)]"1EG2\F/ 5"QF""591A1%Z (0J]*(B8R "?"JA!.ALNM,-K@@5
M="6B(NPT$D( 0@_"V!<< $$*;)!"K(1QAB.XDPHK.0\3!I2&'OR@!Q&RG1"8
M,.M.YR"APNA"#\"S*"H,!"%@4/X%%EI]"2$,H0?WJF]"#U*%@<BB"D-0-V_)
M?8DHH$<)=:G$$)JPA4@00=G#H$43>#"XZ_&4V5&H1!F(P%HF]$ 6TF8VG8H0
MH6 HH:5;P)!ZG^.%''@D%DWP00^@8$U.C,$0NNBN$H*J""!Z.]-V@D&=8K6(
M3@4C"\?NP74H\6T?,*$H$*;V#VMG-&2[4Y[A.8@NB& L89"A!SX0 LTR?NRE
M>XH+U.X!AF91A4XS 9ECJ#46_I9Q'X#;,R&Z]D$6(82-KS:.1"!"%"+!AB+X
MX@R:I,03+'2(*MB)"!NO@A^',8D>\( (B<#Y1WR1;B;XY0B:6$.X#N(%#*$!
M!SR@@OZD8O4*(Q"A"9&HURR$$>$>C 'T;_G[\Y0@BV ,H2Z]P$(.5&'F!?G"
M"W\E M;28,F78"361I""W7+(!<I-.M#"H +6*J*J1_#%,%S@)?"9WWQY@38R
MLP!U](U[$!EC)A@H?LSU#T.& :U';!5)BV-ZH?W&S!(QTC\,^@_CB^I?1K;%
M]T)%8F?^Q:2AH8JY[%OUC?Y>\/\\.*\B).&\$(/[/J*I#&/_#*,7V"\Q=,&:
M%H/$#,,!'T/]/D(8["]OWD__-'#H6$<7'# "MZ\"U\_YF*\2,")$K,(0:*#Z
MT&/73E &9Y R6H@&Y<40;J +9H3Q;C Q;%!=A"$*A* +MOY@!A;*,2[!")#K
MR%PHY'P0"J-0"B=-#6K',#8AAQ"C"Y!I"KO0"[\0,UYA#=+ "L'PA$:D$*KC
M,6+A$,+OA(#0#-T%#N.0#HEJ#-3P(]8J,<C )>K0#_\0$ -1$ >1$ O1#ZU"
M#=SP,;H #PW1$1_QA.3KB82*%1KQ,62A!.7%*N;0,2X+7F*!$R%Q,53A:=Z%
MM88J RLC_DX0^E ($K(B%,\#"P!0%&L1 QF#=6+Q,Q #7WJ1%PVC#(+*J(;Q
MB1#A.K(@_VPP%Q,#$8!N$HVJ\\P+,LQ 3YYB;!XC%-5@=2H'&_/E&=$ $JQB
M#72$&!\#%KI@,!8"5KP1%RUC#OY7D!WC41ZY\0</ Z]B\!=W\1<OH09HL1[+
M\1;K41%@8/KHT4^ 91@**C-T<1Z?D0=L3Q_A#YS:L1):S18OTA!K()TLX\F2
MAYV:$#.X@(AP409*\3& 8*%( EY^ -+:Y0?"B$DP0]-@X-1J8 3=<1!M("(<
M@R&' 1.F1:A\@?@D@PL,JOG<ZX708"<=@PJX$"-K,1C8S!+0X&TR00UHYBW4
MH!!D8A8J(1@4 0V&DA*TTIJ$81',0!/TBO[8A"N]!!$883 F(2P_0A/8$C"\
M!"Q=0AC^APNV\7W20 V&<A988U$JX0F60!%\@1;44!7L TN$@<VLTB^% 1+2
M(#$- _X3@.P19*(2#*<@K<\0:N ,U(,2ID\M(=,78$$1HA((KF!%SD!YGA L
MSG)DI(DM)J$1,R$-U@!6**$U5R<38N$K&R)8M+$B8"$3?,$0T. C*P41U& 5
M8H$M*.$'I(","N$'@N$0T  /+P$-XDN:,,$7MK,18\$,:L 05.$5:( 6+$$-
MA'$5[,.<#F,2KM(7O"1YDJ,4*<&:-@%K, $-9+/-FL0C*B%-T& 1C*LNTZ Z
MVBP8.K,VI<EBAA(6DL,2#V(JA\Q3(,%$L+)2V*PSI:3X[*,N(!./W+ 28,>3
M*H$+>V$2^*\S"R$"QU)#K4\1U* W_B(6@DH5ZJ07V (R%?YB)V7!8O!P,!&F
M"R#), 8S$?\R#>:S95[A*ODC#0P!U%!3$]1@$4)$%PQ!#2;!0C A%F*S<Y#R
M(#JS1H?A%0HA#8:R,GSALQQC7)X2(^<B"JJ N\Z ";) !IQ(^*ZHP-Y&S:B@
M"JC@!7CI3]' "R1,:(9 "+S@J3!*DLA@"VZ@3B2A2K! ")1@#*"@"CHCDG"
M#++ !NID$C+U4[^""VI@"<#@K7+0#!XDFM@*"V"B2-: !SQ-%\J@*=2F"[@
M0CB"!J* "JAF+(2A5,X@"F[ B^@%"'B@"MR'"GH #*@@HCY"JVJ "0J!%UY@
M4?I)&-0""T)#PVQ@"+A ^)2@"OZR8.,&8Q:$( K( +:LXK"H( @L32APH P
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M/LK: 0B!:_E9"E/'QF8[2O1/\,<J"EV%>/,,A&X8=$ DP-[XA:8&SGMGX.9
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M"#%D""M=26@@!FOPTII "4+P<F4V!HC0 SSP&D_"!*Q,!@2!"5(@"<2L"[%
M!!V$!8B@"QBT"DWPV(B<R($U"4W R!2B UA "5(4"4XU!(@3"^S'%>#Q"JO
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M40DBA*T_4JA$)*8Y%57<@ R86(,,E),(2!;$#+C+"&&\H(E9L*L@G(!!;+*
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MQ&=)K$.(!#E;D2'H 27( EGH!"(8@D*@IQLPA!HDF"J4Q5FDQ9O;M_[CCC0
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M<":F* F%,)0EB!*:,$QA4(2M<IZYQ,W<K,)%L (;W((N ,[@[((Q. ,S((.
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M.E+A,Q;@24B#:22-#)VP^64>%/XV$\J(A1]&H*G@X2K6DN0@$T50@SHF'5A
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MN('/?$&%:A*A!ZL8ABR&X .1@'08/VS)#<[W4XVB3A8R>"P8+Y082C#!"(_
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M= 9L&OY$&BRL(7S>EQR6&/QL%,! \Z;)&H3*F)"G0YA!#1P"*(^).(;)(MQ
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MD$$?QJH$!QN82*,QJ[!:"L6I?EA#&!E>U*VL8= 8;ZF+9 !PJD0"4V/(1K.
M89(U;#2(!TM!'6:-U)X4R PEAGGBASRQD.*%HY!*:*I@N"#LK":YV H2+JH@
M@H?&>(A.F&!J@&@J20IU<M(H%@Q&!R8$58*A,VR[0JE>B/[PH8?<"CFVR!?&
MJ@&389X5B$,/95!.2X,-@LYB,+K->!A%=&ALNVJG*@,M,:9@D(HM](M9YIEI
MKMGFFW'.6:!,OD#D/0&GF]:O+A("PN>I'(2PU%FG\B4O51")XMLF)4TC$U^
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M0$UD7;B!)#"!!7,NI7V3J%LTR=.#2ECBMUV2020B43?C $$M42R(&,[$%(&
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MRY0P"^_/)3A0"WDM%C(A ?UB%CK'"U/P/F0P_WK0#&.0#=WP# MJ!^;,Y92
M_\ O$_BC!G9 !G[I#?WP#P$Q$ 5Q$ FQ$+.P%[B@_VZ $M8@"WA !B0$VJY
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M"O;.,7^T*E:!,\D VNX3"[K B^H29\H%"&X 0 RA!@0FIZZ@!G1RK/[4$*E
M""BARD1"1)X"$7#@E[@ !PXA#90 !QK)[<"O$'S!#'@@"PYA#&  (F@!![8@
M$LC@!H3Q!Z8,$0H,0&;!RESU!HY"(I7 "!!A%\B@!L" (J1@"!Y!2/AD"'R
M"';/#/Y>@ H.8<RD( W(8$!&Y@4.84VQI2C&!!%\(+ND90;68!&&0 D:8PUN
M !$@80CFD:'(H!+4P 9TPA!"2A)R8,_68!*HH 9D@C?,8!(<,7RP8 @FP;M$
M0D@601)&\'!ZP P*(32Q !%ZH(JPH <@@2S' DY\P P0@0A&K!*4X <8@8M4
M(; B 0R,PA?4H :\8,T,XA*8X ?2@!<0(0B@%0UD"R.&@ HB0;(>;QBF0 IZ
M@0R)0B!@0H/6@%]W@@=D$0=B8Q%D  T@H0E&3!,^2EI(Y1*B  C28!8,ZS:J
M*!AHH":(( JB3V0*C@9.*@6MZQ'H%7-X  ?(X!!JP J@5?X) H.AAB -Y(R=
MZ!9F8(&!5 $*V"(65($*=( 15D$8K"L2#.&XJ*-QZ=5"-0,'QH!>%S-:>< G
M+D./RBXT;& ,#L$&H* *-+<QE(!=#Z$+E&H8;C4+(L$,=/7&9$ )Q-,7]F02
MJI5!&U4_IJ(3E( ,MD(NR@ T!$,' HQ1>U<0U:US0,YU9:"1>$,8!*0J-@$&
M/E4@M&![NN"#E&!"9,0@:$HWEJ 9N0 MPD0@SB Q*B%G0\F4;H0&%FIJIN '
M,L,,<.#B4I4TM$2/WK<7Q/::!(0H#NLX>D 34&EV:N!%A^$2R.29+$D*6 <C
MQO,&%.([?N"/2H5,:F#D5F'-KOY@@GW!9^"$2MIJ9R;)I:33>&L@-J+P*&@)
M/?1)('A"(!!'-]# <1XW,[B@_28J+*:R5&3 !FK@!FX "#*C$R0&<3+AI02"
M/]*-!CYU""X!%FX@C! !HJ1R( IB$VH@?"HA.[;8[0JE**J-00S!'ZWV.P)4
M(![2*V<A"N\'^ 0C._XD2,X$$5*C>1R)5/RF$_B'*[:G&'WBA8?!!O;(39\#
M)0JAU RY7 T""[ E?;ND*<)KY#PJ,R*!=Y<W/]I-#:P*$X9 $79((#K!:$:D
MDPT1:LR@!YHB%FB@/J>W>?)"*'6#8\BB*4*%G=8B"PQA#0HA"V2 Q)Y#@Y &
M-$3#$/[2P!"$N4&>K#%@^2@4U')6Z3E6\D%^J3O": D$2A<6 0VBH 9VH44T
MX>)DH!<F@>/.0R(-H1#"[@8N0KN690MD@",N0_+*1A9Z@ >XP))<EP;*H!"6
MF0D" PU>0 K4X*DN8PC(X.S@A)JR8#0T07Y;&1& V:LHHEX$(FR.8@P<1_]H
MX$0;0@9XH47LQ2ID22#RAT02 OB4F0W(@*/\(FACH:9C01;\XK2N20TT=0W6
M(+;VQDTL1Q@F.HP,83QZ12 2H2"N8D&PX'F>@ E^N1#,  ;\M"@HM^,NXE5T
MP&>Z6GVK")9C(0IC82J"B#HD(3L,V1!X("_8FJJ(X!!\^OX,8$ 6LB"N@?FT
M:/'\!"(-("IL8"$*ST"@#V$($N2/5MIU$8>O308T@,"7EYF>X^+)#(4)AN00
M#$B58V8-RD 24((2I@ 3C/=&GB 22$6S!]$7H* 'P  2YF<88 )<UH22IO('
M2&DJ<'F.!(())L0&KL ,RJ ,T*#[_,*V#6481%L7@."WR: ,U" Z/,6 [ABF
MT 0 ,6<8RL!Q&*HJLL3J,@MV;* 76B2=O-(7/ @]!N,,RL ,R& -L+1!<$ *
M)'0(7#86TN!#F, G@@$1L  ';B 6BJ(+@KL,TL!E-8$,F. %!(\6[EL&B&!>
M/F<8MF K>",8QJ!AR< ,S, 08/Y!&"(\MK&[&3>:!HXB<T3'PW]V&*+R3(S2
MKX!;PPVA#"OB06-I!@2O#%1LO<U@9$6;F*6I!L+(@?I:?RI'#)K"!B9&"9B
MO<O@# YAK-HX6B@!+5[)+_CZJU4<HD2$%J*P/CU.,'9 +TC\+SZ(CU^+R0=;
M%VXNN#/<$*#\F@K$:&4 %IAP#)K;#-* (YQI&.(<>E_$N!M;N9G;N35(+C([
M$KC !T3&)U$;/=0 #0SA@1?A"G0HIR+AW<"RT?T0$H99-K"%%GZ#>(;94_(B
M&/[KEKE77$IE0KK"(&(5!8<A$1@"-FAGLDELNL^ EVB ([H[95K&;+A&3$2"
M+P2"%_YN(!C@!+&21Q?6I RK0!,8ZCQB(2G%!&:>B2(6(3-$*1,X89L8FLT(
M[B6"P64;)"9^$2-$)L(QE'@^18]I!\+[@J/A2,2IPP:J3A(8XJ$3,KM5FL43
MHCQJ?:8?-"YLH  7A&3>?6NV:1>9,#/.A5<@BEB(!PBF?"JR0*,2L*M R2!B
MEBR:<=O7XN?4H%F8D,MEP,N'YQ'"G!;&?(S_(C6,4C&P.>!GXH_\>J/G/!B,
M0O\PV'!N_I^/X@=2B@T*HM5AQ-8MYNP\7M/1\,8H81&HB;^EK'-@0<^$A>G]
M,+Q6H0IY8 AZ <2'P6H!>$]\83]=("O. [N.@@N:D0E09/X2\LH78&%/=$-@
M)L$72A8L#BD2>@$6>@!F\$:Z=][.-%3-?6 J@$"@=L)Q5@&1^+=[V, UC$05
M4 FQ6L'QK8L6? &OOD/8$LF[Q/ )I, 7> \&NC/DTDUW8D%25"$85E5*)$43
M>H$W$,$FR. 7@N%AZW$(THTWCJ*A;&DK=$<73+W>=(&Z?(%>[H<6IL8,;(#R
M"5.I?($WF*0H'H\?=T 5A&$-F'KI/0H1>B$6]$PWZE<1$.'\#P'&8((BX+ZL
M>0 +R/"(PB<+BB"1%L&J;R4->B$3NEZE%WB_ :+&L(%*<* 9^$I&H5ZSHA 9
M"%%8$QF/8JG"\D+3L%@*?=&*HOYD8(U$ \T,&1CK1:Q9,E0-)#)FH"*!'%TB
MHJ&IUS!$,CCYXIAFURPJ)VG)0,.PR@]A$(?Q2#,0#9"!1C<-ZV)#E:]*+R8Y
M/3@LS=1A+*T.D1')ERH94"F]2 NKQY9AD6H$&SC)1:5@NIA@&58(4=/!A L;
M/HPXL>+%C!LC5D2IT*MAPJ2(&08$UL#*-F(Y_@PZM.C1I$N;WDP&"),MG(2@
M\25DU<!50G0-4S4$2 \T4B(-WC3D1S T<P=F42.SAX\>8)@V'2+F"A ;S0<^
MZO&C1Y>[F(;<'3A+B.;;1H  @2)K(!5#E(>A^;M1R"SU:^CV8"*%$I<HLX9H
MC.^9+_Y8] #$$)D,U,N /PA1R6"O&$%$$X<HDD,LOE#1PQ XL"<,&1GVP,5W
M:&#70WVW#9$A@\/H@N$0/!0RC"]#8#(0&5T,I$IMP[S"A&Y,:.8+$9T,I(MX
MP\"B1 _C050(=D\-).-_3<7"1 ZS0!(%1&H45XD0V6'ARV!=], ##CP $<2-
M6]S(5!=_Q=*$#SX0(1ME79S9@U=TX= #%FA00543%5+"!$2'5 A1)D(L1X5.
M@P5C!@XUW$ $C0-E,H0//%1AVS!,2#)0(8 .0XL0M/!BY#!50#7,) ^%I]DL
M4N1PH*PY<#*,)KGU0$6GF#+:*411*#+0(5* -X1+'9(HV/XP4APB$Q1$"N&2
M%&9(1YUSBP"QW';#5$*$<\,<P@.*4,QWYVGJKLLN:&A$,H9GKR US!K$#H3%
M$%UXUFZ__OX+\+J^="KN8;$X:EC!AEE8V!!L;!0L1 PW-DO$H DSWV:)]9+>
M8+K0<M@L85+FG"ZQ? <E+ @/%,S)@]'"+T2ZP#(RQ18?IC#++B^6,V&TW(P8
MRAH3F7%3OG0<$= ]%_8S8ABO#%'% !=<L-2#61W:3Z$=3%@LOSB]$D2:C!IP
MV6;[RY0P2Y_-=MMNO^VO#6; K=C:=#-F]]UZ[\UWWWXC,IG?@O>;]^"&'XZX
M:9/(5GCB"3L.>>223TYYY99?COYYYHDWKGGGGG\.>NBBCTYZZ::?CGKJJJ_.
M>NNNOVY8(7-IPH3064\29B_),J8$JY3W4D2#=3<&!EBEI1$2[,HOSWSSSI/.
ME!DA55(#YP;#,!E+!RZF!B66^P)&G>M*P45[HC%%"7+/K\]^^^Z__Z@FFQ0L
MBRI%;U:T,#7W,O(LFH \D#,\81B9V$'-)):)F.%(%0H3AB9J4 F&T. 5OM"$
MQ53!"G&5["ZS4)A: A>C_=6L@@HD"R<L)HN<&$T5XD.)*H)5L%=H8H1ALDC.
M;.-   Z#"I<!3P(AXHL:,A!*.H'%$(VF$QLV11<S7!'\G@C%*$H1<HJ*0A-Z
M4"<RX/X@"CCH@@:!<*\S\( IO;"!1D;$A!Z0(7I3& 8F;'# JP@!0S<:!FV(
MD$9+X<@'->B!&LIH!B,(00;L&88LB# $)0CA/T,XB!+(@(66-&42.8C"$(C@
MF2X<:R!3**0A<$ $'% A;5[@02C!(@POW(<'A:3$?2X9H"H(@0D&B1$$R1(G
M(O!@$5%1 AB$8(,AW,\70%"#(F] !O7TT R\ZD$6F+*&(8Q!"#@8@F?6 ),B
M5-,S:/A!O6!"32'P*PTW$ (1NN"=*:ISG>QL)^%N8*(N9(D5,K#-+'"@QV'L
MAS)2R I=!/*(&WCF%SRH3QD&B(GJ-641];2E1J0 GS,P(?Z&.%E1#:1@FS7(
M($Q 2.9.X#B,(9QA&$H@Y,0&<H-F12$F6<C20!I)EQ>XQ!<]N,)5>C ?6+Q
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M S+P C  *$^0K]V:"680 S(@#)3@ A_K D=+ YI1!DUKM-WJ38MPM$!0 RX
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M@+  =!#= ]$ $2 (@X  %C (CD  *,T'"R (MM "$@#2*4 !I7 *&]#8@]
M<& *P[  -NT $3 (I9 !&C ,J(  <E *>U  MOT!'H +H?Z0 &M-V /  J/
M!P,PURL@ 2+? ?^-"_Q.#!$0 J70!PXPWZ"*"QJP GVP AH0Y8?#Z+!- 22
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M!BA</# !%U1LN04E#U*0:(/82N/CH5P6<"2B!ZX;1@(]B/XS;@$];$$%EUN
M*26H5$[!E!AB&G@+NP?ZR"ZT)'P2* 2HQ 2$)/6T?$D@"O3 Y8!03O'T3%P0
M0H]$04*K<EABB]T(& 1$D6W3+(T=Y@([!(KCI3<V8\D6!'#I8,\^_WQ-T&&
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MP/HE;WT#_-X##[B]!7;O?AV,WO[RE[SFE?!XP9OA.0 8OQ]>[WU''.(!BYC
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M$< 9"@ !EKBC#(@ :6(="#B!"[B 6]"6!:  M5$/"<B YJ& %>B Y1 +7*@
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M30U@2F0));]@B15(CVLY@/R$CG\Z@*F8%LX0%C]0@#D) #P5A0C "7MI@5#
M@P( CD/=JC%I@5*P P2P#%PH /;IC2T5B ;(3@J &#\X #PHA20@RF$8.X%X
M@"&\U6$8@0!P@U&H@P)0EDT,!%'P@ D@!E0@ ($!! %HCCYPQJ8KU(YJ )4Q
M@0&@ S=P Q;@TF%!/P$X@15(@14X@6C)@*^!T5MH.Q[!Q[.X  \(A4#8RP-$
M 'A:@35U*CX(  K($N<I!3_ (5,P!404B!&0BPU@NE,X@/Y!2@!3L4]N;;Q
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MBE@H!/ZH"#I0.PP0A&%W(B#<\V#8'HT$1WA(5>H4B _$%IPJM;//Y5+#*&P
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M01*@. QMP!00XS MH)#>)X8AAE"&!)T@088/%-B'!GJ@FM5W!%5UR@(%#G9
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M0D436Z "O;U-+W=GRUSF87>YDYU)&Y-KW@,C^, %CAT<.A?<\R38-/J-"?Y
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M7(X7XF%K?,L%E (J](I*.$0<G((H/ !Z[$$$W$()N,@%. 4JE1 N7  (E-"
MV<0G'  J2(DI-  $E<9%L$H>@F*NF<0;#&(AVDE$2$!G6<0%>, %VL$(F( I
M^(L;C$ +W 4@9( $-% IQ(@H\$$HC, (Q)WE@$ *C (>Q%(?D, (],TMN$$#
MB( @^&$#B"!7T"(+C(8?? (@%"/$$(,<?$ =] &V#,4*D/[ "HR&'91"'7P
M%3$,'!2CLP14"8R O83B_=$,I#0 BO"!8P#.8I2 4 A"!0R#'* '&3I1!G"B
M(-#CPN#"'9P"1=EC3QS O[1 8=@"';C$'L0=*J2 "'38,#A""8# PMS!!0#C
M"#2B.M(!","!2P##&XP -A($('Q"*)P )=[C3A8+("3 8[65'@[#"HR (A*$
MBLA!C6P$!>B!&RP $DU ".Q!K]Q"(%Q !#20'! ''00 "=#!""# 0,#!5<"!
M!33+HK0  _3!-P$"_#0 " C"*8S  H@@,$P ".Q!"40 4(0  J0 '2"4JTA
M'9Q !(2%29A ("C+13P 5M;! OZ<!3!4P ;8@0DD@&?L@0+0@1TT@%+QI/F1
M0@. 5P6@!RY80!V<0BAD@%PD047@P08  P4@).U<1 :(P%S<P0)L)C7^R0!P
M !RX 0$(!ML8SRF@PB=4  $10@",1@3$@5@L  OLP07,$. D0!QT"7K@ 0*,
M !V40(ADA2Y.R EP105\0!^8P%X.0P@TP'OHY&?"YY= (AVDI@;(A0,^!0N
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MPN>P4R7TWC)AX0*=@7$J7#B1>" <#YL[F"CU<T6%$H!2#/M4>AB=#!OZ"-K
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MQB-& ?Z2[2)&CQ-6&-T@5(*.N*+Q2L$##SOTL!EPHXU'[I9//F,K!! &\F.
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MXM#0/DP@:%I) 08(L@ Y@*V-R_[$9 DTZ0:,].$-ZGM81QTZ =S)!2-X$)M
M<#$ V36(>@C!YT&N)Q\X@$\@J$A +1DT"@34\(91G4TI#D"(M'7  Q>LB/8>
MD (^L*08 _B<"38PC#L,P 2A"$0!JI@!$T!E*:=(006R4P$0E$(0"'@#,0"Q
M #@HE*=P:$ ?<.$'!/ !%4E0@ \%@@<$A (7)OA VAY @E"$S0+#4 D=0N&&
M ZRE R3P7@/<@(I3%"!G%Q E*+HZ##T(@ 6AV,, -D8""IP"%Q=8(A\@0)!2
M)$ 0J4A!;_L@@!%\8A (L(DM&@"'4_!A 4AA00.JT@$^ZN$IJ3@ 'G#!AP8
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MX#!,( @3.$^JJ78+309"A_6-96$;6, !LM(Y5Z; >7606U+ YP$$/Z"] FG
M)\X[D$^@<@'QPT@IY!8!*0XC PC6"F0%0@?P]6&GPXB#"+<LN/&!H)8-$ RS
M@2$(!0R$JBG+-B)-@Q$CC@^AUPG% 0:!D9SQ 0&)V8/86%!6@9B@!,1 P-:
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MQX^YO5NS0;KCPYV93L6FX):'#R*)FIL91 3F=:8C$%S*;)QGOG]B.R2'&%;
M9O3F%!1 @*;<;K2"& V\QS_((.SL=V-:0[ KRL%<@G;ZI5O'T ! @\590R!
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ME%16:>656&:IY99<=NEEER#4\65_%[ 0U06G:&#F30W4U@ <-[EWDP1ZX%(
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MS.U8I"M4'.!W)3!! $(!4Q9Y;X+#Z$ *(+G!SGKWN^ -[Y9&$!++E2DJ6]W
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M*5 , G !8=4!GU *A%$_M$4,('  20<"#0 A!_1P2C(1(;  O8$ ![4=;H,
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MS783?D @'LD'GO0)@^<S^"HE]?X)1:0#'+GSJZ%:@'M0 N8Z)70P B,@ B,
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M %$HA0SP@$_ !3O@%5RH@P< !>&#CUN(@"1 A3Y8@)<CA  P 5$H 4D2A0Z
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M6!K3:8 4,@$%/ @)  S3(P8- (P, (Q/<( H(3&P^S4^2,/!F( \PZ$[" 4
M!#LM"?X87'@ )ID#UL!+IS08<%D;! "GP$!)!3@3%OD3A. R/S-&#E$ @TH
M:\P643 20C@ T[F -V".!+ =D8@#@XF/0"C ,PD%!" &-Y"0%M" @U@!+[F
M++J /+N RED @1B!.\$%_1@&)3P(7$  8+B#71L&93L=/50)45@ 0/DU79.(
M$C@!]HP.0*B0/SA#/GFB!0B8MC&)-L*%TB$$84.X^QL&XKR#/L#$MO@ !"@!
MV,E"5)" CJ@# 7 #4; *[S@56T +C8C% \B^!QBU ;@P.X@ E> 60 @%"E#
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M@5ISU!416'%-F#L(W!P-A0R9CS>8@T1=U$9]W#NHM6%X0)DT,9&@@[S,$#K
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MF%]E*?Z!8780,IG3/4B 6?W;4R@E,YW*TX&# AB,/E  >TS3TPF! NB6!D"
MR?L.\ L!0EL1S"Y/X L0B<B7# "!F"LTZ6B $E@_E>"2O7ZUBF48BW7@&)&
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M@T4G'P J\K7QGE*H@QQ>SQJ3E%.8N,,=B.1KBT&(#D9QBABD@^P3A0WPZ:&
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M!A_*!(@T^:X$%\ 3,8"A 0J$H %>^@ %6) ^/T&O!!ALP @Z,(%3$ ,7%*C
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M<ITBVH,XAT&!/5"K?'O 4@F:APO1#0,"(\ ('(P$ @Y@9! !B%_!,H<1-PS
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M0 '8LJ"9?$B !%G5@ NX(3_#N*6Y^G !$)R"DWY)!3 :L"CBI  $U((8'R8
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M@X4 @B1 ?KB%XSW9P U0V9V &[A"*42 !K  2"G-'8!  VB41IR"W8U '5F
M=CE69O521DR #]I8PVC$.EX$"S@ "=S!\ZFB08H5&5*' WB Y5&=%3XE6WC
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M>!H"5-@(4$ HC *%CL %9.8'%,! 2!J]%4 ?E$(<" ! T8$7AH5_783G)1S
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M"P%#/%E +^X>][$ DQ!+2@E-(&3 [-@3L9B AMC!8@'#"-@(*GA !72D1J0
MQ+  3KT!BM5!!50 "!@-KQ86BMW""6  +GCK,,Q=:(V <<S8+8S?1MA!0_4K
M3(FC1ES>)_"!0P)#"1C4J56 ]&R$"?@*(,2K'IS=,)" XY" /;4 !W0 !VC
M"50),;3 OJ8 <> ""6  "(!""RRHPAX1!5! ',1!E.BH6* ?6NY! -R")%HF
MB+T!0H6""0! _/BJ7Q#8)XS" AVL!&3F" R (-A" - -*)1-8.@! 8" 6YQ"
M KA!6?X>P'G401H^@&G&@2SZY.D<%!V@PAXL0 ;DPK-A!%%-"QT@P!ZH"&H*
M B)1*ITVKE@  @$(ZR>0JU5"QY8X28ZX!U< 0S%8SP1JKH!\1>6&+DR,+D;8
M@<)5F>0Y+EJ4 *<6C >( BX4$D;(P?>\P014P*HBBAL<GQGMJPD0BL!FP =\
M AR\E"AHP 4 H$8 (I/L:;Q"2" ,:@J0BUOX 48U[P@(3:1T'=@L"Z9-#FN-
M0 8  Z]RC]3R".NN+U@LZQ#97YN$"NF2"/UBKIDT"(-\2H7T!2I%@#)F[HB,
M;LC<K_Z.A.F*RG?0;WIX@ 1D  20W_RFA.E&!NG2BOV.RO[Z"C#[;G#C'C '
MRP0QH(('?S!,V,(H.!@)KP4%RV\$>P>H$#  GX2;1/ (I[ -P_ -Y[ .[S /
M][ /_S 0![$0#S$1%[$1'S$2)[%(E(()K, *I, 31[$4.W$*5'$40S$67[$6
M9S$77W$6;[$48W$7C_$36S$9<[$94_$7EW$8I[$7@_$;=W$<:_$<?[$8P_$=
MRW$>T_$>I_$=\S$>L[$>"S(@^W$8$[(=(_(A&S(4U_$BD_$<3_$?BW$6G\#-
M*3$F9[)PA% Q  ,PW,(GAS(HWP(HYT(GC[(HIS(JK[(JMS(KC_+&H;(INS(M
MO[(KH[(HEW(NL/(LEW(H[S(P]/YR*O_R*0?S+Y=R,>,R,O_R,0=S,H<R,3-S
M*2\S*W-N,73R-7]R,0OS-#MS*T>S+W<S-T,S-1NS.#\S*(.S.0=S.2NS-X<S
M.[_S,.>R)\MR-8.R)N>S/N\S/_>S/_\S0 <)!7OP"%OE"@<T0H=N#2<T0S<T
M_CHT1$>T1$_TG#(Q!5C "N2)(/"12=C!F9E$(/0B2.B*\K9K#%_%0E.TCV0F
M*(#")\BN2L>T3+N%(!2 !^!!J+EB' S=2(  B#6)@+C!W8)$!^Q?()@.Q,&%
M3#NNK\E(!@S LBVU5#LT,"2 0YXGB,T!H/#E1I2"Q^7%,A$#AOG%SZ PA_@,
M1\!!/_Y]!"H<  J/P$\/ ],Z&*4 !G%0BB=CQ"DH(W\9!S:E]%0C1ZED /P&
MMF'SLUOH00*DQKO)"06D#.OUEP4P#ZZB;FB6@LW05:I$@"*B2=+58@7R-$>T
M5CEE1)ZH-8--2 GXVPH\%QYT #%4 $X)XB@ @P=<= 8(#2HXW@( %"S=T90>
M=NP<%;H(MW'KLUN<0!D^[  D2RB,5HL,7 ?4T1T$0 J(@L:ZD" @Y2GDXS#D
M:4D6]S#$U$CD 0(T %.B2R@D 'N40FXYYD]!P(=H (*8 ,;M@>8%[C"T@(.>
MP@%DP"!8TP$D51]8 & ?]UM,CWDB.(-C\EEUQ.7EI.<0ROZ[/;9LI2$)I.,'
MA  NL),'@!CO"$)22<=.DP0NQ"H$#(!_Y'4I--K4K%8IO!C;-,"TH$)=:H <
M?-<GG,(IB%8?@M<P5-G9'7B#IT5B]V21)SD15V":^,4G)(&<4-T<^L$%T'=]
M1;E?E-8=4?:5GP((/$ "B "E[/1=C(?6:,0*\*<)5$"2/D"?\)*ZENPG]%,&
MY'B:X=OR+$\&(--J.;D&.( "0+"2^XB<?>Z@'_H-HT( Q. P<(#KT(&4 \(M
MT*A;/#&6NP4)N-!"\H8G(TXI-$!$5>!:"TCP]$4I#  PL$"FG*?0R,%%"0(J
M]!D.6N,&V$%\F (":,HM$,,I*/Z T4P-A]0T-2%Z<MCX_Q([LN<P"ZAX.[E!
M *R*'&R=(9:IC8P" HA(A*/?2PW" :R*+42 'YS" #B"WT0U'## )P@"(0C"
MM(""JZ5' FROU C1,(S I^T= 538*3R !11#A-!XKF" EBED( [#'4@ KR,
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M@@(2\$-.WO  #YCF XD: 8R>"/X[3R&@4'!042@:$$'6":]NG%G L89C&CA
MH .;N<4%(L V5!#.%M7+"?8"Q+AA?&)>.3D%'F(%HP"=0(!V:( 0\;>9#RS1
MC@7H(B 1F<CT9"  %_H$ *A6,!AU(& = ,$P,-"B#E1@#V_0  ($T:3^H*(
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M QXHPOX0-(@!P^6=<YV3"<?TKD$L=!()7R."$A/7M2^&( ,J"$/<5,C)&'J
MA5>$.1&97L+#(S[M2 3C"DY&1#!\/@LQP" *.:G$#6B@BTZ,.QB7"',7!#YQ
M2X]!!D, .B8LD8F=[YWO(&(UT'&,B"=+0@PO^,&HNV#X3(2YV(8>QM1EP/!@
M)!WB97B!#@ M;1M8^A!05L429, #)0PAZ2Z0A":>K/=@ .$%9!B&(5Y@ Z!3
M @8O>('+\]UWW>]^/CA^<PW4G),HQ!H67##\G27^@TK8.M\X#L:D&9\3T$.<
M##+0@:73<'LU'V+BJDCZ#Z*@!(]70>5/OL0P=,'Z,0R#^_X["#XFLB!N&<!
M#+RW__W9\^8=4 (6FJ!SW8=!VFX Z(9A"F3@"7I!!V0@V88A#8I "E0AS,I@
MXW: !B!.XG@ ^T#-R#ZMU;+@!:1 )_PL&"K!_(;A%]2/_:!,S18!$71M%@SN
M!_!O!FG0,K3@XJ+LR63@!@*.%FQ !I3@$;K UR0AW29N#-"@!ER "X(!S*3
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M9P1$A_X.Z(!CW."0GB(G<^(.V(8H^B %!"4G;L&3*  $"J4DK9(G^D  *,?
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M<V]E1RAFGX16 NJ #E(@9F/4-/K #=Y@ 1CV-&/W'OG@=74J<!.@ S1  S8
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M@%& 8?X!JC8G @$ 6H2'B]D>=PH0! !.-V,%"H 8],!Y978 4B 4;"%FYZ
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M6SE$ NQ3#U @!)*752HH#BAZ,R+@8W@C C0@AN&@ R+@23X  DZ@! "BQ @
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MB <!8XQ%],,$:1E 5YE0DZ3D),L<>$A@P+%_+A)0+-$GB#->D@]$U!_42G&
M$Z:@7_X1D4 <_(  #5' / HY@!&S&9%MNNH LAP&"RIP@C$5H%:OJ4 #+H"
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M@9R/>,!!FA6 !VY!C M@8"R!. #@-D ;.@@ #N,IP8+<4#U@)& ]%YBQ=0X
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M#8!2">$!YI$!"E@7_H$>>64F8X%FRK&"$@%.$K :(. !6U4 4 9E8_(_+;<
MLE)$TS4,>0!.&#1[DF0?"1$*$G  ^:1&JA01$) $ Y,3)>"#FN5ZJ%  >P0?
M/M@ \.4!\!-.%@(,;K !=88 #P("YB$@M9<:%G("U6$*"5!8>H%X&N@B!S (
MQ"!I+?$2#P6)&3  JU$<*>%HPS (S#9]U<$"!R!Z%H !4V5.[Y<!@; "+7""
M&O4^$6$!\E0OQ)AQ!'0 F2$@)V >2I(!)B!M2!1I?$ ,!8 12L('%E.&V49P
M41(!D/YH 0' !VVA -JE6> T'BQP$'&@A9PV  TQ 'ND 'C5  \)B<DV# >
M5P*RAF-A!PJ@0QJ9*0D0@VB1$"*P)QL@$O52!^0(B=ME.#]H-!+B!R1@!S)5
M"@MP0J:  *5  ;8@"!GP">!H'4WYE%$YE;Q"A7NV@0AB>N)&#!.(+!3P!J,
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M'; N=^ GQ! ">#5^=3 F'P X@G !%= !H= 'UT4'/;55/QH( O")/J$'%/
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M8>X@ 94+<+&%O0UP(2F[84P"1 .[4 $!PU(B,&&$"01QR/Z68>!PPY9/<-E
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MHPY8S$^7B'&+%12F)[=H@1A%>(*$F$ 0DNO)&T @AP%B;01G,@$A[M"00(3
M ]F#PP?F((<[%,06&)"#[#[1EZU(!!AW(X%"[JB'ANR!+(>C9"4M>4E,9E*3
MF]Q1:?Y2H0 [$,-=(%#))[HR#$>9HA2!(<8%V/6 B(3"!,@AP1LJ P<)Y"(.
M$2#&'ABF!V7UIQ02*)4&SC*'6S1-DFW9 ZIN@0J>N,$-]SJ+'&Y1AQ, PP[$
MO$D#;L)+.+! *L (V"B0M99;_,9%9QD&'FQ8G6&$X 2WZ%^G-N"*02  %*BJ
MC!LT8 M4*&X#?%AD=E8E"K*<8EL*20%95M "CW'E G4*!3 JX"T\D"40)/B$
MJ *A 3!J)P)4ND4#@%&,D=K!!(L+&!]:A K<;$!0'0C%;! 8MVT1PYH:^ 0Y
M2R8(=PFB4QHX%BD4@K)2H"(/%S#5E$;0!Q" )6UK[(@&"/X!C S8\B8,$T2O
MHB@*6YWB#K8 :<:(T8<0 ",%?H!#0W+&*D# 8:+B!$8$#(9 8@ # O]#A0CP
M$@)!U"$%$7I#L6Q!!ZGL,9Z"D(,>!($;-UPE8;;"11TLRB9 ? 05@B6&'4;"
M4[2MI13 T$ HZ&!+/%SE$U+A9&M=^UK8QE:V@?-('<1C"[5F+"$I(!I:.!""
M#YC 8,#\R4*2.H(6W*%R6+G*('2&BX:"Q!9P ,$(,NL14(0@!/F)0[Y:,((1
MY$L/(P@!1.B&BE!H-S]J'<%^>D*'";) $#C)ET?<P )7V#*DH0#!=J4"!XMI
MKP2Y0& '0+"'AFQ,(,1 17^J!/X"$'2@-\ !00NDX@9<$",P'U")1TY1@A78
M@06HL"4"VU*B%!QH&(. VAN(L0+EG0"FU:W+1TQ0!Q8  A<<<$3&K@('[5HL
M"09[@Z%"4 (6](8/VFT(*#S04!O-17DI(,4;3N$&=NH%PG,<1BE*X)*VN$1E
MGXB3<QJ:6>TD 2NTX0-B%AB"S+*L0MKIP"?Z\ D^0 00H30M()#UJQ$X[R/5
MC0R&X2"H.:QV!2,H <;J$ (0H-DG@I(#*?X0B&22H 3L[)<(0! (8J2 &+8@
M00@8E4%&G\6=N.C/(4,0F3V41Q!W( 8)L#9;7.=:U[OF=:^'Q%H>W5I[P"X5
MCH1-[/Z>"%O8"D'VCY:MHV8'Z=G%QE&T@03LQ=W(VM36T;*Q76TB31O</R+V
MMA6""A(00G_)-G:/C@VD8HS[1LKFD;E]?6]\YUO?^W:2O?OF[]8"?' "YS68
MM+W)4L AB]#F=\,=_G"(1USB$Z=XQ2U^<8QG7.,;YWC'/?YQ(V4;Y",G><E-
M/O >$;S?)V=YRUW^<IC'O+6V.&5/3B%NF>=<YSOG><]]#EL6U\%@7?9 A,$"
M#,3LZ!00L;9H<,[LK>A!T#@JQ4CZT!43//WG6^=ZU[W^]=8N:P5#]X ?M".7
MLF68&+CH2BBRMR6#14<8I3*EFL[$E=6RNQ2F*-6(<.$*X?Y@B$HT'VV-B''W
MZ$CE%- ">^,=_WC(1_Y'H*AL]MS0 ;4II X-P -KMO8&U&%$ H$X9!Q$A(L.
MK  $>>K5)U+/ ;ZW,P-NV$ >[/(!.T 202EXC%=:\ D6B.(!)Y@(,41!@CC8
M>HU]O,4MM"YYZ$=?^M,'^2?N,*N>Z$$$%2 +B=!BKX3A A062!A9-*"V$NQN
M4Y%*DP>*$H@ 7T8[ ZI ON!@AT\ RYCYDU.D1#@,N?" JP,*/?" 4Q %M0HP
MZEM !FQ !XPXUB(&-",&#" 79/F$JP"&15F>80@$LJ@ .# D%# [6\B3N-F
M"!P&.2"5"QD!*ID#/= #K3H!X/Y3B1[J$D%1E@P(P95II_["F <,0B$<0B*<
MK7N!@Q$)#XMRF4@I!5A"!0G0D[<8@?+0@U#X! WP0"S! (S @U"KBSK8 &#X
M!#%<E86H U38EE2H@).PF$^PE0XXD ZQ"%0*!3NP&!"P U<I0C[L0S_\0[_!
M!1,  0^(DQ6( U2 ET7)FY[R #YXDQ$@/@^I@_'*DK6;F,$RBA*AJ0RBDC9K
M)_*"B"+KLOR *EP(#4%DM%LH!1 @@6QB <8#1%F<15JLQ:TPMVC#&B2RG2)B
MM\J( \2J-R&A-ULL1F,\1F3D$4&  TG3D5*8G&2,1FF<1FJL1FN\1FS,QI73
M1F[L1OYO_$9P#$=Q'$=R+$=S/$=T3$=U7$=V;$=W?$=XC,=UG#MYK$=[O$=\
MS$=]G+Y54 4<F85,R!%?N 1Z!,18R(1,B(5K% 9?F 6'](5B% :'G$B*K$B+
MO$B*=$!A@ 55T(4=\06.[(59G 09D %8V IA& (7T(0;\04B@ $N^$-A*(0F
M@ (LJ((H8()#,,:"' :)A(58T 5?\(5>F(58B 61G,5(N($AZ($>X(&GC$JH
ME$JHK$JI?$H>\($>  *(I+Y8V (A& (E$ (F4(0;484J& *U' (FH 0_G#LM
M*$E$\$F%\ 4=D %)N!%->($:^(&>',)8(((N>(6M6(4N(/X"64#&68"%KL21
MG_Q+/DR$+!C*)?&%6  "CYP^1< !-8@%86!(2B "*OC,86 #'"B$69B[7IB$
M(=@"R!1"+BC)1[B1+) !B.S))WB!O'S-!HP%'G#+')D$()@%6A0&5<"$-3"$
MS.218( %XOQ#1/""85@%,B"#,1B#+KA.[<Q.,+C.[+S.[NS.,)A+7?"!7Y@^
M2; !A<01*I""85"$&WA.E+3)/NP%):@!&3"#K@R&2A@"&<B"]50(55 "&>""
MQMR*YH3(8'B%I-P*73A)A>#-&XD%^;P184!*N@P2"2T2D-Q0)!$&)0!.QQR&
M26""'KG0HUS.&^F%59C."NT)#_Z%T1WA36%XA6"(4 L]40M5A1L]G&"X AB
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M&@ "'3!P88A;_[3;OB&"%\Z1'O[8XQPQ\2'YV3& A"APSREP;S+8;R X@TF
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M@C*HM]P*%=Q ]"S!4+B)G*H?6/A"#ZC4H$W"#>1AAU*>CR4(0DJ0#%Q",+R
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&-F0'!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>x_cg002.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_cg002.gif
M1TE&.#EA%P-, _<   0! 0D%!@X*"PL'"!$-#A,/$!81$QD5%AL7&!T9&B$=
M'B,?("4B(RDE)BLG*"XJ*S$M+C,O,#4Q,CDU-CLW.#TZ.T$]/D(_0$5"0TE%
M1DI'2$U*2U%-3E)/4%524UE65EI76%U:6V%>7F)?8&5B8VAF9FIG:&UJ:W!N
M;W)O<'1Q<GAV=WIW>'UZ>X!^?P!.HP!4I@!<J@!7J %CK@MDK@)GL -JL@ML
MLPIGL!-MLQELLPUQM09PM11SMAMSMAMWN!UYN1=VN!%DKB)WN"1[NRI]NR)T
MMS)^O")MLP!&GT9_O(%_@"R!OB: O3*#OCF$OT6#OC2&P#J&P#J)PC:(P2^%
MP$2-Q$F,PT61QDN2QDV5R$^8R5*6R%29REN<S%23QU&-PV*>S6F?S5Z@SF.B
MSFJCSV:DT&NFT6ZITG2KTWJNU7&FT7VQUG^SV(2"@HB&AXR*BXF'B)".CY&/
MD)23DYB6EYF7F)R;FZ">GZ&?H*2CHZBFIZRKJZFGJ+"OK[&OL+2SL[BWM[FW
MN+R[N\"_OX&RUX2UV8RZVXFWV9.^W9B\W("OU:&_W<"_P);!WIG WIW$X)?#
MX*+&X:7)XZO-Y:C'XK'/YKC.Y;/1Y[;3Z+O5Z;[8Z[G1YZ_0YJ#"W\3#P\C'
MQ\S+R\C'R-#/S]#/T-33T]C7U]S;V]C7V.#?W\/:[,K>[L+6ZN#?X,S@[\[B
M\-3E\=GG\MSJ]-?H\]'A[^3CY.CGY^SL[.CGZ/#O[^+M]NGO]^;P]^?Q^.SS
M^>GP]_3T]/'V^_7Y_/____CW]_#O\
M
M
M
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M@02P:7($>%,+/   &FWJ;8^Z0P(*$$("@(H$<^$# %P(!P>$YP "V "%^("
M B3@ /X!(-R:!#6I"6"G6&0B!BK<  <W)$\/40*5"P\ -X%<8  !.-X 8"4
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M7P*0@_ZN3LOF-A=$ VN:$([\(Z(H:S4SFBK .R,0(2(>.$+X7$"4'#4G!A3
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MR/B!($( ?"!!-F1U A$":.0 MV !$<*)N8 '?( 'VS07&Q!A%- (P*!M?64
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M4*4 >I!D#: !AO$)'A!%4"4!CT,0OF4K=\4 '_ Y'R!H&% 72., <J9EM<(
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MP+XA"LR())61"['!!X,0? DL"K+!/Q?,P3.,P#6LO1\\$-B[< G,P0J\%ZG
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M6$/BC[(?=")?N+A"D3*;0]^E^,&GOW[[[\<_?_WWY[]___\'(/8".$ "%M"
M!T1@ OX5N$ &-M"!#X1@!"4X00I6T((7Q& &-;A!#G;0@Q\$80A%.$(2EM"$
M)T1A"E6X0A:VT(4OA&$,QT:,B=#02C9,"0YAHD,O\3"'%-$A#7VXO2%^KX@]
M%-<197@V8"SQAL,X12A&,H@F7H2'2G1B%K7(+6"H0 )?;$$5E_,&%&"D%AJ0
M(DE,40J)@.(#8G3)&E_"AQ.HY 1W&$8=2""14)R"),"0@!^&T8(-:,"0&K!
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M9G5X"OXQ(I>&7P%PBZL[#%$PX+"W]>UG01Q9%6R@AL1 P0:0"XQ4]!2.Q)@
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MBY.X!.@]"\B 6D"%$A  *?LZR[(K#02!"E@QV0,%?1( #NB#WI*(.SB ZM(
M"KB#.J@#.( M02  IIH(/#B R))"5"P%0@ IB0 $R,HWBGB#-8S$6B &!X
M0K@%."  V'J# P"%6ZB# S"RB;B%!- #8B#$.4@P:02&3TB ?".!10,D$Y P
M$5 K0 (!PS*!!%"NF_(C#P"G.P  %K#$!["[4#" .KB%4/[  '@\JCHX.&(
M!02 +4R\ STD #RB P,8A%NX@P2H)XJ8.T&X!3L0 "E"@3"\!3\@ $'2@P!
M@5IXIPP(A51@@%<2@7;2 P! @5,XA0D )SP0@%$@AE%  #$$A'%DKP(810I@
M@&#4@P&0HA/P2)LTJ@A[@S $!D 0 !/P0PK@ ,M2@!0\I[.RI$ X $  AE"8
MP00S & 0A /P(X=[0V(8! /PRE!8 )"S0TBJA4$8 !*H0@S 0@$HKUR8@$SZ
MA 68L&$ A #X!&Y,@ ?TM @KQ*IC@%"P!3@P@)EJ ?G#!7I"+SE @&G\A'Z4
MN *8@#OXJ'!3 3^B@\/,A4\X /[L>@,!\(!3I(@Y4(!0(,L#L#A5^RP'6 %@
MN 4/,+);<( 24*X08+A:H( 3\",-V"-^',%3H !P"@4!^ !3J 4/D+\+JH4#
M4( !&,:,* 4WR  %(  5:"(0T$J8&P8)^*2RHBL6J,AA,(4#>,I:G(@5V*KS
MQ"X3,+(/4#K@LBP. P:(E A3@*=1,(#E<H!(FJ\2 "?!K*I4I"LWV++^-*W/
M2@!!F B*DX@1^  +B+-),C)@4(#M+,=A< $CE A!@">)T .Z.@5;M 4'V#4X
M("L<"H5G.L@5.TR)& 0&& 9^7"X%&"X7V+(*6((>-8 )_0!P@@,$>+)AB,,J
MV@ &L/Z "M"]!PR$I3JJ=_(C40BXB^.(40BM#6,C!HBY8I#&80A+B1 !;5-,
M.'BF6R &C0NY>AI1/>#1B4B 4NC)&FH!#=R ,EJG19.\B1#284@!W=)1X+ND
MT$(%!; X$;C&8<" 5W* UY.($W@IBH" 42(&!8 K WA 7ELH/3!18DB 33L!
M(R.!JNP#J9((.. G4S"M5 C184 %A(0B#CM/G5( /B"&KIR(#BBGB5A1=X)/
MB:@#NBI4%4. "F.W5%RP$/B "D!0M%I0# @H%7V 06( &P*$!DTPNKJ%4?PL
M[1J&OUPI5'!1!H@S";#46V  4##54-L (VL!DRNRSUH M?ZC0+KZ! $@UXJH
M@$P"!@;( TNJ QY=TLJ2P5!#@>C+NV&P [HZK5RTTRN3*$D]* Z0IB2=B%-X
M1@'MK<X:, BR!0@@ %#U"&"H P  N0_P0O.44]4J2V(( 0?@@'K-@(,#!(:S
MI%"HJD:-K!-H)U.@ '@+ ::ZSAI%@%#EQUOHV;BR@%V;+\T"Q@6H(CG8UIO-
MV7HE@$"PI W3@'KE  >H2& H@'JR(?SLT03(@'KM@*:3/K6-Q&<B,6#,00_0
MQK**T(FH ][4  4P+ 3P18E; )#J5DO* %1:@BVC %0BL?FZ/GU:*,*" Q,=
MAH&3KF<\*E4<ID_HTB 3W03+P?X-R%,T5;NE!88#>,!BBE :TH,%8( )< -B
M@%<,(%N]0RL0D#X%Z%H.(  ^> .ZI8@-^"006+0ZV%8:6@&U\H ]:J)2<(!A
MPB$]R$$.R-$06#0:,JYA0 "P;:([B("*@ #L2JZF#04$H-ZU\ZP5G:UQE*15
M'0;Y7=$J@E!WNMX$ %N@9:,3'+<(D#(*!82.PB75.@&BZ]P26SN?';]UPMEZ
MW0 "L-#9:C\(K@#!_2P!:*>)D%] HLIZK8 $,+NMXBS E @ZV-8>754/8( 4
M.%<3I@A R-M3/<]1NH78K 4#B$&BVJI[K::M0H4#8"H: H6J @5X]"$*N+8@
MKB4C!?X&]ZJ(1GW;#=@Y?K(#?CJ!!>!-KQ6$%:A*'L( %BB^.A(](=*T6VT%
M=\)<"PH%%-A.L$HPWGVQXG.W^AJ&SQR&#Q2R/0T!#PB%3P"%4J Q;X(C"  $
M.KC&5)V(4M ##  ^7"A#,W5:>!(%<!T&!^!7B9 QP514@:(K2/UC4!@%*IN_
M ^ #4 !D/PPE#)  3O)06S5E5 8%/QPDM:(A01!(B7W0 Z@#*;( /)+1BM@
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MV D$T*\40 !+'BA FG *@CI\0 )Z,8$#,N  /@"# A@XE@/&P@<&>* $)A
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MX #180 .AT$'BXS DK:1P%<4$"4#C(+)=AF&"2@@B"!7,12@.$"!M3.!![@
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M' '7L1VCQ:) P (T  ?T(C%P0&8UGP14F'F^02"KT2!/$T[D0@E(@ 1@@+L
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M*=QUT0##'/AU39_C!JQ "3#  T '4H>-$<4C/+K<OO0A\-AC/NH.SGZ."H#
MOIY6#('B98M-!D#%";B7YPQ#"K!O[0"UFI2%;'&5:/_.\D!-"^Q8:M>!R!Y.
M/X*.E?AR)Z)-9* 4Y^Q09LNCS!F?/%+TYVB.AYQ :](!GV+V<5,T(!'?N. !
MAA$#0EYN:"_/;%]2//*!60U#'VQN%(6W/^H.=Z]7 1?T2]9!3%K)3)ZSBJ&
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MG#'IG=V!EC0E6MCR!$R^17R" &# '5B3F45 'PL" Y#'&PR ".A!'1@$]TE
MM0AZQ>Y8"[5 *.!!JMY!J(.% 22I&Q" 5Q^ "PA"',S],,C! (2 'JS]?-0!
M Z" ?GB  F" =_QKDJY_OSPX0)A"0.?3"@&FAB542&R8B@2 0'G8,(P4@0IU
M^$3 D/Y0@P0^=2PDZ*,P(0D'? !1V A, @=!?1B@&$8, @,W?!Q0(,'' P-B
MI@Q(< '(@X):#2?>,4#L%H(3H?@\'*8G@ <]>@ZH& 9L0@9 ?13(+)6@Q2 X
M!T#-9-C" <,Z /AL/< 'V !0ID0XJ(.J%@,+=/A4F,!PYC X!OB$(F&!(1\#
M<02A,%"JH0(]@3), -:0@1Y!'B+<&L;@3<):!3X-JT"6SPD"J$R9I(-*D(!;
MMPY(@/,'PX/-)RSW^3#@3N&M#D"  L2@>(L!.^D(*,X5 R X%!*D)KF=>W?O
MW\&'%S^>?'GSY]&G5__]E@,"!E(37C@LD %4W#U8&!9"1/Y"#*6E\J\TAXX:
MY@T'%**KE ,V2TB!4$XQH,%A%$AM CB&T4DA!>)B@ Z%+#AA/H),2^"64P@(
M!<12HB(L%,;T2$"ATT1I2L5A '% F%P2*&X85 Q "(4.$FKA@F$&*8"R8>Y@
M8)@^$B!,E" 38BB. PK\1(!::B% NV$DT*H#F5RH8!@3]$M(#P^&<8."8?A8
M8,8$@.D# 87\*) DAI;8:!@6-@(EQ83 &N:6%A12@0/#%&BP! UP/$"T86JA
M()<Z)!@F% P3H@##.R+8C@*9$F)AA0Q);1/!.A!H$ 4_%Q"D) 8FO< $A>!H
MX$D$ 2F@04!.\2Z.)4.1$4A $OX:Q  D#9@4E 'B(NR3 @J\A8):Z$ PH5((
MH$P"4M^0<9@(4<&E #D4>@!1%2;2 T%4W%!H ZWT,*# -R 8A@XG$_ID(P]$
M3,B-B11")0&$1/! )D$8 ,86!0:92MM:#- CH5'L)8G$<1' A1@'/DQ(A#NZ
M)*5*#$)II=MTXXT 74,92.N"$!1B#D=^ 6D4& 3J2 @5 K@D0)2$@%$ #Y)J
M0;0DFMWP*:$0V+Q#@00'^'*]J['.6NNMN>ZZO%022&  9+W[A "3M\M@(CZF
MKB6!6DPY( 465&!KHQ(FV@R5!QCX0 [1Z"!KA15<( "C UI0@? "XI6@--W4
MXA"8 _Y2VPP%$K@KY8T3+F@4#VU)^J _^?8;G:$*W)A\Z)L-S8ZA!2G#NU3]
M E% -&*:'*:%C8AAR@&TB\Q K:('68XAAMR88!B =7\3@@])3WX8%!QP87 5
M @#DE@D4\."-2;=C:(4T6=#OD[<9TJ/AA/AH@00%,']#>89.@+1^M7#-=*L[
M5@C!@)[OH#^&-.43O5/(+1+0" .6HEEWR-=F5""\6S @+LO#'%,2$+'-,- 6
M?T 0,#!P  ZX04_="84;3D"!=QT (<,0Q ':]"8#.L!BA7&3<1*2 :T @R'/
M&X9>9N*"-*&"A;5@X5:FMQ%%#>-SF\%="T1P@'BY2RUOR/[4!D0TH8]Y('$M
M\ "#2"*!.X"0$&]2 9M.D9UAV,$!/*P% E1$C% <(%@DT=P),- H(-U'/G4
MG4+\B+\5; 1RE%) 6B@0+X8XX [$4)]H D$G!!)B)G&K!2%L5Q@,](QT>G!?
M D0$*"2&X /[81,/;U$A''J-E:UTY2MAN1X\4* %I-O.+0PPG<),KC1%"\4=
MW@0**<*!F'>0E0D6M1 ]H. !"*A%'10@!V+"X0ZF@*8TB:D'%3D.3*69R0+\
M0 S*(;$$F"/)"1*0 CT,HF%UR!<./7!!DGA@!,;!@ MPL[I . F!LAK&@A!B
M H*UP$R",%%"<G?# 2J ,H1IP?Y$CL> 0/B!7PRQXO)D0M!A/("3))&>"22
M33CHH85\4($$X+/*A QRI>;#$J&F=@H'8, -@SBC@?1W)DC);CMPR!<@$@ "
M.80B Y\2(*74*!^WQ>>?]KK# Q3RJJU0,"&B2TA3*,D0H-3"@PH!Q HH0 !D
MD:YW(6B "E#2%E0@8$F!@.$2TI00"%C,H?HA'09.19@(8 AD"7'!FWY4Q 3<
M9S/C0\I4G!0*!7  #J#X +W6UZ9,:4 F\@&& T@P38PTB"$J$,$@%C6!4E3
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MX $P8$UN; 0TL@.0Y19.X $:H10PX/MZ$1:!T33B  Z X2^,0S$G@*9"(0(
M00\@3'=8("% 084JX XZ !KCL#=]\S>SYA8X*SR8@CAKP9;2C3N2DSQ.P- <
MH#20LSN6DR2$4SDG1,2Z9OP21%)ZJT^V@KVJ!#R]HSJ]8SH5PA8FA X0Q9;*
MHQ3+P_X\2>(ZPT,\#45KZ'-&)D0/ F8[<J$\;H$]XU,\R7,\#.8^2J@\ 70\
MY=-0$K25%O2JE%,\X1.)N 880(_"(H9T>*@\; $X/?1#070\&I0XT2M]ND<$
M(  #[E.E>HM$6;1K@('LQ.X -+*S=*N5"&,#N:,.^K-$OV-$K8P[@!0\AG0[
M2.9JBO1%RP,5!H WO29)82E!@71$H50\6D !0$ $%"#5O*-*0_1+P31,S\M+
MD48/ZL"?UJ-!R50]/J$.[F#12,(4"J@]Y\. R$I)6U1,]?1#@4%[]O1/R:,4
M[J .5@=0#?50$?4WUS1,%S66&C51(352)752*;52@9,82O[A01TU%#151+6&
M4\L+&$2A4Z6T% [T.]Q@)$(!%%B5557D%E:557=L>B*&NI"+NCK54G5U5WGU
M47GU5RTU% "@$8R#= "A!'040#=060\( 8C5EJ1T3PI#/N! D>9#6A.B&!)@
MZH*4(>0@T'*410W(RIJM3H6T2@@# L 57:U,%$SDC12  1R  1C@ 8@A$ 9@
M7AD  2: OMQE,S;C[Q@B8$/!5X'U8!$V815V816U%)CUSEBI/9@J:QAB!)*)
M1(&A 3(4/$@@'M?#;=+"2RD .L-#[E8+#](M97'$ $8AW5#A ^PC(8 H$$"@
M K@(24 @%(F+87FV9WWV9X$V5/[Y0#3X !4^(07>X"@^X0,@  ZZKVX6#17X
M '< P9$4$ 7&R!-50 7N<@&L)B$"07$*E1CR  62%A:'%@Y4X \2P@\LX +^
M)A0$ 1C@X$;"M@56)^AJM6#<H 4::1C\  ,LP/K4I&YN)!7ZX!;H *U>[P1(
M1HT8;6O)!ACTX!9$00X88A3=X!8L0.5 H056H"A-X^$HQ0!&8CMHKX[:C,WP
M2$T.P ,V5 \0X ,V-&AM]W9Q-W=UUV>:E+\D( 0Z$P* @0]4* 0BQB10*(.8
M) $^8 &2U@ P0 1.  '8K 5((UR*([B^]@068 5.X ".YA8P@ )<  14"?8Z
M "<% /Y=?$H"1N 65, !-J !+ 8%&* %?NY#)FAO?5+HW$ "*  3'W'HB"$'
MU5:-FI #2* $!,";M!0%/" #Q,M $L -WH !$,QM1@\ "X $*NXY)8T%7" !
MJJPP'..UC(BN+&T%;6A]L$(T2& 45.!&2B 45L!)=S>'=7B'>?A0#49%*""9
M< E9]."=V":_\N4/!$#EC$CE!*$ _C,R[T!Y)FAB::] \$!.Z$XAV )'!,"?
M6D!_3$ @VT0 _.#<#*".!N$U1B-#&:+WIBU83L#%3J$"&F0$,*<VR&;SKMBO
M!$!%,L"?^ "JVD-%2_=T!V$ ,(3X? 8%2.<-&H52Y!4"(/X@)T3CTFYK\HYB
MC1'"B0C#B7*UAT5YE$FYE,F+V>"(OT*F:.(BMS;#U00!)?!@ &H!J C#M&YD
MCJI%$(!)@KS6.+X+?XX"B#:#8DXAQHZ'#D*%XN:R(>QJ&,0.?R!G ?C7[C:
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M-F8;;" ; R'(D8$%)G&.4'D;3&!J* J(X 8$IP]#AP(ML&" 56\P<) ''*'
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M*F"!J/Q++9U\&"!N.P@%O($8!G )/2,9"@1@QU@).04"+%2+XT*18B:1[$%
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M B$@L0+FT J%41)$!T 473\-ZE"+VE;$&+(C=^4H CA@U0Y0P'/\:*(<0V!
M)AG$ 22)SHAD0 4F^MTP*  'D!6)#VJ^XX<.G!Q(680"\NH(5+JYL^0JS@\.
M^(D#.* @$ *" 3 ]Q0'B0X<$A. #(/A "&22@.'04Y 5@ ,Q%,#9@QA[&,:-
M3XZ//*#58N $\L4,!C"WU%L8 /Z>(51 8O@ @7W3H0&8<4!B$(**$U   1/
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M 1-0FR<A:$A5&-5V1TS287:!!QO@ :!  7F B*AS !4P 2?P $5R!PC +">
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MWA@1KK68$*A  ,8[$"=8"P#0+P90# WD!A)0:00E+?.CER30 C0:$7C@/RT
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MH",-0/J J-*&<8"//J@#*15@4*J*I0/T2)&M!TV$L*V);%J"(&(B0$&0Z%A
M8!@Z"# !C]J*4B&"@23P@ \H^?Z03 _:%*(C@=( ,< M!+OT\DLPPQ1S3#++
M-/-,---4<TTVV^SR! ,T.!#!4P@(3R$'5% L 50 H>Z3 SX 8= 0XE#KO@1)
MF,  #("9(X$0!!U4D#H@_4#0$/A(RB:D"%+ IP.B*NT$HM(R"JD).N5)-[RB
M @$"$"X-882L-AO(@A;N:Z"I%AS8P 45*(C( ;0$&A&]@3P0@2T-4!@F ?Y2
M,^F$$(=IH2R!0M@.) YZ:\ /MH ) 0(/XE 6LB0ID\J[@FXAEJT'7"MJ0Y"
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M%\W&ELB5*#,&* R_'% ZT852E/ZC)&4I35G*4HQ$=[6XPP!8 !(]3, "K/L
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M!E3@ A*+((WQ)88)&( !!XB@(,0@P9D=X($219;*%+   G RC!&Q)<AHAK-
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M@0,I\0 &R  XD @^:('3^KJ"J /WN045X$W7N(42X)([V)=;D,O4V@ )^Q)
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M@ P) 8Z0 /AA&Q6H.PB8"SXP,GVC V$!!@CH@$_P V23+F*8 $^-I@,@!A'
M $&X'*2R1ST0@#L !12 @-+@@ -( 3U0 0&("CZ8ICX( 0@KB@+"@_9L%&+
M@! Y"+W@ PG@ #P !NM8 D%8 06P#^3$@,IL)1# @SH@ )S8)Q4 A3M &1*@
M4,M(@#C<@+'I&P=8@C[P@"<3$.$83&]#K 1P#0=P !<@' ,Z!6MS@T\H!B<)
MA#M(  BQ#@K8@.6,  9P@3[X (S"  HH/ C8D5I8@")UK0[5#1,(50G($!'(
MC3OH /ZR>A9Y\2:3J "<&) X!(&&"(7"I8.Q(X!/K1Y R("!'(8)8-4^$($M
M&08,\(!!F-C<1)0K*8U]J@]30 72B2;,01078(""  '!4$TX, E4< %@6(&7
M!%3A;9-;@  ":! O"00N2@P/0)T/8"(,0 H%F%&!P%++ "W-5)%HNH6!FI,$
M*(5]FA,%B(HHHX 1& BF-8S4%0VC["_G 8$ZJ 4!<"0'0 H+V)8[P-S,0  $
MPX"3$H@5>(!AB /4 8322R*!F)&#H"(CFJ2KS)V!'+"!X!U^HP"PW-(Y/!'2
MU1,)L4GI4BB30 ]_58S@/ 'ON(P$V5*[^(#>8(!]F;LNN?X#&Y(0D[ O-:H)
MQ^F,F<R,!"@H@2B8S%  /*" (!J&#'B<KA@($B"*$&B  ZD#!#B0$YC<3A$-
MG"B_HG #*A*%1V7&S**8?#, _I"0X"0("""D+TX.IZ@D-T@H0:".?6(P>KV/
MY""&,>50[KFMPN(/Z]"D!'A= J"=BD",&D&8O!$-0WD#G>.=V@@N^0P0<?HZ
M%S:*-$I? Z O4Z!3C7R @D %!3@Q!DB SKV<U4B+2I&,)1E>53:E4T@ !4A<
MA"0$ OBZ@>#-81B>P#.@U%"!%F@!-\"V82B!M2@-4^C:$*B#TK@2-^AE-Q"
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MP2%P IB(#Q:'G3)@Y]:G# ="#5-@I^(M H&&=9A@ZE2+ "AJ5F104@$=J@8
M#1M%@ ZJ4P=6G"IEP<(P4P2@AI53L1@!0I\&$++EQX&$6K:>@L6C("%""Q=&
MG5IA(-4P.@=(A.# @,\P#Q)*A>I H-0P"7" &8!3"Q0' RGU%.!SB\\!8,,T
M4"A52T6"6@H9(CP@>X"*6K5.2&!,-0%G5 /0*E<YP(T<.28$D$@(+ 'TH]Z_
M@P\O?CSY\N;/HT^O?CW[]N[?PX\O'M@*!PH49"!T%)B&KXS=0"#!!)P-X\8)
M%A&S @03/.!&0K>0  $$&. %8?X$$5!8$0AW#/,!APAM<-4PP,#1PBDGB/ =
M' %"0-"()4 0@06B5!1"2</TX0%5&5J @@D..+!"0G>D^ D&M]@D@4&A9-!"
M*$=6Q,<&%9W"@000?. ;4AM((($'6AX5B@1XD?#517!4)(<#+A2DGT@6H%)1
M0GK0! P*$ES0@B@2< @,!C?>@8%M=6'0)04I?6+ )V!]0H$%&0#B!@7$H !<
MAW@@Q *0);R1XGXJ!#B!(,/<P4%-?&!@RS"#4)"!;7<$:%I%*H0TIXX5P5&"
M2!],< $=@#Q0"APK@*42GA^ $@)-'!!X"P:@#'-+" X\X$*E1Q'#K$P$^@DM
M,"TX4/Y6*!9<28)MJ,!ID0<N^KEH"WB>$ H%;_AI"EB ;*#<+2+$B %I%9G2
M@AS M(@4!P]D@ <'<8K (1\38.#!("=,*:T#H31E&S 13HA7"!\2HP%:H% 0
M@0060,580B70= H%BWH'2 443# !!WK4U(<#@\K7L\\_ QVTT$,3731YM_!,
M'C%@A@=,+=&-B*1WP$AM'@H$*A03U,14;1'5Z5D04RU)@\<U>K=T357:1E<$
M#-GEW0+F+1O$Z=W:\]WM-9A0CV<+W^7E\O=W>8-W2RX]H[V>V^Q]394'4J-R
MET6$1XL>,+B<%W=XIRCP;WK \,FVZ*.37KKIIQ<MN'M_J_XNI](J)> !"2=3
MKESKX4&@ H) LX[Z[>$E) K6J!-?//$)$5," R*(D(#NWOU.NAYHG<?8*3$9
MG[WVVW/?O?= UW+'KT8/0EKTWZ.?OOKK5R1*'75 R[[\\]-?O_WWXY^__OOS
MW[]ZYW\'@/X;( $+R#_D&3"!"ER@? 3(P =",((2G" %*VC!"V(P@QK<( <[
MZ,$/@C"$(APA"4MHPA.B,(4J7"$+6^C"%\(PAC*<(0UK:,,;XC"'.MPA#WOH
MPQ\",8A"'"(1BVC$(R(QB4I<(A.;Z,0G0C&*4IPB%:MHQ2MB,8M:W"(7N^C%
M+X(QC&(<(QG+:,8SHC&-:EPC&_[;Z,8WPC&.<IPC'>MHQSOB,8]ZW",?^^C'
M/P(RD((<)"$+:<A#(C*1BEPD(QOIR$=",I*2G"0E*VG)2V(RDYK<)"<[Z<E/
M@C*4HAPE*4MIRE,Z41C?467Q6%D_5Z(RENF!)1!I.4-;:@^7XM&E+"_)RSAN
M A*0"$9%A"&)223"%ZAS1!EV(1Y9E$$2X(%$&731'F&P00V_],XN8&'-[_@"
M%LY<I2]@J8M9*+.7FH1%(LYPAD3$(GN^.,,A?N:+-2!"/; 0 R7 <X@SI/,\
MJO1%&IX0!EED#PLRF,$KAB&,+,1 !ET@9C'9L\V*P,(*5]#$,%81 QATP:'>
M4>469/X0 UG(X@H;[>A'N3#2\JCR$3*002)$.AY89*$'-NB!%#9A$5EPH0<S
MN($55'$4810A!Y:H"":D<(,9]* +"%6G)0U1@XB:U ;U'$8BKN"%;=*R#%=@
M@TT%.@PTS#039;WF,-(P4TS8=)M16&@P5F&%H@XC$S,]@T4N6A$JS( -.2!"
M]KHP5%@,8PLSF $92+>*F?93%TZXP2/$DP@:1$$8M)BI-"6;@YKZU3NJ\($/
M6%$>7P A!C.PP6)KL(IA[&((J@U"#5;[6M@:-@;2I,1B;4 $&\0 "-^DJB15
ML5H@E($,3Y6!3[T @QZ$UB)$@ $6VD.)P<["9Y30P1"RB_X>-@C!"GDU*4=C
M080<]%,]AM!$,+#0A.@*3;$V@*9J0WJ454R"$KVHR"Q@P8MBR@(6^[7(+BPQ
M"4T$=!B^P(0DC#J,8%#"!C5(A#5788E@Z (64QU&AG7A"TN\0A@1M@&%A^$*
M2@34%?D=<$5\P0E(9(+%#M6$3X<!"U@(0\252*<J$;%:-NCB$*QMK!=6ZPA?
M9.*I5!C&&9[ZU'X2809#0.PF?A #,ZR5N(M4)1L6F]Y)]" 'AO %%V8 !%@$
M0Q@W5C K!JH)2'#BO\.0!1-BD 594!06^=UP18*)V!OGF!,.?K F)K$)BA:S
MO["5!"4H&L[LRF(5P<#$H(7!BOX#!S3 RF3%+GQ!"30_H@8V@(0S5<$)1*MB
M$IA(,"PH,0G3'@4(-,V>8G> A=5V094#M<(,9MH#2 P#L$0@IB98VT]50B('
M,XW!#S@Z#$GX(*(S>,(N-B$#&P"W";+8 0X0@8@8W "QNNB!#!#!!AH  1(Q
MP'8,B#!N'*0!MEGHM0QZ4--A4(+<OCXVOF]0 TP$@P<S,$,3%MJ#AE:D"S$8
M0C%W, ,N",/A4[!(D6L0"RZ &[B6$ 8/8M"&!P^##.V&KY8#68C51D$2WA5&
M,+:P;A[0%!:K;0,09H!D*YLT!Y,8AE!O8 ,9J$(8AIWI#0S18EXO5 NLA84C
M<& #5_X,0Q-$D'81;CL,56#;"S=8*!$0>PAFGYP)A[C!#8RJBB+0VP?2#,;4
MR< %&$C"##.(0B+6_7,KP,+?1I?%%.C]@YT+XPP_7V@4?!&,0\A"&&68@8Q+
M1]+5UD#@-:[(%&0 !#;D5L\QJ %'T1"#'J33%3/M B2BT.YA;&*Q5#C##F3
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MULW &T9E)HBE6K5@#=#"K6&E5=IEE"U9PN7D,' "[\'5*@ 7)'P=#Y!=#M2
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MQ;+6MZH"$_2:E$UD12@"#2@H5T7;0@T!)V!M(U%"_VWE#/[\P+W)0A'\W"/
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M!H?A!B3!23!!&'3B=B*HJ$YK%8H /EYP86:AJ<*F4R?A?>)"6ZK".&>$2LR
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M).%#%BE=-($,SD 63G'D.&%Z])L76EM!%A 6BKLUD-L7/AMY(78B6.$,RF#
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M$=9,3[C "R84.!Z!"<V(VQ,6UXGC$!HU., 1.M1GJ[QG.-0'UDV]HX3!!HB
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MR0S!;#(#)+HLFMPD,3P2RR$W ,&4>I/8 ,DLPU1Q@R.P'")#>FS<H(DNB<S
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MP3!:ND$J!]*30TT!$SJIE5&L0 98W* E8"TK)B9!B5IY)0J&.(,A?$$$5=S
M*\W3"25>U]SDM$02(,/*7@F:RR!.@HJ.$+4J>CF)O%J$"6B@XF,[48.7SF!"
M-$5TI5?A"REW8B"TR-TPQA#&C\ $=V$(W!@(=-W4KA:%>60B;,]09(L(@RW-
M\4+@S/Y ("5G&3HUYH5O]>:H+E1"%V90)(23FS[D,M>WC\$6?U><2C985UR
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M"V<P;U)@(5W0002!+<M"4+!"!O,V!6CT&A&6/F43$[@S(6YA22F6'T#@3&T
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M?)$),=!? Z$%-X ;4Q!&%F$5(3,#T58(-?E07" #78!5 _X"!K( *%R@"8>
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M?JY0! [5"_?S T502)A1QGZZT4=E!%V$"4$2%T>PVT[!%(K E[ R&K*O(&H
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M(HZHMH- 0(UP @:\HKGRB$R0*'3BG/S)LV$@,:0HNH.0'TFQ@F#0A1I8P!]
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MA/@0!DI@D(W8!4D 'R\^48D89]_!YOBP.L#QBBZ-A;'@A7,^"!CKHT3(4%:
MA"0R42ZAA099A4<H'(]@!4H0D5EXU@PIBX,P$:1HY[L#GWQ&@RK8YAK:"%Z
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M!1T8[P6_BVPY"$BH,R%1XU=  H!#A)\%]7K,@2+P&5@8 B"(E!Y8=%EP!1M
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MH@L]D('=6):Y@9@!;<*P 23V:$:T[<(&G/ A$0;"!#2@92"[@,0IAX%-FLS
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M[( 0I,<,+-Y&#L0AO !)J0+K#<,,/$6<_< 3(&0.O 0;%/ZA%Y01&]0 3<A
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MD!Y)0@TD@D PIBK PAK4@)\P 0YL 9ZF@0R<@2N< 0Y, 2OT'V><P0RLPBY
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M1UAA!NT!@AJ'48,1#E4-F3C#?H:Q335@0@T3D@XD9J (3:3!!T. !1H^*#=
M^N('4\!$(H@0@Y-$A(!GP(3K1/ZSB1BH,P9=T 0EC/ IXJ4A$VD8E61BX A(
M6$$&F; C%S31B2$DL@LS< 0KZ*,B,TF"$D<8G%QRP%HLR,!J$3E$#-3@"T-
M<2!=P"0O<F %2Z1DD1&)0D>>$IHS9((-,P!4,'H@!8,XH0B:D(069E &83AB
M)KJ A0S>E(4>B*L(1< 0E)[R [ .9 NQQ803B'"4-%2S)CUX@D%L4,Q@Q !]
MAYB!(3!AAA5*AZ_TDD1P^U(#IFQS1PKUPF:XD(.-=K0H4WPC$&5B$ =M(A%3
MF('(9@ C83E7$P5E BP4U@5*.-1:NLA!%C QK!AD2@:0/.D95B&,(CB!=#VH
MGAT'._Y/(?O$%Q4-5E%FL8MZ#IG)34X?&KRP!2YL 0Q@ -0P.!$&6A5""E:8
MQ"S H I*%#,34W!"(AY14D-(X0J2 +,;'W&%7B&"NF$(7V[*0 1ZI2%J5"H$
M%%8!"R_$Q1)E0$\9FN"$1=R$"&@X7!%JM*4R,($):GA*&B,S#%XL"().:((7
M5I6&*P]#$D#411@Z>46#P.(+4O!"+!+1(C5$N@SFS(05BF"%&_YL"D2P A4A
MV.5$[ (,F# K!$LJ"RX,P0J9*$-T2K6)*0S!"YG@UBR\P!189*&\:XC,)G M
M!40)HQ!.:#8:4@B&)H@E,G0FPA3<B!0U.('=0AF2$R1AB/X'HF<-5I!%B2/R
MB&(:;\>&M(DA#%X^;H\N(ID  TUV$08I<.$5DP!#0])P!9* ND.>+@.\#E%2
M'HTZ(N4N0AC@A8D\UF035\C?9I 2AJI*0@I- $-T;.*+,.QXA+ZH=D34 +\X
M%\CD*!_&+[P0.C3(4AAAV-$JLB %5!NB"\'@=$T,\00KQ P,F]'$%(Z YI)N
M>PA9L+93."T,-EQA1\$H0Q$J_12?X]S)=<^Y+/".=UXLV>Y]]_O? 5\3(  Q
M\(4W_.$1GWC%+Y[QC7=\K99FN9KP??*2M[Q/*%]YJ0P!-Z"Z/#U_DGG,FZJ>
MHE]RY&\E>NEXGB>9ISS?3=\]U?ZK'B>OKTKI-:\3W'\^]SFA_>.!'WSA#[][
MLB ?\9&??.4OG_G-=_[SH1]]Z4^?^M6W_O6QGWWM;Y_[W??^]\$??O&/G_SE
M-__YT9]^]:^?_>UW__OA'W_YSY_^];?__?&??_WOG__]]___ 3  !7  ";
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M01\G%02' JT1<PL&%ZP R 49>0!62BUX0 P#) 3W!B@UW40,!"8-HT=/!VT
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MR:A@@))&W9DOIP4AH5[6@68=:X-\*#.I-H6H.W,4%)XB%/X,/?2+,5#'[''
M! CQ]9)P]^6#@$)9!D%!4XB1"U,G:M@,1<4H=%6H4LP*V+D(1;9-O6I3X^[(
MQF[WE?5,;;0%*#\M($$=&)"24. [205QP5CND $42, !YY.  K@3B@<LX0(3
MD, !Z2"!V#UJ&"50 0D6D,@[/$ #$4!-+3#   ?09#X94 $'/ 0@!V@ A2B8
MP ;&51 -F)P!(DAY!@XT11), &97XD#X," M5%3 #@K8W DB#@%!N]O"P*!
M*0C1:+W1* ,C. JJ-T"!,&EI%!1H 08>0 %U$N@ R_J MC2#0@Y0[P03T,"U
M"F*+#4R@ A/X]ATFH (*T#PE,O[/&@,:<X<(N)TF84%!"4:U],371Q0)0.$*
M J8?K]L&-?J&)P(:@V/?"< D+AA 1I: &5,0P 2M(4$%AC$(!C"O%@[ %@D,
M< =M#B(!6F(]34[!@$"<NB 1N/EZ;EX,!D3J#19(R6LXW?M;> 8#BEE I$YP
MLS<=(",<6%@<"G6* VP %*0FNV4R4&S%.U@4!Q@(!"C O.M1/2@8(,&+&@ ,
M5 C #;&!P!)2 PH#A$"*&6"^G@^ "P5A 33A A=0. X0@!D0 AJB%'I  !FA
M/-@" 1G :2?0%)^P 'MR"\4S#"8 >Z? ;N(G@G[49<>3:@T&:9DQ .+F(+*!
M,W<R#/YT<'K#T <J,@B%5@J6@FJ-AR;#=@I4Q"=X<DH@@ )!H0>8 0P+8";
MLRC>L@$TX0!T@ JE@"_"0W "F"H; !8B$#86<0(B@"6?8 JE$ H&@ I8\F6H
MH  J( CA-X($!@HBP!;$H ':LC<6D0%64@J(5Q#%4RF<80+,-A^@< !]]@8I
M0 &1,FTHA %66 =3B'MZ< L4TQ$F<7?QPAT<:!EN,@(1- H"I"TC8(=O2(IQ
M40M41 >$\6;W01@%D7>C@&^+@3./,0R141#P8AF8,0H/P!F>$0H?( $<L '"
M>!,?P!$#,X"\]1JQL0"88A 0X <%,0'>@@&]X0 8((P;L/X!"O( N,$H-4$3
M(= "L4$,;^ !Q2&,'"",I5 +IP,?'@ !QE&*%$8@C:=^HI04RW(!==".*$0"
M"\-&WE<0?D  I$:)C=@2>#2,&B (H(!O"'$'E9$;"J*)?? ='A !Z;@!FR,"
M11B"\VAL%E$"79$9!V!C7-**1S$!(C !8Y( 9J("+#$' <(FN?@F.G@*"9 +
M(@"0$,(G4W80.A84@5<KKU80T.@SWI(!9W.%9)$2&.$SNS$,&L!$(R!*84$"
M6.%D!W(*[%$0M8!"Y!=U(+E?%L$'/2,4#G(]&J"']MB'@X![_K@P%@$*E#@,
MJ$  M3 *\68!5O@'ZH8*.G@6Q/Y0D\/ *)["!]\A H%Q)</0D=%$EI&) >DR
M'PHP1A^Y3"UP>G1I )6V2\"@;U4'!Y5Q!QR3%&\B %D)#.KS?SJ!"DFG$1YY
M2OFG$Z7  ,)S"[-1&TTI =Z2C'#0 *A #(C!%DTY :GR%1U( (% #&68$1^P
M 6,B!_*1D^F'!P? %I6"+9@9F:/$!P/@![=@"EV&/1A@';##1<#  @] ##GH
MCX'!F7SP"83P!Q-0*%'!!\# !P(@/&_@ 'LB" RP)QW@ ;E #"B@%'7 ,=TR
M# V &WU0:&5H$J?@9L,  LS6G1GZ1@<@"L!P"RO  %9&'W#P :?4 A*0;80
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MIGSJ%<8'7BG9)BD@%I !5$$!D/?R1T$,@J 4'W 3&L(N1L&,(I(2*V"'*P
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M@H;Z'7=BBBNV^&*,'LHC XI.Z,E%8 RXX[>'6CB 0 0\@&.% U8E80$2ZO
M EN&H=>G4A8XH0X,-" &#PGY, "F+(=)X+:%[A@(5&(@ *$.%2R H!1B(IB@
MM1,<@,,-!)0.L$ ZX"!!@18>VD  [E",>0,)@$&E $]+46"%.DZ 0 .)V*Y
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M@?T1B$!0@ \ @0U@ --+%@90@:PIA5OP  :@ #T@A5/,@$:8C@E(@0H(@8D
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M+W&(J]0^*4%$"$D .A##.R  1GQ/<"L0%5@!#IB LU@! 8"B\7B(02"!$K*
M6M  %=  HL"@!42NSXF.!FBC89"B85" ;.(*[:N7!/#1.D";9ZF#&:T9#W
M%7"\AY # .D#\N  -8'!H+B#WG@("Y"3_:@# ^B  "(!0_*5KKP#%SB:^TD5
M8F!.JH$#]20(/J"##5 2(5U*8%@/-Z!&"/#'\VB!Q"2!%?X(A;^@ W"!O"34
M$Z6!GE5U@=M@4(&@@V(9D*4!!""T'^9$C?W@FQ/( S"-%&OZA!U!$PS@112
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M R %@=&,\/0 4]C'V^'@^ L% G"!4-A?_7 1/<B^/J *&-R36S@!L0"+D?0
M"T!AI7"#TOL$*0$$0?[A1\H#0*B5'A2$ "K7#E@5%)438/YX PQ@DU+P@)W2
M"CGPFEOH*5;)8!!A 8*HTA  !3;]81L"!3]!!1 H1TKZ#PPX@1"S8]=R@_4
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MJ6X3SG41M!)%QCN 8!IOC3AP!_\V6=$)6Y@ ?=YP$6_$1D  S'R#.EB"";"
M8T2%$@@%"["#6R !@9AQ"K  I>0#EO2 ]I D]-P)#:&##-  $$B,4S !/V ;
M%)@(.*"#-YB "K FP1YQX[V?/&50#:=R+7<MZFF^[9R($$  'LJ:82 % \"
M[36%#B$&"N@+0E" )4B0A%CF03&I!PC'"R"* @F%0CZ.4B  $  %-PD5$1"9
M4E")B;C.NMMRJB.!@P*$N&1T2:^ZAZ >#0@@#?  @?B "OXA%=TH'2CZ5V+P
M@V'Y!,H<O'ETJA4HEM>$B5'PJ0?%P 0P212@#1%8X^]\F/2>]*L3A2RY!5"P
M .)8=%XO]FRK] / 3 \09%0PD7L9207@C\3LEUM8 "IJ(Z.PB/HEH4D,90X(
M@13-&?NYB?M) 8=8#)AH$6/'.KFE  U8Q:=>=WG/-NH)9LW%P!W1$?L@A6BG
MTP#)HJ6X2'$4VXJ( .X,%3[! %  !E$ $!3Q%'(' ;-=WQ;)\GF7* S%0,FU
M^(OO> UR$S3";*'8$WV_%[Q<%DZQ(6J<CH^IA2O&*#>H@ H0H@5 FA+HC>OP
M%+!<5I2%%77W^*-3$/O0@#KA>/Z@/_J*>0A"$  &:'H'.(#;VX!<1@ (H?IO
M*I*7%($-^-3T8,EUG.2*0(4!<,)A\- 2" $54( Q1 !<&(BSU[Y.=WE8<8 ^
M1GJ<7D<1H "?M'N^+ZT1^Z[=@I53\!1@H!IBH!JE0'Q6P0,PI A Z";FZ<$]
MUHD'.OS], Q6\13+OZ9@[OMMHV4U]'S1?_#1+WW3WW*22?V^>C?E3GV*(ZIR
MBRNUFJG9+ZG:=[B3X[F:6GW>I[?<_SC<9WW=)[G?#W[@WWW?%WZ56WZ?:WZ"
M6[>2ZWV2.[?B1_Z?<OVC.GWMWW[N[W[OCZ?MWD[Q'W_R+W_S/W_T3W_U7W_V
M;W_W?_Y_^(]_^9]_^J]_^[]__$__.\B_[^__%T$[@.#3IX\>@@8+#D3(1T]!
MA T''C0(46+$AQ/[++1HL>+%A!<1<@3IT>-#D1!-@BQ)<2+*DQQ9NE39L27)
MB#,_QK1)4(_ E#QW)OSILZ=#H2>%%NUYE.A-F#4W.G7Y=*74F$(7?AJF=2O7
MKEZ_@@TK=BS9LF;/HDVK=BW;MF[?PHTK=R[=NG;OXLVK=R_?OG[_ @XL>##A
MPH8/(R9,3.OB88T7/W;\.+)CQI8C4\9\>;+ERIXA?ZX,.O/ETJ%%AQY]6C-K
MU*M3=VZ-6O5KT+-=DVX,VS-OS;VW^M8MW/3PUK9SPZ:-W/YX[<3.GT./+GTZ
M]>K6KV//KGT[]^[>OX,/+WX\^?+FSZ-/KWX]^_;NW\./+W\^_?KV[^//KW\_
M__[^_P,88%C""%B@@0<BF*"""S+8H(,/0ABA=9.DD08;%R:BBX0;<MBAAQ^2
M9X4,,\0@0PPSW'#(5P2NV!6+ W+U8HPM:D4@@9 ,P80L+H+8HX\_ EE?%S/P
MT$050]A@0PR/:)>(##;L,HR,05)9I957<K?%##; (N4A2?80C%:\3-)&(J]T
MM8DAAG"BE2^99++C,)M8LLHPL&2BRC"2J(&)E(^H00E7KQRBAB0LZ@+G,*JH
M<8@OP\12!HJ/="D,)6VP4<F46/YRVJFGG]I%H)9<;J7E#()2TH,,J\Z0AI3!
M:#$#JU,$ XNLA0P3#! R3#&,%S( 804,)+(QQ; RN#H,&[*N2D27D#S918DQ
M#"%,&C+<< ,,7@3#1(FK,L$+J..26ZZY8\5Z YH$)C+##(GX8L,,4D!"AI*)
M#$,&MFH88L,+7L@BKXK!-#%#%L-(:D,/7/ @[\([)&EI##:P00D5,C QS"0H
MUK!%$S?$8(@L7*!8R"N&R$!$++ T@>RY+\,<,Y:C=JD5).X>8D@,-]0<Q0Q5
M[++##%YHE8@7;*@BKR&Y%HQ%OEOJ.<8,-6@R#!I;PI)%#%/X8ND-,[S"B;MM
MW/DUT?Z)Q,!#+\.8$0,0AZBRR2R/RERWW7='J*6ZN2KK[B32$L$B&6Y3(B^^
M+[ZB--,S.$W&##V(NRP/&AY"I"I$;$GBB3 <HHF[5?L2Q QE#(,(BEVJ K*)
M-V0A)]ZOPQZ[?Z/*R<L/\NHR)! L>C'#$)HHN?0PNVRR2M(QJ#@,$#$T'L,.
M4:JQ<Y<ZWZ!*P5$<PL8ACRBR"B7N"LI+$#&$47K:&@ZCRR%=$&$#K[+#'[_\
M\.F=1J% **G%,.W:$/[R6 @#"#.8 H&T *S4V0 +LH"$O)PFJ1YH:%DWV)'I
M;""+,LB@"022Q2':T(OOU< 2PQ,=Z0RQI4P$HPQ6P)6O9OZPN_G!,(8R_(X6
M)J8Y=S$A2L%P K:TL#P;;&(8CC@1$:+@/ES]8$OR4I(5AC&&G44I#1.;Q3 *
M$8,:P&(6( L"%F[P@A[X@A(G$F'09$"T23PI!FI(Q N&EH9==6&&<IPC':%#
M!A\,80A (((5#/$B7G0!9#.(0M6T(HDBN,L':M!*)I!T@S1T00=$2P,2BA E
M0U0R%OO3P1!<L2@KU&!G78@2)7R@@R#ZP@DZ<)4PO!"$1PY##3\HD0VZ0+<Z
MXC*7NM2+,&S42[#P A::=!$L7''+7*U"3K^4$HMZ^:)E:D46M%@;<)XIHV!T
M32NU6D64=NG-;X*3E^$<)SG+^?Z?34G)G.I<)SO;Z<YWPC.>\IPG/>MISWOB
M,Y_ZW"<_^^G/?P(TH (=*$$+:M"#(C2A"ETH0QOJT(="U"^Z"<Q$\U)1MEP4
M01GMSD;MTM&(@O0KP*A%+MASBUJ$-*41)48(*.#2"60 $')I# ?XP)MAW*($
M#$B  CQ@"KVTX -:"456%D-4KWR4*QE=#" HD( $.  .B[D%!HJ:%F  XA9=
M2:I7@)&!$*2%JV2A:BB((0&9?C04%$!%5THAB*V"A1B 0"DQ-H#6LX3" A5X
MJ0C8.A=@:" 07"D%!B@P <-F0+!Q&00'.@J*L@XC!200BUA5"C]B.* #>KC#
M'4@P /[%5I:R#*!#5VH! 0?P(12 P( "4 I7X)QE.'9H@59"@('*A" #L(W+
M'0: @L?200 JP*D!9*J66@C JFSAPP(8D!7 W**XQ"#!<^,ZC$$ H!2\:0$$
MS *, M@4& JX0VR'\8D!N"$/G)V  [0J%V D0 ^6"<4 7( 'SH9@ (2X:6BW
MPMRE#F,#(- *'.#0F;!:]EQ<Q>P;N$(!$7@F%#]5:B@@JQ7WNG88HT I!.S
M&Q(P !A<44 )*@.,4)R"*UH],61&X5Y@:/44$V9Q5VXA@@[< AC $ $';M$8
M8(@BPQ<.A9"'88I27#05!&BP?P%P"OA^XL1%KO!C5JS54?XH(*M;086%<:J5
M(EMF RT008DAH]5;A$+$BP'&8DPQX:V<.,6,.7.:N7)B'RO@K8VQA6YRS)5/
M%$"[C"F&"BK@9\>$PJ]=.04#])!C!_B!&$3N"I=%W!51$$#1M2# 726MZ N+
M0M'$.+-[)6V+83# IHT)!0$$K14)3!;4[MU*+2"KU5'#6:N @,!CJ'QA#X3
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MFG4%!Q2A5T"B<1VB=DW8+7#7,! ")BI= F0%*!S K0U#APW# 9!66%0 .X8
M4,;AFTF "PR#!@B55OS! 1"#!Y28B,GD,(B" ;B6UG7C VS%*1! RXF=5@@"
M1"8=;!V>JRV&&V AV8'5A1F ,,+9 L@4,'"CL>W@(;+58EB 7(Z> 61 !W!
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M+H"::6BG1I:'@FB;.L9LRA@J**-9N4&_*J.EU4(@D( !3-AB\,$ A.9BI (
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M,?0!,*#"&]S"($RDWMX"&!K;-+? FR';/-=!2>4]"JB ZU9;*9Q""B2K%IO
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M"F]*("!Z"T$)" \>.GB 05 H *>(;9#@0@3NGH,0;% Q(4)C8B$4J#!AX,W
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MF%H0,.$!!VYQ S75!EABH#M ?(.FB3"88-0,!"#V#0-(4$&!$282)($0HLT
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MF+:5 _]<R8E8$M\( %%\Q!4!U%;,S(4'\10,& 0%B"$(#MP!KZ(P" %O%A=
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M  BAI?"@(2I@4&HA ;"N!00 FN:)(=ZG(5I K,;GG.#$1:0&:@QK(%8)KBA
M:P3.1":@%&S!#@Q @VKA *Y(/)!0#RP !(RD!1HH%-10_3Z"V< J#V(&$ @@
M+NX@!J/+/8Z0U\Y'? " #[1'FTX@C#H/$S-1$S>Q(3*C]/0  ,[DLD Q@D@
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M)$+!#_3@%NK@G!QR$"+@E3Z !#)&#^3@)DP!#O;T V I%YPO% #!05GB#NC
M)$RA-_L/%>8 7#0"F[791+0&$/XN\19((V5)P4>U9A#@ "IN0=OJA )PMY/O
MF6Y/80GL^4@Q302*Y@.\)@1  10P0 _BM3EJ 01*8'980!0; A0V0"H""@[>
M8 +Z  3N8/_ZX CST!3J  Y 8<QN(4_1U X&@;)"(03*"H\4- _J8-9(X!0<
M@ ]:(&A2( \$@3]$X /XP )2:0/ZH 3@ !6:107T0*>U16L( 0/PX Z2PE=
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MU)(?>V"&*>:89)9IYIEHICG6*1O)),@G'Z!BH1Y?*@4,''2$ MTG*NC!1X&
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M-:<6#K@#E#*T%#^(8!AY\( H,$"]#X0"(<#  #4YLH$^@&(!@_B$0>IPAU(
M$$NH*,$M&N$!.&3@#E^L!1PPL"$.DD"!)K@%9D*A@2:]A0Z# >,I) "(.K3
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M'>1P ?X[)^2KL694JB*R0)*4M Z @,D@Z-""3'*@:0./N]RIY8'#G0)!"8'
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MIB-REB0A< +PUAQO0 $J4 (6$ JUL $UACQMI <24 I5MR!P  <.D#8F %X
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M"X= !%+PLFAP!EUPKF50 T. "5[ !E8 "PA=!&9@O&7@!46@N([P!$70!L)
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M6OC0EN+&K#-(D @ $Y<9WI8&'E!I$I6A!!9RH(I)J,%H4?!!Y630"28T01A
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;%_NQ)_NR-_NS1_NT5_NU9_NV=_NWW_B    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>x_cg003.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_cg003.gif
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M^_7Y_/____CW]_#O\
M
M
M
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M*G!64"<HI'N'F)Y&+757'@Q*P)5WT0)'L8X"$\@# ]@8=H"-!1.!  " 0((
M"!P0@ 2=7%"; 05&9@H! PA @OX$ 5PXP *;S@4( P386'@">I@+@&EP-%
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M/@P*//XC;&$ Z ",.P2  0TX 1P$=8 "1,8$ E"4!T3@@ 4<X '!@ ,%%J
M!%   Y;Y30&N9 HK<G$#%XA1 #H@D X$R4"^^0X"'."P-)9.4E";!6G.>($@
M#:!#P* >$GMC'RN>QCX,H$4O(-!"VN2..W$JP",9$( V;&R.!K##"B+8'0Q@
M(! JD(#0+H !>77Q.QV@ ,\"P+L51-$ %=@ =PA0 >DX\):X9$HM\). !CAL
M1W/IP'86<)M@^"Y]@ "&!0Y0.A)TX@T(4$#I/! (.RB@BQ( QBE(9X 4C,(3
M&3! <?:D 2-1@#RVV "0)O:'[7AG#ITPP7D*D"H0^ 8$ _[1@ 4>T(=@X&<
M<&#7[PQPFRD9R Z3^MW5@ &"WR4 0<%800'2=Z5RDD8#@O!#FD@#T?BDJ3L4
M+$B(YC("AB$G&"V8: #V!(<">?$/?_@H A[ !T%LT$"="(8#>&: %72"!><I
MG0D& 0>>:F!C@QJ >OA0J8[VP4NQ\MT"'A"L8(S 2 \ ABD&98 6"*03+1P
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MJ> +L$ )IPL,KM (BO"[ W$+D_YKNEZ;O20!MH\+#+I@ S/ !9$  S<0O$&
M"/>:"I) OF&0KS! !FC@OEHPK)C@ S 0 _EJLK%PLV5 !#$0"4   U<@$&H
M S80NF(0 T1@!B\ !<" "#<0L#  !=6J"U,  Q(\!;MP"^![!3M@KS=0N:E0
M!/<+ SB@!@(!!3 P!1>LK_W*"D2 P?8J!L @"?<J";]P S4@!3WP C.0 SE;
M!L*["VL@O+> "?JJ"#XP S90 S#P"E<  T4@$$(< SZ\!>TJ"3> P2;<K]K[
MQ1X!MI:0"[%0!DY\!I00L\)[!8UPLZF0QCH\!3T OC,P!4%@ S @MA$L!9)
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M ^',JINP@INX0 ^YQ2K\P(^LJ/Y<%[_P"HK<_ G;R8A+$#:]N)"__3'Q""Z
MKQ;-$;!@]D?+_>9/':J@!5R@NQEQK+O !5C@"!;OKT;!M>=___B?_W!J__K?
M__[__P !3.! @@4-'D284.%"A@T=/H084>)$BA4M7L284>-&CAT]?@094N1(
MDB5-GD294N5*EBU=OH094^9,FC5MWL294^=.GCU]_@0:5.A0HD6-'D6:5.E2
MIDV=/H4:5>I4JE6M7L6:5>M6KEV]?@4;5NQ8G<%.FB6;EB=:M&K=OA78EJ!<
MN'7MWL6;5Z_#3J4X@C(UD"Y=P7L5!B.!X<(%#"MF&21<\$^&7H47SKKP"5AD
MRQU!S/ZA^'DSRA%Y$'+.B'JT1;-U2 "SX\'BI\ -:04R:VK#8]6%1VG0L/C"
MB<>I@?TN'K=3\38K5DM=;O9#G><@@W70_ $T0M$FS;Y)@734@EF]/B@6GB&8
M'@SH,<21&PS$"+-F^3QHFX</0?T$6]0V[+0%WGNCA0@0".4AL_[HH#Z&S)HE
M@U%8&H&ZW@X:P8[#-)+K ><N3"@R$$5*(0)@Z@AAQ(,H,&$TU0(9X#%/!I@P
MKH8Z$2"%.-Z PX$(:+$Q2(DZ&< OP1 P#1@/-CBH-Q4I:NM)(0E2 #3Y\)B2
M([-Z,4 08$*P<"Z!,JQ.P8E&N*#)CD0\S4P-PINE@ _D>/YCQS> :6& .'9<
M88 2" ($@00Z(8B"-H"9I0X33K"C%UH49;274>KHX(TD X3,@3OCPD""MF@!
M,*Y2@$3(E"UM#*:4R@I":]2":#&2,[1Z86L44H.)#S);XXI23,M<)6B66 \J
M)=1552W(50K@>&[6@68)52!)Z0+5UU+0FB6Y5E?-MB!H?>V6(%B!::."@BH+
MQM2"3 %R, Q2H#4N4U8EZ!=!%##UDP-F29>N4HPL")0! #QE@#]<'(7>N$;1
M=DNV AL% 8"!H86!.LP* 01$DY-786\!;I7C8[$E%9B164U8, @Y!J84EH-A
M6+ 'YL"5578)JJR7:*45*%R"7/X>J!<& CGHYB:-?O:4A(39E6=$:_D8F!0T
M8+7GAC=KZY2)!3J%-P=-GK7IU9#=.%F6!3*E ,UH.4 /@]IP@" [#"@9!!-&
M&,'&.1@(II>]&:"C[[\#GV6% BK@0TJN+F2@!:R!\20 4#8KD0((#@;FCP<N
MB  $(/GP-',''C"T@FPGB ,#!Q;8 YA5'IA< Q9"<" !YTP>@0$'2!B!!80V
M@.,$ S2K P(*'#C4#G,%RJ."8#38-(\(*'C \3U"#P8"ZH"9(P-@-&"V Q5R
M1T"%^DS0?0023D@6@PHJD"#!6I;5H/8D2[E ]S8L.'0@6B;(PP88X"@03(\"
MDQ,(W/XDT(#MT"($#Y! !# '@A/DC@&=:($#$' [NY&  1>$&P)88!9A%) "
M$T#@"$Q0@@8@P 3U.<$"&*!"<\TA39^8P!R.YP"B 0,4$GA !,KE"1=]( $.
MN,!CWN  "2"O((#XH /L8(H%Z- !/$0;!B8@ 0UHRX<! - H!$ H[C'10P/)
M P0P\ #Z ,,$*8## /:3!]U=X T+\ N$*K  !\AF!!Y(00M!L*HY.(!ZF[+1
M+#801 G4J!,1?$ 'BJ.!%7R  1'X!/H0$ =@F(("=KC ZK8'##J0[@&;4@$(
M5E [#P )?Q2@0 5JQ(<(< X$P:#%!8[8 6!D8#MW,&,*%OY4@3<L, ()(L@&
ME)"[!;Q0()^@0 0>H &_T&(!1,M ]'SD /9]CUG D![U'(>H3L$2@01YPP/6
M>#M DD^8FQD!'^_&)()X@ 4E8, "1E 9.$RG '<*!>?46)M9:* !#E !!ZCC
M@188CE!S4"="!6(W"V)0@RH0B"<D +\N%N:.9J&% =Q6F!8P@"!P0 !:0AJ(
M/R" 7J,@P.3^H+X>"D)]7@(&'%(0@K.Y!:(G0$TP&B<N VC(!!&XUAX,,*$J
M(LH!SLE#2DU!@#G0XC<%H,4L#( !6Z4@ <&($Z$HL !!T&(/8P0&/FV5AP"P
MCS 7,  +!M$+0!0 -Z-00!UH,?X !&* ?1%PSA\*((AT+4"O R!4( H0 H%4
M *,2\-T%$/ '6OQ! $1+P0)LQ8<!Y*TMG<-5"M)4BP10X!.T: '=@$&!W<RB
M! '@I$H_^ 9";4 #M C&'8$$AP. PA:!$ "6-F"Z7M1A $3<@ 'Z0(L2#& %
MM.!# #33 0/P@;D!>&YT)]<!#/!K#@IXC <*8-U !& _*T# :>=&M1Y]$02C
M^H")K)F"K(X K<^J0 D>,[=.].(3"#@46_8P*/\6P /LHIW)' "O7HS 7 X2
M6!OJ4 <X4&!3=S! ?T-A.Q\" ! 48\ =@#&" 9  $+3X1 #R0(M.1$ !$S,%
M ^;P&/X3%&#%H"@ '<!Y $\$X[\CC8L$6MF+%!2@%Z<H0!QZ40L.4, L$Q@:
M+390@*K.@0"P,D $.D&+.P2 4$H=!,P20)T3!$"OGS# G3; 2_F8RQ0"<)LP
M(@":4C@ #H\1(C#X0( _Z&QW>A: ";)U :H1!*YZ!84!#C4+ !,P KBZ)C
MFSDY2BH!+9) 8 >;+@;<"008V(P))B 9 6BF% @@% 8F6]D >,D$FJ7%&PJ@
ML612&<4("$\; N"!/XPJ 2J@!2W05QG&S((6< " AJ:< D'T(A  (-0L$G P
M#BB7N<Z%KG0EC5%:6$ $!0D!!01""P6 P$Y5)1<")EP'%?Y,@!&CB2HNJSN:
MD%+G#]G"J2",C=/6@:)&==&J @+0AQ Q(,!Q00#-"G!.#H1' 2HH#I#VL !R
M26 @$:-%+0HP"(&, JNU0#4P,CV0!23. )@#1@?^=) *T!H8%KC=B1X C M@
ME-&:H8#C+(!1YL7M LY1P0DT8 M:) #GSJ% > 32 .HDX%(A8"Q!$!B,-LAW
MLCTKP"D^<>6!)(!9*DW ICZ!U8%$0$-.'X@>]C#5Y'A -AC(FYX1$!?6 0/N
M FEI?19P;P(D1P)WTD#<)7TGM$_47&\P$8Z-U%)@#-A_@RH(!C :# =L!YQ?
MM5$G$ "DL=<H$'// \7C OF!=/[" !583 4,;A9-#:0/!^C%+&I4"PD<*@06
M'Q,]]=SWY]0=&"(H-,W# P%$OD'<H^E#2@?2@EFH($W2ZA(P'O#-)?9LJ7M%
M>0;REF>!S,%$)G@^,#;P&@]8H#9 LNJX+Z#T!VA(Y(>B ,^!T0D"].(/!B#D
MS LE^._BR40#08#]4 "BF0"=ZR8?NA,*<(Z:0Z.X&8%&&C>Y, 4CF84%,(T*
M.$ 'N(-@.+F!T  F:0L,^  TFCLXP#Q@B(.X&0@%R(-9*)*R XT,"+YO<2H-
MN3NYH[O]D( /B+C"^,!QNR3AN"UR*0#T *+]$(AW&1->HCM$PI2#H(4'"( "
M(*+3&/ZJFHF3/O X#9!!#5@ #LB<!DB "* O8- #!0 &$F@0LR@%\F"T*C2]
M6JB%#!N\T>LS'L.:%/ L@YB KPL&T@$.#:" KZJ#N+$#W)N 0P%$&1S$8)B#
M4<N,#>@$S1$(!5PMQS$+"PP&!" :7%D!E^N9%%BS6**8!, ICZL%.K*1"SBX
M4L2I/#  VP(. WBN IB0MJB#!G"0=.HE%&">!0"IDK,[I0L]D.+$NK*M#-@
M%^JE%C&+F0F&A<.:"@,&Q/,A!"@.QX,#W#.9!R"4MEB_ECF ;X29I2*(SWN,
M_ZJ-Y .&%4B #>C"HK*1R/DW4Q@ ..# 3NRD ] ,0/" #/[H@ 6X$P]@++.H
M@!7 %3&;F&"P0('(F-$X2&!8  L(Q"9JBQ58'H+8N=60 &:I/(%H@>,SA0-@
MF 2XQ6!P/F!@  H(Q F@.!, P6;L),ER@ ]P)!#0@(#\D ?0,4ECE@"DM]X*
MA 18E3> @(+(H9HQO6#P@-= BY\#A@0@FMH#!A:L#D.1O@D(1 I0@*Q2-0?
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M6]E9N*]. ("L0JL%&*=@4#&3\0 '@( 0&#\49 !;((C4A1 &T( ZZ)/MT0,
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M #M0 9%. 15T2!G[W== E K@81.@ -"( *?$$VI5:B2:A0I0Y%J5Y-91'3K
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MX!ZW%>  XK;M0M=MULZ#)3&!K7'$$'CT]9Z%/#A-8) #!/)'#?B#0!@E@;B
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M2/C2* ;NER!$I@1#"P*&O52*B/R5HN!3$[11T05NE3)A1/Z]C/+9+/=QQ.*
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MTHD :*1#P A% %SBE J0@#XEH$@"?+:10"!@0AZQ4U(20 =@M$ _P- #"48
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M54!B=<!SM!!$],$ =%0"1$E<+0!_T,@IIL /$93Y'(AC/<4&_! <1-E! ,(
MN-R6-=K7)8"/"(*V',0$">!''O[BW>E''+1EH4G%;UR9P^"!?NQ! *@(53S&
M6 )#\0'#*_9"!K07GQE/ (Q%'C D-([D?NR8 ;C68#S'V:7%4Z0&;H DI32
MSYQ E\UC2J1;RRQ09@A 6,X3YQC:L'#$]FQ**>A+D&R B5UC1,S38Y!0J8B:
M,$9$"B@D-R:G<BXGI4#' 0E *58$'   +0Q8"82'P23%" " A)6"  !A 8!
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M4T@VT9" OOVVOCW%*!A6<</$UL))HYP%H23W621%_1G$<K?UH0QW1TCV05A
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M000P0 84Q1TL^@,<0!R(# .H#@D\1P@$307, @D SJ<# ^WT:0-!C]-@9HE
M2*(JC^\P -X,^?@\A"E4. "!P">\>H:,@HW!RU9;Q G@]_Y!9$ <E,!8"<[(
M/("#KZ3YA$!WNTFQ@+!03(CR%44=&(U52&@@OC>WCU9RG8 -^VJA1!UP1<"0
M[('"\4&QZ$BA7@7[V &&%%%V <,>,*2H78!IIX"IE0QNKP  %&=R:&W4U,J]
MBP(MJ  "*,@LY%E1M  !Z.]OL(_RT95)-9!%/%0MP<%DRALFG7!Y8( 91<T
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M$  J >,/ )@-!G(##!5HA Y08=6X6$,1.@BE6.D" 47T8A -L(0R']Q .O>
MOG\NA _".0@"0E&>@>7A1UFQF_X)9I&LA.I$@GEH@-@*T$1@+&!K"0S);"*
MOHOAS9*<,8@M@OE'Z)FD.>/\@P!(DP<$Q#&)-;7I37&:4YO>J$%52\ %+$"!
M G0@CBA#01T^ #!@E*(!':B#"@BRT13QC@1U&,$"?I(' @1C%@*@4B<$H!!3
M2. !$4!!!/1@DF!TX %T> ,"6+(* :0+%&$-#0:0!@P28.Y-19E% S10AQ4,
M@%,Y?(,!VE '"62 (QYP@!WB@( 3&.0!'Y3# 2(9 $ L\0$FJ(,'$J"063@
M W5HP0#0AX(U!4J=&=T#"!9 "U:-0 \K6)1-.K  .5V26'(1[,* (0BF&:0.
M!;@1*/X0,(([C "18@L SL)E  908 (4J( #V.:!Y>Q! )^P100J8(<V%.!2
M)4C@'!80'1>%( XA* !/>E%6AUP =/)*"'$+L((ZR.A*:@W! #ZP@@X(8+(
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M#D #*L #$M$D?.@!+*#9*" $+. !&,#;2L !0$ "-& "+_[C:F#BY12  S*
M#,5F =:47^R@ OY4*F9A 4K 5*%(*3!@ D"  3Z(!1Y@92!@ 4*!EAA@ SP
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M#"(.,$<4"*!E.\*K@(&TDN2_GH,//L(4' @8/,%VZ$:(0R$:@0$"+@ D/"$
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MH)SW]K<Z"K)'?DA>A>(.&D L/$<#2(L_)& [.*)!3:(4 OY@#QQ2P*N#JT!
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M>1!D@($(#LA:$ D+C*!! H-T-$"1&6E@P%L%F4+3J"80P,<<"SA7 3"]9,!
M"!AH(%1)@B"PP0F2@A0" AYT<,%4G1BP008B(# "40C849 ) GXBP"RC!/#7
M+ XD0,=##^<1WE\(1 S3 +Y=%4$$;W0P(VL+CQ=( 0]4F90'!528XP6*;O B
M8 <X,$H>!["FPF8J(!!"!PC4]=4< "2 0 ()&- <7#HJJH%6;QQ@0@@E8!#!
M+ ,I-?Y+!!*$H-9J7XU<T!\(=%!O3HD1%+,(#*#P00H.@%#*H8DND %)*D20
MP;W[ ;-' 2 AE\ &(R3 ($EM + 8,* DX$$)()!00"!O*)0422N4FUC +W)X
M  )%%]"!+:4 @%0P),T2 $%V>-UBZZZ_#GOLLL].NX>=R/95,('8YU0><"!5
M4 1VC**$'7\K/L<>,)UJRG@+,4)4)W_W$D@PLS@/3"F%<=;)'\$TG]0G?X4-
M1QW'<T;+'F_486U2H[PQA[7!,/+W*./3,JU1G72R0A[4!:,'./!G6]@;12@*
M4HHYM&$/K)E%'>HPE#]@YP_C 85L@L&'-IQJ(8-H(,JV]?Y!W:UB(7: PZ_,
MM0! >*)_+^H$'.@P/4:\J!=\P%Y!'&B'"))B%B@#'U$RN+L.<F86"O1?4O[P
MAE'00B*VZ 0&VP"\8'1B,*-P'O5,5[T;\L%:L]BB[D@RQ8Q(KR-?H4 +:$0]
M^XR"#^<SUQ^JU(L[P&%C#5IC+WB8E%*\1W%PF,-@OC*+0 PB$($88U)ZX3O@
M%<03<^ /+4X%BO:9JPYM^,02.:,[K9R.#G#88R<D^94_S.%7H_C#+!( BD"L
M8(# 0$$':/$&.-S/B8#DY =ID<4;VL%\P.C#+&:QQZ30(@'CZ<3X<M<)0A)R
M?(&,&2C&(P'MQ*QVU*RF-:^)S?YLKBA!M N%G3XAB C\1YLLHD4!%$G.:DZS
M%P700SK?>4T,5* 3GUA! 8X)3Q5-,Y\F,LNT*@>, .7S#0&+W1_JQL^$*G2A
M#&W1/DV7%!%\QD.UH6A)  H8?%U !6W$J(CVF3L8@?1%1>' FQID.I!B$J73
M5*E*]7G(#D"OI32ZZ$IO6E,8Y72E)$6I34/T4*"&U%PJ4,L&/GBB_[TTJ!ZE
MJ$M9.E1,CA2G+BH)+3CP%X@61 X5>6E3?UK3BGJHHU'UZD+,VM"TJG6M;&VK
M6]\*U[C*=:YTK:M=[XK7O/(3K7KMJU_7^K^_"G:PA"VL80^+V,0J=K&,;:QC
M'PO9R/Y*=K*4K:QE+XO9S&IVLYSMK&<_"]K0BG:TI"VM:4^+VM2J=K6L;:UK
M7PO;V,IVMK2MK6UOB]O<ZG:WO.VM;W\+W. *=[C$+:YQCXO<Y"IWN<QMKG.?
M"]WH2G>ZU*VN=:^+W>QJ=[O<[:YWOPO>\(IWO.0MKWG/B][TJG>][&VO>]\+
MW_C*=[[TK:]][XO?_.IWO_SMKW__"^  "WC !"ZP@0^,X 0K>,$,;K"#'PSA
M"$MXPA2NL(4OC.$,:WC#'.ZPAS\,XA"+>,0D+K&'?@$B%'](Q9QAL8DK[&+Y
M_F+&7YGQ+F*LS5VP0D2LV(6'=I&*%L$B%B\N,NUTG H?,_[4%;>8'9-3E I?
M>.@6KEC1*R:QXX6*P0= (#(P'@&$'D !%]G<A20FT>1; &$&B !1(F! A%WX
M0A*4:#(NB "#0ZPH$S>X 29*1(DQ<*$+D.#,)<IPA2],HD&)8$.0@?&+1WQ!
M"V6XA)$G_ HL]* &->C!%EY1D%1, A,X%I$J)H&*%3V"!CT ->PB,8,>5-E$
M:9@!%'[!"TE(@LROZ $-'I$B1,1Z!F=8*!9@4(,=PSK6LUYQ[%0! Q@ FQ4P
M>$$7(-UB8&SA!3. 12I@$ -' *,5U>9"04KM[$:\X 6*P':(QC #<$=["JPQ
M0[2C/8,KT!@8DJAVH7'1A'O'8/X&9;@TA'7A@QG,8 <W4'B<@=&%%_1 RN<F
M$1%>4 5WEPC%9G@!#/Z,[A&I&,5H\+BE0WYN%$OA!3CP!26B30E@7*+:9M"X
MR)?P!6!@H08HQR869F #76"B!K%N!6<HCB*D'[WBKB"ZI8%!B4(H^<>%B/DK
M;# #211$$H50^KZSW2!%M+O%,;[$#&I !4-,H08P2,27D5V%1W"![6F0^1CZ
M/(-%:P$&-T"#)<C ]D88G,$H5L39S["+6VRAVFZ'-Q%$SADHP,#<N2NUTB&=
MB$+76$0H_\4A-)^4RS?H%H7(!# P<?9'0^(0+A9]Q3G#!1OH6:%:6#@B=M#I
M'=,X$OY5" (1RL +8(SA"G4'!BRT@ 5+8/L68RA"#Y9P!A7OX@Q+^,$4VLT*
M*'!Z"6G0Q1BZ((E'8($+/OY%%ZSPB$AT(0V9T+X-EF &YA.Z()2HP@^(,(8F
M V,7:2#"#GX_=:GP!5V0"K_ !5A "8A0!+_'8A%7 [  #+JP S. !<# !#-
M!"HF!35P [X0!2X =%GW"Q-X;05Q!3 0!8/78&>  S5@"$D!"8J "H?@ S6P
M U5@";!P!5F0"F@0!7)6!D6P T4P!C[6!;@7!%=099EP!??7!:"&8I#0!#^
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M"Y;PE<6FE+9V"+#P!9@)=6>G?*E@ S2@"+BPFL#P"C\@;?S9 Q#8".L'#%P
M9S.P!3U732A6>S40!$'@CP6QH&6 !HG FTP #&*Y!;L F6TV<J@ "6: >S<
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M$#SZM+K[>*='=(('#&I DEH7O$$6<+!JK(^@B;E@O-Q; TMP"P;(:?>);+
MID& 8KNPA4^GL6L(#)+*"H]: X\&H:]@G1)<$))'CKRY!=<[ T]K=C.0:G [
M XX@H5A*O,;KNJK "HZP@39 9C:J3=+* T8'N$1'";]PFU7@"J@@!3I0<#$:
M@F-7$%5  ^2H"QO8@=QH VJ "C$) T &=%<0";&PCI()#/YBL)TSP)Z:&6N^
M@*8VX,4=2P-H\ LJ.@6ND I3D -FX J]V&ZIT'#.*PDU0 .S*9'%IP4T8+W
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M&"0H,"'!* 090G3XT$E$B0<38L3XL&''C1DW5C0X4>%$DAHAHAQH$23$(XJ
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MG3JV1 A?86J%RW,"L82!%_NO)L;)'ZF"PGQ'\?$C1%"#(XDD2GB;0J@"VW7
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MH4; Q?NR"5CHW"I  X3-VBV0@C2(*SYRA4*@'8SN$H9YA:N>"4/@DJP&ADT
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MZ&!!X'E$CIC)#- ,)@#!@HA2+'BB)+R"(OC $-C/%0R!PN#*+?1 #4#&)L!
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MWT!\P5V,C6540?*@QA.,1Q>X*#!@0?\\0A& Z=LT J6"QF\\ZA88E1D8 27
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MCI$9,(0!4W213&#:5,^$%N!*4!.N$A&)3MBQ1%4!2\\ ;70!2XL84?!P#>S
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MJ0(,P/X"+'!7(D0!$;"M)RYO!DN!<GP!BYS(K'3!77)!%8A)1Z!($WS!%=Q
MV%>[ H5+.?8 $21%)!2!R+CW1QH"-.9R_(8W9\CR#OS 3_'E_PR53%P"#GQ!
MNKK3#@#!%HP!7ZJ2#W15*]R %%Q!&OA $_#IG!1"%?R ?%S!#S2!$6 "*M!
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M^3ACEZX9"X&!W'5KAB2"NV9 @C4#%C!6-7;!<A+S2AB"03 "8V*F(%B"9VX
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M2(FW,8"I D-@B@@")H*X:+$,#W=X$!@@IG M,&!Z( M"C(;:;28LWA3CAI2
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M;B *H. &'H0+!NI+D*01AE@*?/Z@-2S&#'28KJX@"JYJ620A)-DQ/; FB8^
M='3B!IH@"AQ%)X;8D]@6=HL A\=""XY@D7\"$X:8'3%"'G>@"%(!$7( E$,C
M#7( "\!1;K9)#&SC%Z)@"$0/B69BE+>@A=<B$6Y@X(: !O"D"W# G;A@ZY1B
ME*^@"6#H#&(0!^SE@XN@"WQ "R B%7J0DI> /URR"MQ)-F&0A7. MVX!'%OX
M$K.$AQ'Y#+K@@8G@)X+ F)O@(]LS$5!YA8M"BP?NH@3C%8B@"408CYSC!Z*
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M1 $37E$&&3(95\ 5T($JR $)-'"8E\40'4P41. P-? ?NZ &53 %3: 3:E!
M*.%%4^ $42 %-,";9L(%R]$G9G+29+$+.Q $6H %3> :33O,QJP<CC'$N$/+
MKB,).L"H[#$#N1<$O$0<+S$$/> #7U &@,MT9F &C?!WCR %JH"BB@ %:U#0
M8GRD;\++4M#->;*Z'TUN(\T*J) *K8 +A@$+L!(>(]T*<=T*_AK0$06U4L(0
M7:!X?QP&>-4%6^ *?G(:D9 *F9 *L! 8[ $)4Q ^BEP#%OX&'+F2DT4@";<
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MH? (T?[!KQO0GWL)ECN:CR2;@2^@11S NQU0CE8X@S?"@<1(H]4@@B5(Q"N
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MA"&XWT?0L52H@D=8 A]H BF9YXHB+I-"@R$(@BBH#7Z^*&@A%%:H@M],V"$
M AO<""PH$$AN BO(!#5H@J]) R,0"$@>QK)E$-NMYRM(O8VH75)V#G@F A/:
MB"YP$X50A22@I59X9<S]B3$(T0/!K2K A">!A3Q4"DB&.33PI#081L;H"TDX
M@F',#86@!)CF$TFX IH)KXTX QFZ24G3B^S8A2^@:"L0D/XMZ U?$.I"<0)A
MM@+R>(4J4&8X.0)<R,\BP)$J2 QQ%.8JZ)Y",.DQF*,O1H0I"()<YK=Y@07H
MTJQ'J"T-$6;$W@4Q,()4X&?C*@.*KH)%_H4Q0.<IZ!Y)@&?S:I['*0*XL(U'
M*-%R'4V_V 4HN!ZE5H0O,)$F6&1/Y@Q? "/=QHP&*FV^\(4\LAC"^&V6:1F(
M"8:F/=.^*.[BSH^>X0OAK@SG9B+@9ACI9F[.2.XFV@SI]NW+"-/E!N[I+NW3
M^07JUI(+?&X*&N_I]HO?W@7T3AQ?V (;L $?$(@ON($:N('0."4;J(%U[@N#
MD V^,*SAAH1&Q>W,4.[J'B'3L?Z6!D\=":<;A0 EB*%P=<$((UF7#&<<FIP!
M&^ !RA3#&N !_OX%2X !$V?AIW$KDCD#O)L67\ "#U_P&\?QJ[F%E4Z;7\@$
M[+YQ33MQ(,C#'#CQ'=B!5VB%&K#O&? UB\F"XL:$2?@++P#R',?R+-=R+!ID
M)E_+& \")^\"C5@"$Z\!!?^)+9C5$<J"*]]RP$ ?.!?O$9+O-[?S.R\;BK"!
M87H$(#CQ'B "@5C$O(48,>#PRG@%O,-S(OH!Y-$85W R4+NYCU&(EG"BD1EN
M/-?T31^BK)@!GFL%@!'Q&OBBY:N!&FAMOI $324,N.3TR[@!5ND+ G4%7U"$
M-2<,,_X82@=_]5[W]7;92AZ 42P(<1B%LU,/@@;ZA2KH(];X!2D(6RV'A47
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MU=WDGTTB)!0!%04B9" 9V=F #ZT'$\S$=RW&+GQ!#^" #D23+]@ 9T"!&_X
MS#&&&6".&C!>VC$($0 !52Z!A?F$*Q2!#A#7&6"2MCRD2TB>PM!$%:#"#YQ0
M)MV _R0"%OK>##YD.V4$9-"58K!*))5B(=  %* '%!0!)(@5A"09$5U"$]P
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MT( $32&"#'1 ;K00 0,N ,"0K  0)Y! 'F81 @J<+R2!Z  &3."].F@@ V\
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M[80(XXG_ F4%ZZ6 "4IQXPT'%1@I &\<UGN'O6KVG&A<W27;^X$(<& #'7"
M5CTPWK5=0)>K"P0#@A'B09#D 7\@S 3T$)(+G ^0'>@S N@P"@-8>@,;0(#<
M&,!F"!3T 7T@#!\B  P1F&!UP8!#=/W'  KH$I8D)$PM2X& 3G.@ P9HG )F
M,0<&K\X3Q!3@)Q @P<<D4]G \, *"&.*!=!B%&H&1K7S^5"OA5ANJUL!>MW7
MB0+(E(0AJ<,'0!#C:T][="8(ZP><"HQ5F+2J!;WSERG4 ?X4:- FA&D!@[.+
M@#= @!8;7G04M?H&"Z!SS@E>]P?]>PH/D$")GUC%Y>!=$@VH6+/8Y3:CT3J!
M5V+@? NPPR<Z$8I2V.(3' 2%)T8QBP^F\::BRVE(^'#.;XN$! ^V8AT8<#^1
MY"'5(:$ (A$P"%! =A:)3L L[F!K8'3B 2N.&F'.*YD6-[L#X\WNM"D8N98#
M PX^G+ H@K$ N?$-!> %G /V$ (D ^,#$OC#B!E,0=>5(*P@ *F\%]"^!Z 5
MWQ3R< =_T@:SSQ,!$JC; D0'C J$=0[KQ4/#5VB* 7C9#@H !AVF&\4"!QI_
M4$9T?>]'"P9T6R2--OK(+0D"+/X#HP2C"(8#O%P*$JQ.[2'9\H#1ZH=4F\(
M=9@%'PX T@M0K@[3%6&Y2]O/!S!R%C(,<2E*40 4CB#T?Z. ):T^E!HVO=6$
M>79(2A%!:4>.@L$@/@I-D %G:]6#"8CTVE; /10F8,=MWFO80\+=@ $$]BVD
MV@<""JSP*.0/*L@G"(,%H"\8+H  Z@8.$& $1D "H@L.RJWY<,[SD"W"2.
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M&/R  :YM "(/B2\6 V#8DC))?B^6%$& _A; O40B H1LP/[N^X!A Q89&!P
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M#TX @SXO"?-@ C3 _08@G*9N %3@#U8@\);V%!A@ ^@@!0J \!PC?'HUL.A
MSB\P&!IK!+!1LD)BX$("!"A@#^8@G./ SH&P=S)@ 48 !#Y@8-OG#A)K#BC
MNO+ NFYV#O8@!10@!,#:Q@]CC?, Z"S))P(AOZ9.GGJA#4#@JB*M$[SL$TAK
M%,XGV#ZA!#K RRY)!3J@]D)"#Y(4;:;6VD<'#A:RG%"(#J"Q#CIH%$B@ U8@
M<E8Q).A B.Y ;@9K#SI@!! 9$ J9D6AAI5YG%*A(!#@28OYI807F?6<;XQ3:
MX-;_8 0,=Q2NZ:E,X!1H@=: P1/R2\1!(*@(XP\*F;1&8LK+> 7LP'ORX /:
MX!/.A]G'6AM!P1128,=QG2CRP .T_.5ION9#YG@,DUQADC.YM3%Q/C%WWC+[
MTN>[M;3#TC&R\BP34X-V'G":OC %U>;=4NJIONHKIORP/NNU_BVQGBZW_NNY
M'NS%?NS)/NN]ONR5$NW'_NS5ONW77NO97NWCWNWI'NSGONSOONYK?*N_/N_)
MWN_U/O !W^X#O_ )7_#AOO 'W_#;?O&WWO$9_^]KX@^(UZ.%6JA50*A90/,S
MO_-9@ 4^>O-50/0]&O1'G_0U7_[S15_U0]_R4=_R5P#T8S_T4W_T+]_S,9_T
M/[_T+S_W6S_S7Y_T>=_R6Q_S.Y_XD?_S;__X3Q_XE?_X:U_V@[^,I1_SHQ_X
MK9_VD;_TL9_X1;_ZM__S5]_[.3_VGS_[OQ_XF=_XV1_YC7_W8Q_]R__UN9_]
MX?^CC;_[<=_V[18Q1B%V 8+%"H$J5*PHN&(@P8,L6*@@B!"BPX(-%R)\R!"B
M08T8'QJD6/#CQ9$'13YT.+ D0X8;589$&;*DR9(-#[HDB+*BS8LX6XX\Z?-C
MSY0_(<IL&'2E1Z(F=8I4FK/FTXXY9\:\.I5BSILLF1ZU^I.F1:%=G;HT2//C
MBA1Y@/ZY?0LWKMRWP>K:M0NL;MZ[P?;NU8N7[UV_@@D+#GSXL.'"@!$[_LNX
M;V3)@QLWAEPY<63,E#MOGOPWM.;%CT=;-NTY,V3#HA.3MHR9,V79LP?/O8T[
M-V[0J#F_YOO[L^+3K!T+SYR:=/#:FB_S=GT:=FGHJ3O39MY\N7+GT54_1[RZ
M._?LS?7J/H\^O?KU[-N[?P\_OOSY].O;OX\_O_[]_/O[_P]@@ (.2&"!Y_5E
M8((*HH?@@@X^.%>#<$D(H5L(4CCA?K-5R&&''G[X'X8@CDABA[/X=V*)*J[(
M8HLNO@ACC+>],8> P< QBGH2SB)BBZ.T$1^/P-#21HKL]?[5A@K K$!+?GV!
M@$=>,O;7URQ&NM7+*%I^TB0P66[9986SJ*!!!W#T,E<G<@#328WO"0E7)RG,
MF<(>/5IXY91Z[LEG*5J.\LDH8>8WR@$)G'*;B'<>2,$?[@7C0"?V+7HD>GPH
M$%\$CIH208X9HC?+ K/04H"GG\+75R<-H,GG?A+0(65?+1@@@00,V.%6&[1*
ML "N8CK@P1YW2% !JW#-D0$P;SP@%Z461DH7,' $,$(((#! 02W-N@6* \ZV
M"FZX%7[@@ 017%  D-^NU]<*(X  AY1OT3*H6W#"96POI43+;[3!I/AO7*L8
MV0L#@<@[:J*F7!@7@KT@RF^#IO[4F["$M>0)U[Z#1&#AMEZ^-<N^S_(Q5\+^
M8KPD!L"$RB/&)LO;L;RL]G)O!'6(6U\P;UP@0%OR8G 'E@AB<+.7Z_K7UQS,
M6LA 6Y>Y-8<%;QD;S,+1TOR6+0L<W/$;$] 500<9A]G) K0T6$J8#./,=MLA
M!H/F'A:@7)\#?^3!L5MUA !'! Z8T-<)*Y3P@ -NGM#&"0PTV48$%4C@Z!\5
M-,D'!FAF<' ';7"P@ I_6,  "%5J@,$%'=!\P0(/O ',*!<\KF2T<TC 001M
MC<#ZD!:8 DP;$EQ @2? F*(!'PVLP"8%&E"0@ENT=/! !2MHP'LP(U!  0?:
MQFFN!OXK?&W*!"F64&,'=G10 3"U=( !!AK0TLL&JK]!2P7[GK*\!" T.8L&
M;V#P@+G%)0+Q*H4#V@!  0)C$!.P@ 16T!<5-*]U%^@%+32PAPB80%D1P( $
M^N"6$HCM:&YKV!SBP("B68@"?N+="DTQ"A=RB \%^$36FI2'$<SA */H@]CF
M0 &W@. $29- !VS7.O]5P 'OH\4%&/" .,BK;Y)98 'V%0@*;$ "2F($!!@P
M 4$ (XL;F  $@=&!.Y"NA&QLXWU,P0!3Y:<3"+#@ 6P(##L   ZT,,4"@ 2"
M O"!%H$@P,%"4( W"&\.#%C8'@R0(PR0H!<(<%0P%N H!_[8SQ0)N( I2H&
M/0!C R-PRP: -(JFP>\!-:I?[MPR"@3D"!0+" 8=EI8'!^3Q 2?:@P/T90 ,
M\*$4D,(5I,38@2:F( "\"X$'(J@!N-#BC[T !00DT#H"B"P#+0 &!190!U$
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M&3 "&) T#V4"_N--0-<[3*1#"P!"*6  9])(G/8[%' !^_*!(M,"=U5%?]
MZN, V-6 N80!D%@E%Q !;44!]"*'%D)N&O  H@-LAB@7%' S*H!A;[  $]
M'= E&HE2'MDAF!4!*#5),)<L?6$'*C,'*@,,#*4E#Z !ODA*IN  'B99)7
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M'Y\%2P?,L^GQ!WECOX9W"GGP #L(#'U0 ('0"T4'4QBLP8%0 **$>2V@4+3
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M!1 '@3 "WA(,%- !@S '#2 UW#4'I1 '%OP #Y '@2 !"C4+#8 ";6)(TO(
ME'L!*"#,+=('NF0+2BDES08W'DUW!]R2R@("M="[*.P 4;( /A,* ? !?T!#
M0>,!!C '@0 "G?<69?('/7TP M@E$Q O=V  >0 (-4TR?%#4@7 " - 6+?
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MB2F  0O))@L0Z'\T]!#B9R/?"P T A# 4WMA^1&0 >9AA2<2Q"F@ 8-5(10
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MY [R."B$%-2:0P1@3&@#F!9^#K3GG]6[&*%9*J"@ @TNL."!.6;[0X.;0)$
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M< ,$+ 4%.E "!XSD$PP8@086<((38( !(+!-,!(0-<F00 ,X>0 H'@ 5#+
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MV%PA6C>(UKG^=8?0G.O $'O-@8$((>S@%68GN]/=_G;0<6$&-[@"%ZI0 QO
M0 T,6@0,;+ +N =>\&[3P@QL  N#7.(&-;C!+0R2BC-H80R2V(TBNL"%0^0"
M&+A 1")289!')(+RERA$)'"!!BT< ABP2,,6"O$327Q!"VA8.S!>D0A$[.(1
M6_C"YU%Q!<:?X1*K5X,6L% (Q ]>^<LG6>%MT(JVA\'JD#C[U*D. RWX8O5+
MN#X,@'"+5E!][[[HP0NF  PNO* '0'C!U+L !!=,G0L&X4+W;U )8#SB!36
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MP34P"%=0!$A0!15D06   CP$!E7,16 X@[E#O$1(P%2  AB8 E2PA$S(A$N
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M6K"%*14+*.V)&J51)]6*)F4B&:6I8+B !1C3!6" U$G1F#*.U:J#_/@$"D"
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ML-N5C?Z9N'V(V/U=!(@CP4D #K@ 1#6(/%@ S4B XS&%!%@!!G K/D  "Z"
M$ !:TIB% 6")GW@O@R@!!N@ "9@ @DH (XJ ![ #"KB  :B</!*!&.J -YB
M"BB W"F!ZU&!5;T 4VB#!'@ "S )$] A"=" 7.H9(-: F.B$!=@ #T  *P(-
M!CX-FN"E$>"A L@98 "@ V:)/U" %2B $3B%";"AG/D>#/" A$V)U(H !]A2
M.1J 4@ $ U"10%  $Y" "RB HLF #=B "JC7X;%A$#CAF$C7$;@ %,ZI.3
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MW$F 3!J%AI:#_##=R'XN=/HKM>@%!#B>FZ %!? #QET PM'7H#  4#AR6J
M KH)3RB $B T#=  J." *S^)E+H)4P"@RG'Q@Y@#LS*(7OXX  PV"% X@ >
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M,Y_?9 M!"NE/T?B3GC/9IA %VI3<C"8[!2UH0@W:S];P$Z!282B+4D.04&R
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M00LP+68RF[DM%7 MK2RW<UG;G#,:Z(0*@E0'$GA9 2D_TPAZ/8%FF^ -;6B
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M6T1)@A#&"0RD1]"*(Q9F6A!F6E;'0<*!D!1%E$#?.>Z''<A-1G3 'VAD HT
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M']AAA)5 KWP86[ AO6V  SABCBK%0EX;*,!RFR@T'D38"3#,&%LG*D-K10@
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M(0X10C8HD!16H&64"%) $A@5(@AD#Q/B2&&RDY,>LH\42(@S$((PXF,4DC?
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M (I[!N,$>9A%-MN@@5& ( ^"V!F42$F+-L!A%A4(Q%H\"8A/2*H-&1A%".*
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M _Q@#R+@9$*F!;!HL.9@ <!CF-AO"05!!.*"+58@W"SK#^!@ FRJ_&8A OX
M$#PF! ;A#\ L$!HB!4R :.J (?) >W3F#>A@ 1"$Z92+!/: !+I)(\#E#33@
M4P!A VIE#VA!(@ !XN! #D9!@5K@+-[ !/B ]CP.5,[,!J-)$%#.!&[O UH
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M=.+!&R>8,,I>*\TA 0@;;#!+,"&DX $?P)0PH0:=S*62"2:L<(%? Y5 AU"
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MJ '%?^!MDUPB!M1510P2 1@QG%@Q3)#"7R3QA%_H8@9J:%%57R%<3&-&$5?
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M"T50 TV0CY2A"TN@@8+A"TU@>=$( R@(#$0 !*@V!$5P!+^P!D;7 VK0!3<
M#&2 9410!#X 6E*P<(4 #%\P S\@"4'P S4@7SD0!4+0"E<0ER]P!;O0!%#0
M!$7 "U*  TV "DW0 SG0!+\@E#EP!5IP SX  U+0GESP"UN@ U%P YE0!3,
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MJH"01/Y !O,J"67@ JR@!3,@"?UU"S! 8CL0!*@0#(K@"(L0 X^PK;" KZP
M UBP"(IPA"\ "V@  [MP=9# D&>0"]4)"U<P Z^ !;W9"(VP"&]KE9;V I>0
M"#7@"KVZLY)P!BY@"9<!"U7V5_G755?%"EX%:("Q"_!*!#Y !L 0!$MP"T$
M!+@0!%/@MF7@"TO@L^6*"[!0")10!3>PCXW@"VR "M5)"5D0 _55G*?W I9
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M:@-8P HQ< @L!U\8> 8<?@G,!PECT-1:#+E!$ .+M:&3X 2OT'@H9@A=5P8
MN0@ >7=-$*:"@0OF&8(PX(X:>@E3JP:4X 2IL 8D;F<K^@*K*GR2H B51[T2
M" -3T HU(&2IX )F_ (X!\>XF@F/!@DN< F7X )-*N>%0.*($ ,A*05P?.+
ML)ZNX )H<,J*@ HN4 93R6),\ (J>I"0L A6T,X>%K4- 82U5UNRU@I@I5^
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M+@!:5?Y0 W%, YB@"(/+"@Y\!DY/W[*'""-N"?,*"5'0 S+["$57"6@ BTU
M ]M%65^6&%SPE&]+QY:LF3Q&608;E8"!"9'7!"QV"4E@ND>@"HUPF:J HES
M"Z]0!4SP!57P"FD0733:!:R&!E< AUB0EE7@","0!6G0943P V?07V6PF3Z0
M^L!P!C_P: PA!D(&^OW5"*O/C(H@F+R&!K7/8I+@!+*&&;2N<X'1"'LM&+=0
M!5/0!%Y0C+KJ V-0KT1^!>"E"D> ?&K@ PF,F:OW"V=P!)*0!?Q=!D/0!5@
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MFT?$PT[\A4H0(%3X1+-PA$7HPK>:C^MACTP@!$,XA/BX!2 X1F"P!$N\A%W
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..UFJUUFO%UFRUU8   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>x_cg004.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_cg004.gif
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M^_7Y_/____CW]_#O\
M
M
M
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M 0<X4((]X"L0;'!#'8#AAQ!H  1XT!<BAZK'W93B#79X@W$V4"@,!.,-'=A
MB7@3"#G808*TF!;@0BD'3LZ"#B!   ,2H((VR"*"=% F;^P81Q#L\3!3[4 (
MWH NWC#,9_0AB H < "0J10.#_5 "]XT$#SD= _ H$,<3V"<7L2AIY3=X1!I
M08I]=L"4G"@!*>50EPC: 0ZRP/Z#"#Z$@!.X(8(9D&L#7/"&W9""#7TEK$'>
MB,<0V &%6<'3\5H%,%%\XA-E:Z2ECD0 ])#@.0H80  VP!L],!8 <VO#A @P
M@"M-P'\G ,  IG2  62 %$<*P HR,(#I8<FFE:KN  9PI JT![X$ ( *-C"
M0D5J% =# 90(<"4*(%@@<#"3.8\D@4XEA UGLJ ! @>,B3% 3P+QQ 087"/T
MA& W+5#O \0;K2/YP04%1D![6S4+! P  (=*\0 :X(9HR7@ *!@(AH_4GR.Y
M(+, 4,"<$@" &R7@QH<"ABTF=J7R(JE3;0" G-P@8QD'H 0&*44%]&ME"!@G
MK3<V0?X("CPA!4QJ%A9@\XY+@#N@ 0,);2I "P@F.#;P<"ZEP$!U:W2  FR
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M 4(YX "H]A'?I.0!!YRJ >/D%\/F9 )-X?I.RW,0*7SV*PY@X$,#8!DP>MR
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M1P= G/Z"%$X*T N$F29>Y 8NH )^($(5PZ889IMT9! 8U@ "$ AV>3QXH (
MV@O1"&:% 0'YQEW==A[0TY7G80<" 2D.0 "J4X=AFG,]8P#S1@JIF#FD0 IY
MRE ;]R07F#)1V0ND:@!>]RFVB2\I>:AU$"ZF) O1>)P"H:>D<4VB, +24CK
M( $P,@%U$:0^0PJJ>@ _M *W]E/-Z3.!.1A\P:TK0Q 4%TN,N2,4L!MG^:X"
M 4[GL0*D("T$<#]S :W ^IER90!P ":E$!U2Y@FG1SZ?89(6P#HOQ*D-R1J1
MH@"!-#*N,R>%4BC3@@"F- H?4@"]E*=ZL#RR8 (4TP E$/ZCA95;:#).A*(
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MH  $YS2 @ Q H260!Y);CBFF\/X@(#*R*H#  /X( (&I$@BPSP5.Z+@HT%X
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MBTJPQ8"% (X#7&P@JQ2P-M&@ "R*8<X>%B( .!!DBZ(SFFU>P@E"L2HXA$+
MELHU-@L:+3D5N-H;"$ H)0Z !0/YW4GT)0M/$2 \.3R.#'<G@5X 0G]Y4- !
M$A"!W3G2 !-H2PL(@P!3T.(D!J"A+#&2$E)(3P$ X 2&=OX)C%E08'MQ[!9W
MOK* 4-J& !"@W6CDT,#U1&9W&#@6+;8ENMC-<2 >H!XI!W*"H#7@6"ZXGRP^
M<2(!@*V7NYL,2'87&$GJB9A%_"5% C%)D12 %+VPP J[:!,'>:*(B%.+S:X6
M.88VU*$/Y00'D((X!82@%TB 2HJ"T0;[-! !&=C30.2 @!QY8#2S((%( ,8
M$T2S!0EXP -4H1-5/" XEV2*"V":QA9P<P5^8$",/F% -.%T?BU\0#0]P0%
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M7Z/Q1!_R,/347#P/?.@$E2\=B(8+FDL\O[:IU7WP84];W:*1.BE270I1!+N
M+#>[:$S1*$'8O=%_!WS@!3]X3P\^-9[   !<X-#"&[XUC7=\:2 ?^1\^;O*T
M5@!6+$9YSO\] PE(0 8NO^C1=_X^-:,O_6I2;WK6M][UG0<<:U8?\-D[KO:G
M=_2R@;'%Z"KZ]H%?_>Q_G_N&QKYQ/L-]:SQ!O0#L!?FG&7[E T[[1C]_^J.I
M0,TT(MWK1]_@MS<^XV5_>N&G/ORO][WJT;]^]K??_?2]^OOE/W_YER(#'+C
MA.G_?A-@( ,FV+\ %, !), "-, #)#X$5, %9, &=, 'A, (E, )I, *M, +
MQ, ,U, -Y, .], /!,$0%,$1),$2-,$31,$45,$59,$6=,$7A,$8E,$9I,$:
MM,$;Q,$<U,$=Y,$>],$?!,(@%,(A),(B-,(C1,(D5,(E9,(F=,(GA,(HE,(I
MI,(JM/["*\3"+-3"+>3"+O3"+P3#,!3#,23#,C3#,T3#-%3#-63#-G3#-X3#
M.)3#.:3#.K3#.\3#/-3#/>3#/O3#/P3$0!3$023$0C3$0T3$1%3$163$1G3$
M1X3$2)3$2:3$2K3$2\3$3-3$3>3$3O3$3P3%4 S"7RA"4BP-4Q3%5%3%563%
M5JQ"33 $0T"$1C"$1W@%T]B%,!@#5&Q!7Q"#,/"%7Z#%2R -6- "0@ &3)#%
M7?B%7]P%TK@$+I $5Z3&1:2"%Y@!&,C&&< !0Q@-4B2$%WB!1P &5/P%7CS%
MP4/'@4#'=?Q&U%A'4R1%1!!'1/B%&7B!+BA'=@2&+'B!&/Z A3)X 1BXA4@0
M1V3<@B(P@X$ @A>X 5_0"7>LQHG<PRR8 1X @HRT 1N8@4P@C5,@ B)H!1AL
MA9!$A5WH@1D0 ]*(!!V @E] @QFP@5=PA2(@ E0 AB!X 2T8B#+0 3*@R* <
MQ"N0R4OPA5T@!([4@ETXA54 AE:XA%VP!&+<!53 R55 A$H8B%- !$I Q5V0
M!$2 A)$L1U8XA5_8A4QXA54XA5L8B%U@RV<$AE<XA9$\A5,8B%> A$;P2-%(
MA49H!&(L2U0X2D=PA%N,R$MHA$A S*=L2V"0!$/ RX'PA4I A$=P2F#PA4NP
MA%^XA1V @3+8!41P!+<$AEW0!/Z\+ .9;(5?L 1+\(62G $K8(5?@ 5)< 6=
M: 5'0(3)'(B"%,O<%,KA=$,KD$E6& A=X$@LB(08N $SF($@0(0:F(%3D(08
MX $PR$88$ ,TB(%LO(*!N(0?@($8^$XT>$J.% ,EB(%(  (8J(*!0 ,8F,F!
M((,82((QB($G  9#P 'SA($GN,5=D(+RC $8@ )?R 6.K((=^,X<L(2!0(4B
M*$\8P($T&(@FB $I@(+OG %$  96( (8$,<9  /(S$9)^ 4>F $HZ %LS %B
M' .9W(7YM(%;N(09^- @J(&-C(%6H (8*(*!$(,:B %LQ()GE(0<.%(+!5'B
MA-(T)/Y*&[ $77@%,>#(,JB$BY1)*$ $'44%2IB!&[ !*-@!&Z!.* @"&X !
M3/B%&W@!*)"$+Z!.6%A0-)V!'@A(&-@!70"&)X !*M ),I!);B2#'#510V!/
M_B2$& ""4[@$G20$7]C(&4B"*^#((#C*'Y@!(C $+*@!&&@$8(B"'MT!*-C(
MA[2"%Y""5F@$&WB!4\ $'?5*,FU1,=B!/ 4&&_6%F*P!'-512'B$7&V"0]B%
M($V"_HP!&T"#0^B!&!@#8'A/,FB%,=!&TXS2;!W#*>6!'F!1ZG0%29#))&@%
M7W@$,*4$;1P$8/C2&2@#8( $'7V$7X"$27#+=K6$74C5?/X%AE.@3DG0UQEP
MA'T4@QFH 2RXA5^H@AG@3V"H!!R8@58H Q@ @K%,!51XA5NX 88EQ9B<@4MX
M!/J<S">8@2&%@CR%!6#0 IE\A9-]@DIH!4Q8A5RH!.JD!%]@42@8"$/0T4L@
M!/KL59D$UAF(!& 8T2\8B)--@E\ @AG01V @A.ALA1W  2S !+-D!;G4UJW]
M0N/$4YDL@FD\5Z(=B'B= 500UX\%!DOXUWZESE%MA3-8 H[DR$H(V!/5"0T=
M TC@4[<DQ8*U@93]A37%4XY\ 4-8A6S\SB#H@EWXS!E 3V! !>I$A#" @2!@
M1F"841ZX!2@(T)T5VD: @?+L5/[TW-(9J%7(+4LV?81# %H;'=I),%H8R(*!
M*% H:(6-_%I\M(3[+$\;6 )RY-KA[4(LD,E&N$NR!(:Q%4RS15L=C5 Q)5M$
MA817,-(@*(-'J-N 74A3- 3\I((8B,]!S5._)0)+'8,P*(-!4 1*>$HSD (>
MC8$DY0$8P%!@6(50;82"Q5PB'5-=.-DE&(B?#=QD%(,GV-@7Z$U:Q5EWE5#6
M)6!?& 3ZC-W9Y4E@\%PH> 4TA8+T+0-"4(21C 0MF-ML%$SB1>$J),4I5=Y]
M9-ZR!=.TC=#3G<94T-&PA($>>,93N.%=N $8Z-Z\U-T9($=3%(.^'0@L@(%D
M/4UAS?X%,]""404&XRV"J;749RP#ZCR%2*#/:?R%)%CB/_U<J!W34P #+8A0
M7TB"&= "1*U5&R""7 "&@JW.J+6!78#.&T74HCU?*R!%STU6,,:"@8 %2(B$
M4\ ",+C%5<A5])3(%(;D)9Q2O.3%%UY>,-4$Z 4&Z2W:686!2*B$904#-#A3
M&,A7-GU7T?#:'=#:.8:!&\"%!X8!(M "G:R!72@#&9B!,4 $]DS22@T"5"W9
M<TR"&-@!,"#9&9C&)H ! 89:^GP%*9"!&R"$0^"!&$ $1%712MV!)N!(( "&
MB;6!7H6!7\U1&)#=(I#)(("%\"4">-7&)] "&Y"!)7@%./XM D,8 S;MRTCV
MYR?4 ARX 9SDQ4C  1Q(A8$P:!J(A4H0 ASP2$O @1R8QE,XZ($%56T< R"@
M@4A 21I82-&(!)FT@H@,9QP(@E@6SS7^SE8M1S&X ?-LT5S0!1:M@F(N6>0$
MAENH B.E6.&5 AK0V?ZD@1YXA6.U ?/$ 9Z4:"'PRB#  3*(@N\D KPT@XGV
M!4*@@1NX!4S( 1PH6DGP 31U!2R@@89U!$Y=UJ7LUR7 QQC(@4/XY[EVPJ/,
MW&_<A;M&RUA&R\S=:U/$A;MNA5-XQEW !8@T;%2\!4J89[)%1;LF#52XA!;>
MZ528[+Q,R87,A(0>#:@D3)WPA?[#9L>\-D57N(140,R_/DV^/FUY-.QRQ 5>
M*$?29D=7<,N\ADC*E.S&' BH)&RZ!NX^= 1=CH$F>&239@U82.HP".[F=N[3
MP(0JL((S\--&TP4LD(*!?>3CEC]WY.[G!N_P%N_Q)N_R-N_S1N_T5N_U9N_V
M=N_WAN_XEN_YIN_ZMN_[QN_\UN_]%L&S\#[^EK[_AKY"%/#C"Q/) SX 5W!
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M!IIR.OZ 5B0\,$LP=OPXRP$6P*R" A^ZH, GMO@! $D8>-A+"P_TPE8+ :!
MBBD68(#> @VX@2F)+0SPQBR@N*0D ?"P* 68 !@3()$+ G "^&'@*9]00"V
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ML?R'IAF.'?#'6>S3">!!"<B@S)3-8WP(!123PGA8  %#=9:& 7A8 1 ,'!0
M&]@!!S  [BS;42S 2ZA4"]"!""# >1W))@5 X. ! :P/)S0 8JC  ]P+6XR
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M"["3N6)7R0)@"/P&+;B UK9A"RCK"KC <]0!4P)'Q\24P!ZK_=XO_@X1)S
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M #-9+\CG]8@ O\GO'-Z\@8T9W_XR J@ J8&QFFQ  14S=MX%+63  >+;&'F
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M;< !P!S] <@+)PQ SLS"!MCD46# !F1A"YS7&.V!K"@P6WP8@=I!'<0F9T'
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MCFPG-G#&$]<:B2A* ((W] (.\YM%"C3  =6<I!=N:,$*5OZ@ CF8Y3FNVK-
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M!@GP-1DY5/8_P>B$P!6$@F7RG8&3J<,!K%J@=7(>6-MW$+S9 #NV^'<@@<
M9TH.H/X] * %;6A#"^(T=X0'J$FDF([)48[_O,("MNWV;D_E3@)4Q @ Q>_W
M!!#B'J\G).)N],_Y+NG=JL^V)NA?Q,GY2&( V,#^6,  E*CC&J2)3 ^"<$]@
M! "._,_$#G R\&"A@($/",#G(B3W;I!!I.)%5N4$:@CE:.'_"F^=)@"VN,]B
M3*\"VB #\FT@:('06"1RV )JO&(6<# JJ)"=!D(6L(\6ZF:=9L$4L,DKD"\*
M)88$/"#B@D$*NS#D,@)T5F( KLDXJ&7?2L'Q%*E)(F<P8*[C: '^W-!.SNU(
M M$X"$T#;&(6L(^-<)#BH@WY#NL.WRT+V6@RIH(+(T86!O[Q:31%"L=C%NH-
MTL;HL"H/#>5-%BJ/$>G"9 :N%P;1%.#0%AK@#IH$%C4D#B0 1)[K$J]P$ ^"
MN$;"#PC@#H.!$HVC%#3N8;8"#UAG3#)P E;$"\V0$D4A 3XAVK#+3B &%4DN
MWO"@ >#B#Q;@%]J0+4P!_B+N"B$M$!*@/@:QY_;OW1[ RV9"AR!.%?M$ 0*!
M#REQC""&%3& E9)0@4:A &1AI][-!"3  B2 *N3@ 3   J@)#R2@ AZ @$QA
M RB@ C" .2+R AX@@#8@4SK !4B@ 13 >8+!!!J@ 4[ !!RF,T!  B8  [)'
M$!X ?BY ,5Q B8(!CRP@ @PB!?[(2P)(@1-,POWD8 (:8 *80RD?@ +>  .8
M9S+T8);:+[6\XP$F  ((J$8D8"(% AC<0 02)5,"00(>H +DH 'P!0X\@ T>
M0 'V0 \@8 &.;R#8I@(B8'N>A"X3( _T0 (48"\U  54H $8P 3&HQ0R8 (D
M(. <PP+8!BKR  (N  )4(" ]H (L8 +@Z!,N0 XLP $@H#(^80(<0 ( 90';
MH@+\8 +6@A0T20(Z /Y.  (D( *^B!0X0 +&DCE.X 10X"4_J2X_1 /:P ,8
MX +@C#&7*1A.0 (Z$N;$+014<O-H03LY!"^&0S_P8 -TL0$P@'@>0"+?( ,@
MC18P@/X!CF4R5N !A!.31D(.&, !(D!M&$ .,, !&H J9F%-:-,8#P*(1B(/
M!J!N6L K(:!I!L(-(@ #'J!?6, $Z,"N3JP!'  $V  "FJ04)(!Y0* [5M,]
M52 E5W(D6B "*. A@>$3(J !T(@6&  .-N !&L#2:*$F;](V9L$"]& #),!9
MAH,!:+0/ L$!ZH U)8 Y0 &L)" $>J$4=E(W/ #9C*(C)0 $X,(/,I("6C-@
M1"$#>G,#MF(6)$"<.*$".*(!^B J4@!)8Q(C3@(/_(T_@&$4)  ^[6(67L4"
M*B IW-.D5!)" 95#F]!0#K @"80.)F %)FXH/N(3EJ,C&/Y /-X B*2C$X)!
M$/Y/#PX $$)' 9K&58+!\_2#-CAA-?YO)&E" ?I@%O!@ !KB. W*#@;@44XB
M SQ@%GIA!<P-*_)'!6+%9_3C#A) %&NGYYH,:GXH& (! (9,%BP :, EQ$3!
M PC YK)2#O  #]R@ I;)#<+BPEI*H *@54<! :C#!03@HZKF $*,$S  0THH
M -A %N"  $"@%$@E4QYC#WI!%*;IQ/15%N1@ /:$-C(%!/!M%CQ! 0RE0E2@
M%P9T+1Z# N3 $WYJT:[G#B(& ]@S&/[&,01@3UC/)#!'!21V PJ .L9C73#E
M$WH! I*J.X$&&$8  LZF#@*@-_X@8 08404R%1AFB@YFX00(X 1DP0_6%1@>
MP $X018N8("^# '@H@2THA<4:B8@P '41@ZZE2XFH!1D004(P";DH#'P  !4
MP+P@X"I H0#DP%3PA!0-]@UF @4<X&ST@  6D$Q<P&>/,0$VP&-+P-8J( 0"
M\02.=3$.@ ["M0TF8)B H@$\P1:(\45J-2E.)2G45M%H57!I 0\4H )6I0$Z
M2!8<(*R 0C\P($!I=0#$H@4:0!1Z80_X25H10 ^B< $PX!-B;"- H@-F01CF
M,]H4H ':H%5'0AC>0'-[@9&&3!4P0"C*A UL818R0(F.4&"Z9B @8-AF(0),
MAI%( /YM,T![&:"69H$$8H1K*B,FWO1%6$ !/-:L2K +=\)R#B G.*&HNL("
M-D \P,0S)( 3DLP V.H\2<$$!J B')5B9D0! @ V_4,N?*,_%"H\+(< %BTJ
MX$*7.L(D/  #R! 8ND(Z]D"1X&("*N*X;L(@?C>4U"]'1J(!ADERJI-:P*1V
MQ(D6A,$BL*AX8.(MGN,RX,"]2B%<!B<KU\,IYZ)%+,VVRB4\F.;6%& \VB"$
MBNL/;RT"NK  Q"DQ[\(5:_ ROI@K#$"<_@L8: ]1B LAL.D 2$$4!$"KN$8S
MH- KEH*"+H-4B*>.)P@82D$ I*Q^OL@.#ODX0&$6WH<I./Y!#Q+@)!Z@(CP
MBP+A (I8:INF/P>B!?('D?$85(@, P*#=8V#(88PNR# +FQDDG#KUB(J/U9"
M:SN.A]D(7P<"ET\BEA#9 &9M77SW)!@ $ 8G0R] --CRKL2'BO)'%*A%%A:
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M$-K@ -3X*U#$#V9A=4#;E3+BDM&Z<C9Z)-R#>5A@ IX=<:J7KFWFR_3C2#Q
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M0Z\6$*XT0P'&G:*GD_P]R(4JU$U*ZN"'/6"  S$\&0<XL!92N.!;.T'!!C8
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MH ) L<O"6@ !J0Q+ H1110D@, $5W,8##<A 60)!:$.#>=&,;K2C'PWIWTU
M41^YDP4RL)99F* 4+:#+5%1 "A \"AAQR  &D)!;.6   R[ "RT8$%\__),$
MF00$!S   B_M8=)3#H8&76)J%)#&#F_P P8J$#R\P*$!:/;-7T^@3H/ (0$(
M/  M,& [=-*96!;8@"E.5@'UE:8"(HBTN<^-[G2K>[V>$$%(1M&+"4Q9#PU
ME"@., $/O&&S>"B !4+@$!,\P/X/@:A =&XG<()7("ZO9L0H#U '1I3@ 83#
M@P'"AP(#B$)Y#J"#9@ %C!0P( ^(WI' !F "/<#!4S7R)?L,P(B-?],@)X
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MA;W  &F' .(C"J#0"QK!$2;P*"1(4 C@"1^221:0-"B ??X#P3@TD2=OIE_
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M9!K 8QA  GCQ"0K0 "?  AHP (GT'+CQ$_MR1$=4 8%0"@"@B+M' *R5%Q@
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M")RP 7'!'<K!!QZ0&Q8[ 1R@.K_[OR4 LXIA !@0 J[4"W5S G[ -Q' !GP
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M2D$'Y*$>X,P0*Z 2@9P1$#8!Y#(L5,,?=E4'!M  T)EX'S$!L=%9GT"VGW$
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M+!CXAD!.. RLC@W&@ 2G8 KJU*1%P ^P% H"E:H3H.K86?X/&M#A9(>!!%K
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M>I;1\(" (#Z/A#!48C!VP@D+Z \X1VG?\FA# 174A 0QV]\-QT*44>CK 2%
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MNR:> J874/:  Q@ (D^4]K2I!=8&F-IC^% @S7P-!$)>\XDPZN0$5&4$6SS
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M!;00!0@&L)[YV248I4A 539P@#S,0@\#*",M3G5,$CQ ,1WHX2SX,("W@.
M;IC%)_X0,-)/%* .M"C%!$[3"P.PH1>C3B,G#/"MG&R@ C(W 0$(A($3O2$
M+;@X \KS!@S*_0"4DE,(!, &67B" 0&2PP T@ =1>"P$C3P! P(SI5+,X@T
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M86* L3L@". 6!9@ 3IB%. N,#,  4I %%P" M>"$ K #LH. ,PD$ Z"%7E
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M!R*0G8JX*1:GFH" .I@% R !0)@%.SBR:U0?'-Z)"%@G %2?@ZR)^P,&$."
MX^6$Y!TEW/PM!XG>@4J<T_)C/>A?3B!&8*  .[9'.@ SF +$.O 4"JA-%=A4
M.B7;.QY6%!FL3W QFJB #K%:1R&!Z5U<S$  MC4 4QB%@+2*)0,&4_4BF>"$
MM$T+0PE16<#7AMJY;.V@_JUD;?Y]*JYX4/BP"#]( ,+=)%I(4HUP"0Q5,,>=
M@%+^A;5E/].]7*N8UFT5A0-H0W -A@?( #V0A4YXD<M4GMVD#+Y5@+4*!"S>
MJ3E-7\K!(V!1@"UE (Z5 T/) !?8/ L1"ZG@)6%P.&!@@&_ZTZ7#/[5<F*:@
MA03 7@0X" ?@X(L(@+5R%!$X4>N 4]\KD'J4 Y>MB3P@ ..Q"I1<RLB,"190
M##8(@1"HGA80L3Q  ($I:CB-NIQ :G-I@7P)A)M>#)30N*CHA1,0.)V1  GY
M3^IH54?AX^_-0ZD@,!I&9M:81:L@+TKEE;0L *V+ *M GQ=.(%DH "R+B0 T
MUCD1BOYL+0F)W!)/@&BH8<$"P5(3<Q1.P,>^/ "2P0 1@=,!*%YS+4H<6PMV
M;<&;UF>.54]:W  5,HD7&87ZVPP[8,^&]$C7=L.=$"L.B*/A#) %<6BK( &Q
MD(.A[@Q98,I[.=I24 #UB>Q#"C@UU1/CK@G@<F2QH .-/I06:*>HR@Q[J:<,
MN3YYNLJYM(HZ> L*Z+ I]I&N%1<'N+%]K H]G1#0#%6K.(&F50Y$TPG )3C[
MK$UZ,@#*D 4IU:BA>."WTI4 B(H3L,@].(!>X(0%@!<&,)1K'(4+8HU>0 &P
MM@H_2%'46!,H4@Y <%!A/A=QOJ!-$4H_<$7E@ /VM(#P _Z&#LB*)K&*/\A#
M4%CIFABH$L7K HG+%:6%SI!3S?3<M#33U%TK2ZK-F@ :2([=OR%<[FDODI#$
M_'%D F@!/" ! Q M.@" 5,6 ";@#.EB $VF+JN # VB!/1B!!U:!!/  .I"#
M,V>F . $6@B 7@.&3@@ '!$%)YD $Z@JG<&# I #/5 !)Q$%ZZ.,-HA+6HB
M#,"#C!6 :,MANM:)#8  .^ K$-#9 \CJ$TA6#L!TOE(0A8, Q< ()"^5%N3/
M M%P/V  "J" %.C4L5 !!<"#*P\O6DBXFD  [9F0!\AT\T)3W 8&!=B.##B
M$(#T :A-6L"M/' # WBY G@#/?Y8@0EH@$_XA-QU%!5  #I(D %((PLX#1>8
M[A$XLAYL %;LT,H0@3## S= "I/8Z9TH@;VXE [8H-&5 !&P@!J*N@H[@#NH
M%[V2!9'&["515\9Q :910!+8@Q5@:T_HQ-"T$-E<.J7KA3K# SE  'M1!0+
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M 8&5!",8M"C,>ORPJ[Z!+X4J7"$+6^A"[]7.42"H(#!,,;Q+X>$ JD >+4B
M !D-"P\-0"&L,,""8QVD$P?@CA\* #E:(,\F+(! +Y#'B0=4X"!T<,!!X ""
M"H!@,RGP@ 5"8)D7HC&-:EPC&_[;.*I/K$ %C$#()X##!\$L3R<L:(&P]% !
M#,0!<((IA1YH@1P>(20/**@#+?" I8/D\&ZB&$"0WK!(X_3"DFV("R<"H1'+
MV.(-)PB$'AB I$Z:8CDA9(,*DD8+-ZC@/0D)1"K;$$)8JLH"4DI!?# ""!4
M"2&RV$P>-M,+.;# #;7 S0DL !,"2(\B*X  1F0Q@)60X@!9"08*#J >$69
M 8AT(SG+:<YSHG-U=4# "EJP@#>8A@ >"00!5@,"9]9! 2UH@0$RL[ )2(@$
M%0 &'@B@*Q(,@$$A8( *0F"! \@'D@>("S<G<!!0,, #+<# !&Y#"@> P#,2
M>,D)'OZP@0;L@198U!1''VE!!'C ! WP0 A$P $#@,(T#=!3!39P$!4@@ ,R
MY4 (0M !G%XF QHXP0:,A!!6N0 %"4B*'PX  H;V:D,>\(EA)-# +!%@=B%<
MU0/^A0$/9.0!+@#&+$90%)L$H@6<,& ZZVK7N^(UK['*IJI(@8")\.$ HGC
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M^ $$O/Y$'PP I"W- 3!& !6-V<0: FQ 4DR%'P! H=",Q?R,U.PBP2@++4A
M@= "C@'E*?Z+!@A8+RC?^!!:4/9-3_#%3MYA,)! ^Q4. IE/,"@ $F1-MC5
M!8!04+9-,#2 G,'E9B(0@)4/)-;,VN2$'PP 18E->QE B;3+>;V/:#9-E@2
M5U[,!$ ;DF3E24+*!,"36EI !BA5!53<0VT  !Y !30C!Z0 0I""*&1 *4R$
M*.P!")#"XLQAWSB :UR&[Y%3+S2 12Y0[4$*+0B6D('GI5# %/TC:T@:I3P
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M6@ >Y/Z>O+B 4KV'**" +)2 8M5+HYYE0\1%'&  !OB!&Q3(?MC!GR9%(%A
M W  8U K=-RGQHQ I]&3Y5T OXV5)PR 8- " I2&"DQ OW) !:2D''K"">!/
MP#0 =LKDCDX !P2"_UR$!(S=),F"'A1 "%6 Y6(N8I$7"'1E0@R +9P !2QJ
M '  '>10 ]F"! "J'%"  5 8"B  !HC $EJ !ESN.P'#[&9 '\A!!1" *LB"
MDU7$ 800 Q3(&Q3 'G!""5! "B; !, I,'" 01Q =]%" 13(01B2 K# 47*
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M,%?9BYP513# 2CB +'F HD8MC2* L+B!$U'$QNG$]<W"U5%$!@@& T= A8!
M ^6=,(W3+!@ V !G0L2G>A+ 3VQ)O\&3!)@A, '#!)AA"U!3'0C &7D" 0"'
M ES$1U/$P-X%UZ4)<+6 @ $#L:759E"<4N@;T0G+'TQ:NO3>3$"%&:,5GV$R
MCY  ZYI6!?>"05P%K$U& VS&+"A C4# 120J1:A !4GW[X5Q6"@ P^W9"2F
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M8%8*((A9Z,$!$V"3;EJ @$HU0#1Z$  =2.&>$P'#! ,HCRB09QF#A  L5$)
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M=&.U9P/D8($'2 "6SI6 QYAVL19(X (J&$^%Z/  _&S =W"-P-9*@0%3C 9
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M;.$$9"</ H #Z, .#B (>T$",O[ #^2  @P@3<@' 0!S4"P@ ]!4 42C%R8
M ["N @A %F0A +YE#Q!@(52S(0H #SJ!! Y*%A!@ C; !8"! XA$CKS'!BMB
M%O"0!51C QQ !?;@!.Q$A]X@$$Z@ 7"MJ#YL#QJ@/@R*#_2 KY(B 2# 0!;
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M:"^CP O$#F2!!"@@O/&@Q?#@!""@-KAP >YK1VW$1Z]D -@$QBJ  ACSHTU
M=JX;W(&D1)" ISG@2$Y329C$,Z%$2K+X'?FBU;>D2T9X>R$'AKX7*-#$<@R
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M QJ.LL$#P+! 0""T<** '0U=U48$#)5 XGO 2% !:V^8B (P'/37D'4M6)0
M9>#1:.212":IY)),-NGDDU!&*>645%:9Y 9UG%;'!KT (TH&$4! 0F(,K9 !
M>']PZ?YE!A)$( *9V+% T@0O =.&"<"D"1X>(#042 MYD*+ 6'"Y(55#HF@@
M@00AP"D("Q<J( HPG50 00AT>!!,,!O@]D<%%G00B H<S))!)W"=(%R)#11Y
MVAL.L '," ,QQ %(P,01P:(+O4>*!V%Z, M#L@ +@0<OT9)!@"VHP- G& 3#
M20-R5/# !+A=1<>B$O3:"PD02 #!0)Y@,&PO*3C@!RD7#!N,"N)6( A#)U1U
M%0AWG/:N!!>P\(D$=K [;% :7/6)M170(:J^)D PP0,#[=>+'A5D4(&E"\D"
M0IL;E$(C'A.T&9E5&@1"H\8/E.+'2 S!L2"TXI;0I6+ Y/YQ\0034* 67&R$
M.\%;P(""@04:\"$'G2#D<5H;#4 $1Y^GZ3$!!B!P4H('P'B AV(9S/OM Q T
M&V1#LF P:3!L-!#9MN*^^=ZWX9K-D"@;M)W8+!@\!4R])!5,2][TRAJ4:9QD
MT"4M2;V%^ -O)=HF"&32W6:C5KG@\ ,MN J,+ @\Q48(1I90 <Y39]E+!D0V
MI$*??;1JY>NPQR[[[+37;CN5M,S<9.ZP<P(Z5@CHCB3O#'D"-3!X'* [G$8R
MKZ0$06K^I//O$7^:]4L&@L!5 [_7_8_?,WD6E)LZ28OT/];9Y'U)GB\[]DZ.
M7_V2\A])_?#W*SF+\&]3#__M-/[Z'RV$\9Y@S )]P% !UF07C FL"H 0C* $
M)TC!"EK0?!B0  D\@(!\Q<\B&=S@ 7JE) 0::04/<$#XIF1"&K6P@$$A@/J.
M5*077I!\K[,A %W50A/JL#))^J&4T"=$VA712+U@0Y=T^$)9".Z&4(RB%*=(
MQ2@&0@YT\-B4KIC%VG&"#C.LHOW\<$0QFO&,:$RC[<JHQC:Z\8UPC",$V2C'
M.MKQCGC,8QKIJ,<^^O&/.;02'\5GQT$"\I"(3*0B%\G(1CKRD9",I"0G2<E*
M6O*2F,RD)C?)R4YZ\I,YO(HAAUC'&N(P2D(<Y2DQJ4KRB7*-%&REOA3#PU<:
M29:@S/ZE+G?)RU[Z4HKU@YW[:#;+7QH3E,' @QQP)(<P+FD4=&!C(' 5QSW@
MAA-*H]^> A2_.CCS2'C@I@3#"<P2XI)8+:".[$1!0B/Y89FL 2/M_  T"-)"
M#BM$Y0;>@@<XX*@UM"#%,E?SAD_0B ]U*%(@SH0HDS7T-(&8U#$G2DG@," #
M&,B  PY@,ENV:)9U* "9-,?#CX*@(D L*1!AF-*5MC2(Q 1&!=S3 @E8I848
M&%E[7,I38@T )![]J%4>(">5"K68)+WE52+@+%L:%:E0=2$0:0&!0)1/J,%X
M@P:.:LJ8SK*&&'! 56A83):63P[;\ZJM"* !#&#@ ='!ZOXMI0J7JV1@@1]-
MJES+ZBI2!"!;4I6>].1@4V T0 $8S8#%9I$' &348@)X(C!FP8 ! !88%'"#
M5=A9 E(D!IH:ZD4O#%.'4IR3HJB-Y9(<H%G%;" YN^1 D-K@H^>-# -CNUT%
M[#7!"[B@IQ)$@$.EV@8*,) A"K@L[.@P(ZEZ *_!P.CL0+ @",HB 7JC4C @
M9A4(2)8A>$@K0^10@)=HZP(D$ '-NK(I%5B*!*1XEZ5"( M9B  "%%#!:5/+
M7V VP 6;NHH<%'"57IAI Y2QQ0DD"HP5=$(4^K4("S*P :4%XP2H H8?Y&05
M%8A"#]3A1 L^ 0(+L&!FM#B!!?Y&P(D5A,]X&O! @)3IA[8F%'ER^ -&LP0,
M.J@3&&P VAXZL 'X,F0#*P"R:4X 6#_D]L(-J  *@H$!)-#! ON$"R= H*"Q
M%*D7'GZ7B"T  @:_ <N<P(#@9&&"NSH4Q&RY@!N*A(<-9.#$%E$!)UQ0@3+#
M10Y$XX0&.#R+$[B9(7QHPW,L\ ;PT (%%*8,0PJ= 0X,MR&E( $'// 6683@
MHD@8[P8V@(+$;.L!90[$;QD2AZWUF ,<4 'U1!&"#%1MLI_&+8VTFH&1684%
MHVXT0VBA @QHP-5UP)8'+L &S7E@ Z=1@8?&JX$,N$!W=-B !DHP+%F@@!0M
M.!0>W/[J!Q&H%SRS0 $G3%"!A+K  MRVC)WG/%D]GZ#=P7@W"5Y2"@4$@@46
M"($6@^*!#)Q@8'2H@R>R#)Y/\(0AF)LE'@P IT\$@,$6<('V=$<*CDZ6(@Y5
ME@4<RHD*;""?_4VY&:_B"17P(8@-:"U#,FH1"FP@$'=0P$ @L",OY44/!=B4
MR?^ !YWG9D$@R NE!I#BBN0A !R@ QT.L"-A2  #1JN  ;S,$$X,P V<>,.@
M$CB $N#!#0/86@H&0(*SIQT87(:+=X$!!P.$<P05N,H&Y,0&"\ 'VE>90%.M
M@@=4;ZT##EA!'DI @$GMY V!.$$#OD<+ 0 B& >(@!OV@/X!"'2I/G:@0P80
MH%E9-* $@8## =[2 @)@Z3CNL9,"\*#CK:(% FW80P8:T"45("#T&4B K&;1
M !)<\0 O;\, 0F 'VT1F%@[@=$PB\Q 17!$!+P=/+R!@ D'( 0!\Z,4;&'""
MEY]@ 7X0--8$L1$YU,(%S550CQ6@AT!8@".G^41H_,"& O@A,^1'35<A A+
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MC%AS%3?"$*7P!L6F $"Q=T!V 0PA 57! EOU'M3)$!D'%PZ !ZAY BVP BZ
M,]?C;\ @7%8Q"@8P"WJ0D>5C ;(R&$BP BU  @,0#+155PKP!X'PE"W  FR
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M!Q7.T@(WJP(&L&KO00$REALP>90#41#KX@<"L!".9@!6U9O*.0"34C'Z<0(
M4!6=0 !O0 J?@&H$,0 G4 JE,#0,D1V=0 IOH,R8AROA:%!NI<V:&6KHVP:D
MX G' OYD'G(5(V :.7BKGG!ZP. 3;-#.$8!7^0P ;R +JO!L%H$ *N )I5
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M1 %$T0L\$(!G2)% "&0ABWO18A8GF, H.>(&!>Q!#WMX P42=(('@((6="#
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MR^0! :7HA1P*8(K/-:"#I^D) =J0% D A0T!8 ,IFM,""1$ #[(@"02X HQ
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M#X9=XAZ* $Y<W@\,6,!DI:2 B<A!+$@.1$DHPH'Q"4P!NH]*&_0G-2HK8#O
M&(4!9.&:C60 ? ,AA0KTQRU@7" _\.&$ ]Z'@','8P\(T)_A#]""(8.@ X9'
MP&$R8+$>-0 A'@S$D/77 1 @8'P;6!^$D ".^0/+LI0#.)3GHP@4H#"&"#.D
M6[2& ):Q" !1L J#0(@1$0@]"/Z!#M@ !'BD!L@5B4  0;B\.B X@1@W8%"!
M_P*&Z9(%^$D_#UB DEI!%KB -$, <<.#RR.)67@ #,@[WOFWT="J V@ +XD(
M#[",7G ^BI %_Q$8(SP(YPN,!6@WA)@OQ:LQ&SLUDQ,(,-P#!1@XD,B,-)N
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MV F&#ON./6"(7@@$-D  C0NQY4 (,#2/#O.>>-32FRB[PC0-HIP+D $&/L
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M"/<;B!5@$)0:"$^R4XO\%DARGQ$HJ8\L!0*8*+][G7=U"!#X56"82XH(!@?
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M3\7%JC& -P 8!0@1-TCA/0"!! B1"M X/"@ @^B% JBG1E/A$"!?"W ?8&"
M/O$$ @@!3OB# & !A3W7A"A$/,@#"+ \K;I<BA M#^@ #RP $,C %-8#$, 6
M]FD6.O!A%5BW\>HK-M"#*!*U%TL84TDS1_(XN=(#$E@U8$  FF-!'!.% $@5
M43D!/5B![R7-$M"#-I@C!8G4]QF %/ #<IQ#BG"L-%, $M #-C  'J&#I(J(
M4JCD2S: [1B%!1"!2_8K8+ # S )%WA4O:L<!L$#< -;.L <#$ ("XBW$%
M.UB\!O[("0#BWA(P(6!8@.M9Q@%XB$\=US?AK!9@+ 4  3UX@P+@F$A9B P
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M!5<(>,[<P$:-M9:(%AB!BY %#N^ Y],#/3Z(-LB .!D(0/  #$C*@5#L8,
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M;)8!/, Z$0BJATT@K,!:^'FSIV[/Q(H7,V[L^#'DR)(G4ZYLV26I!)Z 5=A
MD)8!/\#L0"#(1\%:.A& ^1F A*"L YT(DCHPR]. M2@LXG%@,*(? J((GC@P
M08($!GJ#(?S-H TP4@;T .L5L1=![-4O<^_N_3OX\.+'DR]/GA2"S1#DU VV
M@+J<!_X10V 0Y,</G@"J_"!(+?4^)PC(T4L#%;S!24%TR,>1'@:00E )#^BQ
MQQYXE$+07(C5I0!TL1UF'H@ABC@BB26:>"**,*$'RD%>5:< ? MR$ $('H
M0@BD^,& =F\H$(('-H9PV"PJ6)#  T'1X<!:!05" (MP62 77<%$) L!A[4E
M6D=-IO@EF&&*.2:998H9$7KJQ9$=C Z5!DP)'AA$"S![0$20G099)\M&M&C0
M058/="3=6W%Y>9!@!+5P )V<$'#AH69*.BFEE5IZ*:8KU:8>'-DA )\"L@3S
M"0'4#2;H'JAEQX *$?UA@"QX#/ @,"%X1D<"LQP* 1L$Q?[5400D>.())RH$
M0 =!< B:*;/-.OLLM-&*E^9!G5:W0!_ B *! H!DM0 &%4" (!X-: ?,)Q!,
M@,$"R 93 @,;4 #!9J)(@(!H=@'3QD!P]?N;!0<@,/ $?!2$ 5:12KLPPPT[
M_##$OXD*S"RV%#1Q=:*L18L?@:P5S$8%!<.)'W06)(H>'A?42RF'TE+15[-X
M-(LLL\QB<D08R1PQSSW[_#/0/BL\$AYTI<1"'4$KO33333O]W= C1?TTU55;
M?37666N]-===>_TUV&&+/3;999M]-MIIJ[TVVVV[_;;:5FH(V=0HU1V277>;
MK3?<)=;]\4MY_];>1WR+W#?BB?XKOGCAY\)D,N.7?J*"!R+@8?A->VS&TEJ]
MU!'R2<'4 20;M%KFB5XJ82[W9++4@?G:L$\6#!TRXX$@1YQ0)PL=5M9.N-1?
M64 **7+( <<;<A@&#"?&(U^'Z9_),5M!(;A[T7 %E6R0'I!''B(+ F20 @D)
M2& *04/KRQ'@<Z?O_N%U,<""AH>VSU$I]$HT@%HGE?(  TAP @D8X"WU8]_@
MNN2^J=T/,71@%&+4]SZ*28 338J4OI @I_AYJ8$B:2 (K=2:G25P@?!3(/PZ
M:,(4LA"!)YR@_?"V0A4B,(88Y"!!MC4<&GKD@A/\X>!BB$(5KJ44 !"- Q("
MN!%( /X83P(9 +*U!PHX+B0D  $P\   "V"@BQ2@BPD"D($N0F ZA),# #1@
MD$ L@$ZT($4*WM R6LAB X%X$,TV((CH?6]V(ZE# +CTE0I,0':2B0AH+B2+
M!.#.),&0@ 4LYBL#>$\RL^! )4D2C ,$I20MN !E,)))Q4D'=""R0*\^PHD&
MT&DM?E! 261A  3I 8(<4<$$#"(""#2I BO0WUHDX :)D$ "$T#!R#SP@ Q
M)Q ><  &AMG'\@2#51&,3@#X4(H3;.P$#7&F!DY@,CK0010;$,T>/-"!$Y"0
M#AO0@!N:Y$YF%J0-HF&#'^A@ 0X8D \;P  >\("LDW4@7OYUH(4"_+ "#(C
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ME& G6A PA (ES9Y%0J0!4-@IRN#AE,(!:(RK(,!@+&,.DOY"1)188KW@=2C
MA_P%D_$="RSC?&"1'BB =2S 6T3$&Q  !NP&^X2 IK4 1BV212!46J&+&W18
M!; >!D1$9[!!"[A "0P +7  ,N4,DP##!="/&P!B^MQ!"Z@9LK1!+D7$"7C&
M!/1*SB# 7\E/'@0#=KS!,BKC^WB L34 LG@ WW416KK "00 +2@(8I <"RJ
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M$B<<0$"R 1M\%#"8 ,.)#!V40 /DRI"Y 8[FJ"C(P0*T09'205!(P$8&H'N
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M&#0*A$JM@&>=#$ (B((L4!YVA 5*JX!(BX ,&MPLE((*#/[ ?H+@&Z T J3
M2.DQX(@58F S':"> O!=<7!"%B/ 'BRH!.091R-(V>791%'''AQ C^"@"A0
M4I?FY;C%\Q% [90H="2A6EDU+12 1>A!ENR,*#@ !)@2\Y1KG00 'UFB@!P/
M[!42'>1O061 %[KQ"Q'QB-A"Z2W  F2  =7%-!H$M2%'VF[A$S+5 RB%"R#2
M+DG !6P.+>Q2!%A )Y7;)P]4,&0 E^S>"I0""K0N0; !^Q%T)XV"1GP%"3R
M!%0 ]7#$'U@  S  !&R=R$* !$3 0+U!*I;"\!"$"'B%"F2 "X@R!\B,,)C
M!#PP)SP ?J0@"U2)7#XO08 ",OX;4R/A"7)   =,3 J3&088T%4Q%"=PP)R5
MP@9$P'#D<@1  #<5Q![<V"JM12<$@)C"!@=4@$E]X<\5&AN8 $'8@0,\0-YM
M  D5A!Q<EF(2Q"R   1 P :D:1TX<4&DG@0\P(]E48_FE05L!"=@@'5T\@6@
M0"=(@!S,0@70RHF[40A 0 1\]$58@ 1   E(DD'DP7@'H![(H!RH-C T=P1(
MP/1M]H5C0/9L)V+@ 4=^N 5D#Y-+  9LCF4BAG<+>!YL^(.DLE=X C)#0 A4
M$AL\89V,=\(PE;H\ %:@YQMDP ,\@*^Z 7!+0.H$ HJ[8H^R &T_ %W0P@4$
M10BT ?X).  #K(!4CD!U9D P"(,%((A%-4!:;5D/34"G ,(Y#LX<'H<QJ0"=
MD, #1L0>G&,OH*1@BTG%E,1=?!#&R%HFP:))I( @.0!TR ZMAX0MC-*KF\2V
MTL*#5T<5?40L?^6<P/7%C%(/,;M!S,*YZ $U*DK.(D'.=@0M\,VO#TZ.'LR(
M?H:SSTFQ2\VX&WLFU8*/SPSL;+NL@T1O5 =<][I(A#NXFX2NL(\IK 4/#D==
MLSO>Q'I'0+O=4(S[?D2(TCM*R.FJA\GJ!(^KHX0=(  (-%ZGNY ?J<"UQ\\'
M6<4&W%!,W(T/10<$6 "/XHN!58 9R5!+!(("G)>X)-_ ._Z23AC2WR#0 ]6\
M2\S8X$"B >E\3?0""+1\8.>T3 0#&Y#RPJL-*9B;'_A\8HA"8MO-'C"K=P2#
M'L#![T2''(0W3FPT'$2LT^B(>5@]PC=&,%1(N2>]VJ\]VWN-TZ-0VZ/-VR?&
MW(,'ZY303M1]L^B]M/!]W/\]X >^X \^X1>^X1\^XB>^XB\^XS>^XS\^Y$>^
MY$\^Y5>^Y5\^YF>^YF\^YW>^YW\^Z(>^Z(\^Z9>^Z9\^ZJ>^ZJ\^Z[>^Z[\^
M[,>^[,\^[=>^[=\^[N>^[N\^[_>^[_\^\ >_\ \_\1>_\1\_\B>_\B\_\S>_
M\S\_]$>_]$\_]5>_]5\_]F>_]OYO/_=WO_=_/_B'O_B//_F7O_F?/_I3S2^D
M/_L_QOHWS/NWO_S//TU@PB-$PBX0Q"] 0B0T0OXS!D X"G,+6$&#!E^%>730
MX*.!#"%&+/@+C9E?$B/N:D40V$6#&CDR_.7+8\%;K79A5+F294N7+V'&E#F3
M9DV;-W'FU+F39T^?.ULA&B,&D:N?,'>5,5029])",5N%D131D!A=,I,R"?.J
MX]&5%ZG$F,&J8Q48,;+X.LB49ZLJ4RX!0P7CA9:N:X%5>0'CU:TI<.72S2)2
M8LF+CEZ\0'07(ZPJ/6ST<(+)X"TL06K<D()J;9(<E I6@L(CLA:C7E&G5KV:
M=6O7K_YAQT9-J,;9&#!P+ :&:(H6M5\/AIDR2.;%,2]BQ'W)UN#%,L@K-5=Y
M\<F+&KY0_>5\*<:+,2Y+/H&!YD81V0:QU+ !"QB6&3/ M#X5(T8D8+>6X&B$
M$1&.)KY:.0N2^SS;CSF63NGA!^54T@4(&&:PX;T:5KF/" A[J&$&'#@#9A<M
M9H!A0$E"M($(&V#X(:3S6&S1Q1=AC%'&&2,Z!08;@ A#"])@2 48+5[H028B
M7J"BL)4B*8\]G23)@8A68#)#""B R>2VN%HA(@?[#BQLD$M^H4*)%JV(\!4R
MWAOL(%0BH20E8%IQA:-?8&GEJLHL@>22-PO:Y1)(3BG(%_Y);*@!D5SDHL27
MD[@JZ)6-=J&$E5\BD1 1@E:1A$]6VKRSSTP@L83/CBY1#A98?OE%DD@\!<:0
M&\VXQ1 )PP#FBQL?V:62'69X A@Q<HAPADF *6*&)X%)Y0<8R*#1V6>AC5;:
M:65$XSW[@(&DAQP(V24+&)XDJ4X/3U'+ST@LN?,68ZMXY;=6))%D16#^A!(6
M5U*M)-")+HGD%*9^<86]7=K\32/V7EG%%TOV[>@4/7\#YM&44,%E%TE:\>41
M]2!)Z11+2CH%W5%=6;7A@HB(0;?SW-M!BAEJP*(DOV:@KX>%GIBAB(LND7#
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M73#3+O'#KZ(3@C@U)3L96B,)W9.DEJ!A=%P5H5;\;KT%<4\_6^>KNJ8(&):
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M"YP "G9 I+4@S=?<_<J !CR<G:;"%YK@![:@">A\7MQ<"\P\+FZ!"(H #);
M"* $A!YS"7J #)B@XA+16B+<!YY "XAT!N+BUWXE!X  "W2A#':@U'5!?)9
M#)8@"5)B%XJ@U2?\32[BS9Z@"IB@!\2@"2K.];3G"]QP,1 IUYF@D)*@XH)H
M%7: "IY@"W! "G Y!ZI #'Q 3:B ")X@!S &!^(M!Z1=(L" OJV X.2;OK%
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M!$E11T3P!#I@$1B:01JK9D/P/7]7:Y7;&MY9!4-@ TO@"Y1PE49@.QOA U,
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MA.Q,ERKP@49H!!\PC5TH-4D=&$MX B 8A%=XDB1@ KW OT=H!,2!)AA(@D%
MA$_Y3JQX @("!BP@@DAX'!ENXROSO>OU"$18Q58UH1B8 9'M$2"P@1O  1[
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MH9V"5($KC8 B$S.SBR4400P\<4\K<B"%,/@ "P4Y!0Z>4(4E)*$*7=D!QX!
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M(<(0L  %(A3!-%6XP1:8  4;M.(6,6"%(V8PHB\0 1B/P$$6EGDI('RU,)&
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MI)<TCVA60;+0K.CFS ;EZ0'I9D"HCR4J"3=88!+"; FR1*+'P+B"2#?X0&
M0:J-'?5K-LB#I)+&!B^[2@TPJUE@C"%3ME.*P)[3%T/LP"%9&%7,7%6<6T3(
M$.K;X",N48E3-$$*M^CPR43J$-Z"^F6%0"PP;F&#= &!8T+I,1#2@"H.KP*\
MFEC)JQVRBDA0TCU*T#8P,"S7;W4%")DI75^ ($0:L^(4,Y".+0.S'C(DH<($
M60\Q_=N@7:0"$3\@"S#@;&U"&/[[%%6(*ZK20&V_H%7?PEG/&.(*AO3"H@:Y
M0,,/3G&)2U@"!N.V ; F\H1+3@0("#,()<+081M0\1>X<& #A3,15^!"WY)
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MQOH 01A"C)X!Q6D!#,C17E$J#F3@2A2!P^CI$RAJNJRJ<+1"HI8!(?A9*KP
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M 2L9B[@(QBNDE!0,@M^AL!0+2VH4RV*%"QFGAB$40L>8L?ZRR(8E9"(68.Z
MI+%!G-'(0/$>\W$?LYX:^W$@KP@@8P@A\Y!JL,(+H\@H+HEO>H@A]P:@[*(@
M?PEX"DY:N'$9 T,E]"-KE$3IF 8DAW)I7((\9?(H^\8NZ$!@P +SJ 84[.S
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M=7RT-^VB0BI(].((GBN,2/S0<M7ZA0]4PB]\SW$L\+.L0E&O!&5W;T_'B&.
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M+>7,JP%!$/0%%L  L Q:7T@!$Y!$Z1'[1"""#23*+OA $/Y"(E%]#.1")<2
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M8J ")GJ@01OX(C@.&:!@7J$++BIA+FG9Q2ER\@HR)&$7KW@%G'XA.9BP$(D
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MP'B$LE(2L"41&TBB%3;@BAB(6 DC!&<WN*G!5& $!8:$91!$E$@D<(1-_\$
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M85#.?4B()4($E-V""$4H Q5P@,X@W 9"J9+"REN!@\]"P0>54C)!8V#02\2
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M/#AP,58!#B5B$ECP$N0PN?(D$6#F$L3 #%Y!-WQHZ 2H$( ($D;B%@8A"\)
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M$:8(96@JET XI)-$PG1FN$003@@FPWH(!V-@LQ@&D6 B4'2&D(C1%]A,!C/
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M$+/M<Y-3HE5V2(M/%B:C.R6#-0-OM@M=T!FZ$ ,ZUR)5U*W[HA.'8$>MD!_
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M.K+: O0)$(=*P%A$"2Q(FHZ_=A@"1LB'C1YE'(8$)DG*DBI$I,1UZA#,$F!
MRG1<9<-K2$)#0P8I="NJQ4@V"%I\9 /81*E0.]>0BK?(F(YJ#^FRX:HCF"3
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M@5E(+!&#T.P""$L@1!8*29H%IF0)H8."#\J0A1D<Y!1K'.0,*($75,P "XK
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M0CB85_ "&R@)&_ 0(K@!-& %2OXZ"'-SB"=@@B.5@B9(,4AH(5V8A!J "2V
M@3)8!1G2'QEJA%A  QLH CO[A2 0@ULX!1HX#"CX'K7P$)Y\!5A8 B;8C!W@
MK;R( 4G(!0_SC2L8BB^(@3% !=:$BTB(@4BX!<BK#3'  3O%A![@"*Q<&E1P
M!2QPC(X8 QH@44S0 0F!!1B(*4FH@8PYA5<P QC(CMYQCADP!%0@!!CH$D/
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MP=@E\== *,! ZNHA1=.D&U: A9G1Z-2@&:A@V0!BR!(6'+" 89HAQM(@&(V
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M#"R!-C+/FDG%#) !, #;2[7""[RB5X)9?61!:D19#S1E4_K 2_7 #! !$/S
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M@*>$03^>W@%5KU(X]$=$!25TQ*^4!L*&_+7O!$U@ EB"H(/=12=#.N,C!4
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MX@=<=G$$!BU\806&1FYII2M@DI(R$KR H>*)N(KH# @L?+G%.(_"B.(C*&9
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M<(P(33:B0HBG4"EBB""62+<2'WX@PHPD+DFHZK81(L.'6X!!PX<EI*!D"2N
M824)'5YII(F!6F$"X21648L(H&\90C9'Y 6B"!H?VB4)'WKHX88>A/"HDA]Z
M&**,(([JN(<E"%F"UD'NEF):*VXAXN:8C8CE(UB8(&*),A[1H3P;OHA+52(T
M:J0(A-#PS1(C;OQ%"W9]6/B+7/Z!@438@12QZ!4I="]C$AU8TD((0W8Q(O%?
MUFUW83&P0*@*K2XAH@@F$$%#AUT(X?NA7\KHP08<B+"<@:2B"$'X <$&$H:[
M88$21, 4$63SA$,,! Q"&(0OC"";V4C*!X482 .=A@@F[*\''N%-YE H!$H
M(PE:H1A"FN!"8)QB"3BX 0ZVH(L$SNF%X/+A0\)0I(0@(@NL6 +=$'*+)X3H
MATUTXA.AV$,)M<)IJFI%D(0WD#3]YB+&N@@20_+"7UP1)$1 0Z; F,4#S0XA
MK? B,,Y0'A%=I8WT">-HV/@1ATCQ(:U(XT>VLS\A^20AL+#C10S#1SZZS8M5
M7"0LWOXHDC'FT2:L,,P-X":6/2*D0ZK"R2N"1#$U:3 G+]S-(DGR'RZNLG)4
M- DH61E&6/R1<)'<A;$:(LDIHE*-\ K")GMRHBK>P@:I@*(33]&^7,9%##UP
M#<4<@@K?').:U;3F-;&9D!V0(5F&F$$6R% $'T0RF^4L)R]OHHL9C.R)9\&,
M.>$93Y*(@9+)DL09Y<D3AZ#!0 ^Q1%I @H73Y).@!37H-2,A&W36!!6#* ,B
ML'A0B4KT%X^@I0]],8@&392C'?4HN,!@S(^T0HB##$,F/YI2E:Z4I2UUZ4Z@
M24B9#O*E-;5I2L6 4I.<]*8]]>E+%_I3H0Z5J$4UJDD<8OZAF\#NJ$W-"2N
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M]V),BVAM(P10BV; %5P+C"I+>(AE=H  4P9*3_:#(PZ%,&X,"MI'-"3!!ZF
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M$JAG.F9@0\."#0=B+%KA+8&&%69@RW3E. 9"G2JA1BDF#%C+7JK 7SP)#7(
M(22A?<:@/[4 27;.CJ# 3_[-,5 S(5"F"-(%(<P$SS;"_.KC"8J 1)5,3 >B
M$%0TZ.BCWB(*&'0$C):@$@MT4_.I#*B /AYA"9B(4W^J*9A -JBQ#,!@!M8Q
M(<( !QS*"HQ@"7+A%#!#%CW&!BSK%YP"&&P 4RZC"LS@$F\&$EX@K(QD!KZ@
M#&JF$_X1H0>&<1\[,@?R$P>XZ15B8&10(08<0PQF8 S"8 FRS5:E8%AO $:T
M8+3 ,0?XY4..H@P2I0QLI ATP0Q2!3X'H0EI(!6<E$GF9!>60'2TP"@VH@A>
M<6#_<1=ZP D*X6)* SH,I!5>0#;,8 ;$0 R:X%NY2-_^L@QTX$IVX0>>H&$_
M!)\>X05.[C?B+;= [4!\H(6,+@@\\'+$P K2QC*X=32E +^:0U-C9@:(( OZ
MAPDH!A9JP&<M]07LK =^0 >DXQ>D  >^P I:]A=Z8 9&#6'<= MP8+:2H!9)
M-6SC21*D8 NVH%+%UJ8J01$&"A*TH MT:B >P0ONRA440?Z'7$%>"2%($@HA
M'.$T((%&8.$,L."N."D1!A484@$,L& 4LY @H&)-W58+#D(MT*3"(&I*K2 ,
M8"$2:.05Y+6P=$4Z/@(25L$2M@ ,!G42O$!1;D$1=D. ^%4,ZJ(05@$52!<8
M,J&M+!4+PH!R?H&(PH!1"<(,PF Y'N$I$,&.?"%S,0\+NJ 5)&%4+<,&6,$,
MJD &M]1XI0,2%B;X+JIW?Q<AZI5"-*$G=V$0ND 36D%;=,%Y(T$1<-$&<C>)
M'.$6T* *"D'^"D2-4"$1+N1""F%V' %Z20D2 +@0*J2?)$$+K  -PC=M)?B)
MIF2"+?A8""$'0@45<B#RJ)(I9?XO@D?CXF!FY>:PLW8!%?+EK'9A%5;X@F$X
MAF7X6Q:*ESI+KA:)?X: "(@ #.3OK&RX)\1(IH(JA\.%)HQ8U%CLCAQB$G+@
MB$A"D2RC"'Y8EUY!8(X"E7K(%;K-$/7(B'T"C&=XC,FXC*UI0,SX)CKQB5;N
M@]/XC>$XCN5XCNFXCNWXCO$XC_5XC_FXC_WXCP$YD 5YD FYD WYD!$YD15Y
MD1FYD1WYD2$YDB5YDBFYDB<XB)_KCD)KIJ)8ES99CY#8DSN9DX]8DT<9E#.9
ME$WYDP4IE5'YE%N9E6.YE%\9EF=9E&\9EW-9E6.)EFM9ESW)E7?YEX-9EGL9
M)] IF?Y[Z9AIBHEK0HQYV9-P.)J969HM^9JQ.9L#.1=:H15<P9M=X9N_N9O!
M&9S#V9O)&9W#^9S'69W1N9S+>9WAN9O969[;69WMF9S%^9W/.9[K.9WKF9T!
MVISWF9[=&9X#>I[]6:#UF:#?V9W'N9\3NI_I69SSN:'7N: ANJ(YVI[;6:(M
MVJ(!.J0U&I\9>J,1.J05.J!+FJ0?>I\C.J;->:5=^IYK&J/Y6:8]>J0=VJ9[
M&J=E>J%I^J<Q^J)1&J1GFJ(7NJ6)^JAU^I_U^::+6J#%.1:2RR94!!6T>JNS
M*[NTVJNYFCC">JO%&JR_6JS/FJR[>JRY>JW5^JW3.JS!VOZLRYJMO]JM[7JN
MR;JNX_JL]1JNM9KF:((0C$!LB&"'#SNQ>7@(=KBQ'9N'$_NQ$5NQ)QNR&_NP
M$?NR%_NR&1NS+7NS-9NR(?NS'SNR+9NS2]NT.WNR,WNT%SNR6YNU4=NS7QNS
M0[NU77NV37NS89NV5?NV:WNT=3NT7[NT;WNV.[NX/9NU@YNT:?NX>SNY*7NU
M/UNQA;NW=WNYEYNY);NZ*UNYDQNZ)9NY;=NZ<?NZC=N\D9N[M;NVO_NWE9NW
MQ]N[J=N]71N^LYNZ5[NR];NRC> ?3:)CDF# ";S #?S $3S!%7S!&;S!'?S!
M(3S")1S!>\V!CB67-BG#)R*FEOX)P[FHPS<\+CQ<PTD\Q$4<FH!ICS@\PTN\
MQ4U<Q7\CQ5\\Q&'<Q4E\Q6-<>&#\Q'G<QD5\QCM<QD%\Q'U<Q8O\QX<<Q74<
MR%D<R9V\R7F<QC\<QVO\R9\<QZ4\RJM\Q*T<RG?<P[5<RKF\R+$<S+]<S(_<
MRU]<R*E<S+L\S(-\R9-<F^F\SNW\SO$\S_5\S_F\S_W\SP$]T 5]T F]T W]
MT!$]T15]T1F]T1W]T2$]TB5]TBF]TBW]TC$]TS5]TSG]IM"VTT$]U#VQ7Z
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M$8H'R/%Z"Q %"""P 0UL  (R:[#+,. &3@4C$%:UQ0($<3'=0HH"&\, ]QR
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M=1_F"1 P8NUF8A>0 B=P BT0+"YF*3#VDS06#+V@9._&-A,P6-I\P"AP BC
M!OMB<(2U7ADP@R% 1)#"!AX "@B  I.M FT@"UHWE&_@ 0F0 0#IQ)S2"=A,
MQ1"  1? 9['B"0L ?<!@?3Q-C,"PS G!"1N5S=RC &$$*=EK4P4%,7S@"9(]
MV)4]Q57M6ZQ]>QY=Q,-LF >&:\#0 1A@.TL3-25 5O@L>&O%,FX%5VCS-TT3
M G<(,B=07OQW/3MU,1(@N_(S;_Y * 'KU9$$)V_ L 'K0P)X9! @0&4(X-/:
MAT0,$%V=L+@)H"N[_&MQ('8",[G^B #+<FX,A+G <%RLG6@\#8Z2HL1&&4V2
M@FDVE6D,$"SU770RU5@<1=7$O1=\P 8NP :%R (EOMPKT#67A #8##N=@ <(
M(#-M(#?%=G -(PH#L &"@$@C@$0)P ;*9  %=>&60@H+<.1X< "Q0@L'@,?
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MA0!1W@JQ*((\:8"6!@6C X$0/$  0J#\4, #'_D Y@\(+*AO@@1P7"T0 D+
MPPX+&JC.#0GN"D&$CCX$AHT&X"*(@PKT" 0% SJ<;,8<VW03* X48#,O@E0H
M0007/L.(%%)^6@X849P$YL]9()M%%,AHD<P6RY;K)4;I(/[]211(@Z&E 3\D
M$Z7/H6CQQ,D_?>KI4,B"6<Y243WA=-+J>@*F%$F#"@913B#PR1;2"/I34$I_
MHN6!/$031<7E:(GU,Q4V $86!F8Q%K59R^MR4)]P1!680T.EX+LYWRR*% &
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M M$ 5PE&!%RBG,#0I[(T[A)X!"%!"'9ITX)@ZC,A !XM@C8[G^1Q>T"BP+N
MH8'9X<@4G+!/3IM(!R(.JPYARM6LY-"B7C"@0TC=GAQ((8H:VJ$7]1/5<D;A
M!P9D"@&WR2HIY,6)4HRB>C$B"!YLY1,]9$]"Y>$ <22 ,VHM-0."Q".$3*&
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M0 (;KXX<1&""0) "!"AX3ETY4(<(EP+FOLH< \HSBU-Q(H=F9WUF(,N!PC4
M W4/#"V!T@%ET2$ =K#4 W1) O[3,MH $+KB9]H N9J;G,-6M.F&()365!NU
M G6@10$2! H%M,^\=' 1 V;7BQ (\IG30T(!!F>!"1@5#@[H$R<84 I9(* \
M>P!FS0<07KN]P7(+B)$'-H C.9  R7BY.J"G"K"5TNJD0#" V>&DKZ,L0&F
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MGS"!&;(G;.D9].X-;5J6S"8(>7,6!%BT&)^%"/@93FB!.B@%$6@!V-8,U9,
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M(#O-&QF%%N&7,SIE)WD#96$:*FS-GS !$"#E@E@ ((GJ",2/=0\!T7< ?HJ
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MZ,8WPC&.<GS.2BSB <-DY0W!&4$+@,&"/J[ !< 001\;5JZLR$("BKQ !2;
M@#?0R@\6< TG'!"EE'!"%A P!0^7HH>E,>R0<QQEGH)$%/Y2HC*5JCQ+5CS
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M[, RYF(52&,,6($/PJ NQ@ .A.(CO$ -*,$+X&(-W (:Q/Z #?! #(#!*^#
M$=K -^JA$*KB/-)CI; B%$:B!3:"#1I"*]C@%[1"(U@A%E(!# 0!)5S"#[P
M%;2"#<R (?B@$LQ %0 #&$ A%!A"$#AD$Q@"$-B #>P"(@CC)=S"%\Q #_R"
M)$!A#Q0"%CAD&?A"&<S #5C"+I0!#"2!!6J!$2!C/?KD3U9**_+ *0+#(_ C
M&L# #BQB02I!*]S #(Q!&2)")*""0QY",A+!#% !,(0!%*;A3=K *PX"#(0E
M%,S $US")2""0UZ")=C@&^["#MP@,!C"$7XE#/! %0Q").0"4/KE7SI**]I
M)/I"+-J@)&0!#!#!"LHB$$2"%?XVPB_D("M8)3#L@D1NI47V "X @QG,P ZD
M82% (28 @2>*8PR^@"%<@@U2@F4& 0R$ 3 0P@P,)3#<PA/<(@WV@ D"9F_Z
MIHN((1JJ(0Y\Y"Z89! LXA4H9E7.0$^BPB T B94)C   0QD9E*2H1D<(2S(
M)A2NPA/  !2TPBF@ BJ<PBVHY RTYBWT  R  3 8(4@F8RY80B-H00_,0!+\
MYG[RYW,$9Q5H 13PP$ "0R3,0 T0@B]@0GMJ 3 DP0P002O<PA*\ ! TI TD
M@22,@0W4P%9V90]DYV>&YAB:8Q#HH21@@12\0B74P Q8 C#DP@_ 9G?>@"'
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MJ3R C6D%)T   C  SPI7T2%+N.2*"&B:5$S).!FMT"[,&!G8 C" 27 &+2C
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M6B\P2( @-;/HG,A7@S<&)("#Z$%M*P0;*$ P<(),83DDV<$ K !G:'EWL $
M $EG$$ =\&\@K$"(J0!E87D?I0 $9$4O5 #N>@("F @=)(0K+X7AYOEQ@X!A
MP)./_0%I*P0<($ ON%9D@3,P$X!K;$ 27W<67<8#!$#]:DL$;( ;M($;G$#S
MXE*U+<2*.+ %"X8!"+,M39I"^!FNY+=70$ <),=ED,*"U_[;':V'6ZR;F30
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M&# \"H"5Z !,8*\&@8 MV(,16(@ HD""Y$2 9,2(+BI$E/ &9# (=50"ZZ6
MC\T&>/XBSC(@*I !#1DR;+#@HN:G :14!GM  MB$-B4AR.E% N$*"5/E/ "I
M(D/3"#P% OM$@!/&8&T(D.K%P(+"#1E ]'I )UA>.BT](2@5D0X$8'X<"(0C
M <,)#QLB>A@1D80'8!96E(WZAM:!3Q$Y(9 %S).'!P@P,*UY&G5JU:M9MW;]
M&G9LV;-IU[9]&W=NW;MYTPXFB%;K!FQJ\B$0K(3DL@OT> K@1R">EJ00; 9&
MIT'-!G1.5V!<<P(&8 ]@"BQEH!0M!&F!<2@1D0]%/PJ"!V/ $Y@*\6 A*Z\H
M&9B72A)(P++RFB4B6NP@H).(!!(D (Y4^@0 3H)!X(^(1/XQ0)91 L!#H$"\
M"@0!! 629;W!$+ ,HYO\*.FT$BCHA!-..FD *1+K P8#%7A$P:0#>LE@A9)Z
M ::SSR2BJ 4+0+(% 8X\ NR"-AY@$1A!4&H*F"8CTN $D'I!X$65:%G@18WP
MF^4 3T8YP$0':SK)DYI"$(\#J 0*Y@!.7&!@E,:(ZZHL-R2(28$\2O*$ .N
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MUTPQ@O> H46"/M0"II," E&6%CT&B ,8/;8$A@T%@O'@U8$(@ ,8.033< !
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M@@$8 ($"+I69G  #?GL"QH),E!=. . 3GN@@70Y0)&!X  ,9X$ %&)"2$R@
M!!E@0%J@I20\K(AO!X"B!ZQG !!) $B"4U19 @$ DE@F$/X'@,!F5(!%#&P1
M1J@R ) 08(>>] PT#Z@ "!H@ A:=A'G,.X *RM*"Z6%  >GZ P(\$ (2E.
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M% :@"[\P./R  .+D7$Y %$0!,2("?CAA%O"  '@" 4+-$P:@%#PA7(2!%!Z
M.&I!\4@@J40!SP)AIP0M,^2 %@AB5P2B!!9 $.80 /QH0UA %DJA R @.#S
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M2N [(@()LB,B[( B5,B@VH!I5D#96J E.$%<1D R:($!U"8BVD#9&,$ NFT
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M:04"!?I6(#* #0O@+P0"2OB 3VC.#@S@Y$"!!,*O B*&%AI@!#"XGTSA=NJ
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M4%9.N">-5'7O!()[K(:M,4(%N(,%$-9TC@27'BL0"H M/:'K\$,#+F#:]N
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M8;6?%$!'F4C0T4L#;KR1@9,15:"A0*:<:U4P<3X$$AUV+%2"'N$&S)T*<(P
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M8W@PAS4L< (C($!N@#!F&'&V( (H<&KL(0=WX$+!P +FP09EE4,I< *BP%[
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MRI(MDBD0ED=2_$.NRN(5HH!7?TJNYI&1%6."6W>M]!H7D^(&&^57N$(M<-
M=;!')1 (>D ")X U(R !ZJ&'$41FVB9 2R,+=[AMP, '*K "'? =+9 "LP<P
M64@"*P,'*\ ",,()$& "L_ ALO[P<'5UFB?PFO7ZLFD!$OFD<2AQ AFP 2O#
MD;;X %.G+J70,'I D@T&#$"SE[;B.YO#?6V 4^'D'?(8 03I;-8C388#2) 3
M#" P(;8I-D##(,&0![902C [MF4Q;RCA+9P@ 9_0"T3""=.V86W0(H\&#!;
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M"E P X-@Q;YPT_>,$$O\SP;MTPH1U&9!!=V<$&2 RPM!U*'<U&/!RSRQ"U)
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MZ1RO!5#N[J$,!#^ ]KQL[BIO"#/  Z =!#: "BEMYC80!%3\!)D?VH5?$)=
MZR@-\)?0 U0P T6P"V10 \'P"#Z0 U4 Q4[@ SX@!D9?!#[@\_Y-!#-]X3^
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M@8DR#F! !,M8@B*XA1XXCX_X!2N @20P@C@!N0@9A(^3I4?@OA")$$K(@1W
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6))))*KDDDTTZ^22444HY)97]!00 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>x_cg005.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_cg005.gif
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M_/____CW]P
M
M
M
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M%BH7I),^:B8P*H3H0&8&L2  CE)*8.=N ]#!Y81@:HKIJOZ'3AKFK()A$
M) A&9 (8Q H+D :H$"NMJQ*;HI/()LM0'@4T$"PLJ<"R20=7(K !40U*:8"$
M#(VR@)VSZ6&  A,81F2)>0@2"!X<&(!CA,5ZQ"*"+R+5 @$,/##F)O@RR@9J
MJ9P Z .579H2,':X]XN>"61 4)(M*"OQQ"-!*24!2>2G  ,)5& F'B)PT($*
MG!34"0L><."!"IL4!,L;('#P 1NE%#0+'2-TX $)==C%RQMOM!$*,&^$X,E
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M)  Y]T1-0<X%U%FUH%D$>%Z+$!""RHS"5 18D 00)(("CVL"OR"!NR;@5EZ
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MIFN!A/TV%YZ05Z'8/2O% 7O !QP@2P 0"G)D)7@P"ZE  @LU7VT@  YP<'Z
M!ST4 /X*, OJ1HF=  M-."#LIHVS-A>"L( 58 =U( '?P@# \ ?:PBVN5E+
MAR00B0$DD $EQBC,]A?GPB=^ B@"@'X"$0(+R : ( ?I 0"]4BLY.9.<YJ<(
M0 )^D =F>(8%RE0OHI\=XP>3EAL"H"I7IB,D  <*17%>LZ0$@*%VTI9V\E%U
MP*LAX =[8 %G2 #ET8T(\(OPA:(N("7L80*#*! J, "!UP 6$&%8\D"\8 $&
M10>G1&7%JFD_2D\!&@%V AZD2'%'JJD.H(+ER*0ON&0"\0%[L@%$R L/,"+.
MT3/(AR-P  @R^CLOL@<KY0%\P <;,  NQ#]DFK)C 25EN?YPO\!M*?D++B
MR<8AD<0XL-!/3*4;"S4 6L(+'B!,RZ0 )45@GY4CT+>?#%"=D622 ^$&-)L
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M:P$*,[Z>[!44IH1!)!"&IX1HT@E^X <J9Q"I  AYL >J8Q"RL FIW'P#40J
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M#6'<PIW<RKW<S.T4E7 (B[ (C?ZP"(]0"PC1"V)0!L@M%KU0!F/0"[[0"(>
M"@;1"EU0"+]@"H70"+O@"]ZM"P9Q"5M0"<U=WU1!!3$P S   S,P S=P" 5!
MW(3P B_0"+^PW0%N$ A.$ L>$0W>X (!X1!^$ B." 2."+XP R^@!0<>X;^0
M!2\0 ZV !B\  [4 "01N"!_>!&D@$#_P C?0"P,QX?9=XT)Q!3-@ T&PXS9@
M S-@"09A"D P!*M0%JHP!$.@"KK0 S,@!@;Q"#G@!+V !CGN"JXP!#]@"K_P
MXED@$&>0 U]@XV+.%#AN Y;0"[J0!OVM!;IP"D7N"I>@"Y4 Y+V@"D7."HA
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MQCI+ (*1YN$-(- #*8"A!S> ( ^CD$4>3+""/* 7L9/Q*3 L@ $/Z/,7*JA
M!(0KU?[,TM@P(<#J86#Q6A?/=Q;X?0DO<EK='O]"%C9F,)!?LN/4C@*T\80%
M?BW !@;3@C&PF$5F1XIDBO(B 9OP[4\I"@@&X/?(\T5SE'U+APH<1LB*D86)
M#2,+NP(CRSU6LUGO_!(,Y)8QL:!Q.YE\F%GH50-^_D4G$D!1)(=9SXEIM([G
M*8L]I]?1;TXMDH'1Z%FTDQ=R?DFG@PQJ3.-9R9O^Q1UD:YA2F#@4"4!IC=.+
M:C<W&A@2 "\_-?T+/#0 HWU8P)8A#>IUGJ#-AG$! ]Y)"R3+0J;SM2=%_5#F
M, .# 37]!052D!@_L-8PG!" )WP;!PRT8;^&V00"*&H'"OX@0,"_L,,$W!WE
M-C#@ 7)0\HDY<VLV-$ 4^HQ "QK@439 H+]AY<,&YB"!!F! N7ZP #!.H( '
M5.#?>N@O!%RP3C]LX \,0 $O)%!5#["A! U8@'Q'>H(&.  %)VB!CBW@!PY(
M !BR"($$)J"!9W." A:0  G0NX<)4$ ";S!,'22  0BH' 1P<$$"Q,V'"4C@
M 2MXR054P'(%)$'+FZB !280 HP* @-UJ, #)H#034R@XG5@ &JUZ@ '>""V
M6>9%"72. 5$  P-X,$P'MNN'HD> RK^0 P7TB0*#5P 0+R%!$EC0@ :<8)UR
M^$!L%9 '/T"  2"P*R H8'2O__YB#IF/  ,XT.D/+. !&:CTG$/P<\Z.= -P
M $$#&+!=(^?^ 6_8 &G7Z8D&X $##X# XW\!<S@8@!-[P$"J.R"'U&\@IYU_
M_1L4+ H)R'0#;Q!! Q104V#P@@0.N#H)D-Y.45S@#Q>(_HLE0($*@'FD+#"X
M!/R@SQ9$H+][>(FMFSP&V(0Z>  %4(%U6H$2F+P&*, #3,"1:H'YJP"Y\X V
M.+\%0+J7> ,&:( 08(,(,*H)P("@^P5/\+P'B#F%>XF".[B7\ ,-H(,)<  +
M4*Z&@@"QV[\YTP![\X!U:@/_DP# TRK*>X _  0'J ,*:( *0*A0P("J*P$E
M.X$)./Z,%6B =9*%$O"_^M,G%2!!"-C!$'@#-D  <:L#NLN\!P"R3<"NEY@
M%. V MBS30@ E*H %RB% KC!7^ %!=BN4?B $L V6!A$WOL#'.,$?:.,.Z"
M%O@H8&B /]  %G@)C L$R/J%%6  3Y"%/2   ,P# # !42 %"6@Q/$@ (>,
M#] P0"  /9"%3F" E](# K  .@@%6"@ ,*L !=@#6*@# 5A$%6" J!I&.30,
M6* X-@@$8)@K6) %%1#!7W@ -@"&4GB E\K$/9 %3P#$7]B# -@$8'@U<<L
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M>%9$2RTW\  /J ";D\2P@H4#!82R]2T/V+9V\H0%&*KLS=4.>%/$DZTYR-\
MC#X4WER^DE?EBM1?B 7/%>!_BS 1\-;!9-EURM0$;D4%* %/Z$Y'Z^#6 H8\
M"#82R/Y53$V + ,&"  O$7CB0(CBEW@ / @% VC%5F2 %J/BE_C9M$H D5VG
M/%BU3BB!#O  !2C9Q$4H"9@#4K!:[O(#4Y55IGH#H<4Y!'@ #PA7PWB .#A!
M!/"K+^5=W[H#:MN#!; K.)"M\,O=#2  Y2NVI6W! )#,3UVG_WR).HBK#&"
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MS=ZO94QQ]+4E(\_:].P&>*H0J "] G#A8S"/MFU-? D7@ 6.LBN.;-BOY83
M>@"54U+4J@"OD[!S2]HVNP S;0"16FH9QX!M^[BC9=;9- P_"#?N:G"35;;7
M7L2Q%?XW3T#H)TZ!=PT%^9J#-GMM'!TM(CVVI$W+-S@V,>TL#GA4&-LKH#37
MY3O40OU8Q! $ 6BGL[;P)4N 3I"%TPJR!(C6ZR)"D 6OL?8M.9A2.IA2M(Z^
M+D6M6=B >!6%!%"N]34R!4"M#-B X18 E1M,6*MS@%769TR YL6U7]AT1*4P
M$<A;0:A>_C)DQ9Y3!8@%_LI8!<CS.7@\"2 LRA59#&#P[)U2$,!._I(O1<NI
M"0@LD#2,#Y!/!>= H5T!.2W4NR;D6P8&!]C (G>Q.V#67^@#:D.\*<6#9 TR
M2#P,8SL,/P@ ;<U': >& >BL3,2H&O>M#]CURGSEKB2 3_YXB0J(91?[ U0M
MR)(U@2PO58SZ6<O%;\]8,-M* &Z&@",.!  HJ-5R@3T0 4NO@_MZ">?D-8I7
M 01H 6=C@!#0 S8@ ,"S+[L:3C!C@'X->2/; +7[@ (.,U@8 -1:)Q:(TSS(
M@ ?HM BH #W8@_CDW 7X #W02Z0[.3W  Q)0@ ^0A0CPLP8+^C8X3VOT,X$.
M,U"<@SU0 :L+!4 0@)R2@UX5.0P0^@G0;<%" !/ >O'+,JA_@SS@ !(>*0P(
M@!UL, X0>MC]!3=8-3A @#?0@Y7/L@]0 !'(@ZG<KLE[B>%,<@NX5%AX@ W(
M SDP $L4.-\2@7,# 0:@LA7 @/YW8D82^(,V2$<\T%C>@X4 F%$5V'0[Z  !
M"&%0)6<]8#J]RH!<A2U3?0-N_P436-HY"$Y'?0!SO,-?H/I?F 729# +,+@0
M<&C?"H7A7Z>)9P,]& %-M*_ISSV*NOX]"($%4"ZYBN@!R"D%D"\/T("(#H#Q
MER\\(  7T(,2,("J(O\@(X"G"H0"4 $]. %[4TL#J(,]  @4#R:$@H5@@Y]?
M#%S\TH.@Q1X2"4+]PE. UZ]?;!3\HB.@C1\V" )E+&D! IQ??@Q E$@16$E
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M]C\&8D\6'W"69-[0 L60PDEO8,&_/J$G%<!+,BSX  =22(('$NP$*'(,)SZ
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MRW3( O[")AQE1L0!!?R"[;T)P0'# B0$,#C PSP CN0! I0*1V1$"_3EFT"
M#OU"!(@>&Z"2"9C4*&@9,%0 0W0" GA;:&:$ GB"+!@ ZOR":58-';RD"I#F
M;F[*+]Q-25  !KU!N[R! B#*1P5" J % ^#&>[1 N["CIP1"'*92/*I>1LA!
M4X;&6?3DEDR @?W" DR@ 311!9B4:AC 6?027V! >M;!*EG !L'"1#3,@3P
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M8AV&+S  #ILMU<C6>W1" 3"-"XSG*$>/Z Q1 'R4F;%! -#"' S &P "&QA
M)X2" )S ']2! G1("+39!RR '?S!"#B XJK 0]!1NX @I21612R =MV-G&3$
M!:1F6I 4,!@ 9^@! 4 $"M0H6CS  L 1!UB  (SK!DQ 'I1E<GCM"OP!&US
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M!VB9?Q.%RH7 -8; D@S90=&!4JA+'7PA']C!D?Z,'"0+=<3]AQT&'AR]I)2
M;;SS'CPCQQ<<T4X'(!"?K:J '83"Q"FS4K0 +<Q)RXO1*+#K9]1!5[P!>W *
MZN"!W.L!IS?-:G* ]5H*+)@ 0&3HX.=705DH A4LB(>#!A6R"LKI4Q 6"@P#
M"_YIL/XIA 44LPJ^V5-PDXN"O%B$*IB'0P85(%&J_#5+!:Q?P/"$V*2P8*@$
M(-ODX6G0A8H3)UKL+#@JP:BA3Z%&E3J5:E6K5[%FU;J5:U>O7ZEN:N#TUPD(
MP,"F5;N6+=90#CH59*. 5UN[=_'FU;N7;]^N:/\DJ.N7)UH2)K2B!8&"<&/'
MCR$/12M9X>3*EV]BMEQP<N?"-ULXP# A J>HFSE_1JUY=6;5J5NCC?T9\TW/
MJ9^V=JVY-F7<;QI8J/#@#V[CLWD?ITT9M>[EL&E;OHU;>F_CRIECA]Y[]6;G
MNZDG#Q]^^GCP4&4_K\ZY._?KS:]'!ZP Y/G:Z]>_ARJKN/Y]]ND+\F.PR @L
MT, #[YJE$YD0;-! 6A;\SL$)*:S00LB L>G"#3GLT,,/00SQ-!%)+-'$$U%,
M4<4566S1Q1=AC%'&&6FLT<8;<<Q1QQUY[-'''X$,4L@AB2S2R".?BPQ ";EB
MTD G<[,*2JFFQ*M*)+&T\$JJMJ0RRR_!#%/,,<DLT\RH2A!**DXT &&M0$+H
M<BE2"JK#)*U8^,"#/4OPY"HFT:*##0YY 6$G)CT1X9=0/JAO*C;J\(I1#;4B
M101*N>+ED]5"T="/$TX,I 0YJ30!$/^ .>'4Q'CBI00&(RN%SJJ Z61*!?.J
MM2Y>2/!3K5%(\  84C[8 **IO/X+!2)>=$H1+3U4(!(8!%;(;#4*-O@#0"[1
M^X6/"FB)TJH0."BHA K:DPJ""5I8H04-"$C(.Z]$P #9/VF]]ZE9*E@5N5_V
M(  83R30T#D+2"BOV]0\F<"F*='R1(!9NQ+$ $P+P@"Q7]Y8@%NLH"05K3H2
M(/6T!.B@,@$Y_+M*%@,$L2VK[P M: 0-Q.5I% ),LPXW/033=RM8#$AHE@)&
MROGC7SZ  (]?/)A@CVVIF@6!XF2I@""31U1:Z*I:>$#:!P;MS%%@&M"C,$?U
M ^86A8Z-BNV"YDZ-A \*2F&#7WB)6R%86I.@!9XJ",$U6?RFN^[=> $)A7*?
M:GR_ ?Z?@B7QH619#? _,:;HET 8N#Q#J#9@3!;**4*M;ZDRE\IRA3SYZ9?.
M@5G\LDT2Z+ST@NB X*:Z84%]JLY/KUSXX*L>$(\&;KH<[LYGVA>M!R)%;9;I
MJ[^)4O@,<E26!DR3;?'5GXJ[[EDHGZP^M$KP0&[+F/(5*EX,!I@!RC<?ZGJ?
MYX5%@9AEL0"C10YZ"D%?:BKPAH)4P U#@=[^Z+: 5<6G5>OC2>LJ6#[4D0\]
MT"O>VCA6@2(UP"1[V$ =)N" # 0O PQX@+!^T08)2$!J!6F!"O"  #]L8@-T
MD,#*/%&!!FS )G^P0(8P4 <./  "J^+$!!Y0@3EH %,H6/Y %&&Q@@VTX0$,
M(,%@^#"!"DB 94.!0+04,@$2%(04&YAA"#0$"P]4P (9H-,L,."'#T@ +2IH
M0 -84 +(9887)XB !"S0,Q&PP8\,&-10/&$!#%! !*@C01M8T  &L& R@*C
M&!7X"S8%0@)QLL"I@)&"&59 *;_  P0:X $Y,  8GZC PU0  0E4H&<*V8 *
M0L, %0#C61/ 0 0&!PQ>B1$#?NI$!9SB!PE@0'#5"04&+$"!#T#$$PW( P8>
M((&$W(0%J^S/)3F3 4Z(I0$04.!D1'#%"_ "A3YL  <TQ D,C'%PA=D 'E#
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MLV#! \+%&5X\X 2S2(4&\$8*"10\%!,H^"](I@A9[ $!INF$ >  BTXPP 3
M"'P=1L&+!(0Z7GW?&PDF((I9L"%T:(/ 'U+A8IN -Q2[9P!(,/#%-+O)!:8^
M2 ,\ X<"?((7?%" I E AU'X00!"B8,! %&*-R0 9S6"10(2(("MH:<!@\OP
M9)I:$/X'/,UJ_?F%"BAP?^@7!&B#$7S>,N 7\H !9@?\>J( >&&J&@L!2F$H
M[J8@_DHA/$!1,*!:ZL3H"(<!*H ")D !/L FVL!W.&/V#DLAXF\6$B"49"]I
M?B$#@ HM3B\5%"(#*LL"-N87'B"G#&*"/F"-+&,#.D A2(9I*JL@]H!Y.$$
MQHD7E T6"H!B.L!P..#*?@$.$.#1$$ 61L$ &"0I4J,E%.+]2*%G@ $"X* L
M"F8I."IW>"'69 -3>,'^!.D7.D$ 8J8@'@ .9($ XJ(@R.47, "-@.$!U"9V
M+N>7>$<!% *^?F$.24(!I ,";I",%((-[ 4#MHF-?@$%]OZF(&*'?L8)&"K
M_0A@5E0@OGZ!%*(E#TJF(,AK* !A, (C0PQ *4X/&/[@ -2G *KKL!!@,&;!
M /)@6GJ) Z)% AKH_$;!$Q" )QC@5 AL6@C"AHQ.!<2F(.K0<L:M(/0D(Q*
M8_*O(/QMR<XM%;NL$8-P* !I,)QBPV1BY10B$.H#QYR"#P@0W8I- ,5F#N[1
M'%7B 5B&%QC _BXH ?P$!=6$:$9A"^,F F2M=^ F 52"O@K" @;%%[Q)(4[
M?4  J#B*!6Y" 1)"J=2& RH+&&+."2FEIOXOJ0[@URY&(2C@#%GK6)QB!1Y
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M%J N=ND#5A0U@:$%[ 4M9@$N= I@*!0JSF\D28V-+D;<:/0#$ !4)N,$&,!
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M#"2&LOXB!X<IZ,!L/X%.1-9:G$(62$V9&$!M(#444&"-^" !TA401A<E$](
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M\'#54P%QC32@"(F&( *A%3TC T#R%V!4(5; 7EP  V=GS2KC<3,C _(1$/
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M!3=@)'R+,R9@ P!A#CP  08E$ 2@3_SG X[;S?CO2BN@UU(Z. G@RKSR@A1
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MVZV;S^X>87K+Y\NS[\D:OOJ>W/F7;Q_?>]GUY]Y\Z EHH'_ZS:=?? Q2ER"
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MC.IV1 ?+O[QA0,%(MFCFS!Q&[&!"'E3P883^-LP1"!(82:(*)"040@0<S6%
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M(<4*8'$";.:!A2[D!0F3@ $1&#!RX+R ]6:Q @]XP Z4^8,']M@67K" $VS
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M<!T0T#$_6,#!O#@!^#3.<1%<0"$,",$><*:ME72"! UH0R@ 40 +;"""+E#
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MH/\7"/BDL!38%0KF$P_P=:'$$1(00=BA AU@.@1P*8^6=W_W2 H ?QS! 1"
M29TT4FW3&D+5%43%!]"C$*P#"YO&$2? /-PU=WY@ &(2"A/ "YX@ 'W!8=A!
M!S.4 *0 ##)F$040"K-  +ZC.4K7.0: 4IKC2MCS><MA 6[T8_O&$E/7%A!
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MG> Y 'B@<VT!#'] @041=8PC7G7( '>H +0F*L!0$EJ" &;1%<! 1!+Q=VX
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M 1P@"J6  F^8TC+!@CSQ!N5S1R$!+GHQ"IVP 0;0%@PP=[)0  =!-YQ0*@)
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M>0,^?MH"L! *^PTZ5B(+(0 !$& !R"<"$! !%Y 6;I=-# T+L0T+#/ &&?
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M@!*T 0*#^04%-E"!!H1B% _ @ H^59(-8, #(H#  R!DE!$\@ TG4$!45)"
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M'%3G"0+LCA,"" 4P&I !J3G 9F\P@+Q$ 0#:3L!FP55(!8;7G- H0"_ J.G
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M40!/@(4$^#OVLYG4^041J"BR\("-8  >B;UR:P.J>;C=J?ZF6SC!Z?, F^$
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MI(R I5\8P@3 H"53G3:P.AP<B U(@5](@$63QU\ 0H60 !J9!04X(-2H P-
MF#9 "79#&#XP-#> )?YRHX$002WD0C^\FPZ@+X/<B^*+C3?PL.3(C')3" 4P
M(@,PO)+8+3HL',>[0\()@>TH2868@U"$"0@@A5$02@L8,FAL  ?9%-,9" L(
MPDE\2JC4/3F(R8&0C([R+F!0@57ZA0[  *,8A0&(B 7XICT(@%'@,Q4+A,#!
M P)(A8$0 91P)ZEX19ZP'J(8!048'ODKOSU0 ('Y! + (*[RL#P0 (0I <P
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M 8;DXH *>("ND9X*P( 3(*U9P(H,D,L/>X 358!,] 08Q?X /2N*$6  $76
M5/D#!J@ #E@ @7206;"+?2H!H^ WD!-/*&DG# "I&20!'06IJ) %(VT $3"*
MI?H #6@#A?J%A;(?#[ J!J"O,!V(D[2/45@*MF(S/W #PHE &0-1!5"HF'(:
M$%T A0(MC B="[  !J =QR"S4_0 !\"*8&0BJ_,#!OC3V7$*"! !NU$ $# *
M&Y0*!-B=L>.%T;(+#R"*!E2((00&$B  "9, *JS$0,(> ZB#>T.8OB2*8<,
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M"O\XDH6@O):QPEG( SWIV3I("$&@*M38A#V@65@HB524A0A26[CP T!H&9M
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MF_9?8!C8XOV#MVDG^Y"K"1 !#-  U?D BV-R-E!D3P"&"[@ %EBFD+ >QUB
MG,* 3'6*U7BLV>.)4#B5?N*N#%BI!]BQWU'"%8B $'B:USP@@/.WPD !#D"5
M[VKR$B!!!4H $A GQZ#T#(@LN6:#!#B!2O<=$^QS$D" RCAK!3@!%4  FQ$-
MC!KU]_JYD&@#=S*H88$%8/6 $4" UHV#K  )-B@W.>CU43"I[' L5Z</#]!3
MV("4%(ATSPJ$!?" %/6N3?C.G/XB ,<Q+ ZX=B%9'A)H*MH2 8[Z"10  058
MM!\C@0]XJZ8P %"O  I  ; (":0Y 1>0\9J#9-0()Q2X=]CHA,/Z ,5:]3]
M@&WO"(%4B$]P+ 80B#KH=)HRP!*  !;X  2(BJ>P@#4'E8FY*S:PFY+S@ F
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MDBY@\,LH"70B"P,8S.$)1"=05P('6G%@PE4@/9C'8UN%0B5!$XPE$0-[R&+
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M!V+*WE5';:)(Y]D#*G"\20O<"J)2'@P0)!$)ADG AI)[(% 0G@%'5T'.$*#
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M2F[V$M@O* "2!UC  ^IS(#!8$"6)./!N[/K%'X)'D*(19 51D@4))+ !-FP
M/X4+"0($H9/WU+$#=:"(:#:#00VB('._@$,"'E0< CS  0YH *=^P2:M ((
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M($J.H2 "H,*'-;875A.IG:'<4H#VS!,!L>"%(W$#M<T\ #_Y*1DL5$N0-A@
M&""D18U'BS1>F')FM6IP!7KB+?ZY_A=8HP"S3P@@"T[,[$<(T ,P<J2<3CYD
M G9#"  \$3 B"I&('*D,(^V@TW']H@\$,)0)(B 1#DA@#W7(P $TFZ05-" 6
ML<'9* + &%Y\8 '[RLH>ZN(6 3P[!&#AE!I/] "%^6$MNJQ@X!* %C7.XA,
M,)P<N,8&!:1B(AF R@+04H< &%<K;U! :GCQ .((RD*4M%2(:6* G-VAM-UZ
M3+B/ HP/W!HBR)8+!'ILRDW^8A-P#,4$,  'E(QG(@AJ+T>.Q);V$L"<&&#
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MTH%N1B2N]>9!"\B!?8A"(/""'+1!/^H!_.+.*& O+! 61/X 0N/:!RD$@BS
M01P\".A";0 [KJ;0[QS<;VSLC J$6FS0+S7-@B<D01V0Y1]4  =88@B4 "RT
MP1O<8AZXP.VNR"B\0842Q"TL'2?@&6J>+_RT< 5OQ1ZX  =/!.&:0 4# ]UZ
MP@S301*TYR*V@1SDE1ZX@!V :N#RL%TL1)AIA O005-9[!M0[HIXPNL:CN>:
M:NB&70OLI-0^TLCP@81%V!NPP:0 0L-04%9)K@G31(&%!!PDP?P$PBC  AO
M 4G]P=VV06KX@1CGC17;$^<" _5FU1ZXG!X@)#6A(31*2@4X$43HAHBHIDZH
M1&68$RQD  +HK=NFG5=5:HHT#OY$/  ;Z,<-PH01GH $9("I/LMH! <#;"TL
ML%\(8, &[$9M=B4"; ""&("8[* !P- &(,!N5D<)A$ "Z&T2*, )B$"0P(0
M&$I#+*(!".@'"(!7A,(#>( *5)Y$1.(&&!T(2$3+ZM+-J, **,!)2-@PBP "
M)(BM?2T.XDUQ^&O@/0#47( $((COI,8H2 !M%=*0%$#Z5<"9:(BJLF #?( '
M@(  H,Q/E  )),!8C(A$; ( ,'1M+4<'Y)]G",(-G8 #-"Q!Q%^1-+0SA8
MG,0M8$ %L($'0$!J+)B ;H!/Q48&V'2^?!@:=4 (<( "D \)3(T'- !CO $"
M>,"_</X EVS 2*B& ZC OS@U @@H!X2&+'C  I1+ZSK;+SA ,H6 \S$("S3
M!(  +T /@E0 ',E"3:^ _B$J?)7 B+!%P+AR*(P0.2M,->WUHJ0(+62 !*"
M!BP&+X2 ":: (C8/[0U$*#A !Y"SH*4 5H> 9<2&!E" KU2 \,""-[$!\CU(
M-WD  EABZ8V* PRB!'R VB* :,8!Z,%S5N@!-PNH #!2"23 "&0 4^]IX"6
M"/Q1<>6: I  "KS?+Y  ;/R"!8A)$C  "HR  LP*)_ ;-2G !XB0H%F !60
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M*O"UCAS 8Q8#CNJ($P1@X26!44[ (P\21E' H0\NN""$7[:3[A<\QA,!-8B
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MD%?I@2,3F,TO/F$ C@))2.^+GUPV4)Y #&!GA/+3Z;(4" 'DC0T'J(,>2&"
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M@XMA+#LY'. "&A !5KYSQO; H@(2^,#/8,$[#3Q@PR (+ L !(P./  $>F(
M"\2IHMD=Y3L7J  (('#)7X07(?Z"I4Q%,T*46VATPQCM2"P,P.1?K""?P F$
M)*W4$8=A  ,*H&8V"2 =%C+YP"$PP']",8$);$ !CV1?:']!SQ!%*! +V$ '
M3J "58E5?Z(2! ,V,$(5)" D=\@ !O;@@4>V00$;J, #L@,W!HIVIFY0@ 96
M'1(YG'(N04DC 3#U"U]<V5LN+1Z(ZH" "0 #2Q2I@&&<PVEA4>DA)V  ")0G
M@1#,\"LYK$ $(CSA@$U;>1,0BU-*P.D'1$>6WT((@RD"BP='F 1-2\ &-I
MR ##!)*6  7<YUF5K8 $#)B%"@;S$!0XVP+I6QS!>HV0<D+@ WI20!O, K$7
M:3,#%?X(>!L9B8",DV !(?'$ RJ@@05<4@X ,%5'9CQJ?_W"C^D+Q;XUD("!
MTAO/$)B ^_XP. *ZL 63^04+4GV;HRPK%D9CP*_;4(#!TE&((=!U:33#"T\D
MP'\(88%_@>.B Q<8[&$7^]=&D76GD.+ F\@#*(98MIP\2%EY*#)&>($18*#]
M)6CGQ4@1TA/@S&(/?'"[J_;0A\&38@_2L?M]95%#1-H!$"WE1!Z$"PNST\</
MBL>(*'Z%]_CD0466;TK=G7(46$![%'"??&777;;&"X?T#F<\'_@ ]U'5,">#
M=THGH V(/-S7*9Q?]X,(YU(_9/6XKT?(Z8V/_%GP1RAOX?Z*'OZ $^7_PO/,
M7S?UK8_[693B(9_ /43PGOJ'>+XII# ]M$6?D)((YQ-\<!\L0G'W PLB#\E"
M2/SG[[;?A.+]/,+VR"_M]$"XL ^:H*TB\H!\XL,/+N:XBF^#&'"%V$\!Q<4/
MTH<4$(7Q<"\4\" [T.\A/C $?^4/]&#\[*\I *_V7J)S( (04!!&VH 7\, /
M.D\ 70KW2$$/ N%77I 6<$\4]$]ORHL4+@\8Z@\$H*M\QD][U&WLHE *IY *
ME0,8I@6:,"!,JI!KOHX+OQ ,(0@"\& //H !+C ,TU XO% -8XD-VQ X)("$
MIA 8/@!P@H,7*.!JBB,0L@0.__X0$-UP.=X0#UW  TSM\E#I-[R0$!<Q.!IQ
ME8P#$I%C$H^CI2K1$KT&$[\.#B(.!9PP$B4Q"@F1%#.1.3#1$8'CZQA1%*UP
M$)OC$2D1%IN"#3BJ:R;Q#7,Q.5 Q$'O1%W\1&(-1&(>1&(O1&(\1&9-1&9<Q
M%IG1&9,QOGCQ&:>1&EM)&JL1&[-1&[>1&[O1&[\1',-1',>1',O1',\1'=-1
M'==Q#2GB&D,Q&-]1$=E1$ZE0'E_B'@DL'\=N']N1'O\1( -2( >2( O2( \2
M'8'!#^R@#AHR#Q*Q.$IA#ZZ1$QHP"D<A#^01&.2N&@F"E3#C.&0!IJ80$!J(
M.3AA!?Y$0"8 $1CP8  #<11&\I4$P2)_8P^(L OU  V9<2-W4@U# 9N$410T
MJ#C0@B?7I0(HH (4 -3<,15A8PX&X$'21A5/Q0-*R2EE$1[IR"GW@ #2APU+
M@T!@80(\ 1A@00#4(Q4AD2K9A"MQ@BRO9DM"!S8.S"WQ$3@@8#8ZJAG3)FTX
M8"^S\A<$80*DXP\ 0/_NTBGM$@X\P"^]4!8J0)0R #7BJRJ!0P4&( -"( ,&
M0-%@HR\CT2Y!DXY8<5+NS3(=D2^K\A)7B2KG$2_QP#[@\37Q\BVUJN!N<P'F
M9#4!AB]Q@A<,P,I$TS5!<Q5)\S7]P@)>4C!)\S?^H (<0OX6I$M+GG(6Z_(R
MB[/)8./3. ($W* T0L#+%+,YGU(QVY(KN;(VV(0\"6,P9,$"U+(ZP[ 1(VN@
M1@4#A&X7;[$?N48\-G%4"L#T%J FP4YTA&L",FP?4_-K1. _1K,^;/,4?Z$-
M)B Y$D"4+H4YX "U'H(/ &#/TI,*3V"Z?E$/*NF52,"$@F._Y)$7'""$I+ C
MS$)LEH6M&" H [%L# 1&W P.&70-<4(!<K08&\">.F(.J@(8EN<#5(065N"^
MV, 32*$-].,-.*!)(:(%2"<0[K,%0@$0(*,3W" 4U*A*V:H%-@ %.H$-+J\.
M/N #Z)(32 ,A]J!5@$$.. 7Z^O[  3[ABL[T-_P !#B !K$O!!C  ^I %A3@
M#]I 0,#/<B(.#K"E!4:A#KS-X=B 33. *.I 0*B$%UJ@4WYG%$8 47&HOX+'
M,_P@XG9#<P"A$S[@*/  !#[ 59NB#O+%#^; $T) 9!8Q"4@A23SC#P;U5D/
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M*)9M5^#R\ "FI$UY.*(306!DI9 47*! FX(!Q/9T@@(8.DP/6(L_&J"B0F$
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M77\! AXT(^Z3!1Y #[R85AY"!!@  S9@$Y;$B55  ; , >1@#[2X(U:  >H
M#QZ A*YR#_;  =C"#@P SW9&F^0 #Q+F%_0@ ?3D#0K@,^&BA?R  Z!G A@
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M%(PJ6;#G5-@ F^0C?2J "1'@7QXZ;F:J(P(](8#J%T3 A%Q +!8I(@!A%@H
M]Q0@)" \*];G91)C$P:@;GI$11(@=_BG=?IB4M(*(4@=&&#==\\+$*SG5-X
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MR  ,3P/@*G#P"P=O ?>2'PND)L=[,,D1&DPN4/#+* AP\@LL"APEF@&SX)%
M"]NM\$8@O"0 R&VS9/A2"""\M!$ML$A0@0I[D( 1+ DH\E,%+OQ2QT@AOG$B
M!BI,-0H;'B!@@4O :7 "3FD]1(('4_'"P!XOY9& <MN]X<<O(;P5" ,[ 6(!
M'+^<1OX=)P;PPL<"#SWDX"]N_22!&[8E4<%+=_Z$6!U5+H EG1AA]08P"9"@
M' MMX&'@* 1\&2=\) "#@" _H40*A9']4@%)/AI61UHP37"H!1&<H <+\J'4
M:69#G4 E R<:V$D+&Q#P 7!24DE4 R%PR89!O\CR!@@*-& L RVHT.4FO&@
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M.#T)&$@6!NC1 [3RDJ$!PWJ=L@"HZF 8.P1L70C8A$> TX96%0XSFOE%)R*
M!PH8"!AV $XH"M 3X)  @E093D90=I.,%(03"/#))SIB .#(X5IY8 !P_G
M6L#$ Z% $'#>0*J'P(( &K(>>R: IXPH@ _ ,$!M7J(!CID& 8A3P!Q^(40U
M\@D/%SA*(-((D^\A9B 8D(IC"""+31" .B]I !TR]A(0$*QC#0&8]V;!"Q41
M+C)Z,/Z,3V9A@,;YKVYO2],!4/D0/\BQ6 SXTOT00 I20!(F^/.)!UHD&2I]
M (R0&@74?A&!X5C-:A="0 H']!9P8J!'#SFG&8/)BU  XP'LI*$O&O"V^,Q-
M%G5( $Q:X*LV?& %'[P-'4*C*<,I8(%@6AP#?L:+.\#D$P:(S.4J1]&*YH9=
M) %.=NZ7PUC P@,VO) $'*"8ZG!D+2V !2P^$-)0+* "*U-! 2;Y"Q/(S2/:
M<L.#0L" %9   PVP#],R  M>W&X4HQ  'F"Q!P-<!D<LF 4L.) 6/B @-6_0
M)4PV@(%1&"NB)X3#*!*BO>#](@,6P!\=!.!. QPE< G1T/XU7=1&.9"&%T/S
M "UB88 WE)$"'^@)54,QBSH(((45>-)#+#"!TD2O-L#!P%M:$"X.^J1$BK&(
M! B+AP%8R ,8\<"29B&' ;0 &($@0!YFP2;[A$ "HL G 6J3@4+]X@$P]$D;
M% "M+<I!%N,QX;H4T(+(<. R82$)'0KPAUEXXD.>L5X%_I#'"#S )7=PJRPL
MV*-.@/47$Y#(+^9 /#P$H 1U(X$<]4" 3_ "$ U84BC:^Y) <&A%'[D* SX
MECS0S8 A$-!#\D" /<PB% QX4@C,<Y($*$8"&QAK&P@P"T 0@!.\",0#)" +
M+4W* AN Q2Q:T*8])$!;Z?,)+/X,((=V?@"%OX! ;A'5&1!  ']R$ !&8,*+
M!XA JB< P%C\((#5AN(!.VX# _C3M0O@6 "D0-11+)P'61QY!&DB@ >\VH(#
MS((6;GW)- V'@/Q5 '^&;:N&YJL2/T0*E41) !MX00H2" !: E !+=]0,9A8
MV,"\0   [T> % X6%G4(P#@K6( ZR((4#[@,)PC@:%),@$J*D-X#AL,&!YR%
M07_,F@8(EF*(;* 3#\G J7]!!P, @K4(Z)'N7HU&&/)* 79XR0DN,,I9-#44
MO/@# S#@DA@U((6\* '\Y$2\+7;J=JEYB <Z5Q05 %L!(2@J'OYKT6Y[^S;
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MAJ$")(2[6'8;:Z$C+\$!5&(!$N$2%=P"$N*[00,+:*0M$/[W$M82A%<%$PR
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MD-Q^6Q''.$;"!_IK0*XBW JQ]8BOCWX MSZ2^P_!&7C _ EU6TQ*"PH>$X%
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MGM[P,/X7@8BQ!"NTC1\!*9 Z2& 4T[.('8=WPSPJD30X/ $)YO@+4AR%%'N
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M1$+10Q@#%&P @UBSHA _L$$-)/$+,L3 !EDHQ!-J, -W-WN[CX"!#;2@"E1
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M=B$"*QQ"#&Q.(=3 4Y4!#E#'GOY @B5D 0XXQ5CHPB'8@"&L0BW< !$T BI
M01#] A84@27L9<HMA/V8@2G<#5 !BR6T&@_50@T4P2*TV@UH"K!4@BILAO95
MPA5M3AG0@'%ECH/ C1FH0IAYT!C,P&&B@IUI 4'T@(.,00Q(P218Z'%@G4(
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M+((E4 (7:,M':8%-@(H6_+MH& (K+((5G(&*F((5W$ 7C/XJY%A!%Q#'(/3
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M6D4.AB"&M>7L,5I@Q-M:48,R2'$13K@>#*!@AHBY H]BN%@4BK:(<V&&$I9
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MX$TNLOZ^7V#A=1EA0O:2$C<J("\C /[%)6)PB2A419YGC)MK>D$Z]?J "6"
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M+G; ;\H."#2-!6&"$F @*UR!"6; %70F#1[P2:PB"+ @_P9!('Z!"I2 9K+
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MHYHPPI]YEZ*9NJF=.E5,H0LDP0S$@ AVECC\\2(T+9A]P17D4%>?6M$,$1*
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M4D2!#^T0(4&[U&#B#FC\ @45*6&AQ%8S#-(++DT \8LA.^R4Q1/MT?715:K
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M,4!!#/"S^Q/P>Z#B%R037@"-*QR?9]_T?H50%(YP'H9'9GBB=0O(@$H3"89
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M"&@0"9(!-830%5M@'9 P!#L !6&F"UW G,5G"EE0"86Q!;O@"UEP T"0!;Y
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M!<G3"ZUD"I" ,;I0<;^0!I=3"#7P"*8 @E1!!MVC"W)["9&@ Q+U. O5?#7
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M _EE4#] !"D\"/6E"SF !38EMWH# VEP"BHS3M2J?#7PRB\0?J80);@[ XX
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M<X<0<?XU*D+ @%=$+9X>)*C6,'9(BZZR>/H72HS PELCNO6%#(:9_>60>HG
M:%#BB\?MET=,%[,,L\6T!(@;?'>*YU]:T=9X[+/7?GONTP3F^H? EU-\B*@?
M3TQ?S!>-3#"<H(S\9L_L17T^Z>\3_CWQ)Q-^_<7L/\UC:>]_94J?_]1'/ON9
M98!B"F"@"HBF_CVP-378T@+]9[P&*K![:8)?!C?XP3'U @OVP\)[QB0&&_ ,
M%ZR0UT.L!T(8QE"&V4N@G- WPS-I80@X)%,->?A#0/D0AT*\(1#75\1!J<\5
M,+A$#(G8E"=RSX=1-&*?*A$G\U6F$/YJ"BYT$0E?K+ 6*/[112O&>*<65E&-
M:P0B%=GH$%9X;8-N?&,=[7A'/.XI?9:PH'GR^$= B@D1*AL3)K0C)GF5<7H.
MV47ZY(6+7 12DI.D9"4M><D_T1&3F^1D)]7H"$24*1+KHEXO3%B]\-W)3KAI
MF2==^4-6[&6#J#@:H$P!/TWNJ1=R?&69=&&*7,JP%;P4E"XL$4RIR+*7'"0F
MFG:!"C[1\A>J:.6@5E'!9C8%%1XL$RI."9%LSG 5M82A*O:VOC2TK8O:PH4K
M*M,*>*X*%ZO,SS+M&2B997%]5X@"9=1'/?K]ZH@V )U CV@65KS )Y&0@CYO
M"- >'N].BW@!2BA!!6XV#HIGLOX?S^CXSS%1#Q(O:*%#_?@09!X4I;\@PP\4
M6#GS=/1.0FH,1!/(,RQ42*)(/*D-CX=$8% A*KZPVDD]RM/U*6A54\2:#1"X
M4>QH9P:FHUM("9@:*_2S$"_XID!=\8*"M$(*TI,@=#)Q/(J2LZ<176E;?^J0
M6L#$(3B8F3^M:KPMM E/(Q037"#"3FW)RQ?,4NL]#7NF0J"&4+?98 ]("2A7
M',L1-0AB)E<)B1F,:0=I<*4OTOC',0#)+-;QDRIJ\%D_::$L*2V>#43FVK4*
MJA>H/5,F=O!$Q[:FCV>R0H5T05NW5087,- K^G9 *90"=X.]@$%5?/'"&:JB
M6V+2@OXZNUB97/C5BVX:3YL*>UCPWNH)/3"#UR2A!3 TT2Q9H$(KP-"%L$@%
M$;[88I# D 61)2D,6B@$SR*QA3+@ @B'](4ALC V;T7"%>^U+D06L0M33(%$
M3=S%(+I@!K6Z8A&^.(3*3 $&+6"$OJU Q!86J@5"'*L5+3)%%4@$3=P0H@=/
M,,2Q3D&&+!#2+)'00A>0B[4N5)<RA6BA(ZY#WRRH042MZ"\B9O<03+S7<6<)
M<E1JT8@ \K@+ZN5P*R"Q!03#40RR^UJ/&SR>061!#&V"A"5,T04P*-,5.$8%
M&C##R#+8( NA%(N9F[(8V57&%#9812&V< CA%@(7AD;T0_XJ$>3AJ?8AC\A"
M&*KRD"^7H16+J 4E1#;BARRZ%FL*2R.VT-^'G+<+/M%%&FQ0!42T^M6S<\49
M]OR01;A"%6>XB2G$T(7F(3),NBA$+0Q-"-X(N@M9N%<F;N +8IM0*P^)1!;*
M4(L@K.L1[Z)$)ES1!?@^9!=F8/8JIOP05=QW%5JHD"L:,=$MI*$6A]"%+Q:!
M"UR0P09:N%<D@GPO7=R 4JIL42^*O8@M#&)5!J^%(Q*^*/UF@1$.<00F'G()
MQR$"O=>IQ1CT'*9(> T7Y%:X0UIQB IO@<_$*P1G>;8(+/9UJ;I@Q3O'^!YX
MJC*\.Q]3)(RP@RV$Q0HZ* ,9</X@GJ;HT G+AD&+#C&#)Q1!.8:0B!EZ8(6'
MH:<01,#1@<*0!2;D=A=#@,(@JM"#T!Q$"F&@ @RLVXH87 (53 !Z)7I!(4)4
M80;%?034BV"K0^! #&;(@9%:,8,A9,$D67B"1L#EG5[@"NA7\X48;A"%,?RB
M$5-=&&W, @8<%'T&F0-#<HRN'""4;!=0\842,%>7O=0DZLI[6.C3D ,<A4'P
M8Z"!<M""$C+D  UCP$$H=V&#Q(LA!TIX& T.[(.&_D+YM,)!L)WB@R<<XB"A
M<4(.J! &)M2@,::H@13(0)I^/J066;#!$SY6!AR8 ?YFB\1^%N8^4]P "I6>
M 60N,?X#)U"S_G,(,Q"\,L@!IE"-LO@%*?B!,@"#&9@=,JB!7W,"&# %E="6
MOENJ))D!)L@"*] S*= (*,D"'3"$0<"!1>B%+K !*$B#70 #%XR32L !+;@<
MVO"%'F""4:D%4\ !,AB$'V"^,7FZZIF!Q] ('#&$J2(\R' V@HD!9D&$%/H%
MK\L"]EB7&["5*ZB![Y,"TJH%'V ",;B2.W.(3)@!+  #)BB"AF@$&%@5*4B.
MU9B!5MB%&*B$6@C!*5B7X!L$0L@!S@JX'UL.75@](LB",[@!]ZF%&4A$,< !
MQNH+,"@#(*B0+^B!AQ@"IG""(2B$,J@!/<0"&R@;)H&,5?YX"3-X A\(C4B
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M 3DM!!IPGU:0B3Y_LH>@!,*AEDNKA&;_@80Q"!JHI4 <@C%\[AO(<U;H="8
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M7I=.'<1E)N4,A1]G5/+X2R7-EP)9X1S:$9=*D ==5:IE4:; 5918'313IJ%
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MW( 3*TQH2@166MC PQ!8F0$$J#LQ1(@/1OBP54-E^%"$#XL(Y,0@ IWA Q%
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M]8LAG.&*6]E!&@Y""'-]87:_D +@LN ],9RM!\#Z12',E<(WPC&.<IQ/U<0
M"3(PP7&MB,'4*O$"J5 A!X<8A!)@H"I=_, )BQ #$,06-3#<,8_F$L,,P-"+
M+^0 $8>P@@ZF(!6,U.P*CR"$#;KX'3 LP@HY&,T.VG-*1&2A)[_(0NDPP@1Z
MM:('4EA$&69@E^]T 98S8-H<BVG,8R+S-I78 A80 8PR-*(79F";&4+BBT$P
MP0JF* 0Q(](%)H!!%6:0BB6RP/Z%1?BB#$?:A1G <)%!6*$+K3"%%T@(-2TX
M00J(R$@6H*"%-1DB*!_K9Q>"%(DC"601%AI*&)Y0!8%2K9]:2%0R*VK1BV(T
MHQK=*$<[JJ+6V"A&5*%1?EP#4N#<YS=A\BA+6^K2E\(TIC*=*4UK:M.;XC2G
M.MTI3WOJTY\"-:A"'2I1BVK4HR(UJ4I=*E.;ZM2G0C6J4ITJ5:MJU:MB-:M:
MW2I7\3.17N@"K&*%35C)6E;8C-6L:45K6<'*5K*ZM:UHI0A;USI6NLHUKFF]
M*US5VM>XYK6O@I7K7\]*6+&ZE:]U#6MB">O8M0;VK9*%K&,C:UC#[A6OBLUK
M8^UZUO[- E:OEP6M7Q=;6-%VMK.8;:MJ45O8TPYVM8"M+&D'F]G6GA:WIJWM
M9$?[V-+2]K>I7:QK-2O<S[X5L2M=B&F)&UO7,E:WG'7N;G]K6]]Z]KJA/2YK
MJ3M=RV[V,[X9Q!&&4(3S J$(YB77><V+7O6J-[WGA2][X?O>]<K7O45([WKC
M.]_\RG>_[0TP@/\[X/D*&+_M-;""[9M@_SJ8OQ#6KX39FU\*'_B]$!;PA@M,
MW_PR>,(AKN^"ZXOA!I_XPP;N<(8Y3&(/WU?$,3;QB$$\8QL_V,+MQ3"+>_SB
M#*.XQ@N^,8*#3.0(T]?'!&XQC&&<8QQ7&,HJ1K*1G^QB'O[_6,DK)K%[*ZS>
M(ZBJ-J9 L)2K[.4LHWG)6A8RE65LY3;3F,@7WK*:TTSG'1\A7+[1Q:+Z[.<_
M SK0@AXTH0MMZ$,C.M&*7C2C&^WH1T,ZTI*>-*4K;>E+8SK3FMYTI -5&U]P
M.M2B'C6D+=/54Z,ZU:I>=:J7R^I7PSK6LIXUK6MMZUOC.M>ZWC6O>^WK7P,[
MV,(>-K&+;>QCW]35R%XVLYOM[&<SU1!8T$(6$E6&+ S(U+7IQ2Y80@DBP O:
MXA[W?J@0 QO$X$NUJ,$,VCT:#V&$*E:@ 9=^ 847Q,"!"X&1:I1-[G\_.Y8[
MF$$2'S$#&]A@!WK"315B,#M43/[!#/X&.,4K3ILK'-P&/0C)>':0<$:9H@Q:
M*$-2(D((+9#A<;^(A!)F, 1$M&(5B[!+*PZQ"%U 0@MBP I&* &&+B3D$#U2
MQ;7!<#V+(QW@L50"$/H6!!ODT0:C*<0,8F#U&2#4$CFP>@Q@T#,B9%P&E1"#
M#&H C$>\H 90Z#H,>C":0<!@!B^800]B4+KOQ!T&+X""IY/N]V5G(094N$(,
M!I$\((!A!C?06;O-0/0:V( U/X#!%4[QB!W H!&N<,(,E'")7HBA!CGPQ7<0
M/@8IV  &C&.W$B+12ZC;&P;4,X42< #1O^.^V!@)O)=B8*075($0,+B!+\8
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M5WB  M0!0P!#8A[$8B[$9]AD"(0E,"3 8UJF1UAF8.9D'3S 80;F8?X"+"3
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M9,"S,L *G.8#K,"?/D!=@@ #>/Y "\0I+$# "03"&R0 )_""'#" "LBE8#X
M!-2!'"A !M!!'1" @FZ" M!!((3 !GS&&SB 'P#"!+@ ,-1! Z" 7"I <K9L
MCT) =<)" YS '[!! 8C +YP !FQ"'AC HW[&'AB ">Q!&Q@ E\I! ^P!(%3
MB3XM7&; !?A!&SR !9#J4P$#+.B!!'"IAK !A79 !@!"'BB IL*"Q6)L77X
MQ[; +[@  ^Q!'F2  43I8;8!A>YE!6PGR*J (+!!QOY" NC!+X0  K2!'W@
M;I)" FQ 'N"! 3RFU^Y!)WS =C(G!HC 'Z2" J  'Z!  IPH'32 "BBH)YR
MJE;<+/Z$0@B8 /'^A@M4@(0F #"$P@+P C H@(+^@@I4YQR,YB_L@0((1" X
M@+L6@%-N @+ Y@<<! BPP"^(@(,R! NXJ$"H0/PRP'\>1 1HZB], !L(Q*'^
M0@7D[R] 0"!0+[/"0H?^0@.$Y2](@*5"0/[ZP6BV0?,*1 AL)P:4@$# @OW*
MZ0*(5P4\I@+\IRPPP"R0\%0^[[!NKU9]AB!(  &L[X:P@8#ZP0(<A!]X[PK0
MJ$!\0.*VKT#(0LG6J *(IT#  0+0*0<X0 A<Y0J@;P4G+@18J@@\\2PHP"S
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MF, ##2!5Y0B()_M\( EL\("Z?A$("7#" , "Q@/(!@L,;$ $%+R=!%20 0E
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MNJD.*JB 4M$#T5^P(0*>0",PU B4%:0+#ARUPSD7:\<'X*>1G?C !$#P@0^
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M!0)X00*Z\B=;(8"I@T@@@OS(X9>R<.10)- 'H.B4;G'XJ1Z",@O[2$"\.]V
MITB0KN*5@!<(^%LL-PD4400TE@@@&W^?_&0DET $)9B !$B Z39M0@$U0\%H
MU]@ :/XABI](GK_H^@!^_6(%L\H#!]K 5*%4P-% >4,!0AP4";1A%K#0)C)A
MS <9%PX/S/XA2.W@6/N4(%QPGOXA"$H0"%A\H 2+A(7O##>!.7<:W>2QCPF"
MG>&[JOL7+/#H[0R0O F4(!:!2("=W^#8&=;P%WQ@0$0_8)@-9-(3!LB#81E
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M>UWX)R3@@?XVBB@WW3C!B'H//4Z@K#;@]!97VN@ I$+  UL*!#(+*&PM*#8
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M ."6_?ZK8FK$OH@ _+,\9J&VU L/$N!U@V<#*, "X@P#B+0!LLT#3@_.ARN
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M #4?H,PG[ P7FDA L76@+AX6'9$--!0"?-C. [R)YS7*84V_. $"B!J143B
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M+S(7*B!+&&"),#=CH@$(>J  FC4*#* "F_ &!M!:;Y  <? +<$!=;U!0O]
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M92DX"RK 5]0YG=+9(7CH!YPP"PN@'9Q0CW0 "R) &'[P 7(Q!Q^ :J6PG1_
M(76 5++  @H""R4PC'\ 8916 I[42DE0&YX@B;!@ AF@E/Z6HDD:T (%>9SB
M0PHB@ $>(!U_\)GS9FB]00IPP%4;0 +)M2BC$'D9T *WH98=P084L@D@X %U
M  LA( J< &&_< >2=9_<&1$8J@$;X&D=$0@F4 )(&@*:Q0?RY!&GA $=X&G
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MN)1;N'5[N(6;N9[+MX"[N:%[NITKMY*+NIHKMJ)+NJ\+M9S;NJ-KNJK[M2R
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M%W(0 "W0":1@!P4@4)7)^#\Q"P'@N$$Q%WC0  U@]U]B()59("@P27LZG0&
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M#8$ZD2"##1J@Z(\'YD! A%$D8."!$WX9!0,*+G#@CZT@>,,"!I;$"!;A]DC
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M 3V1!0D$\+U"$< /L !B'1+P/_XX,. K#.A1&Q+ E%#8B2$># G^_-" .2G
M463Z&3 (M!#2<<8 V )&VH Q"@2 0#5L2 !G"/ 52F'-C6^$8QSE.$>5D,(
M#0@ &#,"#%N%P(\8R$!12N RA23@>_D9!0DLP"0#?.<7>E" 11*0-($$P@"S
MP8@$DJ"53Q0 %K- P"8$\H&1_2&2?XB50!IP0A9X3@5C^D4)9A=+#@BD BSX
MQ9+JP(!?6& %N00&'G@).4 P:" <R")&9I$ !([B $\QRRA4$('CA6M("1#E
M)A!P&;% 8"0(H,-)*C"B7XB@EB"DC@3RE8$0:,4/" !&![(B"V#T(8V> )Y
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MHA?=Z!H"QDS_HX$:Z<$ MOF# &9QNH%\8$RC<!QQ!<")2@[@A%K) P 0_"P
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M!Z"I2!((#E"RD:FO/'@Z@? #3T*<U\ V7Z@#AG(;SX&:H_/ #P3!#^Q HV@
M! "J!U@ ,-DJ!FB!4AL)4E" #WB#O$, /("% !"E$T, $LH  A@)JW@# :"
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M P2T)#OFA$Y  5["@TSF@\WH*;V@/.AUCQ?[&*U@:3;X@Z[)<X'8=!_I!%Y
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M&_ TB@+W!0B7K]AY$.H;N087)E 2G)"!1;PP$*]#)?A%P?Z]#GDPG2?=5=0
MFWY"^PE##L&2@&D.*2#'+QD(9%$=2O\2" "DP"* Q, T@ *."'SB$ O.AAQD
M"09H^'4 H13;DK0!</*+"$-:U1LP%GC@XV/ 2,!3FQ!8Y(D$),Q7EP!SPQ+!
MWA&<J5L((E2PX\Z_C$* '1=M<&IR\@&U 0:\\@VHM *H%@H G,A"0) .30#@
MU")9U,*D#G4R $UX7:3"O[,D0)-##8!<'9L3J,["L X)(D&?C7D 02>CO&%
MJ N1;E"Z>> %L@M0.<0)!+  H\"OV8V$QXU^"& B'02DDO6R;5:UB0!7G@C
M'KPR,+ZU)T+A.B "$ZC !3(07/ZPZX!#\   K!$I#P @70D X#*+6)!T)HC=
M+WA1@ _\0@4-&,D<#$"7/1C@ RVHP /PUC#7.>0-2$K"!SY@@  *  _8P8,
M)L )3P# .Q)X0 M:L   P0YKYO' "Q54$0XP8 4G0 #0A/<+4NC-(6P CEPB
M=($GL:%0$12 R3(XAY$XB ,NR(!]$"2 $+ A!#/Q7 (<P*M (( #+<   ]9&
MQ+591 4&. $;  D+6!A@;XP)@84,"30Y$( $+7B !<@#.Y>=0#^_0$ <]O.
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MAE3 )GC P!SAB30.":2 R? "(%#@X#D$+P0"%^:!'A0-S[0 (.R!'(S"?(3
M"I@B'A1-"'3"K3C$]M4!UN!(NL!!'<RDH93 HH2"")!"?VC '  "(NU!PFC
M+(P"(. !M)Q 6[SD'X3 J4"0'K )"7#""GA5+^K!J5@$'=C2^_$!!G@")VB
M'%Q)E-131_9ESJ% "<A!"U1%++#BB01&8\!""_!==/E&6K; 'N0!R+2=)ZS
M"HS"<24*(*R5'20,"7@""VB:M+" "DQ5NLS!'.S!6P;-E?Z0PO9MC0;H 2<
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M*4C B<ELG^@!';Q! <E"<;6$6^Z(:MZ'"7B8*5(LT\9<![A AM$"+&  D8B
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M3&CS=C2@',3!)\0(=9U6V!X6UL97G )"'W("W@@E'OB!R>S>5IU5<[' @8!
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MP@LQS%###3DL"I@.8)$H!#T^!,F$7TBI(!18%/.#.PPXX<436-Y@ 2,1?O&
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MED=4%#4JCHC!(]_G"E_P8 :!Y$$,HOB+)\#@D3%8HM8P8;I?6$(&(QV*%F#
M2J;T( I#,<0+>K$+LP(G$B\(0R>S<K0L^#(IA(!I45@1@QTXX7TV%4H97O *
M*KB5*;5X 6&C8HD7:*&!4HF$#%BQBVCRQA$SF*'2^O:+;MKO:+J8Y5!L,8,;
MR&V<15G%"Q9A'";\X)WQ?$H0A@ 60EQ!GUF@2B4.VHH0(J42,PA"%FP @]=^
MI*^7^,@BH #8J$BA!D1!Q N<&A4;&)$K60#E4581@_@=Y12L>XHD7J"$*]P
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M22-548F "E !C%3O%Y1@-]?(!K! "90 NKXI3YT  P\A!G0!.,^L$HJ@!Z3
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M$/4IS*X06J$09, 1!!,7JN &1/Z5#.:.=I<P)6L!!NP)6N40)G%A!Z2 $M
MN>23"%A*(J @.,4 !G838FV5"'Q!@($'!B2!YF*8"("@&W&!-M. "CK2UE+0
M$:@@!TX!$LQ %WKL:,8 !VP V:AF)[N*J_(.!_XPD(!@!]8'%;#JI(H"KFI
M''T!OO2U'L>@!<$@!YB !DS!9J] "8XT!Y@LA(:@KAS)(F% EE!X>=^."7R@
M"(H XR@-!WJ@%ECA;V\@NRY3/I..=W:+"'1@%P+7;U9!!X# CW^A!!D4*Z#
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EB( )J( +R( -Z( /"($1*($32($5:($7B($9J($;R('Q$A  .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>x_cg006.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_cg006.gif
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M]^?Q^.SS^>CP]_3S\_#V^O7Y_/____CW]_#O\
M
M
M
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M 1],:8*I>@Q=D#$9#*K!!A :(,%H+8C(J'/[K<K< ?L12MD&^T5XP $,L,J
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M6J]8M26AF<D.H"2!D^:BAQ;  0Z$&&:C@#.7.6SQ%/IDI4!^!E!-09"@6[M
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MRA\(E8#[U$48%9@GI '![A0*HP4.0,!H&V"Y&2;@ <81"!\(I0 /%"87+H@
M<YI3<,?-Q0\5F)X!$B !%LOGWP[H9X40  $&!'3=$$B N?XX4+V2":0$$*K
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M"J_Y D]0"6,PA;00E94X SE0"V@0 ST0#,40!3%@!3!X!E0XA6.P"E/8!8M
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ML%"("14JE3UPHC, !$,8D\"0EP!LP@),A4! "Z)YI)0@A5(P!C?P DO "S8
M TL "?[8&0-*:,&$7 Q<@ ,W<) $00DX@ .VV\AG2@,WL+N9T,B_V@HW@ -R
M*L-2: 8_0 .6\*<T$+D#40EI.K:>B 8TL)\PF E%((<S  7;2 QD< .'*06\
M$)DS8 4*.@-%0)1R')PQX .0,*PT( 4"D0B23 O!0 7':0-=0 R:@ ,T(*,]
M8 -D4 1/2 0YJ :(/ R'(,F[V<C>:@D^()6S@ 4T8,6,X -J:0-'[(.OW)R$
M6,B$# S6F8;Y+!##D,\*&0QSH9"\X("\$ R)* N<@(+668,%G8CWN E=()5
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MV]SO_1(P%Q  ,BH0 '-P"U;B82K  *-P"W@@ 'LT=X.0 '^P&0R  :!P"RB
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MD%*$2:\8"7.IT",--^2P0P\_!#%$$4<DL4033T0Q11579+%%%U^$L<-;$E!
M  <)TC ^ T[)42,+BCGAO6(DP,.8 T+QB ,4@+2K(#L4,$4O8PQ!0$,&#!'E
M  T;2&^"QE  K2 /2B@&/8_&A*^86P[@:DT'BS'% %VRQ/ZQ& ?^B*V%!7 4
M9+E3".@CP9PL@,,$##8\2(*"_B2E( Q8<.PM4 XH, $\U62SF$(\HN.!8O!@
MP"-5,F4@0Q-"N"NO8OY ($$%!KFE@+>&M*,8#50=4@Y-$ZB3H!0DX%'-8OKL
MR Y%!2D JF)RZ<B0!(XI)@14"RID =EV+&@"2(NQ X(-"?&(CU"-:>".@H0Y
M8)1;"."JH :V):@4 L#-=KH0)O ( ET+ZB.!8OS@M2!C5-!%!0X\&L5?.1@(
MMD!A$I!#&(-N&3*\@N"XP%8.<-%K0SX(#$V"!BH@F0(>14% @I(5@ -'$CXH
M2(6,/9(N1IMOQCEGG7?FN6>??_YF\98'"#! V0Y#$6"4.@NR .9)A3$E 6%&
M.8 #JSU@X+T2/"B&F&5!.. !#\"= P$/KB[ #CX..)L##_8;LC$3WB-H Q70
MA<J8@?.J\Q0$1E$S 65G.T8/MJ\V(,"8?R*(V&+D2* !#&HMA@,%'M!@Z8)8
M.+28PZ(LYH)M\0"! PT4N.7A33W/-"P//)@ M!9^)"B7!DR9<0,.-O#@ 0J*
MR8 %@O1HH';!!3'@;-X3..$N%7"$(+P^9]4+@P0@""$5@QS@XR(Z##HA; W>
M+$0!CBV0P(,./," P%(0H-@8"2R>0]$<X_A@HPCT;J![3$LYC\0(\H$EX4@4
M"XA?,?Y*\!X/J$H7@M,;G"CE@LYI2 ,1.%L'-,"N7$@% A] TH,4L( *M$P8
M#,# U290O%) 8#(FH)B&^@ R!>U+0Z000 CA9(",Y((!%3A!D+!5D = "D>]
M EH2E;A$)C;1B4_DV2A.D*$.;2<C"5(3 1#T@$',X3VC0  @'D$(4+"F&"8X
MF(9.T0<1"( 4X@+%&,N8BSPP !2&, 0H3I$3+P&);E$Y@3$0L"F"A(!, BN&
MWY T(WK-)A=PQ*,>8T@0%530<<L:!$)@8P$/"*,!TSEB,5HPL\.T2W2V>D ?
M<-> EB1@$ 6)DRE\R %!,&0@=/!6071Q@%/DX@!Z  4A#/YA1@U,IQA[*%YH
M%##&!!CB$7G$G:V:1Y#H#4L!U/-(*?BP 0-PA04>N 7J/'(+0)Q@ 'K8%<4J
M4()@$D(4+4%9L"00AX+43T.Y@( &_'"+4#A ;PSP'T1.DH".$(0#S?.(*,1)
M$!)PS0,B*$@N7)D9_>@B#J")8$LT$()@&F(4IY 8G/KP 0*$T!B$B$,"2*"@
M.;2S%"TIR"CN0($'="0SA&"70184FX+(RQ &(<@)%#4>%:#@!"MIC$$24"O-
M0=&I3X5J5*4ZU9\19 X!,)HQ--" D*I@:]U34$J<Y* 3'(R2E+N('-85+%&J
MXD]L=0&/*-"8LB:)3"'@2#$,8?X 4'H$%0C@43B510I*K:M=Q8 #Z#;'N&(,
M8D^"@&A!XH O0CDF:9DY2.>B!CH,M.RRCG'(=EXIP5O@U"-P4)0J#( @UW E
M DE]4!]L94P^/*!V"U!+T3P2!\#9S2,2^%Z?."0"BQ0$H)Z;P*D*(@?8% 0$
MJ!K$<HK! GS!LC&C8$FV+$8'^PE( "&U0Y.XI\L$,*4 J]M.<^,E -D:-SP?
MX)NM(HM83U&D802R@Z?TH@0@^:\8#\"#*=)HS:C@:A!%\D"[C&$ I'ADE^DA
M%SU#*:\&AP9[E>.:1U"0RU/HEJH?!G&(13QB)D8P1"<0  CFH((&,*!1!!$%
M 2!@T_X_O.8/)3  X$)P*(+800!P& 0<#@ N%2RU#QB8L4J,C(&:%J,!L!$!
M1N^"JEQPX '&T8 )-O3 #0 G *L;10"BU((#U*$/&GC ),^(+X+X00#&0 4!
M1" (4&7D <]3,O508#]1 *!=$EC2!,9G!P\<  ZX($"%3 $ 4^#B "<(LO5D
M&P@&4& ")W@ X A1 !7\004$>.4$#HF' ]0.4-0Q@!S^X %Q4H!,!&&98P@0
M@I]FA@4&L,,@4)  T)5  +461 !8( @Z3*48HYBU(72!N3[8X2J."4"P&) 1
MQ(;*P0H8P2#D(!4((48O 0 7"Q)PGPX(H( %4:B7_H#FG/YH@&LP3D )_,""
M HS6! S 0Q_2%[(+-)MYB"7 ' 1!9E((0P$;\(.^4458$OP!#@+HW@8 *H@/
M)!F1639(XG@JFP!88'<<:  K3P$ B^AM(@!P$![\26*6M]SE+X<YBP81 @ML
M0 XV/:U8"T*(#VB@!,'RCX8$P3X/K*X8>C!="T+ZH*2'5 ZO_ -:\R#;>#U"
M@2/8>"%"\ ?/-*P%;^%#TG%>$#^@M11*AQ,)-* !R@E<8"HPVK"^IR86<(Q;
MZ;E%"CPPE#^@(!<N )TN6$ Q4(C@ W3(!1SFD"!"M%)[QQ;!1MMEAPJ-HF4&
M:4&#_>"!8KZ%\KNE5Q]"0"^/[/[!="$ W,5LZQ%0?" #&[B4>$*PJ8+Q[E*J
M^/IR5T<(&Z+[97#(!1T:HX34"Z,%P;)#!C1PX-C+9@&$.($%8%@0//@W[1N-
M>QY,=_EB'*,%&N" ?_]@N@_4^A8J6+L2<'0*M7] 6<;PHL_9ZI%!,( @+C#Z
M.%M05!2@P XY 07AR9$62(_*:JJ80\ $5, %!+$#C"H/0"C]L#X&/)%28( &
M:P$&$*"HRH57:(#>8SF"2(4#2 VH<D 1T0!ZBI%!<("EH\ 7A,$8E$$7.<&-
M0Z2EP4%$2A,;Q"(.R<%2J( )L(!/.L!0VL'8*,(>T4$CU,$CW#@DND$EY*D(
MBH,'L/Z "8  TN-!#X%"*=1!K_'!-%&! ]" L>M"H/+",VRJ'NS!)CQ#STD
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M*R((.I N4<" "9" %#"&7*@ ],( ,K( &,, "@ TO6E,;IE,8:@ 4I@#Z-*
M/*  !_B*@@ %FK( .]" 5^B0%+B<"H@2/Y@ +%2<5WV "I!5'LD%$I  "M
M'MD#!G" " @$0W  /*" D0$=4]  22T!B2$$#2B$", ZS1 K/=A4@[  4, #
MKF$!!G@ 8(&##)B#!V  $!@[86 [#F  #S %$7  +HJI"OZX@ D( 8D)A0S
M@R&L@ 8;!0OHUQ"@,0B @ V8 PX@B%/@@%T5@8X8!0RX@PI0 !8H!0QP %PM
M"%78 $^MV&,3V NX,L#Y@,O1 +M3HPI@  @H 6-X #D  0=H@#UX.PD0P@HK
MB%3(@#]@,@AX2 W@@Q+00!4P)E"X0IF%EE*P@$*P@)_  $$@573-"PW DPV(
M@ G   F #6$0 0JP  J BCE UP@ A4'  (*XA1"0  G0 *XP!@Z8 Q)H@ 5
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MEH$."M"RUQ&33&F(GC@4M" !4S"%">":YFB!6Q %;@)4-?& #>A'G.*#.6F
M)9F1/>YC N"1#=" 6R@8"(@).6@ 4!"&0B  $GBI"G@/77@R75 %#$ 502
M"K"#U".($N@<$2  J* (X\.7M\6 4C &.2@ .#B%A-%BH)B,,OI=/+@%O%V6
M6XZ)"<@(0@B #WBI#/B17"  ..A/*Y8U8"8$""@>T3@!.=T S'B,!#N/"1B$
M4S ."\OF6]@=R_* =]H T$"%=>I''PP%O06I'[X%., 6$OZ8@%Z* P9PV6,K
M@$N]!1=@9&.8W&%;8A"0(#G0!5.H@(/)$@F0 U PA@5("5!@@#EHB05(2D(8
M!-X3 '!9W@*!@PE 8[F<$#S8D^/T@#U2@07 !8)N@%JB ]R@* " D%-H '32
M P!  3M^ (B2ESFX!4&0 "B)#12C@_,C@!$PA4&PD=Q(,_@;B&*8@ 4 A%OP
M,:0@@0=HB3I8/4Z&1Q0 @/1H 0<H2%+C$8WU XD] !<PC> L!A>XP%S0 P2(
M$K6^!3Q(&F,0!$M1,T*>$P98DE?X@ V8D'%: ,;8%&TI!A+ @&/88'P9!'^9
M%+$"6^:X,QXD! 7P3<NABCX M_ZD6(I<^(,#\-E-HP Z8(H#<! I?@B9%:7?
MN8.GV) X" !-/@4+^)%HD0!3T 5G0XI"(X%]2HX*F)#B_@M2P+6%E@"$+H4)
M-I#NR0,#* 1=( 3GH$@-L(#4^8S0<  (L VXGEC6, $"H#:].('C-0:]Q@I2
M:(!ID@ 2N(7G_0E$L@,"$,G)IIBZ8$0[" !UV3-:OH-QJ0 /4(6\6X"<L.9:
MF@-&+A,[@)H$^%R=484$2("G+D+"W54),("H5-.>*C7'DA@3X)H^"!47V&T)
MXNM0.84&TI6M.:.?\(,# "]/D8/;'$% 92B8 9ZF?(RUT"_/D1,Z\0@'D*T_
ML+:&>/X+/+"+%,64X!" N-NYY<B%,8$-%OB)V8D9(7&!VW32&U6 ]E)E5R6H
M7$"OY[(0D%F54#%SCP@!F &!#!,/:\&#($>74U!N>6JN.? 6)O>(.S<%![<F
MB;F YJHB!2 D!J <7V+$(;J("?><>?FMC#ADC_@ B%*[<1*,6Q" "J%9!*E0
M@P"P/U?TG<,1))<8[BJ(//"4OJX3"*"G!U!! R%.-7D_:=8#Z:(.13F!"G*S
M^3,4=". &)H?30FIR>X(L/4(!4@/0CAV7AD%.5EV03 2H^F Z5!V;K$V74
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M-HO%$?Y8[!2"4J<.;*CJH8&&8A/D.%W0IUBI!*(JLF30!V0Q70H&%1O1T.+
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M#X!H[7O&V#L0"@P( Y(Q$USPQ_XIHN#)ID5X& 2'A7B%\-(#=@ST&E\*]4$
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M('AB8 3 %XM P"0B2$ Y3;" 7 RBOU\1@!V:[(< .H</.L;4:S;P%@G@QZ!
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M'3P0(?[<0@B40BE<E"!LQ2F,@ 6<0-K%#A^$'@L<@ZI]C2F40 >T "[D@4G
M@;F='V)$X"W@@0I4WEP\P.X0P@=DP B,B1SD$B'42"ZPP)B  J&- +W(0<6
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MJL@>P994IF551J5:ON5;2@M,#OXE63IEYA!#BERE3HKE4\KE7V**15@;8S'
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M% ()0,!,$!VV>@ #W,IF;  $B/Y '[1 JYD" )#"O!7 3'16;CBH KA?'T
M"276Y5! YPA"T]J!TI:1,#R !X#"'RC U9A" I# '[1  WR$DUB (+0*B06
M!N1!"RC !KC 'AB 5G& P/8! Z!-(0S YNF! IQ+(6C !-C!JEA$"6Q1FLQ!
MS)R"6V(L*+B0*3 $7A!"1*'0H_*. ;P'(=C!J?0'*("";&61+MA!@,(L]W:O
M]WZOG*;$7$C  .%;9\V++AA ]3E$QZA 5B"/XOR5(!330"1 C91 6D!5C2G%
M(!3 F,S!)D5 CS6 &&X@=Z3AC,2/0F! 5TF0R'C3!_!;B*1A"+S2("1 ?;#
MJO3!#OX1 @$(V@'QSLN1 +O\"?'L4!\I1$H( R@4 " V0+>U@(44D IC\"B
MQT#L@1^-G8HP4& \0(DPP'8)8"$8@ -L;@*T#EV,@*=@0 K0!4ME(OA.,157
ML163J/@6PUMA7OF,12FDR8%"JH!DQ0=030NX@ H @"F4&$A8BR!8A*2$@ 3
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M A/ '=R"\F[4D$# =LI++FW %0E" 1B#*,"9+A3"!)A84/&)KCP7.?/! 7C
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M%/U0$";2&$%! G3I;'#BX4>B%!O^<4!PP@$,%C!@F'!J$( *6"D(:/%0& 0
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MB 08(Q?S&8H$F*(" 8A #W 0P,A.D0 1]*$%#= ,1/:0..R$X!0]/<50!$&
M4=RB9B3XP 4/, AC)"!K&)'-(/)PB[$4HQ "G:H9"\$HT7".JUWU*E1*2@ #
M($POQHB !520@M,](!>*W&8"ZG, %D#D 3DS!@-ZU;%BJ.  '<)=AW HD!-H
MH!@G<"@@#-"A.3Q 6:41R" .X"."M,PA(6B X+KC$ 4,-;,"40 HC(& N0J$
M;S\B $($5\9BCJ4$?'Q6,1X@S&)L8"P)D)0I(B>07#  3^5T"%ZIN@"!5/-&
MNC" 3_X:TH(-E,(!.2L&(* CD)@:XPY7A)X#*/(!!^PG#B[D P+LM<0%% (U
MVW1('IQKC .(AT\.J8#=BB&"$A0#O0Y! $(:H*E7\,LA+8 /F81;BE\*1*3&
M,&ZZ=.%%BLS!A<70D4,26@SN*.0/XK%#@^'P/ )?M@\"2%<DQ6,_@0C# %9+
M@-B* 8'K.$08*%#('"Q D0VPKWTF*$8#W'0*!8BG KZ)[$9V+! ^Y.06;QP(
M RB#':<IQ ["%8@I3AM?$9#D $DF!5I4P-AK$4X@$F ,')"KB@0DA98,,0&-
M(:*!"2A$!835P)0' AE<)& 4;1:-("XK.-D(A#@2;L MU/[BD$"[@ $*\8!Y
M2G !"&NY(4-4B 8.P !)'\!JB'V  QZ0@ ,4+@]:9D&,!1V"KXZ:U*4>S"D0
MH( ,@L88$JA "6!-AZ3000%Q<($+XD  .I 8(1]Y (RZN$2"^ $ZAHT*D;#(
M@$ 0! 6$'6PQ_E#H/^7&V 2YA1@C@N.$^(&(>\#AK>50@&L>  [@SEUH0U&4
M8BBA-@3! W8;,H$M56 LI!&&,!1 "EPL$@XM0(T+X4  "Y%5MPI BP76 EL8
M_6$!24%.0HJ1 =DH)*$/*#1!4O  .?A;"0$0A Z;$YN*: "<IW'A+2:@@!#8
M82BYD( % O"9S=S"#BS8P'J+(?['@=Q" 27HMY2T3',6<  !\+%# 2R  JM!
MA11S4,$$<B,*_0D$NE1- '4(LH&2-]J%N4B 3XJBR)]6( $@F,-^X+#FV5[@
MYR@(P"V&U!!%BN<!>B"(UT%19%.H6P03AP@AXH""!B1'(@KPD[H'HNUK!;G'
M!4& *8B1"K@*F;'0E),Q$,>"?L<! H1M" ?FJVX):.0#(6 (05I   VP@%N%
MY<! 1H& )1:# G8[A1URQ #O3,""!$%.37@/JKUB0,(&F  O!7*+!U@  +?E
M  @V ",^,&";?HA0 L I" :$Y?+%L,!<59"!AH1 U/16]R"LVV@B[505I[A%
M7H(*"OZ?SJ$ ",.7(!I9 $050UN@,?7_ ="K[B "+J0O1@@JY,"&;@T.[$ 4
MZ*?U!.(!L@849*\A1*JP'(H@HFTH\(U?GNW9_D !;F0.<J/-&N(6%F!_&* /
MU T0+NL.%  .E*#<&M"9; T.&' 4<F$!N*4HY*#!("4W&L("&(/>$L^6&"N2
M5& &E< .DFP4_$4 ^B87% !/T,HA'"!K_*#ABB$$V$<A>@;BYN"7-L \BJ$$
M1L\%<# /Y.0#3@#?HD@@2([K'((/T,@ 1H&)0N!O4 LBX" !2,",&D!.1"7Y
M%. $RDT)Z"!GY@ 0S<@!4*L4X* #",#T("($&.!^,N-[$/Z@0RYP$$10W3Y@
MZTRN01  M C"% X M?[@!"3@D;@D)QPL=L M#W)A#VZJ&!1)3K)0MQ( %(RK
M%$1QSW2K B2 !0 !#L3/(:A0J4ZO <1&QWCL,Z1.3J0.5_@@-V*J]4 A 5I
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M  7FZABJT"'>+Q=ZI1!TZN[R$@.\\M>HB8@^*<\\:P\@@MT$AP H@VB$<B@
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MWJ\$ ,!ICK$Y;4I.BF$.DNH6CH(/C$$*X:*F&,*XT&("_/X.N(*J#VXA%QJ
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MOT !%5K &(Y!1EH  TH@<.J@G$!!#NQ<33*@!$:A!7+A27R$%,8"3CQQ S)
M$$Z C[YD V:95(B/1(J"]5P@ S[%17BF2:X%.4+ SM>3 SC 1G2Q!5*A!#)
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MGS3=DL HJ1XPJ@*ZVE=L9R5W7%5K"(SH1P,F(C#*+4+I>@)H$'@0APMPB$!
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M @%K$YWSB,(ZU!U(8T1Q0!_D9A&+V*%)LZL=_TR6P=WMYP&=M,.(^% ""!A
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M((;H06?+*0%C2U& +"TG!$\DBB@&0)$!IG15M6DN20^,X 0K>,$%,ZE#U12
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M?=J?C(G8G3[I,; #K2O!\%D)\0L+LA"JYSO7U]Z?+7VJ8J_Q>#H,L-#HM.S
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M S)(@[B1 L],M!L@C@RQA!R@@C3(A!^@T3)-FD5@S"L@@C(@ S(X@T/0""*
M!$4P U\@@OF80T'L 5G!3ZR,VK^422)H X8H#V#(U/<PUN&[.3:X@2M A#(-
MADAP3/[0XMMB8(0<< @_;1>G3" V.,[4;$,PH(0MB(X>(#/.HE7_D-5B2(,
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M]$"\L/Z!#TS:AMC/&>" #SR!&01!A+G6#]R W10#$73!D<R Q@Q#%_Q $^B
M&NZ)#T#!E#V>)1 0F.3 "3Z!#?1 K#Q!72D$&/@ $0P5Z_V8#@@-$[0! ?:
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M0@9CJ84,U#"+5E"L&%B :RM$\L%-S$ 1LHC$#/QGB1VHA?X3,R@HJA9123/
MBR!6* )?H_ $PX(VGTZR: W0(-<8?"T8.NA"+#;1@WU)8I1NT 0P&&%+#_W
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M#N(3L& PD0O^_"QY?T"]8ABL((SX$B7H;&7T%2,8,X@%+V+P9F+@8%\#8>Y
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M%88A300B%IQ[%;S "PX!MQOA["9D$H" "<X@L%6WS]> 3Q2AS&B!#89A"=A
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M#((&>!&#"&D TP^<TX:+!:M-Q2(6,6;QM$S8@#7G,4@/T 2$:A5#6)M@%B?
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M V20=E G=0#8-C, "<1 "[EA"_[%\ .*81 V\#7!I7O LQ\DDTX+$05HH3#
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M1(**\?X#2@T#"E/I J).U@,FW8 ,/?1C:A#Q/LG$H"0V8,3):F";.M)B&&0
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M88,E]/D)/\@C+ZI@@QQ  <E7.004H" %&YB&6@2[PI>"<84:5!N$M46(%+A
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ML0477901$R]K/%'##[,@5,D51,0PFTNUQ.E2$9L"T42H[9XQ#!M$6&11+#,
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MA!A/\ $G@#&,2L2@,27Y"2^@4$<J-;,8;/#!$K!7C"E<!@TW@ 4Q&O8Q--2
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M+)@++_ ",-1":-0"#0*#ROE,)HQ?4Y#!4@5E,0B:6,2349P!$ZY$#E1!$_R
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M<$)E7$8.R)(:7,9A $,,,1TL[ M![  0[$@7:,DFX #R_$ B.$X,N& 4R(5
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M0238R4Z("P:M+\""#<3.(KRV45!$EWW0XA[(%'C4O3;&&WNSGS:![R0W<L0
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MJI-H%09]D64@6+I;A1$/"=*D$5\DV:$C8"2Q@1$ @6@CF/Y&,"D(DT8H*\C
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MR;,\S?,\T3,]U7,]V;,]W?,]X3,^Y7,^Z;,^[?,^\3,_]7,_^;,__?,_ 31
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M#61!#FN 4WH@!KA %BHAHB2A%IZ A%3M#&)@EV3E!GA #0PH!A8A&&Q@!J;
M$]2@!EJP,R7**^U"KPYYEWFY2@!/!JY $8"9$60 "Q(AC8D!#6(@"%9!%EHA
M"&) $6C$!B1!%F1!"F9 Q*X@!CJ/#-(X]_17-7QA!^ZH<^C+?V9 D4*9"-!
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M@(8HP8R]2 WL-S'JUZQMX 6XC UB@*7Y>+><2 9J  8R84=JH(^@L"5N0 ;
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M%+X<PN?<(H@M#@  $(:M&$8! ::\QF?<& "=V$3A '1ASPWBQG<\QAG= Q@
M#PB"V (]T8<MQQD=!-3<&!0@#_9<TB,=T06"T0L"#QX@U#\=T6\A 5*ATXO!
M#QA >D.@!$"]+(SA QJ !$(@ 5@ U(D- TB@&.9  @9BTC^]QH7A \B<(.8@
M "0  AY UT]]STOA XYAV'%\SX4!#BJ@SA.<V.Q@VU%"#A0  G!!($2A :;<
M(DJ! ;1<)&(\ 4QAUD5" 4)!('*!VQ."V/I@ AY"%QR@%/X*@A BX'F)C0X
M0-;G0M\9(,9+(0 &P2!R0<OM  /D'2(2 . ]/=@K'10,H 4.@MA*(0$@ LM#
M -\1W! ,8 ),_B&(K05$0 0^P-S9W1A4(-Y;G=,+P0X"P==SH0\P8 3@7!0>
M !1(( /D8"!.H00V@ 3.O!CN8!#\P .J?2!NP00V( 347!=*H $T@ \( @X,
M@04JP ]T@00P -(% A1 8 -4H-V+@0\X@ /LH!B.X00:8 .\/@X '@X(H04P
MX 0.'<U#P.C[ -*%H04XP /\H"#XH (*@0,RX \&H@\Z8 /H0"!NH0$ /A=4
M  -4@ \D8.5WE]@ X0).( 3H@O[8\J !"*(0R#SG16$#3N$/%M\.+$ @]$ )
M"!T$/D $XOT4X  40@ #YJ 8M/[N^P#1-7X@^.  IEP74, #/.#A1X$#'" $
MBASZI5\0! (.2$$.3D @1D#T_?L6)* %5!XE$%\7!(#[1T$!A$$8"* 0!.($
M-J 8["  5$ 0-. !3D 0 ,+"AF*E$FC0(XB!BF*W'K0 !>?!K6(@%'Q0(JR8
MQH8H0,TY $J8'08L0!4S=O(!A#UW%&C @X< H6*$%. !)4(#RCD/!!&:T,(8
MG@8J3"K@4TPEGD$20C!D@&*0' ,CBIG( ,J/ 3\:4?XQ4$+0G *CBM%I(,A0
MA86W&/Z4*J9!PZ Y$"R@U(@WK]Z]?/OZ_0LXL.#!A L;/HQ8[RD%IEIX.)DX
MLM];$!ZX&*0+KYT#'5#<ZE#"K 6S"DR:,F"GE)()! 5\\,.' !]C=QJP"-6U
MF!P)>(W=,F!2@@A2?AB8NM6B@9U3QB:($ 7(;3$(3>\4$Q;BKN3MW+M[_PX^
MO/CO*"GH =5 ._EB+BH4JY/ 6*D%PHPMF%F,A=,[#S3Z4:!1(0X48PH!)A4#
M"@+&M/ !7A^T4(P([O66GP9XL6!A,0N\I1T$=FA$ 1P:83!',15\J!$$A!B3
MP"D:Z;) +L4T4%8Q$G E 8J"] ?':!J%0 )<H16CBXMX_?[! %X5X%&, J1H
ME(L"N@BSP"VAQ*=1'/V-QV677GX97G-,F@ "F(;I$@<&#"1@0D9X(#!1,1^P
M4,P<&^ AD4:G#*(G \*<@H"1)0S9P%MYS<$;7KDD,(@Q2&DD01\$)7F2I)#B
M>$)O)*AG9J>>?@IJJ)&A5()3?CC :7<HN7 !B"HL5E\"^*E0YAP8:(3':,8,
MTE\I#M1'I%L@2/"!!QX\\-B<D.&5@1S&H$1(>KDL8(A>$#1JHJ3&:/"A QL8
M"P("=IAR0+'% E<, X6DR!4$?J#D1P3%D'#"L\; X50H$#1@ 8J0\<$:2A7T
M :BQ'WQ0 "C&*'"+';HB*$&JHOY.3''%?YF0J3$G?/"LQ7P)XP<!=-)Q*TH?
M+)3' 1!4D!%*H)0  @<-_,E +J2:4$PN#3P"&4J[]7;+ 3.=0FL("@A2C"$U
M;U0TH],!LJR,'D]-==56"\:'!?7]\4!&8;+GHRD)V '!,0OCYYAH&NTQH2 0
M$#3S2;@H<(H')81"""BFJ"+G0NIMX,)UQ0C2P'4+'(B7NR ^FL&'#-@!"B&A
MF)*+* H4 HHAHC!'S /X*0[!'_[)JT('>)T@ EZ@V*% IGCQD:B)?-R"P""9
MCW**,+HP< L>%$ &RMM7#T_\>,(\@$$%%CS00 6F4%T"DW?!\;;##BXTDBX'
M:V1' OYYE*)+!+DLEEDQ@U['@,(H[11[,7T8($PI!SQD# >2@K*T* D\)(P'
MDC[ E>()<( $[-0'(( !"TB@ :%;UG?@4#+=*& ",EH THJ!@2#9X5;%X,.$
M!O&V NE!(WP D!UB)P>D@6 A%.(/7CA0%5TTP"3:D< %*_ H#93H T'2" J8
M\X!'W0(%SV( ;FS$E0@$4!"\(5<?=#$(!*  +@?2@_!0T@?6:,0"3'H DW)&
M1)W=XA0&,-()A%? -*KQ+[<P12E.00(/,(=J+3A G.#RF#JTRF0+H4,&&'(
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M'1J>+"4G$^ '<Y  N)0H,>L?"?[0&AC !PG!%LA:"'!@31J ,^JA"Q!0 H0
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M\ !KJ0)RH *5\2A3V *B]QX3$%35(@@:D!&$L $HX0$F$?X"=O !Z00*&/
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M HL% :SQO$:B 1!" 0PP!R9! LAN# ]"$/EX"T'C(B&O"[>@ 8_Q&Q]@2A
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M(XR*T8!RX6D@%L"#+@B0'UPP0" _$X19#I(TFF4I!" XC@'R<XO$E:<8+:"
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M8</V_P,8H( #$EB@@3X5DP<$N1PS1VU>,6"8"2<4PP AO_U1S <D"%1* H6
M LH@!G15S"V$N,  +L98@ $?)5)5C L;%#,(!!J*U],?#Q2#QP0#5: '@NP5
M4,$$(-5U&RI4B0((!>*)0&$QN310"FP8$&3*(")4<*"77X+)4"X5@%(CCV&B
MF::::[+9)EX<,&!!!1484*8H#.@BT @J%*/ 93VY6(P':1532 (?@/6!"*C<
MLL$%)<P1@5"YJ&"! AJP-E I$?Z>P*<%<1C3DR$,%,-'? )1P$>,=-SHGXD,
M=(6'!!TH\0&%40ITFY5T7- 3*!9HH$(+%[A9K+&-]22"!7WDD8(#=G3EZK'3
M4ENMM=<NU-,I!X!RB[<8%'5G+N")QT!T CF0X: "G9+ N+D64T(&/1GS@#"Z
M6#DE!' 4M"P&99(@PD!Y7(5'EP)5H*IA5A%D6U"Z&-!<,7"84)*4MU19S!SN
M%3,!H:$<C*W((QMD1PDAD*"! QY(3++++\,<LWTL2$ 0'@88X^&[*!>C @2G
MZ (' '5QD&-W&MQ"Z8\E:&#,+2H0@,HI O!AC"X0T(%@3W8PX(% I!SPAS"C
M*!"<'?Y7"21!< C.06I!MR!PRD2""/.( A\8P[.)"5@Y1P.A%%,!3Z9HT$"F
M,B,^K2!N)]ZXXX]#OI 'P=&K"P7=8C!5,2WP:TP)$DS@ @C-H>!93\*(5,$&
M%:G" 08<_)'"!\7\ =($)4A[BP0*%SJG!':\!\) ()S+% <&X:)!13YF@,(@
M$H 2APL")5_1*1J-74$&Q',P?>3?&QAJH1M("[[YYZ/O>"[O)I2+4 3I4G[2
M#]U2_E[&L/]0GNGSW[___P,P@(BQ7XSZ0L"['%" "EP@ QOHP&D9QC\1C*#6
M*&C!@= K1A+4FD\NF,$,:C"$'*0@!T=(E0T."83B&R$)6_Z8P@*NT(4F?.$+
M91A#&(JPA38480E).*0>%O"'*@SB!F5(PPGBL(9)O.$1F]C!)/[P@5*<(A6K
M:,4K8C&+6ER@*5C@@B]^L05@#",8Q3C&,Z(QC6I4HQG/V$8RCK&-;U3"&M%(
MQSJF\8TNH*,>^UC&,2KACGC<HR '"4<P\M&-BCPD(0T9QT7^D9$N\*,D*3E)
M2!Y2CXE\)"<OB<A"&E*3GAPC'%A DBVB,I78$H8I3N'*5\(REK!LI2QK:<M;
MXC*7N:2E+GOIRU_6DI? '"8Q;RG,8B(SF<I<IBN/R<Q9GL(4[U,E-:MIS6MB
M,YO:W"8#766_\DEKA0V+XA,+ O["(&)PG 8!ISG9&4YWJC.>Y$0G/<69SG>N
M,XKL3&<^S=G.=:*0GP(-IS_K65!R[I.>^CQ(0D^83V_VDYL2G2A%*VK1BV(T
MHQK=*$<[ZM&/@C2D(ATI24MJTI.B-*4J7>E)B4&,8KSTI2R=*4UK:E.8WC2G
M.MTI12$!AC.8 :B+D(6;B#&,8? TJ4I=*H&L((,9Q$ &,9A!#=A@$)<B!*L#
MD>E6!2)3K>+TJF'UZE9C6HQ&Z( (L^ J3-G*U+?"-:Y\X<(,>/ $*3RA!C:(
M@2+("J:7,B(&-@B&7 MKV,,^Y*59F,$-:B$02MC !CL@;#%HP8@SL*$5!;%$
M&M! B?Z7!J,2E" J,31!"4X48Q64T,0P&$$&2A0#&(D@@R2XR@DUG($1E.4%
M)2I!C$R<00VT*(8LNL!81:RB&,&(!% C 0S$0C>Z<J6K#60A4[K.P!+%D,0-
M9.#=&9 !IL"@P@R\&X,E $,6Y6T#3'L@ RD4HPLP^$$38 #5,RS!OC((;S'.
M4%[O^H 5VY5!#:@@U1CT !AJD,$-; "#+@2#"#&8L R , OI8CC#-WTI%F90
M79Q"8@8S4 0O1&R%3*C!!C)81'QC<(-$1&('+^ "+6PP8I@R8097*(89/$P$
M,NS@!C/X 1EZ$%EB4(+!BN"$%6) A&)8@K$V($,4;A #1/[0PK@W@ 0MV" #
M(@2#%U&(01HT;.8SJY2ZI-VNB!F!",8.MQA1F,$2>+$#\ JD$F58Q"KVRF)B
M2-@*Q2"#AXE*:!LD5PV%;G(4>.&+2MB8%9H0,8MI(>0Q%".P-_!%?Q&L!DML
M@A=N13.I2ZU1#C/6NB]-@X@KP848,,&EQ#!##(  Z1E  JRRL/$BC$J$&0B:
M# CF13'8$(,=T((8B?#P*H 06?/.  :*V(2(-:'<(,0@O(MP<2R*$0L?1%4&
M-FB"8TUM[G-?E+IQIH61:\ +X_[@NC,@PB:LS.+*@GH55NXK,8  [$$SEMAJ
M</&%MVT#6$QA!E&@!"0H88E+U/XBRC/ A')[@&=%Q( 'OQ#(+R1QABK'( IC
M13?)2UY-NM[ #&PP0Q#VRH5B1$*PDBC&+( 0@RL >@9-(*R!@<"*R$H!%HIH
M<+!GT /"*AK9Q5@$G,_PY8W+ K>\\(2(,Z'<'V1[Z8RM!#"Z<(0RQW?>HS8Y
MV<M>Q2;O5:I0I<)SB2$%<4>A!RZ&13$J(>(>_)JOQ?"WC04; _B.@<'$3H.X
M+WR(I\J"%W*_05Y?$.]*3%B[P7!O%Z L;AFD01(PB $5@"R#RIL]]*)WX$O/
M4(0E- 'U6ZCM0(9QAA\PU@K)%8@EFF"#&A2AKZE=P@URH(@R&,$,Q3B$$:!
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M8=Q"(<!(KDAEPX2(YNBD  #/0 Q" "QE H!"+A2"(?J$(1#"NZ0D;]0/*"S
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MZ,$!6$DN8(#7W$(">$ N& ,%*/[ ;K  J72E"QB#*1B !L2/!<S.4_@$"7B
M^)! !S!%W/RD!"A' E2$,-!L,73 M\Z!!;C*!SQC0>@" VR 4.!! 0@%1@C$
M'/S(HFI MR!F IRB,3C%>^@'(#J 'SCG./G-E*B&0("" 'R 4"S'PWY  22B
M+DC [ A"F/K$!5!(V*) 3YP CYQ" 02'+H2  )2) F2(, !L+D3,#SU"=G!0
M"QAJ,2SJA>0-!;A*9?B!,2"'!52$( A 5VA " @$(1B'J5XC"[1 "3S *5FF
M0Y+ C8S":PH$3/:( (2 *+C/ 7C&,93  /"I11" (+S"*=Q"'H"EQC1 GNB"
M+DZ,L_X6@RD\ ):( C'V"(](:Z@LP%:B0 ?XA >T*PD<CW#R:;K2I0&$P+C$
M 0)X!0'DR2TX ),&I+NBSRD80 ,,@" R%.B(P/QF@!7&"XU0A0)$[ER>P@@0
MRRL8P+GT@0)@4 +D08P80@%,)4%,0.=X!7I,Q#=ZP+ .0@+42 (8!@.HRN9@
MB0IP#,LB2 E0;^!H1ORP*C%8@!IJK!Z0B@HPP"#((8+L+$+HPH>P2^?R;PK4
MS*(:XL66B2$<P%L8)00 #P(<<$(TL$"( /Z"@@$88LYF+H(,P@$8@P=@HS$$
M @:'0A +!"!8,$[()0%<R*#.1J5J1CH9PN46!!P<3 <,Z_Z4U,F0"(,"1 ?@
M;O!$C,+=FH(PC$L*/U$36R^;WLZX?(#FKN$!G.2XY((HU$2"4+% K,5 3,0C
M"L0H', #8+("  !)U(L=X(\QP,&/2(!-],0<=(DHV*Q X,&-2*M/\"^S:LBP
MONS]:DT"#,)$5.+RYL+=PL$"JZ\4Y8(%#( "N.-!G"=!@ "/!,N05(!F$(+K
M?  &#&P"7&$H$^=6]@1G,.XA1FYI(D@-GR2W" 0'%$4Q  (!"\("C,M6G!(*
M8$D*8 EJ> TJ'H\Q@ X&8$ &Y.DM4$"EXG,%0( NH X#*( $W&Y/F,"/-$P?
MH,(<,VDQE$+G@H('7, ';$"7$/["/\JEU/;( 6@ /F,  _"++2-4,9!" 4A
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MH PK=1=#']CYI"/M+70LV&)P'H1,IJ=OFP>A0@#B 3B  ZQT UQA"3! "YB
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MP!!&N04))H"[R2B!#WN00 5&<0H./, $T'.<0^ 0MC\D20,0^, MY$>]^JG
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M08 _E ( Y\D% R!@%D( X!:B2*DG60H:0XP41"T0  C^X,L/.*0%!\ #*%I
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M* $H_J" MG7.+"4X !\$80("> "H0A41W(0A %V:(@"CN(620>$'!:CR%@I
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M@%.,8@"FT0!A_XW-%B1@,@M 20D2 "^0"" S*H!2,120F1+,&JBS[L/RVI.
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M[QKB^ B@+^8  P8ASR[P*'+!+,;23QK #SQ ?6Q2_)#B-7+A ?*@(D)! ^#
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M3E_' X(VK9"I YRH 2S@09F-,95' ^*5O5#"M"!@1RIKB!C@Y9!"#S3  OA
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MSQN]TUN]UYN]V]N]WQN^XUN^YYN^Z]N^[QN_\UN_]YN_^]N__QO  US !YS
M"]S 049<#ES!%YS!&]S!"X:'ED(8^F /P)E#,:<4+/'!-YS#E:(4R#953$%H
M7>"41@%]ET(./KK#5YS#A5,I-@";!@$.2J$$_  .=D07_O[/@H3A%$2!#YZ&
MQ8/\P+-%071K,D0A @0!#MZNSPI!_39*5NW 586<R@7<IY'B%A!6((3AM]J#
M<TQA$.Z@(DK@%-ZDRL]\PS&@ZWY+%##L%#Y %SS@I+",S/%@YM <SP^\$"8@
M#_I  @I!% !/ UZA DS!#Q[@%D# %-Y)LO/<T?N[%%P@20PB.7(A,T#!F0JA
M%$ A%TI!J1\=U/O;M$.=U =<7#"%=4:]U%>=U5O=U5\=UF-=UF>=UBV&QYI"
MH0L5,D!A$ 8A;6Z[& +VRI$I042GT5-=M:?E<G9;9U^%MVW[<**ZUJ<=7WXK
M6:A.4\4H6QJ@!$Z  HS$MI'" OX2ZB:TQUUV;2JJN=%+H+:IW=WC98N$QP54
M0&_#31=P6#EJ="D( 0YD$A7Z_0-$H3% (::.) ],EP[LX#5$013\P!0&XQ'6
M2 _BX)Q*X<>C0Q3FH"AT010$H2$ 8<9 8A3T@ ZRQ [ KYY\/$3@P#H& 0(V
M/N$7ON$?7B6_- 1  #'^(.0[(N1/P#_^8+3?7>CGQ1A80@02A!#F[A0LH!1,
M@05,[Q94H 5:  X.C@1287YRX9IP[11H]18^P!"(-QIC?@/\( _D+0/^0!2,
M[A30U2'H0Q PP 4US5 )K ,$ ;'<B@5* 0^>BH'ZX $$H07F3@7Z !1^"@M#
MC('8??X4)F 0<L$#^L#IC.$$_K@4C"[+(V6!1L %$:0#+(0$2&$$=($%UHO(
MAQ[UY<4L!J$"",$#S/T$,N,@2J \KJ3!" 'W)V-$\;ZGGHRN7* 0_L .3F'N
M1*#PJ^3)0D 4@L0A1, 4['SJ""N6^LI2:2TS3"$$7&@P[0 M6/[)-N!J!D$/
M?*3/D%H00L!0L.P/=HT$B,I(2&"L BT'\X 8<&$0_. "1F'MU4OA)"!G4Q\@
MB@D<2+"@P8,($RI<R+"APX<0(TJ<2+&BQ8L8,VHDB.*$'1<;BN'R8*S8+0T&
M;[6 XP*.,(%W2HQJX:=/"X$><HU2T>)4J1+&=(%2H0+/S?YB)&:"*BF(18I7
M DMY$&C'CA\ZQDH6*V&HF*D0/XL9T_!G5*%3>.((Y&!J!!^IQ500,H9G!*@X
M=HJ%Y*-"8 E0<.86(T3TE-AB<O#$;5&*!"AAI_AH -7"3@I!AS=JWLRYL^?/
MH$.+'DVZM.G3J%.K%GAKPD ,H_K($7AJ0DFM!TOR1.6AQ2T,@_ HN%4L XC!
M(G1M$"7HPTE!?#@8$T%(X-B^ATG0*83AUAT7UK=^ "4"CZD. N>H*'4"%* (
MH.24T$6A5*$'MTQ@;J'"% @3Q53@1RX;U+2!,21@)A8')V26QP8C\6'*!'[D
M@<(I( @B%WW$K>;AAR"&*.*()/Z6:.*)*(IVRB!B&0,**!X85HPP@. VD(T"
M"5-''J7P48PH-!5RS&"CF%3=3' 8=@H<<N@R&'$E>5 =,=9])$HQI%PY$ IU
MP*&8+H4,9-,?Q>"A@AUPY%+,*'" 4H@HHQAF3%6F]%$,*'F8! <<Q!D"93$9
M$F0,':?D L<?S!63!PL^@F(8(:6D*.FDE%9JZ:689JHI:+GX&*(Q)9#@4$DH
M%+D0'GEI9LP)(N"XZ:NPQBKKK+36:NMGKBIT6W@W]MKBC:Z:XFI6".6R:T&[
M"B,,L>$-FQFP!IWB;&:X:97KK=AFJ^VVW';KK:[?ABONN.26:^ZYX695[4/7
M/HONN_[PQBOOO/36:^^]^.:K[[[\BIB+*,:,@N,?<,1!TYQ[LL@0'BSB=LL@
MNOB!$+&#F')82;=([.ZQ!>EBH[58ABE0+FJZ&]X@<O:K\LHLM^PR1:"4<$L(
MJ!2$@0NH$G*+ W?DX4%?N98DB@8R#D1("$,O1(*G X$2$D0D%&U0'Z*69(<>
M"XF@\,M<=^WUU_@:(PPQ0Q9$TD"W/!U@I&+E<DPN+Q5#C D5A.+F8)"6\!,I
M/LX9=V-P@" Q'B; 88PH'Q1SB@HG5)<+"RK($68?)JAPRR@0G"",*HR'F0M1
M/(F5]@:EZ-+""5@;:D)>)X1B:-Q@QR[[[+1_R\$'*)B@B_XN&!!;@J=#\7?'
M87J$D$L<<!0SQQRGD"!*<A84$\I4,VI R"D/@#)("<+<D>0'QGPP2BX<J,3G
M!RX8HX(P?)@@# >"A.\Z!Z^P$,<I/[>H@@OL]R&,!K>P _?2Q((_J*!AM4N@
M A?(0$K!+TO&^$W<1F GQ?EA$(( A=%04 PZT$%1=F@+7-HS!XV%(@0"84$A
M6%"".9QN%%&K@!WFD"$0.,D0R1,$'%0@@F*(X!2WJ$ =YA "/X3 28/@8$GH
MD*=;S$$.&1C%+4 0 A^IX $];%<#M\C%+GIQ(Q[HD.)0HC@)=*@4=KB#50XC
MB ;!X8-RJ$/S2I$X\FA.(*9X6OX(",$D8YQB%*(@P6]N80Q#Y$($=F*!'4"1
M 5T00E1AY-TMA $*7'# ,'AH4$G@@+4-\ %!HS!%+M+6E$(H(55?3*4J5\E*
MA6S 8AA[  E(@ $R40DA@@ 0(3!@!UZ60@2BH-X&DG>8$Z# #@_0&0?LL+0\
M%L,%9_* ,'1! A6 P ZET(!-,/"XQ,$A!7;PP#'XT(%> JT8?ZC XN#@!PS@
M@0\;Z,,'1)&"I5B ;:W,IS[WN4!IW:@4+RJ9KW CC#,6XA8>DY9AE!,IW/@!
M%+=0DR[*,B,9@>(/:A)$*$PW!Z\(0ABF.(8Q'E$24/A/(.Y!*$% D5%1"(,4
M:WJ+XOY><@LQ\O.F.,WI385!@HY:)&8G6)].ATK4HMY4BQ.3B!9QA%1>.=57
M!KFE4:=*U:K.KJD+ 9E I&K5KGKUJ_0BUKJP*BNR(LMD8$VK6M?*UK:Z]:U@
M504?A(&'7/@!GP23@PLDAB8X?-(Z=[#IQ)R$5J$5Z5I2C2!FM.*'E'U,(!Z[
M$6&?*HPYB.(/+W%6Q 8BBH+%P50<$]3'_#!9I@JJL&CMU8#@RMK6XFLFM["<
M'!!X,SS4X: 1R$,>0H"=41@@3UHDS$*>^!!0H' @?Y#:04J0LJ&8K"1X(($N
M^"#0@R2M)"[H ![H4#>)9" 5H\& <EU+WO+2"WP#.<5Q3_Z! 8$<LU4W.L;;
MK'6""0S"&',P@1RR<H<3M&!.>4E2BS*9OD>PR$T8LL,>BR$(XK3/)7<RP0E,
M(0H(H$!-QDC!!###!_\Z*8(; $$I^F ,0>0A!?^=4^&,0<?#'$H@)L@3Y5K@
M)%%T)$R X,--'CD'#K#-="=0S"CR  <26 P/>BA!7D9AE%/H@@4F\,.<!)*'
M7 PBJ!;KP'C-R^4NDXL#(,C=[B1P@A-(($RZF,H)NE)2%)]);F4ZXEU )0A1
M5$ 8V-3#'/!R&$)8 ,]H3!Z:=A:*4E0@%R$8Q?:$D0??:, 4ALB)!VHD$'EF
M# 2W*)YU5*"$7%" IR<X10=0EOZ^%/3A%AP8R!PJP((/A$008>1#"(P!AU+\
M9BL;""4&2F&(!LBH#W/=P"G\ (%3!.) $Y##*3A0B$$T8!"(/K64D$:@Q^U"
M$*(2MI>WS>UP35H4 #L)G/X /C](P X:.*>Q,:C!DA B!3/"PQP\D =CF  $
M=3 &'Q[0NQN=  1S,$8> JX'0HFJ&"@8BBA4T$+A$5,@)&CHG4J %)&%,3V*
MT4"&-0B'O.CY X&=RB99( I0G* /+%!0&$TA!SCT[H"*.@I86#-##(C"#\3\
M@"FDR^ 6".(F^!,(SOU@!QT6HQ!R4 $*M=SMICO]5A>G3>($ H%<D, .A&CG
MW^J@1OZ-,9B#1!&&EVJJ"Q3$@0]S$ 3%2P)$7:C K[.APQS2)A 1KV=/?AR%
M'RA>)F.$(&6% ) *@+N!DLEA>!J'>0O^($!AR"$/MT#/)BN8R3GDQ1B7M#GF
MXX(9/QS\T0+Y0+TC[H<&%0. ,2K&'>(PB)N<Q&HN(<$)+M<=4:!0VT_/O>XU
M]<K#W (")#!!!I+4WM S[2"EB( A\E "<JM@%!?@0_/E70P/: P4%I"^'DIA
M@5[2X18-<*&:0Z$*#PCP#M.) PM$A8(0Q,T4$A#$*3:@X,L7H^/%L,"J,,.H
M/XC@#R$P82%1$G(P 2<P A8@"KK  70@ G: >7R !Q.P</Z8(0P>4# /(",H
M0!,9@ >%  %X4 (L<'HMA &O8!/IH1WEXT-300KQ! <6@&HILWLT6(,GXD_6
MD0J&  J1D@LI4U.B51"B\"B%<#B*HP<:I O$D0LU0QM\H$'%4 J#@% 1- I_
M(#8;T!6ZT =0: R H"#"8 BX40H6DPM]8"J0I2;"$E$FX22@,!>EX(,#(10!
M-3)]$ HYTEBZ\ JZ4#+"T >B,$D#,0CC8PI&D75BX0$FM5!B=%$E X2*(PBY
M8 JZ@(,V>(F8&"]D97*P@RV"H!@#P0*=F(FD6(JO8E9GE53@XE1<11!<A56H
MB%2/!551E8I*=1"M:(JZN(N\V/Z+OOB+&<%4J,@9L0B,QGB,R)B,RKB,XW(+
M#(,;>H "<X!AA*55MU&-&R,6?Q5:V?@B%R,HMT FA%0,VWA:S'B.Z/@MA  8
M'0(':Q8'O2,,QX40A#""NH('J$@(U8$0F884AE%OZ1B0 NDM$21@Q? !GD((
MC.8 ?' *>] F[%$J6V%?M&8"GF(')C '=G*%M*9D38,'<& "A,0'=O 6&D0(
M'1$I?J 'RD8(F*,"$9,5(9DZ[I@G WF3.(DI?5 (=F J>;0!H78G1#,*#- '
MNI DI1 2>'!$@\=3A" (?P<'J78!Q< "?$("&D,'$W *>@ ^#] 3<C!W&6 *
MHY !?O[G :)@"!] (/'37BY@!\)@ H30>'"@"W:@)3F9EWHY(BYB,02!1A)P
M"A9X)P<G"BV'$L)E 7&07WF@ FAV L9@0]+!*U6!$QBR1'W0!\1D J#  AH4
M"J(B C5C0\,T!R<@![?@ 21 )HVUEZ[YFI^">R!PA>@1,XI3 :: :@S6%QFP
M%''B0L5@1-7W/H8Q"OMH!S<Q%C.C)G6@!X0 (-5G"G)!F =)'-+$ 0HI"J8@
M2O-')K#YG>!)&K@A&7&@ ARP+!: !^1A$AOP!WDP 60( 5D7 CYS)0QW D"!
M$N2&;E H@7@@ LE3>,H3<" @!U#F0]4!"L=Q B1 /B4& OYXT &E@ <>0&Y
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M"?C]\#+P!.9K"3- !K3  TO."Z#^S96 !3*0!D3  [$@ V<@"5_ "XL0 XW
M"),=SZP ]S\ "58@^$'@^#[PT5BP!I4@ Y$@^Y"P"C!@"5BP \10 V= [91P
M!C/P]XCK"[[POX!*#!]+)<#0M4,\$!L_$,H[OC+PNCM@ VE@ S>@!C.P!5.]
M!) P ^F]SHK "D> "5=@ [)0 U7 "#%@"6S0_P!!Q<>P8OYH9%3B,F,6D1EM
MEM@(]H0(IAM<>,VH<4;3$4M;9M JTD.6)!BLK.2P1(1(K1E U,@X,^L()H_
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M!11D,(,>Z( ,O*BM% AB,"#L /Z.5R2&)\C4 [84HQ)+G@%+9^ T($RE@S(
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MHRP&;0O3WY*%1!GA.YY.1-"5(OZXW@0-D$YAWIQ0BRO"NY:1!:FH2EA0$1\
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IY_W>]_W?!_[@%_[A)_[B-_[C1_[D5_[E9_[F=_[GA_[HEP1^A0\( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>cogo_0023.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0023.gif
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ML+2SL[BWM[R[O+FWN,"_OX&RUX6UV8FWV8RZVX>XVI*^W9B^W8&MU,&_P);
MWIK!WYW$X*+&X:;)XZO,Y:G'XK+.YKC/YK31Y[73Z+O5Z;[8Z[G1YZ_0YJ#"
MW\3#P\C'Q\S+S,C'R-#/S]33U-C7U]S;V]C7V-#/T.#?W\/;[,G>[L'7ZN#?
MX,S@[\[B\-/D\=GG\MSJ]-?H\]#A[^3DY.SKZ^CGY^/N]NCO]^;P]^CP]^?Q
M^.SS^?3T]/'V^O7Y_/____CW]_#O[P
M
M
M
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M0:*C@(0NE $-'<8M4N@ B'9)#L0X107XDB0^.7-U",!8^A0P"!(5KIG#<,$
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M S. "/?7$,( !#40!&S@!FG0 [0G"R#Q?\'W$%8P T# "NXG@SV0!5T !37
M@ILP#*XP!8JP$;_ ?)V'?U0H$/K'?P-A";O'!KNPA;HP!36P VP "[K0")$0
M#+6@"(W@"XZP!6QP<XS0!6N@"P/!"6G0!60P<\*P" /H<GOW"Y'P=6>($+K
M"&,P!OXE. R6L B2L''", F,L(3!T A?UP@.R F,\'*(,'.TX 9=AP@\]PN4
MT BP,'B-T 5H4 N4P BL, Q-, -90 M<)PG#L ME0'MD (($L0EHX 5K4(K#
M  M5, ,W@ AG-PR\@ :XV FU@ ,P@ BP\'5+*!"3*(BB!P0ST 0#P08>R';(
MR A>@(@AYPN+ '9LH(/#4 F,X JTL 9L9PMW. F8L'NZ.!"\Z 5C*!"84 1
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MBVRP S7@ [[0"+0WDI;7"%SZ!K+@!;O'=IAY Y0PD1JYIH YF370BRQ8!<-
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M?#'0BK)*=_/)"&Y: RX9NS, JUW ?".(A:]HD"?H@=W9@:M)<T$P _+KBC,
M>[DYJ\,0#'QK>:Y: [^ !@@X##3+<[Z @_/Y?"] B=_IB._+?,&[>]TI"SP
M XM0KYG0=L/X?#OPL*=+<+_P S4 G@+1"!ZH"*W;KN_: _+J@;!0KTM8K\*G
MOY7 "E+9!:TP>S,@L# [#*VP>QAI"9O "9H@FU(\ ][(".;7"EUX U50 SU
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M 0U"<(&!$T;:X(([/) @EY0X9.&/"21 @9@_&%BB0LA"48 $%31PX"R')L!
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M4:1%!N$#^AI-NL\0=4$,7*1K=$(-M((NZ (G[ "4F$$-3(&9E=DP8,(*LME
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M[4B?N=GA'G>YBYOK:9=ZVQ<I]OW\HA-]YX23_R.+2P2\>*WX7;QTT1)? -Y
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M$1:A-#A!$F1"56"AD]IP"N 01]PP$NZ#%F:$%A"!%4 J)7;!9+# +VB!8KH
M^Z1F+EB!#'A!)2BF/32"$TPD:4J"#60A$''H,VK!"ZK "T3CB)A$%\A@"B<%
M"ZJ #?:"%MR %KH 37[!#0!#!RLA"\)11#0!"ZY '/%#$=P0#AO!$AH!"KK
MSH2!$9Y@##3!</:B%:2 ![H %I!Q"H+1)]0 ,)BQ%:9@!Q)2);Q@"L) 7!9!
M$RI!"P0C#2 2/]KQ'?&#$JI@"O8)$_;)*%IC26H!O_J1$Q3!)]C@&*'1#1S&
M#:Y "[PQ+!!A"K  @G3!"VX "_Z.I2=^80VF( N8$4<L@1&< #'<P DP,8;
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M#1Z4)G!%/?;S]-XS/KD+#&*A$:*K*<PD"XX@KC@".+S $LB !JSB#$XS$HR
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M".)#"Y)4KF2Q)S3!!L)@#:0@_*PI"WK-5@:]T'& N6O@9[C !D;O+WX $;K
M!P84T6EA!K9+$@C=T"]B!M" $7X@O84)+?2S/JR@7(2!"'K@6)Q@.J2 "(R0
M%>2B(V+I.#JF"GI 52Q#3\O/)#27")I $4PF4&@@UGX"JI_V!Q2!#++ !C8A
M%JJ]),+ O;Q C5Z*W8O&!C0!7;-@$;:*^G2+W&O8%ZY@BY[$5S4B!<F@"82
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M@ A?Z%/B1!!.\ 2-: ,^$P6*U7$Q$!-'\ 2LP I$(&8&T5I=P J1, -#!(@
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M0'W#!A"J"XI0$ZR $9L@%;* %=I7$+<30G7E"ZRH:9[&!JS3"K,0&'9!"XB
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MXDM@+N1&D>-G/_WY3X "E'*6(R@.P_"L5GCA([ZXC11T-;,L,*$*",+)&9P
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M&-S.7* HD65Q7SH/(^26ZQVA1U*)=3T:W3.?^97=??,5M[O2\*;Q)F!0\6#
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M B# @BN8@BEP$"!;F:U0";\(&UJUU0!+"[XLB?]9B$E 5W5UD4IJ!$5H@TI
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MA);^R$;X 2;X 7<1!B9 JDG0 DHHQ5:H#K4PB4H@ B?( DQH @>)!*@8AEW
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MHRI$Q, 5PP!"$X8!BQW$X =>*!,,%#&,W'V+!C% PC X$0,:S$!IW\+?%&(
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M:Z"A,#1*D2A@V0G(0T0/,#&,1<# #;R0Q PF5A%9/(X64#."*V@A6X/9@!+
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M2(T4R6 ;$Q !6CD6#N! %0P@R92!%%[$#Y!?#1 ,19!!%1@0$." > T#)M2
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MHE?!8 (,K&*$T^RB!AE5REEF(!Z;52=#6+D!#YS%+1[(A%EE&08O6-$*Y_8
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M!PZ#\\:C"%C!!X;-"<I & [Q%\!O&/[N$X_B(A:Q$3\117R @H)A%ZCP(IQ
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M!I[2"7' .1$A!B+B(KP  8&@4*NM,Z7@.]X 415U(J# >\J@-Q0"#>B#8W#
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MX SN91(V81*F8#D4X0HVHQ,HH16X0 LVS1?4@%7O:!(X81*JX*2ZI NT@+V
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ME< (6X$S#J835I &84 ^(O$Q_-P0G8 (M3 )O1PPK8 D>?Z-:+ 0#&]M$)'
M'()-V$/="4G=$%V3U5U!VO-U);3@"Y:@$[O0"(L0/RD1"XR VFR#'LY!2HQ0
M"UD&,EG&"*]-3XQ UCHVV,&09"G1"A]3"ZJS"_H1,+R0!4P %& D#(LP"6K]
M.*T 7%-=U4+RU (B>DLMV&_W,5<-WH:"-KK -5BMU1AT":(=+41=VI MV1:5
M$K2@!=7=&[X0LH1!VI0 UW)-UV(FU\IA$]BMW3IVUYE=&&M0-,$0#&H+"RW!
M"O5MU*W!"),P&V8]U[X0#&7SUTW6UKZ0W4+=&KI "XR@7;'0VI6@$[P@VUYF
M%7#\"[H0/;[PUBF#07<]9/)EW_YE\9_,V@K"8 /E800P0+9!F2/F'#90P*PL
M,PGM+"_,>AE_/%UM>^3E\<Y\LPGWD07K @2780G]6@.7.VR"(0MG$2OI/!F-
MT+@UT /"\ N+&R1. #"AT@-!,!B.L B=(B&(1FXRPP0PH#]I@$Y O+A>P,\0
M <2'400UP$JT*KV^L ,^[7N; -\"@4ABYP-3D 5?DT>^4 150 8XH#WKH[^.
MV] ]P#(#P05<T .UU0FV9+&%;1[VE!%;0 19("+D$P9:/ 5%T0E&@ -2H.%.
M,!END .R_@/HT0D8)P5]C5@PE2.XY@4[0C17D 58, ,;% Q.  5L0 1O?$.5
M_ LX4/Z^DHP8OG$)CJ$1.- %/'T9K$ #OX &.  $;Z(3B. #WLX$/A!EBY A
MXU[N;_P+/M#MW[Y!MFXG6K%SPLX&4^ $.E$%5T %,JPB7= %/9#)292QC!6X
MBQ O;' _PC %/M %4Y #0%,%1I %6F #Y-/L9. =&P,%/U 11'!!?F$%H/0$
M-U-9#^4*O=(#&<$(/: %7 #M+(+(?8/D I$#7< %.Z ?.:#*L-!9_EX$/#L+
MC(!.#V^QZR(T(&,#']$) 8OK/<<$4. &1, 4N!;J5C #>23O7" %4."^BV!/
M6B ,6Q#SP(X4/D#Q,&'L/  %1LT)18 #3E +D8#T7. #1OZ@($4P!63 L"G!
M"420^+*@37Y1!!O4 PQO]S4Q[U+@ [L@[3@ !6 /55KP VCP3 6!"#G ]-"N
M8 91!4YP!5K@ _J$!2\=+RJB!1;[)$] /E'T&$ #"SH !5@P!=A,"Y>?^5%1
MZE6@[Z%\.Y9: T6Q"3/P$6P0 U/UP6BL$2,\#%$^ _C2"#&0YC6 Y7(K;.BQ
M"0WC$## -S[V"["P%61.1  QXT8-6L.*U*@!9)BN&C<&%KG19=BE&3QJ$!E&
M:\:B86"&N:'5:-*P'D&$#3OYJU&-(,-FX:C!8V"K84QB5!I6Y8>O7SUF,!HV
M!<VP1L,HP8@US$G,&C^ U*!Y)OX+ERP.K5[%FE7K5JX#@9P<%E;LV#$Q>A0<
MRVE&$2-%B#@)-FP'F;!KC$S,$;;5F6%JG(3=A4,622AQA?FP%'82QC!5% ,%
MVW=*6"Q-PF["$>R7%+0_- W3U"-R6"9T&<V8-<Q7C4R@10^S4B;L+!T%=Q1&
MN8/O,+O#-F4)*RO'KV$_<(YM] -EC^-.U(2MI)S5C%IAFUAFA8,XDS=CARV:
MX2KL%>"+B@SCA"5L+!TGY]8],JRQ8HYB?4WIO&D8%L$HB5Q2[*ZQN#@NBS2^
MN^L-)H9AI(>P@MEA*"S.\ZV&86+)09>PO)"(C2'"TNA L"A1;A<IG"CHAY%P
M^ R-R?X81&V87UA$*:PIW.BD!U90^B&Q81;C[:]AT'!,K$5@. Z1!><;)A*@
MW(!B%Q^*DJ]()\?Z+;@>XGJ/M[LZH8ZT!<=2X\4)+\ML,[1\^"R3'49S[21&
M")(1A]:J$ /$'*JKT9(W*XQKF"8B&8:'W7IK98:DAN%"BSB'49)!'\!"PK09
M"IKQ,[&RX(&X&8O"X@9;4/*A/DMH$*:228<A S@IGI/"B[ L@0&3G&3+:+A,
M<CB)E:'$>DJK&1#Q3I:-6(T!R6&VB*$3I6+ P5DO8(!%T!IF@ *]BAS"8=AB
M9V@I%AC"&"8N(+*U)(89)(K%JAEHX@*&&$QS\)<?8(#A0/Y*8N"H"4YH$:8*
M2N0R:9<>>.@VH6%JF:%AA&@J8@?BQO*"WV&RF&$PHRQF1-Z[8'EWF"&2A4&@
MKDY&N:N$X/1.F"%J@*&UL$X"TY)..-G$66%ZT#22\VCIP8@U=NQK3%WZX^&X
M3FQHI!%'%(%!ETUFP (1/F>6+"PI#AQ&%APT'*:51M"803],_AR+B3$^&G,8
M('#"1#1A<%!C$I%H<&08'(Z32[\F!11&DT6TR&P8'W"*3 HK:JD%"N!J6@,Z
MY=3(-JY&SFM%NYJZBPP1RTZBQ$&?9]:DD2PTW\'O1NZRA&I$4O-N&%;&KD&_
M*60=QI4:FG:D8XW%JD421'!@X_X[C-Q8\ JZ3O)B[:V#PT$81 Y?A)(P=*BI
M^).TH$NL7G*@Q9(PO*#D:.)V:/'%-_XZR;BQLB@"ALB'69IWJ&DYNCKWP4H$
MH[ 4'$;KJO"ZL#1(!T^H$29<=S6Q!&X16=@!E_P6"8RD 8$GN5P#AY&&%TWA
M.0O[6EAFEX;:#>-L< H-<0#8OL3@8 V2N!N5H,.#DV F4$4H"@Y4=Y<U"*E<
M&MJ$Q(8!0"=HKTD^@%3;W%>C*8AH&%YPS!2ZUXG"A45%>G/6#P DA<C5@!-B
MZ9'>U$")ZN$M&#UHPAJ<-18@:*4&. !8%[20A6HQP3&^8,3 ? &$&3BK%9OP
MA>Q@4OZM)B D6V"RRAOCJ 4L) 4*/+@00K[HMFSY@A/5&D87!,*#&0!'&$T[
MR11@H(B,N&$DP6 "##A2A*'PH@:?V4%+? $3AZQ,&#=K121F4*T?2&026,A"
M\39AL2S$X'&5@ $0=A% 1!1$#4@)6R<Z 0LV-"1EU[RF1;X2.^],H@==@-,F
M:A#(L0@#?6')X#!VX88JU& R:QB3P:I#(Q/6@ QD",,9WE 06* !"C,H'IFD
M8*,/>JT7P7!"$]!@B28DQDUP,L+:W" D8;A/$]&;)??(,(8UT.2<R]&4>607
MA"JX@1) "&08@8<#(QB!"46 8TT^J*IAE&$R)ZG$>;*S'?XW:/ -V:HA#IJD
MTQZ4E$3$T2$Z*10+?P)T++](:!HL883$O"HLF+ G/L_03(K]P N7T,)0%H$1
M %9A>9F4E54O%+TU]  -9/!"&CC"G7*Q:FUCF4(CU" )2:2A$3?M@:W2,- A
M^C (?-M/$"B!@VI9(JM>0 -7HX"(5JRJ1NN[K)!:T=3(G89$,NSG/P,J0A\8
M%:5R">EYR'#3851"0#52 V$]"+U?(-0(4J6J:P(E%DW\"8!A"8(EYL8]+Y"!
M#40[B9]J6(- &2&'?A.I36LD%DX($8!%Z"E.\Q(I*R+V1K =Z&P#^)JP%(%8
M55!#+7P0%RD4SP9$&P95A6$#+O[@T[C.TH4;IN!.-EKS*C.00C F 0,;Q& H
M;LC7,B^TWQE<PA>^" 8M&+$#A&#"%X6L 1."48D96+,& 1YP@8?"AAOH0A.&
MU(4N?N $7^CB%[](C\EJF04^T4(+ JD!&\C9BG_.P W"* (0!!R#\NW@+*V0
M22V!4(M=O%@8:OG$'B6!T)+9 !9'*QX6$%*4.<W ")/\135?^>!@!'(2,L9F
MFKFR,FZVC)N=&&?+>C#)#.(L++[(&'=E48/J], 38:D%#F GC!U1@D^G"M1)
MU% D\09:&(M 8EB T)JXP<D)=)DHL'"2"0<59R0B)$X/_+:S'0[C"EQ8CP[,
M=9R3N/Y!.3/#P5P_V @D)D<L:K!,YHCC!&*-I4%B<<-Y1'H%B5RH!Z%6G64,
M/2L;&&88BGAU<3XSA?G5P@:#AF_8+A46 WWG/)&"=$IP,!3Q>DT8)!*++F@R
M%;$P82@GP6 5K" +652A"D79F6"+A @?O@UKU&95? *-;9Q&(0Q<$PLBLO6_
MORP[@#1@T((J88."3.+0-'#VJ=>3@[B(&IUWH;58TF 9,C%Z?N9N!/8D_9G0
MH/ UF+5B8GSPZ;!-;%:OX405@S 2CQ/E/)+H=),DTO(D9M*3&_P+S-V&.!L]
M;AA2H(M::4&#107&692@-NX G@-"R:@&G_"T6%KQY$GZPOX&XI&T?[$"DR2_
MT2$=!D(0KE5+F""DPW2_"@ZTHG>'R,3MM!S(&QM2]QLT+"LSL $0GA*3M^,@
MR A)Y$  S_<;4#Z1M+0F#O0.$\HWQ.]6L8%_KQ4$F,I8[PA1NYI5GQ4VM]GU
M)_$$#,9PAC.@80PCH<&?O_,A2<" $B&Q@2]<,8-)M"(+,*A.[FOD!2),,PH(
M[((.6$$++[PV+&S(P<"D8(:P@$P8I^*$+-3@5# I0L%A.0*YV!"?L.0 )YR
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MLHV=3_ZFA$"Q9$R.C$YHIDF@$+$ &-D)AD]^RH4!9)<DIU^ (5^(A65J+U]
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M*,+G3D(,C$JX7J>1#&%0#"I_C5[7'//<O,C?"<TF]$"%-1G\%009H#'"_:$
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M@<!K&@Q!YY Q+UP<^[@Q6"Q8(_""+]AE:R*T5-B <+A"^3)T&)B,6'<.)NQ
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MZD7R#@()R" D?%!\R,<BA/!"G"!X&.^[_&(69J 6&FI^),DG< Y9($D7?D!
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M"G"@"2B!%[K@+';!"YJ "=1&%KQ CIW3(,B !XA@/H3!#9B@"=  +@R'!Z0
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M"^H&Z!?3-C?!89*,!4$+.# 2:?Z LKN& [50"SCP UE@;Q(\$AJM!D<]#%,
MT\/P7U!=Q\- "VY !E+0 TSF"WIM$)Q  VQ1!(S'PCM0%=L)&FHZ##C@U9M0
M V40!HX( TOAJWTMV3A@"W.L'D4<)G?<IT" !?:F!;VVOU>BTBQ= ^P3!8F
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M\ (Q!GLZ"4W< TLQGJPN"3-'$7DLC:)-]RF?UA%:F$&[")VP"3C6"FNP YQ
MNLP<"<#)!*Z0"9W@^IT@S#W "+3P"ZQ@@#\V!4A!"Y- !,K! Y6 "?8E!=X8
M@:C6"HJP6F?@"IO@^JQ "<:$!9Q0>T7Z=#. !:P0#$[A8#5P!JQ !#_ "FP
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MTLJO!*&M)$NP+$NJS,H1:DNT-$L44DLT?$JZK$N[%,,?<!4^T4N^U$L;T$M
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M@AF0H#@Y@V(FM8F8/BD#P!XHBU]PMAEHYQJHN:7@E!V@!6'@!6%H BTVYH1
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MY)+)K9!6)6 .T]: %$C!?G )33:'(MN$(.M"8C9!<@A(,"3"A0C#ZW:$2=R
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MPMU^<+0T[& *1)!"2#;!@R,,(_X+.!*&%NK3@RKYI!%(+$@FX].#[X!-241
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MK(:T;'?9VUZKKC<I\"UD+7)0A3<: :_NU>]^^?N3K987P $6\( K*=_^9M7
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M,L!F"J;J!W#@EEK!"=!)I421$69 J0@"#8B "9J ;KC !GEB"ARA"=K#%[+
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M8$D('V3H[+%L<@ ^?($Z221H+D$'VB0&D(I#V4 '-H(1G/XN@L@@&-3D!9_
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M=%EZ1*F^S>0[^:6"&*H'#&48)D%L#9%E?2):A2&+!L(28N!NL@!9G3B#!N+
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M;/ #%O[16[RZAME2"?I:M&,B#%< !&H@!4 @%C30I'.) ]2C6G7FJE5 G%
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M!41PP%K0! M;[5"0!@43[NMS=+HP1E+ V8VP9J'^/@[A!5G#"T75%JT C$7
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M+^ "&]"$]HL(M3,"*&"#6Q$1_@""K:@"0^N!9_D!0!(&&]@+/#N1(> (I]-
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M)E^H!+)T!5X(@QU0A%VHQ>-! S4 32.$UC2Q!1[1D$H@ [VB)#)HA,(I5EE
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M R" C_1#(Z_0A/!:JF%P!1PH B]HUV*L@4;8A5J8A5I #CK3 J*HF=%(A#1
M!"(("[/E%%P4B1Y K!I8@VU. Y9C!#T"@F!9J3SE!3#V@51-DQTH"N-;A%E
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MH@GCE(+09J"(9]:"=I<D Q.@&(PB+'$876""%*8 A(IBH0=9",8P\#>,1L3
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M2$T"-3Z$-0Z#%+QB&Q!$+6RB0&@!5^D"#MA94O*B0;AD*UI"#AB$)0P4+,#
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MH +9&/Z&ET8J&<:7(F!89!A6)N$DJ"9@Z/&72$CT9< ;8@EJ-Y^".3*A X/
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M 1N0*/YB"B2P>-: #'[ #(.B$XH@!-%@WIXN"QAA"G2H$YH !Y+0"V[K!WC
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MFI%EV*09/&;$9,.X!@PLEG@59#0#QXT:588EDL%JF)$96@03WK4+!ELU,VX
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MH(4J!,&Y6)L9(\A0@RM(H093Z,(.M-/B%\_@!V=@!!J 0)YM>F&_$,:!%K*
MW^M,.++E*<(9W- 0[0 !PWWQ 8?S2P9&G.$'W:M!$9B\F2JXN"\XZ (BV-#;
MS3#!"S^M@1&\X(2^]"#*;) "XFAQ!OD\][WUK;.=[XSG/.MYSWSNLY_9^M:K
M-0@&:_[#6J$W8QY$1]9W1/8=H2?JO4,KFM&&1IQYN*?: 5UZ0=I)M*'[<H-!
M2QIV_#FT[TBL:2)7VM2L!C6B&QKIR'KZU9*FM*+Q4NJ)SN ,FUB0]Z!;W>GV
MF<[G)?:?CWTP]R)[V<QN=IT#C=^Z1#O4>-',M/-B[;QD6MIWV3:UL3UMNV2;
MV]6^MKF]#6[\TBW<ZMZ,N;7];;QL>]S;9INO?VUL9^M[W_SNM[__#7 ]0_O=
M!"^XP0\>9(0K_."J7KC#&7ZU[Q65%5II2R6P^\M?-(<14#%<%VH!BXHC%4!M
MZ83(B\H(X(Z$%HS(-U.%L8B.'Z@58=)%R\$K#$!1(B-2#?X&+N7R<V#:W.4!
M-P@C2%[42=B(JC GPUQSKIL6$;W?PFA$&.9JU/LJG ?HCG;7NWYMKK/[:K C
M=\3!_O"TJWWMTY8X43WB%BL,YI=3L(\O?*"BF7C!%XK@UH%R,,:1N(%-1]6!
M2$C)BAS,<>KA Y6*Y-(512C5%3EX8W;9\"@>317S4PO&#^8+S*ZX@@9!)RKC
MZ6OX3YG^/KOKZB)H\ ;P<7X83S!#T:4&UM^5?J@#UW2A)7-I_JCZU'F!]5UF
M[7L!E?K2?8&!K!FT?.X17T ,-3[;KX]]MKM]J2;4 D>:,S:WS)4)21N))9CS
MEO"+L"L^"'Q<-"XUKJ9H:E 7(?[6VQ(,4@KC_G#YQ?USTPC8(7[;!7^?0DH%
M2!8DU!5J( 7])W[N95X%P8!*PW_!8 .%]!8Z]"GJTPI_<B 1V!8(6$/Q1TH1
MJ'Z1%('U9Q#Y)SJ7T%0@^%4PV%1S50:V4D(XU8"0 C#BQW_I]W,B^"DR*!=
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M U-@>8S@D!")!5Y !MZX*^QH!$8 4".!EI70 XD %E)PD#0)"TQ0B68T#&]
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M) 7*I?XBF!\R^I%%"A FNX;]DO*C2H\W>GMP>MC#T[!81)Q(F4[0#8XI4JI
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MCRF$5.DQ/W$X;U[W0?S\FV+ ,/[9\PZC2YQG\%\/F3;,1^12A P29.4V8>#
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M8A)I8,*CJ!77 R<XV$XI6!OCX@@N>($5XLP46QP7R!@<^?ZAPZ@"K'JP+2,
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MQOGC%,Q,&Z"+LC@"NKQ?+P":/_; LSQE#$B:.;U (L ?N.'+3114#-A"N,2
M)^":3;$D3L1"%P !%C3"5 U#)*CC#)!0.[Y @#G!1)(<N*%+$+3",!#!"\ !
M3JQ!1^8 $7CD,!S!"SQ!-CHF4?X$ R6D 1FX@>_D1"^> 2+ 7DU2@B1L9BTP
M AFP@67^0B4X0D+BY!ND 24$PR5( BVPPHJ=R;K  -[XPB2<01I\R\V$YAI(
MVC#8@B1<PN#@Q&TR@B<(@VNBIB<X M]@%1N0 2.@'DY4 B500B5@9W5JC"LX
M0B7<FB5(@DAU0GBR126 (7 *)W'N0F=Z2FDZ NS1 B*LYB]<@B-@H'GJ3W)*
MPE\2@R4X@F7>9FY:@EKH@B100B_,"25, BL*@R6DP1DT@N$@S21,0BBYI_-8
M@H+.S"Q,@B3\0H&"0A_6YU_>Q"0TPH"6$:18YBPPPAF,YDVX)VIJ@B28Y4TX
M*!I( O[;9((D_";\I0$;\)XC#&@F-.=C&NES:().40$9L \.3">4K($,L%H7
ML$O3'>F5(L?+P,66<BG-I$8EQ)1(-@'2Y8V7$H5C[ R\E(5LO NT, U0^$:9
M[@8=P<N;SJF=MFE.O,&ED!(6/"GFD J=T@R;8FFA$D<YV0(&7LDOR((L((ZA
M0FJD2NJD4FJE6NJE8FJF:NJF<FJG>NJG@FJHBNJHDFJIFNJIHFJJJNJJLFJK
MNNJKPFJLRNJLTFJMVNJMXFJ"$(-6[.I3]*I2_*IV!&M]#"M5%&NN(FNRDB A
M.  $0( %3  $.( 'I,($G()/%"LQ=("S.JL$*, ?#,,&2/X MT) ' ##,/R!
M M3!,.SJKJ:K'+ K3QPK3AQKO>Y$M@+%O :%OMX$O_X!!K1K4/1!*N@$"80
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MDNPQ&^XPL #WSL$&F$ 'Q*L*?  I"_$I/$ <3, $( "\ZO[R'3C !*"K V"
M!%B  /N! UA !%C ^^:"!TC !CB X X#"CR !SS "? M W# ^+[P.%N !%3
M^^+"!SR !B@S!Y3OKFI "PS#"CC !CR "NSJ"83 "@3 'Z0".6/  S"LR^:!
M!+A !$   Q!"W#KQ39" "1"#!3#  X! 3I" !PR#*#P !G3T1^\J":_ .O\R
MNCY 0%. U)*  @0U&0^#(#C ,/0!]_8!!*" !!B "O1!!#S  Q#L ^2!*3C
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MY/C(\O@H5\"NFD*-_\$"["HJ!'D>+$#:XL(#K*L)O"W!9D#Y#H,*< !/_($
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M'BSU3#\N\PY#G_]YH--!+=ORAROO 13P(2  ,9A 9G/LM=.R!%" P8[ ![
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MI7?&,T2FZ*,<.  !G:7$$ 2P %#\:5;Q)05(,L6 PKIB@L=:D "*(=U&+?
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MFF@WB&$M L$X,88 7" 44  _PN("+( %F)," .$.#@ D+$ "*F<#$$4I2,$
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M(1<40 4*044G,#>[U9L>20 RQ3H88 500 5"0 +VPHK("%XH8)-.H4JP,8N
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M%U8@:KOG/*Y&#JS\,[AYGH#!  KA%D@@<?A"+(AA$!# +_R@KH#A%!C@:S;
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MF$>/Q%8\D/ @C\<^&CY^G*#" P0&*SQJV#,LXBV7!$5Y)#4! @0Y&OP,^_,
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M\'=W]=:N<X:T0*]8[PJ6L,0?45"9 7% QNZX%!/W71T$]&6'B<,\4)NX*7B
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M##D,%BKG\P #**""(R/(KAI  00XT%T+>" $"DC:*1SP@=@";RLH<$ +/(
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M_>@WQ)#F$"!9+,0 "@ )9J8 &_ !%@ \ $<"&_#&)! (XT@:?E9N#F !C.$
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M-#B6O/YFH1F&P2&WT#GL00I_P"&K, K$8!?NL9>CL >85!/?<D4@P*7L(PH
M5 A_4%>F8 I$5!<[L0<<3A=^D ?](PI7Q3X<@@M[F0N" PSD_U!_D$( ,6P8
ML%,#"PI$U></+H$"1^TI1*SA+5' AA&#]*?8K5L"20$JB*H4P88")>C!A8>0
MQ&&G&#8D5FA/J88G<>E9"5/F*('$3K$42-'B,!<3&HK24%(@KC]]4)5\6&AB
MQXL_!9[*-2P"2I4L4S%,E37FGXZF4.5ZBI J,4-Y>#9,&.BE4I)JEQYLR?-L
MSU-#@ZY"^$?4,%RB)*+EZU?GGZQFZPY#?)%0GEO%\%XT!?YT6-R7A7A*5(%A
MZ:"(J,"*+41VF*E4%T>U#MMS9\.O#?L.)*3'$,L0?92>VM,'<,.H0&.Z70R,
MX[!;:9FG+4:*:B$$'26&\'/1)$J<7N=>E$FS(5,_N)8S_S/*)\M7?>0V+":*
MZD0_>D@US!4H)RE<Z^$JG L8^00RI+J>+'!NF-JJ&JH4/U8!IK5;AO-/P:R
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M$& @(/X47WL)+A9 BER,;Q@9,"(*.D ZV!A :9!  -L:XE!"IJ(C?SC((13
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M%N.&01T@KU !)&B@KQR .&(\X&3SE0@)/G#9%C^8PJ^&=:QE?34+#P3#>'
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MH"&F($"2??-VA>?6%*,@P$%RX8#[3(_ I[@],1R ATD34K)'9WKVM;]][B_
MJP,A )6N.HA0>("X<T" (431 @4DQ02B284!3C *5 2@Q0'085*T8P@ R*$4
MA%  KT* $S"%/M  !/ -N1&(.R" $6$! @@%U&*<$R$&"T  \= .A\(#4S ]
M!T"%$!B<89@ 3%$!!""_<ZHWPH"R0R $!Q@=/4  EF@!"*"N 0 !@<B# R"X
M&/0(!%B!4< # \"9.M(."HBY !2(%O"]E@B 4B@U#@B%%OX<'2)D.4R!/@)$
M/T,@!?9SOZY1+@/0@$ (!0JH  4Q+L*   X0A4%(%(&   V@DCLH /M@ >,*
M@0<@!%' @#*,+@P@%^\;ACLDA%#0 +5*A;03B$(0 .SCOD9TQ$>,L&*YB'ZZ
MB.VB@!,0BSC(  [X U/0 %+X S?)@PM0$1%(BU-P)%%@@ 0IA*FB !GR&@^
MN5N( TR9@V[*+0R@  ]X"U10M9<( ='@'PW8 #K8H#SH S<ABC+).0K(@SO
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MZ,PY&?Y-CZ$9D=G,*TG-(ZD,3@$,8F#$5R,KSR22U62.(0DIR]3-B4DU V"
MWT0 #ZB9; D>8B@Q[0">X+$=Q;F7AK"PWC%.LXN>Y;R(%8C Z%3*Z43.4UD7
M<^FLJR2&%HA :UD5\12>I7P7 !A/[:R=(1D% !@,J5P:"F 6GYP6 \L%/""
MT-$D_LR79]'*Y!R87,G.I*R34BB>7NG.\S27][S.[7308;@9@=@ 86Q/I?3/
MW=10(_D "\!,'^.Q?3&$!/&=0GG.DAA1A$$5XURB%%4>N)F[%(P2!&@<;$$
M/9"40; (J0&&8<-*I:@ R$$2OUF%B%HZ9).8'CT1W/11#?ZX0:^)SPV54D\A
MPH9 (>8XA-\3CT*H@SVH&6W:M%LX!3KH []8A3NH \!ACCRH@_6\!39=3]'J
M SGPQNA:&SDHTY.D"F#8 SF(TUO @SF@"6+X P=0 <,PA5L(!><H!1(A!#GX
M Z#@TCS /@Z< T(:!6V"QOG(!6@D!MR9&3;-4D(UU @\!)K)TU&8@TN]B$(]
M5(DHACF-4P[, V XA,XDA:$@A3G(@[DH!6A$RYXP#&(@! R1 Z4A$#P="@I
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MM5NJ0_Z <.& ]+N% +B/%6  P7( RFM<$J!1(CF% #"%5PC.#?@  B T8-B
M!VA(">@(9T2% 3@(/7  @2"!!. @R.TK Q@&/D  $)#%\!,CH@T!#A!;VT"
M#NB "H" C/P  > 2W95;"BC:87B $)@ !VA7 Q!=!* 2/U  I/4-/1@J YBN
M/6P!&!J*PY@ #4 \(NLI#[!= I@KU$)>"[BJ@Y (L1N!:G)'%MBPGI6*7*
M"/B "]#%KWK289"E7+"_8=#%%C ?LDJ[II( #["ZI  &#H@ %+  "6@-$7@
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M.3  Z2BZ&.PP[7AH$E600CBF0&SM@<@,B3,39OK.Z%H(]<H%LO4#P%DQGN"
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MMWGR"F6#KF'8@P>XA0>8ZPT@1A$ !J?+@T*/KE#0L Z8<0PPA.$"BE+@,P1
MD)+PQ*-J*OE0-G/^/$!7@,L8A FP@!,(6V)X=51!.#@C./2NMP@@+02XCU$H
M=0NX!=JM:!8B@1M$@&!9$@0P!3H#84*+\ FO4P%?3&*8IIC5OZL8&T=K"!"
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MD!J(_DV]Y[(SPW,H1:=0UI<X;B*\;LH#'@0&ZE\</#BNW@?V(I, 0QB$#H!
M]D(%41  YY<\8JC]JU O(Z6-.K] @? Q8@ (.0QP#1LF(<2P"7B($?@SC)@&
M"</\&$A5,(0!7'\8#.OC@%C!.!.&S3G0YY ) RX>%DR%8%1!#"L*\G$PS,7
M@B!.#'MPA^4'"84&<2A0B-B!.@5#,<BU$21)!, *BOC <OZ8 SH%^P 8=>ME
MP4,(B/TI8'$81E0%AYT2(*J@B;&'W!94H6"8"0@@<SW , S%R&&! @RZ9> 6
M'JD70^!"0&H8!Q %27@8QB+GL T;AI&P"A*#"U0!W@[;PP#JVM2J5[-N[?HU
M[-BR9].N;?LV[MRZ=_/N[1MU:A$"$!!',.$ML0T+-GRP0&*8"@0@/"#(@U4I
M Z7#BB$(-(P0 PP>%,@99NH!!1(0*! [A5Z]!8)K;U&0 $+!<X,<Q#^H0!#"
M3ZE,(,$'#H0 4B'A=5!=02<0,,)U!;$  "$%$1," Q],0,$MT"'P 776K84+
M!1-0%@<">IRP&4@6H#!,* M8L/X!!R9>=5YZ$%Q D(//.: =B29Z@&)Y)!"
M$"H#%GC@0R)I,(@$A.1"P&-R*."!!@Q4Z$<"&X2@ $]Q$$ 02*D0<,HM!, T
M3"$&Y#*," R$  $&!$TPQS K(*"9AB"=D, '%(2 0"Y](-"1 E"Q(%%'%E#0
M!P@II):* 6M:(.DP>21*# @,@##!!!TZ\!-(Q+@PP9,2.#3( N(IH)6F4 &S
M@0,B8,# F@7I@4 ('JS@@01B/<:FF\.<@( '%GQY2FHD,$#"!G% 4%D=5U[@
MP%NX6/" !QAPH,$PJ3P@@08D.-!'+@*4DID#(]R*)@%OZ6' !,1 ^Y"Y'T3
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M#CD62*27:@##'7S4 _A+@K3D'*B6'>C%,-0$#K$ !A"# VS !)Z !5P=0%D
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MT,PF-EJ654XA!G#D*!"8KODK!.#!*8AB!>(!LIX%7YP""EB%WLV/6&[I:DC
MJOU%!>RAN:+%9E2 (3)I(N9@'31K01""!-2?=GS%6"Y 63+ M'T%*0AH0<"@
M)P9&1Y F2Z2==[1@TY0K2Z#K3JW%P"IGH\8!NV( ?69* AB+520FV_QB8ZS"
M'("LN47 5( $#"I.'I!%T++KZLP!!=2-2[Q"I9I@T6H*TNYLK1VB5>ZB2\CH
M6N1"2/[U ;Y>Y6&Y*MTJ$ ]1AW$>YP=(*I9,!E$^P).0A 'LP2BX@ !X10 <
MY.$JY  0PQSL#BFP0)<0@P0TV+E:12XH  J<PA]L ,<!P[20@B$X ,]1B@F\
MQ9P4 BEP@ JE@O"%+ #,@2DDB*2NA05 0"B8@ET00Q_$W2&(0 !8Q^/N@>YF
MA*% 10M05E@00!Z<PF0]P"E@0 3DK@HT10+U 0'(@>(A;[."7[KU@0%,&TBT
M0$.<0AX<0-]\@(^2P@9(P%2D+OM*!*QJ@ 6H0B$8R1*DR2F< @2,8D$\91R8
MPAT(@$/<@0'T@2FL0*7TA%:\RCB:@"F(1O%QRRB<&\_1[_[L&DD<& 9I%,0&
M6$ &$T <#.RP%(( ; P"0##GG4EJU($!N)_A*H\!([ "J],#?  I$(+RY<%8
M%$0+=*\!L,#4&(#*><!FL D!?$U+Y4+B]H0'B"X#O$AJR!DAB,)X9$H/#T/R
MZIH #-4I;-_3084H!/$0_\2HKL4$\)P"3-L6A\L /(X#]%<A]"06<^]^$0 *
M/(9OU2T?%\P=? "(>,"HQL%UK0PNA$ _&8(&=&.C4  '/,8MB,#*1/+*F$((
M%(.I8, &N" &A$(<^*NN]>"WG, J."3AG,!SQ0%4Y($%#*D4I@=#2O):$((&
MI#)PA-IS/7)!S,$$8, @M$ (^OY!!.ER(9Q F<W16NP!!FB '-P""-P!,:@
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MIEN"*\A M#?[,*@!LL="03""O,O"6IS[#>2Y:NQ[#4S"6C3!#/3 ,$3"#-P
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M\,P);, 0;\G%3;OY3;JDHA":+&=#%?. HA+#K@38)T(W$ *P,A0!>AC&*0A
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MMQB%)W=)C%VZ]0&W/ 4"GFR**1L$%Z,P+5Q,08!0+#7,8^;D! 3[@0=(=1C
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ML^0@ F9O& YA]Q[ !5!- ])/!''/ 1K  >@ %1P G/R@\DR !.2@ .Z  Q3
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MB(P"X"D/KNTKE4K0#, %RE(.6(#X_@P7BX$8XD !_LD!#&$#BFH8\H ""L$
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MS$)  H;!! ) #J2L#6LK'U'-*0V  [*2 8A! HJS+DU+ Y)S.8,) D9 D^)
M /BN &3*%(13$0UBY$Z  (!3.#]@ G;)#P9 !_4-%PA 2X=!*X<AS)3J%C9
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M7N&,,/"NA/?N!.#)("P@#G3SKX8A!%# 334 K3:  4C@*5?JE!S7VL:+V2
MT;)X B) :DLA)$\,1VUM%$3@ ;9- )CV+4Z!_>1"-XEO#^Y,DUC  H0-T3)
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M?JH':,I=!TQYZ3R?9%,&T1>&?B7M/%^PRE,[\HTJI!0(N"W#U5Y=A>QH("3
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M>)!Y _$!#6*9M] "3VJA>0, (5 (N1(==8  ?G *G)(*1$$"IZ"6[$83)_
M?U ,'= @ \$ ?9 +!'"C.6J6(& *A:  R#<'"J XJYF@=) *&,HL!)"=>,"=
MP_  FTD(NWD4A4  =6 *A H89?H'MZ 'I5&A$""I,9*=V^EHBDD(J' L>4,
M%8 "!FH RI,'"& <+8  @Z S"' K'K$QTE00N $!I%I03>H1;)$+ E !?X"C
M-B((<HDD=;"8C=DKN*  )% *D,4=?5  SBH*A,"=N?"KMU"+PHH+HQ"MJ#"M
MU7JMH?XP6ITG$O4Q$'&P> $:<4QI"C!(# =@%-=A 0JA CHZ@@8@!PMJ  4T
MJGC 00U% @;P  S@  SP "/A&QZP 1S (- S!Q< GXY&%;G  8[W!]0A.05
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M$)  9_XL9RC!(B+@ !#!2#-A 4-RS1$! 4X[$WT'J[;CS#,!# GP?TBC *B
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MH5 (,3L9E_)T8W'E4 W:!%')#B0!IM >(- ')W K>?#8#9 E6<[$"E#=D_$
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MQ-!SQ/1#KALC"G, LB)A%- ]%"M>".0:&'I@I#W!=<-0# HP/F7+QHQI" >
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M#4P)A0, ()(+A.JFZP 8 4XXY10.9F. C@]GDXH8"H[2# #DAJ$#@3]2B<.
MF_"CK:IA+-@@%P+T-*7/20<"A@"E&!#!30C6"I*#0XJL3 4#"$'%#TC[(&TR
M OQ )0\('L@EA#IY1*$E#4PY!$Z6"JMN 4H_#9.K4 R@8[A:B2%@%&(<".&4
M4!Y8BU5782V$& 5",(7)ZJ2BTDH/)&M6CE1@W>J$V2" <855!M' @%#Z &"#
M5#'H"Q=KL=5V&"XE8FZ%5^P%;J('_@#& 4#E8#25)=Y[1?X H@HA@".I3 @
MKQ'K(KC+!SPP"3]@# A3HJM6N,5> D(1)+1!NASHE&D'2D6 5%P@P-4_I@4$
M 6"&,20 DXS+ !512"#@#D$ N(-I!^8(1>I41'% CEL$B,.4. A0Z,GS$'#9
M7GSWL+D%R>:8^%%4@$ERE% D*)>K.9P:1H\"_B#E!  4$\"M0@3(Y6%Q17E
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M-RT_K\=+).-J:9N7YN'[@F+/X\3/UR7WU^X=;M3C'1L$V( Q^U,[$_$ XP%
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M6,,XZ*DP82FC.8'>.L1EVX-<P0#N"84-:,@95!1U]$43,$@(&(15 * 4N*E
M0*Y;.+8*:) [>*A \(R;K  +:(A+FA6:J,A%E(H5($8.H) XP"@3X!AB:,H)
M. &.<,:..(&9$ 1\Y#+-P,,?(L=#% 3,D(H3"(0[H(!5$*QA"(2M?$6!P(4/
MD!*)  80<*(\""%@"(&;:,IZI)!;T$LT/ 58A$LI&81MRO['462 0*#&5+2M
M8Z, .QR&&OR#"8@ 74,1JQP(K%S+#,  Q$P%:1H(0SB0/^C,#%"*6U  4T"2
M0A !IJN#2Q0-0LC+::Q&^.B]7+D 4DC!%80 $V@GL:J KS014)P +)0.NJ"
M$_!+$:C-QBPS.T" .[@%6 F!0B"$!/@5QY@#5- #!*C$KD  #6"!6W"=KJ"
M5"@%"""-!["#KNBY88B ;"0$ 5 ^$3( \BR$Q-B/NSB%%=@8/R" >@R%43
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MB3 !!F@G$B -"SB07%@3\& !"_#"AX"A%D.KCM" U+E=L1@$^G0B$.F]T,
MG8K=2H'=C$,(G4+7@;  %A@1CM' JBL;O+ ONCV[$,"0"$@4.2"[440 5!B$
MG+G/4."JW8T*"$@4N@T%QZ 017U!O9H !7  !G@ !, 00.08NN",!$PK3)$>
ME(H0Z7  5:*25TR%42@ @!R&!L@#XI (%, 0/7 +Q^ H :C$#]"I"&@0 V")
M4VBQ#>:*"/@#Z F.0I@/0$ N^OZ[RC?]$.2HX,8(#1;HCV'  P( HBVQ8 4H
MFHW=+:]0"54RA!Q>V :^I+5H#JZX@*I0UF:T5"GE"B<;A@P D&%H@>J0@%D!
MA@.XWE-@C/6%B>\,!*<(&J(P6*[$D1LI78G 8H*QX-!P/ JAV^U .@11U+EX
MX9UP@*IMB =$!;[@BJ88RA\IBB,<3_WY@!% J9_56#PPA49>I:44 9W*CC\P
M!0$ 2$JUBP*I #W(#:[0@R+NB G $ ?!9$W.A0<4!0W@QL>2#$GR "DA@1$H
MA4BN%IF%UYM1 %;^E6%P#TV^A=E;ED(X &*PD8[ &?]$+HXB8 09X8$H857(
MY($0A?Y<$,P2V8/*,(11ZHY0L L.))'WW8D%D-_LR(,3QAYGQI$(<*D#\!\7
MJ(L$X$H, !3C2, ZB(,"!<C[N(-B,  41@"+DPH(88P]* Z)H%V[XP 4. $4
MT  .$PO2D.B=J%\/T .).,@"2$ Z,( NTD>KJ ,3  $#N(-3,(!&DHB#]L(%
M6)FB, !L08"2P>B=0("6I6EST:D@SF@YX!(5.($32 $!&#TZ7CQB&&<@(;O]
M&X9XUAD$>(4_2 FNF #L6%43^  $J(H'V(ZXG8FMWJ!*UBL'2!U@*.OWZ@,4
M$(&6=0B7=FKX* 1GKA95LH@Y,-A;".0?\XKV'8; Q1X5(/Z!"L@2[D*(P\B.
MERB3"0@!D#Z_[.!86!Q@8N@#LJN6?S.LB>:,1"F$OX968MB 7PF0!'*GS>9C
MRL:[UHV(!S8B P")"^2*%!@5!" !H%8!!ZB[EU)KTD" ,"D:/9" A_$ $W!H
M#%@ 8EA#KNCHQ X.("0&Y@B%0/"[/A#!"1 \B0#!AV%H$E"!#."PP#HVP388
M[^B*"!6$GJ"2GS8!$0B 5&"!V<"#RC#O$T!O]68!DY.*7)B#D<8\_?& PXB#
MSA4+>>J/UH#FQJZ0U891WCH $@CN7PT!X$Z.T%Z(KS-L [<G@4@%!Y   I#+
MOQ5H*<H#A7@ 0DB\O :!CB6*5/Y@  WO-6(@:0MW2W7N[,^6"/!0 1]!HW(U
M$0*' %7":I 0" @ID12Z&1:X$ ,0!;HUA9B(P*\.@:Y;"G1^;(V 2C66"#Y
MZ&%@;PB)[Q/XU;KC#@5P:8EH2@09BZNX0+@>IPGHJV\;".(S:&:.Y_M0@3[0
M SSX@V_IB)T6;ZOH Q50@+K08E3X8*Y(!3P@ 0'PY15# !%050_@'8'&N[@
M<Y<VBINX!3]7@ I@&3^PT/ SET7F\^>5@[&K<SW( T+H5 O@#:[(@P<H" I)
MZN+>#C?4F0- A:@.C F8 U4P@$8?H:CX:NY(CRS'@/L S[O51-MZ@&4T!3J8
MC3#'._ZC( K'$+3X&PBUR8E5"&2N(('JX%U34 !A*Q\Y.(1"<(I)%Y/#( 8@
M+(I#3W0$<3Z)*.&KH/;'\(,&& @#-NW++EUR-_?BT  K/H6Q1#N(*81"L-5A
MV'>I.&VY[@A2F ,.& #Y0P%Q.8 [R ,[O^1<8':3?O9A4 #UV!O?7M0ZO_-O
M23X/204]0/1?:7>Z%85 @(L;D0BJ]A 0+ :3UX,[P'/"@AAS1W?PC8G@"&*N
MP&,.T L\T -W!091> P.B H+,G5W=8T(A>M?_X 6.$ ?68(WS6L2J(.^6+3S
M(X8(4"5BB/@-"(!!* 5QU7@].!.!YPJ"SPRY:'<*3WN)#_X Q8!7\NW4@3C!
M%9@:"_"X8_[OKC#QQT:% JB#OX?XO5>,QX9K&?>0&K]Q$2K711MAB9  M(]X
M#F![HW [D91, UB!/T %' 3G[K@)%S!VX3$1\*CW\:!R_[-R9F9O4I!.N!^$
M,^L.,9\+Q"<!:7ILQ\ %0\B#/NB#FPKR]AE ,O^/Y-#'/1^+*RZ1!YS0K:@#
MHEEON?"#B*Z0N[D.A[C>8>" /6B*>_Z,!<B%. #(!RR$9[$M!+A%A#B0/<<
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M%#*0JZT6%!P"+42M@0&%I') "S1#8,"9#/')0M\&L/1 !X?8/<RK"SD^RB
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M(*6FX  Q"D%30E0 !:74ID0(@0&7IF(%%PJ%!2# @4& 4S2%:&D(8'HA0E!
MJ@2APPH'D5;B64"8*[ D'L"8DW5B '(YL0 &))HK/4@  B;H U"&:-$),-.=
MPJGE+5\!2[MYP!2A< T?ZDD!?'()&"B@X6,.R\QD8C6FAJ!I0$4Q$%/*)!0T
M3<4'Y'J34V @4<-@K5P_<P<"$42?%."E+P^)IEPMQ*020*G=A!M68@B5J"9@
MR1]$*0$5W.0.PM2 7KGJU4"$E?X@BAV-N?Y0 5L&YQ89'<@?// 9P[3I,1L
M5$E/RA'Q:A2^Y#VH6RGP7(QJM!0<'08J0B !W7R&!""H0P0@ %UVK2MY<9"
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MS@0@COY9*I@  RS70O3!"*" 4:R"'$@((?3!+9P +(:@1:R ",S!9X3"!D
M"U A*O3B"6P8!(R("&P;+LA!""Q!IA#$'YR "9B+,L(B(0 #D?A!5GSC")B
M:4&",2(C^\B!"+A IF01"4!'W?3!P(7""9# MEG''=R"'H3 '"@-G0P$()"
M3@W$( Q"VC C^^CC'?3CO)Q"(Q'"09Y 0OZ?"8Q /,K$(!#"*=@C-1GD+:B
M6&25"-1!_8U(")0D0>R!"*" D9#71,;&-YZ "F!BY.#!7YS"6P0C/N*%/O(C
M'0C=0/C!0&K,1ZZ 6(2"1=[!9P1" TC&?^#%.L:!A%# F/YP"3<:%5&0 AZ
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M*C# !I@JJ^(.!'1 'X# ]8TA 0@$,&@=0X!%&BZ$ L3!*@B =@)9'AB !IQ
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MF, <R/[!'*0E,2@($-+:'P2 QHB" *!"ZX:L6KXE!2!(!)^)'J#%0.R! 7G
MARQ$\D8.&1$/ 3"*!^,R"R9P+Y^+2!A(3*R34@##C@P$3 R&4[30P-5F+N0!
MJ4E& 91B!;#O0$1 '^C@O-RG*A %<EA 4!*$!DB5(6" !C (!L1!KQ03[AA
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M@9_T*"!D7")@LP\#5+C# P5&=> _!RH;9@X"(D*(5PW,&F2 4("YK&:S3'G
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MP@;UD0$(L,"@IDA+"4#  1@\ ?X([J,47$"3 @VHZB^#^0 *0."HB%O !#:
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M*H6+9YFB.H/.=KW1?6N/W"(4$R?YISM4;V&C*^0E3TC&#Z)GE*L\V)(V=U%
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M)PB 6%[A!X>! ^AJ/^T/.?D3 9$I!A%BR41P/^V(&;VH-PWO52K /GF0)SZ
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M D@$ B! !.1@H1[&0.35>HG!$"Z@D"J')@Q #G++=D<' 0I570( Z!Z@53U
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MP8%I[!888" 20XJMET2TS(R?>2<4B@/>A"2&@733&99EV?Y(M-<#","$3<(
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M9MSB%N)@9FYA!8B!WYJ[9.2,O=!2!,X%(:P[L4FD$!J;M?L %X2&-A3@/S;
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M<AO6U$HV##B!0/*@D5 (@#2WT, JKS/'VO"A:"Z@%AX".(Q<2,!(#;E>+17
M K159A0$X-/"J 6!<\D! ((81@<TP!H2=$!+$D".* Q@$0=(K1A,S$J"Y&D
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MHD/@^B)4<',8$LB#(7X;7&==Q )XN<@?!J""NLG(%#V=R G(F:^L"$1QIB@
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M$N"(D3D9%B G38*4AO!XP,%:(KH ?G +XL23/'H*CYJ/I. C&H"H]F@*R(4
MF>4HG+24I!  #.%964FA"$D'"S"0MZ  '.J5(8-1)!D8$-80A("I5:D!?=J7
M[@4<?& R9KFK@P2L#VEQK1JK$7$=N# ? @E#48J6;Q8FX!%T2KDOINH8>) ;
M]ZBI H&K#;$'0,B/3D.4A]ICB@J5P9&JRQH @+$'6$&98_YZH H3D*M:K+&:
M M9AC[$!#.H%5NI3C8"&"W^0!T,&<K1Q F2$"BJ**+E B/8)@,1 " ?S,:G
M$(>0"[A -:/0!X,P(V[#@$]X"WM0"+D#/K@@"'T BS>R!W^ **/@2_,G$,7P
M!R=;0X$PLP6B/J.@!R*['*G0:W_ &GUP![A@ NABC XQ"C-R"Z90#+<3"@_
M JC@**8@J=]*#'FP 'R "S-3"'M@@:*@!Y#08Z.0!SN[A#)+-="8%;D &*F
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M@0V(U$""/G#Y8 (.F#-EC@0)@D 0/80E,H,( @GD2X+FK#/ 7(=Q :,1K(*
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MH2%ST)+]AA&8V43 ;83" P?F,!8-[$$"EAK!"4$B$@9T9P^XB Q,4!@TAUC
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M!G6HQ/ZP "'H21 +.(JWAU! OW3D+J6AP@(7& 1Y*0 HW@[C1H$E1@$D51
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MA0,L,*,-E.2;^&H("/!% @6<@ 0("(T"GCL')#N$KR+@  >8_0<#%$T!GJ.
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M(1<B4\]/8($'8+D8QA<1Q(N\C.BV;]NC!1@WV3"! D2 =QHDG9.Z;QN%4D"
M!S@,A_X0.9*KN9)H@933@)6[  > E9: .9F3 )JS.03 .1-  !'@.:BPO*"K
M0%/P _.[)0 XC$%1.J:SN3$A"%0@@&=IO*Y++4?AL9X:!E&X!56(@SP@C88P
MB.2@#F(8A#HX#%-HC)X:A3FX@RNYA0LLD*3"A3Z0 U6)"E.0LV&@-9.0 SE(
M*FIJB4)X!>H0A28$!E'(A5S0G%O( Q<X%AWB0I<JA3D@!& (A8;@0S\D$#Z,
M SX@C5L0A9(@!#GH P1:0X(8A2>J'EPXA)(@!2F$Q,D@A$@\! 3"A4-,NC]
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MTS5ETS9UTS>%TSB5TSFETSJUTSO%TSS5TSWETS[UTS\%U$ 5U$$EU$+MTX
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>cogo_0024.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0024.gif
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M_/____CW]_#O\
M
M
M
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M6,'#4SB"A[<[?A_060>Z\(40SER%0"L!S ]7 ]/W7WC783!P!.-'9$!P9E2
M<>:W8LE' Q+8 I4 "3IP?4JP"#OV!2\P UX0!3) @;_P U=V"$'P D+@?BY@
M!(<@!2[0 KFP"#UW7Z8@8HT "1Y6 R[@ [TP!"_@ V)0=37@"X[@8>3W7Q9V
M!2T@ TVP@#! ;@NX _W7 DF $%KP C7P@5-6">6VA$!@=RU@"J-6 ZGG!2W
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M T#@!$H@"(^P9LN6C[Y):O0X!=O7 V'0 R-&D3T0@IO(9&@0!/^U?:>P8C1
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M O$X7V4+!,YW@3C@"VDJ RY&L<[Z"\F' V(@ES0 G*T0EA=:L!JZI:?P@EZ
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M&P11"R6  1OP(*%P MRQ!ENC IS@ 1/ !@T1!WDP!Q2P :_""REP 1D00W#
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M$%XT "0+,(M#*A"G'JXI>FU$VAM,!DMC%F44(!EB @(Z4(?\Q X,T$D71X&
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M>4"GQF<?AR0[ TJ7MJY7?< %./[Y29_'-P<TX.,")/'8R:9Q[&FL*@SS=D^
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M47B #5@!!L F7I" 1"TDC&B *]P>3B  HN" 0 *F%#J!EOP%#&B $_@  \A
M#B*!$4!5&[I4%8A K2B"!8"(@+0 ZY%( X" 4%"! U !/U42AT"!Z%F,">@:
MX8D  ID H@ ?]K"K$% !$I" "^BEG^.>S/R% M@$/R  $B@"!H@CYW":1&6(
M.,"6]L"# U 1$?"AXUD#"OBT-K# 7SB GCS6#(" %;  "/X@.0+8,TX8@*@@
MU@20BSYX@ <X 0X(2H>P@!6YR ?@U0-( 3_5&'=*@!$(5=/H)PU  8-9"DA3
M@01  1!  ,KH@P0@@5"-)?U[@%'(@#A: 0!8C7<2@5"5B1+PU5#M T$ZE\P@
M'5>Q !4PF!7)@P.HV0.0B5NMJZ2, #RM5%D8 .=SB#@ @ JQ #F3G'+%%A1[
M@ IH P>0Q&>-U@G @&HMUYR* P,(I@JP1$,L@/:<FIIL&?LS 79= 4_85(;8
M@!.H/&@E@0JP %X !A%P *^=-C<8USP]5S=P@&1-$A8A5R14D@;P43X=6PN@
MA0;<@&2M@ D07')M+M#55,_)6?Y1-8"%Z*$UX%81>%0$:=7' MPU$($-8 #H
M6@USS8P# ,H?ZSF&Z ,$2-D#B*63%0$3T+I?8 ,+Q%T($:D/>-4(3)JDM"'Q
M8S$[&@"BV !E0;'"_=I\2AH &#+&88@V"!I)I=2![5U>B( OZM6@W%QEU8IZ
M-9V.N=1'/9J&71:CM5GN^9A0!81-B-LY%6"/HIC[F#F*&04W8(-/8 T[THDJ
M 84DTJH#MA,Z6(,#E85-C)3D$1V&L 7B&R)E9(A 6 ,#M),[B -9\(1:@+A2
ML. *&2R%J8/?XX0U2&&*B-.DP8.+^(,UH!"_&(5(.8T_>*SMP(/?DP^=&(4X
MH -:J/X%R]R$[N"%/+"/0! Y-RB"*F**C@@$"BZ*3K"2I.F+/5B!(\8((=X$
M@"/BQ2#C._B]C+03RI"% HYB64 3A2O#(0J+4-CAS/#A"O$H!;:L))(%-GB#
M0G0ZL;#A/DK@4:PK-W;#T_"#WTO@!=:)M_EA[@'4E-B3&FV,4!AD!69@L0B+
M;M**#&Z3B#RA]GB#Q3327^CBT["/3LBEBLBT4HB#.7!B*/9B3EB!.Z %8&F5
M36"H->:%509CQ?@$0#AFD!N17-[E*:SE;U*%CE $"E[AALC.Q8CB^Q"?36"/
M)6[B6=B#IONY/B@",\Z,)N5FB6MF/\YD19"XCTH:-U!=A_XH ;,)B3MP YK(
M@U)(8UEFBC9P UGH!,928E%N#UEP XMD"HJ98^VRC[WC53=.B4!XDOALB"@^
MYB<!9;&H92QK+D"0. ?&"(B.EXCVYD-Q*$!0 0S*EC+.I33NZ)2@@X^(J[!H
M9$#&Y+7[S $&ZJ 6ZJ ^M^Y@6.OQR*%6ZJ%.:J19ZM&9@TU0@0&;TZ9.B=UQ
M#(^TZE/9ZAYI$79>ZJ1)VU<\%0RP  5:F; &ZL!0H >0SU)9@P78 _S@41K[
MBM-\.K6V$Q2(,;U6)?SMD3]( 9M,);;V@P>@%:$6I /UZR%BN,:6TZWN:K_0
M:E(QM1JCT^8RE2>I;/1RC5^<@_[=HFS-'FW,+FW3SFNG5NW59FUAL^S-3FW6
MWNS*1FVGW@2)( % ]NI#Z>JD-C5>6"?2%NX:F^RF=NTYVVVKENS:;@])DJ;8
M;@]>< -&BP/E'F[2GFS4YNQ2^46&:H.'J>[A?A(\>!@50.C,WNV4"&[>9J7N
M7F[5_CW3SN[BINSL;H_0SK4:JX/AN.ZB .YT"6_%!IO4/F[H?N_F>A+!A>P%
M9_ &=_#7?O (E_ )I_ *M_ +Q_ ,U_ -Y_ )+W#H5NP.QW#[%F 2%_%5,O&&
MN.P3UVP37W'92W$6U^L89Y&EIG$9CSU@ &L&!SBAIH4BFFT!CF]4J04:QZ@>
MH06M*/[R&1MR''?R)X?R*)?R*:?R" ^%!_!>XY9O[L;NTHX F%;M%T<:+1<!
MHGJL)TE@K<!?4]-RYK:QQ?QP3_DE5YE+]/:+.S  FJSQL[$>",A2$&\5!& +
MV4'O V=O[5;Q*E?T16?T1G?T1Y<Q]XQP!M \H/Z 8--L0#  K8#C&P?B M[M
M"$C#3E,E"=B5S/: %6$ /@!T.@6$OH;T6)?U6:?U6K=U4B$3]J@%-SB!AKE,
MB>N#L/@#Y].#$V #6/\#%+@W-BZ%.Q@!)4F:%%@!67C<)\F#6? ##TF>$J #
M'=2#$<A M@ $I%*,EM,J9>^(43@!!DCACTX:%7";NAHQ%/X@"Z98 Q2 ]H=>
M%JHI@7S_A3V   \@8BS*@V=_$D]0 170[67Q%9#R@Q-@DR25%%8_"XA?"DX
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MW\*EW'"9%8S2D)^P"K2"![O^TL;0/;DZ,.:9:[XYYYU[/C H!/#2Q@)^G$L
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M[;PG/O.ISWT"["^A"DN; BI0P/SSGX+QIV%"]9<\5( "$D@!0@TJ+N-,-"?
MD.A!*PI0=@;FH@)%Z$ _&E"0MDEL]^'H207"AYA)  4HU:A?Q.8!!CSDI";E
M)TYSJM.=\C2<4.RIE(#QT\AX%/ZH1CTJ4I.JU"IQ=*E.?2I4HRK5J5*UJE:]
M*E:SJM6M<K6K7OTJ6,,JUK&2M:QF/2M:TZK6M;*UK6Y]*USC*M>YTK6N=KTK
M7O.JU[WRM:]^_2M@ RO8P1*VL(8]+&(3J]C%,K:QCGTL9",KV<E2MK*6O2QF
M,ZO9S7*VLY[]+&A#*]K1DK:TICTM:E.KVM6RMK5@]85K8RO;V=)6JY38A9-N
M@0K!M((2B[G$+GQABB6^8KB/.84N!&,)7!#&$LG-S"E:\21=6 *VD-'M+UKQ
MBM\R=XG1S0DJ8.$8ZCJ&%9@(#"L$889, *87CBA#(5PAF?26 1+6[==W(X/<
MQ/2BNOZ0N41W)7,+XP+L%.(%:B]:  G 6-<44>@%@P5SW\(4(@B"68(+=HL8
M7]B $JMHP7:OT(C(3'C"@8%M(<)PXL/HP@FK^(49+/P+$[,8!H^8<4YZ48/S
M"D;'DB@,C1/S!"TPR;JLF,$M'H-B(?QB"%?X!2JD$&3 V.#&*PGRE =CXBSC
M.#$E%LB0<X($, B$RP+IA8M_<8D9X%;+@UE""S0LD"O H E,H($1VFR*&N@@
M"D& P2$.8PHGT/@*,E "$VKP@^T^"<N_"+.9 Z,%1OQB%S%PQ"]$;!A6Q"#)
M75[,#:SLYBL3IA!,=@R-4_V+0WSA,*AP H23T.I(M[,7-/Y@KV F88/*P/80
M1PB,*8(@A2<GI@<+[FX0T  E,BS!,;V8P25^@08D0*;-#-9!)3Z=$QWX-C-3
M\,*36E&#7$3&U[_0!80E88-(\T#42?QV3IA !L7H MJ_V/-S%1/L8>-8##"0
M[B]Z(00F_.(6,@"W0!K! CD/9A(U,+&_ >Z+(<B87_!N3+(%TN8A*+LPXB;W
M8WBP8!*ONN))8O9A' Y;)I3!J+9>L!@HH84C7,$7IT "#J1PBE]0P@E*$$-R
M(4$(4R !%H=PQ"",X 16"&303)B"= L!A,!X00J7J &$83SR4[3\%XU  A,H
M 01(Z*(,O3 ##H @", 48@E*"/ZT+[P0[5^4 =.PL((2JG!@78@!"4NX<2R^
MD'4SG.(1/?"!%G!;"9^'(>MH6 (3!I&36U2A!DJP!"&0  DE:%X@?$=TMU<R
M"$@TP@FZ,(-T!0%Y0LP8!]E^A14('' =O!<(5^BN*:3@A"F(UQ=H0+3D!;+X
MGV?=%$PX0B.JT(5/,X()3 A#<@F!=*4S'1*"@ 02E'!C1YC!\V%(\BVNX'S?
MLJ(&C!;(+:S !"?XMA5><+PE"FZ%()2!$+\F1"58@7.=XS@3A-B\$F#:+_C
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M(<! )/R"#BS8#;2F^?T".[JC#A!;K\T 9$HF9E9!)A3G@MG #Z !7EK8(,3
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M B6!"*%AB3"<J(&57VR0),$%KP!BB860&FTI@Z[PP3XL8)"D.R9@K"$C'X#
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M% XA!J:@#)! !VK&WAA$1EZ!!GZ!&P5B'&?D7J( "!(B"<Y 4W[Q4Z*&-,;
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M$-@%D>E&=R4A":H@S7H(F EA$9A # TB".)#$F2 L 9AWDT9D)-G"L1 %V"
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M(_M2"$C0"BUP" =E XO@%CG'&KHP""W $#5 HRF19+K@"DH  S]S)HCPHX*
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M!.!S"U:  TR RK*"!%8P,*U0!M-B!(EB"DW0;K @&6X)7'5">_YVE""Q.H,
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M!!*5P.;M]Z*P@ 0'20E70 -+$!IU<@F7Y@6A8@E.,&V]9'L^<#$Y)S;=4@@
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M^'B$,C 5'U4ZI##67;!5I:LL1_Z%5$D%4T$PH5,XA [!!4(0 V%KA5[%!-B
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M B/0@D'P@5BNEH60 A,Y!2L  ABXX5ZH B&H@D+H 18%\4W!)2RJ K10BR]
M%6]! O$!R:TW+1"1 C.8-ZU_@@Z.N6A_LBF@L'+6@4C@ 5R"H2FXA"2002^
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MB,>,'.O$*8\<A48-B/Q2[[WY.F$&L:.37KKIIZ.>NNJ]HOX<VRZAQK;6+[G
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M<"6\*@_! ,$A#*I[ !TLE($5[((+4J:17&@CP (.]$4NI&NM*LNB7AA.^ !
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M4*HVZ<3%[ (DP$<FAP0L_$X[7T+Z0705-P(/O.GOJLHN2((7P #7=3 ,^$(
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MZ#XB-0+YTG?$@$/YR=Q2!(J&CLFDRD$D@9VH7B\491F( 8DEPB&0QT$,@=)
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M?(DNW("JXX)X(P1Y)$'Q49XNT"BUHUZIAR,:5/I"-,0I' $/.($79 6V5_O
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M$2;1>H!PHB!!!VRF$F2Q$&JQ$"ZG":S+H-QO0,1 TP)*$+X !,_.!UK YY:
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MD^D8C,R E00A)L@M#(P@(QW(DP-'E)V 2G)!"R9#.L5&)XHYH&J9?2HA_+R
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M'B&/!>' C, @5L$)P% 'IN!:\.\00@L(8L(K?\$+@D )EJ"-KN!O=BN=IN#
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M[0'DR"F+AX L$4+)8 T?8EHQ43TU"!"KO4XZT?'6XZ];2)Y&U1V4]-V-1IC
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M0C/6/["'V0U_OA(KH+[J$H:PRHJ1RRDQ2*H#):W L*VINJ2:,@Q]/<*#+[@
MX84OE^A]2LLQRDDUT4G,B!8J-3322R\[#,4QAL8-,K89//Q2R+*Z/-("*URF
M;0,LL,#@A"NX('&T>9."FYF)UM:0)"4UH#Z%$F$:@D-$2WPQ*1/O0I&$T*BP
M,D.2E=3P"BNWMB)#5(4,+^8OK_3@12^FP-"1)>+_<O?7NBR^<LZ4K )#B%K
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M_J%]OD TY_8(J,-A/B22XGHF<]*I<<&K2OA=Z+I$J^D?'F@M%,M;4"2P-"=
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ML1X2WDXDVU_-$7'AM96 3,YM-I9 !H(0(KC@1%[3"U?""*<0,;U ".LM&9"
M"SOM1*=0!H5P"ZR'%JO !$9 +ZQ 4+4ZU)AF"F'0").5"W,3([# U(L@)J^
M!NMG"0MA>41=QY @=94 %JBP"OYSXPLH* :X, A(< N%7=/+K0-.[01D\-LS
MCA;.K;0L5@EAP"A&C1:.O>%H4+%YI N4@-3PC1:M8-Y'"PF0+76UC:408M86
M0=@)?A>98*<"=-ISGF+\T1AD#><Q@N :A=V4H$1F;M[Q'=K>U0JQ/=L/T@-4
MX%COA"=+KH1.Q-CXG>>6$ OG]BD;KM:Z:PJ.$%77["4VD 16T"F'P I&4 -1
ML"DZ, 5FX -;@@8[,!R1M@-5, ;UX1\)H5]M]<UQ(=._( .Y+ 3XDXS"PBH8
MI 2ZTPHQL#4UH!%Q,9IO;0.OP=;)906EHGA @09*  00.RE"X 1C( 118D)5
M4#FY]_X$:&"G_O$#4J!?!"H&.% 6-= *T>8#6H +,V *6" JEA #;F(=4C V
M/F )5R Y:4Q2'_%48A &Y?.;5] IE^$T83 (.M ?3@!@Y3:54N #"U%;J A8
M'X$FVQ(##QD$@+H+/J#M-H A28 _5Y Q4[ #0U >3ZKK6_$F0!#9/.#RG',7
M40 $41 &2<K'_E5>(11TVEX#8: +4U #33!;IC #3B"'_8,UM>X#J7 0A]"A
M%>$(-' %8U FJX $LBE:6W B-5!L?L+V8:#K=E$&/B (45^RHQG=C%GJ$P\#
MDF)"RPY[QJ$+.[!J/9'TXF4188 #82 %'H8*+2 F/\ (@_Z4[I!P"#? &:*%
M/S: !'TO*8<@ Q,?!&G9>#[@ QFT!$D% T_0!?R3180@ ZX?'KX@" 3G!$\:
M!KMN2.;!!# @":OD\L^$-J8' \;#3HY0"$,0'#6@!%1' U(P!D;@9FAA"FCO
M!*_09E6@^Q>87DJ/CSV@!-%? Q@"!CUV"S$0,37P\.53T,Z.0E$  UE4DV&@
M^W-?]U%/4':Z[7'!\Z)T*0!1QDJ-2[]\_?HEI@80,PEQE*E2P]*O,CO03*D!
MRPP.A@EUF)'BX]:O'2&O($3XJ,85+S4._7I$0XL8&H-^"9I1)4P0'KK*<!3T
M*X:I0S&F[-3QRU(+70B%$'(HD/[@KR!@$$:R\:M2C3)A8#A"&5;L6+)ES9X-
M6XE&"R]B>]'(].LA0C1"?E'2<9!)&82Y:N1JU*(2PBA*$%ZJX<O4R5^M:OQ:
M!,0@RE49?T6Q@A )WU^0?/Q*TE9IBTNP:C1%@F8RPBN#?TGAJZ.2I:R-&PJ2
MC' )8X13?!S\9>/0JQ:J?S%AK*L&I%6,6V4]!>,50B]2$C+YU0O'J4HV#E[1
M\GP7PB]8?NF@Y'CD(QX(#VYQ@A!2HU\UQ- -\FN0S5^'D+RN8;I+;&CJ%RTR
MB^&47W1!8R2$3'FL$!I&ZJ4&5#"IK175F$#C%>D0JN*(RXQXL(;QC% -*X1:
M"6JL*/Y^,\B&1PY) J4@'J%M1=4J-"6L56!XJ;_'#FF!DE]PD<)!'B:J@3Z8
M),.KE^/X:A(A1X#090=,Y)/L*80**0BX*R9ZC<K[?D$COR"^0*B2(E'R18?X
M?C&C1H2"<*25#W_Q0HM3:)#RER,:(<ZX0F!P;2^YSDRS/B<7D2$7]_C$[CA!
M<H%!$H24(.,7&"!!R P8?B&$Q,(.D^$7)QB#!094)GFLL1:IBR^2(:)HC 9?
M#"%1N1X-F3"[&C1%B1(<#HJ"Q%\N2540.ZD*TB <,OOE1US04/:6O\"H=#ZY
M3/'0R%^4N,\&,B'YX1<A^".$E4DRG!4A(])8=D\ST@T+"/[5F)V.SG37_;(@
M%)<ED+K,<)@3I5YL<+(1(!8&2RD8=%DDV HU-2(H[4YIA 9)*T3EST"!< 06
M&?HU8X=?-I/O,RWF]!8MF6>F62PB6W@6H5YD,+(&UQ81T5A?*O1B$#,&B2&2
M1>Q"B(DSU5N0$3.8>"PRL<30P1)36I+2",X> 6*7J0[B(3T:FAI8+%,$H:DA
M'4#EP0<K(M&L(2D;41DEI[/[Y8HJ8*$!EU_$+DC**\S;I9&I'RO#,)2:$@,[
M7W"8R(;!=#AE$!T*,8,0+&[XQ8='U+7)B4Y1LD0&(\90<'(R#\GME4+*Z&&)
MXT0S8_/./W^-ABD*"?1!&GXQY/X_A'P U8<=KAC]ER8&840R*:\\[G3'IAOX
MEKBO )6LO:6TX@HID""DC$*$R.(7'G3@'B&Q>T0)P@)OD>&60G*3#XTK8#@%
M0BD/:HJQI,0$050F>$JA 1K,( @RM. 5AX"!$\K0K["<@FTT:(C/$'(((_AB
M*@CI0?.DU;TE,&%VY]N"(/YSD(-8 E ( 0*A H<0W.B-2JXIA!(<,YY?W$('
M#J).I3CTBAH$:@IB.$41$6*:79%H;XVQ@2MX *J#  %4._ !\^!TEZ1XH1!.
ML%^-TO ?L4TD#<KZ10A7(\#JK>@T3EC""8/P!#C)!B4[>,0@\M-#&KSB3ZOK
MD0=- ?ZX AWQ1V988!E:8+\(=NA(/%B>"%%BA(9$CF]$;$6^5$,&PQSD%1."
MH!/,T*^!E4%WGB."=KHWF:T<$!-*1,@.(,%!E/!@=$>@EP=/40@2D:T2T1G9
M(P1A&"D1$1?D2LEG+@$#)(P!?C6#9C3)THLK!.&9.I,!J&H@KOMI)3%BNX(9
MRF"^6Q@B/WKA#"N*:(D:3.$0E>C!+QPF%B$ @0E*8,)7J,(92  !%Q_\!1 H
M81JT&0<E4>A!&2YQA?OH8'2Z.,05:D"B(&@,)DG16T,.(@8IM&*&?@DDGZKP
MIRJ\\S-AD%Q8RH"=7J#G-6$X15+(X -!C%,0C_"%&@>!!/Y=V( 58GF%(*(
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M5/A..OX),2E@@D< D^P(53\EER4EE7MJ3:Z$UFB5UFFEUK)8@D6L5B;+A5<
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M(H$\;.( % E%HS:P)Q4EI WTR<".?B&+!-#B!!E GD,(X!->L $ZP'  D>(
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MBP3,I@Z:A+ !,U#>!XB@KSG*H7/4B8<V< !A" 9>L0S:"11P<HTYY!N!P_N
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MSPCZ8X$-(."1+O= S&?2AQ(\X "T6 ,%.F*:TD@&;UX106ZPK,KO3O1T%L@
M&U10G-FHT@ <N3<'< 0\"4@@ Q?8  '^P.J.Q!M-?RBX2130F)\'0 7K!!%"
M2C "\=FZ$VL0^P9D;LG<*& V_MKDIC/0!E_'H1.?>/0&"J9*]FTB 1^8 R >
M (P3MX3L&#A[ 60R@1SV(0*UJ#I%)"!FHUO2FK96C@4TT :M-]X3&.XF P"8
MF;Q#FY<4&=1G0'X "\3G#Y;'_ -X$<V\LPJ'XM3RLR?LY8@DA $TMG%]7CX
M,*D GI'O"&7;38&2R%DAUG?[&_[8E0('C+O<O&"LI-:PB8AV2X(FH+<.$0 *
MB="BSB9YM <4 <BHW*_=P5]01!T8@&(A1!I9DI:UQP=X%#"\D "$5T=   :T
M02?01<GAFJZUF ZUG:R-( GNSAHHSR09W@5XDVKP0F)\A@$\4D)80++=041
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M=E"(.TV$ 2A''# 8B_7!'TB  _V&'PC 1<S!!'  @]$!@R%;>WV  PP& %@
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MH#0!@"W$P=O@ 00PV'KF@2)X  #\ 2D,0&-@0 0\F4PIQ[0UJ!L,P">,P@
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MK(%P*,3%9D E>4(.>0<*D()WN%9"U,'GN4%\J  RC0+"*O[L"?0!O+9$'V2
MVDE0#UW !4Q12\R!""0MFU2&)W! !NQ!'#S%SUH ![!$')2$I&G&%OW!!F#
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MRAS<01)5$AUD+!X$20K(0L\622C4@N?&P0580.AV4T7. ?Y0Q!UH@ <H0B"
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M<.6!:DOI)J"Q1'""!81J>8"[N).[#F&,!<2![4@$N$M [MU!EG(N(%0 !5#
M;(R"!A0\R(N\69S[,$H$':12'F3 "VW /7EK C0 "@## [B!![#\;\B[M>_6
M NS,P]<'P4= VGZ QI@[!<S2'X2\!>#!!O0[@OA!U5N]]0)0/U%%)P2]WELO
M(=Z]XC1 TB\]1<"!R6] RJ^\!;3\SV@ =+CI4TAI7FPC":"  SP 3-L@!DS
M4.#!+*$ 7$G )H0 7684U#, YVY"T$O T'O Y!M]2\0!MUN 3TA) ZP98(2\
M!)#"S@"\-4T]U5/NX/U&%N'="?Y$@ 1\@&^X/NS_PAT<V$3Q@ETF?=XTY>^7
M1\D[289^0%;P0@F070F<20H\9@9H2"A@  4 S+1L/D#4^C40F(H&$.)\Z#0*
M Z^!(O;\VF0!@X0XOWAYV)-!Q)P%##;4 C9"@H02#E'$43&A$X-0&S@-K)4A
MU$";-W'FU+F39T^?/X$&%=J3U@<+HVH1^#.0A(=?"2:$JE5APZ\X"3KQ6F-@
MUJ8$=8!U(O"+3@)/O-P8H!4*P A9H0Q<M. 4F(0YOQ@ DG6 UX80 ^LPL G,
MZQU>G@K@X06(0$1@OPA_!48G !Q:>02$ M: #;!1#.[<A* ",LY0 TB\C?OK
M EV[O_X*;!H5X$*=439Y-4#!:Y3N7VX6;*)EDY:(H[0<5/@TM6H<!J. K8GP
M^":&$;\\</@EBP @G(]/5"C=DQ>"BZ,2C&+K%N[%"AIJ>:J00%;I3P!$T(H3
M('\< KQ".<"/7_I X#;./ /-JN!^L0"%7T))P+O' C% H!$(\.27%<0[ !!:
M(#AAEMPJ\&0J[0@*Y"L 45/M+@1[JV.\#TI@S;6[G-NDEL(.$Y#  ]ZBS8[;
M!N(E@?/28RNU]GZI( -9.IEO%N*,&X67!Y0[T:H&H%M#@L<>Z\-"G4) H ]>
M4$C@%T\&Z.27/ 1K(X)?.B@@!4XX 8"$6O8C03^U@#D 2?[UVE+MHM*N.LN-
M U09Y0$4ZBLR#@8IB^.R -0[H \"$R"%H%\PJ& .-^*H8(V!/+! %EH\F."7
M3MI\4[ X  @A#UXPP""^^2+%Z,A?T-,LA*.H^^4#$W[A8 -;^OJK#08$*D$[
M"AZ,T+MAH;-I#05"*44$ #;I1 !;!GK@KM6"Q:L!-SP)!EMC-^#%E@U$2-;.
M32+DA8._?JFC@:$ #EC@@0D>&(6J:$$@D(%,^&N!/ :B0P*\\"#(#5F,=).3
M!6AIH.+'*FA#%@,BI1%"AVBQX-2\9N'+*X<L<.,F6[#"KM['UA /MYK?@,"F
M!A3)X]_'XICXYU.+?<P3D@<Z]O[D7U(^-8%-2B' 33#)^G>@30SXQ0\&DOY%
MA:IX>3AB5QGX&)@%-K5I% 0T_(.O4@;8A,P+@ (0LE&"&X5I[%(8.=(_QASH
MDP-*^864 VJ2A3X1ZG5H@S7V^->A.'P&A &'+MA %F" <>CG33D0068)Z/AE
M >\F> ,CL\DR>B":W5PZ4@_6$!HCJV0W]H2G4T[!ZP4>"Z9F#R+_90,59(GU
M)KV!(:5O(%$-O(#!#Q"HM+$Q8@#BV"DNC>W2[CB W)PVN ["!&JAY39@]E"S
MU&2K6I-ZOQM?P-.:/.O[;P]J1)VTV<0"I)$ '$KSF#]L[A<]^UD@1O 7R?V.
M.AEH0/X(LM, X9'" $3BQ0$VP1O(Q(\L"7 (7 ;W-XSP+Q0+&% *ZE<:#ZB@
M%@9(W"\.1PM93 D8*;! @SP'.H=P[R8*@MK4#B>Z"82F)A!:P%(6(+/'J" #
M$.J@X0S BP_4+U]_,&&#VC">@HV1C&4THTY.H &H'6 IORB!P[Q#%@O0X@!7
M(\[4?L$)ERS CB< P2@.,!S?O2I5(GC RO[@N/HX( ^U2$#BJ$.+FDE B@0"
MVQWMY@;Q/(8!FU@4!BQ@ 0E80'1-4I]-^H"O! C2:9WP  8,R8:GR&:5.#E8
M:?8R"D LH)0#H6+WXDB'"M!B 10()0841)W];& #&@! Q?X* #'J3&86;'@
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MT@\@#:4%@NH!X;7S%PW(@T//F%SE+A=@*%!C8-OX1M49]2D3^L4>,,;'5RT
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M), #_&\#!N . "G ,@ ".""*\HBCX,X#'N #0B %L$("_ #O!B($L \G.&
M[@(%&/X KT+@WC@@ /* #LCL%QX 8E1O RI  HC$)DK! @Q  CYB*39*=)Q&
M"JG0"C?A 03M?&X"#QB  R9@ A(G#XKN)OR@ "J@%GP/"#$  CI@ 19P(%"
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MA]M(3KA@0QFP,!D%*QT-DA LD&QXB7>X&0M#A!_2( 4-.MQ4ZWSUM1:>KE/
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M6)&0W3KXTHM,55!U412_!!GWOF(4(@D03+3"&7 )F7'W39GBTA'MF3%1GPQ
MO#)S1_X;)O1V$Q4Q#(/&QT712RLR(4&)\LQ?XOUH1]AU2AE1@R3#WE5!7X,,
M/537'M?T(BA$2L12-I2D4T0"8<&!!=BP0!3/6<D'IVB"$2+Q"UW(Y0M&ZZ '
M/PC"$(IPA E)!,*\DR(A),0Y2^D(#"HQDDM\Y@Q>NT$+:G $V=1@%2/IQ0Z:
M] LMM, &9_O,96KU($M0XC,]N,@+>E0K&S"'$09)S2UJX()!6$)!3)A"Y5I
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MW%8+I$O@:70SVBIKN$.VT0)J47])W5QY-2\\T6@5T.'>\N8N*0R @3[\H00
MV,.]A1:'!EQ% FYX>$(*?A5YAZ(#Y7:VF+:-\5_0(@!]P$JC4X !MC2: R(@
M^"\X<8 $R/HKH1@ +_(P I$?H-4CX00!4MT68"0@#Q;WN%<:W>@-D, JM#B
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M%:1P?OXO& B"!PP<^ N5EQ 7>'J3QPNW%X!_L'7(EWV\$'G"!GX>=X(!*&O
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M"]!L*-!R:]  ',  FS@2'*!K"3$!]N8!$/".?Y 0(P !(=  <? +<9 !*A
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M;5 +ML  'M!H(K"<X)H025B85]$'B-ET,$D+0VF:MEF2KN8!!0 ,<0!ZLI
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M2 ?*B^L!2]=H(: "I5  DQP*?4  M]=V/3RV56?'OP!_&6=^@GR3"%T'7,P
MS9JK?9 '51<'46>SL88 -PG.@: ';_<+I,MM#PVP-#L2#T!TC=8)DDS)?C
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M  )YDQ&P@J7FZS:M"@S _0Q@_:,@ !G?[\-_T:5  %)X?;LLZ@G! ?SLN[(
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M!E!< X _@($-&%HJ:!$! 9=:X[I?\#B ESX&\.27/ " J$%:""C,C?]N^NF
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MXXZY5($"!A1":V>>>^YYDPH68* !.TI:PP$)),@I%%$/K."K6BB@98X)3HB
M@1$J<N,!"U#(XX%--ABH(J4F> "Z/AZ(8 ,5- 0+CP4T]*2"!+/^[(T)4(
MZY8L&#O)!\Q^HZ03+/B(Z;WR@(""LR5[ ((14&B1C@8J>,!NL.XXN*05')@@
M@LA&L?Z@ @WR"&$$/#PHJ9.D(;" %D\& *4D7B+H9)0*C$+!*4\DF( 76SQX
M0 (,ZJ+C@Y3\)D@/#G[QPW4/ )F@CC6<JDB6")Z<J0\(>.E$[<B##85Q"MC
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M!!#(#_YS_=" W=862_9< ' O&@(#'&=G?P1!!<RUW)[%MKBG3:B/!%F13B"
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M#J ;UP.!]'D5VAN>6_,$.A":#M --_  $"0(X2.^))FB"&B 6RH)6OB !ZB
M. @!A?B#_)L C0D!-9.%#)"%U5,\'?J /M@ $9 %#[@#"\":CZB%#Q@=)?(C
M(W* XM$)/,* &)L#":  E1H+%<# "*C!)R$!W\D:8&" B;& KDL!TUL $1@%
M#V  #MB+6@"!T3$!&?) %<S"]:D "]@ G3FA6^NB4=A ]>.%$*"#<8J#N6$
M\TA$"I@ UPL!._  ![@ (K2 !8B N# L#+@ ]0L% JP */X\C0#"@#EP@)52
M!0Z   AH@X7H -8+/15P@_H FUKP1 C  R8$A 8HC/$3@:^@@_&XO_R##D-A
M@-RX@ 2  .K@0=;3&%[P@#[@ -5I$$I4OU&X %'(#2[\A3N8  P00.-S@P:@
M@%%8@>%!.SPX@0%I@$5Y %5)1+IAIK (A5E9 5UT@ <0I(78@*2!DU_(Q?J
M@-E0'.P;0QU"@0@@OZ] @;@@P#\,00EH Q'XM,(S+5Y #,L@!5XH#UK0@P3(
M %XH 'U; $"8@PC8&%6Y@P1 D08X 5H(A09H$0XH@!/8A,G0F0:("Z!X@#6
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M5$O5%/X+V)1-7C  3_B0U2R"GM@$P!#*DN   ^B#47B 5)&%!8"(]6S/N$@
M^#S.-A"[$5"=-D@ XT26R&B HI0(W)2 4/@# ZB 4-@$ >@B![#-4&  I)P
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M9?-0Y5\P >0)!0_X70<PC0#1"92HA<+Q@$$D9!/^@S<X  ].OT!^W*V(@#R
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M[HQQL!9KOD  8-#GBO#:OF H!O"#H5YR,8V !?_(O5/J>!HA@N $ /"$4 B
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M?\E^_W<!*&0_CR?LL8"M_1=@.))F'D6NO]JLMO6X83VA$JT.H)NZP( I(1$
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M2;M?_YX^*<^\XO';WW^@Y_N/3[P80<8"Z#N?K*$Y $Q8)TYCP$X88 1TX("
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MI.\>T(?W1: -2D6K*.OZN_H,MI\:')P6[^  /U4 !8D=R '60(M-$( UFQ@
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MP V:N@,@[H"!^':"5V(ALW@2Y64P#R1%?8JL7#QA84<C$$D":<,#?G'JUZ2
M+A^8@ &J\P"=:FH$Q-G3'PA BUK X1,(UBD?OAM>#7- 3R?6+R\J?.%/ 0+4
MHO[%!RPC4 K$(7$"Z7*R^J#;.6  !7]@ "T\H0=>--@#'I)/'-:<@9,*Q!,O
MAH.F-G'=$/PA!0GPP%\%O0;]R/["#;(8@1\\48<_9  %P-A#QD4EZ#?@910B
MP "BS;W<DP,R)G,(A 0\((L0+,"R<2A !CX@B\ $H@\=\@1#JO.&!>1!#PR
M@YT(X 8]=   S0S @AL0 C^4X !8PD@ +N"&.HCO00R(-R\2XH?PW;<"P5D#
MT(5^FC]4U@\8J  MUD>"DG4H#P8X#>IXD8 (Q $/!PB.&^J9AP5T5@ JZ@,
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M+[Z&"/0!VGW*"-"%!1AD'_0:-*:'9;2& YG(*)S _D")+;7&-68 1':.3X3
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MK_$D5=A%8BA$!<40T$(%6<8!(.1!O?S%?/Z"*O@!(/@!,%B ;/2!2/FDIIR
M\Q!DD$K D#8>()"I3T  'FR ;K87+UB "&Q"'NQ!)R2+PE;  LP$+T3? GQ
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M!CP MWC" 53 "JP! 9P&K?E$"?!(U$7&;] !5FOUEXA '#P 1/A>&=/! *C
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MD[' A("W1PAB1U?% EBBH/H;B$H+03IB/'H;# BV$WO Z7J&E4 ) !7 GP"
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M#3K! SQA%&1S&=U@%#J! SR!&FUP W[A#= O%$;@#FAA QI5#_0O0#@! _#
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M&@!HI6\#@)0@@F$"^F_QD.(N5#=\C58FB")D)2 R^?<"4E3R^/=^HV* ?R&
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MB!14'+HEU(!)UOUB05._]#$6""D!PL!6>K45QTB\'+!)'L+5MIL?0=7! $F
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M7Z>3-$KQ'S3 (UH+/$ '5 W\,0<;;,01R%@7Y(X! R>014&D!!4Z9& #'&A
MBCY0/LX]Q0VCF@-;?I$'3E4 0A0T"@C"Y@<4_2(#YTF02290ASQ,P&H4X%D"
MYF<2%,C*=+]P85!D@8!1/,ATJO):!>*0@:Z128$,,-GD,, !#KQ)>Y[YF.,@
M1R4$6$X%$P10+208%,U$S2DC48'4%.")-<C*)+:3'O5J 0P&;JYS9+D;RS*
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MJ 'EZF0#<#R3X3UW1+PPP/8R)>P5(8 F2)8%!F#-S8) F"2=H'6CWC!(XDR
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M'5(>M*"!@\<CG9 ]-_AZSC4"_Q> \Q$ *>$!#$ "@8@RG1%[!Q "'&!^<6
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M("NT8-NXK=N!/N@JD0 D<'\-8/X?:_ 0%-X&$( "M)#C$[ '4-8E/F[B*W(
M'A "%T#D$[ "$!!S0=$)':?F$-#;B.$;(B "R]$D$N !(F  )5 +&Z#C#@7B
M$;#CNJ'@)3XGO+#FOGTZ83[F'B$+$F !(S#<34(S$E"^"7 "H Z6698"&H#H
MO(#JN>T4)I  #V"D+W%)0!'E'E#I/6X!)9#;W.[MXVZ()0['00X"0PZ612[?
MRNZ$]ET7GD#=UGU?>$#=&9 !#J"1!'L9%Q,"$S(>OZ 9LA  &,2U;9$<?D!W
MQO$? 0(("6 2GH!!)K$&F"$+!;!OGJ 0B<D H ,3*?!"(9 X-^3<,+0!=!H
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M+/KS"T",0 ($T$H#._# YX!-*=SZS >P8K\*!., %72*V]QPPG?F!S2GU ^
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MA0H"$ =/#,!';&!,"8+CB0IP*! #P$,G/   6>2!MZ.8@V#2LXD!S&$4:P"
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M@ \(A398 4#8B\_ B1]<HP^A!1+(J3ZP@ FPNE^@.!HLL5^(1+ER"U+P  Q
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M\)Q.\$3/\1S.[;1.]*1.ZBRCQOE.[UQ/\[2.[I1.]JS.ZA#._E1/^US//Y"
M"OC'Q*C/ ]7/_?1/!%U0!+W/]-S/]G30"8U/!N5/"$U0^HS0X'10^*Q0]]S0
M^?3-$4U-6I@@$D71%%71%671%ETH%4DH%Y71&:71&K71#Q5-#U5-';W1'O71
M'P72(!72(272(C72(T72)%72)672)G72)UT<R'0<7APZ')U0'I6./=BE*F6H
M])(.6;!$*QT%1832,C73,T73-%73%-T$.G(<A@"%C/I0+,4SAJB#T. ,:LI0
MZDB WD+._[&.U4D/.EW30C740_Y%U$1]TDY@ %ZH!4_(BYJ D"%Q0TL$,O3
M*NWRA#"=A4ZX,V# /^"4U(5 CYIPPT^%1:):"/S;,W/Y#?&SQ ?@#EK(G'7$
M "MJB%  SIOKJH78U#U5U& 5UF$EUF+MS4U -0EX  E8%0DQ"#\0"$!X  R
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M5=NU95LD[00$^(U0H*.'4C*Z ($':"^/0("#& G@V(2JDH5/J(4VF H'\ !
MF 6^J!)=?8ZBZ,JIX(#1"!Q>(!=:((LX.( YR(WGV "\@H,'"-Q:8 .Z<  ^
MP A>"(67HJD#F:5-M:';JK42(3BG^ 2QX*FVQ=W<U=W=_=%.\*2Z0 !2R(#+
MX ,_X85O3  )<# #" D]@;--< ,$V  JS("(.J0'.  /0/Z/)UF K,"WRC$(
M/J"+&&L(RI@#@;!<,>+>!: 6MK@,%5B S<. #/C"!S#=;]25,U$,+>F# ]"
M#)C?#2 %^^ Y;'J:;4);WE7@!6;@!D9!G8A;L:#;GGL 7G Q#*C$CD@@OZT#
MKEL(6V"]NDB .+@9@UB0&W'<GIL*\@T<!#H+[$@*4AB2$XZORWB#=UF(BVB
M0.B#\6@)K4B2G-"T37R.9;HH#_8$M'+@)6;B)G;BA?*$ /A)#C@+$4B;6KB
M"F80@P"!2B2 B^I;!NB#IH$#C,  P0. 4VF .[W57[ #\TH/N@0&6K@ NLB
MPI1;!#(-C9HJ +93.&8(#"A,0_YY#%[0Q75Z*8:X X7[!12(@*:P  ]0JR1J
M"4$D9(QP1:KBCB?FY$[V9 ;VA M8@0F @ I8%71]@ Q8 RU1A ?XQPF0!5*8
M"#J("8.X  W9! F0  C0WI!@@.;\ &"0!6JM  >8VKJH@ ?0E0,1 0 <A0@
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M@=R>;%9(]W5O]W?_\5.( 7K_A2\8>";8[!VP[5]H!"'X!3?';AJX;F#'C%.
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M<%3!9X2!Q GB#D!%$ "%2F3%%.! 3V0DR,% Q%!5#*!&NL"D%48!$'Q$)<@
M,-(6).D"%Y#C(1C"+P@!>8F!9F E#L#8%OZ"N87D2);D4;2 FYG*,M$ 1A#"
M4RB'CZ1B3Q@AJ9Q""[P'*\# +I@".;J$?(S/+QS&9@RE<GS!+[PC08A!$O1"
M#+A9+G0!FY7C*Q5""\! TF4%.V9$4A#$(5BA#90![3C"#/[\H@_IP#X.QS[>
MRM=93!0,@K7(8:F@F0?RR$EJ!F>X2R,(0@@R 3*M217X7W AH48")4%<P6<$
M9U:< B.$@7"P4\0812IHQ_Y)&&FTI"$0V"$ P0-]W6&1!G3NQ")8Y^99X;&
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MJ)1L(O!(J1)X #@P\!>$P$IV1 Q8<!>80 AL) R 8%*4  B$  B8XA7^]0B
M0,)VQ!"J;!'4"1(BHQ&4[@D:07P2ZTRH$19ZP"(/P0GL8Q?$X)RL8#X(5C>
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MTN,)DB"RME@%>Z!J@&"Q$(+1R/XRNYNX#"I"P1?I3VOJER"\$5B!( &E%6P
M,7P,%Y);:U)<OJ=@/B9AB^X[Q].":<[ FDHD!AX5](PO"72Y!8(<%F;@"AJA
M"F! E^,,]&# "= G5OWB"AZ!7X, %FX@R(4-!KX@1*H'PALB!O0JQ8B3CV%
M$!CA"FQ "RPA!I &"K:@*:P\#'X@"'(A-X @3WT B7D "A19*%@AIWXAFUT\
M!GAL!Z3\"H0"I^1HJ4!5"BQ-QRF=+? 8K[YD%:CJ$:*D$&SLDJ-@;?YOI)3
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M(&LAL(%K'OSBE6+4KQ46#3;$J/[1HT*! ^E,&,D0I<&"$U4.)+4@8AL_O_Y
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M[]<BJ! *'E#QPGDP*.5!PL4"W8LK0M260(H$E\VH7XV!C + !FV<$, FHVS
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MH)>_#.8O])  .L2! 'VS8A[H]XMF/C.:H"! !A*ZB44R\!<:\&4!T[C&.GB
M ;4 A@0ZH(=:JNLB"YC ".#8@5_T+P,6& 4>.AB'!02G B?XQ1SXZ<]1>2(!
M(Z #!#I BQ.<,'2?X$";1D$*7^)A AEHR"<VX$4P$D0/"/@-!"I  D)YL0X&
MZ"0'#D +GW(@J"?IA $0JH>%D. !=5"! 3X#5P_$X0(.H%P<ZP", 7B"#@%
M5P,P(-D$B. 7%0CC"4*  @D$P'5'3.)(%CL'%!C@/")H !U68(!-[),@M2
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MMW0 -#%2,^?Q-!T0U/2U!AL0![@]$G7 *K3 !W 7;')-V1<1!U*R"7*RL[0
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MX \=%A "##S@5Z'< -TP,('3N:X##0A%+?(& 19>LH@2V00#3M U.RS@ QI
MP!HVL $"5+!'OVA !Z!$ *_U,H2%]$O_'O"_!,AP @E(SOX*$- !18)R(6YH
MV]OB]HNY;> #"0C+*/DSAP4<T +3LQR4!N"'V2U@ K?[A1ZN^ $'V,8!&5N
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M>(]QPP5H\0"GP@4/#?C%+"Q0@0'W80Z:M.@(4FL1ORXD VR0A7S)15_[6@<
M75P#8#_ GP:8E@[AU6XK*[*!D<:8(."]*&>I=)BH#F0.,-NO'TA!5EZ8]2 5
MJ"!;U?XR@O+U;B%']JB.26<+J5I$O[]P &, <(**S &R# $ 52*T&YQB-05G
MM?*,T:I5+G4U% $PK6A'(8!0*;D@=$ J09::,Z?JP0"N87)Q5LI;_N14!5LY
M;$7<<%8.F-8#'F5 QCZR@B6JX,,,#1G)3E/0]B2@%A;5@(]^08H#=P"GFP,&
M!'CWBPG@(8Y)^<0]?[$&C-W!#R6X44$V$*2*O#@/#KGI1Y-:A^ E0!$%:0 ?
M#&*!!ZPA$ MY@W 6<@<);.*DS#8* @9B4@S$(5X&X00>0M#5.%  +@[81!S.
M^A=_+<0"+ZF(!X+T5H+$]:/0X7)V]-H&4AP@*<"0TH/\@/[LR8G'T1D(Q4<*
M4FEG$:0!?J!% L(];K06P2$;,'4H0(W9/BP@ ZZ10 47 HP%(-0$=/7$ 4(0
M!PY0('@)"84>UH!ON*3  "C03F!SO>L;/8!WQ6W/&M:@@KL HQ-X$$%7^T"
M$-1A5CKG>47:\/,3W C:TK[- C  !P)QG" M)<@)1A * V2I00&0A0=P-JT%
MH"K+:.7# FX\E^+87" F#0JJ89, 66@-$'?XPP1" (P#R,(/)!#!'F1QX+UJ
MCPX0  8#C,*0!P /(;, ?!](0((\/!X\^/';BZ!.GH-DH VZ_?3?9='P#8W"
M +(0@0I&00 ]Z&'MM?" J<G.Q/ZS&R#W:V^[J4TJ]X'P=/!_@):[)>^O@E1@
M=$5X][1VZV=Z7W0%H2B VND@ "EE6?EW ,0$1# *QQ#D#6?]!8]E1.$->)2
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MD? )U 3,@!.PE=&,C$WP+.Z##0*HA890JN=A*U[0 )PQ@!LL"H)PP%$8@%^
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ME 7)]5@$ -F?PA :R8#G04^"^/XA1H6 E-V LZI:+BD 5#$ V_-%/B5>-C6
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M&  24W@JOPI>F ";4('@ O"N"(&7$'&AB(.T"WE4[XH*.)Y.D("=Q_4^_P,
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M _7=Q\8$"V" DP2>S($  Q?00@L'$?P7RB]S?.#& *&4$(<L1HV)@4>C5/#
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MP*>_. @A:@W-L="D#T#<AWT1_%+"QP\DH$<M8S:0*D3!AG@"B0E\T/ $%$#
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MQQP>BR+#2??!+Q0%.!#:UM" @N0!A@IUX2S*:9 (L$Z=LL@  N 2B@&$(!C
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MTL()A,4/D'(F*"B20&2!@%'P=B(-.;=3WIL'3R,41>6:"C))F0"IQT0J)I'
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MX3PB&8;C+YV11[CB3=2B4U0 N67+WY 2]54>"0#()H3"'!0 +VS" 02#0$
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MD,*%-,0?#( 3(D1^ NA!3,"T'!"X0!XY)6 %C$*Y0<M&9I)!&$!&LBD=T((
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M[3I1^)4$@%"J7@ "0, "+ !@A(("_/A2N+JI5SI1T,*#[/XYVC(C+XR  3P
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MS&,LMHTN2YV@0 ;B(*F!R,J-*?Y5Z4I9VE*6_@4"?\- !383@2 :I0"O:5\
M0M"&#01@(1:(E3/=PY!.#""AK/M%I4(Q@#CH@00'.,$F"""C#8C@%VY P!SN
MD("Z3,DY3XUJ"4!Q2X?0H@('0,$:(I  Z&S" "O8@P5Z>52K8I6/R/EC01[@
M@3Z,@%E+#4RH1M '%31@ J.HE+ ZA0<"M' # *BE0TH0 !&PX:>UH45?_[J
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4#,>0#,O0#,\0#=-0#==0]0(" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>cogo_0021.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0021.gif
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M[^/M]NCO]^;P]^GP]^SS^>?Q^/3T]/+V^_7Y_/____CW^/#O\
M
M
M
M
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M&7"00E]"$VUTLP1U@D+-Z660 ?X:(T<5AP<9;-!"9KJT< (+K<RQP7^?/;!
M >&QM$D#"QSPP4";J.!S"+@2Q(G'&8 0!Y%S?+!U"Y^(=08**KC21@88M- 3
M&AE<P()ST"J00"5NP*Y"9@+M04(&&I1 [=1A7^*!U&(]4  !YVU"H *VD !
MB P44&>4N8!*@,6Y;-(> F!1\.=T+(& P &'A0"  0LT0$!X)_AF,4M](*"
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M"  @0J2G@ 6T( \>4$ !DM.*!S" 1!Z8 ,5ZXP'S@6@5E_[H5P(28()G.D
M"9.7,=LPAPIPIU=M\%/,]G"P WQ-8RFP11N4U0;:A&!]X3$4 RQ@AS4P,P"X
M"L$!KJA,BA7 !"QZQ; 8D!D,D+ %EVC!GSB0BS<00 $M:,4>R', W.7B$N2B
MCPG41QXVY.($-^V '5Q0.0GT1 +Q*U$"],22=CYNE,'+T@$VL0K]-4 -=LB
M @@@)/&QYP1OH  " .""7* @J4LE401LD3L0<4">5C+ !@S:  . !9L'.,$9
M(+ C'-GAIA.(PQMDE:]<E,  #T# /DL@DQ-P )P5\%HN,G E<QG$%J"=B0I*
MU(!<V*$ "IA WZ0'3KAM]DKA,?Z!_5!4"0(=X#Q3/)XW=\O;WC8$G!@84T]8
M@K9B":054#6 IIAI "%QXIT'X-*1ZEB)313 2IT;+0)H:@%B$>H2Y52 +M*@
ML=^%[Q+-:H-O4$H+"! H,^HK@!U:,3VXO>$ "+ 0"/#+ 9:T +\;(,@JP/D
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MDP65)EO(4P%ST#-=Z#*@;ST6RPII0PO&50 +"(6S0U:(@OXE4"(["F0.J)V
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M+#%:!D!$>T  8(D&:&! :0<'EID&:F!0!7 \^:0E!' !H1D \/$&A]( RW$
M&?-[388FZ-9D>24GQ%)#0D,!%/YI 20@ 00  "AE"Q2@,1/P ;1$5E/C)PSP
M;7-" 'T1G7%(+']&FM%$G1]RB@X0  T#5(+" 2*P(P 0'B2P/HQ2$"H EQ.
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M!)&=S7X  U\ "U" TK?@SU+0W%<0 X9@"C>0S4&PW[C0 TB@W<%,$$Y0 [4
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M*O![M1H"FC(3$\ XP?-G<W BF_Y D'2C"V\P B[@'(5P-7QP"98P 1Y0"*[
M0' P,ESX-22 !EUF!\@W$*R@1:Z0^G:P!Q,  A/V9YE# @;B"BY  J.#E)L
M5K7__P"12^! @@4-'D284.%"@AMT&=R P<Z:!*[V/,C5QD(E.!5<79H HA)!
M"F?VY,EC*=>F!*OL2,AU28*=/17RY"+!H8\*"+E.G!#XX8RG"1XV7<SUX.:F
M!K9.A+C4P@/!$B5R/7SHH84N#Q7L5*KPX5(E!S$?M,ES-A>&,Y<^M,BU(4*)
M/0SMWL6;5^]>OGW]_@4<6/!@PH4-'T:<6/%BQHT=(_Q \&&N#&\$8N!SR4)2
ME;E"J/[(Y<'RY%P6*'#88 %N+C@;.%S*U0&-0#@9.#VP)3"-K1:@<Y68_:%-
MKIJYCI#(E>;$*@>O!$*X^?"#[X$ED*\)(1#$\.(@S@C$9*>VP$X*='U@<?7Q
M>O;MW;^''U_^?/KU[=__BP%K+EMPXMJY; ]+,&!NA!!&\""-T(8C30(^U!M(
MEP6F6FL# ]&3(X.K='E(!=]*^,X#-8BK(*8)<M&@DCT:* &$$3:(+A<5LN/P
MH0W@4@,$[48LSJ8-<V%A A)"$*$#5SZ8 T+\EF2R22>?A#)**:>D,J\#8ISC
M@/\$RF"/2S+0Y8%-!')EE5Q L(R@">HJR 45//"O,H%L:?ZE$I@$:J.5W@0*
M(3CN-HOKC0URJ:0G@5;)[:%*$/ADH$T.@*V-[#QC@\1<.!AN)3O4B$P@3RY-
MLDI11R6U5%-/1375]]Y08 U+WC@@CEPH")6"E#!B(8-/+H&.LDH)>H $-]1@
M XU6+M)E$P566=&256ZD3 57XC /#@@VR<. X#PXUM VM.526CL>,',R%1J8
MPQ(X%/@N%S4&O51!I/1HH))5*F!!EP;@:,4%#-8:356!!R:X8(,/1MB]/3S
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M$,(7:I&+6T!"GB(MZO%H404G/*$)4B"$1S%:BT=0%G.XL (4_"N%0 !0(*$
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M Q@(!4B(@3T<@U ,G;-"/#D+!1D  UR@PEHP!!V4@JM3@A[0!4=4@E" @2[
MA3&*G;.R)QGP@5"@A1V8@4&H!5@8MEQXN%-  ANH!5:\NOY;!&7L@7I$QUSX
M@2&HA=D;!$7C($6H)QF0 1H K%P A #C0$5 A!A0 A*C N0;.2BP 5S8+#T#
M-QJP@2  04"  4BHRB)@2>Z#A5/X-;/D-S]0 E, @G\TA1E(PE+1A5 0!$!S
MA%K(1*@<0B<4MQ@(A"NX@5FH-R$ @KFBMQ^8G1Y @H&@!?*#A5L(A1G LE+
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M9L; :+_X:"B9C/(*Z>(I:<-HFX,XZ<$8Z=A::8U6C)<^G8X>+IF>$IM&C#O
M@ JP /_(A188B8:N!!, '-+8A Q0D,E@ 0_P@ [PF;<!Z*(6"*"6ZH+HA!#
M /_ :;2IF@JH !5HA5S8% BA!1'HA*IV%PSXF5R8 PY@:A'8&CB8C1\1B$M
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ME6" W/@+5VB L[8$!!><#+"8A5#S3Z&)7,B#$SD(-3]K)DD#!A#P.T" X9"
MAQF(2_!IP8&6"&F (\@#.ZB#/6B%-D#SP,@#'2<(KX 02T" B<F$$ECSJW@
M +F$!OB4-^APA-CJ ^CO/=" N*"#.6AMH!F3F&@!-4#Q2ZB $YAU@9@ 0@?S
MA_'M.:@;.%"!&M^$HU"!,M\ .N"/-U !2P\*. B3/9<<# "-A[ %"YCR$[@$
M%"CS2\"*.$CVJU"#")B#L.X0Y%@=/#"/59AUW_:25= %V/[( PAH 4[(A4Y
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M&^B"'IB "AS!&5 4S(A J:#! Z">)537'#")U=E"&Q22!UA@YI%9))X784[
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M(G&!S9I+3(Q0"7-=B;$H%Z093ARZ#9D2ETBCI[:VE9HP8NF\KSG^0 0+U\!
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MB,$,@HCE0&> BE#4LRLZL]D+QEA"MD4B2,YAIB+$$#.R_J$47BK,2UDBBRM
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M!PH1 U<C>4 P%D-1%/%"!_-B%J#E +N'%JCN1M9-&461M&[.::QQ&[G1)HA
M8YRP&\4QG@:"56P@0L11ZICQ2IAQ'>UB#F$B*<*Q)9)"!\,1%D+!:=P1#G\P
M%]I1)>:Q)=QQ'?=1)I)B%DB!,52B(%.%(<?1+M3Q'R-J)7ZD'S="'0/2'PG"
M(6%"%W10(EMQ(Q\R#NV1):0N("W2(=11(^^"%#O$(U="(D=R)FFR)FWR)G$R
M)W5R)S>B$TY  S(@#3YR(6,")OY78A10( ,T( W D"4O<B#7$1<^\B-;H!54
MPA(^  ,XP XX@B,ODBCSC!D] 0VLT1;4 "A/H!,(H@TJP2(V(@_@P"E%DB \
MX0PXXA+(<B/0H"TWDOH(TA_/8!6(DAGG@ ,\02,WP00$DR#68 \VLB!E\C%S
M814$TQ-8X"MY$B;R0 54P#%SP1,\<R,J81,PDR[10"T)8A/F  [B  [:X!+\
M4>IL(0_6<31=@B%U(0]:$P[LP"I;@3;=,A<L@30S$[!<80U00 T6<P\$4P<[
M(315PA;:( \N4C?AX#KAP!8X1 =I 3A-,B9SH1/0  7:P!4XP@[>@"#04Q?N
M8"C!DOXN&. $*B$/)* #*+(T#3(7-D$!4* /\F "-B!+7H$!U#(IZ@ !U, 2
MX" !VD N84/J]D "E%$7,@ #\J /2F !U#(#&O0?S\ #'%0D+>$!1+(.2'0C
M(J!# ?(V&P VOW,5&, [<R$/ * $-!(#5/0N2* %]+,%O+(X=0$$(. ,6F !
M>+0-,N K2R!'+U("2J Y<^$,$, $0H $/& .<J$%['(3&* $I<X$F/1';4$!
M-( $2* "), 6.@$#M/,K0X!'F[(XZ\@2&. #U. #&  V)8 K-\(./B XO[0"
M^-(?'R #2$ $JE0P_?(]&5($Z" \+8 5:F(.%* $TN #%O[ ,^V@ >+2#AA@
M#E8! Q;32M1@(UR! C9!%S;!%>A ZBXA#8"S%8C3%4AS5?-@#5!S(S! !332
M%2H -G,S#5RT$S[!$M# 184S#?2 (#IA%3:!.G5A#M0 -E]! G+U%13@#C0R
M#RJ (%:A#># *G7A$M01-E>A$_#215O!-0^3(/"2.G.A$KJ5'W-!#21T(T(@
M#7*A ^)2%_8@#3PS#4Y@%?9R(S9!#>+ *BV! CCB#N:5("Z@7_-@6DWU#=J@
M776!#MI@%"J .#>"#P"6(.)  O:@36<T RB 3SL@/7/A7QU3%S!!!S=!,"LA
M#=I3/UVA$BRA%3: !#Q!%U S#_Y"5DZ_\@PDP#D-P!/HX$\MP3Q!CA4JP2IS
M01,@8%1SX0A"0"Y+P 3T<P)L(1-0TRA=H6DW8A4JP6FC\P%@<R J@"S;E!4L
M83%+("]=X4>)-DMTH0%4M 6Z%0/VP!5<U"CU$UDQ $N;M"V9L15TT!9D%EES
MH17BMB\E,P/6H"]-EG$?]VQ58A,.H \T\@T8P"I9@ 0(H@5(5W W@5S+MA*F
MTA:LUB6@]"T=X /^5 TH0 TZX$_M8%[;0 -R80-V]01:5"-780$.TQU#X /:
MH +B\@P>H 580 &6%0TLP TXX 2B= (T@$<QH 3B8 *6%0(^02/O  )$4A>L
M,D); /X%)F 56J$!!',3&J!>'8 %HG=9-8 %UH !'%,-*J -/(!K]^!AX1 #
MV,!!^3472& #U, "+K,-(. $CN !2M4.(  .5"! +V$"1/(.VG<4.H$5*" N
M2\ #EK=!.V%(VV "#M,#-N!#&\!C<\$$,H -,,!'2\ !1D MI<X./" /0C<7
M.*!!2X!R'3@7)( Z=^$!Q+,"YN #4" 71" #+B .*@$"*H .Y#=*.6 .)N R
M[Y8@(( K=9!<YZ "4& #'J 09KARX\ "1* "'/,#&@ #@#477  $5,(.'  "
MTJ 3)  %/L !*O<$*G<.*" $*" ][P #3& "W$ N;:$!+/Y!(R] #6R!8?/
M AZY04G@"+(T!.PVC+<S%RQ8)&VADC<@!$1  OXT#T#4%D*  SS  W2A#1A
M B)9!R%@4 D"#@*T$RI ,&?9 S[ *O,@D2N@5%5 7Q5X#N2  28@.S% $RQ@
M?%W! ER!#RI@!"S <*5.!4#4*"-@#B[A 1R@!?8@ AY !;)9,$D@ SP@ ]22
M>D7  F 3#4J@9VEB%8S9 R[A$@Z@5N&7("K #OH  WX91#. 5_&8 S;B$AC
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M!;A6.S_@#5P! J2VAQ7:%12@$C[ #M3@='-ATU?!?$G@@#]A=#V@6T% 14N
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M !NK;)"+'E!7$"G+@@\>71L,_-P 4V[T-1[?(:31E 0G3,#L*A&,9)0!TTK
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MX3&ZV 1V[! 8./2E@SR:LRM=@>,&^:0-\MW$&CB<E$\@P&TV0<!5CF"!5WZ
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M)J"&$)CWJ\-I.0E*8(L,N,8.[9JS@G+A 0]0O28MP$ ;,'"G$V @ U\F]O!
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M4 (AH"4J<%PGD 9VL&TA9 DH !,AQ!1'AW]0R(_]Z"#'I@%JT JO9 M[<'G
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MD N!( -@D,!!( 3_*P1)D NAT 5@[,FUK,?;:XFP8 -3P,2#S,:!(@--  F
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M6IT+D?X !4) !5"L"%A0S[!KB:90 TU0 TO\ W(L"+D "E,PU6"L"%< "58
M"6( " F!"(P]W95HO4!P \?<PH8 "#<<"E(@!%. S6*0"$DP!>&<"XC0!$EP
MW;!P!4"0WF51!C&=$%<M!%\0OKA@!DG0!$ ]!C(0"%30!)RL"%-P"KE@"%80
MOF- !&)PSJ=@"%W WU^@"$A !::<QTZX"#$PT8@  V00RU0@!%<0SG\0Q%2
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MF_XGIOZ0UC,  S^@"U=0 ^NK!$!P"C1 !(@ ">$+"Z!0"XQ U+D !#M "[B
MV#4L!;D "3'@!Z#@Z+  XEZ0%) P!3L@ S% !6Y\YDO="*D T;4= R(.":=
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M0K,^Z7.)AW.!">P\Z@.I!EB^36B 32"!-'" 2]"%NL. R7N%$/" #,B^2IC
M3L@ #" !#V ]2\  #[@ IVN#$C"!"JB =Y. !SB!2L.$#.  "PC!-F@ "6"[
M+2P@]:,Z":@(%\  #@B!A]N#3K2 V].%$Z@ #SB!"W@)6Q@!#<@ $["\"7"
M$7 Y77" /""Z57B^"!"W,\" #?[@ &X+ 1,@@0K@ '7;@PP8@0N@@UQ0@T&L
M"!681U= @$ZP@[$+@4N NUS8 Q'(!5?P  L( 1(X Z*[ #?XMSQH@#8+1PX
MOSF8QERP@Z&#R ]X. GX-C2P@ W8 (9K 140@0K8 ']K@1,8 0AP Q>P@ I@
MN#NP@ _  )"S@Q!0 0N8@$[  UL\@M5I!4>LB%98@$Y( Q?( #8D@0W( -;+
MA1/X2+A;A0TH0H(4 1$ @5$K@:5,@0;T@!;8  >P@U6H@ <0@8?[M!/(  V8
MP#QX  C8O5R,-B^T03',A57H  [  %S\2A PR5S8! S  *UT@5&[B$K @ ZH
M@'E3 _X&D("%[,(,:(, S 438+U5^( -N  V#(%MS(42R(-5T  1P "S^SP5
MR( \8$46< 4.: 5;^  /P("F3*8&F(,]T(.;TP4$, %_^P!<Q !+H ,+&+41
M6(5*Z$4-V+U.\+I<B(!VZX0 3(,'4+<.8,,SP$H]@P"G6X4&,#<.,+NX)* ,
MJ( 0^( 0N( J?(,-J B4#,,]^$?W6X,J#,->= D1 +WJS 4V6$^7\ 0&B$&4
MFX,[\#?EFX,)V+<T&,X04,5<"(&A"P$]R(7CC,=Y5,,*?8 ]L ,!<+H]J$\[
MJ$(2L$!=L("A"S2%_+=.4(!6L .@RX4S2 'N?#@/B(,\:/Y1-!BZ!^B$.Y"
M7<@%^<P%$9  =2,!N .!#+P$ 9@W$&"!5H  ?ZL$"LB%.$@ ;BN!@.1!UFF%
M!VB#/=B#$.A%$VB =D,!V0O#.?!"V+.$56  SYS 5I@ N"/3B@ !.+ % G Z
M.]"Z.<" 2U,!\ /2H3N![#N_\(RS2U" #TA4$6  A,R $-0%X.P$#FBS$O!)
M"T"#7. $!4#(-M/2;?2$!O@V#2"]BKB_7$!*SV2]Y!RU"J #><R%3_A"%EC(
M3M"Z/0B -U W0;1+AWR##-0%$4##3UH #H!-%K"%'V0X[FP#.+"#"SB!57@
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MG,=50(!5> /LA-**P .@DP"54X.8=8D+8%^>S 4/(($Y6/X#V_11%-@#\-L
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M:(!]LX6;JST&#,H,$$/U+H%'5@$,=6$D]FL7Q<ID/(,*&/ZZ-BA@_EO/-D
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MBZ0!"CQ 5DF %/F5V/!09.0!8*#  OC(&]2@5KU*5*C  _YPPJ@))#O5F N
MAIHA(6]*CF]8P/4T@"OM 0.PXP+ 02M"VC3: A[-)O==B%VBP6B2) .T  M$
M !8] !JD'G^L LBT0 @X0%]PXTY @"T((4BH@ 'D'2?E003LQ+^Y109<T':H
MY63\X.U P-)X &QT1 !LB@%$*.M\Q(MB0(PV0*+MDTA<WB:TW26H028UQ'0.
MA!W,01!9@BU<GB7T14&42AO$ 5/J29(%EU_,C9O:@O"QWQZHP0VM0MNM@K@M
MB2[4Z038AP:PC8/&TQS(W25L@BL0Y"H0))]Z*9]PA/'8@8-(ZK-P0JD #1VT
M0:>F!$RVH8:T D$RF4!DPAK(W?Z#J)PKG-5W; (;M.I:N,$FZ,(>;&I2W,'J
M?0E!>L)UJ:FKFE-#\*GFI:JBA@A!_(0G$*0KP,$;0. FY&&NQD&&[ &SCFEJ
M7(*&Q<$:7!Y!T,J4J2IM7,(;9$*NGNI_@!='N.FFM@(=U-XF=$8K1*O-58(:
M0-0EM($GM&NNUH2;VJL;- H<\,%:=,(J,(0KS$&?*JO*@%%"[ '[;4(;4"M+
MM$+#-E%-=$(>=JQ 6$)$-$0GN$&_"@0FK($<O!.ALL$<0& GB!MMG"I&K,(-
MM<(-?8*XE0@MWA"A1D1RJ,!&)"M%%$3$)@1,YJK\$=',E>/#'D4(+!,'N$D4
MEJ?36O[MU:H&UFKMUG)MUWKM\KD"&C1M2[C"&31MF=A(:[ *<NPFVWK(=&"$
M\017)TS:US85=I3CV,8%8DB'G+3MVA8%W]KMJ @NX-J$VHJ(<A %I2 NW#:N
MW_[MX!X%XY+)XNYMX\J%KP1%;FCNVUJNX2JNY(KNZ))NZ9KNZ:)NZJKNZH*(
MWK+NZ\)N[,KN[-)N[=KN[>)N[NKN[O)N[_KN[P)O\ KO\!)O\1KO\2)O\BKO
M\C)O\SKO\T)O]$KO]%)O]5KO]6)O]FKO]G)O]WKO]X)O^(KO^))O^9KO^:)O
F^JKO^K)O^[KO^\)O_,KO_-)O_=KO_>)O_NKO_O)O_[9O0 $  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>cogo_0039.gif
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0039.gif
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ML@MMLPIVN1=UMQ%NM"5\NS-_O19FGDEQFU5[H@%^P()_@"N!OC.$OQ" OUZ
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M^?7Z_/____CW]_#O[P
M
M
M                     "'Y!       (?\+26UA9V5-86=I8VL-9V%M;6$]
M,"XT-30U-0 L      $#;@$ "/X GPD<2+"@P8,($RI<R+"APX<0(TJ<2+&B
MQ8L8,VK<R+&CQX\@0XH<2;*DR9,H4ZI<R;*ERY<P8\J<2;.FS9LX<^K<R;.G
MSY] @PH=2K2HT:-(DRI=RK2ITZ=0HTJ=2K6JU:M8LVK=RK6KUZ\[H0D4"[:L
MV;-HTZJ-2C9DV[5PX\J=2W<J-!DK6K1PT>*/KF=B)SEX\5:CV$@0"$,S9JQP
MW<>0(TN>?!+: P(& @088"#!(X$D !#0!>UM6[*F"Z,>. ) @&.P$B3 !+CV
M0,>4<^O>S5LRM D)(+AP44*! @.:GL%"<2CD<D//8ADP\*JW]>O8LZ_];:##
M0$ ($/Z,>/;JT"5=AP3%$AC+T*%CY&FPH %+("Y#B8X]\O.,V:$6*=2P'GF'
M1(++# HD\ (FL1!B2"\";2+(([AI9^&%&&;($S02=->6!0@P$ T, "B0RP,
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MS%QV@&:<(0#=,RX P !\VQ+ Z/Y8*] 8 9!W0R+  ,+&@D  $ISP0 !4UJT
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MH7<>XC*\>,6>-(K;0&PB-(=@1B#.60-,M&T ]ZJ;!18Q P(H@'??3  )4K"
M "3B&2( 0 LV02(5_%*PL%@:,CAQ @.0X#VS#50TU%0=7!" KI')%P%Z*Q!=
MQ *?N5@N F*P.AA%UT<5"-N+%"  !=Q@ 7-\1HH)X",6D\?"QZIMLZ A@@!$
M0A-[HN<- O" /[@  07 G.$2((A$+"YH\C-N 3X##6948  S>$1H.FG=8;;@
M 0-0D?XQ'?R,V;*@S0)H(P0T,5DW63D 6,80,BX3BQL<4[T/T.@EJ.@" =0V
M&FW\RS$N(PID6&M ??OJ"0; 9A,,H).8V(1 #D& "C R1&=] (1@^]4',T,4
M?A6++APY&<(:X%X^3:-&^S,! 81YS&UNDV[1W *P(D &-3#.W9A1ZUO']AE(
M;F,#H-0L6""@ 5U4TV>(38#/T"T 7WT! $[YC$8,  7SP\5Q&SNL )1 (,(,
ME2%6!1]5%>Q;;)YMK_]0  5$0BPQ  !_GK&( 5"IO)?A1#3*9H,DW2X6-;"
M* W0ZUZTL3XB?H4F5J6M%P5@/"AXDD!@@.U< H($#Y"-!/Z>P0M01SC'?G8!
M64H  $W =M]=_JA6Q**)\#RR!@%(4 2> 0ESHUL!H1($N]L\ !%0+ !OYO>>
MH!$)GS,2Z(,E50W$:2FQX/P$C$F!OP':QEN4YA#'!A$$'O  !@@@ 5FEGKBW
M+!"5D?T!Y;H%V/^]" %8H,U3PJZ"GQ$(<%%+CF\_>]I[(Q8VOOH9AQC  Q8@
MV%=P!@8NWSL;P93+RV@L6U1CW#-0$(!]2Y<&BV9<)- U@4]#^*3=Q9Q8%@&
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M;@-0 ;V@"UW5:X"@>6*!A3J6"(ID(9$3 #1CA![##). ),2A /77'Q% 5C
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M!&" !Y_@"^LK$.U[,\OPP*; !WGP!G" !F90!F) !CIP 1K@ 0;< S[@!%7
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M3M.4_-Y[SL5.$-Z]<0K=K./AC.@9+>W'O.&X/O!Y' 1'< =.31G#H <5#,<
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M4A2AZ"(NON6+I#N5U@+FP5_HYF+%R@WLRD8)^JFM?B$CRLB44I1>#!&,"?*
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MI2].9/)"_E+0: 2]([[A*X1'L(10 #S]>C=:LP19("X?PC==T#?>8RZ54:Y
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MAQ#0@<A0Y#\U>#ID<W-CQ!*$'DYS<B;6,=L&JV1"]X50VOX](3DO&VBY$-7
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M6$Y<>/'.P2? ;X,?AO$LPRKHP02'01M4*\H91VJ+=K =N=V&@HH'MPR:K@?
M^ _$%EF/LQ$10RK4 1B,C)"_AH<PBAP)=8-0>6LGP138 2L<*)IO,O_XPB=$
MN$[LN4.Q9- < 7Z!EUL/^1T<>I;G"9?SP1N(21GBA*B#!=6 <?$2.39ONEF$
M@A-DP 4@J0(&]U9C@!/(N*I?1#*H0J-/01+D=FL' ;#KN/ZP!SOY*,$2@ $>
MC((J*/:MKTDS# ,KW($<@,$2<(>0__JE"WM8&4$22,$<V$$J^,*@)OI(%T,J
MX $8S,ZEDT]'"_6;"7KK@ &X,WBS,X4O6 $(7("WBEU^5R$]74 ./ $(SGEO
MIU<R% ,KC,(GW $>U('#.[P=W,$GI (K%$,ID_M<@Y8S#,,OJ (K?,+"VX'(
MVP'(4[PO#(-<8WQL*X.Y-SH82$&ONPGY['F0&/L4R($=C(*XUSN.P+$G.,$'
M< !QL[GP_) ,OOBK_X GT/NM;ZC*TS>$.L/3S[@N#\,P^(+'LT+6JT(Q#$,R
M:/S4WW#E_$(G #T&Z/O1"_?,!/YW+\'X!SB!(_PWP?-\^Y"T?B!%V-,]24O]
MW?NUWGODW[L3,H2"%?1 P,&XXP0WT=-4\"A^06RUOD_.$WB"U1YBX%\^YF=^
MW?N]YA^+1OQ"*%R!$_0 ,\,XC/N$3_A.ZL_ZV:-]#CB!%7@"3'<^[=>^[=]^
MGAB1,P0#*82^%3S!#_1 #^1 #N  "!!_#O3 #\#^%7@"*?R">5L^[D\_]5>_
M]:_MT$$#,RA#,G2_,A#<]8>_^(\_^=L]W],U-.!]^:\_^[>_^[\__,>__,\_
M_=>__=\__N>__N\___>___\_0#P3.)!@08,'$294N)!A0X</(4:4.)%B18L7
M,6;4N/Z18T>/'T&&%#F29$F3)U&F5+F294N7+V'&E#F39DV;-W'FU+F39T^?
M/X$&%3J4:%&C1Y$F5;J4:5.G3Z%&E3J5:E6K5[%FU;J5:U>O7\&&%3N6;%FS
M9]&F5;N6;5NW;^'&E3N7;EV[=_'FU;N7;U^_?P$'%CR8<&'#AQ$G5KR8<6/'
MCR%'ECR9<F7+ES%GUKR9<V?/GT&'%CV:=&G3IU&G5MW2V6J4T*["=CW[H^RR
MMI]%,R8;-FZBLH\=0Q;M&3->!'UOM7U,%^[D/X\9BT[\V;%8S ;B.C;P^5%H
MTC'FZBX3^\'Q6+\;*\_,V&Z#T:&6MYH,&?UAR0SZS@4!@?ZH9YL>:( ! V0H
M2A=#GGGE!4#\$.480!))1*!$C)&JF6"0R3"89A2J(0$#'(@DJ4@" <20$XX1
MI89%:#@NDD/\P.696QYA"K9 # C!.822@PT3 &IXQK?S3&+FCT!JT$4@3*03
MY \9GX&$R*AB>2"!& 1J(0$&8A%2(-A*8  9+W\RQ@\_D'P$%C0#F0$67/X0
M9+MC+I&*F1X\^$#/'C@L")I78&-& @0,V.290 :PX0\;:IRRIC]/H.&91;H4
M*!),GKDAFE@DA*HU3S;(X8,<-NCDH%MTB02 $@AY (%>JBL/FF,<M>F52*")
M 39C9F F2%X.>>:/"H%RQ@D@?O[X 0@GG*N 4$W(]!.Y@W1)P="':KT(-C]$
MO*4&9AZIX)A#;CDFR$UJE"H5)L!HEXE4O(P% 00D@"8:*Q.HE" 2$B 6*&B@
M80::/P!MAAED:#C&CV<TD= 06"S,00,-/,@@ASX%,B:0!Q3 CH0*8!" DV=:
M>."21(XCBIE8%C;D%5%@?63D806AJA,.)M[@ E-;$T@3%0!(!) $;GGF!0"@
MO>$ 0UUXP%^? K;A&4P6*>Y06 "9D5(1@VH&!PXRR  #''A+L  5$'A!(!H6
M?*"%5TB (%AC5F#  D-G>,&0%&)!040_))  06C\@ ""%ZP;01 5'JBYI$ID
MZS66&/Z, 00[/XR4JK5/@AABB"*"^.29UF))0((#<('%@$'+7>$!";+F5[>Z
M*[C6IU<ZG;#+&Y[1A<)@(Z;X XLQ#H0!MZ&U(0'" 2CZ@0&L!"!KHG!9.(8H
M'HGA%3,O600335YY)%NA.L'@@PT^P(#GWD-(@ ) =L-N$@0@V"X6 &: )@$2
M@H(-DCH342?8' (6D8C$PPZ!C$:DS"?-Z('P-, G@LQ@ +"P  .VTX$ D( $
M!%" "AB @%R$0 &/4($!<D&" 2!@!:KRPQ\ $(,6!"T2 3#$(:3W"@ H( 7/
MTQ=)+O$"3#W##\:XQ"3"%XE8H$HJGQB"$8QPA"&(KC6W,/X VH2V@!,00!<Q
M,, E8@" 3:B@7R2$Q FAQ!-HW$!@&5N8L&ZQ"%$<XABOV Y4'*@!/4408Q0(
M@!^($XL S" 2)2# #>JHB>\\ (-$N<7"QI0;+.D"$\=(A"@2H0E"/*4UY=,3
M#M3G)4T ( 2O($@4   !B FD Q6HH83&%Q,;$&<1E?"2(D:&"5T@41"OB-%/
M')B!#WA  SFP#3,>4 $B D!$)#@ -&X1@!88[0"!V%\B9@  &K1@ )C:Q !H
M( %E3BT6T>C>"PB@O4$N<X@D^=,-!?++1RP"%XO0Q"$ L<JG.!$)19"BZ& 3
M"P+,( 0G($$)8C  7!@C$HDXP?X $@'"2!"@!(K(Y@RBE1-8(,A+F13(N#0A
MBDL\(A%^N*-3FI&#"V" I1<;R"M:@( !O$ 3"%!  1+P  (8(A&KM( "(BD4
M.#VC0K"A 74.X;L*_2&6/>DD!UB* 0ZL[QB&J(  & "M%,RT;(<P@ CZ)91<
MO/&>7OIE=0YAC)IQ@FL]26D&)D8\+UV"  VP  0(L()G\ L:L,"?T0QP@_VY
MX 4U>$0)$K"=301 !@_@7W7&A0 2_.%*?HW",P"!M(QZ!!I*$D@-9'369QC"
M&'\@:LV:VA/.&:$(1IBBEVXA@!O\X0 &.,0,!' ++Z[ !@-8!.,>80 2$'9%
M:GR&(/[T^8Q9%@1^@7C&$3>;%&<\X0=.<,(/GH Q@>2B!B&(3GMFJ$L"@',%
M $A!41Y)LC'%0E(S0I A=I?:GH2BNM8%0BC\A D*D'2')U!!"%9I#)VBH'_/
M>$2ZHO&",>&"!K(1A#&BP;M'8$J^*7'@J$3E ]NLP  L< $,.(:,$B"@KP!0
MVPL",(D'6. 8FDC!*TZ @ IM @!_V*HF+A%#$B" &:\8I%^#% C-5K@AT'"!
M;&B0"R)""18U"A(R4/N441Q!"4I(PA%$)Q!>!. &KR   G"!SDU(%K, ,"'1
M%.#=GYFR)[WRDC&"1)!'Q.(8SL7$)*(;&X( 0@)%@X4)%/[  !><5"B^>P8L
M%#4#SSZB0J4%!)NU8AMHT( "'ZL !* E$!4$H&I$7LDC3!E0&@3"!L1*E4 @
M82+Y]$09T4A&J_&3,09,8" SX'0*2 R+ 6#)UK?0A ((0  2B%@!%=)$  #1
MBPH4@  5,$8B#,  ?L' QY<%1 !L)Y)-S. 1-P#>+Z$AIR@EPF51:88REK$,
M92@#8[<@0(,9((%GN(  N)@! 1QK6UPS Q/ '@ )GI:38V#TI5F3C3$&1PA(
M!"+@62%2-%;MG89_B=">JD@O8MQ(I'QG6@.IN%&: 8SM]$8ZQX#5=^;DGCH6
M[1G(Z 7)B=-76,A&%Z:,#LJ+X_Z>DAAC$PQL8\ & @N6:Z49X$%&R@-:M)*[
MI\=#5R.A@3Z0-@K$0;0!C"Y(H(*1V<CJ8/%TUQ.R(R(]Y^NUR4_'\XR>M$O+
M*67'2=G0SJ.% ,PF;J=*C]C^):.,Q^XZ<49K>@9VA@0^\!'IN^!G<OC4*!XI
MN8B$DJ%9BUOP0LD'R<42)U^>7#Q"D32!QB4@<4=H&/".N(A$>8X1\:S$(A*=
M5T@!/[YVFD#\&;D(*;0^K\^)'X49M[B%ZI>RZJ@+!/B1;L_Q8_\09.C\4;A9
M=?&APHI4L$+ZK#"(+AX @(7E(@$""   'M C"P2 _ $H&B (4  !=&#W*IET
MZV5 J_X97$(3\>_%'T3Q1I-*91C3]_\P)FB\-BCV?$3]<*]_CB$&9"0&'B$2
MI.00-,D_- $2F@(2($  H*>M]&X#V6Y*&*\A= %-AF5JHN /)$2M_H#EI(0K
M>$$!&N  $(  0B"ZAD1:2F !1HXF'N%,\$QA .$&E P6 D'<D*%.S T).L=S
ME*!9!L2T,($ #N$5.('-RN88%(#:1$$3>FR#<@&'IND#(>(5IF?".*%3RI#^
MA"4:-H'"HN(3A,!SAD ( "I! ( $8"&;8"FC< $!'N  V.P6. $[; _Z8B(:
M#"$$U(.CBF/[$,0/Z Z8YJ!=P& *YB#P,F$ %, /A@8 (/XM*7)%1L30&(XL
M4V*!GB)L:BA0*E;A#?*@%=]@%08B%@P  F(@!EQ@>LZC.W8LJ&0"$Q9FTGI!
M$+K%!J A2!IFM'[H*:X,BHQ@"0K/!"0@$;3O4-(I!6H@]F"! %+ !5R@2V@
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M=N>>?PYZ4E&$0$(((<0P92[%/A#(,R^08 PNAT02R<&/2'#+(P],4$,(C]0
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M9F!8Y$!C$H^ WB9&]HQ>,+:SO.WMIZ(#7/M8"P$&($  K.801#6C!@(X!BP
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M =C-(W#AK#-##1H+B#2!9<C1&>3/4%X#M;&/;1%C *,7OP@&F%0   ,48
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ME%%-I+<((4@P R10.8JT" P17?M7&)P  RV!$2T@05<G?WX!4M 0 _-S#",
M#36@"[+S#(EP&0ZD)A70 BFP F "$0IH$2<P58ZT$2GP@'XA?XD $BG!"2^
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M R%P"XE@ 8]  GAQ I@ A[>P/?ESG[?@/,\0 9? #"5P*0)'/&8Y DP3"=!
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M NZ+"<:+O,K+O,[+? <:"8$B+C<@O%6BK0P:F3#1.I% /+  "S6P@"( #2X
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J^..7?W[ZZ[?_?OSSUW]__OOW_W\ !E"  R1@ 0UX0 0F4($+5%Y    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>cogo_0043.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0043.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MRYYK%'R/ZD,,6WW/$FM_:"\7?$W5"TV*=*M< RD^Y18X\M*DY&/,5U5N'7/
MKW&FZ-I-!I[R<NCS&3J.?7Y-N/BGW^3GGC#X&ZU\//$>5XB/M)=M>H T[)#*
M@3!E% W(7CC:H\I4..U?-?Q!I]\WFQ_2?2OP]K5**Q3?N+AHJZ29]O*ARIH
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<M&J\MG/D_P#R^?"_DL_]J(W^6/VK)Z++?5/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>cogo_0042.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0042.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MGD-5/7:F>63X;X_HT=E(0D']VG1I,"N+H"3L>=-#LQ]%2QE3I55!*]!XY"B
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M4IW<]:=)("=AL9("00-S3"ABAZ >HHH#**\DI0YC]VBP&>S0%*43WJ3X*Q7
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M)Y-/&$>WVQK;A2-0S%2)84&\\(3G88Z5TU]N*.&^.;Y+5BS182<MMA/VK-M
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60GUPY._^'.]/7%F=.@+YS_GF@*?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>cogo_0041.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0041.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M>XB_2*X>MQH3#LU"6PH+4(Z"\XH=SRI!./>J<K79PD:$*?1YDPCICB67&O\
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MY]Z])X_Q[T[<Y,\?Y7S<?(155<<+\Y+.L#S,)3Z5JXY,!OC K(V3CK1KL1C
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?JWQDD[#-5E%2FTRZY.-:P4OV@K\YIOIP_ CU'^3_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>cogo_0040.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0040.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M37 2?(5PX',@*4#2QS)2HH2GTJ M$4[+Y:@)N\!/+S<QHD0K+P/N%)]*C"2
M62YA]8QWH2S5XOM5T0<MZ6I+1Q6)13"MBCORB9RR:?#@OM%OHYPAT9]11R7
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MG0;O'D1V&E I<(0=UD>7FQ]*F;B21S<7)TF^H);5O5EL')K@4^1GO1 DR/\
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ML.A8ZA?#TAQ8.0KI6B"*?"Y,=*[R1O\ B%,FN!3=#8M9'A]:R27(49IHFH6
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MEAMOD92 >A4OJ>X%2$/4U%HRZS4/#HG"7Z?R=ESI_/D%?4YZUUMIXUSLBP7
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,_P#Y&M>Y&+U4?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>cogo_0047.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0047.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M]5.BB788/Q4P &[K"&24\&H+(<L3OC8R<XI&/ M#7*<TA>QI\X23N"<#)).
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M1(=/)YH$' D YJ$.U"'LFH0,M\=4IPI'0<&H@DU#B?=CWC<*;*?B3UZ<TRX
MU9"R'D.ON. 9"U%0^5"PM5P-\=J(!2>.E0AP*/BI^8H,B"LF@.)42!Q4(<03
MTJ$%U" \Q[P&%+'4_ !YD\"@0,M\?8 HCX6DXSZTR0),)]Z7_,'Y4;%HSS2C
M6Y 6H []R_H!_P"Z9E6/HM%L4-[9'57)H(M:!E@"<O Z*.*7V0Z@ NJ)H$.[
M$DYVU""A\/2I9#FT>50AT=:A#F3NQ4(<6%$82<'-0A/Z=;'@NNXZJ _*F71
MVX*#41Y:>#C:"/,\4SZ%YLK"\ C:,#L/2JQAP=*9$.Y.*A!"5$K!SWI2#^]7
M\1I@G0HG.3VH,*.I/PYH!.;U9QFH0"GN>)<K=#S^)U3I'F$C_N@PD_)7[K!+
2/0]33]*BOMV0?WFUY4+);/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>cogo_0046.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0046.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MN^RN86_&'1QU \*%CY5R<BQRDW#H[>*4_;2EW\AKVBVF\ZEM[T:UR6H$E:0
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MNLJ],Q0]%:4MA,TK&5*3[X^@/G6K G&+LP:J;M*"L(WHD=%G9E;$N++F\Y6
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MA)QE*L=>G\UU92A%IM&;3XLF>#VY=G^K&I"FRW;<'&=":=BY6IQ&]"EGQ$9
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M8VC5$8P)<E!GL>)K><*<1^7YE/\ ->N](U[RI8F>&]:]+_3R]U#Q::V.@)X
MZ5Z(X:1.;&5A(ZT!TC)Q!W94<T4!E%=;0],<*D*.WTH/ADK=P+[5\8QFBTKR
M!I&QE&@%P/2E"-YYO*C5T2G,BQBQ\PE#!Y2:+[*XKQ%1J%M3=[*<8.^A("7
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MJ()(4<;>"4YQ5Z6S@H;W<E?=(T9FT0[6F5^&7''&D--(;C *6!O+V I;A2G
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;@9 \OF/*A/G@2:XL???3?_ME?_M6>D+?Y/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>cogo_0045.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0045.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M6TLMI)4M:MH '7D\5$Z[#:N5'.?:AV^Z&M,YZ%:IB;E*1D$MK0&DGT*B:/\
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M1=\6*<Z3:K)J>QVQ=M>7&5;W(3!'1HH*2"I1'Q*Q_>NTLUQ5G.P:9QS1DO\
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:+-$R0UO#:BE;I.0E%/CU0#/N]/X1319__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>cogo_0044.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0044.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
M'0   00# 0$             !@,$!0<  @@!"?_$ $00  $# P,!!04%!00)
M!0    $" P0 !1$&$B$Q!Q,B05$4,F%Q@0@50I&A%B,S4E,D<I+A"1=#5&*Q
MP='P)32"HO'_Q  ; 0 !!0$!               "  $#! 4&!__$ #,1  ("
M 00!!  % P0!!0     ! A$#!!(A,4$%$R)1!A0R88$5D;$C<<'PH20S0E+A
M_]H # ,!  (1 Q$ /P#Z01/X*/D*M9>RG C;D?WHI(-&Z 0R/E1C$/=-P65)
M]!1I<%?(VIB,!V60H(' H*)8L#]>>VN2D%7NX%6,-E75&:=20/'13["Q_I'5
MR1PI2?*E$#(-7'P&%#GW:/L9<$# GAJX#!SSS57(BUC872YP=C)QY^M1+A,F
M[9'Q3O?&?6FCV22Z#:PQ6W.\4<=.*D:X(DZ1"ZX:#"&ECKGRHHJAF[,A.."&
M%$<4""8\L,HF64XSS3-\,?R%3JU%K(3Y4,7R"T!%W6I4I0(QBK*5CH9)I]@Y
MXX2$9%,XI"&OMBVS@^5-2''2;HC:,GRJ)KD5"OWJWZTABRX?\%/RH,G+(X=$
M=<DY=%/5!1=BF,,)^5&,1,XI[T@CR%*R.23D.[2A'=KPD4+EM)4@:UPVTIYL
M!(Y&*M89+LI:F-D-:@$*VXQ3S:;"QKBAQ, 42D'K0J5(:4;=#%^(LM*3@],Y
M J2$T^09XY1!ZWV\IG*<?!;&?Q#C'KFJ^22NBQCBZ/-3=J&A["EJ(NXF0ZI6
MPAA.X)/Q-0N45Q99CCF^4@?A=N>AF;JNV/.OMR$8.%IPD@_\72G27V%)2?%!
MY8^VK0+CG=KO28Z58 <7[F3TY'K3R=+CR!&+Z?@G;W+C7Q++L*2U+9."%LJ"
MACZ4:3BK9&VGQ$FVX2!  2GR\O2F7*#::8C8H8;E*5CSJ.323"KR%:T MA('
ME2B^;(V@)O<5Q,I1"3CUQ4T96PZI$<AIPY\!_*BL8]+"SP4''RH6.(.V];A)
M#1YIAQ/[I7_(:5H!V;_=#GH:5H>F6K$3AE)SY5#+L"#X(RY*P\.*+P%$4SEA
M/RHAB(G_ ,8_(4P#_42%E1N;4,U',E70-ZP@R5S$/;"6T^=28YT0SQMD&RI#
M:@3E/THG*V%2BJ/)#S16"'.I _6IHJT132B[0PUCKRQZ)MZ5R6O;I:QE,=I0
M&SXK/D*HY]0L)?TVFGJ.$<[R+WVF:SOQEQITP0%OA++:4;&?$K!!/4@"LG+K
M^3>T_HW%L<7KLPE3BIZ]/$+0YM2E!P#@G<3CKQ47YSFV7?R"2J**E[0]!W.-
M;)K-OER&5EEQ*2I9)P3D 'UQ@5.M?%>2O+TR4ND"%VMFL6;5;H]LCJC>U1&W
M)+H5R2.H_P"'I^M'_4H)+DB_I,FV/+'VD=HM@2R[:[I<TB$O&5**0ZORP,]!
MGSZXJW#6QFNS-S^FSA?!TUV._:\CWKN;-VA!$9XJ#7MJ1R2>A6D= ?6K*RIJ
MD4W"4>SJNUAHH2XTH+"TA86.001G@_44,HOR!=DXT-P!/I2N@!"7 8= *D9.
M:2F,,#;8X/#8_*GWCGJ;7'4,[/TIU*QNC9-I9)P&QBEN8A86EH#&RAW,1M]V
M-_TQ36./HW\)(^%'+L!<(B;D"9  ]:-CQ\BA*DMA/PHJ0+DR)G* <*E>@IGW
M0-WR26GE!:%>E1Y"2+LD)T5E].UQ&100;1-))H$;_I@NI_LJ2%'CBIT^2O.*
MEV DRQWEB7W"B4H/XB.E3SFHQL@QPE/)M(67V>L7RXKDW=8>8 '>@'"G,= ?
MA7+ZS/;.Z].TRC%$LY;V(32(S49"&FD[6PD<!/I6'FR4[1TFFPIKDCKC#;E-
M;G&\XX /3%59YY%N&&$;X!&\Z4C3T$NL!0)R?G4$LLWY)XXH?0.731MN5%0T
M[$2>[SM!]#Y?I4D)RDE%LKY,48R;2 J^:'M[R"W#C(2>A^/P^57L,I0Z91RX
MHOM$79^S*$Z9+K$9EV8H!+B%CR'3:?A6_H-3)NIG-^H:.*C<3I_[+NJY=RTU
M)T9=IBW9NGE -J<_B.1U'C/J$GC-;,ENY.6E'9*B_(_N"A<> ?)NZ<()H8JK
M$-@=PR13CGH.*).A48"0<@TK&H6"Q@9)_.D,9D^IIQ&K"R4(V],4S?(R7!$S
M'B)N%'C/%%)]#QZ/9#ZT >+RI;F T0UP?)2233KL:B1TH^5-%.><XH,A)!!
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MOB3U'(I^^!;JY0RNS)=C[&V^\64*'Q(/./I5+6X/>A<5T:GI6N6EGLR/A_\
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MUT ;4N,F._IZ4]:]J?\ :--.*2AWZ\YKJHZ7V,,,K7#1YSJ]1[VKR03Y3?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>cogo_0052.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0052.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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M,[\\.[Q(M>NF>R[^]*EH5%BROEW$MEQ3ZN3:4^_XK/)**LZ,)=WU], U5?\
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MTI!!\;@"E?@X'L*V<;&L<*.'S^3+DYGD>O\ Z)<M0,T[;@;GSK3'2.?-KO\
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MK33T1[M8($Y'"\DH5Q8\)WJOJD&W+14KIHBX1%*<CI+C6<Y&_P":#7R)]I_
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<_FF7HS\T,L@C,B0<NJWWZ>E6(KL>[T^M&P'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>cogo_0051.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0051.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MX,A*3M7$,$IT8%X' \:G +,6H^$[8&]$EY%-&YAC#@W%1)9.Q@+K6P&V@I)
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M(FLAIN0RVC+OOYSD >)ICDI(J>U*$L$3:FX]\/+7<7[2B/=KC*:5R*1"@*6
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M48IFH'D3Y*)J4\+DA\+,>SF'MR<;8VAM'-\/+,^%7W4Z,K /Y$,'WE'R*E#
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M2/\ .J\Y-%J"R;'$J/*L #/7-0\XR='$7A E"G6LFYBZOAAB-<%@+4K )5@
M9^=5X/&2Q9'.'Y!+CEQVTYP*X<WG6,Q#EV5;8RG&HK+@'.O]*.<]!5I-+"_)
M4L3Y:XX*CN/':VXO=I-2$:NFHM6GT*[V-8H"BEA!\%.$^\ZOU/T I[C'.4L&
M<[)KC<0XM(2,"C%FNNZ.?(E=_BW%I)W[A/-\B:Y<'-Y[%+OA1(@1/@JP!YBI
M.1KO(6JQ_P /JW*;W\L[5WDD<((2E@)3]JB1V!8T!UH2'P*FCE.#48#B^#9D
&>=0%D__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>cogo_0050.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0050.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MV)Y-'PN1L8_<XX\1?'75_BF?:KGX@2[PD$E,":\6VVD=DA#9"3Q\*JT,4:Z
M :FL3D4QY*DE2#L4RP?*VX^'I^M5N3+V_<&9R[%<W%>7>W(17PA+J-S6?0D?
M9-"V@E%,L-$ZGU+X?7AN[6.[2;=-C*#C$J%)+"P1SD*3PI/8I/6CAM:H5DC[
MCOWPZ_B+QI+]N8\5]*Q[?:W&T-R;O;?,<6E>!EU;.W@9Z@$_"I+':]G NFGP
M=CVB_6/4]A@ZBT_<V)]LN3"),62T3L=:4,I4G/J/]JSP@X<L;O\ ACR WN'(
MHF[+M _JJ S/0I"T@Y&*)(5+LSI>(F V6@K">,"J"AR%* SC*E]:@0H"-W55
M,M,6$Q<?:_:J+L<'LN!T_2A#30YB-5$M"U[T$X[TT18W[ZCS4)V>P1UW5"]H
MESS,#:.,]ZIEI4,2 O=SWZU1!J&ES<O ^\:M,"29)4AP@C:HGYT3YZ%==GS_
M /IN?2,NMVGR?"_0-Q*8$?+=R?;64%UW[R K\*>F>YYHTW%4Q^."DMR.,[7I
M'4^H+FW;[#(=E2C]MR.L.M\_=4._Q[UES:B$.S=I]'/,_:C;VG_H0>*&I/)E
MR8ZFU@!:U[0V#\JP3\GCCPF=2'ALS[17ZG^A%XBZ?OL>*_:'Y,=Y8*'&\G<D
M]03V(H8^1QM-MES\-FC))(L9OT&]5-QUO14+<6H92%*P2/PD>M9GYG'=6:5X
M#-5I&NM:_1_\0]!,-MF$ZI@Y6C(W;2?NGX9[5LT_DL>1TF8-5XK+AYD@1B7J
MYV9LID-RH;S)]]M2,I'."1GMZBNMASQEPCBY]-*/*.G?HC_2Y;\-I\_1FN+I
M>+Y9;B&S:68JVU(M[@/O[4K(PA0^Z#\A5N2J@'C;9]&K=,:NL.+<;>^IV-+9
M3(:6I)3N0H92<'USC'PH*I QX8S<FGARK=4LC5]D:'[3O]S-4PDJZ"!IJ5L!
M.>:A?(KRI)[&HV6DV9")">-JJEDVGL2/PJJN"Z%[9'HJH701O1E>9MQQ4L"B
M0Q;AC<L<&J9:0Z;<D_9H;+&W8!&!C-$BZ&WX+>1N1D]^:A$C%OAME;@V?>-!
MDEM+A'<P4\9M6->&WAK?M8$X=A1BF,$C<5/JX;Q^?)I^%W&Q63'S1\;;\_?-
M<:Q^K KVJZW6:H.O$]5K/.T#L.E!GR;8MOX->EQJ<E!?)]*_ KZ-6E?"O1-L
M:3;&?:I38>>?4G*U.$9/RKQVK>;(W*73Z/=Z-8,24<7QV;F;L>(_\M*2A*1B
ME0P-JQTLRW45TVW'R=BT;CN)X-!DC7"-6.5@S)M"4C:4K+JLG.!7/R0:=G0Q
MR35 A?=/6V:R6)D=#F#DI6D'FJQS<9<$S8X2BF^3FSZ2/@=9I6FWM06F(VQ*
M9224H3C<FN]XW6S4MK9YKR_CL<X;HJC@.:U[)*6W,;09#;A&/L[.>I'>O5PJ
M2Y/#36UT?5G^&/KRY:_\+K]IK4UY>N,[3=P:;8#P5EB*XW_+1G. ,I5@"I*5
M*A*C<CK2_69IAE;FSH*'<&X%7IVWM27U)4@'&*CD5&-L-!9&-B0$C@5-Q>T6
MBQL8_P"6#5;@E$5]2,_W0J;B;3WU(S_=BIN)M,_4K/\ =)J;B;2'.)3(]TXI
MD>1+)3"R4>\2:-I%18YN3^&AVH+<)<<2 !G'-55!)C4AQO(]ZJ)8U%=2%+*>
M/>-1)/L&<FG[3EW^(1?)<;PXLECB7CV)-PFNN/H2C*G$(1P$GUYIT4HQ)%[W
MR<4?1:T4BZ>,UHE3&,QQ,'O.*^T<Y/Y#^M8]4TX\G4T$?U%1];]1Q&WX;7LJ
M4CV?"=J>@&.U<;7K=!-?!VO'2V9)1?R4!DNML[0WGC[([FL6.32Y.O+'"3M%
M2]*)4?-:V9]>HI,Y<U1MAAI794S6)"5J<20D$93\36?+"25FK"XW0*72,I&Y
M>0<GK66,-SL;EN/0&Z]MZ)VFW6B HNME'//:MV!>G*S#J_UH4?*_Q>L3MAUG
M<6925!94=AV\'FO8Z>2<-Q\YU4'#*T=B_P (/5B(_BAK;1\ATDW2R-2V>?O,
M/#/_ ,5FCD[X$)*/)].-3)3[.L!6?=Z55%2=@YIA8;F.;CP<"HU8$>'R;$9\
MGRDDD'(I?3-*2:%@M#HH5?92C1G>U^*I1="QY1 .:E$M'MK7XC^M51+0,/IW
MJW?&GQ,;$I6I)(2:, 5YKF>M0AA:U$^]4:"3&G"K'>AHNV8A%PA?/<U.@+LX
MU_B$+GOR=%0DMO!I"9:PK[@7D#C_ +>:;\(O [;->_1%T<N[^)=K988.R'N<
M4K.0 #U^9-<S6R?"1W_'P]LLGV.[M?7>[6V.E%K;!6HJ_E=-^*R:B48QY-VB
M@\LK->PO%"Z10EB]Z:<B^\075'<!Z'-<UYHKH["T\^"R@7Z)<U.S?.+J$_=]
M3WI+RQ;.E&#C"BHUAXB6BSVY3CC86\E'\EO_ !9IN^.14)<98W9JW^U>N=13
M%.-Z>7'A).[S<XW4N<<<$D+;U&5MKHO S*G6T)>E,K"LA3:1A2#\:=Z<7"T#
M&<H.I'#7TO\ 0+<"[JGMH&[;D&NQX_)OA1YGS.%8\EEO_"[@W5CQ_N=ZBQWS
M$@V&2W)< ]Q)6I(2D_F.U="*N5'G]1)P2?Y/J+<[XZ^DH4>,4UQ$K)8WIM2W
MY("!SG-#5!*=A/>+R]:V.>.*FRPGE<$#XUC)^Z:/TT(>I9):U3*6V%9QGUJ>
MF5_-"TZKEYP.U1PHN.>V._VHF^O[T.T;ZK+)R2$+* >?2A";L4@9]X]Z)(6W
M9DC%6R&%]:C*79Y9 3R: <^AJ"2/,RGJHBBK<FA+;C;:-$_2W\.W_$/35@A0
M$OKGQK@\ZR6U# 0&B5Y]1@5EU>L6FG#$U]SK^&\7+78\NH4N50.?07T:8%KU
M)JB<@><P^(37&%9 RK'IC%*R24FI&K$IXXR@^W^YL?Q(U_>(4E433&A9VI+J
MM?\ Q$D)Q"M[)^RG<>JO4#)KCYI1E.[1Z#28)1BHTW7[G.T'QW\:=2Z@?MNH
MO!IRS161L+FY2RL[RGH1@\ '([&DZG!BVVLG)MT>IU#GLR8G1N/0,!^3#7)D
M-)C>>VXM*$JS@8Z_#FN6HU*CL9))PM1Z-9L*OERN5VGQK-]92K4<18RU[?,4
M3COP .Y-/BU*2@S/EW5N!W5FIOI0_6UOAVE&DQ:24%\%K#D4<[T E0*L<8/?
M)KH..DV+>W9R5'7+(_3V[?\ L)=,ZEU=,DB!K*PQ8<M" 3)@J*X\A/;XA0[C
M]ZDIPV5C5A1QY-_ZO^#6_P!);0;NK(]M?90I:WI*8BACKN/%:-#E]-M&'RNF
M65*G?*"GZ/>CFO"W5%DL]BBIC-S'GH=P2A PZL(*O,*NIS@X^5'I]3DGJH.^
M&Z_Z*\AH-/'Q62X^Z*M?WX.HI#@)()[5Z69\]@7>BB/:1ST_WI#-,>R=XAJV
MQT?YLT>,#/T C3Q!^%/,A/:D?R^M")E"V.LOG&*J2X#Q-HE>;\:#::=X2//9
MEX!I=?(]OX)[3Z0D!1Z45E)4*+[>?M53+,%Q)Y!J61+FQ+KB"G&:$8V-P'49
M=!<[G'%,DTU41"57;*S5;GD0V[C$<9;?AK4EM;J<IRM(!5@UQO,1M1R?8]7_
M  K)3S2T_P /G]BK\*K.Y8[+-M\J*TQ(GS79SB6T!(5O. KCH".E9M-DE+'3
M[.GY/3X\69N/T_V).I+4Y-2B*EX!32B0@**4? D=2:Q9X2G+:G3-N@DH14O@
M"[CI>&S(;=N<]GS%G*&P2D*^..IK)EC2VKL[&)O)STBP8M#D"UF<64CSDJ"=
M@P D>@H8X)P6Z7(N>:,WZ<&:V:1%L^H4S6C[*XOA>4Y2M)]:5EA-+=$VPV-U
M(NY-FM-R]^0TPG?SN;Y"JF_?&[*>/;PRND66)#;6W#:=0$)W$$\X^%-T\7-T
M9LZA!6P%UGYDN"\F&M*)##3DIA2\X2XA!PH_G6R+V<G-G[GPO_(K?H\W9V_W
M^"I+#WD06@%./-J&]W!W;<^G/ZUMT,6]3'[)V9?-32\9D2[:HZ,EJ"#R:]-+
MD^:Q5%KHZX,1I9#J\9_WI;BQ\6K+O6SS%PC@-+2I0Z<T4%M[*S+<N '1#<6=
MO?YTVS*HLE(M4K:,8_6JW()8I,E,V]U &X?O5.28R.%KLD^QN?\ XU5A^D7K
MR5"5D8I?P3^HEMM+</6J#8KV9><;JA1D-+1QGK5-%H4Y%40"HU*+(T-A86X,
M$\FHHOL&4TN#UWMK<RW/L/$^6>583DD <UBU^!Y<+_!V/!:S^5UD9+M\?N#C
M]Q<L$B')B[DQV$I0E+AR4H/0$]^_RKS2R/&CW4\?K2=KW/Y!G7GB+#M+LJ0X
M^ D#?PK!'H!2YYI2?!IT^EA&%OX C3U[OR77-7OPVITQYM2V83JP!L(P$@G@
M'O2HR]YNR04<7 B;XZWB/:%#6>D96GT8\I RE])2.A!1G'QK=.<IU&+.9BQ8
M87D?!JV+X\7.[761;H6@KE+A(2I"):]C:7 <_=4<_G0S@DO<PX:E3E48LLM$
MZKOELB(AW90 2/?03G9D]OE6/(H[K1NQ2DHI,+)6KU-AR.5%2EHP5*/-:=/-
M0Y$:W&I+E@TTPF^IEQY0)97'<205;<@G.,T^$'-6<S>H2VFU/";1]RG*=U F
MWI:82D1XA2DI!1C"CCOC'6NKXW#Z;<Y?]'!_B/71R16FQ.Z[_L'%XLTN,"7!
MBNSNL\?LHKK?#DK>2&U$$G%2P>@G<TM=G6=[9WDCGK4L/M%>;%=XSGOQSZ\"
MKW4+V<DYF//#8!BK_2J<K&)-$QJ++6 /9U X]*'<,IDCV&5_<G]*EDIBWE8E
M=*OX$_U%I#QP2*B#9(XWD8J[HHRM*4@*QFJ9$>>QTQ0MT&H#,,#>YQW(HER@
M)16XDE&2 #@=^.M$GM33YL%IVG'AH#M2Z<A-P9DQ@.IV[5K9W9; )Y*1U%<+
MR6@C''ZN/L]5X;S.7)F6GS<K[FA]>Z8?G35/(27=B@OR\<$#FO,*;3H]VE4&
MER!D;QCTM9[\=%O0Y<O4SB"XU$6WL2M!Z;">%?(5T,.FEECN1AEKH8I;<KY"
MR1.UQ-AGVGPHN@9;;2[CRMJ0"<)5U[^E:EI'5R EY#2+B+!.[0M<6B7(?E>%
M[\=2%X<*B ![N[KGTH'H7-\2_P %_P#T]/"-T D;Q:T[K"]KM%FB%%RA*\J4
MRT0M 21UW#C\JO/I5AARS-CU[U$_T^@^%I?1'@JF;@\8R%N CG<1R#6"+2Y1
MT,MN*W![X1V*W7;5J$72,EZ%%BJ=>23A*CT2#\S7;\=B]1TSS'E]5_+X[3Y9
MT=$N]MC;$1V6FT-I"$(2,)2D=@.U=Q8:5(\@]0IS<GV^_P E)J>ZL2TD)2,\
M5;C16Y,IK(ZGVI&$C[54!PN3;$1;8AA91P!54/C31!<NML)*5K2"..>:)Q?P
M I1^1KZSM('_ #$?I5[9 O)%&/K>UIZ%-#Z;&++&D.?64#\*:':P]\09>&95
M,?1D_J+:(D8%5$-CY&'*ME"E)"DC-1D1B2-J0H4#'1(\(Y4L_$T<14NR6#P3
MZ40) 4&)P>ANJX>2IM7YBE3Q[XN+^0\&39D61?!IC4K,FW3W($H;'F5E*^.5
M#L1\,5X/5898<CB?6M#GAJ,"G%@U=O#K2>H;07K[IJWW&7#45PU2 4K:7URE
MQ.%)(['-;=)E>&%MB\\<>7)%2BFOR#,/5MRTU#=MR=1WZWH^SY7GAYL@'. I
M1)Q73Q:S?'ME9O&Z&VY02_L .J$N>(<]YB]/WRX1Y*@7%/3U,MG (Z(()&#T
M[U<M3MYLSO0:*JA$LM->'6F=,1FXVGK1%A JY\EL)W>I)ZGBN5JLSRR?/!IT
M^GQX8K:J"23,\UUY_<5('"2H]N@I,,;JB:C*GT;3\'M/OQ=./7]YI23=G,,A
M7]T@X!^15FO6^*Q[(;F?.?X@S>MG].+Z#L,+2<YZ5TT_@X#5<HKY^\D@B@D.
M@VSUC01)22>]*')&VHH_\..>Z/\ 2HE;&Q=1->3LJF.^^>%$5IC21@FW*0VW
M$E.)W#-%N0*A8TKS6U[%'IQ5NJ!KW46N5?BI)KK\CCCF977O2ZX);W%O"6HD
M U54'=DS:"<U=%F3TJF1#4Q1"!BA8^(S ^RL]\FBB)EVR3D@&B!*.(<W5:%$
M[=V2*DG1(037]R)XF:,7>K;]?0$ RH#)4XCNXUG^HKA^2TD,L7D2]QZ7PVNE
MI\BQM^TUO;Y$>XVUPID(;6D!*@O@@CO7"6&[BSV$<R33^ 6N=DTU(*TSE1WW
M=I/('7- L4ET;YZC'Q:L$)UOL\.4K:MM*4\)0%4&W*,]7$U\#2Y?NK+ Y5A
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8[/AU&,')]]!%_;&!^)K_ -U<&CM;T?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>cogo_0049.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0049.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
M'0   00# 0$             !@0%!P@  @,!"?_$ $<0  $# P,!!08"!@4*
M!P    $" P0 !1$&$B$Q!Q,B05$4,F%Q@9$(%2-"4J&QT18D8G+!%Q@S0U."
M@Y.CX5158Y*B\/'_Q  ; 0 !!0$!               #  $"! 4&!__$ #<1
M  (" 00! P$& P<% 0     ! A$#!!(A,04B05$3%",R87&!D;'1!A4D4J'A
M\!8S0L'Q8O_:  P# 0 "$0,1 #\ ^A,1*0ZA0(Z5=D48#YU'TH:)>PRO[52@
M/0U)A$=)#K8&WGI4L;I Y(9;BZE)4I)J;9"AVTXZDQ@KGQ<4.;X'78ZNI*QQ
M0(!)"1ZV1I0_3-#BBQR40VV#-\T+!<)D-) 5Z4:.1MTQI8EM!0L/661LV\#B
MI-HAM<>CC*NIF.!KJ=P\J#D2718T[;M,+F&W$0T<'W0:7L3$JE9*D*/)\J&O
MQ#OH<]/,%IQ2B,$FB/H@;ZAF*B)"LX"JA)$H\C=%NWM"P!GKZ4R1*A_A[7$Y
M/6I,@^!X8;\&0*2X!OLV4A6*9\CG'&,TQ(]I",I",I"&6&EW>@[J+),' (DH
M4IH8/..:$W3)[1B?2XF6<^M3IM#IH\DI<S\Q4$Z%)#-<4.;"<T]@Z'?2C3AC
MA1X 52E^$=+D(2@XZT.!*437IZ5)4Q-4<97. 2!3OCE$4W?(,71NV]XM<IQM
M ' *AU-#>;;V&4-Q'UVN-E!+\)T%QM7*$C)-!R:I? ?'II+H]':.TE@!2RLI
MX "@#CY&@?;EU03[+(X#M4L\1T?F,)\H\UH 44_3J?I4XZV*ERA2TD]O =:.
MU7I_4[:WK-<VGE)]YOHX/]SK5R.HAD7#*DL4L?XA7J5M#S#97Y*QUX^>:,^2
M*=#/:H[:)*BH\#RJ'O2)-\!-$=2A20#Q4G$A=CZPZGN@13/HC7)U)W(S3+L8
M3GK3$SPG%(1@YI"/:0@>A30IT(XXH\@,6$C<I(;Z@<4)KD)? -3+J$S2DD=>
MN:+[#(R3<QD$>@H31*3&:YW %!5GZ4J(6/FC;B'(_=J/'6IM>D9=A [.;30X
MQ",T;FH=X&,TGP/5B2XW)KAAOE:\A/I]:KSR[0N+'ND5D_$GVPNZ3MDFWV"4
MVJ00 IT>)0/0A('0Y/6LZ61RD:D<"C&QTL:M/Z1T-:9UWNZ94V8PEYY06%*!
M4 <9Z^?-1SRI*@F.#;:0ICW33MYMZG;:B.K<-VU8!S5%:A*5%AX))6 =]A6N
M8^J.0;?)SAMYM90G/]X<?0BC;]Q#;)<@LZ_J32-Q3=(]Q=BOQ5I")S0[LGGC
MO0/+T4./44DK_ QJC/B:)VT)VV-ZV;&G]1A,2_M<@IPE$M'EC'!5Y\<'RK6T
M6J4O1D9EZK3_ $^8!Q""UR7" 4A& 0>N:T%47P4(IOF0\,I=/"20:3)(>K8'
MDJ 6HE.*&.^AV4=@V]:?\R!P*N>E,2-2<TA&PZ4A'M(1%MOU="#J2YQFCM%=
M/:QZ:US;Y#@C,*RO.*%[\AURN#@Z5O25/*\^E3W"H[.*W)^0Q0VZ8GR-=Q4G
MNRGSJ:(-#]HM(#23ZG!II2XHFH)#^^D9-/!>X[.(<#3:G,$!()-1RJH;A1?-
M"&6!&LLFYNNEMUY!0SGR!'D/6LK,[5&E@C'<F4#[?=,7"3?)#UDMTJ2XC*W7
M@2$I^HSFJT)13Y-*:E7I1&D[M.UK"BV]$&.)+MN94TIET$I[SKD^M%=53!*U
MRA/I;\2W;1I"5^;R+*+A$<6"J(E@=UM\^>H-5)Z6#=Q[#QRR:IEE-)=H^G.V
M.Q_G-E@+MUQ0?ZY;5J!.,<J'D:$XSA^(G2?X3E=DOAD(0T7&RG"5XW%&>B3G
MJDGC!Z'BHQDV^!Y0M< ZS!D6^9$;2ON4O.?U%U*BGV:0!DME7[)\AY49VO4!
M<%+@LWV/ZQ.L[.F1-3MN4/\ 02T@>]C("_OP?C6UHM1]2-2,778?IR31*$9(
M*TY%7ERBF/<9M)2..E!OD=G9X<9IQA/C.:1(]VBD(SI2$>TA$'RM*/I62 H$
M5<33*LE3.FD=*R3=5O+!4/+/SH.5518Q$BN69W:CP\XYH-A#FJT/!) 33=L<
M:WK)+D.;=AZT2*;!RH?+%;G[?A)20D&E)42O@<)+JQG"*> QPV*DA,5'A4^0
M/D/.A:J=1HEBQ6P=[4]2VVRVW$I>6&&"$)"MH(2.5*^'RKF_(9WCCZ3H?'Z7
MZDDF58<MUX[5)RKQ<WG;=9G%;8D)@[-Z!^L<8X/7UK+6>2?'9TD-'&4>>@OL
M78[H:,TI1L;6]WWE+')Q1(ZC)DX^ RT6&"MG.Z]D&D%0WXK-H82'004I'!!Z
MU+)J,D4-#289ND 0[-M/:0EM7'3+#ENE1"5?H%D!1\P1G!S\: M=-\3#2\7C
MKTAYI^X6S4#+;_LZ %+++R#C <QRV?[W4>7%7<,E/HY_6898'P+;QHUB:RN*
M4X;=;V@E ]\<I7\QTS5]0WHS8Y=KY%G9](=L%_C71+>UI_+,M X!6.%D_N-/
MIKQY$@>LBLL&RP\4I4M*DIRE20H'YUT,>C!8]1B0C(H2['8H6C>!4B)K[./2
MD/9G<4A69W%(5F=Q2%8-S(L5T!.$_:C]$))-\&MAA1VG5E&!SZ4*3W<!$MJ"
M/NT#@8/S%-0ULSN4JZ 8J$KO@5G@BLC]4#Z4UR^1686>>*(FZY&.+S"7,X2!
M\J3XZ))C9+D-V],F4G&& $)5_:(K/U$]J;;[+VGBYNO@J+VK:^5VB:Y_HE:9
M'>V^+(0S+<2<%Q0Y+0_^^M<W)O.W)G4Z>*PI1]R2;?I;\J9;P$A2$C"0.$#'
M IOH.,;1J+5)^D>8JMJP=H%#PQVMV&RMR@J-+@Z%[B  4\T3,DT-I[79'NI6
M@67$I !)W<?&LW)"GN-3'ZH@)IB>G3^MD,R.8-X"6)*3T*A[BL>H/G5K096L
MB3,ORN!2QN2+ V2$J; EVI\J?E6]0=8?(X=:4>!\Q[I^-=-CKV.'RIIC.(*8
M-VGI6D*0%HEI!''/A6,?6H9%M=H+B>^-,EW1\DS+>TE1*EL?H5$^>.A^V*U,
M$W+&8VHCMR<=!4VC:*)!-+D%)V^!3Y"G?0QF32))I&9/K2'M&9/K3$69D^M(
M8A2)K&8ZE*EJ&:UIX$D9,=4VPLTI?%S$J*QSFJ,X;6:./)O5!<J21@CSIJ)&
M[3Y4G)XYJ$ER(V[T>HIA[/#*P<4]B.#\T)27>O'3-1FZ3;)05M1(9_$3V@2-
M,Z43INR*:5>IS9/B5M2C/O.K)]U*1U-<MY#4.E!>YU/CM.FW-^Q7G\.T6U:V
M[0&X%@DKG6O3R?;)5P"?#.FK/C6%'E2 ?"G[BI8<.VE\ECZMJ4E[%C-::QTU
MIC>RX)4MY "EHC15.;,GIQ1,\>*B$TNYNY ;8NUO2E[F.Q6X=RB/()(]LC*;
M2KY9JC*L7,C8C>7B(^2;E&<BIFDI*2<G;T%,\^-Q)K#DC*@%U;KC2%GMSLNY
MNNK23CN6&N]<41TP!05C^NZB%R:C[*N2)-4:OM5_MZ9EDTEJ:-(;4'6W7(6$
M\$<XS4OLCP3W6!EJEJ,>RF6$T9K!R6WIK4#6Y0E$0[BTOA8[Q.$K^&%A-;,)
MI-<G)9\;]7'NQ\U(VJ%J:+)>6GN)2%,GGS/%6-5&DBMI)7:#304[NU%M9![Q
ML)X/ZR/^U&T<FW16UL*Y#UF3O &:T)JG1GJF*"]X141Z.:Y02>N:7(SX,1,&
M*?GX$;]^5<YIAZ,[X^M(5%=;<V0!D^5;4^CFL;Y#W16 T<'G=5#(C9P.PZ4<
M!/RIB9NVH;>M#EV21ON3ZU$<YN?XU"2IB7+$<AI:DA !PKQ''EBAZN>W&'TL
M-V4HW^+:^2;GK-G2:B7/S?<RZG?M48Z1XQD<@5QV/[S/*9W6/$EIXQ)O_#/V
M:6OLUT()$1AOF.T%'H2=N<Y^O2M3'-PN11E!2:Q71'/X@5]M<Z7#&@W#:+.[
M'<7.O++7?OE_Q%+(;'3( \7EQ5K33QS?J&U4=1"-8F0UI1/;8N8L#45XDO\
M>LA,&Z0=[3Z3G>HJP"V1@>>*EJL6FJR&AS:YMJ=T62F.S;;H)Y,EH>V*:6H!
M!R,@>1\^:YS+B4'M71U.%RGZ[Y16Z=H[6U^LDVY/ZFGVZ,RPN0E,.+WCDI]1
M]W>.4) _?6YX^>"/I<>?DYWR6'59%NA+^I$%M8[6=-.)GV74=WGE<CN9%KFA
M;B2CGQH<.,*Z<5:UGT)0YHH^/>MQ3]5_N6R[.#>9^AUL2 &;BTR)*&5KQN6/
M%C/D<BL:&V;M>QHZI.$N?<G6[.(O6GK??FP2%LM/[5)Y!(&?XUJSR/-B5^QB
MXX1PY6E[CMH^4A%T;C@@96=OQ)3T^Q%/H\FV9#6PW0)-2@M #'/G6UDYY,*"
M]CLX]A&21Q4%&PUTA*'4J.2<<\4=1 .7)NE8SP:9Q)IBEOE(H,E3"+HWVJ]*
M816:3<E-M9CFM23X.9Q+U$@]E[K\F IQWKN]:J9.D;.G]R25D$)^5,%/4'RH
M<NR2.FPFHCFJP1BDW?"$DT^1%-6X%K"< =TL_89JAK[C#DT-%3R%)^T&'!?_
M !!W"]7U'>0X=G>+(4,]"G<H?0URN-U+CY.VA)*//P6/[-;PQ=^SKO62-JU*
M("1[O0;?M6KCE&4712^GMS)S.<]DE*8Y&$C)((.!57E2-2*C5B(QH(4VJXE#
M+;JPT24D!>?*FFK:MCQ6ZTC7M,M\=@IM[#*4CV8)"4CC!'%+5?CC%"\>ONY2
M;(PT-%;CKG6E#J1(C8[QK=A0!/&1Z4*4Y8WM99AAC-;D+;Y9HR&ENKCM+7C&
M .,^HJHY^R+F/3I\@7'U$S:;BB$YM0IW<A"5'J?05/#D<);65/(Z2+P[UVB?
MM//QYFBV8[8W,J9.Q0'0*!)'T)_=6[BE<*B<9GQ[<EC5:9ZV)MLF)604R&T*
M^/D?X5'&]D[8LT=T&D3V$J6-_K@UT5I)6<VOQ.A-.46F231(*Q2=(8_S#!(*
MCQ5CZ<GT5OJ179UBW-*W C<>?A4)1<>PD<BET$498*$_#K523N3+,?PH4;TT
MP]%58#)="=QSZUL3BCF\:Y);[.V4LPB$]":I9>D:V#W#P]!0PIZW[PJ$NR2.
MV_'&*B.:/+''!IEV3?L(9CJ$X"NJDK3STY35/R/X"WH?^X4MUO)7<^TYZ+M
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M&?1FP[)=T84AGQ' R*SI]FGCZ"IXH*^%4PI""X;/9W!@'":FNB!#VI5J7(6
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..(O:HG[2:M;BMLC\'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>cogo_0048.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 cogo_0048.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" "P +$# 1$  A$! Q$!_\0
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MJ6B;;V' L\X);&1]#FO&I;,CC^3WDOU8)_=!&7IYN3<7)J4[EIY2?#]*-N^
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MF9;B1RAD?$HGP\OK6C#C>6>U&/6ZE:7"YO@N^YPH=IA,6FUM!B-%;3':2D8
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-)("3MFV(WF**@3__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>x_coverback.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 x_coverback.jpg
M_]C_X  02D9)1@ ! 0( )0 E  #_VP!#  ," @(" @," @(# P,#! 8$! 0$
M! @&!@4&"0@*"@D("0D*# \,"@L."PD)#1$-#@\0$!$0"@P2$Q(0$P\0$!#_
MVP!# 0,# P0#! @$! @0"PD+$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!#_P  1" 5/ \$# 1$  A$! Q$!_\0
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M[WN[2D &8_8]R/TC+ZSFK/\ ::657C\8C77@#=3MM&!U>0M=V@[I-)&2U*4
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M1O-!PVVT]JZ,?6%OC?:1AM]I[?"Z<;N.7/UK\#'8T"F_"VC$\QHVV-EH!9C
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M2$6A&@=T@B4!P\(")X54(@6E K?L2%2<HKLI[3I^G^R^2OGZPQT@6@+/)K/
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MO*SO&UF0=VE,[J M9Y<=:8YR!Y-))>3VE9WBK29Q4[2J.[2L\N*M)G'[U_\
M9H_33*TG2>K?J9F0NCBU66'2,&]N]D!<^9_Z=[VMOY8Y>Q_P_P"/<)ER7]^.
M'\WDF6L8\:^A&L:9C_X\(]?T5K6:;JG5&MPX_:*:8IVY(;7V)HC]0N/\7"8_
MG]\?EM__ *[=/+GV_&ZW_493_&J__M#_ (G.MLEH+FXTV+ABA="+$B!_GN6/
M_)<-YORLK_Z__LU_$SF'#(\3BTACFAS/<#P0;"Y,?Q-.G^:"8=)<7?D.RTGX
M^A>:4VQ-+ </:5T\?%IAGG*]5^D_T7ZD^J>7)I_2>IZ ,^,N(P<W41CY,C
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MS=(&HG5CCM: '97HB$2./)J.P =AW.KDK+_II'ZU^F+2/_9A?5$;W_G>1_\
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M=0DAGUR N.Q#0WYYO==_#^-CQ^Y>O/Y_S,KJ8^/T/TC_ (?=&TB.-HTR&VT
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MKFLI[];<7)<+K]/%=3PLK2LN3%R87-#0>UQ\_=9Y8?Z>CCR3.>!P L[XUO\
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MZ".T$H_%>*&Z.T_2K)E-&4#S0[=T?VOZ1TQQ_9[I&CZMJV0S'T[&=(\\GM-
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MGAGVL44^VRUH3^!#H^^!WN\!7$7(/)%E0;O! XM/2<<IMR+-,1(<XFT*VO\
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M'$D;E B-T@W>X_*!I%SC?*"OB!<;Y0<=!-<H+:1X0I7906GP)M L3;R@HL8
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M3P@,T^_(0- I<DW:!U5.G+A2"TK=;Q0!*FP:4NA>>6D*9B:MW<PT0IL"#Y'
M;<++*>JDW TSS(*=L%G8>J6S1&S86>7IR YL03<BUAEC6F-9_5-!BE[B8Q9^
M5AGQ=U7^OT@QOICE:UE?E[6$WL/"7'^#WRU8RY/R<>.;M>S=#?2G!TN"+T\0
M]PKN=7*]G\?\3CX9O]O&_(_*RY+K%[!I.CX^'$T,;V]M;?*Z+EV<^)R"7 >?
M"1KV ]HV0F_5+@03?R@]Q N;\H4IF_X;J^$#1:]Y[J\H")=W;?">*:KF!'(5
M[A Y'"N4; 5PL[)6G*J<UUG911JHT?A&CZU\.5.JM-H)-!&J>D^UP\)'UJ3
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M<<=]"O(.]JF62DR?"$N%_P H1E]3:X5RA+H?1L! 6AW&R6CVN$@OA/JOQ(R
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MFZS>?E'O(&^_RG&W4GR)#1/RJD5C-$682;OREI>BAP<9" -D:31&/BN>[?\
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M^W6-<T4LX,OOB3@:4UIC T[V@<*6\QFBG*D M5(J0MG)(-K50"1*A1(UI;N
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MID=6ROS;JH+&2U#+W=NJA:*?Q8LVKE$@_$F86@BE<3E-&^.6/;NKC/3N5$T
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ME5/BMK\2$GPGMGEGH^P<:^=O[*(QSIOCXH(Y_A%NHY\A\<+6L &ZGL6EA!H
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M)LL@ULIR^'C] SY0;N7+%N GU!IL6/W4Y747ACN@G9WJ'M%+#*NGAP]0<RW
MM\\KFM>OAB/PHC0)&ZRRKNXL31C.W=9NJ1>R0M^%%@ZH22!AIKBHJY .5D\B
M^5CDVQA'F9//"AI(SN=D$EW"%S%F,^7\UE%B;&8U)X[2+58S;.^,?JI/:X [
M+21G6-U<",.D<?*N1+%ZH[\YOA5II&7SW;V2GH$6;(19^$Y-T;+(LSL<7>IN
M#PKZ%<HU>A:U^7N<!_=/K7/R8[>D]/:_LPM>#M9LI]7'9Z]$TK7&EK07#??E
M3<=+AE-JL7:6]X1H,_JN:WM(]0TIT-,'K>>VS[DM#]L1J^<SN([D2-\9IF99
MO5F[O"TD/8O''%;VGIGE6AP&@@!VU*I-,LJ:ME[6[*OC"^U3DY7LW2/1#J&4
MSR[REI6F;S\KO.Q3TVQ]+X622S72?5K^FDTK$< *!W1<4WXV.FP$,%BD3'3E
MR]IVT$,:-J1HM ,^0 &CX1H:9_*F&_N4V+D)LV?DVG(C*,_F9)WI;8N+EQ),
MG,<T^%K(X.1;CY0<V^[^54C ;%DT;[D]#0V#*_YJ1\*P?!FD4.Y-%AKB9Y!'
MNV3T6CS U(6/>JFXBQH=/U.J]_\ *J)TU>EZIW?U_P K6%INNG]0/MMU[K6)
MR;S3)C)&"M(PRFS_ !W'L%JV>A3#LC9=4VN\4$;'5\X;\(*P-,+)0- YM@59
M!'6X[A!P-,P6194K*\L]H-?*0A1DGE3^U%LQ !^Z5.71=/1L*%R@98QN4M+V
M!R(VUY2,MRHMN$@29C.=DCA5-%;MPE8H.Z(> HL"/8I#];9D9L[+F=6R#.A.
M]!+X/K.Y<1L]P144JFB^ IOA*'1^4B$86')DO#&,M5)=EE?'J/1W3+Z:YT5D
MTO6_%X99NN'ES>Q=.:#Z0:!%L#:[^NG&W>FZ6WVVPTB3WU6FJP,,,8 UJ+%8
M_P#9RR,AK;4[J]R?$C)0]J?9SYY*'/+I-_*/KDRY,I5T3W T#L%)S*T:QH(M
M'6-\,ZZ8RX;HZNO#*EV;%5[*I7=QY,;K<7=W CRB7W3MQSK ZO +/:/)3M=.
M&0CIJ)S<EI'@A$_VGFY+/(]EZ>;)V,L)9UR;VUK0.T7RN8]U%Y X0-JE:$)2
M0#25^#'Z"E) )4:=&(":0M<=_LG)-M?T$E>VBKBYC*72@/) 1]5K7Q6(*%4E
MU/8O"@:7;HTG*^-#BPAHH!&W)GG1T$9&P"SF596#F1]HM/W2=.J52OD&^0''
M<)RZ)3_9/M1I"VCE/*ZFX./65]9O7,J0O#8B-S7"SF=R^L.?*X>8@X(^P&^3
MRENN=80*2#G"85RN-*,O58E><\OC(/*C31F\B7MD,;^ IMT-;]+IIFP/+P:!
M.UI6GU0=J0=P1^RTF41HMRLEK>"E;XJ2[)\O4+);W;+GRRTZ,<=_2?)U'L=^
M98YYUT\?')7,7-8Y^QW6&6==G%QP^P6NEJ]PLK:]+BDL].H8 QHH+.^NO'Q<
M20 GKQK,K54DO;PHL;8S8::<&R2L+O\ ;68PKRLH@[N46-9(3YN0#=%9V*U&
M?S9O<ZRGC!;IG=0DO<*IC$6LUJ+K:>Y7)IG65U1W:QVZN1G:QVL7V$_)O=5K
MU+%ZHT^[?E.0]Z974+N@GI3/Z@_M[@5>,]1EDS.3/Z<IWV*WF,K++/0C!UP0
M/:P/V5],8C^2WZW73W4+* ;)6])74<^;T/1^I0&M#I1MPLLO:F4^9U R3\T@
MW4+V!U/6V50D"6A-L/KFK- OU!:?7;28_MB-5U5I>:?NG,5[L^%T>H#NJQNJ
MZZ*Y4\T[(8^MT:3?C28TC.T.[N$],*O?EL;8[D>IU"O/U)K6%W=2"]9C4M3+
M[['B[3TTQA8<ATIY5:;8G.EXKGT:W)3\.W]-CI6GN[&D-W2TFUI<7%+ !6U)
ML=")7%K!7A34[I'J$[.T[[H:2,SF9!!.ZFM.LT3960X@BT1EG"7)[G,+EI'%
MR39%E_=;XN#DD5PS.C<!?M6NO'/J#HL@&@"I1?!L,Q^4J4]&13UR4CT-BS'7
MVAPI5+46&F'FAM#NW5;+30Z?G@ 6[PJB=1JM(SZ?7=LM(BO1.FLSNKN=R=EI
MM%]>HZ#+<#:Y6F-M9Y8S32PO(8-UIMF+C=Q2)Z0EK10* Y(2T6%43?H61Q([
MO* #F3VFP,\U=?"<9WP',]UE)<MI7E;N(*F5I"C)/NI%,OD:'7:5.38&:/>@
M%%/X#EC<-J27*$D9W;$*6D]+<II(*")<F,EVZDRZ:&P36Z2@3HW!Q2L"'8[X
M_A+0?KO-@-E<NG209T1%[)41F\V*RE4TJFCJPDD.V'U'!H"-!LNC] ?+*'%@
M((L+M_'XN^G-RYZ>X=*: 6-:3&*L+W.+AZXO*Y>7>6GI>E:9VT&L "BM=-)@
MX795C99_&F,V>8D36C=HX3V64TNE<0 /X28YYA9'4=MD.3DS18;<"4,I=BXF
MCFD+@Y@%)M\5HX0Z\2W42 UVWA3MU\=8W6:/<:\HE]=N%\835P+.WE.NC'(7
MTNP/F!KAP3E+ENWL6B1D,92C.L8T@V%$K.?$W+54N=[B+\HT.R*852D_*FG/
MH28@--I.C$HS)O<:/E#:%\DKC=.*<K2(L&X5PZM#>YU>4R,,'&HC;=3?K'/(
M[QHSPH<>5,XX0!=<)2#:5FJO9%)]RD<\?52-#;B1QQWY2@U" !SLF/&LNDY1
ME=E?ZQGG$9;^[FC:SVX^2]JN[6_"I#CVBN$!60 @(/ (-A358EN;&SM/M'"B
MK9S4\7N896BB?*QSOJHS^2"]OINWK93LR6:<XI]Q/*?9>H$R=09)8'E'8YCZ
M19^8(R76LLJZ,,6<S=5N3M[S5K#)U80QTB02.:X[W2QRKLXHW^D0ES 5$=F/
MAXZ+M %>%-;8Y*)B6CG=/]-L:$R20T$'E0Z<?A;DSUL"L;&\*LF>S25C2%.7
M,+)M18=)\QP<$I$D.9PY::2SFH[M)52,LKIEM3:TM=852,LJQ^KF[8WP:5)V
MQFI@6=OE5HMLKGF@YWP4]*E9C4Y!W'Y5XSUGE63U-XL_JNC&.?/,I&0(G_FH
MK7KMQWGU3O1M:?"\=TKJM1E@UQS[-UI74C>UO^H;6-Q6>1=2C?\ U#LEU4&S
M.HBX6Z5Q"756V7U76C+_ .(2%4Q5V\97+U0OE=[B:6LP1_(A%G%Q%.-\JKAX
M7?;0Z;J;&T"5EECH]M!#J[6@#N-$*=,T9M: :[W%/0T2:AJ_<TD/-)S'8GGA
M#/J-R =QHJYBN9:$Z?-ZIL'@I6-8W_3T+90RVV25GOU.5;S3<*HP0 FS[&HC
M#([(W01;FS -(;M\I48_66U+([;W\*6TC,YF59(M36VO"R66]G)QCE%+XG.'
MV*K;FSPV39^+0)&QI:XY/.Y>,L--':[<KHQNW'ECKU*&0M=RKL9T?%D;<J;$
M06R:Q?PEU4NBR#?*>BT8XN3ON=TBT>Z?E\=QL(VFQJ=*RMP0?(6LJ;'IO2LW
M<&>2#LM6%>N].%WH-LJ\/J,FKQR7,:";6K$6UW;V_=,"V.);RF')/RIIOT,=
M]O" IF:V^$%0$VQ*?Z9TNGDW(!158E\I[GFRHGUI^BR5@<XT;3,')"=TC"S1
M=JFF"E83ND6P4\7;N$JTE+,J,^"I65SPWO20@&:#F@EI9?+#1*04^F?A ?KO
M-!<2%S6-ZSV?$3Y4U,K/YD5 J='LBG:>\[JM>)OU=IN(9LJ(#R488[+/+4>R
M=$Z';F4/ \+V^#"3&/.YLWM?3VD_AP.YH(->%T96S]N;"2_6NQ,8-(K_ *+*
M;=%T:0L[:3T(90_E'Z)5%<F_+^Z7[8<GPLF)[N2KOQYN5]=B)OE2N71C ;:$
M-)3#'W*63K_'FZ,+11%!+%W92%>H1"C^BJQ>#$ZXSM#C]U,^NOC8'5FVYWZH
MCH'])BIO_>"*5>R:#O7Z*:S_ $?.'M407ZJH? 5$@.$H8>3\X3:8A9S3C\*6
M^,*)RUTCA058M@#Q[BBFBW_B (/?ACC0]Y[@.4,\J<84(! (X2<V>1M%".0$
M;D<^4VO%J*<=(V4?M=GCYG*J(=?P$Z$%*HJE)#N3PKFM"TMU#/&(SGA8YW_2
M>S,3S29LCW%SB"XD;HE<N65W?5\,1;QM^B$"J'PI4B\"N$X*&>520LLA;Y*R
MRJ\0DLG?L5"BS-%-+?"5GAQE-6'HETG@FUCDVD9W41^*Q;%6%EV:R,AGYV1A
M/[9!MY3[QI,2/4-<C>'-!W*SN>V^&+-39YGR@P$\WLL\KXWF+>]+8Q<&N.]T
MLG1QS3U'2L8,@&P\>$HZH8.%-W37 >12BML*699-;'RLZZ\*49<H((4.J6$N
M2\M-V=DEEN3,""EH6E>1Q=\IZ2496X<KD995G-0\_HBL,JR^IN 8].)VQVK'
MVWQ:TB&,U-W*J0,CJCZL>$4YXR.J/]YHK7!GG6:R]W&]_P!5OC'+R4FG;;UK
MIP9^UR(F-X()_=!XY6&V)J;HZ:'._=3ECNM\>3PVAUN4  61^JSN#69HSZR2
M/S']T3!7;99F9CCL'&_U6DP+MX7/<X[E4QRRKL;B#=HOP89>C\;*,>YM9V.B
M9&,>HFK[C^ZG0MW\=?G%S;L_N@B_)RC);+*J38 N=3A93F(WZ:Z3)_K@#BPL
M\FV+TGIZ;M["/!"R_8R^/1])R6&)H<!OY39[&Y,[*]OP@??&<U+)#03^J5:X
MS3(:GF7W#[*<OKHQFXS<QDD>0U2K3L>+++[:X1LKCM?^"EKA+LPRXP^9IXHF
MO'PJQNG-GQ[C-ZEBA@<\-JEU<>7KS.?BNKHM#NTV5U2[<5QZB8)@25*:*$Q
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M0:V4US".SX*A41.R1OF^X6@+8Q8I!?MR6:/&87O<#XI3E2N6F:U+4G3ET3+
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M@6AD5 ?=99965KCC+ AW>;4=JKK!$+0:%+65A=[3D8WD!4<BB1A)WX4=JUU
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M<(XW;B);RM)]:6.EW:J+3A?866?U4@22;M=2G1Z#RS[G_P"*$98;4/RMJ_\
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M*D2H=A\ISZ+0T[*W"N(+,AAW)^Z5@Q!,F+'4C$LIX:867QNBS=+&Z\-HYVO
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MXXLE3G\/B^T3,.QM#RLNNVLNR;48^XEP\!9V:\1E]*VDAU4E(C+*FF&\ #]
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MD?YA:YLL?VZ)EM=VNJ^TJ#1D![3L4 %,S:W;*HB_0.0/:0%4GA0!+L*6DFC
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MV1O3IPRV694(-D-0Z\.30:(N@<2.$]>+RLRFSO3<T._,?Y4V.+DP-XY.]C9
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M%*F?[><=6?\ "=OY53X4^O%^K'CU"W_F4Y.G!N?I+ #$).VA82C/+Z_0&F2
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MVNR/U+T5J+)M.A<3=\K3')SYX11U_JC8L&4AVU+3&^L\</7Y5RM4CEZL O\
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MK;CC;/R"61V2*5V:K"Y>&6-C@TARY>T\T^-M  ;VG48M'@@AFZQL=&%]$N>
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MW*M;B+CII-._U.US36ZBPXTT![V#[*=%9N#FR,8S\U$(LV,?ZL]U9C,S-/\
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MI+]KEQ9?7H8?&.R\WN=VAPLJ5ZTS^;%<A>3:55"/-G:TE@Y25"B8 DN50]*
M;3&A$(X*FG!\'/\ 99VJ,H0>T#PI6::6.Z=K#Q:BIOQZAH@K$8T\4LZ@R-52
M1QUH)X0:;6;>Y*A(-(V'"FA(0%PNCNC0V^= 1P$:&U3VAO"05R>*\H"HCY2V
M2) ''E!I1N[;W(O[IRZ"SM#W;?NGN_HNLIAAY.;"0(LJ9E<4\H[6#I&[Z*^H
M&JZ#.W\3FS2X]TX]VX6^'/8QY..5^AND^L=(ZA@#'.#Y30LE>CQ<^_*\WEX]
M5JV:?'V%V.UAK[;KLVYT'.DA%.B(1NC2KUFN-=A!3V6GQE Y"-CXBZ9H*8[*
MY9"6V$CGOH?O<ELPCIG]QW'*:+/0TSS>_'E,X69;V@GMY2C0HRL@BP2@5G]0
MR.:*"C.YD]!PM)<(,V=HN^$JN$T\^VY6=,KGG!)W\I&"DG8-T[5P/+E-HFU.
MU_HKR<MH))*FU)//E@DF_*G8#_B@JV']YW<*;MOU@/)V::48[M3G)KQF=3C[
MFNV73AE=,YC&.U.!I:ZVJ]NG"?UVS<\1]1Q"WPTPY,Z9:6X- OFMT;NZYLY-
M;:_2IV&K"K;/&3]M-BOL4E=-)NCX0*6.7C342D8'-JD8T20!DQD#V[*RR*9V
MT#W;JI\263M;9V1;8<D5AC:X"GM3U$"UI\+7S06X\9KN/A1OT7X^F<X BRLL
M[)\3+0,CR#N5R=KL]E\\C6GN*#!39;": 4Z,OS"7>X% A._47XLK@^0T/"2A
MN/JL62 *O9,K-.SP-<;8^C]EIJ(W0[Y70N[2[=39-#=9[7V1YL,D<E6?)7/G
M&N->$=;Z-^%FDEQ]Z-T/'W7-?'5Q^LE@:\^ ^G(X@W2FVM\<8:'4H<B._*4:
M>3X%_$&)_>UVR8V)AU7N;VN=82HVJRL@O-DVIM((W(./("QQ:;\)[7H?'J;9
M=K)(Y3OP224NS<EC#W@5X46-H3Y&6QX<UPNU,7CZ5S93H#8X5:/Q./5NYP[K
M1J#Q:[.:XV.$:A[0DRVT+3!=EY(<=WVA0.+)J0[J=#:&5F2$5WGE5!MN_H'E
M&/ZHZ00X[^H/_N5V_@?_ %(Y?SO>.OV@]S8W.-<FQ^R]^V[?.S%2<T-]KMU4
MO^SZU1D:BUM@;*K_ -%UJINI-H>[=+T=:6ZYU=B:+@RYN;D-@BA!)<XT2EER
M3CF\CF%K*=#_ %-U#JSU\N3%]'#9(&1.=R]G^Y1AR?R^SXK^/30ZAU/%"'1P
MRDN.P"TED^+F'^RZ'5(\2YI3;WJNVCZ!\OJ1I!<7$_"G^77Q%P(LCJ1QD]LI
MV^ZC+FO^QCA)=J3KI<.]LAL^5GERVS6VDX\>W;7J>'KO:[M?(7?JO$_-_$F5
MN>,?8_\ $_\ *7#''BROPY.H!\;7-=5@%>'>.X7U]KQ9SFQW@H?F@[$VIL=$
MS@')R&VITU[PFS<AK[":;FR^H9;FN<"[8<*F-S8_5LLN)<7&@M,8Y<^1D=3E
M+@27<[K;XY<\M^LUJD_:P[[H895DM4G/:39W\JXQRK(ZA*239)LK2,;D6/)G
M>?9M2N:9?R2SXGB:=).[_2:TN)H7X5QSY\FKNO2?IM](-=ZUSV8N#"]L3-YL
MA_Y6BQ>_RM>/CN5\>7^7^;AA/]/?<S_#1TCA:2[#_$RSY+6COF.P<3X"[+^/
M->/G[^;R997>7CR#JW_#GD8,<DNCYDH-V&EUA3EPV'.;?VE_0O3>N])ZHW)U
M+&:YL9NP-E&,ZTL_[S;VUWU/Q<J!L4\G:0*.ZZ?Y//7).'UCNI.I\7*OTY3R
M5EEGMMCAJO,^H,]LS77N*V'PL*ZL?&)FR'>J;<2 EIJ"SLUC!VC8E!,YDR!\
MKG.W^$:-38?8KA,;<]-G^U VNA:WX49*@V&,WLHJH8PAUBSLI,VTB+NR X<=
MRC(7X]/TT=F+&1\+)(]KFE!)!_:=O*!NK06NHW2!NKFL:1=HT/5F[6@ I:&Z
M@YQ/)2-3(T?"0#2;"QX0%)>X\E+2M(%QO=&@^!LHT%\;B#01 -Q[!W*-@TQV
M"P[R-PE(5:WIK6L_I^<3X4SR+!(!5XYY2^5EEQXW['N?1/U5Q,UC&9W^E*T[
MKT./\J[]KDY/QIKR/2<74](U.(3"8$$>5WX<^&4<5X<\:Y-@84@[V2!7+*5Q
MN(*3"C:?8>[_ -%6O])O_867'<T\):R&HH>"UE%.?/4VZO@25SFC8T@2T-)M
MNKT <\VQ_1*PY]+,F5M$^5+0ASYP2:3%C.9TX:'$\HNCTS.;EN[B0XT%*\82
M9N2UX_11:HERLFKW*@]%>3E@<'=*KDV6SYH Y4;,!D:B " :V2V9/DZ@7.([
MR@B^7+)- I!#\0?DH#^^W<1O9(6N6+H#3R>TJ,9Z67PBS3W!VR?P2,OJD8)=
MMX58W;6>1F<ME.<*_A=6%<O*%BF+7&B1XY53ZY<[XU.A95BB;5(QK::9)W-
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M"J331W33%['#X3BEO=>P029L- M((=]*35/DV2 .67W(.(2.L !"E: DP$E
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MJQR)\T=H-%*8+F3.9T1>2?*N0[EXSFHQ=MBBM9')R9$$OM>Z]A:T<U^G.AY
M!&];A5$6/0=%F! WV3*5H<8@U16&;?&^"#PLJH).+X5\99%>0"&FUK^DPHR6
M=SB4JK?JMH( %)!2]KB=@4LLD3ZX8R >=@N3++;>!9CVV5B15E2D$FDX5*IL
MWTR23RF0*>:.>-P]1M_JE3C,ZHWT27-W%++)49Z;5WX[R^D3+4TFX^JWZ]#.
MT=[=_E*YKF)7ER-:?Q> 0#R6WNJ[EU--&ZE>SM;)[;/!3F>_"N)^-2;E,-N;
MO]U>F>F5Z@P6SL>1ON2L^2>-N'RO'^I])%O/D6N7)W85YCJ,#L>4^T_*AI4<
M?,[2&WN@;&C))'A!Q/\ %_<("N7,LI-8I=D6[9+]K#RY%&MD]%L*[)IVR<$?
M?BNX%MA"X7YY+!W@?=."@F9;GFDR7B5U"@IJHK=,?A"U4DOR@;5O>PQD5SLC
M6RM\>Z?X;,%L&3JG4$ON;$T8[*^>?_1=_P"-_7UP\UV]GR=<(-V-Q8W79>2.
M:8E.3KKR>P;@K'++9Z!2ZMV,<]SV]K1=6I[ZA==UXC]0^N]0ZWUT=!])S.!L
MC.G9N SRVPL,LNS28M[TEH^C]&: W%QF%NUO>[;>N5<NBZLKU/USU%BZDS+T
MS"Q\S3V;EKW#N)^0COJ[+J'Q_P#$-TO-(S3]98[3\IGM[*V_=:SFV&TT[JC
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M2]HH&T]*=]7;W._LC0<$C2=C2#]3;+?)0'3(*NT:-7Z[>ZR:/P@Y5K9@X;E
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M/ZOCS_CO;'RLQJVB:!J0?'D: 3W[->   [Y"/_"QS^>/3XO^:_)_&NYG;_\
MNSX^C.AY['>GJ$D9\M[.%S\WX-E\KU</_BCFQQ]2T[Z&:&S*#LC-EF:S>AM:
MC_P\Y=(Y/_BSDN&K:]'Z<Z8TG2V"##T^*,1\.=&._P#==$_'QQGQ\_S_ /*<
MOY>7N5__ )/FX_9^4 ?HM9\T\Z^970V%L;FAUBP0=TYX5KRKZ^/ZWS^GG:+T
M;IS\N7,>632Q[=C';'^RJIAQ]#/I4WZ>=.,BRRUVHY36NG->/]H_1.316O7
M&L<V,- V5)%1QAW;L.4X#&_1C:.+(5)^F<3PZ   7\JIE^D6>O+?K5]0QT=H
MV4R5MR>@6Q?>^"LN7DUY&F&,?F_Z4..J:ED:EFN)?(XO<7;FR;6''[?6_)_B
M]J+V^E0;2Z;7+"S/E[?<I6SV=D@N*57C](\G('<5.U:9C6\H!I;\\+/.M..,
M9EN[I"?D+&M0P .Z4^#W;1=):><K.B;5@E1E;%8O<L2$08S8.  %DR_:X<J3
M2W\&D!-I<!9)_=5H\;ZFPD@F^$+VM[MVU\(T-K6 %W 4WP;7M8"> DG:^, >
M$:'85$!Q2:1D;#5 H@M%0LJB=U6B&-%@4IRA45"QM;@'^RG5+0AD;2[8#CX3
M@$LC;W46C;[)C2X,8.&#]D#4=[6_[1^R!J)%C:_*/V1L:B#P.W@)[3E/%1&W
M">T:<+54+*.4!Y33JN.KMV0I6.$''Q KA 5(2^H$[A1:N1%P%U247('D \!/
M1JW)6'$'<HZGN*7GW$(T-J"2''?RHNRJL$WRJ0BYQ&]I4Y]1+NX)RK<:YO%<
M*TI>L$!_0K3LB@TC?POJLH\K"M/A2>P.OE<W-/'3QTQ9('-W-+'311E$$[%7
MC\*D^>SN!*VC+;-:C%MPFSNV/SXZ)M7$$&6:<-U=*#M*E'JMW_E/]$WVB2>P
M%*SQ6+0.>#$!:PY/CHQI1G_E/Z+CS.D1>6R$;K.$88TW^FT$^/E5*%DLS:Y'
M[K.KC-:F/4#K^"IBM^,OF0T^P.%JBA'GM%I5'[ 94GM(.UK*G&8U5A.P'(66
M4:8UD]0PZ:?NLLHVF3+YV(0YVQKYI18UE(LN&0!_ZFE+64DSFRQ[<VI;;)\H
MU:8+GYCHW]NZ9+XM5(':EH]C(\\%@X_= 1GD9.PAPW0J$.H8P!/:-DR*9)#&
M0VMALF8;./JP4J@K)Y3?3GI:,T#L+12JA_O?5CY4B+(W60WX2V;KRYO<[^D<
MIWP$G4/4.5IF"Y^FZ<<IW]8H[#Y71P\<SOHN5GBOIC5-+Z@:6N? )P/?%)7=
M?Q1W6_)Q9<7N)8XS+Z=_]A=)S91EP2Y&)D#^O$?VT?NJQ_*Y=:TJXR?LCUZ'
M T/-9I?3\N5K74V?[()LF7UCCL.Q);PTCE&7Y&?[9V?Z>D_3WHK%Z3TQD/\
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M#182)!T9K8)!T#V44!\&[[("P TG#38UQ.Q_LF!< +:[D])HJ+E&B%QD44:
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M8WM\(VFS;@:6CY3)UI)&XHH$\]?.X2.Y;1!(\I[)/O0?U(2GP@JNCF( ).Z
M,AGV!OD)'M:';WW(T-KA-VD$I:&U[)P1W<(UHK5C9QP=T:5*EWAQ'A38TE7=
MP'E+1H.<;V*-!T"Q=J;=!T"DK=A FQ205.-&DY"TB18I5,1I&JV5%9I%Y\)V
M[&]*7#M%\H'967>:2T-[5F3?A'4*2[N\*M'V5OX(2T-JB*2D.AWD$U7]T];+
MXCV_='4;?L7#E+'BJ7UKR:U6ES;#CA6F?3Z"4$#=9Y8M9X80N!W)6?Q57/<
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M=C'\@_*=R+3TS&AAQBV!M4!5K.&8X$#\I_:&DU]EKC+:G+*2-?INE1Q1^H7
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ML@U4@(-E!!\@$MV^4X5!$&RF2F1K@=PJA;4OCLV0F%+F&]AL@T4!$QA 4O8
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M^@OT[UW7']1:CID,^1)SZL(=1^VZUPY<L8+IHM+Z$Z6TF$0X6C8L'8*;Z<8
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M)ND#20FW"!I8)#?*!(^+R>"@6/MSY0C3X;<[H@TF.%4)( 5PA-6 [(#X("1
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ML\K?^/&QG?/HV;6&8['&9Q  LTHQXIE535^,=K'U0P<)QCA>.\&A=[KT>/\
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M:9V5:W3''AA1U&ZN9I?GL*.IRW?HB/36UV]IM5U.V+X]+'^U5UM1;(*9IP'
M.R.E3WB9P&_='2CM%;\0,-;TCK1V@67%LDTE52P#/$T7]E%$+W.#-B:*D1V.
M:C5A!KFR[WLD8@26T)IR38Z@4;0G8(Y3E*K6D=@5RQG5K' 592V<B2>QI\GM
M+HY3#CD@B@(D$H"):;X52E70#7"-PM.T%8='"J$^52)?6%9N6 =RF>WS7#Y5
M[*^IM?MLC8T[WN3EB;$N]WPJ)WUBGHES)J;1*6@^]7X*>CTDQQ.[]@CY]&D^
MYG^Y/<&GK>7/W6>ZU[]Q>=GDSFIR&NX'REK3A_(O]62U&1SB:*<>!^1]+<.
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M&FN1II"61UO)0:!)KE.%0LI*! <P%<)-,9-%\["0A6B_.QG&,R@\! C7_1R
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ME !2<JT*7D$[(.!I$J=]"2?F<@_@&4C=(ME\_E( 9^"@R[)\I4%>0I.$\_\
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M&U0BS7N)*5@OPCS'./<"5*2.< N<E?BH4Y!&]J:HJR3S2BG"Z?MK=35Z!RO
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M4@N8;%H B-_M[4!<QU;("R_:=_* M8_A 6!WA 2O[H#ZS\H#IX" IE&Z '<
M;  0 \C#9W0%!C[3N@.T@/JO9 #SL#19%V@ 'Q42?E 1  !;\H 7)A-%UFD&
M%AR'02"G';[H!QC9T65&<;( -\$[I6*W-/U9_AIU#%@Z3?I@?1:\4+7O?\=E
M.NGA_G_Y1[9');P%Z;BL$#E!+0+JDJK&K'1["BE#RW5,L3O!3\3J@\F(]FX2
MM7)_LGSL?VW56IJIIGLZ'D+*E&<SV=CJ657 8L&U*]CHC[6K3C3EZ-A.RV0,
MC)KDIQ-6QOIR:5[9/<E53X-:; 2-T$WRI)8S\P5)6#E 7QI4(SL#FI'"/5(M
MC0\++*;5+JL+U'B]\3Q2Y<X[./)Y#U5A]KI&$<A<O+CXZ<:\SU!OX;(KPN.Q
MT2J8\C<;J=*,,:4DBS_*=@V:0.)K=5,46FL,?>&JNJ>QA%C6 :53$NRT8@\!
M%P'9$X5E3<!VBDXALI:+:A\!#ARIT-I=H;O2G2MI->+1H)"3?E.1-$1R$(0N
M;+NJ@6LFW3+2QF115!,Y!^5>R0,NUV$M@+--RD99D3;H 7US]T!YX]I([J*[
M5JR:I()M>X>X.H@*\/*C/V>/T3]%]>=-BX\3G N8 VK7I87MB\SEEE]?J3IC
M,#XH2"+I<N<]/CRC4%X<;)%E8V-Y71R"D:]KF]P]P0%M@^4#;HY0%C"-]T!:
MQS?]P057L_*IJL?B22GR ^0'R X[A 5OX" I?R$!6[E #R$!YLJHFAW?F/ZI
MDI<@XK?^4H4&>@!9D%0<O_Q2* I_*DR_(\H,IR=B4A*4YI'RD<),W<[*-+A'
MF\E*F1Y6SBI!)E=V]!*F393G!I%*3)IRZC8*#E+YW['=9UI DTEBK4FH.PW2
M >0@\(T<1::2L5*C=DVEHT1R5<\#N_AP"5$=!WW(27M\\GP+0;C-N=DDZ2'/
M*/1(L::-A-2QKR3N$J$P;\)!<PEH0%S'&N$!<TV!\JH%K'NJJ*FA8T]G"#3N
M]B@.M-%&B6^H*Y1\#H(<#9X0%+KNR$!4[DE 5/&Z K](?" X8Q1I 5EIK<("
M#@ $ '*#?" &=RJ@0D;WL[4JJ?"K,A]*R D*KQ<FC5IY#&1Z9]+NO<WIO7(H
M \>A.0#]MUW?B\O2QQ?E</:/VSH>HMU/!QLZK[X0"[P"O?QO:;CQ<O/*:#?<
M*DB(N$JO$9$TEO!4KUM\Z+N-H&E,L)'A32T5YN.#:09G/QS9V4V%&8U.#<T%
ME95;))0^-VP/[(/:^"1W]6WZJL? 88[[X\+2:!A&_N&_*J,ZN'"HED6Q456Q
M$<FZ (C4C]+1RJ2N' 0%T82H2<P/:;\) MSH/:4:\*V[8_7L4/:Y<^>#IX\]
M/+.K\'9Y /%+FY<?'7A7C?4F,8G;-.W*X+-.G%FVREDA"STUV9XF18 M5(5O
MA[@R\'PM)BRM:#$?W%NZN8L[3O':7=JTF*.U,HL;O )Y5=2[+?\ +^X_=*\?
M_0[*Y=*O< J+Q+[!9]-).S2?[*+Q"4)+@. -M=^RCI5[!2X;@?RE3EC='*H,
M1CLM!*GK3M?-E.]BDK$)B4TG)0M;. T#N3@2_%4.05<TGZ[^)^X2/Q!\H+"
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M)45SU:Y4DZ']WZ("#]C34!638KRF'+""TBA3YS;;P@*S&TC?9 "Y$8H=FZ
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M#=O*B^G DCB!9!W4Z7M47"DE:5\^%.M'M]>W:04]C;CN$K1MP$C@!(Y7W?\
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MJFQY!YV5RE!<615$%5*5,]/U%T;@018^5<K.QI=/UIK3=[GE:S)%Q:G3=;
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M<G;L*9%H/X"="IRE-5R$5R@@LIW*>MA2]VW(2ZF$EY5E0,O!51ED$D W1LI
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M::_,DJ>K*-<H"!%[HE..5O5IVK1NBD3M@<E!6Z280=P4AM:TBDJ3[N%H /*
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M9"BZ5E% !R"GE VH>P$\*-&J=$EH*'QV*2"A\)YW1 &<SM)5!2>4'^G :/*
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MR\N6YN1W#Y1/H>Q_374^]D30X':EW\7^+R/RIZ_173.9WQ,<#=T%%<F4^-]
M\&%I)'"QOUM^EK/RJ:,?BYOY0D:)Y0'R ^0$F<I5>'U-2U?)4..Y4A4_\Q51
MGE]!R@]YV\IG TW*"H";DJJB@I=CNI. YMANJJ[?"Z=VQW4Z+L79!L'="<KL
MOG\H279#2;H)5K/A;E UPD91E$;[HJ"7)_/:55B2YEAY-)+*,EM$E(Y2Z8'?
M8H/9;D@]QV*# R@[H"DC;A%")(KE0%/;\VEH./CINP*<\*AGX[:L<E @-\-$
M[(4'DCIUTI#C7=II(DP\@V$@N8]:!:'ENQY^$!:QQ(]PI3H)<HT''1APW2L
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M-TX^7%^BM"U%N1B,<''8 ;KVN'/^KQ.?#6308^1YM;2[8ZT-;D>+33I='('
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M7=K1=TLLH>]' - *6D=[@@/NX(#[N" ^!M";=K(W  VIJL9MR7W;A3<M+F-
MS[6G+L?"_(<"@%,TM;(0"E>0=R@XI>_R>%(^J)7BB40: 3.!M/0T73D$[(,#
M*TENR/T8*5I 0"_('(2,MF\_HAF69 LTDHJRP=R@3PFRP4#9-D-+K(\)G)LI
MR;W4U6M%TLA;N42C5#22%GN!.^ZJ916G8L]S.2GL6#\;5W-H.>JVC1MC:KP2
M\D):V6C*#5&>"GU K\7&ZMZ4Z*IMD8X;E&B530,>20E8<!S8;;L@%9W%<I?/
MI['$^U*XENE>7I$;CLT*+A5S*D^9HS ".TJ>JNU)Y]*:PD]I2L5C?]E\F$X$
MTU2H*_%<VS6R)5:4/C(-\!/8TBUS@>=D$L;(0F>EGJ_=!:3$@X03O>$&^[R>
M$!:R8#E 7,G;P"4Q8M#_ +IC3[<FT%JJI$M*B@[@J6BH\=J6@K.Q4V!%TC1\
MI:.72OO%'[ISP;4R2$;!,U3GFD!0]Q4BJ'OM.(68)_U@!R2KQ%;71F'M;?%+
M?&5CG?&IA8UL0M5ICVB! LTG!?76.HVF5@F&6W<I@="^SRJ!ACO^ZTC.BBX%
M-"V+8=QX3@LJYI=RU/:>HS'F<WE5*1ECY;@116DJ<C;&S'@#=7+4V&<&:Z@.
MY:3)G88PYCS7N\+29,<L?3&'--UW<K290M&$.5QNKE(=%DT!NF6A<>2" "4L
MIM/Q=ZK7>5&C[1QQ[FT$%?;N!98P?:>4AJ@98+)_5*Z.7TMRL4.X"BXML=E&
M7C- .WA1E%26$.;CCN.RPSQ_TVQI)/ T/.RQN-:S,$]C6NV!4]:KM*^[^T4$
MY$7U;%,0W<JIX/T(@R#W?F5S+2;-F.+E.<?<=E4J+%68[N/<.$%IE-4)%UR#
M:RRK;$@=D.9*03ORH_;3]-+TYJ;^]H[]MET<=TY^3%ZEHF9W!H[M]EV3^WQQ
MWQKL.<&A>ZOK4#7_ '2OW0T%R7B@GUI;)<R8"]T[*)E*09^6UMV4K\:,YGZD
M&7[M@I&V3UCJ%K.ZY*'V2N6AL@_[2M_^RN4]S\83(R/2]IX^5Y65?48PCSLT
M&QW7_=96ML813/<]Y-I;5I%HWLH^CXM8 ?"G2HN8SW!WPFH9&Q &016%!VF6
M/#P$(M:'3<0.K;^$XFUI\+'[0VOA:2:3;MM>DWF*=C";HKKXW%S?'M?3>1W&
M.BKROK@R>BZ.\]P-\A99,VB' 4-9\=0;Y ?(*NM0E(&@E5XW3YQ]O*SL5V!Y
M'!3GP][*\EP;R$P49#AS2$P!(_>U(42RAS2T;(^'('>_M&YNTX860WNF0&5!
MA7_E4@%,/*=!;D<E*F63[6BLRV?E(RO)W_="BK* H[(323);5@>4XO$IR8Z!
M"G)H4Y+2+"0 S$D4EL WE[1RJE"L3/9PXV%6T"X=1>U@!<;_ %53+19?!V-J
MKFGD_NJ[;9ZIK!JH- DF_NE8<E,X-0;5%]I&,CRPX  VC1;T(9+&[8J;!M"1
ML?(;:2@TN,QXL(T-@YL!I!/;96=BMEF3I8(LL!_LHL.9:*,K2AX:!_918N9%
MF1IA (K^%.ES(MGT[Y'\)Z/L"DP7,)(X2/>PSX'M*>SVK<UX-4F3X.+.1N@)
M"7Y03YLP(O=!K!)?!_= TFQY_P!P0%S)B-B;3V:]LMHV6WQW\I#]H/#0*^4+
MV'>*\I42J2=TM*42$#=$@5/=\%%@5EXKW)'%;S\%!AWN2D*A7OI.1-%Z9O('
M?!6F/@K;Z.?8TK;&L.3XU+*,8W5_6%5._5$BHJ<7 [)Z-;"\MHE!4=!-93(Q
M@D6D3<1D;^X<JHC0AC_9VH B,T!905%0FU<9C(C1"N5-,8)2-MT]D/AD-U:N
M4J.AG+39*N5CE!L.26[DG97,CZF$.78L$K29(N(^#*- DJYDC0Z/)) %JI46
M#H)K&Y12$LD':H.3;YU.-H-4^-O*29]!38]@D4AM*59>.' BJO[*,HKL19N)
MSQ^RRL7,B#+Q2'&EEE&A3-%^;;A9V*@$]S7=I%WY24Z7=H0%?K.#B0ZD QP\
MH^2JVBBI7E^P"-AF]78X.=M:C)>#):BXL<:V*B^-L?5^BZD8Y&COKM(//*TP
MR9YXO5>GM4#FM(=S7E=G%DY,\&^TK,!:UQ?Y73C=N7+^IW^)86 ]W*?7U/;P
MOSLIK;]^RN1%K,ZGJ0:+OG[I6%C61U;66Q62_@?*BNB?&$UWJ4-[SZW'BUAG
MEIICCMYSKO55]P[R//YEA_)_MOCQ;9G_ +4__E#^Z7\D7_$/S\PN!%VN'*O?
MQ]))I#W$WRL;6LFE8;W;V@TV,'RG!I:QM&@G3$1M-\)#8J!A<0D>S/';R.WA
M25IM@0=SFD_]$2)^M1IN-0%"_P"RTD33^&$-:WFU?5%NO#[IY_9F-%\E;X9?
MIARX[CV'IB;:/?RM;]>?G-5Z9HTVS"-["SL9-1',2T>WP%FTWXN0-OD#;Y!6
M[=!I!.@V@Y''\)6;4$G_ "J3Q^%F6VQRA1-E"MOLIN2873&ME/8] 9I:1LU#
MYA7*K&DJ?-\"U0]"RFT ,_\ *I,'-PG06Y.UE*@KR-[_ $0@KR'U>R1EN0;0
M97DG8[(&MDV4-[I+LTD+)P#:/OJKX69,8W(2(KR&N;O2SV8"7N/A/L [_:"?
M*KLD,YSP;".VQ%D>0YO)52GH3'GEG)Y5=BL&PZH0V^[S\I[3HTQM5-#WU_=.
M5%^F,&J G\_\IZV1C#GL-5):G1[$B=A(IP(3&W72L/%**<CCHF2-OE3H <K#
M  /:-U-Q.4LGPQ1]@6=Q7C2S)TX/MU$?V2TK99D:<18[?[TEI4S 9&"XBNS^
M%/Q6R^;"<W^E/9["RP'X*6S#/C<VP+1L*3WL&P1LTA)\I[&DFR[U:"7,E .Y
MW3"]DWP@+O7;]D#3CG-.]HV%<E43:#E#2.[=Z0?8-(\N\52#EV'=(;I*J0)%
M7:6CE5N>:1I2I[D:*A93NCXG0W2G?Z@_55*5;C1W=K6BKM7CZQS]C30?D[KY
M'"UC&Q7(;-W2O8^*?4-U2<JGPE]U)4K!4$H'E$+1E!/:O9;V/A?MS:J)L%1O
M!;=[JD"&R&@*05%X\O;RJB*/AD#E6T9&$+ARJD3L9&\DJIX/HF)Q/E.5%QV,
MCD-5\JX=HJ%Y&UJIEI-]FA\4I &ZKNCJ/AFH#=7,V>4,8)]N56]HT.B>.SE5
M(6]+F/%4C0[.G?9.XIE]VA(P;I:TVGI?DPAU[*;"V39>-1.RC+%>-](\W&Y-
M+&QM,B#*A(<Z@L[%RE<\1W-*=*V"DL"BIL,.YQ"C:M+\1WO [TY1<3B*3O:;
M"J,Z7:C$VG>4JK%B-9@][G E99.C";9QF4['GY\I2V*RQ;_I;6VM[6F4<CDK
MKX<M_7-GCIZ;INM1EK*>W]UVX5P<N,.O\]8&AH<-ONMI-^N;YX6:CK3 TN]0
M?I:LM;8K6NHXV M,P_=8Y96-<./;S?J/JY@;(?7%\5W+&\GOKKG#YX\NZBZS
M:+(G'N_YER\O)/TWXN&UYWK76)D<6"7C_F7'ER;=V/!H@_[3/_\ LI_=+O5?
MP_\ ;V3()+B 5->CK0(M)W/*RJI4F#P4X:YC.*50+F-K9 $1W?"0%8[7 \)&
M:XL;B>.4I!6@T['V!I5(FM5IT#V-XWI:8QG::QM[?"TD1?ICI=MS&/ K>E>$
M]3R?'K'3;P!'O]UME]>;G]>FZ)+36$'PLZQK6XK@\#N/A9+_ $([W()]WN0$
MFN)-% 20'0:0J.'=!AY@#84*GPORX]D&2Y<:SJ859+0&E)13.;=VGA "2/#3
M2<NCUM'U6JMT^JJ6877V3E39H.^1OY4 --5;)4 ,E@(WM )\H]IH(059/E(Z
M5Y#S90<+<AYX"9EF6RU.EPLGC-;(T=!/CVY2HA=EQ WLIT99.RN$: .2.S92
M&@[VT>$ -(W?9.4(.<YM6J*NB=WRA*Z/->'67!.716;&0:H :[E<R+J8XNKM
M;PX*]P^IKCZL-O<$;E+J/AU%CR+<$K%"QF,+1VE3I-6_B8RT!Q2L)!XC/CE1
M<3E#R8S'_E&RBP]@YL%A\%'7P2@)M/!/Y2HN+24MGT_D=JC1REN1I[V_T(JY
M0$^":_*I4!FPG?"#@-V*YA-@H-66=NZ"KYKCY M/9+1-V^1:86-DO<N3"SU6
M_(3T:+I&URF-!Y9!Y1H!C(#:5BL0[WB]D:4J=)\G9((N?MMPDN*W26=T(VHD
M<":3 W2R!(/U1(5;32GV&K2,<_C40$B.OLM(SJ+Q8*I(8^UU!.*?=U&]D4+(
MY!=VD!^/*+"J(,X)+<*X\JX5^#&.:-P53,2V44"F57LE&R>TZ'P2@$ 'E--F
MS""3<"U<J>IA#( JV0R)[521;'-)H%7$T3$+(3(9%L0F0V-]@*L:SS&12$51
M5LS"&<UVE:8_"HR)X/E--7@[TG2B1:'<J:VGP/)#?ZH3* R,4$D@;J=;5C?2
M3/Q=CLL\L6L9W-QJ)V6-C3&DF3$\70'[*=+*\B(GW'E1DJ )&D$K*JB< [7!
MP.Z<5?AOB6X*XQJ.5#WAQ-W255BR&M8Q'?0*SLVWQNGGFKN,,AWJB5%C6>H:
M1U%Z$[0YVP/@K3BRTQYL-_'H6D]8, :'2AN_"[^/-P<G%3\]8PMC!#P[[VM^
M['^+_9%K/7F/$PW.T&^$KF<XWF'4WU$A9WE\K=N**PY.>.OBX'D_4?U"$KW-
MBG:3R%P<G/OQZ7'^.P>H:[DY;_\ B&KM<USM;SCQQ+7S/>ZR5$GJO$>\_9,/
MT1*'%Y(=2TKHEJKL+>76HL5$@T=I-<(-:P$"PF5J^)O>;/E&S@MD%@=J1C<:
M GE .<+')<+4PK6HTS$#@WVK21GE6GPX'4"X>*6DB!8@^ M)!9!NG0/_ !+/
MA7C]1R?'IG3I:WL#AN%I?:X.2>;>DZ XN[!>U*<I'+MM,("O[+!I5P<ZQN@E
MB ^!(W" FPD\E 20:#G$&@4#:M^_/E35SX&R8["2B3,8=U""/+#N/"E95D-;
MS2G=,MF<!N4\;Z?P(9]ZM:0;JM\P)NU7@_\ :!(<;2\*Q!TC1[3X2% Y<H V
M31LFR7WN4B*\EUFDE%64=B2@%KW [GY3BH%R>T@4$]*A7D&@5%\IE\HNR4A
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M::,@F%JXFP=%+;@M966<W1\$IH;*Y4=1\+R4]IN(R-VX1LNM%6/E!HO_ "H
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M:-?*<&T"\A-6TXG$D?J@--H_#0BE:V>D;%MHGUGDT\1!A%'RM(SKJN)1>">
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M03?*BP!Y(_==;)#:B1E\! VHDC-&@D%!830*4@<<P DIZ =[-]@E0I?&2.$
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M-BL-L(@:G36$ 6KB:=,W:+5(6,%A.!([#94%,QMEE47[ 3DI& D<;I((M.Z
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M%32$3:0.4Q$T&O8YI&Q3@2!':02B!$R%NR YZJ-!9ZYVK=!)^N:W""J!G-V
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MX%M*4IMY0<<DX0I0[E0J*9>:08<\H351Y*"</"<&2(Y3K/\ :57LI4JD&R!
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MFYW[V$;.)ME\(V-.AUE&P@YQ!/ZJCGJ0>;18-I!VZ1;2:3:"2#S=(V$P:%E
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D[PLKZZ,?'AFLO[LU^ZSRNG1A\ I*=%?* Z>$!% ?(#Y ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R195.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6857438352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash flows used in investing activities from discontinued operations</a></td>
<td class="num">$ (1,159)<span></span>
</td>
<td class="num">$ (1,001)<span></span>
</td>
<td class="num">$ (775)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations', window );">Net cash flows from/used in financing activities from discontinued operations</a></td>
<td class="nump">3,257<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Transaction cost payments</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents', window );">Payments out of provisions for transaction costs attributable to the divested business</a></td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DivestedCashAndCashEquivalents', window );">Divested cash and cash equivalents</a></td>
<td class="num">(628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowsAttributableToDivestedBusiness', window );">Cash flows attributable to divested business</a></td>
<td class="num">(657)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities', window );">Other cash flows used in investing activities, net</a></td>
<td class="num">(502)<span></span>
</td>
<td class="num">(1,001)<span></span>
</td>
<td class="num">(775)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations', window );">Net cash flows used in discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProceedsFromCurrentAndNoncurrentBorrowings', window );">Cash inflow from borrowings</a></td>
<td class="nump">3,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Transaction cost payments</a></td>
<td class="nump">$ 212<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents from discontinued operations. [Refer: Cash and cash equivalents; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as investing activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowsAttributableToDivestedBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowsAttributableToDivestedBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowsAttributableToDivestedBusinessBeforeDivestedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DivestedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DivestedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProceedsFromCurrentAndNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProceedsFromCurrentAndNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R165.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844863104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 7) - Other post-employment benefit plans<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Healthcare cost trend rate assumed for next year</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline', window );">Rate to which the cost trend rate is assumed to decline</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate', window );">Year that the rate reaches the ultimate trend rate</a></td>
<td class="text">2028<span></span>
</td>
<td class="text">2028<span></span>
</td>
<td class="text">2025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanHealthCareCostTrendRateAssumedToDecline</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanYearHealthCareCostTrendRateReachesUltimateTrendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R161.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6854838016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract', window );"><strong>Amounts recognized in the consolidated balance sheet [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PrepaidPostemploymentBenefitPlansAssets', window );">Prepaid benefit cost</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward', window );"><strong>Defined benefit plan, change in net liability [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at beginning of period</a></td>
<td class="num">(3,409)<span></span>
</td>
<td class="num">(3,024)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="num">(336)<span></span>
</td>
<td class="num">(378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Net interest expense</a></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset', window );">Administrative expenses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset', window );">Past service cost and settlements</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurements</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset', window );">Currency translation effects</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Novartis Group contributions</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1', window );">Effect of acquisitions, divestments or transfers</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeInLimitationOnRecognitionOfFundSurplus', window );">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at end of period</a></td>
<td class="num">(3,321)<span></span>
</td>
<td class="num">(3,409)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract', window );"><strong>Amounts recognized in the consolidated balance sheet [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PrepaidPostemploymentBenefitPlansAssets', window );">Prepaid benefit cost</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities', window );">Accrued benefit liability</a></td>
<td class="num">(3,469)<span></span>
</td>
<td class="num">(3,546)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward', window );"><strong>Defined benefit plan, change in net liability [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at beginning of period</a></td>
<td class="num">(954)<span></span>
</td>
<td class="num">(953)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Net interest expense</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset', window );">Past service cost and settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Remeasurements</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset', window );">Currency translation effects</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Novartis Group contributions</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1', window );">Effect of acquisitions, divestments or transfers</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at end of period</a></td>
<td class="num">(612)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract', window );"><strong>Amounts recognized in the consolidated balance sheet [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities', window );">Accrued benefit liability</a></td>
<td class="num">(612)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward', window );"><strong>Defined benefit plan, change in net liability [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at beginning of period</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward', window );"><strong>Defined benefit plan, change in net liability [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at beginning of period</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from past service cost and gains (losses) arising from settlements. [Refer: Gains (losses) arising from settlements, net defined benefit liability (asset); Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastServiceCostAndGainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountsRecognizedInTheConsolidatedBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeInLimitationOnRecognitionOfFundSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeInLimitationOnRecognitionOfFundSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPensionPlanAccruedBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanChangeInNetLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersNetDefinedBenefitLiabilityAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PrepaidPostemploymentBenefitPlansAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PrepaidPostemploymentBenefitPlansAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R191.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6856505232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 14) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome', window );">Equity securities</a></td>
<td class="nump">$ 1,158<span></span>
</td>
<td class="nump">$ 802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueOnSaleOfOtherFinancialAssets', window );">Fair value on sale of other financial assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember', window );">Total fair value adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainLossOnSaleOfOtherFinancialAssets', window );">Gain (loss) on sale of other financial assets</a></td>
<td class="nump">95<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">$ (109)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=nvs_ListedEquitySecuritiesMember', window );">Listed equity securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome', window );">Equity securities</a></td>
<td class="nump">843<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=nvs_NonlistedEquitySecuritiesMember', window );">Non-listed equity securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome', window );">Equity securities</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_AlconMember', window );">Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome', window );">Equity securities</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueOnSaleOfOtherFinancialAssets', window );">Fair value on sale of other financial assets</a></td>
<td class="nump">976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_AlconMember', window );">Alcon | Total fair value adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainLossOnSaleOfOtherFinancialAssets', window );">Gain (loss) on sale of other financial assets</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember', window );">Others | Total fair value adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems', window );"><strong>Disclosure of fair value of investments in equity instruments designated at fair value through other comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainLossOnSaleOfOtherFinancialAssets', window );">Gain (loss) on sale of other financial assets</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 11A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_11A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueOnSaleOfOtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueOnSaleOfOtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GainLossOnSaleOfOtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GainLossOnSaleOfOtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=nvs_ListedEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=nvs_ListedEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=nvs_NonlistedEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInEquityInstrumentsMeasuredAtFairValueThroughOtherComprehensiveIncomeAxis=nvs_NonlistedEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_AlconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_AlconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R169.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839040000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011', window );">Liabilities from share-based payment transactions</a></td>
<td class="nump">$ 326<span></span>
</td>
<td class="nump">$ 273<span></span>
</td>
<td class="nump">$ 261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Expense from share-based payment transactions with employees</a></td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">918<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Expense from share-based payment transactions with employees</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 51<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_51_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R199.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6850236304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Details 8) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems', window );"><strong>Defined contribution pension and other post-retirement plans disclosure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Post-employment benefit expense, defined contribution plans</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R200.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838774432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events subsequent to the December 31 consolidated balance sheet date (Details)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners', window );">Dividends proposed</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountBorrowedUnderTheCreditFacility', window );">Amount borrowed under the credit facility</a></td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SubsequentEventTypAxis=nvs_SubsequentEventMember', window );">Subsequent Event [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare', window );">Dividends proposed, cash per share | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends proposed or declared after the reporting period but before financial statements are authorised for issue. Such dividends are not recognised as a liability at the end of the reporting period because no obligation exists at that time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 137<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_137_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2019-01-01<br> -Paragraph 13<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_13&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, per share, of dividends proposed or declared before financial statements were authorised for issue but not recognised as distribution to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 137<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_137_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountBorrowedUnderTheCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountBorrowedUnderTheCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SubsequentEventTypAxis=nvs_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SubsequentEventTypAxis=nvs_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838610144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current financial debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Disclosure of financial liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory', window );">Disclosure of financial liabilities [text block]</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">19. Non-current financial debt</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities to banks and other financial institutions <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 285</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finance lease obligations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total, including current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Average interest rate 0.2% (2018: 0.3%) </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All bonds are initially recorded at the amount of proceeds received, net of transaction costs. They are subsequently carried at amortized cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognized as a charge to the consolidated income statement over the period of the relevant bond. Financial debts, including current financial debts, contain only general default covenants. The Group is in compliance with these covenants. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The percentage of fixed-rate financial debt to total financial debt was 82% at December 31, 2019, and 80% at December 31, 2018.</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The average interest rate on total financial debt in 2019 was 2.4% (2018: 2.7%).</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 29 contains a maturity table of the Group&#x2019;s future contractual interest payments commitments. </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides a breakdown of straight bonds:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>Coupon </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Currency </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Nominal <br></br> amount </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Issuance <br></br> year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Maturity <br></br> year </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Issuer </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Issue price </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <br></br> (USD <br></br> millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <br></br> (USD <br></br> millions) </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">5.125%</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;000</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2009</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div> </td> <td align="right" width="1%"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Securities Investment Ltd., Hamilton, Bermuda</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.822%</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;000</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2010</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.237%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 998</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.225%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;495</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;493</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.700%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2042</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.325%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 489</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 489</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;150</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2024</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.287%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;139</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;850</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2044</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.196%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;825</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.750%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.134%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 683</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.625%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2026</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.697%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 684</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.250%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2025</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.640%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 517</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 508</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.625%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 550</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2029</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.502%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 568</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 558</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.050%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 325</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2035</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.479%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 330</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.000%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2025</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.010%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;735</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;732</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.000%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2045</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.029%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;219</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;219</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.125%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.127%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;392</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;419</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.625%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2028</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.480%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 553</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 563</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.800%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.609%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 998</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.449%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 996</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 995</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.100%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2027</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.109%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 990</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 989</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.000%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.133%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;396</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;421</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.125%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2027</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.874%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 684</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.500%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.655%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 837</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 853</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.375%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2030</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.957%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 838</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 856</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.700%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2038</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.217%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 832</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 849</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total straight bonds</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;283</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables provide a breakdown of total non-current financial debt, including current portion by maturity and currency: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Breakdown by maturity:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;006</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;067</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;111</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;583</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;585</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;278</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;139</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After 2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Breakdown by currency:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;889</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;964</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;861</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;028</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 184</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 272</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;421</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the comparison of balance sheet and fair value of total non-current financial debt, including current portion: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <br></br> Balance <br></br> sheet </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <br></br> Fair <br></br> values </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <br></br> Balance <br></br> sheet </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <br></br> Fair <br></br> values </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;701</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;438</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 377</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 377</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;889</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;815</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The fair values of straight bonds are determined by quoted market prices. Other financial debts are recorded at notional amounts, which are a reasonable approximation of the fair values. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the pledged assets:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total net book value of property, <br></br>plant and equipment pledged as <br></br>collateral for non-current financial debts </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 3 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 96 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R142.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6870704448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current financial debt (Details 6) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract', window );"><strong>Disclosure of the collateralized non-current financial debt and pledged assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity', window );">Total net book value of property, plant and equipment pledged as collateral for non-current financial debts</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant and equipment pledged as security for liabilities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 74<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_74_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentPledgedAsSecurity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfTheCollateralizedNoncurrentFinancialDebtAndPledgedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R146.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6852881264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions and other non-current liabilities (Details 4)<br> &#165; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases', window );">Product liability contingency, loss exposure not accrued, number of cases</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent', window );">Product liability, government investigations, other legal matters provisions</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate', window );">Product liability contingency, loss exposure not accrued, best estimate</a></td>
<td class="nump">875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IT', window );">Italy | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine', window );">Estimated financial effect of contingent liabilities, maximum fine</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed', window );">Estimated financial effect of contingent liabilities, damages claimed</a></td>
<td class="nump">330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IT', window );">Italy | NAG and Novartis Pharma SpA [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities', window );">Estimated financial effect of contingent liabilities</a></td>
<td class="nump">125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_JP', window );">Japan | Novartis Pharma K.K. [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine', window );">Estimated financial effect of contingent liabilities, maximum fine | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfResolvedAction', window );">Amount of resolved action</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Sandoz [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations', window );">Description of nature of obligation contingent liabilities, number of states with alleged violations</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Sandoz [member] | Enoxaparin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt', window );">Description of nature of obligation contingent liabilities, number of putative cases referred to court</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Sandoz [member] | Enoxaparin [member] | Tennessee class action [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfSettlementInPrinciple', window );">Amount of settlement in principle</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Sandoz [member] | Enoxaparin [member] | Massachusetts case [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfSettlementInPrinciple', window );">Amount of settlement in principle</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Sandoz [member] | Taxotere [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases', window );">Product liability contingency, loss exposure not accrued, number of cases</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | Sandoz [member] | Amiodarone [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases', window );">Product liability contingency, loss exposure not accrued, number of cases</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | NPC and others [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfSettlementInPrinciple', window );">Amount of settlement in principle</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionalAmountOfSettlementInPrinciple', window );">Additional amount of settlement in principle</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US | NPC and others [member] | Reclast/Aclasta [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases', window );">Product liability contingency, loss exposure not accrued, number of cases</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_LegalProceedingsProvisionMember', window );">Legal proceedings provision [member] | US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent', window );">Product liability, government investigations, other legal matters provisions</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 86<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_86_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionalAmountOfSettlementInPrinciple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionalAmountOfSettlementInPrinciple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountOfResolvedAction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountOfResolvedAction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountOfSettlementInPrinciple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountOfSettlementInPrinciple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfPutativeCasesReferredToCourt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfNatureOfObligationContingentLiabilitiesNumberOfStatesWithAllegedViolations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EstimatedFinancialEffectOfContingentLiabilitiesDamagesClaimed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This expresses a maximal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EstimatedFinancialEffectOfContingentLiabilitiesMaximumFine</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityContingencyLossExposureNotAccruedBestEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityContingencyLossExposureNotAccruedNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NAGAndNovartisPharmaSpAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NAGAndNovartisPharmaSpAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NovartisPharmaKKMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NovartisPharmaKKMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_EnoxaparinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_EnoxaparinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=nvs_TennesseeClassActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=nvs_TennesseeClassActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=nvs_MassachusettsCaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=nvs_MassachusettsCaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TaxotereMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TaxotereMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_AmiodaroneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_AmiodaroneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NPCAndOthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NPCAndOthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ReclastAclastaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ReclastAclastaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_LegalProceedingsProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_LegalProceedingsProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838650528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfTradeReceivablesAbstract', window );"><strong>Disclosure of trade receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfTradeReceivablesExplanatoryTextBlock', window );">Trade receivables</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">15. Trade receivables</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total gross trade receivables</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;396</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;853</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movement in the provision for doubtful trade receivables:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;126</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;190</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;162</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combination</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables charged to the consolidated income statement <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;119</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Utilization of provisions for doubtful trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of provisions for doubtful trade receivables credited to the consolidated income statement <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 30 million in 2018 and USD 94 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Reversal of provisions credited to the consolidated income statement from continuing operations were USD 44 million in 2018 and USD 60 million in 2017. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following sets forth the trade receivables that are not overdue as specified in the payment terms and conditions established with Novartis customers, as well as an analysis of overdue amounts and related provisions for doubtful trade receivables: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not overdue</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;763</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;916</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for not more than one month</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 296</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one month <br></br>but less than three months </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 123 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 194 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than three months <br></br>but less than six months </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 103 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 136 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than six months <br></br>but less than one year </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 96 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 98 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 213</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trade receivable balances include sales to drug wholesalers, retailers, private health systems, government agencies, managed care providers, pharmacy benefit managers and government-supported healthcare systems. Novartis continues to monitor sovereign debt issues and economic conditions in the countries it operates, particularly in Argentina, Brazil, Greece, Italy, Portugal, Russia, Saudi Arabia, Spain and Turkey, and evaluates trade receivables in these countries for potential collection risks. The majority of the outstanding trade receivables from Portugal, Saudi Arabia and Spain are due directly from local governments or from government-funded entities. Deteriorating credit and economic conditions as well as other factors in these closely monitored countries have resulted in, and may continue to result in, an increase in the average length of time that it takes to collect these trade receivables, and may require the Group to re-evaluate the estimated collectible amount of these trade receivables in future periods. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the gross trade receivables balance from these closely monitored countries at December 31, 2019 and 2018; the amounts that are past due for more than one year; and the related provisions that have been recorded: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total balance of gross trade <br></br>receivables from closely <br></br>monitored countries </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 1&nbsp;588 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 1&nbsp;729 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 97</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At December 31, 2019, amounts past due for more than one year are not significant in any of these countries on a standalone basis. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Total trade receivables include amounts denominated in the following major currencies:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;466</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;510</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;384</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;551</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 658</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Russian ruble (RUB)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 247</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chinese yuan (CNY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 279</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 282</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">British pound (GBP)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 183</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Brazilian real (BRL)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 206</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canadian dollar (CAD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 136</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Australian dollar (AUD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 125</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 161</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other currencies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;655</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;693</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfTradeReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfTradeReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfTradeReceivablesExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfTradeReceivablesExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0001370368-20-000003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001370368-20-000003-xbrl.zip
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M.SKV*3.>M+ -1;=[T*TM;=CK9\R5A=<61/-.L[K!NZ;5PNIUWQ>0 _+---.
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M+*XVS8NTNI?+G!_02N/J%T .R#&?')OJB:H#O( 7\.(/7JA=]@V7Q;>0 R2
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M!F$@3%"$H899BRBM*-*EC,_-6VJ9%U=I=2_4UV"; (_&FXDUF&5E/\C$VLX
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M(M:*.5I7#;,\J$%G"C2/YLD/Z^2'\S0N\T(KD0SN6!45.965/Z99*;ID#%R
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MW!=%?/!1=%529"DN<=0EJX0UZ)R [M$]>6*3FZ]$I5:%DCC'3^>L%F!R!U[
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M6:,;F?>4^<Z9YO 2P+0#,$T)JL8YHU$/T\YMN=P($ $B0 2(@?2? !$@ D2
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M'Q'+7\W_I65]!.3B(>>9U]C^TVG%TJ*#.=\P1X,-\II&'FTN^.."(>AE+;V
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M]'*37D"D/HC<B0>5)D)?RJ\J57EA 4?8P@=\EEY?.DNU[.$#=O[!CIX1\-D
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M1P)L Q8(D "!H_=>4U4V1A&A)Z10*"YSUW66)F$!0%=N]8N,E4O$S4'?M G
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MH61XT9L60TGL)]7=*@)*&D1)[$(N-N$U7<@5C?1Y<L@$_G"(:.SW^??68Z!
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MD%/AV@'P.,>U(R\\.A23HGY@B+IP ; H!Q:%MQXM@HF[S59?>O?.4J?]?1*
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M9WS[H6],RR,_0WBS,_0[U]TA8^[-9M^FFM9.-3V&#K'$%V"M'LEU"JGQB':
M*<"T*$S5C<1GG%4 X #P=APS"B%U^&U(I-U/2KO?T\C_A=(FP@X+@UXY>.M@
M/RSW 7W^T\%_O=HF,1/]="\W(FIM,.DP2*L6&M@) ,ZS!V=WK0. ]1G#N@4V
M@1:(>I04M49$K0F(6AMU&)]5"PUL @#GV8.SNS8!P/J,8=T"FV#P;4)$S9+T
ML+2DI]\&G89GQ3(#BP"@>>;0[*X] * ^6U"WPAJ@AI=&+"^)HB:&U[3+'JRJ
MA0;V (#S[,'998L 8'VVL&Z!31!>T$R3HAX240_+B[H_&W<8GU4+#6P" .?9
M@[.[-@' ^HQAW0*;H/=M,KIY?1HG73)$U%K_*.H@+P0]?YM_N]_](M)R=OC]
M^+>HD ?##B.S.G&!'0" /$M =G?O!RB?&91;L-_WOXVU5"F/RTAY/.NR>ZI"
M><&.#Y \4TAV=\\',)\=F%NPZ_>^::.K'[<G@1<C(N314<CS[Y>ZBZSG3]/[
M#\*6;AM[N?9[O6_C;AN?$B4$.SO KL.PZ^[N#8#M)&!;L4./ \$F[SRH8&=Y
M!3OJ=;GRA&09P2X-T.LX]+J\4P-H.PK:%NS6_6^]48](EF8>)"4[R&T&#2>S
M#J-/LHQ@MP;H=1QZW=VM ;2=!6T+=NO!MQX-)YRPS*!1^7#"7K_783A6+338
MSP&<9P_.[N[X .LSAG4+;()A(&J-(>IA:5%/O_6T+INH50L-; ( Y]F#L[LV
M <#ZC&'= IN@1SL;W+P^G0I[3 RP0:D4!*W+P9M5"@QL 0#EV8*RNS8 P/D,
MX=R*O3_(0S@);*12GA:7\O3;<-II5%8E+MCW 9!G"<@N[_D Y;."<@OV^_ZW
M::\7;U=$OIF(M2H:][KLB:I69+#O S#/&IC=W?\!TF<*Z1;8 =JW88J@!8H/
M#X==QF:U(@,[ (!YUL#LKAT D#Y32+? #AA\ZZ<(>B)0<+C3-FJU(@,[ (!Y
MUL#LKAT D#Y32+? #NA](Q*.AUN$@BY9@GC08516)2S8^P&,9P?&[N[W .,S
M@G$+]OA^&%(YSK"E\DMX.NERO<>*9 4[/$#QS*#8W?T=0'PV(&[![DXK%E(#
M:A*UGZ9E<R7&HU&'T5B1K&!W!RB>&12[N[L#B,\&Q"W8W?O?!GZ7P*2$![TR
M$IZ-NIPZ6I&L8'<'*)X9%+N[NP.(SP;$K=C=)TS[:5 B[7'V3>MW&XV5R IV
M=X#BF4&QR[L[@/A,0-S([I[$XT_=VV%"< *']T0=\,M:MV_-#T1_ZLYMX\'Q
M#I\_F[_\C]L.KRC_ :P*L@YHB:#E#%!Q7K-_G.-;W<1_Z-8.77[]1+J[PX@R
M=*F[IIM PY6.\1=9L)_0UL$>65TWSL[V#K^_-MVEY= 7M!,E% T<8020*2B'
M3D,)@-1I(%5W'I2T)C&$=>>A32#)EFY7N?&3AWE8?0 RZD.F+K_3$06/EF[3
M \ C=MZQOGE";S0E*P&5UV=WBY9DEI8_D&YYZZ6.$?N'[85-NB "Q!25 ;B*
M8I"[T !T'07=I#CH)C6!K@^@ZRCHIL5!-ZW-*0ZHZP[JFC\% H2Z Z$:G9M@
M<'430I/Z(#0 "'420N-ZW S%=[$'QP8(N7\K(08PP@7=#0"]5D%/7:<# *_3
MP%/*Q2INL0'Z5$=?+7:;^.D1@-0B(-5WA@08=1A&*CM$ 4@M E)U;E%1TWR=
M)C*,+/(+(_SA$_)VV/]ZX:T1OD;&;DG+W78;67*$ V:\N.L"8-I-F*KKYBBU
M(P-,NPE3I1S!4FQ'0&IGD-IT2#9 [IPA5^,9&0Q' )WZ,2( NHZ"KJ:HDF@U
MB>6_=Z9K^FP305R;'\CU*#M)S$4?;"]XLMD-BT:<< KNE?1S*P!(50 I=:),
M]\\!@%0%D%*>LXS3(2!((00UFHJ;&PF1;[H-A!-&P9:18,L ?,"2$;!D #[G
M:\=D5"^=NR[RJ"SO3?W-M(AH69Z?9?#SR#.!# &(,H&89_!C,;BTF3MXI-(F
M#79C,7VX F5HF3*DS1AH0M*P %T 70 KJ:25%/X\J.ULZM8U>FLKE N8&1E<
MP_HJNKX"JA1!E;HK5;(8-J"J/:A2RLG$J[(.P%(:6 IT90*$M 4AM88W D9:
MB9%:HQ$!(ZW$2%TEJ4I[IN)RHAX90LR'[ID?Z/#5':$:[UKL>"KH^RDE$SAU
M25BU )3M!&53Q5P 7V>'K^JL+E&O$8"KG>!2U^,DY1X>\-AF/"IU6R/LW0)(
MMA.2317' GR=';[JJIDE$.6)=!>=Q(=T%3X\OF%7E''G ]!J$%H-I$>5C2,\
M*WQD,@WKCBQK'$#5S16'@X^EM],Q,?J(N':;;1"0&\?'O;E"-[^V:$DH6GZ=
M!"Y?K77['=W9C#<E7G1G+S&5=Y]2TGIXI0@N@!=+9CQ4Y1G?AVZVP ,"&+(&
M5,<3SD\>6:R"*4/&$ZU!LUC=D2$Q<KV%_:Q_F/:[.U\N:0ME 1T(GM1&?L?F
M1\?<OZRKBB NYEK5)FUZ.J4[&3;HR]>6SLCS6L?HC2P?QJ/^11F:8TP%P\I'
MN?GWCC!W&3R,/2*<K>X+U;9WU)>PI-Q_^.6>3O2&F/XTQX/,^>E9B'Z!#)\2
M]SL9G?RC[:J25[H!%@L+5I:FQ&?E<$A+G1"PP3/O#$&G0*?:H5-MN?64J%'^
M.T*S ]1)ECJQI7I6NG26^Q-H$V@3[$QR=.G>L=]?$-X\(KQR\$8GM@FHE"R5
MRA3N66G66>Y3H%N@6[!K5:E93[2<.SU)@X95IV&90CXK33OK70QT#70-=K4J
M=S6_"8G_HOFGCHW3ZFV@6B54BRW5L]*EL]RW0)M F[J_,V4VL#L+A*N,F_I3
MB6'VU9G]]NS! !HU0:/T5@.H40<U3>7, @14A$ C::U79)EY=[!)#QE/09M5
M_^3 RD"\^866.^KGNC8Q6GI.Z_,TLID_@"2%;S!(,IT"@*QV(4LIJR6S="$@
MJUW(4JH$8<9>^&R^VV3&EF37O;,/_47N[+GK.DM3/VWH_AW9Y FT7#\Y!!]M
M1U8^]@.$L3B'_3!S/P1TM0]=[=D3 5WM0U=;]L7<]M8UGEOHU^]8WZ&SL+-.
M^84]4,Z9$) $^YV<,R @"?8V.7O;M6Z;R/I#=Y%EZ><!)0;+L,/)VN$ 3[#/
MR=SG $^PV^4IDES85?#@?%#1NX_!--WN[)9>!)?S%Z2RWZD[XNRB:5>6[KI4
M%P^%H,,2BHD*9KJ[GML&_8.&HG[H%NI \>PLYL/28!E\=SV8!'#26IS4N)I$
M#)6LHO(/NK?#B);]VW^2-',R2]+/O5O=Q'_HU@X%XR^_0N/A)(^ ]?-';-HT
M9-Z:;VB-P9-]$+T'(^_':"EB?=NI^"R$1I?0!/! GI?\O+,7[N I$]?II;D3
M*G=%>,3ZTEO@5]M V/HR[??83UI:(O7L5##O1'9:)6.AMZ"4H)2@E&":2E')
M1\<UP31MH0JF31SL@Z!TH'3=5[KZ]KF.*!TX85JJ= HY81HQ+N&@U<V32D-F
M$\"IFW!JR]K4)>.WM=9C>]8>@(L"<&G+VM(E&[^U1G)[UA: BP)PJ:MZ222#
M$3N[[6FT37HSXT-PGW'E;+8T=#1Z5'Y9D_>]KQ^QLS(]VAK8<5N,HWS""?MP
MEI1+(Z&V2J4"9&Q[@,XS06?];5EC^R7@[$QPIFX"2V8U6\#GF>"SEJJYF4<'
M@-KY0:VF8X<8SFC*4"3-Z#Q Q&0:-DNYFR4@J\'TF?JV.8!(2R%2TXD0\-$F
M?+3'GP5F3[N0U3;#>-] +W+K<69PX4L 3&:YJQ)@3AW,M>O^$)"C#G+:8T,!
MXKJ!N&9"8X2\0P ?)>%34U-!,3.)ADB;]CMY%_F;2V81^YU$G] 2F1_ZF]7F
M(*LB",HK!S#3Y:Y=@#\U\=<Z_S< 27D@M<!+#BA2$T7M.0>".=9%_#6?RB\+
M2H_Z%^ H+H1.@:CJK1#PTQA^VK,) NZZA+NVI3X @E1#T)E[LP!Y*JQ=-:8K
M"(%HX:T1/CP=>>X\X,-AOU/ D;CI 6I40$U[-CK 6MNQUB[/.F!&!<RTQX4
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M>A[;KLVE;CVA=R+B(.; Q1Y]8GJSP\X6M1<J*?S]]G?"X-^BS %$,CI  DC
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M&^ZI0_I27_[53E#2VT AB83I;$QA@%U\LKH""CN+P@;6M/A>[=!+L!W=$0B
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M]-:_6Z:-KAS;W6T0_H%TRULOB>A#=[1[[[6TUS'_!B NG "5Q>5RAKC<V68
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MEE]%/GA%#%F-A\79R M6H061&>23=^1**.8O9WUF]?\F2>:ZG%F]?LN2G(_
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MVUW12S__7W?V[<XV! F>Q$*B"@[-O(-BA N1.5JLB$579S3UD-7;33:!C0J
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M=(Q%$*5D[GG8?-MYU$_YXBP^;81IRKB.!2*$PGEC6+0%":B2_ASSS3)85>*
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MD78-%MM,,T>205"NB\/AJ%:2<MQ1Q74J)TF)Q-BPEI=?X%P\&#CCY>(4B&4
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M*$ )Z@K0ECV0+()R!E$6(\EW)D0?MHUP5':?[X)2ZH_C>?V<T>31Q>],QHC
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M_D#Q.>K>#)4-E#]IF:/83'51F\K.5;P6IO*Q\Q#U4=5UR("14=>>,("TGAT
M#/&4BC8# V AT>W78X35MP8)L$3(Q((V9#@6U<JN@?F6>P23$O:KSE)_=H&
MI4\(#*]T=U=]@$5._R7K9JDUL !02 L9ZK4ZXQJ6!VE(8%9>;0L0  82+458
M$0 *\9LU94^),-F56(<S5GVV^I-$09<KNS5B)$_4/K\PN]+<>5-&2"?H:ZMG
M%#14_?DL6"^%<<(")6WYI+(Z[ZFNIT_F^]IS5CLWO"KIZDR6]8TJ42(%YE2T
MT@W#CP&SJ,8L%EMC6ZB.9W@;77:U'?485U'JVT4PP_ES)?J,&D6@P<K-;X&,
M][X*QU/06:ES.E:A["[,J.3S:?DY]=NVKE:(MJE^??8[4Z\<O+E'[Z9K^8^K
MTS'S<8=1E/?!;W_O?>L-IV'SV4PN3KD->G$_.-[S[NU?Y),7A_QN85^3G<_U
MZ)S07 IU6JDRF+\@W \F<>YS<944!OGRV)F<@(Y>[-E+TPK@<[4FVD<>N+'U
MI><W*J?/*)%ZS$:$-H[*I QSQ02T\-8(SXU_[0()JY&5S19-;YA?-$FVDIL
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MBFEF*:$-QXQ;NPJ%II;(RBQF,U;[G#/2S5(RFS(VR[:BC-?)DA72VUY\\-J
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M[G_I=_N(JZ3[T.?(:[K*MCR6,WNZ7N; )"2QDR+57)SI^O47("5K@R22(HD
MA+EWIC)3&^/[(@*!0" B'*?QHH,* !P9!RS043S0AP8 H!KKJ*9]6R_K/H&#
MVK%.V)GS\Z#04;49^<+RJ&ZWCUI.^BO65NI\P@#&$?YIT$$F K;J%^I"!Y<,
MN?R05: EW6E<2)D26\\M+C*.A6Z\,.(3E1-K".P+QL9/)<4: MO:Z"EUOEFQ
MJKJZT9KI++)B516-L6"IPYEZ#KXT5F)'K4^MGMTR>[FJ1:M%(^CTZEC*5O1E
M'WKTT+OG,^_!;: Z2E"4; KWM6U8^XZM'M3/X;);?*X,'O)O\#N().<%JTO+
M-B1\('/R[]C^,0"@Z28C.00 M&NPB)F,F@TV8%F1)W;H;$>\&%FQ]I[,K=*Q
M <4*[[8]8E5$-\TV:UP1$=]"V[1\O?00T"%@F>L! /B%N=$_MS*B$$D![1LN
M],T*!*F0A^M@+E8>I@;4UY)MM<^PY%O^6_NDAJ/?L7@^,=I-L'JX59&P<91X
M=UYAI4IA L6Y:XO>'%"9AUMZNH> CD_*;KO$4WJT]X%\&HN(=T-!8P6+IXF[
M6DN7,Z;B09)?^Z$;1+H84$>'W>5TM/Q&UO)?V3\%UXM=Z!OIWAIE7K^1)B8V
M]F;U?5%Q"V((5^X+V^I64(H]7=[&])/#-,G_.Z9?)NP,JPNKPZB@J2QH.XAQ
MOT_7Z>QO#P@6--Y=K+K[&T56Q8S:\DL4.AB[V>6]A;A9BG6Y3;X*HRC\13X,
MV H-L[]QR%9<IFJZL\C;B.&B=*VRAV+(V0Y@O+ON[N_S"18Q0*F!VJ#*.KZ7
MRGWSG[=VH>L,>V-*LG+"M/S*H=T%\"^RLWM$O[YV>:NSP!L\QD1.E_SC8M)R
M\'WT$L;D21(O'R+\$N$/+TQC_W-1P?4W>7N>Q1I>/QP%CG<SIHVI1:U LEO(
M/":1JWN% TR+WMY];Y(7[ ([.UUE5=<D]5'P]CG'6VG7%QS0$A/Z:K%0WV:6
MA!?!Y0S0S%P;U3 \F_MA=EB\$(]^H. U.59/]VH(TQ]=I-Z3K_GA0@%:5CU-
M5DZ,"8-\6-6A?*S\6"'XENO69_;.X7A38;,'$ K,LHJGL]+[!4!I L>F%^H&
M<53PU6[3IT+*_/7%G:3%QRE$R\9B3(SA;'<-5D?/"A(VCA+O4SAF+R>00/'=
ME_0916YUX"3;@EI+:&PR0N,J+NVK)]GF"<7P5X"C>#A^011%N$[L6/.]0U(U
M@ 7OE,J1!GQMHP&Z"=]Q,&AV)3/69YSD8?^NGWF+B%6A;"#,Q4OX"T<_LHLJ
M1!%<[.5UV7B"_%LBP:)H>RTB7+W_(7 N6RGPVGSG<I[UUH,-?/+Y0N>\ZXFH
M3:BV]6G@NAY]#N0O\DOT+\M+H+MJI'#=4MR#^.TDE+;ZLQ[6V^RQ+O2+)SHP
M[L)H]T+#25#UB)4OBZ2VTD1;"&PC]*6G!Q/F\J!D:"R46"@PCV'V'VZR0-(6
M(-E"8;0<'\HXSCIR#EH+.JLON?I\1K/MJ''U,GETT5P:U<">&.C>?G\5$%VF
M#V2"2U?JU5IR%G:]PF:?\"MH7O$\O]HV'&?MBIUP-D?!YQ7RZ?U"QOY[%R7C
M8C"///^B)Q9*VB9,1X#8MM2S4"2+967[O=?7K:4"IRF[&)D+->H+A9%FL##:
MC\3.-L'Y;THB=_I\+DKPU_N&X[<P03Z1/B9Q72Y AEE^L*TV9MN-Q!E[WXK8
M[N8M(_J.X7CC WF-?7X%/GLA*Z3+JUF*E"Z?-U\ZZX9P'4!ODY?C,*'WR]:O
M:RW;& UH$Z>5FMP0-5&FM74>P&JF6A[6G:LF9+>:>&,/K9IDT0\0^UN_*1C'
MZ4QYNQUOI[%NE)4 E#$*=:-?619)TRX*^Q)6Y\Z U6'/FSV,(J,.:EFFMGF6
MH>#>.FICG-WN!6^[K=3F-?KEW*8L$GC$']@W()VFW4=A.B?><RN"W'][^BX-
MW+R.?ZU+0(59(4=1.B]8'\-@\H:CV9JLY3#6^@KC(QBO@HBM@"_+8!>\,FQ4
MAKF2'SX,[]YN!QOO@MPS]Z+'KO(]Y&JY 0F[S>J%9K*F" ,"<Z=8C[XISZ)N
MEQOGS6Y#VJ<:1&L.31<%V@S/_'U??1U):.Y$*1$& ))[)CL 1)(NP4$21C":
MP^BL85<@<:._$<;Y0C@.HU\H<B$ :#!G813$[SJ<S2,\I6[K8]$=4=2*KB[#
M_DJ*UR0ZO&N\=-8$<DCX\*WZ,O2ZX"EZN>X5?Y!0&N6I6L9-.QK.)I]7**;Y
MVADM?<TS[%.4_ M'^,#%NU><(%K!>8NB@'VT!NIBXL94,UC('69TN^E-#NK7
M W]Y7M!Z?PS\HD(>@&J-HA6)E)DPH#O+X3B+[1C&!AFX([=I*\N\XV-SB?,^
M5#&@KNYKNQY:(DZ^ECS<)$*S5_Q.=S=;T=/W43PG (X]YQM&?C)UB,MD?[#T
MG9P]$.TK)8V)!]F:: 8WKF%LSP[(4<P(%Q<IELVPZYCDTG(P8VIV4>LK)&Q=
M1@>H241!HX#J7HZFA1F%"H*+7-:C/H?!=)\KC?).JHL/DK FC599J1OLIDX)
MK%GCULX/ZWH7L+7#H]9 -03Q3M2E?Y68WY"(?1FE0RJC/#Z41M_8V# %JN,"
M!A2!#=-@C1 ]<J'BQAN3I1H'#K["R2^,@^4YTV!&YZ:0_=W6%V2U2IMOH8W'
M:!53#J\7YSMTD=2%(,?*XC6(S7JST/CK(NWJ*[-ND]F?KHCW(%\XFA)_!ZJ0
M^=C)1G=CAU9*S+7>HNDLI=NW#YR[+.<S$]C/'H2&CEF]UJ?C?^40%GOC44*6
M@ADSZP47L@W$3A=]!>.:R-=A?*R0$Q0HFKD.RK8@C1U(M'Y@;9UR#G/J )6V
M#YU8%YZ/#8DYEC2 )F.7(>/^A,$KGB&/)CTS&*[#V<S+RW0@BTDOB'4ZZ_:Y
M5PS&175V]8@X,9?.M-F]@I779[""VXQHB:W:J]>+U>!"$K/7[S!,>%\5[(G%
MQY $US1-9PVZ/J$P6#05[QJ'"\BVW?>J6G"1Y%EU8Q9-=$O?2.X>E6S7$+[J
M6\016C-9/FU-E(U8VEV?U;K$Y5I,NK5N;V/X02'Q=E)BA:Z+P07!9J8#"UW-
M8L3H8FE^5RM6@UAI;B-4J9DAS/X&UJPN^QN##\61W+",C7L31T7;\GS+NO:U
M*M"%AQ!3$;J6MN/^"LFXYUA@VW^63CQL9! 'CI.G@;![@^<1II7+Y'G(BU'B
MY74UY-'H :P7S7(:LU[L6]^R52:]%.LNC&["]#TA/[YZ8F9-)6ULC]=O1:Q=
M3=BE8QL# &6:UOX#R^VG/7Q]);N ,4A>O?@G+1])D^P91K2&A.;JWL*\_.D)
M13]Q\A1^X..[>(86O))(&^_*?Q4F23@;CK.7"ZGWQN"0^N0Y$:.L-P6.DU=Z
M7E=N%&==R&B;8<_I8E2!A)=:&$9%X4_DG3@<[$V"94+[]K<SI8]<2 T:,Q'M
M=$4X)%<3>M&05G2.7D,#IQ7-(-%C;X%YJL2I*TQ#7O1TH+BO+TTY%LT^>GFV
M^16F85#>PGD9!V-KH!!IW/&4@T?K6^?I=LK!U#M=B6KS.1S$7YNOT^HJ77_,
M7E+NJM$)P("]G.26)5Y<U@@09O=T%8#F(!L!2FMVWU_I&/](VFN98=K[C8R(
M+/5\E]X3*W2BUV/=P#QR6K^H'+T*PY^+GGL;'_AZ]_? Q5&.,EY4/@1)A)SR
M]#>/PT90>IIPS6E#4TG0C5]AO.E@\K,I2C23V9VN<"5)9=A;EM,V6)?EFQ=S
MYUY0*]I5]GNYJ-Z%U>^Q)DH5Y61Y,W51@;H^ /<;]EVRV(Z0CPLS=_C*OJ+M
M*R)D%":=2,4NLROA%7^UFUV7=5FC".1K_>#9D@Z#&R^>AS'Y,<5;W2OU<AS"
MHBE]=09VJJ:^!*.E_?LNRBI"ZS9$C37._$0R=BOB-MLX+#PTB;V7N\_552-%
M<>TVJS&;W-9!B>#['R'HN[ -5G&>K+L&.'O2CLT>Q-?NGE09PBIFU)C#X<]W
MJP;&5C1F,%_K=FQM#D&\^,JK-/8"3! (9^]>D)?"*?K*TV=V=MD[%>Z"(>!R
M7DM\%X6SZS#+SF<ULEFD.8FP6"$_%$;72IP;I6!OBZNOJU'*5&OVM"Q;K07U
MW<X8BRT\>=-J.+ABK0)KNL:Z3%<2W[/95$-A[4+O,R^!-K%Q;H',<Z:2=9D5
M6 ;DG.DA^P>[_"%<UE5GD[S\<N9KWGR.]M9AW981QWR$V)9;]D:I3:V,M+F%
M5P3OBUX:VMLW>82GR-SK:KM-G>"=?F"N6-L7BIHF<[I+X>/R=LY9%7_[4]>-
M'[*^X@\<$8,=CA7%/!SK+L&U,7(FNT4A>+XP&#N5.O>2C"":*,PBPG(R%'8;
M[XM#,I0]IW%@TW("WK+O6,#1U\"F1.ZD A0&-5NS#MA@O8F#1D^/SYE%5D6&
MZ&?'Y\RG42)5+MC)\3G3JK%.( 4X-SYKSBQ6UN#48V-%SWYZGI S)8H??1;K
M&\F\PG(B/<H/-DJ:83%JX9OQ@RIJ:8_6Y>EQZU&+VE8T0RCCFG3=NPJ5F6F&
M.N88%Y69$8A!W>YN=$AN-#.CSC)J/<LH1?0%L^5_$V5QZG"2*]$M'4LJ:CG8
M,/-*0,W,JM*>YOCK]9D1$XA.&(JUO8=7W8VQC+66T<FU+Q&"SU:V*ZJ,HX&]
M2I-E'/)O.84P3LTRM=;VH^H"3Q6&#)MU&'+N20 H]%RP)IPUL]%7MX9K8\VT
M6#7_\,\7SYPU5I=E.4X8SYO8OE'\-K@P9XSG3>FJF:68QXSGS=YR]%*37:<J
M[P:D:YY7DIJ>Q:5GH=I#[SWJZ^J,GMF0=FCGU0.T7-F:W5HGFG9.:A77!T;7
MM'F35'',)R'38_5DKH-;U1B?S[9?VSB) -560]%VJ'J"U?VT4F<-^79Z0E"H
M=5BW9,YZ&R@$;]3T6*M@"Z2<=]JDJ[$NP:B=(!2"+JP.XRP56+O*.L8VED+%
MTEGY=UF=A2@>O'_21(:ZTGR-IU_ZYBG9S!L\)C_E7N$ TUW<N^]-<@:3EPC'
MY /9]-%R,M_C<!*A^=1SD#^@#F%7Q&NJ6M'G<'P3SCS'\Q>#<_^/[$^RU__'
M7!T@4QG>/N?YW-W5&U[H-%P2 I-7BQ7J:!WF8+XB\C>#VK;YPL3-U%G];WGB
MU@!JJT>Y^F1@-G#HV.7&L;8UF]E*43(5A0&V96O,XO9STNL%9#B*&X>[UV?-
M%SXWW6X3<-MD;*6J 4Y_,R]E'21W)*R3)B@PF85L3'%KP42,)=\P5XV82Z(R
M2J.YG\94S1PO><A^4P)%N;!-AO=B"5L'($)HR46WSX@+]T-"CQ[H66&08EIY
M1G.<P_%]&+KQV]2+W!=$=H\X+E$G71V5(X[3W+AA?OR9R\@WB%]PY!!YAN.W
M,$'^,T[H.UN7^R6-\+K@^C_^V;GLZ$5%WB=&;5379P*'R>[V+6!D-R(Y>+KU
MENC>G!$.@>XF)&^<[A'VL9-@]SD,G%R6/#)H:ZD_UBBR8VP<>>][W.,";4,!
M2' FR:9Q6.*B\IQ.=5L>W-3Z76!DM^?"ZZ6[Y3#^+HRP-PERT8G;:3YDU0R;
MD0,&%,9S@82QURL"23M)@=81,3HFH\H15$J@?4ST#NN0J0@FW')U1T&"DZK3
M3)U9)R10*EHHM%FS4P7+1)^*-WEP3![!;1-WBU4E<6:XMW2XI=D:L,/N\]!P
M#=CYK;3ZO:R,!H,T!U_R/1BG@8O=QM$&MV#"CYA-DQ4QRZ:@M:-FV<!0D]BH
M6:D0N: ^"EG6\N0EC!,\F_OA)WWG0@CZ@4*34'K %):+F=> 8Y<YRELF;6S,
M\)46"X__V6M_U7U##=@;P-9!@;(2-:"OUU:D**CFUY&GJ($', 0(F@R5B0*A
MLO\U &\!6WT%.^VJ@0&SMKRI**?2=?L+R0ZHN< C2-5+#=A<L#9\4M7!U $2
M:U=VN,#].IS-O(3^6/R=;":CQS"8)#B:O1*'A2)G.IA$..^*7$ZOGE"21E[R
MN8O4<Y@\HB1OW#L,,/UTH0U_Y^L^0[GG7I\^L.Z?*0ZWO^=9==E=2IX6+U]
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M>#C^>I"\)G7M<;:BMJ\W4NG65^-B6-DLK J  A+'HUVK644_A87-K /%4[)
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M^^S1KN>$$5=U-EC)DR,$,'IJO6)GJ]/PJS>9)N$XC1>5Q1+XG6-YJ*\-1KT
MG=9;3GK<B0*?W'Y5*3SO(S;]4'?&DXVGG:H<4-P5;=\O9DD.**A;/XENM*S@
M;"R$[Z%50_9WQF$"3SYMRVHX!CE'QWJL+[M\-5:@X&\Q_U7\)F6MU39G8TG
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MC=T^#_>,D^'X#?V^1UX04^6E5VE?24SRU1&%//ENTS>0BMJ<M#NJ$"?D"4B
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M=!X=(?,]C2;\S-("?].&(UX2&:<X*/*ST+\&PSRXX+U66EV@F5\^"$E@AD(
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MHI!U](G$$-$[]L@OO.,$>[XW$<3R(>NIN*A"UM5UZW_" 5FDO@?N]]DO[">
M$86LIV(B"E%'ETC>X.BK%<T]A?4V^MO#-)H:?"U5!.,K\(L61+65#F3^>8[A
M!V$9HW@-  @G#: S'MPQD\"41<62G\7^@>:(^[F"!=(P.4 C@0G"1XW_\IB?
MGG!?$0T+>ET,#Z DL$&!X.-OC ?.-7FOB\#/Z, @)Y')BHHI?SO>G+/(?7$5
M9$(9'[PD,EB!8 1CH\[T%_;^QM$4^3X>W#^E28*#OSFFAGI](6R5*V[RV:Q(
M<(*QW01[P> ^^P^WN%BW- &LM7VDY#-1\!B"L<O<F0WN7[W8F?);2J%?@^2(
MEGS6*0"*_.US.)\F),*8>0X]5HZ\]["]8:G"I91X@B61?0H$(\=F(.X'"ASL
M#AP'^SA"21@-YG.?@$&?;#,3-QK<XP!_M#7?B;&P0NVR!1C%;4TTLH:I?5TD
MBY8(7MX-]+BGA*'&QCS@D6"Q%0 VWB:W-2>&Z^X4;O + "MIS%$D%/E9YVOH
M3#&8%B!VH:/2QC?J;\C[A8+K\)(V]B=_F6.O)5#>_K4S;5CK0C\_Y@>7!,Y*
M.!#YY]'>ILCSB8]_]&9>@MTK%$Q^AFW-PWG[=K4[CPGZ"&&NB,EDI +AR-].
M1VCB>S_O/1?]P&]$IMGW* U\''DD0$.?'OE'@D^$D\'EZ/(A3E#PWMH$G;?7
M?^^DU7K C1@PG!*9N#PH\W, V3"/@ ":@_G-^WN&$XIA-B@K\0!8N]V%:>S0
MH)/ L@6'E'?F[L%'#G_?QS!AS;: -@R%!!Q[5B#Y'Y%,6&A >1OP?93.<]>W
M#&4HD#YBAC3W^/UO_&?H(.RWEO/:-6VPUQ'%0%2"15M*H'E[@N\_(^0%^/'Q
M^D\/?[2$T??!MVWSAKK3YHB2-"8K GK\4V-/GNOZ^!;%R=U?MS?I.VK+8PUN
M=PZ8ND"MD3M6$MBD:!CR7B$7B?V[R)OY^/,:46G('UH"Z_[J9<_E87#&"0$N
M">Q30!CY+Y[7842>)BMUI1[M&TWNX>CYWVT%M*/=)50'FHD" ID$EBHFDOR-
M==D/X2%P+@%8*ZW]!&NEO+&2R$P%@Y*_G6Z5RP);8^U__-,&FQ2&":%$QBPT
ML!RO-7[@__4R#WB%@B!T?KZG4?#PJ!9>( C5;Z'-94="Q\,)^=IHX&37#4>#
MYYOA7P-_XI%G:@FOF[]V-EYP%P40B$FP!HB((_]H;A!-R.>\ (TN!Y=7*0["
M>.!%N"V\!J^CG?+:C@WTTAT0S"2P53&1!&"M:9Q$R/?02_+YF+A/R/EO2D4C
M3N_G\^A?;1GM]^V 38=KJR 0D\ED1024O^5N7S(&@>*6(6=7U'JPUUZ0.$ID
MWC+@R[LV )I-:XOK\N",&@!<$IBN>"CR7XXSO^:A^]G[MQ\>#@+4$E"WWU]%
M&S+'"RH)+%,P"/F;91Y]@+!*X#DH3DA)9)1B(,@[EH5@BX8.] XV)X@D,$(Q
MD.-G?+=7M_^Z77@H'%_.+M\OOSV/)Y=_WO,V1JCA*A#$)+!-,9'D'[S2)D\^
M<G$\793IWZ._O7D:M837U<W;;N,#W8)IK4 P8^A8Y](6REK%1)*_M>8.[OG'
M#\__",/(;:L%.F-)[0JQUVP?*@G64L$@Y+W;!&&.6A_H'2U>&$E@AX) Q[$$
MW"??<1VF'Q%.H^<?+VG:6LTD._L*],B2(TX2F*$XZ/$/4%>"T_:#W]#,\Y.P
MK9&6C#L9.D1S! &6!(8I(H[\372$G33R$@_SQ6UW:HT!<NT$!IM$9BLFHOP-
M^,X+Z*B\Y1UP$+:K@[9=_HA)9+;"@<G/8M\BCR:X\<;TRE?L!7$:40P726^^
MU@OY?!0F@!(8LQ3 <C5L\LR?K]X'CAZ6F%V'(/:\1A>J*0.!3 [S%1-,_M'S
ME4>OW >.AV)Z?W>$PA>4^F%;]0ZOCSL],&VH\Y)A0":!N0H)).]CU9OP*D*Q
MYS\$;GX3X6[MDA_Q=.@R:R7*SW"U/MCN+  !E,",)8"5__J[W>T,!<A%M$?5
M31A](/]_4OR.G;9VPH/=:Z= RR@@PB>!24L *^]U>H7559@Z4YH6]'W,VXY[
M': ](<" )H'UBHHE/Y.]?K@:_/!B\A0KU)Z\.";_'Z43- P2(F!;&Y(ML^T0
MJ]5[/1N<R8("30*S%1E/_@'T]=3S<9X^(&]#D_ &9__4EM$^;DYQZ7U-<8&X
MV@(!30*C%1-)?N9ZA;W_D)_>W&!<AY<T1[]XC<\1478Y':J]PD%- I,5%DS^
MB^Q6/N#;G\L#\3"8_!FVAMNW/W>:E@(T6F"@26"Y8B/*<7L[]0*T*@N/R5O2
M!,=W871%-Q0N1?$5Q^3[G.G"$9+G"";3UB9&LA9C'>IJ#!]."6Q=.I Y)J07
MN"S1?(L0^?X)*#,'9^1P0)/ F(4%D_LI$O6"F^'.PMG]-26!3DS XV>Z5A?H
MQ5YHV,E@P6)#RG_K?(.O0S^<O7MHF25$8WR#K\+W,&FK#=?U<"=)W>V#3U)#
M0$X""Q883MZK\,UE2/[?5T%;_!,MJ]S^@_Y"DPB_MY7X>OUSIT[: KT(@X%.
M @L6&U'^2_#H,B+(O41HDK9V+/S7CL%:&O ^CAQ@DL XQ4&/]VH*PPQ-$W0C
M<OAJ!-$(1<&._UKX#2,_F3KD%P:CZW".@RF:X+8V[S=_[IBC9@+?A7(%3 +3
M%!%'WBLE$-/4@9HF-Y D,$=1L.._4MXZ*7+#B";+_B?UDK8*L!GG+="72$Y(
M26"-8B'(WR;S(R@*T^WE-?*BMH"ZO7_961W[8HQ9;A^L;:TRZ1B)?K_;%=$R
MA0&1=\QZ._F<)^MH/>-?&6#7Y!-\S)36!UL@310.9!(LHL*"R7\]O?,"GZ W
M_+R-YV%KB^GFK !BI:;5AVBE7%&2P#!%PH^_+=Y'83K'=UGO.NK!7E/L^4_(
MGR$O;JU_'6..1[]C -]_@D!.(GL5$4_^]KN*/49@;-<T3-BFRQTTB<Q6-"PY
M#LIR/ZAO<P>.@WT<H22,!O.Y3\"@3[9H1ND%R3T."*QAZOE^:UM8Q@(,M- /
M,(K;FFCDV1-=)+.6"%[>N:G<)S[B#^3[(0$+DV])^!FT!711Y@^6!*NQ<"#R
MCYQO:#FS,Z4Y@OO9^[=_X6E;$Z]98RLM"WB=+C^X)#!/X4#D;Y[YOH*B]$P>
MG4K35J,-AGF"O?;"'RV)K%,8$*%8)WDF-_V9;0SX+Z%0ZP:A0":=H0H#)>^-
MZ,9\,0K5M]#_^Z<7.=/6ZC!W3U\UF-8*!C$)S%54+#FFB+7!*@@9$B&FR)FV
MUR%RUTIU&Z*1<H9) M,4"T%^!OGM]G\'CX-[[@MF=B)C +U#R@TD"0Q1%.QX
MQK!^FJ"US?D5BGS\SM,231UL],H7*PD,4C (.<:JF#P&18F"])JZH1\GR.5T
MP DW5.6*D@3V*!2 _!.SY&?]?+#M]>7#Y1-.T"R,YM,P]N)!0J*+F&."%GI9
M(!3L)+!:P2$%8,=I,"&_MNI?L1@Z\.BA=\\GG[L.9W,4?%ZE+IH3B%K"\=OW
MN]VZ(NB'HT"QE,G,I4"8]SG- D48V#$LO=>#>B<'('X26+?XJ/)?QQ\"\FL+
M[)[2V7MKHP<>GG>+#'4#>)$A-[28C0^Z';LGDKV*A^)1^^2&X1,*TC%RDC0B
MOT13#T\H>D]50=C^RM8?.,!_I]C/[H)=HP@YJ*W=W8_;G5A% YYK$$N_"GB[
MQC6,,V*,A+-54<%:<%\_D.-X 1$R<&\\- G"./&<F,[XOD5Q\@T%X0>.GO^
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M/5@0=;NVP4>)5H[J+22&M>VI!DD2>>]IMNB^A5^5S%3)IJ'ODD@,%(X7YF*
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MW!Z%=3;(K^X>NC7IFLZZ0UH"K]H[R!--=E,GH>G0$8X^/ =OB_>&8F\2H .
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M-KAJU6Q+9TJ1)NK)QAGPQ71^NH"!Q1EPQ2Q< Y+^4\ZPJ'$9%F_C*G\H16)
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MZ/,\.-&X-=,HRTHVHV;YMG,AIR].3NTL^6FRQ5V3VQO9R0):<5 ^0)"=*.:
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M#M.W5XKL=U^EE6>W/ZD)PA9B][ M/GX;)2B\9VA;;"(\8;+?8Y#6D+?E%W6
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MH_3OOK,?'WEGB,=2> JA-/>6JL^E50+<>#;&&4WG)X 7TRJS?ZW=$#G/*,+
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ME H#J3="YD3F.Y,>'>,T7J!PH[S)WX6:@)QB'@RE[BC9<UERF)5G3W7OML)
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M-E7C=AD^;-3?7/_M<QC\C!<59HZBC$?23$-%VU<?H]J68KGZ&(=CDZ,<P5G
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M'+W/>?S-T(IO8"B',HW6KX91UZ\,N7>_5OB3F\\="[JADZ71+ERI"I*)M05
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MK9)[X_D3@*=9*,O69I\._X'<-__NURQQY8F[OT5:S>J??-NC'>,(9#K?_Z3
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M-=FB4VC=5QC@*G+UU;5_N%YB7U@2E&OMGDH+CSSSLL/]LLT$RWPFY4FH;\V
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M+*<W]X5$%F4JG;)&RTCGIV_S5*W9:=-XQGZIE#0FIU2MO'A<&5L47QUFMA9
M4E77Y65]I(L @  4]: ZMN>_7-'Z;DQ53KI<),]-CP=48WIXT.ZE9UIB6E_1
M>PL#2!K#7AKUK!!]]*5,OZ)<,.D-C7]]VG&\(67#OA#<[-/4-:,UD<D[5=WZ
MXX=1VFD@S N*1,(>F3JK&JIFXA8K[*&V[\,M5=B"M=S:'@F4+6Z&N*MFDU5U
MI!_+1K56^%5) *,(\M1@: P-$&H@C0*&QE\2_.9Y:<4\I@1B,]-223!J9^>/
MNY?D7/,?;KS(C<F-UZ0ZI^QQQ-^1[P3A0>HZ?,,Q'^VY!UB?UB'*@M7^\MOP
M6E%'I_SB4P/G!CJG 7Q@#RT='.QSH'%D$OA.<XD/X4$_+W%&X(=C>.I^#OKK
MP@T9(#<U<,C/BYT1]O')X+\<]D]!& 8_7?\M20R@D'SPR5YA!VE-QC"=/X7!
M6V@O*U;3[1_[Z>/17J(" =]?"F_;ON4L\B%VZU+4I4=> NPW^Y>[7"]WOY\L
MB8LE"7)Q];9V];"[=$]%(# 8^-M360;^]O1GD0'%&%X6!T4M,,EN V\&N$[Z
M\M@IDUZI->GWONZNO<1TGKG,Y,$G!C/^R#C3MRARWWS2W&<2;5I1.)-X]_77
M!?;=WQ:IZWS^2I;3A)T>2?6W%_U)-\(PTN?N$\#E;MJ@Y,X$40A4<L6J&["R
M,RQ**=)ERTZHY!X#WZLM/$VAY"HN6WB")UXC\:FT?*,D\=VZ[ZZ#HX\(+XFK
M($+.-+PEEW'BAWY"\R#<IY)V_>NBR3I>!"%ISG0?A ]1M$:?UO%C$.^;-DVB
M6\Q.Z/Y(XHC78/K31V'TA,*7!7YRV8CP9?TC0O]:XU_<O>/_O'ZLBH%Q_@,'
MW-]\N=^^,\H*0<4RN+:,+/TR>,C>Z(K'OT:DPO@%QV73^><@<*(D 'RRP_-5
MYYFD(2*>S6KASFSO&;WAMZ99PBB,R2?,NS7&ATHE1,=6OC_;^4$R Y3/@S*$
MI.:/2XJ$I/*!9(Q'0WZ0)D199XA<L_<:Q+;WB&+R2=[J6'3M59+)T,RR"(^-
MFCMR%GI+QV[!Q\Y P>G8Q^RPOR /S?#2N=_8HY]0.;4WQ6SNZB-EF+.PQT9W
M?OQ%Y/)P4D5H6*<!EAU^<T%R6ED,PU* B9*;+3+&K(5Y?F;?+&S_#;NPFR>7
M-\+I%Z?O*,1?=0.GX$$^!4]_WAT>BV+(EE)Z72Y@Y$4/)'*VVW%<R6'EJTR6
MF*297;*7X5CAZ#SS=LN.0J5*45=$.B?L'+!* C6'^?LZ 0B4#5@ _B8[O[*2
M2,>Z:4 3*1.PW&>I />RBB152\M?;R;?^^(W,\U6NM)5Q*E9P_Q=4/+%R='4
MZF= 5A/H/J/Y%(0DZ3B=%ZX4<IWTZEOD)+^(2-<L_"%J=<BAK7H-;3^R9^11
M@]<%=O,<=^;ZR8&1E>U__+>#W(2EK^C-]N[\^/#$.>5;9;:UM_M5^:PY"Y '
MQ!'_-8P_GCP;<^LG*?[5DN)6YY3D)<;&,[\'\8SB,(A66%JD303IOS5+AH>?
MF?O5,XJV.>4"5P_^+"0]KF[1YL\U>@U25SAZ\">SI,870WL*\+,_'NZ?7Y11
MR0L&*$?TCP(O,O3LOBWB8+Z.CO3W:"\QBF'HA\04\9XI?^\:*6,*)53(!ZTJ
M.DN)8M!:>9SCXS)8.#%'\!!1^'ZF#KY5%!P[/;9%6J0AW<[M-/X4(NLC0JUB
M94#ISEGC0%&FOV.5+IVMHDK1Q[1N04>19[J2A<&[&R7>]Z;G:?4&GZVB:J#F
M3]&7)."$5G61)44U3B[-O(YOM8JD 67.53WL=M-UTZ2.*,?ACJ ^1DXW>:%,
ML$/ !YVFN\@%=H$IT=$)%E+O:)*[^K53=%!T@X89V.[OV9W*41>V<3FCS,2
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MMVU: GN 5<2B_AV,K"I)B:L"DW >]&X9$"6#LY>(<JBLUVF&)WS04A+ $,@
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M9IW$3#ZX'+$6@A5+L?N/G&=]'VP\!QRK4NV#0/DFV[:_F*':RFH'?WA!K$1
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M%_CXE.L'*E*=_L_ &0D9O[Q1I"(<5_)+JZPMTK*J(PE<XUDX24205,H=WX@
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MT#8H,W>S;#G(XB(,AML+T1E8\SB;-YF=_;.!QE7WB!L6P&LJP\Z]NZ5ID0N
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M!L[_MQ@8_B;-Q!':G(KGI])8C>Q7<A@4'G\V[J)NSBX:NWRJ'54>&MF1(&1
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M[2>TVH.&4:^7-F%EQV><R!0'G3 P1(8H@>@R]7R"A72G-/JEB T*:L<-C^%
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M,=9"KO*K!,B>XX.MDJ4N2>BFA&(DB6-+3HJNJ1(M6<&=.#*;Z5=0E,7PG!J
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MB;"+83]UAW!NE$:!?^GWW&X6A2O*<05,EFQB:BADQ+IVVHKI9]@IT 0H%16
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M"SIR/!QXF22YRIPEL()*H'V2#599Y:5@A<X7< ,_G1N_ @COS%5C8__+\BP
M?8=)LRM8U"N]?RT"!JF\;;\VP\$A/&J:.M"L"+B/N,@VZH-^K &*(Q!)C#T3
M%=Y=M>P=865]OQQ J#;+N$ZY;RDCNVY*UPQR[:3NIM:S.3^L&6KS_.RSE*";
M3:?@%A)Y5B%W&"94##00<)VC@A+90FDI0EZ18#GD0^VE(<R9AIQ?%N4#X1K!
M-^6T);X+T8X)7E2KA5T"ED=UL(@!)F#GS?N_LI>6H18NIFS!L4!'*\.Y#(L6
MFJEKOC[L6L$R*!NV$\&*$*%JIQ;E<HJH7Y9CQ0T01C)P@3CWA-&-5H+"W4-8
M)[HCFR$M/BZ>?,7Q$\#+*[[\P>H4 GF^N VC*5B@>A47V4/K] TCQ,;.3,VQ
M?EHE\J&HAX/0K!JS?:G6U'\X(C0&N'2>+P+C$<2A'?^N'C]& 4MWS2LFQ@$H
M'DJ_(1Q\ @TMV6M"C--#NM:FTNO !!^*Z[3CNF1&IAXL2R8YU(.]?,WE$L9X
MM A?)C3K0WP9Z$%XV+<X^;Y[DWRW_B1_-,52B'#6NB#AF_JU=(K/!*F1TD@Y
M5>P8G_61G$*]R *Y.JA>*]CY\%DKU+E>M#AGA>9!GF&PFAPI?B=<$&.%"]4Z
MB_S/\B87H*@,'V(YCP:Z&(1?N26#\^GDQE\;_0N2&VU-7D<C6E/<D[UVK<E7
M<=B$N,BK&4&^(2V+I\_,WBZAR5%R7ET!P.5 NR'Z:DP8AL:)!PB-_N<(2Z+:
M)A\21+! "XFYTYBY(W%F)M%FUJ.DA(A;PZ"I\<>+J$.E2]^[[,'TN4Z U!5?
M92@< N#C+E\4;5O.KQ7*$T-:@*03"W W]%LC"G?!HB3Q]$X6?/BJGV)%&!HK
MKH#AWD":H0F$$POI'?M08]1RY(E?COCK\S2B0CG#3U"<PDTX+KP#\W<9A%_H
MT[OX::F(\3N!]C_1HP&VPCQ-H&Y%"U.\*%"?06T/PK/J!]+6BZMW;.MJ^&29
M0A" %E_,P:JE?!D.&!<D,T%Z#$1&6'.(P%JD[DPB#%@+,Z5H03&RTS:)^MW5
MSE7MS*#"3"C+"!Y-=Y1689;5!^1P\?7#%('=\HTP3V!G#&-[,<L)S(WTS5&4
MCA8SB%F,T"_#C*<3.\FAPW#$E2E."L15'C,LL3$3'6AC)V\R5./CM&WOO]X;
MDJN!16J-/70W_:K8Y3DU1Z(KAL"K[AQK\ (K5YO\0;\&J!GE8]^WW,6^97CP
M56K'<94N^:WH<5[5JOC\$_M0/!OV)%5/;N(XJ=PQJ?YH1?CD'LO1H$WFY&?H
M^5[B+J[5BK1F%_@C=U0=W[M1LUWS>/&&D8T![C\#P1N_V.1T-G<*NM['7@P%
MK+7*+9"4@^,-]0]V3<)[L:Y?71G-Z9I@#/>E#E_+4NK:5*O.0,W4M)GTX@M'
MU6H^@I%'%VY[\?#EZ(\3#9K2<"+34+D!Y?1#YP12-J1OR1G[4.KTJG%$&.I=
M^^6F[*D_/QO:A&)8JFLR]-&/H%4+4'6LN7/GY857<U!W'77M:"Q%J]A40<-*
M $/Y1?V'XG-[&,,'2G4?#FS;Q/IP8$>NZ#X<V.9Y].' /AS8AP/;;F2V5JS[
M<& GIMJ' [MQG/IP8'?/6!\.?/[STX<#NS/7GS <N(G@W?V[I;1P_8_*']8S
M92?VC/U+4'5Z!_A:K>UCLBSJIENA:#)5U(<2@$(*$2WH$*2.O6*/PTUXJQB>
M0>_T],ZNA:7]$>TB4&JNU701^ 4IQ7>Y1:)^A#L?/G_!5@'XO[<O6]3E70]F
M)$=L(0#]^F3]VP8ERA@>Y$)E XZ0$NA877WU=P2;R?>"BZI^3%-_FWI\T,LJ
M?\LMFU]JMFK/Z^CXA)T;!H?*:P?QUP=Z[*Z4@@:B$8@"M&^*WI,!X\H6VG&+
M+27+HGM5C2;%SM'-*[(U%*3=I4\3TY=Z$8]+^O=^>9/6M.5_$')-'N!]FO2?
M6H7&W(LC6FE BG$N@#H"9Q$Z3):CMD&CN0*\!OU)UWTA =SH@Z:G&^GB)ZA)
MN54(D&L)#PB>(=K,I]3?SISNXRB;)UG(RVH[7_2IP[ZIOZA/?.#Z; AU@]M<
M5SYUIO*;A+O%H5],=%-8G-T]<$%FX.B/"*LC3AB949_.Y$KOQRW.F ZJ'IIV
M(ADZS]ZDT+]#8$G-!H;-(2D<0>PCLFM,"YDB0 QTGO H& +@"K&9M)*%'GT?
M30E;<Z-_+?3*+/1%&/V;8$VR?#</?T@@4>Z&Q$.-X+S9GG'!IM$L0IC)D%'1
M>39R2\R*?D\6TS%TO# *RF#YF(H?9_P__?DFXWN>\U1W7;Y;*75Z8Z%AUQT=
MZK_.LL5LSIB=8+6P0 &$7C2*YLA#:!?*@GYJT<(&.CBX@-EN )PM J6#-*#V
M*RTH\T6J1Z(& F7::ZS3A@W"!^M1Z2,=)[-H!'\GO!5A4\E!J!\1Q,(,AD2J
MH&$-,1[*4)FM!+2"/B6W(:8Y=A1.1XLIH548^ M/C.FH,Q!W!BC>U$F$QL0<
MH3]C;V_!5X%F57/M.^0]BTA6@/RV8+[4%9BJZS"%-6_6;[0!X]%?5(8#,K@.
ML]EKR1ESKE_#/Z/W*#\ M0[PH]R"W7/K_YE9'QR\#B[HHL'V+JUW *AP8JPO
M,#$)P,HIANU=B3\2J!(!'"_$>\1N3SWOO")[OC5SOF"H5X",269S/<0\T9II
M9QHN8FU.N%_C)4%VL<2"($!"1%0;!"H?[;W<WK6Z1*E0:8+\ 7@E!N$D5Q[V
M,"%!P'5@83DJ4",8%4+_G!.RUZ!P .F).75"(XX/W@RT0Z9(9#N7^=,B1U=2
M3[S6N1>:>@<Q.Q8 SST!9(*1-E+U]Q93L@5&4RVB@"Z1PZ2W7TA7J'.RD0"I
MG%:SX%-K:4T(J3L=$>+>;81V=6W%R]8LW.<TF41H"^HO;O<\KPP@ D""8N -
M"4+4-=A?@+Y@0F_;NPKOR*P!GP<4^?9.]$( =J3)73B%VT=2P:Q,.6WE4C!Y
MSA00Z;Z#J?_3"('GTS]C@.P]@A-B3(E@FXL)!2;]JLH5BC#4 D(DR^D+OM\D
MTRHB"4N_0*Q@7F"Q&CS%OO7:#)Z#/$O' /0!MVH7:@4,)Y4-((FX@'4W!I+O
M#(64@ASV2]6O,E".VI=&"!9\2!1/IE0N3/8J@JV'8+/22/3<Q87 L5? ?!RI
M6&]Z0DYW?C<'&PJFVT)^DK=>E(H""B;(4N?JNUBJG7(($=5KA28206@B,%6!
MHL8&%?"5S-Y,8'VC.X.ZG64)\Z+@)E3O%V"#PKG\00%'&*AW-E?%IA9$C,8A
MOF;!GG;DN=XN+&@<(C!C3DJ[G0.PZ\%/*H0A.?PSPFG? N& 0#?60HE8T.;X
M5,4L&-6;F+WX:2:Z2P%0L_(8?;+ATGLE>]9,RMPOW7-A10RH?L-8>T(7!LU=
M?_0B!P+9_&Z[4C_B7(W,K(L@]DB&H&?>FD10!:!: 3FO<EH%7%W.^3)%#2%E
M)<C>!S%0!4#=D$0R(%F90Q"V[T)XK"ME4U"#P)7I85 [#/ZU2%#YWX#21UY2
M\<2PE$W1"HH2%OHNV:4OU62S?!@U-Z8N:*L/AKJUF'-SY&=VB2-YLQ!')-%Q
MV*5:FN[#%-0*["N[B@8+?Z3NFY#G%B14GU5"Z"?F'Z8*UU58S=7B.\-T0(KU
MC=;Z6M_"?^"16O+@G'5=$<)T' 2B<A-KKN>> 5N]=M2FK,.D<Z;ZNHW&GF)$
MRRG17@]:P#/(W5# #T]=JE2! UBBFAN25+W7MX!)RYEAZ%PQG#D6)7TO^"V,
MOV$^;9R&$\XH&V/:H:+#>"!-1=(B^#7&ZLJQ/=<SHEA>8^*3M(E=)E7&6,QD
M JE$6]@27NMICHTW<*6'.7!H>C%"OW^GFX*'R6S7H,I!]V/ASWULF/6.U+V/
M*O44@4:]5"/>7JT=@ T5_JE?^3&)><$+7^WZ>793!VX/GOL 0Z\\>TLL7I8X
M=I!;8^*(/;-U*'R^KQ/(HB^F4Q3,5#\QBL'.3[F:P1)'6]8J<K\\WBKF*.1U
M,!X1F"<9@7L2"2\:4^)K5PI<+GP>$I_.9FH<(9RN5\I69A5P*\V7J"'_C#-5
M?R<^OR-<*50X]Y+LH#&:<5H/F ?GJ.Z@#@'O8<ZX7.7>DX"7!P(D&30!>.IZ
M+ZA^N9XR^\V.;9V+(FAD\NT(C#ZF  ;>!\P\;7%D$43?T&'P7XMO+.AIGN]*
M]<QT36[GD=8FLUXC^:M9Q5)Z1!5KR],]J"M6K/34I;%SB"-<1R-_R?U57*IB
MGG79:.;> F'/^R.Q@+3Y_/JDS;AD6F]*SIB8(9&)7 #F*TL"B[19\((\GPHR
M7D-(3/6R(>'00WQU2NZ,?K72#X$DXE[P_["?Z _2TK#CX%0XNF$.&0RP8$0K
M\?2SC6=6:W9VO/BW)I+JB9'C24<_6'\D3FQ]H("V'HCWTF"UXM)_B+00FQ"0
M\[!E .@KCN"?VA"E?!D<%W:3I;4J+C2/HU%,5QNMR>*:D)#EV_79U/=79ASN
M*Y5_1^,O@,@1#.QJ<:=2)AF83E4*(.VU@P"^-*W"J:391B[M4A>"7R@.@IK.
M12I#;77?<=TX53*8FC=]U:LIK4SF.;]B=7T5(T_L'T@(=%AU5L5:W43:T];+
MTCJ,[7>P8#[MZ9E@[2Q1H)T'UG -/L1:(2]F1!3BF%+M6O$]1V9S9FMEJZ^Y
ME=:A653'0$,5[-$JGM5NI[K>%FT6S]*L.(XDW$ANKVZ@JO!6F8N"J 'L@0+=
M>S>:4ME3%>=B\7X9< WV73"#8(^>^$VI_T!_&W0KLT%2L09;1*;"76ON+"]=
M@QA,,HQB>"8#[7OI#T?A7O!7K%U@XM2X#K7%C=^8)AF65;,?JO^#9G/%)[R[
M.2R$_DBI&'3WTB((GLY)Y;*BYK@K=O4T"F'92PHMT\B>)]#UT!,^@#UF#SF:
M45;D&JD<2GT@#['Z?Z];.6GV%(:85?H@ZTS^@8/>WB/_KN"+#(P/(]0 AVIM
M,/Y6?Q!R1.C'D*^C;\20*HJ=@;I4<\RI8LAL?[#S[K\^__%RQ>%S,?<&YV\-
M\: L.A  %UTS6Y&^WJH,J@6NPBB'9[LY-#//R5'AV?+XREO0BWR-R/]>VDIT
M_X YR/I\WHEP&7S\8++((1>U0@! #%VEPUA!UA6%+\PM31RR.V54DVKYS(49
M\J"[-TZJK]^:$[C)H_<$5Y^SD;6<IXH;8%680CE>YBX[_]S>F<O..$A9\1/&
M[ ''Z$DW;4#&CJ\X02D^*^WR<Y0PXQ(M,\\'T+5Z \LR34(K@B9P0]SD8/)G
MY**-M-CI!<82B?$M->S"5V@OQ@I)"TMQ5<?A!$%0$P^P35'H[8.99+D.9TFL
M]P]SN\#'@PD&>AG>'Z8)::1MJ"CG(_-<'IIM)2(OBMH(#1F5'BZ0WN].D^0;
MNM#8 FU8"LN3*)7L@.-5#'_>\U3H<VKSH#B\4ECU00'$-@>DW]G@P1(5XTLI
MZ&FW7#*I9V,8S$56N9$#7AK6[UA'9;88XVBNFWR3<<3?O1>Z6\5X;U9!4J@)
M!1&C:20F_"'\,O5U#AH,M\(42ZI(DHO2L_;\!MQ@A]T$<44OG78[9\^D!X1R
MQDL"Y>YS&D&11%(3DZF,OHQE]$6-^_#+O6Z^KY4+"XSAT(7K4DL<O5PCPQ24
MZ"RA2\^%6+XK-GDLWR@0HA,#NC*6(EZF(A4UF2Z@XI *,B/JZU5E,[(N9B+<
M?3FA2 ;Z<%R/;5':E]PKFE(,JB,#Z;)P"M*0BGB*BE#1K.VN#4H^H0OX-\DD
MP@DL)[D&05(S%M;"I;>"@-(]56%)@W=:RG;^OJX@T!8])/Y3KM_J_6';X."\
M(V2I)6-P7*RBM* ;G"(R9-85E7F4% /[W%8Z<F*'*@JTV"]&D%FY(^K*5-U&
MR2(K[*M]=<D(+ G:H%8G5@C@$C-'/[OF01%;QDK?GZYDG;B"03B;G[""4GN@
MS2I7QG]PD[/)]F7QMMBP@;>]1Z>)K^HB)^2M-JHUX*L/2ERC1_%'%S%0+.BO
MBII<[N6IKCGP7(OZ$T2:^E$\A:IS6^LM-'86FHSXGJ9_FZSZKUBV0)4)<H+X
M[]DXS&ZP7V!$O0)H]>OE$ZTB0:R^DPL H&?C,!VCGH <KK<PT/P:C4&_C F)
M!:H\HVRDY0.='EJWJ/"NU5G?#91B;J)DDNHUHTF:[0)FVKI#^/W'7%^4U"C<
MS>++MR[1(&\INT^M*:Q<-="*VB#?HO1M&C]R98KJ1-D.><Q K&ZN O'Q7,)<
M8'6/%YLWA3[45TB%,ZZD!DZ)B<H5]!_(4 HG20)KR6XXKRX%,]TFCF*5H1[O
M+=L#V3PQG8 \Y$(1DK;I!)@8H8BUK<SD$T,8B7BN79H0UH <Z]^FX>C;[N4(
M&EQ-$0 7,R70]CDU[K;Z 8 .IL8HH^K)?T)TKNTKX0(*MM-VO.I4&$>2+1$0
MOALUOL;+-&'+G0#5W"KQ@:EH%=4"K1\XPW,T=IV+V@2@ZP![,%,P_ET]AO$'
ML1]4GX4DF.E#>LU]GGI(^ <9AX(F VP- P .E4(R:.5$Z9#!HVA2IF;/@JE>
MJ5&(;:)8,F$>YD^/C:W4:Y<4D&,#[)^&VN 4NU"A85N/D7L51.5U;A'J_(<E
MKG_*(KA2<:FV'R/J/(Y,J1VV6&F+G\U)3':%A&.2^XOH/!C/=$*5@DL"I31)
M5D12,]J&VCNHPX+!=Q+JLL4_>&^R6VV>FZDIQ9ZU48%=N>C[N\+)UIVB-PTE
MB@J5<'6YE@@/$YP>96*CN!>I"KF![P)\WU110I$"<PY3!$'PW/=VZ4%X.F"9
M;J(YMLS]R#FH-4Y&.!#;R*+M436W=%=HF%$0.F2\DM3F=LP%97#TZ%WP>&L\
MHS_I9F$\E3UV@E:NSCC!"&-YD3#NH_=B<E>Y7GO!&_^<R,I=.!Z@I<3;BU>\
M%U)P$:2G*#9OEQQ_B*U-+I7G#:673:;;Z$_GG6(H!(&B8A-+QCVRV@D/KT%*
M@%.NYY.QJ)G'^>VTU&W"T12 ]0KYY'^*Q9KB0$LQ%]>ZF<D7%<8K<_=9L9G7
M#3\LCZ*B@&A)J07G/1:SQ92%0$2'Q+K0.<H&[@9$J#-[\LH'CKL#FDP?(_/\
MA-@^ "_3ZFJH4GST$3.G[6A$_@<U:>,BC8OR@%7^ 'L*1N*$#@> OH#EF\28
M J%_&HGG_<9J*VIG]M>8HVWZ7T9=FWVO'4 %U/;RD#:$:F.9 ^%O89*!*\0P
M8V[1>GT'>A,^[+K>\)_H+.G??(BA6@HS>AWU@\4,6MU&;,:)UF!-VZ L:<*&
MV,08Q!BN'RL"TS$NU"1*,SAD _Y7LN!V6<KL*C@-D %$SPA?";HLLK#8##-C
M/ T/4;Y$576/:_<O;4I.V2T3DR>,^^_:[-"J%VSP^Z:.RH-<UNS_L-.Q[@G[
M"BU,%_$8-?@75PK5_< 3SDQ6=[4FTE0:67UHB4Y>!"'EVR2"'!B'WF6> ,+U
MQ@DF--T\_*$XF^84/A>6"6![+34+L(7Y]&:V3BY55Q#4&3 HQE4X^I8Y; $3
M*VJ=Y[71AB'T?S(++#9.%E<Y@)KEA=VKZ7 #?/N*JBD.'.W\_@:JU[_Z[_$J
MK\J%=?H[A9;O#+SN#"$7QFH2+J8 7F.RGFQJ%T3-8IGKCT60B-0'QH42A8GN
M?<]TH(G!ILH@AN<^0(IIJJMZCA\.*1(P5.G70E25FW&<%'-:*G)I*70 D8AY
MZ;YEI?)C08?#_7]82X0HKFO7>U!GM+P&+NF! U/F3;[ 6%^4$49@]*IZUP);
MSL]URAY8[.7OM P$X-7#2!K-CEC&A09<X;6BJ.OI]<[GYO-0!661Q!0>3:D
M BL?$ 0*?0#P]B*J$9I&WR ,0;$U4B66-B&B+-2X6Z?T4B0+!<)+!,C2T EM
M/&Y3C^W*N.<^K"Z M:2+>0YHU.Y!J4K2ZS!F!O>!59#8_*(/(N121NAS<3^@
M3:(+!AG:BR3EF!?C4MW5J4G<*;/]3?70H*D2&MRS]&P[5='69:@W:K2OZP<X
M%=9]R_\/=<TBK>+;*$UBC')/90*DU2ZXHWUB>BC(_4;C*$Q-!X/^!1*V(8 \
M;J3699&(\+%B0.J_$#=RD5)RSJ3-A#8-,;0XI2P,ZDI_W2!I#6%PD&FQAJ(B
MC", N\8+D<]R"/?>K^'+UZ!,S5LHO,5_STP* ABYH$,+H7.EG6QUID7V4E."
MS[>T4OJ0P^TX"UWS'=T<^D.)(SZ8HKC8[@F(?RTPHXW%0G1QVATH<=(]\(BM
M>T[?F.W._W [ 7AA]O?;4CCB9F1O9+J8VN+&0W[$9:&U-%WILV9B8N/(!FO1
MB'''CI@28P4TBG T,4O.-[H[S;D!UC4(>IP--[6O0?(]QA8U:^"1F2 3KH:<
MSK%6FH=A9;PYRIAM9CQCIIY#B\6HH0&GT>'4::OA&P6<]:KJ"28Q9J -V+VQ
MI&2-MLGHF$YO6PDC248EV(PWKF*YO V(N*R>P-[)(6I? 8U363P#YI*QF%EG
M4/K:MN\ZJBL&3;8ZDU!K@.K$K@/FV VJCBMC&-@9>]#63AE9,Y;FA79^=),D
MS'!S9_E<\1D.7![&YXIV4(JPMK-@C4"19]OB-$L3M*.:<^]=/5$L]Y3AU>\%
M<U&PC%<$E&'K1O4LIEP>T8B)M?1<CQW&RV+7+DD!WLO-^_X-;)7=(EY+&E@D
MU)+6!43AK[:B%[9U$7^/:"*RZ(V#8E .78;_%8M?D$ ?WI=K8JJR_P9T03S*
M[%Q6*D3>@'OWD'3L.A;-/8R1=>V=WV?S:7*GU&_:49U$VV#7O-7S*-LP3_9Z
M*E7#Q0Q %$"-P)*B[D*IB*^R^6NTA=V/2*JJ<"]0Z/@)[?:CX.@[8P*3Z\ H
M@8K V$:U2V$\FYJ)L[51>DYR-647QI)L8NE:3';5%8R#M*DB:K4%>76N_<#Q
MARUB_4#.'5#S 2.P<L$P5),"BATF7;&7"*R3FA'SS"(+!VW5B[X]LR2.U=2&
M>8RW9$HM)XMX9-LVN4G<]/!S 2,=4RQ@C*94R4<U"ZS<3"LS='L5EJQLAQ:T
M< '5KKXKI/)"X][-C2B\)=IH_<0K&JEWEP#EOP5JS<R'" U:KAC\L3X-ZN=@
M/=C/JC%2IE8QE*1G%IAV;^,>05FF8S/2Y_G-W]\Y=;Z_=[P/YYX>OA>\%45B
M,C%@GA(*HL/"^ E($_[!T)KH!U$:&M1(81J<C(W2,14 FP[B&]&)QGHMXR"Y
M\)C,6DRGR<CXEU(39?A0? 9\<I>2J4CEJ0?,U7K( FTZ.Y>T5GXIH@2M+"WQ
M.\B=_4Z;\Y!X;XVN6%?I?"&E2G__POG_;NH;,_K43:DUD:$5=0C:.2>]8-MU
MZ&K\;A,1E#<8'@=FEGC@WW!TAT_1&X=3Y*ISJQ.M:7FQL-B_M1E5,V\V&T"=
MP#K9R#A-UG.[C=802EGFU>3)_JA-#-10]^@I]4T3YO(1<3<8U"PBNC"7NPQV
M9&>+,Q)?.@(*?8 GT71*;>ZVNM-&]9*I*]W@5XPY2B%G;VM!1=+T"L3*P"1#
MA_?$+1&7]LV3B#.[$07%H5W 5(FB &E-/,]%&)T6'H8JW@8?M;><'1)"S]/T
M%2&IC:PDP[]"+(+F)V@!5O,<E\FEL0=6@OWE7\RM@&BIF/"5Q(,43W)@K1\F
M0FH@DY(GHV_S:.JJ'*&]0F5VJFXAQ1"2V"_3,EE\]^R;\%;1OD9Q-C<-+&,>
M%&^R]WB^7%-%.-N.J215^2*-:1>TXHBC[(;NF-B\#HSA"%(3X!TXOJ3"J<>(
M0J'MSP\GV>-%E4L9QZ85U:^[5D(#UU,6OX&!?8 W,=^,S;EP[8),P<(04WT4
M$7\;^SV2D79O<)_<L3)2 M53J2* "(@\5Y^I0<7,(FDT>"M *G<*CS/)=C9I
MN/&R^B5M"ZE^H-D0C>;;B,Z-IPHA[$VJ$,-><$= ;:_KI@!5D5YC4!L,EKGD
M,8- J):&:X4N%=$%R<Q?00E1#2QL=7P]=7U@>^8^RTJ5#'B2BZ<8U]^HG,IM
MR(36)E$Q-JJ__UA;L]4"\ []_^+^#1"(A.L6,!MC6*(@M:E7!#<9[T*GX+Z'
MOI+%S:1H(@41668 HD*%F!ER-O5><"%^<@&#\C64<S^E88S\SA48(^#7@XPP
M7#V8Y8+6-7,CEFXX$B5LDB/Q-B.M&IMG3]5_L+@$A*>!J3,%O6=F#,76,B57
MG@,ECG9TS%<$U6-Y7X/*F]EBQD.Q:31:>KS,_"4686-JOU:S*S4VA"X5\U$F
M>?3#N)J<JDJIT-?LO;_9-2N#I'7$SH<W!*\II- 7.=U;*%)[7/AB&XBP)U ^
M#;JP#&/?\,"PC&$5E>+F%E0LDFA![(LHEIV'N5X0KID3,Z4PW2)S.U2&]V!D
M#Q+#U2PI?BSI4^$PR.5P>C1%D2X)%@X=2JY@T7:12I@Z(ZRM1P^%AHJV:9RO
M]?8#&PW9$JL!U)6Y+OB2F40_8$E2C#M2U?%_\;_*UWG1!-N0W0&3FD$\%=G!
M].BG+*E:>FZK!T-Y<:+^ !:L;08P^D*- 93+-&T P;4^T1R-<24]0<A%2=34
MKD C4,&"-N6TFW03ZCN5_D[$W./@1H73_&8$"RIK-V4\WH+S,J$5>PBJ<'JQ
MI, V-I"Z-P>3[7R+LF?Q XQMX@6%I$<##=)QCH*-8\2@V5@ 38N0?V) 0? T
M3[109M"A@[?S#TA8*RP.H,9JMK_0'#&<UW#DK7D#2<O;: Q7#[;1<_C*V/^&
M+L88/[/H![%;D'$V< X7MG1 L)\KK,*[)%U1UMEUB06X,D]&A9AQ;6=JKMHH
MCA/N"]=+LZM5UJXT_]S:!SO1GM9/IHR,+B)YM;UL(*"E#IQ:V:1XJA3,!T@=
M=?+HRP9_/P[SL #V*3S9@80)75,^M1?GTV\V'@VCBV8+J 6/,*J.C%3%&C_A
M[?-.#(I>K[DOK#T!T3$R/A<QUR81SKLV!9+I+1UY^A#FTVC0=Q[%U38?F#=>
MBY=1<N@[>+I7_T)O7[)(M>K&B-0\+Y4K+1/_BO:S=:1_>S?@4@]L0H$IKWO/
M9X@0^DP UNN+0+\PFMH.A4N][,F_140 2X:-<>GZ71%ED&)2,V\?0O:&QVI$
MYJF"8^;A#GPIJ;%"8T^V9$:RCI?ST=[[L S: K\,?-]=E+F5OF@B7+PX?D^+
MZTQQ2S"%VJRMO@LO\1Q1/#$K-AY*=W?U436[1>'*:L4N _9X*S"RD/7<S4C@
M??:34+4-^:XDUIKVSE5SVVY*+HSE+^,E,TZPMR,9%-J.4N;@X! JC&,^GT8@
M1WZ3>H-+$U)Z50,WSH#IQ"4[5:LN=8N=350YRAWM;@2VB8[C"J;!5U^XTRSQ
MGNH^YN8BBP[UDZY@<[0?"348 ;@VBTS\'?P?+H:?3T-$T@WU402N+BO]E"8"
M3;L7_ /WU:0 2#RHBIZP@"@=8Y:!%H[R6]#:+V[MZI44;<BX;5(JJ\/LGH(@
MD5-@MYE]T8NUF,U-[;75),40.N1:,%2^Z@)YY/Q@H5^PZB:4]<*02:+<DJC?
MMBW:*1FX W%GT_EE$:5K>(08S86.8U<\[C2BP!!CD](%6P>8'(FL4')4Y9^+
M\;6#?!8[Z\(M_-!,\6Z[J;:II:P<\.&M*>0)N??:!+7 N23,^UTH.T!%X(7,
M,%R^2+$+,KQ*.&X I0I4PX_[Q27T\&]76R]?P5;N[E2KB9A@C"88P\+62DX]
MZD,&N-RP$2(:DS/LK2PVQ>=]^!P84A5H"!AA;6CPA<?";X?Z!PQ>%CY8E0LE
MNUHKKNF=.]N8#,, "YZ\/XO3BXK!UG)*<E5XAR66=*Y;/^R&=]!A$8"NY3;7
M9C'F;#BHG#4S_D.J9@GT"WAR0;K:"D0JH\M(DTNUPJ9K0#N1"[@/$+3#=1R)
M>I<8^TZ+J$_X?:$7P3>R:I$<UUC9,#Y&]\L[8[+(I4"ZJ\8AZ0-)K<NV8,H4
MLS31L^G0>S2F#X_AZBI59-RG;*+=G>A?JE,X]RJC@)_,<S9;12&O<G@#5* N
M0H1)L]>Z"=JRZV?5J3X3VJC(]!)$.5"2E#-(A0@&>ZL5<%ELS;T6S@-E'L@R
M!.7RFDT\ACZG,E5:%&NAAADV&SVPL,$V\S<I;WBLT@:8V>/6-L ;[EG<T*Z3
MUI&$.]A[>9(CDT9]0IQ/1*8@K0>^ELEZ%'C ")WN5B8^15*UI'1&)HSCU*>]
MBIT0S9AP'I/M_&8KHG8B[=K]MF?;K89WM_V#$_"%M'O8@JQ[UB3M7LZZ9T^5
M=@_;F76GK"QT+>MUZ-/NW4J[EX('K<G(5K"OW3<%ZS^J)@>+'_*3L,R"<X]\
MV-JYK99+Q>-D/2NV>-TDIO>(!V];F].8EB5Q8WE,3T-7Y"B_2][&MHEH(;$H
M3Z^?75R562P)83F VK:YO[/4I* 31RG>+I',=R%*B)76[Z54G\R^>E=D=7*M
MBNP1B7RUI!! D S\<RZ0TM\\" ]Q9TD63](&N_2CC<5Q>WIE+A(W4B1BI.*H
MSNFE?G00&A60F#2:%/*!Q;1E$DMU0,@.@(ID?.Y2OJE0)5R=1BPF#T7LG&9O
MU[)=XO@//_[RL/3=H)"_PT5=(X,W(,'GE(07<?(!:[U$T3IY/U2+%8D_N\./
MF/$3[W[RE)\1[WLE_?!P/GG6SXM %=-^\,?[Y?W&SYWW:VRWE3/MJGDNL#H%
MB$_H<X"/D@.4:;M"#M#0T--6K),9LF&]>Z:(*,A:GR-JTWI_O6DYC.?]V[:K
MNJW7[]@F]*B+>/S684?]3N 7W4>-J 7':DLK-^(ZQ0B"63W28$>@=KUDM'"P
MA8D^@@#TQT6*]$:@8$WQRW)JCP/X=AL SDUQL(<-S0D_8VE85&.L00<I<F$=
M5QQ+:%<WA&[!KY,+H,\*'$%K>^CK!)4C#3Z<1SF2>Q@G-S(K*I]AD6<,!K8^
MRM>$%HV ,.3K"FQDB#3>ZH>00O6FL- &";*32W8^Y.,F&D8.P5HH/SW*O_0I
MU1^ZS.D:A5_]OH!B"CT6_3?P52ZUH?-OE4YQA=+@/\)YV+H>P,\F@(UF&UX0
M'M"&F;)MEJP5:C_8AQ!T D.#L(:NS&/TRHDS, @L_]\8(BACO(I@,)R*J*E9
MT9]P[@9S(L89.?A69L1[G,PT/P*7")!D5@FCFF!K6B$%09G0%ZO)^60P!NZ(
MV X-_'3TV.F4^O(+'*H$ (7F484<6QB <'03*<0\62;916GNEB3"+Z"TE<N(
MD"@0;$I5(QIHSV,7RVR>8%R3S2WN;G%4*(SB$RSF>ODX7"2 (EUAD,-\IPX*
M*P 8*<18AIG"Q%IAAMG<0P'5:W3-<[I2Q%2DMT<*JK/WJ*_=V1^>*+JE@B6)
MKB.\V2GM$]\YK&<&@J4 ;<V+!L@_XBB!(]Z)T%;]$(*C#;/P0/B(5 T1.^6N
MQ+DT)T6<=%J#YKK"V;5DKF8 A43PU6$L1V%U1VW)&\F(U"(-YE)U\%=/!V-4
M9D!2;27>YE:/D[6L*,K@&K3J;8=)6/&M5(-D<12HXSPL47&K"\!0LX\#*!K@
M3+V#M9TH[=Y[V+35;V>1N\/Z8E2F&)>8)3&QRMIB$($@4G6-F[!X*.!4NZT"
MW^"^(,T)(/+9J6:Y5E4J<X@HL%_98@[E(K;F@4I%],0M'P,%-8N(LQ50RFYU
M'6N#&XOP/>TU30X];57%6D=LEL' N+3!)YZMV,^"4K4Y7C?,)2BZ78"5=31Y
M-&J8U(T*QQ1U<FMH%L3RR8F6*%>'2EY"$9RQ&>AA,]@B,*)R!S6'81M]9$'M
M7BFOA UIA%V(D/L&O%( ")X72+*HY FSYB5GIQ: N-G0583?ARBD64W6*0(-
MNUI)).D *QWFI)*)QI<L^T& L2]D)XB)/-8\]HW^'9#^4<SR3S6&YEK]UL_&
MPX%?_WTQ ^= +^/.F[__^?DEYB#D=M]&*>.PLR/UD$!"LR# NL$%Q)/#(#C;
M:U\%K7;W@PN7-1B K0DN_)?"F*ZU'PR\H=8*%S,%$?0X>*N06!WJEK_0%9H%
M.Q=OOV0OG0(W67XN$A)8A\JG\(RL]RLQ+3G!".?/=FY*ZFMG\760Q?IKN6!L
M@4PC>+_JVS5"HY27?N?+9?9R4/H#0O'B7_^"QFYP/D1]A/>1S_B1**[>5;UO
MLB;#QZXL[5V!(R$V.^'*E(S%A-0IEL6/8CWFP[*VJD$\:4, P:B?JT&"VR8B
M?]7*@R<)N'FPBR %(GA@K")H'XD+MZ)$,^7;!;0J.<+0TPKG;F&3*17;>%<X
MQ25$6G%ZL4(11S=.T*."2JF<X9B!Z)'\%:QQ4=@SYI=3EN#A?!GFE#K[+5)I
M%)DM(--0B7-D7^V2P>1DS<-H+%?"IZ5D;O,BVE+&HP!W=Z*=$ZW<D"BSR'D*
MY@VE"3UF$OVGB38NP VNW0,$?+0*<'7=($.,0RE5<3/;)?2?C1 ++BD\LQ1_
MLBBVS-XB]9V-B-6N&MO[%-,I"GQ&/#:8C7&GPSXKROQ-MY4S4/RJMWM^D]EO
M@\]Y"T]0WP7JH]?)$RG7$5(+"DS8Z'B?DEC#ZK1MQZ#F''?-7""4U1-C+VQG
MY9[9\VW/MO7KY>=G"M1>QAX*/[NAJ@--5][T)4<L%[=5M&:A;O%9W/U65>4A
MU< (NA,0UMF^';617_?H","6+A)W1D(91(T6]][MT?SF-Y6$J3DXA+D1W213
M52]V#J0KK;$ZS5%&E;8"K@:(;_/LHU10"? .9]7#IBDQ/9)5^S6;H:^C^(YQ
ML+'FW)878%0DS')W_"5:K[0]"W:/<2.;>KVQ)<RV2B!5,XY;%'663#K4"1Y>
ML2&'*@?F+D26J$FM;+-[+TZ (O+EP@A$*88H ,+CAQ%+:!" A8>OT?[$B]D5
M1449 #YR_)+T1?F=PL$(?7$E"V*K=9Y!</,Q$9(K$$-G[Y*+9.H:)16:(]'P
MK"-JL,+;A:TL+CS:^7KYY:7KFD)(:%MY/%?Z@]>8D,5:)HCW1FJ%:EM7%]>:
MG6U0R!ARQK4K VG2/5RK6;#@@RT,WDTR"-?98NIA"K]A)R-65HT,P[$9KEFA
M\@#)@"K:PGM.*L2,*Y^0^<\8<\TB/8M)Y(,_(?(2O G3:1)DT8RQXHA%7NLB
M8>B:O,XRC6 #!<9YP:10A.6R);<DX;0, Y.3!55Q3W1<8UPE^<W&3"7[27WP
M-W3NM\L$"ZZBR2)E?G,\='2-S^9)7.HXK=X6X<$UWQB]'Q@$'V-(]$H$-YQ7
M$5XEMZV[ ?]$ZH^R&L(8C"?HQ!9/L1N4OYK58YW)A9O6*".#HD;?+#BL;_=T
MF5)<_6X66\E^:1@VQ>[:$B13,(YH'MEK3E6F,^OS0>?J:Z&);4N%A"*A,)Q6
M#Q#(>>U,YML$)DGD=:]]:UH;I#:KJA<I)5A-^(AX<(6>9:J/Q+4_UASZUQX4
MR>XD5:(_$JO8L?IEOLA14&>P_-W(CU7>*5,50N.>/;944@.= ADGJ!$)6EM/
M4<HF_#C*!#W86(7Y#6JK>$D8MQ2V&W#,3J^UC7NPIP1IN$4\A698"0D&@_D.
M-![&?))*UMI3Z6)*(N4R1RZHX-)(_!4[[=\2X'C1OWVKIXEB/Z#R^!\A4,,,
MJ. JCKDL%J4)3H^LRO))AN^?6VJ: UHWM_3>MIV^QQ!=1W-(;AH<:FQ-\HB7
M%6LD7(\O 6M'^J5A6FS9+604RDS*!8BUT'7Q<(HXM,@L3M>:6AI+UF4T&M6:
MXI]!WT'Q&PHR-&'F>3BZ007;5CNRM/'R9C*$JE@J)!KFU^5N=8P^9.IYK.#Z
MPJ$\RLQ11YDQ4-&/V0E3YIA#<P U4QI%U!F.WFH$)E,V-4!]2_5\KKO?&'-D
M4" 8A65<C^_L8M'^W5]%%E79NJKP+5891!E<'_KW7Z $D8IZ+N+Q%W5#]QO^
MPK4#=3_]#O-,%Z:GA6)@[5&?_NCJL5!-V'",5S7Y2&,.L.IAH9MNX?E2^= !
MMXL;:\&D6TR?'!+, _("*P_ZM*QI ;%90#V>*>LCDS)DDDA7- QN?!<.^AL2
M E:A*0-W+-F(QRF'PHJX%%)U"9&!<^52 9&X*8_Z^F41ZVB?AVJ/=;75!QSY
MU_!']S60GD2+- Z.)L"PA[4>.)%IS85,NWAL#&2F.<7Q4CC^=CQ"HLV!KCJ&
MFJ((@'4CJ5PE#J?<R4/-$#(89(*J;XTMD^-00[\[WU%4@W61JAM (;V5%-L"
MT*>:ET"?A;D67BU08\$XR\$M]+8$^:P>!$:#N-&"&H&T-G;OP^F":Q&F*;KB
M7,5@T$.F7)ZCJ!Q!>Z*LT-U1C8BY=J[U:F9J!472K7K GB5H7#"L?8$RR6@<
M$:<WKH,I@1D[IU]>#+DVU0G)-6>$-48BY< UHW::.X(04,O0IVYTCM&&'F67
M0T]*94H1.@K&4_:"2UOYG1;);ED51NQD4Z.WJ<JP'1&YD6D,S2RHI5)[WE<+
M5[-LU^3.3W%6OQ+#TA4Q>6;:- 4D[NX#)14_(2/  ^U<!U(@$Y.&TIWZL-PI
M- 7[0NQ1@%S'"QBZYDE"+N'7+GX&3\(R0NK@]A+0KA#[6YQ\CS$0QS@'43I:
MS#+$F83PH'Z(1)5V05WN@IK#CEHL&_WI:?C==*(+EAOZQ62*YI1-"<NXKQ9:
MTT^>L4Z3C^=095X8CXCI0R %^BA$42]Z1-@JK;^'"^?*VTVJ#[ 7*;-K.E#T
MZF<9^A17BDK=QZ9>GDI2[BP[E.Q6"7\,G/X%-\:H7T"MX$Y*O\$2@5G,42WU
MX7O[=W]3HNIJ7VH>_,Z!4.K _C3Y0.U5%X!G05;II\E']?W2-%Y_2C_X.]51
MPV'=CG-N.#]O-^N]5TU5GH-K080Y4SN(B]26*:W/J\&/-[5;%5.KVRV$>#X)
M_D ;OC7VGC^L OXF5<5P9ACA&B/L#3(>RL!8?]CBQ#D2=E(FB'5BBFPIS,8E
M"1#'5DC2 H9D$N_Z1I"X0RBF-/+=($SQ)9-=R V95C& IBE#27O/)7U,D(G.
M.F,=3P.KK0AUY3@^"*<$:2^.2@S;YKT+;Q_X1:ESKQ_U2DT2MK^H_V-$X3AP
MW0;\),GU9MOG(KT[WC7KWFSQXF@Q[*D"6.,0C,8/%UH:3HTTT"4X-=W"_NW6
MKDCH7X!"+2'5:3\=6ST"."6IQ[T=QV ,%J%K,6QI;EM$_M9&*E20ZQ-![5%^
MR;NI*P]=Z?G ]*)QQAC>Z%YC,%<*Y._V+N:G('B4N;"YD\F?0 $1EG$2O/*L
MU (>>M]Q!\#/HYLH :#@3;02%F%@*G)+%CG^7J#DHITBFGH;+USQ<6Z%9#/R
M>RW>L1MZ9C'@!FR%$7!/Y@C9Q"5H4_?+ MP&+LM^0L2^)VXMNF*\LZZ%)!W,
M@?6W/ MEGH%S+D,T&&"@TQ/MKT68N=3.G2T8)_>9/*U*73S#6@#*W8!U2O6!
M'C9RO1HT/7,658S2F@HK[[$S=)1"CT%!\BG_3<AOY!.SK)1%V[]K9!6G4+BF
MS,ETZH?.EF0,V[%I!@=1@52^'MR=-A<?1S&NLC#HX_"*5]C-.K+!;>TFH($.
M?!D,&^3\A><BAK"BNH@-&)@J0XAC1-&0L.$DWJJ1PL*Q0\N.09)"]]Q?EV^#
MP[V30$O5%#&1B,W*H&#Y&-?PX?V]H?FPL%PXDUVZ=(W][,&T9MH]RW>QSF/J
M+DVM+7;)@.!?BC9F%[2OL%8'1*=0Y@8Y&=37.(69JXJ*&>"+AY$9A#^? X8F
M?V G7U[P@OE0RR 0YA1(,8C?U2P"9NGV@G>E F=/!BIVOO "?CH&>"Q) :P3
M[?ZAF9,D3O$MP]*2^^HH4O9QP[W3([M&: Q5Z#O[V>-C^]D=ZO2AB8ZF^I-X
M(9DM+<J>(6?RLH@6OT#BQL,@P$HM-@_!F^BI=@&*,##:M#<@Y) #Q_+3 >E6
M:<S6:ECOYL[+9_&EV]S5NUA+-O& 35NQ04+>^4S8XE$3C:8@9>7(JMV.>%RR
MIV [?8A\!TS-(SD]!HP7*U3PJ[-S\ZN!Z,Z:WJ&=SJ"2&,&2QHW-3B'2?C%.
M6:=([%FQ@V#E!-<F2J*1%%9;A.TX,D>4>M7*A ]NFE3,RJZ$B;.7'N"MDOT2
MC;%MW@6V4X#;"KWZ3D0!LC-./(.3[UAO\;M@.,+1G2Q2SAYB523)31WB(&UL
M%4IA)H6-/,E!  [_QT1?HL/]Y<O1V?": W3L3GRM, %'=],PNG;6JNC:.7.*
M@,7^P16ZMB;6Y@K!A6^V;.1L]I8HX<CZJH_5D<7!B:S)U?[PM?!=V#\S[JW\
ME!F"J!(N!8JX.!H40I3:IHXKF6D!#0_%SKO3),%69VP$&7A#1&,<N)20]&%\
M#1^K&HHV;%FIR&#4.!GA\$(*C<@'%ZP>6YSMZ@?IT\;<F6&CM\!8Y2FVDD#C
M*ZMB6GFL2+=R8W#?7-9-NPIC)8P4S_!#AL;O[ S:Q#FW,5)=N7;BM2,!3@3M
MX&L1T*%KT.;IW8?05%D@A+.+W#@<-Z=-2@-O<J]",COW6*'!FA@GBZM\LI@:
M(P-3D5)"N?8)@-]Q\]NXKW"AP$GPJ@QI22-(KQ-^$P=(R@>R]%73$P!@Z?X9
MM8Q]%2V]D%Q%L#<BUR$N, 1)NV;@5<Q?0LB9@]\$\NY9S;'!D+35H'8<>ENG
MB=Z!-(" D%X4W,#BX*79J[]19535Q'BSNHE94@EZES\JB5E(D/5ZVPQI& (I
M.K:MRGUJN]*8)5E><Y[<L:OV&,Y9ZSHJ5EG"2FTF^C<$H7;-'+ZD$12?/-:X
M@:^'(:W/VID?5+%M3DV(2\G&F DSW@:9C:?-3JKAF$&N("0&H(Y*=$(SI567
M<QSE>VRQ#%U^RZ:WXP.<)Q,['.F_%I_P<E!*C8E/BPE5%>UYP6EFM_)*G2RD
M>ZHJ;;;!NA7@)H1DKFR?'YX[B\1ZNL(AL=N&F+E^Q$&DKY+;9(3;PT+(/,+\
MNBXX4BX"WSB87GOP2G&/,]X*_I[7JE8P?'!7%]0;=RO9#3BF/47</VH.X]=5
MAA$PXD38R)71[J^5[W%YK;S"?#7!C&7A"Q-6.STU<8KJW7^N3/ZQ3QCY)C&<
MNA@^?F-XD-KM?)020VO-K=H]*7@,:& K1RXAQ53>FE0XFH%RCK(;5(- \CF?
M*M.!A\E/3)^Z\$1X9?!,R,0T"8&!J5F$I[HBICO)G8YI/TCN.;_CX'7RO5 Q
M/_(G;PFNJC/H8PI[G=D%A)?@KX:PC%1$#@-WC^U0DMVX'R-33%9OBG&QVPR8
MMI"-4TV3[\OS31O4W_X4F=*#G[L_FYG?3-4D?W6N7\,_8XQ7?@!80.!'N2"[
MYR46EH.#UXZXP+=?9&U^7,E%3@7,:63AU*G$FDC0Q^GBVCCZR'?._9V&(9&Q
MQ:M8?EU!2 UU.EW37+LK.'B!4'<A*3/Q28O4:Y<69#NTU4C^'=F6/<N/9KB:
M\+&I1%BFU"X/K<3&+:F2+$P(H_L0)#&#_Y0BW,<V/2L,7ALA\0J:4X^_RE-0
MCN:8J@Q\DMV?6HX-E5B9<0@Y.S+2#H9TR/#[&M'6"IM!];FFO!*"W",IEZDG
M,! ,*C$^TV<E<E)?%'2SO_X34<8JSP#*B24$N%OO%#R^;)KUS-3*%?!D=Z#?
MGN(HHMR\5CBRG$R$:)$AC?*^;)A)6<T7BN7Y*Q;-6+H*\.0/GP/F4X SU(C$
MRD]<>Q15!2HKGXL:R>A!C253[01R,Q)N98RW]SM*=LP2,!H\/TQA/5V9A:&8
M$R\)\H?//X%*6B?1L!D_2*_>DSI"^GUM](1.]I<[0JU+H'TL%6\[>O4*S^%@
M/UCM+#V3MW<8_ ;Q<<#?>)/,KDS7!OHV[<HQ@1!J?^,WK7DS!.,5HT3.C?KI
MV )2;6/R<1VK222(A((K_IJET\W@NB<$7UNNC?$PQ^JBOTAM4:([SF+,F$**
M$9,[X-640:/;F(Q'PPYJV,!@2G88)C#%+J9K=,B$J)GR&%9&E8+'8%!<YL<U
M*KG &($IXLNQW8N 3:C&I_ HO@&*(PHAXTHHD;!6")V 6@>+8!GYG_ ^8\.E
MD6LEPU5?8BB[5W>[XD?#< J!.%IS!,B@^]]+$ *D!:O#*B [2. 4=R/*Q) 4
M\Y/!;:<7"!K<M-Q%H>,_DQMKT#W*'\L<@<.2B0>DW!GSB]8,.I]&-TF2F4(P
ME B.2;L5 4&#&622 <N.$/\SL4-QUY2M!J($&&4I/0^W2M2*-Y,6)LAH0B(]
MK JXP[,6J1]OK6JM"!R@%'?:[@5_3[Y#M^2 AH(ME&,U1UA/[IZL[HK#/"$]
MRY-IE'H1>0<>:B2?M,*)9LZR3:+WB@XT.NTH?F8?0)+,JCMB%^X[!7F+*%_'
MH5YQNMMCTBR)B*2**\_9ZB[45"1I,:J#T[S3"^)T%-59&5TG4<=9DJ!H-<7L
MA!4CNVT-6^T>W"9'37CQ;?;JK<V6?YI<.AF7H$Q?]8+]-@46]K6:Z^ZQ@R<K
MKO( [_+ =YX/]IVW#,[QH;61#J#A6#00B#EUPNJJ&_R#N__V-W; :D;^M'8=
MH*!-E702LKD6AF0R,3]3S;/11C:!)=J[]9)^B[ =0+232\3'B_<2<#=K8. ^
MD9GX25];"^W;'IP;5\316L9Q A%S0BU O"8SKTRI;QZ"L$>-UF -J5E>/P=P
M K$,'VM4S'TZ!7>;.>4&HDPMY]9HO5\0>B @%K@NZ3EB#VO>5WIZL%/Q:4!=
MQ-]\B$=[+]L8?*\5+-H(MMI7; (':$$9!!?4 O<>24&GP9^,MZ[G@D;%.W65
MHFUS<&;JKD4#^\@[0B:7[]#2D&17C97KPY('92_ GKTJ<1I4#?L[<LA#$H@"
M@;4EY*8ELVSE%IX(82HU-C5S/CP'Q < A%[EUE1LGS@L6VHK!%@D,5/4$:*G
M?S%/HVG ^]E$7F#AE4%SNKK3/]^1-UA&T2AI1OU;=Z0,NNDR#<D$1,'.$FZI
MEX'Y-)[BMV(8MK*BV!=T<+CGMW*4 LNAZ)6LBL. KT W0/&E _T9_<J:.3G,
M0= _Q=4@2$UMU=]I-^"VXH1GOR*E3PX .N98>ELX", 60XEUEO,%&OWTN7/S
M.=QK!ICU]@7&,8TR@8%S^>&_@4Q:[_[O/SA(N:-_]](($7P&XCO_DZ3?@LL<
M[#SWP8__<_G[2U$QE=W-]+WKQ7LO_GBSYX5YVW>XEM_RKN$#/&\*]34X2SM%
M+>@>]+(LLR=29O/@3V3!/G2M8K$I?,5P.%W7U+#HQ4 K]3B"N6'7,>K!S,)X
ME!5AQ3R<7N2(2LT;Z(_^P)D4PCVAYIHJGV#7,44]2,7GMDN(M(U% SPQ*T(S
M]$))HH6ZE+[0ALM=##PFU(QZ%<;?3)\,)\=R[=RD:?)=";5P8->?:0M</H%:
MY+PV*,@CT#,PULP)/(J^E1LF#_;./"6*P1GMXFM14>X5^T)L@<KRKR_PGZLT
MPJ))FYZBILD$, =I4EAH26LT"4>VK<MA%GC]\%7MG(>RG5-,BYX?"MX![9H"
M16<$&9T4N1WL"X%8@9&J ,1!KUU*?>TFN#E%?,"<%;C_I@CB0=K"'-"]FX91
M1ME O&^@'=?$T6AS*/ V5E=B@XZ+&Y0L<C1A04S$N[QS,U77D/^WD5A5  G,
M2[W/HNP1H"]MRS\JDQKK:B_XC"F/@I$Q$-X1G".Z83#N89G!A2\ZJ!XS-GF7
MMU6>>[ O8:#2A#  :^%DHK>04.+;I0DNZ&[P+2_?@J@V6&NNG,8*\\AUPX80
MW:,LDQ6T?;\#M:A.+R $B\X?6$C .S#@C->C;+]M)A!=97!+N/ H'A-$"MR<
MI% &P7^C?8\70/&/KUU-_1-.QT^%B^O-;,>^6.\"G4K1HG3[7[!!EIG.1<.0
M[MD:$=(#*%B1U)%-T_,M OU_\>Z:9D';CN ;YYV*P+L^,&/30?X]]I;6+/WN
ME:+R K:<#6B_HR7C.G-:5S#G%PZ1GP.TI,;+MGUU9RP4V&<+;4O1AY8Y'E0(
M(.=AO8VRWV6A8;C31QR@X&CO]!='$L% -$:TZ2E_F;81;/9!@@@JF_&=B7S9
M8"OK[ OO(4=?0L##F17*T6-?T7=3;)N=QAX'J#\N>SS8'PIVPN /(*H.AL%-
MI"\XK?SN INW?*GU7UYE3P^*P[$  ,[Z\&(5]<TVGC 6+F=P2 L]4GM:0]NF
MG!OBB3%]*I80G9?4)V%=77S?MO,*JHLLI#B)=_/P!R00!_@#JG7HHR@3!?C:
M3FK753&QPMVICX/=3+:)J<BG60DKI!0P 5!,"QSZ60%J1;D"(RW]VXO]%\%(
M3:?9/ 2+S/[,C\"?^3WTC5VL;9IGZI7YQPMMI([SF[^]&.[O_R)>@W*@UQV^
M">,0?QH'-Q@:U]\Y>/& O7=;?U;>>??@JQ0K#F$-Z9\[L-Q<V)*]+*_NK_E8
M#-9^V?MMP)/#NL<-3J*4.:B<EKU'*^='NN8>T_HU3\4&RMGJ06@9T?,]*@J$
M23ZA5@EXF,&!+?1<^HJBC 17USC=O[WX7Q/\7[74G&QFP:L4!I<164L*ZC_L
MB8<79HNY>:'VB'.U"V='O8+.UC2<N^+6^"J;OQ[BE/57JI,ORT3*'JM?*M>Q
M[N,'\A ^RN)04$U?_MF-F.G!OOOW_L'Q)J>Z.:D<=EHJWZI"F6&UG;W6TC^9
M<JL7IX-#)SE'AT</'OY/J<0:71MO'1BZP9.70=7:>'.;):K9?2E%;/^\%[$-
MG=TOOCXJNW_)%6>T*NT4XR+4.LAM%KS&UF8P%+?DZ>'#)]7?AQQ?P:*N$0?Z
MF(V2VN7U17DWFIJ$1XWPK<)HW1+I.^A%;F-K+,H-F6IN35R#SLE4E:T_'/96
MVN,9*^\1G20NE;K(>&=]2+[- M;,5CMR@G9R/NR^H%6*U?[\QPLY@(VL<ET4
M;.D:-A_\$PQ7-A>3S'CMPT,;JS6A&)R>"+?8?^+43.#ETB!!'NY3PL/EW@2R
M0T4\NFZA?L4HJONQ%0T#%E2S#B(SKB]@3(%;B?0*+M/>&M/:LBKM#W&L=2OV
M2/RIQM$(HO7R'BQV^GQX]V?P%3IZ437CNK6DW/K/\"XX-;E6EY$V#3+>P)&K
M(HUN*;,-57^#X*_+7<I[747)7-\QLW"D%CF"/I@<^R09+3@S-H;$5C*G1%\>
MZ4,[F8:S&?$DSNQ*YE#)8E*9P<<_OGP^#,Q',\P*83>;6./KR.=&7TRG!(V<
M47>AF(6?ZX)DV$2K\ 11 /%->F3A=1(#8 "]J/1K\2T)+8"%W-,HQMG/T^0Z
M#6>4K_^>8"5LX6_9*QC9[L'1P>D TVII!GIL%_'"!O91N]HRO(9RQ4S;A]%(
M#(0458PU6EA^,=+>LOY.X*VK/M!X9?G49Y!R2_3!A_\?F2YBK0Y&R0U07FD)
M5/KK-VH>0AU$%NQ\O+C\^\O7* *J,+3K14X4KWJ79\E4C193U^#HX;)Y [M*
MOBM4/U"P\)H*\RJ>3MU=4 *1W@*"&2U$L//FX^7+W;F*58Y<VN;%'>G/DGAJ
M6$#K.,\FP?DOU(-M^"<87[*<W3V4<-DNP;V"6"3WSLX8F:ZY%$S"L/J5)=>,
MB(=)Y2/7]/VULD2(DJ3S13JZ(=!UZHHD!QS%=F2(X.#CY\-?8(#?1#6"@28(
MIUJ QG=8"5&B53@9^@/AHD*_7C"V^7+,T3)P@IG+P=FQ SFO+]*G._%:F:?;
MR1CT]!.[$V-";(1O^8I?&N$#24$*Q0%*BT[$/;Y<+>$@,</13:1UIQDW(!00
M8 %K5$$8,YNI%)+SS%WO$"-8F]D]H6H$: %F&%ZYWQ#TK6B2M7)W+!8-"G00
M%3 /8YP"=SM<)\D8VT'-E\[=9DD.$(=FGUE.39,DEX**Q8,@$J;M<*VC_I.;
M(&6CXRF&2I\O,<#\=Q2-T[!M=M!9R0[R:J+AHC5%OU1U^U4KK'$8?/;MGC=L
M]_P1S2(X33OTL9?8OTR&E6U/QD)URW*+#X6I1X5%PI^#G:D^C+G2I@/<$O.;
M_":<@D&@53UUF03'^MY(TJD^=8;3O/I)S'B'%@?W3N@##&58IC%77-NNB2NA
MW^J+6X\3:GP8N^MN-M<G+"-DL+M W6&A613?1%>1P<:C:Y] PM <Y%(TOOZ9
MEE0B"&A7,D?0(]EA-DEABY/)KO[M+KS(F6(X#[<J4WUKZ*_?1//RL[$UA;KD
M%U/+WE&I'Z6!%W(YIZLC7\QQ0.9.&3!2&'0<%/6LH$8I<ZVXFV>>8&>CEJ,*
MJ!_]Q<7<7'[#O7/W=;I,6"!!<N]UFRR_/9[GA"ZSH=:T.Z*,-_#4*V4O6 U9
M Z-!5,.[K:OE:5QE.P@.F.??R199R ^U5*I*L4_<2HL*.C9AJ#R<K9BBR2._
MZIDWTBI=RN:%K2)TQ5C<N0I#ATI2;1'@-7;!PO,M4F.%X'A5F(X$&2$<W/>,
M4P;+I:\A@(B"9V$Q& $]$+)#P<[>EP16 (/O#9"H.4S(@$L>K]1U%,>.GYW>
MX>!2"3[D20S!]H,@>'8&(R*0.4\75>3@7 #+I;GAU-O T@8&I>(^R'9:FZQ0
M;>80>]G!X1JV*+:>3$.<HE;ZP&* #9U_TK\OS =?LM5:M0H#-&XXEE<3R+O1
M%M6_M!":<02?PS2+YO1U:+O]#VUO*=!Z%WO!YT6:+037:7$P""%EV=J.B]/U
M>G<65_K.C+3T#P)#?PBAHEQA_UPRX;BT,:X14DKTIKGFXLJIHU)$MK-CT$KT
M<41Z-=UPI4N[K.7/166VZ?%!C"QBF!U'VD3':GI]X[ ]*D>O?LP):,P=]$/"
M;1J8WF;S^Q/S^]S$0*D/Q"X2R0![$]A;!!)3L^MTDY*-7K,\5THO.O=FZ)L:
M WW:2DE@7LEWJ-P1[TX<E\J>DUV\)@VS6EXPQNU&&V($6CWT+)#&DID-H( =
M>C-=JR'V@A4?)VQ[?\7(O*ZU*8B3D^$\NF(BE7<+?"07<,<;5(2(T, 93;5.
M3,.8N*?9W0 RY$( .O^NEV@7; 3"W$K#^1T9% 8W;JSE(LH,]M:8D%XA8HS@
M@R+0'N@MSH$:%("B<P-D&P'%2CC-;PQN]$2;$YB4(L<2Q4:.$%M[(-^-UG T
M8\>4WZC'<\.UBR@\>@&ILDP/5I^Q/][^L?M&NX5Z-5:8P*TT& !1C3N*?.BG
MWA!X?:GW._FW=_6/(]MTA,8R5.E#WF&:7-^)!ANPX\&^CD;PF03A>R!R+G(\
M;3(0+M4\IQOS9 E"$I[1B)JQT$P8$TS2%+")II2G8<[VS$#*\!+J1; 3'QA_
M<H2'#P$X[*?NO9P("GFQ2),KK=,2#IZ!S4 Q\AW[IY?V8MX7_?WF<D6CQ\9*
M  T%KOPV!BDJ5M807^FU&?O+83A??0OC<']?P.4[FF>9Q1=:7G\4P) ,&02
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M*:X"M<CB,H4E>E<I*(."*7)^:D43F:RE;/BK4=@A">-=W#R[NP2PJ?<]"W;
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M=IKM5'4P=;_5^9"U%=U^NZ-_S79*1KCW^^;IC1F4'\2=7T4+W&;)J8YZMW_
MA<NB_0,NA ;;/V _R-V! 7LK?'+<:H5=V9<NU'.[39[J!>]<?,E;\(='8_K[
MT-Z'N4I5EG<VRMW^\7:[HJ3]X^W7MU_?-4LVMZ0"\'P#ID=_$WK)7L=)+HAM
M^[NQURW]^O;KNV7KNR:M0PM6>+B!T&Z?&JV-HG-P]$I-DE0%>?ACRZ&F.SF#
MSJB<?@]:/(-^#YY_!MX>B(3?^5&KW=.&10&B07C__.&61N^GLJ1\A6NYS?+1
M-0W3-7W2KV^_OENWOBLJ^T_/.P==OFI*!^VZ%+?-EP6RI)^@P+>3,^B,JNKW
MH,4SZ/?@^6?@[8$HSF]Y"W!#%U8TY6RB2/KGO*UK[N8I8#SCS>SQ +N[V82A
MK\,H#I(81W.5VCG3/\> &1E=+> ;P/UP,=6/"C[$HST@'/Z8W(9I'F7!Q?L@
MNPE3=:/W6J59J\]:G78KS;T+LRAIN$[.HM^+]LRBWXOVS*+)7E3#R Z[,+TF
MFU0YO;.3AT^OCW<;-@B^_^]WU7= S#KCQW3-:^G7MU_?;5M?24ARWH5>NLVN
M]L_I0J\9\/YU!YSKETN]ZPY(3J]7^O7MU[=?WWM&HR755;MY%1OF!VI<S?Y.
M?8H[M9/RTQD-]+-DR#HY@X?M09ONU'ZO^[U^E+V67&^GAUN6^CZY!\_(<TG"
M!FV9PX[9,OB(5U&NAS.J7+F+G.+GX=54!7GRJO52NG)&[=>QE5/HEE'3[T)K
MI]#O0ANFT._"TUV0LS"]CN+=J9KDKP(]JQ^O'W4[+V716#*16>9N;G0OJVV8
M0K\+;9A"OPMMF,(2/[K5N)H--\5WI!^>L.]X6=@3W]\?DW@7LM]I,IT2XP.A
M7;8Z_=UKK'9/H=^%-DRAWX4V3,';A<[!B;6*5Z%K\>9529$."$-G=$C7%$:_
MOOWZ]NO;\?5MW[U3#5DY78S56+MV0=P$\B,(4]7JU&<O>_WZ]NO;KV^_OAU/
M,5;>5LRVT_ZBXE[,^O7MU[=?WW76]Z![C ('YS\]A<YC7GAOU3Q5P+'*H WS
M%#RQ_&X0S*=AG!.[SK\6T7RFXKP#LN.KDTI.IG;S1-\'J73_M O'>O76')QM
M!XCLP=EV[,=PV.JVS.9'Y: +1[[!?KA_'G;O)E\UI:.S_J9_PIL>%W$WF>PN
M,@5,ZRHGV,5L,3?#^7X3Y6I7+]M(O0KBY'L:SFE%Q/;!@NBO=-(<KE;>[49&
MW08WI'+=CWX^L)PV+/NPE_;G6/;#_>[=W_WE_&B7\\4L2?/HW_9RCN(\C*\C
M: 2EJ[D#PM+@:A6(+_OG'9A2 U=/_/,>;=AMW*7#8?=44^4\3AX.O=.&_1AV
MP7E=O1U=L#/64F%GAUV0K[54V/'9PW>IO^7KL\NS>1BE$$D/1C?Z/2H#W.2E
M(?<!%$UU0,P:J+$-$'2TXK@<=L%R:;(?W7.XJ^9QT@6Q:A+;;?\LFMPE[9]%
M@TM^OPOS:& !;^"(]]?YFM=YR77?GBO\I-T=WXW/Q?$&:DK:L!_'^UOB@1QU
MSZ1J_WBW+V@NDL7#P[,.3&FUZ)]M(.W57]'K7-'@7D_T+V$."X6#*=%&Z<_&
M?)U/HCB,1WH,\C;OWG&JFF4P/.O"1$IZK&(B^Z==F$F#+>G +!KL1P=FT6 O
M#O:[,)$FVU%=W'?8A>DUV*?#;5%CU4[7PR?7&PCUB??Q.**VXSP)H/,K78SR
M10HMR?,TN8VR3G(Q53I9!UUPLAH$M<Z[D)YNX,R<=&$>#?9C.V(IY]OA3YYO
M1PW*42<B= TBC0>]>_^(M_?O_UI$^=WN59@I6(W97,69K:&S6- */X79]>VX
MRD]/MB-;>-*))I8&>9$NU#8U4%9=Z+YK8.AVHD"C05;D8%LJ&URCZI:<E//A
MPZW%Y[_6Z]ZYD14]*\N(M 1HP7/U(]^-XK&*\U>[^"OW<FXJ<XN.$VK4:K95
MTQ[6K$"3?C[]@>0ZUN,:$^#:?X3Q(DSO@N$@.-@?G@^"_$8%XS!7V',PFT\5
MI$KL(S^\^W(9#$^"J=(&5K:G+:I<9<$04RC#?0J0C/7+.(823I',>IIDBQ0^
M_O/LT?U$\U=D^JK^CIC?'-8WOM[-D_DKM)\#\QO6!H?[YOS3DB%_&"F,O[W8
M?Q&,U!16<*2_8G_F1^#/OHK1"S,-YYEZ9?[Q(O@>C?,;O?[[^[^\:+AIUBG0
M8UNY:P%M6U"Y;T%!2]N-FTP:(MDNOT5&"C"?7C@Q.WSA1G_P:!)'#_X0Q]I+
MR:-;%?RIQI'>(I6MBO>V>#J76C,D_^[P!-XDZ3Q)02'N1 A<"8%@-8UF44SH
ME"^[.[?W:;*8WV=O"JK:!@.P/;SRU!_666YVLG4?J%J9_FDKGE9O2JX<Q5K#
M?) MVK_L:5[6G]:6/ZVYY?M45\/.7Y=O _V8Z<-ON WZY&=U+KEV75:YWZT8
MY*I81RL&V:]DOY)M&^36KN0&8WX'6\9&\U'E019.%1;BY#=1.@[FD+[3OZCG
M"EBQ!;Y$V##&+XWBRN;CQ[\\R5IXXG5X)"K$UTR%=VF:$CWC=+V0>H>F>2XV
M\WB]W%2'9CG<EWF>]5)7'9IF/Z]NS>M(J-+3X_7J)KHT3:%*#]?LC5HQS>=/
M5+:$RNC2F"?"%H%4&"2]Z#=J'&3J&G)H72@T\@3HM'OXBR<GG:O9')YVK@!B
MN(%:AS;4;&P+7-/I41?*M+QY; #8^8E'O($U[GW]!K[^AES[)Y:8AM[ML:@0
M/6SUH5W?73\_:K4VO8?+VN[K8?T)#=<,J+1R0EV\R1\PLY;?[>M[W&?;H/<\
MW_KLIV_HV9Q#_2F_46F0JENE7>=6W_B5RE;HVK-6Z]I*F[Q[#8\GG7,C#KOG
M[;?Z:JT4Y,[)L5 <!YW **\;_?Y!J]SD;E^&;Y(LAZ:+ZR099S"S<=<DH[I5
M2AB#IUUH:&O@?PB__G@[IB1"%<>'6S>EL^Y!CY^==V_(':22JNQ7%?[K\;8P
M8!YN-A;9![=K@]OOTR3+H#=R$N5;'=\^.!&W_)J5%>V<D+@RANT&TFD8N!**
MK-VY\K7G<]1NDJIF\VFW/=PPY=#NJ$S#S)9P:H_/6@T?TE"5";?K]+0/66^N
M!DQ-I_HB'P37*M97^10+P,+Q+(JC+*>KO<W2T]Q@%)G$\_WM,.QE*&(#1&=M
MF)+,3'6047;%E(8'G8N.5H<BMF1KCHY;?=??RQL^W9:HA3@W1QN ENUO?+[Q
MOZA,A>GHADJ]U:V:)LC,N!52<RK"0J?;H:3DE-KM)#9/.'2"6;K!UIQV;Q[]
M>)]!WL55UFYO_#Y3.MS E/K;V2LAB^)1,E-=$Y3S#C8#R>*/SHV^@W[8P7[G
MKLSA4><$X^2\U>FK%2?QI'O,+F+TYP</#RKTUZ%W':H?0(30N?NP.JXA;,$M
M\5!EX?A!Y]1[Y91.-G"(VS"/PW;7,32/. ^W8S].VIU=OD]2XV2_<[?URCS-
M!OH<^HJRVHJR3U0T%E^SG[O5564B?'NV@<*%-LWGN-W,A0WK?<1EV6[JO_7G
MLPTU<M71QW87P#]@9@?MID)K-C,9[][?@H9I,9_3_=Z[WYAW_T%<_V&6)<#^
MP\2'81QUL8.Z8P.N<><[-HM66R&50?!6Z\3*@++0Z.VVDE9E><XZ5X+GK7VK
M+;I5J!+[V\ RV)J[,U>IRO(.!<<]]J8.C->_*ML_WGY]^_%NSW@K.QZZ9WM4
M%PYN &:AOPF]'/$DBL-8.Y!3$U2&\N;^;NQU2[^^_?IV?WU]GZI[3NQ1J\*F
MVY91Y4#JE9HDJ0KR\,?V05%W1L$T3/YT<0;]'CS_#/H]:-D,)+S6_C941 A8
M@6&?[=R<6?P5KN4VBT?7-$S7]$F_OOWZ;L'Z-JD@</5,[;X1[S.EDPV4-/6^
M[%(RI>VL"^Z,8MIBT[W?@^>?0;\'+9N!Q%K:BM)JT:1P=-XJ=(IMO*UWIDF6
MO?Q57MH>A7!_;;?I;'1R!OT>//\,^CUHVPPJ'=5VYX:;S6P3*#']I=W Q>ZD
MJ/SLBFBSL:^'K6:_U_U>]WO=[_7&X@\G[<:&73O^<'J/;,%S"<(&3:;#CIE,
M^(A74:Z',ZI<N8L\3Z.K11Y>3560)Z]:+Z0K9]1^%5LYA6XY<?TNM'8*_2[T
M4VCA%![Q@IR%Z744[T[5)'\5Z%G]>/VHA^KR)DS5C3:25)H!$_3'Y#9,\R@+
M+MYW<Z-[C=&&*?2[T(8I]+O0NBGX;G2K87P:SNB!?O0C^K?/48K^Q-?WQR3>
MA21^FB!%9! QXDC[L_B]PFKM%/I=:,,4^EUHW11:#0G7< ZM C7I6@1Z54:L
MS?+1-;72-1W2KV^_OENPOC_W>-MW[U0CB4P78S76WEX0-^G$"L)4M3H9VI_M
M?GW[]>W7MQ]OQY..E;<5@R"WOYJY/\;]^O;KVZ_O6CP1YYV#.QX.6Q4$['2:
MKN+(O57S5 %-CG:]H*1FGH(GEM\-@ODTC',"/?[7(IK/5)QW3796 :_L;PE?
M[OFPU2UZC>=Q<+8=^W%PVFK(@^9'94M(BX?#A].OMF(> H7B;$NVQOWSL"_(
M><R;_F+V_[/WIL]M&]D>Z/=;=?^'+KU2E5,C65BX@/)DJF3)]B@WMO,L.^_>
M^3+5(ILD)B#  $TM^>M?-\"E(0%B0P3)<\!.I1*)(L$^2__Z]%FCF/M_+4]Z
M/^0T'/FR^H0F"8.=A:,/O<J/L N_7D.2W6D&D+F=9A@LK58SY-$,*FJX*4(@
M0]GO;:\9DE'SB!U0G3B:=LI?3Z;4C^5EG?3'XGM80L1Q_^*M_D3&99NA9N[F
MK=D@T.$UPW#I- ./NZ S*2M@,#8JL*VWT-*U0)?-Z-M6[<TM$7-L5SRVGUW1
MFW-4M_%%HDKH:,;^=EK-,)TZ^,1AUKL/"QN?GA2J>_O@YRGM^%B65^>A>%'2
M,&/I8F[C)<G9C^*]X?P(7TT15DYP?'NHB$K![&Y#*"EV[CI-H<Y0 8>*XOBT
MVVCRO':3R>LTF3C'J0'CC851'I4?#/RL[(E'1&:>Q[,^G\6R)&H:1W=^ GW*
MA;XGK"F#VQJ2%.4V@PR$%_["%,YFA'R:$2II.\U0JCI&=YBSN_3L_O#GS.>/
MI[<T89(;DRD+DV5ZW;(W)4O?E0;>FW&0=UK-.,C;O8:@54/(:(8]XCC-R'IP
M+*\1=/3L9M#AU;#-]W^6%Y[<XE0^RJV@%OYZ):?VBUS47_TNUJL:+YFZ</;
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M!DG^)L+NHA-VCMJUPNZ^*&RO=F'OWW@ XI6J9(8MC[=C+:-R\7;O>,M$K-,
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MW^>/2'_/(Y0@3<[)9>>+'U:CG"U+&4VM"4=U[N<- O'O8QH.UF8+;=$:VI2
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M-31EA$%)K[FY/[EYF&;@VK:!;6G2?J?B)A]0M9KQ;V3YU\_L#W'/3[CR5_A
M6*Q@Z/']_;>+C^3WCF7]36U4)]VEQ:31P7]F=S3DXMT!E7WOY4MWTJE0]HDP
M"D^3B2QA31OF![-P-/="D#=?;BY_O6S*D5#\:JL-NU_QIO1U>AYH^C8Y/M8?
M*NVV.52V>1,P,YO,S*9RG&K#CB\5+AGI#,_2)+#>YEYY X!572%9KY#T;\EL
MNEC(_=CG[%0V;V#GPNRZC^DTXX72ED0^8]&,!#Y*53F6O[%DZL?9^!#XE-UD
M+I*+(&#Q2.#P1<+'$]5%4EQ,MH#MFZGX#AJR:):0'^G0 K&<DL^]N;SYT6P;
MN\FTJ5CK]D"3NE53NQ;BS4E3]:3Y$,K1*#Q" *F7-![XT1U-TO*HD_F4OG(L
M_<PX%6KJ)VO[<  @KIB,Q7$P9C3F9$C]8!;7$A8! (?M=J<AE+2Z#FA*:O*P
M6TX-GJ##1.B7TD.N)*9E%1,F/63[R_[GXY3%G(4)PJI:V&D6A4E]+NBDONKN
MD!I&U!H(? J!'QZ&43QB!@,-!JY/.P,-*(48Z.$<:UV*@=;FD\4/$P,WN:C_
M0O^@=S[:FRRBE(G/LKALZ-^F70S)F\\?2_/@IE'P*%/F9/+;'8LI>?/;[TWR
MQ.*GHM>%G9VQR=6\%MH,$)<#\>\1CWT6<OB0A2<O(7/:IIEB_:RQP01=6Y>6
MA>X>WG) +UD/!CT'U,BKQN%=\3ES'8@OJJ71YUX,SX;W<[V8\>C4#X<!G4RR
MW(@WEQ>_W919K-^_I7_\Y_75S=GG_[DZ(1\_?SPA-[]<7Y1]XN+KS57*EU$T
MXTTR;@LZB79@QW$VIJ\'F[[Z\PO:;5,4LFV$_1[3NV@J+LL\\]HB ,UB9<FU
MC$5 Q3<F)YK+03C1D+" W:7=8_V0QS3*.L@6TSF-69(T)X_ [C6E8;?K-+=2
MKVT;9\56C?=_1;',Y$K.+EF:+XJ@!R/2Z)DX\,)D&M"0HVS-;;= CV\M6K(+
M.^BGAXNMCFDJ43-_U6TY'P*:COGL\X1P.9P-%IAHT0',\-S9FO>\.WNK^':G
MW0!?J:W,MQ;W?OP$.9T503TSTJ ^>V8QSG,J#,BAH"N"!4#P(1(;(!;N+@4M
M;'0M:=NKU7==T",7]+"N"Q;JMC)2=J]6HQSA.U@,B4^GL\-"%V,TPMVGMCI=
MI(;KW=X)<I2AJ58-T?:]$^2V% G58 ;7"*7NZZ"T$#BMZ<-1;@6U,+IL OR+
M7-1?_2[6.Z'QR ]/ S;D<[WA[(&?^N& A?S\-'UI]>7SQ@EJ/X7ECREMB\X*
M7QC/S@H2LV' ^CS]>%JZD+5N2-^=E3)D[QM&,9$]LL0WB_5+OV'R]F4$;!0C
M<]RKB6SHVG\FO=NLF&)E85,Z&/CA:($2@IAWFFLE+]]$GD/DBC'R3Q4Y\[IO
MF[OEKL,PNA-J?\=6GGYRM3"[YDX[$BZW5:8Y YJ,Q:%DS4<&R6_09B>/IG*=
M#^_($P:[U@)X,T620B(94O]\9!VEN8FRQXKXR/+W^2/2W_/8+I@0T&G"SA<_
MK(:'6Y8R]5Q3E>O477TK[%FX[GU,P\':G*\MVI&;$E#RZOM9(C5/P+$@L#_V
MD[5!<'PT7B]/F-?1M@6+K0Q*2RCX<5/ZARNRMIG#_JE:>-2*B;B/XJ"LER9
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MJ^5.O&40:W@O[&(ZQ/4F3*8!#;G6E!DDF.9Z#2&DU6XN.+>\&J1DP/FEL%G
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M=JUULB;9$FL)W9/@,>@H?G%1#.B -]J"-'RYJ8C2( J/%M")3-NJ1]NU(O=
MI4_B/NL0EM#E]1=%/5I>?]&M&$4]VNMO*F:]C5]O'<5H^&#"G'('5CZ'W.!'
M,3QQ _<D@ 6#SL1NPDF#;;T':8T>9DA2JW"C,=5S>?L/?[59WM%4@P]D[T3
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M()&4#1!HQGJ[/7<[::/KI5=(4^X&B8&D]6)2+OFNB^X,6$=2VT4GI5[%8#H
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MA+X,'=]PRO$E^MO*,"BGX@D!8/GX!N+9RL"3SEI7,;CENQC2I4L9;KO5;%(
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MABXU[%MKXGBNQ3=H^@=:_O4S_N%X3AAQ?U5?M!;A-8W&L'ZX/O^$_N@WF_]
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MXP>)P%DY.E2V1:73*%IM';)NMJ>>M=I*=]F6QM&O)<YR%(?V/+'>K86ER'4
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MYM7<^RRZGV8<"'>$2 A;U&I#^&;Z1"L,<:I(\,,U"QL);:V-A!SN+L+S71U
MRQSI(G+,& ^C\-7NZ1 $6?F"[#&@PL2?3%C0D"\U2(518>'3T5KX=/7S4)3A
MLP-GA#%G>4Q3#:D*$> ''(1T6$&.7<.]GSDI'W 8)<F:CK?*;EQH((KSU^[F
M35\'>!+W)CE4AB#)T>H@QEB1)7.'/3RA+DS\-'<"FJ!-!(!$2J4*[*1[?$%#
MDG/DZ/[SSN!TKI].EO_38*4,K$A% U;)',BV?KIIGA-4-QPM".57<""3P5])
MP1C]ND*F<9(CHJMIW-'OIFH:$O=K*A7WDZJV5>,L2]5A?=PLVIOX@:DU^NTR
MF.D0*#+'9*2V8B$'HC4XW7\&X<'/M? 4-^=/KW@"2EG;O%K0Q(VP(I?[,6]E
MY2'5 "*=_^?B293R#U]7W6@MRZH7*D=6K>#:,F04C"O/=N,QZ^W/JCC3XOBT
M2/GEQ,0WC<[IX/5;1""%5 *R:@16#.T'RXJ&:;96_IX6?*<UTV2%4F_BXIVL
MJOM_0\[/2.GZ]>9?Z(+(U7A&U*K?L.5&4YM63/]&#@WYWA#]'HU/D14EM>-)
MA:*/N,Z!IT>^^>V<S:>UQ73#:16^2T=.)Y7O:>5]@ GHV.)W4A3\68]$)TT+
M,OS KDS:;H$HQ-BS["CA-VZ'4O8;G=#WD5TF)'SQR1W;:K-KEM:C4SHLEQ:M
MI2,\PU.Q:W"-I0<4H45C@Z^1,R.:=[0OT&C12,+B.7T1QJ>?F%O/E U7?1Q6
M7Y L#QZO5N?[#;= R,7W3N@F[UVL%?GQ$MMX=D=6IMT^8:AV6:FC/0"=+0=@
M'CCD&YSL&;"8X+*)EGU"=@ W(F>VQAC+=DUDX5FO"#Y0:@F8:/UPD,TF&T4@
MT/RP /O!O>6EY6!'OV?=W!LKE12\F?WF'\3R)%>1DYS]-.6&!:EBS\9!1*\=
M=C+]D)T/^I'V:?]UTI8C^ZCF:??U6T&WE+R5KFY>3Y'&.+2=RF8Y88.6$R)R
M70;/C;1J,$2TYI?Q92J;R6H%]QC=/1-9=,GI#*W%A)J5>-YXSVCM/<,3MJ+K
M[QNLO6UP^M)2K?4P:?5*:[!4I$'-I_186S/:/BA=4"KZUS0-*F@3.Y#*ZJ49
M>()"C!/AW&EFX/[T3GXD=3+"F@Z^3O[Z@;4M8E.?L[.N4:'9U= W!H8S';X?
M"S2-,;QIC'G#F6 2LS:H8!(SM'P7GV&8Q%QS\QC.$(!)S!5&;F 2LW9XLA<Q
M3&)6*9"5X]GYZ9V$/;XRW%,[_-P;+^8T\(8^]2"")0^6/%CR8,FKHFL<A24O
MKB#@?H0QRQK#@S'+8/%O.>LP9EDM'#!FN2:S&<8LZP>RT/&!,<L@(V#,LNHP
M)+@=QBR#!FZ&!@YCENL@&<8L5ZE<PIAEA4!D \QJQ\0E0<"8Y>I#XS!F&<8L
MFP72G#'+25R]:+A\%6A?#"[^.B'OO;8BB*OORZ<P6?7P46L(K9NDJP@X$2:K
MJ@EE+3,/)JM";!PFJZI'<I:W]9NZ!)-5JSB",%E5B-/XP0  #R0(3%:%R:IZ
MXE"I0L:P<PR354UI(PZ35>%DPV1557!L/Z_FX !#O?Q##)-58;*JJ?!@LBI,
M5E6?NV5D4Q&>A\FJQH&&R:HP6;66@*-V'@J8K IG&2:K[F[>P&15U9#D:'40
M8ZS(DH')JGI?A2JX)F&R:A6G$R:KJL+=2I?QB/,0(91?_H&$R:J*D[QVN9H1
M]X/)JE56JL)D52U09(X)3%95YEP+3S%,5H7)JC!9%2:KPF15F*P*DU5ALNJZ
M(:SY9-6D3\B6;A])6Y#5H,V/5N#1.^T;#FZFY)+C9FP6:PPBN8/\(-+^YAYF
ME%24:*GIOJ;Z89OV%TE?HDU(5OU&!J=H@896)Z*0XME85(YDZ&52J#7(%JN@
M-FL&FID<ADAH9E*FS^,+7G8:7[<DF.":D@_B(*0W^Q?_P2)J7XC.?T6%1O>H
MV'I#[N":!&PCN0" 0>L4J?!&@[HA]/+WB@[S@',+=95VD0H=HIPW8U!PMK$"
MY'.+WQU!.D1Y1_/2"=-H#/68:'LX.;.W-](NF"K.RBLXHDP!'.WF_KT:0-?.
M4R=O_<AR568).:68GT<_Z&A]D?9;2L=[MURD _UZ"ZMQ6HM[E51@@]TM4Z"W
M?GK5XWHY?U#,PFW^)''_A.B-X^WHZ#%A%P]0\W%4]*IW2@1L]/^Q+Z)]YAZ(
M>76/D;=^2/PX"B/+HQ$7%(=)#/[."AT;X>VA(/7V.!N\X!(J1MJI2QSUG:U!
M&*6I[ZJ4#Z>WU^1\_&><YEG1' ::=,5<F[3?31@%#LL^28[VR<9+*/86+:W&
MCANSY-A4#+#D!G^>!-HUX+7L.=>NG71;N\*3$B@^2O?*3I<RN8/9 :5]WK6Z
MA263"K2YV>0B=YF[3NF6L<7Q#*!&I;J3H#*K:&J4'C>]FIZ##SD&)TO64=IU
M4T$RCBH(M''OU(1 O;-E;L)+Y[2E772N=]K3CN;.:1MZ=D%&RT9_CZ89>2S-
M4[7G=^>T#MJ?YJ-TM1Q3)DM/\0M23B?KG9K@+B&7J$HG5B,G";A$@%YPB0B!
M7^;Z_\$IHHK@!P0*GBZ3G2+Z63-$P].NE*!S6D*/7'"*&.84:9V.M#M]X!0!
MI\A1.46:2E\VLDZ1CM+G4]HIHE+&F)13)*<MT([KAEZ^55AK);8"9S2ETYD\
MOT=;@N$?O]V\I<VO;,NUXZ3KU=TS;<KGL/1M;[>&&.01K!56H51QQT,6"C#K
MID9^)40Z_CAMGK8@CS5$>V+MG9(6A9M/=L(P7B:LHGD<V%,K3& MNPNR?%6R
MPH0R\I@ 6V$</*<?$?1\JF6C^+Y8;7(Y+1IC??*#9>8>V:V3758V1!9+\DU[
MFH6TBR)[#I?L:[FN?,+O"5M!^@2BA]'I,6G_._J0N1_19F;DQ^>-G.!,E\A%
M;C#YZ))YTO=%4RM"4P(.W6'LI7OZ\LZLM8EJ]<CQK'^WOOA+6(^8K%;*K%RG
M/YZ5Z2BMU=:N^A^R)IQDWY,>?X1'Z;IFGKM<6'IJR!]IY_\UUOWIG51'L:3Y
M&.U2=F-/\3AV\=?)^MN9_#CWQJD'*=N]K%A+,NCO!?V]:B8;^GN!49)*9^CO
M!?V] !AX%\WW[$-_KP.2#_V]P/$/_;U4QP']O2   /V]E"8?^GM!1F11.P?H
MA8Q(67\0]/<ZI!YY;/2J=TJ@OQ?T]U*2>NCO51I/0W\OZ.^E*\5'Z5Z!_E[0
MWTMG/-#?J\*3H#*K:&J4'C>]FIX#Z.^E( )MW#LU(5#O;)F;\ +]O>HJ987^
M7I#1 OV]% ("I:R0R0+]O71" ?V]()L%Z%657O6X7DK"0W\O)1& 4T3UTV6R
M4T0_:P;Z>^VMSX%31(G3!_V]P"D"3A'5M)DUIPCT]U(%A4']O7YZMT=#G55'
MGHNIY=WC\,HCRB@CCC;HNHG(_]-TSO#KY,*?S0,\Q5[H/. KUMEBQ[X\DCO+
MMTKJ;]Y[F9U&R5;/K.#>\1:+W*;M?=*7: ^@5;N?X2E*\=)D-IM#3&A<0$;^
M9'4MV3SZM+''!@/MA[%(E[7;I!U6#ME(1"W]A_:'6K4F8^C^_D2;Z+P/^?YK
M-'>7OHMV>J(MH1ZQZRY;0Y$_L*LC3OI*6<N4WQ %V*9<SK+T<[XE0_2=Y5J>
M3;-\,?GRNSA*FG'%'CDIZ.K3]0VB#@7/CS:>G'E,2O5R"6@C-QRN $\L)Z$8
M9ZB-?#1Q/$( V1WRWC *8O:'$V394<PV#=U;#NT:%B#7#T/,^H>-,?D4)1Y[
MY*<(S>DJTX7PQNGBS/TP:N#9W/6?62HT[7^5MC&SV;&PGU$4D-<67>8F$VS3
M[Z5;0'8OLI[D^H^QQE;5-A];<MO$=UW_D9JH21^;,)Z1HT4>Q9KCD=7>7.!M
M@#<:XV1;LZ4=<L[DE^*H>WSE.;'N@N7%DOR8;3&TS<E2V_6="^+3ZO@*\61X
M3OP.PG.$67_@9/?%[PDQX54G<O#6"@-3EF2,[Z)C6PP"6_PF(M8Q$55$8A%[
M-.<]$R(!R>$=WQNW++D\@O\;.]&S 5QROKS3Q5C83?_N37+/O\UC %J'M%
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M6A*KE8$^X"K>RYW?<9RJ@'Q#"*)Y\A7"RQFT^K%?"3ULE,5ARO5>0B\;97$
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M\&<S)Z(^UI EK\[CP)Y:(0ZI W8>T-JJZ/D$S5W+BUC.%OYO[,SI^_5G,T
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M&*9I1VSLMQO&1D\U&!@,],! *M_ @2>H\+QL+9YO"A T0MJR.=H[J5@=^G/
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MQHK3"&,6>RFL[4J+VWI (=P=%U=01GJS/3!S-AAH97=-O&<\OB,_S#.,;HE
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M4?H0W!%%UX7"'S$>D$#J1,3$!S5&?,D8/V$_9"FPTB,L1N'1=TM[UX\B0#V
M"?>*8E?"H=B=!>09TY5?6VK,,E/&?RG!ANCAWW!Y%RS"Y##Q10%$Q?#_1M$#
MRT/\^[<@7-[-PJ7\^'VB*J(8"\Y,$E^0J9G2(WD625$ABM(>:)<B7"GI^ET8
M)WLHVDA.;_<"@[X-7K+@I0<6NJZ.KGCI@86NJW-^O!05T1OUR;JNM-WE2^_K
M37%0",UVC\OXZ)UEB-<ET.3R,X8#;1>36TNK6R_;2R$L^9W9:==K,ZL0FAR6
MPYZV+&M=!<OVAEP#.JO>))3CBSVK.A/4+N$"UT$^R;?0!@!>N>6^*<D!H1>?
MJR"Y"MN>P0 1.+Q$_:IX'B;<HC&F5F?OJ FET2LH0SICRLE0NZ?UFG*9D9W.
MM:PIT8NTQK1OZ8Q>>\BCVL!*&E5HKRI$M)Y%&#L^FM*<?.%JT?Q@6IWJ^/B6
M9@_75HH4JS6MY/<3QP5EQ>O8S:D+<@8+:;#H:(*'P4(>+&RC-C1&X@]S(M&I
MXC!*8R^@3<7#^<@+F&M$-89I#Y3K$VYWE)N:9N ],4MP1M*>:3420J\:O)9R
M^X_CCV&[8X1A4X3]C%V?V,^TT/7 R( Z+6UTV+I[8Q8]J8?C:+$$BL%KN,/
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M?"Z3SW4X!K9)Z!(RXYD3<_AU,!E='%%,2M>Y.<?D="F59V%RNBZPAH^^2_1
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M)#I\'E)GW^A!!1!2'P/._.MV-5B1+L=BG09DBQ'DI;26F5E4VZP&7@.O@=?
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MH2B9\#Z[DNPQ\A0/LI+I&39SGH@]AV)".+H89 ?DB\V,/?*XD"Q=1 1I@J.
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MI)S:(99]/16:H5701<XS(_#:A LK6B:6S"+",ZAQ?L**6C8&W@OL2EL]S=K
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M,:\$!7@?L0Y3/T$C)P97 WL?7!0G3I*"VR)3T_P7\@B$)Q.BT=T;N\W8;;*
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MA2/Z8'K43%+:X&SU,O+CQ"-PT!XP(XR<)\?S65?YJ>,%<9*U5(M3\G_R<RV
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M_NX=(\U_L1/=_+BQP":C4\>,S@IY.;]'L &2E]N2WX$A$WI"B7^'(W%1I9^
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M/F@I)]V$>/2Y7=X]_M0UX2<3?C+A)PV0-.$G"?&17&DQX2<3?C+A)P.O@=?
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M#_UQ!5S(!B;"XZD?, ]& 6K(JG;YSZLTMW5KZ5ZX,'Z;A3YVXN"HWM4,9U^
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MAD>2K$X:ZJ2A&CIPK\:;&;;AF!0K+L21JKD>I=C+P*LLN&3)__0JEC?PXY'
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MKNK^;T(_\ Q;I.*;;RI2L7*2N(J>>4W%_-!WCY:/]7Z&8X(4_OF#<O2KWG:
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MQXIW^TE$.,5LGZ[0=MZM(#!U=B^M*ZK$L4RABN,;AD_5[)NV$Q]X*NJ-6&W
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M>< XK,&4F!-?0!'7DO]JH$-7R(7^/0S\P'!8B:[_8G>O9MHIEB^:3*769\6
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M;YBC+ S7<&1D0H%_\ZWE=OH#J-+9D%D4SVQ$!_P2<K-P3F XP]F0P%KA$P)
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MU62U^-^FSFH=2^@ZJZ6S6FKHR)Q+_G9'YLA,'D%R/42E$F>&L@:AH" G):>
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MFNI@WOKS@)^(=\;$ BU^Q#XY)K(7^%^MK4!Q@!$4<(O">6CSZ"J>@!V&QP<
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M1PK D:7F?#B.7STO QRC0Z$)S:Q%"?X+M:D1;<H4-CJ6MI=[:MO+>50V["D
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M.RA-Z%W'G]N)E^Y9)<,^?$D-'7FXV=,^U%,!NITAY#G0:2BTT$AYX.,*N#O
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M:"%%8D]#%0*M/Q>8D(]HLM4FD^.'SM1,Y_4,36J>HUTHOL+'Y.2+<V;8J\P
MQ2),8T$+*)IMSA8'"U638YEXYW3ISM.MF#])NO-TQSU1NO-_&=HI4,L#]8Q[
MS'+RB!WQC("23GOX=W*%0= W[-\'IL4V"6/[LIH',-;MM:<)RJ;M41F4[<EP
MO1 YY'FK@2&#7=";/T,_L!:;'PE7'-MIP)EA@W:@Q%]2"JICE01P\Y5+*PH9
M\9&@^+ RGD:+&.NUYSY9*\0F?ATS=BMVD$5JP,WA_Z*4I;^$YU[#':R(@R/"
MF'4';_A4U&8YB<9:4"K27*_33HCN'0T,R_8QN&UNA1=X)14#BS"P0/9Z[J/E
MW,,[ %Y4D# G(3S6XV5R?WL"BC-__-7Z*[3F./O.L_SOZ3N@4"R'U38(!#Y]
M'B=;N;;N$(1\_7C*')'G>H_.OE:0R-53X7164V<U+\'9TEE-G=746<V&A !U
M5E-G-34OZ*SF^2E99S5U5E-G-37%ZZRFSFIJ1UMG-7564V<U=5939S4O)JMY
M9"ZG0&=>VN4(3V'-?M$O"+V![Y_6MN$8@>MMU&W.Z[7%CLXTO!6K26&"P\ZM
MZ<243DR=Y]@Z,56YN_35>,)V^[3\(NK@#O#U4I:55+F3#!T/QO5LQSE]%FC8
M*V?MZAQ/P7G=:"68N"S0N5=D!V0NH?>5&T4_K&"0MB9C?F@VT0(,<OJTI@Y.
M45FX'KEWW7E4'D:]!\NDN._)I& ;S]D:9<<-<"J7"^_,%2">;*A/B&L,E!M6
M-ZUG^/KED+YA<Y+WW(UAY[HN\E%$AIY'P^-G>==,Q".=B:Q<?L>!%%;JJW;^
M<:J<0=(='J](-$'S0PLA)I3+<XICMOB?.!;,HP_4":D"%)*AZ6%J=0Q+[B:5
M@+Z%T_=&M0RFOPA2SQ@@IKM""YP/?D33>T8=NK "OX7A%3O$\"9A-;\V6.4F
MVU&O !UE@X,I'0U&4D^#S8T:"CS<TQYH553QWGFP/#<>]NS1%9U;G N>2RC(
M1RM9+[.G7.&45 4E:I/T.[J@GI>,-E6 $K+$*_>D[ES9W-<6^(DL\,H&]..!
M+VCUN]K;/:I8Y*$9*ANC\9>&1Z]GA@__5G4M<U^]!2^]<2W;#B^"E).YY0$;
MWF#-D\GLI:6[XEUMR@4I^YH+JNQILP*^JP!S1W0=>N82Y#KV1KB/#I?T%[?&
M5X'S9A7#Y'@_1[,$/S0K?"71U 'EK)JQ>M'(D516C4(%C24:@-8O+7>6B':*
ME>UVA;;)OMP58<7:?;J9OFV9Y'P%_3[R-X 4MV.:!/5SV]Y(+]GQ!M)D/K?0
M;<(*C:25Q!?WO?'062J JE\G)BT6]S4/<2Q.RV#1W.>N7A Z]VUG8^CL3LJA
MLY#?<_RVM6TTUCLD<#L*CM,0>=0N7+L.61F.<<\VU:63#Z<_^F2&?6SQ&$EF
M,!AS?":.E 1L&680 FJQT-:SJ&/2-KD+S67T(18,C&=-+BT_<#W+3)[FDZ7Q
M0%G=[8Q2/$) $>3G1RMN-U:1;K:S"C%S1'_9X$!_&5/.96MZ\ &%R8&UD-5
M"SBK=.':-IN.27A#FK]T'WUV6ROW@>\MY -!1:OQ&6C?% 90N1XY[$(^) P)
MOR92Z)Z2:UHL"C4?GZG'K$PP1/H#ZJ,H>6W/']"D6"8LC CHOZJMM95\W-[S
MRI?""D9+)B70[)N0](!;AF\2GF&AZUQIW]_G_R=TI3_P_ ?RF%%AK.Z/E-1Z
MM-B"Z1^(RGQ@_]L??;^,<U?XJR(Y'Y7WT(C5@ED+YE,)9AFFG; '[TRHSLY
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MSZY$OZ_3'K04CM1@BN[%L?L@<^S.WQ# V;=LVCP6Z"5'5F](TN2B!CU3S('
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M_4*2CR9<;]"J.F^0BHAC,,G;1W=,>W;RFLB1<#AO($T"X9Y@(XB\N>8>CG\
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M\Y7-__'BYNM_WEW&>Y3_9=1_\?-AIJ$&^]&N<612$")SD-A@XC6_!S#)^%>
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M=$NR<;2:S/76IS,&T ]F/\#19Z!V'<60!9S+';HJ!3[V4N.%=9TY +(''$]
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M_P_@V9LCN%7^W,IQN2)<H"7_!!0#XU<$3/Z-4.[&7 _FNT*^><1?,0-/A:,
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M"SX*W Y2X\V^,>#A-!*9,;P ;$5L%+@=.3QVB^#'M4B2 P>H0>1*E&K E\M
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MI[$DAL+?C.TA8UL"GM+=R</. ]KV9C?7YJER>M"Q9[!KX;Z?UDI]7]+:%6*
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M6=Z]:\L?YV0>P3T+D;]RHK:U5.5[$<[<I@0P#<,.&%MMO%YY334J.8D7E,7
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M;)+,K-:7)5&HO^>A'\1_2I]=&ULS!&CU*8&5+RFC!&:^I/TFA84]#*LI993
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M;2%3#P*G6-(UO,-GL&Z(M\IP !&5!T?POB3LI]^++3#C2U?D0^3#@T##BZW
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M;5Y+T2SRTRUM'EN[PES-$YCN\*H77_?W4C8+=0=7(_F;5U?Z;=[SKFZ"6P:
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M^.^W,MUT<:5K[4%OYP(&T<C\\0=OG<TA%PF4X5O!)KU6L1N]\:*;?L5XNS6
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MB<JIJ7X$%(6@7'5Y0'ZPW?N 4$M45Q 810O29!3!;4OFBL4$#6P#@;PF()N
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M0GLIPD4VQ]#<MDIX?*_3FV!0I0S>KE6J#-%Y?,EZ1;D:0R[SN\/_(E!;G^=
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M^@?<$?#0<+L!Z(IIYK[CB8FGY*ZN&T8 P"H,"&X!(;Z+O.V8)XG/S\?F=7W
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MS0ZB\MD,_!,M4-3K-&/QXJTR!<>(A2<E/$:WUR8,T2H+:Q7M>]?'#Z<Z,QY
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M#H8WX%5>X@O50G6X63 #];07Y)8?52D"+%\EF"OGO&^<K_"Y?F9=Y5VR%.2
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M5*EY,#-<@J 1ZCXKOW!$K?<I*A6>JHSXC 4(6*PA;HN_8P@TMN4/NI8_G+^
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M;=X,2,3-SC6;A[&; \K-:UE+3L=9,B\ JDJVP&=(LJZB\"IB"<,&-.[SB&:
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M(6?=33G'\,^#AW$T,>@_6;#$F=&8//VC77@\[S%:Y&>:O/*$1" 5.+!T'%+
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MOZ2,ED$"I;PX3OE,1W7.,N"<^P)<V@O@13.Q"9;'-7BJXRS#&!>)DOIEWSO
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M#=/D0Q8U^QC$29324W_^CN7+HD##M#DWDVLG1XF&I4B<',$B,Q8OWJHALZ*
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M&3N]6TKM]?NX9/O!FP'59C,/"89=4E[L^B&&+V.@JT_QR22L6Q]^ (U_2O#
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M@VOZEI:[AON_O'-C,-W%<!F%C_,+;RE:-@_38":&>JOA@W@!]_]8V8'AK'S
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M%M(W2UW>D6DB+W%FG"]C_ ^V6D4AH(%A:TSQA: X.L[<3]TDE0H^3[T2%4
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MFW01K_PP_$:3%"J>T<F,IB@8BB5'P"G/^)QAQE#.7Y!9$_ P9USMEB]BS*C
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MZCLZ_6Z[T3MP.[MAZ/7:C=Z!J^<-PVXT;C5ZO7[_A(;JJ-N20=M3JNY&Q8"
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MM,;D:$5\E4;N@@EC%SX&X'JQZ&F:G,%308.8>1]BJ_@2,2%+C/YQ$$9+L'U
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MY&8&94ZI =MKFCC.T)LIKZ\>KIYNL^E4A1J.,BY+%&SKSF]>)62MA'RW#1_
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M)D/-U(.P;Z<AGJLV9CT7=*>TS?!EM:WT996]^!!\6?K!73$A-OEQUL,U<R%
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MJ*<Y@S",'5*.@YTL6GP<[%36$<YE O1@I\+DPQSL5)A\F(.=9LBW8+!3@>W
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M/=K+,K%UJJ#08>\6FZQ.93S:$Y0A%Y&IC<8[L7.[-%!"$T;RY0^P20)U;&6
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M!F&FCBI=&+-L#^ =M5O: P.3FE4GG[0@V&%I!^@$0D$%[#KD$Q!5-B_L6H7
MS10?ERP1^4I;$V4=)S6EE3)?66AB/:V&TJB8;W^RO3N0ZTK;DHDKO<=-I4,&
M^1:DOGEIBI15EK),4S29PU%:Z9?<6ZV"2"IHZ+(G]J#6@K 'P##5U#)#Q-7D
M%=ZJTK;'L@O(50BEP2G>@V;W"81N%P9"38&S*3DT]!IZ8:!*KD"0,+B",8#-
M,F!CZ#7TJ@LVVM0W5Q*AC3:(\%(Z_IV,CJF=J-"BB5XE40]_HG:^84&ZQ+AL
M>UOC7$EV^VC!$][D]8(5N^>KP'UPF9<DPRL@>A2J6[<"&^LTJ5U.5JFT(1A+
MBVI2ZB!,#]BF7H+=QVUPCL'F[#;@IUE%<N)^4AV>IYND7NWNIEK4*2?876M
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M23YY6[.,F*;%-!3.4$IESR&84JIV*6\FR8VWP^Y&2N,;BWV?<,BB.8^2'[?
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MB3=%YBBJ.H*-'JO(G*36 )&LW>GR#-BLF?ODQ,?4%3\3S%WJ#KS5X:0&'DY
MT9NE0R>;WSW39!DF))(GO9D)SXMSGO"49"\=DLR4:+6A\_).F@4L#[;QL&7,
ML**,5AA:'>.)S$FM82/48=L(F9JE=!6%MJ:.4A.C -D(6RV*.@@_F$)%')>0
M?PZ]<&JY/-9/E,:!#58F3 =-5W;25JF?HZFF@EI-M22V8E,OKND0_TX4;^ 1
M"]RX"DL6N-0KS6F1R]MGM$X\K2[@:9X*-7G8X$=,'6F-'O89/_2P0U"?NMBU
MQ&H$\Q^)Y\LO>>@7[/N<]H*HG$H\-E%GD]@4N1&'U7IEMA/A2UY\==&.AE^N
MU*;?75*II-,VUI9O(PD+>0Y[V"-VF,$@KA<9%_+>_VH;U&RNOS^-/=R>^L+M
M6>;DY>;M2S0[G*G!47X^OUE*6FI-9Z(%12+%'WVE.TWPGR=X\6W&BGNYAGS%
MH7_)_AFR?<:A[+]T-A-X063VLSO/U$M_*?OO;LBH1TSMZ?[U\,H;DT$KE9J4
MNUK3^LL$(J)E?"4^DC:=)T\5?TBY+0"+A[F(/F>C[!#QHA-J)5]/C1+!G%>%
MLKB $M[*R<F)5JO/D28X2;AM=9"=TS99?3.Y]Z [CZD!5AE:UYW"4L)-\<@@
M=#8WCBJ5?.^X!J[IM]+!UNP6P9L2;*R$Y59":!0L./]5EIA\YWSB1&\=*SV/
M.]_9E3RC&YLKR,[7DSIU5<I/PCYIOX4USYP\$J'12JLQT%XJH*L#5#I88>O9
M&?-\&04>,&9[<F7+)D*K( MI7<O*\K::X"9Z9N?AYS^V6TJ?ENLLJ5' Z!YC
M(2\R'3]QYLD,->M37W,CN5W7P#).*$:E@&&(2JVGI5+1#>P3NTL<A[J# S0@
MKM!@)TJ&VR/J4L^/-%IEV<E]A#=K2C?TRGW>)8I=3AK@0EC+EM0H((QH-#LB
M^HYX!'-K&&JT+5Q?AXUE:!F S"Q7YTH=7+PY<QV-EM*5L2NLPSC1Q0:KHM)W
M ,*1CB^#$^<FN NO]64%(D;55E,U\BP+2<'I6O;!6-$CKE.I*CVD-O\ZVBIE
M<70+2L75JNX@/B[?_R+G/OZJ>7Q*[1X-&]RF@MI//,<],97,8T HD-6&QO4)
M)YZOU[&M=(0VOP*#,_^SEV$L[&(M[.1]NO!&MXQ)Z:2_FAC=6JS"'+7;LSVO
M4F9VC_09#]LS:%\X"70>3(ZS3NW:E@U65CE6"0E@'^/W4L55EI/\EG9#Z>*.
MS")GI;WBS&*-8Y4L:-T.87E9(3J!W\?F]%MG;TC9J_M=\=$]P+(C=-A@)+JC
M'U_C[SCB47((S5'VUWV&OK)'>8_20YU/R!MB3H:"7L+5;O&8[[#/7/*B3[./
MGA5OS*G"AAP7 U=A0ZNY9VRH'N]]"^KB#O!/R\%I&0[IW<T^!5J)!BW--CQ/
M?M_H->;-6^;-/J7S$HK;:&OKC+>4SN?G6YDXW172>]/M4?6>:8NZ/=X/"7I[
M[%?4"LU#PIP1LLF1+[XA((\R.P+#/[ ;8#Y!E8.P9=-!U-R&A$WQ'#(UE.0G
MWE@L@/7[*[10@\[V10TANX0(:]$GJ!KRM!_P,#EER\$ECB<M3<DPE[F'/GX.
MVY;)GRT!9'G\Y#=,T:+:UVW81RY70[J.;5/Y7>Q<N8)+H_!!IA^=Z4=7W)&[
M8C\ZI<@VC>7VP$UYJ^IHC;I\-9J!;=Q90JEEI&5;DW44N0P31(R(/B=C3BPZ
M:U \YC)VX$\.PI[1?E2)]'= ];D;I\G5N&I-DV+"I>>NR0BLJ\PAQX1W>QAX
M9#I0)G8)\X?]P4W,7@X!X$H<]HY>H]$1T9T1XS[].=-HZOK8'=!P;$"HSP D
M(T?1$;P2G@4%PK,?CQMZF!G))34WSU$8O8[]Y=$84Q[&LJTAY@,2QE?U,K[5
MI[>,8GES\NJDH:_.W]7M:=AE- #HS:'5  N ,MO*&->Y,$,[SNN% P=D))L'
MEA]P>7=>G,J/U%.]F$9;9=6D8X=*S5=AJ^K%PC&'PD&>U1A$PQ"CR8< !$C'
MH%7F*O30Y@)ZC.P\=9RIO*;2K<Q*MSP!^\2HXP6U;4."9*E2&!^4]6W2:9D]
M\NKRKHLJ3>00@9?>T;S*JQ)6>>%9/5-80>PP+^!DE8HLZ%NSJ!I.5JW(:@8G
ML(D<A"Q9.W4(!5MEY5"M=C(;DLOG8WCE?CQQZ0;:[&E6:'@VN14;.AT ZTR0
MH/L'D5\1]J4MC,T#)'Q':XB>L'B=)4XO+G[W1/UA^/6HDNZ<1I:HI*X9_95'
MISM]SP7'+.+:Z(;8@H/.P?R&VE:+ZW+4Q,UKZTZQ.)$MTAT28HKI3#&=*:8K
MI9@NA['1W(<ZM92;7URX?=V:J?K62]A6;7BIU$I2DM]8JIU%%X#EU C8WG0Z
M\&4*1N#YIR4XHONG"7)$UY,P9L)# 7S514WIVX594EUIEU)LL%VC9V&$91GS
M4,0]E,D^]()_LPWO]W,%5A(_FM>;UY?Y^C4"1P6A?GDQO:4&52*@1\-(3GL>
MYED<O[L.XW>R!N%% +#XD-Z;<: 5XS>)2Y78&UXZ[,E[\&0$Z<I]))[L3=ZQ
M?/HH'D,\$_DQD1\3^3'7*#//@;VX1GF+)Q+\!<P'?GP;*RX]"9%=OO=UKSD9
M]L=6>%Y8S)-=$?SH$GZ(0=G?8:GF!],<1>;?1IF'7N!1EW@KMJ]3ZB[AJ]*8
MW,W;LC^5Q___>Q827_LX^_FX\;':!LRC]1O<+?S4,*)@1I@ZH/BV&Y46I*P!
MDBU(9)PF_$%&\ 7!$D97XGIIA^>2NI\,2&E6E6ZO;6ZL[:L)D\N\EHX?ZDO/
M+VV9+#!"TO:&RG*4S[E8J-0%5&]#4Q)H].ZE4F<(<32FQIHK<N!%T2LZC>(@
M/ OC'""7P+NMMD!+&\<P[W%F+"5YE?,8Y@68C%6=G&S>!V,OU3S7Z26;S>94
M>\W;T.;0*L5G9RQ<IV;HL=DZU<*37$ULWZ[;73'M,D_8G,^21]_Z-]2EHV!T
M&0ZJ(V$N:AJK-%F;+65M%"D46*P %I%=_Q+71=KOMIIS*KX0=G[NAF5MF?M0
M6X1?LZ4N^H,LOJSYM,6(LI2*E<C<*&JXXBJ ,E^%C&OXX%=1YG0>=IGW6]JI
MO%"%[YF/G>REH'[@BX-GP2_'TS29\DM\<,6QYPI3>,$JH_-TP6_CMN?*+S*;
M^EM./'E9*ONW0HD"L$M;M. X60MU6=+9ZS'VH^@MRV$."\#4S;_.\J:9C^0U
M03FP ,N&^01-!#Z$+RRKQ'[-+&MKZTG6YFH]X)1=1W:G%CW6MF* 0]EU9.Y1
M*6VR2]BCU=)*FQ<;Y,5NV-4&I\1_(B0";5EKT*>/$7HK'=O,O%I10,=E%7IP
M*!ULS63\,;PRCDR@!+>,UN9SXPP0QD!X/3=@X6)@'9P(%V"R*+"*.KB+B)E\
MAS=[H5)*PRH-W?A<V>$PDJFR2.3+B5:K2MM4*R1V7S615!IW<NZ.VITP-]B=
MIM)PFF]AE0),B@(1=GO3;[>=VWJ3BVM<(-XBO=N<?QM53:"QG/\Q'U<[BNHP
MHFY^\SR8[!DGKQ4+@0CKLWR.;2(_(?11UC1XB''$HB+.^,'Q9>1?XBIL0;?\
MU&5RA-\CHQ:Q?RWJRO!:A239=2A?B=\)"3\G\VO4I@+%W!N&=&\X!\S7M;.C
MLVZ[[KK_6O5XZ_=,$^U%6XW5+(3-(_,YI0AV/.I.OB?=8D-E:S)32)J;^UU&
M'"*B/\6-NZ#)0"N1V#@NI??57HC#U:N!/9$9',:O!T!EI9*\=% M);*W%\)R
M3OJ$R[;;/GX&>I2<U#;/"1AQB(B.G%3QA- RC7##9>YAVH6&)B&-JCE=BCM=
M'H4@,$X).#%('"%U8WX6QM?[5Y&W.7; QHV$P)RT2AD\MQ<"<Z9+\YHBFM08
MH<@P1!V*>]0)KVI"DXGL7&P"2 I(:1J9B8%D>KH(+$E:J5&J2#<A,B&S[4M.
M?^;_V*0'[T#*KMQ*W,FHF0.K6+-WC">AS7N0;%PZMW^UPZ#$0=90*0H'*"V8
M*]$J+R;&T5L[D?=768CR)I 3756JI30>R2E"1=</+6.MSE,/]OOU:Y4)Y:CS
MF1<(=:TAL0-'?$WX3=0EMJSK"?M,B@/H5@Z -A5"ID((4H70]L@NL)5.Z42:
MR0(;^'@)2(R&"=@15H9@./U-6(CE%=+$3ZEN[BF=K)4S$7/[;>DKQZ6T3"AA
M)>VR1WN6UGYO5=M$6#6_O7_N<8=^D/_]Y_\'4$L#!!0    ( %I&/5#9[SNT
MW(@  )IJ!P 0    ;G9S+3(P,3DQ,C,Q+GAS9.R]ZW/<.)(O^GDVXOX/BOZR
M>R).J_6PV_;$SIXHO6Q-2RJMJFSOS)<-B$15H<4B:D!24OFOOPGP#;Y LLJ=
M;/.>N]-R$4C@EXE'9B*1^,__][IV#IZI\!AW__;OQX='_WY 78O;S%W^[=\_
MSZ]^?O_O_^^__K]_^\]7S_ZK9ZWHFAQ #=?[*_SPMY]6OK_YZR^_O+R\'+Z<
M'G*Q_.7DZ.CXE_^YO9FILC]%A6W*DL*OC\(Y]*AUN.3/O\ 'J'+\X>>CXY]/
MC^/B#G.?<L15G8C\Z2_R\R/Q:%S<Y:X;K,LKV+[XQ=]NZ"]0Z&<H106SDGK-
ME;0*SUY2P>7/1/C,.[3X6D$X/DD!2$JVGX<<=?_M+^'';%%6 Y:YGD]<*P'[
M6F!.Q/GC#Q\^_**^_G1 ?%^PQ\"G5URL+^B"! [T)G#_%1"'+1BU?SIX=+CU
ME'SZZ8 Z=$U=/U<A4WS!7.)DBOM$+*E_1];4VQ"+-K %1M#!P8$:1&R]X<(_
M< LURYD4CKD;;A%?CM J/L45?I9_'T([/_UBTF8=NPU;/E4M_QS7DQTX_?GX
M!$9SQVZ4CUB3WF1KWH4597<^R.X<_]J[.]VZLJM^2 *_".X 2;HDOAR3)AUQ
MA,C5ZM0118TMA*=(^N25NWR]C1:NTY]/WOTB/_Z\"!RGLE?--&3U_Y4ETK]^
MMKCXW[1(RQ['BZS% ]<7JJUW\4);U\NR>O$_?DZ)=.R-YV^$)/F^KBM>92WU
MU\]I_:X\"82 C6Z;VWV,>I*KF?SKYY1.QQ[I6Z%19^)*\H].75@0[U&-2$_X
MC5*)6R]4^H4ZOB?_52<8XKK<5]3"'Y/?-QOF+OA_1;_!_Q=_E9O97^/=_H$N
M#M3V]E<B+#FEZS?!7S:";RAL1=3+*@R*P$K0Q=]^@MW\YWB'^M^-H(>PP<8E
M"O3S2[Y:4:"*!SNF0G23=C(F(9>_O_WD ><="GSXM[]\7T .>6P+"*I0!Q\2
MBSAMD4 5*W"02L:FB[9XH IS65LXLNH</AXP4-5M;@52P9NX]J7K,W][#7-.
MK!6/?CJ013\_7->K<6%?+NH()3,[.X/3WO_7$9@'\'\'/Q_$9+)_$M<^"&D>
M9(C^YR\ZE;)& H_:4_>_U-^:^","48FFRGE>MZNK+PF5M:,/L83^JT1@H$_Z
M2B6?+J[!(EO35E*:%6HWB>8X$4U2%_X^YZ[''69+W>F *4H'2<^\433G? V4
M5]3UV#/M)Z<R4@9".VD06BJM [XXL+*-1 (=I7B^(NZ2>M?NY;\"6'TZ2U C
M8R"]-^VD%S8 <CN@JHD?5'2/Q)'&]FQ%J=]*6&?9B@;B.6T03]21 T\2_.&7
M0P^F /%65PY_Z3:%L@0,I/.V03H6T#I8 +%QR[*99SG<"P2]#Y75[3V,7*7$
MP4*RD:RYH#YACM=.&30GVR3/$U@*/X2J84(4_A'3_;\'&TE9Z8@TIGWP'Q'U
M_S.*M8'_)WN2ZXFA8(^["?;@9!1MI0AV+=)F41ZWGZ.C^*K8/2>/#MWY>AM1
M;13E:9?E-B0^3LEK]QF(<L$ZRR]+P6#:';\IRBI#8A1(RHM>TZI(QV B-0AG
MG#8EW.VG;980,E!#&N4T:I,18RZ)<)F[].ZIF*V(:.?3NJ@F8Z)@O"L**:9S
M 'L3V-I :920QMI>JUX%,1,=PDA:XPI8Q>E^RV 5-1.3S%!PXY(8\6<6K-=$
M;*>+&5NZ;,$LJ7=;*BP">';/'69UUP8-B9LLG\=%N6:('I"$ZL$F(OO#B_;:
M]2D0]B]?-]3U*%A34W]%Q15SB6LQXH2',='7SAI+FS9,!/VV3)D)&SF@(1UE
MOG'9C@K@4PW%IWC*L@N+_? #8$Y>.T_=L*Z)P'XM"DQ5_N'9_Y%S^X4Y#DP*
M&,'$73)0%B:>1_VN0JFC:&)MERRB,4DU<5A"]( HJC^\#"_H@@I!;1C1(9^!
M]3>,/#*'^=WWQ2:J)K(\*<HR)GO@D]=(@$JL3DKZAQ>HF4KR7?0><_WGI(O^
M<_ ?<0.CEFLFD%[&9JLF3$S0+A(?[=$.:FE/SVK[EDRDOSLU>!P5!NI3KS'0
M3-?$V]Y:.1L%:ZA/]1*N&6T3 7?3V$8I)SMLW<;:S^-H1-K$_=AETQY]D5WV
MTKXG;1V:,AD N]RWQX'10UI=(\.ZM64V- K18GV'QAA'%GDJ>VWQ60HFNGF5
MQW/<JG,<[;="YTB83*]JJ8SK: E/NZZ/>1IF@BFL>WG!C*M8GJVG.Q#-J:%H
M3AI$<SJ*IL:\[[?$&1 V"?_JX#@85T1C$71=)TTHFTFWL'H:2G=<5AN]-_WF
MKR%Q$REW]0V-$[F5++I.9E/J9J(N3.@VHAYGM:DXNJI1IM3-A%U0L%H)>U2_
M#,7Q9J_"?F,H[-->PGXS"MO$$=]U$3>C;>;E+RSAIE[^<?D6-/&EQL[5.^Z&
M&<?\7N%QS71- JM.BZI80CCCGY5Y#"/B8["<(?][>6E-J9L<Q7:6\>CB-19'
M/]O*F+S)QMQ#W*.!U5(@77=G<_IF$B_LT"TE/F[4YC+I:FF9TS>3><'6:BOS
MT=RB2@[G.]#&2@B9J%\E%_@4I8-1V6J04R_MJI*<B3IE*+-1>:KF=C]MJ9J>
MR<)I++Y1&8HX=$O$$_ "!O., I/ZW 4J)66R4);$.Z2T#KR$V/^5V3'7W([^
MX;,U/;#IAGO,AW_:5+!GX,XSS44<>;X(POR,<N-4&>>2/V3BG&?BC&GG*J37
M:QVN(6BR$F,8%.,R7R?,?@M]'463I1['^!CWD69Q=K6C:TF:#9&"Z?S'#9'1
M"J^5:%?#NY:DV2 IV-I_X" 9S79ZQ]U(_T]\'A?TL6LNS2IJ)GII2?K%NXS+
M)16T#11_>+EES@WG@K@>L23]'=QCRE$SD-M120A2]E#3S]#[X:56-CDFKGV1
MK&>9ZR+):M91IMW:,I#X24G@Z'GI+%7+;]-B/0X*V.F8KW@!\CGG*@* NCWR
M2-11-!'P^Q(!IR3#335+](<7X2QX]$## ,*7,G]FWUNE%=0,%*S3DKD9$CGP
M$JH'/C_P5_3@@EIT_4C%P>FQE&?%.PX'\K?1]FK2<7IY;^IIFCAP6FE/HZ>E
MUR;92]1]6C08"#O>G,>18K"G]AL/C71-I-YVQQ[EVF#Z["PO1!E1DUC1%F;5
MN#DW;:3]I-E U,3OU7)['N5IQ/JNONXFJF82+;B[#20Z^J6;N-_5-=U$U4RF
M!>^TB4Q'-W(#][M>LFFB:B;3PN4:$YF.=VH:N/]V+S)]:RC3-UUD^G:4:3WW
M?]V+3'\UE.G;+C+]=91I)X]"/XVX5Y,&HV'G7HQ1H6YV-_0<$LV$303?WI$Q
MBM98 EWM)1/*9L(MV$QFPAW-IN*IT(X.ETP.!/=UJO0CR/3?_O*7@UJYW@O^
MS#SIQXMO,T4[7?_W(HQ(FQP(ES@C4]J9.U*QMC:^')'*=V+]*P!&*4_M='$6
M>,REGM=9II7D3.18\N)CEMX!7QP\)A1_>,G=<\^_7&\<OI7[TQEUH8>^=\7%
MQ/,XZ)A^]XEI0-E$GB59@R7IGVE"^^ Q(GZPX$)>R(G(C\(U6!O[/DEMVH#)
M"5^/)7@\[&M:/'L)NH&HB7!;K<NC.%LLH_VFL#%]$R%W7ZQ'B;=95/OY,=JT
M8&+S]EJW1]]&>ZET=7*T:L),\@5O1VO)CXZ/5H+I>GC<J@DSV1=.DMO+?CQ7
MKM2M^JWQ351-)-Q291M7<G.=JN<&;MZ B9S[:&VCT%O+I//NW:(%,[$7-^^6
M8A_W[C9BZ;QUMVC!3/#%G;NMX,>-NX58N@:'M6G!3/"%0+'6@A^CQEJ(I6L$
M69L6S 1?B"9K+?@QM*R%6+J&F;5IP4SPA9"SUH(?X\]:B.7=W@7_SE#PO_86
M_+M1\.9B>;]WP;\W%/R[WH)_/PK>7"P?]B[X#X:"?]];\!]&P9N+Y?AH[Y*'
M)LQ$_Z&WZ(^/1MG/!;'I [4H>U:'D7T?G:PB9W)9H,1(5_0.1$IP-,>;A=?Y
M,=<J<F;"*[[K6BV\T8E6Q>W=RLY0=,6WDBM%-PI.9W6_U\;+B1E$GAB*;8PQ
M*6?TCN1EE 311%*C@,I7L*Z.Y$IR9BMBP6M<LYF-_N$J;G=U!E>2,Q->P?-;
M([S1QTOO!7,MMB'.1\&#C;Q*Q&Q&!*,R;B8QT.QSOMX0M\^]E9;-&"RMIZ6!
M>%$[!ZHA=9DI;DD%Z22VH+R8%C4V#H*6TND91=^I,0.M:&<#8M2<N@JK;Z1N
MM]8,=H8=CHW1&(I8*)FI+O<&0&9#A2+?^X'U>J(FHCXJ>5<]0_6 )V1'IX2I
M./<A34-A%N9MDS!'49:SO=>V74O29'-N(\AQ^ZUC^DXE:*1IF\MN%%FX!IUG
M\B2<$V]UY?"7&;1%LXESNOHWVK5A<J1V6K2;XYTQ2@*12_R@'F!90','7M+>
M:%9W' 5=S]O:M6$V"@JNK^ZC8/2,M9)09WVY51MFHZ"H/G<>!:->W4I"WV$0
M&(Z!XH;?=0R,(\!(//VT\Q8M&"CK;>6?D3I?I*-AU.3;"6B?PC?*/K,CL?_P
MTI[1Y3JF.EW\1K=7; D_=\[P5D7.0*9')3+-TI.2>Z+;@T5(\H<7W>[.O#H>
M:QV5W4,>3ZU*LF.NB+NDWK6;7?C2!6^ZD&P7=$5=CSW3:Q<X1[NFR^S2E(FL
MRY*CAFT=,+=VL<TV"&5EBS_\B"@F?4CS6.\C]V(Y=9.-ML2A5II-PLTDS!Y3
M,*:2OOQ7P/SM&0$J]U)R\AA/MG#O$'<G^?Q:-& B[Y+7UL,6?GZ431QLLFT<
M;&0C8WJ_0IA1\C[25^:O'J@CUT4EG3XA?75$343[KC3 +WW*Z07('HB0;BCG
M49BEV>0GMJWZ2)R4F5WE:D[?1,0E;SU=E6:E__F )(T<I&A'>5=9,+V<'@U$
M#?P<+8VCT9U18]OTR[C9)^[+U&(:Q=?'GNGW)F;W!DT&P$[-J'&8M+1X=IQ4
MN:X-$]]U3]MJ%'][&ZC7"&C=C,D@Z&]PC>/ S$CJ>P6NF;2)O+M88:.$6YM+
MO83=MA43N?<VS<9!T&1.]7PXNX&J031":RMM##RH-JMZYMGM=0G#W% ;)=C#
M<.KY[%^/%DW&P(YMM7&D])=;YU<$^S1I-E:*SPOV'RMC4&(OT76-5^[5I-EH
M*>00VL5H&9,-]1%=USL.O9HT&RV%8/==C)8Q[-W4I;?K5WUJ&S$)>N[M.!QU
MD=8NO7Z#H'T[)N-@%[[#<2AT%5%79;1#0V:#H:""=AT,H][904I=M<T.#9D-
MAX*.V7DXC(IE>REU52<[-&0V' I*9.?A,&J.[:74-<E8AX;,AD/A&G7GX3#>
MHFXOI:[O4'1HR&PX%)ZCZ#P<QF<IVDNIZ^L4'1HR&PZ%1RHZ#X?QL8KV4NKZ
M9D6'ALR&0^'IBL[#87S"HKV4NKYDT:$AL^%0>-"B\W 8'[9HB"SJG7#=@':C
MT(_>')=D)30(6QJ=2VT$T>-)!!/B)G/[7>D#"89B'MU&AK+H\7")"7$S09<]
M8V(JZ-$A9!XCV&\%;]V,B?!W$(LXKNP1+SYR;K\PQYFX]C40=Y?LT9'19[1W
MVC03R@;2/CXN3O68M#HK9 EQJ:)1?YSG[>3;U=-K0ME,O@77KJE\?PQ/[K_]
MY2\'?0**N^IEC63-0HH+L]<DI'C4Q1KYWW5=;B1K)M;"I#42Z[@B-_&_ZW+<
M2-9,K(5S%2.Q_A@+<1^Q=CU :R1K)M;"^8B16,>CL2;^=ST(:R1K)M;".8>1
M6,<CKB;^=SW0:B1K)M;">8616,>CJIIK4UV5X#J*)L)\4_1(UM[$&A7?.IYW
MU7GK*)I)L6#%U$MQU'-K>-Y5Q:VC:";%@M%2+\51K:WA>5>-MHZBF10+-DJ]
M%$<MMH;G7178.HIF4BR8)/52')76EE=QNFH\;5LQ.;$I>2FNTXV?43MJ*Y^N
M&E/;5LQ&04&+ZC8*1NVJI7RZ:EQM6S$;!04MK-LH&+6SEO+IJK&U;<5L%!2T
MN&ZC8-3N6LJGJ\;7MA6S45#0 KN-@E$[C,)E>\7:FB1I/B[)*Q/6'B6@V+"#
M'(WF>=FJI3'F6\OS=!<7X%L$J=4)9@P^*^-JO_OH;<S1XY)T1YIL1D-38VR_
MZ^&M OY*T@OITAD-P#QC^]W6;A6N5Y+.1Y?.#VN8I?F+IHOX9<![(K76%?49
M0&PEIEDCM29Y'8-^?70L]Z&$ELR^U/RB:*Z9'U6:QM$"Q_N)%C@VC!8H[&5&
MT0+'HUASJU^_# =M?!^PA%9D+QB]&AV?<^XJO'9MF'@T2D+M8IFV?]1[]&JT
MOD#4U8IHWX[):/A07)P[WE0:#9+V,NIJL[1OQVPL%,R:KF-A-']:RZBKA=2^
M';.Q4#"BNHZ%[VYL.>21.GL<!GT&X%Z'4%<EHWT[9D.HH$1V'4*CLME:1ET/
MT=JW8S86"DIGU[$PJIRM9=3ULD#[=LS&0N%22->Q,%XH:"VCKJFOVK=C-A8*
M-TFZCH4Q\55K&77->]6^';.Q4$A[U74LC%FO6LOH^.@[#09HR&PT?-C5:#@^
M&H=#:REU/3+HT)#1<#C>54:=@^/Q8*&]E+Z7U_+8T&UYO#.WY?'HMVPOI>_E
MN#PV]%P>[\QS>3RZ+ND%75 AJ#TGKV&ZI(EK[RY8VY2ZR4'E2=''%),_\,EK
MG(])QNF.L=D5H0-LZ;(%LXCK3RR+!Z[/W.4]=YC5_XZ.&6V3((*2'&L9X@<D
MH7ZPB<B/AQ$9(9\1CWG3Q;V@&R(4[?_N*-(R2HT"!/$=%Z--%2D9_K%)B?WP
MDII1AUKRE%\P%=M4G#==)6="V422)9F*8]('5D2[;$*.HDT7K&PJV,[RK")G
M(L2RA[0SZZF?(3C*+5BOB=A.%]'=!SY;$4%7W+&IZ"Z]>J(F,BQY0SNB*A=5
M&@9L$=\7[#'PY54+&>!S%W7N8/+QP,LT^<-+N<PTZ2K<<EHF,GUKF#GXAQ?7
M#5T2YUYPBU(;=AGO\T;&JW456!4U$Y&5)'M6Y$"M2>@=!(K@#R^UZ_4&=I7I
M8F*3C:0\7=S1E^N%\&8^V&A$V)VGG GE1FD>EZ;N#DDK39787%&7?[OTY>#Z
MZF$F R/#%GYX\<Z"1P_V'2!\^=QG_2S2,9B(QR4F1DKH@#Z/ZV9-2']WJZ**
MGHG(2AY:KKD;, JOT83;OY'8QE@\Z6PL'OQ'W,[HO*DU%<([U'NQ0F+2S7(^
MW:TM,MX,KS,D^DF\CJ*)H$T-E%&&YIII/XF:TV^4[VD__7>4>9-6U'.U;J!J
M,'];:ERC1,T5H^BX:7^:5]) LYS?]%"\QN0?]0[VOG)NH&HBW!;>^U&>9LIN
M7ZD:T3:1[8XUZ5'Z-8IO3Z'7DC21M;DR/8JQF><G>Y#CB:D@#>,1Q]O2;0RC
MGO.S10-F(>E]3*-Q!K>52N?YW*8%,\$79G=[P8\SOC&?T*[MXC9[<6O#>)S/
M9MSO/(N;Z9J)M5OVJ7&V-K[#N2?!GIH*MMN[K6,T<.-+G'L2[!M3P79[N?6'
M3>IH+-BW>Q+L6U/!=GN[=;RDT?@:YYX$^ZNI8+N]WCJF\FA\CW-/@GUG*MAN
M[[>.>3F:!/!^3X)];RK8;B^XCDDVF@3P84^"_6 JV$(2#2/!CADSS+U&G0V?
M-BV8^:4*)E 'O]1H$)D+IK-IU*8%,]$7C*0.HA]-IKJSG\[SO)ZFV7F284*#
M<18;B;+SO*VG:29*PTRJXZQ,19F-C/G*_-4#=60V\GLIL#0YR/\>VXL/1[^>
M/G84KEDK1NOQN^+I08;ZP0M0/Q A^8--2']\Z:#+#MS9A]6F!;,=N.#-ZK #
MC[XMLUG85>J&Q)L7\M+K95GJI7/\AQ=ND[MB3UX0PX=INMG*HQ.DT5FQ)Q^(
MH5@+F2-'%\A.Q-HY1V@S72/!%G- FCTD->;_I,"U#?>(\U'P8/.).O85%S/B
MQ.\+=4WEUD#51*HG]9F]2F/91VNW0RK%[_7 R+'A"R/'.WMAY'BTF*NNE?1Z
MZ[F>9J.03X]*;R%53N[QJIG9;KFOUQP-GW,LIMZMVX7!2.*;@Y.C,?]R&Q%W
M3;?<3-=,Q*U"ZWX^N*/^ :@!\/?C%DS@I2PT)ECN^%1DUY=[VK5ALD6?%E6S
M6*CMGXH<53:I+@/#?.8&0&9#PXRGG5U;5=0Z^K*RY YX0N^'%]H-)1Z-\U-O
M)Z[]P)8K?[KX[-$P?77WG'.-A U$>?1K6?HYH)Q+>"T38 M)_F>^^!D8$B7&
M_N&%6[)FIFMEO'IVGZ&&U$W$7'+ 5+<69U9@V*V3E7F4>*U-L^,[_6WRZK2Z
MTC]:2H9+:#^Q&I,W$7#C.KU5J_1#<94>Y=UN0>TG]'9MF$A^1TOW. SJ-=^>
M8J^E:2#F%CKU*$GC%;;G\;\Y?9-0KCY+^'A=N*5(CO<M\V-3H1?\G6V%/EXF
M-I=*Y^OB+1HP$WO!]]5:[*/+RU@JG6.M6S1@)O;"J61KL8^GD0U)[CHO[8UD
M341\6I(1HC'@8%S!*S3DG@I: U$#>;;2NT<MK)65VU>X[1HQF;P[LZ7'D=!%
M2)U7[K:MF(V%PD+>:RR,B[R@$^M? ?-8&#]P%GC,I:#==%X!*LF9''F\+\[U
M##TIQ,>$XBBX<D[W<XHU$#5Q?K81XN@7:V!\S_VXB:K)HON^N.C6R'/<94WT
MW.Z[:@-5,_6YN(LVJ,_C1MG ^LY.K":J9@(M1FTU"73T5!D[DCI?)6_1@)FG
MJG#_M+6G:KQ]:BR5SO>.6S1@)O9"KK768O\Q\J[]VU_^<M##2=D];VT363,G
MY7@KJLMTKMU .Q\R-%$UVY8+)PN-V_)XDD#UU1(6T/R*VE&DS70;A0J:<TG2
M\+*55Z[(CAZ4.XJV202]+J^94F\4\VD_,8].#<.-<3_;K>$=Y/%(L(M$Z_?%
MO6RV)O(\+4E(W+C7_AA*<7=Q=KT^WD#43)RCZM1!G*:6YYX-6Q,1E^VP8VCE
MO@3>=:LUIV\F\C&P\CL*O>MV;$[?3.AC6.5W%'K73=N<OIG0QZ#*[RCTM_OV
M5!L*?3R?^(Y"[YHUPIR^F=#'TXE]&V)=IW<#41UJRI6#U[7C>DEC+R\OAZ^/
MPCGD8@F-'9TJ9(\@Y9\B:ZTP\1NM-3G11W&72J9S.IAZHCL4=[=P@Q]7W*9+
M[KL]+^GO=C8(RAZ*:KWNO_NA!T7M=.TZ$AJ([G -*(B_<0T8Q5TIF:Y9L1N(
M[E#<A=?#&L7]_D\O[E]>/?NO9+-A[H*'!:.?7)>']*)?Y8_445<1#LBCYPMB
M^7_[:4$<X*\:)NZS][_W@C\S3_(0%O"IOZ+BCKM6( 34NDE/%W\Z<,F:_NTG
M\^+,<>1YY-]^\D4 [7D!](#Y@>R?2N/[MY^DZ-E?F4_7/QWX "W^9<U=$*;8
M7L,7"?FG@_#W1^(0UX)BEJ V\^.?81 P;L\5 9G/E;C^3[_4LB#L4<R!"VZI
M#+  Z!)&EK^]!L:*M>+D)*H3PS<LVQT[D&#N4D>>A6@'X9AOP*B)^8[Z9YP_
M?2%.0*<+D"*0]+?WP%#_\E\!V\C:GUV;BBN5&S?<V\]AIDEJB?1[4QG,H$@N
M#:E#]1A_X5<S/+;_UQ7T1%C!([W>G\@K$,#JHEKU"BBR7_ -V=SPDA,N'F&*
M^7/ZZI\YW'K*K$R&Q;M =;GK!NN_^C&9G8OKVGV&SUS(UT+2BQ3:\M-4")\0
M9]:*VH$#JT7<]^UYN%N42[%%>=1BS/5:%Y_^$?$JDG1Y\LJ\ H[H1^/^VPP:
MD]K#]^__+5T_4E% D/S<8S39?$V8N[^N/Y"76UBQ!8.I!7WQO HLU>40@_O*
MQ=.U"XOW$A3B6GAU)1$#!%6(>;"H?>3<KL574Q QO()V4?H%\\9T280+37CW
M5,Q61- SXC$+%(@+Y@0^M9OVJ;;5D6Q;&CM2=6*ZN.7/X?WUZ4*.Q1?H,>"Y
M!F/573+H>I234F=)/Q(XV0+]#-;J@3WO,UCFU^Y\1<]3E\%T(4TA]6>!'=VJ
M(F6# W15O:P%Z.GR)*X=2[O(CEXDD+!%<QQD!ORU:_$UG9/7@L>@H1"^E3'L
MY1E=<"'[&EW#+PBTN1@2H6GP(MU;KM!T0>%O.Q'+Y>L&U%-:CK=#/9P,F+C$
MV7H,EF;H^@,HC.5XFXLA@5<W*4$;IIX?R2?V6%ZE#TU) 4I?052@=NYVIH5Q
MBN? 5$WP^D)(Q*]!JY=*.=*6=9  KQ[W\0(E=YKD3E+JG*\;YN95\8WJ5"=O
M0-&DTK>MCF1 :.R8T_6&"R*V%VP!>*AK46_J?ETQ:W7'"Q _D6?8S*FK#GCL
M*K-GQS21,$YSG*<WLB:6Q0-YVKB\YPZS2N:.:6%\L^6!>AMJ^>R9@GFR")P;
M^,O3#G6:O>Z]J2 9 F;,F3P3IKH+2B]\*-BS;5C4EA9.1EU0SQ(L>NA>FP';
M*RYT6%G4@5=DU@[I_3D8=L?]?U!_UVQKI#I0YJTWA E)HZ7K:O=TA\] P,1!
M'Y;/^W'XV94;6EB#RO>7)^K(W]_V8F:'-I P-J\S7 7"A4X(:39\H: ..51S
M\]>6P.??OR7BB4JQ/5!'BD<?ZGEPQJ7Q 8W<.LXVQ$!M4%WLP-(1-A?#!RTT
M9--HC\C_FC_)K2N"^ERWM./ZT5I](7PB.^<>K(KR:7M]_)5\0-W]J0"]EQ)A
MK93'])DZ7!D E; :*^"#J_L$"]$Z59\16(-Y).W\HH/V?,K.3EU0+EZ(L)/8
M1.G/#0_K\HM'0\D_))ZQ#_+TM"*/,_?['E'9]'&7H**CB<O% BSLZ>)<\4R*
M2!XWOL@F$WF:%>VTR, *(^.RH*=[\.+EN_U50,O3Q:+$25D!M+X&;KQ7@J]5
M_VW^XLH+1K M"(\X$2KY:Q@HZ/DSZ#FS&1&L0N3=:>'GT1EUZ0)&,TQA)M?-
M2@:4%$2';@)R(<NHT^R91B#.PVL?T.GTRDER5MFJRE 0EU^S:<!<6>F/1YU7
M.>Y#BR&Y1Q(-S>FCPY9AIS/N 4T;[E@7HP:9!'271P4RU-V',7?#/>^<"+%=
MA'J2AJ.V! 9 12U)R$LK%S3\[WP%'5FNU"A+@MHR&VEZ_57NJ!F=JA^5 >F5
MH%I GZ7SI_'@]"OS5TS&P<V(TCC_'@CFV4PE/$QLBYV1&\Q=HWZ'JKIQMC-J
M"(RWXF+I^6KN7+M9':VX=-87P[#NY*'%API21\L\<Z(A:RR%#]A9.&5F*TK]
M.:R%2BY9#V1= <3^Q])NYZ557P2?J,[)AOG$8=^HK3GI2C[@Z_X=]RL15'S#
M!^(?E(CI0EEGN1M7);\CGAS9WN8%4?H%GQBF+I4]S?==_Q%?M^<O7/905\'U
M7Q%V?"4H+>MZ\7=\G;_B@2CI>_%GA%UGSV5L+_Z,K^NW\MK!BK@5$*H_8X"B
MF5!1/H4R6UDME=2.81F5'([[7C='Y!&$)2_-<6F73%P9*F+Y4S>Y+_U*O7NR
ME>@F"U_:TJ&4CT]NN>NODNUR#W0'R=2,L;P'UNZ6^H!<'I]=0=?,![SQY<\'
MF7W(I?;9-OOR\*5,$0/<N>+B@;+$+(U9V9_,@'B6) Y2T8C1D:/T3!2YD'AY
M6U7!S(OJJQK)*7HQG5+D\JJYK-&F,@)O3LV5XT8DM;>-6]5&$C]HQ(R:J/(V
M%?!#+I=:(W"S:OCAWS*7K8-U-FL6[);*A=G,A#:5D;"B)/CHO&[1JRV!;V4K
M=K?FWF%].20"TP#*DY<5=VS@GCQVIA:7A]&/:::CN@)_A"9M=BQ3?E,\43T
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MRYRRP5J]GQ:D27KK"G02QCX?DM/21>0<RS&@AC*#<30GD?UGVUM*Y.&"2J1
M/%!;,I>YFXLAOM5=TWDM8[]!00Q+AQ;[(_/7JU?C8<N&/7JREA,KP9(>&^GO
MT;2MA@]Z26]E&R&4*N'6E\4 LC01*E]O!%W)J2,O/,A4F7?45X\8E$5EY=:I
M]G4QIP%O>&L08 DU>;<JF08,[T!8*_DA>==2A41.U.>S8/M(K*>Y(/+>DLP<
MDX9_[9SN@+B:S):)_7L0O0/W0.5)JCWG%RQY&ZXPNYK+#X@+<0;H:0"S)4F[
MDSR8"I-()KI+WJ*\=E.-(/.L0\RCG5$;$ ?/5\1=PIHCP>6R;T6@D[L*$OJ5
MPU_R :E=:P_GG9'[>!71\\^?.\3SV(+)T(WP,485@^JSY_R@ZEY_0,,(9HM%
MJ>W)-QMGQ*%>9W;M@-" !E<&[>4KV$L,!LK&SZXZN4TMFTBDC&,=: R'6?$:
MXIW1!1?T*Q=/:F51#C$92!6OV.&JE"Y2[>LA9HKFZ7DK?5N?9Q>G>BR+"A**
M3PA@9GAITM#TZ=@;WS[\1-;,\:$:%>O )ADGU_L3_3CB>[6&4,E//22RSU*6
M%Z \%?TGVE<$OJ"RFRC65BT,F@E6\0V#-/(@$KTB-):T%RPK/N*#H99BB[KV
M+>S&EK3Q+.UER)H"^.#,H,#KUKN'769-+ I=@2Y[F:,*+<&=<7%\4/_)B+"X
M:OR&K>7)2QY;S7=\8"YAG@CZ1>V!A2%8]1$A#(?=0*^V*KF>?*I">Y6WYCL^
M,!]GOTV!\PY?;D$_L0-+=Y?5%4 )YPNQ+.;JS]B7?4#9?9FB.UA3\8D2QU]9
M1'?7UA=!"4FE"LJ8 P5 E07PP3F?W6BZ3.8'?-V=;9C+%O15VQ'U7_%U?&*O
M Y?.03\D&[EC:].Y^C,&*+I*'WARW9'/@SQ&;RC,?+J96/\*8+N3_Y1/9/C;
M^*+QM:L^"4KOPZ--LDP-@-W0VN-9:]\[R$6'Z'G!]UEW_ZYE?02&4TUJ)!,P
MEZ\;L/F)S\6V-D=2#UHHDR5EL67&_W01SY'Z<=)<!=_0B#.;F FS/&U63QI(
MAD+5>\CAL\Y2355R?:#/U TJ4KZVK803^@.5![:63!?J+E-(R?%1.?;6M7""
MSR2D3$Z$LNN\8#);FG199Z9[!4MV1 LGH_*I>Q?J6?3,*RDF^7Z;*^&'?D?]
M/)!8P%LE<H,4M"T)X&3)F:#DR>8OKB[7-(8!EL3[,#ZK9H#L@ Y.!J6;)(@U
M6(?'7)\]^3Q8_9[:5!P[W)F4E3KCW$Y<XFP])C?'"6P41(1'HS&\)D[TH(2=
M2:'CY5P^1L0]?PXJD_T@X^&;6&)<#SL#)@ZT0$)M24[KNKS'K6MA!R]?:+;\
M="NL?5J^?34D\#5W3!@=*9\>7[K,DS$1.0M*GD+"[+XDUNJ6_,Z%"IY(]*C0
M V%K^I1< *(5,G'K[+T9Q,EB]@>^D$+F^S2%SWZ.[%MG&[[>2^WX2./:]8F[
M9-#;$&,M9_+'V#N@]D>$@71ZO"\6?7D:U4Y,W"W)P7!2N5LZ,:Q3S<'P109*
MT_1E6MTSU8)/.Z$T&+[=<Q^^@U[M;!_H(G!MV>W<<[^:XR)Q@G6HB#ALK> <
M4ZZ\2+2"TJO <62&PM0/5EU@0'&Q,H0U]6)'^W3JL,H_@*@V_VCD?Z-)GMN>
M-(8S*/H #>-<5V"\I%>D=L' "KI#96K%D^,3(63H:W@K1/XU74P#7T;/>0KQ
M)[9<E7.S'\'!SN04=AAJO0L&MJ+TI^3<%:7WA%4L?&85!\27].!_NOC");9\
MB(!"+-ACX*=[0<LZZ*YN9X*)HMMGTN/F973#BL_#67 K,&0'=GT1S$,X[QDQ
M.:@N^#C:5L+GK9A8E@B(<\7%G+Q2+U$1PGAS]5L$*36F6]1 G)N@C!'4?N!;
MXDBQ1:\M9&]HE3'"M 9B1E3- Y#P11RPH&YD17;, W>D]%^(L(OSP*P2OGD0
MW9>Z=J>+!>C4DR61S(/.>)YNY.<OC)I60;SHYP= 4]1&B?C;54$@_.H@KX)'
MIR:ZJZ8L HPU$0IZQTVC^PSK(3E=J@O?TI$8!&\U5L$)6^]V@JDA>*M#/9P,
MF#Y380<T.HX"/2U24U/AEC.@0SV<#- E>4%=OI9QW?)A]8S2:E6&<_:B@(0I
MVCEH%"TR7>3%G#\I;BB$^9RWHNO%4UJ#@@@VL^H-NVI8?B'02.!I [-L5VM-
M 97<RT^?]1FK?,, F#K;6^XRV+&EG1Y(_TI&H>U6=S#G5UWPW1//OPCH+?PH
MC=RI2[,G.SNE.!@^WL/0M=B&.*I;,^@GLQF1V&"73-XKC"ZF5FXJO:D@V5AT
M#[',2R*]7\R-TG(D+N"R+X/Q"R0)IH5T6\,:*;.@G@6P8'H3)O2KL,:E,5RE
MT[9.Q^+N#7F4%_<YT/)J@1J7Q@?T@5LK^HD[,FE<E#8\CZVN  8XA9>+7>GH
M%U'TIPHJ4_'@'RE?"K)9,2M9MXV*(M![=".^<$$B/=V]H_Y'X.L-]SS87N8<
M]B:?,">7.:]'_>%X\A^HS\)LJA*@))3-+EOY%7%2V6*?M8E:_1W#/-4<S.E-
MC3R*L@_XNJ_,W7ON =V-PU5\=?:^DI:^Q[ P!IB-2TU\+BO/]ZH7%*T4YF6C
M(;GK? 4=7*ZR%_$RR475N>>""J]P&^DX9LXN"0Z*C^$(D)<17"_* 5QWH2WE
M5_N* ^(+K-*! 'LOO99R^6HY@:VR>\69%*)\R2;LVB$]Q(=3C<O2C/I^6,M+
M.5&]/E45']! ZKBNU(V!OFM6$VW,W-5\BX41$R<&+JS+)2>AG6LCL#5,^9"Y
MPY[.H%:\,* P('ZHI'BA)1F;4Z%9>16X]BP0&R=HQY[V!!%P2UNC3##$G# L
M.QC_:!LYYH-)C.M@7D\KU,%0%YEF$98QPKPX9AZ8KAV@FB6;9:LUHKHBOK6@
MHT[1H+;V55D,R ]GA.4OVWZ3QY?SE;IBQ1UFRW.4L[#EV8I27P]JZEP;WUC3
M9DSJ4HJB-3599TX_.]4<S/%-QRPJ,7.Z5T=U6*ZY\I*^GVUU-W'%-\1.8KW'
MFB>RZBL&UV,>R&=77A'5LU 7?L77<?5PA\9W[3=\G8;I3 4L-='<+>31K_F.
M#TP5B$%T/DWC4I('+0U8RB_,;2NA6HX+5S *>9O2E#8JB=%T$9L'4W=&GN4;
M%; [9Q__[$GC#\]96ZO.I)ANV(*&J$!9V-Z23&1;FQK=U9=8POO6X*H 7-%U
M:]!)'12P\Y-?$T]N]:KXAF\%ZS/Y"MMF?TKX&!1;[R7PLLIG<S'$>FA-Y[6L
M]@8%\8DP]C*<O%5O]=YSIH_=VA+X ,7NDVI M27P CJ6<;7E2/*?\$$P3.=8
M5 *;BF-6_XH*; 6:* W<'7WUKT##);ED.[VIH,LST!;1G,,*Y$"5KBS)$A@
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MX"GV#%V#LB,"]9M,T@:_.:PFI&!'M' RJB[C34DBN_!YNO83;[?$<;)RNEB
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M0-Q2@:Q3=Q=,VPVIP2R2Q0?1Y>J7Z(R31Q[XN0?\2M_NRSR07K"R=T(5P:V
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M*ISJ@A][5/U2U\6;V&)<#SL#(M7P@3HDO![O.&'D]V/A]K2VOJ2S)E=!);8
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M)=W7+K;7%K"QLTSI"76;5+F>/!.F>KW@,FXM<3IG#O;O!7V6[W(YF2C"^0H
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M:>G.,F@XO TO=L%)VY9;G>IGO,ZZ.W5'G7U+:0OE7=:%.ZH"*\,)$NY"]IK
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MZ\./ ^)VQU#P&# -=CB<[^1FJ;_8!K7^;7KO&O4]GYX'>\MBJA1G[]K4_9Y
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MD^J[NCG+);\,1< IKXWJ_RER ?A2<&?OA;_-%U'%("<*I0D=HGOR&8IJ=.-
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MA.,XA[A^[KGK/\S,O2;\J_C00T[O:%)SF+5U&:2_H'<J>B<T>VRJ*'B;'-L
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M;U),,UE&HJ&]B8_=STAA0,&Y#X[ DBL\GFS%QFT5"S=F<RG1\^J)(]#DCB&
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M8 +FU,>;LS?&L<PX ./*2NPH)$GI:I(O'](M[UGSY[MZL<@S=9: 5S\<F#D
MPL#,(?#&=_/!'%QQARXXW 9W[/SXPF$:[>ZWI24.%\,=)"=V4&"S[7HN_Z@'
MR-@<AW?AC9(#3WBLWV9"G[L!M/3"$5N%V4 GUM $82^+)*]3FEX6T(RS[H.A
M2DOT"^AVXAB%O75;!H-,T?XR!4&[ TQ@F%% ZR7Z319, E<=X.C/Q97-<$
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MWL-!-"!*S# <L\>@ V"TN^ :-S_/@RTDEXUDMN<]:]>H7]OW6U>/PFXN2<O
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M28<_2'N[>'U#?&,+?DOSYJ'H>[8;.U6%/@(,]V,%*(,)! SQ/?E.RW$1&.F
MH^(PC4$X83T)!^ZH"I;'Q5FVTEI9^J&MV+*IO\;W?J!#_% AZVY"B.NZ_O@/
M,^(-<\=\F#'X@J]^#C'0B#]4+#NH3.!.M QFRZ/17!Y]CR=G=$*%QYZ*+ZRN
MS#PMSTW_4)YDP08 &?YW2)'L(H((AQ.-Y[$\CL!V&O&)LBDGBYG (1_); S-
MX8.Q78"SAG7<0'>DH&Z Z>1 0R%S%F!<CV2/0'V,U-P23?S?+'(=+OC"G*?2
M >%/PLZQ>99DN;[:OJ4ECDV=3>+,@Y>XP B7D(I5K*4T,YR<F1OB"(LYPN+"
M"CS"NS*A>TN_:B78]P^.+0QO8(79ESTL%WA/Z(0U7HXR&JQMA<,:V2&PLA Y
M(76=H]42JMH-:IK@,#QV!,STQUZ<)6&U/,XN4NGSM_^FZ5BXC&VU5HU+[=D3
MRS-:H^F4TZF S(%^[8(('P2-=^D+'PO#.19M=P#9WAC'$M !$N;':?QT"8\Y
MVM-L[&$%Z0Y@M_FGY/-5G#@#:%6)'!1[,T3%AJC8$!4;HF)#5&R(BN%R+8:H
MV! 5 Q3O%-[-^?>%L,2&8ESFECBLDAT*)S8B[WN>CX=MH-B:XC!*=E3<^(A]
M(U-2]$RA:A.M@,BG&XZT53M<_CQUR3S=THCG+:)-\)X]<:0:VF4/8@LL_EVD
M'12\@T![R,'S5V9,-F>(U@_1^B%:/T3KAVC]$*T?HO7NT?ISP@MY#?B&\B9[
M'FDVZY]N>=_%17=.8&R'Z;C 3&B@63/X88,?-OAAT9?QP0_[4_MA\5;)O="%
M8:7<#W,<VW&*G2/F["1@23D>5>W[ZY+">S;^5E!>CB<WA.MJ4OATQ&%?G6&#
M,!<7Q]]I-IU5-!T]"ILQI0U[JKEH;(?#B#JCY,!+['4NKZOLD;:%>Y8E8,>+
MQJ2/B\^UY'\\&?,T*PA_TF+691@<QS7.D'9G-?*>I+GY3%/7Z>C4'L>QCS.&
M'CS%!>N$E%FR8DL:^Q5K%X)IQZ-3\!@XCIZ<0>W()V*@U1ZW+]3F47 4?0@#
MM@NG2.'V ;4#=#V\N]@=.DP -:L\33N:W@ZC $#MX6E&/Z^H"Z>HX78VP)W&
M 4#^$2_D^(VP@0$_:+N$$"!'D = ,%#BTW)?=/X]R>N4IE(O[F?TE.1)W3XD
MH1"T<Q^(N&.&;#P9BW#@>SHCQ926E\5FB=_U678YGBC>V,5ZFTN2RHJ6[.6[
M)KI#8%/#$"\J *2J?6.AZUB8CGV[,\/<(8Q\&+&L'ZA[9$'Q,Z+36Z-TF8T%
M#)(W!<DMJ+AW17*$H *"=>$(O/RKRBV.BVO"O]+FXW<TJ;D0B>FZ&' (3%AX
MR)N%X#HP7F?TH0(C9>J,Y# G*$9V?@.CTY(/QL?<'<G93%"$7#@./H/:BUFG
MI)Q=Y.S;KS2= F:2?1 DYS"!9Y0KW_#K4<W#.8JO:R%R[('D" 6(AQ>3<;V\
M6UIQ5BYH(H]F1XM%GBU?_2[2K9]N:;G:7VBV@QU'.M":=MC]51"9Q%:0AC3]
M&V#J!F@V85TA8'8N8Z=YT<>,U67^=&<&RMP0A]^O$3-SYR N&+N/M9_58LE8
MFY.-RHS"JB1/0@=/F5BBDS8)9M(\DG1#Q?^FYYPSKE]&>_T.CNV%614.(("X
MFG21%:1(,I*O\J6TS.G=8> 0.$Q!OPBS$"(Z)EMS2X4S*W8#)T^7%[=WH2R+
M<50<>@2&&&1I' 0"WFW=TB0G9=D\ R+E=L_$@E@*AZ7YU^K+7PHA2?GQCP:7
MK<M .):'KK"&D$$')-NUS7G;[-8!1]2I.S+NO((1@&SQK@P788*,=W279<)P
MS>"#A7PP=T??QH7B>PKD?;KA6!&#HN;//CPIIII1KLRDV#PZ4&7&>'7$L;X%
M!0DB@. P79.]0S@/K R]<2Q[!P',*H7@J.V>^GA INN*X[#E('B911#XM&SM
M>+6O,-ZQ7/4BHG=?'&<Q0>$"RB#XY!H]DBR7TWG">$ERNJ9@XXU'CPGG,QR.
M>RL'F83^8HD;V%F^N*MC!_S^[OV,5+]G>7Y"GS>_-)4;7WDE>LQE'O-G*C9L
MZL>I,)&%X^I.4.W%)UZPN9-/C3<O11=W8KJ-)\_Y5V:[YM4/QT6?H"H X#\8
M1HW>[:R #A"9NN&XE],K0G;V8Y_>;T<YM_R=[<0@@^7O, J2JSU!E:"S.!#K
MQ(XN7U,B[[>DHVKM,M_/.*NG,]TZ!56CX!]&<LOI<)K7DP2C'W*VY;%OJ;SK
M54SOV>:U"ATKZH/-+B-!U E[6#"(2()OBE=JN+%-*RM>^VZ&78:!@'JLH4-W
M>73R*9O;L%28(^!Q"G@,");8PXH=A0$&\G*^(/+D]C/])C3FBGQ36 I=5&5C
MJ_*<KR<6+C8MLC_$QG.Y!IU>JFST(;\+41CL@<T( @P:Q&ZHE-&)L\P4*/#M
M"K,-[U!##9/!!EI'<#G^YVWBA\OQ1WDY?K@M/MP6'VZ+![DMWA^ GUDA4\4$
MZ^)ST\NBHERL(/J,1*?V.%)I3%!YL-$AVW/>QF(::]K4>)*<T_2$%N(_JIN<
M""_?D%P(&^#HL@F!;"))']3MNT^DG]T^X+ZUG=OF=CQ1\.H1[0CP%1QVM9L2
M]"Z>:.K1]+]AI>!ZD;,G^=>>5<7QBSAL?%RU\1)5<!5RT>A1D5J(%%QJ*\L=
M],,XTCG[4:@^)1;7?[2%G7M<^[I^ D<^:C\*%T8VO0:2-U[?;D\NQ\67.ZG\
MM[3*6AI["20'^RZ.!-EN^A-!8''M%9+'#X^TL,GPIN#PIN#PIN#PIN!!P!O>
M%#SDV\Z0O=1Q5BT.Z;'>?<O*,H[3"OXTCBM 4?S6CC*+<(I^PYF88]63%$<E
MK(14_(6D&^OCXC)1E3:5>#2$Z]QKKXY83IZ?@3(0KCM_]^^,J1H]@'H&ASJN
M*Z(EU%!USZD'GNV!'R8,P&5<"*](H:^1N/\C#E??5;[,S$9<R9_469[*%U^T
MXM>TP.&M>V)@Y"7Z;EBF?C>U\BX+P9?8AI3&_;"U.8Y#&T^(W!F+B]<U26;"
M >;ZS#9-"QPG&YZH&'F)/'$(YT]RESZ7]ZU'25+/ZR;C]HR*G:N\G"V%.6?2
MFU]5&98[E(PW"V>1?N*L+'=&T;C!/7\*4UBZ@P=Y$"EA4CJ]E38TP^-=]HV7
M4B_P&1(%&UI@K6UQN*A&"ID7*_'#S59KM!>0\MW.[T>TCBU=$\@F ]O\;H'=
M:_:X"C1KOW?+\OR"\6^$JRIG 4? ,3V[H=6)=:0A&Y]@#2XLH6C8@C688%N5
MVUZ&X$_7E8M&Y:\TEY6.9 46'W #C8@C&-%1!8+*(G)>1R*H*AN1ETMV3NI2
M&#+A:;#Y0U:T9Z(^FA)J2!Q!D8ZJ$E88<75EMY;_DI][3HIR0GES^J@."OFH
M3X]?P1'0Z:A1O<LGLD%*TW:V-#FY]S-2A#)+00?&D;7:U3CU()+HN\\%*TE>
MM@^4+9,3O/0$.@2.?)"NGDTGYF/[O,]!,#_/UJ,?CM*IG?U7;X[!@0--E')<
MK%7-S[?L/!J.RJ>=W<I <HCL4:Z#T_)RS3)SK*1IX[.LZ^MZ>8]A1L11?+6K
MIQA2%G$5Y98^4EEN:3P)KS+!QT92M;6C]O0D%I1;V,^T.O^>-!G69]E$[*)H
MD= 0NU;@P$BJK_:S4^TD$[ ?(KYZPMC7IN;7#COK3S7OU;4%W>B5I%C>+. D
M4591"S,@CGAHM^.-D)*(GMK5$%637&Q]YUE; TZH]T88SR A=?97B!%QQ$*[
MJ4E0443.Q62<LV]9,3UE956>DD56D5PNB:JL3%M;'%');M@Z,@G?1:XB56)-
MR>M4^AZKG<XGL:@LF@>+[]GISJ.D[865C3,94UPPT- X(H/=X.Q')F#T-[>X
MIS/"I[0#WMT'PQ'IZYA $D@*SA<C7X<O"!OV%+=E=*,&K.IN:(?522.5][BE
MLO_0\VTVG55L4I>TE5C?CGLO,.D3&T*J0:<2M>&!T#,=#.5.'#_'&3H;^:Y#
MX0CS=S/Q8600.SW%+\=97WJDTT XME\N.<(A^(QP/[L)"5QEY"'+94&"(FWL
MSWCR965_L-[3QE$'R<F\WG!:"L3;@Z))(W&Y^[ZB\L:J[G*U>R=,EZH]J!Y*
M,@TEF8:23#@RLX>23$-)IJ#SSWL=W'\PQG$M5+PT<VPWDCS98S ' <'-P2UG
M,Z/*AWI-[7 82QA<#HS%1>C\^T*L]_2Y_M3=3&Q=*LKG:Q9_GV7);)F&(+D_
M_T[G"_D?OY+RA-+BB_H@)O#(."PN3 MZ$04RO6DY$3)AWQZ;A[Z:?61 ]0GR
M 1R1A4!:%% B'?(\OC5DC#B7&29-)%R9O:%OAN- %H:)G2^P9+\4J73.:N&"
MI!=UM8K:W) GG9 =>^ X,87)VXM%L.C/)Q,JZS2>+;\E9IO*0NE;X3BR!)H9
M&UMQ%QX';S*@(]G#*0,,%<P^Y.]41H]I.GH4&\@I;3DIFW1$.2M)ODY7N15[
MU=%BD6?RK&^7I>=,UU%U)AJ.)Y<2#Y(W/9*EP"XO;N]>_Z) /2(5..XXP!0K
MNM@0'W^\07?^L:IWV9)I*TJ[WPIC!=K_4Q.QRDB]E86T)XS/VW.S!U97N^?B
M+D5IP>-A.E()P]!NZ5J=0D0.KF^3IX^KF]KA.1\Q"%N-![Z(^5&6G35+=2@V
MVU]4S$GRB$O,_D9G69)3O?35#7 $DYR$;V(@KNR;6@@6PZ]M@R-TY(2 A8?X
M)Z00;V-O5Q' )=O?J1S;R5XXSA7E!SMZMY'O%>\0J% ;71,</D9P:,WL1K8*
M&QF-#LBY-,?AKX2?H,ZL=[B2]>^Z7-_AN^%TL8QYCXITE"3"N*6V\P'H$#C\
MG."@=1,'XK#56W1A*YQIN_C\J2&\!0IO#<G$0S+QD$P\)!,?RK0/R<0'2";&
MMSH/T8X?,=IA>W_A?D9WO^3\\H);7QP&/#B.0#D,$:I0]0@<I7X$D:AU@93]
MF_+*.(>U-8XE%XR5,X=# +'O5PK\@#M H'"KW-L]Y?-517$'!+S[XCB  \,!
MY!>,C5>)1@>\@HR'(Q\<C&% &8!QU=1Q=[%Y?CU!\ZW/2E">Y@_"+>)(^\_8
M(NW7I*JY)%D=3E?]'*)VTL;68?V)@N1/9295A%4DW\T7=HET0X;"&N0&\<)L
MJ"$)8J?W0@@GI$@=8M6ZMFA"TDII[\:=S5S$A>4SJZX$B<T#,^."_I,2KH7%
MVA;'IM8N=^;%3^SLVFT*Q?JR2??]-R;_JI]+H/XX=KS.0';@$0FX*Q)W*1<$
M4$=\/8? L3?VAQC$)A:4UT3N4'_!:NX*L^<8.#;= )Q!?"(!>DWC+NW9H^MT
M]AP"Q[[<'V80FUA0]D S&&H]7/T&H-85G5 [PRO'4U;H<$=]P IF6G&V"M]>
M1YZL!ZT T/-):U= N]<%T!\B; R[67?#0=ZJYC@V('W*7L]UASR$LKJ6)CI;
MTO5[5LV:_Y"G%><RWK@9>]K*0O#JB6/O$!(=D  B)P;6G,L2XW8#9VD)FFO!
MCPE"HNG$,'B::4:W6#V/7B! @K]5<0! NMG /H.B1>(\N^R-07A^P(RG*\_@
M.:;_@&6:^74$(?/Q.)%QFFS8SDS?;5,:_\QTN)TTW$[2S][A=M)P.VFXG33<
M3AIN)^$X./[A;R?=THJS<D$3N>)L5$]L4^:>?[JEI5B5FH"SQCWI.-*!@#_\
MBAQ$+K&5I"%-7Z1-W0#-RMH5 F;G,BY -YP^9JPN\Z<[,U#FACA63XV8F3L'
M\5?%X<+G<.&S;SV[%%+G8JXL7VH8%PZQ1N<^.$Q!</ ]^8\+\/!:3EQE&1[2
M&1[2.:R"'?B-G1[#.J2<C>MJDK-OS:, DBU50,?0#$?>:7#,[2R#S[QN5S7E
MEN\QK(]'E#LV2UL<^:#A*V"Z\1UW]GP2(BFOF"SS.^)9*4S#A9"(?+Y=[%@;
MLA](\O6>DZ(D21-84B ,'P1'4FEPZ+L*!-G*_1OAF=R2;%6-_,RJRR+)ZY2F
ME\6U^*5N+[WN:+MZ<]#7)W"\A-3_ZAU47'^FK-<>GB<*CC9FM Y;1NCC$:"%
MN4X-AO)"KU\= 8A!ZPXI/>:=Y\A6T2'Y]IB#!03TAD!U#'$UL"BZW1D0*ZM8
M2@7AV@5JOP4$@F.(5AG9A><J/V]791RBB8#)C';I,K-OO\D@A<ONWJTOCGHS
M?6[Y?>00"K.5)[IZI7$U.>V(V7J"\.HUS[P/O-RD$/D >)O&#7/;/!>433)A
MF\N+K"!%(I-9Y'&W;EGK/!8H=(1_&@>22X1DZ4^,I=^R/!<&1R@O*::9V*5N
MI4EODX@@2YIP_B2%.)?YYJ,DJ>=U+H_[-TL:BA\EZZM4CLOY@F2\2=XHTD^<
ME>7.*)JTZIX_A3$/6YXD""7-6^;&D].F<IVP;+OJ(=E;*H]+/G;G<;'F97=G
MC!U2VV(?_FQ2I\_F-31#DSK6.UY*O<"7U*1@0PNLM2V.Y!(CA<R+E<CS;?4B
MI,$8V1[O=NR*-4LWG'T&"21Z(IB.5.T<=>Z#QQ+[(L- G$8VLS;<XH)D-JCN
MDF9V9G!-J>8]75FXR'MB67KB2)WS1@[$)3B@-4K^4V><IK>TI&*0F;R+0Q]I
MSA;2R=+?"?3HAG,&V<3*H(S"H<C%0GO"29%^)G.J%[VA&4Z5=Q6UE;&XANN>
M)K."Y6SZ]$!*NA?NT0+FU0]'.B8000"G\$A\6TDA?[HF_"L5N\8;SM(Z,>#@
MV -'<B00 2\>P;)O!Q?;MB9!QV,J^'7$D2<)1 +":ES[UC#F#*5#:QS)CD#\
MG/F+G/&R<BHU9R:_TCR5!Z,R%5,=IP".<*"%*EZXHI-<\"G%9U9IJ-=[FAV&
M01/;@,)HT (_&>!3A1!Z@$H)+!4GND#H;PSPZ<"F>=RU@E>.-Z.M_8[Z]K.=
M.\4-YT GLKBB<1NT^H6V<<UY$+C.W$6>SMOOXVG,D!^PP<;$$8&"S>VP,HB\
M[LNX9;G,\6X9.JE+P7I9GK+YP^IY3#\M"3<HCC 72$U""R&V_5<^NME<U9M0
M[JD@ 4;#$7X#KA^!N$=RB68=*?%0\[WHBLJ,]/(!'-%"F$GI42#1MQZJ=V(]
MG1/P(#@BD-"=1B>F(]N0C;0]D(F ],=W&=K= L#Y[7#TO\ZX?$ZK+,?%IN:=
M4?Y<&449/08/@N\RLX<+V(WIR"[?FF19L6%9^:8YKKWA;))58R[_[NGXA1H3
MWZ5I=_<OK SB*LDM?10>*\D%_R"V7(Q\;]] >&O;68MZ%@K*W>9G6IU_3YKP
MZ5DV$5LE6B0TS-83/#3"Z^1=-Z(=90%W-%;;F^=J+:N5\I,@;''/[F?T3*RF
M34Q]&79KRPB;=H_PT1#>4_??*W9E'PYGXZO^T0QYPS/&[]GIUG?N6<O#1M14
MZ^+#AH$ B"9^V)EO,'+/*\KIC/ I+9>Y2?=L2X7,N,$'@:"&)K;7D>L#8N9G
M3GL9'X(TEF!<CP()L57?-!];F\^6K4UB%:]DF'?P8<8&;>Q[K5$ V=B'E 48
M]QT'SNG3G0Y^0WT!W[NET&/@L!*)?2CL=\?:</VGRT X#G]=[BB'X',#<CQ%
M2=YLTSA4)1FJDIASU8:J)$-5DJ$JR9^H*LE0^6*H?#%4OA@J7\3.Y!XJ7PR5
M+X;*%T/EBZ'RQ5#Y8JA\,52^&"I?#)4OALH70^6+?]VUEX%/65&R/$O;@SIY
MH*.)2CBU_^&K6GA((2Z\Y[*J_%-YSRJ2RW-V'=W::0H; $UDP@THUIW7R*:W
M/4,MIDN:#6;7W!+'7@L(!/-@,2Y>7PJ2-T)N,B1J$V"VICBV;-T0<^,1Q4)I
M61>[+H.0G4#T91#=JF>U@G&-G^NJI5RDNAHU=7ID(3,BY.,SUS3-$GE;UA!%
MM;3%L89HY,2\F  +](X4*?M#KW^*GW$8<K/8]'1WBUJ:@Y48(UQF.6G)AH>K
M&%\PX=;HX[J:%CC"469Q&4F/G.QW1)4A(<&KH3+D4!ERJ PY5(8<*D,.E2&'
MRI!#9<A>[X0![G?@2?9_NTUC_&3_"$<W0]K]GROM?CCG&LZY,,$\G'-MP#B<
M<PWG7,=ZSG5<-T^&<Z[AG&LXYQK.N89SKN&<ZP<]YQIBF$,,4_]42IGP;-%R
M\(FS;]7L5BCQEU*6<CG_7G&R8#)'_924LXN<?;OA[-\TT55*"C :CI476!<G
M$/?QS87<P*QHORR6-T>N*9$2D5-P/+D@&?^-Y#6]:JKOEU4YGJS*?VEL29A!
M<?@88.L14@@H8^D_8XNE#X5SA@C^#QG!'PKG#(5SCK%PCH(-?>$-6UL<_J)+
MJ3Q'5B+/M[9THZ2P2-6E''5KGU_/'SZP#))'Y(2WZ933J=RAV&G7A[O @^ Q
MU)[0L3"<8YGY#B#;&^.PRQT@V9O&F,$;KGH/*3!#"LR0 H/*^ XI,$,*##;(
MAJO>0PK,D (SI, ,*3!#"LR0 O.G28%9E3H42^$=Y8]90G4>@*7E#W]UVXE_
M=&!JIY.U+1IOP29X/3Y!+=1OK.*9J;RSN@$.;\$N'&9G NXM4$YS\CW3KX.:
M%CA\!F?A&;F +XU/-Z0T1)P5/^/P(9SEIF<A\K'/$=5!@12!'>J@#'50ACHH
M0QV4H0Y*IXR_YY=]O=$'],:+NQ?H8,XC)P.@?MOL_5$Y </;9L/;9L/;9L/;
M9L/;9L/;9O%GT/"VV?"VV?"V65@$A[?-8B,PO&V&!8GA;;-#A;7_U&^;#34M
MAIH6VIW6^L[D%2M+R=*TR)IU6:P*DZP:<_EWS^J]H<;$L2N U?@-*X/(!F2S
M6,??Z[+*)EG2:/T%XU]*L8 ]5_ 05K,Z_YY0FI97K)A6E,]'CY23*7UNH[(U
M/7T"QVZG>XF4X"*)JU&W8G_,2Y(+<8 FRMX"K5"IWKZ!8_\%TJF>90+>+33C
M6G=GAE8X=F3.Z2U63B*?8GO66S#$ +L,A&.BN=0K",'G!N2'JE!T1B>4<YK>
MD^^JT]MEE:(WVW3&KU*DHM4CVPI>)4B=RE@)V"6HNDH]Z@:82NYH*#0D8V [
MA%71Z)5@@_38U2I[ T:![TL]TK)J;C1<%G?U0YFE&>$F*3OVP+')<Y ? [ %
M%O?*O[H0%#;G2V5FKC+AU@''=LA=V#Y<P7/15];/% S3-SJZR)>!%69?L6*'
M(J3++#<D]W0N;U#QI[-L(KP86@AG6VR,?Y]ER>PSV_5L+C>V.,KP0[AA<1@T
M.\CA>4;KP0+?K%):BQ.2$R&@NQFEU3VGI%D*--ZGM2W&(I4*;?A2U&4C8QD3
MH%+&Z[^<"N%G5>E2I;+[P)A\YL"<,2^- :]URO&U3H5#:S2>LEUR)A&'S3L@
MBZPB>?8'3?69!KHV.)8/%R$Q)T[ 4I1W!AP$:6J&P]WUD*6=&; X_TD)'T_.
MOR\R_J19KG1-L-:?#&=VS9P'D;E6@?6-T-A6K7@4X@NJM.."RK'U)P*JWW%8
M4(-,F)5XL,#NOS$YIB'34-D AZ&TB\Q$/5QFXC=JD9JF"8X3"@>Y&>D'2^Z"
MU=PL.$T+',=U=KD9R8>++7NTZ)NF!8YL1P>QF<B'IY0R+A,="KOX+"UQ)!W:
MQ>C$QA#V#!;V["-8 3\!D"7PF[=M!#'M-YN3Z O&OQ&>EC+EYU?R2,=<_J_8
M.)Q06FQL'D;E7FQ,=6S0WU=PN&%VU'L7 5@%%$1-ED0U9D,9RG;OA,/ILP/D
MRQ':,#3PN:?#91T,ZT:4XS*EF'=52J@Z32KY/)XT0Z-")A,EU7CU+)IH1LL;
M\B0I&$TJRE?.P^LWUT(Z,_43A/U\XE@L?[_\AT!^PX;TBW\/'SJ6Y>404@#K
MPI>"TWE6"4+."2^R8EK>RK6DH.G)TW.M<?&KK$:>-<>VMS1;IZ@H0 \T(H[(
MAQW=H.R"8;SA[#$KV]3]RT)X$K11H'&Q3YX",D!O' $6.SQ@UB(X>3+SJQ#B
M?';H OISJ\%U9S/*WP-X<^MQUX9-[4X:VV$ZES<3RJS2[)0AV8QIS(A4M$!S
MS*.6RJ[(@J>5-J/>DF_7PECPC.1ELR.W2]'2!8<7JA/;KE2=F.DNYM\9_]I<
M\9ER6KH*VMH)AZOG*FI'=KH+^T*P7<YH<Z?35=:V/CC\+E=1NW'37=*F4(2^
MT=&%(@RL[$I>OTS'3>#=<*(,6&W\BLR,6R6_1WI<>9^RLI(71-?$/2?OCII-
M;E'2LYH+!_M&+#Y,%5&&#H%L5= BUXT_'-/IZ7>>B;T2^U:(IJ^-B[FJ(;)5
MQ6[>#%S$!63CAO4>K0I87)KCV,O;P7'G)<+F_9Z3E(J)3;-'N21VV\$?H)BP
M\)Q(D8C=P&51"@?#]!"?<Q^,MPW6 2"Q^^'9=Y=[!*8NF"(1SC3O%C]VPS&R
M7V$B5I_U[MX+353$'187'/$5>]BUC/HD2&-#''ZZC^R9.UN1Y]I6!0K?6A.R
MJ!1?)4X\CZ)92WK^%-:K!$[V^2"RP:1JAMM+AIHH: QWWW@I]0*?^5"PH2\C
M8&N+Q,P[U.1Q9"7(F>X9JQ\J(>SG940K89]N."(H+L+VYRKNG##8?E,LV:?;
MT467O9A3I$S;]V61U[9E2'S'WU,M;^:6.&P@!"XGQO!$9]!5'AO",T-X9@C/
MX/+RA_#,$)Y!M&<>PC-#>&8(S_QPX9DA!#"$ (80P! "0.5.'2($X&<1E]>D
M)F?9NDKNJM9]2YTRZ\^Y$PYK"!&[+X]QY\EFK=W[&6?U='92EX(WL>"R^8-P
MWIN?[-!V&PA'6AH$[A!\1UX>:<(I*>F2>GGU?CPY%8N/$-EXLBY\_637@8XC
MX4A_ ZV,(1B/; C2M!$NR9_I<YCU[KUPE#0"37%?)N,BN:;JB_ I[1"Z-,=1
M1PF"G3MW<4%K"PRM:6LS;%W@\^L( /(]#B A?,;.V&\7A9W%X;,L/Y$T3TAN
M5&%W\)T## > _P,.^,-Q'_N63E%E12TC+$4J!='^6RCR@O+65=1%A/UZ8CEC
M'$VGG$Y)11WHU\;1X(/@"8)ZPL?"<(Y%VQU MC?&$8OI  GSXS1^V-1CCO8T
M&_MXE:@S@-WFGY+/5VA.UR#K3.P@UK&^8OGZY;L8)SA'^HJE)GD,^.C/GR)Y
M3!F['Q4D?RHS\;&QV$6E-6UU1?NVCU-[3!E?;@0/Z5Y#NM>0[C6D>PWI7@=-
M]_(SSD.NUY#K->1Z1;M;=VRY7C>DK,YJ*NN1UCI76]OF0%D(X:VDA2-$D.BG
MC[X5&N.F%[,*!WR38YD1IE]A5+_CL%4FR3(K]7'%_IE55[+BIZP:/BYH4S9<
MBX&],0Y U-)F?DS$Q66/1.%^;%+>O*76%GG7P@4> T<HW(AB1]Z0@+M!Y0[]
M=]EW5W2]!\&1T.@&+Y Y)/BN:=RAW?:B*&P '#F*;K@"&$."J3-VH3#J(=/0
MV;0&?QI6MW6X,EQV<>YS=#==W#ECY@[#'9>>\RI\@3JR&A? 1^'^O,>4FYD+
M6^(4G,M[%32]+'XC/&-UV:I"DE'M&6;WP3 =< ;@9CC]'$X_A]//'^GT<T+*
MAX;\DE<2G \_T;PJY;^D;?WPXM7K%TOK*OZT7#T3W3-4JI\QG2(&M(!:3ET!
M*%?<E#1Y.66//R7+(9LILO[7BW8VK%%8_?U?HSQ_IO%LRR)LNNCZ5GC,EDJ6
MS)'^0XG[R]V90KP;?\5A54SR8AJ:#R7"\R^W"A%N_!5'>--!A'LT'TJ$?[_Y
MIT*$&W_%$4)T$.$>S8<2X>EGE0@W_HHC6N<@PCV:#R7"VR\G"A%N_!5',,U!
MA'LT'TJ$)[=7"A%N_!7'[5D'$>[1?"@1?CJY48APXZ\X[JTZB'"/YH/YD%]4
M3LW&7W'<_700X1[-!UM.?KU0+2?/?P6(\&.<Y627YH.)<*32PHV_0EQKR-6H
M #+<)1I\'K/:%#77D@UA*D,SB-CB;$GL7,0-/ W%X,RQ%$@QN"[Q].$(+>#\
M_!-4BG^W39CK*=KQ'S -)G(PD2#'8V]J7PBN3J4$\Z=K)N3,.$U/Y5&[YJWF
M+L/\<';1@^N#XK9,D+X6?]S(*PJ$IGEP'+'>0V'L(HO#(K\N="2?L^9R,0R$
MNG9@'*'I@R%ND4,$Y^B:\*_"'Q*DWU&Q^18#AJR&$/D@V6FFR)L@S4*O\\?4
M#3 E\6@H'(ZE?<W$CW$LW<>9:IP8T ]UIAKG6#K:F6H?R1%QCJ5!R1'FM<:T
M_=4W.KK-KH$59E]<(\=WZ4.UD7WW*\U5[K"A%0XK:X? RD($M_3\/W56/2T=
MT>Y^:']AK77&YMV,<'I*%EE%<I?(GKTCQBB>DFJ3,?/O?'1&#L"B(J[GJ@]Q
MC>)E6=9B0]M2IX!;^3L.0PB'R<!4[-QW2@1#3PT7JMFG;H##=X7C8>(*[)J-
MZZJL2)%FQ723"(50+2UQN+5PZ3JQ!Q;SUERZ9H]TTP[K#,EN.QS9F($,BIJY
MN(;ECN1TS!LRQQ.KE7%HC2/Y$XZ8,XNA[8]ABCCVP)$T&MP>6:?-H;8JGUFQ
M/ M87]J2.RJL[]&?,,[9-R',\N3I,YE33;#=U SCQJ05MSP(GS ^;PL"/K"Z
M>N;#95/F.0JF,X N;#!7S..N2KOT:1,@S0W1'"88Y:W!)&Q]CW<O7[]Y]^7N
M[.VK5Z^NLSP7U)ZP(GWSZM5'V7@\^2PMH)!&^7PZ>%FLGJ.\JM*7OY)YEE>B
M&^7S.B6M9S.J/GY\^>'-&WUY_(-^&,?^TX(DBR<9N/[\_/+-N_,OMZ_?J6C]
M94FK(+5=&>G=R]'+J_J[(('5?/K\7QLDOG_W7J\U!_@<CKVQHZX<3!Y=-.1G
MH<RO=Y7Y]:LWXO\]4[ATZDX97[#V;9#/]-L_&?_Z18B;IDT0N]R@\\U;HYH<
MYILX=OK.NG)(H< 5YDU+YZY*OWXCZ'S3@<XW[_0*<ZAOXHA;."K,884"5YBW
M+]\+.E5D_@PF\\/+MR9].= G<01-'-7EH#+IHBU2J]\(M0Y(I]#J#X;UZ%#?
MQ!'I<=:70PJELP/S89?.GP6=/\/I?/WQ%ZL#T_LW<5R&]G-@#B04N,*\$DZT
M<,I_V;6$@LXWKR$^^>NW/^M5I?^OX;CN[:@DAQ('7#U>O_SEC99$T)[MEX^&
MM>< G\-QF=U100XFCRX&Y,V[TU\O]ERI=X+"=\\4CCZ=D)+F=]^RZ@_*<U*D
M*Z+$)N_E+T:;T<,'D-S'=[83O8F@"_"_M%3M+G&2JH^N5+U[98B[]O0))%4%
MG,'O40A=5H97[UX)LN2>9Y>LM\Y*^?/[CZ;5H)=/0."/%S7M50A==J:OI'_[
M7J64[^#^[:O7KTP[T\-\$Z(@\4*EAY5*EZUI0^<;!9T_@^D4OOL;@P4YU#<A
M&A,O5GI8J73Q,%ZW)T9[E/XB=/LM:(/TQK#[.,3W()H2+TQZ.(ET]$,%C7O>
ML23Q@S^)'U[^_,'BDO;Z-8B&Q N,'DH>71S5#Z]>;1\FBD;ONQTD_O+*Z+<>
MXHL0/8D7#SVD3#H=YVJH[!#D__EG@ZX<YHL078D7%CVD3+KL@%YKJ'S?(;YO
MLBN'^2)$5^)%2 \IDRX^BB!OVX]:4@D,\[\U>2C]?@N2<Q8S='H(:73Q3E[O
M1/CWU=>=O _O#8'TGC\%T8MX4=6#"*.+P7C7J.W[3:W] -US_?+.D![4\Z<@
M:A$OVGH0872Q%F^;$^-=\MZ^@I#WT92]W/.G(&H1+\9Z$&%T48OW2JU]"]B
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MY8V($-N\(.[;K,\P2&QP04#VY\.P1^XD+JN(I5$FE\W]4UJ[$B,B^+=VY10
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M!&<L@3&6P!A+8(PE,+Y0K7DL@3&6P.AQDQQ+8(PE,"Y,$,<2&&,)# 1B.);
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M6H.,BR,6ON/=I;,*K6%WE8-I=KBQF+^"(UA_N+W%ED/#;B_Z:DR>-WY0!:V
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MFK.!U=26#K!\"_=JN;'@I;XA#HW6CILVE(#Y*:*=;!02;3L<&J0=-RT(\0B
M;I/*2_ZO(DWJ+'B:STA,TC=Q$&@"(AR[XE#S[%@.HPV,P@N+$G(P^#9RL]5J
MFG/Y]G.<50F?U1,CZ^;A5C4X@4;$H13:81:49/A=*HY919)MM=5I?GRR\$F)
MM)@;LJ9%JKM->0R#(P_(#C1_.N&+[F!@\3;ME*4+K@EGVRS\CY01D9[TSV]O
MHHUFI7D,@Z.VK>7R\J;3VSKU0*-<B,3!(K_C5%Q714E7I,[Z:^XRI*[B,DG>
MQ+^+5IPVQD77Z7< 6/\T%-8], *^P6[?_4F$64P\):?T[O'I"?>>>I/U' H
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M @+B?SB>\? !\1\Y7_G\ZC=@%&^DRUN@#';?1Q[NYES;1FT?%K'MCS;XW9H
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M'J%7V0+R"+=0;=]WVV?P\X5S$)P!D"7;(7&$0_0J0FZL 2LJ1[L@\$(('@,
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M88$0',FI)"$)[&G/E]M-\?9#-_QS]:VQ*9ZCZ_6P15COV&4$,077\ N1V0B
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M]!>&G]TB4\Z_U&K4=M:0@!T[QJ?!'.P6C)7>V,5MPXY=%OQ@]VBYOOE?IVM
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MO.N^(*G\!9NB./D]1Q1Q1);/$?W/SM=6SX_D3S^5V</CAOSTRU3@OU6HJ.:
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M9A3&(O"$[R8$2_=.XP[SJY:<GYVQ=*"3_)-8A##$)(YDBC?VJ$6A ]^.LP%
MNQ#[MA,3V96*L9Y_A1Y\!3C^3YP\B>D$'FXU?!.'+BGTZ')[,RSQCD=0&@6D
M.YW@N%O%PSMU:*_%5:H0W\_VHFP.DT98S^-%4>CWOF6#:?V Y$FVGT3$ESFV
M9]C5C.^7&%0V_61/J,J>R-%>AZ=,+T3:3/BXIC9*;&^!M;)"QP]!7 E]($,<
MLR==M''LDD3F:CYHRE6.SWB\Y!),JK$*%YO/UF'Y4RD2PEIVDPZ6?0'ML[JT
M]%E*#05,Q[ "NCGU<.P15^9#F8^-FDPB%HJQZV"GS:'INJ%O67;HS*=I^\S+
MO%/O\HI?>?N0I[1X$(4EQBK7[O7\2I-X^=&[KV)FG5$BVT4/^=GZ:C4(+>T:
M7^AA(48\=WG;-J2L!)I$)#0G^#TM?BNS_*Z^4/F)5/<4SQ],M<?!]&6'Q&!B
M,;8<R^YVY8- H\56&B@Y=9GK0]BA@.D8;D&WUHF#3=F^;CY&*VZZ=[3.<KXY
MHFRER:G-5F2/*!]R0]BS$C.59B:K3R5<.XA,VS5GO(]WF7'=^&_46*S_7PNM
M/$\?WC%I]#VZOM[U(J2=XP].N.(Z01I&K<1B_PFL*+2"^8AUK36IKH&,ZGQN
M?3IUPZ.=0PZURL2/ T)DJW/U1,I]%92F3*I\HA@!<@+'D=T<K*54WV^UHAG7
MV_+T);HIB"SW1H>>0!Y?7UU *&DG'Z A5HZ%G2ANW=<YMNF'-GOQ[#S3DU>]
M3-*5.UULN1A4\&4&S[5;JVR%CNOZ]HPUMC[J:X5@QD=KFP,U-6?##+[48./4
M:N6.9=J1&_K.C.N\%I^L;DR2^@U!6PFMV06#2;LH 352,?*01V193L5'VPQ<
MUW/<<($]A<8\NTQHV;^[T)IA (RTDP9 ?H4AQ@C)CJ2:O;#C\?WPC.QZFY7)
MAK)=!>&%-#"I4+8AV,@.KEP#Q70K,E*W)U'3C9"'7MVDK3G&NASQ*K]?G[9J
ML&D7X^#WYAT[EFZ8FYUX% :.:5LS>O6FHK(HQO&">'S+\:J2^.3'+X3!IYAI
M)\W _(UQX!!9 :3=GIA';SK6C/=DKS?<;5@7-.HQMC^R4@^"-IB[S W#*EL%
M#/KA^L0<B)=V<@=(RCA!;$DQ*)?J)_(0DV+=C*K&?S\(%'HPM$=4PX6K#R>A
M0/N2K4I) TVYZ@=Q'#HRP_F1L6(A/O*F]*+=H?.=DM&'3!),M&<<H6YA/_7<
M$$OSP8^AB,(Y-F\/>FR" A)'IBS9RIMMML%9?E<NQ.Y]>WI1_$P,_8+2A^QM
MP"AD@*%+2NQ'413.0R %[N\;!9= L$F,$FE!Y&LJ0HP3OJGZD+.)Y8XUO)0Z
M'#?.HU$>F^;UTHXN$0V4J#YZ T))!W,$ZHUU4]<UI>6-)R:D2I!Z"RO!I_2>
ME0:>)3NE_X22^RPGQ?-""K9O3R^-.A-#OZ#TT9LV8!0RP-"5N(DQ,D/9Z?MX
M BDHQ(%%A\!Q4-6-DSDHM4/B28O\UGOKT'<CSS+]%^ B9ZT1(ZO(@R:^&Y"O
M[2,#_8%C5G4P7KQ@?6U4Q$T[>0>=PQ+7">5YL9NCI- -3<N+YCQ11$7QS*/1
MT0,/+'[%(]6W#]N-".C%Y+$@/+B7\?H5?X*7HVY8SOB</3RBK-A?G;@K*%MX
M):<OU,I!V4"[$LBN#AU]>]3/JZ->,@Y\V/>1_>-7WL.SM[2X-&=N:GW%F;V'
MM%,3H!,A,5'JD_:<EU[ _N.'0;B8BNFUD#H=@/8M2<=CNG%1OJYJ&6[H=2/7
M2X/ D=V)E?!XH;7YKW*#JQ.]6H4S1)#Z$*T?(AU&"NA*(<!IE,0M]Y4G*Z7'
M7I11_*U"135L?=]]!H0J(R9W69YSEO(33=$,>#-LN9YG!;)E__1]?Y?CB7M.
M^(9G:)^MU/-\4WH__4.>\-!_\I;4_WM[7]#MW?UM@?(R93NS]XRL<@_(>D47
M=YB-/^ &]1^-JL9M5#O@!E<S(VEQG;SJWE%I8>QF&)IE"*"/@9VS<W0I!8('
ME"+'EJY-]5!RI71 "0^.R-(L$8M^>%X@$GL>=F0W]JXPSL2[]A7Z&G&\X?>H
M69^OZ4.<Y75[ZQFY/<SC@HX[*Q<W4/D=V3W6EV#3IA'^;*.JC^6:N#]T1NZ#
M\[%[IH5EZZ[5-%+!(NVQ@B^E.Z'CQ-($=V^S\I&6:,.3L7PE5580<0U^/9NS
M!R0L1W& ]!),RU!I3C @^I@+9>1T$BI";U>Y8>(XOK0DP_RZH*#MIPK!1H\D
M]"X?: !"TTD<7[84:5F7?2;5NQ\),X-WY&V6L@4:86._MBCJ>RO)<[W#VM1N
M>\+0)9I4VYE&F+.-DCZV8N+^=.^#QG$9ZI9W4Q>EL6QML9J*3>?2R$EED :L
M@0]H1TS*Q\)+S0!;H2PWY?'1RXJ+DI-3PQ>P#H%(357:^EB187"I.J.@-B!(
M_2!T94<J<_%894%Q!,5@*EW<$7"\"O+,6%JA\7 .^I&6Y==ZC5(2+-PX:5;=
M%/S[E7M^  GH]W*+AG&BFWXP]%'PJ3I"YR I-% Z3D+7P[*[H\LKS< 5P4%?
M-OQ<MM@C;,XQ&$8V_.*/$ZT$_#@QL85E.Y6OY(FI/-K<I+K+;8>4GY)ER\AP
M,6LUV2C,.<+Z6+#INT3GU0:H)S5)K 0CW?14Z7Q'JJS#%D9V'*2.Y<@N@8F/
M@1T%GA?Y,]:P8]M)(Z;T=^,);;8BEK?[('^;,](W:?6)L1$[/U%?%PWSID@S
M1#,P;QB6OW H9U&H^^']C0.HL_Z3C[SYZUWK$BE.\\+U[<%$_:!=W *JL.V;
M";(]F0KO&MRBS35]>,CJW+CO:7&5,)"E<#YV!!<O<4=JAX\?/^X BDS4Z "Q
M-]> %C/J2&%//WSZ:,M4':%ST!H<9QE:H1/*R@,MKV9*-[].]>N1/7>/()D\
MP*<3;(L4DTAV:> -+0KZ/<OOKFE9E4TA*[Z$F/]6\JYE9F!8T[N*5KQM+:Q&
MJV2&2%$?3>^'2(<Q NJR\[PD3*39@_?O%IZRKZAB$_9IZ^\VV5T6;PC3V-.'
MYY\ 3YHS"@:.JV-\1EK2 !2*FYS\1@L2CQ#QM .FCR),T0DZ-8&AKJ[$CD+;
ME)VM[]LM/^1L$B)EQ?$L9\7+5T;6-"RT10OZRX4"EIX^I.W!=VZZNS@ I9IO
M6<2*99?E)Z.:4B61(XX9S#+O+7*]>,K)=P,-#=]R$H20;W428X+UD<K:L&GP
MGP2?SSW@Q5\2!\AV9#EHEYV QW3_:!;><L]N1?E%:E(\\#O1U3W9762"3M'_
M[)VB3]<P?A*P172;\\ER'<<*+#OPYC.TWRK6><4$DU(/TOZ%;?D?Y0^L;PM;
M<-'. 8'FF@J(9:9QZ]U/GJC>\MCK%QGHC=*-_^[1_MAQ(;_](8U&_1(;[1H@
M\#;%)S;R9)L[T'7_=S_X_IQ+YWF)"-ZCA!)]V6C)C\J(V<C]KL?MSJ'2G&!
M]"&Q,G(Z"17!]1&(Z\1$YK=>0!?4BHR.=Y(%[!^IZ<K62=V9A&^9AKWA"K9V
MVE2Q+C#4%+ZMQB^DW^H2TT<SAP+NRXG:R0RH8SLPS2BR9!F9YF.D2J8F^E0'
M\D_FL&9[3\\.4YE+OU[?^788!+X?F?,I&Z]9F3,Z\GH91S,NK%+!B6%)V5[:
ME)Y/')O3H_;66TQD1YW6>ND@EY:2B/4Q0@.P2A8$( )!EP#8B^RX=SD\&6<5
M:\HV;8^=YXY>=>A=1WD/T//KTPD&DW;:57#] ^(&7BH[Y?F6W!.\W1RQY;DI
MC[/PZFD'A-NY/917QJX^TO3+)VC/1PA-'[(-1DQ'T0/LSXF\((IDGKL9>3G.
MFAGQLR$R(L"/]QT4XO:<@)9K.8R83CACX<Q6A1JM1=+1Z3#*TN?6UX]N>+1S
MN*#)04(KB4VS(S<D]XQYT9RY(??=-/[[:F 2Q^[1;TF:*/V[1J/=D9[P?#"@
M55U,8GNDO>9;Z+F![X4SUCX]&N/A>>.Z1[DUT5O+$QJ-=%<*P?,Q@<Y>L1<Z
M))2G]&J:_8J^?T)LPLG0IA09Y!9*)'AD\!D$8X_AE5&G&)R<&BT=59"-AN3I
M0TJ51AT:IQS'81+:LEN5,]!,Y08!(]A#T_HKD>YM^\"G3_ **<()BBWI#;%=
M!_]*B]\/*;%6TB0.XC2#W4S*U-I;)1%IJ%#]6,]5"DH J <E\G'JFS+G[2R<
M4U"K<[:!]QNQFS@1:M]O>(X5V+;E#5IG*G3@?99G)=O%\1[@;<^MFA.+EWI^
ME,:M/0@BUS9]MA!?1.OWW;BC%,^G\[MF?N6M %6^[S<::7PO5-HUP#U:K64G
M+O4,ZJT+K2B.+5DZD#V2C[LPB^7FOTD#7BX[ NJMAL2^Q'8^=;6-%73]%Z6.
MC]+.;<88.HQPASV#,S['=H125WK-@);5R5'%X9[L%3^V('E)WFZ+++_[(A(N
M+W"YKJS.#]N.;JVCTB U*@,+6(!$T O>I1LFS G&0Q^55$9.)V$B>#OG6DX@
MKW(VGR9$M2;DY(X7]+A52+JYC^#-]A-"HQ7_/-$*<$)T*T'$EZ8'/JS "S;;
M8/H]9X2W%ISIOO-V7_.&M=!JN3S @M-'0WOP7>SY.H8?ZJ-+D8,LW.D\46;9
M:*4Z,(YMD9ZR<LBM"#\-8A=)D\8=9:"XZ..2225$CI==#[^ >KA&'I<+&0T4
MJ3[Z!4)YF4"ECR30(&V?A"1V9'Z\B1DYS*Z?9#@9:../^^=$)+%PW!KV%@56
M$'BN-6/4VSM4Y.(R%5MS&N4] D>\+:97.X1LB?*-X^N(T^E[='U]ZD5(NX8?
MJC8A3MP RUR1Y^TO&7DHHYIN(8<=\ADF37TIUQ%="&<'=&MBI@B[KLS 3<M$
MA17%)1W!_G#".F5CZ1VZ?9#1>?_>H#)+KG+\-MML^=INO5BX?<<9-$-@>V4(
M=")VN\$W:WC<(-E,)V5]=')L!RYBZ<:P#9R+UXJ(E<H68\NQ?ED]=RS3B:17
MXFM_O!,Y7F#;@;_PI#DTSFZY^;(M6*_SN?7UL1L>[1QSZ/EP$D>>D\AVU_6+
M0]LU0Y>]?5DR;32K,GX^%!\[CG-ZG]6/69<0:2<)H%XIDA(+AS+?I_CH65$4
MF%8X([EX[K4LWXHJL[RN2E8F]3=L,<&OB-65GK2J];U'+&:H ]Z;/=RVTMW#
M?KD^#8<"IEW< :?#3&T[E$8SBH^^Y[BF:T<SYE:XNKLKA"_52(#LU*DP\AX]
M8/1:0SO47[(^:T=@IUU$ Q(8>:83^/*#M1V><P"+9&IMB*PK;]NE,TB4^O 0
M@)$.) :XN)H?N%8H<^5UJ<$BMXBUMY\#+>7+L(E#K-\ BD"O'"'DFY8TD++.
M0,_SSU]559'%6[%-O:4WWW.V:;])OZ!BL12[-99?1'T(=(2&YQ$3^YY[NL&\
MGCA-C<_T"1555AI7OVK!6I@<E0= 'R8/Q$M'T QJ;4/LF,1?E-W#[&X-P_@#
M9_8?7UUPFPHT(BV'P /V="$7D41Z]/]7DMW=5P1?/3'[<4?$)G;^&-%=JP:J
MFS7R+3=:O&>,D5F.BN=:D5EGMU59L34]FW.UT%^IP*""U4<[N^%1.#F@'@P<
MNB0FLB"DJ2BH<F6BG8>7]*M356:Y2% 9BQ,5HNQ\=HF+L1M+2SAR9WKV1-Z)
M0JTWJ1#(S6-=;3O_+!#>I#>-GBRDL3M03?G8O838ZK"I>)^W*[$6BJLBUHE&
M1Q^U'X6>3L9/Z,4&-_11U)*V9A$E4:HV__=M*>H_B!2U3Z2LQ&X^-7BBXR)+
MN+VI]>+5Q5?&-L^JIG+U3N,:2\0'<:=MX)@_.T X3F0']#5,@M=9 .Q:-[Z_
MW)5 IP2'2EP?$P&#28>S")HFCR1VZL0RO_+4G)UEQ< 6"+@)LE!?'@2>$_G$
M3"1"$&?NNW,G40^N.7MZSX90YJ":OVC Z5JHWKT<'4(*RY5(')M:J/%@>4XQ
M)OJHNSIT.@T?H6;!LZ/0\F7Q*4MHA(*I>-.R17AE2)W\X)T##KPPD":V[12$
MW%NHAW%H.:_3WS[(A3K-T+P0&]$#'F(E0-0$Q['99DA,:?&/1=1C4DO1<A #
MOH$0IQY*D.Q\J548:UL$O95^B"1?@ *#U511&2W3,I-@T#)61>5HA3;#5.Z6
M_V2\%R^,[92DLMN"34BL5@OUM^?[$OA278^Y6$&HTPR-/JH\!CR=BIK0$+$D
MM:/(EZ5K[<&PTF(5J" Z+U>5!#O5 +T8-8$M6J<@*=3536R?6*EL5]>!8GV%
MT)WSP^3Y(O@[@*6*9CN,F-ENJ7 Q)1>5UVWC':Q.Y$>)+:^)M,3"36&7>*&+
M4WF4$/)";*,59^F)I3%RUVR9V#==U'K;P@YMU[<<;\[(]K(D5:G;7?T:5<<-
M??D#ZUO3%ERT:U"A066Q93JAU5Y,-(A\V_9,;\;DDX<:DS0UTBQ'>9(Q*_E(
M2U$X5S<:[>'>I.]W8+\T6#O(->1GZU-N$%K:21CH$I+?QG<BV86&TR(_%>,.
M+Z%[JA4+EZ;"I$+91@14I;1XJ"L"HYAN*UYXO$%H("WM($2<BJ.@#X$'H976
MKP+Q#$INAUAND,B._V8BM\*:A*=Y_9YM-B)^YX+%X&A=/XYMQY(%0'1V-<>[
M]A=/MJ'><3UT5BJZ2>3_0O2Y&SM$NR'L Y\:,/Z[:5_!VMD48,RT=CEW<96X
MV^D'-"/2B>E+')=XL>P0Y5@<^[*=-^E.#$PBYT):+B?-J5Q.BHK>=9H+U;11
MTJPT(R0TK;SU- 2JG9!8A''\@RX#(C.*$M2WQIU?%\;6U>U6 7"8H&/9(4&R
M\\=Z+Q$YIA?YIAG.W+>KC6 T7\.SSN6$J2^EOQM/:+,E$)6/>7+@1UJ(4.F2
MW VI+NPB._%"F>><#?/VH8Z8_JTD;/QO[\DUVB3;C8!ZD_Z%X1,?ES.+1YA.
M+I0D!UQ<7D\[9)-:0P6!3"-6?:S?&/!T*EI!K^,&*#$]6[;I68;:*I9@(+_!
M5QF<P YMI]W4^7[HNF%HNS/J[@Q6;EK]W@/\3*HW#-M?!+3SB0\=5LJ=>C[^
M;1KH^P2=H)T\6[?6S.3]NU@R (T5CB/7DF:EK?WKCFF[O%+-4CN.#WE"'\@M
M^J'F/>S=3>S?#_;XM3R_OH[ 8-*NT80>+3.&I#$QH;):<R//(1@5YX]N:8S[
M1*4@7<W)"/9*]?(&? LM<CQ?FL]Q!J(JK+-8F_""F4%H1UX<R"MF\AZ\(2GE
M>3'9.Q=.75RW;]0 #(%@AN3$/;T<+A=]] 4*E*J,-]0MDSANE$@G_^GYI51_
M3) LKDE6#5$=RXY3UXIE^XZF]#O/64=2PC[C8W/ :QLMK$L-H/KZ> .I60=Q
MS3(:5#/HUU!13"!-?310&3F=A$=0'0UB,W$CF8XN0&0%I96R^6A9-K!^F.<Y
M"0D]Z;WR'&V>RZR\25F/OZ)J:;W=M<_7G5Q/.809E+2GF\,%HX\*0H%2E0&'
M+AE=RW1#5Y:M9'J"J7CFCEC&]:=@.,#*$V+BV+;,R5Y[#?C!C.>'[J :T>.V
M]TP$I*SVDQHW$S?5/2F,?;S5;N[C?]K/?3,Y VHT32O,D@HH>R0U$/;U[@%P
ME-"HUZZOF)/VAG8R#IQSU<$XQOTNB!.PJT84U$0G^]6;UNZ(-K$IR_M%D!D>
M-@-C%314QD46\6WY58V9R*RT_SKC,+?(5!CK0[AR=C#60TO#ICXF82";><]Z
MOKASXVR2FL.ST='!H0+11]5@,.GP08;.$FG@>RZ6+7BFIM0$^@2^]82MP(JE
M-1NZI^*%]0:RCIM<DX9(8*0 ]=$S)=1T-&6 6ABY"(?2O,4STU5!)V\FF\Y<
M%+EIVK'9BAS7L0(OG+$PV>D:=.<6$MZ)JT-<Z\<,Q=DFJS*B>$>C=V.U:YD?
M2.ZB?(]:!>ZC!KYE?;4< YYV4@4:>N2PV2^1UBYNP4;*]?9(>_=@U9P?:;Q#
M:A.9HJ2UYZP<K61O!.02E,"I%UFQ)4^H, N!52XQ'_'V^+[ AJEWK=WP+1";
M,APDN\1]*-_98TE6+%H+FF!F+%D[2#+3R5@?Y1W;@8N2M6.X!@XF2E'B2B_*
M+<=Y!:T?2'SPYL['CA-YLI/JY<2!:;+E8:TB(A$L$=;L=H,*D5CI,*N+L&'Z
M\$CSW:T)'G*++VPFTPMA,7D?>(1M0N_R[)]UZ#'*#?9C]OV_ET;9?4W^%5^R
M;[:BU -O.J6;#?W._O4?XI\B60G_)=IL3D%L#O)[U?-H;>./GSH$^B/>',-$
MCKO 4\A+WO S^. F8AL))-U+W!(FV@(5SV^SE#5 6,OE3?[7^RRY_TPO>/)G
M]$3>$))_*>A3AA>O<+X':QRA-6YR0^ U/E.I)G'0!D=M[&#/,(M,*<>9ATF?
M^6:67M'9B0W>/86^E80R4[RRUJE$&NY5#Q^I'C-8WX7JY51FH(Q[KGHQ5[W'
M!CMX'G--VV8JUK-REPCRMYS?.&'"XXF*")_:]M]<,WA9M>(6M9)(\96Q%?CJ
M641@%I/_T;=)C5OO+>W8H9AYI/6Q>K/T2K*5GE@WH#6^D@0'IO2ZVLJ*JY+2
MHN#5)<75KB9@YK6H-YF@HGA^S99EWU&!X6MSV[%1$,GN\(N/H6M;H>D-NZ<[
M<+N=L25EFB6(K7^ODH1N<W$-[0O=9,FT_MNCE@X-[=KI2O TY'?K*_,PN+1K
MM*$AG+$3NV;4EQCCV_;A@:D7^]"%<+VIL#QB(CHP\7'/1)WGNL'"G7JP]%&
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M=HN^L#4J[XR1['O#'C+N67]JEQ+KT<LS->.';A6^O!PS-F%?@49O<FV$7N'
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MQL!]^\9# X#?]A$()F->3Q^'2T4?KD&!4I71AD[7D8_\V)-=9ZN/KDTG,*W
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M-5TYEH=M$]\+L>PF).L>SS-/WI+Z?V_O"[J]NW^S+;.<E"4319SEM<=\/;?
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MJ-\;V*$;A8=ZHS-,K(CG-Z[N46[0O"ZV*Q80/$_<YO"WZCL5?].LQ*A ?\L
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MA$MPE/CUX;D"9CJ2;-#P_"0U R^5[2G:3LRNZ1,I"'[S?%#7V8G>7KNQ9).
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MP'(\%,ZX)3D\A[GB.DP?T^V^M5"L1U6; \+;"M_'"IY":Y=_>7T^ 3"R#@Y
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M:=X_;* TW[UO_/#:",Q\$".T'/F!GUC?B*% 6>?$0FW6=PBRP]:7O:'E^V&
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MYQ%+%5=<Q?(&1!>AY@=U1OR[/)JHLI$.'OE+7>]>$P_4<,*'4ORS>!UU,LU
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M%#T&+VG 3^MERU#0K),(X+H^-':HK0H=7"HWW3"SA=<G58@Y'[H K5>>O*'
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MV;?Z ?_0P7YK.$:!?\QANW,60.^CR-$SH8_A#\3-)N ?=%U''HK4AXG9Z3_
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M9UGJG]*J=4%>:WC^?AL"P4\"0M5N@-)]#R$#5RCT6O[;=#5$O_HX)CC4TTT
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MZ38O?LGX^>&T)]3\64LE%E$IATDT!B[A&(\"CU&<-G\:79P;+OPXU>EC9$-
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M9)W3#XU+^K9/J-?ZXM%S_="W F?&7(X66O7/25J66%V9J1=^64]RJ=.>U"P
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M;C[G!3^++60G8D"#RA$GRP([%0(@ISZT;D7&0#,$I7/D!79LSD2!(9'( P_
MUPXF14X2*@NX;SB$+1;M$)??.C4&'[M_4K_([1"NIR[TH3T()>L]N]"+/1MY
M(;95V8,34VE(6T\UG\"9D8EM^TZ@VNI]Q/G3]9;<%D\T6]Y.Q.@&WA*#B?%G
M,95. ?LJ1!]C@<%D_2<9:BYFX)N6K7K>.36EAM3T;>45>(/D)8$;M2<3AY;%
M3^QFZ,]G'*>EM%_DS5.!LT=:-"+,C=!S;F3R0=]SNDV?=\_37ST]R,'WT=A#
MB#;_)@;^M1P7=&?1[ZO6-[C1$K N]H"?;@4A7Z7:\_T<%P7\B]TY2^T.IR7^
ML0XMRW$GH>7Q5[U%6IY(P#KI XTEV=BCGK('>OG%H6/:R ^<&1-1U;Q4$W)Z
M"JKT#2)<UP=UI%<G7M8YY^#G!$D0)$[KTFLA9#L.\LP9[^/NG[#H4?Q$-YQ0
MK\INQN";:CN@#K54=[.EGCR^D?)-%\WXT/]WO-F5E=&GDPLE-# ]7Q4.DS^Z
MMFN%H3_G+/V=IH]/HK0-_DXSS%<8LLOV=_ =3S]$9N-H'U /?EV._:D:^K0A
M\^&U@$B&4/F$<5^TOH\8B9]U<08<R_()LGU5+*O<;X6!Z5J^Y<V__'!E%5D:
M[231ZNIUAZ/("\N+GS):I!D5YY&SONC&'SC*BPS'Q00E$R2BCPU 546_^G1V
MQ\$<L)RT#K^N<+2O8E-]\_H4GEH@UL4]**<)09ZGC,^6ZX9I^\BV;;3 7G\T
MJ:?)@1HY3:WM8";\VC?/Y8X$JS/"@7,;;&IBW+H#LDU^Y'"#.5^I34;DS:!6
M,7.P^6M7NY>)O_K-L_I<(M9%0""Q$X2)3UL]M.7:#O(=9\9=AQ#Z)_K\LF&O
MDK#U9E<4?=R*ZAI$27RA'"W2$ 3^ _QJI_BY!*^:<@%<H>XQ7[,^MT>A9UV$
M@SIHT\:V%;4>Y?CNQ7)"UW+G(W(SEWI?L71_+,6OU:70U+G4==7).L!1#70Y
MF1KRP?69U1,OZYIS<)8,MAP_O-S[4="X1O5E5W G?8RMWE0OWK*T#!SN29A(
M;*=<G/Z<UE,MD^E7'[:.Q-_Z:&< RZ"A2FQ1%&-5UO<E&)^EPZ=9T[/GFG&>
M5AB/=@_Y@M3O5-+42G\[A@ 3 V@/?8@(30Z@HELWU<$L!B0/_,:^XZQ(<^.7
MC.U>CKD/+P9MD\1R80\O9UH%A^1>=R]Z8/$CTW2(\C%#&1)#IN?XCM>K?^&0
M-)#FU%V550V2LLR'K##WCN;E T3R'IQQ&(11$D:ML8S #IV02]<K*#?]3($S
MP\PH=JQ8E3-?!N2=T#(#W^]UB3- G#N<BS3F['L:5P_015 FIT6QH;V8AZR8
MVJ'9>GEH(]<U^23.F+>CEN41IWSIW##YS ]G:9YN'PWA\IM27IW=6FU2'*4;
M\2#BG;S%[B0J9,D5Z.Y+<.*A\/66_"*0?97 KDM<7SBL^P.J8X_UM48D;X%5
MA_%Y1EA_69Y+,-;%SPM+[G^ R&<^!EP)W44A<=O?[:+0<VUDVC/>0(_91Y\O
M2*MLIP<4GQK\K>O;\)3"L$ZRK6NX<\EYMG7K$!,4BF-Q2@MZAT7?=H'A_OJW
M3[?_>[UY3/DNHC5+N\_'UB==+[3'5V[("4PW=/KZ1A1YOF\KHW#R1\<-?8_/
MXIP=Q+=X\RKJE<LN=3%[IG(?5-U,# LBS-AUJD(K>I@)K'REJR+P'>$&^(?6
MYV /K*R+*- PL&T%/O94&:&'6[FJ ?.V2+<[2FY?:)DYE'-@G$I"5:_S1\(.
ME[MU?_$*C\'V@(P_"K%41WP"_ZD'7WLI<>PDZ,/B8;#9>.(!:6]1O@= 2%D^
M=6;:#^U"?LYV<&9KX 4T\=HS6_D&W3=]U[06,U]:X'23BSIU926[;<XV*1$1
M'D,^+"VO$?EOQN*%4+)A?TX:SFY.<0GE@3T\\:/3 8=XFO2%CWN_A],5SY[D
M"S4SV^%RL$YR08/3$8IPY"B?\3=@GL%9WCH'D%F[M:E+C2-F0$]J@Q K%J,>
M7 .2G-A>Z"E?+\[(\3&>>T_A [7!FZZFX&Y@^0FQ52_DKLD_=M4KT"\L^XU/
M*Q]3)H6)"-;'<B%,MX^'!5EF1SQP$!\$AOFK!AP EE68V?8GJ1>9;U@&B^,]
MS./MJ4!J#-NDJBL,C%36#/K7Q^8GDX3-PDQH_#1"%C:5MW0KF,J0J@A#[07\
M"!Q1SZ?*JLZUZRP5(CN YC?;O[/LGWRHC_@E+?"FSDRMM+1]E!KDQ^_-CE!R
ML]W_??UEFOBACX>]<:G#4CS1#>?/4D#NKJ6$C=1I5@M3:3^MQ!2?.OS;P<TO
MZLU6G"V]N*./#]5!"6QU* -+-X6B#IFC.GCK(\N<I3W6<T[@/ 2$@@0I4ZKW
M4]2X/[V._[7C?RBSG;;D4[HO6'*;?-CQWZ+BPG6]=> H80$WP$HEDP-<L9>/
M]H#G=.4CM3?CQ&CH9*>2Z-1C3DMA<,]2SXFPI7IWLZ)MC?-E PT,G+86FY9%
ME4^5CE8,=6!ZY?UG^Z7,K/M$B"ZFT*>&[J(W=-5.:@"7H&60(N);D;T6FR?8
MM;10&E[0#^$D2E2-[ILA]?*F=Q_=NZ>/XC]RJ*5-NAF\KK(!#H&^O %L#JL>
MHI*I5*N1=8^"SZ:C%]3*XRBB2+F#7HCCPU+.@40'1[2QB6++56525 D<C:/;
M;[0H%;*P?==(CDY66UK4*IC>J,&RC]&;/L;;'S(;QQ%HPH-I.C2(5!68YV3G
MP!<3'10%'^Q-0E 0JV+"W^AWRA=TF0^-Q:/;7Q@CN?@Q?V"'^$GEHO(%"JM+
M/-4K UP^KGX4F*[D'^75<B/*47FGT96Q>NIAO";U,=.AP-D4#(*:+'$")XQ5
M"\K\#!Y@N/<#J7H<,0UH0$EKJE+HN9YCA^&,M91JI>G4V:O&U-+22_7/Z]N8
M$A7KFDQHTK3M13@DJIZ+\D?;<@/+:B1CSTD2G9K%U*C:T_&5OZ /53I2[,\F
M%>I%$4KBQ%&1Y7<<QR(^MU 1_7JXR4KF'^._** ^T]V"BP&F!1QY\IW$;@V\
M[)YIU8AUJ08*U:!UU_+)NB8HA '*K \=.M$Q\*R!:[,GON<JVT-]9-D+RY;K
MJ+0?;T(^'$EP64:=6* &QB!S ]TY!#0QDT05D!Z]& S8,==C@F^'/(1-&ZD.
M\1-YM8&1M(9K X?+;&2')%#F;(TVPT%B5(.")\,)B!U;*@$."1LR9"%>8;>]
M)9G=Q]P>4BHDF+^(T@8=3ZC&>J >LH_3G#Z>:PAH-I8IT,I7EAD&MK)PR+PL
M+5B!-_U,<$JJ'NL@(3ZEJA6_#G/^J**.JYEI"<3@Q\#]R]OY;!0J]0B%Z6.=
MO1&S4=2 'DL#0DQ'M1&9@Y)A2<DM?13W70_]5\?)Z'FT&TM<C+"K>H1YES%1
ME(3;?WM^P#).Z;?#Y=@4&0$>]BUJ!JT/_I$?N"&RG6#68B@O&8W3\AJ_FDXM
MXE=-8!7[%7KJ^*WUO4T7.-8YSU#'X?J6E[2W&_"LP'(]=\YN ]?/3-3=TX\_
M36#M_.GXK?7YTP6.=4TS-"<3H20,J:H?Y,WS"TXS$8<5?E=<,64YWMPFIW\?
ML\=MFHM[XM)+WV;B[^??(>UAR.ILQKNL0B@+EQS_XWLCV\,4U\<O$BB?-_FO
M6G!UG+8GGSY]+& B.=@,I 9W.4)V0"Q5&]_*I.7%K6CQ%6$^9E5"]"'#VQR7
MA8?^GA9/5>DG.K]I5:BJ! 2!ZR<);%]$NVA ,_[DV.I2:=VQJ\6,:9!:IYH>
M?4QG''PV'46AX5B/)G%@J@X 2QG*D 2E?^W2XK6R$'XP$$#WW>SV18FI_*W+
M+3R.]!$1+Z&JL\'-MN 0TFA#97U&\3Y"I'S\F6XV"]U5'!"4;3K+!P^/%0B]
M[L$O:FN(AO4Q<SA4-HP]X.)UOL?M5Q4!GX.O TSUC+3@D&$44--+6D(3_-1?
MO(I:C:+0JG '+\(M+2E8#:)LG%M6+J8U$+"["4/LQ9;*WWQ)MWC+C[&;<OK*
MW1(E"_F:_>BUJTFK\?5R,YU*ZJM4?=P+#";K3Q3H$=4V,0Z5U1RFIN4 RSOE
M)KS@C1G%8:"ZNVW&C)KG?^Y<QAU?%FQ3<I#@RL#-^)#P3.ED1W?=RI'./G5K
MT$4?5[2<J&P=4P1WYB21&ZAR&'7T'8-JZ)T[D'^K'$ANL.W_!=[%Q9@Z,;Y<
M9*RLDR]+YM]N/Z7Y"Y.:$@65=EDFVKM(7[]X9;&J#<4[V93B/1==7#])<,)S
MRCI*)3[ 8K1<%'Z(:J>:(GU\USCXRHICPV@*S12AQ$)NH*I%N)2Q#' <$L:1
M81RJR>"&-3&YDV@_,_TWWVN<G!7_.SG9ZOUWX[O/;4^TB0 ?O6S73ASJJ3IO
M'2O[+/BUI!.2/DC&@XVC>+".?N9<40-TJZOWZ$"J=!0760/.'@NPG<2JS*D9
M:#H\%ENV9CJ)Q@)NIH]D1:;E84]U,WJ0E8M:%NN2FZ7O:5X5JY%UN@X>L.ZF
MDRYP>7-BKF6=K>KD5 %L\5N; \KIRI#VU]#$"M?1AD=(<6;?HRD([ID:($14
M>28+F\.@UI!5A='IK>$HIL,W3$19W^K8.Y8Q(UHFT8G^7(L?),JM#*TSV=Z)
M=G=]6M0MM8J?::J_;G6T_VZ@RB7\$F>@D0,:(C>^O,^<@J)##)46QF&;W7/%
M1IY%/8Q589%CX3[1.*-\<\*EJ_Y[L_W._XUERR[0I2V2"HWQ+JWPO!<.*CU
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MT/;Q-I$3(=[UXNWK/E[YB48%5\HRJ\]+!<R(7HWL $W6+FJ :[QC(AS>Q7(
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M6;(]GK8M'4GNO7/VPPV0!"5.EP@-R9*M^?47 %EO$H "6421VCUQIM4M"GB
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M0'&2(C^7W?"=2$4&++!MXLZ-:E1-D1:/W;-+]F%;:AW7-64[BL:\<@(,DSC
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M'TPO;P4NJI:&J80S##PW5>[-F!?D^6X ;;Y=_7_IDB?W&4O(;7-*$<M^/;V
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M63RL'NRS;2&Z_K3I^6O;\2#N'6CK+3#QT!"HCC^F:Q\*T@RDZI<\($9>&,#
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MR/-#3_8D\\1*->3=&'W"S.EF'L3Z5*LB[_#C8X6+6N3 >*%7IOL]2%+D2A.
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M!U*U(.K+_/:>O*>XRB[SBZ(B*9OF%]5YK$?9[ )L;XIR =%IU:'FNM7<$T?
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M/&-TB5*M3/XG*,@7P]J91[4]1$78U@O#)%<>Y<41@I&+^M5#F4I#EF;%5-^
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M=J)KA80#CFZ_D::+1&6JMT\]04[^@J\H5WP5[2+2#ZRB>X;*!RE.$W7HG@\
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MP-D_5]W9Z2F(*MR/Q;;/@=Q4-?,VZ*A$3W54,74\71 &7JP,]@E@!"%D+<^
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ME?=GR\;&TND]U)PXR@6_/]RATS2?G=2/73$<"I:[*^%)ZN.N6')7^!MP+NA
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M3Q[;,J5L.%6Z 14-[MU5C*F<7'755?;7Q#%WQZRG&&M%++=]3!.,LBXKWVE
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M;<T=*10/J7;]&DX_]3WYW1,0S]\RG,^YOJIVSZ8_PKP;O3&?O[;8QG#0((R
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M[H[2WXD9-@>SOWGZ*GFXS"X:#FR"IH_H<7K CC408427=: UHSS4^T& B("
MD&"ZS!%GWE(E/:I0NOWI2!FDC?/_I:)[F6U_HGF//**7&<#Q".:%"2G6K@R(
M ,9-K@P((QJYU/P&0O 4&4U>KL"P%">'^OGA@&CV5'@&&=M#'",2 :0OLQ@1
MBG$$X(2)=,Z>>4C6UJ'DR2OXHDH,=9I$.SN>>Q<-!]<U P-3\-AV.'.@VH]#
M&(%E>VG&(<RB3%_G,:(A"IP6IWK?C=*'(I<_?5#N8??U$^<X1W;7G%^UM,YK
M4IISNF_3Z:'6FV-A6GM;G= 'L9^%^M=(&@!,$769&MX:4Z-:9LP3?=@AT+KQ
MCX$LD[WY.09LY56&"/*)-OPE\$F 24@"QQ:<ZJXK"F^]E#.\>*ISRN^":\1G
MJX;<9?'[AMC>3!N>KGHVG1Y6O3D6QL6W?<1 &4D1UKK<$;DH\GAU6<OI2J4=
MK92VC6HVGG1J.]]H%GI9=.C3Z2%RD$-A6CE;2S&((8:^]@P+@B#R48BP0X^:
M+_R6.8-$V[D%) Y].CTD#G(HC$MGBXDDE'_-#*\'2ET* '6H+/<ST7K_E+WR
MJES6"+8N:[OC)TE4%:#JM'4-[V5ZG!W#O# BQ=;8!4*20*R-NE3^YIA C!PZ
M6UAE61V&N^E2K=I"UJKMO(!JQ[(PHLA60H8T2X"OMW^!@$ (P,G#(F>!P:Z%
M,-T&.SZ;'EE&[H1QK6U!A&&<IMH7)0IP1"*7(2.'+*AN#:.]#9_SP88EG\*P
MFK9F@(BF(=8_.T8$84"1[U [/VQGST3QG16I^C?/;Y>J_-R=[(%[!5OQS8NY
M8SB]KYEX7_/PKF'A6G+07K7[(ZY'GW,'99^A"!/ +($;0\;34%LU,PBE8A@
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MTQ=5Q&&786NL+J=7W48;B3!AZ8"<_2''&$11Z),@[!M:0GD<AV1;U?W%[2H
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M2-X?I*+G.[]>_E1E_OEYZYJ:>%>%2-?)RJ7*7UNX%>4MW8:LI>(_L(>9(&T
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M)=;2LH:37</YH,F27V%<=5LUFE# J-XY/@H@"I6FY0Y-NYYE#7[>%SR/U_)
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M?EXL>A\,MH_[5-Y48]]02%S^)Y+[R7EJ_%,@:YL]WAI.MDVFQY UI\*XOK;
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MGJ601A0#ER'SS]77GZ[8-Y5C<OGS-A+L-U:H'+>N*C\U!!MR#3%+S=:F\7S
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MA;M7)_JV];SY=*'1KEP[!89SBX)C IKQ-Y_8X!+F]-B/+8_"&7C O3"2W?D
M46R&L$5=:7B9AFE;_ED.<)<)?B[S[Q5BL#6*+-).O;(>/)VD%/<NKB1JO!B%
M@=\9: ULW0>V[RMT%37'-9SEX>,A?<CS(HD+\H,JW+P=20X\4N^M!T%RY.*^
MY9:VNO4@@EYW+J4#@.GYMGL.N_NN9%:+#RC3_@EIS>)#'B2[:""DCCB,(Q,:
MAJ@*%N?0<XD"ILZW,W#X)2E@%M H+/)_"Y3LDH=SB,V)8>5D:/A'UB-0(VC'
MO1B1+:P8>3"$PH1L]J/K6+JK.];YI>L+2HF*H45VM6]/W]&N&"M?;N3[AN5W
M'MP-H+O \TS74L=CS1JM&%PSO/G$6?V0_9F@1R9>FUJ=,,XOIZD6(PAT SF=
MRM,U#=]Q+%^AW?:16JLIX5B[@P^[Y _MU^3/)U3L4)8P'P9=]5\NM.N\@&EP
MF$^SU./R89M16?0!&;,:L5.MC/S"\CIE+.&X#QG2,?:^'YO=NS79JVG,KL*M
M[/\FA$BL?<KP8=_X/CYFR=,.O?S]"E*6R4^S 8V/QX8K1RO'JH>ZHTU\7CIQ
M-NX#R\-L)-VX#PZR-XI1#'4D;/Q;JG1@VJ;OZ@H=)K\ESS L8 _$+C0^ ;-!
MK1QR',R&O[P\Q$;0C'MA(.N0LSP_!D:W']<"GFDXIGZ."Z%O=^3\2HP!YO]1
M%.I0#?;MKAGJ=+C#@+>6Q](08G'O6DMGFON!Z4:=80^6Z_NF91D*S<XKG-%,
M&UB%R=S!5/L""X0OM*O-?#<!Y2ATC#L:^DD&N-ITWP)(/+X\7*2HQ'W+*1O
M9R ]1MUMB3W;='3;]Q46)+C"Q"I\>AV]5V*&JMLLB1[0A?9E3LS0(04A;/5P
M7_H0-/3E->!I,,VX#P6RZ/+#./:$];39C[Y#4*O[ED(E]!4^)[2\'_7<<_[K
ML)F+&F/9+@]@)*V6CO2L[X2QXW;>3M 4&I<8F@H/N;=HGR4_7O(W(D2TR!YG
MY<[] >:%]BL]F:&,[-[_&.[),&+3=&!WG(IO>#;9KER5U\L[F/V6D .D]@5%
ME,EJ#3>[),?:;PGZS\R[2S5@.1X=C8W%ANK;9P:]N (-,8Q>W+OPTA5V0QU
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MF[WAV*[A^4"A3YT%8-#S<)4[-'G3J+Y8I="(MHG.9Y9?\F[2<._2R*:.Q1%
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M'WE3AJ=V::LONM$B@Y[3 DK(4?VIAI;)EZ92'(^>JO78=0/IQ1, (7N/X>L
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M=LA>J+.<G'+#_SDD&8KN\26ZHH6M=SL4G6=?Y 1HL*2 YE\&2 LK(J0W1R=
M1@Q$0=IB5C_BK.245<'Y#>X.:!F.:=N%L$7*154W.V&MO:1GP I@"(2E=>X*
M'/YQB_:$H$>8HYL,/V3P:7,H'G&6_(FBS1/-/@1#V/<Y^REZH%4Z[H?/0IU_
M2_5#N4*\?:^6U91JF&RB#[SFU"$E@JC!\IG@\$+8_8.\"B.6G4L^+CU3M"=3
M##H3? S7,73;5&E(Z;_8?]$^?+O57%O7GI+=CG)(M)Q'OFB8=$[JKL:S)7N0
M,<F(9, O?#PZ'!UM&U=C=6> #'UW>>4ZG&3<!P'9T(+0,(P@Z.R]"#Q@ ==S
M+879@^ 7T^U&EZFK01<;53#AIBZ#K^%OKP!A(XC&O5B0O94RD.4CH[L>%B @
M=#W?5E@;$/SB=D/,4P4Q5S3;GAS AKV["G@-)!GW8J '7#*S_PGNG@\Y.;0<
M]IVSW/G,\K/93=K1K/FV!8#KRAC:<D63R4JE_9/6^<SRD]9-VO&DN:9O D>J
M8)34H?\',8D?4/^T=3^T_+SUT/:J]9P)+,,PA[8^ ;9KN#H0]>3B=TJV[QG
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M5<VCJTD["E$8B(*,UV)%3#:WVI;#-)O+"9!MQ.(6IO0 O8V[4N6V,3%:<9C
M N6;-/H'3M+B-T+<@75\915E6<O7;S03@Z=;?$&$U(A,=_%[LMM=TFR[>D[O
M\4V&XZ389M1_\!71-KWPAW)USIBDT,/=R9ODK[!FE?5;^@]E5GLNN:U*)I>-
M90\LAZA,$7IB+/-(U^^$:=II-VNQ3<_(>\8X/4G3T-<+%F--2T/!'ZO8*=:
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M* Q4>M_C)YFQW.&1_Z/E\N@I="C[RO)"*4TI[EM;V0,%LD'H0Y'LL!]=UP4
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MUZ/!1);]F/>7E[9Q9.->/$C7EX]L!+HK:9,/DW.4IZOL.KB)HBJ(&+<ZKU'
MU5EK$4L$@>D,IE,]W#UN&H5=IW4J3W15C20\.PY]>07P&DXS[H6 ?/-:=4>N
MU\?V,FCW0QRCL-C&=4,$<L)'R4/ZX0=O07!+<[5:IN%1GRU:=)7\8Q,6R?.I
M1F1G&5<"._6AWK1 %,2B@M]G(5FYO7<M\(9420>(L=(TFF"-6F+.CH9*?K2,
M,G1Q= __JE]>R94&:[9.;=B*1?>\:,/+X476 K2<P/1MT8E_K2@?XR)GOKWP
M12MHFV&^[9<8E[8@K0# R!(6<.J8J6U 6Q 2=EDJ&?GO%;=@MW&[@<PV8T?+
M*CGB9]$0N&*NS FE/Y46.E4;1TV=R!/<QQK43,ZH-9;>(54O\WH MQX+;.D)
MZ%?L9Q9\V823.(2Q;HM.)NO@8]TY7L %P LL48I#9Q(;/8$^I$E.X]NV<2LE
M[CW9)-4WXNM+$65N"$X;#:>A!4T:\C3:0&P5.G?<U,ZV1NO1>!/IQS,B53:0
M)/)L9(:B#/2S"<P(==$K-?+&HA>[D25RK)9ZD"7>\_L-%J7"2TP1]?@>Q8A8
MJ]$]_,'_LJP2J<EE$\'-N#(W):E(UJ*29EH/I/KKG/I%Z'::=R*5K]1Z5(DB
MOO 9\"UKZOC 0Y:I?E'/HY+&RJ!TJ7,8Q*$3BDR;>NB64;<6A=0^0?X<ULS@
MV9QC15:H> :3_EJWC$2C;#DAW3<LX)]='B:7T:FK^A,UT:[C']<R$Z%@@,M+
M![0BK\B*$=\&7Z>,^PRAUIP4Y]8079?%[/ZKI.](813KU!83YGC>%5N/!IF#
M"3PW@J4+?D#'1K&H"NV9I&FR?ID<AF&8KATB4U2=JZM06U6![3W17'>(:+3S
M^+Z[BR6VBQ]>,(6JY35=DSN5#YJ%R=.X'LD>2?>)ZH-2X)$-@'<B/8I=4<$>
MY=@=<VB 2:8]P]T!'05^TPWN&+)M/,O'O%N.8P)/>,12/AO/* OPT/G8/,.$
M#+5#[V*<O6-9@^-E]^R73"P<-VB%X][3FTQZ08;3 3=$4I\9$"1AZ:$3>+$H
M:70,!>?" H\'>\>CR:F.)S"5*C*YS+66W*KUWTD-F7?9V '# 3$2G0[.M/8C
MM&+GRE]4L9@)NRZ258-A8(6VL&')F>9@OAM]EF'Q[BC#@L=+E,15,R1MZT'7
ML8$IT@TMGJ_P.6+;6P.259\A>/TU!Q),KL?6ZJ0,2RV/=")Q:/F&+[(0/L$D
MW:;ODRIV<AO7\>3",$KE^* $,=.H)HE58:Z(4A4Y.W0>9IC*]:!P-.5X%A#)
MGMIM7;=L7]2^]0PH'K'#O86R=(2#[^FN'8M*G=##Q&_T+-%*QB*L'QGRO-Z4
M>O^_[+EFMK[*\LQ/FKGU2.8(FO%$G$BG"OHNL$-14+92B*H\?TNG,#F1!P*A
MK2GFG=NZ*Q+0TL(^FXB*)V#B_*U=3$]0W2NH4HB1=9>Y08B (PK_40S7687U
M#6:E=],X<-P(=18.LTU#MTVKN5V;7Q*;MB:\XSUOY(-RPAO_=X;8_4*D'5*"
M4NWZX^V=YL\FE*^'IYU5FL%OR[&_T:'IR'ZG>$[[T/*".I%^W(<:V;1$8$$C
MZBPV#X#GDK.:H;"XVRVQ1MGIB4F^UJ[-,A_@^!"O=4L/L&1>6 . I.C$?2LJ
M&_M@>VZ ')%7CW_7]FU+=X"EL%+F5V'H H]I:OQT=>;EY&-X4^JYB0YC@_$M
MJ<GQ%!W A[^\/)Y&T(Q[,2![F X<Z(5"EQ#[T;,]P_*-)DW_W-B*R49X%F1]
M) .-Q%7'JRM&51?%N&_I9>OV$V451<(^9QRK'M"I&E29;_\^R<,=S@^\;6S<
MV)+,AUCSW2KXD*1YD1WX;R.4)P\IVQIAT7Z[3K7K[MLXJK&/TE+LY41LX]K(
MIVZQ>@ZJ6@S7S02\K_G?D T-TK>C35&_7N4B=5PJ]S<>6IJ:Y85R#9. >^51
M4M 1M&!LB/RP[$?#LAW7=%V%[3D6%/."!B[\KY7Q>\K].@3\B)3_E=)]/ .X
M3P2E:Q  ! .A4Y>;!JYE&;;A*[0*%Q3MW:C"__]5\OVYOS'!XN3\KY3SM[.
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M.Z*BK]/PEPOM*_JN_0MG?Y"?_C4?6$H*6@2TQR?#T\')T'3DK__J!M.4[ZP
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M[S9(9LMB/FB00\(WCBHU5Q5#2*P&J*BDX1^4S#,2KB'LH[5-%<*(%^%)7?6
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MFR=LUPX,KGGBR(&,:7F$>;YAYDWJ2)[?1]*@0-BZ'-JA&7&MR_< 8Q*FKW$
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M."!ZRH#371YT2ZI:-03^ \N#JX4NU+6IHCTC31 $EMZ:Z*;9KJ>:IFZM6CW
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MNTZ!T9]\CH@8"C'AXJ):X/#3EN<"^F@Q< KMPIVV-,\U J[;JVLMRH AVB@
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M-"@9)4)T<KH.5,CO)W54A9#AZ40KP;++T#TFDGBA27+=CFS'/(<W3>TC8"K
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M"-*)NG946'6Q'#<T>8IPT9(D)(<OOA*2?Y"8+RRV"-?,T!N:#<\.2V(:H#_
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M79/D.RW>1;JG09X4A^5"YV<\7)VJW_ X* _6=[I:5#2;H\!IX_Z'TUN'W._
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M3&@X3,KD"QJ>L80&6;08<6E#5^836J#6V>N 'FN1&79N%6J3T[QF8ON1G,+
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MF[[< -0S9#J"!:\RKX4Y+<SS#[NKH1CGFV.,=7[\]EV]LK3_-5_N\0+5I"M
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M/](#GTQZ&%D[ M\YKKNC\]4YWD/$)@76WV*!\Z#X\TF^>"#!=S'64*IB1&*
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MCPMMK'F@\89FYS^"X@&Y,S860J!Q0'>[U]G<KL:!71[V9;_V 'S+.T5]L01
M<U_J>0 6?N468;44PK?[5'CK;,R"LF9:((:NB3V6A"^W-$%CY39X14OI1NP5
MYH(RH.+WW*F6E3&[)N*:UGTOH9&T2I:?O:-9GFQ"$9L57B5$N[3Q=\6<BK8-
M$- "[\V#66Z*\%MY'@@>2,(;'8!QOHA]5@;I-/I[,_]03BR>8XU\M38V?=3
MJYZLT@O&.K[7QN.,Q3F+)_**M)BAY<_""YW3I/0&:H(QFCU]2<4>3"9)$08
MC+]VR\43\64QUI4>M\.X+\H.D'%S8U]D:2 4KL>KXSQ*O4G:VG1LP8LQ%Z'9
M'*R]^^%'9!RUUZ"-OM,BH)5>QL/Q6!8DGA 6I]F7A*?I[A70JG5#OW?KI?B[
M2C P"DZB@7.\J916XAT=YW&8KA&HT@QU2^1V L_27L:FQ91A/+S/2))YJ 00
MC"RX<QWD7)BE(B(NVY>"/8\]..!Z<;]&5ZZ>)@!9S/_I380(>+P8)#F)RKR^
MY1'02"SH939!\;OE."K/!'4[][\HFJUH&!8[MYOF_90GF0!W5OWL<X6. 'OT
MO\Z9+<70 LRM-BQU."WR3=F8R<34QM5"U;K_C]997AZ:P3)(+!%?H.$=7Y!(
MCF1Y-4I#EEJ=^U]OS:IH$=AYX2ZM;B\M!UWO+=4T[/_K=;;4 (*3)YM]^4P[
MI:M'VE>+DVJ[;^K3_[IXUC=\&&3H!?\\?F0)CV5*,(G6 ZY?XT'MNWK\ZI$F
M#]QS06H YC@@OT2^]#5@.SZX#_;:U1[.;$W,3,)C,JRS?L3\"Q?3)2XK9LNG
M^);O6Y=.YA6=D.B:R!5G$\]1"-X^\?8OD_=&0]H"U^WZLL6X##,63T ^D)2&
MRZ=!1PF)4U+&(061XPJMPY+ 7A_?0]TR@Q!_"E><\4W$!\2_4A8N#_J6X[X5
MMD[-*8M./^R5[CT4,P(W ]G.9JRX5';!DSLZSY-@*C1J^+1\YK52K+ N.(F^
M\S?=48]QMPOV-FNK$CD5LE0UP\EO+P,\S3#Y(^T;'H\KJA4V"+^A%TX7,%&>
MU@I3MZ$+(-2\B/(Y2HKPZ@%TRW$^\\R(]J0.$+=E.7N[:_<]T>'M(=.AU?51
MQG!H^HR)FC1[=4M?&-JY\]OP8'9-.U\2JILPYV!>7*_'52?_M;*!-.]_XHU:
M:EP7"K0/7/V)])H_%G574G4F(J*WITM%\R)AOCSXE2"+D5WUDN/38K-3&N**
MR])QIV6]TN'X/G](6<A(LF@6OR&EUI>HKK+I#?3$"H2.D\+"L"A4LG4$"BDO
M ^_5_U1! P71QLFM,OA2=$HG1[ 'RX3=NE/MB?];G*?%L^'EV.1]@P2D"'H=
M6\\M[(%*8!!SJQR6"Y0YJS/FU?.:!AKD0:VPSGPKLWP!1!IBNW>\4)S;<DU0
MDJRK-JS5SY=;X/:"S]K,5PFHNX";WH!7!R*0R"@^%\Z3<H,MU/4!1< Z*(KV
M4Q=70JG\SUE<"1WK]-(N+=+EQ(Z_0:*L>X"V3#4)(F_.>%3>W+YMBH+0<8:%
M'X6[NC..<#9"6X5C#@7*#@7*#@7*?"Y0UF5BC;H^D;7DF=W/ !-EFKI9*/^A
M^MSYC[GP)23MQ4A <2((?M<<L8I$_S,2M&3%;:#ER309_9R3Y5DEI4I,5/,$
MT?OGG")HH- !C=V/;!*'GAFI*NEB2?3_,!LC8C.TT'(>/M(DS.GR.45ARMR5
M%>8W&M<H9RR)_:IL Y6S&5IH.5?5GI17($_%^&FTN.8Q$U*@X:D<5L( B[<E
MBOM5! >J!5;!L[;(GU'A]LF7D^3]_*W09@#1!W-B^U4(![OP8W'SQ! VJB[9
M;L'M%^>1UT3,K1]UYZ[0+KXD(RO&JWL-I;J7+S$8G2%7^)C-LG0<.5L=!E^L
M;D9>QC)>7!B!35=KFOKX$@('"V3WA!S&H,<2K ^"PGOY,A/A4H&(T;\@]N[F
M5BL[=<->B*LZ6@UAS/%D(TFRD&'XPJ,:!$$^RPN/ZHP*9 63!:XS6?0C+?\=
MAY>S.6%)\29T'!:V^ Z5FE6VY4_YDM"AO3AW@HM/:E:_B"N:>;,,M"VN2K7P
M;^6H8*-6KHUM_11N]:(.9,;Q);SZ1>A*D4FGTPT?>W*[WNKSZ'CM+!/D("\.
MJ5MV=6VVXQ(J=:+C&J"8IZ[*MU!X_I )D6V^4I\EK-'-%[L&LC;J\^57X.W-
M(?+F$XN'R-LA\M8;&1XB;X?(FR>"/$3>_(^\^>JA>1 1ZYN'UN^*-]XF?T$]
MO#VH<>-+61-O4X.@NM"70B8_^[F+#X?BAW.7P[E+_\Y=W(:#$9<!VJZBZ#0H
MW$O_8,\>)-=C^7 LT+-C 0=SS^\R<[Z_:="P]O:OL)R?%4A]+$&)T8>>52#=
MERJ#.E<_?%8?#ZH,2C<CR(;C,R:?6"RBT@#!@SLA#76/"O6@Y*J)C^,M(O@K
M%Z,JZE$L-? D3P5OPN7DLP=Y(PFX:Q@10JK*I[U8"6Q Y]BW][J6TVL/8G:'
M,DZ',DZ',DX_8QDG1R$XC4G:VG1LX;#$7(1]F8.Z)P7U:[ 1(:3@W[L(U]G@
MU*^\7INO& YB$BU2E@['SZN1U.7C@MH?DG$[WL,0R;@:@G2<34+2["RG]P+'
MO,YAJ&WCBR8^&V#]B4E]*U\TK1YI#N3!BP/G>KNUZN]>@E]CB]:/'QT1K%LJ
M7L0N /O$RWB'+S8D:#UL6#QKN/-"Y0]7[G3DUI_4"A]OJE@W]+5FY^&:BH^;
MU^&:RN&:BN:#+9^<+B,-3H5;;;LB8I<<34D\C.DUC[/I( YO>+;^]4@,H/Q#
MO2)JTS!+M6LC_E-I[7([[/DCX#\H24!2W#0T$]6'%M83J*AJ>?!$'O?L1ZDT
M.^H$EA.(@)G\6BA, I,?AC=/Y+JU'.P,?LU4LVS!1,SD^\Z5?+'\N97QCB86
MXZR597-CI(GVL5.10=GPZ4K/SW=S[/CH@UM7^7!M['!MK*UK8[VZ3-)"2/EG
MJ#'U#G<6O;=GOIX$#MN-^WK"Y"$Z>HB.^BBN0Q$?9!&?*E;3%:\I#8XF_/%5
M4#Z!4K*Z_NF7DJOC7Y:FQNKW_QY$T>;1E#,^(RRN.JZN;V7A:;PEZ;)FBV+9
M4C3K?P$4%<0<"L#A)-T3:?I7O'9[1'5O*/U&$L;S=.<5I88U#4?,%R?$L$ZG
M"?-:9WVM,H[DPEX^07=Q7'MLMU>XSG1/_W9_5C%GMW[;__45L%N^X+<K^,^_
MW57 O_7;KHKQ.(7_!;]=P?_/VS\JX-_Z;?\+)P+@?\%O5_"?WE3!O_5;)/P>
M%4*!F.J[_'8%_Y>3VPKXMWZ+A-^C @, ^%_PVYGV?[VHTO[-;UNO_N(#_"_X
M[0K^NV\G%?!O_1:I_1]Z!?\+?KN"_^3NJ@+^K=]BX>_7XO^"X:[P'WRK,ORW
M?HO$'UXRQ ?X7_#;V>(_J()_Z[?(Q;]?VO^"7]V@Y)BD#\6XTB23R']Z1:,L
ME3])Y#]M(2]^M0Z*UAWI;?W9-#_7XV"$@DVW8:;J@?%F;?+P,/_]\\$972SO
M53C6BS.VG_Y*>IMQ9R\D_")LVN53*%Z'V-N)-2L.8U^<0ET(KD[%$&BTN.8Q
M$\#2\%3F;25,YX0/1,;'[=GP$$^#[TXEM[S$=2U^N74/P9(\U<1]J6G=E90A
M:'0K^W591-%#XAO:DGLMX9^Z]G$;4#HRD&\3)C:K.8F^)#R?KU]=$@,>Q.$@
M3;G,M99LS.8D?K'"^94%>\\F,1NS@,399;PN/WL9/^,*9GMB2/EH>4/X./\Q
MCT@L![VP@$H%M?Z?DAJK1H7U9P1F3U:+447>TV'-0*\9-?=,$#(9"2F<"/+?
M*WBR0_ PZ3<W7^SAV9-YOPRS]7WB0Z)TVG3Z:B8X6P7=A'FZW.:]"^V!F*\^
MIM'MVE?95T;W<,R[E?5YG+%LD8YX1J(+GFP/M?8"![B/+]+5%@Q',>IXUD)$
MY[^LX)AS&$O^')- U!!Z=H*BY8OQ<4-F=/N1[PI>ZYKXHJ;FLN 01MTJ[]KP
MOXU(($:Y>IFG078ZW7P\(S*2IS[SCB_[%2'JQ7!\&8MV<UZ^"3%,[J@8K'Q_
MK4'8J/X^GAD92=T !==3G,]E'14QV/'P*:9).F7SRSBC0@;9%O/5\URSKR]%
MP"Q.=A0"_HC\-YZQ>'++GVCRE4:AAL !/7VIZ=>*N,'\H\^"[Z>"JULB:,:G
M9,Z$/5QET-<VPM_/\13])E;1Z<$A965FL/C';E*P^-6_K^B$1*5?4A/VJ&G1
MUVVN,KJAY-&?R\!H_BQY5ZUI80E];6F/JC_[XBS5J0YO&CIZ[7Q^9+$^F;B6
MI2(9B<3GAN-!FM(L'2;W)!(JP4=3EH2W\C2D,A'.$D5?ZA3;]W=LX(+?*WG
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M>RDH87RKD6QLBT.S8S\.R$45HG4<.#OQ6SW1)^P><G<4'5WE/P0K/$\F.D&
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M>JZ!M;H#$F:GQ8!:0KC<.0KBT8PJ\NG4#9&(.JGVH^;!;'.\H6$Y(P"Z"NN
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M%R26:8H&>HC%+!B^N_9=6 /DF*GYY5LJ=D&%K/^;T8<&D: ;#&Z9UBEZ3>&
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M9%9(S5A)@?H!QX?Y>NFK@QZ>=Q;)%">UG[[FY_Z73YKA6PV[2T)&"?]:W@D
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M62R-_-QV2V%1\OPYJ"'P=TA)\L,;)7>7PN*BZXZ2=?![I&3=AXWHIIN()77
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MD](!2B3DW6QQ?^=B ]20PI9+8'$)V!,9!"@6.C]M<F_W%[Q(30EMN0:69@4
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M23;UY5+W,Y9;Y)#C>-.FP^+ZA.<Y7XYGY?Z4*->,0H5YA4'>N/W NC5?-1%
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MR\$FE=FQ#2.Q*"=ZK',+6,)RV:D,L:>/X]D97[*(Q;JT9>W(_NL83=3B%G@
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M<1,XP-,L816Q-JN):/R1>F\^ *:PY%OG2I9]"H0Z^+Q1=9L LQE8M %+DG
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MRV<.OW+9N_J&?Y?:0SS=.J(U!+&;B.5H>'*I08#'0^?Q]T0HKPNVNDR$%BL
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M\^FC6D&K_1U+)YQFY/!&*,"8DRYA8>A>T233\*-F%!;A;XS%1EC N/P44_I
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MMGW 4I8)=I*LMX8]F8\B@0JF>".ST^]"1>,'A)Y;8Z'8 4;#2DX%P./[O K
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M>#P_].]XFF&B)8K*A%HNF/3QIDC%'9P]7;_6%&U<"4C1]_V3N(:HZ$G8[8]
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M4:!DGZH)D'.('N+4<4Y/=5BF7;"R9 L3WS2M^G\;UK'.2#A81?N#Y45Y*2Y
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M@14V2((/[][L+\T2[=!%5K>"3%N2T_X&LS^_-=DBC1T<[-5HO/XG[W6P+7E
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MY'(GD.036]<*$\+(Q,NL(F:0U'.0<+S!*,"X,(R\;8Q"4RZN P]N;2(U;+L
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MH8?NC#-N>KCW.BFLS#QS\.7ZEHJKE;C+W9-$/*>N<3\;V\)1Q')Q5F#,G
M,^,YH@G[CUIT)3_WWRN@AUQ-,QCE419K'K61_-JZ13XPQDJ2P1!?LGS)^"FB
M#KU3M(#;Q?L!M99L/#$')SK B8W0UDQS:EQ$&%QFI_) Z 2OH .O5EUI4^[;
M5[7"HM$XHL8L"0N[5O9\T%NOI-ZY?]*L%ZJ_DC]FRL"2?Y]FI"@9)4JI5[3H
MQ<ZB1%1+%!C,JFKOFEG5GV5F(%6;_A_&,%88  ELWMN;G(&9Y^F]AO&Q#P[*
M3X>3'/R3&,@<_).#?[(W_!O\DX-_<O!/=LRWL_=/#HXM1$P8'%NX?"DM8M69
M1^0FCRB?2Z%ZN%KZ>R_,+=(EKB&G.81*B5.TP")T<E".$?-;^J*Z]HK$^CR-
MU1N;KADZ]!2E+HPD@$&\2-ER'N6+*":K,HVC3 VDJ2F60]L IAT9</<P5^=N
MJ7BQ+'W1!$/HFF'9&@U FDEHXKX2&=B/+"^G7 MF^D(4TF884Z3LSA<S5=YP
M-96*4#3$LFUJD5*@V>)B?V99_=Q:K6.=OD&O7/_&GE@1M]D9+(D;PA>TOI30
MNU*GX0L8<^%1!1HV=KNWF_MN_M#FD4)U[7_P&/V/:6R+NUK X-%ZU:CBN0(^
M;LH25>EJ33.@LM;JLP%VVZ*9*F^XJH,AM0VQJ Y:I!1HVNH)X:B0*T"/[/%_
MKAM.OH6;L?7D_5[FCL?;OV?(OV7KU%=][QC\PR_*67/T3=2/F/[C<.JX0CVV
M[\6.IP?E<J__6J7EVQZ)5Z1(9U34"!@5]R02O9-1N>T^F>=L-9NK7HZW"2 )
M,16,82D=X6 9[!)H-E@.0@Q02"YUX=8*GIM_1QC8VA-"30?+%M81_3)O6[=?
M/B^#1#"Q90&9%W83T],).##D=_@V/X/%ZQ7\3 QW-C<PX_9'M#7YZ6U^"(OV
MV>H29MTA"39'W*4%7Q[UK)Y)O,I3[0MM-LW/E;>*<O'6B(!Y],!HYL8FRQY8
M8E2ZX903*/#8M>WA1&N_0S7)K4UK5!2DE(8%NO3#PC@4I_*)GFL-()C)GZ.4
MWK&B<.2Q2[=WK  J6>R.7^ P<]3/_;7J+PQY5Q@>#42GBV%^-+";$D:H4L!M
M@874-%+N-[^>ZW[3OAT(+-O5)PJ+_43?L/]%W!TEW@:.L$>&D!LF7E$LQM-:
MYE211MJ&0-WAT[FN91NT NL*U:S4BH'DYZX<*ED;*]? $68B&P.W1F69I]]6
MI9"X"1M_IWQS&4]E#\*?<-*^*Q9=3\H*UH0F\/%7;_>;_6"4_'NUWDR4H%OV
MZ+^+TID3# #0'N,Z+0VTNVWL/]A2;?A'>[EML)A4O/8/+<4W+8. +'M[B ?<
M_^I=&GU+L\H&.I[R'Y:LB++/_-!<7F914? )B9-5// G2C%$67UD3CAF%_Q;
M?QIH\C1Z_PO&0A@M<7MZQ1.\I>[/J+:XM2 ZS0<&ZK6_GIW4^(+2B\ \D%+8
M<$>E4.HR4I=N>UZFE$VG3@+B/A#<2'IF @&%SN..,:))NT>/[\^<5_'.QKN)
M;V!#J8F&)^X^PE3%H83D4$)R*"$YE) <2DC"!L#"V:&$Y+&/:"@AB8)C0PE)
M1$P82D@.;Z/U[FVTBU4AQBR^T+14["*J)ACC$NUV$CU%7K!45PM4-L*R(2C1
MD:#G51;'-&89FZD]VO(&&'%3:!2:^</+2!P4;537=] TPZ(3F!$T4P$/U^^L
M6B^*:HI#M5X<U7K'RWDYC[*%8>=3MT*'G>HV9:  GA1%5CDKXI306"UXZD98
M-C\#?B8"P/ ]D6*9YH)XM?@IVV#1 8V%HK7S!V-W&>6)*/991M]8EL;J2F2Z
M=EC.$ .&%C2 <;PN1-Q16LQ)8KX3FAMCJ29J0-26$/A->[%8T6K#_9TL.1;B
M3R.:7!&N0Y7Z \>U*SPNO%/(863!=?- ];I15,8=ZG5CK-?=GAUT/4,1$_!,
M\I<T5B8U&EIBV4O (J\G#!V73*M'W1;9 E+BKF:/U^W^<T;("XD_9RG_?R6J
MFE:(\92?IT9:X"KAZ[^CA/R3_X^NU*J@LA&68],:21,I87<-S,\ _(IAYQ^>
M <#D4QN> 1B> 7#G;CO/ $S8\L</FV- DVVF;(5,*3"\<6,DI(FALAQ/S7<^
M;3LLUEX[,"U(@=LNF2#U[55MM)0V  'XP7^)&6O%2D<&&+R[E=@A4DUY/&D#
M('C>ZV58@Z<C [XC1E6ROGHOE/T.A,Y[>0)KZ#14@)&K7@HK!)GJ,C7*-D $
M?PN&H($2N%D\BW+-TI7]#+R8A,-.3008MJ^LS%.B*5,@;P"$[E.X$T-'!WS3
MRZ,7MLRY/%>Y4>K-3]<.A.6G@&)H04T#OS_+HTQL$JGPZJB?MM$W!&'Z6\ S
MV8:<!HL\*\4T+Z,RFF;10K/8=0V!H(8[K6W(:6#+)!FC]?\_1F4\UQ@TM2V!
ML(9;_U;TP*\P@5[8^V5X84\^!YR&B^&%/;?)G\T+>Y\)F^71<BYBA9_(K$IM
MEV\1AI88Z^K:[1)6A/D$6.WV-+7%LEV8(%,CZU5XOSPKH3S^"8M1TPP)TQ'0
MT#(\F9,_6)ZI3RM=,RR!K-80FHF!K^HT(_1-;9^3_@ZT+OT23#754 %7]&G)
M"2W5O@EY ZAM,YR)1$<'&+W1-*4I1^ K*U??4K7\:=M!K9SAL+0@ITF@Y"**
MR^B)O+ L2M3Y$?J&4%##&4ELZ&G@P. LRZ+\GOS)65>H+:+ZAE!40_HTS/3
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MC0'C(R8;3T/2 P=EJ1[ _"=+:?F5_SL'1!BB=NF!LM@L^"@P_F.R S4F'F[
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MH6 &W*R$0>-QM39P3=@SR3*->F#5'@8^)KN" YGP(Z3FZ_8CLA-#T00&,*:
M#SUE8$PW=I_KUW@N++72W%-5&QBJF (S#*0%#DZ.UA%8)'^><_JE\BYO N,,
MIGNYGC(O1N-JW,MHF9;B==$)H1R%\70J+SKOT@^&/J;K-H!<>+1?5,RK\?A'
MQWG"YY:_J>3=V!96Y0#3[=J21"]PCZZ>#2#OM8!!B^D"K"4,#.C#2M0=&T\/
MF*4$UZ(U#&A,MUEK(L&@'^3R2F"6_@X#%M/-4T.6]R.QWNE),BHG<W+]NDSK
M"^UXRO\*.RP=1X2Q"].5U"L08 97T8\/I%3F,<D;P.#'="G5T156M;]:.S<G
MT>NFE,U;-4N9K<W4%L8H3)=;2Q)#!PN5_(J8;FL1;8.*-95]K/O >(CL*NU"
MJ@<+MG"DUX8FK87ZM!D,;$RW8S-U\" 0X0PR'ES34C"7B( O\M>J<OOQ)9S2
M&>^9LL1"26CU.S .8[J!=P!/NQIC ]%H97Q8-3Q,EH$688%;$XYK<XKJ#RV(
M1*O?@8D&*LM&^_ T,#CE^1O_R";88$[JTXLD&K>9?2<8\S!92UQI;6RI>LQ9
MLHI%P+:HL3ME6<HF[((\LTSF_G'H!>,%)@.+,['A8P3IJ@H5J1,QA+*MBA!4
M-X3Q#9.EQ8:^!M&!K"IW_T!*,;BJ(I"L"0Q93$84/65AQ;^Z8UZP/&??Q1.!
M*M/6:0L86S"93+2$!39NI2]<%Z%)\1B][3_V<7@[ES:!\>4\JN/J,0G+4NT:
M\[6\,!E8<*ZL6QKG)"K(%:G_>TN/A68RS]EJ-K^LHEENZ5Y\HBCC)]Y(J(QS
MZSI]')XZV:L*V1I_IWQ52*V8W7T6)CJ_G<4.T#W.8<5YZYK9*^<ONX!HFL&J
MXF.RZIBI"\ND&TX!C=,H6Y?AT):O,3>&,0R3K<66QM!*F##A$!J3"U)^)X1N
MK QUO93Q]'AKJ1[/.6QRL*=L-Q-%0D#[GX.)#B9+3W<H-7"OM3?%![E_NYLO
MPJ0'\'IGADJGZ!1=?U*WI]GL:S&[Z ":; _.RJ@M4MH.V]J(FL?/P.0+DPVM
M?73@%KA->MPVR><^>DT7J\4Z+4+^&I]E'QCG,!F#'$EM[$"X7BPS]D:JQ[?J
MHB[)'VDYYQ*PMIMO\D<U[@3G,6!LPA0BTY!T,-MV+V]I[3BZ9C#P,5ETS-1Y
MB8<X+*=3^6 +37:F:U<8'S %ML H;J!9[ ZCG;)S02+A]ZZ_.&'"?<ZR5#P4
ME=PP4>.ZHD&J030?#O8"'":;A3\4 F?8Y6RY>66V-H_-T^7N7:5M.3-9AH%S
M7QC;,5D^@"3#(T=67)=9\/$>5WD\CPI^/*8Q&27_7BE+1MAV@3$#DRW!C5(P
M#Y[(LM8AQ].*TS%;+"/Z=A%E$;\HR$,-K'K DB1_^!D- YSHE.&OJKHM:,3B
MR[CFUXKR[8H+6DJ/ 1@52T(_9^R;R OE^RS?&\1>?T^$ENM)_+A.?$^2-!9L
MN:P!/AQ_/Z+8U!96!/V'7_O!#DORX;<(&W;O7R?LQ4/%DA .[HNWAVA!1J^I
MWM5]V@RFFG>_H4T.@@M._-TJPK $(-3S4TJ=OB%P!_!^ZFOA5K#$ZV+>#?[E
M^<H"S)-6P..[=22/9GF"I8(0#T!>?WFR /*D%2Q5)3R0"D(:F'C7-XN36/:-
M1:#ZH1!%MG@CX8\0GHIB+HP(+U$FS)Q?EIP>6JZMGE*;<%L? :Z''\^GTFW;
MV.Y)UO_]^PFJ?%I_KG^4_K8>Z@ BREXB/N?B!ZZZ_WTCD#7,.Q0.'CO=>]_T
MBI11FAT=DN2U%/D3R?\!O43 9UN5RI\HHB;E#=Q4*)613$KCZ%M1O3(F-X19
M=<%RXEK/EYFQ#JL*K?UM--D+&%*]P2O78H$C8&&E@C7, W'X./O 2L7L-1<O
M^#!8> SEHD8(W"# )PD^Q*#W,F#-1/?= )\46+VSKN0_H#=FSCNQ'4Q[$S^C
M5+\X49<M=*A3%1M4O[_KD]>1G :&R*J^R/3@>ZK#0:W!-AD&RT*QAYSY(CJ\
MQY;DY=MC%M&2;Q#B[KA47?9-;>%<1! 1VHB3S FAL"S7E%?R4D7IQS-B*+S6
MTGNJFX4EJ-L'QULHN]5)V3ME,4)E&[BA'(OWU@>_#?"$Y6]=<)'1>)4+' P%
M)Q7M8!F@9[2D+= )O:._\'FQ7)ZN*?D5Z!H_LZ6K! ;!HKVL98U+W?0PO5&U
M>HT=8!%VY\9S%ZS"BL'QAC/.K8PH$OEH.!)(<#Z=F^!X 1%L8MFSNS6VLS0>
M"XOUR]G8XHER-#J[ODR#OF%7MI;V5G5S;JJK78-4 E6MLI>T$($:(YH<:9)Z
M_CGV[,K6T@.&@I##J?3I1<2A5U>&F1Z(AS-J845C;UJW-,Y6"4E$(2*8+MA\
ML/Z;?;P)DB\P T72/:<SRJ<61[1.<.84BCUS'4CW(RR2KE7ONWT<_:%7UR'^
M'DG^@VG2^DA IZZ(?*=N\V9@_H;=T/?6G3!!U>F!? ?95A\H%'&";AW[PE=I
M[ *$U+!<K5/!BNJ="+[+[R:J# BR[(&%CXXL80 BX2$H6<RH.O+N]-?^7W]M
M@64&#(*'U+EE-S@<=*=V(#R&*_<=$4@M>$EM*TE=D9S$C*_]_T@KIFC;8=F[
MFE<#55,7>@%U6]P;8#%Z(?DWABT["G-U[Z%6*-C\A%36>E!F5%9!:,*DM83D
M9[%[?RRIMI[K+EE1#>;4Y6JQROB\7DAMPHS?*N--5MN#&)</4;+K+<Y(LJY.
M7HIR#PNR#1:7L,_?H/!H(20\]0T%F-%[-CGQJ*1LU:F:]#^^!_Y.HQ:2!OOC
M4(89:5@0RF,95(JY/8WRDM$RI2LQ<9H(P.J_DV2\7-<%4-D<'7L"+WPXBNZ
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M9L8-J=$X_7\?SKM4 #%L10XNHSQ_X[>I*IY%%-78TU(OYU$^(XW$ SI\_V_
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M/.0BU)DAQ7BZ2PUY(-]%=@B?"$VB/-&980"]L1SPD*D?QV5:LZAYG*O/))4
MV0(V2*%/]FCXF/E!R0\/#],C8J^B:*X'(D-S7/8<^@$CU0_3A^=/4PXP,Y%A
M^:-_D'[_K02+E^LQ\$L*-+.G(2P[;FF<"W7MBJS_NR(3=CF/Z$R\QC&*JX S
MKI0^,BZ)0I>[9/R"5Y?O$^714I8_$O[_R76>,TV\9ZO?P9*DH!>&#B# $'G"
M]87KZ93/>SQ5$J<4$^@06+:#=GG,?(#4I_WFB?RU2G.27+P)+=_7[J(=%8LD
M@9D,VFTL( %?B-QF4E<Y\,1IV6!8#@N?# +Q7 U.KW(\.T\VQ)WCN:X;HS8
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M%1-1BN.&Y;(I*Q>H<U\LQZZ1,:P1@> [RB2/:!$3FMR3)(VC[);&2O"-;;&
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M:@< $               @ $Y"08 ;G9S+3(P,3DQ,C,Q+GAS9%!+ 0(4 Q0
M   ( %I&/5 W-6_@+!H  -NQ 0 4              "  4.2!@!N=G,M,C Q
M.3$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( %I&/5"S,[EALQ<! #V\%  4
M          "  :&L!@!N=G,M,C Q.3$R,S%?9&5F+GAM;%!+ 0(4 Q0    (
M %I&/5 [^EL#3F(" *A/&@ 4              "  8;$!P!N=G,M,C Q.3$R
M,S%?;&%B+GAM;%!+ 0(4 Q0    ( %I&/5![)\J+)48! "?.&  4
M      "  08G"@!N=G,M,C Q.3$R,S%?<')E+GAM;%!+!08     !@ & (0!
(  !=;0L    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839084800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated statements of cash flows<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract', window );"><strong>Disclosure of details to the consolidated statements of cash flows [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory', window );">Details to the consolidated statements of cash flows</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;"> <b>23. Details to the consolidated statements of cash flows</b> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.1) Reversal of non-cash items and other adjustments from continuing operations</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation, amortization and impairments on:</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;547</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;783</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;460</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;974</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;428</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;276</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 227</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-cash change in provisions and other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 895</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 86</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gains on disposal and other adjustments on property, plant and equipment; intangible assets; <br></br>financial assets; and other non-current assets, net </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &#x2013;&#x2005;1&nbsp;234 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &#x2013;&#x2005;902 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &#x2013;&#x2005;1&nbsp;077 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-settled compensation expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 673</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;659</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;6&nbsp;438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;108</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;295</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;603</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net financial expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 746</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 708</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;486</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Includes fair value adjustments </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> 2018 includes a reversal of a pre-tax gain (USD 5.8 billion) recognized from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). The net cash proceed of USD 13.0 billion from the divestment was included in the consolidated statements of cash flows in the line "Acquisitions and divestments of interests in associated companies, net." </div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.2) Total amount of taxes paid </font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the total amount of taxes paid was USD&nbsp;2.0 billion (2018: USD&nbsp;1.8 billion, 2017: USD&nbsp;1.6 billion), of which USD&nbsp;1.9 billion (2018: USD&nbsp;1.5 billion, 2017: USD&nbsp;1.5 billion) was included within "Net cash flows from operating activities from continuing operations", USD&nbsp;38 million (2018: USD&nbsp;164 million, 2017: USD&nbsp;124 million) was included within "Net cash flows from operating activities from discontinued operations," and USD&nbsp;79 million (2018: nil, 2017: nil) was included within "Net cash flows used in investing activities from discontinued operations." In 2018, USD&nbsp;139 million (2019: nil, 2017: nil) was included within "Net cash flows used in investing activities from continuing operations." </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.3) Cash flows from changes in working capital and other operating items included in the net cash flows from operating activities from continuing operations </font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">(Increase) in inventories</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;382</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;387</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;203</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">(Increase) in trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;544</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;655</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in trade payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 553</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 252</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 316</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;303</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 941</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;410</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other adjustments, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 199</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 576</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 332</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.4) Cash flows arising from acquisitions and divestments of interests in associated companies </font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, acquisitions and divestments of interests in associated companies included USD 12&#xa0;855 million net of taxes (USD 12&#xa0;994 million before taxes) from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.5) Cash flows arising from acquisitions and divestments of businesses, net</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary of the cash flow impact of acquisitions and divestments. The most significant transactions are described in Note 2. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets recognized as a result of business combinations</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;4&nbsp;124</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;13&nbsp;660</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;874</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value of previously held equity interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Receivables and payables contingent consideration, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 242</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 151</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments, deferred consideration and other adjustments, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;36</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows used for acquisitions of businesses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;3&nbsp;851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;13&nbsp;701</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;759</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows from divestments of businesses, net <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 91</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows used for acquisitions and divestments of businesses, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;3&nbsp;760</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;13&nbsp;683</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;714</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> In 2019, the USD 91 million included USD 4 million net cash outflows from previous years divestments and USD 95 million net cash inflows from business divestments in 2019. The net identifiable assets of the 2019 divested businesses amounted to USD 196 million, comprised of non-current asset of USD 159 million, current assets of USD 96 million including USD 11 million cash and cash equivalents, non-current liabilities USD 18 million and current liabilities of USD 41 million. <br></br>In 2018, USD 18 million represented the net cash inflows from previous years divestments. <br></br>In 2017, the USD 45 million net cash inflows related to the net identifiable assets from a 2017 divestment. The 2017 divested business amounted to USD 48 million, comprised of non-current assets of USD 29 million, current assets of USD 34 million and current liabilities of USD 15 million. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Notes 2 and 24 provide further information regarding acquisitions and divestments of businesses. All acquisitions were for cash. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">23.6) Reconciliation of liabilities arising from financing activities</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Non-current <br></br> financial <br></br> debts </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> financial <br></br> debts and <br></br> derivative <br></br> financial <br></br> instruments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Non-current <br></br> lease liabilities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Current lease <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;470</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;678</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 16 Leases continuing operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;471</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 268</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 16 Leases discontinued operations <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and lease liabilities related to discontinued operations <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;3&nbsp;195</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;582</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments of lease liabilities, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;273</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest payments for amounts included in lease liabilities <br></br>classified as cash flows from operating activities </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &#x2013;&#x2005;51 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">New leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 362</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 131</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations and divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification from non-current to current, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;156</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;703</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 246</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Lease liabilties recognized on January 1, 2019, the date of implementation of IFRS 16 Leases. Note 10 provides additional disclosure. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> In 2018, financial debts included USD 89 million for previously reported finance lease obligations of the Alcon business that have been reclassified on January 1, 2019, to lease liabilities, with the adoption of IFRS 16 Leases. Note 30 provides additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Represents the financial debts and lease liabilities at January 1, 2019, related to the Alcon business reported as discontinued operations. See Notes 1, 2 and 30. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Non-current <br></br> financial <br></br> debts </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> financial <br></br> debts and <br></br> derivative <br></br> financial <br></br> instruments </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;224</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;308</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;856</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;366</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;681</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;462</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;93</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3&nbsp;190</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;678</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 1 687 million. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Non-current <br></br> financial <br></br> debts </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> financial <br></br> debts and <br></br> derivative <br></br> financial <br></br> instruments </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2017</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;897</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;905</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;187</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;755</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;140</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 744</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 359</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;224</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;308</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 644 million. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For net cash flows used in investing activities from discontinued operations, see Note 30. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashFlowStatementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section Presentation of a statement of cash flows<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS07_g10-17_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashFlowStatementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838617232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PropertyPlantAndEquipmentTableTextBlock', window );">Property, plant and equipment [table text block]</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of property, plant and equipment during 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Land </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Buildings </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Construction <br></br> in progress </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Machinery <br></br> and other <br></br> equipment </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 696</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;135</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;155</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;028</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;615</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;655</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;678</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;009</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to right-of-use assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;127</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;23</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 630</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;474</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;551</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;774</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;463</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;350</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;674</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;999</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Accumulated depreciation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;924</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;18&nbsp;332</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 562</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;541</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;118</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to right-of-use assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on disposals and derecognitions <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;674</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;846</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge <sup style="white-space: nowrap">&nbsp;7</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;447</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;345</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;8</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;51</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;205</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;43</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;726</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;14&nbsp;930</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 492</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;339</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;290</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;948</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;069</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Commitments for purchases of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 220</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Capitalized borrowing costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Represents the cost of assets and accumulated depreciation at January 1, 2019 related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Reclassification to right-of-use assets at January 1, 2019, upon adoption of IFRS 16 Leases. Refer to Notes 1 and 10 for additional disclosure. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Note 2 provides additional disclosures related to disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Reclassifications between various asset categories due to completion of plant and other equipment under construction </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Additions in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 23 million. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;6&nbsp;</sup> Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;7&nbsp;</sup> No depreciation charge in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 was recorded. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;8&nbsp;</sup> Impairments in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 2 million. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of property, plant and equipment during 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Land </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Buildings </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Construction <br></br> in progress </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Machinery <br></br> and other <br></br> equipment </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 720</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;064</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;368</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;858</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;010</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;309</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 538</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 931</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 407</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;774</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;212</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;457</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;504</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;887</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 696</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;042</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;155</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;028</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Accumulated depreciation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;485</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;17&nbsp;546</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 56</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 101</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 161</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;574</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;140</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;717</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on disposals and derecognitions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 412</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 595</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;324</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 115</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 361</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 479</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;43</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;924</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;18&nbsp;332</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 653</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;807</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;005</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;231</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;696</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value of property, plant and equipment under finance lease contracts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Commitments for purchases of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 289</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Capitalized borrowing costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 2 provides additional disclosures related to disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Reclassifications between various asset categories due to completion of plant and other equipment under construction </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Additions in the disposal group held for sale were USD 21 million. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Depreciation charge in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 15 million. For depreciation charge related to discontinued operations, refer to Note 30. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838594928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries', window );">Current trade receivables from closely monitored countries</a></td>
<td class="nump">$ 1,588<span></span>
</td>
<td class="nump">$ 1,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear', window );">Current trade receivables from closely monitored countries past due more than one year</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded', window );">Current trade receivables from closely monitored countries past due more than one year, provisions recorded</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionMatrixLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionMatrixLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentTradeReceivablesFromCloselyMonitoredCountries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesPastDueMoreThanOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentTradeReceivablesFromCloselyMonitoredCountriesProvisionsRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836933792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SignificantAccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock', window );">Respective Useful Lives of property, plant and equipment</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Useful life</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20 to 40 years</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and other equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7 to 20 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Furniture and vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 10 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Computer hardware</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock', window );">Respective Useful Lives of Available-for-Use Intangible Assets</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Useful life </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement location <br></br> for amortization and <br></br> impairment charges </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 20 years</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketing know-how</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Technologies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10 to 20 years <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold" <br></br> or "Research <br></br> and development" </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other (including <br></br>computer software) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> In the respective <br></br> functional expense </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon brand name</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Not amortized, <br></br> indefinite useful life </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Other expense" <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RespectiveUsefulLivesOfAvailableforUseIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RespectiveUsefulLivesOfPropertyPlantAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839124832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest expense and other financial income and expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract', window );"><strong>Disclosure of Interest Expense and Other Financial Income and Expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestExpenseTableTextBlock', window );">Interest expense</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;714</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;877</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;741</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense on lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;66</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense arising from discounting long-term liabilities and capitalized borrowing costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;55</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total interest expense from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;850</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;932</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;750</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherFinancialIncomeAndExpenseTableTextBlock', window );">Other financial income and expense</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 245</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency result, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other financial income and expense from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherFinancialIncomeAndExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherFinancialIncomeAndExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6851273504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">$ 8,301<span></span>
</td>
<td class="nump">$ 8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">8,301<span></span>
</td>
<td class="nump">8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Gross carrying amount [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">8,396<span></span>
</td>
<td class="nump">8,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Provision for doubtful receivable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="num">$ (95)<span></span>
</td>
<td class="num">$ (126)<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
<td class="num">$ (162)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionMatrixLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionMatrixLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=nvs_ProvisionForDoubtfulReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=nvs_ProvisionForDoubtfulReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845394224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Expense relating to short-term leases for which recognition exemption has been used</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Expense relating to leases of low-value assets for which recognition exemption has been used</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Cash outflow</a></td>
<td class="nump">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOutflowsForShortTermAndLowValueLeases', window );">Cash outflows for short term and low value leases</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOutflowsForPaymentsOfLeasesInterest', window );">Cash outflows for payments of leases interest</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of lease liability</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">$ 537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WeightedAverageInterestRateLeaseLiabilities', window );">Weighted average interest rate lease liabilities</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseIncentives', window );">Lease incentives</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember', window );">Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashOutflowsForPaymentsOfLeasesInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashOutflowsForPaymentsOfLeasesInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashOutflowsForShortTermAndLowValueLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashOutflowsForShortTermAndLowValueLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LeaseIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LeaseIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WeightedAverageInterestRateLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WeightedAverageInterestRateLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846802368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in consolidated statements of comprehensive income (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Associated companies' movements in comprehensive income</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="num">$ (37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Deferred tax on above items</a></td>
<td class="num">(289)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI', window );">Impact of new tax law income tax relating to available-for-sale financia investments previously recognized through OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember', window );">Equity attributable to owners of parent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeMaketableSecurities', window );">Other comprehensive income, maketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments', window );">Available-for-sale financial investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainLossOnSaleOfOtherFinancialAssets', window );">Other financial assets sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax', window );">Impaired loss on financial assets transferred to the income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Deferred tax on above items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Reclassification to presentation required under IFRS 9 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember', window );">Fair value adjustments on debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeDebtSecurities', window );">Other comprehensive income, debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeMaketableSecurities', window );">Other comprehensive income, maketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember', window );">Fair value adjustments on debt securities | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember', window );">Fair value adjustments on debt securities | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeEquitySecurities', window );">Other comprehensive income, equity securities</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainLossOnSaleOfOtherFinancialAssets', window );">Other financial assets sold</a></td>
<td class="nump">95<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Deferred tax on above items</a></td>
<td class="nump">47<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities | Reclassification to presentation required under IFRS 9 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember', window );">Fair value adjustments on deferred cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax', window );">Amortized net losses on cash flow hedges transferred to the consolidated income statement</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Deferred tax on above items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember', window );">Fair value adjustments on deferred cash flow hedges | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember', window );">Total fair value adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeDebtSecurities', window );">Other comprehensive income, debt securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeMaketableSecurities', window );">Other comprehensive income, maketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeEquitySecurities', window );">Other comprehensive income, equity securities</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments', window );">Available-for-sale financial investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainLossOnSaleOfOtherFinancialAssets', window );">Other financial assets sold</a></td>
<td class="nump">95<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax', window );">Amortized net losses on cash flow hedges transferred to the consolidated income statement</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax', window );">Impaired loss on financial assets transferred to the income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Deferred tax on above items</a></td>
<td class="nump">47<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember', window );">Total fair value adjustments | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 90<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to cash flow hedges, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Cash flow hedges [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 92<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 24C<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24C_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 24E<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24E_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_23_d&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnCashFlowHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to financial assets measured at fair value through other comprehensive income, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Financial assets measured at fair value through other comprehensive income; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 92<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsOnFinancialAssetsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsRelatedToDivestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsRelatedToDivestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GainLossOnSaleOfOtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GainLossOnSaleOfOtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncomeTaxRelatingToAvailableforsaleFinanciaInvestmentsPreviouslyRecognizedThroughOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeAvailableforsaleFinancialInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeMaketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeMaketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ValueAdjustmentOnComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ValueAdjustmentOnComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_ReclassificationToPresentationRequiredUnderIFRS9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_ReclassificationToPresentationRequiredUnderIFRS9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_RestatedValueAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_RestatedValueAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_TotalFairValueAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842251760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes (Details 3) - Continuing operations [member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Applicable tax rate</a></td>
<td class="nump">11.70%<span></span>
</td>
<td class="nump">14.30%<span></span>
</td>
<td class="nump">14.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Effect of disallowed expenditures</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfTaxLosses', window );">Effect of utilization of tax losses brought forward from prior periods</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxRateEffectOfIncomeTaxedAtReducedRates', window );">Effect of income taxed at reduced rates</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation', window );">Tax rate effect of revenues exempt from taxation</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.70%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxRateEffectOfCreditsAndAllowances', window );">Effect of tax credits and allowances</a></td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(2.10%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability', window );">Effect of release of contingent consideration liability</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(1.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxRateEffectFromChangeInTaxRate', window );">Effect of tax rate change on current and deferred tax assets and liabilities</a></td>
<td class="num">(1.40%)<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries', window );">Effect of write down and reversal of write down of investments in subsidiaries</a></td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EffectOfWriteoffOfDeferredTaxAssets', window );">Effect of write-off of deferred tax assets</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxRateEffectFromBenefitsExpiring', window );">Effect of tax benefits expiring in 2017</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods', window );">Effect of prior year items</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Effect of other items</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="num">(0.10%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AverageEffectiveTaxRate', window );">Effective tax rate</a></td>
<td class="nump">20.10%<span></span>
</td>
<td class="nump">9.20%<span></span>
</td>
<td class="nump">17.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Effective income tax rate reconciliation other adjustments</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">Effective income tax rate reconciliation change in enacted tax rate</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain', window );">Effect of income not subject to tax on divestment gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EffectOfUSTaxReformLegislation', window );">Effect of US tax reform legislation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense', window );">Tax benefit arising from previously unrecognised tax loss, tax credit or temporary difference of prior period used to reduce current tax expense</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of benefit arising from a previously unrecognised tax loss, tax credit or temporary difference of a prior period that is used to reduce current tax expense. [Refer: Temporary differences [member]; Unused tax losses [member]; Unused tax credits [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 80<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_80_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from adjustments for the current tax of prior periods. [Refer: Average effective tax rate; Applicable tax rate; Adjustments for current tax of prior periods]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfAdjustmentsForCurrentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the expenses not deductible in determining taxable profit. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from revenue that is exempt from taxation. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfRevenuesExemptFromTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from tax losses. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EffectOfIncomeNotSubjectToTaxOnDivestmentGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EffectOfUSTaxReformLegislation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EffectOfUSTaxReformLegislation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EffectOfWriteoffOfDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EffectOfWriteoffOfDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxRateEffectFromBenefitsExpiring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxRateEffectFromBenefitsExpiring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxRateEffectFromWritedownAndReversalOfWritedownOfInvestSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxRateEffectOfCreditsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxRateEffectOfCreditsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxRateEffectOfIncomeTaxedAtReducedRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxRateEffectOfIncomeTaxedAtReducedRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxRateEffectOfReleaseOfContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838762656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and contingencies [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfLeasingCommitmentsTableTextBlock', window );">Leasing commitments</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 809</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 442</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 319</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 724</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Thereafter</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;943</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;404</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfLeasingCommitmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfLeasingCommitmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838806576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of businesses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAcquisitionOfBusinessesAbstract', window );"><strong>Disclosure of acquisition of businesses [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock', window );">Fair value of assets and liabilities arising from acquisitions</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;550</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;531</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquired research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 342</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;224</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;223</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 381</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 195</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables and other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;107</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;874</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;325</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables and other liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;178</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;627</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net identifiable assets acquired</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;938</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 925</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 94</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets recognized as a result of business combinations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;946</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 999</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net assets recognized as a result of business combinations in the consolidated balance sheet from continuing operations were USD 13 660 million in 2018 and USD 874 million in 2017. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfAcquisitionOfBusinessesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfAcquisitionOfBusinessesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueOfAssetsAndLiabilitiesArisingFromAcquisitionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6851451904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PresentationOfLeasesForLesseeLineItems', window );"><strong>Presentation of leases for lessee [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Operating lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed', window );">Recognition exemption for short term leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Recognition exception for low value leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NewLeaseArrangements', window );">New lease arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_UndiscountedFutureLeasePayments', window );">Undiscounted future lease payments</a></td>
<td class="nump">$ 3,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EffectOfDiscounting', window );">Effect of discounting</a></td>
<td class="num">(1,547)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,736<span></span>
</td>
<td class="nump">$ 1,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16', window );">Weighted average incremental borrowing rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PresentationOfLeasesForLesseeLineItems', window );"><strong>Presentation of leases for lessee [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Operating lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PresentationOfLeasesForLesseeLineItems', window );"><strong>Presentation of leases for lessee [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Operating lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 58<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph C12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_C12_a&amp;doctype=Appendix&amp;subtype=C<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EffectOfDiscounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EffectOfDiscounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NewLeaseArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NewLeaseArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PresentationOfLeasesForLesseeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PresentationOfLeasesForLesseeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_UndiscountedFutureLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_UndiscountedFutureLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838745136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest expense and other financial income and expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestExpenseAbstract', window );"><strong>Interest expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions', window );">Interest expense</a></td>
<td class="num">$ (714)<span></span>
</td>
<td class="num">$ (877)<span></span>
</td>
<td class="num">$ (741)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest expense on lease liabilities</a></td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions', window );">Income/expense arising from discounting long-term liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Total interest expense from continuing operations</a></td>
<td class="num">$ (850)<span></span>
</td>
<td class="num">$ (932)<span></span>
</td>
<td class="num">$ (750)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised due to the unwinding of the discount on provisions, resulting from the effect of the passage of time. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestExpenseExcludingExpenseDueToUnwindingOfDiscountOnProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R132.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838688592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital at beginning of period</a></td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">$ 969<span></span>
</td>
<td class="nump">$ 972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares at beginning of period</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OutstandingShareCapital', window );">Total outstanding share capital at beginning of period</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">869<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IssuedCapitalMovement', window );">Share capital movement of period</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SaleOrIssueOfTreasuryShares', window );">Treasury shares movement of period</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OutstandingShareCapitalMovement', window );">Total shares outstanding movement of period</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital at end of period</a></td>
<td class="nump">936<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="nump">969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares at end of period</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OutstandingShareCapital', window );">Total outstanding share capital at end of period</a></td>
<td class="nump">$ 856<span></span>
</td>
<td class="nump">$ 875<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SaleOrIssueOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity resulting from the sale or issue of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SaleOrIssueOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IssuedCapitalMovement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IssuedCapitalMovement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OutstandingShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OutstandingShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OutstandingShareCapitalMovement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OutstandingShareCapitalMovement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6722316624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract', window );"><strong>Disclosure of marketable securities commodities deposits derivative instruments and cash [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock', window );">Marketable securities, commodities, timedeposits, and derivative financial instruments</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, commodities, time deposits and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 334</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;693</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DebtSecuritiesBreakdownByCurrencyTableTextBlock', window );">Debt securities, breakdown by currency</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 302</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 325</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsTableTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current accounts</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;247</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;121</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity less than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;865</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;150</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DebtSecuritiesBreakdownByCurrencyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DebtSecuritiesBreakdownByCurrencyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MarketableSecuritiesCommoditiesTimedepositsAndDerivativeFinancialInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839240304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred tax assets and liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Disclosure of Deferred Tax Assets and Liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Property, <br></br> plant and <br></br> equipment </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pensions and <br></br> other benefit <br></br> obligations <br></br> of associates </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Inventories </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Tax loss <br></br> carry- <br></br> forwards </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Other assets, <br></br> provisions <br></br> and accruals </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax assets at January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 191</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;233</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;188</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;722</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;175</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;782</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax liabilities at January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;384</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;558</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">At January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net deferred tax balance related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;403</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;123</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;217</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 858</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Credited/(charged) to income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 605</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 308</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;818</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 298</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;166</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;83</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;313</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;289</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;282</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 787</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;271</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax assets at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;469</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;078</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;446</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 255</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;596</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;952</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax liabilities at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;390</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;610</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;325</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;910</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;282</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 787</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;271</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;909</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;867</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax assets at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 137</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;090</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;786</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 97</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;380</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax liabilities at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;613</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2&nbsp;985</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;254</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;455</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;319</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;476</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;331</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;061</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">At January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;476</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;331</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;061</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net deferred tax balance related to disposal group held for sale</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Credited/(charged) to income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 378</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;86</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;113</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 368</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 582</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;874</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 298</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;493</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;51</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax assets at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 191</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;722</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;175</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;782</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax liabilities at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;384</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;558</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;699</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;475</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Includes USD 3 million net deferred tax movement related to disposal group held for sale </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock', window );">Deferred tax assets/liabilities, expected to have impact on current taxes payable</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected to have an impact on current tax payable after more than 12 months</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Deferred tax assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.9</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock', window );">Unremitted earnings retained by consolidated entities for reinvestment</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unremitted earnings that have been retained <br></br>by consolidated entities for reinvestment </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 61 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 73 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock', window );">Temporary differences on which no deferred tax assets have been provided</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investments in subsidiaries</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill from acquisitions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Gross value of tax-loss carry-forwards</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Not capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 total</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One year</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Two years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Three years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Four years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 127</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">More than five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 435</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;684</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 648</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;986</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Not capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 total</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One year</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Two years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Three years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Four years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 70</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 381</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">More than five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 522</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;288</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;810</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 996</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;341</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tax losses carried forward <br></br>that expired </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 9 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 8 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock', window );">CH Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income <br></br> statement <br></br> continuing <br></br> operations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Equity </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax asset <br></br>and liability revaluation </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized <br></br>in consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 234 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 234 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized in other comprehensive income <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;358</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;358</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total revaluation of deferred tax assets and liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 234</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;358</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;124</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Related to post-employment benefits </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock', window );">US Corporate tax rate, impact on the revaluation of deferred assets and liabilities and current income tax liabilities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Income <br></br> statement <br></br> continuing <br></br> operations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Equity </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax asset <br></br>and liability revaluation </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized <br></br>in consolidated income statement <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;440 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;440 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized <br></br>in other comprehensive income <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;254 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;254 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized in retained earnings <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total revaluation of deferred <br></br>tax assets and liabilities </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;440 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;325 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;765 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total revaluation of current tax payables <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total revaluation of deferred tax assets and liabilities, and current income tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;325</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;799</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Items previously recognized in discontinued operations amounted to USD 416 million </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Related to post-employment benefits and available-for-sale financial investments (attributable to continuing operations USD -241 million and attributable to discontinued operations USD -13 million) </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Related to equity-based compensation plans (attributable to continuing operations USD -66 million and attributable to discontinued operations USD -5 million) </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Revaluation of current tax payable attributable to discontinued operations amounted to USD -3 million. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CHCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesExpectedToHaveImpactOnCurrentTaxesPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfUnremittedEarningsRetainedByConsolidatedEntitiesForReinvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TemporaryDifferencesOnWhichNoDeferredTaxAssetsHaveBeenProvidedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_USCorporateTaxRateImpactOnTheRevaluationOfDeferredAssetsAndLiabilitiesAndCurrentIncomeTaxliabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R136.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842553088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details 5)<br> $ / shares in Units, Pure in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfChangesInEquityAbstract', window );"><strong>Statement of changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan', window );">Increase of treasury share repurchase obligation under a share buyback trading plan</a></td>
<td class="nump">$ 284<span></span>
</td>
<td class="num">$ (284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TransactionCostsRecordedInEquity', window );">Transaction costs recorded in equity</a></td>
<td class="nump">253<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxOnTransactionCostsRecordedInEquity', window );">Tax on transaction costs recorded in equity</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaximalAmountOfShareBuybackProgramm', window );">Maximal amount of share buyback programm</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WrittenCallOptionsHeldByMarketMaker', window );">Written call options held by market maker</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WrittenCallOptionsContractualLive', window );">Written call options, contractual live | year</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WrittenCallOptionsContractualLiveRemaining', window );">Written call options, contractual live, remaining | year</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WrittenCallOptionsWeightedAverageExercisePrice', window );">Written call options, weighted average exercise price | $ / shares</a></td>
<td class="nump">$ 63.90<span></span>
</td>
<td class="nump">$ 62.70<span></span>
</td>
<td class="nump">$ 62.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountRecordedInEquityRelatedToHyperinflation', window );">Amount recorded in equity related to hyperinflation</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountRecordedInEquityRelatedToHyperinflation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountRecordedInEquityRelatedToHyperinflation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MaximalAmountOfShareBuybackProgramm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MaximalAmountOfShareBuybackProgramm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxOnTransactionCostsRecordedInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxOnTransactionCostsRecordedInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TransactionCostsRecordedInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TransactionCostsRecordedInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WrittenCallOptionsContractualLive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WrittenCallOptionsContractualLive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WrittenCallOptionsContractualLiveRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WrittenCallOptionsContractualLiveRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WrittenCallOptionsHeldByMarketMaker">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WrittenCallOptionsHeldByMarketMaker</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WrittenCallOptionsWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WrittenCallOptionsWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839019456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other non-current liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract', window );"><strong>Disclosure of detailed information about provisions and non-current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsExplanatory', window );">Disclosure of other provisions [text block]</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued liability for employee benefits:</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Defined benefit pension plans <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;469</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;546</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other long-term employee benefits and deferred compensation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 546</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 600</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other post-employment benefits <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Environmental remediation provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 634</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for product liabilities, governmental investigations and other legal matters</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 214</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 958</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 255</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 497</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total provisions and other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;632</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;319</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 25 provides additional disclosures related to post-employment benefits. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent consideration. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccrualForEnvironmentalLossContingenciesTableTextBlock', window );">Accrual for environmental loss contingencies [table text block]</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 692</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 761</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 773</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;48</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;83</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp; 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;153</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 154</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 714</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 692</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 761</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current provision</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;55</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current environmental remediation provisions at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 634</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 706</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Releases of provisions credited to the consolidated income statement from continuing operations were USD 21 million in 2018 and USD 153 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 7 million in 2018 and USD 154 million in 2017. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock', window );">Accrual for environmental loss contingencies, fiscal year maturity [table text block]</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Expected <br></br> cash outflows </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due within two years</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 141</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due later than two years, but within five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due later than five years, but within 10 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 258</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due after 10 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 105</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total environmental remediation liability provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 714</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock', window );">Accrual for product liabilities government investigations other legal matters loss contingencies [table text block]</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 340</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 351</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to <br></br>discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;42 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;116</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases of provisions <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;107</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to provisions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;369</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 340</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 351</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;121</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current product liabilities, governmental investigations and other legal matters provisions at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 200</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 230</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Releases of provisions credited to the consolidated income statement from continuing operations were USD 107 million in 2018 and USD 63 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 220 million in 2018 and USD 47 million in 2017. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccrualForEnvironmentalLossContingenciesFiscalYearMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccrualForEnvironmentalLossContingenciesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccrualForEnvironmentalLossContingenciesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccrualForProductLiabilitiesGovernmentInvestigationsOtherLegalMattersLossContingenciesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6886862752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 7) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember', window );">Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 37,714<span></span>
</td>
<td class="nump">$ 34,892<span></span>
</td>
<td class="nump">32,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 14,370<span></span>
</td>
<td class="nump">$ 13,428<span></span>
</td>
<td class="nump">12,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Tasigna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,880<span></span>
</td>
<td class="nump">$ 1,874<span></span>
</td>
<td class="nump">1,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Sandostatin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,585<span></span>
</td>
<td class="nump">$ 1,587<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Afinitor/Votubia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,539<span></span>
</td>
<td class="nump">$ 1,556<span></span>
</td>
<td class="nump">1,525<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Promacta/Revolade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,416<span></span>
</td>
<td class="nump">$ 1,174<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Tafinlar + Mekinist [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,338<span></span>
</td>
<td class="nump">$ 1,155<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Gleevec/Glivec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,263<span></span>
</td>
<td class="nump">$ 1,561<span></span>
</td>
<td class="nump">1,943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(19.00%)<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Jakavi [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,114<span></span>
</td>
<td class="nump">$ 977<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Exjade/Jadenu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 1,099<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(11.00%)<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Votrient [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 828<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(9.00%)<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Kisqali [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">104.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Lutathera [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">164.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Kymriah [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Piqray [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,190<span></span>
</td>
<td class="nump">$ 1,139<span></span>
</td>
<td class="nump">887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 23,344<span></span>
</td>
<td class="nump">$ 21,464<span></span>
</td>
<td class="nump">20,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 4,776<span></span>
</td>
<td class="nump">$ 4,558<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,086<span></span>
</td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="nump">1,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Travoprost Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 517<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(16.00%)<span></span>
</td>
<td class="num">(12.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Xiidra [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Beovu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,030<span></span>
</td>
<td class="nump">$ 1,995<span></span>
</td>
<td class="nump">2,144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="num">(7.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 3,429<span></span>
</td>
<td class="nump">3,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Gilenya [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,223<span></span>
</td>
<td class="nump">$ 3,341<span></span>
</td>
<td class="nump">3,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Zolgensma [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Aimovig [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Mayzent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(25.00%)<span></span>
</td>
<td class="num">(22.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,825<span></span>
</td>
<td class="nump">$ 1,767<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | Xolair [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,173<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(12.00%)<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | COPD [member] | Ultibro Breezhaler [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 427<span></span>
</td>
<td class="nump">$ 454<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(6.00%)<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | COPD [member] | Seebri Breezhaler [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(18.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | COPD [member] | Onbrez Breezhaler [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 82<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(19.00%)<span></span>
</td>
<td class="num">(10.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member] | Entresto [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,726<span></span>
</td>
<td class="nump">$ 1,028<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">103.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 6,998<span></span>
</td>
<td class="nump">$ 7,268<span></span>
</td>
<td class="nump">7,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(3.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Galvus Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,297<span></span>
</td>
<td class="nump">$ 1,284<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Diovan Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,064<span></span>
</td>
<td class="nump">$ 1,023<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Exforge Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,025<span></span>
</td>
<td class="nump">$ 1,002<span></span>
</td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Zortress/Certican [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Voltaren/Cataflam [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(6.00%)<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Neoral/Sandimmun(e) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 463<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(10.00%)<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,291<span></span>
</td>
<td class="nump">$ 2,587<span></span>
</td>
<td class="nump">2,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(11.00%)<span></span>
</td>
<td class="num">(13.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 4,222<span></span>
</td>
<td class="nump">$ 3,392<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Cosentyx [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,551<span></span>
</td>
<td class="nump">$ 2,837<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Ilaris [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Other [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeOverPeriodAxis=nvs_PoPYEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BusinessUnitAxis=nvs_OncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BusinessUnitAxis=nvs_OncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TasignaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TasignaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_SandostatinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_SandostatinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_AfinitorVotubiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_AfinitorVotubiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_PromactaRevoladeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_PromactaRevoladeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TafinlarMekinistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TafinlarMekinistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_GleevecGlivecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_GleevecGlivecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_JakaviMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_JakaviMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ExjadeJadenuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ExjadeJadenuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_VotrientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_VotrientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_KisqaliMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_KisqaliMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_LutatheraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_LutatheraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_KymriahMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_KymriahMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_PiqrayMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_PiqrayMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BusinessUnitAxis=nvs_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BusinessUnitAxis=nvs_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_OphthalmologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_OphthalmologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TravoprostGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TravoprostGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_XiidraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_XiidraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_BeovuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_BeovuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_NeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_NeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_GilenyaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_GilenyaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ZolgensmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ZolgensmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_AimovigMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_AimovigMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_MayzentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_MayzentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_RespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_RespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_XolairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_XolairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductPortfolioAxis=nvs_COPDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductPortfolioAxis=nvs_COPDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_UltibroBreezhalerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_UltibroBreezhalerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_SeebriBreezhalerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_SeebriBreezhalerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_OnbrezBreezhalerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_OnbrezBreezhalerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_CardioMetabolicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_CardioMetabolicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_EntrestoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_EntrestoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_EstablishedMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_EstablishedMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_GalvusGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_GalvusGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_DiovanGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_DiovanGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ExforgeGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ExforgeGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ZortressCerticanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ZortressCerticanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_VoltarenCataflamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_VoltarenCataflamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_NeoralSandimmunEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_NeoralSandimmunEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_ImmunologyHepatologyAndDermatologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_ImmunologyHepatologyAndDermatologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_CosentyxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_CosentyxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_IlarisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_IlarisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6852193440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred tax assets and liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,782<span></span>
</td>
<td class="nump">$ 8,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,558)<span></span>
</td>
<td class="num">(5,319)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">$ 1,224<span></span>
</td>
<td class="nump">$ 1,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td class="nump">3,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">1,224<span></span>
</td>
<td class="nump">3,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale', window );">Net deferred tax balance related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity', window );">Charged to equity</a></td>
<td class="num">(83)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Credited/(charged) to other comprehensive income</a></td>
<td class="num">(289)<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Impact of business combinations</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(2,493)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction', window );">Offsetting of deferred tax assets and liabilities within the same tax jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,867)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_PropertyPlantAndEquipmentMember', window );">Property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(390)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(622)<span></span>
</td>
<td class="num">(613)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="num">(431)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="num">(476)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="num">(431)<span></span>
</td>
<td class="num">(476)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale', window );">Net deferred tax balance related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Impact of business combinations</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="num">(282)<span></span>
</td>
<td class="num">(431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_IntangibleAssetsAndGoodwillMember', window );">Intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,384)<span></span>
</td>
<td class="num">(2,985)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="num">(2,141)<span></span>
</td>
<td class="num">(1,698)<span></span>
</td>
<td class="num">(2,141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,151)<span></span>
</td>
<td class="num">(1,698)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="num">(4,151)<span></span>
</td>
<td class="num">(1,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale', window );">Net deferred tax balance related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="nump">605<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity', window );">Charged to equity</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Impact of business combinations</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(2,874)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="num">(2,141)<span></span>
</td>
<td class="num">(4,151)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember', window );">Pensions and other benefit obligations of associates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
<td class="nump">1,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(291)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">836<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">915<span></span>
</td>
<td class="nump">836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Credited/(charged) to other comprehensive income</a></td>
<td class="num">(313)<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_InventoriesMember', window );">Inventories [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,722<span></span>
</td>
<td class="nump">3,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(474)<span></span>
</td>
<td class="num">(455)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">3,248<span></span>
</td>
<td class="nump">3,248<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,248<span></span>
</td>
<td class="nump">3,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">3,248<span></span>
</td>
<td class="nump">3,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale', window );">Net deferred tax balance related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="num">(818)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="nump">2,159<span></span>
</td>
<td class="nump">3,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_TaxLossCarryforwardsMember', window );">Tax loss carryforwards [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">273<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale', window );">Net deferred tax balance related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity', window );">Charged to equity</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Impact of business combinations</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_OtherAssetsProvisionsAccrualsMember', window );">Other assets, provisions and accruals [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxAssets', window );">Gross deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,175<span></span>
</td>
<td class="nump">1,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossDeferredTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(805)<span></span>
</td>
<td class="num">(1,003)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">$ 1,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">$ 980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale', window );">Net deferred tax balance related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Credited/(charged) to income</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity', window );">Charged to equity</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Credited/(charged) to other comprehensive income</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset', window );">Impact of business combinations</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">858<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Pensions and other benefit obligations of associates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="num">(123)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Inventories [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Tax loss carryforwards [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Other assets, provisions and accruals [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance</a></td>
<td class="num">(217)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at beginning of period</a></td>
<td class="num">(217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Net deferred tax balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember', window );">Disposal groups classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInDeferredTaxBalanceRollForward', window );"><strong>Movement in deferred tax balance [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset', window );">Other movements</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense or income relating to changes in deferred tax liabilities and deferred tax assets, recognised in profit or loss. [Refer: Deferred tax assets; Deferred tax expense (income); Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax related to items credited (charged) directly to equity. [Refer: Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 90<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in deferred tax liability (asset) resulting from business combinations. [Refer: Deferred tax liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GrossDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GrossDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GrossDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GrossDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughOtherMovementsDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MovementInDeferredTaxBalanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MovementInDeferredTaxBalanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets or deferred tax liabilities related to disposal group held for sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetDeferredTaxBalanceRelatedToDisposalGroupHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OffsettingOfDeferredTaxAssetsAndLiabilitiesWithinTheSameTaxJurisdiction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_IntangibleAssetsAndGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=ifrs-full_IntangibleAssetsAndGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_PensionsAndOtherBenefitObligationsOfAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_InventoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_InventoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_TaxLossCarryforwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_TaxLossCarryforwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_OtherAssetsProvisionsAccrualsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_OtherAssetsProvisionsAccrualsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6893894160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant transactions (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 23, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 11, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 11, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 08, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 07, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 08, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 21, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 06, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 15, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 27, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 22, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 20, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Nov. 11, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 09, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 06, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 06, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,124,000,000<span></span>
</td>
<td class="nump">$ 13,946,000,000<span></span>
</td>
<td class="nump">$ 999,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Profit (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,590,000,000<span></span>
</td>
<td class="num">(186,000,000)<span></span>
</td>
<td class="nump">204,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,224,000,000)<span></span>
</td>
<td class="num">(3,061,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,787,000,000<span></span>
</td>
<td class="nump">38,719,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Revenue from sale of goods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,498,000,000<span></span>
</td>
<td class="nump">44,833,000,000<span></span>
</td>
<td class="nump">42,381,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,355,000,000<span></span>
</td>
<td class="nump">25,660,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,691,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,691,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_AlconMember', window );">Alcon [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners', window );">Decrease of distribution liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEquityInterestSharesReceived', window );">Percentage of equity interest shares received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,939,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_SandozMember', window );">Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DivestmentDateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, divestment-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CarryingValueOfTheDivestedBusiness', window );">Carrying value of the divested business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfProductsInPortfolioToBeSold', window );">Number of products in portfolio to be sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_SandozMember', window );">Sandoz | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLoss', window );">Impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DivestmentDateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, divestment-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CarryingValueOfTheDivestedBusiness', window );">Carrying value of the divested business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfProductsInPortfolioToBeSold', window );">Number of products in portfolio to be sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsAAAMember', window );">Advanced Accelerator Applications (AAA)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,900,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueOfAcquireeFullYear', window );">Revenue of acquiree full year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfShareCapitalInTenderOffer', window );">Percentage of Share capital in tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOfferPerOrdinaryShare', window );">Cash offer per ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOfferPerADS', window );">Cash offer per ADS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfOrdinarySharePerADS', window );">Number of ordinary share per ADS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueOfEquity', window );">Value of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer', window );">Percentage of share capital tendered at the expiration of the tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer', window );">Total percentage of share capital tendered after the subsequent offering period of the tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer', window );">Percentage of share capital tendered at the subsequent offering period of the tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer', window );">Consideration paid for share capital tendered at the subsequent offering period of the tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_AspenGlobalIncorporatedMember', window );">Aspen Global Incorporated | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (336,000,000)<span></span>
</td>
<td class="num">&#8364; (300)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_TheMedicinesCompanyMember', window );">The Medicines Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="num">$ (9,700,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_TheMedicinesCompanyMember', window );">The Medicines Company | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOfferPerOrdinaryShare', window );">Cash offer per ordinary share</a></td>
<td class="nump">$ 85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_AveXisIncMember', window );">AveXis, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,700,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOfferPerOrdinaryShare', window );">Cash offer per ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer', window );">Percentage of share capital tendered at the expiration of the tender offer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherNetAssets', window );">Other net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_EndocyteMember', window );">Endocyte</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,100,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashOfferPerOrdinaryShare', window );">Cash offer per ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherNetAssets', window );">Other net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_GSKConsumerHealthcareMember', window );">GSK Consumer Healthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Divested interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations', window );">Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,994,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PreTaxProfitLossFromDivestmentOfBusiness', window );">Pre tax profit (loss) from divestment of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_TakedaPharmaceuticalCompanyLimitedMember', window );">Takeda Pharmaceutical Company Limited | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,500,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment', window );">Portion of consideration paid consisting of cash and cash equivalents upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,400,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueOfAcquireeFullYear', window );">Revenue of acquiree full year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialMilestoneMaximumPayments', window );">Potential milestone maximum payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CustomaryPurchasePriceAdjustment', window );">Customary purchase price adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_IFMTreInc.Member', window );">IFM Tre, Inc. | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(285,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">355,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Divested interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate', window );">Acquisition-date fair value of equity interest in acquiree held by acquirer immediately before acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination', window );">Gain (loss) recognised as result of remeasuring to fair value equity interest in acquiree held by acquirer before business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,660,000,000<span></span>
</td>
<td class="nump">874,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Profit (loss) from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,590,000,000<span></span>
</td>
<td class="num">(186,000,000)<span></span>
</td>
<td class="nump">204,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(858,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,121,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Revenue from sale of goods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,809,000,000<span></span>
</td>
<td class="nump">$ 7,153,000,000<span></span>
</td>
<td class="nump">$ 6,774,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Dividend in kind distribution liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,434,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed', window );">Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,409,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Difference between carrying amount of dividends payable and carrying amount of non-cash assets distributed, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,691,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Alcon [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RepaymentOfIntercompanyBalances', window );">Repayment of intercompany balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Dividend in kind distribution liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionalBorrowings', window );">Additional borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Alcon [member] | Borrowings, USD [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Alcon [member] | Borrowings, EUR [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | PowerVision, Inc. | Alcon [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">424,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(289,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">418,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherNetAssets', window );">Other net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 505,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Ziarco Group Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(325,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Encore Vision, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents', window );">Portion of consideration paid (received) consisting of cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(366,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate', window );">Contingent liabilities recognised as of acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Identifiable assets acquired (liabilities assumed)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">389,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Additional recognition, goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The acquisition-date fair value of equity interest in the acquiree held by the acquirer immediately before the acquisition date in a business combination achieved in stages. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph p<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_p_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalRecognitionGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional goodwill recognised, except goodwill included in a disposal group that, on acquisition, meets the criteria to be classified as held for sale in accordance with IFRS 5. [Refer: Goodwill; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B67_d_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalRecognitionGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised as of the acquisition date in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of difference between the carrying amount of dividends payable and the carrying amount of non-cash assets distributed when settling the dividends payable. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 15<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_15&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends payable by means of the distribution of non-cash assets to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gain (loss) recognised as result of remeasuring to fair value the equity interest in the acquiree held by the acquirer before the business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph p<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_p_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossRecognisedAsResultOfRemeasuringToFairValueEquityInterestInAcquireeHeldByAcquirerBeforeBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a reduction of the carrying amount of an asset or cash-generating unit to its recoverable amount. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 130<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_130_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 130<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_130_d_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in dividends payable through a change in the fair value of non-cash assets held for distribution to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDividendsPayableThroughChangeInFairValueOfNoncashAssetsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG63<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of consideration paid or received, consisting of cash and cash equivalents, in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]; Cash and cash equivalents; Consideration paid (received)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 40<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_40_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionalBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionalBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CarryingValueOfTheDivestedBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CarryingValueOfTheDivestedBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashOfferPerADS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This expresses the amount of cash Novartis paid to the owners of AAA per ADS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashOfferPerADS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashOfferPerOrdinaryShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This expresses the amount of cash Novartis paid to the owners of AAA per ordinary share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashOfferPerOrdinaryShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ConsiderationPaidForShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CustomaryPurchasePriceAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CustomaryPurchasePriceAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DivestmentDateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DivestmentDateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfOrdinarySharePerADS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfOrdinarySharePerADS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfProductsInPortfolioToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfProductsInPortfolioToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PercentageOfEquityInterestSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PercentageOfEquityInterestSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PercentageOfShareCapitalInTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PercentageOfShareCapitalInTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PercentageOfShareCapitalTenderedAtTheExpirationOfTheTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PercentageOfShareCapitalTenderedAtTheSubsequentOfferingPeriodOfTheTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PortionOfConsiderationPaidReceivedConsistingOfCashAndCashEquivalentsUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PotentialMilestoneMaximumPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PotentialMilestoneMaximumPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PreTaxProfitLossFromDivestmentOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PreTaxProfitLossFromDivestmentOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RepaymentOfIntercompanyBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RepaymentOfIntercompanyBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueOfAcquireeFullYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueOfAcquireeFullYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TotalPercentageOfShareCapitalTenderedAfterTheSubsequentOfferingPeriodOfTheTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ValueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ValueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_AlconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_AlconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsAAAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsAAAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AspenGlobalIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AspenGlobalIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_TheMedicinesCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_TheMedicinesCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AveXisIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AveXisIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_EndocyteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_EndocyteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_GSKConsumerHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_GSKConsumerHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_TakedaPharmaceuticalCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_TakedaPharmaceuticalCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_IFMTreInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_IFMTreInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_BorrowingsUSDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_BorrowingsUSDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_BorrowingsEURMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_BorrowingsEURMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_PowerVisionInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_PowerVisionInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ZiarcoGroupLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ZiarcoGroupLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_EncoreVisionIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_EncoreVisionIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6874736880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 1) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to continuing and discontinued segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,498<span></span>
</td>
<td class="nump">44,833<span></span>
</td>
<td class="nump">42,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,425)<span></span>
</td>
<td class="num">(14,510)<span></span>
</td>
<td class="num">(13,633)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,252<span></span>
</td>
<td class="nump">31,589<span></span>
</td>
<td class="nump">29,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,369)<span></span>
</td>
<td class="num">(13,717)<span></span>
</td>
<td class="num">(12,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,402)<span></span>
</td>
<td class="num">(8,489)<span></span>
</td>
<td class="num">(8,389)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,031<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,426)<span></span>
</td>
<td class="num">(2,609)<span></span>
</td>
<td class="num">(2,137)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,086<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
<td class="nump">8,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Income from associated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659<span></span>
</td>
<td class="nump">6,438<span></span>
</td>
<td class="nump">1,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(850)<span></span>
</td>
<td class="num">(932)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other financial income and expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">14,095<span></span>
</td>
<td class="nump">9,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,147<span></span>
</td>
<td class="nump">12,800<span></span>
</td>
<td class="nump">7,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution', window );">Net income/loss from discontinued operations before gain on distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Gain on distribution</a></td>
<td class="nump">$ 4,691<span></span>
</td>
<td class="nump">4,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net income/loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,590<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">12,614<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,714<span></span>
</td>
<td class="nump">34,892<span></span>
</td>
<td class="nump">32,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to continuing and discontinued segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="nump">668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,497<span></span>
</td>
<td class="nump">35,633<span></span>
</td>
<td class="nump">32,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,050)<span></span>
</td>
<td class="num">(9,870)<span></span>
</td>
<td class="num">(8,650)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,539<span></span>
</td>
<td class="nump">26,951<span></span>
</td>
<td class="nump">25,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,617)<span></span>
</td>
<td class="num">(10,907)<span></span>
</td>
<td class="num">(9,887)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,152)<span></span>
</td>
<td class="num">(7,675)<span></span>
</td>
<td class="num">(7,615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,586<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="nump">1,027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,069)<span></span>
</td>
<td class="num">(1,475)<span></span>
</td>
<td class="num">(1,124)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,287<span></span>
</td>
<td class="nump">7,871<span></span>
</td>
<td class="nump">7,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Income from associated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,731<span></span>
</td>
<td class="nump">9,859<span></span>
</td>
<td class="nump">10,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to continuing and discontinued segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,872<span></span>
</td>
<td class="nump">10,036<span></span>
</td>
<td class="nump">10,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,334)<span></span>
</td>
<td class="num">(5,530)<span></span>
</td>
<td class="num">(5,800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,601<span></span>
</td>
<td class="nump">4,568<span></span>
</td>
<td class="nump">4,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,218)<span></span>
</td>
<td class="num">(2,305)<span></span>
</td>
<td class="num">(2,126)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,250)<span></span>
</td>
<td class="num">(814)<span></span>
</td>
<td class="num">(774)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(749)<span></span>
</td>
<td class="num">(622)<span></span>
</td>
<td class="num">(351)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">551<span></span>
</td>
<td class="nump">1,332<span></span>
</td>
<td class="nump">1,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Income from associated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to continuing and discontinued segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(871)<span></span>
</td>
<td class="num">(836)<span></span>
</td>
<td class="num">(743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(871)<span></span>
</td>
<td class="num">(836)<span></span>
</td>
<td class="num">(743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">959<span></span>
</td>
<td class="nump">890<span></span>
</td>
<td class="nump">817<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(534)<span></span>
</td>
<td class="num">(505)<span></span>
</td>
<td class="num">(452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(608)<span></span>
</td>
<td class="num">(512)<span></span>
</td>
<td class="num">(662)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(752)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="num">(261)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Income from associated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 656<span></span>
</td>
<td class="nump">$ 6,432<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsSalesToOtherSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6872944656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures - Net sales by region (Details 12) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember', window );">Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_USMember', window );">US [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 16,280<span></span>
</td>
<td class="nump">$ 14,618<span></span>
</td>
<td class="nump">14,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_USMember', window );">US [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember', window );">Asia/Africa/Australasia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 9,799<span></span>
</td>
<td class="nump">$ 9,460<span></span>
</td>
<td class="nump">9,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember', window );">Asia/Africa/Australasia [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_CanadaAndLatinAmericaMember', window );">Canada and Latin America [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,433<span></span>
</td>
<td class="nump">$ 3,414<span></span>
</td>
<td class="nump">3,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_CanadaAndLatinAmericaMember', window );">Canada and Latin America [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_EstablishedMarketsMember', window );">Established Markets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 35,684<span></span>
</td>
<td class="nump">$ 33,491<span></span>
</td>
<td class="nump">31,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_EstablishedMarketsMember', window );">Established Markets [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_EmergingGrowthMarketsMember', window );">Emerging Growth Markets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 11,761<span></span>
</td>
<td class="nump">$ 11,260<span></span>
</td>
<td class="nump">10,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_EmergingGrowthMarketsMember', window );">Emerging Growth Markets [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=srt_EuropeMember', window );">Europe [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 17,933<span></span>
</td>
<td class="nump">$ 17,259<span></span>
</td>
<td class="nump">15,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=srt_EuropeMember', window );">Europe [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 13,789<span></span>
</td>
<td class="nump">$ 11,864<span></span>
</td>
<td class="nump">10,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Asia/Africa/Australasia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 8,458<span></span>
</td>
<td class="nump">$ 8,097<span></span>
</td>
<td class="nump">7,702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Asia/Africa/Australasia [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Canada and Latin America [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,649<span></span>
</td>
<td class="nump">$ 2,635<span></span>
</td>
<td class="nump">2,592<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Canada and Latin America [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Established Markets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 28,573<span></span>
</td>
<td class="nump">$ 26,258<span></span>
</td>
<td class="nump">24,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Established Markets [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Emerging Growth Markets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 9,141<span></span>
</td>
<td class="nump">$ 8,634<span></span>
</td>
<td class="nump">8,104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Emerging Growth Markets [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Europe [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 12,818<span></span>
</td>
<td class="nump">$ 12,296<span></span>
</td>
<td class="nump">11,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Europe [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | US [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,491<span></span>
</td>
<td class="nump">$ 2,754<span></span>
</td>
<td class="nump">3,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | US [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(10.00%)<span></span>
</td>
<td class="num">(16.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Asia/Africa/Australasia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,341<span></span>
</td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="nump">1,391<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Asia/Africa/Australasia [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Canada and Latin America [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 784<span></span>
</td>
<td class="nump">$ 779<span></span>
</td>
<td class="nump">758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Canada and Latin America [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Established Markets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 7,111<span></span>
</td>
<td class="nump">$ 7,233<span></span>
</td>
<td class="nump">7,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Established Markets [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Emerging Growth Markets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="nump">$ 2,626<span></span>
</td>
<td class="nump">2,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Emerging Growth Markets [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Europe [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 5,115<span></span>
</td>
<td class="nump">$ 4,963<span></span>
</td>
<td class="nump">4,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz | Europe [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 37,714<span></span>
</td>
<td class="nump">$ 34,892<span></span>
</td>
<td class="nump">32,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 9,731<span></span>
</td>
<td class="nump">$ 9,859<span></span>
</td>
<td class="nump">$ 10,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeOverPeriodAxis=nvs_PoPYEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_USMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_USMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_CanadaAndLatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_CanadaAndLatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_EstablishedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_EstablishedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_EmergingGrowthMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_EmergingGrowthMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6851134816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">$ 74,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">$ 1,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Reversal of impairment charge</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">55,311<span></span>
</td>
<td class="nump">74,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">35,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">26,524<span></span>
</td>
<td class="nump">35,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible Assets other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">38,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">28,787<span></span>
</td>
<td class="nump">38,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember', window );">Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">15,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">5,424<span></span>
</td>
<td class="nump">15,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember', window );">Alcon brand name [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">2,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">1,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">1,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember', window );">Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">14,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">22,579<span></span>
</td>
<td class="nump">14,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember', window );">Marketing know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">4,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification', window );">Additions included in disposal group to the date of reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">35,700<span></span>
</td>
<td class="nump">32,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(9,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Impact of business combinations</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">4,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">26,825<span></span>
</td>
<td class="nump">35,700<span></span>
</td>
<td class="nump">32,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Intangible Assets other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">69,025<span></span>
</td>
<td class="nump">57,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(1,403)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(19,570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Impact of business combinations</a></td>
<td class="nump">3,914<span></span>
</td>
<td class="nump">12,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill', window );">Disposals and derecognitions</a></td>
<td class="num">(1,055)<span></span>
</td>
<td class="num">(1,395)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="nump">335<span></span>
</td>
<td class="num">(522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">53,419<span></span>
</td>
<td class="nump">69,025<span></span>
</td>
<td class="nump">57,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">16,167<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Impact of business combinations</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">10,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill', window );">Reclassifications</a></td>
<td class="num">(9,069)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill', window );">Disposals and derecognitions</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="nump">49<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">7,429<span></span>
</td>
<td class="nump">16,167<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Alcon brand name [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">2,980<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(2,980)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">6,253<span></span>
</td>
<td class="nump">6,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(276)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(5,369)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill', window );">Disposals and derecognitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">884<span></span>
</td>
<td class="nump">6,253<span></span>
</td>
<td class="nump">6,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">35,412<span></span>
</td>
<td class="nump">34,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1,116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(4,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Impact of business combinations</a></td>
<td class="nump">3,550<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill', window );">Reclassifications</a></td>
<td class="nump">9,069<span></span>
</td>
<td class="nump">479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill', window );">Disposals and derecognitions</a></td>
<td class="num">(544)<span></span>
</td>
<td class="num">(928)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="nump">254<span></span>
</td>
<td class="num">(387)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">43,548<span></span>
</td>
<td class="nump">35,412<span></span>
</td>
<td class="nump">34,105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Marketing know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">5,960<span></span>
</td>
<td class="nump">5,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(5,960)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,960<span></span>
</td>
<td class="nump">5,960<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">1,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="num">(572)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Impact of business combinations</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill', window );">Reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="nump">259<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill', window );">Disposals and derecognitions</a></td>
<td class="num">(436)<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">2,253<span></span>
</td>
<td class="nump">1,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Assets and liabilities classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationPriorToClassificationToAssetsHeldForSale', window );">Amortization prior to classification to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(406)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="num">(301)<span></span>
</td>
<td class="num">(406)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Goodwill | Assets and liabilities classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale', window );">Impairment charges related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Intangible Assets other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(30,306)<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">8,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization charge</a></td>
<td class="num">(2,836)<span></span>
</td>
<td class="num">(3,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions', window );">Accumulated impairments on disposals and derecognition</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(1,175)<span></span>
</td>
<td class="num">(1,049)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Reversal of impairment charge</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="num">(148)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="num">(24,632)<span></span>
</td>
<td class="num">(30,306)<span></span>
</td>
<td class="num">(28,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(1,120)<span></span>
</td>
<td class="num">(1,170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions', window );">Accumulated impairments on disposals and derecognition</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(984)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Reversal of impairment charge</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="num">(2,005)<span></span>
</td>
<td class="num">(1,120)<span></span>
</td>
<td class="num">(1,170)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(4,758)<span></span>
</td>
<td class="num">(4,268)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">4,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization charge</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="num">(721)<span></span>
</td>
<td class="num">(4,758)<span></span>
</td>
<td class="num">(4,268)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(21,218)<span></span>
</td>
<td class="num">(19,631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">2,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization charge</a></td>
<td class="num">(2,657)<span></span>
</td>
<td class="num">(2,521)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions', window );">Accumulated impairments on disposals and derecognition</a></td>
<td class="nump">494<span></span>
</td>
<td class="nump">791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="num">(126)<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="num">(20,969)<span></span>
</td>
<td class="num">(21,218)<span></span>
</td>
<td class="num">(19,631)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Currently marketed products | Assets and liabilities classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale', window );">Impairment charges related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification', window );">Impairment charges related to disposal group held for sale to the date of reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Marketing know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(1,906)<span></span>
</td>
<td class="num">(1,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">1,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(238)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,906)<span></span>
</td>
<td class="num">(1,668)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at beginning of period</a></td>
<td class="num">(1,304)<span></span>
</td>
<td class="num">(1,263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill', window );">Cost of assets related to discontinued operations</a></td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization charge</a></td>
<td class="num">(137)<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions', window );">Accumulated impairments on disposals and derecognition</a></td>
<td class="nump">419<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency translation effects</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill at end of period</a></td>
<td class="num">$ (937)<span></span>
</td>
<td class="num">$ (1,304)<span></span>
</td>
<td class="num">$ (1,263)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets and goodwill resulting from classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughClassifiedAsHeldForSaleIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets and goodwill resulting from disposals and retirements. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsAndRetirementsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from transfers. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reversal of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Reversal of impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccumulatedImpairmentsOnDisposalsAndDerecognitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionsIncludedInDisposalGroupToTheDateOfReclassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmortizationPriorToClassificationToAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmortizationPriorToClassificationToAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpairmentChargesRelatedToDisposalGroupHeldForSaleToTheDateOfReclassification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3.a.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2144</ContextCount>
  <ElementCount>999</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>543</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>49</UnitCount>
  <MyReports>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated income statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/StatementOfIncome</Role>
      <ShortName>Consolidated income statements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated statements of comprehensive income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/StatementOfComprehensiveIncome</Role>
      <ShortName>Consolidated statements of comprehensive income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated balance sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/BalanceSheet</Role>
      <ShortName>Consolidated balance sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004000 - Statement - Consolidated statements of changes in equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/StatementOfChangesInEquity</Role>
      <ShortName>Consolidated statements of changes in equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005000 - Statement - Consolidated cash flow statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/StatementsOfCashFlow</Role>
      <ShortName>Consolidated cash flow statements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2100100 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2100200 - Disclosure - Significant transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSignificantTransactions</Role>
      <ShortName>Significant transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2100300 - Disclosure - Segmentation of key figures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFigures</Role>
      <ShortName>Segmentation of key figures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2100400 - Disclosure - Associated companies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompanies</Role>
      <ShortName>Associated companies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2100500 - Disclosure - Interest expense and other financial income and expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpense</Role>
      <ShortName>Interest expense and other financial income and expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2100600 - Disclosure - Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTaxes</Role>
      <ShortName>Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2100700 - Disclosure - Earnings per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEarningsPerShare</Role>
      <ShortName>Earnings per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2100800 - Disclosure - Changes in consolidated statements of comprehensive income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Changes in consolidated statements of comprehensive income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2100900 - Disclosure - Property, plant and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipment</Role>
      <ShortName>Property, plant and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2101000 - Disclosure - Right-of-use assets and lease liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiability</Role>
      <ShortName>Right-of-use assets and lease liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Goodwill and intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssets</Role>
      <ShortName>Goodwill and intangible assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2101200 - Disclosure - Deferred tax assets and liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilities</Role>
      <ShortName>Deferred tax assets and liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2101300 - Disclosure - Financial and other non-current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssets</Role>
      <ShortName>Financial and other non-current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2101400 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2101500 - Disclosure - Trade receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivables</Role>
      <ShortName>Trade receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2101600 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureMarketableSecurities</Role>
      <ShortName>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2101700 - Disclosure - Other current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureOtherCurrentAssets</Role>
      <ShortName>Other current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2101800 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2101900 - Disclosure - Non-current financial debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebt</Role>
      <ShortName>Non-current financial debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2102000 - Disclosure - Provisions and other non-current liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilities</Role>
      <ShortName>Provisions and other non-current liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Current financial debt and derivative financial instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstruments</Role>
      <ShortName>Current financial debt and derivative financial instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2102200 - Disclosure - Provisions and other current liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilities</Role>
      <ShortName>Provisions and other current liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2102300 - Disclosure - Details to the consolidated statements of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatements</Role>
      <ShortName>Details to the consolidated statements of cash flows</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2102400 - Disclosure - Acquisitions of businesses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinesses</Role>
      <ShortName>Acquisitions of businesses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2102500 - Disclosure - Post-employment benefits for associates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociates</Role>
      <ShortName>Post-employment benefits for associates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2102600 - Disclosure - Equity-based participation plans for associates</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociates</Role>
      <ShortName>Equity-based participation plans for associates</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2102700 - Disclosure - Transactions with related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedParties</Role>
      <ShortName>Transactions with related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2102800 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2102900 - Disclosure - Financial instruments - additional disclosures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosures</Role>
      <ShortName>Financial instruments - additional disclosures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2103000 - Disclosure - Discontinued operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperations</Role>
      <ShortName>Discontinued operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Events subsequent to the December 31 consolidated balance sheet date</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSubsequentEvents</Role>
      <ShortName>Events subsequent to the December 31 consolidated balance sheet date</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2103200 - Disclosure - Principal Group subsidiaries and associated companies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompanies</Role>
      <ShortName>Principal Group subsidiaries and associated companies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2200100 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2300100 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2300200 - Disclosure - Significant transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables</Role>
      <ShortName>Significant transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSignificantTransactions</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2300300 - Disclosure - Segmentation of key figures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</Role>
      <ShortName>Segmentation of key figures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFigures</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2300400 - Disclosure - Associated companies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</Role>
      <ShortName>Associated companies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompanies</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2300500 - Disclosure - Interest expense and other financial income and expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseTables</Role>
      <ShortName>Interest expense and other financial income and expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpense</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2300600 - Disclosure - Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTaxesTables</Role>
      <ShortName>Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTaxes</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2300700 - Disclosure - Earnings per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEarningsPerShareTables</Role>
      <ShortName>Earnings per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEarningsPerShare</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2300800 - Disclosure - Changes in consolidated statements of comprehensive income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables</Role>
      <ShortName>Changes in consolidated statements of comprehensive income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncome</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2300900 - Disclosure - Property, plant and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, plant and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipment</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2301000 - Disclosure - Right-of-use assets and lease liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiabilityTables</Role>
      <ShortName>Right-of-use assets and lease liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureRightOfUseAssetsAndLeaseLiability</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2301100 - Disclosure - Goodwill and intangible assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and intangible assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssets</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2301200 - Disclosure - Deferred tax assets and liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables</Role>
      <ShortName>Deferred tax assets and liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilities</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2301300 - Disclosure - Financial and other non-current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsTables</Role>
      <ShortName>Financial and other non-current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssets</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2301400 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureInventories</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2301500 - Disclosure - Trade receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivablesTables</Role>
      <ShortName>Trade receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTradeReceivables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2301600 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables</Role>
      <ShortName>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureMarketableSecurities</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2301700 - Disclosure - Other current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsTables</Role>
      <ShortName>Other current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureOtherCurrentAssets</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2301800 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquity</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2301900 - Disclosure - Non-current financial debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</Role>
      <ShortName>Non-current financial debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebt</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2302000 - Disclosure - Provisions and other non-current liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables</Role>
      <ShortName>Provisions and other non-current liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilities</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2302100 - Disclosure - Current financial debt and derivative financial instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables</Role>
      <ShortName>Current financial debt and derivative financial instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstruments</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2302200 - Disclosure - Provisions and other current liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Provisions and other current liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilities</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2302300 - Disclosure - Details to the consolidated statements of cash flows (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsTables</Role>
      <ShortName>Details to the consolidated statements of cash flows (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatements</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2302400 - Disclosure - Acquisitions of businesses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesTables</Role>
      <ShortName>Acquisitions of businesses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinesses</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2302500 - Disclosure - Post-employment benefits for associates (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</Role>
      <ShortName>Post-employment benefits for associates (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociates</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2302600 - Disclosure - Equity-based participation plans for associates (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables</Role>
      <ShortName>Equity-based participation plans for associates (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociates</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2302700 - Disclosure - Transactions with related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesTables</Role>
      <ShortName>Transactions with related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedParties</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2302800 - Disclosure - Commitments and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2302900 - Disclosure - Financial instruments - additional disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</Role>
      <ShortName>Financial instruments - additional disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosures</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2303000 - Disclosure - Discontinued operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</Role>
      <ShortName>Discontinued operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperations</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2303200 - Disclosure - Principal Group subsidiaries and associated companies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables</Role>
      <ShortName>Principal Group subsidiaries and associated companies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompanies</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2400102 - Disclosure - Significant accounting policies (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSignificantAccountingPoliciesDetails3</Role>
      <ShortName>Significant accounting policies (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2400200 - Disclosure - Significant transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails</Role>
      <ShortName>Significant transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2400201 - Disclosure - Significant transactions (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSignificantTransactionsDetails2</Role>
      <ShortName>Significant transactions (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2400202 - Disclosure - Significant transactions (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDisposalGroupHeldForSaleDetails</Role>
      <ShortName>Significant transactions (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSignificantTransactionsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2400300 - Disclosure - Segmentation of key figures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails</Role>
      <ShortName>Segmentation of key figures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2400301 - Disclosure - Segmentation of key figures (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails1</Role>
      <ShortName>Segmentation of key figures (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2400302 - Disclosure - Segmentation of key figures (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails2</Role>
      <ShortName>Segmentation of key figures (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2400303 - Disclosure - Segmentation of key figures (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails3</Role>
      <ShortName>Segmentation of key figures (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2400304 - Disclosure - Segmentation of key figures (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails4</Role>
      <ShortName>Segmentation of key figures (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2400305 - Disclosure - Segmentation of key figures (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails5</Role>
      <ShortName>Segmentation of key figures (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2400306 - Disclosure - Segmentation of key figures (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails6</Role>
      <ShortName>Segmentation of key figures (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2400307 - Disclosure - Segmentation of key figures (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails7</Role>
      <ShortName>Segmentation of key figures (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2400308 - Disclosure - Segmentation of key figures (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails8</Role>
      <ShortName>Segmentation of key figures (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2400310 - Disclosure - Segmentation of key figures (Details 10)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails10</Role>
      <ShortName>Segmentation of key figures (Details 10)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2400311 - Disclosure - Segmentation of key figures - Top 20 (Details 11)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails11</Role>
      <ShortName>Segmentation of key figures - Top 20 (Details 11)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2400312 - Disclosure - Segmentation of key figures - Net sales by region (Details 12)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSegmentationOfKeyFiguresDetails12</Role>
      <ShortName>Segmentation of key figures - Net sales by region (Details 12)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2400400 - Disclosure - Associated companies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails</Role>
      <ShortName>Associated companies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2400401 - Disclosure - Associated companies (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails2</Role>
      <ShortName>Associated companies (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2400402 - Disclosure - Associated companies (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails3</Role>
      <ShortName>Associated companies (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>2400403 - Disclosure - Associated companies (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails4</Role>
      <ShortName>Associated companies (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>2400404 - Disclosure - Associated companies (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails5</Role>
      <ShortName>Associated companies (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>2400405 - Disclosure - Associated companies (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesDetails6</Role>
      <ShortName>Associated companies (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAssociatedCompaniesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>2400500 - Disclosure - Interest expense and other financial income and expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails</Role>
      <ShortName>Interest expense and other financial income and expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>2400501 - Disclosure - Interest expense and other financial income and expense (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseDetails2</Role>
      <ShortName>Interest expense and other financial income and expense (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureInterestExpenseAndOtherFinancialIncomeExpenseTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>2400600 - Disclosure - Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTaxesDetails</Role>
      <ShortName>Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTaxesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>2400601 - Disclosure - Taxes (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTaxesDetails2</Role>
      <ShortName>Taxes (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTaxesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>2400602 - Disclosure - Taxes (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTaxesDetails3</Role>
      <ShortName>Taxes (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTaxesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>2400700 - Disclosure - Earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEarningsPerShareDetails</Role>
      <ShortName>Earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEarningsPerShareTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>2400800 - Disclosure - Changes in consolidated statements of comprehensive income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails</Role>
      <ShortName>Changes in consolidated statements of comprehensive income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>2400801 - Disclosure - Changes in consolidated statements of comprehensive income (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails2</Role>
      <ShortName>Changes in consolidated statements of comprehensive income (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>2400802 - Disclosure - Changes in consolidated statements of comprehensive income (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails3</Role>
      <ShortName>Changes in consolidated statements of comprehensive income (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>2400803 - Disclosure - Changes in consolidated statements of comprehensive income (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeDetails4</Role>
      <ShortName>Changes in consolidated statements of comprehensive income (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureChangesInConsolidatedStatementsOfComprehensiveIncomeTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>2400900 - Disclosure - Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentDetails</Role>
      <ShortName>Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePropertyPlantAndEquipmentTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>2401000 - Disclosure - Lease liability and Right-of-use assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails</Role>
      <ShortName>Lease liability and Right-of-use assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>2401001 - Disclosure - Lease liability and Right-of-use assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails2</Role>
      <ShortName>Lease liability and Right-of-use assets (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>2401002 - Disclosure - Lease liability and Right-of-use assets (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails3</Role>
      <ShortName>Lease liability and Right-of-use assets (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>2401003 - Disclosure - Lease liability and Right-of-use assets (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails4</Role>
      <ShortName>Lease liability and Right-of-use assets (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>2401004 - Disclosure - Lease liability and Right-of-use assets (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails5</Role>
      <ShortName>Lease liability and Right-of-use assets (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>2401005 - Disclosure - Lease liability and Right-of-use assets (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails6</Role>
      <ShortName>Lease liability and Right-of-use assets (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>2401006 - Disclosure - Lease liability and Right-of-use assets (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureLeaseLiabilityAndRightOfUseAssetsDetails7</Role>
      <ShortName>Lease liability and Right-of-use assets (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>2401100 - Disclosure - Goodwill and intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>2401101 - Disclosure - Goodwill and intangible assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails2</Role>
      <ShortName>Goodwill and intangible assets (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>2401102 - Disclosure - Goodwill and intangible assets (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails3</Role>
      <ShortName>Goodwill and intangible assets (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>2401103 - Disclosure - Goodwill and intangible assets (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsDetails4</Role>
      <ShortName>Goodwill and intangible assets (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureGoodwillAndIntangibleAssetsTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>2401200 - Disclosure - Deferred tax assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Deferred tax assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>2401201 - Disclosure - Deferred tax assets and liabilities (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails2</Role>
      <ShortName>Deferred tax assets and liabilities (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>2401202 - Disclosure - Deferred tax assets and liabilities (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails3</Role>
      <ShortName>Deferred tax assets and liabilities (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>2401203 - Disclosure - Deferred tax assets and liabilities (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails4</Role>
      <ShortName>Deferred tax assets and liabilities (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>2401204 - Disclosure - Deferred tax assets and liabilities (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesDetails5</Role>
      <ShortName>Deferred tax assets and liabilities (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDeferredTaxAssetsAndLiabilitiesTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>2401300 - Disclosure - Financial and other non-current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails</Role>
      <ShortName>Financial and other non-current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>2401301 - Disclosure - Financial and other non-current assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsDetails2</Role>
      <ShortName>Financial and other non-current assets (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialAndOtherNoncurrentAssetsTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>2401400 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureInventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureInventoriesTables</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>2401500 - Disclosure - Trade receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails</Role>
      <ShortName>Trade receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTradeReceivablesTables</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>2401501 - Disclosure - Trade receivables (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails2</Role>
      <ShortName>Trade receivables (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTradeReceivablesTables</ParentRole>
      <Position>124</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>2401502 - Disclosure - Trade receivables (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails3</Role>
      <ShortName>Trade receivables (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTradeReceivablesTables</ParentRole>
      <Position>125</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>2401503 - Disclosure - Trade receivables (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails4</Role>
      <ShortName>Trade receivables (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTradeReceivablesTables</ParentRole>
      <Position>126</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>2401504 - Disclosure - Trade receivables (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTradeReceivablesDetails5</Role>
      <ShortName>Trade receivables (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTradeReceivablesTables</ParentRole>
      <Position>127</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>2401600 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails</Role>
      <ShortName>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables</ParentRole>
      <Position>128</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>2401601 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails2</Role>
      <ShortName>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables</ParentRole>
      <Position>129</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>2401602 - Disclosure - Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesDetails3</Role>
      <ShortName>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureMarketableSecuritiesTables</ParentRole>
      <Position>130</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R131.htm</HtmlFileName>
      <LongName>2401700 - Disclosure - Other current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsDetails</Role>
      <ShortName>Other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureOtherCurrentAssetsTables</ParentRole>
      <Position>131</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R132.htm</HtmlFileName>
      <LongName>2401800 - Disclosure - Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityDetails</Role>
      <ShortName>Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityTables</ParentRole>
      <Position>132</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R133.htm</HtmlFileName>
      <LongName>2401801 - Disclosure - Equity (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityDetails2</Role>
      <ShortName>Equity (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityTables</ParentRole>
      <Position>133</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R134.htm</HtmlFileName>
      <LongName>2401802 - Disclosure - Equity (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityDetails3</Role>
      <ShortName>Equity (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityTables</ParentRole>
      <Position>134</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R135.htm</HtmlFileName>
      <LongName>2401803 - Disclosure - Equity (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityDetails4</Role>
      <ShortName>Equity (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityTables</ParentRole>
      <Position>135</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R136.htm</HtmlFileName>
      <LongName>2401804 - Disclosure - Equity (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityDetails5</Role>
      <ShortName>Equity (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityTables</ParentRole>
      <Position>136</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R137.htm</HtmlFileName>
      <LongName>2401900 - Disclosure - Non-current financial debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails</Role>
      <ShortName>Non-current financial debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</ParentRole>
      <Position>137</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R138.htm</HtmlFileName>
      <LongName>2401901 - Disclosure - Non-current financial debt (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails2</Role>
      <ShortName>Non-current financial debt (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</ParentRole>
      <Position>138</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R139.htm</HtmlFileName>
      <LongName>2401902 - Disclosure - Non-current financial debt (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails3</Role>
      <ShortName>Non-current financial debt (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</ParentRole>
      <Position>139</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R140.htm</HtmlFileName>
      <LongName>2401903 - Disclosure - Non-current financial debt (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails4</Role>
      <ShortName>Non-current financial debt (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</ParentRole>
      <Position>140</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R141.htm</HtmlFileName>
      <LongName>2401904 - Disclosure - Non-current financial debt (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails5</Role>
      <ShortName>Non-current financial debt (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</ParentRole>
      <Position>141</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R142.htm</HtmlFileName>
      <LongName>2401905 - Disclosure - Non-current financial debt (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtDetails6</Role>
      <ShortName>Non-current financial debt (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureNonCurrentFinancialDebtTables</ParentRole>
      <Position>142</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R143.htm</HtmlFileName>
      <LongName>2402000 - Disclosure - Provisions and other non-current liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>Provisions and other non-current liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables</ParentRole>
      <Position>143</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R144.htm</HtmlFileName>
      <LongName>2402001 - Disclosure - Provisions and other non-current liabilities (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails2</Role>
      <ShortName>Provisions and other non-current liabilities (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables</ParentRole>
      <Position>144</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R145.htm</HtmlFileName>
      <LongName>2402002 - Disclosure - Provisions and other non-current liabilities (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails3</Role>
      <ShortName>Provisions and other non-current liabilities (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables</ParentRole>
      <Position>145</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R146.htm</HtmlFileName>
      <LongName>2402003 - Disclosure - Provisions and other non-current liabilities (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails4</Role>
      <ShortName>Provisions and other non-current liabilities (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables</ParentRole>
      <Position>146</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R147.htm</HtmlFileName>
      <LongName>2402004 - Disclosure - Provisions and other non-current liabilities (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesDetails5</Role>
      <ShortName>Provisions and other non-current liabilities (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherNonCurrentLiabilitiesTables</ParentRole>
      <Position>147</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R148.htm</HtmlFileName>
      <LongName>2402100 - Disclosure - Current financial debt and derivative financial instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Current financial debt and derivative financial instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureCurrentFinancialDebtAndDerivativeFinancialInstrumentsTables</ParentRole>
      <Position>148</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R149.htm</HtmlFileName>
      <LongName>2402200 - Disclosure - Provisions and other current liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Provisions and other current liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables</ParentRole>
      <Position>149</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R150.htm</HtmlFileName>
      <LongName>2402201 - Disclosure - Provisions and other current liabilities (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails2</Role>
      <ShortName>Provisions and other current liabilities (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables</ParentRole>
      <Position>150</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R151.htm</HtmlFileName>
      <LongName>2402202 - Disclosure - Provisions and other current liabilities (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesDetails3</Role>
      <ShortName>Provisions and other current liabilities (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureProvisionsAndOtherCurrentLiabilitiesTables</ParentRole>
      <Position>151</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R152.htm</HtmlFileName>
      <LongName>2402300 - Disclosure - Details to the consolidated cash flow statements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails</Role>
      <ShortName>Details to the consolidated cash flow statements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>152</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R153.htm</HtmlFileName>
      <LongName>2402301 - Disclosure - Details to the consolidated cash flow statements (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails2</Role>
      <ShortName>Details to the consolidated cash flow statements (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>153</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R154.htm</HtmlFileName>
      <LongName>2402302 - Disclosure - Details to the consolidated cash flow statements (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails6</Role>
      <ShortName>Details to the consolidated cash flow statements (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>154</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R155.htm</HtmlFileName>
      <LongName>2402303 - Disclosure - Details to the consolidated cash flow statements (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails3</Role>
      <ShortName>Details to the consolidated cash flow statements (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>155</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R156.htm</HtmlFileName>
      <LongName>2402304 - Disclosure - Details to the consolidated cash flow statements (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails4</Role>
      <ShortName>Details to the consolidated cash flow statements (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>156</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R157.htm</HtmlFileName>
      <LongName>2402305 - Disclosure - Details to the consolidated cash flow statements (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDetailsConsolidatedCashFlowStatementsDetails5</Role>
      <ShortName>Details to the consolidated cash flow statements (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>157</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R158.htm</HtmlFileName>
      <LongName>2402400 - Disclosure - Acquisitions of businesses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesDetails</Role>
      <ShortName>Acquisitions of businesses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureAcquisitionsOfBusinessesTables</ParentRole>
      <Position>158</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R159.htm</HtmlFileName>
      <LongName>2402500 - Disclosure - Post-employment benefits for associates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails</Role>
      <ShortName>Post-employment benefits for associates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>159</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R160.htm</HtmlFileName>
      <LongName>2402501 - Disclosure - Post-employment benefits for associates (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails2</Role>
      <ShortName>Post-employment benefits for associates (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>160</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R161.htm</HtmlFileName>
      <LongName>2402502 - Disclosure - Post-employment benefits for associates (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails3</Role>
      <ShortName>Post-employment benefits for associates (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>161</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R162.htm</HtmlFileName>
      <LongName>2402503 - Disclosure - Post-employment benefits for associates (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails4</Role>
      <ShortName>Post-employment benefits for associates (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>162</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R163.htm</HtmlFileName>
      <LongName>2402504 - Disclosure - Post-employment benefits for associates (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails5</Role>
      <ShortName>Post-employment benefits for associates (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>163</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R164.htm</HtmlFileName>
      <LongName>2402505 - Disclosure - Post-employment benefits for associates (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails6</Role>
      <ShortName>Post-employment benefits for associates (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>164</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R165.htm</HtmlFileName>
      <LongName>2402506 - Disclosure - Post-employment benefits for associates (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails7</Role>
      <ShortName>Post-employment benefits for associates (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>165</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R166.htm</HtmlFileName>
      <LongName>2402507 - Disclosure - Post-employment benefits for associates (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails8</Role>
      <ShortName>Post-employment benefits for associates (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>166</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R167.htm</HtmlFileName>
      <LongName>2402508 - Disclosure - Post-employment benefits for associates (Details 9)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails9</Role>
      <ShortName>Post-employment benefits for associates (Details 9)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>167</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R168.htm</HtmlFileName>
      <LongName>2402509 - Disclosure - Post-employment benefits for associates (Details 10)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesDetails10</Role>
      <ShortName>Post-employment benefits for associates (Details 10)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePostEmploymentBenefitsForAssociatesTables</ParentRole>
      <Position>168</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R169.htm</HtmlFileName>
      <LongName>2402600 - Disclosure - Equity-based participation plans for associates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails</Role>
      <ShortName>Equity-based participation plans for associates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables</ParentRole>
      <Position>169</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R170.htm</HtmlFileName>
      <LongName>2402601 - Disclosure - Equity-based participation plans for associates (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails2</Role>
      <ShortName>Equity-based participation plans for associates (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables</ParentRole>
      <Position>170</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R171.htm</HtmlFileName>
      <LongName>2402602 - Disclosure - Equity-based participation plans for associates (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails3</Role>
      <ShortName>Equity-based participation plans for associates (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables</ParentRole>
      <Position>171</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R172.htm</HtmlFileName>
      <LongName>2402603 - Disclosure - Equity-based participation plans for associates (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails4</Role>
      <ShortName>Equity-based participation plans for associates (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables</ParentRole>
      <Position>172</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R173.htm</HtmlFileName>
      <LongName>2402604 - Disclosure - Equity-based participation plans for associates (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesDetails5</Role>
      <ShortName>Equity-based participation plans for associates (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureEquityBasedParticipationPlansForAssociatesTables</ParentRole>
      <Position>173</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R174.htm</HtmlFileName>
      <LongName>2402700 - Disclosure - Transaction with related parties (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails1</Role>
      <ShortName>Transaction with related parties (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>174</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R175.htm</HtmlFileName>
      <LongName>2402701 - Disclosure - Transactions with related parties (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails2</Role>
      <ShortName>Transactions with related parties (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesTables</ParentRole>
      <Position>175</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R176.htm</HtmlFileName>
      <LongName>2402702 - Disclosure - Transactions with related parties (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesDetails3</Role>
      <ShortName>Transactions with related parties (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureTransactionsWithRelatedPartiesTables</ParentRole>
      <Position>176</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R177.htm</HtmlFileName>
      <LongName>2402801 - Disclosure - Commitments and contingencies (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesDetails2</Role>
      <ShortName>Commitments and contingencies (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureCommitmentsAndContingenciesTables</ParentRole>
      <Position>177</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R178.htm</HtmlFileName>
      <LongName>2402900 - Disclosure - Financial instruments - additional disclosures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails</Role>
      <ShortName>Financial instruments - additional disclosures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>178</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R179.htm</HtmlFileName>
      <LongName>2402901 - Disclosure - Financial instruments - additional disclosures (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails2</Role>
      <ShortName>Financial instruments - additional disclosures (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>179</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R180.htm</HtmlFileName>
      <LongName>2402902 - Disclosure - Financial instruments - additional disclosures (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails3</Role>
      <ShortName>Financial instruments - additional disclosures (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>180</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R181.htm</HtmlFileName>
      <LongName>2402903 - Disclosure - Financial instruments - additional disclosures (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails4</Role>
      <ShortName>Financial instruments - additional disclosures (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>181</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R182.htm</HtmlFileName>
      <LongName>2402904 - Disclosure - Financial instruments - additional disclosures (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails5</Role>
      <ShortName>Financial instruments - additional disclosures (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>182</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R183.htm</HtmlFileName>
      <LongName>2402905 - Disclosure - Financial instruments - additional disclosures (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails6</Role>
      <ShortName>Financial instruments - additional disclosures (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>183</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R184.htm</HtmlFileName>
      <LongName>2402906 - Disclosure - Financial instruments - additional disclosures (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails7</Role>
      <ShortName>Financial instruments - additional disclosures (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>184</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R185.htm</HtmlFileName>
      <LongName>2402907 - Disclosure - Financial instruments - additional disclosures (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails8</Role>
      <ShortName>Financial instruments - additional disclosures (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>185</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R186.htm</HtmlFileName>
      <LongName>2402908 - Disclosure - Financial instruments - additional disclosures (Details 9)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails9</Role>
      <ShortName>Financial instruments - additional disclosures (Details 9)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>186</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R187.htm</HtmlFileName>
      <LongName>2402909 - Disclosure - Financial instruments - additional disclosures (Details 10)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails10</Role>
      <ShortName>Financial instruments - additional disclosures (Details 10)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>187</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R188.htm</HtmlFileName>
      <LongName>2402910 - Disclosure - Financial instruments - additional disclosures (Details 11)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails11</Role>
      <ShortName>Financial instruments - additional disclosures (Details 11)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>188</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R189.htm</HtmlFileName>
      <LongName>2402911 - Disclosure - Financial instruments - additional disclosures (Details 12)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails12</Role>
      <ShortName>Financial instruments - additional disclosures (Details 12)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>189</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R190.htm</HtmlFileName>
      <LongName>2402912 - Disclosure - Financial instruments - additional disclosures (Details 13)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails13</Role>
      <ShortName>Financial instruments - additional disclosures (Details 13)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>190</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R191.htm</HtmlFileName>
      <LongName>2402913 - Disclosure - Financial instruments - additional disclosures (Details 14)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresDetails14</Role>
      <ShortName>Financial instruments - additional disclosures (Details 14)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureFinancialInstrumentsAdditionalDisclosuresTables</ParentRole>
      <Position>191</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R192.htm</HtmlFileName>
      <LongName>2403000 - Disclosure - Discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails</Role>
      <ShortName>Discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>192</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R193.htm</HtmlFileName>
      <LongName>2403001 - Disclosure - Discontinued operations (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails2</Role>
      <ShortName>Discontinued operations (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>193</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R194.htm</HtmlFileName>
      <LongName>2403002 - Disclosure - Discontinued operations (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails6</Role>
      <ShortName>Discontinued operations (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>194</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R195.htm</HtmlFileName>
      <LongName>2403003 - Disclosure - Discontinued operations (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails4</Role>
      <ShortName>Discontinued operations (Details 4)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>195</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R196.htm</HtmlFileName>
      <LongName>2403004 - Disclosure - Discontinued operations (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails5</Role>
      <ShortName>Discontinued operations (Details 5)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>196</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R197.htm</HtmlFileName>
      <LongName>2403005 - Disclosure - Discontinued operations (Details 6)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails3</Role>
      <ShortName>Discontinued operations (Details 6)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>197</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R198.htm</HtmlFileName>
      <LongName>2403006 - Disclosure - Discontinued operations (Details 7)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails7</Role>
      <ShortName>Discontinued operations (Details 7)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>198</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R199.htm</HtmlFileName>
      <LongName>2403007 - Disclosure - Discontinued operations (Details 8)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsDetails8</Role>
      <ShortName>Discontinued operations (Details 8)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureDiscontinuedOperationsTables</ParentRole>
      <Position>199</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R200.htm</HtmlFileName>
      <LongName>2403100 - Disclosure - Events subsequent to the December 31 consolidated balance sheet date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosureSubsequentEventsDetails</Role>
      <ShortName>Events subsequent to the December 31 consolidated balance sheet date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosureSubsequentEvents</ParentRole>
      <Position>200</Position>
    </Report>
    <Report instance="nvs-20191231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R201.htm</HtmlFileName>
      <LongName>2403200 - Disclosure - Principal Group subsidiaries and associated companies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesDetails</Role>
      <ShortName>Principal Group subsidiaries and associated companies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://novartis.com/20191231/role/DisclosurePrincipalGroupSubsidiariesAndAssociatedCompaniesTables</ParentRole>
      <Position>201</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>nvs-20191231.xml</File>
    <File>nvs-20191231.xsd</File>
    <File>nvs-20191231_cal.xml</File>
    <File>nvs-20191231_def.xml</File>
    <File>nvs-20191231_lab.xml</File>
    <File>nvs-20191231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.ifrs.org/taxonomy/2019-03-27/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6853524192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred tax assets and liabilities (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxAssetAndLiabilityValuationAbstract', window );"><strong>Deferred tax asset and liability valuation [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Items previously recognized in consolidated income statement</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (440)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Items previously recognized in other comprehensive income</a></td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings', window );">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Total revaluation of deferred tax assets and liabilities</a></td>
<td class="num">$ (124)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(765)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability', window );">Total revaluation of current income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities', window );">Total revaluation of deferred tax assets and liabilities and current income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(799)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges', window );">Impact of new tax reform effective tax rate after implemetation of new reform changes</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges', window );">Impact of new tax reform effective blended tax rate after implemetation of new reform changes</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxAssetAndLiabilityValuationAbstract', window );"><strong>Deferred tax asset and liability valuation [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Items previously recognized in other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(241)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings', window );">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxAssetAndLiabilityValuationAbstract', window );"><strong>Deferred tax asset and liability valuation [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Items previously recognized in consolidated income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Items previously recognized in other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings', window );">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability', window );">Total revaluation of current income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactLocationAxis=nvs_IncomeStatementMember', window );">Income statement [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxAssetAndLiabilityValuationAbstract', window );"><strong>Deferred tax asset and liability valuation [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Items previously recognized in consolidated income statement</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(440)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Total revaluation of deferred tax assets and liabilities</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(440)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability', window );">Total revaluation of current income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities', window );">Total revaluation of deferred tax assets and liabilities and current income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(474)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactLocationAxis=ifrs-full_EquityMember', window );">Equity [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxAssetAndLiabilityValuationAbstract', window );"><strong>Deferred tax asset and liability valuation [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Items previously recognized in other comprehensive income</a></td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings', window );">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset', window );">Total revaluation of deferred tax assets and liabilities</a></td>
<td class="num">$ (358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities', window );">Total revaluation of deferred tax assets and liabilities and current income tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges', window );">Impact of new tax law effective tax rate after implemetation of new law changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment', window );">Impact of new tax law tax on unremitted earnings period allowed for payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings', window );">Impact of new tax law income tax relating to deferred tax assets on unremitted earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DeferredTaxAssetAndLiabilityValuationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DeferredTaxAssetAndLiabilityValuationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawChangeInDeferredTaxAssetsAndLiabilitiesAndCurrentTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawDeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawDeferredTaxRelatingToComponentsOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawEffectiveTaxRateAfterImplemetationOfNewLawChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUnremittedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncreaseDecreaseInCurrentIncomeTaxLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncreaseDecreaseInDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawTaxOnUnremittedEarningsPeriodAllowedForPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxReformEffectiveBlendedTaxRateAfterImplemetationOfNewReformChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxReformEffectiveTaxRateAfterImplemetationOfNewReformChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactLocationAxis=nvs_IncomeStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactLocationAxis=nvs_IncomeStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactLocationAxis=ifrs-full_EquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactLocationAxis=ifrs-full_EquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R188.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842456512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 11) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TenDayLossFairValueVARModelLineItems', window );"><strong>Ten day loss fair value VAR model [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputation', window );">All financial instruments</a></td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates', window );">Instruments sensitive to foreign currency exchange rates</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements', window );">Instruments sensitive to equity market movements</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates', window );">Instruments sensitive to interest rates</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember', window );">Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TenDayLossFairValueVARModelLineItems', window );"><strong>Ten day loss fair value VAR model [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputation', window );">All financial instruments</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates', window );">Instruments sensitive to foreign currency exchange rates</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements', window );">Instruments sensitive to equity market movements</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates', window );">Instruments sensitive to interest rates</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TenDayLossFairValueVARModelLineItems', window );"><strong>Ten day loss fair value VAR model [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputation', window );">All financial instruments</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates', window );">Instruments sensitive to foreign currency exchange rates</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements', window );">Instruments sensitive to equity market movements</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates', window );">Instruments sensitive to interest rates</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TenDayLossFairValueVARModelLineItems', window );"><strong>Ten day loss fair value VAR model [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputation', window );">All financial instruments</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates', window );">Instruments sensitive to foreign currency exchange rates</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements', window );">Instruments sensitive to equity market movements</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates', window );">Instruments sensitive to interest rates</a></td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsValueAtRiskComputation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsValueAtRiskComputation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToEquityMarketMovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToForeignCurrencyExchangeRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsValueAtRiskComputationSensitiveToInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TenDayLossFairValueVARModelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TenDayLossFairValueVARModelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R178.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6850396352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">$ 24,377<span></span>
</td>
<td class="nump">$ 29,374<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=nvs_CashAndCashEquivalentsMember', window );">Cash and cash equivalents [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">11,112<span></span>
</td>
<td class="nump">13,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through other comprehensive income, category [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through other comprehensive income, category [member] | Available-for-sale marketable securities [member] | Debt securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through other comprehensive income, category [member] | Long-term financial investments, fair value through other comprehensive income [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through other comprehensive income, category [member] | Available-for-sale long-term financial investments [member] | Debt securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through other comprehensive income, category [member] | Available-for-sale long-term financial investments [member] | Equity securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through profit or loss, category [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">1,323<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through profit or loss, category [member] | Equity securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">366<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through profit or loss, category [member] | Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through profit or loss, category [member] | Contingent consideration receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through profit or loss, category [member] | Associated companies at fair value through profit and loss [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember', window );">Financial assets at fair value, class [member] | Financial assets at fair value through profit or loss, category [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Financial assets at amortised cost, category [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">10,727<span></span>
</td>
<td class="nump">13,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Financial assets at amortised cost, category [member] | Trade receivables and other current assets excluding pre-payments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">10,337<span></span>
</td>
<td class="nump">11,024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Financial assets at amortised cost, category [member] | Accrued interest on debt securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Financial assets at amortised cost, category [member] | Time deposits with original maturity more than 90 days [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">2,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member] | Financial assets at amortised cost, category [member] | Long-term loans and receivables from customers and finance lease, advances, security deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsLineItems', window );"><strong>Disclosure of financial assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets</a></td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=nvs_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=nvs_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughOtherComprehensiveIncomeCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AvailableForSaleMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AvailableForSaleMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=ifrs-full_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=ifrs-full_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_LongtermFinancialInvestmentsFairValueThroughOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AvailableforsaleLongtermFinancialInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AvailableforsaleLongtermFinancialInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_FundInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_FundInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_ContingentConsiderationReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_ContingentConsiderationReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_DerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_DerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_TradeReceivablesAndOtherCurrentAssetsExcludingPrepaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R180.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6858292208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember', window );">Contract or underlying principal amout [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="nump">$ 11,057<span></span>
</td>
<td class="nump">$ 10,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_PositiveFairValuesMember', window );">Positive fair values [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_NegativeFairValuesMember', window );">Negative fair values [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member] | Contract or underlying principal amout [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="nump">10,779<span></span>
</td>
<td class="nump">10,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract', window );">Derivative financial instruments, commodity purchase contract</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities', window );">Derivative financial instruments, options on equity securities</a></td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member] | Positive fair values [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract', window );">Derivative financial instruments, commodity purchase contract</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member] | Negative fair values [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities', window );">Derivative financial instruments, options on equity securities</a></td>
<td class="num">$ (110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_PositiveFairValuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_PositiveFairValuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_NegativeFairValuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_NegativeFairValuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838827312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory', window );">Goodwill and intangible assets</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">11. Goodwill and intangible assets</div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of goodwill and intangible assets in 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Alcon <br></br> brand name </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Marketing <br></br> know-how </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;700</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;167</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;980</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;253</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;412</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;960</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;253</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 69&nbsp;025</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to <br></br>discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;9&nbsp;000 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;249 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;2&nbsp;980 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;5&nbsp;369 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;4&nbsp;440 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;5&nbsp;960 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;572 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;19&nbsp;570 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group <br></br>held for sale, net <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 3 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 342</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;550</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;914</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 265</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 259</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 767</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;544</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;436</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;055</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 254</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 335</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;429</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 884</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 43&nbsp;548</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;558</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 53&nbsp;419</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Accumulated amortization</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;406</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;21&nbsp;218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;906</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;30&nbsp;306</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated amortization/impairments <br></br>on assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 101 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4&nbsp;184 </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2&nbsp;592 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;906 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 128 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 8&nbsp;813 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization charge <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;42</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;657</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;137</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;836</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated impairments on disposals <br></br>and derecognitions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 70 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 494 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 419 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 983 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;984</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;105</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;175</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;148</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;005</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;721</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;969</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;937</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;24&nbsp;632</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;579</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 621</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Represents the cost of assets and accumulated amortization at January 1, 2019, related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 2 provides additional disclosures related to assets of disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> No addition in the disposal group held for sale for the period from January 1, 2019 to December 31, 2019 </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;6&nbsp;</sup> No amortization or impairment charges related to the disposal group held for sale for the period from January 1, 2019, to December 31, 2019. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of goodwill and intangible assets in 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Alcon <br></br> brand name </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Marketing <br></br> know-how </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;179</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;462</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;638</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;105</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;960</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;852</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 57&nbsp;997</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group <br></br>held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;9 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;276 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1&nbsp;116 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1&nbsp;403 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;224</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;531</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;756</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 479</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 477</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 728</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 385</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;592</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;928</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;183</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;395</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;183</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;380</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;387</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;522</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;700</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;253</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;412</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;960</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;253</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 69&nbsp;025</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Accumulated amortization</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;429</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;268</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;19&nbsp;631</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;668</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;28&nbsp;000</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated amortization/impairments <br></br>on assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 816 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 925 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization charge <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;570</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;521</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;238</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;310</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;639</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated impairments on disposals <br></br>and derecognitions<sup>4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 209 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 791 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 257 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;257 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;049</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 152</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 200</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;406</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;21&nbsp;218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;906</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;30&nbsp;306</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;294</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;047</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;495</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;054</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 38&nbsp;719</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 2 provides additional disclosures related to assets of disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> No addition in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Impairment charges related to the disposal group held for sale for the write-down of the allocated goodwill were USD 183 million and for the currently marketed products were USD 37 million (thereof USD 9 million recognized for the period from January 1, 2018, to the date of reclassification to assets held for sale). For amortization related to discontinued operations, refer to Note 30. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;6&nbsp;</sup> Amortization related to the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 45 million. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;750</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;339</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;720</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 520</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27&nbsp;586</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;767</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 859</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;125</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;579</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 621</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2018: <sup>1</sup> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Alcon <br></br> brand name </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Marketing <br></br> know-how </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;551</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;377</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;228</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 431</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;042</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;837</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 419</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;115</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;875</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;899</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;054</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 363</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;679</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 123</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;294</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;047</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;495</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;054</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 38&nbsp;719</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Innovative Medicines and Sandoz Divisions&#x2019; cash-generating units, to which goodwill is allocated, each comprise a group of smaller cash-generating units. The valuation method of the recoverable amount of the cash-generating units, to which goodwill is allocated, is based on the fair value less costs of disposal. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following assumptions are used in the calculations:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(As a percentage) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative <br></br> Medicines </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Sandoz </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Terminal growth rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discount rate (post-tax)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The discount rates for all divisions consider the Group&#x2019;s weighted average cost of capital, adjusted to approximate the weighted average cost of capital of a comparable market participant. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value less costs of disposal, for all groupings of cash-generating units containing goodwill, is reviewed for the impact of reasonably possible changes in key assumptions. In particular, we considered an increase in the discount rate, a decrease in the terminal growth rate, and certain negative impacts on the forecasted cash flows. These reasonably possible changes in key assumptions did not indicate an impairment. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">&#x201c;Note 1. Significant accounting policies&mdash;Impairment of goodwill and intangible assets&#x201d; provides additional disclosures on how the Group performs goodwill and intangible asset impairment testing. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the intangible asset and goodwill impairment charges for continuing operations for 2019, 2018 and 2017: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;669</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;591</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;506</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;175</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;841</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;652</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> 2019 includes an impairment of USD 416 million related to the write-down of IPR&amp;D acquired through the 2015 Spinifex Pharmaceuticals Inc. acquisition and USD 108 million write-down related to cessation of clinical development program MOR106 for atopic dermatitis. <br></br>2018 includes an impairment of USD 400 million related to a partial write-down of the <i>Votrient</i> currently marketed product. <br></br>2017 includes an impairment of USD 465 million related to the write-down of the Serelaxin IPR&amp;D. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> 2019 includes impairment of USD 442 million related to the write-down of IPR&amp;D related to the discontinuation of the generic Advair&#xae; development program. <br></br>2018 includes impairments of USD 220 million related to the write-down of the allocated goodwill (USD 183 million) and the currently marketed products (USD 37 million) related to the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio. See Note 2. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the reversal of prior year impairment charges amounted to USD 37 million (2018: nil, 2017: nil).</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Note 30 provides additional disclosures on discontinued operations.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R170.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837318448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates (Details 2)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationAnnualIncentivePlanMember', window );">Annual incentive</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">The Annual Incentive for the Novartis Group CEO and other Executive Committee members (ECN) is paid 50% in cash and 50% in Novartis restricted shares (RSs) or restricted share units (RSUs). For the Novartis Top Leaders (NTLs), the Annual Incentive is paid 70% in cash and 30% in RSs or RSUs. Both the ECN and NTLs can opt to invest up to the maximum cash portion of their Annual Incentive to receive further RSs or RSUs. Any cash is paid out during February or March in the year following the end of the performance period, and the shares are granted during January in the year following the end of the performance period.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationShareSavingsPlanMember', window );">Share savings plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">Associates in certain countries and certain key executives worldwide are encouraged to invest their Annual Incentive in a share savings plan. Under the share savings plan, participants may elect to receive their relevant compensation fully or partially in Novartis shares in lieu of cash. As a reward for their participation in the share savings plan, at no additional cost to the participant, Novartis matches their investments in shares after a holding period of three or five years.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember', window );">Employee Share Ownership Plan (ESOP)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">In Switzerland, Employee Share Ownership Plan (ESOP) participants may choose to receive their Annual Incentive (i) 100% in shares, (ii) 50% in shares and 50% in cash, or (iii) 100% in cash. After expiration of a three-year holding period for Novartis shares invested under the ESOP, participants will receive one matching share for every two invested shares. Associates eligible for the equity plan &#8220;Select&#8221; are not eligible to receive ESOP matching shares starting with the 2017 performance period.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember', window );">Leveraged Share Savings Plan (LSSP)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">The Leveraged Share Savings Plan (LSSP) was available to key executives for performance periods prior to 2016. At the participant&#8217;s election, the Annual Incentive was awarded partly or entirely in shares. The elected number of shares is subject to a holding period of five years. At the end of the holding period, Novartis will match the invested shares at a ratio of 1-to-1 (i.e., one share awarded for each invested share). In the United States, both the LSSP award and the corresponding match are cash settled.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectMember', window );">Select</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">The equity plan &#8220;Select&#8221; is a global equity incentive plan under which eligible associates may annually be awarded a grant subject to a three-year, and for selected units a four-year, staggered vesting period. No awards are granted for performance ratings below a certain threshold. Executive Committee members are not eligible to participate in the equity plan &#8220;Select&#8221; effective from the performance period 2014, and the NTLs are not eligible to participate effective from the performance period 2016. The equity plan &#8220;Select&#8221; currently allows participants in Switzerland to choose the form of their equity compensation in RSs or RSUs. In all other jurisdictions, RSs or RSUs are granted unilaterally. Until 2013, participants could also choose to receive part or the entire grant in the form of tradable share options. Tradable share options expire on their 10th anniversary from the grant date. Each tradable share option entitles the holder to purchase after vesting (and before the 10th anniversary from the grant date) one Novartis share at a stated exercise price that equals the closing market price of the underlying share at the grant date. As the exercise price does not reflect the decrease in the Novartis share due to the Alcon spin, one-fifth of an Alcon share will also be awarded to the option holder upon exercise.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermPerformancePlanMember', window );">Long-Term Performance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">The Long-Term Performance Plan (LTPP) is an equity plan for the ECN, the NTLs and employees of Group units with specific targets. Participants are granted a target number of performance share units (PSUs) at the beginning of every performance period, which are converted into unrestricted Novartis shares after the performance period. The actual payout depends on the achievement of the performance measures and ranges between 0% and 200% of the granted amount. PSUs granted under the LTPP do not carry voting rights, but do carry dividend equivalents that are paid in unrestricted Novartis shares at the end of the performance period. The LTPP awards are subject to a three-year performance and vesting period. Until 2018, the performance criteria were based on Novartis internal performance metrics. Starting in 2019, for new grants the performance criteria are based on both Novartis internal performance metrics and variables that can be observed in the market, which is the ranking of the Novartis total shareholder return (TSR) relative to a global healthcare peer group of 14 companies (updated in November 2019 from 15 companies following the acquisition of one of the companies by another company within the peer group) other companies, over rolling three-year performance periods. TSR for Novartis and the peer companies is calculated as the change in the company share price, which is translated to USD at the relevant exchange rate, including the reinvestment return of dividends, over the three-year performance period. The calculation is based on Bloomberg standard published TSR data, which is publicly available. The position of Novartis in the peer group determines the payout range based on a payout matrix.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember', window );">Long-Term Relative Performance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">The LTRPP is an equity plan for the Novartis ECN and NTLs. The last grant under this plan was made in 2018. The LTRPP performance criteria is based on variables that can be observed in the market, which is the ranking of the Novartis TSR relative to a global healthcare peer group of 15 other companies, over rolling three-year performance periods. The TSR for Novartis and the peer companies is calculated as described in the LTPP section above.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationSpecialShareAwardsMember', window );">Special share awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement', window );">Description of share-based payment arrangement</a></td>
<td class="text">Selected associates, excluding the ECN members, may exceptionally receive Special Share Awards of RSs or RSUs. These Special Share Awards provide an opportunity to reward outstanding achievements or exceptional performance, and aim to retain key contributors. They are based on a formal internal selection process, through which the individual performance of each candidate is thoroughly assessed at several management levels. Special Share Awards have a minimum three-year vesting period. In exceptional circumstances, Special Share Awards may be awarded to attract special expertise and new talents to the &#172;organization. Worldwide, associates at different levels in the organization were awarded RSs and RSUs in 2019, 2018 and 2017. In addition, in 2019, 2018 and 2017, Board members received &#172;unrestricted shares as part of their regular compensation.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of a share-based payment arrangement that existed at any time during the reporting period. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationAnnualIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationAnnualIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationShareSavingsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationShareSavingsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationEmployeeShareOwnershipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLeveragedShareSavingsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermPerformancePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermPerformancePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationSpecialShareAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationSpecialShareAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R174.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838732512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transaction with related parties (Details 1)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers', window );">Executive Commitee members</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RelatedPartiesNumberOfNonexecutiveDirectors', window );">Non-executive directors</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInAssociate', window );">Proportion of voting rights held in associate</a></td>
<td class="nump">33.30%<span></span>
</td>
<td class="nump">33.30%<span></span>
</td>
<td class="nump">33.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GenentechRocheMember', window );">Genentech / Roche [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing', window );">Net expense, royalties cost sharing and profit sharing</a></td>
<td class="num">$ (101)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfContractsWithRelatedParties', window );">Number of contracts with related parties</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GenentechRocheMember', window );">Genentech / Roche [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GenentechRocheMember', window );">Genentech / Roche [member] | Xolair [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 920<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfVotingPowerHeldInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of the voting rights in an associate held by the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfVotingPowerHeldInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetExpenseRoyaltiesCostSharingAndProfitSharing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfContractsWithRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfContractsWithRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RelatedPartiesNumberOfExecutiveCommiteeMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RelatedPartiesNumberOfNonexecutiveDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RelatedPartiesNumberOfNonexecutiveDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GenentechRocheMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GenentechRocheMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_XolairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_XolairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R184.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6850536864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 7) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="nump">$ 6,632<span></span>
</td>
<td class="nump">$ 7,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember', window );">Assets and liabilities classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember', window );">Associated companies at fair value through profit and loss [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchaseFairValueMeasurementAssets', window );">Purchases fair value measurement assets</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisposalsFairValueMeasurementAssets', window );">Disposals fair value measurement assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReclassificationFairValueMeasurementAssets', window );">Reclassification fair value measurement assets</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld', window );">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FundInvestmentsMember', window );">Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="nump">251<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value gains and other adjustments including from divestments recognized in the consolidated income statement</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchaseFairValueMeasurementAssets', window );">Purchases fair value measurement assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisposalsFairValueMeasurementAssets', window );">Disposals fair value measurement assets</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld', window );">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_LongTermFinancialInvestmentsMember', window );">Long term financial investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value gains and other adjustments including from divestments recognized in the consolidated income statement</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome', window );">Fair value adjustments recognized in the consolidated statement of comprehensive income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchaseFairValueMeasurementAssets', window );">Purchases fair value measurement assets</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisposalsFairValueMeasurementAssets', window );">Disposals fair value measurement assets</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReclassificationFairValueMeasurementAssets', window );">Reclassification fair value measurement assets</a></td>
<td class="num">(64)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld', window );">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationReceivablesMember', window );">Contingent consideration receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value gains and other adjustments including from divestments recognized in the consolidated income statement</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets', window );">Cash receipts and payments fair value measurement assets</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(484)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld', window );">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationPayablesMember', window );">Contingent consideration payables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="num">(907)<span></span>
</td>
<td class="num">(852)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value gains and other adjustments including from divestments recognized in the consolidated income statement</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchaseFairValueMeasurementAssets', window );">Purchases fair value measurement assets</a></td>
<td class="num">(401)<span></span>
</td>
<td class="num">(182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets', window );">Cash receipts and payments fair value measurement assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="num">(1,036)<span></span>
</td>
<td class="num">(907)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld', window );">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationPayablesMember', window );">Contingent consideration payables [member] | Assets and liabilities classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_OtherFinancialLiabilitiesMember', window );">Other financial liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value gains and other adjustments including from divestments recognized in the consolidated income statement</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets', window );">Fair value losses (including impairments and amortizations) and other adjustments recognized in the consolidated income statement</a></td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchaseFairValueMeasurementAssets', window );">Purchases fair value measurement assets</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets', window );">Cash receipts and payments fair value measurement assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld', window );">Total fair value gains and (losses) recognized in the consolidated income statement for assets and liabilities held at period end</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Long term financial investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Contingent consideration payables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at beginning of period</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsCarryingValueLevel3', window );">Fair value measurement, carrying value, level 3, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashReceiptsAndPaymentsFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisposalsFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisposalsFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This amount can be a debit or a credit as the table discloses the fair value gain and loses on assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsRecognizedInTheConsolidatedStatementOfComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This amount can be a debit or a credit as the table discloses the fair value gain and loses on assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueGainsAndLossesRecognizedInTheConsolidatedIncomeStatementForAssetsAndLiabilitiesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsCarryingValueLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsCarryingValueLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GainsRecognisedInProfitOrLossFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LossesRecognisedInProfitOrLossFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PurchaseFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PurchaseFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReclassificationFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is a reclassification that can be debit or credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReclassificationFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FundInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FundInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_LongTermFinancialInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_LongTermFinancialInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_ContingentConsiderationPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_OtherFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_OtherFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838827312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Earnings per share</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">7. Earnings per share</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income attributable to shareholders of Novartis AG (USD millions)</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;797</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;499</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;590</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;732</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;611</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Number of shares (in millions)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Weighted average number of shares outstanding used in basic earnings per share</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;346</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Weighted average number of shares in diluted earnings per share</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;344</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;371</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Diluted earnings per share (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.08</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.06</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Basic earnings per share (EPS) is calculated by dividing net income attributable to shareholders of Novartis AG by the weighted average number of shares outstanding in a reporting period. This calculation excludes the average number of issued shares purchased by the Group and held as treasury shares. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For diluted EPS, the weighted average number of shares outstanding is adjusted to assume the vesting of all restricted shares, restricted share units, and the conversion of all potentially dilutive shares arising from options on Novartis shares that have been issued. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">No options were excluded from the calculation of diluted EPS in 2019, 2018 or 2017, as all options were dilutive in all years. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842586992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal Group subsidiaries and associated companies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract', window );"><strong>Disclosure of subsidiaries [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Principal Group subsidiaries and associated companies</a></td>
<td class="text"><a name="anchorNote31"></a> <div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">32. Principal Group subsidiaries and&nbsp;associated&nbsp;companies </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table lists the principal subsidiaries controlled by Novartis, associated companies in which Novartis is deemed to have significant influence, and foundations required to be consolidated under IFRS. It includes all subsidiaries, associated companies and consolidated foundations with total assets or net sales to third parties in excess of USD&nbsp;25&nbsp;million. The equity interest percentage shown in the table also represents the share in voting rights in those entities, except where explicitly noted. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Algeria</div> </td> <td align="right" width="1%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Soci&#xe9;t&#xe9; par actions SANDOZ</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Algiers</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DZD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 650.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Argentina</div> </td> <td align="right" width="1%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Argentina S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buenos Aires</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ARS</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 906.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Australia</div> </td> <td align="right" width="1%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Australia Pty Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Macquarie Park, NSW</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Australia Pty Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Macquarie Park, NSW</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pty Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Macquarie Park, NSW</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Austria</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Austria GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vienna</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vienna</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kundl</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">EBEWE Pharma Ges.m.b.H Nfg. KG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unterach am Attersee</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Bangladesh</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Bangladesh) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gazipur</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BDT</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 162.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Belgium</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma NV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vilvoorde</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz NV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vilvoorde</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon - Couvreur NV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Puurs</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Bermuda</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Investment Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Securities Investment Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance Services Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Triangle International Reinsurance Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trinity River Insurance Co Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 370&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Brazil</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Bioci&#xea;ncias S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">S&#xe3;o Paulo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRL</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 265.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz do Brasil Ind&#xfa;stria Farmac&#xea;utica Ltda.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Camb&#xe9;, PR</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRL</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 190.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Canada</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Canada Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dorval, Quebec</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Canada Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Boucherville, Quebec</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CIBA Vision Canada Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mississauga, Ontario</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82&nbsp;886</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Chile</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Chile S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Santiago de Chile</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CLP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">China</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Beijing Novartis Pharma Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Beijing</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals (HK) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hong Kong</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HKD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">China Novartis Institutes for BioMedical Research Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Shanghai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 320.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Suzhou Novartis Technical Development Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Changshu</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai Novartis Trading Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz (China) Pharmaceutical Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Zhongshan</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Colombia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis de Colombia S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Santaf&#xe9; de Bogot&#xe1;</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> COP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.9</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Croatia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz d.o.o. farmaceutska industrija</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Zagreb</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HRK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Czech Republic</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis s.r.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prague</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CZK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 51.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz s.r.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prague</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CZK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Denmark</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare A/S</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Copenhagen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DKK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz A/S</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Copenhagen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DKK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ecuador</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ecuador S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Quito</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Egypt</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma S.A.E.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cairo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EGP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 193.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.77%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Egypt Pharma S.A.E.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">New Cairo City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EGP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Finland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finland Oy</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Espoo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 459&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">France</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Groupe France S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 903.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma S.A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Saint-Genis-Pouilly</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CELLforCURE</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Les Ulis</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Levallois-Perret</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Germany</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Deutschland GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nuremberg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 155.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nuremberg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Produktions GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Wehr</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Manufacturing GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marburg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz International GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1 A Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oberhaching</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">HEXAL AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Salutas Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barleben</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 42.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Aeropharm GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rudolstadt</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Greece</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Hellas) S.A.C.I.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Metamorphosis / Athens</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Hungary</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Hungary Healthcare Limited Liability Company</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Budapest</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HUF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 545.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Hungary Limited Liability Company</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Budapest</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HUF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 883.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">India</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis India Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 123.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 70.68%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare Private Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Private Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Indonesia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">PT. Novartis Indonesia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Jakarta</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> IDR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ireland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ireland Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dublin</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ringaskiddy Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ringaskiddy, County Cork</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Israel</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Israel Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tel Aviv</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ILS</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Italy</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farma S.p.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Origgio</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications (Italy) S.r.l.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pozzilli</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.p.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Origgio</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Japan</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Holding Japan K.K.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma K.K.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ciba-Geigy Japan Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz K.K.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Latvia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Baltics SIA</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Riga</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Luxembourg</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Investments S.&#xe0; r.l.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Malaysia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Corporation (Malaysia) Sdn. Bhd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kuala Lumpur</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MYR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Mexico</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farmac&#xe9;utica, S.A. de C.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mexico City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MXN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 205.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz, S.A. de C.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mexico City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MXN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 468.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Morocco</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Maroc SA</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Casablanca</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Netherlands</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Netherlands B.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amsterdam</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma B.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amsterdam</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">IDB Holland BV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Baarle-Nassau</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz B.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Almere</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 907&nbsp;560</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">New Zealand</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis New Zealand Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Auckland</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> NZD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 820&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Norway</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Norge AS</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oslo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> NOK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Pakistan</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma (Pakistan) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Karachi</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PKR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.99%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Panama</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma (Logistics), Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Panama City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Peru</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Biosciences Per&#xfa; S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lima</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PEN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Philippines</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare Philippines, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Makati City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PHP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 298.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Philippines Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Makati City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PHP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Poland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Poland Sp. z o.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Warsaw</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Polska Sp. z o.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Warsaw</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lek S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Strykow</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Portugal</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Portugal SGPS Lda.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farma - Produtos Farmac&#xea;uticos S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Farmac&#xea;utica Lda.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 499&nbsp;900</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Romania</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Services Romania S.R.L.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bucharest</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RON</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.R.L.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Targu-Mures</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RON</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 105.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Russian Federation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Moscow</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Neva LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">St. Petersburg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ZAO Sandoz</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Moscow</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Saudi Arabia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Saudi Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Riyadh</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SAR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Singapore</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Singapore) Pte Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Singapore</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Singapore Pharmaceutical Manufacturing Pte Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Singapore</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Asia Pacific Pharmaceuticals Pte Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Singapore</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Slovakia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Slovakia s.r.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bratislava</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Slovenia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lek Pharmaceuticals d.d.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pharmaceuticals d.d.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">South Africa</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis South Africa (Pty) Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Midrand</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ZAR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz South Africa (Pty) Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kempton Park</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ZAR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">South Korea</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Korea Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Seoul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> KRW</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.55%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Spain</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farmac&#xe9;utica, S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barcelona</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 63.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications Iberica, S.L.U.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Esplugues de Llobregat</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Farmac&#xe9;utica S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Madrid</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270&nbsp;450</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Industrial Products S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Les Franqueses del Vall&#xe9;s / Barcelona</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon Cusi S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">El Masnou / Barcelona</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Abadia Retuerta S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sard&#xf3;n de Duero / Valladolid</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sweden</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Sverige AB</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stockholm</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SEK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Switzerland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Holding AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International Pharmaceutical Investment AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Bioventures AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Forschungsstiftung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Stiftung f&#xfc;r Kaderausbildung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Mitarbeiterbeteiligungsstiftung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Stiftung f&#xfc;r Mensch und Umwelt</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stiftung der Novartis AG f&#xfc;r Erziehung, Ausbildung und Bildung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Overseas Investments AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japat AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 350.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International Pharmaceutical AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Services AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Schweizerhalle AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Muttenz</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.9</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Stein AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stein</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 251&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Schweiz AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Risch</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ophthalmics AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fribourg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications International SA</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Geneva</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pharmaceuticals AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Risch</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 160.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33/6 <sup style="white-space: nowrap"> 2</sup> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Taiwan</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Taiwan) Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taipei</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TWD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 170.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Thailand</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Thailand) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bangkok</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> THB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 302.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Turkey</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Saglik, Gida ve Tarim &#xdc;r&#xfc;nleri Sanayi ve Ticaret A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Istanbul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Farmanova Saglik Hizmetleri Ltd. Sti.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Istanbul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Ila&#xe7; Sanayi ve Ticaret A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Istanbul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.99%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Grup Saglik &#xdc;r&#xfc;nleri Ila&#xe7;lari Sanayi ve Ticaret A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Gebze - Kocaeli</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ukraine</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Ukraine LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kyiv</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> UAH</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United Arab Emirates</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Middle East FZE</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dubai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AED</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United Kingdom</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis UK Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals UK Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Grimsby Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Imaging Equipment Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vivacta Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frimley / Camberley</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.9</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ziarco Group Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;904</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frimley / Camberley</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United States of America</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 72.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Capital Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Services, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis US Foundation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 650</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications USA, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Millburn, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">AveXis, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bannockburn, IL</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Inflammasome Research, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Technology LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Institutes for BioMedical Research, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cambridge, MA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CoStim Pharmaceuticals Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cambridge, MA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Encore Vision, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Endocyte, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Navigate BioPharma Services, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Carlsbad, CA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reprixys Pharmaceuticals Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Spinifex Pharmaceuticals, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Institute for Functional Genomics, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">San Diego, CA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oriel Therapeutics, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Durham, NC</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fougera Pharmaceuticals Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Melville, NY</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Eon Labs, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Vaccines and Diagnostics, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Venezuela</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis de Venezuela, S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Caracas</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> VES</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">In addition, the Group is represented by subsidiaries and associated companies with total assets or net sales to third parties below USD 25 million in the following countries: Bosnia/Herzegovina, Bulgaria, Dominican Republic, Guatemala, Kenya, North Macedonia, Nigeria, Puerto Rico, Uruguay and Vietnam </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Share capital may not reflect the taxable share capital and does not include any paid-in surplus. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Approximately 33% of voting shares; approximately 6% of total net income and equity attributable to Novartis. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Significant subsidiary under SEC Regulation S-X Rule 1-02(w) </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">m = million; bn = billion</div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839037840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions of businesses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAcquisitionOfBusinessesAbstract', window );"><strong>Disclosure of acquisition of businesses [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Acquisition of businesses</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">24. Acquisitions of businesses</div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Fair value of assets and liabilities arising from acquisitions</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;550</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;531</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Acquired research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 342</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;224</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;223</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 381</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 195</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables and other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;107</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2&nbsp;874</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;325</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables and other liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;178</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;627</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net identifiable assets acquired</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;938</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 925</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 94</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets recognized as a result of business combinations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;946</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 999</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net assets recognized as a result of business combinations in the consolidated balance sheet from continuing operations were USD 13 660 million in 2018 and USD 874 million in 2017. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Note 2 details significant acquisitions of businesses, specifically, <i>Xiidra</i> and IFM Tre, Inc. in 2019; AAA, AveXis and Endocyte in 2018; and Ziarco and Encore in 2017. The goodwill arising out of these acquisitions is attributable to the growth platform, the assembled workforce, and the accounting for deferred tax liabilities on the acquired assets. Goodwill of USD&nbsp;98 million from 2019 is tax deductible. No goodwill from 2018 and 2017 is tax-deductible. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfAcquisitionOfBusinessesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfAcquisitionOfBusinessesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R157.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6855486448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated cash flow statements (Details 6) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at beginning of period</a></td>
<td class="nump">$ 32,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="nump">1,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Proceeds from non-current financial debts</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">$ (2,856)<span></span>
</td>
<td class="num">(4,933)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayment of non-current financial debts</a></td>
<td class="nump">3,195<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Change in current financial debts</a></td>
<td class="nump">1,582<span></span>
</td>
<td class="num">(1,687)<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of lease liabilities, net</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Impact of business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges', window );">Changes in fair values and other changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfBondsDiscount', window );">Amortization of bonds discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Currency translation effects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(555)<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at end of period</a></td>
<td class="nump">27,384<span></span>
</td>
<td class="nump">32,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Financial debts cash flows from continuing operations</a></td>
<td class="num">(1,582)<span></span>
</td>
<td class="nump">1,687<span></span>
</td>
<td class="num">(644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_NonCurrentFinancialDebtsMember', window );">Non-current financial debts [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at beginning of period</a></td>
<td class="nump">22,470<span></span>
</td>
<td class="nump">23,224<span></span>
</td>
<td class="nump">17,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Proceeds from non-current financial debts</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
<td class="nump">4,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayment of non-current financial debts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Impact of business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges', window );">Changes in fair values and other changes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfBondsDiscount', window );">Amortization of bonds discount</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Currency translation effects</a></td>
<td class="num">(141)<span></span>
</td>
<td class="num">(462)<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReclassificationFromNoncurrentToCurrentNet', window );">Reclassification from non-current to current, net</a></td>
<td class="num">(2,003)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentPortionOfNoncurrentFinancialDebt', window );">Current portion of non-current financial debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,190)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at end of period</a></td>
<td class="nump">20,353<span></span>
</td>
<td class="nump">22,470<span></span>
</td>
<td class="nump">23,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember', window );">Current financial debts and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at beginning of period</a></td>
<td class="nump">9,678<span></span>
</td>
<td class="nump">5,308<span></span>
</td>
<td class="nump">5,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayment of non-current financial debts</a></td>
<td class="num">(3,195)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="num">(187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Change in current financial debts</a></td>
<td class="num">(1,582)<span></span>
</td>
<td class="nump">1,681<span></span>
</td>
<td class="num">(755)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Impact of business combinations</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges', window );">Changes in fair values and other changes</a></td>
<td class="nump">129<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfBondsDiscount', window );">Amortization of bonds discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Currency translation effects</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReclassificationFromNoncurrentToCurrentNet', window );">Reclassification from non-current to current, net</a></td>
<td class="nump">2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentPortionOfNoncurrentFinancialDebt', window );">Current portion of non-current financial debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
<td class="nump">359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at end of period</a></td>
<td class="nump">7,031<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
<td class="nump">5,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Financial debts cash flows from continuing operations</a></td>
<td class="nump">1,582<span></span>
</td>
<td class="num">(1,681)<span></span>
</td>
<td class="nump">$ 755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_NoncurrentLeaseLiabilitiesMember', window );">Non-current lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">New leases</a></td>
<td class="nump">362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Impact of business combinations</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges', window );">Changes in fair values and other changes</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Currency translation effects</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReclassificationFromNoncurrentToCurrentNet', window );">Reclassification from non-current to current, net</a></td>
<td class="num">(156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at end of period</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentLeaseLiabilitiesMember', window );">Current lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of lease liabilities, net</a></td>
<td class="num">(273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities', window );">Interest payments for amounts included in lease liabilities classified as cash flows from operating activities</a></td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">New leases</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Impact of business combinations</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges', window );">Changes in fair values and other changes</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Currency translation effects</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReclassificationFromNoncurrentToCurrentNet', window );">Reclassification from non-current to current, net</a></td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments at end of period</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Change in current financial debts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,687)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Financial debts cash flows from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations | Non-current financial debts [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations | Current financial debts and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations | Non-current lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations | Current lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Non-current financial debts [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Current financial debts and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations', window );">Financial debts and lease liabilities related to discontinued operations</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Non-current lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations', window );">Financial debts and lease liabilities related to discontinued operations</a></td>
<td class="num">(246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Current lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Impact of adoption of IFRS 16 Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations', window );">Financial debts and lease liabilities related to discontinued operations</a></td>
<td class="num">$ (40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to an increase (decrease) in current borrowings. [Refer: Current borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 44B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_44B_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 44B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_44B_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 44B<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from non-current borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmortizationOfBondsDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmortizationOfBondsDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentPortionOfNoncurrentFinancialDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentPortionOfNoncurrentFinancialDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DecreaseThroughLiabilitiesRelatedToDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialDebtsAndDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialDebtsAndDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseInFairValueMeasurementLiabilitiesAndOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestPaymentsForAmountsIncludedInLeaseLiabilitiesClassifiedAsCashFlowsFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReclassificationFromNoncurrentToCurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReclassificationFromNoncurrentToCurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_NonCurrentFinancialDebtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_NonCurrentFinancialDebtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentFinancialDebtsAndDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_NoncurrentLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_NoncurrentLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentLeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentLeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842261984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated cash flow statements - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">$ 7,147<span></span>
</td>
<td class="nump">$ 12,800<span></span>
</td>
<td class="nump">$ 7,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Reversal of non-cash items and other adjustments</a></td>
<td class="nump">9,122<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">5,787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceivedClassifiedAsOperatingActivities', window );">Dividends received from associated companies and others</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">719<span></span>
</td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="nump">214<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="num">(793)<span></span>
</td>
<td class="num">(816)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities', window );">Other financial receipts</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities', window );">Other financial payments</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(270)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Taxes paid</a></td>
<td class="num">(1,876)<span></span>
</td>
<td class="num">(1,506)<span></span>
</td>
<td class="num">(1,487)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges', window );">Net cash flows from operating activities from continuing operations before working capital and provision changes</a></td>
<td class="nump">14,272<span></span>
</td>
<td class="nump">13,111<span></span>
</td>
<td class="nump">11,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities', window );">Payments out of provisions and other net cash movements in non-current liabilities</a></td>
<td class="num">(924)<span></span>
</td>
<td class="num">(638)<span></span>
</td>
<td class="num">(829)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems', window );">Change in net current assets and other operating cash flow items</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">576<span></span>
</td>
<td class="nump">332<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations', window );">Net cash flows from operating activities from continuing operations</a></td>
<td class="nump">13,547<span></span>
</td>
<td class="nump">13,049<span></span>
</td>
<td class="nump">11,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash flows from operating activities from discontinued operations</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Total net cash flows from operating activities</a></td>
<td class="nump">13,625<span></span>
</td>
<td class="nump">14,272<span></span>
</td>
<td class="nump">12,621<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(1,379)<span></span>
</td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(1,325)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Proceeds from sales of property, plant and equipment</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Purchase of intangible assets</a></td>
<td class="num">(878)<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
<td class="num">(969)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Proceeds from sales of intangible assets</a></td>
<td class="nump">973<span></span>
</td>
<td class="nump">823<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities', window );">Purchase of financial assets</a></td>
<td class="num">(302)<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="num">(354)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities', window );">Proceeds from sales of financial assets</a></td>
<td class="nump">1,152<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities', window );">Purchase of other non-current assets</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities', window );">Proceeds from sales of other non-current assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies', window );">Acquisitions and divestments of interests in associated companies, net</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">12,854<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities', window );">Acquisitions and divestments of businesses, net</a></td>
<td class="num">(3,760)<span></span>
</td>
<td class="num">(13,683)<span></span>
</td>
<td class="num">(714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities', window );">Purchase of marketable securities and commodities</a></td>
<td class="num">(228)<span></span>
</td>
<td class="num">(2,440)<span></span>
</td>
<td class="num">(580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities', window );">Proceeds from sales of marketable securities and commodities</a></td>
<td class="nump">2,561<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations', window );">Net cash flows used in investing activities from continuing operations</a></td>
<td class="num">(1,067)<span></span>
</td>
<td class="num">(4,590)<span></span>
</td>
<td class="num">(2,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations', window );">Net cash flows used in investing activities from discontinued operations</a></td>
<td class="num">(1,159)<span></span>
</td>
<td class="num">(1,001)<span></span>
</td>
<td class="num">(775)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Total net cash flows used in investing activities</a></td>
<td class="num">(2,226)<span></span>
</td>
<td class="num">(5,591)<span></span>
</td>
<td class="num">(3,119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities', window );">Dividends paid to shareholders of Novartis AG</a></td>
<td class="num">(6,645)<span></span>
</td>
<td class="num">(6,966)<span></span>
</td>
<td class="num">(6,495)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares', window );">Acquisition of treasury shares</a></td>
<td class="num">(5,533)<span></span>
</td>
<td class="num">(2,036)<span></span>
</td>
<td class="num">(5,490)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions', window );">Proceeds from exercise of options and other treasury share transactions</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Increase in non-current financial debts</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">2,856<span></span>
</td>
<td class="nump">4,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayment of non-current financial debts</a></td>
<td class="num">(3,195)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings', window );">Change in current financial debts</a></td>
<td class="num">(1,582)<span></span>
</td>
<td class="nump">1,687<span></span>
</td>
<td class="num">(644)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of lease liabilities, net</a></td>
<td class="num">(273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries', window );">Impact of change in ownership of consolidated entities</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities', window );">Other financing cash flows, net</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations', window );">Net cash flows used in financing activities from continuing operations</a></td>
<td class="num">(16,884)<span></span>
</td>
<td class="num">(4,077)<span></span>
</td>
<td class="num">(7,318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations', window );">Net cash flows from/used in financing activities from discontinued operations</a></td>
<td class="nump">3,257<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="num">(415)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Total net cash flows used in financing activities</a></td>
<td class="num">(13,627)<span></span>
</td>
<td class="num">(4,244)<span></span>
</td>
<td class="num">(7,733)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Net change in cash and cash equivalents before effect of exchange rate changes</a></td>
<td class="num">(2,228)<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">1,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">69<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Total change in cash and cash equivalents</a></td>
<td class="num">(2,159)<span></span>
</td>
<td class="nump">4,411<span></span>
</td>
<td class="nump">1,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">13,271<span></span>
</td>
<td class="nump">8,860<span></span>
</td>
<td class="nump">7,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 11,112<span></span>
</td>
<td class="nump">$ 13,271<span></span>
</td>
<td class="nump">$ 8,860<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to an increase (decrease) in current borrowings. [Refer: Current borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's investing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) investing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to equity holders of the parent, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from dividends received, classified as operating activities. [Refer: Dividends received]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for finance costs paid, classified as operating activities. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCostsPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from finance income received, classified as operating activities. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire equity or debt instruments of other entities (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of equity or debt instruments of other entities (other than receipts for those instruments considered to be cash equivalents and those held for dealing or trading purposes), classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for changes in ownership interests in subsidiaries that do not result in a loss of control. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 42A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_42A&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 42B<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_42B&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire or redeem entity's shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAcquireOrRedeemEntitysShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from non-current borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowsBeforeWorkingCapitalAndProvisionChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DivestmentsAquisitionsOfInterestsInAssociatedCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PaymentsOutOfProvisionsAndOtherNetCashMovementsInNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProceedsFromExerciseOptionsAndOtherTreasuryShareTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProceedsFromSalesOfFinancialAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PurchaseOfFinancialAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6869888432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated income statements - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to discontinued operations</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales from continuing operations</a></td>
<td class="nump">47,498<span></span>
</td>
<td class="nump">44,833<span></span>
</td>
<td class="nump">42,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="num">(14,425)<span></span>
</td>
<td class="num">(14,510)<span></span>
</td>
<td class="num">(13,633)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit from continuing operations</a></td>
<td class="nump">34,252<span></span>
</td>
<td class="nump">31,589<span></span>
</td>
<td class="nump">29,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="num">(14,369)<span></span>
</td>
<td class="num">(13,717)<span></span>
</td>
<td class="num">(12,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="num">(9,402)<span></span>
</td>
<td class="num">(8,489)<span></span>
</td>
<td class="num">(8,389)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="nump">2,031<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="num">(3,426)<span></span>
</td>
<td class="num">(2,609)<span></span>
</td>
<td class="num">(2,137)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income from continuing operations</a></td>
<td class="nump">9,086<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
<td class="nump">8,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Income from associated companies</a></td>
<td class="nump">659<span></span>
</td>
<td class="nump">6,438<span></span>
</td>
<td class="nump">1,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="num">(850)<span></span>
</td>
<td class="num">(932)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other financial income and expense</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes from continuing operations</a></td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">14,095<span></span>
</td>
<td class="nump">9,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes</a></td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="nump">7,147<span></span>
</td>
<td class="nump">12,800<span></span>
</td>
<td class="nump">7,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution', window );">Net income/loss from discontinued operations before gain on distribution</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Gain on distribution</a></td>
<td class="nump">4,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net income/loss from discontinued operations</a></td>
<td class="nump">4,590<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">12,614<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Attributable to</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Shareholders of Novartis AG</a></td>
<td class="nump">11,732<span></span>
</td>
<td class="nump">12,611<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsPerShareAbstract', window );"><strong>Basic earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations', window );">Basic earnings per share, Continuing operations</a></td>
<td class="nump">$ 3.12<span></span>
</td>
<td class="nump">$ 5.52<span></span>
</td>
<td class="nump">$ 3.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic earnings per share, Discontinued operations</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic earnings per share</a></td>
<td class="nump">5.12<span></span>
</td>
<td class="nump">5.44<span></span>
</td>
<td class="nump">3.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsPerShareAbstract', window );"><strong>Diluted earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations', window );">Diluted earnings per share, Continuing operations</a></td>
<td class="nump">3.08<span></span>
</td>
<td class="nump">5.46<span></span>
</td>
<td class="nump">3.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted earnings per share, Discontinued operations</a></td>
<td class="nump">1.98<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted earnings per share</a></td>
<td class="nump">$ 5.06<span></span>
</td>
<td class="nump">$ 5.38<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations [member]; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsSalesToOtherSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R153.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6851374864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated cash flow statements (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefund', window );">Income taxes paid (refund)</a></td>
<td class="nump">$ 1,993<span></span>
</td>
<td class="nump">$ 1,809<span></span>
</td>
<td class="nump">$ 1,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities', window );">Income taxes paid (refund), classified as investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes paid (refund), classified as operating activities</a></td>
<td class="nump">1,876<span></span>
</td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">1,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities', window );">Income taxes paid (refund), classified as investing activities</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes paid (refund), classified as operating activities</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefund">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefund</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as investing activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839054048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsAndContingenciesAbstract', window );"><strong>Commitments and contingencies [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCommitmentsAndContingenciesTextBlock', window );">Commitments and contingencies</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">28. Commitments and contingencies</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development commitments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has entered into long-term research and development agreements with various institutions, which provide for potential milestone payments by Novartis that may be capitalized. As of December 31, 2019, the Group&#x2019;s commitments to make payments under those agreements, and their estimated timing, were as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 809</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 442</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 319</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 724</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Thereafter</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;943</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;404</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Commitments for capital calls</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group holds investments in funds in which it has committed to invest further upon future capital calls. As of December 31, 2019, the total uncalled capital commitments for the Group&#x2019;s investments in funds amounts to USD 79 million. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 29 contains further information on the Group&#x2019;s investments in funds.</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Other commitments</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has entered into various purchase commitments for services and materials as well as for equipment in the ordinary course of business. These commitments are generally entered into at current market prices and reflect normal business operations. For disclosure of property, plant and equipment purchase commitments, see Note 9. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Guarantees issued</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has issued guarantees to third parties in the ordinary course of business, mostly for tax, customs or other governmental agencies. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, Novartis AG is guarantor of the Group&#x2019;s issued bonds, credit facilities and commercial paper program. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Contingencies</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Group companies have to observe the laws, government orders and regulations of the country in which they operate. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A number of Novartis companies are, and will likely continue to be, subject to various legal proceedings and investigations that arise from time to time, including proceedings regarding product liability; sales and marketing practices; commercial disputes; employment and wrongful discharge; and antitrust, securities, health and safety, environmental, tax, international trade, privacy and intellectual property matters. As a result, the Group may become subject to substantial liabilities that may not be covered by insurance and that could affect our business, financial position and reputation. While Novartis does not believe that any of these legal proceedings will have a material adverse effect on its financial position, litigation is inherently unpredictable and large judgments sometimes occur. As a consequence, Novartis may in the future incur judgments or enter into settlements of claims that could have a material adverse effect on its results of operations or cash flow. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Governments and regulatory authorities around the world have been stepping up their compliance and law enforcement activities in recent years in key areas, including marketing practices, pricing, corruption, trade restrictions, embargo legislation, insider trading, antitrust, cyber security and data privacy. Further, when one government or regulatory authority undertakes an investigation, it is not uncommon for other governments or regulators to undertake investigations regarding the same or similar matters. Responding to such investigations is costly and requires an increasing amount of management&#x2019;s time and attention. In addition, such investigations may affect our reputation, create a risk of potential exclusion from government reimbursement programs in the United States and other countries, and lead to (or arise from) litigation. These factors have contributed to decisions by Novartis and other companies in the healthcare industry, when deemed in their interest, to enter into settlement agreements with governmental authorities around the world prior to any formal decision by the authorities or a court. Those government settlements have involved and may continue to involve, in current government investigations and proceedings, large cash payments, sometimes in the hundreds of millions of dollars or more, including the potential repayment of amounts allegedly obtained improperly and other penalties, including treble damages. In addition, settlements of government healthcare fraud cases often require companies to enter into corporate integrity agreements, which are intended to regulate company behavior for a period of years. Our affiliate Novartis Pharmaceuticals Corporation is a party to such an agreement, which will expire in 2020. Also, matters underlying governmental investigations and settlements may be the subject of separate private litigation. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">While provisions have been made for probable losses, which management deems to be reasonable or appropriate, there are uncertainties connected with these estimates. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 20 contains additional information on these matters.</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A number of Group companies are involved in legal proceedings concerning intellectual property rights. The inherent unpredictability of such proceedings means that there can be no assurances as to their ultimate outcome. A negative result in any such proceeding could potentially adversely affect the ability of certain Novartis companies to sell their products, or require the payment of substantial damages or royalties. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the opinion of management, however, the outcome of these actions will not materially affect the Group&#x2019;s financial position but could be material to the results of operations or cash flow in a given period. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s potential environmental remediation liability is assessed based on a risk assessment and investigation of the various sites identified by the Group as at risk for environmental remediation exposure. The Group&#x2019;s future remediation expenses are affected by a number of uncertainties. These uncertainties include, but are not limited to, the method and extent of remediation, the percentage of material attributable to the Group at the remediation sites relative to that attributable to other parties, and the financial capabilities of the other potentially responsible parties. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 20 contains additional information on environmental liabilities.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CommitmentsAndContingenciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CommitmentsAndContingenciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCommitmentsAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCommitmentsAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838853920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current financial debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract', window );"><strong>Disclosure of financial liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock', window );">Disclosure of non-current portion of non-current borrowings by type</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities to banks and other financial institutions <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 285</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finance lease obligations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total, including current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Average interest rate 0.2% (2018: 0.3%) </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock', window );">Disclosure of detailed information about borrowings</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>Coupon </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Currency </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Nominal <br></br> amount </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Issuance <br></br> year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Maturity <br></br> year </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Issuer </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Issue price </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <br></br> (USD <br></br> millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <br></br> (USD <br></br> millions) </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">5.125%</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;000</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2009</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2019</div> </td> <td align="right" width="1%"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Securities Investment Ltd., Hamilton, Bermuda</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.822%</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;000</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2010</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.237%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 998</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.225%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;495</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;493</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.700%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2012</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2042</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.325%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 489</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 489</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;150</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2024</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.287%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;139</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;850</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2044</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.196%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;825</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.750%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.134%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 683</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.625%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2014</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2026</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.697%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 684</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.250%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2025</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.640%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 517</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 508</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.625%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 550</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2029</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.502%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 568</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 558</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.050%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 325</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2035</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis AG, Basel, Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.479%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 330</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.000%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2025</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.010%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;735</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;732</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">4.000%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2015</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2045</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.029%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;219</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;219</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.125%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.127%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;392</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;419</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.625%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2016</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2028</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.480%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 553</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 563</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.800%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2020</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.609%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 998</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2.400%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2022</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.449%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 996</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 995</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">3.100%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2027</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Capital Corporation, New York, United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.109%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 990</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 989</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.000%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2021</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.133%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;396</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;421</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.125%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 600</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2027</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.874%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 684</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">0.500%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2023</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.655%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 837</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 853</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.375%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2030</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.957%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 838</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 856</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1.700%</div> </td> <td align="right"></td> <td align="right"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2038</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Novartis Finance S.A., Luxembourg, Luxembourg</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.217%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 832</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 849</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total straight bonds</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;283</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock', window );">Non-current financial debt including current portion by maturity</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;006</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;067</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;111</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;583</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;585</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;278</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;139</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After 2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock', window );">Non-current financial debt including current portion by currency</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;889</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;964</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;861</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;028</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 184</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 272</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;421</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock', window );">Comparison of balance sheet and fair value of total non-current financial debt including current portion</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <br></br> Balance <br></br> sheet </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <br></br> Fair <br></br> values </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <br></br> Balance <br></br> sheet </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <br></br> Fair <br></br> values </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;701</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;438</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 377</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 377</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;889</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;660</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;815</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock', window );">Collaerallized non-current financial debt and pledged assets</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total net book value of property, <br></br>plant and equipment pledged as <br></br>collateral for non-current financial debts </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 3 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 96 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCollaerallizedNoncurrentFinancialDebtAndPledgedAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfComparisonOfBalanceSheetAndFairValueOfTotalNoncurrentFinancialDebtIncludingCurrentPortionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDetailedInformationAboutBorrowingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByCurrencyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNoncurrentFinancialDebtIncludingCurrentPortionByMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNoncurrentPortionOfNoncurrentBorrowingsByTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R133.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846480160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details 2) - CHF (SFr)<br> shares in Millions, SFr in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding at beginning of period</a></td>
<td class="nump">2,311.2<span></span>
</td>
<td class="nump">2,317.5<span></span>
</td>
<td class="nump">2,374.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TreasurySharesAcquiredToBeCancelled', window );">Treasury shares acquired to be cancelled</a></td>
<td class="num">(60.3)<span></span>
</td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(66.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherSharePurchases', window );">Other share purchases</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ExerciseOfOptionsAndEmployeeTransactionsShares', window );">Exercise of options and employee transactions shares</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EquityBasedCompensationShares', window );">Equity based compensation shares</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesDeliveredToDivestedBusinessEmployees', window );">Shares delivered to divested business employees</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfOtherShareSales', window );">Other share sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShareMovements', window );">Total movements</a></td>
<td class="num">(46.2)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(56.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding at end of period</a></td>
<td class="nump">2,265.0<span></span>
</td>
<td class="nump">2,311.2<span></span>
</td>
<td class="nump">2,317.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TreasurySharesWithRestrictedUse', window );">Treasury shares with restricted use</a></td>
<td class="nump">117.6<span></span>
</td>
<td class="nump">121.6<span></span>
</td>
<td class="nump">131.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StockRepurchaseProgramAuthorizedAmount1', window );">Shares repurchased on the SIX Swiss Exchange second trading line under the share buyback authority approved</a></td>
<td class="nump">SFr 10<span></span>
</td>
<td class="nump">SFr 10<span></span>
</td>
<td class="nump">SFr 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Total Novartis shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding at beginning of period</a></td>
<td class="nump">2,550.6<span></span>
</td>
<td class="nump">2,616.8<span></span>
</td>
<td class="nump">2,627.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesCancelledForCapitalReduction', window );">Shares cancelled for capital reduction</a></td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(66.2)<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShareMovements', window );">Total movements</a></td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(66.2)<span></span>
</td>
<td class="num">(10.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding at end of period</a></td>
<td class="nump">2,527.3<span></span>
</td>
<td class="nump">2,550.6<span></span>
</td>
<td class="nump">2,616.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember', window );">Total treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding at beginning of period</a></td>
<td class="num">(239.4)<span></span>
</td>
<td class="num">(299.3)<span></span>
</td>
<td class="num">(253.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesCancelledForCapitalReduction', window );">Shares cancelled for capital reduction</a></td>
<td class="nump">23.3<span></span>
</td>
<td class="nump">66.2<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TreasurySharesAcquiredToBeCancelled', window );">Treasury shares acquired to be cancelled</a></td>
<td class="num">(60.3)<span></span>
</td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(66.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherSharePurchases', window );">Other share purchases</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ExerciseOfOptionsAndEmployeeTransactionsShares', window );">Exercise of options and employee transactions shares</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EquityBasedCompensationShares', window );">Equity based compensation shares</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesDeliveredToDivestedBusinessEmployees', window );">Shares delivered to divested business employees</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfOtherShareSales', window );">Other share sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShareMovements', window );">Total movements</a></td>
<td class="num">(22.9)<span></span>
</td>
<td class="nump">59.9<span></span>
</td>
<td class="num">(46.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding at end of period</a></td>
<td class="num">(262.3)<span></span>
</td>
<td class="num">(239.4)<span></span>
</td>
<td class="num">(299.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EquityBasedCompensationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EquityBasedCompensationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ExerciseOfOptionsAndEmployeeTransactionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ExerciseOfOptionsAndEmployeeTransactionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfOtherShareSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfOtherShareSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherSharePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherSharePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ShareMovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ShareMovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharesCancelledForCapitalReduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharesCancelledForCapitalReduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharesDeliveredToDivestedBusinessEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharesDeliveredToDivestedBusinessEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TreasurySharesAcquiredToBeCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TreasurySharesAcquiredToBeCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TreasurySharesWithRestrictedUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TreasurySharesWithRestrictedUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837385120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfTradeReceivablesAbstract', window );"><strong>Disclosure of trade receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForTradeReceivablesTableTextBlock', window );">Provisions for trade receivables</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total gross trade receivables</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;396</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;853</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TradeReceivablesProvisionMovementsTableTextBlock', window );">Trade receivables provision movements</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;126</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;190</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;162</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combination</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables charged to the consolidated income statement <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;119</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Utilization of provisions for doubtful trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of provisions for doubtful trade receivables credited to the consolidated income statement <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 30 million in 2018 and USD 94 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Reversal of provisions credited to the consolidated income statement from continuing operations were USD 44 million in 2018 and USD 60 million in 2017. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OverdueAmountsAndRelatedProvisionsTableTextBlock', window );">Overdue amounts and related provision</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not overdue</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;763</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;916</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for not more than one month</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 161</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 296</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one month <br></br>but less than three months </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 123 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 194 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than three months <br></br>but less than six months </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 103 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 136 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than six months <br></br>but less than one year </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 96 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 98 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 213</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for doubtful trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock', window );">Gross trade receivable from closely monitored countries</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total balance of gross trade <br></br>receivables from closely <br></br>monitored countries </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 1&nbsp;588 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 1&nbsp;729 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past due for more than one year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 97</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock', window );">Trade receivables denominated in other currencies</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;466</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;510</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;384</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;551</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 658</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Russian ruble (RUB)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 247</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Chinese yuan (CNY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 279</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 282</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">British pound (GBP)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 183</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Brazilian real (BRL)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 206</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canadian dollar (CAD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 136</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Australian dollar (AUD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 125</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 161</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Swiss franc (CHF)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other currencies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;655</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;693</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total trade receivables, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;727</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfTradeReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfTradeReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GrossTradeReceivableFromCloselyMonitoredCountriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OverdueAmountsAndRelatedProvisionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OverdueAmountsAndRelatedProvisionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsForTradeReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsForTradeReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TradeReceivablesDenominatedInOtherCurrenciesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TradeReceivablesProvisionMovementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TradeReceivablesProvisionMovementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838755072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock', window );">Movements of goodwill and intangible assets</a></td>
<td class="text"><div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of goodwill and intangible assets in 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Alcon <br></br> brand name </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Marketing <br></br> know-how </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;700</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;167</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;980</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;253</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;412</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;960</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;253</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 69&nbsp;025</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to <br></br>discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;9&nbsp;000 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;249 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;2&nbsp;980 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;5&nbsp;369 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;4&nbsp;440 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;5&nbsp;960 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;572 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;19&nbsp;570 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group <br></br>held for sale, net <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 3 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 342</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;550</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;914</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 265</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 259</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 767</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;544</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;436</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;055</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 254</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 335</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;429</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 884</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 43&nbsp;548</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;558</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 53&nbsp;419</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Accumulated amortization</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;406</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;21&nbsp;218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;906</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;30&nbsp;306</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated amortization/impairments <br></br>on assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 101 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4&nbsp;184 </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2&nbsp;592 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;906 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 128 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 8&nbsp;813 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization charge <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;42</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;657</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;137</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;836</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated impairments on disposals <br></br>and derecognitions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 70 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 494 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 419 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 983 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;984</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;105</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;175</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;148</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;005</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;721</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;969</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;937</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;24&nbsp;632</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;579</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 621</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Represents the cost of assets and accumulated amortization at January 1, 2019, related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 2 provides additional disclosures related to assets of disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> No addition in the disposal group held for sale for the period from January 1, 2019 to December 31, 2019 </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;6&nbsp;</sup> No amortization or impairment charges related to the disposal group held for sale for the period from January 1, 2019, to December 31, 2019. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of goodwill and intangible assets in 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Alcon <br></br> brand name </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Marketing <br></br> know-how </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;179</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;462</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;638</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;105</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;960</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;852</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 57&nbsp;997</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group <br></br>held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;9 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;276 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1&nbsp;116 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1&nbsp;403 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;224</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;531</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;756</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 479</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 477</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 728</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 385</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;592</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;928</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;183</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;395</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;183</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;380</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;387</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;522</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;700</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;253</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;412</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;960</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;253</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 69&nbsp;025</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Accumulated amortization</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;429</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;268</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;19&nbsp;631</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;668</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;28&nbsp;000</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated amortization/impairments <br></br>on assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 816 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 925 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization charge <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;570</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;521</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;238</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;310</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;639</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated impairments on disposals <br></br>and derecognitions<sup>4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 209 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 791 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 257 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;257 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;049</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 152</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 200</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;406</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;21&nbsp;218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;906</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;30&nbsp;306</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;294</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;047</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;495</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;054</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 38&nbsp;719</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 2 provides additional disclosures related to assets of disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Reclassifications between various asset categories as a result of product launches of acquired in-process research and development, and completion of software development </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> No addition in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Derecognitions of assets that are no longer used or being developed and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Impairment charges related to the disposal group held for sale for the write-down of the allocated goodwill were USD 183 million and for the currently marketed products were USD 37 million (thereof USD 9 million recognized for the period from January 1, 2018, to the date of reclassification to assets held for sale). For amortization related to discontinued operations, refer to Note 30. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;6&nbsp;</sup> Amortization related to the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 45 million. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock', window );">Allocation of net book values of goodwill and intangible assets by reporting segment</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;750</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;339</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;720</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 520</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27&nbsp;586</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;767</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 85</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 859</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;125</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;579</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 621</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the allocation of the net book values of goodwill and intangible assets by reporting segment at December 31, 2018: <sup>1</sup> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="1" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Goodwill</div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Intangible assets other than goodwill</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="1" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="1" height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> In-process <br></br> research and <br></br> development </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Alcon <br></br> brand name </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Technologies </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currently <br></br> marketed <br></br> products </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Marketing <br></br> know-how </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;551</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;377</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;228</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 431</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;042</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;837</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 419</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;115</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;875</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;899</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;054</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 363</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;679</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Corporate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 123</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;294</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;047</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;495</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;054</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 38&nbsp;719</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AssumptionsUsedInTheCalculationOfValuationTextBlock', window );">Assumptions used in the calculation of valuation</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(As a percentage) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative <br></br> Medicines </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Sandoz </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Terminal growth rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discount rate (post-tax)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IntangibleAssetImpairmentChargesTextBlock', window );">Intangible asset impairment charges</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Innovative Medicines <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;669</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;591</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;506</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;175</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;841</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;652</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> 2019 includes an impairment of USD 416 million related to the write-down of IPR&amp;D acquired through the 2015 Spinifex Pharmaceuticals Inc. acquisition and USD 108 million write-down related to cessation of clinical development program MOR106 for atopic dermatitis. <br></br>2018 includes an impairment of USD 400 million related to a partial write-down of the <i>Votrient</i> currently marketed product. <br></br>2017 includes an impairment of USD 465 million related to the write-down of the Serelaxin IPR&amp;D. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> 2019 includes impairment of USD 442 million related to the write-down of IPR&amp;D related to the discontinuation of the generic Advair&#xae; development program. <br></br>2018 includes impairments of USD 220 million related to the write-down of the allocated goodwill (USD 183 million) and the currently marketed products (USD 37 million) related to the pending divestment of the Sandoz US dermatology business and generic US oral solids portfolio. See Note 2. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AllocationNetBookValuesIntangibleAssetsandGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AssumptionsUsedInTheCalculationOfValuationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AssumptionsUsedInTheCalculationOfValuationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMovementsOfGoodwillAndIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IntangibleAssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IntangibleAssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R137.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838581584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current financial debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract', window );"><strong>Disclosure of components of non-current financial debts [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 22,167<span></span>
</td>
<td class="nump">$ 25,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LiabilitiesToBanksAndOtherInstitutions', window );">Liabilities to banks and other institutions</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinanceLeaseLiabilities', window );">Finance lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total including current portion of non-current financial debt</a></td>
<td class="nump">22,355<span></span>
</td>
<td class="nump">25,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Less current portion of non-current financial debt</a></td>
<td class="num">(2,002)<span></span>
</td>
<td class="num">(3,190)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Total non-current financial debts</a></td>
<td class="nump">$ 20,353<span></span>
</td>
<td class="nump">$ 22,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AverageInterestRateOnLoansReceived', window );">Average interest rate on loans received</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt', window );">Ratio fixed rate financial debt to total financial debt</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AverageInterestRateOnBorrowings', window );">Average interest rate on borrowings</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BondsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of bonds issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BondsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AverageInterestRateOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AverageInterestRateOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AverageInterestRateOnLoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AverageInterestRateOnLoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfComponentsOfNoncurrentFinancialDebtsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LiabilitiesToBanksAndOtherInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LiabilitiesToBanksAndOtherInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RatioFixedRateFinancialDebtToTotalFinancialDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839075872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred tax assets and liabilities (Details 4) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months', window );">Deferred tax asset expected to have an impact on current taxes payable after more than 12 months</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months', window );">Deferred tax liabilities expected to have an impact on current taxes payable after more than 12 months</a></td>
<td class="nump">5.2<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment', window );">Unremitted earnings retained by consolidated entities for reinvestment</a></td>
<td class="nump">61.0<span></span>
</td>
<td class="nump">73.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionForIncomeTaxesOnUnremittedEarnings', window );">Provision for income taxes on unremitted earnings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DeferredTaxAssetExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DeferredTaxLiabilitiesExpectedToHaveAnImpactOnCurrentTaxesPayableAfterMoreThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionForIncomeTaxesOnUnremittedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionForIncomeTaxesOnUnremittedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_UnremittedEarningsRetainedByConsolidatedEntitiesForReinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6894031952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 8) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember', window );">Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member] | Retail Generics [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 7,590<span></span>
</td>
<td class="nump">$ 7,880<span></span>
</td>
<td class="nump">8,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(6.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member] | Biopharmaceuticals [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,607<span></span>
</td>
<td class="nump">$ 1,436<span></span>
</td>
<td class="nump">1,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member] | Anti Infectives [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 534<span></span>
</td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member] | Anti Infectives [member] | Anti Infectives sold under Sandoz name [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 784<span></span>
</td>
<td class="nump">$ 826<span></span>
</td>
<td class="nump">880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 9,731<span></span>
</td>
<td class="nump">$ 9,859<span></span>
</td>
<td class="nump">$ 10,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeOverPeriodAxis=nvs_PoPYEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_RetailGenericsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_RetailGenericsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_BiopharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_BiopharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_AntiInfectivesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_AntiInfectivesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductPortfolioAxis=nvs_AntiInfectivesSoldUnderSandozNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductPortfolioAxis=nvs_AntiInfectivesSoldUnderSandozNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6849839760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and intangible assets (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Reversal of impairment charge</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(1,175)<span></span>
</td>
<td class="num">(841)<span></span>
</td>
<td class="num">(652)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(442)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(669)<span></span>
</td>
<td class="num">(592)<span></span>
</td>
<td class="num">(591)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(506)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz | Disposal groups classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Intangible Assets other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(1,175)<span></span>
</td>
<td class="num">(1,049)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Reversal of impairment charge</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(984)<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Reversal of impairment charge</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Disposal groups classified as held for sale [member] | Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Innovative Medicines | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">(416)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Innovative Medicines | Votrient [member] | Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Innovative Medicines | Serelaxin [member] | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (465)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Innovative Medicines | Other [member] | Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment charge</a></td>
<td class="num">$ (108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reversal of impairment loss recognised in profit or loss for intangible assets other than goodwill. [Refer: Reversal of impairment loss recognised in profit or loss; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_DisposalGroupsClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_VotrientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_VotrientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_SerelaxinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_SerelaxinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844750368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant transactions (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement', window );">Cumulative currency translation gains/losses recycled through income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
<td class="num">$ (946)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Gain on distribution</a></td>
<td class="nump">$ 4,691<span></span>
</td>
<td class="nump">4,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetAssetsDerecognized', window );">Net assets derecognized</a></td>
<td class="num">(20,025)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Derecognition of distribution liability</a></td>
<td class="num">(23,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed', window );">Difference between net assets and distribution liability</a></td>
<td class="nump">3,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DistributionOfDividendToDividendBearingShares', window );">Distribution of dividend to dividend bearing shares</a></td>
<td class="nump">1,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement', window );">Cumulative currency translation gains/losses recycled through income statement</a></td>
<td class="nump">123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TransactionCosts', window );">Transaction costs recognized in the consolidated income statement</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Gain on distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_AlconMember', window );">Alcon | Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPayable', window );">Derecognition of distribution liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of difference between the carrying amount of dividends payable and the carrying amount of non-cash assets distributed when settling the dividends payable. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 15<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_15&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends payable by means of the distribution of non-cash assets to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRIC<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRIC&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DistributionOfDividendToDividendBearingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DistributionOfDividendToDividendBearingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetAssetsDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetAssetsDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_AlconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_AlconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6871211376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet', window );">Impairment charges and fair value gains on financial assets, net</a></td>
<td class="nump">38<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToRestructuringProvisions', window );">Additions to restructuring provisions</a></td>
<td class="num">(492)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Equity-based compensation of Novartis equity plans</a></td>
<td class="num">(1,067)<span></span>
</td>
<td class="num">(918)<span></span>
</td>
<td class="num">(853)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember', window );">Property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(1,345)<span></span>
</td>
<td class="num">(1,482)<span></span>
</td>
<td class="num">(1,303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(202)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember', window );">Intangible assets and goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(2,836)<span></span>
</td>
<td class="num">(2,587)<span></span>
</td>
<td class="num">(2,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(1,138)<span></span>
</td>
<td class="num">(841)<span></span>
</td>
<td class="num">(652)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet', window );">Impairment charges and fair value gains on financial assets, net</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToRestructuringProvisions', window );">Additions to restructuring provisions</a></td>
<td class="num">(229)<span></span>
</td>
<td class="num">(395)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Equity-based compensation of Novartis equity plans</a></td>
<td class="num">(761)<span></span>
</td>
<td class="num">(645)<span></span>
</td>
<td class="num">(593)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Property, plant and equipment [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(952)<span></span>
</td>
<td class="num">(1,075)<span></span>
</td>
<td class="num">(916)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Right-of-use assets [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Intangible assets and goodwill [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(2,509)<span></span>
</td>
<td class="num">(2,214)<span></span>
</td>
<td class="num">(2,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(632)<span></span>
</td>
<td class="num">(592)<span></span>
</td>
<td class="num">(591)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToRestructuringProvisions', window );">Additions to restructuring provisions</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Equity-based compensation of Novartis equity plans</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz | Property, plant and equipment [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(283)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
<td class="num">(270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz | Right-of-use assets [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz | Intangible assets and goodwill [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(315)<span></span>
</td>
<td class="num">(366)<span></span>
</td>
<td class="num">(447)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(506)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet', window );">Impairment charges and fair value gains on financial assets, net</a></td>
<td class="nump">20<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">(185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToRestructuringProvisions', window );">Additions to restructuring provisions</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Equity-based compensation of Novartis equity plans</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate | Property, plant and equipment [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate | Right-of-use assets [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate | Intangible assets and goodwill [member] | Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionsToRestructuringProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionsToRestructuringProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6849432736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="nump">$ 659<span></span>
</td>
<td class="nump">$ 6,438<span></span>
</td>
<td class="nump">$ 1,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income effect</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Total comprehensive income effect</a></td>
<td class="nump">565<span></span>
</td>
<td class="nump">5,956<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies', window );">Recycling of the Novartis share of other comprehensive income from associated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income effect</a></td>
<td class="num">(94)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Total comprehensive income effect</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="nump">564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember', window );">GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,910<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(557)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Total comprehensive income effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,353<span></span>
</td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Total comprehensive income effect</a></td>
<td class="num">$ (3)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the total comprehensive income of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Joint ventures [member]; Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B16<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B16_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfTotalComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RecyclingOfTheNovartisShareOfOtherComprehensiveIncomeFromAssociatedCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6874339088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details 7) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 12,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">$ 1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">88,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">118,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Reserves</a></td>
<td class="nump">54,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">55,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">20,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="nump">6,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">34,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Financial debts and derivative financial instruments</a></td>
<td class="nump">7,031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current lease liabilities</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">28,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">62,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="nump">$ 118,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember', window );">Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember', window );">Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member', window );">Increase (decrease) due to changes in accounting policy, IFRS 16 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Financial debts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(212)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Financial debts and derivative financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_IncreaseDecreaseDueToChangesInAccountingPolicyIFRS16Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R181.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6849889328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 4) - Contract or underlying principal amout [member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="nump">$ 11,057<span></span>
</td>
<td class="nump">$ 10,823<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember', window );">EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">2,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember', window );">USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="nump">8,019<span></span>
</td>
<td class="nump">6,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstruments', window );">Derivative financial instruments</a></td>
<td class="nump">1,665<span></span>
</td>
<td class="nump">1,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="nump">10,779<span></span>
</td>
<td class="nump">10,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract', window );">Derivative financial instruments, commodity purchase contract</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities', window );">Derivative financial instruments, options on equity securities</a></td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member] | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="nump">1,373<span></span>
</td>
<td class="nump">2,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member] | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="nump">7,760<span></span>
</td>
<td class="nump">6,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract', window );">Derivative financial instruments, commodity purchase contract</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities', window );">Derivative financial instruments, options on equity securities</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember', window );">Derivative financial instruments, at fair value currency related [member] | Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts', window );">Derivative financial instruments, forward foreign exchange rate contracts</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">$ 1,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities', window );">Derivative financial instruments, options on equity securities</a></td>
<td class="nump">$ 19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsCommodityPurchaseContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsForwardForeignExchangeRateContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsOptionsOnEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsPrincipalAmountsAxis=nvs_ContractOrUnderlyingPrincipalAmoutMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=nvs_CurrencyOthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=nvs_CurrencyOthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentNatureOfInstrumentAxis=nvs_DerivativeFinancialInstrumentsAtFairValueCurrencyRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865449568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets and lease liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract', window );"><strong>Lease liabilities and Right of use assets Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Disclosure of leases [text block]</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">10. Right-of-use assets and lease liabilities</div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Impact of adoption of IFRS 16 Leases</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Note 1 explains the changes and new accounting policy introduced on January 1, 2019, resulting from the adoption of the new accounting standard IFRS 16 Leases. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On transition to IFRS 16, the Group elected to apply the practical expedient to not reassess whether a contract is, or contains, a lease at January 1, 2019, the implementation date of IFRS 16. As a result, at the date of implementation, the Group applied IFRS 16 only to contracts that were previously identified as leases under IAS 17 Leases and related interpretations, and the definition of a lease under IFRS 16 was applied only to contracts entered into or changed on or after January 1, 2019. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impact on retained earnings upon implementation of IFRS 16 was USD 3 million arising from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group has entered into various fixed-term leases, mainly for vehicles and real estate. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The lease liabilities recorded in continuing operations on January 1, 2019, were USD 1.7 billion and the right-of-use assets were USD 1.6 billion. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Reconciliation of lease commitment disclosed on December 31, 2018, and lease liability recorded in continuing operations on January 1, 2019, is as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating lease commitments December 31, 2018 <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;612</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating lease commitments December 31, 2018 related to discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;222</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating lease commitments December 31, 2018 related to continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;390</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition exemption for short-term leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition exception for low-value leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease arrangements with commencement date after December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Undiscounted future lease payments continuing <br></br>operations as of January 1, 2019 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 3&nbsp;283 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Effect of discounting</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;547</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Lease liabilities recognized as of January 1, 2019 <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;736</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp; </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> As reported in Annual Report 2018 Note 27 </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> The weighted average incremental borrowing rate at January 1, 2019, the date of implementation of IFRS 16 Leases, was 3.5%. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The right-of-use assets of continuing operations at January 1, 2019, by underlying class of asset comprise the following: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> January 1, 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Land</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 147</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment, and other assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;554</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp; </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Right-of-use assets were lower than the lease liability at the date of implementation of IFRS 16 by USD 182 million, due to adjustments made for recognition of sublease receivables, prepayments and accrued lease payments and transfers from leased assets recorded in property, plant and equipment at December 31, 2018. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The adoption of IFRS 16 on January 1, 2019 had an impact on the classification of the annual lease expense in the consolidated income statement, the recognition of right-of-use assets and lease liabilities in the balance sheet and the classification of the annual lease payments in the consolidated statement of cash flows. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The adoption of IFRS 16 on January 1, 2019 did not significantly impact the individual lines of the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the adjustments to the line items of the January 1, 2019, consolidated balance sheet, due to the implementation of IFRS 16: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> January 1, 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current assets</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;101</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;554</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity and liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reserves</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;471</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provision and other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;212</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;257</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 268</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 267</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;524</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity and liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As a result of applying the modified retrospective method at the date of implementation of IFRS 16 on January 1, 2019, whereby the right-of-use assets were measured at the amount equal to the lease liabilities, there is no impact to the reported deferred tax assets and deferred tax liabilities on the consolidated balance sheet, as the corresponding deferred tax assets and deferred tax liabilities attributable to the lease liability and right-of-use asset relate to income taxes levied by the same taxation authority within the same legal entity, and were therefore offset. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The adoption of IFRS 16 on January 1, 2019 had no significant impact on the individual lines of the consolidated statement of cash flows, except for the principal portion of the lease payments (USD 0.3 billion for the year ended December 31, 2019) that is recognized as an outflow in the cash flow from financing activities and the interest portion of the lease payment (USD 0.1 billion for the year ended December 31, 2019) is recognized as an outflow in the cash flow from operating activities. Prior to the adoption of IFRS 16, the full amount of the lease payments was recognized as an outflow in the cash flow from operating activities. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Current year disclosures</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of the right-of-use assets of continuing operations: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Right-of-use assets at January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;554</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;305</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease contract terminations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total right-of-use assets at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;677</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> No impairments were recorded in the period. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Lease contract terminations also includes modifications to existing leases that result in reductions to the right-of-use assets, and reductions due to sub-leasing. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The right-of-use assets carrying value and depreciation charge of continuing operations at December 31, 2019, are shown below by underlying class of asset: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> December 31, 2019 <br></br> carrying value </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Depreciation <br></br> charge <br></br> 2019 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Land</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 990</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 194</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment, and other assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total right-of-use assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;677</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 305</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The lease liabilities of continuing operations at December 31, 2019, by maturity are as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Lease liabilities <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Lease liabilities <br></br> undiscounted <br></br> 2019 </div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less than one year</div> </td> <td align="right" width="1%"></td> <td align="right" width="16%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div> </td> <td align="right" width="1%"></td> <td align="right" width="16%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 295</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between one and two years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between two and three years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between three and four years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 138</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 173</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between four and five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;081</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;419</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;485</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion of lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;295</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current portion of lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;703</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;190</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At January 1, 2019 and December 31, 2019, there were no material future cash outflows, including extension options, excluded from the measurement of lease liabilities. The Group&#x2019;s most material lease with a lease term extension, representing a lease liability value of USD 0.6 billion, has a determined lease term end date of 2071. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, the Group completed sale and leaseback transactions for certain property, plant and equipment as part of its plans to consolidate sites. Transactions resulted in net cash inflows of USD 0.7 billion and the recognition of USD 96 million of lease liabilities, and USD 37 million of right-of-use assets. The right-of-use assets value reflects the proportion of the property, plant and equipment retained for a period of one to five years, with two five-year extension periods for certain right-of-use assets. The liabilities reflect the net present value of future lease payments. The net gain on the sale and leaseback transactions amounted to USD 478 million. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table provides additional disclosures related to right-of-use assets and lease liabilities of continuing operations: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense on lease liabilities <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense on short-term leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense on low-value leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total cash outflows for leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 339</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cash outflows for short-term leases <br></br>and low-value leases <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br> 15 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Payments of interest <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 51</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Payments of lease liabilities <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 273</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> The weighted average interest rate is 3.9%. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Cash flows from short-term and low-value leases are included within total net cash flows from operating activities. The portfolio of short-term leases to which the Group is committed to at December 31, 2019, is similar to the portfolio of short-term leases the Group entered into during 2019. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Included within total net cash flows from operating activities. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Reported as cash outflows used in financing activities net of lease incentives received of USD 33 million. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The net investment held and the income from subleasing right-of-use assets was not significant. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Note 30 provides additional disclosures on discontinued operations.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LeaseLiabilitiesAndRightOfUseAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R171.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6875558480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates (Details 3) - Select outside North America<br> Pure in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at beginning of period</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period</a></td>
<td class="nump">$ 59.9<span></span>
</td>
<td class="nump">$ 59.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised or sold</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options exercised in share-based payment arrangement</a></td>
<td class="nump">$ 58.4<span></span>
</td>
<td class="nump">$ 58.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period</a></td>
<td class="nump">$ 60.9<span></span>
</td>
<td class="nump">$ 59.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options exercisable in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.9<span></span>
</td>
<td class="nump">$ 59.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 1 month 5 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">$ 59.9<span></span>
</td>
<td class="nump">$ 59.5<span></span>
</td>
<td class="nump">$ 60.9<span></span>
</td>
<td class="nump">$ 59.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember', window );">54.5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember', window );">57.0</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember', window );">57.6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember', window );">66.0</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice54.5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice54.5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.0Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.0Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice66.0Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice66.0Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R175.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6840449632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with related parties (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Benefits other than equity-based compensation</a></td>
<td class="nump">$ 24.8<span></span>
</td>
<td class="nump">$ 26.5<span></span>
</td>
<td class="nump">$ 22.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Equity-based compensation</a></td>
<td class="nump">45.2<span></span>
</td>
<td class="nump">47.3<span></span>
</td>
<td class="nump">54.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">72.6<span></span>
</td>
<td class="nump">76.3<span></span>
</td>
<td class="nump">79.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel of entity or parent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Benefits other than equity-based compensation</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Post-employment benefits</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Equity-based compensation</a></td>
<td class="nump">40.6<span></span>
</td>
<td class="nump">42.5<span></span>
</td>
<td class="nump">49.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">67.5<span></span>
</td>
<td class="nump">70.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_NonExecutiveDirectorMember', window );">Non-Executive Director [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Benefits other than equity-based compensation</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Equity-based compensation</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_NonExecutiveDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_NonExecutiveDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R185.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6857265904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 8) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">$ 11,446<span></span>
</td>
<td class="nump">$ 15,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(20,353)<span></span>
</td>
<td class="num">(22,470)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(7,031)<span></span>
</td>
<td class="num">(9,678)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="num">(15,938)<span></span>
</td>
<td class="num">(16,184)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_MarketableSecuritiesAndTimeDepositsMember', window );">Marketable securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">2,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CommoditiesMember', window );">Commodities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember', window );">Deriviative financial instruments and accrued interest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CashAndCashEquivalentsMember', window );">Cash and cash equivalents [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">11,112<span></span>
</td>
<td class="nump">13,271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialDebtMember', window );">Financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(20,353)<span></span>
</td>
<td class="num">(22,470)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(6,846)<span></span>
</td>
<td class="num">(9,620)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialDebtUndiscountedMember', window );">Financial debt - undiscounted [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(20,505)<span></span>
</td>
<td class="num">(22,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(6,846)<span></span>
</td>
<td class="num">(9,620)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_DerivativeFinancialInstrumentsMember', window );">Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">9,746<span></span>
</td>
<td class="nump">3,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(4,373)<span></span>
</td>
<td class="num">(5,233)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="nump">5,373<span></span>
</td>
<td class="num">(1,583)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member] | Marketable securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member] | Deriviative financial instruments and accrued interest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member] | Cash and cash equivalents [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">9,712<span></span>
</td>
<td class="nump">3,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member] | Financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(4,243)<span></span>
</td>
<td class="num">(5,217)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member] | Financial debt - undiscounted [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(4,243)<span></span>
</td>
<td class="num">(5,217)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(130)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">1,505<span></span>
</td>
<td class="nump">9,831<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(1,402)<span></span>
</td>
<td class="num">(4,118)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">5,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member] | Marketable securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member] | Deriviative financial instruments and accrued interest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member] | Cash and cash equivalents [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">9,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member] | Financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(1,373)<span></span>
</td>
<td class="num">(4,084)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member] | Financial debt - undiscounted [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(1,373)<span></span>
</td>
<td class="num">(4,084)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">2,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(1,256)<span></span>
</td>
<td class="num">(327)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="num">(1,237)<span></span>
</td>
<td class="nump">1,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member] | Marketable securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">2,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member] | Deriviative financial instruments and accrued interest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member] | Financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(1,230)<span></span>
</td>
<td class="num">(319)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member] | Financial debt - undiscounted [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(1,230)<span></span>
</td>
<td class="num">(319)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial debt</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(9,110)<span></span>
</td>
<td class="num">(8,980)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="num">(9,104)<span></span>
</td>
<td class="num">(8,782)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years | Marketable securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years | Deriviative financial instruments and accrued interest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years | Financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(9,110)<span></span>
</td>
<td class="num">(8,980)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years | Financial debt - undiscounted [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(9,150)<span></span>
</td>
<td class="num">(9,025)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(11,243)<span></span>
</td>
<td class="num">(13,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="num">(11,073)<span></span>
</td>
<td class="num">(13,323)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years | Marketable securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years | Commodities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years | Deriviative financial instruments and accrued interest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Current financial assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years | Financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">(11,243)<span></span>
</td>
<td class="num">(13,490)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years | Financial debt - undiscounted [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaturityOfNetDebtLineItems', window );"><strong>Maturity of net debt [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial debts</a></td>
<td class="num">$ (11,355)<span></span>
</td>
<td class="num">$ (13,623)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net debt of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MaturityOfNetDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MaturityOfNetDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_MarketableSecuritiesAndTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_MarketableSecuritiesAndTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CommoditiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CommoditiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_DeriviativeFinancialInstrumentsAndAccruedInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialDebtUndiscountedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialDebtUndiscountedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_DerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_DerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865417648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfIncomeTaxAbstract', window );"><strong>Disclosure of IncomeTax [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Taxes</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">6. Taxes</div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Income before taxes</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;097</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;887</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;385</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 843</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;717</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Current and deferred income tax expense</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;186</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;615</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;462</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;961</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;988</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;451</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current income tax expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;913</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;93</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;305</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 447</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 428</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 615</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Deferred tax income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 354</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 308</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 310</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income tax expense from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Analysis of tax rate</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has a substantial business presence in many countries and is therefore subject to different income and expense items that are non-taxable (permanent differences) or are taxed at different rates in those tax jurisdictions. This results in a difference between our applicable tax rate and effective tax rate. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The main elements contributing to the difference between the Group&#x2019;s overall applicable tax rate (which can change each year since it is calculated as the weighted average tax rate based on the pre-tax income of each subsidiary) and the effective tax rate are shown in the table below: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(As a percentage)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Applicable tax rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14.3</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of disallowed expenditures</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of utilization of tax losses <br></br>brought forward from prior periods </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of income taxed at reduced rates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of income not subject to tax <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax credits and allowances</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of release of <br></br>contingent consideration liability </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;0.5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;0.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1.3 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax rate change <br></br>on current and deferred <br></br>tax assets and liabilities <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;1.4 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 4.8 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of write-off of deferred tax assets <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of write-down and reversal of <br></br>write-down of investments in subsidiaries </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;0.6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 0.0 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1.1 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax benefits expiring in 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of prior-year items</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of other items <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Effective tax rate for continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17.6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Included in 2018 is the effect of income not subject to tax (-3.7%) arising from the portion of the non-taxable gain on the divestment of the Group's investment in GSK Consumer Healthcare Holdings Ltd. attributable to Switzerland. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> 2019 is mainly related to the revaluation of the deferred tax assets and liabilities resulting from the tax reforms enacted in Switzerland in 2019, refer to Note 12 for additional disclosures. <br></br>Included in 2017 is a 4.8% impact related to the revaluation of the deferred tax assets and liabities and a portion of current tax payables. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017, refer to Note 12 for additional disclosures. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> 2019 is primarily related to a non-cash, one-time deferred tax expense for the write-off of a deferred tax asset resulting from legal entity reorganizations. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> In 2019, other items (+3.0%) include changes in uncertain tax positions (+2.6%) and other items (+0.4%). </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The utilization of tax-loss carry-forwards lowered the tax charge by USD&nbsp;11 million in 2019, by USD&nbsp;19 million in 2018, and by USD&nbsp;7 million in 2017.</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For the amount of taxes attributable to discontinued operations, see Note 30.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfIncomeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfIncomeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R189.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873364256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 12)<br> $ in Millions, &#8364; in Billions, &#165; in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets', window );">Transfers out of Level 3 of fair value hierarchy, assets</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10', window );">Amount of change in OCI when pricing parameters for level 3 change more than 10%</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10', window );">Amount of change in OCI when most significant parameters for level 3 change more than 10%</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10', window );">Amount of change in OCI when POS for level 3 change more than 10%</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueOnSaleOfOtherFinancialAssets', window );">Fair value on sale of other financial assets</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MostSignificantForeignExchangeLosses', window );">Most significant foreign exchange losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LongtermFinancialDebtWithACarryingAmount', window );">Long-term financial debt with a carrying amount</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">&#8364; 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaximumMarginPercentageImpactOfCommodityPriceChange', window );">Maximum margin percentage impact of commodity price change</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MaximumHoldingInUnrelatedCompany', window );">Maximum holding in unrelated company</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge', window );">Unrealized income was recognized in other comprehensive income and accumulated in currency translation effects in relation with this net investment hedge</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement', window );">Net investment hedge recognized in the income statement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCommercialPaperMaximumBorrowingAmount', window );">Borrowings commercial paper maximum borrowing amount</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCommercialPaperNumberOfPrograms', window );">Borrowings commercial paper, number of programs</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCreditFacilityCommitted', window );">Borrowings credit facility committed</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCreditFacilityShortTerm', window );">Borrowings credit facility short term</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountBorrowedUnderTheCreditFacility', window );">Amount borrowed under the credit facility</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_VAREstimateConfidenceInterval', window );">VAR estimate confidence interval</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement', window );">Net loss/gain recorded on equity securities and fund investments at fair value through the consolidated income statement</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_USCommercialPaperProgramsMember', window );">US commercial paper programs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCommercialPaperMaximumBorrowingAmount', window );">Borrowings commercial paper maximum borrowing amount</a></td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCommercialPaperNumberOfPrograms', window );">Borrowings commercial paper, number of programs</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_JPCommercialPaperProgramsMember', window );">JP commercial paper programs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems', window );"><strong>Disclosure of derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCommercialPaperMaximumBorrowingAmount', window );">Borrowings commercial paper maximum borrowing amount</a></td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCommercialPaperNumberOfPrograms', window );">Borrowings commercial paper, number of programs</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_VendorAxis=nvs_LargestFinancialInstitutionMember', window );">Largest financial institution [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CounterpartyRiskAbstract', window );"><strong>Counterparty risk [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsHeldWithFinancialInstitution', window );">Percentage of entity's cash and cash equivalents held with financial institution</a></td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">9.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_VendorAxis=nvs_SecondLargestFinancialInstitutionMember', window );">Second largest financial institution [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CounterpartyRiskAbstract', window );"><strong>Counterparty risk [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsHeldWithFinancialInstitution', window );">Percentage of entity's cash and cash equivalents held with financial institution</a></td>
<td class="nump">10.40%<span></span>
</td>
<td class="nump">7.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_VendorAxis=nvs_ThirdLargestFinancialInstitutionMember', window );">Third largest financial institution [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CounterpartyRiskAbstract', window );"><strong>Counterparty risk [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsHeldWithFinancialInstitution', window );">Percentage of entity's cash and cash equivalents held with financial institution</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of transfers of assets out of Level 3 of the fair value hierarchy. [Refer: Level 3 of fair value hierarchy [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransfersOutOfLevel3OfFairValueHierarchyAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountBorrowedUnderTheCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountBorrowedUnderTheCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountOfChangeInOCIWhenMostSignificantParametersForLevel3ChangeMoreThan10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountOfChangeInOCIWhenPOSForLevel3ChangeMoreThan10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountOfChangeInOCIWhenPricingParametersForLevel3ChangeMoreThan10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsCommercialPaperMaximumBorrowingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsCommercialPaperMaximumBorrowingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsCommercialPaperNumberOfPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsCommercialPaperNumberOfPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsCreditFacilityCommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsCreditFacilityCommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsCreditFacilityShortTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsCreditFacilityShortTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashAndCashEquivalentsHeldWithFinancialInstitution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashAndCashEquivalentsHeldWithFinancialInstitution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CounterpartyRiskAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CounterpartyRiskAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDerivativeFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueOnSaleOfOtherFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueOnSaleOfOtherFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LongtermFinancialDebtWithACarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LongtermFinancialDebtWithACarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MaximumHoldingInUnrelatedCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MaximumHoldingInUnrelatedCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MaximumMarginPercentageImpactOfCommodityPriceChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MaximumMarginPercentageImpactOfCommodityPriceChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MostSignificantForeignExchangeLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MostSignificantForeignExchangeLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetInvestmentHedgeRecognizedInTheIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetLossGainRecordedOnEquitySecuritiesAndFundInvestmentsAtFairValueThroughTheConsolidatedIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_UnrealizedIncomeWasRecognizedInOtherComprehensiveIncomeAndAccumulatedInCurrencyTranslationEffectsInRelationWithThisNetInvestmentHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_VAREstimateConfidenceInterval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_VAREstimateConfidenceInterval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_USCommercialPaperProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_USCommercialPaperProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_JPCommercialPaperProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_JPCommercialPaperProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_VendorAxis=nvs_LargestFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_VendorAxis=nvs_LargestFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_VendorAxis=nvs_SecondLargestFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_VendorAxis=nvs_SecondLargestFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_VendorAxis=nvs_ThirdLargestFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_VendorAxis=nvs_ThirdLargestFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R179.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6875664656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">$ 35,822<span></span>
</td>
<td class="nump">$ 38,905<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">32,623<span></span>
</td>
<td class="nump">37,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Current financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">6,846<span></span>
</td>
<td class="nump">9,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Current financial debt [member] | Interest bearning accounts of associates payable on demand [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">1,836<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Current financial debt [member] | Bank and other financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Current financial debt [member] | Commercial paper [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">3,951<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Current financial debt [member] | Current portion of non-current debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Non-current financial debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">20,353<span></span>
</td>
<td class="nump">22,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Non-current financial debt [member] | Current portion of non-current debt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Non-current financial debt [member] | Straight bonds [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">22,167<span></span>
</td>
<td class="nump">25,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Non-current financial debt [member] | Liabilities to banks and other financial institutions [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Non-current financial debt [member] | Finance lease obligations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">1,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member] | Financial liabilities at amortised cost, category [member] | Trade payables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">5,424<span></span>
</td>
<td class="nump">5,840<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueMember', window );">Financial liabilities at fair value, class [member] | Financial liabilities at fair value through profit or loss, category [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueMember', window );">Financial liabilities at fair value, class [member] | Financial liabilities at fair value through profit or loss, category [member] | Contingent consideration and other financial liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">1,065<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueMember', window );">Financial liabilities at fair value, class [member] | Financial liabilities at fair value through profit or loss, category [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems', window );"><strong>Disclosure of financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CurrentFinancialDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_CurrentFinancialDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_InterestBearningAccountsOfAssociatesPayableOnDemandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_InterestBearningAccountsOfAssociatesPayableOnDemandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_BankAndOtherFinancialDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_BankAndOtherFinancialDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_CurrentPortionOfNoncurrentDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_CurrentPortionOfNoncurrentDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_NoncurrentFinancialDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_NoncurrentFinancialDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_StraightBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_StraightBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_LiabilitiesToBanksAndOtherFinancialInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_LiabilitiesToBanksAndOtherFinancialInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_FinanceLeaseObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_FinanceLeaseObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_TradePayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_TradePayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_ContingentConsiderationAndOtherFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_ContingentConsiderationAndOtherFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetItemAxis=nvs_DerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetItemAxis=nvs_DerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6723800592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract', window );"><strong>Disclosure of defined benefit plans [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory', window );">Post-employment benefits for associates</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">25. Post-employment benefits for associates</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defined benefit plans</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In addition to the legally required social security schemes, the Group has numerous independent pension and other post-employment benefit plans. In most cases, these plans are externally funded in entities that are legally separate from the Group. For certain Group companies, however, no independent plan assets exist for the pension and other post-employment benefit obligations of associates. In these cases, the related unfunded liability is included in the balance sheet. The defined benefit obligations (DBOs) of all major pension and other post-employment benefit plans are reappraised annually by independent actuaries. Plan assets are recognized at fair value. The major plans are based in Switzerland, the United States, the United Kingdom, Germany and Japan, which represent 95% of the Group&#x2019;s total DBO for pension plans. Details of the plans in the two most significant countries, Switzerland and the United States, which represent 81% of the Group&#x2019;s total DBO for post-employment benefit plans, are provided below. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Swiss-based pension plans represent the most significant portion of the Group&#x2019;s total DBO and plan assets. For the active insured members born on or after January 1, 1956, or having joined the plans after December 31, 2010, the benefits are partially linked to the contributions paid into the plan. Certain features of Swiss pension plans required by law preclude the plans from being categorized as defined contribution plans. These factors include a minimum interest guarantee on retirement savings accounts, a predetermined factor for converting the accumulated savings account balance into a pension, and embedded death and disability benefits. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">All benefits granted under Swiss-based pension plans are vested, and Swiss legislation prescribes that the employer has to contribute a fixed percentage of an associate&#x2019;s pay to an external pension fund. Additional employer contributions may be required whenever the plan&#x2019;s statutory funding ratio falls below a certain level. The associate also contributes to the plan. The pension plans are run by separate legal entities, each governed by a board of trustees that &ndash; for the principal plans &ndash; consists of representatives nominated by Novartis and the active insured associates. The boards of trustees are responsible for the plan design and asset investment strategy. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In September 2017, the pension regulations in Switzerland were amended, which resulted in a change in accounting from defined benefit to defined contribution for a component of the Swiss pension plans. This change resulted in a reduction to the defined benefit pension plans liability and in a corresponding net pre-tax gain of USD 225 million (CHF 216 million). </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The United States pension plans represent the second-largest component of the Group&#x2019;s total DBO and plan assets. The principal plans (Qualified Plans) are funded, whereas plans providing additional benefits for executives (Restoration Plans) are unfunded. Employer contributions are required for Qualified Plans whenever the statutory funding ratio falls below a certain level. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Furthermore, in certain countries, associates are covered under other post-employment benefit plans and post-retirement medical plans. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the US, other post-employment benefit plans consist primarily of post-employment healthcare benefits, which have been closed to new members since 2015. Part of the costs of these plans is reimbursable under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. There is no statutory funding requirement for these plans. The Group is funding these plans to the extent that it is tax efficient. </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables are a summary of the funded and unfunded defined benefit obligation for pension and other postemployment benefit plans of associates at December 31, 2019 and 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment benefit plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;179</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;210</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;073</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;115</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit obligations related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;662</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;385</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current service cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 378</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 330</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past service costs and settlements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;168</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Administrative expenses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurement losses/(gains) arising from changes in financial assumptions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;791</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;567</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;31</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurement (gains)/losses arising from changes in demographic assumptions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;193</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Experience-related remeasurement losses/(gains)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 184</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 264</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 283</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;374</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions of associates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;066</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;179</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 746</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;073</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at January 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18&nbsp;838</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20&nbsp;275</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 119</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Plan assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 257</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Return on plan assets excluding interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;310</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Group contributions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 420</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 520</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions of associates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Settlements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;193</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;810</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;838</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Limitation on recognition of fund surplus at January 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income on limitation of fund surplus</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Limitation on recognition of fund surplus at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability in the balance sheet at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The reconciliation of the net liability from January 1 to December 31 is as follows:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment benefit plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability at January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;024</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;954</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;953</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less: net liability related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 238</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current service cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;378</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;77</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Administrative expenses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past service costs and settlements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;507</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 64</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Group contributions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 420</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 520</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in limitation on recognition of fund surplus</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Amounts recognized in the consolidated balance sheet</div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid benefit cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 148</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued benefit liability</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;469</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;546</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows a breakdown of the DBO for pension plans by geography and type of member, and the breakdown of plan assets into the geographical locations in which they are held: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Switzerland </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Switzerland </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15&nbsp;106</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;552</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;408</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;066</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;263</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;348</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;179</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof unfunded</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 1&nbsp;136</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 649</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1&nbsp;140</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">By type of member</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Active</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 630</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;197</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;618</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 653</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;616</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;887</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;205</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;517</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;722</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;131</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;531</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;662</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;939</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;717</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;645</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;564</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;421</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;630</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;457</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;042</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;810</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;838</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;649</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;241</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;360</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;341</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows a breakdown of the DBO for other post-employment benefit plans by geography and type of member, and the breakdown of plan assets into the geographical locations in which they are held: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 658</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 88</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 746</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;001</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 72</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;073</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof unfunded</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 882</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 72</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">By type of member</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Active</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 157</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 295</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 522</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 574</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 713</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 760</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;882</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;72</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the principal weighted average actuarial assumptions used for calculating defined benefit plans and other post-employment benefits of associates: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans </div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment benefit plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Weighted average assumptions used to determine benefit obligations at December 31</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discount rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.6%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.5%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.6%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.4%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.7%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected rate of pension increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.4%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.5%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected rate of salary increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest on savings account</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.6%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current average life expectancy <br></br>for a 65-year-old male in years </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 21 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 21 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 21 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current average life expectancy <br></br>for a 65-year-old female in years </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 23 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 23 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 23 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Changes in the aforementioned actuarial assumptions can result in significant volatility in the accounting for the Group&#x2019;s pension plans in the consolidated financial statements. This can result in substantial changes in the Group&#x2019;s other comprehensive income, long-term liabilities and prepaid pension assets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The DBO is significantly impacted by assumptions regarding the rate that is used to discount the actuarially determined post-employment benefit liability. This rate is based on yields of high-quality corporate bonds in the country of the plan. Decreasing corporate bond yields decrease the discount rate, so that the DBO increases and the funded status decreases. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In Switzerland, an increase in the DBO due to lower discount rates is slightly offset by lower future benefits expected to be paid on the associate&#x2019;s savings account where the assumption on interest accrued changes in line with the discount rate. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impact of decreasing interest rates on a plan&#x2019;s assets is more difficult to predict. A significant part of the plan assets is invested in bonds. Bond values usually rise when interest rates decrease and may therefore partially compensate for the decrease in the funded status. Furthermore, pension assets also include significant holdings of equity instruments. Share prices tend to rise when interest rates decrease and therefore often counteract the negative impact of the rising defined benefit obligation on the funded status (although the correlation of interest rates with equities is not as strong as with bonds, especially in the short term). </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The expected rate for pension increases significantly affects the DBO of most plans in Switzerland, Germany and the United Kingdom. Such pension increases also decrease the funded status, although there is no strong correlation between the value of the plan assets and pension/inflation increases. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Assumptions regarding life expectancy significantly impact the DBO. An increase in longevity increases the DBO. There is no offsetting impact from the plan assets, as no longevity bonds or swaps are held by the pension funds. Generational mortality tables are used where this data is available. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the sensitivity of the defined benefit pension obligation to the principal actuarial assumptions for the major plans in Switzerland, the United States, the United Kingdom, Germany and Japan on an aggregated basis: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in 2019 year-end <br></br> defined benefit pension obligation </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in discount rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;787</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in discount rate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 837</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One-year increase in life expectancy</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in rate of pension increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 546</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in rate of pension increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;135</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase of interest on savings account</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease of interest on savings account</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in rate of salary increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in rate of salary increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;55</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The healthcare cost trend rate assumptions used for other post-employment benefits are as follows:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Healthcare cost trend rate <br></br>assumed for next year </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 6.5% </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.0% </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 6.5% </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rate to which the cost trend <br></br>rate is assumed to decline </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4.5% </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.5% </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.5% </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Year that the rate reaches <br></br>the ultimate trend rate </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2028 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2028 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2025 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the weighted average plan asset allocation of funded defined benefit pension plans at December 31, 2019 and&nbsp;2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(as a percentage) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-term <br></br> target <br></br> minimum </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-term <br></br> target <br></br> maximum </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Real estate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alternative investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and other investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash and most of the equity and debt securities have a quoted market price in an active market. Real estate and alternative investments, which include hedge fund, private equity, infrastructure and commodity investments, usually have a quoted market price or a regularly updated net asset value. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The strategic allocation of assets of the different pension plans is determined with the objective of achieving an investment return that, together with the contributions paid by the Group and its associates, is sufficient to maintain reasonable control over the various funding risks of the plans. Based upon the market and economic environments, actual asset allocations may temporarily be permitted to deviate from policy targets. The asset allocation currently includes investments in shares of Novartis AG as per the below table: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investment in shares of Novartis AG</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number of shares (in millions)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Market value (in USD billions)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The weighted average duration of the defined benefit obligation is 15.2 years (2018: 14.6 years).</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s ordinary contribution to the various pension plans is based on the rules of each plan. Additional contributions are made whenever this is required by statute or law (i.e., usually when statutory funding levels fall below predetermined thresholds). The only significant plans that are foreseen to require additional funding are those in the United Kingdom. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The expected future cash flows in respect of pension and other post-employment benefit plans at December 31, 2019, were as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Pension plans </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post- <br></br> employment <br></br> benefit plans </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Novartis Group contributions</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020 (estimated)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 410</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Expected future benefit payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;201</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;116</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;106</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;096</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;087</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2025&#x2013;2029</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 231</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defined contribution plans</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In many subsidiaries, associates are covered by defined contribution plans. Contributions charged to the consolidated income statement for the defined contribution plans were: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined contribution plans continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 422</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 443</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 307</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For defined contribution plans for discontinued operations, see Note 30.</div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS19_g2-7_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865417648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant accounting policies</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">1. Significant accounting policies</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Novartis Group (Novartis or Group) is a multinational group of companies specializing in the research, development, manufacturing and marketing of a broad range of healthcare products led by innovative pharmaceuticals and cost-saving generic pharmaceuticals. The Group is headquartered in Basel, Switzerland. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consolidated financial statements of the Group are prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (IASB). They are prepared in accordance with the historical cost convention, except for items that are required to be accounted for at fair value. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s financial year-end is December 31, which is also the annual closing date of the individual entities&#x2019; financial statements incorporated into the Group&#x2019;s consolidated financial statements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The preparation of financial statements requires management to make certain estimates and assumptions, either at the balance sheet date or during the year, which affect the reported amounts of assets and liabilities, including any contingent amounts, the distribution liability recognized in connection with the distribution of Alcon Inc. to Novartis AG shareholders, as well as of revenues and expenses. Actual outcomes and results could differ from those estimates and assumptions. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Listed below are accounting policies of significance to Novartis or, in cases where IFRS provides alternatives, the option adopted by Novartis. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Scope of consolidation </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated financial statements include all entities, including structured entities, over which Novartis AG, Basel, Switzerland, directly or indirectly has control (generally as a result of owning more than 50% of the entity&#x2019;s voting interest). Consolidated entities are also referred to as &#x201c;subsidiaries.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In cases where Novartis does not fully own a subsidiary, it has elected to value any remaining outstanding non-controlling interest at the time of acquiring control of the subsidiary at its proportionate share of the fair value of the net identified assets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The contribution of a business to an associate or joint venture is accounted for by applying the option under IFRS that permits the accounting for the retained interest of the business contributed at its net book value at the time of the contribution. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Investments in associated companies (generally defined as investments in entities in which Novartis holds between 20% and 50% of voting shares or over which it otherwise has significant influence) and joint ventures are accounted for using the equity method, except for selected venture fund investments for which the Group has elected to apply the method of fair value through the consolidated income statement. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Foreign currencies</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated financial statements of Novartis are presented in US dollars (USD). The functional currency of subsidiaries is generally the local currency of the respective entity. The functional currency used for the reporting of certain Swiss and foreign finance entities is USD instead of their respective local currencies. This reflects the fact that the cash flows and transactions of these entities are primarily denominated in these currencies. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For subsidiaries not operating in hyperinflationary economies, the subsidiary&#x2019;s results, financial position and cash flows that do not have USD as their functional currency are translated into USD using the following exchange rates: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Income, expense and cash flows using for each month the average exchange rate, with the US dollar values for each month being aggregated during the year </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Balance sheets using year-end exchange rates</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Resulting exchange rate differences are recognized in other comprehensive income</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For subsidiaries operating in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period is recorded in retained earnings in equity. The subsequent gains or losses resulting from the restatement of non-monetary assets are recorded in &#x201c;Other financial income and expense&#x201d; in the consolidated income statement. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Non-current assets held for sale or held for distribution to owners</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Non-current assets are classified as assets held for sale or related to discontinued operations when their carrying amount is to be recovered principally through a sale transaction or distribution to owners, and a sale or distribution to owners is considered highly probable. They are stated at the lower of carrying amount and fair value less costs to sell with any resulting impairment recognized. Assets related to discontinued operations and assets of disposal group held for sale are not depreciated or amortized. The prior-year consolidated balance sheet is not restated. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Distribution of Alcon Inc. to Novartis AG shareholders </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During the first quarter of 2019, at the Annual General Meeting (AGM) of Novartis AG shareholders, held on February 28, 2019, the Novartis AG shareholders approved a special distribution by way of a dividend in kind to effect the spin-off of Alcon Inc. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The February 28, 2019, shareholder approval for the spin-off required the Alcon Division and selected portions of corporate activities attributable to Alcon&#x2019;s business (the &#x201c;Alcon business&#x201d;) to be reported as discontinued operations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The shareholder approval to spin off the Alcon business also required the recognition of a distribution liability at the fair value of the Alcon business. The Group elected to measure the distribution liability at the fair value of the Alcon business net assets taken as a whole. The distribution liability was recognized through a reduction in retained earnings. It was required to be adjusted at each balance sheet date for changes in its estimated fair value, up to the date of the distribution to shareholders through retained earnings. Any resulting impairment of the business assets to be distributed would have been recognized in the consolidated income statements in &#x201c;Other expense&#x201d; of discontinued operations, at the date of initial recognition of the distribution liability or at subsequent dates resulting from changes of the distribution liability valuation. At the April 8, 2019 distribution settlement date, the resulting gain, which was measured as the excess amount of the distribution liability over the then-carrying value of the net assets of the business distributed, was recognized on the line &#x201c;Gain on distribution of Alcon Inc. to Novartis AG shareholders&#x201d; in the income statement of discontinued operations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. These fair value measurements were classified as &#x201c;Level 3&#x201d; in the fair value hierarchy. The section &#x201c;&mdash;Impairment of goodwill and intangible assets&#x201d; in this Note 1 provides additional information on key assumptions that are highly sensitive in the estimation of fair values using valuation techniques. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Transaction costs that were directly attributable to the distribution (spin-off) of Alcon to the Novartis shareholders, and that would otherwise have been avoided, were recorded as a deduction from equity. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional disclosures, refer to &#x201c;Note 2. Significant transactions&mdash;Significant transactions in 2019&mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders,&#x201d; and &#x201c;Note 30. Discontinued operations.&#x201d; </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Acquisition of assets </font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Acquired assets are initially recognized on the balance sheet at cost if they meet the criteria for capitalization. If acquired as part of a business combination, the fair value of identified assets represents the cost for these assets. If separately acquired, the cost of the asset includes the purchase price and any directly attributable costs for bringing the asset into the condition to operate as intended. Expected costs for obligations to dismantle and remove property, plant and equipment when they are no longer used are included in their cost. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Property, plant and equipment</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Property, plant and equipment are depreciated on a straight-line basis in the consolidated income statement over their estimated useful lives. Leasehold land is depreciated over the period of its lease, whereas freehold land is not depreciated. The related depreciation expense is included in the costs of the functions using the asset. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Property, plant and equipment are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the respective useful lives for property, plant and equipment:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Useful life</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20 to 40 years</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and other equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7 to 20 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Furniture and vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 10 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Computer hardware</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Government grants obtained for construction activities, including any related equipment, are deducted from the gross acquisition cost to arrive at the balance sheet carrying value of the related assets. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Leases and right-of-use assets</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">From January 1, 2019, with the adoption of IFRS 16 Leases, the Group adopted the following accounting policies for leases and right-of-use assets: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative standalone price. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases. For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease to end of the lease term. The lease term includes the period of any lease extension that in management&#x2019;s assessment is highly probable to be exercised by the Group. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the Novartis incremental borrowing rate for the asset subject to the lease in the respective markets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The portion of the lease payments attributable to the repayment of lease liabilities is recognized in cash flows used in financing activities, and the portion attributable to the payment of interest is included in cash flows from operating activities. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease incentive received and any initial direct costs incurred by Novartis, and expected costs for obligations to dismantle and remove right-of-use assets when they are no longer used. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life of the right-of-use asset or the end of the lease term. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In arrangements where the Group is the lessor, it determines at lease inception whether the lease is a finance lease or an operating lease. Leases that transfer substantially all of the risk and rewards incidental to ownership of the underlying asset to the counterparty (the lessee) are accounted for as finance leases. Leases that do not transfer substantially all of the risks and rewards of ownership are accounted for as operating leases. Lease payments received under operating leases are recognized on a straight-line basis over the lease term in the consolidated income statement in either &#x201c;net sales&#x201d; or &#x201c;other income,&#x201d; depending on the nature of and underlying asset to the lease arrangement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to January 1, 2019, the Group applied the following accounting policies for leases: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Leases that transferred substantially all of the risks and rewards of ownership were recognized as finance leases, with the leased asset measured initially at an amount equal to the lower of their fair value and the present value of the minimum lease payments. Minimum lease payments were the payments over the lease term that the Group, as leasee, was required to make, excluding contingent rent. The underlying asset was accounted for in accordance with the accounting policy applicable to that asset. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Leases that did not transfer substantially all of the risks and rewards of ownership were accounted for as operating leases and were not recognized in the consolidated balance sheet. Payments made under operating leases were recognized in the consolidated income statement on a straight-line basis over the term of the lease. Lease incentives received were deferred and recognized as a component of lease expense over the term of the lease. The future undiscounted lease payments under operating leases were disclosed as commitments in the notes to the consolidated financial statements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Lessor accounting policies were not substantially different from those applied upon the adoption of IFRS 16 Leases, as described above. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2019&#x201d; in this Note 1 provides additional disclosures on the impact of adoption of IFRS 16 Leases. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Goodwill and intangible assets</font> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Goodwill</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Goodwill arises in a business combination and is the excess of the consideration transferred to acquire a business over the underlying fair value of the net identified assets acquired. It is allocated to groups of cash-generating units (CGUs), which are usually represented by the reported segments. Goodwill is tested for impairment annually at the level of these groups of CGUs, and any impairment charges are recorded under &#x201c;Other expense&#x201d; in the consolidated income statement. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets available for use</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has the following classes of available-for-use intangible assets: currently marketed products; technologies; other intangible assets (including computer software); and up to the spin-off date of Alcon business, marketing know-how and the Alcon brand name. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Currently marketed products represent the composite value of acquired intellectual property (IP), patents, and distribution rights and product trade names. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketing know-how represents the value attributable to the expertise acquired for marketing and distributing Alcon surgical products.</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Technologies represent identified and separable acquired know-how used in the research, development and production processes. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Significant investments in internally developed and acquired computer software are capitalized and included in the &#x201c;Other&#x201d; category, and amortized once available for use. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Alcon brand name was shown separately, as it was the only Novartis intangible asset that was available for use with an indefinite useful life. Novartis considers that it was appropriate that the Alcon brand name had an indefinite life since Alcon-branded products had a history of strong revenue and cash flow performance, and Novartis had the intent and ability to support the brand with spending to maintain its value for the foreseeable future. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Except for the Alcon brand name, intangible assets available for use are amortized over their estimated useful lives on a straight-line basis and are evaluated for potential impairment whenever facts and circumstances indicate that their carrying value may not be recoverable. The Alcon brand name was not amortized, but evaluated for potential impairment annually. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the respective useful lives for available-for-use intangible assets and the location in the consolidated income statement in which the respective amortization and any potential impairment charge is recognized: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Useful life </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement location <br></br> for amortization and <br></br> impairment charges </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 20 years</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketing know-how</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Technologies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10 to 20 years <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold" <br></br> or "Research <br></br> and development" </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other (including <br></br>computer software) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> In the respective <br></br> functional expense </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon brand name</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Not amortized, <br></br> indefinite useful life </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Other expense" <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets not yet available for use</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Acquired research and development intangible assets that are still under development and have accordingly not yet obtained marketing approval are recognized as in-process research and development (IPR&amp;D). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">IPR&amp;D is not amortized, but is evaluated for potential impairment on an annual basis or when facts and circumstances warrant. Any impairment charge is recorded in the consolidated income statement under &#x201c;Research and development.&#x201d; Once a project included in IPR&amp;D has been successfully developed, it is transferred to the &#x201c;Currently marketed products&#x201d; category. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of goodwill and intangible assets</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">An asset is considered impaired when its balance sheet carrying amount exceeds its estimated recoverable amount, which is defined as the higher of its fair value less costs of disposal and its value in use. Usually, Novartis applies the fair value less costs of disposal method for its impairment assessment. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. In the limited cases where the value in use method would be applied, net present value techniques would be applied using pre-tax cash flows and discount rates. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Fair value less costs of disposal reflects estimates of assumptions that market participants would be expected to use when pricing the asset or CGUs, and for this purpose, management considers the range of economic conditions that are expected to exist over the remaining useful life of the asset. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimates used in calculating the net present values are highly sensitive and depend on assumptions specific to the nature of the Group&#x2019;s activities with regard to: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected future cash flows</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term sales forecasts </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Actions of competitors (launch of competing products, marketing initiatives, etc.)</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Outcome of research and development activities (compound efficacy, results of clinical trials, etc.)</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected costs to develop IPR&amp;D into commercially viable products</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Profit margins</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Probability of obtaining regulatory approval</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Future tax rate</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate royalty rate for the Alcon brand name</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate terminal growth rate</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate discount rate</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Generally, for intangible assets with a definite useful life, Novartis uses cash flow projections for the whole useful life of these assets. For goodwill and the Alcon brand name, Novartis generally utilizes cash flow projections for a five-year period based on management forecasts, with a terminal value based on cash flow projections usually in line with inflation rates for later periods. Probability-weighted scenarios are typically used. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discount rates used consider the Group&#x2019;s estimated weighted average cost of capital, adjusted for specific country and currency risks associated with cash flow projections to approximate the discount rate that market participants would use to value the asset. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Due to the above factors, actual cash flows and values could vary significantly from forecasted future cash flows and related values derived using discounting techniques. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of associated companies accounted for at equity</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis considers investments in associated companies for impairment evaluation whenever objective evidence indicates the net investment may be impaired, including when a quoted share price indicates a fair value less than the per-share balance sheet carrying value for the investment. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the recoverable amount of the investment is estimated to be lower than the balance sheet carrying amount, an impairment charge is recognized for the difference in the consolidated income statement under &#x201c;Income from associated companies.&#x201d; </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash and cash equivalents</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash and cash equivalents include highly liquid investments with original maturities of three months or less, which are readily convertible to known amounts of cash. Bank overdrafts are usually presented within current financial debts on the consolidated balance sheet, except in cases where a right of offset has been agreed with a bank, which then allows for presentation on a net basis. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Marketable securities, commodities and non-current financial assets </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Commodities, which include gold bullion or coins, are valued at the lower of cost or fair value using current market prices. The changes in fair value below cost are immediately recorded in &#x201c;Other financial income and expense.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketable securities are financial assets consisting principally of equity and debt securities as well as fund investments. Marketable securities held for short-term purposes are principally traded in liquid markets and are classified as marketable securities within current assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &#x201c;Other financial income and expense&#x201d; in the consolidated income statement. Marketable securities held for long-term strategic purposes are classified as non-current financial assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &#x201c;Other income&#x201d; and &#x201c;Other expense&#x201d; in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketable securities are initially recorded at fair value on their trade date, which is different from the settlement date when the transaction is ultimately effected. Quoted securities are remeasured at each reporting date to fair value based on current market prices. If the market for a financial asset is not active or no market is available, fair values are established using valuation techniques. The majority of non-quoted investments are valued initially at fair value through the established purchase price between a willing buyer and seller. Non-quoted investments are subsequently adjusted based on values derived from discounted cash flow analysis or other pricing models. These investment values are classified as &#x201c;Level 3&#x201d; in the fair value hierarchy. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the Group classifies and accounts for its marketable securities and non-current financial assets in the following categories: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Debt securities are valued at fair value through other comprehensive income with subsequent recycling into the consolidated income statement, as they meet both the &#x201c;solely payment of principal and interest&#x201d; and the business model criteria. Unrealized gains and losses, except exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are recognized in the consolidated income statement when the debt instrument is sold, at which time the gain is transferred to &#x201c;Other financial income and expense.&#x201d; Exchange gains and losses related to debt instruments are immediately recognized in the consolidated income statement to &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Fund investments, equity securities of the Novartis venture fund and derivative assets are valued at fair value through profit and loss (FVPL). Unrealized gains and losses, including exchange gains and losses, are recognized in the consolidated income statement, for all fund investments and for equity securities of the Novartis venture fund, to &#x201c;Other income&#x201d; for gains and &#x201c;Other expense&#x201d; for losses, and for derivative assets to &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Equity securities held as strategic investments, typically held outside of the Novartis venture fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Unrealized gains and losses, including exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are reclassified to retained earnings when the equity security is sold. If these equity securities are not designated at date of acquisition as financial assets valued at fair value through other comprehensive income, they are valued at FVPL, as described above. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other non-current financial assets, such as loans and long-term receivables from customers, advances and other deposits, are valued at amortized cost, which reflects the time value of money less any allowances for expected credit losses. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group assesses on a forward-looking basis the expected credit losses associated with its debt securities valued at fair value through other comprehensive income. Impairments on debt securities are recorded in &#x201c;Other financial income and expense.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For other financial assets valued at amortized costs, impairments, which are based on their expected credit losses, and exchange rate losses are included in &#x201c;Other expense&#x201d; in the consolidated income statement. Exchange rate gains and interest income, using the effective interest rate method, are included in &#x201c;Other income&#x201d; or &#x201c;Other financial income&#x201d; in the consolidated income statement, depending on the nature of the item. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 9, the Group classified and accounted for its marketable securities and non-current financial assets in the following categories: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group classified all its equity and quoted debt securities as well as fund investments as available for sale, as they were not acquired to generate profit from short-term fluctuations in price. Unrealized gains, except exchange gains related to quoted debt instruments, were recorded as a fair value adjustment in the consolidated statement of comprehensive income. They were recognized in the consolidated income statement when the financial asset was sold, at which time the gain was transferred either to &#x201c;Other financial income and expense,&#x201d; for the marketable securities held for short-term non-strategic purposes, or to &#x201c;Other income,&#x201d; for all other equity securities and fund investments. Exchange gains related to quoted debt instruments were immediately recognized in the consolidated income statement under &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; A security was assessed for impairment when its market value at the balance sheet date was less than initial cost reduced by any previously recognized impairment. Impairments on equity securities, quoted debt securities and fund investments, and exchange rate losses on quoted debt securities in a foreign currency that were held for short-term non-strategic purposes were recorded in &#x201c;Other financial income and expense.&#x201d; Impairments were recorded for all other equity securities and other fund investments in &#x201c;Other expense&#x201d; in the consolidated income statement. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other non-current financial assets, including loans held for long-term strategic purposes, were carried at amortized cost, which reflects the time value of money less any allowances for uncollectable amounts. For these financial assets, impairments and exchange rate losses were included in &#x201c;Other expense&#x201d; in the consolidated income statement, and exchange rate gains and interest income using the effective interest rate method were included in &#x201c;Other income&#x201d; in the consolidated income statement. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Derivative financial instruments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Derivative financial instruments are initially recognized in the balance sheet at fair value and are remeasured to their current fair value at the end of each subsequent reporting period. The valuation of a forward exchange rate contract is based on the discounted cash flow model, using interest curves and spot rates at the reporting date as observable inputs. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Options are valued based on a modified Black-Scholes model using volatility and exercise prices as major observable inputs. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group utilizes derivative financial instruments for the purpose of hedging to reduce the volatility in the Group&#x2019;s performance due to the exposure to various business related risks. To mitigate these risks, the Group enters into certain derivative financial instruments. The risk reduction is obtained because the derivative&#x2019;s value or cash flows are expected, wholly or partly, to offset changes in the value or cash flows of the recognized assets or liabilities. The overall strategy is aiming to mitigate the currency and interest rate risk of positions that are contractually agreed, and to partially mitigate the exposure risk of selected anticipated transactions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain derivative financial instruments meet the criteria for hedge accounting treatment. A prerequisite for obtaining this accounting-hedge relationship is extensive documentation on inception and proving on a regular basis that the economic hedge is effective for accounting purposes. Other derivative financial instruments do not meet the criteria to qualify for hedge accounting. Changes in the fair value of those derivative instruments are recognized immediately in &#x201c;Other financial income and expense&#x201d; in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, the Group has designated certain long-term debt components as hedges of the translation risk arising on certain net investments in foreign operations. On consolidation, foreign currency differences arising on long-term debt designated as net investment hedges of a foreign operation are recognized in other comprehensive income and accumulated in currency translation effects, to the extent that the hedge is effective. The foreign currency differences arising from hedge ineffectiveness are recognized in the income statement in &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When a hedged net investment is disposed of, the proportionate portion of the cumulative amount recognized in equity in relation to the hedged net investment is transferred to the consolidated income statement as an adjustment to the gain or loss on disposal. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Inventories</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Inventory is valued at the lower of acquisition or production cost determined on a first-in, first-out basis and net realizable value. This value is used for the &#x201c;Cost of goods sold&#x201d; in the consolidated income statement. Unsalable inventory is fully written off in the consolidated income statement under &#x201c;Cost of goods sold.&#x201d; </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Trade receivables</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trade receivables are initially recognized at their invoiced amounts, including any related sales taxes less adjustments for estimated revenue deductions such as rebates, chargebacks and cash discounts. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the provisions for doubtful trade receivable are established using an expected credit loss model (ECL). The provisions are based on a forward-looking ECL, which includes possible default events on the trade receivables over the entire holding period of the trade receivable. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Charges for doubtful trade receivables are recorded as marketing and selling costs recognized in the consolidated income statement within &#x201c;Selling, general and administration&#x201d; expenses. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 9, the Group&#x2019;s accounting policy for provisions for doubtful trade receivables was as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for doubtful trade receivables were established once there was an indication that it was likely that a loss would be incurred. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Significant financial difficulties of a customer, such as probability of bankruptcy, financial reorganization, default or delinquency in payments, were considered indicators that recovery of the trade receivable was doubtful. Charges for doubtful trade receivables, recorded as marketing and selling costs, were recognized in the consolidated income statement within &#x201c;Selling, general and administration&#x201d; expenses. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Legal and environmental liabilities</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis and its subsidiaries are subject to contingencies arising in the ordinary course of business, such as patent litigation, environmental remediation liabilities and other product-related litigation, commercial litigation, and governmental investigations and proceedings. Provisions are recorded where a reliable estimate can be made of the probable outcome of legal or other disputes against the subsidiary. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Contingent consideration</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In a business combination or divestment of a business, it is necessary to recognize contingent future amounts due to previous owners, representing contractually defined potential amounts as a liability or asset. Usually for Novartis, these are linked to milestone or royalty payments related to certain assets and are recognized as a financial liability or financial asset at their fair value, which is then remeasured at each subsequent reporting date. These estimations typically depend on factors such as technical milestones or market performance, and are adjusted for the probability of their likelihood of payment and are appropriately discounted to reflect the impact of time. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Changes in the fair value of contingent consideration liabilities in subsequent periods are recognized in the consolidated income statement in &#x201c;Cost of goods sold&#x201d; for currently marketed products and in &#x201c;Research and development&#x201d; for IPR&amp;D. Changes in contingent consideration assets are recognized in &#x201c;Other income&#x201d; or &#x201c;Other expense,&#x201d; depending on its nature. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The effect of unwinding the discount over time is recognized for contingent liabilities in &#x201c;Interest expense&#x201d; and for contingent assets as interest income recognized in the consolidated income statement within &#x201c;Other financial income and expense.&#x201d; </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defi</font> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">ned benefit pension plans and&nbsp;other&nbsp;post-employment benefits</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The liability in respect of defined benefit pension plans and other post-employment benefits is the defined benefit obligation calculated annually by independent actuaries using the projected unit credit method. The current service cost for such post-employment benefit plans is included in the personnel expenses of the various functions in which associates are employed, while the net interest on the net defined benefit liability or asset is recognized as &#x201c;Other expense&#x201d; or &#x201c;Other income.&#x201d; </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Treasury shares</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Treasury shares are initially recorded at fair value on their trade date, which is different from the settlement date, when the transaction is ultimately effected. Treasury shares are deducted from consolidated equity at their nominal value of CHF&nbsp;0.50 per share. Differences between the nominal amount and the transaction price on purchases or sales of treasury shares with third parties, or the value of services received for the shares allocated to associates as part of share-based compensation arrangements, are recorded in &#x201c;Retained earnings&#x201d; in the consolidated statement of changes in equity. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Revenue recognition</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">From January 1, 2018, with the implementation of the new standard IFRS 15 Revenue from Contracts with Customers, the Group accounting policy for revenue recognition is as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Revenue on the sale of Novartis Group products and services, which is recorded as &#x201c;Net sales&#x201d; in the consolidated income statement, is recognized when a contractual promise to a customer (performance obligation) has been fulfilled by transferring control over the promised goods and services to the customer, substantially all of which is at the point in time of shipment to or receipt of the products by the customer or when the services are performed. If contracts contain customer acceptance provisions, revenue is recognized upon the satisfaction of the acceptance criteria. If products are stockpiled at the request of the customer, revenue is only recognized once the products have been inspected and accepted by the customer, and there is no right of return or replenishment on product expiry. The amount of revenue recognized is based on the consideration Novartis expects to receive in exchange for its goods and services, when it is highly probable that a significant reversal will not occur. If a contract contains more than one performance obligation, the consideration is allocated based on the standalone selling price of each performance obligation. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. Revenues were recognized upon satisfaction of each of the performance obligations in the contract and the consideration was allocated based on the standalone selling price of each performance obligation. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which substantially all the risks and rewards incidental to ownership transfers to the customer were treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair value of the equipment, which approximated the present value of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements were approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements longer than 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &#x201c;Other income.&#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consideration Novartis receives in exchange for its goods or services may be fixed or variable. Variable consideration is only recognized when it is highly probable that a significant reversal will not occur. The most common elements of variable consideration are listed below. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers are provisioned and recorded as a deduction from revenue at the time the related revenues are recorded or when the incentives are offered. They are calculated on the basis of historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Refunds granted to healthcare providers under innovative pay-for-performance agreements (i.e. outcome based arrangements) are provisioned and recorded as a revenue deduction at the time the related sales are recorded. They are calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data are not sufficient for a reliable estimation of the outcome, revenue recognition is deferred until the uncertainty is resolved or until such history is available. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Cash discounts offered to customers are to encourage prompt payment and are provisioned and recorded as revenue deductions at the time the related sales are recorded. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Shelf stock adjustments are generally granted to customers, primarily of the Sandoz Division, to cover the inventory held by them at the time a price decline becomes effective. Revenue deduction provisions for shelf stock adjustments are recorded when the price decline is anticipated, based on the impact of the price decline on the customer&#x2019;s estimated inventory levels. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales returns provisions are recognized and recorded as revenue deductions when there is historical experience of Novartis agreeing to customer returns and Novartis can reasonably estimate expected future returns. In doing so, the estimated rate of return is applied, determined on the basis of historical experience of customer returns and considering any other relevant factors. This is applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that can be placed back in inventory for resale. Where shipments are made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue is only recorded when there is evidence of consumption or when the right of return has expired. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Provisions for revenue deductions are adjusted to actual amounts as rebates, refunds, discounts and returns are processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">&#x201c;Other revenue&#x201d; includes income from profit-sharing arrangements with our collaboration partners, and royalty and milestone income from the out-licensing of intellectual property when Novartis retains an interest in the IP through a license. Royalty income earned through a license is recognized when the underlying sales have occurred. Milestone income is recognized at the point in time when it is highly probable that the relevant milestone event criteria is met, and the risk of reversal of revenue recognition is remote. Other revenue also includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales, and is recognized when control transfers to the third party and our performance obligations are satisfied. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 15 on January 1, 2018, the Group accounting policy for revenue recognition was as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Revenue was recognized on the sale of Novartis Group products and services, and was recorded as &#x201c;Net sales&#x201d; in the consolidated income statement when there was persuasive evidence that a sales arrangement exists; title, risks and rewards for the products are transferred to the customer; the price was determinable; and collectability was reasonably assured. If contracts contain customer acceptance provisions, revenue would be recognized upon the satisfaction of acceptance criteria. If products are stockpiled at the request of the customer, revenue was only recognized once the products have been inspected and accepted by the customer, and there was no right of return or replenishment on product expiry. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. The total consideration was allocated to the separate elements based on their relative fair values. Revenue was recognized once the recognition criteria have been met for each element of the contract. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which Novartis transfers substantially all the risks and rewards incidental to ownership to the customer are treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair values of the equipment, which approximate the present values of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements are approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements in excess of 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &#x201c;Other income.&#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers were recorded as a deduction from revenue at the time the related revenues were recorded or when the incentives were offered. They were calculated on the basis of historical experience and the specific terms in the individual agreements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for refunds granted to healthcare providers under innovative pay-for-performance agreements were recorded as a revenue deduction at the time the related sales were recorded. They were calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data were not sufficient for a reliable estimation of the outcome, revenue recognition was deferred until such history was available. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Cash discounts were offered to customers to encourage prompt payment and were recorded as revenue deductions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Following a decrease in the price of a product, we generally grant customers a &#x201c;shelf stock adjustment&#x201d; for their existing inventory for the involved product. Provisions for shelf stock adjustments, which are primarily relevant within the Sandoz Division, were determined at the time of the price decline or at the point of sale, if the impact of a price decline on the products sold could be reasonably estimated based on the customer&#x2019;s inventory levels of the relevant product. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When there was historical experience of Novartis agreeing to customer returns, and Novartis could reasonably estimate expected future returns, a provision was recorded for estimated sales returns. In doing so, the estimated rate of return was applied, determined based on historical experience of customer returns and considering any other relevant factors. This was applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that could be placed back in inventory for resale. Where shipments were made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue was only recorded when there was evidence of consumption or when the right of return had expired. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for revenue deductions were adjusted to actual amounts as rebates, discounts and returns were processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">&#x201c;Other revenue&#x201d; includes royalty and profit-sharing income, and revenue from activities such as manufacturing services or other services rendered, to the extent such revenue was not recorded under net sales. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201d; provides additional disclosure on the impact of adoption. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Internal research and development (R&amp;D) costs are fully charged to &#x201c;Research and development&#x201d; in the consolidated income statement in the period in which they are incurred. The Group considers that regulatory and other uncertainties inherent in the development of new products preclude the capitalization of internal development expenses as an intangible asset until marketing approval from a regulatory authority is obtained in a major market such as the United States, the European Union, Switzerland or Japan. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Payments made to third parties, such as contract research and development organizations in compensation for subcontracted R&amp;D, that are deemed not to transfer intellectual property to Novartis are expensed as internal R&amp;D expenses in the period in which they are incurred. Such payments are only capitalized if they meet the criteria for recognition of an internally generated intangible asset, usually when marketing approval has been achieved from a regulatory authority in a major market. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Payments made to third parties to in-license or acquire intellectual property rights, compounds and products, including initial upfront and subsequent milestone payments, are capitalized, as are payments for other assets, such as technologies to be used in R&amp;D activities. If additional payments are made to the originator company to continue to perform R&amp;D activities, an evaluation is made as to the nature of the payments. Such additional payments will be expensed if they are deemed to be compensation for subcontracted R&amp;D services not resulting in an additional transfer of intellectual property rights to Novartis. Such additional payments will be capitalized if they are deemed to be compensation for the transfer to Novartis of additional intellectual property developed at the risk of the originator company. Subsequent internal R&amp;D costs in relation to IPR&amp;D and other assets are expensed, since the technical feasibility of the internal R&amp;D activity can only be demonstrated by the receipt of marketing approval for a related product from a regulatory authority in a major market. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Costs for post-approval studies performed to support the continued registration of a marketed product are recognized as marketing expenses. Costs for activities that are required by regulatory authorities as a condition for obtaining marketing approval are capitalized and recognized as currently marketed products. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Inventory produced ahead of regulatory approval is fully provisioned, and the charge is included in &#x201c;Other expense&#x201d; in the consolidated income statement, as its ultimate use cannot be assured. If this inventory can be subsequently sold, the provision is released to &#x201c;Other income&#x201d; in the consolidated income statement, either on approval by the appropriate regulatory authority or, exceptionally in Europe, on recommendation by the Committee for Medicinal Products for Human Use (CHMP), if approval is virtually certain. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Share-based compensation</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Vested Novartis shares and American Depositary Receipts (ADRs) that are granted as compensation are valued at their market value on the grant date and are immediately expensed in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair values of unvested restricted shares (RSs), restricted share units (RSUs) and performance share units (PSUs) in Novartis shares and ADRs granted to associates as compensation are recognized as an expense over the related vesting period. The expense recorded in the consolidated income statement is included in the personnel expenses of the various functions in which the associates are employed. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Unvested restricted shares, restricted ADRs and RSUs are only conditional on the provision of services by the plan participant during the vesting period. They are valued at fair value on the grant date. As RSUs do not entitle the holder to dividends, the fair value is based on the Novartis share price at the grant date adjusted for the net present value of the dividends expected to be paid during the holding period. The fair value of these grants, after making adjustments for assumptions related to forfeiture during the vesting period, is expensed on a straight-line basis over the respective vesting period. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">PSUs are subject to the achievement of certain performance criteria during the vesting period and require plan participants to provide services during this period. The following paragraphs provide an overview of the accounting policies for the share-based compensation plans that grant PSUs. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to performance criteria based on Novartis internal performance metrics and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on assumptions concerning the expected performance against the internal performance metrics throughout the vesting period. The assumptions are based on the Group&#x2019;s targets for those performance metrics, and the expected forfeitures due to plan participants not meeting their service conditions. The assumptions are periodically adjusted over the vesting period. Any change in estimates for past services is recorded immediately as an expense or income in the consolidated income statement, and amounts for the remaining vesting period are expensed on a straight-line basis. As a result, at the end of the vesting period, the charge during the entire vesting period represents the amount that will finally vest. The number of equity instruments that finally vest is determined at the vesting date. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to performance criteria based on variables that can be observed in the market, which for Novartis plans is the Novartis total shareholder return (TSR) relative to a specific peer group of companies over the vesting period, and that are conditional on the provision of services by the plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on the total fair value of the grant over the vesting period. IFRS requires that these variables that can be observed in the market are taken into account in determining the fair value of the PSUs at the grant date. Novartis determined the fair value of these PSUs at the date of grant using a Monte Carlo simulation model. Adjustments to the number of equity instruments granted are only made if a plan participant does not fulfill the service conditions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to both performance criteria based on Novartis internal performance metrics and Novartis TSR relative to a specific peer group of companies over the vesting period and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on a bifurcation into the components based on the performance criteria related to Novartis internal performance metrics and TSR, as described in the paragraphs above. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Measuring the fair values of PSUs granted that include TSR performance criteria requires use of estimates. The Monte Carlo simulation used to determine the fair value of the PSUs TSR performance criteria requires the probability of factors related to uncertain future events; the term of the award; the grant price of underlying shares or ADRs; expected volatilities; the expected correlation matrix of the underlying equity instruments with those of the peer group of companies; and the risk-free interest rate as input parameters. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If a plan participant leaves Novartis for reasons other than retirement, disability or death, then unvested restricted shares, restricted ADRs, RSUs and PSUs are forfeited, unless determined otherwise by the provision of the plan rules or by the Compensation Committee of the Novartis Board of Directors, for example, in connection with a reorganization or divestment. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Government grants</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Grants from governments or similar organizations are recognized at their fair value when there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Government grants related to income are deferred and recognized in the consolidated income statement over the period necessary to match them with the related costs that they are intended to compensate. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The accounting policy for property, plant and equipment describes the treatment of any related grants. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Restructuring charges</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Restructuring provisions are recognized for the direct expenditures arising from the restructuring, where the plans are sufficiently detailed and where appropriate communication to those affected has been made. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Charges to increase restructuring provisions are included in &#x201c;Other expense&#x201d; in the consolidated income statements. Corresponding releases are recorded in &#x201c;Other income&#x201d; in the consolidated income statement. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Taxes</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Taxes on income are provided in the same periods as the revenues and expenses to which they relate and include interest and penalties incurred during the period. Deferred taxes are determined using the comprehensive liability method and are calculated on the temporary differences that arise between the tax base of an asset or liability and its carrying value in the balance sheet prepared for consolidation purposes, except for those temporary differences related to investments in subsidiaries and associated companies, where the timing of their reversal can be controlled and it is probable that the difference will not reverse in the foreseeable future. Since the retained earnings are reinvested, withholding or other taxes on eventual distribution of a subsidiary&#x2019;s retained earnings are only taken into account when a dividend has been planned. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimated amounts for current and deferred tax assets or liabilities, including any amounts related to any uncertain tax positions, are based on currently known facts and circumstances. Tax returns are based on an interpretation of tax laws and regulations, and reflect estimates based on these judgments and interpretations. The tax returns are subject to examination by the competent taxing authorities, which may result in an assessment being made requiring payments of additional tax, interest or penalties. Inherent uncertainties exist in the estimates of the tax positions. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impact of adopting significant new IFRS standard in 2019</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following new IFRS standard has been adopted by Novartis from January 1, 2019: </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 16 Leases</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">IFRS 16 Leases substantially changed the financial statements, as the majority of leases for which the Group is the lessee became on-balance sheet liabilities with corresponding right-of-use assets also recognized on the balance sheet. The lease liability reflects the net present value of the remaining lease payments, and the right-of-use asset corresponds to the lease liability, adjusted for payments made before the commencement date, lease incentives and other items related to the lease agreement. The standard replaces IAS 17 Leases and related interpretations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Upon adoption of the new standard, a portion of the annual operating lease costs, which was previously fully recognized as functional expenses, as a component of operating income, is recorded as interest expense. In addition, the portion of the lease payments that represents the reduction of the lease liability is recognized in the cash flow statement as an outflow from financing activities, which was previously fully recognized as an outflow from operating activities. Given the leases involved, these effects are not significant to the consolidated income statement and consolidated statement of cash flow. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group implemented the new standard on January 1, 2019, and applied the modified retrospective method, with right-of-use assets measured at an amount equal to the lease liability, adjusted by the amount of the prepaid or accrued lease payments relating to those leases recognized in the balance sheet immediately before the date of initial application and did not restate prior years. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Results of our impact assessment: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The undiscounted operating lease commitments as of December 31, 2018, amounted to USD 3.6 billion. This includes approximately USD 0.1 billion of leases with a commencement date in 2019, as well as short-term leases and low-value leases that are recognized from January 1, 2019, upon adoption of IFRS 16, on a straight-line basis as expense in profit and loss. This also includes USD 0.2 billion lease commitments related to the Alcon Division, which is attributable to discontinued operation in 2019. For the remaining undiscounted lease commitments attributable to continuing operations of USD 3.3 billion, the Group recognized on January 1, 2019, lease liabilities of USD 1.74 billion and right-of-use assets of USD 1.55 billion (after the reclassification of USD 0.1 billion from property, plant &amp; equipment, and net adjustments for the USD 0.3 billion recognition of sublease receivables, prepayments, and accrued lease payments recognized as at December 31, 2018). For the lease commitments attributable to discontinued operations, the Group recognized on January 1, 2019, lease liabilities and right-of-use assets of USD 0.2 billion. This does not include the discontinued operations right-of-use assets and lease liability on finance lease agreements of USD 75 million and USD 89 million, respectively. There was an insignificant increase to retained earnings upon adoption of IFRS 16 of USD 3 million that arose from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a lessor, the Group had no significant impact upon adoption. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For further information on the impact of adoption and additional disclosures of IFRS 16 Leases, see Note 10. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impact of adopting significant new IFRS standards in 2018</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following IFRS standards have been adopted by Novartis from January 1, 2018: </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 9 Financial Instruments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented IFRS 9 Financial Instruments as of January 1, 2018, which substantially changed the classi&#xfb01;cation and measurement of &#xfb01;nancial instruments. The standard requires impairments to be based on a forward-looking model, changed the approach to hedging &#xfb01;nancial exposures and related documentation, changed the recognition of certain fair value changes, and amends disclosure requirements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impairment of financial assets, including trade and lease receivables, is now assessed using an expected credit loss model; previously, the incurred loss model was used. Given the nature of Novartis financial assets, the Group had no significant impact to its provisions for doubtful accounts or impairments from this change. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The new hedge accounting model introduced by the standard requires hedge accounting relationships to be based upon the Group&#x2019;s own risk management strategy and objectives, and to be discontinued only when the relationships no longer qualify for hedge accounting. There was no impact upon adoption of the new standard, as the Group&#x2019;s existing hedge relationships continue to be designated as such under the new hedge accounting requirements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The most significant impact to the Group upon adoption of IFRS 9 relates to the treatment of the unrealized gains and losses from changes in fair value on certain of the Group&#x2019;s financial instruments, which were previously classified as available-for-sale marketable securities and financial investments. The unrealized gains and losses (to the extent of previous recognized unrealized gains), which the Group recognized previously in the consolidated statement of other comprehensive income, are from January 1, 2018, recognized in the consolidated income statement. This approach is applied to equity securities where the fair value through other comprehensive income irrevocable option is not applied. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group applied the modified retrospective method upon adoption of IFRS 9 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 9 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 177 million. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 15 Revenue from Contracts with Customers</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented the new standard IFRS 15 Revenue from Contracts with Customers as of January 1, 2018. The standard amended revenue recognition requirements and established principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash &#xfb02;ows arising from contracts with customers. The standard replaced IAS 18 Revenue and IAS 11 Construction contracts and related interpretations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impacts of adoption of the new standard are summarized below: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group&#x2019;s &#x201c;net sales&#x201d; are derived from the sale of drug substances, vision care products, surgical equipment, and other products and services, where control transfers to our customers and our performance obligations are satisfied at the time of shipment to or receipt of the products by the customer, or when the services are performed. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group&#x2019;s &#x201c;other revenue&#x201d; consists of royalty income from the out-licensing of intellectual property, which is recognized as earned, and from manufacturing and other services, where revenue is recognized when control transfers to the third party and our performance obligations are satisfied. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized from these manufacturing and other services arrangements, nor did it change accounting for these royalty arrangements, as the standard&#x2019;s royalty exception is applied for IP licenses. &#x201c;Other revenue&#x201d; also includes revenue from profit-sharing arrangements with our collaboration partners. Furthermore, the Group receives milestone payments related to the out-licensing of IP. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group applied the modified retrospective method upon adoption of IFRS 15 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 15 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 60 million. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">New IFRS standard effective as of January 1, 2020 </font> </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 3 Business Combination amendments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The IASB issued an amendment to IFRS 3 Business Combinations that revised the definition of a business, which assist entities with the evaluation of when an asset or group of assets acquired or disposed of should be considered a business. This amended standard is effective for the Group as of January 1, 2020 and is applicable to transactions entered into on or after January 1, 2020. The amended standard allows an entity to apply an optional concentration test, on a transaction-by-transaction basis, to evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this optional concentration test is met, the entity may choose to consider the transaction an acquisition of an asset or set of assets. The Group does not expect the adoption of this amended standard on January 1, 2020 to have a significant impact on our consolidated financial statements in future periods. However, this will depend on the facts and circumstances of future transactions and if the Group decides to apply the optional concentration test in the assessment of whether an acquired set of activities and assets is or is not a business. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There are no other IFRS standards or interpretations not yet effective that would be expected to have a material impact on the Group. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R156.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839388000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated cash flow statements (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities', window );">Net cash flows</a></td>
<td class="num">$ (3,760)<span></span>
</td>
<td class="num">$ (13,683)<span></span>
</td>
<td class="num">$ (714)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsAndDivestmentsAxis=nvs_AcquisitionsMember', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowFromNetIdentifiableAssets', window );">Net assets recognized as a result of business combinations</a></td>
<td class="num">(4,124)<span></span>
</td>
<td class="num">(13,660)<span></span>
</td>
<td class="num">(874)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate', window );">Fair value of previously held equity interests</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReceivablesAndPayablesContingentConsiderationNet', window );">Receivables and payables contingent consideration, net</a></td>
<td class="nump">242<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherPaymentsAndDeferredConsiderationNet', window );">Payments, deferred consideration and other adjustments, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities', window );">Net cash flows</a></td>
<td class="num">(3,851)<span></span>
</td>
<td class="num">(13,701)<span></span>
</td>
<td class="num">(759)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsAndDivestmentsAxis=nvs_DivestmentsMember', window );">Divestments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities', window );">Net cash flows</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NoncurrentAssetsDivested', window );">Non-current assets divested</a></td>
<td class="nump">159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ConsiderationPaidReceived', window );">Net cash inflows from divestment</a></td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetCashOutflowsFromDivestments', window );">Net cash outflows from divestments</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentAssetsDivested', window );">Current assets divested</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Divested business</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsAndDivestmentsAxis=nvs_DivestmentsMember', window );">Divestments | Current liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Liabilities in subsidiary or businesses acquired or disposed</a></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsAndDivestmentsAxis=nvs_DivestmentsMember', window );">Divestments | Non-current liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Liabilities in subsidiary or businesses acquired or disposed</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The acquisition-date fair value of equity interest in the acquiree held by the acquirer immediately before the acquisition date in a business combination achieved in stages. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph p<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_p_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfEquityInterestInAcquireeHeldByAcquirerImmediatelyBeforeAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 40<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_40_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 39<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConsiderationPaidReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 40<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_40_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConsiderationPaidReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 40<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_40_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowFromNetIdentifiableAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash inflow (outflow) from Net identifiable assets (acquired) or divested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowFromNetIdentifiableAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentAssetsDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentAssetsDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetCashFlowsUsedInAcquisitionsAndDivestmentsOfBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetCashOutflowsFromDivestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetCashOutflowsFromDivestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NoncurrentAssetsDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NoncurrentAssetsDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherPaymentsAndDeferredConsiderationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherPaymentsAndDeferredConsiderationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReceivablesAndPayablesContingentConsiderationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReceivablesAndPayablesContingentConsiderationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AcquisitionsAndDivestmentsAxis=nvs_AcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AcquisitionsAndDivestmentsAxis=nvs_AcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AcquisitionsAndDivestmentsAxis=nvs_DivestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AcquisitionsAndDivestmentsAxis=nvs_DivestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_NoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_NoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R152.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6886904880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated cash flow statements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract', window );"><strong>Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities', window );">Non-cash change in provisions and other non-current liabilities</a></td>
<td class="nump">$ 1,871<span></span>
</td>
<td class="nump">$ 895<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets', window );">Gains on disposal and other adjustments on property, plant and equipment; intangible assets;financial assets; and other non-current assets, net</a></td>
<td class="num">(1,234)<span></span>
</td>
<td class="num">(902)<span></span>
</td>
<td class="num">(1,077)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Equity-settled compensation expense</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Income from associated companies</a></td>
<td class="num">(659)<span></span>
</td>
<td class="num">(6,438)<span></span>
</td>
<td class="num">(1,108)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes</a></td>
<td class="nump">1,793<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">1,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceIncomeCost', window );">Net financial expense</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">Total</a></td>
<td class="nump">9,122<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">5,787<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract', window );"><strong>Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="nump">1,547<span></span>
</td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract', window );"><strong>Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract', window );"><strong>Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="nump">3,974<span></span>
</td>
<td class="nump">3,428<span></span>
</td>
<td class="nump">3,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_FinancialAssetsImpairedMember', window );">Financial assets impaired [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract', window );"><strong>Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">$ (38)<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss; Depreciation and amortisation expense; Impairment loss (reversal of impairment loss) recognised in profit or loss; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for losses (gains) on disposal of non-current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Non-current assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 14<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAmortisationAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdjustmentForChangeInProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_FinancialAssetsImpairedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_FinancialAssetsImpairedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6870476160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of comprehensive income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 11,737<span></span>
</td>
<td class="nump">$ 12,614<span></span>
</td>
<td class="nump">$ 7,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income to be eventually recycled into the consolidated income statement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets', window );">Fair value adjustments on marketable securities, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities', window );">Fair value adjustments on debt securities, net of taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges', window );">Fair value adjustments on deferred cash flow hedges, net of taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Total fair value adjustments on financial instruments, net of taxes</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Associated companies' movements in comprehensive income</a></td>
<td class="num">(94)<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations', window );">Net investment hedge</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="num">(237)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation effects</a></td>
<td class="nump">352<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">2,210<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Total of items to eventually recycle</a></td>
<td class="nump">304<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="nump">1,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Other comprehensive income never to be recycled into the consolidated income statement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Actuarial gains/losses from defined benefit plans, net of taxes</a></td>
<td class="num">(467)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments', window );">Fair value adjustments on equity securities, net of taxes</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Total of items never to be recycled</a></td>
<td class="num">(514)<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="nump">11,527<span></span>
</td>
<td class="nump">12,208<span></span>
</td>
<td class="nump">10,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract', window );"><strong>Attributable to</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Shareholders of Novartis AG</a></td>
<td class="nump">11,525<span></span>
</td>
<td class="nump">12,210<span></span>
</td>
<td class="nump">10,538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Comprehensive income, attributable to non-controlling interests</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract', window );"><strong>Attributable to</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Shareholders of Novartis AG</a></td>
<td class="nump">6,948<span></span>
</td>
<td class="nump">12,417<span></span>
</td>
<td class="nump">10,211<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract', window );"><strong>Attributable to</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Shareholders of Novartis AG</a></td>
<td class="nump">$ 4,577<span></span>
</td>
<td class="num">$ (207)<span></span>
</td>
<td class="nump">$ 327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to available-for-sale financial assets. [Refer: Financial assets available-for-sale; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_91_a&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_7&amp;doctype=Standard&amp;forcepdf=true<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxAvailableforsaleFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) from changes in the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 39<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=39&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2019-01-01<br> -Paragraph 6.5.13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_6.5.13_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeNetOfTaxDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842586992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsAdditionalDisclosureAbstract', window );"><strong>Financial Instruments - additional disclosure [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Disclosure of detailed information about financial instruments [text block]</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">29. Financial instruments &ndash; additional disclosures</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash and cash equivalents</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at fair value through other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Long-term financial investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;158</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 802</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total long-term financial investments - fair value through other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;191</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 833</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at fair value through other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;215</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;158</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables, income tax receivables and other current assets (excluding pre-payments)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15/17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;337</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;024</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances, security deposits and other long-term receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;727</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;635</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at fair value through the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13/16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 286</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Associated companies at fair value through profit and loss</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at fair value through the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;323</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;310</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24&nbsp;377</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29&nbsp;374</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest-bearing accounts of associates payable on demand</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;778</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bank and other financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 719</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 701</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commercial paper</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;289</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;951</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;846</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;620</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities to banks and other financial institutions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 285</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finance lease obligations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Trade payables and commitment for repurchase of own shares <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;840</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 32&nbsp;623</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37&nbsp;930</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities - measured at fair value through the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration (see Note 20/22) and other financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;065</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 917</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities - measured at fair value through the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 975</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;822</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 38&nbsp;905</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Except for straight bonds (see Note 19), the carrying amount is a reasonable approximation of fair value. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Notes 18 and 22 provide additional disclosures related to commitment for repurchase of own shares. </div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Derivative financial instruments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables show the contract or underlying principal amounts and fair values of derivative financial instruments analyzed by type of contract at December&nbsp;31, 2019 and 2018. Contract or underlying principal amounts indicate the gross volume of business outstanding at the consolidated balance sheet date and do not represent amounts at risk. The fair values are determined by reference to market prices or standard pricing models that use observable market inputs at December 31,&nbsp;2019 and 2018. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Contract or underlying principal amount</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Positive fair values </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Negative fair values </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;779</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;823</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 96</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodity purchase contract</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Options on equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments included in marketable securities and in current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;057</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;823</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows by currency contract or underlying principal amount the derivative financial instruments at December&nbsp;31,&nbsp;2019 and 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> EUR</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> USD</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;373</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;760</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;646</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;779</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodity purchase contract</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Options on equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;665</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;057</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> EUR</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> USD</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Other</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;989</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;558</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;276</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;823</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;989</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;558</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;276</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;823</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Derivative financial instruments effective for hedge accounting purposes</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">At the end of 2019 and 2018, there were no open hedging instruments for anticipated transactions. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Fair value by hierarchy</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">As required by IFRS, financial assets and liabilities recorded at fair value in the consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. There are three hierarchical levels, based on an increasing amount of subjectivity associated with the inputs to derive fair valuation for these assets and liabilities, which are as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The assets carried at Level 1 fair value are equity and debt securities listed in active markets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The assets generally included in Level 2 fair value hierarchy are foreign exchange and interest rate derivatives, and certain debt securities. Foreign exchange and interest rate derivatives are valued using corroborated market data. The liabilities generally included in this fair value hierarchy consist of foreign exchange and interest rate derivatives. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Level 3 inputs are unobservable for the asset or liability. The assets generally included in Level 3 fair value hierarchy are various investments in hedge funds and unquoted equity security investments. Contingent consideration carried at fair value is included in this category. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Level 1 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Level 2 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Level 3 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Valued at <br></br> amortized cost </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, time deposits and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt and equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 976</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 581</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;557</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances, security deposits and other long-term receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments and long-term loans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 976</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;213</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;518</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies at fair value through profit and loss</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities at fair value</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;065</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;250</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Level 1 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Level 2 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Level 3 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Valued at <br></br> amortized cost </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 302</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 337</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, time deposits and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 337</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;099</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;589</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt and equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans and receivables from customers and finance lease, advances, security deposits</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments and long-term loans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies at fair value through profit and loss</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities at fair value</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;917</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;975</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The analysis above includes all financial instruments measured at fair value as well as certain financial assets measured at amortized cost. </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The change in carrying values associated with Level 3 financial instruments, using significant unobservable inputs during the year ended December 31, is set forth below: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Associated <br></br> companies at <br></br> fair value through <br></br> profit and loss </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Fund <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Long-term <br></br> financial <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Contingent <br></br> consideration <br></br> receivables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Contingent <br></br> consideration <br></br> payables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Other <br></br> financial <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 145</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 251</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 488</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 396</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;907</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact from discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value gains and other adjustments, <br></br>including from divestments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 12 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 35 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 195 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 1 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value losses (including impairments and <br></br>amortizations) and other adjustments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;15 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;89 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;48 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments recognized in the consolidated statement <br></br>of comprehensive income </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 229</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;401</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash receipts and payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;64</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 581</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of fair value gains and losses recognized <br></br>in the consolidated income statement for assets <br></br>and liabilities held at December 31, 2019 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;15 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 12 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 35 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 106 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;47 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="14"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <b></b> <b></b> <b></b> <b></b> </div> </td> </tr> <tr valign="bottom"> <td colspan="14"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. <b></b> <b></b> <b></b> </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Associated <br></br> companies at <br></br> fair value through <br></br> profit and loss </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Fund <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Long-term <br></br> financial <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Contingent <br></br> consideration <br></br> receivables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Contingent <br></br> consideration <br></br> payables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Other <br></br> financial <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 188</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 166</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 437</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 844</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;852</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;72</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value gains and other adjustments, <br></br>including from divestments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 93 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 36 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 213 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value losses (including impairments and <br></br>amortizations) and other adjustments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;100 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments recognized in the consolidated statement <br></br>of comprehensive income </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;10 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 123</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;182</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash receipts and payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;484</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payable related to disposal group held for sale</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 251</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 488</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 396</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of fair value gains and losses recognized <br></br>in the consolidated income statement for assets <br></br>and liabilities held at December 31, 2018 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 93 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 36 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 113 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, there were several individually non-significant transfers of financial investments from Level 3 to Level 1 for USD&nbsp;64 million (2018: USD&nbsp;78 million), mainly due to initial public offerings of the invested companies. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Realized gains and losses associated with Level 3 long-term financial investments measured at fair value through the consolidated income statement are recorded in the consolidated income statement under &#x201c;Other income&#x201d; or &#x201c;Other expense,&#x201d; respectively. Realized gains and losses associated with Level 3 long-term financial investments measured at fair value through other comprehensive income are not recycled through the consolidated income statement but are instead reclassified to retained earnings. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During the year, the net loss and net gain recorded on associated companies, fund investments and long-term financial investments at fair value through profit and loss were USD 72 million and USD 110 million, respectively. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the pricing parameters for the Level 3 input were to change for associated companies at fair value through profit and loss, fund investments and long-term financial investments by 10% positively or negatively, this would change the amounts recorded in the 2019 consolidated statement of comprehensive income by USD&nbsp;100 million. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">To determine the fair value of a contingent consideration, various unobservable inputs are used. A change in these inputs might result in a significantly higher or lower fair value measurement. The inputs used are, among others, the probability of success, sales forecast and assumptions regarding the discount rate and timing and different scenarios of triggering events. The inputs are interrelated. The significance and usage of these inputs to each contingent consideration may vary due to differences in the timing and triggering events for payments or in the nature of the asset related to the contingent consideration. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the most significant parameters for the Level&nbsp;3 input were to change by 10% positively or negatively, or where the probability of success (POS) is the most significant input parameter, 10% were added or deducted from the applied probability of success, for contingent consideration payables, other financial liabilities and contingent consideration receivables, this would change the amounts recorded in the 2019 consolidated income statement by USD&nbsp;267 million and USD 202 million, respectively. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Equity securities measured at fair value through other comprehensive income</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Equity securities held as strategic investments, typically held outside the Novartis Venture Fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Except for the investment in Alcon Inc. with a fair value of USD 382 million at December 31, 2019, these are made up of individually non-significant investments. At December 31, 2019, the Group holds 53 non-listed equity securities (December 31, 2018: 41) and 29 listed equity securities (December 31, 2018: 26) in this category with the following fair values: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Listed equity securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 843</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 597</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-listed equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 315</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 205</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;158</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 802</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There were no dividends recognized during 2019 and 2018 from these equity securities. In 2019, in accordance with the consolidated foundations Alcon Inc. shares divestment plans, Alcon Inc. shares with a fair value of USD&nbsp;976 million were sold, and the USD&nbsp;62 million gain on disposal was transferred from other comprehensive income to retained earnings during 2019. In addition, in 2019, equity securities that were no longer considered strategic, with a fair value of USD&nbsp;33 million (2018: USD&nbsp;21 million), were sold, and the USD&nbsp;33 million gain on disposal (2018: USD&nbsp;16 million gain) was transferred from other comprehensive income to retained earnings (see Note 8). </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Nature and extent of risks arising from financial instruments</font> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Market risk</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis is exposed to market risk, primarily related to foreign currency exchange rates, interest rates, and the market value of the investments of liquid funds. The Group actively monitors and seeks to reduce, where it deems it appropriate to do so, fluctuations in these exposures. It is the Group&#x2019;s policy and practice to enter into a variety of derivative financial instruments to manage the volatility of these exposures and to enhance the yield on the investment of liquid funds. It does not enter into any financial transactions containing a risk that cannot be quantified at the time the transaction is concluded. In addition, it does not sell short assets it does not have, or does not know it will have, in the future. The Group only sells existing assets or enters into transactions and future transactions (in the case of anticipatory hedges) that it confidently expects it will have in the future, based on past experience. In the case of liquid funds, the Group writes call options on assets it has, or writes put options on positions it wants to acquire and has the liquidity to acquire. The Group expects that any loss in value for these instruments generally would be offset by increases in the value of the underlying transactions. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Foreign currency exchange rate risk</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group uses the US dollar as its reporting currency. As a result, the Group is exposed to foreign currency exchange movements, primarily in European, Japanese and emerging market currencies. Fluctuations in the exchange rates between the US dollar and other currencies can have a significant effect on both the Group&#x2019;s results of operations, including reported sales and earnings, as well as on the reported value of our assets, liabilities and cash flows. This, in turn, may significantly affect the comparability of period-to-period results of operations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Because our expenditures in Swiss francs are significantly higher than our revenues in Swiss francs, volatility in the value of the Swiss franc can have a significant impact on the reported value of our earnings, assets and liabilities, and the timing and extent of such volatility can be difficult to predict. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There is also a risk that certain countries could devalue their currency. If this occurs, it could impact the effective prices we would be able to charge for our products and also have an adverse impact on both our consolidated income statement and balance sheet. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain countries have legal or economic restrictions on the ability of subsidiaries to transfer funds to the Group in the form of cash dividends, loans or advances, but these restrictions do not have an impact on the ability of the Group to meet its cash obligations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The most significant countries in this respect are Argentina and Venezuela, where the governments have implemented capital controls. The net outstanding intercompany payable balance of Argentina and Venezuela Subsidiaries were not material for the Group at December 31, 2019 and at December 31, 2018. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Subsidiaries whose functional currencies have experienced a cumulative inflation rate of more than 100% over the past three years apply the rules of IAS 29 &#x201c;Financial reporting in Hyperinflationary Economies&#x201d;. The hyperinflationary economies in which Novartis operates are Argentina and Venezuela. Venezuela was hyperinflationary for all years presented, and Argentina became hyperinflationary effective July 1, 2018, requiring retroactive implementation of hyperinflation accounting as of January 1, 2018. The impacts of applying IAS 29 was not significant in all years presented. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group manages its global currency exposure by engaging in hedging transactions where management deems appropriate. Novartis may enter into various contracts that reflect the changes in the value of foreign currency exchange rates to preserve the value of assets, commitments and anticipated transactions. Novartis also uses forward contracts and foreign currency option contracts to hedge. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Net investments in subsidiaries in foreign countries are long-term investments. Their fair value changes through movements of foreign currency exchange rates. The Group has designated a certain portion of its long-term euro-denominated straight bonds as hedges of the translation risk arising on certain of these net investments in foreign operations with euro functional currency. As of December 31, 2019, long-term financial debt with a carrying amount of EUR&nbsp;1.8 billion (USD&nbsp;2.1 billion) (December 31, 2018: USD 2.1 billion), has been designated as a hedge instrument. During 2019, USD&nbsp;44 million of unrealized income (unrealized income in 2018: USD 95 million) was recognized in other comprehensive income and accumulated in currency translation effects in relation with this net investment hedge. The hedge remained effective since inception, and no amount was recognized in the consolidated income statement in 2019, 2018 and 2017. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Commodity price risk</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group has only a very limited exposure to price risk related to anticipated purchases of certain commodities used as raw materials by the Group&#x2019;s businesses. A change in those prices may alter the gross margin of a specific business, but generally by not more than 10% of the margin and thus below the Group&#x2019;s risk management tolerance levels. Accordingly, the Group does not enter into significant commodity futures, forward or option contracts to manage fluctuations in prices of anticipated purchases. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Interest rate risk</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group addresses its net exposure to interest rate risk mainly through the ratio of its fixed-rate financial debt to variable-rate financial debt contained in its total financial debt portfolio. To manage this mix, Novartis may enter into interest rate swap agreements, in which it exchanges periodic payments based on a notional amount and agreed-upon fixed and variable interest rates. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Equity risk</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group may purchase equities as investments of its liquid funds. As a policy, it limits its holdings in an unrelated company to less than 5% of its liquid funds. Potential investments are thoroughly analyzed. Call options are written on equities that the Group owns, and put options are written on equities that the Group wants to buy and for which cash is available. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Credit risk</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Credit risks arise from the possibility that customers may not be able to settle their obligations as agreed. To manage this risk, the Group periodically assesses country and customer credit risk, assigns individual credit limits, and takes actions to mitigate credit risk where appropriate. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The provisions for expected credit losses for customers are based on a forward-looking expected credit loss, which includes possible default events on the trade receivables over the entire holding period of the trade receivables. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In measuring the expected credit losses, trade receivables are grouped based on shared credit risk characteristics (such as private versus public receivables) and days past due. In determining the expected credit loss rates, the Group considers current and forward-looking macroeconomic factors that may affect the ability of the customers to settle the receivables, and historical loss rates for each category of customers. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s largest customer accounted for approximately 23% of net sales, and the second largest and third largest customers accounted for 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). No other customer accounted for 6% or more of net sales in either year. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the Group&#x2019;s trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively). There is no other significant concentration of customer credit risk. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Counterparty risk</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Counterparty risk encompasses issuer risk on marketable securities and money market instruments; credit risk on cash, time deposits and derivatives; as well as settlement risk for different instruments. Issuer risk is reduced by only buying securities that are at least A- rated. Counterparty credit risk and settlement risk are reduced by a policy of entering into transactions with counterparties (banks or financial institutions) that feature a strong credit rating. Exposure to these risks is closely monitored and kept within predetermined parameters. The limits are regularly assessed and determined based upon credit analysis, including financial statement and capital adequacy ratio reviews. In addition, reverse repurchasing agreements are contracted, and Novartis has entered into credit support agreements with various banks for derivative transactions. To further reduce the settlement risk, the Group has implemented a multi-currency system, CLS (Continuous Linked Settlement), providing multilateral netting (payment-versus-payment settlement) of cash flows from foreign exchange transactions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s cash and cash equivalents are held with major regulated financial institutions; the three largest ones hold approximately 12.6%, 10.4% and 8.3%, respectively (2018: 9.4%, 7.6% and 7.0%, respectively). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group does not expect any losses from non-performance by these counterparties and does not have any significant grouping of exposures to financial sector or country risk. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Liquidity risk</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Liquidity risk is defined as the risk that the Group could not be able to settle or meet its obligations associated with financial liabilities that are settled by delivering cash or another financial asset. Group Treasury is responsible for liquidity, funding and settlement management. In addition, liquidity and funding risks, and related processes and policies, are overseen by management. Novartis manages its liquidity risk on a consolidated basis according to business needs and tax, capital or regulatory considerations, if applicable, through numerous sources of financing in order to maintain flexibility. Management monitors the Group&#x2019;s net debt or liquidity position through rolling forecasts on the basis of expected cash flows. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has two US commercial paper programs under which it can issue up to USD&nbsp;9.0 billion in the aggregate of unsecured commercial paper notes. Novartis also has a Japanese commercial paper program under which it can issue up to JPY&nbsp;150 billion (approximately USD&nbsp;1.4 billion) of unsecured commercial paper notes. Commercial paper notes totaling USD&nbsp;2.3 billion under these three programs were outstanding as per December 31, 2019 (2018: USD&nbsp;4.0 billion). Novartis further has a committed credit facility of USD&nbsp;6.0 billion, which was renewed in September 2019. This credit facility is provided by a syndicate of banks and is intended to be used as a backstop for the US commercial paper programs. The renewed facility matures in September 2024 and was undrawn as per December 31, 2019, and December 31, 2018. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In December 2019, Novartis entered into a short-term credit facility of USD 7 billion, with a maturity date of June 30, 2020 with a syndicate of banks. On January 7, 2020, Novartis borrowed USD 7 billion under the facility with interest based on the USD LIBOR. </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table sets forth how management monitors net debt or liquidity based on details of the remaining contractual maturities of current financial assets and liabilities, excluding trade receivables and payables as well as contingent considerations at December 31, 2019, and December 31, 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="11" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="11" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term <br></br>investments with original maturity more than 90 days </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 20 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 26 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 16 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 3 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 57 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 122 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 79</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;712</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;112</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;746</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;446</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;9&nbsp;150</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;11&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;20&nbsp;505</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;402</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;031</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;237</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;073</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;938</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="11" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="11" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term <br></br>investments with original maturity more than 90 days </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 39 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 56 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;091 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 198 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 63 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;447 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 142</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;571</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;700</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;271</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;650</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;831</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 198</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;964</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;025</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;13&nbsp;623</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;22&nbsp;648</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;327</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9&nbsp;678</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;583</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;713</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;791</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;782</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;323</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16&nbsp;184</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated balance sheet amounts of financial liabilities included in the above analysis are not materially different to the contractual amounts due on maturity. The positive and negative fair values on derivative financial instruments represent the net contractual amounts to be exchanged at maturity. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group&#x2019;s contractual undiscounted potential cash flows from derivative financial instruments to be settled on a gross basis are as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Derivative financial instruments and accrued interest on derivative financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential outflows in various currencies - from financial derivative liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;814</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;624</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;952</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;390</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential inflows in various currencies - from financial derivative assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 807</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 922</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;385</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Derivative financial instruments and accrued interest on derivative financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential outflows in various currencies - from financial derivative liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;305</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;949</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;598</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;852</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential inflows in various currencies - from financial derivative assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;974</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 593</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;895</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Other contractual liabilities that are not part of management&#x2019;s monitoring of the net debt or liquidity consist of the following items: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contractual interest on non-current liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;36</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;428</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;531</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;439</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;434</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;181</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;081</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;949</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;222</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;424</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;582</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;383</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contractual interest on non-current liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;113</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;459</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;667</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;755</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;994</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;556</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;556</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;339</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Capital risk management</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis strives to maintain a strong credit rating. In managing its capital, Novartis focuses on maintaining a strong balance sheet. As of December 31, 2019, Moody&#x2019;s Investor Service rated the Company A1 for long-term maturities and P-1 for short-term maturities and S&amp;P Global Ratings rated the company AA- for long-term maturities and A-1+ for short-term maturities. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Value at risk</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group uses a value at risk (VAR) computation to estimate the potential 10-day loss in the fair value of its financial instruments. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A 10-day period is used because of an assumption that not all positions could be undone in one day given the size of the positions. The VAR computation includes all financial assets and financial liabilities as set forth in the table on page F-75, except: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Trade receivables, income tax receivables and other current assets</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term loans and receivables, advances and security deposits</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Contingent considerations</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Finance lease obligations</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Lease liabilities</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Trade payables and commitment for repurchase of own shares</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The VAR estimates are made assuming normal market conditions, using a 95% confidence interval. The Group uses a &#x201c;Delta Normal&#x201d; model to determine the observed interrelationships between movements in interest rates, stock markets and various currencies. These interrelationships are determined by observing interest rate movements, stock market movements and foreign currency rate movements over a 60-day period for the calculation of VAR amounts. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimated potential 10-day loss in the fair value of the Group&#x2019;s foreign currency positions (including foreign exchange translation risk), the estimated potential 10-day loss of its equity holdings, and the estimated potential 10-day loss in fair value of its interest rate-sensitive instruments (primarily financial debt and investments of liquid funds under normal market conditions), as calculated in the VAR model, are the following: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 355</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 337</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign <br></br>currency exchange rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 89 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 217 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity <br></br>market movements </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 31 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 122 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to interest rates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 187</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 221</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The average, high and low VAR amounts are as follows:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Average</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> High</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Low</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 348</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 385</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 303</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign <br></br>currency exchange rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 143 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 195 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 86 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity <br></br>market movements </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 36 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 81 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 16 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to <br></br>interest rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 233 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 303 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 187 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Average</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> High</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Low</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 443</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 553</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 337</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign <br></br>currency exchange rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 324 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 473 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 217 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity <br></br>market movements </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 60 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 122 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 22 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to <br></br>interest rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 253 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 361 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 169 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The VAR computation is a risk analysis tool designed to statistically estimate the potential 10-day loss from adverse movements in foreign currency exchange rates, equity prices and interest rates under normal market conditions. The computation does not purport to represent actual losses in fair value on earnings to be incurred by the Group, nor does it consider the effect of favorable changes in market rates. The Group cannot predict actual future movements in such market rates, and it does not claim that these VAR results are indicative of future movements in such market rates or are representative of any actual impact that future changes in market rates may have on the Group&#x2019;s future results of operations or financial position. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 35K<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsAdditionalDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsAdditionalDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6875482096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SignificantAccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory', window );">Scope of consolidation</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Scope of consolidation </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated financial statements include all entities, including structured entities, over which Novartis AG, Basel, Switzerland, directly or indirectly has control (generally as a result of owning more than 50% of the entity&#x2019;s voting interest). Consolidated entities are also referred to as &#x201c;subsidiaries.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In cases where Novartis does not fully own a subsidiary, it has elected to value any remaining outstanding non-controlling interest at the time of acquiring control of the subsidiary at its proportionate share of the fair value of the net identified assets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The contribution of a business to an associate or joint venture is accounted for by applying the option under IFRS that permits the accounting for the retained interest of the business contributed at its net book value at the time of the contribution. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Investments in associated companies (generally defined as investments in entities in which Novartis holds between 20% and 50% of voting shares or over which it otherwise has significant influence) and joint ventures are accounted for using the equity method, except for selected venture fund investments for which the Group has elected to apply the method of fair value through the consolidated income statement. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currencies</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Foreign currencies</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated financial statements of Novartis are presented in US dollars (USD). The functional currency of subsidiaries is generally the local currency of the respective entity. The functional currency used for the reporting of certain Swiss and foreign finance entities is USD instead of their respective local currencies. This reflects the fact that the cash flows and transactions of these entities are primarily denominated in these currencies. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For subsidiaries not operating in hyperinflationary economies, the subsidiary&#x2019;s results, financial position and cash flows that do not have USD as their functional currency are translated into USD using the following exchange rates: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Income, expense and cash flows using for each month the average exchange rate, with the US dollar values for each month being aggregated during the year </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Balance sheets using year-end exchange rates</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Resulting exchange rate differences are recognized in other comprehensive income</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For subsidiaries operating in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period is recorded in retained earnings in equity. The subsequent gains or losses resulting from the restatement of non-monetary assets are recorded in &#x201c;Other financial income and expense&#x201d; in the consolidated income statement. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory', window );">Non-current assets held for sale or held for distribution to owners</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Non-current assets held for sale or held for distribution to owners</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Non-current assets are classified as assets held for sale or related to discontinued operations when their carrying amount is to be recovered principally through a sale transaction or distribution to owners, and a sale or distribution to owners is considered highly probable. They are stated at the lower of carrying amount and fair value less costs to sell with any resulting impairment recognized. Assets related to discontinued operations and assets of disposal group held for sale are not depreciated or amortized. The prior-year consolidated balance sheet is not restated. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DistributionByWayOfDivindendInKindToShareholders', window );">Distribution by way of dividend in kind to shareholders</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Distribution of Alcon Inc. to Novartis AG shareholders </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During the first quarter of 2019, at the Annual General Meeting (AGM) of Novartis AG shareholders, held on February 28, 2019, the Novartis AG shareholders approved a special distribution by way of a dividend in kind to effect the spin-off of Alcon Inc. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The February 28, 2019, shareholder approval for the spin-off required the Alcon Division and selected portions of corporate activities attributable to Alcon&#x2019;s business (the &#x201c;Alcon business&#x201d;) to be reported as discontinued operations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The shareholder approval to spin off the Alcon business also required the recognition of a distribution liability at the fair value of the Alcon business. The Group elected to measure the distribution liability at the fair value of the Alcon business net assets taken as a whole. The distribution liability was recognized through a reduction in retained earnings. It was required to be adjusted at each balance sheet date for changes in its estimated fair value, up to the date of the distribution to shareholders through retained earnings. Any resulting impairment of the business assets to be distributed would have been recognized in the consolidated income statements in &#x201c;Other expense&#x201d; of discontinued operations, at the date of initial recognition of the distribution liability or at subsequent dates resulting from changes of the distribution liability valuation. At the April 8, 2019 distribution settlement date, the resulting gain, which was measured as the excess amount of the distribution liability over the then-carrying value of the net assets of the business distributed, was recognized on the line &#x201c;Gain on distribution of Alcon Inc. to Novartis AG shareholders&#x201d; in the income statement of discontinued operations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The recognition of the distribution liability required the use of valuation techniques for purposes of impairment testing of the Alcon business&#x2019; assets to be distributed and for the measurement of the fair value of the distribution liability. These valuations required the use of management assumptions and estimates related to the Alcon business&#x2019; future cash flows, market multiples to estimate day one market value, and control premiums to apply in estimating the Alcon business fair value. These fair value measurements were classified as &#x201c;Level 3&#x201d; in the fair value hierarchy. The section &#x201c;&mdash;Impairment of goodwill and intangible assets&#x201d; in this Note 1 provides additional information on key assumptions that are highly sensitive in the estimation of fair values using valuation techniques. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Transaction costs that were directly attributable to the distribution (spin-off) of Alcon to the Novartis shareholders, and that would otherwise have been avoided, were recorded as a deduction from equity. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional disclosures, refer to &#x201c;Note 2. Significant transactions&mdash;Significant transactions in 2019&mdash;Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders,&#x201d; and &#x201c;Note 30. Discontinued operations.&#x201d; </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory', window );">Acquisition of assets</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Acquisition of assets </font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Acquired assets are initially recognized on the balance sheet at cost if they meet the criteria for capitalization. If acquired as part of a business combination, the fair value of identified assets represents the cost for these assets. If separately acquired, the cost of the asset includes the purchase price and any directly attributable costs for bringing the asset into the condition to operate as intended. Expected costs for obligations to dismantle and remove property, plant and equipment when they are no longer used are included in their cost. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property plant and equipment</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Property, plant and equipment</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Property, plant and equipment are depreciated on a straight-line basis in the consolidated income statement over their estimated useful lives. Leasehold land is depreciated over the period of its lease, whereas freehold land is not depreciated. The related depreciation expense is included in the costs of the functions using the asset. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Property, plant and equipment are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the respective useful lives for property, plant and equipment:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Useful life</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20 to 40 years</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and other equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7 to 20 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Furniture and vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 10 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Computer hardware</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Government grants obtained for construction activities, including any related equipment, are deducted from the gross acquisition cost to arrive at the balance sheet carrying value of the related assets. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases and right-of-use assets</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Leases and right-of-use assets</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">From January 1, 2019, with the adoption of IFRS 16 Leases, the Group adopted the following accounting policies for leases and right-of-use assets: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As lessee, the Group assesses whether a contract contains a lease at inception of a contract and upon the modification of a contract. The Group elected to allocate the consideration in the contract to the lease and non-lease components on the basis of the relative standalone price. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group recognizes a right-of-use asset and a corresponding lease liability for all arrangements in which it is a lessee, except for leases with a term of 12 months or less (short-term leases) and low-value leases. For these short-term and low-value leases, the Group recognizes the lease payments as an operating expense on a straight-line basis over the term of the lease. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The lease liability is initially measured at the present value of the future lease payments as from the commencement date of the lease to end of the lease term. The lease term includes the period of any lease extension that in management&#x2019;s assessment is highly probable to be exercised by the Group. The lease payments are discounted using the interest rate implicit in the lease or, if not readily determinable, the Novartis incremental borrowing rate for the asset subject to the lease in the respective markets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group remeasures the lease liability (and makes a corresponding adjustment to the related right-of-use asset) whenever there is a change to the lease terms or expected payments under the lease, or a modification that is not accounted for as a separate lease. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The portion of the lease payments attributable to the repayment of lease liabilities is recognized in cash flows used in financing activities, and the portion attributable to the payment of interest is included in cash flows from operating activities. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are initially recognized on the balance sheet at cost, which comprises the amount of the initial measurement of the corresponding lease liability, adjusted for any lease payments made at or prior to the commencement date of the lease, any lease incentive received and any initial direct costs incurred by Novartis, and expected costs for obligations to dismantle and remove right-of-use assets when they are no longer used. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are depreciated on a straight-line basis from the commencement date of the lease over the shorter of the useful life of the right-of-use asset or the end of the lease term. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Right-of-use assets are assessed for impairment whenever there is an indication that the balance sheet carrying amount may not be recoverable using cash flow projections for the useful life. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In arrangements where the Group is the lessor, it determines at lease inception whether the lease is a finance lease or an operating lease. Leases that transfer substantially all of the risk and rewards incidental to ownership of the underlying asset to the counterparty (the lessee) are accounted for as finance leases. Leases that do not transfer substantially all of the risks and rewards of ownership are accounted for as operating leases. Lease payments received under operating leases are recognized on a straight-line basis over the lease term in the consolidated income statement in either &#x201c;net sales&#x201d; or &#x201c;other income,&#x201d; depending on the nature of and underlying asset to the lease arrangement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to January 1, 2019, the Group applied the following accounting policies for leases: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Leases that transferred substantially all of the risks and rewards of ownership were recognized as finance leases, with the leased asset measured initially at an amount equal to the lower of their fair value and the present value of the minimum lease payments. Minimum lease payments were the payments over the lease term that the Group, as leasee, was required to make, excluding contingent rent. The underlying asset was accounted for in accordance with the accounting policy applicable to that asset. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Leases that did not transfer substantially all of the risks and rewards of ownership were accounted for as operating leases and were not recognized in the consolidated balance sheet. Payments made under operating leases were recognized in the consolidated income statement on a straight-line basis over the term of the lease. Lease incentives received were deferred and recognized as a component of lease expense over the term of the lease. The future undiscounted lease payments under operating leases were disclosed as commitments in the notes to the consolidated financial statements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Lessor accounting policies were not substantially different from those applied upon the adoption of IFRS 16 Leases, as described above. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2019&#x201d; in this Note 1 provides additional disclosures on the impact of adoption of IFRS 16 Leases. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Goodwill and intangible assets</font> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory', window );">Goodwill</a></td>
<td class="text"><div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Goodwill</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Goodwill arises in a business combination and is the excess of the consideration transferred to acquire a business over the underlying fair value of the net identified assets acquired. It is allocated to groups of cash-generating units (CGUs), which are usually represented by the reported segments. Goodwill is tested for impairment annually at the level of these groups of CGUs, and any impairment charges are recorded under &#x201c;Other expense&#x201d; in the consolidated income statement. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock', window );">Intangible assets available-for-use</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets available for use</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has the following classes of available-for-use intangible assets: currently marketed products; technologies; other intangible assets (including computer software); and up to the spin-off date of Alcon business, marketing know-how and the Alcon brand name. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Currently marketed products represent the composite value of acquired intellectual property (IP), patents, and distribution rights and product trade names. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketing know-how represents the value attributable to the expertise acquired for marketing and distributing Alcon surgical products.</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Technologies represent identified and separable acquired know-how used in the research, development and production processes. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Significant investments in internally developed and acquired computer software are capitalized and included in the &#x201c;Other&#x201d; category, and amortized once available for use. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Alcon brand name was shown separately, as it was the only Novartis intangible asset that was available for use with an indefinite useful life. Novartis considers that it was appropriate that the Alcon brand name had an indefinite life since Alcon-branded products had a history of strong revenue and cash flow performance, and Novartis had the intent and ability to support the brand with spending to maintain its value for the foreseeable future. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Except for the Alcon brand name, intangible assets available for use are amortized over their estimated useful lives on a straight-line basis and are evaluated for potential impairment whenever facts and circumstances indicate that their carrying value may not be recoverable. The Alcon brand name was not amortized, but evaluated for potential impairment annually. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the respective useful lives for available-for-use intangible assets and the location in the consolidated income statement in which the respective amortization and any potential impairment charge is recognized: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Useful life </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement location <br></br> for amortization and <br></br> impairment charges </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currently marketed products</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5 to 20 years</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketing know-how</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold"</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Technologies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10 to 20 years <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Cost of goods sold" <br></br> or "Research <br></br> and development" </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other (including <br></br>computer software) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3 to 7 years <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> In the respective <br></br> functional expense </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon brand name</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Not amortized, <br></br> indefinite useful life </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> "Other expense" <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock', window );">Intangible assets not yet available-for-use</a></td>
<td class="text"><div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Intangible assets not yet available for use</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Acquired research and development intangible assets that are still under development and have accordingly not yet obtained marketing approval are recognized as in-process research and development (IPR&amp;D). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">IPR&amp;D is not amortized, but is evaluated for potential impairment on an annual basis or when facts and circumstances warrant. Any impairment charge is recorded in the consolidated income statement under &#x201c;Research and development.&#x201d; Once a project included in IPR&amp;D has been successfully developed, it is transferred to the &#x201c;Currently marketed products&#x201d; category. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock', window );">Impairment of goodwill and intangible assets</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of goodwill and intangible assets</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">An asset is considered impaired when its balance sheet carrying amount exceeds its estimated recoverable amount, which is defined as the higher of its fair value less costs of disposal and its value in use. Usually, Novartis applies the fair value less costs of disposal method for its impairment assessment. In most cases, no directly observable market inputs are available to measure the fair value less costs of disposal. Therefore, an estimate is derived indirectly and is based on net present value techniques utilizing post-tax cash flows and discount rates. In the limited cases where the value in use method would be applied, net present value techniques would be applied using pre-tax cash flows and discount rates. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Fair value less costs of disposal reflects estimates of assumptions that market participants would be expected to use when pricing the asset or CGUs, and for this purpose, management considers the range of economic conditions that are expected to exist over the remaining useful life of the asset. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimates used in calculating the net present values are highly sensitive and depend on assumptions specific to the nature of the Group&#x2019;s activities with regard to: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected future cash flows</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Long-term sales forecasts </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Actions of competitors (launch of competing products, marketing initiatives, etc.)</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales erosion rates after the end of patent or other intellectual property rights protection, and timing of the entry of generic competition </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Outcome of research and development activities (compound efficacy, results of clinical trials, etc.)</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Amount and timing of projected costs to develop IPR&amp;D into commercially viable products</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Profit margins</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Probability of obtaining regulatory approval</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Future tax rate</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate royalty rate for the Alcon brand name</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate terminal growth rate</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Appropriate discount rate</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Generally, for intangible assets with a definite useful life, Novartis uses cash flow projections for the whole useful life of these assets. For goodwill and the Alcon brand name, Novartis generally utilizes cash flow projections for a five-year period based on management forecasts, with a terminal value based on cash flow projections usually in line with inflation rates for later periods. Probability-weighted scenarios are typically used. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discount rates used consider the Group&#x2019;s estimated weighted average cost of capital, adjusted for specific country and currency risks associated with cash flow projections to approximate the discount rate that market participants would use to value the asset. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Due to the above factors, actual cash flows and values could vary significantly from forecasted future cash flows and related values derived using discounting techniques. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock', window );">Impairment of associated companies accounted for at equity</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impairment of associated companies accounted for at equity</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis considers investments in associated companies for impairment evaluation whenever objective evidence indicates the net investment may be impaired, including when a quoted share price indicates a fair value less than the per-share balance sheet carrying value for the investment. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If the recoverable amount of the investment is estimated to be lower than the balance sheet carrying amount, an impairment charge is recognized for the difference in the consolidated income statement under &#x201c;Income from associated companies.&#x201d; </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash and cash equivalents</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash and cash equivalents include highly liquid investments with original maturities of three months or less, which are readily convertible to known amounts of cash. Bank overdrafts are usually presented within current financial debts on the consolidated balance sheet, except in cases where a right of offset has been agreed with a bank, which then allows for presentation on a net basis. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock', window );">Marketable securities, commodities and non-current financial assets</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Marketable securities, commodities and non-current financial assets </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Commodities, which include gold bullion or coins, are valued at the lower of cost or fair value using current market prices. The changes in fair value below cost are immediately recorded in &#x201c;Other financial income and expense.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketable securities are financial assets consisting principally of equity and debt securities as well as fund investments. Marketable securities held for short-term purposes are principally traded in liquid markets and are classified as marketable securities within current assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &#x201c;Other financial income and expense&#x201d; in the consolidated income statement. Marketable securities held for long-term strategic purposes are classified as non-current financial assets on the consolidated balance sheet. The financial impacts related to these financial assets are recorded in &#x201c;Other income&#x201d; and &#x201c;Other expense&#x201d; in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Marketable securities are initially recorded at fair value on their trade date, which is different from the settlement date when the transaction is ultimately effected. Quoted securities are remeasured at each reporting date to fair value based on current market prices. If the market for a financial asset is not active or no market is available, fair values are established using valuation techniques. The majority of non-quoted investments are valued initially at fair value through the established purchase price between a willing buyer and seller. Non-quoted investments are subsequently adjusted based on values derived from discounted cash flow analysis or other pricing models. These investment values are classified as &#x201c;Level 3&#x201d; in the fair value hierarchy. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the Group classifies and accounts for its marketable securities and non-current financial assets in the following categories: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Debt securities are valued at fair value through other comprehensive income with subsequent recycling into the consolidated income statement, as they meet both the &#x201c;solely payment of principal and interest&#x201d; and the business model criteria. Unrealized gains and losses, except exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are recognized in the consolidated income statement when the debt instrument is sold, at which time the gain is transferred to &#x201c;Other financial income and expense.&#x201d; Exchange gains and losses related to debt instruments are immediately recognized in the consolidated income statement to &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Fund investments, equity securities of the Novartis venture fund and derivative assets are valued at fair value through profit and loss (FVPL). Unrealized gains and losses, including exchange gains and losses, are recognized in the consolidated income statement, for all fund investments and for equity securities of the Novartis venture fund, to &#x201c;Other income&#x201d; for gains and &#x201c;Other expense&#x201d; for losses, and for derivative assets to &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Equity securities held as strategic investments, typically held outside of the Novartis venture fund, are generally designated at date of acquisition as financial assets valued at fair value through other comprehensive income with no subsequent recycling through profit and loss. Unrealized gains and losses, including exchange gains and losses, are recorded as a fair value adjustment in the consolidated statement of comprehensive income. They are reclassified to retained earnings when the equity security is sold. If these equity securities are not designated at date of acquisition as financial assets valued at fair value through other comprehensive income, they are valued at FVPL, as described above. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other non-current financial assets, such as loans and long-term receivables from customers, advances and other deposits, are valued at amortized cost, which reflects the time value of money less any allowances for expected credit losses. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group assesses on a forward-looking basis the expected credit losses associated with its debt securities valued at fair value through other comprehensive income. Impairments on debt securities are recorded in &#x201c;Other financial income and expense.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For other financial assets valued at amortized costs, impairments, which are based on their expected credit losses, and exchange rate losses are included in &#x201c;Other expense&#x201d; in the consolidated income statement. Exchange rate gains and interest income, using the effective interest rate method, are included in &#x201c;Other income&#x201d; or &#x201c;Other financial income&#x201d; in the consolidated income statement, depending on the nature of the item. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 9, the Group classified and accounted for its marketable securities and non-current financial assets in the following categories: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group classified all its equity and quoted debt securities as well as fund investments as available for sale, as they were not acquired to generate profit from short-term fluctuations in price. Unrealized gains, except exchange gains related to quoted debt instruments, were recorded as a fair value adjustment in the consolidated statement of comprehensive income. They were recognized in the consolidated income statement when the financial asset was sold, at which time the gain was transferred either to &#x201c;Other financial income and expense,&#x201d; for the marketable securities held for short-term non-strategic purposes, or to &#x201c;Other income,&#x201d; for all other equity securities and fund investments. Exchange gains related to quoted debt instruments were immediately recognized in the consolidated income statement under &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; A security was assessed for impairment when its market value at the balance sheet date was less than initial cost reduced by any previously recognized impairment. Impairments on equity securities, quoted debt securities and fund investments, and exchange rate losses on quoted debt securities in a foreign currency that were held for short-term non-strategic purposes were recorded in &#x201c;Other financial income and expense.&#x201d; Impairments were recorded for all other equity securities and other fund investments in &#x201c;Other expense&#x201d; in the consolidated income statement. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Other non-current financial assets, including loans held for long-term strategic purposes, were carried at amortized cost, which reflects the time value of money less any allowances for uncollectable amounts. For these financial assets, impairments and exchange rate losses were included in &#x201c;Other expense&#x201d; in the consolidated income statement, and exchange rate gains and interest income using the effective interest rate method were included in &#x201c;Other income&#x201d; in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory', window );">Description of accounting policy for financial assets [text block]</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Derivative financial instruments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Derivative financial instruments are initially recognized in the balance sheet at fair value and are remeasured to their current fair value at the end of each subsequent reporting period. The valuation of a forward exchange rate contract is based on the discounted cash flow model, using interest curves and spot rates at the reporting date as observable inputs. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Options are valued based on a modified Black-Scholes model using volatility and exercise prices as major observable inputs. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group utilizes derivative financial instruments for the purpose of hedging to reduce the volatility in the Group&#x2019;s performance due to the exposure to various business related risks. To mitigate these risks, the Group enters into certain derivative financial instruments. The risk reduction is obtained because the derivative&#x2019;s value or cash flows are expected, wholly or partly, to offset changes in the value or cash flows of the recognized assets or liabilities. The overall strategy is aiming to mitigate the currency and interest rate risk of positions that are contractually agreed, and to partially mitigate the exposure risk of selected anticipated transactions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain derivative financial instruments meet the criteria for hedge accounting treatment. A prerequisite for obtaining this accounting-hedge relationship is extensive documentation on inception and proving on a regular basis that the economic hedge is effective for accounting purposes. Other derivative financial instruments do not meet the criteria to qualify for hedge accounting. Changes in the fair value of those derivative instruments are recognized immediately in &#x201c;Other financial income and expense&#x201d; in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, the Group has designated certain long-term debt components as hedges of the translation risk arising on certain net investments in foreign operations. On consolidation, foreign currency differences arising on long-term debt designated as net investment hedges of a foreign operation are recognized in other comprehensive income and accumulated in currency translation effects, to the extent that the hedge is effective. The foreign currency differences arising from hedge ineffectiveness are recognized in the income statement in &#x201c;Other financial income and expense.&#x201d; </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When a hedged net investment is disposed of, the proportionate portion of the cumulative amount recognized in equity in relation to the hedged net investment is transferred to the consolidated income statement as an adjustment to the gain or loss on disposal. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Inventories</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Inventory is valued at the lower of acquisition or production cost determined on a first-in, first-out basis and net realizable value. This value is used for the &#x201c;Cost of goods sold&#x201d; in the consolidated income statement. Unsalable inventory is fully written off in the consolidated income statement under &#x201c;Cost of goods sold.&#x201d; </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory', window );">Trade receivables</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Trade receivables</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Trade receivables are initially recognized at their invoiced amounts, including any related sales taxes less adjustments for estimated revenue deductions such as rebates, chargebacks and cash discounts. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">From January 1, 2018, with the adoption of IFRS 9 Financial Instruments, the provisions for doubtful trade receivable are established using an expected credit loss model (ECL). The provisions are based on a forward-looking ECL, which includes possible default events on the trade receivables over the entire holding period of the trade receivable. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Charges for doubtful trade receivables are recorded as marketing and selling costs recognized in the consolidated income statement within &#x201c;Selling, general and administration&#x201d; expenses. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 9, the Group&#x2019;s accounting policy for provisions for doubtful trade receivables was as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for doubtful trade receivables were established once there was an indication that it was likely that a loss would be incurred. These provisions represent the difference between the trade receivable&#x2019;s carrying amount in the consolidated balance sheet and the estimated collectible amount. Significant financial difficulties of a customer, such as probability of bankruptcy, financial reorganization, default or delinquency in payments, were considered indicators that recovery of the trade receivable was doubtful. Charges for doubtful trade receivables, recorded as marketing and selling costs, were recognized in the consolidated income statement within &#x201c;Selling, general and administration&#x201d; expenses. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201d; provides additional disclosure on the impact of adoption of IFRS 9 Financial Instruments. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">Legal and environmental liabilities</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Legal and environmental liabilities</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis and its subsidiaries are subject to contingencies arising in the ordinary course of business, such as patent litigation, environmental remediation liabilities and other product-related litigation, commercial litigation, and governmental investigations and proceedings. Provisions are recorded where a reliable estimate can be made of the probable outcome of legal or other disputes against the subsidiary. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory', window );">Contingent consideration</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Contingent consideration</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In a business combination or divestment of a business, it is necessary to recognize contingent future amounts due to previous owners, representing contractually defined potential amounts as a liability or asset. Usually for Novartis, these are linked to milestone or royalty payments related to certain assets and are recognized as a financial liability or financial asset at their fair value, which is then remeasured at each subsequent reporting date. These estimations typically depend on factors such as technical milestones or market performance, and are adjusted for the probability of their likelihood of payment and are appropriately discounted to reflect the impact of time. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Changes in the fair value of contingent consideration liabilities in subsequent periods are recognized in the consolidated income statement in &#x201c;Cost of goods sold&#x201d; for currently marketed products and in &#x201c;Research and development&#x201d; for IPR&amp;D. Changes in contingent consideration assets are recognized in &#x201c;Other income&#x201d; or &#x201c;Other expense,&#x201d; depending on its nature. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The effect of unwinding the discount over time is recognized for contingent liabilities in &#x201c;Interest expense&#x201d; and for contingent assets as interest income recognized in the consolidated income statement within &#x201c;Other financial income and expense.&#x201d; </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Defined benefit pension plans and other post retirement benefits</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defi</font> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">ned benefit pension plans and&nbsp;other&nbsp;post-employment benefits</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The liability in respect of defined benefit pension plans and other post-employment benefits is the defined benefit obligation calculated annually by independent actuaries using the projected unit credit method. The current service cost for such post-employment benefit plans is included in the personnel expenses of the various functions in which associates are employed, while the net interest on the net defined benefit liability or asset is recognized as &#x201c;Other expense&#x201d; or &#x201c;Other income.&#x201d; </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory', window );">Treasury Shares</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Treasury shares</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Treasury shares are initially recorded at fair value on their trade date, which is different from the settlement date, when the transaction is ultimately effected. Treasury shares are deducted from consolidated equity at their nominal value of CHF&nbsp;0.50 per share. Differences between the nominal amount and the transaction price on purchases or sales of treasury shares with third parties, or the value of services received for the shares allocated to associates as part of share-based compensation arrangements, are recorded in &#x201c;Retained earnings&#x201d; in the consolidated statement of changes in equity. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue recognition</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Revenue recognition</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">From January 1, 2018, with the implementation of the new standard IFRS 15 Revenue from Contracts with Customers, the Group accounting policy for revenue recognition is as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Revenue on the sale of Novartis Group products and services, which is recorded as &#x201c;Net sales&#x201d; in the consolidated income statement, is recognized when a contractual promise to a customer (performance obligation) has been fulfilled by transferring control over the promised goods and services to the customer, substantially all of which is at the point in time of shipment to or receipt of the products by the customer or when the services are performed. If contracts contain customer acceptance provisions, revenue is recognized upon the satisfaction of the acceptance criteria. If products are stockpiled at the request of the customer, revenue is only recognized once the products have been inspected and accepted by the customer, and there is no right of return or replenishment on product expiry. The amount of revenue recognized is based on the consideration Novartis expects to receive in exchange for its goods and services, when it is highly probable that a significant reversal will not occur. If a contract contains more than one performance obligation, the consideration is allocated based on the standalone selling price of each performance obligation. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. Revenues were recognized upon satisfaction of each of the performance obligations in the contract and the consideration was allocated based on the standalone selling price of each performance obligation. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which substantially all the risks and rewards incidental to ownership transfers to the customer were treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair value of the equipment, which approximated the present value of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements were approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements longer than 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &#x201c;Other income.&#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consideration Novartis receives in exchange for its goods or services may be fixed or variable. Variable consideration is only recognized when it is highly probable that a significant reversal will not occur. The most common elements of variable consideration are listed below. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers are provisioned and recorded as a deduction from revenue at the time the related revenues are recorded or when the incentives are offered. They are calculated on the basis of historical experience, regulations, the specific terms in the individual agreements, product pricing and the mix of products, contracts, channels and payors. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Refunds granted to healthcare providers under innovative pay-for-performance agreements (i.e. outcome based arrangements) are provisioned and recorded as a revenue deduction at the time the related sales are recorded. They are calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data are not sufficient for a reliable estimation of the outcome, revenue recognition is deferred until the uncertainty is resolved or until such history is available. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Cash discounts offered to customers are to encourage prompt payment and are provisioned and recorded as revenue deductions at the time the related sales are recorded. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Shelf stock adjustments are generally granted to customers, primarily of the Sandoz Division, to cover the inventory held by them at the time a price decline becomes effective. Revenue deduction provisions for shelf stock adjustments are recorded when the price decline is anticipated, based on the impact of the price decline on the customer&#x2019;s estimated inventory levels. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Sales returns provisions are recognized and recorded as revenue deductions when there is historical experience of Novartis agreeing to customer returns and Novartis can reasonably estimate expected future returns. In doing so, the estimated rate of return is applied, determined on the basis of historical experience of customer returns and considering any other relevant factors. This is applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that can be placed back in inventory for resale. Where shipments are made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue is only recorded when there is evidence of consumption or when the right of return has expired. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Provisions for revenue deductions are adjusted to actual amounts as rebates, refunds, discounts and returns are processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">&#x201c;Other revenue&#x201d; includes income from profit-sharing arrangements with our collaboration partners, and royalty and milestone income from the out-licensing of intellectual property when Novartis retains an interest in the IP through a license. Royalty income earned through a license is recognized when the underlying sales have occurred. Milestone income is recognized at the point in time when it is highly probable that the relevant milestone event criteria is met, and the risk of reversal of revenue recognition is remote. Other revenue also includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales, and is recognized when control transfers to the third party and our performance obligations are satisfied. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Prior to the adoption of IFRS 15 on January 1, 2018, the Group accounting policy for revenue recognition was as follows: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Revenue was recognized on the sale of Novartis Group products and services, and was recorded as &#x201c;Net sales&#x201d; in the consolidated income statement when there was persuasive evidence that a sales arrangement exists; title, risks and rewards for the products are transferred to the customer; the price was determinable; and collectability was reasonably assured. If contracts contain customer acceptance provisions, revenue would be recognized upon the satisfaction of acceptance criteria. If products are stockpiled at the request of the customer, revenue was only recognized once the products have been inspected and accepted by the customer, and there was no right of return or replenishment on product expiry. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Alcon Division, which is reported as discontinued operations, surgical equipment may be sold together with other products and services under a single contract. The total consideration was allocated to the separate elements based on their relative fair values. Revenue was recognized once the recognition criteria have been met for each element of the contract. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For surgical equipment, in addition to cash and installment sales, revenue was recognized under finance and operating lease arrangements. Arrangements in which Novartis transfers substantially all the risks and rewards incidental to ownership to the customer are treated as finance lease arrangements. Revenue from finance lease arrangements was recognized at amounts equal to the fair values of the equipment, which approximate the present values of the minimum lease payments under the arrangements. As interest rates embedded in lease arrangements are approximately market rates, revenue under finance lease arrangements was comparable to revenue for outright sales. Finance income for arrangements in excess of 12 months was deferred and subsequently recognized based on a pattern that approximates the use of the effective interest method and recorded in &#x201c;Other income.&#x201d; Operating lease revenue for equipment rentals was recognized on a straight-line basis over the lease term. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for rebates and discounts granted to government agencies, wholesalers, retail pharmacies, managed healthcare organizations and other customers were recorded as a deduction from revenue at the time the related revenues were recorded or when the incentives were offered. They were calculated on the basis of historical experience and the specific terms in the individual agreements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for refunds granted to healthcare providers under innovative pay-for-performance agreements were recorded as a revenue deduction at the time the related sales were recorded. They were calculated on the basis of historical experience and clinical data available for the product, as well as the specific terms in the individual agreements. In cases where historical experience and clinical data were not sufficient for a reliable estimation of the outcome, revenue recognition was deferred until such history was available. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Cash discounts were offered to customers to encourage prompt payment and were recorded as revenue deductions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Following a decrease in the price of a product, we generally grant customers a &#x201c;shelf stock adjustment&#x201d; for their existing inventory for the involved product. Provisions for shelf stock adjustments, which are primarily relevant within the Sandoz Division, were determined at the time of the price decline or at the point of sale, if the impact of a price decline on the products sold could be reasonably estimated based on the customer&#x2019;s inventory levels of the relevant product. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">When there was historical experience of Novartis agreeing to customer returns, and Novartis could reasonably estimate expected future returns, a provision was recorded for estimated sales returns. In doing so, the estimated rate of return was applied, determined based on historical experience of customer returns and considering any other relevant factors. This was applied to the amounts invoiced, also considering the amount of returned products to be destroyed versus products that could be placed back in inventory for resale. Where shipments were made on a resale or return basis, without sufficient historical experience for estimating sales returns, revenue was only recorded when there was evidence of consumption or when the right of return had expired. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Provisions for revenue deductions were adjusted to actual amounts as rebates, discounts and returns were processed. The provision represents estimates of the related obligations, requiring the use of judgment when estimating the effect of these sales deductions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">&#x201c;Other revenue&#x201d; includes royalty and profit-sharing income, and revenue from activities such as manufacturing services or other services rendered, to the extent such revenue was not recorded under net sales. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The section &#x201c;&mdash;Impact of adopting significant new IFRS standards in 2018&#x201d; provides additional disclosure on the impact of adoption. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Research and development</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Internal research and development (R&amp;D) costs are fully charged to &#x201c;Research and development&#x201d; in the consolidated income statement in the period in which they are incurred. The Group considers that regulatory and other uncertainties inherent in the development of new products preclude the capitalization of internal development expenses as an intangible asset until marketing approval from a regulatory authority is obtained in a major market such as the United States, the European Union, Switzerland or Japan. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Payments made to third parties, such as contract research and development organizations in compensation for subcontracted R&amp;D, that are deemed not to transfer intellectual property to Novartis are expensed as internal R&amp;D expenses in the period in which they are incurred. Such payments are only capitalized if they meet the criteria for recognition of an internally generated intangible asset, usually when marketing approval has been achieved from a regulatory authority in a major market. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Payments made to third parties to in-license or acquire intellectual property rights, compounds and products, including initial upfront and subsequent milestone payments, are capitalized, as are payments for other assets, such as technologies to be used in R&amp;D activities. If additional payments are made to the originator company to continue to perform R&amp;D activities, an evaluation is made as to the nature of the payments. Such additional payments will be expensed if they are deemed to be compensation for subcontracted R&amp;D services not resulting in an additional transfer of intellectual property rights to Novartis. Such additional payments will be capitalized if they are deemed to be compensation for the transfer to Novartis of additional intellectual property developed at the risk of the originator company. Subsequent internal R&amp;D costs in relation to IPR&amp;D and other assets are expensed, since the technical feasibility of the internal R&amp;D activity can only be demonstrated by the receipt of marketing approval for a related product from a regulatory authority in a major market. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Costs for post-approval studies performed to support the continued registration of a marketed product are recognized as marketing expenses. Costs for activities that are required by regulatory authorities as a condition for obtaining marketing approval are capitalized and recognized as currently marketed products. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Inventory produced ahead of regulatory approval is fully provisioned, and the charge is included in &#x201c;Other expense&#x201d; in the consolidated income statement, as its ultimate use cannot be assured. If this inventory can be subsequently sold, the provision is released to &#x201c;Other income&#x201d; in the consolidated income statement, either on approval by the appropriate regulatory authority or, exceptionally in Europe, on recommendation by the Committee for Medicinal Products for Human Use (CHMP), if approval is virtually certain. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share based compensation</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Share-based compensation</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Vested Novartis shares and American Depositary Receipts (ADRs) that are granted as compensation are valued at their market value on the grant date and are immediately expensed in the consolidated income statement. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair values of unvested restricted shares (RSs), restricted share units (RSUs) and performance share units (PSUs) in Novartis shares and ADRs granted to associates as compensation are recognized as an expense over the related vesting period. The expense recorded in the consolidated income statement is included in the personnel expenses of the various functions in which the associates are employed. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Unvested restricted shares, restricted ADRs and RSUs are only conditional on the provision of services by the plan participant during the vesting period. They are valued at fair value on the grant date. As RSUs do not entitle the holder to dividends, the fair value is based on the Novartis share price at the grant date adjusted for the net present value of the dividends expected to be paid during the holding period. The fair value of these grants, after making adjustments for assumptions related to forfeiture during the vesting period, is expensed on a straight-line basis over the respective vesting period. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">PSUs are subject to the achievement of certain performance criteria during the vesting period and require plan participants to provide services during this period. The following paragraphs provide an overview of the accounting policies for the share-based compensation plans that grant PSUs. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to performance criteria based on Novartis internal performance metrics and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on assumptions concerning the expected performance against the internal performance metrics throughout the vesting period. The assumptions are based on the Group&#x2019;s targets for those performance metrics, and the expected forfeitures due to plan participants not meeting their service conditions. The assumptions are periodically adjusted over the vesting period. Any change in estimates for past services is recorded immediately as an expense or income in the consolidated income statement, and amounts for the remaining vesting period are expensed on a straight-line basis. As a result, at the end of the vesting period, the charge during the entire vesting period represents the amount that will finally vest. The number of equity instruments that finally vest is determined at the vesting date. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to performance criteria based on variables that can be observed in the market, which for Novartis plans is the Novartis total shareholder return (TSR) relative to a specific peer group of companies over the vesting period, and that are conditional on the provision of services by the plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on the total fair value of the grant over the vesting period. IFRS requires that these variables that can be observed in the market are taken into account in determining the fair value of the PSUs at the grant date. Novartis determined the fair value of these PSUs at the date of grant using a Monte Carlo simulation model. Adjustments to the number of equity instruments granted are only made if a plan participant does not fulfill the service conditions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For PSUs granted under plans that are subject to both performance criteria based on Novartis internal performance metrics and Novartis TSR relative to a specific peer group of companies over the vesting period and that are conditional on the provision of service by plan participants during the vesting period, the expense is recognized on a straight-line basis over the vesting period, and is determined based on a bifurcation into the components based on the performance criteria related to Novartis internal performance metrics and TSR, as described in the paragraphs above. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Measuring the fair values of PSUs granted that include TSR performance criteria requires use of estimates. The Monte Carlo simulation used to determine the fair value of the PSUs TSR performance criteria requires the probability of factors related to uncertain future events; the term of the award; the grant price of underlying shares or ADRs; expected volatilities; the expected correlation matrix of the underlying equity instruments with those of the peer group of companies; and the risk-free interest rate as input parameters. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">If a plan participant leaves Novartis for reasons other than retirement, disability or death, then unvested restricted shares, restricted ADRs, RSUs and PSUs are forfeited, unless determined otherwise by the provision of the plan rules or by the Compensation Committee of the Novartis Board of Directors, for example, in connection with a reorganization or divestment. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants', window );">Government grants</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Government grants</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Grants from governments or similar organizations are recognized at their fair value when there is a reasonable assurance that the grant will be received and the Group will comply with all attached conditions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Government grants related to income are deferred and recognized in the consolidated income statement over the period necessary to match them with the related costs that they are intended to compensate. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The accounting policy for property, plant and equipment describes the treatment of any related grants. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory', window );">Restructuring charges</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Restructuring charges</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Restructuring provisions are recognized for the direct expenditures arising from the restructuring, where the plans are sufficiently detailed and where appropriate communication to those affected has been made. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Charges to increase restructuring provisions are included in &#x201c;Other expense&#x201d; in the consolidated income statements. Corresponding releases are recorded in &#x201c;Other income&#x201d; in the consolidated income statement. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Taxes</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Taxes</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Taxes on income are provided in the same periods as the revenues and expenses to which they relate and include interest and penalties incurred during the period. Deferred taxes are determined using the comprehensive liability method and are calculated on the temporary differences that arise between the tax base of an asset or liability and its carrying value in the balance sheet prepared for consolidation purposes, except for those temporary differences related to investments in subsidiaries and associated companies, where the timing of their reversal can be controlled and it is probable that the difference will not reverse in the foreseeable future. Since the retained earnings are reinvested, withholding or other taxes on eventual distribution of a subsidiary&#x2019;s retained earnings are only taken into account when a dividend has been planned. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The estimated amounts for current and deferred tax assets or liabilities, including any amounts related to any uncertain tax positions, are based on currently known facts and circumstances. Tax returns are based on an interpretation of tax laws and regulations, and reflect estimates based on these judgments and interpretations. The tax returns are subject to examination by the competent taxing authorities, which may result in an assessment being made requiring payments of additional tax, interest or penalties. Inherent uncertainties exist in the estimates of the tax positions. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">Impact of adopting significant new IFRS standards</a></td>
<td class="text"><div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impact of adopting significant new IFRS standard in 2019</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following new IFRS standard has been adopted by Novartis from January 1, 2019: </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 16 Leases</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">IFRS 16 Leases substantially changed the financial statements, as the majority of leases for which the Group is the lessee became on-balance sheet liabilities with corresponding right-of-use assets also recognized on the balance sheet. The lease liability reflects the net present value of the remaining lease payments, and the right-of-use asset corresponds to the lease liability, adjusted for payments made before the commencement date, lease incentives and other items related to the lease agreement. The standard replaces IAS 17 Leases and related interpretations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Upon adoption of the new standard, a portion of the annual operating lease costs, which was previously fully recognized as functional expenses, as a component of operating income, is recorded as interest expense. In addition, the portion of the lease payments that represents the reduction of the lease liability is recognized in the cash flow statement as an outflow from financing activities, which was previously fully recognized as an outflow from operating activities. Given the leases involved, these effects are not significant to the consolidated income statement and consolidated statement of cash flow. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group implemented the new standard on January 1, 2019, and applied the modified retrospective method, with right-of-use assets measured at an amount equal to the lease liability, adjusted by the amount of the prepaid or accrued lease payments relating to those leases recognized in the balance sheet immediately before the date of initial application and did not restate prior years. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Results of our impact assessment: </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The undiscounted operating lease commitments as of December 31, 2018, amounted to USD 3.6 billion. This includes approximately USD 0.1 billion of leases with a commencement date in 2019, as well as short-term leases and low-value leases that are recognized from January 1, 2019, upon adoption of IFRS 16, on a straight-line basis as expense in profit and loss. This also includes USD 0.2 billion lease commitments related to the Alcon Division, which is attributable to discontinued operation in 2019. For the remaining undiscounted lease commitments attributable to continuing operations of USD 3.3 billion, the Group recognized on January 1, 2019, lease liabilities of USD 1.74 billion and right-of-use assets of USD 1.55 billion (after the reclassification of USD 0.1 billion from property, plant &amp; equipment, and net adjustments for the USD 0.3 billion recognition of sublease receivables, prepayments, and accrued lease payments recognized as at December 31, 2018). For the lease commitments attributable to discontinued operations, the Group recognized on January 1, 2019, lease liabilities and right-of-use assets of USD 0.2 billion. This does not include the discontinued operations right-of-use assets and lease liability on finance lease agreements of USD 75 million and USD 89 million, respectively. There was an insignificant increase to retained earnings upon adoption of IFRS 16 of USD 3 million that arose from subleases that were accounted for as operating lease agreements under IAS 17 and are accounted for as finance leases under IFRS 16. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As a lessor, the Group had no significant impact upon adoption. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For further information on the impact of adoption and additional disclosures of IFRS 16 Leases, see Note 10. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Impact of adopting significant new IFRS standards in 2018</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following IFRS standards have been adopted by Novartis from January 1, 2018: </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 9 Financial Instruments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented IFRS 9 Financial Instruments as of January 1, 2018, which substantially changed the classi&#xfb01;cation and measurement of &#xfb01;nancial instruments. The standard requires impairments to be based on a forward-looking model, changed the approach to hedging &#xfb01;nancial exposures and related documentation, changed the recognition of certain fair value changes, and amends disclosure requirements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impairment of financial assets, including trade and lease receivables, is now assessed using an expected credit loss model; previously, the incurred loss model was used. Given the nature of Novartis financial assets, the Group had no significant impact to its provisions for doubtful accounts or impairments from this change. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The new hedge accounting model introduced by the standard requires hedge accounting relationships to be based upon the Group&#x2019;s own risk management strategy and objectives, and to be discontinued only when the relationships no longer qualify for hedge accounting. There was no impact upon adoption of the new standard, as the Group&#x2019;s existing hedge relationships continue to be designated as such under the new hedge accounting requirements. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The most significant impact to the Group upon adoption of IFRS 9 relates to the treatment of the unrealized gains and losses from changes in fair value on certain of the Group&#x2019;s financial instruments, which were previously classified as available-for-sale marketable securities and financial investments. The unrealized gains and losses (to the extent of previous recognized unrealized gains), which the Group recognized previously in the consolidated statement of other comprehensive income, are from January 1, 2018, recognized in the consolidated income statement. This approach is applied to equity securities where the fair value through other comprehensive income irrevocable option is not applied. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Group applied the modified retrospective method upon adoption of IFRS 9 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 9 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 177 million. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 15 Revenue from Contracts with Customers</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis implemented the new standard IFRS 15 Revenue from Contracts with Customers as of January 1, 2018. The standard amended revenue recognition requirements and established principles for reporting information about the nature, amount, timing and uncertainty of revenue and cash &#xfb02;ows arising from contracts with customers. The standard replaced IAS 18 Revenue and IAS 11 Construction contracts and related interpretations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The impacts of adoption of the new standard are summarized below: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group&#x2019;s &#x201c;net sales&#x201d; are derived from the sale of drug substances, vision care products, surgical equipment, and other products and services, where control transfers to our customers and our performance obligations are satisfied at the time of shipment to or receipt of the products by the customer, or when the services are performed. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Group&#x2019;s &#x201c;other revenue&#x201d; consists of royalty income from the out-licensing of intellectual property, which is recognized as earned, and from manufacturing and other services, where revenue is recognized when control transfers to the third party and our performance obligations are satisfied. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized from these manufacturing and other services arrangements, nor did it change accounting for these royalty arrangements, as the standard&#x2019;s royalty exception is applied for IP licenses. &#x201c;Other revenue&#x201d; also includes revenue from profit-sharing arrangements with our collaboration partners. Furthermore, the Group receives milestone payments related to the out-licensing of IP. The adoption of IFRS 15 did not significantly change the timing or amount of revenue recognized under these arrangements. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group applied the modified retrospective method upon adoption of IFRS 15 on January 1, 2018. This method requires the recognition of the cumulative effect of initially applying IFRS 15 to retained earnings and not to restate prior years. The cumulative effect recorded at January 1, 2018, was an increase to retained earnings of USD 60 million. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">New IFRS standard effective as of January 1, 2020 </font> </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">IFRS 3 Business Combination amendments</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The IASB issued an amendment to IFRS 3 Business Combinations that revised the definition of a business, which assist entities with the evaluation of when an asset or group of assets acquired or disposed of should be considered a business. This amended standard is effective for the Group as of January 1, 2020 and is applicable to transactions entered into on or after January 1, 2020. The amended standard allows an entity to apply an optional concentration test, on a transaction-by-transaction basis, to evaluate whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If this optional concentration test is met, the entity may choose to consider the transaction an acquisition of an asset or set of assets. The Group does not expect the adoption of this amended standard on January 1, 2020 to have a significant impact on our consolidated financial statements in future periods. However, this will depend on the facts and circumstances of future transactions and if the Group decides to apply the optional concentration test in the assessment of whether an acquired set of activities and assets is or is not a business. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There are no other IFRS standards or interpretations not yet effective that would be expected to have a material impact on the Group. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for contingent liabilities and contingent assets. [Refer: Contingent liabilities [member]; Description of nature of contingent assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForContingentLiabilitiesAndContingentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for decommissioning, restoration and rehabilitation provisions. [Refer: Provision for decommissioning, restoration and rehabilitation costs]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDecommissioningRestorationAndRehabilitationProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2019-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for income tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for non-current assets or disposal groups classified as held for sale. [Refer: Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTreasurySharesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfAccountingPolicyForFinancialAssetsCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfAccountingPolicyForFinancialAssetsMarketableSecuritiesCommoditiesAndNoncurrentFinancialAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfAccountingPolicyForImpairmentOfAssociatedCompaniesAccountedForAtEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfAccountingPolicyForImpairmentOfGoodwillAndIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfAccountingPolicyForIntangibleAssetsAvailableforuseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DescriptionOfAccountingPolicyForIntangibleAssetsNotYetAvailableforuseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DistributionByWayOfDivindendInKindToShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DistributionByWayOfDivindendInKindToShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R168.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839167072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 10) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems', window );"><strong>Defined contribution pension and other post-retirement plans disclosure [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Post-employment benefit expense, defined contribution plans</a></td>
<td class="nump">$ 422<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedContributionPensionAndOtherPostretirementPlansDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R198.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843872720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Details 7) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Intangible Assets other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment loss recognised in profit or loss, intangible assets and goodwill</a></td>
<td class="num">$ (1,175)<span></span>
</td>
<td class="num">$ (1,049)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment | Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment loss recognised in profit or loss, intangible assets and goodwill</a></td>
<td class="num">$ (54)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment loss recognised in profit or loss, intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Terminal Growth Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal', window );">Discount Rate (post-tax)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | CyPass [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill', window );">Impairment loss recognised in profit or loss, intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_d_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_e_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discount rate used in the current measurement of fair value less costs of disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 130<br> -Subparagraph f<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_130_f_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for intangible assets and goodwill. [Refer: Impairment loss recognised in profit or loss; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_CyPassMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_CyPassMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R201.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp7214886720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal Group subsidiaries and associated companies (Details)<br> &#8381; in Millions, &#8378; in Millions, &#8372; in Millions, &#8369; in Millions, &#8360; in Millions, &#3647; in Millions, &#2547; in Millions, &#1585;.&#1587; in Millions, &#1583;&#1580; in Millions, &#1583;.&#1605;. in Millions, &#1583;.&#1573; in Millions, &#165; in Millions, z&#322; in Millions, kr in Millions, kr in Millions, kr in Millions, kn in Millions, S/ in Millions, RM in Millions, R$ in Millions, R in Millions, K&#269; in Millions, Ft in Millions, $ in Millions, $ in Millions, $ in Millions,
       in Millions,
       in Millions, &#8361; in Billions, &#8360; in Billions, Rp in Billions, $ in Billions, $ in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="43"></th>
</tr>
<tr>
<th class="th"><div>Jan. 22, 2018</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>INR (&#8360;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>IDR (Rp)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>MYR (RM)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>MXN ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>MAD (&#1583;.&#1605;.)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>NZD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>NOK (kr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>PKR (&#8360;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>PEN (S/)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>PHP (&#8369;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>PLN (z&#322;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>RON (
      )</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>RUB (&#8381;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SGD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>ZAR (R)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>KRW (&#8361;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SEK (kr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>TWD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>THB (&#3647;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>TRY (&#8378;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>UAH (&#8372;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>AED (&#1583;.&#1573;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>GBP (&#163;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>DZD (&#1583;&#1580;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>ARS ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>AUD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>BDT (&#2547;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CLP ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>HKD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>COP ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>HRK (kn)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CZK (K&#269;)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>DKK (kr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EGP (&#1580;.&#1605;.)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>HUF (Ft)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>VEF (
      )</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SAR (&#1585;.&#1587;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties', window );">Principal group companies materiality of assets or sales to third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsAAAMember', window );">Advanced Accelerator Applications (AAA) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Societe par actions SANDOZ, Algiers [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Soci&#233;t&#233; par actions SANDOZ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Algiers<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Algeria<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#1583;&#1580;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#1583;&#1580; 650.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Manufacturing GmbH, Marburg [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Manufacturing GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Marburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Argentina S.A., Buenos Aires [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Argentina S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Buenos Aires<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Argentina<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 906.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Australia Pty Ltd, Macquarie Park, NSW [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Australia Pty Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Macquarie Park, NSW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharmaceuticals Australia Pty Ltd, Macquarie Park, NSW [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharmaceuticals Australia Pty Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Macquarie Park, NSW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Pty Ltd, Macquarie Park, NSW [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Pty Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Macquarie Park, NSW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Australia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Austria GmbH, Vienna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Austria GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Vienna<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Austria<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma GmbH, Vienna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Vienna<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Austria<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz GmbH, Kundl [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Kundl<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Austria<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | EBEWE Pharma Ges.m.b.H Nfg. KG, Unterach am Attersee [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">EBEWE Pharma Ges.m.b.H Nfg. KG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Unterach am Attersee<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Austria<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis (Bangladesh) Limited, Gazipur [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis (Bangladesh) Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Gazipur<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bangladesh<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#2547;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#2547; 162.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma NV, Vilvoorde [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Vilvoorde<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Belgium<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz NV, Vilvoorde [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Vilvoorde<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Belgium<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Alcon - Couvreur NV, Puurs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Alcon - Couvreur NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Puurs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Belgium<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Investment Ltd., Hamilton [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Investment Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hamilton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bermuda<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Securities Investment Ltd., Hamilton [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Securities Investment Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hamilton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bermuda<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Finance Services Ltd., Hamilton [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Finance Services Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hamilton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bermuda<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Triangle International Reinsurance Limited, Hamilton [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Triangle International Reinsurance Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hamilton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bermuda<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Trinity River Insurance Co Ltd., Hamilton [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Trinity River Insurance Co Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hamilton<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bermuda<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Biociencias S.A., Sao Paulo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Bioci&#234;ncias S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">S&#227;o Paulo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Brazil<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | R$</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 265.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz do Brasil Industria Farmaceutica Ltda., Cambe, PR [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz do Brasil Ind&#250;stria Farmac&#234;utica Ltda.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Camb&#233;, PR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Brazil<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | R$</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 190.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharmaceuticals Canada Inc., Dorval, Quebec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharmaceuticals Canada Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dorval, Quebec<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Canada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Canada Inc., Boucherville, Quebec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Canada Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Boucherville, Quebec<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Canada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | CIBA Vision Canada Inc., Mississauga, Ontario [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CIBA Vision Canada Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mississauga, Ontario<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Canada<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Chile S.A., Santiago de Chile [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Chile S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Santiago de Chile<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Chile<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Beijing Novartis Pharma Co., Ltd., Beijing [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Beijing Novartis Pharma Co., Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Beijing<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">China<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharmaceuticals (HK) Limited, Hong Kong [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharmaceuticals (HK) Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hong Kong<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">China<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | China Novartis Institutes for BioMedical Research Co., Ltd., Shanghai [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Shanghai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">China<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Suzhou Novartis Technical Development Co., Ltd., Changshu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Changshu<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">China<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Shanghai Novartis Trading Ltd., Shanghai [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Shanghai Novartis Trading Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Shanghai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">China<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz (China) Pharmaceutical Co., Ltd., Zhongshan [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Zhongshan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">China<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis de Colombia S.A., Santafe de Bogota [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis de Colombia S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Santaf&#233; de Bogot&#225;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Colombia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz d.o.o. farmaceutska industrija, Zagreb [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz d.o.o. farmaceutska industrija<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Zagreb<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Croatia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | kn</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kn 25.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis s.r.o., Prague [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis s.r.o.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prague<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Czech Republic<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | K&#269;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">K&#269; 51.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz s.r.o., Prague [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz s.r.o.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Prague<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Czech Republic<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | K&#269;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">K&#269; 44.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Healthcare A/S, Copenhagen [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Healthcare A/S<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Copenhagen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Denmark<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | kr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kr 14.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz A/S, Copenhagen [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz A/S<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Copenhagen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Denmark<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | kr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kr 12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Ecuador S.A., Quito [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Ecuador S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Quito<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ecuador<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma S.A.E., Cairo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma S.A.E.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cairo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Egypt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#1580;.&#1605;.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#1580;.&#1605;. 193,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Egypt Pharma S.A.E., New Cairo City [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Egypt Pharma S.A.E.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">New Cairo City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Egypt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#1580;.&#1605;.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#1580;.&#1605;. 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Finland Oy, Espoo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Finland Oy<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Espoo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Finland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">459,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Groupe France S.A., Rueil-Malmaison [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Groupe France S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rueil-Malmaison<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">France<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">903,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma S.A.S., Rueil-Malmaison [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma S.A.S.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rueil-Malmaison<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">France<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Advanced Accelerator Applications S.A., Saint Genis Pouilly [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Advanced Accelerator Applications S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Saint-Genis-Pouilly<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">France<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | CELLforCURE, Les Ulis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CELLforCURE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Les Ulis<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">France<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz S.A.S., Levallois-Perret [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz S.A.S.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Levallois-Perret<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">France<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Deutschland GmbH, Wehr [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Deutschland GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nuremberg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma GmbH, Nuremberg [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Nuremberg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Produktions GmbH, Wehr [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Produktions GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Wehr<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz International GmbH, Holzkirchen [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz International GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holzkirchen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | 1 A Pharma GmbH, Oberhaching [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 A Pharma GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oberhaching<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Salutas Pharma GmbH, Barleben [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Salutas Pharma GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Barleben<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | HEXAL AG, Holzkirchen [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">HEXAL AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Holzkirchen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Aeropharm GmbH, Rudolstadt [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aeropharm GmbH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Rudolstadt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Germany<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis (Hellas) S.A.C.I., Metamorphosis/Athens [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis (Hellas) S.A.C.I.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Metamorphosis / Athens<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Greece<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Hungary Healthcare Limited Liability Company, Budapest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Budapest<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hungary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | Ft</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">Ft 545.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Hungary Limited Liability Company, Budapest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Hungary Limited Liability Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Budapest<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hungary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | Ft</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">Ft 883.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis India Limited, Mumbai [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis India Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mumbai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">India<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8360;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8360; 123.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Healthcare Private Limited, Mumbai [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Healthcare Private Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mumbai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">India<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8360;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Private Limited, Mumbai [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Private Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mumbai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">India<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8360;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8360; 32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | PT. Novartis Indonesia, Jakarta [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">PT. Novartis Indonesia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jakarta<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Indonesia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | Rp</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">Rp 7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Ireland Limited, Dublin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Ireland Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dublin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ireland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Ringaskiddy Limited, Ringaskiddy, County Cork [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Ringaskiddy Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ringaskiddy, County Cork<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ireland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Israel Ltd., Petach Tikva [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Israel Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Tel Aviv<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Israel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8362;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Farma S.p.A., Origgio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Farma S.p.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Origgio<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Italy<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Advanced Accelerator Applications (Italy) S.r.l., Pozzilli [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Advanced Accelerator Applications (Italy) S.r.l.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pozzilli<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Italy<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz S.p.A., Origgio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz S.p.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Origgio<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Italy<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Holding Japan K.K., Tokyo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Holding Japan K.K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Tokyo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Japan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma K.K., Tokyo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma K.K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Tokyo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Japan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Ciba-Geigy Japan Limited, Tokyo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ciba-Geigy Japan Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Tokyo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Japan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz K.K., Tokyo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz K.K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Tokyo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Japan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#165;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#165; 100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Baltics SIA, Riga [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Baltics SIA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Riga<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Latvia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Investments S.a r.l., Luxembourg City [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Investments S.&#224; r.l.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Luxembourg City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Finance S.A., Luxembourg City [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Finance S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Luxembourg City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Corporation (Malaysia) Sdn. Bhd., Kuala Lumpur [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Corporation (Malaysia) Sdn. Bhd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Kuala Lumpur<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Malaysia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | RM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">RM 3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Farmaceutica, S.A. de C.V., Mexico City [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Farmac&#233;utica, S.A. de C.V.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mexico City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mexico<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz, S.A. de C.V., Mexico City [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz, S.A. de C.V.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mexico City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mexico<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 468.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Maroc SA, Casablanca [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Maroc SA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Casablanca<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Morocco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#1583;.&#1605;.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#1583;.&#1605;. 80.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Netherlands B.V., Amsterdam [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Netherlands B.V.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Amsterdam<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Netherlands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma B.V., Amsterdam [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma B.V.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Amsterdam<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Netherlands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | IDB Holland BV, Baarle-Nassau [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">IDB Holland BV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Baarle-Nassau<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Netherlands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz B.V., Almere [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz B.V.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Almere<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Netherlands<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis New Zealand Ltd, Auckland [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis New Zealand Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Auckland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">New Zealand<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Norge AS, Oslo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Norge AS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oslo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Norway<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | kr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kr 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma (Pakistan) Limited, Karachi [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma (Pakistan) Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Karachi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pakistan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8360;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8360; 6.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma (Logistics), Inc., Panama City [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma (Logistics), Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Panama City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Panama<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Biosciences Peru S.A., Lima [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Biosciences Per&#250; S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Lima<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Peru<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | S/</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">S/ 6.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Healthcare Philippines, Inc., Manila [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Healthcare Philippines, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Makati City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Philippines<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8369;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8369; 298.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Philippines Corporation, Manila [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Philippines Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Makati City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Philippines<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8369;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8369; 30.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Poland Sp. z o.o., Warsaw [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Poland Sp. z o.o.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Warsaw<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Poland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | z&#322;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">z&#322; 44.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Polska Sp. z o.o., Warsaw [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Polska Sp. z o.o.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Warsaw<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Poland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | z&#322;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Lek S.A., Strykow [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Lek S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Strykow<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Poland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | z&#322;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">z&#322; 11.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Portugal SGPS Lda., Porto Salvo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Portugal SGPS Lda.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Porto Salvo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Portugal<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Farma - Produtos Farmaceuticos S.A., Porto Salvo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Farma - Produtos Farmac&#234;uticos S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Porto Salvo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Portugal<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Farmaceutica Lda., Porto Salvo [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Farmac&#234;utica Lda.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Porto Salvo<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Portugal<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Services Romania S.R.L., Bucharest [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Services Romania S.R.L.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bucharest<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Romania<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital |</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">
       3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz S.R.L., Targu-Mures [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz S.R.L.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Targu-Mures<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Romania<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital |</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">
       105.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma LLC, Moscow [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma LLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Moscow<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Russian Federation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8381;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8381; 20.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Neva LLC, St. Petersburg [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Neva LLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">St. Petersburg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Russian Federation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8381;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | ZAO Sandoz, Moscow [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">ZAO Sandoz<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Moscow<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Russian Federation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8381;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8381; 57.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Saudi Ltd., Riyadh [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Saudi Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Riyadh<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Saudi Arabia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#1585;.&#1587;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#1585;.&#1587; 26.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis (Singapore) Pte Ltd., Singapore [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis (Singapore) Pte Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Singapore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Singapore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Singapore [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Singapore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Singapore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Singapore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Singapore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Slovakia s.r.o., Bratislava [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Slovakia s.r.o.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bratislava<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Slovakia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Lek Pharmaceuticals d.d., Ljubjana [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Lek Pharmaceuticals d.d.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ljubljana<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Slovenia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Pharmaceuticals d.d., Ljubjana [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Pharmaceuticals d.d.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ljubljana<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Slovenia<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis South Africa (Pty) Ltd, Midrand [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis South Africa (Pty) Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Midrand<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">South Africa<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | R</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R 86.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz South Africa (Pty) Ltd, Kempton Park [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz South Africa (Pty) Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Kempton Park<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">South Africa<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | R</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Korea Ltd., Seoul [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Korea Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Seoul<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">South Korea<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8361;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8361; 24.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Farmaceutica, S.A., Barcelona [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Farmac&#233;utica, S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Barcelona<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spain<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Advanced Accelerator Applications Iberica, S.L.U., Esplugues de Llobregat [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Esplugues de Llobregat<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spain<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Farmaceutica S.A., Madrid [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Farmac&#233;utica S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Madrid<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spain<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Industrial Products S.A., Barcelona [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Les Franqueses del Vall&#233;s / Barcelona<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spain<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Alcon Cusi S.A., Barcelona [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Alcon Cusi S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">El Masnou / Barcelona<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spain<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Abadia Retuerta S.A., Sardon de Duero/Valladolid [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Abadia Retuerta S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sard&#243;n de Duero / Valladolid<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spain<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Sverige AB, Stockholm [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Sverige AB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Stockholm<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sweden<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | kr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">kr 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Overseas Investments AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Overseas Investments AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Japat AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Japat AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis International AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis International AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Holding AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Holding AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis International Pharmaceutical Investment AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis International Pharmaceutical Investment AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Ophthalmics AG, Fribourg [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Ophthalmics AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Fribourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Bioventures AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Bioventures AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Forschungsstiftung, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Forschungsstiftung<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Stiftung fuer Kaderausbildung, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Stiftung f&#252;r Kaderausbildung<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Mitarbeiterbeteiligungsstiftung, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Mitarbeiterbeteiligungsstiftung<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Stiftung fuer Mensch und Umwelt, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Stiftung f&#252;r Mensch und Umwelt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Stiftung der Novartis AG fuer Erziehung, Ausbildung und Bildung, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis International Pharmaceutical AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis International Pharmaceutical AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Services AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Services AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Schweizerhalle AG, Muttenz [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Schweizerhalle AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Muttenz<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Stein AG, Stein [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Stein AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Stein<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharma Schweiz AG, Risch [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharma Schweiz AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Risch<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Advanced Accelerator Applications International SA, Geneve [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Advanced Accelerator Applications International SA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Geneva<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Pharmaceuticals AG, Risch [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Pharmaceuticals AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Risch<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Roche Holding AG, Basel [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Roche Holding AG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Basel<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis (Taiwan) Co., Ltd., Taipei [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis (Taiwan) Co., Ltd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Taipei<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Taiwan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis (Thailand) Limited, Bangkok [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis (Thailand) Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bangkok<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Thailand<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#3647;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#3647; 302.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Saglik, Gida ve Tarim Urunleri Sanayi ve Ticaret A.S., Istanbul [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Istanbul<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Turkey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8378;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8378; 98.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Farmanova Saglik Hizmetleri Ltd. Sti., Istanbul [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Farmanova Saglik Hizmetleri Ltd. Sti.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Istanbul<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Turkey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8378;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Ilac Sanayi ve Ticaret A.S., Istanbul [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Ila&#231; Sanayi ve Ticaret A.S.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Istanbul<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Turkey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8378;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Grup Saglik Urunleri Ilaclari Sanayi ve Ticaret A.S., Gebze - Kocaeli [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Gebze - Kocaeli<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Turkey<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8378;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8378; 50.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Ukraine LLC, Kiev [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Ukraine LLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Kyiv<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ukraine<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#8372;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8372; 8.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Middle East FZE, Dubai [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Middle East FZE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dubai<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Arab Emirates<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#1583;.&#1573;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#1583;.&#1573; 7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis UK Limited, London [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis UK Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">London<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 25,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharmaceuticals UK Limited, London [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharmaceuticals UK Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">London<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Grimsby Limited, London [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Grimsby Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">London<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Imaging Equipment Ltd, London [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Imaging Equipment Ltd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">London<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Vivacta Limited, Frimley/Camberley, Surrey [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Vivacta Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Frimley / Camberley<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Ziarco Group Limited, London [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ziarco Group Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">London<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Limited, Frimley/Camberley [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Limited<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Frimley / Camberley<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">United Kingdom<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Corporation, East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Finance Corporation, East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Finance Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Capital Corporation, East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Capital Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Services, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Services, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis US Foundation, East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis US Foundation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Pharmaceuticals Corporation, East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Pharmaceuticals Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Advanced Accelerator Applications USA, Inc., Millburn, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Advanced Accelerator Applications USA, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Millburn, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Institutes for BioMedical Research, Inc., Cambridge, MA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cambridge, MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | CoStim Pharmaceuticals Inc., Cambridge, MA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CoStim Pharmaceuticals Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Cambridge, MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Encore Vision, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Encore Vision, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Endocyte, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Endocyte, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Navigate BioPharma Services, Inc., Carlsbad, CA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Navigate BioPharma Services, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Carlsbad, CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Reprixys Pharmaceuticals Corporation, East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Reprixys Pharmaceuticals Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Spinifex Pharmaceuticals, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Spinifex Pharmaceuticals, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Institute for Functional Genomics, Inc., San Diego, CA [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Institute for Functional Genomics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">San Diego, CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | AveXis, Inc., Bannockburn, IL [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">AveXis, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Bannockburn, IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Inflammasome Research, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Inflammasome Research, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Technology LLC, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Technology LLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Sandoz Inc., Princeton, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sandoz Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Princeton, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Oriel Therapeutics, Inc., Durham, NC [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oriel Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Durham, NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Fougera Pharmaceuticals Inc., Melville, NY [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Fougera Pharmaceuticals Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Melville, NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Eon Labs, Inc., Princeton, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Eon Labs, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Princeton, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis Vaccines and Diagnostics, Inc., East Hanover, NJ [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis Vaccines and Diagnostics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">East Hanover, NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember', window );">Subsidiaries [member] | Novartis de Venezuela, S.A., Caracas [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure of subsidiaries [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Novartis de Venezuela, S.A.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Principal place of business of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Caracas<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Country of incorporation of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Venezuela<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharePaidinCapital', window );">Share/paid-in capital |</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">
       1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">Proportion of voting rights held in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NameOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The name of a subsidiary. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NameOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfVotingPowerHeldInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This expresses a limit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PrincipalGroupCompaniesMaterialityOfAssetsOrSalesToThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharePaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharePaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsAAAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsAAAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=ifrs-full_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SocieteParActionsSANDOZAlgiersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SocieteParActionsSANDOZAlgiersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisManufacturingGmbHMarburgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisManufacturingGmbHMarburgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisArgentinaS.A.BuenosAiresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisArgentinaS.A.BuenosAiresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisAustraliaPtyLtdMacquarieParkNSWMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisAustraliaPtyLtdMacquarieParkNSWMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsAustraliaPtyLtdMacquarieParkNSWMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozPtyLtdMacquarieParkNSWMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozPtyLtdMacquarieParkNSWMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisAustriaGmbHViennaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisAustriaGmbHViennaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaGmbHViennaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaGmbHViennaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozGmbHViennaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozGmbHViennaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_EBEWEPharmaGes.m.b.HNfg.KGViennaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_EBEWEPharmaGes.m.b.HNfg.KGViennaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisBangladeshLimitedGazipurMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisBangladeshLimitedGazipurMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaNVVilvoordeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaNVVilvoordeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozNVVilvoordeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozNVVilvoordeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AlconCouvreurNVPuursMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AlconCouvreurNVPuursMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInvestmentLtd.HamiltonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInvestmentLtd.HamiltonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSecuritiesInvestmentLtd.HamiltonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSecuritiesInvestmentLtd.HamiltonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFinanceServicesLtd.HamiltonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFinanceServicesLtd.HamiltonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_TriangleInternationalReinsuranceLimitedHamiltonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_TriangleInternationalReinsuranceLimitedHamiltonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_TrinityRiverInsuranceCoLtd.HamiltonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_TrinityRiverInsuranceCoLtd.HamiltonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisBiocienciasS.A.SaoPauloMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisBiocienciasS.A.SaoPauloMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozDoBrasilIndustriaFarmaceuticaLtda.CambeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsCanadaInc.DorvalQuebecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozCanadaInc.BouchervilleQuebecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozCanadaInc.BouchervilleQuebecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_CIBAVisionCanadaInc.MississaugaOntarioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_CIBAVisionCanadaInc.MississaugaOntarioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisChileS.A.SantiagoDeChileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisChileS.A.SantiagoDeChileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_BeijingNovartisPharmaCo.Ltd.BeijingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_BeijingNovartisPharmaCo.Ltd.BeijingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsHKLimitedHongKongMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsHKLimitedHongKongMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ChinaNovartisInstitutesForBioMedicalResearchCo.Ltd.ShanghaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SuzhouNovartisTechnicalDevelopmentCo.Ltd.ChangshuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ShanghaiNovartisTradingLtd.ShanghaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ShanghaiNovartisTradingLtd.ShanghaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozChinaPharmaceuticalCo.Ltd.ZhongshanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisDeColombiaS.A.SantafeDeBobotaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisDeColombiaS.A.SantafeDeBobotaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozD.o.o.FarmaceutskaIndustrijaZagrebMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisS.r.o.PragueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisS.r.o.PragueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozS.r.o.PragueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozS.r.o.PragueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHealthcareASCopenhagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHealthcareASCopenhagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozASCopenhagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozASCopenhagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisEcuadorS.A.QuitoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisEcuadorS.A.QuitoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaS.A.E.CairoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaS.A.E.CairoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozEgyptPharmaS.A.E.NewCairoCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozEgyptPharmaS.A.E.NewCairoCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFinlandOyEspooMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFinlandOyEspooMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisGroupeFranceS.A.RueilMalmaisonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisGroupeFranceS.A.RueilMalmaisonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaS.A.S.RueilMalmaisonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaS.A.S.RueilMalmaisonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsS.A.SaintGenisPouillyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_CELLforCURELesUlisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_CELLforCURELesUlisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozS.A.S.LevalloisPerretMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozS.A.S.LevalloisPerretMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisDeutschlandGmbHWehrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisDeutschlandGmbHWehrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaGmbHNurembergMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaGmbHNurembergMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaProduktionsGmbHWehrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaProduktionsGmbHWehrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozInternationalGmbHHolzkirchenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozInternationalGmbHHolzkirchenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_A1APharmaGmbHOberhachingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_A1APharmaGmbHOberhachingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SalutasPharmaGmbHBarlebenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SalutasPharmaGmbHBarlebenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_HEXALAGHolzkirchenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_HEXALAGHolzkirchenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AeropharmGmbHRudolstadtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AeropharmGmbHRudolstadtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHellasS.A.C.I.MetamorphosisAthensMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHungaryHealthcareLimitedLiabilityCompanyBudapestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozHungaryLimitedLiabilityCompanyBudapestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozHungaryLimitedLiabilityCompanyBudapestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisIndiaLimitedMumbaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisIndiaLimitedMumbaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHealthcarePrivateLimitedMumbaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHealthcarePrivateLimitedMumbaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozPrivateLimitedMumbaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozPrivateLimitedMumbaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_PT.NovartisIndonesiaJakartaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_PT.NovartisIndonesiaJakartaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisIrelandLimitedDublinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisIrelandLimitedDublinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisRingaskiddyLimitedRingaskiddyCountyCorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisIsraelLtd.PetachTikvaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisIsraelLtd.PetachTikvaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFarmaS.p.A.OriggioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFarmaS.p.A.OriggioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsItalyS.r.l.PozzilliMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozS.p.A.OriggioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozS.p.A.OriggioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHoldingJapanK.K.TokyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHoldingJapanK.K.TokyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaK.K.TokyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaK.K.TokyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_CibaGeigyJapanLimitedTokyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_CibaGeigyJapanLimitedTokyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozK.K.TokyoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozK.K.TokyoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisBalticsSIARigaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisBalticsSIARigaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInvestmentsS.aR.l.LuxembourgCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInvestmentsS.aR.l.LuxembourgCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFinanceS.A.LuxembourgCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFinanceS.A.LuxembourgCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisCorporationMalaysiaSdn.Bhd.KualaLumpurMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFarmaceuticaS.A.DeC.V.MexicoCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozS.A.DeC.V.MexicoCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozS.A.DeC.V.MexicoCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaMarocSACasablancaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaMarocSACasablancaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisNetherlandsB.V.AmsterdamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisNetherlandsB.V.AmsterdamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaB.V.AmsterdamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaB.V.AmsterdamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_IDBHollandBVBaarleNassauMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_IDBHollandBVBaarleNassauMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozB.V.AlmereMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozB.V.AlmereMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisNewZealandLtdAucklandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisNewZealandLtdAucklandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisNorgeASOsloMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisNorgeASOsloMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaPakistanLimitedKarachiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaPakistanLimitedKarachiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaLogisticsInc.PanamaCityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaLogisticsInc.PanamaCityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisBiosciencesPeruS.A.LimaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisBiosciencesPeruS.A.LimaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHealthcarePhilippinesInc.ManilaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHealthcarePhilippinesInc.ManilaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozPhilippinesCorporationManilaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozPhilippinesCorporationManilaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPolandSp.ZO.o.WarsawMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPolandSp.ZO.o.WarsawMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozPolskaSp.ZO.o.WarsawMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozPolskaSp.ZO.o.WarsawMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_LekS.A.StrykowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_LekS.A.StrykowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPortugalSGPSLda.PortoSalvoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPortugalSGPSLda.PortoSalvoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFarmaProdutosFarmaceuticosS.A.PortoSalvoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozFarmaceuticaLda.PortoSalvoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozFarmaceuticaLda.PortoSalvoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaServicesRomaniaS.R.L.BucharestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaServicesRomaniaS.R.L.BucharestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozS.R.L.TarguMuresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozS.R.L.TarguMuresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaLLCMoscowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaLLCMoscowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisNevaLLCSt.PetersburgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisNevaLLCSt.PetersburgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ZAOSandozMoscowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ZAOSandozMoscowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSaudiLtd.RiyadhMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSaudiLtd.RiyadhMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSingaporePteLtd.SingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSingaporePteLtd.SingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSingaporePharmaceuticalManufacturingPteLtdSingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisAsiaPacificPharmaceuticalsPteLtdSingaporeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSlovakiaS.r.o.BratislavaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSlovakiaS.r.o.BratislavaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_LekPharmaceuticalsD.d.LjubjanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_LekPharmaceuticalsD.d.LjubjanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozPharmaceuticalsD.d.LjubjanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozPharmaceuticalsD.d.LjubjanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSouthAfricaPtyLtdMidrandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSouthAfricaPtyLtdMidrandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozSouthAfricaPtyLtdKemptonParkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozSouthAfricaPtyLtdKemptonParkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisKoreaLtd.SeoulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisKoreaLtd.SeoulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFarmaceuticaS.A.BarcelonaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFarmaceuticaS.A.BarcelonaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsIbericaS.L.U.EspluguesDeLlobregatMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozFarmaceuticaS.A.MadridMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozFarmaceuticaS.A.MadridMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozIndustrialProductsS.A.BarcelonaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozIndustrialProductsS.A.BarcelonaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AlconCusiS.A.BarcelonaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AlconCusiS.A.BarcelonaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AbadiaRetuertaS.A.SardonDeDueroValladolidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AbadiaRetuertaS.A.SardonDeDueroValladolidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSverigeABStockholmMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSverigeABStockholmMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisOverseasInvestmentsAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisOverseasInvestmentsAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_JapatAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_JapatAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInternationalAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInternationalAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisHoldingAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisHoldingAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInternationalPharmaceuticalInvestmentAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInternationalPharmaceuticalInvestmentAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisOphthalmicsAGFribourgMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisOphthalmicsAGFribourgMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisBioventuresAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisBioventuresAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisForschungsstiftungBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisForschungsstiftungBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisStiftungFuerKaderausbildungBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisStiftungFuerKaderausbildungBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisMitarbeiterbeteiligungsstiftungBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisMitarbeiterbeteiligungsstiftungBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisStiftungFuerMenschUndUmweltBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisStiftungFuerMenschUndUmweltBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_StiftungDerNovartisAGFuerErziehungAusbildungUndBildungBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInternationalPharmaceuticalAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInternationalPharmaceuticalAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaServicesAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaServicesAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaSchweizerhalleAGMuttenzMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaSchweizerhalleAGMuttenzMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaSteinAGSteinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaSteinAGSteinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaSchweizAGRischMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaSchweizAGRischMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsInternationalSAGeneveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsInternationalSAGeneveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozPharmaceuticalsAGRischMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozPharmaceuticalsAGRischMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_RocheHoldingAGBaselMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_RocheHoldingAGBaselMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisTaiwanCo.Ltd.TaipeiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisTaiwanCo.Ltd.TaipeiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisThailandLimitedBangkokMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisThailandLimitedBangkokMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisSaglikGidaVeTarimUrunleriSanayiVeTicaretA.S.IstanbulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_FarmanovaSaglikHizmetleriLtd.Sti.IstanbulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozIlacSanayiVeTicaretA.S.IstanbulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozIlacSanayiVeTicaretA.S.IstanbulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozGrupSaglikUrunleriIlaclariSanayiVeTicaretA.S.GebzeKocaeliMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozUkraineLLCKievMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozUkraineLLCKievMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisMiddleEastFZEDubaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisMiddleEastFZEDubaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisUKLimitedLondonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisUKLimitedLondonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsUKLimitedLondonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsUKLimitedLondonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisGrimsbyLimitedLondonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisGrimsbyLimitedLondonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ImagingEquipmentLtdLondonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ImagingEquipmentLtdLondonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_VivactaLimitedFrimleyCamberleySurreyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_VivactaLimitedFrimleyCamberleySurreyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ZiarcoGroupLimitedLondonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ZiarcoGroupLimitedLondonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozLimitedFrimleyCamberleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozLimitedFrimleyCamberleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisCorporationEastHanoverNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisCorporationEastHanoverNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisFinanceCorporationEastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisFinanceCorporationEastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisCapitalCorporationEastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisCapitalCorporationEastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisServicesInc.EastHanoverNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisServicesInc.EastHanoverNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisUSFoundationEastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisUSFoundationEastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsCorporationEastHanoverNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisPharmaceuticalsCorporationEastHanoverNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AdvancedAcceleratorApplicationsUSAInc.MillburnNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInstitutesForBioMedicalResearchInc.CambridgeMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_CoStimPharmaceuticalsInc.CambridgeMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_CoStimPharmaceuticalsInc.CambridgeMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_EncoreVisionInc.EastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_EncoreVisionInc.EastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_EndocyteInc.EastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_EndocyteInc.EastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NavigateBioPharmaServicesInc.CarlsbadCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NavigateBioPharmaServicesInc.CarlsbadCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_ReprixysPharmaceuticalsCorporationEastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_ReprixysPharmaceuticalsCorporationEastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SpinifexPharmaceuticalsInc.EastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SpinifexPharmaceuticalsInc.EastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInstituteForFunctionalGenomicsInc.SanDiegoCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_AveXisInc.BannockburnILMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_AveXisInc.BannockburnILMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisInflammasomeResearchInc.EastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisInflammasomeResearchInc.EastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisTechnologyLLCInc.EastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisTechnologyLLCInc.EastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_SandozInc.PrincetonNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_SandozInc.PrincetonNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_OrielTherapeuticsInc.DurhamNCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_OrielTherapeuticsInc.DurhamNCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_FougeraPharmaceuticalsInc.MelvilleNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_FougeraPharmaceuticalsInc.MelvilleNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_EonLabsInc.PrincetonNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_EonLabsInc.PrincetonNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisVaccinesAndDiagnosticsInc.EastHanoverNJMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_NovartisDeVenezuelaS.A.CaracasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_NovartisDeVenezuelaS.A.CaracasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R194.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6890972784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="nump">$ 1,474<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">519<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R164.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6871484656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 6)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Discount rate | 25 basis point change</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</a></td>
<td class="num">$ (787)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</a></td>
<td class="nump">837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=nvs_LifeExpectancyMember', window );">Life expectancy | 1 year increase</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</a></td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember', window );">Rate of pension increase | 25 basis point change</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</a></td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</a></td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember', window );">Interest on savings account | 25 basis point change</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</a></td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</a></td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember', window );">Salary increase | 25 basis point change</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure of sensitivity analysis for actuarial assumptions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</a></td>
<td class="num">$ (55)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeInActuarialAssumptionAxis=nvs_Change25BasisPointMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeInActuarialAssumptionAxis=nvs_Change25BasisPointMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=nvs_LifeExpectancyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=nvs_LifeExpectancyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeInActuarialAssumptionAxis=nvs_Increase1YearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeInActuarialAssumptionAxis=nvs_Increase1YearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R160.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873433840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined benefit plan, change in benefit obligation [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at beginning of period</a></td>
<td class="nump">$ 22,179<span></span>
</td>
<td class="nump">$ 23,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">330<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset', window );">Past service cost and settlements</a></td>
<td class="num">(168)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset', window );">Administrative expenses</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Remeasurement losses/(gains) arising from changes in financial assumptions</a></td>
<td class="nump">1,791<span></span>
</td>
<td class="num">(567)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Remeasurement (gains) arising from changes in demographic assumptions</a></td>
<td class="num">(193)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset', window );">Experience-related remeasurement losses/(gains)</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability', window );">Currency translation effects</a></td>
<td class="nump">283<span></span>
</td>
<td class="num">(374)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset', window );">Benefit payments</a></td>
<td class="num">(1,256)<span></span>
</td>
<td class="num">(1,263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions of associates</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1', window );">Effect of acquisitions, divestments or transfers</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at end of period</a></td>
<td class="nump">23,066<span></span>
</td>
<td class="nump">22,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined benefit plan, change in fair value of plan assets [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">18,838<span></span>
</td>
<td class="nump">20,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset', window );">Interest income</a></td>
<td class="nump">257<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset', window );">Return on plan assets excluding interest income</a></td>
<td class="nump">1,656<span></span>
</td>
<td class="num">(805)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset', window );">Currency translation effects</a></td>
<td class="nump">304<span></span>
</td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Novartis Group contributions</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Contributions of associates</a></td>
<td class="num">(169)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(193)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset', window );">Benefit payments</a></td>
<td class="num">(1,256)<span></span>
</td>
<td class="num">(1,263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1', window );">Effect of acquisitions, divestments or transfers</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">19,810<span></span>
</td>
<td class="nump">18,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="nump">3,256<span></span>
</td>
<td class="nump">3,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward', window );"><strong>Defined benefit plan, change in limitation on recognition of fund surplus [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LimitationOnRecognitionOfFundSurplus', window );">Limitation on recognition of fund surplus at beginning of period</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeInLimitationOnRecognitionOfFundSurplus', window );">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestIncomeOnLimitationOfFundSurplus', window );">Interest income on limitation of fund surplus</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LimitationOnRecognitionOfFundSurplus', window );">Limitation on recognition of fund surplus at end of period</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability in the balance sheet at end of period</a></td>
<td class="num">(3,321)<span></span>
</td>
<td class="num">(3,409)<span></span>
</td>
<td class="num">$ (3,024)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined benefit plan, change in benefit obligation [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at beginning of period</a></td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset', window );">Current service cost</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Remeasurement losses/(gains) arising from changes in financial assumptions</a></td>
<td class="nump">76<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset', window );">Remeasurement (gains) arising from changes in demographic assumptions</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset', window );">Experience-related remeasurement losses/(gains)</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability', window );">Currency translation effects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset', window );">Benefit payments</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1', window );">Effect of acquisitions, divestments or transfers</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at end of period</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined benefit plan, change in fair value of plan assets [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at beginning of period</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset', window );">Interest income</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset', window );">Return on plan assets excluding interest income</a></td>
<td class="nump">10<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Novartis Group contributions</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset', window );">Benefit payments</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1', window );">Effect of acquisitions, divestments or transfers</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at end of period</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward', window );"><strong>Defined benefit plan, change in limitation on recognition of fund surplus [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability in the balance sheet at end of period</a></td>
<td class="num">(612)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
<td class="num">(953)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined benefit plan, change in benefit obligation [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at beginning of period</a></td>
<td class="num">(662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined benefit plan, change in fair value of plan assets [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at beginning of period</a></td>
<td class="num">(424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward', window );"><strong>Defined benefit plan, change in limitation on recognition of fund surplus [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability in the balance sheet at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined benefit plan, change in benefit obligation [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at beginning of period</a></td>
<td class="num">(385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Benefit obligation at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined benefit plan, change in fair value of plan assets [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at beginning of period</a></td>
<td class="num">$ (40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward', window );"><strong>Defined benefit plan, change in limitation on recognition of fund surplus [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net liability in the balance sheet at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 141<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_141_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ActuarialGainsLossesArisingFromChangesInExperienceRelatedAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdministrativeExpenseNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeInLimitationOnRecognitionOfFundSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeInLimitationOnRecognitionOfFundSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanChangeInLimitationOnRecognitionOfFundSurplusRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersBenefitObligation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughAcquisitionsDivestmentsTransfersDefinedBenefitLiabilityAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestExpenseIncomeDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestIncomeOnLimitationOfFundSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestIncomeOnLimitationOfFundSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LimitationOnRecognitionOfFundSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LimitationOnRecognitionOfFundSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PastServiceCostAndGainsLossesArisingFromSettlementsDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReturnOnPlanAssetsExcludingInterestIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>R190.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6887454800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 13)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CustomersWithNetSalesOverFivePercent', window );">Customers with net sales over five percent</a></td>
<td class="text">The Group&#8217;s largest, second-largest and third-largest customers account for approximately 23%, 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). All segments had sales to these customers in 2019, 2018 and 2017. No other customer accounted for 6% or more of net sales in any year. The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=nvs_LargestCustomerMember', window );">Largest customer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEntitysTradeReceivable', window );">Percentage of entitys trade receivable</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=nvs_SecondLargestCustomerMember', window );">Second largest customer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEntitysTradeReceivable', window );">Percentage of entitys trade receivable</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=nvs_ThirdLargestCustomerMember', window );">Third largest customer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEntitysTradeReceivable', window );">Percentage of entitys trade receivable</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMajorCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMajorCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CustomersWithNetSalesOverFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CustomersWithNetSalesOverFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PercentageOfEntitysTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PercentageOfEntitysTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=nvs_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=nvs_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=nvs_SecondLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=nvs_SecondLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=nvs_ThirdLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=nvs_ThirdLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839055440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other current liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract', window );"><strong>Disclosure of provisions and other current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock', window );">Provisions and other current liabilities</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">22. Provisions and other current liabilities</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes other than income taxes</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 471</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 528</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 507</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued expenses for goods and services received but not invoiced</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;046</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 970</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accruals for royalties</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 653</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 651</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interests on financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 156</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for deductions from revenue</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;595</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;262</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accruals for compensation and benefits, including social security</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;464</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Environmental remediation liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 236</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for product liabilities, governmental investigations and other legal matters <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued share-based payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 326</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent considerations <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commitment for repurchase of own shares <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 284</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 764</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 673</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total provisions and other current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;284</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 20 provides additional disclosures related to legal provisions. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent considerations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Note 18 provides additional disclosures related to commitment for repurchase of own shares. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Provisions are based upon management&#x2019;s best estimate and adjusted for actual experience. Such adjustments to the historic estimates have not been material. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Provisions for deductions from revenue</font> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movement of the provisions for deductions from revenue:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement charge<sup>2</sup></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Revenue <br></br> deductions <br></br> provisions at <br></br> January 1 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Revenue <br></br> deductions <br></br> provisions <br></br> related to <br></br> discontinued <br></br> operations<sup>1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Effect of <br></br> currency <br></br> translation <br></br> and business <br></br> combinations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Payments/ <br></br> utilizations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Adjustments <br></br> of prior years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> Current year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Change in <br></br> provisions <br></br> offset against <br></br> gross trade <br></br> receivables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Revenue <br></br> deductions <br></br> provisions at <br></br> December 31 </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;883 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 0 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;5&nbsp;183 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;193 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 5&nbsp;474 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;981 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;625 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;28 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;19 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;2&nbsp;467 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2&nbsp;659 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;769 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates, returns and other deductions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;754</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;166</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;868</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;845</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;262</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;19&nbsp;348</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;595</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;590 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;4&nbsp;158 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;90 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4&nbsp;541 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;883 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;356 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;78 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;2&nbsp;182 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 83 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;555 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;109 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;625 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates, returns and other deductions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;726</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;51</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;227</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;91</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;956</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 441</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;754</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;672</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;18&nbsp;567</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 19&nbsp;052</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;262</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;461 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;3&nbsp;684 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;62 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 3&nbsp;875 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;590 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;020 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 131 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1&nbsp;954 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 80 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;186 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;356 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates, returns and other deductions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;702</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11&nbsp;814</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;127</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;045</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;726</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;183</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;17&nbsp;452</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;109</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;106</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;252</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;672</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Charges to the consolidated income statement from continuing operations were USD 18 248 million in 2018 and USD 17 772 million in 2017. </div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Restructuring provisions movements</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 507</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 222</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to <br></br>discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &#x2013;&#x2005;8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 492</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 534</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 194</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;479</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;200</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;72</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;64</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005; 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 507</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 521 million in 2018 and USD 186 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Reversal of provisions credited to the consolidated income statement from continuing operations were USD 31 million in 2018 and USD 59 million in 2017. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, additions to provisions of USD&nbsp;492 million were mainly related to the following reorganizations:</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Innovative Medicines Division restructured its field force and supporting functions in Latin America, and following the <i>Xiidra</i> acquisition, its Ophthalmology field force in the US. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Sandoz Division initiatives to realign its organizational structures to improve competiveness. These initiatives include reduction in its headquarters, global functions and countries workforce, and the closure of its development center in Holzkirchen, Germany. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group-wide initiatives to streamline Novartis Technical Operations and implement new technologies, mainly in the Innovative Medicines Division and in the Sandoz Division, continued. In addition, Novartis Business Services launched the next phase of the new operating model to change outsourcing structures and transition activities to service centers. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, additions to provisions of USD 534 million were mainly related to the following reorganizations:</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Innovative Medicines Division&#x2019;s Oncology business unit initiative to streamline its organizational structure. The objective was to enhance agility and efficiency, resulting in an acceleration of operational execution. In addition, a program to reorganize the Japanese business model was launched. Region Europe transformed its approach to market in light of the changing product portfolio. The objective was to speed up patient access. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group-wide initiatives to streamline Novartis Technical Operations and implement new technologies, mainly in the Innovative Medicines Division and in the Sandoz Division, continued. In addition, Novartis Business Services launched an initiative to reorganize its organizational structure to achieve cost efficiencies by shifting activities to global service centers. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">In 2017, additions to provisions of USD&nbsp;194 million were mainly related to the following reorganizations:</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Innovative Medicines Division&#x2019;s Pharmaceuticals business unit adjusted a regional promotional model, which led to a restructuring of the sales force. It also streamlined the above country operating model to facilitate an even higher external competition-oriented focus. Furthermore, the development organization streamlined its activities to create efficiencies. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The former Alcon Division continued initiatives to realign its operations to focus on the Surgical and Vision Care businesses after the Ophthalmic Pharmaceuticals business transfer to the Innovative Medicines Division. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Sandoz Division launched initiatives to focus resources to gain efficiencies.</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Group-wide initiatives to streamline Novartis Technical Operations in the Innovative Medicines and Sandoz Divisions were launched. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>175
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839042736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfEquityAbstract', window );"><strong>Disclosure of equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfEquityTextBlock', window );">Equity</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">18. Equity</div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movement in the share capital:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Jan 1, 2017 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Movement <br></br> in year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Dec 31, 2017 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Movement <br></br> in year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Dec 31, 2018 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Movement <br></br> in year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Dec 31, 2019 </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Share capital</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 972</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 969</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 944</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 936</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Treasury shares</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;80</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding share capital</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 896</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 869</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 875</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 856</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movement in the shares:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>Number of outstanding shares <br></br>(in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Note </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> Novartis <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> treasury <br></br> shares <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> outstanding <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> Novartis <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> treasury <br></br> shares <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> outstanding <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> Novartis <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> treasury <br></br> shares <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> outstanding <br></br> shares </div> </td> <td></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at beginning of year</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;550.6</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;239.4</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616.8</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;299.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;627.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;253.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;374.1</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares canceled for capital <br></br>reduction <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;66.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 66.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;10.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 10.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be <br></br>canceled <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;60.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;60.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;66.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;66.2 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options <br></br>and employee transactions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 18.8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 5.5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 5.5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.6 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon <br></br>employees </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 0.9 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 0.9 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total movements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;23.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;22.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;66.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;46.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;56.6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at end of year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;527.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;262.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;265.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;550.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;239.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;311.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;299.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Approximately 117.6 million treasury shares (2018: 121.6 million; 2017: 131.3 million) are held in Novartis entities that restrict their availability for use. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Novartis reduced its share capital by canceling shares that were repurchased on the SIX Swiss Exchange second trading line during previous years. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 Annual General Meeting (AGM) for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Shares acquired from employees, which were previously granted to them under the respective programs </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Shares delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">18.1) The amount available for distribution as a dividend to shareholders is based on the available distributable retained earnings of Novartis AG determined in accordance with the legal provisions of the Swiss Code of Obligations. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend per share (in CHF)</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.85</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.75</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total dividend payment <br></br>(in USD billion) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 6.6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.0 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 6.5 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">18.2) The following table summarizes the treasury shares movements:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Note </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Number of <br></br> outstanding <br></br> shares <br></br> (in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Equity impact <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Number of <br></br> outstanding <br></br> shares <br></br> (in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Equity impact <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Number of <br></br> outstanding <br></br> shares <br></br> (in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Equity impact <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be canceled <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;351</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;23.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;859</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;66.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;270</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;304</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of treasury shares</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;511</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;973</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;574</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 434</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 255</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation <sup style="white-space: nowrap">&nbsp;4,5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 833</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 756</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon employees</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;450</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;520</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;56.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;707</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 AGM for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Shares acquired from employees, which were previously granted to them under the respective programs </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Shares delivered as a result of options being exercised related to equity-based participation plans and the delivery of treasury shares. The average share price of the shares delivered was significantly below market price, reflecting the strike price of the options exercised. </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Equity-settled share-based compensation is expensed in the consolidated income statement in accordance with the vesting period of the share-based compensation plans. The value for the shares and options granted is credited to consolidated equity over the respective vesting period. In addition, tax benefits arising from tax-deductible amounts exceeding the expense recognized in the income statement are credited to equity. </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Included in 2017 is a USD 71 million impact related to the revaluation of deferred tax assets on equity-based compensation that were previously recognized through retained earnings. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.3) In 2019, Novartis entered into an irrevocable, non-discretionary arrangement with a bank to repurchase Novartis shares on the second trading line under its up-to USD&nbsp;5 billion share buyback. Novartis was able to cancel this arrangement at any time but could be subject to a 90-day waiting period. The commitment under this arrangement therefore reflects the obligated purchases by the bank under such trading plan over a rolling 90-day period, or if shorter, until the maturity date of such trading plan. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2019, this trading plan commitment was fully executed and expired, and as a consequence, there is no contingent liability related to this plan recognized. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018 and 2017, Novartis entered into a similar irrevocable, non-discretionary arrangements with a bank to repurchase Novartis shares. The commitments under these arrangements reflected the expected purchases by the bank under such trading plans over a rolling 90-day period. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The commitment under this arrangement amounted to USD 284 million as of December 31, 2018. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2017, this trading plan commitment was fully executed and expired, and as a consequence, there was no contingent liability related to this plan recognized. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.4) Transaction costs of USD 253 million (2018: USD 79 million; 2017: USD nil) net of tax of USD 36 million (2018: USD 20 million; 2017: USD nil), that are directly attributable to the distribution (spin-off) of Alcon Inc. to Novartis shareholders and that would otherwise have been avoided, are recorded as a deduction from equity. See Note 1. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.5) The impact of change in ownership of consolidated entities represents the excess of the amount paid to non-controlling interest over their carrying value and equity allocation to non-controlling interest due to change in ownership percentage. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.6) Changes in non-controlling interests represent the impact on the non-controlling interest of transactions with minority shareholders, such as change in ownership percentage, dividend payments and other equity transactions. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.7) Other movements includes, for subsidiaries in hyperinflationary economies, the impact of the restatement of the non-monetary assets and liabilities with the general price index at the beginning of the period as well as the restatement of the equity balances of the current year. In 2019, the amount recorded in equity related to hyperinflation accounting was USD 22 million (2018: USD 38 million; 2017: USD nil). See Note 29 for additional disclosures. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">18.8) At December 31, 2019, the market maker held 13 million (2018: 11 million; 2017: 12 million) written call options, originally issued as part of the share-based compensation for associates, that have not yet been exercised. The weighted average exercise price of these options is USD 63.90 (2018: USD 62.70; 2017: USD 62.17), and they have contractual lives of 10 years, with remaining lives up to four years (2018: five years; 2017: six years). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In December 2018, Novartis entered into an agreement with the market maker for its employee options to repurchase a portion of the outstanding written call options that are not exercised in exchange for treasury shares. During 2019, this agreement was fully executed. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>R143.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839074560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions and other non-current liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsLineItems', window );"><strong>Disclosure of other provisions [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Defined benefit pension plans</a></td>
<td class="nump">$ 3,469<span></span>
</td>
<td class="nump">$ 3,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation', window );">Other long-term employee benefits and deferred compensation</a></td>
<td class="nump">546<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherPostemploymentBenefits', window );">Other post-employment benefits</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalRemediationProvisionNoncurrent', window );">Environmental remediation provisions</a></td>
<td class="nump">592<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">$ 706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent', window );">Product liability, government investigations, other legal matters provisions</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationNonCurrent', window );">Contingent consideration</a></td>
<td class="nump">958<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Total provisions and other non-current liabilities</a></td>
<td class="nump">$ 6,632<span></span>
</td>
<td class="nump">$ 7,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ContingentConsiderationNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ContingentConsiderationNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalRemediationProvisionNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalRemediationProvisionNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherLongtermEmployeeBenefitsAndDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>177
<FILENAME>R147.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838791488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other non-current liabilities (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward', window );"><strong>Product liability, government investigations, other legal matters provisions [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions', window );">Product liabilities government investigations other legal matters provisions at beginning of period</a></td>
<td class="nump">$ 340<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations', window );">Provisions related to discontinued operations</a></td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations', window );">Impact of business combinations</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments', window );">Cash payments</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases', window );">Releases</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions', window );">Additions</a></td>
<td class="nump">1,230<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss', window );">Currency translation effects</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions', window );">Product liabilities government investigations other legal matters provisions at end of period</a></td>
<td class="nump">1,369<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent', window );">Less current provision</a></td>
<td class="num">(1,169)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent', window );">Non-current product liabilities, governmental investigations and other legal matters provisions at end of period</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward', window );"><strong>Product liability, government investigations, other legal matters provisions [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases', window );">Releases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsImpactOfBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsReleases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>178
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836907008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoriesDisclosureAbstract', window );"><strong>Inventories Disclosure [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventories</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">14. Inventories</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Raw material, consumables</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 751</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 931</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Work in progress</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finished products</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;207</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;938</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;982</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;956</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the amount of inventory recognized as an expense in &#x201c;Cost of goods sold&#x201d; in the consolidated income statements from continuing operations: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.2</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the recognized amount of inventory provision and reversals of inventory provision recorded in the consolidated income statements from continuing operations: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventory provisions</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;752</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;603</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;416</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversals of inventory provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 216</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 172</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The reversals mainly result from the release of products initially requiring additional quality control inspections and from the reassessment of inventory values manufactured prior to regulatory approval but for which approval was subsequently received. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InventoriesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InventoriesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>179
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873574624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">$ 8,301<span></span>
</td>
<td class="nump">$ 8,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">8,301<span></span>
</td>
<td class="nump">8,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">3,466<span></span>
</td>
<td class="nump">3,510<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">1,384<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | JPY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">658<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | CNY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | RUB</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | BRL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">206<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | GBP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | AUD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | CHF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | CAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">129<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">$ 1,655<span></span>
</td>
<td class="nump">$ 1,693<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionMatrixLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionMatrixLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CNY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CNY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_RUB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_RUB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_BRL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_BRL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_GBP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_GBP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CAD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CAD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=nvs_CurrencyOthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=nvs_CurrencyOthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>180
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873774880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfSignificantTransactionsAbstract', window );"><strong>Disclosure of significant transactions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock', window );">Net gain at completion of spin-off</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> April 8, <br></br> 2019 </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net assets derecognized <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;025</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derecognition of distribution liability</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;434</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Difference between net assets and distribution liability</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;409</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition of Alcon Inc. shares obtained <br></br>through consolidated foundations </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;273 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation gains recycled into <br></br>the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 123 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transaction costs recognized in the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;114</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;691</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> See Note 30 for additional information. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock', window );">Assets and liabilities of disposal group classified as held for sale</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets of disposal group classified as held for sale</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 475</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 478</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 181</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 165</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 841</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 807</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities of disposal group classified as held for sale</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other non-current <br></br>liabilities </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 51</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfAssetsAndLiabilitiesOfDisposalGroupClassifiedAsHeldForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNetGainAtCompletionOfSpinoffTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfSignificantTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfSignificantTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865361952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfIncomeTaxAbstract', window );"><strong>Disclosure of IncomeTax [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeBeforeTaxesTableTextBlock', window );">Income before taxes</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;097</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;887</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;385</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 843</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;717</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentAndDeferredIncomeTaxExpenseTableTextBlock', window );">Current and deferred income tax expense</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;186</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;615</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;462</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;961</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;988</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;451</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current income tax expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;913</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;93</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;305</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Foreign</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 447</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 428</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 615</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Deferred tax income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 354</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 308</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 310</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income tax expense from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfTaxRateTableTextBlock', window );">Analysis of tax rate</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(As a percentage)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Applicable tax rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14.3</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of disallowed expenditures</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of utilization of tax losses <br></br>brought forward from prior periods </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of income taxed at reduced rates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of income not subject to tax <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax credits and allowances</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of release of <br></br>contingent consideration liability </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;0.5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;0.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1.3 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax rate change <br></br>on current and deferred <br></br>tax assets and liabilities <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;1.4 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;0.1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 4.8 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of write-off of deferred tax assets <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of write-down and reversal of <br></br>write-down of investments in subsidiaries </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;0.6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 0.0 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1.1 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of tax benefits expiring in 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of prior-year items</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of other items <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Effective tax rate for continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17.6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Included in 2018 is the effect of income not subject to tax (-3.7%) arising from the portion of the non-taxable gain on the divestment of the Group's investment in GSK Consumer Healthcare Holdings Ltd. attributable to Switzerland. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> 2019 is mainly related to the revaluation of the deferred tax assets and liabilities resulting from the tax reforms enacted in Switzerland in 2019, refer to Note 12 for additional disclosures. <br></br>Included in 2017 is a 4.8% impact related to the revaluation of the deferred tax assets and liabities and a portion of current tax payables. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017, refer to Note 12 for additional disclosures. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> 2019 is primarily related to a non-cash, one-time deferred tax expense for the write-off of a deferred tax asset resulting from legal entity reorganizations. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> In 2019, other items (+3.0%) include changes in uncertain tax positions (+2.6%) and other items (+0.4%). </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AnalysisOfTaxRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AnalysisOfTaxRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentAndDeferredIncomeTaxExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentAndDeferredIncomeTaxExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfIncomeTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfIncomeTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncomeBeforeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncomeBeforeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>182
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843539024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryLineItems', window );"><strong>Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">$ 5,982<span></span>
</td>
<td class="nump">$ 6,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod', window );">Amount of inventory recognized as expense</a></td>
<td class="num">(8,500)<span></span>
</td>
<td class="num">(8,300)<span></span>
</td>
<td class="num">$ (8,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Inventory provisions</a></td>
<td class="num">(752)<span></span>
</td>
<td class="num">(603)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfInventoryWritedown', window );">Reversed inventory Provisions</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryAxis=nvs_InventoryRawMaterialsGrossMember', window );">Raw material, consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryLineItems', window );"><strong>Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">751<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryAxis=nvs_InventoryWorkInProgressGrossMember', window );">Work in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryLineItems', window );"><strong>Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">3,024<span></span>
</td>
<td class="nump">3,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryAxis=nvs_InventoryFinishedGoodsGrossMember', window );">Finished products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoryLineItems', window );"><strong>Inventory</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">$ 2,207<span></span>
</td>
<td class="nump">$ 2,938<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories recognised as an expense during the period. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfInventoriesRecognisedAsExpenseDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognised related to the write-down of inventories to net realisable value. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalOfInventoryWritedown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a reduction in the amount of inventories recognised as an expense due to the reversal of any write-down of inventories resulting from an increase in net realisable value. [Refer: Inventories; Inventory write-down]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalOfInventoryWritedown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InventoryAxis=nvs_InventoryRawMaterialsGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InventoryAxis=nvs_InventoryRawMaterialsGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InventoryAxis=nvs_InventoryWorkInProgressGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InventoryAxis=nvs_InventoryWorkInProgressGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InventoryAxis=nvs_InventoryFinishedGoodsGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InventoryAxis=nvs_InventoryFinishedGoodsGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>183
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842553088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-use assets and lease liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract', window );"><strong>Right of use assets Disclosure and Lease liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock', window );">Reconciliation of lease commitment and lease liability</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating lease commitments December 31, 2018 <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;612</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Operating lease commitments December 31, 2018 related to discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;222</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating lease commitments December 31, 2018 related to continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;390</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition exemption for short-term leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition exception for low-value leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease arrangements with commencement date after December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Undiscounted future lease payments continuing <br></br>operations as of January 1, 2019 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 3&nbsp;283 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Effect of discounting</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;547</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Lease liabilities recognized as of January 1, 2019 <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;736</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp; </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> As reported in Annual Report 2018 Note 27 </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> The weighted average incremental borrowing rate at January 1, 2019, the date of implementation of IFRS 16 Leases, was 3.5%. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Disclosure of quantitative information about right-of-use assets</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> January 1, 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Land</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 147</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment, and other assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;554</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup>&nbsp;&nbsp;&nbsp; </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Right-of-use assets were lower than the lease liability at the date of implementation of IFRS 16 by USD 182 million, due to adjustments made for recognition of sublease receivables, prepayments and accrued lease payments and transfers from leased assets recorded in property, plant and equipment at December 31, 2018. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock', window );">Disclosure of impact on adoption of IFRS 16</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> January 1, 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current assets</div> </td> <td align="right" width="1%"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;101</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;554</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity and liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reserves</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;471</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provision and other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;212</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;257</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 268</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 267</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;524</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity and liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfRightofuseAssetsRollForwardTableTextBlock', window );">Disclosure of Right-of-use assets roll forward</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Right-of-use assets at January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;554</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;305</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease contract terminations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total right-of-use assets at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;677</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> No impairments were recorded in the period. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Lease contract terminations also includes modifications to existing leases that result in reductions to the right-of-use assets, and reductions due to sub-leasing. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock', window );">Disclosure of right-of-use assets carrying value and depreciation charge</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> December 31, 2019 <br></br> carrying value </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Depreciation <br></br> charge <br></br> 2019 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Land</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buildings</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 990</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 194</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vehicles</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 87</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Machinery and equipment, and other assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total right-of-use assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;677</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 305</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock', window );">Disclosure of maturity analysis of lease liability</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Lease liabilities <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Lease liabilities <br></br> undiscounted <br></br> 2019 </div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less than one year</div> </td> <td align="right" width="1%"></td> <td align="right" width="16%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div> </td> <td align="right" width="1%"></td> <td align="right" width="16%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 295</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between one and two years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between two and three years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 202</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between three and four years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 138</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 173</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between four and five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 150</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;081</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;419</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;485</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion of lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;295</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current portion of lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;703</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;190</div> </td> </tr> <tr> <td colspan="5" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock', window );">Additional disclosures related to right-of-use assets and lease liabilities [table text block]</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense on lease liabilities <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense on short-term leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense on low-value leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total cash outflows for leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 339</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cash outflows for short-term leases <br></br>and low-value leases <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br> 15 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Payments of interest <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 51</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Payments of lease liabilities <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 273</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> The weighted average interest rate is 3.9%. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Cash flows from short-term and low-value leases are included within total net cash flows from operating activities. The portfolio of short-term leases to which the Group is committed to at December 31, 2019, is similar to the portfolio of short-term leases the Group entered into during 2019. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Included within total net cash flows from operating activities. </div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Reported as cash outflows used in financing activities net of lease incentives received of USD 33 million. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionalDisclosuresRelatedToRightofuseAssetsAndLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfImpactOnAdoptionOfIFRS16TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMaturityAnalysisOfLeaseLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfRightofuseAssetsCarryingValueAndDepreciationChargeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfRightofuseAssetsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfRightofuseAssetsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReconciliationOfLeaseCommitmentAndLeaseLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RightOfUseAssetsDisclosureAndLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>184
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838922848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in consolidated statements of comprehensive income (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAbstract', window );"><strong>Comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement', window );">Cumulative currency translation gains/losses recycled through income statement</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="num">$ (946)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CumulativeCurrencyTranslationLossesRecycledThroughtIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>185
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846082384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">$ (1,793)<span></span>
</td>
<td class="num">$ (1,295)<span></span>
</td>
<td class="num">$ (1,603)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current tax expense (income)</a></td>
<td class="num">(2,147)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
<td class="num">(1,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax expense (income)</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member] | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current tax expense (income)</a></td>
<td class="num">(1,186)<span></span>
</td>
<td class="num">(615)<span></span>
</td>
<td class="num">(462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax expense (income)</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member] | Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current tax expense (income)</a></td>
<td class="num">(961)<span></span>
</td>
<td class="num">(988)<span></span>
</td>
<td class="num">(1,451)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred tax expense (income)</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="nump">615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">$ (159)<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>186
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873119680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OfficerAndDirectorCompensationTableTextBlock', window );">Executive Officers and Non-Executive Directors Compensation</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Executive Officers</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-Executive Directors</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and other compensation</div> </td> <td align="right" width="5%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18.4</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.8</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.4</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Post-employment benefits</div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 49.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 63.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 67.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 72.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 76.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock', window );">Transactions with former members of the Board of Directors</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currency</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dr. Krauer</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60&nbsp;000</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60&nbsp;000</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60&nbsp;000</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dr. Vasella</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;228</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;279</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OfficerAndDirectorCompensationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OfficerAndDirectorCompensationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>187
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838650528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated statements of cash flows (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract', window );"><strong>Disclosure of details to the consolidated statements of cash flows [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock', window );">Adjustments for non-cash items from continuing operations</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation, amortization and impairments on:</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;547</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;783</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;460</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;974</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;428</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;276</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 227</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-cash change in provisions and other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 895</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 86</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gains on disposal and other adjustments on property, plant and equipment; intangible assets; <br></br>financial assets; and other non-current assets, net </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &#x2013;&#x2005;1&nbsp;234 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &#x2013;&#x2005;902 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &#x2013;&#x2005;1&nbsp;077 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-settled compensation expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 673</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;659</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;6&nbsp;438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;108</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;295</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;603</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net financial expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 746</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 708</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;486</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Includes fair value adjustments </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> 2018 includes a reversal of a pre-tax gain (USD 5.8 billion) recognized from the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. (see Note 2). The net cash proceed of USD 13.0 billion from the divestment was included in the consolidated statements of cash flows in the line "Acquisitions and divestments of interests in associated companies, net." </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock', window );">Cash flows from changes in working capital and other operating items included in operating cash flow from continuing operations</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">(Increase) in inventories</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;382</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;387</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;203</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">(Increase) in trade receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;544</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;655</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in trade payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 553</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 252</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 316</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;303</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in other current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 941</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;410</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other adjustments, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 199</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 576</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 332</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock', window );">Cash flows arising from acquisitions and divestments of businesses</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets recognized as a result of business combinations</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;4&nbsp;124</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;13&nbsp;660</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;874</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value of previously held equity interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Receivables and payables contingent consideration, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 242</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 151</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments, deferred consideration and other adjustments, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;36</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows used for acquisitions of businesses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;3&nbsp;851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;13&nbsp;701</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;759</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows from divestments of businesses, net <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 91</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows used for acquisitions and divestments of businesses, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;3&nbsp;760</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;13&nbsp;683</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;714</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> In 2019, the USD 91 million included USD 4 million net cash outflows from previous years divestments and USD 95 million net cash inflows from business divestments in 2019. The net identifiable assets of the 2019 divested businesses amounted to USD 196 million, comprised of non-current asset of USD 159 million, current assets of USD 96 million including USD 11 million cash and cash equivalents, non-current liabilities USD 18 million and current liabilities of USD 41 million. <br></br>In 2018, USD 18 million represented the net cash inflows from previous years divestments. <br></br>In 2017, the USD 45 million net cash inflows related to the net identifiable assets from a 2017 divestment. The 2017 divested business amounted to USD 48 million, comprised of non-current assets of USD 29 million, current assets of USD 34 million and current liabilities of USD 15 million. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock', window );">Reconciliation of liabilities arising from financing activities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Non-current <br></br> financial <br></br> debts </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> financial <br></br> debts and <br></br> derivative <br></br> financial <br></br> instruments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Non-current <br></br> lease liabilities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Current lease <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;470</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;678</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 16 Leases continuing operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;471</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 268</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 16 Leases discontinued operations <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and lease liabilities related to discontinued operations <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;246</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;3&nbsp;195</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;1&nbsp;582</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments of lease liabilities, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;273</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest payments for amounts included in lease liabilities <br></br>classified as cash flows from operating activities </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &#x2013;&#x2005;51 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">New leases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 362</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 131</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations and divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification from non-current to current, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;156</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 156</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;703</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 246</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Lease liabilties recognized on January 1, 2019, the date of implementation of IFRS 16 Leases. Note 10 provides additional disclosure. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> In 2018, financial debts included USD 89 million for previously reported finance lease obligations of the Alcon business that have been reclassified on January 1, 2019, to lease liabilities, with the adoption of IFRS 16 Leases. Note 30 provides additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Represents the financial debts and lease liabilities at January 1, 2019, related to the Alcon business reported as discontinued operations. See Notes 1, 2 and 30. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Non-current <br></br> financial <br></br> debts </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> financial <br></br> debts and <br></br> derivative <br></br> financial <br></br> instruments </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;224</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;308</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;856</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;366</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;681</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;462</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;93</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;3&nbsp;190</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;678</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 1 687 million. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Non-current <br></br> financial <br></br> debts </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> financial <br></br> debts and <br></br> derivative <br></br> financial <br></br> instruments </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> </div> </td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2017</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;897</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;905</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Increase in non-current financial debts <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Repayment of non-current financial debts <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;187</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in current financial debts <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;755</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair values, and other changes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;140</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of bonds discount</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 744</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 359</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;224</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;308</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Increases in non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Repayment of non-current financial debts were only recorded in the consolidated statements of cash flows from continuing operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Changes in current financial debts included in the consolidated statements of cash flows from continuing operations were USD 644 million. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdjustmentsForNoncashItemsFromContinuingOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowsArisingFromAcquisitionsAndDivestmentsOfBusinessesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowsFromChangesInWorkingCapitalAndOtherOperatingItemsIncludedInOperatingCashFlowFromContinuingOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDetailsToTheConsolidatedCashFlowStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>188
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873888528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">$ 1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments', window );">Adjustments for prepayments and accrued lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandMember', window );">Land [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember', window );">Machinery &amp; equipment and other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdjustmentsForPrepaymentsAndAccruedLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>189
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6849694016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies (Details 6) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="nump">$ 659<span></span>
</td>
<td class="nump">$ 6,438<span></span>
</td>
<td class="nump">$ 1,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShareOfCurrentYearNetIncome', window );">Novartis share of current year consolidated net income</a></td>
<td class="nump">910<span></span>
</td>
<td class="nump">799<span></span>
</td>
<td class="nump">669<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PriorYearAdjustment', window );">Prior year adjustment</a></td>
<td class="num">(129)<span></span>
</td>
<td class="num">(125)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets', window );">Amortization of fair value adjustments relating to intangible assets</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PartialReleaseOfDeferredTaxLiabilityRecognized', window );">Partial release of deferred tax liability recognized</a></td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax', window );">Amortization of fair value adjustments relating to intangible assets tax</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember', window );">GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShareOfCurrentYearNetIncome', window );">Novartis share of current year consolidated net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PriorYearAdjustment', window );">Prior year adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets', window );">Amortization of fair value adjustments relating to intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainOnDivestmentOfInterestsInAssociatedCompanies', window );">Gain on divestment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Net income statement effect</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,910<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax', window );">Amortization of fair value adjustments relating to intangible assets tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmortizationOfFairValueAdjustmentsRelatingToIntangibleAssetsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GainOnDivestmentOfInterestsInAssociatedCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GainOnDivestmentOfInterestsInAssociatedCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PartialReleaseOfDeferredTaxLiabilityRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PartialReleaseOfDeferredTaxLiabilityRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PriorYearAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PriorYearAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ShareOfCurrentYearNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ShareOfCurrentYearNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>190
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837531072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details 6) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 1,949<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">$ 1,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=nvs_SaleAndLeaseBackMember', window );">Sale and lease back [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems', window );"><strong>Disclosure of quantitative information about right-of-use assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashInflowForSaleAndLeaseback', window );">Cash inflow for sale and leaseback</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions', window );">Gains or losses from sales leaseback</a></td>
<td class="nump">$ 478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) arising from sale and leaseback transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesArisingFromSaleAndLeasebackTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashInflowForSaleAndLeaseback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashInflowForSaleAndLeaseback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=nvs_SaleAndLeaseBackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=nvs_SaleAndLeaseBackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>191
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843712912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInAssociate', window );">Proportion of voting rights held in associate</a></td>
<td class="nump">33.30%<span></span>
</td>
<td class="nump">33.30%<span></span>
</td>
<td class="nump">33.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends received</a></td>
<td class="nump">$ 460<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished', window );">Publicly quoted market value of the Novartis interest</a></td>
<td class="nump">$ 16,900<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Useful life measured as period of time, intangible assets other than goodwill</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember', window );">GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of investments in associates if there are quoted market prices for the investment. [Refer: Associates [member]; Investments in associates]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfVotingPowerHeldInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of the voting rights in an associate held by the entity. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfVotingPowerHeldInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>192
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873376096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 77,701<span></span>
</td>
<td class="nump">$ 98,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember', window );">Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 848<span></span>
</td>
<td class="nump">$ 795<span></span>
</td>
<td class="nump">$ 780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 33,032<span></span>
</td>
<td class="nump">$ 41,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 16,280<span></span>
</td>
<td class="nump">$ 14,618<span></span>
</td>
<td class="nump">$ 14,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 28,893<span></span>
</td>
<td class="nump">$ 39,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,442<span></span>
</td>
<td class="nump">$ 2,505<span></span>
</td>
<td class="nump">$ 2,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 3,933<span></span>
</td>
<td class="nump">$ 3,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_DE', window );">Germany</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 4,120<span></span>
</td>
<td class="nump">$ 3,972<span></span>
</td>
<td class="nump">$ 3,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 2,554<span></span>
</td>
<td class="nump">$ 3,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,656<span></span>
</td>
<td class="nump">$ 2,575<span></span>
</td>
<td class="nump">$ 2,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 309<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=nvs_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 21,099<span></span>
</td>
<td class="nump">$ 20,286<span></span>
</td>
<td class="nump">$ 19,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 8,980<span></span>
</td>
<td class="nump">$ 9,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SelectedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SelectedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies. As percent of total selected non-current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=nvs_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=nvs_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>193
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838918096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred tax assets and liabilities (Details 2) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_InvestmentsInSubsidiariesMember', window );">Investments in subsidiaries [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Temporary differences on which no deferred tax has been provided as they are permanent in nature</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_GoodwillFromAcquisitionsMember', window );">Goodwill from acquisitions [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised', window );">Temporary differences on which no deferred tax has been provided as they are permanent in nature</a></td>
<td class="num">$ (24)<span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_InvestmentsInSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_InvestmentsInSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=nvs_GoodwillFromAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=nvs_GoodwillFromAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>194
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846868304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 6)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CustomersWithNetSalesOverFivePercent', window );">Customers with net sales over five percent</a></td>
<td class="text">The Group&#8217;s largest, second-largest and third-largest customers account for approximately 23%, 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). All segments had sales to these customers in 2019, 2018 and 2017. No other customer accounted for 6% or more of net sales in any year. The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=nvs_LargestCustomerMember', window );">Largest customer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEntitysTradeReceivable', window );">Percentage of entitys trade receivable</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=nvs_SecondLargestCustomerMember', window );">Second largest customer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEntitysTradeReceivable', window );">Percentage of entitys trade receivable</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=nvs_ThirdLargestCustomerMember', window );">Third largest customer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMajorCustomersLineItems', window );"><strong>Disclosure of major customers [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PercentageOfEntitysTradeReceivable', window );">Percentage of entitys trade receivable</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMajorCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMajorCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CustomersWithNetSalesOverFivePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CustomersWithNetSalesOverFivePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PercentageOfEntitysTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PercentageOfEntitysTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=nvs_LargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=nvs_LargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=nvs_SecondLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=nvs_SecondLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=nvs_ThirdLargestCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=nvs_ThirdLargestCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>195
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6871478400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant accounting policies (Details 3)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share | SFr / shares</a></td>
<td class="nump">SFr 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_UndiscountedOperatingLeaseCommitments', window );">Undiscounted operating lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShortTermLeasesAndLowValueLeases', window );">Short term leases and low value leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RemainingLeaseCommitments', window );">Remaining lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesToBeRecognized', window );">Lease liabilities to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RightOfUseAssetsToBeRecognized', window );">Right of use assets to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PrepaymentsAndAccruedLeasePayments', window );">Prepayments and accrued lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RemainingLeaseCommitments', window );">Remaining lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LeaseLiabilitiesToBeRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LeaseLiabilitiesToBeRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PrepaymentsAndAccruedLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PrepaymentsAndAccruedLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RemainingLeaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RemainingLeaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RightOfUseAssetsToBeRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RightOfUseAssetsToBeRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ShortTermLeasesAndLowValueLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ShortTermLeasesAndLowValueLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_UndiscountedOperatingLeaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_UndiscountedOperatingLeaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>196
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838749648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfBusinessUnits', window );">Number of Business Units</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfFranchises', window );">Number of Franchises</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfBusinessUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfBusinessUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfFranchises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfFranchises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>197
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6852205248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and intangible assets (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">$ 55,311<span></span>
</td>
<td class="nump">$ 74,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">46,336<span></span>
</td>
<td class="nump">44,593<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">8,892<span></span>
</td>
<td class="nump">9,712<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">26,524<span></span>
</td>
<td class="nump">35,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill | Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">18,750<span></span>
</td>
<td class="nump">18,551<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill | Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">7,767<span></span>
</td>
<td class="nump">7,837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,899<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill | Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible Assets other than Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">28,787<span></span>
</td>
<td class="nump">38,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible Assets other than Goodwill | Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">27,586<span></span>
</td>
<td class="nump">26,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible Assets other than Goodwill | Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">1,125<span></span>
</td>
<td class="nump">1,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible Assets other than Goodwill | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,679<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember', window );">Intangible Assets other than Goodwill | Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember', window );">Acquired research and development [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">5,424<span></span>
</td>
<td class="nump">15,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember', window );">Acquired research and development [member] | Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">5,339<span></span>
</td>
<td class="nump">14,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember', window );">Acquired research and development [member] | Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember', window );">Acquired research and development [member] | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember', window );">Acquired research and development [member] | Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember', window );">Alcon brand name [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember', window );">Alcon brand name [member] | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">163<span></span>
</td>
<td class="nump">1,495<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technologies | Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technologies | Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technologies | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember', window );">Currently marketed products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">22,579<span></span>
</td>
<td class="nump">14,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember', window );">Currently marketed products | Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">21,720<span></span>
</td>
<td class="nump">11,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember', window );">Currently marketed products | Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">859<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember', window );">Currently marketed products | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember', window );">Marketing know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember', window );">Marketing know-how | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets | Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Net book value</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_AlconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_AlconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_IntangibleAssetsOtherThanGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AcquiredResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_AlconBrandNameMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_CurrentlyMarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=nvs_MarketingRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>198
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6889678304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures - Top 20 (Details 11) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember', window );">Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_USMember', window );">US [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 16,280<span></span>
</td>
<td class="nump">$ 14,618<span></span>
</td>
<td class="nump">14,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_USMember', window );">US [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Top 20 products [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 28,646<span></span>
</td>
<td class="nump">$ 26,946<span></span>
</td>
<td class="nump">24,568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of portfolio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">9,068<span></span>
</td>
<td class="nump">7,946<span></span>
</td>
<td class="nump">7,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Tasigna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,880<span></span>
</td>
<td class="nump">1,874<span></span>
</td>
<td class="nump">1,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Sandostatin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,585<span></span>
</td>
<td class="nump">1,587<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Afinitor/Votubia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,539<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">1,525<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Promacta/Revolade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,416<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Tafinlar + Mekinist [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">1,155<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Gleevec/Glivec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,263<span></span>
</td>
<td class="nump">1,561<span></span>
</td>
<td class="nump">1,943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Jakavi [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Exjade/Jadenu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Oncology [member] | Top 20 products [member] | Votrient [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">755<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Top 20 products [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">2,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Top 20 products [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
<td class="nump">1,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Top 20 products [member] | Travoprost Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Top 20 products [member] | Gilenya [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">3,223<span></span>
</td>
<td class="nump">3,341<span></span>
</td>
<td class="nump">3,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | Top 20 products [member] | Xolair [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member] | Top 20 products [member] | Entresto [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,726<span></span>
</td>
<td class="nump">1,028<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Galvus Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Diovan Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Exforge Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Zortress/Certican [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Kisqali [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Voltaren/Cataflam [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Cosentyx [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">3,551<span></span>
</td>
<td class="nump">2,837<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Ilaris [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">671<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Neoral/Sandimmun(e) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 13,789<span></span>
</td>
<td class="nump">$ 11,864<span></span>
</td>
<td class="nump">10,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Change to prior year-end [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Top 20 products [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 10,679<span></span>
</td>
<td class="nump">$ 9,654<span></span>
</td>
<td class="nump">8,445<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Rest of portfolio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">3,110<span></span>
</td>
<td class="nump">2,210<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Tasigna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">804<span></span>
</td>
<td class="nump">806<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Sandostatin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">881<span></span>
</td>
<td class="nump">817<span></span>
</td>
<td class="nump">832<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Afinitor/Votubia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Promacta/Revolade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">691<span></span>
</td>
<td class="nump">581<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Tafinlar + Mekinist [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">481<span></span>
</td>
<td class="nump">457<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Gleevec/Glivec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Exjade/Jadenu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Oncology [member] | Top 20 products [member] | Votrient [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">404<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Ophthalmology [member] | Top 20 products [member] | Travoprost Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Neuroscience [member] | Top 20 products [member] | Gilenya [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,736<span></span>
</td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">1,709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member] | Top 20 products [member] | Entresto [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">556<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Diovan Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Exforge Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Zortress/Certican [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Kisqali [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Cosentyx [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">2,220<span></span>
</td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Ilaris [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">304<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | US [member] | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Neoral/Sandimmun(e) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">23,925<span></span>
</td>
<td class="nump">23,028<span></span>
</td>
<td class="nump">21,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Top 20 products [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">17,967<span></span>
</td>
<td class="nump">17,292<span></span>
</td>
<td class="nump">16,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Rest of portfolio [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">5,958<span></span>
</td>
<td class="nump">5,736<span></span>
</td>
<td class="nump">5,298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Tasigna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">1,068<span></span>
</td>
<td class="nump">1,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Sandostatin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Afinitor/Votubia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Promacta/Revolade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">725<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Tafinlar + Mekinist [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">857<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Gleevec/Glivec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">929<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Jakavi [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">977<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Exjade/Jadenu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">578<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Oncology [member] | Top 20 products [member] | Votrient [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">423<span></span>
</td>
<td class="nump">424<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Top 20 products [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">2,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Ophthalmology [member] | Top 20 products [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
<td class="nump">1,888<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Ophthalmology [member] | Top 20 products [member] | Travoprost Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Neuroscience [member] | Top 20 products [member] | Gilenya [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,487<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Respiratory [member] | Top 20 products [member] | Xolair [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member] | Top 20 products [member] | Entresto [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Galvus Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Diovan Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">978<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="nump">870<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Exforge Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="nump">932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Zortress/Certican [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">316<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Kisqali [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Established Medicines [member] | Top 20 products [member] | Voltaren/Cataflam [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Cosentyx [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
<td class="nump">796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Ilaris [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">367<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines | Rest of the world [member] | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Top 20 products [member] | Neoral/Sandimmun(e) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 37,714<span></span>
</td>
<td class="nump">$ 34,892<span></span>
</td>
<td class="nump">32,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 14,370<span></span>
</td>
<td class="nump">$ 13,428<span></span>
</td>
<td class="nump">12,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Tasigna [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,880<span></span>
</td>
<td class="nump">$ 1,874<span></span>
</td>
<td class="nump">1,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Sandostatin [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,585<span></span>
</td>
<td class="nump">$ 1,587<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Afinitor/Votubia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,539<span></span>
</td>
<td class="nump">$ 1,556<span></span>
</td>
<td class="nump">1,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Promacta/Revolade [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,416<span></span>
</td>
<td class="nump">$ 1,174<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Tafinlar + Mekinist [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,338<span></span>
</td>
<td class="nump">$ 1,155<span></span>
</td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Gleevec/Glivec [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,263<span></span>
</td>
<td class="nump">$ 1,561<span></span>
</td>
<td class="nump">1,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(19.00%)<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Jakavi [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,114<span></span>
</td>
<td class="nump">$ 977<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Exjade/Jadenu [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 975<span></span>
</td>
<td class="nump">$ 1,099<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(11.00%)<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Votrient [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 828<span></span>
</td>
<td class="nump">808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(9.00%)<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Oncology [member] | Kisqali [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">104.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 23,344<span></span>
</td>
<td class="nump">$ 21,464<span></span>
</td>
<td class="nump">20,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 4,776<span></span>
</td>
<td class="nump">$ 4,558<span></span>
</td>
<td class="nump">4,621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Lucentis [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 2,086<span></span>
</td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="nump">1,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Ophthalmology [member] | Travoprost Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 517<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(16.00%)<span></span>
</td>
<td class="num">(12.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,773<span></span>
</td>
<td class="nump">$ 3,429<span></span>
</td>
<td class="nump">3,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Neuroscience [member] | Gilenya [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,223<span></span>
</td>
<td class="nump">$ 3,341<span></span>
</td>
<td class="nump">3,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,825<span></span>
</td>
<td class="nump">$ 1,767<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Respiratory [member] | Xolair [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,173<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="nump">920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="nump">524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Cardiovascular, Renal and Metabolism [member] | Entresto [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,726<span></span>
</td>
<td class="nump">$ 1,028<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">68.00%<span></span>
</td>
<td class="nump">103.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 6,998<span></span>
</td>
<td class="nump">$ 7,268<span></span>
</td>
<td class="nump">7,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="num">(3.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Galvus Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,297<span></span>
</td>
<td class="nump">$ 1,284<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Diovan Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,064<span></span>
</td>
<td class="nump">$ 1,023<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Exforge Group [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 1,025<span></span>
</td>
<td class="nump">$ 1,002<span></span>
</td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Zortress/Certican [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Neoral/Sandimmun(e) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 463<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(10.00%)<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Established Medicines [member] | Voltaren/Cataflam [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="num">(6.00%)<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 4,222<span></span>
</td>
<td class="nump">$ 3,392<span></span>
</td>
<td class="nump">2,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Cosentyx [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 3,551<span></span>
</td>
<td class="nump">$ 2,837<span></span>
</td>
<td class="nump">2,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines | Pharmaceutical [member] | Immunology, Hepatology and Dermatology [member] | Ilaris [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">$ 402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent', window );">Net sales, change in %</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdPartiesChangeInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeOverPeriodAxis=nvs_PoPYEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeOverPeriodAxis=nvs_PoPYEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_USMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_USMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductPortfolioAxis=nvs_Top20ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductPortfolioAxis=nvs_Top20ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductPortfolioAxis=nvs_RestOfPortfolioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductPortfolioAxis=nvs_RestOfPortfolioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BusinessUnitAxis=nvs_OncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BusinessUnitAxis=nvs_OncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TasignaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TasignaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_SandostatinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_SandostatinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_AfinitorVotubiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_AfinitorVotubiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_PromactaRevoladeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_PromactaRevoladeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TafinlarMekinistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TafinlarMekinistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_GleevecGlivecMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_GleevecGlivecMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_JakaviMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_JakaviMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ExjadeJadenuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ExjadeJadenuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_VotrientMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_VotrientMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BusinessUnitAxis=nvs_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BusinessUnitAxis=nvs_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_LucentisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_OphthalmologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_OphthalmologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_TravoprostGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_TravoprostGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_NeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_NeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_GilenyaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_GilenyaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_RespiratoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_RespiratoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_XolairMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_XolairMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_CardioMetabolicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_CardioMetabolicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_EntrestoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_EntrestoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_EstablishedMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_EstablishedMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_GalvusGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_GalvusGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_DiovanGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_DiovanGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ExforgeGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ExforgeGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_ZortressCerticanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_ZortressCerticanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_KisqaliMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_KisqaliMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_VoltarenCataflamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_VoltarenCataflamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FranchiseAxis=nvs_ImmunologyHepatologyAndDermatologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FranchiseAxis=nvs_ImmunologyHepatologyAndDermatologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_CosentyxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_CosentyxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_IlarisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_IlarisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=nvs_NeoralSandimmunEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=nvs_NeoralSandimmunEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_RestOfTheWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_RestOfTheWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>199
<FILENAME>R139.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6855086176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current financial debt (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 22,355<span></span>
</td>
<td class="nump">$ 25,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Later than one year and not later than two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">2,067<span></span>
</td>
<td class="nump">2,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Later than two years and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">2,583<span></span>
</td>
<td class="nump">2,111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Later than three years and not later than four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">2,321<span></span>
</td>
<td class="nump">2,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Later than four years and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">2,139<span></span>
</td>
<td class="nump">2,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember', window );">Later than five years and not later than six years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 11,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanSixYearsMember', window );">Later than six years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,353<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=nvs_LaterThanFiveYearsAndNotLaterThanSixYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=nvs_LaterThanSixYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=nvs_LaterThanSixYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>200
<FILENAME>R131.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838833168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other current assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherCurrentAssetsAbstract', window );"><strong>Other current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">VAT Receivable</a></td>
<td class="nump">$ 508<span></span>
</td>
<td class="nump">$ 588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WithholdingTaxRecoverable', window );">Withholding tax recoverable</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentPrepaidExpensesThirdParty', window );">Prepaid expenses - third party</a></td>
<td class="nump">898<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentPrepaidExpensesAssociatedCompanies', window );">Prepaid expenses - associated companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ReceivablesAssociatedCompanies', window );">Receivables associated companies</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherReceivablesAndCurrentAssets', window );">Other receivables and current assets</a></td>
<td class="nump">1,165<span></span>
</td>
<td class="nump">1,360<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialAssets', window );">Total other current assets</a></td>
<td class="nump">$ 2,680<span></span>
</td>
<td class="nump">$ 2,861<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentPrepaidExpensesAssociatedCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentPrepaidExpensesAssociatedCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentPrepaidExpensesThirdParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentPrepaidExpensesThirdParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherReceivablesAndCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherReceivablesAndCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ReceivablesAssociatedCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ReceivablesAssociatedCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WithholdingTaxRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WithholdingTaxRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>201
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839018720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherCurrentAssetsAbstract', window );"><strong>Other current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherCurrentAssetsTableTextBlock', window );">Other current assets</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">VAT receivable</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 508</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 588</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Withholding tax recoverable</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid expenses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Third parties</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 811</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Receivables from associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other receivables and current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;165</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;360</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;680</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;861</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>202
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6722424912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial and other non-current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract', window );"><strong>Disclosure of financial and other non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfFinancialAssetsTableTextBlock', window );">Financial assets</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;524</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;155</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;790</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;437</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term receivables from customers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 164</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Minimum lease payments <br></br>from finance lease agreements <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 91 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term receivables from finance subleases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other long-term receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances and security deposits</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 254</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;518</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 30 provides additional disclosures on minimal lease payments from finance lease agreements that relate to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent considerations. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOtherNoncurrentAssetsTableTextBlock', window );">Other non-current assets</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred compensation plans</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 414</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 468</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid post-employment benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 148</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 176</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 290</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 738</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 895</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfFinancialAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfFinancialAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOtherNoncurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOtherNoncurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>203
<FILENAME>R135.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6840736736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details 4) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfChangesInEquityAbstract', window );"><strong>Statement of changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TreasurySharesAcquiredToBeCancelled', window );">Treasury shares acquired to be cancelled</a></td>
<td class="num">(60.3)<span></span>
</td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(66.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TreasurySharesAcquiredForCancellationValue', window );">Shares acquired for cancellation, equity impact</a></td>
<td class="num">$ (5,351)<span></span>
</td>
<td class="num">$ (1,859)<span></span>
</td>
<td class="num">$ (5,270)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherSharePurchases', window );">Other share purchases</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherSharePurchasesValue', window );">Other share purchases, equity impact</a></td>
<td class="num">$ (160)<span></span>
</td>
<td class="num">$ (114)<span></span>
</td>
<td class="num">$ (304)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharepurchaseOfTreasuryShares', window );">Purchase of treasury shares</a></td>
<td class="num">(62.0)<span></span>
</td>
<td class="num">(24.5)<span></span>
</td>
<td class="num">(70.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Purchase of treasury shares, equity impact</a></td>
<td class="num">$ (5,511)<span></span>
</td>
<td class="num">$ (1,973)<span></span>
</td>
<td class="num">$ (5,574)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NumberOfOtherShareSales', window );">Other share sales</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherShareSalesEquityImpact', window );">Other share sales, equity impact</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ExerciseOfOptionsAndEmployeeTransactionsShares', window );">Exercise of options and employee transactions shares</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options and employee transactions, equity impact</a></td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EquityBasedCompensationShares', window );">Equity based compensation shares</a></td>
<td class="nump">9.4<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-based compensation, equity impact</a></td>
<td class="nump">$ 833<span></span>
</td>
<td class="nump">$ 756<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesDeliveredToDivestedBusinessEmployees', window );">Shares delivered to divested business employees</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff', window );">Shares delivered to divested business employees, equity impact</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TreasurySharesMovement', window );">Total number of outstanding treasury shares</a></td>
<td class="num">(46.2)<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(56.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EquityImpactOfTreasuryShareMovements', window );">Total equity impact of treasury share movements</a></td>
<td class="num">$ (4,450)<span></span>
</td>
<td class="nump">$ 520<span></span>
</td>
<td class="nump">$ 4,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings', window );">Impact of new tax law income tax relating to revaluation of deferred tax assets on equity based compensation that were previously recognized through retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EquityBasedCompensationShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EquityBasedCompensationShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EquityImpactOfTreasuryShareMovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EquityImpactOfTreasuryShareMovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ExerciseOfOptionsAndEmployeeTransactionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ExerciseOfOptionsAndEmployeeTransactionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncomeTaxRelatingToRevaluationOfDeferredTaxAssetsOnEquityBasedCompensationThatWerePreviouslyRecognizedThroughRetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NumberOfOtherShareSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NumberOfOtherShareSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherSharePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherSharePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherSharePurchasesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherSharePurchasesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherShareSalesEquityImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherShareSalesEquityImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharepurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharepurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharesDeliveredToDivestedBusinessEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharesDeliveredToDivestedBusinessEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TreasurySharesAcquiredForCancellationValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TreasurySharesAcquiredForCancellationValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TreasurySharesAcquiredToBeCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TreasurySharesAcquiredToBeCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TreasurySharesMovement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TreasurySharesMovement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>204
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838716096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Transactions with related parties</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">27. Transactions with related parties</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Genentech/Roche</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has two agreements with Genentech, Inc., United States, and one agreement with Spark Therapeutics, Inc., United States. Both companies are subsidiaries of Roche Holding AG (Roche), which is indirectly included in the consolidated financial statements using equity accounting since Novartis holds 33.3% of the outstanding voting shares of Roche (see Note 4). </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Lucentis</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has licensed from Genentech/Roche the exclusive rights to develop and market <i>Lucentis</i> outside the United States for indications related to diseases of the eye. Novartis pays royalties on the net sales of <i>Lucentis</i> products outside the United States. In 2019, <i>Lucentis</i> sales of USD&nbsp;2.1 billion (2018: USD&nbsp;2.0 billion; 2017: USD&nbsp;1.9 billion) were recognized by Novartis. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Xolair</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis and Genentech/Roche are co-promoting <i>Xolair</i> in the United States, where Genentech/Roche records all sales. Novartis records sales outside the United States. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis markets <i>Xolair</i> and records all sales and related costs outside the United States as well as co-promotion costs in the US. Genentech/Roche and Novartis share the resulting profits from sales in the United States, Europe and other countries, according to agreed profit-sharing percentages. In 2019, Novartis recognized total sales of <i>Xolair</i> of USD&nbsp;1.2 billion (2018: USD&nbsp;1.0 billion; 2017: USD&nbsp;920 million), including sales to Genentech/Roche for the United States market. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Luxturna</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, Novartis entered into an exclusive licensing and commercialization agreement and a supply agreement with Spark Therapeutics, Inc. (Spark) for <i>Luxturna</i> outside the United States. The agreements include regulatory and sales milestones as well as royalties payable to Spark on ex-US sales. On December 17, 2019, Roche acquired Spark. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The net income for royalties, cost sharing and profit sharing arising out of the <i>Lucentis</i>, <i>Xolair</i> and <i>Luxturna</i> agreements with Roche totaled USD&nbsp;101 million in 2019 (net income in 2018: USD&nbsp;34 million; net expense in 2017: USD&nbsp;33 million). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Furthermore, Novartis has several patent license, supply and distribution agreements with Roche. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis Pension Fund</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2018, a Group subsidiary provided an uncommitted overnight credit facility to the Novartis Pension Fund, Switzerland, for up to USD 500 million with interest at the US Federal Funds Rate. This credit facility was not utilized during the years 2019 and 2018. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Executive Officers and Non-Executive Directors compensation</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, there were 15 Executive Committee members (&#x201c;Executive Officers&#x201d;), including those who stepped down during the year (there were 17 members in 2018 and 11 members in 2017, including those who stepped down). </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The total compensation for Executive Committee members and the 13 Non-Executive Directors (13 in 2018 and 2017) using the Group&#x2019;s accounting policies for equity-based compensation and pension benefits was as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Executive Officers</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-Executive Directors</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and other compensation</div> </td> <td align="right" width="5%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18.4</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.8</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22.4</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Post-employment benefits</div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation</div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 49.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 63.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 67.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 72.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 76.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, the IFRS compensation expense decreased due to lower cash buyout payments to new executive officers and the forfeiture of equity-based compensation as a result of the resignation of an executive officer. These effects were partially offset by higher equity based compensation of executive officers appointed over the last three years. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">During 2018, there was a decrease in the IFRS compensation expense for Executive Officers, mainly due to the higher pro-rata accelerated vesting of equity compensation in 2017, required by IFRS, in accordance with the plan rules. This was partly offset by the cash portion of buyout payments for new Executive Officers. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Annual Incentive award, which is fully included in equity-based compensation even when paid out in cash, is granted in January in the year following the reporting period. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The disclosures on Board and executive compensation required by the Swiss Code of Obligations and in accordance with the Swiss Ordinance against Excessive Compensation in Stock Exchange Listed Companies are shown in the Compensation Report of the Group. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Transactions with former members of the Board of Directors</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">During 2019, 2018 and 2017, the following payments (or waivers of claims) were made to former Board members or to &#x201c;persons closely&#x201d; linked to them: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Currency</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dr. Krauer</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60&nbsp;000</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60&nbsp;000</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 60&nbsp;000</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dr. Vasella</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;228</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;279</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Dr. Alex Krauer, Honorary Chairman, is entitled to an amount of CHF&nbsp;60&#xa0;000 for annual periods from one AGM to the next. This amount was fixed in 1998 upon his departure from the Board in 1999, and has not been revised since that date. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Dr. Daniel Vasella, Honorary Chairman, was paid CHF&nbsp;18&#xa0;228 in 2018, and CHF&nbsp;26&#xa0;279 in 2017, for reimbursable costs under his agreement with the Company, which expired on December 31, 2019. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>205
<FILENAME>R154.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6894107424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Details to the consolidated cash flow statements (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">(Increase) in inventories</a></td>
<td class="num">$ (382)<span></span>
</td>
<td class="num">$ (387)<span></span>
</td>
<td class="num">$ (203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">(Increase) in trade receivables</a></td>
<td class="num">(980)<span></span>
</td>
<td class="num">(544)<span></span>
</td>
<td class="num">(655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase in trade payables</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets', window );">Change in other current assets</a></td>
<td class="num">(160)<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities', window );">Change in other current liabilities</a></td>
<td class="nump">1,167<span></span>
</td>
<td class="nump">941<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss', window );">Other adjustments, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems', window );">Total</a></td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 576<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other current assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other current assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other current liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Adjustments to reconcile profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsToReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangeInNetCurrentAssetsAndOtherOperatingCashFlowItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>206
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873885488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of changes in equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Equity attributable to owners of parent [member]</div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Treasury shares</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Total value adjustments</div></th>
<th class="th"><div>Non-controlling interests [member]</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">$ 74,891<span></span>
</td>
<td class="nump">$ 74,832<span></span>
</td>
<td class="nump">$ 972<span></span>
</td>
<td class="num">$ (76)<span></span>
</td>
<td class="nump">$ 81,148<span></span>
</td>
<td class="num">$ (7,212)<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,168<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,639<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,228<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,876<span></span>
</td>
<td class="num">(4,517)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">74,891<span></span>
</td>
<td class="nump">74,832<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">81,148<span></span>
</td>
<td class="num">(7,212)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at beginning of period at Dec. 31, 2016</a></td>
<td class="nump">74,891<span></span>
</td>
<td class="nump">74,832<span></span>
</td>
<td class="nump">972<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">81,148<span></span>
</td>
<td class="num">(7,212)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">7,703<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="nump">2,837<span></span>
</td>
<td class="nump">2,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="nump">10,540<span></span>
</td>
<td class="nump">10,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,666<span></span>
</td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends</a></td>
<td class="num">(6,495)<span></span>
</td>
<td class="num">(6,495)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,495)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Purchase of treasury shares</a></td>
<td class="num">(5,574)<span></span>
</td>
<td class="num">(5,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="num">(5,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReductionOfIssuedCapital', window );">Reduction of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options and employee transactions, equity impact</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-based compensation</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TransactionCostsRecordedInEquity', window );">Transaction costs recorded in equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInNoncontrolingInterests', window );">Changes in non-controlling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInEquity', window );">Total of other equity movements</a></td>
<td class="num">(11,204)<span></span>
</td>
<td class="num">(11,202)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(11,175)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period (Previously stated [member]) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,168<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,639<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period (Increase (decrease) due to changes in accounting policy required by IFRSs [member]) at Dec. 31, 2017</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period (Restated Value Adjustments [member]) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,228<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,876<span></span>
</td>
<td class="num">(4,517)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,168<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,639<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,228<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,876<span></span>
</td>
<td class="num">(4,517)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,168<span></span>
</td>
<td class="nump">969<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,639<span></span>
</td>
<td class="num">(4,340)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(177)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,228<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">77,876<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">78,692<span></span>
</td>
<td class="nump">78,614<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,191<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">12,614<span></span>
</td>
<td class="nump">12,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="num">(406)<span></span>
</td>
<td class="num">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(482)<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="nump">12,208<span></span>
</td>
<td class="nump">12,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,129<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends</a></td>
<td class="num">(6,966)<span></span>
</td>
<td class="num">(6,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Purchase of treasury shares</a></td>
<td class="num">(1,973)<span></span>
</td>
<td class="num">(1,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(1,960)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReductionOfIssuedCapital', window );">Reduction of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options and employee transactions, equity impact</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherShareSales', window );">Other share sales</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-based compensation</a></td>
<td class="nump">756<span></span>
</td>
<td class="nump">756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan', window );">Increase of treasury share repurchase obligation under a share buyback trading plan</a></td>
<td class="num">(284)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TransactionCostsRecordedInEquity', window );">Transaction costs recorded in equity</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Impact of change in ownership of consolidated entities</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInNoncontrolingInterests', window );">Changes in non-controlling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity', window );">Other movements</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInEquity', window );">Total of other equity movements</a></td>
<td class="num">(7,803)<span></span>
</td>
<td class="num">(7,824)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(7,814)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period (Increase (decrease) due to changes in accounting policy required by IFRSs [member]) at Dec. 31, 2018</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period (Restated Value Adjustments [member]) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,617<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,194<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2018</a></td>
<td class="nump">78,692<span></span>
</td>
<td class="nump">78,614<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,191<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,617<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,194<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">78,692<span></span>
</td>
<td class="nump">78,614<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,191<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,617<span></span>
</td>
<td class="nump">944<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,194<span></span>
</td>
<td class="num">(4,452)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">78,692<span></span>
</td>
<td class="nump">78,614<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="nump">82,191<span></span>
</td>
<td class="num">(4,657)<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">11,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="num">(210)<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="nump">11,527<span></span>
</td>
<td class="nump">11,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,638<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends</a></td>
<td class="num">(6,645)<span></span>
</td>
<td class="num">(6,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,645)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DividendPaidNoncashAssetsDistribution', window );">Dividend in kind</a></td>
<td class="num">(23,434)<span></span>
</td>
<td class="num">(23,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Purchase of treasury shares</a></td>
<td class="num">(5,511)<span></span>
</td>
<td class="num">(5,511)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(5,480)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReductionOfIssuedCapital', window );">Reduction of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of options and employee transactions, equity impact</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Equity-based compensation</a></td>
<td class="nump">833<span></span>
</td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff', window );">Shares delivered to divested business employees, equity impact</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TaxesOnTreasuryShares', window );">Taxes on treasury shares</a></td>
<td class="num">(189)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan', window );">Increase of treasury share repurchase obligation under a share buyback trading plan</a></td>
<td class="nump">284<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TransactionCostsRecordedInEquity', window );">Transaction costs recorded in equity</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Impact of change in ownership of consolidated entities</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseInNoncontrolingInterests', window );">Changes in non-controlling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity', window );">Other movements</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ChangesInEquity', window );">Total of other equity movements</a></td>
<td class="num">(34,671)<span></span>
</td>
<td class="num">(34,668)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(34,557)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity at end of period at Dec. 31, 2019</a></td>
<td class="nump">55,551<span></span>
</td>
<td class="nump">55,474<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="nump">59,275<span></span>
</td>
<td class="num">(4,657)<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="nump">$ 55,551<span></span>
</td>
<td class="nump">$ 55,474<span></span>
</td>
<td class="nump">$ 936<span></span>
</td>
<td class="num">$ (80)<span></span>
</td>
<td class="nump">$ 59,275<span></span>
</td>
<td class="num">$ (4,657)<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 107<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReductionOfIssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReductionOfIssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DividendPaidNoncashAssetsDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DividendPaidNoncashAssetsDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsOnFinancialAssetsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsRelatedToDivestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsRelatedToDivestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseInNoncontrolingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseInNoncontrolingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseOfTreasuryShareRepurchaseObligationUnderAShareBuybackTradingPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherShareSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherShareSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharesDeliveredToDivestedBusinessEmployeesAsAResultOfSpinoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TaxesOnTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TaxesOnTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TransactionCostsRecordedInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TransactionCostsRecordedInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_RestatedValueAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_RestatedValueAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>207
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6870056544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NOVARTIS AG<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001114448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">2,265,008,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 20-F, 40-F<br> -Number 240<br> -Section 15<br> -Subsection d-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>208
<FILENAME>R150.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6847541264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other current liabilities (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="nump">$ 5,262<span></span>
</td>
<td class="nump">$ 4,672<span></span>
</td>
<td class="nump">$ 4,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Effects of currency translation and business combinations</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments/utilizations</a></td>
<td class="num">(19,348)<span></span>
</td>
<td class="num">(18,567)<span></span>
</td>
<td class="num">(17,452)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfPriorYear', window );">Additions prior year</a></td>
<td class="num">(220)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="num">(109)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfCurrentYear', window );">Additions current year</a></td>
<td class="nump">20,001<span></span>
</td>
<td class="nump">19,052<span></span>
</td>
<td class="nump">18,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInOffsetAgainstGrossTradeReceivables', window );">Changes in offset against gross trade receivables</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="num">(252)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="nump">5,595<span></span>
</td>
<td class="nump">5,262<span></span>
</td>
<td class="nump">4,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PlansAndProgramRebatesAxis=nvs_USspecificHealthcarePlansAndProgramRebatesMember', window );">US-specific healthcare plans and program rebates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">1,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments/utilizations</a></td>
<td class="num">(5,183)<span></span>
</td>
<td class="num">(4,158)<span></span>
</td>
<td class="num">(3,684)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfPriorYear', window );">Additions prior year</a></td>
<td class="num">(193)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfCurrentYear', window );">Additions current year</a></td>
<td class="nump">5,474<span></span>
</td>
<td class="nump">4,541<span></span>
</td>
<td class="nump">3,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="nump">1,981<span></span>
</td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PlansAndProgramRebatesAxis=nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember', window );">Non-US-specific healthcare plans and program rebates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Effects of currency translation and business combinations</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments/utilizations</a></td>
<td class="num">(2,467)<span></span>
</td>
<td class="num">(2,182)<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfPriorYear', window );">Additions prior year</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfCurrentYear', window );">Additions current year</a></td>
<td class="nump">2,659<span></span>
</td>
<td class="nump">2,555<span></span>
</td>
<td class="nump">2,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInOffsetAgainstGrossTradeReceivables', window );">Changes in offset against gross trade receivables</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(109)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="nump">1,769<span></span>
</td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PlansAndProgramRebatesAxis=nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember', window );">Non-healthcare plans and program-related rebates, returns and other deductions [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
<td class="nump">1,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Effects of currency translation and business combinations</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Payments/utilizations</a></td>
<td class="num">(11,698)<span></span>
</td>
<td class="num">(12,227)<span></span>
</td>
<td class="num">(11,814)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfPriorYear', window );">Additions prior year</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfCurrentYear', window );">Additions current year</a></td>
<td class="nump">11,868<span></span>
</td>
<td class="nump">11,956<span></span>
</td>
<td class="nump">12,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInOffsetAgainstGrossTradeReceivables', window );">Changes in offset against gross trade receivables</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">441<span></span>
</td>
<td class="num">(145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">1,754<span></span>
</td>
<td class="nump">1,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncomeStatementAdjustmentsOfCurrentYear', window );">Additions current year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,248<span></span>
</td>
<td class="nump">17,772<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="num">(194)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | US-specific healthcare plans and program rebates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Non-US-specific healthcare plans and program rebates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Non-healthcare plans and program-related rebates, returns and other deductions [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForDeductionsFromRevenueRollForward', window );"><strong>Provisions for deductions from revenue [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at beginning of period</a></td>
<td class="num">$ (166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue, at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (166)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRefundsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current provision for refunds. [Refer: Refunds provision]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Section Example 4 Refunds policy<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex4_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 87<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRefundsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AcquisitionsThroughBusinessCombinationsOtherProvisionsAndIncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangesInOffsetAgainstGrossTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangesInOffsetAgainstGrossTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncomeStatementAdjustmentsOfCurrentYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncomeStatementAdjustmentsOfCurrentYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncomeStatementAdjustmentsOfPriorYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncomeStatementAdjustmentsOfPriorYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsForDeductionsFromRevenueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsForDeductionsFromRevenueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PlansAndProgramRebatesAxis=nvs_USspecificHealthcarePlansAndProgramRebatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PlansAndProgramRebatesAxis=nvs_USspecificHealthcarePlansAndProgramRebatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PlansAndProgramRebatesAxis=nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PlansAndProgramRebatesAxis=nvs_NonUSspecificHealthcarePlansAndProgramRebatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PlansAndProgramRebatesAxis=nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PlansAndProgramRebatesAxis=nvs_NonhealthcarePlansAndProgramrelatedRebatesReturnsAndOtherDeductionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>209
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839083072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events subsequent to the December 31 consolidated balance sheet date<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events subsequent to the December 31 consolidated balance sheet date</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">31. Events subsequent to the December 31, 2019, consolidated balance sheet date</div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Significant transaction closed in January 2020</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 23, 2019, Novartis entered into an agreement and plan of merger with The Medicines Company, New Jersey, USA. The transaction was completed on January 6, 2020. For details see Note 2, significant transaction entered into in 2019 and closed in 2020. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Increase in current financial debts</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 7, 2020, Novartis borrowed USD 7 billion under a short-term credit facility with a syndicate of banks. For additional information, see Note 29. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Dividend proposal for 2019 and approval of&nbsp;the Group&#x2019;s 2019 consolidated financial statements</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 28, 2020, the Novartis AG Board of Directors proposed the acceptance of the 2019 consolidated financial statements of the Novartis Group for approval by the Annual General Meeting on February 28, 2020. Furthermore, also on January 28, 2020, the Board proposed a dividend of CHF&nbsp;2.95 per share to be approved at the Annual General Meeting on February 28, 2020. If approved, total dividend payments would amount to approximately USD&nbsp;7.0 billion (2018: USD&nbsp;6.6 billion), using the CHF/USD December 31, 2019, exchange rate. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; "></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>210
<FILENAME>R158.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6871720992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions of businesses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems', window );"><strong>Amounts recognised as of acquisition date for each major class of assets acquired and liabilities assumed [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Currently marketed products</a></td>
<td class="nump">3,550<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Acquired research and development</a></td>
<td class="nump">342<span></span>
</td>
<td class="nump">10,224<span></span>
</td>
<td class="nump">$ 1,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Other intangible assets</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate', window );">Deferred tax assets</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialAndOtherAssets', window );">Financial and other assets</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate', window );">Trade receivables and other current assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate', window );">Deferred tax liabilities</a></td>
<td class="num">(107)<span></span>
</td>
<td class="num">(2,874)<span></span>
</td>
<td class="num">(325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Current and non-current financial debts</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TradePayablesAndOtherLiabilities', window );">Trade payables and other liabilities</a></td>
<td class="num">(178)<span></span>
</td>
<td class="num">(627)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IdentifiableAssetsAcquired', window );">Net identifiable assets acquired</a></td>
<td class="nump">3,938<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AcquiredCashAndCashEquivalents', window );">Acquired cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,112)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate', window );">Non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">4,084<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net assets recognized as a result of business combinations</a></td>
<td class="nump">4,124<span></span>
</td>
<td class="nump">13,946<span></span>
</td>
<td class="nump">999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillExpectedDeductibleForTaxPurposes', window );">Goodwill expected to be deductible for tax purposes</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax assets acquired in a business combination. [Refer: Deferred tax assets; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for deferred tax liabilities assumed in a business combination. [Refer: Deferred tax liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillExpectedDeductibleForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill in a business combination that is expected to be deductible for tax purposes. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_k&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillExpectedDeductibleForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-controlling interest in the acquiree recognised at the acquisition date for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_o_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterestInAcquireeRecognisedAtAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AcquiredCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AcquiredCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AcquiredResearchAndDevelopmentIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AmountsRecognisedAsOfAcquisitionDateForEachMajorClassOfAssetsAcquiredAndLiabilitiesAssumedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentlyMarketedProductsIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IdentifiableAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IdentifiableAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TradePayablesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TradePayablesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TradeReceivablesAndOtherCurrentAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>211
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865436640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segmentation of key figures</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">3. Segmentation of key figures 2019, 2018 and 2017</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The businesses of Novartis are divided operationally on a worldwide basis into two identified reporting segments: Innovative Medicines and Sandoz. In addition, we separately report Corporate activities. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Reporting segments are presented in a manner consistent with the internal reporting to the chief operating decision-maker, which is the Executive Committee of Novartis. The reporting segments are managed separately because they each research, develop, manufacture, distribute and sell distinct products that require differing marketing strategies. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Executive Committee of Novartis is responsible for allocating resources and assessing the performance of the reporting segments. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The reporting segments are as follows:</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Innovative Medicines researches, develops, manufactures, distributes and sells patented prescription medicines. The Innovative Medicines Division is organized into two global business units: Novartis Oncology and Novartis Pharmaceuticals. Novartis Oncology consists of the global business franchise Oncology, and Novartis Pharmaceuticals consists of the global business franchises Ophthalmology; Neuroscience; Immunology, Hepatology and Dermatology; Respiratory; Cardiovascular, Renal and Metabolism; and Established Medicines. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Sandoz develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. Sandoz is organized globally into three franchises: Retail Generics, Anti-Infectives and Biopharmaceuticals. In Retail Generics, Sandoz develops, manufactures and markets active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a broad range of therapeutic areas, as well as finished dosage form of anti-infectives sold to third parties. In Anti-Infectives, Sandoz manufactures and supplies active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by Retail Generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products, including biosimilars, and provides biotechnology manufacturing services to other companies. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Income and expenses relating to Corporate include the costs of the Group headquarters and those of corporate coordination functions in major countries. In addition, Corporate includes other items of income and expense that are not attributable to specific segments, such as certain revenues from intellectual property rights, certain expenses related to post-employment benefits, environmental remediation liabilities, charitable activities, donations and sponsorships. Usually, no allocation of Corporate items is made to the segments. As a result, Corporate assets and liabilities principally consist of net liquidity (cash and cash equivalents, marketable securities less financial debts), investments in associated companies, and current and deferred taxes and non-segment-specific environmental remediation and post-employment benefit liabilities. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Our divisions are supported by the Novartis Institutes for BioMedical Research, Global Drug Development, Novartis Technical Operations and Novartis Business Services organizations. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Novartis Institutes for BioMedical Research (NIBR) conducts research activities for the Innovative Medicines Division and also collaborates with Sandoz. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Global Drug Development organization oversees all drug development activities for our Innovative Medicines Division and collaborates with our Sandoz Division on development of its biosimilars portfolio. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Novartis Technical Operations organization manages our manufacturing operations across our Innovative Medicines and Sandoz Divisions. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; Novartis Business Services (NBS) is our shared services organization that delivers business support services across the Group, such as information technology, real estate and facility services, procurement, product lifecycle services, human resources, and financial reporting and accounting operations. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Following the February 28, 2019, shareholders&#x2019; approval of the spin-off of the Alcon business (refer to Notes 1, 2 and 30 for further details), the Group reported its consolidated financial statements for the current and prior years as &#x201c;continuing operations&#x201d; and &#x201c;discontinued operations.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Continuing operations comprise the activities of the Innovative Medicines and Sandoz Divisions, and the continuing Corporate activities. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Discontinued operations include the operational results from the Alcon eye care devices business and certain corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders, and certain other expenses related to the Distribution (refer to Notes 1, 2 and 30 for further details). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The accounting policies mentioned in Note 1 are used in the reporting of segment results. Inter-segmental sales are made at amounts that are considered to approximate arm&#x2019;s length transactions. The Executive Committee of Novartis evaluates segmental performance and allocates resources among the segments based on a number of measures, including net sales, operating income and net operating assets. Segment net operating assets consist primarily of property, plant and equipment; right-of-use assets; intangible assets; goodwill; inventories; and trade and other operating receivables less operating liabilities. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; consolidated income statements</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing and discontinued segments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 783</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 741</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 177</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 38&nbsp;497</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;633</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;872</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;498</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;092</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 63</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;179</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10&nbsp;050</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;870</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;334</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;530</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 959</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;425</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29&nbsp;539</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;601</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;252</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;617</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;534</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;369</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;152</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;814</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;402</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;586</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;475</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;749</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;608</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;426</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 551</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;752</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net loss from discontinued operations before gain on <br></br>distribution of Alcon Inc. to Novartis AG shareholders </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;101 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;186 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;732</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in net income from continuing operations are:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 245</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;952</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;075</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;283</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;285</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;482</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;247</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;509</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;315</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;587</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;239</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;101</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;301</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;632</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;506</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;138</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;841</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges and fair value <br></br>changes on financial assets, net </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 18 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 20 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;113 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 38 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;6 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;229</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;395</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;165</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;492</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;521</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;761</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;645</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;67</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;239</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;067</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;918</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing and discontinued segments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 741</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 668</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 177</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;743</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;633</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;946</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;178</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;743</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;381</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;870</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;650</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;530</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 817</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;633</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;415</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;771</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;887</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;452</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;465</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;615</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;814</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;774</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;389</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;027</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 691</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;922</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;475</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;351</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;662</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;595</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;368</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;261</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net (loss)/income from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;703</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in net income from continuing operations are:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;075</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;916</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;285</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;117</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;482</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;303</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;447</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;587</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;624</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;239</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;84</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;73</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;157</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;591</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;841</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;652</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges and fair value <br></br>changes on financial assets, net </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;42 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;113 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;185 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;227 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;395</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;521</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;645</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;593</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;918</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;853</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; consolidated balance sheets</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Alcon<sup>1</sup> </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71&nbsp;225</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 67&nbsp;055</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;468</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;328</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;971</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 30&nbsp;677</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;209</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;332</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;056</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;804</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;377</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;964</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43&nbsp;683</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;48&nbsp;474</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;62&nbsp;819</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;66&nbsp;871</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;692</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;938</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16&nbsp;184</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net operating assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;893</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 53&nbsp;999</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;664</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;951</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 24&nbsp;007</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71&nbsp;489</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 94&nbsp;876</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in assets and liabilities are:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;632</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;098</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;888</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;878</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 549</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 561</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;696</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to property, plant <br></br>and equipment <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;114 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 822 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 217 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 294 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 519 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 143 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 139 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;474 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;774 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total right-of-use assets <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 136</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;677</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to right-of-use assets <sup style="white-space: nowrap">&nbsp;2, 3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 454</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total goodwill and intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44&nbsp;593</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;892</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;712</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;578</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55&nbsp;311</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74&nbsp;013</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to goodwill and <br></br>intangible assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 647 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;265 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 68 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 196 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 52 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 767 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;592 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total investment in associated <br></br>companies </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 128 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 81 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 7 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 8&nbsp;509 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 8&nbsp;264 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 8&nbsp;644 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 8&nbsp;352 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to investment in associated <br></br>companies </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 44 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 18 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 11 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 11 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 55 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 29 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents, marketable securities, <br></br>commodities, time deposits and derivative <br></br>financial instruments </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 11&nbsp;446 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 15&nbsp;964 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 11&nbsp;446 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 15&nbsp;964 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative <br></br>financial instruments </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 27&nbsp;384 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 32&nbsp;148 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 27&nbsp;384 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 32&nbsp;148 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current income tax and deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;513</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;513</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Excluding the impact of business combinations. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Total right-of-use assets and additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows countries that accounted for more than 5% of at least one of the respective Group totals, as well as regional information for net sales for the years ended December 31, 2019, 2018 and 2017, and for selected non-current assets for the years ended December 31, 2019 and 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="11" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Net sales<sup>1</sup></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total of selected non-current assets<sup>2</sup></div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="11" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div> </td> <td></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Country</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 795</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33&nbsp;032</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41&nbsp;972</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;280</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;618</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;893</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39&nbsp;082</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">France</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;442</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;289</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;976</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Germany</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;972</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;484</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;554</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japan</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;575</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;617</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 309</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 144</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;099</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;286</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;033</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;763</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77&nbsp;701</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Region</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;259</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;760</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 59</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 55&nbsp;913</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Americas</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19&nbsp;713</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;032</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;485</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29&nbsp;389</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39&nbsp;082</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;799</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;460</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;093</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;209</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;066</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77&nbsp;701</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales from operations by location of third-party customer </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies, and in 2019 right-of-use assets recognized with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s largest, second-largest and third-largest customers account for approximately 23%, 17% and 10% of net sales, respectively (2018: 18%, 14% and 8%, respectively; 2017: 19%, 14% and 7%, respectively). All segments had sales to these customers in 2019, 2018 and 2017. No other customer accounted for 6% or more of net sales in any year. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The highest amounts of trade receivables outstanding were for these same three customers and amounted to 14%, 12% and 7%, respectively, of the trade receivables at December 31, 2019 (2018: 12%, 10% and 6%, respectively). </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; net sales by region</font> <font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 <br></br> to 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 <br></br> to 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;818</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;296</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;127</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;789</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;864</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;857</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;458</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;097</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;702</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;649</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;635</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;573</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;258</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24&nbsp;174</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;634</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;115</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;963</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;633</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;754</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;363</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;391</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 784</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 779</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;111</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;383</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;620</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;626</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;677</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;259</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;760</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;280</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;618</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;799</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;460</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;093</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;433</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;414</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;350</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35&nbsp;684</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33&nbsp;491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31&nbsp;557</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;761</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;260</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;781</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales from operations by location of third-party customer. Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines Division net sales by business franchise</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 to <br></br> 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 to <br></br> 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Oncology</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;880</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;874</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;841</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;585</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;587</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;539</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;556</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;525</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Promacta/Revolade</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;416</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;174</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 867</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Tafinlar</i> + <i>Mekinist</i></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;155</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 873</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;561</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;943</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Jakavi</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 777</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 975</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;099</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;059</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 755</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 828</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 808</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kisqali</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 480</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 235</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lutathera</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 441</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kymriah</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Piqray</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 116</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;190</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;139</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 887</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Oncology business unit</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;428</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;274</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ophthalmology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;046</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;888</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Travoprost Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 433</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 517</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 589</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Xiidra</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 192</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Beovu</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;030</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;995</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;144</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Ophthalmology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;776</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;558</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;621</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Immunology, Hepatology and Dermatology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cosentyx</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;551</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;837</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;071</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ilaris</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 671</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 554</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 402</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Immunology, Hepatology and Dermatology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;222</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;392</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Neuroscience</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;223</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zolgensma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 361</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Aimovig</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Mayzent</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Neuroscience</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;773</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;429</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 to <br></br> 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 to <br></br> 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Respiratory</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;173</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;039</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 920</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ultibro Breezhaler</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 427</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 454</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 411</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Seebri Breezhaler</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Onbrez Breezhaler</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 101</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Respiratory</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;767</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;617</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cardiovascular, Renal and Metabolism</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Entresto</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;726</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;028</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 507</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 103</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Cardiovascular, Renal and Metabolism</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;050</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 67</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Established Medicines</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;284</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;064</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 957</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;025</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 960</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 485</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 464</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 414</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Neoral/Sandimmun(e)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 419</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 463</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Voltaren/Cataflam</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 417</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 465</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;587</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;964</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Established Medicines</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;998</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;268</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;481</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Pharmaceuticals business unit</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;344</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;464</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20&nbsp;004</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division net sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division product net sales &ndash; 2019</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Brands </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Business franchise </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Indication </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> US <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> world <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Total <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td width="21%" height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Cosentyx </div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing <br></br> spondylitis and psoriatic arthritis </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2&nbsp;220 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;331 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 3&nbsp;551 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;736</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;223</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;086</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 804</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;076</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;880</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Entresto </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal <br></br> and Metabolism </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Chronic heart failure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 925 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 801 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;726 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 881</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 704</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;585</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;539</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Promacta/Revolade </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP), <br></br> severe aplastic anemia (SAA) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 691 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 725 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;416 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br><i>Tafinlar</i> + <i>Mekinist</i> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and <br></br> adjuvant melanoma; advanced <br></br> non-small cell lung cancer (NSCLC) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 481 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 857 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 1&nbsp;338 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;297</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 334</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 929</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;263</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Respiratory </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA) <br></br> and Chronic Spontaneous Urticaria <br></br> (CSU) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 1&nbsp;173 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 1&nbsp;173 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Jakavi </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF), <br></br> polycytomia vera (PV) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;114 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;114 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 978</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;064</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;012</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;025</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 450</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 525</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 975</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 423</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 755</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Ilaris </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS, <br></br> TRAPS, HIDS/MKD, FMF, SJIA, <br></br> AOSD and gout) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 304 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 367 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 671 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 316</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 485</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kisqali</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HR+/HER2- metastatic breast cancer</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 480</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;679</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;967</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;646</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;958</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;068</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;789</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;925</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division produ</font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">ct net sales &ndash; 2018</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Brands </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Business franchise </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Indication </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> US <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> world <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Total <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td width="21%" height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;765</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;576</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;341</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Cosentyx </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing <br></br> spondylitis and psoriatic arthritis </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;674 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;163 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 2&nbsp;837 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;046</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;046</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 806</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;068</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;874</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 817</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 770</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;587</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 440</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;121</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;561</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 929</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;556</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;284</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;284</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Promacta/Revolade </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP), <br></br> severe aplastic anemia (SAA) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 581 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 593 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 1&nbsp;174 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br><i>Tafinlar</i> + <i>Mekinist</i> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and <br></br> adjuvant melanoma; advanced <br></br> non-small cell lung cancer (NSCLC) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 457 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 698 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 1&nbsp;155 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 521</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 578</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;099</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Respiratory </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA) <br></br> and Chronic Spontaneous Urticaria <br></br> (CSU) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 1&nbsp;039 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 1&nbsp;039 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Entresto </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal <br></br> and Metabolism </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Chronic heart failure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 556 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 472 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 1&nbsp;028 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 939</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;002</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Jakavi </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF), <br></br> polycytomia vera (PV) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 977 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 977 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 404</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 828</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Ilaris </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS, <br></br> TRAPS, HIDS/MKD, FMF, SJIA, <br></br> AOSD and gout) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 262 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 292 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 554 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br>Travoprost Group </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Ophthalmology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated intraocular <br></br> pressure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 194 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 323 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 517 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 464</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;654</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;292</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;946</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;210</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;736</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;946</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;864</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;028</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division product net sales &ndash; 2017</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Brands </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Business franchise </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Indication </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> US <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> world <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Total <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td width="21%" height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;709</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;476</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;185</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Cosentyx </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing <br></br> spondylitis and psoriatic arthritis </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;275 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 796 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 2&nbsp;071 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;316</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;943</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;888</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;888</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 810</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;841</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 832</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;612</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 819</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 706</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;525</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 515</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 544</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;059</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 932</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 960</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 87</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 870</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 957</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Respiratory </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA) <br></br> and Chronic Spontaneous Urticaria <br></br> (CSU) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 920 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 920 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br><i>Tafinlar</i> + <i>Mekinist</i> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and <br></br> adjuvant melanoma; advanced <br></br> non-small cell lung cancer (NSCLC) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 339 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 534 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 873 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Promacta/Revolade </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP), <br></br> severe aplastic anemia (SAA) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 446 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 421 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 867 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 407</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 401</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 808</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Jakavi </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF), <br></br> polycytomia vera (PV) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 777 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 777 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br>Travoprost Group </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Ophthalmology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated <br></br> intraocular pressure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 216 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 373 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 589 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Entresto </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal <br></br> and Metabolism </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Chronic heart failure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 297 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 210 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 507 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Neoral/Sandimmun(e) </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Transplantation </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 38 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 450 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 488 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Voltaren/Cataflam</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Inflammation/pain</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 465</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 465</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;123</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 24&nbsp;568</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;412</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;298</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;710</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;857</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;421</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Sandoz Division net sales by business franchise</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 to <br></br> 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 to <br></br> 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Retail Generics <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;590</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;880</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;409</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Biopharmaceuticals</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;607</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;436</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Anti-Infectives</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 534</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 543</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 516</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division net sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Of which USD 784 million (2018: USD 826 million; 2017: USD 880 million) represents anti-infectives sold under the Sandoz name </div> </td> </tr> </table> </div> <div style="padding-bottom:10px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The product portfolio of Sandoz is widely spread in 2019, 2018 and 2017.</div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; other revenue</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Profit-sharing income</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 732</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 734</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 877</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Royalty income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 188</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Milestone income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 201</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 128</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 231</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;092</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 63</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;179</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Profit-sharing income</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 648</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 877</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 652</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Royalty income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 298</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Milestone income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 128</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>212
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865370304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in consolidated statements of comprehensive income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAbstract', window );"><strong>Comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock', window );">Changes in consolidated statements of comprehensive income</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">8. Changes in consolidated statements of&nbsp;comprehensive income</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated statements of comprehensive income include the Group&#x2019;s net income for the year as well as all other valuation adjustments recorded in the Group&#x2019;s consolidated balance sheet but that under IFRS are not recorded in the consolidated income statement. These include fair value adjustments to financial instruments, actuarial gains or losses on defined benefit pension and other post-employment plans, and currency translation effects, net of tax. </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes these value adjustments and currency translation effects attributable to Novartis shareholders: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on marketable <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on equity <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Actuarial <br></br> gains/(losses) <br></br> from defined <br></br> benefit plans </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Cumulative <br></br> currency <br></br> translation <br></br> effects </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total value <br></br> adjustments </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at January 1, 2017</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 349</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;915</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;642</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;212</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 50</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial losses from defined benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;971</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;872</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2017, as previously reported</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;064</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;340</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 9 on retained <br></br>earnings and OCI <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to presentation required under IFRS 9 <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated value adjustments at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;064</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;517</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial gains from defined benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 320</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 320</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 415</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 65</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;423</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 744</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;452</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial gains from defined benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 398</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;208</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 99</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;919</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;657</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 1 provides additional disclosures related to the impact of adoption of IFRS 9 Financial Instruments. OCI: other comprehensive income </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">8.1) The 2019, 2018 and 2017 changes in the fair value of financial instruments were as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on equity <br></br> securities <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 208</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 227</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Debt securities sold</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred <br></br>to the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains reclassified to the retained earnings:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;140</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 99</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on marketable <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on equity <br></br> securities <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2018, as previously reported</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 9 on retained earnings and <br></br>other comprehensive income <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to presentation required under IFRS 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated fair value adjustments at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 218</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred <br></br>to the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains reclassified to the retained earnings:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 227</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 1 provides aditional disclosures on the impact of adoption of IFRS 9 Financial Instruments. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on marketable <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2017</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 349</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 345</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Available-for-sale marketable securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Available-for-sale financial investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains transferred to the consolidated income statement:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;109</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;109</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred <br></br>to the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impaired financial assets transferred to the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 50</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Included is a USD 18 million impact related to the revaluation of deferred tax liabilities on available-for-sale financial investments held in the US that were previously recognized through other comprehensive income related to continuing operrations. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">8.2) In 2019, cumulative currency translation gains of USD&nbsp;129 million were recycled through the income statement mainly as a result of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders. See Notes 2 and 30. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, cumulative currency translation losses of USD&nbsp;946 million were recycled through the income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. See Notes 2 and 4. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">No currency translation losses or gains were recycled through the income statement in 2017. </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">8.3) Remeasurements from defined benefit plans arise as follows:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Defined benefit pension plans before tax</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;119</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;482</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;367</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other post-employment benefit plans before tax</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxation on above items <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;313</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total after tax</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;467</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 851</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 851</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Included in 2019 is a USD -358 million impact related to the revaluation of deferred tax assets on Swiss post-employment benefits that were previously recognized through other comprehensive income. This revaluation resulted from the Swiss tax reforms enacted by the voters in 2019. Refer to Note 12 for additional disclosures. <br></br>Included in 2017 is a USD -272 million impact related to the revaluation of deferred tax assets on US post-employment benefits that were previously recognized through other comprehensive income (continuing operations USD-259 million and discontinued operations USD -13 million). This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>213
<FILENAME>R183.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6840744576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 6) - Recurring fair value measurement [member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">$ (1,250)<span></span>
</td>
<td class="num">$ (975)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Contingent consideration payables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(1,036)<span></span>
</td>
<td class="num">(907)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Other financial liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 of fair value hierarchy [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(1,065)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Contingent consideration payables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">(1,036)<span></span>
</td>
<td class="num">(907)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Other financial liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="num">$ (29)<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=nvs_ContingentConsiderationPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=nvs_ContingentConsiderationPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=nvs_OtherFinancialLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=nvs_OtherFinancialLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=nvs_DerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=nvs_DerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>214
<FILENAME>R173.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6857982336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates (Details 5) - Non-vested shares granted [member]<br> $ / shares in Units, Pure in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of shares at beginning of period</a></td>
<td class="nump">25.7<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement at beginning of period | $ / shares</a></td>
<td class="nump">$ 77.1<span></span>
</td>
<td class="nump">$ 80.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue', window );">Fair value at grante date at beginning of period | $</a></td>
<td class="nump">$ 1,981<span></span>
</td>
<td class="nump">$ 1,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Vested, number of shares</a></td>
<td class="num">(13.3)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 80.3<span></span>
</td>
<td class="nump">$ 90.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue', window );">Vested, fair value at grante date | $</a></td>
<td class="num">$ (1,068)<span></span>
</td>
<td class="num">$ (965)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Forfeited, number of shares</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments forfeited in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 76.3<span></span>
</td>
<td class="nump">$ 76.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue', window );">Forfeited, fair value at grante date | $</a></td>
<td class="num">$ (328)<span></span>
</td>
<td class="num">$ (145)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Number of shares at end of period</a></td>
<td class="nump">25.8<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement at end of period | $ / shares</a></td>
<td class="nump">$ 71.1<span></span>
</td>
<td class="nump">$ 77.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue', window );">Fair value at grante date at end of period | $</a></td>
<td class="nump">$ 1,835<span></span>
</td>
<td class="nump">$ 1,981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Annual incentive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 78.4<span></span>
</td>
<td class="nump">$ 83.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Share savings plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">4.2<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 83.0<span></span>
</td>
<td class="nump">$ 84.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Select North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 64.0<span></span>
</td>
<td class="nump">$ 77.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 339<span></span>
</td>
<td class="nump">$ 303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Select outside North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 67.4<span></span>
</td>
<td class="nump">$ 79.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Long-Term Performance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 68.9<span></span>
</td>
<td class="nump">$ 85.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Long-Term Relative Performance Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 52.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember', window );">Other share awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward', window );"><strong>Schedule of unvested restricted stock units [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted, number of shares</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of other equity instruments granted in share-based payment arrangement | $ / shares</a></td>
<td class="nump">$ 67.7<span></span>
</td>
<td class="nump">$ 77.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue', window );">Granted, fair value at grante date | $</a></td>
<td class="nump">$ 129<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsForfeitedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsGrantedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsNonVestedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SharebasedCompensationArrangementByOtherEquityInstrumentsVestedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NonvestingAxis=nvs_NonvestedSharesGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationAnnualIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationAnnualIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationShareSavingsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationShareSavingsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermPerformancePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermPerformancePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationLongTermRelativePerformancePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationOtherShareAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationOtherShareAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>215
<FILENAME>R177.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836931072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and contingencies (Details 2)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">$ 4,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_UncalledCapitalCommitmentsForInvestmentsInFunds', window );">Uncalled capital commitments for investments in funds</a></td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Not later than one year</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Later than one year and not later than two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Later than two years and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Later than three years and not later than four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Later than four years and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems', window );"><strong>Schedule for commitments under research and development and other intangible asset purchase [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentsUnderLongtermResearchAgreements', window );">Commitments under long-term research and development agreements</a></td>
<td class="nump">$ 1,943<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CommitmentsUnderLongtermResearchAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CommitmentsUnderLongtermResearchAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleForCommitmentsUnderResearchAndDevelopmentAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_UncalledCapitalCommitmentsForInvestmentsInFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_UncalledCapitalCommitmentsForInvestmentsInFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>216
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838740304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract', window );"><strong>Disclosure of associates [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Associated companies</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">4. Associated companies</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Net income statement effect</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other comprehensive income effect <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total comprehensive income effect</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG, Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 662</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 526</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 456</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 568</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 601</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 564</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">GlaxoSmithKline Consumer <br></br>Healthcare Holdings Ltd., UK </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 5&nbsp;910 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 629 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;557 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;145 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 5&nbsp;353 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 484 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies related to continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 659</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;482</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 565</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;956</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;071</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="20"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="20"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> In 2018, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 511 million was recycled into the consolidated income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. No Novartis share of other comprehensive income recognized by associated companies, net of taxes was recycled into the consolidated income statement in 2019 and 2017. <b></b> <b></b> </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has a significant investment in Roche Holding AG, Basel (Roche), as well as certain other smaller investments that are accounted for as associated companies. The investment in GlaxoSmithKline Consumer Healthcare Holdings Ltd., Brentford, Middlesex, UK, was divested on June 1, 2018, to GlaxoSmithKline plc, Great Britain. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Balance sheet value</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG, Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;445</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;195</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 199</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 157</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;644</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;352</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Roche Holding AG </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Group&#x2019;s holding in Roche voting shares was 33.3% at December 31, 2019, 2018 and 2017. This investment represents approximately 6.2% of Roche&#x2019;s total outstanding voting and non-voting equity instruments at December 31, 2019, 2018 and 2017. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Since full-year 2019 financial data for Roche is not available when Novartis produces its consolidated financial results, a survey of analyst estimates is used to estimate the Group&#x2019;s share of Roche&#x2019;s net income. Any differences between these estimates and actual results will be adjusted in the Group&#x2019;s 2020 consolidated financial statements when available. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following tables show summarized financial information for Roche, including current values of fair value adjustments made at the time of the acquisition of the shares, for the year ended December 31, 2018, and for the six months ended June 30, 2019 (since full-year 2019 data is not yet available): </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(CHF billions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Current assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-current <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> liabilities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-current <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">December 31, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 53.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25.1</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">June 30, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(CHF billions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Revenue </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Net income </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> comprehen- <br></br> sive income </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> comprehen- <br></br> sive income </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">December 31, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.6</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.5</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">June 30, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">A purchase price allocation was performed on the basis of publicly available information at the time of acquisition of the investment. The December 31, 2019, balance sheet value allocation is as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of Roche&#x2019;s estimated net assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;404</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of reappraised intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 297</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Implicit Novartis goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;939</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current value of share in net identifiable assets <br></br>and goodwill </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 5&nbsp;640 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated equity accounting adjustments and translation effects less dividends received</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;805</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance sheet value</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;445</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The identified intangible assets principally relate to the value of currently marketed products and are amortized on a straight-line basis over their estimated average useful life of 20 years. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2019, dividends received from Roche in relation to the distribution of its 2018 net income amounted to USD&nbsp;460 million (2018: USD 464 million in relation to the distribution of its 2017 net income). </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consolidated income statement effects from applying Novartis accounting principles for this investment in 2019, 2018 and 2017 are as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of Roche's <br></br>estimated current-year <br></br>consolidated net income </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 910 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 799 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 669 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prior-year adjustment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;125</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;67</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of fair value <br></br>adjustments relating to <br></br>intangible assets, net of taxes <br></br>of USD 24 million (2018: USD 40 <br></br>million; 2017: USD 42 million) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;162 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;148 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;146 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Partial release of deferred tax liability recognized</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income effect</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 662</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 526</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 456</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The publicly quoted market value of the Novartis interest in Roche (SIX symbol: RO) at December 31, 2019, was USD&nbsp;16.9 billion (2018: USD&nbsp;12.9 billion). </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">GlaxoSmithKline Consumer Healthcare Holdings&nbsp;Ltd.</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On March 27, 2018, Novartis entered into an agreement with GlaxoSmithKline plc, Great Britain (GSK), to divest its 36.5% stake in GSK Consumer Healthcare Holdings Ltd. (GSK Consumer Healthcare) to GSK for USD 13.0 billion in cash. As a result, Novartis discontinued the use of equity method accounting starting from April 1, 2018. The divestment transaction closed on June 1, 2018, and Novartis realized a pre-tax gain of USD 5.8 billion, recorded in income from associated companies. See Note 2. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">GSK Consumer Healthcare was formed in March 2015 via contribution of businesses from both Novartis and GSK. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At December 31, 2017, Novartis had a 36.5% interest in GSK Consumer Healthcare and had four of 11 seats on the GSK Consumer Healthcare board of directors. Furthermore, Novartis had customary minority rights as well as exit rights at a predefined, market-based pricing mechanism. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2018, dividends received from GSK Consumer Healthcare amounted to USD&nbsp;252 million.</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The consolidated income statement effects from applying Novartis accounting principles for this investment in 2018 and 2017 are as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of <br></br>GSK Consumer Healthcare's <br></br>estimated current-year <br></br>consolidated net income </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> 119 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> 589 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prior-year adjustment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of fair value <br></br>adjustments relating to <br></br>intangible assets and inventory, <br></br>net of taxes of USD 1 million <br></br>(2017: USD 1 million) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;7 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pre-tax gain on divestment of GSK Consumer Healthcare</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;790</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income effect</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;910</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 629</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>217
<FILENAME>R187.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846482992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 10) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContractualInterestOnNoncurrentLiabilities', window );">Contractual interest on non-current liabilities</a></td>
<td class="num">$ (5,434)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liability</a></td>
<td class="num">(1,949)<span></span>
</td>
<td class="num">$ (1,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="num">(5,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationLiabilities', window );">Contingent consideration liabilities</a></td>
<td class="num">(1,036)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContractualInterestOnNoncurrentLiabilities', window );">Contractual interest on non-current liabilities</a></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liability</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="num">(5,222)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationLiabilities', window );">Contingent consideration liabilities</a></td>
<td class="num">(62)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContractualInterestOnNoncurrentLiabilities', window );">Contractual interest on non-current liabilities</a></td>
<td class="num">(428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liability</a></td>
<td class="num">(181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationLiabilities', window );">Contingent consideration liabilities</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContractualInterestOnNoncurrentLiabilities', window );">Contractual interest on non-current liabilities</a></td>
<td class="num">(1,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liability</a></td>
<td class="num">(622)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationLiabilities', window );">Contingent consideration liabilities</a></td>
<td class="num">(582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContractualInterestOnNoncurrentLiabilities', window );">Contractual interest on non-current liabilities</a></td>
<td class="num">(3,439)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liability</a></td>
<td class="num">(1,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationLiabilities', window );">Contingent consideration liabilities</a></td>
<td class="num">$ (383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ContingentConsiderationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ContingentConsiderationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ContractualInterestOnNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ContractualInterestOnNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>218
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865412832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred tax assets and liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract', window );"><strong>Disclosure of Deferred Tax Assets and Liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Deferred tax assets and liablities</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">12. Deferred tax assets and liabilities </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Property, <br></br> plant and <br></br> equipment </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Intangible <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pensions and <br></br> other benefit <br></br> obligations <br></br> of associates </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Inventories </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Tax loss <br></br> carry- <br></br> forwards </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Other assets, <br></br> provisions <br></br> and accruals </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax assets at January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 191</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;233</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;188</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;722</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;175</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;782</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax liabilities at January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;384</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;558</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">At January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net deferred tax balance related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;403</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;123</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;217</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 858</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Credited/(charged) to income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 605</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 308</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;818</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 298</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;166</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;83</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;313</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;289</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;282</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 787</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;271</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax assets at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;469</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;078</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;446</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 255</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;596</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;952</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax liabilities at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;390</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;610</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;325</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;910</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;282</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2&nbsp;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 787</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;271</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;909</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;867</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax assets at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 137</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;090</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;786</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 97</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;380</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross deferred tax liabilities at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;613</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2&nbsp;985</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;254</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;455</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;319</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;476</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;331</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;061</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">At January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;476</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;331</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;061</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net deferred tax balance related to disposal group held for sale</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Credited/(charged) to income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 378</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;86</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;113</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 368</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 582</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to equity</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Charged to other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;874</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 298</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;493</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other movements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;51</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax assets at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 191</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;722</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;175</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;782</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gross deferred tax liabilities at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;384</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;558</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;431</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 915</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;248</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">After offsetting the following amount of deferred tax assets and liabilities within the same tax jurisdiction, the balance amounts to: </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;699</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;475</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net deferred tax balance at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. <b> </b> </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Includes USD 3 million net deferred tax movement related to disposal group held for sale </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table presents deferred tax assets and deferred tax liabilities, which are expected to have an impact on current taxes payable after more than 12&nbsp;months: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected to have an impact on current tax payable after more than 12 months</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Deferred tax assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.9</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For unremitted earnings retained by consolidated entities for reinvestment, no provision is made for income taxes that would be payable upon the distribution of these earnings. If these earnings were remitted, an income tax charge could result based on the tax statutes currently in effect. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unremitted earnings that have been retained <br></br>by consolidated entities for reinvestment </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 61 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 73 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Temporary differences on which no deferred tax has been provided as they are permanent in nature related to: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investments in subsidiaries</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill from acquisitions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The gross value of tax-loss carry-forwards that have or have not been capitalized as deferred tax assets, with their expiry dates, is as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Not capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 total</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One year</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Two years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Three years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Four years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 127</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">More than five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 435</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;684</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 648</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;986</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Not capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Capitalized</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 total</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One year</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Two years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Three years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Four years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 70</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 381</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">More than five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 522</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;288</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;810</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 996</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;341</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tax losses carried forward <br></br>that expired </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 9 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 8 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Deferred tax assets related to taxable losses of relevant Group entities are recognized to the extent it is considered probable that future taxable profits will be available against which such losses can be utilized in the foreseeable future. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">The Basel-Stadt cantonal tax reform was approved by voters in February 2019, with parts of the reform retroactively enacted per January 1, 2019. The newly enacted tax rate resulted in a decrease of the blended cantonal and federal tax rate from 22% to 13%. This change impacts the Group&#x2019;s Basel-Stadt-domiciled operating subsidiaries. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Swiss federal tax reform was approved by voters in May 2019. The enactment of the Swiss federal tax reform requires the abolishment of the holding company tax regimes as of January 1, 2020. As a result, the holding company tax rate will increase from the current 8% to 13%, effective January 1, 2020. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The enactment of these Swiss tax reforms required a revaluation of the deferred tax assets and liabilities to the newly enacted tax rates at the date of enactment. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the impact on the revaluation of deferred assets and liabilities in 2019, as at the respective dates of the enactment of the Swiss tax reforms: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income <br></br> statement <br></br> continuing <br></br> operations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Equity </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax asset <br></br>and liability revaluation </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized <br></br>in consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 234 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 234 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized in other comprehensive income <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;358</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;358</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total revaluation of deferred tax assets and liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 234</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;358</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;124</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Related to post-employment benefits </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">On December 22, 2017, the US enacted tax reform legislation (the Tax Cuts and Jobs Act), which &ndash; among other provisions &ndash; reduced the US corporate tax rate from 35% to 21%, effective January 1, 2018. This required a revaluation of the deferred tax assets and liabilities, and a portion of current tax payables to the newly enacted tax rates at the date of enactment. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The enacted US tax reform legislation includes a provision that requires the US parent company&#x2019;s foreign subsidiaries&#x2019; unremitted earnings to be subject to an immediate toll tax on the qualifying amount of unremitted earnings (the deemed repatriated earnings). Previously, these earnings were taxable upon distribution to the US parent company. The toll tax amount owed is payable, without interest, in installments over an eight-year period through 2024. Certain of the Group&#x2019;s US subsidiaries are the parent company of non-US-domiciled companies, and as a result, USD 70 million of deferred tax liabilities related to these entities&#x2019; unremitted earnings, the majority of which were recognized in 2016, were reclassified to current income tax liabilities at December 31, 2017. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table shows the impact on the revaluation of deferred assets and liabilities, and current income tax liabilities at December 31, 2017: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Income <br></br> statement <br></br> continuing <br></br> operations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Equity </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax asset <br></br>and liability revaluation </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized <br></br>in consolidated income statement <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;440 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;440 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized <br></br>in other comprehensive income <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;254 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;254 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Items previously recognized in retained earnings <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total revaluation of deferred <br></br>tax assets and liabilities </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;440 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;325 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;765 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total revaluation of current tax payables <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total revaluation of deferred tax assets and liabilities, and current income tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;325</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;799</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Items previously recognized in discontinued operations amounted to USD 416 million </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Related to post-employment benefits and available-for-sale financial investments (attributable to continuing operations USD -241 million and attributable to discontinued operations USD -13 million) </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Related to equity-based compensation plans (attributable to continuing operations USD -66 million and attributable to discontinued operations USD -5 million) </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Revaluation of current tax payable attributable to discontinued operations amounted to USD -3 million. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDeferredTaxAssetsAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>219
<FILENAME>R149.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6855380544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions and other current liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract', window );"><strong>Disclosure of provisions and other current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Taxes other than income taxes</a></td>
<td class="nump">$ 471<span></span>
</td>
<td class="nump">$ 528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermRestructuringProvision', window );">Restructuring provisions</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AccrualsClassifiedAsCurrent', window );">Accrued expenses for goods and services received but not invoiced</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccruedRoyaltiesPayableClassifiedAsCurrent', window );">Accruals for royalties</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentInterestPayable', window );">Accrued interests on financial debt</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRefundsProvision', window );">Provisions for deductions from revenue</a></td>
<td class="nump">5,595<span></span>
</td>
<td class="nump">5,262<span></span>
</td>
<td class="nump">$ 4,672<span></span>
</td>
<td class="nump">$ 4,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Accurals for compensation and benefits including social security</a></td>
<td class="nump">2,464<span></span>
</td>
<td class="nump">2,527<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionCurrent', window );">Environmental remediation liabilities</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredIncomeClassifiedAsCurrent', window );">Deferred income</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent', window );">Provisions for product liabilities, governmental investigations and other legal matters</a></td>
<td class="nump">1,169<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011', window );">Accrued share-based payments</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">$ 261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationCurrentPortion', window );">Contingent considerations</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CommitmentForRepurchaseOwnShares', window );">Commitment for repurchase own shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentPayables', window );">Other payables</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialLiabilities', window );">Total provisions and other current liabilities</a></td>
<td class="nump">$ 13,338<span></span>
</td>
<td class="nump">$ 12,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccrualsClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals classified as current. [Refer: Accruals]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccrualsClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentInterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current interest payable. [Refer: Interest payable]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentInterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRefundsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current provision for refunds. [Refer: Refunds provision]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Section Example 4 Refunds policy<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex4_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 87<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRefundsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredIncomeClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred income classified as current. [Refer: Deferred income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredIncomeClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities arising from share-based payment transactions. Share-based payment transactions are transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 51<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_51_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesFromSharebasedPaymentTransactions2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermRestructuringProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current provision for restructuring. [Refer: Restructuring provision]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermRestructuringProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccruedRoyaltiesPayableClassifiedAsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccruedRoyaltiesPayableClassifiedAsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CommitmentForRepurchaseOwnShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CommitmentForRepurchaseOwnShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ContingentConsiderationCurrentPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ContingentConsiderationCurrentPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProductLiabilityGovernmentInvestigationsOtherLegalMattersProvisionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>220
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    " !81CU0LU[R">\    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+!:L,P#(9?9?B>R'%'Z4R:RT9/'0Q6V-C-V&IK&L?&UDCZ]G.R
M-F5L#["CI=^?/H%J':3V$5^B#QC)8KH;7-LEJ<.:'8F"!$CZB$ZE,B>ZW-S[
MZ!3E9SQ 4/JD#@B"\R4X)&44*1B!19B)K*F-ECJB(A\O>*-G?/B,[00S&K!%
MAQTEJ,H*6#-.#.>AK>$&&&&$T:7O IJ9.%7_Q$X=8)?DD.R<ZON^[!=3+N]0
MP?OS]G5:M[!=(M5IS+^2E70.N&;7R6^+QZ?=AC6""U[PJA /.[Z2]TLI5A^C
MZP^_F[#SQN[M/S:^"C8U_+J+Y@M02P,$%     @ 6$8]4)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
MLR+7E$8D19_(+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(
MR-^-B/>K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J
M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1
MCVFS(Z=T)LWH,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.
MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.
M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07
M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!
M_]':-\*K^(+ .7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7
M<LW(QU2ODRG8.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD
M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W
M<DOJMI2^M28X2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-M
MNIW<.CB>F)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(
M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R
M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>
M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X
MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5
MYYN<KGHB=OJ7=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(C
ME1P&%A<RY%#NDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>
MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+
MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y
M,M\Y<-LZW@->YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,
M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:
M,]6+K#F-"F]!U4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_
M 5!+ P04    " !81CU0SUN.7*L"  #H"@  &    'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;'56T8Z;,!#\%<0''-B0A$0D4G)5U4JM%%W5]ME)G 0=8&H[
MR?7O:QM"D7?] MC,['CM'6O+AY#OZLJYCCZ:NE7K^*IUMTH2=;SRAJD7T?'6
M_#D+V3!MAO*2J$YR=G*DIDYHFLZ3AE5MO"G=W%YN2G'3==7RO8S4K6F8_+OC
MM7BL8Q(_)]ZJRU7;B613=NS"?W#]L]M+,TK&**>JX:VJ1!M)?E['6[+:46H)
M#O&KX@\U^8YL*@<AWNW@ZVD=IW9%O.9';4,P\[KS5U[7-I)9QY\A:#QJ6N+T
M^QG]LTO>)'-@BK^*^G=UTM=U7,31B9_9K=9OXO&%#PG-XFC(_AN_\]K [4J,
MQE'4RCVCXTUIT0Q1S%(:]M&_J]:]'_V?_$G#"70@T)% <Y=++^16_HEIMBFE
M>$2RW_R.V3,F*VKVYF@GW5:X?V;QRLS>-VF9W&V8 ;'K$72"(",B,;%' 8H)
M["B@4YR>H>O+'#V;T#.<GJ/TW-'S"3WWTH.(&2XP0P5F@#[W!"!B@0O,48$Y
MH!>> $0L<8$%*K  =.*7 (0$4BA0A0(J$$\!0@(*2U1A"16HIX!  I5$4MPI
M*8S@%Q.&"903"?B1P A^16&8P'81U)1;0F$$OZPP3*"P".Y=DH$(%-PN""9P
MOQ#<X@0ZF/J'CV%"IX_[G$ ;4W#Z""9T^KC9"?0R!:>/8$(JN.,)]#-=^"H(
MI@BHX*XGT--TZ:M 3)8&5'#G$^CKS+]<!LS,8=JA0N:S-"WR(I 3Q>\ "OV=
M^;6&8 +FI/@50*&]L\P7@9B0"'X#4.CNS*]G! ,J+9DT&@V7%]=BJ>@H;JWK
M[R:S8QNW=5U<\A_>]X#?F;Q4K8H.0IMVQS4E9R$T-TM)7\SA74W;.0YJ?M;V
M<V&^9=][]0,MNJ&O3,;F=O,/4$L#!!0    ( %A&/5"+9(@W  4  /@8   8
M    >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL?9G=;N,V$(5?Q?#]6IPA14F!
M8R"R4;1 "P1;M+U6;"8V5K)<28FW;U_J9[WRS# WL:5\0QZ.J#DDO;[6S;?V
MZ%RW^%Z5Y_9Q>>RZRT,4M?NCJXIV55_<V?_GM6ZJHO.7S5O47AI7'(:@JHQ0
M*1M5Q>F\W*R'>\_-9EV_=^7I[)Z;1?M>547S7^[*^OJXA.6/&U]/;\>NOQ%M
MUI?BS?WINK\NSXV_BFZM'$Z5.[>G^KQHW.OC\@D>=CKN P;B[Y.[MK/OBWXH
M+W7]K;_X[?"X5+TB5[I]US=1^(\/MW5EV;?D=?P[-;J\]=D'SK__:/V78?!^
M,"]%Z[9U^<_IT!T?E^ER<7"OQ7O9?:VOO[II0/%R,8W^=_?A2H_W2GP?^[IL
MA[^+_7O;U=74BI=2%=_'S]-Y^+R._TGT%"8'X!2 MP"PGP;H*4#_##"?!I@I
MP)" :!S*D)M=T16;=5-?%\WX>"]%/XO@P?CL[_N;0[*'__GTM/[NQT;'Z^BC
M;V="\A'!&0(W(O*-WWI J8<<6;BV]SUL!22Y1W8"DLHJM#A./<3K>7PFQQLQ
MW@SQ9A9O%,G3B-@!.8](8@S)YE:@3!(#&:Y H0Z-.!85QUPQZ24?D7C62ZR)
M7(ZD2+1RQ&A9J!6%6BZ4=)%;WD5BLI1H%2B3:C*BG4"A3@-3.A$5)UPQZ25/
M6"\ 248$"Q!:\G+L!$AA(,&I*#?E<@V1F[).OH Q2">OB,5 WH2=A&FK Z(S
M473&1=/"E+%NM)=,YLY6H"!.R:/8<0JS) G,"E!R+55<LZ7%5$DIU)9.#9'3
M"="Z*')H;!Q0'G !X,H3JAQX3YE1--T2EAJ6;Q'3:: F@V@M3X!<=DIE(W^R
M2@-5S2FPR$0+5(88T"P;$6BN.:.:-4^.G]K4-B4,K6*J)0QF#GLO6_8_X 88
M4P.<F'E'F4J9:DZE1M$J+5&)"J5:=D#@%DB--@?N7C9F+Z, &9U2R9P"4 '/
M!MD+@9LA+6@Y< ?[DM*'L96H3%/OEJADUM:]9MD-@=LA74;DP%V,K8P$!NCL
MV4D-A6:%[(; [3"F=@C<P=*,+OBV @5&93&5S+$,@E-9=D/@=ABS=3KWL"]^
MS4%7="*&7+6$617P<)0=$;DCQM01D3M8 M1]M@(%F"JZ\I :,UG 55 V0^1F
M&%,S1,&^0%%7$2DVI04*E0E(EHT0N1'&U B1FY>Q66@K)YL7<O.BQ3)';C<F
MSNB[(U!2:C@53HUL7,B-RU+C0FXV?K5.]Z!;"4,+AHKF6)($7QS9NC!F^U4;
M>E2RDR!W$DN=!'GU[\=-EW02YL=-]ZP"]LFX92]![B66>LG$S#?'U$H$A"XP
M!"1@>RC["*;\$86FIES4D1=U2XOZQ"3SD:R /2%.Q2NZ<-B);05\2,L%7?."
M3C>LN>8UF.J=D'3^]JN5HBLJ ;NC[A7+U5SS:FYI-9^8]"Y]+,DB17?2.X'R
M20YIELNY1CZU0BT$CKMXH:9;S'QB[I729[ 5*#]J6JC%MB"PQ=!RI=:\4B>T
M4D_,O!]8L8,@@1*G%\<^F5YRH=9\CY'0/<;$W+^=BNZ+1(IM,@3*3R^ZVX]F
MQ[^5:]Z&H_5VL:_?SUU_BCJ[>SN^?\+^^)C<S^%A-Q["_VQF_$W@CZ)Y.YW;
MQ4O==74U'"&_UG7GO$BU\B*/KCC<+DKWVO5?$_^]&<_BQXNNODR_,T2W'SLV
M_P-02P,$%     @ 6$8]4"%OI(K" P  '!$  !@   !X;"]W;W)K<VAE971S
M+W-H965T,RYX;6R-6%V/FSH0_2N(]Q1L;#Y62:0-4=5*K;1J=6^?V<1)4 &G
MX&S:?U_SL2F9&6_[$L Y,SXS-F?&+*^Z_=Z=E#+>S[IJNI5_,N;\$ 3=[J3J
MHGNGSZJQ_QQT6Q?&/K;'H#NWJM@/1G45\#",@[HH&W^]',:>VO527TQ5-NJI
M];I+71?MKXVJ]'7E,_]UX$MY/)E^(%@OS\51?57FO_-3:Y^"FY=]6:NF*W7C
MM>JP\A_9PY8GO<& ^+]4UVYV[_6A/&O]O7_XN%_Y8<](56IG>A>%O;RH7%55
M[\GR^#$Y]6]S]H;S^U?O[X?@;3#/1:=R77TK]^:T\E/?VZM#<:G,%WW]H*:
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MJ(^,([XI%*,)<_=R2K@=*!!#C#&(<^;:$[3ZL@@S9I!QA,F$*,48M(!"O"5
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M>1K&RR)==Z>W%Z>;H3V>W\PL+J^'EO\#4$L#!!0    ( %A&/5 AJ\E''PH
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MT0>6"8'J43;*@R9D.=D S[:L1 ;FRF4R1.#$'J#0)((M0 7)N!<07?:'0 N
M?.9.#YRM V1KJ8<'JN38KIQENEWA!!P@ 2=[_P;-AO89YG0 4Y]GNMW-'-R!
ME"KE^P"9L*SD*3ICMN9^1Y@D:( **Y?Y>G97,2?,!M8"()^;>$[V 9)]DGM0
M\Z]XL1>ISR+=OG(.#Y##)3T'.)O3[FQ+.YUP.$=VM@#ISA:@P\Y6YA-LP<X6
MNY_Q$HN" *(@V2,Z@:H16B9@3,H$@($SH4ZBSH1S.E F(%ODS.$UE\!B)%#-
M1<)#!83<E;U(?1;I]I4U2*"#.M(1>"Q&X0$/XG1&087HC"J$X4'/X6!&J?OL
MI<BZ)U)YQ J)""=Q(#P8D_  3)T)D#H3( H/L@7.Q.YGG,FJ+-(A(1L>4862
M'$KM1>JS2+>OK+8BU4:D(_!$#,(#,)A1K(S882E$X4&V:$:I^QDOL1",5(F1
M\(!#W!0>B&EXP-ER>WQJ!A X4R$,#SI=GFPU8$'=SQW'9ID:5:;*GB6JA'.N
ME+.3&<P6%89A"\ R==;(LC%2C<@6F:,*OBLIH$Z1&I=V8$!IE  D;\$LB,HM
M)2Q$HPI1J3)'%7*NW=W)O#)FSW@AENS.:@X8.>!<<:H[?I:8D1[8B0-([R5[
MDTR'874OUNTWJ[D(:B[)74OEH$*+FP.YNI_K=IW%721Q9^N7$414C/81TW08
M-B-,=K-H*U29XFQB399(D]D*>0)18Y@9,/9$94UV,G.16/4D4CVV=):@/"1K
MWQ!H!I 51V0G=P0TL3Q*5(R2MV- K1160PV!9@#9D"<[/J-F$JN91&4MNU E
MS?/.EK4&,/5YIMM=U@L)REK)!GFBPE!EZYR#J+J/ZG::I4 "*2#U^J0Y5\OU
M0Z"Z!^KV./,>V)#3S@E2J;<UQND@JNZCNIWFG)OH68\L.IHE9<GI16I [+L:
M<V"N<F]J),[&B;*QK#B0/:V$($:FH)]9$),11HFS=*+'0'8_G.C\LAV2,O8H
MV7DSW5?Y..V6D';M4;K;LO<1T+0?J0&Q[I\#DPF1DO-R2<^(;%R79Q_;G ;4
MS]3GF6YW.>.6E''M0XR2WBT*J92W*9F3DY'$615%C!QGX@M&NXN>$V<K!0LT
MEG$F9_J2,KU='DMXZZG]3WQ)6+"O?=T!IG4+@*XJB0YZD=W+ZQQD"^H6@.7J
M%B7KD)).K-B5^02E/F<2!LY4#)RI$#@3+DC.!%OD3,7$F:-WWP=R^%::?RZW
MWQZ?=A>?-_O]9GW\ I"OF\V^:>V-?VNGY:%9WK]]6#5?]X=?R_;W[>NWP;Q^
MV&^>3]]T,WK[NIV;_P-02P,$%     @ 6$8]4)WDF?A[!@  %B0  !@   !X
M;"]W;W)K<VAE971S+W-H965T-BYX;6Q]FEUOVS84AO^*X7O7.H='$ADD 2H)
MPP9L0-%AV[6:*(E1V_(D)>G^_239=>US7K87]4<>4J\HB@])Z_:][;[V+TTS
M++[MMOO^;ODR#(>;];I_>&EV=?^A/33[\2]/;;>KA_%C][SN#UU3/\Z%=MLU
M)TFVWM6;_?+^=O[N4W=_V[X.V\V^^=0M^M?=KN[^*YIM^WZWI.7W+SYOGE^&
MZ8OU_>VA?F[^;(:_#I^Z\=/Z7,OC9M?L^TV[7W3-T]WR(]U4$J8",_'WIGGO
M+]XOIE/YTK9?IP^_/=XMDRE1LVT>AJF*>GQY:\IFNYUJ&G/\>ZIT>3[F5/#R
M_??:?YE/?CR9+W7?E.WVG\WC\'*W],O%8_-4OVZ'S^W[K\WIA-+EXG3VOS=O
MS7;$IR3C,1[:;3__OWAX[8=V=ZIEC+*KOQU?-_OY]?U4__=BN "?"O"Y &4_
M+>!.!=R/ O+3 G(J(*K ^G@J<]M4]5#?WW;M^Z([7MY#/?4BNI&Q]1^F+^?&
MGO\V-D\_?OMV3WERNWZ;*CHQQ9'A2^9,K,?:SX=@=(B"37&771^A!$A^C50
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MCD^J'#\,[>'T%,[Z_"C0_?]02P,$%     @ 6$8]4 /<QX>T 0  T@,  !@
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MC#Y<;;J &M%#L+*Y"3/4AA<V!PIJ'[?W86_'.1L#C]WTA-C\CHO?4$L#!!0
M   ( %A&/5"&>FTHMP$  -$#   9    >&PO=V]R:W-H965T<R]S:&5E=#$R
M+GAM;'U3[6[;(!1]%<0#E 0G71;9EII.TR:M4M1IZV]B7]NHX.L!CMNW'V#7
MLUIK?X![.>?<#R[I@.;9-@".O&C5VHPVSG5'QFS1@!;V!CMH_4V%1@OG35,S
MVQD0921IQ?AF<\NTD"W-T^@[FSS%WBG9PMD0VVLMS.L)% X9W=(WQZ.L&Q<<
M+$\[4<-/<+^ZL_$6FU5*J:&U$EMBH,KHW?9XV@5\!/R6,-C%F81*+HC/P?A>
M9G03$@(%A0L*PF]7N >E@I!/X\^D2>>0@;@\OZE_C;7[6B["PCVJ)UFZ)J,'
M2DJH1*_<(P[?8*IG3\E4_ ^X@O+PD(F/4:"R<25%;QWJ2<6GHL7+N,LV[L-X
MD^PGVCJ!3P0^$PXQ#AL#Q<R_""?RU.! S-C[3H0GWAZY[TT1G+$5\<XG;[WW
MFN_W*;L&G0ER&B%\ =G.".;%YPA\+<*)?Z GM^O\9#7#)/*3!9_SP[K ;E5@
M%P5V_ROQ(X3SS^]BL$5+-9@Z#I,E!?9M'.2%=Y[7.QZ?Y!]\'/8'86K96G)!
MYQ\VMK]"=.!3V=SX"6K\_YH-!94+QT_^;,8I&PV'W?2!V/R+\[]02P,$%
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MXYO--=-"MC1/8^QH\A1[IV0+1T-LK[4P?PZ@<,CHEEX"#[)N7 BP/.U$#;_
M_>Z.QGML5BFEAM9*;(F!*J.WV_UA%_ 1\"AAL N;A$Y.B,_!^5YF=!,* @6%
M"PK"'V>X Z6"D"_C9=*D<\I 7-H7]?O8N^_E)"S<H7J2I6LR^IF2$BK1*_>
MPS>8^OE$R=3\#SB#\O!0B<]1H++Q2XK>.M23BB]%B]?QE&T\ATG_0ELG\(G
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MU%R"LEPK9* I\.WN>,H"/@(>.8QVM4>ADXO6SR'X7A<X"89 0.6" O/+%>Y
MB"#D;;S,FG@I&8CK_9OZ?>S=]W)A%NZT>.*UZPI\P*B&A@W"/>CQ&\S]?,)H
M;OX'7$%X>'#B:U1:V/A%U6"=EK.*MR+9Z[1R%==Q^K.G,VV;0&<"70B'6(=,
MA:+SK\RQ,C=Z1&8Z^YZ%*]X=J3^;*B3C4<1_WKSUV6M)TT-.KD%HQIPF#%UA
M=@N">/6E!-TJ<:+_T=/]-C_=M)A&?OJ/Q2_; MFF0!8%LK5 EGSH<0OSL4NR
M.E0)IHWC9%&E!Q5'>95=)O8VWB)YAT_C_I.9EBN++MKYJXT7T&CMP%M);OP,
M=?Z%+8& QH7M9[\WTYQ-@=/]_(3(\H[+OU!+ P04    " !81CU08]:[W;0!
M  #3 P  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q]4]%NG# 0_!7+
M'Q#?&9I$)T#*):I:J95.J=H\^V !*S:FMCG2O^_:<(2VJ"_8N\S,SMKK;#3V
MU;4 GKQIU;F<MM[W!\9<V8(6[L;TT.&?VE@M/(:V8:ZW(*I(THKQW>Z6:2$[
M6F0Q=[)%9@:O9 <G2]R@M;"_CJ#,F-,]O2:>9=/ZD&!%UHL&OH'_WI\L1FQ1
MJ:2&SDG3$0MU3A_VAV,:\!'P0\+H5GL2.CD;\QJ"SU5.=\$0*"A]4!"X7. 1
ME I":./GK$F7DH&XWE_5/\;>L9>S</!HU(NL?)O3>THJJ,6@_+,9/\'<SP=*
MYN:_P 44PH,3K%$:Y>*7E(/S1L\J:$6+MVF575S'Z<_=E;9-X#.!+X3[2&!3
MH>C\27A19-:,Q$YGWXMPQ?L#Q[,I0S(>1?R'YAUF+P5/><8N06C&'"<,7V'V
M"X*A^E*";Y4X\G_HR>TV/]FTF$1^\H?%9%L@W11(HT#ZWQZW,.E?1=CJ4#78
M)HZ3(Z49NCC*J^PRL0\\7LH[?!KWK\(VLG/D;#Q>;;R VA@/:&5W@S/4X@M;
M @6U#]L[W-MISJ; FWY^0FQYQ\5O4$L#!!0    ( %A&/5"/%+<MN $  -,#
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;'53[6Z<,!!\%<L/$!\^
M<CF= "F7*&JE1CHE:OO;!PM8\0>US9&\?6Q#*$GI'^Q=9F9G[74V:/-B6P"'
M7J50-L>M<]V!$%NV()F]TATH_Z?61C+G0],0VQE@521)0>AFLR.2<86++.9.
MILAT[P17<#+(]E(R\W8$H8<<)_@C\<2;UH4$*;*.-? ,[F=W,CXBLTK%)2C+
MM4(&ZAS?)H=C&O 1\(O#8!=[%#HY:_T2@N]5CC?!$ @H75!@?KG '0@1A+R-
M/Y,FGDL&XG+_H?X0>_>]G)F%.RU^\\JU.=YC5$'->N&>]/ -IGZN,9J:_P$7
M$!X>G/@:I18V?E'96Z?EI.*M2/8ZKES%=1C_[)*)MDZ@$X'.A'VL0\9"T?D]
M<ZS(C!Z0&<^^8^&*DP/U9U.&9#R*^,^;MSY[*6AZG9%+$)HPQQ%#%YAD1A"O
M/I>@:R6.]!_Z=K?.WZY:W$;^]I/%_PBDJP)I%$@_"=Q\Z7$-L_]2A"P.58)I
MXCA95.I>Q5%>9.>)O:7Q4O["QW%_9*;ARJ*S=OYJXP746COP5C97?H9:_\+F
M0$#MPO;&[\TX9V/@=#<](3*_X^(=4$L#!!0    ( %A&/5!$ZW\DM@$  -,#
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;'U388^<(!#]*X0?<+BN
MN[UNU.3VFJ9-VF1S3:^?61V5'# 6<+W^^P)ZUK2F7X09WWOS!H9\1/-B.P!'
M7I74MJ"=<_V),5MUH+B]PQZT_].@4=SYT+3,]@9X'4E*LC1)CDQQH6F9Q]S%
ME#D.3@H-%T/LH!0WO\X@<2SHCKXEGD3;N9!@9=[S%KZ!^]Y?C(_8HE(+!=H*
MU,1 4]"'W>F<!7P$/ L8[6I/0B=7Q)<0?*X+F@1#(*%R08'[Y0:/(&40\C9^
MSIIT*1F(Z_V;^L?8N^_ERBT\HOPA:M<5])Z2&AH^2/>$XR>8^SE0,C?_!6X@
M/3PX\34JE#9^2358AVI6\584?YU6H>,Z3G^.V4S;)J0S(5T(][$.FPI%YQ^X
MXV5N<"1F.ON>ARO>G5)_-E5(QJ.(_[QYZ[.W,LW>Y^P6A&;,><*D*\QN03"O
MOI1(MTJ<TW_H^^,V?[]I<1_Y^[7%0[(MD&T*9%$@^V^/&YC#WUVRU:$J,&T<
M)TLJ''0<Y55VF=B'-%[*'_@T[E^Y:86VY(K.7VV\@ ;1@;>2W/D9ZOP+6P()
MC0O;=WYOICF; H?]_(38\H[+WU!+ P04    " !81CU0Y3)^MK8!  #3 P
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MXS=_-M.<38;3_?R%R/*/R[]02P,$%     @ 6$8]4#"B23"U 0  TP,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL?5/1;IPP$/P5RQ\0WQDNC4Z
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MX]7&"RB-\8!65C<X0S6^L"F04/JPO<.]'>9L"+QIQR?$IG><?0!02P,$%
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MM?$":D0'WDIRYV>H]2]L#B34+FP_^+T9YVP,'';3$V+S.R[^ %!+ P04
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M+Z RQ@-:6=W@##7XPJ9 0N7#=H][.\S9$'C3CD^(3>\X_P-02P,$%     @
M6$8]4+@PQ'VX 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL
M;5-A;]L@$/TKB!]0;"?MDLBVU'2:-FF3HD[;/A/[;*,"YP&.NW\_P*YG=?X"
MW''OW;OCR$<T+[8#<.1526T+VCG7GQBS50>*VSOL0?N;!HWBSINF9;8WP.L(
M4I)E2?+ %!>:EGGT74R9X^"DT' QQ Y*<?/G#!+'@J;TS?$LVLX%!ROSGK?P
M'=R/_F*\Q1:66BC05J F!IJ"/J:G\S[$QX"? D:[.I-0R17Q)1A?ZH(F01!(
MJ%Q@X'Z[P1-(&8B\C-\S)UU2!N#Z_,;^*=;N:[ER"T\H?XG:=04]4%)#PP?I
MGG'\#',]]Y3,Q7^%&T@?'I3X'!5*&U=2#=:AFEF\%,5?IUWHN(_3S7TZP[8!
MV0S(%L AYF%3HJC\(W>\S V.Q$R][WEXXO24^=Y4P1E;$>^\>.N]M_)PS-DM
M\,PAYRDD6X6D2P3SY$N&;"O#.?L/OGO8QN\V%>XB?K?"9\?C-L%^DV ?"?9K
M 4GRKL:MF/=5LE5/%9@V3I,E%0XZ3O+*NPSL8Q;?Y%_X-.W?N&F%MN2*SK]L
M['^#Z,!+2>[\"'7^@RV&A,:%XP=_-M.838;#?OY!;/G&Y5]02P,$%     @
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M)+JKM=W JJ9_1^CPF.7_ %!+ P04    " !81CU0=J5 >,8!   V!   &0
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M%$RYWZ <E19\43&E</HQKUWOUFG1O]'\!+(0R(Z 9R-7^3/5M,BDF (YG_U
M[5\<'8DYF](FW5&X;Z9X9;+7(HG2#%^MT((YS1BRP40K AOUU8+X+$[D/WJ<
M^OFQM\38\>,-G\2)7R#Q"B1.(/FGQ_M=CS[,@]_DX#4Y> 0^[4P\&!+Z35*O
M2>H1B'8F/@S9F>#-]> @&S<8*BC%V+NAW&37V7LD[GK]A<^#^XW*INM5<!':
M7%)WE6HA-)A2PCO3<&O>BC5@4&N[O3=[.4_,'&@Q+(\!7E^DX@]02P,$%
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M0I<1<"B,HV!VN<(+<.Z8;!Y_!M)@U'2!T_V-_;,OWA9S9!I>)/]=EZ;*@DU
M2CBQ"S>OLOL"0T'+@ S5?X,K< MWF5B-0G+MGZ2X:"/%P&)3$>R]7^O&K]W
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MO9S'<@ZT&)87AZS/7O$;4$L#!!0    ( %A&/5 9_V#1!0(  #4&   9
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;'55;6^;,!#^*X@?4 ,AY$6 U'2J
M-FF3HD[;/CMP":@VIK8)W;^?;0AE]/(%V\?S<F?C(^V%?%45@/;>.6M4YE=:
MMWM"5%$!I^I!M-"8-V<A.=5F*2]$M1)HZ4B<D2@($L)IW?AYZF)'F:>BTZQN
MX"@]U7%.Y=\#,-%G?NC? B_UI=(V0/*TI1?X"?I7>Y1F12:5LN;0J%HTGH1S
MYC^&^T,86()#_*ZA5[.Y9TLY"?%J%]_*S ]L1L"@T%:"FN$*3\"853)YO(VB
M_N1IB?/Y3?W9%6^*.5$%3X+]J4M=9?[6]THXTX[I%]%_A;&@M>^-U7^'*S #
MMYD8CT(PY9Y>T2DM^*AB4N'T?1CKQHW]J'^CX81H)$0+ AF,7.9?J*9Y*D7O
MR6'S6VK/.-Q'9F\*&W1;X=Z9Y)6)7O-X':;D:H5&S&' 1#/,!X(8]<DBPBP.
MT2?Z*L'Y*S3%E>.O9OPHOB,0HP*Q$XC_JS%:U(AA5KC)&C59(P+QP@3#K'&3
M!#5)$(%D88)A-KC)!C79( +;A0F&V>$F6]1D^UD@"18F&.;.E[=#37:(P/+@
M,<R=@S?=![U" 2*Q/'H4M#Q[,KNU'.3%]2OE%:)K7+.<1:>>^!BY6_\!'QKJ
M#RHO=:.\D]"F=[@;?A9"@\DE>##?865Z^+1@<-9VNC%S.32R8:%%.S9I,OTI
M\G]02P,$%     @ 6$8]4.FI@;W* 0  -@0  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL;53K;ILP%'X5RP]0$P(TC0"IZ31MTB9%G;;]=N  5GUA
MM@G=V\\VE*&$/]@^_B[GV#[DH])OI@.PZ%UP:0K<6=L?"3%5!X*:!]6#=#N-
MTH):M]0M,;T&6@>2X"2.HHP(RB0N\Q [ZS)7@^5,PEDC,PA!]=\3<#46>(<_
M J^L[:P/D#+O:0L_P/[LS]JMR*)2,P'2,"61AJ; S[OC*?7X /C%8#2K.?*5
M7)1Z\XNO=8$CGQ!PJ*Q7H&ZXP@MP[H5<&G]F3;Q8>N)Z_J'^.=3N:KE0 R^*
M_V:U[0I\P*B&A@[<OJKQ"\SUI!C-Q7^#*W ']YDXCTIQ$[ZH&HQ58E9QJ0CZ
M/HU,AG&<=K)DIFT3XID0+X1#\"&34<C\$[6TS+4:D9[.OJ?^BG?'V)U-Y8/A
M*,*>2]ZXZ+5,LBPG5R\T8TX3)EYA=@N"./7%(MZR.,5W]'VVS=]OIK@/_/V*
M'Z?1MD"R*9 $@60E\'2X*?$>DF2/VQ[IID=Z[_%TXW$/2;+#C0=9W9L W887
M:U"E!AFZ915=FN(Y#O?^'SYUU'>J6R8-NBCK7D^XXT8I"RZ5Z,'ETKDF7A8<
M&NNGCVZNIZ<\+:SJYRXERZ^B_ =02P,$%     @ 6$8]4&;IA+/4 0  G00
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M48'4"Z3_]+A:](AA/C!9H28K1&"S,,$P6]QDC9JL$8'=P@3!1"%NLD%--HA
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MT&KMP*>2W/D9ZOT/6PT!K0O'#_YLYCF;#:>'Y0N1]1]7?P%02P,$%     @
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M_FRF.9L,I_OY"Y'E'Y=_ 5!+ P04    " !81CU0N/\>PCP"  !3!P  &0
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MX$N,OM(]ZX%*E"(RD0#.Q.B)V4F8ZU#\5CY_:O0'9QM+'V_/-JYP(RC,IBC
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M9>*%'\R@CBK?72]*M>_ZT]2<-^-^>[SH]&GZ+R&X_J&Q^@=02P,$%     @
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M,1.\1/0Y*:V$\LFI.YH3RKI4F V!*@ZH6%UE%N JQL2L!!/(!O60Y@2J;&&
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M(A7!Q.1"]'7<,!RIB?2;Z)@5F*#KX9IR5:YTW<RXG%(A>KK"BB!9$M2I@L-
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M(#.?C:W_T[V[O)5WD;3/V)1YW?^=;=[JIBS&6MI0BNS'\'DX]I_GL?Z/8KB
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M<6V,X:<VJ7N7;2\7N7MMNJ]1^[T:CN&'BZ8\C3\Q""Z_<UC^#U!+ P04
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M_($9YUPKZ^UM 13%5G$D"-*.'G.'I?$9XQY FHRD.5#R 315#!WRF8L9@W^
MQIF1DDEA:Z:8XG$D'(*P67(YHP  I!F1\QB:BL'&RZGS:B8=(; 3\N 398#]
MB5.#HF5 K8>'0C,[)P!3(=?VP$(8EX%#-G8RCJR,% .%-%.V:@21\GT,315C
MR^/4\T Q:)(;H74L;<T4DS'3KO&'+93'<XJ!0LVD8\M!4(3%".S&@KJQ9HY5
M@<#^*/C\8A#8L 0U+%(,@AJ14,KV!T0%9%@A2NC8H1E[FD">9E<"@#2+;<T
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MAB2DKFH*0LUP.].U8MKX.'8^HADDJ@VD0B+-&!,IDS AB#92GM[3#!@B_(2
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M5)CY^YA)1S+L2 8=(2,IL('2?BO$X$PS#3<#@<15=^,GH&EG2-J+:B*%1)J
M:?U1;,<MP3DI[N<Y=<9<)H)+27Q]3P#,YV*KK#K#PB7,VD322C 3B*8"$$D
MTI%\'S3M#$YR 5D>+&D"I[ETY+G@1!>=H3J2285(O$MUKB.8\S;7D4PJDK*/
MI"?=QK0@B!=4OP'(I[K7&I2$/5:88J2 SI"'P6*.L:8]DA8S@]7,H")YQDQ"
ME',=2(A*5>(NSJA)'+-G?<949&U#&!%(E! !(,,Z@TG-:E++@3R6%A.,]1UA
MQ+1@-2WH, 8=H)!KN8)12IX%'<8HA(<LYB$;6\((0#J,J*5 .H,9S2+M$DD3
MF%UL[@@CY@2K.4&'L8  N5+?$H0*L0YCT6$,EMPYATG(M0@="*I)%8%8-CI,
M9T[360ZL<,#LXCJ$CB/%1X/0<5K!B%=/-D*)(E6G94Z.1-XYS$&N1>0@D).Z
MRZ@E4H<XS&8.B)Q("@"'R<5UB!R'*<$UB!R'U(O+]2T!* FACJ*6.#D10> P
M!;D6@8- 4441@0B_.TQF#@B<2,;C,;?X#H'C,2/X!H'C@72QL5;O"!7J&[?P
M0. 4SX:-*<BW"!P$BG6=!$&$WSTF,P\$3B0SHR=K*1T"QV-*\ T"QP/I(JIT
M!*B2:GWCM;Y)B3"JQPSD6^0- GGUX $0HW>/N<P#>1/)O.@QM_@.>>,Q(_@&
M>>.U<"E)K:D!=6-*J8,(U(UA4U' #!1:U T"Q5J1(9"0^Q<PEP6@;A*9%P.F
MEM"A;@(FA-"@;H+6+:F>\.8 E%7A'X"V,6Q=%--/:-$V")3J61&!F$(-9)46
M:)M$)M: F25T:)N ^2 T:)N@58M753\ 65<KFZ"532(S2,#D$UJ$#0(Q 14P
M0P6@6=@B4\2,$3LT2\1Y'ALT2]1JQ/OZ>8U C,1ZK@,@PBD1<TILD2L(E(@2
MB9AX(E B[#F*F IBAQ*).(%C@Q*)6F-<KCJ?@P,T1EV@ PP;,-G3 =J!"9F(
MN2*FCGN&TS?JS-3W+.MG5=A@<?9&E+UDKD@X>U-']B:<O:DA>Q.H):2H?3"$
MJI=Z%DGG;\XDQ EG<&K)8 22FG$0*!')E7":)Y#FF3!2PFF>.M(\X31/#6F>
M0)H[Y^N* \'$U[7:(NE<M\88,OLDG.^II>H H,O=BW.O46G"'BNR'PRJCLS"
M@)DC=50=";-":J@ZDBXH?*K9>(Y0(=2*->FRPT=+^IPQ#>66L@.!3%UVP)9(
M&#,FM S*CDPD:\8$DSO*CHQI(3>4'5E7%-;D.HP0Y>NI-^O"0W(FLTG&/)1;
M*@\$,C6O(A#;.LZ8T3*H/#)K K-+[J@\,N:$W%!Y9%!YN'I5!(""U-HVZ\HC
M9#(=9>(E:2D]$"C7\P $$0F<,9=EH' R$4D%4TOI4#@%$T)I4#@%:)="2*-@
MTBA 2S!A4S!IE X?6,$Y7'3FZ<%Z]9@Y$MB"D[.@Y"1D4W!REH[D+#@Y2T-R
M%E#Q&U=+5X"24NJ%@:+3<Z^,B.(I.#]+2WXBD.)8!&)D48AO#.1G(=I5#'..
M=62H&.+X,@TY.H(JMY4VH &8MW4=,L*F;BN6L&*(S\RTU"(09>N 0A1;<Q5#
M7&L&U".%-H))Y/1Y<TR)]\LTU"0C:!(L:W5, <S5"TB+$3:)J;!)2PQQG)F6
MJ@2B:DO?'*(,R5(QQ+]F0&52F!//$#>9Z:A-Q! 7F&FH3D;0)%B1?1,SI"(?
M:6$&.FHDE8XQ,RNIZ+348SZ#IKLWZC$^HR9["*PW)+^!+347]H0SCZCTY#?S
M=@)S)[@O8)F *$!A#E!!F48;(3DD'>N"PAR9P$@)AIQ5D&,M.!"HWJU8C*#I
M0\7LL\RX"9V;NM-("B@?*42Q)YC80,6BS&:42(R@8GLRFS@S!1@J=3BMSEG)
MMMX=A+"D=B]&6&5%I.9V0@+0QJE[#E#:FPY0W!Q,/*%B==E1#%.2Q!4J9YMF
M8TP)60!W)8AIU,$2K201S*@5[1%V&=-BZ> )/T%+I^ZX1A55&?P,576(<)W5
M7%<H^1"'J-B>5U.(95. TQ*\B6%TH:?4& +55=X(FDQ93&P18Z= 9Z?N,UJJ
M5,P"4#Q!B4U4G*:Z8NBHV!LQ'>L30JR; AR7()I>!<I;-1TA5*@W*D;49(6;
MEE7$XRG(Y D"JE'%Z+>!0%MLQ5V(8U2<YKEBF XDGE%Q/:*(N#@%F"]!0+7>
M$5T!(U3]QN=B1$U]X+37A)F0WQ,$5*.*J5?H<5LL%L0\*EZS7#%,&!#[J/@>
M643\G )LF#J@'I0RBF\!2.KI:C&BIGOI;*8AOD]!QD_PWANRAZH$!:C"7%Q"
M7*3BD21B,I?X2,7W2")B[13@R 3Q!%HGU3=P#F&FABU&V&0GP[+JG;A !=E
M04B!V%'OZ")49%L10CREXH$DHC,)<96*[Y%$Q.<IP)ZI0QJTVI%D%7LAF-&O
M- 8MBP+E)V()%>0)U2$%J"**7""*OI]*N"X 723L02464PD]NHC8/@6X-4%(
MM>*QBKX02+UK'+0JHF4H,8<*<H>":&J4]F\@5!$VAQ*KJ00@BI@K2XC95$*/
M*"(.4 'N3A!-L%)4BKXU&K9/8YV@6A8ESPPL0BRE@CRE(*9H(4AG*%!/]"$C
M!E6)0!?1\H=85"7VZ")B'!5@"M4QC4#R6+V2!F'U'OQBA$U?)'>,Y(@359 5
M5<<4H(K4!AW8%IT#B:]5(M!&=,6$.%LE]F@C8C@5X#@%,46B1\M&"*OWLA8C
M;+)<1(^W("Y7B4W:"*&4"1*BF'=.B&=6@&FVT**6.&(E]F@CXHF5U**-$A0]
M:NT%PHR:3)/61H6] BK$B"O B0M"BE!Z!1"A:)82FZT =VRQK"XC]EA)/=J(
M&&0EM6BC!%:#]&H:0BESZXB:KADQ64@\N0),N2B@ *5\D1!%&9.X;0689 M=
MVB0N64D]\HCX9"6UR*.D=8^O/7-SB*J/M5J,J*G-E<E+8LT5X,U% 45K1FJR
M0&TQQYD0WZT NVRA93;QRTKNT4;$,2NY11ME+7J\5A@(5;_>O!A1DX R"YH0
MDZX ERXZ8N?]Y:"QVP#%#J<0XL 58)PM=+^<.&<E]P@CXIV5W"*,LE8\UA8U
M&R&8/J5EA$TV7DJDCS/A)V#913%%KQCK1Q&L+5FFC(@C5X"1MECZI!+JR3W*
MB'AII;0HHZ(EC[=Z*PW G--'FA6PF>;I05C$P2O P@MB"E"E]OW-85N&I1CQ
M^@HP^Q;'IF/B]I4>NZ\0OZ^T&'Y'T"18H3[5<8Y@-JO#+@7XAZU)M..$I9"'
M&,04+ NI0UQ@6SRFA/$*4$>.S<C$DBRE1QT1C[  :R^(*5@\4J^ (U306Z0%
MJ".ZUT_,Q(+<Q""@  4""E!,V%CB3+8&J".V=F*),]F:#G5DB4O8 F=O'=#Y
M")K4FE6@WL=4?2$GP"&#L-KG@2BUDCJ[.,CW>=A\/1Z2O+VZ7W][V1V.P[WX
M].TDYH_V<!!P]?DG^; X':?\9S.GXYW_L=Q\?7K97GU>[W;KY]O#8<!?UNO=
ML.^D^67_O#X.RX>W/U;#E]WAUT.QM#F=JGSZ8[=^O3T=&3U[.[?Z[O]02P,$
M%     @ 6$8]4&_>FA!P P  T@\  !D   !X;"]W;W)K<VAE971S+W-H965T
M.#,N>&ULE5?M;ILP%'T5Q ,,?&V^JB12DVC:I$VJ.FW[31,G006<@=-T;S\#
M+B7V=9?\"=@Y]W _N,?<V5DTS^V!<^F]5F7=SOV#E,>[(&@W!U[E[2=QY+7Z
M9R>:*I=JV>R#]MCP?-L;564 81@'55[4_F+6[STTBYDXR;*H^4/CM:>JRIN_
M2UZ*\]PG_MO&8[$_R&XC6,R.^9[_X/+G\:%1JV!DV185K]M"U%[#=W/_GMRM
M:6_0(WX5_-Q.[KTNE"<AGKO%U^W<#SN/>,DWLJ/(U>6%KWA9=DS*CS^:U!^?
MV1E.[]_8/_?!JV">\I:O1/F[V,K#W$]];\MW^:F4C^+\A>N (M_3T7_C+[Q4
M\,X3]8R-*-O^U]N<6BDJS:)<J?+7X5K4_?6L^=_,< /0!C :D/A# ZH-Z+L!
M^]" :0-F& 1#*'UNUKG,%[-&G+UF*.\Q[]XB<L=4]C?=9I_L_C^5GE;MOBPR
MRF;!2T>D,<L! Q,,&1&!8A\? =@CEF"9T_CR"2L$DEQ"U@@DQ;V@:*"TMZ<3
M^R1RA,%0 M83L D!"XU$#9"XA]0#)&$L,H)%4&SJRQ O@@+J"CE"/8XLCU.6
MX00Q2A!?G[,$)4AL#R(S:0B&&)C5QY@+1U+4D=0BH*DCEQE*D%V?"A+BG19>
MD0P49+3""@5%#F<<;4\LBHRZ*-"VOB=P0TKPGB3TFI1@("LE&,@5#][?Q&[P
M;")4EQ1XPY'HAI3@+4?B_\N,QDRU(8DRLV<P5)H:J+5&11-4RD*'2A"\R\DU
M;8Z!,C!]MD%9R!S.X)U.[%;/)H?))07>Z^2&9@>\V<%N4:N,&C,M$(E#\\W&
M4,P\0-<:-2TC(:Z&!EP3P-8$NXP8",Q7#P%EKJ,+<'4!0"@<KR7@Z@(W'/F
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MC^\^<@:^3!+:R'E5S>WP $0YDSP+9)7 ]RXU$5,3<+:'@;E!P-D>_.CNXY9
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M-:'*Z*.3S@<1;H616HQ>DP$3+HQ?DP[F91$U,U.'GP%9U7:1#JF*L"& ,7,
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M2)6JZP2!*AI+/H(""F !YP"R:0(A_:2,3!,(ZR>E9YI0_ 3 O>C<()6(?Q^
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MA17[4D(Z:AIQ201T5%#?#S0I<C^N:CB4^;+ABVR]L,>\!&$K%;"5J$F!RE5
MP2HV%!!F4@$S65CI6R7(I(X@DTJ02>U!)A?1JJU\/7,H\P7-%2&3M**Y$F12
M 3()VA2I7+%"K&)# :$O%50B+*S<JA+Z4D=J$2J!(;6G&N$B6N>?GZ("F6=O
M%-0CI.R-$OI2045"U*) %?Q7$:CH2$!(3@4D9Z&G 1&P4O.(/R)<I8+2A.!H
M%6]\? UXI )%X!?9^MT"';H(RJD Y01-BE1N!QM4,2Y&":6I@-+D[XD(I*DC
MD*822%-[(,U%=-E8OCH]4OGR](J 3\8&*H$T%4":J$&!RM7B@RKJ=PGOJ:"T
M8V%%.Y7PGCI2W%$)?*D]Y1T7T>HD2+_4 %1JSAJ!^HZ4_2"LIX+ZCJ@]@8J:
M,$*$*B!""^/\E?"96D<\#\$S%91P]"U5O9E1L^ &2*23X"H*+KHU,4:W*"BA
M0A50H:#!@"JW)TINX+4"&R0)\*D ^"RLBIH2WE-'>$\EO*?V\)Z+:'VLJ]O]
M V6QW6BU541\)OI2ER"?"I!/U*9 -;E1$EZ+MBGIRD#ERL(JNRFA1W6D=J41
M+M0 %^J/J9J\I5DAJ-]#@V6.V5QD?<RF$1350(U+WZ90Y3@LJ&+O6HQ@K0:P
MUL*JS1DA46T:<#Y&0%0#I2M!FWI/$ZRU^4CE#R%95"NPG=7Y,4*^&B!?48,"
M5<M[;;"*GCI(SH #Z&MA-7J,D*\V0KX:(5^MAWQ=1,T[4=^B0!9<_4 #Y*LI
M*Y-BA'PU0+ZB-@6J=@?/!JK8],0(1&N@I&9A18.,0+0V4E+3"-%J/24U%]&J
ML?R)-U#FC[PQ4%23GWEC!**UKL.EH:I][[Z!*K89R B0:^B :5;PP @?:R-'
M3!O!8PW4RP1M"M:%BMM2!&6Y15ZVBZQY<\;RE""Y!I!<U*;HS9GK>X&*ON$V
M@MH:0&TKJ[Y@A+2U$=+6"&EK/:3M(FI>G[@\13)/S!LB<AGC:82U-<#:@B8%
MJNK]T0NJYH;8<;:@S@_-=8+MVD@Q3R,0K?44\UQ$Z_QSU2BA;&IE6P/E/"/#
M[8Q@NP;*>:(F]:KJ"H$C56*;RHP@P(:.Q:9#,N%V;>1@;"/8KO4<C;V(UDWJ
M#O.",E]HQL#IV/0X+R.DL %2&#4I* OF,'2L8A,0=M8V (HKVV=C[+3M$9[8
MV/'7'3SQNT5TV5:IMOOG-T@V-[QK4D GY\#66HP>NMUED)#*&R2@JG1T9T=X
MHV*C=$1FAVJ/%!LU=JQV3['11;1^&>JV_F"9V_ICJ-@HW?IC[#!O4&P4M2DH
M2=J64-S :]%>DQW5C<[JIAZ!'=8]<EJW$=+9>L[K7D3-$1_..T*9V]EJX,AN
M?L([@:L-P-6@29%*G$%"*K;0:X3!-L!@5[;4:83!MA$&VPB#;3T,M@&V&ARW
MAV7NO#T#!#8]<,\(?VU=_#54><\+^6L:2-+?H4JG;'>.$?[:1OAK(_RU]?#7
M!KAJ?Q @5+G7,0;8Z\#VC1LAKZV+O(8JMW /5;3').2UH0/$J8\GY+6-D-=&
MR&OK(:\-(-7!#TA(Y?8=&>"NZ6EG1K!KZ\*ND:I.SM0A%>-+C6#7!K#KRK:2
M&<&N;02[-H)=6P]V;8"G#NUZ_ :J0OMZVP!T3??B&6&NK8NY1JKJRMG!:['M
M6T:8:T,57UF%:B/,M8TPUT:8:^MAK@W U$'5S0. ;'9O;A0%S+4&MM_%"'-M
M7<PU4OGR7/!:K&B;$>;:T$'K;*NL$>;:1IAK(\RU]3#7!F!J<,8HDH%#1@TP
MU_R442/0M75!UTA5'70-K\7;E'1W +JFV^&-0-<V ET;@:ZM![HV0%/[TT^1
M*KH#"I$JL'JN1I!KZT*NH0HT*+)&;:]Q\_1YOS]N=\?=V]?W^\=/^\W^[N[I
MZOWAZ\/\*;V^^.G5X_[C?(_RZB>]OG$_?R>OMG+Z^<W_+_/V]9?=I_U?=X^?
M;A^>KGXY'(^'^_F!KZ\^'@['_7R3TQ_F+]WG_>[#CW_<[3\>3W\]$;V/MY\^
M__C'\?#E]-'3+_AV>/SU^;;?_@]02P,$%     @ 648]4,&,$A\\"   (38
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M[X:^5E0V\I/_]U"90T+9 )-LLJX4)MFH9)2-A%DV B-H_&O5O!Q$KYGJ0;#
MYFP0+%VIL$&;Q> QF6V]?S@^@G28W3;/N[9[UF3P[NMS3I]4]YA-]OYU]_S3
M\?&;GV9.#T_]L=H_K'>'V=>F;9OM9?>HS7W3M'5RL_J0DNZQ7MV]OMC4]VWW
M9W?XO3\]LW1ZT39/EZ<'LA:O3X5=_0]02P,$%     @ 648]4/J\OU<E P
M7 T  !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULE5?1;ILP%/T5Q'N+
M;6Q#JB12DVC:I$VJ.FU[IHF3H )FX"3=W\\82L&^1.E+P,ZYYYYK+@=[?I'5
M:WT40GEO>5;4"_^H5/D0!/7V*/*DOI>E*/0_>UGEB=+#ZA#49262G0G*LX @
MQ(,\20M_.3=S3]5R+D\J2POQ5'GU*<^3ZM]*9/*R\+'_/O&<'HZJF0B6\S(Y
MB)]"_2J?*CT*>I9=FHNB3F7A56*_\!_QPX:8 (/XG8I+/;CWFE)>I'QM!M]V
M"Q\UBD0FMJJA2/3E+-8BRQHFK>-O1^KW.9O X?T[^Q=3O"[F):G%6F9_TITZ
M+OS8]W9BGYPR]2PO7T57$/.]KOKOXBPR#6^4Z!Q;F=7FU]N>:B7SCD5+R9.W
M]IH6YGKI^-_#X #2!9 ^ /.K 6$7$'X$T*L!M N@5D#0EF+69I.H9#FOY,6K
MVL=;)DT7X0>J5W_;3)K%-O_IY:GU['F)$8OGP;EAZD"K%D2&H!X1:/H^!X%R
MK(@3'O)QAC4 B<:0#0")814A6&EHXL-QI3.8@8(,U##0$0-'UEJU(&Y A0'Q
M09:V6@!#0VO1-RX(8S11,0/U,D@OMO2V(#9(<S>CEEX 0V-BZ05 @V<XDLM!
MN1R2:V59<2<+X\R2"V!FS.JXC0O"*)IHZPC4&T%Z0TM+Y&K!$UEB,$OL9 EG
M#":8@02S3_0]1K!)H%LZOT,-:^7V\UL#($;L9P. Z. !CB5/^!J^I?D[U/7N
M!T 1LQ6[F,F7%8,N^8C)+?W?H<8O0&PK=D$<85LRQ$0G),.6BD-',D5D@@+V
M5$P_TYZPSV'0Z)"]**Y!L1E&]JJX*$ZFY, ^AD$CP[8<UX#N&+,_>A *TXGW
M'\,^A4&C<EY,P*E"%MIZ7!2-IYH&-C3L.IJ6,\4!>QK^C*D1V-3(3:9&7"NZ
MLST>P-@?1P@23LB%#8V AF;;0X?B5^6Z&$<N +'E!H,M9BZJ@]F^U]Y6G@K5
M[-,&L_T1X9$T6U1K?J6/#NU&_X.F/7?\2*I#6M3>BU1Z VRVJ7LIE= 2T;U>
MRZ,^ZO2#3.Q5<QOI^ZK=[[<#)<ON+!/T!ZKE?U!+ P04    " !91CU08RM&
M$  "  #S!0  &0   'AL+W=O<FMS:&5E=',O<VAE970X."YX;6R55.V.FS 0
M?!7$ YSY,H0(D!JJJI5:*;JJ[6\'EH#.8&H[X?KVM0V'$LZM[OY@[WIV/+/&
MSB;&GT0+()WGG@XB=ULIQSU"HFJA)^*!C3"HE8;QGD@5\C,2(P=2FZ*>HL#S
M8M23;G"+S.2.O,C81=)N@"-WQ*7O"?]S ,JFW/7=E\1C=VZE3J B&\D9OH/\
M,1ZYBM#*4G<]#*)C@\.AR=T/_KY,-=X ?G8PB9NYHYV<&'O2P9<Z=STM""A4
M4C,0-5RA!$HUD9+Q>^%TURUUX>W\A?V3\:Z\G(B DM%?72W;W-VY3@T-N5#Y
MR*;/L/C!KK.8_PI7H JNE:@]*D:%^3K514C6+RQ*2D^>Y[$;S#C-*SA9RNP%
MP5(0K 5^]-^"<"D(-P5H5F:L?B22%!EGD\/GPQJ)_B?\?:B:6>FDZ9U94VZ%
MREX+WXMQAJZ::0$=9E!P PKC>TAI@20K!"D)JX[ JB,P]>&=#IS:&4(K0V@8
MHGLG&YF'&10;T&! NSB*-EXLH! '=BV154OT2DN88CL!MA+@=[0CMC+$;VG'
M#,*W3J-H<_JE!>3_RTUBU9+8M$1VAIV58?>.?J16AO0M_4A?G;R?IIMV6#!X
M^ZNCF^NGG\-OA)^[03@G)M5--O>M84R"XO,>5&=;]0*O 85&ZFFBYGQ^A^9
MLG%Y8M'ZSA=_ 5!+ P04    " !91CU0VGO57WT"  "L"   &0   'AL+W=O
M<FMS:&5E=',O<VAE970X.2YX;6R55NUNFS 4?17$ Q3,-Q6)E 1-F[1)4:=U
MOQWB!%3 S':2[NUG&TJ)N6FS/V!?SCD^]V*NR2Z4O?"2$&&]-G7+%W8I1/?H
M.+PH28/Y ^U(*Y\<*&NPD%-V='C'"-YK4E,[GNM&3H.KUEYF.K9ERXR>1%VU
M9,LL?FH:S/ZN24TO"QO9;X&GZE@*%7"668>/Y"<1O[HMDS-G5-E7#6EY15N+
MD</"7J'''/F*H!'/%;GPR=A2J>PH?5&3;_N%[2I'I":%4!)8WLYD0^I:*4D?
M?P91>UQ3$:?C-_4O.GF9S YSLJ'U[VHORH6=V-:>'/"I%D_T\I4,"86V-63_
MG9Q)+>'*B5RCH#775ZLX<4&;045::?!K?Z]:?;_T3^)DH,$$;R!X(P%%'Q+\
M@>"_$X(/"<% " R"TZ>B:Y-C@9<9HQ>+]:^WPVH7H<= 5K]005UL_4R6A\OH
M>8G<*,Z<LU(:0.L>Y$U!(\*1\N,:'K3&VIO1_>AZA0T ,4SD "2!7?A@IK[F
M!U-^&L(" 2@0: '_JE1A"BN$H$(XLR"+G1C%!D&I4:][0/DGH"O#$6@X A1B
MUS ,@I!A^!Y0_@GHRG ,&HXA!<\PW(,B#6HU*(B,I#80)H"=)*"3!'+B&TZ2
MV2HH2EW32X\*IRAOBKIRDX)N4LA-8+@!03<^$>3"[<2=:02N=T/B1D="__&=
M(;#CK)!WQ\;- 52,;I05P4T%S;O*?,-M!M3T/7NA615GTK(;PH[Z..1604^M
M4'UO$AV/W)6G6KX17ZNC6!\%[S+].?X#LV/5<FM'A3Q0=-L_4"J(].@^R/U5
MRE^'<5*3@U##6(Y9?W[V$T&[X=_ &7]0EO\ 4$L#!!0    ( %E&/5!]:QC^
M7@,   \.   9    >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;)6776^;,!2&
M_PKB?L4?&)LJB5223)NT256G;=<T<1)4P!DX2??O9SY*@WVHLEX4,.\Y?GQL
MWMBSBZI>ZH.4VGLM\K*>^P>MC_=!4&\.LDCK.W64I7FS4U61:O-8[8/Z6,ET
MVP85>4 0BH(BS4I_,6O;'JO%3)UTGI7RL?+J4U&DU=]$YNHR]['_UO"4[0^Z
M:0@6LV.ZES^D_GE\K,Q3,&399H4LZTR57B5W<_\!WZ\):@):Q:],7NJK>Z\9
MRK-2+\W#U^W<1PV1S.5&-RE2<SG+I<SS)I/A^-,G]8<^F\#K^[?LG]O!F\$\
MI[5<JOQWMM6'N2]\;RMWZ2G73^KR1?8#8K[7C_Z;/,O<R!L2T\=&Y77[W]N<
M:JV*/HM!*=+7[IJ5[?72O6&\#X,#2!] A@#3]T<!M ^@[P'1AP%A'Q"^!X0?
M!K ^@%D!03?VMIBK5*>+6:4N7M6MAV/:+#M\S\QT;9K&=G;:=Z:>M6D]+S#B
MT2PX-YEZ4=*)R%C$QZ(E(!H4@6$80 @$DA"H#V'UX8JHQ;H")!;I&I (&)6"
M-:-M/!VALAC.$((9PC9#.!YL; VV$T6MJ&Q%)&8HM,;KJBAC$85I&$C# !J!
M+)I.Q*[Z$4)$=O5=%<;(_,$X$8@303C8PHF<CH@@D5T<0!5'B,,T'*3A$ VQ
M:+C3#PT98Q8-H.+7S",: =((B(9:- *8!&Y_!2M 12)L57 MG.7%.9I873&(
M'+O(H5699>RP?"+86H$K0!0B:P&N71$1=&+",8(M$3G$(7;<#CF%P9@1N\B]
M;%QE@BQ?6T/9$ LG/AL\8>78X:8QFT@!FO #)O]A;1AV1TQO,+>D5XU\BU!D
MSWDO&WTSIGY3A8'=%D-V:QM<TJNNNV)4N$20C$\2P8Z+0<O%-I'KIH2&+A$D
MF_1<#)LN!EV7V$2 H3+N$D$R/$D$&R\&G3>TB0!3Q<"LN3)F?DRGB&#SQ;>X
M;X)=8Q7 P@94T20/[*SX!FM-,&";D8L#J"8GC,"^26[PS82X3L?=!02HA#M;
MP=4FMY#5OCUQU-Y&G4K=[.^N6H=3S0-I-LE6^]*<=KJSR7N:[JCT/:WV65E[
MSTJ;+7B[4=XII:6!1'>F6@=S.AL><KG3S2TW]U5W1.D>M#KVQZ]@. ,N_@%0
M2P,$%     @ 648]4,@\^)I4 @  ; <  !D   !X;"]W;W)K<VAE971S+W-H
M965T.3$N>&ULE57;CILP$/T5Q <L-K? BB EJ:I6:J5HJ[;/#G$"6H.I[83M
MW]<VA"4PJ=J7^,*9<^9,;$_6<?$J2TJ5\U:S1J[=4JGVV?-D4=*:R"?>TD9_
M.7%1$Z67XNS)5E!RM$$U\WR$8J\F5>/FF=W;BSSC%\6JANZ%(R]U3<3O+66\
M6[O8O6V\5.=2F0TOSUIRIM^H^M[NA5YY(\NQJFDC*]XX@I[6[@8_[[!O BSB
M1T4[.9D[QLJ!\U>S^'Q<N\AD1!DME*$@>KC2'67,,.D\?@VD[JAI J?S&_M'
M:UZ;.1!)=YS]K(ZJ7+N)ZQSIB5R8>N'=)SH8BEQG</^%7BG3<).)UB@XD_;7
M*2Y2\7I@T:G4Y*T?J\:.W<!_"X,#_"' 'P-P_-> 8 @(W@-":[[/S%K]0!3)
M,\$[1_3_5DO,H<#/@2YF839M[>PW[5;JW6N.41)EWM4P#:!M#_*GH!'A:?I1
MPX<TMOXB/(CO%78 9 5+!*"-P,8'=S:B%&8(08;0,H1W#/$LS6T/BBVHL: D
M#L.9%P 41#Z<2P3F$BUR"=(()HA!@O@_RK$"&59 .9)Y.7I0-''JARB$91)0
M)H%D5C.99"F3/C@=*:B20BK)3"4%5(('-<,(ODP($DKGMPDME*(X1 ^4'EQ;
M#"BE:*Z$EYX2]. D8?#R;K#_+Q=C0-T=^C"<O2,["(47)]N;O%TU%6?[S$NG
MX)?&]IC)[MA*-K:3>._PO@]])>)<-=(Y<*5?4/O.G3A75">#GG192MWZQ@6C
M)V6F*ST7_?O?+Q1OA][FC0TV_P-02P,$%     @ 648]4#F0;S0A P  [0P
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M37VU'2@5(!UZ#[*3M9R.TX; 0:AE*M=LF!'#1M!^'']HFL'%?U!+ P04
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M@F4U)OS<LB$(LFR(&K<L!@7'D&4C__4$S)!,M@PC>$.B":8UH ?74-+;,1L
MA7$<]S<6  N#.!Q1/7*,8,BY$>\Q>$RLL#_=.WB+XV"*=\'0.Q+TK1N"?+^?
M:@N@@AF>C6B&CQ4\/%<B,F8<O-%Q.-TX>*/C:(IQT>!("N.^;T/,%S]"?=\
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MT0S*S8/B=?L1$'1?(NO_4$L#!!0    ( %E&/5 CK^_R6 ,  %00   9
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M45EX!*'(*[.\<C>K;NRQV:SX611YQ1X;ISV79=;\25C!KVL7NV\#3_GQ)-2
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M*F"'#3 12(-O0(F 2XLBD(H^]P8J]L%WP(0(.3N, '(!8#-0 9NIBK<9PR8
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M:\8.)KI%1 _<&IB@=DJRMI@W=DRR7EN:K&^/T?WN)2:70P=D&1MR-%W3?BL
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M;Z<1,4DKD30;/=R8?<U=0/3&4&N8T<CAW0!J):K->I+EKAGX:XR_AOB31&^
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MOR]C_\=Z\7JS?QG(Z..-)+?_!U!+ P04    " !91CU0T_[7-)L"   %"@
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MJ-EV:$;T<NW,I%T=^T_G4^K9RQ)ADL^#B_'4@58M" ] :1;=8M9C3)3<0C8
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MX]I]#%;;P 08Q',-5S%9.]K*GK$7O?E\6+N^5@042JDIB'I<8 N4:B:EX^=
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MK7D_B_N-9-UPSWCC95?\!E!+ P04    " !91CU0]!>0(Z\$  "C%P  &@
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M!0"0-H<=.Y!C!Q&H WMLF!)J(SM9'!5JHP^UEDP%MLB^&$>%V@BA-N2VK]8
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M/CM/__?P$:H^?,BD_XR7NFK'G[.7][:K]^=1^E3VY??3[]UA_/UY'O]R&#Y
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M=WK1U<?EZ9G&XOI@Y>I_4$L#!!0    ( %E&/5#S_J\3W@$  %4%   :
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M-8-5,E2%6U4R,)DLPV58B"T@1(6$[0%35!9:_5\"4,JX@XW#D!AB$]ELIBC
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MMU-*NY&LZ28PKQ\#5_\!4$L#!!0    ( %E&/5"=@O/T0@(   ,(   :
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M^]Z0_7=V9-S ;21FCXW@RGV]S4%IT0PJ)I2&OO5MW;KVU*^D9*#!!#(0R$C
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M;;NIZ<O^6>H'6G3#DXO&=[_\!U!+ P04    " !91CU0U<<6/'(#  #1#P
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q,C0N>&ULE5=1;YLP$/XKB/<4; R8
M*HG4))HV:9.J3MN>:>(DJ( S<)+NW\\8EQ+[W"8O 9OO[KX[VU]\TS-O7MH]
M8\)[K<JZG?E[(0[W0="N]ZS*VSM^8+7\LN5-E0LY;'9!>VA8OE%&51G@,$R"
M*B]J?SY5<X_-?,J/HBQJ]MAX[;&J\N;?@I7\//.1_S;Q5.SVHIL(YM-#OF,_
MF?AU>&SD*!B\;(J*U6W!:Z]AVYG_@.Y7F'8&"O&[8.=V].YUJ3QS_M(-OFUF
M?M@Q8B5;B\Y%+A\GMF1EV7F2//YJI_X0LS,<O[]Y_Z*2E\D\YRU;\O)/L1'[
MF4]];\.V^;$43_S\E>F$8M_3V7]G)U9*>,=$QECSLE6_WOK8"EYI+Y)*E;_V
MSZ)6S[/V_V8&&V!M@ <#E'QH$&F#Z-V ?&A M $Q#((^%56;52[R^;3A9Z_I
ME_>0=[L(W1-9_74WJ8JMOLGRM'+V-$<D(]/@U'G2H$4/PF/0@ BD^R$&AF(L
ML&4>)9<1E@ DO82L  B%641@II&RCRXRI1GL@8 >B/) +FL5&[7J08D"U0I$
M4YS"86(P3 R%,0JVZ$'Q* S*(D*-LL86&43CQ*PL@$I)C&'."<@Y@3@;<1:)
MQ9E&(3(H R!G_5*02PIQ<6Q8"GJ@-VR5#/207;-5LAM212%\?,-K"J]1GU0>
M0KGY..0$07PBAP]0+AX0OJ'\"#[L*+IF 31JG/$$85.;0%06&H<(1"6.0X1@
M@4& PN T,R,1^^R[XL *@P")P98F(UMC)HYCA&!50* L4',5[",_H9E)!@ 1
M4\@@$$*NG0.K!P+EPY1?C7*L@:9L8R)K+3_T<\D7UBI$(;Z9R9=:<>+(Y&MC
M$F3RM3%IXN +*R.RI9&&)EM;&2VQ B#8)&MC)H[-@&%YQ5?)*[:%<V)JS1("
M65JS E$CK;DD#6LP!C0X#ET^8 W&MV@PAC48@QIL7E$PH)N1*:X0:'1+O60#
M:RL&;V^FS&!;6PDQR=A7O,1575A_,:"_<>BZ4\/:BI-;5@C6.@QJG?DOJ5'C
M?&-7[6&-PJ!&I6;MZ>=Q@E%?4[%FIWK&UEOS8RVZYF T._2E#[CKBXSYA>Q7
M^^[RW4W?[/[(FUU1M]XS%[+K4KW1EG/!),7P3B[<7O;7PZ!D6]&]IO*]Z9O,
M?B#X03?0P=#%S_\#4$L#!!0    ( %E&/5 [:8>J[P(  &\-   :    >&PO
M=V]R:W-H965T<R]S:&5E=#$R-2YX;6R55UUOFS 4_2N(]Q7;8#ZJ)-+Z,6W2
M)E6=MCV[B9.@ F;&2;I_/]M01."Z@I> S;F'>P_WQ/;J(N1K<^1<>6]E435K
M_ZA4?1L$S?;(2];<B)I7^LE>R)(I/92'H*DE9SL;5!8!02@.2I97_F9EYY[D
M9B5.JL@K_B2]YE263/Z[XX6XK'WLOT\\YX>C,A/!9E6S __)U:_Z2>I1T+/L
M\I)732XJ3_+]VO^,;Q])8@(LXG?.+\W@WC.EO CQ:@;?=FL?F8QXP;?*4#!]
M.?-[7A2&2>?QMR/U^W>:P.']._L76[PNYH4U_%X4?_*=.J[]U/=V?,].A7H6
MEZ^\*XCZ7E?]=W[FA8:;3/0[MJ)H[*^W/35*E!V+3J5D;^TUK^SUTO&_A\$!
MI L@?0"./@P(NX!P;D#4!41S V@70$<!05N[%?.!*;9927'Q9-L/-3-MAV^I
M_EQ;,VF_CGVF]6ST['F#*2*KX&R8.M!="R(#4!A?0^X!2'(->0 @Z37D<0I)
MTJC'!+J2OAP"ED,L07A=3@@SA"!#:!FB(4.4H9$@+2BVH,J"TA#AD20 *"$)
MG$L$YA)!N6"8@8(,=($>,<@0S]&C!=&/]0! 3CT2,)=DF@M%COY(089T@1X9
MR)#-T2.;E)HD<3C2 P!E.(9SP0AV+X(4H0X.QS\ 7J )AFV'R1Q5.M2P8AR/
MNP0 D<RE"FQA#'B8(A<';#T<+5$%-A^FLU2A4U7(N%<@4.;H? P;&0-.ILCA
M/PP;$"=+5($MB--9JJ33@M%$%0 4NKXS;&<,^)FBU+'FP"XD:($J!'8AP7-4
MZ5##@K/Q2@QA7/4X%E' S11E#@[8@R1<H@GL00*N?Q--HFD34#0690HBV)4-
M[&8"NMG% 7N0Q$M4@3U(@%404"69[#X^972L"@#"9-10#R!J_,)'$!6346G!
M8%]JCB(_F#SD5>.]"*6WN'8CNA="<<V(;K3@1WWZZ0<%WRMSF^A[V1X!VH$2
M=7>\"?HSUN8_4$L#!!0    ( %E&/5!4<$>\5@,  -80   :    >&PO=V]R
M:W-H965T<R]S:&5E=#$R-BYX;6R56.UNFS 4?17$ Q2NC?FHDDAKIFF3-JGJ
MM.TW39P$%7 &3M.]_<Q'HP2.*_@3,)Q[<N^)CWV=Q5E5+_5!2NV\%7E9+]V#
MUL=[SZLW!UFD]9TZRM*\V:FJ2+495GNO/E8RW;9!1>XQWP^](LU*=[5HGSU6
MJX4ZZ3PKY6/EU*>B2*M_#S)7YZ5+[ON#IVQ_T,T#;[4XIGOY4^I?Q\?*C+P+
MRS8K9%EGJG0JN5NZG^A^S9,FH$7\SN2YOKIWFE*>E7II!M^V2]=O,I*YW.B&
M(C675[F6>=XPF3S^]J3NY3N;P.O[=_8O;?&FF.>TEFN5_\FV^K!T8]?9REUZ
MRO63.G^5?4'"=?KJO\M7F1MXDXGYCHW*Z_;3V9QJK8J>Q:12I&_=-2O;Z[E[
M(X(^# >P/H!= NCC -X'\$& UV76EOHYU>EJ4:FS4W6_UC%M)@7=<R/FIGG8
M:M>^,]76YNGKB@3Y"^^U8>I!#QV(78%X> M9 TAT@7@FA4L>#.;!VGA^G4<0
M)YB!0P;>,@0W#,FPD@X4MJ"R!<7<IT$M !0Q2S4!S"5 N1!F$)!!S- CA SA
M%#TZD/A8#P"RZA'!7*)Q+H(L>L20(9ZA1P(9DBEZ)*-2>1 .YSH 77OF)A?R
ML>U\I BS<%BL2S,T(6P[8E-4Z5'7%1./@^$2 %!"6'YEPB8FX&)!W,*!S4?!
M'%VP_4A,TD6,*A[/%@ *16S)!EN9@)<%!18.;$&*YJB"34CQ)%7B4<$L2H:J
M %!LF__8T 0<+4A8=AWL0^;/4(5A'S*:HDJ/NEU:ABLM +' MH]:-E+@:$&A
MA0.[D/$YJF 7,K@'CE0)QFM&*(:JC$',MU6$_<R GP79E,4N9.$<5; +&=@)
M@2H1*)@-51F#*+:LE S[F0$_"[*L30R[D"5S.C?L0@YV0]"[^>."V7"N(%!H
MV8,X]C,'?A9DJPB[D,_J9RT-[;2.EH^[L^%B"S#D6QH6CNW,@9T%LW%@$_(Y
M32W')N23VEH^;EF)C50!(&Y95CBV,T>-+;---VQ"/J>UY=B$?%)SVZ/"V\5V
MY""$2H8+BW=UP&Q._#_2:I^5M?.LM#FKMB?*G5):&D;_SDA\D.GV,LCE3C>W
MD;FONI-V-]#JV/^+X%W^REC]!U!+ P04    " !91CU08MXM.]T!  #F!
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MN(%;)^8;>\&5>P;[L]*BZE6,E8I]=&U9N[;M]:\T/X'T!#(0</Q? NT)=$)
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M_YM;^LB8I(K1?U(9/:M.;YS4]"CU,%%CWK<[_42R;FCEO+&?7/\'4$L#!!0
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M3 O!<5'@"UJ(A"_N#SC6;KZH/^#H@Y[(B74Z !?$.BR%[OQP3GDX+AE\47_
MP0?]%_5M9$@/!IIU(<7 25WHZ;NC8[5"5*?NR+*V]O)6-NW9U&CT<2SZW)V*
M:N,[]I3VAYL_W/1GK7]DU>E2UM:K;!I9=$=S1RD;H7AZCLJ*L\@.CX=<')OV
M-E+W57_&V3\T\CJ<W[J/0^3M_U!+ P04    " !91CU0\E#OHC,"  "5!@
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M7IZ7'_:;I\N7+QU:O'WST=7_ 5!+ P04    " !91CU0LJQ(V= "   0#
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M3E9W),KJKD0!4,N)@D*X'(10JI %C862@CZ0+ @N!RBZ)UT<ZB9DG(9H6IL
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M;28ZQEH63??KK0^-DN7@1:=29F_],:^ZXW'P_VZ&#>A@0$\&E%PT8(,!N]:
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M;QIR$FH9R34;1]JX$;2?QK4S_V?(_@)02P,$%     @ 648]4#"PG8L4 P
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MQ0^G#6 JM1XE(VP<!(V#*QE)L;_C%3K B-Q"&%]L8,L@:!E<Q4B*/$56! =
M66LY9X!2B:<6(^P7!/V"5V,$O@<X9?CMP;\K,"KV4,9V0<@NA/"2E'@51V*A
M 4H(3(90EP(S98WM@J!=^$03BS<EMP@O%F^"Y;<07E!_QY:;+421$%Z$"CV6
MH[%=:&@77'BUE'C^P@&D*]D88P"*/,6!QD:AH5%PU=7(*%3$OQ/7$$=$_ L8
M]W?Y=J?<L6-HZ!A<>#6R N[,")2*U49N01Y-T)X-(6@67'PU^#+H!%,L-X*E
MHJ! , J-+U"P:VCH&EQ_M51Z%?)R'8",J'P!Z$YY.6//T,@SA !KX!F)$1$"
M4$)H,H@BCP!K;!L:V(92'H_76,1U?(, :RSB^IH]F[5&&RW$M\8R!(MCWU:!
MQI:@I25$QM.%P?ILPAL6QF#--% SQ9XL+*ZY,P$4_W#]%#+EBW72()T4^X &
MUL(\P$=4= 49+( &"2!YA-]X]L3-+2\1:X.!]:1XB3*??=/%R6RNJ0'71M9M
MOF%POAM8M'G4TN!\-[<4;09GJ+FJ:#-HL]-SKF)Q'MMK]CK7%A11WH%PLENX
M/>E1=(L3T-ZR/6EQWMBKMB='5#1)XLC'%F>714XOEU:>%(&1@HLCP=+5+\-Q
M:S/;5*^'MC]7NWAZ/M)]I/Y(D3U?J?OL=##[LYO3.?$?>?VR/S2SIZIMJW(X
M5GRNJM9U),,OW9O?N7Q[OBG<<]M?QMUU?3J?/=VTU7$\>P[.!^#+_P%02P,$
M%     @ 648]4!M9EFT# P   @P  !H   !X;"]W;W)K<VAE971S+W-H965T
M,34Q+GAM;)56;6^;,!#^*XCO+?B%MRJ)U!!-F[1)5:=MGVGB)*B F7&2[M_/
M-I02^^C6+V";Y^Z>.]L/M[AP\=P=&9/>2UTUW=(_2MG>!4&W/;*ZZ&YYRQKU
M9<]%74@U%8>@:P4K=L:HK@(<AG%0%V7CKQ9F[4&L%OPDJ[)A#\+K3G5=B#]K
M5O'+TD?^Z\)C>3A*O1"L%FUQ8-^9_-$^"#4+1B^[LF9-5_+&$VR_]._1W0:E
MVL @?I;LTDW&GD[EB?-G/?FR6_JA9L0JMI7:1:%>9Y:SJM*>%(_?@U-_C*D-
MI^-7[Y],\BJ9IZ)C.:]^E3MY7/JI[^W8OCA5\I%?/K,AH<CWANR_LC.K%%PS
M43&VO.K,T]N>.LGKP8NB4A<O_;MLS/O2?TF2P0PVP(,!'@U0_*X!&0S(FP%]
MUX .!M0R"/I43&TVA2Q6"\$OGNBWMRWT*4)W5%5_JQ=-L<TW59Y.K9Y7*,7)
M(CAK3P-HW8/P%#0B N5^C(&A&&OLF)/X.D(.0"P2&P"2PBP(F"DQ]N0ZTQD/
M%/1 C0<Z]9!0;-6J!\4&U!C0#<H(3:V$(5@:Q7;2$"RA$89I1R#MR*6=X@SV
M$(,>X@^4+@$])  '$EJEZT'1)-DHM J2NQ@4$:MH+@;CF8JE(-L4V.C4WNC4
MB7(S4Y(,#)*Y0;!S\S(G",TL(KF+B0BU2N)B4$9AMBB$A2+\G],_H*ZJ0I/,
M8@RA$(TLSA!*_=!F6,_(&X)8$YLU<B,E=IDA$+&/'@2*YPH-JN4]PM!=078@
M#%">B0/K(2).G-2^D0/F>@OLNOP;LP$P,W<%P=*+ .U-B7/Z7+FDQ%;> ?2N
MS&P T%1GKBG#LHL@W25S/F#A11]17@1++P*TUQ&:' 'BBYU#!ZAO&L^P@:45
M0=IJ7\A\0%W]]]PK ( B^[\63!JAFHF#:3([;\M/C=3=Q&1U;&3OL6ZDK/6U
M;G!-@_7FIN^.OQ7B4#:=]\2E:M-,,[7G7#+%,;Q5M3JJAGR<5&PO]3!18]%W
MI?U$\G;HN(.Q[5_]!5!+ P04    " !91CU0/[?_MT,#  "F#0  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q-3(N>&ULE5=1;YLP$/XKB/<6; R&*HE4B*9-
MVJ1JT[9GFC@)*N ,G*3[]S.&4G(^JN4EV,YW=]^=?6??XB*;E_8@A')>J[)N
ME^Y!J>.#Y[6;@ZCR]EX>1:W_V<FFRI6>-GNO/38BWQJAJO2H[T=>E1>UNUJ8
MM:=FM9 G51:U>&J<]E15>?,W%:6\+%WBOBU\+_8'U2UXJ\4QWXL?0OT\/C5Z
MYHU:MD4EZK:0M=.(W=)]) ]K2CL!@_A5B$L[&3N=*\]2OG23+]NEZW>,1"DV
MJE.1Z\]99*(L.TV:QY]!J3O:[ 2GXS?MGXSSVIGGO!69+'\76W58NK'K;,4N
M/Y7JN[Q\%H-#H>L,WG\59U%J>,=$V]C(LC6_SN;4*ED-6C25*G_MOT5MOI=!
M_YL8+D ' 3H*D.A#@6 0"-X%V(<";!!@0,#K73&Q6><J7RT:>7&:?GN/>7>*
MR /3T=]TBR;8YC\=GE:OGE<D#MC".W>:!E#:@^@4-"(\K7ZT03$;*;7$@^C:
M0H9 ^#5DC4!BG$6 >AH8^>#:TQ#7P% -S&A@UQJ )VD/B@RH'D"< '=M4)R$
MP%\$$^%L0Y1MB+$%04U[4#@Q<D<HW/\,024^!7PQ53[G..4(I1QAE&- .;+L
M\!!@,AL3\0#P13"$XFPYRI9;;$.PSRFW8Q*%"2"+@1AT>XV@"/%G,B!&"<<V
M87#HTMBR0G@"(I<A(&H=7P04^0%.-T'I)MAI ,%+$\M,[ ,JF8WA#*3M&L',
M!9?X>"7U;;X!C.\ FMI)" 6IE"$HPF)(&4&%/)Y).#)3_HE%.IE) H(6]T="
M;ZBK!"_-)$"VFODP=H$=E9!Q&#L$Q6.8_!B*1?X,:_PZ(/9]P*.Y,X/7:!+>
M$CR\:!*L:MK!L\M=X,\9PNL=L0N>-C3S$B!X"2+Q+0[C=8%@A<%VV,[H(.'P
M9L-0C,+:BZ$HG[F-*5X>*%(>8C:3:Q3/5DINB![%\Y72_XG>@)J^/N[@E90A
M(%BC$ BEL$1YD\=J)9J]:01:9R-/M>I>?)/5L=EX-+T&6$]U$]*W#.]J^@[F
M6][LB[IUGJ723VGSX-U)J83FZ-_K?3WHIFF<E&*GNB'7XZ;O'/J)DL>A*_+&
MUFSU#U!+ P04    " !91CU0L-GPQ&L"   6"   &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q-3,N>&ULC5;;CILP$/T5Q <L]]N*1-H$5:W42M%6;9\=,@EH
M#::V$[9_7]L0EAAOE)=@#^?,G!F;F>0]H6^L N#6>X-;MK(KSKMGQV%E!0UB
M3Z2#5KPY$MH@+K;TY+". CHH4H,=WW5CIT%U:Z]S9=O1=4[.'-<M[*C%SDV#
MZ+\-8-*O;,^^&E[K4\6EP5GG'3K!3^"_NAT5.V?R<J@;:%E-6HO"<66_>,^%
MYTJ"0ORNH6>SM253V1/R)C??#BO;E8H 0\FE"R0>%]@"QM*3T/%W=&I/,25Q
MOKYZ_Z*2%\GL$8,MP7_J Z]6=FI;!SBB,^:OI/\*8T*1;8W9?X<+8 &72D2,
MDF"F?JWRS#AI1B]"2H/>AV?=JF<_^K_2S 1_)/@3P8OO$H*1$'P0PKN$<"2$
M&L$94E&U*1!'ZYR2WJ+#\79(WB+O.135+Z51%5N]$^5APGI9>VD8Y,Y%>AI!
MFP'DST$3PA'NIQB^*<;&7]"#^#;"U@!);B&% 9*:503&3 /%#^;\S,P/C?Q0
M\</;2H5:I090K$#M ,HRK9Q; RAU,RU= RCV/BE[9!0<F01'FN !%,W"N)K:
M)<(+=+'WO-PHC8U*8Y-2[8ILXJ6.--'OD0$4N1JH,(#"-#$+3HR"DX7@]).[
ME!KYZ<-W,3/RLT>.-ENDF6CGMEU"M-,O[B%NA(KF;^PO[B-G.Z+FMWWV<0]:
M#1@OUKZ_P@3R0TVQ,VN.#="3&CS,*LFYY;+#S*S3<'OQ97/5[!LY]%33_7 S
M3,P?B)[JEEE[PD7K5@WV2 @'H=%]$M6LQ)">-AB.7"X3L:;#I!HVG'3C%':F
MOP+K_U!+ P04    " !91CU0XJ_T_IH"  #Y"   &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q-30N>&UL?591;YLP$/XKB/<6C#&!*HE4$DV;M$G5IFW/;N(D
MJ("9[23=OY]M*"7'K2]@']]W]]W9^+R\2O6B3T*8X+6I6[T*3\9T#U&D=R?1
M<'TO.]':+P>I&F[L5!TCW2G!]Y[4U%$2QUG4\*H-UTMO>U+KI3R;NFK%DPKT
MN6FX^EN*6EY7(0G?#-^KX\DX0[1>=OPH?@CSLWM2=A:-7O95(UI=R390XK *
M'\G#EL2.X!&_*G'5DW'@4GF6\L5-ONQ78>P4B5KLC'/![>LB-J*NG2>KX\_@
M-!QC.N)T_.;]DT_>)O/,M=C(^G>U-Z=5F(?!7ASXN3;?Y?6S&!)B83!D_U5<
M1&WA3HF-L9.U]L]@=]9&-H,7*Z7AK_V[:OW[.OA_H^&$9" D(X%D'Q+H0*#O
MA/1#0CH04D"(^E1\;;;<\/52R6N@^N7MN-M%Y"&UU=\YHR^V_V;+HZWULB9Y
MNEA&%^=I )4]*)F"1D1DW8\Q$BQ&F<SH-+N-L$$@0,06@>2X"HIF2CV?3OD%
MSD]1?NKYZ6VE<E"I'I1Y4.M!=S1/0+(H"*:+@)*8XH(9*IAA@@L@N >Q:9@B
MCX%@!,32% A&0!ECN. ,%9PA@AG04F:S,(Q1H'>.21A8A.T<,UFG&[$+5.P"
M$TN V,6\)B2#U9V#* '_QQ9Q1/^W&W)4;X[I!44I\UD80C*P,S=S4)&"Q+>(
MHY3$N-X"U5M@>L%"E\4\#! [1]S!G?"1DQNAMK^A1V@\ETH9/$+CV?],"O S
M;A 06\"M@( HA5LWFIS_C5!'WUMUL)/GUKA#=&(=^_=CXOH'L)>NK_N^\NZF
MOQ1\X^I8M3IXEL9V)]]##E(:837&][::)WL/&2>U.!@W7-BQZIMQ/S&R&RX:
MT7C;6?\#4$L#!!0    ( %E&/5!AM'IEL0$  ,0#   :    >&PO=V]R:W-H
M965T<R]S:&5E=#$U-2YX;6QM4UENVS 0O0K! X368B<V) %UBJ(%6L!(T>2;
MED86$2XJ25O)[<-%%A1'/R)G]):9(5D,2K^:#L"B-\&E*7%G;;\CQ-0="&KN
M5 _2_6F5%M2Z4)^(Z370)I $)^EJM2&",HFK(N0.NBK4V7(FX:"1.0M!]?L>
MN!I*G.!KXHF=.NL3I"IZ>H*_8/_U!^TB,JDT3( T3$FDH2WQMV2WSST^ )X9
M#&:V1[Z3HU*O/OC5E'CE"P(.M?4*U"T7> 3.O9 KX_^HB2=+3YSOK^H_0N^N
MER,U\*CX"VML5^('C!IHZ9G;)S7\A+&?-49C\[_A MS!?27.HU;<A"^JS\8J
M,:JX4@1]BRN381U&_2MMF9".A'0BI+&7:!0J_TXMK0JM!J3C['OJCSC9I6XV
MM4^&481_KGCCLI<J>5CG!;EXI1&TCZ!T!MJLLPE#G,'DDBZZI$$@FPEDVV5^
MMLC/ C__7.7ZILH(V@20C*!TCOKDDR_ZY%]\[I/DQB9?L-EN\QL;,CL ?[__
M4'UBTJ"CLNXLP\1;I2PXQ=6=NS2=>U)3P*&U?GOO]CI>K!A8U8]OADP/M_H
M4$L#!!0    ( %E&/5!26F,Y40,  *H.   :    >&PO=V]R:W-H965T<R]S
M:&5E=#$U-BYX;6R-5V%OFS 0_2N([RV< 0-5$JEI-&W2)E6=NGVFB9.@ L[
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MQO:^ZH]!_4-C3L,1S[N=,Y?_ %!+ P04    " !91CU0Q?KU"B8"  !:!@
M&@   'AL+W=O<FMS:&5E=',O<VAE970Q-3DN>&ULC57K;ILP%'X5Q ,4,)?0
MB" UB:9-VJ2HT[K?#CD)J#9FMA.ZMY\OA!+B5?T3[,-W.>=@GQ0]XZ^B!I#>
M&R6M6/FUE-TR"$15 \7B@770JC='QBF6:LM/@>@XX(,A41*@,,P"BIO6+PL3
MV_&R8&=)FA9VW!-G2C'_NP;"^I4?^=? <W.JI0X$9='A$_P$^:O;<;4+1I5#
M0Z$5#6L]#L>5_Q0MM[G&&\!+ [V8K#U=R9ZQ5[WY=ECYH4X("%12*V#UN, &
M"-%"*HT_@Z8_6FKB='U5_V)J5[7LL8 -([^;@ZQ7?NY[!SCB,Y'/K/\*0SVI
M[PW%?X<+$ 77F2B/BA%A?KWJ+"2C@XI*A>(W^VQ:\^P'_2O-34 # 7V6$ ^$
M>"2@Z$-",A"2=T)LNF5+,;W98HG+@K/>X_;K=E@?HFB9J.Y7.FB:;=ZI]@@5
MO9318[@H@HM6&D!K"T)3T(@(E/SH@5P>:W1'C[-;A\T])$OS6\SV'J-2S=V)
MQ,YB8Z,0WRH\NA42IT)B%)(;A2B<M<L)^D_'4J=-ZE) ,QLG*';;9$Z;S*60
MS&R<H-1MLW#:+%P*LQ.P=H(6;IO<:9.[%&:':&-!F0&U!H10.CMH%A/%4] D
M7YM*,+EA%/C)3"_A5>S<2GU*)]%Q0#XA?4-G\;4:G';.O<O8J?L#\U/3"F_/
MI+K_YI8>&9.@<@P?U->OU: ?-P2.4B\7:LWMN+,;R;IAD@?CWTGY#U!+ P04
M    " !91CU0Y@\<V($&  #Z)@  &@   'AL+W=O<FMS:&5E=',O<VAE970Q
M-C N>&ULE9IO;]LV$,:_BN'WKD4>_\A!$J!1,&S !A0=MKU6$R8Q:EN>I"3=
MMY\D*ZYU]UP;OXEMY2%Y(GF_NZ-T^5K57YNGE-K9M^UFUUS-G]IV?[%<-G=/
M:5LV'ZI]VG7_>:CJ;=EV/^O'9;.O4WD_--INEC;+PG);KG?SZ\OAVJ?Z^K)Z
M;C?K7?I4SYKG[;:L_[M)F^KU:F[F;Q<^KQ^?VO["\OIR7SZF/U/[U_Y3W?U:
M'GNY7V_3KEE7NUF='J[F'\W%;0Q]@T'Q]SJ]-B??9_VM?*FJK_V/W^ZOYEEO
M4=JDN[;OHNP^7E*1-IN^I\Z.?\=.Y\<Q^X:GW]]Z_V6X^>YFOI1-*JK-/^O[
M]NEJGL]G]^FA?-ZTGZO77]-X0WX^&^_^]_22-IV\MZ0;XZ[:-,/?V=USTU;;
ML9?.E&WY[?"YW@V?KV/_;\UP SLVL,<&)ORP 8T-Z'L#]\,&;FS@6(/EX5:&
MN;DMV_+ZLJY>9_5A>?=EOXO,A>MF_ZZ_.$SV\+]N>IKNZLNU69G5Y?*E[VD4
MW1Q$]E1T5"R[[H]C6#3&C17-*4Q'*( D3B6W0))C*PC>*0WMW4E['P+NP,$.
MW- !3:;*9K@'#WOPPH2N!\,F^R *@V@WB*PUD2U) 51DC6)-@-8$9(UEUAQ$
M_F0<$HL'-%%9F@@MB<@28I9$8$G&+ $:JVS5'%J2(TL<LR07HRQ,R)DI2(0M
M64%+5L@2SRQ9B4&XL060*+O>9)@0&;(D<$1D8IQNT[*]70#5PH>HV*,0RR![
M(K?'@/E?$;='JKQB#$3;1V.1,3DWQLK)R?E" 9$-3K$&(\Y(QN49MX7D,+F8
M%RE:4-2,P;@T#DV-""T.K)/U'#%8%DBQ"./7(/YRAMR,JLEB!8[?GXBFUF#\
M&L1?XM' 2+@Z88S4&(4U!@/8( (3CP5&XM52%L1: =DD@DTMPB V.8BVI*TW
M1JA!#"5.<R,):?*<.,^!S&8V*KBPF*56LC0&ON160M)ZQK<"B9PRQ1:#U"*0
M$@\Q5B+2!.&?0+7(,VUR,$NM9*F@EY60I(R3%(@6I.5&%J/42I1VD\.CGI6<
M=)8G)4#DM;S18I9:Q%)!+HL@*=#U,]74'DQ2"TG*8["5D 0Q&*D4/[>8I!9F
MLCS26$E)%&FP3(LT%O/40IX*1P?IJE@MJ5'2-XM!:E%*R^EV8V6Z:E:Y$5L9
MR":LG%J$L6PAEL5R2=X26"V@(J<$/\)0I@R$&J<X*&&6$F*IXPM.@)*B<$"B
M7'%/PB0EE)4Z'LY)8I)'&2"Q"M1)J;H11QVO[0CDFYSJ/]9,;<$4)411Q_,!
M GP,GAN#1-IQ!&8H(88Z'GX)T9'XH4$!92YC3G5+\MA@09G5IA'CEB1NO18_
M"/.1XAEG*83!1K!6%RX'B)5%'H.0RAAMIV.L$:S8A=.!;%-8 Z"F+)'#2'.P
M9N=>YT .R>,/T)"RU@ZCT<%ZG6=23E(O<M@#S8(4UCM,1@?K=9ZX.)! BHD!
M-;UB"B:C0V041P<.4(]OJ@*)3JJWJ37*X:9D(T^^"P>@IYS=.,P\!T] >>AW
M"&;"&"!RVGDN!IE[5P7N0'6M#(-AY]Y57#N9Z$4G/$"*)C2;FH.YZ<ZIK!UF
MG7M79>T Z_BSA0*)@K)W/::=?T]5[0'(^)FZE"@AP&/4^7=5U!Y4U'QW \U"
M22\\)IU'I!,%K <Y($^\@$;Q,X])YR'IN-=[!#$Q+R@)U*S!I/.PEA;;!;!.
MVY7*PQY8(W.^>W"0R!VI0"*C1&&/6><AZ\0:2-8%PZ,-$*V\DI]XC$2/\C^M
MY/*88Q[E?R)_]N Y#+@EH#J]IT/VC%4*.3TFIT?DU'9PP+P+J&#5LN> 415@
M5L:](*""5:-SP" *$$1\!0)(N?21,&<"G1'9 J9#@'3@D2T .CBMC J8#^$]
M?"@"2G/4D90'O>$,;PO88P-*8KBW%0$](6"W= M$FBW8\P/T?"43#=@/P^H,
M'XK8#R.LLK@/1?#,DW(EL8C86R-,++@/150?J2-A;XWV#!^*V \C/#OG/C2J
M)F<1VJ:,V%DC=%;N0A$YJS80]M7HS_"@B+TPH@@L/&A4G<X*<=$M$'%;EB<O
M &U3_3B\7-7,[JKG7=N_17-R]?@"UT?;OT#$KM^8B^+P&M;W;@YOA?U1UH_K
M73/[4K5MM1U>(GJHJC9U%F8?N@E[2N7]\<<F/;3]UWXFZ\/;6(<?;;4?WS1;
M'E]WN_X?4$L#!!0    ( %E&/5"/?4\8,@0  *45   :    >&PO=V]R:W-H
M965T<R]S:&5E=#$V,2YX;6R5F-UNXS80A5]%T'U6XI"2[< V$+LH6J %@BVV
MO59LVA96$EV)CK=O7_W%*W,.=Y.;V%(.9PY'XC<TEU=3?VU.6MO@6UE4S2H\
M67M^C*)F=])EUGPR9UVU_SF8NLQL>UD?H^9<ZVS?#RJ+B.(XC<HLK\+ULK_W
M7*^7YF*+O-+/==!<RC*K_]OHPEQ7H0C?;GS.CR?;W8C6RW-VU']I^^7\7+=7
MT2W*/B]UU>2F"FI]6(5/XG&K^@&]XN]<7YO)]Z";RHLQ7[N+W_>K,.X<Z4+O
M;!<B:S]>]58711>I]?'O&#2\Y>P&3K^_1?^UGWP[F9>LT5M3_)/O[6D5SL-@
MKP_9I;"?S?4W/4XH"8-Q]G_H5UVT\LY)FV-GBJ;_&^PNC37E&*6U4F;?AL^\
MZC^O8_RW87@ C0/H-D"D/QP@QP'R^P#53WYPUD_UE\QFZV5MKD$]/*USUKT4
MXE&VQ=QU-_O:]?]K9]NT=U_78J'FR^BUBS2*-H.(IJ*;(FK#WW(0RK$A-ERF
M]QFV0#+#*22<ANS'R_MI+' $!2.H/H*ZBY#$3B$&4=J+JD'D%FL+-+ZY)-!)
MPIPD:8H#I#! "HJ1>)[8#$:8H6*04XQ!E$PF^B!5O'#*@50Q*>QF#MW,@1MR
MW<Q!'O::(=%LCKTLH)<%JHQTO"QXFMG,L8(TGJ<L8KQT8U27Q%V[,4\T*?]@
M!HI\;CP@$<B-<MT(D"AQW2"1QPPDSI,@])B8&>)Y!+GO#%(EL6=%"XPG(9F?
MN<N643/-0\+UPC6I9RD)C#F!..>ND\VHFN91%+MFN"B9B.[=8-0)SKK6C7#=
M). Y,3= E'C,8&R*%)A1+F=&U32/N[2!A'Q6,'\%!#!;VHBMDK\T/P/UO2/,
M8#'_0(<5F)T"PI.M TY&WF21R-=E">.3$#X3=R40(*-4J=OEH"Q1'H021BAQ
MA":II\2$P4?T@=Y/&%;$806Z/W$4/3#$;K%*>OQ@9!%"%NO_Q&GT(*1K!XBD
M!Z"$D44(66P'0(!&K+,@D=<-9A8A9K&N2QQ(+CY_*+EW@I%%$%G,"6*1V_^!
M*/&5!=.*^):1]5OBFT%6%"[Q,083CQ#Q6+<E#K,96TA<XX&+Q+B3"'>LU4K$
M,<<*T'A>%8DY)]%6D74W"7:!J2#7#% M?&^+Q-"4")J^WB8]/T A--TG+0$.
MP9Q^@M9[/QB:$D'3UX\D1IU,/M!,) :41(!BS42"'9-T>SX0^=X[C"CYGEW5
M5G+Z3+W<)\+XD>@7J_(=:&!TR,4'BJ_PFE=PB^,6?U1-3RRD<JNBWKWH%5[T
MZCV+?CNJ?%Z&1-'D<*O4];$_!VR"G;E4MCM$FMR]G34^47<XYMS?B,?M<&+X
M/<QP@/EG5A_SJ@E>C+6F[ _(#L98W7J,/[5%..EL?[LH],%V7V?M]WHX.!PN
MK#F/AZ+1[61V_3]02P,$%     @ 648]4%6 @0 L!P  T2\  !H   !X;"]W
M;W)K<VAE971S+W-H965T,38R+GAM;)5:76_C-A#\*X;?<^;RFX<X0"]!T0(M
M<+BB[;,N41+C;,NUE>3Z[RM9BF%S9Z_B2QS;P_5RI9DAJ;U^:_;?#L]UW<Z^
M;];;PW+^W+:[CXO%X?ZYWE2'#\VNWG;?/#;[3=5V;_=/B\-N7U</QT&;]4(K
MY1>;:K6=WUP?/_N\O[EN7MKU:EM_WL\.+YM-M?_W4[UNWI9SFK]_\&7U]-SV
M'RQNKG?54_U'W?ZY^[SOWBU.41Y6FWI[6#7;V;Y^7,Y_HH]W1+8?<83\M:K?
M#F?_S_JY?&V:;_V;7Q^6<]6G5*_K^[:/474OK_5MO5[WH;I$_AFCSD\_V@\\
M__\]^L_'V7>S^5H=ZMMF_??JH7U>SN-\]E _5B_K]DOS]DL]SLC-9^/T?ZM?
MZW4'[S/I?N.^61^.?V?W+X>VV8Q1NE0VU??A=;4]OKX-WX0X#L,#]#A GP8,
MQ1$'F'& F3K C@-L-F Q3.58F[NJK6ZN]\W;;#]<WUW5WT;TT7;5O^\_/!;[
M^%U7GD/WZ>L-)1>N%Z]]I!'T:0#I,Y#QEY!; ,FBW %(/$$679:G5#5,51_'
MV[/QSGL<P,  YAC 7,Y52,'""):ET$5(6;4&D#^"MD>0-LKG!0,H32&+=8=B
M:5(X9P=S=B!GK[*<!Y [^QU*D3+4+4#%>'81AYPY2BL=',[9PYP]R-GD=?;L
M=ZZ,=GF=$<I8PMD$F$U %10B1!@A%MQY"49(4^Z\Q*\/,:8BD!7N*%)8-!2J
MB!9B",)#!34AK C$)0%4942=SSA2"KF <52(,0CY8($A@^IBA!A88LB6U 53
MGA#G>5T 48/6>5T RHO7&M.9$)^]%6)@$E(HJ0NF(<5)=8F<(9HLNV$ C+R1
MF(1I38C77M!*C=FH54%E-&:CIBF5&5$74W:D<H5!,*LE'FC![1&WF6]ISEJR
M-E_ W"*8L4&X5AJS6R-V,U<:41>&XVW*$P*HD*0*8:70:#4BK8@T5@KM2NX=
MS&Z-V,WO'6[$GCR[4!SE/$GY8*70T*\%)==8*72)8VO,;3W)LS7WX\CNJEN$
M\E;0"8-UPD#7%N9DL$Z8$M<VF-EFDFL;3EGC7.Y."&6LE(^P+8"NG2N-X8S5
MABC/!Z#("SIC,*\-XC73F1%UH2"D+4L(P;I5NY 15@D#]Q!)B(%5POB2.P<S
MVR!F\SLG<*4)^58&@:PT(ZP1!JTF)$\Q6"-,*MF38EY;Q&N^*U5\PB:O"@(Y
MP94L5@B+5A)!V"U9K!!6EU0%L]HB5O.J<+Z25BXO"T"1D>8D'!T@5@=A'6TQ
M#VV)6UO,0SO)K2WW80J4NS5".6E=;S&G+>)TD.XYS$1;XM86,]%.<FO+?=A:
M%?.Z )23G-9A5COHUNS<AA/6*)N[)$)I)>6#>>T0KYDK.;[TOR+##K\$F'2N
MA57"H75$$.X^AU7"E9P).LQL-^E4T'$CMKPN )0$G7'"<1_R:NGTS6&-<"5>
M[3"OW22O=MR&R2IV[@A0W>9!R =KA(-N+<7 &N%*W-IC7OM);NTY8[N==JZ_
M$"7YDL>\]M"OA=V2QTST)7[M,1/])+_VP(G/&3+6!:&T5!?,:L]9[:0EK\=4
M]"5V[863\$EV[;D1!\M.PH%;JS.G'4[O$8I(.KW'W/=P!YY[EP>L-C9/&H H
M?THR@OR%/@A+*X_EP2-YX(\<^)G?E:?<;A$J.<&8/)8:CY8C0;AW I::4'(P
M&+ \A$D'@X'[.2\+ (E5"5AH K1\@94!"TTHL?R Q2%,LOS W9S8T20 Z230
M+6"="<CRH["8"EAG0HGE!^$YV23+#X#1^88+8:1<,)\#XG.4'OMA#H82NX^8
M@W&2W4=NY"[D4@A 05HR1\SFB-@<!:6,F(.QQ.PCYF"<9/:1V[AW^5X+@$@I
MZ>DLIG.$)^FY7T5 9^97"$2"0$5,YXCHS*PH\N=R5TZS=  JBA<<2T-$2Y H
M[- CEH98\O0N"@_1)SV]B]Q\05DX2*X*%H>(##H*=I:P.*02@TZ8TFF202?P
M2$[GRV8 TM)Y9L+BD)!!1\'.$A:'5&+0"3,Z33+HA PZ+PK 2+E@/B=HS\+.
M,V$.IA)[3IB#:9(])VZ]CC4% % @01$29G."!BWL.Y/0%%-BT)TKP"##Y__?
M%:"X_<;<C!!(.N,E)33&*,1HYD;OL/.?RL]-?HS)LA%:;!1B-'.C=UAF-"P?
M@)+K(S39*+1XD)YHD1+:;%11GXT2&FW4M$X;Q6T8%(>#Y-H(C38*>K6P_NAV
M_T*4HEX;)33;J&G=-HI[,>\N!2 MN HIH=5&(<=.$A^DUC<J\6P2F]\FN?8[
M[(<<_R$FRT;@..RCD\Z=26I^HQ+?)JG]C28Y]SO,7]@4*PT'V=QA%F>=TGVS
M^^_5_FFU/<R^-FW;;)9]:_1CT[1U%U!]Z(K\7%</IS?K^K'M_^UWX/NAQWQX
MTS:[Y=! OSAU\=_\!U!+ P04    " !91CU0F \-EKX"  !%"P  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q-C,N>&ULE9;=CILP$(5?!?$ "^8O(4HB):"J
ME5HIVJK;:R=Q EK U';"]NUK&Y8-9K*A-P&;;XZ/)V:894/9*\\($=9;651\
M96="U O'X8>,E)@_T9I4\LF)LA(+.61GA]>,X*,.*@O'<]W(*7%>V>NEGMNQ
M]9)>1)%79,<L?BE+S/YN24&;E8WL]XGG_)P)->&LES4^DY]$_*IW3(Z<7N68
MEZ3B.:TL1DXK>X,6*0I5@"9><M+PFWM+;65/Z:L:?#NN;%<Y(@4Y""6!Y>5*
M$E(42DGZ^-.)VOV:*O#V_EW]B]Z\W,P><Y+0XG=^%-G*GMO6D9SPI1#/M/E*
MN@V%MM7M_CNYDD+BRHE<XT +KG^MPX4+6G8JTDJ)W]IK7NEKTSX)O2X,#O"Z
M *\/0-&G 7X7X'\$!)\&!%U 8 0X[59T;E(L\'K):&.Q]N^ML3I%:!'([!_4
MI$ZV?B;3P^7L=8WBV%LZ5Z740=L6\FZAGG"D?+^&!ZVQ]4;A?C1<(0&0V1!)
M 60.N_#!G?HZ/KB)#Z,(%@A @4 +^(-4N3&L$((*X<B"3+9O)'L,Q2@VT@4*
M!4;" ,B?W?$;@7XC:)G0\ M *#1.4 )"<\,P ,W<.__Q##0\@PP;9VT+0L9I
M2Z9 Z0-H8'@.&IY#"D9>M@ TSC"H9)R;= S)+X0+&XY!PS&D@ S#(&0:G@*E
M#Z"!8>3"%<Z%-,RW#J:,5RJ91*6/J*'K.W49 >7JSLN+P+*[0=Y_%"P$%TTT
MKII R0(HN>'03!Z@%?FCY$%4<"]Y<*5&P913"E/FEVD2E3ZBAJ[AKP,:%VSH
MH(*46;XF4>DCJG7MW/02)6%GW:=QZT OE5 ?Y)O9OA?<Z/;(F-^J'E'W*!\R
M;8/Y [-S7G%K3X7L='0_<J)4$&G2?9(F,]G3]H."G(2ZG<E[UC9V[4#0NFM:
MG;YS7O\#4$L#!!0    ( %E&/5"= %YU7P(  /P(   :    >&PO=V]R:W-H
M965T<R]S:&5E=#$V-"YX;6R55EV/FS 0_"N(]SNP^4Q$D)H[G5JIE:*KVCX[
MB1/0&4QM)US_?6U#$ F+E+P$V\S.[&X\V%G+Q8<L*%7.9\5JN7(+I9JEY\E=
M02LBGWE#:_WFP$5%E)Z*HR<;0<G>!E7,P[X?>Q4I:S?/[-I&Y!D_*5;6=",<
M>:HJ(OZM*>/MRD7N9>&]/!;*+'AYUI C_4G5KV8C],P;6/9E16M9\MH1]+!R
MOZ#E&OLFP")^E[25H[%C2MER_F$FW_8KUS<9449WRE 0_3C3%\J88=)Y_.U)
MW4'3!(['%_8W6[PN9DLD?>'L3[E7Q<I-76=/#^3$U#MOO]*^H,AU^NJ_TS-E
M&FXRT1H[SJ3]=78GJ7C5L^A4*O+9/<O:/MN>_Q(&!^ ^  \!N*NE$[*9OQ)%
M\DSPUA%=\QMB_F.TQ+HW.[-H6V'?Z>2E7CWG^A]-,^]LF'K0N@/A$2B.D@'C
M:8%!!8,JV!*$URH+F"$ &0++$%PQ(!]F"$&&$,@!H9M*.U!L0;4%/27I3*D1
M*!-!,OA&I@-%(YDTF%&)09484@E@A@1D2!YH: HRI/<T-)U6&J:PR@)464 J
M(<R ?'B/^P_4BF9\@NZIMD>-RXW">$8(M@J"O#+90#UJ+/2$@FA&";84"B"E
M.0[85"A\I+6P8Q!HF4EKIYZ)\8P.[!D$FF;2V7C:V7BN(-A:*(&$YK8!;"Z4
M/M)8V#H(],ZDL0M@S\Y\W&%_8?^>QO:HJV]K=+O;O-&Y9>X%/X@XEK5TMESI
M(] >5 ?.%=6$_K-.N=!7D6'"Z$&98:+'HCN/NXGB37_7\(8+3_X?4$L#!!0
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M<J_;VWES7_5'F_V#5B=S;!M>SXY7_P%02P,$%     @ 648]4%Q91Q@Y!
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M94N1!*TB[&6V.7\4<JN[UUG[7@]WE\.'5@=S+QN>+X>7_P-02P,$%     @
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M85U"B>]UV7]C9U8HN%:BUMCRHC&_WO;42%YV+$I*25_:9UZ9YZ7]DL9=&!Y
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M@>[M9SMNFH1+!_P@L7/.N1^^MN_DQ,6KW#.FO+>RJ.34WRM5WX6A7.]9267
M:U;I+ULN2JKT4.Q"60M&-Y94%B&.(A*6-*_\V<3./8G9A!]4D5?L27CR4)94
M_)VS@I^F/O+?)Y[SW5Z9B7 VJ>F.O3#ULWX2>A2V*IN\9)7,>>4)MIWZ]^CN
M$1%#L(A?.3O)SKMG0EEQ_FH&WS93/S(>L8*ME9&@^G%D"U841DG[\<>)^JU-
M0^R^OZLO;? ZF!65;,&+W_E&[:?^R/<V;$L/A7KFIZ_,!93ZGHO^.SNR0L.-
M)]K&FA?2_GOK@U2\="K:E9*^-<^\LL]3\X4DC@83L"/@EH#1IX38$>(/0OPI
M(7&$Y%H+J2.DUUH@CD"NM9 Y0C:P$#;9M<OU0!6=300_>:*IN)J:PD9WF2Z(
MM9FTZV^_Z163>O8XPRB))^'1*#G0O 'A#@BUB%#+MS8P9&..S^@DS?HF%N<8
M1-"H#WH A.*DC_ERCM$!#4!+R*.!L4? HW$T@N..P=S&5B'NN8+'L$("*B16
M(>D'DPY6IP&A9@TKB\IPD(Z[OT$B(0H)!LN^A%#C((*%>]&D8#0I% V!%0BH
M0&[(: 8J9) /@V)\:$!I)^XTBF K(]#*"+)R8<^,087Q#9&B"-[:T375XU"]
M529Q,*P8$)8% [4E!,NB3F7U';]P)B'(\0M;#X%GSCW"MR00WK\HAOP89&;A
M4"CN9B:*.@73'$Q7XA[_C^O[#I\<"#HZTDL:\'Y%Z2TYA'<L(E?ED)S'?)8_
M (-&& _/;0B'"<Z&?H>=*[)D8F<[(NFM^:%2YMSOS+9=USTV5^Q@?FZZ,7OU
M?L@TK=P/*G9Y);T55_H"M]?LEG/%M)M1H).[U]UC.RC85IG73+^+IH5J!HK7
MKCT,VQYU]@]02P,$%     @ 648]4!N^LQUE @  8 D  !H   !X;"]W;W)K
M<VAE971S+W-H965T,3<W+GAM;)56VXZ;,!3\%<0'+-C<0D20FJVJ5FJE:*NV
MST[B!+0&4]L)V[^O;0@BX2"1%WSAG)DSQH.=M5R\RX)2Y7Q4K)8;MU"J67N>
M/!2T(O*%-[36;TY<5$3IH3A[LA&4'&U2Q3SL^[%7D;)V\\S.[42>\8MB94UW
MPI&7JB+BWY8RWFY<Y-XFWLISH<R$EV<-.=.?5/UJ=D*/O 'E6%:TEB6O'4%/
M&_<36F\Q-@DVXG=)6SGJ.T;*GO-W,_AVW+B^J8@R>E &@NCF2E\I8P9)U_&W
M!W4'3I,X[M_0OUCQ6LR>2/K*V9_RJ(J-NW*=(SV1"U-OO/U*>T&1Z_3JO],K
M93K<5*(Y#IQ)^W0.%ZEXU:/H4BKRT;5E;=NVQ[^EP0FX3\!# NZT=$2V\L]$
MD3P3O'5$M_@-,=\8K;%>FX.9M$MAW^GBI9Z]YAA%*/.N!JD/VG9!>!041\D0
MXVF"@06#+-@"!/<L&$8(0(3 (H3W",%#G5U0;(-J&Q2&?@C3A"!-"-&$#S1=
M4#2B25*8) ))(H@D@A%B$"%^8CT3$"%9LI[)1.C*GU&Z EE6$Q:$4P0CI"!"
M^H12Y,-;W%^BM8^*[C;/'-&,EQ D=PX#=@IZQBH(]@I:9)8^:BPX0#-?%\%N
M05.[:,'!# 9L!A0](QBV XH7"8ZGOL4S?P<$NP9-;:,%SV' GD"K9P3#KD#I
M(L'I1#"*Y_[;L'<PZ)UX!@.V!49/",8S!PA>(KB/&A\ * T?]Z,W.AO-W>,'
M$>>RELZ>*WW,VL/PQ+FB&M%_T8M7Z.O.,&#TI$PWT7W1G?G=0/&FO\]XPZ4J
M_P]02P,$%     @ 648]4(>PX[P(!   )Q8  !H   !X;"]W;W)K<VAE971S
M+W-H965T,3<X+GAM;)68;8^C-A2%_PKB!RS8U^9EE$3:S:IJI58:;=7V,Y,X
M$[2 4V FVW]?\S)IQC[NP'R8 +F^W'OB!Q^\N>KV>W=6J@]^U%73;<-SWU\>
MHJ@[G%5==)_T137FFY-NZZ(WI^USU%U:51S'0745\3A.HKHHFW"W&:\]MKN-
M?NFKLE&/;="]U'71_O-%5?JZ#5GX=N%;^7SNAPO1;G,IGM7OJO_C\MB:L^B6
MY5C6JNE*W02M.FW#S^QA+\4P8(SXLU37[NXX&%IYTOK[</++<1O&0T6J4H=^
M2%&8CU>U5U4U9#)U_#TG#6_W' ;>'[]E_VELWC3S5'1JKZN_RF-_WH99&!S5
MJ7BI^F_Z^K.:&Y)A,'?_JWI5E0D?*C'W..BJ&_\'AY>NU_6<Q912%S^FS[(9
M/Z]S_K=A> "?!_#; ";^=P#- \@:$$V5C:U^+?IBMVGU-6BG7^M2#)."/9 1
M\S!<'+4;OS/==N;JZXXSF6ZBUR'3'/1E"N)W092\#]F#D/^R1*:$6QT<UL''
M\?2^C@QG()B!Q@SB+D.>67U,(<D8TDPW$91:W>Y!5$ZIP+4(6(MP:C'=Y#B#
MA!GD"CT2F"'Y6(\I1-YURLP?M_0 4<13AFM)82TIT".)<88,9LA6Z)'##/G'
M>N1NI^8NEAP@R%L)BS%T,=+#HRCS@,M6*,(P=(Q_K,D<(]]!8\/OQA"7GE(P
MO<S%UTC"/3DP=4RLD01SQ^0"2228 CFS17&C,B)/,1AAYC)L1/'EP.BQ=(TH
M&#Z6+1 E<^< V9* &-^LQQ SEV*CB.?9S#%]/%ZA",?T<?:Q(G.,]TDQ:0*B
MLM@S[[EG[70Q-J)X^..8/TYK1,'\<7?9<T41:#6Q)PJ,8IX%@V.2N4NR427Q
MY,  \F2-*AA [BY^KBJI"T9B6RP4)#T/ XY!YB[(1A.?4<,(\GR-5<,(DKL
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M11!L.X2G:-*A'@O.R/ 3 *"(XYU'L(<19&*"'!RP]5 \1Q;8?(A,DH5,D@5
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MWZT*^6#&9-[LWMSG;O^_\6ZWX[O?KK0.]F+V;3?2$?3Q -*O0,:?0ZX!)+Q
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M'4S'U4T*OM-VF)JQ;-J.9J)%W;940=?7+?X!4$L#!!0    ( %E&/5"F-I^
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M'D7@@P_8X+N*0 :?,FH/"@*C*?<1POT!D#T!H@C$($CLLR+ '0)N<@B#FFP
MJ;/_1E"4VAX<79T<^K/?MZ+=E4T7O$BE#R'#46$KI1(Z8?R@:]OKX^9E48FM
MZF]3?=^.9ZYQH>3!G">CRZ%V\0]02P,$%     @ 648]4'A^+CT' P  HPT
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M F)2PAE*,$/Y :4NP R+>Y2Z<(\E+:W=<#%IZF&"8OCSC^_1JD'-CF:RD'$
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M0L$#!81 @6][#($FUA*"3P@4 LY,[%X$GQ$(_T<1X1, 04? 71$!T"C:/B4
M"-T5$0#AB1,'P4<.BAXI(@2*;8\!$++WH3>ZVRK*3Z9O$$[&SK74%\1H=NA-
M5H&^&ZWYM>Y9S)WY5Z9K>+X1?BIJX>R95#>ON1^/C$FJ?/2?5,)RU6,-@Y(>
MI?Z,U3?O&HUN(%G3-U'>T,DM_P!02P,$%     @ 648]4*C*A]7J @  _@L
M !H   !X;"]W;W)K<VAE971S+W-H965T,3DQ+GAM;)5676_:,!3]*U'>V^0Z
MGU2 5$#3)FU2U6G;LPL&HB8QLPUT_WZV$](0WU3EA<3FW.-[CWV<.SUS\2KW
MC"GOK2IK.?/W2AT>@D"N]ZRB\IX?6*W_V7)14:6'8A?(@V!T8X.J,B!AF 85
M+6I_/K5S3V(^Y4=5%C5[$IX\5A45_Q:LY.>9#_YEXKG8[969".;3 ]VQGTS]
M.CP)/0HZEDU1L5H6O/8$V\[\1WA8D=@$6,3O@IUE[]TSI;QP_FH&WS8S/S09
ML9*ME:&@^G%B2U:6ADGG\;<E];LU36#__<+^Q1:OBWFADBUY^:?8J/W,SWUO
MP[;T6*IG?O[*VH(2WVNK_\Y.K-1PDXE>8\U+:7^]]5$J7K4L.I6*OC7/HK;/
M<\M_"<,#2!M N@!(/PR(VH#H/2#^,"!N ^)!0-"48K59447G4\'/GFBV]T#-
M*8*'6*N_-I-6;/N?ED?JV=.<1&DT#4Z&J04M&A#I@:!#!)J^6X-@:RR($QZE
MURLL$4AV#5DAD!S/(D(KC6Q\=%UIC#/$*$-L&>(^0T@F ZT:4&I!=:,5)/F@
M7!>4AP1/)4%32=Q4HJ&HBP:4]%:)!CN[="%D9&M3-(_4R0,(1#A#AC)D-VQ+
MCC+DB!9I,M B=PJ=#"!+%W(' TE7N;-Q=Q!.\&PG:+83+-L49X 0]VQX@V8P
MXGOXS&%N47U-\GAXAA!0,LE&LD%OB$<@F"IC'+B_X1:# ^YP^)3%6]25L6!X
MFA 0"9.1;'"3 ^;R=.32 ]R@D-ZB"FY1R#ZE2N:JDH]<:H [&3 K.]<:(%[.
MQAR$FQ!0%X[XF. N)+>XD. N)(@+W;N+N 9+1X0EN+\(YJ\L'.' _45N\1?!
M_440?R'UNI]'Y\.%8&!X!H)>$U0QL;,-IO36_%@KTTGT9KLF]I&8)FHPO]#-
M;=.*OM,TG?$/*G9%+;T7KG2+9ANI+>>*Z13#>[UA>]V,=X.2;95YS?2[:#K2
M9J#XH>VV@Z[EG_\'4$L#!!0    ( %E&/5 %)3BNBP4  -L>   :    >&PO
M=V]R:W-H965T<R]S:&5E=#$Y,BYX;6R-66%OHS@0_2M1OF?!'AM#E4:Z)JSN
MI#NIVM7=?::-VT0+(0NTV?OW!X2-DIGG5;\D@3S;SX/]WHQ9GNKF6[OSOIO]
MJ,I#>S_?==WQ+HK:YYVOBO93??2'_I^7NJF*KK]L7J/VV/AB.S:JRDC'<1)5
MQ?XP7RW'>X_-:EF_=>7^X!^;6?M6547SWX,OZ]/]7,U_WOBR?]UUPXUHM3P6
MK_ZK[_X^/C;]573I9;NO_*'=UX=9XU_NY[^IN]R8H<&(^&?O3^W5[]DPE:>Z
M_C9<_+&]G\<#(U_ZYV[HHNB_WOW:E^704\_C^]3I_#+FT/#Z]\_>/X^3[R?S
M5+1^79?_[K?=[GZ>SF=;_U*\E=V7^O2[GR9DY[-I]G_Z=U_V\(%)/\9S7;;C
MY^SYK>WJ:NJEIU(5/\[?^\/X?3K_XVAJAAOHJ8&^-%#FEPUH:D ?;6"F!N:C
M#>S4P+(&T7GN8S W15>LEDU]FC7G]7 LAF6G[FS_N)Z'F^/3&?_KX]GV=]]7
MFIQ:1N]#3Q/HX0S25R!'[A:SEAA*;B$; &&]Y "27B!1/Y/+=#2<CA[;TW7[
M#+<GV)[&]N8V')I-]0Q*1M!A!!EGC&6S!2CC+ MM#E":0G,VD+,1G)UEH5^?
M,?9J&$N,KX2D;.*YA!C"3"UD:E%T&8^UE8,XDZ6,+4"9E%A?.4!I2A7FG$#.
MB>!L..-$C**4RQAA -()>TPY ,4Z$&('Z3I)US"Z3@RR4,9HOGXAS*J8448P
M2BA .H6D4[0N..U4#$0]:;9$-P"E;,H>1BY1.G,NL"XRR#F3@>:;+D,1I(2O
M# 3K-9A+(X)IDUA,6L58[F-)6RAY+$?*3,PCC6"I$:&&,$H#JJP"+J4D[933
M5O*AQJ0X:XE2B1:D 2K3.L 96Y'2DG/&.6L9G'Y5"^,$,)W$@C6"J2N/O:6-
M'5!!"[2<.(FALC@5O"4J-3$7:81R<2C8V .5-$$N#6LE[6N1VIAS!JB,N!,B
ME+OJZY8S=D,E[9";\EH!!^-"#3"*/XH<=10*,39"!9PP%IM0.EC::P=G#'S.
MQ)GEG"4L4\&%@?U024.T8C$C#W,93Y @3$O6");$ 4-4V!&5M$0K=%JZV$+%
M0O 02BX/X(BQ"5#&AJBD(UJV/!XFS$VZFV2*3TQ:W0WJM@[ 1J>ET5FNOEI:
MD[$97ZP !0((4,$ :FQR6II<&BI^ M7/Q\L?C=5?2_67FUP#P9:;'*#0)@>P
M\";76/TU4'^^R350;+#)(4QN<@@+;G*-#4!+ PCE11IKLDX^_L"Q/FJICZ#B
MU5+3E'..QTZBG.(Y3PY023#WUE@>M91'6?-J4 OP)!9@#.<+N@F0Q<*HI3""
MLE=+T5,I3_$V .44SQIR@.I#'% CP@)*H%+@XY 4O4!H"$L>@;R>UWTD<_%%
MFG"U02C*4L$8P6Q(9@G++,G,'M2K)+/QC&^&#0"1<KS&AJB05%#@9 LH.]\Q
M)+5XD1 _>D$H[2S?-Q!F*:#LA)6=I+*+>I60%AN^TQ'*IES7,2JTJ+&LDY1U
M4:P2R-G% :+$).+X$)V6!=AB"R&0UO-$B60BOE"*6R=$\5HVAZ@LI$W8M B:
M%G=\0G;$.8-D79-8R@#E0HL".Q:!A%Z<*\.$GC,&('YVET-0:%U@UR*0SG//
M(G F)58%.K?B='_9S^T1.'8K ]Q*Y*U&VA6O4#8 ,QRU,,((I4+9G\'>9Z3W
MB:35 +M2O([9 !1WHQQ@* ZL"(-MSTC;$S6I 4=0LB:%*%%2 52PI#+8](PT
M/?[$UT;Z5+C:-(%7,*  X2(Z86YJ7UEM A0*C43)T$17[P"'U[Y_%<WK_M#.
MGNJNJZOQI=]+77>^[S#^U$]_YXOMY:+T+]WPT_6_F_/KUO-%5Q^G5\G1Y7WV
MZG]02P,$%     @ 648]4$XX,VBK P  A!$  !H   !X;"]W;W)K<VAE971S
M+W-H965T,3DS+GAM;(U8VV[;.!#]%4'OK<2A;@YL [&-8A?8!8(6NWU6;-H6
M(HE>B8ZS?U_J$E<A#UN]6"9U9GAFR#DBN;S)YJ4]"Z&\MZJLVY5_5NKR$ 3M
M_BRJO/TL+Z+6;XZRJ7*EF\TI:"^-R ^]454&%(9)4.5%[:^7?=]3LU[*JRJ+
M6CPU7GNMJKSY?R-*>5OYS'_O^%J<SJKK"-;+2WX2WX3ZY_+4Z%9P]W(H*E&W
MA:R]1AQ7_B-[V''>&?2(?PMQ:R?_O2Z49RE?NL:?AY4?=HQ$*?:J<Y'KQZO8
MBK+L/&D>_XU._?N8G>'T_[OW+WWP.ICGO!5;67XO#NJ\\C/?.XAC?BW55WG[
M0XP!Q;XW1O^7>!6EAG=,]!A[6;;]K[>_MDI6HQ=-I<K?AF=1]\_;\":-1S-L
M0*,!W0U8\DL#/AKPGP;1+PVBT2 R#((AE#XWNUSEZV4C;UXS3.\E[U81>XAT
M]O==9Y_L_IU.3ZM[7]?$TV09O':>1M!F -$$Q.Z(0+N_CT%HC U9YMP880L@
MZ4?(#D RS(+#2'EOSZ?V"VP?0?NHMX\F]FG"C$0-F*3'U$,VH]@(%6 69,1J
M8Q@+,=D8DHT!66.0S8"))X-,$CIPM2&?C)G; 0A1BKDFD&L"N'*#:V*/$IE9
MVP)03,84[0"(90GFFT*^J<4W<RRD#-IGLQ?B MHO?K\0MPLK2L)#L!#+0OC[
M2=F.H(^Y-$ [!'+4+7-(% -<(E.BF#W,PN2+,!9? $H=<L>@WCTR H1CAPLL
M5FR^6C$L5PSIE27L$9I!2[(@+,I,U<+>0N[@C96+(>E*3=Y(=4)3#Q"*AZ8@
M(!2+'0K&L(0Q6\/T9]3E \L*2^=/.186ELV9\@Q(J94Y "(>FYE#*.:*&HL9
M0VJ6FG1L.?OD6%6$]8R0GCEDB+ ,$9L]/X1U@9 NF/,S@HQ%ZU /PNI!'"U'
M5[A8/RB:'RZN9$*5;(4+JL\U#*X]0OL'EPM<>C2_] B7'LTI/4+UDME[802+
M,VL_C& )10[>N/QH1OEM")0?8]9F$<&RR)1;A$IBQ^Z$XVKF=C7K]>V8,8[+
MF<\O9X[+F<\IYQ&4?,A=:NQ>MAP4/0MC\P.+88EC]\H=YR!;'&S%'4$?:/.%
M.9<(97TY@\E1M!+-J3_FM]Y>7FO5G><FO?>KA$?JCK)&_X8][(8+@9]NAON)
MO_/F5-2M]RR5/BCWQ]FCE$IHCN%GG:VSR _W1BF.JONK3_!>,]P+# TE+^.=
M1W"_>%G_ %!+ P04    " !91CU0E"+CVU$"  !2!P  &@   'AL+W=O<FMS
M:&5E=',O<VAE970Q.30N>&ULC57;CILP$/T5Q <L]UM$D#:I5JW42M%6;9\=
M,@EH;<S:3MC^?6U#6 ).E1>PAW-FSLS@<=Y1]L8K &%]$-SPM5T)T:X<AY<5
M$,2?: N-_'*DC" AM^SD\)8!.F@2P8[ONK%#4-W81:YM.U;D]"QPW<".6?Q,
M"&)_-X!IM[8]^VIXK4^54 :GR%MT@I\@?K4[)G?.Z.50$VAX31N+P7%M/WNK
MK:<)&O&[AHY/UI9*94_IF]I\.ZQM5RD"#*50+I!\76 +&"M/4L?[X-0>8RKB
M='WU_J*3E\GL$8<MQ7_J@ZC6=FI;!SBB,Q:OM/L*0T*1;0W9?X<+8 E72F2,
MDF*NGU9YYH*2P8N40M!'_ZX;_>[Z+_&59B;X \$?"5[\7T(P$()/0JB3[Y7I
M5+\@@8J<T<YB?;=:I'X*;Q7(8I;*J&NGO\ELN;1>"C](W=RY*$\#:-.#_ G(
M&Q&.=#_&\$TQ-OZ"'L2W$;8&2&(.$1C3"#0_F/"3Z([&T.@@U ["J8,TF96A
MQ\0:T_1E")-PEHD!E$Q -U(BHY1H*26;=Z3'1),H23R3NUUBO"CSS4IBHY+8
M4)1TIB1>1(GNM2XQ!DD60=+,S$^-_/3QUF=&!]D#K<^6M?2"6;V7F,B[DXGG
MF@^C^T#K!] TSN(X#9B;OS"+[VBY,QB\!YH_@*9Q@ED49S*)"+"3'MK<*NFY
M$>K$3ZSCQ?#LJTDVLV_4A:$GW*>;_K;Y@=BI;KBUIT+.23W-CI0*D K=)UFG
M2EYPXP;#4:AE(M>LG_+]1M!VN,&<\1HM_@%02P,$%     @ 648]4.K;41'&
M @  ,0H  !H   !X;"]W;W)K<VAE971S+W-H965T,3DU+GAM;(U676_;(!3]
M*Y;?6QO\$;M*(C6)IDW:I*I3MV>:D,2J;3P@2??O!YBX#EQ7>XD-.>>><Z_A
MPOS"^)LX4BJ#]Z9NQ2(\2MD]1)'8'FE#Q#WK:*O^V3/>$*F&_!")CE.R,Z2F
MCG <YU%#JC9<SLW<$U_.V4G654N?>"!.34/XWQ6MV641HO Z\5P=CE)/1,MY
M1P[T)Y4OW1-7HVB(LJL:VHJ*M0&G^T7XB!XV*-,$@_A5T8L8O0<ZE5?&WO3@
MVVX1QMH1K>E6ZA!$/<YT3>M:1U(^_MB@X:"IB>/W:_0O)GF5S"L1=,WJW]5.
M'A=A$08[NB>G6CZSRU=J$\K"P&;_G9YIK>#:B=+8LEJ8WV![$I(U-HJRTI#W
M_EFUYGFQ\:\TF( M 0\$E']*2"PA^2"DGQ)22T@=0M2G8FJS(9(LYYQ= MY_
MWH[H580>4E7]K9XTQ3;_J?((-7M>XJ1 \^BL(UG0J@?A$>@#$:GP@P:&-%;8
MHR?YK<(:@,QN(1L 4L N$C#3Q/"3,;^$^2G(3PT_'1>A=#RN>DQN,*W!W"&4
ME4ZR$"J.G:)O -1LEL&.,]!QYCG&<>$X[C'92"7!F9/6V@?=H=S]/@ H11-^
M<]!O[OM-"NP8SCV9S%U,/L0SZT,2E,)>9Z#7F>>UF%A-!<@O_GLUEB"_A&J5
M.+4J_4^")U10#+>'&-))W?X0^T(YGMB=:*(1(4@I<Y40H#1:K[=*8#MZ1!A2
MRETE["MEL;,:UQ *V,L0;'(S([A_H02R[2YLBQHKH32>$((;'?([G1)R&X=%
MW6RAM,032G"#0D"'\G>\18T[(4;>A_!!;AO; !BW,M'HW&PH/Y@[B0BV[-1*
M??B,9H=[SR/6YZXSO]+W(7,>?X3I+U,_"#]4K0A>F52GNCE[]XQ)JAS&]\KA
M4=W?AD%-]U*_SM0[[R\Q_4"RSE[0HN&6N/P'4$L#!!0    ( %E&/5"A0?TF
MRP,  !P3   :    >&PO=V]R:W-H965T<R]S:&5E=#$Y-BYX;6R-F%MOTS 4
MQ[]*E/>1^)+;U%9B'0@DD"80\)RU[AJ1Q"7Q5OCV.(DIJ?TWY&6Y]-Q]?L=>
M5F?9?>^/0JC@9U.W_3H\*G6ZC:)^=Q1-V;^2)]'J7PZR:TJE'[NGJ#]UHMR/
M2DT=T3A.HZ:LVG"S&M\]=)N5?%9UU8J'+NB?FZ;L?MV)6I[7(0G_O/A4/1W5
M\"+:K$[ED_@LU)?30Z>?HHN5?=6(MJ]D&W3BL Y?D]LWG T*H\372IS[V7TP
MI/(HY??AX?U^'<9#1*(6.S68*/7E16Q%70^6=!P_C-'PXG-0G-__L?YV3%XG
M\UCV8BOK;]5>'==A'@9[<2B?:_5)GM\)DU 2!B;[#^)%U%I\B$3[V,FZ'_\&
MN^=>R<98T:$TY<_I6K7C]3S]DA&CAA6H4: 7!<+_J<", ENJP(T"7ZJ0&(7$
M4HBFW,=BWI>JW*PZ>0ZZJ1].Y=!VY#;1R[4;7HZK,_ZFZ]GKMR\;RO)B%;T,
MEHS0W21$9T(LO1;9NB(9RZYE[H%,SJYEW@!7?\U$.I5+/A3F0T=]-M<OL#Z#
M^FS4YS-]0F.K')-,.LJTDTS!K9K= Z%L5K6K4#@,A3NA%%:U[B:19.XDS>RR
M Z$DX3B2!$:2@*(4,;:00@OIXF7)H'ZV8%DR)T_*/07/H9/<<4)9["E4 2T4
MB],D,<8Q7I"H$9IGFE+J\>/!GJ E33PV,&ID.6L$PT:6T$8 27%./(XP2L1E
M*?>%BA$@R?)D,0(D!>U5Q/;\2YUL*?4YPJP0%Q;MB-B.7%R(AQ:"<2&(EX+:
M?G(72\(\CC!5I$".G)VC<!S=I)Z.II@^"NACB9T1=?$C//<XPOA1A)_5"ELC
M=-4*J;W-&*&K\N:>=:2>+9/^=Z/9&IG_Q *$,E\L>")0=R+HI?;,8(IAIWPQ
MJA3#3MT-#Z!JI*[&L"]2/!(H' DVJ49J[L?7UG@@4#@0G+9V!T+B*QL>"!0.
M!)M3Z@Z$&\_F1?$\H.X\0)BZ\R#Q'"49'@?,'0<Z'T_M&2:=D>4'4HPG<_$$
MS6BDKH82\:7K.?I"]NQN-%)S1[Y\,)[,W8M!-S)P:HT]0Y9ABAFDV&Y'YE)\
M0WV.,,;,Q1CT(W,QSCUG:(8Y9I!CSX!EF%&6+^]'3!^#N['3CRY]OCV28_HX
MI,]N1^YNQIYAPC&@W-V*03MR=YOU_6_!,<8<8FQW(W<QOF&>B<,QQAP<JMUN
MY.!4;9^IH]E'A.&[T<>R>ZK:/GB42LEF_&IPD%();2]^I4,^BG)_>:C%00VW
MF;[OIN\UTX.2)_,M*KI\$-O\!E!+ P04    " !91CU026Y"R[H#  !F$
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M_%_LW]JN+J=1G)4R^SE^YM7P>1F_41]A= !, 7 -X,DO \04(.X-2*: Y-X
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M=W2LZ\ZZ(=DG9_OD-OW7D\(>N_Y0N^-FW/F.)UU]GG;U\?6GA<W_4$L#!!0
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M2WU]5'=N%]8:D@W36X3F!S'_#U!+ P04    " !91CU0^V.6:"4"   J!@
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M=9_-K3LR)D%Y#&;J551J< \' D>IMW.UYW9\V8-D;3^9T?#W4/P%4$L#!!0
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MB^ &0" V6<S(IRJX;'WXP1RY<,EOJX 8KBR_C8 0U5:*'TQ^"RB_ 2!T3%=
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MMUAFT44:9CH"LC/R-)I#%[E ;@ $8I/%C'QRXXK5?$=SXV+=.J>;\A9Y].D
M",6*%49'D]XB2F\C(!0KUO0<S7J+/ !U  1B3=^NS(V+V!\W E+'<_J1<YXB
M8A< &G$*B.R<T\VBBUPA-R*R<TXWB2Z2'5>L?#F:'1?;UCG=I+?( U$'1#"F
MO^(T[2VB]C8B0C%'Q+RWR&-1!T0@YHB8'1>Q/VY$I(WG]*<_!YH08B)=I,&G
M(R$[XU&C:721&^0&0B V6<S0)SVN6--W-#TNMJUSNGEOD<>D#H10K%AE=#3S
M+:+Y-A)"L6)=S]'4MXC#4D="(.:$F" 7L3UN)*2/Y_3IGXI'4^DB.'( "*5T
MSYI(%[D^;@ $8I/%C'P2Y(IU;T<3Y&+?.J>;^19Y<NH("%)MQQ!SWR*Z;P (
MG=.#'$.2R6^)IZ<^ D(Q!229(I>P/6X Y!X;!US8>D)_HK&H Q^8LBV;S*1+
MW![WR ?%)HL)^(D,N6+M[<D,N73;.:8G\]X2STY]Y -CQ2K5DYEO"<VW@0^,
M%>M"3Z:^)9Z=.O(!QW3G0]!/6" '?(S']"=3P/ PD2[12-01CYW!J<DTNL3]
M<0,>$)LL9MR3'E>LF3Z9'I>.G4-Z,NTM\=S4 0^*%2N<3^:])?3>1CPH5JR^
M/9GWEGANZH 'Q!P/L^,2EL>->!SC(3V%Z1N(B72)!J("(1MG]&0:7>+ZN)&0
MC3-Z,HLND1Y7K @_F1Z7PLX9/9GVEGAJZD (Q8KUZ2<3WQ**;R,A%/,;+#/?
M$DY-'0F!F!-B?ES"_KB1D#">T?NW Y*,$%/I$HU$'0G9&9R:3*1+*-*-A$!L
MLIBACX*<]6 G$^12V#FC)_/>$L]-'0BA6+&) \G,MX3FVT@(Q8J-"DBFOB6L
MCQL)@9@38H)<XO:X@9 (9_3)+9:)=(D&HHYX[(Q-3:;1)=3H1CQVFN.2672)
M++IB@QN2^7$I[IS0DSEOB:>FCG@@TW8F,.LM<77<B >=T&U*0#+M+6%UW(@'
MVG$V)2"9'9>X.F[@(XU']#"UL9*)=(EFHHZ([$Q.3:;1)=3H1D1VJN.2672)
M++IBS?W)_+B4M@[I)KTET-EHTU*L6'-_,NTMK0U.Q5BQYOYDWEM"[RT]O*RO
M?GW//=U'OOON%]S:Q9/,D$M+@U,QI=O(-+JT-CB58I/%#'_4XZQ0/YD>E[8&
MIR83W]+:X%2,%2O43V:]I;7!J1AS0LQ[2VN#4S'FA)CXEE!\ T*N7(C/"&GV
MM]#)!+FT-#<54[YE#?ZUN:D4FRQFX*,=9],4DMEQ:6MN:C+O+:W-3<58L<[,
M9-);6IN;BK%B P>2:6]I;6XJQHI-"DCFO27TWO+#:G]_CX7T_%<3(5I753)!
M+BW-3:74^:^R2XUI=&EM<"K&)JL9^^C'^=XVK+<FIR8SW]+:Y%2,%2M43Z:]
MI;7)J1AS1$Q\2VN34S'FB)CYEM!\&Q&Y8L]/!E8&FTR/2TM34S&EEW1SZ-+:
MU%2*318S[M&-LP[\9&Y<VIJ:FLQZ2VM34S%6K+@]F?"6UJ:F8FP"AX&_-C45
M8PZ'.6\)G;<1CBL6GM.AG[J;&9>6!J9B2C>LZ7-I;6 JQ2:+&?:HQ5G9?C(M
M+FT-3$TFO*6U@:D8*U;:GDQV2VL#4S%6K&T]F>Z6U@:F8JSHY=Q\MX2^V^-J
M/[O'PO,JGFHUA\FTN+0T*Q53NF/-G4MKLU(I-EG,N$<GSFK$DSEQ:6M6:C+;
M+:W-2L58L3;R9*I;6IN5BK%B9=O)9+>T-BL58\5:LI/9;HE;XX;/7*_82[/6
M/W U*RXMC4K%E&]9(W]M5"K%)HL9^*C$68UX-B4N;XU*S2:[Y;51J1@KUD:>
M377+:Z-2,5:*O%EED]WRVJA4C"D?V6RWS+5QCWS<8\M>;38O+B_-2\64;=IL
M\EQ>FY=*L<EB@GY&*<ZJUK-)<7EK7FHVW2VOS4O%6+&J]6RV6UZ;EXJQ8DW2
MV7RWO#8O%6/%FJ2S"6\9A;?'JL.?WV-/@L2[YV:M+6?X+PU+Q91N6;/G\MJP
M5(I-%C/PT8JSIO5L5ES>&I::S7?+:\-2,5:L:3V;ZY;7AJ5BK%C7=C;;+:\-
M2\58L9+L;+I;YM*XX1WDBKT0S]OL+\2SF7%Y:6 JIG37FCZ7UP:F4FRRF+&/
M6IPU)6?3XO+6P-1LPEOF@:D#(A0K5KB<37;+W!LW($*QTG0+&?ZLNPV(8&^<
M(V+X<V_<B$@;$3F\R2V;&)=I$"H 0BE[W<R>RVC/C8!@N9PN9N2C%6=MZ]FL
MN!QW3NG9?+>,OML(",6*M:UGT]TR]\8-@&!OG+Z'F/"667@; ,'>. 7$C+?,
MO7$#('$\I1\SM3:;&Y>A.PX(H91>U4V@RRC0 2$;Y_1L_EQ&,<XD@VQB7$Y;
MYW0SWC(:;R,A%"M6N)[-=LM<&S<0@K5Q5KB>S7?+[+L-A$"L6:-)-M\MH^_V
M;'>\C_WT'CO2BT.(+6;L0VL<P$$IW:^FSF54YT8X(#99S*A')<Z*"+(I<3EM
M'=%-=,LX)Q7@0*+MIM!4M\R-<0,<V!BG<)CKEGE*Z@ 'Q!P.,^(R%<8!')E^
M>ZYO'2;.93#B@ Y*Z88U;2ZC-C?206UQOIAACSJ<U>QGT^%RWCJ@F^:6<43J
M2 ?%BG619Q/=,M?%C730 =WI,/)Y1NI(QQAS.LR'R]06!W1<L>.YO]M,OLJF
MS67PX8 .2NF&-6DNHS0WTK%3%9?-F<LHPW4[>I@,E\O6V=P<MTSV&M"!DIL-
ME\@FN67NBAOH0,E-Z3#)+?. U($.B$WH,/"I*H[H:'1C99<9,^8RJ'!$Q\:O
MS[/Y<AE]N9&.G9ZX;+I<1@_.1GUD\^!RW3J8F^*6:3HJT$&Q8H-%LDENF8OB
M!CJP*,XF@F2SW#)/1QWH0!G.)H)DD^$R%\4-!_,Z'LRG#>O9M+D,/AP00BG?
MM,8^2G- R,[!W)RYC#*<33'))L/EMG4P-\TMTWA4((1BSU^.A]4,:^Z)&PBA
MF'](:*9;YO&H R$4J[IA38C+V!,W3$*[Q\K+]X\I(R;/9;#B@!%*Z;8U=2ZC
M.C<RLE,4E\V<RZ3$51N<DDV)RVWK?&ZN6Z8)J<0(Q*I-%\EFNV5NBAL8P:8X
M9<1TM\PS4@=&*.:,F!67L2EN9.2*C8S8>G8% "\. *&4[EF3YS+*<R,@.T5Q
MV=RY3%)<M:$PV:2XW+>.Z":[99J1"H!0K-K@C&RZ6^:FN!$0B%6;9)+-=\L\
M)74$!.&7U[68%E>H*:[>'I[)7]QC3[\G_.X^ZQ-YW8K9<P6TN!$/3-F.+>;.
M%73G!CPH-EE,N"_DQ%5K]"[FQ)7;SAF]F.E6<$;J@ ?&JDW-*.:Z%2Z*>\0#
M8]5^15!,=BL\(O41#XQ5&Z]0S(DK6!3W^/[Q#_?8\_>/8.07,^<**'%$Q\89
MO9@W5]";&^G8J8DKILT5\N&JM;P4\^'*L7-&+^:Y%9I["G10K-K0A&*F6^&>
MN($.BCD=IKH5GH\ZT$$QI\.,N((]<2,=5^QX/JG\/,I_HAO V <G#@"AE.]9
M(Q_%.0!DXXA>S)LK),15FW513(@K8>>(7LQR*S3V% "A6+7/08MY;H5KX@9
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MS=;3BP+Z@OI+KJ"^8#BV/A<(Z@$&+@,<J4$/T*9-GG'E'<L @1KT!?WM1CW
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M45V_B*[?2,P]MT),5-,O@ND'Q&!,=W!4'S!B>^!(#.5FZ]D%(:(.J -AH^J
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MP3K R7.NUP0<'0S$4&Y"C%I]$:T^(";"R=]_IQA5ZXN@]1$T%)L\H7I%X-)
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M(X#<)M5#=+<NGJ*'='5_;,"/10V4]:YS6$U] 2])BCXRY$V ]/^/:%,\"@;
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MW[0X"+\W;@\2-)24ZZ<TS:,!8#F2'<%V06W6Z!"VZOX!AI&V]H1J'.):I<3
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M83!9KC12:P'E2T=KP3 "WT]@BD1)F+<-':2ST0MR&R6MI3)! 8Z)V@ +DJJ
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M^5*8;9>FKH4H<U89]NK0LI1G.]<J)GWP)FW9S&= %%V\_<O/[R^/H*73>4_
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M[<-/-4_21)8N"T$#70N%:6MN Y7-/9+T8XK0D*#5@N/&N.*;GLF>LAG7-J'
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MJBD-#Q?Y+Q4TSX_2QIO)W!:#GNKD,V=H4@04$BQR%[2,S_YEUL3CF*[>X J
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M:_=41-:N']U,IBP8@,K;A8NF 5IR!T>.820R"2PJN2_0=BUVG-;'ZBVY5]P
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M_OP-*&C_<1- C7;L %O035#B@*>8#DLFVR.7LU+MYFW9[.;1\] 2C'XI@:T
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MICBA)(JG4_7769+78_HW]#N96#../&Q;D<_RP[%8I4;V_&PVSDJBDP"_K2?
MIF@&Q25'NFU4:SPU2VU[QGS912$!-43*87[,O&H"P5B7!X"S3FX1^[*-QXO'
M(<8BRD&'-GMP6D>_A9K*'9\U@QN>27U;X_P&U'>JXQ[:U'=VG/K&)U)?;7_Q
M4K1:_O?C5#IN)-;XY.H+/>W>&?M^-"_0TB<%^!G<X73MPO.D_9?XP4# ,&(%
MT=/2R-;8]/(*NZ:A0DG#I+N2>L[CC<.[!L3)!/55_OJL&&QL".+I ,R'>\.M
M?&[^\K?;J[@/M)?H'K?\3$EN]R^R5>>SW'-+!.,.,7(:>[_M*J9^20WC/NRC
MB]L?;BZQ^GZJ(I[Q[37V?8/=F0UQX3*.8.1H0U"#*&#9TCT #HQ&@Z$U#_\>
M-NP;WF&1ERS:9MN4>FPB'HB]+W N!'\/U ;$FJ=\2.N:<O=*M,]=?/CX\5+"
M*LT^L'0<8=5F7Q ,X#.3BN:B02]NWM]>\IZ)&6UVM:MQS.(GH"Q@^8JL?OAU
MA1"\N/WI=7Q)DYT7/?8F7Q7+?:UBDHT>'L^^ JMH#']A_K[T^,:YT<L<H<SD
M&'"27N+36J)*7NI*:4U_%%)-1\^U<CRP\K\S$WKF.F4S;,=J=P=IF#W[7,(R
MHY'C13IQP:?UK;PS'4SU!;RC-<YO(KF/#_&.^!3)??@OYQU*6S@&&00FB)#8
M@Y[DRH!#;&;*G7>$=K20T%@\"%TICUWLR+Y;#N7\JU1:U^#&4ZQ'9H.,I2(K
M\12@ U0&@>J!V[(04OI2EQ_%#P('H8%.2A+V5$]7+?@;L&)?76)C-LD>:[8P
M'_4*RV+ .'M69(N=D+YV=XE:1J_*'8I\^:^[>]56C;V&JG5W@US8;N[2!A7Q
M;I-00=#D/FU4G$+Y^Y7Q0W3$> PGUV,3YYVA_R+Y7-QN8(8_$W]Y!5L#2)71
M'UT(BW--U"N5-SZ8GD%S:0_-R;;K973Q_>V?*5*7ETDFX2]>(PP'PUJR%>O,
M5BM"W[![&0E%3X>\JVP:/&#AZ&*3DU+'JL@0+).#(TD"$G7 $.>?I Q-K*UQ
M@5N%N&B78+L"4)X#9H1Y@?]C%R'0\W*HLV,-=(]9RZ=G<>/_R  -"O']F-AK
M;?1JV\8M PJ^>\&?7GK)0U>D31L6*X+%+SF]\&< ^XJL&)AU1]RWZ@@-:XE+
M7.K4^.U-VJ]NJ;.BDEA4Q.EJE61441:8U!]'Y,;9UI158Y-L O(EC+U%*9>F
MR2BNDKDJ#"6M@>'*+/^9;I*>HW(;4\_)H:2*+U"Q RC%B%CX16QU-.A_<0+'
M<&!S$;X\;GVN\AK$HR?X\ALG;_PV:1IS'S3-D!H'.:OV3;^6VG>><+U$;OP7
M8F].PC[E-H=>O> /CUSFMX#.T5\Q?JL7?4P_)\3.]!6_K;GBX0E7/&E>\HA:
MK:358@_W,/FR.S*>?/D=F4R^XAWIM^Z(G,+_CQ*<9O.#-V<R_>UN#J;<5L<J
MVU$]P*[LVRI-7>+MQTZ!,NBTEH"TZ:$9KJ-6B;_T7E7&OHL^I1CX?(]YPLU'
M7ZM.!Q90*,SP$%7T]V114=WQ_W52@< AR!;=LXM4[6_MH_(NL.[I"$MIREVH
M#7.3<VH$;&,"N'@M]WE]*BPNI2N5LV*V]#),#<D@0W$)#2O,DQ>:Q^,IZ9I:
M+$LA^ ^MR:0_NK'44_+F)LES<G$RR3!"L6@P:9E3I0,SDJDP#%=2'] *[B12
MV:L-",>EZFF-#[_YG"YWM+]7<$.Q<&[JYP0@S-N0H<5NR&^STGM6A?CWQ@->
MI2C[]PQ)Z*D W;3G\MQ36SZ4/H/;5[N 9:+E5 ^^-%4K.9W+E!XUO5L,-3FR
M+RX#5VT1L*9KEZ$X%));%4".3)]C:E)D I=TFX3"U/UOPN<@W'2IT"""&9BE
M54^Y7Q38*@VWR@(.XZ5K1A]$I&69<?%3ZXKA907G?)VQEDI]%<K[Q)0OD'MR
MST%KUK>W ZX%R[?P_ D;V:"TZ:DE?M:E#NBPS^MX(H1E<Z([C$)YP/X9YI7>
MP3E.'Q 6L7T Q%IO:-AOHQ_1"EJA&6&98MNCS2Z7"?^(V>IN?Z^==/TM)K:1
M#[THX8]72;G*8&5L#>[!E[F4K?T!6XB!%%YMV*+[1A5]_<&=C\0[A4^=7F2<
MI^:=_/:JJ- ;1098YW33L?9(*JC ?[EW5TJE[',?@X:)$K[!TLN,S;(L#S<8
ML)Q!C)0']'8%W)=H,P85B*MZ9DNLV(1%&=[E4AV>=_-=TS1:$4UMO7LZ7!+3
M;L@NW]0%:X&+<*3:H&G35A=HK(:):E:NN'$&SK6D F=)M"B+!+@&U3YD7#.V
M6KSE"9F07-/ T&F1 ,B%*@Q,3#J'-R>!I $]"Y(6(*H=1H"EU?%S-=EF@ATD
M-4N&+*YKD14U 9^:LQE^(\62&B?$,#:QR&8#5[B!O>O+2AMI'_DYQPOX6Z=9
M?A79/J*X3&L7,QF1@N7:U 7/51E(?TDI(1"VGY,W0B-_!*45ZMN##6%LR+(8
M1]ZU>A-47O"RX_TF*8<%=46>I >&B\@S(9U2V],&"<-O[-GG6@R[W F W$_(
M%O9K2"6M19A@>&S@*576FMN(;#,9JN50,ZM)1 TP6526K;D^O2:*3TK22] $
M(@]%:>W8-T<1_%)"I6??\4'(SH MP.HJW6S7!2M&"\"W.VKBF^:/65GD)$"N
MJ00&HC#"QHMUP;KWF;17L_(7L,\B%SF?8U(Q_8,"A["9=$6=<[">4B/%18&2
M8)=A:.G*VJX=]_<,A4H"#"=6@,:38XL=R>PSB12HZZPSD'E6:$:\L%EB](LK
M4DFW)=2BDE*!_,IWU64O:G1!"9G]^'[8- 8LJN19QTU5ERO9\97%B.Y3X?RV
MX&GZ/9)^VI4DRKNZ_DC1N#275&FSS!\[#V0U"4%(?("T$"^%J3]8N5/B[5^C
M,?VU4TN55>(C7GYZZR>G_WE"QG=&>K@UY$#XH%&L=)O9,U877?SX[KL/EQ3T
M2ES9B'X*6:WC^;#<1I+JNBHH(!)$#>Y\1OJ"45:\7KAAJ'C[HH8'H)16Y/TC
M;X2GU_M+!(GYA"6V5X?O"?VW3Q9YTU2#1GY%P9U5LP/VP3/U-L?J2T7S^S1?
M60&$VW?NS>F"=O$*&P[@S\6/W]U>DD"U$^_HRO$:;YT2A;7.\#"<'"N7PKTD
M2[5,Q1%ED"\*,BA[+J0>>0VH^X H7Y(KN;=C4LS74@H+]6Q4!89J4 4T]>##
M#F#H%*>>+L;J::E)[OE"M'7BK5?=/E3V71FJ3$*UK;=O EB/5(CV2IQ5Y&;A
MD(H^8?'=KJRY;1?*-T@O'9>V%0(1&?W"E':CMEZ3N[>:CG+M4W1K5BI 68PU
M/CQ,L6Q\39[KLNN81U^%QN$<JZPRH8KVT@J 3L9K5U]&K3=LWG@=7J@G!BDS
MC1]BZ4XMW5/"*MEM"<>]7$F7,=!>0DMF":!"9QU:TV_IN57X>M[RI#MN0+C!
MF;RZK><BI\F=\=N7X/9=T5T*CZXQB 8!N:M<T+F[DZ@&,2<W)X$R) BCAL$C
M8B>F^0N)/-P+%WL'1;KQ()F=TV:)'/AV8WWZ(+/<HQ'+ZR5XBLTF93<^:DEV
M5=H:PQR0Y#4VHA@;SJ80DF+-,*I3D*N@+474/*7!1B#WE$5-R<OXO?O"%*\5
MPV;P6ROA ?J!W)9Q.:+MH;36;UE4!O2\0NV+Q_FV'<3PK;5W?QME+CN520@W
MGW$1)&Y=NB$-R8SN*T\P\\RUQB5TL&9=%28N0E@<Z;AP )<P$T*+2Z&[E(LN
M=GOXD SI9!D^_-N/-GJ\I<03G0E2W6@XC:;Q*!J.HME\$,VCZ3"&G[/Q/!I-
MH]%H#/]%TW$,FY"1U3 )EQ]UI,\BW'0VC*:C.(KQO^G4@F\V=>&!L^$D&@\Q
MP<BM_-!"9]%H/HV&XV@R'.(2IX,H[D=]&*5K=-S!?(8[F,$KG*QL-;4XZL\Q
MKSF>S6#$:#+ V*UX@I],Y_!S,)E$[>YHKG@I3#WNVS]Q/>ZO<30$@+J_QD#0
MY@#2V=P] T ?#<;ZSS&,^3T)-5@2!?2$ ] 8S&%0./@)C!MC&=0^_AQ/9I17
M"4N!^0?C >4LS^;1":VE5%G6:!)/]4;G???G@.*MW5_#OMO#6&^Z[^UM.)F[
M/P$W8 *K%+#"Y<1?>X11##LP?TVCR50-";MSL)S%(W42H_Y C3&"[>O^VA%"
M!, &6!E/IK3.P12F F09 #9A-=G)P+QB[ -NOWV]$4JIMPL<N6\F [>$2=_!
M:QR[SX=P_A,U\J0_-\*[([H'4 !.?P:7E[!^/,9U#X<*7 ITLSZ<8=2'70,X
M^D-CQ^D,@\$[  N"FS:>1'"-8-@)8"_^-F-&B7%(3=C,]'6 5XYWML34^AA6
M)>M9<+0;J]P'-CZ+YJ,^(E5_/HX^TM/N1*;SH482>.+'M#X!FE/" #@>!!:^
M0E7$#[52,.LUPM-7*67L%OOB E=P>7@)<.4U20%8JMW"19X.:4\3 -:-+R&^
MY/1-6P[_SEL9O3K@5V%16#F!BZFO,]5^O$)"ASNS50[RDV -\[YT>"3/#P 9
M!D"17V/^SC*S1JB#HH)#.(7N0-G5M1S,ANIW14%B!;B!?GLXTG1F-&NO*2"?
MZ$K?(T<N1^YC15.1:-Y@Z+NU/(0J-#K2,.[/U5\#1>V&L5LKAD^X'2G"Z5Z=
M#37%&0/]>.?*TRRE(6*1'P9ZCX[9\0<'Q\%0$<>^V_I$@5K-[TJC*ZH(KX77
M% ABU>N8*.(WGJO?^VK+(TV\XZ$CS%BJ)# MFPEL0,S-RA1%H.@0TX>.5!%7
M4<3.-G"S88R3G7FBSLPM=.Y6,W<'/-);&<31&XJR-!E:0+&!D%H<<KH#QV+B
MX;GU3"?J1!2.3QR&C(?!LP1E7-\N]<(<A('XMQ)[9QP'<?BW9XJ]+.\"^)'Y
ML\"+(AU@J@B\(_@6$.1,N1?0:()"&$H72D[2]VXZ(J$7?IXF][+ "RN=CR9&
MXH5_XFGW\"+QXA9F<5OP19%W!N@&,B_R!Q +9B+PPN$.AH?$7E_.A2'&6NI%
M.=?]A9P4)=Z9EB99S%6B(&[N9*F7Q5T0FV.X(BSOPK]  V%1\<2*NW#QIB 5
MG27U^F(N['.F":<6<Y$O.GAK07>DN1!+N8H@C^#>'Q5Z?3$7_E($7HNYT^E(
M'0,*N>ZO85/D)6$7CE;$W?Z(A!UNG8#"+JA\@T&'R.L+N?#&P$VLQ=SAV%$7
M+>9.)HK0DY"KX CH=X[(R\(N[ *H*8N[\'.B[H'F19-8Q-T98,?@%*'7;7*,
M_3=8\HU)<&;9%W;?/R !SSWYNW^*!(PBVVAPK@0LLB^2K$%+ AYH5@, 'YXH
M 8OLBSKSG%YA ?2%?K-+#M42***7ED)9_ 1-!59RGA#*TB>_V2V##J/^5Y-!
MT2( E.!Y,J@O=\YC)7<HN7,P[9 [-;$@J5-)I BZ,^1%+2$.2,T-R8@C):=Z
M^KXO(:K+"U?_B^5%+5?,%"EQTTZ5$.+)A7:)XRZY]8B,Z,F%<RVQ*]5=V9"4
M]#X!TOZU!41/*-2D=!!:C1(*'8!0)-27[PO$0RT2CI46/=:S!47"@;)PS+74
M Z\>MZ)ZY2</FU!9E8Y_<U.J^XTK_\D% ]XS -D#KE-_/$:Y:42B'IS7#&62
M^11O*GQ-5LH!<#H4 8<HF@!HQY.AC*9C(1Q*>]8;$![ZXXDZ[UE?G_YPJFG%
M?*+4!6!;2N$= 0><:GX-,H1"]0GQ4UZ5X 1L#(U)(%Q.YFR9I=9^L+XY,D 0
M$6=,WEN&?GAS!F@#9SX'!H+$&]8%&R&)#1A6'RW-)*D )L^F$X]H=X2*$)7F
M]1VFP7/2_U ZGB.;GH%$"W^"4 \[AKV,X8*/)RB\D $/=C.93_S;VAQ_(/.&
M=/TA46B0J="$/4(N"P?BW_W 6X,>VOS@>5@,Z!_CH:F3Z5HN<(!:@ZZ#V(^U
M_D8CNI8S8ZB'O<!9CF%W<. Q(!X<P!#Y)< :P.XMQYO![,SO<*=D(N_5SJ=>
MG1F@TXO>^L$Y(@-3Z@NYP<1Q+,R8JI,V8G$\Y)C!6:*S8AP/O=_1=CGD7!;G
M8>?%/&#E<ALY)JX\K[_AA@0PK)LZIN(T\, Z35 ?RE4 - 8 T9J9S%"&C!\!
M6:;W[.O5T0@X0;O(#[O'4RHE':B:XR4%]%SDH:D$'JC7>M+(MJCO2Z6(&FI
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MA5S#Y56H]X#*@SX-6_3RE7MMYLP"NIK0"&1=LR.+P+K>A KGC>&$XE""=KM
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M%L>40&2$!]9P8<BV75B\!+CQG'' -QK-@@K,C4QBJ6%A'O+?U5NBW(/4@:-
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M,U*Z.!%;UJEN-W<^"RW2MBTW/5TA^O7R+S&K?ML1=W,B[R6UK88&4#[E96S
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MR+&PU5.YW+_N#DGS'BN$U^7 QI_?+.8;D$KXYVV,\5[0)R- /<68;M0-17S
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M>3HV<;ITXP#V,GMFIAWQW1%5*P@Z]G["K@7\PX&?:42:Y:(@,$NJ(EDDV3D
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M&)9;%N5[2)P*WUOCJX:A(I&L.?OA-H^2O2BQ*E9X$+$IMM3LI\-8$E74\<<
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MCT,T5&)65A13=E\1.1,?Y0T-2IBSLL"(I@4I),'5SYXYK\04F0\TM24T);Y
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M8Z>Q'#K 'FL-^Z)ES\5N&/:SSQA]-^OY2:'W7EP7.:.@AEIB"$P( +A$MM\
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MVL!BTU7OK!:MWC=MX3U)I9M'K0V6O.*RR&+VKAQ)5R) ZIK1&4"<N$DME4'
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M5^2$.S(6E1.$XG;!QAB-#YK\LT(EF2O3_V]OL?=BEZE*DHVC/8F%W,<BW[\
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MW'Z,L:Z?1]XI%W-@:6B @7&5C]40&X[28RPGP0$$*W6LKUG]VX*H2&TM2 9
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M1FS2BZ)'L7<"]'1K236MXT;3/^96LE?8R%MH8,<JC&:DR0V/AO^"E4C5,GK
MX$>(L30>_HNV,7E=-ZZ^N-I[-E6UD@PI]E]B*!8%^I+M9P]9AO1&3? .V/6]
MF#<R!\D)X9,9$-_NPRA@X6:"+J"&JC/5&X:Y<<7G1#_E:)V(MZP]>!#;<8 ;
M;FLIK>3X: \'P]V4_L(W&?,, 7Q3U23-F&Q+A0B*\P$%&T;2_'6, J$2+">%
M7=MFF(]:R)?%*B^O7"!/PQ2@, R,ZDC.5J01'.@^O5 H#D7]R3JZUU'>5G5-
MD0,P2)%;[9@[16%3O).X8CLJS2>@(\+P2+VX#K-[JHQW(*OO7:6\Z_V'%B,?
M'ATBZG6RL:[O1<!F<4F_INQP7A^7]<%P9L4="A(DUMS0F7)Q0B0Y2AK<286'
M@\!"N286P\R&%>Y]HZX-.*=5K;\UU^7ZH#H_9T' ('QQ,R+&&)0U>,]IHL<O
M64I%B8# 4.WP6&P7%.4FQO!\9GMX1,4AN6FZK#C-D(0JC1H13[P$\=VW3KA;
M6'H)0T5IYV\P#**'#Q8KV($EHJ*LMYA7L*WE(1Z/1,$V%(N8G=45HB(3M\-8
M)>U0,3(.9208OU'5%[GF5>(L;RM-(7?#(J22RY(R.4ZW]05E'U"B/J6W9"<Y
MX@AQDQ1FY$)7&M;*.0.$%'[@NS $R99'0:Q87*ZI00U[Q>5S6#5=W05ID2<[
M,T%3\D_?5;R<DHN$ _UIDS%Y0<,DB<!/]3<Y(QS/?2$RP@#=J::->^HIS([F
M&5=9F633Z4@,F Y)!DLHL8'QHJJ6#>^G,VY/C#$GFQN;%Y81F"$OHW-"0)@[
MQX&&NR%%","_LWEV6E"X6T\30MGPO,0DF4;#^YTQ;NC-2X-L.AZ93V-8CH]"
MPQ*5381+^^ ,8R-C# Q*: XSBW".CL])/QMI81,YDTG#6]_ZP>>PK#Q74J6P
MK9\?X;W[>/>J3$VY"^.BFPY]6FAK#$&M /=GNQ:+R;".V["F2__=ZV#<9\4Y
M9>;F7^\C,5-I93"QQ5Z&V2=ZV_OC,60$A%L^ =S1SS+.G5V\_"YVF^&)F<S[
M IJP]^Z@V=_67D4;[XBJ*)\"XQ!8CA6]OI)HY8AY1Q>*Y9V[QNO'B7-S[LNU
M_WKGN*&E'3H8<2!'7M(>UH" FQMCF65I,;,0+JB['@&(^HI,X<DR!VLP-.1(
M9;3#!FN$<( ;]&#;&!>+M[(?<V$<]SP:;-<7%.)L3%FT$U,3\I$=C0-WP61"
M=6:X#H@@-C%HW5X3&G:\W1Z-\048E_88=!^)K1;02=17\/+DFKLN/]-XO;T[
MG%..#SBJ#@5].+9N07RLHJ@1".R:<%/,?8O3/I'KT\!E'@8 4N!JJ:'&]KF=
M-*9F'+7JX+,A\@P""_,IT'C(.JI&LLM08-=P]\XA4QYC9:)@V9/$-@P?P@N/
M,!9%$XLV>#@!QHX!;B?>,4Y6:++,H46%3(9>I-RY8#^D$2L>)]\6&UC(=T1O
M\E'_ E4QY;#ID:M$(*D(ZK^E/?89+P?*W (0NY0<W12U#,;A 0C<&&JV;+ /
M840Q#TC,2S"P\>$][.N#@\/?;H19V;SG9Z769ND,EY(3 O_ISZ=/)H.9W:#D
MG$3^3R]QW-Y8[^/%?MO>(^8>-C+V+DSY!MB;KR@EWTVG8[HO]NQH-WW%W?6]
M=_&>(9S$J5,NCV+?OAWZM8MZ(4R ]7<UJJC.)H@_P&+V /JN1R7_GN3X4J!^
M?]S]X&,?8\1]C5U?[2EP-+=B/<"8U\7"HMD4H8SS2,GN<0?=[1(C7$V _B %
M:CV>^DH!/-5UN7H<X/)BB3J%UX"! 0,G4,S$\?CV40=#=CC63K=]3! I$6OV
MFBT<=3[X8E&A)3]@I8)(?[LF: 7HD5,C'-.G!)55A:'XH-9*"8^K:P*7R*6>
M%L(F7L%3<I!;[;*.[<MF7Q6;2P]?@ !":#ZE@3N\)W9^?-,@RR:,ZC?V/$('
MP>UJQ(9#P..**3_MV5VH*3PM)Q G2HPK-^B-.R]:EZ DD@@4J#6E]!CPEO,Q
M0E1P!XL9[+UNE,!BRR.2BHN/O;^^W%SFJZMJ55W<)2P!VMSK];J20)UW:$/$
MQUSK-.'4J4JS;WV-E\>1I"!1&E!V6NWM:L6"17S/^@4-Y'X_J!8"\,Y)H"6A
M5D>_I-VQ_$0]*8I$O(CH*[IW$26#Q^/CL^,S-1EK0'H(S3 F>LWZHR6>!#$(
MBIC2Z:QG0!#2Y.-FO:DN"KIBU0%E\T<[#IAD1Q52&*GMHFT?68>I3:4R62N.
M1IFBYN0&W[\[/G^E8]HZ!QY^8G]Z?F%NBS]U9;JXWS=P*7*VF8)/*L%$CF(.
M\_7-<16@J"#4(VAS<[#)O]+E,ST<<YISGO%LN%;B+; %13,=_F0I/?F4B32A
M%W".%IMY8T%=VGBI^/-509!!8H'%4[2%&_.N)[ 2F!TLB&GDB&(#.)-+N4!L
MQP.Q /JB"-P"#]Z,ECT?;CCH._NZ*(A<RB; ?[3C[&EN-$=475?7ZIUWMQ(M
MD/-<>/1C,O,6S0+N_X*V_Z+6HBW-QBZ1VOI\XSSX8 .;T,T4NDMN"^2_:'H6
MO^1"C)<N^HLK?0I GL\1I;;N>YN1ZQ3H>^6*49!Q%K';M-39O23=<S"Q>O::
MSL-GJRBXBY_J?.UFM$V/4\$1):+P@16*L8SW1=Y4:YC(G0=H,EZJ+\6=/73$
MZ'BFB':!=4YL\92<HI\(6E]/9K!M/3R(1?A ZBR%O@\7).\ :AWR-&5!%S%>
M.R-,/V1>,$Q.ZR\U\5* J-G(<ZB!/%0]I7^8G1I( @.NJPGO1(J#)\9*)*;S
M;DN"A@6)CZ)Q>GAD/(2Y7UJ8PTQP%9K=[9O)P(HW'!V)5$KZ<NMI;,++EVUC
MERL'B68MIR#X6)E@]9R"-?2:5&0#I1(2!TN,U!+.=7+W(6\<JM5*\70*)Q?:
M-&8I&K'THEQT,\(L)T$A,.CE$XINBP)F^H[9;H^-Q&^Y,D1H 9/,KDO4T>2F
M\WA*YWJ!-B'"GROS+7%NC8OQ69,(S![X(# )?1M7VRN)BU/0PJ"@P7:-3OG"
MEYAG\VS/KFG(A1OU5GF#&+>?U^2,\_"^49L.XE1KS\DQL/Z00Z5<HB3.%?JL
M0X3S8H.9,:Z21*0^UMHUL<0F<Q!5SJ<2Z(;/<\#DC:*%]_MA8I_Q*V#9K>RM
M[\V\-;+.H9%)>1IC/B /VA;E!FH9&*/K!!Z#)CC@9]4*3+0KU&ED6"=,G\;N
MV<;P?OWBXRD.1$C'5V_J:WTITMMG$W\ E;Q2EDW_QG22.K+XTVS>JA4X':=+
M!?:\=1=OEVK;4&TG$>3/N\([J8A*UR(%19]!^["UNJL6QA?%*>CUX22_U-3W
MM4._ -V)OAS,4EMDC! L-=P8\'UF.*I!,O:V=(]WHT,)3K$5X01-R@JR]NT(
M$HT;CFJK\/WQ=5VN,AEUVF3^8:>!?)#-QK/L8V+Q!I-Y]E*O@EDV/YHD;"T<
MGD"GSET;F" ^Z&?/"E6/\Z_Z^'0X,%F//BS9)C7(H^/!A*+IUY@)0Q:?T63>
MCGGNCFWN9]/9=$=.+)IU@S&F\XLP,?'$0"P&^1>=V2NX>%UOA3&8)HDF&P]G
M49!SSUJO_5237<*1[7>2W^"(TF:?"=01'2.UR+&OB%,F[@*D^)X',5+P, H!
M89"BKJ8..7E%OFM$>+"%9W>$1^BYZFZ>V,1]/LQP! Q.UME@%^\>#BDU>SX/
MY+[ .P&K]H[""YAM2-")BB4?L"[R;V)%(B'CD?D*XV<5-U1JGR+BNGCX(IW0
MABYH?@?GL C$!OW,YF\&J";9N4<7# Q;48SKO"(1'HAWW6CT73M0F@&<731]
MF.6#T@%9O@<.&E[4=#9D2F):L91<#-137!*I6HQ%.!Q$=\].*:FSI*XTUA^:
M6TLJ*IL%C^*L6(Z$=N]8*8;+JA2K-7.8@E'[2/%=7);%C:O>+>IXL;3(4IJ0
MP( VZJV&\6!*T%K7VJTIX[:+!9=E8[0!&G<^5GV#7G++<,_%YS#S$Y7E%AM.
MVU<I[R"ZA7N',PH[N)^\,!_ZYX5/>^ZB^$*A$.)5U.AGIW3,.\(9&7/?WG.\
M[*:&;Y2-S2*%49?*M7<A1GK&#_.;]"2TE2PF#,Z5N^I'I&"6&&=DN^/"H[GU
M9,*WP<V-(I:)W1/W!OTY:(=T/F?\9%-_6,,!?7K:KK1X_&YWF"=>5VPK,:7&
M\_,-Q89I*1Z1JCI#1SL"/T&+WF<"NC#WS*.+,S/$)^V(2GP$M/1^C5LK*$]#
M[:0#Z6GM,2_9,['*B=5@$3TTH:+2B63MC;B2Y <M%K?97S$*_ Y9^C&3OQU?
MBR!TF!,&>1*!69"3G XPZ 7BL&TQ&+O4FV">Y):"&WYM3#5=0LFWHT[MQ,?:
M@7/5?9A[9OKS0U+NZ;1AZ =5T,7KW9>[4@D]F?+3+J"> %X-IL\Z <X_< ,!
M7WA:4<F'<QA173"T-@])K.]P$1?7&RWRM;E,E6]/]BY/1RXGAX.-DY,X_./U
M&B/.7XKM]!T<"ZEM$^DT1% <!'Q%3@H*C*VZILE3<[,Q+ [&=O+J!;"E^9@
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M#=-ETN8,,(@&ES8W8M,?FTU=4>T>R4K54C \)-.@/=N'V!5^0$>8MJ,/.U.
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M%3'7VYP4]\,CS&ACY-X."YURKJB@>A!3\QCQ;$3$307N\H6UJ*L2N-L&BZ/
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M<-$7K+A:;A#0I&U9B[0"D6D3R2=R.3\Q0A-;9*2: AR=)W)C2SH\NZMY*9S
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MY3J]CK!2UHP?YAZW5BM"8UGKW+WW1MDV80!%N.+ZL'4T[:&8_2!D #IH:70
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MC-0F7AZ_M)GF33;*)O,^+'*\O\?&$Q\&;["X![R718?0ODY%*PGL+U\5^U%
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M&,FEU'I]F2[6V>2.,ZQP@G/ N.5I$K9D(I6Q%C91CNG%S<2;QZ-AV/8B]Z4
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MB[KWI9RC\CQ#22J+$A.N++[,"$T'A)N66DV^2@R#FR\(,/Q:$!-08TP]V.$
M&K;#SJKU<_$R!S:_!\@T2VC;"3)UJ;F4M.H)*)<= =\U9LG1H2U038Q-%(Y#
M':Y^8KWHC9"$^'1U?U91CG2<^9IUNEQC6L*A6(SI;S$"[W#&B$Z(#UB+>OET
MO6(T8TZOJC0XAO2>E/#QY2KGKCMXD:&?'F(&"UD8NPKI5B</X'#BA&.[5%?'
MC8_8\28'+9VMF4CTL'3V:$T5'$]*_]\\G62AFI+P]W+\^<C9HSRT2<UKF2HV
MMWU/B>.1PC( 8MV +I3V_70&0WG2Z +A'VI#?=6*AX-#<WS1/O!-HX$I;8#
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M2FU5B=HD-E[D4JO^[AA_=\7H\?O+[W$V252.LSPODZ^MWB?7T;)N(R52I?7
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MZ5,G+[]<TK58SL,NN\C/\]7@E CH_?I[/"<BSF[E[]RTZ_UB!70P F(B]B#
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M-XDJ%\CQT/)3Q,27 [?G;GWYE^5PQ8@">5#\TGS>@UM<9,0ODWN2-;_%\%>
MP@*\-EK/:+*B,UD30W\6TZC9,VI__JTQMGJ:81SS>,6Y@6.#=M7@V=5,P?8
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M ST_W<8(TW4 /VD56W9QA2R#0$#1B,SE^CO /1_))08&,Q(.2H#_V@J[5#Z
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M\.2;LD<*8N52AD;,8A:M%ZMR.>C#9/EUH)97K O,3H4#&\\\B[6',^>F5)X
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MN^3V[EA;.+YQ">UNLOO#^JD..'M#35OOJ=6.I229$?<+(AB??CE-C^1;#!Z
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MBV1Y<I&NB2,^JB$PF=$:.D1G+]^_I]-__N7R)5+W6%]FB;I]O<8)TX-['S\
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ME\OU/)XV^:0*E.X1>]K<"4.@R*-UQ,-H]'.I@KM5#PP<F8=W-R((TRSC:]/
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MOVOD>8G>C@&]O<V@=]2G*VV5YPI->1^5D09"4NFQ/@"B[JXKTG<LLFI;>P6
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M& ="7[&JTNK=$/]#S/==U&+I:38)0U:#75+IY$C@S1QS[O?73:KD+<II<RC
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M9W_[8_]&1MW0HZW'B#_F >45WG@A-UT<#!H'QCRB%*2J:NTN]?H'V ]%IOV
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MY! @AR\(N4CSM%CZ UC<BB, '+U>*V[2^'0< ^3X!2&7:;U)UGEY^P,W@IP
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MMOU1_%:F[?;N,V[+ZF91EC?O_@M02P,$%     @ 648]4*E/+?,[!0  'W8
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M,>!)0'ABQ). \<20)P'EB3%/ LX3@YX$I"=&/0E83PQ[$M">&/<DX#TQ\$E
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M;;;=R\\W_\^\7/6?%;O7,XZ?_@902P,$%     @ 648]4![??=B9 P  O6\
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M4$L! A0#%     @ 6$8]4!\CSP/     $P(   L              ( !
M %]R96QS+RYR96QS4$L! A0#%     @ 6$8]4"?HAPZ"    L0   !
M         ( !Z0   &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !81CU0
MLU[R">\    K @  $0              @ &9 0  9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " !81CU0F5R<(Q &  "<)P  $P              @ &W
M @  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %A&/5#/6XY<JP(
M .@*   8              "  ?@(  !X;"]W;W)K<VAE971S+W-H965T,2YX
M;6Q02P$"% ,4    " !81CU0BV2(-P %  #X&   &               @ '9
M"P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 6$8]4"%O
MI(K" P  '!$  !@              ( !#Q$  'AL+W=O<FMS:&5E=',O<VAE
M970S+GAM;%!+ 0(4 Q0    ( %A&/5 -IH/I# 4  "H:   8
M  "  0<5  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !8
M1CU0(:O)1Q\*  !Z1P  &               @ %)&@  >&PO=V]R:W-H965T
M<R]S:&5E=#4N>&UL4$L! A0#%     @ 6$8]4)WDF?A[!@  %B0  !@
M         ( !GB0  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0
M   ( %A&/5 #W,>'M $  -(#   8              "  4\K  !X;"]W;W)K
M<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !81CU0C&E,I;4!  #2 P
M&               @ $Y+0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L!
M A0#%     @ 6$8]4"5Y!AFU 0  TP,  !@              ( !)"\  'AL
M+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( %A&/5#H]WC)M0$
M -,#   9              "  0\Q  !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&UL4$L! A0#%     @ 6$8]4(>>:E.Q 0  TP,  !D              ( !
M^S(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !81CU0
MAGIM*+<!  #1 P  &0              @ 'C-   >&PO=V]R:W-H965T<R]S
M:&5E=#$R+GAM;%!+ 0(4 Q0    ( %A&/5!(K9^+M $  -,#   9
M      "  =$V  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%
M  @ 6$8]4!*HGG:V 0  TP,  !D              ( !O#@  'AL+W=O<FMS
M:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !81CU0(,W40[(!  #1 P
M&0              @ &I.@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+
M 0(4 Q0    ( %A&/5#*$JASMP$  -,#   9              "  9(\  !X
M;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 6$8]4&/6N]VT
M 0  TP,  !D              ( !@#X  'AL+W=O<FMS:&5E=',O<VAE970Q
M-RYX;6Q02P$"% ,4    " !81CU0CQ2W+;@!  #3 P  &0
M@ %K0   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( %A&
M/5!$ZW\DM@$  -,#   9              "  5I"  !X;"]W;W)K<VAE971S
M+W-H965T,3DN>&UL4$L! A0#%     @ 6$8]4.4R?K:V 0  TP,  !D
M         ( !1T0  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
M    " !81CU0,*)),+4!  #3 P  &0              @ $T1@  >&PO=V]R
M:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( %A&/5 ^@:J]M0$  -,#
M   9              "  2!(  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL
M4$L! A0#%     @ 6$8]4,[=T>>W 0  TP,  !D              ( !#$H
M 'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !81CU0/3,^
M%[8!  #3 P  &0              @ 'Z2P  >&PO=V]R:W-H965T<R]S:&5E
M=#(T+GAM;%!+ 0(4 Q0    ( %A&/5#%>ZEBN $  -,#   9
M  "  >=-  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @
M6$8]4+!WA0.T 0  TP,  !D              ( !UD\  'AL+W=O<FMS:&5E
M=',O<VAE970R-BYX;6Q02P$"% ,4    " !81CU0PU2P_[8!  #3 P  &0
M            @ '!40  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4
M Q0    ( %A&/5!SZ/=/N $  -,#   9              "  :Y3  !X;"]W
M;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 6$8]4*!_4%ZV 0
MTP,  !D              ( !G54  'AL+W=O<FMS:&5E=',O<VAE970R.2YX
M;6Q02P$"% ,4    " !81CU0 )0 (K@!  #3 P  &0              @ &*
M5P  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( %A&/5##
M#MP\M@$  -,#   9              "  7E9  !X;"]W;W)K<VAE971S+W-H
M965T,S$N>&UL4$L! A0#%     @ 6$8]4&%1$V^S 0  TP,  !D
M     ( !9EL  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %A&/5#"ZS'(M@$  -,#   9              "
M 0EE  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 6$8]
M4"#QGU&U 0  TP,  !D              ( !]F8  'AL+W=O<FMS:&5E=',O
M<VAE970S."YX;6Q02P$"% ,4    " !81CU0J3GBGB$#  "[#@  &0
M        @ 'B:   >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0
M   ( %A&/5!['/_VQ0$  #@$   9              "  3IL  !X;"]W;W)K
M<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ 6$8]4#T<%OK' 0  . 0
M !D              ( !-FX  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q0
M2P$"% ,4    " !81CU0U:?/$38"  "G!P  &0              @ $T<
M>&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( %A&/5##5=76
M'0(  -@&   9              "  :%R  !X;"]W;W)K<VAE971S+W-H965T
M-#,N>&UL4$L! A0#%     @ 6$8]4':E0'C& 0  -@0  !D
M ( !]70  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !8
M1CU0V5$A7=0!  "=!   &0              @ 'R=@  >&PO=V]R:W-H965T
M<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( %A&/5#>3Z(>N0$  -,#   9
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M970U,"YX;6Q02P$"% ,4    " !81CU0&?]@T04"   U!@  &0
M    @ $Q@P  >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    (
M %A&/5#IJ8&]R@$  #8$   9              "  6V%  !X;"]W;W)K<VAE
M971S+W-H965T-3(N>&UL4$L! A0#%     @ 6$8]4&;IA+/4 0  G00  !D
M             ( !;H<  'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"
M% ,4    " !81CU0?6-"A^X!  !G!0  &0              @ %YB0  >&PO
M=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( %A&/5!:Z8IIU@$
M )T$   9              "  9Z+  !X;"]W;W)K<VAE971S+W-H965T-34N
M>&UL4$L! A0#%     @ 6$8]4%."?(.[ 0  TP,  !D              ( !
MJXT  'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !81CU0
M=-(B:N,!   "!0  &0              @ &=CP  >&PO=V]R:W-H965T<R]S
M:&5E=#4W+GAM;%!+ 0(4 Q0    ( %A&/5"4':6<]0$  ,P%   9
M      "  ;>1  !X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%
M  @ 6$8]4 AOZ?O> 0   @4  !D              ( !XY,  'AL+W=O<FMS
M:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    " !81CU0R6>ER+@!  #3 P
M&0              @ 'XE0  >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+
M 0(4 Q0    ( %A&/5" 6[K,U0$  )T$   9              "  >>7  !X
M;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ 6$8]4""3X9?>
M 0   @4  !D              ( !\YD  'AL+W=O<FMS:&5E=',O<VAE970V
M,BYX;6Q02P$"% ,4    " !81CU0XA/%RK@!  #3 P  &0
M@ $(G   >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( %A&
M/5##.TL06P(  -X(   9              "  ?>=  !X;"]W;W)K<VAE971S
M+W-H965T-C0N>&UL4$L! A0#%     @ 6$8]4(Y /MX8 @  V 8  !D
M         ( !B:   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
M    " !81CU0P3&)%\@!   X!   &0              @ '8H@  >&PO=V]R
M:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( %A&/5".(TH N0$  -,#
M   9              "  =>D  !X;"]W;W)K<VAE971S+W-H965T-C<N>&UL
M4$L! A0#%     @ 6$8]4$6F;Y(^ @  U0<  !D              ( !QZ8
M 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !81CU0<I1S
M1"L"   B!P  &0              @ $\J0  >&PO=V]R:W-H965T<R]S:&5E
M=#8Y+GAM;%!+ 0(4 Q0    ( %A&/5#6;)1BN@$  -,#   9
M  "  9ZK  !X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @
M6$8]4+C_'L(\ @  4P<  !D              ( !CZT  'AL+W=O<FMS:&5E
M=',O<VAE970W,2YX;6Q02P$"% ,4    " !81CU0>CXTT/P*  "J2@  &0
M            @ $"L   >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4
M Q0    ( %A&/5#)";4+G0(  ,4)   9              "  36[  !X;"]W
M;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ 6$8]4*/%3\J9 P
MW!   !D              ( !";X  'AL+W=O<FMS:&5E=',O<VAE970W-"YX
M;6Q02P$"% ,4    " !81CU0?+ UJOT!  "?!0  &0              @ '9
MP0  >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( %A&/5 C
MR+$R:P<  .XK   9              "  0W$  !X;"]W;W)K<VAE971S+W-H
M965T-S8N>&UL4$L! A0#%     @ 6$8]4&(5$$R:!0  \R   !D
M     ( !K\L  'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %A&/5!X@*F$G0P  ,-:   9              "
M 7/C  !X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ 6$8]
M4&_>FA!P P  T@\  !D              ( !1_   'AL+W=O<FMS:&5E=',O
M<VAE970X,RYX;6Q02P$"% ,4    " !81CU00H3"<M0#  #%$@  &0
M        @ 'N\P  >&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0
M   ( %E&/5 Y-8ZG?!0  !^<   9              "  ?GW  !X;"]W;W)K
M<VAE971S+W-H965T.#4N>&UL4$L! A0#%     @ 648]4,&,$A\\"   (38
M !D              ( !K P! 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q0
M2P$"% ,4    " !91CU0^KR_5R4#  !<#0  &0              @ $?%0$
M>&PO=V]R:W-H965T<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( %E&/5!C*T80
M  (  /,%   9              "  7L8 0!X;"]W;W)K<VAE971S+W-H965T
M.#@N>&UL4$L! A0#%     @ 648]4-I[U5]] @  K @  !D
M ( !LAH! 'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " !9
M1CU0?6L8_EX#   /#@  &0              @ %F'0$ >&PO=V]R:W-H965T
M<R]S:&5E=#DP+GAM;%!+ 0(4 Q0    ( %E&/5#(//B:5 (  &P'   9
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M970Y-2YX;6Q02P$"% ,4    " !91CU0LKYO+@,#  "5#   &0
M    @ &Q+@$ >&PO=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    (
M %E&/5 CK^_R6 ,  %00   9              "  >LQ 0!X;"]W;W)K<VAE
M971S+W-H965T.3<N>&UL4$L! A0#%     @ 648]4$(8[^A< P  3PX  !D
M             ( !>C4! 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"
M% ,4    " !91CU0+9]9#BH(  !R-P  &0              @ $-.0$ >&PO
M=V]R:W-H965T<R]S:&5E=#DY+GAM;%!+ 0(4 Q0    ( %E&/5"1;]UYDP<
M ' Q   :              "  6Y! 0!X;"]W;W)K<VAE971S+W-H965T,3 P
M+GAM;%!+ 0(4 Q0    ( %E&/5"G:E(=[P$  -L$   :              "
M 3E) 0!X;"]W;W)K<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( %E&
M/5!:G\JIPP(  (D*   :              "  6!+ 0!X;"]W;W)K<VAE971S
M+W-H965T,3 R+GAM;%!+ 0(4 Q0    ( %E&/5 M(3:I-0H  )U$   :
M          "  5M. 0!X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4
M Q0    ( %E&/5#3_M<TFP(   4*   :              "  <A8 0!X;"]W
M;W)K<VAE971S+W-H965T,3 T+GAM;%!+ 0(4 Q0    ( %E&/5#.%48,VP(
M &\+   :              "  9M; 0!X;"]W;W)K<VAE971S+W-H965T,3 U
M+GAM;%!+ 0(4 Q0    ( %E&/5 +H#+T- (  ,$&   :              "
M :Y> 0!X;"]W;W)K<VAE971S+W-H965T,3 V+GAM;%!+ 0(4 Q0    ( %E&
M/5#@7\,:&P,  %D.   :              "  1IA 0!X;"]W;W)K<VAE971S
M+W-H965T,3 W+GAM;%!+ 0(4 Q0    ( %E&/5!!"]*$-P,  $0-   :
M          "  6UD 0!X;"]W;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4
M Q0    ( %E&/5!ZYU7.10(  /@&   :              "  =QG 0!X;"]W
M;W)K<VAE971S+W-H965T,3 Y+GAM;%!+ 0(4 Q0    ( %E&/5#T%Y CKP0
M *,7   :              "  5EJ 0!X;"]W;W)K<VAE971S+W-H965T,3$P
M+GAM;%!+ 0(4 Q0    ( %E&/5 6\M*@4PP  .!5   :              "
M 4!O 0!X;"]W;W)K<VAE971S+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( %E&
M/5!6-WLE/08  &0I   :              "  <M[ 0!X;"]W;W)K<VAE971S
M+W-H965T,3$R+GAM;%!+ 0(4 Q0    ( %E&/5#S_J\3W@$  %4%   :
M          "  4"" 0!X;"]W;W)K<VAE971S+W-H965T,3$S+GAM;%!+ 0(4
M Q0    ( %E&/5"G=\QR)@0  %@6   :              "  5:$ 0!X;"]W
M;W)K<VAE971S+W-H965T,3$T+GAM;%!+ 0(4 Q0    ( %E&/5#$ M5:C H
M ,I(   :              "  ;2( 0!X;"]W;W)K<VAE971S+W-H965T,3$U
M+GAM;%!+ 0(4 Q0    ( %E&/5 LYJ,%VP$  !P%   :              "
M 7B3 0!X;"]W;W)K<VAE971S+W-H965T,3$V+GAM;%!+ 0(4 Q0    ( %E&
M/5 *+3LPD 0  ,\:   :              "  8N5 0!X;"]W;W)K<VAE971S
M+W-H965T,3$W+GAM;%!+ 0(4 Q0    ( %E&/5!M#[$$'P(  /\%   :
M          "  5.: 0!X;"]W;W)K<VAE971S+W-H965T,3$X+GAM;%!+ 0(4
M Q0    ( %E&/5",6@3NMP,  /L1   :              "  :J< 0!X;"]W
M;W)K<VAE971S+W-H965T,3$Y+GAM;%!+ 0(4 Q0    ( %E&/5"5-G'5> (
M -T(   :              "  9F@ 0!X;"]W;W)K<VAE971S+W-H965T,3(P
M+GAM;%!+ 0(4 Q0    ( %E&/5!'!4B1]0$  ' %   :              "
M 4FC 0!X;"]W;W)K<VAE971S+W-H965T,3(Q+GAM;%!+ 0(4 Q0    ( %E&
M/5 LN[PDMP(  !(*   :              "  7:E 0!X;"]W;W)K<VAE971S
M+W-H965T,3(R+GAM;%!+ 0(4 Q0    ( %E&/5"=@O/T0@(   ,(   :
M          "  66H 0!X;"]W;W)K<VAE971S+W-H965T,3(S+GAM;%!+ 0(4
M Q0    ( %E&/5#5QQ8\<@,  -$/   :              "  =^J 0!X;"]W
M;W)K<VAE971S+W-H965T,3(T+GAM;%!+ 0(4 Q0    ( %E&/5 [:8>J[P(
M &\-   :              "  8FN 0!X;"]W;W)K<VAE971S+W-H965T,3(U
M+GAM;%!+ 0(4 Q0    ( %E&/5!4<$>\5@,  -80   :              "
M ;"Q 0!X;"]W;W)K<VAE971S+W-H965T,3(V+GAM;%!+ 0(4 Q0    ( %E&
M/5!BWBT[W0$  .8$   :              "  3ZU 0!X;"]W;W)K<VAE971S
M+W-H965T,3(W+GAM;%!+ 0(4 Q0    ( %E&/5#HE[B)0 (  '4'   :
M          "  5.W 0!X;"]W;W)K<VAE971S+W-H965T,3(X+GAM;%!+ 0(4
M Q0    ( %E&/5!,?YU,#@(  .0%   :              "  <NY 0!X;"]W
M;W)K<VAE971S+W-H965T,3(Y+GAM;%!+ 0(4 Q0    ( %E&/5#%J7.1& (
M -4&   :              "  1&\ 0!X;"]W;W)K<VAE971S+W-H965T,3,P
M+GAM;%!+ 0(4 Q0    ( %E&/5#*DE'7+ (  .@&   :              "
M 6&^ 0!X;"]W;W)K<VAE971S+W-H965T,3,Q+GAM;%!+ 0(4 Q0    ( %E&
M/5#6F%!$OP(  %L*   :              "  <7  0!X;"]W;W)K<VAE971S
M+W-H965T,3,R+GAM;%!+ 0(4 Q0    ( %E&/5"Y2'DA1@0  % 6   :
M          "  ;S# 0!X;"]W;W)K<VAE971S+W-H965T,3,S+GAM;%!+ 0(4
M Q0    ( %E&/5#R4.^B,P(  )4&   :              "  3K( 0!X;"]W
M;W)K<VAE971S+W-H965T,3,T+GAM;%!+ 0(4 Q0    ( %E&/5#%%KX:?0,
M  ,/   :              "  :7* 0!X;"]W;W)K<VAE971S+W-H965T,3,U
M+GAM;%!+ 0(4 Q0    ( %E&/5"]2*3AI@(  )\)   :              "
M 5K. 0!X;"]W;W)K<VAE971S+W-H965T,3,V+GAM;%!+ 0(4 Q0    ( %E&
M/5"K@_]8B0(  +0(   :              "  3C1 0!X;"]W;W)K<VAE971S
M+W-H965T,3,W+GAM;%!+ 0(4 Q0    ( %E&/5!0>ZD[2PP   5I   :
M          "  ?G3 0!X;"]W;W)K<VAE971S+W-H965T,3,X+GAM;%!+ 0(4
M Q0    ( %E&/5"RK$C9T (  ! ,   :              "  7S@ 0!X;"]W
M;W)K<VAE971S+W-H965T,3,Y+GAM;%!+ 0(4 Q0    ( %E&/5!.H]PW5 (
M "0(   :              "  83C 0!X;"]W;W)K<VAE971S+W-H965T,30P
M+GAM;%!+ 0(4 Q0    ( %E&/5#N!;-E; (  ,@(   :              "
M 1#F 0!X;"]W;W)K<VAE971S+W-H965T,30Q+GAM;%!+ 0(4 Q0    ( %E&
M/5 VWY$=KP$  -$#   :              "  ;3H 0!X;"]W;W)K<VAE971S
M+W-H965T,30R+GAM;%!+ 0(4 Q0    ( %E&/5#RB, +; (  #X(   :
M          "  9OJ 0!X;"]W;W)K<VAE971S+W-H965T,30S+GAM;%!+ 0(4
M Q0    ( %E&/5!#3F*9X@(  $D+   :              "  3_M 0!X;"]W
M;W)K<VAE971S+W-H965T,30T+GAM;%!+ 0(4 Q0    ( %E&/5!RR911%P(
M %T&   :              "  5GP 0!X;"]W;W)K<VAE971S+W-H965T,30U
M+GAM;%!+ 0(4 Q0    ( %E&/5!8F2_TJP,  $@3   :              "
M :CR 0!X;"]W;W)K<VAE971S+W-H965T,30V+GAM;%!+ 0(4 Q0    ( %E&
M/5"KMWQU! ,  "8,   :              "  8OV 0!X;"]W;W)K<VAE971S
M+W-H965T,30W+GAM;%!+ 0(4 Q0    ( %E&/5"7O-Y4= (  #\(   :
M          "  <?Y 0!X;"]W;W)K<VAE971S+W-H965T,30X+GAM;%!+ 0(4
M Q0    ( %E&/5 PL)V+% ,  ,(,   :              "  7/\ 0!X;"]W
M;W)K<VAE971S+W-H965T,30Y+GAM;%!+ 0(4 Q0    ( %E&/5!RTVX&A04
M  P?   :              "  ;__ 0!X;"]W;W)K<VAE971S+W-H965T,34P
M+GAM;%!+ 0(4 Q0    ( %E&/5 ;699M P,   (,   :              "
M 7P% @!X;"]W;W)K<VAE971S+W-H965T,34Q+GAM;%!+ 0(4 Q0    ( %E&
M/5 _M_^W0P,  *8-   :              "  ;<( @!X;"]W;W)K<VAE971S
M+W-H965T,34R+GAM;%!+ 0(4 Q0    ( %E&/5"PV?#$:P(  !8(   :
M          "  3(, @!X;"]W;W)K<VAE971S+W-H965T,34S+GAM;%!+ 0(4
M Q0    ( %E&/5#BK_3^F@(  /D(   :              "  =4. @!X;"]W
M;W)K<VAE971S+W-H965T,34T+GAM;%!+ 0(4 Q0    ( %E&/5!AM'IEL0$
M ,0#   :              "  :<1 @!X;"]W;W)K<VAE971S+W-H965T,34U
M+GAM;%!+ 0(4 Q0    ( %E&/5!26F,Y40,  *H.   :              "
M 9 3 @!X;"]W;W)K<VAE971S+W-H965T,34V+GAM;%!+ 0(4 Q0    ( %E&
M/5 [^54]!0<  /PJ   :              "  1D7 @!X;"]W;W)K<VAE971S
M+W-H965T,34W+GAM;%!+ 0(4 Q0    ( %E&/5 2S4(R4@,  ',.   :
M          "  58> @!X;"]W;W)K<VAE971S+W-H965T,34X+GAM;%!+ 0(4
M Q0    ( %E&/5#%^O4*)@(  %H&   :              "  > A @!X;"]W
M;W)K<VAE971S+W-H965T,34Y+GAM;%!+ 0(4 Q0    ( %E&/5#F#QS8@08
M /HF   :              "  3XD @!X;"]W;W)K<VAE971S+W-H965T,38P
M+GAM;%!+ 0(4 Q0    ( %E&/5"/?4\8,@0  *45   :              "
M ?<J @!X;"]W;W)K<VAE971S+W-H965T,38Q+GAM;%!+ 0(4 Q0    ( %E&
M/5!5@($ + <  -$O   :              "  6$O @!X;"]W;W)K<VAE971S
M+W-H965T,38R+GAM;%!+ 0(4 Q0    ( %E&/5"8#PV6O@(  $4+   :
M          "  <4V @!X;"]W;W)K<VAE971S+W-H965T,38S+GAM;%!+ 0(4
M Q0    ( %E&/5"= %YU7P(  /P(   :              "  ;LY @!X;"]W
M;W)K<VAE971S+W-H965T,38T+GAM;%!+ 0(4 Q0    ( %E&/5"1<S;M&P(
M $(&   :              "  5(\ @!X;"]W;W)K<VAE971S+W-H965T,38U
M+GAM;%!+ 0(4 Q0    ( %E&/5"GVM'&.P,  )4/   :              "
M :4^ @!X;"]W;W)K<VAE971S+W-H965T,38V+GAM;%!+ 0(4 Q0    ( %E&
M/5#AN!=")P,  - /   :              "  1A" @!X;"]W;W)K<VAE971S
M+W-H965T,38W+GAM;%!+ 0(4 Q0    ( %E&/5!LQ6AS]P$  !X%   :
M          "  7=% @!X;"]W;W)K<VAE971S+W-H965T,38X+GAM;%!+ 0(4
M Q0    ( %E&/5"C9*S220(  $$'   :              "  :9' @!X;"]W
M;W)K<VAE971S+W-H965T,38Y+GAM;%!+ 0(4 Q0    ( %E&/5 8 HWG@P(
M *\*   :              "  2=* @!X;"]W;W)K<VAE971S+W-H965T,3<P
M+GAM;%!+ 0(4 Q0    ( %E&/5 @V/_?0 0  $<6   :              "
M >), @!X;"]W;W)K<VAE971S+W-H965T,3<Q+GAM;%!+ 0(4 Q0    ( %E&
M/5!<64<8.00  "@6   :              "  5I1 @!X;"]W;W)K<VAE971S
M+W-H965T,3<R+GAM;%!+ 0(4 Q0    ( %E&/5"[X)E+R00  )\:   :
M          "  <M5 @!X;"]W;W)K<VAE971S+W-H965T,3<S+GAM;%!+ 0(4
M Q0    ( %E&/5#^5)S6XP(  (H+   :              "  <Q: @!X;"]W
M;W)K<VAE971S+W-H965T,3<T+GAM;%!+ 0(4 Q0    ( %E&/5!?!H;C(P,
M #\-   :              "  >== @!X;"]W;W)K<VAE971S+W-H965T,3<U
M+GAM;%!+ 0(4 Q0    ( %E&/5"S3<BCS0(  *\*   :              "
M 4)A @!X;"]W;W)K<VAE971S+W-H965T,3<V+GAM;%!+ 0(4 Q0    ( %E&
M/5 ;OK,=90(  & )   :              "  4=D @!X;"]W;W)K<VAE971S
M+W-H965T,3<W+GAM;%!+ 0(4 Q0    ( %E&/5"'L..\" 0  "<6   :
M          "  >1F @!X;"]W;W)K<VAE971S+W-H965T,3<X+GAM;%!+ 0(4
M Q0    ( %E&/5!!@09JVP,  !L5   :              "  21K @!X;"]W
M;W)K<VAE971S+W-H965T,3<Y+GAM;%!+ 0(4 Q0    ( %E&/5!"7>WDM0(
M !\+   :              "  3=O @!X;"]W;W)K<VAE971S+W-H965T,3@P
M+GAM;%!+ 0(4 Q0    ( %E&/5 >4!"C @,  '<-   :              "
M 21R @!X;"]W;W)K<VAE971S+W-H965T,3@Q+GAM;%!+ 0(4 Q0    ( %E&
M/5!8S4S9M 4  #DF   :              "  5YU @!X;"]W;W)K<VAE971S
M+W-H965T,3@R+GAM;%!+ 0(4 Q0    ( %E&/5 /H!"PP (  (0,   :
M          "  4I[ @!X;"]W;W)K<VAE971S+W-H965T,3@S+GAM;%!+ 0(4
M Q0    ( %E&/5!$P%N@V04  &,C   :              "  4)^ @!X;"]W
M;W)K<VAE971S+W-H965T,3@T+GAM;%!+ 0(4 Q0    ( %E&/5#4AC$JR0<
M -,U   :              "  5.$ @!X;"]W;W)K<VAE971S+W-H965T,3@U
M+GAM;%!+ 0(4 Q0    ( %E&/5#^L-@DL@(  .,)   :              "
M 52, @!X;"]W;W)K<VAE971S+W-H965T,3@V+GAM;%!+ 0(4 Q0    ( %E&
M/5"F-I^ 10,  . .   :              "  3Z/ @!X;"]W;W)K<VAE971S
M+W-H965T,3@W+GAM;%!+ 0(4 Q0    ( %E&/5!X?BX]!P,  *,-   :
M          "  ;N2 @!X;"]W;W)K<VAE971S+W-H965T,3@X+GAM;%!+ 0(4
M Q0    ( %E&/5 "<T:L(P0  - 4   :              "  ?J5 @!X;"]W
M;W)K<VAE971S+W-H965T,3@Y+GAM;%!+ 0(4 Q0    ( %E&/5!&AW\HC0(
M -4)   :              "  56: @!X;"]W;W)K<VAE971S+W-H965T,3DP
M+GAM;%!+ 0(4 Q0    ( %E&/5"HRH?5Z@(  /X+   :              "
M 1J= @!X;"]W;W)K<VAE971S+W-H965T,3DQ+GAM;%!+ 0(4 Q0    ( %E&
M/5 %)3BNBP4  -L>   :              "  3R@ @!X;"]W;W)K<VAE971S
M+W-H965T,3DR+GAM;%!+ 0(4 Q0    ( %E&/5!..#-HJP,  (01   :
M          "  ?^E @!X;"]W;W)K<VAE971S+W-H965T,3DS+GAM;%!+ 0(4
M Q0    ( %E&/5"4(N/;40(  %('   :              "  >*I @!X;"]W
M;W)K<VAE971S+W-H965T,3DT+GAM;%!+ 0(4 Q0    ( %E&/5#JVU$1Q@(
M #$*   :              "  6NL @!X;"]W;W)K<VAE971S+W-H965T,3DU
M+GAM;%!+ 0(4 Q0    ( %E&/5"A0?TFRP,  !P3   :              "
M 6FO @!X;"]W;W)K<VAE971S+W-H965T,3DV+GAM;%!+ 0(4 Q0    ( %E&
M/5!);D++N@,  &80   :              "  6RS @!X;"]W;W)K<VAE971S
M+W-H965T,3DW+GAM;%!+ 0(4 Q0    ( %E&/5 ^("8E< (  &4(   :
M          "  5ZW @!X;"]W;W)K<VAE971S+W-H965T,3DX+GAM;%!+ 0(4
M Q0    ( %E&/5#_F;'3^ $  !P%   :              "  0:Z @!X;"]W
M;W)K<VAE971S+W-H965T,3DY+GAM;%!+ 0(4 Q0    ( %E&/5#[8Y9H)0(
M "H&   :              "  3:\ @!X;"]W;W)K<VAE971S+W-H965T,C P
M+GAM;%!+ 0(4 Q0    ( %E&/5!N_"Z\9SX  %\Z @ :              "
M 9.^ @!X;"]W;W)K<VAE971S+W-H965T,C Q+GAM;%!+ 0(4 Q0    ( %E&
M/5!/;QX]<14" +LS"0 4              "  3+] @!X;"]S:&%R9613=')I
M;F=S+GAM;%!+ 0(4 Q0    ( %E&/5"C#<5_&P0  .@I   -
M  "  =42!0!X;"]S='EL97,N>&UL4$L! A0#%     @ 648]4+($@N(="P
M#H0   \              ( !&Q<% 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( %E&/5"I3RWS.P4  !]V   :              "  64B!0!X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( %E&/5 >WWW8F0,  +UO
M   3              "  =@G!0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0  #2 -( 5CH  *(K!0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>221
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839077744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other non-current liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract', window );"><strong>Disclosure of detailed information about provisions and non-current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory', window );">Provisions and other non-current liabilities</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">20. Provisions and other non-current liabilities</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued liability for employee benefits:</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Defined benefit pension plans <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;469</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;546</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other long-term employee benefits and deferred compensation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 546</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 600</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other post-employment benefits <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Environmental remediation provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 634</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for product liabilities, governmental investigations and other legal matters</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 214</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 958</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 255</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 497</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total provisions and other non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;632</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;319</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 25 provides additional disclosures related to post-employment benefits. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent consideration. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis believes that its total provisions are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities in this area, Novartis may incur additional costs beyond the amounts provided. Management believes that such additional amounts, if any, would not be material to the Group&#x2019;s financial condition but could be material to the results of operations or cash flows in a given period. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Environmental remediation provisions</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the movements in the environmental liability provisions:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 692</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 761</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 773</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;48</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;83</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp; 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;153</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 154</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 714</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 692</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 761</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current provision</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;55</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current environmental remediation provisions at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 634</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 706</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Releases of provisions credited to the consolidated income statement from continuing operations were USD 21 million in 2018 and USD 153 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 7 million in 2018 and USD 154 million in 2017. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The material components of the environmental remediation provisions consist of costs to sufficiently clean and refurbish contaminated sites to the extent necessary and to continue surveillance at sites where the environmental remediation exposure is less significant. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A substantial portion of the environmental remediation provisions relate to the remediation of Basel regional landfills in the adjacent border areas in Switzerland, Germany and France. The provisions are reassessed on a yearly basis and adjusted as necessary. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the United States, Novartis has been named under federal legislation (the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended) as a potentially responsible party (PRP) in respect of certain sites. Novartis actively participates in, or monitors, the cleanup activities at the sites in which it is a PRP. The provision takes into consideration the number of other PRPs at each site as well as the identity and financial position of such parties in light of the joint and several nature of the liability. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The expected timing of the related cash outflows as of December 31, 2019, is currently projected as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Expected <br></br> cash outflows </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due within two years</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 141</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due later than two years, but within five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due later than five years, but within 10 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 258</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Due after 10 years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 105</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total environmental remediation liability provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 714</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Provisions for product liabilities, governmental investigations and other legal matters</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis has established provisions for certain product liabilities, governmental investigations and other legal matters where a potential cash outflow is probable and Novartis can make a reliable estimate of the amount of the outflow. These provisions represent the Group&#x2019;s current best estimate of the total financial effect for the matters described below and for other less significant matters. Potential cash outflows reflected in a provision might be fully or partially offset by insurance in certain circumstances. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Novartis has not established provisions for potential damage awards for certain additional legal claims against its subsidiaries if Novartis currently believes that a payment is either not probable or cannot be reliably estimated. In total, these not-provisioned-for matters include more than 3&#xa0;000 individual product liability cases and certain other legal matters. Plaintiffs&#x2019; alleged claims in these matters, which Novartis does not believe to be entirely remote but which do not fulfill the conditions for the establishment of provisions, currently aggregate to, according to the current best belief of Novartis, approximately USD&nbsp;0.9 billion. In addition, in some of these matters there are claims for punitive or multiple (treble) damages, civil penalties and disgorgement of profits that in the view of Novartis are either wholly or partially unspecified, or wholly or partially unquantifiable at present; the Group believes that information about these amounts claimed by plaintiffs generally is not meaningful for purposes of determining a reliable estimate of a loss that is probable or more than remote. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">A number of other legal matters are in such early stages or the issues presented are such that the Group has not made any provisions since it cannot currently estimate either a potential outcome or the amount of any potential losses. For these reasons, among others, the Group generally is unable to make a reliable estimate of possible loss with respect to such cases. It is therefore not practicable to provide information about the potential financial impact of those cases. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">There might also be cases for which the Group was able to make a reliable estimate of the possible loss or the range of possible loss, but the Group believes that publication of such information on a case-by-case basis would seriously prejudice the Group&#x2019;s position in ongoing legal proceedings or in any related settlement discussions. Accordingly, in such cases, information has been disclosed with respect to the nature of the contingency, but no disclosure is provided as to an estimate of the possible loss or range of possible loss. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Note 28 contains additional information on contingencies.</div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Alcon spin-off </font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On April 9, 2019, the Alcon spin-off was completed (see Note 2). Under the Separation and Distribution Agreement that Novartis entered into with Alcon in connection with the separation and the spin-off, Novartis and Alcon each agreed, subject to certain conditions and exclusions, and except to the extent otherwise described below with respect to any matter, to indemnify the other party and its directors, officers, employees and agents against any pending or future liabilities that constitute either a Novartis liability, in the case of Novartis, or an Alcon liability, in the case of Alcon, with the nature of any relevant liability being determined based on whether such claim or liability relates to the Novartis or the Alcon business and products. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Summary of significant legal proceedings</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following is a summary of significant legal proceedings to which Novartis or its subsidiaries are a party or were a party and that concluded in 2019. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Investigations and related litigations</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Southern District of New York (S.D.N.Y.) marketing practices investigation and litigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2013, the US government filed a civil complaint in intervention to an individual <i>qui tam</i> action against Novartis Pharmaceuticals Corporation (NPC) in the United States District Court (USDC) for the S.D.N.Y. The complaint, as subsequently amended, asserts federal False Claims Act (FCA) and common law claims with respect to speaker programs and other promotional activities for certain NPC cardiovascular medications ( <i>Lotrel</i>, <i>Starlix</i> and <i>Valturna</i>) allegedly serving as mechanisms to provide kickbacks to healthcare professionals (HCPs). Also in 2013, New York State filed a civil complaint in intervention asserting similar claims. Neither government complaint in intervention adopted the individual relator&#x2019;s claims with respect to off-label promotion of <i>Valturna</i>, which were subsequently dismissed with prejudice by the court. The individual relator continues to litigate the kickback claims on behalf of other states and municipalities. Novartis is engaged in settlement discussions to resolve the above-described claims, and recorded a provision in the amount of USD 0.7 billion in 2019 in the Innovative Medicines Division. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">S.D.N.Y. Gilenya marketing practices investigation and litigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2013, NPC received a civil investigative demand from the United States Attorney&#x2019;s Office (USAO) for the S.D.N.Y. requesting the production of documents and information relating to marketing practices for <i>Gilenya</i>, including the remuneration of healthcare providers in connection therewith. In 2017, the S.D.N.Y. and New York State declined to intervene in claims raised by an individual relator in a <i>qui tam</i> complaint, which continue to be vigorously contested. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Government generic pricing antitrust investigations, antitrust class actions</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Since 2016, Sandoz Inc. has received grand jury subpoenas and a civil investigative demand and interrogatories from the Antitrust and Civil Divisions of the US Department of Justice (DoJ), and a subpoena and interrogatories from the Attorney General of the State of Connecticut in connection with alleged price fixing and market allocation of generic drugs in the US market as well as alleged FCA violations. The requests are for documents related to the marketing and pricing of generic pharmaceutical products sold by Sandoz Inc. and its subsidiary, Fougera Pharmaceuticals Inc. (Fougera), and related communications with competitors. Sandoz Inc. is cooperating with these investigations, which it believes to be part of a broader inquiry into industry practice. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Since the third quarter of 2016, Sandoz Inc. and Fougera have been sued alongside other generic pharmaceutical companies in numerous individual and putative class action complaints by direct and indirect purchasers and Attorneys General for 54 states and territories. Plaintiffs claim that defendants, including Sandoz, engaged in price fixing and market allocation of generic drugs in the US market, and seek damages and injunctive relief. The actions contain product-specific complaints as well as complaints alleging the existence of an overarching industry conspiracy, and assert violations of federal and state antitrust laws as well as consumer protection laws. The cases have been consolidated for pretrial purposes in the USDC for the Eastern District of Pennsylvania (E.D. Pa.), and the claims are being vigorously contested. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Asia/Russia investigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2017 and 2018, Alcon and Novartis Group companies received document requests and subpoenas from the DoJ and the US Securities and Exchange Commission (SEC) requesting information concerning Alcon accounting, internal controls and business practices in Asia and Russia, including revenue recognition for surgical equipment and related products and services, as well as relationships with third-party distributors, both before and after Alcon became part of the Novartis Group. Alcon and Novartis are cooperating with this investigation. Pursuant to the terms of the Separation and Distribution Agreement, and subject to the conditions and exclusions therein, Novartis will indemnify Alcon in respect of certain fines or other monetary penalties that arise out of the investigations by the DoJ and the SEC at the time of the separation. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Lucentis/Avastin <sup>&#xae;</sup> matters </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In connection with an investigation into whether Novartis entities, F. Hoffmann-La Roche AG, Genentech Inc. and Roche S.p.A. colluded to artificially preserve the market positions of Avastin <sup>&#xae;</sup> and <i>Lucentis</i>, in 2014 the Italian Competition Authority (ICA) imposed a fine equivalent to USD 125 million on the Novartis entities. Novartis paid the fine, subject to the right to later claim recoupment, and appealed before the Consiglio di Stato (CdS). In 2014 and 2015, the Italian Ministry of Health and the Lombardia region sent letters with payment requests for a total equivalent of approximately USD&nbsp;1.3 billion in damages from Novartis and Roche entities based on the above allegations. In 2019, the CdS upheld the ICA decision and fine. Following the CdS decision, several additional Italian regions and hospitals sent letters claiming damages for an aggregate amount of approximately USD 330 million. None of these claims has been asserted in legal proceedings. Novartis has filed a further appeal of the CdS decision. In 2019, the French Competition Authority (FCA) issued a Statement of Objections against Novartis entities alleging anti-competitive practices on the French market for anti-vascular endothelial growth factor treatments for wet age-related macular degeneration from 2008 to 2013, and is expected to issue its final decision in the course of 2020. Novartis continues to vigorously contest all claims in Italy and France. Also, Novartis is challenging policies and regulations allowing off-label/unlicensed use and reimbursement for economic reasons in various countries, including Italy, the UK, Turkey and Brazil. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Japan investigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015, a trial started against a former Novartis Pharma K.K. (NPKK) employee, and also against NPKK under the dual liability concept in Japanese law, over allegations brought by the Tokyo District Public Prosecutor Office for alleged manipulation of data in sub-analysis publications of the Kyoto Heart Study regarding valsartan. The charges against NPKK are subject to a maximum total fine of JPY 4 million. In 2018, the Tokyo High Court upheld a not-guilty ruling of the Tokyo District Court for both the former NPKK employee and NPKK. A further appeal by the Tokyo District Public Prosecutor Office remains pending. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">South Korea investigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2016, the Seoul Western District Prosecutor initiated a criminal investigation into, among other things, allegations that Novartis Korea utilized medical journals to provide inappropriate economic benefits to HCPs, which resulted in a non-material fine in January 2020. Novartis has received requests for information from the DoJ and the SEC regarding this matter, and is cooperating with their ongoing inquiry. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Greece investigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis is investigating allegations of potentially inappropriate economic benefits to HCPs, government officials and others in Greece. Novartis is providing information to the Greek authorities investigating these allegations, including the Greek Coordinating Body for Inspection and Control, and the Greek Body of Prosecution of Financial Crime, from which it received a summons in 2018. Novartis is also responding to subpoenas and document requests from the SEC and DoJ that it received beginning in 2016 in connection with such allegations, and is cooperating with their investigation. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Antitrust class actions</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Enoxaparin</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015, Sandoz and Momenta Pharmaceuticals were sued in a putative antitrust class action in federal court in Tennessee alleging that Momenta and Sandoz engaged in anticompetitive and unfair business conduct with regard to sales of enoxaparin. The same allegations were made by Amphastar in a lawsuit filed in federal court in California and subsequently moved to federal court in Massachusetts. In 2019, Sandoz resolved both matters, with Sandoz agreeing to pay USD 85 million to resolve the Tennessee class action and paying Amphastar approximately USD 39 million to resolve the Massachusetts case. The class action settlement is contingent upon, among other conditions, court approval and the class participants not exceeding an opt-out threshold. Sandoz, Momenta and Amphastar were also engaged in patent litigation concerning enoxaparin that concluded in June 2019. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Exforge</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Since 2018, Novartis Group companies as well as other pharmaceutical companies have been sued by various direct and indirect purchasers of <i>Exforge</i> in multiple US individual and putative class action complaints. They claim that Novartis made a reverse payment in the form of an agreement not to launch an authorized generic, alleging violations of federal antitrust law and state antitrust, consumer protection and common laws, and seeking damages as well as injunctive relief. The cases have been consolidated in the S.D.N.Y. and the claims are being vigorously contested. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Product liability litigation</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Reclast </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">NPC is a defendant in more than 20 US product liability actions involving <i>Reclast</i> and alleging atypical femur fracture injuries, all of which are in New Jersey state or federal court and in California state court, coordinated with claims against other bisphosphonate manufacturers. The claims are being vigorously contested. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Taxotere&#xae; (docetaxel)</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz is a defendant in more than 2&#xa0;900 US product liability actions involving Taxotere <sup>&#xae;</sup> (docetaxel), an oncology product, many of which have been transferred to Multidistrict Litigation in the Eastern District of Louisiana. The complaints allege misleading marketing and that Sanofi, as innovator, and several 505(b)(2) NDA holders (including Sandoz) failed to warn of the risk of permanent alopecia/hair loss. The claims are being vigorously contested. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Amiodarone</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Sandoz entities are named in more than 10 individual and multi-plaintiff US product liability cases involving amiodarone, a cardiac drug indicated to treat life-threatening arrhythmias that have not responded to other treatment. The complaints allege failure to warn, off-label promotion and failure to include medication guides to pharmacies. The claims are being vigorously contested. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Sartans and Ranitidine</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Since 2018, claims have been brought against Sandoz and other pharmaceutical companies alleging injury from carcinogenic impurities found in valsartan and valsartan/HCT film-coated tablets and/or losartan marketed or manufactured by Sandoz, including several putative class actions in Canada and a Multidistrict Litigation in New Jersey. Claims have also been brought alleging injury from carcinogenic impurities in ranitidine-containing medicines, including several putative class actions in Canada. All of these claims are being vigorously contested. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Other matters</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Average Wholesale Price (AWP) litigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Lawsuits have been brought, the latest in February 2016, by various US state governmental entities and private parties against various pharmaceutical companies, including NPC, alleging that they fraudulently overstated the AWP that is or has been used by payors, including state Medicaid agencies, to calculate reimbursements to healthcare providers. NPC remains a defendant in a putative class action brought by private payors in New Jersey, and vigorously contests those claims. NPC resolved an action brought by the state of Illinois for approximately USD 21 million. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">Aimovig&ndash;Amgen Dispute</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015 and 2017, Novartis and Amgen entered into agreements regarding the development and commercialization of <i>Aimovig</i>, which the companies co-commercialize in the US and to which Novartis has exclusive rights in all territories outside of the US, excluding Japan. Amgen issued a termination notice in April 2019, based on an alleged material breach of the collaboration agreements, and this notice, as well as other ancillary matters, are the subject of legal proceedings between Novartis and Amgen. Novartis disputes Amgen&#x2019;s allegations vigorously. The collaboration continues during the litigation between the companies, and will remain in force until and unless a final court decision terminates the agreements. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Concluded legal matters</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">District of Massachusetts (D. Mass.) charitable foundation investigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2016 and 2017, NPC received subpoenas from the USAO for the D. Mass. requesting documents related to NPC&#x2019;s support of 501(c)(3) organizations that provide copayment assistance to Medicare patients who are prescribed Novartis medicines, including the respective accounting and tax treatment, as well as related to pricing strategies for <i>Gleevec</i>, <i>Tasigna</i>, <i>Zometa</i> and <i>Gilenya</i>. In 2018, NPC agreed to a settlement in principle to pay USD 23 million to resolve the investigation into potential violations of federal healthcare laws, including the Anti-Kickback Statute and FCA. In 2019, NPC agreed in principle to pay an additional USD 28 million to resolve related allegations. These settlements are subject to mutually agreeable terms and finalization of the documentation. Novartis considers this matter concluded for the purpose of reporting legal proceedings. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000; font-weight:bold;font-style:italic;">MIVS platform patent infringement litigation</div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2015, Johns Hopkins University (JHU) filed a patent infringement lawsuit against certain Alcon entities alleging that the use of certain Alcon surgical products, principally by third parties, infringes a patent directed to certain methods of ocular surgery. In 2019, JHU and Alcon entered into a confidential resolution of the litigation. Novartis considers this matter concluded. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Summary of product liability, governmental investigations and other legal matters provision movements </font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 340</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 351</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to <br></br>discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;42 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;116</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases of provisions <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;107</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to provisions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;369</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 340</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 351</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less current portion</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;121</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current product liabilities, governmental investigations and other legal matters provisions at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 200</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 230</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Releases of provisions credited to the consolidated income statement from continuing operations were USD 107 million in 2018 and USD 63 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 220 million in 2018 and USD 47 million in 2017. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Novartis believes that its total provisions for investigations, product liability, arbitration and other legal matters are adequate based upon currently available information. However, given the inherent difficulties in estimating liabilities, there can be no assurance that additional liabilities and costs will not be incurred beyond the amounts provided. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other provisions, contingent liabilities and contingent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS37_g84-92_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDetailedInformationAboutProvisionsAndNoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>222
<FILENAME>R141.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6836844992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current financial debt (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 22,167<span></span>
</td>
<td class="nump">$ 25,283<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total</a></td>
<td class="nump">22,355<span></span>
</td>
<td class="nump">25,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueByMeasurementBasisAxis=nvs_CarryingReportedAmountFairValueDisclosureMember', window );">Balance sheet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">22,167<span></span>
</td>
<td class="nump">25,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherNoncurrentFinancialDebt', window );">Others</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total</a></td>
<td class="nump">22,355<span></span>
</td>
<td class="nump">25,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueByMeasurementBasisAxis=nvs_FairValueDisclosureItemAmountsMember', window );">Fair values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems', window );"><strong>Disclosure of fair value measurement of liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">23,701<span></span>
</td>
<td class="nump">25,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherNoncurrentFinancialDebt', window );">Others</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total</a></td>
<td class="nump">$ 23,889<span></span>
</td>
<td class="nump">$ 25,815<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BondsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of bonds issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BondsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherNoncurrentFinancialDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherNoncurrentFinancialDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueByMeasurementBasisAxis=nvs_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueByMeasurementBasisAxis=nvs_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueByMeasurementBasisAxis=nvs_FairValueDisclosureItemAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueByMeasurementBasisAxis=nvs_FairValueDisclosureItemAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>223
<FILENAME>R145.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837410880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Provisions and other non-current liabilities (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionFiscalYearMaturityAbstract', window );"><strong>Environmental provision, fiscal year maturity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionExpectedCashOutflowNextTwoYears', window );">Due within two years</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears', window );">Due later than two years, but within five years</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears', window );">Due later than five years, but within ten years</a></td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionExpectedCashOutflowAfterTenYears', window );">Due after ten years</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvision', window );">Total environmental remediation liability provisions</a></td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 761<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionExpectedCashOutflowAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionExpectedCashOutflowAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanFiveYearsButWithinTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionExpectedCashOutflowLaterThanTwoYearsButWithinFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionExpectedCashOutflowNextTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionExpectedCashOutflowNextTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>224
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865449568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract', window );"><strong>Disclosure of marketable securities commodities deposits derivative instruments and cash [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock', window );">Disclosure of marketable securities commodities deposits derivative instruments and cash</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">16. Marketable securities, commodities, time&nbsp;deposits, derivative financial instruments, and&nbsp;cash and cash equivalents</div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Market</font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">able securities, commodities, time&nbsp;deposits and derivative financial instruments</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, commodities, time deposits and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 334</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;693</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table provides a breakdown of debt securities by currency:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US dollar (USD)</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 302</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Euro (EUR)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japanese yen (JPY)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 325</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Cash and cash equivalents</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current accounts</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;247</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;121</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity less than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;865</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;150</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>225
<FILENAME>R196.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845437728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Discontinued operations (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 1,949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between one and five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 1,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived', window );">Total future payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable', window );">Unearned interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue', window );">Minimum lease payments from finance lease agreements, at present value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinanceLeaseProvision', window );">Finance lease provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceLeaseReceivables', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived', window );">Total future payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable', window );">Unearned interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue', window );">Minimum lease payments from finance lease agreements, at present value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinanceLeaseProvision', window );">Finance lease provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceLeaseReceivables', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Between one and five years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived', window );">Total future payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable', window );">Unearned interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue', window );">Minimum lease payments from finance lease agreements, at present value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinanceLeaseProvision', window );">Finance lease provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceLeaseReceivables', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations | Later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived', window );">Total future payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable', window );">Unearned interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue', window );">Minimum lease payments from finance lease agreements, at present value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinanceLeaseProvision', window );">Finance lease provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceLeaseReceivables', window );">Net book value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables related to finance leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of undiscounted finance lease payments to be received. Finance lease is a lease that transfers substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 94<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_94&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndiscountedFinanceLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of unearned finance income relating to the finance lease payments receivable. Finance lease is a lease that transfers substantially all the risks and rewards incidental to ownership of an underlying asset. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 94<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_94&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnearnedFinanceIncomeRelatingToFinanceLeasePaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinanceLeaseProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinanceLeaseProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MinimumFinaceLeasePaymentsReceivableAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>226
<FILENAME>R166.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6856471568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 8) - Pension plans - USD ($)<br> shares in Millions, $ in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanPlanAssetAllocations', window );">Defined benefit plan, plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EmployerSharesHeldByDefinedBenefitPlan', window );">Shares held by defined benefit plan</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan', window );">Value of shares held by defined benefit plan</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WeightedAverageDurationOfDefinedBenefitObligationYears', window );">Weighted average duration of defined benefit obligation years</a></td>
<td class="text">15 years 2 months 13 days<span></span>
</td>
<td class="text">14 years 7 months 7 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum', window );">Defined benefit plan, target plan asset allocations range minimum</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum', window );">Defined benefit plan, target plan asset allocations range maximum</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanPlanAssetAllocations', window );">Defined benefit plan, plan asset allocations</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum', window );">Defined benefit plan, target plan asset allocations range minimum</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum', window );">Defined benefit plan, target plan asset allocations range maximum</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanPlanAssetAllocations', window );">Defined benefit plan, plan asset allocations</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Real estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum', window );">Defined benefit plan, target plan asset allocations range minimum</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum', window );">Defined benefit plan, target plan asset allocations range maximum</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanPlanAssetAllocations', window );">Defined benefit plan, plan asset allocations</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Alternative investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum', window );">Defined benefit plan, target plan asset allocations range minimum</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum', window );">Defined benefit plan, target plan asset allocations range maximum</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanPlanAssetAllocations', window );">Defined benefit plan, plan asset allocations</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Cash and other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum', window );">Defined benefit plan, target plan asset allocations range minimum</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum', window );">Defined benefit plan, target plan asset allocations range maximum</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanPlanAssetAllocations', window );">Defined benefit plan, plan asset allocations</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanPlanAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanPlanAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanTargetPlanAssetAllocationsRangeMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EmployerSharesHeldByDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EmployerSharesHeldByDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ValueOfEmployerSharesHeldByDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WeightedAverageDurationOfDefinedBenefitObligationYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WeightedAverageDurationOfDefinedBenefitObligationYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_RealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_RealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_AlternativeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_AlternativeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_CashAndOtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_CashAndOtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>227
<FILENAME>R162.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6852794960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">$ 23,066<span></span>
</td>
<td class="nump">$ 22,179<span></span>
</td>
<td class="nump">$ 23,210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">19,810<span></span>
</td>
<td class="nump">18,838<span></span>
</td>
<td class="nump">20,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(3,256)<span></span>
</td>
<td class="num">(3,341)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">8,197<span></span>
</td>
<td class="nump">7,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Deferred pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">2,722<span></span>
</td>
<td class="nump">2,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">12,147<span></span>
</td>
<td class="nump">11,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">15,106<span></span>
</td>
<td class="nump">14,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">14,457<span></span>
</td>
<td class="nump">13,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(649)<span></span>
</td>
<td class="num">(793)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Switzerland | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">6,167<span></span>
</td>
<td class="nump">5,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Switzerland | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">8,939<span></span>
</td>
<td class="nump">8,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">3,552<span></span>
</td>
<td class="nump">3,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">2,311<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(1,241)<span></span>
</td>
<td class="num">(1,188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | US | Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">670<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | US | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">630<span></span>
</td>
<td class="nump">653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | US | Deferred pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | US | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">1,717<span></span>
</td>
<td class="nump">1,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Rest of the world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">4,408<span></span>
</td>
<td class="nump">4,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">3,042<span></span>
</td>
<td class="nump">3,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(1,366)<span></span>
</td>
<td class="num">(1,360)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Rest of the world | Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Rest of the world | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">1,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Rest of the world | Deferred pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="nump">1,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Rest of the world | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">1,491<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(612)<span></span>
</td>
<td class="num">(954)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Deferred pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | US</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">658<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(524)<span></span>
</td>
<td class="num">(882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | US | Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | US | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | US | Deferred pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | US | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">522<span></span>
</td>
<td class="nump">713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Rest of the world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Funded status</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Rest of the world | Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Rest of the world | Active</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Rest of the world | Deferred pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Rest of the world | Pensioners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ObligationByTypeAxis=nvs_UnfundedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ObligationByTypeAxis=nvs_UnfundedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ObligationByTypeAxis=nvs_ActiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ObligationByTypeAxis=nvs_ActiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ObligationByTypeAxis=nvs_DeferredPensionersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ObligationByTypeAxis=nvs_DeferredPensionersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ObligationByTypeAxis=nvs_PensionersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ObligationByTypeAxis=nvs_PensionersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>228
<FILENAME>R192.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6858936880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to continuing and discontinued segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,498<span></span>
</td>
<td class="nump">44,833<span></span>
</td>
<td class="nump">42,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,425)<span></span>
</td>
<td class="num">(14,510)<span></span>
</td>
<td class="num">(13,633)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,252<span></span>
</td>
<td class="nump">31,589<span></span>
</td>
<td class="nump">29,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,369)<span></span>
</td>
<td class="num">(13,717)<span></span>
</td>
<td class="num">(12,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,402)<span></span>
</td>
<td class="num">(8,489)<span></span>
</td>
<td class="num">(8,389)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,031<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,426)<span></span>
</td>
<td class="num">(2,609)<span></span>
</td>
<td class="num">(2,137)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,086<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
<td class="nump">8,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(850)<span></span>
</td>
<td class="num">(932)<span></span>
</td>
<td class="num">(750)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other financial income and expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">14,095<span></span>
</td>
<td class="nump">9,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution', window );">Net income/loss from discontinued operations before gain on distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Gain on distribution</a></td>
<td class="nump">$ 4,691<span></span>
</td>
<td class="nump">4,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net income/loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,590<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">14,095<span></span>
</td>
<td class="nump">9,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,793)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="num">(1,603)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,777<span></span>
</td>
<td class="nump">7,149<span></span>
</td>
<td class="nump">6,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments', window );">Sales to continuing and discontinued segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">7,153<span></span>
</td>
<td class="nump">6,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of goods sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(860)<span></span>
</td>
<td class="num">(3,983)<span></span>
</td>
<td class="num">(3,588)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">949<span></span>
</td>
<td class="nump">3,170<span></span>
</td>
<td class="nump">3,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(638)<span></span>
</td>
<td class="num">(2,754)<span></span>
</td>
<td class="num">(2,532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="num">(585)<span></span>
</td>
<td class="num">(583)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherExpenseByFunction', window );">Other expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(113)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="num">(234)<span></span>
</td>
<td class="num">(73)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other financial income and expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="num">(260)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(159)<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution', window );">Net income/loss from discontinued operations before gain on distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet', window );">Gain on distribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net income/loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,590<span></span>
</td>
<td class="num">$ (186)<span></span>
</td>
<td class="nump">$ 204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherExpenseByFunction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherExpenseByFunction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2019-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from discontinued operations. [Refer: Discontinued operations [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 126<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from the sale of goods. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DifferenceBetweenCarryingAmountOfDividendsPayableAndCarryingAmountOfNoncashAssetsDistributedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetIncomeLossFromDiscontinuedOperationsBeforeGainOnDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsSalesToOtherSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsSalesToOtherSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>229
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6725882736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest expense and other financial income and expense (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherFinancialIncomeAndExpenseAbstract', window );"><strong>Other financial income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromDividends', window );">Dividend income</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Other financial expense</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Currency result, net</a></td>
<td class="num">(160)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Total other financial income and expense from continuing operations</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2019-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as income. Dividends are distributions of profits to holders of equity investments in proportion to their holdings of a particular class of capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherFinancialIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherFinancialIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>230
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845987040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">$ 15,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,474<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">12,069<span></span>
</td>
<td class="nump">15,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts', window );">Net book value of Property, plant and equipment under finance lease contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment', window );">Commitments for purchases of property, plant and equipment</a></td>
<td class="nump">220<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingCostsCapitalised', window );">Capitalized borrowing costs</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">34,028<span></span>
</td>
<td class="nump">34,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(5,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment', window );">Decrease through reclassification to right-of-use assets</a></td>
<td class="num">(127)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(309)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Impact of business combinations</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,474<span></span>
</td>
<td class="nump">1,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and derecognitions</a></td>
<td class="num">(3,409)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="nump">21<span></span>
</td>
<td class="num">(887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">26,999<span></span>
</td>
<td class="nump">34,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale', window );">Additions included in disposal group prior to classification to assets held for sale</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated depreciation, amortisation and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="num">(18,332)<span></span>
</td>
<td class="num">(17,546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(2,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment', window );">Decrease through reclassification to right-of-use assets</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation charge</a></td>
<td class="num">(1,345)<span></span>
</td>
<td class="num">(1,717)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment', window );">Accumulated depreciation on disposals and derecognitions</a></td>
<td class="nump">2,846<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment charge</a></td>
<td class="num">(205)<span></span>
</td>
<td class="num">(324)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Reversal of impairment charge</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="num">(43)<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="num">(14,930)<span></span>
</td>
<td class="num">(18,332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale', window );">Depreciation charge prior to classification to assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale', window );">Impairment charge prior to classification to assets held for sale</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land | Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment', window );">Decrease through reclassification to right-of-use assets</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Impact of business combinations</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Reclassifications</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and derecognitions</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land | Accumulated depreciation, amortisation and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="num">(43)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment', window );">Decrease through reclassification to right-of-use assets</a></td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment charge</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">7,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">6,339<span></span>
</td>
<td class="nump">7,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts', window );">Net book value of Property, plant and equipment under finance lease contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings | Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">14,135<span></span>
</td>
<td class="nump">14,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(1,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment', window );">Decrease through reclassification to right-of-use assets</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Impact of business combinations</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Reclassifications</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and derecognitions</a></td>
<td class="num">(1,551)<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">11,463<span></span>
</td>
<td class="nump">14,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings | Accumulated depreciation, amortisation and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="num">(6,328)<span></span>
</td>
<td class="num">(5,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(562)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation charge</a></td>
<td class="num">(447)<span></span>
</td>
<td class="num">(574)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment', window );">Accumulated depreciation on disposals and derecognitions</a></td>
<td class="nump">1,170<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment charge</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Reversal of impairment charge</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="num">(5,124)<span></span>
</td>
<td class="num">(6,328)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">2,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">2,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress | Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">2,042<span></span>
</td>
<td class="nump">2,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Impact of business combinations</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Reclassifications</a></td>
<td class="num">(1,019)<span></span>
</td>
<td class="num">(1,470)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,001<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and derecognitions</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress | Accumulated depreciation, amortisation and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment', window );">Accumulated depreciation on disposals and derecognitions</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment charge</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Reversal of impairment charge</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and other equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">5,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">3,948<span></span>
</td>
<td class="nump">5,231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and other equipment | Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="nump">17,155<span></span>
</td>
<td class="nump">16,858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(2,678)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment', window );">Decrease through reclassification to right-of-use assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(160)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Impact of business combinations</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment', window );">Reclassifications</a></td>
<td class="nump">630<span></span>
</td>
<td class="nump">931<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">355<span></span>
</td>
<td class="nump">407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment', window );">Disposals and derecognitions</a></td>
<td class="num">(1,774)<span></span>
</td>
<td class="num">(457)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(504)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="nump">13,674<span></span>
</td>
<td class="nump">17,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and other equipment | Accumulated depreciation, amortisation and impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward', window );"><strong>Movements of property, plant and equipment [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at beginning of period</a></td>
<td class="num">(11,924)<span></span>
</td>
<td class="num">(11,485)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment', window );">Costs of assets related to discontinued operations</a></td>
<td class="num">(1,541)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment', window );">Cost of assets related to disposal group held for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(101)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation charge</a></td>
<td class="num">(898)<span></span>
</td>
<td class="num">(1,140)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment', window );">Accumulated depreciation on disposals and derecognitions</a></td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Impairment charge</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment', window );">Reversal of impairment charge</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency translation effects</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment at end of period</a></td>
<td class="num">$ (9,726)<span></span>
</td>
<td class="num">$ (11,924)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 23<br> -IssueDate 2019-01-01<br> -Paragraph 26<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=23&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_26_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual commitments for the acquisition of property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 74<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_74_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractualCommitmentsForAcquisitionOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment through classification as held for sale or inclusion in a disposal group classified as held for sale. [Refer: Disposal groups classified as held for sale [member]; Property, plant and equipment; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughClassifiedAsHeldForSalePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals and retirements. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsAndRetirementsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_v&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers from construction in progress. [Refer: Property, plant and equipment; Construction in progress]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reversal of impairment loss recognised in profit or loss for property, plant and equipment. [Refer: Reversal of impairment loss recognised in profit or loss; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccumulatedDepreciationOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionsIncludedInDisposalGroupPriorToClassificationToAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DecreaseThroughAssetsRelatedToDiscontinuedOperationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DecreaseThroughReclassificationToRightofuseAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DepreciationChargePriorToClassificationToAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpairmentChargePriorToClassificationToAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MovementsOfPropertyPlantAndEquipmentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MovementsOfPropertyPlantAndEquipmentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetBookValueOfPropertyPlantEquipmentUnderFinanceLeaseContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>231
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873391792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDefinedBenefitPlansTableTextBlock', window );">Summary of the funded and unfunded defined benefit obligation for pension and other post retirement benefit plans table</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment benefit plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22&nbsp;179</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;210</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;073</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;115</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit obligations related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;662</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;385</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current service cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 378</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 330</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past service costs and settlements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;168</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Administrative expenses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurement losses/(gains) arising from changes in financial assumptions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;791</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;567</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;31</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurement (gains)/losses arising from changes in demographic assumptions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;193</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Experience-related remeasurement losses/(gains)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 184</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 264</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 283</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;374</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions of associates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;066</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;179</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 746</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;073</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at January 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 18&nbsp;838</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20&nbsp;275</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 119</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Plan assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 257</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Return on plan assets excluding interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;805</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 304</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;310</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Group contributions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 420</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 520</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions of associates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Settlements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;193</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Benefit payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;810</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;838</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Limitation on recognition of fund surplus at January 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;89</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in limitation on recognition of fund surplus (incl. exchange rate differences)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income on limitation of fund surplus</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Limitation on recognition of fund surplus at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability in the balance sheet at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock', window );">Reconciliation of the net liability table</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment benefit plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability at January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;024</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;954</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;953</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Less: net liability related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 238</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current service cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;378</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;77</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Administrative expenses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Past service costs and settlements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remeasurements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;507</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 64</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Group contributions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 420</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 520</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Effect of acquisitions, divestments or transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Change in limitation on recognition of fund surplus</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net liability at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;321</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Amounts recognized in the consolidated balance sheet</div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid benefit cost</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 148</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued benefit liability</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;469</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;546</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfAssumptionsUsedTableTextBlock', window );">Principal weighted average actuarial assumptions</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans </div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post-employment benefit plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Weighted average assumptions used to determine benefit obligations at December 31</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Discount rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.6%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.5%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.6%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.4%</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.7%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected rate of pension increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.4%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.5%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expected rate of salary increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest on savings account</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.8%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.6%</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current average life expectancy <br></br>for a 65-year-old male in years </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 21 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 21 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 21 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current average life expectancy <br></br>for a 65-year-old female in years </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 23 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 23 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 23 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock', window );">The sensitivity of the defined benefit pension obligation to the principal actuarial assumptions</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change in 2019 year-end <br></br> defined benefit pension obligation </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in discount rate</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;787</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in discount rate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 837</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">One-year increase in life expectancy</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in rate of pension increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 546</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in rate of pension increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;135</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase of interest on savings account</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 62</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease of interest on savings account</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point increase in rate of salary increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">25 basis point decrease in rate of salary increase</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;55</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock', window );">The healthcare cost trend rate assumptions used for other post-employment benefits</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Healthcare cost trend rate <br></br>assumed for next year </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 6.5% </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.0% </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 6.5% </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rate to which the cost trend <br></br>rate is assumed to decline </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4.5% </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.5% </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.5% </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Year that the rate reaches <br></br>the ultimate trend rate </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2028 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2028 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2025 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">The weighted average plan asset allocation of funded defined benefit pension plans</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Pension plans</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(as a percentage) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-term <br></br> target <br></br> minimum </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Long-term <br></br> target <br></br> maximum </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 40</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 27</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Real estate</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alternative investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and other investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock', window );">Asset allocation, investments in shares of Novartis AG</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Investment in shares of Novartis AG</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number of shares (in millions)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11.0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Market value (in USD billions)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">The expected future cash flows in respect of pension and other post- employment benefit plans</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Pension plans </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other post- <br></br> employment <br></br> benefit plans </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Novartis Group contributions</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020 (estimated)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 410</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Expected future benefit payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2020</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;201</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2021</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;116</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2022</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;106</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;096</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;087</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">2025&#x2013;2029</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 231</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfDefinedContributionPlansTableTextBlock', window );">Defined contribution plans</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined contribution plans continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 422</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 443</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 307</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock', window );">Breakdown of defined benefit obligation for pension plans and other post-employment benefit</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Switzerland </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Switzerland </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 15&nbsp;106</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;552</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;408</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;066</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;263</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;348</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;179</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof unfunded</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 670</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 1&nbsp;136</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 649</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 1&nbsp;140</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">By type of member</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Active</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 630</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;197</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;618</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 653</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;616</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;887</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;205</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;517</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;722</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;131</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;531</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;662</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;939</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;717</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;645</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;564</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;421</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;630</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;457</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;042</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19&nbsp;810</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;838</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;649</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;241</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;360</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;341</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock', window );">Breakdown of defined benefit obligation for pension plans and other post-employment benefit</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> United <br></br> States </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Rest of <br></br> the world </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Benefit obligation at December 31</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 658</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 88</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 746</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;001</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 72</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;073</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Thereof unfunded</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 882</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 72</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">By type of member</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Active</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 157</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 295</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pensioners</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 522</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 574</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 713</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 760</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value of plan assets at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 134</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 119</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Funded status</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;882</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;72</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;954</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BreakdownOfDefinedBenefitObligationForPensionPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDefinedBenefitPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDefinedBenefitPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNetDefinedBenefitLiabilityAssetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfAssetAllocationInvestmentsInSharesOfNovartisAGTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfDefinedContributionPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfDefinedContributionPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfHealthCareCostTrendRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfSensitivityAnalysisForActuarialAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>232
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838706080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Current financial debt and derivative financial instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract', window );"><strong>Disclosure of current financial debt and derivative instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock', window );">Current financial debt and derivative instruments</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest-bearing accounts of associates <br></br>payable on demand <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;836 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;778 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bank and other financial debt <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 719</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 701</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commercial paper</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;289</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;951</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value of derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;678</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Weighted average interest rate 0.5% (2018: 0.5%) </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Weighted average interest rate 12.9% (2018: 9.6%) </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>233
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873287472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,504<span></span>
</td>
<td class="nump">$ 35,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,866<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,264<span></span>
</td>
<td class="nump">29,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,555<span></span>
</td>
<td class="nump">37,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,737<span></span>
</td>
<td class="nump">12,614<span></span>
</td>
<td class="nump">$ 7,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(210)<span></span>
</td>
<td class="num">(406)<span></span>
</td>
<td class="nump">2,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,527<span></span>
</td>
<td class="nump">12,208<span></span>
</td>
<td class="nump">$ 10,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="nump">$ 32,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="nump">53,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="nump">23,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="nump">25,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="nump">31,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Profit (loss)</a></td>
<td class="nump">8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="num">(600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2019-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2019-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2021-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2019-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants.
Effective 2020-01-01: The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>234
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842252752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 1,949<span></span>
</td>
<td class="nump">$ 1,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">3,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Less current lease liabilities</a></td>
<td class="num">(246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentLeaseLiabilitiesUndiscounted', window );">Less current lease liabilities undiscounted</a></td>
<td class="num">(295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NoncurrentLeaseLiabilitiesUndiscounted', window );">Non-current lease liabilities undiscounted</a></td>
<td class="nump">3,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MostMaterialLeaseWithLeaseTermExtension', window );">Most material lease with lease term extension</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember', window );">Later than one year and not later than two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember', window );">Later than two years and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember', window );">Later than three years and not later than four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember', window );">Later than four years and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">Later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis of total lease liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseLiabilitiesUndiscounted', window );">Lease liabilities undiscounted</a></td>
<td class="nump">$ 2,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentLeaseLiabilitiesUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentLeaseLiabilitiesUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMaturityAnalysisOfTotalLeaseLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LeaseLiabilitiesUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LeaseLiabilitiesUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MostMaterialLeaseWithLeaseTermExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MostMaterialLeaseWithLeaseTermExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NoncurrentLeaseLiabilitiesUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NoncurrentLeaseLiabilitiesUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>235
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844121408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialInstrumentsAdditionalDisclosureAbstract', window );"><strong>Financial Instruments - additional disclosure [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock', window );">Disclosure of financial assets and financial liabilities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Note</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018 <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash and cash equivalents</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;112</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;271</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at fair value through other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Long-term financial investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;158</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 802</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total long-term financial investments - fair value through other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;191</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 833</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at fair value through other comprehensive income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;215</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;158</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables, income tax receivables and other current assets (excluding pre-payments)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15/17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;337</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;024</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short-term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances, security deposits and other long-term receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;727</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;635</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets - measured at fair value through the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13/16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 286</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Associated companies at fair value through profit and loss</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets - measured at fair value through the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;323</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;310</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24&nbsp;377</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29&nbsp;374</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest-bearing accounts of associates payable on demand</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;778</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bank and other financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 719</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 701</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commercial paper</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;289</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;951</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;846</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;620</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Straight bonds</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25&nbsp;283</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities to banks and other financial institutions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 285</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finance lease obligations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 92</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;353</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Trade payables and commitment for repurchase of own shares <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;840</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities - measured at amortized costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 32&nbsp;623</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37&nbsp;930</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"></td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities - measured at fair value through the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration (see Note 20/22) and other financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;065</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 917</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities - measured at fair value through the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 975</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 35&nbsp;822</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 38&nbsp;905</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Except for straight bonds (see Note 19), the carrying amount is a reasonable approximation of fair value. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Notes 18 and 22 provide additional disclosures related to commitment for repurchase of own shares. </div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Derivative financial instruments</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following tables show the contract or underlying principal amounts and fair values of derivative financial instruments analyzed by type of contract at December&nbsp;31, 2019 and 2018. Contract or underlying principal amounts indicate the gross volume of business outstanding at the consolidated balance sheet date and do not represent amounts at risk. The fair values are determined by reference to market prices or standard pricing models that use observable market inputs at December 31,&nbsp;2019 and 2018. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory', window );">Derivative financial instruments</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Contract or underlying principal amount</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Positive fair values </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Negative fair values </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;779</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;823</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 96</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodity purchase contract</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Options on equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments included in marketable securities and in current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;057</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;823</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock', window );">Contract or underlying principal amount the derivative financial instruments, by currency</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> EUR</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> USD</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;373</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;760</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;646</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;779</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodity purchase contract</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Options on equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;665</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;057</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> EUR</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> USD</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Other</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total</div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forward foreign exchange rate contracts</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;989</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;558</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;276</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;823</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;989</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;558</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;276</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;823</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementExplanatory', window );">Fair value by hierarchy</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Level 1 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Level 2 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Level 3 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Valued at <br></br> amortized cost </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 61</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, time deposits and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 224</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt and equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 976</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 581</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;557</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances, security deposits and other long-term receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 329</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments and long-term loans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 976</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;213</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;518</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies at fair value through profit and loss</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities at fair value</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;065</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;250</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Level 1 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Level 2 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Level 3 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Valued at <br></br> amortized cost </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 302</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 325</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 337</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 360</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Time deposits and short term investments with original maturity more than 90 days</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interest on debt securities, time deposits and short-term investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total marketable securities, time deposits and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 337</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;099</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;589</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt and equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans and receivables from customers and finance lease, advances, security deposits</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 512</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments and long-term loans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies at fair value through profit and loss</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial liabilities at fair value</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;917</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;975</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock', window );">Reconciliation of changes in fair value measurement</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Associated <br></br> companies at <br></br> fair value through <br></br> profit and loss </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Fund <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Long-term <br></br> financial <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Contingent <br></br> consideration <br></br> receivables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Contingent <br></br> consideration <br></br> payables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Other <br></br> financial <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 145</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 251</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 488</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 396</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;907</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact from discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 163</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value gains and other adjustments, <br></br>including from divestments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 12 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 35 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 195 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 1 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value losses (including impairments and <br></br>amortizations) and other adjustments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;15 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;89 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;48 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments recognized in the consolidated statement <br></br>of comprehensive income </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 229</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;401</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash receipts and payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;64</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 581</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of fair value gains and losses recognized <br></br>in the consolidated income statement for assets <br></br>and liabilities held at December 31, 2019 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;15 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 12 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 35 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 106 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;47 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="14"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <b></b> <b></b> <b></b> <b></b> </div> </td> </tr> <tr valign="bottom"> <td colspan="14"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. <b></b> <b></b> <b></b> </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="13" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="13" style="border-bottom: solid #000000 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="13" height="3"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Associated <br></br> companies at <br></br> fair value through <br></br> profit and loss </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Fund <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Long-term <br></br> financial <br></br> investments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Contingent <br></br> consideration <br></br> receivables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Contingent <br></br> consideration <br></br> payables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Other <br></br> financial <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 188</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 166</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 437</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 844</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;852</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;72</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value gains and other adjustments, <br></br>including from divestments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 93 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 36 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 213 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value losses (including impairments and <br></br>amortizations) and other adjustments recognized <br></br>in the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;100 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments recognized in the consolidated statement <br></br>of comprehensive income </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;10 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 123</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;182</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash receipts and payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;484</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration payable related to disposal group held for sale</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 251</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 488</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 396</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total of fair value gains and losses recognized <br></br>in the consolidated income statement for assets <br></br>and liabilities held at December 31, 2018 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;22 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 93 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 36 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 113 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory', window );">Equity securities measured at fair value through other comprehensive income</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Listed equity securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 843</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 597</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-listed equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 315</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 205</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;158</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 802</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock', window );">Monitoring of net debt or liquidity based on contractual maturities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="11" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="11" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term <br></br>investments with original maturity more than 90 days </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 20 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 26 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 16 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 3 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 57 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 122 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 79</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;712</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;400</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;112</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;746</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;446</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;9&nbsp;150</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;11&nbsp;355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;20&nbsp;505</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20&nbsp;353</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;4&nbsp;243</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1&nbsp;230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;6&nbsp;846</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;29</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;402</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;256</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;7&nbsp;031</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;373</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1&nbsp;237</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;073</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;938</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="11" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="11" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marketable securities, time deposits and short-term <br></br>investments with original maturity more than 90 days </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 39 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 56 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;091 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 198 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 63 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;447 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commodities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments and accrued interest</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 142</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;571</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;700</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13&nbsp;271</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;650</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;831</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 198</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;964</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;025</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;13&nbsp;623</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;22&nbsp;648</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;490</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;22&nbsp;470</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Financial debt - undiscounted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;5&nbsp;217</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;4&nbsp;084</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;9&nbsp;620</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;327</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;9&nbsp;678</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;583</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;713</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;791</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;8&nbsp;782</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;323</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16&nbsp;184</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock', window );">Derivative financial instruments and accrued interest on derivative financial instruments</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Derivative financial instruments and accrued interest on derivative financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential outflows in various currencies - from financial derivative liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;814</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4&nbsp;624</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;952</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6&nbsp;390</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential inflows in various currencies - from financial derivative assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 807</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 922</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6&nbsp;385</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due within <br></br> one month </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Derivative financial instruments and accrued interest on derivative financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential outflows in various currencies - from financial derivative liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;305</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;949</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;598</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4&nbsp;852</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Potential inflows in various currencies - from financial derivative assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;974</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 593</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;895</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock', window );">Other contractual liabilities of the net debt or liquidity</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contractual interest on non-current liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;36</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;428</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;531</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;439</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;434</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;181</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;081</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;949</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;222</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;424</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;582</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;383</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;036</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one month <br></br> but less than <br></br> three months </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> three months <br></br> but less than <br></br> one year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Due later than <br></br> one year <br></br> but less than <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Due after <br></br> five years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contractual interest on non-current liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;113</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;459</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;667</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;755</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;994</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;556</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;556</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;339</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;907</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfTenDayLossFairValueVARModelTableTextBlock', window );">Ten day loss fair value VAR model</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 355</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 337</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign <br></br>currency exchange rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 89 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 217 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity <br></br>market movements </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 31 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 122 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to interest rates</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 187</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 221</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock', window );">Ten day loss fair value VAR model, average, high, and low VAR amounts</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Average</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> High</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Low</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 348</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 385</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 303</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign <br></br>currency exchange rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 143 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 195 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 86 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity <br></br>market movements </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 36 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 81 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 16 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to <br></br>interest rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 233 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 303 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 187 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Average</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> High</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Low</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">All financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 443</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 553</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 337</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Analyzed by components:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to foreign <br></br>currency exchange rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 324 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 473 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 217 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to equity <br></br>market movements </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 60 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 122 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 22 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Instruments sensitive to <br></br>interest rates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 253 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 361 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 169 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of derivative financial instruments. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for fair value measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IFRS13_g91-99_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: Investments in equity instruments designated at fair value through other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 11A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_11A_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfEachInvestmentInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDerivativeFinancialInstrumentsContractOrUnderlyingPrincipalAmountTheDerivativeFinancialInstrumentsByCurrencyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMonitoringOfNetDebtOrLiquidityBasedOnContractualMaturitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOtherContractualLiabilitiesOfTheNetDebtOrLiquidityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfReconciliationOfChangesInFairValueMeasurementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfTenDayLossFairValueVARModelAverageHighAndLowVARAmountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfTenDayLossFairValueVARModelTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfTenDayLossFairValueVARModelTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialInstrumentsAdditionalDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialInstrumentsAdditionalDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>236
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6849597728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Profit/loss attributable to shareholders of Novartis AG | $</a></td>
<td class="nump">$ 11,732<span></span>
</td>
<td class="nump">$ 12,611<span></span>
</td>
<td class="nump">$ 7,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of shares outstanding used in the basic earnings per share | shares</a></td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">2,319<span></span>
</td>
<td class="nump">2,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options | shares</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of shares in diluted earnings per share | shares</a></td>
<td class="nump">2,319<span></span>
</td>
<td class="nump">2,344<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations', window );">Basic earnings per share, Continuing operations</a></td>
<td class="nump">$ 3.12<span></span>
</td>
<td class="nump">$ 5.52<span></span>
</td>
<td class="nump">$ 3.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic earnings per share, Discontinued operations</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Total basic earnings per share</a></td>
<td class="nump">5.12<span></span>
</td>
<td class="nump">5.44<span></span>
</td>
<td class="nump">3.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations', window );">Diluted earnings per share, Continuing operations</a></td>
<td class="nump">3.08<span></span>
</td>
<td class="nump">5.46<span></span>
</td>
<td class="nump">3.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted earnings per share, Discontinued operations</a></td>
<td class="nump">1.98<span></span>
</td>
<td class="num">(0.08)<span></span>
</td>
<td class="nump">0.08<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Total diluted earnings per share</a></td>
<td class="nump">$ 5.06<span></span>
</td>
<td class="nump">$ 5.38<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OptionsExcludedFromTheCalculation', window );">Options excluded from the calculation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Profit/loss attributable to shareholders of Novartis AG | $</a></td>
<td class="nump">$ 7,142<span></span>
</td>
<td class="nump">$ 12,797<span></span>
</td>
<td class="nump">$ 7,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings per share [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Profit/loss attributable to shareholders of Novartis AG | $</a></td>
<td class="nump">$ 4,590<span></span>
</td>
<td class="num">$ (186)<span></span>
</td>
<td class="nump">$ 204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations [member]; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2019-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OptionsExcludedFromTheCalculation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OptionsExcludedFromTheCalculation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>237
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839402144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at beginning of period</a></td>
<td class="nump">$ 8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Utilization of reversal of provisions for doubtful trade receivables</a></td>
<td class="nump">19,348<span></span>
</td>
<td class="nump">$ 18,567<span></span>
</td>
<td class="nump">$ 17,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at end of period</a></td>
<td class="nump">8,301<span></span>
</td>
<td class="nump">8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at beginning of period</a></td>
<td class="nump">8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at end of period</a></td>
<td class="nump">8,301<span></span>
</td>
<td class="nump">8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Provision for doubtful receivable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at beginning of period</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfDivestmentsOtherProvisions', window );">Impact of divestments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Impact of business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Provisions for doubtful trade receivables charged to the consolidated income statement</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Utilization of reversal of provisions for doubtful trade receivables</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversal of provisions for doubtful trade receivables</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation effects</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at end of period</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member] | Trade receivables [member] | Provision for doubtful receivable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Provisions for doubtful trade receivables charged to the consolidated income statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversal of provisions for doubtful trade receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member] | Trade receivables [member] | Provision for doubtful receivable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfProvisionMatrixLineItems', window );"><strong>Disclosure of provision matrix [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at beginning of period</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Provisions at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in other provisions resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfProvisionMatrixLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfProvisionMatrixLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount reversed for unused other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfDivestmentsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfDivestmentsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=nvs_ProvisionForDoubtfulReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=nvs_ProvisionForDoubtfulReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>238
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6870224960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory', window );">Schedule disclosing information related to associates</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Net income statement effect</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other comprehensive income effect <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total comprehensive income effect</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG, Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 662</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 526</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 456</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 75</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 568</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 601</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 564</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">GlaxoSmithKline Consumer <br></br>Healthcare Holdings Ltd., UK </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 5&nbsp;910 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 629 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;557 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;145 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 5&nbsp;353 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 484 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Associated companies related to continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 659</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;482</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 565</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;956</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;071</div> </td> <td align="right"></td> </tr> <tr> <td colspan="20" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="20"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="20"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> In 2018, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 511 million was recycled into the consolidated income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. No Novartis share of other comprehensive income recognized by associated companies, net of taxes was recycled into the consolidated income statement in 2019 and 2017. <b></b> <b></b> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock', window );">Schedule disclosing information related to associates, balance sheet value</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Balance sheet value</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG, Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;445</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;195</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Others</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 199</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 157</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;644</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;352</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AssociatesSummarizedFinancialInformationTableTextBlock', window );">Associates summarized financial information</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(CHF billions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Current assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-current <br></br> assets </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Current <br></br> liabilities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Non-current <br></br> liabilities </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">December 31, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 53.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25.1</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">June 30, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(CHF billions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Revenue </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Net income </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Other <br></br> comprehen- <br></br> sive income </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> comprehen- <br></br> sive income </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">December 31, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.6</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.5</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">June 30, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 31.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;0.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PurchasePriceAllocationAssociatesTableTextBlock', window );">Purchase price allocation associates</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of Roche&#x2019;s estimated net assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;404</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of reappraised intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 297</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Implicit Novartis goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;939</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Current value of share in net identifiable assets <br></br>and goodwill </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 5&nbsp;640 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated equity accounting adjustments and translation effects less dividends received</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;805</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance sheet value</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;445</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock', window );">Schedule disclosing information related to associates, net income effect</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of Roche's <br></br>estimated current-year <br></br>consolidated net income </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 910 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 799 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 669 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prior-year adjustment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;125</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;67</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of fair value <br></br>adjustments relating to <br></br>intangible assets, net of taxes <br></br>of USD 24 million (2018: USD 40 <br></br>million; 2017: USD 42 million) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;162 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;148 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;146 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Partial release of deferred tax liability recognized</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income effect</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 662</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 526</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 456</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember', window );">GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock', window );">Schedule disclosing information related to associates, net income effect</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis share of <br></br>GSK Consumer Healthcare's <br></br>estimated current-year <br></br>consolidated net income </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> 119 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> 589 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prior-year adjustment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of fair value <br></br>adjustments relating to <br></br>intangible assets and inventory, <br></br>net of taxes of USD 1 million <br></br>(2017: USD 1 million) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> <br></br> &ndash;&nbsp;7 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pre-tax gain on divestment of GSK Consumer Healthcare</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;790</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income effect</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;910</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 629</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B4<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B4_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AssociatesSummarizedFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AssociatesSummarizedFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PurchasePriceAllocationAssociatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PurchasePriceAllocationAssociatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>239
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838650528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in consolidated statements of comprehensive income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAbstract', window );"><strong>Comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfComprehensiveIncomeTableTextBlock', window );">Comprehensive income</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on marketable <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on equity <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Actuarial <br></br> gains/(losses) <br></br> from defined <br></br> benefit plans </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Cumulative <br></br> currency <br></br> translation <br></br> effects </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total value <br></br> adjustments </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at January 1, 2017</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 349</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;915</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;642</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;7&nbsp;212</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 50</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;237</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial losses from defined benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 851</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;208</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 851</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;971</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;872</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2017, as previously reported</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;064</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;340</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 9 on retained <br></br>earnings and OCI <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to presentation required under IFRS 9 <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated value adjustments at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;064</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 329</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;517</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 95</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial gains from defined benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 320</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 320</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 415</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 65</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;423</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 744</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;452</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments on financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net investment hedge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net actuarial gains from defined benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 354</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total value adjustments in 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 398</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;208</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Value adjustments at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 99</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;919</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;657</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 1 provides additional disclosures related to the impact of adoption of IFRS 9 Financial Instruments. OCI: other comprehensive income </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock', window );">Fair value adjustments financial instruments reconciliation</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on equity <br></br> securities <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 208</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 21</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 227</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Debt securities sold</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred <br></br>to the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains reclassified to the retained earnings:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;95</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;140</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value adjustments related to divestments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 99</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on marketable <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on equity <br></br> securities <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2018, as previously reported</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of adoption of IFRS 9 on retained earnings and <br></br>other comprehensive income <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;177 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to presentation required under IFRS 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Restated fair value adjustments at January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 211</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 218</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Equity securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred <br></br>to the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains reclassified to the retained earnings:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 227</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Includes fair value adjustments on equity securities designated as financial assets valued at fair value through other comprehensive income with no subsequent recycling into the consolidated income statement </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 1 provides aditional disclosures on the impact of adoption of IFRS 9 Financial Instruments. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on marketable <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments <br></br> on debt <br></br> securities </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Fair value <br></br> adjustments on <br></br> deferred cash <br></br> flow hedges </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at January 1, 2017</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 349</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 345</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Changes in fair value:</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Available-for-sale marketable securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Available-for-sale financial investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Realized net gains transferred to the consolidated income statement:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other financial assets sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;109</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;109</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortized net losses on cash flow hedges transferred <br></br>to the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 13 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impaired financial assets transferred to the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax on above items <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments during the year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 50</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Fair value adjustments at December 31, 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 388</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 395</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Included is a USD 18 million impact related to the revaluation of deferred tax liabilities on available-for-sale financial investments held in the US that were previously recognized through other comprehensive income related to continuing operrations. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock', window );">Schedule of defined benefit plan amounts recognized in other comprehensive income</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Defined benefit pension plans before tax</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;119</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;482</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;367</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other post-employment benefit plans before tax</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxation on above items <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;313</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 69</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total after tax</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;467</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 851</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;466</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> &ndash;&nbsp;359</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 851</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Included in 2019 is a USD -358 million impact related to the revaluation of deferred tax assets on Swiss post-employment benefits that were previously recognized through other comprehensive income. This revaluation resulted from the Swiss tax reforms enacted by the voters in 2019. Refer to Note 12 for additional disclosures. <br></br>Included in 2017 is a USD -272 million impact related to the revaluation of deferred tax assets on US post-employment benefits that were previously recognized through other comprehensive income (continuing operations USD-259 million and discontinued operations USD -13 million). This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsFinancialInstrumentsReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>240
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6872446416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial and other non-current assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Disclosure of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NoncurrentFinancialAssetsEquityInvestments', window );">Non-current financial assets, equity investments</a></td>
<td class="nump">$ 1,524<span></span>
</td>
<td class="nump">$ 1,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NoncurrentFinancialAsstetsDebtSecurities', window );">Non-current financial asstets debt securities</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NoncurrentFinancialAssetsFundInvestments', window );">Non-current financial assets, fund investments</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NoncurrentFinancialAssetsTotalFinancialInvestments', window );">Noncurrent financial assets, total financial investments</a></td>
<td class="nump">1,790<span></span>
</td>
<td class="nump">1,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Long-term receivables from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinanceLeaseReceivables', window );">Minimum lease payments from finance lease agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LongTermReceivablesFromFinanceSubleases', window );">Long term receivables from finance subleases</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Other long-term receivables</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ContingentConsiderationReceivable', window );">Contingent consideration receivables</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLoansAndReceivables', window );">Long-term loans, advances and security deposits</a></td>
<td class="nump">159<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total financial assets</a></td>
<td class="nump">$ 2,518<span></span>
</td>
<td class="nump">$ 2,345<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinanceLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current finance lease receivables. [Refer: Finance lease receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinanceLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current loans and receivables. [Refer: Loans and receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2021-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ContingentConsiderationReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ContingentConsiderationReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LongTermReceivablesFromFinanceSubleases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LongTermReceivablesFromFinanceSubleases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NoncurrentFinancialAssetsEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NoncurrentFinancialAssetsEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NoncurrentFinancialAssetsFundInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NoncurrentFinancialAssetsFundInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NoncurrentFinancialAssetsTotalFinancialInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NoncurrentFinancialAssetsTotalFinancialInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NoncurrentFinancialAsstetsDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NoncurrentFinancialAsstetsDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>241
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838364096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract', window );"><strong>Disclosure of marketable securities commodities deposits derivative instruments and cash [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DebtInstrumentsHeld', window );">Debt securities</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FundInstrumentsHeld', window );">Fund investments</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_Commodities', window );">Commodities</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents', window );">Time deposits with original maturity more than 90 days</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">2,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial instruments</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestReceivable', window );">Accrued interest on debt securities and time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Total marketable securities, commodities, time deposits and derivative financial instruments</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 2,693<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DebtInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of instruments representing indebtedness held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DebtInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest recognised as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_Commodities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_Commodities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMarketableSecuritiesCommoditiesDepositsDerivativeInstrumentsAndCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FundInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FundInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>242
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6837367744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Current financial debt and derivative financial instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract', window );"><strong>Disclosure of current financial debt and derivative instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock', window );">Current financial debt and derivative financial instruments</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">21. Current financial debt and&nbsp;derivative&nbsp;financial&nbsp;instruments</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest-bearing accounts of associates <br></br>payable on demand <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;836 </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;778 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bank and other financial debt <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 719</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 701</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commercial paper</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;289</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;951</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current portion of non-current financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;190</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fair value of derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total current financial debt and derivative financial instruments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;678</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Weighted average interest rate 0.5% (2018: 0.5%) </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Weighted average interest rate 12.9% (2018: 9.6%) </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The consolidated balance sheet amounts of current financial debt, other than the current portion of non-current financial debt, approximate the estimated fair value due to the short-term nature of these instruments. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Details on commercial papers and short term borrowings are provided under &#x201c;Liquidity risk&#x201d; in Note&nbsp;29. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;"> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>243
<FILENAME>R140.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6841140256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Non-current financial debt (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 22,355<span></span>
</td>
<td class="nump">$ 25,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">12,889<span></span>
</td>
<td class="nump">15,964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">7,861<span></span>
</td>
<td class="nump">8,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">JPY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">184<span></span>
</td>
<td class="nump">272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_CHF', window );">CHF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems', window );"><strong>Disclosure of maturity analysis for non-derivative financial liabilities [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings</a></td>
<td class="nump">$ 1,421<span></span>
</td>
<td class="nump">$ 1,396<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisForNonderivativeFinancialLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_CHF">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_CHF</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>244
<FILENAME>R144.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842564752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other non-current liabilities (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionRollForward', window );"><strong>Environmental provision [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvision', window );">Environmental liabilities provision at beginning of period</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 761<span></span>
</td>
<td class="nump">$ 773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionPayments', window );">Cash payments</a></td>
<td class="num">(30)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionReleases', window );">Releases</a></td>
<td class="num">(83)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionAdditions', window );">Additions</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss', window );">Currency translation effects</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvision', window );">Environmental liabilities provision at end of period</a></td>
<td class="nump">714<span></span>
</td>
<td class="nump">692<span></span>
</td>
<td class="nump">761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionCurrent', window );">Less current provision</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalRemediationProvisionNoncurrent', window );">Non-current environmental remediation provisions at end of period</a></td>
<td class="nump">$ 592<span></span>
</td>
<td class="nump">634<span></span>
</td>
<td class="nump">706<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionRollForward', window );"><strong>Environmental provision [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionReleases', window );">Releases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_EnvironmentalProvisionAdditions', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionReleases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionReleases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalProvisionRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalProvisionRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_EnvironmentalRemediationProvisionNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_EnvironmentalRemediationProvisionNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>245
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6873904912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherCurrentAssetsAbstract', window );"><strong>Other current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory', window );">Other current assets</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">17. Other current assets</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">VAT receivable</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 508</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 588</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Withholding tax recoverable</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid expenses</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Third parties</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 811</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Receivables from associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other receivables and current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;165</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;360</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;680</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;861</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other current assets. [Refer: Other current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>246
<FILENAME>R148.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6872475824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Current financial debt and derivative financial instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract', window );"><strong>Disclosure of current financial debt and derivative instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InterestBearningAccountsOfAssociatesPayableOnDemand', window );">Interest bearning accounts of associates payable on demand</a></td>
<td class="nump">$ 1,836<span></span>
</td>
<td class="nump">$ 1,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Bank and other financial debt</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CommercialPapersIssued', window );">Commercial Papers</a></td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">3,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPortionOfLongtermBorrowings', window );">Current portion of non-current financial debt</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">3,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Fair value of derivative financial instruments</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Total current financial debt and derivative financial instruments</a></td>
<td class="nump">$ 7,031<span></span>
</td>
<td class="nump">$ 9,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WeightedAverageInterestRateAssociates', window );">Weighted average interest rate, associates</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt', window );">Weighted average interest rate on Bank and other financial debt</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="nump">9.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CommercialPapersIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of commercial paper issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CommercialPapersIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPortionOfLongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPortionOfLongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfCurrentFinancialDebtAndDerivativeInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InterestBearningAccountsOfAssociatesPayableOnDemand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InterestBearningAccountsOfAssociatesPayableOnDemand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WeightedAverageInterestRateAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate on interest bearning accounts of associates payable on demand.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WeightedAverageInterestRateAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate on Bank and other financial debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_WeightedAverageInterestRateOnBankAndOtherFinancialDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>248
<FILENAME>R197.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6870696816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Discontinued operations (Details 6) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">$ 1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,271<span></span>
</td>
<td class="nump">$ 8,860<span></span>
</td>
<td class="nump">$ 7,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,867)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,475)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Current and non-current lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,949)<span></span>
</td>
<td class="num">(1,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 2,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">8,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">11,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialAndOtherNoncurrentAssets', window );">Financial and other non-current assets</a></td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">1,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TradeReceivablesAndOtherCurrentAssets', window );">Trade receivables and other current assets</a></td>
<td class="nump">1,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(1,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Current and non-current lease liabilities</a></td>
<td class="num">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentAndNoncurrentFinancialDebt', window );">Current and non-current financial debt</a></td>
<td class="num">(3,538)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_TradePayablesProvisionsAndOtherLiabilities', window );">Trade payables, provisions and other liabilities</a></td>
<td class="num">(2,751)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetAssetsDerecognized', window );">Net assets derecognized</a></td>
<td class="nump">$ 20,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentAndNoncurrentFinancialDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentAndNoncurrentFinancialDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetAssetsDerecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetAssetsDerecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TradePayablesProvisionsAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TradePayablesProvisionsAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_TradeReceivablesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_TradeReceivablesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>249
<FILENAME>R167.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6855747728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 9)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract', window );"><strong>Novartis Group contributions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contributions, next fiscal year (estimated)</a></td>
<td class="nump">$ 410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">1,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Later than one year and not later than two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">1,116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Later than two years and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">1,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Later than three years and not later than four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">1,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Later than four years and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans | Later than five years and not later than ten years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">5,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract', window );"><strong>Novartis Group contributions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Contributions, next fiscal year (estimated)</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Later than one year and not later than two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Later than two years and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Later than three years and not later than four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Later than four years and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans | Later than five years and not later than ten years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract', window );"><strong>Expected future benefit payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment', window );">Expected future benefit payment</a></td>
<td class="nump">$ 231<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanExpectedFutureBenefitPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanExpectedFutureBenefitPaymentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanTenYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>250
<FILENAME>R163.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6850543088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details 5)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember', window );">Pension plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases', window );">Expected rate of pension increase</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Expected rate of salary increase</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount', window );">Interest on savings account</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitAssumptionLifeExpectancyMale', window );">Current life expectancy for a 65-year-old male</a></td>
<td class="text">22 years<span></span>
</td>
<td class="text">22 years<span></span>
</td>
<td class="text">22 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitAssumptionLifeExpectancyFemale', window );">Current life expectancy for a 65-year-old female</a></td>
<td class="text">24 years<span></span>
</td>
<td class="text">24 years<span></span>
</td>
<td class="text">24 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember', window );">Other post-employment benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Discount rate</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitAssumptionLifeExpectancyMale', window );">Current life expectancy for a 65-year-old male</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">21 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitAssumptionLifeExpectancyFemale', window );">Current life expectancy for a 65-year-old female</a></td>
<td class="text">23 years<span></span>
</td>
<td class="text">23 years<span></span>
</td>
<td class="text">23 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 144<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ActuarialAssumptionOfExpectedRatesOfInterestOnSavingsAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitAssumptionLifeExpectancyFemale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitAssumptionLifeExpectancyFemale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitAssumptionLifeExpectancyMale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitAssumptionLifeExpectancyMale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_PensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RetirementPlanTypeAxis=nvs_OtherPostemploymentBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>251
<FILENAME>R193.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6840486144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">$ 245<span></span>
</td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet', window );">Impairment charges and fair value gains on financial assets, net</a></td>
<td class="nump">38<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToRestructuringProvisions', window );">Additions to restructuring provisions</a></td>
<td class="num">(492)<span></span>
</td>
<td class="num">(521)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToRestructuringProvisions', window );">Additions to restructuring provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Equity-based compensation of Novartis equity plans</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(93)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember', window );">Property, plant and equipment [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(1,345)<span></span>
</td>
<td class="num">(1,482)<span></span>
</td>
<td class="num">(1,303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(202)<span></span>
</td>
<td class="num">(301)<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember', window );">Property, plant and equipment [member] | Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="num">(217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember', window );">Right-of-use assets [member] | Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember', window );">Intangible assets and goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">(2,836)<span></span>
</td>
<td class="num">(2,587)<span></span>
</td>
<td class="num">(2,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="num">(1,138)<span></span>
</td>
<td class="num">(841)<span></span>
</td>
<td class="num">(652)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember', window );">Intangible assets and goodwill [member] | Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Depreciation and amortisation expense</a></td>
<td class="num">$ (174)<span></span>
</td>
<td class="num">(1,052)<span></span>
</td>
<td class="num">(1,066)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (391)<span></span>
</td>
<td class="num">$ (57)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 104<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss or reversal of impairment loss recognised in profit or loss. [Refer: Impairment loss recognised in profit or loss; Reversal of impairment loss recognised in profit or loss]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionsToRestructuringProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionsToRestructuringProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpairmentChargesAndFairValueGainsOnFinancialAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_RightofuseAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_IntangibleAssetsAndGoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>252
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842442896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfDefinedContributionPlansTableTextBlock', window );">Defined contribution plans</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined contribution plans continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 422</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 443</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 307</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock', window );">Consolidated income statement, discontinued operations</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from <br></br>discontinued operations </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;777 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 7&nbsp;149 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 6&nbsp;771 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing segments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;809</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;153</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;774</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;860</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;588</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;189</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;638</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;754</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;532</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;585</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;583</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;194</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income/(loss) from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;234</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;73</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;27</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income/(loss) before taxes from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;260</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;103</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 307</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net (loss)/income from discontinued operations <br></br>before gain on distribution of Alcon Inc. <br></br>to Novartis AG shareholders </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;101 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;186 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 204 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> The consolidated income statement amounts are for the period from January 1, 2019, to the completion of the spin-off. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> See Note 2 for further details on the non-taxable non-cash gain on distribution of Alcon Inc. to Novartis AG shareholders. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock', window );">Consolidated income statement, additional information</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;42</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;235</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;217</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;174</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;052</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;066</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;391</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;57</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;93</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. See Note 1 for additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> 2018 includes an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetAdditionalInformationTableTextBlock', window );">Balance sheet, additional information</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 113</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 519</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to goodwill and intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 196</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Note 1 for additional disclosures. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock', window );">Cash flows used in investing activities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments out of provisions for <br></br>transaction costs attributable <br></br>to the spin-off of the <br></br>Alcon business </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> <br></br> &#x2013;&#x2005;29 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Divested cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;628</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows attributable to the spin-off of the Alcon business</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;657</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other cash flows used in investing activities, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;502</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;775</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows used in investing activities from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;1&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;1&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;775</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock', window );">Minimum finance lease payments</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> future <br></br> payments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Unearned <br></br> finance <br></br> income </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Present <br></br> value </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Provision </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Net book <br></br> value </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not later than one year <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 64</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between one and five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 117</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Later than five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 48</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 229</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 213</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 148</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> The current portion of the minimum lease payments was recorded in trade receivables or other current assets (to the extent not invoiced). </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock', window );">Disclosure of net assets derecognized</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;858</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;906</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;121</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 732</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 526</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;469</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables and other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 628</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;713</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;269</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;538</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables, provisions and other liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;751</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets derecognized</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;025</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfDefinedContributionPlansTableTextBlock', window );">Defined contribution plans</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined contribution plans discontinued operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetAdditionalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetAdditionalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashFlowsUsedInInvestingActivitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ConsolidatedIncomeStatementAdditionalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ConsolidatedIncomeStatementDiscontinuedOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfMinimumFinanceLeasePaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNetAssetsDerecognizedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfDefinedContributionPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfDefinedContributionPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>253
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6894081152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in consolidated statements of comprehensive income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Net actuarial gains/losses from defined benefit plans</a></td>
<td class="num">(467.0)<span></span>
</td>
<td class="num">(359.0)<span></span>
</td>
<td class="nump">851.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations', window );">Net investment hedge</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
<td class="num">(237.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation effects</a></td>
<td class="nump">352.0<span></span>
</td>
<td class="nump">315.0<span></span>
</td>
<td class="nump">2,210.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember', window );">Equity attributable to owners of parent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">39.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Reclassification to presentation required under IFRS 9 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(211.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember', window );">Fair value adjustments on marketable securities | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember', window );">Fair value adjustments on debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember', window );">Fair value adjustments on debt securities | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember', window );">Fair value adjustments on debt securities | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember', window );">Fair value adjustments on deferred cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">22.0<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember', window );">Fair value adjustments on deferred cash flow hedges | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">208.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="num">(47.0)<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="num">(95.0)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="num">(142.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">33.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">99.0<span></span>
</td>
<td class="nump">208.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities | Previously stated [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities | Reclassification to presentation required under IFRS 9 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember', window );">Fair value adjustments on equity securities | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_ActuarialLossesFromDefinedBenefitPlansMember', window );">Actuarial gains/losses from defined benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="num">(5,423.0)<span></span>
</td>
<td class="num">(5,064.0)<span></span>
</td>
<td class="num">(5,915.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Net actuarial gains/losses from defined benefit plans</a></td>
<td class="num">(466.0)<span></span>
</td>
<td class="num">(359.0)<span></span>
</td>
<td class="nump">851.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="num">(466.0)<span></span>
</td>
<td class="num">(359.0)<span></span>
</td>
<td class="nump">851.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="num">(30.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="num">(5,919.0)<span></span>
</td>
<td class="num">(5,423.0)<span></span>
</td>
<td class="num">(5,064.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_ActuarialLossesFromDefinedBenefitPlansMember', window );">Actuarial gains/losses from defined benefit plans | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,064.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,064.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_CumulativeCurrencyTranslationEffectsMember', window );">Cumulative currency translation effects</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="nump">744.0<span></span>
</td>
<td class="nump">329.0<span></span>
</td>
<td class="num">(1,642.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations', window );">Net investment hedge</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
<td class="num">(237.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation effects</a></td>
<td class="nump">354.0<span></span>
</td>
<td class="nump">320.0<span></span>
</td>
<td class="nump">2,208.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="nump">398.0<span></span>
</td>
<td class="nump">415.0<span></span>
</td>
<td class="nump">1,971.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="nump">1,142.0<span></span>
</td>
<td class="nump">744.0<span></span>
</td>
<td class="nump">329.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_CumulativeCurrencyTranslationEffectsMember', window );">Cumulative currency translation effects | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">329.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember', window );">Total value adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="num">(4,452.0)<span></span>
</td>
<td class="num">(4,340.0)<span></span>
</td>
<td class="num">(7,212.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9', window );">Increase to retained earnings arising from first application of IFRS 9</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments', window );">Fair value adjustments on financial instruments</a></td>
<td class="num">(45.0)<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold', window );">Fair value adjustments on financial assets sold</a></td>
<td class="num">(95.0)<span></span>
</td>
<td class="num">(16.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Net actuarial gains/losses from defined benefit plans</a></td>
<td class="num">(466.0)<span></span>
</td>
<td class="num">(359.0)<span></span>
</td>
<td class="nump">851.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations', window );">Net investment hedge</a></td>
<td class="nump">44.0<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
<td class="num">(237.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation effects</a></td>
<td class="nump">354.0<span></span>
</td>
<td class="nump">320.0<span></span>
</td>
<td class="nump">2,208.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome', window );">Total value adjustments</a></td>
<td class="num">(208.0)<span></span>
</td>
<td class="nump">65.0<span></span>
</td>
<td class="nump">2,872.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FairValueAdjustmentsRelatedToDivestments', window );">Fair value adjustments related to divestments</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="num">$ (4,657.0)<span></span>
</td>
<td class="num">(4,452.0)<span></span>
</td>
<td class="num">(4,340.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember', window );">Total value adjustments | Increase (decrease) due to changes in accounting policy required by IFRSs [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(177.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember', window );">Total value adjustments | Restated Value Adjustments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems', window );"><strong>Changes in consolidated statements of comprehensive income [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,517.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueAdjustmentOnComprehensiveIncome', window );">Value adjustments on comprehensive income at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,517.0)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 39<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=39&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2019-01-01<br> -Paragraph 6.5.13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_6.5.13_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ChangesInConsolidatedStatementsOfComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsOnFinancialAssetsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsOnFinancialAssetsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FairValueAdjustmentsRelatedToDivestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FairValueAdjustmentsRelatedToDivestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GainsLossesOnValueAdjustmentOnComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseToRetainedEarningsArisingFromFirstApplicationOfIFRS9</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeNetOfTaxFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ValueAdjustmentOnComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ValueAdjustmentOnComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_EquityAttributableToOwnersOfParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_PreviouslyStatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=ifrs-full_IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRSsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_ReclassificationToPresentationRequiredUnderIFRS9Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_ReclassificationToPresentationRequiredUnderIFRS9Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_RestatedValueAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis=nvs_RestatedValueAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnDeferredCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_FairValueAdjustmentsOnEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_ActuarialLossesFromDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_ActuarialLossesFromDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_CumulativeCurrencyTranslationEffectsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_CumulativeCurrencyTranslationEffectsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=nvs_TotalValueAdjustmentsAttributableToNovartisShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>254
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846134144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="nump">$ 8,940<span></span>
</td>
<td class="nump">$ 14,095<span></span>
</td>
<td class="nump">$ 9,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">14,095<span></span>
</td>
<td class="nump">9,102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member] | Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="nump">8,097<span></span>
</td>
<td class="nump">11,887<span></span>
</td>
<td class="nump">5,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations [member] | Foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="nump">843<span></span>
</td>
<td class="nump">2,208<span></span>
</td>
<td class="nump">3,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before taxes</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="num">$ (260)<span></span>
</td>
<td class="num">$ (103)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_CountryOfDomicileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=ifrs-full_ForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>255
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846200880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Changes in consolidated statements of comprehensive income (Details 4) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RemeasurementsFromDefinedBenefitPlansLineItems', window );"><strong>Remeasurements from defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Defined benefit pension plans before tax</a></td>
<td class="num">$ (119)<span></span>
</td>
<td class="num">$ (482)<span></span>
</td>
<td class="nump">$ 1,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans', window );">Other post-employment benefit plans before tax</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation', window );">Taxation on above items</a></td>
<td class="num">(313)<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="num">(592)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Remeasurements from defined benefit plans, total after tax</a></td>
<td class="num">(467)<span></span>
</td>
<td class="num">$ (359)<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI', window );">Impact of new tax law income tax relating to deferred tax assets on US post retirement previously recognized through OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI', window );">Impact of new tax law income tax relating to deferred tax assets on Swiss post retirement previously recognized through OCI</a></td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_NoncontrollingInterestsMember', window );">Non-controlling interests [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RemeasurementsFromDefinedBenefitPlansLineItems', window );"><strong>Remeasurements from defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Remeasurements from defined benefit plans, total after tax</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember', window );">Continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RemeasurementsFromDefinedBenefitPlansLineItems', window );"><strong>Remeasurements from defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI', window );">Impact of new tax law income tax relating to deferred tax assets on US post retirement previously recognized through OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RemeasurementsFromDefinedBenefitPlansLineItems', window );"><strong>Remeasurements from defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI', window );">Impact of new tax law income tax relating to deferred tax assets on US post retirement previously recognized through OCI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnSwissPostRetirementPreviouslyRecognizedThroughOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ImpactOfNewTaxLawIncomeTaxRelatingToDeferredTaxAssetsOnUSPostRetirementPreviouslyRecognizedThroughOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeBeforeTaxesGainsLossesOnRemeasurementsOfOtherPostemploymentBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherComprehensiveIncomeGainsLossesOnRemeasurementsOfDefinedAndOtherPostemploymentBenefitPlansTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RemeasurementsFromDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RemeasurementsFromDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_NoncontrollingInterestsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_NoncontrollingInterestsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>256
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844840992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock', window );">Expense related to all equity-based participation and liabilities arising from equity-based payment transactions</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense related to equity-based <br></br>participation plans </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;067 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 918 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 853 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities arising from equity-based payment transactions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 326</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 261</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock', window );">Schedule of unvested restricted stock units roll forward</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Number <br></br> of shares <br></br> in millions </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br></br> average fair <br></br> value at grant <br></br> date in USD </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Fair value at <br></br> grant date in <br></br> USD millions </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Number <br></br> of shares <br></br> in millions </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br></br> average fair <br></br> value at grant <br></br> date in USD </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Fair value at <br></br> grant date in <br></br> USD millions </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-vested shares at January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 25.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;981</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23.9</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 80.6</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;926</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Granted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Annual Incentive</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 109</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Share savings plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 349</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 348</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Select North America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 339</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 303</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Select outside North America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 175</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 79.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Long-Term Performance Plan</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 68.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 172</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 85.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 129</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Long-Term Relative Performance Plan</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 52.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other share awards</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vested</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;068</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;965</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forfeited</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;145</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-vested shares at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 25.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;835</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 77.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;981</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember', window );">Select outside North America</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Disclosure of number and weighted average remaining contractual life of outstanding share options</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Options outstanding <br></br>at January 1 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 5.6 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 59.9 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 7.4 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 59.5 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sold or exercised</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 58.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58.2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Exercisable at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Disclosure of range of exercise prices of outstanding share options</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Options outstanding </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total/ <br></br> weighted <br></br> average </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number outstanding (millions)</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.9</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remaining contractual life (years)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise price (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember', window );">Select North America</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory', window );">Disclosure of number and weighted average remaining contractual life of outstanding share options</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> ADR <br></br> options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> ADR <br></br> options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Options outstanding <br></br>at January 1 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 15.2 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 60.7 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 20.3 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 59.9 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sold or exercised</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 58.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57.4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 60.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Exercisable at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 60.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory', window );">Disclosure of range of exercise prices of outstanding share options</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>ADR options outstanding </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total/ <br></br> weighted <br></br> average </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number outstanding (millions)</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.4</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.9</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remaining contractual life (years)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise price (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the range of exercise prices for outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfExpenseRelatedToAllEquitybasedParticipationAndLiabilitiesArisingFromEquitybasedPaymentTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectOutsideNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>257
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838746288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other current liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract', window );"><strong>Disclosure of provisions and other current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock', window );">Provisions and other current liabilities</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes other than income taxes</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 471</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 528</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 507</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued expenses for goods and services received but not invoiced</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;046</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 970</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accruals for royalties</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 653</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 651</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued interests on financial debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 156</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for deductions from revenue</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;595</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;262</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accruals for compensation and benefits, including social security</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;464</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;527</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Environmental remediation liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 236</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions for product liabilities, governmental investigations and other legal matters <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 126</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accrued share-based payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 326</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent considerations <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Commitment for repurchase of own shares <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 284</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other payables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 764</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 673</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total provisions and other current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;284</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 20 provides additional disclosures related to legal provisions. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent considerations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Note 18 provides additional disclosures related to commitment for repurchase of own shares. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsForReductionOfRevenueTableTextBlock', window );">Provisions for reduction of revenue</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Income statement charge<sup>2</sup></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Revenue <br></br> deductions <br></br> provisions at <br></br> January 1 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Revenue <br></br> deductions <br></br> provisions <br></br> related to <br></br> discontinued <br></br> operations<sup>1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Effect of <br></br> currency <br></br> translation <br></br> and business <br></br> combinations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Payments/ <br></br> utilizations </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> Adjustments <br></br> of prior years </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> <br></br> <br></br> Current year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Change in <br></br> provisions <br></br> offset against <br></br> gross trade <br></br> receivables </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Revenue <br></br> deductions <br></br> provisions at <br></br> December 31 </div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;883 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 0 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;5&nbsp;183 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;193 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 5&nbsp;474 </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;981 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;625 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;28 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;19 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;2&nbsp;467 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2&nbsp;659 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;769 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates, returns and other deductions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;754</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;166</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;698</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;868</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;845</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;262</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;19&nbsp;348</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;595</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;590 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;4&nbsp;158 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;90 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4&nbsp;541 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;883 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;356 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;78 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;2&nbsp;182 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 83 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;555 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;109 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;625 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates, returns and other deductions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;726</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;51</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;227</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;91</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;956</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 441</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;754</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;672</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;18&nbsp;567</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 19&nbsp;052</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;262</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;">2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;461 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;3&nbsp;684 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;62 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 3&nbsp;875 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;590 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-US-specific healthcare plans <br></br>and program rebates </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;020 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 131 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;1&nbsp;954 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 80 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 2&nbsp;186 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;356 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Non-healthcare plans and program-related rebates, returns and other deductions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;702</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11&nbsp;814</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;127</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;045</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;726</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total 2017</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;183</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 196</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;17&nbsp;452</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;109</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 18&nbsp;106</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;252</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;672</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Charges to the consolidated income statement from continuing operations were USD 18 248 million in 2018 and USD 17 772 million in 2017. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RestructuringProvisionsMovementsTableTextBlock', window );">Restructuring provisions movements</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 507</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 222</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions related to <br></br>discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &#x2013;&#x2005;8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 492</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 534</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 194</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash payments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;479</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;200</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Releases <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;72</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;64</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transfers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005; 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 507</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 153</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Provisions charged to the consolidated income statement from continuing operations were USD 521 million in 2018 and USD 186 million in 2017. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Reversal of provisions credited to the consolidated income statement from continuing operations were USD 31 million in 2018 and USD 59 million in 2017. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfProvisionsAndOtherCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsForReductionOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsForReductionOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RestructuringProvisionsMovementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RestructuringProvisionsMovementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfProvisionsAndOtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>258
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6869840608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Associated companies (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Balance sheet value</a></td>
<td class="nump">$ 8,644<span></span>
</td>
<td class="nump">$ 8,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ShareOfEstimatedNetAssets', window );">Novartis share of estimated net assets</a></td>
<td class="nump">2,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill', window );">Novartis share of re-appraised intangible assets</a></td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalRecognitionGoodwill', window );">Implicit Novartis goodwill</a></td>
<td class="nump">2,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill', window );">Current value of share in net identifiable assets and goodwill</a></td>
<td class="nump">5,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived', window );">Accumulated equity accounting adjustments and translation effects less dividends received</a></td>
<td class="nump">2,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Balance sheet value</a></td>
<td class="nump">$ 8,445<span></span>
</td>
<td class="nump">$ 8,195<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalRecognitionGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional goodwill recognised, except goodwill included in a disposal group that, on acquisition, meets the criteria to be classified as held for sale in accordance with IFRS 5. [Refer: Goodwill; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B67_d_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalRecognitionGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from revaluations to fair value. [Refer: Intangible assets other than goodwill; Revaluation surplus]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevaluationIncreaseDecreaseIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AccumulatedEquityAccountingAdjustmentsAndTranslationEffectsLessDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentValueOfShareInNetIdentifiableAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ShareOfEstimatedNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ShareOfEstimatedNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>259
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6841180832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Lease liability and Right-of-use assets (Details 3)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfTheRightofuseAssetsRollForward', window );"><strong>Movements of the right-of-use assets [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">$ 537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charge</a></td>
<td class="num">(305)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LeaseContractTerminationsRightofuseAssets', window );">Lease contract terminations, right-of-use assets</a></td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisposalsAndRetirementsRightofuseAssets', window );">Impact of divestments</a></td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets', window );">Increase decrease through net exchange differences, right-of-use assets</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets at end of period</a></td>
<td class="nump">1,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember', window );">Discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementsOfTheRightofuseAssetsRollForward', window );"><strong>Movements of the right-of-use assets [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisposalsAndRetirementsRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisposalsAndRetirementsRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_IncreaseDecreaseThroughNetExchangeDifferencesRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LeaseContractTerminationsRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LeaseContractTerminationsRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MovementsOfTheRightofuseAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MovementsOfTheRightofuseAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_DiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>260
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839166784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Cash', window );">Current accounts</a></td>
<td class="nump">$ 3,247<span></span>
</td>
<td class="nump">$ 3,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Time deposits and short term investments with original maturity less than 90 days</a></td>
<td class="nump">7,865<span></span>
</td>
<td class="nump">10,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Total cash and cash equivalents</a></td>
<td class="nump">$ 11,112<span></span>
</td>
<td class="nump">$ 13,271<span></span>
</td>
<td class="nump">$ 8,860<span></span>
</td>
<td class="nump">$ 7,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>261
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>262
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843613520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade receivables (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">$ 8,301<span></span>
</td>
<td class="nump">$ 8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">8,301<span></span>
</td>
<td class="nump">8,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Current [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">7,763<span></span>
</td>
<td class="nump">7,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Not later than one month [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Later than one month and not later than three months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Later than three months and not later than six months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Later than six months and not later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member] | Provision for doubtful receivable [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AnalysisOfOverdueAmountsLineItems', window );"><strong>Analysis of overdue amounts [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Total trade receivables, net</a></td>
<td class="num">$ (95)<span></span>
</td>
<td class="num">$ (126)<span></span>
</td>
<td class="num">$ (190)<span></span>
</td>
<td class="num">$ (162)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AnalysisOfOverdueAmountsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AnalysisOfOverdueAmountsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_NotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_NotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=nvs_ProvisionForDoubtfulReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=nvs_ProvisionForDoubtfulReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>263
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842373856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Segmentation - Consolidated income statements</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; consolidated income statements</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing and discontinued segments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 783</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 741</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 177</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 38&nbsp;497</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;633</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;872</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;498</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;092</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 63</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;179</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10&nbsp;050</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;870</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;334</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;530</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 959</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;425</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 29&nbsp;539</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;601</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;252</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11&nbsp;617</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;534</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;14&nbsp;369</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8&nbsp;152</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;814</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9&nbsp;402</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;586</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;475</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;749</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;608</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;426</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 551</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;752</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 659</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;850</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8&nbsp;940</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;793</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7&nbsp;147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net loss from discontinued operations before gain on <br></br>distribution of Alcon Inc. to Novartis AG shareholders </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;101 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;186 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;737</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 11&nbsp;732</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in net income from continuing operations are:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 245</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;952</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;075</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;283</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;285</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;345</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;482</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;247</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;509</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;315</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;587</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;239</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;101</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;202</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;301</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;632</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;506</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;138</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;841</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges and fair value <br></br>changes on financial assets, net </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 18 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 20 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;113 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 38 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;6 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;229</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;395</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;165</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;492</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;521</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;761</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;645</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;67</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;239</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;067</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;918</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. Notes 1 and 10 provide additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from continuing operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing and discontinued segments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 741</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 668</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 177</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 118</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;743</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 82</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;633</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;946</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;036</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;178</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;836</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;743</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;833</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;381</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;870</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;650</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;530</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 890</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 817</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;14&nbsp;510</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;633</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;951</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;194</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;568</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;415</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 162</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 31&nbsp;589</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 29&nbsp;771</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10&nbsp;907</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9&nbsp;887</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;305</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;452</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13&nbsp;717</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12&nbsp;465</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;675</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7&nbsp;615</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;814</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;774</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;489</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8&nbsp;389</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;027</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 691</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;629</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;922</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;475</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;622</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;351</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;662</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;609</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;871</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;595</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;368</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;261</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;403</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;702</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Income from associated companies</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;432</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6&nbsp;438</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;108</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;932</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;750</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 42</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income before taxes from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;095</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;102</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;295</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;603</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;800</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;499</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net (loss)/income from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;614</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;703</div> </td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Attributable to:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Shareholders of Novartis AG</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 12&nbsp;611</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 7&nbsp;703</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Non-controlling interests</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> 0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in net income from continuing operations are:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;075</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;916</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;285</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;270</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;117</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;482</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;303</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;214</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;366</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;447</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;587</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;624</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;239</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;84</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;73</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;301</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;157</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;591</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;249</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;841</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;652</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges and fair value <br></br>changes on financial assets, net </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;42 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;113 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;185 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;227 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;395</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;94</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;521</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;645</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;593</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;53</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;220</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;208</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;918</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;853</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock', window );">Segmentation - Consolidated balance sheets</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; consolidated balance sheets</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Alcon<sup>1</sup> </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total assets</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71&nbsp;225</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 67&nbsp;055</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 16&nbsp;468</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;328</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25&nbsp;971</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 30&nbsp;677</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 35&nbsp;209</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 118&nbsp;370</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 145&nbsp;563</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;15&nbsp;332</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;13&nbsp;056</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;3&nbsp;804</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3&nbsp;377</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1&nbsp;964</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43&nbsp;683</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;48&nbsp;474</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;62&nbsp;819</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;66&nbsp;871</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total equity</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;551</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 78&nbsp;692</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net debt</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15&nbsp;938</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16&nbsp;184</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net operating assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 55&nbsp;893</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 53&nbsp;999</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;664</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;951</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 24&nbsp;007</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71&nbsp;489</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 94&nbsp;876</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Included in assets and liabilities are:</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;632</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;098</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;888</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;878</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 549</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 561</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;069</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;696</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to property, plant <br></br>and equipment <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;114 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 822 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 217 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 294 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 519 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 143 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 139 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;474 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;774 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total right-of-use assets <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 136</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;677</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to right-of-use assets <sup style="white-space: nowrap">&nbsp;2, 3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 454</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 49</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 537</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total goodwill and intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;336</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44&nbsp;593</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;892</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;712</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;578</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 130</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55&nbsp;311</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74&nbsp;013</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to goodwill and <br></br>intangible assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 647 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;265 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 68 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 107 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 196 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 52 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 24 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 767 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;592 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total investment in associated <br></br>companies </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 128 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 81 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 7 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 8&nbsp;509 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 8&nbsp;264 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 8&nbsp;644 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 8&nbsp;352 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to investment in associated <br></br>companies </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 44 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 18 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 11 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 11 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 55 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 29 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents, marketable securities, <br></br>commodities, time deposits and derivative <br></br>financial instruments </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 11&nbsp;446 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 15&nbsp;964 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 11&nbsp;446 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 15&nbsp;964 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial debts and derivative <br></br>financial instruments </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 27&nbsp;384 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 32&nbsp;148 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 27&nbsp;384 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 32&nbsp;148 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current income tax and deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;513</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;513</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> From February 28, 2019, the Alcon Division was reported as discontinued operations (see Notes 1, 2 and 30). In accordance with IFRS, the December 31, 2018, consolidated balance sheet includes the assets and liabilities of the Alcon eye care devices business and certain Corporate assets and liabilities attributable to the Alcon business. Note 30 provides additional information on discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Excluding the impact of business combinations. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Total right-of-use assets and additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock', window );">Net sales and total of selected non-current assets, by countries and regions</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="11" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Net sales<sup>1</sup></div> </td> <td></td> <td align="center" colspan="7" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total of selected non-current assets<sup>2</sup></div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="11" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="7" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="11" height="3"></td> <td height="1"></td> <td colspan="7" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> %</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> %</div> </td> <td></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Country</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Switzerland</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 848</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 795</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33&nbsp;032</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41&nbsp;972</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 43</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">United States</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;280</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;618</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;893</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39&nbsp;082</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">France</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;442</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;505</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;289</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;976</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Germany</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;120</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;972</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;484</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;554</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japan</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;656</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;575</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;617</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 309</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 144</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21&nbsp;099</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20&nbsp;286</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19&nbsp;033</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;980</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;763</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77&nbsp;701</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Region</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;259</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;760</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 46&nbsp;103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 59</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 55&nbsp;913</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Americas</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19&nbsp;713</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 18&nbsp;032</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;485</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 41</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 29&nbsp;389</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 39&nbsp;082</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;799</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;460</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;093</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;209</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;066</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77&nbsp;701</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 98&nbsp;061</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales from operations by location of third-party customer </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies, and in 2019 right-of-use assets recognized with the implementation of IFRS 16 Leases on January 1, 2019. See Notes 1 and 10 for additional disclosures. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock', window );">Net sales by region</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; net sales by region</font> <font style="font-family:arial,helvetica,sans-serif; font-size:6pt; color:#000000; font-weight:bold; vertical-align:super;">1</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 <br></br> to 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 <br></br> to 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Innovative Medicines</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;818</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;296</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;127</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13&nbsp;789</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;864</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;857</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;458</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;097</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;702</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;649</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;635</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;592</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28&nbsp;573</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26&nbsp;258</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24&nbsp;174</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;141</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;634</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sandoz</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;115</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;963</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4&nbsp;633</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;754</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;363</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;391</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 784</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 779</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 758</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;111</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;383</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;620</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;626</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;677</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Europe</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 17&nbsp;933</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17&nbsp;259</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15&nbsp;760</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">US</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16&nbsp;280</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;618</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 14&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Asia/Africa/Australasia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9&nbsp;799</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;460</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9&nbsp;093</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Canada and Latin America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;433</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;414</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;350</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 47&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 44&nbsp;751</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Established Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35&nbsp;684</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 33&nbsp;491</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31&nbsp;557</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="margin-left: 10px;font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Of which in Emerging Growth Markets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;761</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11&nbsp;260</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10&nbsp;781</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales from operations by location of third-party customer. Emerging Growth Markets comprise all markets other than the Established Markets of the US, Canada, Western Europe, Japan, Australia and New Zealand. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock', window );">Other revenue</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Segmentation &ndash; other revenue</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Profit-sharing income</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 732</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 734</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 877</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Royalty income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 147</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 188</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Milestone income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 201</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 128</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 231</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 55</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;092</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 63</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;179</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. </div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Innovative Medicines </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Sandoz </div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Corporate (including eliminations)</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Group </div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Profit-sharing income</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 874</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 648</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 877</div> </td> <td align="right" width="1%"></td> <td align="right" width="5%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 652</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Royalty income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 162</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 298</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Milestone income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 128</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 173</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;188</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 62</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 88</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;266</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> </tr> <tr> <td colspan="18" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="18"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Other includes revenue from activities such as manufacturing or other services rendered, to the extent such revenue is not recorded under net sales. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock', window );">Net sales by business franchise</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines Division net sales by business franchise</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 to <br></br> 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 to <br></br> 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Oncology</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;880</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;874</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;841</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;585</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;587</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;612</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;539</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;556</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;525</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Promacta/Revolade</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;416</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;174</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 867</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 35</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Tafinlar</i> + <i>Mekinist</i></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;338</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;155</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 873</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 32</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;561</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;943</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Jakavi</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 977</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 777</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 26</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 975</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;099</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;059</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 755</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 828</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 808</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kisqali</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 480</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 235</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lutathera</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 441</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 164</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kymriah</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Piqray</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 116</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;190</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;139</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 887</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Oncology business unit</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;370</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 13&nbsp;428</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 12&nbsp;274</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ophthalmology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;046</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;888</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Travoprost Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 433</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 517</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 589</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Xiidra</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 192</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Beovu</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;030</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;995</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;144</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Ophthalmology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;776</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;558</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4&nbsp;621</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Immunology, Hepatology and Dermatology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cosentyx</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;551</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;837</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;071</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ilaris</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 671</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 554</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 402</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 38</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Immunology, Hepatology and Dermatology</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;222</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;392</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;474</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 37</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Neuroscience</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;223</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;341</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zolgensma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 361</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Aimovig</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 103</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Mayzent</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> nm</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> nm</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 102</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;22</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Neuroscience</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;773</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;429</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;287</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 to <br></br> 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 to <br></br> 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Respiratory</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;173</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;039</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 920</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 13</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Ultibro Breezhaler</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 427</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 454</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 411</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Seebri Breezhaler</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 121</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 151</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Onbrez Breezhaler</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 101</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 23</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Respiratory</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;825</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;767</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;617</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cardiovascular, Renal and Metabolism</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Entresto</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;726</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;028</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 507</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 103</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 22</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 17</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 29</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Cardiovascular, Renal and Metabolism</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;750</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;050</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 67</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 524</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 100</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Established Medicines</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;284</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;064</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 957</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;025</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;002</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 960</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 485</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 464</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 414</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Neoral/Sandimmun(e)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 419</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 463</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 488</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Voltaren/Cataflam</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 417</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 465</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;587</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;964</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Established Medicines</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;998</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;268</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;481</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total Novartis Pharmaceuticals business unit</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;344</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;464</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 20&nbsp;004</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division net sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">nm = not meaningful</div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock', window );">Net sales of Top 20 products</a></td>
<td class="text"><div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division product net sales &ndash; 2019</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Brands </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Business franchise </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Indication </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> US <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> world <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Total <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td width="21%" height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Cosentyx </div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing <br></br> spondylitis and psoriatic arthritis </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 2&nbsp;220 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;331 </div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 3&nbsp;551 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;736</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;487</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;223</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;086</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;086</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 804</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;076</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;880</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Entresto </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal <br></br> and Metabolism </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Chronic heart failure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 925 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 801 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;726 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 881</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 704</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;585</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;003</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 536</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;539</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Promacta/Revolade </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP), <br></br> severe aplastic anemia (SAA) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 691 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 725 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;416 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br><i>Tafinlar</i> + <i>Mekinist</i> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and <br></br> adjuvant melanoma; advanced <br></br> non-small cell lung cancer (NSCLC) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 481 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 857 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 1&nbsp;338 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;297</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;297</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 334</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 929</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;263</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Respiratory </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA) <br></br> and Chronic Spontaneous Urticaria <br></br> (CSU) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 1&nbsp;173 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 1&nbsp;173 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Jakavi </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF), <br></br> polycytomia vera (PV) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;114 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;114 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 978</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;064</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;012</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;025</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 450</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 525</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 975</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 423</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 755</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Ilaris </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS, <br></br> TRAPS, HIDS/MKD, FMF, SJIA, <br></br> AOSD and gout) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 304 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> 367 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 671 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 316</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 485</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Kisqali</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HR+/HER2- metastatic breast cancer</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 230</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 480</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 10&nbsp;679</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;967</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 28&nbsp;646</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5&nbsp;958</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;068</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;789</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 23&nbsp;925</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 37&nbsp;714</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division produ</font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">ct net sales &ndash; 2018</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Brands </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Business franchise </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Indication </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> US <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> world <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Total <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td width="21%" height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;765</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;576</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;341</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Cosentyx </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing <br></br> spondylitis and psoriatic arthritis </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;674 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;163 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 2&nbsp;837 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;046</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;046</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 806</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;068</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;874</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 817</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 770</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;587</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 440</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;121</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;561</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 929</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;556</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;284</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;284</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Promacta/Revolade </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP), <br></br> severe aplastic anemia (SAA) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 581 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 593 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 1&nbsp;174 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br><i>Tafinlar</i> + <i>Mekinist</i> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and <br></br> adjuvant melanoma; advanced <br></br> non-small cell lung cancer (NSCLC) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 457 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 698 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 1&nbsp;155 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 521</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 578</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;099</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Respiratory </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA) <br></br> and Chronic Spontaneous Urticaria <br></br> (CSU) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 1&nbsp;039 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 1&nbsp;039 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Entresto </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal <br></br> and Metabolism </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Chronic heart failure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 556 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 472 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 1&nbsp;028 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 939</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;023</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;002</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Jakavi </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF), <br></br> polycytomia vera (PV) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 977 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 977 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 404</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 424</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 828</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Ilaris </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Auto-inflammatory (CAPS, <br></br> TRAPS, HIDS/MKD, FMF, SJIA, <br></br> AOSD and gout) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 262 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 292 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 554 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br>Travoprost Group </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Ophthalmology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated intraocular <br></br> pressure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 194 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 323 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 517 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Zortress/Certican</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Transplantation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 145</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 464</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;654</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;292</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 26&nbsp;946</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;210</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;736</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;946</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 11&nbsp;864</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23&nbsp;028</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;892</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Top 20 Innovative Medicines Division product net sales &ndash; 2017</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Brands </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Business franchise </div> </td> <td></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> Indication </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> US <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Rest of <br></br> world <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Total <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td width="21%" height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gilenya</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Neuroscience</div> </td> <td align="right" width="1%"></td> <td width="21%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Relapsing multiple sclerosis</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;709</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;476</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;185</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Cosentyx </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Psoriasis, ankylosing <br></br> spondylitis and psoriatic arthritis </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 1&nbsp;275 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 796 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 2&nbsp;071 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Gleevec/Glivec</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia and GIST</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 627</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;316</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;943</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Lucentis</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Ophthalmology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Age-related macular degeneration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;888</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;888</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Tasigna</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic myeloid leukemia</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 810</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;031</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;841</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Sandostatin</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Carcinoid tumors and acromegaly</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 832</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 780</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;612</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Afinitor/Votubia</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Breast cancer/TSC</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 819</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 706</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;525</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"><i>Galvus</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Diabetes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;233</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Exjade/Jadenu</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Chronic iron overload</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 515</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 544</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;059</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Exforge</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 932</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 960</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"><i>Diovan</i> Group</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Hypertension</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 87</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 870</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 957</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Xolair <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Respiratory </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Severe Allergic Asthma (SAA) <br></br> and Chronic Spontaneous Urticaria <br></br> (CSU) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 920 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 920 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br><i>Tafinlar</i> + <i>Mekinist</i> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRAF V600+ metastatic and <br></br> adjuvant melanoma; advanced <br></br> non-small cell lung cancer (NSCLC) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 339 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> 534 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 873 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Promacta/Revolade </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immune thrombocytopenia (ITP), <br></br> severe aplastic anemia (SAA) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 446 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 421 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 867 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Votrient</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Oncology</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Renal cell carcinoma</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 407</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 401</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 808</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Jakavi </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Oncology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Myelofibrosis (MF), <br></br> polycytomia vera (PV) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 777 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 777 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br>Travoprost Group </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Ophthalmology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Reduction of elevated <br></br> intraocular pressure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 216 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 373 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 589 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Entresto </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cardiovascular, Renal <br></br> and Metabolism </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Chronic heart failure </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 297 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 210 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 507 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;"> <br></br>Neoral/Sandimmun(e) </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Immunology, Hepatology <br></br> and Dermatology </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> Transplantation </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 38 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 450 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 488 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Voltaren/Cataflam</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Established Medicines</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Inflammation/pain</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 465</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 465</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Top 20 products total</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 8&nbsp;445</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;123</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 24&nbsp;568</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rest of portfolio</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;412</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5&nbsp;298</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;710</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division sales</div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;857</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 21&nbsp;421</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 32&nbsp;278</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Net sales reflect <i>Xolair</i> sales for all indications. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock', window );">Net sales by business franchise</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Sandoz Division net sales by business franchise</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> <br></br> 2019 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2018 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Change <br></br> (2018 to <br></br> 2019) <br></br> USD % </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> 2017 <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Change <br></br> (2017 to <br></br> 2018) <br></br> USD % </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Retail Generics <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;590</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;880</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8&nbsp;409</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;6</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Biopharmaceuticals</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;607</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;436</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 27</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Anti-Infectives</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 534</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 543</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 516</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total division net sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9&nbsp;731</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 9&nbsp;859</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 10&nbsp;060</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Of which USD 784 million (2018: USD 826 million; 2017: USD 880 million) represents anti-infectives sold under the Sandoz name </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNetSalesBySegementsAndRegionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOperatingSegmentsBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOperatingSegmentsByCountriesAndRegionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOperatingSegmentsNetSalesByBusinessFranchiseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOperatingSegmentsNetSalesOfTop20ProductsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOperatingSegmentsOtherRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>264
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838986560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings per share</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income attributable to shareholders of Novartis AG (USD millions)</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;797</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;499</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;590</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 204</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;732</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12&nbsp;611</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7&nbsp;703</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Number of shares (in millions)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Weighted average number of shares outstanding used in basic earnings per share</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;346</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Weighted average number of shares in diluted earnings per share</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;319</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;344</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;371</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Basic earnings per share (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.00</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.44</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.28</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Diluted earnings per share (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.08</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 5.46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.17</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">- Discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.98</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;0.08</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.08</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5.06</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3.25</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>265
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838823472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial and other non-current assets (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfOtherNoncurrentAssetsAbstract', window );"><strong>Disclosure of other non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DeferredCompensationPlansAssets', window );">Deferred compensation plans assets</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="nump">$ 468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PrepaidPostemploymentBenefitPlansAssets', window );">Prepaid post-employment benefit plans assets</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentNonfinancialAssets', window );">Other non-current assets</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total other non-current assets</a></td>
<td class="nump">$ 738<span></span>
</td>
<td class="nump">$ 895<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentNonfinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentNonfinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DeferredCompensationPlansAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DeferredCompensationPlansAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfOtherNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfOtherNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PrepaidPostemploymentBenefitPlansAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PrepaidPostemploymentBenefitPlansAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>266
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845410944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred tax assets and liabilities (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">$ 2,986<span></span>
</td>
<td class="nump">$ 3,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ValueOfTaxLossCarryforwardsExpired', window );">Tax loss carryforwards expired</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_YearOfExpiryAxis=nvs_OneYearMember', window );">One year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_YearOfExpiryAxis=nvs_TwoYearsMember', window );">Two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_YearOfExpiryAxis=nvs_ThreeYearsMember', window );">Three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_YearOfExpiryAxis=nvs_FourYearsMember', window );">Four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_YearOfExpiryAxis=nvs_FiveYearsMember', window );">Five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_YearOfExpiryAxis=nvs_MoreThanFiveYearsMember', window );">More than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">2,684<span></span>
</td>
<td class="nump">2,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">2,338<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member] | One year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member] | Two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member] | Three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member] | Four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">46<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member] | Five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember', window );">Capitalized [member] | More than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">2,249<span></span>
</td>
<td class="nump">2,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member] | One year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member] | Two years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member] | Three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member] | Four years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member] | Five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember', window );">Not capitalized [member] | More than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets', window );">Gross Value of tax loss carryforwards that have or nave not been capitalized as deferred tax assets</a></td>
<td class="nump">$ 435<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GrossValueOfTaxLossCarryForwardsThatHaveOrHaveNotBeenCapitalizedAsDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ValueOfTaxLossCarryforwardsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ValueOfTaxLossCarryforwardsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_YearOfExpiryAxis=nvs_OneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_YearOfExpiryAxis=nvs_OneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_YearOfExpiryAxis=nvs_TwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_YearOfExpiryAxis=nvs_TwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_YearOfExpiryAxis=nvs_ThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_YearOfExpiryAxis=nvs_ThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_YearOfExpiryAxis=nvs_FourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_YearOfExpiryAxis=nvs_FourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_YearOfExpiryAxis=nvs_FiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_YearOfExpiryAxis=nvs_FiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_YearOfExpiryAxis=nvs_MoreThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_YearOfExpiryAxis=nvs_MoreThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetTreatmentAxis=nvs_CapitalizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BalanceSheetTreatmentAxis=nvs_NotCapitalizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>267
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6845392544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 5) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 47,445<span></span>
</td>
<td class="nump">$ 44,751<span></span>
</td>
<td class="nump">$ 42,338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 77,701<span></span>
</td>
<td class="nump">$ 98,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=srt_EuropeMember', window );">Europe [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 17,933<span></span>
</td>
<td class="nump">$ 17,259<span></span>
</td>
<td class="nump">$ 15,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 46,103<span></span>
</td>
<td class="nump">$ 55,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=srt_AmericasMember', window );">Americas [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 19,713<span></span>
</td>
<td class="nump">$ 18,032<span></span>
</td>
<td class="nump">$ 17,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 29,389<span></span>
</td>
<td class="nump">$ 39,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember', window );">Asia/Africa/Australasia [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdParties', window );">Net sales to third parties from continuing operations</a></td>
<td class="nump">$ 9,799<span></span>
</td>
<td class="nump">$ 9,460<span></span>
</td>
<td class="nump">$ 9,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales', window );">Net sales (in % of total net sales)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssets', window );">Total of selected non-current assets</a></td>
<td class="nump">$ 2,209<span></span>
</td>
<td class="nump">$ 3,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets', window );">Selected non-current assets (in % of total selected non-current assets)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RevenueFromSaleOfGoodsThirdPartiesAsPercentOfTotalNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SelectedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SelectedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of property, plant and equipment; goodwill; intangible assets; and investment in associated companies. As percent of total selected non-current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SelectedNoncurrentAssetsAsPercentOfTotalSelectedNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GeographicalRegionsAxis=nvs_AsiaAfricaAustralasiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>268
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6724525776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal Group subsidiaries and associated companies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract', window );"><strong>Disclosure of subsidiaries [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock', window );">Principal Group subsidiaries and associated companies</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Algeria</div> </td> <td align="right" width="1%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Soci&#xe9;t&#xe9; par actions SANDOZ</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Algiers</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DZD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 650.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Argentina</div> </td> <td align="right" width="1%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Argentina S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Buenos Aires</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ARS</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 906.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Australia</div> </td> <td align="right" width="1%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Australia Pty Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Macquarie Park, NSW</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Australia Pty Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Macquarie Park, NSW</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pty Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Macquarie Park, NSW</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AUD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Austria</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Austria GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vienna</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vienna</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kundl</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">EBEWE Pharma Ges.m.b.H Nfg. KG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Unterach am Attersee</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Bangladesh</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Bangladesh) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gazipur</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BDT</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 162.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Belgium</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma NV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vilvoorde</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz NV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vilvoorde</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 19.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon - Couvreur NV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Puurs</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 110.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Bermuda</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Investment Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Securities Investment Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance Services Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Triangle International Reinsurance Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trinity River Insurance Co Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hamilton</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 370&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Brazil</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Bioci&#xea;ncias S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">S&#xe3;o Paulo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRL</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 265.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz do Brasil Ind&#xfa;stria Farmac&#xea;utica Ltda.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Camb&#xe9;, PR</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> BRL</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 190.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Canada</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Canada Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dorval, Quebec</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Canada Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Boucherville, Quebec</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CIBA Vision Canada Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mississauga, Ontario</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 82&nbsp;886</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Chile</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Chile S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Santiago de Chile</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CLP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">China</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Beijing Novartis Pharma Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Beijing</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals (HK) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Hong Kong</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HKD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 200</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">China Novartis Institutes for BioMedical Research Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Shanghai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 320.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Suzhou Novartis Technical Development Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Changshu</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai Novartis Trading Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shanghai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz (China) Pharmaceutical Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Zhongshan</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Colombia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis de Colombia S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Santaf&#xe9; de Bogot&#xe1;</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> COP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.9</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Croatia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz d.o.o. farmaceutska industrija</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Zagreb</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HRK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Czech Republic</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis s.r.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prague</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CZK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 51.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz s.r.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prague</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CZK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Denmark</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare A/S</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Copenhagen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DKK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz A/S</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Copenhagen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> DKK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ecuador</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ecuador S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Quito</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Egypt</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma S.A.E.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cairo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EGP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 193.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.77%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Egypt Pharma S.A.E.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">New Cairo City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EGP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Finland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finland Oy</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Espoo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 459&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">France</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Groupe France S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 903.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma S.A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rueil-Malmaison</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 43.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Saint-Genis-Pouilly</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CELLforCURE</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Les Ulis</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Levallois-Perret</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Germany</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Deutschland GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nuremberg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 155.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Nuremberg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Produktions GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Wehr</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Manufacturing GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Marburg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz International GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">1 A Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oberhaching</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">HEXAL AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Holzkirchen</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 93.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Salutas Pharma GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barleben</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 42.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Aeropharm GmbH</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Rudolstadt</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Greece</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Hellas) S.A.C.I.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Metamorphosis / Athens</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Hungary</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Hungary Healthcare Limited Liability Company</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Budapest</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HUF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 545.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Hungary Limited Liability Company</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Budapest</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> HUF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 883.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">India</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis India Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 123.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 70.68%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare Private Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 60.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Private Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mumbai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> INR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Indonesia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">PT. Novartis Indonesia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Jakarta</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> IDR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ireland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ireland Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dublin</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ringaskiddy Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ringaskiddy, County Cork</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Israel</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Israel Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tel Aviv</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ILS</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Italy</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farma S.p.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Origgio</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications (Italy) S.r.l.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Pozzilli</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 119&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.p.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Origgio</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Japan</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Holding Japan K.K.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma K.K.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ciba-Geigy Japan Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz K.K.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Tokyo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> JPY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Latvia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Baltics SIA</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Riga</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Luxembourg</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Investments S.&#xe0; r.l.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Luxembourg City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Malaysia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Corporation (Malaysia) Sdn. Bhd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kuala Lumpur</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MYR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Mexico</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farmac&#xe9;utica, S.A. de C.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mexico City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MXN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 205.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz, S.A. de C.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Mexico City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MXN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 468.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Morocco</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Maroc SA</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Casablanca</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> MAD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Netherlands</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Netherlands B.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amsterdam</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma B.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amsterdam</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">IDB Holland BV</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Baarle-Nassau</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz B.V.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Almere</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 907&nbsp;560</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">New Zealand</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis New Zealand Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Auckland</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> NZD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 820&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Norway</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Norge AS</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oslo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> NOK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Pakistan</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma (Pakistan) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Karachi</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PKR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.99%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Panama</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma (Logistics), Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Panama City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Peru</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Biosciences Per&#xfa; S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lima</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PEN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Philippines</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Healthcare Philippines, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Makati City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PHP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 298.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Philippines Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Makati City</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PHP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 30.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Poland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Poland Sp. z o.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Warsaw</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Polska Sp. z o.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Warsaw</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lek S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Strykow</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> PLN</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Portugal</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Portugal SGPS Lda.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farma - Produtos Farmac&#xea;uticos S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Farmac&#xea;utica Lda.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Porto Salvo</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 499&nbsp;900</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Romania</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Services Romania S.R.L.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bucharest</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RON</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz S.R.L.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Targu-Mures</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RON</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 105.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Russian Federation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Moscow</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Neva LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">St. Petersburg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 500.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">ZAO Sandoz</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Moscow</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> RUB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Saudi Arabia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Saudi Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Riyadh</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SAR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26.8</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 75%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Singapore</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Singapore) Pte Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Singapore</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Singapore Pharmaceutical Manufacturing Pte Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Singapore</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 45.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Asia Pacific Pharmaceuticals Pte Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Singapore</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SGD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 39.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Slovakia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Slovakia s.r.o.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bratislava</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Slovenia</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Lek Pharmaceuticals d.d.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 48.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pharmaceuticals d.d.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ljubljana</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">South Africa</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis South Africa (Pty) Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Midrand</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ZAR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz South Africa (Pty) Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kempton Park</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> ZAR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">South Korea</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Korea Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Seoul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> KRW</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> bn</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.55%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Spain</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Farmac&#xe9;utica, S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Barcelona</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 63.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications Iberica, S.L.U.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Esplugues de Llobregat</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 22.6</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Farmac&#xe9;utica S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Madrid</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 270&nbsp;450</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Industrial Products S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Les Franqueses del Vall&#xe9;s / Barcelona</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Alcon Cusi S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">El Masnou / Barcelona</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Abadia Retuerta S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sard&#xf3;n de Duero / Valladolid</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> EUR</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Sweden</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Sverige AB</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stockholm</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> SEK</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Switzerland</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Holding AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International Pharmaceutical Investment AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Bioventures AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Forschungsstiftung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Stiftung f&#xfc;r Kaderausbildung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Mitarbeiterbeteiligungsstiftung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Stiftung f&#xfc;r Mensch und Umwelt</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stiftung der Novartis AG f&#xfc;r Erziehung, Ausbildung und Bildung</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Overseas Investments AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Japat AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 350.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis International Pharmaceutical AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Services AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 20.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Schweizerhalle AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Muttenz</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.9</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Stein AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Stein</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 251&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharma Schweiz AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Risch</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Ophthalmics AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fribourg</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications International SA</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Geneva</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Pharmaceuticals AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Risch</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Roche Holding AG</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Basel</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> CHF</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 160.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33/6 <sup style="white-space: nowrap"> 2</sup> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>As at December 31, 2019 </div> </td> <td></td> <td></td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Share <br></br> capital <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Equity <br></br> interest </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Taiwan</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Taiwan) Co., Ltd.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taipei</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TWD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 170.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Thailand</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis (Thailand) Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bangkok</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> THB</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 302.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Turkey</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Saglik, Gida ve Tarim &#xdc;r&#xfc;nleri Sanayi ve Ticaret A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Istanbul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 98.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Farmanova Saglik Hizmetleri Ltd. Sti.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Istanbul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6.7</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Ila&#xe7; Sanayi ve Ticaret A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Istanbul</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 165.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.99%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Grup Saglik &#xdc;r&#xfc;nleri Ila&#xe7;lari Sanayi ve Ticaret A.S.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Gebze - Kocaeli</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> TRY</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 50.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Ukraine</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Ukraine LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Kyiv</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> UAH</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United Arab Emirates</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Middle East FZE</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dubai</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> AED</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United Kingdom</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis UK Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25.5</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals UK Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.4</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Grimsby Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 250.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Imaging Equipment Ltd</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vivacta Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frimley / Camberley</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.9</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100.0%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Ziarco Group Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">London</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;904</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Limited</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Frimley / Camberley</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> GBP</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">United States of America</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 72.2</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> m</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Finance Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Capital Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Services, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis US Foundation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Pharmaceuticals Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 650</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Advanced Accelerator Applications USA, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Millburn, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 99.2%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">AveXis, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Bannockburn, IL</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Inflammasome Research, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Technology LLC</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> --</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Institutes for BioMedical Research, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> Cambridge, MA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">CoStim Pharmaceuticals Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cambridge, MA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Encore Vision, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Endocyte, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Navigate BioPharma Services, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Carlsbad, CA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reprixys Pharmaceuticals Corporation</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Spinifex Pharmaceuticals, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Institute for Functional Genomics, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">San Diego, CA</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sandoz Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25&nbsp;000</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Oriel Therapeutics, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Durham, NC</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fougera Pharmaceuticals Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Melville, NY</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Eon Labs, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Princeton, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis Vaccines and Diagnostics, Inc.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">East Hanover, NJ</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> USD</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Venezuela</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Novartis de Venezuela, S.A.</div> </td> <td align="right" width="9%"></td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Caracas</div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> VES</div> </td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 14</div> </td> <td width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 100%</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">In addition, the Group is represented by subsidiaries and associated companies with total assets or net sales to third parties below USD 25 million in the following countries: Bosnia/Herzegovina, Bulgaria, Dominican Republic, Guatemala, Kenya, North Macedonia, Nigeria, Puerto Rico, Uruguay and Vietnam </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Share capital may not reflect the taxable share capital and does not include any paid-in surplus. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Approximately 33% of voting shares; approximately 6% of total net income and equity attributable to Novartis. </div> </td> </tr> <tr valign="bottom"> <td colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Significant subsidiary under SEC Regulation S-X Rule 1-02(w) </div> </td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">m = million; bn = billion</div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PrincipalGroupSubsidiariesAndAssociatedCompaniesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>269
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6872795728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant transactions (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract', window );"><strong>Assets of disposal group classified as held for sale [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 12,069<span></span>
</td>
<td class="nump">$ 15,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">26,524<span></span>
</td>
<td class="nump">35,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">28,787<span></span>
</td>
<td class="nump">38,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">7,909<span></span>
</td>
<td class="nump">8,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">5,982<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialAssets', window );">Other current assets</a></td>
<td class="nump">2,680<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets of disposal group held for sale</a></td>
<td class="nump">841<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract', window );"><strong>Liabilities of disposal group classified as held for sale [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">5,867<span></span>
</td>
<td class="nump">7,475<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="nump">6,632<span></span>
</td>
<td class="nump">7,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialLiabilities', window );">Provisions and other current liabilities</a></td>
<td class="nump">13,338<span></span>
</td>
<td class="nump">12,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Liabilities of disposal group held for sale</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember', window );">Assets and liabilities classified as held for sale [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract', window );"><strong>Assets of disposal group classified as held for sale [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">475<span></span>
</td>
<td class="nump">478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialAssets', window );">Other current assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets of disposal group held for sale</a></td>
<td class="nump">841<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract', window );"><strong>Liabilities of disposal group classified as held for sale [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialLiabilities', window );">Provisions and other current liabilities</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Liabilities of disposal group held for sale</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph p<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_p&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AssetsOfDisposalGroupClassifiedAsHeldForSaleAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_LiabilitiesOfDisposalGroupClassifiedAsHeldForSaleAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis=ifrs-full_AssetsAndLiabilitiesClassifiedAsHeldForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>270
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838854064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and intangible assets (Details 3) - Operating segments [member]<br></strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Terminal Growth Rate</a></td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal', window );">Discount Rate (post-tax)</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections', window );">Terminal Growth Rate</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal', window );">Discount Rate (post-tax)</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The growth rate used to extrapolate cash flow projections beyond the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_d_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_e_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discount rate used in the current measurement of fair value less costs of disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 130<br> -Subparagraph f<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_130_f_iii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DiscountRateUsedInCurrentMeasurementOfFairValueLessCostsOfDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>271
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6871748192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 10) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProfitSharingIncome', window );">Profit sharing income</a></td>
<td class="nump">$ 734<span></span>
</td>
<td class="nump">$ 877<span></span>
</td>
<td class="nump">$ 652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalty income</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MilestoneIncome', window );">Milestone income</a></td>
<td class="nump">231<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherRevenueOther', window );">Other</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">1,179<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember', window );">Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProfitSharingIncome', window );">Profit sharing income</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">874<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalty income</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MilestoneIncome', window );">Milestone income</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherRevenueOther', window );">Other</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_SandozMember', window );">Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProfitSharingIncome', window );">Profit sharing income</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalty income</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MilestoneIncome', window );">Milestone income</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_OtherRevenueOther', window );">Other</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=nvs_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">Royalty income</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MilestoneIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MilestoneIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_OtherRevenueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_OtherRevenueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProfitSharingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProfitSharingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>272
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838748496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Associated companies (Details 2) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Balance sheet value</a></td>
<td class="nump">$ 8,644<span></span>
</td>
<td class="nump">$ 8,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember', window );">Roche Holding AG, Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Balance sheet value</a></td>
<td class="nump">8,445<span></span>
</td>
<td class="nump">8,195<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember', window );">Others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems', window );"><strong>Disclosure of associates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Balance sheet value</a></td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_OthersAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>273
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6872149136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segmentation of key figures (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">$ 118,370<span></span>
</td>
<td class="nump">$ 145,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="num">(62,819)<span></span>
</td>
<td class="num">(66,871)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">55,551<span></span>
</td>
<td class="nump">78,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,891<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="nump">15,938<span></span>
</td>
<td class="nump">16,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetOperatingAssets', window );">Net operating assets</a></td>
<td class="nump">71,489<span></span>
</td>
<td class="nump">94,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">12,069<span></span>
</td>
<td class="nump">15,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="nump">1,474<span></span>
</td>
<td class="nump">1,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="nump">55,311<span></span>
</td>
<td class="nump">74,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments in associated companies</a></td>
<td class="nump">8,644<span></span>
</td>
<td class="nump">8,352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToInvestmentInAssociatedCompanies', window );">Additions to investment in associated companies</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Cash and cash equivalents, marketable securities, commodities, time deposits and derivative financial instruments</a></td>
<td class="nump">11,446<span></span>
</td>
<td class="nump">15,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments</a></td>
<td class="nump">27,384<span></span>
</td>
<td class="nump">32,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,802<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentIncomeTaxAndDeferredTaxLiabilities', window );">Current income tax and deferred tax liabilities</a></td>
<td class="nump">8,061<span></span>
</td>
<td class="nump">9,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Innovative Medicines</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">71,225<span></span>
</td>
<td class="nump">67,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="num">(15,332)<span></span>
</td>
<td class="num">(13,056)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetOperatingAssets', window );">Net operating assets</a></td>
<td class="nump">55,893<span></span>
</td>
<td class="nump">53,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">9,632<span></span>
</td>
<td class="nump">10,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="nump">46,336<span></span>
</td>
<td class="nump">44,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments in associated companies</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToInvestmentInAssociatedCompanies', window );">Additions to investment in associated companies</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Sandoz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">16,468<span></span>
</td>
<td class="nump">17,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="num">(3,804)<span></span>
</td>
<td class="num">(3,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetOperatingAssets', window );">Net operating assets</a></td>
<td class="nump">12,664<span></span>
</td>
<td class="nump">13,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">1,888<span></span>
</td>
<td class="nump">2,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="nump">8,892<span></span>
</td>
<td class="nump">9,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments in associated companies</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Alcon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,964)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_NetOperatingAssets', window );">Net operating assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">30,677<span></span>
</td>
<td class="nump">35,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="num">(43,683)<span></span>
</td>
<td class="num">(48,474)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">549<span></span>
</td>
<td class="nump">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to right-of-use assets</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions to intangible assets and goodwill</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments in associated companies</a></td>
<td class="nump">8,509<span></span>
</td>
<td class="nump">8,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_AdditionsToInvestmentInAssociatedCompanies', window );">Additions to investment in associated companies</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments', window );">Cash and cash equivalents, marketable securities, commodities, time deposits and derivative financial instruments</a></td>
<td class="nump">11,446<span></span>
</td>
<td class="nump">15,964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_FinancialDebtsAndDerivativeInstruments', window );">Financial debts and derivative instruments</a></td>
<td class="nump">27,384<span></span>
</td>
<td class="nump">32,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentIncomeTaxAndDeferredTaxLiabilities', window );">Current income tax and deferred tax liabilities</a></td>
<td class="nump">$ 8,061<span></span>
</td>
<td class="nump">$ 9,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net debt of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_AdditionsToInvestmentInAssociatedCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_AdditionsToInvestmentInAssociatedCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CashAndCashEquivalentsMarketableSecuritiesCommoditiesTimeDepositsAndDerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentIncomeTaxAndDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentIncomeTaxAndDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_FinancialDebtsAndDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_FinancialDebtsAndDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_NetOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_NetOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_InnovativeMedicinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_SandozMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_SandozMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_AlconMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_AlconMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=nvs_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=nvs_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>274
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6843597984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable securities, commodities, time deposits, derivative financial instruments and cash and cash equivalents (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DebtInstrumentsHeld', window );">Debt securities held</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">EUR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DebtInstrumentsHeld', window );">Debt securities held</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">JPY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DebtInstrumentsHeld', window );">Debt securities held</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_USD', window );">USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DebtInstrumentsHeld', window );">Debt securities held</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DebtInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of instruments representing indebtedness held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DebtInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>275
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838502896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfEquityAbstract', window );"><strong>Disclosure of equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInTheShareCapitalTableTextBlock', window );">Schedule disclosing information related to movement in the share capital</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Jan 1, 2017 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Movement <br></br> in year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Dec 31, 2017 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Movement <br></br> in year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Dec 31, 2018 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Movement <br></br> in year </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br> Dec 31, 2019 </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Share capital</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 972</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 969</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 944</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 936</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Treasury shares</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;100</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;69</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;80</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding share capital</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 896</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;27</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 869</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 875</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;19</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 856</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MovementInTheShareslTableTextBlock', window );">Schedule disclosing information related to movement in the shares</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>Number of outstanding shares <br></br>(in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Note </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> Novartis <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> treasury <br></br> shares <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Total <br></br> outstanding <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> Novartis <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> treasury <br></br> shares <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> outstanding <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> Novartis <br></br> shares </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> treasury <br></br> shares <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> outstanding <br></br> shares </div> </td> <td></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at beginning of year</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;550.6</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;239.4</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;311.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616.8</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;299.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;627.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;253.0</div> </td> <td align="right" width="1%"></td> <td align="right" width="4%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;374.1</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares canceled for capital <br></br>reduction <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;66.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 66.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;10.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 10.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be <br></br>canceled <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;60.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> &ndash;&nbsp;60.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;23.3 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;66.2 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> &ndash;&nbsp;66.2 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options <br></br>and employee transactions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 18.8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 5.5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 5.5 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.8 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4.6 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon <br></br>employees </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 0.9 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 0.9 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total movements</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;23.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;22.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;66.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;10.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;46.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;56.6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Balance at end of year</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;527.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;262.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;265.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;550.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;239.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;311.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;616.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;299.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;317.5</div> </td> <td align="right"></td> </tr> <tr> <td colspan="22" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Approximately 117.6 million treasury shares (2018: 121.6 million; 2017: 131.3 million) are held in Novartis entities that restrict their availability for use. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Novartis reduced its share capital by canceling shares that were repurchased on the SIX Swiss Exchange second trading line during previous years. </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 Annual General Meeting (AGM) for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Shares acquired from employees, which were previously granted to them under the respective programs </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Shares delivered as a result of options being exercised and physical share deliveries related to equity-based participation plans </div> </td> </tr> <tr valign="bottom"> <td colspan="22"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DividendTableTextBlock', window );">Schedule disclosing information related to Dividend</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Dividend per share (in CHF)</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.85</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.80</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.75</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Total dividend payment <br></br>(in USD billion) </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 6.6 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 7.0 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 6.5 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_SummaryOfTreasurySharesMovementsTableTextBlock', window );">Schedule disclosing information related treasury shares movements</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td height="1"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Note </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Number of <br></br> outstanding <br></br> shares <br></br> (in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Equity impact <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Number of <br></br> outstanding <br></br> shares <br></br> (in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Equity impact <br></br> USD m </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Number of <br></br> outstanding <br></br> shares <br></br> (in millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Equity impact <br></br> USD m </div> </td> <td></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares acquired to be canceled <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;60.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;351</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;23.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;859</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;66.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="6%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;270</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share purchases <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;304</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Purchase of treasury shares</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;62.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;511</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;973</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;70.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5&nbsp;574</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise of options and employee transactions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 210</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 434</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 255</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation <sup style="white-space: nowrap">&nbsp;4,5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 833</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 756</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 612</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Shares delivered to Alcon employees</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 18</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other share sales</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 263</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;46.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;4&nbsp;450</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;520</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;56.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;4&nbsp;707</div> </td> <td align="right"></td> </tr> <tr> <td colspan="16" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Shares repurchased on the SIX Swiss Exchange second trading line under a CHF 10 billion share buyback authority approved at the 2016 AGM for transactions before February 28, 2019, and under a new CHF 10 billion share buyback authority approved at the 2019 AGM for transactions after such date </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Shares acquired from employees, which were previously granted to them under the respective programs </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Shares delivered as a result of options being exercised related to equity-based participation plans and the delivery of treasury shares. The average share price of the shares delivered was significantly below market price, reflecting the strike price of the options exercised. </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Equity-settled share-based compensation is expensed in the consolidated income statement in accordance with the vesting period of the share-based compensation plans. The value for the shares and options granted is credited to consolidated equity over the respective vesting period. In addition, tax benefits arising from tax-deductible amounts exceeding the expense recognized in the income statement are credited to equity. </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Included in 2017 is a USD 71 million impact related to the revaluation of deferred tax assets on equity-based compensation that were previously recognized through retained earnings. This revaluation resulted from the US tax reform legislation enacted on December 22, 2017. Refer to Note 12 for additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;</sup> </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DividendTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DividendTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MovementInTheShareCapitalTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MovementInTheShareCapitalTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MovementInTheShareslTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MovementInTheShareslTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_SummaryOfTreasurySharesMovementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_SummaryOfTreasurySharesMovementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>276
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6870189712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_InventoriesDisclosureAbstract', window );"><strong>Inventories Disclosure [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories by class</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Raw material, consumables</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 751</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 931</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Work in progress</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3&nbsp;024</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3&nbsp;087</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Finished products</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;207</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2&nbsp;938</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 5&nbsp;982</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;956</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock', window );">Amount of inventory recognized as an expense in cost of goods sold</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD billions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8.2</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock', window );">Recognized amount of inventory provisions and reversals of inventory provision</a></td>
<td class="text"><div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventory provisions</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;752</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;603</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;416</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversals of inventory provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 218</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 216</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 172</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfAmountOfInventoryRecognizedAsAnExpenseInCostOfGoodsSoldTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfRecognizedAmountOfInventoryProvisionsAndReversalsOfInventoryProvisionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_InventoriesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_InventoriesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>277
<FILENAME>R134.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838760832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details 3)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>SFr / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_StatementOfChangesInEquityAbstract', window );"><strong>Statement of changes in equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DividendsPayableAmountPerShare', window );">Dividends payable, amount per share | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 2.85<span></span>
</td>
<td class="nump">SFr 2.80<span></span>
</td>
<td class="nump">SFr 2.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends recognised as distributions to owners | $</a></td>
<td class="nump">$ 6,645<span></span>
</td>
<td class="nump">$ 6,966<span></span>
</td>
<td class="nump">$ 6,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 107<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfChangesInEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfChangesInEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>278
<FILENAME>R138.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6846771472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-current financial debt (Details 2)<br> &#8364; in Millions, SFr in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 22,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member', window );">5.125% USD 3 000 million bond 2009/2019 of Novaritis Securities Investment Ltd., Hamilton, Bermuda issued at 99.822% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Securities Investment Ltd., Hamilton, Bermuda<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.822%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member', window );">4.4% USD 1 000 million bond 2010/2020 of Novartis Capital Corporation, New York United States, issued at 99.237% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.237%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member', window );">2.4% USD 1 500 million bond 2012/2022 of Novartis Capital Corporation, New York United States, issued at 99.225% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.225%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member', window );">3.7% USD 500 million bond 2012/2042 of Novartis Capital Corporation, New York United States, issued at 98.325% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">98.325%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member', window );">3.4% USD 2 150 million bond 2014/2024 of Novartis Capital Corporation, New York United States, issued at 99.287% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 2,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.287%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 2,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member', window );">4.4% USD 1 850 million bond 2014/2044 of Novartis Capital Corporation, New York United States, issued at 99.196% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.196%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member', window );">0.75% EUR 600 million bond 2014/2021 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.134% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.134%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member', window );">1.625% EUR 600 million bond 2014/2026 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.697% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">1.625%<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.697%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member', window );">0.25% CHF 500 million bond 2015/2025 of Novartis AG Basel Switzerland, issued at 100.64% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">CHF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis AG, Basel, Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">100.64%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member', window );">0.625% CHF 550 million bond 2015/2029 of Novartis AG Basel Switzerland, issued at 100.502% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.625%<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">CHF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis AG, Basel, Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">100.502%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member', window );">1.050% CHF 325 million bond 2015/2035 of Novartis AG Basel Switzerland, issued at 100.479% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">1.05%<span></span>
</td>
<td class="nump">1.05%<span></span>
</td>
<td class="nump">1.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">CHF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis AG, Basel, Switzerland<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">100.479%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member', window );">3.0% USD 1 750 million bond 2015/2025 of Novartis Capital Corporation, New York United States, issued at 99.010% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member', window );">4.0% USD 1 250 million bond 2015/2045 of Novartis Capital Corporation, New York United States, issued at 98.029% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">98.029%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member', window );">0.125% EUR 1 250 million bond 2016/2023 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 99.127% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.125%<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="nump">0.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.127%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member', window );">0.625% EUR 500 million bond 2016/2028 of Novartis Finance S.A. Luxembourg, Luxembourg, issued at 98.48% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.625%<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="nump">0.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">98.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member', window );">1.800% USD 1'000 million 2017/2020 of Novartis Capital Corporation, New York, United States, issued at 99.609% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.609%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member', window );">2.400% USD 1'000 million 2017/2022 of Novartis Capital Corporation, New York, United States, issued at 99.449% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.449%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member', window );">3.100% USD 1'000 million 2017/2027 of Novartis Capital Corporation, New York, United States, issued at 99.109% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Capital Corporation, New York, United States<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.109%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member', window );">0.000% EUR 1'250 million 2017/2021 of Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.133% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.133%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 1,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member', window );">1.125% EUR 600 million 2017/2027 of Novartis Finance S.A., Luxembourg, Luxembourg, issued at 99.874% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.874%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">684<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member', window );">0.500% EUR 750 million 2018/2023 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.655% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.655%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">853<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member', window );">1.375% EUR 750 million 2018/2030 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.957% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.957%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member', window );">1.700% EUR 750 million 2018/2038 of Novartis Finance S.A., Luxembourg, Luxembourg issued at 99.217% [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Borrowings, coupon</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsOriginalCurrency', window );">Borrowings, original currency</a></td>
<td class="text">EUR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsIssuanceDate', window );">Borrowings, issuance year</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Borrowings, maturity year</a></td>
<td class="text">2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsLender', window );">Borrowings, issuer</a></td>
<td class="text">Novartis Finance S.A., Luxembourg, Luxembourg<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsPremiumDiscount', window );">Borrowings, issue price</a></td>
<td class="nump">99.217%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Straight bonds</a></td>
<td class="nump">$ 832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BondsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of bonds issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BondsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsOriginalCurrency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The currency in which the borrowings are denominated. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsOriginalCurrency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsIssuanceDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsIssuanceDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsLender">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsLender</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsPremiumDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsPremiumDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A5.125USD3000MillionBond20092019OfNovaritisSecuritiesInvestmentLtd.HamiltonBermudaIssuedAt99.822Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1000MillionBond20102020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.237Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A2.4USD1500MillionBond20122022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.225Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A3.7USD500MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.325Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A3.4USD2150MillionBond20122042OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.287Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A4.4USD1850MillionBond20142044OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.196Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.75EUR600MillionBond20142021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.134Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A1.625EUR600MillionBond20142026OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.697Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.25CHF500MillionBond20152025OfNovartisAGBaselSwitzerlandIssuedAt100.64Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.625CHF550MillionBond20152029OfNovartisAGBaselSwitzerlandIssuedAt100.502Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A1.050CHF325MillionBond20152035OfNovartisAGBaselSwitzerlandIssuedAt100.479Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A3.0USD1750MillionBond20152025OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A4.0USD1250MillionBond20152045OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt98.029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.125EUR1250MillionBond20162023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.127Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.625EUR500MillionBond20162028OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt98.48Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A1.800USD1000Million20172020OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.609Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A2.400USD1000Million20172022OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.449Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A3.100USD1000Million20172027OfNovartisCapitalCorporationNewYorkUnitedStatesIssuedAt99.109Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.000EUR1250Million20172021OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.133Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A1.125EUR600Million20172027OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.874Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A0.500EUR750Million20182023OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.655Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A1.375EUR750Million20182030OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.957Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=nvs_A1.700EUR750Million20182038OfNovartisFinanceS.A.LuxembourgLuxembourgIssuedAt99.217Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>279
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838902368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfSignificantTransactionsTextBlock', window );">Significant transactions</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">2. Significant transactions</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2019</font> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Completion of the spin-off of the Alcon business through a dividend in kind distribution to Novartis AG shareholders </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On June 29, 2018, Novartis announced its intention to seek shareholder approval for the spin-off of the Alcon business into a separately traded standalone company, following the complete structural separation of the Alcon business into a standalone company (the Alcon business or Alcon Inc.). </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Novartis AG shareholders approved the spin-off of the Alcon business at the 2019 Annual General Meeting held on February 28, 2019, subject to completion of certain conditions precedent to the distribution. Upon shareholder approval, the Alcon business was reported as discontinued operations, and the fair value of the Alcon business exceeded the carrying value of its net assets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The conditions precedent to the spin-off were met and on April 8, 2019 the spin-off of the Alcon business was effected by way of a distribution of a dividend in kind of Alcon Inc. shares to Novartis AG shareholders and ADR (American Depositary Receipt) holders (the Distribution), which amounted to USD 23.4 billion and is recognized as a reduction to retained earnings. Through the Distribution, each Novartis AG shareholder received one Alcon Inc. share for every five Novartis AG shares/ADRs they held on April 8, 2019, close of business. As of April 9, 2019, the shares of Alcon Inc. are listed on the SIX Swiss Exchange (SIX) and on the New York Stock Exchange (NYSE) under the symbol &#x201c;ALC.&#x201d; </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The dividend in kind distribution liability to effect the spin-off of the Alcon business (the distribution liability) amounted to USD 26.4 billion at March 31, 2019, unchanged from its initial recognition on February 28, 2019, and was in excess of the carrying value of the Alcon business net assets as of February 28, 2019, and as of March 31, 2019. The net assets of the Alcon business amounted to USD 23.1 billion as at March 31, 2019. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On March 6, 2019, Alcon entered into financing arrangements with a syndicate of banks under which it borrowed on April 2, 2019, a total amount of USD 3.2 billion. These borrowings consisted of approximately USD 2.8 billion and the equivalent of USD 0.4 billion in EUR in bridge and other term loans under such Alcon facilities agreement. In addition, approximately USD 0.3 billion of borrowings under a number of local bilateral facilities in different countries, with the largest share of borrowings in Japan, were raised. This resulted in a total gross debt of USD 3.5 billion. These outstanding borrowings of the Alcon legal entities were recorded in the balance sheet and financing cash flow from discontinued operations. Prior to the spin-off, through a series of intercompany transactions, Alcon legal entities paid approximately USD 3.1 billion in cash to Novartis and its affiliates. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">At the April 8, 2019 Distribution, the fair value of the distribution liability of the Alcon business amounted to USD 23.4 billion, a decrease of USD 3.0 billion from March 31, 2019. As mentioned above, prior to the spin-off, through a series of intercompany transactions, Alcon legal entities incurred additional net financial debt and paid approximately USD 3.1 billion in cash to Novartis and its affiliates. This additional net debt and transactions resulted in a decrease in Alcon&#x2019;s net assets to USD 20.0 billion at the date of the Distribution of the dividend in kind to Novartis AG shareholders on April 8, 2019. The distribution liability at April 8, 2019, remained in excess of the then-carrying value of the Alcon business net assets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Certain consolidated foundations own Novartis AG dividend-bearing shares restricting their availability for use by the Group. These Novartis AG shares are accounted for as treasury shares. Through the Distribution, these foundations received Alcon Inc. shares representing an approximate 4.7% equity interest in Alcon Inc. Upon the loss of control of Alcon Inc. through the Distribution, the financial investment in Alcon Inc. was recognized at its fair value based on the opening traded share price of Alcon Inc. on April 9, 2019 (a Level 1 hierarchy valuation). At initial recognition, its fair value of USD 1.3 billion was reported on the Group&#x2019;s consolidated balance sheet as a financial asset. Management has designated this investment at fair value through other comprehensive income. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The total non-taxable, non-cash gain recognized at the distribution date of the spin-off of the Alcon business amounted to USD 4.7 billion consisting of: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> April 8, <br></br> 2019 </div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Net assets derecognized <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;20&nbsp;025</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Derecognition of distribution liability</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 23&nbsp;434</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Difference between net assets and distribution liability</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;409</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Recognition of Alcon Inc. shares obtained <br></br>through consolidated foundations </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;273 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation gains recycled into <br></br>the consolidated income statement </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 123 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Transaction costs recognized in the consolidated income statement</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;114</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;691</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="4"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> See Note 30 for additional information. </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">For additional disclosures on discontinued operations, refer to Note 30.</div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of IFM Tre, Inc. </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On May 7, 2019, Novartis acquired IFM Tre, Inc., a privately held, US-based biopharmaceutical company focused on developing anti-inflammatory medicines targeting the NLRP3 inflammasome. The acquisition gives Novartis full rights to IFM Tre, Inc.&#x2019;s portfolio of NLRP3 antagonists. The NLRP3 antagonists portfolio consists of one clinical program and two preclinical programs: IFM-2427, a first-in-class, clinical-stage systemic antagonist for an array of chronic inflammatory disorders, including atherosclerosis and nonalcoholic steatohepatitis (NASH); a preclinical-stage gutdirected molecule for the treatment of inflammatory bowel disease; and a preclinical-stage central nervous system (CNS)-penetrant molecule. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The previously held interest of 9% was adjusted to its fair value of USD 33 million through the consolidated income statement at acquisition date. This remeasurement resulted in a gain of USD 14 million. The fair value of the total purchase consideration for acquiring the 91% stake Novartis did not already own amounted to USD 361 million. The amount consisted of an initial cash payment of USD 285 million, and the fair value of the contingent consideration of USD 76 million due to the IFM Tre, Inc. shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 355 million, mainly intangibles, and goodwill of USD 39 million. Results of operations since the date of acquisition were not material. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of </font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;font-style:italic;">Xiidra</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On May 8, 2019, Novartis entered into an agreement with Takeda Pharmaceutical Company Limited (Takeda) to acquire the assets associated with <i>Xiidra</i> (lifitegrast ophthalmic solution) 5% worldwide. <i>Xiidra</i> is the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. The transaction bolsters the Novartis front-of-the-eye portfolio and ophthalmic leadership. The transaction closed on July 1, 2019. The purchase price consists of a USD 3.4 billion upfront payment, customary purchase price adjustments of USD 0.1 billion, and the potential milestone payments of up to USD 1.9 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration is USD 3.7 billion. The amount consists of an initial cash payment of USD 3.5 billion, and the net present value of the contingent consideration of USD 0.2 billion, which Takeda is eligible to receive upon the achievement of specified commercialization milestones. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The purchase price allocation resulted in net identifiable assets of approximately USD 3.6 billion, consisting mainly of intangible assets of USD 3.6 billion, and goodwill amounted to approximately USD 0.1 billion. In 2019, from the date of acquisition, the business generated net sales of USD 0.2 billion. Management estimates that net sales for the entire year of 2019 would have amounted to USD 0.3 billion, had the business been acquired at the beginning of the 2019 reporting period. Results of operations since the date of acquisition were not material. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions entered into in 2019 and closed in January 2020</font> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of The Medicines Company</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 23, 2019, Novartis entered into an agreement and plan of merger (the Merger Agreement) with The Medicines Company, a US-based pharmaceutical company headquartered in Parsippany, New Jersey USA. Pursuant to the Merger Agreement, on December 5, 2019, Novartis, through a subsidiary, commenced a tender offer to acquire all outstanding shares of The Medicines Company for USD 85 per share, or a total consideration of approximately USD 9.7 billion in cash on a fully diluted basis. The tender offer expired on January 3, 2020, and on January 6, 2020, the acquiring subsidiary merged with and into The Medicines Company, resulting in The Medicines Company becoming an indirect wholly owned subsidiary of Novartis. Novartis will finance the transaction through available cash and short- and long-term borrowings. As the transaction closed on January 6, 2020 the purchase price allocation is incomplete. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Medicines Company is focused on the development of inclisiran, a potentially first-in-class, twice-yearly therapy that allows administration during patients&#x2019; routine visits to their healthcare professionals and will potentially contribute to improved patient adherence and sustained lower LDL-C levels. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant pending transactions</font> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz &ndash; divestment of US dermatology business and generic US oral solids portfolio</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On September 6, 2018, Novartis announced that it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma USA Inc. (Aurobindo) for USD 0.8 billion in cash and potential earnouts. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Sandoz US portfolios to be sold to Aurobindo include approximately 300 products as well as additional development projects. The sale includes the Sandoz US generic and branded dermatology businesses as well as its dermatology development center. As part of the transaction, Aurobindo will acquire the manufacturing facilities in Wilson, North Carolina, and in Hicksville and Melville, New York. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The transaction is expected to be completed in the first quarter of 2020, pending regulatory approval. As the fair value of the consideration (USD 0.8 billion) less costs to sell is below the carrying value of the divested business (USD 1.0 billion, which includes an allocation of Sandoz goodwill of USD 0.2 billion), an impairment of the net assets to be divested in the amount of USD 0.2 billion was recognized as a reduction to goodwill in 2018. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In the Group&#x2019;s consolidated balance sheet at December 31, 2019 and 2018, the business assets and liabilities of the Sandoz US dermatology business and generic US oral solids portfolio are separately shown as assets and liabilities of disposal group held for sale. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The disposal group, assets and liabilities classified as held for sale consist of the following: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Assets of disposal group classified as held for sale</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 169</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 148</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 475</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 478</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 181</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 165</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 841</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 807</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> December 31, <br></br> 2019 </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> December 31, <br></br> 2018 </div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Liabilities of disposal group classified as held for sale</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other non-current <br></br>liabilities </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 4 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 4 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Provisions and other current liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 45</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 51</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">There are no cumulative income or expenses included in other comprehensive income relating to the disposal group. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Sandoz &ndash; acquisition of the Japanese business of Aspen Global Incorporated</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On November 11, 2019, Sandoz entered into an agreement for the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited. Under the agreement, Sandoz will acquire the shares in Aspen Japan K.K. and associated assets held by AGI. Pursuant to the agreed terms of the transaction, on closing the Group will pay an initial cash consideration of EUR 300 million (approximately USD 336 million). In addition, deferred consideration is due to AGI, upon fulfillment of certain conditions after closing, currently estimated at approximately EUR 100 million (approximately USD 112 million). </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">We have received all relevant approvals and this transaction is expected to be completed in the first quarter of 2020. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Aspen&#x2019;s portfolio in Japan consists of off-patent medicines with a focus on anesthetics and specialty brands. The acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2018</font> </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Advanced Accelerator Applications S.A.</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On October 30, 2017, Novartis entered into a binding memorandum of understanding with Advanced Accelerator Applications S.A. (AAA), a company headquartered in Saint-Genis-Pouilly, France, under which Novartis agreed to commence a tender offer for 100% of the share capital of AAA subject to certain conditions. Novartis commenced the tender offer on December 7, 2017, to purchase all of the outstanding ordinary shares for a price of USD&nbsp;41 per share and USD&nbsp;82 per American Depositary Share (ADS), each representing two ordinary shares of AAA, which expired on January 19, 2018. The offer valued AAA&#x2019;s equity at USD&nbsp;3.9 billion, on a fully diluted basis. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of January 19, 2018, the expiration date of the tender offer, approximately 97% of the then-outstanding fully diluted ordinary shares, including ordinary shares represented by ADSs (hereinafter collectively referred to as &#x201c;the outstanding shares&#x201d;), were validly tendered. On January 22, 2018, Novartis accepted and paid USD 3.9 billion for the outstanding shares tendered in the offer. On January 22, 2018, Novartis commenced a subsequent offering period that expired on January 31, 2018. As of the expiration of the subsequent offering period, an additional 1.8% of the outstanding shares were validly tendered. Novartis accepted and paid approximately USD 60 million, resulting in an increase in Novartis ownership in AAA to 98.7%. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration was USD 3.9 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 1.9 billion, consisting of USD 2.5 billion intangible assets, USD 0.6 billion net deferred tax liabilities, and goodwill of approximately USD 2.0 billion. In 2018, from the date of the acquisition, the business generated net sales of USD 0.4 billion. Management estimated that net sales for the entire year of 2018 would have amounted to USD 0.4 billion had AAA been acquired at the beginning of 2018. The 2018 results from operations since the acquisition were not material. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">As of December 31, 2019, Novartis held 99.2% of the then-outstanding fully diluted ordinary shares, including ordinary shares represented by ADSs. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">AAA is a radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicines &ndash; including <i>Lutathera</i> (USAN: lutetium Lu 177 dotatate/INN: lutetium ( <sup>177</sup>Lu) oxodotreotide), a first-in-class radioligand therapy product for neuroendocrine tumors &ndash; and a portfolio of diagnostic products. Radiopharmaceuticals, such as <i>Lutathera</i>, are unique medicinal formulations containing radioisotopes, which are used clinically for both diagnosis and therapy. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of AveXis, Inc.</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On April 6, 2018, Novartis entered into an agreement and plan of merger with AveXis, Inc., a US-based clinical stage gene therapy company, under which Novartis commenced on April 17, 2018, a tender offer to purchase all outstanding common stock of AveXis, Inc. for USD 218 per share in cash. On May 15, 2018, Novartis completed the acquisition of the common stock of AveXis, Inc. and paid a total of USD 8.7 billion. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration was USD 8.7 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 7.2 billion, consisting of USD 8.5 billion intangible assets, USD 1.6 billion net deferred tax liabilities and other net assets of USD 0.3 billion, and goodwill of approximately USD 1.5 billion. The 2018 results of operations since the date of acquisition were not material. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">AveXis, Inc. is focused on developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. AveXis, Inc.&#x2019;s initial product candidate, AVXS-101, is a proprietary gene therapy currently in development for the treatment of spinal muscular atrophy (SMA) type 1 &ndash; the leading genetic cause of infant mortality &ndash; and SMA types 2 and 3. In addition, AveXis, Inc. has a pipeline of other novel treatments for rare neurological diseases, including Rett syndrome (RTT) and a genetic form of amyotrophic lateral sclerosis (ALS) caused by mutations in the superoxide dismutase 1 (SOD1) gene. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Endocyte, Inc.</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On October 18, 2018, Novartis entered into an agreement and plan of merger with Endocyte, Inc. (Endocyte), a US-based biopharmaceutical company focused on developing targeted therapeutics for cancer treatment. The transaction was completed on December 21, 2018. Under the terms of the agreement, Novartis acquired all outstanding shares of Endocyte common stock for USD 24 per share. The total consideration amounted to USD 2.1 billion. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value of the total purchase consideration was USD 2.1 billion. The purchase price allocation resulted in net identifiable assets of approximately USD 1.5 billion, consisting of USD 1.5 billion intangible assets, USD 0.3 billion net deferred tax liabilities and other net assets of USD 0.3 billion, and goodwill of approximately USD 0.6 billion. The purchase price allocation was preliminary at December 31, 2018, as the transaction closed on December 21, 2018, which was close to the Group&#x2019;s year-end and therefore did not provide sufficient time to complete the valuation of the intangible assets, deferred taxes, assumed liabilities and goodwill. During 2019, there were no significant revisions to the purchase price allocation. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Endocyte uses drug conjugation technology to develop targeted therapies with companion imaging agents, including <sup>177</sup>Lu-PSMA-617, a potential first-in-class investigational radioligand therapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC). </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Corporate &ndash; divestment of </font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">36.5%</font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> stake in </font> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">GlaxoSmithKline Consumer Healthcare Holdings Ltd. </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On March 27, 2018, Novartis entered into an agreement with GlaxoSmithKline plc (GSK) to divest its 36.5% stake in GlaxoSmithKline Consumer Healthcare Holdings Ltd. to GSK for USD 13.0 billion in cash. As a result, Novartis discontinued the use of equity method accounting starting from April 1, 2018. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">On June 1, 2018, the transaction closed and Novartis realized a pre-tax gain of USD 5.8 billion, recorded in income from associated companies. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions in 2017</font> </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Ziarco Group Limited</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 20, 2017, Novartis acquired Ziarco Group Limited (Ziarco), a privately-held company in the United Kingdom that focuses on the development of novel treatments in dermatology. This acquisition added a once-daily oral H4 receptor antagonist in development for atopic dermatitis, commonly known as eczema, to complement the Novartis dermatology portfolio and pipeline. The fair value of the total purchase consideration was USD 420 million. The amount consisted of an initial cash payment of USD&nbsp;325 million and the net present value of the contingent consideration of USD 95 million, due to Ziarco shareholders, which they are eligible to receive upon the achievement of specified development milestones. The purchase price allocation resulted in net identifiable assets of USD&nbsp;395 million and goodwill of USD 25 million. The 2017 results of operations since the date of acquisition were not material. </div> <div> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Innovative Medicines &ndash; acquisition of Encore Vision, Inc.</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">On January 20, 2017, Novartis acquired Encore Vision, Inc. (Encore), a privately-held company in Fort Worth, Texas, in the United States, that focuses on the development of a novel treatment in presbyopia. The fair value of the total purchase consideration was USD 456 million. The amount consisted of an initial cash payment of USD 366 million and the net present value of the contingent consideration of USD 90 million, due to Encore shareholders, which they are eligible to receive upon the achievement of specified development and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 389 million and goodwill of USD 67 million. The 2017 results of operations since the date of acquisition were not material. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">For significant transactions in 2019 for discontinued operations, see Note 30. There were no significant transactions in 2018 and 2017 for discontinued operations. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfSignificantTransactionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfSignificantTransactionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>280
<FILENAME>R159.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6840166224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits for associates (Details)<br> SFr in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure of defined benefit plans [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ConcentrationOfMajorPlansGeographic', window );">Concentration of major plans, geographic</a></td>
<td class="text">The major plans are based in Switzerland, the United States, the United Kingdom, Germany and Japan, which represent 95% of the Group&#8217;s total DBO for pension plans.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements', window );">Description of plan amendments, curtailments and settlements</a></td>
<td class="text">In September 2017, the pension regulations in Switzerland were amended, which resulted in a change in accounting from defined benefit to defined contribution for a component of the Swiss pension plans. This change resulted in a reduction to the defined benefit pension plans liability and in a corresponding net pre-tax gain of USD 225 million (CHF 216 million).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MajorPlansPercentageInGroupDBOPensions', window );">Major plans percentage in group DBO pensions</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans', window );">Most signigicant countries percentage on group DBO post employment benefit plans</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Net Pre-tax curtailment gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">SFr 216<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of defined benefit plan amendments, curtailments and settlements. [Refer: Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2019-01-01<br> -Paragraph 139<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_139_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfPlanAmendmentsCurtailmentsAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ConcentrationOfMajorPlansGeographic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the major plans and the concentration of the Group's DBO by geography.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ConcentrationOfMajorPlansGeographic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MajorPlansPercentageInGroupDBOPensions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MajorPlansPercentageInGroupDBOPensions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_MostSignigicantCountriesPercentageOnGroupDBOPostEmploymentBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>282
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839054048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Equity-based participation plans for associates</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">26. Equity-based participation plans for associates</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The expense related to all equity-based participation plans and the liabilities arising from equity-based payment transactions were as follows: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense related to equity-based <br></br>participation plans </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> 1&nbsp;067 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 918 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 853 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Liabilities arising from equity-based payment transactions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 326</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 273</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 261</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Equity-based participation plans can be separated into the following plans:</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Annual Incentive</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Annual Incentive for the Novartis Group CEO and other Executive Committee members (ECN) is paid 50% in cash and 50% in Novartis restricted shares (RSs) or restricted share units (RSUs). For the Novartis Top Leaders (NTLs), the Annual Incentive is paid 70% in cash and 30% in RSs or RSUs. Both the ECN and NTLs can opt to invest up to the maximum cash portion of their Annual Incentive to receive further RSs or RSUs. Any cash is paid out during February or March in the year following the end of the performance period, and the shares are granted during January in the year following the end of the performance period. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Share savings plans</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Associates in certain countries and certain key executives worldwide are encouraged to invest their Annual Incentive in a share savings plan. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Under the share savings plan, participants may elect to receive their relevant compensation fully or partially in Novartis shares in lieu of cash. As a reward for their participation in the share savings plan, at no additional cost to the participant, Novartis matches their investments in shares after a holding period of three or five years. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify;margin-top:15px;">Novartis operates share savings plans for which associates may only participate in one of the share savings plans in any given year. The most significant are listed below: </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; In Switzerland, Employee Share Ownership Plan (ESOP) participants may choose to receive their Annual Incentive (i) 100% in shares, (ii) 50% in shares and 50% in cash, or (iii) 100% in cash. After expiration of a three-year holding period for Novartis shares invested under the ESOP, participants will receive one matching share for every two invested shares. Associates eligible for the equity plan &#x201c;Select&#x201d; are not eligible to receive ESOP matching shares starting with the 2017 performance period. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt;color:#000000;margin-bottom:0mm;margin-left:9px;margin-right:0mm;margin-top:0mm;text-indent:-9px;">&#x2022; The Leveraged Share Savings Plan (LSSP) was available to key executives for performance periods prior to 2016. At the participant&#x2019;s election, the Annual Incentive was awarded partly or entirely in shares. The elected number of shares is subject to a holding period of five years. At the end of the holding period, Novartis will match the invested shares at a ratio of 1-to-1 (i.e., one share awarded for each invested share). In the United States, both the LSSP award and the corresponding match are cash settled. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Following the introduction of the new compensation programs in 2014, the Novartis Group CEO and the other Executive Committee members are no longer eligible to participate in the share savings plans. From the 2016 performance period onward, the NTLs are also no longer eligible to participate in the share savings plans. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Novartis equity plan &#x201c;Select&#x201d;</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The equity plan &#x201c;Select&#x201d; is a global equity incentive plan under which eligible associates may annually be awarded a grant subject to a three-year, and for selected units a four-year, staggered vesting period. No awards are granted for performance ratings below a certain threshold. Executive Committee members are not eligible to participate in the equity plan &#x201c;Select&#x201d; effective from the performance period 2014, and the NTLs are not eligible to participate effective from the performance period 2016. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The equity plan &#x201c;Select&#x201d; currently allows participants in Switzerland to choose the form of their equity compensation in RSs or RSUs. In all other jurisdictions, RSs or RSUs are granted unilaterally. Until 2013, participants could also choose to receive part or the entire grant in the form of tradable share options. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Tradable share options expire on their 10 <sup>th</sup> anniversary from the grant date. Each tradable share option entitles the holder to purchase after vesting (and before the 10 <sup>th</sup> anniversary from the grant date) one Novartis share at a stated exercise price that equals the closing market price of the underlying share at the grant date. As the exercise price does not reflect the decrease in the Novartis share due to the Alcon spin, one-fifth of an Alcon share will also be awarded to the option holder upon exercise. </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Options under Novartis equity plan &#x201c;Select&#x201d; outside North America</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the activity associated with the share options during the period. The weighted average prices in the table below are translated from Swiss francs into USD at historical rates. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> <br></br> Options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> <br></br> Options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Options outstanding <br></br>at January 1 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 5.6 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 59.9 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 7.4 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 59.5 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sold or exercised</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 58.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 58.2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Exercisable at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 59.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All share options were granted at an exercise price that was equal to the closing market price of the Group&#x2019;s shares at the grant date. The weighted average share price at the dates of sale or exercise was USD&nbsp;89.9. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table summarizes information about share options outstanding at December 31, 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>Options outstanding </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total/ <br></br> weighted <br></br> average </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number outstanding (millions)</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.3</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.9</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.5</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3.4</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remaining contractual life (years)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise price (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 60.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style="padding-bottom:0px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;"> <font style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000; font-weight:bold;">Options under Novartis equity plan &#x201c;Select&#x201d; for North America</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the activity associated with the ADR options during the period: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="3" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="3" style="border-bottom: solid #000000 1px;"></td> <td height="1" width="3" style="border-bottom: solid #FFFFFF 1px;"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> <td colspan="3" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> ADR <br></br> options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> ADR <br></br> options <br></br> (millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br></br> average <br></br> exercise <br></br> price <br></br> (USD) </div> </td> <td></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Options outstanding <br></br>at January 1 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 15.2 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 60.7 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 20.3 </div> </td> <td align="right" width="1%"></td> <td align="right" width="9%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 59.9 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sold or exercised</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 58.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57.4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Outstanding at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 60.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Exercisable at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 60.7</div> </td> <td align="right"></td> </tr> <tr> <td colspan="10" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="10"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">All ADR options were granted at an exercise price that was equal to the closing market price of the ADRs at the grant date. The weighted average ADR price at the dates of sale or exercise was USD&nbsp;85.1. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The following table summarizes information about ADR options outstanding at December 31, 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> <br></br>ADR options outstanding </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> Total/ <br></br> weighted <br></br> average </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Number outstanding (millions)</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.4</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.9</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 9.6</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Remaining contractual life (years)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2.3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Exercise price (USD)</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 54.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 61.9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Long-Term Performance Plan</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Long-Term Performance Plan (LTPP) is an equity plan for the ECN, the NTLs and employees of Group units with specific targets. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Participants are granted a target number of performance share units (PSUs) at the beginning of every performance period, which are converted into unrestricted Novartis shares after the performance period. The actual payout depends on the achievement of the performance measures and ranges between 0% and 200% of the granted amount. PSUs granted under the LTPP do not carry voting rights, but do carry dividend equivalents that are paid in unrestricted Novartis shares at the end of the performance period. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The LTPP awards are subject to a three-year performance and vesting period. Until 2018, the performance criteria were based on Novartis internal performance metrics. Starting in 2019, for new grants the performance criteria are based on both Novartis internal performance metrics and variables that can be observed in the market, which is the ranking of the Novartis total shareholder return (TSR) relative to a global healthcare peer group of 14 companies (updated in November 2019 from 15 companies following the acquisition of one of the companies by another company within the peer group) other companies, over rolling three-year performance periods. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">TSR for Novartis and the peer companies is calculated as the change in the company share price, which is translated to USD at the relevant exchange rate, including the reinvestment return of dividends, over the three-year performance period. The calculation is based on Bloomberg standard published TSR data, which is publicly available. The position of Novartis in the peer group determines the payout range based on a payout matrix. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Long-Term Relative Performance Plan</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The LTRPP is an equity plan for the Novartis ECN and NTLs. The last grant under this plan was made in 2018. The LTRPP performance criteria is based on variables that can be observed in the market, which is the ranking of the Novartis TSR relative to a global healthcare peer group of 15 other companies, over rolling three-year performance periods. The TSR for Novartis and the peer companies is calculated as described in the LTPP section above. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Other share awards</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Selected associates, excluding the ECN members, may exceptionally receive Special Share Awards of RSs or RSUs. These Special Share Awards provide an opportunity to reward outstanding achievements or exceptional performance, and aim to retain key contributors. They are based on a formal internal selection process, through which the individual performance of each candidate is thoroughly assessed at several management levels. Special Share Awards have a minimum three-year vesting period. In exceptional circumstances, Special Share Awards may be awarded to attract special expertise and new talents to the organization. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">Worldwide, associates at different levels in the organization were awarded RSs and RSUs in 2019, 2018 and 2017. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In addition, in 2019, 2018 and 2017, Board members received unrestricted shares as part of their regular compensation.</div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Summary of non-vested share movements</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The table below provides a summary of non-vested share movements (RSs, RSUs and PSUs) for all plans. At the Alcon spin-off date, all RSU and PSU holders, who were not entitled to the dividend in kind in the form of Alcon shares received keep whole awards in Novartis shares to compensate for the loss of the Alcon value from their Novartis shares. These keep whole awards were accounted for as a modification. As they did not increase the value of the original grant, they did not lead to additional expense. In the table below, this is reflected by a zero fair grant date fair value: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="center" colspan="5" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> <td colspan="5" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> <td colspan="5" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"></div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Number <br></br> of shares <br></br> in millions </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Weighted <br></br> average fair <br></br> value at grant <br></br> date in USD </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Fair value at <br></br> grant date in <br></br> USD millions </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Number <br></br> of shares <br></br> in millions </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Weighted <br></br> average fair <br></br> value at grant <br></br> date in USD </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Fair value at <br></br> grant date in <br></br> USD millions </div> </td> <td></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-vested shares at January 1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 25.7</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 77.1</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;981</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 23.9</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 80.6</div> </td> <td align="right" width="1%"></td> <td align="right" width="7%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;926</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Granted</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Annual Incentive</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 78.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 86</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 83.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 109</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Share savings plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 83.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 349</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 84.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 348</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Select North America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 5.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 64.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 339</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 303</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Select outside North America</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 175</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 79.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 167</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Long-Term Performance Plan</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 68.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 172</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.5</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 85.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 129</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Long-Term Relative Performance Plan</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 0.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 52.0</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 16</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">&#x2013; Other share awards</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 67.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 129</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 77.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 93</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Vested</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 80.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;068</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;10.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 90.2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;965</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Forfeited</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;4.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 76.3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1.9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 76.4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;145</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Non-vested shares at December 31</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 25.8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;835</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 25.7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 77.1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;981</div> </td> <td align="right"></td> </tr> <tr> <td colspan="14" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 44<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>283
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6871252848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated balance sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="nump">$ 12,069<span></span>
</td>
<td class="nump">$ 15,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">26,524<span></span>
</td>
<td class="nump">35,294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets other than goodwill</a></td>
<td class="nump">28,787<span></span>
</td>
<td class="nump">38,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments in associated companies</a></td>
<td class="nump">8,644<span></span>
</td>
<td class="nump">8,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">7,909<span></span>
</td>
<td class="nump">8,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Financial assets</a></td>
<td class="nump">2,518<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">738<span></span>
</td>
<td class="nump">895<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">88,866<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">5,982<span></span>
</td>
<td class="nump">6,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Current trade receivables</a></td>
<td class="nump">8,301<span></span>
</td>
<td class="nump">8,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_CurrentIncomeTaxReceivable', window );">Income tax receivable</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialAssets', window );">Marketable securities, commodities, time deposits and derivative financial instruments</a></td>
<td class="nump">334<span></span>
</td>
<td class="nump">2,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">11,112<span></span>
</td>
<td class="nump">13,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialAssets', window );">Other current assets</a></td>
<td class="nump">2,680<span></span>
</td>
<td class="nump">2,861<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners', window );">Total current assets without disposal group</a></td>
<td class="nump">28,663<span></span>
</td>
<td class="nump">34,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets of disposal group held for sale</a></td>
<td class="nump">841<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">29,504<span></span>
</td>
<td class="nump">35,563<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">118,370<span></span>
</td>
<td class="nump">145,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">936<span></span>
</td>
<td class="nump">944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Reserves</a></td>
<td class="nump">54,618<span></span>
</td>
<td class="nump">77,739<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Issued share capital and reserves attributable to Novartis AG shareholders</a></td>
<td class="nump">55,474<span></span>
</td>
<td class="nump">78,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">55,551<span></span>
</td>
<td class="nump">78,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">20,353<span></span>
</td>
<td class="nump">22,470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">5,867<span></span>
</td>
<td class="nump">7,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_ProvisionsAndOtherNoncurrentLiabilities', window );">Provisions and other non-current liabilities</a></td>
<td class="nump">6,632<span></span>
</td>
<td class="nump">7,319<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">34,555<span></span>
</td>
<td class="nump">37,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">5,424<span></span>
</td>
<td class="nump">5,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Financial debts and derivative financial instruments</a></td>
<td class="nump">7,031<span></span>
</td>
<td class="nump">9,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current income tax liabilities</a></td>
<td class="nump">2,194<span></span>
</td>
<td class="nump">2,038<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialLiabilities', window );">Provisions and other current liabilities</a></td>
<td class="nump">13,338<span></span>
</td>
<td class="nump">12,284<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Total current liabilities without disposal group</a></td>
<td class="nump">28,233<span></span>
</td>
<td class="nump">29,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Liabilities of disposal group held for sale</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">28,264<span></span>
</td>
<td class="nump">29,607<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">62,819<span></span>
</td>
<td class="nump">66,871<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="nump">$ 118,370<span></span>
</td>
<td class="nump">$ 145,563<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity.
Effective 2020-01-01: The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets other than non-current assets or disposal groups classified as held for sale or as held for distribution to owners. [Refer: Current assets; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale; Non-current assets or disposal groups classified as held for distribution to owners]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities other than liabilities included in disposal groups classified as held for sale. [Refer: Current liabilities; Disposal groups classified as held for sale [member]; Liabilities included in disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 56<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2019-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2019-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2019-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2020-01-01: The amount of present obligations of the entity arising from past events, the settlement of which is expected to result in an outflow from the entity of resources embodying economic benefits.
Effective 2020-01-01: The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2019-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2019-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph p<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_p&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2019-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2019-01-01<br> -Paragraph 38<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial assets that the entity does not separately disclose in the same statement or note. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2019-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2019-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_CurrentIncomeTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_CurrentIncomeTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_ProvisionsAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_ProvisionsAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>284
<FILENAME>R155.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6842781728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Details to the consolidated cash flow statements (Details 4) - GSK Consumer Healthcare<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 27, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_StatementLineItems', window );"><strong>Statement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInterestsInAssociates', window );">Divestments of interests in associated companies</a></td>
<td class="nump">$ 12,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations', window );">Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations</a></td>
<td class="nump">$ 12,994<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of non-current assets or disposal groups classified as held for sale and discontinued operations. [Refer: Discontinued operations [member]; Disposal groups classified as held for sale [member]; Non-current assets or disposal groups classified as held for sale]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInterestsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of interests in associates. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInterestsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_StatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_StatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=nvs_GSKConsumerHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=nvs_GSKConsumerHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>285
<FILENAME>R151.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6844168992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Provisions and other current liabilities (Details 3) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RestructuringProvisionsMovementsRollForward', window );"><strong>Restructuring provisions movements [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Cash payments</a></td>
<td class="num">$ (19,348)<span></span>
</td>
<td class="num">$ (18,567)<span></span>
</td>
<td class="num">$ (17,452)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember', window );">Restructuring provision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RestructuringProvisionsMovementsRollForward', window );"><strong>Restructuring provisions movements [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Provision at beginning of period</a></td>
<td class="nump">507<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions', window );">Provisions related to discontinued operations</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Cash payments</a></td>
<td class="num">(479)<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Releases</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation effects</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Provision at end of period</a></td>
<td class="nump">$ 438<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember', window );">Restructuring provision | Continuing operations [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_RestructuringProvisionsMovementsRollForward', window );"><strong>Restructuring provisions movements [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">521<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Releases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31)<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in other provisions resulting from the loss of control of a subsidiary. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughLossOfControlOfSubsidiaryOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount reversed for unused other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2019-01-01<br> -Paragraph 84<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_84_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_RestructuringProvisionsMovementsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_RestructuringProvisionsMovementsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_RestructuringProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContinuingAndDiscontinuedOperationsAxis=ifrs-full_ContinuingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>286
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838716096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfDiscontinuedOperationsAbstract', window );"><strong>Disclosure of discontinued operations [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory', window );">Disclosure of discontinued operations [text block]</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">30. Discontinued operations</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Discontinued operations include the operational results from the Alcon eye care devices business and certain Corporate activities attributable to the Alcon business prior to the spin-off, the gain on distribution of Alcon Inc. to Novartis AG shareholders, and certain other expenses related to the Distribution (refer to Notes 1 and 2 for further details). </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The Alcon eye care devices business researched, discovered, developed, manufactured, distributed and sold a broad range of eye care products. Alcon was organized into two global business franchises, Surgical and Vision Care. Alcon also provided services, training, education and technical support for both the Surgical and Vision Care businesses. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Consolidated income statement</font> </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019 <sup style="white-space: nowrap"> 1</sup> </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales to third parties from <br></br>discontinued operations </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> 1&nbsp;777 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 7&nbsp;149 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> 6&nbsp;771 </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Sales to continuing segments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net sales from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;809</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;153</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6&nbsp;774</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other revenues</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of goods sold</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;860</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3&nbsp;588</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Gross profit from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 949</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 3&nbsp;189</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Selling, general and administration</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;638</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;754</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2&nbsp;532</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Research and development</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;142</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;585</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;583</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 47</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;113</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;126</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;194</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Operating income/(loss) from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 71</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;234</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;73</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;25</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;27</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income and expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Income/(loss) before taxes from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 58</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;260</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;103</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Taxes</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 74</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 307</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net (loss)/income from discontinued operations <br></br>before gain on distribution of Alcon Inc. <br></br>to Novartis AG shareholders </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> <br></br> <br></br> &ndash;&nbsp;101 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> &ndash;&nbsp;186 </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> <br></br> <br></br> 204 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Gain on distribution of Alcon Inc. to Novartis AG shareholders <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 4&nbsp;691</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net income/(loss) from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4&nbsp;590</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 204</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> The consolidated income statement amounts are for the period from January 1, 2019, to the completion of the spin-off. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> See Note 2 for further details on the non-taxable non-cash gain on distribution of Alcon Inc. to Novartis AG shareholders. </div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Supplemental disclosures related to the Alcon business distributed to Novartis AG shareholders </font> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net income </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Included in net income from discontinued operations are:</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;42</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;235</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;217</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation of right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Amortization of intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;174</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;052</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;066</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charges on intangible assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;391</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;57</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to restructuring provisions</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity-based compensation of Novartis equity plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;93</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;71</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Depreciation of right-of-use assets recognized from January 1, 2019, the date of implementation of IFRS 16 leases. See Note 1 for additional disclosures. </div> </td> </tr> <tr valign="bottom"> <td colspan="8"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> 2018 includes an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc. </div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Balance sheet </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following were in the balance sheet from discontinued operations for the period from January 1, 2019, to the date of reclassification: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 113</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 519</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to right-of-use assets <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions to goodwill and intangible assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 36</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 196</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Additions to right-of-use assets recognized in 2019 with the implementation of IFRS 16 Leases on January 1, 2019. See Note 1 for additional disclosures. </div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash flows used in investing activities from discontinued operations</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">Cash flows used in investing activities from discontinued operations include the investing activities of the Alcon business, and in addition in 2017 USD 140 million cash outflows for transaction-related expenditures attributable to the series of portfolio transformation transactions completed in 2015. </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Payments out of provisions for <br></br>transaction costs attributable <br></br>to the spin-off of the <br></br>Alcon business </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> <br></br> <br></br> &#x2013;&#x2005;29 </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> </div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> <br></br> <br></br> </div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Divested cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;628</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Cash flows attributable to the spin-off of the Alcon business</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;657</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other cash flows used in investing activities, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &#x2013;&#x2005;502</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;1&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &#x2013;&#x2005;775</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net cash flows used in investing activities from discontinued operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &#x2013;&#x2005;1&nbsp;159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;1&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &#x2013;&#x2005;775</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Cash flows from financing activities from discontinued operations</font> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In 2019, the net cash inflows from financing activities from discontinued operations of USD 3.3 billion (2018: USD 167 million net cash outflows, 2017: USD 415 million net cash outflows) included USD 3.5 billion cash inflows from borrowings in connection with the distribution (spin-off) of the Alcon business to Novartis AG shareholders and USD 212 million (2018: USD 57 million, 2017: nil) transaction cost payment directly attributable to the distribution (spin-off) of the Alcon business to Novartis shareholders (see Notes 1 and 2). </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Intangible assets </font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The Alcon Divisions&#x2019; cash-generating units, to which goodwill is allocated, each comprise a group of smaller cash-generating units. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The valuation method of the recoverable amount of the cash-generating units, to which goodwill is allocated, is based on the fair value less costs of disposal. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">In 2017, the Alcon brand name indefinite life intangible asset was reported in Corporate, as it was used to market products of the Alcon Division and products within the Ophthalmology business franchise of the Innovative Medicines Division. In connection with the spin-off of the Alcon Division, the Novartis Group transferred the full rights of the Alcon brand name to the Alcon Division. As a result, the Innovative Medicines Division started the process of rebranding the products within its Ophthalmology business franchise and is no longer using the Alcon brand name. The Alcon brand name indefinite life intangible asset is therefore reported in the Alcon Division in 2018. In 2018, net sales of the Alcon Division products together are the grouping of cash-generating units, which were used to determine the recoverable amount. In the year before, net sales of products within the Innovative Medicines Ophthalmology business franchise as well as Alcon Division products, which used the Alcon brand name, together were the grouping of cash-generating units, which were used to determine the recoverable amounts. The valuation method is based on the fair value less costs of disposal. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The assumptions used in the calculations of fair value were a discount rate (post-tax) of 7.5% and a terminal growth rate of 3%. The Alcon terminal growth rate assumption of 3% is higher than the expected inflation rate of the medical device industry, and more specifically the ophthalmic sub-segment of the industry. The growth rates are expected to exceed this long-term inflation rate, as the aging population to which Alcon&#x2019;s products are prescribed is growing faster than the general population. The discount rates consider the Group&#x2019;s weighted average cost of capital, adjusted to approximate the weighted average cost of capital of a comparable market participant. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The fair value less costs of disposal, for all groupings of cash-generating units containing goodwill or indefinite life intangible assets, is reviewed for the impact of reasonably possible changes in key assumptions. In particular, we considered an increase in the discount rate, a decrease in the terminal growth rate, and certain negative impacts on the forecasted cash flows. These reasonably possible changes in key assumptions did not indicate an impairment. </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">&#x201c;Note 1. Significant accounting policies&mdash;Impairment of goodwill and intangible assets&#x201d; provides additional disclosures on how the Group performs goodwill and intangible asset impairment testing. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">The 2018 intangible asset and goodwill impairment charges were USD 391 million, including an impairment of USD 337 million related to the write-down of the CyPass currently marketed product, which was acquired with the Alcon Division 2016 acquisition of Transcend Medical, Inc. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Leases</font> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table shows the receivables of the gross investments in finance leases and the net present value of the minimum lease payments, as well as unearned finance income, related to Alcon&#x2019;s surgical equipment lease arrangements. The finance income was recorded in &#x201c;Other income.&#x201d; </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td></td> <td align="center" colspan="9" height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr> <td height="1"></td> <td height="1"></td> <td colspan="9" style="border-bottom: solid #000000 1px;"></td> <td height="1"></td> </tr> <tr bgcolor="white"> <td height="3"></td> <td height="1"></td> <td colspan="9" height="3"></td> <td height="1"></td> </tr> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Total <br></br> future <br></br> payments </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> Unearned <br></br> finance <br></br> income </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Present <br></br> value </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> <br></br> Provision </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> <br></br> Net book <br></br> value </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Not later than one year <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 64</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;5</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 59</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 57</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Between one and five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 117</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 108</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;28</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Later than five years</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 48</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 46</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;35</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 11</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 229</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 213</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;65</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 148</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> The current portion of the minimum lease payments was recorded in trade receivables or other current assets (to the extent not invoiced). </div> </td> </tr> </table> </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The lease liabilities recorded in discontinued operations on January 1, 2019, the date of implementation of IFRS 16 leases (see Note 1), were USD 286 million, and the right-of-use assets were USD 276 million, including USD 89 million and USD 75 million, respectively, for the previously reported finance lease obligations. For discontinued operations, there were no impairments or significant contract terminations of right-of-use assets for the period from January 1, 2019, to February 28, 2019, the date of shareholder approval for the Alcon spin-off. </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Net assets derecognized </font> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table presents the Alcon business net assets at the date of spin-off at April 8, 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Property, plant and equipment</div> </td> <td align="right" width="1%"></td> <td align="right" width="20%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;858</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Right-of-use assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 269</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8&nbsp;906</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Intangible assets other than goodwill</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 11&nbsp;121</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 732</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial and other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 526</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Inventories</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;469</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade receivables and other current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;787</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cash and cash equivalents</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 628</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred tax liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;713</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;269</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Current and non-current financial debts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;538</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Trade payables, provisions and other liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;751</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net assets derecognized</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 20&nbsp;025</div> </td> <td align="right"></td> </tr> <tr> <td colspan="4" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px"> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> <td> <div style="font-family: arial, helvetica,sans-serif; font-size:10pt;color:#00ff00;"></div> </td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Defined contribution plans</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In many subsidiaries, associates are covered by defined contribution plans. Contributions charged to the consolidated income statement for the defined contribution plans were: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contributions for defined contribution plans discontinued operations</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 104</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 99</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style=" padding-bottom: 10px;"> <font style="font-family:arial,helvetica,sans-serif; font-size:14pt; color:#000000; font-weight:bold;">Significant transactions</font> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">In March 2019, Alcon acquired PowerVision, Inc. (PowerVision), a privately held, US-based medical device development company focused on developing accommodative, implantable intraocular lenses. The fair value of the total purchase consideration was USD 424 million. The amount consisted of an initial cash payment of USD 289 million and the net present value of the contingent consideration of USD 135 million, due to PowerVision shareholders, which they are eligible to receive upon the achievement of specified regulatory and commercialization milestones. The purchase price allocation resulted in net identifiable assets of USD 418 million, consisting of intangible assets of USD 505 million, net deferred tax liabilities of USD 93 million, other net assets of USD 6 million, and goodwill of USD 6 million. The 2019 results of operations since the date of the acquisition are not material. </div> <div style="padding-bottom:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; text-indent:20.0pt;">For additional information related to the distribution (spin-off) of the Alcon business to Novartis AG shareholders, effected through a dividend in kind distribution that was completed on April 8, 2019, refer to Note 1 and Note 2. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of discontinued operations. [Refer: Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfDiscontinuedOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfDiscontinuedOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>287
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6839000864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial and other non-current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract', window );"><strong>Disclosure of financial and other non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock', window );">Financial and other non-current assets</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">13. Financial and other non-current assets</div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Financial assets</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Equity securities</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;524</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;155</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Debt securities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 31</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Fund investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 233</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 251</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial investments</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;790</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 1&nbsp;437</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term receivables from customers</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 164</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Minimum lease payments <br></br>from finance lease agreements <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> <br></br> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> <br></br> 91 </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term receivables from finance subleases</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 66</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other long-term receivables</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 104</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Contingent consideration receivables <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 399</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 396</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Long-term loans, advances and security deposits</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 159</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 254</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total financial assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;518</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;345</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 30 provides additional disclosures on minimal lease payments from finance lease agreements that relate to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="6"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Note 29 provides additional disclosures related to contingent considerations. </div> </td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Other non-current assets</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Deferred compensation plans</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 414</div> </td> <td align="right" width="1%"></td> <td align="right" width="14%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 468</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Prepaid post-employment benefit plans</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 148</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 176</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 290</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other non-current assets</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 738</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 895</div> </td> <td align="right"></td> </tr> <tr> <td colspan="6" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfFinancialAndOtherNoncurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>288
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838806000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, plant and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">9. Property, plant and equipment</div> <div style="font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of property, plant and equipment during 2019: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Land </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Buildings </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Construction <br></br> in progress </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Machinery <br></br> and other <br></br> equipment </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 696</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 14&nbsp;135</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 2&nbsp;042</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 17&nbsp;155</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 34&nbsp;028</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;61</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;615</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;655</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2&nbsp;678</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;5&nbsp;009</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to right-of-use assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;127</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;23</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 44</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 57</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 332</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 630</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 6</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 112</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;001</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 355</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;474</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;75</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;551</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;774</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;3&nbsp;409</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 32</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;13</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 21</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 512</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 11&nbsp;463</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;350</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 13&nbsp;674</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 26&nbsp;999</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Accumulated depreciation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;43</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;6&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;11&nbsp;924</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;18&nbsp;332</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to discontinued operations <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 562</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;541</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;118</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassification to right-of-use assets <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 26</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on disposals and derecognitions <sup style="white-space: nowrap">&nbsp;6</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;170</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1&nbsp;674</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2&nbsp;846</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge <sup style="white-space: nowrap">&nbsp;7</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;447</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;898</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1&nbsp;345</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge <sup style="white-space: nowrap">&nbsp;8</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;10</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;51</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;34</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;205</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 3</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;33</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;43</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;20</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;5&nbsp;124</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;60</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;9&nbsp;726</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;14&nbsp;930</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2019</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 492</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 6&nbsp;339</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 1&nbsp;290</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 3&nbsp;948</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 12&nbsp;069</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Commitments for purchases of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 220</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Capitalized borrowing costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 4</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Represents the cost of assets and accumulated depreciation at January 1, 2019 related to the Alcon business reported as discontinued operations. Notes 1, 2 and 30 provide information related to discontinued operations. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Reclassification to right-of-use assets at January 1, 2019, upon adoption of IFRS 16 Leases. Refer to Notes 1 and 10 for additional disclosure. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Note 2 provides additional disclosures related to disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Reclassifications between various asset categories due to completion of plant and other equipment under construction </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Additions in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 23 million. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;6&nbsp;</sup> Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;7&nbsp;</sup> No depreciation charge in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 was recorded. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;8&nbsp;</sup> Impairments in the disposal group held for sale for the period from January 1, 2019, to December 31, 2019 were USD 2 million. </div> </td> </tr> </table> </div> <div style="padding-top:15px;font-family:arial,helvetica,sans-serif; font-size:10pt; color:#000000;text-align:justify; ">The following table summarizes the movements of property, plant and equipment during 2018: </div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br>(USD millions) </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Land </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Buildings </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> Construction <br></br> in progress </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> Machinery <br></br> and other <br></br> equipment </div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"> <br></br> <br></br> Total </div> </td> <td></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Cost</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right" width="1%"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 720</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;064</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;368</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 16&nbsp;858</div> </td> <td align="right" width="1%"></td> <td align="right" width="8%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;010</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Cost of assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;114</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;24</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;309</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impact of business combinations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 15</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 80</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 137</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reclassifications <sup style="white-space: nowrap">&nbsp;2</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 538</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;470</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 931</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Additions <sup style="white-space: nowrap">&nbsp;3</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;250</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 407</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1&nbsp;774</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Disposals and derecognitions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;7</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;212</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;21</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;457</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;697</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;291</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;76</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;504</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;887</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 696</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 14&nbsp;135</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;042</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 17&nbsp;155</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 34&nbsp;028</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"></div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#000000;">Accumulated depreciation</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-style:italic; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">January 1, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;40</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;5&nbsp;983</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;38</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;485</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;17&nbsp;546</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on assets related to disposal group held for sale <sup style="white-space: nowrap">&nbsp;1</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 56</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 4</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 101</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 161</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Depreciation charge <sup style="white-space: nowrap">&nbsp;5</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;574</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;140</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1&nbsp;717</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Accumulated depreciation on disposals and derecognitions <sup style="white-space: nowrap">&nbsp;4</sup> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 180</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 3</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 412</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 595</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;122</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;16</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;185</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;324</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Reversal of impairment charge</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 8</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 20</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency translation effects</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 115</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 2</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 361</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 479</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;43</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;6&nbsp;328</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;37</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;11&nbsp;924</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;18&nbsp;332</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value at December 31, 2018</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 653</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 7&nbsp;807</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 2&nbsp;005</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 5&nbsp;231</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 15&nbsp;696</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 3px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Net book value of property, plant and equipment under finance lease contracts</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 79</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Commitments for purchases of property, plant and equipment</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 289</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Capitalized borrowing costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 6</div> </td> <td align="right"></td> </tr> <tr> <td colspan="12" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom"> <td height="10px" colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;"></div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;1&nbsp;</sup> Note 2 provides additional disclosures related to disposal group held for sale. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;2&nbsp;</sup> Reclassifications between various asset categories due to completion of plant and other equipment under construction </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;3&nbsp;</sup> Additions in the disposal group held for sale were USD 21 million. </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;4&nbsp;</sup> Derecognition of assets that are no longer used and are not considered to have a significant disposal value or other alternative use </div> </td> </tr> <tr valign="bottom"> <td colspan="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;margin-left:10pt; text-indent:-10pt;"> <sup>&nbsp;5&nbsp;</sup> Depreciation charge in the disposal group held for sale for the period from January 1, 2018, to the date of reclassification to assets held for sale was USD 15 million. For depreciation charge related to discontinued operations, refer to Note 30. </div> </td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2019-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2019-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>289
<FILENAME>R182.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6874626928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 5) - Recurring fair value measurement [member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member] | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member] | Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member] | Total available-for-sale marketable securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member] | Time deposits with original maturity more than 90 days [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">2,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Marketable securities, time deposits and derivative financial instruments [member] | Accrued interest on debt securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Financial investments and long-term loans [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">2,518<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Financial investments and long-term loans [member] | Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Financial investments and long-term loans [member] | Available-for-sale financial investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">1,557<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Financial investments and long-term loans [member] | Contingent consideration receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Financial investments and long-term loans [member] | Long-term loans and receivables from customers and finance lease, advances, security deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Associated companies at fair value through profit and loss [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member] | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member] | Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member] | Total available-for-sale marketable securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 of fair value hierarchy [member] | Financial investments and long-term loans [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 of fair value hierarchy [member] | Financial investments and long-term loans [member] | Available-for-sale financial investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">976<span></span>
</td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member] | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member] | Total available-for-sale marketable securities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 of fair value hierarchy [member] | Marketable securities, time deposits and derivative financial instruments [member] | Derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Financial investments and long-term loans [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">1,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Financial investments and long-term loans [member] | Fund investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Financial investments and long-term loans [member] | Available-for-sale financial investments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Financial investments and long-term loans [member] | Contingent consideration receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">399<span></span>
</td>
<td class="nump">396<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 of fair value hierarchy [member] | Associated companies at fair value through profit and loss [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Valued at amortized cost [member] | Marketable securities, time deposits and derivative financial instruments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Valued at amortized cost [member] | Marketable securities, time deposits and derivative financial instruments [member] | Time deposits with original maturity more than 90 days [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">2,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Valued at amortized cost [member] | Marketable securities, time deposits and derivative financial instruments [member] | Accrued interest on debt securities and time deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Valued at amortized cost [member] | Financial investments and long-term loans [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Valued at amortized cost [member] | Financial investments and long-term loans [member] | Long-term loans and receivables from customers and finance lease, advances, security deposits [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">$ 329<span></span>
</td>
<td class="nump">$ 512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2019-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_TotalMarketableSecuritiesTimeDepositsAndDerivativeFinancialInstrumentsGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_FundInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_FundInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_TotalAvailableforsaleMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_TotalAvailableforsaleMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_TimeDepositsWithOriginalMaturityMoreThan90DaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_DerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_DerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_AccruedInterestOnDebtSecuritiesAndTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialInvestmentsAndLongtermLoansGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_FinancialInvestmentsAndLongtermLoansGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_AvailableforsaleFinancialInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_AvailableforsaleFinancialInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_ContingentConsiderationReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_ContingentConsiderationReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=nvs_LongtermLoansAndReceivablesFromCustomersAndFinanceLeaseAdvancesSecurityDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_GroupsOfFinancialAssetsLiabilitiesAxis=nvs_AssociatedCompaniesAtFairValueThroughProfitAndLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=nvs_ValuedAtAmortizedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=nvs_ValuedAtAmortizedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>290
<FILENAME>R172.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6850821056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity-based participation plans for associates (Details 4) - Select North America<br> Pure in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at beginning of period</a></td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">20.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at beginning of period</a></td>
<td class="nump">$ 60.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Number of share options exercised or sold</a></td>
<td class="num">(5.6)<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options exercised in share-based payment arrangement</a></td>
<td class="nump">$ 58.6<span></span>
</td>
<td class="nump">$ 57.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement at end of period</a></td>
<td class="nump">$ 61.9<span></span>
</td>
<td class="nump">$ 60.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Number of share options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options exercisable in share-based payment arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.9<span></span>
</td>
<td class="nump">$ 60.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years 3 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">$ 60.7<span></span>
</td>
<td class="nump">$ 60.7<span></span>
</td>
<td class="nump">$ 61.9<span></span>
</td>
<td class="nump">$ 60.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember', window );">54.5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember', window );">57.0</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember', window );">57.6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember', window );">66.0</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward', window );"><strong>Disclosure of number and weighted average exercise prices of share options [roll forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding at end of period</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract', window );"><strong>Disclosure of number and weighted average remaining contractual life of outstanding share options [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Number of share options outstanding in share-based payment arrangement</a></td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average remaining contractual life of outstanding share options</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding share options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exercise price of outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2019-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2019-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nvs_EquityBasedParticipationNovartisEquityPlanSelectNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice54.5Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice54.5Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.0Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.0Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice57.6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice66.0Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=nvs_ExercisePrice66.0Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>291
<FILENAME>R176.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6840386016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with related parties (Details 3)<br> $ in Millions</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>CHF (SFr)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation</a></td>
<td class="nump">$ 72.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NovartisPensionFundMember', window );">Novartis Pension Fund [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_BorrowingsCreditFacilityUncommitted', window );">Borrowings credit facility uncommitted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember', window );">Key management personnel of entity or parent [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation</a></td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_DrAlexKrauerMember', window );">Dr. Alex Krauer [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 60,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_DrDanielVasellaMember', window );">Dr. Daniel Vasella [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management personnel compensation | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 18,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 26,279<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2019-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_BorrowingsCreditFacilityUncommitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_BorrowingsCreditFacilityUncommitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NovartisPensionFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_NovartisPensionFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_DrAlexKrauerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_DrAlexKrauerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_DrDanielVasellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=nvs_DrDanielVasellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>292
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6865411456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest expense and other financial income and expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract', window );"><strong>Disclosure of Interest Expense and Other Financial Income and Expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInterestExpenseExplanatory', window );">Interest expense and other financial income and expense</a></td>
<td class="text"><div style="font-family:arial,helvetica,sans-serif; font-size:16pt; color:#000000; font-weight: bold; margin-bottom:20px;margin-top:30px;">5. Interest expense and&nbsp;other&nbsp;financial&nbsp;income&nbsp;and&nbsp;expense</div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Interest expense</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;714</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;877</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;741</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest expense on lease liabilities</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;66</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> </div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Expense arising from discounting long-term liabilities and capitalized borrowing costs</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;70</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;55</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;9</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total interest expense from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> &ndash;&nbsp;850</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;932</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> &ndash;&nbsp;750</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div> <div style="font-family:arial,helvetica,sans-serif; font-size:11pt; color:#000000; font-weight:bold;">Other financial income and expense</div> <div style="padding-top:10px; padding-bottom:30px;"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse" width="100%"> <tr valign="bottom"> <td height="12"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#000000;">(USD millions)</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; font-weight:bold; color:#000000;"> 2019</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2018</div> </td> <td></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:8pt; color:#666666;"> 2017</div> </td> <td></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Interest income</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 245</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 292</div> </td> <td align="right" width="1%"></td> <td align="right" width="11%"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 110</div> </td> <td align="right" width="1%"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Other financial income</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> 12</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> 1</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Financial expense</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;52</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;39</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;11</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 1px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;">Currency result, net</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#000000;"> &ndash;&nbsp;160</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;68</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; color:#666666;"> &ndash;&nbsp;58</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 2px;"></td> </tr> <tr valign="bottom" bgcolor="#ffffff"> <td height="16"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;">Total other financial income and expense from continuing operations</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#000000;"> 45</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 186</div> </td> <td align="right"></td> <td align="right"> <div style="font-family:arial,helvetica,sans-serif;font-size:10pt; font-weight:bold; color:#666666;"> 42</div> </td> <td align="right"></td> </tr> <tr> <td colspan="8" style="border-bottom: solid #000000 3px;"></td> </tr> </table> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInterestExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interest expense. [Refer: Interest expense]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2019-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2019-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2019-03-27<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInterestExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DisclosureOfInterestExpenseAndOtherFinancialIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>293
<FILENAME>R186.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3.a.u2</span><table class="report" border="0" cellspacing="2" id="idp6838640928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments - additional disclosures (Details 9) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities', window );">Potential outflows in various currencies - from financial derivative liabilities</a></td>
<td class="num">$ (6,390)<span></span>
</td>
<td class="num">$ (4,852)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets', window );">Potential inflows in various currencies - from financial derivative assets</a></td>
<td class="nump">6,385<span></span>
</td>
<td class="nump">4,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Not later than one month [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities', window );">Potential outflows in various currencies - from financial derivative liabilities</a></td>
<td class="num">(814)<span></span>
</td>
<td class="num">(1,305)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets', window );">Potential inflows in various currencies - from financial derivative assets</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">1,328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Later than one month and not later than three months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities', window );">Potential outflows in various currencies - from financial derivative liabilities</a></td>
<td class="num">(4,624)<span></span>
</td>
<td class="num">(2,949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets', window );">Potential inflows in various currencies - from financial derivative assets</a></td>
<td class="nump">4,656<span></span>
</td>
<td class="nump">2,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember', window );">Later than three month and not later than twelve months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems', window );"><strong>Derivative financial instruments and accrued interest on derivative financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities', window );">Potential outflows in various currencies - from financial derivative liabilities</a></td>
<td class="num">(952)<span></span>
</td>
<td class="num">(598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets', window );">Potential inflows in various currencies - from financial derivative assets</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="nump">$ 593<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_DerivativeFinancialInstrumentsAndAccruedInterestOnDerivativeFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PotentialInflowsInVariousCurrenciesFromFinancialDerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nvs_PotentialOutflowsInVariousCurrenciesFromFinancialDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=nvs_LaterThanThreeMonthAndNotLaterThanTwelveMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
